<SEC-DOCUMENT>0001292814-22-001951.txt : 20220429
<SEC-HEADER>0001292814-22-001951.hdr.sgml : 20220429
<ACCEPTANCE-DATETIME>20220429155910
ACCESSION NUMBER:		0001292814-22-001951
CONFORMED SUBMISSION TYPE:	20-F
PUBLIC DOCUMENT COUNT:		158
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220429
DATE AS OF CHANGE:		20220429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Afya Ltd
		CENTRAL INDEX KEY:			0001771007
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-EDUCATIONAL SERVICES [8200]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			E9
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		20-F
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38992
		FILM NUMBER:		22874993

	BUSINESS ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
		BUSINESS PHONE:		55 (31) 3515 7500

	MAIL ADDRESS:	
		STREET 1:		ALAMEDA OSCAR NIEMEYER, NO 119
		STREET 2:		SALA 504 VILA DA SERRA
		CITY:			NOVA LIMA, MINAS GERAIS
		STATE:			D5
		ZIP:			00000
</SEC-HEADER>
<DOCUMENT>
<TYPE>20-F
<SEQUENCE>1
<FILENAME>afyaform20f_2021.htm
<DESCRIPTION>20-F
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8"?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:afya="http://afya.com.br/20211231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
<!-- Field: Set; Name: xdx; ID: xdx_029_IFRS%2D2021_currency_srt -->
<!-- Field: Set; Name: xdx; ID: xdx_03A_afya_afya.com.br_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_046_20210101_20211231 -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityCentralIndexKey_0001771007 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05A_edei%2D%2DDocumentFiscalPeriodFocus_FY -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DDocumentFiscalYearFocus_2021 -->
<!-- Field: Set; Name: xdx; ID: xdx_051_edei%2D%2DCurrentFiscalYearEndDate_%2D%2DLS0xMi0zMQ== -->
<!-- Field: Set; Name: xdx; ID: xdx_056_edei%2D%2DEntityIncorporationStateCountryCode_D5 -->
<!-- Field: Set; Name: xdx; ID: xdx_055_edei%2D%2DDocumentTransitionReport_false -->
<!-- Field: Set; Name: xdx; ID: xdx_07F_XDX_C%2D%2D\Users\Toshio\Desktop\DIRECT\afya%2D20220429T185830Z%2D001\afyaform20f__2021.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_061_BRL_1_iso4217%2D%2DBRL -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_062_BRLPShares_3_iso4217%2D%2DBRL_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_069_Pure_4_xbrli%2D%2Dpure -->
<!-- Field: Set; Name: xdx; ID: xdx_06C_N_5_Number -->
<!-- Field: Set; Name: xdx; ID: xdx_060_USDPShares_0_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_066_USDBRL_0_iso4217%2D%2DUSD -->
<body>
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityCentralIndexKey">0001771007</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalPeriodFocus">FY</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentFiscalYearFocus">2021</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:CurrentFiscalYearEndDate">--12-31</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityIncorporationStateCountryCode">D5</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0045" name="dei:EntityCurrentReportingStatus">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0046" name="dei:EntityInteractiveDataCurrent">Yes</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0050" name="dei:DocumentAccountingStandard">International Financial Reporting Standards</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" contextRef="AsOf2021-12-31" id="xdx2ixbrl0084" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2020-12-31" id="xdx2ixbrl0193" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0262" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0263" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherComprehensiveIncome" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0264" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0304" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0308" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0313" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0314" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0315" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0316" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0317" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0318" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0324" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0325" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0326" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0327" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0328" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0329" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0336" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0337" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0338" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0339" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0340" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0341" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0343" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0348" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0349" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0350" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0351" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0352" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0359" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0360" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0361" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0362" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0363" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0365" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0370" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0372" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0373" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0374" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0376" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0379" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0381" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0382" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0383" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0385" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0386" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0387" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0388" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0390" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0391" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0392" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0393" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0394" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0395" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0401" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0402" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0403" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0404" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0405" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0407" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0409" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0414" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0418" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0419" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0420" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0421" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0425" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0426" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0427" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0428" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0429" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0431" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0434" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0436" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0437" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0438" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0439" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0440" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0442" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0447" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0449" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0450" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0456" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0457" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0458" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0459" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0460" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0461" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0467" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0468" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0469" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0470" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0471" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0472" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0478" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0480" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0481" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0482" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0483" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0484" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0486" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0489" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0491" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0492" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0493" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0494" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0495" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0497" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0500" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0502" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0503" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0504" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0505" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0506" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0508" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0511" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0512" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0513" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0514" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0515" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0516" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0517" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0518" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0522" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0524" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0526" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0527" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0528" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0530" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0535" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0537" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0538" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0544" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0545" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0546" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0547" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0548" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0549" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0555" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0556" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0557" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0558" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0559" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0560" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0566" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0568" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0569" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0570" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0571" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0572" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0574" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0577" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0578" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0580" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0581" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0582" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0583" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0585" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0588" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0591" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0592" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0593" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0594" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0596" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0599" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0602" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0603" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0604" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0605" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0607" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0610" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0611" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0612" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0614" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0615" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0616" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" id="xdx2ixbrl0618" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember" id="xdx2ixbrl0621" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" id="xdx2ixbrl0622" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" id="xdx2ixbrl0623" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" id="xdx2ixbrl0624" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0625" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0626" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" id="xdx2ixbrl0627" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" id="xdx2ixbrl0628" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OtherReservesMember" id="xdx2ixbrl0636" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_custom_RetainedEarningsReserveMember" id="xdx2ixbrl0637" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0660" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0664" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0665" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0679" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0760" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0761" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaymentsOfNotesPayable" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0773" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:CashAdvancesAndLoansFromRelatedParties" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0779" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:CashAdvancesAndLoansFromRelatedParties" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0780" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0804" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TreasuryShares1" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0805" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalIncreaseOfFinancialActivities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0807" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0815" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:SharebasedCompensationPlanReceipts" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl0820" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:SharebasedCompensationPlanReceipts" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl0821" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0823" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_BuildingsMember" id="xdx2ixbrl1237" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P25Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MachineryAndEquipmentsMember" id="xdx2ixbrl1238" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P10Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_VehiclesMember" id="xdx2ixbrl1239" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P4Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl1240" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P10Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ItEquipmentMember" id="xdx2ixbrl1241" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LibraryBooksMember" id="xdx2ixbrl1242" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P10Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl1243" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P10Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl1244" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1248" name="afya:ContractualLeaseTerm">P1Y</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1306" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1328" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1335" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1339" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1340" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1342" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1349" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1419" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1423" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1424" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" id="xdx2ixbrl1428" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1448" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1452" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1453" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1454" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1455" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1456" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1459" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1460" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1461" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1462" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1463" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1466" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1467" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1468" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1469" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1470" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1473" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1474" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1475" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1476" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1477" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1480" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1481" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1482" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1483" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1484" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1487" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1488" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1489" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1490" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1491" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1494" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1495" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1496" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1497" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1498" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="xdx2ixbrl1501" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="xdx2ixbrl1502" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="xdx2ixbrl1503" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="xdx2ixbrl1504" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" id="xdx2ixbrl1505" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1614" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1615" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1616" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1617" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" id="xdx2ixbrl1618" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1619" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1621" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1623" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1626" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-11-09_custom_IClinicMember" id="xdx2ixbrl1631" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1632" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1633" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1634" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1635" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" id="xdx2ixbrl1636" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1641" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1642" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1648" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1650" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1651" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1656" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1657" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1658" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1659" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1666" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1672" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1673" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1674" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1675" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1678" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1697" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" id="xdx2ixbrl1704" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1705" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1708" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1711" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1729" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1730" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1731" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1732" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1735" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1737" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1738" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1739" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1740" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1745" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1751" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" id="xdx2ixbrl1752" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1753" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1754" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1755" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1756" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" id="xdx2ixbrl1759" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" id="xdx2ixbrl1801" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1806" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1807" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-11-09_custom_IClinicMember" id="xdx2ixbrl1809" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1810" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1811" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="xdx2ixbrl1812" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1814" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="xdx2ixbrl1818" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="xdx2ixbrl1819" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-11-03_custom_ShospMember" id="xdx2ixbrl1821" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1822" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" id="xdx2ixbrl1823" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl1990" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl1992" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" id="xdx2ixbrl1996" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2000" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2002" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2004" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2006" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2012" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2014" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2016" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2018" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2040" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2042" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2050" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2052" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2064" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2100" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2108" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2112" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2114" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2122" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2124" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2136" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2160" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2162" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2172" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" id="xdx2ixbrl2176" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2180" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2182" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2184" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2186" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" id="xdx2ixbrl2188" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2192" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2194" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2198" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" id="xdx2ixbrl2264" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" id="xdx2ixbrl2272" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" id="xdx2ixbrl2274" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" id="xdx2ixbrl2278" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" id="xdx2ixbrl2280" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" id="xdx2ixbrl2282" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CreditsWithShareholdersRelatedPartyTransactions" contextRef="AsOf2021-12-31" id="xdx2ixbrl2509" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2021-12-31" id="xdx2ixbrl2518" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AccountsPayableToSellingShareholders" contextRef="AsOf2020-12-31" id="xdx2ixbrl2522" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2020-12-31" id="xdx2ixbrl2525" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AccountsPayableCurrent1" contextRef="AsOf2020-12-31" id="xdx2ixbrl2528" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NoncurrentPayablesToRelatedParties1" contextRef="AsOf2020-12-31" id="xdx2ixbrl2531" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member" id="xdx2ixbrl2563" name="afya:OperatingLeaseTermOfContract">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member" id="xdx2ixbrl2567" name="afya:LesseeFinancesLeaseRenewalTerm">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member" id="xdx2ixbrl2569" name="afya:LesseeFinancesLeaseRenewalTerm">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" id="xdx2ixbrl2583" name="afya:LesseeFinancesLeaseRenewalTerm">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="xdx2ixbrl2595" name="afya:OperatingLeaseTermOfContract">P20Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" id="xdx2ixbrl2597" name="afya:LesseeFinancesLeaseRenewalTerm">P20Y</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2018-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2720" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:MinorityInterestOfAcquiree" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2722" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:MinorityInterestOfAcquiree" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2723" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdditionalMinorityInterestOfAcquiree" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2726" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:AdditionalMinorityInterestOfAcquiree" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2727" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2735" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" id="xdx2ixbrl2736" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2750" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2762" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2774" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="xdx2ixbrl2775" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2776" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2777" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2778" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2780" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2781" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2782" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2783" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2786" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2788" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2798" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2810" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2813" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2817" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2829" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2836" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2837" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2840" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2844" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2853" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2865" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2870" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2872" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2877" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2884" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2889" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" id="xdx2ixbrl2896" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2897" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="xdx2ixbrl2900" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2901" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl2904" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2913" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2918" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2920" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2927" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2930" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2932" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2933" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2939" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2942" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="xdx2ixbrl2943" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2944" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2945" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2946" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2948" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2949" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2950" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2951" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2954" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2956" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2963" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2966" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2968" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2975" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2978" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2980" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="xdx2ixbrl2981" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="xdx2ixbrl2982" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="xdx2ixbrl2983" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="xdx2ixbrl2984" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="xdx2ixbrl2986" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2987" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl2988" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl2990" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl2992" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl2997" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl2999" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl3004" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl3009" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl3011" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" id="xdx2ixbrl3014" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl3016" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl3021" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl3023" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember" id="xdx2ixbrl3028" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl3033" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember" id="xdx2ixbrl3035" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl3045" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_custom_LaboratoriesAndClinicsMember" id="xdx2ixbrl3057" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3071" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3077" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3079" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3122" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3172" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3175" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3180" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3181" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3182" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3183" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3185" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="xdx2ixbrl3186" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3227" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3229" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3231" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3237" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3239" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3241" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3243" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3255" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3257" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3267" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3271" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3284" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3286" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3300" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3303" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3304" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3311" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3313" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3314" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3315" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3316" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3318" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3319" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3321" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3324" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3326" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="xdx2ixbrl3340" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="xdx2ixbrl3439" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" id="xdx2ixbrl3460" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3465" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" id="xdx2ixbrl3523" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" id="xdx2ixbrl3527" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember" id="xdx2ixbrl3531" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember" id="xdx2ixbrl3542" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CustomerRelationshipsMedicineMember" id="xdx2ixbrl3554" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P6Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CustomerRelationshipsOtherCoursesMember" id="xdx2ixbrl3556" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P4Y6M</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember" id="xdx2ixbrl3558" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_EducationContentMember" id="xdx2ixbrl3560" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P3Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember" id="xdx2ixbrl3562" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P2Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember" id="xdx2ixbrl3564" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P30Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" id="xdx2ixbrl3566" name="ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">P5Y</ix:nonNumeric>
  <ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" id="xdx2ixbrl3576" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentyOneMember" id="xdx2ixbrl3651" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentyFourMember" id="xdx2ixbrl3660" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_BottomOfRangeMember" id="xdx2ixbrl3725" name="afya:ContractualLeaseTerm">P5Y</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_TopOfRangeMember" id="xdx2ixbrl3727" name="afya:ContractualLeaseTerm">P30Y</ix:nonNumeric>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl3749" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl3751" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfLeaseLiabilities" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl3755" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:DepreciationExpenseLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl3781" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsInterestExpense" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl3783" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsPaymentsOfLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl3787" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2020-12-31" id="xdx2ixbrl3799" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:RightofuseAssetsCurrent" contextRef="AsOf2021-12-31" id="xdx2ixbrl3807" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" id="xdx2ixbrl3823" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" id="xdx2ixbrl3835" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_FESARMember" id="xdx2ixbrl3851" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_MedPhoneMember" id="xdx2ixbrl3855" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:CompensationOfLegalProceedingsDisbursement" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" id="xdx2ixbrl3915" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2019-12-31" id="xdx2ixbrl4011" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_custom_RestrictedCashMember" id="xdx2ixbrl4039" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2021-12-31_custom_RestrictedCashMember" id="xdx2ixbrl4041" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="xdx2ixbrl4224" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4226" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4228" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4258" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4266" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4268" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="xdx2ixbrl4274" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4276" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4278" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="xdx2ixbrl4294" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4296" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4298" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4328" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4336" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NotePayables" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4338" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" id="xdx2ixbrl4344" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" id="xdx2ixbrl4346" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" id="xdx2ixbrl4348" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" id="xdx2ixbrl4372" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_custom_DividendsPayableMember" id="xdx2ixbrl4398" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl4408" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_custom_DividendsPayableMember" id="xdx2ixbrl4450" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" id="xdx2ixbrl4480" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember" id="xdx2ixbrl4494" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2021-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" id="xdx2ixbrl4531" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2021-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl4533" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2020-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" id="xdx2ixbrl4548" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2020-12-31_ifrs-full_Level3OfFairValueHierarchyMember" id="xdx2ixbrl4550" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2021-12-31" id="xdx2ixbrl4591" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-12-31_custom_ModifiedPlanMember" id="xdx2ixbrl4611" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74</ix:nonFraction>
  <ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-12-31_custom_OriginalPlanMember" id="xdx2ixbrl4612" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99</ix:nonFraction>
  <ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2021-12-31" id="xdx2ixbrl4763" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">17000</ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" id="xdx2ixbrl4945" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" id="xdx2ixbrl4946" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" id="xdx2ixbrl4968" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ChangesInFairValueOfDerivativeInstruments" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl5130" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ChangesInFairValueOfDerivativeInstruments" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl5132" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl5138" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl5139" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ChangeInFairValueOfDerivativeInstruments" contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl5150" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:ChangeInFairValueOfDerivativeInstruments" contextRef="From2020-01-012020-12-31" id="xdx2ixbrl5151" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl5172" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2019-01-012019-12-31" id="xdx2ixbrl5228" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5255" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5263" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5271" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5278" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5284" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  <ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" id="xdx2ixbrl5307" unitRef="BRL" xs:nil="true"></ix:nonFraction>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="afya-20211231.xsd" xlink:type="simple" />
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2021-01-01to2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_dei_BusinessContactMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_IssuedCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TreasurySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OtherReservesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RetainedEarningsReserveMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_RetainedEarningsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-29_custom_GuardayaEmpreendimentosAndParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GuardayaEmpreendimentosAndParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-29</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-272019-03-29_custom_MedcelEditoraAndCBBWebMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraAndCBBWebMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-27</xbrli:startDate>
        <xbrli:endDate>2019-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-272019-03-29_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-27</xbrli:startDate>
        <xbrli:endDate>2019-03-29</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-162019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-16</xbrli:startDate>
        <xbrli:endDate>2019-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-072019-07-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-07</xbrli:startDate>
        <xbrli:endDate>2019-07-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-18_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-18</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-23_custom_UnderwritersMember_custom_OverAllotmentsMember_custom_ClassACommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:OverAllotmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-23_custom_ClassACommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-22</xbrli:startDate>
        <xbrli:endDate>2019-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-22</xbrli:startDate>
        <xbrli:endDate>2019-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-02-06</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-05</xbrli:startDate>
        <xbrli:endDate>2020-02-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-02-05</xbrli:startDate>
        <xbrli:endDate>2020-02-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-03-10</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-09</xbrli:startDate>
        <xbrli:endDate>2020-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-09</xbrli:startDate>
        <xbrli:endDate>2020-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-03-09</xbrli:startDate>
        <xbrli:endDate>2020-03-10</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-25_custom_MedcelEditoraAndCBBWebMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraAndCBBWebMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-08_custom_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-16_custom_CliquefarmaDrogariasOnlineLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13_custom_ShospTecnologiadaInformacaoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiadaInformacaoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-01_custom_SociedadePadraodeEducacaoSuperiorLtdMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraodeEducacaoSuperiorLtdMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-01_custom_RXPROSolucoesdeTecnologiaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesdeTecnologiaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AfyaParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeDoAcoSAUNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeDoAcoSAUNIVACOMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEEventosSAMedcelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MedcelEditoraEEventosSAMedcelMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEEventosSAMedcelMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAUniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAUniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaUniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaUniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsSAMedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsSAMedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaCliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaCliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtdaShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtdaShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtdaSOCIESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtdaSOCIESPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtdaRXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtdaRXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtdaRXPROLOGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtdaRXPROLOGMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_HarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UNIFIPMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UNIGRANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_PEBMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-05_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_SociedadeUniversitariaFipmocSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-05_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_SociedadeUniversitariaGranarioSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_SociedadeUniversitariaFipmocSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-302020-01-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-30</xbrli:startDate>
        <xbrli:endDate>2020-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-21_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-21</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-192021-01-21_custom_IClinicMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-19</xbrli:startDate>
        <xbrli:endDate>2021-01-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-25_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25_custom_MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-01_custom_HarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-062021-04-08_custom_HarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-06</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-062021-04-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-06</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-16_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-142021-04-16_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-14</xbrli:startDate>
        <xbrli:endDate>2021-04-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-112021-05-13_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-11</xbrli:startDate>
        <xbrli:endDate>2021-05-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_UNIFIPMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30_custom_UNIFIPMocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-08-04_custom_UNIGRANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-08-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-022021-08-04_custom_UNIGRANMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-02</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-01_custom_PXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-09-282020-10-01_custom_PXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-09-28</xbrli:startDate>
        <xbrli:endDate>2020-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-282020-01-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-28</xbrli:startDate>
        <xbrli:endDate>2020-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-05_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-032020-05-05_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-03</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-032020-05-05_custom_PEBMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-03</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-20_custom_PEBMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-182020-07-20_custom_PEBMEDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-18</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-01_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-01_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-09_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-072020-11-09_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-07</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-192021-01-21_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-19</xbrli:startDate>
        <xbrli:endDate>2021-01-21</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-142021-04-16_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-14</xbrli:startDate>
        <xbrli:endDate>2021-04-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-112021-03-13_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-11</xbrli:startDate>
        <xbrli:endDate>2021-03-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-03</xbrli:startDate>
        <xbrli:endDate>2020-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-08-03</xbrli:startDate>
        <xbrli:endDate>2020-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_LicencesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-30</xbrli:startDate>
        <xbrli:endDate>2020-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-032020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-03</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-07-19</xbrli:startDate>
        <xbrli:endDate>2020-07-20</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-03</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-02</xbrli:startDate>
        <xbrli:endDate>2020-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-11-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-05-04</xbrli:startDate>
        <xbrli:endDate>2020-05-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-11-082020-12-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-11-08</xbrli:startDate>
        <xbrli:endDate>2020-12-09</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_BankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_InterbankCertificatesOfDepositMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:InterbankCertificatesOfDepositMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_USDMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TuitionFeesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FIESMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalCreditsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MobileAppSubscriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OthersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LaterThanOneEightyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LaterThanOneEightyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_UEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-09-05</xbrli:startDate>
        <xbrli:endDate>2018-09-06</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-10-292019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-10-29</xbrli:startDate>
        <xbrli:endDate>2019-10-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-23</xbrli:startDate>
        <xbrli:endDate>2018-04-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AssociatesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BuildingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MachineryAndEquipmentsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LandMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_VehiclesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_FixturesAndFittingsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ItEquipmentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LibraryBooksMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LaboratoriesAndClinicsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LeaseholdImprovementsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ConstructionInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EducationalPlatformAndSoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformAndSoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_BrandNamesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_EducationalPlatformMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_SoftwareInProgressMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MocMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CustomerRelationshipsMedicineMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsMedicineMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_CustomerRelationshipsOtherCoursesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_EducationContentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwentyTwentyThreeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwentyTwentyOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwentyTwentyFourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_TwentyTwentySevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentySixMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFour1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_TwentyTwentyFour1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFour1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-01_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-01_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-05-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-07-03_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-07-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-20_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-20</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-07-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-07-22</xbrli:startDate>
        <xbrli:endDate>2019-07-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-12-222020-12-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-12-22</xbrli:startDate>
        <xbrli:endDate>2020-12-23</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-10-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-10-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30_custom_FinanciadoradeEstudoseProjetosFINEPMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-242021-04-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-24</xbrli:startDate>
        <xbrli:endDate>2021-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_CurrencyRiskMember_currency_EUR">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_FESARMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MedPhoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_MedPhoneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MedicinaeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_MedicalHarbourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_CliquefarmaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ShospMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_UnigranrioMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RXPROMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_GuaranhunsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-01-012018-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-01-01</xbrli:startDate>
        <xbrli:endDate>2018-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-05-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-04-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-08-13_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-08-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UniRedentorMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-01-31_custom_UniRedentorMember1110236375">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-05-05_custom_UniSLMember1110236484">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-05-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-09_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-09</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-03">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-03</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-11-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-11-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-05_custom_UniSLMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-25</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-082021-04-08_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-08</xbrli:startDate>
        <xbrli:endDate>2021-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-08_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-162021-04-16_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-16</xbrli:startDate>
        <xbrli:endDate>2021-04-16</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-16_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-16">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-16</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-05-132021-05-13_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-05-13</xbrli:startDate>
        <xbrli:endDate>2021-05-13</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-05-13_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-05-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-08-022021-08-04_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-08-02</xbrli:startDate>
        <xbrli:endDate>2021-08-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-04">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-10-012021-10-01_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-10-01</xbrli:startDate>
        <xbrli:endDate>2021-10-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-01_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-11-01</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-032021-11-05_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-03</xbrli:startDate>
        <xbrli:endDate>2021-11-05</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-05_custom_FCMPBMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-05</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_RestrictedCashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:RestrictedCashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_RestrictedCashMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:RestrictedCashMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_TradeReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_TradeReceivablesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsOneMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_ForeignCurrencyExposuresMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_IncreaseForeignCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_DecreaseForeignCurrencyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_LoansAndFinancingMember1110241046">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember1110241156">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_LoansAndFinancingMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_DividendsPayableMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-232021-01-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-23</xbrli:startDate>
        <xbrli:endDate>2021-01-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-232021-03-25">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-23</xbrli:startDate>
        <xbrli:endDate>2021-03-25</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-232021-04-26">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-23</xbrli:startDate>
        <xbrli:endDate>2021-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-01">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-01</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_ShareBasedCompensationPlansMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_ModifiedPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OriginalPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ModifiedPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OriginalPlanMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-01-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-03-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-04-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-06-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-11-30</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-30">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-01-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-04-01</xbrli:startDate>
        <xbrli:endDate>2021-04-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-06-01</xbrli:startDate>
        <xbrli:endDate>2021-06-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-11-01</xbrli:startDate>
        <xbrli:endDate>2021-11-30</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-03-01</xbrli:startDate>
        <xbrli:endDate>2021-03-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_ClassBOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassAPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ClassBPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-242018-04-26_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-24</xbrli:startDate>
        <xbrli:endDate>2018-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-04-26_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-04-232018-04-26_custom_ClassAPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-04-23</xbrli:startDate>
        <xbrli:endDate>2018-04-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-04-26_custom_ClassAPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-04-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-08-252018-08-26_custom_ClassBPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-08-25</xbrli:startDate>
        <xbrli:endDate>2018-08-26</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-08-26_custom_ClassBPreferenceSharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-08-26</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2018-12-022018-12-04_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2018-12-02</xbrli:startDate>
        <xbrli:endDate>2018-12-04</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-04_ifrs-full_OrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-04</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-062019-03-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-06</xbrli:startDate>
        <xbrli:endDate>2019-03-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-04-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-04-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-08</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-102019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-10</xbrli:startDate>
        <xbrli:endDate>2019-03-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-03-12</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-03-112019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-03-11</xbrli:startDate>
        <xbrli:endDate>2019-03-12</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-06-152019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAUEPCMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAUEPCMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-06-15</xbrli:startDate>
        <xbrli:endDate>2019-06-18</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-06-13">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-06-13</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-23_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-23</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-10-27_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-10-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_custom_SegmentOfBusinessOneUnitMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:SegmentOfBusinessOneUnitMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_UndergradMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_ContinuingEducationMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_custom_DigitalServicesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2018-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2019-01-01</xbrli:startDate>
        <xbrli:endDate>2019-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2020-01-01</xbrli:startDate>
        <xbrli:endDate>2020-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2021-01-01</xbrli:startDate>
        <xbrli:endDate>2021-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2019-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2021-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2020-12-31</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-01-27_custom_ClassAOrdinarySharesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-01-27</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-02-24_custom_IClinicParticipacoesSAMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicParticipacoesSAMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-02-24</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-07_custom_ClassBOrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="AsOf2022-03-07_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001771007</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:instant>2022-03-07</xbrli:instant>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="BRL">
      <xbrli:measure>iso4217:BRL</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="BRLPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:BRL</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Pure">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="N">
      <xbrli:measure>afya:Number</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="USDBRL">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact001345" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001346" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001347" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001348" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1349" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001350" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001402" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001403" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001404" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001405" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="Fact001406" toRefs="Footnote001407"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1806" toRefs="Footnote002319"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1801" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="Fact001802" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="Fact001803" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="Fact001804" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="Fact001805" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl1807" toRefs="Footnote002320"></ix:relationship>
  <ix:relationship fromRefs="Fact002441" toRefs="Footnote002465"></ix:relationship>
  <ix:relationship fromRefs="Fact002442" toRefs="Footnote002465"></ix:relationship>
  <ix:relationship fromRefs="Fact002447" toRefs="Footnote002466"></ix:relationship>
  <ix:relationship fromRefs="Fact002448" toRefs="Footnote002466"></ix:relationship>
  <ix:relationship fromRefs="Fact002506" toRefs="Footnote002559"></ix:relationship>
  <ix:relationship fromRefs="Fact002507" toRefs="Footnote002559"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl2509" toRefs="Footnote002560"></ix:relationship>
  <ix:relationship fromRefs="Fact002510" toRefs="Footnote002560"></ix:relationship>
  <ix:relationship fromRefs="Fact002521" toRefs="Footnote002561"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl2522" toRefs="Footnote002561"></ix:relationship>
  <ix:relationship fromRefs="Fact002633" toRefs="Footnote002656"></ix:relationship>
  <ix:relationship fromRefs="Fact002634" toRefs="Footnote002656"></ix:relationship>
  <ix:relationship fromRefs="Fact002882" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002883" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl2884" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002885" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002886" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002887" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002888" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl2889" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002890" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002891" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact002892" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3014" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003015" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3016" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003017" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003018" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003019" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003020" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3021" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003022" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3023" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="Fact003024" toRefs="Footnote003061"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3180" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3181" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3182" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3183" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="Fact003184" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3185" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3186" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="Fact003187" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="Fact003188" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="Fact003189" toRefs="Footnote003373"></ix:relationship>
  <ix:relationship fromRefs="Fact003087" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003089" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003091" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003092" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003093" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003094" toRefs="Footnote003374 Footnote003375"></ix:relationship>
  <ix:relationship fromRefs="Fact003171" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3172" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003173" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003174" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3175" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003176" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003177" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003178" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003179" toRefs="Footnote003376"></ix:relationship>
  <ix:relationship fromRefs="Fact003443" toRefs="Footnote003544"></ix:relationship>
  <ix:relationship fromRefs="Fact003635" toRefs="Footnote003696"></ix:relationship>
  <ix:relationship fromRefs="Fact003637" toRefs="Footnote003696"></ix:relationship>
  <ix:relationship fromRefs="Fact003639" toRefs="Footnote003696"></ix:relationship>
  <ix:relationship fromRefs="Fact003641" toRefs="Footnote003696"></ix:relationship>
  <ix:relationship fromRefs="Fact003643" toRefs="Footnote003696"></ix:relationship>
  <ix:relationship fromRefs="Fact003645" toRefs="Footnote003699"></ix:relationship>
  <ix:relationship fromRefs="Fact003647" toRefs="Footnote003699"></ix:relationship>
  <ix:relationship fromRefs="Fact003649" toRefs="Footnote003699"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3651" toRefs="Footnote003699"></ix:relationship>
  <ix:relationship fromRefs="Fact003653" toRefs="Footnote003699"></ix:relationship>
  <ix:relationship fromRefs="Fact003654" toRefs="Footnote003702"></ix:relationship>
  <ix:relationship fromRefs="Fact003656" toRefs="Footnote003702"></ix:relationship>
  <ix:relationship fromRefs="Fact003658" toRefs="Footnote003702"></ix:relationship>
  <ix:relationship fromRefs="xdx2ixbrl3660" toRefs="Footnote003702"></ix:relationship>
  <ix:relationship fromRefs="Fact003662" toRefs="Footnote003702"></ix:relationship>
  <ix:relationship fromRefs="Fact003663" toRefs="Footnote003704"></ix:relationship>
  <ix:relationship fromRefs="Fact003665" toRefs="Footnote003704"></ix:relationship>
  <ix:relationship fromRefs="Fact003667" toRefs="Footnote003704"></ix:relationship>
  <ix:relationship fromRefs="Fact003669" toRefs="Footnote003704"></ix:relationship>
  <ix:relationship fromRefs="Fact003671" toRefs="Footnote003704"></ix:relationship>
  <ix:relationship fromRefs="Fact003678" toRefs="Footnote003711"></ix:relationship>
  <ix:relationship fromRefs="Fact003680" toRefs="Footnote003711"></ix:relationship>
  <ix:relationship fromRefs="Fact003682" toRefs="Footnote003711"></ix:relationship>
  <ix:relationship fromRefs="Fact003683" toRefs="Footnote003711"></ix:relationship>
  <ix:relationship fromRefs="Fact003672" toRefs="Footnote003716"></ix:relationship>
  <ix:relationship fromRefs="Fact003674" toRefs="Footnote003716"></ix:relationship>
  <ix:relationship fromRefs="Fact003676" toRefs="Footnote003716"></ix:relationship>
  <ix:relationship fromRefs="Fact003677" toRefs="Footnote003716"></ix:relationship>
  <ix:relationship fromRefs="Fact004884" toRefs="Footnote004931"></ix:relationship>
  <ix:relationship fromRefs="Fact004885" toRefs="Footnote004931"></ix:relationship>
  <ix:relationship fromRefs="Fact004886" toRefs="Footnote004931"></ix:relationship>
  <ix:relationship fromRefs="Fact005214" toRefs="Footnote005241"></ix:relationship>
  <ix:relationship fromRefs="Fact005215" toRefs="Footnote005241"></ix:relationship>
  <ix:relationship fromRefs="Fact005216" toRefs="Footnote005241"></ix:relationship>
  <ix:relationship fromRefs="Fact005222" toRefs="Footnote005242"></ix:relationship>
  <ix:relationship fromRefs="Fact005223" toRefs="Footnote005242"></ix:relationship>
  <ix:relationship fromRefs="Fact005224" toRefs="Footnote005242"></ix:relationship>
  <ix:relationship fromRefs="Fact005319" toRefs="Footnote005332"></ix:relationship>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<!-- Field: Rule-Page --><div style="margin-top: 1pt; margin-bottom: 1pt; width: 100%"><div style="border-top: Black 3.5pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 14pt Times New Roman, Times, Serif; margin: 0; text-align: center">UNITED STATES<br />
SECURITIES AND EXCHANGE COMMISSION</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Washington, D.C. 20549</p>

<!-- Field: Rule-Page --><div style="margin: 1pt 3in"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 16pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>FORM <span id="xdx_905_edei--DocumentType_c20210101__20211231_z5pVt5daJEBj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:DocumentType">20-F</ix:nonNumeric></span></b></p>

<p style="font: 8pt Times New Roman, Times, Serif; margin: 0 0 6pt">(Mark One)</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 12pt"><span id="xdx_90F_edei--DocumentRegistrationStatement_c20210101__20211231_z8htZ2BCDnsi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentRegistrationStatement">&#9744;</ix:nonNumeric></span></span></td><td><b>REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES<br />
EXCHANGE ACT OF 1934 </b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 12pt"><span id="xdx_902_edei--DocumentAnnualReport_c20210101__20211231_zVVoZYgijxYf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:DocumentAnnualReport">&#9746;</ix:nonNumeric></span></span></td><td><b>ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br />
ACT OF 1934<br />
For the fiscal year ended <span id="xdx_90A_edei--DocumentPeriodEndDate_dd_c20210101__20211231_zZvGUuvx7ek6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate">December 31, 2021</ix:nonNumeric></span></b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 12pt"><span id="xdx_90E_edei--DocumentTransitionReport_c20210101__20211231_zshLjFcN7fLi"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentTransitionReport">&#9744;</ix:nonNumeric></span></span></td><td><b>TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE<br />
ACT OF 1934</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>OR</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 6pt"><tr style="vertical-align: top">
<td style="width: 0.25in"></td><td style="width: 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 12pt"><span id="xdx_90D_edei--DocumentShellCompanyReport_c20210101__20211231_zJLqdmEh8AFh"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:DocumentShellCompanyReport">&#9744;</ix:nonNumeric></span></span></td><td><b>SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES<br />
EXCHANGE ACT OF 1934<br />
Date of event requiring this shell company report</b></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 1.5in; text-indent: -0.5in"><b>For the transition period from to .</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">Commission file number: <span id="xdx_904_edei--EntityFileNumber_c20210101__20211231_zkGKgT1UJee7"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityFileNumber">001-38992</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 16pt"><b><span id="xdx_90C_edei--EntityRegistrantName_c20210101__20211231_zU1yC80igOQf"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityRegistrantName">AFYA LIMITED</ix:nonNumeric></span><br />
</b></span><span style="font-size: 9pt">(Exact name of Registrant as specified in its charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">N/A<br />
<span style="font-size: 9pt">(Translation of Registrant&#8217;s name into English)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 12pt"><b>The Cayman
Islands</b></span><span style="font-size: 8pt"><br />
</span><span style="font-size: 9pt">(Jurisdiction of incorporation or organization)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_90B_edei--EntityAddressAddressLine1_c20210101__20211231_zols6QkqMdt2"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine1">Alameda Oscar
Niemeyer</ix:nonNumeric></span>, <span id="xdx_909_edei--EntityAddressAddressLine2_c20210101__20211231_zCxjtry5tdui"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressAddressLine2">No. 119</ix:nonNumeric></span>, Room 504 <br />
Vila da Serra, <span id="xdx_906_edei--EntityAddressCityOrTown_c20210101__20211231_zRE78v8jywBj"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityAddressCityOrTown">Nova Lima
Minas Gerais</ix:nonNumeric></span> &#8211; MG, <span id="xdx_90A_edei--EntityAddressCountry_c20210101__20211231_ztbvHkPpAd7l"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br />
</b></span><span style="font-size: 9pt">(Address of principal executive offices)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center"><span style="font-size: 12pt"><b><span id="xdx_90C_edei--ContactPersonnelName_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zAe00j1jo4a7"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:ContactPersonnelName">Virgilio Deloy
Capobianco Gibbon</ix:nonNumeric></span><br />
Chief Executive Officer<br />
Tel.: +<span id="xdx_900_edei--CityAreaCode_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zAaBfJ0weQW7"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:CityAreaCode">55</ix:nonNumeric></span> (31) <span id="xdx_90A_edei--LocalPhoneNumber_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zwvwgwOwGtHj"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:LocalPhoneNumber">3515-7550</ix:nonNumeric></span> Email: <span id="xdx_90F_edei--ContactPersonnelEmailAddress_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zPLVOVqfcXka"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:ContactPersonnelEmailAddress">ir@afya.com.br</ix:nonNumeric></span><br />
<span id="xdx_90B_edei--EntityAddressAddressLine1_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_z2B8xAN0CsW9"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine1">Alameda Oscar Niemeyer</ix:nonNumeric></span>, <span id="xdx_900_edei--EntityAddressAddressLine2_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zjYccNaEYBod"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:EntityAddressAddressLine2">No. 119</ix:nonNumeric></span>, Room 504<br />
Vila da Serra, Nova Lima, <span id="xdx_90C_edei--EntityAddressCityOrTown_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zYfv4YQki7uj"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" name="dei:EntityAddressCityOrTown">Minas Gerais</ix:nonNumeric></span><br />
<span id="xdx_90F_edei--EntityAddressCountry_c20210101__20211231__dei--EntityAddressesAddressTypeAxis__dei--BusinessContactMember_zqwPMyvNM8a9"><ix:nonNumeric contextRef="From2021-01-012021-12-31_dei_BusinessContactMember" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry">Brazil</ix:nonNumeric></span><br />
</b></span><span style="font-size: 9pt">(Name, Telephone, E-mail and/or Facsimile number and Address of Company Contact Person)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Securities registered or to be registered pursuant
to Section 12(b) of the Act:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Title
    of each class</p></td>
    <td style="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Trading
    Symbol(s)</p></td>
    <td style="width: 33%; padding-right: 2.9pt; padding-left: 2.9pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center">Name
    of each exchange on which registered</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span id="xdx_90D_edei--Security12bTitle_c20210101__20211231_z3UAZITmcuv"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:Security12bTitle">Class A common shares</ix:nonNumeric></span>, par value US$0.00005 per share</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span id="xdx_905_edei--TradingSymbol_c20210101__20211231_zfR87LbCYan2"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:TradingSymbol">AFYA</ix:nonNumeric></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center"><span id="xdx_90A_edei--SecurityExchangeName_c20210101__20211231_zy7DhTSSIzzd"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:exchnameen" name="dei:SecurityExchangeName">Nasdaq</ix:nonNumeric></span> Global Select Market</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Securities registered or to be registered pursuant
to Section 12(g) of the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Securities for which there is a reporting obligation
pursuant to Section 15(d) of the Act:</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><b>None</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate the number of outstanding shares of each of the issuer&#8217;s
classes of capital or common stock as of the close of the period covered by the annual report.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in">The number of outstanding shares as of December 31, 2021 was
<span id="xdx_900_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zbmgtfoKIQ2i"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">46,265,141</ix:nonFraction></span> Class A common shares and <span id="xdx_906_edei--EntityCommonStockSharesOutstanding_iI_pid_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_ztzS4We2YtBh"><ix:nonFraction name="dei:EntityCommonStockSharesOutstanding" contextRef="AsOf2021-12-31_custom_ClassBOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,802,763</ix:nonFraction></span> Class B common shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark if the registrant is a well-known seasoned
issuer, as defined in Rule 405 of the Securities Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="xdx_90E_edei--EntityWellKnownSeasonedIssuer_c20210101__20211231_zSkgEPNQ9u33"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityWellKnownSeasonedIssuer">Yes</ix:nonNumeric></span> <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span><span style="font-size: 9pt">	</span>No
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">If this report is an annual or transition report, indicate by check
mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Yes <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span><span style="font-size: 9pt">	</span><span id="xdx_905_edei--EntityVoluntaryFilers_c20210101__20211231_zQDDpSHlxJl"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:EntityVoluntaryFilers">No</ix:nonNumeric></span>
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"><b>Note</b> &#8211; Checking the box above will not relieve any registrant
required to file reports pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 from their obligations under those Sections.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark whether the registrant (1)&#160;has filed
all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for
such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements
for the past 90 days.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="xdx_904_edei--EntityCurrentReportingStatus_dxL_c20210101__20211231_zJUzGNeVQTdb"><span style="-sec-ix-hidden: xdx2ixbrl0045">Yes</span></span> <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span><span style="font-size: 9pt">	</span>No
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark whether the registrant has submitted electronically
every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the
preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span id="xdx_90E_edei--EntityInteractiveDataCurrent_dxL_c20210101__20211231_zjEGUCrlASI1"><span style="-sec-ix-hidden: xdx2ixbrl0046">Yes</span></span> <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span><span style="font-size: 9pt">	</span>No
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark whether the registrant is a large accelerated
filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definition of &#8220;large accelerated filer,&#8221;
&#8220;accelerated filer,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.25in"><span id="xdx_90A_edei--EntityFilerCategory_c20210101__20211231_zYEocF5yDO8e"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory">Large Accelerated Filer</ix:nonNumeric></span> <span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9746;</span>	Accelerated
Filer <span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span>	</p>

<p style="font: 10pt/90% Times New Roman, Times, Serif; margin: 0 0 6pt; text-indent: 0.25in">Non-accelerated Filer <span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span>	Emerging
growth company <span style="font-family: MS Gothic, Helvetica, Sans-Serif"><span id="xdx_904_edei--EntityEmergingGrowthCompany_c20210101__20211231_zr1sTJiHgR0k"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">If an emerging growth company that prepares its financial statements
in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards&#8224; provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt"> &#8224;The term &#8220;new or revised financial accounting standard&#8221;
refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark whether the registrant has filed a report
on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section
404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_edei--IcfrAuditorAttestationFlag_c20210101__20211231_zFbEEDIYeg65"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleantrue" name="dei:IcfrAuditorAttestationFlag">&#9746;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt">Indicate by check mark which basis of accounting the registrant has
used to prepare the financial statements included in this filing:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span>	U.S.
GAAP</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9746;</span>	<span id="xdx_90D_edei--DocumentAccountingStandard_dxL_c20210101__20211231_z8Sk9lOLv3e" title="::XDX::International%20Financial%20Reporting%20Standards"><span style="-sec-ix-hidden: xdx2ixbrl0050">International
Financial Reporting Standards</span></span> as issued by the International Accounting Standards Board</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt 0.5in"><span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span>	Other</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">If &#8220;Other&#8221; has been checked in response to the previous
question, indicate by check mark which financial statement item the registrant has elected to follow.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span>
Item 17	<span style="font-family: MS Gothic, Helvetica, Sans-Serif">&#9744;</span> Item 18</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">If this is an annual report, indicate by check mark whether the
registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center">Yes <span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9744;</span><span style="font-size: 9pt">	</span><span id="xdx_906_edei--EntityShellCompany_c20210101__20211231_znks3dIOGue6"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" format="ixt:booleanfalse" name="dei:EntityShellCompany">No</ix:nonNumeric></span>
<span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt">&#9746;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt"><span></span></span></p>

<!-- Field: Page; Sequence: 2; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"></p>




<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><span style="text-transform: uppercase"><span id="TableOfContents"></span><b>table of contents</b></span></p>

<!-- Field: Rule-Page --><div style="margin: 1pt 187.2pt"><div style="border-top: Black 0.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page</span></p>



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="width: 90%; text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 0cm"><a href="#a_20f001">PART I&#160; INTRODUCTION</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0cm; padding-bottom: 6pt">1</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f002">ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">5</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f003">ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">5</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f004">ITEM 3. KEY INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">5</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f005">A.&#160;&#160;&#160;Selected Financial Data</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">5</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f006">B.&#160;&#160;&#160;Capitalization and Indebtedness</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">13</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f007">C.&#160;&#160;&#160;Reasons for the Offer and Use of Proceeds</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">13</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f008">D.&#160;&#160;&#160;Risk Factors</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">14</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 0cm"><a href="#a_20f009">Summary of Risk Factors</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">14</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f010">ITEM 4. INFORMATION ON THE COMPANY</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">48</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f011">A.&#160;&#160;&#160;History and Development of the Company</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">48</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f012">B.&#160;&#160;&#160;Business Overview</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">52</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f013">C.&#160;&#160;&#160;Organizational Structure</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">100</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f014">D.&#160;&#160;&#160;Property, Plant and Equipment</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">100</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f015">ITEM 4A. UNRESOLVED STAFF COMMENTS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">101</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f016">ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">101</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f017">A.&#160;&#160;&#160;Operating Results</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">101</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f018">B.&#160;&#160;&#160;Liquidity and Capital Resources</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">111</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f019">C.&#160;&#160;&#160;Research and Development, Patents and Licenses</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">113</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f020">D.&#160;&#160;&#160;Trend Information</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">113</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f021">E.&#160;&#160;&#160;Critical Accounting Estimates</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">114</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f022">ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">114</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f023">A.&#160;&#160;&#160;Directors and Senior Management</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">114</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f024">B.&#160;&#160;&#160;Compensation</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">119</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f025">C.&#160;&#160;&#160;Board Practices</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">120</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f026">D.&#160;&#160;&#160;Employees</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">122</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f027">E.&#160;&#160;&#160;Share Ownership</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">122</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f028">ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">123</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f029">A.&#160;&#160;&#160;Major Shareholders</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">123</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f030">B.&#160;&#160;&#160;Related Party Transactions</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">125</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f031">C.&#160;&#160;&#160;Interests of Experts and Counsel</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">127</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f032">ITEM 8. FINANCIAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">128</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f033">A.&#160;&#160;&#160;Consolidated Statements and Other Financial Information</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">128</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f034">B.&#160;&#160;&#160;Significant Changes</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">132</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f035">ITEM 9. THE OFFER AND LISTING</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
</table>
<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f036">A.&#160;&#160;&#160;Offer and Listing Details</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f037">B.&#160;&#160;&#160;Plan of Distribution</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f038">C.&#160;&#160;&#160;Markets</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f039">D.&#160;&#160;&#160;Selling Shareholders</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f040">E.&#160;&#160;&#160;Dilution</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f041">F.&#160;&#160;&#160;Expenses of the Issue</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f042">ITEM 10. ADDITIONAL INFORMATION</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f043">A.&#160;&#160;&#160;Share Capital</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f044">B.&#160;&#160;&#160;Memorandum and Articles of Association</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">133</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f045">C.&#160;&#160;&#160;Material Contracts</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">150</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f046">D.&#160;&#160;&#160;Exchange Controls</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">150</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f047">E.&#160;&#160;&#160;Taxation</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">151</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f048">F.&#160;&#160;&#160;Dividends and Paying Agents</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">154</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f049">G.&#160;&#160;&#160;Statement by Experts</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">154</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f050">H.&#160;&#160;&#160;Documents on Display</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">154</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f051">I.&#160;&#160;&#160;Subsidiary Information</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">154</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f052">ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">155</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f053">ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">155</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f054">A.&#160;&#160;&#160;Debt Securities</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">155</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f055">B.&#160;&#160;&#160;Warrants and Rights</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">155</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f056">C.&#160;&#160;&#160;Other Securities</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">156</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f057">D.&#160;&#160;&#160;American Depositary Shares</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">156</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 0cm"><a href="#a_20f058">PART II</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f059">ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f060">A.&#160;&#160;&#160;Defaults</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f061">B.&#160;&#160;&#160;Arrears and delinquencies</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f062">ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND USE OF PROCEEDS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f063">A.&#160;&#160;&#160;Material modifications to instruments</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f064">B.&#160;&#160;&#160;Material modifications to rights</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f065">C.&#160;&#160;&#160;Withdrawal or substitution of assets</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f066">D.&#160;&#160;&#160;Change in trustees or paying agents</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f067">E.&#160;&#160;&#160;Use of proceeds</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f068">ITEM 15. CONTROLS AND PROCEDURES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f069">A.&#160;&#160;&#160;Disclosure Controls and Procedures</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">157</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f070">B.&#160;&#160;&#160;Management&#8217;s Annual Report on Internal Control Over Financial Reporting</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">158</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f071">C.&#160;&#160;&#160;Attestation Report of the Registered Public Accounting Firm</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 23.75pt"><a href="#a_20f072">D.&#160;&#160;&#160;Changes in Internal Control Over Financial Reporting</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
</table>
<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->



<table cellpadding="0" cellspacing="0" style="width: 100%">
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="width: 90%; text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f073">ITEM 16. RESERVED</a></td>
    <td style="width: 10%; text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f074">ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f075">ITEM 16B. CODE OF ETHICS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f076">ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">159</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f077">ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">160</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f078">ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED PURCHASERS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">160</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f079">ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">161</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f080">ITEM 16G. CORPORATE GOVERNANCE</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">161</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f081">ITEM 16H. MINE SAFETY DISCLOSURE</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">161</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f082">ITEM 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">162</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 0cm"><a href="#a_20f083">PART III</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">163</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f084">ITEM 17. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">163</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f085">ITEM 18. FINANCIAL STATEMENTS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">163</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 12.25pt"><a href="#a_20f086">ITEM 19. EXHIBITS</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">163</td></tr>
  <tr style="font: 10pt Times New Roman; text-align: left; vertical-align: bottom; text-transform: uppercase">
    <td style="text-align: left; padding-top: 0cm; padding-bottom: 6pt; padding-left: 0cm"><a href="#a_20f087">Index to Financial Statements</a></td>
    <td style="text-align: right; padding-top: 0cm; padding-bottom: 6pt">F-1</td></tr>
</table>
<p style="font: 7pt Times New Roman,serif; margin: 0 0 6pt; text-transform: uppercase">&#160;</p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 3 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-transform: uppercase; text-align: center"><span id="a_20f001"></span>PART I<br />
<br />
<span style="color: #0D0E00">INTRODUCTION</span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Definitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Unless otherwise indicated or the context otherwise requires,
all references in this annual report to &#8220;Afya&#8221; or the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;our,&#8221; &#8220;ours,&#8221;
&#8220;us&#8221; or similar terms refer to Afya Limited, together with its subsidiaries; all references in this annual report to &#8220;Afya
Brazil&#8221; refer to Afya Participa&#231;&#245;es S.A. (formerly NRE Participa&#231;&#245;es S.A.); all references in this annual
report to &#8220;BR Health&#8221; refer to BR Health Participa&#231;&#245;es S.A.; all references in this annual report to &#8220;Medcel&#8221;
refer to Guardaya Empreendimentos e Participa&#231;&#245;es S.A., or Guardaya, and its subsidiaries Medcel Editora e Eventos S.A.,
or Medcel Editora, and CBB Web Servi&#231;os e Transmiss&#245;es On Line S.A., or CBB Web; and all references in this annual report
to &#8220;IPTAN&#8221; refer to IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A., &#8220;IESVAP&#8221;
refer to Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., &#8220;CCSI&#8221; refer to Centro de Ci&#234;ncias
em Sa&#250;de de Itajub&#225; S.A., &#8220;IESP&#8221; refer to Instituto de Ensino Superior do Piau&#237; S.A., &#8220;FADEP&#8221;
refer to FADEP&#8212;Faculdade Educacional de Pato Branco Ltda., &#8220;FASA&#8221; refer to Instituto Educacional Santo Agostinho S.A.,
&#8220;IPEMED&#8221; refer to Instituto de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda., &#8220;IPEC&#8221; refer to
Instituto Paraense de Educa&#231;&#227;o e Cultura Ltda,, &#8220;UniRedentor&#8221; refer to Sociedade Universit&#225;ria Redentor
S.A., &#8220;UniSL&#8221; refer to Centro Universit&#225;rio S&#227;o Lucas Ltda., &#8220;PEBMED&#8221; refer to PEBMED Institui&#231;&#227;o
de Pesquisa M&#233;dica e Servi&#231;os Tecnol&#243;gicos da &#193;rea da Sa&#250;de S.A., &#8220;FESAR&#8221; refer to Faculdade
de Ensino Superior da Amaz&#244;nia Reunida, &#8220;MedPhone&#8221; refer to MedPhone Tecnologia em Sa&#250;de Ltda., &#8220;FCMPB&#8221;
Centro Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda., &#8220;UNIFIPMoc&#8221; refer to Sociedade Padr&#227;o de Educa&#231;&#227;o
Superior Ltda., &#8220;iClinic&#8221; refer to iClinic Participa&#231;&#245;es S.A., iClinic Desenvolvimento de Software Ltda. and
Black River Brazil Participa&#231;&#245;es S.A., &#8220;Medicinae&#8221; refer to Medicinae Solutions S.A., &#8220;Medical Harbour&#8221;
refer to Medical Harbour Aparelhos M&#233;dico-Hospitalares e Servi&#231;os em Tecnologia Ltda., and &#8220;Cliquefarma&#8221; refer
to Cliquefarma Drogarias Online Ltda, &#8220;Shosp&#8221; refer to Shosp Tecnologia da Informacao Ltda, &#8220;Unigranrio&#8221; refer
to Companhia Nilza Cordeiro Herdy de Edua&#231;&#227;o e Cultura, Instituto de Ensino Superior de Palho&#231;a S/S Ltda., Sociedade
Educacional de Palho&#231;a S/S Ltda., and Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda., collectively, &#8220;RX
PRO&#8221; refer to RX PRO Solu&#231;&#245;es de Tecnologia Ltda. and RX PRO LOG Transporte e Logistica Ltda., collectively, &#8220;Garanhuns&#8221;
refer to Faculdade Itpac Garanhuns - Instituto Tocantinense Presidente Antonio Carlos Ltda,&#8220;Al&#233;m da Medicina&#8221; refer
to BMV Atividades M&#233;dicas Ltda, &#8220;Cardiopapers&#8221; refer to Cardiopapers Solu&#231;&#245;es Digitais Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The term &#8220;Brazil&#8221; refers to the Federative
Republic of Brazil and the phrase &#8220;Brazilian government&#8221; refers to the federal government of Brazil. &#8220;Central Bank&#8221;
refers to the Brazilian Central Bank <i>(Banco Central do Brasil).</i> References in the annual report to &#8220;<i>real,</i>&#8221; &#8220;<i>reais</i>&#8221;
or &#8220;R$&#8221; refer to the Brazilian <i>real,</i> the official currency of Brazil and references to &#8220;U.S. dollar,&#8221; &#8220;U.S.
dollars&#8221; or &#8220;US$&#8221; refer to U.S. dollars, the official currency of the United States.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Financial Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya is a Cayman Islands exempted company with limited
liability duly registered with the Cayman Islands Registrar of Companies and incorporated on March 22, 2019. Afya became the holding company
of Afya Brazil, formerly denominated NRE Participa&#231;&#245;es S.A., through the completion of the corporate reorganization described
in note 1 to our audited consolidated financial statements (as defined below) and in Item 4. Information on the Company&#8212;A. History
and Development of the Company&#8212;Our Pre-IPO Corporate Reorganization.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Until the contribution of Afya Brazil&#8217;s shares
to us, we had not commenced operations and had only nominal assets and liabilities and no material contingent liabilities or commitments.
Subsequent to the completion of the corporate reorganization, we began to consolidate financial information in order to reflect the operations
of Afya Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result, the audited consolidated financial statements
prepared by Afya subsequent to the completion of the reorganization are presented &#8220;as if&#8221; Afya Brazil is the predecessor of
Afya. Accordingly, our audited consolidated financial statements included elsewhere in this annual report on Form 20-F reflect: (i)&#160;the
historical operating results of Afya Brazil prior to such reorganization; (ii)&#160;the consolidated results of Afya and Afya Brazil following
the reorganization; and (iii)&#160;the assets and liabilities of Afya Brazil at their historical cost.</p>


<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The consolidated financial information of Afya and Afya
Brazil contained in this annual report is derived from our audited consolidated financial statements as of December 31, 2021 and 2020
and for the years ended December 31, 2021, 2020 and 2019, together with the notes thereto. The consolidated financial information of Afya
and Afya Brazil contained in this annual report as of December 31, 2019 and 2018 and for the year ended December 31, 2018 are derived
from our annual report on Form 20-F for the fiscal year ended December 31, 2020, filed with the SEC on April 30, 2021. All references
herein to &#8220;our financial statements,&#8221; &#8220;our audited consolidated financial information,&#8221; and &#8220;our audited
consolidated financial statements&#8221; are to Afya&#8217;s consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya is a holding company, and as such, the primary source
of revenue derives from its interest in its operational companies in Brazil. As a result, Afya&#8217;s functional currency as well as
of its subsidiaries is the Brazilian <i>real</i>. We prepare our annual consolidated financial statements in accordance with International
Financial Reporting Standards, or IFRS, as issued by the International Accounting Standards Board, or IASB.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Summary consolidated historical financial data have been
derived from our audited consolidated financial statements, included elsewhere in this annual report. The financial results of IPTAN,
IESVAP, CCSI, IESP, FADEP, Medcel, FASA<i>, </i>IPEMED, IPEC, UniRedentor, UniSL, PEBMED, FESAR, MedPhone, FCMPB, iClinic, Medicinae,
Medical Harbour, Cliquefarma, Shosp, UNIFIPMoc, Unigranrio, RX PRO and Garanhuns (and together with IPTAN, IESVAP, CCSI, IESP, FADEP,
Medcel, FASA<i>, </i>IPEMED, IPEC, UniRedentor, UniSL, PEBMED, FESAR, MedPhone, FCMPB, iClinic, Medicinae, Medical Harbour, Cliquefarma,
Shosp, UNIFIPMoc, Unigranrio, RX PRO and Garanhuns, the &#8220;Acquired Companies&#8221;) are included in our historical results for the
periods following the closing of each such transaction, meaning April 26, 2018, April 26, 2018, May 30, 2018, November 27, 2018, December
5, 2018, March 29, 2019, April 3, 2019, May 9, 2019, August 13, 2019, January 31, 2020, May 5, 2020, July 20, 2020, November 3, 2020,
November 4, 2020, November 9, 2020, January 21, 2021, March 25, 2021, April 8, 2021, April 16, 2021, May 13, 2021, June 1, 2021, August
4, 2021, October 1, 2021 and November 5, 2021, respectively. Except as otherwise indicated, the financial results of Al&#233;m da Medicina
and Cardiopapers are not reflected in the summary consolidated historical financial data included elsewhere in this annual report as the
consummation of the acquisition of such entity occurred after the fiscal year ended December 31, 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our fiscal year ends on December 31 of each year, so
all references to a particular fiscal year are to the applicable year ended December 31.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Historical undergraduate programs combined tuition fees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The term &#8220;historical undergraduate programs combined
tuition fees&#8221; refers to the sum equal to the total tuition fees charged to undergraduate students, as recorded in the historical
operating information of Afya Brazil and the Acquired Companies, since the consummation of their respective acquisition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The historical undergraduate programs combined tuition
fees information included elsewhere in this annual report (i)&#160;was derived from historical operating information for Afya Brazil and
for each of the Acquired Companies since the consummation of their respective acquisition; (ii)&#160;is akin to gross tuition fees charged
to undergraduate students; (iii)&#160;differs from the tuition fees set forth in our audited consolidated financial statements, which
are presented as the sum of (a)&#160;gross tuition fees charged to undergraduate students, (b)&#160;gross tuition fees charged to graduate
students and (c)&#160;scholarships; and (iv)&#160;does not represent net revenue as disclosed in our audited consolidated financial statements
included elsewhere in this annual report. For the years ended December 31, 2021, 2020 and 2019, historical undergraduate programs combined
tuition fees charged to undergraduate students by us were R$1,990 million, R$1,236.5 million and R$794.3 million, respectively. Historical
undergraduate programs combined tuition fees does not include tuition fees we charge graduate students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our consolidated operating history and recent acquisitions
may make it difficult for investors to evaluate our business, financial condition, results of operations and prospects. We experienced
rapid and significant expansion in the years ended December 31, 2021, 2020 and 2019 due to the effects of the acquisition of the Acquired
Companies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Because the historical and operational information included
elsewhere in this annual report may not be representative of our results and operations as a consolidated company, investors may have
limited financial and operational information on which to evaluate us and their investment decision. See &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our operating history as a consolidated</p>


<!-- Field: Page; Sequence: 7 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">company, our recent acquisitions and the comparability of our results may
make it difficult for investors to evaluate our business, financial condition, results of operations and prospects.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The past performance of Afya Brazil and the Acquired
Companies, as reflected in the historical undergraduate programs combined tuition fees information included elsewhere in this annual report,
may not be indicative of our future performance or any future anticipated synergies, future operating efficiencies or cost savings that
may result from these acquisitions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Convenience Translation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The reporting currency for our audited consolidated financial
statements is the Brazilian <i>real</i> and, solely for the convenience of the reader, we have provided convenience translations into
U.S. dollars using the selling exchange rates published by the Central Bank on its website. Unless otherwise indicated, convenience translations
from <i>reais</i> into U.S. dollars in this annual report use the Central Bank offer exchange rate published on December 31, 2021, which
was R$5.580 per US$1.00. No representation is made that the Brazilian <i>reais</i> amounts referred to could have been, or could be, converted
into U.S. dollars at any particular rate. See &#8220;Item 3. Key Information&#8212;A. Selected Financial Data&#8212;Exchange Rates&#8221;
for information regarding historical exchange rates of <i>reais</i> to U.S. dollars.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Market Data</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This annual report contains data related to economic
conditions in the market in which we operate. The information contained in this annual report concerning economic conditions is based
on publicly available information from third-party sources that we believe to be reasonable. Market data and certain industry forecast
data used in this annual report were obtained from internal reports and studies, where appropriate, as well as estimates, market research,
publicly available information (including information available from the United States Securities and Exchange Commission website) and
industry publications. We obtained the information included in this annual report relating to the industry in which we operate, as well
as the estimates concerning market shares, through internal research, a report by a third-party consulting firm commissioned by us, public
information and publications on the industry prepared by official public sources, such as the Central Bank, the Brazilian Institute of
Geography and Statistics <i>(Instituto Brasileiro de Geografia e Estat&#237;stica),</i> or the IBGE, the Organisation for Economic Co-operation
and Development, or OECD, the Brazilian Ministry of Education <i>(Minist&#233;rio da Educa&#231;&#227;o),</i> or MEC, the An&#237;sio
Teixeira National Institute of Educational Studies and Research <i>(Instituto Nacional de Estudos e Pesquisas Educacionais An&#237;sio
Teixeira),</i> or the INEP, the Institute of Applied Economic Research <i>(Instituto de Pesquisa Econ&#244;mica Aplicada),</i> or the
IPEA as well as private sources, such as Bloomberg, consulting and research companies in the Brazilian and international education industry,
the Brazilian Economic Institute of Funda&#231;&#227;o Getulio Vargas <i>(Instituto Brasileiro de Economia da Funda&#231;&#227;o
Getulio Vargas),</i> or FGV/IBRE, the Association of American Medical Colleges, or AAMC among others.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Industry publications, governmental publications and
other market sources, including those referred to above, generally state that the information they include has been obtained from sources
believed to be reliable, but that the accuracy and completeness of such information is not guaranteed. While we are not aware of any misstatements
regarding the market and industry data presented herein, our estimates involve risks and uncertainties and are subject to change based
on various factors, including those discussed in the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors.&#8221; Except
as disclosed in this annual report, none of the publications, reports or other published industry sources referred to in this annual report
were commissioned by us or prepared at our request. Except as disclosed in this annual report, we have not sought or obtained the consent
of any of these sources to include such market data in this annual report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Rounding</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have made rounding adjustments to some of the figures
included in this annual report. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of
the figures that preceded them.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Forward-Looking Statements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This annual report on Form 20-F contains information
that constitute forward-looking statements within the meaning of Section 27A of the Securities Act, and Section 21E of the Securities
Exchange Act of 1934, as amended, or Exchange Act, that are not based on historical facts and are not assurances of future results. The
forward-looking</p>


<!-- Field: Page; Sequence: 8 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">statements contained in this annual report, which address our expected business
and financial performance, among other matters, contain words such as &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;estimate,&#8221;
&#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;plan,&#8221; &#8220;aim,&#8221; &#8220;will,&#8221; &#8220;may,&#8221; &#8220;should,&#8221;
&#8220;could,&#8221; &#8220;would,&#8221; &#8220;likely,&#8221; &#8220;potential&#8221; and similar expressions. We have made forward-looking
statements that address, among other things, our current expectations, plans, forecasts, projections and strategies about future events
and financial trends that affect, or may affect, our business, industry, market share, reputation, financial condition, results of operations,
margins, cash flow and/or the market price of our common shares, all of which are subject to known and unknown risks and uncertainties.
Our actual results may differ materially from those expressed or implied in the forward-looking statements due to various factors, including,
but not limited to, those identified under the section entitled &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8221; in this annual
report. These risks and uncertainties include factors relating to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>health epidemics, pandemics and similar outbreaks, including the COVID-19 pandemic and measures taken in response;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to provide online classes to our students and keep them engaged with online classes during the COVID-19 pandemic, and
our ability to resume on-campus practical classes for our medical students during the COVID-19 pandemic;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the passing of any municipal, state or federal laws or regulations and the outcome of legal proceedings requiring the mandatory discount
of tuition fees during the COVID-19 pandemic;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to implement our business strategy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in government regulations and legislation applicable to the education industry in Brazil, both in the traditional and distance
learning segments, including tax regulations and/or legislation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>government interventions, including changes in, or termination of, education industry programs such as the Higher Education Student
Financing Fund (<i>Fundo de Financiamento ao Estudante do Ensino Superior</i>), or FIES, and/or the University for All Program (<i>Programa
Universidade para Todos</i>), or PROUNI, both in the traditional and distance learning segments, that affect the economic or tax regime,
the collection of tuition fees or the regulatory framework applicable to educational institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in the financial condition of the students enrolling in our institutions in general and in the competitive conditions in the
education industry, both in the traditional and distance learning segments, or changes in the financial condition of our institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to adapt to technological changes in the educational sector, including in relation to distance learning programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the availability of government authorizations on terms and conditions and within periods acceptable to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to continue attracting and retaining new students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to maintain the academic quality of our programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to compete and conduct our business in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the success of operating initiatives, including advertising and promotional efforts and new product, service and concept development
by us and our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in consumer demands and preferences and technological advances, and our ability to innovate to respond to such changes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the availability of qualified personnel and the ability to retain such personnel;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our capitalization and level of indebtedness;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the interests of our controlling shareholders;</td></tr></table>


<!-- Field: Page; Sequence: 9 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a decline in the number of students enrolled in our programs or the amount of tuition we can charge;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in labor, distribution and other operating costs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our compliance with, and changes to, government laws, regulations and tax matters that currently apply to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>general economic, financial, political, demographic and business conditions in Brazil, as well as any other countries we may serve
in the future and their impact on our business;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>fluctuations in interest, inflation and exchange rates in Brazil and any other countries we may serve in the future;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>other factors that may affect our financial condition, liquidity and results of operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the effectiveness of our risk management policies and procedures, including our internal control over financial reporting; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the other factors discussed under the section &#8220;Risk Factors&#8221; in this annual report on Form 20-F.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Prospective investors are cautioned that any such forward-looking
statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially
from those in the forward-looking statements. The accompanying information contained in this annual report on Form 20-F, including without
limitation the information set forth under the heading &#8220;Item 5. Operating and Financial Review and Prospects,&#8221; identifies
important factors that could cause such differences. In light of the risks, uncertainties and assumptions associated with forward-looking
statements, you should not place undue reliance on any forward-looking statements. Additional risks that we may currently deem immaterial
or that are not presently known to us could also cause the forward-looking events discussed in this annual report on Form 20-F not to
occur.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our forward-looking statements speak only as of the date
of this annual report on Form 20-F, and we do not undertake any obligation to update them in light of new information or future developments
or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence
of unanticipated events.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f002"></span>ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f003"></span>ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f004"></span>ITEM 3. KEY INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f005"></span>A.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Selected
Financial Data</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth selected consolidated
historical financial data of Afya as of and for the years ended December 31, 2021, 2020 and 2019 and of Afya Brazil as of and for the
years ended December 31, 2018. The selected consolidated historical financial data as of December 31, 2021, 2020 and 2019 and for the
years ended December 31, 2021, 2020 and 2019 has been derived from our audited consolidated financial statements, included elsewhere in
this annual report. The financial results of the Acquired Companies are included in our historical results for the periods following the
closing of each such transaction, respectively. See &#8220;Part I&#8212;Introduction&#8212;Financial Information.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The selected audited consolidated historical financial
data should be read in conjunction with &#8220;Part I&#8212;Introduction&#8212;Financial Information,&#8221; &#8220;Item 5. Operating
and Financial Review and Prospects&#8221; and our audited consolidated financial statements, including the respective notes thereto, included
elsewhere in this annual report.</p>


<!-- Field: Page; Sequence: 10 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The selected audited consolidated historical financial
data presented in this annual report may not be indicative of future performance.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="text-align: center; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya</p></td>
    <td style="text-align: center; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya Brazil</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="text-align: center">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 51%; text-align: center">&#160;</td>
    <td style="text-align: center; padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="text-align: center; padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="text-align: center; padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td>
    <td style="text-align: center; padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2019</p></td>
    <td style="text-align: center; padding-right: 5pt; vertical-align: top; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2018</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ million(1))</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">(in R$ millions)</td></tr>
  <tr>
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom"><b>Income Statement Data</b></td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Net revenue&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">308.1</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">1,719.4</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">1,201.2</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">750.6</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">333.9</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Cost of services&#9;</td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(116.9)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(652.3)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(434.7)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(308.9)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(168.1)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom"><b>Gross profit</b>&#9;</td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>191.2</b></p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,067.1</b></p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>766.5</b></p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>441.8</b></p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>165.9</b></p></td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">General and administrative expenses&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(111.6)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(622.6)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">(402.9)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(239.1)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(70.0)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Other (expenses) income, net&#9;</td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(0.6)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(3.6)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(0.3)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.6</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">0.6</p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif"><b>Operating income</b>&#9;</td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>79.0</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>440.9</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>363.3</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>205.3</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>96.4</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Finance income&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">11.6</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">64.6</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">62.3</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">51.7</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">10.4</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Finance expenses&#9;</td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(43.7)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(243.8)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(98.3)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(72.4)</p></td>
    <td style="text-align: right; padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(8.2)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Finance result&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(32.1)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(179.2)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">(36.0)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">(20.7)</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">2.3</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif">Share of income of associate&#9;</td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.1</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">11.8</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">7.7</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.4</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif"><b>Income before income taxes</b>&#9;</td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>49.0</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>273.5</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>335.1</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>186.9</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>98.7</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif">Income taxes expense&#9;</td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(5.6)</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(31.2)</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(27.1)</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(14.2)</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(4.0)</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif"><b>Net income</b>&#9;</td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>43.4</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>242.3</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>308.0</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>172.8</b></p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>94.7</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif"><b>Net income attributable to:</b></td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Equity holders of the parent&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">40.0</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">223.3</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">292.1</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">153.9</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">86.3</td></tr>
  <tr style="background-color: White">
    <td style="font: 10pt Times New Roman,serif; vertical-align: bottom">Non-controlling interests&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">3.4</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">19.0</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">15.9</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">18.8</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">8.4</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; text-align: right; padding-right: 5pt; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; text-align: right; padding-right: 5pt; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif"><b>Earnings per share</b></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: right">US$</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: right">R$</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: right">R$</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: right">R$</p></td>
    <td style="text-align: right; padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: right">R$</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif"><b>Basic earnings per share</b></td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif">Common shares&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">0.43</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">2.39</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">3.15</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">2.03</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">1.84</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman,serif"><b>Diluted earnings per share</b></td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 10pt Times New Roman,serif">Common shares&#9;</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">0.42</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">2.37</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">3.12</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">2.02</td>
    <td style="font: 10pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt">1.81</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2021 have been translated to U.S. dollars using an
exchange rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further
information about recent fluctuations in exchange rates.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Historical
    Afya</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Historical
    Afya Brazil</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of December
    31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 52%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td>
    <td style="padding-right: 5pt; vertical-align: top; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2018</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ million(1))</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">(in R$ millions)</td></tr>
  <tr>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Balance Sheet Data</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Assets</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Current assets</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Cash and cash equivalents&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">134.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">748.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,045.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">943.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">62.3</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Restricted cash&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>&#8212;</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>&#8212;</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">14.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Trade receivables&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">67.8</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">378.4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">302.3</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">125.4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">58.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Inventories&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">7.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.1</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Recoverable taxes&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">25.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">21.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.3</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif">Derivatives&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.6</td></tr>
    <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 52%; font-family: Times New Roman,serif">Other assets&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">7.6</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">42.5</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">29.6</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">17.9</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">8.9</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total current assets</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>216.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,206.9</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,405.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,111.8</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>133.5</b></p></td></tr>
  </table>

<!-- Field: Page; Sequence: 11 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Historical
    Afya</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Historical
    Afya Brazil</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of December
    31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 52%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td>
    <td style="padding-right: 5pt; vertical-align: top; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2018</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ million(1))</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif"><b>Non-current assets</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Restricted cash&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.8</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Trade receivables&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">27.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">7.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.2</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Related parties&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.6</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Derivatives&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.7</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Other assets&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">32.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">180.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">74.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Property and equipment&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">75.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">419.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">260.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">139.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">65.8</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Investment in associate&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">8.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">48.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">51.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">45.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif">Right-of-use assets(2)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">118.9</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">663.7</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">419.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">274.3</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Intangible assets&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">699.0</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">3,900.9</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2,573.0</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,312.3</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">682.5</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total non-current assets</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>939.0</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>5,240.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>3,387.6</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,800.7</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>784.9</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total assets</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,155.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>6,447.4</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>4,793.1</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>2,912.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>918.4</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif"><b>Liabilities</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif"><b>Current liabilities</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Trade payables&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">59.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">35.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">8.1</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Loans and financing&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">23.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">128.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">107.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">53.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">26.8</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Derivatives&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Lease liabilities(2)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">25.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">62.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">22.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Accounts payable to selling shareholders&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">42.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">239.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">188.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">131.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">88.9</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Notes Payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">14.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Advances from customers&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">20.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">114.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">63.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">36.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">13.7</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Labor and social obligations&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">23.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">131.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">77.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">46.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">32.0</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Taxes payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">26.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">33.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">19.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.5</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Income taxes payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.3</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif">Dividends payable&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.1</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Other liabilities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.7</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">15.2</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">6.3</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">0.4</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.0</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total current liabilities</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>137.3</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>766.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>589.4</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>333.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>182.3</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif"><b>Non-current liabilities</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Loans and financing&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">223.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,246.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">510.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">51.0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Lease liabilities(2)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">123.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">689.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">385.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">261.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif">Accounts payable to selling shareholders&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">78.8</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">440.0</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">329.8</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">168.4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">88.9</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Notes Payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">58.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">65.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Taxes payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">96.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">21.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">21.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.2</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Provision for legal proceedings&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">26.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">148.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">53.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.5</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Other liabilities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">0.4</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.5</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">3.8</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.0</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">2.2</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total non-current liabilities</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>480.4</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,680.9</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,369.9</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>465.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>145.7</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total liabilities</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>617.7</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>3,447.4</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,959.3</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>798.7</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>328.1</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Equity</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Share capital&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">-</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">315.0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Additional paid-in capital&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">425.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2,375.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2,323.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,931.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">125.0</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Share-based compensation reserve&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">16.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">94.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">50.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.2</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Treasury stock&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(27.3)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(152.6)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Earnings reserves&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">113.1</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">631.3</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">408.0</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">115.9</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">59.8</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Equity attributable to equity holders of the <br />
parent</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>528.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,948.1</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,782.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>2,065.1</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>502.0</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif">Non-controlling interests&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">9.3</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">51.9</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">51.6</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">48.6</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">88.4</p></td></tr>

<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; width: 52%; font-family: Times New Roman,serif"><b>Total equity</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>537.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>3,000.0</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>2,833.8</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>2,113.7</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>590.4</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; font-family: Times New Roman,serif"><b>Total liabilities and equity</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,155.2</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>6,447.4</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>4,793.1</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>2,912.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>918.4</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> as of December 31, 2021 have been translated to U.S. dollars using an exchange
rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central Bank. These
translations should not be considered representations that any such amounts have been, could have been or could be converted at that or
any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further information
about recent fluctuations in exchange rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>On January 1, 2019, we adopted IFRS 16. See note 13.2.2 to our audited consolidated financial statements.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 12 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Non-GAAP Financial Measures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This annual report presents our Adjusted EBITDA and Operating
Cash Conversion Ratio information for the convenience of investors, which are non-GAAP financial measures. A non-GAAP financial measure
is generally defined as one that purports to measure financial performance but excludes or includes amounts that would not be so adjusted
in the most comparable GAAP measure.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We calculate our Adjusted EBITDA as net income <i>plus/minus</i>
finance result <i>plus</i> income taxes expense <i>plus</i> depreciation and amortization <i>plus</i> interest received on late payments
of monthly tuition fees, <i>minus</i> income share associate, <i>plus</i> share-based compensation expense <i>plus/minus</i> non-recurring
expenses. We calculate our Operating Cash Conversion Ratio as the cash flows from operations <i>plus/minus</i> income taxes paid divided
by Adjusted EBITDA <i>plus/minus</i> non-recurring expenses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We present Adjusted EBITDA because we believe this measure
provides investors with a supplemental measure of the financial performance of our core operations that facilitates period-to-period comparisons
on a consistent basis. We also present Operating Cash Conversion Ratio because we believe this measure provides investors with a measure
of how efficiently we convert our EBITDA into cash. The non-GAAP financial measures described in this annual report are not a substitute
for the IFRS measures of earnings. Additionally, our calculations of Adjusted EBITDA and Operating Cash Conversion Ratio may be different
from the calculations used by other companies, including our competitors in the education services industry, and therefore, our measures
may not be comparable to those of other companies.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Adjusted EBITDA and Operating Cash Conversion Ratio</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 52%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td>
    <td style="padding-right: 5pt; vertical-align: top; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2018</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ millions(1))</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(except percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Adjusted EBITDA&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">135.3</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">754.8</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">563.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">331.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">119.9</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Operating Cash Conversion Ratio&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">100.8%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">100.8%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">75.7%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">100.5%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">75.1%</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt"><span style="background-color: white">(1)</span></td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2021 have been translated to U.S. dollars using
an exchange rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further
information about recent fluctuations in exchange rates.</td></tr></table>


<!-- Field: Page; Sequence: 13 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Reconciliation of Non-GAAP Financial Measures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following tables set forth the Adjusted EBITDA reconciliation
to our net income and the Operating Cash Conversion Ratio reconciliation to our cash flow from operations for the years ended December
31, 2021, 2020, 2019 and 2018, in each case, our most recent directly comparable financial measures calculated and presented in accordance
with IFRS. For further information on why our management chooses to use these non-GAAP financial measures, and on the limits of using
these non-GAAP measures, please see &#8220;Item 3. A. Selected Financial Data&#8212;non-GAAP Financial Measures.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Reconciliation between Net Income and Adjusted EBITDA</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya</p></td>
    <td style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya Brazil</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="text-align: center">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 50%; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; width: 11%; text-align: center; padding-left: 5pt">2021</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; width: 10%; text-align: center; padding-left: 5pt">2021</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; width: 10%; text-align: center; padding-left: 5pt">2020</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; width: 11%; text-align: center; padding-left: 5pt">2019</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; width: 8%; text-align: center; padding-left: 5pt">2018(9)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ millions(1))</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Net income</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>43.4</b></td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>242.3</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>308.0</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>172.8</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>94.7</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Finance result&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">32.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">179.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">36.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">20.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(2.3)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Income taxes expense&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.6</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">31.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">27.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">14.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.0</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Depreciation and amortization&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">27.6</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">154.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">108.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">73.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.1</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Interest received(2)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">23</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Income share associate&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(2.1)</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(11.8)</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(7.7)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(2.4)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Share-based compensation expense&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">7.8</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">43.4</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">32.6</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.2</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Non-recurring expenses(3):</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-left: 18.7pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Integration of new companies(4)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.8</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-left: 18.7pt; font-family: Times New Roman,serif; text-indent: -9.35pt">M&amp;A advisory and due diligence(5)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">13.5</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.4</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-left: 18.7pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Expansion projects(6)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.8</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.7</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-left: 18.7pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Restructuring expenses(7)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.1</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.4</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">12.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.7</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; padding-left: 18.7pt; font-family: Times New Roman,serif; text-indent: -9.35pt">Mandatory discounts in tuition fees(8)&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">6.0</p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">33.4</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">6.5</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Adjusted EBITDA</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>135.2</b></p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>754.8</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>563.1</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>331.2</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>119.9</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2021 have been translated to U.S. dollars using an
exchange rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further
information about recent fluctuations in exchange rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Consists of interest received on late payments of monthly tuition fees.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>We believe these adjustments are appropriate to provide additional information to investors about certain material non-cash, non-recurring
items that we do not expect to continue at the same level in the future.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>Consists of expenses related to the integration of newly acquired schools.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(5)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(6)</td><td>Consists of expenses related to professional and consultant fees in connection with the opening of new campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(7)</td><td>Consists of expenses related to the employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(8)</td><td>Consists of mandatory discounts in tuition fees (due to COVID-19 on-site classes restrictions) related to individual and collective
legal proceedings.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(9)</td><td>On January 1, 2019 we adopted IFRS 16 using the modified retrospective method of adoption. See note 13.2.2 to our audited consolidated
financial statements. Accordingly, the information presented for the years ended</td></tr></table>


<!-- Field: Page; Sequence: 14 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt">December 31, 2018 is not comparable with 2021, 2020 and 2019 due to
the impacts of the adoption of IFRS-16 since 2019.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Reconciliation between Cash Flow from Operations and
Operating Cash Conversion Ratio</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya</p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Historical
    Afya Brazil</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="6" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2019</p></td>
    <td colspan="2" style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2018(8)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in US$ millions(1))</td>
    <td colspan="5" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="6" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(except percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Net cash flows from operating activities</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>113.1</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>630.8</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>371.5</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>299.2</b></td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>80.3</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Income taxes paid&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">35.7</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">19.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">8.5</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.9</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif"><b>Net cash flows from operating activities, before income taxes paid</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>119.5</b></p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>666.5</b></p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>390.9</b></p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>307.7</b></p></td>
    <td colspan="2" style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>84.2</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Adjusted EBITDA&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">135.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">754.8</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">563.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">331.2</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">119.9</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Integration of new companies(2)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.9</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.3</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">M&amp;A advisory and due diligence(3)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">13.5</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.8</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.4</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Expansion projects(4)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">18.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.7</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Restructuring expenses(5)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.4</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">12.1</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.7</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Mandatory discounts in tuition fees(6)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">33.4</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Adjusted EBITDA ex. non-recurring expenses&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">118.6</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">661.4</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">516.6</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">306.3</p></td>
    <td colspan="2" style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">112.0</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Operating Cash Conversion Ratio</b>(7)&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>100.8%</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>100.8%</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>75.7%</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>100.5%</b></p></td>
    <td colspan="2" style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>75.1%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="width: 53%">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 10%; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 9%; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 9%; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 9%; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 1%; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 9%; padding-left: 5pt">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>For convenience purposes only, amounts in reais for the year ended December 31, 2021 have been translated to U.S. dollars using an
exchange rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further
information about recent fluctuations in exchange rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Consists of expenses related to the integration of newly acquired schools.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Consists of expenses related to professional and consultant fees in connection with due diligence services for our M&amp;A transactions.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>Consists of expenses related to professional and consultant fees in connection with the opening of new campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(5)</td><td>Consists of expenses related to the employee redundancies in connection with the organizational restructuring of our acquired companies.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(6)</td><td>Consists of mandatory discounts in tuition fees (due to COVID-19 on-site classes restrictions) related to individual and collective
legal proceedings.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(7)</td><td>We calculate Operating Cash Conversion Ratio as the cash flows from operations <i>plus/minus</i> income taxes paid divided by Adjusted
EBITDA <i>plus/minus</i> non-recurring expenses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(8)</td><td>On January 1, 2019 we adopted IFRS 16 using the modified retrospective method of adoption. See note 13.2.2 to our audited consolidated
financial statements. Accordingly, the information presented for the years ended December 31, 2018 is not comparable with 2021, 2020 and
2019 due to the impacts of the adoption of IFRS-16 since 2019.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 15 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Operating Data (Historical)</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">As of December
    31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 56%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2019</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: top; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2018</p></td></tr>
  <tr>
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Educational Level</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Undergraduate medical degree students&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">16,017</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11,030</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6,597</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4,540</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Other non-medical undergraduate courses students&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">45,101</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">25,176</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">17,372</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">15,180</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Total undergraduate students(1)</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>61,118</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>36,206</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>23,969</b></td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt"><b>19,720</b></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Preparatory courses &#8211; B2C&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17,171</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11,316</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9,577</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Preparatory courses &#8211; B2B&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4,460</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,723</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,182</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Total preparatory courses(2)</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>21,631</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>13,039</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>10,759</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>&#8212;</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Medical specializations(3)&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">3,189</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">4,181</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">1,588</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Total students</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>85,938</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>53,426</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>36,316</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>19,720</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Operating undergraduate medical school campuses(4)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">30</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">19</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">12</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Approved undergraduate medical school campuses(4)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">35</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">24</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">20</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Operating medical school seats&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2,481</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,893</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,222</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">917</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Approved medical school seats(4)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2,731</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2,143</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,572</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,167</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Digital Health Services &#8211; Clinical Decision Software</b></td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Whitebook active payers</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">125,372</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">106,977</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">81,874</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">iClinic active payers</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17,978</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Excludes students that have not, by the beginning of the next school semester, paid monthly tuition fees which are due and payable.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Consists of Medcel only. Excludes (i)&#160;students that have not paid monthly fees within 30 days of becoming due and payable, and
(ii)&#160;students that have canceled their preparatory courses subscription. The information in this table as it relates to Medcel is
as of December 31, 2021, 2020 and 2019 only and does not set forth information as of December 31, 2018, as we acquired Medcel on March
29, 2019. We concluded the integration of Medcel in May 2020.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Refers to specialized medical courses for doctors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>Approved undergraduate medical school campuses and approved medical school seats refer to our total number of undergraduate medical
school campuses and seats approved by MEC for the periods indicated, whether or not operating. All our undergraduate medical school operating
campuses and medical school seats are also approved undergraduate medical school campuses and medical school seats, however not all of
our approved undergraduate medical school campuses and medical school seats are operating undergraduate medical school campuses and medical
school seats.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Exchange Rates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian foreign exchange system allows the purchase
and sale of foreign currency and the international transfer of <i>reais</i> by any person or legal entity, regardless of the amount, subject
to certain regulatory procedures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The real/U.S. dollar exchange rate reported by the Central
Bank was R$4.031 per US$1.00 on December 31, 2019, which reflected a 4.0% depreciation in the real against the U.S. dollar during 2019.
The real/U.S. dollar exchange rate reported by the Central Bank was R$5.196 per US$1.00 on December 31, 2020, which reflected a 28.9%
depreciation in the real against the U.S. dollar during 2020. As of December 31, 2021, the exchange rate for the sale of U.S. dollars
as reported by the Central Bank was R$5.580 per US$1.00, which reflected a 7.3% depreciation in the real against the U.S during 2021.
As of April 28, 2022, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.011 per US$1.00, which reflected
an appreciation of 10.2% in the real against the U.S. dollar since December 31, 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Central Bank has intervened occasionally in the foreign
exchange market to attempt to control instability in foreign exchange rates. We cannot predict whether the Central Bank or the Brazilian
government will continue to allow the <i>real</i> to float freely or will intervene in the exchange rate market by re-implementing a currency
band system or otherwise. The <i>real</i> may depreciate or appreciate substantially against the U.S. dollar in the future. Furthermore,
Brazilian law provides that, whenever there is a serious imbalance in Brazil&#8217;s balance of payments or</p>


<!-- Field: Page; Sequence: 16 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">there are serious reasons to foresee a serious imbalance, temporary restrictions
may be imposed on remittances of foreign capital abroad. We cannot assure you that the Brazilian government will not place restrictions
on remittances of foreign capital abroad in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth, for the periods indicated,
the high, low, average and period-end exchange rates for the purchase of U.S. dollars expressed in Brazilian <i>reais</i> per U.S. dollar.
The monthly and annual average rates are calculated by using the average of reported exchange rates by the Central Bank on each day during
a monthly period and on the last day of each month during an annual period, respectively.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 60%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Year</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period-end</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">2017&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.308</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.193</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.051</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.381</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">2018&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.875</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.656</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.139</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.188</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">2019&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.031</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.946</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">3.652</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.260</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">2020&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.196</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.158</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.021</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.937</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">2021&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.580</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.395</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.920</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.839</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the year.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 64%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Month</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period-end</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Average(1)</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Low(2)</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">High(3)</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">October 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.643</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.539</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.391</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.712</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">November 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.619</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.557</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.417</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.669</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">December 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.580</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.651</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.556</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.737</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">January 2022&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.357</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.534</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.357</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.704</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">February 2022&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.139</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.197</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.014</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.328</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">March 2022&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.738</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.968</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.738</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.135</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">April 2022 (through April 28, 2021)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.011</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.749</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.617</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">5.016</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt"><i>Source:</i> Central Bank.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Represents the average of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Represents the minimum of the exchange rates on the closing of each day during the month.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Represents the maximum of the exchange rates on the closing of each day during the month.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f006"></span>B.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Capitalization
and Indebtedness</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f007"></span>C.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Reasons
for the Offer and Use of Proceeds</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f008"></span>D.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Risk
Factors</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f009"></span>Summary of Risk Factors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">An investment in our Class A common shares is subject
to a number of risks, including risks relating to our business and industry, risks relating to Brazil and risks relating to our Class
A common shares. The following list summarizes some, but not all, of these risks. Please read the information in the section entitled
&#8220;Risk Factors&#8221; for a more thorough description of these and other risks.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">&#160;</p>


<!-- Field: Page; Sequence: 17 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Business and Industry</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>We may not be able to identify and acquire new medical higher education institutions or meet our strategic and financial goals
in connection with any business acquisition we seek, and difficulties in effectively integrating and managing a growing number of acquisitions
may adversely affect our strategic objectives.</i> We expect to continue to acquire medical higher education institutions and healthtech
companies as part of our strategy to expand our operations, including through acquisitions that may be material in size and/or of strategic
relevance. We cannot assure you that we will continue to be able to identify post-secondary education institutions focused on medicine
that provide suitable acquisition opportunities, or to acquire such institutions on favorable terms when necessary.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>We may require additional funds to continue our expansion strategy. If we are unable to obtain adequate financing on favorable
terms to complete any potential acquisition and implement our expansion plans, our growth strategy may be materially and adversely affected.</i>
In addition, we may face significant challenges in the process of integrating the operations of any acquired companies with our existing
business, such as the inability to manage a greater number of geographically dispersed employees and create and implement efficient uniform
controls, procedures and policies, in addition to the incurrence of high or unexpected integration costs. In particular, the social distancing
policies currently in place in Brazil resulting from the COVID-19 outbreak may place additional challenges for an expedited and timely
integration of such acquired companies with our existing business.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Our revenues are highly concentrated in the tuition fees we charge for our medical courses and other health sciences programs,
and any economic, market or regulatory factors adversely affecting such medical courses and health sciences programs could lead to decreased
demand in the medical and health courses we offer, which could materially adversely affect us.</i> Economic, market or regulatory factors,
such as in the context of an economic crisis due to the COVID-19 pandemic, affecting either the amount of tuition fees we are able to
charge for the medical courses and health sciences programs we offer or the ability of our students to pay such tuition fees could result
in significantly decreased demand for our services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Changes to the rules or delays or suspension of tuition payments made through FIES may adversely affect our cash flows and our
business. </i>We are subject to the risks associated with delays in the transfer of monthly tuition payments from the FIES program operated
by the Brazilian federal government, as well as to changes to the rules to renew FIES contracts.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>If we lose the benefits of federal tax exemptions provided under the PROUNI program, our business, financial condition and results
of operations may be materially adversely affected. </i>We may be disqualified from the PROUNI program and lose our tax exemptions if
we do not comply with certain requirements, such as providing total or partial scholarships for a percentage of students who paid their
tuition in the previous year, granting partial scholarships, and submitting to MEC semi-annual records of attendance, achievement and
dropout of students receiving scholarships, among others.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Our limited operating history as a consolidated company, our recent acquisitions and the comparability of our results may make
it difficult for investors to evaluate our business, financial condition, results of operations and prospects. </i>Because the historical
information included elsewhere in this annual report may not be representative of our results as a consolidated company, investors may
have limited financial information on which to evaluate us, their investment decision and our prior performance.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>An increase in delays and/or defaults in the payment of tuition fees may adversely affect our income and cash flows.</i> We depend
on the full and timely payment of the tuition we charge our students, including tuition payments we receive through FIES, which is largely
outside of our control.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Brazil</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>The Brazilian federal government has exercised, and continues to exercise, significant influence over the Brazilian economy. This
involvement as well as Brazil&#8217;s political and economic conditions could harm us and the price of our Class A common shares. </i>The
Brazilian government&#8217;s actions to control inflation and other policies and regulations have often involved, among other measures,
increases or decreases in interest</td></tr></table>


<!-- Field: Page; Sequence: 18 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 36pt">rates, changes in fiscal policies, wage and price controls, foreign
exchange rate controls, blocking access to bank accounts, currency devaluations, capital controls and import and export restrictions.
Uncertainty over whether the Brazilian federal government will implement reforms or changes in policy or regulation affecting these or
other factors in the future may affect economic performance and contribute to economic uncertainty in Brazil.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Economic uncertainty and political instability in Brazil may harm our business and the price of our Class A common shares. </i>Political
crises have affected and continue to affect the confidence of investors and the general public, which have historically resulted in economic
deceleration and heightened volatility in the securities offered by companies with significant operations in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Inflation and certain measures by the Brazilian government to curb inflation have historically harmed the Brazilian economy and
Brazilian capital markets, and high levels of inflation in the future would harm our business and the price of our Class A common shares.
</i>Inflation, policies adopted to curb inflationary pressures and uncertainties regarding possible future governmental intervention have
contributed to economic uncertainty and heightened volatility in the Brazilian capital markets.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Exchange rate instability may have adverse effects on the Brazilian economy, us and the price of our Class A common shares. </i>The
Brazilian government has implemented various economic plans and used various exchange rate policies, including sudden devaluations, periodic
mini-devaluations (during which the frequency of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate
markets and a floating exchange rate system. In addition, domestic and international reactions to restrictive economic policies could
have a negative impact on the Brazilian economy.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Infrastructure and workforce deficiency in Brazil may impact economic growth and have a material adverse effect on us. </i>Growth
is limited by inadequate infrastructure, including potential energy shortages and deficient transportation, logistics and telecommunication
sectors, general strikes, the lack of a qualified labor force, and the lack of private and public investments in these areas, which limit
productivity and efficiency.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Developments and the perceptions of risks in other countries, including other emerging markets, the United States and Europe, may
harm the Brazilian economy and the price of our Class A common shares. </i>The market for securities offered by companies with significant
operations in Brazil is influenced by economic and market conditions in Brazil and, to varying degrees, market conditions in other Latin
American and emerging markets, as well as the United States, Europe and other countries. To the extent the conditions of the global markets
or economy deteriorate, including as a result of the COVID-19 outbreak, the business of companies with significant operations in Brazil
may be harmed.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Certain Risks Relating to Our Class A Common Shares</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>An active trading market for our Class A common shares may not be sustainable. If an active trading market is not maintained, investors
may not be able to resell their shares and our ability to raise capital in the future may be impaired. </i>Although our Class A common
shares are listed and being traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained.
The stock market in general has experienced substantial price and volume fluctuations that have often been unrelated or disproportionate
to the operating performance of particular companies affected, such as in the context of an economic crisis due to the COVID-19 pandemic.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>The Esteves Family and Bertelsmann, our largest group of shareholders, own 100% of our outstanding Class B common shares, which
represents approximately 90.6% of the voting power of our issued share capital, and control all matters requiring shareholder approval.
This concentration of ownership and voting power limits your ability to influence corporate matters.</i> The decisions of the Esteves
Family and Bertelsmann on these matters may be contrary to your expectations or preferences, and they may take actions that could be contrary
to your interests. So long as the Esteves Family and Bertelsmann continue to beneficially own a sufficient number of Class B common shares,
even if they beneficially own significantly less than 50% of our outstanding share capital, acting together, they will be able to effectively
control our decisions.</td></tr></table>


<!-- Field: Page; Sequence: 19 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Class A common shares eligible for future sale may cause the market price of our Class A common shares to drop significantly. </i>The
market price of our Class A common shares may decline as a result of sales of a large number of our Class A common shares in the market
(including Class A common shares issuable upon conversion of Class B common shares) or the perception that these sales may occur. Our
shareholders or entities controlled by them or their permitted transferees will be able to sell their shares in the public market from
time to time without registering them, subject to certain limitations on the timing, amount and method of those sales imposed by regulations
promulgated by the SEC.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Our Articles of Association contain anti-takeover provisions that may discourage a third party from acquiring us and adversely
affect the rights of holders of our Class A common shares. </i>Our Articles of Association contain certain provisions that could limit
the ability of others to acquire our control, including a provision that grants authority to our board of directors to establish and issue
from time to time one or more series of preferred shares without action by our shareholders and to determine, with respect to any series
of preferred shares, the terms and rights of that series.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>If securities or industry analysts publish inaccurate or unfavorable research, about our business, the price of our Class A common
shares and our trading volume could decline. </i>The trading market for our Class A common shares will depend in part on the research
and reports that securities or industry analysts publish about us, our business, our market or our competitors. In the event one or more
of the analysts who covers us downgrades us or releases negative publicity about our Class A common shares, our share price would likely
decline.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>It is unlikely that we will declare any dividends on our common shares in the foreseeable future and therefore, you must rely on
price appreciation of our common shares for a return on your investment. </i>We do not anticipate paying any dividends in the foreseeable
future. Instead, we intend to retain earnings, if any, to fund the operation of our business and future growth. Any decision to declare
and pay dividends in the future will be made at the discretion of our general meeting of shareholders, acting pursuant to a proposal by
our board of directors, or by our board, and will depend on, among other things, our results of operations, cash requirements, financial
condition, contractual restrictions and other factors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>There can be no assurance that we will not be a passive foreign investment company, or PFIC, for any taxable year, which could
subject United States investors in our Class A common shares to significant adverse U.S. federal income tax consequences</i>. Based on
the composition of our income and assets and the value of our assets, including goodwill, which is based on the price of our Class A common
shares, we believe that we were not a PFIC for the taxable year of 2021. However, because we hold a substantial amount of cash (relative
to the assets shown on our balance sheet) and because our PFIC status for any taxable year will depend on the composition of our income
and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price of our Class
A common shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Our Business and Industry</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to identify and acquire new medical
higher education institutions or meet our strategic and financial goals in connection with any business acquisition we seek, and difficulties
in effectively integrating and managing a growing number of acquisitions may adversely affect our strategic objectives.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We expect to continue to acquire medical higher education
institutions, as part of our strategy to expand our operations, including through acquisitions that may be material in size and/or of
strategic relevance, and healthtech companies, as part of our strategy to become the partner of choice for every physician in Brazil not
only through educational products, but also providing digital services relevant to their daily routine. We cannot assure you that we will
continue to be able to identify post-secondary education institutions focused on medicine that provide suitable acquisition opportunities,
or to acquire such institutions on favorable terms when necessary.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, our previous and any future acquisitions
involve a number of risks and challenges that may have a material adverse effect on our business and results, including the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition may not contribute to our commercial strategy or the image of our institution;</td></tr></table>


<!-- Field: Page; Sequence: 20 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a future acquisition may be subject to approval by Brazil&#8217;s Administrative Council for Economic Defense <i>(Conselho Administrativo
de Defesa Econ&#244;mica,</i> or CADE) or other regulatory authorities, which may deny the necessary approvals for, or impose conditions
or restrictions on, the acquisition;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>we may face contingent and/or successor liabilities (either currently known or unknown to us) in connection with, among others things,
(i)&#160;judicial and/or administrative proceedings of the acquired institutions, including but not limited to, regulatory, tax, labor,
social security, environmental and intellectual property proceedings, and (ii)&#160;financial, reputational and technical issues, including
with respect to accounting practices, financial statement disclosures and internal controls, as well as other regulatory matters, all
of which may not be sufficiently indemnifiable under the relevant acquisition agreement;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the acquisition process may require additional funds and/or may be time-consuming, and the attention of our management may be diverted
from their day-to-day responsibilities and our operations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our investments in acquisitions may not generate the expected returns, and we may mismanage administrative and financial resources
as part of the integration process;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the business model of the institutions we acquire may differ from ours, and we may be unable to adapt them to our business model or
do so efficiently;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>we may not be able to integrate efficiently and successfully the operations of the institutions we acquire, including their personnel,
financial systems, distribution or operating procedures;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>certain acquisitions may impact our financial reporting obligations and the preparation of our consolidated financial statements,
resulting in delays to such preparation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the acquisitions may generate goodwill, the impairment of which will result in the reduction of our net income and dividends, and
our financial statements may be affected as a result of the application of our accounting policies to the results of our acquisitions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the transfer of management of the target institution resulting from a change of control or corporate restructuring must be notified
to the MEC within 60 days from the consummation of the acquisition, and MEC may impose additional restrictions on its reaccreditation;
and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>we may be unable to provide the acquired company with the necessary resources to support its operations and if, by the time of the
reaccreditation of the acquired company with the MEC, the MEC finds that we have failed to meet any applicable reaccreditation requirements,
it may impose additional restrictions or conditions on the reaccreditation of the acquired company.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may require additional funds to continue our expansion
strategy. If we are unable to obtain adequate financing on favorable terms to complete any potential acquisition and implement our expansion
plans, our growth strategy may be materially and adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, we may face significant challenges in the
process of integrating the operations of any acquired companies with our existing business, such as the inability to manage a greater
number of geographically dispersed employees and create and implement efficient uniform controls, procedures and policies, in addition
to the incurrence of high or unexpected integration costs. In particular, the social distancing policies currently in place in Brazil
resulting from the COVID-19 outbreak may place additional challenges for an expedited and timely integration of such acquired companies
with our existing business. As of the date of this annual report, we have fully integrated the operations of 16 of our acquisitions and
are in the process of integrating the operations of another 10 of our acquisitions with our existing business (Medphone, Shosp, Cliquefarma,
Medical Harbour, Medicinae, iClinic, Unigranrio, RX PRO, Al&#233;m da Medicina and Cardiopapers). The anticipated benefits of the acquisitions
we may pursue will not be achieved unless we successfully and efficiently integrate the acquired companies into our operations and effectively
manage, market and apply our business strategy to them. We may also be unable to integrate faculty and personnel with different professional
experiences and from different corporate cultures, and our relationship with current and new employees, including professors, may be impaired.
In addition, we may face challenges in entering into successful collective bargaining arrangements with unions due to differences in the
negotiation procedures followed in the different geographic regions of the acquired companies. If we are not able to</p>


<!-- Field: Page; Sequence: 21 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">manage our expanded operations and these integrations effectively, our business
could be materially adversely affected.</p>



<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">As of the date of this annual report, the COVID-19 pandemic is still evolving, and Brazilian authorities may once again impose a lockdown
of our on-campus activities for an undefined extended period of time, among other measures, all of which are outside of our control and
have materially adversely affected our business and results of operations. For further information, see &#8220; -- Public health outbreaks,
epidemics or pandemics, such as the COVID-19 pandemic, have adversely affected and may continue to adversely affect our business,&#8221;
and &#8220;Item 5. Operating and Financial Review and Prospects.&#8221;&#160;</span></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our revenues are highly concentrated in the tuition fees
we charge for our medical courses and other health sciences programs, and any economic, market or regulatory factors adversely affecting
such medical courses and health sciences programs could lead to decreased demand in the medical and health courses we offer, which could
materially adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A significant portion of our historical undergraduate
programs combined tuition fees are currently concentrated in the tuition fees we charge for our medical courses and other health sciences
programs across our network. For the years ended December 31, 2021, 2020 and 2019, 88.0%, 86.0% and 81.7%, respectively, of total historical
undergraduate programs combined tuition fees were derived from tuition fees we or our subsidiaries charged for medical courses and other
health sciences programs. Therefore, economic, market or regulatory factors, such as in the context of an economic crisis due to the COVID-19
pandemic, affecting either the amount of tuition fees we are able to charge for the medical courses and health sciences programs we offer
or the ability of our students to pay such tuition fees could result in significantly decreased demand for our services, which could materially
adversely affect us.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Changes to the rules or delays or suspension of tuition
payments made through FIES may adversely affect our cash flows and our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Some of our students finance their tuition fees through
the Higher Education Student Financing Fund <i>(Fundo de Financiamento ao Estudante do Ensino Superior,</i> or FIES) created by the Brazilian
federal government, and operated through the National Fund for Educational Development <i>(Fundo Nacional de Desenvolvimento da Educa&#231;&#227;o,</i>
or FNDE), which offers financing to low-income students enrolled in undergraduate programs in private higher education institutions. As
of 2018, we have adhered to the &#8220;New FIES,&#8221; a new federal program aimed at providing student financing. Similar to the FIES,
the New FIES provides financial support for low-income students throughout Brazil, in particular in the North, Northeast and Midwest regions.
As a result, our exposure to the risks associated with delays in the transfer of monthly tuition payments from the FIES program operated
by the Brazilian federal government, which we calculate by dividing the sum of the historical undergraduate programs combined tuition
fees financed through FIES by total historical undergraduate programs combined tuition fees, was 8.0%, 11.8% and 9.4% of total historical
undergraduate programs combined tuition fees as of December 31, 2021, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Should (i)&#160;the Brazilian federal government terminate
or reduce the transfer of monthly payments to our institutions that participate in FIES or New FIES, (ii)&#160;the students benefiting
from FIES or New FIES fail to meet the requirements for enrollment in the programs or (iii)&#160;the Brazilian federal government extend
the term to make reimbursements under FIES or New FIES or adversely change their rules, our results of operations and cash flow may be
materially adversely affected. We may also experience a decline in revenues and a decline in the number of students at our campuses from
the FIES and the New FIES programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Moreover, recent changes to the rules to renew FIES contracts,
as well as the shutdown of the system to enter into new student financing agreements, may negatively affect the number of students enrolled
in our courses, causing a reduction in our revenues. For more information regarding the changes to FIES contracts, see &#8220;Item 4.
Information on the Company&#8212;Business Overview&#8212;Regulatory Overview.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we lose the benefits of federal tax exemptions provided
under the PROUNI program, our business, financial condition and results of operations may be materially adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Some of our students participate in the University for
All Program <i>(Programa Universidade para Todos,</i> or PROUNI program). Through the PROUNI program, the Brazilian federal government
grants a number of full and</p>


<!-- Field: Page; Sequence: 22 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">partial scholarships to low-income post-secondary education students. As
a result of our participation in the PROUNI program, we benefit from certain federal tax exemptions relating to bachelor&#8217;s and associate&#8217;s
degree programs, such as (i)&#160;income tax, (ii)&#160;Social Contribution Tax on Gross Revenue (<i>Programa de Integra&#231;&#227;o
Social</i>, or PIS), (iii)&#160;Social Security Financing Tax on Gross Revenue (<i>Contribui&#231;&#227;o para o Financiamento da
Seguridade Social</i>, or COFINS), and (iv)&#160;Social Contribution Tax on Net Profit (<i>Contribui&#231;&#227;o Social sobre o Lucro
L&#237;quido</i>, or CSLL), regarding our revenues from undergraduate and associate programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may be disqualified from the PROUNI program and lose
our tax exemptions if we do not comply with certain requirements, such as providing total or partial scholarships for a percentage of
students who paid their tuition in the previous year, granting partial scholarships, and submitting to MEC semi-annual records of attendance,
achievement and dropout of students receiving scholarships, among others. See &#8220;Item 4. Information on the Company&#8212;Business
Overview&#8212;Regulatory Overview.&#8221; If we lose our tax exemptions or are unable to comply with other, more stringent requirements
that may be introduced in the future, our business, financial condition and results of operations could be materially adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">There is a risk that additional changes in tax laws may
prohibit, interrupt or modify the use of existing tax exemptions, and we cannot assure you that we will fully maintain such tax and other
benefits related to PROUNI in the event the tax laws are amended further. Any suspension, accelerated default, repayment or inability
to renew our tax exemptions may have an adverse effect on our results of operations. As of the date of this annual report, there are two
main proposed tax law amendments that are under review by the Brazilian congress: (i)&#160;Bill No. 3,887/2020, which expressly revokes
the PIS and COFINS tax exemptions for the PROUNI program; and (ii)&#160;Constitutional Amendment Proposal No. 45/2020, which proposes
a new tax to substitute PIS and COFINS (and other state and municipal taxes) with no tax exemptions. If we lose our tax exemptions and
incentives, if we are unable to comply with future requirements or if changes in the law limit our ability to maintain these tax benefits,
our business, financial condition and results of operations may be significantly and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our operating history as a consolidated company, our
recent acquisitions and the comparability of our results may make it difficult for investors to evaluate our business, financial condition,
results of operations and prospects.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our operating history as a consolidated company and recent
acquisitions may make it difficult for you to evaluate our business, financial condition, results of operations and prospects. Because
the historical information included elsewhere in this annual report may not be representative of our results as a consolidated company,
investors may have limited financial information on which to evaluate us, their investment decision and our prior performance. Our results
of operations for the year ended December 31, 2021 are not directly comparable to our results of operations for the year ended December
31, 2020, and our results of operations for the year ended December 31, 2020 are not directly comparable to our results of operations
for the year ended December 31, 2019, due to the effects of the acquisition of the Acquired Companies. Our ability to forecast our future
operating results, including revenue, cash flows and profitability, as well as the operational inefficiencies that we may face as we continue
to integrate the Acquired Companies, is limited and subject to a number of uncertainties. Moreover, past performance is no assurance of
future returns.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The interests of our management team may be focused on
the short-term market price of our Class A common shares, which may not coincide with your interests. In addition, our shareholders may
suffer dilution of their interests in our share capital and in the value of their investments due to the issuance of new shares for settlement
of our share-based incentive plans.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our directors and officers, among others, own shares
issued by us and are beneficiaries under our stock option plans. Our 2018 stock option plan, which has now been formally terminated, was
fully vested and exercised upon the completion of our initial public offering and we approved a new stock option plan for our managers
and employees in August 2019 (as amended in July 2020), and reserved up to 4% of our common shares at any time for issuance under this
new equity incentive plan. See &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8212;New Long-Term Incentive
Plan.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Due to the issuance of stock options to members of our
management team, a significant portion of their compensation is closely tied to our results of operations and, more specifically to the
trading price of our Class A common shares, which may lead such individuals to direct our business and conduct our activities with an
emphasis on short-term profit generation. In view of the market disruption caused by the COVID-19 pandemic, the trading</p>


<!-- Field: Page; Sequence: 23 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">price of our Class A common shares has significantly decreased, which if
sustained for a longer period of time may also adversely affect our ability to retain members of our management. As a result of these
factors, the interests of our management team may not coincide with the interests of our other shareholders that have longer-term investment
objectives.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Once the options have been exercised by the participants,
our board of directors will determine whether our capital stock should be increased through the issuance of new shares to be subscribed
by participants, or if they will be settled through shares held in treasury. In the event settlement occurs through the issuance of new
shares, our shareholders will suffer dilution, of their interests in our share capital and in the value of their investments, up to a
maximum of 4% of our common shares at any time.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In case of new stock option grants, whether under existing
plans or new plans that may be approved by our shareholders at the shareholders&#8217; meeting, our shareholders will be subject to additional
dilution. For additional information on our stock option plan, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B.
Compensation of Directors and Officers&#8221; for additional information.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An increase in delays and/or defaults in the payment
of tuition fees may adversely affect our income and cash flows.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We depend on the full and timely payment of the tuition
we charge our students, including tuition payments we receive through FIES, which is largely outside of our control, such as in the context
of an economic crisis due to the COVID-19 pandemic. An increase in payment delinquency or default by our students may have a material
adverse effect on our cash flows and our business, including our ability to meet our obligations. Our allowance for doubtful accounts
expenses as a percentage of our net revenues was 2.8%, 2.7% and 2.0% for the years ended December 31, 2021, 2020 and 2019, respectively.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Difficulties in identifying, opening and efficiently
managing new campuses or in obtaining regulatory authorizations and accreditations on a timely basis as part of our organic growth strategy
may adversely affect our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our organic strategy includes expanding by opening new
campuses and integrating them into our educational network. This growth plan creates significant challenges in terms of maintaining our
teaching quality and culture, as a result of the complexity and difficulty of effectively managing a greater number of campuses and programs.
If we are unable to maintain our current quality standards, we may lose market share and be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Establishing new campuses poses important challenges
and requires us to make significant investments in infrastructure, marketing, personnel and other pre-operational expenses, mainly identifying
new sites for lease or purchase. We prioritize identifying strategic sites, negotiating the purchase or lease of properties, building
or refurbishing facilities (including libraries, laboratories and classrooms), obtaining local permits, hiring and training faculty and
staff, and investing in administration and support.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are also required to register our new campuses with
MEC, before opening and operating them, as well as having our new programs accredited by MEC in order to issue official degrees and certificates
to our students. If we do not succeed in identifying and establishing our campuses in a cost-effective manner or in obtaining such authorizations
or accreditations on a timely basis, or if MEC imposes restrictions or conditions on our accreditation requests for new campuses, our
business may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to successfully expand our presence
and performance in the distance learning business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may face difficulties in successfully operating our
distance learning program and in implementing and investing in the technologies necessary to operate a successful distance learning program,
where the technological needs, the expectations of our customers and market standards change rapidly. We have to quickly modify our products
and services to adapt to new distance learning technologies, practices and standards. We may be adversely affected if current or future
competitors introduce products or service platforms that are superior to those we offer, or if our resources are not adequate to develop
and adapt our technological capabilities rapidly enough to maintain our competitive position.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the success of our distance learning programs
depends on the general population having easy and affordable access to the internet, as well as on other technological factors that are
outside of our control. If the</p>


<!-- Field: Page; Sequence: 24 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">internet becomes inaccessible or access costs increase to levels higher
than current prices, or if the number of students interested in distance learning educational methods does not increase, we may be unable
to successfully implement our distance learning program strategy, which would have an adverse effect on our growth strategy.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We face significant competition in each program we offer
and each geographic region in which we operate. If we fail to compete efficiently, we may lose market share and our profitability may
be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We compete with various public and private post-secondary
education institutions, including distance learning institutions. Our competitors may offer programs or courses similar to or better than
those offered by us, have access to more funds, be more prestigious or well-regarded within the academic community, have more conveniently
located campuses with better infrastructure, or charge lower tuition. In addition, on April 5, 2018, MEC issued Ordinance No. 328/18,
pursuant to which, among other measures, MEC imposed a five-year suspension on the granting of authorizations for the creation of new
medical education courses. Accordingly, institutions cannot create and implement new undergraduate medical education courses until April
2023. In the event MEC lifts these restrictions prior to April 2023, this may result in the creation of new medical education courses,
which will in turn increase competition and may create greater pricing or operating pressure on us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Although an ordinance authorizing a new course in medicine
should occur through a public call, i.e., through the <i>Mais M&#233;dicos</i> Program (<i>Programa Mais M&#233;dicos</i>), some educational
institutions have been judicially challenging this restriction to compel MEC to receive and review requests for new medicine courses outside
the <i>Mais M&#233;dicos</i> Program (<i>Programa Mais M&#233;dicos</i>) rules by alleging that these rules are an undue restriction
on freedom of competition. Certain courts may ultimately compel the MEC to receive and review these requests. Accordingly, and to compete
effectively, we may be required to reduce our tuition or increase our operating expenses (including our costs per student) in order to
retain or attract students or to pursue new market opportunities. Furthermore, we were awarded, seven new undergraduate campuses as part
of the &#8220;Mais M&#233;dicos&#8221; program, all of which are located in remote regions of Brazil and which operations are subject
to the verification by the MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements. We cannot assure you
that there will be sufficient student demand to fill all medical school seats available on such campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result of the foregoing, our revenues and profitability
may decrease. We cannot assure you that we will be able to compete successfully against our current or future competitors. If we are unable
to maintain our competitive position or otherwise respond to competitive pressures effectively, we may lose our market share, our profits
may decrease and we may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to update, improve or offer the content
of our existing programs to our students on a cost-effective basis, which may materially adversely affect our ability to attract and retain
students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">To differentiate ourselves and remain competitive, we
must continually update our courses and develop new educational programs, including through the adoption of new technological tools. Updates
to our current courses and the development of new educational programs may not be readily accepted by our students or by the market. Also,
we may not be able to introduce new educational programs at the same pace as our competitors or at the pace required by the labor market.
If we do not adequately modify our educational programs in response to market demand, whether due to financial restrictions, unusual technological
changes or otherwise, our ability to attract and retain students may be impaired and we may be materially adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we continue to grow, we may not be able to appropriately
manage the expansion of our business and staff, the increased complexity of our software and platforms, or grow in our addressable market.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are currently experiencing a period of significant
expansion and are facing a number of expansion-related issues, such as the acquisition and retention of experienced and talented personnel,
cash flow management, corporate culture and efficacy of internal controls, among others. These issues and the significant amount of time
spent on addressing them may result in the diversion of our management&#8217;s attention from other business issues and opportunities.
In addition, we believe that our corporate culture and values are critical to our success, and we have invested a significant amount of
time and resources building them. If we fail to preserve our corporate culture and values, our ability to recruit, retain and develop
personnel and to effectively implement our strategic plans may be harmed.</p>


<!-- Field: Page; Sequence: 25 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We must constantly update our software, enhance and improve
our billing, transaction and other business systems, and add and train new software designers and engineers, as well as other personnel.
This process is time intensive and expensive, and may lead to higher costs in the future. Furthermore, we may need to enter into relationships
with various strategic partners other online service providers and other third parties necessary to our business. The increased complexity
of managing multiple commercial relationships could lead to execution problems that can affect current and future revenues, and operating
margins.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We cannot assure you that our current and planned platform
and systems, procedures and controls, personnel and third-party relationships will be adequate to support our future operations. In addition,
our current expansion has placed significant strain on management and on our operational and financial resources, and this strain is expected
to continue. Our failure to manage growth effectively could seriously harm our business, results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The ability to attract, recruit, retain and develop key
personnel and qualified employees is critical to our success and growth. If we lose key personnel, our business, financial condition and
results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In order for us to successfully compete and grow, we
must attract, recruit, retain and develop the necessary personnel who can provide the needed expertise across the entire spectrum of our
intellectual capital needs. While we have a number of our key personnel who have substantial experience with our operations, we must also
develop our personnel to provide succession plans capable of maintaining continuity in the midst of the inevitable unpredictability of
human capital. However, the market for qualified personnel is competitive, and we may not succeed in recruiting additional personnel or
may fail to effectively replace key current personnel who depart with qualified or effective successors. We must continue to hire additional
personnel to execute our strategic plans. Our effort to retain and develop personnel may also result in significant additional expenses,
which could adversely affect our profitability. We cannot assure you that qualified employees will continue to be employed, that we will
manage them successfully, or that, in the future, we will be able to attract qualified personnel with similar skills and expertise at
equivalent cost and retain them.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are also dependent upon the ability and experience
of a number of our key personnel who have substantial experience with our operations. Many of our key personnel have worked for us for
a significant amount of time or were recruited by us specifically due to their industry experience. It is possible that the failure to
retain or attract the services of one or a combination of our senior executives, board members (including those with M&amp;A experience
related to our industry), or key managers, could have a material adverse effect on our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><span style="background-color: white">Any increase in
the attrition rates of students in our education programs may adversely affect our results of operations.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">We believe that
our attrition rates are primarily related to the personal motivation and financial situation of our current and potential students, as
well as to socioeconomic conditions in Brazil. Significant changes in future attrition rates and/or failure to re-enroll may affect our
enrollment numbers, such as in the context of an economic crisis due to the COVID-19 pandemic, and may have a material adverse effect
on our revenues and our results of operations.</span></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Public health outbreaks, epidemics or pandemics, such
as the COVID-19 pandemic, have adversely affected and may continue to adversely affect our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Public health outbreaks, epidemics or pandemics, such
as the COVID-19 pandemic, could materially adversely impact our business. In December 2019, a novel strain of coronavirus (COVID-19) was
reported to have emerged in Wuhan, China. COVID-19 has since spread to most of the countries around the globe, including every state in
Brazil. On March&#160;11, 2020, the World Health Organization declared the COVID-19 outbreak a pandemic, and on March 20, 2020, the Brazilian
federal government declared a national emergency with respect to COVID-19, which remained in place as of December 31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The global COVID-19 outbreak is an unprecedented and
rapidly evolving situation. The spread of COVID-19, or actions taken to mitigate its spread, has and may continue to have material and
adverse effects on our ability to operate effectively. We may be required to completely or partially close facilities, and we may suffer
labor</p>


<!-- Field: Page; Sequence: 26 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">shortages, particularly of our teaching faculty, which is mostly composed
of doctors who continue to work shifts at hospitals and are consequently more exposed to COVID-19 than non-medical administrative staff.
Likewise, we may suffer financial and reputational harm were an outbreak to occur among our students, as our students participating in
in-person hospital and healthcare residency programs are more exposed to COVID-19 than our students who are currently partaking in educational
activities solely via our online platform. We may not be able to provide online classes to our students and keep them engaged with online
classes during the COVID-19 pandemic or resume on-campus practical classes for the majority of our medical students during the COVID-19
pandemic. Factors that have affected and will continue influencing the effect on our operations, most of which are outside of our control,
include the economic consequences and duration of the outbreak, new information that emerges concerning the severity of COVID-19 and actions
taken to contain the outbreak or treat its impact, among others.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The extent of the adverse effect on our operations, including,
among others, the regular functioning of our facilities, will depend on the extent and severity of the continued spread of COVID-19 in
Brazil. Since March 17, 2020, there have been interruptions of our on-campus activities due to Brazilian government authorities&#8217;
mandatory lockdowns, which remained in place as of December 31, 2020 to varying degrees depending on the region of Brazil, with a significant
portion of our nonpractical educational activities being temporarily offered through our online platform (rather than on-site), and the
calendar of our practical educational activities being rescheduled to when authorities will allow on-campus activities to resume. As of
the date of this annual report, all lockdown restrictions have been revoked by Brazilian authorities in our campus locations and we successfully
resumed our on-campus activities and classes.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In response to the impact of the COVID-19 pandemic, we
assessed whether we had satisfied all of our contracts containing customer performance obligations in accordance with IFRS 15, and concluded
it was necessary to defer a portion of our net revenue for the second half of 2020. We were able to manage, replace and reschedule these
activities so that all of our performance obligations were satisfied and we recognized these revenues from customers. Some of our second
half practical educational activities (particularly for students in the first to fourth years) will need to be replaced during the first
half of 2021. Therefore, a portion of our revenue recognition has been postponed.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, through 2020 and 2021, the States of Rio
de Janeiro, Par&#225;, Tocantins, Piau&#237;, Rond&#244;nia, Maranh&#227;o, Bahia, Cear&#225; and Para&#237;ba had state decrees
in place guaranteeing discounts to all students in such states, and we consequently granted mandatory discounts to our students in the
total amount of R$33.4 million for the year ended December 31, 2021 and R$6.5 million for the year ended December 31, 2020. Initially,
many of these mandatory discounts programs were suspended as their constitutionality was challenged before Brazilian superior courts.
The laws of the states of Bahia, Maranh&#227;o and Cear&#225; regarding the reduction of tuition fees in private educational institutions
were ruled as unconstitutional by the Brazilian Federal Supreme Court in December 2020, and the laws of the States of Rio de Janeiro and
Par&#225; were also ruled as unconstitutional thereafter. Beginning in March 2021, we began invoicing our students without regard to
any purported mandatory discounts. Further, on November 18, 2021, the Brazilian Federal Supreme Court (<i>Supremo Tribunal Federal</i>),
or the STF, held, by a majority decision, that judicial decisions and rulings that impose a generic reduction of tuition fees in private
educational institutions based on the outbreak of the COVID-19 pandemic are unconstitutional. Nonetheless, we are still facing individual
and class action legal proceedings all across the country. For further information, see &#8220;Item 6. Directors, Senior Management and
Employees&#8212;A. Directors and Senior Management&#8212;Legal Proceedings.&#8221; The total mandatory discounts granted due to COVID-19,
net of discounts that have been recovered from previous period, totaled R$33.4 million during 2021 and R$24.8 million was related to FCMPB
(R$6.5 million for the year ended December 31, 2020).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The COVID-19 pandemic is still evolving, and Brazilian
authorities may once again impose a lockdown of our on-campus activities for an undefined extended period of time, among other measures,
all of which are outside of our control and may materially adversely affect our business, financial condition, results of operations and
cash flows for an extended period of time. We may also suffer labor shortages, particularly of our teaching faculty, which is mostly composed
of doctors that continue to have work shifts at hospitals and are consequently more exposed to COVID-19 than non-medical administrative
staff. The COVID-19 pandemic is expected to cause a material and adverse effect on the general economic, financial, political, demographic
and business conditions in Brazil, which may reduce the disposable income of our students and their families, and consequently (i)&#160;result
in an adverse impact on the ability of our students (current and/or prospective) to pay our tuition fees and/or (ii)&#160;trigger an increase
in our attrition rates. As a result, it is still uncertain whether or not the pandemic will lead to a risk of an increase in</p>


<!-- Field: Page; Sequence: 27 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">impairment of our financial assets and a reduction of our cash generation
and the recoverable amounts of our cash-generating units.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the impact of the COVID-19 pandemic amplifies
the risk that disruptions in public and private infrastructure, including communications and financial services, could materially and
adversely disrupt our normal business operations. We have transitioned a significant subset of our employees to a remote work environment
in an effort to mitigate the spread of COVID-19, which may exacerbate certain risks to our business, including an increased demand for
information technology resources, increased risk of phishing and other cybersecurity attacks, and increased risk of the unauthorized dissemination
of personal information, sensitive personal information or proprietary or confidential information about us or our customers or other
third parties. Further, we process personal data, and we therefore will be subject to the Brazilian Data Protection Law (<i>Lei Geral
de Prote&#231;&#227;o de Dados</i>, or LGPD). Considering that our processing of personal data has increased as a result of the measures
we adopted due to the COVID-19 pandemic, if we fail to comply with any provisions provided for in the LGPD, we could be subject to lawsuits
filed by the data subjects, public authorities and private associations, including those for compensation for damages arising from the
violation of the data subjects&#8217; rights, and we could be subject to the penalties provided for not only in the LGPD, but also in
sectorial legislation, such as the Brazilian Consumer Defense and Protection Code (<i>C&#243;digo de Defesa do Consumidor</i>) and the
Brazilian Civil Framework of the Internet (<i>Marco Civil da Internet</i>). If we do not comply with the LGPD and are in turn subject
to sanctions, we may suffer financial and reputational losses, which may adversely affect our financial results. See &#8220;Item 3. Key
Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Failure to prevent or detect a malicious
cyber-attack on our systems and databases could result in a misappropriation of confidential information or access to highly sensitive
information,&#8221; &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our
success depends on our ability to monitor and adapt to technological changes in the education sector and maintain a technological infrastructure
that works adequately and without interruption,&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating
to Our Business and Industry&#8212;Failure to comply with data privacy regulations could result in reputational damage to our brands and
adversely affect our business, financial condition and results of operations.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The rapid development and fluidity of this situation
precludes our ability to predict the ultimate adverse impact of COVID-19 on us. We are continuing to monitor the spread of the COVID-19
and related risks. There are no comparable recent events that may provide guidance as to the effect of the spread of COVID-19 pandemic,
and, as a result, the ultimate impact of the COVID-19 pandemic is highly uncertain and subject to change.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We could be adversely affected if we are unable to renegotiate
collective bargaining agreements with the labor unions representing our professors and administrative employees or by strikes and other
union activity.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our payroll costs and expenses account for the majority
of the costs of services and general and administrative expenses, or 53.1%, 53.3% and 59.2% of such costs and expenses for the years ended
December 31, 2021, 2020 and 2019, respectively. Our faculty and administrative employees are represented by labor unions in the higher
education sector and are covered by collective bargaining agreements or similar arrangements determining the number of working hours,
minimum compensation, vacations and fringe benefits, among other terms. These agreements are subject to annual renegotiation and may be
so modified. We could also be adversely affected if we fail to achieve and maintain cooperative relationships with our professors&#8217;
or administrative employees&#8217; unions or face strikes, stoppages or other labor disruptions by our professors or employees. In addition,
we may not be able to pass on any increase in costs arising from the renegotiation of collective bargaining agreements to the monthly
tuition fees paid by students, which may have a material adverse effect on our business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may be held liable for extraordinary events that may
occur at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may be held liable for the actions of officers, directors,
professors or other employees at our campuses, including allegations of non-compliance by officers, directors, professors or other employees
with specific legislation and regulations implemented by MEC relating to our programs. In the event of accidents, injuries or other damages
affecting students, professors, other employees or third parties at our campuses, we may face claims alleging that we were negligent,
provided inadequate supervision or were otherwise liable for the injury. We may also be subject to claims alleging that officers, directors,
professors or other employees committed moral or sexual harassment or other unlawful acts. Our insurance coverage may not cover certain
indemnifications we may be required to pay, be insufficient to cover these types of claims, or may not cover certain acts or events. We
may also</p>


<!-- Field: Page; Sequence: 28 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">not be able to renew our current insurance policies under the same terms.
Such liability claims may affect our reputation and harm our financial results. See &#8220;Item 4. Information on the Company&#8212;Business
Overview&#8212;Insurance.&#8221; In addition, we may also be subject to legal proceedings by current and/or former students alleging breaches
of rights granted by the Brazilian Consumer Protection Code <i>(C&#243;digo de Defesa do Consumidor),</i> and to legal proceedings by
current and/or former employees alleging breaches of applicable labor laws. Even if unsuccessful, these claims may cause negative publicity,
reduce enrollment numbers, increase student attrition rates, entail substantial expenses and divert the time and attention of our management,
materially adversely affecting our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may face restrictions and penalties under the Brazilian
Consumer Protection Code in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil has a series of strict consumer protection laws,
referred to collectively as the Consumer Protection Code <i>(C&#243;digo de Defesa do Consumidor).</i> These laws apply to all companies
in Brazil that supply products or services to Brazilian consumers. They include protection against misleading and deceptive advertising,
protection against coercive or unfair business practices and protection in the formation and interpretation of contracts, usually in the
form of civil liabilities and administrative penalties for violations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">These penalties are often levied by the Brazilian Consumer
Protection Agencies <i>(Funda&#231;&#227;o de Prote&#231;&#227;o e Defesa do Consumidor,</i> or PROCONs), which oversee consumer
issues on a district-by-district basis. Companies that operate across Brazil may face penalties from multiple PROCONs, as well as from
the National Secretariat for Consumers <i>(Secretaria Nacional do Consumidor</i>, or SENACON). Companies may settle claims made by consumers
via PROCONs by paying compensation for violations directly to consumers and through a mechanism that allows them to adjust their conduct,
called a conduct adjustment agreement <i>(Termo de Ajustamento de Conduta,</i> or TAC).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazilian public prosecutors may also commence investigations
of alleged violations of consumer rights and require companies to enter into TACs. Companies that violate TACs face potential enforcement
proceedings and other potential penalties such as fines, as set forth in the relevant TAC. Brazilian public prosecutors may also file
public civil actions against companies who violate consumer rights or competition rules, seeking strict adherence to the consumer protection
laws and compensation for any damages to consumers. In certain cases, we may also face investigations and/or sanctions by the CADE, in
the event our business practices are found to affect the competitiveness of the markets in which we operate or the consumers in such markets.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Any change or review of the tax treatment of our activities,
or the loss or reduction in tax benefits on the sale of books (including digital content) may materially adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian Federal Constitution, in Article 150, exempts
production, sale and resale activities involving books. In this sense, Medcel is not taxed by the federal VAT (tax on industrial activity,
or &#8220;IPI&#8221;), the state VAT (tax on sale or resale of products, or &#8220;ICMS&#8221;) and the municipal VAT (tax on services,
or &#8220;ISS&#8221;). Accordingly to Brazilian federal law No. 10,865/2004, the Company is also benefited from a zero tax rate on Federal
Social Contributions, PIS and COFINS, which are calculated on gross revenue. If the Brazilian government or tax authority or the Brazilian
superior courts decide to change or review the tax treatment for the production or sales of books (including digital books and e-readers),
and we are unable to pass any cost increase onto our students, our results may be materially adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we are unable to maintain consistent educational quality
throughout our network, including the educational materials of our post-secondary education institutions, or keep or adequately train
our faculty members, we may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our teaching faculty, including teachers and professors
at our post-secondary education institutions, is essential for maintaining the quality of our programs and the strength of our brand and
reputation. We promote training in order for our faculty to attain and maintain the qualifications we require and for us to provide updating
programs on trends and changes in their areas. Due to shortages in the supply of qualified professors, competition for hiring and retaining
qualified professionals has increased substantially. We cannot assure you that we will succeed in retaining our current professors or
recruiting or training new professors who meet our quality standards, particularly as we continue to expand our operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The quality of our academic curricula and the infrastructure
of our campuses are also key elements of the quality of the education we provide. We cannot assure you that we will succeed in identifying
facilities with</p>


<!-- Field: Page; Sequence: 29 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">adequate infrastructure for our new campuses, develop adequate infrastructure
in properties we acquire or have enough resources to continue expanding through acquisitions or development of new projects. In addition,
we cannot assure you that we will be able to develop academic curricula for our new programs with the same levels of excellence as existing
programs and meeting the standards set forth by MEC. Shortages of qualified professors, adequate infrastructure or quality academic curricula
for new programs according to our business model and the parameters set forth by MEC, may have a material adverse effect on our business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our business depends on the continued success of the
brands of each of our institutions, as well as the <span style="font-style: normal">&#8220;</span>Afya<span style="font-style: normal">&#8221;</span>
brand, and if we fail to maintain and enhance the recognition of our brands, we may face difficulty enrolling new students, and our reputation
and operating results may be harmed.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe that market awareness of our brands has contributed
significantly to the success of our business. Maintaining and enhancing our brands is critical to our efforts to grow student enrollments.
Failure to maintain and enhance our brand recognition could have a material and adverse effect on our business, operating results and
financial condition. We have devoted significant resources to our brand promotion efforts in recent years, but we cannot assure you that
these efforts will be successful. If we are unable to further enhance our brand recognition, or if we incur excessive marketing and promotion
expenses, or if our brand image is negatively impacted by any negative publicity, our business and results of operations may be materially
and adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we are not able to maintain our current MEC evaluation
ratings and the evaluation ratings of our students, we may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We and our students are regularly evaluated and rated
by MEC. If our campuses, programs or students receive lower scores from MEC than in previous years in any of its evaluations, including
the IGC <i>(&#205;ndice Geral de Cursos),</i> and the Student Performance National Exam <i>(Exame Nacional de Desempenho de Estudantes,</i>
or ENADE), we may experience a reduction in enrollments and be adversely affected by perceptions of decreased educational quality, which
may negatively affect our reputation and, consequently, our results of operations and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Finally, in the event that any of our programs receive
unsatisfactory evaluations, the post-secondary education institution offering the programs may be required to enter into an agreement
with MEC setting forth proposed measures and timetables to improve the program and remedy the unsatisfactory evaluation. Non-compliance
with the terms of the agreement may result in additional penalties on the institution. These penalties could include, but are not limited
to, suspending our ability to enroll students in our programs, denial of accreditation or re-accreditation of our institutions or prohibiting
us from holding regular class sessions, all of which can adversely affect our results of operations and financial condition.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to supervision by MEC and, consequently,
may suffer sanctions as a result of non-compliance with any regulatory requirements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazilian Federal Law No. 10,861/2004, regulated by Decree
No. 9,235/2017, implemented the activities of supervision of post-secondary education entities and courses in the Brazilian federal education
system. The Secretariat for Regulation and Supervision of Post-secondary Education, or SERES, of MEC is responsible for the regular and
special supervision of the corresponding courses and programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Regular supervision derives from complaints and allegations
by students, parents and faculty members, as well as by public entities and the press. These complaints and allegations involve specific
cases of entities with courses showing evidence of irregularities or deficiencies. We are subject to those complaints and representations.
Special supervision, on the other hand, may be commenced by MEC itself, based on its post-secondary education regularity and quality standards,
and involves more than one course or entity, grouped according to the criteria chosen for the special supervision. These criteria may
include unsatisfactory results in the ENADE and the Difference Indicator between Expected and Actual Performance <i>(Indicador de Diferen&#231;a
entre os Desempenhos Observado e Esperado),</i> among other quality indicators, the history of course evaluations by INEP, as well as
compliance with specific legal requirements as, for example, the minimum ratio between faculty members with master&#8217;s or doctorate
degrees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Administrative irregularities can include, among others:
(i)&#160;unlicensed or irregular post-secondary courses; (ii)&#160;any outsourcing of post-secondary education activities; (iii)&#160;the
failure to file a re-accreditation or recognition or renewal request with respect to post-secondary education courses within the time
periods enacted by MEC pursuant to Decree No. 9,235/2017; and (iv)&#160;failure to comply with any penalties imposed by the MEC.</p>


<!-- Field: Page; Sequence: 30 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If MEC concludes, as part of its supervisory activities,
that an irregularity constitutes an imminent risk or threat to students or the public interest, it may impose the following measures on
the relevant educational institution for a period to be determined by SERES: (i)&#160;suspend the admission of new students; (ii)&#160;suspend
the offering of undergraduate or postgraduate <i>lato sensu </i>courses; (iii)&#160;suspend the institution&#8217;s discretionary ability
to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspend the license
to establish new distance learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and prohibit new
regulatory requests; (vi)&#160;suspend participation in the New FIES; (vii)&#160;suspend participation in PROUNI; and (viii)&#160;suspend
or restrict participation in other federal education programs. The educational institution can contest the MEC&#8217;s findings by filing
motions with MEC or with Brazilian courts.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Upon completion of the supervisory process and to the
extent MEC concludes that there are administrative irregularities, SERES may apply the penalties provided for by Law No. 9,394/1996, namely
(i)&#160;discontinue courses; (ii)&#160;directly intervene in the educational institution; (iii)&#160;temporarily suspend the institution&#8217;s
discretionary ability to, among other things, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;disqualify
the institution as an educational institution; (v)&#160;reduce the number of student vacancies; (vi)&#160;temporarily suspend new student
enrollments; or (vii)&#160;temporarily suspend courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The post-secondary education sector is highly regulated,
and our failure to comply with existing or future laws and regulations could significantly impact our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are subject to various federal laws and extensive
government regulations by MEC, <i>Conselho Nacional de Educa&#231;&#227;o</i> (National Education Council, or CNE), INEP, FIES and
the National Post-secondary Education Assessment Commission <i>(Comiss&#227;o Nacional de Avalia&#231;&#227;o da Educa&#231;&#227;o
Superior,</i> or CONAES), among others, including, but not limited to Law No. 12,871, of October 22, 2013, which created the &#8220;<i>Mais
M&#233;dicos</i>&#8221; program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazilian education regulations define three types of
post-secondary education institutions: (i)&#160;colleges, (ii)&#160;university centers and (iii)&#160;universities. The three categories
depend on previous accreditation by MEC to operate. Colleges differ from the other categories with respect to the programs offered, as
colleges depend on previous authorization from MEC to implement new programs, while university centers and universities are not subject
to such requirements, except for courses in law, medicine, psychology, nursing and dentistry, which require the prior approval of MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">All accredited educational institutions require the prior
approval of MEC to create campuses outside their headquarters. All post-secondary education programs must be recognized by MEC as a requirement,
together with registration of the program, to validate the diplomas issued by them. However, pursuant to article 101 of Ordinance No.
23/2017 of MEC, issued diplomas may be valid even if the program is not formally recognized by MEC, so long as the educational institution
has filed the request with MEC to certify the program, and the request is pending formal review and approval by MEC. As a result, any
failure to comply with legal and regulatory requirements by post-secondary education entities may result in the imposition of sanctions
by MEC, as well as damage to the program&#8217;s reputation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">MEC must authorize our campuses located outside our headquarters
before they can start their operations and programs. For further information, see &#8220;Item 4. Information on the Company&#8212;Business
Overview&#8212;Regulatory Overview.&#8221; Distance learning programs, as well as on-campus learning, are also subject to strict accreditation
requirements for their implementation and operation. We must comply with all such requirements in order to obtain and renew all authorizations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We cannot assure you we will be able to comply with these
regulations and maintain the validity of our authorizations, enrollments and accreditations in the future. If we fail to comply with these
regulatory requirements, MEC could place limitations on our operations, including cancellation of programs, reduction in the number of
positions we offer to students, termination of our ability to issue degrees and certificates and revocation of our accreditation, any
of which could adversely affect our financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We cannot assure you that we will obtain accreditation
or re-accreditation of our post-secondary education institutions, or that our courses will receive authorization or reauthorization as
scheduled, or that they will have all of the accreditations, re-accreditations, authorizations and re-authorizations required by MEC.
The absence of such accreditations and authorizations from the MEC or any delays in obtaining them could adversely affect our financial
condition and results of operations.</p>


<!-- Field: Page; Sequence: 31 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, we may also be adversely affected by any
changes in the laws and regulations applicable to post-secondary education institutions, particularly by changes related to: (i)&#160;any
revocation of accreditation of private educational institutions; (ii)&#160;the imposition of controls on monthly tuition payments or restrictions
on the profitability of private educational institutions; (iii)&#160;faculty credentials; (iv)&#160;academic requirements for courses
and curricula; (v)&#160;infrastructure requirements of campuses, such as libraries, laboratories and administrative support; (vi)&#160;the
&#8220;<i>Mais M&#233;dicos</i>&#8221; Program; (vii)&#160;the promulgation by the MEC of new rules and regulations affecting post-secondary
education, in particular with respect to distance learning programs; and (viii) local restrictions imposed to curb the impact of the COVID-19
pandemic in the places we operate.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may be materially adversely affected if we are unable
to obtain these authorizations, accreditations and course recognitions in a timely manner, if we cannot introduce new courses as quickly
as our competitors, if we are not able to or do not comply with any new rules or regulations promulgated by the MEC or if laws and regulations
are passed adverse to the business and operations of post-secondary education institutions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to operate in strategically
located property that is easily accessible by public transportation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe that urban mobility, inadequate public transportation
systems and high transportation costs in many Brazilian cities make the location and accessibility of campuses a decisive factor for students
choosing an educational institution. Therefore, a key component of the success of our business consists in finding, renting and/or buying
strategically located property that meets the needs of our students. We cannot guarantee that we will be able to keep our current property
or acquire new property that is strategically located in the future. In addition, acquisition costs, costs associated with improvements,
construction, and repairs of existing properties and rental values for the properties we use might increase in the future and could have
a material adverse effect on our business. Finally, due to demographic and socioeconomic changes in the regions in which we operate, we
cannot guarantee that the location of our campuses will continue to be attractive and convenient to students.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to protect or enforce our intellectual property
and other proprietary rights could adversely affect our business and financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">We rely and expect to continue to rely on a combination of trademark, copyright,
patent and trade secret protection laws, as well as confidentiality and license agreements with our employees, consultants and third parties
with whom we have relationships to protect our intellectual property and proprietary rights. As of the date of this annual report, we
had no issued patents and one patent application pending in Brazil. As of December 31, 2021, we were party to 281 agreements, with third-party
authors with respect to educational content. As of December 31, 2021, we owned 157 trademark registrations and 154 registered domain names
in Brazil. We also had 31 pending trademark applications in Brazil as of the date of this annual report and unregistered trademarks that
we use to promote our brand. From time to time, we expect to file additional patent, copyright and trademark applications in Brazil and
abroad. Nevertheless, these applications may not be approved or otherwise provide the full protection we seek. Any dismissal of our &#8220;AFYA&#8221;
trademark application may impact our business. Third parties may challenge any patents, copyrights, trademarks and other intellectual
property and proprietary rights owned or held by us. Third parties may knowingly or unknowingly infringe, misappropriate or otherwise
violate our patents, copyrights, trademarks and other proprietary rights, and we may not be able to prevent infringement, misappropriation
or other violation without substantial expense to us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Furthermore, we cannot guarantee that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will provide competitive advantages to us;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our competitors or others will not design around our intellectual property or proprietary rights;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our ability to assert or enforce our intellectual property or proprietary rights against potential competitors or to settle current
or future disputes will not be limited by our agreements with third parties;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>our intellectual property and proprietary rights will be enforced in jurisdictions where competition may be intense or where legal
protection may be weak;</td></tr></table>


<!-- Field: Page; Sequence: 32 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>any of the patents, trademarks, copyrights, trade secrets or other intellectual property or proprietary rights that we presently employ
in our business will not lapse or be invalidated, circumvented, challenged or abandoned; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>we will not lose the ability to assert or enforce our intellectual property or proprietary rights against or to license our intellectual
property or proprietary rights to others and collect royalties or other payments.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If we pursue litigation to assert or enforce our intellectual
property or proprietary rights, an adverse decision in any of these legal actions could limit our ability to assert our intellectual property
or proprietary rights, limit the value of our intellectual property or proprietary rights or otherwise negatively impact our business,
financial condition and results of operations. If the protection of our intellectual property and proprietary rights is inadequate to
prevent use or misappropriation by third parties, the value of our brand and other intangible assets may be diminished, competitors may
be able to more effectively mimic our service and methods of operations, the perception of our business and service to customers and potential
customers may become confused in the marketplace and our ability to attract customers may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may in the future be subject to intellectual property
claims, which are costly to defend and, if we do not succeed in defending such claims, could harm our business, financial condition and
operating results.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">From time to time, third parties may allege in the future
that we or our business infringes, misappropriates or otherwise violates their intellectual property or proprietary rights, including
with respect to our publications. Many companies, including various &#8220;non-practicing entities&#8221; or &#8220;patent trolls,&#8221;
are devoting significant resources to developing or acquiring patents that could potentially affect many aspects of our business. We have
not exhaustively searched patents related to our technology. In addition, the publishing industry has been, and we expect in the future
will continue to be, the target of counterfeiting and piracy. We may implement measures in an effort to protect against these potential
liabilities that could require us to spend substantial resources. Any costs incurred as a result of liability or asserted liability relating
to sales of unauthorized or counterfeit educational materials could harm our business, reputation and financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Third parties may initiate litigation against us without
warning. Others may send us letters or other communications that make allegations without initiating litigation. We have in the past and
may in the future receive such communications, which we assess on a case-by-case basis. We may elect not to respond to the communication
if we believe it is without merit or we may attempt to resolve disputes out of court by electing to pay royalties or other fees for licenses.
If we are forced to defend ourselves against intellectual property claims, whether they are with or without merit or are determined in
our favor, we may face costly litigation, diversion of technical and management personnel, inability to use our current website or inability
to market our service or merchandise our products. As a result of a dispute, we may have to develop non-infringing technology, including
partially or fully revising any publication that infringes intellectual property rights, enter into licensing agreements, adjust our merchandising
or marketing activities or take other action to resolve the claims. These actions, if required, may be unavailable on terms acceptable
to us or may be costly or unavailable. If we are unable to obtain sufficient rights or develop non-infringing intellectual property or
otherwise alter our business practices, as appropriate, on a timely basis, our reputation or brand, our business and our competitive position
may be affected adversely and we may be subject to an injunction or be required to pay or incur substantial damages and/or fees and/or
royalties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Most of our services are provided using proprietary software
and our software is mainly developed by our employees, who assign to us their copyrights over the software. In this regard, though applicable
law establishes that employers shall have full title over rights relating to software developed by their employees, we could be subject
to lawsuits by former employees claiming ownership of such software. As a result, we may be required to obtain licenses of such software,
incurring costs relating to payments of royalties and/or damages and we may be forced to cease the use of such software. If we are unable
to use certain of our proprietary software as a result of any of the foregoing or otherwise, this could have a material adverse effect
on our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, we use open source software in connection
with certain of our products and services. Companies that incorporate open source software into their products have, from time to time,
faced claims challenging the ownership of open source software and/or compliance with open source license terms. As a result, we could
be subject to suits by parties claiming ownership of what we believe to be open source software or non-compliance with open source licensing
terms. Some open source software licenses require users who distribute or use open</p>


<!-- Field: Page; Sequence: 33 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">source software as part of their software to publicly disclose all or part
of the source code to such software and/or make available any derivative works of the open source code on unfavorable terms or at no cost.
Any requirement to disclose our proprietary source code or pay damages for breach of contract could have a material adverse effect on
our business, financial condition and results of operations.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Unfavorable decisions in our legal, arbitration or administrative
proceedings may adversely affect us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are, and we, our controlling shareholders, directors
or officers may be in the future, party to legal, arbitration and administrative investigations, inspections and proceedings arising from
the ordinary course of our business or from nonrecurring corporate, tax, criminal or regulatory events, involving our suppliers, students,
faculty members, as well as environmental, competition and tax authorities, especially with respect to civil, tax, criminal and labor
claims. We cannot guarantee that the results of these proceedings will be favorable to us or that we have made sufficient provisions for
liabilities that may arise as a result of these or other proceedings. Adverse decisions on material legal, arbitration or administrative
proceedings may damage our reputation and may adversely affect our results of operations and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, Mr. Nicolau Carvalho Esteves, our chairman
and one of our controlling shareholders, is currently party to a public civil proceeding filed by the federal prosecutor&#8217;s office
against Mr. Carvalho Esteves and other individuals in connection with certain irregular administrative acts alleged to have taken place
during each of their respective terms as Health Secretary of the State of Tocantins <i>(Secret&#225;rio de Sa&#250;de do Estado de
Tocantins)</i> between 2012 and 2014, a position held by Mr. Carvalho Esteves for a period of four months, from March 9, 2012 to July
20, 2012. In February 2022, a decision was issued, dismissing the motions submited by the public prosecutor&#8217;s office, to date no
appeal has been filed by the public prosecutor&#8217;s office. The court suit is classified as remote by the office.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If Mr. Carvalho Esteves is found liable, he may be subject
to penalties, including a three-year prohibition on him or any legal entity under his control transacting with public entities or being
granted tax incentives/benefits, including Afya. We cannot guarantee that the results of these proceedings will be favorable to Mr. Carvalho
Esteves and any adverse decision may (i)&#160;damage our reputation, (ii)&#160;disqualify us from participating in the PROUNI program,
and consequently cause us to lose our current tax incentives/benefits, including with respect to (a)&#160;corporate income tax (IRPJ)
and CSLL rates, which were at an aggregate effective tax rate of 8.1% and 7.6% for the years ended December 31, 2020 and 2019, respectively,
and which would gradually increase to an aggregate effective tax rate of up to 34.0%, and (b)&#160;PIS and COFINS rates, which are currently
zero and which would gradually increase to an aggregate tax rate of up to 3.65%, (iii)&#160;result in our suspension from the New FIES
program which would prohibit our institutions from enrolling new students that are funded by FIES (for the years ended December 31, 2021
and 2020, FIES represented 8.0% and 11.8% and of our historical undergraduate programs combined tuition fees), and (iv)&#160;prevent us
from entering into new agreements with public entities located in Brazil, any of which may have an adverse effect on our business, reputation,
results of operations and the price of our Class A common shares. For further information, see &#8220;Item 6. Directors, Senior Management
and Employees&#8212;A. Directors and Senior Management&#8212;Legal Proceedings.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are currently in the process of obtaining or renewing
local licenses and permits, including licenses from the fire department, for some of the real estate we use. Failure to obtain renewals
of these licenses and permits in a timely manner may result in penalties, including closures of some of our campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The use of all of our buildings, including our operational
and administrative buildings, is subject to the successful issuance of an occupancy permit <i>(Habite-se),</i> or equivalent certificate,
issued by the municipality where the property is located, certifying that the building was constructed in compliance with applicable zoning
and municipal regulations. In addition, non-residential properties are required to have a use and operations license and/or permit, issued
by the competent municipality, and a fire department inspection certificate, issued by the fire department, prior to being used regularly.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are currently in the process of obtaining and/or renewing
these licenses for some of the real estate we use. The absence of such licenses may result in penalties ranging from fines to forced demolition
of the areas that were not built in compliance with applicable codes or, in the worst-case scenario, the temporary or permanent closure
of the campus or branch lacking the licenses and permits to the extent the relevant penalties and fines have not been paid and the licenses
and permits have not been obtained following notifications from the relevant authorities. Any penalties imposed, and in particular, the
forced closure of any of our campuses or branches, may result in a material</p>


<!-- Field: Page; Sequence: 34 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">adverse effect on our business. Moreover, in the event of any accident at
our campuses or branches, the lack of such licenses may result in civil and criminal liability, as well as cause the cancellation of insurance
policies, if any, for the respective campus or branch and may damage our reputation.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to maintain or renew our existing
leases.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We lease substantially all of the properties on our campuses.
According to Brazilian lease laws, a lessee has the right to renew existing leases for subsequent terms equal to the original term of
the lease. In order for a lessee to enforce this right, the following criteria must be met (i)&#160;the non-residential lease agreement
must have a fixed term equal to or greater than five consecutive years, or, in the event there is more than one agreement or amendment
thereto regarding the same real estate, the aggregate term in such agreement or amendment must be greater than five consecutive years
(ii)&#160;the lessee must have been using the property for the same purpose for a minimum and continuous period of three years and (iii)&#160;the
lessee must claim the right of automatic renewal at the most one year and at least six months prior to the end of the term of the lease
agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Lease agreements with terms lasting less than five years
are not entitled to a right of compulsory renewal and, as a result, the lessor has the right to refuse renewal of the lease upon expiration
of its term. The lease agreements relating to our campuses generally have terms lasting from five to 20 years and are renewable in accordance
with applicable Brazilian lease laws. If we are forced to close any of our campuses due to the termination of a lease agreement and our
inability to renew the lease, our business and results of operations may be adversely affected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, most of our lease agreements are not registered
with the relevant real estate registries. We therefore do not have a right of first refusal over the applicable property in the event
of a sale by its landlord and the subsequent purchaser may require that we vacate the property.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Acquisitions of educational institutions, in certain
circumstances, must be approved by the Administrative Council for Economic Defense.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazilian legislation provides that acquisitions of educational
institutions meeting certain requirements must be approved by Brazil&#8217;s Administrative Council for Economic Defense <i>(Conselho
Administrativo de Defesa Econ&#244;mica,</i> or CADE) prior to the completion of the acquisition if one of the companies or group of
companies involved has gross annual revenues in Brazil of at least R$750.0 million in the year immediately prior to the acquisition and
any other party or group of companies involved has gross income of at least R$75.0 million in that same period. As part of this process,
CADE must determine whether the specific operation affects the competitiveness of the market in question or the consumers in such markets.
CADE may not approve our future acquisitions or may condition approval of our acquisitions on our disposal of some of the operations of
the target of the acquisition, or impose restrictions on the operations and commercialization of the target. Failure to obtain approval
for future acquisitions or any conditional approvals of future acquisitions may result in expenses that may adversely affect our results
of operations and financial condition. As a result of our growth strategy through acquisitions of new entities, we may need additional
funds to implement our strategy. Therefore, if we cannot obtain adequate financing to conclude any potential acquisition and implement
our expansion plans, our growth strategy will be affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Some of the properties that we occupy are owned by companies
controlled by one of our controlling shareholders. Therefore, we are exposed to conflicts of interest, since the administration of such
properties may conflict with our interests, those of such controlling shareholder and those of our other shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Some of the properties we occupy, including properties
where some of our campuses are located, are owned and operated by companies controlled by one of our controlling shareholders. Therefore,
the interests of our controlling shareholder in the administration of such property may conflict with our interests and those of our other
shareholders. For further information, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;Related Party Transactions&#8221;
and note 8 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our holding company structure makes us dependent on the
operations of our subsidiaries. We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the performance
of our subsidiaries is not positive.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are a Cayman Islands exempted company with limited
liability. Our material assets are our direct and indirect equity interests in our subsidiaries. We control a number of subsidiary companies
that carry out the business</p>


<!-- Field: Page; Sequence: 35 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">activities of our corporate group. Our ability to comply with our financial
obligations and to pay dividends to our shareholders depends on our ability to receive distributions from the companies we control, which
in turn depends on the cash flow and profits of those companies. There is no guarantee that the cash flow and profits of our controlled
companies will be sufficient for us to comply with our financial obligations and pay dividends or interest on shareholders&#8217; equity
to our shareholders. Furthermore, exchange rate fluctuation will affect the U.S. dollar value of any distributions our subsidiaries make
with respect to our equity interests in those subsidiaries.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the Brazilian federal government recently
stated that the income tax exemption on the distribution of dividends may be repealed and income tax assessed on the distribution of dividends
in the future, and that applicable taxes on the payment of interest on shareholders&#8217; equity may be increased in the future. Any
repeal of the income tax exemption on the distribution of dividends and any increase in applicable taxes on the payment of interest on
shareholders&#8217; equity may adversely affect us.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We and our subsidiaries may be held directly or indirectly
responsible for labor claims pursuant to contracted services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">To meet the needs of our students and offer greater comfort
and quality in all areas and aspects of our activities, we depend on service providers and suppliers for services such as cleaning, surveillance,
telemarketing and security. We may be adversely affected if these third-party service providers and suppliers do not meet their obligations
under Brazilian labor laws. In particular, according to Brazilian law we may be liable to the employees of these service providers and
suppliers for labor obligations of these service providers and suppliers to the extent such service providers and suppliers fail to indemnify
such employees pursuant to court orders, and we may also be fined by the relevant authorities. If we are held liable for such claims,
we may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may not be able to pass on increases in our costs
by adjusting our monthly tuition fees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our primary source of income is the monthly tuition payments
we charge to our students. Our payroll costs and expenses account for the majority of the costs of services and general and administrative
expenses, or 53.1%, 53.3% and 59.2% of such costs and expenses for the years ended December 31, 2021, 2020 and 2019, respectively. Our
utilities expenses (comprised mainly of water, electricity and telephone expenses) represented 0.8%, 0.7% and 1.2%, respectively, of our
costs of services and general and administrative expenses. Personnel costs and expenses, lease values and the cost of electricity are
adjusted regularly using indices that reflect changes in inflation levels. If we are not able to transfer any increases in our costs and
expenses to students by increasing the amounts of their monthly tuition fees, such as in the context of an economic crisis due to the
COVID-19 pandemic, our operating results may be adversely affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If we are not able to attract and retain students, or
are unable to do so without decreasing our tuition fees, our revenues may decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The success of our business depends primarily on the
number of students enrolled in our programs and the tuition fees that they pay. Our ability to attract and retain students depends mainly
on the tuition fees we charge, the convenient locations of our facilities, the infrastructure of our campuses and the quality of our programs
as perceived by our existing and potential students. These factors are affected by, among other things, our ability to (i)&#160;respond
to increasing competitive pressures, (ii)&#160;develop our educational systems to address changing market trends and demands from post-secondary
education institutions and students, (iii)&#160;develop new programs and enhance existing programs to respond to changes in market trends
and student demands, (iv)&#160;adequately prepare our students for careers in their chosen professional occupations, (v)&#160;successfully
implement our expansion strategy, (vi)&#160;manage our growth while maintaining our teaching quality and (vii)&#160;effectively market
and sell our programs to a broader base of prospective students. If we are unable to continue to attract new students to enroll in our
programs and to retain our current students without significantly decreasing tuition, for example as a result of changes in our students
preferences due to an economic crisis arising from the COVID-19 pandemic, our revenues and our business may decline and we may be adversely
affected.</p>


<!-- Field: Page; Sequence: 36 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Digital Services segment is subject to seasonal fluctuations,
which may cause our operating results to fluctuate from quarter-to-quarter and adversely impact our working capital and liquidity throughout
the year, adversely affecting our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya has now three reporting segments: (1) Undergrad,
which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate programs;
(2) Continuing Education, which provides specialization programs and graduate courses; and (3) Digital Services, which provides content
and technology for medical education, clinical decisions software, practice management tools and electronic medical records, doctor-patient
relationship, telemedicine and digital prescription.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Digital Services are comprised mostly by Medcel, Pebmed
and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality, Medcel revenues are concentrated
in the first and last quarter of the year, as a result of enrollments of Medcel&#8217;s clients period. The majority of Medcel&#8217;s
revenues is derived from printed books and e-books, which are recognized at the point in time when control is transferred to the customer.
Consequently, Digital Services segment generally has higher revenues and results of operations in the first and last quarter of the year
compared to the second and third quarters of the fiscal year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the deterioration of Brazilian macroeconomic
conditions as a result of the COVID-19 pandemic resulted in the reduction of the disposable income of current and prospective customers
of our Continuing Education, leading to the postponement of their residency and post-graduate specialization plans, consequently reducing
the demand for our residency preparatory courses and medical post-graduate specialization programs. Uncertainties in relation to the COVID-19
pandemic have also affected the decision to purchase products that are not of primary need for the doctor, especially for post-graduate
specialization programs. Regarding the preparatory courses, it is worth adding that there was a drop in demand in the courses with short
duration due to the uncertainty on whether there would be exams or any related delays.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Accordingly, we expect quarterly fluctuations in our
revenues and operating results to continue. These fluctuations could result in volatility and adversely affect our liquidity and cash
flows. As our business grows, these seasonal fluctuations may become more pronounced. As a result, we believe that sequential quarterly
comparisons of our financial results may not provide an accurate assessment of our financial position.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b><i>We face risks relating to our Digital Services
segment. </i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may face risks relating to the expansion, including
through acquisitions, of our Digital Services segment, which provides content and technology for medical education, clinical decisions
software, practice management tools and electronic medical records, doctor-patient relationship, telemedicine and digital prescriptions.
Companies operating in this segment are subject to significant execution risk since they are providing new digital features and developing
a new market. In addition, we also face operational risks relating to the integration of any such companies to build our ecosystem, including
userbase and platform integration risks, among other risks. As a result, any acquisitions we may make in this segment involve a number
of uncertainties, risks and challenges that may have a material adverse effect on our business and results of operations, and result in
the risk of impairment. See also &#8220;&#8212;We may not be able to identify and acquire new medical higher education institutions or
meet our strategic and financial goals in connection with any business acquisition we seek, and difficulties in effectively integrating
and managing a growing number of acquisitions may adversely affect our strategic objectives.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are subject to environmental laws and regulations,
which may become more stringent in the future and increase our obligations and capital expenditures with respect to their compliance.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are subject to several environmental municipal, state
and federal laws. Compliance with these laws and regulations is monitored by governmental agencies and bodies that may impose administrative,
civil and criminal sanctions on us. Violations of these laws and regulations may result in the imposition of criminal and administrative
sanctions, as well as civil liability, seeking redress for alleged environmental damages and damages to third parties. Causing environmental
damage may lead to administrative sanctions, which may include, among other consequences, penalties such as fines (ranging from R$50 to
R$50 million), revocation of our licenses and authorizations, and the temporary or permanent suspension of our activities. There is no
limit to the amount that the courts may award to cover the costs of remediation in the case of civil liability or, if the environmental
damage cannot be repaired, the payment of an indemnity. In addition, a claim seeking compensation for environmental damages is not subject
to a statute of limitations. The enactment of more stringent laws and regulations or more</p>


<!-- Field: Page; Sequence: 37 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">stringent interpretations of existing laws and regulations may force us
to increase our capital expenditures relating to environmental compliance, therefore diverting funds from previously planned investments.
These changes could have a material adverse effect on us. Governmental agencies or other authorities may also significantly delay or deny
the issuance of permits and authorizations required for our operations, preventing us from making constructions and improvements in our
campuses. In addition, the improper disposal of solid waste, as well as accidents resulting from the transportation of such wastes, may
give rise to administrative, civil and criminal sanctions. Considering the provision on strict and joint environmental civil liability,
the hiring of third parties to provide services for the collection, transportation and final disposal of waste does not exempt us from
liability for any environmental damage caused by such third parties.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may be adversely affected if the government changes
its investment strategy in education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to Brazilian Federal Law No. 9,394/1996, as
amended, providing education is a duty of the government and of the family, and private education is permitted, in accordance with the
terms set forth by the Brazilian constitution and applicable laws and regulations. Certain public institutions may have certain competitive
advantages over us in the admissions process, as they do not charge tuition fees and may be perceived to be more prestigious than private
institutions, but the limited number of positions available and the competitive nature of the admission process to public institutions
significantly restricts access to these institutions by students. However, the Brazilian government may change its policy and increase
the competition we face by (i)&#160;increasing the level of public investment in basic education and post-secondary education in general,
opening a higher amount of positions and increasing the quality of education offered by public entities; and (ii)&#160;shifting resources
from institutions that are centers of excellence and research to public post-secondary education institutions. The introduction and extension
of affirmative action admission policies by federal and state institutions based on income, race or ethnicity criteria could also heighten
the level of competition in the industry. Any policy change affecting the level of public investment in any aspect of the education sector
may adversely affect us. As of the date of this annual report, our management is not aware of any pending policy changes or proposed legislation
affecting the level of public investment in the education sector in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Government agencies, MEC and third parties may conduct
inspections, file administrative proceedings or initiate litigation against us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Because we operate in a highly regulated industry, government
agencies, MEC or third parties may conduct inspections, file administrative proceedings or initiate litigation for non-compliance with
regulations against us or the institutions we purchase. If the results of these proceedings or litigations are unfavorable to us, or if
we are unable to successfully defend our cases, we may be required to pay monetary damages or be subject to fines, limitations, injunctions
or other penalties. Even if we adequately address issues raised by an inspection conducted by an agency or successfully defend our case
in an administrative proceeding or court action, we may have to set aside significant financial and management resources to settle issues
raised by these proceedings or to those lawsuits or claims. Administrative proceedings or court actions brought against us may damage
our reputation, even if such lawsuits or claims are without merit.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to prevent or detect a malicious cyber-attack
on our systems and databases could result in a misappropriation of confidential information or access to highly sensitive information.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cyber-attacks are becoming more sophisticated and pervasive.
Across our business, we hold large volumes of personally identifiable information, including that of employees, institutions, customers,
students and parents and legal guardians. Individuals may try to gain unauthorized access to our data in order to misappropriate such
information for potentially fraudulent purposes, and our security measures may fail to prevent such unauthorized access. A breach of our
systems could result in a devastating impact on our reputation, financial condition or student experience. In addition, if we were unable
to prove that our systems are properly designed to detect an intrusion, we could be subject to severe penalties and loss of existing or
future business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to the Brazilian Data Protection Law <i>(Lei
Geral de Prote&#231;&#227;o de Dados,</i> or LGPD), security breaches that may result in significant risk or damage to personal data
must be reported to the ANPD, the data protection regulatory body, within a reasonable time period. The notice to the ANPD must include:
(a)&#160;a description of the nature of the personal data affected by the breach; (b)&#160;the affected data subjects; (c)&#160;the technical
and security measures adopted; (d)&#160;the risks related to the breach; (e)&#160;the reasons for any delays in reporting the breach,
if applicable; and (f)&#160;the measures adopted to revert or mitigate the effects of the damage caused by the breach.</p>


<!-- Field: Page; Sequence: 38 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Failure to comply with the LGPD may result in formal
warnings, public sanctions, the deletion of data, or the suspension of data processing activities. Furthermore, a company may be subject
to a fine equal to up to 2% of its gross sales, or the gross sales of its economic group in Brazil, in the preceding fiscal year, excluding
taxes, but limited to a total of R$50 million per infraction. LGPD sanctions are expected to go into effect in August 2021.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our success depends on our ability to monitor and adapt
to technological changes in the education sector and maintain a technological infrastructure that works adequately and without interruption.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Information technology is an essential factor for our
growth. Our information technology systems and tools may become obsolete or insufficient, or we may have difficulties in following and
adapting to technological changes in the education sector, particularly in the distance learning segment where the technological needs
and expectations of our customers and market standards change rapidly and we must quickly adapt to new distance learning technology, practices
and standards. Moreover, our competitors may introduce better products or service platforms. Our success depends on our ability to efficiently
improve our current products while developing and introducing new products that are accepted in the marketplace. Additionally, a failure
to upgrade our technology, features, content, security infrastructure, network infrastructure, or other infrastructure associated with
our platform could harm our business. Adverse consequences could include unanticipated disruptions, slower response times, bugs, degradation
in levels of customer support, impaired quality of users&#8217; experiences of our educational platform and delays in reporting accurate
financial information.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our business, particularly our distance learning segment,
depends on our information technology infrastructure functioning properly and without interruptions. Several problems regarding our information
technology structure, such as viruses, hackers, system interruptions and technical difficulties regarding our satellite transmissions
of data, sound and image, may have a material adverse effect on us and our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, we face risks associated with unauthorized
access to our systems, including by hackers and due to failures of our electronic security measures. These unauthorized entries into our
systems can result in the theft of proprietary or sensitive information, including student information, or cause interruptions in the
operation of our systems. As a result, we may be forced to incur considerable expenses to protect our systems from electronic security
breaches and to mitigate our exposure to technological problems and interruptions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Internet Act (Law No. 12,965/2014) applies only to
personal data collected through the internet, and establishes other principles and rules with respect to the privacy and protection of
the personal and behavioral data of internet users. The Internet Act guarantees, among others, the privacy of internet and privately stored
communications. Any data processing activity is subject to the data subject&#8217;s informed, free and express consent.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Decree No. 8,771/2016, which regulates the Internet Act,
requires internet app providers to maintain certain security measures in connection with the storage of personal data, including: (i)&#160;strict
controls on access to personal data; (ii)&#160;authentication safeguards; (iii)&#160;detailed data inventories (e.g., date, time and duration
of access to the data, identity of the employee that accessed the data and the actions taken), and (iv)&#160;use of IT solutions to ensure
the data is protected (for example, data encryption or other equivalent protective measures). If we fail to comply with the provisions
of the Internet Act, we may be subject to sanctions and penalties, including damages, which will be assessed based on the nature and degree
of our non-compliance, among other factors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On August 15, 2018, the LGPD was published. Following
ratification by Brazil&#8217;s President of Converted Law No. 34/2020 relating to Provisional Measure No. 959/2020, the General Personal
Data Protection Law became effective as of September 18, 2020, although the penalties established under the General Personal Data Protection
Law became effective as of August 1, 2021, in accordance with Law No. 14,010/2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The LGPD regulates the use of personal data in Brazil.
The LGPD significantly transformed the data protection system in Brazil and is in line with recent European legislation (the General Data
Protection Regulation, or GDPR). The LGPD establishes detailed rules for the collection, use, processing and storage of personal data.
It will affect all economic sectors, including the relationship between customers and suppliers of goods and services, employees and employers
and other relationships in which personal data is collected, both in the digital and physical environment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If we fail to comply with the LGPD, we and our subsidiaries
may also be subject to the following sanctions, on an individual or cumulative basis: (1)&#160;warnings; (2)&#160;an obligation to disclose
the infraction; (3)&#160;an obligation to temporarily block and/or delete personal data; and (4)&#160;a fine of up to 2% of our revenue
or the revenue of our</p>


<!-- Field: Page; Sequence: 39 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">economic group in the most recent fiscal year, excluding taxes, not to exceed
R$50.0 million per infraction. In addition, we may be held liable for any individual or collective property and moral damages caused by
us and be held jointly and severally liable for any individual or collective property and moral damages caused by our subsidiaries and
service suppliers to the extent such damages resulted from non-compliance with the LGPD.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Failure to comply with data privacy regulations could
result in reputational damage to our brands and adversely affect our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Any perceived or actual unauthorized disclosure of personally
identifiable information, whether through breach of our network by an unauthorized party, employee theft, misuse or error or otherwise,
could harm our reputation, impair our ability to attract and retain our customers, or subject us to claims or litigation arising from
damages suffered by individuals. Failure to adequately protect personally identifiable information could potentially lead to penalties,
significant remediation costs, reputational damage, the cancellation of existing contracts and difficulty in competing for future business.
In addition, we could incur significant costs in complying with relevant laws and regulations regarding the unauthorized disclosure of
personal information, which may be affected by any changes to data privacy legislation at both the federal and state levels.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Companies subject to the LGPD (including our Brazilian
operations) are required to comply with the obligations of the LGPD. Failure to comply with the LGPD may result in formal warnings, public
sanctions, the deletion of sensitive data, or the suspension of data processing activities. Furthermore, a company may be subject to a
fine equal to up to 2% of its gross sales, or the gross sales of its economic group in Brazil, in the preceding fiscal year, excluding
taxes, but limited to a total of R$50 million per infraction.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b><i>In the past, we and our independent registered
public accounting firm identified material weaknesses in our internal control over financial reporting and, if we fail to maintain effective
internal controls over financial reporting, we may be unable to accurately report our results of operations, meet our reporting obligations
or prevent fraud.</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Disclosure controls and procedures over financial reporting
are designed to provide reasonable assurance that information required to be disclosed by the Company is accumulated and communicated
to management, and recorded, processed, summarized and reported in accordance with applicable rules.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">These disclosure controls and procedures have inherent
limitations which include the possibility that judgments in decision-making can be faulty and that breakdowns occur because of errors
or mistakes. Additionally, controls can be circumvented by any unauthorized management override of controls. Consequently, our businesses
are exposed to risk from potential noncompliance with policies, employee misconduct or negligence and fraud, which could result in regulatory
sanctions, civil claims and serious reputational or financial harm. It is not always possible to deter employee misconduct and the precautions
we take to prevent and detect this activity may not always be effective. Accordingly, because of the inherent limitations in the control
system, misstatements due to error or fraud may occur and not be detected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In the past, we have identified material weaknesses in
our internal control over financial reporting, and we cannot assure that significant deficiencies or material weaknesses in our internal
control over financial reporting will not be identified in the future. In addition, if we fail to maintain the adequacy of our internal
control over financial reporting, as the laws, regulations and policies standards are modified, supplemented or amended from time to time,
we may not be able to conclude on an ongoing basis that we have effective internal control over financial reporting in accordance with
Section 404 of the Sarbanes-Oxley Act of 2002. If we fail to maintain an effective internal control environment, we could suffer material
misstatements in our financial statements, fail to meet our reporting obligations or fail to prevent fraud, which would likely cause investors
to lose confidence in our reported financial information, the trading price of our shares and ADSs could decline, and we could be subject
to sanctions or investigations by NASDAQ, the SEC or other regulatory authorities. Failure to remedy any future material weakness in our
internal controls over financial reporting, or to implement or maintain other effective control systems required of public companies in
the United States, could also restrict our future access to capital markets and reduce or eliminate the trading market for our shares
and ADSs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For details of the controls and remediation plan mentioned
above, see the section of this annual report entitled &#8220;Item 15. Controls and Procedures - B. Management&#8217;s Annual Report on
Internal Control Over Financial Reporting.&#8221;</p>


<!-- Field: Page; Sequence: 40 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b><i>We may be adversely affected by the ongoing armed
conflict between Russia and Ukraine.</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result of the current geopolitical tensions and
conflict between Russia and Ukraine, and the recent recognition by Russia of the independence of the self-proclaimed republics of Donetsk
and Luhansk in the Donbas region of Ukraine, the governments of the United States, the European Union, Japan and other jurisdictions have
recently announced the imposition of sanctions on certain industry sectors and parties in Russia, Belarus and the regions of Donetsk and
Luhansk, as well as enhanced export controls on certain products and industries. These and any additional sanctions and export controls,
as well as any counter responses by the governments of Russia or other jurisdictions, could adversely affect, directly or indirectly,
the global supply chain, with negative implications on the availability of raw materials, energy prices, and our customers, as well as
the local and global financial markets and financial services industry and the global economy in general, which has also been impacted
by the ongoing COVID-19 pandemic.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Brazil</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The Brazilian federal government has exercised, and continues
to exercise, significant influence over the Brazilian economy. This involvement as well as Brazil&#8217;s political and economic conditions
could harm us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian federal government frequently exercises
significant influence over the Brazilian economy and occasionally makes significant changes in policy and regulations. The Brazilian government&#8217;s
actions to control inflation and other policies and regulations have often involved, among other measures, increases or decreases in interest
rates, changes in fiscal policies, wage and price controls, foreign exchange rate controls, blocking access to bank accounts, currency
devaluations, capital controls and import and export restrictions. We have no control over and cannot predict what measures or policies
the Brazilian government may take in the future. We and the market price of our securities may be harmed by changes in Brazilian government
policies, as well as general economic factors, including, without limitation:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>growth or downturn of the Brazilian economy;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>interest rates and monetary policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>exchange rates and currency fluctuations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>inflation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>liquidity of the domestic capital and lending markets, in particular in the current context of the COVID-19 pandemic;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>import and export controls;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>exchange controls and restrictions on remittances abroad and payments of dividends;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>modifications to laws and regulations according to political, social and economic interests;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>fiscal policy and changes in tax laws;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>economic, political and social instability, including general strikes and mass demonstrations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the regulatory framework governing the educational industry;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>labor and social security regulations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>energy and water shortages and rationing;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>commodity prices;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in demographics, in particular declining birth rates, which will result in a decrease in the number of enrolled students in
education in the future; and</td></tr></table>


<!-- Field: Page; Sequence: 41 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>other political, diplomatic, social and economic developments in or affecting Brazil.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Uncertainty over whether the Brazilian federal government
will implement reforms or changes in policy or regulation affecting these or other factors in the future may affect economic performance
and contribute to economic uncertainty in Brazil, which may have an adverse effect on our activities and consequently our operating results,
and may also adversely affect the trading price of our Class A common shares. Recent economic and political instability has led to a negative
perception of the Brazilian economy and higher volatility in the Brazilian securities markets, which also may adversely affect us and
our Class A common shares. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Significant Factors Affecting Our Results
of Operations&#8212;Brazilian Macroeconomic Environment.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><i>Economic uncertainty and political instability in Brazil may harm
our business and the price of our Class A common shares.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil&#8217;s political environment has historically
influenced, and continues to influence, the performance of the country&#8217;s economy. Political crises have affected and continue to
affect the confidence of investors and the general public, which have historically resulted in economic deceleration and heightened volatility
in the securities offered by companies with significant operations in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The recent economic instability in Brazil has contributed
to a decline in market confidence in the Brazilian economy as well as to a deteriorating political environment. In addition, various ongoing
investigations into allegations of money laundering and corruption being conducted by the Office of the Brazilian Federal Prosecutor,
including the largest such investigation, known as &#8220;<i>Opera&#231;&#227;o Lava Jato,</i>&#8221; have negatively impacted the
Brazilian economy and political environment. The potential outcome of these investigations is uncertain, but they have already had an
adverse impact on the image and reputation of the implicated companies, and on the general market perception of the Brazilian economy.
We cannot predict whether the ongoing investigations will result in further political and economic instability, or if new allegations
against government officials and/or executives of private companies will arise in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, political demonstrations in Brazil over
the last few years have affected the development of the Brazilian economy and investors&#8217; perceptions of Brazil. For example, street
protests, which started in mid-2013 and continued through 2016, demonstrated the public&#8217;s dissatisfaction with the worsening Brazilian
economic condition (including an increase in inflation and fuel prices as well as rising unemployment), and the perception of widespread
corruption. Moreover, on October 28, 2018, Jair Bolsonaro won the Brazilian presidential election and took office on January 1, 2019.
It is unclear if and for how long the political divisions that arose before the election will continue under President Jair Bolsonaro&#8217;s
presidency and the effects that such divisions will have on his ability to govern Brazil and implement reforms. The continuation of any
such political divisions may result in a congressional impasse, political unrest, protests or strikes that materially adversely affect
us. In addition, uncertainties relating to the implementation by the new Brazilian government of changes to monetary, fiscal and social
security policy and related legislation may contribute to economic instability. These uncertainties and new measures may increase the
volatility of the Brazilian capital markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Furthermore, a failure by the Brazilian government to
implement necessary reforms may result in diminished confidence in the Brazilian government&#8217;s budgetary condition and fiscal stance,
which could result in downgrades of Brazil&#8217;s sovereign foreign credit rating by credit rating agencies, negatively impact Brazil&#8217;s
economy, and lead to further depreciation of the <i>real</i> and an increase in inflation and interest rates, which could adversely affect
our business, financial condition and results of operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Also, the ongoing COVID-19 pandemic is expected to continue
causing a material and adverse effect on the general economic, financial, political, demographic and business conditions in Brazil, which
may reduce the disposable income of our students and their families, and consequently (1)&#160;adversely affect the ability of our students
(current and/or prospective) to pay our tuition fees and/or (2)&#160;increase our attrition rates.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Any of the above factors may harm the Brazilian economy
and, consequently, our business and the price of our Class A common shares.</p>


<!-- Field: Page; Sequence: 42 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Inflation and certain measures by the Brazilian government
to curb inflation have historically harmed the Brazilian economy and Brazilian capital markets, and high levels of inflation in the future
would harm our business and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In the past, Brazil has experienced extremely high rates
of inflation. Inflation and some of the measures taken by the Brazilian government in an attempt to curb inflation have had significant
negative effects on the Brazilian economy generally. Inflation, policies adopted to curb inflationary pressures and uncertainties regarding
possible future governmental intervention have contributed to economic uncertainty and heightened volatility in the Brazilian capital
markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to the National Consumer Price Index (<i>&#205;ndice
Nacional de Pre&#231;os ao Consumidor Amplo</i>, or IPCA), which is published by the Brazilian Institute for Geography and Statistics
(<i>Instituto Brasileiro de Geografia e Estat&#237;stica</i>, or IBGE), Brazilian inflation rates were 4.3%, 3.7% and 2.9% as of December&#160;31,
2019, 2018 and 2017, respectively. Brazil may experience high levels of inflation in the future and inflationary pressures may lead to
the Brazilian government intervening in the economy and introducing policies that could harm our business and the trading price of our
Class&#160;A common shares. In the past, the Brazilian government&#8217;s interventions included the maintenance of a restrictive monetary
policy with high interest rates that restricted credit availability and reduced economic growth, causing volatility in interest rates.
For example, the official interest rate in Brazil decreased from 14.25% as of December&#160;31, 2015, to 4.50% as of December&#160;31,
2018, as established by the Monetary Policy Committee (<i>Comit&#234; de Pol&#237;tica Monet&#225;ria do Banco Central do Brasil</i>),
or COPOM. On February&#160;7, 2018, the COPOM reduced the base interest rate (<i>Sistema Especial de Liquida&#231;&#227;o e Cust&#243;dia</i>)
or the SELIC rate, to 6.75% and further reduced the SELIC rate to 6.50% on March&#160;21, 2018. The COPOM reconfirmed the SELIC rate of
6.50% on May&#160;16, 2018, and subsequently on June&#160;20, 2018. As of December 31, 2018, the SELIC rate was 6.50%. The COPOM reconfirmed
the SELIC rate of 6.50% on February 6, 2019, but reduced the SELIC rate to 6.00% on August 1, 2019 and further reduced the rate to 4.50%
on December 12, 2019. On February 5, 2020, the COPOM reduced the SELIC rate to 4.25% and further reduced the rate to 3.75% on March 18,
2020, to 3.00% on June 5, 2020, to 2.25% on June 17, 2020, to 2.00% on August 5, 2020. On March 17, 2021, the COPOM raised the SELIC rate
to 2.75% and further raised the SELIC rate to 3.50% on May 5, 2021, to 4.25% on June 16, 2021, to 5.25% on August 4, 2021, to 6.25% on
September 22, 2021, to 7.75% on October 27, 2021, to 9.25% on December 8, 2021, to 10.75% on February 2, 2022 and to 11.75% on March 16,
2022. As of the date of this annual report, the SELIC rate is 11.75%. Conversely, more lenient government and Central Bank policies and
interest rate decreases have triggered and may continue to trigger increases in inflation, and, consequently, growth volatility and the
need for sudden and significant interest rate increases, which could negatively affect us and increase our indebtedness.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Exchange rate instability may have adverse effects on
the Brazilian economy, us and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian currency has been historically volatile
and has been devalued frequently over the past three decades. Throughout this period, the Brazilian government has implemented various
economic plans and used various exchange rate policies, including sudden devaluations, periodic mini-devaluations (during which the frequency
of adjustments has ranged from daily to monthly), exchange controls, dual exchange rate markets and a floating exchange rate system. Although
long-term depreciation of the real is generally linked to the rate of inflation in Brazil, depreciation of the real occurring over shorter
periods of time has resulted in significant variations in the exchange rate between the real, the U.S. dollar and other currencies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The real/U.S. dollar exchange rate reported by the Central
Bank was R$4.031 per US$1.00 on December 31, 2019, which reflected a 4.0% depreciation in the real against the U.S. dollar during 2019.
The real/U.S. dollar exchange rate reported by the Central Bank was R$5.196 per US$1.00 on December 31, 2020, which reflected a 22.4%
depreciation in the real against the U.S. dollar during 2020. The real/U.S. dollar exchange rate reported by the Central Bank was R$5.580
per US$1.00 on December 31, 2021, which reflected a 7.3% depreciation in the real against the U.S. dollar during 2020. As of April 28,
2022, the exchange rate for the sale of U.S. dollars as reported by the Central Bank was R$5.011 per US$1.00, which reflected an appreciation
of 10.2% in the real against the U.S. dollar since December 31, 2021. There can be no assurance that the real will not again depreciate
against the U.S. dollar or other currencies in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A devaluation of the <i>real</i> relative to the U.S.
dollar could create inflationary pressures in Brazil and cause the Brazilian government to, among other measures, increase interest rates.
Any depreciation of the <i>real</i> may generally restrict access to the international capital markets. It would also reduce the U.S.
dollar value of our results of</p>


<!-- Field: Page; Sequence: 43 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">operations. Restrictive macroeconomic policies could reduce the stability
of the Brazilian economy and harm our results of operations and profitability. In addition, domestic and international reactions to restrictive
economic policies could have a negative impact on the Brazilian economy. These policies and any reactions to them may harm us by curtailing
access to foreign financial markets and prompting further government intervention. A devaluation of the <i>real</i> relative to the U.S.
dollar may also, as in the context of the current economic slowdown, decrease consumer spending, increase deflationary pressures and reduce
economic growth.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On the other hand, an appreciation of the real relative
to the U.S. dollar and other foreign currencies may deteriorate the Brazilian foreign exchange current accounts. Depending on the circumstances,
either devaluation or appreciation of the <i>real</i> relative to the U.S. dollar and other foreign currencies could restrict the growth
of the Brazilian economy, as well as our business, results of operations and profitability.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Infrastructure and workforce deficiency in Brazil may
impact economic growth and have a material adverse effect on us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our performance depends on the overall health and growth
of the Brazilian economy. Brazilian GDP growth has fluctuated over the past few years, with growth of 3.0% in 2013 but decreasing to 0.5%
in 2014, a contraction of 3.5% in 2015, a contraction of 3.3% in 2016, a growth of 1.0% in 2017, a growth of 1.1% in 2018 and 1.1% in
2019,a contraction of 4.1% in 2020, and a growth of 4.6% in 2021. Growth is limited by inadequate infrastructure, including potential
energy shortages and deficient transportation, logistics and telecommunication sectors, general strikes, the lack of a qualified labor
force, and the lack of private and public investments in these areas, which limit productivity and efficiency. Any of these factors could
lead to labor market volatility and generally impact income, purchasing power and consumption levels, which could limit growth and ultimately
have a material adverse effect on us.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Developments and the perceptions of risks in other countries,
including other emerging markets, the United States and Europe, may harm the Brazilian economy and the price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The market for securities offered by companies with significant
operations in Brazil is influenced by economic and market conditions in Brazil and, to varying degrees, market conditions in other Latin
American and emerging markets, as well as the United States, Europe and other countries. To the extent the conditions of the global markets
or economy deteriorate, including as a result of the COVID-19 outbreak, the business of companies with significant operations in Brazil
may be harmed. The weakness in the global economy has been marked by, among other adverse factors, lower levels of consumer and corporate
confidence, decreased business investment and consumer spending, increased unemployment, reduced income and asset values in many areas,
reduction of China&#8217;s growth rate, currency volatility and limited availability of credit and access to capital. Developments or
economic conditions in other emerging market countries have at times significantly affected the availability of credit to companies with
significant operations in Brazil and resulted in considerable outflows of funds from Brazil, decreasing the amount of foreign investments
in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Crises and political instability in other emerging market
countries, the United States, Europe or other countries could decrease investor demand for securities offered by companies with significant
operations in Brazil, such as our Class A common shares. In June 2016, the United Kingdom had a referendum in which the majority voted
to leave the European Union (so-called &#8220;Brexit&#8221;).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The announcement of Brexit caused significant volatility
in global stock markets and currency exchange rate fluctuations. The United Kingdom formally withdrew from the European Union on January
31, 2020. On December 24, 2020, the United Kingdom and the European Commission reached an agreement on the terms of its future cooperation
with the European Union. On December 31, 2020, the European Union (Future Relationship) Act was enacted in the United Kingdom. Significant
political and economic uncertainty remains about whether the terms of the relationship between the United Kingdom and the European Union
will differ materially in practice from the terms before withdrawal. We have no control over and cannot predict the effect of the United
Kingdom&#8217;s exit from the European Union nor over whether and to which effect any other member state will decide to exit the European
Union in the future. These developments, as well as potential crises and forms of political instability arising therefrom or any other
as of yet unforeseen development, may harm our business and the price of our Class&#160;A common shares.</p>


<!-- Field: Page; Sequence: 44 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, public health crises, pandemics and epidemics,
could have a material adverse effect on global, national and local economies, as well as on our business, our subsidiaries and our students
by disrupting our activities and delaying transactional activities (including acquisitions). For instance, the outbreak of COVID-19 has
severely impacted global economic activity and caused significant volatility and negative pressure in the financial markets. The potential
impact of a pandemic, epidemic or outbreak of a contagious disease on our subsidiaries and our students is difficult to predict, and could
have a material adverse effect on our results of operations and financial condition, as well as heighten the volatility of the price of
our Class A common shares. See &#8220;&#8212;Certain Risks Relating to Our Business and Industry&#8212;Public health outbreaks, epidemics
or pandemics, such as the COVID-19 pandemic, have adversely affected and may continue to adversely affect our business.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Any further downgrading of Brazil&#8217;s credit rating
could reduce the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We and the trading price of our Class A common shares
may be harmed by investors&#8217; perceptions of risks related to Brazil&#8217;s sovereign debt credit rating. Rating agencies regularly
evaluate Brazil and its sovereign credit ratings, which are based on a number of factors, including macroeconomic trends, fiscal and budgetary
conditions, indebtedness metrics and the perspective of changes in any of these factors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The rating agencies began to review Brazil&#8217;s sovereign
credit rating in September 2015. Subsequently, the three major rating agencies downgraded Brazil&#8217;s investment-grade status:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>In 2015, Standard &amp; Poor&#8217;s initially downgraded Brazil&#8217;s credit rating from BBB-negative to BB-positive and subsequently
downgraded it again from BB-positive to BB, maintaining its negative outlook, citing a worse credit situation since the first downgrade.
On January 11, 2018, Standard &amp; Poor&#8217;s further downgraded Brazil&#8217;s credit rating from BB to BB-stable. The BB-stable rating
was reaffirmed on November 30, 2021.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>In December 2015, Moody&#8217;s reviewed and downgraded Brazil&#8217;s issue and bond ratings from Baa3 to below investment grade,
Ba2 with a negative outlook, citing the prospect of a further deterioration in Brazil&#8217;s debt indicators, considering the low growth
environment and the challenging political scenario. In April 2018, Moody&#8217;s reaffirmed its Ba2 rating, but altered its outlook from
&#8220;negative&#8221; to &#8220;stable,&#8221; also supported by the projection that the Brazilian government would approve fiscal reforms
and that economic growth in Brazil would resume gradually. On April 12, 2022, Moody&#8217;s maintained Brazil&#8217;s credit rating at
Ba2-stable.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>In 2016, Fitch downgraded Brazil&#8217;s sovereign credit rating to BB-positive with a negative outlook, citing the rapid expansion
of the country&#8217;s budget deficit and the worse-than-expected recession. In February 2018, Fitch downgraded Brazil&#8217;s sovereign
credit rating again to BB-negative, citing, among other reasons, fiscal deficits, the increasing burden of public debt and an inability
to implement reforms that would structurally improve Brazil&#8217;s public finances. On December 14, 2021, Fitch reaffirmed Brazil&#8217;s
credit rating at BB-negative.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil&#8217;s sovereign credit rating is currently rated
below investment grade by the three main credit rating agencies. Consequently, the prices of securities offered by companies with significant
operations in Brazil have been negatively affected. A prolongation or worsening of the current Brazilian recession and continued political
uncertainty, among other factors, could lead to further ratings downgrades. Any further downgrade of Brazil&#8217;s sovereign foreign
credit ratings could heighten investors&#8217; perception of risk and, as a result, cause the trading price of our Class A common shares
to decline.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Risks Relating to Our Class A Common Shares</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An active trading market for our Class A common shares
may not be sustainable. If an active trading market is not maintained, investors may not be able to resell their shares and our ability
to raise capital in the future may be impaired.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Although our Class A common shares are listed and being
traded on the Nasdaq Global Select Market, an active trading market for our shares may not be maintained. If an active market for our
Class A common shares is not maintained, it may be difficult for you to sell shares without depressing the market price for the shares
or at all. An</p>


<!-- Field: Page; Sequence: 45 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">inactive trading market may also impair our ability to raise capital to
continue to fund operations by selling shares and may impair our ability to acquire other companies or technologies by using our shares
as consideration. In addition to the risks described above, the market price of our Class A common shares may be influenced by many factors,
some of which are beyond our control, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>announcements by us or our competitors of significant contracts or acquisitions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>technological innovations by us or competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the failure of financial analysts to cover our Class A common shares or changes in financial estimates by analysts;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>actual or anticipated variations in our operating results;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>changes in financial estimates by financial analysts, or any failure by us to meet or exceed any of these estimates, or changes in
the recommendations of any financial analysts that elect to follow our Class A common shares or the shares of our competitors;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>future sales of our shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>investor perceptions of us and the industries in which we operate.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the stock market in general has experienced
substantial price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of particular
companies affected, such as in the context of an economic crisis due to the COVID-19 pandemic. These broad market and industry factors
may materially harm the market price of our Class A common shares, regardless of our operating performance. In the past, following periods
of volatility in the market price of certain companies&#8217; securities, securities class action litigation has been instituted against
these companies. This litigation, if instituted against us, could adversely affect our financial condition or results of operations. If
a market is not maintained, the liquidity and price of our Class A common shares could be seriously harmed.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The Esteves Family and Bertelsmann, our largest group
of shareholders, own 100% of our outstanding Class B common shares, which represents approximately 90.6% of the voting power of our issued
share capital, and control all matters requiring shareholder approval. This concentration of ownership and voting power limits your ability
to influence corporate matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira
Tavares and NRE Capital Ventures Limited, or the Esteves Family, and Bertelsmann control our company and beneficially own 48.9% of our
issued share capital through their beneficial ownership of all of our outstanding Class B common shares, and consequently, 90.6% of the
combined voting power of our issued share capital. Our Class B common shares are entitled to 10 votes per share and our Class A common
shares, which are the common shares trading on NASDAQ, are entitled to one vote per share. Our Class B common shares are convertible into
an equivalent number of Class A common shares and generally convert into Class A common shares upon transfer subject to limited exceptions.
As a result, the Esteves Family and Bertelsmann control the outcome of all decisions at our shareholders&#8217; meetings, and are able
to elect a majority of the members of our board of directors. They are also able to direct our actions in areas such as business strategy,
financing, distributions, acquisitions and dispositions of assets or businesses. For example, the Esteves Family and Bertelsmann may cause
us to make acquisitions that increase the amount of our indebtedness or outstanding Class A common shares, sell revenue-generating assets
or inhibit change of control transactions that benefit other shareholders. The decisions of the Esteves Family and Bertelsmann on these
matters may be contrary to your expectations or preferences, and they may take actions that could be contrary to your interests. They
are able to prevent any other shareholders, including you, from blocking these actions. For further information regarding shareholdings
in our company, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221; In addition,
for so long as they beneficially own more than two-thirds of our issued share capital, the Esteves Family and Bertelsmann also have the
ability to unilaterally amend our Articles of Association, which may be amended only by special resolution of shareholders (requiring
a two-thirds majority, of those attending the relevant shareholder meeting, vote).</p>


<!-- Field: Page; Sequence: 46 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">So long as the Esteves Family and Bertelsmann continue
to beneficially own a sufficient number of Class B common shares, even if they beneficially own significantly less than 50% of our outstanding
share capital, acting together, they will be able to effectively control our decisions. For example, if our Class B common shares amounted
to 15% of our outstanding common shares, beneficial owners of our Class B common shares (consisting of the Esteves Family and Bertelsmann),
would collectively control 63.8% of the voting power of our outstanding common shares. If the Esteves Family and Bertelsmann sell or transfer
any of their Class B common shares, they will generally convert automatically into Class A common shares, subject to limited exceptions,
such as transfers to affiliates, to trustees for the holder or its affiliates and certain transfers to U.S. tax exempt organizations.
The fact that any Class B common shares convert into Class A common shares if the Esteves Family or Bertelsmann sell or transfer them
means that the Esteves Family and Bertelsmann will in many situations continue to control a majority of the combined voting power of our
outstanding share capital, due to the voting rights of any Class B common shares that they retain. However, if our Class B common shares
at any time represent less than 10% of the total number of shares in the capital of the Company outstanding, the Class B common shares
then outstanding will automatically convert into Class A common shares. For a description of our dual class equity structure, see &#8220;Item
10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Class A common shares eligible for future sale may cause
the market price of our Class A common shares to drop significantly.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The market price of our Class A common shares may decline
as a result of sales of a large number of our Class A common shares in the market (including Class A common shares issuable upon conversion
of Class B common shares) or the perception that these sales may occur. These sales, or the possibility that these sales may occur, also
might make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we have outstanding 46,265,141
Class A common shares and 45,802,763 Class B common shares that, except as set forth below, are freely tradable without restriction or
further registration under the Securities Act by persons other than our affiliates within the meaning of Rule 144 of the Securities Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our shareholders or entities controlled by them or their
permitted transferees will be able to sell their shares in the public market from time to time without registering them, subject to certain
limitations on the timing, amount and method of those sales imposed by regulations promulgated by the SEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If any of our shareholders, the affiliated entities controlled
by them or their respective permitted transferees were to sell a large number of their shares, including common shares issuable upon conversion
of the Series A perpetual convertible preferred shares, the market price of our Class A common shares may decline significantly. In addition,
the perception in the public markets that sales by them might occur may also adversely affect the market price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Articles of Association contain anti-takeover provisions
that may discourage a third party from acquiring us and adversely affect the rights of holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association contain certain provisions
that could limit the ability of others to acquire our control, including a provision that grants authority to our board of directors to
establish and issue from time to time one or more series of preferred shares without action by our shareholders and to determine, with
respect to any series of preferred shares, the terms and rights of that series. These provisions could have the effect of depriving our
shareholders of the opportunity to sell their shares at a premium over the prevailing market price by discouraging third parties from
seeking to obtain our control in a tender offer or similar transactions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">If securities or industry analysts publish inaccurate
or unfavorable research, about our business, the price of our Class A common shares and our trading volume could decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The trading market for our Class A common shares will
depend in part on the research and reports that securities or industry analysts publish about us, our business, our market or our competitors.
In the event one or more of the analysts who covers us downgrades us or releases negative publicity about our Class A common shares, our
share price would likely decline.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Further, as we are not required to publish quarterly
financial information, if we cease to publish that information, any analysts covering us may not have enough information to compare us
to our peers on a regular</p>


<!-- Field: Page; Sequence: 47 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">basis and may choose to cease coverage. If one or more of these analysts
ceases to cover us or fails to regularly publish reports on us, interest in our Class A common shares may decrease, which may cause our
share price or trading volume to decline.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">It is unlikely that we will declare any dividends on
our common shares in the foreseeable future and therefore, you must rely on price appreciation of our common shares for a return on your
investment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We do not anticipate paying any dividends in the foreseeable
future. Instead, we intend to retain earnings, if any, to fund the operation of our business and future growth. Any decision to declare
and pay dividends in the future will be made at the discretion of our general meeting of shareholders, acting pursuant to a proposal by
our board of directors, or by our board, and will depend on, among other things, our results of operations, cash requirements, financial
condition, contractual restrictions (including under our outstanding Series A perpetual convertible preferred shares) and other factors
that our general meeting of shareholders or board of directors may deem relevant. Accordingly, investors will most likely have to rely
on sales of their common shares, which may increase or decrease in value, as the only way to realize cash from their investment. As a
result, capital appreciation in the price of our Class A common shares, if any, will be your only source of gain on an investment in our
Class A common shares. There is no guarantee that the price of our common shares will ever exceed the price that you pay.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b><i>Our Series A perpetual convertible preferred shares
have rights, preferences and privileges that are not held by, and are preferential to, the rights of our common shares, which could adversely
affect our liquidity and financial condition, and may result in the interests of the holders of our Series A perpetual convertible preferred
shares differing from those of our common shareholders.</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Series A perpetual convertible preferred shares ranks
senior to our common shares with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation,
dissolution or winding up of our affairs. The holders of Series A perpetual convertible preferred shares have the right to receive a liquidation
preference entitling them to be paid out of our assets available for distribution to stockholders before any payment may be made to holders
of any other class or series of our share capital, an amount equal to the greater of (a) the sum of the original liquidation preference
plus all accrued but unpaid dividends or (b) the amount that such holder would have been entitled to receive upon our liquidation, dissolution
and winding up if all outstanding shares of such series of Series A perpetual convertible preferred shares had been converted into common
shares immediately prior to such liquidation, dissolution or winding up. In addition, the holders of the Series A perpetual convertible
preferred shares are entitled to a cumulative dividend at the rate of 6.5% per annum. The holders of the Series A perpetual convertible
preferred shares are also entitled to participate in dividends declared or paid on our common shares on an as-converted basis. The holders
of our Series A perpetual convertible preferred shares also have the right, subject to certain exceptions, to require us to repurchase
all or any portion of the Series A perpetual convertible preferred shares upon certain change of control events at the repurchase price
set forth in the applicable certificate of designations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">These dividend and share repurchase obligations could
impact our liquidity and reduce the amount of cash flows available for general corporate purposes. Our obligations to the holders of the
Series A perpetual convertible preferred shares could also limit our ability to obtain additional financing or increase our borrowing
costs, which could have an adverse effect on our financial condition. These preferential rights could also result in divergent interests
between the holders of shares of Series A perpetual convertible preferred shares and holders of our common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The issuance of Series A perpetual convertible preferred
shares reduces the relative voting power of holders of our common stock, and the conversion and sale of those shares would dilute the
ownership of holders of common shares and may adversely affect the market price of our common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, 150,000 Series A perpetual convertible
preferred shares were outstanding, representing approximately 8.4% of our outstanding common shares, including the Series A perpetual
convertible preferred shares on an as-converted basis. Holders of Series A perpetual convertible preferred shares are entitled to a cumulative
dividend at the rate of 6.5% per annum. Because holders of our Series A perpetual convertible preferred shares are entitled to vote on
certain matters described in &#8220;&#8212;SoftBank and any other holders of our Series A perpetual convertible preferred shares may exercise
influence over us,&#8221; the issuance of the Series A perpetual convertible preferred shares, and the subsequent issuance of additional
Series A perpetual convertible preferred shares, effectively reduce the relative voting power of the holders of our common shares.</p>


<!-- Field: Page; Sequence: 48 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the conversion of the Series A perpetual
convertible preferred shares into common shares would dilute the ownership interest of existing holders of our common shares. Furthermore,
any sales in the public market of the common shares issuable upon conversion of the Series A perpetual convertible preferred shares would
increase the number of shares of our common shares available for public trading, and could adversely affect prevailing market prices of
our common shares. Sales of a substantial number of shares of our common shares in the public market, or the perception that such sales
might occur, could have a material adverse effect on the price of our common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">SoftBank and any other holders of our Series A perpetual
convertible preferred shares may exercise influence over us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, outstanding Series A perpetual
convertible preferred shares represented approximately 8.4% of our outstanding common shares, including the Series A perpetual convertible
preferred shares on an as-converted basis. The terms of the Series A perpetual convertible preferred shares require the approval of a
majority of our Series A perpetual convertible preferred shares by a separate class vote for us to take the following decisions, among
others described in the respective certificate of designations:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>amend our organizational documents in a manner that would have an adverse effect on the Series A perpetual convertible preferred shares;
or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 36pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>issue securities that are senior to, or equal in priority with, the Series A perpetual convertible preferred shares.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Circumstances may occur in which the interests of SoftBank
and its affiliates could diverge from, or even conflict with, the interests of our other shareholders. For example, the existence of SoftBank
as a significant shareholder may have the effect of delaying or preventing changes in control or management or limiting the ability of
our other shareholders to approve transactions that they may deem to be in our best interests. SoftBank and its affiliates may seek to
cause us to take courses of action that, in their judgment, could enhance its investment in us but which might involve risks to our other
shareholders or adversely affect us or our other shareholders.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our dual class equity structure means our shares will
not be included in certain indices. We cannot predict the impact this may have on our share price.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2017, FTSE Russell, S&amp;P Dow Jones and MSCI announced
changes to their eligibility criteria for inclusion of shares of public companies on certain indices to exclude companies with multiple
classes of shares of common stock from being added to such indices. FTSE Russell announced plans to require new constituents of its indices
to have at least five percent of their voting rights in the hands of public stockholders, whereas S&amp;P Dow Jones announced that companies
with multiple share classes, such as ours, will not be eligible for inclusion in the S&amp;P 500, S&amp;P MidCap 400 and S&amp;P SmallCap
600, which together make up the S&amp;P Composite 1500. MSCI also opened public consultations on their treatment of no-vote and multi-class
structures and temporarily barred new multi-class listings from its ACWI Investable Market Index and U.S. Investable Market 2500 Index;
however, in October 2018, MSCI announced its decision to include equity securities &#8220;with unequal voting structures&#8221; in its
indices and to launch a new index that specifically includes voting rights in its eligibility criteria.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We cannot assure you that other stock indices will not
take a similar approach to FTSE Russell, S&amp;P Dow Jones and MSCI in the future. Under the announced policies, our dual class equity
structure would make us ineligible for inclusion in any of these indices and, as a result, mutual funds, exchange-traded funds and other
investment vehicles that attempt to passively track these indices will not invest in our stock. It continues to be somewhat unclear what
effect, if any, these policies will have on the valuations of publicly traded companies excluded from the indices, but in certain situations
they may depress these valuations compared to those of other similar companies that are included. Exclusion from indices could make our
Class A common shares less attractive to investors and, as a result, the market price of our Class A common shares could be adversely
affected.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The dual class equity structure of our common stock has
the effect of concentrating voting control with the Esteves Family and Bertelsmann; this will limit or preclude your ability to influence
corporate matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Each Class A common share entitles its holder to one
vote per share, and each Class B common share will entitle its holder to 10 votes per share, so long as the total number of the issued
and outstanding Class B common</p>


<!-- Field: Page; Sequence: 49 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">shares is at least 10% of the total number of shares outstanding. Due to
the 10-to-one voting ratio between our Class B and Class A common shares, the beneficial owners of our Class B common shares (composed
of the Esteves Family and Bertelsmann) collectively will continue to control a majority of the combined voting power of our common shares
and therefore be able to control all matters submitted to our shareholders so long as the total number of the issued and outstanding Class
B common shares is at least 10% of the total number of shares outstanding.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, our Articles of Association provide that
at any time when there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (1)&#160;a
share split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or
rights to acquire shares or following capitalization of profits, (2)&#160;a merger, consolidation, or other business combination involving
the issuance of Class B common shares as full or partial consideration, or (3)&#160;an issuance of Class A common shares, whereby holders
of the Class B common shares are entitled to purchase a number of Class B common shares that would allow them to maintain their proportional
ownership interests in Afya (following an offer by us to each holder of Class B common shares to issue to such holder, upon the same economic
terms and at the same price, such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest
in Afya pursuant to our Articles of Association).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Future transfers by holders of Class B common shares
will generally result in those shares converting to Class A common shares, subject to limited exceptions, such as certain transfers effected
to permitted transferees or for estate planning or charitable purposes. The conversion of Class B common shares to Class A common shares
will have the effect, over time, of increasing the relative voting power of those holders of Class B common shares who retain their shares
in the long term.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In light of the above provisions relating to the issuance
of additional Class B common shares, the fact that future transfers by holders of Class B common shares will generally result in those
shares converting to Class A common shares, subject to limited exceptions as provided in the Articles of Association; as well as the 10-to-one
voting ratio of our Class B common shares and Class A common shares, holders of our Class B common shares will in many situations continue
to maintain control of all matters requiring shareholder approval. This concentrated control will limit or preclude your ability to influence
corporate matters for the foreseeable future. For a description of our dual class equity structure, see &#8220;Item 10. Additional Information&#8212;B.
Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Voting Rights.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We are a Cayman Islands exempted company with limited
liability. The rights of our shareholders, including with respect to fiduciary duties and corporate opportunities, may be different from
the rights of shareholders governed by the laws of U.S. jurisdictions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are a Cayman Islands exempted company with limited
liability. Our corporate affairs are governed by our Articles of Association and by the laws of the Cayman Islands. The rights of shareholders
and the responsibilities of members of our board of directors may be different from the rights of shareholders and responsibilities of
directors in companies governed by the laws of U.S. jurisdictions. In particular, as a matter of Cayman Islands law, directors of a Cayman
Islands company owe fiduciary duties to the company and separately a duty of care, diligence and skill to the company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under Cayman Islands law, directors and officers owe
the following fiduciary duties: (i)&#160;duty to act in good faith in what the director or officer believes to be in the best interests
of the company as a whole; (ii)&#160;duty to exercise powers for the purposes for which those powers were conferred and not for a collateral
purpose; (iii)&#160;directors should not improperly fetter the exercise of future discretion; (iv)&#160;duty to exercise powers fairly
as between different sections of shareholders; (v)&#160;duty to exercise independent judgment; and (vi)&#160;duty not to put themselves
in a position in which there is a conflict between their duty to the company and their personal interests. Our Articles of Association
have varied this last obligation by providing that a director must disclose the nature and extent of his or her interest in any contract
or arrangement, and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the
Nasdaq, and unless disqualified by the chairman of the relevant meeting, such director may vote in respect of any transaction or arrangement
in which he or she is interested and may be counted in the quorum at the meeting. Conversely, under Delaware corporate law, a director
has a fiduciary duty to the corporation and its stockholders (made up of two components) and the director&#8217;s duties prohibit self-dealing
by a director and mandate that the best interest of the corporation and its shareholders take precedence over any interest possessed by
a director, officer or controlling shareholder and not shared by the</p>


<!-- Field: Page; Sequence: 50 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">shareholders generally. See &#8220;Item 10. Additional Information&#8212;B.
Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Principal Differences between Cayman Islands and U.S.
Corporate Law.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may need to raise additional capital in the future
by issuing securities, use our Class A common shares as acquisition consideration or enter into corporate transactions with an effect
similar to a merger, which may dilute your interest in our share capital and affect the trading price of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may need to raise additional funds to grow our business
and implement our growth strategy going forward through public or private issuances of common shares or securities convertible into, or
exchangeable for, our common shares, which may dilute your interest in our share capital or result in a decrease in the market price of
our common shares. In addition, we may also use our Class A common shares as acquisition consideration or enter into mergers or other
similar transactions in the future, which may dilute your interest in our share capital or result in a decrease in the market price of
our Class A common shares. Any fundraising through the issuance of shares or securities convertible into or exchangeable for shares, the
use of our Class A common shares as acquisition consideration, or the participation in corporate transactions with an effect similar to
a merger, may dilute your interest in our capital stock or result in a decrease in the market price of our Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we have different disclosure
and other requirements than U.S. domestic registrants and non-emerging growth companies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a foreign private issuer, we are subject to different
disclosure and other requirements than domestic U.S. registrants. For example, as a foreign private issuer, in the United States, we are
not subject to the same disclosure requirements as a domestic U.S. registrant under the Exchange Act, including the requirements to prepare
and issue quarterly reports on Form 10-Q or to file current reports on Form 8-K upon the occurrence of specified significant events, the
proxy rules applicable to domestic U.S. registrants under Section 14 of the Exchange Act or the insider reporting and short-swing profit
rules applicable to domestic U.S. registrants under Section 16 of the Exchange Act. In addition, we rely on exemptions from certain U.S.
rules which permit us to follow Cayman Islands legal requirements rather than certain of the requirements that are applicable to U.S.
domestic registrants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We follow Cayman Islands laws and regulations that are
applicable to Cayman Islands companies. However, Cayman Islands laws and regulations applicable to Cayman Islands companies do not contain
any provisions comparable to the U.S. proxy rules, the U.S. rules relating to the filing of reports on Form 10-Q or 8-K or the U.S. rules
relating to liability for insiders who profit from trades made in a short period of time, as referred to above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Furthermore, foreign private issuers are required to
file their annual report on Form 20-F within 120 days after the end of each fiscal year, while U.S. domestic issuers that are accelerated
filers are required to file their annual report on Form 10-K within 75 days after the end of each fiscal year. Foreign private issuers
are also exempt from Regulation Fair Disclosure, aimed at preventing issuers from making selective disclosures of material information,
although we will be subject to Cayman Islands laws and regulations having substantially the same effect as Regulation Fair Disclosure.
As a result of the above, even though we are required to file reports on Form 6-K disclosing the limited information which we have made
or are required to make public pursuant to Cayman Islands law, or are required to distribute to shareholders generally, and that is material
to us, you may not receive information of the same type or amount that is required to be disclosed to shareholders of a U.S. company.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">As a foreign private issuer, we rely on permitted exemptions
from certain Nasdaq corporate governance standards applicable to U.S. issuers, including the requirement that a majority of an issuer&#8217;s
directors consist of independent directors. This may afford less protection to holders of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Section 5605 of the Nasdaq equity rules requires listed
companies to have, among other things, a majority of their board members be independent, and to have independent director oversight of
executive compensation, nomination of directors and corporate governance matters. As a foreign private issuer, however, we are permitted
to, and we will, follow home country practice in lieu of the above requirements. See &#8220;Item 10. Additional Information&#8212;B. Memorandum
and Articles of Association&#8212;Description of Share Capital&#8212;Principal Differences between Cayman Islands and U.S. Corporate Law.&#8221;</p>


<!-- Field: Page; Sequence: 51 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">We may lose our foreign private issuer status, which
would then require us to comply with the Exchange Act&#8217;s domestic reporting regime and cause us to incur significant legal, accounting
and other expenses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In order to maintain our current status as a foreign
private issuer, either (a)&#160;more than 50% of our Class A common shares must be either directly or indirectly owned of record by non-residents
of the United States or (b)(i)&#160;a majority of our executive officers or directors may not be U.S. citizens or residents, (ii)&#160;more
than 50% of our assets cannot be located in the United States and (iii)&#160;our business must be administered principally outside the
United States. If we lose this status, we would be required to comply with the Exchange Act reporting and other requirements applicable
to U.S. domestic issuers, which are more detailed and extensive than the requirements for foreign private issuers. We may also be required
to make changes in our corporate governance practices in accordance with various SEC and Nasdaq rules. The regulatory and compliance costs
to us under U.S. securities laws if we are required to comply with the reporting requirements applicable to a U.S. domestic issuer may
be significantly higher than the costs we will incur as a foreign private issuer.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our shareholders may face difficulties in protecting
their interests because we are a Cayman Islands exempted company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our corporate affairs are governed by our Articles of
Association, by the Companies Act (as revised) of the Cayman Islands and the common law of the Cayman Islands. The rights of our shareholders
and the fiduciary responsibilities of our directors under the laws of the Cayman Islands are not as clearly established as they would
be under statutes or judicial precedent in some jurisdictions in the United States. Therefore, you may have more difficulty protecting
your interests than would shareholders of a corporation incorporated in a jurisdiction in the United States, due to the comparatively
less formal nature of Cayman Islands law in this area.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">While Cayman Islands law allows a dissenting shareholder
to express the shareholder&#8217;s view that a court-sanctioned reorganization of a Cayman Islands company would not provide fair value
for the shareholder&#8217;s shares, Cayman Islands statutory law does not specifically provide for shareholder appraisal rights in connection
with a merger or consolidation of a company. This may make it more difficult for you to assess the value of any consideration you may
receive in a merger or consolidation or to require that the acquirer gives you additional consideration if you believe the consideration
offered is insufficient. However, Cayman Islands statutory law provides a mechanism for a dissenting shareholder in a merger or consolidation
to apply to the Grand Court of the Cayman Islands for a determination of the fair value of the dissenter&#8217;s shares if it is not possible
for the company and the dissenter to agree on a fair price within the time limits prescribed.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Shareholders of Cayman Islands exempted companies (such
as us) have no general rights under Cayman Islands law to inspect corporate records and accounts or to obtain copies of lists of shareholders.
Our directors have discretion under our Articles of Association to determine whether or not, and under what conditions, our corporate
records may be inspected by our shareholders, but are not obliged to make them available to our shareholders. This may make it more difficult
for you to obtain information needed to establish any facts necessary for a shareholder motion or to solicit proxies from other shareholders
in connection with a proxy contest.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">United States civil liabilities and certain judgments
obtained against us by our shareholders may not be enforceable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are a Cayman Islands exempted company and substantially
all of our assets are located outside of the United States. In addition, the majority of our directors and officers are nationals and
residents of countries other than the United States. A substantial portion of the assets of these persons is located outside of the United
States. As a result, it may be difficult to effect service of process within the United States upon these persons. It may also be difficult
to enforce in U.S. courts judgments obtained in U.S. courts based on the civil liability provisions of the U.S. federal securities laws
against us and our officers and directors who are not resident in the United States and the substantial majority of whose assets are located
outside of the United States.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Further, it is unclear if original actions predicated
on civil liabilities based solely upon U.S. federal securities laws are enforceable in courts outside the United States, including in
the Cayman Islands and Brazil. Courts of the Cayman Islands may not, in an original action in the Cayman Islands, recognize or enforce
judgments of U.S. courts predicated upon the civil liability provisions of the securities laws of the United States or any state of the
United States on the grounds that such provisions are penal in nature. Although there is no statutory enforcement in the Cayman Islands
of judgments obtained in the United States, courts of the Cayman Islands will recognize and enforce</p>


<!-- Field: Page; Sequence: 52 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">a foreign judgment of a court of competent jurisdiction if such judgment
is final, for a liquidated sum, provided it is not in respect of taxes or a fine or penalty, is not inconsistent with a Cayman Islands&#8217;
judgment in respect of the same matters, and was not obtained in a manner which is contrary to the public policy of the Cayman Islands.
In addition, a Cayman Islands court may stay proceedings if concurrent proceedings are being brought elsewhere.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Judgments of Brazilian courts to enforce our obligations
with respect to our Class A common shares may be payable only in reais.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Most of our assets are located in Brazil. If proceedings
are brought in the courts of Brazil seeking to enforce our obligations in respect of our Class A common shares, we may not be required
to discharge our obligations in a currency other than the <i>real.</i> Under Brazilian exchange control laws, an obligation in Brazil
to pay amounts denominated in a currency other than the <i>real </i>may only be satisfied in Brazilian currency at the exchange rate,
as determined by the Central Bank, in effect on the date the judgment is obtained, and such amounts are then adjusted to reflect exchange
rate variations through the effective payment date. The then-prevailing exchange rate may not afford non-Brazilian investors with full
compensation for any claim arising out of or related to our obligations under the Class A common shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Our Class A common shares may not be a suitable investment
for all investors, as an investment in our Class A common shares presents risks and the possibility of financial losses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The investment in our Class A common shares is subject
to risks. Investors who wish to invest in our Class A common shares are thus subject to asset losses, including loss of the entire value
of their investment, as well as other risks, including those related to our Class A common shares, us, the sector in which we operate,
our shareholders and the general macroeconomic environment in Brazil, among other risks.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Each potential investor in our Class A common shares
must therefore determine the suitability of that investment in light of its own circumstances. In particular, each potential investor
should:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient knowledge and experience to make a meaningful evaluation of our Class A common shares, the merits and risks of investing
in our Class A common shares and the information contained in this annual report;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>have access to, and knowledge of, appropriate analytical tools to evaluate, in the context of its particular financial situation,
an investment in our Class A common shares and the impact our Class A common shares will have on its overall investment portfolio;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>have sufficient financial resources and liquidity to bear all of the risks of an investment in our Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>understand thoroughly the terms of our Class A common shares and be familiar with the behavior of any relevant indices and financial
markets; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>be able to evaluate (either alone or with the help of a financial adviser) possible scenarios for economic, interest rate and other
factors that may affect its investment and its ability to bear the applicable risks.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">There can be no assurance that we will not be a passive
foreign investment company, or PFIC, for any taxable year, which could subject United States investors in our Class A common shares to
significant adverse U.S. federal income tax consequences.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0.45pt 0 12pt; text-indent: 36pt">Under the Internal Revenue Code of 1986, as amended
(the &#8220;Code&#8221;), we will be a PFIC for any taxable year in which, after the application of certain look-through rules with respect
to subsidiaries, either (i) 75% or more of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average
quarterly value of our assets consists of assets that produce, or are held for the production of, &#8220;passive income.&#8221; Passive
income generally includes dividends, interest, certain non-active rents and royalties, and capital gains. Cash is generally a passive
asset for these purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>


<!-- Field: Page; Sequence: 53 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Based on the composition of our income and assets and
the value of our assets, including goodwill, which is based on the price of our Class A common shares, we believe that we were not a PFIC
for the taxable year of 2021. However, because we hold a substantial amount of cash (relative to the assets shown on our balance sheet)
and because our PFIC status for any taxable year will depend on the composition of our income and assets and the value of our assets from
time to time (which may be determined, in part, by reference to the market price of our Class A common shares, which could be volatile),
there can be no assurance that we will not be a PFIC for any taxable year. If our Class A common share price declines while we continue
to hold a substantial amount of cash for any taxable year, our risk of being or becoming a PFIC will increase. In addition, as we continue
to expand our business through acquisitions and organically, our risk of becoming a PFIC will increase if we engage in activities that
generate substantial passive income. Moreover, the extent to which our goodwill will be treated as an active asset is not entirely clear.
If we are a PFIC for any taxable year during which a U.S. investor holds Class A common shares, we generally will continue to be treated
as a PFIC with respect to that U.S. investor for all succeeding years during which the U.S. investor holds Class A common shares, even
if we ceased to meet the threshold requirement for PFIC status. Such a U.S. investor may be subject to certain adverse U.S. federal income
tax consequences. See &#8220;Item 10. Additional Information&#8212;10.E. Taxation&#8212;U.S. Federal Income Tax Considerations&#8212;Passive
Foreign Investment Company Rules.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f010"></span>ITEM 4. INFORMATION ON THE COMPANY</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f011"></span>A.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>History
and Development of the Company</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya Limited is a publicly held company listed on the
Nasdaq since July 2019, and therefore subject to certain reporting requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We were incorporated on March 22, 2019 as a Cayman Islands
exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes are unrestricted
and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act (as revised)
of the Cayman Islands, or the Companies Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our affairs are governed principally by (i)&#160;our
Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman Islands. As provided
in our Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity to carry on or undertake any business
or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers and privileges. Our registered office
is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The SEC maintains an internet site (http://www.sec.gov)
that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our internet address is https://ir.afya.com.br/.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our
History</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_001.jpg" alt="" />&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We founded Afya Brazil with the goal of revolutionizing
medical education in Brazil by providing a more effective, individualized and intuitive learning experience. In order to achieve that,
we have assembled institutions that collectively will help us fulfill our mission. The combination of Afya Brazil, one of the largest
Brazilian medical education groups, and Medcel, one of the leaders in residency exams preparatory courses, was the first step toward achieving
our goal.</p>


<!-- Field: Page; Sequence: 54 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya benefits from over 20 years of medical education
experience through Afya Brazil and Medcel, both of which were founded and managed by physicians, with a focus on academic excellence and
deep roots in technology and innovation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We were founded in 1999 with the opening of our first
medical school, Centro Universit&#225;rio ITPAC, by the Esteves Family, a family of medical professionals with a passion for medical
education. Since its inception, our focus has been medical and related health courses. As of December 31, 2019, 8,306 physicians had graduated
with us since the founding of our predecessor companies. Over the last decade, Afya Brazil grew into a large medical education group,
with several campuses and as of December 31, 2021, had 61,118 undergrad students, of which 35,899 were health-related students and 25,219
were non-health related students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medcel, which was incorporated into Afya Brazil in 2019,
was founded by Dr. Atilio Barbosa in 2004, a pioneer in online medical preparatory courses. In 2007, Medcel launched a proprietary platform
to broadcast online classes. Over the years, Medcel evolved from its online platform into an adaptive digital learning environment where
students can access digital media, watch medical case studies, listen to podcasts and answer personalized quizzes. Finally, in 2018, Medcel
began offering its high-quality tech-enabled content in different formats and to other academic institutions. As of December 31, 2021,
Medcel had 17,171 enrolled students and provided residency preparatory courses to 43 partner institutions, as part of our B2B distribution
network.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2016, the private equity group Crescera Investimentos
(formerly Bozano Investimentos) joined forces with Afya Brazil and Medcel, laying out the foundations for the creation of the largest
medical education group in Brazil. See &#8220;&#8212;BR Health Investment in Afya Brazil,&#8221; below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On June 7, 2021, Crescera Educacional II Fundo de Investimento
em Participa&#231;&#245;es Multiestrategia, or &#8220;Crescera Educacional&#8221;, sold the entirety of its 23,074,134 Class B common
shares of Afya to an affiliate of Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221;.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The industry expertise of the founders of Afya Brazil
and Medcel combined with the governance and financial support of Crescera Investimentos allowed the group to dive deeper into its mission
as a thematic educational service provider focused on the lifelong learning career of physicians in Brazil. We achieve this through the
production and distribution of high-quality content through technology.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In order to achieve our goals, we have laid the foundations
of Afya focusing on a four-step process:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Management Professionalization</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our highly skilled and experienced management team has
extensive experience in the education industry and were hired from some of the best health, education and technology institutions in Brazil.
Our management team is part of a company-wide strategy to attract and retain the best talent. Our CEO, Virgilio Deloy Capobianco Gibbon,
has over 13 years of experience in education. Our CFO, Luis Andr&#233; Blanco, has over 12 years of experience as CFO, and L&#233;lio
de Souza Junior, our Vice President of Innovation &amp; Digital Services, has more than 22 years of experience in tech companies.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Integration of Processes &amp; Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In order to create synergies, we have developed several
initiatives to improve operational efficiency and to integrate processes across all our campuses and operations. Our high standard Shared
Services Center and Integrated Systems (ERP + Academic System + Learning Management System) went live in October 2017. These initiatives
will help us grow our student base and keep our marginal costs low.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2017, we began to roll out the integration of the
educational curriculum throughout all medical school units. This rollout begins with the new entrants curriculum and will be fully completed
as the course matures its students. Accordingly, we have been streamlining the teaching methodology and quality across our undergraduate
medical courses. Since the second half of 2019, all undergraduate medical students have access to our fully integrated Educational Curriculum.</p>


<!-- Field: Page; Sequence: 55 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continuing Innovation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We take a blended approach to our methodology, integrating
in-person teaching with online tools and features. By integrating face-to-face and online features through data collection and analysis,
we are able to individualize the student experience at all times. Through seven key initiatives, we create a 100% student-centric ecosystem.
These initiatives include: Medical content mapping, proprietary methodological assembly, significant learning experiences, comprehensive
adaptive learning, daily learning process evaluation, and practical learning and knowledge.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Organic Growth and Entry into Adjacent Markets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2018, the MEC awarded new licenses to Afya Brazil,
allowing it, subject to the verification by the MEC of the satisfactory implementation by Afya Brazil of all regulatory requirements,
to operate seven new medical schools through the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, with an aggregate amount of 350 new
medical school seats per year. As of April 4, 2022, two of these campuses are already operating, as described below. We expect four more
to start its operations in the second semester of 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On May 9, 2019, we consummated the acquisition of IPEMED,
marking our entry into the medical graduate and specialization segment. IPEMED is a leading medical graduate school founded over 13 years
ago, with over 2,300 students across eleven different campuses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On October 2, 2020, we announced that the Secretary of
Regulation and Supervision of Higher Education of the MEC granted authorization to Afya to operate the undergraduate medicine course in
Santa In&#234;s in the State of Maranh&#227;o, under <i>Mais M&#233;dicos II</i> program. This medical school is the first authorized
in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program for Afya and will contribute 50 seats to our operating seats base.
Santa In&#234;s is one of the seven undergraduate campuses Afya was awarded in 2018 in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program, the largest number awarded to any education group.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On December 30, 2020, the Secretary of Regulation and
Supervision of Higher Education of the MEC granted the authorization to Afya operate the undergraduate medicine course in Cruzeiro do
Sul in the State of Acre, under <i>Mais M&#233;dicos II </i>program. This medical school is the second authorized school in connection
with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program for Afya and will contribute 50 seats to our operating seats base. Cruzeiro
do Sul is one of the seven undergraduate campuses Afya was awarded in 2018 in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program, the largest number awarded to any education group.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On February 23, 2022, we announced that the Secretary
of Regulation and Supervision of Higher Education of the Ministry of Education (&#8220;MEC&#8221;) authorized the operations of the medical
schools in Abaetutuba, in the State of Par&#225;, and Itacoatiara, in the State of Amazonas, both under Mais M&#233;dicos II program.
With the authorizations, Afya reaches its third and fourth authorized schools to start operating under the Mais Medicos II program. Each
medical school will contribute with 50 seats.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On March 16, 2022, the Secretary of Regulation
and Supervision of Higher Education of MEC authorized the operation of medical schools in Bragan&#231;a, in the State of Par&#225;,
and Manacapuru, in the State of Amazonas, both under the Mais M&#233;dicos II program (our fifth and sixth authorized schools under
the Mais Medicos II program, respectively). Each medical school will contribute with 50 seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 18, 2022, the Secretary of Regulation and Supervision
of Higher Education of MEC authorized 28 seats additional at Centro Universit&#225;rio S&#227;o Lucas in Ji-Parana State of Rond&#244;nia.
With this authorization, we reach 2,759 approved seats, which will represent around 19,865 students at maturity, considering FIES and
PROUNI.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The acquisitions of PEBMED, MedPhone, iClinic, Medicinae,
Medical Harbour, Cliquefarma, Shosp, RX PRO and Alem da Medicina, marked our evolution in the digital health services sector, complementing
our end-to-end offering to healthcare professionals. For more information on PEBMED, MedPhone, iClinic, Medicinae, Medical Harbour, Cliquefarma,
Shosp, RX PRO, Alem da Medicina and Cardiopapers, see &#8220;&#8212;B. Business Overview.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">BR Health Investment in Afya Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2016, BR Health (which merged into Afya Brazil on
March 29, 2019) acquired a 30% interest in the share capital of Afya Brazil from certain members of the Esteves family (which has since
increased to 41.5% following</p>


<!-- Field: Page; Sequence: 56 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">share capital increases and the subscription of new shares by BR Health).
The acquisition was secured by the following guarantees by certain members of the Esteves family members (and/or companies controlled
by them at the time) in favor of BR Health with respect to certain indemnification obligations of certain members of the Esteves family
members: (i)&#160;a fiduciary assignment of 70% of certain educational services credit rights of IESVAP up to August 2022, (ii)&#160;a
pledge of shares pursuant to which Nicolau Carvalho Esteves pledged 308,998 common shares owned by him in Afya Brazil, and Ros&#226;ngela
de Oliveira Tavares Esteves pledged 92,859 common shares owned by her in Afya Brazil, valid up to April 2024 and which can be partially
released on certain dates subject to certain conditions being met, and (iii)&#160;mortgages <i>(hipotecas)</i> over land located in Aragua&#237;na
and Porto Nacional in the State of Tocantins. Certain of the guarantees were amended in 2018 to cover certain Esteves family indemnification
obligations in connection with the IPTAN and IESVAP transactions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 28, 2019, prior to the merger of BR Health into
Afya Brazil, BR Health assigned the guarantees described above to Crescera, and Crescera and certain members of the Esteves family renegotiated
the guarantees, which are composed of: (i)&#160;a pledge of shares pursuant to which Ros&#226;ngela de Oliveira Tavares Esteves pledged
2,497,275 shares owned by her in Univa&#231;o Patrimonial Ltda., (ii)&#160;mortgages (<i>hipotecas</i>) over land located in Aragua&#237;na
and Porto Nacional in the State of Tocantins, and (iii)&#160;a fiduciary assignment of land located in Parna&#237;ba, in the State of
Piau&#237;, and in Palmas, in the State of Tocantins.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Pre-IPO Corporate Reorganization</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Prior to the consummation of our initial public offering,
certain members of the Esteves Family, Crescera, other members of the Esteves family and the other shareholders of Afya Brazil, or the
Afya Brazil Minority Shareholder Group, contributed all of their shares in Afya Brazil to us. In return for this contribution, we issued
58,485,140 new Class B common shares to Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves and Crescera and 17,370,248
new Class A common shares to the other members of the Esteves family and the Afya Brazil Minority Shareholder Group, in each case in a
one-to-28 exchange for the shares of Afya Brazil contributed to us.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 29, 2019, BR Health (a wholly-owned subsidiary
of Crescera that controlled Guardaya), and Guardaya (which owns 100% of Medcel Editora and CBB Web) merged into Afya Brazil, resulting
in the transfer to Afya Brazil of 100% of Medcel Editora and CBB Web and 15% of Uni&#227;o Educacional do Planalto Central S.A., or
UEPC, a medical school located in the Federal District.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Additionally, on June 18, 2019, Afya Brazil acquired
an additional 15% interest in UEPC through a contribution by Crescera of its additional 15% interest in UEPC into Afya Brazil&#8217;s
share capital. The purchase price was R$24.5 million. This contribution was conducted as part of our corporate reorganization and pursuant
to the terms and conditions of (i)&#160;a purchase agreement between BR Health and UEPC&#8217;s controlling shareholders, which was assigned
by BR Health to Crescera on March 25, 2019, and which required Crescera to acquire the 15% interest in UEPC directly from UEPC&#8217;s
controlling shareholders, and (ii)&#160;an investment agreement dated March 29, 2019, among Crescera, certain members of the Esteves family,
certain minority shareholders and Afya Brazil, pursuant to which Crescera agreed to subsequently contribute its additional 15% interest
in UEPC into Afya Brazil&#8217;s share capital in exchange for a certain number of shares in Afya Brazil, to be calculated at the time
of the contribution in accordance with the calculation formula set forth in the investment agreement.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Roll-up transactions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On June 14, 2019, we concluded the roll-up of the minority
shareholders of FASA to Afya Brazil. On June 16, 2019, we concluded the roll-up of the minority shareholders of IESP to Afya Brazil. On
June 17, 2019, we concluded the roll-up of the minority shareholders of UNIVA&#199;O to Afya Brazil. See &#8220;Item 4. Information
of the Company&#8212;C. Organizational Structure&#8212;&#8221; for our current corporate structure.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Pre-IPO and Post-IPO Acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Please see &#8220;&#8212;Business Overview&#8212;Our
Recent Acquisitions&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Initial Public Offering and Recent Equity Follow-on Offering</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In July 2019, we completed our initial public offering,
in which we sold an aggregate of 15,805,841 of our Class A common shares at a public offering price of US$19.00 per common share. We received
approximately US$242.7 million of net proceeds from our initial public offering (i.e., after deducting underwriting discounts,</p>


<!-- Field: Page; Sequence: 57 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">commissions and offering expenses). Our shares began trading on the Nasdaq
Global Select Market on July 19, 2019, under the symbol &#8220;AFYA.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In February 2020, we completed an equity follow-on offering,
in which we sold an aggregate of 3,260,480 of our Class A common shares at a public offering price of US$27.50 per common share. We received
approximately US$86.6 million of net proceeds from our follow-on offering (i.e., after deducting underwriting discounts, commissions and
offering expenses).</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">SoftBank Investment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 26, 2021, we announced that the SoftBank Latin
America Fund, or SoftBank, agreed to purchase R$822 million, equivalent to US$150 million, of Afya&#8217;s Series A perpetual convertible
preferred shares, subject to customary closing conditions. In addition, Crescera Educacional II Fundo de Investimento em Participa&#231;&#245;es
Multiestrat&#233;gia and the Esteves Family agreed to sell 2,270,208 Class A common shares to SoftBank. In connection with such sale,
at the time, Paulo Passoni from SoftBank was appointed as a board member of Afya, being replaced by Maria Tereza Azevedo in 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The key terms of the Series A perpetual convertible preferred
shares, as set forth under the relevant certificate of designations, are: (i) 6.5% per annum cumulative dividend payable quarterly and
in Brazilian <i>reais</i> (payable in U.S. dollars in Brazilian <i>reais</i> equivalent); (ii) SoftBank shall have the right at any time,
to convert its Series A perpetual convertible preferred shares into 5,917,888 common shares, at an initial conversion price established
at US$25.35; (iii) SoftBank shall have the right to redeem any time after the 5<sup>th</sup> year anniversary at 105% premium; and (iv)
Afya will have the right to force conversion after the 3<sup>rd</sup> year anniversary if forced conversion trigger conditions are satisfied.
For further information, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness&#8212;Financing
&#8211; Series A Perpetual Convertible Shares&#8221; and note 13.2.1(f) to our audited consolidated financial statements included elsewhere
in this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">SoftBank and its affiliates will beneficially own approximately
8.4% of the total shares of the Company (on an as-converted basis for the Series A perpetual convertible preferred shares).</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Crescera Transfer of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On June 7, 2021, we announced that an affiliate of Bertelsmann
SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221; acquired 23,074,134 Class B Afya&#8217;s common shares held by Crescera Educacional II
Fundo de Investimento em Participa&#231;&#245;es Multiestrategia, or &#8220;Crescera Educacional&#8221;.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Since Afya&#8217;s inception, Bertelsmann has indirectly
held a stake in Afya through its investment in Crescera Educacional. In addition, Bertelsmann has had Daulins Emilio, the Managing Director
at Bertelsmann Brazil Investments (BBI) and Head of the Bertelsmann Corporate Center in Brazil, as a member of Afya&#8217;s board of directors
since 2019.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under Afya&#8217;s amended and restated memorandum and
articles of association and shareholders agreement between the Esteves family and Crescera Educacional, Bertelsmann has the right to acquire
Crescera Educacional&#8217;s Class B common shares and become party to the shareholders&#8217; agreement. In connection with such transaction,
Bertelsmann has appointed Kay Krafft and Shobhna Mohn as members of Afya&#8217;s board of directors, together with Daulins R&#234;ni
Em&#237;lio, who was already a member of Afya&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0cm"><b>Bertelsmann to Increase Stake in Afya</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">On April 25, 2022,
we announced that we were notified that an affiliate of Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221; has agreed to buy 6,000,000
Class B common shares of Afya at the purchase price of US$26.90 per share, pursuant to a binding offer made by Nicolau Carvalho Esteves,
Ros&#226;ngela de Oliveira Tavares Esteves and</span></p>


<!-- Field: Page; Sequence: 58 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">NRE Capital Ventures Ltd (together with Nicolau Carvalho Esteves and
Ros&#226;ngela de Oliveira Tavares Esteves, the &#8220;Esteves Family&#8221;), as previously disclosed to the market on March 7, 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">Following the transaction,
Bertelsmann and the Esteves Family will beneficially own 57.5% and 33.1% voting interest, and 31.0% and 17.8% of the total shares respectively,
in Afya.</span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f012"></span>B.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Business
Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are the leading medical education group in Brazil
based on number of medical school seats, as published by MEC as of December 31, 2020, delivering an end-to-end physician-centric ecosystem
that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their medical
residency preparation, graduation program, medical post-graduate specialization programs and continuing medical education activities,
or CME, including through digital health services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our innovative methodological approach combines integrated
content, interactive learning, and an adaptive experience for lifelong medical learners. Through our educational content and technology-enabled
activities, we focus on effective, personalized learning that mirrors one-on-one tutoring.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have the largest medical education footprint in Brazil.
Our undergraduate and graduate campuses are spread across 13 Brazilian states, and our digital medical platform is available across Brazil.
As of December 31, 2021, our network of 46 undergraduate and graduate medical school campuses consisted of 30 undergrad operating units
(units that have been approved by MEC and that have commenced operations) and five approved units (units that have been approved by MEC
but that have not yet commenced operations), compared to 25 and 20 operating units as of December 31, 2020 and as of December 31, 2019,
respectively. As of December 31, 2021, our network of 2,731 medical school seats consisted of 2,481 operating seats (seats that have been
approved by MEC and that have commenced operations) and 278 approved seats (seats that have been approved by MEC but that have not yet
commenced operations), compared to 1,893 and 1,222 operating seats as of December 31, 2020 and as of December 31, 2019, respectively.
We plan to expand our network by opening, subject to the verification by the MEC of the satisfactory implementation by Afya Brazil of
all regulatory requirements, the seven approved medical school campuses we were awarded in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program (the Brazilian federal government initiative to reduce shortages of doctors in the most underserved and vulnerable regions of
Brazil) by December 31, 2021, taking our total to 35 operating medical school campuses in 13 Brazilian states and approximately 2,481
available medical school seats per year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Following our acquisition of Medcel in the first quarter
of 2019 and IPEMED in the second quarter of 2019, we also offer residency preparatory courses and medical postgraduate specialization
programs, delivering printed and digital content, an online medical education platform and practical medical training.</p>


<!-- Field: Page; Sequence: 59 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The acquisition of PEBMED, Medphone, iClinic, Medicinae,
Medical Harbour, Cliquefarma, Shosp and RX PRO marked our evolution in the digital health services sector, complementing our end-to-end
offering to healthcare professionals.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Through PEBMED, we acquired three different products:
(i)&#160;Whitebook, a mobile and web application that assists doctors and medical professionals in clinical daily decision-making; (ii)&#160;Nursebook,
a mobile application that assists nurses in clinical decision-making; (iii) Portal PEBMED, a website that offers free content, including
opinions, papers and updates in connection with medical news and scientific publications. PEBMED has more than 194,000 monthly active
users on the Whitebook and Nursebook platforms and approximately 4 million monthly active users to Portal PEBMED. The acquisition expanded
our products and services offerings and offers significant cross-sell and upsell opportunities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">iClinic is a SaaS
model physician focused technology company and one of the leading medical practice management software in Brazil. They seek to empower
doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase their
productivity and deliver better healthcare services. Their portfolio includes: (i)&#160;</span>Electronic Medical Record: the first electronic
medical record as a SaaS model in Brazil focused on the physician experience; (ii)&#160;Clinical Management System: with this software
doctors can schedule patients online, organize their financial records, use marketing tools to promote their clinics and others; (iii)&#160;Telemedicine:
a platform to provide online consultations fully integrated with doctor&#8217;s schedule and records; and (iv)&#160;Physicians Marketplace:
a website that connects doctors and patients to schedule consultations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">As of December
31, 2021, the software had almost 18,000 users. The platform is currently used for almost 2.5 million medical consultations per month,
of which around 8,500 were through telemedicine and prescribed more than 341,600 electronic medical prescriptions. </span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medicinae is a healthcare technology company specializing
in healthcare payments and financial services. It offers a financial platform that allows healthcare professionals to manage receivables
in an efficient and scalable way using FIDC (receivables investment fund). We believe Medicinae relieves a number of challenges in the
healthcare payments industry, by reducing long payment cycles for professionals and consolidating financial information, improving the
consumer financial experience.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical Harbour offers educational health and medical
imaging solutions through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow
the exploration, and knowledge of human anatomy with digital resources: (i)&#160;educational health solutions: Athena Hub specialized
in anatomy was created to support dynamic teaching and allow physicians, teachers and students to interact and manipulate a real human
body on a digital platform. Considering the high prices, restriction policies and difficulty on maintaining a human body for anatomy classes,
Athena Hub allows students to interact with a digital human body instead of the aged and degenerate bodies for educational purposes. The
solution count with virtual body, anatomy modules, and real exam analysis with photorealistic rendering. And (ii)&#160;medical imaging
solutions: Athena DICOM and MH Cloud specialized in medical imaging with a range of products that simplifies radiology and teleradiology.
Allow physicians to visualize, manipulate, share and store medical imaging with the certification of ANVISA (Brazilian Health Agency).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cliquefarma is a healthtech company operating a free-to-use
website that tracks prescription drugs, cosmetics and personal hygiene product prices in Brazil. Users of Cliquefarma can search for medications
or healthcare products and compare prices from over 15,000 pharmacies in Brazil. The traffic generated is monetized through a cost-per-click
model, where drugstores pay for each click on their ads, and a cost-per-acquisition model, where drugstores pay for each concluded sale.
In 2021, Cliquefarma generated traffic of 16.8 million visitors.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">Shosp is a clinical management software
that offers all functionalities needed for clinics all over Brazil to manage their financials, patients&#8217; appointments, medical records,
marketing, and others. The acquisition of Shosp reinforces the digital prescription digital pillar and creates synergies with iClinic
and Medicinae solutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">RX PRO is a Digital Platform that connects physicians
with the pharmaceutical industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians.
RX PRO has already delivered free samples to more than 50,000 physicians with an innovative digital experience, with an NPS of 86 and
as of today has more than 12 pharmaceutical companies using its platform. RX PRO is monetized by providing a B2B subscription service
to the pharmaceutical industry.</p>


<!-- Field: Page; Sequence: 60 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Al&#233;m da Medicina is an online medical content
platform for physicians and medical students that provides educational tools and technical medical content to assist them throughout their
careers. Its robust content includes mentoring for residency, soft skills, finance, accounting, and investment basics for physicians.
Al&#233;m da Medicina had more than 4,000 subscribers as of December 31, 2021, with a general NPS of 77 and almost 100,000 followers
on Instagram.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cardiopapers is the main medical content and education
platform in the Cardiology field, offering courses and books developed by physicians and for physicians, covering all phases of the medical
career, aligned with Afya&#8217;s overall business strategy. CardioPapers had 7.000 students in 2021 and almost 215.000 followers on Instagram.
The company expects R$18.8 million of gross revenue for 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-family: Calibri,sans-serif">&#160;</span>In
addition to health sciences courses, which comprise medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education,
physiotherapy, nutrition and biomedicine, we also offer degree programs and courses in other subjects and disciplines across several of
our campuses, including undergraduate and postgraduate courses in business administration, accounting, law, civil engineering, industrial
engineering and pedagogy. These non-health courses are not part of our core business, although the number of non-health sciences courses
we offer has increased as a consequence of our strategic acquisitions in 2020, 2019 and 2018 of multi-disciplinary schools with strong
health sciences programs, which are our principal focus. Although non-health courses are not part of our growth strategy, we expect to
continue to offer them to the extent they generate local demand. Following our acquisition of Medcel in the first quarter of 2019 and
IPEMED in the second quarter of 2019, we also offer residency preparatory courses and medical post-graduate specialization programs, delivering
printed and digital content, an online medical education platform and practical medical training.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had 61,118 enrolled students,
compared to 36,206 enrolled students as of December 31, 2020, representing an increase of 68.8% for the period, and compared to 23,969
enrolled students as of December 31, 2019, representing an increase of 51.1% for the period.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our business model is characterized by high revenue visibility
and operating leverage. Approximately 90% of our historical revenue for the years ended December 31, 2021, 2020 and 2019 was composed
of the monthly tuition fees we charge students enrolled in our undergraduate and graduate courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our ability to execute our business model and strategy,
primarily through our (i)&#160;acquisitions (which represented approximately 80.5% of our total growth in terms of net revenue in 2021,
54.0% of our total growth in terms of net revenue in 2020 and 62.0% of our total growth in terms of net revenue in 2019) and (ii)&#160;organic
growth (which represented approximately 19.5% of our total growth in terms of net revenue in 2021, 46.0% of our total growth in terms
of net revenue in 2020 and 39.0% of our total growth in terms of net revenue in 2019), has led to growth, profitability and cash generation:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Our net revenue totaled R$1,719.4 million, R$1,201.2 million and R$750.6 million in 2021, 2020 and 2019, respectively, representing
a compound annual growth rate, or CAGR, of 51.4% since 2019;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Medical school&#8217;s tuition fees represented 75.9%, 73.7% and 69.3% of our historical undergraduate programs combined tuition fees
in 2021, 2020 and 2019, respectively. The average monthly ticket for medical school tuition fees was R$8,615 for year ended December 31,
2021, which represents an increase of 6.8% from R$8,065 for year ended December 31, 2020, which represents an increase of 10.3% from the
R$7,311 average monthly ticket for medical school tuition fees for the year ended December 31, 2019;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Residency preparatory course, continuing medical education, medical post graduate specialization programs offerings and digital services
totaled R$224.9 million and R$200.3 million in net revenue for the years ended December 31, 2021 and 2020, respectively;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We generated net income of R$242.3 million, R$308.0 million and R$172.8 million in 2021, 2020 and 2019, respectively, representing
a CAGR of 18.4% since 2019;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Our Adjusted EBITDA totaled R$754.8 million, R$563.1 million and R$331.2 million in 2021, 2020 and 2019, respectively, representing
a CAGR of 50.5% since 2019;</td></tr></table>


<!-- Field: Page; Sequence: 61 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Our Operating Cash Conversion Ratio was 100.8%, 75.7% and 100.5% for the years ended December 31, 2021, 2020 and 2019, respectively.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Quality is a cornerstone of our value proposition. As
of December 2021, our average Institutional Concept score, which is measured and published by MEC, and is based on certain institutional
planning and development, academic, and management criteria, was 4.4 on a scale of 1 to 5, compared to the Brazilian average of 3.5.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats. The operation of certain of these campuses was subject to the verification by MEC of the satisfactory
implementation by Afya Brazil of all regulatory requirements. As of the date of this annual report, four of these campuses are already
in operation. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Our Geographic Presence.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Recent Acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The entry point to a medical career begins in undergraduate
institutions, so part of our mission is to consolidate this market. Accordingly, expanding our operations through acquisitions has been
a key component of our growth strategy. We have been able to apply our operating business model to our acquisitions, allowing us to add
quality, value and increase profitability.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, we have equipped ourselves through key initiatives
for strategic and relevant acquisitions to our portfolio, including: the creation of a Shared Services Center dedicated to serving our
campuses and running our integration processes, the centralization of content creation and the creation of a dedicated sales team for
each market we operate in.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our recent acquisitions include:</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">IPTAN and IESVAP</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 11, 2018, certain members of the Esteves family,
BR Health and Afya Brazil entered into an investment and purchase agreement providing for (a)&#160;an initial Afya Brazil capital increase
which was paid: (i)&#160;by certain members of the Esteves family with the contribution of the ownership interest held by certain members
of the Esteves family in IPTAN and IESVAP in an amount equal to R$11.6 million; and (ii)&#160;by BR Health through a cash contribution
in an amount equal to R$55.0 million, followed by (b)&#160;a sale by certain members of the Esteves family to BR Health of shares in Afya
Brazil for a purchase price equal to R$37.5 million. The transaction was consummated on April 26, 2018 and the aggregate purchase price
was R$200.3 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">IPTAN is a post-secondary education institution located
in the city of S&#227;o Jo&#227;o Del Rei, in the State of Minas Gerais. It offers on-campus post-secondary undergraduate and graduate
education courses in medicine and other academic subjects and disciplines. IPTAN contributed 49 undergraduate medical seats to Afya.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">IESVAP is a post-secondary education institution located
in the city of Parna&#237;ba, in the State of Piau&#237;. It offers on-campus post-secondary undergraduate education courses in medicine,
dentistry and law. IESVAP contributed 80 undergraduate medical seats to Afya.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">CCSI</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On May 30, 2018, Afya Brazil acquired control of CCSI,
through the acquisition of 60% of CCSI. CCSI is a post-secondary education institution located in the city of Itajub&#225;, in the State
of Minas Gerais. CCSI offers on-campus post-secondary undergraduate courses in medicine. This acquisition was strategic to Afya Brazil.
The purchase price paid by Afya Brazil amounted to R$39.0 million, of which (i)&#160;R$9.2 million was paid in cash on the acquisition
date, and (ii)&#160;R$29.8 million was paid through several monthly installments, which are adjusted by the IGP-M rate, and the last installment
owed was paid in May 2019.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">IESP</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On November 27, 2018, Afya Brazil acquired control of
IESP, through the acquisition of 80.0% of IESP. IESP is a post-secondary education institution located in the city of Teresina, in the
State of Piau&#237;. It offers on-campus undergraduate medicine courses and a variety of other on-campus and distance learning post-secondary</p>


<!-- Field: Page; Sequence: 62 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">undergraduate and graduate education programs. This acquisition was strategic
to Afya Brazil. The purchase price paid by Afya Brazil amounted to R$248.9 million, of which (i)&#160;R$129.8 million paid in cash on
the acquisition date; (ii)&#160;R$4.0 million was paid in December 2018; (iii)&#160;R$8.9 million was paid in February 2019; and (iv)&#160;R$106.2
million was paid in three equal installments of R$35.4 million due on November 27, 2019, November 27, 2020 and November 27, 2021, respectively,
adjusted by the CDI rate and customary purchase price adjustment mechanisms.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">FADEP</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On December 5, 2018, Afya Brazil acquired control of
FADEP, through the acquisition of 100% of RD Administra&#231;&#227;o e Participa&#231;&#227;o Ltda., which has an 89% interest
in FADEP and Afya Brazil also acquired 11% interest in FADEP from the selling shareholder. FADEP is a post-secondary education institution
located in the city of Pato Branco, in the State of Paran&#225;. It offers on-campus post-secondary undergraduate and graduate education
courses in medicine and other academic subjects and disciplines. The acquisition of FADEP represented an opportunity for Afya Brazil to
achieve greater scale and to expand its operations to the southern region of Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The purchase price paid by Afya Brazil amounted to R$133.0
million, of which (i)&#160;R$80.1 million was paid in cash on the acquisition date; and (ii)&#160;R$18.2 million was paid in June 2019
(iii)&#160;R$18.7 million was paid in December 2019 and (iv)&#160;R$19.1 million was paid in June 2020, as adjusted by the SELIC rate.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Medcel</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 29, 2019, (i)&#160;BR Health, a wholly-owned
subsidiary of Crescera that controlled Guardaya; and (ii)&#160;Guardaya which owns 100% of Medcel Editora and CBB Web, were merged into
Afya Brazil, resulting in the transfer to Afya Brazil of 100% of Guardaya, Medcel Editora and CBB Web shares. In connection with this
transaction, 15% of UEPC&#8217;s shares were also acquired by Afya Brazil. Afya Brazil issued 378,696 Class B common shares as a consideration
for the interest held by Crescera in BR Health and Guardaya. The fair value of the purchase consideration was R$259.1 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Additionally, on June 18, 2019, Afya Brazil acquired
an additional 15% interest in UEPC through a contribution by Crescera of its additional 15% interest in UEPC into Afya Brazil&#8217;s
share capital. UEPC is a medical school and has 120 undergraduate medical seats. UEPC also offers courses in business administration,
architecture, accounting, law, physical education, nursing, civil engineering, pharmacy, physical therapy, veterinary medicine, nutrition,
dentistry, pedagogy and psychology, among others.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">FASA</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On February 12, 2019, Afya Brazil entered into a purchase
agreement with the shareholders of FASA providing for the acquisition of 90% of FASA by Afya Brazil. FASA is a post-secondary education
institution with campuses located in the States of Bahia and Minas Gerais. It offers on-campus postsecondary undergraduate courses in
medicine. The FASA transaction was consummated on April 3, 2019. The purchase price was R$201.6 million, of which (i)&#160;R$102.3 million
was paid in cash on the acquisition date; (ii)&#160;R$ 39.7 million was paid in April 2020; (iii)&#160;R$29.8 million was paid in April
2021; and (iv)&#160;R$29.8 million is payable in April 2022, adjusted by the IPCA rate <i>plus</i> 4.1% per year and customary purchase
price adjustment mechanisms. On June 14, 2019, we concluded the roll-up of the minority shareholders of FASA to Afya Brazil.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">IPEMED</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On May 9, 2019, Afya Brazil acquired control of IPEMED,
through the acquisition of 100% of its shares. IPEMED is a post-secondary education institution with campuses located in the States of
Bahia, Minas Gerais, Rio de Janeiro, S&#227;o Paulo and in the Federal District (<i>Distrito Federal</i>). It focuses on medical graduate
programs. The purchase price was R$97.5 million, of which: (i)&#160;R$ 25.0 million was paid in cash as advance through April 2019; (ii)&#160;R$27.2
million was paid in cash on the acquisition date; and (iii)&#160;R$45.3 million is payable in five annual installments due from February
2020 through February 2024 adjusted by the CDI rate and customary purchase price adjustment mechanisms.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">IPEC</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On August 13, 2019, Afya Brazil acquired 100% of the
share capital of IPEC, which at the time of the acquisition was a non-operational post-secondary education institution with governmental
authorization to offer on-</p>


<!-- Field: Page; Sequence: 63 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">campus, post-secondary undergraduate courses in medicine in the State of
Par&#225;. The acquisition contributed approximately 120 medical seats to Afya. IPEC became operational in September 2019.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The aggregate purchase price was R$108 million, of which:
(i)&#160;R$54 million was paid in cash on the transaction closing date, and (ii)&#160;R$54 million is payable in two equal installments,
adjusted by the CDI rate, and due annually at the end of the first and the second year from the transaction closing date. In August 2020,
we paid R$28.1&#160;million, adjusted by the CDI rate and in August 2021, we paid R$ 28.8 million, adjusted by the CDI rate.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">UniRedentor</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 31, 2020, we acquired 100% of UniRedentor.
UniRedentor is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate courses in medicine
in the State of Rio de Janeiro. UniRedentor also offers other health-related undergraduate degrees and graduate programs in medicine and
health, as well as other courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The aggregate purchase price of R$214.6 million was adjusted
by R$4.5 million and was comprised by: (i) R$114.6 million paid in cash on the acquisition date; and (ii) R$100 million payable in five
equal installments from January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4.5 million was
deducted from the first installment paid in January 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The acquisition contributed 112 medical school seats
to us, with a potential 44 additional medical school seats subject to approval by MEC.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">UniSL</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On May 5, 2020, we acquired 100% of the total share capital
of UniSL. UniSL is a post-secondary education institution with governmental authorization to offer on-campus, undergraduate courses in
medicine in the State of Rond&#244;nia.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The aggregate purchase consideration of R$201.5 million
was adjusted by R$7.8 million, of which: (i) 70% paid in cash on the transaction closing date; and (ii) 30% payable in cash in three equal
installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment of R$7.8 million was deducted from the first
installment due in May 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The acquisition contributed 182 medical school seats
to us. There are 100 additional seats still pending approval that, if approved by MEC, will result in a potential additional payment by
us of up to R$80.0 million, adjusted by the CDI rate.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">PEBMED</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 20, 2020, we acquired 100% of the total share
capital of&#160;PEBMED. PEBMED offers content and clinical tools for healthcare professionals, including mobile and web apps. The original
purchase price of R$132.9 million was adjusted by R$0.03 million and was comprised by: (i) R$115.3 million paid in cash on the acquisition
date; and (ii) R$17.5 million was paid with Afya Brazil&#8217;s shares which were subsequently contributed to us in exchange for the issuance
of 141,976 of our shares. The price multiple is equivalent to four times PEBMED&#8217;s annual recurring revenue.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This acquisition will contribute to the development and
expansion of our online services, increasing our monthly active users and bringing active physicians to our digital platform.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">FESAR</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">On November 3,
2020, we </span>acquired<span style="background-color: white">, through Afya Brazil, 100% of the total share capital of&#160;FESAR. FESAR
is a post-secondary education institution with government authorization to offer on-campus, undergraduate courses in medicine in the State
of Par&#225;. </span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">T<span style="background-color: white">he aggregate purchase
price was R$260.8 million, including the CDI rate adjustment from the signing date and the real state of the operation, estimated at R$17.3
million, of which 100% was paid in cash on the closing of the</span></p>


<!-- Field: Page; Sequence: 64 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">operation. The purchase consideration was adjusted by R$1.5 million and
was paid on February 25, 2021. This acquisition contributed 120 medical school seats to us.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">MedPhone</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">On November 4,
2020, Afya Brazil concluded the acquisition of 100% of the total share capital of MedPhone. The net purchase price was R$6.4 million,
and was paid in cash on the acquisition date. MedPhone is a clinical decision and leaflet consultation app in Brazil, that helps physicians,
medical students and other healthcare professionals to make faster and more accurate decisions on a daily basis. MedPhone has more than
175,000 registered users and more than 58,000 monthly active users, with an NPS score of 75. The app has more than 9,100 reviews in the
AppStore with a score of 4.9 out of 5.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">The integration
of MedPhone&#8217;s clinical decision software with PEBMED will create great synergy and allow us to offer both products through the same
platform. </span></p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">FCMPB</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">On November 9,
2020, we acquired, through Afya Brazil, 100% of the total share capital of&#160;FCMPB. FCMPB is a post-secondary education institution
with government authorization to offer on-campus, undergraduate courses in the State of Para&#237;ba. </span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">The total net purchase
price of R$379.9 million was adjusted to R$378.8 million and comprised (i) R$189.9 million paid in cash on the transaction closing date,
and (ii) R$188.9 million payable in cash in four equal installments through 2024, adjusted by the CDI rate. The acquisition contributed
157 medical school seats to us.</span></p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">iClinic</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 21, 2021, we completed the acquisition of
100% of the total share capital of iClinic, through our wholly-owned subsidiary Afya Brazil. iClinic is a SaaS model physician focused
technology company and the leading practice management software in Brazil. This software empowers doctors to be more independent and have
more control over the non-medicine aspect of their practices by digitalizing their daily routine, so they can increase their productivity
and deliver better healthcare. The aggregate purchase price of R$191.1 million is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Medicinae</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 25, 2021, Afya Brazil acquired 100% of the total
share capital of Medicinae, a leading Brazilian healthcare technology company that specializes in healthcare payments and financial services.
The aggregate purchase price of R$9.2 million is comprised of: (i) R$5.6 million of which 100% was paid in cash on the transaction closing
date; and (ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$4.4 million is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3.6 million is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Medical Harbour</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 8, 2021, Afya Brazil acquired 100% of the total
share capital of Medical Harbour, which offers educational health and medical imaging solutions through an interactive platform for anatomical
study, 3D virtual dissection and analysis of medical images, which allow the exploration, and knowledge of human anatomy with digital
resources. The aggregate purchase price of R$11.3 million is comprised of: (i) R$5.0 million of which 100% was paid in cash on the transaction
closing date; and (ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$9.0 million is payable in connection with product
development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$6.3 million is based on the present
value of the obligation considering the facts and circumstances at the acquisition date.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Cliquefarma</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 16, 2021, Afya Brazil acquired 100% of the total
share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal
hygiene product prices in</p>


<!-- Field: Page; Sequence: 65 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Brazil. The aggregate purchase price of R$22.1 million is comprised of:
(i)R$16.2 million paid in cash; (ii) R$3.0 million settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#8220;contingent
consideration&#8221;) of R$3.0 million is payable in relation to product development. The contingent consideration of R$2.9 million is
based on the present value of the obligation considering the facts and circumstances at the acquisition date.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Shosp </i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On May 13, 2021, we announced the acquisition
of 100% of the total share capital of Shosp, a clinical management software that offers all functionalities needed for clinics all over
Brazil to manage their financials, patients appointments, medical records, marketing, and others. Afya&#8217;s intention is to reinforce
the Digital Services operating segment. The aggregate purchase price of R$7.9 million is comprised of: (i) R$5.9 million paid in cash;
(ii) R$454 thousand in consideration to be transferred; and (iii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$1.8
million payable in relation to product development. The contingent consideration of R$1.6 million is based on the present value of the
obligation considering the facts and circumstances at the acquisition date.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>UNIFIPMoc </i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On June 1, 2021, we announced the closing
of its acquisition, through Afya Participa&#231;&#245;es S.A., of 100% of the total share capital of UNIFIPMoc. The aggregate purchase
price was R$328.3 million paid in cash at date of acquisition. There are 40 additional seats still pending approval, which, if approved
by MEC, will result in a potential additional payment of up to R$50,000. UNIFIPMoc is a post-secondary education institution with governmental
authorization to offer on-campus, undergraduate degree programs in medicine and healthcare, as well as in other courses, in the states
of Minas Gerais and Bahia.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Unigranrio</i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On August 4, 2021, we announced the closing
of its acquisition, through Afya Participa&#231;&#245;es S.A., of 100% of the total share capital of Unigranrio. The original aggregate
purchase price was R$626.1 million, which was later adjusted to R$619.0 million as result of net debt adjustments. The purchase price
was paid 60% in cash on the closing date, and the remaining 40% will be paid in four equal annual installments, adjusted by the CDI rate.
There are 82 additional seats still pending approval which, if approved by MEC, will result in a potential additional payment of up to
R$90,200. Unigranrio is a post-secondary education institution with government authorization to offer on-campus, undergraduate medical
and health-related courses in the state of Rio de Janeiro and Santa Catarina.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>RX PRO</i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On October 1, 2021, we announced the closing
of the acquisition of 100% of the total share capital of RX PRO, a solution that connects physicians with the pharmaceutical industry,
providing specialized and personalized marketing for those companies, in a more convenient way for physicians. RX PRO does this by delivering
free samples to a community of pre-selected physicians and offering medical updates regarding pharmaceutical products and treatments in
a fast and efficient way for doctors. RX PRO incorporates the digital prescription pillar and further strengthens Afya&#8217;s digital
ecosystem thesis. The aggregate purchase price paid to sellers was R$45.6 million, of which R$30.3 million was paid in cash and R$5.1
million paid in Afya stock. An earn-out of up to R$21 million can be paid related to gross revenue achievements for 2022, 2023 and 2024.
The contingent consideration of R$10.2 million is based on the present value of the obligation considering the facts and circumstances
at the acquisition date.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Garanhuns</i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On November 5, 2021, we announced that
the Secretary of Regulation and Supervision of the MEC authorized the operation of the medical school in Garanhuns in the State of Pernambuco.
This authorization is in connection with a previous requirement made by ITPAC, a subsidiary of Afya Participa&#231;&#245;es (Afya
Brazil), to expand their operation and open a branch in the city of Garanhuns, before the consolidation of Afya.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Al&#233;m da Medicina</i></p>


<!-- Field: Page; Sequence: 66 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On March 4, 2022, we announced the closing
of the acquisition of 100% of the total share capital of Al&#233;m da Medicina. Al&#233;m da Medicina is a medical content online
platform for physicians and medical students that provides educational tools besides technical medical content that can assist them throughout
their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting, and investment basics for physicians.
Al&#233;m da Medicina had more than 4,000 subscribers in 2021, with a general NPS of 77 and almost 100,000 followers on Instagram. This
business combination incorporates new capabilities to the content &amp; technology for the medical education pillar and further strengthens
Afya&#8217;s digital ecosystem. The aggregate purchase price (enterprise value) paid to sellers was R$16.0 million, which was 100% paid
in cash. An earn-out of up to R$19.2 million can be paid related to gross revenue achievements for 2023 and 2024.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Cardiopapers</i></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">On April 4, 2022, we announced the closing
of the acquisition of 100% of the total share capital of Cardiopapers. CardioPapers is the main medical content and education platform
in the Cardiology field, offering courses and books developed by physicians and for physicians, covering all phases of the medical career,
aligned with Afya&#8217;s overall business strategy. The platform includes more than ten courses, such as a cardiology specialist degree
preparatory course, cardiological emergencies course, preoperative course, dyslipidemia course, EKG course and diabetes course, exploring
the cardiologic medical field and also expanding to other medical areas. CardioPapers had 7,000 students in 2021 and almost 215,000 followers
on Instagram. The company expects R$18.8 million of gross revenue for 2022. This business combination incorporates new capabilities to
the content &amp; technology for the medical education pillar and further strengthens Afya's digital ecosystem. The aggregate purchase
price (enterprise value) paid to sellers was R$35.0 million, of which 100% was paid in cash. An earn-out of up to R$15 million is payable,
of which R$14 million is related to revenue goals and R$1 million related to other goals, both of which established with respect to 2023
and 2024.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Competitive Strengths</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continuous focus on disrupting traditional medical education</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We have an in-depth understanding of medical education and the related issues faced by students in Brazil. As the largest medical
education group in Brazil, we are able to identify trends and adapt our services accordingly;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We have developed a methodological approach to learning that incorporates individualization and technology in both digital and physical
format;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We currently produce content that is centralized, continuously updated and available to all our institutions and students;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We have the largest operating infrastructure in medical education in Brazil, with more than 1,000 partner teaching hospitals and clinics
and almost 248,000 physicians and specialists in our ecosystem;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We have developed the first instructional medical web series created globally, and we have completed the first two seasons and have
already begun working on the third season;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first education group in Brazil to offer a fully digital and customized service for medical residency exam preparation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We believe we are the first player to offer supplemental medical education content to third-party institutions through a business-to-business
model; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>We started offering content and clinical tools for healthcare professionals, including mobile and web apps.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">High-quality standards</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Quality is a cornerstone of our value proposition. Our
operating infrastructure and innovative methodological approach has achieved high levels of satisfaction across our medical schools. Through
our digital platforms, we monitor our students&#8217; learning experience using several criteria and variables. According to Educainsights,
our Net</p>


<!-- Field: Page; Sequence: 67 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Promoter Score, or NPS, a widely known survey methodology that measures
the willingness of customers to recommend a company&#8217;s products and services, was 42 for medical students that graduated more than
five years ago, 34 for medical students that graduated more than two years ago and less than five years ago, and 54 for medical students
that graduated less than two years ago. This gradual improvement in our NPS score shows our continuing commitment to high-quality education
and the medical careers of our students. Additionally, as of December 31, 2020, our average Institutional Score (<i>Conceito Institucional</i>),
which is measured and published by MEC, and is based on certain institutional planning and development, academic and management criteria,
was 4.3 on a scale of 1 to 5, compared to the Brazilian average of 3.5. See &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview&#8212;Regulatory Processes of Post-secondary Education Institutions&#8212;Accreditation of Post-secondary Education Institutions
and Authorization and Recognition of Programs&#8221; for further information on the <i>Conceito Institucional.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, through our online medical education platform
that offers distance learning residency preparatory courses, we are able to monitor our students&#8217; learning experience using several
criteria and variables, including the educational materials they access and use, frequently asked questions, their study hours and schedule,
and their attendance record. Furthermore, as a result of the quality of the content and methodology and the differentiated services offered
by Medcel, third-party medical schools proactively contact it seeking to adopt Medcel&#8217;s medical education content to improve their
medical students&#8217; learning experience and academic scores. As of December 31, 2020, six third-party schools had adopted Medcel&#8217;s
medical education content compared to approximately nine as of December 31, 2019.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">The nature of our business model</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Attractive financial model:</i> We have a strong combination
of significantly low customer acquisition costs, calculated as the sum of sales and marketing and personnel expenses divided by student
additions, which were approximately R$2,016, R$2,488 and R$1,900 per student as of December 31, 2021, 2020 and 2019, respectively, high
occupancy rates of approximately 100% of medical seats in our medical schools as of December 31, 2021, 2020 and December 31, 2019, and
strong operating cash conversion of 100.8%, 75.7% and 100.5% as of December 31, 2021, December 31, 2020 and December 31, 2019, respectively.
As of December 31, 2021, our Life Time Value (LTV) was R$353,404, calculated as the sum of R$58,901 gross income per student divided by
16.7% (to account for one-sixth of the student base graduating every year). As of December 31, 2020, our Life Time Value (LTV) was R$286,227,
calculated as the sum of R$47,704 gross income per student divided by 16.7% (to account for one-sixth of the student base graduating every
year). As of December 31, 2019, our Life Time Value (LTV), calculated as the sum of R$55,463 gross income per student divided by 16.7%
(to account for one-sixth of the student base graduating every year), was R$332,777.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Contracted growth:</i> We have contracted growth visibility
into medical schools that are in the initial six years of operations as a result of the six-year maturation cycle of our medical school
seats.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This cycle begins when a medical school becomes operational,
with a first year medical school class that progresses through the required six years as the next classes begin behind it, and ends when
the medical school has six school years of medical students and has therefore reached capacity at maturation (i.e., the maximum number
of approved seats). Since the maximum number of medical seats per medical school is set by regulation, the only way to grow our medical
school seats, and thus our numbers of enrollments, is through acquisitions or starting new medical schools. As of December 31, 2021, we
had 2,731 approved medical school seats out of an expected total capacity of 19,663 medical school enrollments by 2027, which gives us
visibility as to the growth potential of our revenues over the period. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical
School Regulatory Capacity and Capacity at Maturation.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>End-to-end ecosystem:</i> Successfully integrating
the businesses we invest in or acquire, allows us to offer an end-to-end physician-centric ecosystem. The point of entry of one business
unit is the point of exit from another, which increases cross-selling and upselling opportunities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Difficult to replicate:</i> We believe the combination
of regulatory barriers, demand and supply imbalance and our end-to-end physician-centric ecosystem are difficult to replicate and that
it would take a significant amount of time for competitors to reach the scale of our operation.</p>


<!-- Field: Page; Sequence: 68 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Self-reinforcing network effects of our education
cycle:</i> As we aim to be the trusted content and knowledge partner for lifelong medical learners in Brazil, we have created and have
been nurturing an education cycle that entails differentiation, talented stakeholders and recognition. Our continuous focus on implementing
all stages of our cycle has allowed us to continuously expand our footprint.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center"><img src="afyaform20f_002.jpg" alt="" /></p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Extensive M&amp;A track record</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have extensive capabilities in, and a strong track
record of, identifying, negotiating and successfully integrating acquisitions. We have developed an integration model, operated by a dedicated
team responsible for analyzing, mapping and integrating the systems of our acquired businesses, that we believe enables us to fully integrate
the businesses we acquire in an efficient manner and within 12 months of their acquisition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our integration model is composed of four stages:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Stage 1 (Preliminary Analysis): Preliminary analysis of the available infrastructure, organizational structure and teaching model
of the acquired business to identify potential integration issues.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Stage 2 (Detailed Mapping): Detailed migration diagnosis and mapping of the systems, processes and teaching model of the acquired
business to be integrated into our centralized shared-services center and academic model.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Stage 3 (Integration/Migration): Centralization and migration of the systems and processes into our shared services center and standardization
of the teaching model of the acquired business.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Stage 4 (Ongoing Support): Post migration/integration remote and on-site support and monitoring to stabilize the integrated operations
of the acquired business.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2021, 2020 and 2019, we successfully acquired or invested
in a total of 18 companies, increasing our number of medical schools seats, expanding into new medical education segments and integrating
new technologies that allow us to innovate and enhance our value proposition to lifelong medical learners. As of the date of this annual
report, we have fully integrated the operations of 16 of our acquisitions and are in the process of integrating the operations of another
10 of our acquisitions with our existing business (Medphone, Shosp, Cliquefarma, Medical Harbour, Medicinae, iClinic, Unigranrio, RX PRO,
Al&#233;m da Medicina and Cardiopapers).</p>


<!-- Field: Page; Sequence: 69 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our limited operating history as a consolidated company
and our recent acquisitions entail a number of challenges, such as effectively integrating the operations of any acquired companies with
our existing business and managing a growing number of campuses. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;We may not be able to identify and acquire new medical higher education institutions
or meet our strategic and financial goals in connection with any business acquisition we seek, and difficulties in effectively integrating
and managing a growing number of campuses may adversely affect our strategic objectives&#8221; and &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our limited operating history as a consolidated company,
our recent acquisitions and the comparability of our results may make it difficult for investors to evaluate our business, financial condition,
results of operations and prospects.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Purpose driven culture</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical education requires a core human value: compassion.
As we endeavor to revolutionize medical education in Brazil, we believe that by training and educating better physicians we are helping
people and their communities across Brazil. This mission has united families and entrepreneurs, executives and sponsors with over 20 years
of know-how and expertise in the education sector. Our internal satisfaction survey conducted in 2019 showed employee satisfaction levels
of 81.5 out of a possible 100, based on several criteria, such as trust in, and a commitment to, our values, leadership satisfaction,
work satisfaction, learning and development, and active participation in our activities, reinforcing our strong commitment to our mission
and purpose.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Growth Strategies</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We aim to continue to grow organically and through acquisitions
and to generate greater shareholder value by implementing the following strategic initiatives:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Maturation of current number of authorized medical school
seats</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We benefit from contracted growth visibility in our medical
schools that are in the initial six years of operations, which we derive from two main sources: (1)&#160;the six-year maturation cycle
of our medical school seats, which begins when a medical school becomes operational, with a first year medical school class which progresses
through the required six years as the next classes begin behind it, and which ends when the medical school has six school years of medical
students and has therefore reached capacity at maturation (i.e., the maximum number of approved seats), and (2)&#160;new enrollments from
our seven awarded campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Since the maximum number of medical seats per medical
school is set by applicable regulations, the only way to grow our medical school seats, and thus our number of enrollments, is through
acquisitions or starting new medical schools. Assuming full compliance with applicable regulations and that our seven new &#8220;<i>Mais
M&#233;dicos</i>&#8221; campuses mature as expected with 50 medical seats for each campus, we estimate reaching a total medical student
base of 19,638 students by 2027. See &#8220;Item 5. Operating and Financial Review and Prospects&#8212;Medical School Regulatory Capacity
and Capacity at Maturation&#8221; and &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business
and Industry&#8212;The post-secondary education sector is highly regulated, and our failure to comply with existing or future laws and
regulations could significantly impact our business.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Open new campuses in connection with the &#8220;Mais
M&#233;dicos&#8221; program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats. The operation of such campuses is subject to the verification by MEC of the satisfactory implementation
by Afya Brazil of all regulatory requirements. As of the date of this annual report, MEC had inspected six of the campuses, and the final
verification was published in (i)&#160;October 2020 for ITPAC Santa In&#234;s; (ii)&#160;December 2020 for ITPAC Cruzeiro do Sul; (iii)
February 2022 for ITPAC Abaetetuba (iv) February 2022 for ITPAC Itacoatiara; (v)&#160;March 2022 for ITPAC Bragan&#231;a and (vi) March
2022 for ITPAC Manacapuru.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our medical residency preparation enrollments
base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Competition for medical residencies should increase as
the number of graduating physicians grows and the number of available residency seats remains static. According to a third-party consulting
firm, the number of</p>


<!-- Field: Page; Sequence: 70 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">applicants for medical residency programs is expected to grow at a rate
of 13.4% per year through 2022. We plan to continue to grow our medical residency exam preparation student enrollments, leveraging the
academic outcome, scalability and learning experience of our digital platform.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our graduate programs enrollments base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Due to the shortage of medical residency seats and the
growing demand for medical graduate courses, we believe we will be able to expand our current offering in this segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We intend to continue developing our business-to-business
strategy by increasing the number of partners and student enrollments through increased marketing and sales effort.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cross-sell across our existing medical student base</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Because our solutions target the lifelong education journey
of medical students, we have identified an opportunity to increase student enrollments at a low marginal cost driven by cross-selling
opportunities, such as increasing the number of former undergraduate students subscribing to our medical residency exam solutions and
the number of former undergraduate and/or medical residency students applying to our graduate and CME courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our B2B capabilities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">B2B contracts are effective customer entry points to
our products and services. Students are familiar with our platforms, increasing our brand equity and helping us attract more physicians
to enroll in preparatory courses, graduate programs and CME products.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expand our distribution channels</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We plan to continuously expand our distribution network
by increasing our presence in direct and third-party channels, launching graduate courses or CME for third-party continuing medical education
hubs (including, but not limited to, hospitals, clinics and other medical schools) to grow our graduate medical footprint, through partnerships
with such third-party continuing medical education hubs.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Leverage infrastructure and extract synergies from acquisitions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe we have been able to successfully integrate
our acquisitions into our ecosystem. We plan to implement several measures to improve the profitability of recent acquisitions, including
but not limited to:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining fee discounts and scholarship policies;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Integrating operations with our shared-services center;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Streamlining faculty training in line with our career plan; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Integrating teaching models into our academic model.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Continue to selectively pursue M&amp;A opportunities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We plan to selectively pursue acquisitions that will
complement our current medical education services offering and/or enhance our product portfolio, such as digital content platforms, continuing
medical education institutions and other medical certification companies, among others. We are currently evaluating possible acquisition
opportunities and submit non-binding proposals from time to time. We believe that we have developed a strong capability and track record
of acquisitions. In 2021 to date, we acquired or invested in eleven companies. The acquisitions will increase our total number of approved medical school seats to 2,759 from 2,143 as of
December 31, 2020. In 2020, we acquired or invested in six companies and agreed to acquire two companies, which increased our medical
school seats by more than 36% over the year. In 2019, we acquired or invested in six companies, which increased our medical school seats
by more than 33% over the year. In 2018, we acquired or invested in five companies, which increased our medical school seats by more than
118.3% over the year. Our acquisition of Medcel enabled us to access the medical residency preparation market, and the acquisition of
IPEMED, enabled us to enter the graduate</p>


<!-- Field: Page; Sequence: 71 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">and specialization courses market. Our acquisition strategy is mainly focused
on expanding our medical school footprint by adding new institutions to our existing portfolio.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Enter into new markets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe our end-to-end physician-centric ecosystem
is equipped to serve medical students in complementary segments where our innovative, methodological, data-driven approach can continue
to disrupt traditional vendors and legacy business models. We believe opportunities exist in new sectors and regions of Brazil. In the
future, we intend to focus on expanding further into continuing medical education. We may also seek to grow our business by selectively
expanding into international markets with similar fundamentals.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Develop new products</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We plan to continuously evolve our platform and offer
solutions that keep up with the growing demands of our students. We have a planned pipeline of new products, including new medical web-series
seasons, corporate medical training, new extension health programs, a tutoring suite, a peer-to-peer suite and a virtual reality product.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Geographic Presence</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our headquarters and most of our shared services operations
are located in Nova Lima, in the State of Minas Gerais. Our content creation and dedicated sales team is located in S&#227;o Paulo,
in the State of S&#227;o Paulo.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, our network consisted of a total
of 46 undergraduate and graduate campuses, composed of (i) 35 undergraduate medical school campuses, 30 of which are operating units (units
that have been approved by MEC and that have commenced operations) and five of which are approved units (units that have been approved
by MEC, but that have not yet commenced operations), (ii) 11 graduate campuses that offer medicine- and health-related courses. We plan
to expand our network by opening the five approved undergraduate medical school campuses we were awarded in connection with the &#8220;<i>Mais
M&#233;dicos</i>&#8221; program by 2022/2023. As of December 31, 2021, we had 17,171 students enrolled in our online prep-courses spread
across Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The chart and table below illustrate our current footprint
of undergraduate and graduate medical schools.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center">&#160;<img src="afyaform20f_003.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"></p>


<!-- Field: Page; Sequence: 72 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 20%; font-family: Times New Roman,serif; text-align: left"><b>Campus</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 6%; font-family: Times New Roman,serif; text-align: left"><b>State</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 25%; font-family: Times New Roman,serif; text-align: left"><b>Brand</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 19%; font-family: Times New Roman,serif; text-align: left"><b>Year of Acquisition</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 18%; font-family: Times New Roman,serif; text-align: left"><b>Approved Seats(2)</b></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; width: 12%; font-family: Times New Roman,serif; text-align: left"><b>Semester(1)</b></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Porto Nacional</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">TO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Before 2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">120</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.04</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Pato Branco</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PR</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FADEP</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Pato Branco</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PR</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FADEP</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">60</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.18</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Itajub&#225;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MG</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FMIT</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">87</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">01.68</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Parna&#237;ba</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">IESVAP</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">80</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.15</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Palmas</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">TO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">120</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Teresina</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNINOVAFAPI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">110</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.04</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Teresina</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNINOVAFAPI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">61</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">S&#227;o Jo&#227;o Del Rei</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MG</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNIPTAN</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">38</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.15</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">S&#227;o Jo&#227;o Del Rei</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MG</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNIPTAN</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">11</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">1.16</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Aragua&#237;na</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">TO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNITPAC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">80</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.06</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Ipatinga</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MG</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Univa&#231;o</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2018</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">100</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">01.99</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Marab&#225;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FACIMPA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">120</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.19</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Vit&#243;ria da Conquista</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">BA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FASA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">100</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">01.15</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Itabuna</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">BA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FASA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">85</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">02.18</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Camet&#225;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">To be started</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Cruzeiro do Sul</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">AC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.20</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Santa In&#234;s</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">AM</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.20</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Manacapuru</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">AM</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.22</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Itacoatiara</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Abaetetuba</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.22</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Bragan&#231;a</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC - Mais M&#233;dicos</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">50</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Itaperuna</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RJ</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Uniredentor </td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2019</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">112</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.15</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Jo&#227;o Pessoa</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PB</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FCMPB</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2020</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">124</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.17</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Jo&#227;o Pessoa</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PB</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FCMPB</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2020</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">33</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.18</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Reden&#231;&#227;o</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FESAR</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2020</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">120</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.18</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Porto Velho</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UniSL</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2020</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">52</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.19</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Porto Velho</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UniSL</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2020</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">130</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.05</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Guanambi</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">BA</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">FIP GUANAMBI</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2021</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">60</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.18</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Garanhuns</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">PE</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">ITPAC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2021</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">120</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">1.22</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Montes Claros</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">MG</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNIFIPMOC</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2021</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">100</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.07</td></tr>
  <tr style="background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Duque de Caxias</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RJ</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNIGRANRIO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2021</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">198</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.07</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Rio de Janeiro</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RJ</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UNIGRANRIO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2021</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">110</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.18</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; border-left: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">Ji-Paran&#225;</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">RO</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">UniSL</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2022</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">28</td>
    <td style="border-right: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; font-family: Times New Roman,serif; text-align: left">2.22</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Schools with six or more years of operations are considered fully matured.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Number of medical seats presented are estimated.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<!-- Field: Page; Sequence: 73 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Industry Overview</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s education environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil&#8217;s education environment has become increasingly
open to private capital. At the same time, the government has continued to play an important role through the municipalities, states,
and federal government.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Post-secondary education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Higher education in Brazil differs significantly from
pre-secondary education. The majority of higher education schools are under private management and account for approximately 88% (both
for profit and nonprofit) of all higher education institutions. Higher education institutions are divided into three categories depending
on the number of courses they offer, seniority of the teaching staff, and amount of research they conduct: they can be classified as colleges,
university centers or universities. Typical post-secondary programs take between four to six years to complete. While some courses in
these programs only occur during a certain period of the day (i.e., morning, afternoon, or evening), others are offered as full day courses.
Tuition is paid on a monthly basis, primarily out of pocket by students and their families. Government financing is available, but not
easily accessible. The main programs are FIES and PROUNI, which together accounted for 40% of total financing in 2014 prior to more regulated
policies in recent years.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Introduction to Brazil&#8217;s medical education industry</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In Brazil, aspiring physicians apply to medical school
following graduation from secondary education. Medical school in Brazil is a six year undergraduate program. Upon graduation, medical
students gain a license and can start working as a generalist physician. At this point, they usually consider alternatives to gain a certification
for one or more medical specialties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The first and most common path to obtaining a medical
specialty certification is through a medical residency program. If a candidate chooses the medical residency path, the student must pass
an entrance examination, referred to as R1 exam administered by each institution offering a residency program. After getting approved
by a residency institution, the student then starts the first year of residency with the support of a government study grant throughout
the specialization period. If the physician wants to pursue a sub specialty, he or she will need additional years of study, which may
or may not require incremental entrance tests.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical professionals, that do not choose or fail to
be admitted into a residency program can still pursue a medical specialty certification through other alternatives. For instance, a generalist
can take the specialist certification exam to become a specialist after meeting a variety of eligibility criteria. Those criteria can
include internships, hours of work under supervision of a medical specialist, or hours of study in a certified graduate program, among
other methods. Depending on the desired level of medical specialty, it can take four to 10 years for a generalist to meet the criteria
and, in this context, graduate programs can be a shorter path to reach eligibility sooner.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As medical science continues to evolve very rapidly,
medical professionals must seek ways to stay up to date on those developments. For that purpose, physicians and other medical professionals
tend to use numerous sources of continuing medical education, or CME, including short term programs, scientific paper digests, and medical
congresses, among others.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical education system: Brazil vs. United States</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">While Brazil mandates that students pursue a six year
specific undergraduate medical education, a student in the United States must typically earn a four year undergraduate degree prior to
applying for medical school. Although no specific undergraduate degree is required, pre medical, biology, and health focused majors are
recommended.</p>


<!-- Field: Page; Sequence: 74 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A U.S. student must apply to medical school programs
upon finishing his undergraduate degree, typically taking another four years to complete medical school. As is the case in Brazil, the
U.S. medical school application process is highly competitive and has historically seen increasing medical course applications. In 2018,
21,622 U.S. students were enrolled out of 52,777 medical school applicants, representing an applicants per enrolled student ratio of 2.4x.
Additionally, the number of medical school applicants increased at a 2.7% Compound Annual Growth Rate, or CAGR from 2010 to 2018, according
to the AAMC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">While Brazilian students have the option to either pursue
a medical residency or work as a generalist after graduating, U.S. students are required to go through a residency program after completing
medical school to become an authorized physician. To do this, the student must enroll in the National Residency Matching Program, or NRMP,
which matches physician applicants to U.S. residency training programs. In 2017, 35,969 U.S. medical school graduates applied for 31,757
residency positions, representing an applicants per enrolled student ratio of 1.2x. To complete the program and become an authorized physician,
each student must also pass the United States Medical Licensing Examination, or USMLE.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The diagram below illustrates the structure and timeline
of the Brazilian medical education system relative to the United States:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_004.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: MEC</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center">&#160;<img src="afyaform20f_012.jpg" alt="" /></p>



<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: AAMC</p>

<!-- Field: Page; Sequence: 75 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Regulatory overview and &#8220;<i>Mais M&#233;dicos</i>&#8221; program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical education in Brazil is subject to regulatory
terms that aim to define the supply of medical seats across the country. From 2013 to 2018, the Brazilian government put initiatives in
place to increase the number of annual medical school and residency vacancies, which have been recently revised.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2013, Law No. 12,871 defined the protocol for the
creation of new medical courses in Brazil to address issues such as the unequal distribution of doctors across Brazilian states. Among
the criteria that support the creation of medical schools seats, two relevant aspects are (i)&#160;the importance of these new openings
in a specified region and (ii)&#160;the sufficiency of the current medical infrastructure in both public regional hospitals and in the
applicant medical institution in order to obtain government authorization.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">To reduce the shortage of doctors and mitigate the perceived
healthcare inequality, the Brazilian federal government implemented a strategic initiative called &#8220;<i>Mais M&#233;dicos</i>.&#8221;
The program&#8217;s main objectives included addressing the provision of doctors for primary care in municipalities, strengthening health
care infrastructure, and allocating medical workforce to underserved areas.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to WHO, from its inception in 2013 until 2018,
&#8220;<i>Mais M&#233;dicos</i>&#8221; assigned physicians to over 4,000 municipalities benefiting poorer areas. For example, during
that period, 63% of physicians working in this program in northeastern Brazil were assigned to work among the region&#8217;s poorest municipalities.
Until July 2014, 91% of the municipalities in northern Brazil with a shortage of physicians had been provided, on average, almost five
physicians per municipality. Studies have demonstrated there was a significant increase, from 62.7% to 70.4%, in the population receiving
primary care coverage from 2014 to 2016.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Regarding academics, &#8220;<i>Mais M&#233;dicos</i>&#8221;
implemented short- and long-term measures to improve the Brazilian medical training system in both quantitative and qualitative ways.
Among these measures was the opening of new medical school slots, in both undergraduate courses and residency programs. From its creation
in 2013 until 2018, &#8220;<i>Mais M&#233;dicos</i>&#8221; reached an annual contribution of 11,400 new student slots in medical schools
as well as 12,400 student slots for medical residency.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">With the increase in annual offerings through &#8220;<i>Mais
M&#233;dicos</i>,&#8221; the MEC announced on April 5, 2018, that the government had decided to freeze the new offering of medical seats
for a period of five years. The decision was based on the previously defined target of at least 11,000 annual medical seats, which according
to WHO had already been achieved.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Brazilian medical education quantitative assessment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Given the national regulatory framework, expanding medical
seats depends mostly on quality attributes and the need for additional doctors in the given geography. The number of medical seats remained
approximately unchanged between 2005 and 2012, but increased at a faster pace from 2012 to 2014 to mitigate the shortage of physicians
in the country.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Over the last five years, &#8220;<i>Mais M&#233;dicos</i>&#8221;
has raised the medical seats offerings. From 2013 to 2018, it created approximately 13,000 seats in medical schools throughout the country,
which contributed to the increase in enrollment in private medical schools. After the recent assessment of current medical seats offered
versus planned back in 2013, the number of seats has been held constant at 36,700 by MEC since April 2018.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">From 2010 to 2020, first-year enrollments in private
medical schools have increased by 17,629, representing a 5.4% CAGR, compared to an additional 3,358 public medical first-year enrollments
during that period.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to Demografia M&#233;dica, the number of
physicians in Brazil increased from 320,477 to 500,000 from 2010 to 2020, representing a 56.0% increase. With that demand in place, a
supply of new healthcare professionals is expected to keep growing to keep up with the increased demand for public and private health
services.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">By 2023 the total number of physicians in Brazil is expected
to increase to 527,059 professionals, implying 2.44 doctors per 1,000 inhabitants, compared to the current level, below 2.2 doctors per
1,000 inhabitants. At the same time, the number of events per doctor is expected to slightly increase, driven primarily by the suppressed
demand related to the public sector, with total events per doctor expected to reach 4,665 from the current 4,518.</p>


<!-- Field: Page; Sequence: 76 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Projection of the ratio of events per doctor in Brazil
(2018 to 2023)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_005.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: IBGE, INEP, and third-party consulting firm analysis.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil is not expected to reach an excess supply of physicians
through 2028, even considering the increasing number of medical graduates over the next 10 years.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Fundamentals of medical education in Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The medical education market in Brazil is supported mainly
by the higher demand for medical courses than the actual seats offering, the low and uneven medical density when compared to the Organization
of Economic Cooperation and Development, or OECD average, Brazil&#8217;s fast aging population, and compelling financial rewards for those
seeking to pursue a medical career.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Brazil&#8217;s aging population</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil&#8217;s aging population is expected to drive
an increase in demand for physicians and other healthcare service providers. Brazil&#8217;s aging ratio is twice that of the United Kingdom
and three times that of the United States. Compared to 1995, life expectancy at birth is up from 66 years to 76 years, driven primarily
by medical and health improvements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">By 2030, 13.5% of the Brazilian population is expected
to be older than 65 years, compared to 7.3% in 2010. Furthermore, in 2060, the percentage of the population of 60 years and older is expected
to exceed the number of people of 19 years and under, according to the Instituto Brasileiro de Geografia e Estat&#237;stica, or IBGE.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Population distribution by age group&#8212;Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_006.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: IBGE</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Increase in medical services demand</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The long-suppressed demand for health services in Brazil
is expected to continue to increase given demographic changes in Brazil as well as a larger portion of the population being able to access
private healthcare services. As of</p>


<!-- Field: Page; Sequence: 77 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">December 31, 2020, Private Health Insurance penetration in Brazil reached
24.2%, according to data from ANS. This is lower than countries such as Germany, Australia and the United States, which according to the
OECD have 33.9%, 54.9% and 63.0% penetration, respectively.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Even with the expected increase in medical graduation,
the demand for healthcare services is expected to surpass the current supply of physicians by medical schools creating a continued demand
for medical courses and graduate education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to the OECD, Brazil currently has 2.1 doctors
per 1,000 inhabitants, which is considerably below the international average and the average of developed countries, which have been through
the demographic changes that are expected to happen in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For example, according to WHO, Argentina had an average
of 4.0 doctors per 1,000 inhabitants in 2017. Considering the projections of a total of 521,106 physicians in 2023 versus Brazil&#8217;s
population growth over the same period, Brazil would have approximately 2.1 doctors per 1,000 inhabitants, which is still below the OECD
average.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Doctors per thousand inhabitants, according to selected
OECD countries&#8212;Brazil, 2018</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_007.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: OECD</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shortage and distribution of medical professionals in
Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil&#8217;s low medical density and inequality in
physician distribution is illustrated in the figure below. S&#227;o Paulo and Rio de Janeiro have 2.8 and 3.5 doctors per 1,000 inhabitants,
respectively, while the states of Amap&#225; and Maranh&#227;o have 1.1 and 0.9 doctors per inhabitant, respectively. The north and
northeast regions are the nation&#8217;s most underserved areas in the country and have been the focus of physicians&#8217; assignment
by the government. According to &#8220;Demografia M&#233;dica no Brazil&#8221;, the national average of physicians per 1,000 inhabitants
is 2.1, while the average outside urban capitals is 1.3.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Even with the expected increase in physicians over the
next 10 years, Brazil&#8217;s medical density is expected to remain low when compared to developed countries, and is not expected to achieve
the average medical density of the OECD.</p>


<!-- Field: Page; Sequence: 78 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Distribution of doctors according to Brazilian states&#8212;2018</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_008.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: Scheffer M. et al., Demografia M&#233;dica no Brasil 2018</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Compelling financial rewards for pursuing a medical career</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: left">One of the notable arguments for pursuing a medical career
in Brazil is the financial outcome for the future physician, with higher salaries and fast payback. The main points of view that support
the increasing demand for medical education analysis are: (i) nearly 100% employability of medical school graduates in Brazil; (ii) significantly
higher salaries for medical school graduates than those enrolled in engineering courses (by approximately 128%), and (iii) a five-year
post-graduation average payback period.</p>


<!-- Field: Page; Sequence: 79 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_009.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: Instituto de Pesquisa Econ&#244;mica Aplicada&#8212;IPEA,
Brazilian Ministry of Labor, Third-party consulting firm analysis</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Even when considering the comparatively high tuition
paid during the six-year medical undergraduate program, its above average income after graduation results in an average payback period
of four years, a relatively short period compared to other undergraduate education majors.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Supply and demand imbalance for medical education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The number of applicants for medical school remained
relatively constant from 2014 to 2017, with 196,000 applicants in both years. This compares to a 12.5% CAGR for the increase of seats
openings for medical schools in the same period. Although the students seats have been increasing at higher rates, there remains a significant
gap between the demand and supply of medical education, which is expected to drive continued competitiveness in medical entrance exams.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Applicants/openings for medical schools</p>

<p style="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 10pt"><img src="afyaform20f_010.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: INEP, MEC, third-party consulting firm analysis. 2017-2023
figures are projections.</p>


<!-- Field: Page; Sequence: 80 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Total openings for medical school (in thousands)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center"><img src="afyaform20f_011.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: INEP, MEC, third-party consulting firm analysis. 2018-2023
figures are projections.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">With future residency slots expected to remain virtually
unchanged over the upcoming years and an occupancy rate of approximately 60% of current residency seats available as of 2017, increased
competitiveness is expected in residency programs.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Applicants/openings for medical residency</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_013.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: MEC. 2019-2023 figures are projections.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Expansion in graduate programs and CME</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The number of public and private medical graduate courses
is not measured by any institution, as it is developing and growing as residency slots become increasingly restricted. Typically educational
institutions partner with hospitals to provide an adequate infrastructure for teaching students. Unlike residencies, students pay out-of-pocket
monthly tuition of around R$4,000, according to a third-party consulting firm. These are usually one to two year courses and there is
currently no government student financing for this segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Both graduate and other CME courses are expected to take
advantage of the increasing graduation rates in Brazil, which are expected to add more than 130,000 new physicians over the next five
years, in addition to the current 454,848 doctors that are expected to continue to access this market.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Projection of the number of doctors in Brazil (2018
to 2023)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_014.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: Scheffer M. et al., Demografia M&#233;dica no Brasil 2018,
third-party consulting firm analysis</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Technological innovation driving enhancements to medical
education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Technology has played a central role in shaping the medical
profession. However, regulations coupled with restrictive characteristics of medical education hinder the ability of undergraduate distance
learning programs to expand in Brazil. However, the residency preparatory market has rapidly shifted towards a more technological approach.
Tech enabled features are promoting distance learning to spread within the sector, primarily because they facilitate enhanced student
access to educational content.</p>


<!-- Field: Page; Sequence: 81 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">By eliminating the necessity of physical presence, both
the market and the penetration rate are expected to expand. For these reasons, information and communication technology services in the
education market are expected to grow from US$83.2 billion in 2019 to US$99.0 billion in 2023 worldwide, representing a 4.4% CAGR, according
to Technavio. North America accounted for 40.6% of this market in 2018, indicating room for international expansion. In contrast, South
America comprised 6.0% of the market in 2018 and is expected to grow at a 7.0% CAGR until 2023.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Market assessment and forecasts on medical education</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Medical schools</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">There are currently 337 medical schools in Brazil, of
which 60% are private and 40% are governmentally run, according to MEC. In terms of student seats, the relative distribution is comparable:
68% are private while 32% are governmentally run. The market is also highly fragmented. A student that begins a medical school program
at the age of 18 would typically be expected to complete the program at 24 years old.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The medical schools segment shows that the current supply
of students&#8217; seats in medical courses has not been sufficient to service the growth in demand for medical education in Brazil. The
total number of enrolled medical students in private schools reached 108,000 in 2018 and is expected to increase to approximately 166,000
in 2023, assuming there will not be new openings by the government in the next five years.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Total students enrolled in private universities (in
thousands)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_015.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: INEP, third-party consulting firm analysis. 2019-2023 figures
are projections.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">With the increasing demand creating a favorable scenario
for medical school tuition, a rise in the average current tuition is expected to post a 5.1% CAGR in the next five years, reaching R$119,000
in 2023 according to a third-party consulting firm. Both increases in the number of enrolled students and average tuition support a market
14.9% CAGR between 2018 and 2023, implying that the current R$10 billion market would grow to become a R$19.8 billion market by 2023.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Residency and preparatory courses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The number of medical residency student slots available
each year is regulated by the MEC and the Ministry of Health. Only hospitals are allowed to offer residency slots and no educational institution
does it unless it has its own teaching hospital. Each student receives a scholarship from the government for the duration of their residency
(from one to two years). Given the perceived lack of funding from the government, the number of residency students seats is expected to
remain approximately unchanged in the future.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Openings for medical residency (in thousands)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_016.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: MEC. 2019-2023 figures are projections.</p>


<!-- Field: Page; Sequence: 82 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to Demografia M&#233;dica, in 2017, there
were 790 hospitals that offered residency programs. The market is fragmented and the number of students&#8217; seats varies depending
on the specialty the physician is looking for. In 2018, four main areas of interest corresponded to the first choice of approximately
40% of recently graduated students applying to residency programs. A student that begins a medical residency program at the age of 24
would typically be expected to complete the program at 26 or 27 years old, depending on the student&#8217;s chosen specialty.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Assuming that 80% of the students enrolled in the fifth
and sixth years of medical schools have an interest in taking the R1 test and that the R3 students will continue to grow at current rates,
the preparatory courses segment is expected to grow from its current market size of R$1.0 billion to approximately R$2.4 billion by 2023,
at a 18.7% CAGR.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Graduate programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Similar dynamics affect the graduate segment, in which
a student that begins a graduate program at the age of 24 would typically be expected to complete the program at 26 or 27 years old, depending
on the chosen course. Graduate courses are expected to benefit from the increase in new physicians graduating over the coming years, and
have an average duration of two to three years. The current graduate market accounts for a total of R$3.7 billion and is expected to grow
at a 13.5% CAGR until 2023. According to a third-party consulting firm, the implied applicant/opening ratio for medical residency programs
was 4.3 in 2018.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This increase is primarily supported by the continuing
need for specialization, which is expected to raise the current 77,000 students to approximately 118,000 students by end of 2023. A factor
that supports the demand is the possibility of a student pursuing more than a single specialization along their career. In line with the
increasing number of enrollments, the demand for specialization is expected to see price increases during the same period, implying a
CAGR of 4.0%.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Specialization students (in thousands)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_017.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: MEC, third-party consulting firm analysis. 2019-2023 figures
are projections.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">CME</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Doctors and other medical professionals are expected
to continuously educate themselves on evolving developments within their practice throughout their careers. Consequently, the CME market
in Brazil is expected to experience an increase in demand as the number of medical school graduates increases. The total number of physicians
in Brazil is expected to increase from approximately 450,000 in 2018 to approximately 530,000 in 2023.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Total physicians in Brazil (in millions)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_018.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: Scheffer M. et al., Third-party consulting firm analysis.
2019-2023 figures are projections.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">With both expected growth in the number of physicians
between 2018 and 2023 and a tuition adjustment over this period, the CME market is expected to reach a total value of R$2.4 billion by
2023, compared to R$1.6 billion</p>


<!-- Field: Page; Sequence: 83 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">in 2018, implying an 8.5% CAGR. The increase is also supported by the need
for continued education on new technologies and procedures, two recurring topics in the medical education segment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Another important element of the CME market is that it
is currently not mandatory for doctors to regularly take CME courses. We expect this to change and become more in line with other countries,
where physicians must show their respective medical associations that they are up to date.</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Other health non-medical school programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Other health-related undergraduate courses which include
dentistry, pharmacy, nutrition, physiotherapy, psychology, nursing, and physical education, enrolled a total of 1.3 million students in
2018, representing a R$17 billion market. Although the impact of regulation and macroeconomic factors are comparable to those of medical
school programs, fundamentals of other health non-medical school programs differ from those of medical schools because of consumer preferences,
and the number of students is expected to remain flat. For health-related non-medical schools, average tuition growth rates are expected
to be in line with consumer inflation. These other health-related courses are expected to grow at a 13.2% CAGR between 2018 and 2023,
reaching a total addressable market of R$31.8 billion.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Non-medical health students enrolled (in millions)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_019.jpg" alt="" /></p>

<p style="font: italic 8pt Times New Roman,serif; margin: 0 0 10pt">Source: INEP, Third-party consulting firm analysis. 2019-2023 figures
are projections.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Total health education market potential</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Considering all medical segments combined, there was
an addressable market related to medical careers of approximately R$16.4 billion as of December 31, 2018 and encompassing over 700,000
lifelong medical learners, composed of:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a R$10.0 billion addressable medical school market, calculated as (i)&#160;the number of medical student enrollments totaling 108,000,
based on historical enrollment trends, and the addition of new medical schools seats (as published by the MEC), <i>multiplied by </i>(ii)&#160;the
estimated R$92,400 average annual tuition per student, based on an average of the annual tuition fees charged by private medical schools
in Brazil;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a R$1.0 billion addressable residency preparatory courses market, calculated as (i)&#160;the number of medical residency candidates
totaling 71,000, based on historical medical school graduation records and the number of medical school residency candidates (as published
by the MEC), <i>multiplied by</i> (ii)&#160;the estimated R$15,000 average annual course fees per candidate, based on an average of the
annual course fees charged by the four largest residency preparatory course providers in Brazil;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a R$3.7 billion addressable medical specialization courses market, calculated as (i)&#160;the number of physicians seeking specialization
courses totaling 76,600, based on historical medical school graduation and medical specialization course enrollment records (as published
by the MEC), <i>multiplied by</i> (ii)&#160;the estimated R$48,800 average annual course fees per physician, based on an average of the
annual course fees charged by the four largest medical specialization course providers in Brazil; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a R$1.6 billion addressable continuing medical education, or CME, market, calculated as (i)&#160;the number of physicians seeking
CME courses totaling 454,848, based on the number of active physicians in Brazil (as published by the Brazilian Medical Association <i>(Associa&#231;&#227;o
M&#233;dica Brasileira))</i>, <i>multiplied by</i> (ii)&#160;the estimated R$3,500 annual average amount spent per physician on CME
courses, based on the findings of a primary survey conducted by a third-party consulting firm.</td></tr></table>


<!-- Field: Page; Sequence: 84 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The total addressable market is expected to grow to R$31.6
billion and to over 910,000 lifelong medical learners by 2023. If the other health-related non-medical courses are added to this figure,
the addressable market increases to R$34.3 billion in 2018 and a projected R$64.9 billion in 2023.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Market Opportunity</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to a third-party consulting firm, the total
addressable market for the medical and healthcare career segment in Brazil was R$66.5 billion as of March 31, 2020, composed of (i)&#160;a
R$14.0 billion medical school market, (ii)&#160;a R$1.5 billion residency preparatory courses market, (iii)&#160;a R$4.8 billion medical
specialization courses market, (iv)&#160;a R$1.8 billion continuing medical education market, (v)&#160;a R$23.0 billion other health courses
market and (vi)&#160;a R$21.4 billion medical digital services market. We estimate that we currently capture approximately 1.5% of the
total addressable market based on our net revenue for the last 12 months ended June 30, 2020. This market encompasses over 800,000 lifelong
medical learners in Brazil, composed of 136,000 medical students, 91,000 students seeking residency preparatory courses, 90,000 and 500,000
physicians seeking to enroll in specialization courses and CME, respectively, and 1,680,000 students in other health courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical education in Brazil benefits from a combination
of demographic and social factors, such as the expected increase in the number of people over 65 due to the increase in average life expectancy,
as well as the shortage of medical professionals in Brazil, which has resulted in an imbalance between supply and demand. It also benefits
from macroeconomic and financial factors, such as the increase in average household income, which has resulted in an increase in demand
for medical services and an increase in private and public healthcare spending. Accordingly, we expect the medical education market in
Brazil to continue to grow.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Additionally, given our end-to-end and physician-centric
ecosystem, our strong business model, and our reputation for quality, we believe that we are well positioned to take advantage of the
favorable growth dynamics of the medical education market in Brazil. According to a third-party consulting firm, the total addressable
market for medical education is expected to grow at a CAGR of 10.4% from 2020 to 2025, reaching R$23.0 billion in 2025. Including other
healthcare education services, the addressable market is expected to grow at a CAGR of 9.6% in the same period, reaching R$105.3 billion
by 2025.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 44%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: left">Information</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Medical<br />
    School</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Preparatory<br />
    Courses for<br />
    Residency</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Specialization<br />
    Courses</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Continuing<br />
    Medical<br />
    Education</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Other Health
    Courses</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Medical
    Digital Services</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.75pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Total</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Total market (2020)(1) R$ billion&#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">14.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">1.5</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">4.8</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">1.8</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">23.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">21.4</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">66.5</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Total market (2025)(1) R$ billion&#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">23.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">3.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">9.1</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">3.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">35.0</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">32.2</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">105.3</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">CAGR (5 years)&#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">10.4%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">14.9%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">13.6%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">10.8%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">8.8%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">8.5%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">9.6%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">AVG Ticket (2020)(1) R$&#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">103,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">16,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">53,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">3,900</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">14,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Total number of students (2020)(1) &#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">136,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">91,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">90,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">500,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">1,680,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Total number of students (2025)(1) &#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">171,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">143,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">142,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">600,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">2,110,000</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Afya&#8217;s market share (2020)(2)&#9;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">6.7%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">12.6%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">5.0%</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#8212;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#8212;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">&#160;</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 9pt Times New Roman,serif; margin: 0 0 4.5pt 18pt; text-indent: -18pt"><i>Source: Third-party consulting firm as of March
31, 2020.</i></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Estimated by the third-party consulting firm.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Afya&#8217;s total students 2020 / total number of students 2020, by segment.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Underlying Trends of Medical Education in Brazil</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition to a large and underpenetrated total addressable
market, we have identified other trends that contribute to the strength of the markets we serve:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Increased life expectancy and demand for medical services: </b>The Brazilian population is aging at the fastest rate in its recent
history. Average life expectancy is currently 76.2 years, and the number of people</td></tr></table>


<!-- Field: Page; Sequence: 85 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 36pt">over 65 should double from 7% of the total population in 2012 to 14%
of the total population in 2033. This has led to, and is expected to continue to drive, increased demand for healthcare professionals.
In addition, private healthcare spending and public healthcare spending in Brazil grew at a CAGR of 14.0% and 11.8%, respectively, from
2010 to 2015, primarily due to an increase in demand for medical services as a result of an aging population and an increase in average
household income. These trends have continued since 2015 to date.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Shortage of medical professionals in Brazil: </b>There is a shortage of medical professionals in Brazil, primarily due to the uneven
socio-economic environment. On average, Brazilian cities with less than 50,000 inhabitants, which corresponds to approximately 90% of
all cities in Brazil, have less than one physician per 1,000 residents. Brazil is expected to have an average of 3.07 physicians per 1,000
inhabitants by 2028, below the average of 3.4 for 2018 Organization for Economic Cooperation and Development, or OECD, countries.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Attractive financial incentives: </b>The medical profession is lucrative. Medical professionals are highly employable, with salaries
that are on average more than three times higher than the average salary for other professions such as engineering, nursing and law, and
1.9 to 3.8 times higher than the net present value of engineering, nursing or law programs in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Supply and demand imbalance for medical education: </b>The number of available medical course seats in Brazil is controlled by
MEC, which has limited medical school intakes to current levels until 2023, resulting in a significant imbalance between supply and demand.
In the last three years, medical schools have on average received five applications per available medical course seat, and four applications
per available residency program vacancy, and the number of applications are expected to increase. We believe that graduate courses will
gradually become a more popular, high-demand destination for physicians that are not admitted into residency programs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>CME Expansion: </b>The growing number of physicians in Brazil and the demand for ongoing education on new medical procedures, drugs,
technologies and developments will continue to drive demand for CME.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Technological innovation is driving medical education: </b>The current generation of medical students and professionals requires
instantly accessible digital content. Over 600,000 biomedical articles have been published globally every year since 2005, and it is critical
for lifelong learners to be able to access information and learning methodologies regardless of location and physical availability.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Limited scope of existing product offerings: </b>By generally limiting their focus on individual aspects of a student&#8217;s education
cycle, traditional education providers have struggled to build comprehensive student track records and profile databases. Consequently,
there is a general lack of integrated platforms that apply accumulated student information to efficiently tailor experiences to, or produce
bespoke materials for, the particular needs of each student.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe we are well-positioned to take advantage of
this market and its trends, bringing a more effective, personal and diversified service to our students, which will enable us to continue
to grow our market share.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Competition</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe we are the only company in Brazil with a focus
on the entire learning career of a physician. However, several companies provide solutions that compete in some of the markets in which
we operate.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We compete directly or indirectly with other post-secondary
institutions that offer medical courses or any of the other higher education courses in our portfolio. This market is very fragmented
and currently, there are more than 300 other institutions that offer medical courses in Brazil. The following table sets forth our main
competitors and the number of approved medical seats they had as of December 31, 2021:</p>



<!-- Field: Page; Sequence: 86 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td colspan="2" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">Number of Approved Medical Seats</td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 81%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Company</p></td>
    <td style="padding-right: 5pt; width: 19%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of<br />
    April 1, 2022</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Afya Brazil&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">2,731</td></tr>

<tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; width: 81%; font-family: Times New Roman,serif; padding-left: 3pt">Player 1</td>
    <td style="padding-right: 5pt; width: 19%; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">1,742</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Player 2</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">1,533</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Player 3</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">636</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Player 4</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">473</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The market for graduate medical courses is relatively
new and a few small players operate in this segment.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Products and Services</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We offer the following educational products and services
to lifelong medical learners enrolled across our evolving distribution network, as well as to third-party medical schools.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical Schools</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>A fully integrated core curriculum is offered to our medical school students across all our campuses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>All our medical students have access to our supplemental instructional platforms as part of the internship module of their medical
course, which we implemented for all incoming medical students of the fifth and sixth academic year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2021, this product had 16,017 enrolled students, and had total historical combined tuition fees of R$1,511.4 million
for the year ended December 31, 2021, which represented 26.2% and 75.9% of our total number of our undergraduate enrolled students and
our historical undergraduate programs combined tuition fees, respectively. As of December 31, 2020, this product had 11,030 enrolled students,
and had total historical combined tuition fees of R$911.0 million for the year ended December 31, 2020, which represented 30.5% and 73.7%
of our total number of our undergraduate enrolled students and our historical undergraduate programs combined tuition fees, respectively.
As of December 31, 2019, this product had 6,597 enrolled students, and had total historical combined tuition fees of R$550.2 million for
the year ended December 31, 2019, which represented 17.2% and 69.3% of our total number of our undergraduate enrolled students and our
historical undergraduate programs combined tuition fees, respectively.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical Residency Preparatory Courses</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Instructional content in digital format is offered to medical students and newly graduated physicians to prepare them for medical
residency exams.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Supplementary instructional content in digital format is offered to third-party medical schools that adopt our services.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2021, we had 21,631 enrolled students in our medical residency preparatory courses. As of December 31, 2020, we
had 13,039 enrolled students in our medical residency preparatory courses.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Graduate Courses</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Graduate medical courses are offered to our medical school students across all our campuses. These students also have access to some
of our supplemental instructional platforms.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Supplemental instructional content for different medical specializations is offered to individual lifelong medical learners in our
graduate courses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2021, we had 3,189 enrolled students in our graduate courses. As of December 31, 2020, we had 4,181 enrolled students
in our graduate courses.</td></tr></table>


<!-- Field: Page; Sequence: 87 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Other Programs</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Other national core curriculum is offered to all students across all of our undergraduate campuses: healthcare degrees and a subset
of non-healthcare degrees, including business and engineering degrees offered by the companies we invested in or acquired.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2021, these programs had 45,101 enrolled students, and had total combined tuition fees of R$478.7 million for the
year ended December 31, 2021, which represented 73.8% and 24.1% of our total number of enrolled students and our historical undergraduate
programs combined tuition fees, respectively. As of December 31, 2020, these programs had 25,176 enrolled students, and had total combined
tuition fees of R$325.5 million for the year ended December 31, 2020, which represented 41.0% and 14.0% of our total number of enrolled
students and our historical undergraduate programs combined tuition fees, respectively. As of December 31, 2019, these programs had 17,372
enrolled students, and had total historical combined tuition fees of R$248.1 million for the year ended December 31, 2019, which represented
72.5% and 31.1% of our total number of enrolled students and total historical combined tuition fees from all courses offered, respectively.</td></tr></table>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Digital health services</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Subscription-based mobile app and website portal focused on assisting health professionals and students with clinical decision-making
for 30 medical specializations through tools such as medical calculators, charts and updated content, including prescriptions, clinical
scores, medical procedures and laboratory exams, among others.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Free instructional content we offer to physicians, healthcare professionals and students.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>As of December 31, 2021, we had approximately 248,000 monthly active subscribers, consisting of approximately: 16,200 in Content and
Technology for Medical Education, 194,300 in Clinical Decision Software and 37,000 in Clinical Management Tools.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Our acquisition of PEBMED marked our entry in the digital health services sector, which we believe adds value to our platform. In
particular, our acquisition of PEBMED included the Whitebook product, which added approximately 125,300 active users to our platform and
increase our penetration in the segments in which we already operate through digital health services.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt; text-indent: 0cm">The following chart sets forth our market share by
career aging cohort as of December 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt; text-align: center; text-indent: 0cm"><img src="afyaform20f_020.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 88 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Lifelong Medical Learner Clients</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had a total of 85,938 students
across all our segments, including 16,017 enrolled in our undergraduate medical programs. As of December 31, 2021, we had 21,631 enrolled
students in our medical residency preparatory courses and 3,189 enrolled students in our medical specialization programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition to health sciences courses, which comprise
medicine, dentistry, nursing, radiology, psychology, pharmacy, physical education, physiotherapy, nutrition and biomedicine, we also offer
degree programs and courses in other non-health sciences subjects and disciplines across several of our campuses, including undergraduate
and post graduate courses in business administration, accounting, law, civil engineering, industrial engineering and pedagogy. These non-health
sciences courses are not part of our core business&#8212;the number we offer has increased as a consequence of our strategic acquisitions
in 2018, 2019, 2020 and 2021 of multi-disciplinary schools with strong health sciences programs, which are our principal focus. Although
non-health courses are not part of our growth strategy, we expect to continue to offer them to the extent they generate local demand.
These non-health sciences programs represented 12.0%, 14.0% and 18.3% of total historical undergraduate programs combined tuition fees
for all courses offered in 2021, 2020 and 2019.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The attractive dynamics for medical education in Brazil,
including high demand for medical services and low medical density, combined with the exceptional rewards a physician receives (e.g.,
high wages, fast payback), create the perfect environment for us, with high demand for health sciences programs throughout the entire
medical career. This scenario enables us to target a unique student profile during our selection process, capturing the most capable individuals
in Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to Educainsights, medical students are, at
the outset of their medical journey, different from students that pursue other career paths. For example, while 27% of students from non-medical
undergraduate courses have a private high school background, that number increases to 82% for medical students. In addition, 64% and 65%
of medical students have a father and mother with at least a higher education diploma, respectively, while for non-medical courses, these
figures are 16% and 22%, respectively. As a result, we are able to create a distinguished network of Afya students, which we believe is
essential to the success of our long-term brand building initiatives.</p>


<!-- Field: Page; Sequence: 89 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">The following chart sets forth certain differences between medical and non-medical
students in Brazil:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_021.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, as of December 31, 2021, we had 43 contracts
with other partner companies, which represents our B2B segment. These partnerships allow us to increase our distribution outreach to other
institutions around the country and help us achieve our mission.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Student Financing and Incentive Programs</p>

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Student financing program&#8212;Fundo de Financiamento Estudantil
(<span style="font-style: normal">&#8220;</span>FIES<span style="font-style: normal">&#8221;</span>)</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">FIES is a MEC program created by Law No. 10,260/2001
to provide financing to undergraduate students who are unable to finance their own education.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">After going through several reforms from 2015 onwards,
the government launched the &#8220;New FIES&#8221; in early 2018, to be provided in the following categories:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Public FIES&#8212;Per capita income of up to three minimum wages, with zero interest rate. The financing is provided by federal government
funds and contributions from Higher Education Institutions, or HEIs, through the fund FG-FIES. Therefore, the credit risk is divided between
the government and the private HEIs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Private FIES (&#8220;P-FIES&#8221;)&#8212;Per capital income of up to five minimum wages, with low interest rates. Regional funds
and private financial institutions, provide the financing.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, our exposure to FIES was 7.0%
of our total student base, which represented 8.0% of our total gross revenue for that period. See &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Changes to the rules or delays or suspension of tuition payments
made through FIES may adversely affect our cash flows and our business.&#8221; for further information.</p>


<!-- Field: Page; Sequence: 90 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic 10pt Times New Roman,serif; margin: 0 0 10pt 18pt">Incentive program&#8212;Programa Universidade Para Todos</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Programa Universidade Para Todos,</i> or PROUNI, was
established in 2005 through Law No. 10,096/2005, which offers full and partial scholarships (50%), in private HEIs for undergraduate and
subsequent courses of specific training, to Brazilian students without a higher education diploma. Additionally, the Government offers
federal tax exemptions to the higher education institutions adhering to PROUNI.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Private higher education institutions, whether for profit
or not, may join PROUNI by signing a term of adhesion (valid for 10 years), and at least (i)&#160;offer a full scholarship for every 10.7
students who pay a regular monthly fee and are regularly enrolled at the end of the previous school year; or (ii)&#160;an integral scholarship
for every 22 students who pay the regular monthly tuition fees in specific undergraduate and subsequent courses, provided they also offer
scholarships of 50% or 25%, in amounts necessary so that the sum of the benefits granted is equivalent to 8.5% of its annual revenue.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The tax exemptions (in whole or in part) for HEIs that
participate in this program are the following:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>IRPJ (income tax) and CSLL (social contribution), with respect to the portion of net income in proportion to revenues from traditional
and technology undergraduate programs; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>COFINS (Contribution for the Financing of Social Security) and PIS (Program of Social Integration), concerning revenues from traditional
and technology undergraduate programs.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, our exposure to PROUNI was 6.1%
of our student base. Although we fulfilled all required scholarships to receive 100% of tax exemption, PROUNI does not cover our operation
outside of our undergraduate programs.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Other private financing program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya offers private financing program through external
partners (Banco Santander and Raydan) for undergraduate students. The credit risk is taken 100% by the partner.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Key Benefits for our Lifelong Medical Learners</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe the end-to-end physician-centric ecosystem
we have been developing for our students sets us apart from our peers, as we deliver content and learning activities that are tailored
to each student&#8217;s needs. This contributes to a more interactive and enjoyable learning process for our students, breaking away from
a teaching system that we perceive as presenting students with an overwhelming amount of content, unengaging classes and scattered information.
We achieve this based on three main pillars: innovative data-oriented methodology, a cutting-edge platform and state-of-the-art operating
environment.</p>


<!-- Field: Page; Sequence: 91 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_022.jpg" alt="" /></p>

<p style="font: 10pt/0.05pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Innovative, Data-oriented Methodology</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our proprietary methodology to support our students&#8217;
lifelong medical education is based on the following concepts:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Standardized medical curricula:</i> The organization
of our medical curricula around interdisciplinary macro-medical topics to guide the development of in-person teaching plans and online
learning tools, offering a scalable solution for schools through weekly synchronized content;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Active learning:</i> Educational strategy to foster
independent, critical and creative student thinking, as well as encourage effective teamwork through case-based problem-solving exercises,
debates and small-group discussions;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Blended learning:</i> Balanced in-person teaching
with technology-assisted activities to improve student and teacher efficiency and results; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Adaptive learning:</i> A personalized instruction
and assessment tool that provides training and content tailor-made to each student&#8217;s individual profile. Students can access real-time
feedback on areas in which they can improve, effective learning methods and teaching/study plans that are most suitable for them.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cutting-Edge Digital Platform</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We deliver modern, bespoke verbal and practical teaching.
We continuously invest in creating innovative, technology-enabled activities and features to enhance our platform. We offer our medical
school students doing internships or studying for residency exams the following features through our digital platform:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Web portal and in-app communication:</i> Online platform
combining supplementary instructional content and a personalized communication tool for students, through which they can also access our
content offline;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Learning tools</i>: We have over 36,000 digitally
managed and delivered instructional tools designed by teachers to address complex learning objectives. Content is organized and tagged
by theme and delivered in various formats,</p>


<!-- Field: Page; Sequence: 92 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">including, among others, online classes, podcasts, quizzes and books, to
cater to different learning methods and the preferences of each student. As of December 31, 2021, our learning tools consisted of more
than 17,079 video classes, 5,033 book chapters, 3,888 podcasts and an exam bank of approximately 120,000 questions;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Assessment tool</i>: Broad database suite composed
of quizzes and problem-solving activities, through which students can choose the subjects they would like to focus on, with additional
teacher-led instructional content;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Tutoring/mentoring platform</i>: An online monitoring
and support platform for both undergraduate and graduate medical students, which we launched in October 2019. The platform allows tutors
to interact with students through emails, video calls, voice calls and push notifications, and keeps records of such interactions. It
also allows students to ask the tutors questions and schedule appointments. The platform also tracks individual student performance and
progress; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Digital health services platform</i>: A combination
of mobile and web applications focused on helping physicians, nurses, healthcare professionals and medical students in their clinical
decision-making and providing medical references and updates for the medical community.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">State-of-the-Art Operating Environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For us, individualized learning should be used not just
when offering content or technology-supported activities, but also during in-person encounters. Our professors can use our resources to
approach lessons more objectively, focusing on each student&#8217;s needs:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Modern teaching facilities:</i> We have designed our
classrooms to engage students in active learning. We rely on cutting-edge didactical equipment and simulation labs and state-of-the-art
realistic simulation technologies;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Medical specializations centers:</i> Our campuses
offer simulation centers and clinics where students can practice primary and secondary care, leveraging the learning process and providing
medical assistance to the local population; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Practical learning network:</i> Throughout the internship
cycle, our students can access over 60 partner teaching hospitals and clinics, the largest network of any education group in Brazil.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Evolving Distribution Network</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe that an effective end-to-end physician-centric
ecosystem goes beyond offering the largest and most complete operating infrastructure to the students enrolled at our campuses and with
access to our digital platforms. Through our evolving distribution model, we also expect to empower lifelong medical learners across our
growing network of diversified partner teaching hospitals, clinics and third-party medical schools by increasing our products and services
offerings as we continue to expand our business-to-business, or B2B capabilities. Our partnerships include renowned institutions such
as the Brazilian Cancer Foundation, which joined our network in January 2020.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Seasonality of Operations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya has now three reporting segments: (1) Undergrad,
which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate programs;
(2) Continuing Education, which provides specialization programs and graduate courses; and (3) Digital Services, which provides content
and technology for medical education, clinical decisions software, practice management tools and electronic medical records, doctor-patient
relationship, telemedicine and digital prescription.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Digital Services are comprised mostly by Medcel, Pebmed
and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality, Medcel revenues are concentrated
in the first and last quarter of the year, as a result of enrollments of Medcel&#8217;s clients period. The majority of Medcel&#8217;s
revenues is derived from printed books and e-books, which are recognized at the point in time when control is transferred to the customer.
Consequently, Digital Services segment generally has higher revenues and results of operations in the first and last quarter of the year
compared to the second and third quarters of the fiscal year.</p>


<!-- Field: Page; Sequence: 93 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Marketing and Sales</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our marketing strategy is focused on identifying, qualifying
and converting potential students into enrollments.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We execute our marketing strategy as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Identification: </b>We use online and offline media channels to distribute relevant content for all decision-making phases of current
and future physicians, so that they interact with our solutions throughout their learning careers.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Qualification: </b>After we obtain data on a potential student, we identify his/her needs by offering content that matches his/her
academic phase. In addition, through our score models, we can identify potential students that are more likely to enroll with us.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Conversion: </b>From that point on, we contact our sales department (online and inside sales) to convert potential students into
enrolled students through structured sales campaigns and continuous monitoring of conversion indices.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As our business model is end-to-end and physician-centric,
we aim to accompany our lifelong learners at each stage of their careers. Therefore our sales funnels are calibrated according to the
segment&#8217;s supply-demand curve (graduation, preparatory, etc.), level of competition and other strategic variables.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For example, in medical schools, the most challenging
task is to identify potential students interested in attending medical school in a given cycle, since conversion typically occurs organically
due to the high demand for these courses. Our challenge is to attract and enroll the best ENEM students in our medical schools. With respect
to the medical residency preparatory phase and graduate programs, our main focus is to show potential students the benefits of our methodology
in terms of results and cost-benefit in order to guide them towards adopting our solutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our marketing and sales efforts are supported by Salesforce
products (Sales Cloud, Marketing Cloud and Einstein), as well as other online analytical tools such as Google Analytics.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our business model, combined with the use of CRM tools
gives us a unique competitive advantage: The ability to identify, market and offer products to virtually all medical students and physicians
in Brazil.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Technology and Intellectual Property</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Technology</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In recent years, we have implemented several initiatives
to improve operational efficiency and to integrate processes across several campuses and operations. We plan to continue this process
in the future to fully consolidate Afya Brazil&#8217;s integrated systems with those of our recent acquisitions.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shared Services Center</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have invested in a modern Shared Services Center,
or SSC, to process back-office and non-student facing transactions that has idle capacity and is expected to enable student base growth
with low marginal costs.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Integrated Systems</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have adopted third-party systems to handle our internal
systems in a fully integrated manner:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Enterprise Resource Planning, or ERP: </b>TOTVS ERP RM is the leading solution in the Education Industry in Brazil and delivers
a flexible systemic solution that fits our companies&#8217; processes to improve management and organization. At the same time, it allows
high governance of the processes, with complete control of all back-office activities, preventing operational errors and allowing efficient
tax-related calculations and control of government obligations.</td></tr></table>


<!-- Field: Page; Sequence: 94 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Academic System: </b>TOTVS RM Educacional is a mature platform that allows the configuration of the student payment plan attached
to the disciplines enrolled and processes preventing manual financial transactions and making the process more flexible and efficient.
This system includes both Student and Faculty Portals, with features that allow mobile frequency monitoring and provide payment solutions
to students and also manages the faculties&#8217; timesheet and payroll.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Learning Management System, or LMS: </b>Canvas LMS is a cloud-native, highly scalable system that connects all digital learning
tools and evaluation resources accessed nationally by our faculties and students.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of the date of this annual report, ESMC, iClinic,
Medicinae, Medical Harbour, Cliquefarma, Shosp, UnifipMoc, UningranRio, RX Pro, Al&#233;m da Medicina and Cardiopapers independently
operate their own ERP systems. We are working to migrate the systems from the companies described above in order to fully incorporate
them into our integrated systems.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Intellectual Property</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We rely on a combination of copyright, trademark and
trade secret laws, as well as employee and third-party non-disclosure, confidentiality and other types of contractual arrangements to
establish, maintain and enforce our intellectual property rights, including with respect to our proprietary rights related to our products
and services. In addition, we license technology from third parties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we owned more than 30,000 learning
materials (e.g., classes, materials and videos) that comply with the national curriculum and that are developed by our teachers.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Insurance</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have insurance policies with reputable insurers in
amounts considered sufficient by our management to cover potential losses arising from indemnities that we may have to pay to third parties
as a result of our operations. The policies for our operating units have an aggregate coverage limit of up to approximately R$390.9 million.
The Company and its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking in the market coverage
compatible with its size and operations. We seek coverage against risks that are compatible with our scale and type of operations, considering
the nature of our activities, the risks we are exposed to, market practices in our industry, and the advice of our insurance consultants.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">While we believe our insurance contracts reflect standard
market practices, there are certain types of risks that may not be covered by the policies (such as war, terrorism, acts of God and force
majeure, liability for certain harm or interruption of certain activities). Therefore, if any of these uncovered events occur, we may
be obliged to incur additional costs to remedy the situation, reconstitute our assets and/or indemnify our customers, which may adversely
affect us. Furthermore, even in the event that we incur a loss that is covered by our policies, we cannot assure that damages awarded
by our insurers will be sufficient to cover the losses arising from the insured event. See &#8220;Item 3. Key Information&#8212;D. Risk
Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We may be held liable for extraordinary events that may occur
at our campuses, which may have an adverse effect on our image and, consequently, our results of operations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Regulatory Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian Constitution establishes education as a
right for all citizens and a duty of the State and the family. Accordingly, the government is required to provide all Brazilian citizens
with access to free primary education with compulsory attendance. Private investment in education is permitted as long as entities providing
education services comply with the applicable rules and regulations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Brazilian education system is organized under a cooperative
management among federal, state and municipal governments. The federal branch is required to organize and coordinate the federal educational
system in order to guarantee equal opportunity and quality of education throughout Brazil. The states and the Federal District are required
to focus on secondary education, while municipalities are responsible for providing pre-primary school and primary education.</p>


<!-- Field: Page; Sequence: 95 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Private Higher Education Institutions are part of the
federal educational system and their activities are regulated by the federal government, and universities have didactic, scientific and
administrative autonomy as provided by the Brazilian Constitution.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Additionally, Law No. 9,394 of December 20, 1996, named
by National Education Guidelines Law <i>(Lei de Diretrizes e Bases da Educa&#231;&#227;o,</i> or LDB) provides the guidelines for
the provision of educational services in Brazil and sets forth the federal government&#8217;s duty to, among others: (i)&#160;coordinate
the national education system; (ii)&#160;prepare the National Education Plan; (iii)&#160;provide technical and financial assistance to
the states, the Federal District and municipalities; and (iv)&#160;define, in cooperation with other federal entities, the responsibilities
and guidelines for primary and secondary education, with the federal government&#8217;s priority in post-secondary education, issuing
rules and regulations regarding undergraduate and graduate programs, and carrying out the activities relating to the accreditation of
institutions, authorization and recognition of courses and monitoring and evaluation of the educational system as a whole.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the federal government, through Law No.
10,172 of January 9, 2001, implemented the first National Education Plan <i>(Plano Nacional de Educa&#231;&#227;o,</i> or PNE), with
a duration of 10 years from the date of its publication. The PNE established objectives for post-secondary education to be met by all
branches of government. The primary goal was to offer post-secondary education to at least 30% of the population aged 18 to 24 by 2010.
After the expiration of the first PNE, a new plan was enacted and the objectives were revised for the period of 2014 to 2024, consolidated
by Law No. 13,005 of June 25, 2014.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The new goals consist of: (1)&#160;increasing post-secondary
education enrollment rates to 50% of the population aged 18 to 24; (2)&#160;increasing the quality of post-secondary education by raising
the proportion of academic staff with master&#8217;s degrees and doctorate degrees to 75%, of which at least 35% shall be doctorates;
and (3)&#160;increasing progressively <i>stricto sensu</i> postgraduate programs. Such goals apply to each federation territory, and provide
orientation for the private education sector.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Finally, each of the federal, state and municipal governments
are required to prepare a 10-year education plan and to establish policies, guidelines and objectives applicable to the segment of the
Brazilian education system over which it has responsibility.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Post-secondary Education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The post-secondary education sector is subject to comprehensive
government regulation. Its purpose is to ensure the quality of educational services, through evaluations of the ability of educational
institutions to meet minimum standards established by CNE and approved by MEC. This evaluation includes the analysis of pedagogical projects,
the infrastructure of Higher Educational Institutions, or HEIs, and their academic staff, and the results of such evaluations are considered
in the proceedings for opening new units and new courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Therefore, activities and courses offered by HEIs in
Brazil depend on authorizations and are subject to ongoing regulation, guided by the results of quality assessments. The federal responsibility
to regulate, monitor and evaluate post-secondary education institutions and programs is exercised by the MEC, the CNE, the INEP and the
CONAES.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Ministry of Education</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Ministry of Education, or MEC, is the highest authority
for post-secondary education within the Brazilian national education system, whose competence consists, among other prerogatives, of the
following: (1)&#160;confirming CNE&#8217;s accreditation decisions for post-secondary education institutions; (2)&#160;confirming evaluation
systems and criteria adopted by the INEP; (3)&#160;confirming opinions and regulation proposals from the CNE; (4)&#160;issuing rules and
instructions for compliance with laws, decrees and regulations pertaining to education issues; and (5)&#160;regulating and monitoring
the post-secondary education system through its secretariats.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">National Education Council</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The National Education Council, or CNE, is a consulting
and decision-making body monitored by the MEC, collectively comprised of the Chamber of Primary and Secondary Education, or CEB, and the
Chamber of Post-secondary Education, or CES, each composed of 12 members appointed by the President of Brazil.</p>


<!-- Field: Page; Sequence: 96 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">CNE is required, among other responsibilities, to: (i)&#160;issue
regulations to implement MEC&#8217;s guidelines, as well as advise and support MEC in its activities and decisions; (ii)&#160;decide on
accreditation applications and renewals from post-secondary education institutions engaged in distance learning, based on the opinion
of the relevant secretariats; (iii)&#160;propose guidelines and deliberate on the preparation of the evaluation instruments for accreditation
and re-accreditation of institutions to be elaborated by INEP; (iv)&#160;issue guidelines to be observed by SERES for accreditation and
re-accreditation of universities, university centers and colleges; (v)&#160;determine, through the CES, the inclusion and exclusion of
course designation from the catalog of advanced technology courses; (vi)&#160;rule on appeals of decisions issued by SERES, CEB or CES;
and (vii)&#160;analyze and propose questions regarding the application of post-secondary education legislation to the MEC.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">An&#237;sio Teixeira National Institute for Educational
Research</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The An&#237;sio Teixeira National Institute for Educational
Research, or INEP, is a federal body linked to the MEC whose main responsibilities are, among others, to: (i)&#160;design, plan, coordinate
and operationalize actions for the evaluation of HEIs, undergraduate courses and government schools, as well as the National Student Performance
Examination, or ENADE, the examinations and assessments of undergraduate students; (ii)&#160;design, plan, coordinate, operationalize
and evaluate indicators related to post-secondary education resulting from examinations and inputs from official databases, the establishment
and maintenance of databases of specialized evaluators and collaborators, including the appointment of evaluation committees; (iii)&#160;prepare
and submit to MEC the instruments for external evaluation <i>(in loco),</i> in accordance with the guidelines proposed by the SERES and
by other competent bodies; (iv)&#160;design, plan, evaluate and update the indicators for the external evaluation instruments in place,
in accordance with the guidelines proposed by CONAES; (v)&#160;chair the Technical Committee for Evaluation Monitoring; and (vi)&#160;plan,
coordinate, operationalize and evaluate the actions necessary to achieve its objectives.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">National Higher Education Evaluation Commission</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The National Higher Education Evaluation Commission,
or CONAES, is a coordination and monitoring body of the National Higher Education Evaluation System, or SINAES, monitored by MEC, composed
of a President and 13 members, including one representative of the INEP, one representative of the <i>Funda&#231;&#227;o de Coordena&#231;&#227;o
de Aperfei&#231;oamento de Pessoal de N&#237;vel Superior</i> (Foundation for the Coordination of Improvement of Post-secondary Education
Personnel, or CAPES), three representatives of the MEC (one of which must come from the body responsible for the regulation and monitoring
of post-secondary education), one representative of the student body of post-secondary education institutions, one representative of the
academic staff of post-secondary education institutions, one representative of the administrative body of post-secondary education institutions,
and five members appointed by the Minister of Education, with distinguished scientific, philosophic and artistic knowledge and proven
expertise in post-secondary evaluation or management.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Among other activities CONAES is required to: (i)&#160;propose
and evaluate the dynamics, procedures and mechanisms for institutional evaluation, courses and student performance; (ii)&#160;establish
guidelines for the organization of evaluation committees, analyze reports, prepare opinions and submit recommendations to the competent
bodies; (iii)&#160;formulate proposals for the development of HEIs, based on the analysis and recommendations produced in the evaluation
processes; (iv)&#160;communicate with the state educational systems, with the aim to establish common actions and criteria for the evaluation
and supervision of post-secondary education; and (v)&#160;annually submit for approval by the Minister of Education the list of courses
for which students will apply for the ENADE.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Organization of Post-secondary Education Institutions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In order to allow post-secondary education institutions
to fulfill their objectives, the LDB also provides that post-secondary education includes the following programs:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Undergraduate courses,</i> including traditional and technological undergraduate courses, offering specific training and diplomas
to students, open to candidates who have completed high school or equivalent and who have been approved in the respective selection or
entrance examinations;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Post-graduate courses,</i> including master's and doctoral degrees, specialization courses, further training courses and others,
open to candidates who hold a diploma in an undergraduate course and who meet the requirements laid down by educational institutions;
and</td></tr></table>


<!-- Field: Page; Sequence: 97 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Extension courses,</i> understood as any academic, technical or cultural activity that is not included as an integral and compulsory
part of the undergraduate and postgraduate curriculum, in which the students receive certificates. Such courses are open to candidates
who meet the requirements established in each case by educational institutions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to the LDB, post-secondary education can be
provided by public or private institutions. A private post-secondary education institution must be controlled, managed and supported by
an individual or a legal entity with responsibility for financing its supported entities. Post-secondary education institutions may be
supported by for-profit or not-for-profit private institutions, or supporting entities, as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Private in the strict sense:</i> private for-profit institutions created and maintained by one or more private individuals or legal
entities;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Community:</i> incorporated by groups of individuals or by one or more legal entities and that include representatives of the community
in their organizational structure;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Confessional:</i> incorporated by groups of individuals or by one or more legal entities that meet the specific confessional and
ideological orientation and that include representatives of the community in their organizational structure; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Philanthropic,</i> in the form of the applicable regulations.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to their organization and academic prerogatives,
post-secondary education institutions can be:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Colleges:</i> colleges are public or private HEIs offering post-secondary programs in one or more areas, maintained by a single
supporting entity and with isolated management and direction. Colleges are allowed to offer programs along several levels, namely bachelor&#8217;s,
associate&#8217;s, specialization and graduate programs (master&#8217;s and doctorate degrees). Colleges have minimum requirements with
regard to the qualification of faculty members and their labor practices, and cannot establish new campuses, courses, or spots without
prior authorization from MEC;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>University Centers:</i> university centers are public or private education institutions offering several bachelor&#8217;s, associate&#8217;s
and graduate programs, and are expected to provide appropriate work conditions, education and qualification opportunities for their professors.
To be considered a university center, the institution shall comply with such requirements: (i)&#160;at least one-fifth of the faculty
members of a university center must hold a master&#8217;s or doctorate degree; (ii)&#160;at least 20% of the faculty members must work
on a full-time basis; (iii)&#160;at least eight undergraduate courses shall be recognized and have obtained a satisfactory concept in
the on-site external evaluation carried out by INEP; (iv)&#160;have an institutionalized extension program in the areas of knowledge covered
by their undergraduate courses; (v)&#160;have a scientific initiation program with a project supervised by doctoral or masters professors,
which may include programs of professional or technological initiation and initiation to teaching; (vi)&#160;have obtained an Institutional
Concept, or CI, greater than or equal to four in the on-site external evaluation performed by INEP; and (vii)&#160;have not been penalized
as a result of an administrative supervision process in the last two years; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Universities:</i> universities are public or private education institutions offering several post-secondary programs, continuing
education and research development. Like University Centers, certain requirements for university re-accreditation must be observed, namely:
(i)&#160;one-third of the academic staff is hired on a full-time basis; (ii)&#160;one-third of the faculty members must have a master&#8217;s
or doctoral degree; (iii)&#160;at least 60.0% of the undergraduate courses shall be recognized and have a satisfactory concept obtained
in the evaluation proceedings carried out by INEP; (iv)&#160;have an institutionalized extension program in the areas of knowledge covered
by their undergraduate courses; (v)&#160;have a scientific initiation program with a project supervised by master&#8217;s or doctoral
professors, which may include programs of professional or technological initiation and initiation to teaching; (vi)&#160;have obtained
CI greater than or equal to four in the external evaluation carried out by INEP; (vii)&#160;regularly offer four master&#8217;s degree
courses and two PhD courses recognized by MEC; and (viii)&#160;have not been penalized as a result of an administrative supervision process
in the last two years.</td></tr></table>


<!-- Field: Page; Sequence: 98 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The LDB provides that the following powers are granted
to universities and university centers in the exercise of their autonomy, amongst others: (i)&#160;to create, organize and discontinue
post-secondary education programs on their premises, subject to the applicable regulation; (ii)&#160;to establish the curricula for programs,
subject to the applicable general guidelines; (iii)&#160;to establish plans, programs and projects in connection with scientific research,
artistic production and extra-curricular activities; (iv)&#160;to establish the number of student offerings available; and (v)&#160;to
create and change their bylaws in accordance with the applicable general rules, as well as to award degrees, diplomas and other certificates.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Distance Learning</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance learning in Brazil is regulated by article 80
of the LDB, by Decrees 9,057 and 9,235, both of 2017, by Ordinances No. 11 and 23, both of 2017, and CNE&#8217;s Resolution No. 1, of
2016.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance learning is defined as the educational method
in which didactic and pedagogic processes are conducted through information and communication media and technologies, with students and
teachers interacting in educational activities while located in different locations or at different times.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to the applicable regulations, distance learning
is subject to different factors compared to traditional methods, including: (i)&#160;reduced transmission costs in commercial channels
of sound and audiovisual broadcasting; (ii)&#160;concession of channels with exclusive educational purposes; and (iii)&#160;minimal time
reservation, with no onus on the public authorities, by the concessionaries of commercial channels.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance learning can be offered at the following levels
and as part of the following educational methods: (i)&#160;primary and secondary education, as long as it is used only to supplement learning
processes or in emergency situations; (ii)&#160;education for young people and adults, according to specific legal criteria; (iii)&#160;special
education, according to specific legal criteria; (iv)&#160;professional education, covering technical programs at the secondary level
and technological programs at the post-secondary level; and (v)&#160;post-secondary education, covering graduate, master&#8217;s programs,
specializations, and doctorate studies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Graduate courses (bachelor&#8217;s, licentiate and technological)
may be offered using distance learning methods whenever a post-secondary institution is regularly accredited by the MEC for this purpose.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to Decree No. 9,057, 2017, institutional accreditation
and reaccreditation, as well as the authorization and recognition of courses and their renewal will be subject to on-site evaluation,
with the aim to verify the existence and suitability of the method, infrastructure, technology and personnel that may enable the execution
of the activities provided in the Institutional Development Plan or PDI and the Pedagogical Project of the Course, or PPC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">HEIs accredited for the offering of post-secondary education
in the distance modality that hold autonomy prerogatives (universities and university centers) do not require authorization for operation
of the post-secondary course in the distance modality, but shall inform the MEC about the offering of the course within 60 days of the
date of creation of such course, for the purposes of supervision, evaluation and recognition. Also, accredited HEIs must inform the MEC
about the creation of distance learning supporting units and the alteration of their addresses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Although distance learning is defined by the absence
of direct contact between students and teachers, there are activities that must be conducted on-site, such as tutorials, evaluations,
internships, professional practice, laboratory and dissertation defense, which are to be provided in the educational and development projects
of the institution and the course. Accordingly, the distance learning institutions must provide the necessary infrastructure for the students
to conduct those activities, using the headquarters of the education institution or smaller supporting units throughout the country. Distance
learning supporting units are no longer subject to on-site evaluation or required to obtain prior authorization of MEC in order to be
set up or operated. Pursuant to Ordinance No. 11/2017, such units can be created by a unilateral decision of the institution itself.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance courses and programs must be projected with
the same defined duration for the respective on-site courses. The evaluation of the performance of students for the purposes of promotion,
conclusion of the course and obtainment of diplomas and certificates must be conducted through the conclusion of the programmed activities
and on-site exams by the accredited HEIs, following procedures and criteria defined in respective PPC.</p>


<!-- Field: Page; Sequence: 99 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The evaluation of the distance learning courses is performed
in a very similar manner as the evaluation of on-site courses. In the event of any irregularity or non-compliance to any of the previously
established conditions set by the MEC, the competent body may initiate an administrative proceeding that may result in one or more penalties,
such as: (i)&#160;forfeiture of accreditation or reaccreditation to operate as a distance learning institution; (ii)&#160;intervention;
(iii)&#160;temporary suspension of autonomy prerogatives; (iv)&#160;initiate reaccreditation proceedings; (v)&#160;reduction of available
vacancies within courses; (vi)&#160;temporary suspension of new students admissions; and (vii)&#160;temporary suspension of courses offered.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Diplomas and certificates for distance learning courses
and programs from accredited institutions are valid throughout the national territory and institutions are not entitled to set different
criteria for diplomas issued for distance learning courses and those issued for on-site courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance learning courses may be offered only by HEIs
that hold specific accreditations for this purpose. It is MEC&#8217;s responsibility to promote the accreditation acts of post-secondary
institutions. To act outside the institution&#8217;s local geographic reach, the institution shall require an extraterritorial accreditation
to the MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Distance learning courses or programs require periodic
renewal. Also, the accredited institution must initiate the authorized coursework within 24 months from the accreditation, and if the
institution does not implement the authorized activities in such time frame, it will be subject to an administrative proceeding that may
result in the canceling of the given authorization.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to Decree No. 9,057/2017, post-secondary courses
may be offered in the distance learning modality through a partnership between an accredited distance HEI and another company. In this
case, applicable regulations establish that educational activities must be conducted in the facilities of the accredited HEI, which will
be responsible before MEC for the regularity of the teaching and learning processes. Accordingly, the HEI must inform MEC of its partnerships,
describing their purpose and most relevant aspects, in order for MEC to be able to assess eventual irregularities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In any case, distance learning courses and programs are
subject to the evaluation rules of the SINAES in the same manner that on-site courses are.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Regulatory Processes of Post-secondary Education Institutions</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Accreditation of Post-secondary Education Institutions
and Authorization and Recognition of Courses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A post-secondary education institution is initially accredited
as a college. The accreditation as a university or university center is only granted after the institution has operated as a college and
met satisfactory quality standards, including positive assessments in the SINAES. In addition, the HEI must fulfill other legal requirements
that could vary according to the respective category, such as the requirement that a certain percentage of faculty members meet minimum
graduation standards (i.e., a doctorate or master&#8217;s degree), and specific types of labor regimes.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The application for qualification of a post-secondary
education institution must be supported by various documents, including:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Supporting entity:</i> (i)&#160;incorporation documents, duly registered with the competent body, evidencing its existence and
legal capacity, in accordance with civil legislation; (ii)&#160;proof of registration in the National Taxpayer&#8217;s Registry or, CNPJ;
(iii)&#160;certificates of tax and social security compliance; (iv)&#160;proof of ownership of assets capable of supporting the education
institution; (v)&#160;financial statements; and (vi)&#160;consent form executed by the supporting entity&#8217;s legal representative,
vouching for the veracity and regularity of the provided information and the financial capability of the supporting entity; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><i>Post-secondary education institution:</i> (i)&#160;proof of payment of the on-site evaluation fee related to the external evaluation
to be performed by INEP; (ii)&#160;PDI; (iii)&#160;bylaws and internal regulations; (iv)&#160;identification and qualification of managers,
with a description of their academic and administrative experience; (v)&#160;receipt of regularity and availability of the teaching facilities;
(vi)&#160;plan of accessibility assurance, pursuant to the regulation and followed by a technical report by a competent professional or
public body; and (vii)&#160;compliance with the legal requirements related to the safety of the building, including having an escape route
in case of fire, proved by a specific report issued by the competent public body.</td></tr></table>


<!-- Field: Page; Sequence: 100 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In relation to the accreditation process of a new post-secondary
educational institution and linked course authorizations, MEC may issue a temporary accreditation act to expedite the operation, pursuant
to article 24 of Decree No. 9,235/2017, as long as the supporting entity complies with all the following requirements:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>all self-supporting post-secondary education institutions have been reaccredited in the last five years obtaining an average Institutional
Score <i>(Conceito Institucional)</i> greater or equal to &#8220;4&#8221;;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>none of its post-secondary education institutions have been subject to administrative penalties by MEC in the last two years; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the courses to be offered by the new post-secondary institution, which are limited to a maximum of five courses, must already be offered
by other institutions supported by the same supporting entity and duly recognized by MEC in the last five years with a Program Score <i>(Conceito
de Curso)</i> greater or equal to &#8220;4&#8221;.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Following the initial accreditation as a post-secondary
education institution, colleges depend on an authorization issued by the MEC to offer post-secondary education courses. Within their autonomy,
universities and university centers do not depend on authorization by the MEC to create the majority of post-secondary education courses
and campuses in the same city as its headquarters, except for medicine, dentistry, psychology, nursery and law courses, which necessarily
must be previously authorized by the MEC. In any other cases, institutions are required to inform the MEC about the programs they offer
for purposes of monitoring, evaluation and further recognition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, Ordinance No. 328/2018 enacted by MEC suspended
the opening new undergraduate courses in medicine until 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In the authorization for post-secondary on-site courses
of the federal education system the external in loco evaluation can be waived after documentary analysis if the following requirements
are met: (i)&#160;having an Institutional Score <i>(Conceito Institucional)</i> greater than or equal to &#8220;3&#8221;; (ii)&#160;absence
of a supervision process; and (iii)&#160;the institution offers other courses in the same area of knowledge which meet the minimum evaluation
standards.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Requesting authorization for a course must be supported
by the following documents, among others: (i)&#160;proof of payment of the on-site evaluation fee; (ii)&#160;the PPC, outlining the number
of students, classes, description of the program and other relevant academic elements, and describing the facilities, technology and staff
for the distance learning support units, if applicable; (iii)&#160;list of faculty members, together with the relevant agreements entered
into with the education institution, together with their respective titles, working hours and work regime; and (iv)&#160;proof of availability
of the teaching facilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Universities and university centers may also apply for
the accreditation of a campus not located in the same city as its headquarters, provided that it is located in the same state. Such campuses
and programs must integrate the same set of universities or university centers and will only enjoy autonomous prerogatives if there is
compliance with the same headquarters requirements and if a high quality degree is shown, through an average Institutional Score <i>(Conceito
Institucional)</i> greater or equal to &#8220;4&#8221;. Therefore, even in the case of universities or university centers, prior authorization
from the MEC is necessary to create any courses on campuses not located in the same city as the university&#8217;s headquarters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Once authorization for a given program has been issued,
post-secondary education institutions, including university centers and universities, must also file a request for the recognition of
the program as a condition for the national validation of the respective diploma. The requirement must be filed with MEC after the midway
point of the term established for the completion of the corresponding program and three-quarters completion of such term, and must include
the following documents, among others: (i)&#160;PPC, including the number of students, schedules and other pertinent academic information,
(ii)&#160;list of faculty members, listed in the national registry of instructors, and (iii)&#160;proof of availability of the teaching
facilities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Authorization and recognition of courses, as well as
accreditation of post-secondary education institutions must have a limited term and be renewed periodically following the regular evaluation
process, currently established according to the evaluation cycles of the SINAES.</p>


<!-- Field: Page; Sequence: 101 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our post-secondary education institutions are accredited
by the MEC and their courses are duly authorized. We also make every effort to comply with all applicable regulations to maintain our
institutions and courses compliant with MEC regulations.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Modification of Supporting Entity</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to Decree No. 9,235/2017 and Ordinance No. 23/2017,
modification of a supporting entity occurs whenever there is a change in the supporting entity or its controlling shareholder, affecting
the decision-making process. Although it no longer depends on the approval of MEC, MEC must be informed within 60 days of the consummation
of the event for the purposes of updating the registration with MEC. Such notice must be followed by all the legal documents related to
the alteration, duly registered and the term of commitment executed by the legal representatives of both the current and new supporting
entities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The new supporting entity or controlling shareholder
must meet the requirements necessary for the accreditation of a post-secondary education institution, which will be assessed by MEC in
the context of the institution&#8217;s reaccreditation proceedings. Additionally, the LDB also provides that educational institutions
must inform the MEC of any change in their bylaws, which must be registered with the competent bodies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The transfer of programs or courses between HEIs is strictly
prohibited and may subject the involved entities to penalties such as: (i)&#160;suspension of new students&#8217; admission; (ii)&#160;suspension
of the offering of undergraduate or postgraduate <i>lato sensu</i> courses; (iii)&#160;suspension of the institution&#8217;s autonomy
to, among others, create new post-secondary courses and establish course curricula, if applicable; (iv)&#160;suspension of the license
to establish new distance-learning programs; (v)&#160;override any ongoing regulatory requests filed by the institution and prohibit the
filing of any new regulatory requests; (vi)&#160;suspension of the participation in the New FIES; (vii)&#160;suspension of the participation
in PROUNI; and (viii)&#160;suspension or restriction to participate in other federal educational programs.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Financing Alternatives for Students: Incentive Programs</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Programs providing public funding to students enrolled
with private higher education institutions have been a major public policy to expand access to post-secondary education in Brazil, especially
for the low-income segment of the population. The most important programs are the following.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">University for All Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The University for All Program, or PROUNI is a tax incentive
program created through the Provisional Measure No. 213, of September 10, 2004, later converted into Law No. 11,096, of January 13, 2005,
that addresses the exemption of certain federal taxes imposed to post-secondary institutions that grant scholarships to low-income students
enrolled in undergraduate courses and technology graduate courses. By granting tax incentives to IES, PROUNI has played an important role
in inciting the growth and private investment in the post-secondary education sector.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Private post-secondary institutions may adhere to PROUNI
by the execution of a specific agreement with MEC, valid for 10 years and renewable for the same period. Such agreement must be emended
every semester with an additional term establishing the number of scholarships to be offered in each course, unit and class, and what
percentage of scholarships shall be granted to indigenous and afro-Brazilians. In order to participate in PROUNI, an educational institution
must:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>be up to date with its tax obligations; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>comply with the following requirements: (1)&#160;offer at least one full-time scholarship to every 10.7 regularly paying students
enrolled at the end of the past school year, excluding the full-time scholarships granted through PROUNI or by the institution; or (2)&#160;offer
one full-time scholarship to every 22 regularly paying students enrolled in traditional and technological graduation courses, provided
that it also offers scholarships (25% or 50% of the tuition) with a value equal to 8.5% of the paying students&#8217; annual revenue,
available to students enrolled in traditional and technological graduation courses at the school year.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The ratio between the number of scholarships and the
number of regularly paying students must be complied with annually. If the entity does not comply with the ratio during a school year
because of the withdrawal of</p>


<!-- Field: Page; Sequence: 102 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->97<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">students, the institution must adjust the number of scholarships in a proportionate
matter for the subsequent school year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to Normative Ruling No. 1,394, of September
12, 2013, issued by the Brazilian Federal Revenue Office, a post-secondary education institution that has adhered to the PROUNI is exempt,
totally or partly, from the following taxes for the duration of the adherence period:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Income Tax (&#8220;IRPJ&#8221;) and Social Contribution on Net Income (&#8220;CSLL&#8221;), with respect to the net income proportionate
to the revenue derived from the Undergraduate Degree Programs and Extension courses; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Contribution for Social Security Financing (&#8220;Cofins&#8221;) and Contribution to the Social Integration Plan (&#8220;PIS&#8221;),
with respect to the revenue derived from the traditional and technological graduation courses.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In case a post-secondary education institution requires
its exclusion from the PROUNI, its tax incentives will be suspended from the date of the solicitation and will not be applicable for the
entire period of the basis of calculation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Normative Ruling No. 1,394, of September 12, 2013, introduced
new provisions regarding the tax exemptions granted by PROUNI, in particular the form to calculate the extension of the benefits. According
to this Normative Ruling, in addition to the tax exemptions obtained by HEI signatories to PROUNI, tax exemptions are calculated based
on the Proportion of Effective Occupation of the Scholarships, or POEB, and the exemption related to IRPJ would be calculated without
taking into account the additional 10%.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">According to Article 7, II, amended by Normative Ruling
No. 1,417, dated September 6, 2013, the calculation of the exemption also includes the additional 10% of IRPJ, in addition to the CSLL
rate. The amount calculated is the amount of the IRPJ and CSLL exemption, respectively, which may be deducted from the IRPJ and CSLL in
relation to the totality of our activities. Accordingly, with the issuance of Normative Ruling No. 1,417, of September&#160;6, 2013, the
IRPJ / CSLL exemption on our operating income proportionate to the POEB will also include the additional 10% of IRPJ.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Moreover, considering that Normative Ruling No. 1,417,
dated September 6, 2013, creates a potential limit to the amount of the tax exemption, the application of these new provisions will result
in a reduction in value of the tax exemption obtained. Nevertheless, the legality of the provisions introduced by Normative Ruling No.
1,417, of September 6, 2013, is being discussed before the judiciary, with several motions still pending.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Other modifications of the fiscal incentive granted by
PROUNI were established by Normative Ruling No. 1,476, of July 1, 2014, which also amends the aforementioned Normative Ruling No. 1,417,
of September 6, 2013, in order to (i)&#160;exclude several amounts from the concept of profit of the holding, which impacts the enjoyment
of the exemption related to CSLL and IRPJ; and (ii)&#160;exclude the POEB from the applicable calculation, specifically for HEI with terms
of adherence to PROUNI signed up to June 26, 2011, which also affects the calculation of the exemption specifically enjoyed for the terms
of adhesion celebrated in the period prior to that date.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Student Financing Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The <i>Programa de Financiamento Estudantil</i> (Student
Financing Program, or FIES), created by Law No. 10,260, of July 12, 2001, is a MEC program to finance students that cannot bear the total
costs of their education. FIES has been the most important program for the expansion of access to higher education in Brazil during the
last decade, and it is currently responsible for a significant part of the revenues of the majority of private higher education institutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">FIES consists of funding granted by the National Fund
for Educational Development, or FNDE to students regularly enrolled in an on-site course of a post-secondary private HEI registered in
the FIES that has been positively evaluated by the MEC. After a specific selection proceeding, students may be partially or wholly funded
by FIES and, in that case, FNDE will be responsible for crediting the correspondent amount due by the student to the private higher education
institution.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Payments are made with government bonds whose primary
purpose is to compensate tax debts from the private higher education institution. In case there are no debts to be compensated, the institution
can resell the bonds to the government by means of a specific proceeding that currently occurs on monthly basis. The frequency of these
proceedings could vary according to public financial constraints and the discretion of FNDE.</p>


<!-- Field: Page; Sequence: 103 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->98<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">FIES has been substantially reshaped by Law No 13,530,
dated December 7, 2017, and currently the program is not as broad as it used to be. According to applicable regulations, in order to enroll
students that have been selected by FIES, private higher education institutions are required to contribute to the fund 13% of the amount
due by the student to the institution as consideration for the educational services rendered in the first year of studies. This amount
is subject to change in the following years and could vary between 10% and 25% of the consideration due, depending on specific circumstances.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">National Higher Education Evaluation System</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The National Higher Education Evaluation System, or SINAES
was created by Law No. 10,861 of April 14, 2004, with the purpose of evaluating post-secondary education institutions, undergraduate courses
and measuring student academic performance. The main objective of this evaluation system is to assess the quality of education in the
country, providing guidelines for MEC to decide upon institutional reaccreditation, recognition and renewal of recognition of courses.
Additionally, SINAES is responsible for improving the quality of post-secondary education in Brazil given that MEC can identify deficiencies
and establish specific conditions for institutions to remedy their issues and resume their operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The SINAES is monitored and coordinated by the CONAES
and INEP has a very important role in all processes. The results of the evaluation of post-secondary education institutions and their
programs are public and represented on a five level scale as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Level 5 indicates excellent conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Level 4 indicates more than satisfactory conditions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Levels 3 indicates satisfactory conditions; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Levels 1 and 2 indicate unsatisfactory conditions.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to applicable regulations, evaluation processes
consist of a preliminary assessment of several conditions relating to the institution and its courses, such as infrastructure, titles
of faculty members, work schedule of faculty members and student performance. Every year INEP establishes a method to evaluate those elements
and for them to correspond to a number in the five level scale.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The preliminary assessment is a complex process based
on quality indicators as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(a)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>National
Student Performance Examination</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The National Student Performance Examination, or ENADE,
is a test applied to a number of students that are completing courses. It evaluates students&#8217; knowledge regarding the content provided
in the curricular guidelines of the respective undergraduate course, their skills and competencies. ENADE&#8217;s results are considered
in the composition of quality indexes for courses and institutions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(b)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Preliminary
Course Concept</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Preliminary Course Concept, or CPC, is compound of
the ENADE score, the Difference Indicator between Observed and Expected Performance, or IDD, and factors that include teacher titles,
the work schedule of faculty staff and infrastructure of the institution. It is an indicator of the state of undergraduate courses in
the country. CPC 1 and 2 courses are automatically included in the INEP examiner&#8217;s visit schedule for on-site verification of teaching
conditions. Courses with a concept equal to or greater than 3 can choose not to receive the visit of the evaluators and, thus, transform
the CPC into a permanent concept (the Course Concept). The CPC is released every year for a specific group of courses along with the results
of ENADE.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(c)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>General
Course Index</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The General Course Index, or IGC, of the institution
summarizes in a single indicator the results of CPC and the evaluation of master&#8217;s and doctorate courses of each educational institution.
With regard to graduate courses, CAPES indexes are used and adapted to the scale according to a methodology provided by INEP, given that
they are organized in a different manner. IGC also goes from 1 to 5 and is published by INEP/MEC, after the release of the</p>


<!-- Field: Page; Sequence: 104 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->99<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">results of ENADE and CPC. The IGC is a criterion in the accreditation and
re-accreditation processes of institutions and also in the authorization process for new courses: institutions with IGCs less than 3,
for example, may have their applications for new courses rejected by the MEC. Similarly, the indicator is used to guide the expansion
of quality education: institutions with good performance are exempted from the authorization of the MEC to open courses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">(d)</span><span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Indicator
of Difference Between Observed and Expected Performance</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Indicator of Difference Between Observed and Expected
Performance, or IDD, is aimed at providing a reference of the contribution of the course to the learning of each student. For that purpose,
it compares the results of the ENADE with the performance of the same student in the ENEM. The indicator has a scale of 1 to 5.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Following preliminary assessments, all institutions are
typically subject to an on-site evaluation to confirm the results. However, given the size of the system, MEC gives institutions the option
to convert the results of the preliminary assessments into final results and, therefore, forgo on-site evaluations. For institutions that
obtain unsatisfactory levels, MEC on-site evaluations are mandatory.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Even before the on-site evaluation, MEC is entitled to
apply precautionary measures when preliminary assessments of the institution or course are not considered satisfactory, such as: (i)&#160;suspension
of new enrollments within the respective course or the entire institution; (ii)&#160;reduction of vacancies; and (iii)&#160;suspension
of all regulatory proceedings for institutional reaccreditation, new authorizations, recognitions or renewals of recognitions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Should the level be confirmed as less than three by the
on-site evaluation, MEC may propose a term of commitment to the institution, in order for it to correct the unsatisfactory conditions
within a specific deadline. Failure to uphold, in full or in part, the conditions established in the term of commitment may result in
one or more penalties to be applied by the MEC, such as: (i)&#160;temporary suspension of the opening of a selection process of graduation
courses; (ii)&#160;disqualification from the operating authorization of the higher education institution or recognition of courses offered;
and (iii)&#160;warning, suspension or cancellation of the mandate of the officer responsible for the action not executed, in the case
of public HEI.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">After the on-site evaluations, institutions and courses
obtain definitive quality concepts, as follows:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(a)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Institutional
Concept, which is the result of the on-site evaluation of the institution performed by INEP; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(b)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Course
Concept, which is the result of the on-site evaluation of the course performed by INEP.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Accreditation for Postgraduate programs</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lato sensu</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Post-secondary HEIs accredited for offering undergraduate
courses and that have at least one regular undergraduate course or a <i>stricto sensu</i> postgraduate course can offer <i>lato sensu
</i>postgraduate in the subjects in which they are accredited, either on-site or through distance learning.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The offering of postgraduate programs does not require
an authorization to operate, even if it is offered by a college. However, it must be notified to MEC, through MEC&#8217;s system (e-MEC),
within 60 days of the date of creation of such course.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The <i>lato sensu</i> postgraduate courses are aimed
at students who hold a diploma in an undergraduate course and satisfy the criteria of the institution that is offering the postgraduate
course. The postgraduate courses must meet the following requirements: (i)&#160;curriculum with a minimum study load of 360 hours; and
(ii)&#160;a teaching staff composed of at least 30% graduates of <i>stricto sensu</i> postgraduate courses.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Stricto sensu</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The authorization and recognition of <i>stricto sensu</i>
postgraduate courses (masters and doctorates) must be evaluated by CAPES, submitted to CNE&#8217;s deliberation and approved by MEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The HEIs can only initiate master's and doctorate courses
activities following publication of the homologation of CNE&#8217;s favorable opinion by MEC in the Official Gazette.</p>


<!-- Field: Page; Sequence: 105 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->100<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As part of its analysis, CAPES must consider the general
requirements and the specific parameters of the subject area to which each course is linked. The general requirements are: (i)&#160;alignment
of the proposal with the postgraduate planning of the institution; (ii)&#160;suitability and justification of the proposal for the regional
or national development and its economic and social importance; (iii)&#160;clarity and consistency of the proposal with detailed information
on its objectives, area of concentration, lines of research, curricular structure, discipline and bibliographic references; (iv)&#160;clarity
of the criteria adopted to select the students, justifications for the profile of the aimed formation and profile of the egress; (v)&#160;proof
that the teaching staff has academic, didactic, technical and scientific competence and qualifications related to the purpose of the course;
(vi)&#160;a permanent teaching staff to ensure the regularity and quality of teaching, research and orientation activities; (vii)&#160;indication
of up to five intellectual productions of each permanent teacher; and (viii)&#160;physical and technological infrastructure of teaching
and research adequate for the development of the proposed activities.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Authorizations of new <i>stricto sensu</i> postgraduate
courses must be requested at specific dates, as defined by CAPES and published in the Official Gazette.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">The &#8220;<i>Mais M&#233;dicos</i>&#8221; program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Law No. 12,871/2013, established the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program, an initiative designed to address medical professional shortages in certain municipalities and underserved regions of Brazil
and improve healthcare infrastructure and services. This law establishes specific regulations for medical courses, including criteria
for approving the creation of new courses in Brazil involving the definition of its location, the mandatory contribution to the public
health infrastructure according to the specific categories established by Ordinance No. 16/2014 issued by MEC (i.e., training of health
professionals, building or reforming of health service structure, purchasing of medical equipment and supplies and study grant to the
medical residency program) and also the conditions for public-private partnerships to implement the course.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Within the &#8220;<i>Mais M&#233;dicos</i>&#8221; program,
supporting entities are no longer able to choose the location of their courses or establish all conditions of supply, which have been
transferred to MEC. The proceedings to implement a medical course, therefore, are more bureaucratic and time consuming. Basically, MEC
publishes a public auction notice to select municipalities that will receive medical courses. After this selection, it issues another
public auction notice with the criteria for private higher institutions to compete for the right to implement courses in the municipalities
previously selected.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Since its creation in 2013, the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program has created 11,400 new medical school seats and 12,400 new medical residencies annually, composed of public and private institutions.
Notwithstanding this, the number of private vacancies was the lowest in Brazilian history when compared to regimes that previously ruled
the offering of medical courses from 1996-2002 and 2002-2013.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 5, 2018, prompted by Brazil achieving the World
Health Organization target for medical school seats, MEC issued Ordinance No. 328/2018, pursuant to which, among other measures, MEC imposed
a five-year suspension on the granting of any authorizations for the creation of new medical education courses or on issuing acts for
the expansion of existing ones. In the current legal scenario, institutions are not allowed to create any new medical education courses
until April 2023, except for (i) &#8220;<i>Mais M&#233;dicos</i>&#8221; medical courses that have already been authorized through ongoing
or completed public auctions; (ii)&#160;medical vacancy increase requests filed with MEC up to December 4, 2018; and (iii)&#160;medical
courses created under federal public university expansion projects, whose requests for new vacancies may be filed only once in accordance
with MEC regulations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Furthermore, pursuant to Ordinance No. 523/2018, enacted
by MEC on June 1, 2018, each medical school that has been granted a &#8220;<i>Mais M&#233;dicos</i>&#8221; program medical course authorization
or that is applying for one may file a motion with MEC requesting a maximum of 100 additional medical school seats. This right is limited
to a single motion per medical school and is subject to several requirements, including but not limited to, requirements related to the
availability of medical school infrastructure (including access to public health facilities through partnerships with the local Brazilian
Public Health System (<i>Sistema &#218;nico de Sa&#250;de,</i> or &#8220;SUS&#8221;) authorities), obligations to meet certain quality
assurance standards, and the absence of any penalties in the two years prior to the filing of the motion restricting medical school vacancies.</p>

<p style="font: 10pt/0.05pt Times New Roman,serif; margin: 0">&#160;</p>


<!-- Field: Page; Sequence: 106 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->101<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f013"></span>C.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Organizational
Structure</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">All of our subsidiaries are incorporated in Brazil. The following is a chart of
our current corporate structure as of the date of this annual report:</p>

<p style="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 10pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; text-align: center; margin-top: 0; margin-bottom: 10pt"><img src="afyaform20f_023.jpg" alt="" /></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 18pt">(1)</td><td>Except for UEPC, all subsidiaries are controlled and/or wholly-owned by Afya Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 18pt">(2)</td><td>CIS means Centro Integrado de Sa&#250;de de Teresina Ltda.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt">
<tr style="vertical-align: top">
  <td style="width: 18pt">(3)</td>
  <td>ADMED means Al&#233;m da Medicina.</td></tr>
</table>


<p style="font: bold 10pt Times New Roman,serif; margin: 12pt 0pt 10pt"><span id="a_20f014"></span>D.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Property,
Plant and Equipment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our corporate headquarters, which include product development,
sales, marketing, and business operations, are located in Nova Lima, State of Minas Gerais. It consists of 1,000 square meters of space
under a lease that expires in 2022.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition to our corporate headquarters and as of December
31, 2021, we leased almost all of our operational, sales, and administrative facilities. We believe that our facilities are suitable and
adequate for our business as presently conducted, however, we periodically review our facility requirements and may acquire new space
to meet the needs of our business or consolidate and dispose of facilities that are no longer required.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f015"></span><span style="color: #0D0E00">ITEM 4A. </span>UNRESOLVED STAFF COMMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">None.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f016"></span>ITEM 5. OPERATING AND FINANCIAL REVIEW AND PROSPECTS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f017"></span>A.<span style="font-weight: normal">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Operating
Results</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Overview</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are the leading medical education group in Brazil
based on the number of medical school seats, as published by MEC as of December 31, 2020, delivering an end-to-end physician-centric ecosystem
that serves and empowers students to be lifelong medical learners from the moment they join us as medical students through their medical
residency preparation, graduation program, and CME.</p>


<!-- Field: Page; Sequence: 107 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->102<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our innovative methodological approach combines integrated
content, interactive learning, and an adaptive experience for lifelong medical learners. Through our educational content and technology-enabled
activities, we focus on effective, personalized learning that mirrors one-on-one tutoring.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had 85,938 enrolled students,
compared to 53,426 enrolled students as of December 31, 2020, representing a growth of 60.9% for the period, and compared to 36,316 enrolled
students as of December 31, 2019, representing a growth of 47.1% for the period.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our ability to execute our business model and strategy,
primarily through our (i) acquisitions (which represented approximately 85.2% of our total growth in terms of net revenue in 2021, 54.0%
of our total growth in terms of net revenue in 2020 and 62.0% of our total growth in terms of net revenue in 2019) and (ii) organic growth
(which represented approximately 14.8% of our total growth in terms of net revenue in 2021, 46.0% of our total growth in terms of net
revenue in 2020 and 39.0% of our total growth in terms of net revenue in 2019), has led to growth, profitability and cash generation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2018, we were also awarded seven new undergraduate
campuses in connection with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, the largest number awarded to any education group, with
a total of 350 new medical school seats. The operation of such campuses is subject to the verification by MEC of the satisfactory implementation
by Afya Brazil of all regulatory requirements. As of the date of this annual report, MEC already inspected six of these campuses and already
issued the authorization to operate. Accordingly, we plan to expand our network, and expect to open an additional campus starting in 2022/2023,
taking our total to 35 campuses in 13 Brazilian states and approximately 2,759 available medical school seats per year.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Our Growth</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our revenue growth and increased profitability have been
driven by:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Maturation of current number of authorized medical school seats</b> &#8211; Anticipated and contracted growth visibility until
2027 from new medical seats awarded to our schools, that are in the process of maturing, and new seats from our awarded campuses in connection
with the &#8220;<i>Mais M&#233;dicos</i>&#8221; program and which are expected to become operational by 2022;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Ability to set price</b> &#8211; readjustment of tuition fees paid by students enrolled in our medical schools above published
inflation indexes. In 2018, we increased the tuition fees for our first-year incoming medical students, on average, by 13.0% (an increase
considerably above the 3.7% IPCA inflation rate for this same period) Since 2018, this tuition fees readjustment has applied to all new
first-year incoming students. Given that the average length of our medical courses is six years, this tuition fee readjustment will guarantee
revenue growth until 2024;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Expansion of medical residency preparation and graduate programs enrollments</b> &#8211; Increase in number of students adopting
our digital platform, as well as partners and students enrolling in our medical graduate courses;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Deepening of relationships across lifelong medical learners base</b> &#8211; Cross-selling opportunities such as increasing the
number of former undergraduate students subscribing to our medical residency prep solutions and the number of former undergraduate and/or
medical residency prep students applying to our graduate and CME courses;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>M&amp;A</b> &#8211; Acquisition or investment in businesses that complement our medical education services offering. In 2021, we
acquired or invested in nine companies, UNIFIPMoc and Garanhuns, medical schools which increased our medical school seats by more than
37% when compared to December 31, 2020, and iClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp and RX PRO, digital health services
companies that strengthened our digital business strategy. In 2020, we acquired or invested in six companies, UniRedentor, UniSL, FESAR
and FCMPB, medical schools which increased our medical school seats by more than 36% when compared to December 31, 2019, and PEBMED and
MedPhone, digital health services companies that strengthened our digital business strategy; and</td></tr></table>


<!-- Field: Page; Sequence: 108 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->103<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td><b>Synergies extraction</b> &#8211; Successful implementation of several measures to improve the profitability of recent acquisitions,
such as streamlining fee discounts and scholarship policies, integrating operations with our shared-services center; and aligning newly
acquired faculty teams with our career plan.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Key Business Metrics</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We review the following key metrics to evaluate our business,
measure our performance, identify trends affecting our business, formulate business plans and make strategic decisions:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Contribution of Medicine to Total historical undergraduate
programs combined tuition fees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe the metric that best demonstrates our focus
on medical education and its relevance to our products and services offering is historical undergraduate programs combined tuition fees
from medicine as a percentage of our total undergraduate programs combined tuition fees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For the years ended December 31, 2021, 2020 and 2019,
historical undergraduate programs combined tuition fees from medicine were 75.9%, 73.7% and 69.3%, respectively, of total undergraduate
programs combined tuition fees.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Historical undergraduate programs combined tuition fees*</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth information that was derived
from the historical operating information, for the year ended December 31, 2020, for Afya Brazil, for each of the Acquired Companies since
the date of acquisition. It does not represent net revenue as disclosed in our financial statements included elsewhere in this annual
report, which are presented as the sum of (a)&#160;gross tuition fees charged to undergraduate students, (b)&#160;gross tuition fees charged
to graduate students and (c)&#160;scholarships.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; width: 53%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: bottom; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2019</p></td>
    <td style="padding-right: 5pt; text-align: center; vertical-align: top; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2018</p></td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; text-align: center">&#160;</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: center; padding-left: 5pt">(in US$ millions(1))</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: center; padding-left: 5pt">(in R$ millions)</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: center; padding-left: 5pt">&#160;</td></tr>
  <tr>
    <td style="font: bold 8pt/9pt Times New Roman,serif; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="4" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: center; padding-left: 5pt">(except percentages)</td>
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: center; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Medical school programs&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">270.8</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,511.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">911.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">550.2</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">253.4</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Other undergraduate health sciences programs&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">42.9</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">239.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">152.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">98.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">44.9</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Other undergraduate programs(2)&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">42.9</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">239.2</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">173.0</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">145.6</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">47.4</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Undergraduate programs combined tuition fees</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>356.6</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,990.1</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,236.5</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>794.3</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>345.8</b></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">% Medicine(3)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">75.9%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">75.9%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">73.7%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">69.3%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">73.3%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-family: Times New Roman,serif">% Health sciences programs(4)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">88.0%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">88.0%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">86.0%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">81.7%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">86.3%</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">*</td><td>Historical undergraduate programs combined tuition fees is the sum equal to the total tuition fees charged to undergraduate
                                                        students, as derived from historical operating information of Afya Brazil and the Acquired Companies for the years ended December
                                                        31, 2021, 2020, 2019 and 2018. For the years ended December 31, 2021, 2020, 2019 and 2018, the historical undergraduate programs
                                                        combined tuition fees charged to undergraduate students by us were R$1,990.1 million, R$1,236.5 million, R$794.3 million, and
                                                        R$345.8 million, respectively. Historical undergraduate programs combined tuition fees does not include tuition fees we charge
                                                        graduate students. We present historical undergraduate programs combined tuition fees because, given our limited operating history
                                                        and that our historical financial information and operational information included elsewhere in this annual report may not be
                                                        representative of our results and operations as a consolidated company, we believe that it may help investors assess the past
                                                        operating results of the Acquired Companies as combined with Afya Brazil. This metric also shows the percentage of revenues we
                                                        derive from our medicine and health sciences programs, which are our core business. We present historical undergraduate programs
                                                        combined tuition fees as the sum of gross tuition fees charged to undergraduate students, which differs from the tuition fees set
                                                        forth in our financial statements, which are presented as the sum of (a) gross tuition fees charged to undergraduate students, (b)
                                                        gross tuition fees charged to graduate students and (c) scholarships which are presented as the sum of gross tuition fees charged to
                                                        students net of cancellations, discounts and taxes, and which also include revenue from admission fees and income from leases, among
                                                        others. The past performance of Afya Brazil and the Acquired Companies, as reflected in the historical undergraduate programs
                                                        combined tuition fees information, may not be indicative of our future performance or any future anticipated synergies, future operating efficiencies or cost savings that may result from these
acquisitions. For further information, see &#8220;Part I&#8212;Introduction&#8212;Financial Information&#8212;Historical Undergraduate
Programs Combined Tuition Fees.&#8221;</td></tr></table>


<!-- Field: Page; Sequence: 109 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->104<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>For convenience purposes only, amounts in <i>reais</i> for the year ended December 31, 2021 have been translated to U.S. dollars using
an exchange rate of R$5.580 to US$1.00, the commercial selling rate for U.S. dollars as of December 31, 2021, as reported by the Central
Bank. These translations should not be considered representations that any such amounts have been, could have been or could be converted
at that or any other exchange rate. See &#8220;Item 3. Key Information&#8212;Selected Financial Data&#8212;Exchange Rates&#8221; for further
information about recent fluctuations in exchange rates.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Represents all non-health sciences undergraduate programs.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Calculated as medical school programs divided by the historical undergraduate programs combined tuition fees.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>Calculated as the sum of medical school programs and other undergraduate health sciences programs, divided by the historical undergraduate
programs combined tuition fees.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical School Regulatory Capacity and Capacity at Maturation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical school regulatory capacity and capacity at maturation
are operating metrics that provide visibility into our medical school enrollments contracted growth given the supply and demand imbalance
in the medical school market and the fact that our medical schools have historically operated very close to their regulatory capacity.
Accordingly, the gradual increase in our capacity helps explain the increase in our medical school enrollments, which in turn helps explain
our medical school enrollments contracted growth. Contracted growth refers only to schools that are in the initial six years of operation.
In addition, since the maximum number of medical seats per medical school is set by applicable regulations, the only way to grow our medical
school seats, and therefore our number of enrollments, is through acquisitions or starting new medical schools.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Medical school regulatory capacity is defined by the
number of medical schools seats available per year awarded by the MEC <i>plus</i> the additional seats associated with PROUNI and FIES,
<i>multiplied by</i> the number of years of operations since the seats were awarded, up to the sixth year of operations (maturation).
Capacity at maturation represents the maximum number of approved seats at a medical school six years after becoming operational. Our medical
schools have a six-year maturation cycle because medical school programs in Brazil are for a duration of six years. A maturation cycle
represents the period starting when a medical school commences its operations with a first year medical school class of students which
progresses through the required six years as the next classes begin behind it, and ends when the medical school has six school years of
medical students and has therefore reached capacity at maturation (i.e., the maximum number of approved seats).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For illustration, a medical school that is awarded 100
seats from the MEC has the opportunity to add up to 20 additional seats:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to PROUNI (one seat for every 10.7 seats awarded by MEC); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>10 more seats by adhering to FIES (10% of the seats awarded by MEC).</td></tr></table>


<!-- Field: Page; Sequence: 110 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->105<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">Illustrative evolution of regulatory capacity per
medical school</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 6pt; text-align: center"><img src="afyaform20f_024.jpg" alt="" /></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our medical school regulatory capacity was 2,731 and
2,481 seats and our capacity at maturation was 17,863 and 15,430 as of December 31, 2021 and December 31, 2020. Assuming our medical schools
continue to operate at full capacity, we estimate reaching a total medical student base of 19,865 students by 2028. Assuming we are able
to consummate our projected acquisitions, we expect our future medical student base to reach approximately 19,865 students at maturity.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Medical School Occupancy Rate</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The occupancy rate of our medical schools is the ratio
of the number of students effectively enrolled divided by the regulatory capacity in a given period. While we believe retention rates
are an important measure of quality and customer satisfaction, we believe that occupancy rate is a more meaningful metric as it captures
not only our ability to retain students but also to find new students to compensate for eventual dropouts. Our management does not separately
measure retention rates to make decisions about our business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth our medical seats occupancy
rate as of the dates indicated.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">As of December
    31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 61%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; width: 13%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; width: 13%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; width: 13%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Occupancy rate&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">~100.0%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">~100.0%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">~100.0%</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Significant Factors Affecting Our Results of Operations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We believe that our results of operations and financial
performance will be driven by the following trends and factors:</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Regulatory Environment and Mais M&#233;dicos Program</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our business is significantly influenced by the regulatory
environment of the educational industry in Brazil. We are subject to various federal laws and extensive government regulations by MEC,
CNE, INEP, FIES and CONAES, among others. In particular, medical education in Brazil is subject to regulations that aim to control the
supply of medical seats across Brazil and their geographic allocation including, but not limited to Law No. 12,871/2013, which created
the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, whose main objectives include addressing the provision of doctors for primary care
in municipalities, strengthen health care infrastructure and allocate medical workforce to vulnerable areas. With the increase in annual
offerings through &#8220;<i>Mais M&#233;dicos,</i>&#8221; the Education Ministry announced on April 5, 2018 that the Brazilian federal
government had decided to freeze the new offering of medical seats for a period of five years.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The decision was based on the previously defined target
of at least 11,000 annual medical seats, which according to the World Health Organization, or WHO, was achieved in 2018. For further information,
see &#8220;Item 4.</p>


<!-- Field: Page; Sequence: 111 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->106<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Information on the Company&#8212;Business Overview&#8212;Regulatory Overview,&#8221;
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;The post-secondary
education sector is highly regulated, and our failure to comply with existing or future laws and regulations could significantly impact
our business,&#8221; and Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We are subject to supervision by
MEC and, consequently, may suffer sanctions as a result of non-compliance with any regulatory requirements.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Scholarships, Student Financing and Tax Benefits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A large number of our students fund their tuition fees
through financing from FIES. In addition, we participate in the PROUNI scholarship program, and we benefit from tax benefits in return.
For more information on our students enrolled in these programs, see &#8220;Item 4. Information on the Company&#8212;Business Overview&#8212;Regulatory
Overview&#8212;Financing Alternatives for Students: Incentive Programs&#8212;University for All Program (PROUNI),&#8221; &#8220;Regulatory
Overview&#8212;Financing Alternatives for Students: Incentive Programs&#8212;Student Financing Program (FIES),&#8221; &#8220;Item 3. Key
Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Changes to the rules or delays or suspension
of tuition payments made through FIES may adversely affect our cash flows and our business,&#8221; and &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;If we lose the benefits of federal tax exemptions provided
under the PROUNI program, our business, financial condition and results of operations may be materially adversely affected.&#8221; In
addition to PROUNI and FIES, Afya participates in private financing programs through external partners (Banco Santander and Raydan) for
undergraduate students.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Brazilian Macroeconomic Environment</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">All of our operations are located in Brazil. As a result,
our revenues and profitability are affected by political and economic developments in Brazil and the effect that these factors have on
the availability of credit, disposable income, employment rates and average wages in Brazil. Our operations, and the industry in general,
may be affected changes in economic conditions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Brazil is the largest economy in Latin America, as measured
by gross domestic product, or GDP. The following table shows data for real GDP, inflation and interest rates in Brazil and the U.S. dollar/<i>real</i>
exchange rate at the dates and for the periods indicated.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 70%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Real growth (contraction) in gross domestic product&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.6%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(4.1)%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.1%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Inflation (IGP-M)(1)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">17.8%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">23.1%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">7.3%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Inflation (IPCA)(2)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">10.1%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.5%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.3%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Long-term interest rates&#8212;TJLP (average)(3)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.8%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.9%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.2%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">CDI interest rate(4)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">9.1%</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.9%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.4%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Period-end exchange rate&#8212;<i>reais</i> per US$1.00&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.581</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.196</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">4.030</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Average exchange rate&#8212;<i>reais</i> per US$1.00(5)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.412</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.158</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.946</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Appreciation (depreciation) of the <i>real</i> vs. US$ in the period(6)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(7.3)%</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(28.9%)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(4.0)%</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-family: Times New Roman,serif">Unemployment rate(7)&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11.1%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">13.5%</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">11.9%</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt"><i>Source:</i> FGV, IBGE, Central Bank and Bloomberg.</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Inflation (IGP-M) is the general market price index measured by the FGV.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Inflation (IPCA) is a broad consumer price index measured by the IBGE.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>TJLP is the Brazilian long-term interest rate (average of monthly rates for the period).</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>The CDI <i>(certificado de dep&#243;sito interbanc&#225;rio)</i> interest rate is an average of interbank overnight rates in Brazil.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(5)</td><td>Average of the exchange rate on each business day of the year.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(6)</td><td>Comparing the US$ closing selling exchange rate as reported by the Central Bank at the end of the period&#8217;s last day with the
day immediately prior to the first day of the period discussed.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(7)</td><td>Average unemployment rate for the year as measured by the IBGE.</td></tr></table>


<!-- Field: Page; Sequence: 112 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->107<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Inflation directly affects our current operating costs
and expenses, adjusted by reference to indexes that reflect the inflation rate such as the IGP-M or IPCA, primarily as a result of annual
adjustments to faculty member and employee salaries. Historically, inflation has been more than offset by the tuition fees we charge our
students.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our financial performance is also marginally tied to
fluctuations in interest rates, such as the CDI rate, because such fluctuations affect the value of our financial investments. We are
also exposed to fluctuations in interest rates on our accounts payable to selling shareholders which are indexed to the CDI, IPCA and
SELIC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, the COVID-19 pandemic and measures taken
in response may continue adversely impacting the Brazilian macroeconomic environment and our business. The COVID-19 pandemic is still
evolving in Brazil and pandemic may result in an adverse effect on the general economic, financial, political, demographic and business
conditions in Brazil, which may adversely impact the ability of our students to pay our tuition fees and increase our attrition rates.
As of the date of this annual report, all of the lockdown restrictions have been revoked by Brazilian authorities in our campus locations
and the Company has also successfully resumed all of our practical classes in medicines courses and all of our in-classroom classes. See
&#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Public health outbreaks,
epidemics or pandemics, such as the COVID-19 pandemic, have adversely affected and may continue to adversely affect our business.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Acquisitions</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may face significant challenges in the process of
integrating the operations of our acquired companies. If we are not able to manage these integrations effectively, our results of operations
may be affected. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;We
may not be able to identify and acquire new medical higher education institutions or meet our strategic and financial goals in connection
with any business acquisition we seek, and difficulties in effectively integrating and managing a growing number of acquisitions may adversely
affect our strategic objectives&#8221; and Item 4. Information on the Company&#8212;B. Business Overview&#8212;Our Recent Acquisitions.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Business Segments</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">During 2021, in connection with the recent acquisitions
of digital and technology companies, the Company revised its operating segments. As result, the Company has three operating segments as
opposed to the previously reported Business Unit 1 (educational services through undergraduate and graduate courses related to medicine,
other health sciences and other undergraduate programs) and Business Unit 2 (residency preparatory courses and medical post-graduate specialization
programs, delivering printed and digital content, an online medical education platform). The three reportable segments are as follows:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other
undergraduate programs;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Continuing Education, which provides specialization programs and graduate courses; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Digital Services, which provides content and technology for medical education, clinical decisions software, practice management tools
and electronic medical records, doctor-patient relationship, telemedicine and digital prescription.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Due to changes in operating segments, segment information
for the years ended December 31, 2020 and 2019 has been restated. Segment information is presented consistently with the internal reports
provided to the our chief executive officer, who is our chief operating decision maker (CODM) and is responsible for allocating resources,
assessing the performance of our operating segments, and making our strategic decisions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">No operating segments have been aggregated to form the
above reportable operating segments. There is only one geographic region and the results are monitored and evaluated as a single business.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">There were no revenues derived from the Digital Services
segment prior to the consolidation of Medcel and IPEMED in our financial statements starting on March&#160;29, 2019 and May 9, 2019, respectively.
For further information, see note 4 to our audited consolidated financial statements included elsewhere in this annual report.</p>


<!-- Field: Page; Sequence: 113 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->108<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt"><b>Description of Principal Line Items</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Net revenue</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our revenue consists primarily of tuition fees we charge
for medical schools and other undergraduate and graduate programs, as well as from fees we charge for our medical residency preparatory
courses and mobile app subscription for digital medical content. We also generate revenue from other student fees and certain education-related
activities that typically trend with tuition revenues.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Cost of services</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cost of services includes expenses related to payroll,
rent, hospital agreements, utilities and depreciation and amortization. Cost of services amounted to 37.9%, 36.2% and 41.1% of our net
revenue in the years ended December 31, 2021, 2020 and 2019, respectively.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Operating expenses</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our operating expenses includes expenses for personnel,
general and administrative, management and officer compensation, marketing and other income (expenses), net.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Personnel.</i> Personnel expenses consist of wages,
overtime, benefits (meal vouchers, transportation vouchers and medical and dental insurance, among others), profit sharing, social contribution
and payroll taxes. In Brazil, social contribution and payroll taxes consist of the Brazilian Social Security Institute <i>(Instituto Nacional
do Seguro Social)</i> contribution, or INSS, and the Brazilian Unemployment Severance Fund <i>(Fundo de Garantia do Tempo de Servi&#231;o)</i>
contribution, or FGTS.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>General and administrative.</i> General and administrative
expenses mainly consist of: (i)&#160;building infrastructure expenses, such as rent and property maintenance; (ii)&#160;utilities expenses;
(iii)&#160;expenses for computer system maintenance and office automation, such as software licenses, as well as for integrated accounting,
treasury, financial planning and cost management systems; (iv)&#160;sales and marketing expenses; (v)&#160;allowance for doubtful accounts;
and (vi)&#160;amounts paid for professional services, such as consultants, auditors and outside counsel.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Other income (expenses), net.</i> Other income (expenses),
net, consists mainly of miscellaneous income and/or expense items.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Finance result</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our finance result includes finance income and finance
expenses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our finance income consists mainly of income from interest
earned on financial investments and interest received on late payments from students. Our finance expenses consist mainly of interest
expenses from accounts payable to selling shareholders, loans and lease liabilities, foreign exchange associated with our cash in US Dollars
and banking fees.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We also have cash and cash equivalents denominated in
U.S. dollars, and accordingly, we have foreign exchange gain or losses from the changes in U.S. dollars against the Brazilian <i>real.</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Income taxes expense</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Income taxes expense includes current income taxes and
social contribution.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Historical Consolidated Results of Operations</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2021 Compared to the year ended
December 31, 2020</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth our historical consolidated
income statement data for the years ended December&#160;31, 2021 and 2020:</p>


<!-- Field: Page; Sequence: 114 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->109<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 67%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Variation
    (%)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions, except for percentages)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Net revenue&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,719.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,201.2</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">43.1%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Cost of services&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(652.3)</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(434.7)</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">50.1%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Gross profit</b></td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>1,067.1</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>766.5</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>39.2%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">General and administrative expenses&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(622.6)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(402.9)</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">54.6%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Other income (expenses), net&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(3.6)</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(0.3)</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">926.2%</p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Operating income</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>440.9</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>363.3</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>21.3%</b></p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Finance income&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">64.6</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">62.3</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">3.7%</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Finance expenses&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(243.8)</p></td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(98.3)</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">148.1%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Finance result</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(179.2)</b></p></td>
    <td style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(36.0)</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>398.2%</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Share of income of associate&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">11.8</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>7.7</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">53.2%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Income before income taxes</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>273.5</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>335.1</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right"><b>(18.4%)</b></p></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Income taxes expense&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(31.2)</p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">(27.1)</p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">15.2%</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Net income</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>242.3</b></p></td>
    <td style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>308.0</b></p></td>
    <td style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>(21.3%)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Net revenue</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Net revenue for the year ended December 31, 2021 was
R$1,719.4 million, an increase of R$518.2 million, or 43.1%, from R$1,201.2 million for the year ended December 31, 2020. This increase
was primarily driven by: (i) organic revenue growth, mainly due to the maturation of medical school seats; (ii)&#160;consolidation of
the results of operations of acquired companies in 2021 (IClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp, Unifipmoc, Unigranrio
and RX Pro) including two Mais Medicos campuses opened at the end of 2020 (Santa Ines and Cruzeiro do Sul), (iii) increase in the average
ticket of Medical programs and, (iv) the fact that PEBMED has 12 months of net revenue in 2021, against approximately
five months in 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Undergrad segment, net revenue for the year ended
December 31, 2021 was R$1,498.4 million, an increase of 49.5%, or R$495.9 million, from R$1,002.5 million for the year ended December
31, 2020. This increase was primarily attributable to the factors discussed above.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">In our Continuing Education segment, net
revenue for the year ended December 31, 2021 was R$73.0 million, a decrease of 31.9%, or R$34.2 million, from R$107.2 million for the
year ended December 31, 2020. This decrease was primarily attributable to a reduction in active paying students because of: (a) in-person
practical programs that have not been offered since the first half of 2020 and, (b) physicians&#8217; decision to postpone admission to
specialization courses due to the COVID-19 pandemic.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">In our Digital Services segment, net revenue
for the year ended December 31, 2021 was R$147.9 million, an increase of 61.6%, from R$91.5 million for the year ended December 31, 2020
considering intercompany transactions. This increase was primarily attributable to: (i) the consolidation of the results of operations
of acquired companies in 2021 (IClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp and RX Pro); and (ii) the fact that PEBMED has 12 months of net revenue in 2021, against approximately
five months in 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Cost of services</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cost of services for the year ended December 31, 2021
was R$652.3 million, an increase of R$217.6 million, or 50.0%, from R$434.7 million for the year ended December 31, 2020. This increase
was primarily attributable to (i) the consolidation of the results of operations of acquired companies in 2021 (IClinic, Medicinae, Medical
Harbour, Cliquefarma, Shosp, Unifipmoc, Unigranrio and RX Pro), and a corresponding increase in payroll expenses, and (ii)&#160;an increase
in severance related costs and other costs associated with the downsizing of teaching staff rosters at some of our recently acquired units
to take advantage of synergies and increase in salaries due to inflation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a percentage of net revenue, our cost of services
increased to 37.9% for the year ended December 31, 2021, compared to 36.2% for the year ended December 31, 2020.</p>


<!-- Field: Page; Sequence: 115 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->110<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Undergrad segment, cost of services for the year
ended December 31, 2021 was R$555.0 million, an increase of R$173.0 million, or 45.3%, from R$382.0 million for the year ended December
31, 2020, considering intercompany transactions. This increase was primarily attributable to the factors discussed above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Continuing Education segment, cost of services
for the year ended December 31, 2021 was R$50.8 million, an increase of R$10.8 million, or 27%, from R$40.0 million for the year ended
December 31, 2020. This increase was primarily attributable to (i) new units (6 branches) of IPEMED and (ii) increase in salaries due
to inflation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Digital Services segment, cost of services for
the year ended December 31, 2021 was R$50.5 million, an increase of R$36.2 million, or 253.1%, from R$14.3 million for the year ended
December 31, 2020. This increase was primarily attributable to (i) the fact that PEBMED has 12 months of net revenue in 2021, against
approximately five months in 2020; and (ii) an increase in salaries due to inflation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Gross profit</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result of the foregoing, gross profit for the year
ended December 31, 2021 was R$1,067.1 million, an increase of R$300.5 million, or 39.2%, from R$766.5 million for the year ended December
31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Undergrad segment, gross profit for the year ended
December 31, 2021 was R$943.4 million, an increase of R$322.9 million, or 52.0%, from R$620.5 million for the year ended December 31,
2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Continuing Education segment, gross profit for
the year ended December 31, 2021 was R$22.2 million, a decrease of R$45.0 million, or 67%, from R$67.2 million for the year ended December
31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In our Digital Services segment, gross profit for the
year ended December 31, 2021 was R$101.5 million, an increase of R$22.6 million, or 28.7%, from R$78.8 million for the year ended December
31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>General and administrative expenses</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">General and administrative expenses for the year ended
December 31, 2021 was R$622.6 million, an increase of R$219.7 million, or 54.6%, from R$402.9 million for the year ended December 31,
2020. This increase was primarily attributable to (i)&#160;the consolidation of the results of operations of acquired companies in 2021
(iClinic, Medicinae, Medical Harbour, Cliquefarma, Shosp, Unifipmoc, Unigranrio and RX Pro)), (ii)&#160;&#160;an increase in maintenance
expenses, to R$47.1 million for the year ended December 31, 2021, from R$20.7 million for the year ended December 31, 2020, as a result
of improvals in acquired acquisitions; and (iii) an increase in sales and marketing, to R$ 39.5 million ended December 31, 2021, from
18.3 million for the year ended December 31, 2020, also related mostly to acquisitions advertising.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Operating income</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For the reasons discussed above, operating income for
the year ended December 31, 2021 was R$440.9 million, an increase of R$77.6 million, or 21.3%, from R$363.3 million for the year ended
December 31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Finance result</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Finance result for the year ended December 31, 2021 was
a net finance expense of R$179.2 million, compared to a net finance expense of R$36.0 million for the year ended December 31, 2020, for
the reasons described below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Finance income.</i> Finance income for the year ended
December 31, 2021 was R$64.6 million, an increase of R$2.3 million, from R$62.3 million for the year ended December 31, 2020. This increase
was primarily attributable to (i) an increase in interest received of R$11.2 million (ii)&#160;an increase in income from financial investments
of R$11.3 million, and (iii) no amount in 2021 related to changes in fair value of derivative instruments that corresponded to R$20.7
million in 2020 since the Company did not have any derivative instruments in 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Finance expenses.</i> Finance expenses for the year
ended December 31, 2021 was R$243.8 million, an increase of R$145.5 million, from R$98.3 million for the year ended December 31, 2020.
This increase was primarily attributable to (i) an increase in interest expenses on lease liabilities of R$22.8 million, as a result of
the companies acquired and new lease agreements in the period (ii) an increase in interest expense of R$82.9 million mainly by net</p>


<!-- Field: Page; Sequence: 116 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->111<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 10pt">debt resulting from the acquisitions in 2021 (accounts payable to selling
shareholders, loans and financing, including perpetual convertible preferred shares); and (iii) an increase in foreign exchange loss of
R$13.3&#160;million in 2021, as a result of adverse foreign exchange impacts on our cash and banks in the period.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Income before income taxes</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result of the foregoing, income before income taxes
for the year ended December 31, 2021 was R$273.5 million, a decrease of R$61.6 million, or 18.4%, from R$335.1 million for the year ended
December 31, 2020.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Income taxes expense</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Income taxes expense for the year ended December 31,
2021 was R$31.2 million, an increase of R$4.1 million, from R$27.1 million for the year ended December 31, 2020. Despite our Prouni incentives,
this increase was primarily attributable to: (i) the increase in our taxable profit as a result of the positive impact of our organic
growth; (ii) the consolidation of the results of operations of acquired companies in 2021 (IClinic, Medicinae, Medical Harbour, Cliquefarma,
Shosp, Unifipmoc, Unigranrio and RX Pro) during the course of 2021; and (iii) presumed profit (<i>lucro presumido</i>) taxation regime
applicable to Medcel and PEBMED.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Net income</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a result of the foregoing, our net income for the
year ended December 31, 2021 was R$242.3 million, a decrease of R$65.7 million, or 21,3%, from R$308.0 million for the year ended December
31, 2020.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Year Ended December 31, 2020 Compared to the year ended
December 31, 2019</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Due to changes in operating segments, segment information
for the years ended December 31, 2020 and December 31, 2019 has been restated. Accordingly, set forth below is a discussion of certain items
reflecting the change in operating segments.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Net revenue</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: White">Net revenue for
the year ended December 31, 2020 was R$1,201.2 million, an increase of R$450.6 million, or 60.0%, from R$750.6 million for the year ended
December 31, 2019. This increase was primarily driven by: (i) organic revenue growth, mainly due to the maturation of medical school
seats; and (ii) consolidation of the results of operations of acquired companies in 2020 (Uniredentor, UniSL, PEBMED, FESAR, Medphone
and FCMPB).</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: White">In our Undergrad
segment, net revenue for the year ended December 31, 2020 was R$1,002.5 million, an increase of 53.3%, or R$348.7 million, from R$653.8
million for the year ended December 31, 2019. This increase was primarily attributable to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: White">In our Continuing
Education segment, net revenue for the year ended December 31, 2020 was R$107.2 million, an increase of 65.2%, or R$42.3 million, from
R$64.9 million for the year ended December 31, 2019. This increase was primarily attributable to IPEMED, that had 12 months of net revenue
in 2020, against approximately seven months in 2019.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: White">In our Digital
Services segment, net revenue for the year ended December 31, 2020 was R$91.5 million, an increase of 186.0%, or R$32.0 million, from
R$59.5 million for the year ended December 31, 2019. This increase was primarily attributable to the acquisition of PEBMED in 2020 and
the fact that in 2020 Medcel had 12 months of net revenue against approximately nine months in 2019.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Cost of services</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cost of services for the year ended December 31, 2020
was R$434.7 million, an increase of R$125.8 million, or 40.7%, from R$308.9 million for the year ended December 31, 2019. This increase
was primarily attributable to the consolidation of the results of operations of acquired companies in 2020 (Uniredentor, UniSL, PEBMED,
FESAR, Medphone and FCMPB), and (i) a corresponding increase in payroll expenses, and (ii) an increase in severance related costs and
other costs associated with the downsizing of teaching staff rosters at some of our recently acquired units to take advantage of synergies.</p>


<!-- Field: Page; Sequence: 117 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->112<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a percentage of net revenue, our cost of
services decreased to 36.1% for the year ended December 31, 2020, compared to 41.1% for the year ended December 31, 2019.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Undergrad segment, cost of services for the year ended December 31, 2020 was R$382.0 million, an increase of R$103.0 million, or 36.9%,
from R$279.0 million for the year ended December 31, 2019. This increase was primarily attributable to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Continuing Education segment, cost of services for the year ended December 31, 2020 was R$40.0 million, an increase of R$10.7 million,
or 36.7%, from R$29.3 million for the year ended December 31, 2019. This increase was primarily attributable to the factors discussed
above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Digital Services segment, cost of services for the year ended December 31, 2020 was R$14.3 million, an increase of R$9.9 million, or
224.8%, from R$4.4 million for the year ended December 31, 2019. This increase was primarily attributable to the factors discussed above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White"><i>Gross
profit</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">As a
result of the foregoing, gross profit for the year ended December 31, 2020 was R$766.5 million, an increase of R$324.7 million, or 73.5%,
from R$441.8 million for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Undergrad segment, gross profit for the year ended December 31, 2020 was R$620.5 million, an increase of R$245.8 million, or 65.6%, from
R$374.7 million for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Continuing Education segment, gross profit for the year ended December 31, 2020 was R$67.2 million, an increase of R$31.6 million, or
88.7%, from R$35.6 million for the year ended December 31, 2019.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">In our
Digital Services segment, gross profit for the year ended December 31, 2020 was R$78.8 million, an increase of R$47.3 million, or 150.5%,
from R$31.5 million for the year ended December 31, 20</span>19.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">For
comparative discussions regarding General and administrative expenses, Operating income, Finance result, Finance income, Finance expenses,
Income before income taxes, Income taxes expense and Net income, see our annual report on Form 20-F for the fiscal year ended December
31, 2020, filed with the SEC on April 30, 2021.</span></p>



<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">C<b>ritical Accounting Estimates and Assumptions</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our consolidated financial statements are prepared in
conformity with IFRS. In preparing our audited consolidated financial statements, we make assumptions, judgments and estimates that can
have a significant impact on amounts reported in our consolidated financial statements. We base our assumptions, judgments and estimates
on historical experience and various other factors that we believe to be reasonable under the circumstances. Actual results could differ
materially from these estimates under different assumptions or conditions. We regularly reevaluate our assumptions, judgments and estimates.
Our significant accounting policies are described in note 2 and our critical accounting estimates and assumptions are described in note
3 to our audited consolidated financial statements included elsewhere in this annual report. We believe that the following critical accounting
policies are more affected by the significant judgments and estimates used in the preparation of our consolidated financial statements.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Identification and fair-value measurement of assets and liabilities
acquired in a business combination</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We account for business combinations using the acquisition
method. Such method requires recognizing and measuring the identifiable assets acquired, the liabilities assumed and any non-controlling
interest in the acquiree. Identifiable assets and liabilities assumed must be classified or designated on the basis of our own contractual
terms, economic conditions, operating and accounting policies and other relevant conditions as at the acquisition date. Such assessment
requires judgments on the methods used to determine the fair value of the assets acquired and liabilities assumed, including valuation
techniques that may require prospective financial information inputs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Impairment of non-financial assets</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Impairment exists when the carrying value of an asset
or cash generating unit (&#8220;CGU&#8221;) or group of CGUs exceeds its recoverable amount, defined as the higher of its fair value less
costs of disposal and its value in use. The fair value less costs of disposal calculation is based on data available from binding sales
transactions, conducted at arm&#8217;s length, for similar assets or observable market prices less incremental costs of disposing of the
asset. The value in use calculation is based on a discounted cash flow model, or DCF model. The cash flows are derived from the budget
for the next five years and do not include restructuring activities to which we have not yet committed or</p>


<!-- Field: Page; Sequence: 118 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->113<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 10pt">significant future investments that will enhance the performance of the
assets of the CGU being tested. The recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected
future cash-inflows and the growth rate used for extrapolation purposes. These estimates are most relevant to goodwill and indefinite
lived intangible assets recognized by us. The key assumptions used to determine the recoverable amount for the different CGUs, including
a sensitivity analysis, are disclosed and further explained in note 12 to our audited consolidated financial statements included elsewhere
in this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Share-based compensation</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Estimating fair value for share-based compensation transactions
requires determination of the most appropriate valuation model, which depends on the terms and conditions of the grant. This estimate
also requires determination of the most appropriate inputs to the valuation model including the expected life of the share option or appreciation
right, volatility and dividend yield and making assumptions about them. For the measurement of the fair value of equity-settled transactions
we use the Binomial model. We had stock plans that were fully exercised on July 31, 2019, for which the Monte Carlo and Black &amp; Scholes
pricing model were used for the Afya Brazil Long-Term Incentive Plan and Guardaya&#8217;s stock option plan (which was transferred to
the Afya Brazil Long-Term Incentive Plan), respectively. For further information on the assumptions and models used for estimating the
fair value for share-based compensation transactions, see note 16 to our audited consolidated financial statements included elsewhere
in this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Leases &#8211; Estimating the incremental borrowing rate</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are unable to readily determine the implicit interest
rate in lease arrangements, therefore, we use incremental borrowing rate, or IBR, to measure lease liabilities. The IBR is the rate of
interest that we would have to pay to borrow over a similar term, and with a similar security, the funds necessary to obtain an asset
of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects what we &#8216;would have to
pay&#8217;, which requires estimation when no observable rates are available (such as for subsidiaries that do not enter into financing
transactions) or when they need to be adjusted to reflect the terms and conditions of the lease. The IBR is estimated using observable
inputs (such as market interest rates) when available and is required to make certain entity-specific estimates.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt"><b>Recent Accounting Pronouncements</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The new amendments and interpretations that were applied
for the first time in 2021 did not have a significant impact on our consolidated financial statements.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f018"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Liquidity and Capital Resources</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had R$748.6 million in cash
and cash equivalents. We believe that our current available cash and cash equivalents and the cash flows from our operating activities
will be sufficient to meet our working capital requirements and capital expenditures in the ordinary course of business for the next 12
months. Future cash needs in the short and long term will be funded by our operating cash flow and from funds raised in the debt or equital
capital markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table shows the historical cash flows for
the years ended December 31, 2021, 2020 and 2019:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">For the Year
    Ended December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 67%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">2019</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-family: Times New Roman,serif">Cash Flow Data</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Net cash flows from operating activities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">630.9</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">371.5</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">299.2</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Net cash flows used in investing activities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(1,274.1)</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(1,042.8)</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">(354.1)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Net cash flows from financing activities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">364.7</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">756.4</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">921.4</td></tr>
  </table>


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"></p>


<!-- Field: Page; Sequence: 119 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->114<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Operating Activities</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We had net cash flows from operating activities of R$630.9
million in 2021, as compared to R$371.5 million in 2020, mainly due to the maturation of medical seats, an increase in the average ticket
of medical programs and consolidation of acquisitions of medical schools and digital services. The
main variations in our operating assets and liabilities were: (i) a decrease in the growth of the trade receivables from R$164.3 million
as of December 31, 2020 to R$79.7 million as of December 31, 2021, affected by the end of the grace period of tuition renegotiation that
occurred in 2020 and (ii) a change in advances from customers from R$(1.9) million as of December 31, 2020 to R$36.0 million as of December
31, 2021, mainly due to the better economic environment in our locations and acquisitions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Investing Activities</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We had net cashflows used in investing activities of
R$1,274.0 million in 2021, as compared to net cash flows from investing activities of R$1,042.8 million in 2020. The main variations in
our investing activities were: (i) an increase of Intangibles assets from R$47.7 million as of December 31, 2020 to R$150.9 million as
of December 31, 2021 related to Garanhuns acquisition, Educational Platform / Software development and (ii) acquisition of subsidiaries,
net of cash acquired of R$92.1 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Financing Activities</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We had net cash flows from financing activities of R$364.7
million in 2021, as compared to R$756.4 million in 2020, mainly due to the outflow of R$213.7 for our Repurchase programs in addition
to an inflow reduction of R$184.7 from issuance of loans combined with equity capital markets (ECM) transactions when compared to 2020.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="font-size: 10pt">For a discussion
of changes in our consolidated cash flows in the year ended December 31, 2020 compared to the year ended December 31, 2019, see our annual
report on Form 20-F for the fiscal year ended December 31, 2020, filed with the SEC on April 30, 2021.</span></p>



<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Liquidity</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">Our management has responsibility for monitoring<span style="font-size: 8pt; background-color: White">&#160;</span> <span style="font-size: 10pt">liquidity
risk. In order to achieve the Company&#8217;s objective, our management regularly reviews the risk and maintains appropriate reserves, including
bank credit facilities with first tier financial institutions. Our management also continuously monitors projected and actual cash flows
and the combination of the maturity profiles of the financial assets and </span>liabilities.</p>

<p style="margin: 0; font-family: Times New Roman, Times, Serif"></p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">The main requirements for financial resources
used by the Company arise from the need to make payments for suppliers, operating expenses, labor and social obligations, loans and financing
and accounts payable to selling shareholders.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0">Our total liquidity, which we calculate as
the sum of cash and cash equivalents, decreased 28.4%, from R$1,045.0 as of December 31, 2020 to R$748.6 million as of December 31, 2021.
In addition to that, we had a positive working capital of R$440.4 million in 2021 from R$816.1 million in 2020 . The main reasons for these
changes are disclosed above, on topics "Investing Activities" and "Financing Activities".</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Indebtedness</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Loans</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had outstanding debt, comprised
of our loans and financings, in the aggregate amount of R$1,374.8 million, and lease liabilities of R$714.1 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On October 1, 2020, Afya Brazil entered into a loan with
Banco Ita&#250; Unibanco S.A. in the amount of R$ 500,000 adjusted by the CDI rate plus an interest rate of 1.62% per year and is repayable
in three installments in October 2022, April 2023 and October 2023.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 3, 2020, Afya Brazil entered into a loan agreement
with Banco Votorantim S.A. in the amount of R$ 100,000 adjusted by the CDI rate plus an interest rate of 1.65% per year and was repaid
at maturity on July 5, 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On May 5, 2020, as a result of the acquisition of UniSL,
the Company assumed loans agreements with BNDES which has an interest rate of 10.03% per year and maturity in 2024. This amount was prepaid
in September 2021.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 23, 2019, Medcel entered into a loan of R$16.2
million with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments on R&amp;D,
which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of R$6.7 million
and R$4.1 million, respectively, were drawn down in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There are no financial covenants under this agreement. The total loan balance is guaranteed by a bank
warranty.</p>


<!-- Field: Page; Sequence: 120 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->115<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On October 28, 2020, UNIFIPmoc entered into a loan with
Banco Ita&#250; Unibanco S.A. in the amount of R$30.0 million. On June 30, 2021 this agreement was amended and is now adjusted by the
CDI rate plus an interest rate of 1.75% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 43%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>Financial institution</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 15%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>Currency</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 13%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>Interest rate</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 8%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>Maturity</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 8%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 1%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-right: 5pt; width: 8%; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Banco Ita&#250; Unibanco S.A. (a)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">CDI + 1.62% p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2023</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">510,972</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">504,365</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Banco Votorantim (b)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">CDI + 1.65% p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2021</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">-</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">101,785</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">BNDES (c)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">10.03% p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2024</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">-</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">471</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">FINEP (d)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">TJLP p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2027</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">10,145</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">10,864</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Softbank (f)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">6.5% p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2026</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">822,560</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Banco Ita&#250; Unibanco S.A. (e)</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Brazilian real</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">CDI + 1.75% p.y.</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">2024</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">31,199</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>1,374,876</b></span></td>
    <td>&#160;</td>
    <td style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt"><b>617,485</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Current</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">128,720</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">107,162</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">Non-current</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: center; line-height: 10.5pt; padding-left: 3pt">&#160;</td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">1,246,156</span></td>
    <td>&#160;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; line-height: 10.5pt; padding-left: 3pt"><span style="font-size: 9pt">510,323</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Financing &#8211; Series A Perpetual Convertible Shares</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 26, 2021, the Company issued and sold 150,000
shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with a par value of U.S.$0.00005
per share of the Company for US$150.0 million, equivalent to R$821.8 million, on the issuance date. The Series A perpetual convertible
preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend rights or rights upon liquidation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Each Series A perpetual convertible preferred share is
entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into the Company&#8217;s Class A common
shares at an initial conversion price of US$25.35. The Company may require the conversion of any or all of the Series A perpetual convertible
preferred shares at any time on or after the three-year anniversary of the original issuance date if certain conditions set forth in the
certificate of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s stock price is equal or above 150%
of the conversion rate). The Company may also redeem any or all of the Series A perpetual convertible preferred shares for cash, shares
of its common shares or a combination thereof at its election, at any time on or after the seven-year anniversary of the original issuance
date as determined in the certificate of designation. On or after the five-year anniversary of the original issuance date, the holders
of the Series A perpetual convertible preferred shares shall have the right to redeem all of the outstanding Series A perpetual convertible
preferred shares for cash, the Company&#8217;s common shares or a combination thereof (at the Company&#8217;s election, subject to certain
conditions) to be determined in the certificate of designation. Upon the occurrence of a change of control, the holders will have the
right to redeem their Series A perpetual convertible preferred shares for cash at a price set forth in the certificate of designation.
The Series A perpetual convertible preferred shares will be entitled to the same voting rights as the common shares only when converted
into common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Company determined that the Series A perpetual convertible
preferred shares should be classified as a financial liability at amortized cost upon their issuance since they are redeemable primarily
according to the decision of the holder and there is a contractual obligation to deliver assets (cash, common shares or a combination
thereof) that could not be avoided by the Company in an event of redemption. The financial liability is denominated in Brazilian <i>Reais</i>
and thus not subject to foreign exchange changes. The initial transaction costs that are directly attributable to the issuance of Series
A perpetual convertible preferred shares were measured at fair value together with the financial liability on initial measurement. The
transaction costs totaled R$13.0 million, including legal counsels and advisors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For further information on our loans and financing, see
note 13.2.1 to the audited consolidated financial statements, included elsewhere in this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 18pt"><i>Share Buyback Program </i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For further information on our share buyback
program, see note 17 (e) to the audited consolidated financial statements, included elsewhere in this annual report, Exhibit 2.1,
&#8220;Description of Securities Registered Under</p>


<!-- Field: Page; Sequence: 121 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->116<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 10pt">Section 12 of the Exchange Act - Share Repurchases&#8221; and &#8220;Item
16E. Purchases Of Equity Securities By The Issuer And Affiliated Purchasers&#8221;.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Tabular Disclosure of Contractual Obligations</i></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is a summary of our contractual obligations,
based on contractual undiscounted amounts, as of December 31, 2021:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Payments
    Due by Period as of December 31, 2021</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 45%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Total</p></td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Less than<br />
    1 year</p></td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">1 &#8211;
    3 years</p></td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">3 &#8211;
    5 years</p></td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">More than<br />
    5 years</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="5" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Trade payables&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">59.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">59.1</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Loans and financing (1)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,753.3</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">217.9</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">585.7</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">948.5</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1.2</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Lease liabilities&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,628.2</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">103.0</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">211.9</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">204.7</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">1,108.6</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Accounts payable to selling shareholders&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">780.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">246.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">445.1</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">89.0</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Notes payable&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">89.9</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">15.6</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">74.3</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Advances from customers&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">114.6</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">114.6</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Total</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>4,425.2</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>756.3</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,317.0</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,242.2</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>1,109.8</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Loans and financing includes the obligations related to our Series A perpetual convertible preferred shares discussed in note 13.2.1(f)
to our audited consolidated financial statements included elsewhere in this annual report.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Future cash needs in the&#160;short and long term will
be funded by our operating cash flow and from proceeds raised in the debt or equital capital markets.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021 we did not have any off-balance
sheet arrangements.</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"><span style="background-color: White">Principal Capital Expenditures<span style="font-size: 8pt; font-weight: normal">&#160;</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">We made
capital expenditures (consisting of purchase of property and equipment and intangible assets) of R$276.8 million, R$137.6 million and
R$121.7 million in 2021, 2020 and 2019, respectively. During these years, our capital expenditures mainly included expenditures related
to the expansion and maintenance of our campuses and headquarters including leasehold improvements, the integration of our acquisitions,
the implementation of our shared services center, and the development of the project that led to the certification of seven new greenfield
medical schools as part of the &#8220;<i>Mais M&#233;dicos</i>&#8221; program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><span style="background-color: White">For
2022, we have budgeted capital expenditures of R$293.5 million, mostly to support the growth in our business and operations. We expect
to meet our capital expenditure needs for the foreseeable future from our operating cash flow and our existing cash and cash equivalents.
Our future capital requirements may be adjusted from time to time as they depend on several factors, including our growth rate, the expansion
of our research and development efforts, employee headcount, marketing and sales activities, the introduction of new features to our
existing products, the continued market acceptance of our products, and any impact on our business of the COVID-19 pandemic and measures
taken in response. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Public
health outbreaks, epidemics or pandemics, such as the COVID-19 pandemic, have adversely affected and may continue to adversely affect
our business.&#8221;</span></p>



<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f019"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Research and Development,
Patents and Licenses</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of the date of this annual report, we had no issued
patents and one patent application pending in Brazil. We are party to 281 agreements, with third-party authors with respect to educational
content. We own 157 trademark registrations. As of December 31, 2021, we owned 154 registered domain names in Brazil. We also have 31
pending trademark applications in Brazil as of the date of this annual report and unregistered trademarks that we use to promote our brand.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;Item 4. Information on the Company&#8212;D.
Property, plant and equipment&#8212;Technology and Intellectual Property.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f020"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Trend Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 11, 2020, the World Health Organization declared
COVID-19 a pandemic, and on March 20, 2020 the Brazilian federal government declared a national emergency with respect to COVID-19. The
impact on our operations still is highly uncertain and cannot be predicted with confidence. The spread of COVID-19, or actions taken to
mitigate this spread, could have material and adverse effects on our ability to operate effectively, including as a result of the complete
or partial closure of facilities or labor shortages. The extent of the adverse impact on our operations, including, among others, the
regular functioning of our facilities, will depend on the extent and severity of the continued spread of the coronavirus in Brazil. Since
March 17, 2020, there has been an interruption of our on-campus activities in light of authorities imposed lockdowns, with a significant
portion of our non-practical educational activities being temporarily offered through our online platform (rather than on-site) and the
calendar of our practical educational activities being rescheduled to when authorities allow on-campus activities to resume. By the date
of issuance of this annual report, all of the lockdown restrictions have been revoked by Brazilian authorities in our campus locations
and we have also successfully resumed all of our practical classes in medicines courses and all of our classroom classes.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For further information &#8220;Item 3. Key Information&#8212;D.
Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Public health outbreaks, epidemics or pandemics, such as
the COVID-19 pandemic, have adversely affected and may continue to adversely affect our business.&#8221;</p>


<!-- Field: Page; Sequence: 122 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->117<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Other than as disclosed elsewhere in this annual report,
we are not aware of any other trends, uncertainties, demands, commitments or events for the year ended December 31, 2021 that are reasonably
likely to have a material and adverse effect on our net revenues, income, profitability, liquidity or capital resources, or that would
cause the disclosed financial information to be not necessarily indicative of future results of operations or financial conditions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f021"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Critical Accounting Estimates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f022"></span>ITEM 6. DIRECTORS, SENIOR MANAGEMENT AND EMPLOYEES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f023"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Directors and Senior Management</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are managed by our board of directors and by our senior
management, pursuant to our Memorandum and Articles of Association and the Cayman Islands Companies Act (as revised).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Board of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our board of directors is currently composed of 11 members.
Each of our director shall hold office for a two (2) year term and are eligible for re-election. Under our Amended and Restated Memorandum
and Articles of Association: (i) Bertelsmann, for so long as it holds a number of our Class B common shares in excess of 10% of the total
number of outstanding Class B common shares (referred to herein as the &#8220;Ownership Threshold&#8221;), shall be entitled to appoint,
at its sole discretion, up to three (3) of our directors, and shall be entitled at any time to remove, substitute or replace any of its
appointed directors for any reason in its sole discretion; (ii) the Esteves Family, for so long as it holds our Class B common shares
in excess of the Ownership Threshold, shall be entitled to appoint, at its sole discretion, up to three (3) of our directors, and shall
be entitled at any time to remove, substitute or replace any of its appointed directors for any reason in its sole discretion; and (iii)
Bertelsmann and the Esteves Family, for so long as they hold our Class B common shares in excess of the Ownership Threshold shall be entitled
to jointly appoint, at their sole discretion, up to one (1) director and shall be entitled at any time to remove, substitute or replace
their appointed director for any reason in their sole discretion. Directors appointed by the board of directors hold office until the
next annual general meeting. Our directors do not have a retirement age requirement under our Articles of Association. Subject to the
foregoing, the directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table lists the current members of our
board of directors:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 81%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: left">Name</p></td>
    <td style="text-align: center; padding-right: 5pt; width: 6%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Age</p></td>
    <td style="padding-right: 5pt; width: 13%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Nicolau Carvalho Esteves&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">69</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Chairman</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Renato Tavares Esteves&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">34</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">S&#233;rgio Mendes Botrel Coutinho&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">43</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Kay Krafft&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">51</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Shobhna Mohn&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">57</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Daulins R&#234;ni Em&#237;lio&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">48</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Maria Tereza Azevedo&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">40</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Vanessa Claro Lopes&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">46</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Fl&#225;vio Dias&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">45</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Independent Director</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Jo&#227;o Paulo Seibel de Faria&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">46</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Independent Director*</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Miguel Filisbino Pereira de Paula&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: center; padding-left: 3pt">60</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Independent Director*</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">*</td><td>Member of our Audit Committee.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is a brief summary of the business experience
of our directors. Unless otherwise indicated, the current business addresses for our directors is Alameda Oscar Niemeyer, No. 119, rooms
502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Nicolau Carvalho Esteves.</i> Nicolau Carvalho Esteves
is the Chairman of our board of directors, a position he has held since July 2019. He is a qualified orthopedist and has over 25 years
of experience in the education industry.</p>


<!-- Field: Page; Sequence: 123 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->118<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">He was the Chairman of the board of directors of Afya Brazil from August
2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He is the founding shareholder of the following companies,
for which he served as Chief Executive Officer for the periods indicated (i)&#160;<i>ITPAC&#8212;Instituto Tocantinense Presidente Ant&#244;nio
Carlos S.A.</i> (1999-2016); (ii)&#160;<i>ITPAC Porto Nacional&#8212;Instituto Tocantinense Presidente Ant&#244;nio Carlos Porto S.A.</i>
(2008-2016); (iii)&#160;<i>IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A.</i> (2003-2016) and (iv)&#160;<i>Instituto
de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A.</i> (2016-2018). He holds a Medicine degree from <i>Faculdade de Medicina
de Barbacena,</i> a master&#8217;s degree in Business Administration from FGV, a master&#8217;s degree in Corporate Finance from <i>Funda&#231;&#227;o
Dom Cabral,</i> a master&#8217;s degree in Business Administration from FEAD and a Business Administration degree from AIEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Renato Tavares Esteves.</i> Renato Tavares Esteves
is a member of our board of directors, a position he has held since July 2019. He was a member of the board of directors of Afya Brazil
from August 2016 to December 2019, when the board of directors of Afya Brazil was extinguished. He served as executive officer of the
following companies: <i>Instituto de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A., UNIVA&#199;O&#8212;Uni&#227;o
Educacional do Vale do A&#231;o S.A., IPTAN&#8212;Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A., ITPAC&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos S.A.,</i> and <i>Instituto de Ensino Superior do Piau&#237; S.A.&#8212;IESP. </i>He holds
a degree in medicine from Faculdade de Medicina de Barbacena, and a master&#8217;s degree in Business Administration and Corporate Finance
from FGV.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>S&#233;rgio Mendes Botrel Coutinho.</i> S&#233;rgio
Mendes Botrel Coutinho is a member of our board of directors, a position he has held since July 2019. He is a managing partner at Arien
Invest, a private equity firm. Before joining Arien Invest, he was a partner at An&#225;lise Estrat&#233;gica, responsible for its
M&amp;A Advisory and Strategic Consultancy division, and was also a partner at Gabrich &amp; Botrel Advogados, advising on corporate law,
corporate governance and mergers and acquisitions. He holds a law degree from FUMEC, a master&#8217;s degree in Corporate Law from <i>Faculdade
de Direito Milton Campos</i> and a doctorate in Corporate Law from PUC/MG. He was an MBA Professor at IBMEC (2009-2017) and is an LLM
Professor at IBMEC.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Kay Krafft. </i>Kay Krafft is a member of our board
of directors, a position he has held since August 2021. He is the founding CEO of Bertelsmann Education Group. Until 2014, he was Chief
Investment Officer of music rights management company BMG, building up the company from a start-up to a major player in the music industry
through acquisitions as well as the establishment of an international presence. Before joining BMG&#8217;s Executive Board, he served
as EVP and global head of M&amp;A at Bertelsmann while implementing major portfolio adjustments during this time. Prior to joining Bertelsmann,
Kay Krafft was a partner at professional services firm Deloitte.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Shobhna Mohn. </i>Shobhna Mohn is a
member of our board of directors, a position she has held since August 2021. She is Chief Strategy Officer at Bertelsmann Investments.
Currently, Shobhna is responsible for the strategic design and execution of Bertelsmann&#8217;s global VC investment funds in China, India,
Brazil, US/Europe as well as investments in Africa and Southeast Asia. Her focus is on governance, insights, knowledge exchange, identification
and steering of long-term strategic holdings. Main target areas of focus are on growth platforms such as e-commerce services, fintech,
logistics, education and health. As a member of the Investment Committees that evaluate and approve Bertelsmann&#8217;s VC investment
targets, she has played a key role in the VC investments of over Euro 1.4 billion since 2006 in more than 380 Investments with a current
global portfolio of 270 investments. Shobhna is a member of the Bertelsmann Group Management Committee since 2019. She has been at Bertelsmann
since 1996 in various roles including Growth Regions Strategy, Investor Relations, and Venture Capital. She holds Bachelor's (B.A.) and
Master's degrees (both M.A. and M.Phil) in Mathematics from the Delhi University in India, and a M.Phil degree in Operations Research/Management
Science from Columbia Business School in New York, USA.</p>

<p style="font: 10pt Times New Roman,serif; text-indent: 18pt; margin-right: 0; margin-left: 0"><i>Daulins R&#234;ni Em&#237;lio. </i>Daulins
R&#234;ni Em&#237;lio is a member of our board of directors, a position he has held since August 2019. Mr. Emilio is a Managing Director
at Bertelsmann Brazil Investments (BBI) and Head of the Bertelsmann Corporate Center in Brazil, a subsidiary of Bertelsmann SE &amp; Co.
KGaA, a relevant investor in education in the world. Mr. Emilio joined Bertelsmann in 2012, where he has been responsible for Bertelsmann&#8217;s
strategy for new businesses in Brazil as well as for finding business opportunities in the Education sector. He is also the Chairman of
the Board at Afferolab and a board member at Companhia das Letras and Intervalor. Before working at Bertelsmann, he was a consultant working
across multiple industries during his tenures at Boston Consulting Group, McKinsey &amp; Co. and Arthur Andersen. Mr. Emilio holds a bachelor&#8217;s
degree in Mechanical Engineering from Unicamp, a master&#8217;s degree in Economics from USP, and a Ph.D. in Economics from Boston</p>


<!-- Field: Page; Sequence: 124 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->119<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin-right: 0pt; margin-left: 0pt">University. During his Ph.D. at Boston University, his research
focused on Economics of Education and Economic Theory.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Maria Tereza Azevedo</i>. Maria Tereza Azevedo is
a member of our board of directors, a position she has held since April 2022. She joined Softbank LatAm fund in 2021 as Investment Director
leading the Education industry. Prior to joining Softbank, she was an Executive Director at Santander and Director at UBS Investment Bank
leading the TMT strategy and LatAm Education and the Technology, Media, and Telecommunications teams, respectively. She has extensive
experience in helping LatAm companies access the equity capital markets and holds a master&#8217;s degree in Corporate Finance and a bachelor&#8217;s
degree in Economics Science from IBMEC. Maria Tereza also serves as a board member of Descomplica and UOL EdTech.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Vanessa Claro Lopes.</i> Vanessa Claro Lopes is a
member of our board of directors and an independent member of our audit and ethics committee, positions she has held since July 2019.
She is currently an independent member of the board of directors of Lojas Americanas S.A., member of the fiscal councils of Cosan S.A.,
Cosan Log&#237;stica SA and Comgas S.A., the chairperson of the audit committee at Tegma Logistica S.A., a member of the audit committee
at Embraer S.A. and Lojas Americanas S.A. She was formerly the chairperson of the fiscal council of Via Varejo S.A. from 2014 to 2018,
a member of the fiscal council of Terra Santa Agro S.A. from 2016 to 2018, a member of the fiscal council of Gerdau S.A from 2016 to 2017
and a member of the fiscal councils of Est&#225;cio Participa&#231;&#245;es S.A. and Renova Energia S.A. from 2017 to 2019. With
over 25 years&#8217; experience in corporate governance and internal and external audits of large private and listed companies, she started
her career in 1995 at PricewaterhouseCoopers in advisory services and was responsible for the creation of the revenue assurance specialists
department in Brazil for the telecoms sector. She was an executive officer and the head of the internal accounting department of TAM S.A.
from 2010 to 2014, an executive officer and the head of the internal accounting department of Globex Utilidades S.A. (Grupo P&#227;o
de A&#231;&#250;car) from 2004 to 2010 and a coordinator and the head of the accounting department of Grupo Telefonica from 2000 to
2004. She holds an MBA from EAESP/FGV, a master&#8217;s degree in management systems from Universidade Federal Fluminense (UFF), a master&#8217;s
degree in computer networks from S&#227;o Judas University, an accounting degree from Universidade Federal Fluminense (UFF) and a systems
analysis degree from FATEC/BS. She was formerly a professor of audit systems and information security at Objetivo University from 1997
to 1998.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Fl&#225;vio Dias. </i>Fl&#225;vio Dias is an independent
member of our board of directors, a position he has held since July 2020. Mr. Dias has 20 years&#8217; experience in the Brazilian retail
sector, having been the executive in charge in three of the five top e-commerce companies in Brazil, including Walmart.com, Cnova and
Via Varejo. Outside the retail sector, Mr. Dias played a key role in the conception and construction of the first digital bank in Brazil,
Banco Original. In recent years, he has become a professional investor and advisor in the tech startups ecosystem. Mr. Dias has been acting
as advisor and board member for large corporations in a variety of sectors. Currently, he is the partner of 500 Startups in Brazil, in
charge of building and growing the fund operations in the country.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Jo&#227;o Paulo Seibel de Faria. </i>Jo&#227;o
Paulo Seibel de Faria is a member of our board of directors and an independent member of our audit and ethics committee, positions he
has held since August 2020. He is currently the CFO of OLX, a position he has held since August 26, 2020. He has more than 25 years of
experience in companies like Arthur Andersen S/C, Ericsson Telecomunica&#231;&#245;es and Microsoft. He spent 18 years at Microsoft
in different leadership roles in Latin America and the U.S. in sales, marketing and in finance, including his last role as chief financial
officer in Brazil. Since October 2019, he has been working as Latin America chief financial officer for Didi Chuxing (China Giant Mobility
Company that owns 99 Tecnologia in Brazil). Mr. Faria holds a bachelor&#8217;s degree in business management from FAAP and an Executive
MBA from IBMEC Business School (both in S&#227;o Paulo). Additionally he holds several executive sessions in leadership, strategy and
global business environment from Funda&#231;&#227;o Dom Cabral, INSEAD and Devry.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Miguel Filisbino Pereira de Paula</i>. Miguel Filisbino
Pereira de Paula is a member of our board of directors and an independent member of our audit and ethics committee, positions he has held
since August 2020. He has more than 35 years of experience in human resources in the Brazilian corporate world, holding positions such
as senior HR director of Grupo P&#227;o de A&#231;ucar, HR vice president of Est&#225;cio Participa&#231;&#245;es, head of organization
development at Votorantim Cimentos and HR of Grupo Gerdau. He holds an MBA degree from USP and a post-grad degree in HR from PUCRS.</p>


<!-- Field: Page; Sequence: 125 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->120<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Executive Officers</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our executive officers are responsible for the management
and representation of our company. We have a strong centralized team led by Virgilio Deloy Capobianco Gibbon, our CEO, with broad experience
in the education industry.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table lists our current executive officers.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 71%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Name</p></td>
    <td style="padding-right: 5pt; width: 6%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Age</p></td>
    <td style="padding-right: 5pt; width: 23%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Position</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Virgilio Deloy Capobianco Gibbon&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">47</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Chief Executive Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Luis Andr&#233; Carpintero Blanco&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">48</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Chief Financial Officer</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">L&#233;lio de Souza Junior&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">48</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Vice President of Innovation &amp; Digital Services</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is a brief summary of the business experience
of our executive officers. Unless otherwise indicated, the current business addresses for our executive officers is Alameda Oscar Niemeyer,
No 119, rooms 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas Gerais, Brazil.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Virgilio Deloy Capobianco Gibbon.</i> Virgilio Deloy
Capobianco Gibbon is our Chief Executive Officer, a position he has held since July 2019. He has been the Chief Executive Officer of Afya
Brazil since August 2016. Prior to joining us, he was Chief Operating Officer and Chief Financial Officer of Est&#225;cio Participa&#231;&#227;o
S.A., from March 2010 to March 2012, and March 2012 to June 2016, respectively. He was also Executive Director of Business Consulting
and Education Industry at TOTVS Consulting from October 2007 to December 2009, and Senior Manager of Business Consulting at Accenture
from 2000 to 2007. He holds a degree in economics from PUC-RJ. He is currently a board member of EABH&#8212;Escola Americana of Belo Horizonte.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>Luis Andr&#233; Blanco.</i> Luis Andr&#233; Blanco
is our Chief Financial Officer, a position he has held since April 2020. Prior to joining us, he served as CFO for OdontoPrev for 10 years,
where he oversaw corporate finance &#8211; treasury, financial planning, M&amp;A, tax and accounting operations, legal and compliance.
Prior to that, Luis served as a Financial Officer at Vivo S.A from 2003 to 2009 and also as CFO at <i>Tele Centro &#8211; Oeste Celular
Participa&#231;&#245;es</i> from 2000 to 2003. Luis holds a bachelor&#8217;s degree in engineering from the Federal University of
Rio de Janeiro and an executive program degree from University of Westminster, London, England.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><i>L&#233;lio de Souza Junior.</i> L&#233;lio de
Souza Junior is our Vice President of Innovation &amp; Digital Services, a position he has held since January 2022. Prior to joining us,
he served as CEO for Intelie for 5 years, where he had the chance to support the internationalization of the company, the acquisition
process by RigNet (later on acquired by Viasat, NASDAQ: VSAT) and to experience a very well succeeded growth history. Prior to that, Lelio
served as a Corporate Officer at TOTVS from 2008 &#8211; 2016 and also as Senior Manager in Accenture from 2000-2008. Lelio holds a bachelor&#8217;s
degree in Mechanical Engineering from the Federal University of Minas Gerais (UFMG) and executive programs degrees from University of
Wharton, Pennsylvania, USA and Insper, S&#227;o Paulo, Brazil.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Family Relationships</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Nicolau Carvalho Esteves, the chairman of our board of
directors, is the father of Renato Tavares Esteves, one of our directors.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Legal Proceedings</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">In 2016, the federal prosecutors&#8217; office filed a public civil proceeding
against Mr. Nicolau Carvalho Esteves, our chairman and one of our controlling shareholders, and certain other individuals, for irregular
administrative acts alleged to have taken place during each of their respective terms as Health Secretary of the State of Tocantins <i>(Secret&#225;rio
de Sa&#250;de do Estado de Tocantins)</i> between 2012 and 2014, a position held by Mr. Carvalho Esteves for a period of four months,
from March 9, 2012 to July 20, 2012. The prosecution alleges that Mr. Carvalho Esteves and the other individuals did not apply federal
funds in compliance with mandatory budgeting rules required by applicable federal statutes. On September 19, 2017, the lower court dismissed
the federal prosecutor&#8217;s claims on the basis that the alleged improper acts were carried out to allow the public healthcare system
in the State of Tocantins to continue to provide basic healthcare services, given there were insufficient public funds allocated for that
purpose at the time. The federal prosecutor&#8217;s office appealed the lower court&#8217;s decision and on October 30, 2018, the federal
court of appeals granted the appeal to overturn the lower court&#8217;s decision and to nullify the evidentiary phase of the</p>


<!-- Field: Page; Sequence: 126 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->121<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">proceedings on the procedural technicality that the State of Tocantins had not
been properly notified of its right to file its motion on evidence. On May 3, 2019, Mr. Carvalho Esteves filed an appeal of the federal
court of appeals decision with the Supreme Court of Justice In February 2022, a decision was issued, dismissing the motions submited by
the Public Prosecutor Office, to date no appeal has been filed by the referred entity. The court suit is classified as remote by the office.
If Mr. Carvalho Esteves is found liable, he may be subject to penalties, including a three-year prohibition on him or any legal entity
under his control transacting with public entities or being granted tax incentives/benefits, including Afya.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f024"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Compensation</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under Cayman Islands law, we are not required to disclose
compensation paid to our senior management on an individual basis and we have not otherwise publicly disclosed this information elsewhere.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our executive officers, directors and management receive
fixed and variable compensation. They also receive benefits in line with market practice in Brazil. The fixed component of their compensation
is set on market terms and adjusted annually.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The variable component consists of cash bonuses and awards
of shares (or the cash equivalent). Cash bonuses or paid to executive officers and members of our management based on previously agreed
targets for the business. Shares (or the cash equivalent) are awarded under our share options long-term incentive program, as discussed
below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth the fixed and variable
compensation of our key management personnel for the periods indicated:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; width: 67%; text-align: center; padding-left: 3pt">&#160;</td>
    <td style="padding-right: 5pt; text-align: right; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2019</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">&#160;</td>
    <td colspan="3" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">(in R$ millions)</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt">Short-term employee benefits&#9;</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">11.9</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">9.6</td>
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">4.9</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">Share-based compensation plans&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">20.3</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">24.0</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">13.9</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt"><b>Total compensation</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>32.2</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>33.6</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: bottom; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>18.8</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Afya Brazil Long-Term Incentive Plan</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Certain members of our management participated in the
share option long-term incentive program, or the LTIP, of Afya Brazil. Beneficiaries under the LTIP were granted rights to buy shares
based on certain criteria. All unvested share options were automatically vested upon the consummation of our initial public offering,
and the LTIP was terminated on January 10, 2020.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">New Long-Term Incentive Plan</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On August 30, 2019, our board of directors approved the
establishment of the new equity incentive plan, or the New LTIP, as amended on July 29, 2020, with the purpose of advancing the interests
of our shareholders by enhancing our ability to attract, retain and motivate individuals to perform at the highest level.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The New LTIP and the applicable option agreement to be
entered into between us and the beneficiary, or the Option Agreement, governs the issuance of equity incentive awards with respect to
our Class A common shares, or the Options. The calculation of the strike price of the Option will be set forth in the applicable Option
Agreement, as approved by the board of directors, upon the granting of the Option to the beneficiary. If a beneficiary is dismissed by
us, resigns, retires or dies, the portion of his or her Options under the New LTIP that has vested at that date will be satisfied, but
the non-vested portion will be canceled. If a beneficiary is terminated for cause, all of his or her Options under the New LTIP will be
canceled. The maximum aggregate number of shares that can be issued to beneficiaries under the New LTIP may not exceed 4% of our share
capital at any time. As of December 31, 2021, a total of 3,086,728 options are outstanding under the New LTIP. For further information
about vesting periods and strike price, see note 16.b to our audited consolidated financial statements.</p>


<!-- Field: Page; Sequence: 127 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->122<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f025"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Board Practices</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Duties of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a matter of Cayman Islands law, a director of a Cayman
Islands company is considered a fiduciary of the company. Accordingly, directors owe fiduciary duties to their companies to act in accordance
with the best interests of the company, to exercise their powers for the purposes for which they are conferred and not to place themselves
in a position where there is a conflict between their personal interests and their duty to the company. Accordingly, a director owes a
company a duty not to make a profit based on his or her position as director (unless the company permits him or her to do so) and a duty
not to put himself or herself in a position where the interests of the company conflict with his or her personal interests or his or her
duties to a third party.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">However, a company&#8217;s articles of association may
permit a director to vote on a matter in which he or she has a personal interest if he or she has disclosed the nature of his or her interest
to the board of directors. Our Articles of Association provide that a director must disclose the nature and extent of any material interests
in any contract or arrangement, and that he or she may vote at any meeting on any resolution concerning an interested matter, provided
he or she has disclosed the nature of his or her interest.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A director of a Cayman Islands company also owes to the
company duties to exercise independent judgment in carrying out his or her functions and to exercise reasonable skill, care and diligence,
which has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise the care, skill
and diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience reasonably to
be expected of a person acting as a director. Additionally, a director must exercise the knowledge, skill and experience that he or she
actually possesses.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Election and Terms of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;Item 10. Additional Information.&#8212;B.
Memorandum and Articles of Association&#8212;Appointment, Disqualification and Removal of Directors.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Board Committees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our board of directors has established an (i)&#160;audit,
risks and ethics committee; (ii)&#160;compensation committee; and (iii)&#160;a business expansion committee. In the future, our board
of directors may establish other committees, as it deems appropriate, to assist with its responsibilities.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Audit, Risks and Ethics Committee</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The audit, risks and ethics committee, or the audit committee,
which consists of Vanessa Claro Lopes (elected to the committee on July 8, 2019), Jo&#227;o Paulo Seibel de Faria (elected to the committee
on August 26, 2020) and Miguel Filisbino Pereira de Paula (elected to the committee on August 26, 2020), assists our board of directors
in overseeing our accounting and financial reporting processes and the audits of our financial statements. In addition, the audit committee
is directly responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting
firm. Vanessa Claro Lopes serves as chairman of the audit committee. The audit committee consists exclusively of members of our supervisory
board who are financially literate, and Vanessa Claro Lopes is considered an &#8220;audit committee financial expert&#8221; as defined
by the SEC. Our board of directors has determined that Vanessa Claro Lopes, Jo&#227;o Paulo Seibel de Faria and Miguel Filisbino Pereira
de Paula satisfy the &#8220;independence&#8221; requirements set forth in Rule 10A-3 under the Exchange Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 29, 2021, our board of directors approved
the audit committee charter. The audit committee complies with applicable SEC and Nasdaq rules. Notwithstanding anything to the contrary
established in the audit committee charter, the audit committee is responsible for, among other things:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the appointment, compensation, retention and oversight of any auditor or accounting firm engaged for the purpose of preparing or issuing
an audit report or performing other audit, review or attest services;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>pre-approval of the audit services and non-audit services to be provided by our independent auditor before the auditor is engaged
to render such services;</td></tr></table>


<!-- Field: Page; Sequence: 128 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->123<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>review and discussions with the independent auditor its responsibilities under generally accepted auditing standards, the planned
scope and timing of the independent auditor&#8217;s annual audit plan(s) and significant findings from the audit;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>obtaining and review of a report from the independent auditor describing all relationships between the independent auditor and the
Company consistent with the applicable PCAOB requirements regarding the independent auditor&#8217;s communications with the audit committee
concerning independence;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>confirming and evaluating the rotation of the audit partners on the audit engagement team as required by law;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>review with management and the independent auditor, in separate meetings whenever the audit committee deems appropriate, any analyses
or other written communications prepared by the management and/or the independent auditor setting forth significant financial reporting
issues and judgments made in connection with the preparation of the financial statements, including analyses of the effects of alternative
IFRS methods on the financial statements; and other critical accounting policies and practices of the Company;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>review, in conjunction with the Chief Executive Officer and Chief Financial Officer of the Company, the Company&#8217;s disclosure
controls and procedures and internal control over financial reporting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>establishing procedures for the receipt, retention and treatment of complaints received by the Company regarding accounting, internal
accounting controls or auditing matters, and the confidential, anonymous submission by employees of the Company of concerns regarding
questionable accounting or auditing matters; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>approving or ratifying any related person transaction (as defined in our related person transaction policy) in accordance with our
related person transaction policy.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The audit committee meets as often as it determines is
appropriate to carry out its responsibilities, but in any event, pursuant to its charter, the audit committee ordinarily meets at least
six times per year.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Information contained on our website shall not constitute,
or be deemed incorporated as, a part of this annual report.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, our audit committee monitors ongoing compliance
with our code of ethics and related compliance policies.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>People and ESG Committee</i></b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Since our initial public offering, we have established
a compensation committee. The compensation committee, which consists of Rafael Munerato de Almeida, Renato Tavares Esteves and Miguel
Filisbino Pereira de Paula, assists our board of directors in reviewing and approving the compensation structure, including all forms
of compensation, relating to our directors and executive officers. On January 29, 2021, our board of directors approved the compensation
committee charter and included the responsibility for the committee to indicate and recommend for board approval the appointment of our
independent directors, directors and executive officer. On May 26, 2021 our board of directors approved the amendment of the internal
bylaws of the compensation committee to change its name to People and ESG Committee and also to include strategical sustainability matters
and approve reports, adhere to national and/or international protocols, agreements, principles or treaties to be discussed and recommended
by the committee. Notwithstanding anything to the contrary established in the audit committee charter, the committee also reviews the
total compensation package for our executive officers and directors and recommends to the board of directors for determination the compensation
of each of our directors and executive officers, and will periodically review and approve any long-term incentive compensation or equity
plans, programs or similar arrangements, annual bonuses and employee pension and benefits plans. As permitted by the listing requirements
of Nasdaq, we have opted out of Nasdaq Listing Rule 5605(d), which requires that a compensation committee consist entirely of independent
directors. On August 25, 2021, the Board of Directors appointed Mr. Kay Krafft as a member of the People and ESG Committee.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt"><b><i>Business Expansion Committee</i></b></p>


<!-- Field: Page; Sequence: 129 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->124<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The business expansion committee, which consists of S&#233;rgio
Mendes Botrel Coutinho, Renato Esteves and Daulins R&#234;ni Em&#237;lio, assists our board of directors to evaluate potential acquisition
opportunities and new business opportunities, and makes recommendations to our board of directors as to whether we should pursue them.
On January 29, 2021, our board of directors approved the business expansion committee charter. On August 25, 2021 the Board of Directors
appointed Mr. Daulins R&#234;ni Em&#237;lio as leader member of the business expansion committee.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f026"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Employees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had 8,079 employees, 6.7%
of which were based in our offices in Nova Lima and 93.3% of which were based in other cities elsewhere in Brazil. We also engage temporary
employees and consultants as needed to support our operations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had 281 medical content creators,
who are responsible for developing our learning materials (including media, podcasts, quizzes, classes, among others), including 212 physician
professors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The table below breaks down our full-time personnel by
function as of December 31, 2021:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 78%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Function</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Number of
    Employees</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">% of Total</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">Management&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">65</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">0.8%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">Shared Services Center and IT, Sales and Marketing&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">557</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">6.9%</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">Faculties&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">2,986</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 3pt">37.0%</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">General and Administrative&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">4,471</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">55.3%</p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; font-family: Times New Roman,serif; padding-left: 3pt"><b>Total</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>8,079</b></p></td>
    <td style="padding-right: 5pt; text-align: right; padding-left: 3pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>100.0%</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our employees in Brazil are represented by the labor
unions of independent sales agents and of consulting, information, research and accounting firms for the geographic area in which they
render services. We believe we have a constructive relationship with these unions, as we have never experienced strikes, work stoppages
or disputes leading to any form of downtime.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f027"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Ownership</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For information regarding the share ownership of our
directors and senior management, see &#8220;Item 7. Major Shareholders and Related Party Transactions&#8212;A. Major Shareholders.&#8221;
For information as to stock options granted to our directors, executive officers and other employees, see &#8220;Item 6. Directors, Senior
Management and Employees&#8212;B. Compensation&#8212;Afya Brazil Long-Term Incentive Plan&#8221; and &#8220;Item 6. Directors, Senior
Management and Employees&#8212;B. Compensation&#8212;New Long-Term Incentive Plan.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f028"></span>ITEM 7. MAJOR SHAREHOLDERS AND RELATED PARTY TRANSACTIONS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f029"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Major Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table and accompanying footnotes presents
information relating to the beneficial ownership of our Class A common shares, our Class B common shares, and our Series A perpetual convertible
preferred shares as of April 22, 2022:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>each person or group of affiliated persons, known by us to own beneficially 5% or more of our outstanding shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>each of our executive officers and directors individually; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>all executive officers and directors as a group.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The number of common shares beneficially owned by each
entity, person, executive officer or director is determined in accordance with the rules of the SEC, and the information is not necessarily
indicative of beneficial ownership for any other purpose. Under such rules, beneficial ownership includes any shares over which the individual
has sole or shared voting power or investment power as well as any shares that the individual has the right to acquire within 60 days
through the exercise of any option, warrant or other right. Except as otherwise indicated, and subject to applicable community property laws, the persons named in
the table have sole voting and investment power with respect to all common shares held by that person.</p>


<!-- Field: Page; Sequence: 130 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->125<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Unless otherwise indicated below, the business address
for each beneficial owner is c/o Afya, Alameda Oscar Niemeyer, No. 119, rooms 502, 504, 1,501 and 1,503, Vila da Serra, Nova Lima, Minas
Gerais, Brazil.</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 7pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="6" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares
Beneficially Owned</p></td>
    <td rowspan="3" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">% of Total
    Voting Power(1)</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 7pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Common Shares</p></td>
    <td colspan="2" style="padding-right: 5pt; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Preferred
    Shares</p></td></tr>
  <tr>
    <td style="font: bold 7pt/9pt Times New Roman,serif; vertical-align: bottom; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Class A</p></td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: bottom; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Class B</p></td>
    <td colspan="2" style="padding-right: 5pt; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Series A</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="width: 43%">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shareholders</p></td>
    <td style="padding-right: 5pt; width: 10%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Shares</p></td>
    <td style="padding-right: 5pt; width: 7%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td>
    <td style="padding-right: 5pt; width: 7%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">%</p></td></tr>
  <tr>
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt"><b>5% Shareholders party to our shareholders&#8217; agreements</b></span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Bertelsmann SE &amp; Co. KGaA (2)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">29,074,134</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">63.5%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">57.9%</span></td></tr>
  <tr style="background-color: White">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt">Nicolau Carvalho Esteves (3)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt">Ros&#226;ngela de Oliveira Tavares Esteves&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="background-color: White">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt">NRE Capital Ventures Limited&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">16,707,489</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">36.5%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">33.2%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Renato Tavares Esteves (4)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">2,545,844</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">5.7%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.5%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Vanessa Tavares Esteves (5)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">2,479,440</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">5.6%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.5%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">L&#237;lian Tavares Esteves de Carvalho (6)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">2,533,911</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">5.7%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.5%</span></td></tr>
  <tr style="background-color: White">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt"><b>Other 5% Shareholders</b></span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Ameriprise Financial, Inc. (7)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">2,758,086</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">6.2%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.5%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Jackson Square Partners, LLC (8)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">1,897,676</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">4.3%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.4%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">AustralianSuper Pty Ltd (9)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">1,758,697</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">4.0%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.3%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Ronald Baron (10)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">4,542,496</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">10.2%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.9%</span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt">SoftBank Group Corp. (11)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">2,433,323</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">5.5%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">150,000</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">100%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.5%</span></td></tr>
  <tr style="background-color: White">
    <td style="font: 9pt Times New Roman,serif; vertical-align: bottom"><span style="font-size: 8pt"><b>Other Executive Officers and Directors (12)</b></span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; text-align: right; padding-left: 5pt">&#160;</td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 5pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Kay Krafft (13)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Shobhna Mohn (14)&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Fl&#225;vio Dias &#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Jo&#227;o Paulo Seibel de Faria&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Miguel Filisbino Pereira de Paula&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">S&#233;rgio Mendes Botrel Coutinho&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Daulins Reni Emilio&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Maria Tereza Azevedo&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Vanessa Claro Lopes&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Rafael Munerato de Almeida&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">L&#233;lio de Souza Junior&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Luis Andr&#233; Carpintero Blanco&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">39,170</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.1%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font: 9pt Times New Roman,serif"><span style="font-size: 8pt">Virg&#237;lio Deloy Capobianco Gibbon&#9;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">694,731</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">1.3%</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">&#8212;</span></td>
    <td style="font: 9pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 5pt"><span style="font-size: 8pt">0.1%</span></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Percentage of total voting power represents voting power with respect to all of our Class A common shares and Class B common shares,
as a single class. Holders of our Class B common shares are entitled to 10 votes per share, whereas holders of our Class A common shares
are entitled to one vote per share. For more information about the voting rights of our Class A common shares and Class B common shares,
see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital.&#8221;
The terms of our Series A perpetual convertible preferred shares require the approval of a majority of our Series A perpetual convertible
preferred shares voting as a separate class for us to take the following decisions, among others described in the certificate of designations:
(1) amend our organizational documents in a manner that would have an adverse effect on the Series A perpetual convertible preferred shares;
and issue securities that are senior to, or equal in priority with, the Series A perpetual convertible preferred shares; except as provided
in the the certificate of designations, our Series A perpetual convertible preferred shares otherwise are not entitled to vote.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Based on a statement by Bertelsmann SE &amp; Co. KGaA and Erste WV G&#252;tersloh GmbH (collectively, &#8220;Bertelsmann&#8221;) on
Schedule 13D filed on April 18, 2022, the date of the last available Schedule 13D filed by such person with the SEC. Such person&#8217;s
business address is at Carl-Bertelsmann-Strasse 270, 33311 G&#252;tersloh, Germany.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(3)</td><td>Mr. Nicolau Carvalho Esteves is a member of our board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(4)</td><td>Based on a statement by Renato Tavares Esteves on Schedule 13G filed on February 14, 2022, the date of the last available Schedule
13G filed by such person with the SEC. Renato Tavares Esteves is a member of our board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(5)</td><td>Based on a statement by Vanessa Tavares Esteves on Schedule 13G filed on February 14, 2022, the date of the last available Schedule
13G filed by such person with the SEC.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(6)</td><td>Based on a statement by Lilian Tavares Esteves de Carvalho on Schedule 13G filed on February 14, 2022, the date of the last available
Schedule 13G filed by such person with the SEC.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(7)</td><td>Based on a statement on Schedule 13G filed on February 14, 2022 by Ameriprise Financial, Inc., the date of the last available Schedule
13G filed by such person with the SEC. Such person&#8217;s business address is at 145 Ameriprise Financial Center, Minneapolis, MN 55474.</td></tr></table>

<!-- Field: Page; Sequence: 131 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->126<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(8)</td><td>Based on a statement on Schedule 13G filed on February 11, 2022 by Jackson Square Partners, LLC, the date of the last available Schedule
13G filed by such person with the SEC. Such person&#8217;s business address is at One Letterman Drive, Building A, Suite A3-200, San Francisco,
CA 94129.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(9)</td><td>Based on a statement on Schedule 13G filed on January 25, 2022 by AustralianSuper Pty Ltd, the date of the last available Schedule
13G filed by such person with the SEC. Such person&#8217;s business address is at Level 33, 50 Lonsdale Street, Melbourne, Victoria, 3000,
Australia.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(10)</td><td>Based on a statement on Schedule 13G filed on April 7, 2022, by BAMCO, Inc., Baron Capital Group, Inc., Baron Capital Management,
Inc., and Ronald Baron, the date of the last available Schedule 13G by such persons with the SEC. Such persons&#8217; business address
is 767 Fifth Avenue, 49th Floor, New York, NY 10153.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(11)</td><td>Based on a statement on Schedule 13G filed on May 13, 2021 by SoftBank Group Corp. the date of the last available Schedule 13G by
such person with the SEC. Such person&#8217;s business address is 1-7-1 Kaigan, Minato-ku, Tokyo 105-7537 Japan.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(12)</td><td>Disclosure regarding the equity interest held by Messrs. Nicolau Carvalho Esteves and Renato Tavares Esteves, both members of our
board of directors, in us, is above.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(13)</td><td>Mr. Kay Krafft, a member of our board of directors, is the founding CEO of Bertelsmann Education Group. Mr. Krafft disclaims beneficial
ownership of the shares held by Bertelsmann except to the extent, if any, of his pecuniary interest therein.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 4.5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(14)</td><td>Ms. Shobhna Mohn, a member of our board of directors, is the Chief Strategy Officer at Bertelsmann Investments. Ms. Mohn disclaims
beneficial ownership of the shares held by Bertelsmann except to the extent, if any, of her pecuniary interest therein.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">The holders of
our Class A common shares and Class B common shares have identical rights, except that the Esteves Family and Bertelsmann as holders of
Class B common shares (i)&#160;are entitled to 10 votes per share, whereas holders of our Class A common shares are entitled to one vote
per share, (ii)&#160;have certain conversion rights and (iii)&#160;are entitled to maintain a proportional ownership interest by purchasing
additional Class B common shares in the event that additional Class A common shares are issued. For more information see &#8220;Item 10.
Additional Information&#8212;B. </span>Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Preemptive or Similar
Rights&#8221; and &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Description of Share Capital&#8212;Conversion.&#8221;
Each Class B common share is convertible into one Class A common share.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are not aware of any other shareholder that beneficially
owns more than 5% of our common shares nor of any arrangements the operation of which may at a subsequent date result in a change of control
of the company.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Shareholders&#8217; Agreement</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 7, 2019, Crescera and the Esteves Family entered
into a shareholders&#8217; agreement, or the Original Shareholders&#8217; Agreement. The Original Shareholders&#8217; Agreement specifies
that Crescera may not transfer its shares in the Company, in whole or in part, without first offering them to Bertelsmann SE&amp; Co.
KGaA, or Bertelsmann, which will have the option to acquire such shares. If Crescera and Bertelsmann are unable to agree the sale and
purchase of the offered shares within five business days of being notified of Crescera&#8217;s proposal, Crescera can sell the shares
to a third party within specified time limits. Further, the Esteves Family is bound by a non-compete obligation preventing it from directly
or indirectly carrying on a competing business that is in direct competition with us, subject to certain limited exceptions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On June 7, 2021, in connection with the acquisition by
Bertelsmann of all Afya shares held by Crescera as of such date pursuant to a share purchase agreement also entered into on such date,
the Original Shareholders&#8217; Agreement was terminated and the Esteves Family and Bertelsmann determined to enter into an amended and
restated shareholders&#8217; agreement, or the A&amp;R Shareholders&#8217; Agreement. The A&amp;R Shareholders&#8217; Agreement provides
that the parties shall cooperate to ensure that Afya enters into a customary registration rights agreement with the parties. Further,
while Bertelsmann holds an interest in Afya, the Esteves Family is bound by a non-compete obligation preventing it from directly or indirectly
carrying on a competing business that is in direct competition with us, subject to certain limited exceptions.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f030"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Related Party Transactions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition to the compensation arrangements with directors
and executive officers described under &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation&#8221; and certain
other rights of certain of the holders of our common shares as described under &#8220;&#8212;A. Major Shareholders&#8212;Shareholders&#8217;
Agreement,&#8221; the following is a description of each transaction since January 1, 2019 and each currently proposed transaction in
which the amount involved in the transactions is material to us and any related party.</p>


<!-- Field: Page; Sequence: 132 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->127<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Lease Agreements</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria
S.A.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya Brazil has entered into lease agreements with RVL
Esteves Gest&#227;o Imobili&#225;ria S.A., or RVL, an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr.
Renato Esteves is an executive officer, as described below:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On June 21, 2016, RVL entered into lease agreements (as
amended on April 26, 2018) with ITPAC &#8211; Instituto Tocantinense Presidente Ant&#244;nio Carlos S.A., or ITPAC, and Itpac Porto Nacional
&#8211; Instituto Tocantinense Presidente Antonio Carlos Porto S.A., or ITPAC Porto Nacional, pursuant to which RVL Esteves Gest&#227;o
Imobili&#225;ria S.A. agreed to lease campuses to ITPAC and ITPAC Porto Nacional in the cities of Aragua&#237;na and Porto Nacional,
both located in the State of Tocantins. The lease agreements are adjustable in accordance with the provisions of each lease agreement.
The lease agreements are for an initial term of 20 years, and are renewable for an additional 20 years subject to the provisions of each
lease agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On November 1, 2016, RVL entered into a lease agreement
with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices located in the city of Nova Lima, State of Minas
Gerais, where Afya Brazil&#8217;s principal executive offices are located. On February 9, 2019 the agreement was amended to extend lease
terms and adjust the lease amounts, subject to certain discount conditions set forth in the lease agreement and adjustable in accordance
with the provisions of the lease agreement. The lease agreement is for an initial term of five years, and may be renewable for an additional
five years subject to the provisions of the lease agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On September 6, 2018, RVL entered into a lease agreement
with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus in the city of Palmas, State of Tocantins. The lease agreement
is for an amount equal to 7.5% of the monthly net revenue of ITPAC during the prior semester, which will start to become due once the
new ITPAC campus becomes operational, subject to the provisions of the lease agreement. The lease agreement is for an initial term of
20 years, starting on the date the new ITPAC campus becomes operational, and is renewable for an additional 20 years subject to the provisions
of the lease agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On October 30, 2019, RVL entered into a lease agreement
with IPTAN, pursuant to which RVL agreed to lease to IPTAN the new IPTAN medical campus, currently under construction by RVL in the city
of Santa In&#234;s, State of Maranh&#227;o. The lease agreement is for a monthly amount equal to: (i) up to June 2020, R$12,000.00;
and (ii) after June 2020 and until March 2024, 6.5% of the monthly net revenue of IPTAN assessed during the prior semester, in each case
adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term of five years counted
from the conclusion of the construction works, and may be renewable for an additional five years subject to the provisions of the lease
agreement.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The lease payments in connection with the lease agreements
with RVL totaled R$15.3 million and R$11.3 million in the years ended December 31, 2021 and 2020, respectively.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease agreement with UNIVA&#199;O Patrimonial Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 14, 2016, UNIVA&#199;O Patrimonial Ltda., an
entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves is the chief executive officer,
entered into a lease agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O Patrimonial Ltda. agreed
to lease the UNIVA&#199;O campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais. The lease agreement is adjustable
in accordance with the provisions of the lease agreement. The lease agreement is for an initial term of 20 years, and is renewable for
an additional 20 years subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement totaled
R$3.2 million and R$2.9 million in the years ended December 31, 2021 and 2020, respectively.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Lease agreement with IESVAP Patrimonial Ltda.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On April 25, 2018, IESVAP Patrimonial Ltda., an entity
controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, entered into a lease agreement
with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to lease the IESVAP campus to IESVAP located
in the city of Parna&#237;ba, State of Piau&#237;. The lease agreement is for an amount equal to 7.5% of the monthly net revenue of
IESVAP during 2018. The lease agreement is for an initial term of 20 years, and is</p>


<!-- Field: Page; Sequence: 133 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->128<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">renewable for an additional 20 years subject to the provisions of the lease
agreement. The lease payments in connection with this lease agreement totaled R$4.6 million and R$3.5 million in the years ended December
31, 2021 and 2020, respectively.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">UEPC Services Agreement</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On February 25, 2019, Medcel entered into a services
agreement with UEPC, pursuant to which Medcel agreed to provide certain educational services and content to UEPC, available on Medcel&#8217;s
online platform. The services agreement is for an amount equal to R$1.3 million, payable by UEPC to Medcel subject to the terms of the
services agreement. For the years ended December 31, 2021 and 2020, the revenues in connection with this services agreement totaled R$0.8
million and R$0.1 million, respectively.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 0cm">See note 8 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">ITPAC Garanhuns Assignment Agreement</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On March 28, 2019, our shareholder Nicolau Carvalho Esteves
entered into an agreement with Afya Brazil pursuant to which he assigned to Afya Brazil, in connection with a pending authorization by
MEC to operate a medical school, the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of Garanhuns,
State of Pernambuco. The consummation of the assignment is subject to the approval of the ITPAC Garanhuns medical school authorization
by MEC, which must be obtained within 10 years from the execution of the assignment agreement. The purchase price paid by Afya Brazil
to Nicolau Carvalho Esteves to the extent MEC&#8217;s approval is obtained within the prescribed time period is R$900,000 <i>multiplied
by</i> the number of medical school seats authorized by MEC. Once operational, ITPAC Garanhuns is expect to generate 120 new medical school
seats. In 2008, two public civil proceedings were filed by the Brazilian federal government and the federal public prosecutor for the
suspension of the activities of the Garanhuns Greenfield unit, claiming that the status of the Garanhuns Greenfield unit with the MEC
was irregular.On November 5, 2021, the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#8220;MEC&#8221;)
authorized the operation of the medical school in Garanhuns in the State of Pernambuco. ITPAC Garanhuns authorization guaranteed 120 medical
seats to Afya, totaling a purchase price of R$108 million of which: 50% in cash on the transaction closing date and 50% in two equal annual
installments, adjusted by the CDI rate<span style="font-family: Calibri,sans-serif">.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;Item 8. Financial Information&#8212;Consolidated
Statements and Other Financial Information&#8212;Legal and Administrative Proceedings&#8212;Civil Matters.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Related person transaction policy</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 29, 2021, our board of directors approved
the related party transactions and conflicts of interests&#8217; policy that set forth our guidelines and procedures regarding agreements
with related parties.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our related person transaction policy states that related
person transactions must be approved or ratified by our executive officers and board of directors. In determining whether to approve or
ratify a transaction with a related person, our executive officers or board of directors will consider all relevant facts and circumstances,
including without limitation the commercial reasonableness of the terms, of the transaction the benefit and perceived benefit, or lack
thereof, to us, opportunity costs of alternate transaction, the materiality and character of the related person&#8217;s direct or indirect
interest and the actual or apparent conflict of interest of the related person.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to the related transaction policy, our executive
officers or board of directors will not approve or ratify a related person transaction unless it has determined that, upon consideration
of all relevant information, such transaction is in, or not inconsistent with, our best interests and the best interests of our shareholders.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Indemnification agreements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have executed indemnification agreements with our
directors and executive officers. The indemnification agreements and our Articles of Association require us to indemnify our directors
and executive officers to the fullest extent permitted by law.</p>


<!-- Field: Page; Sequence: 134 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->129<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Employment agreements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Virg&#237;lio Deloy Capobianco Gibbon, L&#233;lio
de Souza Junior and Luis Andr&#233; Carpintero Blanco entered into employment agreements with the Company. None of our directors have
entered into service agreements with the Company.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For a description of the compensation paid to our directors
and executive officers, see &#8220;Item 6. Directors, Senior Management and Employees&#8212;B. Compensation.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Long-Term Incentive Plan</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;Item 6. Directors, Senior Management and Employees&#8212;B.
Compensation&#8212;Afya Brazil Long-Term Incentive Plan.&#8221; and &#8220;Item 6. Directors, Senior Management and Employees&#8212;B.
Compensation&#8212;New Long-Term Incentive Plan.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f031"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Interests of Experts and
Counsel</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f032"></span>ITEM 8. FINANCIAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f033"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Consolidated Statements
and Other Financial Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See Exhibits.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Legal and Administrative Proceedings</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">From time to time, we are involved in disputes that arise
in the ordinary course of our business. Any claims against us, whether meritorious or not, can be time consuming, result in costly litigation,
require significant management time and result in the diversion of significant operational resources.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We and our subsidiaries are subject to a number of judicial
and administrative proceedings in the Brazilian court systems, including civil, labor and tax law and social security claims and other
proceedings, which we believe are common and incidental to business operations in Brazil, in general. We recognize provisions for legal
proceedings in our financial statements, when we are advised by independent outside counsel that (i)&#160;it is probable that an outflow
of resources will be required to settle the obligation, and (ii)&#160;a reliable estimate can be made of the amount of the obligation.
The assessment of the likelihood of loss includes analysis by outside counsel of available evidence, the hierarchy of laws, available
case law, recent court rulings and their relevance in the legal system. Our provisions for probable losses arising from these matters
are estimated and periodically adjusted by management. In making these adjustments our management relies on the opinions of our external
legal advisors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we had provisions recorded in
our audited consolidated financial statements in connection with legal proceedings for which we believe a loss is probable, in an aggregate
amount of R$148.3&#160;million, and had made judicial deposits in an aggregate amount of R$18.8 million. However, legal proceedings are
inherently unpredictable and subject to significant uncertainties. If one or more cases were to result in a judgment against us in any
reporting period for amounts that exceeded our management&#8217;s expectations, the impact on our operating results or financial condition
for that reporting period could be material.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Civil Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we and our subsidiaries were
party to approximately 6,695 civil proceedings, 2,674 of which are collection proceedings, 3,571 of which are judicial proceedings and
450 of which are administrative proceedings. The civil claims to which we are a party generally relate to consumer claims, including those
related to student complaints. We believe these proceedings are unlikely to have a material adverse impact, individually, or in the aggregate,
on our results of operations or financial condition.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On November 14, 2008, a civil suit was filed by Alessandra
Vanessa Leite e Silva and others as plaintiffs against ITPAC Porto Nacional and others, seeking (i)&#160;to void IESPEN&#8217;s decision
to revoke their IESPEN membership and all subsequent decisions taken by IESPEN starting in April 4, 2004, and (ii)&#160;the payment of</p>


<!-- Field: Page; Sequence: 135 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->130<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">damages for loss of profits. On September 15, 2015, the lower court rendered
a judgment in favor of the plaintiffs, granting interlocutory relief. On December 13, 2016, following an interlocutory appeal of the plaintiffs,
the lower court froze 5% of ITPAC&#8217;s monthly revenues in favor of the plaintiffs, and on January 9, 2017, ITPAC appealed the lower
court judgment and filed an interlocutory appeal to suspend the order to freeze 5% of its revenues. On May&#160;24, 2017, an injunction
was issued suspending the freeze order. As of the date of this annual report, the appeal against the Lower Court judgment and the interlocutory
appeal are pending the decision of the appeals court. As of November 2020, the lower court deferred ITPAC request and excluded ITPAC from
the proceeding. We estimate the amount of any claim for damages that may be imposed on us as a result of these proceedings to be approximately
R$15.3 million, with the likelihood of loss as possible. On May 27, 2021, there was a final non-appealable decision and the claim was
considered groundless, with no obligation of payment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On October 9, 2012, a civil suit was filed by Marly Luzia
Bernardes Rocha against ITPAC Porto Nacional and others, alleging (i)&#160;that Municipal Law No. 1780/03 in connection with IESPEN&#8217;s
creation is unconstitutional, and therefore that IESPEN&#8217;s dissolution and assignment of all its contingencies to ITPAC Porto Nacional
should be voided; (ii)&#160;that ITPAC Porto Nacional acted in bad faith and failed in its duties to pay for corresponding material damages,
loss of profits, loss of opportunity and moral damages; (iii)&#160;that Maria Aurora Pinto Leite e Silva and Celso Eduardo Avelar Freire,
shareholders of IESPEN, did not pay up corporate capital; and (iv)&#160;that ITPAC Porto Nacional should compensate the plaintiffs for
alleged illicit enrichment in connection with the dissolution. On January 12, 2014, ITPAC filed its defense, which is pending review by
the competent lower court. On November 13, 2016, the lower court froze 8% of ITPAC Porto Nacional&#8217;s monthly revenues in favor of
the plaintiffs, and the freeze order was overturned on January 12, 2017. We estimate the amount of any claim for damages that may be imposed
on us as a result of these proceedings to be approximately R$24.1 million, with the likelihood of loss as possible.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In 2008, two public civil proceedings were filed by the
Brazilian federal government and the federal public prosecutor for the suspension of the activities of the Garanhuns Greenfield unit,
claiming that the status of the Garanhuns Greenfield unit with the MEC was irregular. As of the date of this annual report, the activities
of the Garanhuns Greenfield unit are suspended pursuant to a judgment of the 23rd Federal Court of the State of Pernambuco. On February
27, 2020, the Superior Court of Justice confirmed the judgment of the 23rd Federal Court of the State of Pernambuco and the Garanhuns
Greenfield unit remains suspended. Afya Brazil is currently in discussions with MEC to obtain the necessary authorizations for the Garanhuns
Greenfield unit, and to the extent those authorizations are obtained, this proceeding will be extinguished. In July 2019, ITPAC Araguaina
filed an administrative proceeding requesting MEC&#8217;s reappraisal of its previous decision that denied the request of transferring
the administrative proceeding related to the medical course authorization, filed in 2011, from the state educational system to the federal
educational system, pursuant to applicable regulation. On September 2, 2020, MEC published Ordinance no. 722 recognizing the right of
ITPAC and determining the review of the regularization request formulated in 2011 by the institution. On November 05, 2021, the instruction
authorizing the start of educational activities was published.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On November 30, 2019, a public proceeding was filed by
Domingos Borges da Silva against Centro de Ensino S&#227;o Lucas, other educational institutions and the city hall of Porto Velho, alleging
(i) that the defendants were purportedly not granting all the full scholarships to undergraduate students from &#8220;Programa de Inclus&#227;o
Social Universidade Para Todos &#8211; Faculdade da Prefeitura&#8221;, provided by Municipal Law No. 1,887/10 and modified by Municipal
Law No. 2,284/16; (ii) that due to the lack of full scholarships, the Treasury was being jeopardized because the agreement was for tax
waive in exchange to the full scholarships for the beneficiary from the referred Program; (iii) therefore, the plaintiff requires to be
awarded a preliminary injunction to revoke Municipal Laws Nos. 1,887/10 and 2,284/16 and the suspension of the adhesion contracts to the
Program signed by the defendants; and (iv) that the defendants should be liable for alleged material damages and loss of profits. On January
13, 2020, the lower court denied the preliminary injunction. On March 3, 2020, S&#227;o Lucas was served. The lawsuit was not ruled
by the lower court yet. It is important to highlight that Centro de Ensino S&#227;o Lucas is currently granting scholarships from the
Program and, by December 2020, there were 290 scholarships being offered. We estimate the amount of any claim for damages that may be
imposed on us as a result of this proceeding to be approximately of R$10.8 million, with the likelihood of loss as probable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The provisions related to civil proceedings whose likelihood
of loss is assessed as probable are R$22.9 million as of December 31, 2021. There are other civil proceedings assessed by management and
our legal counsels as possible risk of loss, for which no provisions are recognized in the amount of R$56.5 million as of December 31,
2021.</p>


<!-- Field: Page; Sequence: 136 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->131<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Labor Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, we and our subsidiaries were
party to approximately 266 labor proceedings, 203 of which are judicial proceedings and 63 of which are administrative proceedings. The
principal labor proceedings to which we are a party were filed by former employees or service providers seeking enforcement of labor rights
allegedly not provided by us. The judicial proceedings relate to employment bonds (judicial proceedings filed by former service providers),
overtime, premiums for hazardous workplace conditions, statutory severance, fines for severance payment delays, and compensation for workplace-related
accidents. The administrative proceedings relate to the alleged failure by us to comply with certain labor laws, including with respect
to working hours, the registration of employment agreements, disabled workers&#8217; hiring quotas and the protection of underage workers
and apprentices.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The provisions related to labor proceedings whose likelihood
of loss is assessed as probable are R$25.5 million as of December 31, 2021. There are other labor proceedings assessed by management and
our legal counsels as possible risk of loss, for which no provisions are recognized in the amount of R$5.0 million as of December 31,
2021.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Tax and Social Security Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, certain of our subsidiaries
were party to 71 tax and social security proceedings, 47 of which are judicial proceedings and 24 of which are administrative proceedings,
for which we did not record any provisions based on the advice of our external legal counsel that the likelihood of loss is possible.
The tax claims to which these subsidiaries are party are mostly tax foreclosures filed by Brazilian federal and municipal tax authorities.
The most significant tax claim is in an amount of R$47.4 million, in which Unigranrio is a plaintiff in a tax debit annulment action that
seeks to void three tax assessments relating to tax immunities in the collection of ISS taxes. As of the date of this annual report, a
decision by the trial court is pending.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">ITPAC Porto Nacional is party to one tax foreclosure
proceeding filed by the Brazilian federal government on July 12, 2010 for the collection of social security contribution on payroll debts
in the total historical amount of R$2.8 million, for which we did not record any provisions based on the advice of our external legal
counsel that the likelihood of loss is possible. As of the date of this annual report, the amount of this proceeding is approximately
R$2.9 million and the proceeding is pending the decision of the lower court.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">UniSL is party to tax proceeding filed by city of Porto
Velho on July 19, 2017 for having allegedly incurred in insufficient payment of ISS taxes in the total historical amount of R$6.0 million.
As of the date of this annual report, the amount of this proceeding is approximately R$12.8 million and the likelihood of loss as possible.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The provisions related to taxes proceedings whose likelihood
of loss is assessed as probable are R$99.8 million as of December 31, 2021. There are other Taxes proceedings assessed by Management and
its legal counsels as possible risk of loss, for which no provisions are recognized in the amount of R$4.4 million as of December 31,
2021.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">&#8220;Mais M&#233;dicos&#8221; Proceedings</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 15, 2019, Sociedade de Ensino Superior Est&#225;cio
de S&#225; Ltda., or SESES, filed a writ against SERES, requesting a judicial review of SERES&#8217;s decision to disqualify the SESES
bid to open a medical school in the city of Bragan&#231;a, State of Par&#225;, as part of the public procurement for the &#8220;<i>Mais
M&#233;dicos</i>&#8221; program, and award it to ITPAC Porto Nacional. The lower court granted a preventive injunction in favor of SESES,
suspending SERES&#8217;s award of the medical school to ITPAC Porto Nacional. ITPAC Porto Nacional joined these proceedings as a co-defendant.
On March 6, 2019, the federal prosecutor issued an opinion to dismiss the writ. On September 11, 2019, the lower court dismissed the writ
and revoked the suspension of the award of the medical school granted by MEC to ITPAC Porto Nacional, and we became authorized by MEC
to open and operate a medical school in the city of Bragan&#231;a. As of the date of this annual report, the proceedings are pending
the review of the appeal by the Federal Court of Appeals.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On January 31, 2019, Brasil Educa&#231;&#227;o S.A.,
or BR Educa&#231;&#227;o, filed proceedings against SERES, requesting a judicial review of SERES&#8217;s decision to disqualify the
BR Educa&#231;&#227;o bid to open a school in the city of Abaetetuba, State of Par&#225;, as part of the public procurement for
the &#8220;<i>Mais M&#233;dicos</i>&#8221; program, and award it to ITPAC Porto Nacional. ITPAC Porto Nacional joined these proceedings
as a co-defendant. The lower court granted a preventive injunction in favor of BR Educa&#231;&#227;o, suspending SERES&#8217;s award
of the medical school to ITPAC Porto Nacional.</p>


<!-- Field: Page; Sequence: 137 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->132<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">This injunction was subsequently repealed by the Federal Court of Appeals
upon preliminary review. As of the date of this annual report, the proceedings are pending the issuance of the final decision by the lower
court and the Federal Court of Appeals, and ITPAC Porto Nacional is authorized by MEC to open and operate a medical school in the city
of Abaetetuba.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On February 2, 2019, in proceedings separate to those
of BR Educa&#231;&#227;o, Faculdades Integradas Caraj&#225;s S/C Ltda., or Faculdades Caraj&#225;s, filed a writ against SERES,
requesting a judicial review of SERES&#8217;s decision to disqualify the Faculdades Caraj&#225;s bid to open a medical school in the
city of Abaetetuba, State of Par&#225;, as part of the public procurement for the &#8220;<i>Mais M&#233;dicos</i>&#8221; program,
and award it to ITPAC Porto Nacional. The lower court granted a preventive injunction in favor of Faculdades Caraj&#225;s, suspending
SERES&#8217;s award of the school to ITPAC Porto Nacional. On October 10, 2019, Faculdades Caraj&#225;s filed a motion to dismiss the
writ, and the writ was dismissed by the lower court on January 10, 2020. Consequently, ITPAC Porto Nacional is authorized by MEC to open
and operate a medical school in the city of Abaetetuba.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In July 2019, Instituto Metropolitano de Ensino Ltda.,
or IME, filed a lawsuit against SERES requesting the cancellation of the results of the public procurement for the &#8220;<i>Mais M&#233;dicos</i>&#8221;
program in connection with the awards granted to IPTAN and ITPAC Aragua&#237;na to open medical schools in the cities of Itacoatiara
and Manacapuru, located in the State of Amazonas. IME alleges that SERES&#8217;s final decision with respect to IME&#8217;s participation
in the public procurement was irregular. On September 11, 2019, the lower court granted a preventive injunction in favor of IME, suspending
SERES&#8217;s award of the medical schools to IPTAN and ITPAC Aragua&#237;na. IPTAN and ITPAC Aragua&#237;na joined these proceedings
as co-defendants. The preventive injunction was suspended following an appeal filed by SERES, and SERES, IPTAN and ITPAC Aragua&#237;na
filed their responses to IME&#8217;s allegations. As of the date of this annual report, these proceedings are pending the decision of
the lower court. On February 14, 2020, the preventive injunction granted in favor of IME to suspend the results of the public procurement
in the cities of Itacoatiara and Manacapuru was revoked by the Federal Court of Appeals. This decision gave a suspensive effect for the
appeal filed by IPTAN and ITPAC Aragua&#237;na, rendering the decisions of the first instance without effect.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Dividends and Dividend Policy</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have not adopted a dividend policy with respect to
future distributions of dividends. The amount of any distributions will depend on many factors such as our results of operations, financial
condition, cash requirements, prospects and other factors deemed relevant by our board of directors and, where applicable, our shareholders.
We currently intend to retain all available funds and any future earnings, if any, to fund the development and expansion of our business
and we do not anticipate paying any cash dividends in the foreseeable future. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Class A Common Shares&#8212;It is unlikely that we will declare any dividends on our common shares in the foreseeable
future and therefore, you must rely on price appreciation of our common shares for a return on your investment.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We may make any future determination to pay dividends
based on an ordinary shareholder resolution, but no dividend may exceed the amount recommended by our board of directors. Even if our
board of directors recommends a dividend payment, the form, frequency and amount will depend on a number of factors, including our future
operations and earnings, our capital requirements and surplus, our general financial condition, impositions of restrictions on conversions
and remittances of funds abroad in the jurisdictions where we operate, contractual restrictions and other factors that the board of directors
may deem relevant. Cash dividends on our common shares, if any, will be paid in U.S. dollars.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In the year ended December 31, 2021, holders of the Series
A perpetual convertible preferred shares received dividends in kind with a value in the aggregate of approximately R$22.1 million and
in cash amounting to US$4.2 million.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are a holding company incorporated in the Cayman Islands.
We rely on dividends and distributions from our subsidiaries in Brazil for our cash requirements, including funds to pay our operating
expenses, service any debt we may incur and pay dividends and other cash distributions to our shareholders. Also, payments of dividends
from Afya Brazil to Afya Limited may be made according to cash requirements. Our holding company structure makes us dependent on the operations
of our subsidiaries and therefore, any determination to pay dividends in the future will depend on our ability to receive distributions
from them. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain Risks Relating to Our Business and Industry&#8212;Our
holding company structure makes us dependent on the operations</p>


<!-- Field: Page; Sequence: 138 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->133<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">of our subsidiaries. We depend on dividend distributions by our subsidiaries,
and we may be adversely affected if the performance of our subsidiaries is not positive.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Cayman Islands Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Companies Act and our Articles of Association,
a Cayman Islands company may pay a dividend out of either its profit or share premium account, but a dividend may not be paid if this
would result in the company being unable to pay its debts as they fall due in the ordinary course of business. According to our Articles
of Association, dividends can be declared and paid out of funds lawfully available to us, which include the share premium account. Dividends,
if any, would be paid in proportion to the number of common shares a shareholder holds. For further information, see &#8220;Item 10. Additional
Information&#8212;E. Taxation&#8212;Cayman Islands Tax Considerations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Certain Brazilian Legal Requirements Related to Dividends</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our ability to pay dividends is directly related to positive
and distributable net results from our Brazilian subsidiaries. See &#8220;Item 3. Key Information&#8212;D. Risk Factors&#8212;Certain
Risks Relating to Our Business and Industry&#8212;Our holding company structure makes us dependent on the operations of our subsidiaries.
We depend on dividend distributions by our subsidiaries, and we may be adversely affected if the performance of our subsidiaries is not
positive.&#8221; Our Brazilian subsidiaries are required under Federal Law No. 6,404 dated December 15, 1976, as amended, to distribute
a mandatory minimum dividend to shareholders each year, which cannot be lower than 25% of their income for the prior year, unless a lower
mandatory minimum dividend is provided for in such subsidiary by-laws or such distribution is suspended by a decision of such subsidiary&#8217;s
shareholders at its annual shareholders&#8217; meeting based on a report by its board of directors that such distribution would be incompatible
with its financial condition at that time.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, if, for any legal reasons due to new laws
or bilateral agreements between countries, our Brazilian subsidiaries are unable to pay dividends to Cayman Islands companies, or if a
Cayman Islands company becomes incapable of receiving them, we may not be able to make any dividend payments in the future.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of the date of this annual report, Afya Brazil and
certain of our subsidiaries are required by their respective bylaws to distribute the following minimum dividends to shareholders: (i)&#160;Afya
Brazil, ITPAC&#8212;Instituto Tocantinense Presidente Ant&#244;nio Carlos&#160;S.A. (ITPAC Aragua&#237;na), ITPAC Porto Nacional&#8212;Instituto
Tocantinense Presidente Ant&#244;nio Carlos&#160;S.A., IESP&#8212;Instituto de Ensino Superior do Piau&#237;&#160;S.A., IPTAN&#8212;Instituto
de Ensino Superior Presidente Tancredo de Almeida Neves S.A., Uni&#227;o Educacional do Planalto Central S.A.(UEPC), Instituto Educacional
Santo Agostinho S.A. (FASA), Sociedade Universit&#225;ria Redentor S.A. (UniRedentor), PEBMED Institui&#231;&#227;o de Pesquisa
M&#233;dica e Servi&#231;os Tecnol&#243;gicos da &#193;rea da Sa&#250;de S.A. (PEBMED), FESAR &#8211; Sociedade de Educa&#231;&#227;o,
Cultura e Tecnologia da Amaz&#244;nia S.A. (FESAR), Iclinic Desenvolvimento de Software S.A. (Iclinic), Iclinic Participa&#231;&#245;es
S.A. (Iclinic Participa&#231;&#245;es), Black River Participa&#231;&#245;es S.A. (Black River), Medicinae Solutions S.A. (Medicinae)&#8212;at
least 25% of adjusted net profit in each fiscal year; (ii)&#160;Medcel Editora e Eventos&#160;S.A. (Medcel Editora)&#8212;at least 50%
of adjusted net profit in each fiscal year; (iii)&#160;IESVAP&#8212;at least 80% of adjusted net profit in each fiscal year; (iv)&#160;UNIVA&#199;O&#8212;at
least 90% of adjusted net profit in each fiscal year; (v)&#160;Centro de Ci&#234;ncias em Sa&#250;de de Itajub&#225;&#160;S.A. (CCSI)&#8212;at
least 2% of net profit in each fiscal year. FADEP, Centro Integrado de Sa&#250;de de Teresina&#160;Ltda., Instituto de Pesquisa e Ensino
M&#233;dico do Estado de Minas Gerais&#160;Ltda. (IPEMED), Instituto Paraense de Educa&#231;&#227;o e Cultura&#160;Ltda. (IPEC),
ESMC Educa&#231;&#227;o Superior&#160;Ltda. (ESMC), Centro Universit&#225;rio S&#227;o Lucas Ltda. (UniSL), Centro Superior de
Ci&#234;ncias da Sa&#250;de S/S Ltda. (FCMPB), Medphone Tecnologia em Sa&#250;de Ltda. (Medphone), Medical Harbour Aparaelhos M&#233;dico
&#8211; Hospitalares e Servi&#231;os em Tecnologia Ltda. (Medical Harbour) e CliqueFarma Drogarias Online Ltda. (CliqueFarma), are limited
liability companies and their articles of association do not stipulate a mandatory minimum dividend.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have not declared or paid any dividends to our shareholders
since our incorporation in the Cayman Islands on March 22, 2019. Afya Brazil did not declare or pay any dividends to its shareholders
in 2018 and 2020. On June 13, 2019, Afya Brazil approved the payment of interim dividends totaling R$38 million to Afya Brazil shareholders
of record on June 13, 2019. The dividend amount was determined based on Afya Brazil&#8217;s net income for the five months ended May 31,
2019. Neither Afya nor the public shareholders of Afya were entitled to receive such dividend, which was paid in September 2019. See note
17 to our audited consolidated financial statements for additional information.</p>


<!-- Field: Page; Sequence: 139 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->134<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f034"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Significant Changes</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Except as disclosed elsewhere in this annual report,
we have not experienced any significant changes since the date of our audited consolidated financial statements included in this annual
report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f035"></span>ITEM 9. THE OFFER AND LISTING</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f036"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Offer and Listing Details</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 19, 2019, we completed our initial public offering.
On February 7, 2020, we completed a follow-on offering. Our common shares have been listed on the Nasdaq since July 19, 2019 under the
symbol &#8220;AFYA.&#8221; Prior to that date, there was no public trading market for our common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f037"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Plan of Distribution</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f038"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Markets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;&#8212;A. Offer and Listing Details&#8221;
above.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f039"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Selling Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f040"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dilution</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f041"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Expenses of the Issue</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f042"></span>ITEM 10. ADDITIONAL INFORMATION</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f043"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Share Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f044"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Memorandum and Articles
of Association</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Description of Share Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We were incorporated on March 22, 2019 as a Cayman Islands
exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes are unrestricted
and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our affairs are governed principally by (i)&#160;our
Memorandum and Articles of Association; (ii)&#160;the Companies Act; and (iii)&#160;the common law of the Cayman Islands. As provided
in our Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity to carry on or undertake any business
or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers and privileges. Our registered office
is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association authorize the issuance
of share capital of up to 1,000,000,000 shares of a nominal or par value of US$0.00005 each, which, at the date of this annual
report, comprise 500,000,000 Class A common shares and 250,000,000 Class B common shares (which may be converted into Class A common
shares in the manner contemplated in our Articles of Association), and 250,000,000 shares of such class or classes (howsoever
designated) and having the rights that our board of directors may determine. As of the date of this annual report we have 44,509,593
Class A common shares, and 45,802,763 Class B common shares, 3,410,475 common shares held in
treasury and 150,000 Series A perpetual convertible preferred shares of our authorized share capital issued and
outstanding.</p>


<!-- Field: Page; Sequence: 140 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->135<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is a summary of the material provisions
of our authorized share capital and our Articles of Association.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Share Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Memorandum and Articles of Association currently
authorize two classes of common shares: Class A common shares, which are entitled to one vote per share, and Class B common shares, which
are entitled to 10 votes per share and to maintain a proportional ownership interest in the event that additional Class A common shares
are issued. Any holder of Class B common shares may convert his or her shares at any time into Class A common shares on a share-for-share
basis. The rights of the two classes of common shares are otherwise identical, except as described below. The implementation of this dual
class equity structure was required by the Esteves Family and Crescera, our principal shareholders in the year of 2019, as a condition
of undertaking the initial public offering of our common shares. See &#8220;&#8212;Anti-Takeover Provisions in Our Articles of Association&#8212;Two
Classes of Common Shares.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, our total authorized share capital
was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>500,000,000 shares are designated as Class A common shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares are designated as Class B common shares; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>250,000,000 shares of such class or classes (howsoever designated) and having the rights as the Board may determine.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, Afya had a total issued
share capital of R$17 thousand, represented by 93,722,831 common shares comprised by 46,265,141 Class A common shares, 45,802,763
Class B common shares, 1,654,927 common shares held in
treasury and 150,000 Series A perpetual convertible preferred shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Treasury Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As of December 31, 2021, Afya had 1,654,927 common shares in
treasury.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Issuance of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Except as expressly provided in our Articles of Association,
our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with or dispose of
any unissued shares in the company&#8217;s capital without the approval of our shareholders (whether forming part of the original or any
increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or restrictions,
whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions, and at such times
as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions of the Companies
Act. In accordance with its Articles of Association, Afya shall not issue bearer shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association provide that at any time
that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&#160;a share split,
subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or rights to acquire
shares or following capitalization of profits, (ii)&#160;a merger, consolidation, or other business combination, or (iii)&#160;an issuance
of shares including Class A common shares or any other class of share designated as a common share pursuant to the Articles of Association,
whereby each holder of the Class B common shares is entitled to purchase a number of Class B common shares that would allow it to maintain
its proportional ownership interests in Afya (following an offer by Afya to each holder of Class B common shares to issue to such holder,
upon the same economic terms and at the same price, such number of Class B common shares as would ensure such holder may maintain a proportional
ownership interest in Afya pursuant to our Articles of Association). In light of: (a)&#160;the above provisions; (b)&#160;the fact that
future transfers by holders of Class B common shares will generally result in those shares converting to Class A common shares, subject
to limited exceptions as provided in the Articles of Association; and (c)&#160;the ten-to-one voting ratio between our Class B common
shares and Class A common shares, means that holders of our Class B common shares will in many situations continue to maintain control
of all matters requiring shareholder approval.</p>


<!-- Field: Page; Sequence: 141 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->136<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">This concentration of ownership and voting power will limit or preclude
your ability to influence corporate matters for the foreseeable future. For more information see &#8220;&#8212;Preemptive or Similar Rights.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association also provide that the issuance
of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares and the prior written
consent of a Bertelsmann Director and Esteves Family Director as set out below in &#8220;&#8212;Proceedings of the Board of Directors.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Fiscal Year</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our fiscal year begins on January 1 of each year and
ends on December 31 of the same year.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Voting Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The holders of the Class A common shares and Class B
common shares have identical rights, except that (i)&#160;the holder of Class B common shares is entitled to 10 votes per share, whereas
holders of Class A common shares are entitled to one vote per share, (ii)&#160;Class B common shares have certain conversion rights and
(iii)&#160;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common
shares and/or preferred shares are proposed to be issued. For more information see below &#8220;&#8212;Preemptive or Similar Rights&#8221;
and &#8220;&#8212;Conversion.&#8221; The holders of Class A common shares and Class B common shares vote together as a single class on
all matters (including the election of directors) submitted to a vote of shareholders, except as provided below and as otherwise required
by law.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association provide as follows regarding
the respective rights of holders of Class A common shares and Class B common shares:</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="background-color: white">(i)</span><span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>Class
consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation to the
rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming one
class if they consider that all such classes would be affected in the same way by the proposal;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(ii)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>the
rights conferred on holders of Class A common shares shall not be deemed to be varied by the creation or issue of further Class B common
shares and vice versa; and</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">(iii)<span style="font-family: Courier New">&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span>the
rights attaching to the Class A common shares and the Class B common shares shall not be deemed to be varied by the creation or issue
of shares with preferred or other rights, including, without limitation, shares with enhanced or weighted voting rights.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As set forth in the Articles of Association, the holders
of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of authorized
shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares may be
increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders of a
majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a general
meeting.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Preemptive or Similar Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Class A common shares and Class B common shares are
not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &#8220;&#8212;Conversion&#8221;),
redemption or sinking fund provisions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Class B common shares are entitled to maintain a
proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective
until the date specified therein or 12 months from the date of the waiver.</p>


<!-- Field: Page; Sequence: 142 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->137<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Conversion</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The outstanding Class B common shares are convertible
at any time as follows: (i)&#160;at the option of the holder, a Class B common share may be converted at any time into one Class A common
share or (ii)&#160;upon the election of the holders of all the then issued and outstanding Class B common shares, all outstanding Class
B common shares may be converted into a like number of Class A common shares. In addition, each Class B common share will convert automatically
into one Class A common share upon any transfer, whether or not for value, except for certain transfers described in the Articles of Association,
including transfers to holders of Class B common shares, to affiliates, transfers to Bertelsmann SE &amp; Co. KGaA and any of its affiliates,
to and between the Esteves Family, Bertelsmann, their family members and their respective children, heirs and successors, trusts solely
for the benefit of the shareholder or their affiliates, and to partnerships, corporations and other entities exclusively owned or controlled
by the Class B shareholder or their affiliates and certain transfers to organizations that are exempt from taxation under Section 501(c)(3)
of the Internal Revenue Code of 1986, as amended. Furthermore, each Class B common share will convert automatically into one Class A common
share and no Class B common shares will be issued thereafter if, at any time, the total number of the issued and outstanding Class B common
shares is less than 10% of the total number of shares outstanding. To the extent that Bertelsmann or the Esteves Family cease to be a
Class B common shareholder, the rights nominally vested to each shall vest in their permitted transferee within the meaning of our Articles
of Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">No class of our common shares may be subdivided or combined
unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Equal Status</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Except as expressly provided in our Articles of Association,
Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and are identical
in all respects as to all matters.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In the event of any merger, consolidation, scheme, arrangement
or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not Afya is the surviving
entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the same form of consideration
as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive, or the right to elect
to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares. In the event of any
(i)&#160;tender or exchange offer to acquire any Class A common shares or Class B common shares by any third-party pursuant to an agreement
to which Afya is a party, or (ii)&#160;any tender or exchange offer by Afya to acquire any Class A common shares or Class B common shares,
the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the same form of consideration
as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive, or the right to elect
to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Record Dates</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For the purpose of determining shareholders entitled
to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive dividend
or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors may
set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">General Meetings of Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a condition of admission to a shareholders&#8217;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to any special rights or restrictions as to voting
then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case of a shareholder
being a corporation, by its duly authorized representative not being himself or herself a shareholder entitled to vote) shall have one
vote per Class A common share and 10 votes per Class B common share.</p>


<!-- Field: Page; Sequence: 143 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->138<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a Cayman Islands exempted company, Afya is not obliged
by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the company will
hold an annual general meeting of shareholders, at a time determined by the board of directors, provided that the board of directors of
Afya has the discretion whether or not to hold an annual general meeting. For the annual general meeting of shareholders the agenda will
include, among other things, the presentation of the annual accounts and the report of the directors. In addition, the agenda for an annual
general meeting of shareholders will only include such items as have been included therein by the board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Also, Afya may, but is not required to (unless required
by the laws of the Cayman Islands), hold other extraordinary general meetings during the year. General meetings of shareholders are generally
expected to take place in Nova Lima, Brazil, but may be held elsewhere if the directors so decide.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act provides shareholders a limited right
to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&#8217;s Articles of Association. However, these rights may be provided in a company&#8217;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to regulatory requirements, the annual general
meeting and any extraordinary general meetings must be called by not less than 10 clear calendar days&#8217; notice prior to the relevant
shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled to receive
notice, with regards to the annual general meeting, and the holders of 95% in par value of the shares entitled to attend and vote at an
extraordinary general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those holders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya will give notice of each general meeting of shareholders
by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman Islands law, Nasdaq
and SEC requirements. The holders of registered shares may be given notice of a shareholders&#8217; meeting by means of letters sent to
the addresses of those shareholders as registered in our shareholders&#8217; register, or, subject to certain statutory requirements,
by electronic means.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b>Holders whose shares are registered in the name of
DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member of
the company and must rely on the procedures of DTC regarding notice of shareholders&#8217; meetings and the exercise of rights of a holder
of the Class A common shares.</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A quorum for a general meeting consists of any one or
more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue and entitled
to vote upon the business to be transacted, provided that such a quorum must also include (i)&#160;Bertelsmann for so long as it holds
Class B common shares in excess of the Ownership Threshold, and (ii)&#160;the Esteves Family for so long as it holds Class B common shares
in excess of the Ownership Threshold.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A resolution put to a vote at a general meeting shall
be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote of a
simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting at
the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Pursuant to our Articles of Association, general meetings
of shareholders are to be chaired by the chairman of our board of directors or in his absence the vice-chairman of the board of directors.
If the chairman or vice-chairman of our board of directors is absent, the directors present at the meeting shall appoint one of them to
be chairman of the general meeting. If neither the chairman nor another director is present at the general meeting within 15 minutes after
the time appointed for holding the meeting, the shareholders present in person or by proxy and entitled to vote may elect any one of the
shareholders to be chairman. The order of business at each meeting shall be determined by</p>


<!-- Field: Page; Sequence: 144 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->139<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">the chairman of the meeting and he or she shall have the right and authority
to prescribe such rules, regulations and procedures and to do all such acts and things as are necessary or desirable for the proper conduct
of the meeting, including, without limitation, the establishment of procedures for the maintenance of order and safety, limitations on
the time allotted to questions or comments on the affairs of the Company, restrictions on entry to such meeting after the time prescribed
for the commencement thereof, and the opening and closing of the polls. The chairman shall not have the right to vote in his capacity
as chairman and shall not have a casting vote.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Liquidation Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If Afya is voluntarily wound up, the liquidator, after
taking into account and giving effect to the rights of preferred and secured creditors and to any agreement between Afya and any creditors
that the claims of such creditors shall be subordinated or otherwise deferred to the claims of any other creditors and to any contractual
rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral or any multi-lateral
set-off or netting arrangements between the company and any person or persons) and subject to any agreement between Afya and any person
or persons to waive or limit the same, shall apply our property in satisfaction of its liabilities <i>pari passu</i> and subject thereto
shall distribute the property amongst the shareholders according to their rights and interests in Afya.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Special Matters</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya may not without the prior written consent of (i)&#160;Bertelsmann
for so long as it holds Class B common shares and (ii)&#160;the Esteves Family for so long as it holds Class B common shares in excess
of the Ownership Threshold: change the number of directors; change the structure, function, and/or number of the board of executive officers
(which comprises the three senior executive officers that manage the day-to-day business activities of Afya, subject to the overall supervision
of the board of directors); amend its Memorandum and Articles of Association; vary the rights attaching to shares; approve any merger
or consolidation of Afya with one or more constituent companies (as defined in the Companies Act), the contribution by Afya of any assets
to any subsidiary and/or the creation of any joint venture by Afya; approve any business combination; approve the winding-up, liquidation
or dissolution of Afya; or take certain actions in respect of its share capital as set out in the Articles of Association; register as
an exempted limited duration company; or approve the transfer by way of continuation of Afya to a jurisdiction outside the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our Articles of Association contain stringent anti-corruption,
anti-money laundering and certain other related measures applicable to us, our officers and directors, and its service providers. The
Articles of Association provide that if one of our shareholders is found to have been involved in an act of corruption, money laundering
or other related irregular act, the directors shall convene a meeting to consider the circumstances of such incident, and establish a
course of action to be taken against such shareholder. The actions range from (i)&#160;suspending such shareholder from his/her duties
as a director, officer and/or employee (if applicable) of the Company; (ii)&#160;terminating such duties; (iii)&#160;directing such shareholder
to transfer the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&#160;if such transfer is not
possible, resolve that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our Articles of Association
provide that we shall not engage the services of any provider that has been found to violate applicable anti-corruption laws, and further
provide that we and our shareholders shall not violate applicable anti-corruption laws.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Changes to Capital</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the restrictions contained in the Articles
of Association and summarized above in &#8220;&#8212;Special Matters,&#8221; Afya may from time to time by ordinary resolution:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</td></tr></table>


<!-- Field: Page; Sequence: 145 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->140<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our shareholders may by special resolution, subject to
confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction, reduce
its share capital or any capital redemption reserve in any manner permitted by law.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, subject to the provisions of the Companies
Act and our Articles of Association, Afya may:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>issue shares on terms that they are to be redeemed or are liable to be redeemed;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>purchase its own shares (including any redeemable shares); and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</td></tr></table>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Transfer of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to any applicable restrictions set forth in the
Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of transfer in the
usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Class A common shares are traded on the Nasdaq in
book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&#8217;s rules and regulations.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">However, our board of directors may, in its absolute
discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does not approve
or is issued under any share incentive scheme for employees which contains a transfer restriction that is still applicable to such common
share. The board of directors may also decline to register any transfer of any common share unless:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is in respect of only one class of shares;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the instrument of transfer is properly stamped, if required;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the common shares transferred are free of any lien in favor of Afya; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If the directors refuse to register a transfer they are
required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice of such
refusal.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Share Repurchases</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act and the Articles of Association permit
Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf of Afya,
and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by the SEC,
the Nasdaq, or by any recognized stock exchange on which our securities are listed. Set forth below is a description of our share repurchase
programs.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="text-decoration: underline">1<sup>st</sup> Share Repurchase Program</span>. Our Board
of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase up to 1,015,844
of its outstanding Class A common</p>


<!-- Field: Page; Sequence: 146 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->141<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">shares in the open market, based on prevailing market prices, or in privately
negotiated transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase
or December 31, 2021, depending upon market conditions. We intend to repurchase the shares to execute the stock option program for the
executives of the company and expect to utilize our existing funds to fund repurchases made under this program. Our Board of Directors
also authorized management to appoint BofA Securities, Inc. as our agent to purchase Securities on its behalf in the open market. It is
our intention such purchases benefit from the safe harbor provided by Rule 10b-18 (&#8220;Rule 10b-18&#8221;) promulgated by the SEC under
the Exchange Act. Accordingly, we shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases of our common shares under the program. The share buyback program was completed on October
21, 2021, upon the completion of the purchase of the full amount of Class A common shares permitted under the program.</p>

<p style="font: 10pt Times New Roman,serif; text-align: justify; text-indent: 18pt; margin-right: 0; margin-left: 0"><span style="text-decoration: underline">2<sup>nd</sup>
Share Repurchase Program</span>. After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase
of 1,015,844 Class A common shares, our Board of Directors approved a new share repurchase program on October 27, 2021. Under the second
share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion of the repurchase
or December 31, 2022, depending upon market conditions. We intend to repurchase the shares to execute the stock option program for the
executives of the company and expect to utilize our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&#8217;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second repurchase program was completed upon the purchase of the
full amount of Class A common shares permitted under the second repurchase program.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: justify; text-indent: 18pt"><span style="text-decoration: underline">3<sup>rd</sup> Share Repurchase
Program</span>. After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class A common shares,
our Board of Directors has approved a new share repurchase program on January 27, 2022. Under the third repurchase program, Afya may repurchase
up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float, in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on January 27, 2022 until the earlier of the completion of the repurchase
or December 31, 2022, depending upon market conditions.</p>

<p style="font: 10pt Times New Roman,serif; text-align: justify; text-indent: 18pt; margin-right: 0; margin-left: 0">The share repurchases
may be made from time to time through open market transactions and are subject to market and business conditions, levels of available
liquidity, cash requirements for other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares for use
in its stock option program, as consideration in future business combination transactions and for general corporate purposes. Afya expects
to utilize its existing funds and future dividends to be received from Afya Brazil to fund repurchases made under this program. Afya&#8217;s
Board of Directors will review the share repurchase program periodically and may authorize adjustments to its terms and size or suspend
or discontinue the program.</p>

<p style="font: 10pt Times New Roman,serif; text-align: justify; text-indent: 18pt; margin-right: 0; margin-left: 0">The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&#8217;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have not adopted a dividend policy with respect to
payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a simple majority
of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be paid to shareholders
but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of directors may also declare
dividends. Dividends may be declared and paid out of funds lawfully available to Afya. Except as otherwise provided by the rights attached
to shares and the Articles of Association of Afya, all dividends shall be paid in proportion to the number of Class A common shares or
Class B common shares a shareholder holds at the date the</p>


<!-- Field: Page; Sequence: 147 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->142<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">dividend is declared (or such other date as may be set as a record date);
but, (i)&#160;if any share is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank
for dividend accordingly, and (ii)&#160;where we have shares in issue which are not fully paid up (as to par value) we may pay dividends
in proportion to the amounts paid up on each share.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The holders of Class A common shares and Class B common
shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to time. In
the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class A common shares
or Class B common shares, (i)&#160;the holders of Class A common shares shall receive Class A common shares, or rights to acquire Class
A common shares, as the case may be; and (ii)&#160;the holders of Class B common shares shall receive Class B common shares, or rights
to acquire Class B common shares, as the case may be.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Series A perpetual convertible preferred shares rank
senior to our common with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Company. The holders of Series A perpetual convertible preferred shares are entitled to
a cumulative dividend at the rate of 6.5% per annum, payable quarterly in arrears. Dividends are payable in kind through the issuance
of additional Series A perpetual convertible preferred shares, in cash, or in any combination of both, at our discretion. In the year
ended December 31, 2021, holders of the Series A perpetual convertible preferred shares received dividends in kind with a value in the
aggregate of approximately R$22.1 million and in cash amounting to US$4.2 million. The holders of the Series A perpetual convertible preferred
shares are also entitled to participate in dividends declared or paid on our common stock on an as-converted basis.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</p>

<p style="font: 12pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-size: 10pt">Afya is managed by its
board of directors. The Articles of Association provide that, unless otherwise determined by a special resolution of shareholders, the
board of directors will be composed of four to 11 directors, with the number being determined by a majority of the directors then in office.
There are no provisions relating to retirement of directors upon reaching any age limit. The Articles of Association also provide that,
while our shares are admitted to trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements
of the U.S. securities laws applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares may appoint
up to three directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&#8220;Bertelsmann
Directors&#8221;), and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership Threshold may appoint
up to three directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&#8220;Esteves Family
Directors&#8221;), in addition for so long as both hold Class B common shares, they may appoint a further director (the &#8220;Joint Director&#8221;)
and are entitled at any time to remove, substitute or replace the Joint Director. The board of directors shall have a chairman that for
so long as both Bertelsmann and the Esteves Family hold Class B common shares in excess of the Ownership Threshold, which chairman is
appointed in rotation for a term of a year by each of them as prescribed in the Articles of Association, such right to be exercised initially
by </span><span style="font-size: 9.5pt">Bertelsmann</span><span style="font-size: 10pt">. Once neither </span><span style="font-size: 9.5pt">Bertelsmann</span>
<span style="font-size: 10pt">nor the Esteves Family hold Class B common shares in excess of the Ownership Threshold, the chairman is
elected by the board of directors then in office instead. The directors may elect a vice chairman of the board of directors.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For the names of our directors, see &#8220;Item 6. Directors,
Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Board of Directors.&#8221;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Any vacancies on the board of directors that arise other
than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director by resolution
passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than a quorum). Any
such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</p>


<!-- Field: Page; Sequence: 148 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->143<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the foregoing, additions to the existing board
(within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our board of directors has an audit committee in place.
See &#8220;Item 6. Directors, Senior Management and Employees&#8212;A. Directors and Senior Management&#8212;Audit Committee.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A director may be removed with or without cause by ordinary
resolution, save that each Bertelsmann Director may be removed by Bertelsmann at its discretion and each Esteves Family Director may be
removed by the Esteves Family at its discretion.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The notice of general meeting must contain a statement
of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting. The director
is entitled to attend the meeting and be heard on the motion for his removal.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The office of a director will be vacated automatically
if he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &#8220;&#8212;Anti-Corruption.&#8221;</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Articles of Association provide that our business
is to be managed and conducted by the board of directors, save that Afya may not without (i)&#160;the consent of a Bertelsmann Director
while there is a Bertelsmann Director and (ii)&#160;the consent of an Esteves Family Director while there is an Esteves Family Director:
create new classes of shares, issue new shares, options, warrants or convertible securities of similar nature conferring the right upon
the holders thereof to subscribe for purchase or receive any class of shares or securities in the capital of Afya; repurchase or redeem
any shares; approve the payment of any remuneration to a Director or executive Officer; approve any incentive plan (as set out in the
Articles of Association); change our accounting practices except as required by applicable law; execute and/or terminate any shareholders&#8217;
agreement, quotaholders&#8217; agreement, or any other agreements related to our interest in any subsidiary; approve our financial statements;
effect an initial public offering and/or follow-on offerings of Afya, or hire any investment banks or service providers inherent to the
initial public offering; approve the listing and/or the delisting of our securities with any designated stock exchange; change our dividend
policy and/or approve any dividend, create and/or use our reserves; approve any budget, as well as any amendment and/or change to such
budget; conduct, negotiate, terminate and/or amend any business, agreement, or transaction between Afya and any related party; acquire,
sell or encumber any of our permanent assets, in one transaction or in a series of transactions, which value exceeds the equivalent of
R$250 thousands; approve any sale or encumbrance, for the benefit of a person of shares issued by any subsidiary, or the admission of
any new partner or shareholder in such subsidiaries; create or dissolve any committees of the Directors; carry out any investments outside
the scope of the core business of Afya or its controlled persons (as set out in the Articles of Association); incorporate any entity;
acquire, sell or encumber the capital stock of entities in which Afya has an interest; appoint or terminate the engagement of any auditor
that is not an Authorized Auditor as set out in the Articles of Association; provide any guarantee in respect of any person or related
person of any of our shareholders, director and/or officers inter alia; negotiate, amend, renew, change of terminate any lease agreement
or enter into any new lease agreement; appoint any executive officer; approve the delegation of any powers by the board of directors;
or take actions in connection with the Company&#8217;s Anti-Corruption measures.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The quorum necessary for the board meeting shall be a
simple majority of the directors then in office (subject to there being a minimum of two directors present), provided that such a quorum
must include at least one Bertelsmann Director for so long as there is at least one Bertelsmann Director and one Esteves Family Director
for so long as there is one Esteves Family Director and business at any meeting shall be decided by a majority of votes, provided such
a majority must include at least one Bertelsmann Director for so long as there is at least one Bertelsmann Director and one Esteves Family
Director for so long as there is one Esteves Family Director. In the case of an equality of votes, neither the chairman of the board nor
the chairman of the meeting shall have a casting vote.</p>


<!-- Field: Page; Sequence: 149 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->144<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the foregoing and the provisions of the Articles
of Association, the board of directors may regulate its proceedings as they determine is appropriate. Board meetings shall be held at
least once every calendar quarter and shall take place either in Nova Lima, Brazil, or at such other place as the directors may determine.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the provisions of the Articles of Association,
to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors may from
time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures, bonds
and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company or
of any third-party.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Inspection of Books and Records</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Holders of Afya shares have no general right under Cayman
Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board of directors
may determine from time to time whether and to what extent our accounting records and books shall be open to inspection by shareholders
who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders with the right
to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as defined in the
Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan). Such right to receive
annual financial statements may be satisfied by publishing the same on the company&#8217;s website or filing such annual reports as we
are required to file with the SEC.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Register of Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Class A common shares are held through DTC, and DTC
or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&#8217; register as the holder of our Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under Cayman Islands law, Afya must keep a register of
shareholders that includes:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>whether voting rights attach to the shares in issue;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the date on which the name of any person was entered on the register as a member; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the date on which any person ceased to be a member.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <i>prima facie</i> legal title to the shares as set against his or her name in the register of shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">However, there are certain limited circumstances where
an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal
position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be rectified
where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification
of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination
by a Cayman Islands court.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Exempted Company</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Afya is an exempted company with limited liability under
the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that is registered
in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The
requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges listed
below:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</td></tr></table>


<!-- Field: Page; Sequence: 150 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->145<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company&#8217;s register of shareholders is not open to inspection;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company does not have to hold an annual general meeting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may issue shares with no par value;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a limited duration company; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an exempted company may register as a segregated portfolio company.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">&#8220;Limited liability&#8221; means that the liability
of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances,
such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances in which
a court may be prepared to pierce or lift the corporate veil).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are subject to reporting and other informational requirements
of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply with the
Nasdaq rules in lieu of following home country practice.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Some provisions of the Articles of Association may discourage,
delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the capital structure
of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions, which are summarized
below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to encourage
persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions could also have the
effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in
the market price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These provisions may
also have the effect of preventing changes in the management of Afya. It is possible that these provisions could make it more difficult
to accomplish transactions that shareholders may otherwise deem to be in their best interests.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Class B common shares of Afya are entitled to 10
votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common shares
of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of most matters
submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger, takeover,
or other change of control transaction that other shareholders may view as beneficial.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">So long as the Esteves Family and Bertelsmann have the
ability to determine the outcome of most matters submitted to a vote of shareholders as well as the overall management and direction of
Afya, third parties may be deterred in their willingness to make an unsolicited merger, takeover, or other change of control proposal,
or to engage in a proxy contest for the election of directors. As a result, the fact that Afya has two classes of common shares may have
the effect of depriving you as a holder of Class A common shares of an opportunity to sell your Class A common shares at a premium over
prevailing market prices and make it more difficult to replace the directors and management of Afya.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Preferred Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our board of directors is given wide powers to issue
one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</p>


<!-- Field: Page; Sequence: 151 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->146<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Despite the anti-takeover provisions described above,
under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of Association,
for what they believe in good faith to be in the best interests of Afya.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For further information on our outstanding Series A perpetual
convertible preferred shares, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8212;Indebtedness&#8212;Financing&#8212;Series
A Perpetual Convertible Shares&#8221; and note 13.2.1(f) to our audited consolidated financial statements included elsewhere in this annual
report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Grand Court of the Cayman Islands may, on the application
of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the Company&#8217;s affairs
and report thereon in a manner as the Grand Court shall direct.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the provisions of the Companies Act, any shareholder
may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion that this winding
up is just and equitable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Notwithstanding the U.S. securities laws and regulations
that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on the general
laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our Articles of
Association.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Cayman Islands courts ordinarily would be expected
to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya, or derivative
actions in our name, to challenge (i)&#160;an act which is ultra vires or illegal, (ii)&#160;an act which constitutes a fraud against
the minority and the wrongdoers themselves control Afya, and (iii)&#160;an irregularity in the passing of a resolution that requires a
qualified (or special) majority.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Registration Rights and Restricted Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Although no shareholders of Afya have formal registration
rights, they or entities controlled by them or their permitted transferees will be able to sell their shares in the public market from
time to time without registering them, subject to certain limitations on the timing, amount and method of those sales imposed by regulations
promulgated by the SEC.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Principal Differences between Cayman Islands and U.S. Corporate Law</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act was modeled originally after similar
laws in England and Wales but does not follow subsequent statutory enactments in England and Wales. In addition, the Companies Act differs
from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences between
the provisions of the Companies Act applicable to Afya and the laws applicable to companies incorporated in the United States and their
shareholders.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Mergers and Similar Arrangements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act permits mergers or consolidations between
two Cayman Islands companies, or between a Cayman Islands company and a company incorporated in another jurisdiction (provided that is
facilitated by the laws of that other jurisdiction).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Where the merger or consolidation is between two Cayman
Islands companies the directors of each company must approve a written plan of merger or consolidation, which must then be authorized
by (a)&#160;a special resolution (usually a majority of 66 2/3 % in value) of the shareholders of each company; and (b)&#160;such other
authorization, if any, as may be specified in such constituent company&#8217;s articles of association. No shareholder resolution is required
for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary company)
and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent company must be obtained,
unless the court waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Companies
Act (which includes certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or
consolidation. Where the merger or consolidation involves a foreign company, the procedure is similar, save that with respect to</p>


<!-- Field: Page; Sequence: 152 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->147<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">the foreign company, the director of the Cayman Islands company is required
to make a declaration to the effect that, having made due enquiry, he is of the opinion that the requirements set out below have been
met: (i) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign company and by
the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of those constitutional
documents have been or will be complied with; (ii)&#160;that no petition or other similar proceeding has been filed and remains outstanding
or order made or resolution adopted to wind up or liquidate the company in any foreign jurisdictions; (iii)&#160;that no receiver, trustee,
administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs
or property or any part thereof; (iv)&#160;that no scheme, order, compromise or similar arrangement has been entered into or made in any
jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Moreover, Cayman Islands law also has separate statutory
provisions that facilitate the reconstruction or amalgamation of companies, in certain circumstances, schemes of arrangement will generally
be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as
a &#8220;scheme of arrangement&#8221; which may be tantamount to a merger. In the event that a merger was sought pursuant to a scheme
of arrangement (the procedure of which are more rigorous and take longer to complete than the procedures typically required to consummate
a merger in the United States), the arrangement in question must be approved by a majority in number of each class of shareholders and
creditors with whom the arrangement is to be made, and who must in addition represent three-fourths in value of each such class of shareholders
or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting or meetings summoned for that
purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman
Islands. While a dissenting shareholder would have the right to express to the court the view that the transaction should not be approved,
the court can be expected to approve the arrangement if it satisfies itself that:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Afya is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to majority
vote have been complied with;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the shareholders have been fairly represented at the meeting in question;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is such as a businessman would reasonably approve; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount
to a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If a scheme of arrangement or takeover offer (as described
below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights, which would otherwise ordinarily be
available to dissenting shareholders of United States corporations, providing rights to receive payment in cash for the judicially determined
value of the shares.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Squeeze-out Provisions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">When a takeover offer is made and accepted by holders
of 90.0% of the shares to whom the offer is made within four months, the offeror may, within a two-month period, require the holders of
the remaining shares to transfer such shares on the terms of the offer. An objection may be made to the Grand Court of the Cayman Islands
but is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt; text-indent: 18pt">Further, transactions similar to a merger, reconstruction
and/or an amalgamation may in some circumstances be achieved through other means to these statutory provisions, such as a share capital
exchange, asset acquisition or control, through contractual arrangements, of an operating business.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shareholders&#8217; Suits</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt; text-indent: 18pt">Maples and Calder (Cayman) LLP, our Cayman Islands counsel
is not aware of any reported class action having been brought in a Cayman Islands court. Derivative actions have been brought in the Cayman
Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, we will be the proper plaintiff
in any claim based on a breach of duty owed to us, and a claim against (for example) our officers or directors usually may not be brought
by a shareholder. However, based on English authorities, which would in all likelihood be of</p>


<!-- Field: Page; Sequence: 153 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->148<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 12pt">persuasive authority and be applied by a court in the Cayman Islands, exceptions
to the foregoing principle apply in circumstances in which:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a company is acting or proposing to act illegally or beyond the scope of its authority;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number
of votes which have actually been obtained; and</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>those who control the company are perpetrating a &#8220;fraud on the minority.&#8221;</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A shareholder may have a direct right of action against
us where the individual rights of that shareholder have been infringed or are about to be infringed.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Borrowing Powers</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our directors may exercise all the powers of Afya to
borrow money and to mortgage or charge its undertaking, property and assets (present and future) and uncalled capital or any part thereof
and to issue debentures, debenture stock, mortgages, bonds and other such securities whether outright or as security for any debt, liability
or obligation of Afya or of any third party. Such powers may be varied by a special resolution of shareholders (requiring a two-thirds
majority vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Indemnification of Directors and Executive Officers and
Limitation of Liability</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act does not limit the extent to which
a company&#8217;s articles of association may provide for indemnification of directors and officers, except to the extent that it may
be held by the Cayman Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences
of committing a crime. Our Articles of Association provide that we shall indemnify and hold harmless our directors and officers against
all actions, proceedings, costs, charges, expenses, losses, damages, liabilities, judgments, fines, settlements and other amounts incurred
or sustained by such directors or officers, other than by reason of such person&#8217;s dishonesty, willful default or fraud, in or about
the conduct of our company&#8217;s business or affairs (including as a result of any mistake of judgment) or in the execution or discharge
of his duties, powers, authorities or discretions, including without prejudice to the generality of the foregoing, any costs, expenses,
losses or liabilities incurred by such director or officer in defending (whether successfully or otherwise) any civil, criminal or other
proceedings concerning Afya or our affairs in any court whether in the Cayman Islands or elsewhere. This standard of conduct is generally
the same as permitted under the Delaware General Corporation Law for a Delaware corporation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Insofar as indemnification for liabilities arising under
the Securities Act may be permitted to Our directors, officers or persons controlling the Company under the foregoing provisions, we have
been informed that, in the opinion of the SEC, this indemnification is against public policy as expressed in the Securities Act and is
therefore unenforceable.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Directors&#8217; and Controlling Shareholders&#8217;
Fiduciary Duties</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a matter of Cayman Islands law, a director of a Cayman
Islands company is in the position of a fiduciary with respect to the company. Accordingly, directors and officers owe the following fiduciary
duties: (1) duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole;
(2) duty to exercise powers for the purposes for which those powers were conferred and not for a collateral purpose; (3) directors should
not properly fetter the exercise of future discretion; (4) duty to exercise powers fairly as between different sections of shareholders;
(5) duty to exercise independent judgment; and (6) duty not to put themselves in a position in which there is a conflict between their
duty to the company and their personal interests. However, this obligation may be varied by the company&#8217;s articles of association,
which may permit a director to vote on a matter in which he has a personal interest provided that he has disclosed that nature of his
interest to the board of directors. With respect to the duty of directors to avoid conflicts of interest, our Articles of Association
vary from the applicable provisions of Cayman Islands law mentioned above by providing that a director must disclose the nature and extent
of his or her interest in any contract or arrangement, and following such disclosure and subject to any separate requirement under applicable
law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting, such director may vote in respect
of any transaction or arrangement in which he or she is interested and may be counted in the quorum at the meeting.</p>


<!-- Field: Page; Sequence: 154 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->149<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A director of a Cayman Islands company also owes to the
company duties to exercise independent judgment in carrying out his functions and to exercise reasonable skill, care and diligence, which
has both objective and subjective elements. Recent Cayman Islands case law confirmed that directors must exercise the care, skill and
diligence that would be exercised by a reasonably diligent person having the general knowledge, skill and experience reasonably to be
expected of a person acting as a director.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Additionally, a director must exercise the knowledge,
skill and experience which he or she actually possesses.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">A general notice may be given to the board of directors
to the effect that (i)&#160;the director is a member or officer of a specified company or firm and is to be regarded as interested in
any contract or arrangement which may after the date of the notice be made with that company or firm; or (ii)&#160;he or she is to be
regarded as interested in any contract or arrangement which may after the date of the notice to the board of directors be made with a
specified person who is connected with him or her, will be deemed sufficient declaration of interest. This notice shall specify the nature
of the interest in question. Following the disclosure being made pursuant to our Articles of Association and subject to any separate requirement
under applicable law or the listing rules of the Nasdaq, and unless disqualified by the chairman of the relevant meeting, a director may
vote in respect of any transaction or arrangement in which he or she is interested and may be counted in the quorum at the meeting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In comparison, under Delaware corporate law, a director
of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care
and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person
would exercise under similar circumstances. Under this duty, a director must inform himself or herself of, and disclose to shareholders,
all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in
a manner he or she reasonably believes to be in the best interests of the corporation. He or she must not use his or her corporate position
for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation
and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the
shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the
honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence
of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must
prove the procedural fairness of the transaction, and that the transaction was of fair value to the corporation.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Furthermore, as a matter of Cayman Islands law and in
contrast to the position under Delaware corporate law, controlling shareholders of Cayman Islands companies do not owe fiduciary duties
to those companies, other than the limited duty that applies to all shareholders to exercise their votes to amend a company&#8217;s articles
of association in good faith in the interests of the company. The absence of this minority shareholder protection might impact the ability
of minority shareholders to protect their interests.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Shareholder Proposals</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Delaware General Corporation Law, a shareholder
has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing
documents. The Delaware General Corporation Law does not provide shareholders an express right to put any proposal before the annual meeting
of shareholders, but Delaware corporations generally afford shareholders an opportunity to make proposals and nominations provided that
they comply with the notice provisions in the certificate of incorporation or bylaws. A special meeting may be called by the board of
directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Companies Act provides shareholders with only limited
rights to requisition a general meeting and does not provide shareholders with any right to put any proposal before a general meeting.
However, these rights may be provided in a company&#8217;s articles of association. Our Articles of Association provide that upon the
requisition of one or more shareholders representing not less than one-third of the voting rights entitled to vote at general meetings,
the board will convene an extraordinary general meeting and put the resolutions so requisitioned to a vote at such meeting. The Articles
of Association provide no other right to put any proposals before annual general meetings or extraordinary general meetings.</p>


<!-- Field: Page; Sequence: 155 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->150<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Cumulative Voting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Delaware General Corporation Law, cumulative
voting for elections of directors is not permitted unless the corporation&#8217;s certificate of incorporation specifically provides for
it.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cumulative voting potentially facilitates the representation
of minority shareholders on a board of directors since it permits the minority shareholder to cast all the votes to which the shareholder
is entitled on a single director, which increases the shareholder&#8217;s voting power with respect to electing such director. As permitted
under Cayman Islands law, our Articles of Association do not provide for cumulative voting. As a result, the shareholders of Afya are
not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Removal of Directors</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The office of a director shall be vacated automatically
if, among other things, he or she (i)&#160;becomes prohibited by law from being a director, (ii)&#160;becomes bankrupt or makes an arrangement
or composition with his creditors, (iii)&#160;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder
of discharging his duties as director, (iv)&#160;resigns his office by notice to us or (v)&#160;has for more than six months been absent
without permission of the directors from meetings of the board of directors held during that period, and the remaining directors resolve
that his/her office be vacated.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Transaction with Interested Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Delaware General Corporation Law provides that, unless
the corporation has specifically elected not to be governed by this statute, it is prohibited from engaging in certain business combinations
with an &#8220;interested shareholder&#8221; for three years following the date that this person becomes an interested shareholder. An
interested shareholder generally is a person or a group who or which owns or owned 15% or more of the target&#8217;s outstanding voting
shares or who or which is an affiliate or associate of the corporation and owned 15% or more of the corporation&#8217;s outstanding voting
shares within the past three years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the
target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on
which the shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction
which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware corporation to negotiate
the terms of any acquisition transaction with the target&#8217;s board of directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cayman Islands law has no comparable statute. As a result,
Afya cannot avail itself of the types of protections afforded by the Delaware business combination statute. However, although Cayman Islands
law does not regulate transactions between a company and its significant shareholders, it does provide that the board of directors owe
duties to ensure that these transactions are entered into bona fide in the best interests of the company and for a proper corporate purpose
and, as noted above, a transaction may be subject to challenge if it has the effect of constituting a fraud on the minority shareholders.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Dissolution; Winding Up</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Delaware General Corporation Law, unless the
board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding 100% of the total voting power
of the corporation. If the dissolution is initiated by the board of directors it may be approved by a simple majority of the corporation&#8217;s
outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement
in connection with dissolutions initiated by the board. Under Cayman Islands law, a company may be wound up by either an order of the
courts of the Cayman Islands or by a special resolution of its members or, if the company resolves by ordinary resolution that it be wound
up because it is unable to pay its debts as they fall due. The court has authority to order winding up in a number of specified circumstances
including where it is, in the opinion of the court, just and equitable to do so.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Companies Act, Afya may be dissolved, liquidated
or wound up by a special resolution of shareholders (requiring a two-thirds majority vote). Our Articles of Association also give its
board of directors authority to petition the Cayman Islands Court to wind up Afya.</p>


<!-- Field: Page; Sequence: 156 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->151<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Variation of Rights of Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Delaware General Corporation Law, a corporation
may vary the rights of a class of shares with the approval of a majority of the outstanding shares of that class, unless the certificate
of incorporation provides otherwise. Under our Articles of Association, if the share capital is divided into more than one class of shares,
the rights attached to any class may only be varied with the written consent of the holders of two-thirds of the shares of that class
or the sanction of a special resolution passed at a separate meeting of the holders of the shares of that class.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Also, except with respect to share capital (as described
above), alterations to our Articles of Association may only be made by special resolution of shareholders (requiring a two-thirds majority
vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Amendment of Governing Documents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Under the Delaware General Corporation Law, a corporation&#8217;s
certificate of incorporation may be amended only if adopted and declared advisable by the board of directors and approved by a majority
of the outstanding shares entitled to vote, and the bylaws may be amended with the approval of a majority of the outstanding shares entitled
to vote and may, if so provided in the certificate of incorporation, also be amended by the board of directors. Under Cayman Islands law,
our Articles of Association generally (and save for certain amendments to share capital described in this section) may only be amended
by special resolution of shareholders (requiring a two-thirds majority vote).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Rights of Non-Resident or Foreign Shareholders</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">There are no limitations imposed by our Articles of Association
on the rights of non-resident or foreign shareholders to hold or exercise voting rights on our shares. In addition, there are no provisions
in the Articles of Association governing the ownership threshold above which shareholder ownership must be disclosed.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f045"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material Contracts</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For information concerning certain contracts important
to our business, see &#8220;Item 5. Operating and Financial Review and Prospects&#8212;B. Liquidity and Capital Resources&#8221; and Item
4. Information on the Company&#8212;B. Business Overview&#8212;Our Recent Acquisitions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Except as otherwise described in this annual report on
Form 20-F, we have not entered into any material contracts other than in the ordinary course of business.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f046"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Exchange Controls</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See &#8220;Item 3. Key Information&#8212;A. Selected
Financial Data&#8212;Exchange Rates&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f047"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Taxation</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">Cayman Islands Tax Considerations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The Cayman Islands laws currently levy no taxes on individuals
or corporations based upon profits, income, gains or appreciation and there is no taxation in the nature of inheritance tax or estate
duty or withholding tax applicable to us or to any holder of Class A common shares. There are no other taxes likely to be material to
us levied by the government of the Cayman Islands except for stamp duties which may be applicable on instruments executed in, or after
execution brought within the jurisdiction of the Cayman Islands. No stamp duty is payable in the Cayman Islands on transfers of shares
of Cayman Islands companies except those which hold interests in land in the Cayman Islands. The Cayman Islands is not party to any double
tax treaties which are applicable to any payments made by or to our company. There are no exchange control regulations or currency restrictions
in the Cayman Islands.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a Cayman Islands exempted company with limited liability,
we are entitled, upon application, to receive an undertaking as to tax concessions pursuant to Section 6 of the Tax Concessions Act (as
revised). This undertaking would provide that, for a period of 20 years from the date of issue of the undertaking, no law thereafter enacted
in the Cayman Islands imposing any taxes to be levied on profits, income, gains or appreciation will apply to us or our operations.</p>


<!-- Field: Page; Sequence: 157 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->152<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Payments of dividends and capital in respect of our Class
A common shares will not be subject to taxation in the Cayman Islands and no withholding will be required on the payment of a dividend
or capital to any holder of our Class A common shares, nor will gains derived from the disposal of our Class A common shares be subject
to Cayman Islands income or corporation tax.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">There is no income tax treaty or convention currently
in effect between the United States and the Cayman Islands.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">U.S. Federal Income Tax Considerations</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is a description of the material U.S. federal
income tax consequences to the U.S. Holders described below of owning and disposing of Class A common shares, but it does not purport
to be a comprehensive description of all tax considerations that may be relevant to a particular person&#8217;s decision to own the securities.
This discussion applies to you only if you hold Class A common shares as capital assets for U.S. federal income tax purposes. In addition,
it does not describe any state, local or non-U.S. tax consequences or all of the tax consequences that may be relevant in light of your
particular circumstances, including alternative minimum tax consequences, the potential application of the provisions of the Code known
as the Medicare contribution tax and tax consequences applicable to you if you are subject to special rules, such as:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>one of certain financial institutions;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a dealer or trader in securities who uses a mark-to-market method of tax accounting;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>holding a Class A common shares as part of a straddle, wash sale, conversion transaction or integrated transaction or entering into
a constructive sale with respect to a Class A common share;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a person whose functional currency for U.S. federal income tax purposes is not the U.S. dollar;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an entity classified as partnerships for U.S. federal income tax purposes;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a tax-exempt entity, an &#8220;individual retirement account&#8221; or a &#8220;Roth IRA&#8221;;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a person who acquired our Class A common shares pursuant to the exercise of an employee stock option or otherwise as compensation;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a person that owns or is deemed to own ten percent or more of our stock (by vote or value); or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>holding shares in connection with a trade or business conducted outside of the United States.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If you are an entity classified as a partnership for
U.S. federal income tax purposes, the U.S. federal income tax treatment of a partner will generally depend on the status of the partner
and your activities. Partnerships holding Class A common shares and partners in such partnerships should consult their tax advisers as
to the particular U.S. federal income tax consequences of holding and disposing of the Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">This discussion is based on the Internal Revenue Code
of 1986, as amended (the &#8220;Code&#8221;), administrative pronouncements, judicial decisions, and final, temporary and proposed Treasury
regulations all as of the date hereof, any of which is subject to change, possibly with retroactive effect.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">You are a &#8220;U.S. Holder&#8221; if for U.S. federal
income tax purposes you are a beneficial owner of Class A common shares and:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a citizen or individual resident of the United States;</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>a corporation created or organized in or under the laws of the United States, any state therein or the District of Columbia; or</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>an estate or trust the income of which is subject to U.S. federal income taxation regardless of its source.</td></tr></table>


<!-- Field: Page; Sequence: 158 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->153<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Taxation of Distributions</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is subject to the discussion in &#8220;&#8212;Passive
Foreign Investment Company Rules&#8221; below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As discussed above under &#8220;Item 8. Financial Information&#8212;Dividends
and Dividend Policy,&#8221; we do not currently intend to pay dividends. In the event that we pay dividends, distributions paid on our
Class A common shares, other than certain <i>pro rata</i> distributions of Class A common shares, will be treated as dividends for U.S.
federal income tax purposes to the extent paid out of our current or accumulated earnings and profits (as determined under U.S. federal
income tax principles). Because we do not maintain calculations of our earnings and profits under U.S. federal income tax principles,
it is expected that distributions generally will be reported to you as dividends. Subject to applicable limitations, dividends paid to
certain non-corporate U.S. Holders may be eligible for taxation as &#8220;qualified dividend income&#8221; and therefore may be taxable
at rates applicable to long-term capital gains, provided the Class A common shares are treated as readily tradeable on an established
securities market in the United States. You should consult your tax adviser regarding the availability of the reduced tax rate on dividends
in your particular circumstances. The amount of any dividend will be treated as foreign-source dividend income and will not be eligible
for the dividends-received deduction generally available to U.S. corporations under the Code. Dividends will be included in your income
on the date of receipt.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As discussed in &#8220;&#8212;Cayman Island Tax Considerations,&#8221;
there are currently no applicable withholding taxes under Cayman Island law. However, if any non-U.S. income taxes were withheld from
distributions on your Class A common shares, the amount of the withheld tax would be includible in your income as a dividend. Subject
to applicable limitations, some of which vary depending upon your circumstances, the non-U.S. withholding tax may be potentially creditable
against your U.S. federal income tax liability. Recently issued Treasury regulations impose additional requirements for non-U.S. taxes
to be eligible for foreign tax credit, and we cannot assure you that any non-U.S. income taxes would be creditable against your U.S. federal
income tax liability. The rules governing foreign tax credits are complex, and you should consult your tax adviser regarding the creditability
or deductibility of non-U.S. taxes, if any, in your particular circumstances (including any applicable limitations).</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Sale or Other Disposition of Class A Common Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following is subject to the discussion in &#8220;&#8212;<i>Passive
Foreign Investment Company Rules</i>&#8221; below.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For U.S. federal income tax purposes, gain or loss realized
on the sale or other disposition of a Class A common share will be capital gain or loss, and will be long-term capital gain or loss if
you have held the Class A common share for more than one year. The amount of the gain or loss will equal the difference between your tax
basis in the Class A common share disposed of and the amount realized on the disposition, in each case as determined in U.S. dollars.
This gain or loss will generally be U.S.-source gain or loss for foreign tax credit purposes. Long-term capital gains of non-corporate
U.S. Holders are eligible for reduced rates of taxation. The deductibility of capital losses is subject to limitations. If any non-U.S.
taxes were imposed on gains from dispositions of the Class A common shares, it is expected that those taxes would not be creditable against
your U.S. federal income tax liability. You should consult your tax adviser regarding the U.S. federal income tax consequences if any
non-U.S. income taxes were imposed on disposition gains.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Passive Foreign Investment Company Rules</p>

<p style="font: 10pt Times New Roman,serif; margin: 0.45pt 0 12pt; text-indent: 36pt">Under the Code, we will be a PFIC for any taxable
year in which, after the application of certain &#8220;look-through&#8221; rules with respect to subsidiaries, either (i) 75% or more
of our gross income consists of &#8220;passive income,&#8221; or (ii) 50% or more of the average quarterly value of our assets consists
of assets that produce, or are held for the production of, &#8220;passive income.&#8221; For purposes of the above calculations, we will
be treated as if we hold our proportionate share of the assets of, and receive directly our proportionate share of the income of, any
other corporation in which we directly or indirectly own at least 25%, by value, of the shares of such corporation. Passive income generally
includes dividends, interest, certain non-active rents or royalties and investment gains. Cash is generally a passive asset for these
purposes. Goodwill is an active asset to the extent attributable to activities that produce active income.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Based on the composition of our income and assets and
the value of our assets, including goodwill, which is based on the price of our Class A common shares, we believe that we were not a PFIC
for the taxable year of 2021. However, because we hold a substantial amount of cash (relative to the assets shown on our balance sheet)
and</p>


<!-- Field: Page; Sequence: 159 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->154<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">because our PFIC status for any taxable year will depend on the composition
of our income and assets and the value of our assets from time to time (which may be determined, in part, by reference to the market price
of our Class A common shares, which could be volatile), there can be no assurance that we will not be a PFIC for any taxable year. If
our Class A common share price declines while we continue to hold a substantial amount of cash for any taxable year, our risk of being
or becoming a PFIC will increase. In addition, as we continue to expand our business through acquisitions and organically, our risk of
becoming a PFIC will increase if we engage in activities that generate substantial passive income. Moreover, the extent to which our goodwill
will be treated as an active asset is not entirely clear. If we were a PFIC for any taxable year during which you hold Class A common
shares, we generally would continue to be treated as a PFIC with respect to you for all succeeding years during which you hold Class A
common shares, even if we ceased to meet the threshold requirements for PFIC status.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If we were a PFIC for any taxable year and any of our
subsidiaries or other companies in which we owned or were treated as owning equity interests were also a PFIC (any such entity, a &#8220;Lower-tier
PFIC&#8221;), you would be deemed to own a proportionate amount (by value) of the shares of each Lower-tier PFIC and would be subject
to U.S. federal income tax according to the rules described in the subsequent paragraph on (i) certain distributions by a Lower-tier PFIC
and (ii) dispositions of shares of Lower-tier PFICs, in each case as if you held such shares directly, even though you would not receive
the proceeds of those distributions or dispositions.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If we were a PFIC for any taxable year during which you
held any of our Class A common shares, you could be subject to adverse tax consequences. Generally, gain recognized upon a disposition
(including, under certain circumstances, a pledge) of Class A common shares would be allocated ratably over your holding period for the
shares. The amounts allocated to the taxable year of disposition and to years before we became a PFIC would be taxed as ordinary income.
The amount allocated to each other taxable year would be subject to tax at the highest rate in effect for that taxable year for individuals
or corporations, as appropriate, and an interest charge would be imposed on the tax on such amount. Further, to the extent that distributions
received on your Class A common shares in a taxable year exceeded 125% of the average of the annual distributions on those shares during
the preceding three taxable years or your holding period, whichever was shorter, the excess distributions would be subject to taxation
in the same manner as gain, described immediately above.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Alternatively, if we were a PFIC and if the Class A common
shares were &#8220;regularly traded&#8221; on a &#8220;qualified exchange,&#8221; you could be eligible to make a mark-to- market election
that would result in tax treatment different from the general tax treatment for PFICs described above. The Class A common shares would
be treated as &#8220;regularly traded&#8221; in any calendar year in which more than a <i>de minimis </i>quantity of the Class A common
shares were traded on a qualified exchange on at least 15 days during each calendar quarter. The Nasdaq, on which the Class A common shares
are listed, is a qualified exchange for this purpose. Once made, the election cannot be revoked without the consent of the IRS unless
the shares cease to be marketable.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If you make the mark-to-market election, you generally
will recognize as ordinary income any excess of the fair market value of your Class A common shares at the end of each taxable year over
their adjusted tax basis, and will recognize an ordinary loss in respect of any excess of the adjusted tax basis of the Class A common
shares over their fair market value at the end of the taxable year (but only to the extent of the net amount of income previously included
as a result of the mark-to-market election). If you make the election, your tax basis in your Class A common shares will be adjusted to
reflect these income or loss amounts. Any gain recognized on the sale or other disposition of Class A common shares in a year when we
are a PFIC will be treated as ordinary income and any loss will be treated as an ordinary loss (but only to the extent of the net amount
of income previously included as a result of the mark-to-market election, with any excess treated as a capital loss). This election cannot
be made with respect to any of our subsidiaries because the shares of which are not regularly traded. Accordingly, you may continue to
be subject to tax under the PFIC excess distribution regime with respect to any lower-tier PFICs notwithstanding your mark-to-market election
for the Class A common shares.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We do not intend to provide information necessary for
you to make a qualifying electing fund election which would result in alternative treatment.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">In addition, if we were a PFIC for any taxable year in
which we paid a dividend or for the prior taxable year, the preferential dividend rates discussed above with respect to dividends paid
to certain non-corporate U.S. Holders would not apply.</p>


<!-- Field: Page; Sequence: 160 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->155<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">If you own Class A common shares during any year in which
we are a PFIC, you generally must file annual reports on IRS Form 8621 (or any successor form) with respect to us, generally with your
federal income tax return for that year. A failure to file one or more of these forms as required may toll the running of the statute
of limitations in respect of each of your taxable years for which such form is required to be filed. As a result, the taxable years with
respect to which you fail to file the form may remain open to assessment by the IRS.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">You should consult your tax adviser regarding whether
we are a PFIC and the potential application of the PFIC rules.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Information Reporting and Backup Withholding</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Payments of dividends and sales proceeds that are made
within the United States or through certain U.S.-related financial intermediaries generally are subject to information reporting, and
may be subject to backup withholding, unless (i) you are a corporation or other exempt recipient or (ii) in the case of backup withholding,
you provide a correct taxpayer identification number and certify that you are not subject to backup withholding.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Backup withholding is not an additional tax. The amount
of any backup withholding from a payment to you will be allowed as a refund or credit against your U.S. federal income tax liability and
may entitle you to a refund, provided that the required information is timely furnished to the IRS.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Foreign Financial Asset Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Certain U.S. Holders who are individuals (and certain
specified entities) may be required to report information relating to their ownership of Class A common shares, or non-U.S. accounts through
which Class A common shares are held. You should consult your tax adviser regarding your reporting obligations with respect to the Class
A common shares.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f048"></span>F.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Dividends and Paying Agents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f049"></span>G.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Statement by Experts</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f050"></span>H.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Documents on Display</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are subject to the informational requirements of the
Exchange Act applicable to foreign private issuers. Accordingly, we are required to file reports and other information with the SEC, including
annual reports on Form 20-F within four months from the end of each of our fiscal years, and reports on Form 6-K. You can read our SEC
filings over the Internet at the SEC&#8217;s website at www.sec.gov. You may also read and copy any document we file with the SEC at its
public reference room at 100 F. Street, N.E., Washington, D.C. 20549. You may obtain copies of these documents upon the payment of the
fees prescribed by the SEC. Please call the SEC at 1-800-SEC-0330 for further information about the public reference room.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f051"></span>I.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Subsidiary Information</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See note 2.2 to our audited consolidated financial statements
for a description of the Company&#8217;s subsidiaries.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f052"></span>ITEM 11. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are exposed to market risks in the ordinary course
of our business, including the effects of interest rate changes and foreign currency fluctuations. We monitor market, credit and operational
risks in line with the objectives in capital management, supported by the oversight of our Board of Directors, in decisions related to
capital management and to ensure their consistency with our objectives and assessment of risks. Information relating to quantitative and
qualitative disclosures about these market risks is described below.</p>


<!-- Field: Page; Sequence: 161 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->156<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Interest Rate Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Interest rate risk is the risk that the fair value or
future cash flows of a financial instrument will fluctuate because of changes in market interest rates. The Company&#8217;s exposure to
the risk of changes in market interest rates relates primarily to the Company&#8217;s cash equivalents and financial investments classified
as restricted cash with floating interest rates and accounts payable to selling shareholders.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table demonstrates the sensitivity to a
reasonably possible change in the current interest rates on cash equivalents, restricted cash, loans and financing and derivatives and
accounts payable to selling shareholders. With all variables held constant, the Company&#8217;s income before income taxes is affected
through the impact on floating interest rate, as follows:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 7pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">&#160;</td>
    <td style="font: bold 7pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">&#160;</td>
    <td style="font: bold 7pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">&#160;</td>
    <td style="font: bold 7pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">&#160;</td>
    <td colspan="4" style="padding-right: 5pt; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Increase
    / decrease in basis points</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 7pt/9pt Times New Roman,serif; padding-right: 5pt; width: 36%; text-align: center; padding-left: 3pt">&#160;</td>
    <td style="padding-right: 5pt; width: 8%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Balance as
    of December 31, 2021</p></td>
    <td style="padding-right: 5pt; width: 11%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Index &#8211;
    % per year</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Base rate</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">+75</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">-75</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">+150</p></td>
    <td style="padding-right: 5pt; width: 9%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">-150</p></td></tr>
  <tr>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; vertical-align: top; padding-left: 3pt">&#160;</td>
    <td colspan="7" style="font: 8pt Times New Roman,serif; padding-right: 5pt; vertical-align: bottom; text-align: right; padding-left: 3pt"><span style="font-size: 6pt"><b>(amounts in R$ thousands, unless otherwise stated)</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Cash equivalents&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">636,847</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">100.38% CDI</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">58,440</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">4,776</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(4,776)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">9,553</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(9,553)</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Loans and financing&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(510,972)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">CDI + 1,62%</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(55,032)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(3,832)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">3,832</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(7,665)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">7,665</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Loans and financing&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(31,199)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">CDI + 1,75%</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(3,401)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(234)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">234</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(468)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">468</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Loans and financing&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(10,145)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">TJLP</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(617)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(76)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">76</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(152)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">152</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Accounts payable to selling shareholders&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(612,121)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">CDI</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(56,009)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(4,591)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">4,591</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(9,182)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">9,182</td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Accounts payable to selling shareholders&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(41,581)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">IPCA + 4,1%</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(1,708)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(312)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">312</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(624)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">624</td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; padding-left: 3pt">Notes payable&#9;</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(72,726)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 3pt">IPCA</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(531)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(545)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">545</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">(1,091)</td>
    <td style="font: 8pt Times New Roman,serif; padding-right: 5pt; text-align: right; padding-left: 3pt">1,091</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For further information, see note 13.4.1 to our audited
consolidated financial statements included elsewhere in this annual report.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Foreign Currency Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Foreign currency risk is the risk that the fair value
or future cash flows of an exposure will fluctuate because of changes in foreign exchange rates. Our exposure to the risk of changes in
foreign exchange rates relates to cash and cash equivalents denominated in U.S. dollars in the amount of R$23.2 million as of December
31, 2021. See note 13.4.1 to our audited consolidated financial statements for a sensitivity analysis of the impact of a hypothetical
10% change in the exchange rate variation on our cash and cash equivalents as of December 31, 2021.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Credit Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Credit risk is the risk that a counterparty will not
meet its obligations under a financial instrument or customer contract, leading to a financial loss. We are exposed to credit risk from
our operating activities (primarily trade receivables) and from our financing activities, including cash and cash equivalents and restricted
cash. We manage customer credit risk based on the established policy, procedures and control relating to customer credit risk management.
Outstanding customer receivables are regularly monitored. Credit risk from balances with banks and financial institutions is managed by
our treasury department in accordance with our policy. Investments of surplus funds are made only with approved counterparties and within
limits assigned to each counterparty.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our maximum exposure to credit risk for the components
of the statements of financial position as of December 31, 2021 and 2020 is the carrying amounts of our financial assets. For more information,
see note 13.4.2 to our audited consolidated financial statements.</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Liquidity Risk</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our management is responsible for monitoring liquidity
risk. To this end, management regularly reviews the risk and maintains appropriate reserves, including bank credit facilities with first-tier
financial institutions. Management also continuously monitors projected and actual cash flows and the combination of the maturity profiles
of the financial assets and liabilities. The main requirements for financial resources used by us arise from the need to make payments
for suppliers, operating expenses, labor and social obligations, loans and financing and accounts payable to selling shareholders.</p>


<!-- Field: Page; Sequence: 162 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->157<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">For more information, see &#8220;Item 5. Operating and
Financial Review and Prospects&#8212;F. Tabular Disclosure of Contractual Obligations.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f053"></span>ITEM 12. DESCRIPTION OF SECURITIES OTHER THAN EQUITY SECURITIES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f054"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Debt Securities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f055"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Warrants and Rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f056"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Other Securities</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f057"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;American Depositary Shares</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>


<!-- Field: Page; Sequence: 163 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->158<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="a_20f058"></span>PART II</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f059"></span>ITEM 13. DEFAULTS, DIVIDEND ARREARAGES AND DELINQUENCIES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f060"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Defaults</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f061"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Arrears and delinquencies</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">No matters to report.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f062"></span>ITEM 14. MATERIAL MODIFICATIONS TO THE RIGHTS OF SECURITY HOLDERS AND
USE OF PROCEEDS</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f063"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications
to instruments</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f064"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Material modifications
to rights</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f065"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Withdrawal or substitution
of assets</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f066"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Change in trustees or paying
agents</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f067"></span>E.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Use of proceeds</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On July 19, 2019, our registration Statement on Form
F-1 (File No 333-232309), as amended, was declared effective by the SEC for our initial public offering of our Class A common shares,
pursuant to which we sold a total of 15,805,841 Class A common shares, par value $0.00005 per share, at a public offering price of US$19.00
per share. BofA Securities,&#160;Inc., Goldman Sachs&#160;&amp;&#160;Co.&#160;LLC, and UBS Securities&#160;LLC, Itau BBA USA Securities,&#160;Inc.
acted as the representatives of the underwriters in our initial public offering.&#160;We received approximately US$242.7 million of net
proceeds from our initial public offering (i.e., after deducting underwriting discounts, commissions and offering expenses).</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">On February 6, 2020, our registration Statement on Form
F-1 (File No 333-236246), as amended, was declared effective by the SEC for a public offering of our Class A common shares, pursuant to
which we sold a total of 3,260,480 Class A common shares, par value $0.00005 per share, at a public offering price of US$27.50 per share.
BofA Securities,&#160;Inc., Goldman Sachs&#160;&amp;&#160;Co.&#160;LLC, and UBS Securities&#160;LLC, Itau BBA USA Securities,&#160;Inc.
acted as the representatives of the underwriters of this offering.&#160;We received approximately US$86.6 million of net proceeds from
our follow-on offering (i.e., after deducting underwriting discounts, commissions and offering expenses).</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f068"></span>ITEM 15. CONTROLS AND PROCEDURES</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f069"></span>A.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Disclosure Controls and
Procedures</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">Under the supervision
and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we have evaluated the
effectiveness of the design and operation of our disclosure controls and procedures as of December 31, 2021. There are inherent limitations
to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention
or overriding of the controls and procedures. Accordingly, even effective controls and procedures can only provide reasonable assurance
of achieving their control objectives. Based on that evaluation, as of December 31, 2021, our Chief Executive Officer and Chief Financial
Officer have concluded that these controls and procedures are effective to</span></p>


<!-- Field: Page; Sequence: 164 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->159<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 10pt">provide reasonable assurance that all material information required
to be filed in this annual report has been made known to them in a timely fashion.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">Our disclosure controls
and procedures are effective to provide reasonable assurance that information required to be disclosed in the reports that we file or
submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC&#8217;s rules
and forms and are effective to provide reasonable assurance that information to be disclosed in the reports that we file or submit under
the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer,
to allow timely decisions regarding required disclosure.</span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f070"></span>B.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Management&#8217;s Annual
Report on Internal Control Over Financial Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">Our management is responsible
for establishing and maintaining effective internal control over financial reporting as defined in Rule 13a-15(f) of the Exchange Act.
Our internal control over financial reporting is designed to provide reasonable assurance to our management and board of directors regarding
the preparation and fair presentation of published financial statements. Because of its inherent limitations, internal control over financial
reporting may not prevent or detect misstatements.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">In accordance with
guidance issued by the Securities and Exchange Commission, companies are permitted to exclude acquisitions from their final assessment
of internal control over financial reporting for the first fiscal year in which the acquisition occurred. As such, our management&#8217;s
evaluation of internal control over financial reporting excluded the internal control activities of ICLINIC, which was acquired in January
2021, MEDICINAE, acquired in March 2021, MEDICAL HARBOUR and CLIQUE FARMA, acquired in April 2021, SHOSP, acquired in May 2021, UNIFIPMOC,
acquired in June 2021, UNIGRANRIO, acquired in August 2021 and RXPRO, acquired in October 2021 as discussed in note 5 to our audited consolidated
financial statements. We have included the financial results of these in the consolidated financial statements from the date of acquisition.
Such entities represented approximately 7% and 2% of total equity and net assets, respectively, as of December 31, 2021 and 13% and 17%
of net revenue and net income, respectively, for the year then ended. </span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">Our management, with
the participation of the Chief Executive Officer and Chief Financial Officer, under the oversight of our board of directors, evaluated
the effectiveness of the Company&#8217;s internal control over financial reporting as of December 31, 2021. In making this assessment,
management used the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control &#8211;
Integrated Framework (2013), or COSO 2013. Based on this assessment, management believes that, as of December 31, 2021, our internal control
over financial reporting was effective and had no material weaknesses, based on those criteria.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">In 2021, we conducted
the remediation of the material weakness in the ITGC environment to be completed, which was accomplished through several actions, such
as: review of all IT General Controls to address the issues related to the material weaknesses, standardization of logins, implement the
Segregation of Duties matrix (SOD), improvements in all accesses granting and recertification processes, realized a complete review of
our ERP access profiles based on the RBAC methodology (Role-based access control) and last but not least, we have further strengthened
our IT technical team and the IT Governance.</span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f071"></span>C.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Attestation Report of the
Registered Public Accounting Firm</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The effectiveness of internal control over financial
reporting as of December 31, 2021, which did not include an evaluation of the internal control over financial reporting of ICLINIC, UNIFIPMOC,
UNIGRANRIO, RXPRO, MEDICAL HARBOUR, CLIQUE FARMA, SHOSP and MEDICINAE, has been audited by Ernst &amp; Young Auditores Independentes S.S.,
or EY, the independent registered public accounting firm that also audited our consolidated financial statements as of and for the year
then ended. EY has issued an attestation report on the effectiveness of our internal controls over financial reporting as of December 31, 2021.
Their attestation report on internal controls over financial reporting is included herein.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f072"></span>D.&#160;&#160;&#160;&#160;&#160;&#160;&#160;Changes in Internal Control
Over Financial Reporting</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">We have mapped new
controls to the PEBMED revenue process (all evaluated as effective), increase our IT technical team and the IT Governance Team, review
all IT General Controls to address the issues related to the material weaknesses (remediated as described in ITEM B), we have implemented
new system GESPLAN to improve our Financial Operations Management, Cash Flow and Leasing Management (IFRS 16).</span></p>


<!-- Field: Page; Sequence: 165 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->160<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0pt 0pt 10pt"></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">In 2021, we conducted
the remediation of the material weakness in the ITGC environment to be completed, which was accomplished through several actions, such
as: review of all IT General Controls to address the issues related to the material weaknesses, standardization of logins, implement the
Segregation of Duties matrix (SOD), improvements in all accesses granting and recertification processes, realized a complete review of
our ERP access profiles based on the RBAC methodology (Role-based access control) and last but not least, we have further strengthened
our IT technical team and the IT Governance.</span></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><span style="font-weight: normal">With the exception
of the changes listed above, there were no other changes in our internal control over financial reporting (as such term is defined in
Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the year ended December 31, 2021 that materially affected or
are reasonably likely to materially affect our internal control over financial reports.</span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f073"></span>ITEM 16. RESERVED</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f074"></span>ITEM 16A. AUDIT COMMITTEE FINANCIAL EXPERT</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The audit committee, which currently consists of Vanessa
Claro Lopes, Jo&#227;o Paulo Seibel de Faria and Miguel Filisbino Pereira de Paula, assists our board of directors in overseeing our
accounting and financial reporting processes and the audits of our financial statements. In addition, the audit committee is directly
responsible for the appointment, compensation, retention and oversight of the work of our independent registered public accounting firm.
Vanessa Claro Lopes serves as Chairman of the audit committee. The audit committee consists exclusively of members of our board of directors
who are financially literate, and Vanessa Claro Lopes qualifies as &#8220;audit committee financial expert&#8221; as defined in Item 16A
of Form 20-F. Our board of directors has determined that Vanessa Claro Lopes, Jo&#227;o Paulo Seibel de Faria and Miguel Filisbino Pereira
de Paula satisfy the &#8220;independence&#8221; requirements set forth in Rule 10A-3 under the Exchange Act. For more information, see
&#8220;Item 6. Directors, Senior Management and Employees&#8212;C. Board Practices&#8212;Board Committees&#8212;Audit Committee.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f075"></span>ITEM 16B. CODE OF ETHICS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Our activities are subject to a code of ethics, which
is applicable to all our members and entities, including our directors, officers, managers, teachers and other staff (including interns).
Our code of ethics is also applicable to relevant third parties involved in our activities, such as suppliers, consultants and other service
providers. Our code of ethics describes our mission, vision and values and provides the relevant conduct standards that must be followed
by our members and entities. It regulates our interactions with our suppliers, students, clients, competitor suppliers and governmental
entities and agents. Our code of ethics also sets forth fundamental rules of conduct related to the safeguarding of our financial books
and records, conflict of interest situations, the protection of our confidential information and assets and our compliance with applicable
laws and relevant information on whistleblowing procedures. The Code of Ethics is included as an exhibit to this annual report. We have
also posted a copy of our code of business conduct and ethics on our website at https://ir.afya.com.br/corporate-governance/governance-overview.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f076"></span>ITEM 16C. PRINCIPAL ACCOUNTANT FEES AND SERVICES</p>

<p style="font: italic bold 10pt Times New Roman,serif; margin: 0 0 10pt 9.35pt">Audit and Non-Audit Fees</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The following table sets forth the aggregate fees by
categories specified below in connection with certain professional services rendered by Ernst &amp; Young Auditores Independentes S.S.,
our principal accountants, for the periods indicated. Our independent registered public accounting firm was Ernst &amp; Young Auditores
Independentes S.S. for the years ended December 31, 2021 and 2020.</p>



<!-- Field: Page; Sequence: 166 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->161<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>
<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="2" style="padding-right: 5pt; text-align: center; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Year Ended
    December 31,</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; width: 75%; text-align: center">&#160;</td>
    <td style="padding-right: 5pt; text-align: center; width: 14%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2021</p></td>
    <td style="padding-right: 5pt; text-align: center; width: 11%; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">2020</p></td></tr>
  <tr style="vertical-align: bottom">
    <td style="font: bold 8pt/9pt Times New Roman,serif; text-align: center">&#160;</td>
    <td colspan="2" style="font: bold 8pt/9pt Times New Roman,serif; padding-right: 5pt; text-align: center; padding-left: 5pt">(in R$ millions)</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Audit fees (1)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">6.3</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">5.3</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">Audit-related fees (2)&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td>
    <td style="padding-right: 5pt; vertical-align: top; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">2.7</td></tr>

<tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; width: 77%; font-family: Times New Roman,serif">Tax fees&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; width: 13%; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">0.2</td>
    <td style="padding-right: 5pt; vertical-align: top; width: 10%; font-family: Times New Roman,serif; text-align: right; padding-left: 5pt">&#8212;</td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif">All other fees&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 0.5pt solid; font: 10pt Times New Roman,serif; margin: 0; text-align: right">&#8212;</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: bottom; font-family: Times New Roman,serif"><b>Total fees</b>&#9;</td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>6.5</b></p></td>
    <td style="padding-right: 5pt; text-align: right; vertical-align: top; padding-left: 5pt">
    <p style="border-bottom: Black 1.5pt double; font: 10pt Times New Roman,serif; margin: 0 0 1pt; text-align: right"><b>8.0</b></p></td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(1)</td><td>Audit fees include fees for the audit of our annual consolidated financial statements; audit of the effectiveness of internal control
over financial reporting, audit of statutory financial statements of subsidiaries; review of our interim financial statements, and audit
of financial statements of acquired businesses.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">(2)</td><td>Audit-related fees include fees for the preparation and issuance of comfort letters in connection with our equity offerings.</td></tr></table>

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The policy of our audit committee is to pre-approve all
audit and non-audit services provided by Ernst &amp; Young Auditores Independentes S.S., including audit services, audit-related services,
tax services and other services as described above, other than those for <i>de minimus</i> services that are approved by the audit committee
prior to the completion of the audit.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f077"></span>ITEM 16D. EXEMPTIONS FROM THE LISTING STANDARDS FOR AUDIT COMMITTEES</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We are relying on the exemption under Rule 10A-3(b)(1)(iv)(A)(2)
of the Exchange Act, which provides that a minority of the members of the listed issuer&#8217;s audit committee may be exempt from the
independence requirements of paragraph (b)(1)(ii) of Rule 10A-3 for one year from the date of effectiveness of the registration statement
covering an initial public offering of securities listed by the issuer. Our audit committee currently comprises three directors, all of
whom are independent directors.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We do not believe that our reliance on the temporary
exemption permitted by Rule 10A-3(b)(1)(iv)(A)(2) materially adversely affects the ability of our audit committee to act independently
or to satisfy the requirements of Rule 10A-3 under the Exchange Act. Our audit committee will consist solely of independent directors
within one year of our initial public offering.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f078"></span>ITEM 16E. PURCHASES OF EQUITY SECURITIES BY THE ISSUER AND AFFILIATED
PURCHASERS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Set forth below, in tabular format, is disclosure on
the repurchase of our Class A common shares for the year ended December 31, 2021:</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5pt; width: 36%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Period</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 16%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Total Number
    of Shares Purchased (1)</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 16%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Average Price
    Paid per Share</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 16%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Total Number
    of Shares Purchased as Part of Publicly Announced Plans or Programs</p></td>
    <td style="padding-right: 5pt; text-align: right; width: 16%; padding-left: 3pt">
    <p style="border-bottom: Black 0.5pt solid; font: bold 7pt/9pt Times New Roman,serif; margin-top: 1pt; margin-bottom: 2pt; text-align: center">Maximum Number
    (or Approximate Dollar Value) of Shares that May Yet Be Purchased under the Plans or Programs</p></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">January 1 to January 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">155,025</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 125.15</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">155,025</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">155,025</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">February 1 to February 28, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">116,005</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 124.80</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">116,005</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">116,005</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">March 1 to March 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">250,087</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 123.45</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">250,087</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">250,087</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">April 1 to April 30, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 0.00</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">May 1 to May 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 0.00</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">June 1 to June 30, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 0.00</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">July 1 to July 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 0.00</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">0</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">August 1 to August 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">10,000</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 119.36</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">10,000</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">10,000</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">September 1 to September 30, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">289,385</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 112.66</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">289,385</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">289,385</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">October 1 to October 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">228,379</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 106.14</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">228,379</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">228,379</td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">November 1 to November 30, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">231,972</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 84.87</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">231,972</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">231,972</td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5pt; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt">December 1 to December 31, 2021&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">861,198</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">R$ 82.70</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">861,198</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt">861,198</td></tr>

  <tr style="background-color: rgb(204,238,255)">
    <td style="padding-right: 5pt; text-align: left; vertical-align: bottom; font-family: Times New Roman,serif; padding-left: 3pt"><b>Total</b>&#9;</td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt"><b>2,142,051</b></td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt"><b>R$ 90.34</b></td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt"><b>2,142,051</b></td>
    <td style="padding-right: 5pt; vertical-align: top; text-align: right; font-family: Times New Roman,serif; padding-left: 3pt"><b>2,142,051</b></td></tr>
  </table>


<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->
<p style="font: 10pt Times New Roman,serif; margin: 0 0 5pt 18pt; text-indent: -18pt">(1) For more information on our second share repurchase
program and our third share repurchase program, see &#8220;Item 10. Additional Information&#8212;B. Memorandum and Articles of Association&#8212;Share
Repurchases.&#8221;</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt">&#160;</p>
<!-- Field: Page; Sequence: 167 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->162<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f079"></span>ITEM 16F. CHANGE IN REGISTRANT&#8217;S CERTIFYING ACCOUNTANT</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">None.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f080"></span>ITEM 16G. CORPORATE GOVERNANCE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Cayman Islands law restricts transactions between a company
and its directors unless there are provisions in the Articles of Association which provide a mechanism to alleviate possible conflicts
of interest. Additionally, Cayman Islands law imposes on directors&#8217; duties of care and skill and fiduciary duties to the companies
which they serve. Under our Articles of Association, a director must disclose the nature and extent of his interest in any contract or
arrangement, and following such disclosure and subject to any separate requirement under applicable law or the listing rules of the Nasdaq,
and unless disqualified by the chairman of the relevant meeting, the interested director may vote in respect of any transaction or arrangement
in which he or she is interested. The interested director shall be counted in the quorum at such meeting and the resolution may be passed
by a majority of the directors present at the meeting.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Subject to the foregoing and our Articles of Association,
our directors may exercise all the powers of Afya to vote compensation to themselves or any member of their body in the absence of an
independent quorum. Our Articles of Association provide that, in the event a Compensation Committee is established, it shall be made up
of such number of independent directors as is required from time to time by the Nasdaq rules (or as otherwise may be required by law).
We currently have no intention to establish a Compensation Committee.</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">As a foreign private issuer, we are permitted to follow
home country practice in lieu of certain Nasdaq corporate governance rules, subject to certain requirements. We currently rely, and will
continue to rely, on the foreign private issuer exemption with respect to the following rules:</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(b), which requires that independent directors comprise a majority of a company&#8217;s board of directors. As allowed
by the laws of the Cayman Islands, independent directors do not comprise a majority of our board of directors.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(e)(1), which requires that a company have a nominations committee comprised solely of &#8220;independent directors&#8221;
as defined by Nasdaq. As allowed by the laws of the Cayman Islands, we do not have a nominations committee nor do we have any current
intention to establish one.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5605(d) &amp; (e), which require that compensation for our executive officers and selection of our director nominees be
determined by a majority of independent directors. As allowed by the laws of the Cayman Islands, we do not have a nomination and corporate
governance committee or remuneration committee nor do we have any current intention to establish either.</td></tr></table>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 10pt"><tr style="vertical-align: top">
<td style="width: 18pt"></td><td style="width: 18pt"><span style="font-family: Symbol">&#183;</span></td><td>Nasdaq Rule 5635, which requires an issuer to obtain shareholder approval prior to an issuance of securities (in certain circumstances)
in connection with certain events, including: (i) the acquisition of the stock or assets of another company; (ii) equity-based compensation
of officers, directors, employees or consultants; (iii) a change of control; and (iv) private placements.&#160; Cayman Islands law does
not require shareholder approval prior to an issuance of securities to the extent the securities are authorized.</td></tr></table>


<!-- Field: Page; Sequence: 168 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->163<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f081"></span>ITEM 16H. MINE SAFETY DISCLOSURE</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f082"></span>ITEM 16I. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">Not applicable.</p>


<!-- Field: Page; Sequence: 169 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->164<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0"><span style="text-transform: uppercase"><b>&#160;</b></span></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-transform: uppercase; text-align: center"><span id="a_20f083"></span>PART III</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f084"></span>ITEM 17. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">We have responded to Item 18 in lieu of this item.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f085"></span>ITEM 18. FINANCIAL STATEMENTS</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">See our consolidated financial statements beginning on
page F-1.</p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt"><span id="a_20f086"></span>ITEM 19. EXHIBITS</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 10%">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Exhibit No.</p></td>
    <td style="width: 90%">
    <p style="border-bottom: Black 0.5pt solid; font: bold 8pt/9pt Times New Roman,serif; margin: 1pt 0 2pt; text-align: center">Description</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-3_1.htm">1.1</a></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-3_1.htm">Memorandum and Articles of Association of Afya (incorporated herein by reference to Exhibit 3.1 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="ex01-2.htm">1.2*</a></td>
    <td style="font-family: Times New Roman,serif"><a href="ex01-2.htm">Amended and Restated Memorandum and Articles of Association of Afya adopted on July 23, 2021, effective as of August 5, 2021.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000129281421002044/ex99-2.htm">1.3</a></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000129281421002044/ex99-2.htm">Certificate of Designations of Series A Perpetual Convertible Preferred Shares of Afya dated May 3, 2021 (incorporated herein by reference to Exhibit 99.2 of the Registrant&#8217;s Report on Form 6-K filed with the SEC on May 3, 2021</a>).</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="ex02-1.htm">2.1*</a></td>
    <td style="font-family: Times New Roman,serif"><a href="ex02-1.htm"><span style="background-color: white">Description of Securities registered under Section 12 of the Exchange Act.</span></a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_2.htm">4.1</a> &#8224;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_2.htm">English translation of Purchase Agreement dated as of January 11, 2018, among Nicolau Carvalho Esteves, Ros&#226;ngela de Oliveira Tavares Esteves, NRE Participa&#231;&#245;es S.A. and BR Health Participa&#231;&#245;es S.A. (incorporated herein by reference to Exhibit 10.2 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm">4.2</a> &#8224;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_3.htm">English translation of Purchase Agreement dated as of November 27, 2018, among NRE Participa&#231;&#245;es S.A., JC JOINT Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia, Breno Miranda Trabulo Pinheiro Correia and Cristina Maria Miranda de Sousa (incorporated herein by reference to Exhibit 10.3 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm">4.3</a> &#8224;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_4.htm">English translation of Purchase Agreement dated as of December 5, 2018, among NRE Participa&#231;&#245;es S.A., Jo&#227;o Carlos Ribeiro Pedroso, Leoni Margarida Bertolin, Jos&#233; Carlos Janu&#225;rio, Ricardo Pedroso, Daiane Pedroso Canto and RD Administra&#231;&#227;o e Participa&#231;&#227;o Ltda (incorporated herein by reference to Exhibit 10.4 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_5.htm">4.4</a> &#8224;</td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000104746919004047/a2239191zex-10_5.htm">English translation of Investment and Purchase Agreement dated as of March 29, 2019, among Afya Participa&#231;&#245;es S.A. (formerly NRE Participa&#231;&#245;es S.A.), BR Health Participa&#231;&#245;es S.A. and Guardaya Empreendimentos e Participa&#231;&#245;es S.A. (incorporated herein by reference to Exhibit 10.5 to the Registration Statement on Form F-1 filed with the SEC on July 9, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000129281421001953/ex4-3.htm">4.5</a></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000129281421001953/ex4-3.htm">English translation of Bank Note (<i>C&#233;dula de Cr&#233;dito Banc&#225;rio</i>) issued by Afya Participa&#231;&#245;es S.A. on September 23, 2020 (incorporated herein by reference to Exhibit 4.5 to the annual report on Form 20-F <span>for the year ended December 31, 2020, </span>filed with the SEC on April 30, 2021).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">8.1*</td>
    <td style="font-family: Times New Roman,serif"><a href="ex8-1.htm">List of Subsidiaries.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000095010319008297/dp108627_ex1401.htm">11.01</a></td>
    <td style="font-family: Times New Roman,serif"><a href="http://www.sec.gov/Archives/edgar/data/1771007/000095010319008297/dp108627_ex1401.htm">English translation of the Code of Ethics of Afya (incorporated herein by reference to Exhibit 14.1 to the Registration Statement on Form F-1 filed with the SEC on June 24, 2019, File No. 333-232309).</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">12.1*</td>
    <td style="font-family: Times New Roman,serif"><a href="ex12-1.htm">Certification of the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">12.2*</td>
    <td style="font-family: Times New Roman,serif"><a href="ex12-2.htm">Certification of the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act.</a></td></tr>
  </table>

<!-- Field: Page; Sequence: 170 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->165<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 10%; font-family: Times New Roman,serif">13.1*</td>
    <td style="width: 90%; font-family: Times New Roman,serif"><a href="ex13-1.htm">Certification of the Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">13.2*</td>
    <td style="font-family: Times New Roman,serif"><a href="ex13-2.htm">Certification of the Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif"><a href="ex23-1.htm">23.1*</a></td>
    <td style="font-family: Times New Roman,serif"><a href="ex23-1.htm">Consent of Ernst &amp; Young Auditores Independentes S.S.</a></td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.INS*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Instance Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.SCH*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Taxonomy Extension Schema Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.CAL*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Taxonomy Extension Calculation Linkbase Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.DEF*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Taxonomy Extension Definition Linkbase Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.LAB*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Taxonomy Extension Label Linkbase Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">101.PRE*</td>
    <td style="font-family: Times New Roman,serif">Inline XBRL Taxonomy Extension Presentation Linkbase Document</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">104*</td>
    <td style="font-family: Times New Roman,serif">Cover Page Interactive Data File (the cover page XBRL tags are embedded within the inline XBRL document).</td></tr>
  </table>
<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 5%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman,serif; width: 100%; margin-top: 0; margin-bottom: 5pt"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 18pt">*</td><td>Filed herewith.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 5pt 0.25in; text-indent: -0.25in"><span>&#8224;
Certain provisions, exhibits and schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K.</span></p>

<!-- Field: Page; Sequence: 171 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->166<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: center; text-indent: 18pt"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">The registrant hereby certifies that it meets all of
the requirements for filing on Form 20-F and that it has duly caused and authorized the undersigned to sign this annual report on Form
20-F on its behalf.</p>

<table cellspacing="0" cellpadding="0" style="float: right; width: 50%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td colspan="2" style="font-family: Times New Roman,serif"><b>AFYA LIMITED</b></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%; font-family: Times New Roman,serif">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 95%; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">Name:&#9;Virgilio Deloy Capobianco Gibbon</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">Title:&#9;Chief Executive Officer</td></tr>
  </table><div style="clear: both"></div>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b>&#160;</b></p>

<table cellspacing="0" cellpadding="0" style="float: right; width: 50%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td colspan="2" style="font-family: Times New Roman,serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 5%; font-family: Times New Roman,serif">By:</td>
    <td style="border-bottom: Black 1pt solid; width: 95%; font-family: Times New Roman,serif">/s/ Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">Name:&#9;Luis Andr&#233; Carpintero Blanco</td></tr>
  <tr style="vertical-align: top">
    <td style="font-family: Times New Roman,serif">&#160;</td>
    <td style="font-family: Times New Roman,serif">Title:&#9;Chief Financial Officer</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: April 29, 2022</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">&#160;</p>


<!-- Field: Page; Sequence: 172 -->
    <div style="border-bottom: Gray 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->167<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="font: 9pt Times New Roman, Times, Serif; text-align: left; width: 100%"><a href="#TableOfContents" style="font-weight: bold">Table of Contents</a>&#160;</td></tr><tr><td style="text-align: center">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0cm; color: red"><b></b></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 20pt 0 10pt; text-align: center"><span id="a_20f087"></span>Index to Financial Statements</p>

<p style="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt"><b>Audited Consolidated Statements&#8212;Afya Limited</b></p>

<p style="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"><span style="text-decoration: underline">Page<span style="font-family: Times New Roman,serif; font-size: 10pt"><b><sup></sup></b></span></span></p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse; font-size: 10pt">
  <tr style="vertical-align: top">
    <td style="width: 90%; padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Reports of Independent Registered Public Accounting Firm (Auditor Firm ID: 0<span id="xdx_902_edei--AuditorFirmId_c20210101__20211231_zqtGmHbXWpvi" title="Auditor Firm Id"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorFirmId">1448</ix:nonNumeric></span>)</td>
    <td style="width: 10%; text-align: right; font-family: Times New Roman,serif">F-1</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Consolidated Statements of Financial Position as of December 31, 2021 and 2020</td>
    <td style="text-align: right; font-family: Times New Roman,serif">F-5</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Consolidated Statements of Income and Comprehensive Income for the years ended December 31, 2021, 2020 and 2019</td>
    <td style="text-align: right; font-family: Times New Roman,serif">F-6</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Consolidated Statements of Changes in Equity for the years ended December 31, 2021, 2020 and 2019</td>
    <td style="text-align: right; font-family: Times New Roman,serif">F-7</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Consolidated Statements of Cash Flows for the years ended December 31, 2021, 2020 and 2019</td>
    <td style="text-align: right; font-family: Times New Roman,serif">F-8</td></tr>
  <tr style="vertical-align: top">
    <td style="padding-left: 9pt; text-indent: -9pt; font-family: Times New Roman,serif">Notes to the Consolidated Financial Statements for the years ended December 31, 2021, 2020 and 2019</td>
    <td style="text-align: right; font-family: Times New Roman,serif">F-9</td></tr>
  </table>
<p style="font: 10pt Times New Roman,serif; margin: 0">&#160;</p>


<p style="font: 10pt Times New Roman,serif; margin: 0; text-indent: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 6pt; text-align: center"><span style="font-family: MS Gothic, Helvetica, Sans-Serif; font-size: 9pt"><span>&#160;</span></span></p>


<!-- Field: Page; Sequence: 173 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 16pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Afya
Limited</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Consolidated
financial statements</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>as
of December 31, 2021 and 2020 and</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>for
the years ended December 31, 2021, 2020 and 2019</b></span></p>


<!-- Field: Page; Sequence: 174 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0.15in 78pt; color: #333333"><b></b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><b>Report of Independent Registered
Public Accounting Firm </b></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">To the Shareholders and the Board of Directors of</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Afya Limited</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Opinion on the Financial Statements</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We have audited the accompanying consolidated statements
of financial position of Afya Limited (the Company) as of December 31, 2021 and 2020, the related consolidated statements of income and
comprehensive income, changes in equity and cash flows for each of the three years in the period ended December 31, 2021, and the related
notes (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements
present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its
operations and its cash flows for each of the three years in the period ended December 31, 2021, in conformity with International Financial
Reporting Standards (IFRS) as issued by the International Accounting Standards Board - IASB.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We also have audited, in accordance with the standards of
the Public Company Accounting Oversight Board (United States) (PCAOB), the Company's internal control over financial reporting as of December
31, 2021, based on criteria established in Internal Control-Integrated Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission (2013 framework) and our report dated March 31, 2022 expressed an unqualified opinion thereon.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Basis for Opinion</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">These financial statements are the responsibility of the
Company's management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We
are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with
the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We conducted our audits in accordance with the standards
of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements
are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures
included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included
evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation
of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Critical Audit Matter</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">The critical audit matter communicated below is a matter
arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee
and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging,
subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated
financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion
on the critical audit matter or on the account or disclosure to which it relates.</p>

<p style="font: 11pt/103% Arial, Helvetica, Sans-Serif; margin: 0 15.6pt 0.45pt 37pt; text-indent: -0.5pt"></p>

<p style="font: 11pt/103% Arial, Helvetica, Sans-Serif; margin: 0 15.6pt 0.45pt 37pt; text-indent: -0.5pt">&#160;</p>


<!-- Field: Page; Sequence: 175; Options: NewSection -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt/103% Arial, Helvetica, Sans-Serif; margin: 0 0 5.25pt 1.4in; text-indent: -0.5pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="font: 12pt/106% Times New Roman, Times, Serif; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt">&#160;</td>
    <td style="font: 12pt/106% Times New Roman, Times, Serif; width: 86%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; line-height: 106%"><b>Accounting for Business combinations</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>&#160;</i></p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>Description of the Matter</i></p></td>
    <td style="font: 12pt/106% Times New Roman, Times, Serif; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt; line-height: 106%">&#160;</span><span style="font-size: 10pt; line-height: 106%"><br />
<span style="font-family: Arial, Helvetica, Sans-Serif">As described in Note 5 of the consolidated financial statements, the Company, through its wholly owned subsidiary Afya Participa&#231;&#245;es S.A., completed the acquisition of several entities during the year ended December 31, 2021 for a total aggregated purchase consideration of R$ 1,234,460&#160;thousand. Such transactions were accounted for as business combinations, in accordance with the requirements of IFRS 3 <i>Business Combinations, </i>and the Company estimated the fair value of net assets acquired for each one of those acquisitions, including acquired intangible assets.</span><br />
<br />
<span style="font-family: Arial, Helvetica, Sans-Serif">Auditing the Company's accounting for such acquisitions was complex and involved significant auditor judgement due to the significant estimation uncertainty in the Company&#8217;s determination of the fair value of identified intangible assets of R$861,031&#160;thousand, which principally consisted of licenses, customer relationships, trademark and developed technology. The significant estimation uncertainty was primarily due to the sensitivity of the respective fair values to underlying assumptions about the future performance of the acquired businesses. The Company used valuation techniques to measure licenses, customer relationships, trademark and developed technology. The significant assumptions used to estimate the value of these intangible assets included discount rates and certain assumptions that form the basis of the forecasted results, such as revenue growth rates, projected profit margins and royalty rates. These significant assumptions are forward looking and could be affected by future economic events and market conditions.</span></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>&#160;</i></p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><i>How We Addressed the Matter in Our Audit</i></p></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt">
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0">We obtained an understanding, evaluated the design and tested the operating
    effectiveness of the Company's controls over accounting for business combinations, including controls over the recognition and measurement
    of identifiable intangible assets. For example, we tested controls over management's evaluation of underlying assumptions in the valuation
    models applied, and we also tested management's controls over the data used in the valuation models.</p>
    <p style="font: 10pt/106% Arial, Helvetica, Sans-Serif; margin: 0"><br />
    To test the estimated fair value of the intangible assets acquired, we performed audit procedures that included, among others, evaluating
    the valuation methodology and the significant assumptions used by the Company; obtaining the reports prepared by the Company&#180;s valuation
    specialist; testing the completeness and accuracy of underlying data used in the estimation of fair value of intangible assets acquired;
    involving our valuation specialists to assist with the evaluation of the methodology and key assumptions used by the Company and comparing
    the key assumptions used to the ones used by the Company in relation to past acquisitions and available third-party industry information.
    We also assessed the Company&#8217;s disclosures in Note 5 to the consolidated financial statements.</p></td></tr>
  </table>
<p style="font: 11pt/103% Arial, Helvetica, Sans-Serif; margin: 0 0 5.25pt 1.4in; text-indent: -0.5pt">&#160;</p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 25.7pt"></p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 0 25.7pt">&#160;</p>

<p style="font: 10pt/103% Arial, Helvetica, Sans-Serif; margin: 0 314.9pt 11.05pt 30.7pt; color: #333333; text-indent: -0.5pt">/s/&#160;<span id="xdx_90D_edei--AuditorName_c20210101__20211231_zzVa2O1M1dQg"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorName">ERNST &amp;
YOUNG</ix:nonNumeric></span><br />
Auditores Independentes S.S.</p>

<p style="font: 10pt/103% Arial, Helvetica, Sans-Serif; margin: 0 22.85pt 11.05pt 30.7pt; color: #333333; text-indent: -0.5pt">We have
served as the Company's auditor since 2016.</p>

<p style="font: 10pt/103% Arial, Helvetica, Sans-Serif; margin: 0 22.85pt 0.45pt 30.7pt; color: #333333; text-indent: -0.5pt"><span id="xdx_90F_edei--AuditorLocation_c20210101__20211231_zVRnkDRIC0Se"><ix:nonNumeric contextRef="From2021-01-01to2021-12-31" name="dei:AuditorLocation">Belo Horizonte,
Brazil</ix:nonNumeric></span></p>

<p style="font: 10pt/103% Arial, Helvetica, Sans-Serif; margin: 0 22.85pt 11.05pt 30.7pt; color: #333333; text-indent: -0.5pt">March 31,
2022</p>





<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b></b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b></b></span></p>

<!-- Field: Page; Sequence: 176 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b></b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><b>Report of Independent Registered Public Accounting
Firm </b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">To the Shareholders and the Board of Directors of</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Afya Limited</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Opinion on Internal Control over Financial Reporting</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We have audited Afya Limited&#8217;s (&#8220;the Company&#8221;) internal
control over financial reporting as of December 31, 2021, based on criteria established in Internal Control-Integrated Framework issued
by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). &#160;In our opinion, the
Company maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2021, based
on the COSO criteria.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">As indicated in the accompanying Management&#8217;s Annual Report on Internal
Control over Financial Reporting, management&#8217;s assessment of and conclusion on the effectiveness of internal control over financial
reporting did not include the internal controls of iClinic Participa&#231;&#245;es S.A., iClinic Desenvolvimento de Software Ltda.
and Black River Brazil Participa&#231;&#245;es S.A. (&#8220;iClinic&#8221;), Medicinae Solutions S.A. (&#8220;Medicinae&#8221;), Medical
Harbour Aparelhos M&#233;dico-Hospitalares e Servi&#231;os em Tecnologia Ltda (&#8220;Medical Harbour&#8221;), Cliquefarma Drogarias
Online Ltda (&#8220;Cliquefarma&#8221;), Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;), Sociedade Padr&#227;o
de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;), Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura,
Instituto de Ensino Superior de Palho&#231;a S/S Ltda., Sociedade Educacional de Palho&#231;a S/S Ltda., and Policlinica Policl&#237;nica
e Centro de Est&#233;tica Duque de Caxias Ltda (&#8220;Unigranrio&#8221;) and RX PRO Solu&#231;&#245;es de Tecnologia Ltda. and
RX PRO LOG Transporte e Logistica Ltda. (&#8220;RX PRO&#8221;), which are included in the 2021 consolidated financial statements of the
Company and constituted 7% and 2% of total and net assets, respectively, as of December 31, 2021 and 13% and 17% of net revenue and net
income, respectively, for the year then ended. Our audit of internal control over financial reporting of the Company also did not include
an evaluation of the internal <span style="color: #333333">control over financial reporting of iClinic</span>., Medicinae, Medical Haurbour&#8221;,
CliquePharma, Shosp, UnifipMoc, Unigranrio and RX PRO. <span style="color: #333333">We also have audited, in accordance with the standards
of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s consolidated statements of financial position
as of December 31, 2021 and 2020, the related consolidated statements of income and comprehensive income, changes in equity and cash flows
for each of the three years in the period ended December 31, 2021, and the related notes and our report dated March 31, 2022 expressed
</span>an unqualified opinion thereon<span style="color: #333333">.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333"><b>Basis for Opinion</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="color: #333333">The Company&#8217;s management is responsible
for maintaining effective internal control over financial reporting and for its assessment</span> of the effectiveness of internal control
over financial reporting included in the accompanying Management&#8217;s Annual Report on Internal Control over Financial Reporting. Our
responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a
public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the
U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">We conducted our audit in accordance with the standards of the PCAOB. Those
standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial
reporting was maintained in all material respects.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Our audit included obtaining an understanding of internal control over financial
reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal
control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that
our audit provides a reasonable basis for our opinion.</p>
<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b></b></span></p>

<!-- Field: Page; Sequence: 177 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b></b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Definition and Limitations of Internal Control Over Financial Reporting</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">A company&#8217;s internal control over financial reporting is a process
designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements
for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting
includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded
as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts
and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and
(3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s
assets that could have a material effect on the financial statements.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Because of its inherent limitations, internal control over financial reporting
may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk
that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures
may deteriorate.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">/s/ ERNST &amp; YOUNG</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Auditores Independentes S.S.</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">Belo Horizonte, Brazil</p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0">March 31, 2022</p>
<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 178 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Afya
Limited</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Consolidated statements
of financial position</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 and 2020</span></p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(In
thousands of Brazilian reais)</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_304_111_pn3n3_zyi5LzZGUkGf" summary="xdx: Statement - Consolidated statements of financial position" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 46%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Notes</b></span></td>
    <td id="xdx_494_20211231_zutdlQsJnEVb" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 25%; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2021</b></span></td>
    <td style="vertical-align: top; width: 1%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20201231_zqGXrScNTPLk" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 23%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>2020</b></span></td></tr>
  <tr id="xdx_40F_eifrs-full--AssetsAbstract_iB_zedQav3ZonNh">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Assets</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--CurrentAssetsAbstract_i01B_zxFmp1Prq381">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Current
    assets</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_eifrs-full--CashAndCashEquivalents_i02I_maCAzOd0_zKUk0DtL16S" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    and cash equivalents</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--CurrentTradeReceivables_i02I_maCAzOd0_zQKOC7tmzqo3" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 21.3pt; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    receivables</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">378,351</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">302,317</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--Inventories_i02I_maCAzOd0_zSsKPijxOGl7" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 21.3pt; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,827</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:Inventories" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,509</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentTaxAssets_i02I_maCAzOd0_zJqNfdwU5Fcl" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 21.3pt; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recoverable
    taxes</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,579</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTaxAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,019</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--OtherCurrentAssets_i02I_maCAzOd0_ziAiZpPdVzs9" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 21.3pt; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    assets</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">9</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,533</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherCurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,614</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--CurrentAssets_i02TI_mtCAzOd0_maAz3Ml_zjPCJt3pO294" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total current assets</b></span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,206,852</ix:nonFraction></b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,405,501</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--NoncurrentAssetsAbstract_i01B_z42sXyd6OU8j" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Non-current
    assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--NoncurrentRestrictedCashAndCashEquivalents_i02I_maCLzqMp_zzYwwvuvZck8" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Restricted
    cash</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl0084">-</span></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncurrentRestrictedCashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--NoncurrentTradeReceivable_i02I_maCLzqMp_zOoDBO1hsnjg" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    receivables</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NoncurrentTradeReceivable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherNoncurrentAssets_i02I_maCLzqMp_zfw5nQj88e3e" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    assets</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">9</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">180,306</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherNoncurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,037</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--InvestmentsInSubsidiariesJointVenturesAndAssociates_i02I_maCLzqMp_z2JdrtFXtbv" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Investment
    in associate</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--PropertyPlantAndEquipment_i02I_maCLzqMp_ziAOjfIZAYyl" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Property
    and equipment</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">11</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,808</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">260,381</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--RightofuseAssets_i02I_maCLzqMp_zQzn7jj2eZYd" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Right-of-use
    assets</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.2</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,074</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--IntangibleAssetsOtherThanGoodwill_i02I_maCLzqMp_zLxb70hdRFje" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Intangible
    assets</span></td>
    <td style="white-space: nowrap; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">12</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,900,835</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsOtherThanGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,573,010</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--NoncurrentAssets_i02TI_mtCLzqMp_maAz3Ml_zI2AO77hSnrf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    non-current assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,240,554</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,387,592</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--Assets_iTI_mtAz3Ml_zWGdl3XFPI8f" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    assets</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,447,406</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,093</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--LiabilitiesAbstract_iB_zbyHM9vyPqBj" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentLiabilitiesAbstract_i01B_zsngQKNRknCa" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Current
    liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--TradeAndOtherCurrentPayables_i02I_maCLzSEL_zHjeNhAOcHai" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    payables </span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,098</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,743</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--ShorttermBorrowings_i02I_maCLzSEL_zIPvTRE5qp2e" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Loans
    and financing</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.1</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,720</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ShorttermBorrowings" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,162</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--CurrentLeaseLiabilities_i02I_maCLzSEL_z2L8lCl0h5Ue" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Lease
    liabilities</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.2</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,955</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,976</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--TradeAndOtherCurrentPayablesToRelatedParties_i02I_maCLzSEL_z6BJCkrg4Wl4" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Accounts
    payable to selling shareholders</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.3</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,849</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,420</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--NotePayableCurrent_i02I_maCLzSEL_zUUUegMoVyC9" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Notes
    payable </span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.4</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NotePayableCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,478</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NotePayableCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,503</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentDepositsFromCustomers_i02I_maCLzSEL_zs9B1YsjNSic" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Advances
    from customers </span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,585</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentDepositsFromCustomers" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,839</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentRecognisedLiabilitiesDefinedBenefitPlan_i02I_maCLzSEL_ziizj8SrB1Sl" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Labor
    and social obligations</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">131,294</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,855</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_ecustom--CurrentTaxesPayable_i02I_maCLzSEL_zKsZIx4Zl1c3" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Taxes
    payable</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,715</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:CurrentTaxesPayable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,976</ix:nonFraction></span></td></tr>
  <tr id="xdx_40C_eifrs-full--CurrentTaxLiabilitiesCurrent_i02I_maCLzSEL_zd2iTNGx9Zsj" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Income
    taxes payable</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,649</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CurrentTaxLiabilitiesCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,574</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--OtherCurrentLiabilities_i02I_maCLzSEL_zolYR441D1yk" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    liabilities</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,163</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherCurrentLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,331</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--CurrentLiabilities_i02TI_mtCLzSEL_maLzwob_zNb1Czpmfzn2" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 4.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    current liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">766,506</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">589,379</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--NoncurrentLiabilitiesAbstract_i01B_zcRAqshZTrfe" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Non-current
    liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eifrs-full--LongtermBorrowings_i02I_maNLzjxc_zWJbyXJMTk48" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Loans
    and financing</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.1</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,246,156</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:LongtermBorrowings" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">510,323</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--NoncurrentLeaseLiabilities_i02I_maNLzjxc_znxt23IOETIf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Lease
    liabilities&#160;</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.2</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">689,130</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">385,727</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--NoncurrentPayablesToRelatedParties_i02I_maNLzjxc_zI7y7e0n2dri" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Accounts
    payable to selling shareholders</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.3</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">439,977</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncurrentPayablesToRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">329,820</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_ecustom--NotesPayableNonCurrentLiabiites_i02I_maNLzjxc_zZFPn3iD9LL4" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Notes
    payable</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">13.2.4</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NotesPayableNonCurrentLiabiites" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,248</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NotesPayableNonCurrentLiabiites" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,678</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--NoncurrentTaxesPayable_i02I_maNLzjxc_z6vQrZ9yEC1e" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Taxes
    payable</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,598</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:NoncurrentTaxesPayable" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,425</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--LongtermLegalProceedingsProvision_i02I_maNLzjxc_zZb8MDJLfu84" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Provision
    for legal proceedings</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">23</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,287</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:LongtermLegalProceedingsProvision" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,139</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--OtherNoncurrentLiabilities_i02I_maNLzjxc_z2I0M5fIA2X5" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    liabilities</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 1.1pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,486</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.4pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:OtherNoncurrentLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,822</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--NoncurrentLiabilities_i02TI_mtNLzjxc_maLzwob_zVuA6pTI8Tw4" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    non-current liabilities</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 1.1pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,680,882</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,369,934</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40A_eifrs-full--Liabilities_iTI_mtLzwob_maEALzAut_znjv4lsYdhDh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    liabilities</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.65pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,447,388</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Liabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,959,313</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_eifrs-full--EquityAbstract_iB_zRn7Uj6UB3Jg" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Equity</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_eifrs-full--IssuedCapital_i02I_maEATOOzLiT_zlweYQIvBvWi" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Share
    capital</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">17</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdditionalPaidinCapital_i02I_maEATOOzLiT_zoE30XqjQ0Cb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Additional
    paid-in capital</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AdditionalPaidinCapital" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,323,488</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--ReserveOfSharebasedPayments_i02I_maEATOOzLiT_zXa2rkUpUkw7" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Share-based
    compensation reserve</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,101</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ReserveOfSharebasedPayments" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,724</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--TreasuryShares_i02NI_di_msEATOOzLiT_zE9QLyJl5gja" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Treasury
    stock</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">(<ix:nonFraction name="ifrs-full:TreasuryShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152,630</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl0193">-</span></span></td></tr>
  <tr id="xdx_409_eifrs-full--RetainedEarnings_i02I_maEATOOzLiT_zFrI5M7PlRhf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-left: 14.2pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Retained
    earnings</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,317</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:RetainedEarnings" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">407,991</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--EquityAttributableToOwnersOfParent_i02TI_mtEATOOzLiT_maEzBhQ_zUrUCnkBJ2Ff" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Equity
    attributable to equity holders of the parent</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,948,149</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:EquityAttributableToOwnersOfParent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,782,220</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_403_eifrs-full--NoncontrollingInterests_i01I_maEzBhQ_zxuKoijec3J9" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Non-controlling
    interests</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,869</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:NoncontrollingInterests" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,560</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--Equity_i01TI_mtEzBhQ_maEALzAut_zgORRpUiU9Ya" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    equity</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: -2.3pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 5.2pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_402_eifrs-full--EquityAndLiabilities_iTI_mtEALzAut_zO4QMw536IQc" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    liabilities and equity</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 5.2pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,447,406</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,093</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The accompanying
notes are an integral part of the consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 179 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Afya
Limited</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Consolidated statements
of income and comprehensive income</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the years ended
December 31, 2021, 2020 and 2019</span></p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(In
thousands of Brazilian reais, except earnings per share)</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30B_113_pn3n3_zquyy5FeWFEj" summary="xdx: Statement - Consolidated statements of income and comprehensive income" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 52%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Notes</b></span></td>
    <td id="xdx_49D_20210101__20211231_zzeAYkMMZlIk" style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td id="xdx_49C_20200101__20201231_zYsl9VZGukGj" style="border-bottom: black 1pt solid; white-space: nowrap; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td id="xdx_494_20190101__20191231_zRyq4BGLtoV6" style="border-bottom: black 1pt solid; width: 14%; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--Revenue_maGPzYxE_zWMJDXXkSJs2" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    revenue</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--CostOfSales_msGPzYxE_zD4bbjw3fj0e" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">652,300</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">434,654</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">308,853</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_eifrs-full--GrossProfit_iT_mtGPzYxE_maPLFOAzfGr_zttZLFtfYoNd" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">766,537</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">441,777</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--GeneralAndAdministrativeExpense_iN_di_msPLFOAzfGr_z6c7xgILdAm3" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">20</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">402,855</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,120</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--OtherIncome_maPLFOAzfGr_z0vof7MAMGZ3" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    (expenses) income, net</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,561</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">347</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,594</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossFromOperatingActivities_iT_mtPLFOAzfGr_maPLBTzyZh_z70xfSEYKvFf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,895</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">363,335</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">205,251</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--FinanceIncome_maFICzc2O_zIj2QdO5VyD2" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Finance
    income</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,290</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,689</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--FinanceCosts_iN_di_msFICzc2O_zYgx4NMunllj" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Finance
    expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,796</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,269</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,365</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncomeCost_iT_mtFICzc2O_maPLBTzyZh_zpVI1tJJQPUf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    result</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">179,230</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,979</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinanceIncomeCost" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,676</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_maPLBTzyZh_zdNPWtNgOORf" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,698</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,362</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_iT_mtPLBTzyZh_maPLz8Yl_z1HUYlMciHv9" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">335,054</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">186,937</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--IncomeTaxExpenseContinuingOperations_iN_di_msPLz8Yl_zubuUmtxVoEb" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">22</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,179</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,067</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,175</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_408_eifrs-full--ProfitLoss_iT_mtPLz8Yl_maCIzYWK_zNQfNySkzCse" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--OtherComprehensiveIncome_maCIzYWK_zezofRxjT0x2" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    comprehensive income</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0262">-</span></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0263">-</span></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0264">-</span></span></td></tr>
  <tr id="xdx_40B_eifrs-full--ComprehensiveIncome_iT_mtCIzYWK_zfIvHIVkymXa" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    comprehensive income</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--ProfitLossAttributableToAbstract_iB" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    attributable to</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--ProfitLossAttributableToOwnersOfParent_i01_maCIzhsm_zg2hRvAVMKwk" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Equity
    holders of the parent</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToOwnersOfParent" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLossAttributableToNoncontrollingInterests_i01_maCIzhsm_z05Y5B05a9K9" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;&#160;Non-controlling
    interests</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,912</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLossAttributableToNoncontrollingInterests" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,846</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--ComprehensiveIncome_i01T_mtCIzhsm_zAoB7geXys9b" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span><span style="display: none; font-family: Times New Roman, Times, Serif; visibility: hidden">Total comprehensive income</span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-left: 3.5pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_401_eifrs-full--BasicEarningsPerShareAbstract_iB" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Basic
    earnings per share</b></span></td>
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_i01_pdd" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Per
    common share </span></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.39</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.15</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.03</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsPerShareAbstract_iB_z31UkwcgnPB8" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="font: 8pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><b>Diluted earnings per share</b></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt">&#160;</td>
    <td style="text-align: right; line-height: 10.5pt">&#160;</td></tr>
  <tr id="xdx_405_eifrs-full--DilutedEarningsLossPerShare_i01_pid_uBRLPShares_zlMJj1MA9SQl" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap"><p style="font: 8pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Per common
    share</span></p>
    <p style="font: 8pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"></span></p></td>
    <td style="white-space: nowrap; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.37</ix:nonFraction></span></td>
    <td style="white-space: nowrap; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.12</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.02</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The accompanying
notes are an integral part of the consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 180 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Afya
Limited</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Consolidated statements
of changes in equity</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the years ended
December 31, 2021, 2020 and 2019</span></p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(In
thousands of Brazilian reais)</i></span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30E_114_pn3n3_zuO3DKbhhwob" summary="xdx: Statement - Consolidated statements of changes in equity" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%">&#160;</td>
    <td id="xdx_4B9_ifrs-full--ComponentsOfEquityAxis_ifrs-full--IssuedCapitalMember_zndi5pyJBHr1" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B5_ifrs-full--ComponentsOfEquityAxis_ifrs-full--AdditionalPaidinCapitalMember_zV2uNQSvzYD6" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ComponentsOfEquityAxis_ifrs-full--TreasurySharesMember_zvktA0YZd8nf" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BF_ifrs-full--ComponentsOfEquityAxis_ifrs-full--ReserveOfSharebasedPaymentsMember_zcnCHN8QtvP1" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B3_ifrs-full--ComponentsOfEquityAxis_ifrs-full--OtherReservesMember_zSDgKTwZGEAe" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ComponentsOfEquityAxis_custom--RetainedEarningsReserveMember_z6EDCjjzlCjf" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BE_ifrs-full--ComponentsOfEquityAxis_ifrs-full--RetainedEarningsMember_zYRo6T8daG4" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BA_ifrs-full--ComponentsOfEquityAxis_ifrs-full--EquityAttributableToOwnersOfParentMember_zTGaB6g4nzz4" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4BD_ifrs-full--ComponentsOfEquityAxis_ifrs-full--NoncontrollingInterestsMember_zaNxQI0aONAh" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td>
    <td id="xdx_4B9_zPUu3yxV8Qwe" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="8" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Equity
    attributable to equity holders of the parent</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="white-space: nowrap; width: 35%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Share
    capital</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 0.25pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additional
    paid-in capital</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Treasury
    shares</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Share-based
    compensation reserve</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Legal
    reserve</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%"><p style="font: 8pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Retained
    earnings</b></span></p>
    <p style="font: 8pt/115% Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>reserve</b></span></p></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Retained
    earnings</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Non-controlling
    interests</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    equity</b></span></td></tr>
  <tr id="xdx_43F_c20190101__20191231_eifrs-full--Equity_iS_zkWPYbgMMJ7l" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balances
    at January 1, 2019</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">315,000</ix:nonFraction></b></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,014</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0304">-</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,161</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_OtherReservesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,223</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_custom_RetainedEarningsReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,584</ix:nonFraction></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0308">-</span></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">501,982</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,372</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">590,354</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_43C_c20190101__20191231_eifrs-full--ProfitLoss_z7BpqCSONkAl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    income </span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0313">-</span></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0314">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0315">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0316">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0317">-</span></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0318">-</span></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,846</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></span></td></tr>
  <tr id="xdx_43A_c20190101__20191231_eifrs-full--ComprehensiveIncome_zueXZxrF0Jfa" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Total
    comprehensive income</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0324">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0325">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0326">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0327">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0328">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0329">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,846</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20190101__20191231_ecustom--CapitalIncreaseWithCash_zRXfSiIBdJZ2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase with cash</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,000</ix:nonFraction></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0336">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0337">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0338">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0339">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0340">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0341">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,000</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0343">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,000</ix:nonFraction></span></td></tr>
  <tr id="xdx_43E_c20190101__20191231_eifrs-full--IncreaseDecreaseThroughOtherContributionsByOwners_zvhn4KKAWcH8" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase from shares contribution of shareholders</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,768</ix:nonFraction></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,358</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0348">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0349">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0350">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0351">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0352">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,126</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">44,774</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,352</ix:nonFraction></span></td></tr>
  <tr id="xdx_430_c20190101__20191231_ecustom--CapitalIncreaseFromCorporateReorganization_iI_zIhCOMBxlKj6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase from the corporate reorganization</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,062</ix:nonFraction></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">137,051</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0359">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0360">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0361">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0362">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0363">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">259,113</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0365">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseFromCorporateReorganization" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">259,113</ix:nonFraction></span></td></tr>
  <tr id="xdx_43A_c20190101__20191231_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zGktNCOJE5y8" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share-based
    compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,627</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0370">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,114</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0372">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0373">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0374">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,742</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0376">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,742</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20190101__20191231_ecustom--AllocationToAdditionalPaidinCapital_iI_zsUJLiHFVPt5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Allocation to additional paid-in capital
</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0379">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,001</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0381">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0382">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0383">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:AllocationToAdditionalPaidinCapital" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">33,001</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0385">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0386">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0387">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0388">-</span></span></td></tr>
  <tr id="xdx_43A_c20190101__20191231_eifrs-full--DividendsPaid_z9rNLl4SZmK5" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    declared</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0391">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0392">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0393">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0394">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0395">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">38,000</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">38,000</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,812</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">51,812</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43A_c20190101__20191231_ecustom--DividendsCancelled_iI_z1tmYzNibak8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    cancelled</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0401">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0402">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0403">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0404">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0405">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,107</ix:nonFraction></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0407">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,107</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0409">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DividendsCancelled" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,107</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20190101__20191231_ecustom--CorporateReorganization_zoiy2L38Tsj7" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Corporate
    reorganization</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">635,830</ix:nonFraction>)</span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">668,904</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0414">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,161</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,223</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:CorporateReorganization" contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">23,690</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0418">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0419">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0420">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0421">-</span></span></td></tr>
  <tr id="xdx_431_c20190101__20191231_eifrs-full--IssueOfEquity_zdp07y50armb" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Issuance
    of common shares in initial public offering</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16</ix:nonFraction></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">992,762</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0425">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0426">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0427">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0428">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0429">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">992,778</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0431">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">992,778</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20190101__20191231_eifrs-full--ShareIssueRelatedCost_zJR2lNTLwd2b" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Shares
    issuance cost</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0434">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79,670</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0436">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0437">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0438">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0439">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0440">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79,670</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0442">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79,670</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_439_c20200101__20201231_eifrs-full--Equity_iS_zLbz2uCsdky" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balances
    at December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,931,047</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0447">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,114</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0449">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0450">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,916</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,065,094</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,632</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,113,726</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20200101__20201231_eifrs-full--ProfitLoss_zB0J3uFjG9Og" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    income </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0456">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0457">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0458">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0459">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0460">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0461">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,912</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20200101__20201231_eifrs-full--ComprehensiveIncome_zS61r9hUi4n5" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Total
    comprehensive income</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0467">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0468">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0469">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0470">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0471">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0472">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,912</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></span></td></tr>
  <tr id="xdx_43D_c20200101__20201231_eifrs-full--IncreaseDecreaseThroughOtherContributionsByOwners_zzL8r1HeEVe4" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase from shares contribution of shareholders</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0478">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,531</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0480">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0481">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0482">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0483">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0484">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,531</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0486">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,531</ix:nonFraction></span></td></tr>
  <tr id="xdx_438_c20200101__20201231_eifrs-full--IssueOfEquity_zA0gPqiTUVQ6" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Issuance
    of common shares in follow-on public offering</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0489">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">389,170</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0491">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0492">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0493">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0494">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0495">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">389,170</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0497">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IssueOfEquity" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">389,170</ix:nonFraction></span></td></tr>
  <tr id="xdx_430_c20200101__20201231_eifrs-full--ShareIssueRelatedCost_zmHNA7M1jObc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Shares
    issuance cost</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0500">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,704</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0502">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0503">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0504">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0505">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0506">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,704</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0508">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,704</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_437_c20200101__20201231_eifrs-full--DividendsPaid_zKLlpVek02i" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    declared</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0511">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0512">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0513">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0514">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0515">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0516">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0517">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0518">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,984</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaid" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,984</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43B_c20200101__20201231_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_z6WmsrBdkvD6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Shared-based
    compensation</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0522">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,444</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0524">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,610</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0526">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0527">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0528">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,054</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0530">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,054</ix:nonFraction></span></td></tr>
  <tr id="xdx_436_c20210101__20211231_eifrs-full--Equity_iS_za7eTLuVDfc4" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balances
    at December 31, 2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,323,488</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0535">-</span></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,724</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0537">-</span></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0538">-</span></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">407,991</ix:nonFraction></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,782,220</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,560</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_439_c20210101__20211231_eifrs-full--ProfitLoss_zkrhGi1epNEg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    income </span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0544">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0545">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0546">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0547">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0548">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0549">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></span></td></tr>
  <tr id="xdx_432_c20210101__20211231_eifrs-full--ComprehensiveIncome_zYZjyReMedL7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Total
    comprehensive income</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0555">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0556">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0557">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0558">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0559">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0560">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,957</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ComprehensiveIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231_ecustom--CapitalIncreaseWithCash_zr0nXEJNX0kh" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0566">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0568">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0569">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0570">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0571">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0572">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0574">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseWithCash" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,500</ix:nonFraction></span></td></tr>
  <tr id="xdx_433_c20210101__20211231_ecustom--TreasuryShares1_zbQ4D4mp18Je" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Treasury
    shares</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0577">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0578">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0580">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0581">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0582">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0583">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0585">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43E_c20210101__20211231_ecustom--TreasurySharesTransferredFromExerciseOfOptions_zLAFDyY6DAA1" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Treasury
    shares transferred from exercise of options</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0588">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">21,861</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,197</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0591">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0592">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0593">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0594">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0596">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromExerciseOfOptions" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231_ecustom--TreasurySharesTransferredFromSharesContributionOnBusinessCombination_zcuaoI0oXi4c" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Treasury
    shares transferred from shares contribution on business combination</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0599">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">783</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,895</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0602">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0603">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0604">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0605">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0607">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td></tr>
  <tr id="xdx_434_c20210101__20211231_eifrs-full--IncreaseDecreaseThroughSharebasedPaymentTransactions_zhe3cwyYqY1k" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share-based
    compensation</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0610">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0611">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0612">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0614">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0615">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0616">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0618">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td></tr>
  <tr id="xdx_437_c20210101__20211231_ecustom--DividendsDeclaredToNoncontrollingInterests_zqxiIn3iO0P9" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    declared to non-controlling interests</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0621">-</span></span></td>
    <td style="padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0622">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0623">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0624">-</span></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0625">-</span></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0626">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0627">-</span></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0628">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,648</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:DividendsDeclaredToNoncontrollingInterests" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,648</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_432_c20210101__20211231_eifrs-full--Equity_iE_zIHEVGWIS1X3" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balances
    at December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 0.25pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,375,344</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_TreasurySharesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152,630</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,101</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0636">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl0637">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_RetainedEarningsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">631,317</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,948,149</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,869</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The accompanying
notes are an integral part of the consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 181 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C0504D"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Afya
Limited</b></span></p>

<p style="font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Consolidated
statements of cash flows</span></p>

<p style="font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the years
ended December 31, 2021, 2020 and 2019</span></p>

<p style="border-bottom: Black 0.5pt solid; font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(In
thousands of Brazilian reais)</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" id="xdx_30D_112_pn3n3_zTeWQJ9Makbd" summary="xdx: Statement - Consolidated statements of cash flows" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_497_20210101__20211231_zEdtx8Uw6qpi" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49C_20200101__20201231_z34m2xHpbG1a" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49A_20190101__20191231_zERxVOujRsGf" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr id="xdx_400_eifrs-full--CashFlowsFromUsedInOperatingActivitiesAbstract_iB_zW3Pm4p5iKgb">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    activities</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_ecustom--IncomeLossBeforeIncomeTaxes_i01N_di_maCzcId_msAFRPLzCai_zvJ7msG7qAEd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    before income taxes</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">273,462</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">335,054</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncomeLossBeforeIncomeTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">186,937</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdjustmentsForReconcileProfitLossAbstract_i01B_zUisRthUqHJl" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Adjustments
    to reconcile income before income taxes</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustmentsForDepreciationAndAmortisationExpense_i02_maCzcId_maAFRPLzCai_zn0Bu6noX2za" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; width: 54%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation
    and amortization</span></td>
    <td style="white-space: nowrap; vertical-align: top; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,220</ix:nonFraction></span></td>
    <td style="vertical-align: top; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,744</ix:nonFraction></span></td>
    <td style="vertical-align: top; width: 15%; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,152</ix:nonFraction></span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_i02N_di_msCzcId_msAFRPLzCai_zCcgImyDHvR2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    of property and equipment</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,604</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0660">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">78</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--DisposalsIntangibleAssetsAndGoodwill_i02N_di_msCzcId_msAFRPLzCai_zj1F9PdsWmxf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    of intangible</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsIntangibleAssetsAndGoodwill" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,374</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0664">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0665">-</span></span></td></tr>
  <tr id="xdx_40F_ecustom--AllowanceForDoubtfulAccountsOfOpeartingActivities_i02_maCzcId_maAFRPLzCai_zGB6rbPMrvo5" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Allowance
    for doubtful accounts</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,819</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,081</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AllowanceForDoubtfulAccountsOfOpeartingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,040</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--AdjustmentsForSharebasedPayments_i02_maCzcId_maAFRPLzCai_zQuMu4QBp7Fa" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share-based
    compensation expense</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,377</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,610</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForSharebasedPayments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,114</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_eifrs-full--AdjustmentsForUnrealisedForeignExchangeLossesGains_i02_maCzcId_maAFRPLzCai_zJnyRFr0iyG8" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    foreign exchange differences</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,973</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,613</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,321</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_eifrs-full--AdjustmentsForFinanceCosts_i02_maCzcId_maAFRPLzCai_zS3wEkjwwAv" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    loss (gain) on derivatives</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0679">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,739</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForFinanceCosts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,780</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_ecustom--AccruedInterestOfOpeartingActivities_i02_maCzcId_maAFRPLzCai_zdx923YPa0M8" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accrued
    interest</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,437</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,543</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AccruedInterestOfOpeartingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,002</ix:nonFraction></span></td></tr>
  <tr id="xdx_40D_eifrs-full--InterestExpenseOnLeaseLiabilities_i02_maCzcId_maAFRPLzCai_z4F2kP3AUl9g" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accrued
    lease interest</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,458</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,469</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_ecustom--ShareOfIncomeOfAssociateOfOpeartingActivities_i02N_di_msCzcId_msAFRPLzCai_zkR2lppXDxjf" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,698</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:ShareOfIncomeOfAssociateOfOpeartingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,362</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdjustmentsForProvisions_i02_maCzcId_maAFRPLzCai_zxECD3wOOWTg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Provision
    for legal proceedings</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,664</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,354</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForProvisions" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,568</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--IncreaseDecreaseInOperatingLiabilities1Abstract_i02B_zzwtoOCYBgw2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Changes
    in assets and liabilities</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40A_eifrs-full--AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_i03_maCzcId_maAFRPLzCai_zOPdAbxCdTv6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    receivables</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">79,665</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">164,286</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,556</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustmentsForDecreaseIncreaseInInventories_i03_maCzcId_maAFRPLzCai_zBw5mqNmKay8" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,720</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,110</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInInventories" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">236</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--IncreaseDecreaseInRecoverableTaxes_i03N_di_msCzcId_msAFRPLzCai_z4zg4iTBhGTi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Recoverable
    taxes</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,327</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,709</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:IncreaseDecreaseInRecoverableTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,940</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--AdjustmentsForDecreaseIncreaseInOtherAssets_i03_maCzcId_maAFRPLzCai_zZa4jnSzC3q9" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    assets</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,425</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">23,902</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,403</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--AdjustmentsForIncreaseDecreaseInTradeAccountPayable_i03_maCzcId_maAFRPLzCai_zCWJBRv3Q59a" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    payables</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,479</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,475</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,029</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustmentsForIncomeTaxExpense_i03_maCzcId_maAFRPLzCai_z8Wm0BlcOHR3" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes
    payables</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,902</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">552</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncomeTaxExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,940</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_i03_maCzcId_maAFRPLzCai_z6e14FZYI45f" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances
    from customers</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,009</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,951</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,324</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--OtherAdjustmentsForNoncashItems_i03_maCzcId_maAFRPLzCai_zU1zSStFh3ze" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor
    and social obligations</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,449</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,125</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherAdjustmentsForNoncashItems" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,124</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustmentsForIncreaseDecreaseInOtherLiabilities_i03_maCzcId_maAFRPLzCai_zMUnXj3yoAJi" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    liabilities</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,693</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,771</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,881</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--AdjustmentsForReconcileProfitLoss_i03T_mtAFRPLzCai_maCzH28_z7PPekvVPFY2" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span><span style="display: none; font-family: Times New Roman, Times, Serif; visibility: hidden">Total</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">666,550</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">390,881</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForReconcileProfitLoss" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,722</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--IncomeTaxesPaidRefundClassifiedAsOperatingActivities_i02N_di_msCzH28_zESR8nsUxnSf" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes paid</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,683</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,374</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,506</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--CashFlowsFromUsedInOperatingActivities_i01T_mtCzH28_maCzoCy_zGw2OWAU11gd" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    cash flows from operating activities</b></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">630,867</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">371,507</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInOperatingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">299,216</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--CashFlowsFromUsedInInvestingActivitiesAbstract_iB_zzulS8aESmOh" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Investing
    activities</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_i01N_di_msCzcnP_z7YaGNqJ9HS5" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition
    of property and equipment</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,869</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,832</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,964</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--DividendsReceived_i01_maCzcnP_zgd46FNMlZr3" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    received</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,770</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0760">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0761">-</span></span></td></tr>
  <tr id="xdx_402_eifrs-full--PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_i01N_di_msCzcnP_zeHIjVCTf4l1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition
    of intangibles assets</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,931</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,753</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,745</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--RestrictedCashOfInvestingActivities_i01_maCzcnP_zAN1q83xoX22" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Restricted
    cash</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,103</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,788</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RestrictedCashOfInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,530</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--PaymentsOfNotesPayable_i01_maCzcnP_zU2VjgNNeyl6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments
    of notes payable</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfNotesPayable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,068</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:PaymentsOfNotesPayable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,974</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0773">-</span></span></td></tr>
  <tr id="xdx_400_eifrs-full--PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_i01N_di_msCzcnP_zZsoPQsynISd" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Acquisition
    of subsidiaries, net of cash acquired</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,006,057</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">913,991</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">241,568</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--CashAdvancesAndLoansFromRelatedParties_i01_maCzcnP_zzGelyoyDk9k" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    to related parties</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0779">-</span></span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0780">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAdvancesAndLoansFromRelatedParties" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,598</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--CashFlowsFromUsedInInvestingActivities_i01T_mtCzcnP_maCzoCy_zRovKG4N5H3d" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    cash flows used in investing activities</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,274,052</ix:nonFraction>)</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,042,762</ix:nonFraction>)</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:CashFlowsFromUsedInInvestingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">354,149</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--CashFlowsFromUsedInFinancingActivitiesAbstract_iB_zjTFuXHkr8Fc" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Financing
    activities</b></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 2.8pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--IssuanceOfLoansAndFinancing_i01_maCzNgf_zeNZkOqdSIe3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Issuance
    of loans and financing</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IssuanceOfLoansAndFinancing" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">809,539</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IssuanceOfLoansAndFinancing" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">605,041</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IssuanceOfLoansAndFinancing" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,383</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_eifrs-full--RepaymentsOfBorrowingsClassifiedAsFinancingActivities_i01N_di_msCzNgf_zbwxjaya5awa" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments
    of loans and financing</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,076</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">155,090</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,093</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_403_eifrs-full--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_i01N_di_msCzNgf_zONhP6VHntS8" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payments
    of lease liabilities</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,751</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,455</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,779</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_ecustom--TreasuryShares1_i01_maCzNgf_z63kENfA6LGh" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Treasury
    shares</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:TreasuryShares1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">213,722</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0804">-</span></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0805">-</span></span></td></tr>
  <tr id="xdx_40E_ecustom--CapitalIncreaseOfFinancialActivities_i01_maCzNgf_zD49vUL6xyc" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    increase</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0807">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseOfFinancialActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,444</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalIncreaseOfFinancialActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,628</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--DividendsPaidClassifiedAsFinancingActivities_i01N_di_msCzNgf_zke0WuOtnCUe" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends
    paid to non-controlling interests</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,984</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DividendsPaidClassifiedAsFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,812</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_eifrs-full--ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_i01_maCzNgf_zqziLmXjLyzg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Proceeds
    from &#160;shares public offering</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0815">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">389,170</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">992,778</ix:nonFraction></span></td></tr>
  <tr id="xdx_409_ecustom--SharebasedCompensationPlanReceipts_i01_maCzNgf_z2nHqfq5clk9" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share-based
    compensation plan receipts</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:SharebasedCompensationPlanReceipts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,336</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0820">-</span></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0821">-</span></span></td></tr>
  <tr id="xdx_40B_eifrs-full--PaymentsForShareIssueCosts_i01N_di_msCzNgf_zxP1fYfTHO1j" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    issuance costs</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl0823">-</span></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,704</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:PaymentsForShareIssueCosts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,670</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--CashFlowsFromUsedInFinancingActivities_i01T_mtCzNgf_maCzoCy_znOAomd7g4ye" style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    cash flows from (used in) financing activities</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">364,678</ix:nonFraction></b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">756,422</ix:nonFraction></b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:CashFlowsFromUsedInFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">921,435</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40C_eifrs-full--EffectOfExchangeRateChangesOnCashAndCashEquivalents_i02_maCzcId_maCzoCy_zVC0ijneupca" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Net
    foreign exchange differences</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,973</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,666</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,447</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_iT_mtCzoCy_zbN9JGFPYLka" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    increase in cash and cash equivalents</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">296,480</ix:nonFraction>)</b></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,833</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">880,949</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40F_eifrs-full--CashAndCashEquivalents_iS_zRDVVDSeVO72" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    and cash equivalents at the beginning of the year</span></td>
    <td style="border-top: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></span></td>
    <td style="border-top: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">943,209</ix:nonFraction></span></td>
    <td style="border-top: black 1.5pt double; vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,260</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_eifrs-full--CashAndCashEquivalents_iE_zNTHGZfOqLC9" style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    and cash equivalents at the end of the year</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 9.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">943,209</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
<!-- Field: Split-Segment; Name: Segment%2D1 -->
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The accompanying
notes are an integral part of the consolidated financial statements.</span></p>


<!-- Field: Page; Sequence: 182; Options: NewSection; Value: 8 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory"><p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zQazWaK7wYYf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">1</span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_822_zSAe1tVzeXy8">Corporate information</span></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Limited (&#8220;Afya&#8221;),
collectively with its subsidiaries referred to as the &#8220;Company&#8221;, is a holding company incorporated under the laws of the
Cayman Islands on March 22, 2019. Afya Limited became the holding company of Afya Participa&#231;&#245;es S.A. (hereafter referred
to as &#8220;Afya Brazil&#8221;), formerly denominated NRE Participa&#231;&#245;es S.A., through the completion of the corporate
reorganization in July 2019. Up to that date, Afya Limited did not have commenced operations and had only nominal assets and liabilities
and no material contingent liabilities or commitments. Accordingly, Afya Limited&#8217;s consolidated financial information substantially
reflect the operations of Afya Brazil after the corporate reorganization.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company is
formed by a network of higher education and post graduate institutions focused on medicine located in 18 Brazilian states forming the
largest educational group by the number of medical seats in the country and by services that comprises the development and sale of electronically
distributed educational courses on medicine science, related printed and technological educational content. The Company also offers services
to empower the physicians in their daily routine providing supporting clinic decisions thought mobile app subscription and deliver practice
management tools through a SaaS model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Corporate
reorganization</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 29, 2019,
Afya Brazil merged (i) BR Health Participa&#231;&#245;es S.A. (&#8220;BR Health&#8221;), a wholly-owned subsidiary of Bozano Educacional
II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia (&#8220;Crescera&#8221;) that controlled Guardaya Empreendimentos
and Participa&#231;&#245;es S.A. (&#8220;Guardaya&#8221;) and was one of Afya Brazil&#8217;s shareholders; and (ii) Guardaya which
owned <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190329__ifrs-full--BusinessCombinationsAxis__custom--GuardayaEmpreendimentosAndParticipacoesSAMember_zTSs8prpwbV6"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2019-03-29_custom_GuardayaEmpreendimentosAndParticipacoesSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Medcel Editora e Eventos S.A. (&#8220;Medcel Editora&#8221;) and CBB Web Servi&#231;os e Transmiss&#245;es On Line S.A. (&#8220;CBB
Web&#8221;), focused on medical residency preparation courses located in the state of S&#227;o Paulo, resulting in the transfer to
Afya Brazil of <span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zZhCbWeb9P15" title="Proportion of ownership interest in subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="From2019-03-272019-03-29_custom_MedcelEditoraAndCBBWebMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Medcel Editora and CBB Web and <span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAhGTBbODjkf" title="Proportion of ownership interest in subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="From2019-03-272019-03-29_custom_UniaoEducacionalDoPlanaltoCentralSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;), a medical school located in the Federal District. On June
18, 2019 Afya Brazil acquired an additional <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190616__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zcLSbrmUB804" title="Proportion of ownership interest in subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestInSubsidiary" contextRef="From2019-06-162019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">15</ix:nonFraction></span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
interest in UEPC resulting in an interest of <b><span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zDUvlz9EscHb" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span></b>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 7, 2019,
each of Afya Brazil&#180;s shareholders had agreed to contribute their respective shares on Afya Brazil into Afya Limited, <span id="xdx_90C_eifrs-full--RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_c20190707__20190708_zqqSgLf0rXok" title="Description of exchanging and rights of shares"><ix:nonNumeric contextRef="From2019-07-072019-07-08" name="ifrs-full:RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital">exchanging
one common share into 28 Class A or Class B common shares</ix:nonNumeric></span> of Afya Limited. The holders of the Class A common shares and Class B common
shares have identical rights, except that (i) the holder of Class B common shares is entitled to 10 votes per share, whereas holders
of Class A common shares are entitled to one vote per share, (ii) Class B common shares have certain conversion rights and (iii) the
holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common shares and/or
preferred shares are proposed to be issued. The holders of Class A common shares and Class B common shares vote together as a single
class on all matters (including the election of directors) submitted to a vote of shareholders, unless otherwise required by law and
subject to certain exceptions.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 183 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Initial
public offering</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 18, 2019,
Afya Limited priced its initial public offering (&#8220;IPO&#8221;) of <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_c20190718__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-18_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,744,210</ix:nonFraction></span> Class A common shares, which began trading on the Nasdaq
Global Select Market (&#8220;NASDAQ&#8221;) on July 19, 2019 under the symbol &#8220;AFYA&#8221;. On July 23, 2019, the underwriters
exercised the option to buy an additional <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__custom--SaleOfStockAxis__custom--OverAllotmentsMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zeQgmPLluhy" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_OverAllotmentsMember_custom_ClassACommonSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,061,631</ix:nonFraction></span> Class A common shares to cover over-allotments, totaling <span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">15,805,841</ix:nonFraction></span> Class A common
shares, which <span id="xdx_903_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_pdd" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,888,887</ix:nonFraction></span> Class A common shares were offered by Afya Limited and <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,916,954</ix:nonFraction></span> Class A common shares were offered by the selling
shareholders at the initial public offering price. The initial offering price was US$ <span id="xdx_90E_ecustom--NumberOfPerShares_iI_pid_uBRLPShares_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zOI7f2nBetEc" title="per share"><ix:nonFraction name="afya:NumberOfPerShares" contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">19.00</ix:nonFraction></span> per Class A common share.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 23, 2019,
the share capital of Afya Limited was increased by <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zHld9PSt37q3" title="Number of shares issed (shares)"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">13,888,887</ix:nonFraction></span> Class A shares through the proceeds received as a result of the IPO of
US$ <span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_z4T2at628cIe" title="Proceeds from issue of shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">263,888</ix:nonFraction></span> thousand (or R$ <span id="xdx_90A_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zoAfUHzaAdSi" title="Proceeds from issue of shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">992,778</ix:nonFraction></span>). The net proceeds from the IPO were US$ <span id="xdx_905_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zdqkcqwYipk3" title="Net proceeds from issue of shares"><ix:nonFraction name="afya:ProceedsFromIssueOfOrdinarySharesNet" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">242,711</ix:nonFraction></span> thousand (or R$ <span id="xdx_90B_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zjDEP3lk5UCl" title="Net proceeds from issue of shares"><ix:nonFraction name="afya:ProceedsFromIssueOfOrdinarySharesNet" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">913,108</ix:nonFraction></span>), after deducting US$ <span id="xdx_904_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zMhznXuV3LTg" title="Fee and commission expense"><ix:nonFraction name="ifrs-full:FeeAndCommissionExpense" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">15,833</ix:nonFraction></span>
thousand (or R$ <span id="xdx_90D_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zPcqdPb29D06" title="Fee and commission expense"><ix:nonFraction name="ifrs-full:FeeAndCommissionExpense" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">59,566</ix:nonFraction></span>) in underwriting discounts and commissions and other offering expenses totaled US$ <span id="xdx_900_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zzttUX1Zesmi" title="Other offering expenses"><ix:nonFraction name="afya:OtherOfferingExpenses" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,344</ix:nonFraction></span> thousand (or R$ <span id="xdx_90D_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zwTrsvDKuUMi" title="Other offering expenses"><ix:nonFraction name="afya:OtherOfferingExpenses" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">20,104</ix:nonFraction></span>).
The share issuance costs totaled R$ <span id="xdx_902_eifrs-full--ShareIssueRelatedCost_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pn3n3" title="Share issuance costs"><ix:nonFraction name="ifrs-full:ShareIssueRelatedCost" contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">79,670</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Limited transferred
US$ <span id="xdx_909_ecustom--TransferredAmountToGBankAccounts_c20210101__20211231_zmniPZSOQgi8" title="Transferred amount to bank accounts"><ix:nonFraction name="afya:TransferredAmountToGBankAccounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">251,800</ix:nonFraction></span> thousand (or R$ <span id="xdx_902_ecustom--TransferredAmountToGBankAccounts_c20200101__20201231_zuvwKcw4a8u8" title="Transferred amount to bank accounts"><ix:nonFraction name="afya:TransferredAmountToGBankAccounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">961,438</ix:nonFraction></span>) of the net proceeds from the Cayman Islands to bank accounts in Brazil. These deposits were invested
on first-line financial institutions in Brazil and denominated in Brazilian reais.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Issuance
of additional common shares</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 6,
2020, Afya completed its follow-on public offering of <span id="xdx_90B_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of additional common shares issued"><ix:nonFraction name="afya:NumberOfAdditionalCommonSharesIssued" contextRef="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">3,019,928</ix:nonFraction></span> Class A common shares offered by the Company and <span id="xdx_909_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_pdd" title="Number of additional common shares issued"><ix:nonFraction name="afya:NumberOfAdditionalCommonSharesIssued" contextRef="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">9,406,812</ix:nonFraction></span> Class A common
shares offered by the selling shareholders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The offering price
was US$ <span id="xdx_902_ecustom--AdditionalOfferingPrice_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_pdd" title="Additional offering price"><ix:nonFraction name="afya:AdditionalOfferingPrice" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">27.50</ix:nonFraction></span> per Class A common share and gross proceeds of US$ <span id="xdx_904_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zJ7mreNY4214" title="Additional shares gross proceeds"><ix:nonFraction name="afya:AdditionalSharesGrossProceeds" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">83,048</ix:nonFraction></span> thousand (R$ <span id="xdx_90E_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJeeASryH5Re" title="Additional shares gross proceeds"><ix:nonFraction name="afya:AdditionalSharesGrossProceeds" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">358,286</ix:nonFraction></span>). The Company received net proceeds of US$
<span id="xdx_900_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zUAlIhoBrTRj" title="Net proceeds of additional shares"><ix:nonFraction name="afya:NetProceedsOfAdditionalShares" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">78,846</ix:nonFraction> </span>thousand (R$ <span id="xdx_906_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_z0PXlltCxZx2" title="Net proceeds of additional shares"><ix:nonFraction name="afya:NetProceedsOfAdditionalShares" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">339,648</ix:nonFraction></span>), after deducting US$ <span id="xdx_900_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_z0TwEq31xdLl" title="Other offering expenses"><ix:nonFraction name="afya:OtherOfferingExpenses" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">4,202</ix:nonFraction></span> thousand (R$ <span id="xdx_903_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJ2kpzSUC4rl" title="Other offering expenses"><ix:nonFraction name="afya:OtherOfferingExpenses" contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">18,638</ix:nonFraction></span>) in underwriting discounts, commissions and other offering
expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 10, 2020,
the underwriters exercised their option to acquire additional <span id="xdx_900_ecustom--NumberOfAdditionalCommonSharesIssued_c20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_pdd" title="Number of additional common shares issued"><ix:nonFraction name="afya:NumberOfAdditionalCommonSharesIssued" contextRef="AsOf2020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">240,552</ix:nonFraction></span> Class A common shares at the offering price, resulting in gross
proceeds of US$ <span id="xdx_905_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zmb8OsxCNcga" title="Additional shares gross proceeds"><ix:nonFraction name="afya:AdditionalSharesGrossProceeds" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">6,615</ix:nonFraction></span> thousand (R$ <span id="xdx_90B_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zeOESRIFVE4j" title="Additional shares gross proceeds"><ix:nonFraction name="afya:AdditionalSharesGrossProceeds" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">30,884</ix:nonFraction></span>). The net proceeds from the additional shares were US$ <span id="xdx_90F_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zZgOWrs6vvBk" title="Net proceeds of additional shares"><ix:nonFraction name="afya:NetProceedsOfAdditionalShares" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">6,387</ix:nonFraction></span> thousand (R$ <span id="xdx_903_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zoPt9P1kfc8d" title="Net proceeds of additional shares"><ix:nonFraction name="afya:NetProceedsOfAdditionalShares" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">29,819</ix:nonFraction></span>), after deducting
U$ 228 thousand (R$ <span id="xdx_908_ecustom--OtherOfferingExpenses_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zW8z2nx53BFe" title="Other offering expenses"><ix:nonFraction name="afya:OtherOfferingExpenses" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,066</ix:nonFraction></span>) in underwriting discounts and commissions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Afya
transferred US$ <span id="xdx_90D_eifrs-full--ProceedsFromIssueOfOrdinaryShares_uUSDBRL_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zGBVnaPPX0K7"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="USDBRL">68,060</ix:nonFraction></span> thousand (R$ 294,312) of the net proceeds to bank accounts in Brazil with an increase in the capital of Afya Brazil.
These deposits were invested in first-line financial institutions in Brazil and denominated in Brazilian reais.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Acquisitions
in 2021</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(<span style="background-color: white">i)
On January 21, 2021, Afya Brazil acquired iClinic (comprised by iClinic Participa&#231;&#245;es S.A., iClinic Desenvolvimento de
Software Ltda. and Black River Brazil Participa&#231;&#245;es S.A.). iClinic is a SaaS model physician focused technology company
and the leading medical practice management software in Brazil. See Note 5.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(ii)
On March 25, 2021, Afya Brazil acquired Medicinae Solutions S.A. (&#8220;Medicinae&#8221;), through the acquisition of <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zkE3PCYSJSJl" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2019-03-25_custom_MedcelEditoraAndCBBWebMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of its shares.
Medicinae is a leading Brazilian healthcare technology company that specializes in healthcare payments and financial services. See Note
5.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 184 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(iii)
On April 8, 2021, Afya Brazil acquired <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_zMCsl38jUynh" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-04-08_custom_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Medical Harbour Aparelhos M&#233;dicos Hospitalares e Servi&#231;os
em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;). Medical Harbour offers educational health and medical imaging solutions through
an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration, and
knowledge of human anatomy with digital resources. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(iv)
On April 16, 2021, Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaMember_zsi0QUe7Ycbg" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-04-16_custom_CliquefarmaDrogariasOnlineLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;),
a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in
Brazil. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(v)
On May 13, 2021, Afya Brazil acquired <span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiadaInformacaoLtdaMember_zjOOWTIdjOCi" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-05-13_custom_ShospTecnologiadaInformacaoLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;),
which provides a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their financials,
patients appointments, medical records, marketing, and others. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(vi)
On June 1, 2021, Afya Brazil acquired <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraodeEducacaoSuperiorLtdMember_z80GEkQ1zN98" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-06-01_custom_SociedadePadraodeEducacaoSuperiorLtdMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda.
(&#8220;UNIFIPMoc&#8221;), which provides a post-secondary education institution with government authorization to offer on-campus, undergraduate
degrees programs in medicine and health, as well as other courses,in the states of Minas Gerais and Bahia. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(vii)
On August 4, 2021, Afya Brazil acquired <span id="xdx_90F_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804_zQk1K6CEdM" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-08-04" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of (&#8220;Unigranrio&#8221;), comprised of (i) Companhia Nilza
Cordeiro Herdy de Educa&#231;&#227;o e Cultura; (ii) Instituto de Ensino Superior de Palho&#231;a S/S Ltda.; (iii) Sociedade Educacional
de Palho&#231;a S/S Ltda.; and (iv) Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda. Unigranrio is a post-secondary
education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and
health, as well as other courses, in the States of Rio de Janeiro and Santa Catarina. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(viii)
On </span><span style="font-family: Arial, Helvetica, Sans-Serif">October 1, 2021, Afya Brazil <span style="background-color: white">acquired
</span><span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesdeTecnologiaLtdaMember_z1LXS9gDUpI1" title="Percentage of voting equity interests acquired"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-10-01_custom_RXPROSolucoesdeTecnologiaLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of (&#8220;RX PRO&#8221;), comprised of (i) RX PRO Solu&#231;&#245;es de Tecnologia Ltda.
and (ii) RX PRO LOG Transporte e Logistica Ltda.. RX PRO consists of a solution that connects physicians with the pharmaceutical industry,
providing specialized and personalized marketing for those companies, in a more convenient way for physicians. <span style="background-color: white">See
Note 5.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(ix) On November
05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#34;MEC&#34;) authorized the operation
of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil
pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of
Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the transaction does not fall
under the definition of business, but an acquisition of license with indefinite useful life recognized in intangible assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: italic 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"><span style="text-decoration: underline">COVID-19</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In December 2019,
a novel strain of coronavirus (COVID-19) was reported to have emerged in Wuhan, China. COVID-19 has since spread to most of the countries
around the globe, including every state in Brazil. On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a
pandemic, and on March 20, 2020 the Brazilian federal government declared a national emergency with respect to COVID-19.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 185 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Since March 17,
2020, there has been some interruption of our on-campus activities due to Brazilian government authorities&#8217; mandatory lockdowns.
We managed to rapidly adapt our business to these unusual times, and although there has been an interruption of our on-campus activities,
we are offering our non-practical educational activities to our students through our online platform (rather than on-site). Regarding
the offering of practical classes, we quickly resumed our in-hospital and health care residency programs for fifth and sixth-year students,
which represents the largest portion of our practical curriculum.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">During 2020, the
States of Rio de Janeiro, Par&#225;, Tocantins, Piau&#237;, Rond&#244;nia, Bahia and Maranh&#227;o had issued state decrees granting
discounts to our students because of COVID-19. These mandatory discounts have been suspended as their constitutionality has been challenged
in the superior courts. As long as it has not been declared constitutional, we started to invoice our students without these discounts
and, from March 2021, with the discount granted during 2020.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Additionally, we
are also face individual and collective legal proceedings all across the country. On November 18, 2021, the Brazilian Federal Court of
Justice (STF) decided, by majority of the votes, that any lawsuit with decisions to apply linear discounts in monthly tuition fees for
private universities with respect to the COVID-19 pandemic are unconstitutional. The decisions were made in connection to the suits &#8220;Argui&#231;&#245;es
de Descumprimento de Preceito Fundamental &#8211; ADPF&#8221;, numbers 706 e 713, distributed by ANUP (Associa&#231;&#227;o Nacional
das Universidades Particulares) e CRUB (Conselho de Reitores das Universidades Brasileiras), respectively. Therefore, the Company shall
not apply linear discounts in any active monthly tuition fees that are related to the effects to the Covid-19 pandemic. Regarding the
discounts granted by the date of issuance of these financial statements, the Company is charging back the students as final legal decisions
are given by Brazilian courts.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The total mandatory
discounts granted due to COVID-19, net of discounts that have been recovered from previous period, totaled R$ <span id="xdx_903_eifrs-full--LegalProceedingsProvision_iI_c20211231_zKWFazDz5acd"><ix:nonFraction name="ifrs-full:LegalProceedingsProvision" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">33,081</ix:nonFraction></span> during 2021 and
R$ <span id="xdx_90D_eifrs-full--LegalProceedingsProvision_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWD9XnjyR1de" title="Amount of legal proceedings"><ix:nonFraction name="ifrs-full:LegalProceedingsProvision" contextRef="AsOf2021-12-31_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">24,800</ix:nonFraction></span> was related to FCMPB (R$ <span id="xdx_90F_eifrs-full--LegalProceedingsProvision_iI_c20201231_z9uJW14ffzJj" title="Amount of legal proceedings"><ix:nonFraction name="ifrs-full:LegalProceedingsProvision" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">6,545</ix:nonFraction></span> for the year ended December 31, 2020).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of the date
of these financial statements, the COVID-19 pandemic has had no significant impact on the payment default rates of our students. Furthermore,
there have been no significant impacts on our financial performance and position of assets and there have been no significant changes
in our financial condition triggering impairment indicators in these financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">By the date of
issuance of these financial statements all of the lockdown restrictions have been revoked by Brazilian authorities in our campus locations
and the Company has also successfully retaken all of its practical classes in medicines courses and all of its classroom classes.</span></p>

</ix:nonNumeric><p id="xdx_813_zjujxGogZzx" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_z0iPNsYghpG2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">2</span></td><td id="xdx_82F_zNpHFSAhsv4b"><span style="font-family: Arial, Helvetica, Sans-Serif">Significant
                                            accounting policies</span></td></tr></table>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">2.1
Basis for preparation of the consolidated financial statements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS)
as issued by the International Accounting Standards Board (IASB).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
consolidated financial statements have been prepared on a historical cost basis, except for derivative financial instruments that have
been measured at fair value.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 186 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
corporate reorganization described in Note 1, occurred on July 7, 2019, was accounted for as a reorganization of entities under common
control whereby Afya Limited was created as a holding company of Afya Brazil. As a result, the assets and liabilities of Afya Brazil
is carried at historical cost and there was no step-up in basis or goodwill, or other intangible assets recorded as a result of the corporate
reorganization.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As
a result, the consolidated financial statements prepared by the Company subsequent to the completion of the reorganization are presented
&#8220;as if&#8221; Afya Brazil is the predecessor of the Company. Accordingly, these consolidated financial statements reflect: (i)
the historical operating results of Afya Brazil prior to the reorganization; (ii) the consolidated results of the Company and Afya Brazil
following the reorganization; (iii) the assets and liabilities of Afya Brazil at their historical cost; and (iv) the Company&#8217;s
equity and earnings per share for all periods presented.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya
Limited is a holding company, as such the primary source of revenue derives from its interest on the operational companies in Brazil.
As result, the Brazilian Real has been assessed as the Company`s functional currency.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The consolidated
financial statements are presented in Brazilian reais (&#8220;BRL&#8221; or &#8220;R$&#8221;), which is the Company&#8217;s functional
and presentation currency. All amounts are rounded to the nearest thousand.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These consolidated
financial statements as of and for the year ended December 31, 2021 were authorized for issue by the Board of Directors on March 31,
2022.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 187 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.2
Basis consolidation</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock"><p id="xdx_891_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zsVPd9Duk2yg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_ziR2Bi73TCt4">The table below
is a list of the Company&#8217;s subsidiaries and associate:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Direct
    and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 37%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Principal
    activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Investment
    type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z9jrchiGBFF5" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember" name="ifrs-full:NameOfSubsidiary">Afya
    Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember" name="afya:PrincipalActivities">Holding</ix:nonNumeric></span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Nova
    Lima - MG</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zfPPjlT6Kkgk" title="Direct and indirect interest of subsidiary"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z81sgS5rqk5d"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_AfyaParticipacoesSAMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zlLqRdcvRFHg" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" name="ifrs-full:NameOfSubsidiary">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. &#8211; (&#8220;ITPAC Porto&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto
    Nacional - TO</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zuPMmw3wfPnh"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_z1gCmCNpQ22l"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zp8cDC89brzd" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" name="ifrs-full:NameOfSubsidiary">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos S.A. &#8211; (&#8220;ITPAC Araguaina&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Aragua&#237;na
    - TO</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zZr780lHnMKj"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_znkcPDndLpHg"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zzgTEeAITCaf" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" name="ifrs-full:NameOfSubsidiary">Uni&#227;o
    Educacional do Vale do A&#231;o S.A. &#8211; (&#8220;UNIVA&#199;O&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" name="afya:PrincipalActivities">Medicine
    undergraduate degree program</ix:nonNumeric></span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ipatinga
    - MG</ix:nonNumeric></span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zw9mKjXKumXe"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zmRXUq8RcCQf"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8lUk4TjP301" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="ifrs-full:NameOfSubsidiary">IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o
    Jo&#227;o Del Rei - MG</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zhgnUXrf9B6"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8zMttg6TuG2"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="ifrs-full:NameOfSubsidiary">Instituto
    de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Parna&#237;ba
    - PI</ix:nonNumeric></span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zXZfBs9lbLO1"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7YhIBToUkM"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" name="ifrs-full:NameOfSubsidiary">Centro
    de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" name="afya:PrincipalActivities">Medicine
    undergraduate degree program</ix:nonNumeric></span></td>
    <td id="xdx_987_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itajub&#225;
    - MG</ix:nonNumeric></span></td>
    <td id="xdx_989_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zk7AvKsTopUg"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zR74VG9GF9n4"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">60</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="ifrs-full:NameOfSubsidiary">Instituto
    de Ensino Superior do Piau&#237; S.A. (&#8221;IESP&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="afya:PrincipalActivities">Undergraduate
    and graduate degree programs</ix:nonNumeric></span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Teresina
    - PI</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1Fvs8Tu0qc6"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zZLxsFwTVQV4"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zwVz5DAgrVC4" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" name="ifrs-full:NameOfSubsidiary">Centro
    Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zG1GHFtBdDc3" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" name="afya:PrincipalActivities">Outpatient
    care</ix:nonNumeric></span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zMRPtND9HMda" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Teresina
    - PI</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z1bd0JojSvSc" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zPlN4mLVXMO7"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSCfLmYxV9Yb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="ifrs-full:NameOfSubsidiary">FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Pato
    Branco - PR</ix:nonNumeric></span></td>
    <td id="xdx_988_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5itm1udu7si"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zNoH6J07gun"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zkBXSmgej9Vl" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember" name="ifrs-full:NameOfSubsidiary">Medcel
    Editora e Eventos S.A. (&#8220;Medcel&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWoGVwZ1Oz6b" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember" name="afya:PrincipalActivities">Medical
    education content</ix:nonNumeric></span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zqPXxGnD3Icg" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o
    Paulo - SP</ix:nonNumeric></span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zFwBFHa8TK04" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWJfl7mO54r3"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zIlljRou1qXd"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_MedcelEditoraEEventosSAMedcelMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" name="ifrs-full:NameOfSubsidiary">Instituto
    Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes
    Claros - MG</ix:nonNumeric></span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zR9XvVblqBO5"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zBhFtS1cPyhe"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zcNVhEYP8Hfe" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" name="ifrs-full:NameOfSubsidiary">ESMC
    Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zqkBLT94ust2" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zWFpXKcyaYOd" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes
    Claros - MG</ix:nonNumeric></span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zU7GNr6Ahbg" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zKCrhOJip3sl"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zeAarzahU0Jb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="ifrs-full:NameOfSubsidiary">Instituto
    de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="afya:PrincipalActivities">Graduate</ix:nonNumeric></span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Belo
    Horizonte - MG</ix:nonNumeric></span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zvAR6lnmH631"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ztIOR3UOML5c"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="ifrs-full:NameOfSubsidiary">Instituto
    Paraense de Educa&#231;&#227;o e Cultura Ltda (&#8220;IPEC&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="afya:PrincipalActivities">Medicine
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Marab&#225;
    - PA</ix:nonNumeric></span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zH1ceiFsZORe"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z78wqHEKQT44"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zH1Gzov441T5" title="Name"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" name="ifrs-full:NameOfSubsidiary">Sociedade
    Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zVJVK8SqdCEg" title="Principal activities" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" name="afya:PrincipalActivities">Undergraduate
    and graduate degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zWzd9WRAle0g" title="Location" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Itaperuna
    - RJ</ix:nonNumeric></span></td>
    <td id="xdx_987_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z26iLiewMOH" title="Investment type" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z1pSxbqLpV8l"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z5Vsjtwez8q7"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z70LPVoBpu08"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" name="ifrs-full:NameOfSubsidiary">Centro
    Universit&#225;rio S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zDt07DaWPUYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z6e62UX5uqmf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Porto
    Velho - RO</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zSfSL4ghqbGk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zbQoGUiBXOC4"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zl14O4MVUBc6"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zrRJ83407jc4"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" name="ifrs-full:NameOfSubsidiary">Peb
    Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda (&#8220;PebMed&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_989_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z3KxsZNZJoGl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" name="afya:PrincipalActivities">Content
    and clinical tools and online platform</ix:nonNumeric></span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z06r92Wpk1Mj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio
    de Janeiro - RJ</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zwx3gE8e7o43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zZt2n2mB702a"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zEE4E4yT3B7k"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zDKOv7iS51ak"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" name="ifrs-full:NameOfSubsidiary">Faculdade
    de Ensino Superior da Amaz&#244;nia Reunida &#8211; (&#8220;FESAR&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98E_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zkzNYLFNvlBl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zOhtVFZD7Cc2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Reden&#231;&#227;o
    &#8211; PA</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zv89I1HV3Mg5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zZ4rlxgEK94a"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zNgRf63Of6va"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zSQVD7WjIOii"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" name="ifrs-full:NameOfSubsidiary">Centro
    Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_98F_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zxFuJ4TzS5w9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" name="afya:PrincipalActivities">Medicine
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zDkL5P7ERIYh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Jo&#227;o
    Pessoa &#8211; PB</ix:nonNumeric></span></td>
    <td id="xdx_980_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zY9m1ORoDnhe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zBgCynWMyzV1"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zR3jOGXQjyJ2"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_z4sfZ27y49ra"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" name="ifrs-full:NameOfSubsidiary">MedPhone
    Tecnologia em Sa&#250;de Ltda. (&#8220;MedPhone&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zaHBVqt7IaTj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" name="afya:PrincipalActivities">Content
    and clinical tools and online platform</ix:nonNumeric></span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zA7SEKHrLVP9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Recife
    &#8211; PE</ix:nonNumeric></span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zkt9e1J0G1X4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zHI2Dlz7iHsb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zpOstkaWEOdg"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zpRgK3ImWPFi"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" name="ifrs-full:NameOfSubsidiary">iClinic
    Desenvolvimento de Software Ltda (&#8220;iClinic&#8221;)</ix:nonNumeric></span>*</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zFTwhzrx3nA5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" name="afya:PrincipalActivities">Electronic
    Medical Record, Clinical Management System</ix:nonNumeric></span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zlVXzC2ylHSe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Ribeir&#227;o
    Preto - SP</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_z9PqGrLMOxpc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zdySchrxCPId"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zvUNn2HMeB7b"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zw9QhWexOPuh"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" name="ifrs-full:NameOfSubsidiary">Medicinae
    Solutions S.A. (&#8220;Medicinae&#8221;)</ix:nonNumeric></span>*</span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z7ns4bSXQK7j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" name="afya:PrincipalActivities">Healthcare
    payments and financial services</ix:nonNumeric></span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zQIYUa5bVxn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio
    de Janeiro &#8211; RJ</ix:nonNumeric></span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z9CmVh0K3cab" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zxhSU6hdsAn6"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zBxcDO4O3SBe"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_MedicinaeSolutionsSAMedicinaeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zPFJIz7hWfK6"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" name="ifrs-full:NameOfSubsidiary">Medical
    Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</ix:nonNumeric></span> * </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zwIp9XAoADei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" name="afya:PrincipalActivities">Educational
    health and medical imaging</ix:nonNumeric></span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zQsGUFEXuomg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Florian&#243;polis
    &#8211; SC</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zDwHTzZawaUe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zLPKrY4fz6d8"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_ze1vu47f0fvb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zzPOLeuN3OBb"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" name="ifrs-full:NameOfSubsidiary">Cliquefarma
    Drogarias Online Ltda.(&#8220;Cliquefarma&#8221;)</ix:nonNumeric></span>* </span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zSHLOXonvx2b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" name="afya:PrincipalActivities">Online
    platform</ix:nonNumeric></span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zVJ2NnB1MVi9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o
    Paulo &#8211; SP</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zJmAfpqxLCHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zaTbbqTjOQW5"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zTxJp3vO7E3e"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zG3JXW9mztmd"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" name="ifrs-full:NameOfSubsidiary">Shosp
    Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)*</ix:nonNumeric></span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zToBTjW2TyD7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" name="afya:PrincipalActivities">Electronic
    Medical Record, Clinical Management System</ix:nonNumeric></span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zEee92923w5d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Rio
    de Janeiro &#8211; RJ</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z1rUwDHM3Mo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zpPjmUPHeXp3"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z5Wub04kkKe3"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_z9MzGbzDeRZi"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" name="ifrs-full:NameOfSubsidiary">Sociedade
    Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;) *</ix:nonNumeric></span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zr807cyaagH8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zKTB5doQXmMi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Montes
    Claros - MG</ix:nonNumeric></span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zYpJQ0andVK5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zSt9MOyTyqVk"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zOXOqP0yuHZi"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zMS6ni7bueL6"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" name="ifrs-full:NameOfSubsidiary">Companhia
    Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura. (&#8220;Unigranrio&#8221;) *</ix:nonNumeric></span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zUIIelInsaR1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" name="afya:PrincipalActivities">Undergraduate
    and graduate degree programs</ix:nonNumeric></span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_z89RRuYvrq6g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Duque
    de Caxias - RJ</ix:nonNumeric></span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zQ2lR5fHJMZ2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zWwnDDV4gEU"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zDL0RjrJPfj7"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zR5zY0CnhaZ9"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" name="ifrs-full:NameOfSubsidiary">Policl&#237;nica
    e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;) *</ix:nonNumeric></span></span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zsoPxbXMt8Wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" name="afya:PrincipalActivities">Medical
    Care</ix:nonNumeric></span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zpZ3ZVyRo7ji" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Duque
    de Caxias - RJ</ix:nonNumeric></span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zWT8ia76dsc4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zUZ3PipdfPcl"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zm7Ac6Qd74Y5"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zYZa9ItnOA7h"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" name="ifrs-full:NameOfSubsidiary">Sociedade
    Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) *</ix:nonNumeric></span></span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zgFnX4WgFzXg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" name="afya:PrincipalActivities">Basic
    Education</ix:nonNumeric></span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zFx7qQwnQvm8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Palho&#231;a
    - SC</ix:nonNumeric></span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zp4mHnx9s383" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6LF5Q7lAzml"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6RXromp2B59"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zUfp5LnGTZQ6"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" name="ifrs-full:NameOfSubsidiary">Instituto
    de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) *</ix:nonNumeric></span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zbwI988zz4Wi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zxUZTVNXxla1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Palho&#231;a
    - SC</ix:nonNumeric></span></td>
    <td id="xdx_981_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_z2tNX8hq96D6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zfk7rzN3pg6j"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zJs3gY7NUhv"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zzEuP4VgRLy2"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" name="ifrs-full:NameOfSubsidiary">RX
    PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zQgX8XxTHMK9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" name="afya:PrincipalActivities">Marketing
    for pharmaceutical industry</ix:nonNumeric></span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zvgcWDbNbM22" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o
    Paulo &#8211; SP</ix:nonNumeric></span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zmObsQxJcxGj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zyMXF4luwsq3"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_z1uMVf24jDik"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zl6TCLqYadkd"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" name="ifrs-full:NameOfSubsidiary">RX
    PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</ix:nonNumeric></span></span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zfsA4FvRPL0h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" name="afya:PrincipalActivities">Marketing
    for pharmaceutical industry</ix:nonNumeric></span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zYcbgW51QvLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">S&#227;o
    Paulo &#8211; SP</ix:nonNumeric></span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zMnXUPAy3qbc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" name="afya:InvestmentType">Subsidiary</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zO1th5XT7Tgb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zcIYkH7cioyc"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zvcJDpsfLF3"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" name="ifrs-full:NameOfSubsidiary">Uni&#227;o
    Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;)</ix:nonNumeric></span> </span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zLLXEsOvus75" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" name="afya:PrincipalActivities">Undergraduate
    degree programs</ix:nonNumeric></span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zdlQVhNz98i5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" name="ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary">Bras&#237;lia
    - DF</ix:nonNumeric></span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAnRWBRjJ3Tj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" name="afya:InvestmentType">Associate</ix:nonNumeric></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zWfviYY5pRLb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_z3F8ZHPm91Zh"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">30</ix:nonFraction></span>%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">* See Note 5 for
further details of the business combinations during 2021.</span></p>

</ix:nonNumeric><p id="xdx_8AE_zBV9DnKyLmT2" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
financial information of the acquired subsidiaries is included in the Company&#8217;s consolidated financial statements beginning on
the respective acquisition dates.<br />
</span></p>


<ix:exclude><!-- Field: Page; Sequence: 188 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company consolidates the financial information for all entities it controls. Control is achieved when the Company is exposed to, or has
rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over
the investee. Consolidation of a subsidiary begins when the Company obtains control over the subsidiary and it ceases when the Company
loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are
included in the consolidated financial statements from the date the Company gains control until the date the Company ceases to control
the subsidiary.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">When
necessary, adjustments are made to the financial statements of subsidiaries in order to bring their accounting policies in line with
the Company&#8217;s accounting policies. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to
transactions are eliminated in full on consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">A
change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction. If the Company
loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other
components of equity, while any resulting gain or loss is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Non-controlling
interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated
statements of income and comprehensive income and consolidated statements of changes in equity.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.3
Summary of significant accounting policies</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This note provides
a description of the significant accounting policies adopted in the preparation of these consolidated financial statements in addition
to other policies that have been disclosed in other notes to these consolidated financial statements. These policies have been consistently
applied to all periods presented.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
accounting policies have been consistently applied to all consolidated companies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:BusinessCombinationsAndGoodwillPolicyExplanatory"><p id="xdx_845_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zXGmTUPzPJU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_866_zaEnDGm2gzv8">a)
Business combinations and goodwill</span> </b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Business combinations
are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred,
which is measured at acquisition date fair value, and the amount of any non-controlling interests in the acquiree. For each business
combination, the Company elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate
share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs are expensed as incurred and included in general and
administrative expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the Company
acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and designation in accordance
with the contractual terms, economic circumstances and pertinent conditions as of the acquisition date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is initially
measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interests
and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair value of the net assets
acquired is in excess of the aggregate consideration transferred, the Company re-assesses whether it has correctly identified all of
the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognized at the
acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration
transferred, then the gain is recognized in the consolidated statement of income.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 189 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Company&#8217;s cash-generating units that are expected to benefit
from the combination, irrespective of whether other assets or liabilities of the acquire are assigned to those units.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Where goodwill
has been allocated to a cash-generating unit (CGU) and part of the operation within that unit is disposed of, the goodwill associated
with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal. Goodwill
disposed in these circumstances is measured based on the relative values of the disposed operation and the portion of the cash-generating
unit retained.</span></p>

</ix:nonNumeric><p id="xdx_858_zZ9yvLY2hpc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory"><p id="xdx_84F_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zgzG63K0xsU1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zHhT9uXICLRb">b)
Current versus non-current classification</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company presents
assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it
is:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held
                                            primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash
                                            or cash equivalent unless restricted from being exchanged or used to settle a liability for
                                            at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All other assets
are classified as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A liability is
current when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is expected to be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is held primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is due to be settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There
                                            is no unconditional right to defer the settlement of the liability for at least twelve months
                                            after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company classifies
all other liabilities as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Deferred tax assets
and liabilities are classified as non-current assets and liabilities.</span></p>

</ix:nonNumeric><p id="xdx_852_zgpvJcmdVX6g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory"><p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z1UoK9K8FA54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_znBt0lSNy64l">c)
Fair value measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability
takes place either: (i) in the principal market for the asset or liability; or (ii) in the absence of a principal market, in the most
advantageous market for the asset or liability.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The principal or
the most advantageous market must be accessible by the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The fair value
of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 190 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A fair value measurement
of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest
and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company uses
valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All assets and
liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy,
described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            1 &#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            2 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            3 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets and
liabilities that are recognized in the financial statements at fair value on a recurring basis, the Company determines whether transfers
have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to
the fair value measurement as a whole) at the end of each reporting period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At each reporting
date, the Company analyzes the movements in the values of assets and liabilities which are required to be remeasured or re-assessed as
per the Company&#8217;s accounting policies. For this analysis, the Company verifies the major inputs applied in the latest valuation
by agreeing the information in the valuation computation to contracts and other relevant documents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company also
compares the change in the fair value of each asset and liability with relevant external sources to determine whether the change is reasonable.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of fair value disclosures, the Company has determined classes of assets and liabilities on the basis of the nature, characteristics and
risks of the asset or liability and the level of the fair value hierarchy, as explained above.</span></p>

</ix:nonNumeric><p id="xdx_858_zqlMbMSo3f5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory"><p id="xdx_84B_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_ztYvUYq4jBpk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86C_zZNwJYQfZUg1">d)
Financial instruments &#8211; initial recognition and measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial instrument
is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 191 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"></td><td style="width: 14.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>i)</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Company&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair
value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. Trade receivables that do not
contain a significant financing component or for which the Company has applied the practical expedient, are measured at the transaction
price determined under IFRS 15.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">In order
for a financial asset to be classified and measured at amortized cost or fair value through OCI (Other Comprehensive Income), it needs
to give rise to cash flows that are &#8220;solely payments of principal and interest (SPPI)&#8221; on the principal amount outstanding.
This assessment is referred to as the SPPI test and is performed at an instrument level.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash
flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets,
or both.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Purchases
or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the market
place (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
purposes of subsequent measurement, financial assets are classified as: financial assets at amortized cost or financial assets at fair
value through profit or loss. There is no financial assets designated as fair value through OCI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at amortized cost</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company measures financial assets at amortized cost if both of the following conditions are met:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The financial asset is held within a business model with the objective to hold financial assets in order to collect contractual cash
flows, and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
on the principal amount outstanding.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at amortized cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. Gains and
losses are recognized in the statement of income when the asset is derecognized, modified or impaired.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 192 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss include financial assets held for trading, financial assets designated upon initial recognition
at fair value through profit or loss, or financial assets mandatorily required to be measured at fair value. Financial assets are classified
as held for trading if they are acquired for the purpose of selling or repurchasing in the near term. Derivatives, including separated
embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial
assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit
or loss, irrespective of the business model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair
value recognized in the statement of income. This category includes derivative instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e.,
removed from the Company&#8217;s statement of financial position) when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The rights to receive cash flows from the asset have expired; or</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows
in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either (a) the Company has transferred
substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks
and rewards of the asset, but has transferred control of the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">When
the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially
all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset
to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred asset
and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Company could be required to repay.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Impairment
of financial assets</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Further
disclosures relating to impairment of financial assets are also provided in the following notes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Significant accounting estimates and assumptions &#8211; Note 3</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Trade receivables &#8211; Note 7</span></p>


<ix:exclude><!-- Field: Page; Sequence: 193 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company recognizes an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or loss.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and the cash flows the Company
expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash
flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
trade receivables, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit
risk, but instead recognizes an allowance for credit losses based on lifetime ECLs at each reporting date. The Company has established
a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors
and the economic environment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company considers a financial asset to be in default when internal or external information indicates that the Company is unlikely to
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Company. A financial
asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings,
payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s financial liabilities include trade payables, loans and financing, notes payable, lease liabilities, advances from costumers
and accounts payable to selling shareholders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
measurement of financial liabilities depends on their classification, as described below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
liabilities at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated
upon initial recognition as at fair value through profit or loss.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also
includes, when applicable, derivative financial instruments entered into by the Company that are not designated as hedging instruments
in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 194 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Loans
and borrowings</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">After
initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and
losses are recognized in the statement of income when the liabilities are derecognized as well as through the EIR amortization process.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR.
The EIR amortization is included as finance expenses in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
liability is derecognized when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability
is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially
modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Offsetting
of financial instruments</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and
settle the liabilities simultaneously.</span></p>

</ix:nonNumeric><p id="xdx_857_zctr6eHpZJwk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents"><p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zDlIQMFTwAod" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_867_zDF9074Mtcx9">e)
Cash and cash equivalents</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Cash and cash equivalents
in the statement of financial position comprise cash at banks and on hand, and short-term financial investments with an original maturity
of three months or less, which are subject to an insignificant risk of changes in value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of the statement of cash flows, cash and cash equivalents consist of cash and short-term financial investments, as they are considered
an integral part of the Company&#8217;s cash management.</span></p>

</ix:nonNumeric><p id="xdx_850_z9FiFEU3Hcrj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_zo6V8jmS1mue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_863_zp9r4v6lemA4">f)
Restricted cash</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Restricted cash
in the statement of financial position comprise of financial investments in investment funds that serve as collateral for loan agreements
and other commitments.</span></p>

</ix:nonNumeric><p id="xdx_850_zniZLxzjTHze" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories"><p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zLO4ZjkpxVjj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zgKIkbUiRZ37">g)
Inventories</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Inventories are
valued at the lower of cost and net realizable value. The costs of inventories are based on the average cost method and include costs
incurred in the purchase of inventories and other costs incurred in bringing them to their current location and condition. Costs of purchased
inventory are determined after deducting any discounts and recoverable taxes.</span></p>

</ix:nonNumeric><p id="xdx_85D_zawMF2um1Ye" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 195 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zs5910DRxwp1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zN7I4VlTO1ya">h)
Property and equipment</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Property and equipment
is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Subsequent expenditures
are capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfEstimatedUsefulLives"><p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zgTXvHbXwfZh">Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Building</span></td>
    <td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" title="Useful lives of assets::XDX::P25Y" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">25
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Machinery
    and equipment</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" title="::XDX::P10Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Vehicles</span></td>
    <td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" title="::XDX::P4Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1239">4
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Furniture
    and fixtures</span></td>
    <td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" title="::XDX::P10Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1240">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">IT
    equipment</span></td>
    <td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" title="::XDX::P5Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1241">5
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Library
    books</span></td>
    <td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" title="::XDX::P10Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1242">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Laboratories
    and clinics</span></td>
    <td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" title="::XDX::P10Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Leasehold
    improvements</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" title="::XDX::P20Y" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1244">20
    years</span></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8AE_zExqFxbNA5be" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br /></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An item of property
and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefit is expected
from its use or disposal. Any gain or loss arising on the derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of income when the asset is derecognized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The residual values,
useful lives and methods of depreciation of property and equipment are reviewed at each financial year end and adjusted prospectively,
if appropriate.</span></p>

</ix:nonNumeric><p id="xdx_850_zP1wjw1OPeL6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z54pJUq5MSSk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zbLzWvYYJg3e">i)
Leases</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As from January
1, 2019, the determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the inception
of the contract. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a specific asset
(or assets) and the arrangement conveys a right to use the asset (or assets), even if that asset is (or those assets are) not explicitly
specified in an arrangement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Company
as a lessee</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company
recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 196 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Right-of-use
assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets
are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Unless the Company is reasonably certain to obtain ownership
of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the
shorter of its estimated useful life and the lease term. Right-of use assets are subject to impairment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Lease
liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the commencement
date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease
term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable
lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments
also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for
terminating a lease, if the lease term reflects the Company exercising the option to terminate. The variable lease payments that do not
depend on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In calculating
the present value of lease payments, the Company uses the incremental borrowing rate at the lease commencement date if the interest rate
implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect
the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured
if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment
to purchase the underlying asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Short-term
leases and leases of low-value assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
the short-term lease recognition exemption to its short-term leases of properties (i.e., those leases that have a lease term of <span id="xdx_90A_ecustom--ContractualLeaseTerm_dxL_c20210101__20211231_zf5MLExeIDub" title="Lease term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl1248">12 </span></span>months
or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption
to leases that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense
on a straight-line basis over the lease term.</span></p>

</ix:nonNumeric><p id="xdx_85B_zogGB7vJ1fPi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOKA4C8TmvD9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zJnbovsjkWMc">j)
Intangible assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is
their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated
amortization and accumulated impairment losses. Internally generated intangibles are not capitalized and the related expenditure is reflected
in the statement of income in the period in which the expenditure is incurred.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The useful lives
of intangible assets are assessed as finite or indefinite.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 197 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The amortization
period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting
period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset
are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization
expense on intangible assets with finite lives is recognized in the statement of income in the expense category that is consistent with
the function of the intangible assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating
unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable.
If not, the change in useful life from indefinite to finite is made on a prospective basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An intangible asset
is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income.</span></p>

</ix:nonNumeric><p id="xdx_852_zxbnU4ApNj8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory"><p id="xdx_84E_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zJ3A9hpxuzQ6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zacqbnkRPoBa">k)
Impairment of non-financial assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses,
at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment
testing for an asset is required, the Company estimates the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is
the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal and its value in use. The recoverable amount is determined
for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups
of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written
down to its recoverable amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent
market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used. These
calculations are corroborated by valuation multiples, quoted share prices for publicly traded companies or other available fair value
indicators.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company bases
its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company&#8217;s
CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years, considering
the companies activities and maturation period of its graduate and undergraduate courses. A long-term growth rate is calculated and applied
to project future cash flows after the last projected year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For impairment
testing, goodwill acquired through business combinations and licenses with indefinite useful lives are allocated to their respective
CGUs. The Company has defined each of its operating subsidiaries as a CGU, except for &#8220;Practice Management Tools &amp; Electronic
Prescription&#8221; and &#8220;Clinical Decision Software&#8221; where the subsidiaries were combined as one CGU following the business
strategic pillars and &#8220;Moc&#8221; where we have 2 different educational institution operating in the same municipality (Montes
Claros).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Whenever applicable,
impairment losses of continuing operations are recognized in the statement of income in expense categories consistent with the function
of the impaired asset.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 198 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets excluding
goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the
asset&#8217;s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation,
had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is tested
for impairment annually as at December 31 and when circumstances indicate that the carrying value may be impaired.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Impairment is determined
for goodwill by assessing the recoverable amount of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount
of the CGU is less than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed
in future periods.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are tested for impairment annually as at December 31 at the CGU level, as appropriate, and when circumstances
indicate that the carrying value may be impaired.</span></p>

</ix:nonNumeric><p id="xdx_85E_zM8v2dJCLAK5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:PolicyExplanatoryInvestments"><p id="xdx_840_ecustom--PolicyExplanatoryInvestments_zp92p4k14z53" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zm2GPpW2ebch">l)
Investments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Investments in
associates are initially recognized at consideration transferred and adjusted thereafter for the equity method, being increased or reduced
from its interest in the investee's income after the acquisition date. An associate is an entity over which the Company has significant
influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is
not control or joint control over those policies.</span></p>

</ix:nonNumeric><p id="xdx_855_zJxqhdslJCqf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:AccountsPayableToSellingShareholdersPolicyExplanatory"><p id="xdx_840_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_z7Btth29dxk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_865_zjIKH8Rtxiph">m)
Accounts payable to selling shareholders</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These amounts represent
liabilities related to the acquisitions made by the Company which are not yet due. Accounts payable to selling shareholders are presented
as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their
fair value and subsequently measured at amortized cost using the effective interest method.</span></p>

</ix:nonNumeric><p id="xdx_85C_z7QtDdjZo6bi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zYxyM6o1glsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zazXTRkSedzl">n)
Provisions</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Provisions are
recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow
of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount
of the obligation. The expense relating to a provision is presented in the statement of income, net of any reimbursement, when applicable.</span></p>

</ix:nonNumeric><p id="xdx_85E_zKd0Ih1nhaYc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DividendsPayablePolicyExplanatory"><p id="xdx_842_ecustom--DividendsPayablePolicyExplanatory_z397t1pS5jC3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86E_z15jdl7MGCZ3">o)
Dividends payable</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
a liability to pay a dividend when the distribution is authorized and the distribution is no longer at the discretion of the Company.
The distribution is authorized when it is required to pay a minimum dividend of the net income for the year in accordance with the Brazilian
Corporate Law (applicable for Afya Brazil) and the Company&#8217;s By-Laws or is approved by the shareholders. A corresponding amount
is recognized directly in equity.</span></p>

</ix:nonNumeric><p id="xdx_85A_zEcLxXZFdrEb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 199 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:LaborAndSocialObligationsPolicyExplanatory"><p id="xdx_84E_ecustom--LaborAndSocialObligationsPolicyExplanatory_zyuMWjV52mJk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86B_zInMviYYmc74">p)
Labor and social obligations</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Labor and social
obligations are expensed as the related service is provided. A liability is recognized for the amount expected to be paid if the Company
has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation
can be estimated reliably.</span></p>

</ix:nonNumeric><p id="xdx_851_zY2GIsDa1tO" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SharebasedPaymentsPolicyExplanatory"><p id="xdx_846_ecustom--SharebasedPaymentsPolicyExplanatory_zmQw3Ia7vck7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_864_zEpxtV9J1cY">q)
Share-based payments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain key executives
of the Company receive remuneration in the form of share-based payments, whereby the executives render services as consideration for
equity instruments (equity-settled transactions).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The expense of
equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">That expense is
recognized in general and administrative expenses, together with a corresponding increase in equity, over the period in which the service
and, where applicable, the performance conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of income for a period
represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Service and non-market
performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market
performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated
service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award
and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">No expense is recognized
for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include
a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition
is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the terms
of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided
the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any
modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.
Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately
through the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The dilutive effect
of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.</span></p>

</ix:nonNumeric><p id="xdx_851_z0xnLBbFBRZf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 200 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory"><p id="xdx_847_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zIAU51gxhdvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zuG4RQveJnAk">r)
Revenue from contracts with customers</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Tuition fees
and other revenue</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company's revenue
consists primarily of tuition fees charged for medical courses. The Company also generates revenue from tuition fees for other undergraduate
courses, student fees, certain education-related activities, digital education content and subscription of digital services.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenues are recognized
when services are rendered to the customer and the performance obligation is satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from tuitions
and digital education content are recognized over time when services are rendered to the customer and the Company satisfies its performance
obligation under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for
those services. Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other revenues
are recognized at a point in time when the service is rendered to the customer at an amount that reflects the consideration to which
the Company expects to be entitled in exchange for the service. Other revenues are presented net of the corresponding discounts, returns
and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Printed books,
e-books, healthcare payments, online platforms and marketing for pharmaceutical industry revenues are transferred at point in time</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from sale
of printed books, e-books, healthcare payments, online platforms and marketing for pharmaceutical industry are recognized at the point
in time when control of the asset or services is transferred to the customer, generally on delivery of the goods at the customer&#8217;s
location and permission to access the digital content. The Company considers whether there are other promises in the contract that are
separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price
for the printed books and e-books, the Company considers the effects of variable consideration, financing component, noncash consideration,
and consideration payable to the customer to be not significant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
concluded that it is the principal in its revenue arrangements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses
collectability on a portfolio basis prior to recording revenue. Generally, students cannot re-enroll for the next academic session without
satisfactory resolution of any past-due amounts. If a student withdraws from an institution, the Company's obligation to issue a refund
depends on the refund policy at that institution and the timing of the student's withdrawal. Generally, the refund obligations are reduced
over the course of the academic term.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Trade
receivables </i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Trade receivables
represent the Company&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before
payment of the consideration is due). Refer to accounting policies of financial assets in Financial instruments &#8211; initial recognition
and subsequent measurement.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 201 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Advances
from customers</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Advances from customers
(a contract liability) are the obligation to transfer services to a customer for which the Company has received consideration (or an
amount of consideration is due) from the customer, as a result of pre-paid tuition, digital education content and mobile app subscription
for digital medical content received from customers and is recognized separately in current liabilities, when the payment is received.
Advances from customers are recognized as revenue when the Company performs all obligations related to the contract, generally in the
following month.</span></p>

</ix:nonNumeric><p id="xdx_857_zeGkJvv1S2ol" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:TaxesPolicyExplanation"><p id="xdx_84F_ecustom--TaxesPolicyExplanation_z5qycgmF9NF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_868_z8LSmzg94np6">s)
Taxes</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
Company&#8217;s subsidiaries joined the PROUNI (<i>Programa Universidade para Todos &#8211; </i>University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number
of student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
taxes and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PIS
and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
regulation of PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS.
For income from other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_907_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z6M7MuXIJc7j" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.65</ix:nonFraction></span>% and <span id="xdx_90C_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zQWtielBNzl6" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">3.00</ix:nonFraction></span>%, respectively, and for non-teaching
activities, PIS is charged at a rate of <span id="xdx_90D_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_znwbL7c5ouAg" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.65</ix:nonFraction></span>% and to COFINS at <span id="xdx_905_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zW2vj2NmWk9b" title="Tax rate"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.6</ix:nonFraction></span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><i>Current
income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Current
income taxes were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service,
specifically regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Current income
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates
and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.4
Changes in accounting policies and disclosures</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><i>New
standards, interpretations and amendments adopted by the Company</i></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain amendments
apply for the first time in 2021, but do not have an impact on these financial statements of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.</span></p>

</ix:nonNumeric><p id="xdx_85D_zTpuUYmQKRo7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_812_zj42QgCB22ai" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 202 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SignificantAccountingEstimatesAndAssumptionsExplanatory"><p id="xdx_802_ecustom--SignificantAccountingEstimatesAndAssumptionsExplanatory_zzeUm1K0YJg7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">3</span></td><td id="xdx_82D_zVay4qDcM8oj"><span style="font-family: Arial, Helvetica, Sans-Serif">Significant
                                            accounting estimates and assumptions</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The preparation
of the Company&#8217;s consolidated financial statements requires management to make judgments, estimates and assumptions that affect
the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Uncertainty about these assumptions
and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in
future periods. Accounting estimates and judgments are continually evaluated and are based on historical experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are recognized
prospectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other disclosures
relating to the Company&#8217;s exposure to risks and uncertainties includes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Capital management &#8211; Note 15</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Financial instruments risk management objectives and
policies &#8211; Note 13.4</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Sensitivity analyses disclosures &#8211; Note 13.4.1</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Estimates
and assumptions</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The key assumptions
about the future and other key sources of estimated uncertainty as of the reporting date that include a significant risk of a material
adjustment to the carrying amounts of assets and liabilities within the next financial year, are described below. The Company based its
assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and
assumptions about future developments, however, may change due to market changes or circumstances that arise and that are beyond the
Company&#8217;s control. Such changes are reflected in the assumptions when they occur.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Identification
and fair-value measurement of assets and liabilities acquired in a business combination</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Business combinations
are accounted for using the acquisition method. Such method requires recognizing and measuring the identifiable assets acquired, the
liabilities assumed and any non-controlling interest in the acquiree. The Company, as the acquirer, must classify or designate the identifiable
assets and liabilities assumed on the basis of its own contractual terms, economic conditions, operating and accounting policies and
other relevant conditions as at the acquisition date. Such assessment requires judgments from the Company on the methods used to determine
the fair value of the assets acquired and liabilities assumed, including valuation techniques that may require prospective financial
information inputs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Impairment
of non-financial assets</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Impairment exists
when the carrying value of an asset or cash generating unit (&#8220;CGU&#8221;) or group of CGUs exceeds its recoverable amount, defined
as the higher of its fair value less costs of disposal and its value in use. The fair value less costs of disposal calculation is based
on data available from binding sales transactions, conducted at arm&#8217;s length, for similar assets or observable market prices less
incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash flow model (&#8220;DCF&#8221;
model). The cash flows are derived from the budget for the next five years and do not include restructuring activities to which the Company
has not yet committed or significant future investments that will enhance the performance of the assets of the CGU being tested. The
recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future cash-inflows and the growth
rate used for extrapolation purposes.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 203 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These estimates
are most relevant to goodwill and indefinite lived intangible assets recognized by the Company. The key assumptions used to determine
the recoverable amount for each CGU, including a sensitivity analysis, are disclosed and further explained in Note 12.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Share-based
compensation</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Estimating fair
value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms
and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including
the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about them. For the
measurement of the fair value of equity-settled transactions, the Company uses the Binomial model. As disclosed in Note 16 (b) the Company
had stock plans that were fully exercised on July 31, 2019, for which the Monte Carlo and Black &amp; Scholes pricing model were used
for the Afya Brazil and Guardaya plans, respectively. The assumptions and models used for estimating fair value for share-based payment
transactions are disclosed in Note 16 (b).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Leases
- Estimating the incremental borrowing rate</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company cannot
readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities.
The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds
necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects
what the Company &#8216;would have to pay&#8217;, which requires estimation when no observable rates are available (such as for subsidiaries
that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for
example, when leases are not in the subsidiary&#8217;s functional currency).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company estimates
the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates.</span></p>

</ix:nonNumeric><p id="xdx_81B_zkAg3kNJ8fd4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zXiee9PB0UD8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_zPsVcVvCGsik">Segment
                                            information</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">During
2021, in connection with the recent acquisitions of digital and technology companies, the Company revised its operating segments. As
result, the Company has three operating segments as opposed to the previously reported Business Unit 1 (educational services through
undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs) and Business Unit 2 (residency
preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education
platform). The three reportable segments are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate
programs;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Continuing Education, which provides specialization programs and graduate courses; and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226; Digital
Services, which provides content and technology for medical education, clinical decisions software, practice management tools and electronic
medical records, doctor-patient relationship, telemedicine and digital prescription.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 204 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Due
to changes in operating segments, the segment information for the years ended December 31, 2020 and 2019 have been restated. Segment
information is presented consistently with the internal reports provided to the Company's Chief Executive Officer (CEO), which is the
Chief Operating Decision Maker (CODM) and is responsible for allocating resources, assessing the performance of the Company's operating
segments, and making the Company's strategic decisions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">No
operating segments have been aggregated to form the above reportable operating segments. There is only one geographic region and the
results are monitored and evaluated as a single business.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory"><p id="xdx_89E_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zUXaad5h7Mt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
presents assets and liabilities information for the Company&#8217;s operating segments as of December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BD_z6Dl3226OiKg" style="display: none; visibility: hidden">Schedule of assets and liabilities information for the company's operating segments</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8MLTeLTx8Eg" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,072,135</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98E_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbVFzSw7bDIh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105,629</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3yTtB30bp4f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">272,122</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuz4SrTqbpZg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,449,886</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zVZBuUmI6Jl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,480</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCZHCBnPwmC3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,447,406</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCiYwv2SGRb2" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,048,869</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSH91O5qMXPh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,737</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVxSdq2WUk5c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,726</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziklBiCLTjgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,209,332</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU9TCYrspu92" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,480</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvNdOu3kDsO6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,206,852</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7XcCkhEw8Ae" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,023,266</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zA5VsNbylyS" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,892</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6nefN7y2TRa" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">154,396</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkVTThyKJ84j" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,240,554</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zitjGMD2cAI5" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">&#160;</span>-</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zp1ta45AlkXe" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,240,554</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7DmuYsO6lZ2" title="Total liabilities and equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,072,135</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zP4GuCZng308" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105,629</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXnKRcfMoZu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">272,122</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdf9esFrs6Vi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,449,886</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGGsJ8njCp6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,480</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfIsZb6DBfki" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,447,406</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z73qH9UhnQMb" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">645,657</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfbTKIYCgO4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,300</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzXJcgzmKX24" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,029</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyNFrZLEm6b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">768,986</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z9Y0teMUP8hc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,480</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL785sASxyQj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">766,506</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zMh8wjNmNWph" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,551,175</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVkQP8DwOvo2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,705</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znm34ac8P3fd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,002</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJofVDjsfYvl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,680,882</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMP1pP9NayAe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1328">&#160;</span>-</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeODj5QqzXEj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,680,882</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zNPkui3JDCXb" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,875,303</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLV03pSCs0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,624</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zhSqjOhCy4kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,091</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zo9OCkJrIsqc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zRZ9hVcHk6sf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1335">-</span></span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zudpHTwC1Sda" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxW6GOyh5p6a" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXztkO1pXN8c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zlgayYjOO0Xl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1340">&#160;</span>-</span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYk7FhznPFY6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zV9f0OAq88Kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">&#160;</span>-</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfLt9c28re4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F43_zEiPbqoS5K5k">(*)</sup></span></td>
    <td id="xdx_982_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_z8Z07kclveO8" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001345" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">220,202</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zOHURYnnL0hj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001346" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,682</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zj2qXv5ttDLc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001347" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,095</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_z5zVSU1kxZ9c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001348" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">301,979</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zOUZ2Z6wHbk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#160;</span>-</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_zi078UuCD8pe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001350" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">301,979</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVM7VrXO608a" title="Total assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,541,988</ix:nonFraction>
    </b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgIQqf9KZOw2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,300</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBrPaJfVEQX" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,920</ix:nonFraction>
    </b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmcTOdyXAnV1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,208</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98D_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTHUBYo8pXS1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">115</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIshRjt5PAn3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Assets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,093</ix:nonFraction>
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlYP8VQec1Mk" title="Current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,280,342</ix:nonFraction>
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeRXNhOfbFFh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,119</ix:nonFraction>
    </span></td>
    <td id="xdx_986_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zwTtaq8T745l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,155</ix:nonFraction>
    </span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKj5GPP3vy68" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,405,616</ix:nonFraction>
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsxs1kTY0l7g" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">115</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zakpQFwpXwT2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,405,501</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zWNHMq6L4Tkj" title="Non-current assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,261,646</ix:nonFraction>
    </span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTdLd7DQ7cgb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,181</ix:nonFraction>
    </span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ze5H4zjymO34" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">97,765</ix:nonFraction>
    </span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIofv54SBTtf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,387,592</ix:nonFraction>
    </span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z6rLjJ6vCvi4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,387,592</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLXdI8yhvmak" title="Total liabilities and equity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,541,988</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOroIN3xZ24b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,300</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ztksHlB6YDT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182,920</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zEXJwQlkTYr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,208</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zBuTUknHMrZ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">115</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfgSZbUDFxJ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:EquityAndLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,793,093</ix:nonFraction>
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeFbQFXF3xR9" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">522,523</ix:nonFraction>
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zZcVnQoBRGV7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,491</ix:nonFraction>
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zebGn39LZbCb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,480</ix:nonFraction>
    </span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkz0YGcVv4l7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">589,494</ix:nonFraction>
    </span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zWpbe1lNJVR5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">115</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKQeG0M01CU8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">589,379</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zfTLFbhfvCF1" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,261,894</ix:nonFraction>
    </span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwEQrwHchIYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,763</ix:nonFraction>
    </span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2GNB2dTMx56" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,277</ix:nonFraction>
    </span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZAp55oRudYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,369,934</ix:nonFraction>
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zEewhR4q3msk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,369,934</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z5ZIZhCCkTj1" title="Equity" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,757,571</ix:nonFraction>
    </span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z6yHBhIeJSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,046</ix:nonFraction>
    </span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEK6hJIjxKN5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,163</ix:nonFraction>
    </span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQfDgxPUEnhi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction>
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrtD1T8lsJq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Equity" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction>
    </span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhMOYSlizIT5" title="Investments in associate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfgWOhPRxtxj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo5DwTYI56Q8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F4C_zBxKJImE4Crc">(*)</sup></span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_zMVvAvt1rHAj" title="Capital expenditures" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" id="Fact001402" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83,256</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zazZPeAwVhs1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" id="Fact001403" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,638</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zAimAi2DWkI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" id="Fact001404" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,587</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_zxE3Uosvryii" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" id="Fact001405" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,481</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_z03yDhCO92Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CapitalExpenditures" contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember" id="Fact001406" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,481</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span id="xdx_F0C_zR84OS3BjgG3" style="font-family: Arial, Helvetica, Sans-Serif">(*)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F11_ziC9kXBmC7V2" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote001407" xml:lang="en-US">Capital expenditures consider
the acquisitions of property and equipment and intangible assets.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A8_z6yXhYAnCmR1" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 205 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfOperatingSegmentsExplanatory"><p id="xdx_896_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zsa5CU9Jbtv4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
present the statements of income for the Company&#8217;s operating segments for the years ended December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zjn7d2J1ixD2" style="display: none; visibility: hidden">Schedule of operating income for each operating segment</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zmCnusGSmTfg" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQIOTgtMh26" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP54ICgmDHU7" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,980</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zK07raONaxBh" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcfR1uGvSje5" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1419">-</span></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09UC1Zy5hn" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zw5AvcJretxf" title="Inter-segment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td>
    <td id="xdx_984_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zNSYD9ibSAMj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0tl7xWgZSBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zO22ITfRij4b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z6xohWGDzlxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn66q1dembFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_ztPUOoJKQnmd" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRp5ZA1qfWih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJnYCEH3PiY2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ztEZXNY4shc3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,723,349</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zKZd8vNxlyda" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfHKcGZgZhA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zx3qtbk8jZNk" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">554,995</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zyT8JV2Gp2U2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">50,773</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zqDEZH2cnAag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">50,510</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z66YXzCxRKh7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">656,278</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zur3vkJqsUf7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,978</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlYx00wRNTQe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">652,300</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z9QS1YcnAoP2" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">943,413</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrBxOB0cCMi9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,210</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z9H6NAmQohve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,448</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhu6XTtM69Sk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zLGmCzyOfPOc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1448">-</span></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlW6DFTP8wj5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,067,071</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYDcXnseYfuk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    income, net</span></td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zwAh4f6K9YW5" title="Other income, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zK48EaYqAVOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></span></td>
    <td id="xdx_98A_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvFclGluazB7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1454">-</span></span></td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYvCHApM9xM5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zatEsAm3vxq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1456">-</span></span></td>
    <td id="xdx_984_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBH76Aw3eNwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,561</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zPLBOq91G2Rg" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOFVsb2qbo7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znKL3ekNOds1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfFwq4OQufba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSYy2ypOt0Fl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1463">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDnIGbt5P0vk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">440,895</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td id="xdx_98E_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zZqpsQUYwAZj" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSITHa1kksR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></span></td>
    <td id="xdx_985_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zbQJAAMWjr9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1468">-</span></span></td>
    <td id="xdx_988_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuLoiW7eLipg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4v3e95oYAil" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54jzkPM69a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td id="xdx_982_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbXTcDAbzuue" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td>
    <td id="xdx_98F_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbP00rn6ptme" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></span></td>
    <td id="xdx_981_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFT7e649bJm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td>
    <td id="xdx_987_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSnJm8O1U3G8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td>
    <td id="xdx_98E_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zQV7Jyq4FzOe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1477">-</span></span></td>
    <td id="xdx_98A_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFv2ki8MtSkh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">243,796</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVeZqdFjTOF2" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zq3wPYfIg6A6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">-</span></span></td>
    <td id="xdx_987_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zdqkjn5rkXlh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_986_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zv9SJIrkjH6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znauMNkCHoFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGFvtvNu9mU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td id="xdx_98B_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zXocjNwis6fa" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1487">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zG5u25ptKUwl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAP6Gsmv2A1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1489">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk12QYpcqIQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zIW64Gu5WRx8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1491">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z9wnRO1YUqL8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLC2mhBVl89k" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRZMGfEXIET9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1495">-</span></span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVJ1BEjQ8KHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1496">-</span></span></td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zANwLJS6iHo3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1497">-</span></span></td>
    <td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4o67f8H9fc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM9XoS9scxrd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,179</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrcm1bEkq25f" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zapeaLWLGu58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3V2t2MyAd77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zsVVHwddoLa2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsnawhcfXuza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUctAe4vVO5c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">242,283</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDC8UDO21mWl" title="External costumer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,002,461</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zEcx1To2S5m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zCH41Ch9sFRh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,533</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfpKqpzJfUT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNl0cA8uXSQl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXBGfLYjAsS1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,619</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6CYVJGfNnsc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,619</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcBy1toXIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zEkbeKC8ZqCf" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,002,461</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zo1e8oIrAxHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvwSFLaOvOs3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,152</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zywJFkXLb6Jl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,202,810</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zO6vs1JNkWRl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcXG2AIYDrG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeCn3gsLjny3" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">381,964</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwL2IG2m6mok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">40,000</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zsUj6uQQ7cWd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,309</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zybx7Xnboczd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">436,273</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU3lLMUxiZpf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,619</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOHk0pFEBM2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">434,654</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zelGlg74jymd" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">620,497</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJO5ZwVr7Mt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,197</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znsxjwm2z3lc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,843</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdcwavh3dSy2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">766,537</ix:nonFraction></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM6vuMDtlXz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">766,537</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn6SsoOwGUxl" title="General and administrative expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">402,855</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJFBo8Q9APe" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">347</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNoO3yoMY3O3" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">363,335</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--FinanceIncome_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zU6qk3y1QKU9" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,290</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHlk40GClwb4" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">98,269</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyAfEr5VyH0i" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,698</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLEu9Zpk7vNc" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">335,054</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zi8fEVN7iCmd" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27,067</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLoss_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLik8i0J3mTf" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307,987</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zoqVZTyudwld" title="External customer" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">653,760</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhdvTR31m8K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,870</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zykdxQd49jg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,000</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSRuobNwycId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQ2kRrUNrq3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:DepositsFromExternalCustomer" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2Q5Ljpj6918" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,880</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zRdQikltGF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:InterSegment" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,880</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm42aORow3vb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:InterSegment" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhoksJcN7Vu5" title="Net revenue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">653,760</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvGXbNp8r0h1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,870</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAZqhNaTN5g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,880</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7wlWUORR2K4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">754,510</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ziVhZtMXnQ5j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmUAZA7lHE82" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPnzwgkBt38" title="Cost of services" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">279,066</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zh9iqzRdBhV8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">29,261</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z60TTF6PBJdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,406</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAy7VCyaMOY6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">312,733</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zhseQ1vqhRZ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,880</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdd4gtywTZM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">308,853</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxEUKwLLX7Eh" title="Gross profit" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">374,694</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdZiUuhYcQT9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,609</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrNW4RggKXLf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,474</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zNcqykE2YGdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">441,777</ix:nonFraction></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zu2MRhWGTqd9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:GrossProfit" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">441,777</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HwfjymDrrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,120</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8Lo6rOZeQPl" title="Other expenses, net" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:OtherGainsLosses" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,594</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOepLPYaDEV2" title="Operating income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossFromOperatingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">205,251</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--FinanceIncome_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3DWf5MzwPCg" title="Finance income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,689</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5xhI8ZChiL1" title="Finance expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:FinanceExpense" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">72,365</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zS5vJ0Cwy856" title="Share of income of associate" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,362</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWiU1UMM1rf" title="Income before income taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">186,937</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKsLvStPHT25" title="Income taxes expenses" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,175</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXJCMcLQLWZa" title="Net income" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">172,762</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zRe6tM3JCC43" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 206 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Seasonality
of operations</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Undergrad
&#180;s and Continuing Education tuition revenues are related to the intake process and monthly tuition fees charged to students over
the period thus the Company do not have significant fluctuations during the semester.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Digital Services
are comprised mostly by Medcel, Pebmed and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel revenues are concentrated in the first and last quarter of the year, as a result of enrollments of Medcel&#8217;s clients period.
The majority of Medcel&#8217;s revenues is derived from printed books and e-books, which are recognized at the point in time when control
is transferred to the customer. Consequently, Digital Services segment generally has higher revenues and results of operations in the
first and last quarter of the year compared to the second and third quarters of the year.</span></p>

</ix:nonNumeric><p id="xdx_816_z7iz1omxdGtg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 207 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfBusinessCombinationsExplanatory"><p id="xdx_80A_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zScZQhdJJykf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>5</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_824_zOvRgZlfvy4h">Business
                                            combinations</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">5.1
Acquisitions in 2021</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock"><p id="xdx_895_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_zydnIkVgntta" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The preliminary
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zzwDCBsCntad" style="display: none; visibility: hidden">Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>iClinic</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medicinae</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medical
    Harbour</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cliquefarma</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Shosp</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unifipmoc</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unigranrio</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>RXPRO</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zwtIXfJ3G7ag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,659</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zVjH5L39Ijak" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">201</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zcbD4US4ZI4b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8C0vggHKqp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,009</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zYBnfQ05a0m1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">397</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zjmZh8ccMdGi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,140</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zwrrlblXCHTf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,755</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHLyohhr0NGc" title="Cash and cash and equivalents" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Restrict
    cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCash1_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zNztwnmvO589" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RestrictedCash1" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,050</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zKdPH7Lzqlfe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></span></td>
    <td id="xdx_98A_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zgYRJOmTnsGb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z0GN1GUgLeQ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zf8c1xQUgfr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1617">-</span></span></td>
    <td id="xdx_983_ecustom--RestrictedCash1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z53WzDOYrQ24" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1618">-</span></span></td>
    <td id="xdx_989_ecustom--RestrictedCash1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhzp36kGiWff" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1619">-</span></span></td>
    <td id="xdx_98F_ecustom--RestrictedCash1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zieeKPxVQcek" title="Restricted Cash" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    receivables</span></td>
    <td id="xdx_983_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zeVTSSHngSx9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXCFVs0Xu2L8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zBh5ZZqtVXNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">159</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSFPUvTrubR" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">501</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z9lKAvNygxB3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></span></td>
    <td id="xdx_98C_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zWR5hDBQBICg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,309</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zBe7w78O3lGg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">26,622</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zrZDNwOCHD54" title="Trade Receivales" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,211</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zd4d5QuWRw3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></span></td>
    <td id="xdx_98F_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zCXBH1g6JvDc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1632">-</span></span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zW5s2DvyuqR2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1633">-</span></span></td>
    <td id="xdx_985_ecustom--Inventories1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVqNE2o83APb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1634">-</span></span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zWfUYfMxl3C2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zj95J1ynNjk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1636">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z3E4BawG4hb7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">352</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--Inventories1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWxpeUjQ2QLh" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:Inventories1" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">246</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recoverable
    taxes</span></td>
    <td id="xdx_987_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zjwdwX6QW9Z3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zmivR5K0WOMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zTydqBTDti8k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfUwAObNp3g5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zvdJYDeaW7f5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2kbPWa7BN4k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,295</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zudRuLdAgU93" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">738</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zNNWkT7XpOzc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    assets</span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zahU2d5tvIm2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_ztZkd1LjYYf2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zjfiFhVkEIVh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z4eG2MnZr7z4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></span></td>
    <td id="xdx_989_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOBHJcyVMtvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2xNKVXvi7Nk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">702</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqJqfmsJCYFg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,159</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zC49thdaxI1" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">366</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Right-of-use
    assets</span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGTZCOqWuLCh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9EegalhAM4j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></span></td>
    <td id="xdx_989_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z8EbQAtPTm47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1657">-</span></span></td>
    <td id="xdx_98C_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1bFVKAnQd59" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></span></td>
    <td id="xdx_98A_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zARWkuDMhblk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zuIMjs6QsTPl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,079</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z0b35cYRyEx8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,265</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeUHmVdTTi67" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Property
    and equipment</span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zOWnSveQdmce" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">473</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zx352TrGEWag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zzVhGoC0Xg2h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zlQBXOr4eWn6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></span></td>
    <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zocZsUxXX5cc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2qNOwYggSN9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,277</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zrwg6iWBjLw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40,775</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeof2tPnW995" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Indemnification
    assets</span></td>
    <td id="xdx_98A_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zv3egaittoJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,252</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zhwse1stMJHk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1672">-</span></span></td>
    <td id="xdx_988_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zKKImePLzdXd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></span></td>
    <td id="xdx_987_ecustom--ImdemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXgs5yFqUBYe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></span></td>
    <td id="xdx_98F_ecustom--ImdemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zsw5pfgHZT43" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></span></td>
    <td id="xdx_981_ecustom--ImdemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zDRFWaVLS3d3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,331</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--ImdemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zCgsmKa5V7Ef" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ImdemnificationAssets" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,669</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--ImdemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zAp8B8hM9Pud" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Intangible
    assets</span></td>
    <td id="xdx_98A_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zyb3aTKfykM" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,987</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zz0kTozBblrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,518</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zeZhfZMc8GWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,359</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zioBiHHzsfe9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,991</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zriVEy5xOCVi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,856</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zwOqcnJIIl3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227,534</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zykk4coI7tZ1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">510,356</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6NkOBisldk" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,330</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z71bJDBx7DZa" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,802</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zB6vm6TmLgAh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,751</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z2vBKqRH3msl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,601</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8E0bvGY4JOh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,501</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_znZ2IPsbb6Rf" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,259</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zRg1SJE6uyug" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">353,667</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9DniEVSUVUe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">784,691</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zt1RhNgaWt41" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,480</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    payables</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zHyuniKOR8Gc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">619</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zdTd0tjSGTOe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zlaVkoIDPUV7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zELVprZOvSCb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHmGIWxJ7K76" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z7rixxBoo4ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">985</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z2P9gdvJ5562" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,197</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHJDs8hDFZU" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,060</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Loans
    and financing</span></td>
    <td id="xdx_986_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zrLa6f2WZfx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zzwGdN7xpwg6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqCe2W0GYrK8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">299</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zcsDoYotJ8bd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">580</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRX9dZLrAnwd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zyY8xHlPVuYj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,179</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z8srDnSSSLPd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,533</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zO4SBH3HkqVj" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Labor
    and social obligations</span></td>
    <td id="xdx_98D_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zxBXGgCVmZN1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,414</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGJ8vzV5Hgn9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">159</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zscuFA8FckCg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAz4Rw6Ppf28" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHBV1pZQGxJf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zKcCjT8avFTf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,306</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zGfJeCs9zGyd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,854</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjaIwr2y9IGc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Taxes
    and contributions payable</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zZ2fFPO8qXRk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zT0hxQ8OtVT5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zCvkX8wJW2Z1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZlRzKlQMxuj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">307</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zMvUPcZCGE3h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zhGOF4ZB06ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">758</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcyrqeVSsOW" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,025</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwJ4tKmzGUne" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_986_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zst7tNJVY892" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,252</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z7Auj4CvUws8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zYQaVSrSikLf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1730">-</span></span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zCwmqBkOFFhk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zVOWJ7pb1424" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zABEDqCX9bDh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,331</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zh6PfGp51iO5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,669</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7NhuwDPUMac" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1735">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Leases
    liabilities</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zz2G1gzJu8Zg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zMIxg8UbmN01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zuolztjgJEo4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1738">-</span></span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMs3ElPuT71l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zmHwWPACyx3k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zUWygh0obg88" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,079</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zQ0bsuMLl7W7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,265</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zxVMSx2HBQI6" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Advances
    from customers</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zX797RaT5Ks4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">400</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfyXM4VTDP86" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></span></td>
    <td id="xdx_98C_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znXXtY9MmHu3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zhNUe6QghYgb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zGDrZLhSggEg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zyLgGLgo3HN6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,745</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zNEU8656p6q5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,387</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zhX4veV1vLvi" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1751">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    liabilities</span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zgN3yNmWV7gg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1752">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9JsKcrvvmc1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zEi88OnO4qLk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfkXz9Qo5wdg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z4FRKRt54z7d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zYdl9FwFsuH8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,739</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9clBQgJw7bk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,878</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7IYuGaEO33g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKmsXmnA3HDk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,850</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zBIzYz5VHy2d" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">163</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z4wBUrWQ0I46" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">345</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZP5K2Holqg4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,000</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHyaH5AG0dp3" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">380</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zmz8P8Vdlgd2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,122</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zolJcRpEOWP6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">295,808</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwYTYNoj2ET8" title="Total" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,304</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zQ5fxvqaoCme" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,952</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zxuvaSVFlEzb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,588</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_ziV6wP4QOr5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,256</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSGev9bCEwH1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,501</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFtch7xFbYzj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,879</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zsYEBLuwSoNf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">240,545</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXtLcknO5EAg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">488,883</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcG7RIuGVhwe" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,176</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Preliminary
    goodwill arising on acquisition</span></td>
    <td id="xdx_981_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_znce3FcKtQsh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,168</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zsiWkqMxBvH9" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,584</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z7ykbSwRV2i6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,022</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMCOxUv89k2e" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,588</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHZfHTtw9xTd" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,022</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcU7nPSexrBi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqkOjB8qam4f" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">130,073</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zflnfEBkbVXi" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,446</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z0FJUEIRMIB" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">191,120</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXdvMFXObbF1" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,172</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zNNpCFcNaWL7" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,278</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAnlV0Sfo0pa" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,089</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zLEjf5DEkY7b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,901</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z5eFVhCWgPrb" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">328,322</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zk2KNwWadx7a" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">618,956</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqwmsWOsXJj4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,622</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid</span></td>
    <td id="xdx_981_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_ziedsoW7DRfc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">119,620</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGFhSIdhnFw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,600</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqmJhiEXno4a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,000</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1ajmlEGDBOj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,166</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zEHlO2PsFFp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,855</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zVBQ0DlyNpyb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">328,322</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zDh1LzvYiCw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">375,670</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z3r0KnrEwN0f" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,263</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Contingent
    consideration</span></td>
    <td id="xdx_982_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_fKCoqKQ_____zW2ibgJpQ7T2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></span></td>
    <td id="xdx_986_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_fKCoqKQ_____zPrB9eUny0Ic" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicinaeMember" id="Fact001802" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,572</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_fKCoqKQ_____zjX9spV1fQJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_MedicalHarbourMember" id="Fact001803" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,278</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_fKCoqKQ_____zWJYWKHdKVb1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" id="Fact001804" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,923</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_fKCoqKQ_____z00b5mTAh6p3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_ShospMember" id="Fact001805" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,592</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCop_zLrJMURP4RN5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(*)</sup><span style="-sec-ix-hidden: xdx2ixbrl1806">-</span></span></td>
    <td id="xdx_98C_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCoqKQ_____zVozj4iDnJxi" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(**)</sup><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span></span></td>
    <td id="xdx_98F_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_ztlNmgAuuiBf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,171</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Consideration
    to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zfbJEFzkrZ4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zau9Y5BOJrUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></span></td>
    <td id="xdx_984_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zvQN9Axx6S9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zDNakicKC1Qe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></span></td>
    <td id="xdx_98B_ecustom--ConsiderationToBeTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztsvu9qpEzc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXy56yRKZ931" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></span></td>
    <td id="xdx_98A_ecustom--ConsiderationToBeTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zF98bEbiNrCk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,286</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z05PCzDawVr8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:ConsiderationToBeTransferred" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Paid
    in shares</span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zDU5SDBtFKJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,500</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGLHuYT9RL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zOtjBnq9pXhg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zS1QabTYdYi4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--PaidInShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zUQQ8lm8aMN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></span></td>
    <td id="xdx_982_ecustom--PaidInShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhG2fcFWoNj8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zOo0CHhdQvlh" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zfUxgugHQiLl" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="afya:PaidInShares" contextRef="AsOf2020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,112</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transaction
    costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zJqasYn0v6E3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-082020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">856</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfk8yIcx9Ja7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-082020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zIkvr0M6W70k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zmaeklgwo2N7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">336</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zhZnuJNf67V6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-022020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXkSvbiwoFE4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-07-192020-07-20_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">177</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zqWQTSjixGyf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaFipmocSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,990</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6E6LnOQXhfa" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-01-012020-12-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">264</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKt7oPmwaHL" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-082020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,961</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z0mdhm7MiaX9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-082020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,399</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z62Vu9TOlMUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,953</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfhBVCCMM4ee" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,157</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zNTt7VALLe8d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-022020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,458</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zD8KWoqdhRrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-07-192020-07-20_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">322,182</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z48woKyFJInc" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">340,915</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zucUHqr8J9w2" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-01-302020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,172</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGa3sfVuzh6c" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-082020-11-09_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">118,817</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zSbdbol3fAH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-082020-11-09_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,516</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrUqBedfIAy6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,097</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXnvrcDlKGs1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,493</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOSkPnUfV7Jk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-022020-11-03_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,646</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFeeTYAM5402" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-07-192020-07-20_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">322,359</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zfnlapsyczbl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">351,905</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zmXGGc2NhKEj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-01-302020-01-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,436</ix:nonFraction></b></span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 40 additional seats
still pending approval, which, if approved by the Ministry of Education, will result in a potential additional payment of up to
R$ 50,000.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">**</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200.</span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A0_zrTGjrIsHock" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(a)
Acquisition of iClinic</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">On
January 21, 2021, Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zvPHUtenh4X9"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-01-21_custom_IClinicMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of iClinic (comprised by iClinic Participa&#231;&#245;es, iClinic
Desenvolvimento and Black River). <span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zb7MG8Hx0K4g"><ix:nonNumeric contextRef="From2021-03-232021-03-25_custom_IClinicMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$191,120 is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">iClinic
is a SaaS model physician focused technology company and the leading medical practice management software in Brazil. iClinic empower
doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase their
productivity and deliver better healthcare services. With the acquisition of iClinic to our platform, Afya will make another step to
become the one stop shop for physicians in Brazil.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 208 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
acquisition of iClinic was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction
costs to date amount to R$<span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zISAr3QvAayg" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-01-192021-01-21_custom_IClinicMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">856</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes
purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_IClinicMember" escape="true" name="afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock"><p id="xdx_894_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zC4v6h0VeMj4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_zov9ELuceLXb" style="display: none; visibility: hidden">Schedule of acquisition of UniRedentor</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVMIRzdnM1Q" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210119__20210121__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z5WXLkJTe2ek" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-01-192021-01-21_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zGwfikASF2s4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, iClinic has contributed R$ <span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zT4eOyWKiYa6" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-192021-01-21_custom_IClinicMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,456</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90F_eifrs-full--ProfitLossBeforeTax_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zuqR5KEoMeS6" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-192021-01-21_custom_IClinicMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">8,250</ix:nonFraction></span> of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zl8UGpJrZqAc" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_IClinicMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,158</ix:nonFraction></span>
and income before income taxes would have been decreased by R$ <span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zliEXjyoa2t8"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_IClinicMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,320</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(b)
Acquisition of Medicinae</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 25, 2021,
Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zlkbAFRmtQZb"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-03-25_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Medicinae, a leading Brazilian healthcare technology company that specializes
in healthcare payments and financial services. <span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--MedicinaeMember_zwdd8oz27DZ6"><ix:nonNumeric contextRef="From2021-03-232021-03-25_custom_MedicinaeMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$9,172 is comprised by: i) R$ 5,600 of which 100% was
paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$ 4,400 is payable
in connection with product development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3,572 is based
on the present value of the obligation considering the facts and circumstances at the acquisition date.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 209 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">The
acquisition will expand Afya&#8217;s digital health services, as it offers a unique financial platform that allows healthcare professionals
all over Brazil to manage receivables in an efficient and scalable way using FIDC (Receivables Investment Fund).</span><span style="font-family: Arial, Helvetica, Sans-Serif"><br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 210 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Medicinae relieves
a number of challenges in the healthcare payments industry, as reduces long payment cycles for professionals and consolidates financial
information, improving the consumer financial experience. Afya&#8217;s intention is to grow the Digital Services segment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Medicinae was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zhLMnP9ZwlO9"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">117</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" escape="true" name="afya:ScheduleOfAcquisitionOfUnislTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfUnislTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGAk6QiRz1oi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zu05rfh6d9Je" style="display: none; visibility: hidden">Schedule of acquisition of UniSL</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210323__20210325__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_ze6Zg5M2ZAWk" title="Valuation technique" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><ix:nonNumeric contextRef="From2021-03-232021-03-25_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></ix:nonNumeric></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zfKAWrFm0Jq8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Medicinae has contributed R$ <span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_z8VsqeG0tYa4" title="Transaction costs"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">359</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXzcaLDn2U3"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,518</ix:nonFraction></span> of loss before income taxes to the Company. If the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXmC5Fqtkgk"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">105</ix:nonFraction></span>
and income before income taxes would have been decreased by R$ <span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zKjvD9aArSk1"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">113</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(c)
Acquisition of Medical Harbour</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 8, 2021,
Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zg5uTlNqJb0i"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-06-01_custom_HarbourMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Medical Harbour, which offers educational health and medical imaging solutions
through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration,
and knowledge of human anatomy with digital resources. <span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_z3neehsYlys8"><ix:nonNumeric contextRef="From2021-04-062021-04-08_custom_HarbourMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$11,278 is comprised by: i) R$ 5,000 of which
100% was paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 9,000
is payable in connection with product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration
of R$6,278 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This acquisition
enables Afya to start providing a high quality solution to study the human body, allowing efficient classes and remote practical sessions
with greater student acceptance and scalability. Additionally, Afya will be able to distribute Medical Harbour solutions to all of its
ecosystem, creating B2C and B2B growth opportunities.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 211 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Medical Harbour was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zzYlEJ05a7P9"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-04-062021-04-08_custom_HarbourMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">144</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Medical Harbour
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_HarbourMember" escape="true" name="afya:ScheduleOfAcquisitionOfPebmedTableTextBlock"><p id="xdx_890_ecustom--ScheduleOfAcquisitionOfPebmedTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zKtdf2BhXfS9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zW5lALiYIUvk" style="display: none; visibility: hidden">Schedule of acquisition of PEBMED</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zyOszcZMTczk" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z1sutBCAaPrl" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember" title="Valuation technique" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></ix:nonNumeric></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AC_ziJCec7O6Akb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; color: #222222">From
the date of acquisition, Medical Harbour has contributed R$ <span id="xdx_90A_eifrs-full--RevenueOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zLaiI8OYwUI8" title="Revenue of acquiree since acquisition date"><ix:nonFraction name="ifrs-full:RevenueOfAcquiree" contextRef="From2021-04-062021-04-08_custom_HarbourMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">484</ix:nonFraction></span> of net revenue and R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210406__20210408_zdh3PUNoUarb" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-04-062021-04-08" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,945</ix:nonFraction></span> of loss before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue </span><span style="font-family: Arial, Helvetica, Sans-Serif">for
the period ended December 31, 2021 <span style="color: #222222">would have been increased by R$ <span id="xdx_906_eifrs-full--RevenueOfCombinedEntity_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zrCyXP6dq4T9" title="Revenue of combined entity as if combination occurred at beginning of period"><ix:nonFraction name="ifrs-full:RevenueOfCombinedEntity" contextRef="From2021-01-012021-12-31_custom_HarbourMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">268</ix:nonFraction></span> and income before income taxes would
have been increased by R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zbtQz7ZFDzqh" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_custom_HarbourMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">127</ix:nonFraction></span>.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(d)
Acquisition of Cliquefarma</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 16, 2021,
Afya Brazil acquired <span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_ze4khYsatlWg"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-04-16_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks
prescription drugs, cosmetics and personal hygiene product prices in Brazil. <span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zEanXusokxJl"><ix:nonNumeric contextRef="From2021-04-142021-04-16_custom_CliquefarmaMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$ 22,089 is comprised by:
(i) R$ 16,166 paid in cash; (ii) R$3,000 settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#8220;contingent
consideration&#8221;) of R$ 3,000 is payable in relation to product development. The contingent consideration of R$2,923 is based on
the present value of the obligation considering the facts and circumstances at the acquisition date.</ix:nonNumeric></span></span></p>


<ix:exclude><!-- Field: Page; Sequence: 212 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Users of Cliquefarma
can easily search for medications or healthcare products and compare prices from over 15,000 pharmacies in Brazil. The traffic generated
is monetized through a cost-per-click model, where drugstores pay for each click on their advertisements, a cost-per-acquisition, where
drugstores pay for each concluded sale.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Cliquefarma will enhance the Digital Services segment, creating the opportunity to leverage traffic and GMV with prescriptions generated
from Afya&#8217;s physician ecosystem.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Cliquefarma was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zj66LApPJcEg" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-04-142021-04-16_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">336</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Cliquefarma
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" escape="true" name="afya:ScheduleOfAcquisitionOfFesarTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfFesarTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zrWMfV6zM5F2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_z7UrP5URV2fc" style="display: none; visibility: hidden">Schedule
of acquisition of FESAR</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zsOFIQ0cjkO9" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210414__20210416__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z8UvFfDdR9gh" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-04-142021-04-16_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zxFaJcJ2wGUb" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Cliquefarma has contributed R$ <span id="xdx_903_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zLz0BHIL3Tg2"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,268</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zePGV8EXdhCi"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,752</ix:nonFraction></span> of income before income taxes to the Company. Should the
acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ <span id="xdx_906_ecustom--IncreaseInRevenue_c20210101__20211231_z3hr7J1piBAl"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,435</ix:nonFraction></span> and income before income taxes would have been increased by R$ <span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231_zHoQUO2Pfo7b" title="Income loss before income taxes"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">926</ix:nonFraction></span>.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 213 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(e)
Acquisition of Shosp</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On May 13, 2021,
Afya Brazil acquired <span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zWCdfHCjvQV6"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-05-13_custom_ShospMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Shosp, a clinical management software that offers all functionalities needed
for clinics all over Brazil to manage their financials, patients appointments, medical records, marketing, and others. Afya&#8217;s intention
is to reinforce the Digital Services operating segment. <span id="xdx_90F_eifrs-full--DescriptionOfAcquiree_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zl64E1rqsqO2"><ix:nonNumeric contextRef="From2021-05-112021-05-13_custom_ShospMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$7,901 is comprised by: i) R$ 5,855 was paid
in cash; ii) R$ 454 of consideration to be transferred; and iii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 1,793
is payable in relation to product development. The contingent consideration of R$1,592 is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Shosp was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90F_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zS5MqJVrUo39"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-05-112021-05-13_custom_ShospMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">188</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Shosp and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ShospMember" escape="true" name="afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock"><p id="xdx_89B_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--ShospMember_zIt6dmS6HhHc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zRJn4wkUPehb" style="display: none; visibility: hidden">Schedule
of acquisition of MedPhone</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVrX3w2BfcB6" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210311__20210313__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zP8amaDKxti7" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-03-112021-03-13_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_z644E8379db1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Shosp has contributed R$ <span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zsiWdXQTo7I4"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-05-112021-05-13_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,376</ix:nonFraction></span> of net revenue and R$ <span id="xdx_909_eifrs-full--ProfitLossBeforeTax_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zHfssh0JQNZa"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-05-112021-05-13_custom_ShospMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">448</ix:nonFraction></span> of income before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_90F_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTh6ni3Ldoi1"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_ShospMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">306</ix:nonFraction></span>
and income before income taxes would have been decreased by R$ <span id="xdx_907_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTGeMr13s5qf"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_ShospMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">82</ix:nonFraction></span>.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 214 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(f)
Acquisition of UNIFIPMoc</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On June 1, 2021,
Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zUgilgkEYKed"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-06-30_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UNIFIPMoc&#8221;).
<span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zVfSlnQaZSXc"><ix:nonNumeric contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price is R$ 328,322 and the total amount was paid in cash. There are 40 additional seats still pending approval,
which, if approved by the Ministry of Education, will result in a potential additional payment of up to R$ 50,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">UNIFIPMoc is a
post-secondary education institution with government authorization to offer on-campus, undergraduate courses in medicine in the states
of Minas Gerais and Bahia. The acquisition is in line with the Company&#8217;s strategy to focus on medical education, including medical
school.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UNIFIPMoc was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_905_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zYOk5sV9EZdc"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">177</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of UnifipMoc
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember" escape="true" name="afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock"><p id="xdx_893_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zlhKd4NkmGuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_zIOGWUEM2l1g" style="display: none; visibility: hidden">Schedule of acquisition of FCMPB</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-082020-11-09_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">With-and-without
    method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-03_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_zzosRnJ4uRa8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 215 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">From
the date of acquisition, UNIFIPMoc has contributed R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zxKEoQv35rg"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,887</ix:nonFraction></span> of net revenue and R$ <span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zB7knbp338H5"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">19,458</ix:nonFraction></span> of income before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have
been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zXFBMDDN7Jsb"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">46,150</ix:nonFraction></span> and income before income taxes would have been increased by R$ <span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zfkuEWXScq89"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">12,847</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(g)
Acquisition of UNIGRAN</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On August 4, 2021,
Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVgBS8kKsHq"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-08-04_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura, Instituto
de Ensino Superior de Palho&#231;a S/S Ltda., Sociedade Educacional de Palho&#231;a S/S Ltda., and Policl&#237;nica e Centro de
Est&#233;tica Duque de Caxias Ltda. (combined denominated &#8220;Unigranrio&#8221;). <span id="xdx_90B_eifrs-full--DescriptionOfAcquiree_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zDp9Lkzh44a4"><ix:nonNumeric contextRef="From2021-08-022021-08-04_custom_UNIGRANMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate original purchase price of R$ 626,116
of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four equal installments through 2022 to
2025, adjusted by the CDI rate, was adjusted by R$7,160, because of the actual net debt, to R$618,956. There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Unigranrio is a
post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro and Santa Catarina</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Unigranrio was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zKqyGF07nLW2"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-08-022021-08-04_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">10,990</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Unigranrio
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 216 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UNIGRANMember" escape="true" name="afya:ScheduleOfAcquisitionOfUnigranTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfAcquisitionOfUnigranTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zyXgO4PauZ0j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BB_zWeg2ldwu09l">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zBMyQzLIX536" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">With-and-without
    method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zh0AZu39YWsk" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zBFJxXVdeKZ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Unigranrio has contributed R$ <span id="xdx_908_eifrs-full--Revenue_pn3n3_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zsAGozjP5cU1"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-08-022021-08-04_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123,369</ix:nonFraction></span> of net revenue and R$ <span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_z6o9kxarbBT6"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-08-022021-08-04_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">33,450</ix:nonFraction></span> of income before income taxes to the Company. Should
the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ <span id="xdx_908_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zV9cUuBYsyNj"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">150,456</ix:nonFraction></span> and income before income taxes would have been increased by R$ <span id="xdx_90C_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVhaZ3AMLxC5"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_UNIGRANMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">22,191</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(h)
Acquisition of RXPRO</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 1, 2021,
Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zSg67NDqZUZk"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2020-10-01_custom_PXPROMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of RX PRO, comprised of (i) RX PRO Solu&#231;&#245;es de Tecnologia Ltda. and (ii) RX PRO LOG Transporte
e Logistica Ltda..Solu&#231;&#245;es de Tenologia Ltda. RX PRO consists of a solution that connects physicians with the pharmaceutical
industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians. Afya&#8217;s
intention is to reinforce the Digital Services operating segment. <span id="xdx_903_eifrs-full--DescriptionOfAcquiree_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zV1Dwlx8phE4"><ix:nonNumeric contextRef="From2020-09-282020-10-01_custom_PXPROMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price of R$45,622 is comprised by: i) R$ 30,263
was paid in cash; ii) R$ 76 to be paid as price adjustment, iii) R$5,112 settled with Afya's treasury shares on the transaction closing
date; and (iv) an earn-out (&#8220;contingent consideration&#8221;) of R$ 21,000 is payable in relation to revenue achievements. The
contingent consideration of R$10,171 is based on the present value of the obligation considering the facts and circumstances at the acquisition
date.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of RXPRO was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_za4ueQEPAnAi"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-09-282020-10-01_custom_PXPROMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">264</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 217 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of RXPRO and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PXPROMember" escape="true" name="afya:ScheduleOfAcquisitionOfRXPROTableTextBlock"><p id="xdx_892_ecustom--ScheduleOfAcquisitionOfRXPROTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKHdu9aa3eTj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zLLkcFdWjoij">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z3zRq7R9cJwb" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zeZZoDFgzDC2" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zwWF1IKRBx9h" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A5_zXAUqLUKQkpj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, RXPRO has contributed R$ <span id="xdx_902_eifrs-full--Revenue_pn3n3_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zTO1Cysirib"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-09-282020-10-01_custom_PXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">907</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zYNxu6P2qGZ4"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-09-282020-10-01_custom_PXPROMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">984</ix:nonFraction></span> of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_904_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKt5eZWV9Xf3"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2021-01-012021-12-31_custom_PXPROMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,155</ix:nonFraction></span>
and income before income taxes would have been decreased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zRgyTxXETXa4"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2021-01-012021-12-31_custom_PXPROMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">325</ix:nonFraction></span>.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 218 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>5.2
Acquisitions in 2020</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock"><p id="xdx_89D_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_zsNqcDkcP1aa" style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><span id="xdx_8BE_zMeSHT02Wbp6">The
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></span></p>

<p style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b> </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniRedentor<sup id="xdx_F59_zAvFUToNjFz8">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniSL<sup id="xdx_F5F_zCrp9wUMkNth">**</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>PEBMED</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FESAR</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>MedPhone</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FCMPB</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zAVb3yo3wBJg" title="Cash and cash and equivalents" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,796</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zNxa5tHdSZLf" title="Cash and cash and equivalents" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,245</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zEOClRFGyeTg" title="Cash and cash and equivalents" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,119</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zxkS1YUMKw0a" title="Cash and cash and equivalents" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,236</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zK3fJxFOyUib" title="Cash and cash and equivalents" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z73IKoju1AF5" title="Cash and cash and equivalents" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    receivables </span></td>
    <td id="xdx_98E_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zgebA5hQHK2b" title="Trade receivables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,800</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zmwtcWPAC5O2" title="Trade receivables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,567</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z5J7bC2F7m5d" title="Trade receivables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,984</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDbopQFTRoDj" title="Trade receivables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_ztSTqHM49wSc" title="Trade receivables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1992">-</span></span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zjVTUcP68ki5" title="Trade receivables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TradeReceivablesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,148</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td>
    <td id="xdx_98D_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zIYUiIS7KTd" title="Inventories" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td>
    <td id="xdx_980_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zAORDJDdEw6i" title="Inventories" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:InventoryRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">467</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_znAO7mDFhcYb" title="Inventories" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2000">-</span></span></td>
    <td id="xdx_982_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zLtyNUiPfRnh" title="Inventories" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td>
    <td id="xdx_987_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zJA29mowuDqd" title="Inventories" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2004">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zyhKgYKsRsn9" title="Inventories" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Recoverable
    taxes</span></td>
    <td id="xdx_980_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLzQhKtmmn1g" title="Recoverable taxes" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdU8ltsEqaRj" title="Recoverable taxes" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RecoverableTaxesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">822</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zTDrr01O6US7" title="Recoverable taxes" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrJovtlYZABf" title="Recoverable taxes" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2014">-</span></span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zc822jJkMSz" title="Recoverable taxes" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVulIgfPSYg2" title="Recoverable taxes" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    assets</span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLlVTGuu8227" title="Other assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,486</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zhKffr4l9Ioj" title="Other assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,251</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zCMHVcSXhRN7" title="Other assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">161</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zzbJUllMn8" title="Other assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfRCws1fjAL1" title="Other assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zevt8PCqwfkd" title="Other assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">123</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Indemnification
    assets</span></td>
    <td id="xdx_98B_ecustom--IndemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z2YfRdUlLECj" title="Indemnification assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">710</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--IndemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zHJ6GfXXjym4" title="Indemnification assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,645</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--IndemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z1BB1trtemak" title="Indemnification assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,350</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--IndemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z4KMY1wZOVod" title="Indemnification assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IndemnificationAssets" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,871</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--IndemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zqzGNull8Fq2" title="Indemnification assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></span></td>
    <td id="xdx_989_ecustom--IndemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zGbNk9BHa0D3" title="Indemnification assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2042">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Right-of-use
    assets</span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zHAUsoWFdwR5" title="Right-of-use assets" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,265</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zf2UGB0tyJN8" title="Right-of-use assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,062</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zR4myGuTPKfh" title="Right-of-use assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">865</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zIvd0Jkhm42d" title="Right-of-use assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zRBPD644qCH7" title="Right-of-use assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2052">-</span></span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRQkSu6TAHE6" title="Right-of-use assets" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:RightOfUseAssetsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,663</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property
    and equipment</span></td>
    <td id="xdx_980_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCxWtOhqSzAk" title="Property and equipment" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,207</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zypUcLIgkH49" title="Property and equipment" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,144</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z6OJON8HlN59" title="Property and equipment" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">391</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ztKSE8KkK655" title="Property and equipment" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,176</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z1IgIrP2N5a4" title="Property and equipment" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zOraqDymNOfa" title="Property and equipment" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">962</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible
    assets</span></td>
    <td id="xdx_981_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zoiVPseg9SA5" title="Intangible assets" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">142,399</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z3UBQHD3wfU8" title="Intangible assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,097</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziE4HZePi3Qe" title="Intangible assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,372</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zztkEPGfxmc7" title="Intangible assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,106</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQjfQEYLB78" title="Intangible assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,727</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zCuTrBJS2Yed" title="Intangible assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">264,782</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zG0Ql09YhReg" title="Total Assets" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,666</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ztqESusg2JTg" title="Total Assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,300</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zs6YJCMJrGQ5" title="Total Assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83,242</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zf2XLTNzDKn3" title="Total Assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">201,431</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zakIjhXPqXg8" title="Total Assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,796</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_pn3n3" title="Total Assets" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">297,778</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYVYWnqzF3M9" title="Trade payables" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">746</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zUeODflqDsC" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,554</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zVHLo99fsbSa" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,024</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrAoBduLXoeh" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">143</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zciqmDMxQIWg" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zYqvcBOcnoy" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">173</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7MFMjiQLnfl" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,187</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z9UX0SPbVkUf" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,541</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zRZgCBuidBY1" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2108">-</span></span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z6wlcFGs5WLj" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,087</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zlYcE3rXpVU4" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></span></td>
    <td id="xdx_98C_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zHWMKKvUX61a" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2114">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease
    liabilities</span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zuTjCGJDqTQf" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,265</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zbmDpqPWIV1f" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,062</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zofQ8vOGAEL8" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">865</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z1AIfhIdKzO8" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfXl2nWtp5M6" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zvSzwv0hrGV" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LeaseLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,663</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor
    and social obligations</span></td>
    <td id="xdx_983_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZQtTVdjn7Fe" title="Labor and social obligations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,471</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zTm4DtlvHAsk" title="Labor and social obligations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,070</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zmCpWtu8RVQ6" title="Labor and social obligations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,786</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP5eWwj185oc" title="Labor and social obligations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,801</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFj6WtjBDTNl" title="Labor and social obligations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z1eGhO7wZC47" title="Labor and social obligations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:LaborAndSocialObligationsAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,832</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes
    payable </span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zGyMOGfYZaEd" title="Taxes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">850</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z8x56FftsgBb" title="Taxes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,779</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zB167xTyiR26" title="Taxes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,210</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zQe2elXTOKYc" title="Taxes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQQwFxmywf5" title="Taxes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVt8OMeZ03U9" title="Taxes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:TaxesPayableAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z0GDZywEkHi7" title="Provision for legal proceedings" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">710</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zyzcOPBK1LJl" title="Provision for legal proceedings" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,645</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zFoEjEBYMY8d" title="Provision for legal proceedings" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,350</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z8EmaEquKx6" title="Provision for legal proceedings" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:ProvisionForLegalProceedingsAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,871</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zW9eaPY1rY8b" title="Provision for legal proceedings" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z6lBY2197RB3" title="Provision for legal proceedings" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2162">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances
    from customers</span></td>
    <td id="xdx_98D_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zU9OVtZgQ8eh" title="Advances from customers" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,994</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zJsENwKvpIpg" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,084</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zhenAaZMRQ2a" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,312</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zH9Qck7htWMe" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">759</ix:nonFraction></span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZxnNK94xKGf" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zcy4zBkrXJl2" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:AdvancesFromCustomersAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,781</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCu2FCwNbwO6" title="Notes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></span></td>
    <td id="xdx_986_ecustom--NotesPayables_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zVCVwA8tJib2" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,526</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--NotesPayables_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zx5J2lS5JmVc" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2180">-</span></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zk4QjeBuhmM8" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2182">-</span></span></td>
    <td id="xdx_988_ecustom--NotesPayables_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zi6QsQiH4Aja" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_ztexIzbGEB8k" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    liabilities</span></td>
    <td id="xdx_98E_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCbwHPDABXg2" title="Other liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z1b3gRLxDBW7" title="Other liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,754</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zqCIWe7c3oA3" title="Other liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2192">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zBbdYryDw0vg" title="Other liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2194">-</span></span></td>
    <td id="xdx_981_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVHvUY5i16cd" title="Other liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:OtherLiabilitiesAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">228</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zlULXa3tMbj1" title="Other liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2198">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYJkeeIrOMCh" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,223</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdvLlR3bqZDd" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">232,015</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z9Bq5YYaGa61" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,547</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkrUtMYxydX1" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,690</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZrHEYduPMC4" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">230</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zE1gAprjJYs3" title="Total Liabilites" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,454</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zMuTCasS8IS2" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">132,443</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zO5EeInsfHA7" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,285</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziB5IfohSoTc" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,695</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zO5IkSBPt9Lg" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">190,741</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2MeYPvL7nX" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,566</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zJii1mi8hbM9" title="Total identifiable net assets at fair value" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">268,324</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #0D0E00">Goodwill
    arising on acquisition</span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEBP0fVsvRh" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zeD5ej7YtfCj" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zfsbdJODltpf" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">84,175</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zNIvYgJo0kxb" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zIiqISV2FmK5" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,843</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zXWghwhespDd" title="Preliminary goodwill arising on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:GoodwillRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEAl8YBTEC3" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">210,105</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpfJ9eg4bKi5" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">193,705</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zzjkQ6xOOoK9" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">132,870</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zMVSb9ZWRxPc" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">262,405</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zpDoOnBklbOk" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,409</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z85IH8rQhUe4" title="Purchase consideration transferred" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">378,807</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid</span></td>
    <td id="xdx_983_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zjrHviUw1Q21" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,607</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zxQDz4vAwmnc" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,065</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zjjP3lEhVQic" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115,339</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDQcHzpwEIPa" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">260,836</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFrE7Fhwfpua" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,373</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWgoITNOLXMg" title="Cash paid" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashTransferred" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,913</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payable
    in installments</span></td>
    <td id="xdx_983_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zTPu93oUK5G1" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,498</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpT2t0QR7Mc7" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,640</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zSGtZ0Esp2te" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2264">-</span></span></td>
    <td id="xdx_987_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zISaWfRjlkFe" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,569</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4UFAFAqtikk" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRhGJXWF9RCi" title="Payable in installments" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PayablInInstallmentsAcquisitionDate" contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,894</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Paid
    in Afya Brazil&#8217;s shares</span></td>
    <td id="xdx_98C_ecustom--PaidInAfyaBrazilsShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZdjBS4eo4F2" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2272">-</span></span></td>
    <td id="xdx_98B_ecustom--PaidInAfyaBrazilsShares_iI_pp0i_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zZR29SxWh5ml" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span></span></td>
    <td id="xdx_989_ecustom--PaidInAfyaBrazilsShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zDFZAGwkTe3i" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:PaidInAfyaBrazilsShares" contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,531</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDP8i6MEP4H3" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZnYuBkzFTNc" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></span></td>
    <td id="xdx_988_ecustom--PaidInAfyaBrazilsShares_iI_pii_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zQLsUbZrIDS" title="Paid in Afya Brazil&apos;s shares" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction
    costs (included in cash flows from operating activities)</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7sY5B4QLffc" title="Transaction costs (included in cash flows from operating activities)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,380</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pin3_c20200503__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zvPYmbPS5kX6" title="Paid in Afya Brazil&apos;s shares" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-05-032020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="0" scale="3" unitRef="BRL">1,666</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zebx1JhzEYh5" title="Transaction costs (included in cash flows from operating activities)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">613</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zGRXSxClklu7" title="Transaction costs (included in cash flows from operating activities)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,047</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2WJXEDLrr0k" title="Transaction costs (included in cash flows from operating activities)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zPT7QjmULYp9" title="Transaction costs (included in cash flows from operating activities)" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">721</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid, net of cash acquired with the subsidiary (included in cash flows from investing activities) </span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z5nxvCxmHf57" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">102,811</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_pn3n3" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">137,820</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zXUNj4fH6FK2" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,220</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zVKeYuO8YR14" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">256,600</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z13yUYixlnpj" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,313</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zuZKl77xuRU1" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,813</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYkZLwsBvKQg" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,191</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ziKynDSkF499" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,486</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zgCV2RnT839b" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,833</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zUwKk8nsj9K7" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">258,647</ix:nonFraction></b></span></td>
    <td id="xdx_981_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVGl60C0Oby7" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,471</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201209__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zpObDsnvBPl8" title="Net of cash flow on acquisition" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:NetOfCashFlowOnAcquisition" contextRef="From2020-11-082020-12-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">190,534</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; color: #0D0E00; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F06_ztIuyFXfHNm5" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F17_zaO3k9qNVr96" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002319" xml:lang="en-US">During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.</ix:footnote></span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.25in; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_ztROSjqJfKFh" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00">**</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_z3KRsfIOe955" style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00"><ix:footnote id="Footnote002320" xml:lang="en-US">During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p</ix:footnote></span><span style="font-family: Arial, Helvetica, Sans-Serif">roperty
and equipment of R$7<span style="color: #0D0E00">.</span></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A6_zeDZBZbaaHOh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="color: #0D0E00">&#160;</span></span></p>

<p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(a)
Acquisition of UniRedentor</b></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On January 31,
2020, Afya Brazil acquired <span id="xdx_903_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zhjHb8uWIB8h"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of UniRedentor. <span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zEDgTjf970E8"><ix:nonNumeric contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" name="ifrs-full:DescriptionOfAcquiree">The original purchase price of R$214,608, was adjusted by R$4,503
and was comprised by: i) R$114,607 paid in cash on the acquisition date; and ii) R$100,000 is payable in five equal installments from
January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4,503 was deducted from the first installment
due in January 2021.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">UniRedentor is
a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro. The acquisition contributed with 112 medical school
seats, with a potential 44 additional medical school seats subject to the approval by MEC and is in line with the Company&#8217;s strategy
to focus on medical education, including medical school.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UniRedentor was accounted for under IFRS 3 &#8211; Business Combinations.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 219 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z4RzU6Q9YUJd"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,380</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniRedentorMember" escape="true" name="afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock"><p id="xdx_895_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z2fcWB3rBBlc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zjxRcRDmmTY7">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z7YEmaeRyFH9" title="Valuation technique" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue"><p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></ix:nonNumeric></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zin473Y7fpD4" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zwwvqrnMvcpl" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">UniRedentor
contributed R$ <span id="xdx_904_eifrs-full--Revenue_pn3n3_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z0z01XsnGzK4"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,065</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zsDEelRNmaj5"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">30,952</ix:nonFraction></span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_909_ecustom--IncreaseInRevenue_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zMqg9CnYbPNc"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">5,931</ix:nonFraction></span> and income before income taxes for 2020
would have been increased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z5NfCkHU6i79"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2020-01-282020-01-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">321</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(b)
Acquisition of UniSL</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020,
Afya Brazil acquired <span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zieGbQg07okj"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2020-05-05_custom_UniSLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of UniSL. UniSL is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate courses in medicine and health, as well as other courses, in the State of Rond&#244;nia. <span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_z0AOGqM8tGE"><ix:nonNumeric contextRef="From2020-05-032020-05-05_custom_UniSLMember" name="ifrs-full:DescriptionOfAcquiree">The original
purchase consideration of R$201,521 was adjusted by R$7,816, of which: (i) 70% is payable in cash on the transaction closing date, and
(ii) 30% is payable in cash in three equal installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment
of R$7,816 was deducted from the first installment due in May 2021.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
contributed with 182 medical school seats. There are 100 additional seats still pending approval which, if approved by MEC, will result
in a potential additional payment of up to R$<span id="xdx_90F_ecustom--AdditionalPaymentMade_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_z356B59gSgP" title="Additional payment made"><ix:nonFraction name="afya:AdditionalPaymentMade" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">80,000</ix:nonFraction></span>, adjusted by the CDI rate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Given the future
event that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably
estimated and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will
result in additional licenses, which will be measured accordingly if and when approved.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 220 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UniSL was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zrpuLIKQtsEk"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,666</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_UniSLMember" escape="true" name="afya:ScheduleOfAcquisitionOfUnisl1TableTextBlock"><p id="xdx_89C_ecustom--ScheduleOfAcquisitionOfUnisl1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zCTapHyGyKZ4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zbdcoyY1QUHb">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_984_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z75keHgw1i0c" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">With-and-without
    method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zwT9hpoM2CUh" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_z6gRNBCjnpqc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">UniSL
contributed R$ <span id="xdx_90D_eifrs-full--Revenue_pn3n3_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQAcobrdvYh1"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,894</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQB8tZH9PFob"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">30,649</ix:nonFraction></span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_90D_ecustom--IncreaseInRevenue_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_znlaPHVgpD8c"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">57,477</ix:nonFraction></span> and income before income taxes for
2020 would have been increased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zbB2TNHrVCX5"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2020-05-032020-05-05_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">9,455</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(c)
Acquisition of PEBMED</b></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 20, 2020,
Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zwRSu4NjQDn"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of PEBMED. <span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDxIxlh0XL4"><ix:nonNumeric contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" name="ifrs-full:DescriptionOfAcquiree">The original purchase price of R$ 132,900 was adjusted by R$ 30 and was comprised
by: i) R$115,339 paid in cash on the acquisition date; and ii) R$ 17,531 was paid with Afya Brazil&#8217;s shares which were afterwards
contributed to the Company in exchange of issuance of 141,976 of its own shares.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">PEBMED offers content
and clinical tools for healthcare professionals, including web portals and mobile apps. With the integration of PEBMED into our platform,
Afya will continue to expand offerings for the medical professionals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of PEBMED was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$ <span id="xdx_906_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQC1cck3vX4g"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">613</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 221 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_PEBMEDMember" escape="true" name="afya:ScheduleOfAcquisitionOfPebmed1TableTextBlock"><p id="xdx_898_ecustom--ScheduleOfAcquisitionOfPebmed1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zXTNHJmUDlE4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zOiGDpc7oG1g">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zNmcdf3oWjei" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrpCM5e8RLhi" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zah1wOgtfIO3" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zZvi6L7Lzg13" style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">PEBMED
contributed R$ <span id="xdx_905_eifrs-full--Revenue_pn3n3_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zviPVnG2oQbg"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,535</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90B_eifrs-full--ProfitLossBeforeTax_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zV87y7ZK8Y1f"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,413</ix:nonFraction></span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_905_ecustom--IncreaseInRevenue_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDfEJiZKTmo4"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">17,452</ix:nonFraction></span> and income before income taxes for
2020 would have been increased by R$ <span id="xdx_902_ecustom--DecreasedInIncomeBeforeIncomeTaxes_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zZTmdgnIJuja"><ix:nonFraction name="afya:DecreasedInIncomeBeforeIncomeTaxes" contextRef="From2020-07-182020-07-20_custom_PEBMEDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,813</ix:nonFraction></span>.</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(d)
Acquisition of FESAR</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On November 3,
2020, Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zgw8od6U1fM6"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-06-01_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of FESAR. <span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkLFztzSRPA"><ix:nonNumeric contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" name="ifrs-full:DescriptionOfAcquiree">The aggregate purchase price was R$260,836, including the CDI rate adjustment
from the signing date and the real state of the operation, estimated at R$ 17,397, of which 100% was paid in cash on the closing of the
operation. The purchase consideration was adjusted by R$1,569 and was paid on February 25, 2021.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">FESAR is a post-secondary
education institution with government authorization to offer on-campus, undergraduate courses in medicine and health, as well as other
courses, in the State of Par&#225; and medical course represents 70% of its 2019&#8217;s net revenue. The acquisition contributed with
120 medical school seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of FESAR was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90E_ecustom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z0zrK9swxVLh">2,047</span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 222 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" escape="true" name="afya:ScheduleOfAcquisitionOfFesar1TableTextBlock"><p id="xdx_897_ecustom--ScheduleOfAcquisitionOfFesar1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zYfWbd8k9GH4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zYGDzv9uTPV8">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zaLtaUATzVif" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">With-and-without
    method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_986_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zyAQaPdz1ko7" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A3_zD0Bff6SIUgg" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">FESAR
contributed R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zaF1nUR1cAG6" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,280</ix:nonFraction></span> of net revenue and R$ <span id="xdx_901_eifrs-full--ProfitLossBeforeTax_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z21SJqBDOIAi" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,751</ix:nonFraction></span> of income before income taxes to the Company in 2020. If the acquisition had taken place
at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_909_ecustom--IncreaseInRevenue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP3cNrQjCzLa" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">29,113</ix:nonFraction></span> and income before income taxes for 2020 would
have been increased by R$ <span id="xdx_909_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zsAILdcpoxBi" title="Increase in income before income taxes"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">14,918</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(e)
Acquisition of MedPhone</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">On
November 4, 2020, Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfhoCIpGaQ3l"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-06-01_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of MedPhone. <span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20201102__20201104__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zv3hdwdWEsn" title="Description of acquiree"><ix:nonNumeric contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember" name="ifrs-full:DescriptionOfAcquiree">The net purchase price was R$6,373 of which 100% was paid
in cash on the closing of the operation. The purchase price was adjusted to R$6,409, this price adjustment of R$ 36 was paid on February
2, 2021.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">MedPhone
is a clinical decision and leaflet consultation app in Brazil, that helps physicians, medical students and other healthcare professionals
to make faster and more accurate decisions on a daily basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
acquisition of MedPhone was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Transaction
costs to date amount to R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z6PV8ThsVeqh" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">158</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">There
are no trade receivables, right of use assets or lease liabilities associated with the acquisition of MedPhone.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 223 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember" escape="true" name="afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock"><p id="xdx_895_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z3vbHMRhcPJe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B4_zpb10HpQncm2">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zOVS1YPmqEHc" title="Valuation technique" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_BrandNamesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Relief
    from royalty</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zoXBh7qPJcph" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zRjmfbyWdBG5" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Replacement
    cost</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zAlzKp1ya0u7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">Medphone
contributed R$ <span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zsOUGQBUigml" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49</ix:nonFraction></span> of net revenue and R$ <span id="xdx_904_eifrs-full--ProfitLossBeforeTax_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zguN7LWvW269" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">57</ix:nonFraction></span> of loss before income taxes to the Company in 2020. If the acquisition had taken place at
the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_90C_ecustom--IncreaseInRevenue_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4gqNdsrs9h4" title="Increase in revenue"><ix:nonFraction name="afya:IncreaseInRevenue" contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">142</ix:nonFraction></span> and income before income taxes for 2020 would have
been increased by R$ <span id="xdx_904_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zh2nvdlmuErf"><ix:nonFraction name="afya:IncreaseInIncomeBeforeIncomeTaxes" contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">46</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(f)
Acquisition of FCMPB</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">On
November 9, 2020, Afya Brazil acquired <span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_ztDqMNTY9mVg"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2021-11-09_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the share capital of FCMPB. <span id="xdx_906_eifrs-full--DescriptionOfAcquiree_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zVygu7oAtge9"><ix:nonNumeric contextRef="From2020-11-072020-11-09_custom_FCMPBMember" name="ifrs-full:DescriptionOfAcquiree">The total net purchase price of R$379,913 was adjusted to
R$378,807 and is comprised of (i) R$189,913 paid in cash on the transaction closing date, and (ii) R$188,894 is payable in cash in four
equal installments through 2024, adjusted by the CDI rate.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">FCMPB
is a post-secondary education institution with government authorization to offer on-campus, undergraduate courses in the State of Para&#237;ba
and medical course represents 99% of its 2019&#8217;s net revenue. The acquisition contributed with 157 medical school seats</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
acquisition of FCMPB was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Transaction
costs to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zAlGYuNybu91"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2020-11-072020-11-09_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">721</ix:nonFraction></span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 224 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_FCMPBMember" escape="true" name="afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock"><p id="xdx_891_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOBpQx2ren03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B3_zxZLgCnXCsEf">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: black"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zs5p8J3xdUik" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_LicencesMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">With-and-without
    method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" title="Valuation technique" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonNumeric contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember" name="ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">Multi-period
    excess earnings method</ix:nonNumeric></b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_zRTgQCQd4Nba" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">FCMPB
contributed R$ <span id="xdx_90A_eifrs-full--Revenue_pn3n3_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zMuF15x0bQAa" title="Net revenue"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-11-072020-11-09_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,509</ix:nonFraction></span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOVx47gvTNt6" title="Income loss before income taxes"><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-11-072020-11-09_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">3,570</ix:nonFraction></span> of income before income taxes to the Company in 2020. FCMPB was constituted through
a spin-off recently in August, 2020 and there is no information before this period to be presented.</span></p>

</ix:nonNumeric><p id="xdx_814_zoSsTNThTIjg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zRNddwx4n64" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>6</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_82E_zdNRbjiNGyYj">Cash
                                            and cash equivalents</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory"><p id="xdx_896_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zep5cpAxzMnk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_z6Tlk5tVKuTe" style="display: none; visibility: hidden">Schedule of cash and cash equivalents</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_494_20211231_zhIs5sZaH5Pf" style="border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20201231_z12DwGphZZZ3" style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_zkyM9A130qQc" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,487</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Cash" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,729</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_eifrs-full--CashEquivalents_iI_z7I6HlvNsys9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">660,075</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">987,313</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--CashAndCashEquivalents_iI_zjXuW90T7sj2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif">&#160;Cash and cash
    equivalents</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_z28CIaNg5uaa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Cash equivalents
correspond mainly to financial investments in Bank Certificates of Deposit (&#8220;CDB&#8221;) with highly rated financial institutions
and investments funds managed by highly rated financial institutions. As of December 31, 2021, the average interest on these investments
are equivalent to <span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_ztaM2DvRaVdd" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2021-12-31_custom_BankCertificatesOfDepositMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100.38</ix:nonFraction></span>% of the Interbank Certificates of Deposit (&#8220;CDI&#8221;) (December 31, 2020: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--InterbankCertificatesOfDepositMember_zf5VXktJJiT3" title="Percentage of average interest"><ix:nonFraction name="afya:PercenatgeOfAverageInterestOnFinancialInstrument" contextRef="AsOf2020-12-31_custom_InterbankCertificatesOfDepositMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90.95</ix:nonFraction></span>%). These funds are available
for immediate use and have insignificant risk of changes in value. Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_c20211231__srt--CurrencyAxis__custom--USDMember_zf5MmUtQshSi" title="Cash equivalents (a)"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2021-12-31_custom_USDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">23,228</ix:nonFraction></span> as of
December 31, 2021 (December 31, 2020: R$<span id="xdx_902_eifrs-full--CashEquivalents_iI_c20201231__srt--CurrencyAxis__custom--USDMember_zSrkruIrDXLg" title="Cash equivalents (a)"><ix:nonFraction name="ifrs-full:CashEquivalents" contextRef="AsOf2020-12-31_custom_USDMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">70,523</ix:nonFraction></span>).</span></p>

</ix:nonNumeric><p id="xdx_81C_z3vXmJjb5HKj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>


<!-- Field: Page; Sequence: 225 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zTSHSwTDNuse" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>7</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zQysDuS9pYtl">Trade
                                            receivables</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureOfTradeAndOtherReceivables1Explanatory"><p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_z6b1Qk5I7Xmj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zX8Tm0BxMpJ7" style="display: none; visibility: hidden">Schedule of trade accounts receivable, net and notes receivable</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zaZofXwly2wk" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_TuitionFeesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,915</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z74W3KJi8Z31" title="Trade receivables, gross" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_TuitionFeesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">195,318</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    content <sup id="xdx_F48_zUO4e8brM0M">(a)</sup></span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zOV30KCsXofj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_EducationalContentMember" id="Fact002441" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,227</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zg1672CjJlih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_EducationalContentMember" id="Fact002442" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,931</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zTCLIoJgxW24" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_FIESMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,342</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8koS9msPeif" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_FIESMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,425</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    credits</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zQ4a75Of75n9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_EducationalCreditsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,375</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zlpqgXRsuZj2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_EducationalCreditsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,248</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mobile
    app subscription <sup id="xdx_F4E_zOa0ciKTexrc">(b)</sup></span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_z1MV2dvkFeAk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_MobileAppSubscriptionMember" id="Fact002447" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,946</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_zWLBo9AKjKJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_MobileAppSubscriptionMember" id="Fact002448" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,526</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Others</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_z6I9Rx5eNiH" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_OthersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,001</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zfn7aUmMY7Gh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_OthersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,476</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_c20211231_zLBKL11Rm3y7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">450,806</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_c20201231_zLCSmEvtYPR2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">342,924</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(-)
    Allowance for doubtful accounts</span></td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20211231_zBkEMKa2PMHi" title="(-) Allowance for doubtful accounts" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,013</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20201231_zZmq4vdSYDo9" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccountsFoReceivable1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,980</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--TradeReceivables_iI_c20211231_zSTFHCVuTpjk" title="Trade receivables, net" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,793</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--TradeReceivables_iI_c20201231_zaqIgysBXjOb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,944</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_980_eifrs-full--CurrentTradeReceivables_iI_c20211231_zScJjlPWwHM4" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">378,351</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_iI_c20201231_zxihBwvEorl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentTradeReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">302,317</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zbmRZtLv3i1g" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zX4sEv6BVB7k" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zYXsJQ38ODgj" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1E_zEcoPHFhNVO8" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002465" xml:lang="en-US">Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.</ix:footnote></span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zNzDoXuVEQU6" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_z6NwoKmSmTvg" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002466" xml:lang="en-US">Related to trade receivables
from mobile applications subscriptions for digital medical content.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zVsAlkpv1RL3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory"><p id="xdx_895_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_zAwhsbHdfyhe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 and 2020, the aging of trade receivables was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_zkokUPFKxvo" style="display: none; visibility: hidden">Schedule of aging of trade accounts receivable</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Neither
    past due nor impaired</span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zmDSzjnGs491" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">184,382</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zyPih9uvje8" title="Trade receivable" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">145,076</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Past
    due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1
    to 30 days</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zYU6waBpya8e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_ifrs-full_CurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,932</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z6DNxDfqC5cl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_ifrs-full_CurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,365</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31
    to 90 days</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zLUHzFxJit2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,299</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zlphyAszTvGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,198</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">91
    to 180 days</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zKXHpKOsyJ3e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,764</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zsqTxBBQZtAg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,521</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">More
    than 180 days</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zmiFGDiMyKX" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31_custom_LaterThanOneEightyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,429</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_znlov2MSuhO6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31_custom_LaterThanOneEightyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,764</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231_zPG8AONvukig" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">450,806</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231_z4TICkXN3d39" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:ReceivablesGross" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">342,924</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AE_zXoxPEMEX9k3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:AllowanceForDoubtfulAccountsExplanatory"><p id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsExplanatory_zQ98EYNT8Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The changes in
the allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019, was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zh6ifQJcKy49" style="display: none; visibility: hidden">Schedule of allowance for doubtful accounts</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 60%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_493_20210101__20211231_zQwptMmF38Hh" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_495_20200101__20201231_zWOPOHXBLRSb" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_494_20190101__20191231_zsQ3E8BXifx2" style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_zQHR6SKfOs2f" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the beginning of the period</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,980</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,763</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,537</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_z8ZbFhKS0wQj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,819</ix:nonFraction>)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,081</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,040</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_zmLORFRGbM52" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,786</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,864</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,814</ix:nonFraction>&#160;&#160;&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_zIQ6MP0Y8gS6" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the end of the period</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">45,013</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,980</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,763</ix:nonFraction>)
    </b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zWV8Ndlnwiqj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_810_zgdzTZThqbAh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 226 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfRelatedPartyExplanatory"><p id="xdx_806_eifrs-full--DisclosureOfRelatedPartyExplanatory_zdAst755fjb4" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>8</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zUUbyhNLmH97">Related
                                            parties</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfRelatedPartiesExplanatory"><p id="xdx_897_ecustom--ScheduleOfRelatedPartiesExplanatory_zHTPNSmwfAB3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zA9nOBZYRjOc">The table below
summarizes the balances and transactions with related parties:</span></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49D_20211231_zFAMpuVZ6ke3" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_499_20201231_z8IkEVggsgqe" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--TradeReceivablesRelatedPartyTransactions_iI_zVTPXnt6ywSf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables <sup id="xdx_F47_zor9ngjglRtg">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2021-12-31" id="Fact002506" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">692</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeReceivablesRelatedPartyTransactions" contextRef="AsOf2020-12-31" id="Fact002507" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">174</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--CreditsWithShareholdersRelatedPartyTransactions_iI_zRKH3INWi5Ob" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Related
    parties <sup id="xdx_F42_zPsDLPAGjoB1">(b)</sup></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CreditsWithShareholdersRelatedPartyTransactions" contextRef="AsOf2020-12-31" id="Fact002510" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_zytw8aCO5ye1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span style="display: none; visibility: hidden">TOTAL</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">692</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsReceivableRelatedPartyTransactions" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">595</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_407_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_z17ngage4Oo3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">692</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:TradeAndOtherCurrentPayablesToRelatedParties1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">174</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zOJRRKNzkTmd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2518">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssetsOfRelatedParty1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--AccountsPayableToSellingShareholders_iI_zRqWB7IxYx7l" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders <sup id="xdx_F4F_zx3htuzXoK11">(c)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholders" contextRef="AsOf2021-12-31" id="Fact002521" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,556</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2522">-</span></span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsPayableRelatedPartyTransactions_iTI_zjHCjdgL5nP8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif; visibility: hidden">&#160;Total</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountsPayableRelatedPartyTransactions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,556</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td></tr>
  <tr id="xdx_401_ecustom--AccountsPayableCurrent1_iI_zD0CpvdKYxg7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableCurrent1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,278</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2528">-</span></span></td></tr>
  <tr id="xdx_400_ecustom--NoncurrentPayablesToRelatedParties1_iI_zk0v0IIndaP9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentPayablesToRelatedParties1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,278</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other
    income</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC
    <sup id="xdx_F40_ztkneTU0jBr4">(a)</sup></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zo377Gzq2ink" title="Other income" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_UEPCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zXqUxwWTdaa3" title="Other income" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31_custom_UEPCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zy4r6G9wnxa6" title="Other income" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31_custom_UEPCMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">557</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zKfnxqWhVlq2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">752</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231_z2hBRocfajw1" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231_zz9RW70uHdf3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:OtherIncomeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">557</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL
    Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_987_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z9MWpTJVG9Hb" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,336</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zXDItSZyVpe2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,288</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOpXLwRJQoWg" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,417</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O
    Patrimonial Ltda.</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zXDNNpZ3zMB5" title="Lease" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,210</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z72NlVDU4xY" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,915</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zZyKhU1V9m9g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,816</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP
    Patrimonial Ltda.</span></td>
    <td id="xdx_980_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zDrbBZrTCal3" title="Lease" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,560</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zPFPbbEv8YNc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,470</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zmhhRsQRSk7d" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,609</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_z6GM6uMWpsI5" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,106</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231_zq8uPh334pHc" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,673</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_c20190101__20191231_pn3n3" title="Lease" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:LeasesAsLesseeRelatedPartyTransactions" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,842</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zIWsuYYX5gp" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F12_z5FfuMNv5D9k" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002559" xml:lang="en-US">Refers to sales of educational content
from Medcel to UEPC.</ix:footnote></span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zLN6utXXTwe1" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_zHL1ntwquFYg" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002560" xml:lang="en-US">Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.</ix:footnote></span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zRr8V9KKHa56" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F11_zDDVZy0CIS66" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002561" xml:lang="en-US">Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zvyUrDYJypu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Brazil has
entered into lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, as described below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
June 21, 2016, RVL entered into lease agreements (as amended on April 26, 2018) with ITPAC &#8211; Instituto Tocantinense Presidente
Ant&#244;nio Carlos S.A., or ITPAC, and Itpac Porto Nacional &#8211; Instituto Tocantinense Presidente Antonio Carlos Porto S.A., or
ITPAC Porto Nacional, pursuant to which RVL Esteves Gest&#227;o Imobili&#225;ria S.A. agreed to lease campuses to ITPAC and ITPAC
Porto Nacional in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are
adjustable in accordance with the provisions of each lease agreement. The lease agreements are for an initial term of <span id="xdx_903_ecustom--OperatingLeaseTermOfContract_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zpAlcTyi13u5" title="Lease term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2563">20</span></span> years, and are
renewable for an additional 20 years subject to the provisions of each lease agreement.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 227 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
November 1, 2016, RVL entered into a lease agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices
located in the city of Nova Lima, State of Minas Gerais, where Afya Brazil&#8217;s principal executive offices are located. On February
9, 2019 the agreement was amended to extend lease terms and adjust the lease amounts, subject to certain discount conditions set forth
in the lease agreement and adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of five years, and may be renewable for an additional five years subject to the provisions of the lease agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
September 6, 2018, RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus
by RVL in the city of Palmas, State of Tocantins. The lease agreement is for an amount equal to <span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180905__20180906__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember_zxnsAt16Trmk" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% of the monthly net revenue of ITPAC
during the prior semester, which will start to become due once the new ITPAC campus becomes operational, subject to the provisions of
the lease agreement. The lease agreement is for an initial term of <span id="xdx_90B_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zySCVqNvIqpb" title="Percentage of revenue::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2567">20</span></span> years, starting on the date the new ITPAC campus becomes operational,
and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zQHBkRpjh266" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2569">20</span></span> years subject to the provisions of the lease agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 30,
2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL agreed to lease to IPTAN the new IPTAN medical campus, currently
under construction by RVL in the city of Santa In&#234;s, State of Maranh&#227;o. The lease agreement is for a monthly amount equal
to (i) up to June 2020, R$12 and (ii) after June 2020 and until March 2024, 6.5% of the monthly net revenue of IPTAN</span> assessed during
the prior semester, in each case adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of 5 years counted from the conclusion of the construction works, and may be renewable for an additional 5 years subject to the
provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On August 02, 2021,
RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus,
in the city of Garanhuns, State of Pernambuco. The lease agreement is for a monthly amount equal to <span id="xdx_909_ecustom--DescriptionOfLeaseTerm_c20191029__20191030__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" title="Description of lease term"><ix:nonNumeric contextRef="From2019-10-292019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" name="afya:DescriptionOfLeaseTerm">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_pn3n3" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">40</ix:nonFraction></span>; (ii) after
June 2022 and until December 2028, <span id="xdx_90D_eifrs-full--PercentageOfEntitysRevenue_dp_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsyxmYqwhPt8" title="Renewal term"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">6.5</ix:nonFraction></span>% of the monthly net revenue of ITPAC</ix:nonNumeric></span> Garanhuns assessed during the prior semester, in each case
adjustable in accordance with the provisions of the lease agreement; and (iii) after 2029 the monthly amount should be adjust by inflation
rate (IPCA). The lease agreement is for a term of 20 years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The lease payments
in connection with the lease agreements with RVL totaled R$<span id="xdx_90D_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zCHhPIigyLa8" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,336</ix:nonFraction></span> and R$<span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zhH9eGt9GAbf" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,288</ix:nonFraction></span> in the years ended December 31, 2021 and 2020, respectively.
In the year ended December 31, 2019, the lease payments in connection with the lease agreements with RVL totaled R$1<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20190101__20191231__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zRzsTFLo2Jh5" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">0,417</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreement with UNIVA&#199;O Patrimonial Ltda.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 14, 2016,
UNIVA&#199;O Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves
is the chief executive officer, entered into a lease agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O
Patrimonial Ltda. agreed to lease the UNIVA&#199;O campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais.
The lease agreement is adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term
of 20 years, and is renewable for an additional <span id="xdx_90E_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsdrHOPcqEac" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2583">20</span></span> years subject to the provisions of the lease agreement. The lease payments in connection
with this lease agreement totaled R$<span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z400aEfi31l1" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,210</ix:nonFraction></span> and R$<span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zqSmF7AMl80e" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,915</ix:nonFraction></span> in the years ended December 31, 2021 and 2020, respectively. In the year ended
December 31, 2019, the lease payments in connection with this lease agreement totaled R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_pn3n3" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,816</ix:nonFraction></span>.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 228 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreement with IESVAP Patrimonial Ltda.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 25, 2018,
IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive
officer, entered into a lease agreement with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to
lease the IESVAP campus to IESVAP located in the city of Parna&#237;ba, State of Piau&#237;. <span id="xdx_90F_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuBwNBw337Dd" title="Description of lease term"><ix:nonNumeric contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" name="afya:DescriptionOfLeaseTerms">The lease agreement is for an amount
equal to <span id="xdx_900_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zlLSOz759e35" title="Percentage of revenue"><ix:nonFraction name="ifrs-full:PercentageOfEntitysRevenue" contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.5</ix:nonFraction></span>% of the monthly net revenue of IESVAP during 2018</ix:nonNumeric></span>. The lease agreement is for an initial term of <span id="xdx_908_ecustom--OperatingLeaseTermOfContract_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFbnwpS7847l" title="Lease term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2595">20</span></span> years, and is renewable
for an additional <span id="xdx_905_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zf3p0TQJwte1" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2597">20</span></span> years subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement
totaled R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zbKeUwS942n8" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,560</ix:nonFraction></span> and R$<span id="xdx_903_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z4u0hzmzA9wb" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,470</ix:nonFraction></span> in the years ended December 31, 2021 and 2020, respectively. In the year ended December 31, 2019, the lease
payments in connection with this lease agreement totaled R$<span id="xdx_908_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_pn3n3" title="Lease expenses"><ix:nonFraction name="ifrs-full:CashOutflowForLeases" contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,609</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Key
management personnel compensation</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock"><p id="xdx_892_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_zB80mLv5U6l4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zjGIIOd6WbXe">Key management
personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 4%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="width: 3%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term
    employee benefits</span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_zy5oJImO2QQ1" title="Short-term employee benefits" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,933</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20200101__20201231_pn3n3" title="Short-term employee benefits" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,629</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20190101__20191231_pn3n3" title="Short-term employee benefits" style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,947</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation plan</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zFOzMHPWLGol" title="Share-based compensation plans" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,251</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--KeyManagementPersonnelCompensation_c20200101__20201231_pn3n3" title="Share-based compensation plans" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,989</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--KeyManagementPersonnelCompensation_c20190101__20191231_pn3n3" title="Share-based compensation plans" style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:KeyManagementPersonnelCompensation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,893</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zTsER7rH0PAl" title="Total" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,184</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20200101__20201231_zlHdUK86xtXg" title="Total" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,618</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_c20190101__20191231_pn3n3" title="Total" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,840</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_zZPRnVfA1wXb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Compensation of
the Company&#8217;s key management includes short-term employee benefits comprised by salaries, labor and social charges, and other ordinary
short-term employee benefits. The amounts disclosed in the table above are the amounts recognized as an expense in general and administrative
expenses during the reporting period related to key management personnel.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The executive officers
participate in share-based compensation plans described in Note 16 (b).</span></p>

</ix:nonNumeric><p id="xdx_812_zFdfkPdP55Ph" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfOtherAssetsExplanatory"><p id="xdx_803_eifrs-full--DisclosureOfOtherAssetsExplanatory_zyixwY9OtSE4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>9</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zWXLdiSWkG8g">Other
                                            assets</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 the Company has R$<span id="xdx_906_ecustom--OtherCurrentAssets1_iI_c20211231_z3h2ymb5Wthl" title="TotalAssets"><ix:nonFraction name="afya:OtherCurrentAssets1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">222,839</ix:nonFraction></span> (R$ <span id="xdx_909_ecustom--OtherCurrentAssets1_iI_c20201231_zy1Kug55MQGa" title="TotalAssets"><ix:nonFraction name="afya:OtherCurrentAssets1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">103,651</ix:nonFraction></span> in December 31, 2020) accounted for as Others assets as follow:</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureOfOtherAssetsTableTextBlock"><p id="xdx_893_ecustom--DisclosureOfOtherAssetsTableTextBlock_z0mZ8VPwyvU" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_z0iZVeWMgMua" style="display: none; visibility: hidden">Schedule
of Other Assets</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49A_20211231_ze0H6LTEmB39" style="border-bottom: black 1pt solid; vertical-align: top; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49E_20201231_zG4ahnYBdjRf" style="border-bottom: black 1pt solid; vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_maAzeR4_zGMAje5cFJJa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification
    assets <sup id="xdx_F4A_zckFy3zL5CEh">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2021-12-31" id="Fact002633" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">135,355</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<ix:nonFraction name="ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate" contextRef="AsOf2020-12-31" id="Fact002634" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,499</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--JudicialDeposits_iI_maAzeR4_z4nMEHY7I5R8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial
    deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,825</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,451</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentPrepaidExpenses_iI_maAzeR4_zLTpYYE9zZfb" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid
    expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,110</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<ix:nonFraction name="ifrs-full:CurrentPrepaidExpenses" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,291</ix:nonFraction>
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_maAzeR4_zU0e0fR2ZLK3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,450</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,411</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_ecustom--OtherAssets1_iI_maAzeR4_zV0fIqT6dcq9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,099</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherAssets1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,999</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--Assets1_iTI_mtAzeR4_zImaWDaO5qK2" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<b>Total</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:Assets1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">222,839</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&#160;<ix:nonFraction name="afya:Assets1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,651</ix:nonFraction>
    </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CurrentAssets1_iI_z0uxoNiykdGk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,533</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentAssets1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,614</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_ecustom--NoncurrentAssets1_iI_zwxeteUaAHSe" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">180,306</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentAssets1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,037</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zmlIUcWq5LB9" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F13_zQccXvRQc3Yj" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote002656" xml:lang="en-US">Under the terms of the Share Purchase
and Sale Agreements (&#34;Agreements&#34;) between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zBkj7WdPT4N5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

</ix:nonNumeric><p id="xdx_811_zqE9PWpvOis9" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 229 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfJointVenturesExplanatory"><p id="xdx_80D_eifrs-full--DisclosureOfJointVenturesExplanatory_zcSicmYBKOia" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>10</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_828_zDsDP9sGlhR7">Investment
                                            in associate</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfInvestments"><p id="xdx_893_ecustom--ScheduleOfInvestments_zzSKJ0qizyvd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In connection with
the corporate reorganization, described in Note 1 regarding the merger with BR Health, the Company acquired a 30% interest in UEPC, a
medical school located in the Federal District, that offers higher education and post-graduate courses, both in person and long-distance
learning. The Company&#8217;s interest in UEPC is accounted for using the equity method. The following table illustrates the summarized
financial information of the Company&#8217;s investment in UEPC:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zegUpHFamie3" style="display: none; visibility: hidden">Schedule of investments</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_495_20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_ztuFjR6lWCCj" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49F_20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zutTJWB1NOSh" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--CurrentAssets_iI_ziNRzqN8aVLa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,976</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">55,413</ix:nonFraction></span></td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentAssets_iI_zkysyWkAnADj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">109,805</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentAssets" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82,575</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentLiabilities_iI_zcdpcfOW3luf" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,049</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">34,531</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLiabilities_iI_zZJ0OrYijEZ5" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">91,086</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NoncurrentLiabilities" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">76,132</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_ecustom--EquityInAssociate_iI_pn3n3_zNdNHY5uOJ02" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,646</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityInAssociate" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,325</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40F_ecustom--CompanyShareInEquity1_iI_zncKuEDDgSdg" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s
    share in equity &#8211; 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,294</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CompanyShareInEquity1" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,227</ix:nonFraction></span></td></tr>
  <tr id="xdx_404_eifrs-full--Goodwill_iI_zTWHOCQEGj3e" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,183</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_znBr9zNPrT1d" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:InvestmentGrossAmount" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_496_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zMGhJOUNcZQ9" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z01qreZIZnPe" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zd8VHpPGpZti" style="width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr id="xdx_40E_eifrs-full--Revenue_zxTnnxGzFvc8" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net
    revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">127,618</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,965</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Revenue" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,816</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--CostOfSales_zZUBc69Iyqih" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">57,935</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,926</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,459</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zli07pMMZvN2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,025</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,341</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,476</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_z9ZRA8rKUZOe" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance
    result</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,585</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,882</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,121</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_zd0sGZqBIs3i" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income
    before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,073</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,816</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,760</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40F_eifrs-full--IncomeTaxExpenseContinuingOperations_zh29JpX4Fe12" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,748</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">252</ix:nonFraction>)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncomeTaxExpenseContinuingOperations" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,275</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_eifrs-full--ProfitLoss_z11LxfdFLAi2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    income for the period</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,325</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,564</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLoss" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,485</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_zTbangbaaco6" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s
    share of income for the period </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,698</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:CompanyShareOfProfitss" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,362</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zx55YM9V8TE6" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zKWB50vA4P11" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z8lEV9pC1Lu" style="border-bottom: black 1pt solid; width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentsInAssociates_iS_zWtjCksUTzqa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,634</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></span></td></tr>
  <tr id="xdx_408_ecustom--MinorityInterestOfAcquiree_zlqSJLaQhuNi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of minority interest (15%) in March 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2722">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2723">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MinorityInterestOfAcquiree" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,458</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--AdditionalMinorityInterestOfAcquiree_zC6y6OBKIP86" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of additional interest (15%) in June 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionalMinorityInterestOfAcquiree" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,457</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--DividendsReceived1_zeyf8wFxDexl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,770</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,922</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DividendsReceived1" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,643</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--DividendsReceived_zneCLdZD8Hr8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DividendsReceived" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,960</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2735">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossOfAcquiree_zZ9lZe3En97g" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,797</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,698</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfitLossOfAcquiree" contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,362</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iE_zdxGaReHhpy7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing
    balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,477</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,410</ix:nonFraction></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:InvestmentsInAssociates" contextRef="AsOf2019-12-31_ifrs-full_AssociatesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,634</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zCGSMXs6lXm7" style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
Company tests at least annually the recoverability of the carrying amount of goodwill and there was no impairment for this goodwill.</span></p>

</ix:nonNumeric><p id="xdx_812_zR26j3EAlf6g" style="font: 11pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"></span></p>


<!-- Field: Page; Sequence: 230 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zk4hRNRyM8dj" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>11</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_82C_zeKtI6PzYUJ2">Property
                                            and equipment</span></b></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory"><p id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zBwyJ0giRUl3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zXB5MRKKrsa9" style="display: none; visibility: hidden">Schedule
of detailed information about property, plant and equipment</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 24%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_ztR2ztUIgz46" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Building</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zWF4kv1Mf272" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Machinery
    and equipment</b></span></td>
    <td id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zk3CSQXZAzo" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Lands</b></span></td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zqcdivLUIRk8" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Vehicles</b></span></td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zScXVWbPlrOj" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Furniture
    and fixtures</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zN2CJpmui0ja" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>IT
    equipment</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_znYhjBfijHs5" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Library
    books</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LaboratoriesAndClinicsMember_zy8nGF7You35" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Laboratories
    and clinics</b></span></td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_z1lVkTwLfhpd" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Leasehold
    improvements</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zEMD0wm5Ie93" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Construction
    in progress</b></span></td>
    <td id="xdx_4B6_z8qJbJuS5uMg" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zgRvAijtZECi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,503</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,770</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">182</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,897</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,243</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,838</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">597</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,882</ix:nonFraction></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,736</ix:nonFraction></b></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">91,648</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_439_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zEa98fDb9NZ4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2762">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,838</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,235</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">422</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,976</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,241</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,205</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,488</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,525</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,964</ix:nonFraction></span></td></tr>
  <tr id="xdx_43C_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zGspkmT9FpNd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfers</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2775">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2777">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">525</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2781">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2782">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2783">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">525</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_433_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zoBzLOAs4s5g" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2786">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,988</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2788">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,565</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,035</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,096</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">418</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,541</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">470</ix:nonFraction></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,216</ix:nonFraction></span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zRRN4GV3tug1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2798">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,329</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,005</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">707</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,438</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,994</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,139</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,049</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,911</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,731</ix:nonFraction></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,303</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_436_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zXnm95dVmXBk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2810">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,806</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">672</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,550</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,657</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,012</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2817">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,748</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,387</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,832</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_ziefd94qkGxk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,771</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,973</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,724</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">508</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,061</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,493</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,473</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,787</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,090</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">47,880</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_43A_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_z1DeFmkR0Vsh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,148</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,395</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2836">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">367</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,049</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,559</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,502</ix:nonFraction>)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2844">-</span></b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zwgSj3L7hoD6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,919</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,503</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,401</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,215</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,131</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,511</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,624</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2853">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,005</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,706</ix:nonFraction></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">314,015</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_438_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zLjL82Q7WBaj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,384</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,268</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,451</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">111</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,075</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,511</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,392</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,720</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,957</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,869</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zkTAUX2nG8qh" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2870">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,810</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">346</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,684</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,138</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,142</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2877">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,425</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,078</ix:nonFraction></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,623</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zmVa3mkW0ree" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F40_zfRRSU4R0uSb">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" id="Fact002882" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" id="Fact002883" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,213</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" id="Fact002885" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">205</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" id="Fact002886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,862</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" id="Fact002887" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,985</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" id="Fact002888" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">86</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" id="Fact002890" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">550</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" id="Fact002891" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">417</ix:nonFraction>)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact002892" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,532</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zdkueYwI1JVg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,068</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">82</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,376</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">34,538</ix:nonFraction>)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2904">-</span></b></span></td></tr>
  <tr id="xdx_436_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iE_zdyfnPjcixRb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52,433</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,371</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,467</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">69,834</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,184</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,072</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152,976</ix:nonFraction></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,786</ix:nonFraction></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">487,975</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Depreciation</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zyljSFzGWkT6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,696</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2920">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">59</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,261</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,489</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,015</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">27</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">338</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2927">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,885</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zbhO1ufDHiua" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,097</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,629</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,495</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,648</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">359</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,317</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,545</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43F_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zHOXVqwwX09d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2949">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2950">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2951">-</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447</ix:nonFraction></span></td></tr>
  <tr id="xdx_434_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zEtqFc7DOExf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,793</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2956">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">59</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,890</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,537</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,663</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">386</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,655</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2963">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">36,983</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_43D_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zmXu7XEiXQC2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2966">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,065</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,199</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,314</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,154</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,729</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2975">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,651</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_430_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zW5xiZEyjQU1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">464</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2981">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2982">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2983">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">464</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2986">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2987">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></span></td></tr>
  <tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_z7E17VH1y7Od" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">19,322</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">171</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,089</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,851</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,817</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,384</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">53,634</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zGCt13y8OgLg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,673</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,215</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">196</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,601</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,529</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,416</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3009">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,831</ix:nonFraction>)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3011">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:DepreciationPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,461</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zNwBYQYnFny7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F43_zFwjlOCX43gh">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3014">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" id="Fact003015" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,146</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3016">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" id="Fact003017" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" id="Fact003018" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,194</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" id="Fact003019" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,458</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" id="Fact003020" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">633</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3021">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" id="Fact003022" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">350</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:DisposalsPropertyPlantAndEquipment" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" id="Fact003024" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,928</ix:nonFraction></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iE_zPlBfJXWFNej" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,673</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,391</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">220</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,496</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">14,922</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,600</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3033">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,865</ix:nonFraction>)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3035">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">68,167</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z4MrY4J9dN9i" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,760</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,980</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,852</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,247</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,338</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,262</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,472</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,111</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,786</ix:nonFraction></b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,808</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_438_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zkuoCqmg5qWj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_BuildingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,919</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_custom_MachineryAndEquipmentsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,181</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_LandMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,401</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_VehiclesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,044</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_FixturesAndFittingsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,042</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_custom_ItEquipmentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,660</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_custom_LibraryBooksMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,807</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3057">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_LeaseholdImprovementsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">117,621</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31_ifrs-full_ConstructionInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,706</ix:nonFraction></b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:PropertyPlantAndEquipment" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">260,381</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F09_zWaExgtmeRMc" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F11_z8MiGztrV118" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003061" xml:lang="en-US">the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A9_zGVLKLv4lZkl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses,
at each reporting date, whether there is an indication that a property and equipment asset may be impaired. If any indication exists,
the Company estimates the asset&#8217;s recoverable amount. There were no indications of impairment of property and equipment as of and
for the years ended December 31, 2021, 2020 and 2019.</span></p>

</ix:nonNumeric><p id="xdx_81A_zXUYL6ZDP2qg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>


<!-- Field: Page; Sequence: 231 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfIntangibleAssetsExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zxxqkltlzGje" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>12</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_zR55wnJWD8Fa">Intangible
                                            assets and goodwill</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfIntangibleAssetsTableTextBlock"><p id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_zgxmCWdKyXog" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_z6CNYptVO0dh" style="display: none; visibility: hidden">Schedule of intangible assets</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 24%; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Customer
    relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Education
    content</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Developed
    technology </b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Educational
    platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software
    in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkxsuhUaV5l9" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">169,535</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhaDuACraDhe" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">445,616</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHs2gwz7FaO4" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPsSmKAbzb9h" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,303</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zptr5G7guQEk" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,288</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfIJtY98dNm9" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3077">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgVdcREIzvdh" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf6tA5ZCKvg3" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">577</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUiRBzQHaGd1" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,175</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcF2rYhO8RKj" title="Intangible assets and goodwill, balance at beginnning" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">688,494</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F44_zGflIxppYzX1">(i)</sup> <sup id="xdx_F42_zAmXwDBmqTAi">(ii)</sup></span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zKHd9jvJkPu7" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" id="Fact003087" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,030</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z0zbWSeN8hL9" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact003089" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zL8N7OhxPjhf" title="Additions" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact003091" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,101</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJjOI3pxaJA4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact003092" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">8,769</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJBqYGmy7gil" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact003093" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">875</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zecGZ2M4FaXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact003094" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,775</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR1UoBsoDr43" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">285,844</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvviFS7HpiY6" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,156</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeaCpQSf5Gzi" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,111</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z07h0F5KREy3" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,110</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znrhXtBCZ8Ni" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformAndSoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7iVNfDjgI4" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_custom_EducationalPlatformAndSoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,845</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg8UJ7rr2Fr8" title="Business combinations" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">550,371</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNumYlMzBxIl" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">459,409</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLoTM6YqnQY6" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">703,772</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLr2xOJt0RF6" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,111</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7XYVQlAfSmj" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,413</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsWxj88AuHZ9" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,389</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjEjhdNwkqb6" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO81qsEtl7r4" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWNQkVXU31Sa" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,191</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpzHay8lTyRe" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,050</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvvRK5zgnxi8" title="Intangible assets and goodwill, balance at beginnning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,361,640</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD0JnCltpD61" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,175</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeunoOf2RDW2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,227</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoY5CWPbrz2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">247</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zytdoG1JSEB6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,649</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5xrZd2YGPuj" title="Disposal" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">460</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--Disposal_pn3n3_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlg4GHNqNo1a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">460</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zALR5Fv0JCNa" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">351,247</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkjxVi1pGvM4" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">747,498</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgn0GpcbgYVa" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,903</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znu21tk3vc8a" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,126</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzyK3v3xPJte" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,117</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUKPVciX5vR4" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">355</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqF30wiFGyKl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">484</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPz7SO6H8O6b" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,303,730</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTQ1rtT6InQe" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">810,656</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zomSze4aW6Y7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,451,270</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVHqcQBJ7rG7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,014</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbmI77B3unzg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">283,539</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD9tzR12okJb" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,221</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkHU2FN390d" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUivKqpwPjZc" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">355</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrHMFJKqe5Sk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,902</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXHJ8vb2DkV6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,297</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyZxnBMFQGNg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,684,559</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F48_z75kiZZ6VCga">(iii)</sup></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z08XjpZh0qMj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" id="Fact003171" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z5J2Zgd32oA6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3172">-</span></span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSO4JbJcODv9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact003173" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">684</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zBdR4iXMAZR3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact003174" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,044</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zCr11aO1hLWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zaEz9a8dB838" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" id="Fact003176" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">996</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zS0YV8HvJKgj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact003177" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,686</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zQYmrFsHGW84" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact003178" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,700</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zWwl093j8nwc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact003179" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,110</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F4A_zZEoSxeGOff4">*</sup></span></td>
    <td id="xdx_98A_ecustom--Disposal_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zOF7zA2Ksu8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3180">-</span></span></td>
    <td id="xdx_985_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z4Rm6jRHskEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3181">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zzPdTfZ8IQ87" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z7Ml7PG2qXM5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3183">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zxqK38cQYOG6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" id="Fact003184" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,020</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z9yVKOOMngZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></span></td>
    <td id="xdx_988_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAfpD7EyucX1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zkWkDnVFplf4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" id="Fact003187" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,743</ix:nonFraction>)</span></td>
    <td id="xdx_98A_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zBS4JsvAGhql" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" id="Fact003188" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">417</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zQZYCIVsM807" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" id="Fact003189" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,140</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKg84LKNay84" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">373,680</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTMivMWO8NCc" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">606,136</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3Dl9KSSdVgc" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,355</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCVehoHl3O82" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,054</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzRqdd0WvCzi" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,474</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zH9u7D27jOG8" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,046</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXX7ElwXfpL6" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,599</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl7dJ43XXPEg" title="Business combinations" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,267</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgRntUVoIfl4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,234,611</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyIWtt7sa1g" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,184,336</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAPIpgLTkPr5" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,165,406</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWgb5DbKx6Sc" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">133,369</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNS41JHdYfHe" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">431,277</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhO2u0poXFEe" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,759</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z01UObTkkUxb" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,305</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHr9BvWD3WE8" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,397</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7SLw7iMTnDa" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,444</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN7Z7PDKTc65" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,847</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW6Co3FHS8J1" title="Intangible assets and goodwill, balance at end" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,093,140</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVTMWFTXcKm7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9VOEa0LPMX6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3229">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zY677rsPs7id" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3231">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDluYcBLQg89" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,945</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOXSiuHHtrA9" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,080</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z27eu706jec3" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3237">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzwI10IbOTUe" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziv62DwYuaM2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3241">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK8e1ET41Lj" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3243">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zP2S4NpLP8r" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,025</ix:nonFraction>)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhrweN45PrQ2" title="Amortization" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,150</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6IOj47FpXzk" title="Amortization" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">34,927</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJW5zpZm2r1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,456</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zs90LkueKM5j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,876</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zt7fch5NkyA" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">868</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYTtHO5sl67c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,277</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQmvxq2n688e" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3255">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSu9HcwpMEn5" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3257">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbgv1P4XFhTf" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,150</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgJoXUJ4msVg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,872</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCbASu4xufMg" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,536</ix:nonFraction>)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjGhWA7ZVr44" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,876</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0NCtljo8nZ2" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3267">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK34BN7uaF6" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">868</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziL4KQqog2wc" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3271">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRv64Sfjrd58" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,302</ix:nonFraction>)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuFsprRvxeXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,352</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0C3m4tNdZl7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,960</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4vpqQI1Pb4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,180</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfiDzAUqRoS9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,816</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbb1l4caHOaf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOPpLfFpFxOh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,367</ix:nonFraction>)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvU1BNA0OIZ2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">62,707</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zygf6PLXLsI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:Disposal" contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">460</ix:nonFraction></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzfmtAqKJ6Nh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:Disposal" contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">460</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcY9MbR8nUPh" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3284">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqYkFl7Z3hKi" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJSgRwo85sd" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,502</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH7fLAJ1wDp4" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">85,832</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0rnZC4GJW2h" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,256</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW5U72wxINI8" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,692</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIx7B4AkeS7" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVDa8yMeN2gd" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,235</ix:nonFraction>)</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zczVseOSEilc" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3300">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIYMYwyxNBWk" title="Intangible assets and goodwill, balance at beginnning" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">111,549</ix:nonFraction>)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAF7Qly5ZWah" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3303">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCybXu0S6oZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3304">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxBHx5BmYGCb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,027</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zubKmkJvsSr5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">56,438</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EdFV6wvHi4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,844</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znzLhDc6I1rg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,980</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx9BVkCtRRxl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">625</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRh8kfUgG3b7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,608</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgb9oFhb3f3c" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3311">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy60RBVK31uj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">80,522</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjS56W2a53k6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3313">-</span></span></td>
    <td id="xdx_98B_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaRwrN4jQncc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3314">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWx0KpoTeV8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3315">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKIWxUuidp11" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3316">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zniuF1KTm6S3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">599</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNSJ2wMjN4E8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3318">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztXIRdEGc6Pb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_989_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx80T1pUaD7h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">365</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsl8H8S8gC0e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_za2dEqEd4pWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:Disposal" contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">234</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgxV2qVoxrik" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZoR9jljaXpl" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRypdi6t7ic7" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,529</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCGkk9S8s8ei" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">142,270</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGLksVBw85s9" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,699</ix:nonFraction>)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1UoVgcFv9Ob" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,672</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbIWImgRqNY8" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">657</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuQKaZTOr9N1" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,478</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC2BpddUhYGj" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3340">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkf9uBnobtQ" title="Intangible assets and goodwill, balance at end" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">192,305</ix:nonFraction>)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zE8V3FvUgpW4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,184,336</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs06UttAd1j6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,165,406</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zhg2fl7uqYFc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">124,840</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zFK1NxBXXfEa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">289,007</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_znmlefgFDmD4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,060</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zcpKvMmISzH1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationContentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">633</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zKvaXM4yuvl3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">33,740</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOXO8lmqO1O8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_EducationalPlatformMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,966</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zsGNAUEBbOQk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,847</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231_zrCyYTQlGNH3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,900,835</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zygN9kzpFb3j" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">810,656</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw1uNmd1WAG2" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,451,270</ix:nonFraction></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zHacTJWMU0x4" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,512</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJmT39SbdOD6" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">197,707</ix:nonFraction></b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zrkdGCswOQXj" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,965</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVOpwR97WGPl" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationContentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,613</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zq0p7p2NQYIa" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">323</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zkrqGmCTUae1" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_EducationalPlatformMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,667</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_z45HSGqjFwG4" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,297</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231_zooUxMWZ3Pwl" title="Intangible assets and goodwill" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IntangibleAssetsAndGoodwill" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,573,010</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F00_zZu9Mg5u23Y7" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_zfAsL5DpRmci" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003373" xml:lang="en-US">the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F05_zKMB1nvNcvOa" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_zuLRtVLlgLe6" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"><ix:footnote id="Footnote003374" xml:lang="en-US">The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.</ix:footnote></span></td>
</tr></table>

<p style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F06_zFr7UWC0GTN" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(ii)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F13_z4ydhiKEJR74" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"><ix:footnote id="Footnote003375" xml:lang="en-US">On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#225;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.</ix:footnote></span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zQCa6c3fio5" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(iii)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F12_zj85er5T4eEe" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"><ix:footnote id="Footnote003376" xml:lang="en-US">On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#34;MEC&#34;) authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A3_zh1ydSjV844i" style="font: italic bold 11pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Licenses with indefinite
useful life include intangible assets acquired through business combinations. The licenses for medicine and other courses granted by
the Ministry of Education (&#8220;MEC&#8221;) to the companies acquired have no expiration date and the Company has determined that these
assets have indefinite useful lives.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For impairment
testing goodwill and licenses with indefinite useful lives acquired through business combinations are allocated to CGUs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company performed
its annual impairment test on December 31, 2021, 2020 and 2019.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 232 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company tests
at least annually the recoverability of the carrying amount of goodwill and licenses with indefinite useful lives for each CGU. The process
of estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's
best estimate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">There was no impairment
for goodwill and licenses with indefinite useful lives as of December 31, 2021, 2020 and 2019.</span></p>

<p style="font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock"><p id="xdx_890_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_z6bXJpTV1et4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The carrying amounts
of goodwill and licenses with indefinite useful life by CGU and their carrying amount as of December 31, 2021 and 2020 was:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B6_zQ2HWeYUNpIc" style="display: none; visibility: hidden">Schedule of assumptions for impairment test</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-bottom: 9pt; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Carrying
    amount</b></span></td>
    </tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPTAN</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zbY6uLfmZk36" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zQ44mvcqaUVb" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,446</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zILJh7pp2P0e" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z7F4qyn8fxKb" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,214</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDwKKaIHGISl" title="Cash generating units" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">140,522</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zT0DF7HP30ri" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,397</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESVAP</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zeAlZ1lG6jmb" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z2jWHo6SBAL4" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,956</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zhewlffkoZP1" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zN5TCgI8Bcnk" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,366</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zpoP56TV7iH5" title="Cash generating units" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,260</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_znplQR4TgBth" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">112,898</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zEF9aIYGp6w3" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_z4MLayuCI2dg" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,664</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJsfo1O1AnIh" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zVzwvkUo4MW3" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,737</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zlj1p2hOL8f5" title="Cash generating units" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,030</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zn4bvgn4Xuk9" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">48,411</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oudzNoxTH1" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zFmUglBqt9nd" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">73,838</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zp1WEpbSH0ng" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmoYi85jZk23" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">179,693</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zAvLjw9x63I3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">346,286</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zGuwFrKq5z7c" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">380,410</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FADEP</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6JJBTzO7Gnf" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_ztPOG9HJe517" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">49,661</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zwkjEdn8wOVk" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zzUfKFV3e7o4" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,606</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zdUPnDfbZjDj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,791</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zZbQNT5am1Pk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">160,787</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medcel
    and CBBW<sup id="xdx_F48_zNSFhX0F0RO2">*</sup></span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zDfBOeCKubog" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,294</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z1JGVJeH9E6" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,294</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z5uNFxi4L4k9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3439">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zFqBytiQsYEf" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,300</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_iI_pn3n3_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_fKg_____ztl9lzUOXBB1" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember" id="Fact003443" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">219,359</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FASA</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z8J5aIV2d8J5" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zuF058AECMj8" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,903</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zoWPq3zhxFC2" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zL14y5Bxsnn4" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,507</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zO1CnMq2b9Y8" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">302,330</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zC4CVcHh4s5b" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">267,279</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEMED</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zSn4IVr4r26g" title="Goodwill" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,647</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zZtwYkmG5cUd" title="Goodwill" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,647</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zwk1TqrwtMa4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zB0wKsrmXjF7" title="Cash generating units" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">126,965</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zATzj8DzHIT9" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">119,227</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEC</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zy3wu7ci7542" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3465">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z9ZTXYNTrxu" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zZfZtW4hTfvb" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">108,000</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zXIuCaIclsbg" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">131,360</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbIvODB8kxLb" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">122,325</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniRedentor</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zooFqLCww3d1" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zNfhLSfBRWn8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,662</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zci9L4EpLiI7" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOr0ulV5Ag" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">121,477</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zXrgIGCutbea" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">246,320</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zV7tIYVAlFLl" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">253,370</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniSL</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zIg3R16vOWyl" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zfBfvoywZNuh" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,420</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zVKFXgAP3Xal" title="Licenses with indefinite useful life" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">249,387</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zCKJwtd6cwX" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">249,387</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zn4nr0KHUH56" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">305,044</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zYlwgzZ2e4yd" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">258,234</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FESAR</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zSQ4xRAHWTva" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zrLi267lEdF8" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">71,664</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zEEI52Bztufk" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgVdNu8bS2xf" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">141,616</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z964NDcXsZK3" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">279,038</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zjHsiwYHJuRh" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">263,914</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FCMPB</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3Rkn0Ao1yFl" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmQn89lLYon" title="Goodwill" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">110,483</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN7qrDgglIF" title="Licenses with indefinite useful life" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYNYf4vh1LAe" title="Licenses with indefinite useful life" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">235,018</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYvScuJiCTg9" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">401,244</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNFFAxDs88z3" title="Cash generating units" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">380,682</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Practice
    Management Tools &amp; Electronic Prescription</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zQBq792otTv6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">113,362</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zLHyWfz1RyZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zuSb1p53M0K1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">227,909</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Clinical
    Decision Software</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z5TusdNxsOOh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,018</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zhQ298J9oL8b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,018</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z7J9B7c8kWKg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3527">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z2df3kzHhzJg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">147,592</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zxB4PyWZpbI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">149,805</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medical
    Harbour</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zM6Ahi9d9bcb" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,022</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zXQs57WQt4Pb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z1hnh4QgkZrf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,150</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Moc</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_z5CwvpIq3x8j" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">87,777</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zaYmPTngbDOc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">184,597</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zGWUL66Ru19k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,649</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zYQ5lD9Dv0r8" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">356,789</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zbpEn8piGm3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,230</ix:nonFraction></span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Unigranrio</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKgF53O2SEEc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">130,073</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z9WlEuJYLFRe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">421,538</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zMTF6mdjYZnf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">630,185</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">RXPRO</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zuO3hAGg5vKc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:Goodwill" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,446</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zL5HKRinwMAk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zkCZQE0iPnsc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:CashGeneratingUnits" contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">46,788</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="width: 37%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zKnFfqu5FuT" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_z9LAT5xSQ9wg" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003544" xml:lang="en-US">CBBW as merged by Medcel on May 1,
2020.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A4_zJz10JLC0DNe" style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>The
main assumptions used by the Company to determine the value in use of the CGUs were:</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Student
enrollment</i> &#8211; refer to the number of students that are currently enrolled in each CGU.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Tuition fees
</i>&#8211; is the monthly fee charged to students.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Occupancy rate
</i>&#8211; the occupancy rate of the medical schools is the ratio of the number of <i>students effectively enrolled divided by the regulatory
capacity in a given period.</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Regulatory capacity
</i>&#8211; the regulatory capacity is defined by the number of medical schools seats available per year awarded by MEC, multiplied by
the number of years of operations since the seats were awarded.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Faculty &#8211;
</i>refer to the cost with faculty in the CGU, which means the amount paid to teachers and doctors.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Digital content
platform users </i>&#8211; refer to mobile app subscription, clinical management system, healthcare payments, medical imaging, online
courses for digital content users and marketing for pharmaceutical industry.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 233 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Capital expenditure
</i>&#8211; refers to investments to be made on intangible assets related to developments and platform improvements especially on the
digital services CGUs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Discount
rates</i> - discount rates represent the current market assessment of the risks specific to the CGU being tested. The pre-tax discount
rate applied to cash flow projections is <span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20211231_zTdloaaNAW3d" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.10</ix:nonFraction></span>% in 2021 (<span id="xdx_90B_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20201231_zcTO54Zv5HWj" title="Discount rate applied to cash flow projections"><ix:nonFraction name="ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">13.00</ix:nonFraction></span>% in 2020).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Significant
estimate: impact of possible changes in key assumptions</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zuJWN0TfAbm9" title="Description of key assumptions on which management has based cash flow projections"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember" name="ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">An
increase of 25 basis points in management&#8217;s estimated discount rate applied to the cash flow projections of each CGU for the year
ended December 31, 2021, or a decrease of 25 basis points on estimated EBITDA would have not resulted in significant impacts on these
financial statements.</ix:nonNumeric></span></span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Other
intangible assets</span></p>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #365F91"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets,
other than goodwill and licenses with indefinite useful lives, are valued separately for each acquisition and are amortized during each
useful life. The useful lives and methods of amortization of other intangibles are reviewed at each financial year end and adjusted prospectively,
if appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock"><p id="xdx_89B_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zDhySJj7Mhya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The estimated useful
lives of intangible assets are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zNmiBNZ2nE37" style="display: none; visibility: hidden">Schedule of estimated useful lives</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; medicine</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_ztZshgpE3eKe" title="Estimated useful lives of intangible assets::XDX::P6Y"><span style="-sec-ix-hidden: xdx2ixbrl3554">6</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zT0Z181dGW43" title="Estimated useful lives of intangible assets::XDX::P4Y6M"><span style="-sec-ix-hidden: xdx2ixbrl3556">4.5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Software
    license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zKckB0ycDaJi" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3558">5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Education
    content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVci0b1UmKDa" title="Estimated useful lives of intangible assets::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl3560">3</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxGX5pwOIP32" title="Estimated useful lives of intangible assets::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl3562">2</span></span>
    - <span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLHLgPUum7Gd" title="Estimated useful lives of intangible assets::XDX::P30Y"><span style="-sec-ix-hidden: xdx2ixbrl3564">30</span></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Developed
    technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zteOoECwHqFj" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3566">5</span></span>
    years</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zzCjzXUwfrkb" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the years ended
December 31, 2021, 2020 and 2019, there were no indicatives that the Company&#8217;s intangible assets with finite useful lives might
be impaired.</span></p>

</ix:nonNumeric><p id="xdx_81D_zBfQksefQ6h5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
<!-- Field: Split-Segment; Name: Segment%2D2 -->
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfFinancialInstrumentsExplanatory"><p id="xdx_803_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zo4u4iFsuux5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zDSjz8RFnzF7">Financial
                                            assets and financial liabilities</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:FinancialAssetsExplanatory"><p id="xdx_891_ecustom--FinancialAssetsExplanatory_zc1c86qjZ8bl" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets </b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zGIRecehDRH5" style="display: none; visibility: hidden">Schedule of financial assets</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 62%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and cash equivalents</span></td>
    <td id="xdx_980_eifrs-full--CashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z03ZdlVAmuyj" title="Cash and cash equivalents" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">748,562</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z9DzQt2fYyue" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CashAndCashEquivalents" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,045,042</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_98B_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zMOE0qi3k7wb" title="Restricted cash" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3576">-</span></span></td>
    <td id="xdx_985_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbZGaXJax9pj" title="Restricted cash" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables</span></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zojqVaJ0ymYc" title="Trade receivables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">405,793</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--TradeReceivables_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfM93KhBTTch" title="Trade receivables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeReceivables" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">309,944</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zSJzBDSCrOa7" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,154,355</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zQhQFzLRiiS4" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,357,039</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_984_eifrs-full--CurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRFOlrs3xDBe" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,126,913</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--CurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zYU2OCkrM039" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialAssets" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,347,359</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zPTsNaCmALXj" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zKdgR5H3ZhF9" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialAssets" contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,680</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AD_z20UFcfpWMLa" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial instruments
at amortized cost include trade receivables and cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:FinancialLiabilitiesExplanatory"><p id="xdx_897_ecustom--FinancialLiabilitiesExplanatory_z1BtDbTpK2P7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_zMFltixnOV3b" style="display: none; visibility: hidden">Schedule of financial liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            liabilities</b></span></td></tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGujMwpBIsql" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,098</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z9RVWJNX8MOf" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,743</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zJsr3bK2PUq4" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzQW49rQgfa2" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zqnByovspL8c" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zB7ahHdc6D5k" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5pX9tYOjdF" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zo6A68v69oyf" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_985_ecustom--NotePayable_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zwj5XlxPbf38" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayable" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--NotePayable_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z3WKaiaMZMuf" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayable" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_98A_eifrs-full--Advances_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zkRg48MJ5Vyb" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,585</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGyTy7ai7HR7" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,839</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBjRb4vqEDJg" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,015,196</ix:nonFraction></b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5ePpUjn3h7e" title="Total" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,759,191</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_985_eifrs-full--CurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5UTx4cF9Dvf" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">581,685</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFFsBL9CLegh" title="Current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentFinancialLiabilities" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">467,643</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zfYOj0W3Ax72" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,433,511</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zEsJHwwCVhHe" title="Non-current" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentFinancialLiabilities" contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,291,548</ix:nonFraction></span></td></tr>
  </table>

</ix:nonNumeric><p id="xdx_8A4_zSAP4gbQumZe" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<ix:exclude><!-- Field: Page; Sequence: 234 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 4pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Loans
                                            and financing</b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:LoansAndFinancingExplanatory"><p id="xdx_892_ecustom--LoansAndFinancingExplanatory_zTt3dLIkxESj" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B8_zm3SzwoyE2Kf" style="display: none; visibility: hidden">Schedule of loans and financing</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    institution</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zB9RXIJFJVAj" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember" id="Fact003635" name="afya:FinancialInstitution">Banco
    Ita&#250; Unibanco S.A</ix:nonNumeric></span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F22_zmBicpqB3fhl">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zYR9l0wMdXAj" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember" id="Fact003637" name="ifrs-full:BorrowingsInterestRateBasis">CDI
    + 1.62% p.y.</ix:nonNumeric></span></td>
    <td id="xdx_984_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zMd6gF9kkEXl" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember" id="Fact003639" name="ifrs-full:BorrowingsMaturity">2023</ix:nonNumeric></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zuLdcpeoqIm2" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentyThreeMember" id="Fact003641" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">510,972</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_z8n583HwbbKg" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_custom_TwentyTwentyThreeMember" id="Fact003643" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">504,365</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zgOHluBj2Edd" title="Financial institution"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember" id="Fact003645" name="afya:FinancialInstitution">Banco
    Votorantim</ix:nonNumeric></span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zZnlxaKoTEe1" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember" id="Fact003647" name="ifrs-full:BorrowingsInterestRateBasis">CDI
    + 1.65% p.y.</ix:nonNumeric></span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zlhSjcf7D22h" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember" id="Fact003649" name="ifrs-full:BorrowingsMaturity">2021</ix:nonNumeric></span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zqYSXD2EwY69" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3651">-</span></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_z5UcOoeiRcrj" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_custom_TwentyTwentyOneMember" id="Fact003653" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">101,785</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zljZDy8OCAea" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember" id="Fact003654" name="afya:FinancialInstitution">BNDES</ix:nonNumeric>
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F2B_zA7LUbK9optk">(c)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_980_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zsDgiQxc1D7f" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember" id="Fact003656" name="ifrs-full:BorrowingsInterestRateBasis">10.03%
    p.y.</ix:nonNumeric></span></td>
    <td id="xdx_988_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zHIVWpm4A1qa" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember" id="Fact003658" name="ifrs-full:BorrowingsMaturity">2024</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_z9kLfBNBI75e" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3660">-</span></span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zvyskOp0QlWj" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_custom_TwentyTwentyFourMember" id="Fact003662" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">471</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_903_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zBok37LEBPij" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember" id="Fact003663" name="afya:FinancialInstitution">FINEP</ix:nonNumeric>
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F22_zkOEk5Nuq1Jf">(d)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zzIAMQ110FRc" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember" id="Fact003665" name="ifrs-full:BorrowingsInterestRateBasis">TJLP
    p.y.</ix:nonNumeric></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zko24wZWX3o2" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember" id="Fact003667" name="ifrs-full:BorrowingsMaturity">2027</ix:nonNumeric></span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zTicJgL5xpwi" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentySevenMember" id="Fact003669" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,145</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zcXkhNP30Wk3" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_custom_TwentyTwentySevenMember" id="Fact003671" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,864</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zdnl6BDqLCDg" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember" id="Fact003672" name="afya:FinancialInstitution">Softbank</ix:nonNumeric>
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F20_zUULCq1sRBM7">(f)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_z832kBOIMMog" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember" id="Fact003674" name="ifrs-full:BorrowingsInterestRateBasis">6.5%
    p.y.</ix:nonNumeric></span></td>
    <td id="xdx_982_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zFq3Wb4wpEId" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember" id="Fact003676" name="ifrs-full:BorrowingsMaturity">2026</ix:nonNumeric></span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zKDjFTAF4TX7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentySixMember" id="Fact003677" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">822,560</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zwnfUFyxiuq8" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member" id="Fact003678" name="afya:FinancialInstitution">Banco
    Ita&#250; Unibanco S.A</ix:nonNumeric></span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F2D_zlY8kskBqIVc">(e)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zYzY8fAL4UI8" title="Interest rate" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member" id="Fact003680" name="ifrs-full:BorrowingsInterestRateBasis">CDI
    + 1.75% p.y.</ix:nonNumeric></span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zV5azFwWzxGg" title="Maturity" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member" id="Fact003682" name="ifrs-full:BorrowingsMaturity">2024</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zyyrDty0YKDc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_custom_TwentyTwentyFour1Member" id="Fact003683" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,199</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20211231_zXcbIvravYPk" title="Loans and financing" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LoansAndFinancing1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20201231_zjjxY0DZLkTi" title="Loans and financing" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LoansAndFinancing1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingCurrent_iI_c20211231_z1tnahTyvGs6" title="Current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">128,720</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--LoansAndFinancingCurrent_iI_c20201231_zEnAh2msUbJ8" title="Current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,162</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancingNonCurrent_iI_c20211231_z2AMx6ZuXH0i" title="Non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,246,156</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancingNonCurrent_iI_c20201231_zRMYJYTEENb1" title="Non-current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancingNonCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">510,323</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0A_zTi7mUqwIWO1" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_z51L1HBzMn4b" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003696" xml:lang="en-US">On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2020-10-01_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">500,000</ix:nonFraction></span> adjusted by the CDI rate plus an interest rate of
<span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb"><ix:nonFraction name="afya:IntrestRate" contextRef="AsOf2020-10-01_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.62</ix:nonFraction></span>% per year and is repayable in three installments in October 2022, April 2023 and October 2023.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zalDbRqnSNfk" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_z810umuNjO51" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003699" xml:lang="en-US">On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ <span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,000</ix:nonFraction></span> adjusted by the CDI rate plus an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l"><ix:nonFraction name="afya:IntrestRate" contextRef="AsOf2020-07-03_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.65</ix:nonFraction></span>%
per year and was repaid at maturity on July 5, 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_z9k3Dh9scuNh" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F18_zwCXLV6lCHHe" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003702" xml:lang="en-US">On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk"><ix:nonFraction name="afya:IntrestRate" contextRef="AsOf2020-05-20_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.03</ix:nonFraction></span>% per year and maturity in 2024.
This amount was prepaid in September 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F05_z42M0s1Bbhib" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_zYD7jefjnWq1" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003704" xml:lang="en-US">On July 23, 2019, Medcel entered
into a loan of R$ <span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,153</ix:nonFraction></span> with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$<span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche"><ix:nonFraction name="afya:BorrowingsAmountFirstTranche" contextRef="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,734</ix:nonFraction></span> and R$<span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche"><ix:nonFraction name="afya:BorrowingsAmountFirstTranche" contextRef="From2020-12-222020-12-23_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,130</ix:nonFraction></span>, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zlqH3DSjUbDg" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F19_z79xim6Tpy76" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003711" xml:lang="en-US">On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount"><ix:nonFraction name="ifrs-full:NotionalAmount" contextRef="AsOf2020-10-23_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,000</ix:nonFraction></span>. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of <span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate"><ix:nonFraction name="afya:IntrestRate" contextRef="AsOf2021-06-30_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">1.75</ix:nonFraction></span>% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zJ7yTusJG991" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F17_zsY2G5AhKIb3" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003716" xml:lang="en-US">On April 26, 2021, the Company issued
and sold <span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares"><ix:nonFraction name="ifrs-full:NumberOfSharesAuthorised" contextRef="AsOf2021-04-26" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">150,000</ix:nonFraction></span> shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$<span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8"><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="AsOf2021-04-26" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">0.00005</ix:nonFraction></span> per share of the Company for US$<span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5"><ix:nonFraction name="ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset" contextRef="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">150,000</ix:nonFraction></span> thousands, equivalent to R$ <span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9"><ix:nonFraction name="ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset" contextRef="From2021-04-242021-04-26" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">821,805</ix:nonFraction></span> on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A5_zIfvgl7MHz9j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 235 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Each Series A perpetual
convertible preferred share is entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into
the Company&#8217;s Class A common shares at an initial conversion price of US$25.35. The Company may require the conversion of any or
all of the Series A perpetual convertible preferred shares at any time on or after the three-year anniversary of the original issuance
date if certain conditions set forth in the certificate of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s
stock price is equal or above 150% of the conversion rate). The Company may also redeem any or all of the Series A perpetual convertible
preferred shares for cash, shares of its common shares or a combination thereof at its election, at any time on or after the seven-year
anniversary of the original issuance date as determined in the certificate of designation. On or after the five-year anniversary of the
original issuance date, the holders of the Series A convertible perpetual preferred shares shall have the right to redeem all of the
outstanding Series A convertible perpetual preferred shares for cash, the Company&#8217;s common shares or a combination thereof (at
the Company&#8217;s election, subject to certain conditions) to be determined in the certificate of designation. Upon the occurrence
of a change of control, the holders will have the right to redeem their Series A convertible perpetual preferred shares for cash at a
price set forth in the certificate of designation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Series A convertible
perpetual preferred shares will be entitled with the same voting rights of the common shares only when converted into it.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company determined
that the Series A perpetual convertible preferred shares should be classified as financial liability at amortized cost upon their issuance
since is redeemable primarily according to the decision of the holder and there is a contractual obligation to deliver assets (cash,
shares of its common shares or a combination thereof) that could not be avoided by the Company in an event of redemption. The financial
liability is denominated in Brazilian Reais and thus not subject to foreign exchange changes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In addition, as
the entire instrument is classified as a liability, the embedded put option to redeem the Series A perpetual convertible preferred shares
for cash is an embedded derivative. The embedded derivative will not be treated separately once the exercise price of the option is closely
related to the host contract.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The initial transaction
costs that are directly attributable to the issuance of Series A perpetual convertible preferred shares were measured at fair value together
with the financial liability on initial measurement. The transaction costs totaled R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210101__20211231_z7V09DW8wQTk" title="Transaction costs"><ix:nonFraction name="ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">13,030</ix:nonFraction></span>, including legal counsels and advisors.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 236 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Leases</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
lease contracts for properties. The lease contracts generally have maturities in the lease terms between <span id="xdx_906_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEbEKLnEajnl" title="Contractual lease term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3725">5</span></span> and <span id="xdx_90D_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zPBvxHEPo68" title="Contractual lease term::XDX::P30Y"><span style="-sec-ix-hidden: xdx2ixbrl3727">30</span></span> years. There are no
sublease or variable payments in-substance lease agreements in the period.</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:LeasesExplanatory"><p id="xdx_895_ecustom--LeasesExplanatory_zdFVv4xpSlk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_z2Ngwn0Scl7d" style="display: none; visibility: hidden">Schedule of right-of-use assets and lease liabilities</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Set out below are
the carrying amounts of right-of-use assets and lease liabilities and the movements during the period</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use
    assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20200101__20201231_zqMCxYvkXOH5" title="Right-of-use assets, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">274,275</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_c20200101__20201231_z13elCLROPzc" title="Lease liabilities, balance at beginning" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,515</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_c20200101__20201231_z6IRPRU2zli2" title="Right-of-use assets, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,743</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_c20200101__20201231_zEwb6VKoZrvg" title="Lease liabilities, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,743</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_c20200101__20201231_znnBIG4RpgMl" title="Right-of-use assets, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,161</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_c20200101__20201231_z8Q38gDPoVci" title="Lease liabilities, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">34,161</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsBusinessCombinations_c20200101__20201231_zQIMNbNUtEF6" title="Right-of-use assets, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,855</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--BusinessCombinationsLeaseLiabilities_c20200101__20201231_zmBMNPscqWfj" title="Lease liabilities, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,855</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20200101__20201231_zxJRBXE0VABi" title="Right-of-use assets, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">29,386</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--DepreciationExpenseLeaseLiabilities_c20200101__20201231_ztoJHksNIQwj" title="Lease liabilities, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_c20200101__20201231_zSJL3sOUeBic" title="Right-of-use assets, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3751">-</span></span></td>
    <td id="xdx_98E_eifrs-full--InterestExpenseOnLeaseLiabilities_c20200101__20201231_ztdCIYhn2xd7" title="Lease liabilities, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,458</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20200101__20201231_zRHrFTjKobl6" title="Right-of-use assets, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20200101__20201231_zZmFBezSUrib" title="Lease liabilities, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,455</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsDisposals_c20200101__20201231_zfklWTEvp40a" title="Right-of-use assets, disposals" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:RightofuseAssetsDisposals" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,574</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--LeaseLiabilitiesDisposals_c20200101__20201231_zT6cJrMY9Jad" title="Lease liabilities, disposals" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesDisposals" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,574</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iS_c20210101__20211231_zsmJlIEdwvV9" title="Right-of-use assets, balance at ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,074</ix:nonFraction></b></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesRightToUse_iS_c20210101__20211231_z1WBXaNYsR7c" title="Lease liabilities, balance at beginning" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LeaseLiabilitiesRightToUse" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20210101__20211231_z7BMii514BZ2" title="Right-of-use assets, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionsToRightofuseAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,689</ix:nonFraction></span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_c20210101__20211231_zuERlh8VD2Qf" title="Lease liabilities, additions" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AdditionsToLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,689</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsRemeasurement_c20210101__20211231_zNgO35WReje3" title="Right-of-use assets, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsRemeasurement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,962</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesRemeasurement_c20210101__20211231_ze9Od1Y85TQa" title="Lease liabilities, remeasurement" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LeaseLiabilitiesRemeasurement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">95,962</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsBusinessCombinations_c20210101__20211231_z26LFNnLEpt4" title="Right-of-use assets, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsBusinessCombinations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--BusinessCombinationsLeaseLiabilities_c20210101__20211231_zEnCU0VThshd" title="Lease liabilities, business combinations" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BusinessCombinationsLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20210101__20211231_zgUpk7wCIWPk" title="Right-of-use assets, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationRightofuseAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,237</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--DepreciationExpenseLeaseLiabilities_c20210101__20211231_zDzLXE6FWy5l" title="Lease liabilities, depreciation expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3781">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_c20210101__20211231_zVNxOroU8ceb" title="Right-of-use assets, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3783">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_c20210101__20211231_zOZ5mQKnk673" title="Lease liabilities, interest expense" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpenseOnLeaseLiabilities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20210101__20211231_z98zlrLmRQc1" title="Right-of-use assets, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3787">-</span></span></td>
    <td id="xdx_982_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20210101__20211231_z8n1QD5C6SMd" title="Lease liabilities, payments of lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">87,751</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsDisposals_c20210101__20211231_zNzxQZuSvoyh" title="Right-of-use assets, disposals" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:RightofuseAssetsDisposals" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,316</ix:nonFraction>)</span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesDisposals_c20210101__20211231_zPa9mSlSONS3" title="Lease liabilities, disposals" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesDisposals" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,244</ix:nonFraction>)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20210101__20211231_zqh7jc5JGnUa" title="Right-of-use assets, balance at ending" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RightofuseAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></b></span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitieRightToUse_iE_c20210101__20211231_z9HvVroLhE3i" title="Lease liabilities, balance at ending" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:LeaseLiabilitieRightToUse" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsCurrent_iI_c20201231_zRgyXsBj6bpg" title="Right-of-use assets, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3799">-</span></span></td>
    <td id="xdx_980_eifrs-full--CurrentLeaseLiabilities_iI_c20201231_zaok1A04GPYg" title="Lease liabilities, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,976</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_c20201231_zf8S8erXCa0i" title="Right-of-use assets, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">419,074</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_c20201231_zDVL5zRrc4Wj" title="Lease liabilities, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">385,727</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current </span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_c20211231_zzBoYoAOHOW8" title="Right-of-use assets, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3807">-</span></span></td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_c20211231_zH8nfPFzdmg4" title="Lease liabilities, current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:CurrentLeaseLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,955</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsNonCurrent_iI_c20211231_znL8zaOo0366" title="Right-of-use assets, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RightofuseAssetsNonCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">663,686</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLeaseLiabilities_iI_c20211231_z7rV6IKfaR4c" title="Lease liabilities, non-current" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentLeaseLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">689,130</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zJVZs6BUTinl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company reassessed
its current versus non-current segregation methods for the year ended December 31, 2021. The current lease liabilities balances are presented
as the amount expected to be amortized from the principal in the next twelve months.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognized
lease expense from short-term leases and low-value assets of R$ <span id="xdx_906_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20210101__20211231_zUBwunBlu2J9" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">11,229</ix:nonFraction></span> for the year ended December 31, 2021 (R$ <span id="xdx_902_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20200101__20201231_zhznklNszsi1" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">2,555</ix:nonFraction></span> and R$ <span id="xdx_90B_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20190101__20191231_zwB0Ni97VgFg" title="Amount recognized lease expense from short-term leases and low-value assets"><ix:nonFraction name="ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">4,494</ix:nonFraction></span> for
the years ended December 31, 2020 and 2019).</span></p>


<ix:exclude><!-- Field: Page; Sequence: 237 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Accounts
                                            payable to selling shareholders</b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:AccountsPayableToSellingShareholdersExplanatory"><p id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_zwneqjNLUICj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zdyavAhnUimd" style="display: none; visibility: hidden">Schedule of accounts payable to selling shareholders</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IESP <sup id="xdx_F4E_zWKVmswV4FW1">(a)</sup></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z85FAX0S8Bqk" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3823">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmq4trAf5RP9" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,771</ix:nonFraction>
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FASA <sup id="xdx_F4F_zZK2jTl7IkOk">(b)</sup></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zHDyYiE9Zvc8" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,581</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zn7o6AOm8RN2" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,356</ix:nonFraction>
    </span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEMED <sup id="xdx_F41_zn0dW2zvySV2">(c)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z0JJNT8ctO73" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">30,233</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z6FOyUFC0rpb" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">38,622</ix:nonFraction>
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC <sup id="xdx_F42_zqshtSFUUJp1">(d)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zTVdM1GIN6T1" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Gyn0T3qRkc" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">28,307</ix:nonFraction>
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniRedentor <sup id="xdx_F43_z60A7817VGR6">(e)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z1WnX2DYQNdk" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85,506</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zhGM91ycQBNl" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">97,773</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniS&#227;oLucas <sup id="xdx_F43_zh0awc82kzx3">(f)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zadNHOjGgTLi" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">42,672</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z2UTq3y6tC3k" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,386</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FCMPB <sup id="xdx_F45_zETWa31mD7Ma">(g)</sup></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6jFf3ch3JY3" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">149,175</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN2ftEHazwa1" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">189,420</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FESAR <sup id="xdx_F48_zgceDiGCoM72">(h)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z7FFdVFhYtgj" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5MX6rtar9Y2" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_FESARMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,569</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of MEDPHONE <sup id="xdx_F4D_zXuPicD2So23">(i)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zrCRWkNvLQtl" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zfitZgNNXH7k" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_MedPhoneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medicinae <sup id="xdx_F47_zGPDRY4hsnCi">(j)</sup></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zq7q1Uv4FbU5" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_MedicinaeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,887</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medical Harbour <sup id="xdx_F47_zzd3kqoEQ6R">(k)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znSSTKulYKoj" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_MedicalHarbourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,801</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Cliquefarma <sup id="xdx_F4E_zFJxLok3zxa7">(l)</sup></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z3uHvbCFHZJ4" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_CliquefarmaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,050</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Shosp <sup id="xdx_F46_zQwb0PHQiFif">(m)</sup></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2DjnXTO02Zh" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_ShospMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,141</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Unigranrio <sup id="xdx_F43_zJGhKY3IkE9e">(n)</sup></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z6o6KrnXQkh4" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_UnigranrioMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">249,979</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of RXPRO <sup id="xdx_F4B_zypPFxudJAOg">(o)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zZw1MMFKcix9" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_RXPROMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,245</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Guaranhuns <sup id="xdx_F43_zZ0sTE37enL5">(p)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zGa2EMCQqlmd" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_GuaranhunsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,556</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20211231_zZaewIbiNLVb" title="Accounts payable to selling shareholders" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedParties1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20201231_zEfXZBdmg33d" title="Accounts payable to selling shareholders" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedParties1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20211231_zZR0JQXDprzk" title="Current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,849</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20201231_zaKv1YAlf93j" title="Current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,420</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20211231_z3UJBu42wWw" title="Non-current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">439,977</ix:nonFraction></span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20201231_z6BKJz3iTOxe" title="Non-current" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersNonCurrent" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">329,820</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ziNL8qn9OVxc" title="Opening balance" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyBh4I5Cyeoj" title="Opening balance" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">300,237</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsPtTtFyRWVk" title="Opening balance" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">177,730</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    flows</span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholderCashFlows_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRba8aLk3XMc" title="Cash flows" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">192,681</ix:nonFraction>)</span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholderCashFlows_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsMXqxUmkyO6" title="Cash flows" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">134,518</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholderCashFlows_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zekqO0N1Y1U4" title="Cash flows" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AccountsPayableToSellingShareholderCashFlows" contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">92,688</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC and Guaranhus</span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zlf0ViKTCJt6" title="Acquisition of IPEC" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmet3t8zdbK6" title="Acquisition of IPEC" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec" contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98C_eifrs-full--InterestExpense_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zh1XghtwXkw4" title="Interest" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,915</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--InterestExpense_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkQW4S3oAsn9" title="Interest" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,884</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z6jYxkHuRfg4" title="Interest" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InterestExpense" contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">17,977</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Installments
    on Business combinations</span></td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zBrFwYQP07c1" title="Business combinations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,816</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zGWbt4hfcmj4" title="Business combinations" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">343,140</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk5EcJ66v1Te" title="Business combinations" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:AccountsPayableToSellingShareholdersBusinessCombinations" contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">144,538</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Contingent
    consideration on Business combinations</span></td>
    <td id="xdx_981_ecustom--ContingentConsiderationOnBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze99p5bfPpuc" title="Contingent consideration on Business combinations" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ContingentConsiderationOnBusinessCombinations" contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,536</ix:nonFraction></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation
    of legal proceedings disbursement</span></td>
    <td id="xdx_988_ecustom--CompensationOfLegalProceedingsDisbursement_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zYlPrTpTTmq9" title="Compensation of legal proceedings disbursement" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></span></td>
    <td id="xdx_98B_ecustom--CompensationOfLegalProceedingsDisbursement_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zfUU8fxRnMHa" title="Compensation of legal proceedings disbursement" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:CompensationOfLegalProceedingsDisbursement" contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,503</ix:nonFraction>)</span></td>
    <td id="xdx_98F_ecustom--CompensationOfLegalProceedingsDisbursement_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze4tL1PZawPa" title="Compensation of legal proceedings disbursement" style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:CompensationOfLegalProceedingsDisbursement" contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,320</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing
    balance</b></span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20211231_zwWMZDfdXzz" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedParties2" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20201231_zzYBtX29kCH2" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedParties2" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20191231_zkeE4Pu6R6H7" title="Closing balance" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedParties2" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">300,237</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zv63289LzEth" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1B_zgUAj77fQk92" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003926" xml:lang="en-US">On November 27, 2018, Afya Brazil
acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20180101__20181231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z4qWcJqh1xUd" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2018-01-012018-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">80</ix:nonFraction></span>% of IESP and R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zVuTOntw0072" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">106,200</ix:nonFraction></span> is payable in three equal installments of R$<span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zxKyqP5yhY" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,400</ix:nonFraction></span>, each adjusted by the CDI rate through the payment
date. The remaining installment was paid in November 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zhZQQRjmtG75" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_z3QFuTYoEqH6" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003933" xml:lang="en-US">On April 3, 2019, Afya Brazil acquired
<span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z7XnVlpSfqu8" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2019-01-012019-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">90</ix:nonFraction></span>% of FASA and R$ <span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zs0rUtxXi5Cf" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,695</ix:nonFraction></span> was paid in April 2020, R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zaXdD0P8Fxh2"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,770</ix:nonFraction></span> was paid in April, 2021, and R$ <span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20220403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zq18SwOoMG7"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2022-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">29,770</ix:nonFraction></span> is payable in April 2022; each installment
adjusted by the IPCA rate + 4.1% per year.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zNn6SbNXKow6" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F14_zpiGi8IUG3Y9" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003940" xml:lang="en-US">On May 9, 2019, Afya Brazil acquired
<span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zO6RGgnXR905" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of IPEMED and R$ <span id="xdx_903_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zJRChPwWv7A8" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">45,303</ix:nonFraction></span> is payable in five equal installments of R$ <span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zb0l4ohzl159" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties1" contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,061</ix:nonFraction></span>, adjusted by the CDI rate, and due annually in February
2020, 2021, 2022, 2023 and 2024.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zOt4w6Wkxz28" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_zLyO0cSJD5h7" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003947" xml:lang="en-US">On August 13, 2019, Afya Brazil
acquired <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zC8nvwJKAmlb" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of IPEC and R$<span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190813__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zc3VTX2xZwO" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2019-08-13_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span> is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the
first and the second year from the transaction closing date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zXafWS45PoGj" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zvV6Q4UkBYs1" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003952" xml:lang="en-US">On January 31, 2020, Afya Brazil
acquired <span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zemKfTaWOCW" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_UniRedentorMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of UniRedentor and R$<span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF8be0Lxbtbd" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-01-31_custom_UniRedentorMember1110236375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">100,000</ix:nonFraction></span> is payable in five equal installments from January 2021 through July 2024, adjusted by the
CDI rate. The purchase consideration was adjusted by R$<span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zSOwnFQiVdd8" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2020-01-31_custom_UniRedentorMember1110236375" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,503</ix:nonFraction></span> and such amount was deducted from the first installment paid in February
2021.</ix:footnote></span></td>
</tr></table>


<ix:exclude><!-- Field: Page; Sequence: 238 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zB57gfdzaN2k" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F13_z4kvTsPsM6M6" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003959" xml:lang="en-US">On May 5, 2020, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zZJFOvx7ivQl" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_UniSLMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of UniSL and R$ <span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zkx4sLnWGaZ7" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-05-05_custom_UniSLMember1110236484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,456</ix:nonFraction></span> is payable in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration
was adjusted by R$<span id="xdx_904_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zHcxL6Efv0dg" title="Equal installments payables"><ix:nonFraction name="afya:EqualInstallmentsPayablesToRelatedParties" contextRef="AsOf2020-05-05_custom_UniSLMember1110236484" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,816</ix:nonFraction></span> and such amount was deducted from the first installment paid on May 5, 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F06_z35OSOwAaon2" style="font-family: Arial, Helvetica, Sans-Serif">(g)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1F_zcGrR7lQ5R4j" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003966" xml:lang="en-US">On November 9, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zPVFC9IyMQPl" title="Ownership Interest"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of FCMPB and R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZRPKMvZBp69" title="Remaining accounts payable"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-11-09_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">188,894</ix:nonFraction></span> is payable in four installments through November 2024, adjusted by the CDI rate.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F04_zBAR9sLU1I7f" style="font-family: Arial, Helvetica, Sans-Serif">(h)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_ziEfKwWW2PD6" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003971" xml:lang="en-US">On November 3, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwuk4GghLIe4"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of FESAR paid in cash and R$<span id="xdx_903_ecustom--CashTransferredTransaction_iI_c20201103_zaQWkcVVQ525" title="Cash on the transaction closing date"><ix:nonFraction name="afya:CashTransferredTransaction" contextRef="AsOf2020-11-03" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,569</ix:nonFraction></span> of price adjustment was paid on February 25, 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0C_z7wRV9wy7h85" style="font-family: Arial, Helvetica, Sans-Serif">(i)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_zF4qniF3CIa" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003975" xml:lang="en-US">On November 4, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNx2GJ2g6oik"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2020-01-012020-12-31_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of MedPhone paid in cash and R$<span id="xdx_902_ecustom--CashTransferredTransaction_iI_c20201104_zIuX9r673xQ5"><ix:nonFraction name="afya:CashTransferredTransaction" contextRef="AsOf2020-11-04" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36</ix:nonFraction></span> of price adjustment was paid on February 2, 2021.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zYhXumGsklLl" style="font-family: Arial, Helvetica, Sans-Serif">(j)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F10_zvrhRBRUHY3c" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003978" xml:lang="en-US">On March 25, 2021, Afya Brazil acquired
<span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210323__20210325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zO6SyjqODtod"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-03-232021-03-25_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Medicinae and an earn-out (&#8220;contingent consideration&#8221;) of up of R$ <span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210305__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBEDWkEbyHn1"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-03-05_custom_UniSLMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,400</ix:nonFraction></span> is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$<span id="xdx_907_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210325_zj2gQJModqXk"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2021-03-25" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,887</ix:nonFraction></span> is based on the present value of the obligation
considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition
date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0B_zmrfcFiYSna2" style="font-family: Arial, Helvetica, Sans-Serif">(k)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1F_zKH6Z5xMI421" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003982" xml:lang="en-US">On April 8, 2021, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210408__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zCwaNP6gbIkc"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-04-082021-04-08_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Medical Harbour and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_900_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zWiugvjBH466"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-04-08_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,000</ix:nonFraction></span> is payable in relation to product development
goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$<span id="xdx_902_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210408_ztq8TsDI9bo3"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2021-04-08" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,801</ix:nonFraction></span> is based on the present value of the
obligation considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from
the acquisition date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_zic2lNOonq9k" style="font-family: Arial, Helvetica, Sans-Serif">(l)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_zAzhkm1LyH9d" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003986" xml:lang="en-US">On April 16, 2021, Afya Brazil acquired
<span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210416__20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZBAEeUDaQ4a"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-04-162021-04-16_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Cliquefarma and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z1aWp9bANHv6"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-04-16_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000</ix:nonFraction></span>, adjusted by the CDI rate, is payable in relation
to product development. The contingent consideration of R$<span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210416_zhVJ13vYYy8a"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2021-04-16" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,050</ix:nonFraction></span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zimx5sAe3Q5a" style="font-family: Arial, Helvetica, Sans-Serif">(m)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F16_z3Ypn6VwQW9c" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003990" xml:lang="en-US">On May 13, 2021, Afya Brazil acquired
<span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210513__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zbv1BsGfHWVf"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-05-132021-05-13_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Shosp and R$ <span id="xdx_906_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20210513_z3ZUFmEpUbO5"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-05-13" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">454</ix:nonFraction></span> will be paid, and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zGZHllMfQ7A3"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-05-13_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,793</ix:nonFraction></span> is payable in relation
to product development. The contingent consideration of R$ <span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210513_zp4A5zkvUaH8"><ix:nonFraction name="ifrs-full:DefinedBenefitObligationAtPresentValue" contextRef="AsOf2021-05-13" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,141</ix:nonFraction></span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zYxXw7KwaOEi" style="font-family: Arial, Helvetica, Sans-Serif">(n)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1C_z6d9bo4Byk1j" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003995" xml:lang="en-US">On August 4, 2021, Afya Brazil acquired
<span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210802__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zFSfON2j3lMc"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-08-022021-08-04_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of Unigranrio. The adjusted aggregate purchase price is R$ <span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_c20211004_zj5L1805Wg13"><ix:nonFraction name="ifrs-full:NoncurrentPayablesForPurchaseOfEnergy" contextRef="AsOf2021-10-04" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">618,956</ix:nonFraction></span> of which 60% was paid in cash on the transaction closing date,
and 40% is payable in cash in four equal installments through 2022 to 2025, adjusted by the CDI rate.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F03_zPYdaXJ54hLh" style="font-family: Arial, Helvetica, Sans-Serif">(o)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zG0eJg2Jb9i2" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote003998" xml:lang="en-US">On October 01, 2021, Afya Brazil
acquired <span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zoNgvH2MPTc7"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-10-012021-10-01_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of RXPRO and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZ9wnw1fvIOc"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-10-01_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,000</ix:nonFraction></span> is payable in relation to revenue
achievements until 2024. The contingent consideration of R$ <span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20221101_z7TP8wlyiZV8"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2022-11-01" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,245</ix:nonFraction></span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</ix:footnote></span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0D_zFBWHTxNp5Rc" style="font-family: Arial, Helvetica, Sans-Serif">(p)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F12_zHY8VC1ZsVP1" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote004002" xml:lang="en-US">On November 05, 2021, Afya Brazil
concluded the acquisition of <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211103__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwymGW7j6Drb"><ix:nonFraction name="ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" contextRef="From2021-11-032021-11-05_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of ITPAC Garanhuns and R$<span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20211105_zbhmCjeFIhad"><ix:nonFraction name="ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations" contextRef="AsOf2021-11-05" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span> was paid in cash on the transaction closing date, and (ii) R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zITzyB2teMSh"><ix:nonFraction name="afya:RemainingTradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-11-05_custom_FCMPBMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,000</ix:nonFraction></span>
is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the first and the second year from the
transaction closing date.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A9_zwVza87MlcMe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 239 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Notes
                                            payable</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">With
the acquisition of UniSL, Afya Brazil assumed notes payable regarding the previous acquisition of a portion of the operations of Universidade
Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018. Two of the UniSL campuses, located in the cities of Ji-Paran&#225;
and Porto Velho in the State of Rond&#244;nia, were acquired in such transaction. As of December 31, 2021, the notes payable of R$<span id="xdx_903_ecustom--NotesPayable1_iI_c20211231_zS5gl9hQJnTi" title="Notes payable"><ix:nonFraction name="afya:NotesPayable1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">72,726</ix:nonFraction></span>,
has a final maturity in 2023 and is adjusted by 100% of IPCA-E.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock"><p id="xdx_89F_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_z5DCGf8Y4wg8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B7_zJTQk38nruLk">Set out below are
the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020</span>:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Notes
    payable</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_982_ecustom--NotesPayables_iS_c20200101__20201231_zsgyxJTQLrq3" title="Notes payable beginning" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_987_ecustom--BusinessCombination_c20200101__20201231_zEpHfKXIrc2k" title="Business combination" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:BusinessCombination" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,526</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_983_ecustom--Payments_c20200101__20201231_z5s1hgd150E6" title="Payments" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,974</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_983_ecustom--MonetaryIndexation_c20200101__20201231_z5sFIIhY5sZ3" title="Monetary indexation" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MonetaryIndexation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,629</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_983_ecustom--NotesPayables_iE_c20200101__20201231_zKzhEKGuq7M3" title="Notes payable ending" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2021</span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iS_c20210101__20211231_zQj34gCMCMgj" title="Notes payable beginning" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_98E_ecustom--Payments_c20210101__20211231_zfnn8PvVPfJ5" title="Payments" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,068</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_982_ecustom--MonetaryIndexation_c20210101__20211231_zm5KCf2MpGn9" title="Monetary indexation" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:MonetaryIndexation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,613</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_985_ecustom--NotesPayables_iE_c20210101__20211231_zVJ4rjE8NzCe" title="Notes payable ending" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:NotesPayables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20201231_zk3AyucBk55l" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentLiabilities1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,503</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_988_ecustom--NoncurrentLiabilities1_iI_c20201231_zsrEYzmSBoid" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentLiabilities1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">65,678</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20211231_zqz2X3AcGCrj" title="Current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:CurrentLiabilities1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,478</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_987_ecustom--NoncurrentLiabilities1_iI_c20211231_zDsDEsuFnyb1" title="Non-current liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NoncurrentLiabilities1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,248</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zU7lpfOmnbmc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Fair
                                            values </b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:FairValuesExplanatory"><p id="xdx_89E_ecustom--FairValuesExplanatory_zZU9RxJtTm0f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zZOUXTUSAMNb">The table below
is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts
that are reasonable approximation of fair values:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_980_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zlSrl1jMBG5e" title="Financial assets, at carrying amount" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4039">-</span></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_ztw50xcwItNi" title="Financial assets, at fair value" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4041">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDWBYwMcpDag" title="Financial assets, at carrying amount" style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2020-12-31_custom_RestrictedCashMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDsTMBLsDEsh" title="Financial assets, at fair value" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2020-12-31_custom_RestrictedCashMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zoP3rH7SDWcg" title="Financial assets, at carrying amount" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_TradeReceivablesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zMmzoQSdPNfh" title="Financial assets, at fair value" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2021-12-31_ifrs-full_TradeReceivablesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zpDlE02rC7H5" title="Financial assets, at carrying amount" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2020-12-31_ifrs-full_TradeReceivablesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zw00yKc1rcl2" title="Financial assets, at fair value" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2020-12-31_ifrs-full_TradeReceivablesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231_zn9IsJRzjBp6" title="Financial assets, at carrying amount" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231_z9vAXN5tQtMg" title="Financial assets, at fair value" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231_zvDerqFpVeNi" title="Financial assets, at carrying amount" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,680</ix:nonFraction>
    </b></span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231_zzAU7wmjRS7c" title="Financial assets, at fair value" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialAssetsAtFairValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,680</ix:nonFraction>
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7eXKxNleE4i" title="Financial liabilities, at carrying amount" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zmiCnYGnHSse" title="Financial liabilities, at fair value" style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,387,136</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zwWZlHXPlce4" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z4cagkzuI0Ze" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">637,723</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqy3kpIDoFR1" title="Financial liabilities, at carrying amount" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zb4COTQVfhqc" title="Financial liabilities, at fair value" style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0tTACsYIcjc" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyu1EH2P2C0l" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zAExwPDUDcSa" title="Financial liabilities, at carrying amount" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_za8yg0zGZuNc" title="Financial liabilities, at fair value" style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zANRVRvAK3u1" title="Financial liabilities, at carrying amount" style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3KlOM3pM9mh" title="Financial liabilities, at fair value" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zwHQ6rpBhmC5" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrDFkE52IZtk" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2021-12-31_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zKd8zO5jweyk" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z5X9mEIKgvqe" title="Financial liabilities, at fair value" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2020-12-31_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231_zqheb4BLrFqj" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,841,513</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231_zEQQF9NjmRmb" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,853,773</ix:nonFraction></b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20201231_zqT8L7GErqU8" title="Financial liabilities, at carrying amount" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,659,609</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231_zzjde6jmSWKa" title="Financial liabilities, at fair value" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinancialLiabilitiesAtFairValue" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,679,847</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zTnT4uIAV0jk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company assessed that the fair values of cash and cash equivalents, current trade receivables and other current assets, trade payables,
advances from customers and other current liabilities approximate their carrying amounts largely due to the short-term maturities of
these instruments.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 240 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
fair value of interest-bearing borrowings and loans are determined by using the DCF method using discount rate that reflects the issuer&#8217;s
borrowing rate as of the end of the reporting period. The own non-performance risk at December 31, 2021 was assessed to be insignificant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            instruments risk management objectives and policies</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s principal financial liabilities comprise loans and financing, lease liabilities, accounts payable to selling shareholders,
notes payable, trade payables and advances from customers. The main purpose of these financial liabilities is to finance the Company&#8217;s
operations. The Company&#8217;s principal financial assets include trade receivables and cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company is
exposed to market risk, credit risk and liquidity risk. The Company monitors market, credit and liquidity risks in line with the objectives
in capital management and counts with the support, monitoring and oversight of the Board of&#160;Directors in decisions related to capital
management and its alignment with the objectives and risks. The Company&#8217;s policy is that no trading of derivatives for&#160;speculative
purposes may be undertaken. The Board of Directors reviews and agrees policies for managing each of these risks, which are summarized
below.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            instruments risk management objectives and policies</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
The Company&#8217;s exposure to market risk is related to interest rate risk and foreign currency risk.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The sensitivity
analysis in the following sections relate to the position as of December 31, 2021.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(i)
Interest rate risk</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company&#8217;s exposure to the risk of changes in market interest rates relates primarily to the Company&#8217;s
cash equivalents, loans and financing, accounts payable to selling shareholders and notes payable, with floating interest rates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Sensitivity
analysis</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table demonstrates the sensitivity to a reasonably possible change in interest rates on cash equivalents, loans and financing
and accounts payable to selling shareholders and notes payable. With all variables held constant, the Company&#8217;s income before income
taxes is affected through the impact on floating interest rates, as follows:</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock"><p id="xdx_89F_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zHe53FQOmRll" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zat4SI5YH5wd" style="display: none; visibility: hidden">Schedule of sensitivity analysis effects on income statement</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Increase
    / decrease in basis points</b></span></td></tr>
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balance
    as of December, 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Index
    &#8211; % per year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Base
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>+75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;+150</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;-150</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    equivalents</span></td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zkMmVcQLnvu6" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">636,847</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member" name="afya:IndexRatePerYear">100.38%
    CDI</ix:nonNumeric></span></td>
    <td id="xdx_98B_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zA95Ma8zHKxe" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">58,440</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zDelf0lhW9xb" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,776</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zfrjmrzbO768" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,776</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zGNW0hylZpS" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,553</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_z5FqeLfVGyh1" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,553</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zR5BYkQ6ua3a" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">510,972</ix:nonFraction>)</span></td>
    <td id="xdx_983_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember" name="afya:IndexRatePerYear">CDI
    + 1,62%</ix:nonNumeric></span></td>
    <td id="xdx_98E_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zYrQiVkgZG7" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,032</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zCDu5y3QwTva" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,832</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zGvYyCPWFxvi" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,832</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zL5sCZpPLF3b" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,665</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zjec1WlNflx1" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,665</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zvRceLz9iUhh" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,199</ix:nonFraction>)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember" name="afya:IndexRatePerYear">CDI
    + 1,75%</ix:nonNumeric></span></td>
    <td id="xdx_982_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zbldYpljfgye" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,401</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zHWpH13UYzRc" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">234</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zluvRGbN4XVl" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">234</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zn92w0pz9l0e" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">468</ix:nonFraction>)</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zKfzG8913TJl" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">468</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7kfyVoPNm84" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,145</ix:nonFraction>)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember" name="afya:IndexRatePerYear">TJLP</ix:nonNumeric></span></td>
    <td id="xdx_986_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zymYT2fjrLU" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">617</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0QEExR22rg5" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">76</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zXlq3A2x2SYa" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zPtpw6gYoE38" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">152</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zync6RthPxK4" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zNzxR8xNO4n1" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">612,121</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember" name="afya:IndexRatePerYear">CDI</ix:nonNumeric></span></td>
    <td id="xdx_989_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zW022jV7R6xj" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">56,009</ix:nonFraction>)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zibUHYUa7Oel" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,591</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zCZzXSwIz3Jk" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,591</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zIE3nL0Sl9J5" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,182</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_za9oDGDF1xgg" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,182</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zLTcAtOYEOS9" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">41,581</ix:nonFraction>)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember" title="Index - % per year" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember" name="afya:IndexRatePerYear">IPCA
    + 4,1%</ix:nonNumeric></span></td>
    <td id="xdx_985_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zyZynExQ2cTh" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,708</ix:nonFraction>)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0sNJe5lIG5i" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">312</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zFEj6X8pkN6d" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">312</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zUUwEl6Y6h3b" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">624</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zEXLvE4Mw6R1" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">624</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zv9D85Z2GyGf" title="Balance as of ending" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:FinancialAssets" contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">72,726</ix:nonFraction>)</span></td>
    <td id="xdx_980_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrh6F5yzAhkf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember" name="afya:IndexRatePerYear">IPCA</ix:nonNumeric></span></td>
    <td id="xdx_983_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zfF2DneRexki" title="Base rate" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="afya:BaseRate" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">531</ix:nonFraction>)</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zatr49n2q818" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">545</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_pn3n3" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">545</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zuvc6ZEsPX39" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,091</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_ziI61PtYcwC8" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsOneMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,091</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zjctsLlrBt5j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>


<ix:exclude><!-- Field: Page; Sequence: 241 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(ii)
Foreign currency risk</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Foreign
currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange
rates. The Company&#8217;s exposure to the risk of changes in foreign exchange rates relates to cash and cash equivalents denominated
in U.S. dollars in the amount of R$<span id="xdx_908_eifrs-full--CreditExposure_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zeIXNN0O4jE9" title="Exposure risk"><ix:nonFraction name="ifrs-full:CreditExposure" contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">23,228</ix:nonFraction></span> as of December 31, 2021 (December 31, 2020: R$<span id="xdx_903_eifrs-full--CreditExposure_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z6YWQ7TX1Ifa" title="Exposure risk"><ix:nonFraction name="ifrs-full:CreditExposure" contextRef="AsOf2020-12-31_ifrs-full_CurrencyRiskMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">70,523</ix:nonFraction></span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Foreign
currency sensitivity</span></span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock"><p id="xdx_89B_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zyr8Zg34xvOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zbUvoYfOqgxa" style="display: none; visibility: hidden">Schedule of currencies used in sensitivity analysis</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table demonstrates the sensitivity in the Company&#8217;s income before income taxes of a <span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_uPure_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpVCAKSniQMh" title="Percentage of sensitivity change in the Euro exchange rate"><ix:nonFraction name="afya:SensitivityChangeInTheEuroExchangeRate" contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10</ix:nonFraction></span>% change in the U.S. dollar exchange
rate (R$<span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zoAOQUxCI73i" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember" format="ixt:numdotdecimal" decimals="INF" unitRef="N">5.5799</ix:nonFraction></span> to U.S. dollar <span id="xdx_906_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__srt--CurrencyAxis__currency--EUR_z00xfSouENQ5" title="Closing foreign exchange rate"><ix:nonFraction name="ifrs-full:ClosingForeignExchangeRate" contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember_currency_EUR" format="ixt:numdotdecimal" decimals="INF" unitRef="N">1.00</ix:nonFraction></span>) as of December 31, 2021, with all other variables held constant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 37%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember_ztDJvmNDSlti" title="Cash and cash equivalents" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_ForeignCurrencyExposuresMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,228</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember_zK6CpS8zyDUb" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_IncreaseForeignCurrencyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,323</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember_zpsVsSJOVS1" title="Cash and cash equivalents" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseInCashAndCashEquivalents" contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_DecreaseForeignCurrencyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,323</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A6_zjwEt9xbEXSi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Credit
                                            risk</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Credit
risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial
loss. The Company is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities,
including cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Customer
credit risk is managed by the Company based on the established policy, procedures and control relating to customer credit risk management.
Outstanding customer receivables are regularly monitored. See Note 7 for additional information on the Company&#8217;s trade receivables.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Credit
risk from balances with banks and financial institutions is management by the Company&#8217;s treasury department in accordance with
the Company&#8217;s policy. Investments&#160;of surplus funds are made only with approved counterparties and within limits assigned to
each counterparty.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s maximum exposure to credit risk for the components of the statements of financial position at December 31, 2021 and 2020
is the carrying amounts of its financial assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"></td><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Liquidity
                                            risk</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company&#8217;s
Management has responsibility for monitor liquidity risk. In order to achieve the Company&#8217;s objective, Management regularly reviews
the risk and maintains appropriate reserves, including bank credit facilities with first tier financial institutions. Management also
continuously monitors projected and actual cash flows and the combination of the maturity profiles of the financial assets and liabilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The main requirements
for financial resources used by the Company arise from the need to make payments for suppliers, operating expenses, labor and social
obligations, loans and financing and accounts payable to selling shareholders.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 242 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock"><p id="xdx_893_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_za0yScJSdrej" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zFkJPusodgkc">The
tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zR9ZkQIDins9" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,098</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z5ESeiYiJu25" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4224">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zOvm3azUSBs6" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4226">-</span></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXcsvktPk5lh" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">-</span></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zfLFM8oJPa5a" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,098</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zAxP8BwZb9Bk" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">217,903</ix:nonFraction></span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCmazm93nvAb" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">585,686</ix:nonFraction></span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zIJrnlln4042" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">948,503</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7QoigujE0Fj" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,212</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeFK3fOUlXu" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,753,304</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zglTCcVoV3j8" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">103,003</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zp5n9N8ODbL4" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">211,894</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zFaYTrBHa43b" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">204,744</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFkneZOqHSi2" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,108,555</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zF8LfSWBn2Lj" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,628,196</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSuGOEgdO9Zk" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">246,059</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zSOb24gSUJta" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">445,066</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zTnAuGVP3Luc" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">88,989</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zghUk6ER8yqk" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4258">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDpcXG5ur67" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">780,114</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zIPwKdlJlYb1" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">15,644</ix:nonFraction></span></td>
    <td id="xdx_985_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z6BOp1GaV2D7" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">74,306</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z1N6g9dOfRv1" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4266">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkTvLYtv4Moj" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4268">-</span></span></td>
    <td id="xdx_988_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcOoi4gTMJXe" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">89,950</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHdgYToVRh4h" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,585</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z4jVhcodwudk" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4274">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEHsT2votfHh" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4276">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zX70wZHR0elg" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4278">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJ3EBS582on9" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">114,585</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zejCy1whiy7e" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">756,292</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zf3xtPAAbAY4" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,316,952</ix:nonFraction></b></span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_znnUWNIzipzd" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,242,236</ix:nonFraction></b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWZ5Ztlfr7Qh" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,109,767</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zx88NWt85IIe" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,425,247</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHUzNQNtkepj" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,743</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zmk8tw64dIek" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4294">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zPyPlVsWUS8b" title="Trade payables" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zya1DGm6Zaf6" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4298">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcu3rSjjuoag" title="Trade payables" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToTradeSuppliers" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,743</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zb5DxVkLnxbh" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">125,137</ix:nonFraction></span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zXHoZ9KYiKBa" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">566,157</ix:nonFraction></span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zL5GI9yVFTF7" title="Loans and financing" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,010</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_ztti00xRVKTh" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,094</ix:nonFraction></span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZHk0tkigzj5" title="Loans and financing" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">698,398</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_982_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHy6r1lGO0a4" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,092</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCJZr99KjTsh" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">131,225</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zDk8gHEqyHLf" title="Lease liabilities" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">124,114</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7bapOfNibzk" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">705,115</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zh7LW7LtcVzc" title="Lease liabilities" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,023,546</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zajemD1YjNn9" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">191,145</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zwey8TOCU595" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">262,340</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zxlxhQ84QTEj" title="Accounts payable to selling shareholders" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,153</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zboMg8va7zJa" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4328">-</span></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zs5k486his6" title="Accounts payable to selling shareholders" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">534,638</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98F_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zYL7ZAGkP7O2" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,083</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zLILVAJLuqMi" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">83,803</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zZgvcHYr2YP6" title="Notes payable" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4336">-</span></span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zvHtRfvXMfde" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4338">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcnOG1lmTZe1" title="Notes payable" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NotePayables" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">94,886</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zMvjaRfcnLLa" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,839</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zdKLp1ZpCM1h" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4344">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zLR7BgSFl1Xc" title="Advances from customers" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4346">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkghtfKDDgw5" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4348">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zQeuxPIJCtHg" title="Advances from customers" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:Advances" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">63,839</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z3bZ3kUs2V93" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">490,039</ix:nonFraction></b></span></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zQFuZyfnwZZc" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,043,525</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zAMKqlZrEICh" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">209,277</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zz1VRG3s4AV6" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">708,209</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAXiAJL5BLOf" title="Financial liabilities contractual undiscounted" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:FinancialLiabilitiesContractualUndiscounted" contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,451,050</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A0_zwOe0rLZM1k7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory"><p id="xdx_897_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_zQIjwPYbRiLi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_z0ZCC6n1vFYh" style="display: none; visibility: hidden">Schedule of changes in liabilities arising from financing activities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.5</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Changes
                                            in liabilities arising from financing activities</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions
    <sup id="xdx_F59_zjmlxRS0kB19">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzKV1KrzomN6" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBhMABRspry2" title="Payments" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">158,076</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0IWU803TwE8" title="Addition" style="border-top: black 1pt solid; padding-right: -5.5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">809,539</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zE251ENp5sa8" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,909</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zttz7OkvSqMj" title="Foreign exchange movement" style="border-top: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4372">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsELnO5IGU7c" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,591</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z12f4fJYZuU6" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">428</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zcau0ImGxAs" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember1110241046" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zpineiBbhIl9" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlOf5eg67ARj" title="Payments" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">87,751</ix:nonFraction>)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zjLHdTlougR3" title="Addition" style="padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">158,651</ix:nonFraction></span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD66xhLXBfld" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">67,212</ix:nonFraction></span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"> -</span> </td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs7pHPy5hh44" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">139,514</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYLqGr2Ib4I2" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,244</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3T3KLwlRaJi" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember1110241156" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zxh7TigBpiyh" title="Payments" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,648</ix:nonFraction>)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zyZD4UVYcmyl" title="Addition" style="padding-right: 0.6pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,648</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z3AaPlZtHqO9" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4398">-</span></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231_zc79fNAkOCFl" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,188</ix:nonFraction></b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zvz4G9Gc8K12" title="Payments" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">264,475</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_z0WhhH6xXUWf" title="Addition" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">986,838</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zgOWWOfpIolg" title="Interest" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">136,121</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zHEs9vEAlam7" title="Foreign exchange movement" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4408">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zE5qX9c3Ohsk" title="Business combination" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">176,105</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zSdC8sXzBLuc" title="Other" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,816</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231_zMmivOiIrttd" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,088,961</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znNgfRvcvrL5" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,357</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z488AWFL9Pc1" title="Payments" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">155,090</ix:nonFraction>)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQRS8K72PG9" title="Addition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">605,041</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQGzat4E5Rf" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,031</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zxcFFwNfLEd5" title="Foreign exchange movement" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,279</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z2yFEffKsgu3" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">75,815</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z3fQhUiEyV5j" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">52</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL4vlWbpDMa9" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zsjemhoyBpQ2" title="Liabilities arising from financing activities, beginning" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,515</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdWYi7ZLYlA8" title="Payments" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">55,455</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg9GKhMDeIrj" title="Addition" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,904</ix:nonFraction></span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJo0bAFtKMv" title="Interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">44,458</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx4oCQ5QMSuc" title="Business combination" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,855</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAjwku3wyR92" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,574</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEwNsjCJhI8j" title="Liabilities arising from financing activities, ending" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zRPzgaQjMI1c" title="Payments" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,984</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zQFazbpww7P9" title="Addition" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,984</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ziEhcLhcy8Q1" title="Liabilities arising from financing activities, ending" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4450">-</span></span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231_z9O73Awb2TQi" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">344,872</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zXTJtxdYXYt7" title="Payments" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">223,529</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_znMpIvd6m0a6" title="Addition" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">716,929</ix:nonFraction></b></span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zTNEZIwf4iP3" title="Interest" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">54,489</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zHoiW39bFVNi" title="Foreign exchange movement" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">21,279</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zwQnIS48Otcc" title="Business combination" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">152,670</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zGoDMH5X1lt8" title="Other" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,522</ix:nonFraction>)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231_z2FUiU9hwEpj" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,065,188</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2019</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zvIedUS2OSce" title="Liabilities arising from financing activities, beginning" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2018-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">77,829</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAztwm1hTDFe" title="Payments" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">75,093</ix:nonFraction>)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zHzQ9tv2pVrf" title="Addition" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,383</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zaQRffcT0426" title="Interest" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,025</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zX2e90SRtrF2" title="Foreign exchange movement" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,126</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbScPCHhooj5" title="Business combination" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,087</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zU8NOeGHXQGl" title="Other" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4480">-</span></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zOdCTOm6NpEj" title="Liabilities arising from financing activities, ending" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31_custom_LoansAndFinancingMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,357</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg6AfYkrklbd" title="Liabilities arising from financing activities, beginning" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2018-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">212,360</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJFXc4dUb3vh" title="Payments" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,779</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zV7vCpqtxln6" title="Addition" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,100</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z56k3GTEIkH8" title="Interest" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">31,469</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlsE1REWk4sa" title="Business combination" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">61,365</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z45ORsY1yHKk" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4494">-</span></span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBpJyPU22eAh" title="Liabilities arising from financing activities, ending" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">284,515</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zPxIx3kYyRWk" title="Liabilities arising from financing activities, beginning" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,107</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zXE7a5RQ5nU5" title="Payments" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">51,812</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zF3LHI3EOmD3" title="Addition" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,812</ix:nonFraction></span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuntcQFNIZ6d" title="Liabilities arising from financing activities, ending" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,107</ix:nonFraction>)</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231_zWjhmNV0jbFl" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">294,296</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231_ze9pHOp2ROnf" title="Payments" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">166,684</ix:nonFraction>)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_z7YmPXLx5G6l" title="Addition" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,295</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zoMYYBaUIlnj" title="Interest" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">37,494</ix:nonFraction></b></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zVuSmFJMulSj" title="Foreign exchange movement" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,126</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zXDuM8hDZEo3" title="Business combination" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">104,452</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zy4hVBxUQKYi" title="Other" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(<ix:nonFraction name="ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,107</ix:nonFraction>)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231_zlBo7XnlR6i3" title="Liabilities arising from financing activities, ending" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><ix:nonFraction name="ifrs-full:LiabilitiesArisingFromFinancingActivities" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">344,872</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zC1w9HM6N3oc" style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1C_zmkOARTph9rj" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote004521" xml:lang="en-US">The additions of loans and financing
include proceeds from the SoftBank transaction of R$<span id="xdx_905_ecustom--ProceedsFromLoansAndFinancing_c20210101__20211231_zPVJqip9Bt1a" title="Proceeds from loans and financing"><ix:nonFraction name="afya:ProceedsFromLoansAndFinancing" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">822,569</ix:nonFraction></span>, net of the transaction costs of R$<span id="xdx_90C_ecustom--NetOfTransactionCosts_iI_c20211231_zcVZhLnJfqc3" title="Net of the transaction costs"><ix:nonFraction name="afya:NetOfTransactionCosts" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,030</ix:nonFraction></span>.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AF_zrPuddarGcH9" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

</ix:nonNumeric><p id="xdx_815_zrDk8YzJ68ok" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 243 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:FairValueMeasurementExplanatory"><p id="xdx_809_ecustom--FairValueMeasurementExplanatory_zXXHNh7FBgE" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>14</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zgXvLEPyUS55">Fair
                                            value measurement</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfFairValueMeasurementExplanaory"><p id="xdx_89E_ecustom--ScheduleOfFairValueMeasurementExplanaory_zJdM6EE0ONbe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table provides the fair value measurement hierarchy of the Company&#8217;s assets and liabilities as of December 31, 2021 and
2020.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8B7_zuzV93xmQ3ec" style="display: none; visibility: hidden">Schedule of fair value measurement</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Quoted
    prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    unobservable inputs (Level 3)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zhCth7nfvbEa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_znrXf6XTbL7d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4531">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zh0cJ9cruixh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,442</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrCMoM2zWKQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4533">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_iI_c20211231_zStnHx8NqgQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,387,136</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZkKgWYT9iX5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,387,136</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_c20211231_zZ7P1fK7rEQk" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">714,085</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilities1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zPPxReUN5cC8" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilities1" contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">714,085</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231_zcj97k18b3I1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">679,826</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zWL81pm1CXx4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">679,826</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--FairValueNotesPayables1_iI_c20211231_zyHtMiPTzqL" title="Notes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FairValueNotesPayables1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">72,726</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayables1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpuOJXK9a8yi" title="Notes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FairValueNotesPayables1" contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">72,726</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>

<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zIVPAfCRPCU" title="Trade receivable (non-current)" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zDdyksXKlg0c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zroCEOrEYjxh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NoncurrentTradeReceivables" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,627</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVWLihjpycw4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    Cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231_zStMHCpteDac" title="Restricted Cash" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RestrictedCashAndCashEquivalents1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwHOzYpyXmnc" title="Restricted Cash" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:RestrictedCashAndCashEquivalents1" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,053</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancingLiabilities_iI_c20201231_zjh4MpveyTqb" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">637,723</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0Lv31jMWA7f" title="Loans and financing" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LoansAndFinancingLiabilities" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">637,723</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesOne_iI_c20201231_zwBQDzdY2NT5" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesOne" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">447,703</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesOne_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z7GRegCInEb5" title="Lease liabilities" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseLiabilitiesOne" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">447,703</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231_zZ9n1MKhJrM8" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">518,240</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zThldZNf5Lmb" title="Accounts payable to selling shareholders" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TradeAndOtherPayablesToRelatedPartiesLiabilities" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">518,240</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231_zvYjDKuF67L4" title="Notes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FairValueNotesPayablesLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">76,181</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zOQRkNJjWW8j" title="Notes payable" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FairValueNotesPayablesLiabilities" contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">76,181</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A8_z8kJNTy4GSF4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">There
were no transfers between Levels during 2021 and 2020.</span></p>

</ix:nonNumeric><p id="xdx_81C_z3A3WRJbibUf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 244 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:CapitalManagementExplanatory"><p id="xdx_801_ecustom--CapitalManagementExplanatory_z3W4qDu8Ldi5" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>15</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zi5FKcER2iB5">Capital
                                            management</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">For
the purposes of the Company&#8217;s capital management, capital considers total equity. The primary objective of the Company&#8217;s
capital management is to maximize the shareholder value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfCapitalManagementExplanatory"><p id="xdx_890_ecustom--ScheduleOfCapitalManagementExplanatory_zSXw9J05DwR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company manages its capital structure and makes adjustments in light of changes in economic conditions and to maintain and adjust the
capital structure, the Company may adjust the dividend payment to shareholders, repurchase programs, return capital to shareholders or
issue new shares. The Company monitors capital using net debt and total equity. The Company includes within net debt, loans and financing,
lease liabilities, accounts payable to selling shareholders and notes payable less cash and cash equivalents and restricted cash.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zYbAG1njvf42" style="display: none; visibility: hidden">Schedule of capital management</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20211231_zcBAwwFSF051" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 3%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20201231_zOBjXxSE9zBi" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--LoansAndFinancing_iI_zfuNYegJ5Ic4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,374,876</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:LoansAndFinancing" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">617,485</ix:nonFraction></span></td></tr>
  <tr id="xdx_40B_eifrs-full--LeaseLiabilities_iI_zu3ceoK2G632" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">714,085</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:LeaseLiabilities" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">447,703</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_zngcvFUNVsji" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">679,826</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TradeAndOtherPayablesToRelatedParties" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">518,240</ix:nonFraction></span></td></tr>
  <tr id="xdx_403_eifrs-full--NotesAndDebenturesIssued_iI_zN6xagKBEBJ9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NotesAndDebenturesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,726</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NotesAndDebenturesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">76,181</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--CashAndCashEquivalents1_iI_zetZoWqwVcBj" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    cash and cash equivalents</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:CashAndCashEquivalents1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">748,562</ix:nonFraction>)</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:CashAndCashEquivalents1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,045,042</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iI_zPcj7UmCh6w1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    restricted cash</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4591">-</span></span></td>
    <td style="text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:RestrictedCashAndCashEquivalents" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,053</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NetDebt_iI_zy7btShsQYOk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    debt</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NetDebt" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,092,951</ix:nonFraction></b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:NetDebt" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">612,514</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_40D_ecustom--EquityOne1_iI_zQORETf8TjQ1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Total
    equity</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:EquityOne1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,000,018</ix:nonFraction></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:EquityOne1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,833,780</ix:nonFraction></span></td></tr>
  <tr id="xdx_405_ecustom--EquityAndNetDebt1_iI_zPnbRiMXpDF6" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total
    equity and net debt</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityAndNetDebt1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,092,969</ix:nonFraction></b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:EquityAndNetDebt1" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,446,294</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A2_zUG8UFzdhGOh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">No
changes were made in the objectives, policies or processes for managing capital during the years ended December 31, 2021 and 2020.</span></p>

</ix:nonNumeric><p id="xdx_817_z2vPrhOz8NX6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:LaborAndSocialObligationsExplanatory"><p id="xdx_801_ecustom--LaborAndSocialObligationsExplanatory_zKIey5nfNsR3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>16</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_826_zF2BQqIRskPj">Labor
                                            and social obligations</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Variable compensation (bonuses)</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
Company recorded bonuses related to variable compensation of employees and management in cost of services and general and administrative
expenses of R$ <span id="xdx_90D_ecustom--ShareBasedCompensationOfEmployees_c20210101__20211231_ztVDnOMGr3uj"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">25,587</ix:nonFraction></span>, R$ <span id="xdx_902_ecustom--ShareBasedCompensationOfEmployees_c20200101__20201231_zJRieRfYAZ84" title="Compensation of employees"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">9,514</ix:nonFraction></span> and R$<span id="xdx_904_ecustom--ShareBasedCompensationOfEmployees_c20190101__20191231_zIjk60grz1sb"><ix:nonFraction name="afya:ShareBasedCompensationOfEmployees" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">6,871</ix:nonFraction></span> for the years ended December 31, 2021, 2020 and 2019, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Afya Limited share-based compensation plan</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
stock options plan approved on August 30, 2019 as a result of the IPO will govern the issuance of equity incentive awards with respect
to Company&#8217;s Class A common shares. The fair value of the stock options was estimated at the grant date using the Binomial pricing
model, taking into account the terms and conditions on which the stock options were granted. The Company accounts for the stock options
plan as an equity-settled plan.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 29, 2020,
the board of directors approved a change in the strike price of the current share-based compensation plan. The strike price is now measured
in Brazilian Reais (where the Company&#8217;s operations are located and valuated) adjusted by CDI rate instead of U.S. dollar adjusted
by T-Bond. Furthermore, the first tranche had its vesting period extended from May 2020 to May 2021, including one year lock-up period
after the vesting period. This change was assessed as a modification by the Company and was accounted in accordance with IFRS 2.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As result, the
expense related to the share-based payment of the Company reflects the cost of the original award at grant date over the vesting period
plus the incremental fair value of the repriced options at modification date over the vesting period of the options.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 245 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions"><p id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_zmsYqQFDMnee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following table list the inputs to the model used to determine the incremental fair value of the stock options as result of the modification:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"></span></p>

<p><span id="xdx_8B6_zDiFiXiF6J05" style="display: none; visibility: hidden">Schedule of model used to determine the fair value of the stock options</span></p>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified
    plan</b></span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original
    plan (*)</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span title="Strike price at the measurement date"><span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zmds9KRJts3c" title="Strike price at the measurement date::XDX::74"><span style="-sec-ix-hidden: xdx2ixbrl4611">74.38</span></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zfHQJSCbNWla" title="::XDX::99"><span style="-sec-ix-hidden: xdx2ixbrl4612">99.09</span></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zikEpRzdvrKd" title="Dividend yield" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</span></td>
    <td id="xdx_983_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zNs2TbZo0EOb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td title="Expected volatility" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcJuRknD5n66" title="Expected volatility, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction></span>%
    - <span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziOKPFTlMpd3" title="Expected volatility, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">76</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvC04AGrVMB9" title="Expected volatility, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">42</ix:nonFraction></span>%
    - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQnmBwyw9yX6" title="Expected volatility, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">76</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC7J3qP5Spvd" title="Risk-free interest rate, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.0</ix:nonFraction></span>%
    - <span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTUGwEJczfg7" title="Risk-free interest rate, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">4.9</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFL775XlsT8j" title="Risk-free interest rate, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.2</ix:nonFraction></span>%
    - <span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zl98hXWVL7Hc" title="Risk-free interest rate, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.4</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhhCcjUornw9" title="Expected life of stock options, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC8kyN9npfh6" title="Expected life of stock options, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">4</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zArbdkriwVG1" title="Expected life of stock options, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z48eQDHsKsdb" title="Expected life of stock options, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">4</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td id="xdx_98E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zANukntkjuIf" title="Share price at the measurement date" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-12-31_custom_ModifiedPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">133.68</ix:nonFraction></span></td>
    <td id="xdx_988_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zmlQJLff5s15" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-12-31_custom_OriginalPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">133.68</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zs50DLgOtC9l" title="Model used" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></td>
    <td id="xdx_982_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zoBcfJP3oiH3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zSYMFbIIVHMc"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-12-31_custom_ModifiedPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">69.54</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zUPrRZuIRT93"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-12-31_custom_OriginalPlanMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">57.12</ix:nonFraction></span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(*) The strike price
of the original plan was based in U.S. dollars.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">On
January 25, 2021, March 25, 2021, April 26, 2021, </span><span style="font-family: Arial, Helvetica, Sans-Serif">June <span style="font-size: 11pt">1,
2021 and November 1, 2021, the Company granted <span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210123__20210125_zLQf4GTPqm8b" title="Number of stock option granted"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-01-232021-01-25" format="ixt:numdotdecimal" decimals="INF" unitRef="N">545,000</ix:nonFraction></span>, <span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210323__20210325_zuov2pSLaSJi"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-03-232021-03-25" format="ixt:numdotdecimal" decimals="INF" unitRef="N">65,000</ix:nonFraction></span>, <span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210423__20210426_zoibUUmIYKBc"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-04-232021-04-26" format="ixt:numdotdecimal" decimals="INF" unitRef="N">139,000</ix:nonFraction></span>, <span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210601__20210601_zRy0sLCQ3Z7b"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-06-012021-06-01" format="ixt:numdotdecimal" decimals="INF" unitRef="N">180,000</ix:nonFraction></span> and <span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20211101__20211101_zp0HRvV9K5b3"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-11-012021-11-01" format="ixt:numdotdecimal" decimals="INF" unitRef="N">241,000</ix:nonFraction></span> additional stock options, respectively:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>January
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>March
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>April
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>June
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>November
    2021</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_906_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210131_zN7MXTnWC9F" title="Strike price at the measurement date"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">115</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210331_zEZTVjWGQ4Si"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210430_zPe5CQsqH05c"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210630_zRivVyK90W8k"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">105</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20211130_zbvB8BLLBTU1"><ix:nonFraction name="afya:StrikePriceeAtMeasurementDateShareOptionsGrante" contextRef="AsOf2021-11-30" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">85</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210101__20210131_zWAzgjRRYcT9" title="Dividend yield"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-01-012021-01-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210301__20210331_z2PoNYhk6y9c"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-03-012021-03-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210401__20210430_zz3M8yK9X9Ek"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-04-012021-04-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210601__20210630_z3EbZIaazc2i"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-06-012021-06-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20211101__20211130_zOAgHRoLQ2Hi"><ix:nonFraction name="ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted" contextRef="From2021-11-012021-11-30" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">0.0</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z2v7QnO2LVkd" title="Expected volatility, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">38</ix:nonFraction></span>%
    - <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEjBssXknPW6" title="Expected volatility, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">67</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1aMda4defl"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-03-012021-03-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">42</ix:nonFraction></span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKok13N0cTGe"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4oldicjdHc"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">43</ix:nonFraction></span>%
    - <span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaf1Ku0j3Qx6"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">51</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYsbrfcpGnM3"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">43</ix:nonFraction></span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zrEZ4neSZ3n5"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">63</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfMc4ilJUDU3"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">41</ix:nonFraction></span>% - <span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdpffPNRg0t7"><ix:nonFraction name="ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">65</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBlfN2599uj7" title="Risk-free interest rate, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">2.1</ix:nonFraction></span>%
    - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8a77JTiuyS8" title="Risk-free interest rate, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.1</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zAs2oRLyqTzg"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.2</ix:nonFraction></span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLFcmzX3077d"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.5</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0O7jeGgONM3"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.1</ix:nonFraction></span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2yZdPFq8ca9"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.1</ix:nonFraction></span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCffft5OLCSk"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">5.8</ix:nonFraction></span>%
    - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8mipFFMqcf3"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.3</ix:nonFraction></span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zimeTnJOFLJ"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">10.4</ix:nonFraction></span>% -
    <span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBWLgC10hwvk"><ix:nonFraction name="ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">12.5</ix:nonFraction></span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFx69OPM0vu5" title="Expected life of stock options, minimum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211; <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLc6QZbKjYmf" title="Expected life of stock options, maximum"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">5</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBWzBTxaLaB4"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211; <span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zopl7TeHH4M4"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">5</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4JIsUdPUPIc"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211;<span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQkbbAhNu99e"> <ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">5</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4Z7WDYfbKnd"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span>
    &#8211; <span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXHsQ2vDMGJf"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">5</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zW5mYe6tYEil"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1</ix:nonFraction></span> &#8211;
    <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUcgeGO4owxj"><ix:nonFraction name="ifrs-full:DescriptionOfOptionLifeShareOptionsGranted" contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">5</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210131_zxisUK9o0gXj" title="Share price at the measurement date"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">129</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20210331_zNq7Y6QIPvZ1"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">108</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_900_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210430_zMcqRXffU9R9"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">119</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_901_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210630_zRZayV1UUICl"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">121</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$ <span id="xdx_905_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20211130_zNZzpLNQNjD6"><ix:nonFraction name="afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted" contextRef="AsOf2021-11-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">8</ix:nonFraction></span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zVytSGbj2Jjd" title="Model used"><ix:nonNumeric contextRef="From2021-01-012021-01-31" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zkzwsvDcv6U3"><ix:nonNumeric contextRef="From2021-01-012021-01-31" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210401__20210430_zptc5uKQjDZ7"><ix:nonNumeric contextRef="From2021-04-012021-04-30" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210601__20210630_z7U9a5jvqC32"><ix:nonNumeric contextRef="From2021-06-012021-06-30" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20211101__20211130_zAUpEU1PNjF"><ix:nonNumeric contextRef="From2021-11-012021-11-30" name="ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted">Binomial</ix:nonNumeric></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_905_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210131_zxiTJ8nhYXW8" title="Weighted average fair value at the measurement date"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-01-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">46.81</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20210331_zQOhrOZJWIUf"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-03-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">40.20</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210430_z6JY6YEPMur3"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-04-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">46.04</ix:nonFraction></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90D_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210630_zYym4YcSD9qa"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-06-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">49.10</ix:nonFraction></span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20211130_zAEPF5yE6vfb"><ix:nonFraction name="afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" contextRef="AsOf2021-11-30" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">46.28</ix:nonFraction></span></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
</ix:nonNumeric><p id="xdx_8A2_zffesYa88Rfi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfSharebasedCompensationPlan"><p id="xdx_89B_ecustom--ScheduleOfSharebasedCompensationPlan_zBxBX5mxpL8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and movements in stock options during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span><span id="xdx_8BB_zxUQPB34wi9i" style="display: none; visibility: hidden">Schedule of share-based compensation plan</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Weighted
    average exercise price (in Reais)</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Number
    of stock options</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2021</b></span></td>
    <td style="border-bottom: #365F91 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt; width: 40%"><span style="font-family: Arial, Helvetica, Sans-Serif">Outstanding
    at January 1</span></td>
    <td title="Outstanding at the beginning" id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pii_c20210101__20211231_zwfeeWrUeHi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 32%"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">78.22</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20210101__20211231_zcdB9ZmaJIZ1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">2,510,983</ix:nonFraction></span></td>
    <td title="Outstanding at the beginning" id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20200101__20201231_zR0b3iIYygG2" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right; width: 17%"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">2,364,214</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Granted</span></td>
    <td title="Granted" id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zrbY5z13g8rc" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">109.18</ix:nonFraction></span></td>
    <td title="Granted" id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210101__20211231_zjoev2zBy0yf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">1,170,000</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20200101__20201231_zQSDLBtuRH15" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">477,220</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Forfeited</span></td>
    <td title="Forfeited" id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zqqEjz1OEfof" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">112.89</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20210101__20211231_zFqplPVq3xId" title="Forfeited" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="N">60,000</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20200101__20201231_zH1ov44eBSug" title="Forfeited" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="N">274,359</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_z7icwi64Avzk" title="Exercised" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">78.15</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20210101__20211231_zIhfOtvyGrW2" title="Exercised" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="N">442,669</ix:nonFraction>)</span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20200101__20201231_z4r0CjzHreuf" title="Exercised" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="N">56,092</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Expired</span></td>
    <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zUGk3urD049i" title="Expired" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">78.21</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_c20210101__20211231_z9Rj84xZWVoc" title="Expired" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(<ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="N">91,586</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_d0_c20200101__20201231_zgDBbEeDI1Al" title="Expired" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><ix:nonFraction name="ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" contextRef="From2020-01-012020-12-31" format="ixt:zerodash" decimals="-3" scale="3" sign="-" unitRef="N">-</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Outstanding
    at December 31</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pii_c20210101__20211231_zS7kMhBO5ZM8" title="Outstanding at the ending" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonFraction name="ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">92.33</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_c20210101__20211231_zTQJ00NQ5Yo5" title="Outstanding at the ending" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">3,086,728</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_c20200101__20201231_zwKPzjW3T5j3" title="Outstanding at the ending" style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><ix:nonFraction name="ifrs-full:NumberOfOutstandingShareOptions" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="N">2,510,983</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A7_zvQNsaGmBeJ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
share-based compensation expense, including the incremental fair value as result of the modification in 2020, recognized in general and
administrative expenses in the statement of income for the year ended December 31, 2021 was R$ <span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z0D9dtiP0Qi1"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">43,377</ix:nonFraction></span> (December 31, 2020: R$ <span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zNTtE5UQwLVd" title="Share-based compensation expense"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2020-01-012020-12-31_custom_ShareBasedCompensationPlansMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">32,610</ix:nonFraction></span> and
December 31, 2019: R$ <span id="xdx_906_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20190101__20191231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zwCf5a7wgTxf"><ix:nonFraction name="ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees" contextRef="From2019-01-012019-12-31_custom_ShareBasedCompensationPlansMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">18,114</ix:nonFraction></span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>


<ix:exclude><!-- Field: Page; Sequence: 246 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 5pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Stock
options exercised during the year ended December 31, 2021 have been settled using the treasury shares of the Company. The reduction in
the treasury share equity component is equal to the cost incurred to acquire the shares, on a weighted average basis. Any difference
of the cash received from employees upon exercise of the options in relation to treasury shares weighted average cost is recorded in
paid-in-capital.</span></p>

</ix:nonNumeric><p id="xdx_810_zTdVbkz1ZI0h" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory"><p id="xdx_802_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zCUef4ng2Kgc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>17</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span><span id="xdx_823_zJS4iocWnIDe">Equity</span></span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Share capital</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">As
of December 31, 2021, the Company&#8217;s share capital was R$ <span id="xdx_90D_eifrs-full--IssuedCapital_iI_dxL_c20211231_zkFl3hylg87a" title="Share capital::XDX::17000"><span style="-sec-ix-hidden: xdx2ixbrl4763">17</span></span> (R$ <span id="xdx_908_ecustom--IssuedCapital2_iI_c20201231_z88OvZ8VC8v3" title="Share capital"><ix:nonFraction name="afya:IssuedCapital2" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">17</ix:nonFraction></span> as of December 31, 2020) represented by <span id="xdx_905_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20211231_zX0Fx6VyDrCf" title="Total number of shares"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,722,831</ix:nonFraction></span> shares comprised
by <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zvn5jmKTCivg" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2021-12-31_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">47,920,068</ix:nonFraction></span> class A common shares and <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zs72sWLDWoH8" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2021-12-31_custom_ClassBOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,802,763</ix:nonFraction></span> class B common shares (<span style="background-color: white"><span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231_zT9fwQzOQEtg" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,146,731</ix:nonFraction></span> </span>shares
comprised by <span style="background-color: white"><span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z05ixiCtVNs6"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2020-12-31_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">45,112,416</ix:nonFraction></span> class A common shares and <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_z50JrCbgbiOc"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2020-12-31_custom_ClassBOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">48,034,315</ix:nonFraction></span> class B common shares</span> as of
December 31, 2020).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">b)
Afya Brazil</span></p>

<p style="font: bold 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; text-indent: 40pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Prior
to the completion of Afya&#8217;s IPO in July 2019, Afya Brazil was the predecessor of Afya. As such, the consolidated financial statements
reflect the operating results of Afya Brazil prior to the reorganization. As of December 31, 2018, Afya Brazil&#8217;s share capital
was R$ <span id="xdx_901_eifrs-full--IssuedCapital_iI_c20191231_zJYQI89axeM7"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">315,000</ix:nonFraction></span> represented by <span id="xdx_900_eifrs-full--IssuedCapital_iI_c20181231_zZLmFUFKoIn6"><ix:nonFraction name="ifrs-full:IssuedCapital" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,443,541</ix:nonFraction></span> shares, comprised of <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z932MQo9lHii" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-12-31_ifrs-full_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,411,895</ix:nonFraction></span> common shares, <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zM5D7yrJisof"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-12-31_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,523</ix:nonFraction></span> Class A preferred shares and <span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zB0PoDztupTl"><ix:nonFraction name="afya:NumberOfSharesIssued1" contextRef="AsOf2020-12-31_custom_ClassBOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,123</ix:nonFraction></span> Class
B preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Common
shares were the only class of shares with voting rights.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Class
A preferred shares had the following characteristics: <span id="xdx_90F_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_z7dSbZ9VTPi4" title="Description of ratio of convertible shares"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ClassAPreferenceSharesMember" name="afya:DescriptionOfRatioOfConvertibleShares">(i) do not grant voting rights at the shareholders meetings; (ii) the right to
receive an amount, as dividend, per share equal to 17.7 times the amount received per common share; and (iii) were convertible into common
shares at the ratio of 1 preferred share for 17.7 common shares in the situations described in the Shareholders Agreemen</ix:nonNumeric></span>t.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zLM9Y0GpEMFe" title="Description of ratio of convertible shares"><ix:nonNumeric contextRef="From2021-01-012021-12-31_custom_ClassBPreferenceSharesMember" name="afya:DescriptionOfRatioOfConvertibleShares">Class
B preferred shares had no voting rights and had priority in capital reimbursement in case of liquidation of the Company, with no premium.
Class B preferred shares were convertible into common shares at the ratio of 1 Class B preferred share f1or 1 common share, in certain
situations.</ix:nonNumeric></span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
April 26, 2018, the shareholders approved a capital increases of (i) R$<span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20180424__20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrotvYPmY3oa" title="Proceeds from issue of ordinary shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2018-04-242018-04-26_ifrs-full_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">55,000</ix:nonFraction></span> through the issuance of <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zMEPyv3MIj1i" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-04-26_ifrs-full_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">124,994</ix:nonFraction></span> common shares; and (ii)
R$ <span id="xdx_901_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180423__20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zYkVqvEC1bz5" title="Proceeds from issue of preference shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfPreferenceShares" contextRef="From2018-04-232018-04-26_custom_ClassAPreferenceSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">11,670</ix:nonFraction></span> through the issuance of <span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zv2o9Y2DtU9j" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-04-26_custom_ClassAPreferenceSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">26,523</ix:nonFraction></span> Class A preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
August 31, 2018, the Board of Directors approved a capital increase of R$<span id="xdx_902_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180825__20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zRX0kPJto14b"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfPreferenceShares" contextRef="From2018-08-252018-08-26_custom_ClassBPreferenceSharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">1,304</ix:nonFraction></span> through the issuance of <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zE3qjOUl7Px8"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-08-26_custom_ClassBPreferenceSharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">5,123</ix:nonFraction></span> Class B preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 4, 2018, the shareholders approved a capital increase of R$<span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20181202__20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zIgEZVeI2Wj3" title="Proceeds from issue of ordinary shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2018-12-022018-12-04_ifrs-full_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">99,999</ix:nonFraction></span> through the issuance of <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zYJluITyO1nf" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2018-12-04_ifrs-full_OrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">137,298</ix:nonFraction></span> common shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 31, 2018, the shareholders approved a capital increase of R$ <span id="xdx_902_ecustom--CapitalIncreaseWithEarningsReserves_iI_c20181231_zALWCjrvlF1c" title="Capital increase with earnings reserves"><ix:nonFraction name="afya:CapitalIncreaseWithEarningsReserves" contextRef="AsOf2018-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">80,541</ix:nonFraction></span> with earnings reserves and retained earnings without an
issuance of new shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 8, 2019, the shareholders of Afya Brazil approved a renounce of dividends for the year ended December 31, 2016 of R$<span id="xdx_906_eifrs-full--DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_c20190306__20190308_zROQVh5V9oZ" title="Renounce of dividends for prior years"><ix:nonFraction name="ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" contextRef="From2019-03-062019-03-08" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">4,107</ix:nonFraction></span>; and
an increase of capital through the issuance of <span id="xdx_90E_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190408__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zmHPUry4wrdl" title="Number of shares in entity held by entity or by its subsidiaries or associates | shares"><ix:nonFraction name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" contextRef="AsOf2019-04-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">37,200</ix:nonFraction></span> common shares, in the amount of R$ <span id="xdx_904_eifrs-full--ParValuePerShare_iI_c20190308__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zbjgOufP8C2" title="Par value per share"><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="AsOf2019-03-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">0.01</ix:nonFraction></span>, subscribed entirely by the shareholders
BR Health and certain members of the Esteves Family.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 247 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 12, 2019, the shareholders of Afya Brazil approved amongst other matters: (i) the change in its legal name to Afya Participa&#231;&#245;es
S.A.; (ii) a capital increase through the issuance of <span id="xdx_901_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zb3goYMjzMjg" title="Number of shares in entity held by entity or by its subsidiaries or associates shares"><ix:nonFraction name="ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">156,337</ix:nonFraction></span> common shares, in the amount of R$ <span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190310__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zDuhNQLedbYh" title="Proceeds from issue of ordinary shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2019-03-102019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">150,000</ix:nonFraction></span>, subscribed entirely by BR Health;
and (iii) the propose to repurchase <span id="xdx_904_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zFrC6ascDGZ" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">160,000</ix:nonFraction></span> common shares issued by the Company, at the acquisition price of R$ <span id="xdx_908_ecustom--AcquisitionPrice_iI_pid_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zjwVGIkFndg3" title="Acquisition price"><ix:nonFraction name="afya:AcquisitionPrice" contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">206.25</ix:nonFraction></span> per share, in
the total amount of R$<span id="xdx_902_ecustom--AcquisitionsHeldByShareholders_c20190311__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zeSTJRsAePd" title="Acquisitions held by shareholders"><ix:nonFraction name="afya:AcquisitionsHeldByShareholders" contextRef="From2019-03-112019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">33,001</ix:nonFraction></span>, all held by the shareholder Nicolau Carvalho Esteves. The Company's common shares object of the repurchase
approved were immediately canceled by the Company, without reduction of its share capital.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 29, 2019, Afya Brazil issued 378,696 common shares to the shareholders of BR Health and Guardaya, and had a capital increase of
R$ 122,062 and an additional paid-in capital of R$ 137,051.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">In
June 2019, Afya Brazil&#8217;s shareholders approved an increase of capital through the issuance of 157,202</span> common shares in
exchange of the acquisitions of FASA, IESP and Univa&#231;o minority interests, in the total amount of R$ 24,310<span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
June 18, 2019, the shareholders of Afya Brazil approved an increase of capital through the issuance of 27,211 common shares in exchange
of the acquisition of an addition 15% interest at UEPC, in the total amount of R$ 24,458, subscribed entirely by the shareholder Bozano
Educacional II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">In
addition to the capital increase related to the acquisition of the non-controlling interests of FASA, IESP and Univa&#231;o and the
interest in UEPC, the Company had an additional paid-in capital of R$ <span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190615__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAUEPCMember_zrqr9NoSaq68" title="Proceeds from issue of ordinary shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2019-06-152019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">36,358</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>c)
Additional paid in capital</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the year ended December 31, 2021, Afya had capital increases regarding business combinations purchase price paid in shares totaling R$<span id="xdx_901_ecustom--ProceedsFromIssueOfOrdinarySharesOne_pid_c20210101__20211231_z7wg6v7PwYY7" title="Purchase prices paid shares"><ix:nonFraction name="afya:ProceedsFromIssueOfOrdinarySharesOne" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">74,500</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya
also had additional paid in capital regarding capital reserves on transferring treasury shares from the exercise of stock options and
contribution of Afya Brazil shares paid to RX PRO selling shareholders, totaling R$<span id="xdx_90A_ecustom--AdditionalPaidinCapital1_iI_c20211231_z66XWCT1dKPb" title="Additional paid-in capital"><ix:nonFraction name="afya:AdditionalPaidinCapital1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">21,861</ix:nonFraction></span> and R$<span id="xdx_90C_ecustom--AdditionalPaidinCapital2_iI_c20211231_zsEJ1nhL7vga"><ix:nonFraction name="afya:AdditionalPaidinCapital2" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">783</ix:nonFraction></span> respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>d)
Dividends</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 8, 2019,
the shareholders of Afya Brazil approved the cancellation of dividends for the year ended December 31, 2016 of R$<span id="xdx_900_ecustom--CancellationOfDividend_c20190306__20190308_z0eYqwjQp8Of" title="Cancellation of dividend"><ix:nonFraction name="afya:CancellationOfDividend" contextRef="From2019-03-062019-03-08" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">4,107</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">On
June 13, 2019, Afya Brazil approved the payment of interim dividends totaling R$ <span id="xdx_905_eifrs-full--DividendPayables_iI_c20190613_zUXljSimK2Ib" title="Dividend payables"><ix:nonFraction name="ifrs-full:DividendPayables" contextRef="AsOf2019-06-13" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">38,000</ix:nonFraction></span> to Afya Brazil shareholders of record on June
13, 2019. The dividend amount was determined based on the Afya Brazil&#8217;s net income for the five months ended May 31, 2019 and were
paid on September 26, 2019. Afya and its public shareholders were not entitled to receive such dividends.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the year ended December 31, 2021, CCSI and IESVAP approved the payment of interim dividends of R$ <span id="xdx_906_ecustom--InterimDividends_c20210101__20211231_zEuFBrFxT2Y7" title="Dividend paid"><ix:nonFraction name="afya:InterimDividends" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">65,521</ix:nonFraction></span>, which R$<span id="xdx_90E_ecustom--DividendsPaidClassifiedAsFinancingActivities1_c20210101__20211231_zNftfI9huwQ4" title="Dividends paid classified"><ix:nonFraction name="afya:DividendsPaidClassifiedAsFinancingActivities1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">46,873</ix:nonFraction></span> was distributed
to Afya Brazil and R$ <span id="xdx_90F_eifrs-full--DividendsPaidToNoncontrollingInterests_c20210101__20211231_zc3TGUMrlo79" title="Dividends paid to non-controlling interests"><ix:nonFraction name="ifrs-full:DividendsPaidToNoncontrollingInterests" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">18,648</ix:nonFraction></span> to non-controlling shareholders.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 248 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>e)
Buy-back program</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 23, 2020, the Company announced that its Board of Directors has approved a share buy-back program. Under the share buyback program,
Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20201223__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zR6599ml2Jnf" title="Repurchase of ordinary shares"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2020-12-23_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,015,844</ix:nonFraction></span> of its outstanding Class A common shares in the open market, based on prevailing market prices, or
in privately negotiated transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of
the repurchase or December 31, 2021, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 27,
2021, the Company&#8217;s board of directors approved a new share repurchase program. Afya may repurchase up to <span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zS451Ld9A0J6"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2021-10-27_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,383,108</ix:nonFraction></span> of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on October
28, 2021 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
share buy-back program takes place in accordance with the conditions established by the Board of Directors. Afya intends to repurchase
the shares to execute the Stock Option Program for the executives of the Company. This program was concluded on October 21, 2021.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">During
2021, the Company repurchased <span id="xdx_905_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211231_zPdPx82wfbp3"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">2,142,051</ix:nonFraction></span> shares at the weighted average price of R$ <span id="xdx_907_eifrs-full--ParValuePerShare_iI_pii_c20211231_zwFXDTVZCKo5" title="Par value per share"><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">99.76</ix:nonFraction></span> (in Brazilian Reais) or US$ <span id="xdx_900_ecustom--IssuedCapital1_iI_c20211231_zRoMAvq2dqv4" title="Share capital"><ix:nonFraction name="afya:IssuedCapital1" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">18.00</ix:nonFraction></span>, amounting
to R$ <span id="xdx_900_ecustom--ProceedsFromIssueOfOrdinaryShares1_c20210101__20211231_zy3bagK4YOb2" title="Proceeds from issue of shares"><ix:nonFraction name="afya:ProceedsFromIssueOfOrdinaryShares1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">213,722</ix:nonFraction></span>. During year ended December 31, 2021, <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231_zsoMUuhfkgWe" title="Total number of shares"><ix:nonFraction name="ifrs-full:NumberOfSharesIssued" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">442,669</ix:nonFraction></span> of these shares were used by the Company any to settle the share-based program,
totaling R$<span id="xdx_907_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20210101__20211231_ztRxLozywXqf" title="Proceeds from issue of ordinary shares"><ix:nonFraction name="ifrs-full:ProceedsFromIssueOfOrdinaryShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">55,197</ix:nonFraction></span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfTreasurySharesMovement"><p id="xdx_895_ecustom--ScheduleOfTreasurySharesMovement_zFt2BV2K0pJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and <span id="xdx_8BD_zPN5GJUExpFk">movements in treasury</span> shares during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 52%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Number
    of shares</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 31%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Average
    price (in Brazilian Reais)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Outstanding
    at January 1, 2021</span></td>
    <td title="Share outstanding beginning period" style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Repurchased</span></td>
    <td title="Repurchased" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,142,051</span></td>
    <td title="Average price" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99.76</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from exercise of options</span></td>
    <td title="Transferred from exercise of options" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(442,669)</span></td>
    <td title="Average price" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">124.08</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from shares contribution</span></td>
    <td title="Transferred from shares contribution" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(44,455)</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">111.94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Outstanding
    at December 31, 2021</b></span></td>
    <td title="Share outstanding ending period" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,654,927</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>92.23</b></span></td></tr>
  </table>

<p id="xdx_8B7_z1aX04b5fbje" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
</ix:nonNumeric></ix:nonNumeric><p id="xdx_816_zVjOHbNOFWE2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfEarningsPerShareExplanatory"><p id="xdx_80F_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zz7jiRkRTZxk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>18</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_827_zAYWhsxScowg">Earnings
                                            per share (EPS)</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Basic
EPS is calculated by dividing net income attributable to the equity holders of the Company by the weighted average number of common shares
outstanding during the period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Diluted
EPS is calculated by dividing net income attributable to the equity holders of the parent by the weighted average number of common shares
outstanding during the period plus the weighted average number of shares that would be issued on conversion of all potential shares with
dilutive effects.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Diluted
earnings per share are computed including stock options granted to key management using the treasury shares method when the effect is
dilutive. The Company has the stock option plan in the category of potentially dilutive shares.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 249 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureOfEarningsPerShareTableExplanatory"><p id="xdx_895_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zvO9wQw5hjxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table reflects the net income and share data used in the basic and diluted EPS calculations:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8BB_z1H4Ge2ZKZ7b" style="display: none; visibility: hidden">Schedule of earnings per share</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zW0x86suTJM1" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_498_20200101__20201231_z6FXBIQMmft8" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_491_20190101__20191231_z2eGmxKqSGx7" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_zxMCjhVeAKI1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable
    to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">223,326</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">292,075</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">153,916</ix:nonFraction></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--WeightedAverageShares_pid_uShares_ze6o6kIW9NPd" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,291,480</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">92,683,848</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:WeightedAverageShares" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">75,969,797</ix:nonFraction></span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pii_uShares_zmm94uY87Rqj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from
    stock options</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">811,818</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">951,920</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">221,846</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustedWeightedAverageShares_pii_uShares_z8Ay99zJtfmh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">94,103,298</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">93,635,768</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdjustedWeightedAverageShares" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">76,191,643</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_pii_uBRLPShares_zqVfvYX9qn35" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Basic
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.39</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.15</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<ix:nonFraction name="ifrs-full:BasicEarningsLossPerShare" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.03</ix:nonFraction>
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pii_uBRLPShares_zbVlDHHNVrHk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.37</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">3.12</ix:nonFraction></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<ix:nonFraction name="ifrs-full:DilutedEarningsLossPerShare" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">2.02</ix:nonFraction>
    </span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A1_zeZCTZtLrAL2" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_818_zJvyduYHr3k3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfRevenueExplanatory"><p id="xdx_809_eifrs-full--DisclosureOfRevenueExplanatory_zBTUQ9f7bSjh" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>19</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_z9pi8rv5BWQb">Revenue</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfNetSalesRevenueExplanatory"><p id="xdx_89F_ecustom--ScheduleOfNetSalesRevenueExplanatory_zmHOcoHYmbL8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B5_z2IXdQRslSPf" style="display: none; visibility: hidden">Schedule of net sales revenue</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231_zyvynLrOqoZ7" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_497_20200101__20201231_zdZ3g4Wum2V" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_498_20190101__20191231_z5QGMDk6PTC" style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_zUkFa4r72yr6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees <sup id="xdx_F45_zcBDb6lUWZX3">(*)</sup></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-01to2021-12-31" id="Fact004884" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,124,589</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2020-01-012020-12-31" id="Fact004885" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,388,735</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2019-01-012019-12-31" id="Fact004886" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">856,561</ix:nonFraction></span></td></tr>
  <tr id="xdx_402_ecustom--OtherRevenue1_zJUnPlsRenj1" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">167,441</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,817</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:OtherRevenue1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">43,116</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_ecustom--DeductionAbstract_iB_zEc5q1UxzoJ6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deductions</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--DeductionOfGrantedDiscounts_zQ9WBcE1O59k" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Granted
    discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">229,254</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">89,017</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfGrantedDiscounts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,767</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_407_ecustom--DeductionOfEarlyPaymentDiscounts_zzoLznGIKNTb" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Early
    payment discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,879</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">29,299</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfEarlyPaymentDiscounts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,523</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_403_ecustom--DeductionOfReturnsOfNetRevenue_z86z3WFCYgId" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Returns</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">42,373</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,437</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfReturnsOfNetRevenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,462</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--DeductionOfTaxes_zQ2t0uiFjn67" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Taxes</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">74,232</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">49,629</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfTaxes" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">28,157</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_ecustom--DeductionOfProuni_zjrn8zhC0K08" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;PROUNI</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">176,921</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">107,979</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:DeductionOfProuni" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">61,138</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_400_eifrs-full--RevenueFromContractsWithCustomers_zAJrnzH8RHul" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    revenue from contracts with customers</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:RevenueFromContractsWithCustomers" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></b></span></td></tr>
  <tr id="xdx_407_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zGuoiYiKyJKg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing
    of revenue recognition of net revenue from contracts with customers</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--FeeAndCommissionIncome_zSsyFi1ZWG8c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition,
    digital content and app subscription fees - Transferred over time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,640,889</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,128,558</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">713,827</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--NetRevenueOtherTransferredPoint_zeFcdIT5s78" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    - Transferred at a point in time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,482</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,633</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,803</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zYduzUneiSzc" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">(*)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F13_zbUolZ3FsJd9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><ix:footnote id="Footnote004931" xml:lang="en-US">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A8_z9EK9h3Mslm8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company`s revenue from contracts with customers are all in Brazil. The Company is not subject to the payment of the social integration
program tax (Programa de Integra&#231;&#227;o Social, or PIS) and the social contribution on revenues tax (Contribui&#231;&#227;o
para o Financiamento da Seguridade Social, or COFINS) on the revenue from under graduation degrees under the PROUNI program.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 250 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following table presents statements of income for the Company&#8217;s operating segments for the years ended December 31, 2021, 2020
and 2019:</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfRevenueBySegment"><p id="xdx_89D_ecustom--ScheduleOfRevenueBySegment_zU6FqluihLW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zVmMS04dsLNi">Schedule of revenue by segment</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue
    by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types
    of services or goods</b></span></td>
    <td id="xdx_981_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKGt24N5mZxf" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGaco47k2cVh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQERCis6ZFF3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z6MgPp8SqUbk" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_z3gA79fqz9R4" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z3lOv2MtZ18i" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,486,111</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdpbYGmGCzih" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXxcd5Sfcwvc" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4945">-</span></span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z9P8a00yWMda" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4946">-</span></span></td>
    <td id="xdx_98F_ecustom--ProfessionalFeesExpense1_pn3n3_c20210101__20211231_zNMeeh1GxBM4" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProfessionalFeesExpense1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,559,094</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXNi8C4Hkuqg" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,297</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDVGRRCqtxkf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z7N2eKcdk0G3" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_z8XcJ394f622" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">160,277</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z98wkf2mrIif" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,498,408</ix:nonFraction></b></span></td>
    <td id="xdx_98B_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zBV2rjetsya1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zaNuHUrjHX56" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">151,958</ix:nonFraction></b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_znxz0CTNR5a8" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zk25RXXHv6Vh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,719,371</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    over time</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zwcQttcSSTBc" title="Transferred over time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,486,111</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzEIlJGihbz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,983</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgI9x2Q2wrz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">81,795</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zT1tfP3pJT41" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,640,889</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    at a point in time</span></td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqwTvNOGotC4" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">12,297</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxxlErX2jNQf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4968">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMoD9DADFXhg" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">70,163</ix:nonFraction></span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zBT7KScVc2I1" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,978</ix:nonFraction>)</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_zBh34sN79DXa" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">78,482</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zlm1oRwiewva" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2020-01-012020-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,002,461</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLMNFS1srROb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zHLC1uFcizP7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,152</ix:nonFraction></b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231_pn3n3" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--SegmentOfBusinessOneUnitMember_zo128EkT9JZb" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProfessionalFeesExpense1" contextRef="From2020-01-012020-12-31_custom_SegmentOfBusinessOneUnitMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">997,055</ix:nonFraction></span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0EcPHU3jc2g" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProfessionalFeesExpense1" contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_986_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231_zqh9I2xfCNee" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProfessionalFeesExpense1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,104,252</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXeEqWgiG0kb" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2020-01-012020-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,406</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIs5R1prWR0h" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,152</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231_zlQhvD1JH3Za" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">96,939</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zx06Pcjlzle2" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2020-01-012020-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,002,461</ix:nonFraction></b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zs0U5zD1WAk6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDp8jCOlamph" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">93,152</ix:nonFraction></b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231_z2kNWpQBvzt1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,201,191</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLjVGEt3ZzY7" title="Transferred over time" style="vertical-align: bottom; padding-right: 2.55pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2020-01-012020-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">997,055</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvDdTtl2Oq8c" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">107,197</ix:nonFraction></span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfvak12265m6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,306</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231_zCdmUie0L504" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,128,558</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zuNtbBthRV94" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2020-01-012020-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,406</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJrsOeAWUhYd" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">68,846</ix:nonFraction></span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,619</ix:nonFraction>)</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231_zEbTNHEcj9nf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,633</ix:nonFraction></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zd3fDHCdXNd4" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">653,760</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zqVKN9jh84w2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,870</ix:nonFraction></b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2KsslMQdyig" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,880</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zIq5DHUeOcn8" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231_zx9FQZa4jyLb" title="Types of services or goods" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:PaymentsToSuppliersForGoodsAndServices" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zO1X1lpTz9Da" title="Tuition fees" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,957</ix:nonFraction></span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj3l7PlhqXN7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:ProfessionalFeesExpense" contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">60,195</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98D_ecustom--ProfessionalFeesExpense1_pn3n3_c20190101__20191231_zigXcitC4lIf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProfessionalFeesExpense1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">709,152</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ3vUcYNlc1h" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,803</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4M8QEFMhXj2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,675</ix:nonFraction></span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zq1nk4cLDEr6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,880</ix:nonFraction></span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zXqmRjUEwSqi" title="Other" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231_zbCA4pSUZzse" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherRevenue" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">41,478</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPSQqGx2ZTh" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">653,760</ix:nonFraction></b></span></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJ4632C6EWxi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,870</ix:nonFraction></b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMrlEGBiTpei" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,880</ix:nonFraction></b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zSgumwJU0Rbi" title="Timing of revenue recognition" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231_z6QVlZREvbLi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="afya:TimingRevenueRecognition" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">750,630</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLOWEJKaZqBi" title="Transferred over time" style="vertical-align: bottom; padding-right: -2.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">648,957</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWMDmSFiNtV3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,870</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231_zLI4e8HkYsv7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:FeeAndCommissionIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">713,827</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_988_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQa9pWMQebLh" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2019-01-012019-12-31_custom_UndergradMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,803</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIJ01XzrNAfj" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,880</ix:nonFraction></span></td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zNNTXj7dMPEf" title="Transferred at a point in time" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,880</ix:nonFraction>)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231_zYeedTPsTeCb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:NetRevenueOtherTransferredPoint" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">36,803</ix:nonFraction></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8A4_zXHAwK07PHuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81A_z0KGNjcUGWml" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 251 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfExpensesByNatureExplanatory"><p id="xdx_808_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zcMStsRPac4f" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>20</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zh6fe9yTcuSg">Expenses
                                            and costs by nature</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:SummaryOfExpensesByNatureTableTextBlock"><p id="xdx_897_ecustom--SummaryOfExpensesByNatureTableTextBlock_zZlnbaVBKAm8" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B9_zz5KIFrq1RKa" style="display: none; visibility: hidden">Schedule of expenses by nature</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zASNR3Tik5Z2" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20200101__20201231_z87ngSk9iQOk" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49C_20190101__20191231_zUvyNPNXpG1j" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--CostOfSales_zwR11BJJyiri" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">652,300</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">434,654</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:CostOfSales" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">308,853</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zPnFjZj40Bmb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">622,615</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">402,855</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:GeneralAndAdministrativeExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">239,120</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ExpenseByNature_zRr3fv2mxPzi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,274,915</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">837,509</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:ExpenseByNature" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">547,973</ix:nonFraction>)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--Payroll_zrh1jzRDTwS7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payroll" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">677,564</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payroll" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">446,473</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Payroll" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">324,252</ix:nonFraction>)
    </span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_zC1BhQbjxRyc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital
    and medical agreements</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,449</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">37,988</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:HospitalAndMedicalAgreements" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">16,429</ix:nonFraction>)
    </span></td></tr>
  <tr id="xdx_407_eifrs-full--DepreciationExpense_z1IUNSU8NyRk" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    and amortization</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">154,220</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">108,744</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:DepreciationExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">73,152</ix:nonFraction>)
    </span></td></tr>
  <tr id="xdx_408_ecustom--LeaseExpenses_zNFGvIx7vTYc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">11,229</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,555</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:LeaseExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,494</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--UtilitiesExpense_zKGvIKSUZYB6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">10,643</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,892</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UtilitiesExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,628</ix:nonFraction>)
    </span></td></tr>
  <tr id="xdx_40C_eifrs-full--RepairsAndMaintenanceExpense_zIrk4OVrV6O7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,141</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,746</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:RepairsAndMaintenanceExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,658</ix:nonFraction>)
    </span></td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_zrNf1Q369RTl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">43,377</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,610</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:SharesBasedCompensation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,114</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--TaxExpenses_zRuKGSsZ31R" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,997</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">5,326</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,696</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--ServicesExpense_zC7DM0dyCPi6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical
    services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,881</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,037</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:ServicesExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,271</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_zIGZ31SIkot4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales
    and marketing</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,506</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">18,361</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:SalesAndMarketingExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">12,966</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_ecustom--AllowanceForDoubtfulAccounts_zoHp1Ec5SfS6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance
    for doubtful accounts</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccounts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">47,819</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccounts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">32,081</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:AllowanceForDoubtfulAccounts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,040</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_eifrs-full--TravelExpense_zodnFKTqumY6" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,542</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,550</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TravelExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,054</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_ecustom--ConsultingFees_zXuHmzH9bZ41" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting
    fees</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">38,818</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,276</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:ConsultingFees" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">13,060</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_405_ecustom--Other_zUzBp07dkQr" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Other" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">103,729</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Other" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">66,870</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:Other" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">39,159</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--ExpenseByNatureOne_iT_zKYFsO0wi141" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,274,915</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">837,509</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:ExpenseByNatureOne" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">547,973</ix:nonFraction>)</b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AB_zQsxiaGDAWvb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_817_zUWgVRU5i4x1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory"><p id="xdx_805_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zOAwpxR2FgB3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>21</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zt33nKUGZvlg">Finance
                                            result</span></b></span></td></tr></table>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfFinanceResult"><p id="xdx_897_ecustom--ScheduleOfFinanceResult_zRtn4GBtjlA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B2_zVbwQGDP0Kh9" style="display: none; visibility: hidden">Schedule of finance result</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49B_20210101__20211231_zV5Euy2eB5ih" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_490_20200101__20201231_zyyaSJOhf6yf" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 5.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49F_20190101__20191231_zaiVwXKTJzL9" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--InvestmentIncome_zYnnf5Zwgjga" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    from financial investments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,773</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,479</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:InvestmentIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,965</ix:nonFraction></span></td></tr>
  <tr id="xdx_400_ecustom--ChangesInFairValueOfDerivativeInstruments_zETaOgK8agah" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Changes
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5130">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ChangesInFairValueOfDerivativeInstruments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">20,739</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5132">-</span></span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromInterest_zxPhDMuI8iEb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    received</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">23,040</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">11,876</ix:nonFraction></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:RevenueFromInterest" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">9,680</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_eifrs-full--NetForeignExchangeGain_zVjIGHM6Ajc3" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5138">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5139">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:NetForeignExchangeGain" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,321</ix:nonFraction></span></td></tr>
  <tr id="xdx_401_eifrs-full--OtherFinanceIncome_zcb4rfG6joFe" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,753</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,196</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherFinanceIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,723</ix:nonFraction></span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_zD47KnUqqMm4" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    income</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">64,566</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">62,290</ix:nonFraction></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:FinanceIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">51,689</ix:nonFraction></b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ChangeInFairValueOfDerivativeInstruments_znyFRGXcxVDl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Change
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5150">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5151">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:ChangeInFairValueOfDerivativeInstruments" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,780</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_401_ecustom--InterestExpense1_ztvQ3LNvNyM" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">108,437</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">25,543</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpense1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">24,002</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_408_ecustom--InterestExpenseOnLeaseLiabilities1_zT5P2x644es9" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense on lease liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">67,212</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">44,458</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:InterestExpenseOnLeaseLiabilities1" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">31,469</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_403_ecustom--FinancialDiscountsGrantedExpenses_zeYxNw0kKkzb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial
    discounts granted</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">23,193</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">8,081</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:FinancialDiscountsGrantedExpenses" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">923</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_404_eifrs-full--BankAndSimilarCharges_zttp0aut67Pf" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank
    fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,878</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,333</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:BankAndSimilarCharges" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,876</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_409_eifrs-full--NetForeignExchangeLoss_zVPpI4SXYZh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">17,973</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:NetForeignExchangeLoss" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,613</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5172">-</span></span></td></tr>
  <tr id="xdx_404_ecustom--TaxOnFinancialOperations_z9kUCMmq4fX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF
    taxes (taxes on financial transactions)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,306</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,661</ix:nonFraction>)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxOnFinancialOperations" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">6,801</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--OtherFinanceCost_zUApyGb0GNc5" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">15,797</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,580</ix:nonFraction>)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:OtherFinanceCost" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,514</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_402_eifrs-full--FinanceCosts_iN_di_zpM1EJArnKi7" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">243,796</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">98,269</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:FinanceCosts" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">72,365</ix:nonFraction>)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceResult_zjql1nAyciV" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">179,230</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">35,979</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="afya:FinanceResult" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">20,676</ix:nonFraction>)</b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AF_znjpaFornZ3e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

</ix:nonNumeric><p id="xdx_81A_zWopEtugu3nb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfIncomeTaxExplanatory"><p id="xdx_807_eifrs-full--DisclosureOfIncomeTaxExplanatory_zGuLbjeT7E1f" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>22</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_820_z5gdoexqvU0c">Income
                                            taxes</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Income taxes are
comprised of taxation over operations in Brazil, related to Corporate Income Tax (&#34;IRPJ&#34;) and Social Contribution on Net Profit
(&#34;CSLL&#34;). According to Brazilian tax legislation, income taxes and social contribution are assessed and paid by legal entity
and not on a consolidated basis.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 252 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Reconciliation
of income taxes expense</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory"><p id="xdx_89A_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_zOVESf5Xynl2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following is a reconciliation of income tax expense to profit (loss) for the year, calculated by applying the combined Brazilian statutory
rates at 34% for the years ended December 31, 2021, 2020 and 2019:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B3_zQFstNDjvwf" style="display: none; visibility: hidden">Schedule of reconciliation of income tax expense</span></span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 56%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zlKxdtAQtCV4" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_496_20200101__20201231_zuEhJyWQZ9o7" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_499_20190101__20191231_z5IwB6tJzOS" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLossBeforeTax_zxizHVlqds7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">273,462</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">335,054</ix:nonFraction></b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:ProfitLossBeforeTax" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">186,937</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income
    taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20210101__20211231_z9xqAugZTHN4" title="Statutory rates"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20200101__20201231_zXNlgHWvuJed"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20190101__20191231_zL4NDjvXzDtc"><ix:nonFraction name="ifrs-full:ApplicableTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">34</ix:nonFraction></span>%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pii_z9Jw8nlf2kHl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory
    rates</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">92,977</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">113,918</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxExpenseIncomeAtApplicableTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">63,559</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40C_ecustom--ReconciliationAdjustmentsAbstract_iB_pii_zxF1trvIRDj8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pii_zimGS9YP1gq3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities
    not subject to taxation</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">37,794</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">8,474</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">1,265</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40A_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pii_zHF5GuRbzrU8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive
    <sup id="xdx_F45_z3QBg1jC6bM5">(a)</sup></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2021-01-01to2021-12-31" id="Fact005214" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">194,830</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2020-01-012020-12-31" id="Fact005215" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">120,851</ix:nonFraction></span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:ProgramaUniversidadeParaTodosFiscalIncentive" contextRef="From2019-01-012019-12-31" id="Fact005216" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">73,397</ix:nonFraction></span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pii_ztuiRAsbA8Pd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax
    assets</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">86,233</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">41,319</ix:nonFraction>)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:UnrecognisedDeferredTaxAssets" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">19,342</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pii_zvnrnuCTsCL" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income
    tax regime effect <sup id="xdx_F47_zpWgkFpTW1wb">(b)</sup></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2021-01-01to2021-12-31" id="Fact005222" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">7,066</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2020-01-012020-12-31" id="Fact005223" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">2,640</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" contextRef="From2019-01-012019-12-31" id="Fact005224" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">351</ix:nonFraction></span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustments_pii_zXVPe5J7Mu91" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">6,232</ix:nonFraction>)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="afya:PermanentAdjustments" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">2,567</ix:nonFraction></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5228">-</span></span></td></tr>
  <tr id="xdx_405_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pii_zk61X8wbPKNe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">4,293</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">15,866</ix:nonFraction></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:TaxExpenseOtherThanIncomeTaxExpense" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">3,757</ix:nonFraction>)</span></td></tr>
  <tr id="xdx_406_eifrs-full--CurrentTaxExpenseIncome_pii_zT3DjncGRDMd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense &#8211;
    current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">31,179</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">27,067</ix:nonFraction>)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(<ix:nonFraction name="ifrs-full:CurrentTaxExpenseIncome" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="BRL">14,175</ix:nonFraction>)</b></span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxRateEffectFromChangeInTaxRate_pii_dp_uPure_zQjJMw8LZVV2" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">11.40</ix:nonFraction>%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">8.08</ix:nonFraction>%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:TaxRateEffectFromChangeInTaxRate" contextRef="From2019-01-012019-12-31" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">7.58</ix:nonFraction>%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zybEHm3TG5Nf" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F17_z7hcORHSMY7b" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote005241" xml:lang="en-US">The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.</ix:footnote></span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0D_zUlifPwbXyal" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F1A_zHtN0tns1nch" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote005242" xml:lang="en-US">Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8AD_zSOCr1wZdpFi" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Deferred
income taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021, the Company had unrecognized deferred income tax assets on temporary differences and tax losses in the amount of R$ <span id="xdx_902_eifrs-full--DeferredTaxExpenseIncome_c20210101__20211231_zU732Km70ZRj" title="Unrecognized deferred income tax assets"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2021-01-01to2021-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">432,226</ix:nonFraction></span>
(tax-basis) (R$ <span id="xdx_908_eifrs-full--DeferredTaxExpenseIncome_c20200101__20201231_zQ37nLecwVW4" title="Unrecognized deferred income tax assets"><ix:nonFraction name="ifrs-full:DeferredTaxExpenseIncome" contextRef="From2020-01-012020-12-31" format="ixt:numdotdecimal" decimals="0" unitRef="BRL">214,387</ix:nonFraction></span> (tax-basis) as of December 31, 2020) which does not have any tax planning opportunities available that could
support the recognition of these temporary differences as deferred tax assets. Accordingly, the Company did not recognize deferred tax
assets.</span></p>

</ix:nonNumeric><p id="xdx_819_zryScylBvey3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfInsuranceContractsExplanatory"><p id="xdx_80D_eifrs-full--DisclosureOfInsuranceContractsExplanatory_zaU8rFfgppQ1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>23</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_820_z7DHQZ3JX1zh">Insurance
                                            contracts and contingencies</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Insurance contracts</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company and
its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking in the market coverage compatible with
its size and operations.</span></p>


<ix:exclude><!-- Field: Page; Sequence: 253 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Legal proceedings and contingencies</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfLegalProceedingsAndContingencies"><p id="xdx_899_ecustom--ScheduleOfLegalProceedingsAndContingencies_zCjeLFkoBj6a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The provisions
related to labor, civil and taxes proceedings whose likelihood of loss is assessed as probable are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BA_z9iIAEb3Zzyg" style="display: none; visibility: hidden">Schedule of legal proceedings and contingencies</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2018</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z8UDO3SiwKFg" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,233</ix:nonFraction></b></span></td>
    <td id="xdx_981_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znA9eMVrxCn" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,232</ix:nonFraction></b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBjyEpOS3yW6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5255">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zd3NiUXIP3Cl" title="Balance as of beginning of the year" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,465</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zQo7x8ZyWDfh" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,301</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zW9cJqkEBTT3" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,071</ix:nonFraction></span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHLNMLdpaue3" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5263">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zJEeaKOhYIbc" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,372</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHQHaP7e8ieh" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">737</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zkRZZHOMAshc" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,508</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFMIeGWTCOV9" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMkfliPLzhWi" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,245</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zY8daNmGE5x3" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,770</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuCWvzFir1F5" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,043</ix:nonFraction>)</span></td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBAIj2LDiYj2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5278">-</span></span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zzC2fHPV583l" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">4,813</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2019</b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zf7PBBcYjDyf" title="Balance as of beginning of the year" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,501</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zmonYaDRHCnb" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,768</ix:nonFraction></b></span></td>
    <td id="xdx_983_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLv1QkxmcQPl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5284">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z3K5hDatdlmk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,269</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zdYGwM4Lqmt" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,741</ix:nonFraction></span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zs5IqC2vuyF8" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,348</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zbbyvoi3MvO3" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">27,487</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" title="Business combinations" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">32,576</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zeBdtifnQRJ5" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">562</ix:nonFraction></span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq9oKLk6EVSg" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">10,869</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3CFb076mkie" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,853</ix:nonFraction></span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" title="Additions" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">19,284</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98B_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z4OLg8ZshPV9" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,285</ix:nonFraction>)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zccjfXBLQBD" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">2,705</ix:nonFraction>)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zSwqsnEJZps7" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5307">-</span></span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" title="Reversals" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">3,990</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2020</b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze3puQZUVxac" title="Balances as of end of the year" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,519</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zSHII53AtlGl" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">13,280</ix:nonFraction></b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zjpz44KKYkp9" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">35,340</ix:nonFraction></b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zgR22mw7n2r4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,139</ix:nonFraction></b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze4s4nAt2ZL5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">16,597</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znSN8BC2m9Y6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">6,017</ix:nonFraction></span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zxT1u4yM7JK" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">57,638</ix:nonFraction></span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zf4JeejDjFF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">80,252</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions
    <sup id="xdx_F48_zf7Sl47iLX5d">*</sup></span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_fKg_____zKj0zwSsNKnc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" id="Fact005319" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,418</ix:nonFraction></span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2UNDxa6RFc7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,101</ix:nonFraction></span></td>
    <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9wRoocXHyTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">14,225</ix:nonFraction></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zdeRYaSdPmAf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:AdditionalProvisionsOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">24,744</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFtJt91QLSBd" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,044</ix:nonFraction>)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zI9LtvfMCSIi" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">1,470</ix:nonFraction>)</span></td>
    <td id="xdx_98A_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zeQhGJuOw3zl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">7,334</ix:nonFraction>)</span></td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8YA4KKCj5h7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(<ix:nonFraction name="ifrs-full:UnusedProvisionReversedOtherProvisions" contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" sign="-" unitRef="BRL">9,848</ix:nonFraction>)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2021</b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zX8giQ4gU5Mj" title="Balance as of ending of the year" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">25,490</ix:nonFraction></b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zJX2O4P55Jfa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">22,928</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHBevEWvLmxa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">99,869</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zOJZyP2lUQJ4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:Provisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">148,287</ix:nonFraction></b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_zTwrzJY5utsk" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"></td><td style="text-align: justify"><span id="xdx_F15_zCbwxgxWXBY7" style="font-family: Arial, Helvetica, Sans-Serif"><ix:footnote id="Footnote005332" xml:lang="en-US">The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.</ix:footnote></span></td>
</tr></table>

</ix:nonNumeric><p id="xdx_8A7_zuUbiMBqApJ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement"><p id="xdx_896_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_zFatfWCJR4hh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">There are other
civil, labor, taxes and social security proceedings assessed by Management and its legal counsels as possible risk of loss, for which
no provisions are recognized, as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zk09jwvyWY3g" style="display: none; visibility: hidden">Schedule of social security proceedings assessed by Management</span>&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 17%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_982_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVN1npePd7x5" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">5,098</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zaIEIzu4as5a" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">2,318</ix:nonFraction></span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zDIk0IypT0g4" title="Total" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">3,570</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z8kMG0xChqwj" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">56,501</ix:nonFraction></span></td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" title="Total" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">59,969</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2KQDeH9A2yd" title="Total" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">39,135</ix:nonFraction></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes
    and social security</span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zejfGsQ62ggf" title="Total" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,459</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_pn3n3" title="Total" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">4,375</ix:nonFraction></span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zfS1CcgPpF8g" title="Total" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">7,583</ix:nonFraction></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231_z3HPbKuhXzB6" title="Total" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2021-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">66,058</ix:nonFraction></b></span></td>
    <td id="xdx_98F_eifrs-full--OtherProvisions_c20201231_pn3n3" title="Total" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2020-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">66,662</ix:nonFraction></b></span></td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_iI_pn3n3_c20191231_ztNLLA91sHP" title="Total" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><ix:nonFraction name="ifrs-full:OtherProvisions" contextRef="AsOf2019-12-31" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">50,288</ix:nonFraction></b></span></td></tr>
  </table>
</ix:nonNumeric><p id="xdx_8AA_zVTS3MWAlVil" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
judicial deposits recorded in other assets (non-current) in the amount of R$ <span id="xdx_900_ecustom--JudicialDeposits_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Judicial deposits"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">18,825</ix:nonFraction></span> as of December 31, 2021 (December 31, 2020: R$ <span id="xdx_906_ecustom--JudicialDeposits_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zn2vUkEoHn12" title="Judicial deposits"><ix:nonFraction name="afya:JudicialDeposits" contextRef="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">1,451</ix:nonFraction></span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Under the terms
of the Share Purchase and Sale Agreements (&#34;Agreements&#34;) between the Company and the selling shareholders of the subsidiaries
acquired, the Company assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and
civil), which are or will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission,
prior to or on the closing dates of the acquisitions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Accordingly, and
considering that the provisions for legal proceedings recorded by the Company that result from causes arising from events occurring prior
to the closing dates of the acquisitions, any liability for the amounts to be disbursed, in case of their effective materialization in
loss, belongs exclusively to the selling shareholders. In this context, the Agreements state that the Company and its subsidiaries are
indemnified and therefore exempt from any liability related to said contingent liabilities and, therefore, the provision amounts related
to such contingencies are presented in the non-current liabilities and the correspondent amount of R$ <span id="xdx_903_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_z3Fi2tG0ge5e" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">135,355</ix:nonFraction></span> (December 31, 2020: R$
<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zQQdBFFRe6Vd" title="Contingencies correspondent amount"><ix:nonFraction name="afya:ContingenciesCorrespondentAmount" contextRef="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember" format="ixt:numdotdecimal" decimals="-3" scale="3" unitRef="BRL">53,499</ix:nonFraction></span>) is presented in non-current other assets.</span></p>

</ix:nonNumeric><p id="xdx_814_z0my7SEtoo4i" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>


<!-- Field: Page; Sequence: 254 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page -->
<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="afya:DisclosureNoncashTransactionsExplanatory"><p id="xdx_800_ecustom--DisclosureNoncashTransactionsExplanatory_z7SIn7x4vqV6" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>24</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_827_zqgwZ69J0JDj">Non-cash
                                            transactions</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">During the years
ended December 31, 2021, 2020 and 2019, the Company carried out non-cash transactions which are not reflected in the statement of cash
flows. The main non-cash transactions in 2021 were the issuance of shares for the acquisitions of iClinic, Cliquefarma, and RXPRO, addition
of the provision for legal proceedings with corresponding indemnification assets, additions and remeasurements of right-of-use assets
and lease liabilities.</span></p>

</ix:nonNumeric><p id="xdx_816_zhALKoZablx1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<ix:nonNumeric contextRef="From2021-01-01to2021-12-31" escape="true" name="ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory"><p id="xdx_80C_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zMvB6X2ICdca" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"></td><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>25</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zZJ3r6bDBff3">Subsequent
                                            events</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Repurchase shares program</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On January 27,
2022, the Company&#8217;s board of directors approved a new share repurchase program. Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zoPsJp6DiXC3" title="Repurchase shares program"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2022-01-27_custom_ClassAOrdinarySharesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">1,874,457</ix:nonFraction></span> of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January
27, 2022 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Medical schools authorizations</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 23,
2022, Afya announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#8220;MEC&#8221;)
authorized the operations of the medical schools in Abaetetuba, in the State of Par&#225;, and Itacoatiara, in the State of Amazonas,
both under Mais M&#233;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">On
March 16, 2022, MEC authorized the operations of the medical schools in </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Bragan&#231;a,
in the State of Par&#225;, and Manacapuru, in the State of Amazonas</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">,
both under Mais M&#233;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>c)
Acquisition of Al&#233;m da Medicina</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 24,
2022, Afya Brazil announced the acquisition of <span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pii_dp_uPure_c20220224__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicParticipacoesSAMember_zZ7kQn1Thc4k" title="Proportion of ownership interest"><ix:nonFraction name="ifrs-full:PercentageOfVotingEquityInterestsAcquired" contextRef="AsOf2022-02-24_custom_IClinicParticipacoesSAMember" format="ixt:numdotdecimal" decimals="INF" scale="-2" unitRef="Pure">100</ix:nonFraction></span>% of the total share capital of Al&#233;m da Medicina. The deal was closed March
4, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Al&#233;m da
Medicina is a medical content online platform for physicians and medical students that provides educational tools besides technical medical
content that can assist them throughout their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting,
and investment basics for physicians.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The aggregate purchase
price was R$16.000 paid in cash. An earn-out of up to R$19.200 can be paid related to gross revenue achievements for 2023 and 2024.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
date fair value of each major class of consideration, including the allocation of the purchase price has not been completed by the Company
as of the issuance date of these annual financial statements. The impact on revenue and profit or loss of the combined entity for the
current reporting period as if the acquisition date had been as of the beginning of the annual reporting period is not available as the
Company did not conclude this acquisition by December 31, 2021. Therefore, these financial statements do not include this information.
The transaction costs to date amounted to R$ 211.&#160;Any goodwill generated in the transaction is not expected to be deductible for
tax purposes.<br /></span></p>


<ix:exclude><!-- Field: Page; Sequence: 255 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><p style="margin-top: 0; margin-bottom: 0">&#160;</p><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence -->&#160;</td></tr></table></div>
    <div style="page-break-before: always; margin-top: 6pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%"><p style="font: 13pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left; color: #C0504D"><b>Afya Limited</b></p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Notes to the consolidated financial statements</p><p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: left">Expressed in thousands of Brazilian reais, unless otherwise stated</p></td></tr></table><p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p></div>
    <!-- Field: /Page --></ix:exclude>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>d)
Bertelsmann Explores Increasing Stake in Afya </b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 7, 2022,
Afya announced that it was notified that Nicolau Carvalho Esteves and Ros&#226;ngela de Oliveira Tavares Esteves, or the Esteves family,
have made a binding offer to sell <span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220307__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_z5rW4jJu8cU8"><ix:nonFraction name="afya:RepurchaseOfOrdinaryShares" contextRef="AsOf2022-03-07_custom_ClassBOrdinarySharesMember_custom_NicolauCarvalhoEstevesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="Shares">6,000,000</ix:nonFraction></span> Class B common shares of Afya at the purchase price of US$<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20220307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zRlzg9QRHtj" title="Purchase prices per share"><ix:nonFraction name="ifrs-full:ParValuePerShare" contextRef="AsOf2022-03-07_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember" format="ixt:numdotdecimal" decimals="INF" unitRef="BRLPShares">26.90</ix:nonFraction></span> per share to an affiliate
of Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221;. Bertelsmann&#8217;s acceptance of the offer remains subject to due diligence
and Bertelsmann board approval.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>e)
Medical Seats Increase in Centro Universit&#225;rio S&#227;o Lucas</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 18, 2022,
Afya announced that MEC authorized the increase of 28 seats of Centro Universit&#225;rio S&#227;o Lucas, in Ji-Parana located in
the state of Rond&#244;nia.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The earn-out related
to the seats approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which: (i) 50% is payable
in 30 days, and (ii) 50% is payable in cash in two equal installments through 2024.</span></p>

</ix:nonNumeric><p id="xdx_812_zo6luIukT41f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">***</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"></span></p>

<table cellpadding="0" cellspacing="0" style="width: 100%"><tr><td style="text-align: center; width: 100%">F-82&#160;</td></tr></table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.2
<SEQUENCE>2
<FILENAME>ex01-2.htm
<DESCRIPTION>EX-1.2
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: right"><B>Exhibit 1.2</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>THE COMPANIES ACT (AS REVISED)</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>EXEMPTED COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AMENDED AND RESTATED </B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>MEMORANDUM AND ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: left; text-indent: 1.5in">&nbsp;</P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AFYA LIMITED</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by Special Resolution passed on JULY 23, 2021)</B></FONT></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;</B></FONT></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>&nbsp;<BR STYLE="clear: both">
</B></FONT></P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>THE COMPANIES ACT (AS REVISED)</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>EXEMPTED COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>MEMORANDUM OF ASSOCIATION</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AFYA LIMITED</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by Special Resolution passed on JULY 23, 2021)</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1</TD><TD STYLE="text-align: justify">The name of the Company is <B>Afya Limited</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">2</TD><TD STYLE="text-align: justify">The registered office of the Company shall be at the offices of of Maples Corporate Services Limited,
PO Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman Islands, or at such other place within the Cayman Islands as the Directors may
decide.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3</TD><TD STYLE="text-align: justify">Subject to the following provisions of this Memorandum, the objects for which the Company is established
are unrestricted.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4</TD><TD STYLE="text-align: justify">Subject to the following provisions of this Memorandum, the Company shall have and be capable of exercising
all the functions of a natural person of full capacity irrespective of any question of corporate benefit, as provided by Section 27(2)
of the Companies Act (as revised).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5</TD><TD STYLE="text-align: justify">Nothing in this Memorandum shall permit the Company to carry on a business for which a licence is required
under the laws of the Cayman Islands unless duly licensed.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6</TD><TD STYLE="text-align: justify">The Company shall not trade in the Cayman Islands with any person, firm or corporation except in furtherance
of the business of the Company carried on outside the Cayman Islands; provided that nothing in this clause shall be construed as to prevent
the Company effecting and concluding contracts in the Cayman Islands, and exercising in the Cayman Islands all of its powers necessary
for the carrying on of its business outside the Cayman Islands.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7</TD><TD STYLE="text-align: justify">The liability of each Member is limited to the amount from time to time unpaid on such Member's shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8</TD><TD STYLE="text-align: justify">The share capital of the Company is US$50,000 divided into 1,000,000,000 shares of a nominal or par value
of US$0.00005 each which, at the date on which this Memorandum becomes effective, comprise (i) 500,000,000 Class A Common Shares; (ii)
250,000,000 Class B Common Shares (which Class B Common Shares may be converted into Class A Common Shares in the manner contemplated
in these Articles of Association of the Company); and (iii) 250,000,000 shares of such class or classes (howsoever designated) and having
the rights as the Board may determine from time to time in accordance with Article 4 of the Articles of Association of the Company, PROVIDED
THAT, subject to the Law and the Articles of Association, the Company shall have the power to issue all or any part of its capital, whether
original, redeemed, increased or reduced, with or without any preference,
priority, special privilege or other rights or subject to any postponement of rights or to any condition or restriction whatsoever and
so that, unless the conditions of issue shall otherwise expressly provide, every issue of shares, whether stated to be common, preference
or otherwise shall be subject to the powers on the part of the Company hereinbefore provided.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9</TD><TD STYLE="text-align: justify">The Company may exercise the power contained in the Law to deregister in the Cayman Islands and be registered
by way of continuation in another jurisdiction.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10</TD><TD STYLE="text-align: justify">Capitalised terms that are not defined in this Memorandum of Association bear the meaning given in the
Articles of Association of the Company.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>THE COMPANIES ACT (AS REVISED)</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>EXEMPTED COMPANY LIMITED BY SHARES</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AMENDED AND RESTATED</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>ARTICLES OF ASSOCIATION</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>OF</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><B>AFYA LIMITED</B></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0; text-align: center"><FONT STYLE="text-transform: uppercase"><B>(adopted
by Special Resolution passed on JULY 23, 2021)</B></FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">1</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Preliminary</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.1</TD><TD STYLE="text-align: justify">The regulations contained in Table A in the First Schedule of the Law shall not apply to the Company and
the following regulations shall be the Articles of Association of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">1.2</TD><TD STYLE="text-align: justify">In these Articles:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the following terms shall have the meanings set opposite if not inconsistent with the subject or context:</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Allotment&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; font: 12pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">shares are taken to be allotted when a person acquires the unconditional right to be included in the Register of Members in respect of those shares;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Affiliate&quot;</B></FONT></TD>
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">in respect of a Person, means any other Person that, directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is Under Common Control with, such Person, and (i) in the case of a natural person, shall include, without limitation, such person&rsquo;s spouse, parents and children, a trust for the benefit of any of the foregoing, a company, partnership or any natural person or entity wholly or jointly owned by any of the foregoing, and (ii) in the case of an entity, shall include a partnership, a corporation or any natural person or entity which directly or indirectly, through one or more intermediaries, Controls, is Controlled by, or is Under Common Control with, such entity; </FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Anti-Corruption Law&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means the Anti-Corruption Act (as revised) of the Cayman Islands, the United States of America Foreign Corrupt Practices Act and any Brazilian law, in each case as amended from time to time, that inhibits or prohibits corruption or the practice of any offer, payment, promise of payment or authorization of payment of any value or other form of property, gift, promise of offer, or authorization to donate anything of value to any governmental agent or any political party or member of a political party or candidate for public office;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Articles&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">these articles of association of the Company as from time to time amended in accordance with applicable Law and these Articles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Audit Committee&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the audit committee of the Company formed by the Board pursuant to Article 24 hereof, or any successor of the audit committee;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Authorised Auditor&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means any of the following audit firms, or international entities of the same group, as the case may be: (i) Deloitte Touche Tohmatsu; (ii) KPMG; (iii) Ernst &amp; Young Terco; or (iv)&nbsp;PriceWaterhouseCoopers;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&ldquo;Bertelsmann&rdquo;</B></FONT></TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Bertelsmann SE &amp; Co. KGaA, a company headquartered in the City of G&uuml;tersloh, Germany and/or its Affiliates;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Bertelsmann Director&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a director appointed by Bertelsmann in accordance with Article 21.1; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Board or Board of Directors&quot; or &quot;Directors&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the board of directors of the Company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Business Combination&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a statutory amalgamation, merger, consolidation, arrangement or other reorganisation requiring the approval of the members of one or more of the participating companies, as well as a short-form merger or consolidation that does not require a resolution of members;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Business Day&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">any day on which banks are not required or authorised by law to close in the City of New York/NY, USA and/or in the following cities in Brazil: in the City of S&atilde;o Paulo, State of S&atilde;o Paulo, in the City of Nova Lima, State of Minas Gerais, in the City of Brasilia, Federal District, or in the City of Rio de Janeiro, State of Rio de Janeiro;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Chairman&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the chairman of the Board of Directors appointed in accordance with Article 20.2;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Class A Common Shares&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">class A common shares of a nominal or par value of US$0.00005 each in the capital of the Company having the rights provided for in these Articles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Class B Common Shares&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">class B common shares of a nominal or par value of US$0.00005 each in the capital of the Company having the rights provided for in these Articles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Clear Days&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">in relation to a period of notice means that period excluding both the day when the notice is given or deemed to be given and the day for which it is given or on which it is to take effect;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Clearing House&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a clearing house recognised by the laws of the jurisdiction in which shares in the capital of the Company (or depository receipts thereof) are listed or quoted on a stock exchange or interdealer quotation system in such jurisdiction;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Common Shares&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Class A Common Shares, Class B Common Shares and shares of such other classes as may from time to time be designated by the Board pursuant to these Articles as being common shares for the purposes of Article &#8206;5.2;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Company&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the above named company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Company&rsquo;s Website&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the website of the Company and/or its web-address or domain name;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Compensation Committee&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the compensation committee of the Company formed by the Board pursuant to Article 24.7 hereof, or any successor of the compensation committee;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Control&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">(including the terms &quot;<B>Controls</B>,&quot; &quot;<B>Controlled by</B>&quot; and &quot;<B>Under Common Control with</B>&quot;) means, with respect to any Person or group of Persons (&quot;<B>Controlling Person</B>&quot;), directly or indirectly: (a) the ability of the Controlling Person, whether through the ownership of voting securities of another Person (&quot;Controlled Person&quot;) or by contract or otherwise to: (i) elect the majority of the board of directors or other similar managing body of such Controlled Person, or (ii) direct the management policies of such Controlled Person, or (b)&nbsp;the ownership of rights that entitle the Controlling Person to have the majority of the votes in such Controlled Person&rsquo;s general meeting;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Corruption Act&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means any act involving the gift, offer, receipt or agreement to receive (solely or jointly with other Persons) any payment, gratuity or other advantage in business with the public or private sector that: (i) violates or is intended to violate any Anti-Corruption Laws; (ii) influences or is intended to influence any Person to act; (iii) improperly rewards any Person for acting in disagreement with expected good faith, impartiality or trust; or (iv) influences (or is intended to influence) a governmental authority to grant or maintain an advantage in the conduct of business;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt; text-align: justify"><B>&quot;Designated Stock </B></P>
    <P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt; text-align: justify"><B>Exchange&quot;</B></P></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Nasdaq Global Market and any other stock exchange or interdealer quotation system listed in Schedule 4 of the Law on which shares in the capital of the Company are listed or quoted;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Directors&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Directors for the time being of the Company or, as the case may be, those Directors assembled as a Board or as a committee of the Board;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Dividend&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">includes a distribution or interim dividend or interim distribution;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Electronic&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the same meaning as in the Electronic Transactions Act (as revised);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Electronic Communication&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a communication sent by Electronic means, including Electronic posting to the Company&rsquo;s Website, transmission to any number, address or internet website (including the SEC&rsquo;s website) or other Electronic delivery methods as otherwise decided and approved by the Board;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Electronic Record&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the same meaning as in the Electronic Transactions Act (as revised);</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Electronic Signature&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the same meaning as in the Electronic Transactions Act (as revised);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Esteves Family&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means, jointly, Nicolau Carvalho Esteves (enrolled before the Brazilian Individual Taxpayers&rsquo; Register CPF/ME under No.&nbsp;119.441.616-00) and Rosangela de Oliveira Tavares Esteves (enrolled before the Brazilian Individual Taxpayers&rsquo; Register CPF/ME under No&nbsp;279.226.266-49);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Esteves Family Director&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a director appointed by the Esteves Family in accordance with Article&nbsp;21.2;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Exchange Act&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Securities Exchange Act of 1934, as amended of the United States of America;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Executed&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">includes any mode of execution;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Founder Shares&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">(i.e. <I>partes benefici&aacute;rias</I>) means any securities that grant a percentage of the Company's annual profits to its holder, with no corresponding interest in the share capital of the Company and no par value;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Holder&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">in relation to any share, the Member whose name is entered in the Register of Members as the holder of the share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Incentive Plan&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">any incentive plan established or implemented by the Company pursuant to which any Person who provides services of any kind to the Company or any of its direct or indirect subsidiaries (including, without limitation, any employee, executive, officer, director, consultant, secondee or other provider of services) may receive and/or acquire newly-issued shares of the Company or any interest therein; </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Incriminating Event&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means (i) the definitive, evidenced, involvement of any Member in a Corruption Act or in money laundering; and/or (ii) any act of improbity involving any Member, confirmed by a duly published Appeal Court decision (decis&atilde;o de 2a inst&acirc;ncia), and which necessarily affects the ability or prevents the Company and/or its Subsidiaries from transacting with public entities or from being granted tax incentives/benefits;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Indemnified Person&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">every Director, alternate Director, Secretary or other Officer for the time being or from time to time of the Company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Independent Director&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a Director who is an independent director as defined in the rules of any Designated Stock Exchange or in Rule 10A-3 under the Exchange Act, as the case may be;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Islands&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the British Overseas Territory of the Cayman Islands;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Law&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Companies Act (as revised);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Lease Agreements&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means any lease agreements (including free lease agreement) entered into by the Company or any of the Company&rsquo;s Subsidiaries, at any time, with respect to the main place of business of the Company and/or its Subsidiaries and/or their respective branches;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Major Shareholders&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means Bertelsmann and the Esteves Family;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Member&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the same meaning as in the Law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Memorandum&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the memorandum of association of the Company as from time to time amended in accordance with applicable Law and these Articles;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Month&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a calendar month;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">
    <P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt; text-align: justify"><B>&quot;Nominating and Corporate </B></P>
    <P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt; text-align: justify"><B>Governance Committee&quot;</B></P></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the nominating and corporate governance committee of the Company formed by the Board pursuant to Article 24 hereof, or any successor of the nominating and corporate governance committee;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Officer&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means any officer of the Company appointed by the Board in accordance with these Articles and includes any Secretary;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Ordinary Resolution&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a resolution (i) of a duly constituted general meeting of the Company passed by a simple majority of the votes cast by, or on behalf of, the Members entitled to vote present in person or by proxy and voting at the meeting, or (ii) approved in writing by all of the Members entitled to vote at a general meeting of the Company in one or more instruments each signed by one or more of the Members and the effective date of the resolution so adopted shall be the date on which the instrument, or the last of such instruments, if more than one, is executed;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Other Indemnitors&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">persons or entities other than the Company that may provide indemnification, advancement of expenses and/or insurance to the Indemnified Persons in connection with such Indemnified Persons&rsquo; involvement in the management of the Company;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&ldquo;Ownership Threshold&rdquo;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a number of Class B Common Shares representing 10% of the total outstanding number of Class B Common Shares. </FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Paid up&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">paid up as to the par value of the shares and includes credited as paid up;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Permitted Transfer&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the meaning set forth in Article&nbsp;5.4(3);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Permitted Transferee&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the meaning set forth in Article&nbsp;5.4(3);</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Person&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">any individual, corporation, general or limited partnership, limited liability company, joint stock company, joint venture, estate, trust, association, organisation or any other entity or governmental entity;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Related Party&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means: (i) with respect to a Person other than an individual, any of the Controlled Persons, Controlling Persons and/or any other Person under common Control with, and/or shareholders and/or quotaholders, directly or indirectly holding more than ten percent (10%) of the shares of the total voting capital or capital stock or undivided interest (in relation to an investment fund established as a condominium) of such Person, and its employees and/or administrators; and (ii) in relation to an individual: (a) all ascending or descending family members in direct degree, spouse and/or relatives from the 1<SUP>st</SUP> to the 4<SUP>th </SUP>degree; and (b) any of the Controlled Companies or its shareholders and/or quotaholders holding directly or indirectly more than ten percent (10%) of the shares or quotas representing the total voting or capital stock of the referred Person, as well as its employees and/or administrators;</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Register of Members&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the register of Members required to be kept pursuant to the Law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Seal&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the common seal of the Company including every duplicate seal;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;SEC&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Securities and Exchange Commission of the United States of America or any other federal agency for the time being administering the Securities Act;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Secretary&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">any person appointed by the Directors to perform any of the duties of the secretary of the Company, including a joint, assistant or deputy secretary;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Securities Act&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">the Securities Act of 1933 of the United States of America, as amended, or any similar federal statute and the rules and regulations of the SEC thereunder, all as the same shall be in effect at the time;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Share&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a share in the share capital of the Company and includes a fraction of a share;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Signed&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">includes an Electronic Signature or a representation of a signature affixed by mechanical means;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Special Resolution&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">has the same meaning as in the Law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Subsidiary&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">means, with respect to any Person, any company or other organisation, whether incorporated or unincorporated, that, at the time of determination, is directly or indirectly wholly-owned or Controlled by such Person and/or any one or more of its Subsidiaries;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Treasury Share&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a share held in the name of the Company as a treasury share in accordance with the Law;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;U.S. Person&quot;</B></FONT></TD>
    <TD STYLE="padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">a Person who is a citizen or resident of the United States of America; and</FONT></TD></TR>
  </TABLE>

<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 33%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"><B>&quot;Written and in Writing&quot;</B></FONT></TD>
    <TD STYLE="width: 67%; padding-top: 12pt; padding-bottom: 6pt; text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">includes all modes of representing or reproducing words in visible form including in the form of an Electronic Record.</FONT></TD></TR>
  </TABLE>
<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">unless the context otherwise requires, words or expressions defined in the Law shall have the same meanings
herein, but excluding any statutory modification thereof not in force when these Articles become binding on the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">unless the context otherwise requires: (i) words importing the singular number shall include the plural
number and vice-versa, and (ii) words importing the masculine gender only shall include the feminine or neutral gender;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">the word &quot;may&quot; shall be construed as permissive and the word &quot;shall&quot; shall be construed
as imperative;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">the headings herein are for convenience only and shall not affect the construction of these Articles;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">references to statutes are, unless otherwise specified, references to statutes of the Islands and, subject
to paragraph (b) above, include any statutory modification or re-enactment thereof for the time being in force;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">the terms &quot;hereof,&quot; &quot;herein,&quot; &quot;hereto&quot; and &quot;hereunder,&quot; as well
as words of a similar meaning, when used in these Articles, shall refer to these Articles as a whole and not to any specific provision
of these Articles;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">whenever the words &quot;include,&quot; &quot;includes,&quot; &quot;including&quot; and similar expressions
are used under the terms of these Articles, they shall mean &quot;include, among others,&quot; &quot;includes, without limitation&quot;
and &quot;including, without limitation,&quot; respectively or a similar expression indicating a non-restrictive enumeration; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">where an Ordinary Resolution is expressed to be required for any purpose, a Special Resolution is also
effective for that purpose.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">2</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Formation Expenses</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Directors may
pay, out of the capital or any other monies of the Company, all expenses incurred in or about the formation and establishment of the Company
including the expenses of registration.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">3</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Situation of Offices of the
Company</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.1</TD><TD STYLE="text-align: justify">The registered office of the Company shall be at such address in the Islands as the Board shall from time
to time determine.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">3.2</TD><TD STYLE="text-align: justify">The Company, in addition to its registered office, may establish and maintain such other offices, places
of business and agencies in the Islands and elsewhere as the Board may from time to time determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">4</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">4.1</TD><TD STYLE="text-align: justify">(a)&#9;Subject to the rules of any Designated Stock Exchange and to the provisions, if any, in the Memorandum
and these Articles, the Board has general and unconditional authority to allot, grant options over, offer or otherwise deal with or dispose
of any unissued shares in the capital of the Company without the approval of Members (whether forming part of the original or any increased
share capital), either at a premium or at par, with or without preferred, deferred or other special rights or restrictions, whether in
regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions, and at such times as the
Board may decide, but so that: (i)&nbsp;no share shall be issued at a discount, except in accordance with the provisions of the Law and
these Articles; and (ii)&nbsp;no Founder Shares shall be issued by the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Subject to the rules of any Designated Stock Exchange and to the provisions, if any, in the Memorandum
and these Articles (including, without limitation, Article 23.4), in particular and without prejudice to the generality of paragraph (a)
above, the Board is hereby empowered to authorise by resolution or resolutions from time to time and without the approval of Members:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the creation of one or more classes or series of preferred shares, to cause to be issued such preferred
shares and to fix the designations, powers, preferences and relative participating, optional and other rights, if any, and the qualifications,
limitations and restrictions thereof, if any, including, without limitation, the number of shares constituting each such class or series,
dividend rights, conversion rights, redemption privileges, voting rights and powers (including full or limited or no voting rights or
powers) and liquidation preferences, and to increase or decrease the number of shares comprising any such class or series (but not below
the number of shares of any class or series of preferred shares then outstanding) to the extent permitted by law. Without limiting the
generality of the foregoing, the resolution or resolutions providing for the establishment of any class or series of preferred shares
may, to the extent permitted by law, provide that such class or series shall be superior to, rank equally with or be junior to the preferred
shares of any other class or series;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">to designate for issuance as Class A Common Shares or Class B Common Shares from time to time any or all
of the authorised but unissued shares of the Company which have not at that time been designated by the Memorandum or by the Directors
as being shares of a particular class;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">to create one or more further classes of shares which represent common shares for the purposes of Article
&#8206;5.2; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">to re-designate authorised but unissued Class B Common Shares from time to time as shares of another class.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Company shall not issue shares or warrants to bearer.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Subject to the rules of any Designated Stock Exchange, the Memorandum and these Articles (including, without
limitation, Article 23.4), the Board shall have general and unconditional authority to issue options, warrants or convertible securities
of similar nature conferring the right upon the holders thereof to subscribe for, purchase or receive any class of shares or securities
in the capital of the Company to such persons, on such terms and conditions and at such times as the Board may decide.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.2</TD><TD STYLE="text-align: justify">Notwithstanding Article &#8206;4.1, at any time when there are Class A Common Shares in issue, Class&nbsp;B
Common Shares may only be issued pursuant to:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">a share-split, subdivision or similar transaction or as contemplated in Articles &#8206;5.6 or &#8206;34(b)
below;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">a Business Combination; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">an issuance of shares (including, without limitation, Class A Common Shares, any other class of share
designated as a Common Share as per these Articles, and/or preferred shares), whereby each holder of Class B Common Shares is entitled
to purchase a number of Class B Common Shares that would allow such holder to maintain its proportional ownership interest in the Company
pursuant to Article &#8206;4.3.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.3</TD><TD STYLE="text-align: justify">With effect from the date on which any shares of the Company are first admitted to trading on a Designated
Stock Exchange, subject to Articles &#8206;4.4, &#8206;4.5 and &#8206;4.6, the Company shall not issue Common Shares and/or preferred
shares to a person on any terms unless:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">it has made an offer to each person who holds Class B Common Shares to issue to him on the same economic
terms such number of Class B Common Shares as would allow each holder of Class B&nbsp;Common Shares to maintain its proportional ownership
interest in the Company; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the period during which any such offer set forth in Article&nbsp;4.3(a) may be accepted has expired or
the Company has received notice of the acceptance or refusal of every offer so made in accordance with Article&nbsp;4.3(a).</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">An offer made pursuant
to this Article &#8206;4.3 may be made in either hard copy or by Electronic Communication, must state a period during which it may be
accepted and the offer shall not be withdrawn before the end of that period. The period referred to must be at least fifteen (15) Business
Days beginning with the date on which the offer is deemed to be delivered in accordance with Article &#8206;36.</P>


<!-- Field: Page; Sequence: 14 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.4</TD><TD STYLE="text-align: justify">An offer shall not be regarded as being made contrary to the requirements of Article &#8206;4.3 by reason
only that:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">fractional entitlements are rounded or otherwise settled or sold at the discretion of the Board, as long
as it does not materially negatively impact the proportional ownership interest of the Class B Common Shares; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">no offer of Class B Common Shares is made to a shareholder where the making of such an offer would in
the view of the Board pose legal or practical problems in or under the laws or securities rules of any territory or the requirements of
any regulatory body or stock exchange such that the Board considers it is necessary or expedient in the interests of the Company to exclude
such shareholder from the offer; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the offer is conditional upon the said issue of Common Shares and/or preferred shares proceeding.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.5</TD><TD STYLE="text-align: justify">The provisions of Article &#8206;4.3 do not apply in relation to the issue of:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Class A Common Shares if these are, or are to be, wholly or partly paid up otherwise than in cash; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Class A Common Shares which would, apart from any renunciation or assignment of the right to their allotment,
be held under or issued pursuant to an Incentive Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.6</TD><TD STYLE="text-align: justify">Holders of Class B Common Shares may from time to time by consent in writing (in one or more counterparts)
approved by the holder or holders of all issued and outstanding Class B Common Shares, referring to this Article &#8206;4.6, authorise
the Board to issue Common Shares for cash and, on the granting of such an authority, the Board shall have the power to issue (pursuant
to that authority) Common Shares for cash as if Article &#8206;4.3 above did not apply to:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">one or more issuances of Class A Common Shares to be made pursuant to that authority; and/or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">such issuances with such modifications as may be specified in that authority.</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">Unless previously
revoked, the authority granted in accordance with this Article 4.6 shall expire on the date (if any) specified in the authority or, if
no date is specified, twelve (12) months after the date on which the authority is granted, but the Company may before the power expires
make an offer or agreement which would or might require Class A Common Shares to be issued after it expires.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.7</TD><TD STYLE="text-align: justify">Notwithstanding Article &#8206;4.1 and subject to Article 23.4, no non-voting Common Shares shall be issued
without such issuance first being approved by an Ordinary Resolution of Members which resolution is also passed with the affirmative vote
of a majority of the then issued and outstanding Class A Common Shares.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 15 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.8</TD><TD STYLE="text-align: justify">The Company may issue fractions of a share of any class and a fraction of a share shall be subject to
and carry the corresponding fraction of liabilities (whether with respect to nominal or par value, premium, contribution, calls or otherwise
howsoever), limitations, preferences, privileges, qualifications, restrictions, rights and other attributes of a whole share of that class
of shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.9</TD><TD STYLE="text-align: justify">The Company may, in so far as the Law permits, pay a commission to any person who is not a Related Party
in consideration of his subscribing or agreeing to subscribe, whether absolutely or conditionally, or procuring or agreeing to procure
subscriptions (whether absolute or conditional) for any shares in the capital of the Company. Such commissions may be satisfied by the
payment of cash or the allotment of fully or partly paid up shares or partly in one way and partly in the other. The Company may also,
on any issue of shares, pay such brokerage fees as may be lawful.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.10</TD><TD STYLE="text-align: justify">Except as required by law, no person shall be recognised by the Company as holding any share upon any
trust and the Company shall not be bound by or be compelled in any way to recognise (even when having notice thereof) any equitable, contingent,
future or partial interest in any share (except only as by these Articles or by law otherwise provided) or any other rights in respect
of any share except an absolute right to the entirety thereof in the holder.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">4.11</TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">If at any time the share capital is divided into different classes of shares, the rights attached
to any class of shares (unless otherwise provided by these Articles or the terms of issue of the shares of that class) may be varied with
the consent in writing of the holders of two-thirds of the issued shares of that class or with the sanction of a Special Resolution passed
at a separate general meeting of the holders of the shares of that class, in any case subject to Article 19.3. To every such separate
general meeting, the provisions of these Articles relating to general meetings shall <I>mutatis mutandis</I> apply, but so that the necessary
quorum shall be any one or more persons holding or representing by proxy not less than one-third of the issued shares of the class;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">For the purposes of this Article &#8206;4.11, the Directors may treat all classes of shares or any two
or more classes of shares as forming one class if they consider that all such classes would be affected in the same way by the proposals
under consideration.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The rights conferred upon the holders of the shares of any class shall not, unless otherwise expressly
provided by the terms of issue of the shares of that class, be deemed to be varied by:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the creation or issue of further shares ranking <I>pari passu</I> therewith;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">by the redemption or purchase of any shares of any class by the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the cancellation of authorised but unissued shares of that class; or</TD></TR></TABLE>


<!-- Field: Page; Sequence: 16 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">the creation or issue of shares with preferred or other rights including, without limitation, the creation
of any class or issue of shares with enhanced or weighted voting rights.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The rights conferred upon holders of Class A Common Shares shall not be deemed to be varied by the creation
or issue from time to time of further Class B Common Shares and the rights conferred upon holders of Class B Common Shares shall not be
deemed to be varied by the creation or issue from time to time of further Class A Common Shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">4.12</TD><TD STYLE="text-align: justify">The Directors may accept contributions to the capital of the Company otherwise than in consideration of
the issue of shares and the amount of any such contribution may, unless otherwise agreed at the time such contribution is made, be treated
by the Company as a distributable reserve, subject to the provisions of the Law and these Articles.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">5</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Class A Common Shares and Class
B Common Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.1</TD><TD STYLE="text-align: justify">Holders of Class A Common Shares and Class B Common Shares have the right to receive notice of, attend,
speak and vote at general meetings of the Company. Holders of Class&nbsp;A Common Shares and Class B Common Shares shall at all times
vote together as one class on all resolutions submitted to a vote by the Members in general meetings. Each Class A Common Share shall
entitle the holder to one (1) vote on all matters subject to a vote at general meetings of the Company, and each Class B Common Share
shall entitle the holder to ten (10) votes on all matters subject to a vote at general meetings of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.2</TD><TD STYLE="text-align: justify">Without prejudice to any special rights conferred thereby on the holders of any other shares or class
of shares established pursuant to the Memorandum and/or these Articles from time to time, holders of Common Shares shall:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Be entitled to such dividends as the Board may from time to time declare;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">In the event of a winding-up or dissolution of the Company, whether voluntary or involuntary or for the
purposes of a reorganisation or otherwise or upon any distribution of capital, be entitled to the surplus assets of the Company; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Generally be entitled to enjoy all of the rights attaching to shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.3</TD><TD STYLE="text-align: justify">In no event shall Class A Common Shares be convertible into Class B Common Shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.4</TD><TD STYLE="text-align: justify">Class B Common Shares shall be convertible into Class A Common Shares as follows:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify"><B><I>Right of Conversion</I></B>. Class B Common Shares shall be convertible into the same number of
Class A Common Shares, on a share-to-share basis, in the following manner:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(1)</TD><TD STYLE="text-align: justify">a holder of Class B Common Shares has the right to call upon the Company to effect a conversion of all
or any of his Class B Common Shares which right shall be exercised, at any time after issue
and without payment of any additional sum, by notice in writing given to the Company at its registered office (and which conversion shall
be effected by the Company promptly upon delivery of the said notice);</TD></TR></TABLE>


<!-- Field: Page; Sequence: 17 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 1.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(2)</TD><TD STYLE="text-align: justify">the holder(s) of all of the then issued and outstanding Class B Common Shares have the right to require
that all outstanding Class B Common Shares be converted, which right shall be exercised, at any time after issue and without payment of
any additional sum, by notice in writing (which may be in one or more counterparts) signed by each of such holders given to the Company
at its registered office (and which conversion shall be effected by the Company promptly upon delivery of the said notice);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(3)</TD><TD STYLE="text-align: justify">a Class B Common Share shall automatically convert into a Class A Common Share immediately and without
further action by the holder upon the registration of any transfer of a Class B Common Share (whether or not for value and whether or
not the certificate(s) (if any) representing such Class B Common Share are surrendered to the Company) in the Register of Members, other
than the following permitted transfers (&quot;<B>Permitted Transfer</B>&quot; and the transferee, a &quot;<B>Permitted Transferee</B>&quot;):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">a transfer (i)&nbsp;to the holder of Class B Common Shares, and/or (ii)&nbsp;to their children, heirs
and successors of the holder of Class B Common Shares, and/or (iii)&nbsp;to an Affiliate of a holder of the Class B Common Share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">a transfer to one or more trustees of a trust established for the benefit of the holder or an Affiliate
of the holder of the Class B Common Share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">a transfer to a partnership, corporation or other entity exclusively owned or controlled by the holder
of the Class B Common Share or an Affiliate of the holder of the Class B Common Share;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1.5in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">transfers to organisations that are exempt from taxation under Section&nbsp;501(3)(c) of the United States
Internal Revenue Code of 1986, as amended (or any successor thereto).</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 1.5in; text-align: justify; text-indent: 0in">For the avoidance
of doubt, the creation of any pledge, charge, encumbrance or other security interest or third party right of whatever description on any
Class B Common Shares to secure a holder&rsquo;s contractual or legal obligations shall not be deemed to be a transfer unless and until
any such pledge, charge, encumbrance or other third party right is enforced and results in such third party (or its nominee) holding legal
title to the related Class B Common Shares, in which case all the related Class B Common Shares shall be automatically and immediately
converted into the same number of Class A Common Shares.</P>


<!-- Field: Page; Sequence: 18 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(4)</TD><TD STYLE="text-align: justify">In the event a Major Shareholder should cease to hold Class B Common Shares, all rights afforded to such
Major Shareholder in these Articles shall be automatically transferred to its respective Permitted Transferee.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(5)</TD><TD STYLE="text-align: justify">if at any time, the total number of the issued and outstanding Class B Common Shares is less than 10%
of the total number of shares in the capital of the Company outstanding, the Class B Common Shares then in issue shall automatically and
immediately convert into Class A Common Shares and no Class B Common Shares shall be issued by the Company thereafter.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify"><B><I>Mechanics of Conversion</I></B>.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD STYLE="text-align: justify">Before any holder of Class B Common Shares shall be entitled to convert such Class B Common Shares into
Class A Common Shares pursuant to sub-paragraph (a)&nbsp;(1) above, the holder shall, if available, surrender the certificate or certificates
therefor, duly endorsed (where applicable), at the registered office of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD STYLE="text-align: justify">Upon the occurrence of one of the bases of conversion provided for in paragraph (a) above, the Company
shall enter or procure the entry of the name of the relevant holder of Class B Common Shares as the holder of the relevant number of Class
A Common Shares resulting from the conversion of the Class B Common Shares in, and make any other necessary and consequential changes
to, the Register of Members and shall procure that certificate(s) in respect of the relevant Class&nbsp;A Common Shares, together with
a new certificate for any unconverted Class&nbsp;B Common Shares comprised in the certificate(s) surrendered by the holder of the Class&nbsp;B
Common Shares, are issued to the holders of the Class A Common Shares and Class B Common Shares, as the case may be, if so requested.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD STYLE="text-align: justify">Any conversion of Class B Common Shares into Class A Common Shares pursuant to this Article 5 shall be
effected by means of the re-designation and re-classification of the relevant Class B Common Share as a Class A Common Share together
with such rights and restrictions for the time being attached thereto and shall rank pari passu in all respects with the Class A Common
Shares then in issue. Such conversion shall become effective forthwith upon entries being made in the Register of Members to record the
re-designation and re-classification of the relevant Class B Common Shares as Class A Common Shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD STYLE="text-align: justify">If the conversion is in connection with an underwritten public offering of securities, the conversion
may, at the option of any holder tendering such Class B Common Shares for conversion, be conditional upon the closing with the underwriters
of the sale of securities pursuant to such offering, in which event any persons entitled to receive Class A Common Shares upon conversion
of such Class B Common Shares shall not be deemed to have converted such Class B Common Shares until immediately prior to the closing
of such sale of securities.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 19 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD STYLE="text-align: justify">Upon conversion of any Class B Common Shares, the composition of the authorised share capital of the Company
shall automatically be varied and amended by a reduction in the relevant number of authorised Class B Common Shares and a corresponding
increase in the relevant number of authorised Class A Common Shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Effective upon and with effect from the conversion of a Class B Common Share into a Class A Common Share
in accordance with this Article 5.4, the converted share shall be re-designated as and be treated for all purposes as a Class A Common
Share and shall carry the rights and be subject to the restrictions attaching to Class A Common Shares including, without limitation,
the right to one vote on matters subject to a vote at general meetings of the Company</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.5</TD><TD STYLE="text-align: justify">No subdivision of Class A Common Shares into shares of an amount smaller than the nominal or par value
of such shares at the relevant time shall be effected unless Class B Common Shares are concurrently and similarly subdivided in the same
proportion and the same manner, and no subdivision of Class B Common Shares into shares of an amount smaller than the nominal or par value
of such shares at the relevant time shall be effected unless Class A Common Shares are concurrently and similarly subdivided in the same
proportion and the same manner.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.6</TD><TD STYLE="text-align: justify">No consolidation of Class A Common Shares into shares of an amount larger than the nominal or par value
of such shares at the relevant time shall be effected unless Class B Common Shares are concurrently and similarly consolidated in the
same proportion and the same manner, and no consolidation of Class B Common Shares into shares of an amount larger than the nominal or
par value of such shares at the relevant time may be effected unless Class A Common Shares are concurrently and similarly consolidated
in the same proportion and the same manner.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.7</TD><TD STYLE="text-align: justify">In the event that a dividend or other distribution is paid by the issue of Class A Common Shares or Class
B Common Shares or rights to acquire Class A Common Shares or Class B Common Shares (i) holders of Class A Common Shares shall receive
Class A Common Shares or rights to acquire Class A Common Shares, as the case may be; and (ii) holders of Class B Common Shares shall
receive Class B Common Shares or rights to acquire Class B Common Shares, as the case may be.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.8</TD><TD STYLE="text-align: justify">No Business Combination (whether or not the Company is the surviving entity) shall proceed unless by the
terms of such transaction: (i) the holders of Class A Common Shares have the right to receive, or the right to elect to receive, the same
form of consideration as the holders of Class&nbsp;B Common Shares, and (ii) the holders of Class A Common Shares have the right to receive,
or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B Common Shares.
The Directors shall not approve such a transaction unless the requirements of this Article are satisfied.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.9</TD><TD STYLE="text-align: justify">No tender or exchange offer to acquire any Class A Common Shares or Class B Common Shares by any third
party pursuant to an agreement to which the Company is to be a party, nor any tender or exchange offer by the Company to acquire any Class&nbsp;A
Common Shares or Class&nbsp;B Common Shares shall be approved by
the Company unless, by the terms of such transaction: (i)&nbsp;the holders of Class A Common Shares shall have the right to receive, or
the right to elect to receive, the same form of consideration as the holders of Class B Common Shares, and (ii)&nbsp;the holders of Class
A Common Shares shall have the right to receive, or the right to elect to receive, at least the same amount of consideration on a per
share basis as the holders of Class B Common Shares. The Directors shall not approve such a transaction unless the requirements of this
Article are satisfied.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 20 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">5.10</TD><TD STYLE="text-align: justify">Save and except for voting rights and conversion rights and as otherwise set out in Article &#8206;4.3
and in this Article &#8206;5, Class A Common Shares and the Class B Common Shares shall rank pari passu and shall have the same rights,
preferences, privileges and restrictions and share ratably and otherwise be identical in all respects as to all matters.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">6</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Share Certificates</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.1</TD><TD STYLE="text-align: justify">A Member shall only be entitled to a share certificate if the Directors resolve that share certificates
shall be issued. Share certificates representing Shares, if any, shall be in such form as the Directors may determine. Share certificates
shall be signed by one or more Directors or other person authorised by the Directors. The Directors may authorise certificates to be issued
with the authorised signature(s) affixed by mechanical process. All certificates for Shares shall be consecutively numbered or otherwise
identified and shall specify the Shares to which they relate. All certificates surrendered to the Company for transfer or conversion shall
be cancelled and subject to these Articles and, save as provided in Articles &#8206;6.3, &#8206;7 and &#8206;8 below and in the case of
a conversion of shares pursuant to Article &#8206;(2), no new certificate shall be issued until the former certificate representing a
like number of relevant Shares shall have been surrendered and cancelled.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.2</TD><TD STYLE="text-align: justify">Every share certificate of the Company shall bear legends required under applicable laws, including the
Securities Act.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">6.3</TD><TD STYLE="text-align: justify">If a share certificate is defaced, worn-out, lost or destroyed, it may be renewed on such terms (if any)
as to evidence and indemnity and payment of the expenses reasonably incurred by the Company in investigating evidence as the Directors
may determine but otherwise free of charge, and (in the case of defacement or wearing-out) on delivery to the Company of the old certificate.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">7</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Lien</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.1</TD><TD STYLE="text-align: justify">The Company shall have a first and paramount lien on every share (not being a share which is fully paid
as to its par value and share premium) for all moneys (whether presently payable or not) payable at a fixed time or called in respect
of that share (including any premium payable). The Directors may at any time declare any share to be wholly or in part exempt from the
provisions of this Article. The Company&rsquo;s lien on a share shall extend to any amount in respect of it.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 21 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.2</TD><TD STYLE="text-align: justify">The Company may sell in such manner as the Directors determine any shares on which the Company has a lien
if a sum in respect of which the lien exists is presently payable and is not paid within fourteen (14) Clear Days after notice has been
given to the holder of the share or to the person entitled to it in consequence of the death or bankruptcy of the holder, demanding payment
and stating that if the notice is not complied with the shares may be sold.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.3</TD><TD STYLE="text-align: justify">To give effect to a sale, the Directors may authorise some person to execute an instrument of transfer
of the shares sold to, or in accordance with the directions of, the purchaser. The title of the transferee to the shares shall not be
affected by any irregularity or invalidity in the proceedings in reference to the sale.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">7.4</TD><TD STYLE="text-align: justify">The net proceeds of the sale, after payment of the costs, shall be applied in payment of so much of the
sum for which the lien exists as is presently payable, and any residue shall (upon surrender to the Company for cancellation of the certificate
for the shares sold, if any, and subject to a like lien for any moneys not presently payable as existed upon the shares before the sale)
be paid to the person entitled to the shares at the date of the sale.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">8</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Calls on Shares and Forfeiture</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.1</TD><TD STYLE="text-align: justify">Subject to the terms of allotment, the Directors may make calls upon the Members in respect of any moneys
unpaid on their shares (whether in respect of nominal value or premium) and each Member shall (subject to receiving at least fourteen
(14) Clear Days&rsquo; notice specifying when and where payment is to be made) pay to the Company as required by the notice the amount
called on his shares. A call may be required to be paid by instalments. A call may, before receipt by the Company of any sum due thereunder,
be revoked in whole or in part and payment of a call may be postponed in whole or in part. A person upon whom a call is made shall remain
liable for calls made upon him notwithstanding the subsequent transfer of the shares in respect of which the call was made.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.2</TD><TD STYLE="text-align: justify">A call shall be deemed to have been made at the time when the resolution of the Directors authorising
the call was passed.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.3</TD><TD STYLE="text-align: justify">The joint holders of a share shall be jointly and severally liable to pay all calls in respect of the
share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.4</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable, the person from whom it is due and payable
shall pay interest on the amount unpaid from the day it became due and payable until it is paid at the rate fixed by the terms of allotment
of the share or in the notice of the call or, if no rate is fixed, at an annual rate of ten percent (10%), but the Directors may waive
payment of the interest wholly or in part.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.5</TD><TD STYLE="text-align: justify">An amount payable in respect of a share on allotment or at any fixed date, whether in respect of nominal
value or premium or as an instalment of a call, shall be deemed to be a call, and if it is not paid when due, all the provisions of these
Articles shall apply as if that amount had become due and payable by virtue of a call.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 22 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.6</TD><TD STYLE="text-align: justify">Subject to the terms of allotment, the Directors may make arrangements on the issue of shares for a difference
between the holders in the amounts and times of payment of calls on their shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.7</TD><TD STYLE="text-align: justify">If a call remains unpaid after it has become due and payable, the Directors may give to the person from
whom it is due not less than fourteen (14) Clear Days&rsquo; notice requiring payment of the amount unpaid, together with any interest
which may have accrued. The notice shall name the place where payment is to be made and shall state that if the notice is not complied
with the shares in respect of which the call was made will be liable to be forfeited.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.8</TD><TD STYLE="text-align: justify">If the notice is not complied with, any share in respect of which it was given may, before the payment
required by the notice has been made, be forfeited by a resolution of the Directors and the forfeiture shall include all dividends or
other moneys payable in respect of the forfeited shares and not paid before the forfeiture.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.9</TD><TD STYLE="text-align: justify">Subject to the provisions of the Law, a forfeited share may be sold, re-allotted or otherwise disposed
of on such terms and in such manner as the Directors determine either to the person who was before the forfeiture the holder or to any
other person, and at any time before a sale, re-allotment or other disposition, the forfeiture may be cancelled on such terms as the Directors
think fit. Where, for the purposes of its disposal a forfeited share is to be transferred to any person, the Directors may authorise any
person to execute an instrument of transfer of the share to that person.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.10</TD><TD STYLE="text-align: justify">A person any of whose shares have been forfeited shall cease to be a Member in respect of them and shall
surrender to the Company for cancellation the certificate for the shares forfeited, if any, but shall remain liable to the Company for
all moneys which at the date of forfeiture were presently payable by him to the Company in respect of those shares with interest at the
rate at which interest was payable on those moneys before the forfeiture or, if no interest was so payable, at an annual rate of ten percent
(10%), from the date of forfeiture until payment but the Directors may waive payment wholly or in part or enforce payment without any
allowance for the value of the shares at the time of forfeiture or for any consideration received on their disposal.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">8.11</TD><TD STYLE="text-align: justify">A statutory declaration by a Director or the Secretary that a share has been forfeited on a specified
date shall be conclusive evidence of the facts stated in it as against all persons claiming to be entitled to the share and the declaration
shall (subject to the execution of an instrument of transfer if necessary) constitute a good title to the share and the person to whom
the share is disposed of shall not be bound to see to the application of the consideration, if any, nor shall his title to the share be
affected by any irregularity in or invalidity of the proceedings in reference to the forfeiture or disposal of the share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">9</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Transfer of Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.1</TD><TD STYLE="text-align: justify">Subject to these Articles, any Member may transfer all or any of his shares by an instrument of transfer
in the usual or common form or in a form prescribed by any Designated Stock Exchange or in any other form approved by the Board and may
be under hand or, if the transferor or transferee is a Clearing House, by
hand or by Electronic Signature or by such other manner of execution as the Board may approve from time to time. Without prejudice to
the generality of the foregoing, title to listed shares of the Company may be evidenced and transferred in accordance with the laws applicable
to and the rules and regulations of the Designated Stock Exchange on which such shares are listed.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 23 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.2</TD><TD STYLE="text-align: justify">The instrument of transfer shall be executed by or on behalf of the transferor and the transferee provided
that the Board may dispense with the execution of the instrument of transfer by the transferee in any case which it thinks fit in its
discretion to do so. Without prejudice to Article 9.1, the Board may also resolve, either generally or in any particular case, upon request
by either the transferor or transferee, to accept mechanically executed transfers including, where applicable, in accordance with the
laws and rules applicable to the Designated Stock Exchange. The transferor shall be deemed to remain the holder of the share until the
name of the transferee is entered in the Register of Members in respect thereof. Nothing in these Articles shall preclude the Board from
recognising a renunciation of the allotment or provisional allotment of any share by the allottee in favour of some other person.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.3</TD><TD STYLE="text-align: justify">The Board may in its absolute discretion and without giving any reason therefor, refuse to register a
transfer of any share:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">that is not fully paid up (as to both par value and any premium) to a Person of whom it does not approve;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">issued under any share incentive plan for employees upon which a restriction on transfer imposed thereby
still subsists;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">to more than four joint holders; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">on which the Company has a lien.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.4</TD><TD STYLE="text-align: justify">Without limiting the generality of Article &#8206;9.3, the Board may also decline to recognise any instrument
of transfer unless:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">the instrument of transfer is in respect of only one class of shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the Shares are fully paid (as to both par value and any premium) and free of any lien;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the instrument of transfer is lodged at the registered office or such other place at which the Register
of Members is kept in accordance with the Law accompanied by any relevant share certificate(s), if any, and/or such other evidence as
the Board may reasonably require to show the right of the transferor to make the transfer (and, if the instrument of transfer is executed
by some other person on his behalf, the authority of that person so to do); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">if applicable, the instrument of transfer is duly and properly stamped.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 24 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.5</TD><TD STYLE="text-align: justify">If the Directors refuse to register a transfer of a share, they shall within fifteen (15) Business Days
after the date on which the transfer was lodged with the Company send to the transferee notice of the refusal.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.6</TD><TD STYLE="text-align: justify">The registration of transfers of shares or of any class of shares may, after compliance with any notice
requirement of any Designated Stock Exchange, be suspended and the Register of Members be closed at such times and for such periods (not
exceeding in the whole thirty (30) days in any year) as the Board may determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">9.7</TD><TD STYLE="text-align: justify">The Company shall be entitled to retain any instrument of transfer which is registered, but any instrument
of transfer which the Directors refuse to register shall be returned to the person lodging it when notice of the refusal is given.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">10</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Transmission of Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.1</TD><TD STYLE="text-align: justify">If a Member dies, the survivor, or survivors where he was a joint holder, and his personal representatives
where he was a sole holder or the only survivor of joint holders shall be the only persons recognised by the Company as having any title
to his interest; but nothing in these Articles shall release the estate of a deceased Member from any liability in respect of any share
which had been jointly held by him.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.2</TD><TD STYLE="text-align: justify">A person becoming entitled to a share in consequence of the death or bankruptcy of a Member may, upon
such evidence being produced as the Directors may properly require, elect either to become the holder of the share or to have some person
nominated by him registered as the transferee. If he elects to become the holder he shall give notice to the Company to that effect. If
he elects to have another person registered he shall execute an instrument of transfer of the share to that person. All these Articles
relating to the transfer of shares shall apply to the notice or instrument of transfer as if it were an instrument of transfer executed
by the Member and the death or bankruptcy of the Member had not occurred.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">10.3</TD><TD STYLE="text-align: justify">A person becoming entitled to a share by reason of the death or bankruptcy of a Member shall have the
rights to which he would be entitled if he were the holder of the share, except that he shall not, before being registered as the holder
of the share, be entitled in respect of such share to attend or vote at any meeting of the Company or at any separate meeting of the holders
of any class of shares in the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">11</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Changes of Capital</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 1in">11.1</TD><TD STYLE="text-align: justify">(a)&#9;Subject to and in so far as permitted by the provisions of the Law and these Articles (including,
without limitation, Article 19.3), the Company may from time to time by Ordinary Resolution alter or amend the Memorandum to:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall
prescribe;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 25 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">consolidate and divide all or any of its share capital into shares of larger amounts than its existing
shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">convert all or any of its paid up shares into stock and reconvert that stock into paid up shares of any
denomination;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">sub-divide its existing shares, or any of them, into shares of smaller amounts than is fixed by the Memorandum
provided that in the subdivision, the proportion between the amount paid and the amount, if any, unpaid on each reduced share shall be
the same as it was in the case of the share from which the reduced share is derived; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to
be taken by any person, and diminish the amount of its share capital by the amount of the shares so cancelled.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Except so far as otherwise provided by the conditions of issue, the new shares shall be subject to the
same provisions with reference to the payment of calls, lien, transfer, transmission, forfeiture and otherwise as the shares in the original
share capital.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.2</TD><TD STYLE="text-align: justify">Whenever as a result of a consolidation of shares any Members would become entitled to fractions of a
share, the Directors may, on behalf of those Members, sell the shares representing the fractions for the best price reasonably obtainable
to any person (including, subject to the provisions of the Law, the Company) and distribute the net proceeds of sale in due proportion
among those Members, and the Directors may authorise some person to execute an instrument of transfer of the shares to, or in accordance
with the directions of, the purchaser. The transferee shall not be bound to see to the application of the purchase money nor shall his
title to the shares be affected by any irregularity in or invalidity of the proceedings in reference to the sale.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">11.3</TD><TD STYLE="text-align: justify">The Company may by Special Resolution reduce its share capital and any capital redemption reserve in any
manner and with and subject to any incident, consent, order or other matter required by law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">12</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Redemption and Purchase of
Own Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Law and these Articles, the Company may:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">issue shares on terms that they are to be redeemed or are liable to be redeemed at the option of the Company
or the Member on such terms and in such manner as the Directors may, before the issue of shares, determine;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">purchase its own shares (including any redeemable shares) in such manner and on such terms as the Directors
may determine and agree with the relevant Member; and</TD></TR></TABLE>


<!-- Field: Page; Sequence: 26 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">make a payment in respect of the redemption or purchase of its own shares in any manner authorised by
the Law, including out of capital.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.2</TD><TD STYLE="text-align: justify">The Directors may, when making a payment in respect of the redemption or purchase of shares, if so authorised
by the terms of issue of the shares (or otherwise by agreement with the holder of such shares) make such payment in cash or in specie
(or partly in one and partly in the other).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">12.3</TD><TD STYLE="text-align: justify">Upon the date of redemption or purchase of a share, the holder shall cease to be entitled to any rights
in respect thereof (excepting always the right to receive (i) the price therefor and (ii) any dividend which had been declared in respect
thereof prior to such redemption or purchase being effected) and accordingly his name shall be removed from the Register of Members with
respect thereto and the share shall be cancelled.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">13</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Treasury Shares</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.1</TD><TD STYLE="text-align: justify">The Directors may, prior to the purchase, redemption or surrender of any Share, determine that such Share
shall be held as a Treasury Share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">13.2</TD><TD STYLE="text-align: justify">The Directors may determine to cancel a Treasury Share or transfer a Treasury Share on such terms as they
think proper (including, without limitation, for nil consideration).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">14</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Register of Members</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.1</TD><TD STYLE="text-align: justify">The Company shall maintain or cause to be maintained an overseas or local Register of Members in accordance
with the Law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">14.2</TD><TD STYLE="text-align: justify">The Directors may determine that the Company shall maintain one or more branch registers of Members in
accordance with the Law. The Directors may also determine which Register of Members shall constitute the principal register and which
shall constitute the branch register or registers, and to vary such determination from time to time.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">15</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Closing Register of Members
or Fixing Record Date</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.1</TD><TD STYLE="text-align: justify">For the purpose of determining Members entitled to notice of, or to vote at any meeting of Members or
any adjournment thereof, or Members entitled to receive payment of any dividend or other distribution, or in order to make a determination
of Members for any other purpose, the Directors may provide that the Register of Members shall be closed for transfers for a stated period
which shall not in any case exceed thirty (30) days. If the Register shall be so closed for the purpose of determining those Members that
are entitled to receive notice of, attend or vote at a meeting of Members, the Register shall be so closed for at least ten (10) Clear
Days immediately preceding such meeting and the record date for such determination shall be the date of the closure of the Register.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.2</TD><TD STYLE="text-align: justify">In lieu of, or apart from, closing the Register of Members, the Directors may fix, in advance or in arrears,
a date as the record date for any such determination of Members entitled to notice of, or to vote at any meeting of the Members
or any adjournment thereof, or for the purpose of determining the Members entitled to receive payment of any dividend or other distribution,
or in order to make a determination of Members for any other purpose, provided that such a record date shall not exceed forty (40) Clear
Days prior to the date where the determination will be made.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 27 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">15.3</TD><TD STYLE="text-align: justify">If the Register of Members is not so closed and no record date is fixed for the determination of Members
entitled to notice of, or to vote at, a meeting of Members or Members entitled to receive payment of a dividend or other distribution,
the date on which notice of the meeting is sent or posted or the date on which the resolution of the Directors resolving to pay such dividend
or other distribution is passed, as the case may be, shall be the record date for such determination of Members. When a determination
of Members entitled to vote at any meeting of Members has been made as provided in this Article, such determination shall apply to any
adjournment thereof.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">16</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">General Meetings</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.1</TD><TD STYLE="text-align: justify">An annual general meeting of the Company may at the discretion of the Board be held in the year in which
these Articles were adopted and shall be held in each year thereafter at such time as determined by the Board and the Company may, but
shall not (unless required by the Law) be obliged to, in each year hold any other general meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.2</TD><TD STYLE="text-align: justify">The agenda of the annual general meeting shall be set by the Board and shall include the presentation
of the Company&rsquo;s annual accounts and the report of the Directors (if any).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.3</TD><TD STYLE="text-align: justify">Annual general meetings shall be held in the City of Nova Lima, State of Minas Gerais, Brazil or in such
other places as the Directors may determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.4</TD><TD STYLE="text-align: justify">All general meetings other than annual general meetings shall be called extraordinary general meetings
and the Company shall specify the meeting as such in the notices calling it.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.5</TD><TD STYLE="text-align: justify">The Directors may, whenever they think fit, convene an extraordinary general meeting of the Company, and
they shall on a Members&rsquo; requisition in accordance with these Articles forthwith proceed to convene an extraordinary general meeting
of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.6</TD><TD STYLE="text-align: justify">A Members&rsquo; requisition is a requisition of one or more Members holding at the date of deposit of
the requisition shares representing in the aggregate not less than one-third of the votes entitled to be cast at general meetings of the
Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.7</TD><TD STYLE="text-align: justify">The Members&rsquo; requisition must state the objects of the meeting and must be signed by the requisitionists
and deposited at the principal office of the Company and may consist of several documents in like form each signed by one or more requisitionists.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.8</TD><TD STYLE="text-align: justify">If there are no Directors as at the date of the deposit of the Members&rsquo; requisition or if the Directors
do not within fourteen (14) Clear Days from the date of the deposit of the Members&rsquo; requisition duly proceed to convene a general
meeting to be held within a further fourteen (14) days, the requisitionists, or any
of them representing more than one-half of the total voting rights of all of the requisitionists, may themselves convene a general meeting,
but any meeting so convened shall be held no later than the day which falls three (3) months after the expiration of the first said fourteen
(14) Clear Day period.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 28 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.9</TD><TD STYLE="text-align: justify">A general meeting convened as aforesaid by requisitionists shall be convened in as close to the same manner
as possible as that in which general meetings are to be convened by Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">16.10</TD><TD STYLE="text-align: justify">Except as set forth in Articles &#8206;16.1 to &#8206;16.9, the Members have no right to propose resolutions
to be considered or voted upon at annual general meetings or extraordinary general meetings of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">17</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Notice of General Meetings</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.1</TD><TD STYLE="text-align: justify">At least ten (10) Clear Days&rsquo; notice specifying the place, the day and the hour of each general
meeting and the agenda of the meeting shall be given in the manner hereinafter provided, including, but not limited to, as described in
Article&nbsp;36, to such persons as are entitled to vote or may otherwise be entitled under these Articles to receive such notices from
the Company; provided that a general meeting of the Company shall, whether or not the notice specified in this Article has been given
and whether or not the provisions of these Articles regarding general meetings have been complied with, be deemed to have been duly convened
if it is so agreed:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in the case of an annual general meeting, by all of the Members entitled to attend and vote thereat; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the case of an extraordinary general meeting, by a majority in number of the Members (which shall include
the Major Shareholders) having a right to attend and vote at the meeting, together holding not less than 95%, in par value of the Shares
giving that right.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">17.2</TD><TD STYLE="text-align: justify">The accidental omission to give notice of a general meeting to, or the non-receipt of notice of a meeting
by, any Person entitled to receive notice that is not a Major Shareholder shall not invalidate the proceedings at that general meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">18</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Proceedings at General Meetings</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.1</TD><TD STYLE="text-align: justify">No business shall be transacted at any meeting unless a quorum is present at the time when the meeting
proceeds to business. One or more Members holding not less than one-third in aggregate of the voting power of all Shares in issue and
entitled to vote, present in person or by proxy or, if a corporation or other non-natural Person, by its duly authorised representative,
shall represent a quorum provided, however, that such a quorum must also include (i)&nbsp;Bertelsmann, for so long as it holds Class B
Common Shares in excess of the Ownership Threshold, and (ii)&nbsp;the Esteves Family, for so long as it holds Class B Common Shares in
excess of the Ownership Threshold.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 29 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.2</TD><TD STYLE="text-align: justify">If a quorum is not present within half an hour from the time appointed for the meeting to commence or
if during such a meeting a quorum ceases to be present, the meeting, if convened upon a Members&rsquo; requisition, shall be dissolved
and in any other case it shall stand adjourned and shall reconvene on the same day in the next week at the same time and/or place or to
such other day, time and/or place as the Directors may determine, and if at the reconvened meeting a quorum is not present within half
an hour from the time appointed for the meeting to commence, the Members present shall be a quorum; provided, however, that such a quorum
must also include (i)&nbsp;Bertelsmann, for so long as it holds Class B Common Shares in excess of the Ownership Threshold, and (ii)&nbsp;the
Esteves Family, for so long as it holds Class B Common Shares in excess of the Ownership Threshold.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.3</TD><TD STYLE="text-align: justify">A person may participate in a general meeting by conference telephone or other communications equipment
by means of which all the persons participating in the meeting can communicate with each other at the same time. Participation by a Member
in a meeting in this manner is treated as presence in person at that meeting and is counted in a quorum and entitled to vote.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.4</TD><TD STYLE="text-align: justify">The Chairman or in his absence the vice-chairman of the Board (if any) shall preside as chairman of the
meeting, but if neither the Chairman nor such vice-chairman (if any) is present within fifteen (15) minutes after the time appointed for
holding the meeting and willing to act, the Directors present shall elect one of their number to be chairman and, if there is only one
Director present and willing to act, he shall be chairman. If no Director is willing to act as chairman, or if no Director is present
within fifteen (15) minutes after the time appointed for holding the meeting, the Members present in person or by proxy and entitled to
vote shall choose one of their number to be chairman.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.5</TD><TD STYLE="text-align: justify">The order of business at each such meeting shall be as determined by the chairman of the meeting. The
chairman of the meeting shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts
and things as are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment of procedures
for the maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the Company, restrictions
on entry to such meeting after the time prescribed for the commencement thereof, and the opening and closing of the polls. The chairman
of the meeting shall announce at each such meeting the date and time of the opening and the closing of the polls for each matter upon
which the Members will vote at such meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.6</TD><TD STYLE="text-align: justify">A Director shall, notwithstanding that he is not a Member and that he has no right to vote, be entitled
to attend and speak at any general meeting and at any separate meeting of the holders of any class of shares in the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.7</TD><TD STYLE="text-align: justify">The chairman of the meeting may, with the consent of any meeting at which a quorum is present (and shall
if so directed by the meeting), adjourn the meeting from time to time, but no business shall be transacted at any adjourned meeting other
than business which might properly have been transacted at the meeting had the adjournment not taken place. When a meeting is adjourned
for fourteen (14) days or more, at least seven (7) Clear Days&rsquo; notice shall be given in the manner herein provided, including, but
not limited to, as described in Article &#8206;36, specifying the time, place and agenda of the adjourned
meeting. Otherwise it shall not be necessary to give any such notice.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 30 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.8</TD><TD STYLE="text-align: justify">At each meeting of the Members, all corporate actions, including the election of Directors, to be taken
by vote of the Members (except as otherwise required by applicable law and except as otherwise provided in these Articles) shall be authorised
by Ordinary Resolution. Where a separate vote by a class or classes or series is required, save as provided in Article &#8206;4.11, the
affirmative vote of the majority of Shares of such class or classes or series present in person or represented by proxy at the meeting
and voting shall be the act of such class or series (unless provided otherwise in the resolutions providing for the issuance of such class
or series).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.9</TD><TD STYLE="text-align: justify">At any general meeting a resolution put to the vote of the meeting shall be decided on a poll.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.10</TD><TD STYLE="text-align: justify">A poll shall be taken in such manner as the chairman of the meeting directs and he may appoint scrutineers
(who need not be Members) and fix a place and time for declaring the result of the poll. The result of the poll shall be deemed to be
the resolution of the meeting at which the poll was taken.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.11</TD><TD STYLE="text-align: justify">The chairman of the meeting shall not be entitled to a casting vote.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">18.12</TD><TD STYLE="text-align: justify">If for so long as the Company has only one Member:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in relation to a general meeting, the sole Member or a proxy for that Member or (if the Member is a corporation)
a duly authorised representative of that Member is a quorum and Article &#8206;18.1 is modified accordingly;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">the sole Member may agree that any general meeting be called by shorter notice than that provided for
by these Articles; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">all other provisions of these Articles apply with any necessary modification (unless the provision expressly
provides otherwise).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">19</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Votes of Members</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.1</TD><TD STYLE="text-align: justify">Subject to any rights or restrictions attached to any shares (including without limitation the enhanced
voting rights attaching to Class B Common Shares provided for in Article &#8206;5), every Member who (being an individual) is present
in person or by proxy or (being a corporation) is present by a duly authorised representative (not being himself a Member entitled to
vote) or by proxy, shall on a poll have one vote for every share of which he is the holder (or, in the case of a Class B Common Share,
ten (10) votes for every Class B Common Share of which he is the holder).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.2</TD><TD STYLE="text-align: justify">In the case of joint holders, the vote of the senior joint holder who tenders a vote, whether in person
or by proxy, shall be accepted to the exclusion of the votes of the other joint holders; and seniority shall be determined by the
order in which the names of the holders stand in the Register of Members.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 31 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.3</TD><TD STYLE="text-align: justify">The Members shall not, without the prior written consent of (i) Bertelsmann, for so long as it holds Class
B Common Shares in excess of the Ownership Threshold and (ii) the Esteves Family, for so long as it holds Class B Common Shares in excess
of the Ownership Threshold:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">change the number of Directors;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">change the structure, function, and/or number of the Board of Executive Officers;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">amend these Articles and/or the Memorandum;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">vary the rights attaching to any Shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">approve any merger or consolidation of the Company with one or more constituent companies (as defined
in the Statute), the contribution by the Company of any assets to any Subsidiary and/or the creation of joint ventures by the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">approve any Business Combination;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">approve the winding-up, liquidation and dissolution of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">take any action set out in Article 11.1(a);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">register the Company as an exempted limited duration Company; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">approve the transfer by way of continuation of the Company to a jurisdiction outside the Islands.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.4</TD><TD STYLE="text-align: justify">A Member in respect of whom an order has been made by any court having jurisdiction (whether in the Islands
or elsewhere) in matters concerning mental disorder may vote, by his receiver, curator bonis or other person authorised in that behalf
appointed by that court, and any such receiver, curator bonis or other person may vote by proxy. Evidence to the satisfaction of the Directors
of the authority of the person claiming to exercise the right to vote shall be received at the registered office of the Company, or at
such other place as is specified in accordance with these Articles for the deposit or delivery of forms of appointment of a proxy, or
in any other manner specified in these Articles for the appointment of a proxy, not less than forty-eight (48) hours before the time appointed
for holding the meeting or adjourned meeting at which the right to vote is to be exercised and in default the right to vote shall not
be exercisable.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.5</TD><TD STYLE="text-align: justify">No Member shall, unless the Directors otherwise determine, be entitled to vote at any general meeting
or at any separate meeting of the holders of any class of shares in the Company, either in person or by proxy or by a corporate representative,
in respect of any share held by him unless all moneys presently payable by him in respect of that share have been paid.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 32 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.6</TD><TD STYLE="text-align: justify">No objection shall be raised to the qualification of any voter except at the meeting or adjourned meeting
at which the vote objected to is tendered, and every vote not disallowed at the meeting shall be valid. Any objection made in due time
shall be referred to the chairman of the meeting whose decision shall be final and conclusive.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.7</TD><TD STYLE="text-align: justify">Votes may be given either personally or by proxy. Deposit or delivery of a form of appointment of a proxy
does not preclude a Member from attending and voting at the meeting or at any adjournment of it, save that only the Member or his proxy
may cast a vote.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.8</TD><TD STYLE="text-align: justify">A Member entitled to more than one vote need not, if he votes, use all his votes or cast all votes he
uses the same way.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.9</TD><TD STYLE="text-align: justify">Subject as set out herein, an instrument appointing a proxy shall be in writing in any usual form or in
any other form which the Directors may approve and shall be executed by or on behalf of the appointor save that, subject to the Law, the
Directors may accept the appointment of a proxy received in an Electronic Communication at an address specified for such purpose, on such
terms and subject to such conditions as they consider fit. The Directors may require the production of any evidence which they consider
necessary to determine the validity of any appointment pursuant to this Article.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.10</TD><TD STYLE="text-align: justify">Subject to Article 19.10 below, the form of appointment of a proxy and any authority under which it is
executed or a copy of such authority certified notarially or in some other way approved by the Directors may:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">in the case of an instrument in writing, be left at or sent by post to the registered office of the Company
or such other place within the Islands or elsewhere as is specified in the notice convening the meeting or in any form of appointment
of proxy sent out by the Company in relation to the meeting at any time before the time for holding the meeting or adjourned meeting at
which the person named in the form of appointment of proxy proposes to vote;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the case of an appointment of a proxy contained in an Electronic Communication, where an address has
been specified by or on behalf of the Company for the purpose of receiving Electronic Communications:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">in the notice convening the meeting; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">in any form of appointment of a proxy sent out by the Company in relation to the meeting; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">in any invitation contained in an Electronic Communication to appoint a proxy issued by the Company in
relation to the meeting;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 33 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 1in; text-align: justify; text-indent: 0in">be received at such
address at any time before the time for holding the meeting or adjourned meeting at which the person named in the form of appointment
of proxy proposes to vote;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">in the case of a poll taken more than forty-eight (48) hours after it is demanded, be deposited or delivered
as required by paragraphs (a) or (b) of this Article after the poll has been demanded and at any time before the time appointed for the
taking of the poll; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">where the poll is taken immediately but is taken not more than forty-eight (48) hours after it was demanded,
be delivered at the meeting at which the poll was demanded to the chairman of the meeting or to the secretary or to any Director;</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">and a form of appointment
of proxy which is not deposited or delivered in accordance with this Article 19.10 or Article 19.11 is invalid.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.11</TD><TD STYLE="text-align: justify">Notwithstanding Article&nbsp;19.10 above, the Directors may by way of note to or in any document accompanying
the notice of a general meeting (or adjourned meeting) fix the latest time by which the appointment of a proxy must be communicated to
or received by the Company (being not more than 48 hours before the relevant meeting).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.12</TD><TD STYLE="text-align: justify">A vote or poll demanded by proxy or by the duly authorised representative of a corporation shall be valid
notwithstanding the previous determination of the authority of the person voting or demanding a poll unless notice of the determination
was received by the Company at the registered office of the Company or, in the case of a proxy, any other place specified for delivery
or receipt of the form of appointment of proxy or, where the appointment of a proxy was contained in an Electronic Communication, at the
address at which the form of appointment was received, before the commencement of the meeting or adjourned meeting at which the vote is
given or the poll demanded or (in the case of a poll taken otherwise than on the same day as the meeting or adjourned meeting) the time
appointed for taking the poll.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.13</TD><TD STYLE="text-align: justify">Any corporation or other non-natural person which is a Member of the Company may in accordance with its
constitutional documents, or, in the absence of such provision, by resolution of its directors or other governing body, authorise such
person as it thinks fit to act as its representative at any meeting of the Company or of any class of Members, and the person so authorised
shall be entitled to exercise the same powers on behalf of the corporation which he represents as the corporation could exercise if it
were an individual Member.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">19.14</TD><TD STYLE="text-align: justify">If a Clearing House (or its nominee(s)) or depositary (or its nominee(s)) is a Member of the
                                                             Company, it may, by resolution of its directors or other governing body or by power or attorney, authorise such Person(s) as it
                                                             thinks fit to act as its representative(s) at any general meeting of the Company or of any class of shareholders of the Company,
                                                             provided that, if more than one Person is so authorised, the authorisation shall specify the number and class of shares in respect
                                                             of which such Person is so authorised. A Person so authorised pursuant to this Article shall be entitled to exercise the same powers
                                                             on behalf of the recognised clearing house (or its nominee(s)) or depositary (or its nominee(s)) which he represents as that
                                                             recognised clearing house (or its nominee(s)) or depositary
(or its nominee(s)) could exercise if it were an individual Member holding the number and class of shares specified in such authorisation.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 34 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">20</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Number of Directors and Chairman</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.1</TD><TD STYLE="text-align: justify">Subject to Article 19.3, the Board shall consist of such number of Directors as a majority of the Directors
then in office may determine from time to time, provided that, unless otherwise determined by the Members acting by Special Resolution,
the Board shall consist of not less than four (4) Directors and not more than eleven (11) Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">20.2</TD><TD STYLE="text-align: justify"><B>Chairman</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">The Board of Directors shall have a Chairman appointed in a rotation procedure by (i) Bertelsmann, for
so long as it holds Class B Common Shares in excess of the Ownership Threshold, and (ii) the Esteves Family, for so long as it holds Class
B Common Shares in excess of the Ownership Threshold; thereafter, the Chairman shall be appointed by a majority of the Directors then
in office. Such appointment rights shall continue indefinitely and shall alternate on a yearly basis.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Esteves Family shall have the right to appoint the first Chairman and, at the expiration of the term
of such Chairman, Bertelsmann shall have the right to appoint the next Chairman for the following term, and so on, in each case only for
so long as it holds Class B Common Shares in excess of the Ownership Threshold.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">The Directors may also elect a vice-chairman of the Board of Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The Chairman shall preside as chairman at every meeting of the Board of Directors at which he is present.
Where the Chairman is not present at a meeting of the Board of Directors, the vice-chairman of the Board of Directors (if any) shall act
as chairman, or in his absence, the attending Directors may choose one Director to be the chairman of the meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">21</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Appointment, Disqualification
and Removal of Directors</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.1</TD><TD STYLE="text-align: justify"><B>Appointment</B></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Bertelsmann, for so long as it holds Class B Common Shares in excess of the Ownership Threshold, shall
be entitled to appoint, at its sole discretion, up to three (3) Directors, and shall be entitled at any time to remove, substitute or
replace any of its appointed Directors for any reason in its sole discretion. Any such appointment, removal, substitution or replacement
shall be effected by way of notice in writing to the Company signed by (or on behalf of) Bertelsmann.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">The Esteves Family, for so long as it holds Class B Common Shares in excess of the Ownership Threshold,
shall be entitled to appoint, at its sole discretion, up to three&nbsp;(3) Directors, and shall be entitled at
any time to remove, substitute or replace any of its appointed Directors for any reason in its sole discretion. Any such appointment,
removal, substitution or replacement shall be effected by way of notice in writing to the Company signed by (or on behalf of) the Esteves
Family.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 35 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 1in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">Bertelsmann and the Esteves Family, for so long as they hold Class B Common Shares in excess of the Ownership
Threshold, shall be entitled to appoint, at their sole discretion, up to one&nbsp;(1) Director and shall be entitled at any time to remove,
substitute or replace their appointed Director for any reason in their sole discretion (provided that if only one of Bertelsmann and the
Esteves Family holds Class B Common Shares in excess of the Ownership Threshold, then only Bertelsmann or the Esteves Family, as applicable,
shall have the rights pursuant to this Article 21.1(c)). Any such appointment, removal, substitution or replacement shall be effected
by way of notice in writing to the Company signed by (or on behalf of) them.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Directors not appointed as set out in Articles 21.1(a), 21.1(b) and 21(c) shall be elected by an Ordinary
Resolution.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.2</TD><TD STYLE="text-align: justify">Persons proposed by the Board for election by Ordinary Resolution of Members at a general meeting of the
Company shall be nominated only and after consultation with the Nominating and Corporate Governance Committee (if such committee is established).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.3</TD><TD STYLE="text-align: justify">Each Director shall hold office for a two (2) year term, notwithstanding any agreement between the Company
and such Director. Directors are eligible for re-election.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.4</TD><TD STYLE="text-align: justify">Any vacancies on the Board arising other than upon the removal of a Director by resolution passed at a
general meeting can be filled by the remaining Director(s) (notwithstanding that the remaining Director(s) may constitute fewer than the
number of Directors required by Article &#8206;20.1 or fewer than is required for a quorum pursuant to Article &#8206;28.1), except for
vacancies resulted from the removal, dismissal and/or withdraw of a Bertelsmann Director or an Esteves Family Director, which shall be
filled as set out in Articles 21.1(a) and 21.1(b). Any such appointment shall be as an interim Director to fill such vacancy until the
next annual general meeting of Members (and such appointment shall terminate at the commencement of the annual general meeting).</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.5</TD><TD STYLE="text-align: justify">Additions to the existing Board (subject to the maximum provided for in Article &#8206;20.1 above) may
be made by Ordinary Resolution.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.6</TD><TD STYLE="text-align: justify">There is no age limit for Directors of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.7</TD><TD STYLE="text-align: justify">No shareholding qualification shall be required for a Director. A Director who is not a Member shall nevertheless
be entitled to receive notice of and to attend and speak at general meetings of the Company.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 36 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.8</TD><TD STYLE="text-align: justify">While any shares of the Company are admitted to trading on a Designated Stock Exchange, the Board must
at all times comply with the residency and citizenship requirements of securities laws of the United States applicable to foreign private
issuers and shall at no time have a majority of Directors who are U.S. Persons. Notwithstanding any other provision in these Articles,
no appointment or election of a U.S. Person as a Director shall be permitted if such appointment or election would have the effect of
creating a majority of Directors who are U.S. Persons, and any such appointment or election shall be disregarded for all purposes.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.9</TD><TD STYLE="text-align: justify">Directors that are not a Bertelsmann Director or an Esteves Family Director may be removed (with or without
cause) by Ordinary Resolution of Members. The notice of general meeting must contain a statement of the intention to remove the Director
and must be served on the Director not less than ten (10) days before the meeting. The Director is entitled to attend the meeting and
be heard on the motion for his removal.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">21.10</TD><TD STYLE="text-align: justify">The office of a Director shall be vacated automatically if:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">he or she becomes prohibited by law from being a Director;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">he or she becomes bankrupt or makes any arrangement or composition with his creditors generally;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">he or she dies or is, in the opinion of all his co-Directors, incapable by reason of mental disorder of
discharging his duties as Director;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">he or she resigns his or her office by notice to the Company; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">he or she has for more than six (6) months been absent without permission of the Directors from meetings
of Directors held during that period and the remaining Directors resolve that his or her office be vacated.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">22</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Alternate Directors</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.1</TD><TD STYLE="text-align: justify">Any Director (but not an alternate Director) may by writing appoint any other Director, or any other person
willing to act, to be an alternate Director and by writing may remove from office an alternate Director so appointed by him.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.2</TD><TD STYLE="text-align: justify">An alternate Director shall be entitled to receive notice of all meetings of Directors and of all meetings
of committees of Directors of which his appointor is a member, to attend and vote at every such meeting at which the Director appointing
him is not personally present, to sign any written resolution of the Directors (in place of his appointor) and generally to perform all
the functions of his appointor as a Director in his absence.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.3</TD><TD STYLE="text-align: justify">An alternate Director shall cease to be an alternate Director if his appointor ceases to be a Director.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 37 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.4</TD><TD STYLE="text-align: justify">Any appointment or removal of an alternate Director shall be by written notice to the Company at its registered
office, signed by the Director making or revoking the appointment, or in any other manner approved by the Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">22.5</TD><TD STYLE="text-align: justify">Subject to the provisions of these Articles, an alternate Director shall be deemed for all purposes to
be a Director and shall alone be responsible for his own acts and defaults and shall not be deemed to be the agent of the Director appointing
him.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">23</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Powers of Directors</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Law, the Memorandum and these Articles (including Article 23.4 below),
to any directions given by Ordinary Resolution and to the listing rules of any Designated Stock Exchange, the business of the Company
shall be managed by the Directors and the delegated Officers who may exercise all the powers of the Company. No alteration of the Memorandum
or Articles and no such direction shall invalidate any prior act of the Directors which would have been valid if that alteration had not
been made or that direction had not been given. The powers given by this Article shall not be limited by any special power given to the
Directors by these Articles and a meeting of Directors at which a quorum is present may exercise all powers exercisable by the Directors,
subject to the limitations set forth in these Articles and in applicable Law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.2</TD><TD STYLE="text-align: justify">Subject to Article 23.4 below, the Board may exercise all the powers of the Company to raise capital or
borrow money and to mortgage or charge all or any part of the undertaking, property and assets (present and future) and uncalled capital
of the Company and, subject to the Law, to issue debentures, bonds and other securities, whether outright or as collateral security for
any debt, liability or obligation of the Company or of any third party.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.3</TD><TD STYLE="text-align: justify">Subject to Article 23.4 below, upon any Incriminating Event, the Directors shall convene a board meeting
to consider the Incriminating Event and its impact on the Company and, at that meeting, shall take one of the following actions: (i) resolve
that the Member in question be suspended from their duties as Director, officer and/or employee, unpaid, for a period of no more than
6 months; (ii) resolve that the Member in question be terminated from any positions he or she holds with the Company (e.g. as Director,
officer and/or employee); (iii) direct (which direction the Member in question shall be obliged to follow) that the Member in question
transfer all of his or her Shares to his or her heirs and/or children; or (iv) in the event the direction in (iii) is not possible of
unsuccessful, resolve that any Shares held by the Member in question be compulsorily repurchased by the Company at the mean market price
per share at market close daily for the 30 days preceding the Incriminating Event. The Member in question shall be entitled to attend
the relevant board meeting and to make representations on his or her behalf at that meeting. In the event the Member in question is a
Director, he shall not be entitled to vote on any of the actions set out in (i) through (iv) above, notwithstanding Article 27.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.4</TD><TD STYLE="text-align: justify">The Directors shall not, without the prior written consent of: (i) at least one (1) Esteves Family Director,
for so long as there is at least one (1) Esteves Family Director; and (ii) at least one (1) Bertelsmann Director, for so long as there
is at least one (1) Bertelsmann Director:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 38 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">create new classes of Shares, issue new Shares or any options, warrants or convertible securities of similar
nature conferring the right upon the holders thereof to subscribe for, purchase or receive any class of shares or securities in the capital
of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">repurchase or redeem any Shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">approve the payment of any remuneration to a Director or executive Officer;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">approve any Incentive Plan;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">change the Company&rsquo;s accounting practices (including, without limitation, write-off of receivables
or any amount in any other balance sheet account or income statement), except as required by applicable law;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">execute and/or terminate any shareholders&rsquo; agreement, quotaholders&rsquo; agreement, or any other
agreements related to the Company&rsquo;s interest in any Subsidiary;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">approve the financial statements of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">effect an initial public offering and/or follow-on offerings of the Company, or hire any investment banks
or service providers inherent to the initial public offering;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">approve the listing and/or the delisting of securities of the Company with any Designated Stock Exchange;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(j)</TD><TD STYLE="text-align: justify">change the dividend policy of the Company and/or approve any Dividend, create and/or use of reserves of
the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(k)</TD><TD STYLE="text-align: justify">approve any budget of the Company, as well as any amendment and/or change to such budget;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(l)</TD><TD STYLE="text-align: justify">take any action set out in Article 23.2;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(m)</TD><TD STYLE="text-align: justify">conduct, negotiate, terminate and/or amend any business, agreement, or transaction between the Company
and any Related Party;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(n)</TD><TD STYLE="text-align: justify">acquire, sell or encumber any permanent assets of the Company, in one transaction or in a series of transactions,
which value exceeds the equivalent of two hundred and fifty thousand Brazilian Reais (R$250,000.00);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(o)</TD><TD STYLE="text-align: justify">approve any sale or encumbrance, for the benefit of a Person(s), of shares issued by any Subsidiary, or
the admission of any new partner or shareholder in such Subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(p)</TD><TD STYLE="text-align: justify">create or dissolve any committees of the Directors;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 39 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(q)</TD><TD STYLE="text-align: justify">carry out any investments outside the scope of the core business of the Company or its Controlled Persons.
For the purpose of this Article, &quot;core business&quot; means any activity related to the offer of higher education courses (undergraduate
degrees, master&rsquo;s degrees, Doctor's degrees and MBAs) and does not include real estate investments and/or investments related to
basic education courses (nursery, elementary and high schools);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(r)</TD><TD STYLE="text-align: justify">incorporate any entity on behalf of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(s)</TD><TD STYLE="text-align: justify">acquire, sell or encumber the capital stock of entities in which the Company has an interest;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(t)</TD><TD STYLE="text-align: justify">appoint or terminate the engagement of any independent auditor that is not an Authorised Auditor;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(u)</TD><TD STYLE="text-align: justify">provide any guarantee in respect of any Person or Related Parties of any Member of the Company and/or
shareholder, director and/or Officer and/or its Subsidiaries;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(v)</TD><TD STYLE="text-align: justify">negotiate, amend, renew, change, and/or terminate any Lease Agreement, or enter into any new Lease Agreement,
or enter into any legal proceedings in respect of any Lease Agreement, or take any action that may affect the right to use and/or the
payment of any obligation undertaken in any Lease Agreement;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(w)</TD><TD STYLE="text-align: justify">appoint any executive Officer of the Company;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(x)</TD><TD STYLE="text-align: justify">approve the delegation of any powers by the Board as set out in Article 24.1; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(y)</TD><TD STYLE="text-align: justify">determine what action should be taken by the Directors pursuant to Article 23.3 in case of an Incriminating
Event, provided that in the event either of Bertelsmann or the Esteves Family are in any way interested in or associated with the Incriminating
Event, the written consent of: (i) at least one (1) Esteves Family Director, for so long as there is at least one (1) Esteves Family Director;
and/or (ii) at least one (1) Bertelsmann Director, for so long as there is at least one (1) Bertelsmann Director, as applicable and that
would otherwise be required by this Article 23.4, shall not be required.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">The values contemplated in Article&nbsp;23.4 shall be updated annually in June by the Extended Consumer
Price Index (IPCA) or any similar index that acts as a substitute.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">23.5</TD><TD STYLE="text-align: justify">The exercise of voting rights by the Company in relation to any of its Subsidiaries or exercise of voting
rights by any member of the board of directors of any such Subsidiaries appointed by the Company, with respect to the matters listed in
Article 23.4 shall always be subject to the prior written consent of: (i) at least one (1) Esteves Family Director, for so long as there
is at least one (1) Esteves Family Director; and (ii) at least one (1) Bertelsmann Director, for so long as there is at least one (1)
Bertelsmann Director.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 40 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">24</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Delegation of Directors' Powers,
Service Providers and Acts of Improbity</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.1</TD><TD STYLE="text-align: justify">Subject to these Articles, the Directors may from time to time appoint any Person, whether or not a Director,
to hold such office in the Company as the Directors may think necessary for the administration of the Company, including without prejudice
to the foregoing generality, the offices of chief executive officer, chief operating officer and chief financial officer (&quot;<B>Board
of Executive Officers</B>&quot;), one or more vice presidents, managers or controllers, at such remuneration (whether by way of salary
or commission or participation in profits or partly in one way and partly in another) and with such powers and duties as the Directors
may think fit. The executive Officers of the Company elected shall have an unified term of two&nbsp;(2) years.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.2</TD><TD STYLE="text-align: justify">Subject to the overall authority of the Board of Directors to manage the affairs of the Company, the day-to-day
operations and activities of the Company shall be exercised by the Board of Executive Officers formed by at least two (2) and no more
than seven (7) Officers, namely: (i)&nbsp;one (1) Chief Executive Officer; (ii) one (1) Chief Financial Officer; and (iii) the other Officers
without a specific designation. Bertelsmann Directors will have the right to appoint the Chief Financial Officer of the Company, for so
long as there is at least one (1) Bertelsmann Director. Bertelsmann Directors and the Esteves Family Directors will have the right to
appoint the Chief Executive Officer of the Company, for so long as there is at least one (1) Bertelsmann Director and/or (1) Esteves Family
Director.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.3</TD><TD STYLE="text-align: justify">The Board may, subject to Article 23.4, change the structure, composition and/or function of the executive
officers of the Subsidiaries of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.4</TD><TD STYLE="text-align: justify">Without limiting the generality of Article &#8206;24.1, the Directors may appoint one or more of their
body to the office of managing Director or to any other executive office under the Company, and the Company may enter into an agreement
or arrangement with any Director for his/her employment, subject to applicable law and any listing rules of the SEC or any Designated
Stock Exchange, or for the provision by him of any services outside the scope of the ordinary duties of a Director. Any such appointment,
agreement or arrangement may be made upon such terms as the Directors determine and they may remunerate any such Director for his services
as they think fit. Any appointment of a Director to an executive office shall terminate automatically if he ceases to be a Director but
without prejudice to any claim to damages for breach of the contract of service between the Director and the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.5</TD><TD STYLE="text-align: justify">The Directors and/or the executive Officers (minimum of two (2) Officers, acting jointly, being one the
Company&rsquo;s chief executive officer) may, by power of attorney or otherwise, appoint any person to be the agent of the Company for
such purposes and on such conditions as they determine, including authority for the agent to delegate all or any of his powers.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.6</TD><TD STYLE="text-align: justify">Subject to applicable law and the listing rules of any Designated Stock Exchange, the Directors may delegate
any of their powers to any committee (including, without limitation, an Audit Committee, Compensation Committee and Nominating and Corporate
Governance Committee), consisting of one or more Directors. They may also delegate to any executive Officer or committee of executive
Officers such of their powers as they consider desirable to be exercised by him or them. Any such delegation
may be made subject to any conditions the Directors may impose, and either collaterally with or to the exclusion of its own powers and
may be revoked or altered. Subject to any such conditions, the proceedings of a committee with two or more members shall be governed by
the provisions of these Articles regulating the proceedings of Directors so far as they are capable of applying. Where a provision of
these Articles refers to the exercise of a power, authority or discretion by the Directors and that power, authority or discretion has
been delegated by the Directors to a committee, the provision shall be construed as permitting the exercise of the power, authority or
discretion by the committee.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 41 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.7</TD><TD STYLE="text-align: justify">Without limiting the generality of Article &#8206;24.6, the Board shall establish a permanent Audit Committee
and may establish a Compensation Committee and a Nominating and Corporate Governance Committee and, where such committees are established,
the Board may adopt formal written charters for such committees and, if so, shall review and assess the adequacy of such formal written
charters on an annual basis. Each of these committees shall be empowered to do all things necessary to exercise the rights of such committee
set forth in these Articles and shall have such powers as the Board may delegate pursuant to Article &#8206;24.6 and as required by the
rules of the Designated Stock Exchange or applicable law. Each of the Audit Committee, the Compensation Committee and the Nominating and
Corporate Governance Committee, if established, shall consist of such number of directors as the Board shall from time to time determine
(or such minimum number as may be required from time to time by any Designated Stock Exchange). For so long as any class of Shares is
listed on a Designated Stock Exchange, the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee
shall be made up of such number of Independent Directors as is required from time to time by the rules of the Designated Stock Exchange
or otherwise required by applicable law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.8</TD><TD STYLE="text-align: justify">At least one (1) member of the Audit Committee will be an audit committee financial expert as determined
by the rules adopted by the Designated Stock Exchange. Such financial expert shall have a special past employment experience in finance
or accounting, requisite professional certification in accounting, or any other comparable experience or background which results in the
individual&rsquo;s financial sophistication.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.9</TD><TD STYLE="text-align: justify">The Company shall not use any agent, representative, or sales consultant, unless such agent, representative,
or sales consultant has been properly vetted by the Company to ensure they maintain good business practices and operate in compliance
with Anti-Corruption Laws.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">24.10</TD><TD STYLE="text-align: justify">The Company and its Members shall not violate any Brazilian Anti-Corruption Laws or laws related to acts
of improbity.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">25</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Remuneration and Expenses of
Directors</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.1</TD><TD STYLE="text-align: justify">The Directors shall be entitled to such remuneration as the Board may determine and, unless otherwise
determined, the remuneration shall be deemed to accrue from day to day. If established, the Compensation Committee will assist the Board
in reviewing and approving compensation decisions.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 42 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.2</TD><TD STYLE="text-align: justify">Members of the Audit Committee may be paid annual compensation in the form of a fixed salary in such amount
as the Board may determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.3</TD><TD STYLE="text-align: justify">A Director who, at the request of the Directors, goes or resides outside of their place of residence at
the time of appointment due to a request of the Company, makes a special journey or performs a special service on behalf of the Company
may be paid such reasonable additional remuneration (whether by way of salary, percentage of profits or otherwise) and expenses as the
Directors may decide.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">25.4</TD><TD STYLE="text-align: justify">The Directors may be paid all traveling, hotel and other expenses properly incurred by them in connection
with their attendance at meetings of Directors or committees of Directors or general meetings or separate meetings of the holders of any
class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">26</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Directors' Gratuities and Pensions</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Directors may
cause the Company to provide benefits, whether by the payment of gratuities or pensions or by insurance or otherwise, for any existing
Director or any Director who has held but no longer holds any executive office or employment with the Company or with any body corporate
which is or has been a Subsidiary of the Company or a predecessor in business of the Company or of any such subsidiary, and for any member
of his family (including a spouse and a former spouse) or any person who is or was dependent on him, and may (as well before as after
he ceases to hold such office or employment) contribute to any fund and pay premiums for the purchase or provision of any such benefit.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">27</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Directors' Interests</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.1</TD><TD STYLE="text-align: justify">Subject to the Law, the listing rules of any Designated Stock Exchange and Article 23.3, if a Director
has disclosed to the other Directors the nature and extent of any direct or indirect interest which the Director has in any transaction
or arrangement with the Company, a Director notwithstanding his office:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">may be a party to or otherwise interested in any transaction or arrangement with the Company or in which
the Company is otherwise interested;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">may be a director or other officer of, or employed by, or a party to any transaction or arrangement with,
or otherwise interested in, any body corporate promoted by the Company or in which the Company is otherwise interested; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">shall not by reason of his office be accountable to the Company for any benefit which he derives from
any such office or employment or from any such transaction or arrangement or from any interest in any such body corporate and no such
transaction or arrangement shall be liable to be avoided on the ground of any such interest or benefit.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.2</TD><TD STYLE="text-align: justify">For the purposes of Article &#8206;27.1:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 43 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">a general notice given to the Directors to the effect that (1) a Director is a member or officer of a
specified company or firm and is to be regarded as having an interest in any transaction or arrangement which may after the date of the
notice be made with that company or firm; or (2) a Director is to be regarded as interested in any transaction or arrangement which may
after the date of the notice be made with a specified person who is connected with him or her shall be deemed to be a sufficient disclosure
that the Director has an interest of the nature and extent so specified; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">an interest of which a Director has no knowledge and of which it is unreasonable to expect him to have
knowledge shall not be treated as an interest of his.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.3</TD><TD STYLE="text-align: justify">A Director must disclose any direct or indirect interest in any transaction or arrangement with the Company,
and following a declaration being made pursuant to these Articles, subject to any separate requirement for Audit Committee approval under
applicable law or the listing rules of any Designated Stock Exchange, and unless disqualified by the chairman of the relevant meeting,
a Director may vote in respect of any such transaction or arrangement in which such Director is interested and may be counted in the quorum
at such meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">27.4</TD><TD STYLE="text-align: justify">Notwithstanding the foregoing, no &quot;Independent Director&quot; (as defined herein) and with respect
of whom the Board has determined constitutes an &quot;Independent Director&quot; for purposes of compliance with applicable law or the
Company&rsquo;s listing requirements, shall without the consent of the Audit Committee take any of the foregoing actions or any other
action that would reasonably be likely to affect such Director&rsquo;s status as an &quot;Independent Director&quot; of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">28</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Proceedings of Directors</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.1</TD><TD STYLE="text-align: justify">The quorum for the transaction of the business of the Directors shall be a simple majority of the Directors
then in office (subject to there being a minimum of two (2) Directors present), provided, however, that such a quorum must also include
at least one (1) Esteves Family Director for so long as there is at least one (1) Esteves Family Director and one (1) Bertelsmann Director
for so long as there is at least one (1) Bertelsmann Director. A person who holds office as an alternate Director shall, if his appointor
is not present, be counted in the quorum. A Director who also acts as an alternate Director shall, if his appointor is not present, count
twice towards the quorum, but one such Director shall not constitute a quorum on his own.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.2</TD><TD STYLE="text-align: justify">Subject to the provisions of these Articles, the Directors may regulate their proceedings as they determine
is appropriate. Unless otherwise required by these Articles or by applicable Law, questions subject to the approval of the Board and/or
questions arising at any meeting of the Board shall be decided by a majority of votes provided, however, that any such majority must also
include at least one (1) Esteves Family Director for so long as there is at least one (1) Esteves Family Director and one (1) Bertelsmann
Director for so long as there is at least one (1) Bertelsmann Director. Neither the Chairman of the Board, nor the chairman of the meeting
will have a second or casting vote. A Director who is also an alternate Director shall be entitled in the absence of his appointor to
a separate vote on behalf of his appointor in addition to his own vote.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 44 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.3</TD><TD STYLE="text-align: justify">Meetings of the Directors shall be held on a bimonthly basis and shall take place either in the City of
Nova Lima, in the State of Minas Gerais, Brazil or at such other place as the Directors may determine.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.4</TD><TD STYLE="text-align: justify">A Person may participate in a meeting of the Directors or any committee of Directors by conference telephone
or other communications equipment by means of which all the persons participating in the meeting can communicate with each other at the
same time. Participation by a person in a meeting in this manner is treated as presence in person at that meeting and is counted in a
quorum and entitled to vote.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.5</TD><TD STYLE="text-align: justify">A resolution in writing (in one or more counterparts) signed by all the Directors or all the members of
a committee of the Directors (an alternate Director being entitled to sign such a resolution on behalf of his appointor and if such alternate
Director is also a Director, being entitled to sign such resolution both on behalf of his appointor and in his capacity as a Director)
shall be as valid and effective as if it had been passed at a meeting of the Directors, or committee of Directors as the case may be,
duly convened and held. Unless otherwise provided by its terms, such a resolution shall be effective from the date and time of the last
signature.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.6</TD><TD STYLE="text-align: justify">A Director or alternate Director may, and another Officer on the direction of a Director or alternate
Director shall, call a meeting of the Directors by at least five (5) Business Days&rsquo; notice in writing to every Director and alternate
Director which notice shall set forth time, place and agenda for the respective meeting unless notice is waived by all the Directors (or
their alternates) either at, before or after the meeting is held. To any such notice of a meeting of the Directors all the provisions
of these Articles relating to the giving of notices by the Company to the Members shall apply mutatis mutandis.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.7</TD><TD STYLE="text-align: justify">Notwithstanding Article 28.6, if all Directors so agree to the meeting, a Director or alternate Director
may, or other Officer on the direction of a Director or alternate Director may, call a meeting of the Directors on shorter notice than
is provided for in Article 28.6 by notice in writing to every Director and alternate Director, which notice shall set forth the general
nature of the business to be considered.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.8</TD><TD STYLE="text-align: justify">Subject to these Articles, the continuing Directors (or a sole continuing Director, as the case may be)
may act notwithstanding any vacancy in their body, but if and so long as their number is reduced below the number fixed by or pursuant
to these Articles as the necessary quorum of Directors, the continuing Directors or Director may act for the purpose of increasing the
number of Directors to be equal to such fixed number, or of summoning a general meeting of the Company, but for no other purpose.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.9</TD><TD STYLE="text-align: justify">All acts done by any meeting of the Directors or of a committee of the Directors (including any
                                                            person acting as an alternate Director) shall, notwithstanding that it is afterwards discovered that there was some defect in the
                                                            appointment of any Director or alternate Director, and/or that they or any of them were disqualified, and/or had vacated their
                                                            office and/or were not entitled to vote, be as valid as if every such person had been duly appointed and/or not disqualified to be a
                                                            Director or alternate Director and/or had not
vacated their office and/or had been entitled to vote, as the case may be.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 45 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">28.10</TD><TD STYLE="text-align: justify">A Director who is present at a meeting of the Directors at which action on any Company matter is taken
shall be presumed to have assented to the action taken unless his dissent shall be entered in the minutes of the meeting or unless he
shall file his written dissent from such action with the person acting as the secretary of the meeting before the adjournment thereof
or shall forward such dissent by registered mail to the Company immediately after the conclusion of the meeting. Such right to dissent
shall not apply to a Director who voted in favour of such action.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">29</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Secretary and Other Officers</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Directors may
by resolution appoint a Secretary and may by resolution also appoint such other Officers as may from time to time be required upon such
terms as to the duration of office, remuneration and otherwise as they may think fit PROVIDED THAT, the Directors may only appoint persons
as directors of the Company in accordance with Article 21.3. Such Secretary or other Officers need not be Directors and in the case of
the other Officers may be ascribed such titles as the Directors may decide. The Directors may by resolution remove from that position
any Secretary or other Officer appointed pursuant to this Article.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">30</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Minutes</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Directors shall
cause minutes to be made in books kept for the purposes of recording:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all appointments of Officers made by the Directors; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">all resolutions and proceedings of meetings of the Company, of the holders of any class of shares in the
Company and of the Directors and of committees of Directors, including the names of the Directors present at each such meeting.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">31</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Seal</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.1</TD><TD STYLE="text-align: justify">The Company may, if the Directors so determine, have a Seal. The Seal shall only be used by the authority
of the Directors or of a committee of Directors authorised by the Directors. The Directors may determine who shall sign any instrument
to which the Seal is affixed, and unless otherwise so determined every such instrument shall be signed by a Director or by such other
person as the Directors may authorise.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.2</TD><TD STYLE="text-align: justify">The Company may have for use in any place or places outside the Islands a duplicate Seal or Seals, each
of which shall be a reproduction of the Seal of the Company and, if the Directors so determine, shall have added on its face the name
of every place where it is to be used.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.3</TD><TD STYLE="text-align: justify">The Directors may by resolution determine (i) that any signature required by this Article need not be
manual but may be affixed by some other method or system of reproduction or mechanical or Electronic Signature and/or (ii) that
any document may bear a printed reproduction of the Seal in lieu of affixing the Seal thereto.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 46 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">31.4</TD><TD STYLE="text-align: justify">No document or deed otherwise duly executed and delivered by or on behalf of the Company shall be regarded
as invalid merely because at the date of the delivery of the deed or document, the Director, Secretary or other Officer or person who
shall have executed the same or affixed the Seal thereto, as the case may be, for and on behalf of the Company shall have ceased to hold
such office and authority on behalf of the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">32</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Dividends</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.1</TD><TD STYLE="text-align: justify">Subject to the provisions of the Law, the Company may by Ordinary Resolution declare dividends (including
interim dividends) in accordance with the respective rights of the Members, but no dividend shall exceed the amount recommended by the
Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.2</TD><TD STYLE="text-align: justify">Subject to the provisions of the Law, the Directors may declare dividends in accordance with the respective
rights of the Members and authorise payment of the same out of the funds of the Company lawfully available therefor. If at any time the
share capital is divided into different classes of shares, the Directors may pay dividends on shares which confer deferred or non-preferred
rights with regard to dividends as well as on shares which confer preferential rights with regard to dividends, but no dividend shall
be paid on shares carrying deferred or non-preferred rights if, at the time of payment, any preferential dividend is in arrears. The Directors
may also pay at intervals settled by them any dividend payable at a fixed rate if it appears that there are sufficient funds of the Company
lawfully available for distribution to justify the payment. Provided the Directors act in good faith they shall not incur any liability
to the holders of shares conferring preferred rights for any loss they may suffer by the lawful payment of a dividend on any shares having
deferred or non-preferred rights.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.3</TD><TD STYLE="text-align: justify">The Directors may, before recommending or declaring any dividend, set aside out of the funds legally available
for distribution such sums as they think proper as a reserve or reserves which shall, at the discretion of the Directors, be applicable
for meeting contingencies, or for equalising dividends or for any other purpose to which those funds may be properly applied and pending
such application may, at the like discretion, either be employed in the business of the Company or be invested in such investments (other
than shares in the capital of the Company) as the Directors may from time to time think fit.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.4</TD><TD STYLE="text-align: justify">Except as otherwise provided by the rights attached to shares and subject to Article 15, all dividends
shall be paid in proportion to the number of shares a Member holds as of the date the dividend is declared; save that (a) if any share
is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank for dividend accordingly;
and (b) where the Company has shares in issue which are not fully paid up (as to par value) the Company may pay dividends in proportion
to the amount paid up on each share.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 47 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.5</TD><TD STYLE="text-align: justify">The Directors may deduct from a dividend or other amounts payable to a person in respect of a share any
amounts due from him to the Company on account of a call or otherwise in relation to a share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.6</TD><TD STYLE="text-align: justify">Any Ordinary Resolution or Directors&rsquo; resolution declaring a dividend may direct that it shall be
satisfied wholly or partly by the distribution of assets and, where any difficulty arises in regard to such distribution, the Directors
may settle the same and in particular may issue fractional certificates and fix the value for distribution of any assets and may determine
that cash shall be paid to any Member upon the footing of the value so fixed in order to adjust the rights of Members and may vest any
assets in trustees.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.7</TD><TD STYLE="text-align: justify">Any dividend or other moneys payable on or in respect of a share may be paid by cheque sent by post to
the registered address of the person entitled or, if two or more persons are the holders of the share or are jointly entitled to it by
reason of the death or bankruptcy of the holder, to the registered address of that one of those persons who is first named in the Register
of Members or to such person and to such address as the person or persons entitled may in writing direct. Subject to any applicable law
or regulations, every cheque shall be made payable to the order of the person or persons entitled or to such other person as the person
or persons entitled may in writing direct and payment of the cheque shall be a good discharge to the Company. Any joint holder or other
person jointly entitled to a share as aforesaid may give receipts for any dividend or other moneys payable in respect of the share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.8</TD><TD STYLE="text-align: justify">No dividend or other moneys payable in respect of a share shall bear interest against the Company unless
otherwise provided by the rights attached to the share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">32.9</TD><TD STYLE="text-align: justify">Any dividend which has remained unclaimed for six years from the date when it became due for payment shall,
if the Directors so resolve, be forfeited and cease to remain owing by the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">33</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Financial Year, Accounting
Records and Audit</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.1</TD><TD STYLE="text-align: justify">Unless the Directors otherwise prescribe, the financial year of the Company shall end on 31 December in
each year and, following the year of incorporation, shall begin on 1 January each year.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.2</TD><TD STYLE="text-align: justify">The books of account relating to the Company&rsquo;s affairs shall be kept in such manner as may be determined
from time to time by the Directors. The books of account shall be kept at the registered office or at such other place or places as the
Directors think fit, and shall always be open to the inspection of the Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.3</TD><TD STYLE="text-align: justify">No Member shall be entitled to require discovery of or any information with respect to any detail of the
Company&rsquo;s trading or any matter which is or may be in the nature of a trade secret or secret process which may relate to the conduct
of the business of the Company and which in the opinion of the Directors it will be inexpedient in the interests of the Members of the
Company to communicate to the public.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 48 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.4</TD><TD STYLE="text-align: justify">The Directors may from time to time determine whether and to what extent and at what times and places
and under what conditions or regulations the accounts and books and corporate records of the Company or any of them shall be open to the
inspection of Members not being Directors, and no Member (not being a Director) shall have any right of inspecting any account or book
or document of the Company except as conferred by applicable law, the listing rules of any Designated Stock Exchange or authorised by
the Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.5</TD><TD STYLE="text-align: justify">Subject to Articles &#8206;33.4, and &#8206;33.6 a printed copy of the Directors&rsquo; report, if any,
accompanied by the consolidated statements of financial position, profit or loss, comprehensive income (loss), cash flows and changes
in shareholders&rsquo; equity, including every document required by the Law to be annexed thereto, made up to the end of applicable financial
year, shall be sent to the Members at least ten (10) Business Days before the date of the general meeting and laid before the Company
at the annual general meeting held in accordance with Article 16.2, provided that this Article 33.5 shall not require a copy of those
documents to be sent to any person whose address the Company is not aware of or to more than one of the joint holders of any shares.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.6</TD><TD STYLE="text-align: justify">The requirement to send to a Person referred to in Article &#8206;33.5 the documents referred to in that
Article shall be deemed satisfied where, in accordance with all applicable laws, rules and regulations, including, without limitation,
the rules of any Designated Stock Exchange, the Company publishes copies of the documents referred to in Article &#8206;33.5 on the Company&rsquo;s
Website, transmits it to SEC&rsquo;s website or in any other permitted manner (including by sending any other form of Electronic Communication),
and that person has agreed or is deemed by the Company to have agreed to treat the publication or receipt of such documents in such manner
as discharging the Company&rsquo;s obligation to send to him a copy of such documents.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.7</TD><TD STYLE="text-align: justify">Subject to applicable law and to the rules of any Designated Stock Exchange, the accounts relating to
the Company&rsquo;s affairs shall, on an annual basis, be audited by an Authorised Auditor chosen by the Directors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.8</TD><TD STYLE="text-align: justify">The Directors, having considered the recommendations of the Audit Committee, shall appoint an auditor
of the Company who shall hold office until removed from office by a resolution of the Board, and shall fix his or their remuneration.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">33.9</TD><TD STYLE="text-align: justify">Every auditor of the Company shall have a right of access at all times to the books and accounts of the
Company and shall be entitled to require from the Directors and Officers such information and explanation as may be necessary for the
performance of the duties of the auditors.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">34</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Capitalisation of Profits</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Directors may:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">subject as provided in this Article, resolve to capitalise any undivided profits of the Company not required
for paying any preferential dividend (whether or not they are available for distribution) or any sum standing to the credit of the Company&rsquo;s
share premium account or capital redemption reserve;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 49 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">appropriate the sum resolved to be capitalised to the Members who would have been entitled to it if it
were distributed by way of dividend and in the same proportions and apply such sum on their behalf either in or towards paying up the
amounts, if any, for the time being unpaid on any shares held by them respectively, or in paying up in full unissued shares or debentures
of the Company of a nominal amount equal to such sum, and allot the shares or debentures credited as fully paid to those Members, or as
they may direct, in those proportions, or partly in one way and partly in the other, provided that on any such capitalisation holders
of Class A Common Shares shall receive Class A Common Shares (or rights to acquire Class A Common Shares, as the case may be) and holders
of Class B Common Shares shall receive Class B Common Shares (or rights to acquire Class B Common Shares, as the case may be);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">resolve that any shares so allotted to any Member in respect of a holding by him of any partly-paid shares
rank for dividend, so long as such shares remain partly paid, only to the extent that such partly paid shares rank for dividend;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">make such provision by the issue of fractional certificates or by payment in cash or otherwise as they
determine in the case of shares or debentures becoming distributable under this Article in fractions; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">authorise any person to enter on behalf of all the Members concerned into an agreement with the Company
providing for the allotment to them respectively, credited as fully paid, of any shares or debentures to which they may be entitled upon
such capitalisation, any agreement made under such authority being binding on all such Members.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">35</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Share Premium Account</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.1</TD><TD STYLE="text-align: justify">The Directors shall in accordance with Section 34 of the Law establish a share premium account and shall
carry to the credit of such account from time to time a sum equal to the amount or value of the premium paid on the issue of any share
or capital contributed as described in Article &#8206;4.12.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">35.2</TD><TD STYLE="text-align: justify">There shall be debited to any share premium account:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">on the redemption or purchase of a share the difference between the nominal value of such share and the
redemption or purchase price provided always that at the discretion of the Directors such sum may be paid out of the profits of the Company
or, if permitted by Section 37 of the Law, out of capital; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">any other amounts paid out of any share premium account as permitted by Section 34 of the Law.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">36</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Notices</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.1</TD><TD STYLE="text-align: justify">Except as otherwise provided in these Articles and subject to the rules of any Designated Stock Exchange,
any notice or document may be served by the Company or by the Person entitled to give notice to any Member either personally
or by posting it airmail or by air courier service in a prepaid letter addressed to such Member at his address as appearing in the Register
of Members, or by electronic mail to any electronic mail address such Member may have specified in writing for the purpose of such service
of notices, or by advertisement in appropriate newspapers in accordance with the requirements of any Designated Stock Exchange or by placing
it on the Company&rsquo;s Website. In the case of joint holders of a Share, all notices shall be given to that one of the joint holders
whose name stands first in the Register of Members in respect of the joint holding, and notice so given shall be sufficient notice to
all the joint holders.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 50 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.2</TD><TD STYLE="text-align: justify">Notices posted to addresses outside the Cayman Islands shall be forwarded by prepaid airmail.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.3</TD><TD STYLE="text-align: justify">Any notice or other document, if served by:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">post, shall be deemed to have been served five days after the time when the letter containing the same
is posted;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">recognised courier service, shall be deemed to have been served 48 hours after the time when the letter
containing the same is delivered to the courier service;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">electronic mail, shall be deemed to have been served immediately upon the time of the transmission by
electronic mail; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">placing it on the Company&rsquo;s Website, shall be deemed to have been served one (1) hour after the
notice or document is placed on the Company&rsquo;s Website.</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">36.3.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In
proving service by post or courier service it shall be sufficient to prove that the letter containing the notice or documents was properly
addressed and duly posted or delivered to the courier service.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.4</TD><TD STYLE="text-align: justify">A Member present, either in person or by proxy, at any meeting of the Company or of the holders of any
class of shares in the Company shall be deemed to have received notice of the meeting, and, where requisite, of the purpose for which
it was called.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.5</TD><TD STYLE="text-align: justify">Any notice or document delivered or sent by post to or left at the registered address of any Member in
accordance with the terms of these Articles shall notwithstanding that such Member be then dead or bankrupt, and whether or not the Company
has notice of his death or bankruptcy, be deemed to have been duly served in respect of any Share registered in the name of such Member
as sole or joint holder, unless his name shall at the time of the service of the notice or document, have been removed from the Register
of Members as the holder of the Share, and such service shall for all purposes be deemed a sufficient service of such notice or document
on all Persons interested (whether jointly with or as claiming through or under him) in the Share.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.6</TD><TD STYLE="text-align: justify">Notice of every general meeting of the Company shall be given to:</TD></TR></TABLE>


<!-- Field: Page; Sequence: 51 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all Members holding Shares with the right to receive notice and who have supplied to the Company an address,
facsimile number or email address for the giving of notices to them; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">every Person entitled to a Share in consequence of the death or bankruptcy of a Member, who but for his
death or bankruptcy would be entitled to receive notice of the meeting.</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">No other Person
shall be entitled to receive notices of general meetings.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">36.7</TD><TD STYLE="text-align: justify">The Company shall make available to any Member, upon request, any agreements executed between the Company
and its Related Parties, any shareholder agreements to which the Company is a party and the details of any Incentive Plan.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">37</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Winding Up</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">Subject to Article
19.3:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.1</TD><TD STYLE="text-align: justify">The Board shall have the power in the name and on behalf of the Company to present a petition to the court
for the Company to be wound up.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.2</TD><TD STYLE="text-align: justify">If the Company is wound up, the liquidator may, with the sanction of a Special Resolution and any other
sanction required by the Law, divide among the Members in specie the whole or any part of the assets of the Company and may, for that
purpose, value any assets and determine how the division shall be carried out as between the Members or different classes of Members.
The liquidator may, with the like sanction, vest the whole or any part of the assets in trustees upon such trusts for the benefit of the
Members as he with the like sanction determines, but no Member shall be compelled to accept any assets upon which there is a liability.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">37.3</TD><TD STYLE="text-align: justify">If the Company shall be wound up and the assets available for distribution amongst the Members as such
shall be insufficient to repay the whole of the paid up capital, such assets shall be distributed so that, as nearly as may be, the losses
shall be borne by the Members in proportion to the capital paid up, or which ought to have been paid up, at the commencement of the winding
up, on the shares held by them respectively. If in a winding up the assets available for distribution amongst the Members shall be more
than sufficient to repay the whole of the capital paid up at the commencement of the winding up, the excess shall be distributed <I>pari
passu</I> amongst the Members in proportion to the capital paid up at the commencement of the winding up on the shares held by them respectively.
This Article is to be without prejudice to the rights of the holders of shares issued upon special terms and conditions.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">38</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Indemnity</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.1</TD><TD STYLE="text-align: justify">Every Indemnified Person for the time being and from time to time of the Company and the personal representatives
of the same shall be indemnified and secured harmless out of the assets and funds of the Company against all actions, proceedings, costs,
charges, expenses, losses, damages, liabilities, judgments, fines, settlements and other amounts (including reasonable attorneys&rsquo; fees and
expenses and amounts paid in settlement and costs of investigation (collectively &quot;<B>Losses</B>&quot;) incurred or sustained by him
otherwise than by reason of his own dishonesty, wilful default or fraud in or about the conduct of the Company&rsquo;s business or affairs
(including as a result of any mistake of judgment) or in the execution or discharge of his duties, powers, authorities or discretions,
including without prejudice to the generality of the foregoing, any Losses incurred by him in defending or investigating (whether successfully
or otherwise) any civil, criminal, investigative and administrative proceedings concerning or in any way related to the Company or its
affairs in any court whether in the Islands or elsewhere. Such Losses incurred in defending or investigating any such proceeding shall
be paid by the Company as they are incurred upon receipt, in each case, of an undertaking by or on behalf of the Indemnified Person to
repay such amounts if it is ultimately determined by a non-appealable order of a court of competent jurisdiction that such Indemnified
Person is not entitled to indemnification hereunder with respect thereto.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 52 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.2</TD><TD STYLE="text-align: justify">No such Indemnified Person of the Company and the personal representatives of the same shall be liable
(i) for the acts, receipts, neglects, defaults or omissions of any other Director or Officer or agent of the Company or (ii) by reason
of his having joined in any receipt for money not received by him personally or in any other act to which he was not a direct party for
conformity or (iii) for any loss on account of defect of title to any property of the Company or (iv) on account of the insufficiency
of any security in or upon which any money of the Company shall be invested or (v) for any loss incurred through any bank, broker or other
agent or any other party with whom any of the Company&rsquo;s property may be deposited or (vi) for any loss, damage or misfortune whatsoever
which may happen in or arise from the execution or discharge of the duties, powers, authorities or discretions of his office or in relation
thereto or (vii) for any loss occasioned by any negligence, default, breach of duty, breach of trust, error of judgement or oversight
on such Person&rsquo;s part, unless he has acted dishonestly, with wilful default or through fraud.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.3</TD><TD STYLE="text-align: justify">The Company hereby acknowledges that certain Indemnified Persons may have certain rights to indemnification,
advancement of expenses and/or insurance from or against (other than directors&rsquo; and officers&rsquo; or similar insurance obtained
or maintained by or on behalf of the Company or any of its subsidiaries, including any such insurance obtained or maintained pursuant
to Article 38.4 hereof) Other Indemnitors. The Company hereby agrees that: (i) it is the indemnitor of first resort (i.e., its obligations
to an Indemnified Person are primary and any obligation of any Other Indemnitors to advance expenses or to provide indemnification for
the same expenses or liabilities incurred by such Indemnified Person are secondary); (ii) it shall be required to advance the full amount
of expenses incurred by an Indemnified Person and shall be liable for the full amount of all Losses to the extent legally permitted and
as required by the terms of these Articles (or any other agreement between the Company and an Indemnified Person) without regard to any
rights an Indemnified Person may have against any Other Indemnitors; and (iii) it irrevocably waives, relinquishes and releases any Other
Indemnitors from any and all claims against the Other Indemnitors for contribution, subrogation or any other recovery of any kind in respect
thereof. The Company further agrees that no advancement or payment by any Other Indemnitors on behalf of an Indemnified Person with respect
to any claim for which such Indemnified Person has sought indemnification from the Company shall affect the foregoing, and without prejudice
to Article 39 below, Other Indemnitors shall have a right of contribution and/or be subrogated to the extent of such advancement or payment
to all of the rights of recovery of such Indemnified Person against the Company. For the avoidance of doubt, no Person or entity providing
directors&rsquo; or officers&rsquo; or similar insurance obtained or maintained by or on behalf of the Company or any of its subsidiaries,
including any Person providing such insurance obtained or maintained pursuant to Article 38.4 hereof, shall be an Other Indemnitor.</TD></TR></TABLE>


<!-- Field: Page; Sequence: 53 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">38.4</TD><TD STYLE="text-align: justify">The Directors may exercise all the powers of the Company to purchase and maintain insurance for the benefit
of a Person who is or was (whether or not the Company would have the power to indemnify such Person against such liability under the provisions
of this Article 38 or under applicable law): (a) a Director, alternate Director, Secretary or auditor of the Company or of a company which
is or was a subsidiary of the Company or in which the Company has or had an interest (whether direct or indirect); or (b) the trustee
of a retirement benefits scheme or other trust in which a person referred to in Article 38.1 is or has been interested, indemnifying him
against any liability which may lawfully be insured against by the Company.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">39</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Claims Against the Company</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">Notwithstanding
Article &#8206;38.3, unless otherwise determined by a majority of the Board, in the event that (i) any Member (the &quot;<B>Claiming Party</B>&quot;)
initiates or asserts any claim or counterclaim (&quot;<B>Claim</B>&quot;) or joins, offers substantial assistance to or has a direct financial
interest in any Claim against the Company and (ii) the Claiming Party (or the third party that received substantial assistance from the
Claiming Party or in whose Claim the Claiming Party had a direct financial interest) does not obtain a judgment on the merits in which
the Claiming Party prevails, then each Claiming Party shall, to the fullest extent permissible by law, be obligated jointly and severally
to reimburse the Company for all fees, costs and expenses (including, but not limited to, all reasonable attorneys&rsquo; fees and other
litigation expenses) that the Company may incur in connection with such Claim.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">40</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Untraceable Members</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">40.1</TD><TD STYLE="text-align: justify">Without prejudice to the rights of the Company under Article &#8206;40.2, the Company may cease sending
cheques for dividend entitlements or dividend warrants by post if such cheques or warrants have been left uncashed on two (2) consecutive
occasions. However, the Company may exercise the power to cease sending cheques for dividend entitlements or dividend warrants after the
first occasion on which such a cheque or warrant is returned undelivered.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">40.2</TD><TD STYLE="text-align: justify">The Company shall have the power to sell, in such manner as the Board thinks fit, any shares of a Member
who is untraceable, but no such sale shall be made unless:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all cheques or warrants in respect of dividends of the shares in question, being not less than three (3)
in total number, for any sum payable in cash to the holder of such shares in respect of them sent during the relevant period in the manner
authorised by these Articles of the Company have remained uncashed;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 54 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">so far as it is aware at the end of the relevant period, the Company has not at any time during the relevant
period received any indication of the existence of the Member who is the holder of such shares or of a person entitled to such shares
by death, bankruptcy or operation of law; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">the Company, if so required by the rules governing the listing of shares on the Designated Stock Exchange,
has given notice to, and caused advertisement in newspapers to be made in accordance with the requirements of, the Designated Stock Exchange
of its intention to sell such shares in the manner required by the Designated Stock Exchange, and a period of three (3) months or such
shorter period as may be allowed by the Designated Stock Exchange has elapsed since the date of such advertisement.</TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">40.2.1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;For
the purposes of the foregoing, the &quot;relevant period&quot; means the period commencing twelve (12) years before the date of publication
of the advertisement referred to in this Article &#8206;40.2 and ending at the expiry of the period referred to in that paragraph.</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">40.3</TD><TD STYLE="text-align: justify">To give effect to any such sale the Board may authorise some person to transfer the said shares and an
instrument of transfer signed or otherwise executed by or on behalf of such persons shall be as effective as if it had been executed by
the registered holder or the person entitled by transmission to such shares, and the purchaser shall not be bound to see to the application
of the purchase money nor shall his title to the shares be affected by any irregularity or invalidity in the proceedings relating to the
sale. The net proceeds of the sale will belong to the Company and upon receipt by the Company of such net proceeds it shall become indebted
to the former Member for an amount equal to such net proceeds. No trust shall be created in respect of such debt and no interest shall
be payable in respect of it and the Company shall not be required to account for any money earned from the net proceeds which may be employed
in the business of the Company or as it thinks fit. Any sale under this Article shall be valid and effective notwithstanding that the
Member holding the shares sold is dead, bankruptcy or otherwise under any legal disability or incapacity.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">41</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Amendment of Memorandum of
Articles</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.1</TD><TD STYLE="text-align: justify">Subject to the Law and these Articles, the Company may by Special Resolution change its name or change
the provisions of the Memorandum with respect to its objects, powers or any other matter specified therein.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in">41.2</TD><TD STYLE="text-align: justify">Subject to the Law and as provided in these Articles, the Company may at any time and from time to time
by Special Resolution, alter or amend these Articles in whole or in part.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: bold 11pt Arial, Helvetica, Sans-Serif; margin-top: 12pt; margin-bottom: 6pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.5in"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">42</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Transfer by Way of Continuation</FONT></TD></TR></TABLE>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify; text-indent: 0in">The Company may
by Special Resolution resolve to be registered by way of continuation in a jurisdiction outside the Islands or such other jurisdiction
in which it is for the time being incorporated, registered or existing. In furtherance of a resolution adopted pursuant to this Article,
the Directors may cause an application to be made to the Registrar of Companies to deregister the Company in the Islands or such
other jurisdiction in which it is for the time being incorporated, registered or existing and may cause all such further steps as they
consider appropriate to be taken to effect the transfer by way of continuation of the Company.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 0pt; text-align: center">55</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; margin-top: 12pt; margin-bottom: 6pt; text-align: center"></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 12pt 0 6pt 0.5in; text-align: justify"></P>

<P STYLE="font: 10.5pt Arial, Helvetica, Sans-Serif; margin: 6pt 0 6pt 0.5in; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>3
<FILENAME>ex02-1.htm
<DESCRIPTION>EX-2.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: right">Exhibit 2.1</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center">DESCRIPTION OF SECURITIES REGISTERED UNDER
SECTION 12 OF THE EXCHANGE ACT</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following is a description of our outstanding
securities registered under Section 12 of the Exchange Act as required pursuant to the relevant Items under Form 20-F. As of December
31, 2021, Afya Limited (&ldquo;we,&rdquo; &ldquo;us,&rdquo; and &ldquo;our&rdquo;) had the following series of securities registered pursuant
to Section 12(b) of the Exchange Act:</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center; width: 34%; padding-right: 2.9pt; padding-left: 2.9pt; vertical-align: bottom">
    <P STYLE="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid">Title
    of each class</P></TD>
    <TD STYLE="text-align: center; width: 33%; padding-right: 2.9pt; padding-left: 2.9pt; vertical-align: bottom">
    <P STYLE="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid">Trading
    Symbol(s)</P></TD>
    <TD STYLE="text-align: center; width: 33%; padding-right: 2.9pt; padding-left: 2.9pt; vertical-align: bottom">
    <P STYLE="font: bold 8pt/9pt Times New Roman, Times, Serif; margin: 1pt 0 2pt; text-align: center; border-bottom: Black 0.5pt solid">Name
    of each exchange on which registered</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Class A common shares, par value US$0.00005 per share</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">AFYA</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-right: 2.9pt; padding-left: 2.9pt; text-align: center">Nasdaq Global Select Market</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 10pt 0; text-indent: 0.25in">We were incorporated on March 22, 2019 as a Cayman
Islands exempted company with limited liability duly registered with the Cayman Islands Registrar of Companies. Our corporate purposes
are unrestricted and we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies
Act (as revised) of the Cayman Islands, or the Companies Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our affairs are governed principally by (i)&nbsp;our
Amended and Restated Memorandum and Articles of Association; (ii)&nbsp;the Companies Act; and (iii)&nbsp;the common law of the Cayman
Islands. As provided in our Amended and Restated Memorandum and Articles of Association, subject to Cayman Islands law, we have full capacity
to carry on or undertake any business or activity, do any act or enter into any transaction, and, for such purposes, full rights, powers
and privileges. Our registered office is c/o Maples Corporate Services Limited, P.O. Box 309, Ugland House, Grand Cayman, KY1-1104, Cayman
Islands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: center; text-indent: 0in"><B>CLASS A COMMON SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>Item 9. General</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>9.A.3 Preemptive rights</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">See &ldquo;&mdash;Item 10.B Memorandum and
articles of association&mdash;Preemptive or Similar Rights&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>9.A.5 Type and class of securities</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><FONT STYLE="background-color: white">As
of December 31, 2021, Afya had a total issued share capital of R$17 thousand, represented by 93,722,831 common shares comprised by
46,265,141 Class A common shares, and 45,802,763 Class B common shares and 1,654,927 common shares held in treasury and 150,000
Series A perpetual convertible preferred shares.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As of December 31, 2021, our total authorized
share capital was US$50,000, divided into 1,000,000,000 shares par value US$0.00005 each, of which: (i) 500,000,000 shares are designated
as Class A common shares; (ii)&nbsp;250,000,000 shares are designated as Class B common shares; and (iii) 250,000,000 shares of such class
or classes (howsoever designated) and having the rights as the Board may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Amended and Restated Memorandum and Articles
of Association currently authorize two classes of common shares: Class A common shares, which are entitled to one vote per share, and
Class B common shares, which are entitled to 10 votes per share and to maintain a proportional ownership interest in the event that additional
Class A common shares are issued. Any holder of Class B common shares may convert his or her shares at any time into Class A common shares
on a share-for-share basis. The rights of the two classes of common shares are otherwise identical, except as described in our Amended
and Restated Memorandum and Articles of Association. The implementation of this dual class equity structure was required by the Esteves
Family and Crescera, our principal shareholders in the year of 2019, as a condition of undertaking the initial public offering of our
common shares. See &ldquo;&mdash;Anti-Takeover Provisions in Our Articles of Association&mdash;Two Classes of Common Shares.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>Item 9.A.6. Limitations or qualifications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>Item 9.A.7. Other rights</B><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Not applicable.</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0in"><B>Item 10.B Memorandum and articles of association</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The following information describes our Class
A common shares and provisions set forth by our Amended and Restated Memorandum and Articles of Association, the Companies Act; and the
common law of the Cayman Islands. This description is only a summary. You should read and refer to our Amended and Restated Memorandum
and Articles of Association included as Exhibit&nbsp;1.2 to our annual report on Form 20-F for the fiscal year ended December 31, 2021.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Description of Our Amended and Restated Memorandum and Articles
of Association</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><I>History of Share Capital</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On July 19, 2019, our registration statement
on Form F-1 (File No 333-232309), as amended, was declared effective by the SEC for to our initial public offering of our Class A common
shares, pursuant to which we sold a total of 15,805,841 Class A common shares, par value $0.00005 per share, at a public offering price
of US$19.00 per share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On February 6, 2020, our registration statement
on Form F-1 (File No 333-236246), as amended, was declared effective by the SEC for a public offering of our Class A common shares, pursuant
to which we sold a total of 3,260,480 Class A common shares, par value $0.00005 per share, at a public offering price of US$27.50 per
share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we announced that the SoftBank
Latin America Fund, or SoftBank, agreed to purchase R$822 million, equivalent to US$150 million, of Afya&rsquo;s Series A perpetual convertible
preferred shares, subject to customary closing conditions. In addition, Crescera Educacional II Fundo de Investimento em Participa&ccedil;&otilde;es
Multiestrat&eacute;gia and the Esteves Family agreed to sell 2,270,208 Class A common shares to SoftBank. In connection with such sale,
at the time, Paulo Passoni from SoftBank was appointed as a board member of Afya, being replaced by Maria Tereza Azevedo in 2022. The key terms of the Series A perpetual convertible preferred
shares, as set forth under the relevant certificate of designations, are: (i) 6.5% per annum cumulative dividend payable quarterly and
in Brazilian reais (payable in U.S. dollars in Brazilian reais equivalent); (ii) SoftBank shall have the right at any time, to convert
its Series A perpetual convertible preferred shares into 5,917,888 common shares, at an initial conversion price established at US$25.35;
(iii) SoftBank shall have the right to redeem any time after the 5th year anniversary at 105% premium; and (iv) Afya will have the right
to force conversion after the 3rd year anniversary if forced conversion trigger conditions are satisfied. The Series A perpetual convertible
preferred share will be entitled to the same voting rights as the common shares only when converted into common shares. For further information,
see &ldquo;Item 5. Operating and Financial Review and Prospects&mdash;B. Liquidity and Capital Resources&mdash;Indebtedness&mdash;Financing&mdash;Series
A Perpetual Convertible Shares&rdquo; in our annual report on Form 20-F for the fiscal year ended December 31, 2021 and note 13.2.1(f)
to our audited consolidated financial statements included elsewhere in our annual report on Form 20-F for the fiscal year ended December
31, 2021. SoftBank and its affiliates will beneficially own approximately 8.4% of the total shares of the Company (on an as-converted
basis for the Series A perpetual convertible preferred shares).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><FONT STYLE="background-color: white">As of
December 31, 2021, Afya had 1,654,927 shares in treasury.</FONT></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><I>General</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders adopted our Amended and Restated
Memorandum and Articles of Association, effective as of August 5, 2021, included as Exhibit 1.2 to our annual report on Form 20-F for
the fiscal year ended December 31, 2021. The following summary is subject to and qualified in its entirety by Afya Limited&rsquo;s Amended
and Restated Memorandum and Articles of Association. This is not a summary of all the significant provisions of our Amended and Restated
Memorandum and Articles of Association, of the Companies Act or of the common law of the Cayman Islands and does not purport to be complete.
Capitalized terms used but not defined herein have the meanings given to them in our annual report on Form 20-F for the fiscal year ended
December 31, 2021.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 9pt"><I>Corporate Purposes</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our corporate purposes are unrestricted and
we have the authority to carry out any object not prohibited by law as provided by Section 7(4) of the Companies Act.</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Issuance of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, our board of directors has general and unconditional authority to allot, grant options over, offer or otherwise deal with
or dispose of any unissued shares in the company&rsquo;s capital without the approval of our shareholders (whether forming part of the
original or any increased share capital), either at a premium or at par, with or without preferred, deferred or other special rights or
restrictions, whether in regard to dividend, voting, return of capital or otherwise and to such persons, on such terms and conditions,
and at such times as the directors may decide, but so that no share shall be issued at a discount, except in accordance with the provisions
of the Companies Act. In accordance with its Articles of Association, Afya shall not issue bearer shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide that at
any time that there are Class A common shares in issue, additional Class B common shares may only be issued pursuant to (i)&nbsp;a share
split, subdivision of shares or similar transaction or where a dividend or other distribution is paid by the issue of shares or rights
to acquire shares or following capitalization of profits, (ii)&nbsp;a merger, consolidation, or other business combination, or (iii)&nbsp;an
issuance of shares including Class A common shares or any other class of share designated as a common share pursuant to the Articles of
Association, whereby each holder of the Class B common shares is entitled to purchase a number of Class B common shares that would allow
it to maintain its proportional ownership interests in Afya (following an offer by Afya to each holder of Class B common shares to issue
to such holder, upon the same economic terms and at the same price, such number of Class B common shares as would ensure such holder may
maintain a proportional ownership interest in Afya pursuant to our Articles of Association). In light of: (a)&nbsp;the above provisions;
(b)&nbsp;the fact that future transfers by holders of Class B common shares will generally result in those shares converting to Class
A common shares, subject to limited exceptions as provided in the Articles of Association; and (c)&nbsp;the ten-to-one voting ratio between
our Class B common shares and Class A common shares, means that holders of our Class B common shares will in many situations continue
to maintain control of all matters requiring shareholder approval. This concentration of ownership and voting power will limit or preclude
your ability to influence corporate matters for the foreseeable future. For more information see &ldquo;&mdash;Preemptive or Similar Rights.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association also provide that
the issuance of non-voting common shares requires the affirmative vote of a majority of the then-outstanding Class A common shares and
the prior written consent of a Bertelsmann Director and Esteves Family Director as set out below in &ldquo;&mdash;Proceedings of the Board
of Directors.&rdquo;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Fiscal Year</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our fiscal year begins on January 1 of each
year and ends on December 31 of the same year.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Voting Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of the Class A common shares and
Class B common shares have identical rights, except that (i)&nbsp;the holder of Class B common shares is entitled to 10 votes per share,
whereas holders of Class A common shares are entitled to one vote per share, (ii)&nbsp;Class B common shares have certain conversion rights
and (iii)&nbsp;the holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common
shares and/or preferred shares are proposed to be issued. For more information see below &ldquo;&mdash;Preemptive or Similar Rights&rdquo;
and &ldquo;&mdash;Conversion.&rdquo; The holders of Class A common shares and Class B common shares vote together as a single class on
all matters (including the election of directors) submitted to a vote of shareholders, except as provided below and as otherwise required
by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association provide as follows
regarding the respective rights of holders of Class A common shares and Class B common shares:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><FONT STYLE="background-color: white">(i)</FONT><FONT STYLE="font-family: Courier New, Courier, Monospace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Class
consents from the holders of Class A common shares or Class B common shares, as applicable, shall be required for any variation to the
rights attached to their respective class of shares, however, the directors may treat any two or more classes of shares as forming one
class if they consider that all such classes would be affected in the same way by the proposal;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(ii)<FONT STYLE="font-family: Courier New, Courier, Monospace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
rights conferred on holders of Class A common shares shall not be deemed to be varied by the creation or issue of further Class B common
shares and vice versa; and</P>


<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">(iii)<FONT STYLE="font-family: Courier New, Courier, Monospace">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>the
rights attaching to the Class A common shares and the Class B common shares shall not be deemed to be varied by the creation or issue
of shares with preferred or other rights, including, without limitation, shares with enhanced or weighted voting rights.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As set forth in the Articles of Association,
the holders of Class A common shares and Class B common shares, respectively, do not have the right to vote separately if the number of
authorized shares of such class is increased or decreased. Rather, the number of authorized Class A common shares and Class B common shares
may be increased or decreased (but not below the number of shares of such class then outstanding) by the affirmative vote of the holders
of a majority of the voting power of the issued and outstanding Class A common shares and Class B common shares, voting together in a
general meeting.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Preemptive or Similar Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares and Class B common
shares are not entitled to preemptive rights upon transfer and are not subject to conversion (except as described below under &ldquo;&mdash;Conversion&rdquo;),
redemption or sinking fund provisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares are entitled to maintain
a proportional ownership interest in the event that additional common and/or preferred shares are issued. As such, if Afya issues common
and/or preferred shares, it must first make an offer to each holder of Class B common shares to issue to such holder on the same economic
terms such number of Class B common shares as would ensure such holder may maintain a proportional ownership interest in Afya. This right
to maintain a proportional ownership interest may be waived by all of the holders of Class B common shares, such waiver to remain effective
until the date specified therein or 12 months from the date of the waiver.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Conversion</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The outstanding Class B common shares are convertible
at any time as follows: (i)&nbsp;at the option of the holder, a Class B common share may be converted at any time into one Class A common
share or (ii)&nbsp;upon the election of the holders of all the then issued and outstanding Class B common shares, all outstanding Class
B common shares may be converted into a like number of Class A common shares. In addition, each Class B common share will convert automatically
into one Class A common share upon any transfer, whether or not for value, except for certain transfers described in the Articles of Association,
including transfers to holders of Class B common shares, to affiliates, transfers to Bertelsmann SE &amp; Co. KGaA and any of its affiliates,
to and between the Esteves Family, Bertelsmann, their family members and their respective children, heirs and successors, trusts solely
for the benefit of the shareholder or their affiliates, and to partnerships, corporations and other entities exclusively owned or controlled
by the Class B shareholder or their affiliates and certain transfers to organizations that are exempt from taxation under Section 501(c)(3)
of the Internal Revenue Code of 1986, as amended. Furthermore, each Class B common share will convert automatically into one Class A common
share and no Class B common shares will be issued thereafter if, at any time, the total number of the issued and outstanding Class B common
shares is less than 10% of the total number of shares outstanding. To the extent that Bertelsmann or the Esteves Family cease to be a
Class B common shareholder, the rights nominally vested to each shall vest in their permitted transferee within the meaning of our Articles
of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">No class of our common shares may be subdivided
or combined unless the other class of common shares is concurrently subdivided or combined in the same proportion and in the same manner.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Equal Status</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Except as expressly provided in our Articles
of Association, Class A common shares and Class B common shares have the same rights and privileges and rank equally, share ratably and
are identical in all respects as to all matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In the event of any merger, consolidation,
scheme, arrangement or other business combination requiring the approval of our shareholders entitled to vote thereon (whether or not
Afya is the surviving entity), the holders of Class A common shares shall have the right to receive, or the right to elect to receive,
the same form of consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right
to receive, or the right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B
common shares. In the event of any (i)&nbsp;tender or exchange offer to acquire any Class A common shares or Class B common shares by any third-party pursuant to an
agreement to which Afya is a party, or (ii)&nbsp;any tender or exchange offer by Afya to acquire any Class A common shares or Class B
common shares, the holders of Class A common shares shall have the right to receive, or the right to elect to receive, the same form of
consideration as the holders of Class B common shares, and the holders of Class A common shares shall have the right to receive, or the
right to elect to receive, at least the same amount of consideration on a per share basis as the holders of Class B common shares.</P>


<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Record Dates</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the purpose of determining shareholders
entitled to notice of, or to vote at any general meeting of shareholders or any adjournment thereof, or shareholders entitled to receive
dividend or other distribution payments, or in order to make a determination of shareholders for any other purpose, Our board of directors
may set a record date which shall not exceed 40 clear days prior to the date where the determination will be made.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">General Meetings of Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a condition of admission to a shareholders&rsquo;
meeting, a shareholder must be duly registered as a shareholder of Afya at the applicable record date for that meeting and, in order to
vote, all calls or installments then payable by such shareholder to Afya in respect of the shares that such shareholder holds must have
been paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any special rights or restrictions
as to voting then attached to any shares, at any general meeting every shareholder who is present in person or by proxy (or, in the case
of a shareholder being a corporation, by its duly authorized representative not being himself or herself a shareholder entitled to vote)
shall have one vote per Class A common share and 10 votes per Class B common share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">As a Cayman Islands exempted company, Afya
is not obliged by the Companies Act to call annual general meetings; however, the Articles of Association provide that in each year the
company will hold an annual general meeting of shareholders, at a time determined by the board of directors, provided that the board of
directors of Afya has the discretion whether or not to hold an annual general meeting. For the annual general meeting of shareholders
the agenda will include, among other things, the presentation of the annual accounts and the report of the directors. In addition, the
agenda for an annual general meeting of shareholders will only include such items as have been included therein by the board of directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Also, Afya may, but is not required to (unless
required by the laws of the Cayman Islands), hold other extraordinary general meetings during the year. General meetings of shareholders
are generally expected to take place in Nova Lima, Brazil, but may be held elsewhere if the directors so decide.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act provides shareholders a limited
right to request a general meeting and does not provide shareholders with any right to put any proposal before a general meeting in default
of a company&rsquo;s Articles of Association. However, these rights may be provided in a company&rsquo;s Articles of Association. Our
Articles of Association provide that upon the requisition of one or more shareholders representing not less than one-third of the voting
rights entitled to vote at general meetings, the board will convene an extraordinary general meeting and put the resolutions so requisitioned
to a vote at such meeting. The Articles of Association provide no other right to put any proposals before annual general meetings or extraordinary
general meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to regulatory requirements, the annual
general meeting and any extraordinary general meetings must be called by not less than 10 clear calendar days&rsquo; notice prior to the
relevant shareholders meeting and convened by a notice discussed below. Alternatively, upon the prior consent of all holders entitled
to receive notice, with regards to the annual general meeting, and the holders of 95% in par value of the shares entitled to attend and
vote at an extraordinary general meeting, that meeting may be convened by a shorter notice and in a manner deemed appropriate by those
holders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya will give notice of each general meeting
of shareholders by publication on its website and in any other manner that it may be required to follow in order to comply with Cayman
Islands law, Nasdaq and SEC requirements. The holders of registered shares may be given notice of a shareholders&rsquo; meeting by means
of letters sent to the addresses of those shareholders as registered in our shareholders&rsquo; register, or, subject to certain statutory
requirements, by electronic means.</P>


<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><B>Holders whose shares are registered in the
name of DTC or its nominee, which we expect will be the case for all holders of Class A common shares, will not be a shareholder or member
of the company and must rely on the procedures of DTC regarding notice of shareholders&rsquo; meetings and the exercise of rights of a
holder of the Class A common shares.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A quorum for a general meeting consists of
any one or more persons holding or representing by proxy not less than one-third of the aggregate voting power of all shares in issue
and entitled to vote upon the business to be transacted, provided that such a quorum must also include (i)&nbsp;Bertelsmann for so long
as it holds Class B common shares in excess of 10% of the total number of outstanding Class B common shares (referred to herein as the
&ldquo;Ownership Threshold&rdquo;), and (ii)&nbsp;the Esteves Family for so long as it holds Class B common shares in excess of the Ownership
Threshold.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A resolution put to a vote at a general meeting
shall be decided on a poll. An ordinary resolution to be passed by the shareholders at a general meeting requires the affirmative vote
of a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote, present in person or by proxy and voting
at the meeting. A special resolution requires the affirmative vote on a poll of no less than two-thirds of the votes cast by the shareholders
entitled to vote who are present in person or by proxy at a general meeting. Both ordinary resolutions and special resolutions may also
be passed by a unanimous written resolution signed by all the shareholders of our Company, as permitted by the Companies Act and our Articles
of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Pursuant to our Articles of Association, general
meetings of shareholders are to be chaired by the chairman of our board of directors or in his absence the vice-chairman of the board
of directors. If the chairman or vice-chairman of our board of directors is absent, the directors present at the meeting shall appoint
one of them to be chairman of the general meeting. If neither the chairman nor another director is present at the general meeting within
15 minutes after the time appointed for holding the meeting, the shareholders present in person or by proxy and entitled to vote may elect
any one of the shareholders to be chairman. The order of business at each meeting shall be determined by the chairman of the meeting and
he or she shall have the right and authority to prescribe such rules, regulations and procedures and to do all such acts and things as
are necessary or desirable for the proper conduct of the meeting, including, without limitation, the establishment of procedures for the
maintenance of order and safety, limitations on the time allotted to questions or comments on the affairs of the Company, restrictions
on entry to such meeting after the time prescribed for the commencement thereof, and the opening and closing of the polls. The chairman
shall not have the right to vote in his capacity as chairman and shall not have a casting vote.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Liquidation Rights</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If Afya is voluntarily wound up, the liquidator,
after taking into account and giving effect to the rights of preferred and secured creditors and to any agreement between Afya and any
creditors that the claims of such creditors shall be subordinated or otherwise deferred to the claims of any other creditors and to any
contractual rights of set-off or netting of claims between Afya and any person or persons (including without limitation any bilateral
or any multi-lateral set-off or netting arrangements between the company and any person or persons) and subject to any agreement between
Afya and any person or persons to waive or limit the same, shall apply our property in satisfaction of its liabilities <I>pari passu</I>
and subject thereto shall distribute the property amongst the shareholders according to their rights and interests in Afya.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Special Matters</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya may not without the prior written consent
of (i)&nbsp;Bertelsmann for so long as it holds Class B common shares and (ii)&nbsp;the Esteves Family for so long as it holds Class B
common shares in excess of the Ownership Threshold: change the number of directors; change the structure, function, and/or number of the
board of executive officers (which comprises the three senior executive officers that manage the day-to-day business activities of Afya,
subject to the overall supervision of the board of directors); amend its Memorandum and Articles of Association; vary the rights attaching
to shares; approve any merger or consolidation of Afya with one or more constituent companies (as defined in the Companies Act), the contribution
by Afya of any assets to any subsidiary and/or the creation of any joint venture by Afya; approve any business combination; approve the
winding-up, liquidation or dissolution of Afya; or take certain actions in respect of its share capital as set out in the Articles of
Association; register as an exempted limited duration company; or approve the transfer by way of continuation of Afya to a jurisdiction
outside the Cayman Islands.</P>


<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Corruption and Anti-Money Laundering</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our Articles of Association contain stringent
anti-corruption, anti-money laundering and certain other related measures applicable to us, our officers and directors, and its service
providers. The Articles of Association provide that if one of our shareholders is found to have been involved in an act of corruption,
money laundering or other related irregular act, the directors shall convene a meeting to consider the circumstances of such incident,
and establish a course of action to be taken against such shareholder. The actions range from (i)&nbsp;suspending such shareholder from
his/her duties as a director, officer and/or employee (if applicable) of the Company; (ii)&nbsp;terminating such duties; (iii)&nbsp;directing
such shareholder to transfer the entirety of his/her shareholding in the Company to his/her children and/or heirs; or (iv)&nbsp;if such
transfer is not possible, resolve that the shares in the Company owned by such shareholder be mandatorily redeemed by us. Further, our
Articles of Association provide that we shall not engage the services of any provider that has been found to violate applicable anti-corruption
laws, and further provide that we and our shareholders shall not violate applicable anti-corruption laws.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Changes to Capital</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the restrictions contained in the
Articles of Association and summarized above in &ldquo;&mdash;Special Matters,&rdquo; Afya may from time to time by ordinary resolution:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>increase its share capital by such sum, to be divided into shares of such amount, as the resolution shall prescribe;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>consolidate and divide all or any of its share capital into shares of a larger amount than its existing shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>convert all or any of its paid-up shares into stock and reconvert that stock into paid up shares of any denomination;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>subdivide its existing shares or any of them into shares of a smaller amount, provided that in the subdivision the proportion between
the amount paid and the amount, if any, unpaid on each reduced share shall be the same as it was in the case of the share from which the
reduced share is derived; or</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>cancel any shares which, at the date of the passing of the resolution, have not been taken or agreed to be taken by any person and
diminish the amount of its share capital by the amount of the shares so canceled.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our shareholders may by special resolution,
subject to confirmation by the Grand Court of the Cayman Islands on an application by the Company for an order confirming such reduction,
reduce its share capital or any capital redemption reserve in any manner permitted by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">In addition, subject to the provisions of the
Companies Act and our Articles of Association, Afya may:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>issue shares on terms that they are to be redeemed or are liable to be redeemed;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>purchase its own shares (including any redeemable shares); and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>make a payment in respect of the redemption or purchase of its own shares in any manner authorized by the Companies Act, including
out of its own capital.</TD></TR></TABLE>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Transfer of Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to any applicable restrictions set
forth in the Articles of Association, any shareholder of Afya may transfer all or any of his or her common shares by an instrument of
transfer in the usual or common form or in the form prescribed by the Nasdaq or any other form approved by the Company&rsquo;s board of
directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are traded on the
Nasdaq in book-entry form and may be transferred in accordance with our Articles of Association and Nasdaq&rsquo;s rules and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, our board of directors may, in its
absolute discretion, decline to register any transfer of any common share which is either not fully paid up to a person of whom it does
not approve or is issued under any share incentive scheme for employees which contains a transfer restriction that
is still applicable to such common share. The board of directors may also decline to register any transfer of any common share unless:</P>


<!-- Field: Page; Sequence: 7 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is lodged with Afya, accompanied by the certificate (if any) for the common shares to which it relates
and such other evidence as our board of directors may reasonably require to show the right of the transferor to make the transfer;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is in respect of only one class of shares;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the instrument of transfer is properly stamped, if required;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the common shares transferred are free of any lien in favor of Afya; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>in the case of a transfer to joint holders, the transfer is not to more than four joint holders.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">If the directors refuse to register a transfer
they are required, within 15 business days after the date on which the instrument of transfer was lodged, to send to the transferee notice
of such refusal.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Share Repurchases</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Companies Act and the Articles of Association
permit Afya to purchase its own shares, subject to certain restrictions. The board of directors may only exercise this power on behalf
of Afya, and subject to the Companies Act, the Articles of Association and to any applicable requirements imposed from time to time by
the SEC, the Nasdaq, or by any recognized stock exchange on which our securities are listed. Set forth below is a description of our share
repurchase programs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><U>1<SUP>st</SUP> Share Repurchase Program</U>.
Our Board of Directors approved a share buyback program on December 23, 2020. Under the share buyback program, Afya may repurchase up
to 1,015,844 of its outstanding Class A common shares in the open market, based on prevailing market prices, or in privately negotiated
transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of the repurchase or December
31, 2021, depending upon market conditions. We intend to repurchase the shares to execute the stock option program for the executives
of the company and expect to utilize our existing funds to fund repurchases made under this program. Our Board of Directors also authorized
management to appoint BofA Securities, Inc. as our agent to purchase Securities on its behalf in the open market. It is our intention
such purchases benefit from the safe harbor provided by Rule 10b-18 (&ldquo;Rule 10b-18&rdquo;) promulgated by the SEC under the Exchange
Act. Accordingly, we shall not take, nor permit any person or entity under its control to take, any action that could jeopardize the availability
of Rule 10b-18 for purchases of our common shares under the program. The share buyback program was completed on October 21, 2021, upon
the completion of the purchase of the full amount of Class A common shares permitted under the program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-right: 0; margin-left: 0"><U>2<SUP>nd</SUP>
Share Repurchase Program</U>. After the completion of our first share repurchase program on October 21, 2021 that resulted in the purchase
of 1,015,844 Class A common shares, our Board of Directors approved a new share repurchase program on October 27, 2021. Under the second
share repurchase program, Afya may repurchase up to 1,383,108 of its outstanding Class A common shares in the open market, based on prevailing
market prices, or in privately negotiated transactions, beginning on October 28, 2021 until the earlier of the completion of the repurchase
or December 31, 2022, depending upon market conditions. We intend to repurchase the shares to execute the stock option program for the
executives of the company and expect to utilize our existing funds to fund repurchases made under this program. The Board of Directors
of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in the open market.
It is Afya&rsquo;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by the SEC under the
Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action that could jeopardize
the availability of Rule 10b-18 for purchases under the program. The second repurchase program was completed upon the purchase of the
full amount of Class A common shares permitted under the second repurchase program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify; text-indent: 0.25in"><U>3<SUP>rd</SUP> Share
Repurchase Program</U>. After the completion of our second share repurchase program, which resulted in the purchase of 1,383,108 Class
A common shares, our Board of Directors has approved a new share repurchase program on January 27, 2022. Under the third repurchase program,
Afya may repurchase up to 1,874,457 of its outstanding Class A common shares which represents 4% of its free float, in the open market,
based on prevailing market prices, or in privately negotiated transactions,
beginning on January 27, 2022 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.</P>


<!-- Field: Page; Sequence: 8 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-align: justify"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-right: 0; margin-left: 0">The share
repurchases may be made from time to time through open market transactions and are subject to market and business conditions, levels of
available liquidity, cash requirements for other purposes, regulatory, and other relevant factors. Afya intends to repurchase the shares
for use in its stock option program, as consideration in future business combination transactions and for general corporate purposes.
Afya expects to utilize its existing funds and future dividends to be received from Afya Brazil to fund repurchases made under this program.
Afya&rsquo;s Board of Directors will review the share repurchase program periodically and may authorize adjustments to its terms and size
or suspend or discontinue the program.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; text-indent: 0.25in; margin-right: 0; margin-left: 0">The Board
of Directors of Afya also authorized management to appoint BofA Securities, Inc. as its agent to purchase the shares on its behalf in
the open market. It is Afya&rsquo;s intention that such purchases benefit from the safe harbor provided by Rule 10b-18 promulgated by
the SEC under the Exchange Act. Accordingly, Afya shall not take, nor permit any person or entity under its control to take, any action
that could jeopardize the availability of Rule 10b-18 for purchases under the program.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Dividends and Capitalization of Profits</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We have not adopted a dividend policy with
respect to payments of any future dividends by Afya. Subject to the Companies Act, our shareholders may, by resolution passed by a simple
majority of the voting rights entitled to vote at a general meeting, declare dividends (including interim dividends) to be paid to shareholders
but no dividend shall be declared in excess of the amount recommended by the board of directors. The board of directors may also declare
dividends. Dividends may be declared and paid out of funds lawfully available to Afya. Except as otherwise provided by the rights attached
to shares and the Articles of Association of Afya, all dividends shall be paid in proportion to the number of Class A common shares or
Class B common shares a shareholder holds at the date the dividend is declared (or such other date as may be set as a record date); but,
(i)&nbsp;if any share is issued on terms providing that it shall rank for dividend as from a particular date, that share shall rank for
dividend accordingly, and (ii)&nbsp;where we have shares in issue which are not fully paid up (as to par value) we may pay dividends in
proportion to the amounts paid up on each share.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The holders of Class A common shares and Class
B common shares shall be entitled to share equally in any dividends that may be declared in respect of our common shares from time to
time. In the event that a dividend is paid in the form of Class A common shares or Class B common shares, or rights to acquire Class A
common shares or Class B common shares, (i)&nbsp;the holders of Class A common shares shall receive Class A common shares, or rights to
acquire Class A common shares, as the case may be; and (ii)&nbsp;the holders of Class B common shares shall receive Class B common shares,
or rights to acquire Class B common shares, as the case may be.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Series A perpetual convertible preferred share
rank senior to our common with respect to dividend rights and rights on the distribution of assets on any voluntary or involuntary liquidation,
dissolution or winding up of the affairs of the Company. The holders of Series A perpetual convertible preferred share are entitled to
a cumulative dividend at the rate of 6.5% per annum, payable quarterly in arrears. Dividends are payable in kind through the issuance
of additional Series A perpetual convertible preferred share, in cash, or in any combination of both, at our discretion. In the year ended
December 31, 2021, holders of the Series A perpetual convertible preferred shares received dividends in kind with a value in the aggregate
of approximately R$22.1 million and in cash amounting to US$4.2 million. The holders of the Series A perpetual convertible preferred share
are also entitled to participate in dividends declared or paid on our common stock on an as-converted basis.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Appointment, Disqualification and Removal of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is managed by its board of directors.
The Articles of Association provide that, unless otherwise determined by a special resolution of shareholders, the board of directors
will be composed of four to 11 directors, with the number being determined by a majority of the directors then in office. There are no
provisions relating to retirement of directors upon reaching any age limit. The Articles of Association also provide that, while our shares
are admitted to trading on Nasdaq, the board of directors must always comply with the residency and citizenship requirements of the U.S.
securities laws applicable to foreign private issuers. Bertelsmann for so long as it holds Class B common shares may appoint up to three
directors at its discretion (and is entitled at any time to remove substitute or replace such directors) (&ldquo;Bertelsmann Directors&rdquo;),
and the Esteves Family for so long as it holds Class B common shares in excess of the Ownership Threshold may appoint up to three directors
at its discretion (and is entitled at any time to remove substitute or replace such directors) (&ldquo;Esteves Family Directors&rdquo;),
in addition for so long as both hold Class B common shares, they may appoint a further director (the &ldquo;Joint Director&rdquo;) and
are entitled at any time to remove, substitute or replace the Joint Director. The board of directors shall have a chairman that for so
long as both Bertelsmann and the Esteves Family hold Class B common shares in excess of the Ownership Threshold, which chairman is appointed
in rotation for a term of a year by each of them as prescribed in the Articles of Association, such right to be exercised initially by
<FONT STYLE="font-size: 9.5pt">Bertelsmann</FONT><FONT STYLE="font-size: 10pt">. Once neither </FONT><FONT STYLE="font-size: 9.5pt">Bertelsmann</FONT>
<FONT STYLE="font-size: 10pt">nor the Esteves Family hold Class B common shares in excess of the Ownership Threshold, the chairman is
elected by the board of directors then in office instead. The directors may elect a vice chairman of the board of directors.</font></P>


<!-- Field: Page; Sequence: 9 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, the Articles of Association
provide that directors shall be elected by an ordinary resolution of our shareholders, which requires the affirmative vote of a simple
majority of the votes cast on the resolution by the shareholders entitled to vote who are present, in person or by proxy, at the meeting.
Each director shall be appointed and elected for a two-year term or until his or her death, resignation or removal, and is eligible for
re-election.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">For the names of our directors, see &ldquo;Item
6. Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Board of Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Any vacancies on the board of directors that
arise other than in respect of the Bertelsmann and/or Esteves Family director appointments set out above or upon the removal of a director
by resolution passed at a general meeting can be filled by the remaining directors (notwithstanding that they may constitute less than
a quorum). Any such appointment shall be as an interim director to fill such vacancy until the next annual general meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing, additions to the
existing board (within the limits set pursuant to the Articles of Association) may be made by ordinary resolution of the shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors has an audit committee
in place. See &ldquo;Item 6. Directors, Senior Management and Employees&mdash;A. Directors and Senior Management&mdash;Audit Committee.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Grounds for Removing a Director</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">A director may be removed with or without cause
by ordinary resolution, save that each Bertelsmann Director may be removed by Bertelsmann at its discretion and each Esteves Family Director
may be removed by the Esteves Family at its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The notice of general meeting must contain
a statement of the intention to remove the director and must be served on the director not less than 10 calendar days before the meeting.
The director is entitled to attend the meeting and be heard on the motion for his removal.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The office of a director will be vacated automatically
if he or she (i)&nbsp;becomes prohibited by law from being a director, (ii)&nbsp;becomes bankrupt or makes an arrangement or composition
with his creditors, (iii)&nbsp;dies or is in the opinion of all his co-directors, incapable by reason of mental disorder of discharging
his duties as director, (iv)&nbsp;resigns his office by notice to us or (v)&nbsp;has for more than six months been absent without permission
of the directors from meetings of the board of directors held during that period, and the remaining directors resolve that his or her
office be vacated. Further, the Directors may remove a Director as set out above in &ldquo;&mdash;Anti-Corruption.&rdquo;</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Proceedings of the Board of Directors</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Articles of Association provide that our
business is to be managed and conducted by the board of directors, save that Afya may not without (i)&nbsp;the consent of a Bertelsmann
Director while there is a Bertelsmann Director and (ii)&nbsp;the consent of an Esteves Family Director while there is an Esteves Family
Director: create new classes of shares, issue new shares, options, warrants or convertible securities of similar nature conferring the
right upon the holders thereof to subscribe for purchase or receive any class of shares or securities in the capital of Afya; repurchase
or redeem any shares; approve the payment of any remuneration to a Director or executive Officer; approve any incentive plan (as set out
in the Articles of Association); change our accounting practices except as required by applicable law; execute and/or terminate any shareholders&rsquo;
agreement, quotaholders&rsquo; agreement, or any other agreements related to our interest in any subsidiary; approve
our financial statements; effect an initial public offering and/or follow-on offerings of Afya, or hire any investment banks or service
providers inherent to the initial public offering; approve the listing and/or the delisting of our securities with any designated stock
exchange; change our dividend policy and/or approve any dividend, create and/or use our reserves; approve any budget, as well as any amendment
and/or change to such budget; conduct, negotiate, terminate and/or amend any business, agreement, or transaction between Afya and any
related party; acquire, sell or encumber any of our permanent assets, in one transaction or in a series of transactions, which value exceeds
the equivalent of R$250 thousands; approve any sale or encumbrance, for the benefit of a person of shares issued by any subsidiary, or
the admission of any new partner or shareholder in such subsidiaries; create or dissolve any committees of the Directors; carry out any
investments outside the scope of the core business of Afya or its controlled persons (as set out in the Articles of Association); incorporate
any entity; acquire, sell or encumber the capital stock of entities in which Afya has an interest; appoint or terminate the engagement
of any auditor that is not an Authorized Auditor as set out in the Articles of Association; provide any guarantee in respect of any person
or related person of any of our shareholders, director and/or officers inter alia; negotiate, amend, renew, change of terminate any lease
agreement or enter into any new lease agreement; appoint any executive officer; approve the delegation of any powers by the board of directors;
or take actions in connection with the Company&rsquo;s Anti-Corruption measures.</P>


<!-- Field: Page; Sequence: 10 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The quorum necessary for the board meeting
shall be a simple majority of the directors then in office (subject to there being a minimum of two directors present), provided that
such a quorum must include at least one Bertelsmann Director for so long as there is at least one Bertelsmann Director and one Esteves
Family Director for so long as there is one Esteves Family Director and business at any meeting shall be decided by a majority of votes,
provided such a majority must include at least one Bertelsmann Director for so long as there is at least one Bertelsmann Director and
one Esteves Family Director for so long as there is one Esteves Family Director. In the case of an equality of votes, neither the chairman
of the board nor the chairman of the meeting shall have a casting vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the foregoing and the provisions
of the Articles of Association, the board of directors may regulate its proceedings as they determine is appropriate. Board meetings shall
be held at least once every calendar quarter and shall take place either in Nova Lima, Brazil, or at such other place as the directors
may determine.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Articles of
Association, to any directions given by ordinary resolution of the shareholders and the listing rules of the Nasdaq, the board of directors
may from time to time at its discretion exercise all powers of Afya, including, subject to the Companies Act, the power to issue debentures,
bonds and other securities of the company, whether outright or as collateral security for any debt, liability or obligation of our company
or of any third-party.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Inspection of Books and Records</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Holders of Afya shares have no general right
under Cayman Islands law to inspect or obtain copies of the list of shareholders or corporate records of the Company. However, the board
of directors may determine from time to time whether and to what extent our accounting records and books shall be open to inspection by
shareholders who are not members of the board of directors. Notwithstanding the above, the Articles of Association provide shareholders
with the right to receive annual financial statements and upon request agreements executed by the Company and its Related Parties (as
defined in the Articles of Association), shareholder agreements to which the Company is a party and details of any incentive plan). Such
right to receive annual financial statements may be satisfied by publishing the same on the company&rsquo;s website or filing such annual
reports as we are required to file with the SEC.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Register of Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class A common shares are held through
DTC, and DTC or Cede &amp; Co., as nominee for DTC, and recorded in the shareholders&rsquo; register as the holder of our Class A common
shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, Afya must keep a
register of shareholders that includes:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the names and addresses of the shareholders, a statement of the shares held by each member and of the amount paid or agreed to be
considered as paid, on the shares of each member;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>whether voting rights attach to the shares in issue;</TD></TR></TABLE>


<!-- Field: Page; Sequence: 11 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the date on which the name of any person was entered on the register as a member; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>the date on which any person ceased to be a member.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Under Cayman Islands law, the register of shareholders
of Afya is prima facie evidence of the matters set out therein (i.e., the register of shareholders will raise a presumption of fact on
the matters referred to above unless rebutted) and a shareholder registered in the register of shareholders is deemed as a matter of Cayman
Islands law to have <I>prima facie</I> legal title to the shares as set against his or her name in the register of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">However, there are certain limited circumstances
where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct
legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be
rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order
for rectification of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject
to re-examination by a Cayman Islands court.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Exempted Company</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Afya is an exempted company with limited liability
under the Companies Act. The Companies Act distinguishes between ordinary resident companies and exempted companies. Any company that
is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted
company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges
listed below:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company does not have to file an annual return of its shareholders with the Registrar of Companies;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company&rsquo;s register of shareholders is not open to inspection;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company does not have to hold an annual general meeting;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may issue shares with no par value;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for
20 years in the first instance);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register as a limited duration company; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&#183;</FONT></TD><TD>an exempted company may register as a segregated portfolio company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">&ldquo;Limited liability&rdquo; means that
the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional
circumstances, such as involving fraud, the establishment of an agency relationship or an illegal or improper purpose or other circumstances
in which a court may be prepared to pierce or lift the corporate veil).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">We are subject to reporting and other informational
requirements of the Exchange Act, as applicable to foreign private issuers. Except as otherwise disclosed in this annual report, we comply
with the Nasdaq rules in lieu of following home country practice.</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Anti-Takeover Provisions in Our Articles of Association</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Some provisions of the Articles of Association
may discourage, delay or prevent a change in control of Afya or management that shareholders may consider favorable. In particular, the
capital structure of Afya concentrates ownership of voting rights in the hands of the Esteves Family and Bertelsmann. These provisions,
which are summarized below, are expected to discourage coercive takeover practices and inadequate takeover bids. These provisions are
also designed to encourage persons seeking to acquire control of Afya to first negotiate with the board of directors. However, these provisions could also have the effect
of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market
price of the Class A common shares that often result from actual or rumored hostile takeover attempts. These provisions may also have
the effect of preventing changes in the management of Afya. It is possible that these provisions could make it more difficult to accomplish
transactions that shareholders may otherwise deem to be in their best interests.</P>


<!-- Field: Page; Sequence: 12 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 10pt"></P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Two Classes of Common Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Class B common shares of Afya are entitled
to 10 votes per share, while the Class A common shares are entitled to one vote per share. Since they own of all of the Class B common
shares of Afya, the Esteves Family and Bertelsmann currently have the ability to elect all directors and to determine the outcome of most
matters submitted for a vote of shareholders. This concentrated voting control could discourage others from initiating any potential merger,
takeover, or other change of control transaction that other shareholders may view as beneficial.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">So long as the Esteves Family and Bertelsmann
have the ability to determine the outcome of most matters submitted to a vote of shareholders as well as the overall management and direction
of Afya, third parties may be deterred in their willingness to make an unsolicited merger, takeover, or other change of control proposal,
or to engage in a proxy contest for the election of directors. As a result, the fact that Afya has two classes of common shares may have
the effect of depriving you as a holder of Class A common shares of an opportunity to sell your Class A common shares at a premium over
prevailing market prices and make it more difficult to replace the directors and management of Afya.</P>

<P STYLE="font: italic bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt 9.35pt">Preferred Shares</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Our board of directors is given wide powers
to issue one or more classes or series of shares with preferred rights. Such preferences may include, for example, dividend rights, conversion
rights, redemption privileges, enhanced voting powers and liquidation preferences.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Despite the anti-takeover provisions described
above, under Cayman Islands law, our board of directors may only exercise the rights and powers granted to them under the Articles of
Association, for what they believe in good faith to be in the best interests of Afya.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in"><I>Series A Perpetual Convertible Preferred
Shares</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">On April 26, 2021, we announced that the SoftBank
Latin America Fund, or SoftBank, agreed to purchase R$822 million, equivalent to US$150 million, of Afya&rsquo;s Series A perpetual convertible
preferred shares, subject to customary closing conditions. The key terms of the Series A perpetual convertible preferred shares, as set
forth under the relevant certificate of designations, are: (i) 6.5% per annum cumulative dividend payable quarterly and in Brazilian reais
(payable in U.S. dollars in Brazilian reais equivalent); (ii) SoftBank shall have the right at any time, to convert its Series A perpetual
convertible preferred shares into 5,917,888 common shares, at an initial conversion price established at US$25.35; (iii) SoftBank shall
have the right to redeem any time after the 5th year anniversary at 105% premium; and (iv) Afya will have the right to force conversion
after the 3rd year anniversary if forced conversion trigger conditions are satisfied. The Series A perpetual convertible preferred share
will be entitled to the same voting rights as the common shares only when converted into common shares. Holders of the Series A perpetual
convertible preferred share are also entitled to a separate class vote with respect to, among other things, amendments to the Company&rsquo;s
organizational documents in a manner materially adverse to the rights, preferences, privileges or voting power of the Series A perpetual
convertible preferred share, authorization or issuances by the Company of securities that are senior to, or equal in priority with, the
Series A perpetual convertible preferred share, increases in the number of authorized shares of Series A perpetual convertible preferred
share, and issuances of Series A perpetual convertible preferred share after the issuance date, other than shares issued as in-kind dividends
with respect to the Series A perpetual convertible preferred share issued after the issuance date. Except for the right to participate
in any issuance of new equity securities by the Company as set forth in the securies purchas agreement for the Series A perpetual convertible
preferred share, the holders of Series A perpetual convertible preferred share shall not have any preemptive rights. For further information
on our outstanding Series A perpetual convertible preferred shares, see &ldquo;Item 5. Operating and Financial Review and Prospects&mdash;B.
Liquidity and Capital Resources&mdash;Indebtedness&mdash;Financing &ndash; Series A Perpetual Convertible Shares&rdquo; in our annual
report on Form 20-F for the fiscal year ended December 31, 2021 and note 13.2.1(f) to our audited consolidated financial statements included
elsewhere in our annual report on Form 20-F for the fiscal year ended December 31, 2021.</P>


<!-- Field: Page; Sequence: 13 -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence -->&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0 0 10pt">Protection of Non-Controlling Shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Grand Court of the Cayman Islands may,
on the application of shareholders holding not less than one fifth of the shares of Afya in issue, appoint an inspector to examine the
Company&rsquo;s affairs and report thereon in a manner as the Grand Court shall direct.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Subject to the provisions of the Companies
Act, any shareholder may petition the Grand Court of the Cayman Islands which may make a winding up order, if the court is of the opinion
that this winding up is just and equitable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">Notwithstanding the U.S. securities laws and
regulations that are applicable to Afya, general corporate claims against Afya by its shareholders must, as a general rule, be based on
the general laws of contract or tort applicable in the Cayman Islands or their individual rights as shareholders as established by our
Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0 0 10pt; text-indent: 0.25in">The Cayman Islands courts ordinarily would
be expected to follow English case law precedents, which permit a minority shareholder to commence a representative action against Afya,
or derivative actions in our name, to challenge (i)&nbsp;an act which is ultra vires or illegal, (ii)&nbsp;an act which constitutes a
fraud against the minority and the wrongdoers themselves control Afya, and (iii)&nbsp;an irregularity in the passing of a resolution that
requires a qualified (or special) majority.</P>

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">14</P>

<!-- Field: Rule-Page --><DIV STYLE="margin: 0pt auto 3pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 11pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 10pt"></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-8.01
<SEQUENCE>4
<FILENAME>ex8-1.htm
<DESCRIPTION>EX-8.01
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 8.01</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">LIST OF SUBSIDIARIES OF AFYA LIMITED</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt; text-indent: 18pt">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse; font-size: 10pt">
  <TR>
    <TD STYLE="width: 87%; font-family: Times New Roman,serif"><FONT STYLE="font-size: 7pt"><B>Name of Subsidiary</B></FONT></TD>
    <TD STYLE="width: 13%; font-family: Times New Roman,serif; text-align: center"><FONT STYLE="font-size: 7pt"><B>Jurisdiction of Incorporation or Organization</B></FONT></TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Afya Participa&ccedil;&otilde;es S.A. (&ldquo;Afya Brazil&rdquo;)</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos Porto S.A. &ndash; (&ldquo;ITPAC Porto&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Instituto Tocantinense Presidente Ant&ocirc;nio Carlos S.A. &ndash; (&ldquo;ITPAC Aragua&iacute;na&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Uni&atilde;o Educacional do Vale do A&ccedil;o S.A. &ndash; (&ldquo;UNIVA&Ccedil;O&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">IPTAN - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&ldquo;IPTAN&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Instituto de Educa&ccedil;&atilde;o Superior do Vale do Parna&iacute;ba S.A. (&ldquo;IESVAP&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Centro de Ci&ecirc;ncias em Sa&uacute;de de Itajub&aacute; S.A. (&ldquo;CCSI&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Instituto de Ensino Superior do Piau&iacute;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Centro Integrado de Sa&uacute;de de Teresina </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">FADEP &ndash; Faculdade Educacional de Pato Branco Ltda </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Medcel Editora e Eventos S.A. (&ldquo;Medcel&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Instituto Educacional Santo Agostinho S.A. (&ldquo;FASA&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">ESMC Educa&ccedil;&atilde;o Superior Ltda. (&ldquo;ESMC&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Instituto de Pesquisa e Ensino M&eacute;dico do Estado de Minas Gerais Ltda (&ldquo;IPEMED&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Instituto Paraense de Educa&ccedil;&atilde;o e Cultura Ltda </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Sociedade Universit&aacute;ria Redentor S.A. (&ldquo;UniRedentor&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Centro Universit&aacute;rio S&atilde;o Lucas Ltda. (&ldquo;UniSL&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">PebMed Institui&ccedil;&atilde;o de Pesquisa M&eacute;dica e Servi&ccedil;os Tecnol&oacute;gicos da &Aacute;rea da Sa&uacute;de </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Faculdade de Ensino Superior da Amaz&ocirc;nia Reunida &ndash; (&ldquo;FESAR&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Centro Superior de Ci&ecirc;ncias da Sa&uacute;de S/S Ltda. (&ldquo;FCMPB&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">MedPhone Tecnologia em Sa&uacute;de Ltda. (&ldquo;MedPhone&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">iClinic Desenvolvimento de Software Ltda </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Medicinae Solutions S.A. (&ldquo;Medicinae&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Medical Harbour Aparelhos M&eacute;dico Hospitalares e Servi&ccedil;os em Tecnologia Brazil </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Cliquefarma Drogarias Online Ltda.(&ldquo;Cliquefarma&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="background-color: White">
    <TD STYLE="vertical-align: bottom; font-family: Times New Roman,serif">Shosp Tecnologia da Informa&ccedil;&atilde;o Ltda. (&ldquo;Shosp&rdquo;) </TD>
    <TD STYLE="vertical-align: top; font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Sociedade Padr&atilde;o de Educa&ccedil;&atilde;o Superior Ltda. (&ldquo;UnifipMoc&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Companhia Nilza Cordeiro Herdy de Educa&ccedil;&atilde;o e Cultura. (&ldquo;Unigranrio&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Policl&iacute;nica e Centro de Est&eacute;tica Duque de Caxias Ltda. (&ldquo;Policl&iacute;nica&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Sociedade Educacional de Palho&ccedil;a S/A Ltda. (&ldquo;SOCIESP&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Instituto de Ensino Superior de Palho&ccedil;a S/S Ltda. (&ldquo;IESP PALHO&Ccedil;A&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">RX PRO Solu&ccedil;&otilde;es de Tecnologia Ltda. (&ldquo;RX PRO&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">RX PRO LOG Transporte e Log&iacute;stica Ltda. (&ldquo;RX PRO LOG&rdquo;)&nbsp;&nbsp;</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">Uni&atilde;o Educacional do Planalto Central S.A. (&ldquo;UEPC&rdquo;) </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">BMV Atividades M&eacute;dicas Ltda.</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">NASPP &ndash; N&uacute;cleo de Aten&ccedil;&atilde;o &agrave; Sa&uacute;de e de Pr&aacute;ticas Profissionalizantes Ltda. </TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="font-family: Times New Roman,serif">Cardiopapers Solucoes Digitais Ltda.</TD>
    <TD STYLE="font-family: Times New Roman,serif; text-align: center">Brazil</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD STYLE="font-family: Times New Roman,serif">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.1
<SEQUENCE>5
<FILENAME>ex12-1.htm
<DESCRIPTION>EX-12.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 12.1</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL EXECUTIVE OFFICER</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt"><FONT STYLE="background-color: white">I,</FONT>&#9;Virgilio Deloy Capobianco
Gibbon, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2021 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: April 29, 2022</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right"></P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-12.2
<SEQUENCE>6
<FILENAME>ex12-2.htm
<DESCRIPTION>EX-12.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 12.2</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION BY THE PRINCIPAL FINANCIAL AND ACCOUNTING
OFFICER</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">I, Luis Andr&eacute; Carpintero Blanco, certify that:</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">1.</TD><TD>I have reviewed this annual report on Form 20-F for the year ended December 31, 2021 of Afya Limited (the &ldquo;Company&rdquo;);</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">2.</TD><TD>Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary
to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period
covered by this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">3.</TD><TD>Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material
respects the financial condition, results of operations and cash flows of the Company as of, and for, the periods presented in this report;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">4.</TD><TD>The Company&rsquo;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures
(as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the Company and have:</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD>Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision,
to ensure that material information relating to the Company, including its consolidated subsidiaries, is made known to us by others within
those entities, particularly during the period in which this report is being prepared;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD><FONT STYLE="background-color: white">Designed such internal control over &#64257;nancial reporting, or caused such internal control
over &#64257;nancial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of &#64257;nancial
reporting and the preparation of &#64257;nancial statements for external purposes in accordance with generally accepted accounting principles</FONT>;</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(c)</TD><TD>Evaluated the effectiveness of the Company&rsquo;s disclosure controls and procedures and presented in this report our conclusions
about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(d)</TD><TD>Disclosed in this report any change in the Company&rsquo;s internal control over financial reporting that occurred during the period
covered by the annual report that has materially affected, or is reasonably likely to materially affect, the Company&rsquo;s internal
control over financial reporting; and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 18pt"></TD><TD STYLE="width: 18pt">5.</TD><TD>The Company&rsquo;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial
reporting, to the Company&rsquo;s auditors and the audit committee of the Company&rsquo;s board of directors (or persons performing the
equivalent functions):</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(a)</TD><TD>All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which
are reasonably likely to adversely affect the Company&rsquo;s ability to record, process, summarize and report financial information;
and</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman,serif; margin-top: 0; margin-bottom: 10pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 36pt"></TD><TD STYLE="width: 18pt">(b)</TD><TD>Any fraud, whether or not material, that involves management or other employees who have a significant role in the Company&rsquo;s
internal control over financial reporting.</TD></TR></TABLE>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Chief Financial Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: April 29, 2022<B><BR STYLE="clear: both">
</B></P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.1
<SEQUENCE>7
<FILENAME>ex13-1.htm
<DESCRIPTION>EX-13.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 13.1</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2021 of the
Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Virgilio Deloy Capobianco Gibbon</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Chief Executive Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: April 29, 2022</P>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-13.2
<SEQUENCE>8
<FILENAME>ex13-2.htm
<DESCRIPTION>EX-13.2
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman,serif; margin: 0"><B>&nbsp;</B></P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 0 0 10pt; text-align: right">Exhibit 13.2</P>

<P STYLE="font: bold 10pt Times New Roman,serif; margin: 10pt 0; text-align: center">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350
AS ADOPTED<BR>
PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a)
and (b) of Section 1350, Chapter 63 of Title 18, United States Code), the undersigned officer of Afya Limited (the &ldquo;Company&rdquo;),
does hereby certify, to such officer&rsquo;s knowledge, that:</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">The Annual Report on Form 20-F for the year ended December 31, 2021 of the
Company (the &ldquo;Report&rdquo;), as filed with the U.S. Securities and Exchange Commission on the date hereof, fully complies with
the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and information contained in the Report fairly presents,
in all material respects, the financial condition and results of operations of the Company.</P>

<TABLE CELLSPACING="0" CELLPADDING="0" ALIGN="RIGHT" STYLE="width: 50%; border-collapse: collapse; font-size: 10pt">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 100%; font-family: Times New Roman,serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; font-family: Times New Roman,serif">/s/ Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Luis Andr&eacute; Carpintero Blanco</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-family: Times New Roman,serif">Chief Financial Officer</TD></TR>
  </TABLE><BR STYLE="clear: both">
<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman,serif; margin: 0 0 10pt">Date: April 29, 2022</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>9
<FILENAME>ex23-1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B></B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: right; color: #333333"><B>Exhibit 23.1</B></P>
<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>&nbsp;</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: center; color: #333333"><B>Consent of Independent Registered
Public Accounting Firm</B></P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt/18pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">We consent to the incorporation by reference in the Registration
Statement (Form S-8 No. 333-251147) pertaining to the Long-term Incentive Plan of Afya Limited of our reports dated March 31, 2022, with
respect to the consolidated financial statements of Afya Limited, and the effectiveness of internal control over financial reporting of
Afya Limited, included in its Annual Report (Form 20-F) for the year ended December 31, 2021.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">/s/ ERNST &amp; YOUNG</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Auditores Independentes S.S.</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">&nbsp;</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">Belo Horizonte, Brazil</P>

<P STYLE="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #333333">April 29, 2022</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>afyaform20f_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "9!%X# 2(  A$! Q$!_\0
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M'Q1IHNI;;?(98AEU"9P*+"YXFU2BJUK>V][ )K>59$/=3FK (-*Q2:8M%%%
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MO);QO(H5F0$KZ'%,N>(SBID^XOTH*?PH,=CBF^3'G/EKGUQ4E%!(@&*6BB@
MHHHH 9QUZFE X]*=10 A/RY%8]E?WTVKW=O-;%((VQ')S\PQ6S5=?^/A_K05
M'J2CIZ\TZ@44$AWI:3O2T"04444#"D-+10 PJ#UK*UG55TDV_P"X>3SGV *,
MXXK7Q56[4,4RJG!XR,XICB]22,[D#<\\X/:I< =J1>@Y_2G4A-A2T44 %%%%
M #3R<=J;QT Z4^DZT6$[VT&^OIZ5FZ=JT-_>W-M&K!H/O9'OBM0C JM;1QI/
M*5C52>I"X)IV+C\+N6 N.@I<#&*6EI$W$QVI:** "BBB@ HHHH **** "BBB
M@!*0L ,DX I"1@YKFO%^L26%K%:6HW7=T=B >_>G8NG!SERHEUCQ=I^F2"(-
MY\YZ1Q\FLD^+M4E(>/09Q&.=Q9:YK4KZT\&0*J1QSZM+\SN_49__ %US[?$'
MQ S%A<D*#RHZ4VD>SALJG77-26G6_P"ECU?2_%MIJ,WD3*UM/TV25T2$8X.:
M\ET?Q#9>*U^P:C D5\W%O.O7/^-=KX8U*=GFTV^<-=VQP&_O#UHL<.+P?LKV
M5FOZNCIP]9^I:W9:8O[^90W91R:;K6J1:3I<MU*VW'RK[L>GZUY_=WMIHMD=
M:U4>?J5SS&C?P#J*$C+#8=U)6W\NIU0\5O*2T&F3RQC^($#^=7++Q/9W$@CE
M5K>0]GKR&;X@ZY),7CF2!1T"GM6MHWC2/5IA8:] CB0XCG'\)HT/2JY34A#G
M:T/8EE1P&!!'8BG[QC.:Y70[N2POCI5T_F(PW6[_ -X=<?E723NL43.Q 1!D
MDT:'CU(.G*SVZ"7=[;V<1EGD5% SS7.2^*5FR+2RGG7/WE./YUC7M[%<02ZS
MJQ!M8SB"(]'_ ,\UQ5[\1=6>Y(M=EI".$1?2E8]3"99.O\'S?0]2A\7VT<@C
MN[:6U). 7Y'Z5T,-Q'<()(G5T/0@UXKIGQ"N)6\C68TN;23Y2>X]ZZ_3[K^P
M=0M!%(&TF]($9SPI_P BBQ&)RZ=%N,M_P?H>@Y'<TQIHU4L7 5>I-)D,@([_
M ,JX?4KR;7M3GL;>7R]-MANN)%/7'4?H:$C@HTG4DULD;ESXMTZ&4QQLTSCL
M@-1V_B^SD;]^CP@]"RFO.]4\=6^FDV.@VL:QI\OFGO\ 2J=G\1M0W%;VVBGC
M(^91GD4[(]6.55'#G47KMW/;H+F&XB$D,@=#W%2AACK7GFGW\=O##J>D2DV#
ML!/;YX0GO_.N\@E2>!)4.589!I6/*K4G3?\ 7W#Y701DNVU1U/I7+:AXWL[2
M8V]I')>2 XQ'_C5;Q5J%QJ&HQZ%8N5,G-PP_A3_]8KE-:\36?A?9IFAPHTJC
M$LS=<U2.O"X+VC6EY/\ #U.K7Q=J,)#2Z'<*C<[MRGBMO2O$ECJV5CD"RC[T
M;<$5XW'\1->63<;A9!GH3Q]*ZW3;^T\66WGVRK::S;?.2G\8_P YI)G9BLJG
M1CS5%H^JV^9ZD""*0L!WK(\/:J=4TY)7&V9?EE7T:JGB?5I+.W6VM,&[N&"1
MCN >":1XSI2Y_9K<LZMXGT[2ODEEWRGHB<FL4>.5!S_95R$S][(KF-3U*Q\)
MCY46]U5QN=GYV9K"_P"%D:P7+$1;.NWFJT1ZU'+)5(IP7_!]#UW2O%&FZG\L
M<NR7H4<8-;>X8SFO)]+U.P\8((R%L]64?NI%XW&NW\-:M+?026MWQ=VQV.#W
M'K29Q8G"2I7NK-;HZ'<I'6L[4M;L=,3-Q, W91R34.O:F-'TJ2XXW=$'J3Q7
M"7%[;Z%9_P!LZN@N=2NAF*%OX._^-*Q.'P_M%S/:]DNK.F/BAKB0/!I5Q(@_
MBW <5?L?$]E<R>5,&@D/ 5Z\@G^(6NR2%H;A((R?N@_=%;&B^,H]9==/UR)"
M7XCN1ZT]STZV35J=-3FM.W5>I[$)%P"""#T-.W#IFN6\/WDL%XVE73;P@#0N
M>Z]OY5T4\J01-+*0%09)]*#Q)TW&7*A;B[@M8S)/(J(.I)K"G\7V2R;8$DG
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MTWQ'JW]EP)Y:[[F3Y88QU+=J?+J<"IR;Y5OYFS<7EO:KNFE1![FJ$>N:7YS
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M_2N&\8Z2=<L8=>T]=Y9?W\(Y(%-['-E%2E"K&4O-7\SSO!'3&?3/6GQL!,K
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M25/ (0G-:MM=PW<*S0MN0]Z UZ$PP3Q2FD7[Q%+2#42E/2C%+0,K-(B L[8
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M="YVFL>]\0Z@=7UM8IYFBD.P#^X W45[5%IME#.\T=NBR.,,P'6HSH^GG/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
H* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>afyaform20f_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (C K4# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH :3CK2YS7/^(G$<T$QD#A,_P"CDD;_ '&.
MXJ)=2N+2=O,F/EM,P.Y?NC;D"@#HRVT98X'J:?7&7FI7EW;QQR/L#)&^T)S(
M2W/TQ5HZOJ(ENMK(%B#X0CD =#[T =1GWHKD;J^U,Q%9+C;LDA?S%3 PPR0:
MV;"^DGEO$9RWE-\IV_+C'&* -7 ]*3 ':N/CU[46A=TE1V\HD@1_ZMMP S]1
M5R?4KZWG\EK@%T6,JIC_ -<3U_*@#HB0!R0/Z4 C<!D9/:N:FU&\E6XMW0$V
M^?,)7K\PV_I5=K^Z6]:X5Q*\=NY"!,!#D<'UH ZX@8]J:I5^5(8>HK)T^YNK
MK3KDRRHQ .QUQZ=ZS-,FO[>"".-@5%L9V!3EFR>,T".K"J.BBG8KE(]9U+[$
M92R-N9!N&,QYZY%7[S4+J&PLW\U4,K!9)L9"<=:!FX!@TM<S_:]Y]NV"=6VR
MK&(Q'RZD<M4<>K:F5W-+&/,C=EW)@*0V!S]* .I/2FAPW0@_0US)UZY6-#O.
M&ARNY/O/NP?TJK8W%S#-;.9W2(^<67;G)!H ['/?-*I!S@YKCI-4OKBVEQ.R
MK')&RR;!G!ZYJP;^ZMMZ>>L8:9PTWE]<#(X]Z .JHKEX]5U.8;]Z1A(T8J4^
M\3_G-:6AWTUY#*)WW2(^"0!M_"@#6HHHH **** "BBB@ HHHH **** "HI)D
MB_UDBH#TW'%2UE:_;"XTB8"+>X V\9(Y% %Z.XCE8A)5<@9.TYXJ;-<M-:7$
M%[++:>9$L<46%0<-SR*5KC4S/=-YLBNHDVQX.,?PX[4 =136.!DFN85]4M[Z
M,&:YEB(^8$?[&?YU6F>^N+9PYNA$LD;]RP!ZT =8DB.2$93M.#@]#4IP!DXQ
M7*JUW#/Y;27*V[3OF1%^8]-M;%S,+S2KM8&D+*K("."6 [4 :(P:7 ]*Y=&O
MDLA)#+<$111X4CD\_-3I+R]<&97G$?V@A8\$%EXZ>E '2 @G (..*)&2.,O(
M5"CJ37*C[9;&["M<+NN07)SPGJ*9J#7\UJ(9)9W#0@IY:\.=W\7X4 =<N",]
M0>]*17.ZO<7</D+;"<,L:L"GW2<C((ICRZHMP9DDF;,LBB,CY0-O'ZT =")$
M,AC##>!DCOBB*2.4;HV#+TR.:Y_0!</J$T\QF8O @9I1CYLG(%4[9M2@M+A%
M$T9ZQ;1ZOR?K0!V&*":Y:ZFU&',9FN=J*_EL@R78'@&DGN]9M[@_+(Z1@2L
M.&!&-H^AH ZA94,C1AP77DC/(I9)%C0N[!5'))KDF&I022/^]WN(A(XZXQS^
M5-OWU":T$,DL[HT)VF-3\[9Z-^% '8*V5!SD'H:=7'M>7RM<)#-)O10JQ>P(
MRP^@K?T=IFM&,TIE^<[2P(./?- &C1110 4444 %%%% !1110 4444 %%%%
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MFT.]"QH59HD#J%5QE?FR#S[5KZ5IS6UQ=3S)\\LGRDMD[?Y4 6[>^M[G>R.
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M,"C I:* $V@]10 !T&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M374+8$\2+PRGK6G3 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MS=-O5"?NKT IW(J4/9K5G14444& 4444 %%%% !1110 4444 %%%% !1110
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ML+X%Q$T9]5Y%<:BU,JGM2N:O TJFZ/3;'5TE >WG##V-=#8>(9(V"R$D5XW
MSQ,'1V5AW4XKH+#7G7:EUR.SCK0I'%B,JE%7IGMUCJ45THPPSBK^<UY=INJF
M-A)%)N4^AKM]+UA+J,!F&ZM$[GCRA*+LS:I,4@;<,BG51)1U'38=0@*2+\PZ
M'TK AE,#-I.JC? _$4K=JZRL[5]-74+-DQ^\'(-(#%LIIM!OQ:SDM;2']V_;
M%=4KAU# Y!Z5S-J1J]A)IMV0MW#]QN_'0U8T"^D#/87)Q-$<<]Z!G04444Q!
M1110 4444 %(:6B@!A0&D\L$\FI,4F* U&[!1Y8P13\4F* &[!3'V1H7=@%
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MQK5BT#3).&16VG"DX/TQ3['4([\RF( HC !@?O C.: +M%%% !1110 4444
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MU*&SVH H#2HUU0WRR,K,,%0.#6A3=WM0&S]?2@!U%-W4;OR]: '44F?:C=0
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MJ"0VS$[#SD8_&@3A)*[1?HIN[VHWB@D4C-9\NCVLLLS.&VRCYTW':3ZX]:T
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M'73@.1*F5:%6IE7BH9UP@"C IU%%"+D[!2@4 4HZU1RSF+BG 4@IX%,XJDP
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M;A8I#,\A!(P'4C''/6MC'OS2;<=* '4444 %%%% !1110 4444 %4]30R6Z
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M?^0)0NP>5\J_=]:KD.*68*4K6T., IXI%! Y&#3P*1<ZE]0%.H IP%,XZDP
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M UNU@7AV>+;,_P!Z,BDQHWZ***8@HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *H:K%YMHX]JOFHKA-\3#VI,#QWQ-:>=IEU%C) W#\*\U5:]EURVQ-,A
M'# BO(I(FCG=&&"K$8K-GMY8^9.(U5J=%I%6IU6H;/<A$<BU.B\4U$J;&*DZ
MX1MJ)BBEHXIH)R 4H% %. IG)4F %. H IP%4<-28HIP%(!3J9Q5)@!3@* *
M6J..I,*6BBF<DI7"BBBF2:&DINN&?'05Z5X8AQ%OQ7G^B1%@6Q]XUZEH<!BL
MU)[BEU$S6HHHJB0HJ*>>.WA:60X51S5*QUNTOY3'$WS#L>] &E1110 4444
M%%%% !1110 UE#$':"1T)'2F>2F2=BY/4XYJ6B@"K'8PQ7,MPB 22*%/I@=J
ME%O&HP(T ] *EHH B,"$Y\M<YST[U$]A;N4)A0;6W * !GUJU3)ID@B:60X1
M1DGVH 8UO&S[S$A;U(&:1[9)(VC*@!E*\#G!J2&9)X5EC.489!QBGT 5X[6*
M*&.)(U"1C"@CI3Q"O&8UX/' J6B@"$V\9<.8D+#H=HS1]GB*!&B0J.@(! J:
MB@! , "EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "N>UL^5K6G3=,/M)^M=#7/^*4Q;0SCK'(#FDP.@HID3;X4;/50:?3 *
M*** "BBB@ HHHH **** "BBB@ HHHH *,UE:SJC:?"GEIND<X4>]9L.OW=G.
M(M3MRF[[K <?G2 Z8T$9!J.&:.XC$D9#*>0:EH X[Q+9$'S O%>2>(['R-1\
MY1\LO)^M>_ZE;_:+9Q@=*\KUW3?M$$L1&'7E#42.[ 5O954< BU85:01E258
M88'D>AJ8+@5DS[*G%-<R% P*6DHI%R=A:4"@"E JCEJ3% IU%*!31Q5)B@4X
M"D IX IG%4F ZTX"D IU4CBJ3"EHHJCDG*X4444S,*55+N$4<FDK1TNWWR^:
MPX' ]Z .CT&R!ECC"\+CFO2+>(10JH]*YKPQ98!D85U0&!20F+1115$F)XG8
MKI+ '&3BLKR5LM;T\Q)M5X0#[U?\4MNM[> 'F20"HKH;_$MG"H_U,0!-(9TH
MI:04M,04444 %%%% !1110 4444 %%%% !69X@D$>C7'JP"C\36G6'XG<_8H
M(A_RTE H!&GIZ[-/@7T059J.!=D"+Z**DI %%%%, HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K+U^'SM)F7&2!FM
M2HKF/S;>1/[RF@"GHLPGTBV;.2$ /UK1K \,N5MKBV8\PRG\C6^.E( HHHI@
M%%%% !1110 4444 %%%% !1110!S>NXDU?3XST\P'%+J6H0Q3R6E_'N@E!,4
M@&=OM4FM6=T;ZWO+5 [0_P )K(F,M]HCR2 &YM)B6'L:D9L^%V<V!5L[58A<
M^E;M4M*E2;3XI$4*"HSBKM-"$894BN+\1::4D,B#WKM352^M5N82I'.*&AI]
MCQ#6M/\ +E-RB_*?O#T/K6/^%>CZMIIA=T9<H>V*X74;!K.7@9B)^4^E8RCJ
M?3Y9F'/'V<]RE2@4F*>*1Z=2=@%*!0!3@*9QU)@!3QUH IP%,XJDP IP'-%*
M*I'%4F+2TE+3.*<PHHHJC(***5$+L%49)Z"@!\$33RJB]SR?05UNE6&]XXD'
MRK6?IMAY8"@9=OO&O0-"TL01AV'-+<#5TZU%M;A0*N4@&!2U1 445#<3K;P/
M(QP%% &+?K]N\16D(Y2$&1JCTS_2_$=Y<#E5.P'Z55L[TQVFH:K)UD/EQ>]:
MOAVS-OIXD?[\IW'-2,V:***H04444 %%%% !1110 4444 %%%% !7/ZTWGZU
M86P.=I+D5OFN>MA]K\4W$I^[" HI,#H5^Z*6@44P"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2T4 <U9'
M[#XFG@/"SKD#W%=*.E<WX@4VU_:7R_P. WTKHE8,@(/!&:0#J***8!1110 4
M444 %%%% !1110 4444 (17+>6L'B&YMI,B*[0@>F:ZJL+Q%9-+ MU",30G<
M#28$'AZY:VGFTV8_/&Q"Y[BNCKDKUOM=K;ZU:_ZV+B9171Z?>)?6J3(<Y'-"
M MTAI:*8&5JVG+=0,0HW8K@=2TTKOBE3*GVKU(C(K,U'2HKI"0H!J6BH3<'=
M'A]]ISV;Y'S1GOZ55 KT35-':$.KIN0]L5R-WH[PY: ;E_NGJ*AH]S#YCS1Y
M:FYEXIPHVD'##![BE I&TZF@H%/Z4@I0*9Q5)B@4M%+5(XZDPHHHJCGN%%%3
MP6DMPWR# _O&@"*.-Y&"H,L:W+"P$6.-TAZFI].TO:VU 6<CEB*[+2-"V[7D
M&?:EN(CT/2"=LDB_G76)&(U"CI21Q+$H51BI*:$V%%%&1BF("<"N6UN\?4+J
M/3;8DECAR.PJ]KNK?98Q;P?/._ "]:HPJF@:<UQ.-]]/T]<GM]*3&A;FU2XO
MK33(/]5;#=)CU]ZZ9$"(% P *Q?#UE)#$]S<9,\QW,36Y0@84444Q!1110 4
M444 %%%% !1110 4444 1SR"*%Y&Z*I/Y5B>&HR\,UVP^:9R:L>(KCR=+:-3
M\\Q"+^-6]+@^S:?#'C&%&:74?0N4444Q!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2$TM49=5LX[_P"PM<*+G9YG
MEGKM]:!I-[%VCBJUM>07=ND\,H:-AE3TS0U[;K%+-YR;(L[R#G;CKF@.5D.K
MV1OK"2%0#(1E><<T_3([B+3X8[E0LJ+M.#G-16&M6&H[A:SJQ7DJ05.#T.#6
M@'7'4?G0#BUH.'2BF^8G]X?G074?Q#\Z LQU)4,5U!/'YD4T;H?XE((J3>OJ
M/SH"S'\45G1ZQ8RWS6:3YF4D$!3MR.HSTS5_>,<D?G0*PZBF[U]1^= =3T(H
M =11FB@ HHHH *;(H>,JPR",$4ZB@#DL-H>K,D@S97/#9Z T[Y_#^I@KDV,Y
M^4_W?:MS5=/34+-HV'S8^4U@Z?.LD;Z+JJ\](W<\'V^HJ1G512+*BNA!5AD$
M4^N7LKBXT2^^Q7;%H'/[N3'6NG!!&0>*:$+2&EHI@5+NRCN8RK*.17(:EH$D
M1+1C(KNJC:-7&"H(^E)H+M;'DMYI:2'$L6#_ 'EZUDSZ/(N?*8,/1A@U[#<Z
M1!./N 'Z5BW7AD9)3-2T=$:\EH>6/:S1??B88[XXI@KT&?0+A.BDCZ50DT5R
M?FMP?^ 4#=:Z..HKK?["_P"G4?\ ?%*NB$'Y;91_P"G<R<KG)(C.V%4GZ"K4
M6FW$A!*[%_VJZ^'0IV( BP/]VM2V\,NQ!DZ47%H<;;Z0BD$@R-^E;]CHTTY
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/3=G&>N : .RR/45!/<Q6X5I6"AF"CZFN:ETZ_32XHT@=YWW&1C(6*M_#QN
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M<'(H Z*BN<CU^6.VB>>&(LY&Y5DY +8'&/YXJ:VU*2'1KJ\ES,8Y7 7('&[
M'% &[16$=<F6Y6#[$S2 (9 C9V[OPY_,5&^LM.$W(UNPN!&T8;YP.?O CIQ0
M!T-%<K#X@F-W-(\+;'\M88BV1DYYR![5:D\031(#_9[[Q&97#/MP <'&1S0!
MT%%8@UN5X[B6*TW0P?>8R8;/4\8J>#51<65S=I%^ZBR5(;[^!D]J -2BN?BU
M^2=DC2R_?-+Y>/,X48SG./0]*0>(G,,DPLI#$BEE?/7!Q@Y&!^= '0T5FZ;J
M+WCS120>4\17/S;@01D<X%:(Z4 +1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,**7W%1N'?'-/HH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #5:\LX+Z#
MR;A-Z9#8R1@CZ59HH S6TBS%KY$40C R5(Y()&"?<U!8:'':G]Y)YH!4JHR%
M4@8SC)YK9HH S&T33F.3;\@YX8COG^=3BPMOLLEL(AY+DLR^I)R35MNE<YJ&
MKWECJ,D6T-&I$I.W_EGW'YT :TNF6DLZSM%^]4  JQ' Z9QUIB:38JQ9806W
MA\EB3D=/_P!58_\ :^HM+ A*1F1%<;@ &R>G/M4>G7]Q#?M!$XEWSREH-N"!
MV.: -D:)IRB15M5'F$,V">2.AJ0:79[-ODY&PQY+$G:3G&363<ZO>0RW(9,.
ML6Y(AA@OKGWI(-0U"9K6))X\2S%2^ QV@9QQP#0!K?V5:"1YHX0DKIL+ ^V.
MG2DM]-2WTC[ K<;"N['K[5A1:I=PQ1Q1;(@Q=LD !CNQCD5JV%_<2ZI-;S.#
M@;E" %0/<]<T 6;72;2SBB6.%0T9)#>Y[U%<:):20SI&OEM,"&()(&>O&<5J
MCI2T 9D.CV=O$JQ1!64[PV23NQC.35RSMUM+5(%)(08R3R?>IZ* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $-84
M]VRZZ8W+@'Y$(DX7Y<Y*_P!:WJA:VA:;S6B0R$8W$<XH S-!F>6&Y5[@SF.=
MU#%LG':I=8U%]/MDDCV[F?;EN@J]#;06^?)B1,]=HQ4%]817R()&8&-MRD>M
M &7#JUZ[XE6%%2 32'D]<\53GUVZD@DA!B1BCMYC< @#H/?FNBM=/M[2W$*(
M"N-I+<DBE^P6I4*;>/"\CY10!BQZU)!"D3%"P\E1N/)W#FH;C7KEQ=I \?RQ
M%XW (Q@X/UKHC9VQD#F",L.AV]*065J"Y$$>6X;Y>M &*NM7AO(K=(XY  F]
MA_%N')'-='5;[%;!D;R8\H/E.WI5F@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ II16.2H/&.13J* &F.-L913CID=*!&@;<$4-Z
M@<TZB@!OEIDG8N3U..M CC7&U%&.F!3J* &&*,XRBG'3(I0B*Q8*H)ZD"G44
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %4=2LWN[8I'*\;CH58BKU%
M'/Z7JDMO,-/U(E9A_JY&Z.*WLY[U0U32H]1@P?ED'*L.HK,T_59K&<6&ID@]
M(YCT/UI =)130<\@Y'M3J8!1110 4444 %%%% !1110 4444 %%%% !1110
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MOUI^?\XHR>QH"[&Q6\,";(HUC7T48%28IN?<_E1DT"'44Q9 XRK!AZ@TN30
MZBDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>afyaform20f_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (C ED# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M**#,**** "BBB@ HHHH **** ,S4ODO["4\(LA!/U4@?J:?K1 TU@W0N@_\
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MMT7_ #DU9QJ(YW0-[;3_ (U-8P>1:HI7#X&[ZU8H'.:YG9%'[=-'Q/:R ^J
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MT^+Z'^=.U!_+L)CWV$#\JDMH_*MXT]!07]CYDM%%%! 445D^(]<B\/Z/+>R
ML1\J*.[&@NG3E4DH15VS5+!>I ^II001D5X.NN:YXGOYF?5)K6) 6&R5E4'/
M"X'^>*L^&_'NJ:1?B#49I;BW!VNLCEF7'H30>S+(JRB^62<ETU_,]OI"0.I
MJG?:G!9::]\QW1A=PQ_%7F$NOZIKVHB+[9);Q$Y)1RJH/7B@\,]<!!Z'-%>3
M:9XHU/1]0\BXGDGB5P'5W+9'MFO5+:X2ZMHYXSE'&10!+1110 4444 %%%%
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MZ6WOW_#[BQKEC<+X&A@.?,A12X^@YKSL%;726P1YUR=IQU5!_CDU[BRJZE6
M*G@@UQ>I_#VWN9C+9W'D9/*%,C^8I'Q\I<TG)]3A+DB[MK>Z!'FK^ZD'<XY!
M_7]*]<\.026^@6D<GW@O/YFL31O =KI\Z7%U-]HD0Y4;,#^9KKP !@=!02%%
M%% !1110 4444 %%%% %'5Y?*TV4#[T@\M1[MQ_6K%I$(+.&,#&U!^=4+_\
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M3;$GKU)]35VB@VQ685\595'IV6AYIXL\$7WG3SZ3EX)\-+"!SD>E<QIOA#Q
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MC(K30YZJC#'\J#(\^6(:IJ5JUN"9IL"1 .A'&?R&:]AC*V.G1B5L+%&JD_0
M51TCPWI^C?-;HS2=-[D$T:A.E[+]BCD0(C SN6' ZX_E073AS/R)+"U\Z26]
MN$!>4_(&_A3M^F*NM:6[  Q*0/:JCZJF[99P/<A>"T?W1^/0T^SU'[5<RP-
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MB[@'O^/]*V*S=2M%0/?Q.T4\:'+*,[@.Q% 4FM8]S2HJO93/<644LBA79<D
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M>K:ZC%"G-O ODL.S?WC^8S6AX:L'C\6Q1189$?>&[%.QH/ 4FG<JZO\ #?6
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MU;HHH,I2<G=A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ.96>%U7[Q&!4E% +0H65U!'81AY%38,$$]#63KNGZ'XAB"7HRRC"RKC(_&M
M\VD!E\TQ*7_O5+M'H*#>%7DGSPNGZGG5IX"\.6TXE:::YP>(L#FNSMH[R.W2
M*"*&&)1A%QT'TK2P/04M!I7QE6M;VCOZ_P!(HBSGF8&ZG#*#G8BX!^O-7@
M .@HHH.:4FPJ.??Y#[!EL<"I*1\[#MZXXH$MRMIVP6$00\!0#]:XKXI:O-9:
M3!9PL5^TE@Y![#''ZUV>EX^P1D=3RWUKG/B!X<EU[1U:V!:>WRRJ!DL#C('O
MQ0=^!E3AC8NIM?\ K\3R;2UM[6S#WB!CJ#>0A;^!3QO_ %/Y5#I=U<Z!XBB:
M-BKPRC/NI_Q!JOJTDTUX%D@: 1((UB(Y4#/^)K?\/Z->>*M6LG^SLD<( FGQ
M\K '/YXXIGV-1J$)5*OPM._Z?AH>XP3B2SCG8A0R!SGMD9J@?$NC"X\@ZC;^
M9G&-XK@/B)KTT$RZ+;/MAB10^#U.,C^E<K%I\3Z3ABW]HR*9HQG^ '&,?3FN
MZE@U*"E-VN?F-;&6J.,%L>V7\3-Y>H69W2H.B]'0]OY'\*DM-6M;Q_+5BD@&
M2CC!KS;X<>(ITU :9,VZ"53L!/W6Z_XUZ==V%M>H$N(E< Y'M7-7HNC/E9V8
M?$0K4US(LT5DZ>IL]1GL0[M"J*\>\\CKD#]*UJQ-)QY78****" HHHH ****
M "BBB@ HHHH **** ,G46W:SIL;#"AF;<>A.UN*UJR-1_>:UIT+C]WN9@?5@
MK<5KT&M3X8^GZGA7BG3G?QY=1W)V1%S*6;IMZC^8K)MM02]U6YCG.VVO 4 )
M^X ?E_(<5[5XG\)67B6!1,3'.GW95_D?:N(B^$4_VC][J*>3GJ(^<?G3/J,+
MF>&E12JRY6E;[NJ_ @^%-G.FO7CL/EACV.1TR3_]8UZ_6;H>AV>@6"VEFI Z
MLQZL?4UI4CP,QQ2Q6(=2.VWW#)I5@A>5SA$4LQ]A6.EB^L@7%ZV+=C\D&.WN
M?_K5IWL!N;&>!3@R1LH/U%0Z3<_:+,J4V/"WEL/< '^HH.>#<8.4=R*32%@(
METXK;R@8P%^5A[BD%OJLW^LNXXL?W(\Y_6M2B@7M9==2C;:8D,_VB:1I[C&-
M[=OH.U7J**")2<G=A11102%%%% !1110 5DZE?,\KZ;!;>?*T99@6VA1Z]#Z
MBM:L[4;:3S(KVV&9XNJ_WU[C^OX4&M'EYM?Z9-I<,UOIEO#<$>8B!3CM@5)=
M31Q1X<;BW 0=342ZE;O:M,KC*]4SR#Z$4MK;,&^T3DF9QT[+["@&G=RF5[+3
M61<W#%D!S'%VC'I[UIT44$3FY.["BBB@D**** "BBB@ HHHH **** "BBB@
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M)R?YU9HHH,Y-MW84444".&\?ZS-;+%8P.R;P6D(.,^G]:X^ULXGL/+D!^UW
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%17,JPV\CM
MT"F@:5W8K:6,P2/V:0G^G]*O56L(S%91JW7D_F<U9H*J.\F%%%%! 4444 ,E
MB2>-HY%#(PP0:R;> :"QBC1S8N=V>6,9[_ATK9I" P((!!Z@T%QFTN5[,;%-
M'/&'B=74]U.:?6>^EJLADM)7MV/4)R#^!R*B:34K%CN7[7 /F+\!E'TXS05R
M*7PO[_ZL:C,%4LQ  &2366VL222%;2REG7.!(" I/XU!<7DNL'[)88\DX\Z8
M]AP2H]^U;,,200I$@ 50  *!\JIKWU=]C,-QJEX?)2U^R_WY68-CZ<T'0E/6
M]NB3]X[AR/RK6HH%[9KX=#(;1IF'DG4)_LV/N?+G\\5J11)#$L<8PBC 'I3Z
M*"95)2T85CZ_XDT_P[;>;>2?.P^2,?>:MBO"/'=Q<ZIXSEM<L2K+#&O8 _\
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ME6+6^M[Q28)-V.H(((_.G1VEM",1V\2#_90"J,Z+;:Y;R@;5F4H=O<\8S^=
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M$>M6JS[5%35;K/,A ()]./\ ZU ^;F3NC0HHHH,@K$FU^.65HK22'"\&61\
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M$C4#Z4%6BM]3B_'\5Y?>&GF2,K#&P8I@[B,CDUYC,XLM)AMXW'GSMYLI!SM
M/ _0&OH.:&.XA>&50T;@JRGN*\^U7X813W+RV-SY:L<['YQ]*]'"8B$(\D]#
MSL90E.7/!>1Y]?*MZMK>1$&28".1 >0PXSCWQ^M>@K\,M/U#2;.5WEMKHQ(9
M-I&"<<\$5>\/_#NTTNX2YNY/M$J<JO\ "#ZUVW2HQ=>,TH0V1OESKX2;JQ?*
MV<9H?PXTK2+@7$CR7,J_=#D;1^ %=DR*R[64%?0BEHKA.VOB*M>7-5E=E1-+
ML8Y/,2UC#>N*M@8'%%%!B%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 53U#4[32[<S7<H1>PZDU<KR/Q;?W&I:YY66VC:$3TR!F@#L%\?Z69=I2
M8)V<CBNDL[VWO[=9[:59(SW%>0W$<,]L^G0JOG6@W!@.7/1AGZFM?X?ZA+'J
MK6NXF*1,X]P?_KT >GT45R'B?6=1.MVF@Z5(L-Q.N]Y6&=JYQQP?>@VH495I
M\L=.OHD=?17.6,>H^'XKFXU?5%N+)$W!F7YE(SGH/I3+'QOIUY>PV[0W, G.
M(I)4PKGVH+>%J.[I^\EU7_!.FHKE;OQYIEK/<0F&YDD@;#A$S@<<_2J/B+QT
M;&+39M/B>2*Y8,S;>J\@@>^107# 8B<DN6U^_I?\CN**Y)]6BN?$6ER?:;N#
MSH6<6Q4!3@=Z)/B%I29Q#=,$D*2%8^$P<9)S0+ZC6=N2+?\ P[7Z'6T5D?\
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M9%<*SJH&5'/->C44"_M*5U:.B>GRCRV&I]Q<^E.HHH/-"BBB@ HHHH ****
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M=P[5IT4#=>J[WD]?,****#(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH CGF6WA:1SP/UJ"TB8LUS*,22#[O\ ='I44C-?W'E(,0Q/EG_O
M'T'^>U:%!H_=5NK"FR2)#&9)'5$7DLQP!3JX;XAZG+!#;V<;%5DW,Q'?&/\
M&@S-.X\=:1!-Y8=I/]I1D5LZ=JMGJD/F6DRN!U /(^HKR2R2""U2&Y4;[[@,
MW6,=C^I_*I?#=[<:5X@@B)(S*L;J?0G% 'L=%(#D TM ",H888 CWK'N+2"+
M5;5+=/+D9B[E?[N#_7%;-9%VMQ87<E[$JS+)A2K'#+T'%!M1;NTF7KFZ\DB-
M$,DK=$'IZT64+Q1%I<>:Y+-_A26MN4+3R\S2<G_9'I5J@B327*@HHHH("BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M7=_ZV.;U3PI<3:PFH:?/!'B+RO)FC#(H]@0<5?\ #7AY?#]I*AE\R65][D#
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
+%%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>afyaform20f_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &J \<# 2(  A$! Q$!_\0
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MBD%+0 4444 %%%% !1110 44E% "T44G>@!:*,T'I0 44E H 6BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH 3%&*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *0FEK#\3^)++PSI;
MWEV23G;'&!DNW84";25V:-]JEEIL/FWES'"GJYQ7+R_$_P +1S%/MV[!QN5#
MBO,HK/5/B3<ZAJ-YJ,=M'9@$(X)5%.?3Z5/9_"R;4+%+NTUFTE@D^Z?*(S3T
MV9ASU6N:,=#V32O$>DZTH-A>QS'&=JGG\JU-U?.VK>%];\$SQ:C;W(VHV!/
M<;2>Q'I7J7@/QS%XFMOLMUB/4HE^=<<./446[#A6;?+-69W%%)2TC<*,T5FW
M^M6>FW5M;W+.KW+;4(7(S[GM0-)O8T<T9K,77;%M1GL0[>; F^0E?E ^M+=Z
MY86=F;J2<&,C(V\D_04#Y97V-+-&:S(=<LI+3[2TGEQ^K]:DN=7M+6*1VDW>
M7'YI"\DK[4!RRO:QH45EW.MVUM:VUPRRLMSCRU5<DY&>>?2I;?5[.YCB=)A^
M]&4!X- N5VO8OYHJC_:MHR!DDWJ9/+RO3-5V\1:>E_\ 8_-S(%+,0/E4#U-
MU%O9&MFC-4'UBP2.-WNHPLGW>>M.?5+*.41/<('(# 9['I0+E?8NYHJ))XY6
M=48,4.& [&I,T"%HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !"\32:#HPBMGQ=W)V)CJH[FO#V9V<L[%G)R6/<]S76_$?4#>^+I(@WR6R!
M/?O7(UU4XV5SR<34YI6#K7<>#M.N;K2R4"A&D.UB>M</[^E>D?#.7[9#-IQ.
MUK=O,#>H;M^E1B7+E]W<6&IPJ3M4V-C^P)P,F9 :Y[Q9I5S;:-*2H90020>U
M>HMIB!<[^IR.*X'XE3MI^G):*=QOC@$<;0.:X*,J_.N;8[Z^$PZA>&YY;G/(
M[T8SW(/J.U%%>N>3<]C^&OB>;5;&33KN0O=6V-I8\LG_ -:N^!XKY^\$ZBVF
M^+;.7/RR'RF_&OH'L*Y*L;2/6PT^: [M11169T!1110 4444 %%%% !1110
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M2?Q!_P!"Q)_W_'^%)_PE'B#_ *%B3_O^/\*Z['UHP/>L3T.>/\IR7_"4:_\
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MNFW 8D,?7I4'_",:A(N6EA5^>A) ).:T_P#A+]+S_K'_ .^:M6_B+3;GA+I
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M>9R-WHMY+-8K#!' CG9<K&V5"#T_&NL10B*JC ' I]%,SE)RW"BBB@D****
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MWMX$L8MY,R>8<XPN>:U 1CV]Z=D'N/6DP",4"ZW&2<@$=*CSZ?I4^!C'&*
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M'87T5U*Q6.,_,0"3CZ"G3=F=.,I^THN)ZH.11^-<G_PL#0QP990?>%O\*/\
MA8.A?\]I?^_+?X5V71\K[*?8ZRBN3_X6#H7_ #VE_P"_+?X4?\+!T+_GM+_W
MY;_"BZ#V4^QUE%<H/B!HAQB67G_IBW^%2?\ "<Z3ZS?]^6_PH#V4^QT])D>M
M<S_PG.D>LW_?IO\ "JFH>,K2YLY(K&XEAN"/D8P,1G\J+H<:,V[6.NGF$$$D
MC=$4L:\?O+E[V]FN'.6=SCZ"MJU\>+J6FW>GW4;)>+&5#(/E;MG/:N> P .]
M)A.E*F[20M2VLJPW44C#*JP+#VJ*CZ]/>I:NK$['H%HENEJGV10(6^8 5-@'
MCUXKG_#E^[VQA?!B3[D@[^U:]S=K%;2O'AG525 ]:\6HTJC5ST87<;G*ZY);
M&[6&T14BB&,*._>LR@R>83(6#$G)(.>:*]F"M%'GR=Y!C/YUZ!X(OC-I<ELY
MRT#<'VKS^MOPUK%MH][*]R7$;I_ I8_D*M"M?0]*EACF4K(@93V(!JG_ &+I
MN<_8H,_[@J.VU^SN=+?48R_DIG.4.>/;&:ATWQ-8:K<&"W,N_&?FC9?YBF"4
MTM#7CC2)-BJ%4=@,"G]N*PY?%.G0ZE]@8R^=N"\1G&3[XJ34_$=AI$B1W)DW
M/R-J%OY"@7)*XWQ+:7%[IJ1VR%I!<1,<'' 89K<KF=5U9[K08;O3&E7?<1KG
M:0=NX9XKIJ ::BDPHHHH)"BBB@ I&Z?_ %\4M!H XB>Y4>-F>PNKB:2!&:[@
MSPP(^5%![YI+K4YW\6:+.!/;">-UGMWY9.F 0/Y^]=G]GA$OF"&/?_>VC/YT
MODH9/,,:^9C&['./K0!Q.I^,[^PU*^T]+%9KFT7SRJ_Q1'N/?-92^/-7BTBV
MN[JV57:4_*%)\V/."?8C(KT5-/MDNY+H0+Y\J[7<C)(]/I3Q:0*JJ((L Y "
MC ^E '#?\)5JZZ9;:A.(88)KLQD!262,'CCWKO8G$D2NOW6&136MXGV[HHV"
MG(RH.*D48&* %HHHH **** "BBB@#E;G_DH5M_UZ'^9KJ!7*7LL</Q MFDD5
M%^R'ECCN:Z,7]G_S]0_]]B@TFG:):HJO]OL_^?J#_OX*/M]I_P _4'_?P4&9
M8--XJ!K^TQD74/\ W\%<_%XQM8]7?3[]1;-NQ#(6!60>N1T_&@J,)2^$J^-+
MXA8;-&ZG<^*X^M3Q',)]=G8.'4 !2#D5ET'@8F3E4=Q1GG'7%<QX=TO2]266
MYO'EG(D8>3$I!4Y[_P"%=3$VR9&]&%7],:YT.6\A2Q:XM;B=KB.2$@'+=F^F
M/UKBQ5FTF>SDFD9-;F9:>&O#)B>[0;DB^^9&^X?<>M1>*[[3)O#$J',2QKN@
M9TP./2DU/PO=:]J+ZW.QM;E"K0V@/R.!_P ],=3UK4U=K[Q#IR::VG&W61E,
M\DK J@&/N_6N3E@NI[SE-K5:&-I3^;I%I)M8!HP1N&*N5;U%HS=;(\;(U"C%
M5*]2F_=1\3BTE6DD;GA:^^QZN(V.(IQ@CWKT7M7D4+F.XB=>JNIS7JMO>6\R
MJJ31L^T$JK@FM#MP,FX<I!?:/9:FH%W;)(1T)'/YU03P?HZ,I%L6V\A6<D&M
MA[RVB8J\\:L.H+ &G27$$2!I)413T+-@&@])3FE9,(8(X$6.) B+T ' J:H5
MN(&C\U94,8ZL&X_.B.ZMY6VQSQN<9PK F@EWW9-14(O+8OL$\9;T#"EDN8(B
M!),B$]F;% K$II*9Y\7EA_,78>C9XI!-'(#Y;JV.N#TH"P_BN!\>:B9+N'3T
M/R1_.X!Z^U='!XFLCJTVG7)^SW"'Y!(?]8OJ#TKSG6IC<:U>2L23YA SZ"@J
M4)1W11X[?C1Z8HHH)]3J/#MI;2V<4K)O8L58>AKH?LD07'D+C_=KE?!UY':Z
MZBS-A)5*C/0'M7IC@$#'\JY9T7-WYK%1Y%]DX+7+&U%G<2K'M,:]N[=JY&NG
M\9ZE#=7Z6]NV5B&),=":YBM:47%6;N)J*?NH*Z[P)J1AO9+!VPDHW(#V/>N1
MJYI$YMM9LY0V,2C)]N]:B/9:*A^TP?\ /6/_ +Z%+]I@_P">R?\ ?0H EHJ+
M[3!_SV3_ +Z%'VF#_GLG_?0H EH-1?:8/^>R?]]"@W,'_/:/_OH4 24R:00P
MO(>B*2:HZGJB6%A+<11_:709\J-ADUE'Q%8:QH-R]I./,V8:,GYE/<8H*4)-
M7.?N)VN;F29R278D?2HJ0# %+02<IXYD1;?3X7D6,2R[0Y' /O4UIX9\.I$B
M7$\CS8^:7D*QK<U736U;1I;6/R_.5UEC#C(8KV-27.L7M[8O8IHDHGDB\LF3
M'E*<8)Q_*O-KI.;N>KAY2C!)$-E::)X=F,<  G8;N,LV/Z5SUY<V \?V;VKD
MO,A#J!SGWK:T&TN?!T$UK]FN-2AF(?SU;,@.,;23V_I5FVMI;K7[C7+FV^S9
MA$,4;8WX]36<(Q4DTS2<Y---%D\$_6C&1Z4=:*]5.YX[W.U\/7?VG3@K$EXS
MM.?TJ[<V<%["8KF%9$/9QFN>\)L1<729X*J:ZK%,2;3NCGSX.T8D_P"C'']T
M.<5JV6GVVGQ>7;0I$OHHZU;HQ05*<I:-A2T44$A1110 4444 %%%% !1110
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MC_[Y%+]D@_YXI^53@48KL/E>:7<@^R0?\\4_*C[)!_SQ3\JGQ1B@.:7<@%I
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M,Z#"N?0^AK+#X9Q5YFN)Q<9OE@+13YH98&*S1LA'J*9C%=IQ'0>$Q_I=R?\
M8'\ZZRN>\+6QCM9)V&#(>/H*Z&@ HHHH **** "BBB@ HHHH **** "BBB@
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MEVU62V,;+&D>0Q'#'/:A"90N([Z9+V:Z1(TC1Q%MZL,'K7%_"-MQU8M]X/\
MAUKTZ6,20M&<892*Y'P-H3Z+:ZB)%PTETV,C^'M32C;4R<7SW1J:II,MW=K=
M6\J)+Y9B<2#(VG&<>]:-G;+9VT-LC,PB&W<QZTEV[QV<SQJ6D5<J!WJ2V+3V
MT4C*49U!(/4&BY=CAM*\/O?>(;DRH1:V\S')Z,>N*]#4!5  P!P!34C5 0J@
M9Y..]/I%A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %!HHH S-<L!J&E30@ OC<GU'2N2\+Z3'<SS37
M4>?).W8PQSSUKOR,U7^RI&S-$BJSG+8[T'/4H*4U/L5+U0NE78  'D., 8'0
MU0AB,=C:CHIA3&.W%6M::X32;A;:'S)G79M'8'J11IJS2Z/;+=1>7*(PN.XQ
MP*#1Q5K'D'BR\@@^(UE^Y!\@@-[Y_P#UUZ;>77]GZ<;@1&7: H3^\3VKG_$'
M@U]0\=Z7J"@&$?ZXXZD=*Z_5+=O[*<11>8ZL'*>O/:IC>[N=6(Y'&')T,SP\
MU[IUPVD7\$<;R[KB!DY7!ZK^%0>+]/B2&.]A0*^[8P4?>S6O;SK?ZLMRMO)$
ML497,BX))["M4VJ3J!,@91@A6'>K..K2C45C(\+Z/_9]D991^_FY/L/2NA'2
MFA<4ZD7""A%105Y1\9-6>.ULM+0D+*QD?G[P'05ZO7C7QGMI?M^F7&S]T0R[
MO>FC/$-JF[%;X30R3MKL43!9'A"JQ[9KTC0M&FT+2YK:6Z\U2^]"6.>>HKSS
MX._\?6LY_P">:UZ+>%?LWS*QY[*U-QN[BP]5QI**6Y@_$&VMY/!M_.\2R20X
M9&(Y!S7DG@C6SI7B6PNU8A681R@=P:];\<;SX!U+<1M*+M'.>M>$>'[:>]UW
M3;:W'[V29<?G36QSUW:HN4^MT(90PZ'D4ZHH%*1HC=54 U+4'H(*Q/$VCC5M
M+9%&9XOGC]R.U;=(1F@#S_P% PU.\:12KPH%(/8Y.:ZW?;V.HW$DK)$)0I+,
M< XJS#I\%O>3W,:!9)P-^.^*@U8V?EQ)=PI*)'"*K#/- @U2YC6W2+EI9S^Z
M"C.2.:C_ +,3^U4U!OO^5LVUI"-0JJ% "C ]J;(",9-,EP4GJ5[DN+60Q#Y\
M<57TX.(91Y9CBS\BGJ/4U='WJ@MKM;LS*GWH7V,/>@+79QOCV'%[:3X^\-OX
MUTGA721I>DH77$TPWR9['TJ[=Z3;ZA+;R7*[A VY5]36@!@<4BQ:*** "BBB
M@ HHHH *#110!QWB/3C;W)NXE_=R<,!V-:VE:=#:6L;; 967)8UKS0I/&8Y%
M#*>QJ$1&-0O51Q^% F85W&)?%]KP-XMVP>X^E1:JR1:7<S2IQ%&25_"HI[J]
M_P"$PB=;)S$B&(-CC![YK<O[%+N":(@;9$*,OJ",4-Z:"LG)7/._AI-#<:-,
M$C"F*9B<=P23_6M_6#=7EQ'I]C;"6:W9;IG8X"C' _&E\#^&VT31Y(I!AWG9
MCZD!B!^F*T[FX&E:Y/<26\TD5Q$ IA7."O8TH7MJ:5U'VKE'8NV=Q!KFEQ7,
ML "RJ<JPY4@X/ZUSCZ4[:PUE&"5SG/HM=-I2$Z=%MBV9RVW&,9-7X[9$D:4
M>8W5J9"'6\*6\"11CY5  J6DQ2T#"BBB@ HHHH **** "BBB@ HHHH ****
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M56L9X[B.1HTV .5(]3ZT!8L! #D4N*6B@ HHHH **** "BBB@ HHHH ****
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MK"2.9$M+'F*,)\X]MWI[5C7?@D:GX@UB:YREI=0*L(#?<E/WF ]Z[C%&/<T
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MT-PH$DRL?,60X'7'K^=7(K%XM1>X5D2-A]Q!][ZU?P*7% "#I2T44 %&***
M$P*7%%% !BC%%% !BBBB@ Q1BBB@ Q2&EI#0 UV5%+,0 !DD]!7CGB'XB:UK
M6H2V'AB*18XB094'SN.F1[5U'Q3UV32O#2VUO)LN+QO+!'4#O7#?"9I$U^^,
M0+.+7Y1ZFGLKG-4FY35-.QARV?C.:0R3+JS,>2WF,/ZU8L?%WBOPO=1Q7$]P
MR#I;W1)W#V)YKU_PW;ZS;6UXFJ,S%GWQL3G /:LSQSHMGJ?AV\N;E"9K9/,C
M<=124KA4P[IOW97-OPGXNLO%5AYUO\DZ<2PMU4UT8Z5\R^"M>DT?Q'97D<F(
MI7$4P]CW-?3,;K)&KJ<JPR#[4VBJ%3G5V.HHHI&X48HHH ,"C%%% !BBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2E
MHH S]3TY=0A4>8T<D;!XW4_=8>H[BLY-;N[$^5JMJPQ_R\0KF-A_,5T-(54]
M5!^HH*3[F4OB+2VP!>)D^H-/_M[3?^?M/R-6WL[:7[\$;?A3/[-LO^?:+_OD
M4![I7_M[3/\ G[2C^WM,_P"?M*L?V=9?\^T7Y4?V=9_\^T7Y4![I7_M[3/\
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M1110 4444 %%%% !1110 4444 %%%% !12'I6+=>(([?7HM)CMY)9F0R.P(
MC7UYZT ;=%8R>)M&>.XD%_%MM_\ 6DY&W\Z6Z\2:=;I\MRDCF/>BH>H^O:@#
M6(YKA?$WPOT;Q#<O=*\EI<.<L8E!5C[K717GB33[-959]TZ(',(."0?0]Z;_
M ,)/IJP[Y9MC^493'C<P4#.>*+DRBI*S/);GX&:@DQ%MJ%M)%VWQD'^=:FE?
M NS4I)JNHO+CEHH4"J?;)YKT2?Q/:KX<77+2&:[M"N[]WP<?C4 \8:?&EO\
M:DEMY+A]D<9&23MW?RIW9DL/"]S8TS3+/2;&.TLK=(84& JKC\_>KHK"L?%6
MFWD5J6G6"6Y.(XG/)J1?$$!U.[M#&P2U \V8GY1GI2-TK&S167+KVF0I&[W:
M;'D\M7'(+?6HSXET<79M?M\7G*0I7GJ: -BBDSFEH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHI".* ,V^O;"WN4\]2\V,J$0LP'KQVJTL]O(ZG<N[&X \$#Z5D:GI5W)=R
M7%J0?-CV,"Y4J<YR#6<OA:[^V/+-.96,6T/N((-!K&$6M6=&?[/>(DF QE^N
M1C=_C2R-8!7C=H0/XE+ 8KFKSPI/*(PCCRP1NB!(!]3]:LR>'KF.UNUMS&99
MWSE\\KCI[4AN$>YL?:[!K@0?(6C&02. /K2PW&G1SBVADA$D@+!%(^:L.+PY
M=IY8ED$BA2K(#C/' S4^G:+=6]W97$R0LT41C8CJHSQ]:8I0@MF6)=2T6V:2
M)PJ@-A_D.-P]_7FM%393'S@86)7[P(.16'-X8\U[V9F#2S2AD!/RJN1G]!5>
MZT.[AE@C@)V27#>8%SCRCV]C2#EAW.A#V$06-?*P21A<'![T-+I\AV'RF ^;
M(Q@8]ZPI/#UXQG2)EAA9LJJG)Z8Z_E3Y-&U!PKQI!$RQ["@Y4\]:+AR0[FY+
M)82B,2O V[[F2.?I5P8  '2N/@\+70AE$KQERK"+.<(21C%=>@*HH)R0,9ID
MS44[)CJ***" HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9'K0 ZBFY]Z,^] #J*;D>M&1ZT .HIN?>C/O0 ZBFY]Z,^] #J*3/O2;@.]
M#LBDR/450O=7LK&,F:=0P_@!RQ^@ZU0THWFH:C)J,R/# !LAB/\ $/[Q%!2B
M;]%%%!(4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC_A&;+^_<?\ ?XUM44!S,Q?^$9LO[]Q_W^-'_",V7]^X_P"_QK:HH#F9B_\
M",V7]^X_[_&@^&;+'W[C_O\ &MJD- <S.??3-5L/WEC?>>J_\L)^A_&H?^$G
M>=5MK>U8ZB6VO _\'N3Z>E=(WUXJLFG6J7TEZD"K<R*%:3N10"DNIF+H5S<_
M-J&H32$]8T.U1[ U*/#5EC[]S_W^-; X%**!<S,;_A&;+^_<?]_C1_PC-E_>
MN/\ O\:VLTF:!\S,;_A&;+^]<?\ ?XT?\(S9?WKC_O\ &MG-+F@.9F+_ ,(S
M9?WKC_O\:/\ A&;+^_<?]_C6UFC- <S,7_A&;+^_<?\ ?XT?\(S9?WKC_O\
M&MJDS0',S&_X1FR_O7'_ '^-'_",V7]^X_[_ !K:HH#F9B_\(S9?W[C_ +_&
MC_A&;+^]<?\ ?XUM44!S,Q?^$9LO[UQ_W^-'_",V7]^X_P"_QK:HH#F9B_\
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M,&_E,RCT7HOZ &K>MW4UI8AXOEWN$9\9V ]ZTDC6)%1%"JHP !T%#Q++&4<
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MGH_L:]_Z"MQ3#E7<W-U)NK$_L:]_Z"MQ1_8][_T%9Z Y5W-S=2;JQ/[&O?\
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MNI-U8G]C7O\ T%;BC^QKW_H*W% <J[FWNI=U8?\ 8][_ -!6>C^QKW_H*W%
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M^Q[W_H*ST!RKN;FZDW5B?V->_P#05N*/[&O?^@K<4!RKN;>ZEW5A_P!CWO\
MT%9Z/[&O?^@K<4!RKN;>ZC=6)_8][_T%9Z/['O?^@K/0'*NYM[J-U8G]CWO_
M $%9Z/[&O?\ H*ST!RKN;FZDW5B?V->_]!6XH_L>]_Z"L] <J[FWNI=U8?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;2!0T*$*<CCH:1K&V=E9H4)7I\HJQ119!S/N,6&-#E44'&,@=J?113$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
A44 %%%% !1110 4444 %%%% !1110 4444 %%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>afyaform20f_012.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_012.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $Z \T# 2(  A$! Q$!_\0
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M5&U6Q,[V\D#!BK)(,'-:0//M36IS--.S'4444""BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M2 RH\0P ?[M .C(ZW(I:RM$N9[JU,DT\,^3P\73Z$5JT&;5G8****!!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"BBBI.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *#THHH ::\=^-
M$;"\TR3&5VLN:]CQTKC/B1X<DU[PR[6ZYN[;][&!U/J*:,JT7*#L>2?#_P#Y
M'K2_^NC?^@FO=9@?/;]U#UZM)@UX3\/CCQWIF>-LC Y[':<@U] M&K.3^XY/
M<<U5SEH1O'4Q"G^E;HXX3(#P!)FO-/C1NW:,6X;:^:]4DM66X9T%L".A%>6?
M&K._1]S*3M?)!XI*[9K6TIM'">$EDD\7:6D?),X)'L.M?5R_=%>"?!WPT^H:
MV^MS1D6ML-L)(^^_?^E>]CI1+<,)%QAJ+1114G4%%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M -C3[Z#4K1;FW+>6Q(^88((X-6JYWPS#JL G34HU09'DJGW0O;/^UZUT0Z4
M%%%% !28'H*6B@!,#TI<#THHH 3:!V'Y48'7 I>U(3@9H 3 [BC ]*KR7UM&
M</,B_4T1WMM(?DF0_C0/EEV+( ]*,#TI%(/(.:=0(3 '84;1Z"EHH ,4444
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M,A^C59!!&0<T I)["X'I28'I2T4#"BBB@ HHHH **** "BBB@ HHHH ****
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M.U\&7)DLIH&/^K;C-=-7!>&[.]NC<?8[][4*0&VHK;C^(K?_ +(UG_H.S?\
M?I/\*ZZ;]T^<Q=**K2]Y+[S?_&C\:P/['UK_ *#LW_?J/_XFC^R-:_Z#LW_?
MI/\ "KN<WLX_S+\3?_&C\:P?[(UK_H/3?]^D_P *3^Q]9_Z#LW_?J/\ ^)HN
M'LX_S+\3?_&C\:P?[(UK_H/3?]^D_P *3^Q]9_Z#LW_?J/\ ^)HN'LX_S+\3
M?_&C\:P?[(UK_H/3?]^D_P */[(UK_H/3?\ ?I/\*+A[./\ ,OQ-W\:/QK!_
ML?6?^@[+_P!^H_\ XFC^Q]9_Z#LO_?J/_P")H#V<?YE^)O?C2_C6!_8^L_\
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MVMLEI;QP1C"QC JCEP^&<:CD^A8HHHH/0"BBB@ HHHH **** "BBB@ HHHH
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M12%ML2XSO5LXS7H= !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% "%L#/MFJ.F:S8:Q%++87*3I$YC<J>C#M4/B&VU"[T:>WTR1([F0;=S?
MW>]<UX$T;4]/M=8L[ZUAM8WDVQ>2,;OEP6^M '<;Q[?G2>:O'(YZ<UY,J:W?
MZ%)?DRE([K[+*@).Z&,[0P YSD<T_6+>^'AVW@L8KBX#^8\%S(&#1G<,(!G(
M'7K0!ZMYBC.2!CKD]*<&#=*\SN=)O5T/5+J^^V)?2SC:0Q8,H08!&>A(KN/#
MCW,F@V;7=H+68Q#="#G;0!JT444 %%%% !1110 4444 %%%% !1110 4444
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MUBZ I5[\[G=3/E7<<L*VJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ,5#/:P7
M.SSHEDV-N7<,X/K4U% "8]S1BEHH 3:*6BB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!,48!I:* (H;>*"(1Q($09.U>!SR:DQ[TM%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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ME_3.CHKG?[;U?_H"R?\ ?5']MZO_ - 63_OJBX>QE_3.BHKG/[;U?_H"R?\
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M/K1CZTZB@5AE+WIV!10,3 H[TM% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
3 **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>afyaform20f_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "] [$# 2(  A$! Q$!_\0
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M9GIUK8M+J&]M8[F!Q)%(-R,O0B@":BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJM?7T&G6DMU=2K%#$NYG;H!4+ZQ91:7_:3SJ+0KO$GJ/:@"_17.MX
MWT-+"*\:[_=22&,#RVW CKD=0/>M)M:L$NK.W-U&9;P$P*#G>!U(H T****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBJ4VJV=OJ%O82SHMU<!C%'W8#O
M0!=HK+O]?T[3+N&UNKA4FE^ZN,X^OI5)/&FB/<2P&[$;QJS$R(RC ]">M '0
MT5E:-XAT_7HI)-/G\P1G# J58?4&M4=* "BBB@ HHHH **** "BBB@ HHHH
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M"<]*SM5^(FKZ=J5Q:Q>#-2NHXFP)D==K?2@#5&ASZGX7U-=4LHGO;YG9HCT
M'"+^0!_&MKP[:2V'A^RM9DV211A2H[>U86H>,K^R\-66JQ^&KZ>:X^]:*P#Q
M\]S3?#'C74M?U-K2[\,7VF($+>=.P*GVXH [.BO.M1^)&L6.HW-M'X*U.XCA
MD*"5'4!P.A'M70ZIXBU.RT2SO[3P_<WLUPJE[9)%5HLC."3Z4 =)17)^'_%.
MLZM?O;WWA>[TV-8]PEEE5@3Z<5FS^.?$D4TB)X%U"0(Q 99EPP]: .^HKGM5
MU_4[#0[6^MM N;RYF(#VB2*&CX[DU4\/^*=9U?46MK[PM=Z;$(RXFEE5@2,?
M+@>N?TH ZRBN#NO''B*"ZFBB\#W\R(Y59%F3# 'K6IJ_B75]/TZQN;7PU=7T
MUP/WL$4J@P<=R: .HHKF?#?B/5=:GGCO_#MSI:QH&5Y9%8.>X&*R;OQQXB@N
MI8HO ]_,B.5619T <#N![T =Y17+ZYX@US3])L;K3_#TU[<3@&:W$@#0\9P?
MQXJ'PUXD\0ZM>31:KX:ETV-(]R2-(&#GTH ZZBO.7\<>,UE=1X%N"JL0&$PY
M'K70^(==UK2].M)]-T&349Y?];"L@'E\4 /\8Z1?:UHS6EFT!!RTD4P.),#@
M9'O7,ZEH^LW?@^PT<VX-Y:*EPZ0-A74$C8">AY%;/AOQ)XAU:XN$U3PS+IR1
MQ%XW:4$2-_=K';QKXP%P4'@6XV!L!_.'(SUH H2:5XA.B7-NND3XNV94;S5-
MS"O'#$\$''Z5?@\,^(H=8T*[<6,JVH$;#Y@84'8?6NBU[5]=L+.RDTK0#J$D
MH)FC,P3RN!Z]:3PYK'B#4I+A=8\/'35C4&,^>'WG\* .E&>^*6N!F\5>-TGD
M2/P4SQJQ"O\ :1\PSUK5UO7/$ME;V;Z;X;-])*F9D\\+Y1],]Z .IHKFO#FL
M^(-1,_\ :^@'30@^0^<K[_RZ5C_\)5XW\\I_PA)V;\;OM:_=SUQ]* .]HKFO
M$>L^(--%M_9'A\ZD9!F7]\$\L^GO4>B:YXDOH;QM3\.FQ>)"85\X-YAQTH Z
MFBO/U\5^.#( W@AE7< 6^UJ<#UK6\4:OXIT^*S;0="CU!I 3.KS!?+..GO0!
MU5%<CX;UGQ;?B^_MOP_%8&.,-;!9PWFMW!]*P_\ A*/B1]HV?\(9;^7YF-WV
MC^'/6@#TJBN.\2ZUXPL)K4:)X>BOT>(-*6G"['[K5CPYJ_B>^T^[EUO1(["X
MC_U$:RAO,XH ZFBO-'\4_$D3$#P9 8PV-WVD<C/U]*WO$^L^+-/:T_L+08M0
M#H3-NF"^6?2@#K3T-<!=>']<A\86NN2-:7<<+R,SC<'CCVG"@=,UJ>&M8\5:
MA;WSZYH46GR1K_HZB7<)#BLBVUWXB//"MQX8M$C=@)"+C.U<\GKZ4 4]4T;5
M]1\3QZQ9VLCPW:1%-Q&V#:?F#@]<_P \5K:K8ZM<-JM\^CQ7CIMALK1WPI&<
ML^??C\JT/$VH>)[*6W70-'M[Z)E/FF24+M/I3=#U+Q5<V%_)JNCV]M<QC_1H
MTF#"4\]3GCM0 WPC:7BW5_?:E:3P7MQL#LX4*P4' 4#L,UU8Z5Y];:[\0WN8
M5G\+V:1LX$C+/RH[G\JU_$NI^*[*\@CT#1K>]MS'F5Y)0I5L].M '5T5SF@Z
MCXDNM,NI-9TN&TNUSY$4<FX/@9&?QK BU[XBF9!)X7LU0N S"XZ#/)H ]"HK
MD?$6J^+[.]A31=$M[R!H\R.\H&UO2K&C:CXHN=&OI=4TJWM;]%8VT2R;ED.#
MC//KB@#IJ*\UM=;^*;75NMSX=TM83(HE99CD+GYB.?2MCQ3J7CBTU.)/#>DV
M5Y9E,L\[X8-Z=1[4 =E17):/J'C.;P_?S:KI=E#J:$_988Y"5?TSS6)8ZU\4
M'O;=;SP_I<=NS@2NLI)5?4<T >D45R'BG4?&EI>6Z^'-*LKRW:/,KSR%2&]!
M3]"O_&-SH5])K&FV5MJ2-_HT<;DHXQWYH ZRBN!M+_XDM=P+=:9I"VY;]ZRL
MVX+[<U>UZ\\<PZH5T2PTV:QVC#SL=Q/?N* .PK/UJUNKW3)[:SF2&:0 !W!(
MQGD<>U9NG7'BAO#US)J-K9)JRY\F.(GRSSQGFL.UO_B0UW MSIFD+ 9%$K([
M9"]R.: (+#2-6T[P+/H$UM#'/=M-%;BW)*Q@@D;B?7I^-8T?AG7Y+-673[J*
M*V,9:!YU,TI7@^6W11WY]*[C4KCQ4OB.TCT^SL7T@D>?)*6\Q1WQ72X% 'E2
MZ#XBB?3YX[&5+Q$9(98I%"Q L#B5?XOJ*]1@$HB03%3($&\J."W?'M4FT>E+
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@!,#THP/04M% !@>E%%% !BC ]*** #%%%% !BBBB@ HHHH **** #
M]**** "BBB@ HHHH ,4444 %&*** "DI:* "C%%% !BBBB@ HQ110 8HQ110
M E+110 4444 %%%% !1BBB@ HQ110 48HHH ,"BBB@ HHHH ,4444 %%%% !
M@>E&*** # HHHH ,48%%% !BBBB@ Q1@444 %&*** "C%%% !BBBB@ HP/2B
MB@ HHHH ,48HHH ,#THQ110 8'I1110 8'I1110 F!Z4N*** # ]**** #%)
M@>E+10 8%%%% !1BBB@ P/2BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=S10!PW_  LVP_Z >O?^"Z3_  H_X6;8?] /7O\ P72?X5W-% '#?\+-L/\
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M$0'Y6P<C<.Y!)H W(G\R)'_O ']*DI H&,=!2T %%%% !1110 4444 %%%%
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M;6<T6U&QT(/3%=3:^%;:SB$4=Q</"6RZ2/D,N,;>.U&E^#])TJ666")V=U*
MR/NV*?X5]!0!D:?XAUBYL_#L\BP[+R5H[QQ_"V&P!^(KMAU-9\.BV4%O;0)%
MB.WD\R,>AY_QK1 Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%(3CZ4 +1BN%NO'#/XDN-/LWAV10RJJ.?G>=2/TYJK:>.+V
MQTZ2'5P4UISB.WEC"J,@D'*DY7B@#T2BN0'B>Y/PZCUQ9;>2[>%>5'R-)G!
M_I6%'\0+^+1+B*Z\J+65D*+'.NS8O]YP#CIZ&@#TRBO,7\<ZU)J<+VT:RZ:)
M($EF2,&,;@-VYLY!R> *]-% "T444 %%%% !1110 4444 %%%% !1110 AII
M=0,EE '&2:S/$>HW>EZ2US8VCW4^Y5"+_"">6_"O(8M9U*]A6RNKRZA2.6XD
M,US(8_-88PH(ST'04 >X[@&P2 3T'K2EE7&Y@,\#)Q7E"7,FJW>E&'4[JVO$
MAA=VFFVI$OIC'SLWO6AXQN(;O7XK.'5+E;HPAE"S>7%" W,C8Y)[8H ]'SZT
M*X;H0<<'%>5WOB#5+?Q9I\5U)>K;QH\/F1K\D@"9\T^O/.*VO 4;M=W5U%J$
MLEI*@*033>9(3G[Y_NY]* .\HHHH **** "BBB@ HHHH **** "BBB@ II..
MM.K@?B)KFH:;;P16D%R(=Z2R3V_)R'^Y^/4^PH [O>NXKN&?3/- =6)"L#C@
MX.:\]N8()=7NKF&\N;62"Q\^9FD.U'8<*5QP!R:G\"7:P-=Q2W\5V61)6N8Y
M692S$_+@C@\=!0.S.[W@MMW+GTSS07"C+,H'N:\V\.WDA\426XODNY+OSO\
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M-#PZKV_QK2K@?"%E,VN?:KO19M->&)XH8UQY2H6)Z]68]>>F:[T4"U%HHHH
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M1?\ ?1_QK)SA?<O^R*LM4>Q_:H?^>B_G2B>)F #J2>@S7C7_  F=U_SZQ?\
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M?LDW3VI2E%;E_4)5W>*/3_[4M/\ GJ*#JEIU\X5YC_PFEG_SYS_F*#XTM/\
MGTF_,5'/#N']D5>S/5(+F*Y4F)PV*L#I7*>"]9BU:VN'BC>,(P!W'K75CI3/
M+JTW3FX,****#,**** *=_>BR57*%L\<51_MY.\#?G47BB\M;.VC:YF6)2<
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MF&*9TB/5 >*S?[4L3_R^0?\ ?5']JV(_Y?(/^^J+,.>A:UU]Z+E%4_[5L/\
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MP^9]S+_X1_1_^@9:_P#?L4O_  C^D?\ 0,M?^_8K3HHL',S,_L#2/^@9:_\
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M+7_OT/\ "@^'=&/73+7_ +]BM6BBP7;TN90\.:+C_D%VO_?L4?\ ".:-_P!
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M -^Q2?\ "/Z1_P! RU_[]BM2BBP<S,O_ (1_2/\ H&6O_?L4'P_I'_0,M?\
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M  C^D?\ 0,M?^_8H_P"$?TC_ *!EK_W[%:E%%A\S,S^P-(_Z!EK_ -^Q2?\
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MQ\H+-Z'D]*ZSP[JAUG1+>^;;NDSNV@@9!Q_2@#4HHHH **** "BBB@ HHHH
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M;=2D6,C8"<X!S6W10!E+X<TE=3341I\/VM%"B7'( &*U!2T4 %%%% !1110
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M\\#O6[10!ACP=X?%J+8:7"(0X<*,_>'0U/=>&]'O%99["%U954C&.%Z5JT4
M8LGA'0)OL_F:7 WV=0D61]T YQ^=7['3;?3VN'A!WW$IDD9L9)]/H.U6Z* "
FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>afyaform20f_006.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_006.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &' HL# 2(  A$! Q$!_\0
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M&.[8F<1*')ZYQ6I28&,4M !1110 4444 %%%% !1110 4444 %%%% !1110
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M_*DI3T7Z#^5)7*?H$?A04444%!1110 4444 %%%% !1110 4444"9O\ @O\
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MRGZ!#X4%%%%(H**** "BBB@ HHHH **** "BBB@ HHHH 1NE>]^&?^1>LO\
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M+0 'I7FWQG_Y%2W_ .O@5Z2>E>:_&?\ Y%2W_P"O@4I;&V'_ (L?4\Y/1?\
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MC?\ /0_E1S(7U.O_ "L[&BN-_P"%BZ-_ST/Y4?\ "Q=&_P">A_*CF0?4Z_\
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M5BH [FBN0U?QU:V$-F]I:S7KW*>8L<0Y"^IJ^/%=@^FV5Y$6D%TX1$'7/?\
M*@#H*0]#2 YQV/I2GH: /$/&P'_"57/'\(KGN/3]*Z'QM_R--S_NBN>KEE?F
M/O,"E]7AZ!QZ4?@***1UV0?A^E'X?I112"R#'M1^ _*BB@+(,>WZ48]OTHHI
MW860?@/RHQ[444!9"\>E)QZ444!9!QZ?I1^ HHH"R#CTH_#]**0T!96V(Q_R
M'M"_Z_XZ^DU^[7S8/^0_H7_7_'7THOW16]/8^.SG_>!12T"D-:'DBT5QOC3Q
M[9^$I;&!HVGNKJ98A&O\(/<U9\2^+DT.&SA@MGN]0O?]1;(<$^_TH ZFBN1\
M-^,9-3U*;2=4L7T_4X@&\ICD.#W%=-=W*6MG+</]V-2Q_"@"Q17F]M\2=5OE
M$UGX1OIK5I-J3 C!&>36MKOC.;3[NUTW3].DO-5N$WFW4X\H>IH [*BN2\+>
M,3K>H7.EWUE)8ZE;#+POW7U%=;0 AZ5YM\9O^15@_P"O@5Z4>E>;?&;_ )%2
M#_KX%*6QMA_XL?4\W/\ #QV'\J7CTH/\/^Z/Y4E<MS[^$5RH/P%)^ _*EHH*
ML@Q[48]J** LA/P'Y4N/:BBD%D''I^E'X?I110%D'X?I1^'Z444!9=@_ ?E1
MCVHHH"R[!CVH_#]***8608]J,#THH'6DPLEK8[3X:#_B=7&/[@KUQ>E>2?#/
M_D-W'^X*]<'2NF&Q\7F^F*:"BL'Q/XHL_#-K%)<!I9IVV0P)]YS[55\-^,8-
M=N9;*:UFLK^(;FMYAABO8U9YAU%%<W>>,-.L_%-IX>RSWEP,X7^$>];=W=PV
M-I+=7$@2&)"[L>P% %FBN!LOB=8W%_ DUC<V]E<R>7!=N/D<U<U+Q]:6&LFS
M%K--;QL%FND&4C)[&@#LJ*R?[;MVU6#3X@9))8_-R.R^M:HZ<4 +1110 444
M4 %%%% !1110 4444 %%%% !7/>+_P"Q8]*6ZUS!M[=PZ*?XF[ #O70UA>)_
M"]EXIL([2]>5$C?>IC;!S0!R5M!JGB?5[;6M0LA8:98CS+6#(,LIQP3[>U<'
MXC\26^HV]SJNJ6]R+X706WA>(XBC'4CZUZQIG@6'3=1BNQJM_*8^D<DN5_*M
MC6=!LM;LQ:W48V!P^5&.10 W2[^&^T"WN(68"2WRH888\>E>2^&=*UK4/#VI
MZA;ZLEKY%Q(P@(R'P>DGM7K5QH%O<:A97?FRH;1=J(C84CW%8.I_#FPO[Z:>
M*]O+2*X.;B"!]J2?44 8]KH\_B_0;#6;6\;2[N-&BE:(?(RC@D56M[E-%,,M
MK92:@8F:'3XMP4RN?OMS7HHT>VBT7^RX 88!'Y8V<$"LS4O"%CJ&CP6"/+;M
M;\Q3Q'#H?7- $OA?Q'_;]I)YUJUK>0/Y<\#')5JWST-9'A_0+7P_9?9X&>1W
M.^6:0Y>1O4FM<]#0!XAXV_Y&FY_W17/5T/C;_D:;G_=%<]7+/XC[W _[O **
M**1V6"BBB@04444#L%%%% @HHHH'8**** L%%%% @I#2TAH#H1C_ )#^A?\
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M+H?A"+1+R2X&H7ER77!6>3<OY59Y9Y/:Z]IMMXGT"\DCNFU":;?=R-$<Y/\
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M8KTS_A5]M_S]24?\*OMO^?J2CV;#^V</W/-,48KTO_A6%O\ \_4E'_"L+?\
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M&VT3GG^U(?ZUVZ]!0 ZB@44 %%%% !1110 4444 %%%%  >E<)\2O^//2O\
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M\)KKO_/S4WCW_D:I/]VN9K"4W<^RP."H3P\7*.IT'_";:[_S]4O_  FNO?\
M/U^E<]14<\CJ^H8;^1'0_P#":Z]_S]?I1_PFNO?\_1KGJ*.>0?4,-_(CH/\
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MG- QU%)D]Z,\T +13<G-&>V: '44@YI: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *#THI#T- ')>/=8UW1]"FFT2R6XD
M\MB[L?\ 5CUK.N?$'B"'X=VFHV%LMY>R6^^5B<;3CDUU/B:-Y?#.I)&"SM;N
M !U)P:QM)MID^&L5NT;B461&SOG% %KP/J-WJ?A.SN[Z3?<R*2Y]#Z5P$_BF
M;4?$VIV\WB]-*2WF\J&'9G<?4G'%=5X0OVTO1=*TR>UF\^X#8./E7ZUS=]K>
MAPP:W8:GX<\K4I'955(]QG)^ZP/:@"]XNUB[L[NSLI]??3K5+;S%O43=]ID'
M\/2M/3=<U35[/2;9&V3NOF7,@'2/L?8FK'A_3OL/@"Q&MVJSS6T)<1RKO*GL
M.:YO7+>YM='AOYWN;6"^E+7;6Z_-&G\*@#I0!ZNGW0,YXZ^M*:X[X>2WDFB2
M_:))Y+<2XMGG'SLGJ:[#M0!XMX]_Y&J3_=KF1TKIO'O_ "-4G^[7,CI7-/XC
M[S+O]VAZ!1114'8@HHHH *0TM(:8=",?\A_0O^O^.OI1?NBOFL?\A_0O^O\
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MAK6(S YWE!G\ZFEMXIXS'+&KH>JL,@U)10!#;VEO:)LMX4B7KA%P*E*@TM%
M#$ACCSL0+DY.!U-,GM+>Z0)/"DJCLZYJ:B@".*"*",1Q1JB#HJC J3'-%%
M>E>;?&?_ )%2W_Z^!7I#=*\V^,V?^$5MQ_T\"IEL;8?^+'U/.3T'T'\J2GE)
M,+^[?H.Q]*3RY/\ GF__ 'R:YK,^]C4ARK4;13O+D_YYO_WR:/+D_P">;_\
M?)HLRO:P[C:*=Y<G_/-_^^31Y<G_ #S?_ODT68>UAW&T4[RY/^>;_P#?)H\N
M3_GF_P#WR:+,/:P[C:*=Y<G_ #S?_ODT>7)_SS?_ +Y-%F'M8=QM%.\N3_GF
M_P#WR:/+D_YYO_WR:+,/:P[C:*=Y<G_/-_\ ODT>7)_SS?\ [Y-%F'M8=QM%
M.\N3_GF__?)H\N3_ )YO_P!\FBS#VL.XVNA\$?\ (TV_T-8'EO\ \\W_ .^3
M70^"4<>*;?*,.#R1503YCCQU2+P\M3VP4CQ)*N'16'H1F@4X5TGPQ$EI;HP9
M(45AT(7%(;.V:;SC!&9/[VT9J>B@!GE)NW;1N]>]1M96KS"9H(S*.CE1FIZ*
M &LBLN& (]#398(IDV2QJZ>C#(J2B@!J(J*%4 *. !VIU%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!6DLK:9RTD$;MZE033/[.L_^?:+_O@5;(HQ04IR2LF_O*O]
MFV?_ #[1?]\"C^SK/_GVB_[X%6L48H#VD^[^\J_V=9_\^T7_ 'P*/[.L_P#G
MVB_[X%6L48H#VD^[^\J_V=9_\^T7_? I/[.L_P#GVB_[X%6CUHQ18/:3[O[S
M@OB':V\,&B-%#&A_M.'E5 />N\4<"N)^)'_'OHG_ &$XOZUVR_=%%B7)MZNX
M\44"B@ HHHH **** "BBB@ HHHH 0\BN$^)@!L=+# $&\7(-=V>E<+\2_P#C
MSTK_ *_%H!'5PZ=9F%";:+.T?P#TJ7^SK/\ Y]HO^^!4L'^HC_W1_*I<4%^T
MGW95_LZS_P"?:+_O@4?V=9_\^T7_ 'P*M8HQ0+VD^[^\J_V=9_\ /M%_WP*3
M^S;+_GVB_P"^!5O%)0'M)]W]Y5_LZR_Y]HO^^!2_V=9_\^T7_? JSTI<4![2
M?=_>5?[.L_\ GVB_[X%']G6?_/M%_P!\"K6*,4![2?=_>5?[.L_^?:+_ +X%
M']G6?_/M%_WP*M8HQ0'M)]W]Y5_LZS_Y]HO^^!1_9UG_ ,^T7_? JUBC% >T
MGW?WE7^SK/\ Y]HO^^!1_9UG_P ^T7_? JUBC% >TGW?WE7^SK/_ )]H?^^!
M3H[*VB??'!&K>H4"K&*,4 YR>C;$Q2BC%*.*"0HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** &G@UFW>O:;8S>3<74<<F
M,[2:TCUKQ?Q\!_PD[_[M*4N4[,#A5B:O(W8Z+QWK6GZA'HD5K=)))_:41VJ?
MK7HJ\J*^;  ->T+_ *_HZ^DU'RBE&5]0QN%6&J<B=QPI:!15'&%%%% !1110
M 4444 %%%% "'I7!_$YTBT[39'8*BW:DD]J[P]*\W^,W_(JV_P#U\"DW9%TX
M<\U'N=9%XGT=8D!OHLA1W]JD_P"$IT;_ )_HOSKP? ^7_=%)@>_YUDZI]$LA
MBU?G/>?^$IT;_G^B_.C_ (2G1O\ G^A_[ZKP; ]_SHP/2CVOD/\ L"/\Y[S_
M ,)3HW_/]%_WU3?^$IT;.!?1?G7A&!Z4$#'?MWIJJ)Y#%*_,?1D,R7$2RQ,&
M1AD$5-6+X9XT"T_W!6U6JU1\[./))Q[!11FB@@**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *3/M2U&Z[T9<D9
M!&10!S>J^/\ P_H^I?8+F\'G+CS-O(C_ -X]JZ*"YBN8$FA=7C<95E.017F-
MZFB^'AJ&CV%D=:UG4)&:4&(/Y9(XW'L!79>%M*N-!\)6UC.X:>"(EB#D ]:
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MZYKVY?NBN)^) (M]#_["D7]:[=1\HH22"OB)UY<T]Q12T44S$**** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
?"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>afyaform20f_007.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_007.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "A ML# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8ZTN4<L+.*NSHZ#25FZQ<RV\<9A?:2>:1A"+D[(@US0!K5Q:S?;9[=K?<55
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MA[:"NBT/_CR;_?-<[71:'_QY-_OFE+8Y<9_#-*N2O?\ C^G_ -\UUM<E>_\
M']/_ +YI1,,'\;(*#10:H]$VM!^_-^%;=8F@_?F_"MNHEN>3B/XC.:UG_D(-
M_NBL^M#6?^0@W^Z*SZM;'HT/X:"K>E_\A*'ZFJE6]+_Y"4/U- ZWP,ZH5B:_
MTA^IK;%8FO\ 2'ZFH6YYF'_B(Q:***T/7'P_Z^/_ 'A78CI7'0_Z^/\ WA78
MCI43//QOQ(HZQ_R#G_"N9KIM8_Y!S_A7,TXFN"^!A2'H:6D/0TSK>QUUC_QY
MQ?[HIUU_QZR?[M-L?^/.+_=%.NO^/63_ ':CJ>*_C^9R HH%%:'LH*Z'0O\
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M %#5O^0=+7,5T^K?\@Z6N8JX['HX+X&%(>E+01P:9V,ZG2_^0=#_ +M27_\
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M6F!@8%%% !52YTVSO+B">XMHY98"3$[+DKGTJW10!@7'@[0KF>"5]/A'DN9
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M=K=;=M-MS$KF0(4X#'O4T6CZ?!.\\5G"DKD,S!>21TJ_10!%'#'"@2- J+T
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
8B@ HHHH **** "BBB@ HHHH **** /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>afyaform20f_008.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_008.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 'Z R(# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX8WME?>#XFL;:2V6.5XY(GD+[7!YP3U%=LO2O?N?.[:"T444P"BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM%)FEH&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MI@^AC43T:(:6I# W5"KKZYQ2/#)&NYEP.A(YYJ7%K4I5(C****DT"BDSS2T
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M%)FE%4(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M"#!Q6M*K.E[U['/7IQKWCRZHW9?%-S#>O&8T:-6QQ7.:KXZU./494M718@<
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MI7[1<RSDRN%Z#/I0!QGAG0X-5'B.\TRWEM/#T]GY%LDC']\Z]95!Z=.M=_\
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M)[7,ZC:B[%"\\07&F>%H+VX02:A<1[HXU'KSGZ 5H:)?S:CX?MK^5 99(M[
M#J:Q)]#?7]-L]2M+Z2*7[ (4C R,[<$>V2/TJ328-0T32=-TB4F22X5E9\\P
M\<8KT)TJ+C9;W_ XHU*JFV]K%;2O%=_>ZS;02&WD2XD9# H_>1 =S5VZ\3O_
M ,)79Z5:('MVDV338X+8S@&LJP\-:FEW9PM;1V[6\C/)>HWS2@U+)X-OH-2T
M][7496@BG:1V(&4)[UK*&'Y_D9)U^73N:&L^*9+3Q#8Z79IN5YDCN9<< GHH
M]\5HZ?J4LVLZCIMUM\RW8/$0.J'I7.7W@J_2:T-IJ,LB_;?M$A8#*$_Q>_\
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M5\B1B"!@=A6SCAM3&]>Q=T_Q1J,UY8&Z2$6FI%E@VCYD(Z9K:T+4Y-1@N4N
MHN+:8QOC]#7/:9X?U47FEP7D*1VNF,[+*&_UF>16IX70R7.K7V/DN+GY!Z@=
MZPQ,*7(W VH2J\RYCI**0<"ES7D=#TPI.I '.>!]:/ZU7FURQTJY:.[CFC8*
M#'*J;@36U*DZCLC*I/D5S4339%P99$B4]R<U#<E-RQQG*1C /OZU!%.M];)=
MP2&:&0;@]+FKJW@^6QE33E[\W<"!R">#P?:O/)-$U/>VBBR;R6O1<"Z!^4+G
M-=A)X@TZ*TENFFQ#'(8]P'+-Z =ZGTW5+75;;S[20E0<,I&"I]"*UI5*E!-\
MNA-2,*S6NQ@^)8M1U73)[:*R<Q03H63/_'P@ZX_*H= M+VT@URYM[%[2WF^:
MTM7.65L8)K:N?$FEVNI"PEG(FR%)P=H)Z FB[\2:78ZB+&>X(FR%) RJD],G
MM6RJU>3E4-#-TZ?-S.0>&[!M/T&VMW3;*1ODSU+$\DUK8K*O_$>F:;=);W,Y
M\Q@"=JD[1ZGTJW#J-M<7;VL;YE1!)C'53W%<M6-24N>2W.FG.$5RQ9LS!4TM
M1"=RL?WI[Y]*SQG'-7$_Y!,W^^*J']*BKT(H*W-'S$/Z5B>(/^0PW7[BUMD_
MK5'Q$87AMY&CVW)X)'<"ML*]TSKH2<:\//0Y^BBBN@]T0\BK%E>SV%RD\$C(
MZD$X/457YS2U49.+NC.I2C4@X3U3/:=$\1V>KVJ,DH$@ #*QP<UMA@P&.]>"
M6Y\A/M#2.@)P AP6KO\ PGXRCDC-I?L(VC^ZQ/4>]>K1Q2E:,M&?$8_)Y46Z
ME'5'?[?>EK+_ .$BTK_G]B_[ZJW%?6\ZAHI5<'I@UUJ2>QX\J<XJ\DT6:3;2
M;Q33,JC+?*/<XID$E%)N%-$R,S*&!8=1GD4 *5S2XXQ3?.3=C<,^F:&E5?O$
M#G R<9- #Z*C,R XW#/IFE,BJ,L0![F@!]%,\U""0RD#WH$J,F]6!7U!H ?1
M40N(BNX.I7ID'BI 01D4 +1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%)FC- %74+M+*TDF?H!Q[FO
M-[R[EO+II9"23TSVKH/%]TQGCM@2$QDBN9'2OG<SQ#G/V<=+'T&5X=1A[674
M6B@=**\H]A!1110 4444 %%%% !2'I2T&FG835R..&.&,)$@1!DA5X IVP9!
MP,COCFG44-MBL)^'%'ZTM%(=D'3O4<<,40;RXU3<<M@=3ZU)134FM%U%9!BB
MBBD4%%%% !3><\4ZDH2U$W;4M6JA5EN'Z1C"^[&JOU[G-6[E?(MHK?(Y&]_K
M52M:FGNF%*\FY!BEHHK(Z ICQB1&1P&1N&4C@BGT4;:B:N-5%1 J   8 % 7
M!)XR>O%.HIW>]Q6$P:3FG4E T@ZC!&0>M-CC2% D2*B#D*HIV*6CF:5@L(**
M6BI 0=:5IA%!*\@#Q1H692H.10 2>%)^@KG/%VLM8VRZ?;NJS3C]ZW4JOI79
MA:<W)-&51J2L<K_;]W#>O<V,C6T)?>L"GY /3%>A7LSOH\MS&-KO:F15'J5Y
MKRD_=(Z<=/2O6[49T^S!&0;= 0?IR#7?C+))F?+T1YQ=Q,OASPU*D_DPB<F6
M7J$8]S71>&=5CC6^%U=1/ ER(XKL+M\TGU]36QI^BPV-A+9,5GMFD9DCD4$*
M"<XQ4EQI%I<6T5KY:Q01N'$<2@ D5E4Q=.2Y+&$,+-2YKGGFI2JEEKEE(1_:
M$NHQM&A'S,,]JD\1[[0ZQ9VUS:O]J:)I(9/]:'P.%]?Z5Z-)96LEPMP]M"TR
M<*Y0;A]#1)96LURMS+:PO<+TE9 6'XU2S&*M[NQ+P<GU/-)OM-EJFKM<WPMI
MA;Q2)'(F?/P,;>>U=+'([^)]#FV".::S/FH!C ^E=+/9VMS(DD]M!+(G*%X]
MQ7\:@BTU8]>?59'\R3RQ'&F.$'>D\;"HM5T".$E#5,W)E^S6"PN<R2$.1Z"J
M6 ":NWNVXB%XG&3M=?0^U4N]>?6=V=6&^"_40]*RO$+.+B"%A@)'\I]<UK$9
MQ3-8MOMVCI,D9:>W.W@<E:VPMKLWIU%3K0;.2I:,_7_"DKH>Y[Z?,KA4L-O+
M<$B),XZDG J&M&:WGEM+=K:&1K>0<!5)RW?-7"/,SGQ%7DLKVN5[QE4I"IRL
M0P<>M5@2W45H_P!C7D4)GN;6X2$=0L99F^@JI=0?9YR@W;2 1N&",^OO53C)
M>\]"*-:E)^S3NR+ JU;:A=VC!H+B1"O(PW%5<BDW#UJ(RDMF:3I4IJSM^!['
MX0UU]9TW,Q'GI\K5ROQ<AUM='^V0:BMMIL,D.^&,'?*QD Y/8"H?AS(XUJ50
M<(8\D>]=YXE\/P>)]%?3+F62**1T<M&><JP8?RKV\//GIIL^ S/#QP^)<8[#
MM4OI=/\ "UW>1#,T%HTBY[D+FO'_  +J+B_T?4]035(;C4?,VW)GW17#]=I7
M^$>E>OW'AY+K4X+J2[G\F.W:W:VW?NY >Y'K7.Z3\,K'3-1AF?4KVYM+4N;2
MTE(V0;NN,#GVK8X#A=)AU#1O$EI>^*;/4XS?:BR03K>90$GY0R#MBNX\2W4U
M]\2O#.AAW2W59+Z4*<;R@^53[9IUG\-+:#58+FYUC4+RRMIS<6]E.X9$D/?.
M,G%6?$>CWA\9>'M?L8&G-L[VUR@(_P!5(.6_ XH \]O(=2TWQ3>:UXDLM233
MY]6\N":*[VK&A.$^3N#7IOC#3M/U'0'GU"ZN8+:U0S%H)2A( [UER?#.VFU/
MS9=8U"73#<_:_P"SG<-'YOKDC..^*M0^%KW4M%UG3-7O9O)OKAC%AP3''V4<
M<#VH \]BT75K/X;/J<$^HR)J%RLDT:2,\D=KGHOOCK5CPE+_ &O<>*O#^GZI
M>V6D(D4L,UP2)(E/WL%N0#@\UZ9J7AB"_P##D>C)>7-HL2*(IX)-KH5Z'_ZU
M8+?#*UDT34K.;5[V2\U-E^UWS,OF2*O1!QPN.U '*>'M.&HIXJ71KB]/AT6G
MEP2S2$^9<("2Z$\XR!7HG@#5I=;\$Z;>S9,K1[7)[D<$_I6#;^"[OPEX;U"+
M2]2U#4V-H;>VLYF78A/&1C&,9S^%=/X0T7_A'O"NGZ8QS)#$!(?5N_ZT ;E%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 E5;R_@L8]\T@459)KA?%=P\FI>5GY4&<5S8NO[&GS(WPM#V
MU3EN4];O5OM1>5#E.BUGTBTM?*5:CJ3<WU/K*5-4X*"Z!1114&MPHHHH ***
M* "BBB@ HHHH **** "BBDSS0 M%&:* "BBB@ HHHH *2EI*!/8MW.)XDN0>
M0-CCT/:JM21W4$8^PMGSIQE/;%1Y[=ZVK1>DNYC1NKQ"BDS2UB;(****!A11
M10 4444 %%%% !2'O]*6DZG H0GL<MXQOK^SFLUM[AX860GY#C)]ZXR222:1
MGE<N[=68Y)KI?&\SOJ5O"3^[2+('UKEZ^AHQM31SQ[FEH6G?VIK%O;$XCSOD
M/^R*]/9@S%@,#L/05Y5IFIW.E7@N;5@'Q@[AD$>E>C:1J<6LZ<MU&GENIVRQ
M@YVG_"N;'0E-)Q*O:5V7LT9HQ2<5X_6QM=-!FE&2P &2>@]:LK:;8A+._EH?
MN^IIWVBWM\&"(N^/OOV-:JC;XC!UKZ05P^QQQ1[KJ4JQZ(O6H;=M/N0TD5X'
MC4X(3DY]*HZC;R:E;/#]H>%G/S.G7%<YX'5+?1;M"^(TNW&YC_,UTJ%.5-SC
MT,'[1246]SK;W5=.LX5M3.D7F'/[U@"::,'D$$=17%^*HM.-V\,<(NM6OD"(
MK-Q$/[WM75Z=;M::;:VS2^:\,2HSYZD=Z6(@N2,^K*P\US."Z%D]:LV4\D-P
MH0X#'# C/%5Z=&VQPX.-O))["L*#:J*QT5DG!W.5U'Y=1N1CCS#@56'-2:KK
M^C3WT]PGGDDG**O#'US533]1MM1<P%#!<D?(,Y5AZ?6O5E1D_>/1H8NGR1BR
M;M[]JJZSK-[974=M9WLL2)$ RH<#=6@D2*&>XF2WC1@K-)ZYZ5SWB"(Q:Q,3
MRCX:-^S+ZBM*$&M3+&U:=1I%C3_%&IVU_#+<7]U) K?.F\\BM8W6G37 C&H!
MI9?F5B#M^C'UK AL8(($N=1E95D&8X(_OO[GT%+=6]M-H\=_;QF$B<PLI;(?
MC((_K6\H<RU."G/V4KT]/D;VH:N^BV]O!!';N\J[IPRACCM]*H0^*W1]AT^V
M%N_$BA?F/T/:N=).[DG/J:55+,%4$EN !WI65MBF[MMMZGIO@3Q'I<7B>.WB
MBE7SU*K)*<<^F*[WQ=X[TOPE%$MRS2W<S*([=/O$$XR?05XEI.CW,6K64CSP
M12+,AV-)\PYKU?XI:4MQX0GG@LQ+>&6!=Z)E]HD!Q790TC9'@9HOWJG>]SNV
MNHX[0W,K;(U3>Q/88S7(Z/\ $*+5]16--*O8[&8,8+TKE'"]2?05<UR\-Q8M
MX>2"?[1>Z?)LD"_(IVXP3V->3^#K:]LKG1K/3([\:G )(]1BG!\H*!P.>,'M
MBMCS#T72_B9:ZCK%O:MIUU#:7<K0VMVQ&V1EZ\=JZ'6O$,.D7VF6/EM-=:A/
MY,<:]AU9C[ 5XKX9LYH?%6CO;07AU9;^0WMO,A\F&,DY9>PKT/6T*_&3PS)+
MQ"]G<I&QZ>9@=/?% %Q?B)!/KK6=KIEY<627/V62]B&464=1CK@>M;?B+7I=
M#M(IXM,NM0+MMV6X&1[FO$=.TR^T:^ET^V74%\0)K.Z( 'RF@+9+>F"*]7U?
MQ5]H\):Y-IB2O>V8:W*A>?,Z<#\: *5E\4+*ZT/5-5DTR\MX=/.QQ)C+O_='
MJ:MV?CX3Z1>ZC/HFHVT5O&KJ&4,92>@4"L:_T*RT_P"%%O9W]A=W,;!);I;;
MB0L3EF-9'AC4'TBZ\1:GHUCJ%WX?CAB\FWESN+_Q% ?0?RH ZJR^(T5S9ZN9
M=*N;>_TI%EGLW(W%#R&!^F:['3;Z'4]-M[VW.8ID#K]#7DGAIX3K'BZ]L8KA
M]$N;)I9;B[4AC*5.5!/\(Z5V?PL65/AWI*S[@QC) ;KM)X_2@#LJ*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MKJUBC\UKJ)DZX!Y/X5S%S+Y]S)+W=LC/85UTJ-M9%T:,J[MLCK)+O2B,QWR
MXY!!YI 590Z,K(>C+7'8^GY59MKRXM#F&4J/0C(K2=*G(W>7R@O=E<ZC/KTH
MR*Q8M>NB<3JDB'T&#5N77;:*0I]A<XQSYE9?57T9A*C5B[<I?^@HS68_B"$H
M?+L<-V+29%0#Q#?9Y$#+_<V8'YT?5M-6"H5I?9-K.?I2H S@>IK+&OP;?FL3
MN]I.*K3:Y=OE8A'$A[;<G\Z<<-9W;!8>M)VY;$%W>2+JK7*GYHG!3\*Z>8?O
M2PZ-@Y_"N,8ELD\D\D]ZZ#3-6AN#':W*,LI7:LH/&?0BMJM/VD6D:XJ@Z<8R
M2VW+_O2TC+ABIZ@TM><TUHSFBU:X4449'J*15PHHR/449'J*!70444F1G&:!
MBT44F1G% "T!=S!>F3C-)FL?Q%KL6CP-;QG??2H0 #Q$#W/OS6U"DZDTNA%2
M5E9;G(>)[]-0UR9HQB.+]VI]<<5CT9R3R2>YHKWXKE5B(K0/I5BSO[K3YC):
M3O$3UVG@_457JQI\#7>HVT"#<9)57;CJ,\TW8':QWWA:[U"^TR:;479U,@\E
MF&"?7\*VDY8<=QFA@J_(H 1!M51P!5NP@!?SY#B*/DD]S7B5&JE9V1%^2FVQ
M=58_:E&?E5  .PJE3KB;+RS/R "Q_"N1TYM4UGPXU\FH/;BYN&D9@F6CB!("
MK[\4U1=:3=]"8S5*"5M3K.AJ@FBV2V$MFL3>3,Q=P#U-97@V_NKW3[D7-PTP
MBG9(FDP)=O\ M#UK UO6]0@U^[1=0N(7AE188XE!AVGKO/8UI#"U.=PB[6)G
MB(<JFT=/=>$=(O+DW$L,GF[0NY7(P ,5L6\$=M;QPP@B.-0JY.>/K7!:MX@N
MYM;N8!?75K%9(I!MHMZECR6<_P!VIM5U/4;Z]O$M=3:"+3[%;@-$,":0\G/^
MR:T>$KR45*6GS,HXJE&[BCN^O3FF7$BQV-TS$!1"V3^%<W8ZI=/J6@W=T[K:
MZI;8D0CY0X'453\8ZAJL=U+82A8[%FS$T:XWCW-32PCA-.3-E75561R8Q@'O
M2Y*D$,0PY!'!!H5&=PJ#+,0 O>NOTWP0QQ)JLYC3KY$/+'ZGI7I2G&*U-7)1
M5CG;W5[O4;>&&X92L?/ ^\?4^].M]5:&W6">WCNHXSNB\SJA_P *VM1\$7BS
MDZ8XN(#R%=P&3VYZUS-Q;36L[17$1CD4X(/%.$U+X2;QEN/N+J2[NC/<$,QZ
M@= /05H:ZSF2UCB0+9>6#:A!PV>OU;-9 //'.*TM.UN]TN(QVY@9-VY?-CWF
M-O5,]*M/N$H]B0:5:6RJ-1U 6\Y&[RD3>RCW-/C?1].;[1#<2WDZC]VOE[%4
M^I]:R))&EE>65BSNVYF(ZFE$4I&1#*0?1#1>P*#9N^#K :OXPLHIFS^\\UV/
M)..:][M?$FDWVOSZ%;W*37MO$)947D(,XP3TSG'%>1_">P2Y\2W!FC<&.W(!
MZ;<UTOAS1K+0OC-J%GI\/E1?V.CGDDLQEY))Y)_^M751^"YX&92O6Y5T.S\1
M>+M%\+&!M6G:$S9V;8F;I]!Q6?!\1/"\^D3:M#>9MTE\HMY+!F?T QDU7\7>
M*K/_ (02^U32Y(KIPQMH7VYVRL=O&?2JYM] \&>#]+M=198=Q&V[> .$F8<R
M-V'XUJ>>=/H.NZ5XCLVOM,E61,[')4JRD=B#SFL^]FT'7M0;SKC$NA7"3-.#
MM$3XZ%OIU'O7,_"F55B\1P0,+L1W98:@O NB1U '''M3? >BV?B+P?J$6K0F
M=I-6FDF3<4+LK<!L=10!V%CXLT+4/#[^(8KI!IZ;E,[KC[I(.._456\):WX>
MUA;M-&8[P_F3I(A5R6_B(/:O)?(E;X!D6J[4AU5F<*N0JB5NWH*Z[P3KZ6>O
MZK%+K$&I:7#;12MJ.Q5V,>J$KP<>G:@#K]=\<>'_  _>K8ZC=[92NYP$+!%/
M=L#@?6F:QXX\.^'OLT=S<\3Q^<B0QE_W?]_Y1P*Y+XCZKX>OM.U.PCU.*PU
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M&LJU>55WEL:QARZL,X/'!K+UO2[2[$6HW"EWM_E*=G';/TK4Z<TC*LD;Q/\
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M?;#=>0GV@KL\W:-VWTSZ4 3KTI:0<"EH **** "BBB@ HHHH **** "BBB@
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M^']4,T:65Z\MA=0OA@I8E2/IG%6V\ G3=%FM=)N[@WMS=)-<7<LGSO@\Y/\
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M.EP>6H&5R:T1UKW,+15.DHGSN)K.=63'4445UG,%%%% !1110 4444 %%%%
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MP,9!H,XENY+99+@O$6/!7-><:AK)M];B2T1K>WLW\L(')W*#SFNWU3QGI%C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M. !0>OMVH,C>\)SZO'JY@T2-&O;A#&KL/]6#U8'M6EX\O$NKG3].29[^ZT^
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MWA.T:"R:5^LAR!7%ET'*O=D9E-1H674Z/ ]****^E/FPHHHH **** "BBB@
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M_P#_ %JPK3PGJ=Y/<11_9T$#;'D:0!"WH#W--M?"NK76H75DL2)-:C,OF.
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M;5F;QE*I1C*6YS5%)T')XI:DG<*.W]:<D;RN$C5G9C@*H))->J> ?A;-=O\
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MA_S]R?G5.D[USJO4[LZ/JU'^5':>&+JXNK9S/*TA#8R:VB6&<'OZFL#PD?\
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M<WJ?S-&X^I_,TE% "[F_O'\S1N;^\?S-)10!8B&4R34@J.+_ %8J2@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C%%% "
M8JM=NR64SJ<%48@U:J-D#J5/0\'-#V!-)ZGRE?2O/J%S+*Q9VD8LQ[G-1K#*
MT3RK$[1I]YU'"^F:]P?X2Z3)>W=R\LK^=DHA/$9/I7%^(]'N/!WAZPL0JR7$
MMX9'.,^8%^Z"*Y)4FM6?0PQT))0B<1-8WEM#'-/:S1(_".Z$ _0T36E[#;)<
M3P7*0R#Y9'#;6]*[C6[O4;7PQ/#K$IGU+4G22"UVY2W4=#[?2I!?7VJ>$=>@
MNVE;4(@KRPS)M2*/H-GH:'#HA_66TG)+<X""&>XG6.W2668_=6/);\,4[[-=
MK=_9S;SBZS_J]K;R?YUV7@06]OI.O7LS312PPC#Q#]X%_P!FM^Q@C34KO4;B
M[GE+::)()"H\Y%[_ (^]$:8ZF+4*DE9:'E=Q!/;3/%=1/%+P660$'\<U?M('
MBDNK.\L[HI+%NDCC&' ZAJZ/6KS[%>:1K!!U&*Y@/V=;P?.A!ZMZU=U>[>/X
MKVDN,^='"CCH&#+@\?C2Y;,(XCFC%):6;.(&E:=>JR:;+=BZ RL<^")/H>QK
M/FT?4H)H89;*99)SMC7&=Q].*ZBQT%+[QQ+I,=W]E43LJR#J!GH*]J\-^"=/
MT"#:I:X?S/,5YOF*GVIQI\QA7Q$:25MVCGOAO\/&\/*VHZB8Y+R5 %0#/E#Z
M^M>DA>O- 7%.%=*BEH>-4FZDKL3'O1BEHJB Q1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5%-DC '-2U%-TS0&O0Y_4O#AO[MIQ,4R.F*J#P@V/^/D_E6!XJ\3ZKI^MR
M6UM,$B49 (S6*/&FN8_X^5_[YKRZJP_.^9'T.&P./G2C*FU8[G_A$&_Y^/TI
M#X0./^/G'X5P_P#PFFN?\_*_]\TA\9ZX<9N5_P"^:SY<)V-GE^9+JCU'2-+.
MFQ&/?ORV<U?V-G-<QX'U:\U73Y)+R0.ZOM! Q739.XCFO3HJ*II1V/GL3"<*
MLHU-Q?+([4OEMCI63KWB+3_#ED+K4)BJLP5%499B?059OM0BL-.EO9A(8XT#
ME4!+'/0 =S6IB7/+;TH\ML=*YQ?&5@+6[DN(;FWFMF56MY%^<EONXQP<UHZ5
MJZZHDA^RW%M)&VUHYUP?J.Q_"@#2\MNP-'EMZ4TL<'D_G65_PD>G_P#"2QZ
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MEJ*8$KQS[4":N>.^.3_Q4TW^Z*YX=*]'\1^"KO5]6>\BG158 89<UE_\*WU
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M=">I'I3?"7AQO#UE=B>83WEY<R7,\H'WF8\#\!@5T-% !1110 4444 %%%%
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MG*Y-/H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,CUHW#UH 6BDW#UHW#UH 6BDR*,CUH 6BC.:* "BBB@ HHHH **** "BBB@
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M&G]G7%O>3V<]N;]$C:4R?>,8(($9]3[5F7S-;7]SK,5Q9W,BF%?L4\690,#
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M)_"GB"\UE]332+:_%]IJVAMGD %E)W9?;Z<T =O'K\Z^!5UZYM2L_P!C%PT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L_6='M]<TJ?3KIY%AG
M7:QC(# >V0:T**!IV=T8^@^&=-\.6"6=A&0JCEWQO;ZD 5L8HHI)6!R<G=A1
M113$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
I10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>afyaform20f_009.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_009.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )  X\# 2(  A$! Q$!_\0
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MEZHL5]]HE,TH*84,?[H'2MI/!^@1Z.^E+I=N+)VWM%MSEO7/K7+?\+M\%?\
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MI[AO6NH3P)HT>FP6"I+Y$%T;I!GG>3DYJ%OAYH4FIK>R"XDVS"986?*!QWH
MZHC!HHY)YHH **** "BBB@ HHHH **** "BBB@ HHH[9H 4=1]:TD^X*S1U'
MUK23[@H =5*\_P!</]VKM4KP'SA_N\4 5998H$WS2QQ)_>=@!2JRNH=&5E/1
ME.0:^?OCWJ&JQ>([6U$DT>G^2&CVD@,>YJI\.]>^(RZ-+'H%DU_:*_WY1G!]
M 30!]&T5Y&=?^,)_YE^'_OD?XTG]O?&'_H7XO^^1_C0!Z[023UR2.E>1?V]\
M8?\ H7XO^^1_C2_V]\8?^@!%_P!\C_&@#UJ:-;B)XIE$D;C#J_(85EZ=X7T3
M2+EKFPTZ*&=AC>!DJ/;/2O./[>^,/_0OQ?\ ?(_QH_M[XP_]"_%_WR/\: /7
MLGGGK^M RN2.#[<9KR'^WOC#_P!"_%_WR/\ &E_M[XP_]"_%_P!\C_&@#U[<
MW<D_C2?-P0<$=/:O(O[>^,/_ $+\7_?(_P :/[>^,/\ T+\7_?(_QH ]3ATR
MTMM1N+^"!4NK@ 2R#JX'K5H],=LYQFO(O[>^,/\ T+\7_?(_QH_M[XP_]"_%
M_P!\C_&@#UJYB2[@D@G&^.0%64GL:ATZPM=*LHK.PMTM[>/.V-!@"O*O[>^,
M/_0OQ?\ ?(_QI?[>^,/_ $+\7_?(_P : /7LM_>8?0T$L3D\GW->0_V]\8?^
MA?B_[Y'^-']O?&'_ *%^+_OD?XT >NDMZ]L U'/"ES;2V\PW12C:Z9X([UY-
M_;WQA_Z%^+_OD?XT?V]\8?\ H7XO^^1_C0!ZI8:=::79I:6,"06Z=$08%6<5
MY%_;WQA_Z%^+_OD?XT?V]\8?^A?B_P"^1_C0!ZY17D7]O?&'_H7XO^^1_C2_
MV]\8?^@!%_WR/\: /699H8 #--'$#P"[ 9I^<C((((R"#G(KY.^(6M^+;G6E
MC\1K+:3HORPKE5 ]1BO;/@M>ZI?>"=^IF1T20BW=^I7_  H ]%-<?X_^%UGX
M[2"Y%P;6\B&T2 9##T-=@>E:,'^I6@#SWPE\'/#OA[3&AO;6+4KF0Y>69 ?P
M'H*Z ?#WPG_T +'_ +]"NFHH YG_ (5[X2_Z %C_ -^A1_PKWPE_T +'_OT*
MZ:B@#F?^%>^$O^@!8_\ ?H4?\*]\)?\ 0 L?^_0KIJ* .9_X5[X2_P"@!8_]
M^A1_PKWPE_T +'_OT*Z:B@#F?^%>^$O^@!8_]^A1_P *]\)?] "Q_P"_0KIJ
M* .9_P"%>^$O^@!8_P#?H4?\*]\)?] "Q_[]"NFHH YG_A7OA/\ Z -C_P!^
MA1_PKWPG_P! &Q_[]"NFHH YG_A7OA/_ * %C_WZ%'_"O?"7_0 L?^_0KIJ*
M .9_X5[X2_Z %C_WZ%'_  KWPE_T +'_ +]"NFHH YG_ (5[X3_Z -C_ -^A
M1_PKWPG_ - &Q_[]"NFHH YG_A7OA+_H 6/_ 'Z%'_"O?"7_ $ +'_OT*Z:B
M@#F?^%>^$O\ H 6/_?H4?\*]\)?] "Q_[]"NFHH \K\9_!+1?$(BDTQ8],GC
MX/E(-KCW%=%\/_A_9^!-,DMX)6GGF.Z65N,^V*[*B@ '%077^I-3U!=?ZDT
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M.L+_ (4WX)_Y\)O^_E'_  IOP3_SX3?]_* -W_A._"G_ $'K7\Z/^$[\*?\
M0>M?SK"_X4WX)_Y\)O\ OY1_PIOP3_SX3?\ ?R@#=_X3OPI_T'K7\Z/^$[\*
M?]!ZU_.L+_A3?@G_ )\)O^_E'_"F_!/_ #X3?]_* -W_ (3KPI_T';3\Z/\
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M?@*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ I*6B@!1U'UK23[@K-'4?6M)/N"@!U4KS_7#_ ':N
MU2O/]</]V@"O1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 'I6C!_J5K./2M&#_4K0!)1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=?ZDU/4
M%U_J30!1HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MN4NXPOE7*8W(1T- $LOQ"T2*V@GQ<2>:I;8J?,F.N[Z4[Q1XL?2-"T_4=/\
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M>X1GJC1XX_&O1AXCT8P/,-1B\M3M8@'KU'%,?Q-IOV2::UNUN1"N]D3@@>M
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MYH[YHHH ,4444 %%%% !1110 4444 %%%% !1110 4?I110 4=A110 4444
M%%%%  >E:,'^I6LX]*T8/]2M $E(:6B@!BQJ&+  $]3ZT[%+10 F!1M%+10
MF*18U3.T 9Y/O3J* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M-5/J%Q5.9(%U:W.W$NTX('7ZT 7J*.:* "BBB@ HHHH **** "BBB@ HHHH
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M2?<% #JI7G^N'^[5VJ5Y_KA_NT 5Z*** "BBB@ HHHH **** "BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H+K_4FIZ@NO\
M4F@"C6?JFD6^JK$)6>.2([HY$'*UH44 <Z?!>E,=H,P@;!FB#?+*W]X^]7M,
MT&VTJ=YX9999&78ID/W%]!6I0: .6^(%M!-X5DFDA1Y(IH_+=EY7YA730_\
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MWS7DE>M_#C_D6Q_OFM:/Q,\///\ =UZG9#I10.E%=)\D%%%% !1110 4444
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M55/XCS\U_P!U9Z%11176?#(****!A1110 4444 %%%% !1110 4444 %%%%
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M HHHH **** "BBB@!1U'UK23[@K-'4?6M)/N"@!U4KS_ %P_W:NU2O/]</\
M=H KT=.:*JZC?1Z;82W<O1 <#U-%[%0BY22CN<KXZUTV\"Z9 ^)7&92O8>E>
M=\^M37=U+?74MU*27D8G\*AKDG+F9]UE^%6&HJ/5A1114':%%%% !11FGQ12
M3RK%"C22,<!5&31:XG)1W8SO5O3W"W!4D<BNHTKX=W]V%DO9!;H>=G4UU^G^
M M'L<,8S*X_B8UM"FT[GA9AF6&E3=.]V><N1Y3<]JPMP]:]\&AZ:$V_8XORJ
MK-X4T:88-E&/H,5I.',>3EN8K"7YE>YX=VSVHKU;4/AOIMP";5W@?V.17%ZS
MX,U32-T@0W$ _C3DCZBL'2:/H,-FN'JNVS.=HH_#OBBH/3N@HHHH&%%%% ;Z
M"@D$$$@KR".H->J>$-=_M;3Q%,P-S -K9[UY56AHNI2:5JD5RC?*6"N/45I"
M=G8\W,\&L31=EJCVBBF0RK/!'*G*N,BGUU'Q,DT[/H!Z5H0?ZI:SSTK0@_U2
MT")#7FGQ0_U]E^->EFO-/BA_K[+\:BI\)Z.5?[U'YGGQHH-%<B/N$%>M_#C_
M )%L?[YKR2O6_AQ_R+8_WS6M'XF>'GG^[KU.R'2B@=**Z3Y(**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *@NO]2:GJ"Z_U)H HT44$@#)
M( ]2<"@ HH]!D9/09Z_2@$=B#CK@YQ0!S?CW_D3[C_KM%_Z$*Z&#_CU@_P"N
M:_RKGO'O_(GW/M-'_P"A"NA@_P"/6#_KFO\ *@!]%%% !1110 448HH ****
M "@'!'UHH7J/K0!5L;=[<3^9CYW)&*M#I5+3)'<7.]B<2$#/I5V@ HHHH **
M** "BBB@ HHHH **** "LSQ'_P B]>_[E:=9GB/_ )%Z]_W*3V-:'\6/J>,C
M[HI:0?=%+7$?H:V#O7;?#G_C\N_]RN)[UVWPY_X_+O\ W*NG\1Y^:_[I(]"H
MHHKL9\,M_D%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% "C
MJ/K6DGW!6:.H^M:2?<% #JI7G^N'^[5VJ5Y_KA_NT!<K]<?6N"^(.I@K#IR'
MC[TF#7>%E0%FX !)KQC7+PW^M7,Y.5W$+]*SJRLCV,FPZJUW)[(S_?WZ4445
MR'V(4444P"BBK%E9S:A>16MNI,LIQTZ4$SFH1YF6-'T6[UN[$%LG0_/(>BBO
M7= \+V.A6X$<:O.1\TC#)-3Z!H,&AZ>EO$H+$?._<FM?;TXKKA!+4^+S#,9X
MB3C%VB(%'H*?BDHJSS!:*** $(YIKH'&&4$>XI])0&IQ/BCP-!J"/=6 $5R!
MDA> U>6SP2VL\D$R%)$.&!%?0Q!]*XSQOX674K1K^V0+=1#)Q_$*RG3OJCW,
MKS25*7LZCNG^!Y111R,@C!_K17-:Q]8K6N@HHHH&%!&1110%KZ'IG@35#>:6
MUI(V9+<_+GTKK*\E\'WYL/$,//R3?(:]:Z5U4Y71\1FN'5'$-K9@>E:$'^J6
ML\]*T(/]4M:'FDAKS3XH?Z^R_&O2S7FGQ0_U]E^-14^$]'*O]ZC\SSXT4&BN
M1'W""O6_AQ_R+8_WS7DE>M_#C_D6Q_OFM:/Q,\///]W7J=D.E% Z45TGR044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=?ZDU/4%U_J3
M0!1KF_&#PBTMHY$ED=W(15)"@^K8]*Z2D(!&"H/U&: /,[RWU"UCGCBFN;C4
ME5!8RC.TKCY@*W_"8D74G6-9EB$ \XRY_P!;WKK0 O("@CIQT^GI1@#@ #Z#
MK0!R'Q%.HCPZOV40FT,T?V@R?>^\.E=;!_Q[0_\ 7-?Y5S_CW_D4+G_KM%_Z
M$*Z"#_CUA_ZYK_*@!]5-3U&'2[47$X8QE@GR^]6_?TK-U[2VU?3#:I((SOW
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MT ZUUUE="]L8;H(465 RJ3D@&@">BBB@ HHHH *S/$?_ "+U[_N5IUF>(_\
MD7KW_<I/8UH?Q8^IXR/NBEI!]T4M<1^AK8.]=M\.?^/R[_W*XGO7;?#G_C\N
M_P#<JZ?Q'GYK_NDCT*BBBNQGPRW^04444AA1110 4444 %%%% !1110 4444
M %%%% !1110 4444 *.H^M:2?<%9HZCZUI)]P4 .JE>?ZT?[M7:I7G^M7Z4
M8^O77V/0KN;T3 KQ?.22>23FO4?'D_E>'-@.#)(!7EV,5SUGJ?69#2Y:,I]V
M%%%%8GNA1110 9Q7H_PYT4)%)JLR?.WRQ^PKSJ.,S2QH <NP6O>='M%L=(MH
M N-B#/UK6C'74\'/<0X4U2CU-$4M(*6ND^4"BBB@ HHR/6C(]: "BDR/44M
M!3'4,A4]#Q3C2$<4!<\8\:Z/_96MLT8Q#<?,!Z&N;KUCXB:=]IT(W(7YX3NS
MCM7D^0>1Z"N6HK2/M<IQ#K8=7Z:!11169Z@4444 A\4I@GBE7AD<,*]NLYQ<
MV4$P.0Z UX:>A^G%>O>%+CS_  W:DG)5=M;46?/9]33A&1M]JT(/]4M9YZ5H
M0?ZI:Z3Y>^A(:\T^*'^OLOQKTLUYI\4/]?9?C6=3X3T<J_WJ/S//C10:*Y$?
M<(*];^''_(MC_?->25ZW\./^1;'^^:UH_$SP\\_W=>IV0Z44#I172?)!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4%U_J34]077^I- %
M&BBB@ HHHH YOQY_R*%Q_P!=8_\ T*MUIX+73XYKF5(HDB4L[G '%87CW_D4
M+@CG]]%_Z$*YGXQV6J7GP^MUTQ9'6,JTZ1]2N* .ZTO7=*UO>=-OH;HIPPC/
M(_"M':3_  G\J^3_ (>:)XNO=:)\.F2UE53YDTF53Z=*]3/A?XN<_P#$_M/^
M^_\ ZU 'J]Z'2PN652&6)B"!WQ7GMO<ZYHUG9:JOF>7,#'('8MDD\-CMBLD^
M%OBVP(.O69!Z@R=?TJ-O!_Q4DA\E]8L&B_YYLW _2@#I9/$FLW=K*&MQ&D48
M9RJX+\]OK2KXSU-%5VMD=9!M6/;S%T&6_/\ 2N9'@WXIC 75]/"@8'S=O3I2
M#P7\4 7/]J:=F08<Y^\/RH [WPE<WMU)JINYQ<,DP",H^4#VKIMC#L?RKQV'
MP=\5+9-EOK%A$N>0C8_I4G_",?%S_H/VG_??_P!:@#U>[N;>QMVGNYD@A7[S
MR< 5!IFL:9K$9ETV^BN40X;RVSCZUX)X_P##?Q&AT)9=9OA>V:OS';,6(]R
M,TGP'T[5QXMDN%CFBT]8B)RP(5CV'/>@#W6*Y@TF"XFOIDMXVD)4L<9%7K6Z
MM[Z 36DRS1'HR'->0?$U-3NM029TEDL8R4&P9 /OBH/!>C^,+BQFDT>Y^Q6Q
M;D39&X^U 'LMW80WJ(EQ&65'#J/0BJ6J^&]/UJX2XO87:5% !#8'7-<=_8'Q
M%'']M6OYT?V!\1?^@U;?G0!T-IX+LX[>=;D,TDLWG!XSM*D=*ED\%:-*REH)
M<CJV_E^_S5S/]@?$7_H-6WYT?V!\1?\ H-6WYT =4/!^CFYCF>V=_+;<D;L2
MBD\=*U;.RBL;98($98U.0I.=OM]*X#^P/B+_ -!JV_.D.@?$7_H-6OYT =Y>
MZE9Z;&KWMS' &/&\XS4T%Q#=0K-!*LL;=&4Y!KP?QKI?B2VO8CKCO=@C"2Q@
ME1[5WOPGMK^WT"X-TLB0.^84D!SCZ&@#OZ*** "LSQ'_ ,B]>_[E:=9GB/\
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MKWKQ"P30;PGIY1KP5#E!Z5SUNA]/D#?)-"T445CU/HNH4444 %>H> FW>'0
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ML?\ KXC_ /0A0!](?&__ ))S#_UT3^5>&?#H_P#%P=%]K@5[G\;_ /DG$/\
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M*^S?!/\ R(VC?]>XKXR'45]F^"?^1&T;_KW% &[1110 4444 %%%% !1110
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M=6\3?:;"PDFA\L#</6M#X8:!JNC7NH/J%H\"NH"%N]>DAB.A/YTA)/4DXZ4
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MFO\ *@!]%%% $=Q&TUI/$OWGC91]2*^<+OX&>+9KN:54M]KN6'S]LU])TF*
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MH8/^/6#_ *YK_*N?\>\^$+C'_/:/_P!"%=!!_P >L'_7-?Y4 /HHHH ****
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M_6@#RSX]_P#(C6__ %\BOFDGFOI;X]_\B-;_ /7R*^:.] !2CK24#K0!]._
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MP*%B147T48K2-)]3R\1GL+6I(X?2/A^%*RZI+D]?*3I^-=K;6L%G"(;>-8T
MZ**FHK512/#Q&+JUW[[N@HHHJCE"BBB@ HHHH #TK0@_U2UGGI6A!_JEH D-
M>:?%#_7V7XUZ6:\T^*'^OLOQJ*GPGHY5_O4?F>?&B@T5R(^X05ZW\./^1;'^
M^:\DKUOX<?\ (MC_ 'S6M'XF>'GG^[KU.Q'2OE+X\_\ )1)/^N*U]6CI7RE\
M>?\ DHDG_7%:Z3Y(\NHHHH 4=17VM\._^1!T;_KW6OBD=17VM\._^1!T;_KW
M6@#IV^Z?I7Q1\0_^1^UG_KX:OM=ONGZ5\4?$/_D?M9_Z^&H YBBBB@"WI?\
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MZ]Q0!MR_ZF;_ *YM_*OBG7_^0_?_ /7=OYU]K2_ZF;_KFW\J^*=?_P"0_?\
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MN'^[5VJ5Y_KA_NT 5Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH 4=1]:TD^X*S1U'UK23[@H =5*\_P!</]VKM4KS_7#_ ': *]%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >
ME:,'^I6LX]*T8/\ 4K0 \UA7GA33;Z_%[,KF3.>#P?PK>HH Y/\ X0#20[LI
ME4EM\?S_ '#G)(J9O!EB4C(FG%Q&VY9MWS9KIL44 8D7AG3X]XPYWIL8LW44
MS2/"EAHU[)<VWF%F!"AFSM'>M[%&* ,>ZT))]1>\2>2-Y%"N!C! K/UGPN+B
MTC.GOY5U%D(Y]^M=128% '/:7X6M[*UB$S-)<"/:[YX)JJW@#1V>7*R;7'"[
MONM_>KK,4F* ,"S\):?:6KPJ';S!AW)Y-5M8\*K/91#3V\NYAR(V8] >#74X
MHQ0!FZ+ISZ9I4%H\AD=%^9CW-4[OPKIU[) \R-OAE:564X.2,$?2MX#%)B@#
M M/"UI;7+3-+-*Y^Z';(7V%0VG@VPMY'D=Y)'9]V,X YSTZ5TN!2XH X_5_"
M,MSJ$<EE/Y,3L#,"<DUUT:[4 ZX Y]:=BC% !45S MS;20/G:Z[3BI:* .7N
M/!L%W;)!<7<[HG" G@"DB\!:+%J,5\L3F>-@RDMQP,=*ZC%+B@! ,=*6C%%
M!1110 5!=?ZDU/4%U_J30!1HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[N?O$UK4 %%%% !WS1110 4?@*** #%'2BB@ H'%%% !1R.YHHH *,#THHH
M*/3VHHH **** "BBB@ QSGO0.*** "BBB@ HHHH 4=1]:TD^X*S1U'UK23[@
MH =5*\_UP_W:NU2O/]</]V@"O1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 'I6C!_J5K./2M&#_4K0!)1110
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M/2B@R=[V8HZCZUI)]P5FCJ/K6DGW!0(=5*\_UP_W:NU2O/\ 7#_=H KT444
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7*U:* ,JBM6B@#+'4?6M)/N"G44 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>afyaform20f_010.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_010.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "B XX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MH)Q0 45CW?B.PM=7ATP^;+<R$ B*/<$STW'L*NZA?P:7I\]]=%A#"A=]JDG
M]J +=%1P3)<V\4\>=DB!USZ$9%24 %%%% !1110 4444 %&:*Q-3\26VG:G;
MZ8D4ES?3C<L,94$+_>Y(_2@#;S15>ZN3;6S3+$\C#@1KU)]*R]!\1V^MO<P"
M":VN[23RYX)1RK>Q[T ;E%%% !1110 4444 %%%% !15:^U"UTVT>ZO)EA@0
M99VZ"GV]S#=6R7$#[X7 96'<>M $U%4;#5[#4C(+.Y64QG# 9!_7J/?I5Z@
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M1169] %%%%( HHH- 'KGPV_Y%G_MH:[0=:XOX;?\BS_VT-=H.M=:V1\!C?\
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M^7_.C[?>?\_+_G5>B@#4TN\NI-2@1YW92W()KL17#Z1_R%+?_>KN10 4444
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MDC0 4444 %%%% !0>A^E%!Z'Z4 =OHO_ "";?_=_K5^J&B_\@FW_ -W^M7Z
M"J6K?\@NX_W*NU2U;_D%W'^Y0!PP^Z**!]T44 %%%% !1110 5UOAK_D%_\
M;0UR5=;X:_Y!?_;0T ;/:BCM10!%/_Q[R?[IKS\_>?\ WC7H$_\ Q[R?[IKS
M\_>?_>- "4444 %%%% !1110!TGA7_5W7^\O\JZ*N=\*_P"KNO\ >7^5=%0
M4&B@T <'J7_(4N?]^JM6M2_Y"ES_ +]5: "BBB@ HHHH *V_#/\ Q_O_ -<Z
MQ*V_#/\ Q_O_ -<Z .KHHHH 0]*Y#Q'_ ,A3_@-=>>E<AXC_ .0I_P !H R3
MUHH/6B@ HHHH **** +ND?\ (4MO]ZNY%<-I'_(4MO\ >KN10 4444 %)VI:
M3M0!E>)/^0!>_P#7(UX&OW17OGB3_D7[W_KD:\#7[H^E853ZC(/@G\A:***S
M/H+!1110.P4&BD]:!'KOPV_Y%G_MH:[0=:XOX;?\BS_VT-=H.M=4=D? 8W_>
M)^K%IDO^J;Z4^HYO]4WTIG.MSYZO_P#D)77_ %V?^=5ZL7__ "$KK_KL_P#.
MJ]<CW9^A4/X<?1!1110;6"BBB@+!7H7PL_X^-1_X#7GM>A?"S_CXU'_@-73^
M(\S-_P#=)?(].%+2#I2UT'Q(AKPSQE_R-=]]5_\ 0:]R/6O#?&7_ "-=]]5_
M]!K.IL>WD/\ O#]#"HHHK ^NL%%%% 6"C_"BCM2$T=;\.O\ D:#_ -<Z]D'2
MO&_AU_R-)_ZYU[&.E=-/8^.SK_>GZ(6BBBK/(.4\3_\ '_#_ -<_ZUB5M^)_
M^/\ A_ZY_P!:Q* "BBB@ HHHH *M:;_R$[;_ 'ZJU:TW_D)VW^_0!WE%%% !
M7,^*?OVOT:NFKF?%/W[7Z-0!SYZT4'K10 4444 %%%%  /O+_O"O0;?_ (]X
M_P#='\J\^'WE_P!X5Z#;_P#'O'_NC^5 $M%%% &-XF_Y!@_ZZ"N2-=;XF_Y!
M@_ZZ"N2- !1110 4444 %!Z'Z44'H: .WT7_ )!-O_N_UJ_6?HO_ "";?_=_
MK6A0 52U;_D%W'^Y5VJ6K?\ (+N/]R@#AA]T44@/RBEH **** "BBB@ KK?#
M7_(+_P"VAKDA76^&O^07_P!M#0!L]J*!THH BG_X]Y/]TUY^?O/_ +QKT"X_
MX]Y/]TUY^?O-_O&@!**** "BBB@ HHHH Z3PK_J[K_>7^5=%7.^%?]7=?[R_
MRKHJ "@T4&@#@]2_Y"ES_OU5JUJ7_(4N?]^JM !1110 4444 %;?AG_C_?\
MZYUB5M^&?^/]_P#KG0!U=%%% "'I7(>(_P#D*?\  :Z\]*Y#Q'_R%/\ @- &
M2>M%'>B@ HHHH **** +ND?\A2V_WJ[D5PVD?\A2V_WJ[D4 %%%% !5+^U]-
MQ_Q_VW_?U?\ &KM<O_PKOPI_T!XO^^W_ ,: )_$6J:>^@W@6^MB3$>/-%>$K
M<P;1^_BZ?WQ7MQ^'?A3'_('B/U=S_6D_X5UX1_Z 5K_X]_C43AS'J8#,?JB:
MM>YXG]J@_P">\?\ WV*/M,'_ #WC_P"^Q7MG_"NO"'?0K7\C_C1_PKKPA_T
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M[_&D/PZ\)<8T&U_\>_QH]D#S]?R'G_P]O;6/Q,6>ZA4>7U,@KUX:OIN/^/\
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M_O\ +1]OLO\ G\M_^_RUTO\ PKKPC_T!;?\ -O\ &C_A77A'_H"V_P";?XT
M<U]OLO\ G\M_^_RT?;[+_G\M_P#O\M=-_P *Y\)?] 2W_-O\:/\ A7/A+_H"
M6_YM_C0!S0O[3*_Z7;]1_P M17>P:OIPAC!O[;.T?\M1Z5C_ /"N/"6/^0);
M_FW^-+_PKOPI_P! >+_OM_\ &@#;_M?3?^?^V_[^K_C1_:^F_P#/_;?]_5_Q
MK%_X5WX4_P"@/%_WV_\ C2?\*[\*?] >+_OM_P#&@"3Q'JNGOIH"WUL3O'25
M:Y7[?9_\_<!_[:BNF_X5WX4[Z-"1[N_^-)_PKGPE_P! 2W_-O\: .9^WV?\
MS^6__?U:/M]G_P _EO\ ]_5KIO\ A77A'_H"V_YM_C2?\*Z\(_\ 0$@_[Z;_
M !H YK[?9?\ /Y;_ /?Y:/M]E_S^6_\ W^6NE_X5UX1_Z MO^;?XTO\ PKGP
ME_T!;?\ -O\ &@#F?M]G_P _=O\ ]_10+^S[7EO_ -_5KIO^%<^$O^@);_FW
M^-'_  KGPE_T!+?\V_QH O:-JVG+I4 :_M@0O3S5]?K5[^U]-_Y_[;_OZO\
MC6(/AWX3 P-&B ] [_XTO_"N_"G_ $!XO^^W_P : -K^U]-_Y_[;_OZO^-4]
M4U;3FTV<+?VV2O3S5_QJC_PKOPI_T!XO^^W_ ,:0_#OPH?\ F#Q'ZN_^- ',
M"^M,#_3+?_OZ*/MUG_S]P?\ ?T5TW_"N?"7_ $!+?\V_QI/^%=>$?^@);_FW
M^- '-?;[+_G\M_\ O\M'V^S_ .?RW_[^K72_\*Z\)?\ 0%M_S;_&E_X5UX2_
MZ MO^;?XT <S]OLQ_P O=O\ ]_11]OLO^?RW_P"_RUTO_"NO"/\ T!;?\V_Q
MI?\ A7/A(_\ ,%M_S;_&@#FA?V?_ #^6_P#W]%=5X<U33X],PU]; [SUE%1?
M\*Y\)?\ 0$M_S;_&E'P[\*#IHT(^CL/ZT ;8U?3<?\?]M_W]7_&C^U]-_P"?
M^V_[^K_C6)_PKOPI_P! >+_OM_\ &E_X5WX4_P"@/%_WV_\ C0!K3ZMIQ@<"
M_ML[3_RU7T^M<$;^SRW^F6_4_P#+4>M=-_PKOPK_ - >+_OM_P#&F_\ "N?"
M73^Q+?\ -O\ &@#FOM]E_P _EO\ ]_EH^WV7_/Y;_P#?Y:Z;_A7/A+_H"6_Y
MM_C2?\*Z\(_] 6W_ #;_ !H YK[?9?\ /Y;_ /?Y:/M]E_S^6_\ W^6NE_X5
MUX1_Z MO^;?XTO\ PKKPC_T!;?\ -O\ &@#F?M]E_P _EO\ ]_EH^WVG:\M_
M^_HKIO\ A7/A(_\ ,$M_S;_&C_A7/A+_ * EO^;?XT 1^&=3L(X[G?>VRY8'
M_6CTKH/[7TW_ )_[;_OZO^-88^'7A,=-%@'KAF_QIW_"N_"G_0'B_P"^W_QH
M VO[7TW_ )_[;_OZO^-!U?3?^?\ MO\ OZO^-8O_  KOPI_T!XO^^W_QI#\.
M_"G_ $!XO^^W_P : ,+4M1L6U*X(O+;!?KYHJK]OLO\ G\M_^_RUTW_"N?"1
M)/\ 8D'U+-_C1_PKGPE_T!+?\V_QH YG[?9?\_EO_P!_EH^WV?\ S]V__?T5
MTO\ PKKPC_T!;?\ -O\ &E_X5UX1_P"@+;_FW^- ',_;[+_G\M_^_JT?;[+_
M )_+?_O\M=+_ ,*Z\(_] 6W_ #;_ !H_X5UX1_Z MO\ FW^- '-?;[+_ )_+
M?_O\M;7AS4K%+YRU[;@;.\JU<_X5SX2_Z EO^;?XT#X=>$P>-%A'T9_\: -S
M^U]-_P"?^V_[^K_C1_:^F_\ /_;?]_5_QK%_X5WX4_Z \7_?;_XT?\*[\*?]
M >+_ +[?_&@#:.KZ;C_C_MO^_J_XUR?B'4;)]3RE[;D;?^>HK1_X5WX4_P"@
M/%_WV_\ C2'X=>$SR=%@)]V8_P!: .9-_9Y/^F6__?U:/M]E_P _EO\ ]_EK
MIO\ A7/A+_H"6_YM_C2?\*Z\(_\ 0%M_S;_&@#FOM]G_ ,_EO_W]6C[?9?\
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M6+KNFW-E:^#[(12S-;W2"1D7(7IR?2J_BCPT;B^O;+0IKJ*YU=@+P*<1*O\
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M]Q@U;T#7/[9@N/-M7M+NVE,,\#G)0]1S[@YKG]*UZVMM*U'5%TZ]:Z=A).3
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M($56)"@$]2!UIU% !BBBB@ HHHH **** "D(!&,>U+10 A56SD9SZT;12T4
M-**V-P!P<C-.Q110 4444 %%%% !1110 4FT8QCCTI:* $"J  !@#L*,"EHH
M **** "BBB@ HHHH *0C-+10 F!2!%7H .<\4ZB@!-H]*-HQBEHH **** "B
MBB@ HHHH ,4F!2T4 -"*"2% )ZGUI=HI:* &K&B?=4*.N!3J** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
' HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>afyaform20f_011.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_011.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #" XX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[O\ @7K7I%QI]K=S0S3P(\D#;HV/\)]J@M-%TZQO);NVM(HYY<[G'4Y.3^M
M&B*6FCCTI=U 7%HI <BEH ***JWM]%8P>;+DKG'% %JJ]W;O<VSQ1W#P,PXD
M3JOTK-_X2:R_NO\ E1_PDUG_ '7_ "H EM=%6T\^9+AFOIP!+<N@); P..E-
M@T"*TLI(+:ZGBDEF\Z6=2-\C<9SQTP,4S_A)K/\ NO\ E1_PDUG_ '7_ "H
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MZD# _&EN_%&DV-V;:XNU608W84D)GIN(&!61XP-C?65QH2O MQ?@"9F91Y:
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MM)!_9&$_E_$] /Q2G_Z!X_[^4^#XG3RW,41L%^=PN?,Z9->>5-9_\?\ ;?\
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M4/\ N"N!/W?QKOK'_CRA_P!P4 6**** *6K?\@R?_=KAAT'TKN=6_P"09/\
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M^%$->*^/?^1KG_W*]J->*^/?^1KG_P!RHJ;'L9)_O)S)ZT4'K17,?8!1110
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MZ+PKUN?PKG>]=%X5ZW/X4 =)1110 AZ&O/[G_CZF_P!\UZ >AKS^Y_X^IO\
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MLZN66[/T#"_P8^@4445)T!1110 5UWPU_P"1L/\ U[M_2N1KKOAK_P C8?\
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M![]_PJSY\/V?S_,7RMN_?VV]<T<J#ZW7_F9YE_PIF#_H8+__ +Y%'_"F(/\
MH8+[_OE:]-MKB*[MX[B"0212+N1QT(]:EHY4'UNO_,SSW3OAI=:5&Z6/BK4(
M58Y.(U-7/^$(U?\ Z''4/^_2UVV/:BFC"4I2ES2W.*_X0C6/^AQU#_OTM(?!
M&L8_Y''4/^_2UV]!H$>83_!Z.XG>:7Q%?M(YRS;%YJ/_ (4Q;]O$%_\ ]\K7
MJ6*8[+%&TDA"JHR23T%+E3-UBJR5E)GF'_"F8/\ H8+_ /[Y%'_"F8/^A@O_
M /OD5Z#INN:9J\,DUC>1RI&<.>1M^H.,5+9:G9:C"TMK<)(B?>(XQ^='*A_6
MZ_\ ,SSG_A3,'_0P7_\ WR*/^%,P?]#!?_\ ?(KTF"_M+FS^V0SH]O@GS >.
M"0?U!IFG:I8ZM;&XL+A9X0Q7>F<9'44<J#ZW7_F9YS_PIF#_ *&"_P#^^15F
MP^%#:9<?:+/Q+?Q2D;=WEJ>*])Q0/I1RHF6)JR5G(XG_ (0G6/\ H<=0_P"_
M2TO_  A&L?\ 0XZA_P!^EKMJ*9B<0?!.L?\ 0XZAS_TR6LN\^$IU&X:XN_$M
M_)*W&[8HKTLTF*'YE0J2@[Q=CRW_ (4O;_\ 0P7W_?"T?\*7M_\ H8+[_OE:
M]1JA:ZUIMY?365O=QR7,/WXP>1_C^%+E1M];K_S,\]_X4S!_T,%__P!\BC_A
M3,'_ $,%_P#]\BO1K;5+"[N9;>"YCDEB^^JGI_C^%+::C9WTD\=K<)*T#[)0
MO\+>AHY4'UNO_,SSC_A2]O\ ]#!??]\K1_PI>W_Z&"^_[X6O1K?5+*ZNY+6"
MX62:,9=5YQ^/2KF*.5!];K_S,\RM_A MI<I<0>([])4/RML6M?\ X0C6#_S.
M.H9_ZY+7;8H%->1E.I.H[R=SBO\ A"-8_P"AQU#_ +]+2'P1K'_0XZA_WZ6N
MWI.]!!YSJ/POGU9HVOO%%_,T0(0^6HQFJ?\ PIBW_P"@_??]\+7J6/:C%+E1
MM#$58+EC)I'EO_"F8/\ H8+_ /[Y%'_"F8/^A@O_ /OD5Z#+KNF0:K%IDEVB
MWDOW(L'G\<8!IW]LZ=_:/]G_ &I/M7_//^F>F?:CE17UNO\ S,\\_P"%,P?]
M#!?_ /?(H_X4S!_T,%__ -\BO1DU.RDU![!+F-KJ-0SQ \@'UJG!XIT.YOA9
M0ZE ]R6*",$Y)'4"CE0?6Z_\S.%_X4Q;_P#0P7W_ 'R*5/@U"CJR>(;Y64Y!
MV+Q7J%+@TN5(3Q59JSDSB1X(U<#Y?&&H >@B6E_X0C6/^AQU#_OTM=J!@4M4
M8'$_\(1K'_0XZA_WZ6HI_ .IW*;)O%^HLN<X\I:[NB@#SS_A6-S_ -#5J/\
MWPM'_"L;C_H:M1_[X6O0ZS-2\0:7H[QIJ%[' TAPH;/ZXZ?C0!Q__"L;C_H:
MM1_[]K1_PK&Y_P"AJU'_ +]K797&N:9:W$4$U[$LLH!09SD'H<CI4TFIV4-]
M#927*+=3@M'$3RP'4B@#A_\ A6-Q_P!#5J/_ 'PM'_"L;C_H:M1_[X6NUFUB
MP@OTLI;I$N'^ZA_EGH#[5=% 'GI^&-S_ -#7J/\ W[6K:>!M61 J^,-1"@8
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MO5XY W_"8:@PQT,2UVE%% !1110 4444 9VM2V%O8&YU$QB&([@)" "W;K7
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MMM_#%79?#VERZ?'8M9Q"VC/R(!C;ZX^M7[>VBM8$@A14C0855& !0!+1110
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MK2Y7EL;&&"1UVLR+R10!I"BD P*6@ HHHH **** $/2N$URUT;5M2@TU);6
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
$0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>afyaform20f_013.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_013.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "# XD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF^M58@W$0([%Q0"3>Q9J*Y9UMY&B7,@4[1[U']OM/^?F+_OL4GV^T_Y^8O\
MOL4#Y9=C"TRVO]%T2V6.S\^ZN)]]RI(^4L>3GOVKF;WP5?SWE[IPA4P76HKJ
M$=YWB]5]<]OI7H?VZT/_ "\1?]]BD^W6G_/Q#_WV* Y9=BTHPH'H*,BJWV^T
M_P"?F+_OL4?;[4C/VF+_ +[% <LNQ:S14,5S#,V(I4<CKM8&IJ!--;A1110
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M;2X]1M90;=UW;CQMQU!]"*J:=XITW4[P6T$IW.I:$NNT3 '!*GO@T ;=%%%
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M^*-E_P ^<WYBNLT#6H]>TQ;V)&C5B1ANM--/8RJX6M25ZD;&M1113, HHHH
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M_P )5HF,?VC;?]_!1_PE6B?]!&V_[^"C0/95/Y7]QJ6D"6EG#;1#$<*+&OT
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M_"SKR_\ WF'J>4T445RGWO0****8@HHHI P]:^@M(_Y!5M_US%?/M?06D_\
M(*MO]P5O2ZGSG$&T"Z.M.IH'-.K4^:1S/C[_ )$^]^@_G7BA_I7M?C[_ )$^
M]^@_G7BE85=T?5Y#_ EZ_H%%%%9'NV"BBB@ I#T/TI:0]#]* >Q[;X%_Y%.T
M^AKI17->!/\ D5+3Z&NDKK6Q^>XC^++U%K+\1?\ (OW_ /UQ;^5:E97B+_D7
M[_\ ZXM_*F]B*7QKU1X$OW!2TB_< I<UR/<_0X[(****"@HHHH !]X5Z;\+/
M^/"]_P"NG]*\R'45Z;\+#_H%[_UT_I5T]SRLY_W5_(]$[4=J*2N@^,(Y?]4_
MT-?/VK?\AF]_ZZFOH&7_ %3_ $-?/VK?\AF]_P"NIK*KLCZ#(/CF5****P/J
M HHHH **** .Z^%O_(=O?^N _G7J]>4?"W_D.7O_ %P'\Z]7KJAL?%9Q_O<O
ME^044451YA5U"_M]+L9+RZ8K#'C<0">I ' ]R*PCX^\/_P#/S)_WY;_"NGI,
M4 >6^/O%&EZKI$$5DT\TBS!BJ0MG'Y5YW]I7_GWO/^_#?X5]+%0?6C:*B4$V
M>GA<SJ8:G[.*T/FG[2O_ #[WG_@._P#A1]I7_GWO/_ =_P#"OI;&**GV2.G^
MW:_\J/FG[2O_ #[WG_@._P#A1]I7_GWO/_ =_P#"OI;BBCV2#^W:W\J/FG[2
MO_/O>?\ @._^%'VE<C_1[OJ/^7=_\*^E\4F,T_9H3SRLU;E1QVE^-]"M]+MH
MI+B176, @PMQ^E6_^$^\/_\ /U)_WY;_  KIL48K0\5N[;.9_P"$^\/_ //S
M)_WY;_"N>\9^+M(U+PY<6]I)-+*2"%6%LG]*](Q2;?K2:NBJ<W"2DNA\T_:5
M_P"?>\_\!W_PH^TK_P ^]Y_X#O\ X5]+;1]**CV2/8_MVM_*CYI^TK_S[WG_
M (#O_A1]I7_GWO/_  ';_"OI:C%+V2'_ &[6_E1\T_:5_P"?>\_\!V_PH^TK
M_P ^]Y_X#O\ X5]+8H H]D@_MVO_ "H^:?M*C/\ HUY_X#O_ (5Z9X)\6Z3I
MGAV.WNGFBE!)VM"P/\J]*VBDVCWJH043DQ>95,5#DDCF_P#A/O#_ /S\R?\
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MU.1^%=97&^%/#UYIVJW>H72);F>*.)XHVR'91@OCU/7-=D.E !1110 4444
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M85">PK?H **** "BBB@ HHHH **** #%)@>@YHHH 7%&*** #%%%% !1110
M4444 %&*** # QBC%%% !@>E%%% !1110 4444 %%%% !BDP/2BB@!<#THP/
M2BB@ HHHH **** "BBB@ HQ110 8'I1@>E%% !1110 4444 %%%% !1110 4
MF!Z444 +@>E&*** # ]**** "BBB@ HHHH *, ]:** $P/2EP/2BB@ Q1BBB
M@ HHHH **** "BBB@ HP/2BB@!,#T%+@'M110 8HHHH **** "BBB@ HHHH
M" >HI, =A110 8&,8%+@>E%% !1110 4444 %%%% !1110 F!C&!2X!HHH ,
M#THHHH **** "BBB@ HHHH *3 ]!110 M&!Z444 %%%% !1110 4444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>afyaform20f_014.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_014.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ", Y,# 2(  A$! Q$!_\0
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M3UKG_P#A8OA,>9_I'W_O_NC\WU]: (K+3M/O] U"^U606L>IR;6D5MA10V%
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M6,5A'.&C\PLSD5WQZ5XG\5K>2;Q9$R#(%N._O2O8N%.51\L%=EW_ (7)>?\
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MT9]C7??\*:@_Z#]_^9_QH_X4U!_T'[_\S1[)C_MRAV9P.?:O3_A6?^)9?_\
M7<?RK._X4W#_ -!^_P#SJ]I_PTN]*C:.Q\4:A$CG+#/4U4(-.YPYAF=+$T>2
M*/0QTI<UQ'_"%:S_ -#=J/\ G\:/^$*UG_H;M1_(_P"-:G@';YHS7$?\(5K/
M_0W:A^1_QH_X0K6?^ANU#\C_ (T =OFO-_BI_J;#O^\/\JT?^$*UK_H;M0_(
M_P"-4;_X9W.JJ@OO$^HRA.5[8_6E)75CIP=94:RJ/H>:?@:/SKOO^%-P_P#0
M?U#\S_C1_P *:@_Z#^H?F?\ &L529])_;M#LS@,'WIP)Z[F'TXKO?^%-0?\
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M>06]CJ]GK?AC0C##]NLYVDFNH6.3#GG?[L.U>OT &!Z48'I110 F!Z4N***
M#%%%% !1110 4F!Z4M% !@>E&!Z444 &*BN)XK:%YIG5(T&YF;H!4M4M4%I]
MBD>^V_9DP[[C@<<B@!EKK.G7MB][;7D4MLF=TBMPN*4:QIS:>]^+R(VB#)F!
M^45P+:;;P6&I7ZLD4.I7=NTELC\)#YB@D@>H_2I[.2U3Q;XC1T4Z5#&DFQC\
MAG]!VS@#B@#N3J5D+ 7WVF+[*5W";=\N*GM[B&[@CG@=9(G&5=3P17F$^E?V
M/9^'M/-P'LI-1:2[1'S'&QY1,]@/2NQ\).Y&KK_RP34YE@]-O&<>V=U '28'
MI1BBB@ HP*** "BBB@ HHHH **** # ]*,444 %%%!H S]0UG3M+EBCO;R&!
MYCB,.V-U.N=4L;*6**YNHHGEX16/+?2N?\7VNGW5K-8F*"2^OH]BF5L;%[L?
M0#U]:YDQPK?^*5U%S)]GL42T:0\F,*,$>OS=Z /0YM:TVVU&.PFO88[N4?)$
MS<M5E[RWCO(K5YD6>4%DC)Y8#J17G3V-OKWAS2;&8(FH20P7-U<N^'AP <^Q
MX%:VJB+_ (6-X6D1PQ:WN 'SRR[10!V]&*** # ]*,#THHH ,4444 %%%% !
M1110 48%%% !BC%%% "'VJG;:G8WD\\%O=1R2P?ZU%/*_6K3J&5E;HPP?I7!
MS:=:C6;_ %73&CC,%C):Q*C@F9_O$D#TS0!V4.HV=P\ZQ7,3F XE"G[E16>N
M:7?P33VM[#+%#Q(RM]SZUYUX>">9X9C7_53Z?*]^2PPP# _,?7-;VEV&E2ZC
MJNKLL$-C/"BB(, &5#]\@>_ H ZO3M5L=7@,]A<QW$08J60YP15[%<=X5T^W
MBUO4-6B,=NNH!?+M48?=7^(CU-=C0 8'I1@444 &!Z4444 %%%% !1110 4F
M!Z4M% !@>E%%% !5/4=3LM*MOM%_<)!#D+N<X&35RL7Q')8Q6/F7D*3/RD,;
M8^9F&.AH N2ZI8PV2WLEU&MLV-LN?E.>E%UJMA96\<]Q=Q112L%1V/#$]*X>
MQTJ+2/\ A'M-FN$FME-RTP#[D639E5!]LM531$BOO!$\%XB2&:XFM=/$QQB-
MN 1GL.N?:@#T'4-8TW2XHY;Z\BMXY"-C.>&S5U"' 8'((XQTKD+_ $2)_!/]
MFVLMK=W,5J84DN&R& '//;ZUO^'V$GA_3F$9CS;I\A))7"@8YH T\48%%% !
MBDP/04M% "8'H*6BB@ HHHH **** "BBB@ HHHH **** "BBB@#,U70--UIX
MFO[59C%RA8G@U%+X:TN33(M/^RJ+>$DQ 'E">I!_$UL44 9,OAS2IM-ATZ2S
M1K2$Y2/MG.<_6GZAH5CJ?DFYAW&(%5*G!VGJ/I6G10!'#"D$211($C0855Z
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M'N[C3HWG<@LV2,X& .O2K[Z/827UK>-;(;BU4K _>,'J!5^B@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4'BR[']GZ?<:5<W(NA/,?WD9P 0!^'!KN:* /.H/"6LI>Z?,?L_EP:C-<O\
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9** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>afyaform20f_015.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_015.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "/ X<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*,CUHR/6@ HHR/6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **S=<
MU:/0](N-1FC>1(5W%4&2:A_X2"T3PR-=E)2V,'GX/7&,XH V**YN/Q?8RZ%8
MZFJ2%KX9M[?'SR'G@?E6Y92S36R27$!@D(R8RV<?C0!8HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *#2'H:XW76DC^(GAORY9%61)@Z!SM;"\9'2@#LZ
M*\^FMM8T[QY;7>J;+RPNYA%;2Q2.K6KD':&7.U@>><5;U#1[2W\4:3':_:Q<
MRW!N9I3=2$%%!R"-V,9QVH [:BD'2EH **** "BBB@ HHHH **** "BBB@ H
MHHH *:YVJ6P3@9P*=36( SZ4 8NF^)+6]T&35IP;6",N'\P_=VD@_P J+?Q%
M"VCRZM=H;2Q7YHY)&Y=>QQ[]JXV]TB^O_AS-;I;REDU!YI8""#)&)"2OKS[5
M5U?3KK5;">ZM(+F718KJVF^PN6!(48D"@\XZ<>U 'I&DW\VI6?VE[5[='.8U
M<\LO8GTS6A7,>%0[RZE<0M/_ &9+(AM4FSE,* V >0,]JZ>@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "C(%1W$RV]O+,P)6-"YQUP!FL*V\6
M6-SX7771N2W;A%;AF;. /J30!T&1C-+7-+XQLCICW+JR7"3?9FMVX82GHM:F
MC:M%J]FTR*R/&YCD1NJL#@B@#1HHHH **** "BBB@ HHHH **** "BDS1F@!
M:*** "J]S?VEG)#'<W,43SOLB5VP7;T%6*XCXA1Q-<^&9&"[TU6/:Q[9!S0!
MT]YK.G6%[;VEU=Q0SS_ZM';!:BYUC3K34(;&XNX8[F;_ %<;N 6KF_&>FV&K
M;=,<0)=7&'>XD.&@C4_>4]C5/QO8HVF:??VT%O>BSFB,FX'S7' !5AR/7WH
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M  E^N_\ 00D_[Y7_  H_X2_7O^@C)_WR/\*GVD3M_L+$=T>Z9'J*,CVKPO\
MX2_7O^@C)_WR/\*/^$NUW_H(R?\ ?(_PH]I$/["Q'='N?&.U(, 8  'H*\-_
MX2_7O^@C)_WR/\*/^$OU[_H(R?\ ?(_PH]K$7]A8CNCW,  8& /:ES7A?_"7
MZ]_T$I/^^1_A1_PEVN_]!&3_ +Y7_"CVL1_V%B.Z/=,CU%&17A?_  E^O?\
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MCTT=!10.@HKH/C HHHH *XOXF?\ (M+_ -=!7:5Q?Q,_Y%I?^N@J9;'5@?\
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M]+P_M,****P/I HHHH$%%%% !1110 4444 %>K_"[_D79_\ KX;^E>45ZO\
M"[_D79_^OAOZ5I2W/'SO_=OFCNJ***Z#X\**** "BD9E12S,% [DXJ/[3!_S
MWC_[Z% $A-8?B[_D5-3_ .N#5KFX@/\ RVC_ .^A6)XMGA;PKJ0$T>?(;^(4
MGL:4?XL?5'APZ"EIH=,#][&>/[PHWI_STC_[Z%<MC]!4E8=12;D_YZ)_WU1N
M3_GHG_?5(?.A:*3<G_/1/^^J-R?\]$_[ZIASH6BDW)_ST3_OJC<G_/1/^^J
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MG[-,.JH3T7.>*]'P,4@15^ZH'.3CUH 4=!2T44 %%%% !1110 4444 %%%%
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44 %%%% !1110 4444 %%%% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>afyaform20f_016.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_016.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "_ WX# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MMZ'.?O?E1X9U#Q%/JMY9ZP+)HX$0A[<'[QYQ0!UM%<Q<ZU?P^.;32@D7V*>
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M-9K>[2>=2X&U0><>M=-]H@[RJ?QI1<P?\]5_.@+,FI:@^U0_\]4_.AKN$?\
M+5/SH"S[$]%,1PZY4@CU%.S0(6BBF.^P9) 'J: 'TE0_:H?^>B_G1]IA(_UJ
M_G0.S[&#X?TB]T_5]=N;B-!'>3+)#M?.0 >OIU%3:58WNG:?=R>2K7LT[2;=
MXY!(P"?85L?:8/\ GJOYTGVB#_GJOYT!9F!=Z5>S>-+'4UC3[-#"5<EAD$Y[
M?C735#]I@_YZK^='VJ'_ )ZI^= 69/14!NX<@>:GYU*K;ER#D4"U'4444 %%
M%% !1110 444&@ HI*0LJ]2!VYH =13<BD1UD&5.10 ^BBB@ HHHH ****
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MG_?-'_"=Z[_S\)_WS2]I$[?[#Q/D>RI96J0^2EO$L7]P(-OY5((HP00B@J,
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M_CTA_P!]?ZUY@.]>G_$S_CT@_P!]?ZUY@.]85/B/L<G?^RH6BBBLCUPHHHH
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MN_UKP+M_GT->^^'_ /D"6W^[_6MJ74^=S_X8&H.E% Z45L?,A1110 4E+24
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MW_Y%T?[Y_G7D->O?#?\ Y%T?[Q_G6M+<\3._X'S.S%% HK<^2*U__P >$O\
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MH?Y5Y]WKT'XH?\?=G]#_ "KS[O7-/XF?;Y3_ +G$****@]$****8!72^!/\
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M2URGW\=@HHHI#"BBB@":S_X_K?\ ZZK_ #%?0.G?\>,/^X/Y5\_6?_'];_\
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MBA_$CZH\'3[@^E+2)]P?2EKD/T);(****!A1110 =O\ /H:]]\/_ /($MO\
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MIA/X\?4\;'2EI!TI:Y3[^.P4444AA1110!-9_P#'];_]=5_F*^@=._X\8?\
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M_"P+0_\ ,)U?_P !?_KUO#8^1S*I&IB)2@[H[#-1R_ZE_P#=-<G_ ,+ M/\
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M8$ V^/ZTI;%X:2C6BWM<\Z'W:6GBVU(#_D"ZA_W[_P#KT?9M1_Z NH?]^_\
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MK%K<RZ+J(CCD#-B+)Q^=.*?,8XG&4)49*,EL>_+T%+7'CX@6@_YA.K_C:_\
MUZ7_ (6!:?\ 0)U?_P !O_KUTGQ!UQKR;XF_\ARV_P"N1_G75'X@6F.-)U;_
M ,!O_KUPWC/4IM=U&">ST?4BJ1[6W08YS]:F:O$]'*YQIXCFF[(Y@]:*?]FU
M+OHNH?A%_P#7H^S:C_T!=0_[]_\ UZP<6?5K'X;^=#**?]FU'_H"ZA_WZ_\
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M 74?^_7_ ->C[-J/_0%U#_OW_P#7I<K[&_U[#?SH913_ +-J/_0%U#_OW_\
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H:!J6LNUIJ#6\EC\K!B!O5AU(XKJD7:H4'@#%.HH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>afyaform20f_017.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_017.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "' XT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_?%'_"?Z_P#\]X_^^*YBBCF8?V?AOY$=/_PG^O\ _/>/_OBC_A/M>_Y[Q_\
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MU%HHHH( ]*::<>E-- CQ/QQ_R-MU^'\JYSM71^./^1MNOP_E7.=JYI_$S[S
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MT]:]2^)O_()A_P"NJ_UKRT]:PJ[H^PR7_=OF%%%%9GL!1112 **** "BBB@
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M:\F^)O\ R'H/^N(_F:B?PGI93_O<3B****YC[5!1110,**** "BBB@ HHHH
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M_P">\/\ WV*]>_X57X2_Z!O_ (]1_P *K\(_] T?]]4>R\P_U@_N'D/GP_\
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M_HH_M*R_Y_+?_OZ*YC_A6GAO_GWF_P"_E'_"M/#?_/O-_P!_*9Q'3_VE9?\
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M17,#X:>&_P#GWF_[^4?\*T\-_P#/O-_W\K0\DZ?^TK+_ )_+?_OZ*/[2LO\
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M*\O\1>&KN.[O--T>Y,PU:X66XB9?]1C&6W=N":]-MXS#;QQGG:H&: ):***
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MQNSW'<YXKH_#2W,?AW3UNU"SB$*X48&1QT[4 :^**** "BBB@ HHHH ****
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>afyaform20f_018.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_018.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #" XD# 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD) ZF@!:*;D>HI<CUH
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M &Q0'0?Q4@L29I=U1^8GJ/RH\Q/4?E0%B3-&:C\Q?[P_*CS%_O"G81+12 Y
M-+2 **** "D/6EIC'!YZ>M #LX%&:P9?%FDQR-&UU$"I(/SBD'B_2,?\?47_
M 'V*7,C;ZO6_E9OYHS6!_P )?I'_ #]1?]]BC_A+](_Y^HO^^Q1=!]7K?RLL
M^(=%77=)^QF01NLB2HY&<,K UFVGA_4;5Y[I;V'[=.8U9]I*^6O4?C5D^+M(
M/_+U%_W\%)_PEVD'_E[B_P"^Q1=!]7K?RLS]3\ V%_JVGZA'^YDMKDW$@&?W
MA/IZ4LWA"::-;-KB+^STOOMB*5)=>^W]>M7_ /A+M(_Y^HO^_@I?^$NTC_G[
MB_[^"BZ#ZO6_E9OKPH ["C-8'_"7Z1_S]1?]]BC_ (2_2/\ GZB_[[%%T'U:
MM_*S?S1FL#_A+](_Y^HO^^Q0?%^D8_X^HO\ OL4<R#ZO6_E9ODXH#9K,T[6[
M'57=+:9)&3[P5LXK17'.*$[F<HN+M+1C^M%)2TR0HHH[4 )GBDW5D^)-6DT;
M19[R*-9'C&0K' /->?GXG:E_SXP=?[YJ7-+<Z\/@:^(5Z2/5MPI=U>3_ /"S
M]2_Y\8/^_AI?^%GZE_SY0?\ ?9J?:1-_[(Q?8]6W54N].L[YT:YMXY2ARNY<
MXKS3_A9^I?\ /E!_WV:/^%GZE_SY6_\ WV:/:Q#^R,7V/3H[.VBG,\<*)*5"
M%U4 E1T%(;.W99%>&-EE_P!8-GWSZGUKS+_A9^I?\^5O_P!]FC_A9^I?\^,'
M_?PT>UB']D8OL>FV=C:V$?EVL*1)Z*,59W5Y3_PL_4O^?&#_ +^&C_A9^I?\
M^,'_ '\-'M8A_9&+['J^ZC=7E'_"S]2_Y\H/^^S1_P +/U+_ )\K?_OLT>UB
M']D8OL>K[J7->3GXGZD 3]AM^G]\UZ+HM^^I:7!=R*JO(FXJIR!51DI;'/B,
M'6PZ3J+<TZ*0&EJCE"D-+2&@!,XK#U;Q9IFC7(M[IV$A&< 5MGZ5Y#\2% U^
M+(!^3O4R=HW.S 8>.)K*G)V.T_X6)H7_ #U?\J/^%AZ%_P ]7_*O&\4'GL*R
M]JSZ#^P\/_,SV3_A8FA?\]7_ "H/Q$T(?\M7_*O&QQ0>?2CVPO[#P_\ ,SV/
M_A8NA?\ /1_RI1\1-"/_ "T?\J\;_*ES]*/;!_8>'_F9['_PL/0_^>K_ )4G
M_"Q="_YZ/^5>.Y/M2?E1[8/[#P_\S/8_^%BZ%_ST?\J7_A8>A_\ /1_RKQO\
MJ7/TH]L']AX?^9GL9^(FA#_EJ_Y5+9^.]'O;N.VBD8R2' XKQ8\]A6KX9 _X
M2*R_ZZ ?F0*%5;9E7R:C3IN:;T/>@<BEIL?W!3JW/F1:*** "H+J3R;627;G
M8I;'T%3U5U#_ )!US_UR;^1H'%7:1YX/BDY)QI7'_70?X4'XH2'_ )A?_D0?
MX5YWQD\=S1^%<_M)7/L(93AW%/E_%GHG_"T)/^@7_P"1!_A1_P +0D_Z!G_D
M0?X5YW^%'X4>TD7_ &1ANWYGHG_"T)/^@9_Y$'^%'_"T9/\ H%_^11_A7G?X
M4?A1[20?V1ANWXL]$_X6A)_T"_\ R(/\*/\ A:$G_0+_ /(@_P *\[_"C\*/
M:L/[(PW;\6>B?\+0D_Z!?_D0?X4?\+0D_P"@7_Y$'^%>=_A1^%'M)!_9&&[?
MF>B?\+0D_P"@9_Y$'^% ^*$F1_Q*_P#R(/\ "O._PH&,]*/:2#^R,-_+^9[7
MX3\4GQ*EPS6OD>2P'+9SD5THKSCX5?ZC4/\ ?7^1KT<=:WB[QN?*XVE&E7E"
M.R%HHHIG*%(:6D/6@#@/B8O_ !*H,\_O>./:O+L+_='Y#_"O4_B9_P @F#_K
MK_2O+*YZK?,?89*D\-=]PPO]T?D/\*,+_='Y#_"BBLKGKV78,+_='Y#_  HP
MO]T?D/\ "BBBX678,+_='Y#_  HPO]T?D/\ "BBBX678,+_='Y#_  HPO]T?
MD/\ "BBBX678,+_='Y#_  HPO]T?D/\ "BBBX6780J.,!1\P[>]?06B<:-:?
M]<Q7S\>WU%?06B_\@:T_ZYBMZ/<^;SY)<MB_1116Q\X%%%% !1110 W%>7_$
MB\NK;5;58+B6-3'DA'(KU&O)_B?_ ,A>S_ZY?UJ9OW3ORN,98E*2T.3_ +6U
M'_G^N?\ OZ:/[6U'_G^N?^_IJG17+S/N?8_5:7\J^XN?VMJ/_/\ 7/\ W]-'
M]JZC_P _US_W]-4Z*:D^X?5:7\J^XN?VKJ'_ #_7/_?TTG]JZA_S_7/_ ']-
M5**KF?</JM/^5?<6_P"U=0_Y_KG_ +^FE_M;4?\ G^N?^_IJG12YF'U6E_*O
MN+G]K:C_ ,_US_W]-']K:C_S_7/_ ']-4Z*3D^X?5:7\J^XN?VKJ/_/]<_\
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M6'_(3M/^NB_SJO5BP_Y"=I_UT7^=7'=&.(_A2]#Z%@_U"?[H_E4E1P?ZA/\
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M_$[_ )#%I_US->L&O)_B=_R&+3_KF:B?PGHY3_O2.'HHHKE/MPHHHH ****
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MZYBMZ'4^=S_^&C=%+2"EK8^9"D-+2&@ ]:\@^)'_ "'X_P#<KU_UKR#XD?\
M(?C_ -RIG\)ZF3_[TCCJ***Y#[0**** "BBB@ HHHH **** "M;PS_R,-G_U
MT7_T(5DUK>&?^1AL_P#KHO\ Z$*J.Z.?%?P)>A[PG^K7Z"G4U/\ 5K]!3JZS
MX![BT444""JNH?\ (.N?^N3?R-6JJZA_R#KG_KDW\C05#XD?/'<_6BCN?K17
M&]V?H</A7H%%%%(L**** "BBB@ HHHH *.]%'>@#TCX4_P#'MJ/^^G\C7HZU
MYQ\*?^/;4?\ ?3^1KT=:ZX?"?"9G_ODQU%%%4<04AZTM(>M '!?$S_D$P?\
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M#YZU#_D*77_70U6JSJ'_ "%+K_KH:K5QRW/T+#_PH^@4444C8**** "BBB@
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MZ6["BBB@0&F/TIYIC]* /GK4/^0I=?\ 70U6JSJ'_(4NO^NAJM7'+<_0L/\
MPH^@4444C8**** "BBB@ HHHH ****0,[[X6?\A+4O\ <6O4NYKRWX6?\A+4
MO]Q:]2[FNNG\)\1FO^]2%%% HJSS@I.PI:3L*!,Y?QY_R*UW_N_U%>+GO]:]
MH\>?\BM=_P"[_45XN>_UK"KN?69#_"D%%%%8L]T**** "BBB@ HHHH ****
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M*/\ A3MC_P!!S4_S3_"O3**7*NQK]:K_ ,S^\\S_ .%.V/\ T'-3_-/\*/\
MA3MC_P!!S4_S3_"O3*:S!!DD #J2>E'*NP?6J_\ ,_O/-?\ A3MC_P!!S4_S
M3_"C_A3MC_T'-3_-/\*] MM2LKP2FWN8Y!$<2;6^[]:?!?6URKO!/'(J':Q5
MNAHY5V#ZU7_F?WGGG_"G;'_H.:G^:?X4?\*=L?\ H.:G^:?X5Z&M[;O"9EG0
MP@D%PW (IUM=P7:;X)5D7."5-'*NP?6J_P#,_O/.O^%.V/\ T'-3_-/\*/\
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M_P T_P *]#O+^UT^+S;N=(8\XW,<#--?4K**!+A[F,0N,JY;[U'*NP?6J_\
M,_O//O\ A3MC_P!!S4_S3_"C_A3MC_T'-3_-/\*]"EO[6&..22XC1)#A&9N&
M-)/J-I:E1//&A;[N6ZT<J[!]:K_S/[SS[_A3MC_T'-3_ #3_  I?^%.V/_0<
MU/\ -/\ "O2@0R@@Y!&<BEHY5V#ZU7_F?WGF?_"G;'_H.ZG^:?X4?\*=L?\
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ML'UJO_,_O//O^%.V/_0<U/\ -/\ "C_A3MC_ -!S4_S3_"O0Q?6S79M!.AN
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M'_\ $5UM+3,#D?\ A$-2_P"AOUK\X_\ XBC_ (1#4O\ H;]:_./_ .(KKJ*
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M_P#B*/\ A$-2_P"AOUK\X_\ XBNNI*9F5=+LY;#3HK::\FO)$SF>?&]LDGG
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MGB&.,_>C< >O]*[^71[&>RBM);97MXB&2,] 1TH.DVK7,=PT>]XQA QX7\*
M(_#\<T?A_3UGR)1;IN!ZCY1Q6G2 <4M !1110 4444 %%%% !1110 4444 %
M%%% "$9&*XS7;"UO=:L[>!HHI(9#<32AAO!],_TKL_6LJ7P]IDMX;M[-6N"V
M_?N;[W8]: //[F1UT=9?G.I-K!/?>!N/'KC;BN@G@@O/%$$EKY<9L%<%U(!D
M<@<9'7D_I73'1[/^T?[0$"_:L??S[=:BB\/:9!>"ZBLP)P2V_<>I.?6@#B(7
M=3X6,)87+32F4*.3\QSN_'UKTH=*HV^CV=O?2WB0*L\ARS>_?%7P* %%%%%
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M;=O)[T <-;;63PP!D74D\PN.><$N3O[XY[UKV&GVEWXQGU6-H8K2.$VR1JP
ME(_B..H]ZZ9-$L8[N:Z6 >;-G<<\'/6H(O#&E0,S162H60QG#-RI[=: .=\/
MJ;;Q_JL4ME&K2('AGA8[#'V!'3-=U5.PTNUTV%8K:/:J\=<FKE "T444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
/ %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>afyaform20f_019.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_019.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ## VD# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDS1F@!:*3-&:
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MR#Z5?_X2K0_^@I;?]]BC_A*M#_Z"EM_WV* ]A5_D?W'#:9\,KY4MXKJ^,/\
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M^?YTVN1GZ)3^&/H%%%%26%%%% !1110 4444 %(>GXTM(>GXTR9_"SZ"T/\
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M-9VN?\@>Z_ZY&D]BZ?\ $CZH\ ;[[?4TE*WWV^II*Y3]"I_ @HHHI%A1110
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M\;]0HHHH)"BJM_J%OIMLUS=2".%<9<@\9.*R_P#A,M![ZA'GZ&@#=K,\0?\
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MT)K>11J$>2I'0T/8<=T>*-_K)/\ ?/\ ,TE5'U6Q#.?M*G+G'!]32?VK8_\
M/PGYURM.Y]]2Q%+D7O="Y15/^U;'_GX3\Z/[5LO^?A/SI69?UBE_,BY15/\
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M-_P@/A/OX>L"?7R172T4 <T? /A/'_(NZ?\ ]^12?\(#X3_Z%VP_[\BNFHH
MYG_A O"G_0OV/_?H4O\ P@?A7_H7K'_OT*Z6B@+ON<U_P@/A3_H7K#_OR*0^
M ?"?_0O6/_?H5TU(>M ^9]SF?^$"\)_]"_8_]^A1_P (%X3_ .A?L?\ OT*Y
MK4_$/B_1_'VF6<ZVT^FZG,T:0QKEXU'\1K-M?B3J4NK079,)TV;5O[-5 N&
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>afyaform20f_020.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_020.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %8 H\# 2(  A$! Q$!_\0
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M9-=6%_:07KK'!/,B;69ON@A6++G_ &@*DA\2P7.L76EVUE>3W%JX68JJ!4!
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MS^W\-:E'IWBN*+3I(5OT06D4ERLC-A2.6+'GZGZ$BNBU;3;F[\(I81P[Y]L
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M-FUR[A$=SJ,GF8'\,:C:B_3 )_X%FI=<L=175;#5]*BCFF@#0SPNVWS8FP2
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $5S_ ,>LW^X?Y46W_'K#_N#^5%S_
M ,>LW^X?Y46W_'K#_N#^5 $M16W_ !ZP_P"X/Y5+45M_QZP_[@_E0!+1110
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M XW3 ?>V9^5>QY/<8+#J8*K3CS2MI_7XW_SL=%1112.,**** "BBB@ HHHH
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M;E&4C&.'EVX)R<*3ZBO1:*+D+'N*2BK=]=]$NW9;=];]#E_!&O7&O:;-+)#
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M3;CEE7!^0' '?C/K4UMX32U\3-JT=Q&(B_F+"(,,I\H1X#Y^Y@9VXZ]ZI_\
M"T/!W_08_P#):;_XBMO1/$6E>(X)9]*N_M$<3;'/ELF#C/1@*-2:CQL(RE4B
MTGO=6W^7E8U****1YX4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% $5S_ ,>LW^X?Y46W_'K#_N#^5%S_
M ,>LW^X?Y46W_'K#_N#^5 $M16W_ !ZP_P"X/Y5+45M_QZP_[@_E0!+1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %5]0E>#3;J:,X>.%V4XZ$ D
M58JGJW_(&OO^O>3_ -!-!4-9+U/G_P#X6AXQ_P"@Q_Y+0_\ Q%'_  M#QC_T
M&/\ R6A_^(KD**ULC]&^HX7_ )]Q^Y'7_P#"T/&/_08_\EH?_B*/^%H>,?\
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M7A5:1V/N,@_W)>K_ $"BBBF>T=?\+_\ DHNE?]MO_1+U]&5\Y_"__DHNE?\
M;;_T2]?1E1+<^,XB_P!ZC_A7YL****D\ **** "BBB@ KYS^*'_)1=5_[8_^
MB4KZ,KYS^*'_ "475?\ MC_Z)2JCN>_P[_O4O\+_ #1R%%%%6?9A7M/P2_Y
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M:GZ>%%%% 'U)X4_Y$[0_^P?!_P"BUK7K(\*?\B=H?_8/@_\ 1:UKUD?F5?\
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M-S0Q9(C!Z*3GD@=3TS5VD<TH\K:"BBB@04444 17/_'K-_N'^5%M_P >L/\
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MVA_]@^#_ -%K6O61X4_Y$[0_^P?!_P"BUK7K(_,J_P#%GZO\V%%%%!D%%%%
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M<_5*/LN2^K>]M_D?)-%?6WV:#_GC'_WR*/LT'_/&/_OD4^8[?]9?^G7X_P#
M/GCX7_\ )1=*_P"VW_HEZ^C*B^S0?\\8_P#OD4?9H/\ GC'_ -\BI;N>+F..
M^NU54Y;65M[DM%1?9H/^>,?_ 'R*/LT'_/&/_OD4C@):*B^S0?\ /&/_ +Y%
M'V:#_GC'_P!\B@"6BHOLT'_/&/\ [Y%'V:#_ )XQ_P#?(H EKYS^*'_)1=5_
M[8_^B4KZ'^S0?\\8_P#OD4?9H/\ GC'_ -\BFG8[\NQWU*JZG+>ZMO8^2:*^
MMOLT'_/&/_OD4?9H/^>,?_?(JN8]K_67_IU^/_ /DFO:?@E_R!]5_P"OA?\
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M17UM]F@_YXQ_]\BC[-!_SQC_ .^13YCJ_P!9?^G7X_\  /#_ (+_ /(XW?\
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MFF+K$;Q6KK;3DW7,*?+EAMW9^]@<>O-)IUE<6VAQ6\LDCRBV5"C[?D8+C (
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M]:L=)TX7]Q(S0$94Q*7+#&<C'; )STP*L!))K.,;GMI"H)";25..G((K$O\
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M/7K3X-=TVYOHK**Y#7$MN+I$V,,Q'HV2,?AU]J@6&7[3KA\I\2!?+.T_/^Z
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M=V%N%46<C8<%]RDA<*1N'4CK4.DV=SH-S,]U:SL+FTBCC6WB,NUU+G8=N=N
MZ@$X7WXH Z+^V=/%G9W9N0(+QT2!BI^=F^Z,8R,^]1WNOV&GW:VUQ]J$KG:@
M2SF<.<9PI52&.,]#V-<W_9.ISZ99:0MDA:TT_P N22:5HE25Q@%&"-N90&Z=
M-W6M!DU"Z'AB6ZMY?M$-PPNB$.%812*6/H">A[Y'K0!JRZ]IL$+RS7!B5&C1
M_,C92K28V@@C(ZCZ=\5;>]MHGG629(_(C$DI<[513G!)/&/E/Y5SE_ITEWJ%
M_'+:/);S7MMD%"5= @#'Z#O4=MI]\K7]J]O-*MLUJD3/_P O$<<C/@,>"=A
M.3U'/6@#H;+5K34)&C@:4.%W@2P/$67U7>!N'N,]1ZU=K&L+RYO-9D:,WGV
M0G<MS;&';(6X"[E4D8SZBMF@ HHI",@C./>@"@NMZ>]Y]F69V??Y6]87,6_^
M[YF-F[/&,YSQUI+77=/O;O[-!+*9-SH"T$B(S(<,%8J%8@@]">AK)MY;VWAT
MK3K>.\AN86BCN$^SYA9!]]O,*E>>O#9]LU!IEG=V9M+J=;IH4O;S-OY1.S<\
MA60 #/(XYR,/Q0!TL6H6LUY=6D<P:>U"F9,'*;AD?7CTJG9>(],U!HQ;S2XE
M0R1-);21K(!R=I90&XYP,UA:?8ZK:7UG?W%FB^>)4N&BE>21O,)==Z;!M"G
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M_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>/\__ *]
M%ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>
M/\__ *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7
MH\W4?^?>/\__ *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S
M[Q_G_P#7H\W4?^?>/\__ *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %Z
MBJ/FZC_S[Q_G_P#7H\W4?^?>/\__ *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\
M_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>/\__ *] %ZBJ/FZC_P ^\?Y__7H\
MW4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>/\__ *] %ZBJ/FZC_P ^
M\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>/\__ *] %ZBJ
M/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4?^?>/\__
M *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %ZBJ/FZC_S[Q_G_P#7H\W4
M?^?>/\__ *] %ZBJ/FZC_P ^\?Y__7H\W4?^?>/\_P#Z] %FY_X]9O\ </\
M*BV_X]8?]P?RJH[:A)&R&"/# @X/_P!>KL*E((U;@JH!_*@!]%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
7%%%% !1110 4444 %%%% !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>afyaform20f_021.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_021.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (Z W@# 2(  A$! Q$!_\0
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M"Q15?[6O]Q_RH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\
M*C[6O]Q_RH L457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_RH^UK_<?\J +%%5_M
M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\ *C[6O]Q_RH L457^UK_<?\J/M:_W
M'_*@"Q15?[6O]Q_RH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\
M<?\ *C[6O]Q_RH L457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_RH^UK_<?\J +%
M%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\ *C[6O]Q_RH L457^UK_<?\J/
MM:_W'_*@"Q15?[6O]Q_RH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[
M6O\ <?\ *C[6O]Q_RH L457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_RH^UK_<?\
MJ +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\ *C[6O]Q_RH L457^UK_<
M?\J/M:_W'_*@"Q15?[6O]Q_RH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q
M15?[6O\ <?\ *C[6O]Q_RH L457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_RH^UK
M_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\ *C[6O]Q_RH L457^
MUK_<?\J/M:_W'_*@"Q15?[6O]Q_RH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\
M*@"Q15?[6O\ <?\ *C[6O]Q_RH L457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_R
MH^UK_<?\J +%%5_M:_W'_*C[6O\ <?\ *@"Q15?[6O\ <?\ *C[6O]Q_RH L
M457^UK_<?\J/M:_W'_*@"Q15?[6O]Q_RJ93N&: '4444 %%%% !1110 F*,4
MM% "8]Z,>]+10 F/>C'O2YHH 3'O1CWI<T9H 3'O1CWI:* $Q[T8]Z6B@!,>
M]&/>ES1F@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:*
M $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI
M:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1C
MWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O
M1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3
M'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z7-&: $Q[T8]Z7
M-% "8]Z,>]+FC- "8]Z,>]+10 F/>C'O2T4 )CWHQ[TM% "8]Z,>]+10 F/>
MC'O2YHH 3'O1CWI:* $Q[T8]Z6B@!,>]&/>EHH 3'O1CWI:* $Q[T8]Z6B@!
M,>]+C%%% !1110 4444 %-9MJDTZHY 67:*8=3 MO%]G<ZE>60C97M59F)[X
MJWIOB&TO]+2_++!$_0R, *XJ;1M2BNKFZAM)C)-<F-@%Y\MNK?3BH)=#U"&*
MQ\VSE>UA9U>/R]W&>#BD=_U:DU?F/19]6M+> 2O<P!2"5)<#=@=O6LZP\41:
M@EE)% PCN207+8V$#/XUQ-KHUS;2+)-87,]N\<@C7RL[&/3CL*=!HFJII6DP
MK97"21).I&/N90@9^M!/U>FM.8](BU*UF9A%<0R%/O!'!Q]?2JM_X@M+'3IK
MT2)+%",ML;/\LUQ6G:<\=DGE:+<B[B@8.Q0*';I@^M5+?1]0^P:B([&X026R
MJB[-N6QR,=Z!1P]-_:/0-0UR'3M)^WR(64D!%4\L3T JA:>*P[3)?V4EBT:>
M8/-/#+C/I1K5HTWAE8'LY+C 7,<?##'\0]Q7,V-AJ*R3P6\-])8/;N'%V#D-
MM. ":"(4X2BVV>@0ZA!.%,4T;;AD?-SCZ5'<ZO9VT(D>XAVG.WY\;L=<?K7#
M&VN[35;>]33KHQ/;% JIRC8/7\ZI66EW4$"_;M+NI3)"5B&PDQL2V?QY%!:P
MT+_$=]8>(;2\TZ&]D=((YON>8XYJY+J-K",S3Q1\9 9P,_K7FDFCWXTZP6>R
ME,:VGEE/+W;'P,<=C[UHV_AVX>\_TNU>=$LL*TB?Q8/'UH"6'IK[1V8UJS.H
MBQ$T9G*!]H89QZU/!J%O<R.D$T,C(<$*^37%Q:5<)>0&2QE)>Q1"P0 A@N""
M1WI/"-A>66I*GV6;R@A#22)L*G)ZY^]^%!$J,5&Z9VTU_;V\B1S311NYP%=P
M"?I2F^MUD$;31B0Y^4L,_P ZX3Q18WEWJTH33Y6/ECRI%CW98,.A['%.&@W5
MQ>ZI.;1A(T>(6*<$^U!4</#E3<CN(;Z&X+"&2-RIPP#@X_*K.:X+P?IEW!J$
M<TL,L#);B.53#L#-W)/<^]=[0858J,K)A2TE+09A12$X&:Q==\4:=X=>V&H.
MZB=PH94)"Y.,D^E &W17(W'Q'\/6QN_-NRJVK['8H<%O0'N:N#QIHX\/1:W)
M=*EF^%+$8*MG&".HY!'X4 =%17,7OCO1[.22$/++.DAB,443.V[&>@]B/SI=
M5\96=GX<MM:M ;JWGE2-=@R?F.#^1H Z7-&:YJQ\<Z/J&JK8PR2?O"5AF>-E
MCF8=0K$8)%9FM^/I="\3MI]S8)]C\LNDH?YW(&>%],\9]C0!W%+7$^&/'DFM
MWCV]UIS6S26XN[7:=WFPDX!^O2KC_$'P^D0E-ZNWRO.)Q_#EE_/<N/QH ZJB
MN/;XE>'TLK>[,\ABE?8Q$9_=G_:]/I4UY\0-$LHKEWFD<6^T,4B)7<>0,],X
M(- '54F:Q8_%%A+X?.M*)OLH'0H=Q.<  =223CBN?N_B3:1W.G)# 0DTCI="
MX!C>WVX)W*>1P>_I0!W6:6N1T#QM%X@U^^T^V@(@ME0K*P(WY4G//;CBNN%
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MT>V?7I4;>(-+331J+7]N+0G'F[QC/I]?:N U'P_>VNHW$RZ9++ID=VDGV>)
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M$9SDL&#]&)&>A_6@#J+31=/LKF2Y@MHXY9?O,JX/;T^E:&.H]:%Z=Z7% #2
M:6EHH **** "BBB@ HHH- !124HH **** "BBB@ HHHH *#110 E& >U+10
MF!Z4W8O]T?E3Z* &E0>H'Y5%/!%<1-%,BO&PP5;I4])0%RA8:18Z:K"SMDBW
M<$A?T^E7Z*6@&[[B4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 4W-#,H') %<UK/BR&T
MD-G81M>WK=(H>=OUICC"4W[I=\07NDVNF2#5?*>W8<Q2 '=VZ&O)+?PAK N+
MK4?!@N-.TV09>QE=E$HSSLX./PKT/2/"LD]VVJ:XYN;ISF.-SE81Z"NN5 @
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ME6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\
MGXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$
ME6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\
MGXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$
ME6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\
MGXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$
ME6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\
MGXDH^RO_ ,_$E6:* *WV5_\ GXDH^RO_ ,_$E6:* *WV5_\ GXDJ=00N">:=
M10 4444 %%%% !110: $)%)D4-VKEG\8[-5_L\Z?,9N2 .X]:"HP<MCJA2UE
MPZS 8YI+C]RL1(.[VJ>/5;*61(TN$+O]T9ZT XM="[1FJ2ZI9/<>0MPC2_W
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MXANE3[P'8^]!;A&2O$[C-%5K6]@O(5FMYEDC;HR]*L9I&3TW'44W)]:49S0
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M\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O\
MGX;\J/(F_P"?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?AORH\B;_GX
M;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_ )^&_*CR)O\ GX;\J +%%5_(
MF_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?AORH\B;_G
MX;\J +%%5_(F_P"?AORH\B;_ )^&_*@"Q15?R)O^?AORH\B;_GX;\J +%%5_
M(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O\ GX;\J/(F
M_P"?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?AORH\B;_GX;\J +%%5
M_(F_Y^&_*CR)O^?AORH L457\B;_ )^&_*CR)O\ GX;\J +%%5_(F_Y^&_*C
MR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?AORH\B;_GX;\J +%%
M5_(F_P"?AORH\B;_ )^&_*@"<C/>JM[I]K?VYANH(YD_NNN:=Y$W_/P?RH\B
M;_GX;\J8+1W1RY\*W6C/)=Z%?21MU^RS'?$W]120^-7LK@6NNV9LY3]UDRR-
M^/:NI^SR_P#/P?RJM<Z7#>0F&[6.6(_PN@-%S55$_C1;MKB.YB26)@R,,J1W
MJ>N$O?#FKZ(6G\/ZB8XL[FMYFR@'MGI6*/BY9VB36MR)+K4H>#%:C<"?<]J0
MY4E:\'='JCL%7<QP!U->>ZU\5;&WU%](T.VDU750Q0PHI"J1W)'4?3TK!M=/
M\:_$%LZMJJZ=HK'/V:S<"5AZ,1[9_2O0=!\*:5X;M5M](MHK<!0&D" N_NS=
MZ#%Z;G*MX4\1>-80_B[4'T^TZC3-/;8'_P!]SEJ['0/"^C>&K,6VE6$5NHZL
M!EF^K'DUH""7M.1CT44>1-_S\'\J +-%5_(F_P"?AORH\B;_ )^&_*@"Q15?
MR)O^?AORH\B;_GX;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_
MY^&_*@"Q15?R)O\ GX;\J/(F_P"?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15
M?R)O^?AORH\B;_GX;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_ )^&_*CR
M)O\ GX;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q1
M5?R)O^?AORH\B;_GX;\J +%%5_(F_P"?AORH\B;_ )^&_*@"Q15?R)O^?AOR
MH\B;_GX;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q
M15?R)O\ GX;\J/(F_P"?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?AO
MRH\B;_GX;\J +%%5_(F_Y^&_*CR)O^?AORH L457\B;_ )^&_*CR)O\ GX;\
MJ +%%5_(F_Y^&_*CR)O^?AORH L457\B;_GX;\J/(F_Y^&_*@"Q15?R)O^?A
MORJ=00O/)H 6EHHH **** "BBB@ HHHH **** "BBB@ HI**!7%HI*.*!BT4
MAXH% "T44E "T4E)0 ZBF\4Z@ HHHH **.E)N [B@!:*3(]1Z4M !11FC- !
M1110 449I-PSC(R/>@!:*3</4=,]:,C&<C% "T44 @]#0 449I,CU% "T4 @
M]#1F@ HHHH **** "BBB@ HHHH **** "BHY)4B1G=U51R23C K@?$/Q#_TE
M]+\*VK:KJG/F&$;HXNWS'I0!WDTR01/)*ZQH@Y=S@"N'USXH:/92FSTI9=7O
MV^[#:KN"^I)["J.D>#?%&M$W'C37+B2!^3IUHYAC'^]LP6_.NQT?PKH6@\Z9
MI%I:N3\SI&-Q]RW)/YT <!;^#_%/CB?[7XMU":UTUCNBTVVD,>!V#X!SV[UW
M6D^$M"T&S^R:=IMO#&PPQ"#+_4]36_10%WT.1OO!5IN:ZTJ62PNQR'A;"Y]Q
M5.W\0:SH9\O7;0R1#@7,"Y&/5J[JHIX8YXS'*BNAZJR@@_G3-8U?YE<I:5K%
MGJT FM)UD7T[BM$<C/-<U>>$[8*\NE-)IUT?X[9MH/U7H:S;?7-9T"<0Z\@F
MM <?;(EX'^\.U ."EK [FBJMG?07L0E@F21&&05-6<#UI&330M%)2T %%%%
M!1110 4444 %%%% !1110 4444 %%%)D8SGB@!:*3</449&0,\F@!:*,CUI-
MP/0B@!:*,C.,T9H **3(]12YH **,CUHR/6@ HI,CU%&1ZB@!:*3(]:7(]:
M"BDR/44;AC.1B@!:*,C.,TF01G(Q0 M%&1ZT9'K0 44F0>XI20.IH **0$'H
M12T %%&1ZTFX>HYH 6BDW#.,C\Z 0>A% "T444 %%%% !1110 4444 %%%%
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M&OV/7+2\;5KF2SL)9'L[0JN(P^"P)[Y(H ] '3BEI #@4M !03@9-%(W3\:
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MFB@"MON_^><?YT;[O_GG'^=6:* *V^[_ .><?YT;[O\ YYQ_G5FB@"MON_\
MGG'^=&^[_P"><?YU9HH K;[O_GG'^=&^[_YYQ_G5FB@"MON_^><?YT;[O_GG
M'^=6:* *V^[_ .><?YT;[O\ YYQ_G5FB@"MON_\ GG'^=&^[_P"><?YU9HH
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M/"EBS')V$?J:#9_POF;.^Z_YYQ_G1ON_^><?YU8I:#$K;[O_ )YQ_G1ON_\
MGG'^=6:* *V^[_YYQ_G1ON_^><?YU9HH K;[O_GG'^=&^[_YYQ_G5FB@"MON
M_P#GG'^=&^[_ .><?YU9HH K;[O_ )YQ_G1ON_\ GG'^=6:* *V^[_YYQ_G1
MON_^><?YU9HH K;[O_GG'^=&^[_YYQ_G5FB@"MON_P#GG'^=&^[_ .><?YU9
MHH K;[O_ )YQ_G1ON_\ GG'^=6:* *V^[_YYQ_G1ON_^><?YU9HH K;[O_GG
M'^=&^[_YYQ_G5FB@"MON_P#GG'^=&^[_ .><?YU9HH K;[O_ )YQ_G1ON_\
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MT44E "T4E% "T4E% "T4E H 6B@TE "T4E% "T4E% "T4E% "T444 %%)10
MM%)2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@]**#T- #0
M:"P Y(%9FO37<&CW+6*!Y]GRC.._)_+-<KHNLG38YI+K4))HDB\R2*:(K(I
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M[\TRZIK,E[(B+% PC"^6@8'\3P*CMO $R:W!?76J-,EM*TL06(!VS_"Q]/\
MZ] '=K]T4M(@PHXQ[8I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
M/2BB@"EJ6G1ZE8RVLK,$D&,J<$<Y'\JP8O!<1$C7MU-=NT?DHSX!1<8_'K75
M44%QG*.S.23P9NMI(+K4+B974(H. %56!' ^E7[CPQ:W5S--*TC>;"82,]!_
MG%;N*4"@?M9]SEK;P;&HF-[=2W;RQ&$,^/D7&!CWID/@Q1!+%<WUQ<;HO)C+
M8_=K_6NLQ1B@/:S[G,S>$+>9&#3R@FV%OQCH,<_I2:KX;AD$]UAYW, A\LG
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M=N?O1Z@&(]BM>H5YAX!C^Q?$;QI:=%=K>50/=2#_ $KTX<YH 6BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ IO:G4W% ,Y_QI)L\)ZB?^F>/UQ5KPY&(]
M!LU'41XK)\?2%?#KP@G,TB(/Q;/]*Z*QB$-M'$/X0!0:R7[HMT44M!D&*,44
M4 )BEHHH **** "BBB@ HHHH *2EHH 2BEHH 2BEHH 2BEHH 2BEHH 2BEHH
M 2BEHH 2BEHH 2BEHH ;@_C]>*6EHH 2BEHH 2BEHH 2BEHH **** "BBB@
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M_@5 %C-&:@W7'_/-/^^J-UQ_SS3_ +ZH GS1FH-UQ_SS3_OJC=<?\\T_[ZH
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M>QH =129_P XJ&>[AM8C+/*D<:G!9CB@">BFA\C(Y&,YQUIJRY<KD9QGCN*
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M^(+JX@NKF*66\>"V;<YY;@D%N@SCK5:WU?QEYM[C5KOSH=_VV$DXC42'[F0
M#MQC!-?07EJ.0B_E5.^TFTU"TGMIX04F&'QP3^- 'A4GB#Q+-HOFVNK:B=+2
M^FB%R[DRC!^53CDU[%X)DOY?".G/JD[SWC19=WX+<\'GVQ5W2M!L-&TX6-G
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M;6/[.D6 1DD?0UV-(YJL8QE:+N%+24M!F%%%% !1110 4444 %%%% !1110
ME+110 4444 %%%% !1110 4444 %%%% !0:*#0 UB #GIWK@_AJ3/-XHO3RL
M^KR!6]0JJ*[/491!IUS,QPL<;.3Z8%<9\(+=X? JRR??N+N:8GZM_P#6H [Q
M!A13J!10 4444 %%%% !1110 4444 %%%% !1110 E4=73S-(O$QG= _\JOU
M!<IOM94/\2D?I0..DD8G@R3?X8L^?NKM_6NAKD_ <G_$F> ]89G4CTKK*"ZJ
MM-BT444&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 F*#2T4 -Q_G-4;O2+*_D5[FW21@,9-7\48H&FUL1QPI
M"@2)%51T &,4YD#J589!&"*=BC% GJ5K:R@LX1%;QJD8.0!4^TY!SS3L44 W
M=W,?Q#JQT32S=B$S-O5 @.,DG%4;3Q-*+U[;4[(VA6+S=XD#+@=>G-3>,-.N
M=5T/[-:H7D,T9(! X#9-4;KPW]ET^YFT^,S7\L13,SYX]!^=,WIJGR>\:D/B
M?2)K:2=;I1'&<.2"-OUIK>*M'CACE:[ 27.TX/..]<5_PC&KR6U^HL9 +C;A
M9'7)P?8UIZOH%V+N(P64DENUIY1CA"G8WXD4C;V%'FMS'377B72K-D6>[12Z
MAE]P>]1IXFL)-2>R#G<D?FEQTQ7+MX6O3YRK:!E-B8HR[ X?' ^N:NQ:/>Q7
M8S8;T>R$3.&7AL=.M G2HK2YT>GZY8:LSI:S;RG48(/X5J5Q'A+2-1L+]VEM
MG@MA"$'FE2V[V()XKMZ#GJQC&7NA2TE+09A1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %!HH- '.^.[K['X'UB8'#"V<#'J
M147P]M?L?@/2(^Y@#M]3S5?XF?\ (@:I_P!<S6IX1S_PB.E9_P"?9/Y"@#;%
M% HH **** "BBB@ HHHH **** "BBB@ HHHH *81E<&GTT]*8,XSPN_V3Q)J
MU@,[#)YB^V<?XUVE<3IWR_$>_"_=,0)_):[:@UK;IBT444C(**** "BBB@ H
MHHH **** "BBC- !11FC- !11FC- !1110 4444 %%%&: "BBB@ HHHH **,
MT9H **,T9H **,T4 %%%% !1110 449HH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** &[?>C;TYIU% #<'/7Z<4 >].HQ0 W!]?T
MH"^IS3J* &A<'.:=BDI: #%%%% !2$TC' )KA/'VJ:KINM>'%TG,LTMR5-MO
MV+-\IX)Q^/X4 =V&SV_6EW>V!ZFO!5^(.O:=X5TV6.^C>[WR/<QR$,^WS&&#
MD=N!]*WF^*%\%G6.U,TUG";BZC7'", T9''H10!ZYD]QSWYHS_D5YAX-\;ZO
M?Z?JTVL>4J6\2SQ3EUP W&UL#J/ZT> /&^JZW>ZC9ZBT<S0Q">*1, %2 1_.
M@#T_=Z<_2D+ =?I7AL7Q"\6/ME$MF89+5+P+P#Y;,P"].ORFM"^\?:Y('OH+
MBWCM+F/R8K4,#-"XB#^9TZ')H ]B#@TI./\ Z]?/Z>+_ !3;6^BW_P#:RW++
MISW%PI8'>OF*.1_>K5D^)^O2ZU<36]JIL(SY?V=F4,2%5MW3I\PH ]KS1N]N
M/K7G\_B76M-^'EOX@NC#+,VV:41]!$W3MUQ7&7?CWQ#X@TU_L4GV(++&4E!'
M(<C9V],_E0![D6P.F?I2@YKQRZ\>>(K2WFTJ66V75+:XD22\<@1D* P'3J>E
M>D^$]9;Q!X7T_57A,+7,0<H3D@Y(_I0!MT4"B@ HHHH **** "BD)P*3=],_
M6@!U!IN[TQBC=^(]J .?\=6QN_!&L0JNYS;/M^M0_#RZ^U^ M'DSDBW56]B!
MTKH;J$7-K+ P!$B%2#[BN&^%#O:Z%J.CS/F73M0DAP3T4[2/YT >@"BD!X[?
MA2T %%%% !1110 4444 %%%% !1110 444E "TPFG9JIJ-VEII]Q<.P"Q1LQ
M/T% )7=CE?#:_:?%>K7>=P5_+#?3'^%=K7+>"+5XM&^T2IMEN9&E)]0>E=1G
M!'(H-:K]ZPZBDW?2C)]L4&0M%)FEH **** "BBB@ HHHH 0\"FO(L8RS #L2
M<4^N$^(*W%Q+I5A&\(BN)2KBX;$;<<!CZ9H [<S( #N&#T.<9^E'F L!CK[]
MJ\56[CUUK6UM;*T7[+#(K1WL^V(LO\2'![CCI]:UK:QO!I>DZLEV%S!#'&S$
MF7<,< =UR#^% 'JBR!LD8(SC(.:$E5\@%202" >F#7*^%]7AN[F:T2WD1V)D
M,SL"78-\P(ZC!-<M+=ZM8WVM:G:ZB8X([Y5\G:#E2V#0!ZMFC/M7D;>+M2CU
MJWDCU662UN+R6#YQ&L0 ) Q\V[((QT[5//XMU^WAOXQ(TESI0G%RH09)+,8C
MC']W;0!ZKNYQ1GG&/SK@/!NJZQ<:O);WMW)<0-;+*/,\LLKD G 4DXY[@5D:
MMKOB*+[;>0:P(XH[[R(H3$#A<D<_E0!ZKN[8/-,,JHA9RJX&3DUYL-9U>ZO+
M?19=9^RE)9!+>[0#)C[H]JQTU34]0^U/=ZB9]MF\2$#:LFV3 ?\ I0![(K;N
M1R/7M2EL5Y%?Z]X@T"""U346N#<6$;QCRPIB8G&1GJ/J?QJXFL^(Y--NK*+4
M2DINEB@NY!&[J#C.0I*YY/<4 >H@YZBD+8QZ5YJNJZOI_B01WVI79LQ<+;K,
MD*M$QP/E89RK9SD<]:TO'&I:W8RI;Z3=".:]C,=L-@.V08)_3- ';-*J ;V5
M<^I[TBRJ7V97=C.,]J\TM=>U'6;,W9N 8!<): F,<3*H$A'_  ,&J%@-4EFL
MQ;ZLT4\=G,[2E<[BKOQ^E 'K;2JB;V(5<9R3Q0944C<P&XX7)^]]*\^FU"[U
M7X6?;)Y"\ZL0\@&,A9",\>P%1^(M8B>T\/3:?>QO/Y;21[3G&(\Y(_.@#T?-
M,$R%RNY=P&2N>0/I7E:>(/$6D-9R7>K"]^V:?]H*>4%\MO4>U4SJNI:7>ZM?
M)J7]H7<EK;X>-0/*W \X/'?VH ]CWC_]5+NYQ7E,.J>)IKI-.CU22+SI8BLL
MJ(S@,&+* ">N.M3W6L:ROVZ;^WTA-C>I:BW9!F4;AEOQ!.* /3P?:D)Q7F5S
MKFK6]C?7EUK>PW%Z8+2W2(%@JG!';GD54T_Q'K&H7<&CG5VMLR39NIU0L0%4
MJIP2 ?F- 'JT<J2@E'5QGJIS3MWM7C7AW7K[1;.[M_[2C>,0W<ZRM@!Y5*8Q
MGZFKNJ^*]3:RB>WU.?SH;'[3(D,:;=VXX+,2."..G:@#U??DD#&1[TH8$ ^M
M>-2^(M7TQ]5GMKUYI;RZMXTP1B!6BR2-Q Y..AZYKN/!-_J5W'?QZA<-,()@
M(GD*[\;3D':2,\#OW[=* .OHI!T&:6@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 1AD8K$UNXT>TFLKO560
M2QRL;8GKNVGI^&:VS_6N"^(FE7%_-I4UO;S3- \A^12<?NVQQ]<4 :">%/#&
MJVEM.-/B:)E8KGC<&;)!SSUJY8Z1X>W74EM9PKY@^SS97&Y8_DVG/H!C\*\F
MN=-\23VDDX@U1)+>VB:!(U8#=D;N/SI?$D?B+[#!*L6I;Q/*QA2%\OEB1RO?
MZT >G:%I/AB :EI.FPQLR/MNXR,YZ$#GMR*NZ3X8T31=[Z?:11DIY;N.X]#^
M&*\GN-,\31:K?:KI5GJ$-_<7:HJ%3RGE#D]NHZU0TNW\5+#OF?5&L'D5M118
M9/,4DC?L!!)_X#0!Z[IFD>&-4L%N+"V@EMTC-N" < *3Q^9-3)X0\/1:D=2%
MG%YWEK!N+<8"[0/RXKB=!M-7L/@Y+;V5K=Q78ED*(Z$2E"W!VGG.*P)8KP6E
MHHCU_P#L;R2V?*D\W[7CGC[P7..O% 'H5Q8>"]/NWTV2"".=5"&+;R%<[@/I
MQ6@W@WPX^HO>?8HO.\ORVP> ,8S]>GY5Y3%I7B6XDAN)]/NGNV@MMKM'@G .
M,GMBJ"IXMB>]F::^1RS?;U>*1 $+G.UF4*3C'W30![S-INGSZ0=/EAC:Q,8C
M\LGY=O857C\,:*D'DII\*QX7Y0O]W.W\LFO#WGUV^T/;83:@^D)?SH'V.T@
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M5H44 8^D>&],T1G:RA97?@LS%CCT^E2RZ#IDT3126B,C2>8P/=LD_P!:TZ*
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M@*H& H ^E,C1%4 #'&.E24,F<^9Z;!M4=A^5+@>E)2TB!-H'84;5]!^5+10
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M.ZL;A)[>0 JZ-D?2@"Q]IA_YZ+^='VF'_GHOYT_:N<8Y_"C:/3^5 #/M,/\
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M3#_ST7\ZDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?SJ3:/[O\ *C:/[O\
M*@"/[3#_ ,]%_.C[3#_ST7\ZDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?S
MJ3:/[O\ *C:/[O\ *@"/[3#_ ,]%_.C[3#_ST7\ZDVC^[_*C:/[O\J (_M,/
M_/1?SH^TP_\ /1?SJ3:/[O\ *C:/[O\ *@"/[3#_ ,]%_.C[3#_ST7\ZDVC^
M[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?SJ3:/[O\ *C:/[O\ *@"/[3#_ ,]%
M_.C[3#_ST7\ZDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?SJ3:/[O\ *C:/
M[O\ *@"/[3#_ ,]%_.C[3#_ST7\ZDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\
M/1?SJ3:/[O\ *C:/[O\ *@"/[3#_ ,]%_.C[3#_ST7\ZDVC^[_*C:/[O\J (
M_M,/_/1?SH^TP_\ /1?SJ3:/[O\ *C:/[O\ *@"/[3#_ ,]%_.C[3#_ST7\Z
MDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?SJ3:/[O\ *C:/[O\ *@"/[3#_
M ,]%_.C[3#_ST7\ZDVC^[_*C:/[O\J (_M,/_/1?SH^TP_\ /1?SJ3:/[O\
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M+:5D*,T:Y5NHX[U;IH'-.H **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW'_*C[:O]Q_RH M455^VK_<?\J/MJ_W'_*@"U157[:O]Q_RH^VK_ ''_ "H
MM455^VK_ ''_ "H^VK_<?\J +5%5?MJ_W'_*C[:O]Q_RH M455^VK_<?\J/M
MJ_W'_*@"U157[:O]Q_RH^VK_ ''_ "H M455^VK_ ''_ "H^VK_<?\J +5%5
M?MJ_W'_*C[:O]Q_RH M455^VK_<?\J/MJ_W'_*@"U157[:O]Q_RH^VK_ ''_
M "H M455^VK_ ''_ "H^VK_<?\J +5%5?MJ_W'_*C[:O]Q_RH M455^VK_<?
M\J/MJ_W'_*@"U157[:O]Q_RH^VK_ ''_ "H M455^VK_ ''_ "H^VK_<?\J
M+5%5?MJ_W'_*C[:O]Q_RH M455^VK_<?\J/MJ_W'_*@"U157[:O]Q_RH^VK_
M ''_ "H M455^VK_ ''_ "H^VK_<?\J +5%5?MJ_W'_*C[:O]Q_RH M455^V
MK_<?\J/MJ_W'_*@"U157[:O]Q_RH^VK_ ''_ "H M455^VK_ ''_ "H^VK_<
M?\J +5%5?MJ_W'_*C[:O]Q_RH M455^VK_<?\J/MJ_W'_*@"U157[:O]Q_RH
M^VK_ ''_ "H M455^VK_ ''_ "H^VK_<?\J +5%5?MJ_W'_*C[:O]Q_RH M4
M55^VK_<?\JL*VX4 .HHHH **** "@T44 )2T44 %%%% !1110 4444 %%%%
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MJ"-U '2>8I.,_E3J\4\/2"QO=&U%K:2$%[E)+AI,B?(.!CZUT=[XPUNT\/\
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M2WC@GN(':/8,,B!N,_4<UZ19\VD!_P"F2\_A0!8HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "DZ4M% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 C=.F:;MY[Y]33Z* .;\7^#
M-,\9Z>EGJ2MM1MR,OW@:L^&_#=CX6T6'2[!"L,8(R>K$DG)_/]*VZ* &;<'.
M">U.QQC%+10!S&I^!])U/4Q?2Q.KDY98_E5_]X=ZO'PWIGVM9EM@A6)8@%&
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M2VO@_1[/5FU&.U_?E2,-DJ.,$X]2*Z*B@#F;;P7H]O=RW MRQ?< KC*H",$
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< !1110 4444 %%%% !1110 4444 %%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>afyaform20f_022.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_022.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )] I$# 2(  A$! Q$!_\0
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M5EM$Z^BN('Q2T,_\N]__ -\)_P#%TO\ PM#1/^?:_P#^_:?_ !=+F1?U.O\
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M#*>A!ZU/GBD8M-;BYI:;FE[TQ)W%HHHH&%%%% !1110 4444 %%%% !1110
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M?F-NBTJ)ONG_ ):5Z!:6<%C;I;P1JJ+T & *3.G2EZD>GV$-A:I!;J(XU&
M.:MX&>.E+TR::Q&.E,YVVW<4_6FDTA.:2D&@4444Q!137.U=W?FN%;Q1JKLS
M0LC+@G CSM'O0W8UITI3V.\HK@%\4:JRJXD0AN WE?*3Z#FNTTR[-]I\%P1@
MRJ&Q054H3IK4MT49SS108!1110 4444 %%%% !1101B@ / S7.ZW>DMY2'ZU
ML7]R+>W9CUQ7'32F:0R')S2N.PW/<TE'7J#1TZ\>]258*,$GA23[5>TS3'U&
M3!XB'5A750:7;6T1$<:EP.N*=A7.)6-G?;M.??M4DUM+"H9P,'@$5;D#1:K<
M1OQO)'/8^M13AX+<13')9L\_PBBP7*=% !P.,9Z9]**0R>TN&MYE;/&>:["V
ME$T*D&N(K=T6]X\MCTJDQ-'0T4F<C-+3)"BBB@ HHHH **** "BBEQF@!**:
M[!%.3C')/M7*W'CW2H[AXU\UMIP2JY%)NQ<(.6QUE%<>?B%I>,;)_KLKHM,U
M6UU2Q2ZMI-T;>W2BX3IRBKLO4"@#CK13)7<7I0&Q244A=24&D(!X(I@-2 T#
MUZ'*^)O"R:DHNK-O(OH^8Y%XS]:K>&O%#R3G3-20PWD?R[FZ2>]=G@$8Q7,>
M)_#2:I&L]M^ZO(N4=>"?;-!O&2DK2.F1L\]!Z5)7%>%_$LKW!TC4_P!W?Q]V
M_B%=F&SQZ4S*<;,D'2BFCI2T$"T4E+0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !24M'>@0G2DS3JC=PB%G.!0-$%U<QVL#S3$*B\L2>E>>W$
MEWXYU?RHBR:7$W7H'J36M0N/%6L?V/I[%;.,_P"D2#O[5VNE:9;Z98I;6Z!4
M4<8[T'2DJ<>9_$2V-E#86ZP1*%1!@8JWZTF,C!X I&-(P<G+5[@6 XJ,\T$Y
MHH$%%%%,04R2:*( R2*H/=CBGDX&:X[QH^#:==@8Y+' S@TGM<UH4_:3Y3H;
MC4[01,!<Q!L=G%>;A+AT9H956,*&=,@%UW'I5=@D+%)-GF;06*C(Q0TL+*H)
M "C:"%Q63E<]JCA/9IW9*/W@CEA;;9F7"0$\[N<G^=>@:%?VB:-:*9XE98P"
M"X&*\Z62)&5E.&Z$A>GTI%\AR$&,L0!E>,TXR*Q&#4TO>/6X;F";<(I4<KR0
MK U-]*X'PJ_EZKM)4E8R'V<#.>_X5WH;=SG/TK5;'BUZ'LY-"T444&""BBB@
M HHHH *"0H)HK.U6\%O P!Y:@#'U>\,LOE@_*.M9B(7D"+WIK,7))/)-6++B
M\CZ?>'6H9:)$LADB:0 CL!5O3;6.*YS<1AXF. S<5<GB1CE2H8>G:H1!+=1L
MID'R,"S>U'439T<,,-N,0QJ@/I4W>H89$DC5D(( QQ6=<Z]!;7!@9'+"J)&:
MSIL,Q$X)68G:/?TJM%X;=Y US.''&1ZU<M;ZWU:<81@8CFM8<]>#TH&8.L:,
MTRQ/:I\R<8]17.S6TUN<31LGU%==?:S!9/Y/,DO]T54.KVEVPM[N$Q[NC,*5
M@N<N0:D@E:&4,I[U9U.Q^Q7'RX,3\H1W%4J74H[.QN!-; YYJW7*Z/>F.01L
M>*ZE6#+D52)8M%%%,04444 %%%%- Q#63JOB/3]'D$=U-M<C(4#)K6(RI!'%
M<#=01WGQ!$=Q&LB"/@.,^M2S>E%2W+UUXWTNXBD@25LLA .T_P"%0> ;:";1
M7DDA1BTK'<RYSTK;OM#T^.TD9+. %4[*.*P_ E_;6NCR133(A\YL G'I2>YT
M7A[.\#I+ZQM5LIF\B+(0_P 'M7%>$_$=AHNEO!=RLA,AP-I/]*U?&>LC^R56
MRNEW,^UMK<XKF3HITS5=+$DHG2X<;E9?I0]&:TH)TVYG8+X]T<N5,SX SNV'
M_"MG2]<L=80M:2A]O4=#48T'3/*S]B@_%17,>'(H[;QQJ,,2B.,+PB]*=SGY
M833Y>AWN>:*".]%,XY:,*4-BDHI!<ESFAEW#!Z4P&G@YXH&<IXI\-_VA&+NT
M(CO8OF1QU/L:;X5\2F\0V%]^ZOX>&1NX]:ZPH#UKC/%?AYS(NKZ9\E]"<D#_
M ):"@WC)27*SM5.5R*=GFN;\,>((]8LOF^2YCXDC]#71CKGUIF$X.+'4M)2T
M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:1R:=4;$AC0%A&X
M6N'\6:Y-/<)HFE$O=3<2,/X16QXJU]=(TUO+P;F3Y8D[DFL_P?H#VJ'4KW+7
MDXRQ;^$>E)G13C9>T9I^'M!BT6P6(#,K8+MZGO6[T_*@ 4=*#*4N8:33.M*Q
MR:2F2T%%%% @HS11F@.IB^*9I(=$D:.4QL64;AZ&O/9ENF.R9^"1A&<?-7I^
MKQ)+I5RKJ&78>#]*\U5D%O)NM_.);9O+'">^:B6YZN"E9!-N4,@#1 !OER"
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MCI69X&U1KK3C93G_ $BU;RV!ZX%(Z)KGI<ZW.RHHHIG.%%%% !1110 4444
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MA]>U #7=8D:1SA5&37BWC'QI,?$"+:RD1QMS@UW7C[Q$NDZ3)$C8E<$<'FO
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M9[D<58LKI[2Y6=3C# 5MP^-HI&V7NE120G@[!TI=4T6RN[$ZOHS9AQ^\C/\
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M4[H.Y)&#11108MA1110 4444  SG':L/Q3K,>CZ5+(S -C"\]ZVI'$:,S'
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MT"UK,!U*'^5!4=SSO[);R"RNO[1DM;E8PI5!GI^%3)>72:M;V3:DUU#<Q/U
MXX/M5WPM:"6ZE:: 8CC5,R+W%8?DS0:I!(L$A6U9M^T>N?\ &FMCT(2C)ZFY
MX&QYNH(1MV2!/KC(KIM;!_L2\R /W3#/X5Q_AJ:ZTF>^FDT^ZDCN)2Z;5[9/
MO6S?ZU+=6,\"Z9=AY$*C*\<_C2,:R_?)HYP7SZ?I%Y=6[".0F-%91_LBI+^U
M^V1FVOM=G9>K(%R/S JA<6-W)8)8?9Y5N5D$KAAQM'^171:;9M<Z%?R?9OFE
MWE0P^:F=,Y1M?J6_#^W^UKQ8CNCB14#>O0UU&<\UR/A!)/-NW:%T7A3N]>*Z
M[I2//JN[N%%%%!D.7K3Q3$IQZ_A28SB/%@QXJ\.G_I[C_P#0UKO:X3Q;_P C
M1X<_Z^X__0UKNZ43IQ'\.GZ/\PHHHJCE"BBB@ K@_B<F;"R?LK/_ .RUWE<7
M\2H\^'UDQ]PG^E*6QT81I5E?^M#H=*;=IMN1W0?RJ^>E9>@.)-%MB?\ GF*U
M#TH1G5_B,B/6DI3UI*9F%&>!39)4AB:21@J*,DGL*R%\5Z(SA!J$1).!P?\
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MS?9=6,22N7*A1QG\*WO#V@IH<$BB5II)6W/(PZFA(56<7$VJ***HX>@4444
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M3VSP /K06D'I[T=^.?I5F_L;C3KK[/<KME SS4UEHFI:G$TEE:231J<-L&:
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M^J.YZBF,*<"",T'!H.<B-%.84V@04444P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** U#\*3(]ZQ-?\0)H8B8PLX<Y
M.WGCO38O%5O)&'^RWGS#*XCZT&GL96N;W8'K16?I^JP:A)(B)(DL8!9)!@@'
MI6A02XV"BBB@D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ '-2+2+CO3N!2&(Q(K!\4:XFCZ<S#YIGXB7N36I?WT-A:RSS.
M%1!DDFN&T>UG\8:Y_:MTK"RA;]RI'!]Z#:E'[;-3P=HCV\+:I?9:[N3N^;JH
M]*[,*,"HUC"C"KTJ4=*9E4J.<N8 ,=*6BB@@****!A1110 4444 %%%% !11
M10 4444 %%%% !33U-.I.] #&Z<]*X_Q?X>>[A6_L#Y=[;G=D=6'I79'FFM&
M&!!&<T%0FXLYGPMXB&KV:I+^[NH_D=#UR.*Z0<\UP7B/1KC1]1.NZ6#E/]=$
MO0CZ5T^A:W!K-@D\+#)'SKW4TMC6I%-7B:^,U&5Q3U.>?7I2L,TD8$0HI2,4
ME,84444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 44A.!FN8U/Q1<V=Q=+#9"2*V WON]1F@I0<]$4O'49E%K&",OO4?D*L6 U
MFULX84LH) J !F/_ ->L>>\O?%#QF.U5#;,78,3_ )[5;LO&-T[K;)8 E<J#
MGKCK_*IN=\XRY$C=T>TOEU*[N[V..,2JH^4^F?\ &MVL[1=1_M/3X[EH]FXD
M%>M:--'!-N]@HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?VH[&@1D5&1@U)CC@YHP#2,2*BG,N*;0,****8@HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ABB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>afyaform20f_023.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_023.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (  X<# 2(  A$! Q$!_\0
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M/8_"VJ163:<UR9(1-O$NW&688Q@_W?UH-J%"I7GR4U=G8T5YA_PN*'_H"/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MW9QS&RLN#ZAACIR*]5\67^JZ;X<NKC1+%KW4<!88@,\DXW$>@&3^%>=?'_\
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MC*MY<(ORJ,[8E 4]<<L02!CKFNN^&>O:KK.BWUOK;K)J&FWLEI+*N/WFW'/
M [D?@*Q?@W_S-/\ V%&_K5[X7?\ 'QXO_P"P]<?SH L>+'\9ZEXEM-'\/.=,
ML!$99]3:(."W.$&1]/S]N:'@#Q3KC^*M5\(>(YX[N^L5,L=U&H 905R#@#LZ
MD<>N:H>*+[7?%WQ(F\&Z1K,ND6ME;">>:('<[84]5()'SJ,9'?KQ6-\.=,N=
M&^-.L:?>7\E_<0V3![F3.Z3)B.3DD]\=>U '0^-O^2P^"O\ @?\ .O4*\O\
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M&V*']YM5ODZ[0PZ'KUKZ&KR;7_\ DXOP[_UXG_T&>@#UA=P10QRV.3[TM%%
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MOO#'UYKJ** "N.\4^ EU_6[37;#59]*UBU3RX[A(Q(NWGJA(Y^9N_?O78T4
M(H(4 G) Y/K2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI' !X9&]P0>^:Z'PAJ-]K.G3:I>K)$)Y-L-NXQY:H K=.N7#G/IB@#HJ***
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MD@;S%+X)P2N0.%/7'IU(KEH]%UJ&TLHIK%)XM*U)[B*".5<3PLK[%3=@ H7
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M4MZFM:>UK$0LDRW*%4)Z G/!-<WJ?@ZY_P"$:OK:'9//)+>S!4 5G$V_"@G
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MT=+:VU:[NU,S1>68Y3)AD*,7WX8<, .3GD##;G2?$\LM_P"1)J$327$>66Y
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M*_\ "OH_^AG\3?\ @>/_ (F@WI0I23]I/E^3?Y,["BN/_P"%?1_]#/XF_P#
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M<<X&L6H_WGQ_.G_\);X>_P"@S9?]_A0!LT5C?\);X>_Z#-E_W^%'_"6^'O\
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ME1Y4?_/-?RI]% #/*C_YYK^5'E1_\\U_*GT4 ,\J/_GFOY4>5'_SS7\J?10
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M_P"^!1]FM_\ GA%_WP*EHH B^S6__/"+_O@4?9K?_GA%_P!\"I:* (OLUO\
M\\(O^^!1]FM_^>$7_? J6B@"+[-;_P#/"+_O@4?9K?\ YX1?]\"I:* (OLUO
M_P \(O\ O@4?9K?_ )X1?]\"I:* (OLUO_SPB_[X%'V:W_YX1?\ ? J6B@"+
M[-;_ //"+_O@4?9K?_GA%_WP*EHH B^S6_\ SPB_[X%--G:L<FVA)]XQ4]%
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M$T1C:5U9R6VG!& P'(%='0 4444 %%%% !1110 4444 %%%% !1110 4444
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M^$WU7_H2]9_[X_\ K5V?:JD]S,+M;:".-G,9D)D8@<$ #@'KGKV]Z ^L4/\
MGRO_  *1R_\ PF^J_P#0EZS_ -\?_6H_X3?5?^A+UG_OC_ZU=0VI6Z7,D#$A
MHR@9N,#=G!)SQR"/K4*:S;NZ*(I\.0%8I@9P#]> P/Z=>* ^L4/^?*_\"D9>
MC^*+_4]2CM9_#6I6,; DSSKA%P,\_6NEJE-JD$$\L3A]T<9D^7#;@,9P <Y&
MX=0/:A]0"O;@Q.OFR,C!NJ[5)Z#.>G;UI'/5G"<KPCRKU;_,NT5GC4P<.(SL
M,9?;N7=G(&,[L=_6E75[9Q&RB3RG1)/,V_* P)7/?G%!F7Z*H6VIK/*$,4B%
MF(7=@8& ><GWZ#-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?(7<MMX],XK9J7OH<U=1C5DH;7T"BBBD9!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%1-<P(Q5IXU((!!<#!/04
M2T4P2QLQ4.I(." >_I3Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LW5++4[MHCI^K_ & *
M#O'V99=_IUZ5I44%0FX.Z_S_ #.=_L?Q)_T-?_E.C_QH_L?Q)_T-?_E.C_QK
MHJ*+FWUJ?9?^ Q_R.=_L?Q)_T-?_ )3H_P#&C^Q_$G_0U_\ E.C_ ,:Z*BBX
M?6I]E_X#'_(YW^Q_$G_0U_\ E.C_ ,:/['\2?]#7_P"4Z/\ QKHJ*+A]:GV7
M_@,?\CG?['\2?]#7_P"4Z/\ QJCJL'B'2K'[4_B=I%\R./:NGQ Y=@N>OO78
M5@^,/^0!_P!O5O\ ^CDHN'UJ?9?^ Q_R(_['\2?]#7_Y3H_\:/['\2?]#7_Y
M3H_\:Z*L?5[B^@N8VMDF:-87=A$A.6#+Q]TY.-V!D9]:+A]:GV7_ (#'_(J_
MV/XD_P"AK_\ *='_ (T?V/XD_P"AK_\ *='_ (UH:A>WEK:32PVS32*Q\N)(
MBQ90,^HQD]_T-->XO);*<F*1)E<A55"#CL0<G/UX^@HN'UJ?9?\ @,?\BC_8
M_B3_ *&O_P IT?\ C1_8_B3_ *&O_P IT?\ C71447#ZU/LO_ 8_Y'._V/XD
M_P"AK_\ *='_ (T?V/XD_P"AK_\ *='_ (UT5%%P^M3[+_P&/^13TRVO;6V,
M=_?_ &V4L2)?)6/ XXP/QY]ZN444&$I.3NPHHHH$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4M5U>RT2Q:\O
MYA%""%!QDDGH !U-36=Y;ZA9Q7=I*LL$J[D=>XJIK>AV/B"P-G?HS1[MZLK8
M96Z9!_$TEGX?TRQM([:WMRD48PJB1O\ &@#3HJE_95G_ ,\F_P"_C?XT?V59
M_P#/)O\ OXW^- &=-8W+W5PPM2T#H0B JI#G.&Z]O[W7GVJY#;W4.I'C?;'Y
MMS'D,0=QZ_[H QW//:LSQ39PV>@2SV_F1RB6$!EE;.#*@/?T)%;']E6?_/)O
M^_C?XT 7:*I?V59_\\F_[^-_C1_95G_SR;_OXW^- %VBJ7]E6?\ SR;_ +^-
M_C1_95G_ ,\F_P"_C?XT 7:R)M.NGFE96B:)TD01R.<#>3ENGT&/K5K^RK/_
M )Y-_P!_&_QJCK>GV]OH.HS1*Z21VLKHPE;((4D'K0!<CLI(=06:(HL6TK("
M26?.3GV^8_S]>+]9&F:=:RZ39R2([.\",S&1LDE1D]:M?V59_P#/)O\ OXW^
M- %VBJ7]E6?_ #R;_OXW^-']E6?_ #R;_OXW^- %VLW5[:>YB1(5+8W$X(],
M#J1CZCD5+_95G_SR;_OXW^-']E6?_/)O^_C?XT 4#8W7V7>D3+>(HP2PVO)G
M)<^Q('H2#@UK6BR+;(LB[7&01G.>>"?<]3]:PM'LH9[_ %E)?,=8;S9&#*WR
MKY2' Y]2?SK6_LJS_P">3?\ ?QO\: +M%4O[*L_^>3?]_&_QH_LJS_YY-_W\
M;_&@"[15+^RK/_GDW_?QO\:HZW86]OH.HS0JZ2QVLKHPD;((4D'K0!MT5D:9
MIUM-I5G+(CL[P(S,9&Y)49/6K7]E6?\ SR;_ +^-_C0!=HJE_95G_P \F_[^
M-_C1_95G_P \F_[^-_C0!=HJE_95G_SR;_OXW^-']E6?_/)O^_C?XT 7:*I?
MV59_\\F_[^-_C68EC ?%,]N1)Y*V4;A/-; 8NX)Z^@'Y4 =!15+^RK/_ )Y-
M_P!_&_QH_LJS_P">3?\ ?QO\: +M%4O[*L_^>3?]_&_QH_LJS_YY-_W\;_&@
M"[15+^RK/_GDW_?QO\:/[*L_^>3?]_&_QH NT52_LJS_ .>3?]_&_P :/[*L
M_P#GDW_?QO\ &@"[17,^*[*"U\.7$T DCD5X@&65LC,B@]_0UL_V59_\\F_[
M^-_C0!=HJE_95G_SR;_OXW^-']E6?_/)O^_C?XT 7:*I?V59_P#/)O\ OXW^
M-']E6?\ SR;_ +^-_C0!=HJE_95G_P \F_[^-_C1_95G_P \F_[^-_C0!=HK
MFO"MI%>^&[2XN?,DF??N=I6R<.P]?05L?V59_P#/)O\ OXW^- %VBJ7]E6?_
M #R;_OXW^-']E6?_ #R;_OXW^- %VL'QA_R /^WJW_\ 1R5H_P!E6?\ SR;_
M +^-_C6)XLTZUBT+<D; _:;<??8]94]Z .HHJE_95G_SR;_OXW^-']E6?_/)
MO^_C?XT 7:*I?V59_P#/)O\ OXW^-']E6?\ SR;_ +^-_C0!=HJE_95G_P \
MF_[^-_C5/5].MH=%OI8E=9$MY&5A*V00I(/6@#9HK&TC3[:?1;"657>1[>-F
M8RMDDJ,GK5S^RK/_ )Y-_P!_&_QH NT52_LJS_YY-_W\;_&C^RK/_GDW_?QO
M\: +M%4O[*L_^>3?]_&_QH_LJS_YY-_W\;_&@"[16)<6%NFLV,2JXC>.4LOF
M-@D;<=_<U>_LJS_YY-_W\;_&@"[15+^RK/\ YY-_W\;_ !H_LJS_ .>3?]_&
M_P : +M%4O[*L_\ GDW_ '\;_&C^RK/_ )Y-_P!_&_QH NT52_LJS_YY-_W\
M;_&C^RK/_GDW_?QO\: +M%4O[*L_^>3?]_&_QK+M;*!_$^I6["0PQV]NR)YK
M84L9<GKWP/RH Z&BJ7]E6?\ SR;_ +^-_C1_95G_ ,\F_P"_C?XT 7:*I?V5
M9_\ /)O^_C?XT?V59_\ /)O^_C?XT 7:*I?V59_\\F_[^-_C1_95G_SR;_OX
MW^- %VBJ7]E6?_/)O^_C?XT?V59_\\F_[^-_C0!=HKF/#MI%=/JXG\R3RM1E
MBCW2M\J@+@#GIS6U_95G_P \F_[^-_C0!=HJE_95G_SR;_OXW^-']E6?_/)O
M^_C?XT 7:*I?V59_\\F_[^-_C1_95G_SR;_OXW^- %VBJ7]E6?\ SR;_ +^-
M_C1_95G_ ,\F_P"_C?XT 7:*YGP_9PW)U7SO,?RM0EC3=*WRJ,8 YZ5L_P!E
M6?\ SR;_ +^-_C0!=HJE_95G_P \F_[^-_C1_95G_P \F_[^-_C0!=HJE_95
MG_SR;_OXW^-']E6?_/)O^_C?XT 7:*I?V59_\\F_[^-_C1_95G_SR;_OXW^-
M %VBJ$FEV8C8B-L@'_EHW^-9?ABTAO?#.GW-R'DFDA#.YD;)/YT ='15+^RK
M/_GDW_?QO\:/[*L_^>3?]_&_QH NT52_LJS_ .>3?]_&_P :/[*L_P#GDW_?
MQO\ &@"[16+);16OB+3A"'4/#/N&]B#C9CJ?>MJ@ HHHH **** "BBB@ HHK
MP+XF7]Y!X]U".&[GC0+%A4D( _=KV!II7._+L"\;5=)2M97/?:*^5/[5U'_G
M_NO^_P W^-']JZC_ ,_]U_W^;_&JY3VO]6)_\_5]S_S/HWQE_P BS-_UWM__
M $<E;U?*3ZC?2+MDO;AEZX:5B/YT[^U=1_Y_[K_O\W^-'*'^K$_^?J^Y_P"9
M]5T5\J?VKJ/_ #_W7_?YO\:/[5U'_G_NO^_S?XT<H?ZL3_Y^K[G_ )GU717A
MGB2^NT^&GA65+J=9':;<XD(+?,>I[UP_]JZC_P _]U_W^;_&DHF&'X>E6BY*
MHE9M;=G;N?5=9OB'_D6M5_Z\YO\ T U\S?VKJ/\ S_W7_?YO\:1M3OW4JU]<
MLI&"#*Q!'YT^4W_U8G_S]7W/_,^H-(_Y MA_U[Q_^@BKE?*8U/4%4*M]<@ 8
M $K<?K2_VKJ/_/\ W7_?YO\ &CE#_5B?_/U?<_\ ,^JZ*^5/[5U'_G_NO^_S
M?XUVWP[OKR;_ (2'S;J=]NE2LNZ0G!XY'O2<3'$</2HTG4=1.WEYI=_,]UHK
MY4_M74?^?^Z_[_-_C1_:NH_\_P#=?]_F_P :?*;?ZL3_ .?J^Y_YGT?H/_(2
MU_\ Z_Q_Z*CK<KY374KY"Q6]N 6.6(E;D^IYI?[5U'_G_NO^_P W^-'*'^K$
M_P#GZON?^9]5T5\PZ-J>H-KFGJU]<E3<Q@@RMS\P]Z]ILO"^GZW=ZK=7KWAE
M%_*@V74B *",# .*35CS\;E*P;7M*FENB\[=SM:S?$/_ "+6J_\ 7G-_Z :R
M?^$ T/UO_P#P.E_^*I&^'VA.I5A?,I&"#>RD$?\ ?5+0X/9X?^=_^ __ &QN
MZ1_R!;#_ *]X_P#T$5<KEA\/]"50J_;@ , "^EX_\>I?^$ T/UO_ /P.E_\
MBJ- ]GA_YW_X#_\ ;'445P=KIT.CZ_X@L;5YS;C2ED"RS-)AB7!/S$^@I?#G
M@/PQ>^&=*NKC28Y)YK2*21R[_,Q4$GKZT6-)86E"/-*;MI:R[J_<[NBN7_X5
MUX2_Z T7_?Q__BJ/^%=>$O\ H#1?]_'_ /BJ-#/EPW\\O_ 5_P#)'45CQ_\
M(Y7/_8/B_P#1DE9__"NO"7_0&B_[^/\ _%4?\*Z\)?\ 0&B_[^/_ /%4:!RX
M;^>7_@*_^2.HHKE_^%=>$O\ H#1?]_'_ /BJ/^%=>$O^@-%_W\?_ .*HT#EP
MW\\O_ 5_\D=117+_ /"NO"7_ $!HO^_C_P#Q54=:\">&;+1+ZZMM)CCGA@=X
MW#O\K 9!ZT:#C3PTI**G+7^ZO_DCMJ*XF'0M.UOQMXC_ +1MS/Y)MA'^\9=N
M8N>A'I6I_P ()X;_ .@;_P"1Y/\ XJ@)T:,+*4G>R>W=7[G145SO_"">&_\
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MKH@]OM\__P 709<F'_G?_@/_ -L:FA_\B_IO_7K%_P"@BK]<X/ OA\  6UT
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MG_Q5 <N'_F?_ ("O_DCHJ*YW_A!/#?\ T#?_ "/)_P#%4?\ "">&_P#H&_\
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M!+7\C_C1H'+A?YI?<O\ ,W/M=M_S\1?]]BE6Y@9@JSQDGH XK"_X0/PM_P!
M2U_(_P"-9NK^%M#TF32[JPTR"WG&HP*'0'."W-!4*6'F^6,I7]%Y^?D=I17"
MW6@:7KWQ%U&/5+1;E(K&%D#,1@DMGH16E_PKKPE_T!HO^_C_ /Q5 2HT()<\
MG=I/1+K\SJ**Y?\ X5UX2_Z T7_?Q_\ XJC_ (5UX2_Z T7_ '\?_P"*HT)Y
M<-_/+_P%?_)'32_ZI_\ =-8O@[_D3]*_Z]UJG_PKKPE_T!HO^_C_ /Q5(/AS
MX2 P-&C_ !ED/_LU&@<N&_GE_P" K_Y(ZFBN7_X5UX2_Z T7_?Q__BJ/^%=>
M$O\ H#1?]_'_ /BJ- Y<-_/+_P !7_R1U%%<O_PKKPE_T!HO^_C_ /Q59NO^
M!_#>G:)<W=II4<5Q$%9'#N=IW#U-!4*6'G)14Y:_W5_\D=->?\C'IG_7&?\
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M_P#>F_\ 0C7))K>K10Q0QZI>I%"08D6X<*A'3 SQ^%)'+AJ,ZE)\KM[T^_\
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M7 54P;6*0KMZY+,S9]\9Z"N=\1?\??BK_L(Z;_Z#'7I"6T$;LZ0QJ[OYC,$
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M<1_.S!M?!NBVMC?6:V\LD%]M%P))W8OMZ?-G(_ U'_P@WA__ )]KK_P/G_\
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M\(9X9_Z 5A_WX6MRB@F.(K15HS:7J_\ ,P_^$,\,_P#0"L/^_"T?\(9X9_Z
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M"NHKE_'O_(!M_P#K_MO_ $8*:W.K!?[Q#U_S-K49)8S;[3,(2Y$IA0NV,''
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M6#XU_P"1-U7_ *X'^8H M?VU_P!0S4O_  '_ /KT?VU_U#-2_P# ?_Z]:E%
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M:E_X#_\ UZI:=_R/.M_]>UM_[/70T 9?]M?]0S4O_ ?_ .O1_;7_ %#-2_\
M ?\ ^O6I10!E_P!M?]0S4O\ P'_^O1_;7_4,U+_P'_\ KUJ44 9?]M?]0S4O
M_ ?_ .O1_;7_ %#-2_\  ?\ ^O6I10!E_P!M?]0S4O\ P'_^O4,WB6"WE@CE
ML-15YWV1@P?>;!..OH#6U6!X@_Y"_A[_ *_6_P#13T 6_P"VO^H9J7_@/_\
M7H_MK_J&:E_X#_\ UZU** ,O^VO^H9J7_@/_ /7H_MK_ *AFI?\ @/\ _7K4
MHH R_P"VO^H9J7_@/_\ 7H_MK_J&:E_X#_\ UZU** ,O^VO^H9J7_@/_ /7H
M_MK_ *AFI?\ @/\ _7K4HH R_P"VO^H9J7_@/_\ 7JO:>)H;V-WATW4BJ2-&
M?W ^\IP>A]:W*P?"?_'A??\ 81N?_1AH M?VU_U#-2_\!_\ Z]']M?\ 4,U+
M_P !_P#Z]:E% &7_ &U_U#-2_P# ?_Z]']M?]0S4O_ ?_P"O6I10!E_VU_U#
M-2_\!_\ Z]']M?\ 4,U+_P !_P#Z]:E% &7_ &U_U#-2_P# ?_Z]']M?]0S4
MO_ ?_P"O6I10!CS^($M[>2>33-2"1J78^1V R>]2?VW_ -0S4O\ OQ_]>I=;
M_P"0!J/_ %ZR_P#H)J\/NCZ4 9G]M?\ 4,U+_P !_P#Z]']M?]0S4O\ P'_^
MO6I10!@/>2W6N:=(NG7R1QB17:2' &X#'?VK?HHH **** "BBB@ HHHH JZG
M_P @J\_ZX/\ ^@FLW7?$,ND7MA9V^F3W]Q>"0HD3JI 3;G[W^]^E:6I_\@J\
M_P"N#_\ H)K$U?\ Y'SPS_UQO/\ T&.A'1AHQE4]Y723?W)L9_PDNN?]"??_
M /@1%_C1_P )+KG_ $)]_P#^!$7^-="UTJW7V<([N K-M'"@D@$_D?RJ&'5+
M:XLVN82SH&V  <L3C&,^N01[$&F5[>E_SZ7WR_S.7UC5M=U31KRP7PG?1M<1
M-&':>(A<CKUJU%XBUR.%$/A"_.U0,_:(NWXUKW'B"QM$F-QYT;0K$SH8B6'F
MR-&G ZY92./KTJV+^W-\EH&)E>+S1@<;<XZT"]M2O_#7WR_S,#_A)=<_Z$^_
M_P# B+_&D/B;6U!)\'W^!S_Q\1?XUK0:]8SV2789UA>))T9T(W1MC#?3D?3O
M6A+_ *E_]TT#5:E_SZ7WR_S*VDZBFK:1::A'&T:7,2RA&.2 1G%95SXHECUB
M\TZTT2^O7M-GFO"T84;UW#[S#M4O@S_D2M&_Z](_Y56T3_D=?%/^]:_^BJ"U
M3IQJ5;JZC>RN_P":W3R'_P#"1ZG_ -"IJG_?</\ \76;K^I:OJV@WEA#X7U)
M))X]BL[PX'UP]=&NLV[PO*B3-&LS0!@GWI%<QE1_P($>G&>E21ZI;2:E_9_S
MK=>0LY1D(PK%@.>F<JW'M2,O:TO^?:^^1E?\)'J?_0J:I_WW#_\ %T?\)'J?
M_0J:I_WW#_\ %UIKJ]O(\B0K+,\<AC*HG.1U//89'-74<21JX# , <,,$?4=
MJ ]K2_Y]K[Y$-A=IJ&G6M[&K*EQ$DJJW4!@" ?SK+U+Q59:9J36#VU_<7"QK
M(PM;9I0JDD#..G0U8\-?\BKI'_7E#_Z *HV?_)0=5_Z\+;_T*2F7"G352IS*
MZC?K;9VW&?\ ":VG_0)US_P72?X5E:UXFCOGTPPZ3K1%O?)/)G3Y!\H# ]O<
M5V,>H6DHE9)E98BX=@#M4J2&YZ<$$'Z&B:_M8'C2290TB%T7J2HQD\=AN7GW
M%!/M*'_/O_R9_P"1A_\ ":VG_0)US_P72?X4'QM9@9.E:YC_ +!TG^%;RWEN
M\J1I*'9T#KMY!4YP<CC!P:BBO[6^MF>UG253'O!4]5(X8>H/K0"J4/\ GW_Y
M,_\ (=IU_!JNG6]_;%C!.@="PP<'VJU6!X'_ .1(T?\ Z]EK?I&=>"A5E!;)
MM?<V96MZW_8XM%6RGO)KJ4Q1Q0%020I;^(@=%-4O^$CU/_H5-4_[[A_^+I?$
M/_(<\-?]?S_^B9*V1>0&\FM Q\Z&))G&.BL6"G/U1ORIFW[N%.#<+MWZOO;H
M8O\ PD>I_P#0J:I_WW#_ /%T?\)'J?\ T*FJ?]]P_P#Q=:L.K6DZ,T;D[7CC
M(*D$%PK+^&&'/U]*9%K-I/<100EWDE:8 !>GDR".0G/8,0/?M01[6E_S[7WR
M.;U_4M7U;0[JPB\+ZDDDR@!G>' Y!_O^U:7_  D>I_\ 0J:I_P!]P_\ Q=7H
M?$%A<+&\32-&]O#=;]APL<I(0GTSM/TQS4[ZK:1V,UXSMY4+M&^%.=RMM(Q]
M10'M:7_/M??(RO\ A(]3_P"A4U3_ +[A_P#BZ/\ A(]3_P"A4U3_ +[A_P#B
MZU6U2V6;R\N0'6-Y /E1FQM4GU.Y?S%/BOHYYS'$DK(&9/-"_)N&<C/L01GI
MGCK0'M:7_/M??(P;GQ?<V,2S7OAS4K> NB&1FB(4LP49PY/4BNHKFO'G_(K/
M_P!?-M_Z.2NEH'64'2C.,;7;6[>UN_J%%9VLZS:Z'8?:KK>VYA'%%&-SRN>B
MJ.Y-8J^']5UW$WB'498H'Y&FV3F-%'H[CYG/KT&>E(FG1O'GF^6/Y^BZ_@O,
MW;K6M+L6VW6HVD+_ -QYE#'Z#.367-XST\'%I9:K?G_IUL9&'YD ?K6IIFC:
M;HT/DZ=906R'KY:8+?4]3^-7J 4J$7\+?J[?DG^9S \0>(I^;7PA/L];F]CB
M/Y#<:!<^-)L$6&B6J]Q-<R.?PVJ!73UE7-L_]K&X>R-S"T7EX&SY2>O#$<'%
M,KZQ!?#3C^+_ #9BW5CXUO);=I)_#ZK!.)EVQS$Y (YYYX/M5EU\;C'EW'AU
MACJT,P_]G-7_ "+DS7D?V9PKW E23<NUAM4>N<\'MVJG%I=[%ILEH(@5^Q[(
MQO&0YQN3KV()STYQVHN'UG^Y'_P'_@D>_P <1C)C\/3XZA7F0_AD&C^U_%D'
M^N\+P3J.K6VH+G'LK*,_G6SIL#0)(DEOLDW'=+\O[W+$YX.>_?UJ]0'UB+WI
MQ^YK\F<ROC$QG;>^'=<MCW86GFH/Q0FM"W\3Z)<@;=2MXW/_ "SG;RG_ .^7
MP?TK6IDL,4\9CFC22,]5=00?P-(4IT9?8:]'?\U^HJ2)*@>-U=3T*G(-.KFK
MCP;:02M=Z#*VCWQ.=]N,Q/[/%]TC\J73?$%W!J2:1XAMX[:]<$P7$1)@N0.N
MTGE6'=33&Z"E%RHN]MUL_NZKT^XZ0G R>E9%[XGTJRR@N#=3#CR+-#/)GW5,
MX_'%8\=A-XSD:\O[EQH.\_9K.([?M*@XWR,.2"1D+Z8KJ;6TMK&W6WM((H(5
M^['$@51^ H"5.G2TGK+JEHEY7[][+3N<\/%.IW.?L'A/59!ZW1CM\_\ ?39K
M/L[OQ1::OJ-Z?"4CK>-&=HU"'*;4"^O-=O10'MZ72DOOE_FCF4\7/"^S4_#^
MKV7K((//C'_ HR?Y5L66M:9J!VVE]!*_>,. X^JGD?B*O5GZMHFGZW;^5?6R
M2$?ZN4##Q'U5NH-(3E0F]8N/H[_@_P#,T**YC2M2U#2M6CT'7)/M#3 FQOPH
M'GA1DHX[.!^8JYK^MSZ>UO8Z=;?:M5N\^1$<A$48W.Y[*,CW/046!X:?M%!:
MWU3Z6[_YWV-B66.",R2R)&B]6=@ /QK'G\6Z+"<)=FY/I:1//G\4!%5++PA%
M)<)?Z_<-JVH [@9?]3$?1(^@^IR>]=,!@8% 25"#M=R]-%\MW^".&UWQ&VIV
MUO#:Z#KS&.ZAG+'3W4%4<,<9[X%:L?C2T)_TC2M<M4S]^?3I,#\@:Z2BF/VE
M#_GW_P"3/_(S+;Q#H]V0L6I6V\](W<(__?+8/Z5I]:@O+*UU"W:WO+:*XA;J
MDJ!A^1KEY["^\'@W.C(]UHR_-/II)9X1W:$DY]]A]\=:00ITZND':71.UG\^
M_KIYHZ^BJ]C?6VHV$-[:2K);S+O1QT(KFCJFJ^*)WBT&46.E1DH^I/'N:8@X
M(A4\8Z_,?PZ4$4Z$I-WT2W;Z?\'RW.EN;ZSLEW75U! /660+_.LN?Q=HT/$5
MQ)>-V6S@>?/XH"/UI^E^%M)TI_.CMA/>-R]Y<?O)G/J6/],5LT#?L(O2\ON7
M^;.8_P"$S);]WX:\12+V8604'_OI@:SM&\07FF6<T=QX7UTM)=32KY5NC<,Y
M89^<>M=Q13*]K0_Y]_\ DTCG(O&=EG%WIVL6/O<:?)C\U#"M&#Q#HUR0(M4M
M"Y_@,H5O^^3S6E4-U:6U["8;JWBGB;JDJ!@?P-(ERHR^RU\[_FB8'(R.E%<I
M)X8OM&W3^%[]H5')TZY8R6[^RYYC_ XK6T+6TUJUD+6\MK=V[^5<VTH^:)\9
MQ[@@Y![B@<Z*4>>F[K[FO5?JKHU:CFGAMXS)-*D:#JSL /S-8NNZ[-:74&DZ
M9#]HU:Z4LBG[D"9P97_V1Z=R,5'9>#=.BG%YJ;/JVH=[B]PX'^ZGW5'T% 1H
MQC%3JNU]DMWY^2\WOT1/<^+='@XBN'O7_NV,37!_- 0/Q-4_^$MNIL_8_"VM
MR>\T*P@_]]-G]*Z<    8 [44 JE&*^"_JW^B1P]M?\ B"WUR_U4^%+LQW4<
M4:H+F'<I3=DD;O>M'_A+KF# O?#&MQ$]XH%G4?BC$_I73T4Q^VI=::^^7_!,
M2V\6:-<$*]RUJ_\ <O(F@(/I\X /X5L1RQS('BD5T/1E.0:<RJZE74,I&"",
M@BN;N_!MFL[7FB3/HU]U\RU \M_9X_NL/RI"2H3=KN/XK]'^9TM%8N@:S)?&
MXT^_5(]6LB$N8U^ZV?NR)_LL.?;I2Z[K$]B8;+388[G5;K/D0NV%51]Z1SV4
M?F3P*"?83]I[/K^%N]^UM;]C8)"@EB !U)K+N/$NBVI8/J5NSKP8XF\QQ_P%
M<G]*RX_!RW[BX\2WLNJS]1"28[>/_=C'7ZG.:T[Z8Z1%91V4,$5L)")(UCP!
M&%8G:!C!&,]#TQWS05*-&&EW)^6B^]Z_@BC)XSMLXM=(UN\'K#I[@?F^VLK5
M-;O[^]TNX@\,:T$M9S,PDB12P*,N -Q]>];DFJ7CWJQVZJT4KKY>U06VXDYY
M8 Y* CV-3O?W4<TS%HS&EP(!'LY(*@YSGU.?H#0'M*-M*?\ Y,_\C./C%T.)
M?#'B%,=2+,.!_P!\L<U:@\7Z1*P6:2XLF]+VVDA'_?3 +^M68;^9X)[N1T$4
M.<QA.3A0>N>I)X]OSHMM1FD^SQ2&,RF=HIMH./N%AC/MM_6@'4HM?!;TD_U1
M;M=0LKT9M+RWN!ZQ2A_Y&K-9&J>&-'UAO,NK*/[0.5N(ODE4]B''/%9#W^L^
M$V!U61M4T;H;U8\3V_O(HX9?]H<^M,<:,*NE)^]V?7T>S]-'VN==138I4FB2
M6)U>-U#*RG((/0BN8N]8U'6]0FTOP_B*&!_+N]3<96,]TC'\3^_04C.E1E4;
MZ);M[+^NV[.BN;VTLDWW5U# OK+(%'ZUD7'C#28F*VYN;YO2QMGF!_X$HV_K
M3],\)Z-I4OGQVHGO"<M=W)\V5CZ[FZ?ABMN@M^PB]+R_#_-G,#Q9>S FT\*Z
MT^.\T:0Y_P"^FS^E4-(U#7]+LYU?PI=R"6YEF&VYAR-[%L8W9XS7;44Q^VI=
M*:^^7_ .8_X2V[AQ]K\+:W'[PQ+,!_WRV?TJU;^+]'F.V>6>R;TOK=X!_P!]
M, OZUNT4A.I1DO@MZ-_JF0V]W;7:;[:XBF3^]&X8?I4U8.I>#](U";[2D!LK
MX<K=V;>5(#ZY'!_'-0:?K-YIFIQ:)KN6EE)%GJ  "7..=K ?=?V[]J!^QC.-
MZ3NUNGO\NC_/R.EI"0H))  ZDUFZ[K46B623-"]Q/-((;>WC^]+(>BCT]2>P
MK'A\,7>M$77BFY:?)W+IL+E;>+T#8Y<CU/% J=%./M*CM'[V_1?J[(U+GQ1H
MML2K:A%*XZI;YF8?\!0$U0/B^:=BNG^&]:N?1W@$"'Z%R/Y5T4,$5M"L,$21
M1(,*B*% 'L!3C(@D"%UWD9"YY(H!3HQ^Q?U?^2_4Y.^U+Q3?:=<6R^$O+\Z)
MXR7U*+*Y&,X .>OJ*G76O%2J=_A!3@<!-3C)/Y@5TN]" =RX89!SU%,6Y@>$
MS+-&8AU<,-H_&F/V]/\ Y]Q_\F_S.=_X2V[MSMU#POK,![M!&MPH_%#_ $J]
M;^*]$N"%-\MNY_@ND: Y],.!FM99HG*A948L-P 8'(]:5T26-HY$5T8896&0
M1[BD*52C+[%O1_HT_P Q4=9%#(P93T(.0:6N6N/")L)'O/#%T=,N2=QMNMK,
M?1D_A],KC%:VB:I+J=FYNK8VM[ YBN("V[8X /![@@@@^AH%.E'EYZ<KK[FO
M5?JM/0TZ***# **** "BBB@"KJ?_ ""KS_K@_P#Z":Q-7_Y'SPS_ -<;S_T&
M.MO4_P#D%7G_ %P?_P!!-8/B2#5D\0:+J>F:6=06T2X66,3I%C>$ Y8^Q_*F
MCIPG\1J]KJ6^G1FQ>:6+N>:83O'(\*Q(R$C9@MSC.#][OTQ4<6CF!V,=V[ F
M-@)$7ADXS\NW^' _ 5E_V]XH_P"A,E_\&4'^-']O>*/^A,E_\&4'^-%A_5*G
M>/\ X%'_ #*NJ3V4GB5K2:Z<7$Z6I*K;,<&VN!( !G)W>;C(X&TG)Z#H+/21
M:31.)MRQ!T0;>B':%&<]@N*Y.:+5I]474)/ TQF4,/\ D)P<DE3NSUR-F!@X
MPS<<FM;^WO%'_0F2_P#@R@_QIM+H;5<(K1]FUMK>4=_O+5KX8BMM(LK#[5*?
M(@2"63&3*%3;@!BP53G.![>E:T<3PV BDD,KI'M+D8+8'4US_P#;WBC_ *$R
M7_P90?XTCZYXH9&7_A#)>1C_ )",'^-*QBL)4OO'_P "C_F7?!G_ ")6C?\
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MGWG<1@#MUW5+_P )9J'_ $*6L_\ ?,?_ ,5187U.MV7WQ_\ DC6_LMMLL8G
MBEF28C9\V5V\9ST.WT[U$MU:Z,\5I/?0A7D?:K+\RY#R?,<\#"MR1SBL[_A+
M-0_Z%+6?^^8__BJR-5O+G5;ZSNI?#&NJUM)O "ITV,/E._@Y8'//W<=":+&M
M+!2<OWFB]8__ "1M>.SGPJY'3[3;?^CDKI:X/7M4U37=+&GQ>&=5A9YX6\R5
M4VJ%D5CG#>@KO*":\'3HPC+>\NJ?;LV<IXH==.\0:)K5VA?3;4R13-C(@9P
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M**1S!2,JNI5@&4C!!&0:6B@#GKOP3H5Q/]HAM6L;C_GM8R- W_CN ?Q%0_\
M"*7\!'V/Q7K"#TG9)_\ T):Z>BG<Z5BZZ5G*_K9_FF<R-!\2[\GQE-MST_L^
M#./KBD_X1.]G_P"/SQ7K4GM!(D _\=7/ZUT]%%P^MU>EEZ1C_D<]9^"= M+A
M;EK+[5<@Y\Z[D:9L^OS$C]*Z$  8 P***1E4JU*KO.3?J%%%%!F5+_3+'5(/
M)O[."YC[+*@;'TSTK"/@^6R_Y FO:CIRC[D#.)X4'H$?.!^-=110;4\15IKE
MB].VZ^YW1S'V;QM:\1:AHU\/6XMWA/\ XX2*J26?BDW:W#Z/X?EF",I=;B4*
M=Q4G*E<$Y1#GKP.:[*BG<U6+DOL1^ZWY-',%O'+GB/P]$I]7F<C\,#-)_87B
M2]XU#Q,88N\>G6RQ'_OMMQ_2NHHHN3]:DOAC%?\ ;J_6Y@67@W1;.X6ZDMWO
M;L?\O%](9WSZ_-P#] *WZ**1E4JSJ.\W<****#,K7NGV6I0&"^M8;F(_PRH&
M'ZU@GP/8VY)TJ_U/2@>?+M+DB,GUV-D?EBNGHH-J>(JTU:$FEVZ?<[K\#F!H
M/B6$@0>+W* ]+BPCD/Y@J:!IGC#=SXCL=N>O]G\X_P"^ZZ>BG<OZW/JH_P#@
M,?\ (YC^P/$<W%SXOFV>EM8QQ'\SN-"^!M.F8-JEWJ.JD'(6]N2R ^R+@?I7
M3T47#ZY67PNWHDOR5_Q(+2SM;" 06=M%;Q#HD2!0/P%3T44CG;;=V%%%% BK
M>Z;8ZE'Y=]9V]RG831A\?G6&W@+0D8O91W6GN3DM9W4D?Z X_2NFHH-J>(JT
MU:$FEZ_IM^!S/_"',&!7Q/XB4#&!]L4_S4YH_P"$/<ON;Q/XB.>H^UJ!^B"N
MFHIW+^N5_P";\%_\B<P/ 6B2D&^-]J+#O>7DDGZ9 /Y5M6&D:;I:[;"PMK88
MQ^ZB"D_4CK5VBD1/$5JBM.3:]=/NT7X!11108A1110 4444 %%%% %74_P#D
M%7G_ %P?_P!!-6JJZG_R"KS_ *X/_P"@FK5 !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 <]X,_Y <W_7]=?^CGK4BU.&6^
MEM-KK(C[!N PV%#$CZ9&?J/6LOP9_P @.;_K^NO_ $<];#6%LQ<F/EW+D[B#
MN*[2?;CBAG1B_P"//U_R((]7BG@DDAC>0HP 48Y4]'X_A///L:@;Q!;A+B01
M.\<";RR,K _('['@8;J>*O-86S'(0QDJ%)B=HS@=!E2/4TBZ=:):R6JPXAE&
M'4,>?E"^OH!0<X^UN1=0F0(R88K@]_<$<$>]8.B?\CKXI_WK7_T56G>ZY9V-
M]!9R^:9IF"JJQL>H."..>G.,X[XK,T3_ )'7Q3_O6O\ Z*IV.NE"4:51M;QT
M_P# D=+1112.0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO_/Y'^= %^BJ']MZ;_S^1_G1_;>F_P#/Y'^= %^BJ']MZ;_S^1_G1_;>F_\
M/Y'^= %^BJ']MZ;_ ,_D?YT?VWIO_/Y'^= %^BJ']MZ;_P _D?YT?VWIO_/Y
M'^= %^BJ']MZ;_S^1_G1_;>F_P#/Y'^= %^BJ']MZ;_S^1_G1_;>F_\ /Y'^
M= %^BJ']MZ;_ ,_D?YT?VWIO_/Y'^= %^BJ']MZ;_P _D?YT?VWIO_/Y'^=
M%^BJ']MZ;_S^1_G2'7-, )-Y%@>] &A17.:)XWT?7]2DL;-IEF4$KYB8$@'4
MKR?UQ71T %%%% !1110 4444 %%%0_:[;_GXB_[[% TF]B:BH?M=M_S\1?\
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M5+*C'=%,!U,;C@^N.HK?H,ZE*5-\LOZ] HHHH,PHHHH **** "BBB@ HHHH
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M1-7LM>A.+9W6TOT'\2,<(_U5C^3$5=\2ZE+8:=%!:DB]OIEM+8]E=L_,?]T
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MTS#'&C;6D*1LJD_,^<YQZ]*#(U:*QTU=I+NS@26"0W ()3&%.UF!'S9(^7'
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MFSIZ*YG_ (1W7=@3_A,+[&<_\>T.?SVYI#X2O)L?:_%.M2+CE8I$AS_WRN:
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M\00_,M]I]SC_ )9R6SQ9_P"!AVQ_WR:T+6X-PCAXS'+&VR1"<X. >#W&"/\
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M%:M,I3H0VCS/ST7W+7[V<A?V_C/5]/FM)+71+:&=2C@SRLX!],+BK'VGQM
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MG7!*LJC#8 8XR?0Y_3KQ4R:=;) 85$OEG&!YSG;C^Z<_+^&*=]@M0 !$ !D
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M[\!3CS2KS^&"O\^B^_\ (?X)GF\+^)+OPG?/O$C>9;2= QQG]0!]""*])S7
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>afyaform20f_024.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 afyaform20f_024.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %T YT# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M$=!FGFF2_P"J?Z&@+7=CEW\8VT<KI]FD^4D=!3?^$TMO^?63]*Y&X_X^I?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EKD_B+XDN_"?@^YU>RBCD
MGB90%DSCDT =7FBOF+_AHGQ/G_CPL/R;_&E_X:(\4'_F'V'Y-_C0!].45\Q_
M\-#^*?\ H'V'Y-_C1_PT1XH!YL+#\F_QH ^G*6N"^%?C._\ &WAV;4-0AACE
M28Q@1 XQ^-=Z* "BBB@ I#2TAH @NXX9K:2*X :%U(<'IBN*'A+X? <6.F_D
M/\*[*^S]BE_W3_*O* !MSC]:N,;G=@\(L1>[M8Z;_A$_ '_/EIWZ?X4@\)_#
M_P#Y\=._3_"N:VCT_6C:/3]:OV:.[^R(_P QTW_"*?#_ /Y\=._3_"M[P]I&
M@Z6DYT*"")9"/-\D]<=,UYW@>GZUVW@K_CTN/]\5,H6.;%Y>J%/GN=72TE+6
M9Y@4444 )4<O^K;_ '34M0S_ .H?_=-"W&E=H\DN+J 74P\^/AS_ !"HOM-O
M_P ]XO\ OH5S-Z/^)A=?]=6[^]0X/^35^T/MZ=/W$=9]JMS_ ,MHO^^A2_:K
M?_GO'_WU7)8_SFD_SUI^U-/9GK/@>6*2YG$<B/@?PG/I7<CI7EWPLXO+SZ?X
M5ZC4-W=SY',5;$20M%%%(X0HHHH 0]*^*_B/_P CYJ?^^O\ Z M?:AZ5\5_$
M?_D?-3_WU_\ 0%H Y6BBB@ KV/\ 9W_Y'6[_ .O5OYBO'*]C_9W_ .1UN_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M+S_=_P *]0KR_P"%O_'Y>?[O^%>H51\=F7^\R%HHHH. **** $/2OBOXC_\
M(^:G_OK_ .@+7VH>E?%?Q'_Y'S4_]]?_ $!: .5HHHH *]C_ &=_^1UN_P#K
MU;^8KQRO8_V=_P#D=;O_ *]6_F* /IM>GXG^=+2+T_$_SI: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH ***K7-]:60!NKF*$-T,CA<_G0!9HK,_X2#1O^@K9?]_U_QH_X2'1O
M^@K9?]_U_P : -.BLS_A(=&_Z"ME_P!_U_QI?^$@T;&?[5LO^_Z_XT :5%10
M7$-S LT$J2Q.,JZ'(/XU+0 4444 %!Z&BB@#S'XSZ%J6O^%8;?3+5[B8/N*K
MUZK7@:_#/QHA/EZ-=*".W';ZU]=ZI?C3K-YRI8*,X%<\?&B \0-5*-S>GAJM
M57@KGS&/ACXS5MPT6Y#>HXI!\,/&0;<-$N<YSG%?3G_":+_S[M1_PFB?\^[4
M^1FOU'$?RGS(?ACXR)).AW)[]*^DOA+I5[HW@.UL]0@:"X5CN1NU6?\ A-4'
M_+NWYUTNG78OK*.X"E0XS@FDXV,JN'J4E><;7+E%)2U)@%%%% "&LS7O^01<
M_P"X:TSUK'\2RB'0KN0C("&FC2C_ !$>:21)/&8I5#(PP5/>J\NF6$MJEK+;
M(T"?=C/056&MP]?+:C^W(/[C5KSQ/L52NE=%F/2[".V:WCM46%CDJ!WJ>&"*
MW39$@4$Y) Y/UJA_;D']QZ/[;@SS&V*%.(U1MLCT_P %?\@4_P#70UTHKDO
M%TMWH!D4$#S6&#[5UE9-W9\EC%;$3]1:*!12.8*0TM(: *>J?\@RY_ZY-_*O
MGE>AKZ&U3_D&7/\ UR;^5?/*]#29]!D>TPHHHI'T 5ZC\+?^0=>?]=1_*O+J
M]1^%O_(.O/\ KJ/Y543R\W_W9GH-+24M!\F%%%% !45Q_P >\G^Z:EJ*X_X]
MY/\ =- X[H^>;S_C_N?^NK?SJN>M6+S_ (_[G_KJW\Z@(YI'WE/X$)0.M%*!
MS2+3/0?A;_Q^7G^[_A7J%>7?"W_C\O/]W_"O4:H^.S+_ 'F0M%%%!P!1110
MAZ5\5_$?_D?-3_WU_P#0%K[4/2OBOXC_ /(^:G_OK_Z M '*T444 %>Q_L[_
M /(ZW?\ UZM_,5XY7L?[._\ R.MW_P!>K?S% 'TVO3\3_.EI%Z?B?YTM !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;?53=I+$JBWN@J%1_#SQ52\6*XLM380JIMIE$1 P0N<8HL"Q:E+EL='\+O\
MC\O/I_A7J->7_"XYN[O_ '?\*]0'2F?,YE_O,A:***#@"BBB@!#TKXK^(_\
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M#^5?:OA?_D5]+_Z](O\ T$5\7>(]6&L:W/=(NV,MM3_=SQ7VCX7_ .17TO\
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M\O/]W_"O4*\O^%O_ !^7G^[_ (5ZA5'QV9?[S(6BBB@X HHHH 0]*^*_B/\
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M /E<? CQ.#G:>/9?_BJ^F=$M9+'1;&TD_P!9# B-]0N*OT"@!:*** "BBB@
M-<UXT_Y Z?\ 705TM<UXT_Y!"_\ 7054=SHPG\>/J>5>*(9;C24C@B:5_/5B
MJC/ IFN:A=01Q6]OI\\Z2KES'_"/2MPD@T9/I6[5V?42I7;9RQCNVO;+58["
M2!$C:)H,98<$ _CFM?0K>6WTK$XQ++*TI'ID_P#UJTLGTI#DCI2%['EN_(]4
MTC_D%P?[M7JHZ1_R"H/]VKU8/<^3J_&_4****1 4AI:2@#E?'O\ R+5Q_N&O
M&.YKV?QY_P BS<_[IKR;3[&&[+FXO([:($#+#.2>E!]+E,E&A)ON4<48JY<Z
M9<6^H_8?ON2,,.A!/6K+Z+*MY<Q22 1VX!EE]![4CUI5X(R3T->Y^#/^15L?
M]RO%KZR>RD4,=T<@W(XZ,,BO:?!G_(JV/^Y0CQ\ZDI4H-'04444SYP**** &
MGK6'XOX\,WO_ %S-;AZUA^+O^1:O?^N9H-:'\2/J>*6%NT\A"7"0R1C<K-CD
M^U;3:DD]_-$9U666T$37 XRX]Q7-@90#Z48'>D?9SH*HTY=CI1=VXABT^:6-
MY3;>4\X/&0<CFL_4YXQ866GHRN8 2[J>"WI65TZ4[M1<4<*HOF70];^&7_(L
MG_KL_P#.NUKBOAE_R+)_Z[/_ #KMA3/DL;_O$_4****#E"D-+2&@"GJG_(,N
M?^N3?RKYY7H:^AM4_P"09<_]<F_E7SRO0TF?09'M,,T444CZ *]1^%O_ "#K
MS_KJ/Y5Y=7J/PM_Y!UY_UU'\JJ)Y>;_[LST&EI*6@^3"BBB@ J*X_P"/>3_=
M-2U%<?\ 'O)_NF@<=T?/-Y_Q_P!S_P!=6_G5<]:L7G_'_<_]=6_G5<]:1]Y3
M^!!0.M% ZTBT>A?"W_C\O/\ =_PKU"O+_A;_ ,?EY_N_X5ZA5'QV9?[S(6BB
MB@X HHHH 0]*^*_B/_R/FI_[Z_\ H"U]J'I7Q7\1_P#D?-3_ -]?_0%H Y6B
MBB@ KV/]G?\ Y'6[_P"O5OYBO'*]C_9W_P"1UN_^O5OYB@#Z;7I^)_G2TB]/
MQ/\ .EH **** "BBB@ HHHH ***#0 TYSQ7*WWPZ\+:A>RW=WIL<D\K9=CWK
MJZJ3?ZX\U+=@.8_X5AX/_P"@3%1_PK#PA_T"8JZ/!]:,'UI<P['.?\*Q\(?]
M F*K6G> /#6EW\=Y9Z=''/'RK ]*V<'UJ6#_ %OX4U(1;HHHJ@"BBB@ I*6D
MQ0!7FGQ((@I)]>U9?B&+S- O5$CQGR\AHS@@_P"36S(!M)QS6?J5H]_ID]I'
M((VE7;O(R!0!Q6KZA=KX<\)VD<Q5;YHTN'[LNWD5I>$IYH=:US1WF,D%FR/%
MGJH;/'Z5/<^%&N-!TNPEND^TZ<5:*?8<%@N.G:KF@:#_ &.UW/-,)[R[DWRR
M!2..P_G0!LK<;)%BVL2>_:K0/%1Q*-N<<^M28H 6BBB@ HHHH *KSQRLX9)
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M@S_D5;'_ '*\-<DC)))]2:]R\&'_ (I6Q_W*#S,VI\E&"\SH****#YX****
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M110 4444 -(W#%-\I:DHH 9Y2TGE+4E% #0NT8%.HHH **** "BBB@ HHHH
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M "/FI_[Z_P#H"U]IGI7Q;\2/^1\U/_?7_P! 6@#E**** "O8_P!G?_D=;O\
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MS_A7GC?_ )Y6'YBC_A7?C?\ YYV'YBO=<#THP/2E8[5F.(M;F/"?^%=^-_\
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M3K@_*?;- &J_B:U$0DCCEE4PI*-@SG<0 /KS5!_'=G'IEQ>26EPOV>8021@
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M3RLJ&"#)7=3;CQ+9V^XMN*K$LA88Q\W09]:35KBRLM *:PRK&Z",_(6W-CT
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M4C/.1WH ]"\^+<J^8NYAE1GJ*DKB/ \EWJB-<:C T<UCBTC)/#XY+?CFNW%
M"T444 )5:+4;.><PPW4,DHSE%<$C'M5AONGKT[5Y!ITLH\1VLUG%/%+(MS$4
M*'Y9.<!F- '>:KXG2RUFQT^)8YC<E@=K9*D GI^!JSX?U^+6K"*1FCCN'W?N
M0PSP<'BO.K-H+B\\.7'V6==3MW=+]F0_(2A!]NIJUIEA);+H5Q;P2QW;3W"2
M,!R%(X!_$4 >GQWMK+*\4=Q$TB#+*K@E?K6=J6L;-/DFTV6VGE1@&5I0 ,^Y
M-<+IC6-TDK%]0CU*WA9+T1QE=A+<D]FYQ6>;:]_X1S68Y8UG<-%Y5W;J5\T9
M_N]010!ZLNH6\?E1W$\4<T@&$+CDGTHFU73K=RDU];1.I *O*JD'Z$UYG?0W
M5S_:UM>PSF]:*-M,?'^R.F.X(YS63J&EWLESK OH+EYUTZ')!.#,-F<8[]:
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M,ZR&U BD QD>F:T%AA"G;&@5N>%'-<EX455\1^)E   GB _(UV(P  ,8[4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *X*SATW7O'$EWIUQNCMT(NXPORO(
M&P,GU'-=[4,-M;V^[R((HMQRVQ N3ZG% ''Z;X<U72KVYM8WLY+&:5I5N'C_
M 'L9/;TJKI/A;6[37(K^>:VD98Y(I&R<MN((/Z5W]&!Z4 8OAG2I]&T9;.>1
M'=2Q!3WK:I<44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5G:U:RWNES6
M\*Q.SX!2495AW!K0II8!L$C\Z /.X_ UY:V%K+92)%-97AN;:WE)9%! W+G.
M<&M*[\/ZQJ.KZ3JEY/;A[3S#(J9P W0*?PKL@RE2V1@=Z@FO;6W>)99T4RD*
M@)^\: .*M?!U_IMU;:C'-'+=VUQ+)Y>,!T<^OKS0G@NZL;R'6+>:,WRW+SO"
M5(5@P QQZ 5WJG.?K02HX)% 'G\G@.[9?/BN(A/-?+=S K@+@@X'Y5TGB?3=
M0U.RBCT^>.,K,K2*_21!U7_/I6M-<P6T#3RRJL:]6)XJ!+V5]2%NMJYMS%O%
MP"-I.>G]?PH XJS\%:I!:6:>?;+)::K]M0 '!0@_*:]"480#T&*175LX.<<4
MH92V 1GTH =124M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!%/@PR
MYV[3G%>/P6R-8Z=<M/<>>=<:#+;LF(GD'VKV0C/':HOLT6,>6G'(X[^M 'E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
H* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>34
<FILENAME>afya-20211231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: +6opo7xRiXgOn8uNbXNcWaSI6aPtwJl5iZkxt217fZm6jygk9spqGy0yRnQWoXUO -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:afya="http://afya.com.br/20211231" elementFormDefault="qualified" targetNamespace="http://afya.com.br/20211231">
    <annotation>
      <appinfo>
	<link:roleType roleURI="http://afya.com.br/role/Cover" id="Cover">
	  <link:definition>00000001 - Document - Cover</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" id="StatementsOfFinancialPosition">
	  <link:definition>00000002 - Statement - Consolidated statements of financial position</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" id="StatementsOfIncomeAndComprehensiveIncome">
	  <link:definition>00000003 - Statement - Consolidated statements of income and comprehensive income</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" id="StatementsOfChangesInEquity">
	  <link:definition>00000004 - Statement - Consolidated statements of changes in equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/StatementsOfCashFlows" id="StatementsOfCashFlows">
	  <link:definition>00000005 - Statement - Consolidated statements of cash flows</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CorporateInformation" id="CorporateInformation">
	  <link:definition>00000006 - Disclosure - Corporate information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SignificantAccountingPolicies" id="SignificantAccountingPolicies">
	  <link:definition>00000007 - Disclosure - Significant accounting policies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" id="SignificantAccountingEstimatesAndAssumptions">
	  <link:definition>00000008 - Disclosure - Significant accounting estimates and assumptions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SegmentInformation" id="SegmentInformation">
	  <link:definition>00000009 - Disclosure - Segment information</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/BusinessCombinations" id="BusinessCombinations">
	  <link:definition>00000010 - Disclosure - Business combinations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalents" id="CashAndCashEquivalents">
	  <link:definition>00000011 - Disclosure - Cash and cash equivalents</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TradeReceivables" id="TradeReceivables">
	  <link:definition>00000012 - Disclosure - Trade receivables</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/RelatedParties" id="RelatedParties">
	  <link:definition>00000013 - Disclosure - Related parties</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/OtherAssets" id="OtherAssets">
	  <link:definition>00000014 - Disclosure - Other assets</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociate" id="InvestmentInAssociate">
	  <link:definition>00000015 - Disclosure - Investment in associate</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipment" id="PropertyAndEquipment">
	  <link:definition>00000016 - Disclosure - Property and equipment</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" id="IntangibleAssetsAndGoodwill">
	  <link:definition>00000017 - Disclosure - Intangible assets and goodwill</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" id="FinancialAssetsAndFinancialLiabilities">
	  <link:definition>00000018 - Disclosure - Financial assets and financial liabilities</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FairValueMeasurement" id="FairValueMeasurement">
	  <link:definition>00000019 - Disclosure - Fair value measurement</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CapitalManagement" id="CapitalManagement">
	  <link:definition>00000020 - Disclosure - Capital management</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligations" id="LaborAndSocialObligations">
	  <link:definition>00000021 - Disclosure - Labor and social obligations</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/Equity" id="Equity">
	  <link:definition>00000022 - Disclosure - Equity</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/EarningsPerShareEps" id="EarningsPerShareEps">
	  <link:definition>00000023 - Disclosure - Earnings per share (EPS)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/Revenue" id="Revenue">
	  <link:definition>00000024 - Disclosure - Revenue</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" id="ExpensesAndCostsByNature">
	  <link:definition>00000025 - Disclosure - Expenses and costs by nature</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FinanceResult" id="FinanceResult">
	  <link:definition>00000026 - Disclosure - Finance result</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IncomeTaxes" id="IncomeTaxes">
	  <link:definition>00000027 - Disclosure - Income taxes</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" id="InsuranceContractsAndContingencies">
	  <link:definition>00000028 - Disclosure - Insurance contracts and contingencies</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/Non-cashTransactions" id="Non-cashTransactions">
	  <link:definition>00000029 - Disclosure - Non-cash transactions</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SubsequentEvents" id="SubsequentEvents">
	  <link:definition>00000030 - Disclosure - Subsequent events</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" id="SignificantAccountingPoliciesPolicies">
	  <link:definition>00000031 - Disclosure - Significant accounting policies (Policies)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SignificantAccountingPoliciesTables" id="SignificantAccountingPoliciesTables">
	  <link:definition>00000032 - Disclosure - Significant accounting policies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SegmentInformationTables" id="SegmentInformationTables">
	  <link:definition>00000033 - Disclosure - Segment information (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsTables" id="BusinessCombinationsTables">
	  <link:definition>00000034 - Disclosure - Business combinations (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" id="CashAndCashEquivalentsTables">
	  <link:definition>00000035 - Disclosure - Cash and cash equivalents (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TradeReceivablesTables" id="TradeReceivablesTables">
	  <link:definition>00000036 - Disclosure - Trade receivables (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/RelatedPartiesTables" id="RelatedPartiesTables">
	  <link:definition>00000037 - Disclosure - Related parties (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/OtherAssetsTables" id="OtherAssetsTables">
	  <link:definition>00000038 - Disclosure - Other assets (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/InvestmentInAssociateTables" id="InvestmentInAssociateTables">
	  <link:definition>00000039 - Disclosure - Investment in associate (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" id="PropertyAndEquipmentTables">
	  <link:definition>00000040 - Disclosure - Property and equipment (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" id="IntangibleAssetsAndGoodwillTables">
	  <link:definition>00000041 - Disclosure - Intangible assets and goodwill (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" id="FinancialAssetsAndFinancialLiabilitiesTables">
	  <link:definition>00000042 - Disclosure - Financial assets and financial liabilities (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FairValueMeasurementTables" id="FairValueMeasurementTables">
	  <link:definition>00000043 - Disclosure - Fair value measurement (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CapitalManagementTables" id="CapitalManagementTables">
	  <link:definition>00000044 - Disclosure - Capital management (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" id="LaborAndSocialObligationsTables">
	  <link:definition>00000045 - Disclosure - Labor and social obligations (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/EquityTables" id="EquityTables">
	  <link:definition>00000046 - Disclosure - Equity (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" id="EarningsPerShareEpsTables">
	  <link:definition>00000047 - Disclosure - Earnings per share (EPS) (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/RevenueTables" id="RevenueTables">
	  <link:definition>00000048 - Disclosure - Revenue (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" id="ExpensesAndCostsByNatureTables">
	  <link:definition>00000049 - Disclosure - Expenses and costs by nature (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FinanceResultTables" id="FinanceResultTables">
	  <link:definition>00000050 - Disclosure - Finance result (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IncomeTaxesTables" id="IncomeTaxesTables">
	  <link:definition>00000051 - Disclosure - Income taxes (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" id="InsuranceContractsAndContingenciesTables">
	  <link:definition>00000052 - Disclosure - Insurance contracts and contingencies (Tables)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" id="CorporateInformationDetailsNarrative">
	  <link:definition>00000053 - Disclosure - Corporate information (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" id="TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails">
	  <link:definition>00000054 - Disclosure - The table below is a list of the Company&#8217;s subsidiaries and associate: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" id="DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails">
	  <link:definition>00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" id="ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails">
	  <link:definition>00000056 - Disclosure - Schedule of assets and liabilities information for the company's operating segments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" id="ScheduleOfOperatingIncomeForEachOperatingSegmentDetails">
	  <link:definition>00000057 - Disclosure - Schedule of operating income for each operating segment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" id="ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails">
	  <link:definition>00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" id="SignificantAccountingPoliciesDetailsNarrative">
	  <link:definition>00000059 - Disclosure - Significant accounting policies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" id="ScheduleOfAcquisitionOfUniredentorDetails">
	  <link:definition>00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" id="ScheduleOfAcquisitionOfUnislDetails">
	  <link:definition>00000061 - Disclosure - Schedule of acquisition of UniSL (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" id="ScheduleOfAcquisitionOfPebmedDetails">
	  <link:definition>00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" id="ScheduleOfAcquisitionOfFesarDetails">
	  <link:definition>00000063 - Disclosure - Schedule of acquisition of FESAR (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" id="ScheduleOfAcquisitionOfMedphoneDetails">
	  <link:definition>00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" id="ScheduleOfAcquisitionOfFcmpbDetails">
	  <link:definition>00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" id="ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails">
	  <link:definition>00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" id="FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails">
	  <link:definition>00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" id="ScheduleOfCashAndCashEquivalentsDetails">
	  <link:definition>00000068 - Disclosure - Schedule of cash and cash equivalents (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" id="BusinessCombinationsDetailsNarrative">
	  <link:definition>00000069 - Disclosure - Business combinations (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" id="ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails">
	  <link:definition>00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" id="ScheduleOfAgingOfTradeAccountsReceivableDetails">
	  <link:definition>00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" id="ScheduleOfAllowanceForDoubtfulAccountsDetails">
	  <link:definition>00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" id="TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails">
	  <link:definition>00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" id="CashAndCashEquivalentsDetailsNarrative">
	  <link:definition>00000074 - Disclosure - Cash and cash equivalents (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" id="KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails">
	  <link:definition>00000075 - Disclosure - Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" id="RelatedPartiesDetailsNarrative">
	  <link:definition>00000076 - Disclosure - Related parties (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" id="ScheduleOfOtherAssetsDetails">
	  <link:definition>00000077 - Disclosure - Schedule of Other Assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfInvestmentsDetails" id="ScheduleOfInvestmentsDetails">
	  <link:definition>00000078 - Disclosure - Schedule of investments (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" id="ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails">
	  <link:definition>00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" id="ScheduleOfIntangibleAssetsDetails">
	  <link:definition>00000080 - Disclosure - Schedule of intangible assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" id="ScheduleOfAssumptionsForImpairmentTestDetails">
	  <link:definition>00000081 - Disclosure - Schedule of assumptions for impairment test (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" id="OtherAssetsDetailsNarrative">
	  <link:definition>00000082 - Disclosure - Other assets (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" id="ScheduleOfEstimatedUsefulLivesDetails">
	  <link:definition>00000083 - Disclosure - Schedule of estimated useful lives (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" id="ScheduleOfFinancialAssetsDetails">
	  <link:definition>00000084 - Disclosure - Schedule of financial assets (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" id="ScheduleOfFinancialLiabilitiesDetails">
	  <link:definition>00000085 - Disclosure - Schedule of financial liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" id="ScheduleOfLoansAndFinancingDetails">
	  <link:definition>00000086 - Disclosure - Schedule of loans and financing (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" id="IntangibleAssetsAndGoodwillDetailsNarrative">
	  <link:definition>00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" id="ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails">
	  <link:definition>00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" id="ScheduleOfAccountsPayableToSellingShareholdersDetails">
	  <link:definition>00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" id="SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details">
	  <link:definition>00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" id="TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails">
	  <link:definition>00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" id="ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails">
	  <link:definition>00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" id="ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails">
	  <link:definition>00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" id="TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails">
	  <link:definition>00000094 - Disclosure - The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts: (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" id="ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails">
	  <link:definition>00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" id="FinancialAssetsAndFinancialLiabilitiesDetailsNarrative">
	  <link:definition>00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" id="ScheduleOfFairValueMeasurementDetails">
	  <link:definition>00000097 - Disclosure - Schedule of fair value measurement (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" id="ScheduleOfCapitalManagementDetails">
	  <link:definition>00000098 - Disclosure - Schedule of capital management (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" id="ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails">
	  <link:definition>00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" id="ScheduleOfShare-basedCompensationPlanDetails">
	  <link:definition>00000100 - Disclosure - Schedule of share-based compensation plan (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" id="LaborAndSocialObligationsDetailsNarrative">
	  <link:definition>00000101 - Disclosure - Labor and social obligations (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" id="ScheduleOfEarningsPerShareDetails">
	  <link:definition>00000102 - Disclosure - Schedule of earnings per share (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" id="ScheduleOfNetSalesRevenueDetails">
	  <link:definition>00000103 - Disclosure - Schedule of net sales revenue (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" id="ScheduleOfRevenueBySegmentDetails">
	  <link:definition>00000104 - Disclosure - Schedule of revenue by segment (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" id="ScheduleOfExpensesByNatureDetails">
	  <link:definition>00000105 - Disclosure - Schedule of expenses by nature (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfFinanceResultDetails" id="ScheduleOfFinanceResultDetails">
	  <link:definition>00000106 - Disclosure - Schedule of finance result (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" id="ScheduleOfReconciliationOfIncomeTaxExpenseDetails">
	  <link:definition>00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/EquityDetailsNarrative" id="EquityDetailsNarrative">
	  <link:definition>00000108 - Disclosure - Equity (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" id="ScheduleOfLegalProceedingsAndContingenciesDetails">
	  <link:definition>00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" id="ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails">
	  <link:definition>00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" id="IncomeTaxesDetailsNarrative">
	  <link:definition>00000111 - Disclosure - Income taxes (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" id="InsuranceContractsAndContingenciesDetailsNarrative">
	  <link:definition>00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:roleType roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" id="SubsequentEventsDetailsNarrative">
	  <link:definition>00000113 - Disclosure - Subsequent events (Details Narrative)</link:definition>
	  <link:usedOn>link:presentationLink</link:usedOn>
	  <link:usedOn>link:calculationLink</link:usedOn>
	  <link:usedOn>link:definitionLink</link:usedOn>
	</link:roleType>
	<link:linkbaseRef xlink:type="simple" xlink:href="afya-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="afya-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="afya-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Calculation Links" />
	<link:linkbaseRef xlink:type="simple" xlink:href="afya-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2021q4" schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" />
    <import namespace="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full" schemaLocation="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
    <import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
    <import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
    <import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
    <element id="afya_ClassAOrdinarySharesMember" name="ClassAOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassBOrdinarySharesMember" name="ClassBOrdinarySharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RetainedEarningsReserveMember" name="RetainedEarningsReserveMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_GuardayaEmpreendimentosAndParticipacoesSAMember" name="GuardayaEmpreendimentosAndParticipacoesSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelEditoraAndCBBWebMember" name="MedcelEditoraAndCBBWebMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoPlanaltoCentralSAMember" name="UniaoEducacionalDoPlanaltoCentralSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassACommonSharesMember" name="ClassACommonSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InitialPublicOfferingMember" name="InitialPublicOfferingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnderwritersMember" name="UnderwritersMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OverAllotmentsMember" name="OverAllotmentsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareholdersMember" name="ShareholdersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" name="MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaDrogariasOnlineLtdaMember" name="CliquefarmaDrogariasOnlineLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospTecnologiadaInformacaoLtdaMember" name="ShospTecnologiadaInformacaoLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadePadraodeEducacaoSuperiorLtdMember" name="SociedadePadraodeEducacaoSuperiorLtdMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROSolucoesdeTecnologiaLtdaMember" name="RXPROSolucoesdeTecnologiaLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadeDeCienciasMedicasDaParaibaMember" name="FaculdadeDeCienciasMedicasDaParaibaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AfyaParticipacoesSAMember" name="AfyaParticipacoesSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" name="InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" name="InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" name="UniaoEducacionalDoValeDoAcoSAUNIVACOMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" name="IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" name="InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" name="CentroDeCienciasEmSaudeDeItajubaSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" name="InstitutoDeEnsinoSuperiorDoPiauiSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" name="CentroIntegradoDeSaudeDeTeresinaCISMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" name="FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelEditoraEEventosSAMedcelMember" name="MedcelEditoraEEventosSAMedcelMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoEducacionalSantoAgostinhoSAMember" name="InstitutoEducacionalSantoAgostinhoSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ESMCEducacaoSuperiorLtdaESMCMember" name="ESMCEducacaoSuperiorLtdaESMCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" name="InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" name="InstitutoParaensedeEducacaoeCulturaLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaRedentorSAUniRedentorMember" name="SociedadeUniversitariaRedentorSAUniRedentorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroUniversitarioSaoLucasLtdaUniSLMember" name="CentroUniversitarioSaoLucasLtdaUniSLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" name="PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" name="FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" name="CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" name="MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" name="IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicinaeSolutionsSAMedicinaeMember" name="MedicinaeSolutionsSAMedicinaeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" name="MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" name="CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospTecnologiaDaInformacaoLtdaShospMember" name="ShospTecnologiaDaInformacaoLtdaShospMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" name="SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" name="CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" name="PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" name="SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" name="InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" name="RXPROSolucoesDeTecnologiaLtdaRXPROMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" name="RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MachineryAndEquipmentsMember" name="MachineryAndEquipmentsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ItEquipmentMember" name="ItEquipmentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LibraryBooksMember" name="LibraryBooksMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaboratoriesAndClinicsMember" name="LaboratoriesAndClinicsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramOfSocialIntegrationMember" name="ProgramOfSocialIntegrationMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TeachingActivitiesMember" name="TeachingActivitiesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContributionForTheFinancingOfSocialSecurityMember" name="ContributionForTheFinancingOfSocialSecurityMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NonTeachingActivitiesMember" name="NonTeachingActivitiesMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UndergradMember" name="UndergradMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContinuingEducationMember" name="ContinuingEducationMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DigitalServicesMember" name="DigitalServicesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TotalReportableSegmentsMember" name="TotalReportableSegmentsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdjustmentsAndEliminationsMember" name="AdjustmentsAndEliminationsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicMember" name="IClinicMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CliquefarmaMember" name="CliquefarmaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_HarbourMember" name="HarbourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShospMember" name="ShospMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UNIFIPMocMember" name="UNIFIPMocMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UNIGRANMember" name="UNIGRANMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PXPROMember" name="PXPROMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniRedentorMember" name="UniRedentorMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniSLMember" name="UniSLMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PEBMEDMember" name="PEBMEDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" name="FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedPhoneTecnologiaEmSaudeLtdaMember" name="MedPhoneTecnologiaEmSaudeLtdaMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FCMPBMember" name="FCMPBMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicinaeMember" name="MedicinaeMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedicalHarbourMember" name="MedicalHarbourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaFipmocSAMember" name="SociedadeUniversitariaFipmocSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaGranarioSAMember" name="SociedadeUniversitariaGranarioSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RXPROMember" name="RXPROMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SociedadeUniversitariaRedentorSAMember" name="SociedadeUniversitariaRedentorSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CentroUniversitarioSaoLucasLtdaMember" name="CentroUniversitarioSaoLucasLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" name="InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BankCertificatesOfDepositMember" name="BankCertificatesOfDepositMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterbankCertificatesOfDepositMember" name="InterbankCertificatesOfDepositMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_USDMember" name="USDMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TuitionFeesMember" name="TuitionFeesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalContentMember" name="EducationalContentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FIESMember" name="FIESMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalCreditsMember" name="EducationalCreditsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MobileAppSubscriptionMember" name="MobileAppSubscriptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OthersMember" name="OthersMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" name="LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaterThanOneEightyMember" name="LaterThanOneEightyMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UEPCMember" name="UEPCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RVLEstevesGestaoImobiliariaSAMember" name="RVLEstevesGestaoImobiliariaSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UNIVACOPatrimonialLtdaMember" name="UNIVACOPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IESVAPPatrimonialLtdaMember" name="IESVAPPatrimonialLtdaMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseAgreements1Member" name="LeaseAgreements1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" name="InstitutoTocantinensePresidenteAntonioCarlosSAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" name="InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationContentMember" name="EducationContentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalPlatformMember" name="EducationalPlatformMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SoftwareInProgressMember" name="SoftwareInProgressMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EducationalPlatformAndSoftwareInProgressMember" name="EducationalPlatformAndSoftwareInProgressMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DevelopedTechnologyIntangibleAssetsMember" name="DevelopedTechnologyIntangibleAssetsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CarryingAmountsMember" name="CarryingAmountsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelAndCBBWMember" name="MedcelAndCBBWMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FESARMember" name="FESARMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PracticeManagementToolsAndElectronicPrescriptionMember" name="PracticeManagementToolsAndElectronicPrescriptionMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClinicalDecisionSoftwareMember" name="ClinicalDecisionSoftwareMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MocMember" name="MocMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnigranrioMember" name="UnigranrioMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CustomerRelationshipsMedicineMember" name="CustomerRelationshipsMedicineMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CustomerRelationshipsOtherCoursesMember" name="CustomerRelationshipsOtherCoursesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyThreeMember" name="TwentyTwentyThreeMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyOneMember" name="TwentyTwentyOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyFourMember" name="TwentyTwentyFourMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentySevenMember" name="TwentyTwentySevenMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentySixMember" name="TwentyTwentySixMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TwentyTwentyFour1Member" name="TwentyTwentyFour1Member" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanciadoradeEstudoseProjetosFINEPMember" name="FinanciadoradeEstudoseProjetosFINEPMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedPhoneMember" name="MedPhoneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_GuaranhunsMember" name="GuaranhunsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersMember" name="AccountsPayableToSellingShareholdersMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedCashMember" name="RestrictedCashMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingMember" name="LoansAndFinancingMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayableMember" name="NotesPayableMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashEquivalents1Member" name="CashEquivalents1Member" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsMember" name="IncreaseBasisPointsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseBasisPointsMember" name="DecreaseBasisPointsMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseBasisPointsOneMember" name="IncreaseBasisPointsOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseBasisPointsOneMember" name="DecreaseBasisPointsOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingTwoMember" name="LoansAndFinancingTwoMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingOneMember" name="LoansAndFinancingOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersOneMember" name="AccountsPayableToSellingShareholdersOneMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersSevenMember" name="AccountsPayableToSellingShareholdersSevenMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ForeignCurrencyExposuresMember" name="ForeignCurrencyExposuresMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseForeignCurrencyMember" name="IncreaseForeignCurrencyMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreaseForeignCurrencyMember" name="DecreaseForeignCurrencyMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPayableMember" name="DividendsPayableMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationPlansMember" name="ShareBasedCompensationPlansMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ModifiedPlanMember" name="ModifiedPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OriginalPlanMember" name="OriginalPlanMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassAPreferenceSharesMember" name="ClassAPreferenceSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ClassBPreferenceSharesMember" name="ClassBPreferenceSharesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BRHealthMember" name="BRHealthMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NicolauCarvalhoEstevesMember" name="NicolauCarvalhoEstevesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" name="UniaoEducacionalDoPlanaltoCentralSAUEPCMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SegmentOfBusinessOneUnitMember" name="SegmentOfBusinessOneUnitMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LabourMember" name="LabourMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CivilMember" name="CivilMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesMember" name="TaxesMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TypesOfRiskMember" name="TypesOfRiskMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesAndSocialSecurityMember" name="TaxesAndSocialSecurityMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsNonCurrentMember" name="OtherAssetsNonCurrentMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IClinicParticipacoesSAMember" name="IClinicParticipacoesSAMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTradeReceivable" name="NoncurrentTradeReceivable" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayableCurrent" name="NotePayableCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentTaxesPayable" name="CurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayableNonCurrentLiabiites" name="NotesPayableNonCurrentLiabiites" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentTaxesPayable" name="NoncurrentTaxesPayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IfrsStatementLineItems" name="IfrsStatementLineItems" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalIncreaseWithCash" name="CapitalIncreaseWithCash" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalIncreaseFromCorporateReorganization" name="CapitalIncreaseFromCorporateReorganization" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllocationToAdditionalPaidinCapital" name="AllocationToAdditionalPaidinCapital" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsCancelled" name="DividendsCancelled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CorporateReorganization" name="CorporateReorganization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasuryShares1" name="TreasuryShares1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredFromExerciseOfOptions" name="TreasurySharesTransferredFromExerciseOfOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" name="TreasurySharesTransferredFromSharesContributionOnBusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsDeclaredToNoncontrollingInterests" name="DividendsDeclaredToNoncontrollingInterests" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncomeLossBeforeIncomeTaxes" name="IncomeLossBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" name="AllowanceForDoubtfulAccountsOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccruedInterestOfOpeartingActivities" name="AccruedInterestOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" name="ShareOfIncomeOfAssociateOfOpeartingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" name="IncreaseDecreaseInOperatingLiabilities1Abstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseDecreaseInRecoverableTaxes" name="IncreaseDecreaseInRecoverableTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedCashOfInvestingActivities" name="RestrictedCashOfInvestingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfNotesPayable" name="PaymentsOfNotesPayable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IssuanceOfLoansAndFinancing" name="IssuanceOfLoansAndFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalIncreaseOfFinancialActivities" name="CapitalIncreaseOfFinancialActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharebasedCompensationPlanReceipts" name="SharebasedCompensationPlanReceipts" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" name="DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SignificantAccountingEstimatesAndAssumptionsExplanatory" name="SignificantAccountingEstimatesAndAssumptionsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureFairValueMeasurementAbstract" name="DisclosureFairValueMeasurementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueMeasurementExplanatory" name="FairValueMeasurementExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureCapitalManagementAbstract" name="DisclosureCapitalManagementAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalManagementExplanatory" name="CapitalManagementExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureLaborAndSocialObligationsAbstract" name="DisclosureLaborAndSocialObligationsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsExplanatory" name="LaborAndSocialObligationsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsAbstract" name="DisclosureNoncashTransactionsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureNoncashTransactionsExplanatory" name="DisclosureNoncashTransactionsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" name="BusinessCombinationsAndGoodwillPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" name="CurrentVersusNoncurrentClassificationPoliciesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" name="FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" name="ImpairmentOfNonfinancialAssetsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PolicyExplanatoryInvestments" name="PolicyExplanatoryInvestments" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" name="AccountsPayableToSellingShareholdersPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPayablePolicyExplanatory" name="DividendsPayablePolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsPolicyExplanatory" name="LaborAndSocialObligationsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharebasedPaymentsPolicyExplanatory" name="SharebasedPaymentsPolicyExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesPolicyExplanation" name="TaxesPolicyExplanation" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" name="SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfEstimatedUsefulLives" name="ScheduleOfEstimatedUsefulLives" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" name="ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" name="ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" name="ScheduleOfAcquisitionOfUniredentorTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfUnislTableTextBlock" name="ScheduleOfAcquisitionOfUnislTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" name="ScheduleOfAcquisitionOfPebmedTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfFesarTableTextBlock" name="ScheduleOfAcquisitionOfFesarTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" name="ScheduleOfAcquisitionOfMedphoneTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" name="ScheduleOfAcquisitionOfFcmpbTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" name="ScheduleOfAcquisitionOfUnigranTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" name="ScheduleOfAcquisitionOfRXPROTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" name="ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" name="ScheduleOfAcquisitionOfUnisl1TableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" name="ScheduleOfAcquisitionOfPebmed1TableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" name="ScheduleOfAcquisitionOfFesar1TableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" name="DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" name="DisclosureOfTradeAndOtherReceivables1Explanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" name="DisclosureOfTradeAccountsReceivableByAgingExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsExplanatory" name="AllowanceForDoubtfulAccountsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfRelatedPartiesExplanatory" name="ScheduleOfRelatedPartiesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" name="SummaryOfKeyManagementPersonnelCompensationTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfOtherAssetsTableTextBlock" name="DisclosureOfOtherAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfInvestments" name="ScheduleOfInvestments" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfIntangibleAssetsTableTextBlock" name="SummaryOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" name="SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" name="SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialAssetsExplanatory" name="FinancialAssetsExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesExplanatory" name="FinancialLiabilitiesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingExplanatory" name="LoansAndFinancingExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeasesExplanatory" name="LeasesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersExplanatory" name="AccountsPayableToSellingShareholdersExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" name="ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValuesExplanatory" name="FairValuesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" name="SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" name="SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" name="SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" name="ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFairValueMeasurementExplanaory" name="ScheduleOfFairValueMeasurementExplanaory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfCapitalManagementExplanatory" name="ScheduleOfCapitalManagementExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" name="ScheduleOfModelUsedToDetermineFairValueOfStockOptions" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSharebasedCompensationPlan" name="ScheduleOfSharebasedCompensationPlan" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfTreasurySharesMovement" name="ScheduleOfTreasurySharesMovement" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DisclosureOfEarningsPerShareTableExplanatory" name="DisclosureOfEarningsPerShareTableExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfNetSalesRevenueExplanatory" name="ScheduleOfNetSalesRevenueExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfRevenueBySegment" name="ScheduleOfRevenueBySegment" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SummaryOfExpensesByNatureTableTextBlock" name="SummaryOfExpensesByNatureTableTextBlock" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfFinanceResult" name="ScheduleOfFinanceResult" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" name="ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfLegalProceedingsAndContingencies" name="ScheduleOfLegalProceedingsAndContingencies" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" name="ScheduleOfSocialSecurityProceedingsAssessedByManagement" nillable="true" xbrli:periodType="duration" type="nonnum:textBlockItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SaleOfStockAxis" name="SaleOfStockAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="afya_SaleOfStockDomain" name="SaleOfStockDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfPerShares" name="NumberOfPerShares" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProceedsFromIssueOfOrdinarySharesNet" name="ProceedsFromIssueOfOrdinarySharesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherOfferingExpenses" name="OtherOfferingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TransferredAmountToGBankAccounts" name="TransferredAmountToGBankAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfAdditionalCommonSharesIssued" name="NumberOfAdditionalCommonSharesIssued" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalOfferingPrice" name="AdditionalOfferingPrice" nillable="true" xbrli:periodType="duration" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalSharesGrossProceeds" name="AdditionalSharesGrossProceeds" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetProceedsOfAdditionalShares" name="NetProceedsOfAdditionalShares" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PrincipalActivities" name="PrincipalActivities" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentType" name="InvestmentType" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalExpenditures" name="CapitalExpenditures" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepositsFromExternalCustomer" name="DepositsFromExternalCustomer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterSegment" name="InterSegment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceExpense" name="FinanceExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedCash1" name="RestrictedCash1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesAsOfAcquisitionDate" name="TradeReceivablesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Inventories1" name="Inventories1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RecoverableTaxesAsOfAcquisitionDate" name="RecoverableTaxesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssetsAsOfAcquisitionDate" name="OtherAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightOfUseAssetsAsOfAcquisitionDate" name="RightOfUseAssetsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ImdemnificationAssets" name="ImdemnificationAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LaborAndSocialObligationsAsOfAcquisitionDate" name="LaborAndSocialObligationsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxesPayableAsOfAcquisitionDate" name="TaxesPayableAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" name="ProvisionForLegalProceedingsAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesAsOfAcquisitionDate" name="LeaseLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdvancesFromCustomersAsOfAcquisitionDate" name="AdvancesFromCustomersAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherLiabilitiesAsOfAcquisitionDate" name="OtherLiabilitiesAsOfAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsiderationToBeTransferred" name="ConsiderationToBeTransferred" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaidInShares" name="PaidInShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetOfCashFlowOnAcquisition" name="NetOfCashFlowOnAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxAuthorityAxis" name="TaxAuthorityAxis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="afya_TaxAuthorityDomain" name="TaxAuthorityDomain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContractualLeaseTerm" name="ContractualLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IndemnificationAssets" name="IndemnificationAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayables" name="NotesPayables" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PayablInInstallmentsAcquisitionDate" name="PayablInInstallmentsAcquisitionDate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaidInAfyaBrazilsShares" name="PaidInAfyaBrazilsShares" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInRevenue" name="IncreaseInRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseInIncomeBeforeIncomeTaxes" name="IncreaseInIncomeBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalPaymentMade" name="AdditionalPaymentMade" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DecreasedInIncomeBeforeIncomeTaxes" name="DecreasedInIncomeBeforeIncomeTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReceivablesGross" name="ReceivablesGross" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccountsFoReceivable1" name="AllowanceForDoubtfulAccountsFoReceivable1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" name="WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeReceivablesRelatedPartyTransactions" name="TradeReceivablesRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CreditsWithShareholdersRelatedPartyTransactions" name="CreditsWithShareholdersRelatedPartyTransactions" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherCurrentPayablesToRelatedParties1" name="TradeAndOtherCurrentPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssetsOfRelatedParty1" name="NoncurrentAssetsOfRelatedParty1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholders" name="AccountsPayableToSellingShareholders" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableCurrent1" name="AccountsPayableCurrent1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentPayablesToRelatedParties1" name="NoncurrentPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherIncomeRelatedPartyTransactions" name="OtherIncomeRelatedPartyTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PercenatgeOfAverageInterestOnFinancialInstrument" name="PercenatgeOfAverageInterestOnFinancialInstrument" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TypeOfArrangement1Axis" name="TypeOfArrangement1Axis" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrldt:dimensionItem" />
    <element id="afya_TypeOfArrangement1Domain" name="TypeOfArrangement1Domain" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OperatingLeaseTermOfContract" name="OperatingLeaseTermOfContract" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LesseeFinancesLeaseRenewalTerm" name="LesseeFinancesLeaseRenewalTerm" nillable="true" xbrli:periodType="duration" type="xbrli:durationItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerm" name="DescriptionOfLeaseTerm" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfLeaseTerms" name="DescriptionOfLeaseTerms" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_JudicialDeposits" name="JudicialDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherAssets1" name="OtherAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Assets1" name="Assets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentAssets1" name="CurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentAssets1" name="NoncurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EquityInAssociate" name="EquityInAssociate" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareInEquity1" name="CompanyShareInEquity1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InvestmentGrossAmount" name="InvestmentGrossAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompanyShareOfProfitss" name="CompanyShareOfProfitss" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MinorityInterestOfAcquiree" name="MinorityInterestOfAcquiree" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalMinorityInterestOfAcquiree" name="AdditionalMinorityInterestOfAcquiree" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsReceived1" name="DividendsReceived1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Disposal" name="Disposal" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashGeneratingUnits" name="CashGeneratingUnits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherCurrentAssets1" name="OtherCurrentAssets1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancing" name="LoansAndFinancing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayable" name="NotePayable" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialInstitution" name="FinancialInstitution" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancing1" name="LoansAndFinancing1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingCurrent" name="LoansAndFinancingCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingNonCurrent" name="LoansAndFinancingNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EqualInstallmentsPayablesToRelatedParties" name="EqualInstallmentsPayablesToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IntrestRate" name="IntrestRate" nillable="true" xbrli:periodType="instant" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BorrowingsAmountFirstTranche" name="BorrowingsAmountFirstTranche" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionsToLeaseLiabilities" name="AdditionsToLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsRemeasurement" name="RightofuseAssetsRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesRemeasurement" name="LeaseLiabilitiesRemeasurement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsBusinessCombinations" name="RightofuseAssetsBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombinationsLeaseLiabilities" name="BusinessCombinationsLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DepreciationExpenseLeaseLiabilities" name="DepreciationExpenseLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsInterestExpense" name="RightofuseAssetsInterestExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" name="RightofuseAssetsPaymentsOfLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" name="PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsDisposals" name="RightofuseAssetsDisposals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesDisposals" name="LeaseLiabilitiesDisposals" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesRightToUse" name="LeaseLiabilitiesRightToUse" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitieRightToUse" name="LeaseLiabilitieRightToUse" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsCurrent" name="RightofuseAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RightofuseAssetsNonCurrent" name="RightofuseAssetsNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherPayablesToRelatedParties1" name="TradeAndOtherPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersCurrent" name="AccountsPayableToSellingShareholdersCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersNonCurrent" name="AccountsPayableToSellingShareholdersNonCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholderCashFlows" name="AccountsPayableToSellingShareholderCashFlows" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" name="AccountsPayableToSellingShareholdersAcquisitionOfIpec" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AccountsPayableToSellingShareholdersBusinessCombinations" name="AccountsPayableToSellingShareholdersBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContingentConsiderationOnBusinessCombinations" name="ContingentConsiderationOnBusinessCombinations" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CompensationOfLegalProceedingsDisbursement" name="CompensationOfLegalProceedingsDisbursement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherPayablesToRelatedParties2" name="TradeAndOtherPayablesToRelatedParties2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RemainingTradeAndOtherPayablesToRelatedParties" name="RemainingTradeAndOtherPayablesToRelatedParties" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EqualInstallmentsPayablesToRelatedParties1" name="EqualInstallmentsPayablesToRelatedParties1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashTransferredTransaction" name="CashTransferredTransaction" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BusinessCombination" name="BusinessCombination" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Payments" name="Payments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MonetaryIndexation" name="MonetaryIndexation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CurrentLiabilities1" name="CurrentLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NoncurrentLiabilities1" name="NoncurrentLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IndexRatePerYear" name="IndexRatePerYear" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_BaseRate" name="BaseRate" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotePayables" name="NotePayables" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialLiabilitiesContractualUndiscounted" name="FinancialLiabilitiesContractualUndiscounted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" name="IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProceedsFromLoansAndFinancing" name="ProceedsFromLoansAndFinancing" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetOfTransactionCosts" name="NetOfTransactionCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NotesPayable1" name="NotesPayable1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SensitivityChangeInTheEuroExchangeRate" name="SensitivityChangeInTheEuroExchangeRate" nillable="true" xbrli:periodType="duration" type="num:percentItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingLiabilities" name="LoansAndFinancingLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilities1" name="LeaseLiabilities1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" name="TradeAndOtherPayablesToRelatedPartiesLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueNotesPayables1" name="FairValueNotesPayables1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RestrictedCashAndCashEquivalents1" name="RestrictedCashAndCashEquivalents1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseLiabilitiesOne" name="LeaseLiabilitiesOne" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FairValueNotesPayablesLiabilities" name="FairValueNotesPayablesLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CashAndCashEquivalents1" name="CashAndCashEquivalents1" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EquityOne1" name="EquityOne1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_EquityAndNetDebt1" name="EquityAndNetDebt1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" name="StrikePriceeAtMeasurementDateShareOptionsGranted" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" name="SharePriceFairValueAtMeasurementDateShareOptionsGranted" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" name="WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" name="StrikePriceeAtMeasurementDateShareOptionsGrante" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ShareBasedCompensationOfEmployees" name="ShareBasedCompensationOfEmployees" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_OtherRevenue1" name="OtherRevenue1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionAbstract" name="DeductionAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfGrantedDiscounts" name="DeductionOfGrantedDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfEarlyPaymentDiscounts" name="DeductionOfEarlyPaymentDiscounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfReturnsOfNetRevenue" name="DeductionOfReturnsOfNetRevenue" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfTaxes" name="DeductionOfTaxes" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DeductionOfProuni" name="DeductionOfProuni" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" name="TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NetRevenueOtherTransferredPoint" name="NetRevenueOtherTransferredPoint" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProfessionalFeesExpense1" name="ProfessionalFeesExpense1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TimingRevenueRecognition" name="TimingRevenueRecognition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Payroll" name="Payroll" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_HospitalAndMedicalAgreements" name="HospitalAndMedicalAgreements" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LeaseExpenses" name="LeaseExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_SharesBasedCompensation" name="SharesBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxExpenses" name="TaxExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AllowanceForDoubtfulAccounts" name="AllowanceForDoubtfulAccounts" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ConsultingFees" name="ConsultingFees" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_Other" name="Other" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ExpenseByNatureOne" name="ExpenseByNatureOne" nillable="true" xbrli:periodType="duration" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ChangesInFairValueOfDerivativeInstruments" name="ChangesInFairValueOfDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ChangeInFairValueOfDerivativeInstruments" name="ChangeInFairValueOfDerivativeInstruments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpense1" name="InterestExpense1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterestExpenseOnLeaseLiabilities1" name="InterestExpenseOnLeaseLiabilities1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinancialDiscountsGrantedExpenses" name="FinancialDiscountsGrantedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxOnFinancialOperations" name="TaxOnFinancialOperations" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_FinanceResult" name="FinanceResult" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ReconciliationAdjustmentsAbstract" name="ReconciliationAdjustmentsAbstract" abstract="true" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" name="TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProgramaUniversidadeParaTodosFiscalIncentive" name="ProgramaUniversidadeParaTodosFiscalIncentive" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_UnrecognisedDeferredTaxAssets" name="UnrecognisedDeferredTaxAssets" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PermanentAdjustments" name="PermanentAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IssuedCapital2" name="IssuedCapital2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_NumberOfSharesIssued1" name="NumberOfSharesIssued1" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DescriptionOfRatioOfConvertibleShares" name="DescriptionOfRatioOfConvertibleShares" nillable="true" xbrli:periodType="duration" type="xbrli:stringItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CapitalIncreaseWithEarningsReserves" name="CapitalIncreaseWithEarningsReserves" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_RepurchaseOfOrdinaryShares" name="RepurchaseOfOrdinaryShares" nillable="true" xbrli:periodType="instant" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionPrice" name="AcquisitionPrice" nillable="true" xbrli:periodType="instant" type="num:perShareItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AcquisitionsHeldByShareholders" name="AcquisitionsHeldByShareholders" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProceedsFromIssueOfOrdinarySharesOne" name="ProceedsFromIssueOfOrdinarySharesOne" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalPaidinCapital1" name="AdditionalPaidinCapital1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_AdditionalPaidinCapital2" name="AdditionalPaidinCapital2" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CancellationOfDividend" name="CancellationOfDividend" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_InterimDividends" name="InterimDividends" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_DividendsPaidClassifiedAsFinancingActivities1" name="DividendsPaidClassifiedAsFinancingActivities1" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_IssuedCapital1" name="IssuedCapital1" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ProceedsFromIssueOfOrdinaryShares1" name="ProceedsFromIssueOfOrdinaryShares1" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_ContingenciesCorrespondentAmount" name="ContingenciesCorrespondentAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" />
    <element id="afya_LoansAndFinancingThreeMember" name="LoansAndFinancingThreeMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember" name="PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_CBBWebServicosETransmissoesOnlineSAMember" name="CBBWebServicosETransmissoesOnlineSAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
    <element id="afya_MedcelEditoraEEventosSAMember" name="MedcelEditoraEEventosSAMember" abstract="true" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>35
<FILENAME>afya-20211231_cal.xml
<DESCRIPTION>XBRL CALCULATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20211231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20211231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20211231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20211231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:href="afya-20211231.xsd#SignificantAccountingEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20211231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20211231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20211231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20211231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20211231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20211231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20211231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20211231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20211231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20211231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20211231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20211231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20211231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20211231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvents" xlink:href="afya-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20211231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20211231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20211231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20211231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20211231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20211231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20211231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20211231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagementTables" xlink:href="afya-20211231.xsd#CapitalManagementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20211231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20211231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20211231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20211231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:href="afya-20211231.xsd#TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:href="afya-20211231.xsd#DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:href="afya-20211231.xsd#ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUniredentorDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUnislDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfPebmedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFesarDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfMedphoneDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFcmpbDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:href="afya-20211231.xsd#ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:href="afya-20211231.xsd#FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20211231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:href="afya-20211231.xsd#TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:href="afya-20211231.xsd#KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20211231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssumptionsForImpairmentTestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20211231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="afya-20211231.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:href="afya-20211231.xsd#ScheduleOfLoansAndFinancingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:href="afya-20211231.xsd#ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:href="afya-20211231.xsd#SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:href="afya-20211231.xsd#TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:href="afya-20211231.xsd#ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:href="afya-20211231.xsd#TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:href="afya-20211231.xsd#ScheduleOfFairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfCapitalManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:href="afya-20211231.xsd#ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:href="afya-20211231.xsd#ScheduleOfShare-basedCompensationPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:href="afya-20211231.xsd#ScheduleOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:href="afya-20211231.xsd#ScheduleOfNetSalesRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfRevenueBySegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:href="afya-20211231.xsd#ScheduleOfExpensesByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:href="afya-20211231.xsd#ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:href="afya-20211231.xsd#ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:href="afya-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-fullInventories" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullInventories" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentAssets" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullNoncurrentRestrictedCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullNoncurrentRestrictedCashAndCashEquivalents" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentAssets" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAssets" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayableCurrent" xlink:label="loc_afyaNotePayableCurrent" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_afyaNotePayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCurrentLiabilities" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableNonCurrentLiabiites" xlink:label="loc_afyaNotesPayableNonCurrentLiabiites" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_afyaNotesPayableNonCurrentLiabiites" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullNoncurrentLiabilities" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullLiabilities" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquity" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullEquityAndLiabilities" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullGrossProfit" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullFinanceIncomeCost" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLossBeforeTax" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullProfitLoss" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullComprehensiveIncome" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullDisposalsIntangibleAssetsAndGoodwill" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullDisposalsIntangibleAssetsAndGoodwill" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-fullAdjustmentsForFinanceCosts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForFinanceCosts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:calculationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:calculationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:calculationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:calculationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" />
      <link:calculationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:calculationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:calculationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:calculationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:calculationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:calculationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:calculationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:calculationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="loc_afyaRestrictedCashOfInvestingActivities" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaRestrictedCashOfInvestingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaymentsOfNotesPayable" xlink:label="loc_afyaPaymentsOfNotesPayable" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_afyaPaymentsOfNotesPayable" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-fullCashAdvancesAndLoansFromRelatedParties" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:to="loc_ifrs-fullCashAdvancesAndLoansFromRelatedParties" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuanceOfLoansAndFinancing" xlink:label="loc_afyaIssuanceOfLoansAndFinancing" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaIssuanceOfLoansAndFinancing" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseOfFinancialActivities" xlink:label="loc_afyaCapitalIncreaseOfFinancialActivities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaCapitalIncreaseOfFinancialActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharebasedCompensationPlanReceipts" xlink:label="loc_afyaSharebasedCompensationPlanReceipts" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_afyaSharebasedCompensationPlanReceipts" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-fullPaymentsForShareIssueCosts" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:to="loc_ifrs-fullPaymentsForShareIssueCosts" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting estimates and assumptions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="00000030 - Disclosure - Subsequent events" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Significant accounting policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Significant accounting policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagementTables" xlink:title="00000044 - Disclosure - Capital management (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000045 - Disclosure - Labor and social obligations (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000046 - Disclosure - Equity (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000047 - Disclosure - Earnings per share (EPS) (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000048 - Disclosure - Revenue (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000049 - Disclosure - Expenses and costs by nature (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000050 - Disclosure - Finance result (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000051 - Disclosure - Income taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000052 - Disclosure - Insurance contracts and contingencies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:title="00000054 - Disclosure - The table below is a list of the Company&#8217;s subsidiaries and associate: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:title="00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:title="00000056 - Disclosure - Schedule of assets and liabilities information for the company&apos;s operating segments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:title="00000057 - Disclosure - Schedule of operating income for each operating segment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:title="00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000059 - Disclosure - Significant accounting policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:title="00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:title="00000061 - Disclosure - Schedule of acquisition of UniSL (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:title="00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:title="00000063 - Disclosure - Schedule of acquisition of FESAR (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:title="00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:title="00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:title="00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:title="00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="00000068 - Disclosure - Schedule of cash and cash equivalents (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000069 - Disclosure - Business combinations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:title="00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:title="00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:title="00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000074 - Disclosure - Cash and cash equivalents (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:title="00000075 - Disclosure - Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000076 - Disclosure - Related parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:title="00000077 - Disclosure - Schedule of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_afyaAssets1" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:title="00000078 - Disclosure - Schedule of investments (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:title="00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000080 - Disclosure - Schedule of intangible assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:title="00000081 - Disclosure - Schedule of assumptions for impairment test (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000082 - Disclosure - Other assets (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000083 - Disclosure - Schedule of estimated useful lives (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:title="00000084 - Disclosure - Schedule of financial assets (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="00000085 - Disclosure - Schedule of financial liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:title="00000086 - Disclosure - Schedule of loans and financing (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:title="00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:title="00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:title="00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:title="00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:title="00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:title="00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:title="00000094 - Disclosure - The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts: (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:title="00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:title="00000097 - Disclosure - Schedule of fair value measurement (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:title="00000098 - Disclosure - Schedule of capital management (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:title="00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:title="00000100 - Disclosure - Schedule of share-based compensation plan (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000101 - Disclosure - Labor and social obligations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:title="00000102 - Disclosure - Schedule of earnings per share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:title="00000103 - Disclosure - Schedule of net sales revenue (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:title="00000104 - Disclosure - Schedule of revenue by segment (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:title="00000105 - Disclosure - Schedule of expenses by nature (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:title="00000106 - Disclosure - Schedule of finance result (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:title="00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000108 - Disclosure - Equity (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:title="00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:title="00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000111 - Disclosure - Income taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="00000113 - Disclosure - Subsequent events (Details Narrative)" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>36
<FILENAME>afya-20211231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20211231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20211231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20211231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20211231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:href="afya-20211231.xsd#SignificantAccountingEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20211231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20211231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20211231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20211231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20211231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20211231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20211231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20211231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20211231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20211231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20211231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20211231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20211231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20211231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvents" xlink:href="afya-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20211231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20211231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20211231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20211231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20211231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20211231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20211231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20211231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagementTables" xlink:href="afya-20211231.xsd#CapitalManagementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20211231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20211231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20211231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20211231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:href="afya-20211231.xsd#TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:href="afya-20211231.xsd#DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:href="afya-20211231.xsd#ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUniredentorDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUnislDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfPebmedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFesarDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfMedphoneDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFcmpbDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:href="afya-20211231.xsd#ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:href="afya-20211231.xsd#FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20211231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:href="afya-20211231.xsd#TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:href="afya-20211231.xsd#KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20211231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssumptionsForImpairmentTestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20211231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="afya-20211231.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:href="afya-20211231.xsd#ScheduleOfLoansAndFinancingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:href="afya-20211231.xsd#ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:href="afya-20211231.xsd#SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:href="afya-20211231.xsd#TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:href="afya-20211231.xsd#ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:href="afya-20211231.xsd#TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:href="afya-20211231.xsd#ScheduleOfFairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfCapitalManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:href="afya-20211231.xsd#ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:href="afya-20211231.xsd#ScheduleOfShare-basedCompensationPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:href="afya-20211231.xsd#ScheduleOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:href="afya-20211231.xsd#ScheduleOfNetSalesRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfRevenueBySegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:href="afya-20211231.xsd#ScheduleOfExpensesByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:href="afya-20211231.xsd#ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:href="afya-20211231.xsd#ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:href="afya-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription_50" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement_50" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport_50" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport_50" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport_50" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport_50" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate_50" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate_50" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate_50" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus_50" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus_50" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate_50" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber_50" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName_50" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey_50" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber_50" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber_50" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode_50" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1_50" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2_50" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3_50" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown_50" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince_50" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry_50" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode_50" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion_50" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode_50" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber_50" xlink:type="arc" order="29" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension_50" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications_50" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial_50" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer_50" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer_50" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle_50" xlink:type="arc" order="35" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag_50" xlink:type="arc" order="36" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol_50" xlink:type="arc" order="37" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName_50" xlink:type="arc" order="38" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle_50" xlink:type="arc" order="39" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation_50" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm_50" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements_50" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer_50" xlink:type="arc" order="43" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers_50" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus_50" xlink:type="arc" order="45" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent_50" xlink:type="arc" order="46" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory_50" xlink:type="arc" order="47" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness_50" xlink:type="arc" order="48" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany_50" xlink:type="arc" order="49" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod_50" xlink:type="arc" order="50" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany_50" xlink:type="arc" order="53" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent_50" xlink:type="arc" order="55" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding_50" xlink:type="arc" order="56" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock_50" xlink:type="arc" order="57" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName_50" xlink:type="arc" order="58" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress_50" xlink:type="arc" order="59" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag_50" xlink:type="arc" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId_50" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName_50" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation_50" xlink:type="arc" order="63" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullIssuedCapitalMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullTreasurySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-fullOtherReservesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullOtherReservesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RetainedEarningsReserveMember" xlink:label="loc_afyaRetainedEarningsReserveMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_afyaRetainedEarningsReserveMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullRetainedEarningsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEquityMember" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithCash" xlink:label="loc_afyaCapitalIncreaseWithCash_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithCash_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherContributionsByOwners_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherContributionsByOwners_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseFromCorporateReorganization" xlink:label="loc_afyaCapitalIncreaseFromCorporateReorganization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseFromCorporateReorganization_110" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions_110" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllocationToAdditionalPaidinCapital" xlink:label="loc_afyaAllocationToAdditionalPaidinCapital_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllocationToAdditionalPaidinCapital_110" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid_110" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsCancelled" xlink:label="loc_afyaDividendsCancelled_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsCancelled_110" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CorporateReorganization" xlink:label="loc_afyaCorporateReorganization_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCorporateReorganization_110" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-fullIssueOfEquity_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssueOfEquity_110" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-fullShareIssueRelatedCost_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullShareIssueRelatedCost_110" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasuryShares1_110" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="loc_afyaTreasurySharesTransferredFromExerciseOfOptions_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromExerciseOfOptions_110" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination_110" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsDeclaredToNoncontrollingInterests" xlink:label="loc_afyaDividendsDeclaredToNoncontrollingInterests_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsDeclaredToNoncontrollingInterests_110" xlink:type="arc" order="17" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting estimates and assumptions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="00000030 - Disclosure - Subsequent events" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Significant accounting policies (Policies)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Significant accounting policies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HarbourMember" xlink:label="loc_afyaHarbourMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaHarbourMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaShospMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIFIPMocMember" xlink:label="loc_afyaUNIFIPMocMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIFIPMocMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIGRANMember" xlink:label="loc_afyaUNIGRANMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIGRANMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PXPROMember" xlink:label="loc_afyaPXPROMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPXPROMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniRedentorMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniSLMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDMember" xlink:label="loc_afyaPEBMEDMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPEBMEDMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFCMPBMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" xlink:label="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUniredentorTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUniredentorTableTextBlock_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnislTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnislTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnislTableTextBlock_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfPebmedTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfPebmedTableTextBlock_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesarTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFesarTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFesarTableTextBlock_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfMedphoneTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfMedphoneTableTextBlock_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFcmpbTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFcmpbTableTextBlock_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnigranTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnigranTableTextBlock_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfRXPROTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfRXPROTableTextBlock_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" xlink:label="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnisl1TableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnisl1TableTextBlock_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfPebmed1TableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfPebmed1TableTextBlock_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFesar1TableTextBlock_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFesar1TableTextBlock_150" xlink:type="arc" order="12" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagementTables" xlink:title="00000044 - Disclosure - Capital management (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000045 - Disclosure - Labor and social obligations (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000046 - Disclosure - Equity (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000047 - Disclosure - Earnings per share (EPS) (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000048 - Disclosure - Revenue (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000049 - Disclosure - Expenses and costs by nature (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000050 - Disclosure - Finance result (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000051 - Disclosure - Income taxes (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000052 - Disclosure - Insurance contracts and contingencies (Tables)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuardayaEmpreendimentosAndParticipacoesSAMember" xlink:label="loc_afyaGuardayaEmpreendimentosAndParticipacoesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaGuardayaEmpreendimentosAndParticipacoesSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraAndCBBWebMember" xlink:label="loc_afyaMedcelEditoraAndCBBWebMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraAndCBBWebMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtdaMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtdaMember_250" xlink:type="arc" order="251" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiadaInformacaoLtdaMember" xlink:label="loc_afyaShospTecnologiadaInformacaoLtdaMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiadaInformacaoLtdaMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraodeEducacaoSuperiorLtdMember" xlink:label="loc_afyaSociedadePadraodeEducacaoSuperiorLtdMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraodeEducacaoSuperiorLtdMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesdeTecnologiaLtdaMember" xlink:label="loc_afyaRXPROSolucoesdeTecnologiaLtdaMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesdeTecnologiaLtdaMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassACommonSharesMember" xlink:label="loc_afyaClassACommonSharesMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassACommonSharesMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockAxis" xlink:label="loc_afyaSaleOfStockAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaSaleOfStockAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockDomain" xlink:label="loc_afyaSaleOfStockDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_afyaSaleOfStockAxis" xlink:to="loc_afyaSaleOfStockDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockDomain" xlink:label="loc_afyaSaleOfStockDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_afyaSaleOfStockAxis" xlink:to="loc_afyaSaleOfStockDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InitialPublicOfferingMember" xlink:label="loc_afyaInitialPublicOfferingMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaSaleOfStockDomain" xlink:to="loc_afyaInitialPublicOfferingMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OverAllotmentsMember" xlink:label="loc_afyaOverAllotmentsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaSaleOfStockDomain" xlink:to="loc_afyaOverAllotmentsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnderwritersMember" xlink:label="loc_afyaUnderwritersMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUnderwritersMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareholdersMember" xlink:label="loc_afyaShareholdersMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaShareholdersMember_160" xlink:type="arc" order="163" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currencyUSD_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyUSD_110" xlink:type="arc" order="113" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_340" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary_340" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" xlink:label="loc_ifrs-fullRightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_340" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued_340" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfPerShares" xlink:label="loc_afyaNumberOfPerShares_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfPerShares_340" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares_340" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesNet" xlink:label="loc_afyaProceedsFromIssueOfOrdinarySharesNet_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinarySharesNet_340" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionExpense" xlink:label="loc_ifrs-fullFeeAndCommissionExpense_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionExpense_340" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherOfferingExpenses" xlink:label="loc_afyaOtherOfferingExpenses_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherOfferingExpenses_340" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-fullShareIssueRelatedCost_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullShareIssueRelatedCost_340" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TransferredAmountToGBankAccounts" xlink:label="loc_afyaTransferredAmountToGBankAccounts_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransferredAmountToGBankAccounts_340" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfAdditionalCommonSharesIssued" xlink:label="loc_afyaNumberOfAdditionalCommonSharesIssued_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfAdditionalCommonSharesIssued_340" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalOfferingPrice" xlink:label="loc_afyaAdditionalOfferingPrice_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalOfferingPrice_340" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalSharesGrossProceeds" xlink:label="loc_afyaAdditionalSharesGrossProceeds_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalSharesGrossProceeds_340" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetProceedsOfAdditionalShares" xlink:label="loc_afyaNetProceedsOfAdditionalShares_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetProceedsOfAdditionalShares_340" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-fullLegalProceedingsProvision_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLegalProceedingsProvision_340" xlink:type="arc" order="15" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:title="00000054 - Disclosure - The table below is a list of the Company&#8217;s subsidiaries and associate: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAfyaParticipacoesSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeDoAcoSAUNIVACOMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoValeDoAcoSAUNIVACOMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraEEventosSAMedcelMember" xlink:label="loc_afyaMedcelEditoraEEventosSAMedcelMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraEEventosSAMedcelMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="loc_afyaESMCEducacaoSuperiorLtdaESMCMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaESMCEducacaoSuperiorLtdaESMCMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_260" xlink:type="arc" order="261" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_280" xlink:type="arc" order="281" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAUniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAUniRedentorMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAUniRedentorMember_300" xlink:type="arc" order="301" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaUniSLMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaUniSLMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaUniSLMember_320" xlink:type="arc" order="321" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" xlink:label="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_420" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_420" xlink:type="arc" order="421" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeSolutionsSAMedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsSAMedicinaeMember_440" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeSolutionsSAMedicinaeMember_440" xlink:type="arc" order="441" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_460" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_460" xlink:type="arc" order="461" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtdaCliquefarmaMember_480" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtdaCliquefarmaMember_480" xlink:type="arc" order="481" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiaDaInformacaoLtdaShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtdaShospMember_500" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtdaShospMember_500" xlink:type="arc" order="501" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_520" xlink:type="arc" order="521" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_540" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_540" xlink:type="arc" order="541" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" xlink:label="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_560" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_560" xlink:type="arc" order="561" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" xlink:label="loc_afyaSociedadeEducacionalDePalhocaSALtdaSOCIESPMember_580" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalDePalhocaSALtdaSOCIESPMember_580" xlink:type="arc" order="581" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_600" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_600" xlink:type="arc" order="601" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtdaRXPROMember_620" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtdaRXPROMember_620" xlink:type="arc" order="621" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" xlink:label="loc_afyaRXPROLOGTransporteELogisticaLtdaRXPROLOGMember_640" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROLOGTransporteELogisticaLtdaRXPROLOGMember_640" xlink:type="arc" order="641" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember_660" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember_660" xlink:type="arc" order="661" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NameOfSubsidiary" xlink:label="loc_ifrs-fullNameOfSubsidiary_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNameOfSubsidiary_690" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities_690" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary_690" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType_690" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_690" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_690" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:title="00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaboratoriesAndClinicsMember" xlink:label="loc_afyaLaboratoriesAndClinicsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLaboratoriesAndClinicsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_90" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:title="00000056 - Disclosure - Schedule of assets and liabilities information for the company&apos;s operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets_130" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_130" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_130" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities_130" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_130" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_130" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_130" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_130" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures_130" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:title="00000057 - Disclosure - Schedule of operating income for each operating segment (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer_190" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment_190" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_190" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales_190" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit_190" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense_190" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses_190" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities_190" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_190" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense_190" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_190" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_190" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_190" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_190" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:title="00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaFipmocSAMember" xlink:label="loc_afyaSociedadeUniversitariaFipmocSAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaFipmocSAMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaGranarioSAMember" xlink:label="loc_afyaSociedadeUniversitariaGranarioSAMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaGranarioSAMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCash1" xlink:label="loc_afyaRestrictedCash1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedCash1_220" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate_220" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Inventories1" xlink:label="loc_afyaInventories1_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInventories1_220" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate_220" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate_220" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_220" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ImdemnificationAssets" xlink:label="loc_afyaImdemnificationAssets_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaImdemnificationAssets_220" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_220" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate_220" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_220" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_220" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_220" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_220" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_220" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred_220" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate_220" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred_220" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInShares" xlink:label="loc_afyaPaidInShares_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaidInShares_220" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_220" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_220" xlink:type="arc" order="28" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition_220" xlink:type="arc" order="29" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000059 - Disclosure - Significant accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityAxis" xlink:label="loc_afyaTaxAuthorityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaTaxAuthorityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityDomain" xlink:label="loc_afyaTaxAuthorityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_afyaTaxAuthorityAxis" xlink:to="loc_afyaTaxAuthorityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityDomain" xlink:label="loc_afyaTaxAuthorityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_afyaTaxAuthorityAxis" xlink:to="loc_afyaTaxAuthorityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaTaxAuthorityDomain" xlink:to="loc_afyaProgramOfSocialIntegrationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaTaxAuthorityDomain" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaTeachingActivitiesMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaNonTeachingActivitiesMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm_60" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate_60" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:title="00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:title="00000061 - Disclosure - Schedule of acquisition of UniSL (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:title="00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:title="00000063 - Disclosure - Schedule of acquisition of FESAR (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:title="00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:title="00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_30" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:title="00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaGranarioSAMember" xlink:label="loc_afyaSociedadeUniversitariaGranarioSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaGranarioSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_130" xlink:type="arc" order="131" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_170" xlink:type="arc" order="171" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_200" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:title="00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" xlink:label="loc_afyaInstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullInventoryRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInventoryRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndemnificationAssets" xlink:label="loc_afyaIndemnificationAssets_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndemnificationAssets_150" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate_150" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate_150" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate_150" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate_150" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate_150" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate_150" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotesPayables_150" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate_150" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate_150" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred_150" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred_150" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PayablInInstallmentsAcquisitionDate" xlink:label="loc_afyaPayablInInstallmentsAcquisitionDate_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPayablInInstallmentsAcquisitionDate_150" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInAfyaBrazilsShares" xlink:label="loc_afyaPaidInAfyaBrazilsShares_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaidInAfyaBrazilsShares_150" xlink:type="arc" order="25" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_150" xlink:type="arc" order="26" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_150" xlink:type="arc" order="27" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition_150" xlink:type="arc" order="28" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="00000068 - Disclosure - Schedule of cash and cash equivalents (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000069 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedicinaeMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HarbourMember" xlink:label="loc_afyaHarbourMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaHarbourMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaShospMember_150" xlink:type="arc" order="151" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIFIPMocMember" xlink:label="loc_afyaUNIFIPMocMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIFIPMocMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIGRANMember" xlink:label="loc_afyaUNIGRANMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIGRANMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PXPROMember" xlink:label="loc_afyaPXPROMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPXPROMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniRedentorMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniSLMember_290" xlink:type="arc" order="291" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDMember" xlink:label="loc_afyaPEBMEDMember_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPEBMEDMember_310" xlink:type="arc" order="311" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_360" xlink:type="arc" order="361" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_400" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFCMPBMember_400" xlink:type="arc" order="401" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_430" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree_430" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_430" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_430" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_430" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue_430" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes_430" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-fullRevenueOfAcquiree_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueOfAcquiree_430" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfCombinedEntity" xlink:label="loc_ifrs-fullRevenueOfCombinedEntity_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueOfCombinedEntity_430" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaymentMade" xlink:label="loc_afyaAdditionalPaymentMade_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaymentMade_430" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreasedInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaDecreasedInIncomeBeforeIncomeTaxes_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDecreasedInIncomeBeforeIncomeTaxes_430" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:title="00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaTuitionFeesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalContentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaFIESMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalCreditsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaMobileAppSubscriptionMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaOthersMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables_150" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:title="00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-fullCurrentMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullCurrentMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneEightyMember" xlink:label="loc_afyaLaterThanOneEightyMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneEightyMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:title="00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUEPCMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions_180" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CreditsWithShareholdersRelatedPartyTransactions" xlink:label="loc_afyaCreditsWithShareholdersRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCreditsWithShareholdersRelatedPartyTransactions_180" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions_180" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1_180" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1_180" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="loc_afyaAccountsPayableToSellingShareholders_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholders_180" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions_180" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableCurrent1" xlink:label="loc_afyaAccountsPayableCurrent1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableCurrent1_180" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="loc_afyaNoncurrentPayablesToRelatedParties1_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentPayablesToRelatedParties1_180" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions_180" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions_180" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000074 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaBankCertificatesOfDepositMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterbankCertificatesOfDepositMember" xlink:label="loc_afyaInterbankCertificatesOfDepositMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaInterbankCertificatesOfDepositMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_afyaUSDMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents_50" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:title="00000075 - Disclosure - Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following: (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000076 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ReserveQuantitiesLineItems" xlink:label="loc_srtReserveQuantitiesLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Axis" xlink:label="loc_afyaTypeOfArrangement1Axis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_afyaTypeOfArrangement1Axis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Domain" xlink:label="loc_afyaTypeOfArrangement1Domain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_afyaTypeOfArrangement1Axis" xlink:to="loc_afyaTypeOfArrangement1Domain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Domain" xlink:label="loc_afyaTypeOfArrangement1Domain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_afyaTypeOfArrangement1Axis" xlink:to="loc_afyaTypeOfArrangement1Domain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaTypeOfArrangement1Domain" xlink:to="loc_afyaLeaseAgreements1Member_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_deiLegalEntityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember_10" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm_150" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases_150" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms_150" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:title="00000077 - Disclosure - Schedule of Other Assets (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:title="00000078 - Disclosure - Schedule of investments (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_ifrs-fullAssociatesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets_80" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets_80" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities_80" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities_80" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate_80" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1_80" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_80" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount_80" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue_80" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales_80" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense_80" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome_80" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax_80" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations_80" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss_80" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss_80" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_80" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MinorityInterestOfAcquiree" xlink:label="loc_afyaMinorityInterestOfAcquiree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaMinorityInterestOfAcquiree_80" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalMinorityInterestOfAcquiree" xlink:label="loc_afyaAdditionalMinorityInterestOfAcquiree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalMinorityInterestOfAcquiree_80" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1_80" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived_80" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree_80" xlink:type="arc" order="21" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:title="00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_770" xlink:type="arc" order="771" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLandMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaboratoriesAndClinicsMember" xlink:label="loc_afyaLaboratoriesAndClinicsMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLaboratoriesAndClinicsMember_70" xlink:type="arc" order="72" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullConstructionInProgressMember_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_1770" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_1770" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_1770" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_1770" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDisposalsPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisposalsPropertyPlantAndEquipment_1770" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1770" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment_1770" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000080 - Disclosure - Schedule of intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember_50" xlink:type="arc" order="51" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember_70" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformMember_70" xlink:type="arc" order="71" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaSoftwareInProgressMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformAndSoftwareInProgressMember" xlink:label="loc_afyaEducationalPlatformAndSoftwareInProgressMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformAndSoftwareInProgressMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DevelopedTechnologyIntangibleAssetsMember" xlink:label="loc_afyaDevelopedTechnologyIntangibleAssetsMember_380" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaDevelopedTechnologyIntangibleAssetsMember_380" xlink:type="arc" order="381" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember_700" xlink:type="arc" order="702" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_1520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_1520" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_1520" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_1520" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Disposal" xlink:label="loc_afyaDisposal_1520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDisposal_1520" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1520" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill_1520" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:title="00000081 - Disclosure - Schedule of assumptions for impairment test (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_60" xlink:type="arc" order="62" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember_80" xlink:type="arc" order="82" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelAndCBBWMember" xlink:label="loc_afyaMedcelAndCBBWMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelAndCBBWMember_100" xlink:type="arc" order="102" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_120" xlink:type="arc" order="122" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_140" xlink:type="arc" order="142" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_160" xlink:type="arc" order="162" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember_180" xlink:type="arc" order="182" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember_200" xlink:type="arc" order="202" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember_220" xlink:type="arc" order="222" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember_240" xlink:type="arc" order="242" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember_260" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember_260" xlink:type="arc" order="262" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="loc_afyaClinicalDecisionSoftwareMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaClinicalDecisionSoftwareMember_270" xlink:type="arc" order="272" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember_290" xlink:type="arc" order="292" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MocMember" xlink:label="loc_afyaMocMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMocMember_300" xlink:type="arc" order="302" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_320" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember_320" xlink:type="arc" order="322" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_330" xlink:type="arc" order="332" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill_350" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife_350" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits_350" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits_350" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000082 - Disclosure - Other assets (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000083 - Disclosure - Schedule of estimated useful lives (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="loc_afyaCustomerRelationshipsMedicineMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsMedicineMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_80" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:title="00000084 - Disclosure - Schedule of financial assets (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalents_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets_30" xlink:type="arc" order="5" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="00000085 - Disclosure - Schedule of financial liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_30" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_30" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_30" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayable" xlink:label="loc_afyaNotePayable_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayable_30" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances_30" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_30" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities_30" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities_30" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:title="00000086 - Disclosure - Schedule of loans and financing (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyThreeMember" xlink:label="loc_afyaTwentyTwentyThreeMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyThreeMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyOneMember" xlink:label="loc_afyaTwentyTwentyOneMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyOneMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFourMember" xlink:label="loc_afyaTwentyTwentyFourMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFourMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySevenMember" xlink:label="loc_afyaTwentyTwentySevenMember_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySevenMember_90" xlink:type="arc" order="91" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySixMember" xlink:label="loc_afyaTwentyTwentySixMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySixMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFour1Member" xlink:label="loc_afyaTwentyTwentyFour1Member_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFour1Member_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-fullBorrowingsByNameAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullBorrowingsByNameAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-fullBorrowingsByNameMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-fullBorrowingsByNameMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanciadoradeEstudoseProjetosFINEPMember" xlink:label="loc_afyaFinanciadoradeEstudoseProjetosFINEPMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullBorrowingsByNameMember" xlink:to="loc_afyaFinanciadoradeEstudoseProjetosFINEPMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution_310" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis_310" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity_310" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_310" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing1" xlink:label="loc_afyaLoansAndFinancing1_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing1_310" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent_310" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent_310" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties_310" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IntrestRate" xlink:label="loc_afyaIntrestRate_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntrestRate_310" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-fullNotionalAmount_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNotionalAmount_310" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BorrowingsAmountFirstTranche" xlink:label="loc_afyaBorrowingsAmountFirstTranche_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBorrowingsAmountFirstTranche_310" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-fullNumberOfSharesAuthorised_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesAuthorised_310" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare_310" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-fullContributionsToPlanNetDefinedBenefitLiabilityAsset_310" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContributionsToPlanNetDefinedBenefitLiabilityAsset_310" xlink:type="arc" order="13" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections_40" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_40" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:title="00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:title="00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_40" xlink:type="arc" order="41" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember_140" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember_140" xlink:type="arc" order="141" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneMember" xlink:label="loc_afyaMedPhoneMember_160" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneMember_160" xlink:type="arc" order="161" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeMember_180" xlink:type="arc" order="181" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember_190" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember_190" xlink:type="arc" order="191" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember_200" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember_200" xlink:type="arc" order="201" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember_210" xlink:type="arc" order="211" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember_220" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember_220" xlink:type="arc" order="221" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember_230" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember_230" xlink:type="arc" order="231" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuaranhunsMember" xlink:label="loc_afyaGuaranhunsMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGuaranhunsMember_240" xlink:type="arc" order="241" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_340" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_340" xlink:type="arc" order="341" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_720" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedParties1_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedParties1_720" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent_720" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent_720" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="loc_afyaAccountsPayableToSellingShareholderCashFlows_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholderCashFlows_720" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec_720" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense_720" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations_720" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="loc_afyaContingentConsiderationOnBusinessCombinations_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingentConsiderationOnBusinessCombinations_720" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompensationOfLegalProceedingsDisbursement" xlink:label="loc_afyaCompensationOfLegalProceedingsDisbursement_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompensationOfLegalProceedingsDisbursement_720" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties2" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedParties2_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedParties2_720" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests_720" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties_720" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties_720" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties1_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties1_720" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashTransferredTransaction" xlink:label="loc_afyaCashTransferredTransaction_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashTransferredTransaction_720" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue_720" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations_720" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_720" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy_720" xlink:type="arc" order="18" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:title="00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:title="00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashMember" xlink:label="loc_afyaRestrictedCashMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaRestrictedCashMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-fullTradeReceivablesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullTradeReceivablesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember_120" xlink:type="arc" order="121" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_150" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue_150" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities_150" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue_150" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue_150" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:title="00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:label="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullInterestRateRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullInterestRateTypesMember" xlink:to="loc_ifrs-fullFloatingInterestRateMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaCashEquivalents1Member_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaCashEquivalents1Member_20" xlink:type="arc" order="23" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="loc_afyaLoansAndFinancingTwoMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingTwoMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingOneMember_120" xlink:type="arc" order="123" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_180" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_180" xlink:type="arc" order="183" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember_240" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember_240" xlink:type="arc" order="243" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersSevenMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersSevenMember_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersSevenMember_300" xlink:type="arc" order="303" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember_360" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember_360" xlink:type="arc" order="363" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsMember_20" xlink:type="arc" order="24" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsMember" xlink:label="loc_afyaDecreaseBasisPointsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaDecreaseBasisPointsMember_30" xlink:type="arc" order="34" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsOneMember_40" xlink:type="arc" order="44" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsOneMember" xlink:label="loc_afyaDecreaseBasisPointsOneMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaDecreaseBasisPointsOneMember_50" xlink:type="arc" order="54" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets_430" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear_430" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate_430" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_430" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_430" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_430" xlink:type="arc" order="4" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:title="00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:label="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullRiskExposuresAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaForeignCurrencyExposuresMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaIncreaseForeignCurrencyMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaDecreaseForeignCurrencyMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents_40" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:title="00000094 - Disclosure - The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts: (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullLiquidityRiskMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember_30" xlink:type="arc" order="32" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayables" xlink:label="loc_afyaNotePayables_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayables_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:title="00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaLoansAndFinancingMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaDividendsPayableMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_280" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromLoansAndFinancing" xlink:label="loc_afyaProceedsFromLoansAndFinancing_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromLoansAndFinancing_280" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfTransactionCosts" xlink:label="loc_afyaNetOfTransactionCosts_280" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfTransactionCosts_280" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember_60" xlink:type="arc" order="61" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_srtCurrencyAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currencyEUR_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR_90" xlink:type="arc" order="92" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_110" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm_110" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_110" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayable1" xlink:label="loc_afyaNotesPayable1_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotesPayable1_110" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditExposure" xlink:label="loc_ifrs-fullCreditExposure_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCreditExposure_110" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate_110" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate_110" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:title="00000097 - Disclosure - Schedule of fair value measurement (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-fullMeasurementAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullMeasurementAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAggregatedMeasurementMember" xlink:to="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables_90" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="loc_afyaLoansAndFinancingLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingLiabilities_90" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilities1" xlink:label="loc_afyaLeaseLiabilities1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilities1_90" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities_90" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayables1" xlink:label="loc_afyaFairValueNotesPayables1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayables1_90" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashAndCashEquivalents1" xlink:label="loc_afyaRestrictedCashAndCashEquivalents1_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedCashAndCashEquivalents1_90" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesOne" xlink:label="loc_afyaLeaseLiabilitiesOne_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesOne_90" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayablesLiabilities" xlink:label="loc_afyaFairValueNotesPayablesLiabilities_90" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayablesLiabilities_90" xlink:type="arc" order="7" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:title="00000098 - Disclosure - Schedule of capital management (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:title="00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember_40" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember_40" xlink:type="arc" order="42" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember_50" xlink:type="arc" order="52" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted_300" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted_300" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted_300" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted_300" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionLifeShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionLifeShareOptionsGranted_300" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted_300" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted_300" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_300" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante_300" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante_300" xlink:type="arc" order="8" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:title="00000100 - Disclosure - Schedule of share-based compensation plan (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000101 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaShareBasedCompensationPlansMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees_120" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement_120" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_120" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees_120" xlink:type="arc" order="2" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:title="00000102 - Disclosure - Schedule of earnings per share (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:title="00000103 - Disclosure - Schedule of net sales revenue (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:title="00000104 - Disclosure - Schedule of revenue by segment (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-fullEliminationOfIntersegmentAmountsMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_ifrs-fullEliminationOfIntersegmentAmountsMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SegmentOfBusinessOneUnitMember" xlink:label="loc_afyaSegmentOfBusinessOneUnitMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaSegmentOfBusinessOneUnitMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices_170" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense_170" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProfessionalFeesExpense1" xlink:label="loc_afyaProfessionalFeesExpense1_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProfessionalFeesExpense1_170" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue_170" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition_170" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome_170" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint_170" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint_170" xlink:type="arc" order="6" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:title="00000105 - Disclosure - Schedule of expenses by nature (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:title="00000106 - Disclosure - Schedule of finance result (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:title="00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000108 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember_80" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember_80" xlink:type="arc" order="81" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAPreferenceSharesMember" xlink:label="loc_afyaClassAPreferenceSharesMember_100" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAPreferenceSharesMember_100" xlink:type="arc" order="101" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBPreferenceSharesMember" xlink:label="loc_afyaClassBPreferenceSharesMember_110" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBPreferenceSharesMember_110" xlink:type="arc" order="111" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BRHealthMember" xlink:label="loc_afyaBRHealthMember_210" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaBRHealthMember_210" xlink:type="arc" order="212" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NicolauCarvalhoEstevesMember" xlink:label="loc_afyaNicolauCarvalhoEstevesMember_250" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaNicolauCarvalhoEstevesMember_250" xlink:type="arc" order="252" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAUEPCMember_270" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAUEPCMember_270" xlink:type="arc" order="271" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital_330" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital2" xlink:label="loc_afyaIssuedCapital2_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapital2_330" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1_330" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued_330" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfRatioOfConvertibleShares" xlink:label="loc_afyaDescriptionOfRatioOfConvertibleShares_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfRatioOfConvertibleShares_330" xlink:type="arc" order="4" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares_330" xlink:type="arc" order="5" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfPreferenceShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfPreferenceShares_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfPreferenceShares_330" xlink:type="arc" order="6" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithEarningsReserves" xlink:label="loc_afyaCapitalIncreaseWithEarningsReserves_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithEarningsReserves_330" xlink:type="arc" order="7" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" xlink:label="loc_ifrs-fullDividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_330" xlink:type="arc" order="8" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="loc_ifrs-fullSharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_330" xlink:type="arc" order="9" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare_330" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares_330" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionPrice" xlink:label="loc_afyaAcquisitionPrice_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionPrice_330" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionsHeldByShareholders" xlink:label="loc_afyaAcquisitionsHeldByShareholders_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionsHeldByShareholders_330" xlink:type="arc" order="13" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesOne" xlink:label="loc_afyaProceedsFromIssueOfOrdinarySharesOne_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinarySharesOne_330" xlink:type="arc" order="14" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital1" xlink:label="loc_afyaAdditionalPaidinCapital1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaidinCapital1_330" xlink:type="arc" order="15" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital2" xlink:label="loc_afyaAdditionalPaidinCapital2_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaidinCapital2_330" xlink:type="arc" order="16" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CancellationOfDividend" xlink:label="loc_afyaCancellationOfDividend_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCancellationOfDividend_330" xlink:type="arc" order="17" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendPayables" xlink:label="loc_ifrs-fullDividendPayables_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendPayables_330" xlink:type="arc" order="18" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterimDividends" xlink:label="loc_afyaInterimDividends_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterimDividends_330" xlink:type="arc" order="19" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPaidClassifiedAsFinancingActivities1" xlink:label="loc_afyaDividendsPaidClassifiedAsFinancingActivities1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsPaidClassifiedAsFinancingActivities1_330" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests_330" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital1" xlink:label="loc_afyaIssuedCapital1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapital1_330" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinaryShares1" xlink:label="loc_afyaProceedsFromIssueOfOrdinaryShares1_330" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinaryShares1_330" xlink:type="arc" order="23" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:title="00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember_10" xlink:type="arc" order="12" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_290" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions_290" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions_290" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions_290" xlink:type="arc" order="3" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:title="00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember_0" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember_30" xlink:type="arc" order="33" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember_60" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesAndSocialSecurityMember_60" xlink:type="arc" order="63" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_afyaTypesOfRiskMember_0" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions_130" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions_130" xlink:type="arc" order="0" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000111 - Disclosure - Income taxes (Details Narrative)" />
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfAssetsMember" xlink:to="loc_afyaOtherAssetsNonCurrentMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaJudicialDeposits_30" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount_30" xlink:type="arc" order="1" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="00000113 - Disclosure - Subsequent events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xbrldt:contextElement="segment" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:type="arc" order="10" xbrldt:closed="true" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember_0" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember_0" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember_20" xlink:type="arc" order="21" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember_30" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember_30" xlink:type="arc" order="31" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:type="arc" order="2" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicParticipacoesSAMember" xlink:label="loc_afyaIClinicParticipacoesSAMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicParticipacoesSAMember_10" xlink:type="arc" order="11" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:type="arc" order="3" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xbrldt:contextElement="segment" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember_10" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NicolauCarvalhoEstevesMember" xlink:label="loc_afyaNicolauCarvalhoEstevesMember_20" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaNicolauCarvalhoEstevesMember_20" xlink:type="arc" order="22" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares_50" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired_50" xlink:type="arc" order="1" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare_50" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare_50" xlink:type="arc" order="2" />
    </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>37
<FILENAME>afya-20211231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="dei_EntityAddressesAddressTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US">Entity Addresses, Address Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="dei_BusinessContactMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_BusinessContactMember" xlink:to="dei_BusinessContactMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_BusinessContactMember_lbl" xml:lang="en-US">Business Contact [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="ifrs-full_ClassesOfShareCapitalAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfShareCapitalAxis" xlink:to="ifrs-full_ClassesOfShareCapitalAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfShareCapitalAxis_lbl" xml:lang="en-US">Classes of share capital [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="afya_ClassAOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassAOrdinarySharesMember" xlink:to="afya_ClassAOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassAOrdinarySharesMember_lbl" xml:lang="en-US">Class A Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="afya_ClassBOrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassBOrdinarySharesMember" xlink:to="afya_ClassBOrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassBOrdinarySharesMember_lbl" xml:lang="en-US">Class B Ordinary Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComponentsOfEquityAxis" xlink:to="ifrs-full_ComponentsOfEquityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComponentsOfEquityAxis_lbl" xml:lang="en-US">Components of equity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapitalMember" xlink:to="ifrs-full_IssuedCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapitalMember_lbl" xml:lang="en-US">Issued capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="ifrs-full_AdditionalPaidinCapitalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapitalMember" xlink:to="ifrs-full_AdditionalPaidinCapitalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapitalMember_lbl" xml:lang="en-US">Additional paid-in capital [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="ifrs-full_TreasurySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasurySharesMember" xlink:to="ifrs-full_TreasurySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasurySharesMember_lbl" xml:lang="en-US">Treasury shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:to="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPaymentsMember_lbl" xml:lang="en-US">Reserve of share-based payments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReservesMember" xlink:label="ifrs-full_OtherReservesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReservesMember" xlink:to="ifrs-full_OtherReservesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReservesMember_lbl" xml:lang="en-US">Other reserves [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RetainedEarningsReserveMember" xlink:label="afya_RetainedEarningsReserveMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RetainedEarningsReserveMember" xlink:to="afya_RetainedEarningsReserveMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RetainedEarningsReserveMember_lbl" xml:lang="en-US">Retained Earnings Reserve [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="ifrs-full_RetainedEarningsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarningsMember" xlink:to="ifrs-full_RetainedEarningsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarningsMember_lbl" xml:lang="en-US">Retained earnings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember_lbl" xml:lang="en-US">Equity attributable to owners of parent [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="ifrs-full_NoncontrollingInterestsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterestsMember" xlink:to="ifrs-full_NoncontrollingInterestsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterestsMember_lbl" xml:lang="en-US">Non-controlling interests [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="ifrs-full_BusinessCombinationsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BusinessCombinationsAxis" xlink:to="ifrs-full_BusinessCombinationsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BusinessCombinationsAxis_lbl" xml:lang="en-US">Business combinations [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuardayaEmpreendimentosAndParticipacoesSAMember" xlink:label="afya_GuardayaEmpreendimentosAndParticipacoesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_GuardayaEmpreendimentosAndParticipacoesSAMember" xlink:to="afya_GuardayaEmpreendimentosAndParticipacoesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_GuardayaEmpreendimentosAndParticipacoesSAMember_lbl" xml:lang="en-US">Guardaya Empreendimentos And Participacoes S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:to="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SignificantInvestmentsInSubsidiariesAxis_lbl" xml:lang="en-US">Subsidiaries [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraAndCBBWebMember" xlink:label="afya_MedcelEditoraAndCBBWebMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelEditoraAndCBBWebMember" xlink:to="afya_MedcelEditoraAndCBBWebMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedcelEditoraAndCBBWebMember_lbl" xml:lang="en-US">Medcel Editora And C B B Web [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:to="afya_UniaoEducacionalDoPlanaltoCentralSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralSAMember_lbl" xml:lang="en-US">Uniao Educacional Do Planalto Central S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassACommonSharesMember" xlink:label="afya_ClassACommonSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassACommonSharesMember" xlink:to="afya_ClassACommonSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassACommonSharesMember_lbl" xml:lang="en-US">Class A Common Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockAxis" xlink:label="afya_SaleOfStockAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SaleOfStockAxis" xlink:to="afya_SaleOfStockAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SaleOfStockAxis_lbl" xml:lang="en-US">Sale of Stock [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InitialPublicOfferingMember" xlink:label="afya_InitialPublicOfferingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InitialPublicOfferingMember" xlink:to="afya_InitialPublicOfferingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InitialPublicOfferingMember_lbl" xml:lang="en-US">Initial Public Offering [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:to="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CategoriesOfRelatedPartiesAxis_lbl" xml:lang="en-US">Categories of related parties [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnderwritersMember" xlink:label="afya_UnderwritersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnderwritersMember" xlink:to="afya_UnderwritersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnderwritersMember_lbl" xml:lang="en-US">Underwriters [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OverAllotmentsMember" xlink:label="afya_OverAllotmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OverAllotmentsMember" xlink:to="afya_OverAllotmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OverAllotmentsMember_lbl" xml:lang="en-US">Over Allotments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="srt_CurrencyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_CurrencyAxis" xlink:to="srt_CurrencyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_CurrencyAxis_lbl" xml:lang="en-US">Currency [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="currency_USD" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_USD" xlink:to="currency_USD_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_USD_lbl" xml:lang="en-US">United States of America, Dollars</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareholdersMember" xlink:label="afya_ShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareholdersMember" xlink:to="afya_ShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareholdersMember_lbl" xml:lang="en-US">Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" xlink:label="afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" xlink:to="afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_lbl" xml:lang="en-US">Medical Harbour Aparelhos Medicos Hospitalarese Servicosem Tecnologia Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaMember" xlink:label="afya_CliquefarmaDrogariasOnlineLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaDrogariasOnlineLtdaMember" xlink:to="afya_CliquefarmaDrogariasOnlineLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaDrogariasOnlineLtdaMember_lbl" xml:lang="en-US">Cliquefarma Drogarias Online Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiadaInformacaoLtdaMember" xlink:label="afya_ShospTecnologiadaInformacaoLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospTecnologiadaInformacaoLtdaMember" xlink:to="afya_ShospTecnologiadaInformacaoLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospTecnologiadaInformacaoLtdaMember_lbl" xml:lang="en-US">Shosp Tecnologiada Informacao Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraodeEducacaoSuperiorLtdMember" xlink:label="afya_SociedadePadraodeEducacaoSuperiorLtdMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadePadraodeEducacaoSuperiorLtdMember" xlink:to="afya_SociedadePadraodeEducacaoSuperiorLtdMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadePadraodeEducacaoSuperiorLtdMember_lbl" xml:lang="en-US">Sociedade Padraode Educacao Superior Ltd [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesdeTecnologiaLtdaMember" xlink:label="afya_RXPROSolucoesdeTecnologiaLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROSolucoesdeTecnologiaLtdaMember" xlink:to="afya_RXPROSolucoesdeTecnologiaLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROSolucoesdeTecnologiaLtdaMember_lbl" xml:lang="en-US">R X P R O Solucoesde Tecnologia Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="afya_FaculdadeDeCienciasMedicasDaParaibaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:to="afya_FaculdadeDeCienciasMedicasDaParaibaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadeDeCienciasMedicasDaParaibaMember_lbl" xml:lang="en-US">Faculdade De Ciencias Medicas Da Paraiba [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="afya_AfyaParticipacoesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AfyaParticipacoesSAMember" xlink:to="afya_AfyaParticipacoesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AfyaParticipacoesSAMember_lbl" xml:lang="en-US">Afya Participacoes S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos Porto S A Itpac Porto Nacional [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S A I T P A C Araguaina [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" xlink:label="afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" xlink:to="afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember_lbl" xml:lang="en-US">Uniao Educacional Do Vale Do Aco S A U N I V A C O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:to="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_lbl" xml:lang="en-US">I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:to="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_lbl" xml:lang="en-US">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:to="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroDeCienciasEmSaudeDeItajubaSAMember_lbl" xml:lang="en-US">Centro De Ciencias Em Saude De Itajuba S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Do Piaui S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:to="afya_CentroIntegradoDeSaudeDeTeresinaCISMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroIntegradoDeSaudeDeTeresinaCISMember_lbl" xml:lang="en-US">Centro Integrado De Saude De Teresina C I S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:to="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_lbl" xml:lang="en-US">F A D E P Faculdade Educacional De Pato Branco Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraEEventosSAMedcelMember" xlink:label="afya_MedcelEditoraEEventosSAMedcelMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelEditoraEEventosSAMedcelMember" xlink:to="afya_MedcelEditoraEEventosSAMedcelMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedcelEditoraEEventosSAMedcelMember_lbl" xml:lang="en-US">Medcel Editora E Eventos S A Medcel [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:to="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoEducacionalSantoAgostinhoSAMember_lbl" xml:lang="en-US">Instituto Educacional Santo Agostinho S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="afya_ESMCEducacaoSuperiorLtdaESMCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:to="afya_ESMCEducacaoSuperiorLtdaESMCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ESMCEducacaoSuperiorLtdaESMCMember_lbl" xml:lang="en-US">E S M C Educacao Superior Ltda E S M C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:to="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_lbl" xml:lang="en-US">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:to="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoParaensedeEducacaoeCulturaLtdaMember_lbl" xml:lang="en-US">Instituto Paraensede Educacaoe Cultura Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAUniRedentorMember" xlink:label="afya_SociedadeUniversitariaRedentorSAUniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaRedentorSAUniRedentorMember" xlink:to="afya_SociedadeUniversitariaRedentorSAUniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaRedentorSAUniRedentorMember_lbl" xml:lang="en-US">Sociedade Universitaria Redentor S A Uni Redentor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaUniSLMember" xlink:label="afya_CentroUniversitarioSaoLucasLtdaUniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroUniversitarioSaoLucasLtdaUniSLMember" xlink:to="afya_CentroUniversitarioSaoLucasLtdaUniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroUniversitarioSaoLucasLtdaUniSLMember_lbl" xml:lang="en-US">Centro Universitario Sao Lucas Ltda Uni S L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" xlink:label="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" xlink:to="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_lbl" xml:lang="en-US">Peb Med Instituicao De Pesquisa Medica E Servicos Ltda Peb Med [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" xlink:label="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" xlink:to="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_lbl" xml:lang="en-US">Faculdade De Ensino Superior Da Amazonia Reunida F E S A R [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" xlink:to="afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_lbl" xml:lang="en-US">Centro Superior de Ciencias da Saude S/S Ltda (FCMPB) [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" xlink:label="afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" xlink:to="afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_lbl" xml:lang="en-US">Med Phone Tecnologia Em Saude Ltda Med Phone [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" xlink:to="afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_lbl" xml:lang="en-US">I Clinic Desenvolvimento De Software Ltdai Clinic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeSolutionsSAMedicinaeMember" xlink:label="afya_MedicinaeSolutionsSAMedicinaeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicinaeSolutionsSAMedicinaeMember" xlink:to="afya_MedicinaeSolutionsSAMedicinaeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicinaeSolutionsSAMedicinaeMember_lbl" xml:lang="en-US">Medicinae Solutions S A Medicinae [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" xlink:to="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_lbl" xml:lang="en-US">Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda Medical Harbour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" xlink:label="afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" xlink:to="afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_lbl" xml:lang="en-US">Cliquefarma Drogarias Online Ltda Cliquefarma [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiaDaInformacaoLtdaShospMember" xlink:label="afya_ShospTecnologiaDaInformacaoLtdaShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospTecnologiaDaInformacaoLtdaShospMember" xlink:to="afya_ShospTecnologiaDaInformacaoLtdaShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospTecnologiaDaInformacaoLtdaShospMember_lbl" xml:lang="en-US">Shosp Tecnologia Da Informacao Ltda Shosp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" xlink:to="afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_lbl" xml:lang="en-US">Sociedade Padrao De Educacao Superior Ltda Unifip Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" xlink:to="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_lbl" xml:lang="en-US">Companhia Nilza Cordeiro Herdy De Educacaoe Cultura Unigranrio [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" xlink:label="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" xlink:to="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_lbl" xml:lang="en-US">Policlinica E Centro De Estetica Duque De Caxias Ltda Policlinica [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" xlink:label="afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" xlink:to="afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_lbl" xml:lang="en-US">Sociedade Educacional De Palhoca S A Ltda S O C I E S P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" xlink:label="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" xlink:to="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior De Palhoca S S Ltda I E S P P A L H O C A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" xlink:label="afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" xlink:to="afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember_lbl" xml:lang="en-US">R X P R O Solucoes De Tecnologia Ltda R X P R O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" xlink:label="afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" xlink:to="afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_lbl" xml:lang="en-US">R X P R O L O G Transporte E Logistica Ltda R X P R O L O G [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:to="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis_lbl" xml:lang="en-US">Classes of property, plant and equipment [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="ifrs-full_BuildingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BuildingsMember" xlink:to="ifrs-full_BuildingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BuildingsMember_lbl" xml:lang="en-US">Buildings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="afya_MachineryAndEquipmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MachineryAndEquipmentsMember" xlink:to="afya_MachineryAndEquipmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MachineryAndEquipmentsMember_lbl" xml:lang="en-US">Machinery And Equipments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember" xlink:label="ifrs-full_VehiclesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_VehiclesMember" xlink:to="ifrs-full_VehiclesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_VehiclesMember_lbl" xml:lang="en-US">Vehicles [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="ifrs-full_FixturesAndFittingsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FixturesAndFittingsMember" xlink:to="ifrs-full_FixturesAndFittingsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FixturesAndFittingsMember_lbl" xml:lang="en-US">Fixtures and fittings [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ItEquipmentMember" xlink:label="afya_ItEquipmentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ItEquipmentMember" xlink:to="afya_ItEquipmentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ItEquipmentMember_lbl" xml:lang="en-US">It Equipment [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LibraryBooksMember" xlink:label="afya_LibraryBooksMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LibraryBooksMember" xlink:to="afya_LibraryBooksMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LibraryBooksMember_lbl" xml:lang="en-US">Library Books [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaboratoriesAndClinicsMember" xlink:label="afya_LaboratoriesAndClinicsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaboratoriesAndClinicsMember" xlink:to="afya_LaboratoriesAndClinicsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaboratoriesAndClinicsMember_lbl" xml:lang="en-US">Laboratories And Clinics [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="ifrs-full_LeaseholdImprovementsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseholdImprovementsMember" xlink:to="ifrs-full_LeaseholdImprovementsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseholdImprovementsMember_lbl" xml:lang="en-US">Leasehold improvements [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityAxis" xlink:label="afya_TaxAuthorityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxAuthorityAxis" xlink:to="afya_TaxAuthorityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxAuthorityAxis_lbl" xml:lang="en-US">Tax Authority [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="afya_ProgramOfSocialIntegrationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramOfSocialIntegrationMember" xlink:to="afya_ProgramOfSocialIntegrationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramOfSocialIntegrationMember_lbl" xml:lang="en-US">Program of social integration ("pis") [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="ifrs-full_ProductsAndServicesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProductsAndServicesAxis" xlink:to="ifrs-full_ProductsAndServicesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProductsAndServicesAxis_lbl" xml:lang="en-US">Products and services [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TeachingActivitiesMember" xlink:label="afya_TeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TeachingActivitiesMember" xlink:to="afya_TeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TeachingActivitiesMember_lbl" xml:lang="en-US">Teaching Activities [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:to="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember_lbl" xml:lang="en-US">Contribution for the financing of social security ("COFINS") [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NonTeachingActivitiesMember" xlink:label="afya_NonTeachingActivitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonTeachingActivitiesMember" xlink:to="afya_NonTeachingActivitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NonTeachingActivitiesMember_lbl" xml:lang="en-US">Non-teaching activities [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="ifrs-full_SegmentConsolidationItemsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentConsolidationItemsAxis" xlink:to="ifrs-full_SegmentConsolidationItemsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentConsolidationItemsAxis_lbl" xml:lang="en-US">Segment consolidation items [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="ifrs-full_OperatingSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OperatingSegmentsMember" xlink:to="ifrs-full_OperatingSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OperatingSegmentsMember_lbl" xml:lang="en-US">Operating segments [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="ifrs-full_SegmentsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SegmentsAxis" xlink:to="ifrs-full_SegmentsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SegmentsAxis_lbl" xml:lang="en-US">Segments [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="afya_UndergradMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UndergradMember" xlink:to="afya_UndergradMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UndergradMember_lbl" xml:lang="en-US">Undergrad [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="afya_ContinuingEducationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContinuingEducationMember" xlink:to="afya_ContinuingEducationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContinuingEducationMember_lbl" xml:lang="en-US">Continuing Education [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="afya_DigitalServicesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DigitalServicesMember" xlink:to="afya_DigitalServicesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DigitalServicesMember_lbl" xml:lang="en-US">Digital Services [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TotalReportableSegmentsMember" xlink:label="afya_TotalReportableSegmentsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TotalReportableSegmentsMember" xlink:to="afya_TotalReportableSegmentsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TotalReportableSegmentsMember_lbl" xml:lang="en-US">Total Reportable Segments [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="afya_AdjustmentsAndEliminationsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdjustmentsAndEliminationsMember" xlink:to="afya_AdjustmentsAndEliminationsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdjustmentsAndEliminationsMember_lbl" xml:lang="en-US">Adjustments And Eliminations [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="afya_IClinicMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicMember" xlink:to="afya_IClinicMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicMember_lbl" xml:lang="en-US">I Clinic [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="afya_CliquefarmaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CliquefarmaMember" xlink:to="afya_CliquefarmaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CliquefarmaMember_lbl" xml:lang="en-US">Cliquefarma [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HarbourMember" xlink:label="afya_HarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_HarbourMember" xlink:to="afya_HarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_HarbourMember_lbl" xml:lang="en-US">Harbour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="afya_ShospMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShospMember" xlink:to="afya_ShospMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShospMember_lbl" xml:lang="en-US">Shosp [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIFIPMocMember" xlink:label="afya_UNIFIPMocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UNIFIPMocMember" xlink:to="afya_UNIFIPMocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UNIFIPMocMember_lbl" xml:lang="en-US">U N I F I P Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIGRANMember" xlink:label="afya_UNIGRANMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UNIGRANMember" xlink:to="afya_UNIGRANMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UNIGRANMember_lbl" xml:lang="en-US">U N I G R A N [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PXPROMember" xlink:label="afya_PXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PXPROMember" xlink:to="afya_PXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PXPROMember_lbl" xml:lang="en-US">P X P R O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="afya_UniRedentorMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniRedentorMember" xlink:to="afya_UniRedentorMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniRedentorMember_lbl" xml:lang="en-US">Uni Redentor [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="afya_UniSLMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniSLMember" xlink:to="afya_UniSLMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniSLMember_lbl" xml:lang="en-US">Uni S L [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDMember" xlink:label="afya_PEBMEDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PEBMEDMember" xlink:to="afya_PEBMEDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PEBMEDMember_lbl" xml:lang="en-US">P E B M E D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:to="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_lbl" xml:lang="en-US">Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="afya_MedPhoneTecnologiaEmSaudeLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:to="afya_MedPhoneTecnologiaEmSaudeLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedPhoneTecnologiaEmSaudeLtdaMember_lbl" xml:lang="en-US">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="afya_FCMPBMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FCMPBMember" xlink:to="afya_FCMPBMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FCMPBMember_lbl" xml:lang="en-US">F C M P B [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="afya_MedicinaeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicinaeMember" xlink:to="afya_MedicinaeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicinaeMember_lbl" xml:lang="en-US">Medicinae [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="afya_MedicalHarbourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedicalHarbourMember" xlink:to="afya_MedicalHarbourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedicalHarbourMember_lbl" xml:lang="en-US">Medical Harbour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaFipmocSAMember" xlink:label="afya_SociedadeUniversitariaFipmocSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaFipmocSAMember" xlink:to="afya_SociedadeUniversitariaFipmocSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaFipmocSAMember_lbl" xml:lang="en-US">Sociedade Universitaria Fipmoc S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaGranarioSAMember" xlink:label="afya_SociedadeUniversitariaGranarioSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaGranarioSAMember" xlink:to="afya_SociedadeUniversitariaGranarioSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaGranarioSAMember_lbl" xml:lang="en-US">Sociedade Universitaria Granario S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="afya_RXPROMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RXPROMember" xlink:to="afya_RXPROMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RXPROMember_lbl" xml:lang="en-US">R X P R O [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets other than goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="ifrs-full_BrandNamesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BrandNamesMember" xlink:to="ifrs-full_BrandNamesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BrandNamesMember_lbl" xml:lang="en-US">Brand names [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:to="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CustomerrelatedIntangibleAssetsMember_lbl" xml:lang="en-US">Customer-related intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:to="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TechnologybasedIntangibleAssetsMember_lbl" xml:lang="en-US">Technology-based intangible assets [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="ifrs-full_LicencesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LicencesMember" xlink:to="ifrs-full_LicencesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LicencesMember_lbl" xml:lang="en-US">Licences [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAMember" xlink:label="afya_SociedadeUniversitariaRedentorSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SociedadeUniversitariaRedentorSAMember" xlink:to="afya_SociedadeUniversitariaRedentorSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SociedadeUniversitariaRedentorSAMember_lbl" xml:lang="en-US">Sociedade Universitaria Redentor S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaMember" xlink:label="afya_CentroUniversitarioSaoLucasLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CentroUniversitarioSaoLucasLtdaMember" xlink:to="afya_CentroUniversitarioSaoLucasLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CentroUniversitarioSaoLucasLtdaMember_lbl" xml:lang="en-US">Centro Universitario Sao Lucas Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" xlink:label="afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" xlink:to="afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_lbl" xml:lang="en-US">Instituicao De Pesquisa Medicae Servicos Tecnologicos Da Area Da Saude S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialAssetsAxis" xlink:to="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialAssetsAxis_lbl" xml:lang="en-US">Classes of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="afya_BankCertificatesOfDepositMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BankCertificatesOfDepositMember" xlink:to="afya_BankCertificatesOfDepositMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BankCertificatesOfDepositMember_lbl" xml:lang="en-US">Bank Certificates Of Deposit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterbankCertificatesOfDepositMember" xlink:label="afya_InterbankCertificatesOfDepositMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterbankCertificatesOfDepositMember" xlink:to="afya_InterbankCertificatesOfDepositMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterbankCertificatesOfDepositMember_lbl" xml:lang="en-US">Interbank Certificates Of Deposit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_USDMember" xlink:label="afya_USDMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_USDMember" xlink:to="afya_USDMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_USDMember_lbl" xml:lang="en-US">U S D [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TuitionFeesMember" xlink:label="afya_TuitionFeesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TuitionFeesMember" xlink:to="afya_TuitionFeesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TuitionFeesMember_lbl" xml:lang="en-US">Tuition Fees [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalContentMember" xlink:label="afya_EducationalContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalContentMember" xlink:to="afya_EducationalContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalContentMember_lbl" xml:lang="en-US">Educational Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FIESMember" xlink:label="afya_FIESMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FIESMember" xlink:to="afya_FIESMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FIESMember_lbl" xml:lang="en-US">F I E S [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalCreditsMember" xlink:label="afya_EducationalCreditsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalCreditsMember" xlink:to="afya_EducationalCreditsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalCreditsMember_lbl" xml:lang="en-US">Educational Credits [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MobileAppSubscriptionMember" xlink:label="afya_MobileAppSubscriptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MobileAppSubscriptionMember" xlink:to="afya_MobileAppSubscriptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MobileAppSubscriptionMember_lbl" xml:lang="en-US">Mobile App Subscription [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OthersMember" xlink:label="afya_OthersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OthersMember" xlink:to="afya_OthersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OthersMember_lbl" xml:lang="en-US">Others [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:to="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ImpairmentOfFinancialAssetsAxis_lbl" xml:lang="en-US">Impairment of financial assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:to="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember_lbl" xml:lang="en-US">Financial assets neither past due nor impaired [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="ifrs-full_PastDueStatusAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PastDueStatusAxis" xlink:to="ifrs-full_PastDueStatusAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PastDueStatusAxis_lbl" xml:lang="en-US">Past due status [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="ifrs-full_CurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentMember" xlink:to="ifrs-full_CurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentMember_lbl" xml:lang="en-US">Current [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:to="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_lbl" xml:lang="en-US">Later Than One Months And Not Later Than Three Months [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:to="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_lbl" xml:lang="en-US">Later than three months and not later than six months [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneEightyMember" xlink:label="afya_LaterThanOneEightyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaterThanOneEightyMember" xlink:to="afya_LaterThanOneEightyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaterThanOneEightyMember_lbl" xml:lang="en-US">Later Than One Eighty [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UEPCMember" xlink:label="afya_UEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UEPCMember" xlink:to="afya_UEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UEPCMember_lbl" xml:lang="en-US">U E P C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RVLEstevesGestaoImobiliariaSAMember" xlink:to="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RVLEstevesGestaoImobiliariaSAMember_lbl" xml:lang="en-US">R V L Esteves Gestao Imobiliaria S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="afya_UNIVACOPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UNIVACOPatrimonialLtdaMember" xlink:to="afya_UNIVACOPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UNIVACOPatrimonialLtdaMember_lbl" xml:lang="en-US">U N I V A C O Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="afya_IESVAPPatrimonialLtdaMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IESVAPPatrimonialLtdaMember" xlink:to="afya_IESVAPPatrimonialLtdaMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IESVAPPatrimonialLtdaMember_lbl" xml:lang="en-US">I E S V A P Patrimonial Ltda [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Axis" xlink:label="afya_TypeOfArrangement1Axis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TypeOfArrangement1Axis" xlink:to="afya_TypeOfArrangement1Axis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TypeOfArrangement1Axis_lbl" xml:lang="en-US">Type Of Arrangement 1 [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseAgreements1Member" xlink:label="afya_LeaseAgreements1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseAgreements1Member" xlink:to="afya_LeaseAgreements1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseAgreements1Member_lbl" xml:lang="en-US">Lease Agreements 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="dei_LegalEntityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LegalEntityAxis" xlink:to="dei_LegalEntityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LegalEntityAxis_lbl" xml:lang="en-US">Legal Entity [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:to="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember" xlink:label="ifrs-full_AssociatesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssociatesMember" xlink:to="ifrs-full_AssociatesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssociatesMember_lbl" xml:lang="en-US">Associates [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis_lbl" xml:lang="en-US">Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="ifrs-full_GrossCarryingAmountMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossCarryingAmountMember" xlink:to="ifrs-full_GrossCarryingAmountMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossCarryingAmountMember_lbl" xml:lang="en-US">Gross carrying amount [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember" xlink:label="ifrs-full_LandMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LandMember" xlink:to="ifrs-full_LandMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LandMember_lbl" xml:lang="en-US">Land [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="ifrs-full_ConstructionInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ConstructionInProgressMember" xlink:to="ifrs-full_ConstructionInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ConstructionInProgressMember_lbl" xml:lang="en-US">Construction in progress [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:to="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AccumulatedDepreciationAndAmortisationMember_lbl" xml:lang="en-US">Accumulated depreciation and amortisation [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis_lbl" xml:lang="en-US">Classes of intangible assets and goodwill [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember" xlink:label="ifrs-full_GoodwillMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillMember" xlink:to="ifrs-full_GoodwillMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillMember_lbl" xml:lang="en-US">Goodwill [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="ifrs-full_ComputerSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComputerSoftwareMember" xlink:to="ifrs-full_ComputerSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComputerSoftwareMember_lbl" xml:lang="en-US">Computer software [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationContentMember" xlink:label="afya_EducationContentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationContentMember" xlink:to="afya_EducationContentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationContentMember_lbl" xml:lang="en-US">Education Content [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformMember" xlink:label="afya_EducationalPlatformMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalPlatformMember" xlink:to="afya_EducationalPlatformMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalPlatformMember_lbl" xml:lang="en-US">Educational Platform [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SoftwareInProgressMember" xlink:label="afya_SoftwareInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SoftwareInProgressMember" xlink:to="afya_SoftwareInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SoftwareInProgressMember_lbl" xml:lang="en-US">Software In Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformAndSoftwareInProgressMember" xlink:label="afya_EducationalPlatformAndSoftwareInProgressMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EducationalPlatformAndSoftwareInProgressMember" xlink:to="afya_EducationalPlatformAndSoftwareInProgressMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EducationalPlatformAndSoftwareInProgressMember_lbl" xml:lang="en-US">Educational Platform And Software In Progress [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DevelopedTechnologyIntangibleAssetsMember" xlink:label="afya_DevelopedTechnologyIntangibleAssetsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DevelopedTechnologyIntangibleAssetsMember" xlink:to="afya_DevelopedTechnologyIntangibleAssetsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DevelopedTechnologyIntangibleAssetsMember_lbl" xml:lang="en-US">Developed Technology Intangible Assets [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CarryingAmountsMember" xlink:label="afya_CarryingAmountsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CarryingAmountsMember" xlink:to="afya_CarryingAmountsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CarryingAmountsMember_lbl" xml:lang="en-US">Carrying Amounts [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelAndCBBWMember" xlink:label="afya_MedcelAndCBBWMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelAndCBBWMember" xlink:to="afya_MedcelAndCBBWMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedcelAndCBBWMember_lbl" xml:lang="en-US">Medcel And C B B W [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FESARMember" xlink:label="afya_FESARMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FESARMember" xlink:to="afya_FESARMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FESARMember_lbl" xml:lang="en-US">F E S A R [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="afya_PracticeManagementToolsAndElectronicPrescriptionMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:to="afya_PracticeManagementToolsAndElectronicPrescriptionMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PracticeManagementToolsAndElectronicPrescriptionMember_lbl" xml:lang="en-US">Practice Management Tools And Electronic Prescription [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="afya_ClinicalDecisionSoftwareMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClinicalDecisionSoftwareMember" xlink:to="afya_ClinicalDecisionSoftwareMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClinicalDecisionSoftwareMember_lbl" xml:lang="en-US">Clinical Decision Software [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MocMember" xlink:label="afya_MocMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MocMember" xlink:to="afya_MocMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MocMember_lbl" xml:lang="en-US">Moc [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnigranrioMember" xlink:label="afya_UnigranrioMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnigranrioMember" xlink:to="afya_UnigranrioMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnigranrioMember_lbl" xml:lang="en-US">Unigranrio [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="afya_CustomerRelationshipsMedicineMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CustomerRelationshipsMedicineMember" xlink:to="afya_CustomerRelationshipsMedicineMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CustomerRelationshipsMedicineMember_lbl" xml:lang="en-US">Customer Relationships Medicine [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="afya_CustomerRelationshipsOtherCoursesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CustomerRelationshipsOtherCoursesMember" xlink:to="afya_CustomerRelationshipsOtherCoursesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CustomerRelationshipsOtherCoursesMember_lbl" xml:lang="en-US">Customer Relationships Other Courses [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="ifrs-full_RangeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RangeAxis" xlink:to="ifrs-full_RangeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RangeAxis_lbl" xml:lang="en-US">Range [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="ifrs-full_BottomOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BottomOfRangeMember" xlink:to="ifrs-full_BottomOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BottomOfRangeMember_lbl" xml:lang="en-US">Bottom of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="ifrs-full_TopOfRangeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TopOfRangeMember" xlink:to="ifrs-full_TopOfRangeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TopOfRangeMember_lbl" xml:lang="en-US">Top of range [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:to="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtAmortisedCostMember_lbl" xml:lang="en-US">Financial assets at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfFinancialLiabilitiesAxis_lbl" xml:lang="en-US">Classes of financial liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:to="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtAmortisedCostMember_lbl" xml:lang="en-US">Financial liabilities at amortised cost, class [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="ifrs-full_MaturityAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MaturityAxis" xlink:to="ifrs-full_MaturityAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MaturityAxis_lbl" xml:lang="en-US">Maturity [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyThreeMember" xlink:label="afya_TwentyTwentyThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyThreeMember" xlink:to="afya_TwentyTwentyThreeMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyThreeMember_lbl" xml:lang="en-US">2023 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyOneMember" xlink:label="afya_TwentyTwentyOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyOneMember" xlink:to="afya_TwentyTwentyOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyOneMember_lbl" xml:lang="en-US">2021 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFourMember" xlink:label="afya_TwentyTwentyFourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFourMember" xlink:to="afya_TwentyTwentyFourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyFourMember_lbl" xml:lang="en-US">2024 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySevenMember" xlink:label="afya_TwentyTwentySevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySevenMember" xlink:to="afya_TwentyTwentySevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentySevenMember_lbl" xml:lang="en-US">2027 [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySixMember" xlink:label="afya_TwentyTwentySixMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySixMember" xlink:to="afya_TwentyTwentySixMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentySixMember_lbl" xml:lang="en-US">Twenty Twenty Six [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFour1Member" xlink:label="afya_TwentyTwentyFour1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFour1Member" xlink:to="afya_TwentyTwentyFour1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TwentyTwentyFour1Member_lbl" xml:lang="en-US">Twenty Twenty Four 1 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="ifrs-full_BorrowingsByNameAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsByNameAxis" xlink:to="ifrs-full_BorrowingsByNameAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsByNameAxis_lbl" xml:lang="en-US">Borrowings by name [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanciadoradeEstudoseProjetosFINEPMember" xlink:label="afya_FinanciadoradeEstudoseProjetosFINEPMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanciadoradeEstudoseProjetosFINEPMember" xlink:to="afya_FinanciadoradeEstudoseProjetosFINEPMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanciadoradeEstudoseProjetosFINEPMember_lbl" xml:lang="en-US">Financiadorade Estudose Projetos F I N E P [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="ifrs-full_TypesOfRisksAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfRisksAxis" xlink:to="ifrs-full_TypesOfRisksAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfRisksAxis_lbl" xml:lang="en-US">Types of risks [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="ifrs-full_CurrencyRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrencyRiskMember" xlink:to="ifrs-full_CurrencyRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrencyRiskMember_lbl" xml:lang="en-US">Currency risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="currency_EUR" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="currency_EUR" xlink:to="currency_EUR_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="currency_EUR_lbl" xml:lang="en-US">Euro Member Countries, Euro</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneMember" xlink:label="afya_MedPhoneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedPhoneMember" xlink:to="afya_MedPhoneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MedPhoneMember_lbl" xml:lang="en-US">MEDPHONE [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuaranhunsMember" xlink:label="afya_GuaranhunsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_GuaranhunsMember" xlink:to="afya_GuaranhunsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_GuaranhunsMember_lbl" xml:lang="en-US">Guaranhuns [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="afya_AccountsPayableToSellingShareholdersMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersMember" xlink:to="afya_AccountsPayableToSellingShareholdersMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersMember_lbl" xml:lang="en-US">Accounts Payable To Selling Shareholders [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashMember" xlink:label="afya_RestrictedCashMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashMember" xlink:to="afya_RestrictedCashMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedCashMember_lbl" xml:lang="en-US">Restricted Cash [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="ifrs-full_TradeReceivablesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivablesMember" xlink:to="ifrs-full_TradeReceivablesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivablesMember_lbl" xml:lang="en-US">Trade receivables [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="afya_LoansAndFinancingMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingMember" xlink:to="afya_LoansAndFinancingMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingMember_lbl" xml:lang="en-US">Loans And Financing [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="ifrs-full_LeaseLiabilitiesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilitiesMember" xlink:to="ifrs-full_LeaseLiabilitiesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilitiesMember_lbl" xml:lang="en-US">Lease liabilities [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableMember" xlink:label="afya_NotesPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableMember" xlink:to="afya_NotesPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayableMember_lbl" xml:lang="en-US">Notes Payable[Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="ifrs-full_InterestRateRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestRateRiskMember" xlink:to="ifrs-full_InterestRateRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestRateRiskMember_lbl" xml:lang="en-US">Interest rate risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="ifrs-full_TypesOfInterestRatesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfInterestRatesAxis" xlink:to="ifrs-full_TypesOfInterestRatesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfInterestRatesAxis_lbl" xml:lang="en-US">Types of interest rates [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="ifrs-full_FloatingInterestRateMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FloatingInterestRateMember" xlink:to="ifrs-full_FloatingInterestRateMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FloatingInterestRateMember_lbl" xml:lang="en-US">Floating interest rate [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashEquivalents1Member" xlink:label="afya_CashEquivalents1Member" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashEquivalents1Member" xlink:to="afya_CashEquivalents1Member_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashEquivalents1Member_lbl" xml:lang="en-US">Cash Equivalents [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="ifrs-full_ProbabilityOfDefaultAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProbabilityOfDefaultAxis" xlink:to="ifrs-full_ProbabilityOfDefaultAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProbabilityOfDefaultAxis_lbl" xml:lang="en-US">Probability of default [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsMember" xlink:label="afya_IncreaseBasisPointsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsMember" xlink:to="afya_IncreaseBasisPointsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsMember_lbl" xml:lang="en-US">Increase in basis points +75 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsMember" xlink:label="afya_DecreaseBasisPointsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseBasisPointsMember" xlink:to="afya_DecreaseBasisPointsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseBasisPointsMember_lbl" xml:lang="en-US">Decrease in basis points -75 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="afya_IncreaseBasisPointsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsOneMember" xlink:to="afya_IncreaseBasisPointsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseBasisPointsOneMember_lbl" xml:lang="en-US">Increase in basis points +150 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsOneMember" xlink:label="afya_DecreaseBasisPointsOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseBasisPointsOneMember" xlink:to="afya_DecreaseBasisPointsOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseBasisPointsOneMember_lbl" xml:lang="en-US">Decrease in basis points -150 [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="afya_LoansAndFinancingTwoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingTwoMember" xlink:to="afya_LoansAndFinancingTwoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingTwoMember_lbl" xml:lang="en-US">Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingOneMember" xlink:label="afya_LoansAndFinancingOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingOneMember" xlink:to="afya_LoansAndFinancingOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingOneMember_lbl" xml:lang="en-US">Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersOneMember" xlink:to="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersOneMember</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersSevenMember" xlink:label="afya_AccountsPayableToSellingShareholdersSevenMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersSevenMember" xlink:to="afya_AccountsPayableToSellingShareholdersSevenMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersSevenMember_lbl" xml:lang="en-US">Accounts payable to selling shareholders [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresAxis" xlink:label="ifrs-full_RiskExposuresAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RiskExposuresAxis" xlink:to="ifrs-full_RiskExposuresAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RiskExposuresAxis_lbl" xml:lang="en-US">Risk variables [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="afya_ForeignCurrencyExposuresMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ForeignCurrencyExposuresMember" xlink:to="afya_ForeignCurrencyExposuresMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ForeignCurrencyExposuresMember_lbl" xml:lang="en-US">Exposure [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="afya_IncreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseForeignCurrencyMember" xlink:to="afya_IncreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseForeignCurrencyMember_lbl" xml:lang="en-US">Increase in Foreign Currency Sensitivity +10% [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="afya_DecreaseForeignCurrencyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseForeignCurrencyMember" xlink:to="afya_DecreaseForeignCurrencyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreaseForeignCurrencyMember_lbl" xml:lang="en-US">Decrease in Foreign Currency Sensitivity -10% [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="ifrs-full_LiquidityRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiquidityRiskMember" xlink:to="ifrs-full_LiquidityRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiquidityRiskMember_lbl" xml:lang="en-US">Liquidity risk [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="ifrs-full_LaterThanOneYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearMember" xlink:to="ifrs-full_LaterThanOneYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearMember_lbl" xml:lang="en-US">Later than one year [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:to="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember_lbl" xml:lang="en-US">Later than one year and not later than three years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than three years and not later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="ifrs-full_LaterThanFiveYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LaterThanFiveYearsMember" xlink:to="ifrs-full_LaterThanFiveYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LaterThanFiveYearsMember_lbl" xml:lang="en-US">Later than five years [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis_lbl" xml:lang="en-US">Liabilities arising from financing activities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPayableMember" xlink:label="afya_DividendsPayableMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayableMember" xlink:to="afya_DividendsPayableMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPayableMember_lbl" xml:lang="en-US">Dividends Payable [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis" xlink:label="ifrs-full_MeasurementAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_MeasurementAxis" xlink:to="ifrs-full_MeasurementAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_MeasurementAxis_lbl" xml:lang="en-US">Measurement [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:to="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_lbl" xml:lang="en-US">Not measured at fair value in statement of financial position but for which fair value is disclosed [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:to="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LevelsOfFairValueHierarchyAxis_lbl" xml:lang="en-US">Levels of fair value hierarchy [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level2OfFairValueHierarchyMember" xlink:to="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level2OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 2 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Level3OfFairValueHierarchyMember" xlink:to="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Level3OfFairValueHierarchyMember_lbl" xml:lang="en-US">Level 3 of fair value hierarchy [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="ifrs-full_DefinedBenefitPlansAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitPlansAxis" xlink:to="ifrs-full_DefinedBenefitPlansAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitPlansAxis_lbl" xml:lang="en-US">Defined benefit plans [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="afya_ShareBasedCompensationPlansMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationPlansMember" xlink:to="afya_ShareBasedCompensationPlansMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationPlansMember_lbl" xml:lang="en-US">Share Based Compensation Plans [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:to="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TypesOfSharebasedPaymentArrangementsAxis_lbl" xml:lang="en-US">Types of share-based payment arrangements [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ModifiedPlanMember" xlink:label="afya_ModifiedPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ModifiedPlanMember" xlink:to="afya_ModifiedPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ModifiedPlanMember_lbl" xml:lang="en-US">Modified Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OriginalPlanMember" xlink:label="afya_OriginalPlanMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OriginalPlanMember" xlink:to="afya_OriginalPlanMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OriginalPlanMember_lbl" xml:lang="en-US">Original Plan [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OrdinarySharesMember" xlink:to="ifrs-full_OrdinarySharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OrdinarySharesMember_lbl" xml:lang="en-US">Ordinary shares [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAPreferenceSharesMember" xlink:label="afya_ClassAPreferenceSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassAPreferenceSharesMember" xlink:to="afya_ClassAPreferenceSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassAPreferenceSharesMember_lbl" xml:lang="en-US">Class A Preference Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBPreferenceSharesMember" xlink:label="afya_ClassBPreferenceSharesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ClassBPreferenceSharesMember" xlink:to="afya_ClassBPreferenceSharesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ClassBPreferenceSharesMember_lbl" xml:lang="en-US">Class B Preference Shares [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BRHealthMember" xlink:label="afya_BRHealthMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BRHealthMember" xlink:to="afya_BRHealthMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BRHealthMember_lbl" xml:lang="en-US">B R Health [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NicolauCarvalhoEstevesMember" xlink:label="afya_NicolauCarvalhoEstevesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NicolauCarvalhoEstevesMember" xlink:to="afya_NicolauCarvalhoEstevesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NicolauCarvalhoEstevesMember_lbl" xml:lang="en-US">Nicolau Carvalho Esteves [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" xlink:to="afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember_lbl" xml:lang="en-US">Uniao Educacional Do Planalto Central S A U E P C [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="ifrs-full_EliminationOfIntersegmentAmountsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:to="ifrs-full_EliminationOfIntersegmentAmountsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EliminationOfIntersegmentAmountsMember_lbl" xml:lang="en-US">Elimination of intersegment amounts [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SegmentOfBusinessOneUnitMember" xlink:label="afya_SegmentOfBusinessOneUnitMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SegmentOfBusinessOneUnitMember" xlink:to="afya_SegmentOfBusinessOneUnitMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SegmentOfBusinessOneUnitMember_lbl" xml:lang="en-US">Segment Of Business One Unit [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:to="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfContingentLiabilitiesAxis_lbl" xml:lang="en-US">Classes of contingent liabilities [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:to="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsContingentLiabilityMember_lbl" xml:lang="en-US">Legal proceedings contingent liability [member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="ifrs-full_ClassesOfProvisionsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfProvisionsAxis" xlink:to="ifrs-full_ClassesOfProvisionsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfProvisionsAxis_lbl" xml:lang="en-US">Classes of other provisions [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LabourMember" xlink:label="afya_LabourMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LabourMember" xlink:to="afya_LabourMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LabourMember_lbl" xml:lang="en-US">Labour [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CivilMember" xlink:label="afya_CivilMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CivilMember" xlink:to="afya_CivilMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CivilMember_lbl" xml:lang="en-US">Civil [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesMember" xlink:label="afya_TaxesMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesMember" xlink:to="afya_TaxesMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesMember_lbl" xml:lang="en-US">Taxes [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypesOfRiskMember" xlink:label="afya_TypesOfRiskMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TypesOfRiskMember" xlink:to="afya_TypesOfRiskMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TypesOfRiskMember_lbl" xml:lang="en-US">Types Of Risk [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="afya_TaxesAndSocialSecurityMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesAndSocialSecurityMember" xlink:to="afya_TaxesAndSocialSecurityMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesAndSocialSecurityMember_lbl" xml:lang="en-US">Taxes And Social Security [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="ifrs-full_ClassesOfAssetsAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClassesOfAssetsAxis" xlink:to="ifrs-full_ClassesOfAssetsAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClassesOfAssetsAxis_lbl" xml:lang="en-US">Classes of assets [axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="afya_OtherAssetsNonCurrentMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsNonCurrentMember" xlink:to="afya_OtherAssetsNonCurrentMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsNonCurrentMember_lbl" xml:lang="en-US">Other Assets Non Current [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicParticipacoesSAMember" xlink:label="afya_IClinicParticipacoesSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IClinicParticipacoesSAMember" xlink:to="afya_IClinicParticipacoesSAMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IClinicParticipacoesSAMember_lbl" xml:lang="en-US">I Clinic Participacoes S A [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="dei_EntityAddressesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesTable_lbl" xml:lang="en-US">Entity Addresses [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="dei_EntityAddressesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressesLineItems_lbl" xml:lang="en-US">Entity Addresses [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="dei_ContactPersonnelName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelName" xlink:to="dei_ContactPersonnelName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelName_lbl" xml:lang="en-US">Contact Personnel Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="dei_ContactPersonnelEmailAddress" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_ContactPersonnelEmailAddress" xlink:to="dei_ContactPersonnelEmailAddress_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_ContactPersonnelEmailAddress_lbl" xml:lang="en-US">Contact Personnel Email Address</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorFirmId_lbl" xml:lang="en-US">Auditor Firm Id</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorName_lbl" xml:lang="en-US">Auditor Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditorLocation_lbl" xml:lang="en-US">Auditor Location</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfFinancialPositionAbstract" xlink:to="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract_lbl" xml:lang="en-US">Statement of financial position [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AssetsAbstract" xlink:to="ifrs-full_AssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AssetsAbstract_lbl" xml:lang="en-US">Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssetsAbstract" xlink:to="ifrs-full_CurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssetsAbstract_lbl" xml:lang="en-US">Current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalents_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="ifrs-full_CurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTradeReceivables_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Inventories" xlink:to="ifrs-full_Inventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Inventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssets" xlink:label="ifrs-full_CurrentTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxAssets" xlink:to="ifrs-full_CurrentTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxAssets_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="ifrs-full_OtherCurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentAssets" xlink:to="ifrs-full_OtherCurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentAssets_lbl" xml:lang="en-US">Total current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssetsAbstract" xlink:to="ifrs-full_NoncurrentAssetsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssetsAbstract_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:to="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentRestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTradeReceivable" xlink:label="afya_NoncurrentTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTradeReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="ifrs-full_OtherNoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipment_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="ifrs-full_RightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentAssets_lbl" xml:lang="en-US">Total non-current assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Assets_lbl" xml:lang="en-US">Total assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesAbstract" xlink:to="ifrs-full_LiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesAbstract_lbl" xml:lang="en-US">Liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilitiesAbstract" xlink:to="ifrs-full_CurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayables" xlink:to="ifrs-full_TradeAndOtherCurrentPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayables_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="ifrs-full_ShorttermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShorttermBorrowings" xlink:to="ifrs-full_ShorttermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShorttermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="ifrs-full_CurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayableCurrent" xlink:label="afya_NotePayableCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayableCurrent" xlink:to="afya_NotePayableCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayableCurrent_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="ifrs-full_CurrentDepositsFromCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentDepositsFromCustomers" xlink:to="ifrs-full_CurrentDepositsFromCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentDepositsFromCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:to="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentTaxesPayable" xlink:label="afya_CurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentTaxesPayable" xlink:to="afya_CurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent_lbl" xml:lang="en-US">Income taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="ifrs-full_OtherCurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherCurrentLiabilities" xlink:to="ifrs-full_OtherCurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherCurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CurrentLiabilities_lbl" xml:lang="en-US">Total current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="ifrs-full_LongtermBorrowings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LongtermBorrowings_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities&#160;</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableNonCurrentLiabiites" xlink:label="afya_NotesPayableNonCurrentLiabiites" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableNonCurrentLiabiites" xlink:to="afya_NotesPayableNonCurrentLiabiites_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotesPayableNonCurrentLiabiites_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTaxesPayable" xlink:label="afya_NoncurrentTaxesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentTaxesPayable_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="ifrs-full_LongtermLegalProceedingsProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermLegalProceedingsProvision" xlink:to="ifrs-full_LongtermLegalProceedingsProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermLegalProceedingsProvision_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="ifrs-full_OtherNoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherNoncurrentLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_NoncurrentLiabilities_lbl" xml:lang="en-US">Total non-current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="ifrs-full_Liabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Liabilities_lbl" xml:lang="en-US">Total liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAbstract" xlink:to="ifrs-full_EquityAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAbstract_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssuedCapital" xlink:to="ifrs-full_IssuedCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssuedCapital_lbl" xml:lang="en-US">Share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="ifrs-full_AdditionalPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalPaidinCapital" xlink:to="ifrs-full_AdditionalPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalPaidinCapital_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="ifrs-full_ReserveOfSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ReserveOfSharebasedPayments" xlink:to="ifrs-full_ReserveOfSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ReserveOfSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation reserve</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="ifrs-full_TreasuryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_TreasuryShares_lbl" xml:lang="en-US">Treasury stock</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="ifrs-full_RetainedEarnings" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RetainedEarnings" xlink:to="ifrs-full_RetainedEarnings_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RetainedEarnings_lbl" xml:lang="en-US">Retained earnings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_lbl" xml:lang="en-US">Equity attributable to equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="ifrs-full_NoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncontrollingInterests" xlink:to="ifrs-full_NoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncontrollingInterests_lbl" xml:lang="en-US">Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_Equity_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_EquityAndLiabilities_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeStatementAbstract" xlink:to="ifrs-full_IncomeStatementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeStatementAbstract_lbl" xml:lang="en-US">Profit or loss [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Revenue" xlink:to="ifrs-full_Revenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Revenue_lbl" xml:lang="en-US">Net revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="ifrs-full_CostOfSales" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CostOfSales" xlink:to="ifrs-full_CostOfSales_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CostOfSales_lbl" xml:lang="en-US">Cost of services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="ifrs-full_GrossProfit" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_GrossProfit_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_lbl" xml:lang="en-US">General and administrative expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherIncome" xlink:to="ifrs-full_OtherIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherIncome_lbl" xml:lang="en-US">Other (expenses) income, net</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_lbl" xml:lang="en-US">Operating income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncome_lbl" xml:lang="en-US">&#160;&#160;Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_FinanceCosts_lbl" xml:lang="en-US">&#160;&#160;Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="ifrs-full_FinanceIncomeCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_FinanceIncomeCost_lbl" xml:lang="en-US">Finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:to="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ProfitLoss_lbl" xml:lang="en-US">Net income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="ifrs-full_OtherComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherComprehensiveIncome" xlink:to="ifrs-full_OtherComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherComprehensiveIncome_lbl" xml:lang="en-US">Other comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_ComprehensiveIncome_lbl" xml:lang="en-US">&#160;Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="ifrs-full_ProfitLossAttributableToAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToAbstract" xlink:to="ifrs-full_ProfitLossAttributableToAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToAbstract_lbl" xml:lang="en-US">Income attributable to</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:to="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToOwnersOfParent_lbl" xml:lang="en-US">&#160;&#160;Equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:to="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossAttributableToNoncontrollingInterests_lbl" xml:lang="en-US">&#160;&#160;Non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="ifrs-full_BasicEarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsPerShareAbstract" xlink:to="ifrs-full_BasicEarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsPerShareAbstract_lbl" xml:lang="en-US">Basic earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="ifrs-full_BasicEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BasicEarningsLossPerShare_lbl" xml:lang="en-US">Per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsPerShareAbstract" xlink:to="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract_lbl" xml:lang="en-US">Diluted earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DilutedEarningsLossPerShare_lbl" xml:lang="en-US">Per common share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfChangesInEquityTable" xlink:to="ifrs-full_StatementOfChangesInEquityTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfChangesInEquityTable_lbl" xml:lang="en-US">Statement of changes in equity [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="afya_IfrsStatementLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IfrsStatementLineItems" xlink:to="afya_IfrsStatementLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IfrsStatementLineItems_lbl" xml:lang="en-US">IfrsStatementLineItems [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Equity_2_lbl" xml:lang="en-US">Beginning balance, value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLoss_2_lbl" xml:lang="en-US">Net income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ComprehensiveIncome" xlink:to="ifrs-full_ComprehensiveIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ComprehensiveIncome_2_lbl" xml:lang="en-US">Total comprehensive income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithCash" xlink:label="afya_CapitalIncreaseWithCash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseWithCash" xlink:to="afya_CapitalIncreaseWithCash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalIncreaseWithCash_lbl" xml:lang="en-US">Capital increase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners_lbl" xml:lang="en-US">Capital increase from shares contribution of shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseFromCorporateReorganization" xlink:label="afya_CapitalIncreaseFromCorporateReorganization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseFromCorporateReorganization" xlink:to="afya_CapitalIncreaseFromCorporateReorganization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalIncreaseFromCorporateReorganization_lbl" xml:lang="en-US">Capital increase from the corporate reorganization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:to="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllocationToAdditionalPaidinCapital" xlink:label="afya_AllocationToAdditionalPaidinCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllocationToAdditionalPaidinCapital" xlink:to="afya_AllocationToAdditionalPaidinCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllocationToAdditionalPaidinCapital_lbl" xml:lang="en-US">Allocation to additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaid" xlink:label="ifrs-full_DividendsPaid" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaid" xlink:to="ifrs-full_DividendsPaid_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaid_lbl" xml:lang="en-US">Dividends declared</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsCancelled" xlink:label="afya_DividendsCancelled" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsCancelled" xlink:to="afya_DividendsCancelled_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsCancelled_lbl" xml:lang="en-US">Dividends cancelled</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CorporateReorganization" xlink:label="afya_CorporateReorganization" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CorporateReorganization" xlink:to="afya_CorporateReorganization_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CorporateReorganization_lbl" xml:lang="en-US">Corporate reorganization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="ifrs-full_IssueOfEquity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IssueOfEquity" xlink:to="ifrs-full_IssueOfEquity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IssueOfEquity_lbl" xml:lang="en-US">Issuance of common shares in follow-on public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="ifrs-full_ShareIssueRelatedCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ShareIssueRelatedCost_lbl" xml:lang="en-US">Shares issuance cost</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasuryShares1" xlink:label="afya_TreasuryShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasuryShares1" xlink:to="afya_TreasuryShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasuryShares1_lbl" xml:lang="en-US">Treasury shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="afya_TreasurySharesTransferredFromExerciseOfOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:to="afya_TreasurySharesTransferredFromExerciseOfOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredFromExerciseOfOptions_lbl" xml:lang="en-US">Treasury shares transferred from exercise of options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:to="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination_lbl" xml:lang="en-US">Treasury shares transferred from shares contribution on business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsDeclaredToNoncontrollingInterests" xlink:label="afya_DividendsDeclaredToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsDeclaredToNoncontrollingInterests" xlink:to="afya_DividendsDeclaredToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsDeclaredToNoncontrollingInterests_lbl" xml:lang="en-US">Dividends declared to non-controlling interests</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Equity_3_lbl" xml:lang="en-US">Ending balance, value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_StatementOfCashFlowsAbstract" xlink:to="ifrs-full_StatementOfCashFlowsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_StatementOfCashFlowsAbstract_lbl" xml:lang="en-US">Statement of cash flows [abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract_lbl" xml:lang="en-US">Operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="afya_IncomeLossBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncomeLossBeforeIncomeTaxes_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract_lbl" xml:lang="en-US">Adjustments to reconcile income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Disposals of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsAndGoodwill" xlink:label="ifrs-full_DisposalsIntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_DisposalsIntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DisposalsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Disposals of intangible</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:to="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsOfOpeartingActivities_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForSharebasedPayments" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:to="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="ifrs-full_AdjustmentsForFinanceCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForFinanceCosts" xlink:to="ifrs-full_AdjustmentsForFinanceCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForFinanceCosts_lbl" xml:lang="en-US">Net loss (gain) on derivatives</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="afya_AccruedInterestOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccruedInterestOfOpeartingActivities" xlink:to="afya_AccruedInterestOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccruedInterestOfOpeartingActivities_lbl" xml:lang="en-US">Accrued interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_lbl" xml:lang="en-US">Accrued lease interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:to="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="ifrs-full_AdjustmentsForProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForProvisions_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInOperatingLiabilities1Abstract_lbl" xml:lang="en-US">Changes in assets and liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_lbl" xml:lang="en-US">Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:to="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncomeTaxExpense_lbl" xml:lang="en-US">Taxes payables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_lbl" xml:lang="en-US">Income taxes paid</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_lbl" xml:lang="en-US">Net cash flows from operating activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract_lbl" xml:lang="en-US">Investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsReceived" xlink:label="ifrs-full_DividendsReceived" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsReceived_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of intangibles assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="afya_RestrictedCashOfInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashOfInvestingActivities" xlink:to="afya_RestrictedCashOfInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RestrictedCashOfInvestingActivities_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaymentsOfNotesPayable" xlink:label="afya_PaymentsOfNotesPayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfNotesPayable" xlink:to="afya_PaymentsOfNotesPayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfNotesPayable_lbl" xml:lang="en-US">Payments of notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_lbl" xml:lang="en-US">Acquisition of subsidiaries, net of cash acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:label="ifrs-full_CashAdvancesAndLoansFromRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:to="ifrs-full_CashAdvancesAndLoansFromRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAdvancesAndLoansFromRelatedParties_lbl" xml:lang="en-US">Loans to related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_lbl" xml:lang="en-US">Net cash flows used in investing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract_lbl" xml:lang="en-US">Financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuanceOfLoansAndFinancing" xlink:label="afya_IssuanceOfLoansAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuanceOfLoansAndFinancing" xlink:to="afya_IssuanceOfLoansAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IssuanceOfLoansAndFinancing_lbl" xml:lang="en-US">Issuance of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseOfFinancialActivities" xlink:label="afya_CapitalIncreaseOfFinancialActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseOfFinancialActivities" xlink:to="afya_CapitalIncreaseOfFinancialActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CapitalIncreaseOfFinancialActivities_lbl" xml:lang="en-US">Capital increase</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:to="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities_lbl" xml:lang="en-US">Proceeds from &#160;shares public offering</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharebasedCompensationPlanReceipts" xlink:label="afya_SharebasedCompensationPlanReceipts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharebasedCompensationPlanReceipts" xlink:to="afya_SharebasedCompensationPlanReceipts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharebasedCompensationPlanReceipts_lbl" xml:lang="en-US">Share-based compensation plan receipts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="ifrs-full_PaymentsForShareIssueCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_PaymentsForShareIssueCosts_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_lbl" xml:lang="en-US">Net cash flows from (used in) financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_lbl" xml:lang="en-US">Net foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_lbl" xml:lang="en-US">Net increase in cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_CashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents at the beginning of the year</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_CashAndCashEquivalents_3_lbl" xml:lang="en-US">Cash and cash equivalents at the end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_lbl" xml:lang="en-US">Disclosure of significant accounting policies [text block]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Corporate information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory_lbl" xml:lang="en-US">Disclosure of notes and other explanatory information [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_2_lbl" xml:lang="en-US">Significant accounting policies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" xlink:label="afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" xlink:to="afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract_lbl" xml:lang="en-US">Significant Accounting Estimates And Assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SignificantAccountingEstimatesAndAssumptionsExplanatory" xlink:label="afya_SignificantAccountingEstimatesAndAssumptionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SignificantAccountingEstimatesAndAssumptionsExplanatory" xlink:to="afya_SignificantAccountingEstimatesAndAssumptionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SignificantAccountingEstimatesAndAssumptionsExplanatory_lbl" xml:lang="en-US">Significant accounting estimates and assumptions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory_lbl" xml:lang="en-US">Segment information</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsExplanatory_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:to="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRelatedPartyExplanatory_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfOtherAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfOtherAssetsExplanatory_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_lbl" xml:lang="en-US">Investment in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsExplanatory_lbl" xml:lang="en-US">Intangible assets and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:to="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialInstrumentsExplanatory_lbl" xml:lang="en-US">Financial assets and financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="afya_DisclosureFairValueMeasurementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureFairValueMeasurementAbstract" xlink:to="afya_DisclosureFairValueMeasurementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureFairValueMeasurementAbstract_lbl" xml:lang="en-US">Fair Value Measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueMeasurementExplanatory" xlink:label="afya_FairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueMeasurementExplanatory" xlink:to="afya_FairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueMeasurementExplanatory_lbl" xml:lang="en-US">Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="afya_DisclosureCapitalManagementAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCapitalManagementAbstract" xlink:to="afya_DisclosureCapitalManagementAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureCapitalManagementAbstract_lbl" xml:lang="en-US">Capital Management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalManagementExplanatory" xlink:label="afya_CapitalManagementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalManagementExplanatory" xlink:to="afya_CapitalManagementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalManagementExplanatory_lbl" xml:lang="en-US">Capital management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureLaborAndSocialObligationsAbstract" xlink:to="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract_lbl" xml:lang="en-US">Labor And Social Obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="afya_LaborAndSocialObligationsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsExplanatory_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:to="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEarningsPerShareExplanatory_lbl" xml:lang="en-US">Earnings per share (EPS)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueExplanatory_lbl" xml:lang="en-US">Revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:to="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfExpensesByNatureExplanatory_lbl" xml:lang="en-US">Expenses and costs by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:to="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory_lbl" xml:lang="en-US">Finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:to="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIncomeTaxExplanatory_lbl" xml:lang="en-US">Income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInsuranceContractsExplanatory" xlink:label="ifrs-full_DisclosureOfInsuranceContractsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfInsuranceContractsExplanatory" xlink:to="ifrs-full_DisclosureOfInsuranceContractsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfInsuranceContractsExplanatory_lbl" xml:lang="en-US">Insurance contracts and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="afya_DisclosureNoncashTransactionsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsAbstract" xlink:to="afya_DisclosureNoncashTransactionsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsAbstract_lbl" xml:lang="en-US">Non-cash Transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="afya_DisclosureNoncashTransactionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureNoncashTransactionsExplanatory" xlink:to="afya_DisclosureNoncashTransactionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureNoncashTransactionsExplanatory_lbl" xml:lang="en-US">Non-cash transactions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:to="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory_lbl" xml:lang="en-US">Subsequent events</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:to="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsAndGoodwillPolicyExplanatory_lbl" xml:lang="en-US">a) Business combinations and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:to="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory_lbl" xml:lang="en-US">b) Current versus non-current classification</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_lbl" xml:lang="en-US">c) Fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:to="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_lbl" xml:lang="en-US">d) Financial instruments &#8211; initial recognition and measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:to="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_lbl" xml:lang="en-US">e) Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">f) Restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories_lbl" xml:lang="en-US">g) Inventories</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">h) Property and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory_lbl" xml:lang="en-US">i) Leases</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_lbl" xml:lang="en-US">j) Intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:to="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory_lbl" xml:lang="en-US">k) Impairment of non-financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PolicyExplanatoryInvestments" xlink:label="afya_PolicyExplanatoryInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PolicyExplanatoryInvestments" xlink:to="afya_PolicyExplanatoryInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PolicyExplanatoryInvestments_lbl" xml:lang="en-US">l) Investments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersPolicyExplanatory_lbl" xml:lang="en-US">m) Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:to="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory_lbl" xml:lang="en-US">n) Provisions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPayablePolicyExplanatory" xlink:label="afya_DividendsPayablePolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayablePolicyExplanatory" xlink:to="afya_DividendsPayablePolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPayablePolicyExplanatory_lbl" xml:lang="en-US">o) Dividends payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsPolicyExplanatory" xlink:to="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsPolicyExplanatory_lbl" xml:lang="en-US">p) Labor and social obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="afya_SharebasedPaymentsPolicyExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharebasedPaymentsPolicyExplanatory" xlink:to="afya_SharebasedPaymentsPolicyExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharebasedPaymentsPolicyExplanatory_lbl" xml:lang="en-US">q) Share-based payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:to="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory_lbl" xml:lang="en-US">r) Revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPolicyExplanation" xlink:label="afya_TaxesPolicyExplanation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPolicyExplanation" xlink:to="afya_TaxesPolicyExplanation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesPolicyExplanation_lbl" xml:lang="en-US">s) Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:to="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_lbl" xml:lang="en-US">The table below is a list of the Company&#8217;s subsidiaries and associate:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfEstimatedUsefulLives" xlink:label="afya_ScheduleOfEstimatedUsefulLives" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfEstimatedUsefulLives" xlink:to="afya_ScheduleOfEstimatedUsefulLives_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfEstimatedUsefulLives_lbl" xml:lang="en-US">Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:to="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of assets and liabilities information for the company's operating segments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsExplanatory_lbl" xml:lang="en-US">Schedule of operating income for each operating segment</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:to="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfBusinessCombinationsTable_lbl" xml:lang="en-US">Disclosure of detailed information about business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" xlink:label="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" xlink:to="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_lbl" xml:lang="en-US">Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnislTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfUnislTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnislTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUnislTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfUnislTableTextBlock_lbl" xml:lang="en-US">Schedule of acquisition of UniSL</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfPebmedTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfPebmedTableTextBlock_lbl" xml:lang="en-US">Schedule of acquisition of PEBMED</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesarTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfFesarTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfFesarTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfFesarTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfFesarTableTextBlock_lbl" xml:lang="en-US">Schedule of acquisition of FESAR</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" xlink:label="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" xlink:to="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_lbl" xml:lang="en-US">The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:label="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock_lbl" xml:lang="en-US">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:to="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_lbl" xml:lang="en-US">Schedule of cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:to="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAndOtherReceivables1Explanatory_lbl" xml:lang="en-US">Schedule of trade accounts receivable, net and notes receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:to="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory_lbl" xml:lang="en-US">Schedule of aging of trade accounts receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsExplanatory" xlink:label="afya_AllowanceForDoubtfulAccountsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsExplanatory" xlink:to="afya_AllowanceForDoubtfulAccountsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsExplanatory_lbl" xml:lang="en-US">Schedule of allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfRelatedPartiesExplanatory" xlink:label="afya_ScheduleOfRelatedPartiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfRelatedPartiesExplanatory" xlink:to="afya_ScheduleOfRelatedPartiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfRelatedPartiesExplanatory_lbl" xml:lang="en-US">The table below summarizes the balances and transactions with related parties:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:to="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock_lbl" xml:lang="en-US">Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfOtherAssetsTableTextBlock" xlink:to="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfOtherAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of Other Assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfInvestments" xlink:label="afya_ScheduleOfInvestments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfInvestments" xlink:to="afya_ScheduleOfInvestments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfInvestments_lbl" xml:lang="en-US">Schedule of investments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_lbl" xml:lang="en-US">Schedule of detailed information about property, plant and equipment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:to="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:to="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_lbl" xml:lang="en-US">Schedule of assumptions for impairment test</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:to="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_lbl" xml:lang="en-US">Schedule of estimated useful lives</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialAssetsExplanatory" xlink:label="afya_FinancialAssetsExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialAssetsExplanatory" xlink:to="afya_FinancialAssetsExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialAssetsExplanatory_lbl" xml:lang="en-US">Schedule of financial assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialLiabilitiesExplanatory" xlink:label="afya_FinancialLiabilitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesExplanatory" xlink:to="afya_FinancialLiabilitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesExplanatory_lbl" xml:lang="en-US">Schedule of financial liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingExplanatory" xlink:label="afya_LoansAndFinancingExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingExplanatory" xlink:to="afya_LoansAndFinancingExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingExplanatory_lbl" xml:lang="en-US">Schedule of loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeasesExplanatory" xlink:label="afya_LeasesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeasesExplanatory" xlink:to="afya_LeasesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeasesExplanatory_lbl" xml:lang="en-US">Schedule of right-of-use assets and lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersExplanatory" xlink:label="afya_AccountsPayableToSellingShareholdersExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersExplanatory" xlink:to="afya_AccountsPayableToSellingShareholdersExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersExplanatory_lbl" xml:lang="en-US">Schedule of accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:label="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:to="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_lbl" xml:lang="en-US">Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValuesExplanatory" xlink:label="afya_FairValuesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValuesExplanatory" xlink:to="afya_FairValuesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValuesExplanatory_lbl" xml:lang="en-US">The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:to="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_lbl" xml:lang="en-US">Schedule of sensitivity analysis effects on income statement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:to="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_lbl" xml:lang="en-US">Schedule of currencies used in sensitivity analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:to="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_lbl" xml:lang="en-US">The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:to="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_lbl" xml:lang="en-US">Schedule of changes in liabilities arising from financing activities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfFairValueMeasurementExplanaory" xlink:label="afya_ScheduleOfFairValueMeasurementExplanaory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFairValueMeasurementExplanaory" xlink:to="afya_ScheduleOfFairValueMeasurementExplanaory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFairValueMeasurementExplanaory_lbl" xml:lang="en-US">Schedule of fair value measurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfCapitalManagementExplanatory" xlink:label="afya_ScheduleOfCapitalManagementExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfCapitalManagementExplanatory" xlink:to="afya_ScheduleOfCapitalManagementExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfCapitalManagementExplanatory_lbl" xml:lang="en-US">Schedule of capital management</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:label="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:to="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions_lbl" xml:lang="en-US">Schedule of model used to determine the fair value of the stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfSharebasedCompensationPlan" xlink:label="afya_ScheduleOfSharebasedCompensationPlan" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSharebasedCompensationPlan" xlink:to="afya_ScheduleOfSharebasedCompensationPlan_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSharebasedCompensationPlan_lbl" xml:lang="en-US">Schedule of share-based compensation plan</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfTreasurySharesMovement" xlink:label="afya_ScheduleOfTreasurySharesMovement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfTreasurySharesMovement" xlink:to="afya_ScheduleOfTreasurySharesMovement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfTreasurySharesMovement_lbl" xml:lang="en-US">[custom:ScheduleOfTreasurySharesMovement]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:label="afya_DisclosureOfEarningsPerShareTableExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:to="afya_DisclosureOfEarningsPerShareTableExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DisclosureOfEarningsPerShareTableExplanatory_lbl" xml:lang="en-US">Schedule of earnings per share</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfNetSalesRevenueExplanatory" xlink:to="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfNetSalesRevenueExplanatory_lbl" xml:lang="en-US">Schedule of net sales revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfRevenueBySegment" xlink:label="afya_ScheduleOfRevenueBySegment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfRevenueBySegment" xlink:to="afya_ScheduleOfRevenueBySegment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfRevenueBySegment_lbl" xml:lang="en-US">Schedule of revenue by segment</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfExpensesByNatureTableTextBlock" xlink:label="afya_SummaryOfExpensesByNatureTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SummaryOfExpensesByNatureTableTextBlock" xlink:to="afya_SummaryOfExpensesByNatureTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SummaryOfExpensesByNatureTableTextBlock_lbl" xml:lang="en-US">Schedule of expenses by nature</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfFinanceResult" xlink:label="afya_ScheduleOfFinanceResult" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfFinanceResult" xlink:to="afya_ScheduleOfFinanceResult_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfFinanceResult_lbl" xml:lang="en-US">Schedule of finance result</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:to="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_lbl" xml:lang="en-US">Schedule of reconciliation of income tax expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfLegalProceedingsAndContingencies" xlink:label="afya_ScheduleOfLegalProceedingsAndContingencies" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfLegalProceedingsAndContingencies" xlink:to="afya_ScheduleOfLegalProceedingsAndContingencies_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfLegalProceedingsAndContingencies_lbl" xml:lang="en-US">Schedule of legal proceedings and contingencies</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:to="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement_lbl" xml:lang="en-US">Schedule of social security proceedings assessed by Management</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_lbl" xml:lang="en-US">Percentage of voting equity interests acquired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:to="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestInSubsidiary_lbl" xml:lang="en-US">Proportion of ownership interest in subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" xlink:label="ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" xlink:to="ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_lbl" xml:lang="en-US">Description of exchanging and rights of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="ifrs-full_NumberOfSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesIssued_lbl" xml:lang="en-US">Number of shares issed (shares)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfPerShares" xlink:label="afya_NumberOfPerShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfPerShares" xlink:to="afya_NumberOfPerShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfPerShares_lbl" xml:lang="en-US">per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_lbl" xml:lang="en-US">Proceeds from issue of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesNet" xlink:label="afya_ProceedsFromIssueOfOrdinarySharesNet" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromIssueOfOrdinarySharesNet" xlink:to="afya_ProceedsFromIssueOfOrdinarySharesNet_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProceedsFromIssueOfOrdinarySharesNet_lbl" xml:lang="en-US">Net proceeds from issue of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionExpense" xlink:label="ifrs-full_FeeAndCommissionExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionExpense" xlink:to="ifrs-full_FeeAndCommissionExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FeeAndCommissionExpense_lbl" xml:lang="en-US">Fee and commission expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherOfferingExpenses" xlink:label="afya_OtherOfferingExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherOfferingExpenses" xlink:to="afya_OtherOfferingExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherOfferingExpenses_lbl" xml:lang="en-US">Other offering expenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ShareIssueRelatedCost" xlink:to="ifrs-full_ShareIssueRelatedCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ShareIssueRelatedCost_2_lbl" xml:lang="en-US">Share issuance costs</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TransferredAmountToGBankAccounts" xlink:label="afya_TransferredAmountToGBankAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredAmountToGBankAccounts" xlink:to="afya_TransferredAmountToGBankAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TransferredAmountToGBankAccounts_lbl" xml:lang="en-US">Transferred amount to bank accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfAdditionalCommonSharesIssued" xlink:label="afya_NumberOfAdditionalCommonSharesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfAdditionalCommonSharesIssued" xlink:to="afya_NumberOfAdditionalCommonSharesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfAdditionalCommonSharesIssued_lbl" xml:lang="en-US">Number of additional common shares issued</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalOfferingPrice" xlink:label="afya_AdditionalOfferingPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalOfferingPrice" xlink:to="afya_AdditionalOfferingPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalOfferingPrice_lbl" xml:lang="en-US">Additional offering price</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalSharesGrossProceeds" xlink:label="afya_AdditionalSharesGrossProceeds" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalSharesGrossProceeds" xlink:to="afya_AdditionalSharesGrossProceeds_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalSharesGrossProceeds_lbl" xml:lang="en-US">Additional shares gross proceeds</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetProceedsOfAdditionalShares" xlink:label="afya_NetProceedsOfAdditionalShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetProceedsOfAdditionalShares" xlink:to="afya_NetProceedsOfAdditionalShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetProceedsOfAdditionalShares_lbl" xml:lang="en-US">Net proceeds of additional shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="ifrs-full_LegalProceedingsProvision" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LegalProceedingsProvision" xlink:to="ifrs-full_LegalProceedingsProvision_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LegalProceedingsProvision_lbl" xml:lang="en-US">Amount of legal proceedings</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable_lbl" xml:lang="en-US">Disclosure of subsidiaries [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NameOfSubsidiary" xlink:label="ifrs-full_NameOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NameOfSubsidiary" xlink:to="ifrs-full_NameOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NameOfSubsidiary_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PrincipalActivities" xlink:label="afya_PrincipalActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PrincipalActivities" xlink:to="afya_PrincipalActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PrincipalActivities_lbl" xml:lang="en-US">Principal activities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:to="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary_lbl" xml:lang="en-US">Location</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentType" xlink:label="afya_InvestmentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentType" xlink:to="afya_InvestmentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentType_lbl" xml:lang="en-US">Investment type</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_lbl" xml:lang="en-US">Direct and indirect interest of subsidiary</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable_lbl" xml:lang="en-US">Disclosure of detailed information about property, plant and equipment [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_lbl" xml:lang="en-US">Useful lives of assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:to="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOperatingSegmentsTable_lbl" xml:lang="en-US">Disclosure of operating segments [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Assets" xlink:to="ifrs-full_Assets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Assets_2_lbl" xml:lang="en-US">Total assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentAssets_2_lbl" xml:lang="en-US">Current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentAssets_2_lbl" xml:lang="en-US">Non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAndLiabilities" xlink:to="ifrs-full_EquityAndLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAndLiabilities_2_lbl" xml:lang="en-US">Total liabilities and equity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLiabilities_2_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLiabilities_2_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Equity_4_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="ifrs-full_InvestmentsInAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentsInAssociates_lbl" xml:lang="en-US">Investments in associate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalExpenditures" xlink:label="afya_CapitalExpenditures" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalExpenditures" xlink:to="afya_CapitalExpenditures_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalExpenditures_lbl" xml:lang="en-US">Capital expenditures</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DepositsFromExternalCustomer" xlink:label="afya_DepositsFromExternalCustomer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepositsFromExternalCustomer" xlink:to="afya_DepositsFromExternalCustomer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepositsFromExternalCustomer_lbl" xml:lang="en-US">External customer</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterSegment" xlink:label="afya_InterSegment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterSegment" xlink:to="afya_InterSegment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterSegment_lbl" xml:lang="en-US">Inter-segment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GrossProfit" xlink:to="ifrs-full_GrossProfit_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GrossProfit_2_lbl" xml:lang="en-US">Gross profit</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherGainsLosses" xlink:label="ifrs-full_OtherGainsLosses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherGainsLosses" xlink:to="ifrs-full_OtherGainsLosses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherGainsLosses_lbl" xml:lang="en-US">Other expenses, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" xlink:to="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossFromOperatingActivities_2_lbl" xml:lang="en-US">Operating income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinanceIncome_2_lbl" xml:lang="en-US">Finance income</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanceExpense" xlink:label="afya_FinanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceExpense" xlink:to="afya_FinanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceExpense_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_lbl" xml:lang="en-US">Share of income of associate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossBeforeTax_2_lbl" xml:lang="en-US">Income before income taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations_2_lbl" xml:lang="en-US">Income taxes expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Cash and cash and equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCash1" xlink:label="afya_RestrictedCash1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCash1" xlink:to="afya_RestrictedCash1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedCash1_lbl" xml:lang="en-US">Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade Receivales</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Inventories1" xlink:label="afya_Inventories1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Inventories1" xlink:to="afya_Inventories1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Inventories1_lbl" xml:lang="en-US">[custom:Inventories1-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="afya_OtherAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:OtherAssetsAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:to="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Property, plant and equipment recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ImdemnificationAssets" xlink:label="afya_ImdemnificationAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ImdemnificationAssets" xlink:to="afya_ImdemnificationAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ImdemnificationAssets_lbl" xml:lang="en-US">[custom:ImdemnificationAssets-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Identifiable intangible assets recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Trade and other payables recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Borrowings recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="afya_TaxesPayableAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:TaxesPayableAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_lbl" xml:lang="en-US">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Indemnification assets recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Goodwill recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_lbl" xml:lang="en-US">Consideration transferred, acquisition-date fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="ifrs-full_CashTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashTransferred_lbl" xml:lang="en-US">Cash transferred</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Contingent consideration recognised as of acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ConsiderationToBeTransferred" xlink:label="afya_ConsiderationToBeTransferred" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsiderationToBeTransferred" xlink:to="afya_ConsiderationToBeTransferred_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsiderationToBeTransferred_lbl" xml:lang="en-US">[custom:ConsiderationToBeTransferred-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInShares" xlink:label="afya_PaidInShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaidInShares" xlink:to="afya_PaidInShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaidInShares_lbl" xml:lang="en-US">[custom:PaidInShares-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_lbl" xml:lang="en-US">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_lbl" xml:lang="en-US">Cash and cash equivalents in subsidiary or businesses acquired or disposed</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="afya_NetOfCashFlowOnAcquisition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetOfCashFlowOnAcquisition" xlink:to="afya_NetOfCashFlowOnAcquisition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetOfCashFlowOnAcquisition_lbl" xml:lang="en-US">[custom:NetOfCashFlowOnAcquisition]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable_lbl" xml:lang="en-US">Disclosure of disaggregation of revenue from contracts with customers [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContractualLeaseTerm" xlink:label="afya_ContractualLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContractualLeaseTerm" xlink:to="afya_ContractualLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContractualLeaseTerm_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="ifrs-full_ApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ApplicableTaxRate_lbl" xml:lang="en-US">Tax rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:to="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfIntangibleAssetsTable_lbl" xml:lang="en-US">Disclosure of detailed information about intangible assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:to="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_lbl" xml:lang="en-US">Valuation technique</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesAsOfAcquisitionDate" xlink:to="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeReceivablesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="ifrs-full_InventoryRecognisedAsOfAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_InventoryRecognisedAsOfAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InventoryRecognisedAsOfAcquisitionDate_lbl" xml:lang="en-US">Inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RecoverableTaxesAsOfAcquisitionDate" xlink:to="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RecoverableTaxesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Recoverable taxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssetsAsOfAcquisitionDate" xlink:to="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssetsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndemnificationAssets" xlink:label="afya_IndemnificationAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndemnificationAssets" xlink:to="afya_IndemnificationAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IndemnificationAssets_lbl" xml:lang="en-US">Indemnification assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:to="afya_RightOfUseAssetsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RightOfUseAssetsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Right-of-use assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Property and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Intangible assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Total Assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:to="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:to="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LaborAndSocialObligationsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Labor and social obligations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxesPayableAsOfAcquisitionDate" xlink:to="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TaxesPayableAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Taxes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:to="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ProvisionForLegalProceedingsAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Provision for legal proceedings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:to="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AdvancesFromCustomersAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayables" xlink:label="afya_NotesPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotesPayables_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:to="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherLiabilitiesAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Other liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Total Liabilites</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Total identifiable net assets at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_GoodwillRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Preliminary goodwill arising on acquisition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:to="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred_2_lbl" xml:lang="en-US">Purchase consideration transferred</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashTransferred" xlink:to="ifrs-full_CashTransferred_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashTransferred_2_lbl" xml:lang="en-US">Cash paid</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PayablInInstallmentsAcquisitionDate" xlink:label="afya_PayablInInstallmentsAcquisitionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PayablInInstallmentsAcquisitionDate" xlink:to="afya_PayablInInstallmentsAcquisitionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PayablInInstallmentsAcquisitionDate_lbl" xml:lang="en-US">Payable in installments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInAfyaBrazilsShares" xlink:label="afya_PaidInAfyaBrazilsShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaidInAfyaBrazilsShares" xlink:to="afya_PaidInAfyaBrazilsShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaidInAfyaBrazilsShares_lbl" xml:lang="en-US">Paid in Afya Brazil's shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_2_lbl" xml:lang="en-US">Transaction costs (included in cash flows from operating activities)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:to="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_2_lbl" xml:lang="en-US">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetOfCashFlowOnAcquisition" xlink:to="afya_NetOfCashFlowOnAcquisition_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NetOfCashFlowOnAcquisition_2_lbl" xml:lang="en-US">Net of cash flow on acquisition</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Cash" xlink:label="ifrs-full_Cash" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Cash" xlink:to="ifrs-full_Cash_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Cash_lbl" xml:lang="en-US">Cash and bank deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents" xlink:label="ifrs-full_CashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashEquivalents_lbl" xml:lang="en-US">Cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashAndCashEquivalents" xlink:to="ifrs-full_CashAndCashEquivalents_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashAndCashEquivalents_4_lbl" xml:lang="en-US">&#160;Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="ifrs-full_DescriptionOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfAcquiree" xlink:to="ifrs-full_DescriptionOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfAcquiree_lbl" xml:lang="en-US">Description of acquiree</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:to="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_3_lbl" xml:lang="en-US">Transaction costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossBeforeTax" xlink:to="ifrs-full_ProfitLossBeforeTax_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLossBeforeTax_3_lbl" xml:lang="en-US">Income loss before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInRevenue" xlink:label="afya_IncreaseInRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInRevenue" xlink:to="afya_IncreaseInRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInRevenue_lbl" xml:lang="en-US">Increase in revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:to="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseInIncomeBeforeIncomeTaxes_lbl" xml:lang="en-US">Increase in income before income taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="ifrs-full_RevenueOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfAcquiree" xlink:to="ifrs-full_RevenueOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueOfAcquiree_lbl" xml:lang="en-US">Revenue of acquiree since acquisition date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfCombinedEntity" xlink:label="ifrs-full_RevenueOfCombinedEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueOfCombinedEntity" xlink:to="ifrs-full_RevenueOfCombinedEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueOfCombinedEntity_lbl" xml:lang="en-US">Revenue of combined entity as if combination occurred at beginning of period</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaymentMade" xlink:label="afya_AdditionalPaymentMade" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalPaymentMade" xlink:to="afya_AdditionalPaymentMade_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalPaymentMade_lbl" xml:lang="en-US">Additional payment made</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreasedInIncomeBeforeIncomeTaxes" xlink:label="afya_DecreasedInIncomeBeforeIncomeTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreasedInIncomeBeforeIncomeTaxes" xlink:to="afya_DecreasedInIncomeBeforeIncomeTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DecreasedInIncomeBeforeIncomeTaxes_lbl" xml:lang="en-US">[custom:DecreasedInIncomeBeforeIncomeTaxes]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsTable_lbl" xml:lang="en-US">Disclosure of financial assets [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReceivablesGross" xlink:label="afya_ReceivablesGross" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReceivablesGross_lbl" xml:lang="en-US">Trade receivables, gross</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:to="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1_lbl" xml:lang="en-US">(-) Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivables" xlink:label="ifrs-full_TradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeReceivables_lbl" xml:lang="en-US">Trade receivables, net</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTradeReceivables" xlink:to="ifrs-full_CurrentTradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentTradeReceivables_2_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="ifrs-full_NoncurrentTradeReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentTradeReceivables" xlink:to="ifrs-full_NoncurrentTradeReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentTradeReceivables_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable_lbl" xml:lang="en-US">Disclosure of financial assets that are either past due or impaired [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReceivablesGross" xlink:to="afya_ReceivablesGross_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ReceivablesGross_2_lbl" xml:lang="en-US">Trade receivable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US">Balances at the beginning of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:to="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_lbl" xml:lang="en-US">Write-offs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_2_lbl" xml:lang="en-US">Balances at the end of the period</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable_lbl" xml:lang="en-US">Disclosure of transactions between related parties [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="afya_TradeReceivablesRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesRelatedPartyTransactions" xlink:to="afya_TradeReceivablesRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeReceivablesRelatedPartyTransactions_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CreditsWithShareholdersRelatedPartyTransactions" xlink:label="afya_CreditsWithShareholdersRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CreditsWithShareholdersRelatedPartyTransactions" xlink:to="afya_CreditsWithShareholdersRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CreditsWithShareholdersRelatedPartyTransactions_lbl" xml:lang="en-US">Related parties</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsReceivableRelatedPartyTransactions_lbl" xml:lang="en-US">&#160;TOTAL</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherCurrentPayablesToRelatedParties1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="afya_NoncurrentAssetsOfRelatedParty1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="afya_AccountsPayableToSellingShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholders" xlink:to="afya_AccountsPayableToSellingShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholders_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableCurrent1" xlink:label="afya_AccountsPayableCurrent1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableCurrent1" xlink:to="afya_AccountsPayableCurrent1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableCurrent1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="afya_NoncurrentPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentPayablesToRelatedParties1" xlink:to="afya_NoncurrentPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentPayablesToRelatedParties1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="afya_OtherIncomeRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherIncomeRelatedPartyTransactions" xlink:to="afya_OtherIncomeRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherIncomeRelatedPartyTransactions_lbl" xml:lang="en-US">Other income</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="ifrs-full_LeasesAsLesseeRelatedPartyTransactions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:to="ifrs-full_LeasesAsLesseeRelatedPartyTransactions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeasesAsLesseeRelatedPartyTransactions_lbl" xml:lang="en-US">Lease</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:to="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PercenatgeOfAverageInterestOnFinancialInstrument_lbl" xml:lang="en-US">Percentage of average interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashEquivalents" xlink:to="ifrs-full_CashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CashEquivalents_2_lbl" xml:lang="en-US">Cash equivalents (a)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:to="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits_lbl" xml:lang="en-US">Short-term employee benefits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="ifrs-full_KeyManagementPersonnelCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_KeyManagementPersonnelCompensation" xlink:to="ifrs-full_KeyManagementPersonnelCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_KeyManagementPersonnelCompensation_lbl" xml:lang="en-US">Share-based compensation plans</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable_lbl" xml:lang="en-US">Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ReserveQuantitiesLineItems" xlink:label="srt_ReserveQuantitiesLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ReserveQuantitiesLineItems" xlink:to="srt_ReserveQuantitiesLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="srt_ReserveQuantitiesLineItems_lbl" xml:lang="en-US">Reserve Quantities [Line Items]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TypeOfArrangement1Axis" xlink:to="afya_TypeOfArrangement1Axis_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TypeOfArrangement1Axis_2_lbl" xml:lang="en-US">TypeOfArrangement1Axis [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="afya_OperatingLeaseTermOfContract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OperatingLeaseTermOfContract" xlink:to="afya_OperatingLeaseTermOfContract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OperatingLeaseTermOfContract_lbl" xml:lang="en-US">Lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="ifrs-full_PercentageOfEntitysRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfEntitysRevenue" xlink:to="ifrs-full_PercentageOfEntitysRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PercentageOfEntitysRevenue_lbl" xml:lang="en-US">Percentage of revenue</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="afya_LesseeFinancesLeaseRenewalTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LesseeFinancesLeaseRenewalTerm" xlink:to="afya_LesseeFinancesLeaseRenewalTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LesseeFinancesLeaseRenewalTerm_lbl" xml:lang="en-US">Renewal term</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="afya_DescriptionOfLeaseTerm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerm" xlink:to="afya_DescriptionOfLeaseTerm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerm_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="ifrs-full_CashOutflowForLeases" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashOutflowForLeases" xlink:to="ifrs-full_CashOutflowForLeases_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashOutflowForLeases_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="afya_DescriptionOfLeaseTerms" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DescriptionOfLeaseTerms_lbl" xml:lang="en-US">Description of lease term</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate_3_lbl" xml:lang="en-US">Indemnification assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_JudicialDeposits" xlink:label="afya_JudicialDeposits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_JudicialDeposits" xlink:to="afya_JudicialDeposits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_JudicialDeposits_lbl" xml:lang="en-US">Judicial deposits</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="ifrs-full_CurrentPrepaidExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentPrepaidExpenses" xlink:to="ifrs-full_CurrentPrepaidExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentPrepaidExpenses_lbl" xml:lang="en-US">Prepaid expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReceivables" xlink:label="ifrs-full_OtherReceivables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherReceivables" xlink:to="ifrs-full_OtherReceivables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherReceivables_lbl" xml:lang="en-US">Other FIES receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssets1" xlink:label="afya_OtherAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherAssets1_lbl" xml:lang="en-US">Other assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Assets1" xlink:label="afya_Assets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_Assets1_lbl" xml:lang="en-US">&#160;Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentAssets1" xlink:label="afya_CurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentAssets1" xlink:to="afya_CurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CurrentAssets1_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentAssets1" xlink:label="afya_NoncurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentAssets1_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityInAssociate" xlink:label="afya_EquityInAssociate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_EquityInAssociate_lbl" xml:lang="en-US">Equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareInEquity1" xlink:label="afya_CompanyShareInEquity1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareInEquity1" xlink:to="afya_CompanyShareInEquity1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareInEquity1_lbl" xml:lang="en-US">Company&#8217;s share in equity &#8211; 30%</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="ifrs-full_Goodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Goodwill" xlink:to="ifrs-full_Goodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Goodwill_lbl" xml:lang="en-US">Goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentGrossAmount" xlink:label="afya_InvestmentGrossAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentGrossAmount" xlink:to="afya_InvestmentGrossAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InvestmentGrossAmount_lbl" xml:lang="en-US">Carrying amount of the investment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncome" xlink:to="ifrs-full_FinanceIncome_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinanceIncome_3_lbl" xml:lang="en-US">Finance result</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLoss" xlink:to="ifrs-full_ProfitLoss_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProfitLoss_3_lbl" xml:lang="en-US">Net income for the period</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareOfProfitss" xlink:label="afya_CompanyShareOfProfitss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompanyShareOfProfitss" xlink:to="afya_CompanyShareOfProfitss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompanyShareOfProfitss_lbl" xml:lang="en-US">Company&#8217;s share of income for the period</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_InvestmentsInAssociates_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MinorityInterestOfAcquiree" xlink:label="afya_MinorityInterestOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MinorityInterestOfAcquiree" xlink:to="afya_MinorityInterestOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MinorityInterestOfAcquiree_lbl" xml:lang="en-US">Acquisition of minority interest (15%) in March 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalMinorityInterestOfAcquiree" xlink:label="afya_AdditionalMinorityInterestOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalMinorityInterestOfAcquiree" xlink:to="afya_AdditionalMinorityInterestOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalMinorityInterestOfAcquiree_lbl" xml:lang="en-US">Acquisition of additional interest (15%) in June 2019</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsReceived1" xlink:label="afya_DividendsReceived1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DividendsReceived1_lbl" xml:lang="en-US">Dividends received</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsReceived" xlink:to="ifrs-full_DividendsReceived_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DividendsReceived_2_lbl" xml:lang="en-US">Dividends receivable (included in Other assets)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="ifrs-full_ProfitLossOfAcquiree" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfitLossOfAcquiree" xlink:to="ifrs-full_ProfitLossOfAcquiree_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfitLossOfAcquiree_lbl" xml:lang="en-US">Share of income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentsInAssociates" xlink:to="ifrs-full_InvestmentsInAssociates_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_InvestmentsInAssociates_3_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in goodwill [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_2_lbl" xml:lang="en-US">As of December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_lbl" xml:lang="en-US">Transfer</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsPropertyPlantAndEquipment_lbl" xml:lang="en-US">Disposals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_3_lbl" xml:lang="en-US">As of December 31, 2021</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_lbl" xml:lang="en-US">Depreciation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PropertyPlantAndEquipment" xlink:to="ifrs-full_PropertyPlantAndEquipment_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PropertyPlantAndEquipment_4_lbl" xml:lang="en-US">As of December 31, 2020</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable_lbl" xml:lang="en-US">Disclosure of reconciliation of changes in intangible assets and goodwill [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at beginnning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Disposal" xlink:label="afya_Disposal" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Disposal" xlink:to="afya_Disposal_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Disposal_lbl" xml:lang="en-US">Disposal</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Intangible assets and goodwill, balance at end</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Amortization</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_3_lbl" xml:lang="en-US">Intangible assets and goodwill</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:to="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife_lbl" xml:lang="en-US">Licenses with indefinite useful life</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashGeneratingUnits" xlink:label="afya_CashGeneratingUnits" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashGeneratingUnits" xlink:to="afya_CashGeneratingUnits_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashGeneratingUnits_lbl" xml:lang="en-US">Cash generating units</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherCurrentAssets1" xlink:label="afya_OtherCurrentAssets1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherCurrentAssets1" xlink:to="afya_OtherCurrentAssets1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherCurrentAssets1_lbl" xml:lang="en-US">TotalAssets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_lbl" xml:lang="en-US">Estimated useful lives of intangible assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_lbl" xml:lang="en-US">Restricted cash</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeReceivables" xlink:to="ifrs-full_TradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeReceivables_2_lbl" xml:lang="en-US">Trade receivables</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="ifrs-full_FinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialAssets_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="ifrs-full_CurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialAssets_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="ifrs-full_NoncurrentFinancialAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialAssets_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:to="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFinancialLiabilitiesTable_lbl" xml:lang="en-US">Disclosure of financial liabilities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_lbl" xml:lang="en-US">Trade payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="afya_LoansAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancing_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="ifrs-full_LeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_LeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayable" xlink:label="afya_NotePayable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayable" xlink:to="afya_NotePayable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotePayable_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Advances" xlink:label="ifrs-full_Advances" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Advances" xlink:to="ifrs-full_Advances_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_Advances_lbl" xml:lang="en-US">Advances from customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="ifrs-full_FinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FinancialLiabilities_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="ifrs-full_CurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentFinancialLiabilities_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="ifrs-full_NoncurrentFinancialLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable_lbl" xml:lang="en-US">Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialInstitution" xlink:label="afya_FinancialInstitution" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstitution" xlink:to="afya_FinancialInstitution_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialInstitution_lbl" xml:lang="en-US">Financial institution</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="ifrs-full_BorrowingsInterestRateBasis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsInterestRateBasis" xlink:to="ifrs-full_BorrowingsInterestRateBasis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsInterestRateBasis_lbl" xml:lang="en-US">Interest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsMaturity" xlink:label="ifrs-full_BorrowingsMaturity" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BorrowingsMaturity" xlink:to="ifrs-full_BorrowingsMaturity_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BorrowingsMaturity_lbl" xml:lang="en-US">Maturity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="afya_LoansAndFinancing_2_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing1" xlink:label="afya_LoansAndFinancing1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing1" xlink:to="afya_LoansAndFinancing1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancing1_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingCurrent" xlink:label="afya_LoansAndFinancingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="afya_LoansAndFinancingNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties_lbl" xml:lang="en-US">Equal installments payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IntrestRate" xlink:label="afya_IntrestRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IntrestRate" xlink:to="afya_IntrestRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IntrestRate_lbl" xml:lang="en-US">Intrest rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="ifrs-full_NotionalAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotionalAmount" xlink:to="ifrs-full_NotionalAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotionalAmount_lbl" xml:lang="en-US">Loan amount</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BorrowingsAmountFirstTranche" xlink:label="afya_BorrowingsAmountFirstTranche" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BorrowingsAmountFirstTranche" xlink:to="afya_BorrowingsAmountFirstTranche_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BorrowingsAmountFirstTranche_lbl" xml:lang="en-US">Borrowings amount first tranche</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="ifrs-full_NumberOfSharesAuthorised" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesAuthorised" xlink:to="ifrs-full_NumberOfSharesAuthorised_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfSharesAuthorised_lbl" xml:lang="en-US">Covertable preffered stock shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="ifrs-full_ParValuePerShare" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ParValuePerShare_lbl" xml:lang="en-US">Par value per share</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:label="ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:to="ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset_lbl" xml:lang="en-US">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:to="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections_lbl" xml:lang="en-US">Discount rate applied to cash flow projections</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:to="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_lbl" xml:lang="en-US">Description of key assumptions on which management has based cash flow projections</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_RightofuseAssets_2_lbl" xml:lang="en-US">Right-of-use assets, balance at ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, balance at beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="ifrs-full_AdditionsToRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsToRightofuseAssets" xlink:to="ifrs-full_AdditionsToRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsToRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="afya_AdditionsToLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToLeaseLiabilities" xlink:to="afya_AdditionsToLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionsToLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, additions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="afya_RightofuseAssetsRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRemeasurement" xlink:to="afya_RightofuseAssetsRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsRemeasurement_lbl" xml:lang="en-US">Right-of-use assets, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="afya_LeaseLiabilitiesRemeasurement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRemeasurement" xlink:to="afya_LeaseLiabilitiesRemeasurement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesRemeasurement_lbl" xml:lang="en-US">Lease liabilities, remeasurement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="afya_RightofuseAssetsBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsBusinessCombinations" xlink:to="afya_RightofuseAssetsBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsBusinessCombinations_lbl" xml:lang="en-US">Right-of-use assets, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="afya_BusinessCombinationsLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsLeaseLiabilities" xlink:to="afya_BusinessCombinationsLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombinationsLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="ifrs-full_DepreciationRightofuseAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationRightofuseAssets" xlink:to="ifrs-full_DepreciationRightofuseAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationRightofuseAssets_lbl" xml:lang="en-US">Right-of-use assets, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="afya_DepreciationExpenseLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationExpenseLeaseLiabilities" xlink:to="afya_DepreciationExpenseLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DepreciationExpenseLeaseLiabilities_lbl" xml:lang="en-US">Lease liabilities, depreciation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="afya_RightofuseAssetsInterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsInterestExpense" xlink:to="afya_RightofuseAssetsInterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsInterestExpense_lbl" xml:lang="en-US">Right-of-use assets, interest expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:to="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_InterestExpenseOnLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:to="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_lbl" xml:lang="en-US">Right-of-use assets, payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:label="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:to="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_lbl" xml:lang="en-US">Lease liabilities, payments of lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsDisposals" xlink:label="afya_RightofuseAssetsDisposals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsDisposals" xlink:to="afya_RightofuseAssetsDisposals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsDisposals_lbl" xml:lang="en-US">Right-of-use assets, disposals</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesDisposals" xlink:label="afya_LeaseLiabilitiesDisposals" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesDisposals" xlink:to="afya_LeaseLiabilitiesDisposals_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesDisposals_lbl" xml:lang="en-US">Lease liabilities, disposals</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesRightToUse" xlink:label="afya_LeaseLiabilitiesRightToUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRightToUse" xlink:to="afya_LeaseLiabilitiesRightToUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_LeaseLiabilitiesRightToUse_lbl" xml:lang="en-US">Lease liabilities, balance at beginning</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RightofuseAssets" xlink:to="ifrs-full_RightofuseAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_RightofuseAssets_3_lbl" xml:lang="en-US">Right-of-use assets, balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitieRightToUse" xlink:label="afya_LeaseLiabilitieRightToUse" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitieRightToUse" xlink:to="afya_LeaseLiabilitieRightToUse_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_LeaseLiabilitieRightToUse_lbl" xml:lang="en-US">Lease liabilities, balance at ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsCurrent" xlink:label="afya_RightofuseAssetsCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsCurrent" xlink:to="afya_RightofuseAssetsCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsCurrent_lbl" xml:lang="en-US">Right-of-use assets, current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLeaseLiabilities" xlink:to="ifrs-full_CurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_CurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="afya_RightofuseAssetsNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsNonCurrent" xlink:to="afya_RightofuseAssetsNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RightofuseAssetsNonCurrent_lbl" xml:lang="en-US">Right-of-use assets, non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLeaseLiabilities" xlink:to="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentLeaseLiabilities_2_lbl" xml:lang="en-US">Lease liabilities, non-current</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:to="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToRelatedParties_2_lbl" xml:lang="en-US">Opening balance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties1" xlink:label="afya_TradeAndOtherPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeAndOtherPayablesToRelatedParties1_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_lbl" xml:lang="en-US">Current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_lbl" xml:lang="en-US">Non-current</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholderCashFlows" xlink:to="afya_AccountsPayableToSellingShareholderCashFlows_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows_lbl" xml:lang="en-US">Cash flows</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:to="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_lbl" xml:lang="en-US">Acquisition of IPEC</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="ifrs-full_InterestExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InterestExpense" xlink:to="ifrs-full_InterestExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InterestExpense_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="afya_ContingentConsiderationOnBusinessCombinations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContingentConsiderationOnBusinessCombinations" xlink:to="afya_ContingentConsiderationOnBusinessCombinations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContingentConsiderationOnBusinessCombinations_lbl" xml:lang="en-US">Contingent consideration on Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompensationOfLegalProceedingsDisbursement" xlink:label="afya_CompensationOfLegalProceedingsDisbursement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompensationOfLegalProceedingsDisbursement" xlink:to="afya_CompensationOfLegalProceedingsDisbursement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CompensationOfLegalProceedingsDisbursement_lbl" xml:lang="en-US">Compensation of legal proceedings disbursement</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties2" xlink:label="afya_TradeAndOtherPayablesToRelatedParties2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedParties2" xlink:to="afya_TradeAndOtherPayablesToRelatedParties2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherPayablesToRelatedParties2_lbl" xml:lang="en-US">Closing balance</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:to="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_2_lbl" xml:lang="en-US">Ownership Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:to="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties_lbl" xml:lang="en-US">Remaining accounts payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties1" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties1_lbl" xml:lang="en-US">Equal installments payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashTransferredTransaction" xlink:label="afya_CashTransferredTransaction" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashTransferredTransaction" xlink:to="afya_CashTransferredTransaction_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashTransferredTransaction_lbl" xml:lang="en-US">Cash on the transaction closing date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:to="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DefinedBenefitObligationAtPresentValue_lbl" xml:lang="en-US">Defined benefit obligation, at present value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:to="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations_lbl" xml:lang="en-US">Transaction price allocated to remaining performance obligations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:to="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesForPurchaseOfEnergy_lbl" xml:lang="en-US">Non-current payables for purchase of energy</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="afya_NotesPayables_2_lbl" xml:lang="en-US">Notes payable beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombination" xlink:label="afya_BusinessCombination" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombination" xlink:to="afya_BusinessCombination_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BusinessCombination_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Payments" xlink:label="afya_Payments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payments" xlink:to="afya_Payments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Payments_lbl" xml:lang="en-US">Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MonetaryIndexation" xlink:label="afya_MonetaryIndexation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MonetaryIndexation" xlink:to="afya_MonetaryIndexation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_MonetaryIndexation_lbl" xml:lang="en-US">Monetary indexation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="afya_NotesPayables_3_lbl" xml:lang="en-US">Notes payable ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentLiabilities1" xlink:label="afya_CurrentLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentLiabilities1" xlink:to="afya_CurrentLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_CurrentLiabilities1_lbl" xml:lang="en-US">Current liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentLiabilities1" xlink:label="afya_NoncurrentLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentLiabilities1" xlink:to="afya_NoncurrentLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NoncurrentLiabilities1_lbl" xml:lang="en-US">Non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssets_2_lbl" xml:lang="en-US">Financial assets, at carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="ifrs-full_FinancialAssetsAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssetsAtFairValue" xlink:to="ifrs-full_FinancialAssetsAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialAssetsAtFairValue_lbl" xml:lang="en-US">Financial assets, at fair value</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilities" xlink:to="ifrs-full_FinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilities_2_lbl" xml:lang="en-US">Financial liabilities, at carrying amount</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialLiabilitiesAtFairValue" xlink:to="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinancialLiabilitiesAtFairValue_lbl" xml:lang="en-US">Financial liabilities, at fair value</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable_lbl" xml:lang="en-US">Disclosure of risk management strategy related to hedge accounting [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinancialAssets" xlink:to="ifrs-full_FinancialAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="ifrs-full_FinancialAssets_3_lbl" xml:lang="en-US">Balance as of ending</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndexRatePerYear" xlink:label="afya_IndexRatePerYear" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndexRatePerYear" xlink:to="afya_IndexRatePerYear_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IndexRatePerYear_lbl" xml:lang="en-US">Index - % per year</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BaseRate" xlink:label="afya_BaseRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BaseRate" xlink:to="afya_BaseRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_BaseRate_lbl" xml:lang="en-US">Base rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:to="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_lbl" xml:lang="en-US">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_2_lbl" xml:lang="en-US">Cash and cash equivalents</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayables" xlink:label="afya_NotePayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotePayables_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesContractualUndiscounted" xlink:to="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted_lbl" xml:lang="en-US">Financial liabilities contractual undiscounted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable_lbl" xml:lang="en-US">Disclosure of reconciliation of liabilities arising from financing activities [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Liabilities arising from financing activities, ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Payments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Addition</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Interest</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Foreign exchange movement</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Business combination</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Liabilities arising from financing activities, ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LiabilitiesArisingFromFinancingActivities_3_lbl" xml:lang="en-US">Liabilities arising from financing activities, beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromLoansAndFinancing" xlink:label="afya_ProceedsFromLoansAndFinancing" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromLoansAndFinancing" xlink:to="afya_ProceedsFromLoansAndFinancing_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProceedsFromLoansAndFinancing_lbl" xml:lang="en-US">Proceeds from loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfTransactionCosts" xlink:label="afya_NetOfTransactionCosts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetOfTransactionCosts" xlink:to="afya_NetOfTransactionCosts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetOfTransactionCosts_lbl" xml:lang="en-US">Net of the transaction costs</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable_lbl" xml:lang="en-US">Disclosure of detailed information about borrowings [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContractualLeaseTerm" xlink:to="afya_ContractualLeaseTerm_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ContractualLeaseTerm_2_lbl" xml:lang="en-US">Contractual lease term</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:to="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_lbl" xml:lang="en-US">Amount recognized lease expense from short-term leases and low-value assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayable1" xlink:label="afya_NotesPayable1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayable1" xlink:to="afya_NotesPayable1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NotesPayable1_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditExposure" xlink:label="ifrs-full_CreditExposure" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CreditExposure" xlink:to="ifrs-full_CreditExposure_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CreditExposure_lbl" xml:lang="en-US">Exposure risk</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SensitivityChangeInTheEuroExchangeRate" xlink:to="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate_lbl" xml:lang="en-US">Percentage of sensitivity change in the Euro exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="ifrs-full_ClosingForeignExchangeRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ClosingForeignExchangeRate" xlink:to="ifrs-full_ClosingForeignExchangeRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ClosingForeignExchangeRate_lbl" xml:lang="en-US">Closing foreign exchange rate</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable_lbl" xml:lang="en-US">Disclosure of fair value measurement of assets [table]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentTradeReceivables" xlink:to="ifrs-full_NoncurrentTradeReceivables_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NoncurrentTradeReceivables_2_lbl" xml:lang="en-US">Trade receivable (non-current)</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="afya_LoansAndFinancingLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingLiabilities" xlink:to="afya_LoansAndFinancingLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LoansAndFinancingLiabilities_lbl" xml:lang="en-US">Loans and financing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilities1" xlink:label="afya_LeaseLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilities1" xlink:to="afya_LeaseLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilities1_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:to="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_lbl" xml:lang="en-US">Accounts payable to selling shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayables1" xlink:label="afya_FairValueNotesPayables1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayables1" xlink:to="afya_FairValueNotesPayables1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_FairValueNotesPayables1_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashAndCashEquivalents1" xlink:label="afya_RestrictedCashAndCashEquivalents1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashAndCashEquivalents1" xlink:to="afya_RestrictedCashAndCashEquivalents1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RestrictedCashAndCashEquivalents1_lbl" xml:lang="en-US">Restricted Cash</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesOne" xlink:label="afya_LeaseLiabilitiesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesOne" xlink:to="afya_LeaseLiabilitiesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseLiabilitiesOne_lbl" xml:lang="en-US">Lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayablesLiabilities" xlink:label="afya_FairValueNotesPayablesLiabilities" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayablesLiabilities" xlink:to="afya_FairValueNotesPayablesLiabilities_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_FairValueNotesPayablesLiabilities_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureCapitalManagementAbstract" xlink:to="afya_DisclosureCapitalManagementAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureCapitalManagementAbstract_2_lbl" xml:lang="en-US">Schedule Of Capital Management</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="ifrs-full_NotesAndDebenturesIssued" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndDebenturesIssued" xlink:to="ifrs-full_NotesAndDebenturesIssued_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NotesAndDebenturesIssued_lbl" xml:lang="en-US">Notes payable</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashAndCashEquivalents1" xlink:label="afya_CashAndCashEquivalents1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashAndCashEquivalents1" xlink:to="afya_CashAndCashEquivalents1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CashAndCashEquivalents1_lbl" xml:lang="en-US">Less: cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RestrictedCashAndCashEquivalents" xlink:to="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RestrictedCashAndCashEquivalents_2_lbl" xml:lang="en-US">Less: restricted cash</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDebt" xlink:label="ifrs-full_NetDebt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetDebt" xlink:to="ifrs-full_NetDebt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetDebt_lbl" xml:lang="en-US">Net debt</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityOne1" xlink:label="afya_EquityOne1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityOne1" xlink:to="afya_EquityOne1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EquityOne1_lbl" xml:lang="en-US">Total equity</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityAndNetDebt1" xlink:label="afya_EquityAndNetDebt1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityAndNetDebt1" xlink:to="afya_EquityAndNetDebt1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EquityAndNetDebt1_lbl" xml:lang="en-US">Total equity and net debt</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable_lbl" xml:lang="en-US">Disclosure of terms and conditions of share-based payment arrangement [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Strike price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:to="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted_lbl" xml:lang="en-US">Dividend yield</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted_lbl" xml:lang="en-US">Expected volatility, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted_lbl" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionLifeShareOptionsGranted_lbl" xml:lang="en-US">Expected life of stock options, maximum</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:to="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted_lbl" xml:lang="en-US">Share price at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:to="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted_lbl" xml:lang="en-US">Model used</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:to="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_lbl" xml:lang="en-US">Weighted average fair value at the measurement date</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_lbl" xml:lang="en-US">Strike price at the measurement date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DisclosureLaborAndSocialObligationsAbstract" xlink:to="afya_DisclosureLaborAndSocialObligationsAbstract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_DisclosureLaborAndSocialObligationsAbstract_2_lbl" xml:lang="en-US">Schedule Of Share-based Compensation Plan</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="ifrs-full_NumberOfOutstandingShareOptions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_lbl" xml:lang="en-US">Outstanding at the beginning</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Forfeited</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Exercised</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_lbl" xml:lang="en-US">Expired</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_lbl" xml:lang="en-US">Expired</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2_lbl" xml:lang="en-US">Outstanding at the ending</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_2_lbl" xml:lang="en-US">Outstanding at the ending</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:to="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfDefinedBenefitPlansTable_lbl" xml:lang="en-US">Disclosure of defined benefit plans [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="afya_ShareBasedCompensationOfEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareBasedCompensationOfEmployees" xlink:to="afya_ShareBasedCompensationOfEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareBasedCompensationOfEmployees_lbl" xml:lang="en-US">Compensation of employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of stock option granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_lbl" xml:lang="en-US">Share-based compensation expense</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:to="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends_lbl" xml:lang="en-US">Net income attributable to equity holders of the parent</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="ifrs-full_WeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageShares" xlink:to="ifrs-full_WeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:to="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_lbl" xml:lang="en-US">Effects of dilution from stock options</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="ifrs-full_AdjustedWeightedAverageShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustedWeightedAverageShares" xlink:to="ifrs-full_AdjustedWeightedAverageShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustedWeightedAverageShares_lbl" xml:lang="en-US">Weighted average number of outstanding shares adjusted for the effect of dilution</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BasicEarningsLossPerShare" xlink:to="ifrs-full_BasicEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_BasicEarningsLossPerShare_2_lbl" xml:lang="en-US">Basic earnings per share (R$)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DilutedEarningsLossPerShare" xlink:to="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DilutedEarningsLossPerShare_2_lbl" xml:lang="en-US">Diluted earnings per share (R$)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="ifrs-full_ProfessionalFeesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProfessionalFeesExpense" xlink:to="ifrs-full_ProfessionalFeesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProfessionalFeesExpense_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherRevenue1" xlink:label="afya_OtherRevenue1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_OtherRevenue1_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionAbstract" xlink:label="afya_DeductionAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionAbstract" xlink:to="afya_DeductionAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionAbstract_lbl" xml:lang="en-US">Deductions</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="afya_DeductionOfGrantedDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfGrantedDiscounts" xlink:to="afya_DeductionOfGrantedDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfGrantedDiscounts_lbl" xml:lang="en-US">&#160;&#160;Granted discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfEarlyPaymentDiscounts" xlink:label="afya_DeductionOfEarlyPaymentDiscounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfEarlyPaymentDiscounts" xlink:to="afya_DeductionOfEarlyPaymentDiscounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfEarlyPaymentDiscounts_lbl" xml:lang="en-US">&#160;&#160;Early payment discounts</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="afya_DeductionOfReturnsOfNetRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfReturnsOfNetRevenue" xlink:to="afya_DeductionOfReturnsOfNetRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfReturnsOfNetRevenue_lbl" xml:lang="en-US">&#160;&#160;Returns</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfTaxes" xlink:label="afya_DeductionOfTaxes" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfTaxes" xlink:to="afya_DeductionOfTaxes_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfTaxes_lbl" xml:lang="en-US">&#160;&#160;Taxes</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfProuni" xlink:label="afya_DeductionOfProuni" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DeductionOfProuni" xlink:to="afya_DeductionOfProuni_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DeductionOfProuni_lbl" xml:lang="en-US">&#160;&#160;PROUNI</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="ifrs-full_RevenueFromContractsWithCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromContractsWithCustomers" xlink:to="ifrs-full_RevenueFromContractsWithCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Net revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:label="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:to="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_lbl" xml:lang="en-US">Timing of revenue recognition of net revenue from contracts with customers</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="ifrs-full_FeeAndCommissionIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FeeAndCommissionIncome_lbl" xml:lang="en-US">Tuition, digital content and app subscription fees - Transferred over time</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="afya_NetRevenueOtherTransferredPoint" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NetRevenueOtherTransferredPoint_lbl" xml:lang="en-US">Other - Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:to="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsToSuppliersForGoodsAndServices_lbl" xml:lang="en-US">Types of services or goods</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProfessionalFeesExpense1" xlink:label="afya_ProfessionalFeesExpense1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProfessionalFeesExpense1" xlink:to="afya_ProfessionalFeesExpense1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ProfessionalFeesExpense1_lbl" xml:lang="en-US">Tuition fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue" xlink:label="ifrs-full_OtherRevenue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherRevenue_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TimingRevenueRecognition" xlink:label="afya_TimingRevenueRecognition" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TimingRevenueRecognition" xlink:to="afya_TimingRevenueRecognition_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TimingRevenueRecognition_lbl" xml:lang="en-US">Timing of revenue recognition</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FeeAndCommissionIncome" xlink:to="ifrs-full_FeeAndCommissionIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_FeeAndCommissionIncome_2_lbl" xml:lang="en-US">Transferred over time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetRevenueOtherTransferredPoint" xlink:to="afya_NetRevenueOtherTransferredPoint_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_NetRevenueOtherTransferredPoint_2_lbl" xml:lang="en-US">Transferred at a point in time</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="ifrs-full_ExpenseByNature" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ExpenseByNature_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Payroll" xlink:label="afya_Payroll" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payroll" xlink:to="afya_Payroll_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Payroll_lbl" xml:lang="en-US">Payroll</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="afya_HospitalAndMedicalAgreements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_HospitalAndMedicalAgreements" xlink:to="afya_HospitalAndMedicalAgreements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_HospitalAndMedicalAgreements_lbl" xml:lang="en-US">Hospital and medical agreements</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationExpense" xlink:label="ifrs-full_DepreciationExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_DepreciationExpense_lbl" xml:lang="en-US">Depreciation and amortization</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseExpenses" xlink:label="afya_LeaseExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_LeaseExpenses_lbl" xml:lang="en-US">Lease expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UtilitiesExpense" xlink:label="ifrs-full_UtilitiesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UtilitiesExpense" xlink:to="ifrs-full_UtilitiesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UtilitiesExpense_lbl" xml:lang="en-US">Utilities</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="ifrs-full_RepairsAndMaintenanceExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepairsAndMaintenanceExpense" xlink:to="ifrs-full_RepairsAndMaintenanceExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepairsAndMaintenanceExpense_lbl" xml:lang="en-US">Maintenance</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharesBasedCompensation" xlink:label="afya_SharesBasedCompensation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_SharesBasedCompensation_lbl" xml:lang="en-US">Share-based compensation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxExpenses" xlink:label="afya_TaxExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxExpenses" xlink:to="afya_TaxExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxExpenses_lbl" xml:lang="en-US">Tax expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="ifrs-full_ServicesExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ServicesExpense" xlink:to="ifrs-full_ServicesExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ServicesExpense_lbl" xml:lang="en-US">Pedagogical services</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="ifrs-full_SalesAndMarketingExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SalesAndMarketingExpense" xlink:to="ifrs-full_SalesAndMarketingExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SalesAndMarketingExpense_lbl" xml:lang="en-US">Sales and marketing</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccounts" xlink:label="afya_AllowanceForDoubtfulAccounts" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccounts" xlink:to="afya_AllowanceForDoubtfulAccounts_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AllowanceForDoubtfulAccounts_lbl" xml:lang="en-US">Allowance for doubtful accounts</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TravelExpense" xlink:label="ifrs-full_TravelExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TravelExpense" xlink:to="ifrs-full_TravelExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TravelExpense_lbl" xml:lang="en-US">Travel expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ConsultingFees" xlink:label="afya_ConsultingFees" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ConsultingFees" xlink:to="afya_ConsultingFees_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ConsultingFees_lbl" xml:lang="en-US">Consulting fees</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Other" xlink:label="afya_Other" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_Other_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ExpenseByNatureOne" xlink:label="afya_ExpenseByNatureOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpenseByNatureOne" xlink:to="afya_ExpenseByNatureOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:label="afya_ExpenseByNatureOne_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentIncome" xlink:label="ifrs-full_InvestmentIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InvestmentIncome" xlink:to="ifrs-full_InvestmentIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InvestmentIncome_lbl" xml:lang="en-US">Income from financial investments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangesInFairValueOfDerivativeInstruments" xlink:label="afya_ChangesInFairValueOfDerivativeInstruments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ChangesInFairValueOfDerivativeInstruments" xlink:to="afya_ChangesInFairValueOfDerivativeInstruments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ChangesInFairValueOfDerivativeInstruments_lbl" xml:lang="en-US">Changes in fair value of derivative instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromInterest" xlink:label="ifrs-full_RevenueFromInterest" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RevenueFromInterest" xlink:to="ifrs-full_RevenueFromInterest_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RevenueFromInterest_lbl" xml:lang="en-US">Interest received</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="ifrs-full_NetForeignExchangeGain" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeGain" xlink:to="ifrs-full_NetForeignExchangeGain_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeGain_lbl" xml:lang="en-US">Foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncome" xlink:label="ifrs-full_OtherFinanceIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherFinanceIncome_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangeInFairValueOfDerivativeInstruments" xlink:label="afya_ChangeInFairValueOfDerivativeInstruments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ChangeInFairValueOfDerivativeInstruments" xlink:to="afya_ChangeInFairValueOfDerivativeInstruments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ChangeInFairValueOfDerivativeInstruments_lbl" xml:lang="en-US">Change in fair value of derivative instruments</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterestExpense1" xlink:label="afya_InterestExpense1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpense1" xlink:to="afya_InterestExpense1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpense1_lbl" xml:lang="en-US">Interest expense</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="afya_InterestExpenseOnLeaseLiabilities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterestExpenseOnLeaseLiabilities1" xlink:to="afya_InterestExpenseOnLeaseLiabilities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterestExpenseOnLeaseLiabilities1_lbl" xml:lang="en-US">Interest expense on lease liabilities</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="afya_FinancialDiscountsGrantedExpenses" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialDiscountsGrantedExpenses" xlink:to="afya_FinancialDiscountsGrantedExpenses_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinancialDiscountsGrantedExpenses_lbl" xml:lang="en-US">Financial discounts granted</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="ifrs-full_BankAndSimilarCharges" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_BankAndSimilarCharges" xlink:to="ifrs-full_BankAndSimilarCharges_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_BankAndSimilarCharges_lbl" xml:lang="en-US">Bank fees</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="ifrs-full_NetForeignExchangeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NetForeignExchangeLoss_lbl" xml:lang="en-US">Foreign exchange differences</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxOnFinancialOperations" xlink:label="afya_TaxOnFinancialOperations" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxOnFinancialOperations" xlink:to="afya_TaxOnFinancialOperations_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxOnFinancialOperations_lbl" xml:lang="en-US">IOF taxes (taxes on financial transactions)</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceCost" xlink:label="ifrs-full_OtherFinanceCost" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherFinanceCost_lbl" xml:lang="en-US">Other</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:label="ifrs-full_FinanceCosts_2_lbl" xml:lang="en-US">Finance expenses</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanceResult" xlink:label="afya_FinanceResult" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceResult" xlink:to="afya_FinanceResult_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_FinanceResult_lbl" xml:lang="en-US">Finance result</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ApplicableTaxRate" xlink:to="ifrs-full_ApplicableTaxRate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ApplicableTaxRate_2_lbl" xml:lang="en-US">Statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:to="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseIncomeAtApplicableTaxRate_lbl" xml:lang="en-US">Income taxes at statutory rates</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="afya_ReconciliationAdjustmentsAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ReconciliationAdjustmentsAbstract" xlink:to="afya_ReconciliationAdjustmentsAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ReconciliationAdjustmentsAbstract_lbl" xml:lang="en-US">Reconciliation adjustments:</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:to="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_lbl" xml:lang="en-US">Tax effect on loss from entities not subject to taxation</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:to="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProgramaUniversidadeParaTodosFiscalIncentive_lbl" xml:lang="en-US">PROUNI - Fiscal Incentive</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnrecognisedDeferredTaxAssets" xlink:label="afya_UnrecognisedDeferredTaxAssets" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnrecognisedDeferredTaxAssets" xlink:to="afya_UnrecognisedDeferredTaxAssets_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_UnrecognisedDeferredTaxAssets_lbl" xml:lang="en-US">Unrecognized deferred tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:to="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_lbl" xml:lang="en-US">Presumed profit income tax regime effect</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PermanentAdjustments" xlink:label="afya_PermanentAdjustments" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PermanentAdjustments" xlink:to="afya_PermanentAdjustments_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_PermanentAdjustments_lbl" xml:lang="en-US">Permanent adjustments</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_lbl" xml:lang="en-US">Other</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="ifrs-full_CurrentTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentTaxExpenseIncome" xlink:to="ifrs-full_CurrentTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentTaxExpenseIncome_lbl" xml:lang="en-US">Income taxes expense &#8211; current</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:to="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxRateEffectFromChangeInTaxRate_lbl" xml:lang="en-US">Effective rate</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital2" xlink:label="afya_IssuedCapital2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapital2" xlink:to="afya_IssuedCapital2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IssuedCapital2_lbl" xml:lang="en-US">Share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfSharesIssued1" xlink:label="afya_NumberOfSharesIssued1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfSharesIssued1" xlink:to="afya_NumberOfSharesIssued1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NumberOfSharesIssued1_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfSharesIssued" xlink:to="ifrs-full_NumberOfSharesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_NumberOfSharesIssued_2_lbl" xml:lang="en-US">Total number of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfRatioOfConvertibleShares" xlink:label="afya_DescriptionOfRatioOfConvertibleShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfRatioOfConvertibleShares" xlink:to="afya_DescriptionOfRatioOfConvertibleShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfRatioOfConvertibleShares_lbl" xml:lang="en-US">Description of ratio of convertible shares</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:to="ifrs-full_ProceedsFromIssueOfOrdinaryShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ProceedsFromIssueOfOrdinaryShares_2_lbl" xml:lang="en-US">Proceeds from issue of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfPreferenceShares" xlink:label="ifrs-full_ProceedsFromIssueOfPreferenceShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ProceedsFromIssueOfPreferenceShares" xlink:to="ifrs-full_ProceedsFromIssueOfPreferenceShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ProceedsFromIssueOfPreferenceShares_lbl" xml:lang="en-US">Proceeds from issue of preference shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithEarningsReserves" xlink:label="afya_CapitalIncreaseWithEarningsReserves" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseWithEarningsReserves" xlink:to="afya_CapitalIncreaseWithEarningsReserves_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalIncreaseWithEarningsReserves_lbl" xml:lang="en-US">Capital increase with earnings reserves</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" xlink:label="ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" xlink:to="ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_lbl" xml:lang="en-US">Renounce of dividends for prior years</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:to="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_lbl" xml:lang="en-US">Number of shares in entity held by entity or by its subsidiaries or associates shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="afya_RepurchaseOfOrdinaryShares" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepurchaseOfOrdinaryShares" xlink:to="afya_RepurchaseOfOrdinaryShares_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RepurchaseOfOrdinaryShares_lbl" xml:lang="en-US">Repurchase of ordinary shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionPrice" xlink:label="afya_AcquisitionPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionPrice" xlink:to="afya_AcquisitionPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionPrice_lbl" xml:lang="en-US">Acquisition price</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionsHeldByShareholders" xlink:label="afya_AcquisitionsHeldByShareholders" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AcquisitionsHeldByShareholders" xlink:to="afya_AcquisitionsHeldByShareholders_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AcquisitionsHeldByShareholders_lbl" xml:lang="en-US">Acquisitions held by shareholders</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesOne" xlink:label="afya_ProceedsFromIssueOfOrdinarySharesOne" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromIssueOfOrdinarySharesOne" xlink:to="afya_ProceedsFromIssueOfOrdinarySharesOne_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProceedsFromIssueOfOrdinarySharesOne_lbl" xml:lang="en-US">Purchase prices paid shares</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital1" xlink:label="afya_AdditionalPaidinCapital1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalPaidinCapital1" xlink:to="afya_AdditionalPaidinCapital1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_AdditionalPaidinCapital1_lbl" xml:lang="en-US">Additional paid-in capital</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital2" xlink:label="afya_AdditionalPaidinCapital2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalPaidinCapital2" xlink:to="afya_AdditionalPaidinCapital2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalPaidinCapital2_lbl" xml:lang="en-US">[custom:AdditionalPaidinCapital2-0]</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CancellationOfDividend" xlink:label="afya_CancellationOfDividend" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CancellationOfDividend" xlink:to="afya_CancellationOfDividend_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CancellationOfDividend_lbl" xml:lang="en-US">Cancellation of dividend</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendPayables" xlink:label="ifrs-full_DividendPayables" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendPayables" xlink:to="ifrs-full_DividendPayables_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendPayables_lbl" xml:lang="en-US">Dividend payables</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterimDividends" xlink:label="afya_InterimDividends" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InterimDividends" xlink:to="afya_InterimDividends_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_InterimDividends_lbl" xml:lang="en-US">Dividend paid</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPaidClassifiedAsFinancingActivities1" xlink:label="afya_DividendsPaidClassifiedAsFinancingActivities1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPaidClassifiedAsFinancingActivities1" xlink:to="afya_DividendsPaidClassifiedAsFinancingActivities1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsPaidClassifiedAsFinancingActivities1_lbl" xml:lang="en-US">Dividends paid classified</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:to="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidToNoncontrollingInterests_lbl" xml:lang="en-US">Dividends paid to non-controlling interests</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital1" xlink:label="afya_IssuedCapital1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapital1" xlink:to="afya_IssuedCapital1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_IssuedCapital1_lbl" xml:lang="en-US">Share capital</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinaryShares1" xlink:label="afya_ProceedsFromIssueOfOrdinaryShares1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromIssueOfOrdinaryShares1" xlink:to="afya_ProceedsFromIssueOfOrdinaryShares1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_ProceedsFromIssueOfOrdinaryShares1_lbl" xml:lang="en-US">Proceeds from issue of shares</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable_lbl" xml:lang="en-US">Disclosure of contingent liabilities in business combination [table]</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Provisions" xlink:label="ifrs-full_Provisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:label="ifrs-full_Provisions_lbl" xml:lang="en-US">Balances as of end of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_lbl" xml:lang="en-US">Business combinations</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_lbl" xml:lang="en-US">Additions</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:to="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_UnusedProvisionReversedOtherProvisions_lbl" xml:lang="en-US">Reversals</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:label="ifrs-full_Provisions_2_lbl" xml:lang="en-US">Balance as of ending of the year</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions" xlink:label="ifrs-full_OtherProvisions" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_OtherProvisions_lbl" xml:lang="en-US">Total</link:label>
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="ifrs-full_DeferredTaxExpenseIncome" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DeferredTaxExpenseIncome" xlink:to="ifrs-full_DeferredTaxExpenseIncome_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DeferredTaxExpenseIncome_lbl" xml:lang="en-US">Unrecognized deferred income tax assets</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="afya_ContingenciesCorrespondentAmount" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContingenciesCorrespondentAmount" xlink:to="afya_ContingenciesCorrespondentAmount_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ContingenciesCorrespondentAmount_lbl" xml:lang="en-US">Contingencies correspondent amount</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RepurchaseOfOrdinaryShares" xlink:to="afya_RepurchaseOfOrdinaryShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="afya_RepurchaseOfOrdinaryShares_2_lbl" xml:lang="en-US">Repurchase shares program</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:to="ifrs-full_PercentageOfVotingEquityInterestsAcquired_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_PercentageOfVotingEquityInterestsAcquired_2_lbl" xml:lang="en-US">Proportion of ownership interest</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ParValuePerShare" xlink:to="ifrs-full_ParValuePerShare_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ifrs-full_ParValuePerShare_2_lbl" xml:lang="en-US">Purchase prices per share</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SaleOfStockAxis" xlink:to="afya_SaleOfStockAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_SaleOfStockAxis_doc" xml:lang="en-US">Axis represent sale of stock.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InitialPublicOfferingMember" xlink:to="afya_InitialPublicOfferingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_InitialPublicOfferingMember_doc" xml:lang="en-US">The member represent initial public offering.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_UnderwritersMember" xlink:to="afya_UnderwritersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_UnderwritersMember_doc" xml:lang="en-US">The member represent underwriters.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OverAllotmentsMember" xlink:to="afya_OverAllotmentsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_OverAllotmentsMember_doc" xml:lang="en-US">The member represent over allotments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromIssueOfOrdinarySharesNet" xlink:to="afya_ProceedsFromIssueOfOrdinarySharesNet_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_ProceedsFromIssueOfOrdinarySharesNet_doc" xml:lang="en-US">The cash inflow from the issuing of ordinary shares, net.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherOfferingExpenses" xlink:to="afya_OtherOfferingExpenses_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_OtherOfferingExpenses_doc" xml:lang="en-US">The amoun of other offering expenses.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TransferredAmountToGBankAccounts" xlink:to="afya_TransferredAmountToGBankAccounts_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TransferredAmountToGBankAccounts_doc" xml:lang="en-US">The amoun of transferred amount to bank accounts.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NumberOfAdditionalCommonSharesIssued" xlink:to="afya_NumberOfAdditionalCommonSharesIssued_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NumberOfAdditionalCommonSharesIssued_doc" xml:lang="en-US">Number of additional common shares issued.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalOfferingPrice" xlink:to="afya_AdditionalOfferingPrice_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AdditionalOfferingPrice_doc" xml:lang="en-US">The amoutn of additional offering price.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalSharesGrossProceeds" xlink:to="afya_AdditionalSharesGrossProceeds_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AdditionalSharesGrossProceeds_doc" xml:lang="en-US">The amount fo additional shares gross proceeds.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NetProceedsOfAdditionalShares" xlink:to="afya_NetProceedsOfAdditionalShares_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NetProceedsOfAdditionalShares_doc" xml:lang="en-US">Net proceeds of additional shares.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialInstitution" xlink:to="afya_FinancialInstitution_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_FinancialInstitution_doc" xml:lang="en-US">Information about financial institution.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyThreeMember" xlink:to="afya_TwentyTwentyThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentyThreeMember_doc" xml:lang="en-US">The member stands for twenty twenty three.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyOneMember" xlink:to="afya_TwentyTwentyOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentyOneMember_doc" xml:lang="en-US">The member stands for twenty twenty one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentyFourMember" xlink:to="afya_TwentyTwentyFourMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentyFourMember_doc" xml:lang="en-US">The member stands for twenty twenty four.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TwentyTwentySevenMember" xlink:to="afya_TwentyTwentySevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TwentyTwentySevenMember_doc" xml:lang="en-US">This member stands for twenty twenty seven.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingCurrent_doc" xml:lang="en-US">The amount refers to loans and financing current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingNonCurrent_doc" xml:lang="en-US">The amount refers to loans and financing non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsRemeasurement" xlink:to="afya_RightofuseAssetsRemeasurement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsRemeasurement_doc" xml:lang="en-US">The amount of right of use assets re measurement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsBusinessCombinations" xlink:to="afya_RightofuseAssetsBusinessCombinations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsBusinessCombinations_doc" xml:lang="en-US">The amount of business combinations right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsInterestExpense" xlink:to="afya_RightofuseAssetsInterestExpense_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsInterestExpense_doc" xml:lang="en-US">The amount of Interest expense right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:to="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsPaymentsOfLeaseLiabilities_doc" xml:lang="en-US">The amount of Payments of lease liabilities right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsDisposals" xlink:to="afya_RightofuseAssetsDisposals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsDisposals_doc" xml:lang="en-US">The amount of right of use assets disposals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionsToLeaseLiabilities" xlink:to="afya_AdditionsToLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AdditionsToLeaseLiabilities_doc" xml:lang="en-US">The amount of additions to lease liabilities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRemeasurement" xlink:to="afya_LeaseLiabilitiesRemeasurement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LeaseLiabilitiesRemeasurement_doc" xml:lang="en-US">The amount of lease liabilities re measurement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombinationsLeaseLiabilities" xlink:to="afya_BusinessCombinationsLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BusinessCombinationsLeaseLiabilities_doc" xml:lang="en-US">The amount of business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DepreciationExpenseLeaseLiabilities" xlink:to="afya_DepreciationExpenseLeaseLiabilities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DepreciationExpenseLeaseLiabilities_doc" xml:lang="en-US">The amount of depreciation expense.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesDisposals" xlink:to="afya_LeaseLiabilitiesDisposals_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LeaseLiabilitiesDisposals_doc" xml:lang="en-US">The amount of lease liabilities disposals.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsCurrent" xlink:to="afya_RightofuseAssetsCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsCurrent_doc" xml:lang="en-US">The amount of current right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RightofuseAssetsNonCurrent" xlink:to="afya_RightofuseAssetsNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RightofuseAssetsNonCurrent_doc" xml:lang="en-US">The amount of non current right to use of assets.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedPhoneMember" xlink:to="afya_MedPhoneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_MedPhoneMember_doc" xml:lang="en-US">The member stands for medphone.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders non current.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersMember" xlink:to="afya_AccountsPayableToSellingShareholdersMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersMember_doc" xml:lang="en-US">This member stands for accounts payable to selling shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholderCashFlows" xlink:to="afya_AccountsPayableToSellingShareholderCashFlows_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholderCashFlows_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholder cash flows.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:to="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders acquisition of ipec.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_doc" xml:lang="en-US">The amount refers to accounts payable to selling shareholders business combinations.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CompensationOfLegalProceedingsDisbursement" xlink:to="afya_CompensationOfLegalProceedingsDisbursement_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_CompensationOfLegalProceedingsDisbursement_doc" xml:lang="en-US">The amount refers to compensation of legal proceedings disbursement.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BusinessCombination" xlink:to="afya_BusinessCombination_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BusinessCombination_doc" xml:lang="en-US">The amount of business combination.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Payments" xlink:to="afya_Payments_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_Payments_doc" xml:lang="en-US">The amount of payments.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MonetaryIndexation" xlink:to="afya_MonetaryIndexation_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_MonetaryIndexation_doc" xml:lang="en-US">The amount of monetary indexation.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableMember" xlink:to="afya_NotesPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NotesPayableMember_doc" xml:lang="en-US">The member stands for notes payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingMember" xlink:to="afya_LoansAndFinancingMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingMember_doc" xml:lang="en-US">This member stands for loans and financing.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashMember" xlink:to="afya_RestrictedCashMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RestrictedCashMember_doc" xml:lang="en-US">This member stands for restricted cash.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IndexRatePerYear" xlink:to="afya_IndexRatePerYear_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IndexRatePerYear_doc" xml:lang="en-US">Information about index rate per year.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CashEquivalents1Member" xlink:to="afya_CashEquivalents1Member_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_CashEquivalents1Member_doc" xml:lang="en-US">This member stands for cash equivalents1.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BaseRate" xlink:to="afya_BaseRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BaseRate_doc" xml:lang="en-US">The amount refers to base rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersOneMember" xlink:to="afya_AccountsPayableToSellingShareholdersOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersOneMember_doc" xml:lang="en-US">This member stands for accounts payable to selling shareholders.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingOneMember" xlink:to="afya_LoansAndFinancingOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingOneMember_doc" xml:lang="en-US">The member stands for loans and financing one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingTwoMember" xlink:to="afya_LoansAndFinancingTwoMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingTwoMember_doc" xml:lang="en-US">The member stands for loans and financing two.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersSevenMember" xlink:to="afya_AccountsPayableToSellingShareholdersSevenMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_AccountsPayableToSellingShareholdersSevenMember_doc" xml:lang="en-US">The member stands for accounts payable to selling share holders seven.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsMember" xlink:to="afya_IncreaseBasisPointsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseBasisPointsMember_doc" xml:lang="en-US">This member stands for increase basis points.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseBasisPointsMember" xlink:to="afya_DecreaseBasisPointsMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DecreaseBasisPointsMember_doc" xml:lang="en-US">This member stands for decrease basis points.</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingThreeMember" xlink:label="afya_LoansAndFinancingThreeMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingThreeMember" xlink:to="afya_LoansAndFinancingThreeMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_LoansAndFinancingThreeMember_doc" xml:lang="en-US">The member stands for loans and financing member.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseBasisPointsOneMember" xlink:to="afya_IncreaseBasisPointsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseBasisPointsOneMember_doc" xml:lang="en-US">This member stands for increase basis points one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseBasisPointsOneMember" xlink:to="afya_DecreaseBasisPointsOneMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DecreaseBasisPointsOneMember_doc" xml:lang="en-US">This member stands for decrease basis points one.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ForeignCurrencyExposuresMember" xlink:to="afya_ForeignCurrencyExposuresMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_ForeignCurrencyExposuresMember_doc" xml:lang="en-US">The member represent foreign currency exposures.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseForeignCurrencyMember" xlink:to="afya_IncreaseForeignCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseForeignCurrencyMember_doc" xml:lang="en-US">The member represent increse in foreign currency sensitivity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DecreaseForeignCurrencyMember" xlink:to="afya_DecreaseForeignCurrencyMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DecreaseForeignCurrencyMember_doc" xml:lang="en-US">The member represent decrease in foreign currency sensitivity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NotePayables_doc" xml:lang="en-US">The amount of note payables.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinancialLiabilitiesContractualUndiscounted" xlink:to="afya_FinancialLiabilitiesContractualUndiscounted_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_FinancialLiabilitiesContractualUndiscounted_doc" xml:lang="en-US">The amount of financial liabilities contractual undiscounted.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsPayableMember" xlink:to="afya_DividendsPayableMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DividendsPayableMember_doc" xml:lang="en-US">This member stands for the dividends payable.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_doc" xml:lang="en-US">The amount of increase through interest on liabilities arising from financing activities.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SensitivityChangeInTheEuroExchangeRate" xlink:to="afya_SensitivityChangeInTheEuroExchangeRate_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_SensitivityChangeInTheEuroExchangeRate_doc" xml:lang="en-US">Information about percentage of sensitivity change in the euro exchange rate.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:to="afya_RemainingTradeAndOtherPayablesToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_RemainingTradeAndOtherPayablesToRelatedParties_doc" xml:lang="en-US">The remaining amount of payables due to related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties_doc" xml:lang="en-US">The amount of equal installments payables due to related parties.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_BorrowingsAmountFirstTranche" xlink:to="afya_BorrowingsAmountFirstTranche_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_BorrowingsAmountFirstTranche_doc" xml:lang="en-US">The amount refers to borrowing first tranche.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerm" xlink:to="afya_DescriptionOfLeaseTerm_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_DescriptionOfLeaseTerm_doc" xml:lang="en-US">Information about description of lease term.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:to="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember_doc" xml:lang="en-US">This member stands for Institutode Ensino Superior Presidente Trancredode Almeida Neves SA.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:to="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember_doc" xml:lang="en-US">This member stands for instituto tocantinense presidente antonio carlos s a.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_InvestmentType" xlink:to="afya_InvestmentType_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_InvestmentType_doc" xml:lang="en-US">The investment type of a subsidiary.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:to="afya_MedPhoneTecnologiaEmSaudeLtdaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_MedPhoneTecnologiaEmSaudeLtdaMember_doc" xml:lang="en-US">The member stands for med phone technologia em saude ltd.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:to="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_doc" xml:lang="en-US">The member stands for faculdade de ensino superior de amazon amazonia reunida.</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember" xlink:label="afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember" xlink:to="afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_PEBMEDInstituicaoDePesquisaMedicaServicosTecnologicosDaareaDaSaudeSAMember_doc" xml:lang="en-US">The member stands for PEBMED.</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CBBWebServicosETransmissoesOnlineSAMember" xlink:label="afya_CBBWebServicosETransmissoesOnlineSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CBBWebServicosETransmissoesOnlineSAMember" xlink:to="afya_CBBWebServicosETransmissoesOnlineSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_CBBWebServicosETransmissoesOnlineSAMember_doc" xml:lang="en-US">This member stands for entities that are controlled by another entity.</link:label>
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraEEventosSAMember" xlink:label="afya_MedcelEditoraEEventosSAMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_MedcelEditoraEEventosSAMember" xlink:to="afya_MedcelEditoraEEventosSAMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_MedcelEditoraEEventosSAMember_doc" xml:lang="en-US">This member stands for entities that are controlled by another entity.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TaxAuthorityAxis" xlink:to="afya_TaxAuthorityAxis_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_TaxAuthorityAxis_doc" xml:lang="en-US">Axis represent tax authority.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProgramOfSocialIntegrationMember" xlink:to="afya_ProgramOfSocialIntegrationMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_ProgramOfSocialIntegrationMember_doc" xml:lang="en-US">The member represent tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NonTeachingActivitiesMember" xlink:to="afya_NonTeachingActivitiesMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_NonTeachingActivitiesMember_doc" xml:lang="en-US">The member represent services.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:to="afya_ContributionForTheFinancingOfSocialSecurityMember_doc" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:label="afya_ContributionForTheFinancingOfSocialSecurityMember_doc" xml:lang="en-US">The member represent tax.</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentAssets" xlink:to="ifrs-full_CurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentAssets_3_lbl" xml:lang="en-US">Current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTradeReceivable" xlink:to="afya_NoncurrentTradeReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTradeReceivable_2_lbl" xml:lang="en-US">NoncurrentTradeReceivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentAssets" xlink:to="ifrs-full_OtherNoncurrentAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentAssets_2_lbl" xml:lang="en-US">Other non-current assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentAssets" xlink:to="ifrs-full_NoncurrentAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentAssets_3_lbl" xml:lang="en-US">Non-current assets [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentLiabilities" xlink:to="ifrs-full_CurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentLiabilities_3_lbl" xml:lang="en-US">Current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LongtermBorrowings" xlink:to="ifrs-full_LongtermBorrowings_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LongtermBorrowings_2_lbl" xml:lang="en-US">Non-current portion of non-current borrowings</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentPayablesToRelatedParties" xlink:to="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentPayablesToRelatedParties_2_lbl" xml:lang="en-US">Non-current payables to related parties</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayableNonCurrentLiabiites" xlink:to="afya_NotesPayableNonCurrentLiabiites_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayableNonCurrentLiabiites_2_lbl" xml:lang="en-US">NotesPayableNonCurrentLiabiites</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentTaxesPayable" xlink:to="afya_NoncurrentTaxesPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentTaxesPayable_2_lbl" xml:lang="en-US">NoncurrentTaxesPayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherNoncurrentLiabilities" xlink:to="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherNoncurrentLiabilities_2_lbl" xml:lang="en-US">Other non-current liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentLiabilities" xlink:to="ifrs-full_NoncurrentLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentLiabilities_3_lbl" xml:lang="en-US">Non-current liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Liabilities" xlink:to="ifrs-full_Liabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Liabilities_2_lbl" xml:lang="en-US">Liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TreasuryShares" xlink:to="ifrs-full_TreasuryShares_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TreasuryShares_2_lbl" xml:lang="en-US">Treasury shares [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EquityAttributableToOwnersOfParent" xlink:to="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent_2_lbl" xml:lang="en-US">Equity attributable to owners of parent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Equity" xlink:to="ifrs-full_Equity_5_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Equity_5_lbl" xml:lang="en-US">Equity [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_GeneralAndAdministrativeExpense" xlink:to="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_GeneralAndAdministrativeExpense_2_lbl" xml:lang="en-US">General and administrative expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceCosts" xlink:to="ifrs-full_FinanceCosts_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceCosts_3_lbl" xml:lang="en-US">Finance costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_FinanceIncomeCost" xlink:to="ifrs-full_FinanceIncomeCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_FinanceIncomeCost_2_lbl" xml:lang="en-US">Finance income (cost)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncomeLossBeforeIncomeTaxes" xlink:to="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncomeLossBeforeIncomeTaxes_2_lbl" xml:lang="en-US">IncomeLossBeforeIncomeTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Adjustments for gain (loss) on disposals, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisposalsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_DisposalsIntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisposalsIntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Disposals, intangible assets and goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:to="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ShareOfIncomeOfAssociateOfOpeartingActivities_2_lbl" xml:lang="en-US">ShareOfIncomeOfAssociateOfOpeartingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForProvisions" xlink:to="ifrs-full_AdjustmentsForProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForProvisions_2_lbl" xml:lang="en-US">Adjustments for provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in trade accounts receivable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in inventories</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseDecreaseInRecoverableTaxes" xlink:to="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseDecreaseInRecoverableTaxes_2_lbl" xml:lang="en-US">IncreaseDecreaseInRecoverableTaxes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in other assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable_2_lbl" xml:lang="en-US">Adjustments for increase (decrease) in trade accounts payable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers_2_lbl" xml:lang="en-US">Adjustments for decrease (increase) in loans and advances to customers</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems_2_lbl" xml:lang="en-US">Other adjustments for non-cash items</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities_2_lbl" xml:lang="en-US">Adjustments for increase (decrease) in other liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:to="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLoss_2_lbl" xml:lang="en-US">Adjustments to reconcile profit (loss)</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities_2_lbl" xml:lang="en-US">Income taxes paid (refund), classified as operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) operating activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of property, plant and equipment, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of intangible assets, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashOfInvestingActivities" xlink:to="afya_RestrictedCashOfInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedCashOfInvestingActivities_2_lbl" xml:lang="en-US">RestrictedCashOfInvestingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:to="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities_2_lbl" xml:lang="en-US">Purchase of other long-term assets, classified as investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) investing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Repayments of borrowings, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Payments of lease liabilities, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CapitalIncreaseOfFinancialActivities" xlink:to="afya_CapitalIncreaseOfFinancialActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CapitalIncreaseOfFinancialActivities_2_lbl" xml:lang="en-US">CapitalIncreaseOfFinancialActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities_2_lbl" xml:lang="en-US">Dividends paid, classified as financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_PaymentsForShareIssueCosts" xlink:to="ifrs-full_PaymentsForShareIssueCosts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_PaymentsForShareIssueCosts_2_lbl" xml:lang="en-US">Payments for share issue costs</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities_2_lbl" xml:lang="en-US">Cash flows from (used in) financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:to="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents_2_lbl" xml:lang="en-US">Effect of exchange rate changes on cash and cash equivalents</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalents_3_lbl" xml:lang="en-US">Increase (decrease) in cash and cash equivalents after effect of exchange rate changes</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:to="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory_2_lbl" xml:lang="en-US">Disclosure of cash and cash equivalents [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:to="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory_2_lbl" xml:lang="en-US">Disclosure of trade and other receivables [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:to="ifrs-full_DisclosureOfOtherAssetsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfOtherAssetsExplanatory_2_lbl" xml:lang="en-US">Disclosure of other assets [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:to="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfJointVenturesExplanatory_2_lbl" xml:lang="en-US">Disclosure of joint ventures [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:to="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory_2_lbl" xml:lang="en-US">Disclosure of property, plant and equipment [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LaborAndSocialObligationsExplanatory" xlink:to="afya_LaborAndSocialObligationsExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LaborAndSocialObligationsExplanatory_2_lbl" xml:lang="en-US">LaborAndSocialObligationsExplanatory</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:to="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_2_lbl" xml:lang="en-US">Disclosure of share capital, reserves and other equity interest [text block]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfMedphoneTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfFcmpbTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfUnigranTableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfUnigranTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfRXPROTableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfRXPROTableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfUnisl1TableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfPebmed1TableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:to="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ScheduleOfAcquisitionOfFesar1TableTextBlock_2_lbl" xml:lang="en-US">ScheduleOfAcquisitionOfFesar1TableTextBlock</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:to="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_2_lbl" xml:lang="en-US">Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:to="ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_InventoryRecognisedAsOfAcquisitionDate_2_lbl" xml:lang="en-US">Inventory recognised as of acquisition date</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayables" xlink:to="afya_NotesPayables_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayables_4_lbl" xml:lang="en-US">NotesPayables</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:to="afya_AllowanceForDoubtfulAccountsFoReceivable1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccountsFoReceivable1_2_lbl" xml:lang="en-US">AllowanceForDoubtfulAccountsFoReceivable1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:to="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets_3_lbl" xml:lang="en-US">Allowance account for credit losses of financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeReceivablesRelatedPartyTransactions" xlink:to="afya_TradeReceivablesRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeReceivablesRelatedPartyTransactions_2_lbl" xml:lang="en-US">TradeReceivablesRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CreditsWithShareholdersRelatedPartyTransactions" xlink:to="afya_CreditsWithShareholdersRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CreditsWithShareholdersRelatedPartyTransactions_2_lbl" xml:lang="en-US">CreditsWithShareholdersRelatedPartyTransactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssetsOfRelatedParty1" xlink:to="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssetsOfRelatedParty1_2_lbl" xml:lang="en-US">NoncurrentAssetsOfRelatedParty1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholders" xlink:to="afya_AccountsPayableToSellingShareholders_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholders_2_lbl" xml:lang="en-US">AccountsPayableToSellingShareholders</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:to="ifrs-full_AmountsPayableRelatedPartyTransactions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountsPayableRelatedPartyTransactions_2_lbl" xml:lang="en-US">Amounts payable, related party transactions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableCurrent1" xlink:to="afya_AccountsPayableCurrent1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableCurrent1_2_lbl" xml:lang="en-US">AccountsPayableCurrent1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentPayablesToRelatedParties1" xlink:to="afya_NoncurrentPayablesToRelatedParties1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentPayablesToRelatedParties1_2_lbl" xml:lang="en-US">NoncurrentPayablesToRelatedParties1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:to="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_2_lbl" xml:lang="en-US">Amount incurred by entity for provision of key management personnel services provided by separate management entity</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OperatingLeaseTermOfContract" xlink:to="afya_OperatingLeaseTermOfContract_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OperatingLeaseTermOfContract_2_lbl" xml:lang="en-US">OperatingLeaseTermOfContract</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DescriptionOfLeaseTerms" xlink:to="afya_DescriptionOfLeaseTerms_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DescriptionOfLeaseTerms_2_lbl" xml:lang="en-US">DescriptionOfLeaseTerms</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherAssets1" xlink:to="afya_OtherAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherAssets1_2_lbl" xml:lang="en-US">OtherAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Assets1" xlink:to="afya_Assets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Assets1_2_lbl" xml:lang="en-US">Assets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentAssets1" xlink:to="afya_CurrentAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentAssets1_2_lbl" xml:lang="en-US">CurrentAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentAssets1" xlink:to="afya_NoncurrentAssets1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentAssets1_2_lbl" xml:lang="en-US">NoncurrentAssets1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EquityInAssociate" xlink:to="afya_EquityInAssociate_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EquityInAssociate_2_lbl" xml:lang="en-US">EquityInAssociate</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_DividendsReceived1" xlink:to="afya_DividendsReceived1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_DividendsReceived1_2_lbl" xml:lang="en-US">DividendsReceived1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Additions other than through business combinations, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Acquisitions through business combinations, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:to="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationPropertyPlantAndEquipment_2_lbl" xml:lang="en-US">Depreciation, property, plant and equipment</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IntangibleAssetsAndGoodwill" xlink:to="ifrs-full_IntangibleAssetsAndGoodwill_4_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IntangibleAssetsAndGoodwill_4_lbl" xml:lang="en-US">Intangible assets and goodwill [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:to="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_2_lbl" xml:lang="en-US">Additions other than through business combinations, intangible assets other than goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_2_lbl" xml:lang="en-US">Acquisitions through business combinations, intangible assets and goodwill</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialAssets" xlink:to="ifrs-full_CurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialAssets_2_lbl" xml:lang="en-US">Current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialAssets" xlink:to="ifrs-full_NoncurrentFinancialAssets_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialAssets_2_lbl" xml:lang="en-US">Non-current financial assets</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:to="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TradeAndOtherPayablesToTradeSuppliers_2_lbl" xml:lang="en-US">Trade payables [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing" xlink:to="afya_LoansAndFinancing_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancing_3_lbl" xml:lang="en-US">LoansAndFinancing</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_LeaseLiabilities" xlink:to="ifrs-full_LeaseLiabilities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_LeaseLiabilities_3_lbl" xml:lang="en-US">Lease liabilities [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayable" xlink:to="afya_NotePayable_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayable_2_lbl" xml:lang="en-US">NotePayable</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Advances" xlink:to="ifrs-full_Advances_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Advances_2_lbl" xml:lang="en-US">Advances received, representing contract liabilities for performance obligations satisfied at point in time</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_CurrentFinancialLiabilities" xlink:to="ifrs-full_CurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_CurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NoncurrentFinancialLiabilities" xlink:to="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NoncurrentFinancialLiabilities_2_lbl" xml:lang="en-US">Non-current financial liabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancing1" xlink:to="afya_LoansAndFinancing1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancing1_2_lbl" xml:lang="en-US">LoansAndFinancing1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingCurrent" xlink:to="afya_LoansAndFinancingCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingCurrent_3_lbl" xml:lang="en-US">LoansAndFinancingCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingNonCurrent" xlink:to="afya_LoansAndFinancingNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingNonCurrent_3_lbl" xml:lang="en-US">LoansAndFinancingNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesRightToUse" xlink:to="afya_LeaseLiabilitiesRightToUse_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesRightToUse_2_lbl" xml:lang="en-US">LeaseLiabilitiesRightToUse</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitieRightToUse" xlink:to="afya_LeaseLiabilitieRightToUse_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitieRightToUse_2_lbl" xml:lang="en-US">LeaseLiabilitieRightToUse</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedParties1" xlink:to="afya_TradeAndOtherPayablesToRelatedParties1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherPayablesToRelatedParties1_2_lbl" xml:lang="en-US">TradeAndOtherPayablesToRelatedParties1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersCurrent_3_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:to="afya_AccountsPayableToSellingShareholdersNonCurrent_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersNonCurrent_3_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersNonCurrent</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:to="afya_AccountsPayableToSellingShareholdersBusinessCombinations_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AccountsPayableToSellingShareholdersBusinessCombinations_3_lbl" xml:lang="en-US">AccountsPayableToSellingShareholdersBusinessCombinations</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_EqualInstallmentsPayablesToRelatedParties1" xlink:to="afya_EqualInstallmentsPayablesToRelatedParties1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_EqualInstallmentsPayablesToRelatedParties1_2_lbl" xml:lang="en-US">EqualInstallmentsPayablesToRelatedParties1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_CurrentLiabilities1" xlink:to="afya_CurrentLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_CurrentLiabilities1_2_lbl" xml:lang="en-US">CurrentLiabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NoncurrentLiabilities1" xlink:to="afya_NoncurrentLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NoncurrentLiabilities1_2_lbl" xml:lang="en-US">NoncurrentLiabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotePayables" xlink:to="afya_NotePayables_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotePayables_3_lbl" xml:lang="en-US">DerivativeLiabilitiesCrossCurrencyInterestRateSwaps [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through financing cash flows, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:to="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_3_lbl" xml:lang="en-US">IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:to="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_2_lbl" xml:lang="en-US">Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_NotesPayable1" xlink:to="afya_NotesPayable1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_NotesPayable1_2_lbl" xml:lang="en-US">NotesPayable1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LoansAndFinancingLiabilities" xlink:to="afya_LoansAndFinancingLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LoansAndFinancingLiabilities_2_lbl" xml:lang="en-US">LoansAndFinancingLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilities1" xlink:to="afya_LeaseLiabilities1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilities1_2_lbl" xml:lang="en-US">LeaseLiabilities1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:to="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_TradeAndOtherPayablesToRelatedPartiesLiabilities_2_lbl" xml:lang="en-US">TradeAndOtherPayablesToRelatedPartiesLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayables1" xlink:to="afya_FairValueNotesPayables1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueNotesPayables1_2_lbl" xml:lang="en-US">FairValueNotesPayables1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_RestrictedCashAndCashEquivalents1" xlink:to="afya_RestrictedCashAndCashEquivalents1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_RestrictedCashAndCashEquivalents1_2_lbl" xml:lang="en-US">RestrictedCashAndCashEquivalents1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseLiabilitiesOne" xlink:to="afya_LeaseLiabilitiesOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseLiabilitiesOne_2_lbl" xml:lang="en-US">LeaseLiabilitiesOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FairValueNotesPayablesLiabilities" xlink:to="afya_FairValueNotesPayablesLiabilities_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FairValueNotesPayablesLiabilities_2_lbl" xml:lang="en-US">FairValueNotesPayablesLiabilities</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NotesAndDebenturesIssued" xlink:to="ifrs-full_NotesAndDebenturesIssued_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NotesAndDebenturesIssued_2_lbl" xml:lang="en-US">Notes and debentures issued</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:to="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_StrikePriceeAtMeasurementDateShareOptionsGrante_2_lbl" xml:lang="en-US">StrikePriceeAtMeasurementDateShareOptionsGrante</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:to="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_3_lbl" xml:lang="en-US">Weighted average exercise price of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfOutstandingShareOptions" xlink:to="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfOutstandingShareOptions_3_lbl" xml:lang="en-US">Number of share options outstanding in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options forfeited in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options exercised in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:to="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_2_lbl" xml:lang="en-US">Number of share options expired in share-based payment arrangement</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:to="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees_2_lbl" xml:lang="en-US">Expense from share-based payment transactions with employees</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_OtherRevenue1" xlink:to="afya_OtherRevenue1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_OtherRevenue1_2_lbl" xml:lang="en-US">OtherRevenue1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProfessionalFeesExpense1" xlink:to="afya_ProfessionalFeesExpense1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProfessionalFeesExpense1_2_lbl" xml:lang="en-US">ProfessionalFeesExpense1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherRevenue" xlink:to="ifrs-full_OtherRevenue_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherRevenue_2_lbl" xml:lang="en-US">Other revenue</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_ExpenseByNature" xlink:to="ifrs-full_ExpenseByNature_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_ExpenseByNature_2_lbl" xml:lang="en-US">Expenses, by nature</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_DepreciationExpense" xlink:to="ifrs-full_DepreciationExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_DepreciationExpense_2_lbl" xml:lang="en-US">Depreciation expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_LeaseExpenses" xlink:to="afya_LeaseExpenses_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_LeaseExpenses_2_lbl" xml:lang="en-US">LeaseExpenses</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_SharesBasedCompensation" xlink:to="afya_SharesBasedCompensation_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_SharesBasedCompensation_2_lbl" xml:lang="en-US">SharesBasedCompensation</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AllowanceForDoubtfulAccounts" xlink:to="afya_AllowanceForDoubtfulAccounts_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AllowanceForDoubtfulAccounts_2_lbl" xml:lang="en-US">AllowanceForDoubtfulAccounts</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_Other" xlink:to="afya_Other_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_Other_2_lbl" xml:lang="en-US">Other [Default Label]</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ExpenseByNatureOne" xlink:to="afya_ExpenseByNatureOne_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ExpenseByNatureOne_2_lbl" xml:lang="en-US">ExpenseByNatureOne</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceIncome" xlink:to="ifrs-full_OtherFinanceIncome_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceIncome_2_lbl" xml:lang="en-US">Other finance income</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_NetForeignExchangeLoss" xlink:to="ifrs-full_NetForeignExchangeLoss_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_NetForeignExchangeLoss_2_lbl" xml:lang="en-US">Net foreign exchange loss</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherFinanceCost" xlink:to="ifrs-full_OtherFinanceCost_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherFinanceCost_2_lbl" xml:lang="en-US">Other finance cost</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_FinanceResult" xlink:to="afya_FinanceResult_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_FinanceResult_2_lbl" xml:lang="en-US">FinanceResult</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:to="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_TaxExpenseOtherThanIncomeTaxExpense_2_lbl" xml:lang="en-US">Tax expense other than income tax expense</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapital2" xlink:to="afya_IssuedCapital2_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IssuedCapital2_2_lbl" xml:lang="en-US">IssuedCapital2</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_AdditionalPaidinCapital1" xlink:to="afya_AdditionalPaidinCapital1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_AdditionalPaidinCapital1_2_lbl" xml:lang="en-US">AdditionalPaidinCapital1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_IssuedCapital1" xlink:to="afya_IssuedCapital1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_IssuedCapital1_2_lbl" xml:lang="en-US">IssuedCapital1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="afya_ProceedsFromIssueOfOrdinaryShares1" xlink:to="afya_ProceedsFromIssueOfOrdinaryShares1_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="afya_ProceedsFromIssueOfOrdinaryShares1_2_lbl" xml:lang="en-US">ProceedsFromIssueOfOrdinaryShares1</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_Provisions" xlink:to="ifrs-full_Provisions_3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_Provisions_3_lbl" xml:lang="en-US">Provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:to="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions_2_lbl" xml:lang="en-US">Acquisitions through business combinations, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_AdditionalProvisionsOtherProvisions" xlink:to="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_AdditionalProvisionsOtherProvisions_2_lbl" xml:lang="en-US">Additional provisions, other provisions</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ifrs-full_OtherProvisions" xlink:to="ifrs-full_OtherProvisions_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ifrs-full_OtherProvisions_2_lbl" xml:lang="en-US">Other provisions</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>38
<FILENAME>afya-20211231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.13a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://afya.com.br/role/Cover" xlink:href="afya-20211231.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:href="afya-20211231.xsd#StatementsOfFinancialPosition" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:href="afya-20211231.xsd#StatementsOfIncomeAndComprehensiveIncome" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:href="afya-20211231.xsd#StatementsOfChangesInEquity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/StatementsOfCashFlows" xlink:href="afya-20211231.xsd#StatementsOfCashFlows" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformation" xlink:href="afya-20211231.xsd#CorporateInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:href="afya-20211231.xsd#SignificantAccountingEstimatesAndAssumptions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformation" xlink:href="afya-20211231.xsd#SegmentInformation" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinations" xlink:href="afya-20211231.xsd#BusinessCombinations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalents" xlink:href="afya-20211231.xsd#CashAndCashEquivalents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivables" xlink:href="afya-20211231.xsd#TradeReceivables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedParties" xlink:href="afya-20211231.xsd#RelatedParties" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssets" xlink:href="afya-20211231.xsd#OtherAssets" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociate" xlink:href="afya-20211231.xsd#InvestmentInAssociate" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipment" xlink:href="afya-20211231.xsd#PropertyAndEquipment" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwill" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilities" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurement" xlink:href="afya-20211231.xsd#FairValueMeasurement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagement" xlink:href="afya-20211231.xsd#CapitalManagement" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligations" xlink:href="afya-20211231.xsd#LaborAndSocialObligations" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Equity" xlink:href="afya-20211231.xsd#Equity" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEps" xlink:href="afya-20211231.xsd#EarningsPerShareEps" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Revenue" xlink:href="afya-20211231.xsd#Revenue" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNature" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResult" xlink:href="afya-20211231.xsd#FinanceResult" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxes" xlink:href="afya-20211231.xsd#IncomeTaxes" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingencies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/Non-cashTransactions" xlink:href="afya-20211231.xsd#Non-cashTransactions" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEvents" xlink:href="afya-20211231.xsd#SubsequentEvents" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesPolicies" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SegmentInformationTables" xlink:href="afya-20211231.xsd#SegmentInformationTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsTables" xlink:href="afya-20211231.xsd#BusinessCombinationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TradeReceivablesTables" xlink:href="afya-20211231.xsd#TradeReceivablesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesTables" xlink:href="afya-20211231.xsd#RelatedPartiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsTables" xlink:href="afya-20211231.xsd#OtherAssetsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InvestmentInAssociateTables" xlink:href="afya-20211231.xsd#InvestmentInAssociateTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:href="afya-20211231.xsd#PropertyAndEquipmentTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValueMeasurementTables" xlink:href="afya-20211231.xsd#FairValueMeasurementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CapitalManagementTables" xlink:href="afya-20211231.xsd#CapitalManagementTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityTables" xlink:href="afya-20211231.xsd#EquityTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:href="afya-20211231.xsd#EarningsPerShareEpsTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RevenueTables" xlink:href="afya-20211231.xsd#RevenueTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:href="afya-20211231.xsd#ExpensesAndCostsByNatureTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinanceResultTables" xlink:href="afya-20211231.xsd#FinanceResultTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesTables" xlink:href="afya-20211231.xsd#IncomeTaxesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesTables" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:href="afya-20211231.xsd#CorporateInformationDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:href="afya-20211231.xsd#TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:href="afya-20211231.xsd#DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:href="afya-20211231.xsd#ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:href="afya-20211231.xsd#SignificantAccountingPoliciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUniredentorDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfUnislDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfPebmedDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFesarDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfMedphoneDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:href="afya-20211231.xsd#ScheduleOfAcquisitionOfFcmpbDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:href="afya-20211231.xsd#ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:href="afya-20211231.xsd#FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfCashAndCashEquivalentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:href="afya-20211231.xsd#BusinessCombinationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:href="afya-20211231.xsd#ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:href="afya-20211231.xsd#ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:href="afya-20211231.xsd#TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:href="afya-20211231.xsd#CashAndCashEquivalentsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:href="afya-20211231.xsd#KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:href="afya-20211231.xsd#RelatedPartiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfOtherAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:href="afya-20211231.xsd#ScheduleOfInvestmentsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfIntangibleAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:href="afya-20211231.xsd#ScheduleOfAssumptionsForImpairmentTestDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:href="afya-20211231.xsd#OtherAssetsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:href="afya-20211231.xsd#ScheduleOfEstimatedUsefulLivesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialAssetsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinancialLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:href="afya-20211231.xsd#ScheduleOfLoansAndFinancingDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:href="afya-20211231.xsd#IntangibleAssetsAndGoodwillDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:href="afya-20211231.xsd#ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:href="afya-20211231.xsd#SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:href="afya-20211231.xsd#TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:href="afya-20211231.xsd#ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:href="afya-20211231.xsd#TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:href="afya-20211231.xsd#ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:href="afya-20211231.xsd#FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:href="afya-20211231.xsd#ScheduleOfFairValueMeasurementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfCapitalManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:href="afya-20211231.xsd#ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:href="afya-20211231.xsd#ScheduleOfShare-basedCompensationPlanDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:href="afya-20211231.xsd#LaborAndSocialObligationsDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:href="afya-20211231.xsd#ScheduleOfEarningsPerShareDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:href="afya-20211231.xsd#ScheduleOfNetSalesRevenueDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:href="afya-20211231.xsd#ScheduleOfRevenueBySegmentDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:href="afya-20211231.xsd#ScheduleOfExpensesByNatureDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:href="afya-20211231.xsd#ScheduleOfFinanceResultDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:href="afya-20211231.xsd#ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/EquityDetailsNarrative" xlink:href="afya-20211231.xsd#EquityDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:href="afya-20211231.xsd#ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:href="afya-20211231.xsd#ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:href="afya-20211231.xsd#IncomeTaxesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:href="afya-20211231.xsd#InsuranceContractsAndContingenciesDetailsNarrative" xlink:type="simple" />
    <link:roleRef roleURI="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:href="afya-20211231.xsd#SubsequentEventsDetailsNarrative" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesTable" xlink:label="loc_deiEntityAddressesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesLineItems" xlink:label="loc_deiEntityAddressesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="loc_deiEntityAddressesAddressTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_deiEntityAddressesAddressTypeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AddressTypeDomain" xlink:label="loc_deiAddressTypeDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesAddressTypeAxis" xlink:to="loc_deiAddressTypeDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_BusinessContactMember" xlink:label="loc_deiBusinessContactMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiAddressTypeDomain" xlink:to="loc_deiBusinessContactMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelName" xlink:label="loc_deiContactPersonnelName" />
      <link:presentationArc order="580" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_ContactPersonnelEmailAddress" xlink:label="loc_deiContactPersonnelEmailAddress" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiContactPersonnelEmailAddress" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="loc_deiIcfrAuditorAttestationFlag" />
      <link:presentationArc order="600" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiIcfrAuditorAttestationFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="loc_deiAuditorFirmId" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorFirmId" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="loc_deiAuditorName" />
      <link:presentationArc order="620" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="loc_deiAuditorLocation" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityAddressesLineItems" xlink:to="loc_deiAuditorLocation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfFinancialPosition" xlink:title="00000002 - Statement - Consolidated statements of financial position">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="loc_ifrs-fullStatementOfFinancialPositionAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssetsAbstract" xlink:label="loc_ifrs-fullAssetsAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="loc_ifrs-fullCurrentAssetsAbstract" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAssetsAbstract" xlink:to="loc_ifrs-fullCurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Inventories" xlink:label="loc_ifrs-fullInventories" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullInventories" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxAssets" xlink:label="loc_ifrs-fullCurrentTaxAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentAssets" xlink:label="loc_ifrs-fullOtherCurrentAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherCurrentAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentAssetsAbstract" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="loc_ifrs-fullNoncurrentAssetsAbstract" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentRestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullNoncurrentRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentRestrictedCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTradeReceivable" xlink:label="loc_afyaNoncurrentTradeReceivable" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_afyaNoncurrentTradeReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentAssets" xlink:label="loc_ifrs-fullOtherNoncurrentAssets" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentAssetsAbstract" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="loc_ifrs-fullLiabilitiesAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullCurrentLiabilitiesAbstract" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayables" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShorttermBorrowings" xlink:label="loc_ifrs-fullShorttermBorrowings" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullShorttermBorrowings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullTradeAndOtherCurrentPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayableCurrent" xlink:label="loc_afyaNotePayableCurrent" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_afyaNotePayableCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentDepositsFromCustomers" xlink:label="loc_ifrs-fullCurrentDepositsFromCustomers" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentDepositsFromCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:label="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentRecognisedLiabilitiesDefinedBenefitPlan" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentTaxesPayable" xlink:label="loc_afyaCurrentTaxesPayable" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_afyaCurrentTaxesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentTaxLiabilitiesCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherCurrentLiabilities" xlink:label="loc_ifrs-fullOtherCurrentLiabilities" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherCurrentLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="loc_ifrs-fullNoncurrentLiabilitiesAbstract" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermBorrowings" xlink:label="loc_ifrs-fullLongtermBorrowings" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermBorrowings" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesToRelatedParties" xlink:label="loc_ifrs-fullNoncurrentPayablesToRelatedParties" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableNonCurrentLiabiites" xlink:label="loc_afyaNotesPayableNonCurrentLiabiites" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_afyaNotesPayableNonCurrentLiabiites" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentTaxesPayable" xlink:label="loc_afyaNoncurrentTaxesPayable" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_afyaNoncurrentTaxesPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LongtermLegalProceedingsProvision" xlink:label="loc_ifrs-fullLongtermLegalProceedingsProvision" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullLongtermLegalProceedingsProvision" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherNoncurrentLiabilities" xlink:label="loc_ifrs-fullOtherNoncurrentLiabilities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullOtherNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullNoncurrentLiabilitiesAbstract" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Liabilities" xlink:label="loc_ifrs-fullLiabilities" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAbstract" xlink:label="loc_ifrs-fullEquityAbstract" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapital" xlink:label="loc_ifrs-fullAdditionalPaidinCapital" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullAdditionalPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPayments" xlink:label="loc_ifrs-fullReserveOfSharebasedPayments" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullReserveOfSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasuryShares" xlink:label="loc_ifrs-fullTreasuryShares" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullTreasuryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarnings" xlink:label="loc_ifrs-fullRetainedEarnings" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullRetainedEarnings" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParent" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterests" xlink:label="loc_ifrs-fullNoncontrollingInterests" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEquityAbstract" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfFinancialPositionAbstract" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome" xlink:title="00000003 - Statement - Consolidated statements of income and comprehensive income">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="loc_ifrs-fullIncomeStatementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherIncome" xlink:label="loc_ifrs-fullOtherIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncomeCost" xlink:label="loc_ifrs-fullFinanceIncomeCost" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullFinanceIncomeCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:label="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherComprehensiveIncome" xlink:label="loc_ifrs-fullOtherComprehensiveIncome" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullOtherComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToAbstract" xlink:label="loc_ifrs-fullProfitLossAttributableToAbstract" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToOwnersOfParent" xlink:label="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToOwnersOfParent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossAttributableToNoncontrollingInterests" xlink:label="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProfitLossAttributableToAbstract" xlink:to="loc_ifrs-fullProfitLossAttributableToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsPerShareAbstract" xlink:label="loc_ifrs-fullBasicEarningsPerShareAbstract" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBasicEarningsPerShareAbstract" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="loc_ifrs-fullDilutedEarningsPerShareAbstract" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIncomeStatementAbstract" xlink:to="loc_ifrs-fullDilutedEarningsPerShareAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDilutedEarningsPerShareAbstract" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfChangesInEquity" xlink:title="00000004 - Statement - Consolidated statements of changes in equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="loc_ifrs-fullStatementOfChangesInEquityAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityAbstract" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="loc_ifrs-fullComponentsOfEquityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullComponentsOfEquityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityMember" xlink:label="loc_ifrs-fullEquityMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityMember" order="100" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapitalMember" xlink:label="loc_ifrs-fullIssuedCapitalMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullIssuedCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalPaidinCapitalMember" xlink:label="loc_ifrs-fullAdditionalPaidinCapitalMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullAdditionalPaidinCapitalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TreasurySharesMember" xlink:label="loc_ifrs-fullTreasurySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullTreasurySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ReserveOfSharebasedPaymentsMember" xlink:label="loc_ifrs-fullReserveOfSharebasedPaymentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullReserveOfSharebasedPaymentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReservesMember" xlink:label="loc_ifrs-fullOtherReservesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullOtherReservesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RetainedEarningsReserveMember" xlink:label="loc_afyaRetainedEarningsReserveMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_afyaRetainedEarningsReserveMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RetainedEarningsMember" xlink:label="loc_ifrs-fullRetainedEarningsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullRetainedEarningsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullEquityAttributableToOwnersOfParentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncontrollingInterestsMember" xlink:label="loc_ifrs-fullNoncontrollingInterestsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullComponentsOfEquityAxis" xlink:to="loc_ifrs-fullNoncontrollingInterestsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComprehensiveIncome" xlink:label="loc_ifrs-fullComprehensiveIncome" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullComprehensiveIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithCash" xlink:label="loc_afyaCapitalIncreaseWithCash" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherContributionsByOwners" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherContributionsByOwners" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseFromCorporateReorganization" xlink:label="loc_afyaCapitalIncreaseFromCorporateReorganization" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseFromCorporateReorganization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughSharebasedPaymentTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllocationToAdditionalPaidinCapital" xlink:label="loc_afyaAllocationToAdditionalPaidinCapital" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllocationToAdditionalPaidinCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaid" xlink:label="loc_ifrs-fullDividendsPaid" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaid" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsCancelled" xlink:label="loc_afyaDividendsCancelled" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsCancelled" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CorporateReorganization" xlink:label="loc_afyaCorporateReorganization" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCorporateReorganization" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssueOfEquity" xlink:label="loc_ifrs-fullIssueOfEquity" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssueOfEquity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-fullShareIssueRelatedCost" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullShareIssueRelatedCost" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromExerciseOfOptions" xlink:label="loc_afyaTreasurySharesTransferredFromExerciseOfOptions" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromExerciseOfOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:label="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTreasurySharesTransferredFromSharesContributionOnBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsDeclaredToNoncontrollingInterests" xlink:label="loc_afyaDividendsDeclaredToNoncontrollingInterests" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsDeclaredToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity_2" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/StatementsOfCashFlows" xlink:title="00000005 - Statement - Consolidated statements of cash flows">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="loc_ifrs-fullStatementOfCashFlowsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncomeLossBeforeIncomeTaxes" xlink:label="loc_afyaIncomeLossBeforeIncomeTaxes" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_afyaIncomeLossBeforeIncomeTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForDepreciationAndAmortisationExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullDisposalsIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullDisposalsIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:label="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAllowanceForDoubtfulAccountsOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments" xlink:label="loc_ifrs-fullAdjustmentsForSharebasedPayments" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForSharebasedPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:label="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForUnrealisedForeignExchangeLossesGains" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForFinanceCosts" xlink:label="loc_ifrs-fullAdjustmentsForFinanceCosts" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForFinanceCosts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccruedInterestOfOpeartingActivities" xlink:label="loc_afyaAccruedInterestOfOpeartingActivities" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaAccruedInterestOfOpeartingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareOfIncomeOfAssociateOfOpeartingActivities" xlink:label="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaShareOfIncomeOfAssociateOfOpeartingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="loc_ifrs-fullAdjustmentsForProvisions" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullAdjustmentsForProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseDecreaseInOperatingLiabilities1Abstract" xlink:label="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInInventories" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseDecreaseInRecoverableTaxes" xlink:label="loc_afyaIncreaseDecreaseInRecoverableTaxes" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_afyaIncreaseDecreaseInRecoverableTaxes" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInOtherAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncomeTaxExpense" xlink:label="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncomeTaxExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:label="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems" xlink:label="loc_ifrs-fullOtherAdjustmentsForNoncashItems" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullOtherAdjustmentsForNoncashItems" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:label="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForReconcileProfitLoss" xlink:label="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIncreaseDecreaseInOperatingLiabilities1Abstract" xlink:to="loc_ifrs-fullAdjustmentsForReconcileProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:label="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAdjustmentsForReconcileProfitLossAbstract" xlink:to="loc_ifrs-fullIncomeTaxesPaidRefundClassifiedAsOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInOperatingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInOperatingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashOfInvestingActivities" xlink:label="loc_afyaRestrictedCashOfInvestingActivities" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaRestrictedCashOfInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaymentsOfNotesPayable" xlink:label="loc_afyaPaymentsOfNotesPayable" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_afyaPaymentsOfNotesPayable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:label="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullPurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAdvancesAndLoansFromRelatedParties" xlink:label="loc_ifrs-fullCashAdvancesAndLoansFromRelatedParties" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullCashAdvancesAndLoansFromRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInInvestingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInInvestingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuanceOfLoansAndFinancing" xlink:label="loc_afyaIssuanceOfLoansAndFinancing" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaIssuanceOfLoansAndFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullRepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TreasuryShares1" xlink:label="loc_afyaTreasuryShares1" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaTreasuryShares1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseOfFinancialActivities" xlink:label="loc_afyaCapitalIncreaseOfFinancialActivities" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaCapitalIncreaseOfFinancialActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullDividendsPaidClassifiedAsFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:label="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullProceedsFromGovernmentGrantsClassifiedAsFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharebasedCompensationPlanReceipts" xlink:label="loc_afyaSharebasedCompensationPlanReceipts" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_afyaSharebasedCompensationPlanReceipts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsForShareIssueCosts" xlink:label="loc_ifrs-fullPaymentsForShareIssueCosts" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullPaymentsForShareIssueCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullCashFlowsFromUsedInFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:label="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCashFlowsFromUsedInFinancingActivitiesAbstract" xlink:to="loc_ifrs-fullEffectOfExchangeRateChangesOnCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents_2" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfCashFlowsAbstract" xlink:to="loc_ifrs-fullCashAndCashEquivalents_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformation" xlink:title="00000006 - Disclosure - Corporate information">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForBusinessCombinationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPolicies" xlink:title="00000007 - Disclosure - Significant accounting policies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions" xlink:title="00000008 - Disclosure - Significant accounting estimates and assumptions">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" xlink:label="loc_afyaDisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SignificantAccountingEstimatesAndAssumptionsExplanatory" xlink:label="loc_afyaSignificantAccountingEstimatesAndAssumptionsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureSignificantAccountingEstimatesAndAssumptionsAbstract" xlink:to="loc_afyaSignificantAccountingEstimatesAndAssumptionsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformation" xlink:title="00000009 - Disclosure - Segment information">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfEntitysReportableSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinations" xlink:title="00000010 - Disclosure - Business combinations">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalents" xlink:title="00000011 - Disclosure - Cash and cash equivalents">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfCashAndCashEquivalentsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivables" xlink:title="00000012 - Disclosure - Trade receivables">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfTradeAndOtherReceivablesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedParties" xlink:title="00000013 - Disclosure - Related parties">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRelatedPartyExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfRelatedPartyExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssets" xlink:title="00000014 - Disclosure - Other assets">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOtherAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfOtherAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfOtherAssetsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociate" xlink:title="00000015 - Disclosure - Investment in associate">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfJointVenturesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfJointVenturesExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipment" xlink:title="00000016 - Disclosure - Property and equipment">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwill" xlink:title="00000017 - Disclosure - Intangible assets and goodwill">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities" xlink:title="00000018 - Disclosure - Financial assets and financial liabilities">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialInstrumentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialInstrumentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurement" xlink:title="00000019 - Disclosure - Fair value measurement">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueMeasurementExplanatory" xlink:label="loc_afyaFairValueMeasurementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_afyaFairValueMeasurementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagement" xlink:title="00000020 - Disclosure - Capital management">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="loc_afyaDisclosureCapitalManagementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalManagementExplanatory" xlink:label="loc_afyaCapitalManagementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaCapitalManagementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligations" xlink:title="00000021 - Disclosure - Labor and social obligations">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaLaborAndSocialObligationsExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Equity" xlink:title="00000022 - Disclosure - Equity">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:label="loc_ifrs-fullDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEps" xlink:title="00000023 - Disclosure - Earnings per share (EPS)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEarningsPerShareExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfEarningsPerShareExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Revenue" xlink:title="00000024 - Disclosure - Revenue">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfRevenueExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNature" xlink:title="00000025 - Disclosure - Expenses and costs by nature">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfExpensesByNatureExplanatory" xlink:label="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfExpensesByNatureExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResult" xlink:title="00000026 - Disclosure - Finance result">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory" xlink:label="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinanceIncomeExpenseExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxes" xlink:title="00000027 - Disclosure - Income taxes">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIncomeTaxExplanatory" xlink:label="loc_ifrs-fullDisclosureOfIncomeTaxExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIncomeTaxExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingencies" xlink:title="00000028 - Disclosure - Insurance contracts and contingencies">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfInsuranceContractsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfInsuranceContractsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfInsuranceContractsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/Non-cashTransactions" xlink:title="00000029 - Disclosure - Non-cash transactions">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureNoncashTransactionsAbstract" xlink:label="loc_afyaDisclosureNoncashTransactionsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureNoncashTransactionsExplanatory" xlink:label="loc_afyaDisclosureNoncashTransactionsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureNoncashTransactionsAbstract" xlink:to="loc_afyaDisclosureNoncashTransactionsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEvents" xlink:title="00000030 - Disclosure - Subsequent events">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory" xlink:label="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfEventsAfterReportingPeriodExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesPolicies" xlink:title="00000031 - Disclosure - Significant accounting policies (Policies)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombinationsAndGoodwillPolicyExplanatory" xlink:label="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaBusinessCombinationsAndGoodwillPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:label="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaCurrentVersusNoncurrentClassificationPoliciesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForFairValueMeasurementExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:label="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForMeasuringInventories" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForMeasuringInventories" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:label="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaImpairmentOfNonfinancialAssetsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PolicyExplanatoryInvestments" xlink:label="loc_afyaPolicyExplanatoryInvestments" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaPolicyExplanatoryInvestments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersPolicyExplanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAccountsPayableToSellingShareholdersPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:label="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDescriptionOfAccountingPolicyForProvisionsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPayablePolicyExplanatory" xlink:label="loc_afyaDividendsPayablePolicyExplanatory" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDividendsPayablePolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsPolicyExplanatory" xlink:label="loc_afyaLaborAndSocialObligationsPolicyExplanatory" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLaborAndSocialObligationsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharebasedPaymentsPolicyExplanatory" xlink:label="loc_afyaSharebasedPaymentsPolicyExplanatory" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSharebasedPaymentsPolicyExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:label="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfRevenueFromContractsWithCustomersExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPolicyExplanation" xlink:label="loc_afyaTaxesPolicyExplanation" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaTaxesPolicyExplanation" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesTables" xlink:title="00000032 - Disclosure - Significant accounting policies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:label="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfEstimatedUsefulLives" xlink:label="loc_afyaScheduleOfEstimatedUsefulLives" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfEstimatedUsefulLives" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SegmentInformationTables" xlink:title="00000033 - Disclosure - Segment information (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:label="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsExplanatory" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsTables" xlink:title="00000034 - Disclosure - Business combinations (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HarbourMember" xlink:label="loc_afyaHarbourMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIFIPMocMember" xlink:label="loc_afyaUNIFIPMocMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIFIPMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIGRANMember" xlink:label="loc_afyaUNIGRANMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIGRANMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PXPROMember" xlink:label="loc_afyaPXPROMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDMember" xlink:label="loc_afyaPEBMEDMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPEBMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" xlink:label="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUniredentorTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUniredentorTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnislTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnislTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnislTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmedTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfPebmedTableTextBlock" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfPebmedTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesarTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFesarTableTextBlock" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFesarTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfMedphoneTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfMedphoneTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFcmpbTableTextBlock" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFcmpbTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnigranTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnigranTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfRXPROTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfRXPROTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" xlink:label="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfUnisl1TableTextBlock" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfUnisl1TableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfPebmed1TableTextBlock" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfPebmed1TableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:label="loc_afyaScheduleOfAcquisitionOfFesar1TableTextBlock" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaScheduleOfAcquisitionOfFesar1TableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsTables" xlink:title="00000035 - Disclosure - Cash and cash equivalents (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:label="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TradeReceivablesTables" xlink:title="00000036 - Disclosure - Trade receivables (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfTradeAndOtherReceivables1Explanatory" xlink:label="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDisclosureOfTradeAndOtherReceivables1Explanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:label="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDisclosureOfTradeAccountsReceivableByAgingExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsExplanatory" xlink:label="loc_afyaAllowanceForDoubtfulAccountsExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAllowanceForDoubtfulAccountsExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesTables" xlink:title="00000037 - Disclosure - Related parties (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfRelatedPartiesExplanatory" xlink:label="loc_afyaScheduleOfRelatedPartiesExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfRelatedPartiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:label="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfKeyManagementPersonnelCompensationTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsTables" xlink:title="00000038 - Disclosure - Other assets (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfOtherAssetsTableTextBlock" xlink:label="loc_afyaDisclosureOfOtherAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDisclosureOfOtherAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InvestmentInAssociateTables" xlink:title="00000039 - Disclosure - Investment in associate (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfInvestments" xlink:label="loc_afyaScheduleOfInvestments" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfInvestments" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/PropertyAndEquipmentTables" xlink:title="00000040 - Disclosure - Property and equipment (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillTables" xlink:title="00000041 - Disclosure - Intangible assets and goodwill (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:label="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:label="loc_afyaSummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables" xlink:title="00000042 - Disclosure - Financial assets and financial liabilities (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialAssetsExplanatory" xlink:label="loc_afyaFinancialAssetsExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFinancialAssetsExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialLiabilitiesExplanatory" xlink:label="loc_afyaFinancialLiabilitiesExplanatory" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFinancialLiabilitiesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingExplanatory" xlink:label="loc_afyaLoansAndFinancingExplanatory" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLoansAndFinancingExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeasesExplanatory" xlink:label="loc_afyaLeasesExplanatory" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeasesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersExplanatory" xlink:label="loc_afyaAccountsPayableToSellingShareholdersExplanatory" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAccountsPayableToSellingShareholdersExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:label="loc_afyaScheduleOfCarryingAmountOfNotesPayableTableTextBlock" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfCarryingAmountOfNotesPayableTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValuesExplanatory" xlink:label="loc_afyaFairValuesExplanatory" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFairValuesExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:label="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:label="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:label="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:label="loc_afyaChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValueMeasurementTables" xlink:title="00000043 - Disclosure - Fair value measurement (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfFairValueMeasurementExplanaory" xlink:label="loc_afyaScheduleOfFairValueMeasurementExplanaory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_afyaScheduleOfFairValueMeasurementExplanaory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CapitalManagementTables" xlink:title="00000044 - Disclosure - Capital management (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="loc_afyaDisclosureCapitalManagementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfCapitalManagementExplanatory" xlink:label="loc_afyaScheduleOfCapitalManagementExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaScheduleOfCapitalManagementExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsTables" xlink:title="00000045 - Disclosure - Labor and social obligations (Tables)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:label="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfModelUsedToDetermineFairValueOfStockOptions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfSharebasedCompensationPlan" xlink:label="loc_afyaScheduleOfSharebasedCompensationPlan" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_afyaScheduleOfSharebasedCompensationPlan" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityTables" xlink:title="00000046 - Disclosure - Equity (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfTreasurySharesMovement" xlink:label="loc_afyaScheduleOfTreasurySharesMovement" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfTreasurySharesMovement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EarningsPerShareEpsTables" xlink:title="00000047 - Disclosure - Earnings per share (EPS) (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureOfEarningsPerShareTableExplanatory" xlink:label="loc_afyaDisclosureOfEarningsPerShareTableExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDisclosureOfEarningsPerShareTableExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RevenueTables" xlink:title="00000048 - Disclosure - Revenue (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfNetSalesRevenueExplanatory" xlink:label="loc_afyaScheduleOfNetSalesRevenueExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfNetSalesRevenueExplanatory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfRevenueBySegment" xlink:label="loc_afyaScheduleOfRevenueBySegment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfRevenueBySegment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ExpensesAndCostsByNatureTables" xlink:title="00000049 - Disclosure - Expenses and costs by nature (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SummaryOfExpensesByNatureTableTextBlock" xlink:label="loc_afyaSummaryOfExpensesByNatureTableTextBlock" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSummaryOfExpensesByNatureTableTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinanceResultTables" xlink:title="00000050 - Disclosure - Finance result (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfFinanceResult" xlink:label="loc_afyaScheduleOfFinanceResult" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfFinanceResult" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesTables" xlink:title="00000051 - Disclosure - Income taxes (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:label="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfReconciliationOfIncomeTaxExpenseExplanatory" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesTables" xlink:title="00000052 - Disclosure - Insurance contracts and contingencies (Tables)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfLegalProceedingsAndContingencies" xlink:label="loc_afyaScheduleOfLegalProceedingsAndContingencies" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfLegalProceedingsAndContingencies" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:label="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaScheduleOfSocialSecurityProceedingsAssessedByManagement" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CorporateInformationDetailsNarrative" xlink:title="00000053 - Disclosure - Corporate information (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:label="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuardayaEmpreendimentosAndParticipacoesSAMember" xlink:label="loc_afyaGuardayaEmpreendimentosAndParticipacoesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaGuardayaEmpreendimentosAndParticipacoesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraAndCBBWebMember" xlink:label="loc_afyaMedcelEditoraAndCBBWebMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraAndCBBWebMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtdaMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiadaInformacaoLtdaMember" xlink:label="loc_afyaShospTecnologiadaInformacaoLtdaMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiadaInformacaoLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraodeEducacaoSuperiorLtdMember" xlink:label="loc_afyaSociedadePadraodeEducacaoSuperiorLtdMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraodeEducacaoSuperiorLtdMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesdeTecnologiaLtdaMember" xlink:label="loc_afyaRXPROSolucoesdeTecnologiaLtdaMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesdeTecnologiaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassACommonSharesMember" xlink:label="loc_afyaClassACommonSharesMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassACommonSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockAxis" xlink:label="loc_afyaSaleOfStockAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaSaleOfStockAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SaleOfStockDomain" xlink:label="loc_afyaSaleOfStockDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaSaleOfStockAxis" xlink:to="loc_afyaSaleOfStockDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InitialPublicOfferingMember" xlink:label="loc_afyaInitialPublicOfferingMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaSaleOfStockDomain" xlink:to="loc_afyaInitialPublicOfferingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OverAllotmentsMember" xlink:label="loc_afyaOverAllotmentsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaSaleOfStockDomain" xlink:to="loc_afyaOverAllotmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnderwritersMember" xlink:label="loc_afyaUnderwritersMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUnderwritersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareholdersMember" xlink:label="loc_afyaShareholdersMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_srtCurrencyAxis" order="60" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_USD" xlink:label="loc_currencyUSD" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyUSD" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestInSubsidiary" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestInSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" xlink:label="loc_ifrs-fullRightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRightsPreferencesAndRestrictionsAttachingToClassOfShareCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfPerShares" xlink:label="loc_afyaNumberOfPerShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfPerShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesNet" xlink:label="loc_afyaProceedsFromIssueOfOrdinarySharesNet" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinarySharesNet" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionExpense" xlink:label="loc_ifrs-fullFeeAndCommissionExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherOfferingExpenses" xlink:label="loc_afyaOtherOfferingExpenses" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherOfferingExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ShareIssueRelatedCost" xlink:label="loc_ifrs-fullShareIssueRelatedCost" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullShareIssueRelatedCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TransferredAmountToGBankAccounts" xlink:label="loc_afyaTransferredAmountToGBankAccounts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTransferredAmountToGBankAccounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfAdditionalCommonSharesIssued" xlink:label="loc_afyaNumberOfAdditionalCommonSharesIssued" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfAdditionalCommonSharesIssued" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalOfferingPrice" xlink:label="loc_afyaAdditionalOfferingPrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalOfferingPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalSharesGrossProceeds" xlink:label="loc_afyaAdditionalSharesGrossProceeds" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalSharesGrossProceeds" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetProceedsOfAdditionalShares" xlink:label="loc_afyaNetProceedsOfAdditionalShares" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetProceedsOfAdditionalShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsProvision" xlink:label="loc_ifrs-fullLegalProceedingsProvision" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLegalProceedingsProvision" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails" xlink:title="00000054 - Disclosure - The table below is a list of the Company&#8217;s subsidiaries and associate: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AfyaParticipacoesSAMember" xlink:label="loc_afyaAfyaParticipacoesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaAfyaParticipacoesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember" xlink:label="loc_afyaUniaoEducacionalDoValeDoAcoSAUNIVACOMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoValeDoAcoSAUNIVACOMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroIntegradoDeSaudeDeTeresinaCISMember" xlink:label="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroIntegradoDeSaudeDeTeresinaCISMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelEditoraEEventosSAMedcelMember" xlink:label="loc_afyaMedcelEditoraEEventosSAMedcelMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelEditoraEEventosSAMedcelMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ESMCEducacaoSuperiorLtdaESMCMember" xlink:label="loc_afyaESMCEducacaoSuperiorLtdaESMCMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaESMCEducacaoSuperiorLtdaESMCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAUniRedentorMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAUniRedentorMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaUniSLMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaUniSLMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" xlink:label="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" xlink:label="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMedPhoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" xlink:label="loc_afyaIClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicDesenvolvimentoDeSoftwareLtdaiClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeSolutionsSAMedicinaeMember" xlink:label="loc_afyaMedicinaeSolutionsSAMedicinaeMember" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeSolutionsSAMedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember" xlink:label="loc_afyaCliquefarmaDrogariasOnlineLtdaCliquefarmaMember" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaDrogariasOnlineLtdaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospTecnologiaDaInformacaoLtdaShospMember" xlink:label="loc_afyaShospTecnologiaDaInformacaoLtdaShospMember" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospTecnologiaDaInformacaoLtdaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" xlink:label="loc_afyaSociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" xlink:label="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" xlink:label="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember" xlink:label="loc_afyaSociedadeEducacionalDePalhocaSALtdaSOCIESPMember" />
      <link:presentationArc order="590" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeEducacionalDePalhocaSALtdaSOCIESPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" />
      <link:presentationArc order="610" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember" xlink:label="loc_afyaRXPROSolucoesDeTecnologiaLtdaRXPROMember" />
      <link:presentationArc order="630" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROSolucoesDeTecnologiaLtdaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember" xlink:label="loc_afyaRXPROLOGTransporteELogisticaLtdaRXPROLOGMember" />
      <link:presentationArc order="650" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROLOGTransporteELogisticaLtdaRXPROLOGMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember" />
      <link:presentationArc order="670" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NameOfSubsidiary" xlink:label="loc_ifrs-fullNameOfSubsidiary" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNameOfSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PrincipalActivities" xlink:label="loc_afyaPrincipalActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPrincipalActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary" xlink:label="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPrincipalPlaceOfBusinessOfSubsidiary" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentType" xlink:label="loc_afyaInvestmentType" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails" xlink:title="00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable" xlink:label="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfPropertyPlantAndEquipmentTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaboratoriesAndClinicsMember" xlink:label="loc_afyaLaboratoriesAndClinicsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLaboratoriesAndClinicsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails" xlink:title="00000056 - Disclosure - Schedule of assets and liabilities information for the company&apos;s operating segments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Assets" xlink:label="loc_ifrs-fullAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EquityAndLiabilities" xlink:label="loc_ifrs-fullEquityAndLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquityAndLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Equity" xlink:label="loc_ifrs-fullEquity" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullEquity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalExpenditures" xlink:label="loc_afyaCapitalExpenditures" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalExpenditures" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails" xlink:title="00000057 - Disclosure - Schedule of operating income for each operating segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfOperatingSegmentsTable" xlink:label="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentConsolidationItemsAxis" xlink:label="loc_ifrs-fullSegmentConsolidationItemsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentConsolidationItemsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSegmentConsolidationItemsMember" xlink:label="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentConsolidationItemsAxis" xlink:to="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OperatingSegmentsMember" xlink:label="loc_ifrs-fullOperatingSegmentsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSegmentConsolidationItemsMember" xlink:to="loc_ifrs-fullOperatingSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfOperatingSegmentsTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TotalReportableSegmentsMember" xlink:label="loc_afyaTotalReportableSegmentsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaTotalReportableSegmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdjustmentsAndEliminationsMember" xlink:label="loc_afyaAdjustmentsAndEliminationsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaAdjustmentsAndEliminationsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DepositsFromExternalCustomer" xlink:label="loc_afyaDepositsFromExternalCustomer" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDepositsFromExternalCustomer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterSegment" xlink:label="loc_afyaInterSegment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterSegment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossProfit" xlink:label="loc_ifrs-fullGrossProfit" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGrossProfit" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherGainsLosses" xlink:label="loc_ifrs-fullOtherGainsLosses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherGainsLosses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="loc_ifrs-fullProfitLossFromOperatingActivities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossFromOperatingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanceExpense" xlink:label="loc_afyaFinanceExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails" xlink:title="00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaFipmocSAMember" xlink:label="loc_afyaSociedadeUniversitariaFipmocSAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaFipmocSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaGranarioSAMember" xlink:label="loc_afyaSociedadeUniversitariaGranarioSAMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaGranarioSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCash1" xlink:label="loc_afyaRestrictedCash1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedCash1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Inventories1" xlink:label="loc_afyaInventories1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInventories1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ImdemnificationAssets" xlink:label="loc_afyaImdemnificationAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaImdemnificationAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContingentConsiderationRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ConsiderationToBeTransferred" xlink:label="loc_afyaConsiderationToBeTransferred" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaConsiderationToBeTransferred" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInShares" xlink:label="loc_afyaPaidInShares" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaidInShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative" xlink:title="00000059 - Disclosure - Significant accounting policies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityAxis" xlink:label="loc_afyaTaxAuthorityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaTaxAuthorityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxAuthorityDomain" xlink:label="loc_afyaTaxAuthorityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaTaxAuthorityAxis" xlink:to="loc_afyaTaxAuthorityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProgramOfSocialIntegrationMember" xlink:label="loc_afyaProgramOfSocialIntegrationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaTaxAuthorityDomain" xlink:to="loc_afyaProgramOfSocialIntegrationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContributionForTheFinancingOfSocialSecurityMember" xlink:label="loc_afyaContributionForTheFinancingOfSocialSecurityMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaTaxAuthorityDomain" xlink:to="loc_afyaContributionForTheFinancingOfSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesAxis" xlink:label="loc_ifrs-fullProductsAndServicesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullProductsAndServicesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProductsAndServicesMember" xlink:label="loc_ifrs-fullProductsAndServicesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesAxis" xlink:to="loc_ifrs-fullProductsAndServicesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TeachingActivitiesMember" xlink:label="loc_afyaTeachingActivitiesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NonTeachingActivitiesMember" xlink:label="loc_afyaNonTeachingActivitiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProductsAndServicesMember" xlink:to="loc_afyaNonTeachingActivitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails" xlink:title="00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails" xlink:title="00000061 - Disclosure - Schedule of acquisition of UniSL (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails" xlink:title="00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails" xlink:title="00000063 - Disclosure - Schedule of acquisition of FESAR (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails" xlink:title="00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails" xlink:title="00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfIntangibleAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfIntangibleAssetsTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails" xlink:title="00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaGranarioSAMember" xlink:label="loc_afyaSociedadeUniversitariaGranarioSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaGranarioSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsOtherThanGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsOtherThanGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_2" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:label="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails" xlink:title="00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SociedadeUniversitariaRedentorSAMember" xlink:label="loc_afyaSociedadeUniversitariaRedentorSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaSociedadeUniversitariaRedentorSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroUniversitarioSaoLucasLtdaMember" xlink:label="loc_afyaCentroUniversitarioSaoLucasLtdaMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroUniversitarioSaoLucasLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" xlink:label="loc_afyaInstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeCienciasMedicasDaParaibaMember" xlink:label="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFaculdadeDeCienciasMedicasDaParaibaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesAsOfAcquisitionDate" xlink:label="loc_afyaTradeReceivablesAsOfAcquisitionDate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InventoryRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullInventoryRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInventoryRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RecoverableTaxesAsOfAcquisitionDate" xlink:label="loc_afyaRecoverableTaxesAsOfAcquisitionDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRecoverableTaxesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsAsOfAcquisitionDate" xlink:label="loc_afyaOtherAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherAssetsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndemnificationAssets" xlink:label="loc_afyaIndemnificationAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndemnificationAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightOfUseAssetsAsOfAcquisitionDate" xlink:label="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRightOfUseAssetsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaborAndSocialObligationsAsOfAcquisitionDate" xlink:label="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLaborAndSocialObligationsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesPayableAsOfAcquisitionDate" xlink:label="loc_afyaTaxesPayableAsOfAcquisitionDate" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTaxesPayableAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:label="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProvisionForLegalProceedingsAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdvancesFromCustomersAsOfAcquisitionDate" xlink:label="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdvancesFromCustomersAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotesPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherLiabilitiesAsOfAcquisitionDate" xlink:label="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherLiabilitiesAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesRecognisedAsOfAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwillRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:label="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitiondateFairValueOfTotalConsiderationTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashTransferred" xlink:label="loc_ifrs-fullCashTransferred" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashTransferred" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PayablInInstallmentsAcquisitionDate" xlink:label="loc_afyaPayablInInstallmentsAcquisitionDate" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPayablInInstallmentsAcquisitionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaidInAfyaBrazilsShares" xlink:label="loc_afyaPaidInAfyaBrazilsShares" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPaidInAfyaBrazilsShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:label="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfCashFlowOnAcquisition" xlink:label="loc_afyaNetOfCashFlowOnAcquisition" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfCashFlowOnAcquisition" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails" xlink:title="00000068 - Disclosure - Schedule of cash and cash equivalents (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Cash" xlink:label="loc_ifrs-fullCash" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCash" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/BusinessCombinationsDetailsNarrative" xlink:title="00000069 - Disclosure - Business combinations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfBusinessCombinationsTable" xlink:label="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BusinessCombinationsAxis" xlink:label="loc_ifrs-fullBusinessCombinationsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullBusinessCombinationsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForBusinessCombinationsMember" xlink:label="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBusinessCombinationsAxis" xlink:to="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicMember" xlink:label="loc_afyaIClinicMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaIClinicMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HarbourMember" xlink:label="loc_afyaHarbourMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIFIPMocMember" xlink:label="loc_afyaUNIFIPMocMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIFIPMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIGRANMember" xlink:label="loc_afyaUNIGRANMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUNIGRANMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PXPROMember" xlink:label="loc_afyaPXPROMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PEBMEDMember" xlink:label="loc_afyaPEBMEDMember" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaPEBMEDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:label="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForBusinessCombinationsMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfBusinessCombinationsTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneTecnologiaEmSaudeLtdaMember" xlink:label="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_2" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneTecnologiaEmSaudeLtdaMember_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfAcquiree" xlink:label="loc_ifrs-fullDescriptionOfAcquiree" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInRevenue" xlink:label="loc_afyaIncreaseInRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseInIncomeBeforeIncomeTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfAcquiree" xlink:label="loc_ifrs-fullRevenueOfAcquiree" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueOfCombinedEntity" xlink:label="loc_ifrs-fullRevenueOfCombinedEntity" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenueOfCombinedEntity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaymentMade" xlink:label="loc_afyaAdditionalPaymentMade" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaymentMade" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreasedInIncomeBeforeIncomeTaxes" xlink:label="loc_afyaDecreasedInIncomeBeforeIncomeTaxes" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDecreasedInIncomeBeforeIncomeTaxes" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails" xlink:title="00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TuitionFeesMember" xlink:label="loc_afyaTuitionFeesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaTuitionFeesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalContentMember" xlink:label="loc_afyaEducationalContentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FIESMember" xlink:label="loc_afyaFIESMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaFIESMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalCreditsMember" xlink:label="loc_afyaEducationalCreditsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaEducationalCreditsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MobileAppSubscriptionMember" xlink:label="loc_afyaMobileAppSubscriptionMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaMobileAppSubscriptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OthersMember" xlink:label="loc_afyaOthersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaOthersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccountsFoReceivable1" xlink:label="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAllowanceForDoubtfulAccountsFoReceivable1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTradeReceivables" xlink:label="loc_ifrs-fullCurrentTradeReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails" xlink:title="00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ImpairmentOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember" xlink:label="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullImpairmentOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember" xlink:label="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForImpairmentOfFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsNeitherPastDueNorImpairedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusAxis" xlink:label="loc_ifrs-fullPastDueStatusAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable" xlink:to="loc_ifrs-fullPastDueStatusAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PastDueStatusMember" xlink:label="loc_ifrs-fullPastDueStatusMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusAxis" xlink:to="loc_ifrs-fullPastDueStatusMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentMember" xlink:label="loc_ifrs-fullCurrentMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:label="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneMonthsAndNotLaterThanThreeMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:label="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_ifrs-fullLaterThanThreeMonthsAndNotLaterThanSixMonthsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaterThanOneEightyMember" xlink:label="loc_afyaLaterThanOneEightyMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPastDueStatusMember" xlink:to="loc_afyaLaterThanOneEightyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReceivablesGross" xlink:label="loc_afyaReceivablesGross" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaReceivablesGross" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails" xlink:title="00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="loc_ifrs-fullAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:label="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaWriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets" xlink:label="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAllowanceAccountForCreditLossesOfFinancialAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails" xlink:title="00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UEPCMember" xlink:label="loc_afyaUEPCMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeReceivablesRelatedPartyTransactions" xlink:label="loc_afyaTradeReceivablesRelatedPartyTransactions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeReceivablesRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CreditsWithShareholdersRelatedPartyTransactions" xlink:label="loc_afyaCreditsWithShareholdersRelatedPartyTransactions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCreditsWithShareholdersRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsReceivableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsReceivableRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherCurrentPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherCurrentPayablesToRelatedParties1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentAssetsOfRelatedParty1" xlink:label="loc_afyaNoncurrentAssetsOfRelatedParty1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentAssetsOfRelatedParty1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholders" xlink:label="loc_afyaAccountsPayableToSellingShareholders" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholders" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountsPayableRelatedPartyTransactions" xlink:label="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmountsPayableRelatedPartyTransactions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableCurrent1" xlink:label="loc_afyaAccountsPayableCurrent1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableCurrent1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentPayablesToRelatedParties1" xlink:label="loc_afyaNoncurrentPayablesToRelatedParties1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNoncurrentPayablesToRelatedParties1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherIncomeRelatedPartyTransactions" xlink:label="loc_afyaOtherIncomeRelatedPartyTransactions" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaOtherIncomeRelatedPartyTransactions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeasesAsLesseeRelatedPartyTransactions" xlink:label="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeasesAsLesseeRelatedPartyTransactions" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative" xlink:title="00000074 - Disclosure - Cash and cash equivalents (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BankCertificatesOfDepositMember" xlink:label="loc_afyaBankCertificatesOfDepositMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaBankCertificatesOfDepositMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterbankCertificatesOfDepositMember" xlink:label="loc_afyaInterbankCertificatesOfDepositMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaInterbankCertificatesOfDepositMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_srtCurrencyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_USDMember" xlink:label="loc_afyaUSDMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_afyaUSDMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PercenatgeOfAverageInterestOnFinancialInstrument" xlink:label="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaPercenatgeOfAverageInterestOnFinancialInstrument" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashEquivalents" xlink:label="loc_ifrs-fullCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails" xlink:title="00000075 - Disclosure - Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensationShorttermEmployeeBenefits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_KeyManagementPersonnelCompensation" xlink:label="loc_ifrs-fullKeyManagementPersonnelCompensation" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullKeyManagementPersonnelCompensation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:label="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/RelatedPartiesDetailsNarrative" xlink:title="00000076 - Disclosure - Related parties (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:label="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ReserveQuantitiesLineItems" xlink:label="loc_srtReserveQuantitiesLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_srtReserveQuantitiesLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Axis" xlink:label="loc_afyaTypeOfArrangement1Axis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_afyaTypeOfArrangement1Axis" order="10" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypeOfArrangement1Domain" xlink:label="loc_afyaTypeOfArrangement1Domain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaTypeOfArrangement1Axis" xlink:to="loc_afyaTypeOfArrangement1Domain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseAgreements1Member" xlink:label="loc_afyaLeaseAgreements1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaTypeOfArrangement1Domain" xlink:to="loc_afyaLeaseAgreements1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LegalEntityAxis" xlink:label="loc_deiLegalEntityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_deiLegalEntityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityDomain" xlink:label="loc_deiEntityDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiLegalEntityAxis" xlink:to="loc_deiEntityDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RVLEstevesGestaoImobiliariaSAMember" xlink:label="loc_afyaRVLEstevesGestaoImobiliariaSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaRVLEstevesGestaoImobiliariaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UNIVACOPatrimonialLtdaMember" xlink:label="loc_afyaUNIVACOPatrimonialLtdaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaUNIVACOPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IESVAPPatrimonialLtdaMember" xlink:label="loc_afyaIESVAPPatrimonialLtdaMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiEntityDomain" xlink:to="loc_afyaIESVAPPatrimonialLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:label="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoTocantinensePresidenteAntonioCarlosSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:label="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OperatingLeaseTermOfContract" xlink:label="loc_afyaOperatingLeaseTermOfContract" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaOperatingLeaseTermOfContract" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfEntitysRevenue" xlink:label="loc_ifrs-fullPercentageOfEntitysRevenue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_ifrs-fullPercentageOfEntitysRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LesseeFinancesLeaseRenewalTerm" xlink:label="loc_afyaLesseeFinancesLeaseRenewalTerm" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaLesseeFinancesLeaseRenewalTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerm" xlink:label="loc_afyaDescriptionOfLeaseTerm" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashOutflowForLeases" xlink:label="loc_ifrs-fullCashOutflowForLeases" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_ifrs-fullCashOutflowForLeases" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfLeaseTerms" xlink:label="loc_afyaDescriptionOfLeaseTerms" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtReserveQuantitiesLineItems" xlink:to="loc_afyaDescriptionOfLeaseTerms" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfOtherAssetsDetails" xlink:title="00000077 - Disclosure - Schedule of Other Assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:label="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullIndemnificationAssetsRecognisedAsOfAcquisitionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentPrepaidExpenses" xlink:label="loc_ifrs-fullCurrentPrepaidExpenses" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCurrentPrepaidExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherReceivables" xlink:label="loc_ifrs-fullOtherReceivables" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullOtherReceivables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssets1" xlink:label="loc_afyaOtherAssets1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaOtherAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Assets1" xlink:label="loc_afyaAssets1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentAssets1" xlink:label="loc_afyaCurrentAssets1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaCurrentAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentAssets1" xlink:label="loc_afyaNoncurrentAssets1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaNoncurrentAssets1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfInvestmentsDetails" xlink:title="00000078 - Disclosure - Schedule of investments (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:label="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTransactionsBetweenRelatedPartiesTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AssociatesMember" xlink:label="loc_ifrs-fullAssociatesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_ifrs-fullAssociatesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentAssets" xlink:label="loc_ifrs-fullCurrentAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentAssets" xlink:label="loc_ifrs-fullNoncurrentAssets" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLiabilities" xlink:label="loc_ifrs-fullCurrentLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="loc_ifrs-fullNoncurrentLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityInAssociate" xlink:label="loc_afyaEquityInAssociate" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEquityInAssociate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareInEquity1" xlink:label="loc_afyaCompanyShareInEquity1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareInEquity1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InvestmentGrossAmount" xlink:label="loc_afyaInvestmentGrossAmount" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInvestmentGrossAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Revenue" xlink:label="loc_ifrs-fullRevenue" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncomeTaxExpenseContinuingOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLoss" xlink:label="loc_ifrs-fullProfitLoss" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompanyShareOfProfitss" xlink:label="loc_afyaCompanyShareOfProfitss" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompanyShareOfProfitss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MinorityInterestOfAcquiree" xlink:label="loc_afyaMinorityInterestOfAcquiree" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaMinorityInterestOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalMinorityInterestOfAcquiree" xlink:label="loc_afyaAdditionalMinorityInterestOfAcquiree" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalMinorityInterestOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsReceived1" xlink:label="loc_afyaDividendsReceived1" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsReceived1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsReceived" xlink:label="loc_ifrs-fullDividendsReceived" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsReceived" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossOfAcquiree" xlink:label="loc_ifrs-fullProfitLossOfAcquiree" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfitLossOfAcquiree" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentsInAssociates" xlink:label="loc_ifrs-fullInvestmentsInAssociates_2" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInvestmentsInAssociates_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails" xlink:title="00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="780" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis" xlink:label="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipmentMember" xlink:label="loc_ifrs-fullPropertyPlantAndEquipmentMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfPropertyPlantAndEquipmentAxis" xlink:to="loc_ifrs-fullPropertyPlantAndEquipmentMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BuildingsMember" xlink:label="loc_ifrs-fullBuildingsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullBuildingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MachineryAndEquipmentsMember" xlink:label="loc_afyaMachineryAndEquipmentsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaMachineryAndEquipmentsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LandMember" xlink:label="loc_ifrs-fullLandMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLandMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_VehiclesMember" xlink:label="loc_ifrs-fullVehiclesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullVehiclesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FixturesAndFittingsMember" xlink:label="loc_ifrs-fullFixturesAndFittingsMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullFixturesAndFittingsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ItEquipmentMember" xlink:label="loc_afyaItEquipmentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaItEquipmentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LibraryBooksMember" xlink:label="loc_afyaLibraryBooksMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLibraryBooksMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LaboratoriesAndClinicsMember" xlink:label="loc_afyaLaboratoriesAndClinicsMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_afyaLaboratoriesAndClinicsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseholdImprovementsMember" xlink:label="loc_ifrs-fullLeaseholdImprovementsMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullLeaseholdImprovementsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ConstructionInProgressMember" xlink:label="loc_ifrs-fullConstructionInProgressMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullPropertyPlantAndEquipmentMember" xlink:to="loc_ifrs-fullConstructionInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisposalsPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDisposalsPropertyPlantAndEquipment" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDisposalsPropertyPlantAndEquipment" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_2" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationPropertyPlantAndEquipment" xlink:label="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDepreciationPropertyPlantAndEquipment" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="loc_ifrs-fullPropertyPlantAndEquipment_3" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPropertyPlantAndEquipment_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails" xlink:title="00000080 - Disclosure - Schedule of intangible assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LicencesMember" xlink:label="loc_ifrs-fullLicencesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullLicencesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CustomerrelatedIntangibleAssetsMember" xlink:label="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullCustomerrelatedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformMember" xlink:label="loc_afyaEducationalPlatformMember" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SoftwareInProgressMember" xlink:label="loc_afyaSoftwareInProgressMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaSoftwareInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationalPlatformAndSoftwareInProgressMember" xlink:label="loc_afyaEducationalPlatformAndSoftwareInProgressMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationalPlatformAndSoftwareInProgressMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DevelopedTechnologyIntangibleAssetsMember" xlink:label="loc_afyaDevelopedTechnologyIntangibleAssetsMember" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaDevelopedTechnologyIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GrossCarryingAmountMember" xlink:label="loc_ifrs-fullGrossCarryingAmountMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullGrossCarryingAmountMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AccumulatedDepreciationAndAmortisationMember" xlink:label="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" />
      <link:presentationArc order="710" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_ifrs-fullAccumulatedDepreciationAndAmortisationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Disposal" xlink:label="loc_afyaDisposal" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDisposal" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAmortisationIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwill" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwill_3" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwill_3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails" xlink:title="00000081 - Disclosure - Schedule of assumptions for impairment test (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:label="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CarryingAmountMember" xlink:label="loc_ifrs-fullCarryingAmountMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis" xlink:to="loc_ifrs-fullCarryingAmountMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CarryingAmountsMember" xlink:label="loc_afyaCarryingAmountsMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCarryingAmountMember" xlink:to="loc_afyaCarryingAmountsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInGoodwillTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:label="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CentroDeCienciasEmSaudeDeItajubaSAMember" xlink:label="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCentroDeCienciasEmSaudeDeItajubaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:label="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFADEPFaculdadeEducacionalDePatoBrancoLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedcelAndCBBWMember" xlink:label="loc_afyaMedcelAndCBBWMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedcelAndCBBWMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PracticeManagementToolsAndElectronicPrescriptionMember" xlink:label="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaPracticeManagementToolsAndElectronicPrescriptionMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClinicalDecisionSoftwareMember" xlink:label="loc_afyaClinicalDecisionSoftwareMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaClinicalDecisionSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MocMember" xlink:label="loc_afyaMocMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMocMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Goodwill" xlink:label="loc_ifrs-fullGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullGoodwill" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife" xlink:label="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIntangibleAssetsWithIndefiniteUsefulLife" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashGeneratingUnits" xlink:label="loc_afyaCashGeneratingUnits" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashGeneratingUnits" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/OtherAssetsDetailsNarrative" xlink:title="00000082 - Disclosure - Other assets (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherCurrentAssets1" xlink:label="loc_afyaOtherCurrentAssets1" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaOtherCurrentAssets1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails" xlink:title="00000083 - Disclosure - Schedule of estimated useful lives (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsMedicineMember" xlink:label="loc_afyaCustomerRelationshipsMedicineMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsMedicineMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CustomerRelationshipsOtherCoursesMember" xlink:label="loc_afyaCustomerRelationshipsOtherCoursesMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaCustomerRelationshipsOtherCoursesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ComputerSoftwareMember" xlink:label="loc_ifrs-fullComputerSoftwareMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullComputerSoftwareMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EducationContentMember" xlink:label="loc_afyaEducationContentMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_afyaEducationContentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BrandNamesMember" xlink:label="loc_ifrs-fullBrandNamesMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullBrandNamesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TechnologybasedIntangibleAssetsMember" xlink:label="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullTechnologybasedIntangibleAssetsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:label="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialAssetsDetails" xlink:title="00000084 - Disclosure - Schedule of financial assets (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullFinancialAssetsAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="loc_ifrs-fullCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivables" xlink:label="loc_ifrs-fullTradeReceivables" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialAssets" xlink:label="loc_ifrs-fullCurrentFinancialAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialAssets" xlink:label="loc_ifrs-fullNoncurrentFinancialAssets" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails" xlink:title="00000085 - Disclosure - Schedule of financial liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialLiabilitiesTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialLiabilitiesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtAmortisedCostMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtAmortisedCostMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayable" xlink:label="loc_afyaNotePayable" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentFinancialLiabilities" xlink:label="loc_ifrs-fullCurrentFinancialLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentFinancialLiabilities" xlink:label="loc_ifrs-fullNoncurrentFinancialLiabilities" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentFinancialLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails" xlink:title="00000086 - Disclosure - Schedule of loans and financing (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyThreeMember" xlink:label="loc_afyaTwentyTwentyThreeMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyThreeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyOneMember" xlink:label="loc_afyaTwentyTwentyOneMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFourMember" xlink:label="loc_afyaTwentyTwentyFourMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySevenMember" xlink:label="loc_afyaTwentyTwentySevenMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentySixMember" xlink:label="loc_afyaTwentyTwentySixMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentySixMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TwentyTwentyFour1Member" xlink:label="loc_afyaTwentyTwentyFour1Member" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_afyaTwentyTwentyFour1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameAxis" xlink:label="loc_ifrs-fullBorrowingsByNameAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullBorrowingsByNameAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsByNameMember" xlink:label="loc_ifrs-fullBorrowingsByNameMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameAxis" xlink:to="loc_ifrs-fullBorrowingsByNameMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanciadoradeEstudoseProjetosFINEPMember" xlink:label="loc_afyaFinanciadoradeEstudoseProjetosFINEPMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullBorrowingsByNameMember" xlink:to="loc_afyaFinanciadoradeEstudoseProjetosFINEPMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialInstitution" xlink:label="loc_afyaFinancialInstitution" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialInstitution" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsInterestRateBasis" xlink:label="loc_ifrs-fullBorrowingsInterestRateBasis" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsInterestRateBasis" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BorrowingsMaturity" xlink:label="loc_ifrs-fullBorrowingsMaturity" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullBorrowingsMaturity" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing1" xlink:label="loc_afyaLoansAndFinancing1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingCurrent" xlink:label="loc_afyaLoansAndFinancingCurrent" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingNonCurrent" xlink:label="loc_afyaLoansAndFinancingNonCurrent" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IntrestRate" xlink:label="loc_afyaIntrestRate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIntrestRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotionalAmount" xlink:label="loc_ifrs-fullNotionalAmount" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNotionalAmount" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BorrowingsAmountFirstTranche" xlink:label="loc_afyaBorrowingsAmountFirstTranche" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBorrowingsAmountFirstTranche" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesAuthorised" xlink:label="loc_ifrs-fullNumberOfSharesAuthorised" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesAuthorised" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:label="loc_ifrs-fullContributionsToPlanNetDefinedBenefitLiabilityAsset" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullContributionsToPlanNetDefinedBenefitLiabilityAsset" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative" xlink:title="00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis" xlink:label="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable" xlink:to="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IntangibleAssetsAndGoodwillMember" xlink:label="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfIntangibleAssetsAndGoodwillAxis" xlink:to="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GoodwillMember" xlink:label="loc_ifrs-fullGoodwillMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullIntangibleAssetsAndGoodwillMember" xlink:to="loc_ifrs-fullGoodwillMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfDiscountRatesAppliedToCashFlowProjections" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:label="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails" xlink:title="00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullRightofuseAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionsToRightofuseAssets" xlink:label="loc_ifrs-fullAdditionsToRightofuseAssets" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAdditionsToRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionsToLeaseLiabilities" xlink:label="loc_afyaAdditionsToLeaseLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAdditionsToLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsRemeasurement" xlink:label="loc_afyaRightofuseAssetsRemeasurement" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesRemeasurement" xlink:label="loc_afyaLeaseLiabilitiesRemeasurement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeaseLiabilitiesRemeasurement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsBusinessCombinations" xlink:label="loc_afyaRightofuseAssetsBusinessCombinations" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombinationsLeaseLiabilities" xlink:label="loc_afyaBusinessCombinationsLeaseLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaBusinessCombinationsLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationRightofuseAssets" xlink:label="loc_ifrs-fullDepreciationRightofuseAssets" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDepreciationRightofuseAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DepreciationExpenseLeaseLiabilities" xlink:label="loc_afyaDepreciationExpenseLeaseLiabilities" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDepreciationExpenseLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsInterestExpense" xlink:label="loc_afyaRightofuseAssetsInterestExpense" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpenseOnLeaseLiabilities" xlink:label="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullInterestExpenseOnLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsPaymentsOfLeaseLiabilities" xlink:label="loc_afyaRightofuseAssetsPaymentsOfLeaseLiabilities" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsPaymentsOfLeaseLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:label="loc_afyaPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaPaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsDisposals" xlink:label="loc_afyaRightofuseAssetsDisposals" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsDisposals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesDisposals" xlink:label="loc_afyaLeaseLiabilitiesDisposals" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeaseLiabilitiesDisposals" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesRightToUse" xlink:label="loc_afyaLeaseLiabilitiesRightToUse" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeaseLiabilitiesRightToUse" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RightofuseAssets" xlink:label="loc_ifrs-fullRightofuseAssets_2" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullRightofuseAssets_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitieRightToUse" xlink:label="loc_afyaLeaseLiabilitieRightToUse" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeaseLiabilitieRightToUse" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsCurrent" xlink:label="loc_afyaRightofuseAssetsCurrent" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentLeaseLiabilities" xlink:label="loc_ifrs-fullCurrentLeaseLiabilities" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RightofuseAssetsNonCurrent" xlink:label="loc_afyaRightofuseAssetsNonCurrent" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaRightofuseAssetsNonCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities" xlink:label="loc_ifrs-fullNoncurrentLeaseLiabilities" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullNoncurrentLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails" xlink:title="00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:label="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:label="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEnsinoSuperiorDoPiauiSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoEducacionalSantoAgostinhoSAMember" xlink:label="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoEducacionalSantoAgostinhoSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:label="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:label="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoParaensedeEducacaoeCulturaLtdaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniRedentorMember" xlink:label="loc_afyaUniRedentorMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniRedentorMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniSLMember" xlink:label="loc_afyaUniSLMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniSLMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FCMPBMember" xlink:label="loc_afyaFCMPBMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFCMPBMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FESARMember" xlink:label="loc_afyaFESARMember" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaFESARMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedPhoneMember" xlink:label="loc_afyaMedPhoneMember" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedPhoneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicinaeMember" xlink:label="loc_afyaMedicinaeMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicinaeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MedicalHarbourMember" xlink:label="loc_afyaMedicalHarbourMember" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaMedicalHarbourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CliquefarmaMember" xlink:label="loc_afyaCliquefarmaMember" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaCliquefarmaMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShospMember" xlink:label="loc_afyaShospMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaShospMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnigranrioMember" xlink:label="loc_afyaUnigranrioMember" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUnigranrioMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RXPROMember" xlink:label="loc_afyaRXPROMember" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaRXPROMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_GuaranhunsMember" xlink:label="loc_afyaGuaranhunsMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaGuaranhunsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:label="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaInstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfSignificantInvestmentsInSubsidiariesTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties1" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedParties1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedParties1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersCurrent" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersNonCurrent" xlink:label="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersNonCurrent" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholderCashFlows" xlink:label="loc_afyaAccountsPayableToSellingShareholderCashFlows" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholderCashFlows" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:label="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersAcquisitionOfIpec" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestExpense" xlink:label="loc_ifrs-fullInterestExpense" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullInterestExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersBusinessCombinations" xlink:label="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAccountsPayableToSellingShareholdersBusinessCombinations" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingentConsiderationOnBusinessCombinations" xlink:label="loc_afyaContingentConsiderationOnBusinessCombinations" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingentConsiderationOnBusinessCombinations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CompensationOfLegalProceedingsDisbursement" xlink:label="loc_afyaCompensationOfLegalProceedingsDisbursement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCompensationOfLegalProceedingsDisbursement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedParties2" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedParties2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedParties2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:label="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProportionOfOwnershipInterestsHeldByNoncontrollingInterests" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RemainingTradeAndOtherPayablesToRelatedParties" xlink:label="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRemainingTradeAndOtherPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EqualInstallmentsPayablesToRelatedParties1" xlink:label="loc_afyaEqualInstallmentsPayablesToRelatedParties1" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaEqualInstallmentsPayablesToRelatedParties1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashTransferredTransaction" xlink:label="loc_afyaCashTransferredTransaction" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCashTransferredTransaction" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitObligationAtPresentValue" xlink:label="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDefinedBenefitObligationAtPresentValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations" xlink:label="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTransactionPriceAllocatedToRemainingPerformanceObligations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentPayablesForPurchaseOfEnergy" xlink:label="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentPayablesForPurchaseOfEnergy" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details" xlink:title="00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaNotesPayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BusinessCombination" xlink:label="loc_afyaBusinessCombination" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaBusinessCombination" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Payments" xlink:label="loc_afyaPayments" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaPayments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_MonetaryIndexation" xlink:label="loc_afyaMonetaryIndexation" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaMonetaryIndexation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayables" xlink:label="loc_afyaNotesPayables_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaNotesPayables_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CurrentLiabilities1" xlink:label="loc_afyaCurrentLiabilities1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaCurrentLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NoncurrentLiabilities1" xlink:label="loc_afyaNoncurrentLiabilities1" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaNoncurrentLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails" xlink:title="00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFinancialAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFinancialAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFinancialAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashMember" xlink:label="loc_afyaRestrictedCashMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaRestrictedCashMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeReceivablesMember" xlink:label="loc_ifrs-fullTradeReceivablesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_ifrs-fullTradeReceivablesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFinancialAssetsTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsAtFairValue" xlink:label="loc_ifrs-fullFinancialAssetsAtFairValue" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssetsAtFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilities" xlink:label="loc_ifrs-fullFinancialLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesAtFairValue" xlink:label="loc_ifrs-fullFinancialLiabilitiesAtFairValue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialLiabilitiesAtFairValue" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails" xlink:title="00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:label="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateRiskMember" xlink:label="loc_ifrs-fullInterestRateRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullInterestRateRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfInterestRatesAxis" xlink:label="loc_ifrs-fullTypesOfInterestRatesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfInterestRatesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InterestRateTypesMember" xlink:label="loc_ifrs-fullInterestRateTypesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfInterestRatesAxis" xlink:to="loc_ifrs-fullInterestRateTypesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FloatingInterestRateMember" xlink:label="loc_ifrs-fullFloatingInterestRateMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullInterestRateTypesMember" xlink:to="loc_ifrs-fullFloatingInterestRateMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialAssetsAxis" xlink:label="loc_ifrs-fullClassesOfFinancialAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullClassesOfFinancialAssetsAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssetsMember" xlink:label="loc_ifrs-fullFinancialAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialAssetsAxis" xlink:to="loc_ifrs-fullFinancialAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialAssetsMember" xlink:to="loc_afyaCashEquivalents1Member" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfFinancialLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" order="40" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialLiabilitiesMember" xlink:label="loc_ifrs-fullFinancialLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfFinancialLiabilitiesAxis" xlink:to="loc_ifrs-fullFinancialLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashEquivalents1Member" xlink:label="loc_afyaCashEquivalents1Member_2" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaCashEquivalents1Member_2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingTwoMember" xlink:label="loc_afyaLoansAndFinancingTwoMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingTwoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingOneMember" xlink:label="loc_afyaLoansAndFinancingOneMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersOneMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersOneMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AccountsPayableToSellingShareholdersSevenMember" xlink:label="loc_afyaAccountsPayableToSellingShareholdersSevenMember" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaAccountsPayableToSellingShareholdersSevenMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayableMember" xlink:label="loc_afyaNotesPayableMember" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullFinancialLiabilitiesMember" xlink:to="loc_afyaNotesPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProbabilityOfDefaultAxis" xlink:label="loc_ifrs-fullProbabilityOfDefaultAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullProbabilityOfDefaultAxis" order="50" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForProbabilityOfDefaultMember" xlink:label="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullProbabilityOfDefaultAxis" xlink:to="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsMember" xlink:label="loc_afyaIncreaseBasisPointsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsMember" xlink:label="loc_afyaDecreaseBasisPointsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaDecreaseBasisPointsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseBasisPointsOneMember" xlink:label="loc_afyaIncreaseBasisPointsOneMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaIncreaseBasisPointsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseBasisPointsOneMember" xlink:label="loc_afyaDecreaseBasisPointsOneMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForProbabilityOfDefaultMember" xlink:to="loc_afyaDecreaseBasisPointsOneMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinancialAssets" xlink:label="loc_ifrs-fullFinancialAssets" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFinancialAssets" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IndexRatePerYear" xlink:label="loc_afyaIndexRatePerYear" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIndexRatePerYear" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BaseRate" xlink:label="loc_afyaBaseRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaBaseRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:label="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails" xlink:title="00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:label="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresAxis" xlink:label="loc_ifrs-fullRiskExposuresAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable" xlink:to="loc_ifrs-fullRiskExposuresAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RiskExposuresMember" xlink:label="loc_ifrs-fullRiskExposuresMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresAxis" xlink:to="loc_ifrs-fullRiskExposuresMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ForeignCurrencyExposuresMember" xlink:label="loc_afyaForeignCurrencyExposuresMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaForeignCurrencyExposuresMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseForeignCurrencyMember" xlink:label="loc_afyaIncreaseForeignCurrencyMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaIncreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DecreaseForeignCurrencyMember" xlink:label="loc_afyaDecreaseForeignCurrencyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRiskExposuresMember" xlink:to="loc_afyaDecreaseForeignCurrencyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalents" xlink:label="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseInCashAndCashEquivalents" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails" xlink:title="00000094 - Disclosure - The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts: (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:label="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiquidityRiskMember" xlink:label="loc_ifrs-fullLiquidityRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullLiquidityRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MaturityAxis" xlink:label="loc_ifrs-fullMaturityAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable" xlink:to="loc_ifrs-fullMaturityAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedTimeBandsMember" xlink:label="loc_ifrs-fullAggregatedTimeBandsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMaturityAxis" xlink:to="loc_ifrs-fullAggregatedTimeBandsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearMember" xlink:label="loc_ifrs-fullLaterThanOneYearMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:label="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanOneYearAndNotLaterThanThreeYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanThreeYearsAndNotLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LaterThanFiveYearsMember" xlink:label="loc_ifrs-fullLaterThanFiveYearsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedTimeBandsMember" xlink:to="loc_ifrs-fullLaterThanFiveYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToTradeSuppliers" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToTradeSuppliers" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotePayables" xlink:label="loc_afyaNotePayables" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotePayables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Advances" xlink:label="loc_ifrs-fullAdvances" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdvances" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialLiabilitiesContractualUndiscounted" xlink:label="loc_afyaFinancialLiabilitiesContractualUndiscounted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFinancialLiabilitiesContractualUndiscounted" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails" xlink:title="00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:label="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesAxis" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingMember" xlink:label="loc_afyaLoansAndFinancingMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaLoansAndFinancingMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilitiesMember" xlink:label="loc_ifrs-fullLeaseLiabilitiesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_ifrs-fullLeaseLiabilitiesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPayableMember" xlink:label="loc_afyaDividendsPayableMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLiabilitiesArisingFromFinancingActivitiesMember" xlink:to="loc_afyaDividendsPayableMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:label="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LiabilitiesArisingFromFinancingActivities" xlink:label="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_3" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullLiabilitiesArisingFromFinancingActivities_3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromLoansAndFinancing" xlink:label="loc_afyaProceedsFromLoansAndFinancing" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromLoansAndFinancing" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetOfTransactionCosts" xlink:label="loc_afyaNetOfTransactionCosts" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetOfTransactionCosts" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative" xlink:title="00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable" xlink:label="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullRangeAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrencyRiskMember" xlink:label="loc_ifrs-fullCurrencyRiskMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_ifrs-fullCurrencyRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_CurrencyAxis" xlink:label="loc_srtCurrencyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDetailedInformationAboutBorrowingsTable" xlink:to="loc_srtCurrencyAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_AllCurrenciesDomain" xlink:label="loc_currencyAllCurrenciesDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srtCurrencyAxis" xlink:to="loc_currencyAllCurrenciesDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/currency/2021/currency-2021.xsd#currency_EUR" xlink:label="loc_currencyEUR" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_currencyAllCurrenciesDomain" xlink:to="loc_currencyEUR" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:label="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContractualLeaseTerm" xlink:label="loc_afyaContractualLeaseTerm" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContractualLeaseTerm" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:label="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NotesPayable1" xlink:label="loc_afyaNotesPayable1" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNotesPayable1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CreditExposure" xlink:label="loc_ifrs-fullCreditExposure" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullCreditExposure" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SensitivityChangeInTheEuroExchangeRate" xlink:label="loc_afyaSensitivityChangeInTheEuroExchangeRate" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSensitivityChangeInTheEuroExchangeRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClosingForeignExchangeRate" xlink:label="loc_ifrs-fullClosingForeignExchangeRate" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullClosingForeignExchangeRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails" xlink:title="00000097 - Disclosure - Schedule of fair value measurement (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureFairValueMeasurementAbstract" xlink:label="loc_afyaDisclosureFairValueMeasurementAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureFairValueMeasurementAbstract" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_MeasurementAxis" xlink:label="loc_ifrs-fullMeasurementAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullMeasurementAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AggregatedMeasurementMember" xlink:label="loc_ifrs-fullAggregatedMeasurementMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullMeasurementAxis" xlink:to="loc_ifrs-fullAggregatedMeasurementMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:label="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAggregatedMeasurementMember" xlink:to="loc_ifrs-fullNotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LevelsOfFairValueHierarchyAxis" xlink:label="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AllLevelsOfFairValueHierarchyMember" xlink:label="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullLevelsOfFairValueHierarchyAxis" xlink:to="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level2OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel2OfFairValueHierarchyMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel2OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Level3OfFairValueHierarchyMember" xlink:label="loc_ifrs-fullLevel3OfFairValueHierarchyMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullAllLevelsOfFairValueHierarchyMember" xlink:to="loc_ifrs-fullLevel3OfFairValueHierarchyMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NoncurrentTradeReceivables" xlink:label="loc_ifrs-fullNoncurrentTradeReceivables" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNoncurrentTradeReceivables" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancingLiabilities" xlink:label="loc_afyaLoansAndFinancingLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLoansAndFinancingLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilities1" xlink:label="loc_afyaLeaseLiabilities1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilities1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:label="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTradeAndOtherPayablesToRelatedPartiesLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayables1" xlink:label="loc_afyaFairValueNotesPayables1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayables1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RestrictedCashAndCashEquivalents1" xlink:label="loc_afyaRestrictedCashAndCashEquivalents1" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRestrictedCashAndCashEquivalents1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseLiabilitiesOne" xlink:label="loc_afyaLeaseLiabilitiesOne" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaLeaseLiabilitiesOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FairValueNotesPayablesLiabilities" xlink:label="loc_afyaFairValueNotesPayablesLiabilities" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaFairValueNotesPayablesLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfCapitalManagementDetails" xlink:title="00000098 - Disclosure - Schedule of capital management (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureCapitalManagementAbstract" xlink:label="loc_afyaDisclosureCapitalManagementAbstract" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LoansAndFinancing" xlink:label="loc_afyaLoansAndFinancing" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaLoansAndFinancing" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LeaseLiabilities" xlink:label="loc_ifrs-fullLeaseLiabilities" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_ifrs-fullLeaseLiabilities" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TradeAndOtherPayablesToRelatedParties" xlink:label="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_ifrs-fullTradeAndOtherPayablesToRelatedParties" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NotesAndDebenturesIssued" xlink:label="loc_ifrs-fullNotesAndDebenturesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_ifrs-fullNotesAndDebenturesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CashAndCashEquivalents1" xlink:label="loc_afyaCashAndCashEquivalents1" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaCashAndCashEquivalents1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RestrictedCashAndCashEquivalents" xlink:label="loc_ifrs-fullRestrictedCashAndCashEquivalents" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_ifrs-fullRestrictedCashAndCashEquivalents" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetDebt" xlink:label="loc_ifrs-fullNetDebt" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_ifrs-fullNetDebt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityOne1" xlink:label="loc_afyaEquityOne1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaEquityOne1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_EquityAndNetDebt1" xlink:label="loc_afyaEquityAndNetDebt1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureCapitalManagementAbstract" xlink:to="loc_afyaEquityAndNetDebt1" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails" xlink:title="00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:label="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfSharebasedPaymentArrangementsAxis" xlink:label="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharebasedPaymentArrangementsMember" xlink:label="loc_ifrs-fullSharebasedPaymentArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfSharebasedPaymentArrangementsAxis" xlink:to="loc_ifrs-fullSharebasedPaymentArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ModifiedPlanMember" xlink:label="loc_afyaModifiedPlanMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaModifiedPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OriginalPlanMember" xlink:label="loc_afyaOriginalPlanMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSharebasedPaymentArrangementsMember" xlink:to="loc_afyaOriginalPlanMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangeAxis" xlink:label="loc_ifrs-fullRangeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable" xlink:to="loc_ifrs-fullRangeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RangesMember" xlink:label="loc_ifrs-fullRangesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangeAxis" xlink:to="loc_ifrs-fullRangesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BottomOfRangeMember" xlink:label="loc_ifrs-fullBottomOfRangeMember" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullBottomOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TopOfRangeMember" xlink:label="loc_ifrs-fullTopOfRangeMember" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullRangesMember" xlink:to="loc_ifrs-fullTopOfRangeMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted" xlink:label="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpectedDividendAsPercentageShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfExpectedVolatilityShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfRiskFreeInterestRateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionLifeShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionLifeShareOptionsGranted" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionLifeShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:label="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaSharePriceFairValueAtMeasurementDateShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted" xlink:label="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDescriptionOfOptionPricingModelShareOptionsGranted" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:label="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaWeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_StrikePriceeAtMeasurementDateShareOptionsGrante" xlink:label="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaStrikePriceeAtMeasurementDateShareOptionsGrante" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails" xlink:title="00000100 - Disclosure - Schedule of share-based compensation plan (Details)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfShareOptionsForfeitedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfShareOptionsExercisedInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfShareOptionsExpiredInSharebasedPaymentArrangement" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019" xlink:label="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullWeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfOutstandingShareOptions" xlink:label="loc_ifrs-fullNumberOfOutstandingShareOptions_2" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullNumberOfOutstandingShareOptions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative" xlink:title="00000101 - Disclosure - Labor and social obligations (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DisclosureLaborAndSocialObligationsAbstract" xlink:label="loc_afyaDisclosureLaborAndSocialObligationsAbstract" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDefinedBenefitPlansTable" xlink:label="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaDisclosureLaborAndSocialObligationsAbstract" xlink:to="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansAxis" xlink:label="loc_ifrs-fullDefinedBenefitPlansAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDefinedBenefitPlansTable" xlink:to="loc_ifrs-fullDefinedBenefitPlansAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DefinedBenefitPlansMember" xlink:label="loc_ifrs-fullDefinedBenefitPlansMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansAxis" xlink:to="loc_ifrs-fullDefinedBenefitPlansMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationPlansMember" xlink:label="loc_afyaShareBasedCompensationPlansMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDefinedBenefitPlansMember" xlink:to="loc_afyaShareBasedCompensationPlansMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ShareBasedCompensationOfEmployees" xlink:label="loc_afyaShareBasedCompensationOfEmployees" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaShareBasedCompensationOfEmployees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:label="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfShareOptionsGrantedInSharebasedPaymentArrangement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:label="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullExpenseFromSharebasedPaymentTransactionsWithEmployees" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfEarningsPerShareDetails" xlink:title="00000102 - Disclosure - Schedule of earnings per share (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends" xlink:label="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAdjustmentToProfitLossForPreferenceShareDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_WeightedAverageShares" xlink:label="loc_ifrs-fullWeightedAverageShares" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:label="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdjustedWeightedAverageShares" xlink:label="loc_ifrs-fullAdjustedWeightedAverageShares" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullAdjustedWeightedAverageShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BasicEarningsLossPerShare" xlink:label="loc_ifrs-fullBasicEarningsLossPerShare" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullBasicEarningsLossPerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="loc_ifrs-fullDilutedEarningsLossPerShare" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDilutedEarningsLossPerShare" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails" xlink:title="00000103 - Disclosure - Schedule of net sales revenue (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherRevenue1" xlink:label="loc_afyaOtherRevenue1" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaOtherRevenue1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionAbstract" xlink:label="loc_afyaDeductionAbstract" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfGrantedDiscounts" xlink:label="loc_afyaDeductionOfGrantedDiscounts" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionOfGrantedDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfEarlyPaymentDiscounts" xlink:label="loc_afyaDeductionOfEarlyPaymentDiscounts" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionOfEarlyPaymentDiscounts" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfReturnsOfNetRevenue" xlink:label="loc_afyaDeductionOfReturnsOfNetRevenue" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionOfReturnsOfNetRevenue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfTaxes" xlink:label="loc_afyaDeductionOfTaxes" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionOfTaxes" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DeductionOfProuni" xlink:label="loc_afyaDeductionOfProuni" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaDeductionOfProuni" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromContractsWithCustomers" xlink:label="loc_ifrs-fullRevenueFromContractsWithCustomers" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullRevenueFromContractsWithCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:label="loc_afyaTimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaTimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullFeeAndCommissionIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaNetRevenueOtherTransferredPoint" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails" xlink:title="00000104 - Disclosure - Schedule of revenue by segment (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:label="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsAxis" xlink:label="loc_ifrs-fullSegmentsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable" xlink:to="loc_ifrs-fullSegmentsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SegmentsMember" xlink:label="loc_ifrs-fullSegmentsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsAxis" xlink:to="loc_ifrs-fullSegmentsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UndergradMember" xlink:label="loc_afyaUndergradMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaUndergradMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContinuingEducationMember" xlink:label="loc_afyaContinuingEducationMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaContinuingEducationMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DigitalServicesMember" xlink:label="loc_afyaDigitalServicesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaDigitalServicesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EliminationOfIntersegmentAmountsMember" xlink:label="loc_ifrs-fullEliminationOfIntersegmentAmountsMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_ifrs-fullEliminationOfIntersegmentAmountsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SegmentOfBusinessOneUnitMember" xlink:label="loc_afyaSegmentOfBusinessOneUnitMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSegmentsMember" xlink:to="loc_afyaSegmentOfBusinessOneUnitMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PaymentsToSuppliersForGoodsAndServices" xlink:label="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPaymentsToSuppliersForGoodsAndServices" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfessionalFeesExpense" xlink:label="loc_ifrs-fullProfessionalFeesExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProfessionalFeesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProfessionalFeesExpense1" xlink:label="loc_afyaProfessionalFeesExpense1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProfessionalFeesExpense1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherRevenue" xlink:label="loc_ifrs-fullOtherRevenue" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherRevenue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TimingRevenueRecognition" xlink:label="loc_afyaTimingRevenueRecognition" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaTimingRevenueRecognition" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FeeAndCommissionIncome" xlink:label="loc_ifrs-fullFeeAndCommissionIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullFeeAndCommissionIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NetRevenueOtherTransferredPoint" xlink:label="loc_afyaNetRevenueOtherTransferredPoint" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNetRevenueOtherTransferredPoint" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfExpensesByNatureDetails" xlink:title="00000105 - Disclosure - Schedule of expenses by nature (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CostOfSales" xlink:label="loc_ifrs-fullCostOfSales" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCostOfSales" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense" xlink:label="loc_ifrs-fullGeneralAndAdministrativeExpense" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullGeneralAndAdministrativeExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ExpenseByNature" xlink:label="loc_ifrs-fullExpenseByNature" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullExpenseByNature" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Payroll" xlink:label="loc_afyaPayroll" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaPayroll" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_HospitalAndMedicalAgreements" xlink:label="loc_afyaHospitalAndMedicalAgreements" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaHospitalAndMedicalAgreements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DepreciationExpense" xlink:label="loc_ifrs-fullDepreciationExpense" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDepreciationExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LeaseExpenses" xlink:label="loc_afyaLeaseExpenses" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaLeaseExpenses" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UtilitiesExpense" xlink:label="loc_ifrs-fullUtilitiesExpense" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullUtilitiesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RepairsAndMaintenanceExpense" xlink:label="loc_ifrs-fullRepairsAndMaintenanceExpense" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullRepairsAndMaintenanceExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_SharesBasedCompensation" xlink:label="loc_afyaSharesBasedCompensation" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaSharesBasedCompensation" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxExpenses" xlink:label="loc_afyaTaxExpenses" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaTaxExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ServicesExpense" xlink:label="loc_ifrs-fullServicesExpense" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullServicesExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SalesAndMarketingExpense" xlink:label="loc_ifrs-fullSalesAndMarketingExpense" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullSalesAndMarketingExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AllowanceForDoubtfulAccounts" xlink:label="loc_afyaAllowanceForDoubtfulAccounts" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaAllowanceForDoubtfulAccounts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TravelExpense" xlink:label="loc_ifrs-fullTravelExpense" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullTravelExpense" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ConsultingFees" xlink:label="loc_afyaConsultingFees" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaConsultingFees" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_Other" xlink:label="loc_afyaOther" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaOther" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ExpenseByNatureOne" xlink:label="loc_afyaExpenseByNatureOne" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaExpenseByNatureOne" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfFinanceResultDetails" xlink:title="00000106 - Disclosure - Schedule of finance result (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_InvestmentIncome" xlink:label="loc_ifrs-fullInvestmentIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullInvestmentIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangesInFairValueOfDerivativeInstruments" xlink:label="loc_afyaChangesInFairValueOfDerivativeInstruments" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaChangesInFairValueOfDerivativeInstruments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_RevenueFromInterest" xlink:label="loc_ifrs-fullRevenueFromInterest" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullRevenueFromInterest" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeGain" xlink:label="loc_ifrs-fullNetForeignExchangeGain" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullNetForeignExchangeGain" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceIncome" xlink:label="loc_ifrs-fullOtherFinanceIncome" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullOtherFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceIncome" xlink:label="loc_ifrs-fullFinanceIncome" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullFinanceIncome" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ChangeInFairValueOfDerivativeInstruments" xlink:label="loc_afyaChangeInFairValueOfDerivativeInstruments" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaChangeInFairValueOfDerivativeInstruments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterestExpense1" xlink:label="loc_afyaInterestExpense1" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaInterestExpense1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterestExpenseOnLeaseLiabilities1" xlink:label="loc_afyaInterestExpenseOnLeaseLiabilities1" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaInterestExpenseOnLeaseLiabilities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinancialDiscountsGrantedExpenses" xlink:label="loc_afyaFinancialDiscountsGrantedExpenses" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFinancialDiscountsGrantedExpenses" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_BankAndSimilarCharges" xlink:label="loc_ifrs-fullBankAndSimilarCharges" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullBankAndSimilarCharges" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NetForeignExchangeLoss" xlink:label="loc_ifrs-fullNetForeignExchangeLoss" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullNetForeignExchangeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxOnFinancialOperations" xlink:label="loc_afyaTaxOnFinancialOperations" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaTaxOnFinancialOperations" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherFinanceCost" xlink:label="loc_ifrs-fullOtherFinanceCost" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullOtherFinanceCost" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_FinanceCosts" xlink:label="loc_ifrs-fullFinanceCosts" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullFinanceCosts" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_FinanceResult" xlink:label="loc_afyaFinanceResult" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaFinanceResult" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails" xlink:title="00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="loc_ifrs-fullProfitLossBeforeTax" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullProfitLossBeforeTax" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ApplicableTaxRate" xlink:label="loc_ifrs-fullApplicableTaxRate" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullApplicableTaxRate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseIncomeAtApplicableTaxRate" xlink:label="loc_ifrs-fullTaxExpenseIncomeAtApplicableTaxRate" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullTaxExpenseIncomeAtApplicableTaxRate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ReconciliationAdjustmentsAbstract" xlink:label="loc_afyaReconciliationAdjustmentsAbstract" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaReconciliationAdjustmentsAbstract" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:label="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaTaxEffectOnIncomeFromEntitiesNotSubjectToTaxation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProgramaUniversidadeParaTodosFiscalIncentive" xlink:label="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaProgramaUniversidadeParaTodosFiscalIncentive" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UnrecognisedDeferredTaxAssets" xlink:label="loc_afyaUnrecognisedDeferredTaxAssets" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaUnrecognisedDeferredTaxAssets" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:label="loc_ifrs-fullTaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullTaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_PermanentAdjustments" xlink:label="loc_afyaPermanentAdjustments" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_afyaPermanentAdjustments" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxExpenseOtherThanIncomeTaxExpense" xlink:label="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullTaxExpenseOtherThanIncomeTaxExpense" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CurrentTaxExpenseIncome" xlink:label="loc_ifrs-fullCurrentTaxExpenseIncome" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullCurrentTaxExpenseIncome" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TaxRateEffectFromChangeInTaxRate" xlink:label="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullTaxRateEffectFromChangeInTaxRate" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/EquityDetailsNarrative" xlink:title="00000108 - Disclosure - Equity (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAPreferenceSharesMember" xlink:label="loc_afyaClassAPreferenceSharesMember" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAPreferenceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBPreferenceSharesMember" xlink:label="loc_afyaClassBPreferenceSharesMember" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBPreferenceSharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_BRHealthMember" xlink:label="loc_afyaBRHealthMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaBRHealthMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NicolauCarvalhoEstevesMember" xlink:label="loc_afyaNicolauCarvalhoEstevesMember" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaNicolauCarvalhoEstevesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember" xlink:label="loc_afyaUniaoEducacionalDoPlanaltoCentralSAUEPCMember" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaUniaoEducacionalDoPlanaltoCentralSAUEPCMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_IssuedCapital" xlink:label="loc_ifrs-fullIssuedCapital" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullIssuedCapital" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital2" xlink:label="loc_afyaIssuedCapital2" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapital2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NumberOfSharesIssued1" xlink:label="loc_afyaNumberOfSharesIssued1" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaNumberOfSharesIssued1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_NumberOfSharesIssued" xlink:label="loc_ifrs-fullNumberOfSharesIssued" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullNumberOfSharesIssued" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DescriptionOfRatioOfConvertibleShares" xlink:label="loc_afyaDescriptionOfRatioOfConvertibleShares" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDescriptionOfRatioOfConvertibleShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfOrdinaryShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfOrdinaryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ProceedsFromIssueOfPreferenceShares" xlink:label="loc_ifrs-fullProceedsFromIssueOfPreferenceShares" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProceedsFromIssueOfPreferenceShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CapitalIncreaseWithEarningsReserves" xlink:label="loc_afyaCapitalIncreaseWithEarningsReserves" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCapitalIncreaseWithEarningsReserves" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" xlink:label="loc_ifrs-fullDividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:label="loc_ifrs-fullSharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullSharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionPrice" xlink:label="loc_afyaAcquisitionPrice" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AcquisitionsHeldByShareholders" xlink:label="loc_afyaAcquisitionsHeldByShareholders" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAcquisitionsHeldByShareholders" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinarySharesOne" xlink:label="loc_afyaProceedsFromIssueOfOrdinarySharesOne" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinarySharesOne" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital1" xlink:label="loc_afyaAdditionalPaidinCapital1" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaidinCapital1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_AdditionalPaidinCapital2" xlink:label="loc_afyaAdditionalPaidinCapital2" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaAdditionalPaidinCapital2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CancellationOfDividend" xlink:label="loc_afyaCancellationOfDividend" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaCancellationOfDividend" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendPayables" xlink:label="loc_ifrs-fullDividendPayables" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendPayables" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_InterimDividends" xlink:label="loc_afyaInterimDividends" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaInterimDividends" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_DividendsPaidClassifiedAsFinancingActivities1" xlink:label="loc_afyaDividendsPaidClassifiedAsFinancingActivities1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaDividendsPaidClassifiedAsFinancingActivities1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DividendsPaidToNoncontrollingInterests" xlink:label="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullDividendsPaidToNoncontrollingInterests" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IssuedCapital1" xlink:label="loc_afyaIssuedCapital1" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaIssuedCapital1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ProceedsFromIssueOfOrdinaryShares1" xlink:label="loc_afyaProceedsFromIssueOfOrdinaryShares1" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaProceedsFromIssueOfOrdinaryShares1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails" xlink:title="00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesMember" xlink:label="loc_afyaTaxesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:label="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAcquisitionsThroughBusinessCombinationsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_AdditionalProvisionsOtherProvisions" xlink:label="loc_ifrs-fullAdditionalProvisionsOtherProvisions" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullAdditionalProvisionsOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_UnusedProvisionReversedOtherProvisions" xlink:label="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullUnusedProvisionReversedOtherProvisions" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_Provisions" xlink:label="loc_ifrs-fullProvisions_2" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullProvisions_2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails" xlink:title="00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:label="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfContingentLiabilitiesAxis" xlink:label="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ContingentLiabilitiesMember" xlink:label="loc_ifrs-fullContingentLiabilitiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfContingentLiabilitiesAxis" xlink:to="loc_ifrs-fullContingentLiabilitiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_LegalProceedingsContingentLiabilityMember" xlink:label="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullContingentLiabilitiesMember" xlink:to="loc_ifrs-fullLegalProceedingsContingentLiabilityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfProvisionsAxis" xlink:label="loc_ifrs-fullClassesOfProvisionsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullClassesOfProvisionsAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisionsMember" xlink:label="loc_ifrs-fullOtherProvisionsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfProvisionsAxis" xlink:to="loc_ifrs-fullOtherProvisionsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_LabourMember" xlink:label="loc_afyaLabourMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaLabourMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_CivilMember" xlink:label="loc_afyaCivilMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaCivilMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TaxesAndSocialSecurityMember" xlink:label="loc_afyaTaxesAndSocialSecurityMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullOtherProvisionsMember" xlink:to="loc_afyaTaxesAndSocialSecurityMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksAxis" xlink:label="loc_ifrs-fullTypesOfRisksAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfContingentLiabilitiesInBusinessCombinationTable" xlink:to="loc_ifrs-fullTypesOfRisksAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_TypesOfRisksMember" xlink:label="loc_ifrs-fullTypesOfRisksMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksAxis" xlink:to="loc_ifrs-fullTypesOfRisksMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_TypesOfRiskMember" xlink:label="loc_afyaTypesOfRiskMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullTypesOfRisksMember" xlink:to="loc_afyaTypesOfRiskMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OtherProvisions" xlink:label="loc_ifrs-fullOtherProvisions" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullOtherProvisions" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/IncomeTaxesDetailsNarrative" xlink:title="00000111 - Disclosure - Income taxes (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DeferredTaxExpenseIncome" xlink:label="loc_ifrs-fullDeferredTaxExpenseIncome" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDeferredTaxExpenseIncome" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative" xlink:title="00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable" xlink:label="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsAxis" xlink:label="loc_ifrs-fullClassesOfAssetsAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfFairValueMeasurementOfAssetsTable" xlink:to="loc_ifrs-fullClassesOfAssetsAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfAssetsMember" xlink:label="loc_ifrs-fullClassesOfAssetsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsAxis" xlink:to="loc_ifrs-fullClassesOfAssetsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_OtherAssetsNonCurrentMember" xlink:label="loc_afyaOtherAssetsNonCurrentMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfAssetsMember" xlink:to="loc_afyaOtherAssetsNonCurrentMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_JudicialDeposits" xlink:label="loc_afyaJudicialDeposits" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaJudicialDeposits" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ContingenciesCorrespondentAmount" xlink:label="loc_afyaContingenciesCorrespondentAmount" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaContingenciesCorrespondentAmount" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://afya.com.br/role/SubsequentEventsDetailsNarrative" xlink:title="00000113 - Disclosure - Subsequent events (Details Narrative)">
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:label="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="loc_ifrs-fullStatementOfChangesInEquityTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullDisclosureOfNotesAndOtherExplanatoryInformationExplanatory" xlink:to="loc_ifrs-fullStatementOfChangesInEquityTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IfrsStatementLineItems" xlink:label="loc_afyaIfrsStatementLineItems" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_afyaIfrsStatementLineItems" order="200" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalAxis" xlink:label="loc_ifrs-fullClassesOfShareCapitalAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullClassesOfShareCapitalAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ClassesOfShareCapitalMember" xlink:label="loc_ifrs-fullClassesOfShareCapitalMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalAxis" xlink:to="loc_ifrs-fullClassesOfShareCapitalMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassAOrdinarySharesMember" xlink:label="loc_afyaClassAOrdinarySharesMember" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassAOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_ClassBOrdinarySharesMember" xlink:label="loc_afyaClassBOrdinarySharesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_afyaClassBOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_OrdinarySharesMember" xlink:label="loc_ifrs-fullOrdinarySharesMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullClassesOfShareCapitalMember" xlink:to="loc_ifrs-fullOrdinarySharesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_SignificantInvestmentsInSubsidiariesAxis" xlink:label="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForSubsidiariesMember" xlink:label="loc_ifrs-fullEntitysTotalForSubsidiariesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullSignificantInvestmentsInSubsidiariesAxis" xlink:to="loc_ifrs-fullEntitysTotalForSubsidiariesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_IClinicParticipacoesSAMember" xlink:label="loc_afyaIClinicParticipacoesSAMember" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForSubsidiariesMember" xlink:to="loc_afyaIClinicParticipacoesSAMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_CategoriesOfRelatedPartiesAxis" xlink:label="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullStatementOfChangesInEquityTable" xlink:to="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" order="30" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_EntitysTotalForRelatedPartiesMember" xlink:label="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullCategoriesOfRelatedPartiesAxis" xlink:to="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_NicolauCarvalhoEstevesMember" xlink:label="loc_afyaNicolauCarvalhoEstevesMember" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ifrs-fullEntitysTotalForRelatedPartiesMember" xlink:to="loc_afyaNicolauCarvalhoEstevesMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="afya-20211231.xsd#afya_RepurchaseOfOrdinaryShares" xlink:label="loc_afyaRepurchaseOfOrdinaryShares" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_afyaRepurchaseOfOrdinaryShares" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_PercentageOfVotingEquityInterestsAcquired" xlink:label="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullPercentageOfVotingEquityInterestsAcquired" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd#ifrs-full_ParValuePerShare" xlink:label="loc_ifrs-fullParValuePerShare" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_afyaIfrsStatementLineItems" xlink:to="loc_ifrs-fullParValuePerShare" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670107815112">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">20-F<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentRegistrationStatement', window );">Document Registration Statement</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentShellCompanyReport', window );">Document Shell Company Report</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AFYA LIMITED<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001771007<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">D5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Alameda Oscar
Niemeyer<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 119<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Nova Lima
Minas Gerais<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class A common shares<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AFYA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAccountingStandard', window );">Document Accounting Standard</a></td>
<td class="text">International Financial Reporting Standards<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm Id</a></td>
<td class="text">1448<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">ERNST &
YOUNG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Belo Horizonte,
Brazil<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">46,265,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="nump">45,802,763<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember', window );">Business Contact [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Alameda Oscar Niemeyer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">No. 119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Minas Gerais<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">BR<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">55<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">3515-7550<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelName', window );">Contact Personnel Name</a></td>
<td class="text">Virgilio Deloy
Capobianco Gibbon<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_ContactPersonnelEmailAddress', window );">Contact Personnel Email Address</a></td>
<td class="text">ir@afya.com.br<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelEmailAddress">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Email address of contact personnel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelEmailAddress</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_ContactPersonnelName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of contact personnel</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_ContactPersonnelName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAccountingStandard">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAccountingStandard</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:accountingStandardItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentRegistrationStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a registration statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentRegistrationStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentShellCompanyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentShellCompanyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_BusinessContactMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108141176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of financial position - BRL (R$)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssetsAbstract', window );"><strong>Current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 748,562,000<span></span>
</td>
<td class="nump">R$ 1,045,042,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Trade receivables</a></td>
<td class="nump">378,351,000<span></span>
</td>
<td class="nump">302,317,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Inventories', window );">Inventories</a></td>
<td class="nump">11,827,000<span></span>
</td>
<td class="nump">7,509,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxAssets', window );">Recoverable taxes</a></td>
<td class="nump">25,579,000<span></span>
</td>
<td class="nump">21,019,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentAssets', window );">Other assets</a></td>
<td class="nump">42,533,000<span></span>
</td>
<td class="nump">29,614,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Total current assets</a></td>
<td class="nump">1,206,852,000<span></span>
</td>
<td class="nump">1,405,501,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssetsAbstract', window );"><strong>Non-current assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,053,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentTradeReceivable', window );">Trade receivables</a></td>
<td class="nump">27,442,000<span></span>
</td>
<td class="nump">7,627,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">180,306,000<span></span>
</td>
<td class="nump">74,037,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Investment in associate</a></td>
<td class="nump">48,477,000<span></span>
</td>
<td class="nump">51,410,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">Property and equipment</a></td>
<td class="nump">419,808,000<span></span>
</td>
<td class="nump">260,381,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets</a></td>
<td class="nump">663,686,000<span></span>
</td>
<td class="nump">419,074,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsOtherThanGoodwill', window );">Intangible assets</a></td>
<td class="nump">3,900,835,000<span></span>
</td>
<td class="nump">2,573,010,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Total non-current assets</a></td>
<td class="nump">5,240,554,000<span></span>
</td>
<td class="nump">3,387,592,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="nump">6,447,406,000<span></span>
</td>
<td class="nump">4,793,093,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilitiesAbstract', window );"><strong>Current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayables', window );">Trade payables</a></td>
<td class="nump">59,098,000<span></span>
</td>
<td class="nump">35,743,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShorttermBorrowings', window );">Loans and financing</a></td>
<td class="nump">128,720,000<span></span>
</td>
<td class="nump">107,162,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">24,955,000<span></span>
</td>
<td class="nump">61,976,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">239,849,000<span></span>
</td>
<td class="nump">188,420,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayableCurrent', window );">Notes payable</a></td>
<td class="nump">14,478,000<span></span>
</td>
<td class="nump">10,503,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentDepositsFromCustomers', window );">Advances from customers</a></td>
<td class="nump">114,585,000<span></span>
</td>
<td class="nump">63,839,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan', window );">Labor and social obligations</a></td>
<td class="nump">131,294,000<span></span>
</td>
<td class="nump">77,855,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">26,715,000<span></span>
</td>
<td class="nump">32,976,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxLiabilitiesCurrent', window );">Income taxes payable</a></td>
<td class="nump">11,649,000<span></span>
</td>
<td class="nump">4,574,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherCurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">15,163,000<span></span>
</td>
<td class="nump">6,331,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Total current liabilities</a></td>
<td class="nump">766,506,000<span></span>
</td>
<td class="nump">589,379,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilitiesAbstract', window );"><strong>Non-current liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermBorrowings', window );">Loans and financing</a></td>
<td class="nump">1,246,156,000<span></span>
</td>
<td class="nump">510,323,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities&#160;</a></td>
<td class="nump">689,130,000<span></span>
</td>
<td class="nump">385,727,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">439,977,000<span></span>
</td>
<td class="nump">329,820,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayableNonCurrentLiabiites', window );">Notes payable</a></td>
<td class="nump">58,248,000<span></span>
</td>
<td class="nump">65,678,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentTaxesPayable', window );">Taxes payable</a></td>
<td class="nump">96,598,000<span></span>
</td>
<td class="nump">21,425,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LongtermLegalProceedingsProvision', window );">Provision for legal proceedings</a></td>
<td class="nump">148,287,000<span></span>
</td>
<td class="nump">53,139,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherNoncurrentLiabilities', window );">Other liabilities</a></td>
<td class="nump">2,486,000<span></span>
</td>
<td class="nump">3,822,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Total non-current liabilities</a></td>
<td class="nump">2,680,882,000<span></span>
</td>
<td class="nump">1,369,934,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Liabilities', window );">Total liabilities</a></td>
<td class="nump">3,447,388,000<span></span>
</td>
<td class="nump">1,959,313,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAbstract', window );"><strong>Equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="nump">17,000<span></span>
</td>
<td class="nump">17,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalPaidinCapital', window );">Additional paid-in capital</a></td>
<td class="nump">2,375,344,000<span></span>
</td>
<td class="nump">2,323,488,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ReserveOfSharebasedPayments', window );">Share-based compensation reserve</a></td>
<td class="nump">94,101,000<span></span>
</td>
<td class="nump">50,724,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TreasuryShares', window );">Treasury stock</a></td>
<td class="num">(152,630,000)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RetainedEarnings', window );">Retained earnings</a></td>
<td class="nump">631,317,000<span></span>
</td>
<td class="nump">407,991,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAttributableToOwnersOfParent', window );">Equity attributable to equity holders of the parent</a></td>
<td class="nump">2,948,149,000<span></span>
</td>
<td class="nump">2,782,220,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncontrollingInterests', window );">Non-controlling interests</a></td>
<td class="nump">51,869,000<span></span>
</td>
<td class="nump">51,560,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Total equity</a></td>
<td class="nump">3,000,018,000<span></span>
</td>
<td class="nump">2,833,780,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="nump">R$ 6,447,406,000<span></span>
</td>
<td class="nump">R$ 4,793,093,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTaxesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTaxesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotesPayableNonCurrentLiabiites">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotesPayableNonCurrentLiabiites</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentDepositsFromCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current deposits from customers. [Refer: Deposits from customers]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentDepositsFromCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current net defined benefit liability. [Refer: Net defined benefit liability]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The current amount of current tax liabilities. [Refer: Current tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph n<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_n&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph r<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_r&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Inventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Inventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The non-current portion of non-current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LongtermLegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Section Example 10 A court case<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 87<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LongtermLegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph q<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_q&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Paragraph 22<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_22&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentRestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentRestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherCurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherCurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherNoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherNoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ReserveOfSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity resulting from share-based payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ReserveOfSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RetainedEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A component of equity representing the entity's cumulative undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph IG6<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IG6&amp;doctype=Implementation%20Guidance<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RetainedEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShorttermBorrowings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShorttermBorrowings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph k<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_k&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TreasuryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>An entity&#8217;s own equity instruments, held by the entity or other members of the consolidated group.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TreasuryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108553064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of income and comprehensive income - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeStatementAbstract', window );"><strong>Profit or loss [abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">R$ 1,719,371<span></span>
</td>
<td class="nump">R$ 1,201,191<span></span>
</td>
<td class="nump">R$ 750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">(652,300)<span></span>
</td>
<td class="num">(434,654)<span></span>
</td>
<td class="num">(308,853)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="nump">1,067,071<span></span>
</td>
<td class="nump">766,537<span></span>
</td>
<td class="nump">441,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(622,615)<span></span>
</td>
<td class="num">(402,855)<span></span>
</td>
<td class="num">(239,120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherIncome', window );">Other (expenses) income, net</a></td>
<td class="num">(3,561)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="nump">2,594<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="nump">440,895<span></span>
</td>
<td class="nump">363,335<span></span>
</td>
<td class="nump">205,251<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">&#160;&#160;Finance income</a></td>
<td class="nump">64,566<span></span>
</td>
<td class="nump">62,290<span></span>
</td>
<td class="nump">51,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">&#160;&#160;Finance expenses</a></td>
<td class="num">(243,796)<span></span>
</td>
<td class="num">(98,269)<span></span>
</td>
<td class="num">(72,365)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncomeCost', window );">Finance result</a></td>
<td class="num">(179,230)<span></span>
</td>
<td class="num">(35,979)<span></span>
</td>
<td class="num">(20,676)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod', window );">Share of income of associate</a></td>
<td class="nump">11,797<span></span>
</td>
<td class="nump">7,698<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="nump">273,462<span></span>
</td>
<td class="nump">335,054<span></span>
</td>
<td class="nump">186,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="num">(31,179)<span></span>
</td>
<td class="num">(27,067)<span></span>
</td>
<td class="num">(14,175)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="nump">242,283<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherComprehensiveIncome', window );">Other comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">&#160;Total comprehensive income</a></td>
<td class="nump">242,283<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToAbstract', window );"><strong>Income attributable to</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToOwnersOfParent', window );">&#160;&#160;Equity holders of the parent</a></td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">292,075<span></span>
</td>
<td class="nump">153,916<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests', window );">&#160;&#160;Non-controlling interests</a></td>
<td class="nump">R$ 18,957<span></span>
</td>
<td class="nump">R$ 15,912<span></span>
</td>
<td class="nump">R$ 18,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsPerShareAbstract', window );"><strong>Basic earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Per common share</a></td>
<td class="nump">R$ 2.39<span></span>
</td>
<td class="nump">R$ 3.15<span></span>
</td>
<td class="nump">R$ 2.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsPerShareAbstract', window );"><strong>Diluted earnings per share</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Per common share</a></td>
<td class="nump">R$ 2.37<span></span>
</td>
<td class="nump">R$ 3.12<span></span>
</td>
<td class="nump">R$ 2.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncomeCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income or cost associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncomeCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_viii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 91<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_91_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of operating income that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossAttributableToOwnersOfParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81B<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81B_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossAttributableToOwnersOfParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39M<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39M_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670099989640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated statements of changes in equity - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Issued capital [member]</div></th>
<th class="th"><div>Additional paid-in capital [member]</div></th>
<th class="th"><div>Treasury shares [member]</div></th>
<th class="th"><div>Reserve of share-based payments [member]</div></th>
<th class="th"><div>Other reserves [member]</div></th>
<th class="th"><div>Retained Earnings Reserve [Member]</div></th>
<th class="th"><div>Retained earnings [member]</div></th>
<th class="th"><div>Equity attributable to owners of parent [member]</div></th>
<th class="th"><div>Non-controlling interests [member]</div></th>
<th class="th"><div>Total</div></th>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Beginning balance, value at Dec. 31, 2018</a></td>
<td class="nump">R$ 315,000<span></span>
</td>
<td class="nump">R$ 125,014<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 2,161<span></span>
</td>
<td class="nump">R$ 7,223<span></span>
</td>
<td class="nump">R$ 52,584<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 501,982<span></span>
</td>
<td class="nump">R$ 88,372<span></span>
</td>
<td class="nump">R$ 590,354<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">153,916<span></span>
</td>
<td class="nump">153,916<span></span>
</td>
<td class="nump">18,846<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">153,916<span></span>
</td>
<td class="nump">153,916<span></span>
</td>
<td class="nump">18,846<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalIncreaseWithCash', window );">Capital increase</a></td>
<td class="nump">150,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">150,000<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">150,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Capital increase from shares contribution of shareholders</a></td>
<td class="nump">48,768<span></span>
</td>
<td class="nump">36,358<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">85,126<span></span>
</td>
<td class="num">(44,774)<span></span>
</td>
<td class="nump">40,352<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalIncreaseFromCorporateReorganization', window );">Capital increase from the corporate reorganization</a></td>
<td class="nump">122,062<span></span>
</td>
<td class="nump">137,051<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">259,113<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">259,113<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">17,627<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,114<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">35,742<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">35,742<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AllocationToAdditionalPaidinCapital', window );">Allocation to additional paid-in capital</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">33,001<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(33,001)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
<td class="num">(38,000)<span></span>
</td>
<td class="num">(13,812)<span></span>
</td>
<td class="num">(51,812)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DividendsCancelled', window );">Dividends cancelled</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,107<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,107<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,107<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CorporateReorganization', window );">Corporate reorganization</a></td>
<td class="num">(635,830)<span></span>
</td>
<td class="nump">668,904<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(2,161)<span></span>
</td>
<td class="num">(7,223)<span></span>
</td>
<td class="num">(23,690)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of common shares in follow-on public offering</a></td>
<td class="nump">16<span></span>
</td>
<td class="nump">992,762<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">992,778<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">992,778<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Shares issuance cost</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(79,670)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(79,670)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(79,670)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2019</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">1,931,047<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">18,114<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">115,916<span></span>
</td>
<td class="nump">2,065,094<span></span>
</td>
<td class="nump">48,632<span></span>
</td>
<td class="nump">2,113,726<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">292,075<span></span>
</td>
<td class="nump">292,075<span></span>
</td>
<td class="nump">15,912<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">292,075<span></span>
</td>
<td class="nump">292,075<span></span>
</td>
<td class="nump">15,912<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners', window );">Capital increase from shares contribution of shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">17,531<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,531<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">17,531<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,444<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">32,610<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,054<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">38,054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaid', window );">Dividends declared</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(12,984)<span></span>
</td>
<td class="num">(12,984)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssueOfEquity', window );">Issuance of common shares in follow-on public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">389,170<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">389,170<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">389,170<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Shares issuance cost</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(19,704)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,704)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(19,704)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2020</a></td>
<td class="nump">17<span></span>
</td>
<td class="nump">2,323,488<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">50,724<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">407,991<span></span>
</td>
<td class="nump">2,782,220<span></span>
</td>
<td class="nump">51,560<span></span>
</td>
<td class="nump">2,833,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">18,957<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ComprehensiveIncome', window );">Total comprehensive income</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">223,326<span></span>
</td>
<td class="nump">18,957<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalIncreaseWithCash', window );">Capital increase</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">74,500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions', window );">Share-based compensation</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">43,377<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(213,722)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasurySharesTransferredFromExerciseOfOptions', window );">Treasury shares transferred from exercise of options</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(21,861)<span></span>
</td>
<td class="nump">55,197<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,336<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">33,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination', window );">Treasury shares transferred from shares contribution on business combination</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(783)<span></span>
</td>
<td class="nump">5,895<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,112<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">5,112<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DividendsDeclaredToNoncontrollingInterests', window );">Dividends declared to non-controlling interests</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
<td class="num">(18,648)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Ending balance, value at Dec. 31, 2021</a></td>
<td class="nump">R$ 17<span></span>
</td>
<td class="nump">R$ 2,375,344<span></span>
</td>
<td class="num">R$ (152,630)<span></span>
</td>
<td class="nump">R$ 94,101<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 631,317<span></span>
</td>
<td class="nump">R$ 2,948,149<span></span>
</td>
<td class="nump">R$ 51,869<span></span>
</td>
<td class="nump">R$ 3,000,018<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllocationToAdditionalPaidinCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllocationToAdditionalPaidinCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalIncreaseFromCorporateReorganization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalIncreaseFromCorporateReorganization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalIncreaseWithCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalIncreaseWithCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CorporateReorganization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CorporateReorganization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsCancelled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsCancelled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsDeclaredToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsDeclaredToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasuryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasuryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredFromExerciseOfOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredFromExerciseOfOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ComprehensiveIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ix<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ix&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ComprehensiveIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends recognised as distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 107<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_107&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssueOfEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in equity through the issue of equity instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssueOfEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108202472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated statements of cash flows - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncomeLossBeforeIncomeTaxes', window );">Income before income taxes</a></td>
<td class="nump">R$ 273,462<span></span>
</td>
<td class="nump">R$ 335,054<span></span>
</td>
<td class="nump">R$ 186,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract', window );"><strong>Adjustments to reconcile income before income taxes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense', window );">Depreciation and amortization</a></td>
<td class="nump">154,220<span></span>
</td>
<td class="nump">108,744<span></span>
</td>
<td class="nump">73,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment', window );">Disposals of property and equipment</a></td>
<td class="nump">1,604<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">78<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsIntangibleAssetsAndGoodwill', window );">Disposals of intangible</a></td>
<td class="nump">2,374<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities', window );">Allowance for doubtful accounts</a></td>
<td class="nump">47,819<span></span>
</td>
<td class="nump">32,081<span></span>
</td>
<td class="nump">15,040<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForSharebasedPayments', window );">Share-based compensation expense</a></td>
<td class="nump">43,377<span></span>
</td>
<td class="nump">32,610<span></span>
</td>
<td class="nump">18,114<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains', window );">Net foreign exchange differences</a></td>
<td class="nump">17,973<span></span>
</td>
<td class="nump">4,613<span></span>
</td>
<td class="num">(13,321)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForFinanceCosts', window );">Net loss (gain) on derivatives</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(20,739)<span></span>
</td>
<td class="nump">1,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccruedInterestOfOpeartingActivities', window );">Accrued interest</a></td>
<td class="nump">108,437<span></span>
</td>
<td class="nump">25,543<span></span>
</td>
<td class="nump">24,002<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Accrued lease interest</a></td>
<td class="nump">67,212<span></span>
</td>
<td class="nump">44,458<span></span>
</td>
<td class="nump">31,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ShareOfIncomeOfAssociateOfOpeartingActivities', window );">Share of income of associate</a></td>
<td class="num">(11,797)<span></span>
</td>
<td class="num">(7,698)<span></span>
</td>
<td class="num">(2,362)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForProvisions', window );">Provision for legal proceedings</a></td>
<td class="nump">10,664<span></span>
</td>
<td class="nump">5,354<span></span>
</td>
<td class="num">(2,568)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract', window );"><strong>Changes in assets and liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable', window );">Trade receivables</a></td>
<td class="num">(79,665)<span></span>
</td>
<td class="num">(164,286)<span></span>
</td>
<td class="num">(35,556)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories', window );">Inventories</a></td>
<td class="num">(3,720)<span></span>
</td>
<td class="num">(3,110)<span></span>
</td>
<td class="num">(236)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseDecreaseInRecoverableTaxes', window );">Recoverable taxes</a></td>
<td class="num">(2,327)<span></span>
</td>
<td class="num">(13,709)<span></span>
</td>
<td class="num">(3,940)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets', window );">Other assets</a></td>
<td class="num">(19,425)<span></span>
</td>
<td class="num">(23,902)<span></span>
</td>
<td class="num">(7,403)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable', window );">Trade payables</a></td>
<td class="nump">14,479<span></span>
</td>
<td class="nump">4,475<span></span>
</td>
<td class="nump">3,029<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncomeTaxExpense', window );">Taxes payables</a></td>
<td class="num">(14,902)<span></span>
</td>
<td class="num">(552)<span></span>
</td>
<td class="nump">4,940<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers', window );">Advances from customers</a></td>
<td class="nump">36,009<span></span>
</td>
<td class="num">(1,951)<span></span>
</td>
<td class="nump">19,324<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherAdjustmentsForNoncashItems', window );">Labor and social obligations</a></td>
<td class="nump">23,449<span></span>
</td>
<td class="nump">11,125<span></span>
</td>
<td class="nump">6,124<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities', window );">Other liabilities</a></td>
<td class="num">(2,693)<span></span>
</td>
<td class="nump">22,771<span></span>
</td>
<td class="num">(10,881)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForReconcileProfitLoss', window );">&#160;Total</a></td>
<td class="nump">666,550<span></span>
</td>
<td class="nump">390,881<span></span>
</td>
<td class="nump">307,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities', window );">Income taxes paid</a></td>
<td class="num">(35,683)<span></span>
</td>
<td class="num">(19,374)<span></span>
</td>
<td class="num">(8,506)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInOperatingActivities', window );">Net cash flows from operating activities</a></td>
<td class="nump">630,867<span></span>
</td>
<td class="nump">371,507<span></span>
</td>
<td class="nump">299,216<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities', window );">Acquisition of property and equipment</a></td>
<td class="num">(125,869)<span></span>
</td>
<td class="num">(89,832)<span></span>
</td>
<td class="num">(56,964)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends received</a></td>
<td class="nump">11,770<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities', window );">Acquisition of intangibles assets</a></td>
<td class="num">(150,931)<span></span>
</td>
<td class="num">(47,753)<span></span>
</td>
<td class="num">(64,745)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCashOfInvestingActivities', window );">Restricted cash</a></td>
<td class="nump">8,103<span></span>
</td>
<td class="nump">14,788<span></span>
</td>
<td class="nump">7,530<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaymentsOfNotesPayable', window );">Payments of notes payable</a></td>
<td class="num">(11,068)<span></span>
</td>
<td class="num">(5,974)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities', window );">Acquisition of subsidiaries, net of cash acquired</a></td>
<td class="num">(1,006,057)<span></span>
</td>
<td class="num">(913,991)<span></span>
</td>
<td class="num">(241,568)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAdvancesAndLoansFromRelatedParties', window );">Loans to related parties</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">1,598<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInInvestingActivities', window );">Net cash flows used in investing activities</a></td>
<td class="num">(1,274,052)<span></span>
</td>
<td class="num">(1,042,762)<span></span>
</td>
<td class="num">(354,149)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IssuanceOfLoansAndFinancing', window );">Issuance of loans and financing</a></td>
<td class="nump">809,539<span></span>
</td>
<td class="nump">605,041<span></span>
</td>
<td class="nump">7,383<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities', window );">Payments of loans and financing</a></td>
<td class="num">(158,076)<span></span>
</td>
<td class="num">(155,090)<span></span>
</td>
<td class="num">(75,093)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities', window );">Payments of lease liabilities</a></td>
<td class="num">(87,751)<span></span>
</td>
<td class="num">(55,455)<span></span>
</td>
<td class="num">(39,779)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TreasuryShares1', window );">Treasury shares</a></td>
<td class="num">(213,722)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalIncreaseOfFinancialActivities', window );">Capital increase</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">5,444<span></span>
</td>
<td class="nump">167,628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities', window );">Dividends paid to non-controlling interests</a></td>
<td class="num">(18,648)<span></span>
</td>
<td class="num">(12,984)<span></span>
</td>
<td class="num">(51,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities', window );">Proceeds from &#160;shares public offering</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">389,170<span></span>
</td>
<td class="nump">992,778<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharebasedCompensationPlanReceipts', window );">Share-based compensation plan receipts</a></td>
<td class="nump">33,336<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsForShareIssueCosts', window );">Share issuance costs</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(19,704)<span></span>
</td>
<td class="num">(79,670)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashFlowsFromUsedInFinancingActivities', window );">Net cash flows from (used in) financing activities</a></td>
<td class="nump">364,678<span></span>
</td>
<td class="nump">756,422<span></span>
</td>
<td class="nump">921,435<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents', window );">Net foreign exchange differences</a></td>
<td class="num">(17,973)<span></span>
</td>
<td class="nump">16,666<span></span>
</td>
<td class="nump">14,447<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Net increase in cash and cash equivalents</a></td>
<td class="num">(296,480)<span></span>
</td>
<td class="nump">101,833<span></span>
</td>
<td class="nump">880,949<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the beginning of the year</a></td>
<td class="nump">1,045,042<span></span>
</td>
<td class="nump">943,209<span></span>
</td>
<td class="nump">62,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents at the end of the year</a></td>
<td class="nump">R$ 748,562<span></span>
</td>
<td class="nump">R$ 1,045,042<span></span>
</td>
<td class="nump">R$ 943,209<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccruedInterestOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccruedInterestOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalIncreaseOfFinancialActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalIncreaseOfFinancialActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncomeLossBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncomeLossBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInOperatingLiabilities1Abstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInOperatingLiabilities1Abstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseDecreaseInRecoverableTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseDecreaseInRecoverableTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IssuanceOfLoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IssuanceOfLoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedCashOfInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedCashOfInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareOfIncomeOfAssociateOfOpeartingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareOfIncomeOfAssociateOfOpeartingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharebasedCompensationPlanReceipts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharebasedCompensationPlanReceipts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TreasuryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TreasuryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForFinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForFinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForReconcileProfitLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForReconcileProfitLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForSharebasedPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForSharebasedPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAdvancesAndLoansFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from advances and loans from related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAdvancesAndLoansFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 50<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_50_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in intangible assets and goodwill resulting from disposals. [Refer: Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for dividends paid by the entity, classified as financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 31<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_31&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherAdjustmentsForNoncashItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherAdjustmentsForNoncashItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsForShareIssueCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for share issue costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsForShareIssueCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 20<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=20&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103203144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory', window );">Corporate information</a></td>
<td class="text"><p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zQazWaK7wYYf" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">1</span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_822_zSAe1tVzeXy8">Corporate information</span></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Limited (&#8220;Afya&#8221;),
collectively with its subsidiaries referred to as the &#8220;Company&#8221;, is a holding company incorporated under the laws of the
Cayman Islands on March 22, 2019. Afya Limited became the holding company of Afya Participa&#231;&#245;es S.A. (hereafter referred
to as &#8220;Afya Brazil&#8221;), formerly denominated NRE Participa&#231;&#245;es S.A., through the completion of the corporate
reorganization in July 2019. Up to that date, Afya Limited did not have commenced operations and had only nominal assets and liabilities
and no material contingent liabilities or commitments. Accordingly, Afya Limited&#8217;s consolidated financial information substantially
reflect the operations of Afya Brazil after the corporate reorganization.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company is
formed by a network of higher education and post graduate institutions focused on medicine located in 18 Brazilian states forming the
largest educational group by the number of medical seats in the country and by services that comprises the development and sale of electronically
distributed educational courses on medicine science, related printed and technological educational content. The Company also offers services
to empower the physicians in their daily routine providing supporting clinic decisions thought mobile app subscription and deliver practice
management tools through a SaaS model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Corporate
reorganization</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 29, 2019,
Afya Brazil merged (i) BR Health Participa&#231;&#245;es S.A. (&#8220;BR Health&#8221;), a wholly-owned subsidiary of Bozano Educacional
II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia (&#8220;Crescera&#8221;) that controlled Guardaya Empreendimentos
and Participa&#231;&#245;es S.A. (&#8220;Guardaya&#8221;) and was one of Afya Brazil&#8217;s shareholders; and (ii) Guardaya which
owned <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190329__ifrs-full--BusinessCombinationsAxis__custom--GuardayaEmpreendimentosAndParticipacoesSAMember_zTSs8prpwbV6">100</span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Medcel Editora e Eventos S.A. (&#8220;Medcel Editora&#8221;) and CBB Web Servi&#231;os e Transmiss&#245;es On Line S.A. (&#8220;CBB
Web&#8221;), focused on medical residency preparation courses located in the state of S&#227;o Paulo, resulting in the transfer to
Afya Brazil of <span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zZhCbWeb9P15" title="Proportion of ownership interest in subsidiary">100</span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Medcel Editora and CBB Web and <span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAhGTBbODjkf" title="Proportion of ownership interest in subsidiary">15</span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
of Uni&#227;o Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;), a medical school located in the Federal District. On June
18, 2019 Afya Brazil acquired an additional <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190616__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zcLSbrmUB804" title="Proportion of ownership interest in subsidiary">15</span></span><span style="font-family: Arial, Helvetica, Sans-Serif">%
interest in UEPC resulting in an interest of <b><span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zDUvlz9EscHb" title="Percentage of voting equity interests acquired">30</span></b>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 7, 2019,
each of Afya Brazil&#180;s shareholders had agreed to contribute their respective shares on Afya Brazil into Afya Limited, <span id="xdx_90C_eifrs-full--RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_c20190707__20190708_zqqSgLf0rXok" title="Description of exchanging and rights of shares">exchanging
one common share into 28 Class A or Class B common shares</span> of Afya Limited. The holders of the Class A common shares and Class B common
shares have identical rights, except that (i) the holder of Class B common shares is entitled to 10 votes per share, whereas holders
of Class A common shares are entitled to one vote per share, (ii) Class B common shares have certain conversion rights and (iii) the
holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common shares and/or
preferred shares are proposed to be issued. The holders of Class A common shares and Class B common shares vote together as a single
class on all matters (including the election of directors) submitted to a vote of shareholders, unless otherwise required by law and
subject to certain exceptions.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Initial
public offering</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 18, 2019,
Afya Limited priced its initial public offering (&#8220;IPO&#8221;) of <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_c20190718__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)">13,744,210</span> Class A common shares, which began trading on the Nasdaq
Global Select Market (&#8220;NASDAQ&#8221;) on July 19, 2019 under the symbol &#8220;AFYA&#8221;. On July 23, 2019, the underwriters
exercised the option to buy an additional <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__custom--SaleOfStockAxis__custom--OverAllotmentsMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zeQgmPLluhy" title="Number of shares issed (shares)">2,061,631</span> Class A common shares to cover over-allotments, totaling <span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)">15,805,841</span> Class A common
shares, which <span id="xdx_903_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_pdd" title="Number of shares issed (shares)">13,888,887</span> Class A common shares were offered by Afya Limited and <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)">1,916,954</span> Class A common shares were offered by the selling
shareholders at the initial public offering price. The initial offering price was US$ <span id="xdx_90E_ecustom--NumberOfPerShares_iI_pid_uBRLPShares_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zOI7f2nBetEc" title="per share">19.00</span> per Class A common share.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 23, 2019,
the share capital of Afya Limited was increased by <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zHld9PSt37q3" title="Number of shares issed (shares)">13,888,887</span> Class A shares through the proceeds received as a result of the IPO of
US$ <span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_z4T2at628cIe" title="Proceeds from issue of shares">263,888</span> thousand (or R$ <span id="xdx_90A_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zoAfUHzaAdSi" title="Proceeds from issue of shares">992,778</span>). The net proceeds from the IPO were US$ <span id="xdx_905_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zdqkcqwYipk3" title="Net proceeds from issue of shares">242,711</span> thousand (or R$ <span id="xdx_90B_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zjDEP3lk5UCl" title="Net proceeds from issue of shares">913,108</span>), after deducting US$ <span id="xdx_904_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zMhznXuV3LTg" title="Fee and commission expense">15,833</span>
thousand (or R$ <span id="xdx_90D_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zPcqdPb29D06" title="Fee and commission expense">59,566</span>) in underwriting discounts and commissions and other offering expenses totaled US$ <span id="xdx_900_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zzttUX1Zesmi" title="Other offering expenses">5,344</span> thousand (or R$ <span id="xdx_90D_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zwTrsvDKuUMi" title="Other offering expenses">20,104</span>).
The share issuance costs totaled R$ <span id="xdx_902_eifrs-full--ShareIssueRelatedCost_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pn3n3" title="Share issuance costs">79,670</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Limited transferred
US$ <span id="xdx_909_ecustom--TransferredAmountToGBankAccounts_c20210101__20211231_zmniPZSOQgi8" title="Transferred amount to bank accounts">251,800</span> thousand (or R$ <span id="xdx_902_ecustom--TransferredAmountToGBankAccounts_c20200101__20201231_zuvwKcw4a8u8" title="Transferred amount to bank accounts">961,438</span>) of the net proceeds from the Cayman Islands to bank accounts in Brazil. These deposits were invested
on first-line financial institutions in Brazil and denominated in Brazilian reais.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Issuance
of additional common shares</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 6,
2020, Afya completed its follow-on public offering of <span id="xdx_90B_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of additional common shares issued">3,019,928</span> Class A common shares offered by the Company and <span id="xdx_909_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_pdd" title="Number of additional common shares issued">9,406,812</span> Class A common
shares offered by the selling shareholders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The offering price
was US$ <span id="xdx_902_ecustom--AdditionalOfferingPrice_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_pdd" title="Additional offering price">27.50</span> per Class A common share and gross proceeds of US$ <span id="xdx_904_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zJ7mreNY4214" title="Additional shares gross proceeds">83,048</span> thousand (R$ <span id="xdx_90E_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJeeASryH5Re" title="Additional shares gross proceeds">358,286</span>). The Company received net proceeds of US$
<span id="xdx_900_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zUAlIhoBrTRj" title="Net proceeds of additional shares">78,846 </span>thousand (R$ <span id="xdx_906_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_z0PXlltCxZx2" title="Net proceeds of additional shares">339,648</span>), after deducting US$ <span id="xdx_900_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_z0TwEq31xdLl" title="Other offering expenses">4,202</span> thousand (R$ <span id="xdx_903_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJ2kpzSUC4rl" title="Other offering expenses">18,638</span>) in underwriting discounts, commissions and other offering
expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 10, 2020,
the underwriters exercised their option to acquire additional <span id="xdx_900_ecustom--NumberOfAdditionalCommonSharesIssued_c20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_pdd" title="Number of additional common shares issued">240,552</span> Class A common shares at the offering price, resulting in gross
proceeds of US$ <span id="xdx_905_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zmb8OsxCNcga" title="Additional shares gross proceeds">6,615</span> thousand (R$ <span id="xdx_90B_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zeOESRIFVE4j" title="Additional shares gross proceeds">30,884</span>). The net proceeds from the additional shares were US$ <span id="xdx_90F_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zZgOWrs6vvBk" title="Net proceeds of additional shares">6,387</span> thousand (R$ <span id="xdx_903_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zoPt9P1kfc8d" title="Net proceeds of additional shares">29,819</span>), after deducting
U$ 228 thousand (R$ <span id="xdx_908_ecustom--OtherOfferingExpenses_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zW8z2nx53BFe" title="Other offering expenses">1,066</span>) in underwriting discounts and commissions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Afya
transferred US$ <span id="xdx_90D_eifrs-full--ProceedsFromIssueOfOrdinaryShares_uUSDBRL_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zGBVnaPPX0K7">68,060</span> thousand (R$ 294,312) of the net proceeds to bank accounts in Brazil with an increase in the capital of Afya Brazil.
These deposits were invested in first-line financial institutions in Brazil and denominated in Brazilian reais.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Acquisitions
in 2021</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(<span style="background-color: white">i)
On January 21, 2021, Afya Brazil acquired iClinic (comprised by iClinic Participa&#231;&#245;es S.A., iClinic Desenvolvimento de
Software Ltda. and Black River Brazil Participa&#231;&#245;es S.A.). iClinic is a SaaS model physician focused technology company
and the leading medical practice management software in Brazil. See Note 5.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(ii)
On March 25, 2021, Afya Brazil acquired Medicinae Solutions S.A. (&#8220;Medicinae&#8221;), through the acquisition of <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zkE3PCYSJSJl" title="Percentage of voting equity interests acquired">100</span>% of its shares.
Medicinae is a leading Brazilian healthcare technology company that specializes in healthcare payments and financial services. See Note
5.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(iii)
On April 8, 2021, Afya Brazil acquired <span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_zMCsl38jUynh" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of Medical Harbour Aparelhos M&#233;dicos Hospitalares e Servi&#231;os
em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;). Medical Harbour offers educational health and medical imaging solutions through
an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration, and
knowledge of human anatomy with digital resources. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(iv)
On April 16, 2021, Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaMember_zsi0QUe7Ycbg" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of Cliquefarma Drogarias Online Ltda. (&#8220;Cliquefarma&#8221;),
a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in
Brazil. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(v)
On May 13, 2021, Afya Brazil acquired <span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiadaInformacaoLtdaMember_zjOOWTIdjOCi" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of Shosp Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;),
which provides a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their financials,
patients appointments, medical records, marketing, and others. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(vi)
On June 1, 2021, Afya Brazil acquired <span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraodeEducacaoSuperiorLtdMember_z80GEkQ1zN98" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda.
(&#8220;UNIFIPMoc&#8221;), which provides a post-secondary education institution with government authorization to offer on-campus, undergraduate
degrees programs in medicine and health, as well as other courses,in the states of Minas Gerais and Bahia. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(vii)
On August 4, 2021, Afya Brazil acquired <span id="xdx_90F_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804_zQk1K6CEdM" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of (&#8220;Unigranrio&#8221;), comprised of (i) Companhia Nilza
Cordeiro Herdy de Educa&#231;&#227;o e Cultura; (ii) Instituto de Ensino Superior de Palho&#231;a S/S Ltda.; (iii) Sociedade Educacional
de Palho&#231;a S/S Ltda.; and (iv) Policl&#237;nica e Centro de Est&#233;tica Duque de Caxias Ltda. Unigranrio is a post-secondary
education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and
health, as well as other courses, in the States of Rio de Janeiro and Santa Catarina. See Note 5.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">(viii)
On </span><span style="font-family: Arial, Helvetica, Sans-Serif">October 1, 2021, Afya Brazil <span style="background-color: white">acquired
</span><span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesdeTecnologiaLtdaMember_z1LXS9gDUpI1" title="Percentage of voting equity interests acquired">100</span>% of the total share capital of (&#8220;RX PRO&#8221;), comprised of (i) RX PRO Solu&#231;&#245;es de Tecnologia Ltda.
and (ii) RX PRO LOG Transporte e Logistica Ltda.. RX PRO consists of a solution that connects physicians with the pharmaceutical industry,
providing specialized and personalized marketing for those companies, in a more convenient way for physicians. <span style="background-color: white">See
Note 5.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(ix) On November
05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized the operation
of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil
pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of
Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the transaction does not fall
under the definition of business, but an acquisition of license with indefinite useful life recognized in intangible assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: italic 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"><span style="text-decoration: underline">COVID-19</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In December 2019,
a novel strain of coronavirus (COVID-19) was reported to have emerged in Wuhan, China. COVID-19 has since spread to most of the countries
around the globe, including every state in Brazil. On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a
pandemic, and on March 20, 2020 the Brazilian federal government declared a national emergency with respect to COVID-19.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Since March 17,
2020, there has been some interruption of our on-campus activities due to Brazilian government authorities&#8217; mandatory lockdowns.
We managed to rapidly adapt our business to these unusual times, and although there has been an interruption of our on-campus activities,
we are offering our non-practical educational activities to our students through our online platform (rather than on-site). Regarding
the offering of practical classes, we quickly resumed our in-hospital and health care residency programs for fifth and sixth-year students,
which represents the largest portion of our practical curriculum.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">During 2020, the
States of Rio de Janeiro, Par&#225;, Tocantins, Piau&#237;, Rond&#244;nia, Bahia and Maranh&#227;o had issued state decrees granting
discounts to our students because of COVID-19. These mandatory discounts have been suspended as their constitutionality has been challenged
in the superior courts. As long as it has not been declared constitutional, we started to invoice our students without these discounts
and, from March 2021, with the discount granted during 2020.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Additionally, we
are also face individual and collective legal proceedings all across the country. On November 18, 2021, the Brazilian Federal Court of
Justice (STF) decided, by majority of the votes, that any lawsuit with decisions to apply linear discounts in monthly tuition fees for
private universities with respect to the COVID-19 pandemic are unconstitutional. The decisions were made in connection to the suits &#8220;Argui&#231;&#245;es
de Descumprimento de Preceito Fundamental &#8211; ADPF&#8221;, numbers 706 e 713, distributed by ANUP (Associa&#231;&#227;o Nacional
das Universidades Particulares) e CRUB (Conselho de Reitores das Universidades Brasileiras), respectively. Therefore, the Company shall
not apply linear discounts in any active monthly tuition fees that are related to the effects to the Covid-19 pandemic. Regarding the
discounts granted by the date of issuance of these financial statements, the Company is charging back the students as final legal decisions
are given by Brazilian courts.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The total mandatory
discounts granted due to COVID-19, net of discounts that have been recovered from previous period, totaled R$ <span id="xdx_903_eifrs-full--LegalProceedingsProvision_iI_c20211231_zKWFazDz5acd">33,081</span> during 2021 and
R$ <span id="xdx_90D_eifrs-full--LegalProceedingsProvision_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWD9XnjyR1de" title="Amount of legal proceedings">24,800</span> was related to FCMPB (R$ <span id="xdx_90F_eifrs-full--LegalProceedingsProvision_iI_c20201231_z9uJW14ffzJj" title="Amount of legal proceedings">6,545</span> for the year ended December 31, 2020).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of the date
of these financial statements, the COVID-19 pandemic has had no significant impact on the payment default rates of our students. Furthermore,
there have been no significant impacts on our financial performance and position of assets and there have been no significant changes
in our financial condition triggering impairment indicators in these financial statements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">By the date of
issuance of these financial statements all of the lockdown restrictions have been revoked by Brazilian authorities in our campus locations
and the Company has also successfully retaken all of its practical classes in medicines courses and all of its classroom classes.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103667128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory', window );">Significant accounting policies</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_z0iPNsYghpG2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">2</span></td><td id="xdx_82F_zNpHFSAhsv4b"><span style="font-family: Arial, Helvetica, Sans-Serif">Significant
                                            accounting policies</span></td></tr></table>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">2.1
Basis for preparation of the consolidated financial statements</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS)
as issued by the International Accounting Standards Board (IASB).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
consolidated financial statements have been prepared on a historical cost basis, except for derivative financial instruments that have
been measured at fair value.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
corporate reorganization described in Note 1, occurred on July 7, 2019, was accounted for as a reorganization of entities under common
control whereby Afya Limited was created as a holding company of Afya Brazil. As a result, the assets and liabilities of Afya Brazil
is carried at historical cost and there was no step-up in basis or goodwill, or other intangible assets recorded as a result of the corporate
reorganization.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As
a result, the consolidated financial statements prepared by the Company subsequent to the completion of the reorganization are presented
&#8220;as if&#8221; Afya Brazil is the predecessor of the Company. Accordingly, these consolidated financial statements reflect: (i)
the historical operating results of Afya Brazil prior to the reorganization; (ii) the consolidated results of the Company and Afya Brazil
following the reorganization; (iii) the assets and liabilities of Afya Brazil at their historical cost; and (iv) the Company&#8217;s
equity and earnings per share for all periods presented.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya
Limited is a holding company, as such the primary source of revenue derives from its interest on the operational companies in Brazil.
As result, the Brazilian Real has been assessed as the Company`s functional currency.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The consolidated
financial statements are presented in Brazilian reais (&#8220;BRL&#8221; or &#8220;R$&#8221;), which is the Company&#8217;s functional
and presentation currency. All amounts are rounded to the nearest thousand.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These consolidated
financial statements as of and for the year ended December 31, 2021 were authorized for issue by the Board of Directors on March 31,
2022.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.2
Basis consolidation</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_891_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zsVPd9Duk2yg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_ziR2Bi73TCt4">The table below
is a list of the Company&#8217;s subsidiaries and associate:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Direct
    and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 37%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Principal
    activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Investment
    type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z9jrchiGBFF5" title="Name">Afya
    Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Holding</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Nova
    Lima - MG</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zfPPjlT6Kkgk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z81sgS5rqk5d">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zlLqRdcvRFHg" title="Name">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. &#8211; (&#8220;ITPAC Porto&#8221;)</span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Porto
    Nacional - TO</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zuPMmw3wfPnh">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_z1gCmCNpQ22l">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zp8cDC89brzd" title="Name">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos S.A. &#8211; (&#8220;ITPAC Araguaina&#8221;)</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Aragua&#237;na
    - TO</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zZr780lHnMKj">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_znkcPDndLpHg">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zzgTEeAITCaf" title="Name">Uni&#227;o
    Educacional do Vale do A&#231;o S.A. &#8211; (&#8220;UNIVA&#199;O&#8221;)</span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    undergraduate degree program</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Ipatinga
    - MG</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zw9mKjXKumXe">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zmRXUq8RcCQf">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8lUk4TjP301" title="Name">IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Jo&#227;o Del Rei - MG</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zhgnUXrf9B6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8zMttg6TuG2">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Name">Instituto
    de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Parna&#237;ba
    - PI</span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zXZfBs9lbLO1">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7YhIBToUkM">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Name">Centro
    de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    undergraduate degree program</span></td>
    <td id="xdx_987_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Itajub&#225;
    - MG</span></td>
    <td id="xdx_989_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zk7AvKsTopUg">60</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zR74VG9GF9n4">60</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Name">Instituto
    de Ensino Superior do Piau&#237; S.A. (&#8221;IESP&#8221;)</span> </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Teresina
    - PI</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1Fvs8Tu0qc6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zZLxsFwTVQV4">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zwVz5DAgrVC4" title="Name">Centro
    Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;)</span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zG1GHFtBdDc3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Outpatient
    care</span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zMRPtND9HMda" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Teresina
    - PI</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z1bd0JojSvSc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zPlN4mLVXMO7">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSCfLmYxV9Yb">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Name">FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Pato
    Branco - PR</span></td>
    <td id="xdx_988_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5itm1udu7si">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zNoH6J07gun">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zkBXSmgej9Vl" title="Name">Medcel
    Editora e Eventos S.A. (&#8220;Medcel&#8221;)</span> </span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWoGVwZ1Oz6b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medical
    education content</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zqPXxGnD3Icg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo - SP</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zFwBFHa8TK04" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWJfl7mO54r3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zIlljRou1qXd">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Name">Instituto
    Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;)</span> </span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zR9XvVblqBO5">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zBhFtS1cPyhe">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zcNVhEYP8Hfe" title="Name">ESMC
    Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;)</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zqkBLT94ust2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zWFpXKcyaYOd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zU7GNr6Ahbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zKCrhOJip3sl">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zeAarzahU0Jb">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Name">Instituto
    de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;)</span> </span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Graduate</span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Belo
    Horizonte - MG</span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zvAR6lnmH631">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ztIOR3UOML5c">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Name">Instituto
    Paraense de Educa&#231;&#227;o e Cultura Ltda (&#8220;IPEC&#8221;)</span> </span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    degree programs</span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marab&#225;
    - PA</span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zH1ceiFsZORe">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z78wqHEKQT44">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zH1Gzov441T5" title="Name">Sociedade
    Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;)</span> </span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zVJVK8SqdCEg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zWzd9WRAle0g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Itaperuna
    - RJ</span></td>
    <td id="xdx_987_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z26iLiewMOH" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z1pSxbqLpV8l">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z5Vsjtwez8q7">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z70LPVoBpu08">Centro
    Universit&#225;rio S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zDt07DaWPUYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z6e62UX5uqmf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Porto
    Velho - RO</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zSfSL4ghqbGk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zbQoGUiBXOC4">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zl14O4MVUBc6">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zrRJ83407jc4">Peb
    Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda (&#8220;PebMed&#8221;)</span></span></td>
    <td id="xdx_989_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z3KxsZNZJoGl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Content
    and clinical tools and online platform</span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z06r92Wpk1Mj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro - RJ</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zwx3gE8e7o43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zZt2n2mB702a">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zEE4E4yT3B7k">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zDKOv7iS51ak">Faculdade
    de Ensino Superior da Amaz&#244;nia Reunida &#8211; (&#8220;FESAR&#8221;)</span></span></td>
    <td id="xdx_98E_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zkzNYLFNvlBl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zOhtVFZD7Cc2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Reden&#231;&#227;o
    &#8211; PA</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zv89I1HV3Mg5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zZ4rlxgEK94a">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zNgRf63Of6va">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zSQVD7WjIOii">Centro
    Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</span></span></td>
    <td id="xdx_98F_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zxFuJ4TzS5w9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    degree programs</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zDkL5P7ERIYh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Jo&#227;o
    Pessoa &#8211; PB</span></td>
    <td id="xdx_980_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zY9m1ORoDnhe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zBgCynWMyzV1">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zR3jOGXQjyJ2">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_z4sfZ27y49ra">MedPhone
    Tecnologia em Sa&#250;de Ltda. (&#8220;MedPhone&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zaHBVqt7IaTj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Content
    and clinical tools and online platform</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zA7SEKHrLVP9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recife
    &#8211; PE</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zkt9e1J0G1X4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zHI2Dlz7iHsb">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zpOstkaWEOdg">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zpRgK3ImWPFi">iClinic
    Desenvolvimento de Software Ltda (&#8220;iClinic&#8221;)</span>*</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zFTwhzrx3nA5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Electronic
    Medical Record, Clinical Management System</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zlVXzC2ylHSe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Ribeir&#227;o
    Preto - SP</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_z9PqGrLMOxpc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zdySchrxCPId">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zvUNn2HMeB7b">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zw9QhWexOPuh">Medicinae
    Solutions S.A. (&#8220;Medicinae&#8221;)</span>*</span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z7ns4bSXQK7j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Healthcare
    payments and financial services</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zQIYUa5bVxn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro &#8211; RJ</span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z9CmVh0K3cab" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zxhSU6hdsAn6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zBxcDO4O3SBe">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zPFJIz7hWfK6">Medical
    Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span> * </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zwIp9XAoADei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Educational
    health and medical imaging</span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zQsGUFEXuomg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Florian&#243;polis
    &#8211; SC</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zDwHTzZawaUe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zLPKrY4fz6d8">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_ze1vu47f0fvb">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zzPOLeuN3OBb">Cliquefarma
    Drogarias Online Ltda.(&#8220;Cliquefarma&#8221;)</span>* </span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zSHLOXonvx2b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Online
    platform</span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zVJ2NnB1MVi9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zJmAfpqxLCHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zaTbbqTjOQW5">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zTxJp3vO7E3e">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zG3JXW9mztmd">Shosp
    Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)*</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zToBTjW2TyD7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Electronic
    Medical Record, Clinical Management System</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zEee92923w5d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro &#8211; RJ</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z1rUwDHM3Mo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zpPjmUPHeXp3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z5Wub04kkKe3">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_z9MzGbzDeRZi">Sociedade
    Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;) *</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zr807cyaagH8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zKTB5doQXmMi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zYpJQ0andVK5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zSt9MOyTyqVk">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zOXOqP0yuHZi">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zMS6ni7bueL6">Companhia
    Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura. (&#8220;Unigranrio&#8221;) *</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zUIIelInsaR1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_z89RRuYvrq6g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Duque
    de Caxias - RJ</span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zQ2lR5fHJMZ2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zWwnDDV4gEU">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zDL0RjrJPfj7">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zR5zY0CnhaZ9">Policl&#237;nica
    e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;) *</span></span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zsoPxbXMt8Wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medical
    Care</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zpZ3ZVyRo7ji" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Duque
    de Caxias - RJ</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zWT8ia76dsc4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zUZ3PipdfPcl">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zm7Ac6Qd74Y5">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zYZa9ItnOA7h">Sociedade
    Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) *</span></span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zgFnX4WgFzXg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Basic
    Education</span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zFx7qQwnQvm8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Palho&#231;a
    - SC</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zp4mHnx9s383" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6LF5Q7lAzml">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6RXromp2B59">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zUfp5LnGTZQ6">Instituto
    de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) *</span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zbwI988zz4Wi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zxUZTVNXxla1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Palho&#231;a
    - SC</span></td>
    <td id="xdx_981_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_z2tNX8hq96D6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zfk7rzN3pg6j">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zJs3gY7NUhv">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zzEuP4VgRLy2">RX
    PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zQgX8XxTHMK9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marketing
    for pharmaceutical industry</span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zvgcWDbNbM22" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zmObsQxJcxGj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zyMXF4luwsq3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_z1uMVf24jDik">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zl6TCLqYadkd">RX
    PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</span></span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zfsA4FvRPL0h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marketing
    for pharmaceutical industry</span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zYcbgW51QvLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zMnXUPAy3qbc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zO1th5XT7Tgb">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zcIYkH7cioyc">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zvcJDpsfLF3">Uni&#227;o
    Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;)</span> </span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zLLXEsOvus75" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zdlQVhNz98i5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Bras&#237;lia
    - DF</span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAnRWBRjJ3Tj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zWfviYY5pRLb">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_z3F8ZHPm91Zh">30</span>%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">* See Note 5 for
further details of the business combinations during 2021.</span></p>

<p id="xdx_8AE_zBV9DnKyLmT2" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
financial information of the acquired subsidiaries is included in the Company&#8217;s consolidated financial statements beginning on
the respective acquisition dates.<br/>
</span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company consolidates the financial information for all entities it controls. Control is achieved when the Company is exposed to, or has
rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over
the investee. Consolidation of a subsidiary begins when the Company obtains control over the subsidiary and it ceases when the Company
loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are
included in the consolidated financial statements from the date the Company gains control until the date the Company ceases to control
the subsidiary.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">When
necessary, adjustments are made to the financial statements of subsidiaries in order to bring their accounting policies in line with
the Company&#8217;s accounting policies. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to
transactions are eliminated in full on consolidation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">A
change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction. If the Company
loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other
components of equity, while any resulting gain or loss is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Non-controlling
interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated
statements of income and comprehensive income and consolidated statements of changes in equity.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.3
Summary of significant accounting policies</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This note provides
a description of the significant accounting policies adopted in the preparation of these consolidated financial statements in addition
to other policies that have been disclosed in other notes to these consolidated financial statements. These policies have been consistently
applied to all periods presented.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
accounting policies have been consistently applied to all consolidated companies.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p id="xdx_845_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zXGmTUPzPJU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_866_zaEnDGm2gzv8">a)
Business combinations and goodwill</span> </b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Business combinations
are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred,
which is measured at acquisition date fair value, and the amount of any non-controlling interests in the acquiree. For each business
combination, the Company elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate
share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs are expensed as incurred and included in general and
administrative expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the Company
acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and designation in accordance
with the contractual terms, economic circumstances and pertinent conditions as of the acquisition date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is initially
measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interests
and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair value of the net assets
acquired is in excess of the aggregate consideration transferred, the Company re-assesses whether it has correctly identified all of
the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognized at the
acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration
transferred, then the gain is recognized in the consolidated statement of income.</span></p>




<p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Company&#8217;s cash-generating units that are expected to benefit
from the combination, irrespective of whether other assets or liabilities of the acquire are assigned to those units.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Where goodwill
has been allocated to a cash-generating unit (CGU) and part of the operation within that unit is disposed of, the goodwill associated
with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal. Goodwill
disposed in these circumstances is measured based on the relative values of the disposed operation and the portion of the cash-generating
unit retained.</span></p>

<p id="xdx_858_zZ9yvLY2hpc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zgzG63K0xsU1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zHhT9uXICLRb">b)
Current versus non-current classification</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company presents
assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it
is:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held
                                            primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash
                                            or cash equivalent unless restricted from being exchanged or used to settle a liability for
                                            at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All other assets
are classified as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A liability is
current when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is expected to be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is held primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is due to be settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There
                                            is no unconditional right to defer the settlement of the liability for at least twelve months
                                            after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company classifies
all other liabilities as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Deferred tax assets
and liabilities are classified as non-current assets and liabilities.</span></p>

<p id="xdx_852_zgpvJcmdVX6g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z1UoK9K8FA54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_znBt0lSNy64l">c)
Fair value measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability
takes place either: (i) in the principal market for the asset or liability; or (ii) in the absence of a principal market, in the most
advantageous market for the asset or liability.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The principal or
the most advantageous market must be accessible by the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The fair value
of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A fair value measurement
of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest
and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company uses
valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All assets and
liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy,
described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            1 &#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            2 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            3 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets and
liabilities that are recognized in the financial statements at fair value on a recurring basis, the Company determines whether transfers
have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to
the fair value measurement as a whole) at the end of each reporting period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At each reporting
date, the Company analyzes the movements in the values of assets and liabilities which are required to be remeasured or re-assessed as
per the Company&#8217;s accounting policies. For this analysis, the Company verifies the major inputs applied in the latest valuation
by agreeing the information in the valuation computation to contracts and other relevant documents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company also
compares the change in the fair value of each asset and liability with relevant external sources to determine whether the change is reasonable.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of fair value disclosures, the Company has determined classes of assets and liabilities on the basis of the nature, characteristics and
risks of the asset or liability and the level of the fair value hierarchy, as explained above.</span></p>

<p id="xdx_858_zqlMbMSo3f5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84B_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_ztYvUYq4jBpk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86C_zZNwJYQfZUg1">d)
Financial instruments &#8211; initial recognition and measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial instrument
is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"/><td style="width: 14.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>i)</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Company&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair
value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. Trade receivables that do not
contain a significant financing component or for which the Company has applied the practical expedient, are measured at the transaction
price determined under IFRS 15.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">In order
for a financial asset to be classified and measured at amortized cost or fair value through OCI (Other Comprehensive Income), it needs
to give rise to cash flows that are &#8220;solely payments of principal and interest (SPPI)&#8221; on the principal amount outstanding.
This assessment is referred to as the SPPI test and is performed at an instrument level.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash
flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets,
or both.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Purchases
or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the market
place (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
purposes of subsequent measurement, financial assets are classified as: financial assets at amortized cost or financial assets at fair
value through profit or loss. There is no financial assets designated as fair value through OCI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at amortized cost</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company measures financial assets at amortized cost if both of the following conditions are met:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The financial asset is held within a business model with the objective to hold financial assets in order to collect contractual cash
flows, and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
on the principal amount outstanding.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at amortized cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. Gains and
losses are recognized in the statement of income when the asset is derecognized, modified or impaired.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss include financial assets held for trading, financial assets designated upon initial recognition
at fair value through profit or loss, or financial assets mandatorily required to be measured at fair value. Financial assets are classified
as held for trading if they are acquired for the purpose of selling or repurchasing in the near term. Derivatives, including separated
embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial
assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit
or loss, irrespective of the business model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair
value recognized in the statement of income. This category includes derivative instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e.,
removed from the Company&#8217;s statement of financial position) when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The rights to receive cash flows from the asset have expired; or</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows
in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either (a) the Company has transferred
substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks
and rewards of the asset, but has transferred control of the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">When
the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially
all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset
to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred asset
and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Company could be required to repay.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Impairment
of financial assets</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Further
disclosures relating to impairment of financial assets are also provided in the following notes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Significant accounting estimates and assumptions &#8211; Note 3</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Trade receivables &#8211; Note 7</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company recognizes an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or loss.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and the cash flows the Company
expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash
flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
trade receivables, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit
risk, but instead recognizes an allowance for credit losses based on lifetime ECLs at each reporting date. The Company has established
a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors
and the economic environment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company considers a financial asset to be in default when internal or external information indicates that the Company is unlikely to
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Company. A financial
asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings,
payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s financial liabilities include trade payables, loans and financing, notes payable, lease liabilities, advances from costumers
and accounts payable to selling shareholders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
measurement of financial liabilities depends on their classification, as described below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
liabilities at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated
upon initial recognition as at fair value through profit or loss.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also
includes, when applicable, derivative financial instruments entered into by the Company that are not designated as hedging instruments
in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Loans
and borrowings</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">After
initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and
losses are recognized in the statement of income when the liabilities are derecognized as well as through the EIR amortization process.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR.
The EIR amortization is included as finance expenses in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
liability is derecognized when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability
is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially
modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Offsetting
of financial instruments</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and
settle the liabilities simultaneously.</span></p>

<p id="xdx_857_zctr6eHpZJwk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zDlIQMFTwAod" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_867_zDF9074Mtcx9">e)
Cash and cash equivalents</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Cash and cash equivalents
in the statement of financial position comprise cash at banks and on hand, and short-term financial investments with an original maturity
of three months or less, which are subject to an insignificant risk of changes in value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of the statement of cash flows, cash and cash equivalents consist of cash and short-term financial investments, as they are considered
an integral part of the Company&#8217;s cash management.</span></p>

<p id="xdx_850_z9FiFEU3Hcrj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_zo6V8jmS1mue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_863_zp9r4v6lemA4">f)
Restricted cash</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Restricted cash
in the statement of financial position comprise of financial investments in investment funds that serve as collateral for loan agreements
and other commitments.</span></p>

<p id="xdx_850_zniZLxzjTHze" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zLO4ZjkpxVjj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zgKIkbUiRZ37">g)
Inventories</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Inventories are
valued at the lower of cost and net realizable value. The costs of inventories are based on the average cost method and include costs
incurred in the purchase of inventories and other costs incurred in bringing them to their current location and condition. Costs of purchased
inventory are determined after deducting any discounts and recoverable taxes.</span></p>

<p id="xdx_85D_zawMF2um1Ye" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zs5910DRxwp1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zN7I4VlTO1ya">h)
Property and equipment</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Property and equipment
is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Subsequent expenditures
are capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zgTXvHbXwfZh">Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Building</span></td>
    <td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">25
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Machinery
    and equipment</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Vehicles</span></td>
    <td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1239">4
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Furniture
    and fixtures</span></td>
    <td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1240">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">IT
    equipment</span></td>
    <td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1241">5
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Library
    books</span></td>
    <td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1242">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Laboratories
    and clinics</span></td>
    <td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Leasehold
    improvements</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1244">20
    years</span></span></td></tr>
  </table>

<p id="xdx_8AE_zExqFxbNA5be" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An item of property
and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefit is expected
from its use or disposal. Any gain or loss arising on the derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of income when the asset is derecognized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The residual values,
useful lives and methods of depreciation of property and equipment are reviewed at each financial year end and adjusted prospectively,
if appropriate.</span></p>

<p id="xdx_850_zP1wjw1OPeL6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z54pJUq5MSSk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zbLzWvYYJg3e">i)
Leases</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As from January
1, 2019, the determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the inception
of the contract. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a specific asset
(or assets) and the arrangement conveys a right to use the asset (or assets), even if that asset is (or those assets are) not explicitly
specified in an arrangement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Company
as a lessee</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company
recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Right-of-use
assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets
are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Unless the Company is reasonably certain to obtain ownership
of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the
shorter of its estimated useful life and the lease term. Right-of use assets are subject to impairment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Lease
liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the commencement
date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease
term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable
lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments
also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for
terminating a lease, if the lease term reflects the Company exercising the option to terminate. The variable lease payments that do not
depend on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In calculating
the present value of lease payments, the Company uses the incremental borrowing rate at the lease commencement date if the interest rate
implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect
the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured
if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment
to purchase the underlying asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Short-term
leases and leases of low-value assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
the short-term lease recognition exemption to its short-term leases of properties (i.e., those leases that have a lease term of <span id="xdx_90A_ecustom--ContractualLeaseTerm_dxL_c20210101__20211231_zf5MLExeIDub" title="Lease term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl1248">12 </span></span>months
or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption
to leases that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense
on a straight-line basis over the lease term.</span></p>

<p id="xdx_85B_zogGB7vJ1fPi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOKA4C8TmvD9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zJnbovsjkWMc">j)
Intangible assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is
their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated
amortization and accumulated impairment losses. Internally generated intangibles are not capitalized and the related expenditure is reflected
in the statement of income in the period in which the expenditure is incurred.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The useful lives
of intangible assets are assessed as finite or indefinite.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The amortization
period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting
period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset
are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization
expense on intangible assets with finite lives is recognized in the statement of income in the expense category that is consistent with
the function of the intangible assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating
unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable.
If not, the change in useful life from indefinite to finite is made on a prospective basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An intangible asset
is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income.</span></p>

<p id="xdx_852_zxbnU4ApNj8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zJ3A9hpxuzQ6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zacqbnkRPoBa">k)
Impairment of non-financial assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses,
at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment
testing for an asset is required, the Company estimates the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is
the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal and its value in use. The recoverable amount is determined
for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups
of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written
down to its recoverable amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent
market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used. These
calculations are corroborated by valuation multiples, quoted share prices for publicly traded companies or other available fair value
indicators.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company bases
its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company&#8217;s
CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years, considering
the companies activities and maturation period of its graduate and undergraduate courses. A long-term growth rate is calculated and applied
to project future cash flows after the last projected year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For impairment
testing, goodwill acquired through business combinations and licenses with indefinite useful lives are allocated to their respective
CGUs. The Company has defined each of its operating subsidiaries as a CGU, except for &#8220;Practice Management Tools &amp; Electronic
Prescription&#8221; and &#8220;Clinical Decision Software&#8221; where the subsidiaries were combined as one CGU following the business
strategic pillars and &#8220;Moc&#8221; where we have 2 different educational institution operating in the same municipality (Montes
Claros).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Whenever applicable,
impairment losses of continuing operations are recognized in the statement of income in expense categories consistent with the function
of the impaired asset.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets excluding
goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the
asset&#8217;s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation,
had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is tested
for impairment annually as at December 31 and when circumstances indicate that the carrying value may be impaired.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Impairment is determined
for goodwill by assessing the recoverable amount of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount
of the CGU is less than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed
in future periods.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are tested for impairment annually as at December 31 at the CGU level, as appropriate, and when circumstances
indicate that the carrying value may be impaired.</span></p>

<p id="xdx_85E_zM8v2dJCLAK5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p id="xdx_840_ecustom--PolicyExplanatoryInvestments_zp92p4k14z53" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zm2GPpW2ebch">l)
Investments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Investments in
associates are initially recognized at consideration transferred and adjusted thereafter for the equity method, being increased or reduced
from its interest in the investee's income after the acquisition date. An associate is an entity over which the Company has significant
influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is
not control or joint control over those policies.</span></p>

<p id="xdx_855_zJxqhdslJCqf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_840_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_z7Btth29dxk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_865_zjIKH8Rtxiph">m)
Accounts payable to selling shareholders</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These amounts represent
liabilities related to the acquisitions made by the Company which are not yet due. Accounts payable to selling shareholders are presented
as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their
fair value and subsequently measured at amortized cost using the effective interest method.</span></p>

<p id="xdx_85C_z7QtDdjZo6bi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zYxyM6o1glsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zazXTRkSedzl">n)
Provisions</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Provisions are
recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow
of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount
of the obligation. The expense relating to a provision is presented in the statement of income, net of any reimbursement, when applicable.</span></p>

<p id="xdx_85E_zKd0Ih1nhaYc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_842_ecustom--DividendsPayablePolicyExplanatory_z397t1pS5jC3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86E_z15jdl7MGCZ3">o)
Dividends payable</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
a liability to pay a dividend when the distribution is authorized and the distribution is no longer at the discretion of the Company.
The distribution is authorized when it is required to pay a minimum dividend of the net income for the year in accordance with the Brazilian
Corporate Law (applicable for Afya Brazil) and the Company&#8217;s By-Laws or is approved by the shareholders. A corresponding amount
is recognized directly in equity.</span></p>

<p id="xdx_85A_zEcLxXZFdrEb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84E_ecustom--LaborAndSocialObligationsPolicyExplanatory_zyuMWjV52mJk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86B_zInMviYYmc74">p)
Labor and social obligations</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Labor and social
obligations are expensed as the related service is provided. A liability is recognized for the amount expected to be paid if the Company
has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation
can be estimated reliably.</span></p>

<p id="xdx_851_zY2GIsDa1tO" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_846_ecustom--SharebasedPaymentsPolicyExplanatory_zmQw3Ia7vck7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_864_zEpxtV9J1cY">q)
Share-based payments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain key executives
of the Company receive remuneration in the form of share-based payments, whereby the executives render services as consideration for
equity instruments (equity-settled transactions).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The expense of
equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">That expense is
recognized in general and administrative expenses, together with a corresponding increase in equity, over the period in which the service
and, where applicable, the performance conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of income for a period
represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Service and non-market
performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market
performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated
service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award
and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">No expense is recognized
for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include
a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition
is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the terms
of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided
the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any
modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.
Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately
through the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The dilutive effect
of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.</span></p>

<p id="xdx_851_z0xnLBbFBRZf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_847_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zIAU51gxhdvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zuG4RQveJnAk">r)
Revenue from contracts with customers</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Tuition fees
and other revenue</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company's revenue
consists primarily of tuition fees charged for medical courses. The Company also generates revenue from tuition fees for other undergraduate
courses, student fees, certain education-related activities, digital education content and subscription of digital services.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenues are recognized
when services are rendered to the customer and the performance obligation is satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from tuitions
and digital education content are recognized over time when services are rendered to the customer and the Company satisfies its performance
obligation under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for
those services. Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other revenues
are recognized at a point in time when the service is rendered to the customer at an amount that reflects the consideration to which
the Company expects to be entitled in exchange for the service. Other revenues are presented net of the corresponding discounts, returns
and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Printed books,
e-books, healthcare payments, online platforms and marketing for pharmaceutical industry revenues are transferred at point in time</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from sale
of printed books, e-books, healthcare payments, online platforms and marketing for pharmaceutical industry are recognized at the point
in time when control of the asset or services is transferred to the customer, generally on delivery of the goods at the customer&#8217;s
location and permission to access the digital content. The Company considers whether there are other promises in the contract that are
separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price
for the printed books and e-books, the Company considers the effects of variable consideration, financing component, noncash consideration,
and consideration payable to the customer to be not significant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
concluded that it is the principal in its revenue arrangements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses
collectability on a portfolio basis prior to recording revenue. Generally, students cannot re-enroll for the next academic session without
satisfactory resolution of any past-due amounts. If a student withdraws from an institution, the Company's obligation to issue a refund
depends on the refund policy at that institution and the timing of the student's withdrawal. Generally, the refund obligations are reduced
over the course of the academic term.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Trade
receivables </i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Trade receivables
represent the Company&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before
payment of the consideration is due). Refer to accounting policies of financial assets in Financial instruments &#8211; initial recognition
and subsequent measurement.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Advances
from customers</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Advances from customers
(a contract liability) are the obligation to transfer services to a customer for which the Company has received consideration (or an
amount of consideration is due) from the customer, as a result of pre-paid tuition, digital education content and mobile app subscription
for digital medical content received from customers and is recognized separately in current liabilities, when the payment is received.
Advances from customers are recognized as revenue when the Company performs all obligations related to the contract, generally in the
following month.</span></p>

<p id="xdx_857_zeGkJvv1S2ol" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_84F_ecustom--TaxesPolicyExplanation_z5qycgmF9NF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_868_z8LSmzg94np6">s)
Taxes</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
Company&#8217;s subsidiaries joined the PROUNI (<i>Programa Universidade para Todos &#8211; </i>University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number
of student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
taxes and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PIS
and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
regulation of PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS.
For income from other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_907_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z6M7MuXIJc7j" title="Tax rate">0.65</span>% and <span id="xdx_90C_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zQWtielBNzl6" title="Tax rate">3.00</span>%, respectively, and for non-teaching
activities, PIS is charged at a rate of <span id="xdx_90D_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_znwbL7c5ouAg" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_905_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zW2vj2NmWk9b" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><i>Current
income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Current
income taxes were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service,
specifically regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Current income
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates
and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.4
Changes in accounting policies and disclosures</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><i>New
standards, interpretations and amendments adopted by the Company</i></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain amendments
apply for the first time in 2021, but do not have an impact on these financial statements of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.</span></p>

<p id="xdx_85D_zTpuUYmQKRo7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant accounting policies applied by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103244584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting estimates and assumptions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract', window );"><strong>Significant Accounting Estimates And Assumptions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SignificantAccountingEstimatesAndAssumptionsExplanatory', window );">Significant accounting estimates and assumptions</a></td>
<td class="text"><p id="xdx_802_ecustom--SignificantAccountingEstimatesAndAssumptionsExplanatory_zzeUm1K0YJg7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif">3</span></td><td id="xdx_82D_zVay4qDcM8oj"><span style="font-family: Arial, Helvetica, Sans-Serif">Significant
                                            accounting estimates and assumptions</span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The preparation
of the Company&#8217;s consolidated financial statements requires management to make judgments, estimates and assumptions that affect
the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Uncertainty about these assumptions
and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in
future periods. Accounting estimates and judgments are continually evaluated and are based on historical experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are recognized
prospectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other disclosures
relating to the Company&#8217;s exposure to risks and uncertainties includes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Capital management &#8211; Note 15</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Financial instruments risk management objectives and
policies &#8211; Note 13.4</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Sensitivity analyses disclosures &#8211; Note 13.4.1</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Estimates
and assumptions</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The key assumptions
about the future and other key sources of estimated uncertainty as of the reporting date that include a significant risk of a material
adjustment to the carrying amounts of assets and liabilities within the next financial year, are described below. The Company based its
assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and
assumptions about future developments, however, may change due to market changes or circumstances that arise and that are beyond the
Company&#8217;s control. Such changes are reflected in the assumptions when they occur.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Identification
and fair-value measurement of assets and liabilities acquired in a business combination</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Business combinations
are accounted for using the acquisition method. Such method requires recognizing and measuring the identifiable assets acquired, the
liabilities assumed and any non-controlling interest in the acquiree. The Company, as the acquirer, must classify or designate the identifiable
assets and liabilities assumed on the basis of its own contractual terms, economic conditions, operating and accounting policies and
other relevant conditions as at the acquisition date. Such assessment requires judgments from the Company on the methods used to determine
the fair value of the assets acquired and liabilities assumed, including valuation techniques that may require prospective financial
information inputs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Impairment
of non-financial assets</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Impairment exists
when the carrying value of an asset or cash generating unit (&#8220;CGU&#8221;) or group of CGUs exceeds its recoverable amount, defined
as the higher of its fair value less costs of disposal and its value in use. The fair value less costs of disposal calculation is based
on data available from binding sales transactions, conducted at arm&#8217;s length, for similar assets or observable market prices less
incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash flow model (&#8220;DCF&#8221;
model). The cash flows are derived from the budget for the next five years and do not include restructuring activities to which the Company
has not yet committed or significant future investments that will enhance the performance of the assets of the CGU being tested. The
recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future cash-inflows and the growth
rate used for extrapolation purposes.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These estimates
are most relevant to goodwill and indefinite lived intangible assets recognized by the Company. The key assumptions used to determine
the recoverable amount for each CGU, including a sensitivity analysis, are disclosed and further explained in Note 12.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Share-based
compensation</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Estimating fair
value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms
and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including
the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about them. For the
measurement of the fair value of equity-settled transactions, the Company uses the Binomial model. As disclosed in Note 16 (b) the Company
had stock plans that were fully exercised on July 31, 2019, for which the Monte Carlo and Black &amp; Scholes pricing model were used
for the Afya Brazil and Guardaya plans, respectively. The assumptions and models used for estimating fair value for share-based payment
transactions are disclosed in Note 16 (b).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Leases
- Estimating the incremental borrowing rate</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company cannot
readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities.
The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds
necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects
what the Company &#8216;would have to pay&#8217;, which requires estimation when no observable rates are available (such as for subsidiaries
that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for
example, when leases are not in the subsidiary&#8217;s functional currency).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company estimates
the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SignificantAccountingEstimatesAndAssumptionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SignificantAccountingEstimatesAndAssumptionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103222440">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory', window );">Segment information</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zXiee9PB0UD8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_zPsVcVvCGsik">Segment
                                            information</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">During
2021, in connection with the recent acquisitions of digital and technology companies, the Company revised its operating segments. As
result, the Company has three operating segments as opposed to the previously reported Business Unit 1 (educational services through
undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs) and Business Unit 2 (residency
preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education
platform). The three reportable segments are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate
programs;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Continuing Education, which provides specialization programs and graduate courses; and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226; Digital
Services, which provides content and technology for medical education, clinical decisions software, practice management tools and electronic
medical records, doctor-patient relationship, telemedicine and digital prescription.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Due
to changes in operating segments, the segment information for the years ended December 31, 2020 and 2019 have been restated. Segment
information is presented consistently with the internal reports provided to the Company's Chief Executive Officer (CEO), which is the
Chief Operating Decision Maker (CODM) and is responsible for allocating resources, assessing the performance of the Company's operating
segments, and making the Company's strategic decisions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">No
operating segments have been aggregated to form the above reportable operating segments. There is only one geographic region and the
results are monitored and evaluated as a single business.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zUXaad5h7Mt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
presents assets and liabilities information for the Company&#8217;s operating segments as of December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BD_z6Dl3226OiKg" style="display: none; visibility: hidden">Schedule of assets and liabilities information for the company's operating segments</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8MLTeLTx8Eg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,072,135
    </b></span></td>
    <td id="xdx_98E_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbVFzSw7bDIh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>105,629</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3yTtB30bp4f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>272,122</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuz4SrTqbpZg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,449,886</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zVZBuUmI6Jl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,480)</b></span></td>
    <td id="xdx_983_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCZHCBnPwmC3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,447,406</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCiYwv2SGRb2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,048,869</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSH91O5qMXPh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,737</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVxSdq2WUk5c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">117,726</span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziklBiCLTjgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,209,332</span></td>
    <td id="xdx_98F_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU9TCYrspu92" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,480)</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvNdOu3kDsO6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,206,852</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7XcCkhEw8Ae" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,023,266</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zA5VsNbylyS" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,892</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6nefN7y2TRa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">154,396</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkVTThyKJ84j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,240,554</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zitjGMD2cAI5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">&#160;</span>-</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zp1ta45AlkXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,240,554</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7DmuYsO6lZ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,072,135</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zP4GuCZng308" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>105,629</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXnKRcfMoZu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>272,122</b></span></td>
    <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdf9esFrs6Vi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,449,886</b></span></td>
    <td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGGsJ8njCp6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,480)</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfIsZb6DBfki" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,447,406</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z73qH9UhnQMb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">645,657</span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfbTKIYCgO4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,300</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzXJcgzmKX24" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91,029</span></td>
    <td id="xdx_984_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyNFrZLEm6b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">768,986</span></td>
    <td id="xdx_988_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z9Y0teMUP8hc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;(2,480)</span></td>
    <td id="xdx_986_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL785sASxyQj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">766,506</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zMh8wjNmNWph" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,551,175</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVkQP8DwOvo2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">47,705</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znm34ac8P3fd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82,002</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJofVDjsfYvl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,680,882</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMP1pP9NayAe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1328">&#160;</span>-</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeODj5QqzXEj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,680,882</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zNPkui3JDCXb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,303</span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLV03pSCs0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,624</span></td>
    <td id="xdx_989_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zhSqjOhCy4kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99,091</span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zo9OCkJrIsqc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,000,018</span></td>
    <td id="xdx_98C_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zRZ9hVcHk6sf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1335">-</span></span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zudpHTwC1Sda" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,000,018</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxW6GOyh5p6a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td>
    <td id="xdx_982_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXztkO1pXN8c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zlgayYjOO0Xl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1340">&#160;</span>-</span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYk7FhznPFY6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td>
    <td id="xdx_986_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zV9f0OAq88Kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">&#160;</span>-</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfLt9c28re4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F43_zEiPbqoS5K5k">(*)</sup></span></td>
    <td id="xdx_982_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_z8Z07kclveO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">220,202</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zOHURYnnL0hj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,682</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zj2qXv5ttDLc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,095</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_z5zVSU1kxZ9c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">301,979</span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zOUZ2Z6wHbk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#160;</span>-</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_zi078UuCD8pe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">301,979</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVM7VrXO608a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,541,988
    </b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgIQqf9KZOw2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,300
    </b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBrPaJfVEQX" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182,920
    </b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmcTOdyXAnV1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,208
    </b></span></td>
    <td id="xdx_98D_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTHUBYo8pXS1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(115)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIshRjt5PAn3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,093
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlYP8VQec1Mk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,280,342
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeRXNhOfbFFh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,119
    </span></td>
    <td id="xdx_986_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zwTtaq8T745l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">85,155
    </span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKj5GPP3vy68" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,405,616
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsxs1kTY0l7g" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(115)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zakpQFwpXwT2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,405,501
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zWNHMq6L4Tkj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,261,646
    </span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTdLd7DQ7cgb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,181
    </span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ze5H4zjymO34" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">97,765
    </span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIofv54SBTtf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,387,592
    </span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z6rLjJ6vCvi4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,387,592
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLXdI8yhvmak" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,541,988
    </b></span></td>
    <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOroIN3xZ24b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,300
    </b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ztksHlB6YDT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182,920
    </b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zEXJwQlkTYr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,208
    </b></span></td>
    <td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zBuTUknHMrZ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(115)</b></span></td>
    <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfgSZbUDFxJ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,093
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeFbQFXF3xR9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">522,523
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zZcVnQoBRGV7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,491
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zebGn39LZbCb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52,480
    </span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkz0YGcVv4l7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">589,494
    </span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zWpbe1lNJVR5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(115)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKQeG0M01CU8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">589,379
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zfTLFbhfvCF1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,261,894
    </span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwEQrwHchIYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,763
    </span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2GNB2dTMx56" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,277
    </span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZAp55oRudYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,369,934
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zEewhR4q3msk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,369,934
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z5ZIZhCCkTj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,757,571
    </span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z6yHBhIeJSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,046
    </span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEK6hJIjxKN5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,163
    </span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQfDgxPUEnhi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,833,780
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrtD1T8lsJq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,833,780
    </span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhMOYSlizIT5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfgWOhPRxtxj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo5DwTYI56Q8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F4C_zBxKJImE4Crc">(*)</sup></span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_zMVvAvt1rHAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">83,256</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zazZPeAwVhs1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,638</span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zAimAi2DWkI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,587</span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_zxE3Uosvryii" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">109,481</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_z03yDhCO92Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">109,481</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span id="xdx_F0C_zR84OS3BjgG3" style="font-family: Arial, Helvetica, Sans-Serif">(*)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_ziC9kXBmC7V2" style="font-family: Arial, Helvetica, Sans-Serif">Capital expenditures consider
the acquisitions of property and equipment and intangible assets.</span></td>
</tr></table>

<p id="xdx_8A8_z6yXhYAnCmR1" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br/></span></p>




<p id="xdx_896_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zsa5CU9Jbtv4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
present the statements of income for the Company&#8217;s operating segments for the years ended December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zjn7d2J1ixD2" style="display: none; visibility: hidden">Schedule of operating income for each operating segment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zmCnusGSmTfg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,498,408</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQIOTgtMh26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">72,983</span></td>
    <td id="xdx_980_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP54ICgmDHU7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,980</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zK07raONaxBh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcfR1uGvSje5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1419">-</span></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09UC1Zy5hn" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zw5AvcJretxf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td>
    <td id="xdx_984_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zNSYD9ibSAMj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0tl7xWgZSBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_982_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zO22ITfRij4b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_989_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z6xohWGDzlxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,978)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn66q1dembFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_ztPUOoJKQnmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,498,408</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRp5ZA1qfWih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>72,983</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJnYCEH3PiY2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>151,958</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ztEZXNY4shc3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,723,349</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zKZd8vNxlyda" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,978)</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfHKcGZgZhA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,719,371</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zx3qtbk8jZNk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(554,995)</span></td>
    <td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zyT8JV2Gp2U2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,773)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zqDEZH2cnAag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,510)</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z66YXzCxRKh7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(656,278)</span></td>
    <td id="xdx_980_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zur3vkJqsUf7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_981_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlYx00wRNTQe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(652,300)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z9QS1YcnAoP2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>943,413</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrBxOB0cCMi9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,210</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z9H6NAmQohve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,448</b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhu6XTtM69Sk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zLGmCzyOfPOc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1448">-</span></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlW6DFTP8wj5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYDcXnseYfuk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(622,615)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    income, net</span></td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zwAh4f6K9YW5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zK48EaYqAVOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></span></td>
    <td id="xdx_98A_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvFclGluazB7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1454">-</span></span></td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYvCHApM9xM5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zatEsAm3vxq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1456">-</span></span></td>
    <td id="xdx_984_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBH76Aw3eNwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,561)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zPLBOq91G2Rg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOFVsb2qbo7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znKL3ekNOds1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfFwq4OQufba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSYy2ypOt0Fl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1463">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDnIGbt5P0vk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>440,895</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td id="xdx_98E_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zZqpsQUYwAZj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSITHa1kksR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></span></td>
    <td id="xdx_985_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zbQJAAMWjr9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1468">-</span></span></td>
    <td id="xdx_988_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuLoiW7eLipg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4v3e95oYAil" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54jzkPM69a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,566</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td id="xdx_982_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbXTcDAbzuue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td>
    <td id="xdx_98F_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbP00rn6ptme" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></span></td>
    <td id="xdx_981_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFT7e649bJm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td>
    <td id="xdx_987_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSnJm8O1U3G8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td>
    <td id="xdx_98E_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zQV7Jyq4FzOe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1477">-</span></span></td>
    <td id="xdx_98A_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFv2ki8MtSkh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(243,796)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVeZqdFjTOF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zq3wPYfIg6A6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">-</span></span></td>
    <td id="xdx_987_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zdqkjn5rkXlh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_986_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zv9SJIrkjH6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znauMNkCHoFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGFvtvNu9mU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,797</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td id="xdx_98B_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zXocjNwis6fa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1487">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zG5u25ptKUwl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAP6Gsmv2A1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1489">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk12QYpcqIQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zIW64Gu5WRx8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1491">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z9wnRO1YUqL8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>273,462</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLC2mhBVl89k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRZMGfEXIET9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1495">-</span></span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVJ1BEjQ8KHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1496">-</span></span></td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zANwLJS6iHo3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1497">-</span></span></td>
    <td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4o67f8H9fc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM9XoS9scxrd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,179)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrcm1bEkq25f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zapeaLWLGu58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3V2t2MyAd77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zsVVHwddoLa2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsnawhcfXuza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUctAe4vVO5c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>242,283</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDC8UDO21mWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,002,461</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zEcx1To2S5m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">107,197</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zCH41Ch9sFRh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91,533</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfpKqpzJfUT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,201,191</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNl0cA8uXSQl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,201,191</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXBGfLYjAsS1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_980_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6CYVJGfNnsc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_98E_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcBy1toXIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,619)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zEkbeKC8ZqCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,002,461</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zo1e8oIrAxHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>107,197</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvwSFLaOvOs3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>93,152</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zywJFkXLb6Jl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,202,810</b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zO6vs1JNkWRl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,619)</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcXG2AIYDrG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,201,191</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeCn3gsLjny3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(381,964)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwL2IG2m6mok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(40,000)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zsUj6uQQ7cWd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,309)</span></td>
    <td id="xdx_982_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zybx7Xnboczd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(436,273)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU3lLMUxiZpf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOHk0pFEBM2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(434,654)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zelGlg74jymd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>620,497</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJO5ZwVr7Mt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>67,197</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znsxjwm2z3lc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>78,843</b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdcwavh3dSy2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>766,537</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM6vuMDtlXz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>766,537</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn6SsoOwGUxl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="General and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(402,855)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJFBo8Q9APe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(347)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNoO3yoMY3O3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>363,335</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--FinanceIncome_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zU6qk3y1QKU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,290</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHlk40GClwb4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(98,269)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyAfEr5VyH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,698</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLEu9Zpk7vNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>335,054</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zi8fEVN7iCmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(27,067)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLoss_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLik8i0J3mTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>307,987</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zoqVZTyudwld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">653,760</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhdvTR31m8K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,870</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zykdxQd49jg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,000</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSRuobNwycId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">750,630</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQ2kRrUNrq3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">750,630</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2Q5Ljpj6918" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_98A_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zRdQikltGF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm42aORow3vb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,880)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhoksJcN7Vu5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>653,760</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvGXbNp8r0h1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>64,870</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAZqhNaTN5g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>35,880</b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7wlWUORR2K4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>754,510</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ziVhZtMXnQ5j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,880)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmUAZA7lHE82" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>750,630</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPnzwgkBt38" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(279,066)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zh9iqzRdBhV8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(29,261)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z60TTF6PBJdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,406)</span></td>
    <td id="xdx_98F_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAy7VCyaMOY6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(312,733)</span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zhseQ1vqhRZ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdd4gtywTZM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(308,853)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxEUKwLLX7Eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>374,694</b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdZiUuhYcQT9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>35,609</b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrNW4RggKXLf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,474</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zNcqykE2YGdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>441,777</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zu2MRhWGTqd9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>441,777</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HwfjymDrrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(239,120)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8Lo6rOZeQPl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,594</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOepLPYaDEV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>205,251</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--FinanceIncome_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3DWf5MzwPCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,689</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5xhI8ZChiL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(72,365)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zS5vJ0Cwy856" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,362</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWiU1UMM1rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>186,937</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKsLvStPHT25" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,175)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXJCMcLQLWZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>172,762</b></span></td></tr>
  </table>
<p id="xdx_8A4_zRe6tM3JCC43" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Seasonality
of operations</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Undergrad
&#180;s and Continuing Education tuition revenues are related to the intake process and monthly tuition fees charged to students over
the period thus the Company do not have significant fluctuations during the semester.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Digital Services
are comprised mostly by Medcel, Pebmed and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel revenues are concentrated in the first and last quarter of the year, as a result of enrollments of Medcel&#8217;s clients period.
The majority of Medcel&#8217;s revenues is derived from printed books and e-books, which are recognized at the point in time when control
is transferred to the customer. Consequently, Digital Services segment generally has higher revenues and results of operations in the
first and last quarter of the year compared to the second and third quarters of the year.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS08_g20-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103284472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory', window );">Business combinations</a></td>
<td class="text"><p id="xdx_80A_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zScZQhdJJykf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>5</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_824_zOvRgZlfvy4h">Business
                                            combinations</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">5.1
Acquisitions in 2021</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_zydnIkVgntta" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The preliminary
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zzwDCBsCntad" style="display: none; visibility: hidden">Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>iClinic</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medicinae</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medical
    Harbour</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cliquefarma</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Shosp</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unifipmoc</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unigranrio</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>RXPRO</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zwtIXfJ3G7ag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,659</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zVjH5L39Ijak" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">201</span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zcbD4US4ZI4b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">47</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8C0vggHKqp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,009</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zYBnfQ05a0m1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">397</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zjmZh8ccMdGi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,140</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zwrrlblXCHTf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34,755</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHLyohhr0NGc" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">91</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Restrict
    cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCash1_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zNztwnmvO589" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,050</span></td>
    <td id="xdx_98E_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zKdPH7Lzqlfe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></span></td>
    <td id="xdx_98A_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zgYRJOmTnsGb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z0GN1GUgLeQ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zf8c1xQUgfr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1617">-</span></span></td>
    <td id="xdx_983_ecustom--RestrictedCash1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z53WzDOYrQ24" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1618">-</span></span></td>
    <td id="xdx_989_ecustom--RestrictedCash1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhzp36kGiWff" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1619">-</span></span></td>
    <td id="xdx_98F_ecustom--RestrictedCash1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zieeKPxVQcek" style="vertical-align: top; text-align: right" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    receivables</span></td>
    <td id="xdx_983_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zeVTSSHngSx9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,201</span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXCFVs0Xu2L8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zBh5ZZqtVXNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">159</span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSFPUvTrubR" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">501</span></td>
    <td id="xdx_986_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z9lKAvNygxB3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></span></td>
    <td id="xdx_98C_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zWR5hDBQBICg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34,309</span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zBe7w78O3lGg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">26,622</span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zrZDNwOCHD54" style="vertical-align: top; text-align: right" title="Trade Receivales"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,211</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zd4d5QuWRw3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></span></td>
    <td id="xdx_98F_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zCXBH1g6JvDc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1632">-</span></span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zW5s2DvyuqR2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1633">-</span></span></td>
    <td id="xdx_985_ecustom--Inventories1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVqNE2o83APb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1634">-</span></span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zWfUYfMxl3C2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zj95J1ynNjk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1636">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z3E4BawG4hb7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">352</span></td>
    <td id="xdx_986_ecustom--Inventories1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWxpeUjQ2QLh" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">246</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recoverable
    taxes</span></td>
    <td id="xdx_987_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zjwdwX6QW9Z3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">72</span></td>
    <td id="xdx_989_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zmivR5K0WOMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">15</span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zTydqBTDti8k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfUwAObNp3g5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zvdJYDeaW7f5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_98F_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2kbPWa7BN4k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,295</span></td>
    <td id="xdx_98E_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zudRuLdAgU93" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">738</span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zNNWkT7XpOzc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">112</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    assets</span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zahU2d5tvIm2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">20</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_ztZkd1LjYYf2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zjfiFhVkEIVh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2</span></td>
    <td id="xdx_987_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z4eG2MnZr7z4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></span></td>
    <td id="xdx_989_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOBHJcyVMtvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2xNKVXvi7Nk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">702</span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqJqfmsJCYFg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">12,159</span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zC49thdaxI1" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">366</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Right-of-use
    assets</span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGTZCOqWuLCh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">88</span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9EegalhAM4j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></span></td>
    <td id="xdx_989_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z8EbQAtPTm47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1657">-</span></span></td>
    <td id="xdx_98C_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1bFVKAnQd59" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></span></td>
    <td id="xdx_98A_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zARWkuDMhblk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zuIMjs6QsTPl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">52,079</span></td>
    <td id="xdx_985_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z0b35cYRyEx8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,265</span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeUHmVdTTi67" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">82</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Property
    and equipment</span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zOWnSveQdmce" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">473</span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zx352TrGEWag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">17</span></td>
    <td id="xdx_981_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zzVhGoC0Xg2h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34</span></td>
    <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zlQBXOr4eWn6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></span></td>
    <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zocZsUxXX5cc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5</span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2qNOwYggSN9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">24,277</span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zrwg6iWBjLw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">40,775</span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeof2tPnW995" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">42</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Indemnification
    assets</span></td>
    <td id="xdx_98A_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zv3egaittoJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,252</span></td>
    <td id="xdx_986_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zhwse1stMJHk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1672">-</span></span></td>
    <td id="xdx_988_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zKKImePLzdXd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></span></td>
    <td id="xdx_987_ecustom--ImdemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXgs5yFqUBYe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></span></td>
    <td id="xdx_98F_ecustom--ImdemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zsw5pfgHZT43" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></span></td>
    <td id="xdx_981_ecustom--ImdemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zDRFWaVLS3d3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,331</span></td>
    <td id="xdx_989_ecustom--ImdemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zCgsmKa5V7Ef" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,669</span></td>
    <td id="xdx_983_ecustom--ImdemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zAp8B8hM9Pud" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Intangible
    assets</span></td>
    <td id="xdx_98A_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zyb3aTKfykM" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">84,987</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zz0kTozBblrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,518</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zeZhfZMc8GWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,359</span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zioBiHHzsfe9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">14,991</span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zriVEy5xOCVi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,856</span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zwOqcnJIIl3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">227,534</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zykk4coI7tZ1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">510,356</span></td>
    <td id="xdx_984_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6NkOBisldk" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,330</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z71bJDBx7DZa" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>95,802</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zB6vm6TmLgAh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,751</b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z2vBKqRH3msl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,601</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8E0bvGY4JOh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>16,501</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_znZ2IPsbb6Rf" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,259</b></span></td>
    <td id="xdx_98C_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zRg1SJE6uyug" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>353,667</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9DniEVSUVUe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>784,691</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zt1RhNgaWt41" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>8,480</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    payables</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zHyuniKOR8Gc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">619</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zdTd0tjSGTOe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zlaVkoIDPUV7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6</span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zELVprZOvSCb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">8</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHmGIWxJ7K76" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z7rixxBoo4ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">985</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z2P9gdvJ5562" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,197</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHJDs8hDFZU" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,060</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Loans
    and financing</span></td>
    <td id="xdx_986_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zrLa6f2WZfx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zzwGdN7xpwg6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqCe2W0GYrK8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">299</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zcsDoYotJ8bd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">580</span></td>
    <td id="xdx_989_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRX9dZLrAnwd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zyY8xHlPVuYj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,179</span></td>
    <td id="xdx_987_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z8srDnSSSLPd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,533</span></td>
    <td id="xdx_988_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zO4SBH3HkqVj" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Labor
    and social obligations</span></td>
    <td id="xdx_98D_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zxBXGgCVmZN1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,414</span></td>
    <td id="xdx_980_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGJ8vzV5Hgn9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">159</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zscuFA8FckCg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4</span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAz4Rw6Ppf28" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">102</span></td>
    <td id="xdx_982_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHBV1pZQGxJf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">89</span></td>
    <td id="xdx_989_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zKcCjT8avFTf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,306</span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zGfJeCs9zGyd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">22,854</span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjaIwr2y9IGc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">62</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Taxes
    and contributions payable</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zZ2fFPO8qXRk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">77</span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zT0hxQ8OtVT5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4</span></td>
    <td id="xdx_988_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zCvkX8wJW2Z1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZlRzKlQMxuj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">307</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zMvUPcZCGE3h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">123</span></td>
    <td id="xdx_98B_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zhGOF4ZB06ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">758</span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcyrqeVSsOW" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">94,025</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwJ4tKmzGUne" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">100</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_986_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zst7tNJVY892" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,252</span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z7Auj4CvUws8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zYQaVSrSikLf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1730">-</span></span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zCwmqBkOFFhk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zVOWJ7pb1424" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zABEDqCX9bDh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,331</span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zh6PfGp51iO5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,669</span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7NhuwDPUMac" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1735">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Leases
    liabilities</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zz2G1gzJu8Zg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">88</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zMIxg8UbmN01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zuolztjgJEo4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1738">-</span></span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMs3ElPuT71l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zmHwWPACyx3k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zUWygh0obg88" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">52,079</span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zQ0bsuMLl7W7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,265</span></td>
    <td id="xdx_985_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zxVMSx2HBQI6" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">82</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Advances
    from customers</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zX797RaT5Ks4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">400</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfyXM4VTDP86" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></span></td>
    <td id="xdx_98C_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znXXtY9MmHu3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">35</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zhNUe6QghYgb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zGDrZLhSggEg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">167</span></td>
    <td id="xdx_987_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zyLgGLgo3HN6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,745</span></td>
    <td id="xdx_985_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zNEU8656p6q5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,387</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zhX4veV1vLvi" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1751">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    liabilities</span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zgN3yNmWV7gg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1752">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9JsKcrvvmc1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zEi88OnO4qLk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfkXz9Qo5wdg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z4FRKRt54z7d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zYdl9FwFsuH8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,739</span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9clBQgJw7bk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,878</span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7IYuGaEO33g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKmsXmnA3HDk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>3,850</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zBIzYz5VHy2d" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>163</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z4wBUrWQ0I46" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>345</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZP5K2Holqg4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,000</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHyaH5AG0dp3" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>380</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zmz8P8Vdlgd2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>113,122</b></span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zolJcRpEOWP6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>295,808</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwYTYNoj2ET8" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,304</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zQ5fxvqaoCme" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>91,952</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zxuvaSVFlEzb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,588</b></span></td>
    <td id="xdx_98C_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_ziV6wP4QOr5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,256</b></span></td>
    <td id="xdx_98D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSGev9bCEwH1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>15,501</b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFtch7xFbYzj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,879</b></span></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zsYEBLuwSoNf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>240,545</b></span></td>
    <td id="xdx_980_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXtLcknO5EAg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>488,883</b></span></td>
    <td id="xdx_984_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcG7RIuGVhwe" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,176</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Preliminary
    goodwill arising on acquisition</span></td>
    <td id="xdx_981_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_znce3FcKtQsh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">99,168</span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zsiWkqMxBvH9" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,584</span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z7ykbSwRV2i6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,022</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMCOxUv89k2e" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,588</span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHZfHTtw9xTd" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,022</span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcU7nPSexrBi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,777</span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqkOjB8qam4f" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">130,073</span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zflnfEBkbVXi" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">38,446</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z0FJUEIRMIB" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>191,120</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXdvMFXObbF1" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>9,172</b></span></td>
    <td id="xdx_986_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zNNpCFcNaWL7" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>11,278</b></span></td>
    <td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAnlV0Sfo0pa" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>22,089</b></span></td>
    <td id="xdx_989_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zLEjf5DEkY7b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,901</b></span></td>
    <td id="xdx_983_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z5eFVhCWgPrb" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>328,322</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zk2KNwWadx7a" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>618,956</b></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqwmsWOsXJj4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>45,622</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid</span></td>
    <td id="xdx_981_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_ziedsoW7DRfc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">119,620</span></td>
    <td id="xdx_988_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGFhSIdhnFw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,600</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqmJhiEXno4a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,000</span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1ajmlEGDBOj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">16,166</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zEHlO2PsFFp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,855</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zVBQ0DlyNpyb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">328,322</span></td>
    <td id="xdx_98A_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zDh1LzvYiCw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">375,670</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z3r0KnrEwN0f" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,263</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Contingent
    consideration</span></td>
    <td id="xdx_982_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_fKCoqKQ_____zW2ibgJpQ7T2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></span></td>
    <td id="xdx_986_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_fKCoqKQ_____zPrB9eUny0Ic" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,572</span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_fKCoqKQ_____zjX9spV1fQJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,278</span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_fKCoqKQ_____zWJYWKHdKVb1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,923</span></td>
    <td id="xdx_98D_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_fKCoqKQ_____z00b5mTAh6p3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,592</span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCop_zLrJMURP4RN5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(*)</sup><span style="-sec-ix-hidden: xdx2ixbrl1806">-</span></span></td>
    <td id="xdx_98C_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCoqKQ_____zVozj4iDnJxi" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(**)</sup><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span></span></td>
    <td id="xdx_98F_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_ztlNmgAuuiBf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,171</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Consideration
    to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zfbJEFzkrZ4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zau9Y5BOJrUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></span></td>
    <td id="xdx_984_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zvQN9Axx6S9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zDNakicKC1Qe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></span></td>
    <td id="xdx_98B_ecustom--ConsiderationToBeTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztsvu9qpEzc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">454</span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXy56yRKZ931" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></span></td>
    <td id="xdx_98A_ecustom--ConsiderationToBeTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zF98bEbiNrCk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">243,286</span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z05PCzDawVr8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">76</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Paid
    in shares</span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zDU5SDBtFKJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,500</span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGLHuYT9RL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zOtjBnq9pXhg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zS1QabTYdYi4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,000</span></td>
    <td id="xdx_983_ecustom--PaidInShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zUQQ8lm8aMN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></span></td>
    <td id="xdx_982_ecustom--PaidInShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhG2fcFWoNj8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zOo0CHhdQvlh" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zfUxgugHQiLl" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,112</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transaction
    costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zJqasYn0v6E3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">856</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfk8yIcx9Ja7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">117</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zIkvr0M6W70k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">144</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zmaeklgwo2N7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">336</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zhZnuJNf67V6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">188</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXkSvbiwoFE4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">177</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zqWQTSjixGyf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,990</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6E6LnOQXhfa" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">264</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKt7oPmwaHL" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">117,961</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z0mdhm7MiaX9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,399</span></td>
    <td id="xdx_98E_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z62Vu9TOlMUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,953</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfhBVCCMM4ee" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">15,157</span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zNTt7VALLe8d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,458</span></td>
    <td id="xdx_988_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zD8KWoqdhRrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">322,182</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z48woKyFJInc" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">340,915</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zucUHqr8J9w2" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,172</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGa3sfVuzh6c" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>118,817</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zSbdbol3fAH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,516</b></span></td>
    <td id="xdx_988_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrUqBedfIAy6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,097</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXnvrcDlKGs1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>15,493</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOSkPnUfV7Jk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,646</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFeeTYAM5402" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>322,359</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zfnlapsyczbl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>351,905</b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zmXGGc2NhKEj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>30,436</b></span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 40 additional seats
still pending approval, which, if approved by the Ministry of Education, will result in a potential additional payment of up to
R$ 50,000.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">**</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200.</span></td>
</tr></table>

<p id="xdx_8A0_zrTGjrIsHock" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(a)
Acquisition of iClinic</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">On
January 21, 2021, Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zvPHUtenh4X9">100</span>% of the share capital of iClinic (comprised by iClinic Participa&#231;&#245;es, iClinic
Desenvolvimento and Black River). <span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zb7MG8Hx0K4g">The aggregate purchase price of R$191,120 is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">iClinic
is a SaaS model physician focused technology company and the leading medical practice management software in Brazil. iClinic empower
doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase their
productivity and deliver better healthcare services. With the acquisition of iClinic to our platform, Afya will make another step to
become the one stop shop for physicians in Brazil.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
acquisition of iClinic was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction
costs to date amount to R$<span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zISAr3QvAayg" title="Transaction costs">856</span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes
purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_894_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zC4v6h0VeMj4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_zov9ELuceLXb" style="display: none; visibility: hidden">Schedule of acquisition of UniRedentor</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVMIRzdnM1Q" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210119__20210121__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z5WXLkJTe2ek" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8AB_zGwfikASF2s4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, iClinic has contributed R$ <span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zT4eOyWKiYa6" title="Net revenue">16,456</span> of net revenue and R$ <span id="xdx_90F_eifrs-full--ProfitLossBeforeTax_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zuqR5KEoMeS6" title="Income loss before income taxes">8,250</span> of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zl8UGpJrZqAc" title="Increase in revenue">1,158</span>
and income before income taxes would have been decreased by R$ <span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zliEXjyoa2t8">1,320</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(b)
Acquisition of Medicinae</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 25, 2021,
Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zlkbAFRmtQZb">100</span>% of the total share capital of Medicinae, a leading Brazilian healthcare technology company that specializes
in healthcare payments and financial services. <span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--MedicinaeMember_zwdd8oz27DZ6">The aggregate purchase price of R$9,172 is comprised by: i) R$ 5,600 of which 100% was
paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$ 4,400 is payable
in connection with product development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3,572 is based
on the present value of the obligation considering the facts and circumstances at the acquisition date.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">The
acquisition will expand Afya&#8217;s digital health services, as it offers a unique financial platform that allows healthcare professionals
all over Brazil to manage receivables in an efficient and scalable way using FIDC (Receivables Investment Fund).</span><span style="font-family: Arial, Helvetica, Sans-Serif"><br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Medicinae relieves
a number of challenges in the healthcare payments industry, as reduces long payment cycles for professionals and consolidates financial
information, improving the consumer financial experience. Afya&#8217;s intention is to grow the Digital Services segment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Medicinae was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zhLMnP9ZwlO9">117</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfUnislTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGAk6QiRz1oi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zu05rfh6d9Je" style="display: none; visibility: hidden">Schedule of acquisition of UniSL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210323__20210325__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_ze6Zg5M2ZAWk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8A2_zfKAWrFm0Jq8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Medicinae has contributed R$ <span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_z8VsqeG0tYa4" title="Transaction costs">359</span> of net revenue and R$ <span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXzcaLDn2U3">1,518</span> of loss before income taxes to the Company. If the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXmC5Fqtkgk">105</span>
and income before income taxes would have been decreased by R$ <span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zKjvD9aArSk1">113</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(c)
Acquisition of Medical Harbour</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 8, 2021,
Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zg5uTlNqJb0i">100</span>% of the total share capital of Medical Harbour, which offers educational health and medical imaging solutions
through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration,
and knowledge of human anatomy with digital resources. <span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_z3neehsYlys8">The aggregate purchase price of R$11,278 is comprised by: i) R$ 5,000 of which
100% was paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 9,000
is payable in connection with product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration
of R$6,278 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This acquisition
enables Afya to start providing a high quality solution to study the human body, allowing efficient classes and remote practical sessions
with greater student acceptance and scalability. Additionally, Afya will be able to distribute Medical Harbour solutions to all of its
ecosystem, creating B2C and B2B growth opportunities.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Medical Harbour was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zzYlEJ05a7P9">144</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Medical Harbour
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfAcquisitionOfPebmedTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zKtdf2BhXfS9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zW5lALiYIUvk" style="display: none; visibility: hidden">Schedule of acquisition of PEBMED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zyOszcZMTczk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z1sutBCAaPrl" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8AC_ziJCec7O6Akb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; color: #222222">From
the date of acquisition, Medical Harbour has contributed R$ <span id="xdx_90A_eifrs-full--RevenueOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zLaiI8OYwUI8" title="Revenue of acquiree since acquisition date">484</span> of net revenue and R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210406__20210408_zdh3PUNoUarb" title="Net revenue">1,945</span> of loss before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue </span><span style="font-family: Arial, Helvetica, Sans-Serif">for
the period ended December 31, 2021 <span style="color: #222222">would have been increased by R$ <span id="xdx_906_eifrs-full--RevenueOfCombinedEntity_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zrCyXP6dq4T9" title="Revenue of combined entity as if combination occurred at beginning of period">268</span> and income before income taxes would
have been increased by R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zbtQz7ZFDzqh" title="Income loss before income taxes">127</span>.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(d)
Acquisition of Cliquefarma</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 16, 2021,
Afya Brazil acquired <span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_ze4khYsatlWg">100</span>% of the total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks
prescription drugs, cosmetics and personal hygiene product prices in Brazil. <span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zEanXusokxJl">The aggregate purchase price of R$ 22,089 is comprised by:
(i) R$ 16,166 paid in cash; (ii) R$3,000 settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#8220;contingent
consideration&#8221;) of R$ 3,000 is payable in relation to product development. The contingent consideration of R$2,923 is based on
the present value of the obligation considering the facts and circumstances at the acquisition date.</span></span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Users of Cliquefarma
can easily search for medications or healthcare products and compare prices from over 15,000 pharmacies in Brazil. The traffic generated
is monetized through a cost-per-click model, where drugstores pay for each click on their advertisements, a cost-per-acquisition, where
drugstores pay for each concluded sale.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Cliquefarma will enhance the Digital Services segment, creating the opportunity to leverage traffic and GMV with prescriptions generated
from Afya&#8217;s physician ecosystem.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Cliquefarma was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zj66LApPJcEg" title="Transaction costs">336</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Cliquefarma
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfFesarTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zrWMfV6zM5F2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_z7UrP5URV2fc" style="display: none; visibility: hidden">Schedule
of acquisition of FESAR</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zsOFIQ0cjkO9" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210414__20210416__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z8UvFfDdR9gh" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8A3_zxFaJcJ2wGUb" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Cliquefarma has contributed R$ <span id="xdx_903_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zLz0BHIL3Tg2">3,268</span> of net revenue and R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zePGV8EXdhCi">1,752</span> of income before income taxes to the Company. Should the
acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ <span id="xdx_906_ecustom--IncreaseInRevenue_c20210101__20211231_z3hr7J1piBAl">1,435</span> and income before income taxes would have been increased by R$ <span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231_zHoQUO2Pfo7b" title="Income loss before income taxes">926</span>.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(e)
Acquisition of Shosp</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On May 13, 2021,
Afya Brazil acquired <span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zWCdfHCjvQV6">100</span>% of the total share capital of Shosp, a clinical management software that offers all functionalities needed
for clinics all over Brazil to manage their financials, patients appointments, medical records, marketing, and others. Afya&#8217;s intention
is to reinforce the Digital Services operating segment. <span id="xdx_90F_eifrs-full--DescriptionOfAcquiree_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zl64E1rqsqO2">The aggregate purchase price of R$7,901 is comprised by: i) R$ 5,855 was paid
in cash; ii) R$ 454 of consideration to be transferred; and iii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 1,793
is payable in relation to product development. The contingent consideration of R$1,592 is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Shosp was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90F_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zS5MqJVrUo39">188</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Shosp and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--ShospMember_zIt6dmS6HhHc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zRJn4wkUPehb" style="display: none; visibility: hidden">Schedule
of acquisition of MedPhone</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVrX3w2BfcB6" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210311__20210313__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zP8amaDKxti7" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8AD_z644E8379db1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Shosp has contributed R$ <span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zsiWdXQTo7I4">1,376</span> of net revenue and R$ <span id="xdx_909_eifrs-full--ProfitLossBeforeTax_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zHfssh0JQNZa">448</span> of income before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_90F_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTh6ni3Ldoi1">306</span>
and income before income taxes would have been decreased by R$ <span id="xdx_907_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTGeMr13s5qf">82</span>.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(f)
Acquisition of UNIFIPMoc</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On June 1, 2021,
Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zUgilgkEYKed">100</span>% of the total share capital of Sociedade Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UNIFIPMoc&#8221;).
<span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zVfSlnQaZSXc">The aggregate purchase price is R$ 328,322 and the total amount was paid in cash. There are 40 additional seats still pending approval,
which, if approved by the Ministry of Education, will result in a potential additional payment of up to R$ 50,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">UNIFIPMoc is a
post-secondary education institution with government authorization to offer on-campus, undergraduate courses in medicine in the states
of Minas Gerais and Bahia. The acquisition is in line with the Company&#8217;s strategy to focus on medical education, including medical
school.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UNIFIPMoc was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_905_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zYOk5sV9EZdc">177</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of UnifipMoc
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_893_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zlhKd4NkmGuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_zIOGWUEM2l1g" style="display: none; visibility: hidden">Schedule of acquisition of FCMPB</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8AD_zzosRnJ4uRa8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">From
the date of acquisition, UNIFIPMoc has contributed R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zxKEoQv35rg">69,887</span> of net revenue and R$ <span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zB7knbp338H5">19,458</span> of income before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have
been increased by R$ <span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zXFBMDDN7Jsb">46,150</span> and income before income taxes would have been increased by R$ <span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zfkuEWXScq89">12,847</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(g)
Acquisition of UNIGRAN</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On August 4, 2021,
Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVgBS8kKsHq">100</span>% of the total share capital of Companhia Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura, Instituto
de Ensino Superior de Palho&#231;a S/S Ltda., Sociedade Educacional de Palho&#231;a S/S Ltda., and Policl&#237;nica e Centro de
Est&#233;tica Duque de Caxias Ltda. (combined denominated &#8220;Unigranrio&#8221;). <span id="xdx_90B_eifrs-full--DescriptionOfAcquiree_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zDp9Lkzh44a4">The aggregate original purchase price of R$ 626,116
of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four equal installments through 2022 to
2025, adjusted by the CDI rate, was adjusted by R$7,160, because of the actual net debt, to R$618,956. There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Unigranrio is a
post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro and Santa Catarina</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of Unigranrio was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zKqyGF07nLW2">10,990</span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Unigranrio
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfAcquisitionOfUnigranTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zyXgO4PauZ0j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BB_zWeg2ldwu09l">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zBMyQzLIX536" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zh0AZu39YWsk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A5_zBFJxXVdeKZ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, Unigranrio has contributed R$ <span id="xdx_908_eifrs-full--Revenue_pn3n3_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zsAGozjP5cU1">123,369</span> of net revenue and R$ <span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_z6o9kxarbBT6">33,450</span> of income before income taxes to the Company. Should
the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ <span id="xdx_908_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zV9cUuBYsyNj">150,456</span> and income before income taxes would have been increased by R$ <span id="xdx_90C_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVhaZ3AMLxC5">22,191</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(h)
Acquisition of RXPRO</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 1, 2021,
Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zSg67NDqZUZk">100</span>% of RX PRO, comprised of (i) RX PRO Solu&#231;&#245;es de Tecnologia Ltda. and (ii) RX PRO LOG Transporte
e Logistica Ltda..Solu&#231;&#245;es de Tenologia Ltda. RX PRO consists of a solution that connects physicians with the pharmaceutical
industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians. Afya&#8217;s
intention is to reinforce the Digital Services operating segment. <span id="xdx_903_eifrs-full--DescriptionOfAcquiree_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zV1Dwlx8phE4">The aggregate purchase price of R$45,622 is comprised by: i) R$ 30,263
was paid in cash; ii) R$ 76 to be paid as price adjustment, iii) R$5,112 settled with Afya's treasury shares on the transaction closing
date; and (iv) an earn-out (&#8220;contingent consideration&#8221;) of R$ 21,000 is payable in relation to revenue achievements. The
contingent consideration of R$10,171 is based on the present value of the obligation considering the facts and circumstances at the acquisition
date.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of RXPRO was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_za4ueQEPAnAi">264</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of RXPRO and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_892_ecustom--ScheduleOfAcquisitionOfRXPROTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKHdu9aa3eTj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zLLkcFdWjoij">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z3zRq7R9cJwb" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zeZZoDFgzDC2" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zwWF1IKRBx9h" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8A5_zXAUqLUKQkpj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">From the date of
acquisition, RXPRO has contributed R$ <span id="xdx_902_eifrs-full--Revenue_pn3n3_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zTO1Cysirib">907</span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zYNxu6P2qGZ4">984</span> of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ <span id="xdx_904_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKt5eZWV9Xf3">3,155</span>
and income before income taxes would have been decreased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zRgyTxXETXa4">325</span>.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>5.2
Acquisitions in 2020</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89D_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_zsNqcDkcP1aa" style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><span id="xdx_8BE_zMeSHT02Wbp6">The
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></span></p>

<p style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b> </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniRedentor<sup id="xdx_F59_zAvFUToNjFz8">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniSL<sup id="xdx_F5F_zCrp9wUMkNth">**</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>PEBMED</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FESAR</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>MedPhone</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FCMPB</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zAVb3yo3wBJg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,796</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zNxa5tHdSZLf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,245</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zEOClRFGyeTg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,119</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zxkS1YUMKw0a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,236</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zK3fJxFOyUib" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z73IKoju1AF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    receivables </span></td>
    <td id="xdx_98E_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zgebA5hQHK2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,800</span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zmwtcWPAC5O2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,567</span></td>
    <td id="xdx_981_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z5J7bC2F7m5d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,984</span></td>
    <td id="xdx_989_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDbopQFTRoDj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_ztSTqHM49wSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1992">-</span></span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zjVTUcP68ki5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,148</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td>
    <td id="xdx_98D_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zIYUiIS7KTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td>
    <td id="xdx_980_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zAORDJDdEw6i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">467</span></td>
    <td id="xdx_984_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_znAO7mDFhcYb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2000">-</span></span></td>
    <td id="xdx_982_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zLtyNUiPfRnh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td>
    <td id="xdx_987_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zJA29mowuDqd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2004">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zyhKgYKsRsn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Recoverable
    taxes</span></td>
    <td id="xdx_980_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLzQhKtmmn1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3</span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdU8ltsEqaRj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">822</span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zTDrr01O6US7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrJovtlYZABf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2014">-</span></span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zc822jJkMSz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVulIgfPSYg2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    assets</span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLlVTGuu8227" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,486</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zhKffr4l9Ioj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,251</span></td>
    <td id="xdx_985_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zCMHVcSXhRN7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">161</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zzbJUllMn8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42</span></td>
    <td id="xdx_983_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfRCws1fjAL1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9</span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zevt8PCqwfkd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">123</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Indemnification
    assets</span></td>
    <td id="xdx_98B_ecustom--IndemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z2YfRdUlLECj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">710</span></td>
    <td id="xdx_984_ecustom--IndemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zHJ6GfXXjym4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,645</span></td>
    <td id="xdx_980_ecustom--IndemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z1BB1trtemak" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,350</span></td>
    <td id="xdx_985_ecustom--IndemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z4KMY1wZOVod" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,871</span></td>
    <td id="xdx_986_ecustom--IndemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zqzGNull8Fq2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></span></td>
    <td id="xdx_989_ecustom--IndemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zGbNk9BHa0D3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2042">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Right-of-use
    assets</span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zHAUsoWFdwR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,265</span></td>
    <td id="xdx_987_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zf2UGB0tyJN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,062</span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zR4myGuTPKfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">865</span></td>
    <td id="xdx_983_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zIvd0Jkhm42d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zRBPD644qCH7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2052">-</span></span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRQkSu6TAHE6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,663</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property
    and equipment</span></td>
    <td id="xdx_980_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCxWtOhqSzAk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,207</span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zypUcLIgkH49" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,144</span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z6OJON8HlN59" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">391</span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ztKSE8KkK655" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,176</span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z1IgIrP2N5a4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zOraqDymNOfa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">962</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible
    assets</span></td>
    <td id="xdx_981_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zoiVPseg9SA5" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">142,399</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z3UBQHD3wfU8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">314,097</span></td>
    <td id="xdx_985_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziE4HZePi3Qe" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,372</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zztkEPGfxmc7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">167,106</span></td>
    <td id="xdx_983_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQjfQEYLB78" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,727</span></td>
    <td id="xdx_980_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zCuTrBJS2Yed" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">264,782</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zG0Ql09YhReg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,666</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ztqESusg2JTg" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>421,300</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zs6YJCMJrGQ5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>83,242</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zf2XLTNzDKn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>201,431</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zakIjhXPqXg8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,796</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>297,778</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYVYWnqzF3M9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">746</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zUeODflqDsC" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,554</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zVHLo99fsbSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,024</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrAoBduLXoeh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">143</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zciqmDMxQIWg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zYqvcBOcnoy" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">173</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7MFMjiQLnfl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">16,187</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z9UX0SPbVkUf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,541</span></td>
    <td id="xdx_983_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zRZgCBuidBY1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2108">-</span></span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z6wlcFGs5WLj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,087</span></td>
    <td id="xdx_98A_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zlYcE3rXpVU4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></span></td>
    <td id="xdx_98C_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zHWMKKvUX61a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2114">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease
    liabilities</span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zuTjCGJDqTQf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,265</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zbmDpqPWIV1f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,062</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zofQ8vOGAEL8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">865</span></td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z1AIfhIdKzO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfXl2nWtp5M6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zvSzwv0hrGV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,663</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor
    and social obligations</span></td>
    <td id="xdx_983_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZQtTVdjn7Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,471</span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zTm4DtlvHAsk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,070</span></td>
    <td id="xdx_987_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zmCpWtu8RVQ6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,786</span></td>
    <td id="xdx_988_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP5eWwj185oc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,801</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFj6WtjBDTNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z1eGhO7wZC47" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,832</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes
    payable </span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zGyMOGfYZaEd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">850</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z8x56FftsgBb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,779</span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zB167xTyiR26" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,210</span></td>
    <td id="xdx_985_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zQe2elXTOKYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">29</span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQQwFxmywf5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2</span></td>
    <td id="xdx_98F_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVt8OMeZ03U9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z0GDZywEkHi7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">710</span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zyzcOPBK1LJl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,645</span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zFoEjEBYMY8d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,350</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z8EmaEquKx6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,871</span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zW9eaPY1rY8b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z6lBY2197RB3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2162">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances
    from customers</span></td>
    <td id="xdx_98D_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zU9OVtZgQ8eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,994</span></td>
    <td id="xdx_980_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zJsENwKvpIpg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,084</span></td>
    <td id="xdx_984_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zhenAaZMRQ2a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,312</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zH9Qck7htWMe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">759</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZxnNK94xKGf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zcy4zBkrXJl2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,781</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCu2FCwNbwO6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></span></td>
    <td id="xdx_986_ecustom--NotesPayables_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zVCVwA8tJib2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">80,526</span></td>
    <td id="xdx_981_ecustom--NotesPayables_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zx5J2lS5JmVc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2180">-</span></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zk4QjeBuhmM8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2182">-</span></span></td>
    <td id="xdx_988_ecustom--NotesPayables_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zi6QsQiH4Aja" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_ztexIzbGEB8k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    liabilities</span></td>
    <td id="xdx_98E_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCbwHPDABXg2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z1b3gRLxDBW7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,754</span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zqCIWe7c3oA3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2192">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zBbdYryDw0vg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2194">-</span></span></td>
    <td id="xdx_981_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVHvUY5i16cd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">228</span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zlULXa3tMbj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2198">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYJkeeIrOMCh" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>44,223</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdvLlR3bqZDd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>232,015</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z9Bq5YYaGa61" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>34,547</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkrUtMYxydX1" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,690</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZrHEYduPMC4" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>230</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zE1gAprjJYs3" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>29,454</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zMuTCasS8IS2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>132,443</b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zO5EeInsfHA7" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>189,285</b></span></td>
    <td id="xdx_986_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziB5IfohSoTc" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>48,695</b></span></td>
    <td id="xdx_987_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zO5IkSBPt9Lg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>190,741</b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2MeYPvL7nX" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,566</b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zJii1mi8hbM9" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>268,324</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #0D0E00">Goodwill
    arising on acquisition</span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEBP0fVsvRh" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zeD5ej7YtfCj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td id="xdx_982_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zfsbdJODltpf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">84,175</span></td>
    <td id="xdx_983_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zNIvYgJo0kxb" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zIiqISV2FmK5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,843</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zXWghwhespDd" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEAl8YBTEC3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>210,105</b></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpfJ9eg4bKi5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>193,705</b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zzjkQ6xOOoK9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>132,870</b></span></td>
    <td id="xdx_98C_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zMVSb9ZWRxPc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>262,405</b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zpDoOnBklbOk" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,409</b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z85IH8rQhUe4" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>378,807</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid</span></td>
    <td id="xdx_983_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zjrHviUw1Q21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">114,607</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zxQDz4vAwmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,065</span></td>
    <td id="xdx_98C_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zjjP3lEhVQic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">115,339</span></td>
    <td id="xdx_98F_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDQcHzpwEIPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">260,836</span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFrE7Fhwfpua" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,373</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWgoITNOLXMg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">189,913</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payable
    in installments</span></td>
    <td id="xdx_983_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zTPu93oUK5G1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">95,498</span></td>
    <td id="xdx_98D_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpT2t0QR7Mc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52,640</span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zSGtZ0Esp2te" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2264">-</span></span></td>
    <td id="xdx_987_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zISaWfRjlkFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,569</span></td>
    <td id="xdx_986_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4UFAFAqtikk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36</span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRhGJXWF9RCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">188,894</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Paid
    in Afya Brazil&#8217;s shares</span></td>
    <td id="xdx_98C_ecustom--PaidInAfyaBrazilsShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZdjBS4eo4F2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2272">-</span></span></td>
    <td id="xdx_98B_ecustom--PaidInAfyaBrazilsShares_iI_pp0i_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zZR29SxWh5ml" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span></span></td>
    <td id="xdx_989_ecustom--PaidInAfyaBrazilsShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zDFZAGwkTe3i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,531</span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDP8i6MEP4H3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZnYuBkzFTNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></span></td>
    <td id="xdx_988_ecustom--PaidInAfyaBrazilsShares_iI_pii_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zQLsUbZrIDS" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction
    costs (included in cash flows from operating activities)</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7sY5B4QLffc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,380</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pin3_c20200503__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zvPYmbPS5kX6" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,666</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zebx1JhzEYh5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">613</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zGRXSxClklu7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,047</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2WJXEDLrr0k" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zPT7QjmULYp9" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">721</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid, net of cash acquired with the subsidiary (included in cash flows from investing activities) </span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z5nxvCxmHf57" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">102,811</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">137,820</span></td>
    <td id="xdx_98A_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zXUNj4fH6FK2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">114,220</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zVKeYuO8YR14" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">256,600</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z13yUYixlnpj" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,313</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zuZKl77xuRU1" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">189,813</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYkZLwsBvKQg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>104,191</b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ziKynDSkF499" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>139,486</b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zgCV2RnT839b" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>114,833</b></span></td>
    <td id="xdx_989_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zUwKk8nsj9K7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>258,647</b></span></td>
    <td id="xdx_981_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVGl60C0Oby7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,471</b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201209__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zpObDsnvBPl8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>190,534</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; color: #0D0E00; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F06_ztIuyFXfHNm5" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_zaO3k9qNVr96" style="font-family: Arial, Helvetica, Sans-Serif">During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.</span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.25in; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_ztROSjqJfKFh" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00">**</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_z3KRsfIOe955" style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00">During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p</span><span style="font-family: Arial, Helvetica, Sans-Serif">roperty
and equipment of R$7<span style="color: #0D0E00">.</span></span></td>
</tr></table>

<p id="xdx_8A6_zeDZBZbaaHOh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="color: #0D0E00">&#160;</span></span></p>

<p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(a)
Acquisition of UniRedentor</b></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On January 31,
2020, Afya Brazil acquired <span id="xdx_903_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zhjHb8uWIB8h">100</span>% of the share capital of UniRedentor. <span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zEDgTjf970E8">The original purchase price of R$214,608, was adjusted by R$4,503
and was comprised by: i) R$114,607 paid in cash on the acquisition date; and ii) R$100,000 is payable in five equal installments from
January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4,503 was deducted from the first installment
due in January 2021.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">UniRedentor is
a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro. The acquisition contributed with 112 medical school
seats, with a potential 44 additional medical school seats subject to the approval by MEC and is in line with the Company&#8217;s strategy
to focus on medical education, including medical school.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UniRedentor was accounted for under IFRS 3 &#8211; Business Combinations.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z4RzU6Q9YUJd">1,380</span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z2fcWB3rBBlc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zjxRcRDmmTY7">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z7YEmaeRyFH9" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zin473Y7fpD4" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A1_zwwvqrnMvcpl" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">UniRedentor
contributed R$ <span id="xdx_904_eifrs-full--Revenue_pn3n3_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z0z01XsnGzK4">96,065</span> of net revenue and R$ <span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zsDEelRNmaj5">30,952</span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_909_ecustom--IncreaseInRevenue_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zMqg9CnYbPNc">5,931</span> and income before income taxes for 2020
would have been increased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z5NfCkHU6i79">321</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(b)
Acquisition of UniSL</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020,
Afya Brazil acquired <span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zieGbQg07okj">100</span>% of the total share capital of UniSL. UniSL is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate courses in medicine and health, as well as other courses, in the State of Rond&#244;nia. <span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_z0AOGqM8tGE">The original
purchase consideration of R$201,521 was adjusted by R$7,816, of which: (i) 70% is payable in cash on the transaction closing date, and
(ii) 30% is payable in cash in three equal installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment
of R$7,816 was deducted from the first installment due in May 2021.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
contributed with 182 medical school seats. There are 100 additional seats still pending approval which, if approved by MEC, will result
in a potential additional payment of up to R$<span id="xdx_90F_ecustom--AdditionalPaymentMade_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_z356B59gSgP" title="Additional payment made">80,000</span>, adjusted by the CDI rate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Given the future
event that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably
estimated and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will
result in additional licenses, which will be measured accordingly if and when approved.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of UniSL was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zrpuLIKQtsEk">1,666</span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfAcquisitionOfUnisl1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zCTapHyGyKZ4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zbdcoyY1QUHb">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_984_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z75keHgw1i0c" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zwT9hpoM2CUh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A0_z6gRNBCjnpqc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">UniSL
contributed R$ <span id="xdx_90D_eifrs-full--Revenue_pn3n3_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQAcobrdvYh1">113,894</span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQB8tZH9PFob">30,649</span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_90D_ecustom--IncreaseInRevenue_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_znlaPHVgpD8c">57,477</span> and income before income taxes for
2020 would have been increased by R$ <span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zbB2TNHrVCX5">9,455</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(c)
Acquisition of PEBMED</b></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 20, 2020,
Afya Brazil acquired <span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zwRSu4NjQDn">100</span>% of the share capital of PEBMED. <span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDxIxlh0XL4">The original purchase price of R$ 132,900 was adjusted by R$ 30 and was comprised
by: i) R$115,339 paid in cash on the acquisition date; and ii) R$ 17,531 was paid with Afya Brazil&#8217;s shares which were afterwards
contributed to the Company in exchange of issuance of 141,976 of its own shares.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">PEBMED offers content
and clinical tools for healthcare professionals, including web portals and mobile apps. With the integration of PEBMED into our platform,
Afya will continue to expand offerings for the medical professionals.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of PEBMED was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$ <span id="xdx_906_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQC1cck3vX4g">613</span> and were expensed and are included in general and administrative expenses in the consolidated statement of income.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_898_ecustom--ScheduleOfAcquisitionOfPebmed1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zXTNHJmUDlE4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zOiGDpc7oG1g">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zNmcdf3oWjei" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrpCM5e8RLhi" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zah1wOgtfIO3" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8A1_zZvi6L7Lzg13" style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">PEBMED
contributed R$ <span id="xdx_905_eifrs-full--Revenue_pn3n3_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zviPVnG2oQbg">17,535</span> of net revenue and R$ <span id="xdx_90B_eifrs-full--ProfitLossBeforeTax_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zV87y7ZK8Y1f">3,413</span> of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_905_ecustom--IncreaseInRevenue_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDfEJiZKTmo4">17,452</span> and income before income taxes for
2020 would have been increased by R$ <span id="xdx_902_ecustom--DecreasedInIncomeBeforeIncomeTaxes_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zZTmdgnIJuja">1,813</span>.</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(d)
Acquisition of FESAR</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On November 3,
2020, Afya Brazil acquired <span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zgw8od6U1fM6">100</span>% of the share capital of FESAR. <span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkLFztzSRPA">The aggregate purchase price was R$260,836, including the CDI rate adjustment
from the signing date and the real state of the operation, estimated at R$ 17,397, of which 100% was paid in cash on the closing of the
operation. The purchase consideration was adjusted by R$1,569 and was paid on February 25, 2021.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">FESAR is a post-secondary
education institution with government authorization to offer on-campus, undergraduate courses in medicine and health, as well as other
courses, in the State of Par&#225; and medical course represents 70% of its 2019&#8217;s net revenue. The acquisition contributed with
120 medical school seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
of FESAR was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Transaction costs
to date amount to R$<span id="xdx_90E_ecustom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z0zrK9swxVLh">2,047</span> and were expensed and are included in general and administrative expenses in the consolidated statement of
income.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_897_ecustom--ScheduleOfAcquisitionOfFesar1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zYfWbd8k9GH4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zYGDzv9uTPV8">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zaLtaUATzVif" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_986_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zyAQaPdz1ko7" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A3_zD0Bff6SIUgg" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">FESAR
contributed R$ <span id="xdx_906_eifrs-full--Revenue_pn3n3_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zaF1nUR1cAG6" title="Net revenue">6,280</span> of net revenue and R$ <span id="xdx_901_eifrs-full--ProfitLossBeforeTax_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z21SJqBDOIAi" title="Income loss before income taxes">3,751</span> of income before income taxes to the Company in 2020. If the acquisition had taken place
at the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_909_ecustom--IncreaseInRevenue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP3cNrQjCzLa" title="Increase in revenue">29,113</span> and income before income taxes for 2020 would
have been increased by R$ <span id="xdx_909_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zsAILdcpoxBi" title="Increase in income before income taxes">14,918</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(e)
Acquisition of MedPhone</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">On
November 4, 2020, Afya Brazil acquired <span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfhoCIpGaQ3l">100</span>% of the share capital of MedPhone. <span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20201102__20201104__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zv3hdwdWEsn" title="Description of acquiree">The net purchase price was R$6,373 of which 100% was paid
in cash on the closing of the operation. The purchase price was adjusted to R$6,409, this price adjustment of R$ 36 was paid on February
2, 2021.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">MedPhone
is a clinical decision and leaflet consultation app in Brazil, that helps physicians, medical students and other healthcare professionals
to make faster and more accurate decisions on a daily basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
acquisition of MedPhone was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Transaction
costs to date amount to R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z6PV8ThsVeqh" title="Transaction costs">158</span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">There
are no trade receivables, right of use assets or lease liabilities associated with the acquisition of MedPhone.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z3vbHMRhcPJe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B4_zpb10HpQncm2">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zOVS1YPmqEHc" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zoXBh7qPJcph" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zRjmfbyWdBG5" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<p id="xdx_8AF_zAlzKp1ya0u7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">Medphone
contributed R$ <span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zsOUGQBUigml" title="Net revenue">49</span> of net revenue and R$ <span id="xdx_904_eifrs-full--ProfitLossBeforeTax_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zguN7LWvW269" title="Income loss before income taxes">57</span> of loss before income taxes to the Company in 2020. If the acquisition had taken place at
the beginning of the period, net revenue for 2020 would have been increased by R$ <span id="xdx_90C_ecustom--IncreaseInRevenue_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4gqNdsrs9h4" title="Increase in revenue">142</span> and income before income taxes for 2020 would have
been increased by R$ <span id="xdx_904_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zh2nvdlmuErf">46</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>(f)
Acquisition of FCMPB</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">On
November 9, 2020, Afya Brazil acquired <span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_ztDqMNTY9mVg">100</span>% of the share capital of FCMPB. <span id="xdx_906_eifrs-full--DescriptionOfAcquiree_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zVygu7oAtge9">The total net purchase price of R$379,913 was adjusted to
R$378,807 and is comprised of (i) R$189,913 paid in cash on the transaction closing date, and (ii) R$188,894 is payable in cash in four
equal installments through 2024, adjusted by the CDI rate.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">FCMPB
is a post-secondary education institution with government authorization to offer on-campus, undergraduate courses in the State of Para&#237;ba
and medical course represents 99% of its 2019&#8217;s net revenue. The acquisition contributed with 157 medical school seats</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
acquisition of FCMPB was accounted for under IFRS 3 &#8211; Business Combinations.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Transaction
costs to date amount to R$<span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zAlGYuNybu91">721</span> and were expensed and are included in general and administrative expenses in the consolidated statement
of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_891_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOBpQx2ren03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B3_zxZLgCnXCsEf">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: black"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zs5p8J3xdUik" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<p id="xdx_8A8_zRTgQCQd4Nba" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">FCMPB
contributed R$ <span id="xdx_90A_eifrs-full--Revenue_pn3n3_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zMuF15x0bQAa" title="Net revenue">10,509</span> of net revenue and R$ <span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOVx47gvTNt6" title="Income loss before income taxes">3,570</span> of income before income taxes to the Company in 2020. FCMPB was constituted through
a spin-off recently in August, 2020 and there is no information before this period to be presented.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfBusinessCombinationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfBusinessCombinationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103362184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory', window );">Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zRNddwx4n64" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>6</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_82E_zdNRbjiNGyYj">Cash
                                            and cash equivalents</span></b></span></td></tr></table>

<p id="xdx_896_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zep5cpAxzMnk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_z6Tlk5tVKuTe" style="display: none; visibility: hidden">Schedule of cash and cash equivalents</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_494_20211231_zhIs5sZaH5Pf" style="border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20201231_z12DwGphZZZ3" style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_zkyM9A130qQc" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,487</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,729</span></td></tr>
  <tr id="xdx_405_eifrs-full--CashEquivalents_iI_z7I6HlvNsys9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">660,075</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">987,313</span></td></tr>
  <tr id="xdx_406_eifrs-full--CashAndCashEquivalents_iI_zjXuW90T7sj2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif">&#160;Cash and cash
    equivalents</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>748,562</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,045,042</b></span></td></tr>
  </table>
<p id="xdx_8A2_z28CIaNg5uaa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Cash equivalents
correspond mainly to financial investments in Bank Certificates of Deposit (&#8220;CDB&#8221;) with highly rated financial institutions
and investments funds managed by highly rated financial institutions. As of December 31, 2021, the average interest on these investments
are equivalent to <span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_ztaM2DvRaVdd" title="Percentage of average interest">100.38</span>% of the Interbank Certificates of Deposit (&#8220;CDI&#8221;) (December 31, 2020: <span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--InterbankCertificatesOfDepositMember_zf5VXktJJiT3" title="Percentage of average interest">90.95</span>%). These funds are available
for immediate use and have insignificant risk of changes in value. Cash equivalents denominated in U.S. dollars totaled R$<span id="xdx_90D_eifrs-full--CashEquivalents_iI_c20211231__srt--CurrencyAxis__custom--USDMember_zf5MmUtQshSi" title="Cash equivalents (a)">23,228</span> as of
December 31, 2021 (December 31, 2020: R$<span id="xdx_902_eifrs-full--CashEquivalents_iI_c20201231__srt--CurrencyAxis__custom--USDMember_zSrkruIrDXLg" title="Cash equivalents (a)">70,523</span>).</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103202424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory', window );">Trade receivables</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zTSHSwTDNuse" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>7</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zQysDuS9pYtl">Trade
                                            receivables</span></b></span></td></tr></table>

<p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_z6b1Qk5I7Xmj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zX8Tm0BxMpJ7" style="display: none; visibility: hidden">Schedule of trade accounts receivable, net and notes receivable</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zaZofXwly2wk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">279,915</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z74W3KJi8Z31" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">195,318</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    content <sup id="xdx_F48_zUO4e8brM0M">(a)</sup></span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zOV30KCsXofj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">69,227</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zg1672CjJlih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,931</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zTCLIoJgxW24" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61,342</span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8koS9msPeif" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,425</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    credits</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zQ4a75Of75n9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,375</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zlpqgXRsuZj2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,248</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mobile
    app subscription <sup id="xdx_F4E_zOa0ciKTexrc">(b)</sup></span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_z1MV2dvkFeAk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,946</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_zWLBo9AKjKJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,526</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Others</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_z6I9Rx5eNiH" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,001</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zfn7aUmMY7Gh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,476</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_c20211231_zLBKL11Rm3y7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>450,806</b></span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_c20201231_zLCSmEvtYPR2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>342,924</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(-)
    Allowance for doubtful accounts</span></td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20211231_zBkEMKa2PMHi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(45,013)</span></td>
    <td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20201231_zZmq4vdSYDo9" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,980)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--TradeReceivables_iI_c20211231_zSTFHCVuTpjk" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>405,793</b></span></td>
    <td id="xdx_984_eifrs-full--TradeReceivables_iI_c20201231_zaqIgysBXjOb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>309,944</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_980_eifrs-full--CurrentTradeReceivables_iI_c20211231_zScJjlPWwHM4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">378,351</span></td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_iI_c20201231_zxihBwvEorl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">302,317</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zbmRZtLv3i1g" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zX4sEv6BVB7k" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zYXsJQ38ODgj" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1E_zEcoPHFhNVO8" style="font-family: Arial, Helvetica, Sans-Serif">Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zNzDoXuVEQU6" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_z6NwoKmSmTvg" style="font-family: Arial, Helvetica, Sans-Serif">Related to trade receivables
from mobile applications subscriptions for digital medical content.</span></td>
</tr></table>

<p id="xdx_8AF_zVsAlkpv1RL3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_zAwhsbHdfyhe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 and 2020, the aging of trade receivables was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_zkokUPFKxvo" style="display: none; visibility: hidden">Schedule of aging of trade accounts receivable</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Neither
    past due nor impaired</span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zmDSzjnGs491" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">184,382</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zyPih9uvje8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,076</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Past
    due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1
    to 30 days</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zYU6waBpya8e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,932</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z6DNxDfqC5cl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,365</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31
    to 90 days</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zLUHzFxJit2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">69,299</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zlphyAszTvGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,198</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">91
    to 180 days</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zKXHpKOsyJ3e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,764</span></td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zsqTxBBQZtAg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,521</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">More
    than 180 days</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zmiFGDiMyKX" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,429</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_znlov2MSuhO6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,764</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231_zPG8AONvukig" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>450,806</b></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231_z4TICkXN3d39" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>342,924</b></span></td></tr>
  </table>
<p id="xdx_8AE_zXoxPEMEX9k3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsExplanatory_zQ98EYNT8Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The changes in
the allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019, was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zh6ifQJcKy49" style="display: none; visibility: hidden">Schedule of allowance for doubtful accounts</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 60%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_493_20210101__20211231_zQwptMmF38Hh" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_495_20200101__20201231_zWOPOHXBLRSb" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_494_20190101__20191231_zsQ3E8BXifx2" style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_zQHR6SKfOs2f" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the beginning of the period</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,980)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,763)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,537)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_z8ZbFhKS0wQj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,819)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,081)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,040)</span></td></tr>
  <tr id="xdx_402_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_zmLORFRGbM52" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,786</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,864</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,814&#160;&#160;&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_zIQ6MP0Y8gS6" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the end of the period</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(45,013)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(32,980)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(14,763)
    </b></span></td></tr>
  </table>
<p id="xdx_8A2_zWV8Ndlnwiqj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of trade and other receivables. [Refer: Trade and other receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103311848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRelatedPartyExplanatory', window );">Related parties</a></td>
<td class="text"><p id="xdx_806_eifrs-full--DisclosureOfRelatedPartyExplanatory_zdAst755fjb4" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>8</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zUUbyhNLmH97">Related
                                            parties</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_897_ecustom--ScheduleOfRelatedPartiesExplanatory_zHTPNSmwfAB3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zA9nOBZYRjOc">The table below
summarizes the balances and transactions with related parties:</span></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49D_20211231_zFAMpuVZ6ke3" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_499_20201231_z8IkEVggsgqe" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--TradeReceivablesRelatedPartyTransactions_iI_zVTPXnt6ywSf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables <sup id="xdx_F47_zor9ngjglRtg">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">692</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">174</span></td></tr>
  <tr id="xdx_400_ecustom--CreditsWithShareholdersRelatedPartyTransactions_iI_zRKH3INWi5Ob" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Related
    parties <sup id="xdx_F42_zPsDLPAGjoB1">(b)</sup></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421</span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_zytw8aCO5ye1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span style="display: none; visibility: hidden">TOTAL</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>692</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>595</b></span></td></tr>
  <tr id="xdx_407_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_z17ngage4Oo3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">692</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">174</span></td></tr>
  <tr id="xdx_402_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zOJRRKNzkTmd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2518">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--AccountsPayableToSellingShareholders_iI_zRqWB7IxYx7l" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders <sup id="xdx_F4F_zx3htuzXoK11">(c)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,556</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2522">-</span></span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsPayableRelatedPartyTransactions_iTI_zjHCjdgL5nP8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif; visibility: hidden">&#160;Total</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>54,556</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td></tr>
  <tr id="xdx_401_ecustom--AccountsPayableCurrent1_iI_zD0CpvdKYxg7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,278</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2528">-</span></span></td></tr>
  <tr id="xdx_400_ecustom--NoncurrentPayablesToRelatedParties1_iI_zk0v0IIndaP9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,278</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other
    income</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC
    <sup id="xdx_F40_ztkneTU0jBr4">(a)</sup></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zo377Gzq2ink" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">752</span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zXqUxwWTdaa3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">104</span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zy4r6G9wnxa6" style="vertical-align: top; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">557</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zKfnxqWhVlq2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>752</b></span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231_z2hBRocfajw1" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>104</b></span></td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231_zz9RW70uHdf3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>557</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL
    Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_987_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z9MWpTJVG9Hb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,336</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zXDItSZyVpe2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,288</span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOpXLwRJQoWg" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,417</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O
    Patrimonial Ltda.</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zXDNNpZ3zMB5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,210</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z72NlVDU4xY" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,915</span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zZyKhU1V9m9g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,816</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP
    Patrimonial Ltda.</span></td>
    <td id="xdx_980_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zDrbBZrTCal3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,560</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zPFPbbEv8YNc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,470</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zmhhRsQRSk7d" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,609</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_z6GM6uMWpsI5" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>23,106</b></span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231_zq8uPh334pHc" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>17,673</b></span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>15,842</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zIWsuYYX5gp" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_z5FfuMNv5D9k" style="font-family: Arial, Helvetica, Sans-Serif">Refers to sales of educational content
from Medcel to UEPC.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zLN6utXXTwe1" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zHL1ntwquFYg" style="font-family: Arial, Helvetica, Sans-Serif">Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zRr8V9KKHa56" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_zDDVZy0CIS66" style="font-family: Arial, Helvetica, Sans-Serif">Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.</span></td>
</tr></table>

<p id="xdx_8AF_zvyUrDYJypu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya Brazil has
entered into lease agreements with RVL Esteves Gest&#227;o Imobili&#225;ria S.A. (&#8220;RVL&#8221;), an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, as described below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
June 21, 2016, RVL entered into lease agreements (as amended on April 26, 2018) with ITPAC &#8211; Instituto Tocantinense Presidente
Ant&#244;nio Carlos S.A., or ITPAC, and Itpac Porto Nacional &#8211; Instituto Tocantinense Presidente Antonio Carlos Porto S.A., or
ITPAC Porto Nacional, pursuant to which RVL Esteves Gest&#227;o Imobili&#225;ria S.A. agreed to lease campuses to ITPAC and ITPAC
Porto Nacional in the cities of Aragua&#237;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are
adjustable in accordance with the provisions of each lease agreement. The lease agreements are for an initial term of <span id="xdx_903_ecustom--OperatingLeaseTermOfContract_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zpAlcTyi13u5" title="Lease term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2563">20</span></span> years, and are
renewable for an additional 20 years subject to the provisions of each lease agreement.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
November 1, 2016, RVL entered into a lease agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices
located in the city of Nova Lima, State of Minas Gerais, where Afya Brazil&#8217;s principal executive offices are located. On February
9, 2019 the agreement was amended to extend lease terms and adjust the lease amounts, subject to certain discount conditions set forth
in the lease agreement and adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of five years, and may be renewable for an additional five years subject to the provisions of the lease agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">On
September 6, 2018, RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus
by RVL in the city of Palmas, State of Tocantins. The lease agreement is for an amount equal to <span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180905__20180906__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember_zxnsAt16Trmk" title="Percentage of revenue">7.5</span>% of the monthly net revenue of ITPAC
during the prior semester, which will start to become due once the new ITPAC campus becomes operational, subject to the provisions of
the lease agreement. The lease agreement is for an initial term of <span id="xdx_90B_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zySCVqNvIqpb" title="Percentage of revenue::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2567">20</span></span> years, starting on the date the new ITPAC campus becomes operational,
and is renewable for an additional <span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zQHBkRpjh266" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2569">20</span></span> years subject to the provisions of the lease agreement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 30,
2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL agreed to lease to IPTAN the new IPTAN medical campus, currently
under construction by RVL in the city of Santa In&#234;s, State of Maranh&#227;o. The lease agreement is for a monthly amount equal
to (i) up to June 2020, R$12 and (ii) after June 2020 and until March 2024, 6.5% of the monthly net revenue of IPTAN</span> assessed during
the prior semester, in each case adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of 5 years counted from the conclusion of the construction works, and may be renewable for an additional 5 years subject to the
provisions of the lease agreement.</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On August 02, 2021,
RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus,
in the city of Garanhuns, State of Pernambuco. The lease agreement is for a monthly amount equal to <span id="xdx_909_ecustom--DescriptionOfLeaseTerm_c20191029__20191030__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" title="Description of lease term">(i) up to June 2022, R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_pn3n3" title="Lease expenses">40</span>; (ii) after
June 2022 and until December 2028, <span id="xdx_90D_eifrs-full--PercentageOfEntitysRevenue_dp_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsyxmYqwhPt8" title="Renewal term">6.5</span>% of the monthly net revenue of ITPAC</span> Garanhuns assessed during the prior semester, in each case
adjustable in accordance with the provisions of the lease agreement; and (iii) after 2029 the monthly amount should be adjust by inflation
rate (IPCA). The lease agreement is for a term of 20 years.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The lease payments
in connection with the lease agreements with RVL totaled R$<span id="xdx_90D_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zCHhPIigyLa8" title="Lease expenses">15,336</span> and R$<span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zhH9eGt9GAbf" title="Lease expenses">11,288</span> in the years ended December 31, 2021 and 2020, respectively.
In the year ended December 31, 2019, the lease payments in connection with the lease agreements with RVL totaled R$1<span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20190101__20191231__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zRzsTFLo2Jh5" title="Lease expenses">0,417</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreement with UNIVA&#199;O Patrimonial Ltda.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 14, 2016,
UNIVA&#199;O Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#226;ngela Esteves
is the chief executive officer, entered into a lease agreement with UNIVA&#199;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#199;O
Patrimonial Ltda. agreed to lease the UNIVA&#199;O campus to UNIVA&#199;O, located in the city of Ipatinga, State of Minas Gerais.
The lease agreement is adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term
of 20 years, and is renewable for an additional <span id="xdx_90E_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsdrHOPcqEac" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2583">20</span></span> years subject to the provisions of the lease agreement. The lease payments in connection
with this lease agreement totaled R$<span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z400aEfi31l1" title="Lease expenses">3,210</span> and R$<span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zqSmF7AMl80e" title="Lease expenses">2,915</span> in the years ended December 31, 2021 and 2020, respectively. In the year ended
December 31, 2019, the lease payments in connection with this lease agreement totaled R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_pn3n3" title="Lease expenses">2,816</span>.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Lease
agreement with IESVAP Patrimonial Ltda.</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On April 25, 2018,
IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive
officer, entered into a lease agreement with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to
lease the IESVAP campus to IESVAP located in the city of Parna&#237;ba, State of Piau&#237;. <span id="xdx_90F_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuBwNBw337Dd" title="Description of lease term">The lease agreement is for an amount
equal to <span id="xdx_900_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zlLSOz759e35" title="Percentage of revenue">7.5</span>% of the monthly net revenue of IESVAP during 2018</span>. The lease agreement is for an initial term of <span id="xdx_908_ecustom--OperatingLeaseTermOfContract_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFbnwpS7847l" title="Lease term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2595">20</span></span> years, and is renewable
for an additional <span id="xdx_905_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zf3p0TQJwte1" title="Renewal term::XDX::P20Y"><span style="-sec-ix-hidden: xdx2ixbrl2597">20</span></span> years subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement
totaled R$<span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zbKeUwS942n8" title="Lease expenses">4,560</span> and R$<span id="xdx_903_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z4u0hzmzA9wb" title="Lease expenses">3,470</span> in the years ended December 31, 2021 and 2020, respectively. In the year ended December 31, 2019, the lease
payments in connection with this lease agreement totaled R$<span id="xdx_908_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_pn3n3" title="Lease expenses">2,609</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Key
management personnel compensation</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_892_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_zB80mLv5U6l4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zjGIIOd6WbXe">Key management
personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 4%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="width: 3%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term
    employee benefits</span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_zy5oJImO2QQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,933</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20200101__20201231_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,629</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20190101__20191231_pn3n3" style="text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,947</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation plan</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zFOzMHPWLGol" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,251</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--KeyManagementPersonnelCompensation_c20200101__20201231_pn3n3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,989</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--KeyManagementPersonnelCompensation_c20190101__20191231_pn3n3" style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,893</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zTsER7rH0PAl" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,184</b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20200101__20201231_zlHdUK86xtXg" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>33,618</b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>18,840</b></span></td></tr>
  </table>
<p id="xdx_8AF_zZPRnVfA1wXb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Compensation of
the Company&#8217;s key management includes short-term employee benefits comprised by salaries, labor and social charges, and other ordinary
short-term employee benefits. The amounts disclosed in the table above are the amounts recognized as an expense in general and administrative
expenses during the reporting period related to key management personnel.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The executive officers
participate in share-based compensation plans described in Note 16 (b).</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRelatedPartyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Section Disclosures<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS24_g13-24_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRelatedPartyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103273560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOtherAssetsExplanatory', window );">Other assets</a></td>
<td class="text"><p id="xdx_803_eifrs-full--DisclosureOfOtherAssetsExplanatory_zyixwY9OtSE4" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>9</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zWXLdiSWkG8g">Other
                                            assets</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 the Company has R$<span id="xdx_906_ecustom--OtherCurrentAssets1_iI_c20211231_z3h2ymb5Wthl" title="TotalAssets">222,839</span> (R$ <span id="xdx_909_ecustom--OtherCurrentAssets1_iI_c20201231_zy1Kug55MQGa" title="TotalAssets">103,651</span> in December 31, 2020) accounted for as Others assets as follow:</span></p>

<p id="xdx_893_ecustom--DisclosureOfOtherAssetsTableTextBlock_z0mZ8VPwyvU" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_z0iZVeWMgMua" style="display: none; visibility: hidden">Schedule
of Other Assets</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49A_20211231_ze0H6LTEmB39" style="border-bottom: black 1pt solid; vertical-align: top; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49E_20201231_zG4ahnYBdjRf" style="border-bottom: black 1pt solid; vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_maAzeR4_zGMAje5cFJJa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification
    assets <sup id="xdx_F4A_zckFy3zL5CEh">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">135,355</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;53,499</span></td></tr>
  <tr id="xdx_402_ecustom--JudicialDeposits_iI_maAzeR4_z4nMEHY7I5R8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial
    deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,825</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;1,451</span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentPrepaidExpenses_iI_maAzeR4_zLTpYYE9zZfb" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid
    expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,110</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2,291
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_maAzeR4_zU0e0fR2ZLK3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,450</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,411</span></td></tr>
  <tr id="xdx_405_ecustom--OtherAssets1_iI_maAzeR4_zV0fIqT6dcq9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,099</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,999</span></td></tr>
  <tr id="xdx_402_ecustom--Assets1_iTI_mtAzeR4_zImaWDaO5qK2" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<b>Total</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>222,839</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&#160;103,651
    </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CurrentAssets1_iI_z0uxoNiykdGk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,533</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,614</span></td></tr>
  <tr id="xdx_40E_ecustom--NoncurrentAssets1_iI_zwxeteUaAHSe" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">180,306</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">74,037</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zmlIUcWq5LB9" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_zQccXvRQc3Yj" style="font-family: Arial, Helvetica, Sans-Serif">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</span></td>
</tr></table>

<p id="xdx_8AF_zBkj7WdPT4N5" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOtherAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of other assets. [Refer: Other assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOtherAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103631432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfJointVenturesExplanatory', window );">Investment in associate</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--DisclosureOfJointVenturesExplanatory_zcSicmYBKOia" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>10</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_828_zDsDP9sGlhR7">Investment
                                            in associate</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_893_ecustom--ScheduleOfInvestments_zzSKJ0qizyvd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In connection with
the corporate reorganization, described in Note 1 regarding the merger with BR Health, the Company acquired a 30% interest in UEPC, a
medical school located in the Federal District, that offers higher education and post-graduate courses, both in person and long-distance
learning. The Company&#8217;s interest in UEPC is accounted for using the equity method. The following table illustrates the summarized
financial information of the Company&#8217;s investment in UEPC:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zegUpHFamie3" style="display: none; visibility: hidden">Schedule of investments</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_495_20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_ztuFjR6lWCCj" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49F_20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zutTJWB1NOSh" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--CurrentAssets_iI_ziNRzqN8aVLa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33,976</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,413</span></td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentAssets_iI_zkysyWkAnADj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">109,805</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">82,575</span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentLiabilities_iI_zcdpcfOW3luf" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(35,049)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(34,531)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLiabilities_iI_zZJ0OrYijEZ5" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,086)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,132)</span></td></tr>
  <tr id="xdx_400_ecustom--EquityInAssociate_iI_pn3n3_zNdNHY5uOJ02" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>17,646</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,325</b></span></td></tr>
  <tr id="xdx_40F_ecustom--CompanyShareInEquity1_iI_zncKuEDDgSdg" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s
    share in equity &#8211; 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,294</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,227</span></td></tr>
  <tr id="xdx_404_eifrs-full--Goodwill_iI_zTWHOCQEGj3e" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_znBr9zNPrT1d" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,410</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_496_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zMGhJOUNcZQ9" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z01qreZIZnPe" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zd8VHpPGpZti" style="width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr id="xdx_40E_eifrs-full--Revenue_zxTnnxGzFvc8" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net
    revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">127,618</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">113,965</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,816</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CostOfSales_zZUBc69Iyqih" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,935)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,926)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,459)</span></td></tr>
  <tr id="xdx_408_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zli07pMMZvN2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,025)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(27,341)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,476)</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_z9ZRA8rKUZOe" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance
    result</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,585)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,882)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,121)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_zd0sGZqBIs3i" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income
    before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>41,073</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,816</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>12,760</b></span></td></tr>
  <tr id="xdx_40F_eifrs-full--IncomeTaxExpenseContinuingOperations_zh29JpX4Fe12" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,748)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(252)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,275)</span></td></tr>
  <tr id="xdx_405_eifrs-full--ProfitLoss_z11LxfdFLAi2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    income for the period</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>39,325</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,564</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>10,485</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_zTbangbaaco6" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s
    share of income for the period </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>11,797</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>7,698</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,362</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zx55YM9V8TE6" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zKWB50vA4P11" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z8lEV9pC1Lu" style="border-bottom: black 1pt solid; width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentsInAssociates_iS_zWtjCksUTzqa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">45,634</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></span></td></tr>
  <tr id="xdx_408_ecustom--MinorityInterestOfAcquiree_zlqSJLaQhuNi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of minority interest (15%) in March 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2722">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2723">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,458</span></td></tr>
  <tr id="xdx_40A_ecustom--AdditionalMinorityInterestOfAcquiree_zC6y6OBKIP86" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of additional interest (15%) in June 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,457</span></td></tr>
  <tr id="xdx_401_ecustom--DividendsReceived1_zeyf8wFxDexl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,770)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,922)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,643)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--DividendsReceived_zneCLdZD8Hr8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,960)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2735">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossOfAcquiree_zZ9lZe3En97g" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,797</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,698</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,362</span></td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iE_zdxGaReHhpy7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing
    balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,410</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>45,634</b></span></td></tr>
  </table>
<p id="xdx_8A0_zCGSMXs6lXm7" style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
Company tests at least annually the recoverability of the carrying amount of goodwill and there was no impairment for this goodwill.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfJointVenturesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of joint ventures. [Refer: Joint ventures [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B4<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B4_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfJointVenturesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103204584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory', window );">Property and equipment</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zk4hRNRyM8dj" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>11</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_82C_zeKtI6PzYUJ2">Property
                                            and equipment</span></b></span></td></tr></table>

<p style="margin-top: 0; margin-bottom: 0"/>

<p id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zBwyJ0giRUl3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zXB5MRKKrsa9" style="display: none; visibility: hidden">Schedule
of detailed information about property, plant and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 24%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_ztR2ztUIgz46" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Building</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zWF4kv1Mf272" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Machinery
    and equipment</b></span></td>
    <td id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zk3CSQXZAzo" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Lands</b></span></td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zqcdivLUIRk8" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Vehicles</b></span></td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zScXVWbPlrOj" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Furniture
    and fixtures</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zN2CJpmui0ja" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>IT
    equipment</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_znYhjBfijHs5" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Library
    books</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LaboratoriesAndClinicsMember_zy8nGF7You35" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Laboratories
    and clinics</b></span></td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_z1lVkTwLfhpd" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Leasehold
    improvements</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zEMD0wm5Ie93" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Construction
    in progress</b></span></td>
    <td id="xdx_4B6_z8qJbJuS5uMg" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zgRvAijtZECi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,503</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,770</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>11,897</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,243</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>12,838</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>597</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>11,882</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,736</b></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>91,648</b></span></td></tr>
  <tr id="xdx_439_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zEa98fDb9NZ4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2762">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">422</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,976</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,241</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,205</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">34</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,488</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,525</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,964</span></td></tr>
  <tr id="xdx_43C_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zGspkmT9FpNd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfers</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2775">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2777">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(525)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2781">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2782">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2783">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(525)</span></td></tr>
  <tr id="xdx_433_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zoBzLOAs4s5g" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2786">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,988</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2788">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">103</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,565</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,035</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,096</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">418</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,541</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">470</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,216</span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zRRN4GV3tug1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2798">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>44,329</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,005</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>707</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,438</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,994</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,139</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,049</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,911</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>36,731</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,303</b></span></td></tr>
  <tr id="xdx_436_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zXnm95dVmXBk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2810">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,806</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">672</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,550</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,657</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,012</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2817">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">54,748</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,387</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>89,832</b></span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_ziefd94qkGxk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,771</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,973</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,724</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">508</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,061</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,493</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,473</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,787</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,090</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>47,880</b></span></td></tr>
  <tr id="xdx_43A_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_z1DeFmkR0Vsh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,148</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,395</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2836">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">367</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,049)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,559</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(43,502)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2844">-</span></b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zwgSj3L7hoD6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>25,919</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,503</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>13,401</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,215</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>29,131</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,511</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,624</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2853">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>122,005</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,706</b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>314,015</b></span></td></tr>
  <tr id="xdx_438_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zLjL82Q7WBaj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,268</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,451</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">111</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,075</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,511</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,392</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,720</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">59,957</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>125,869</b></span></td></tr>
  <tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zkTAUX2nG8qh" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2870">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,810</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">346</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">16,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,138</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,142</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2877">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,425</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,078</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>65,623</b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zmVa3mkW0ree" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F40_zfRRSU4R0uSb">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,213)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(205)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,862</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,985)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(86)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(550)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(417)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(17,532)</b></span></td></tr>
  <tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zdkueYwI1JVg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,068</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,376</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(34,538)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2904">-</span></b></span></td></tr>
  <tr id="xdx_436_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iE_zdyfnPjcixRb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>52,433</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>77,371</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,852</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,467</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>69,834</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>53,184</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,072</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>152,976</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,786</b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>487,975</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Depreciation</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zyljSFzGWkT6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(9,696)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2920">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(59)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,261)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,489)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,015)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(27)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(338)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2927">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(25,885)</b></span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zbhO1ufDHiua" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,097)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,629)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,495)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,648)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(359)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,317)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,545)</span></td></tr>
  <tr id="xdx_43F_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zHOXVqwwX09d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2949">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2950">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2951">-</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447</span></td></tr>
  <tr id="xdx_434_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zEtqFc7DOExf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(13,793)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2956">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(59)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(5,890)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,537)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,663)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(386)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,655)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2963">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(36,983)</b></span></td></tr>
  <tr id="xdx_43D_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zmXu7XEiXQC2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2966">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,065)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(112)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,199)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,314)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,154)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(78)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,729)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2975">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(16,651)</span></td></tr>
  <tr id="xdx_430_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zW5xiZEyjQU1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(464)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2981">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2982">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2983">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">464</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2986">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2987">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></span></td></tr>
  <tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_z7E17VH1y7Od" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(19,322)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(171)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,089)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,851)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,817)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,384)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(53,634)</b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zGCt13y8OgLg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,673)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,215)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(196)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,601)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,529)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,416)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3009">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,831)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3011">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(30,461)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zNwBYQYnFny7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F43_zFwjlOCX43gh">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3014">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,146</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3016">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,194</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,458</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">633</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3021">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">350</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,928</span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iE_zPlBfJXWFNej" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,673)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(16,391)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(220)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(12,496)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(14,922)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(13,600)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3033">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,865)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3035">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(68,167)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z4MrY4J9dN9i" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>50,760</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>60,980</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,247</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>57,338</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>38,262</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>16,472</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>144,111</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,786</b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>419,808</b></span></td></tr>
  <tr id="xdx_438_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zkuoCqmg5qWj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>25,919</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>49,181</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>13,401</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,044</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,042</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,660</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,807</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3057">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>117,621</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,706</b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>260,381</b></span></td></tr>
  </table>
<p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F09_zWaExgtmeRMc" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_z8MiGztrV118" style="font-family: Arial, Helvetica, Sans-Serif">the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.</span></td>
</tr></table>

<p id="xdx_8A9_zGVLKLv4lZkl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses,
at each reporting date, whether there is an indication that a property and equipment asset may be impaired. If any indication exists,
the Company estimates the asset&#8217;s recoverable amount. There were no indications of impairment of property and equipment as of and
for the years ended December 31, 2021, 2020 and 2019.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for property, plant and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS16_g73-79_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103258600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory', window );">Intangible assets and goodwill</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zxxqkltlzGje" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>12</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_zR55wnJWD8Fa">Intangible
                                            assets and goodwill</span></b></span></td></tr></table>

<p id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_zgxmCWdKyXog" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_z6CNYptVO0dh" style="display: none; visibility: hidden">Schedule of intangible assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 24%; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Customer
    relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Education
    content</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Developed
    technology </b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Educational
    platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software
    in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkxsuhUaV5l9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>169,535</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhaDuACraDhe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>445,616</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHs2gwz7FaO4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPsSmKAbzb9h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>63,303</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zptr5G7guQEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>8,288</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfIJtY98dNm9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3077">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgVdcREIzvdh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf6tA5ZCKvg3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>577</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUiRBzQHaGd1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,175</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcF2rYhO8RKj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>688,494</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F44_zGflIxppYzX1">(i)</sup> <sup id="xdx_F42_zAmXwDBmqTAi">(ii)</sup></span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zKHd9jvJkPu7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,030</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z0zbWSeN8hL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zL8N7OhxPjhf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,101</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJjOI3pxaJA4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,769</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJBqYGmy7gil" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">875</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zecGZ2M4FaXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">122,775</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR1UoBsoDr43" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">285,844</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvviFS7HpiY6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">150,156</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeaCpQSf5Gzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,111</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z07h0F5KREy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,110</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znrhXtBCZ8Ni" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,305</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformAndSoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7iVNfDjgI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,845</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg8UJ7rr2Fr8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">550,371</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNumYlMzBxIl" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>459,409</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLoTM6YqnQY6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>703,772</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLr2xOJt0RF6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>32,111</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7XYVQlAfSmj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>125,413</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsWxj88AuHZ9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,389</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjEjhdNwkqb6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO81qsEtl7r4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWNQkVXU31Sa" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>12,191</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpzHay8lTyRe" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,050</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvvRK5zgnxi8" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,361,640</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD0JnCltpD61" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,175</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeunoOf2RDW2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,227</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoY5CWPbrz2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">247</span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zytdoG1JSEB6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,649</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5xrZd2YGPuj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Disposal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(460)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--Disposal_pn3n3_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlg4GHNqNo1a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(460)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zALR5Fv0JCNa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">351,247</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkjxVi1pGvM4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">747,498</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgn0GpcbgYVa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,903</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znu21tk3vc8a" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,126</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzyK3v3xPJte" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,117</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUKPVciX5vR4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">355</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqF30wiFGyKl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">484</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPz7SO6H8O6b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,303,730</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTQ1rtT6InQe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>810,656</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zomSze4aW6Y7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,451,270</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVHqcQBJ7rG7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>75,014</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbmI77B3unzg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>283,539</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD9tzR12okJb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>16,221</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkHU2FN390d" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUivKqpwPjZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>355</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrHMFJKqe5Sk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>27,902</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXHJ8vb2DkV6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,297</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyZxnBMFQGNg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,684,559</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F48_z75kiZZ6VCga">(iii)</sup></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z08XjpZh0qMj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z5J2Zgd32oA6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3172">-</span></span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSO4JbJcODv9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">684</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zBdR4iXMAZR3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,044</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zCr11aO1hLWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zaEz9a8dB838" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">996</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zS0YV8HvJKgj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,686</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zQYmrFsHGW84" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,700</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zWwl093j8nwc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">176,110</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F4A_zZEoSxeGOff4">*</sup></span></td>
    <td id="xdx_98A_ecustom--Disposal_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zOF7zA2Ksu8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3180">-</span></span></td>
    <td id="xdx_985_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z4Rm6jRHskEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3181">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zzPdTfZ8IQ87" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z7Ml7PG2qXM5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3183">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zxqK38cQYOG6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,020</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z9yVKOOMngZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></span></td>
    <td id="xdx_988_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAfpD7EyucX1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zkWkDnVFplf4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,743)</span></td>
    <td id="xdx_98A_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zBS4JsvAGhql" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(417)</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zQZYCIVsM807" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,140)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKg84LKNay84" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">373,680</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTMivMWO8NCc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">606,136</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3Dl9KSSdVgc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,355</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCVehoHl3O82" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,054</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzRqdd0WvCzi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,474</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zH9u7D27jOG8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">33,046</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXX7ElwXfpL6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,599</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl7dJ43XXPEg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,267</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgRntUVoIfl4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,234,611</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyIWtt7sa1g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,184,336</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAPIpgLTkPr5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,165,406</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWgb5DbKx6Sc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>133,369</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNS41JHdYfHe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>431,277</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhO2u0poXFEe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,759</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z01UObTkkUxb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHr9BvWD3WE8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>34,397</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7SLw7iMTnDa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>76,444</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN7Z7PDKTc65" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,847</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW6Co3FHS8J1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,093,140</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVTMWFTXcKm7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9VOEa0LPMX6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3229">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zY677rsPs7id" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3231">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDluYcBLQg89" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,945)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOXSiuHHtrA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,080)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z27eu706jec3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3237">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzwI10IbOTUe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziv62DwYuaM2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3241">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK8e1ET41Lj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3243">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zP2S4NpLP8r" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,025)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhrweN45PrQ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,150)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6IOj47FpXzk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(34,927)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJW5zpZm2r1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,456)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zs90LkueKM5j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,876)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zt7fch5NkyA" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(868)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYTtHO5sl67c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(43,277)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQmvxq2n688e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3255">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSu9HcwpMEn5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3257">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbgv1P4XFhTf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,150)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgJoXUJ4msVg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(37,872)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCbASu4xufMg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,536)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjGhWA7ZVr44" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,876)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0NCtljo8nZ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3267">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK34BN7uaF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(868)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziL4KQqog2wc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3271">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRv64Sfjrd58" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(49,302)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuFsprRvxeXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,352)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0C3m4tNdZl7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(47,960)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4vpqQI1Pb4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,180)</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfiDzAUqRoS9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,816)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbb1l4caHOaf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(32)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOPpLfFpFxOh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,367)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvU1BNA0OIZ2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,707)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zygf6PLXLsI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">460</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzfmtAqKJ6Nh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">460</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcY9MbR8nUPh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3284">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqYkFl7Z3hKi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJSgRwo85sd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,502)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH7fLAJ1wDp4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(85,832)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0rnZC4GJW2h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,256)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW5U72wxINI8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,692)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIx7B4AkeS7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(32)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVDa8yMeN2gd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,235)</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zczVseOSEilc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3300">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIYMYwyxNBWk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(111,549)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAF7Qly5ZWah" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3303">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCybXu0S6oZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3304">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxBHx5BmYGCb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,027)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zubKmkJvsSr5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,438)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EdFV6wvHi4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,844)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znzLhDc6I1rg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(8,980)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx9BVkCtRRxl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(625)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRh8kfUgG3b7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,608)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgb9oFhb3f3c" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3311">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy60RBVK31uj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(80,522)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjS56W2a53k6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3313">-</span></span></td>
    <td id="xdx_98B_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaRwrN4jQncc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3314">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWx0KpoTeV8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3315">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKIWxUuidp11" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3316">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zniuF1KTm6S3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(599)</span></td>
    <td id="xdx_98F_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNSJ2wMjN4E8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3318">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztXIRdEGc6Pb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_989_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx80T1pUaD7h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">365</span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsl8H8S8gC0e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_za2dEqEd4pWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(234)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgxV2qVoxrik" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZoR9jljaXpl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRypdi6t7ic7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,529)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCGkk9S8s8ei" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(142,270)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGLksVBw85s9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(12,699)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1UoVgcFv9Ob" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(16,672)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbIWImgRqNY8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(657)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuQKaZTOr9N1" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,478)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC2BpddUhYGj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3340">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkf9uBnobtQ" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(192,305)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zE8V3FvUgpW4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,184,336</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs06UttAd1j6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,165,406</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zhg2fl7uqYFc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>124,840</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zFK1NxBXXfEa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>289,007</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_znmlefgFDmD4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,060</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zcpKvMmISzH1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>633</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zKvaXM4yuvl3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>33,740</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOXO8lmqO1O8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>64,966</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zsGNAUEBbOQk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,847</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231_zrCyYTQlGNH3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,900,835</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zygN9kzpFb3j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>810,656</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw1uNmd1WAG2" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,451,270</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zHacTJWMU0x4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>71,512</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJmT39SbdOD6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>197,707</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zrkdGCswOQXj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,965</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVOpwR97WGPl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,613</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zq0p7p2NQYIa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>323</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zkrqGmCTUae1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>19,667</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_z45HSGqjFwG4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,297</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231_zooUxMWZ3Pwl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,573,010</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F00_zZu9Mg5u23Y7" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_zfAsL5DpRmci" style="font-family: Arial, Helvetica, Sans-Serif">the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F05_zKMB1nvNcvOa" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(i)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zuLRtVLlgLe6" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.</span></td>
</tr></table>

<p style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F06_zFr7UWC0GTN" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(ii)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_z4ydhiKEJR74" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#225;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.</span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zQCa6c3fio5" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(iii)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_zj85er5T4eEe" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.</span></td>
</tr></table>

<p id="xdx_8A3_zh1ydSjV844i" style="font: italic bold 11pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Licenses with indefinite
useful life include intangible assets acquired through business combinations. The licenses for medicine and other courses granted by
the Ministry of Education (&#8220;MEC&#8221;) to the companies acquired have no expiration date and the Company has determined that these
assets have indefinite useful lives.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For impairment
testing goodwill and licenses with indefinite useful lives acquired through business combinations are allocated to CGUs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company performed
its annual impairment test on December 31, 2021, 2020 and 2019.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company tests
at least annually the recoverability of the carrying amount of goodwill and licenses with indefinite useful lives for each CGU. The process
of estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's
best estimate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">There was no impairment
for goodwill and licenses with indefinite useful lives as of December 31, 2021, 2020 and 2019.</span></p>

<p style="font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p id="xdx_890_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_z6bXJpTV1et4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The carrying amounts
of goodwill and licenses with indefinite useful life by CGU and their carrying amount as of December 31, 2021 and 2020 was:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B6_zQ2HWeYUNpIc" style="display: none; visibility: hidden">Schedule of assumptions for impairment test</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-bottom: 9pt; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Carrying
    amount</b></span></td>
    </tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPTAN</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zbY6uLfmZk36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zQ44mvcqaUVb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zILJh7pp2P0e" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,214</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z7F4qyn8fxKb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,214</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDwKKaIHGISl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">140,522</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zT0DF7HP30ri" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">126,397</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESVAP</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zeAlZ1lG6jmb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,956</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z2jWHo6SBAL4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,956</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zhewlffkoZP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">81,366</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zN5TCgI8Bcnk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">81,366</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zpoP56TV7iH5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">112,260</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_znplQR4TgBth" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">112,898</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zEF9aIYGp6w3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_z4MLayuCI2dg" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJsfo1O1AnIh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,737</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zVzwvkUo4MW3" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,737</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zlj1p2hOL8f5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,030</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zn4bvgn4Xuk9" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,411</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oudzNoxTH1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">73,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zFmUglBqt9nd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">73,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zp1WEpbSH0ng" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">179,693</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmoYi85jZk23" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">179,693</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zAvLjw9x63I3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">346,286</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zGuwFrKq5z7c" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">380,410</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FADEP</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6JJBTzO7Gnf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,661</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_ztPOG9HJe517" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,661</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zwkjEdn8wOVk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">70,606</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zzUfKFV3e7o4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">70,606</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zdUPnDfbZjDj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">153,791</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zZbQNT5am1Pk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">160,787</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medcel
    and CBBW<sup id="xdx_F48_zNSFhX0F0RO2">*</sup></span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zDfBOeCKubog" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,294</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z1JGVJeH9E6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,294</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z5uNFxi4L4k9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3439">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zFqBytiQsYEf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,300</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_iI_pn3n3_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_fKg_____ztl9lzUOXBB1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">219,359</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FASA</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z8J5aIV2d8J5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,903</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zuF058AECMj8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,903</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zoWPq3zhxFC2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">144,507</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zL14y5Bxsnn4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">144,507</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zO1CnMq2b9Y8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">302,330</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zC4CVcHh4s5b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">267,279</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEMED</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zSn4IVr4r26g" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,647</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zZtwYkmG5cUd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,647</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zwk1TqrwtMa4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zB0wKsrmXjF7" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">126,965</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zATzj8DzHIT9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">119,227</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEC</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zy3wu7ci7542" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3465">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z9ZTXYNTrxu" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zZfZtW4hTfvb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zXIuCaIclsbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">131,360</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbIvODB8kxLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">122,325</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniRedentor</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zooFqLCww3d1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zNfhLSfBRWn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zci9L4EpLiI7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121,477</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOr0ulV5Ag" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121,477</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zXrgIGCutbea" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">246,320</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zV7tIYVAlFLl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">253,370</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniSL</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zIg3R16vOWyl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zfBfvoywZNuh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zVKFXgAP3Xal" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,387</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zCKJwtd6cwX" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,387</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zn4nr0KHUH56" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">305,044</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zYlwgzZ2e4yd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">258,234</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FESAR</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zSQ4xRAHWTva" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zrLi267lEdF8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zEEI52Bztufk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,616</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgVdNu8bS2xf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,616</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z964NDcXsZK3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">279,038</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zjHsiwYHJuRh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">263,914</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FCMPB</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3Rkn0Ao1yFl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmQn89lLYon" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN7qrDgglIF" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYNYf4vh1LAe" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYvScuJiCTg9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">401,244</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNFFAxDs88z3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">380,682</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Practice
    Management Tools &amp; Electronic Prescription</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zQBq792otTv6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">113,362</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zLHyWfz1RyZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zuSb1p53M0K1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">227,909</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Clinical
    Decision Software</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z5TusdNxsOOh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zhQ298J9oL8b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z7J9B7c8kWKg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3527">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z2df3kzHhzJg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,592</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zxB4PyWZpbI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">149,805</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medical
    Harbour</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zM6Ahi9d9bcb" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,022</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zXQs57WQt4Pb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z1hnh4QgkZrf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,150</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Moc</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_z5CwvpIq3x8j" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,777</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zaYmPTngbDOc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">184,597</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zGWUL66Ru19k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,649</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zYQ5lD9Dv0r8" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">356,789</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zbpEn8piGm3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,230</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Unigranrio</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKgF53O2SEEc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">130,073</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z9WlEuJYLFRe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">421,538</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zMTF6mdjYZnf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">630,185</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">RXPRO</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zuO3hAGg5vKc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">38,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zL5HKRinwMAk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zkCZQE0iPnsc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46,788</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="width: 37%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zKnFfqu5FuT" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_z9LAT5xSQ9wg" style="font-family: Arial, Helvetica, Sans-Serif">CBBW as merged by Medcel on May 1,
2020.</span></td>
</tr></table>

<p id="xdx_8A4_zJz10JLC0DNe" style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>The
main assumptions used by the Company to determine the value in use of the CGUs were:</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Student
enrollment</i> &#8211; refer to the number of students that are currently enrolled in each CGU.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Tuition fees
</i>&#8211; is the monthly fee charged to students.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Occupancy rate
</i>&#8211; the occupancy rate of the medical schools is the ratio of the number of <i>students effectively enrolled divided by the regulatory
capacity in a given period.</i></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Regulatory capacity
</i>&#8211; the regulatory capacity is defined by the number of medical schools seats available per year awarded by MEC, multiplied by
the number of years of operations since the seats were awarded.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Faculty &#8211;
</i>refer to the cost with faculty in the CGU, which means the amount paid to teachers and doctors.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Digital content
platform users </i>&#8211; refer to mobile app subscription, clinical management system, healthcare payments, medical imaging, online
courses for digital content users and marketing for pharmaceutical industry.</span></p>




<p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Capital expenditure
</i>&#8211; refers to investments to be made on intangible assets related to developments and platform improvements especially on the
digital services CGUs.</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Discount
rates</i> - discount rates represent the current market assessment of the risks specific to the CGU being tested. The pre-tax discount
rate applied to cash flow projections is <span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20211231_zTdloaaNAW3d" title="Discount rate applied to cash flow projections">12.10</span>% in 2021 (<span id="xdx_90B_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20201231_zcTO54Zv5HWj" title="Discount rate applied to cash flow projections">13.00</span>% in 2020).</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Significant
estimate: impact of possible changes in key assumptions</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zuJWN0TfAbm9" title="Description of key assumptions on which management has based cash flow projections">An
increase of 25 basis points in management&#8217;s estimated discount rate applied to the cash flow projections of each CGU for the year
ended December 31, 2021, or a decrease of 25 basis points on estimated EBITDA would have not resulted in significant impacts on these
financial statements.</span></span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Other
intangible assets</span></p>

<p style="font: bold 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #365F91"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets,
other than goodwill and licenses with indefinite useful lives, are valued separately for each acquisition and are amortized during each
useful life. The useful lives and methods of amortization of other intangibles are reviewed at each financial year end and adjusted prospectively,
if appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89B_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zDhySJj7Mhya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The estimated useful
lives of intangible assets are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zNmiBNZ2nE37" style="display: none; visibility: hidden">Schedule of estimated useful lives</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; medicine</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_ztZshgpE3eKe" title="Estimated useful lives of intangible assets::XDX::P6Y"><span style="-sec-ix-hidden: xdx2ixbrl3554">6</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zT0Z181dGW43" title="Estimated useful lives of intangible assets::XDX::P4Y6M"><span style="-sec-ix-hidden: xdx2ixbrl3556">4.5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Software
    license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zKckB0ycDaJi" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3558">5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Education
    content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVci0b1UmKDa" title="Estimated useful lives of intangible assets::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl3560">3</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxGX5pwOIP32" title="Estimated useful lives of intangible assets::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl3562">2</span></span>
    - <span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLHLgPUum7Gd" title="Estimated useful lives of intangible assets::XDX::P30Y"><span style="-sec-ix-hidden: xdx2ixbrl3564">30</span></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Developed
    technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zteOoECwHqFj" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3566">5</span></span>
    years</span></td></tr>
  </table>
<p id="xdx_8A4_zzCjzXUwfrkb" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the years ended
December 31, 2021, 2020 and 2019, there were no indicatives that the Company&#8217;s intangible assets with finite useful lives might
be impaired.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIntangibleAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS38_g118-128_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIntangibleAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103299352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory', window );">Financial assets and financial liabilities</a></td>
<td class="text"><p id="xdx_803_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zo4u4iFsuux5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zDSjz8RFnzF7">Financial
                                            assets and financial liabilities</span></b></span></td></tr></table>

<p id="xdx_891_ecustom--FinancialAssetsExplanatory_zc1c86qjZ8bl" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets </b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zGIRecehDRH5" style="display: none; visibility: hidden">Schedule of financial assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 62%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and cash equivalents</span></td>
    <td id="xdx_980_eifrs-full--CashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z03ZdlVAmuyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">748,562</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z9DzQt2fYyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,045,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_98B_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zMOE0qi3k7wb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3576">-</span></span></td>
    <td id="xdx_985_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbZGaXJax9pj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables</span></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zojqVaJ0ymYc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">405,793</span></td>
    <td id="xdx_98F_eifrs-full--TradeReceivables_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfM93KhBTTch" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">309,944</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zSJzBDSCrOa7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,154,355</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zQhQFzLRiiS4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,357,039</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_984_eifrs-full--CurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRFOlrs3xDBe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,126,913</span></td>
    <td id="xdx_981_eifrs-full--CurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zYU2OCkrM039" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,347,359</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zPTsNaCmALXj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zKdgR5H3ZhF9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,680</span></td></tr>
  </table>
<p id="xdx_8AD_z20UFcfpWMLa" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial instruments
at amortized cost include trade receivables and cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_897_ecustom--FinancialLiabilitiesExplanatory_z1BtDbTpK2P7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_zMFltixnOV3b" style="display: none; visibility: hidden">Schedule of financial liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            liabilities</b></span></td></tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGujMwpBIsql" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z9RVWJNX8MOf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zJsr3bK2PUq4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzQW49rQgfa2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zqnByovspL8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zB7ahHdc6D5k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5pX9tYOjdF" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zo6A68v69oyf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_985_ecustom--NotePayable_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zwj5XlxPbf38" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_98C_ecustom--NotePayable_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z3WKaiaMZMuf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_98A_eifrs-full--Advances_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zkRg48MJ5Vyb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGyTy7ai7HR7" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBjRb4vqEDJg" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,015,196</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5ePpUjn3h7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,759,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_985_eifrs-full--CurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5UTx4cF9Dvf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">581,685</span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFFsBL9CLegh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">467,643</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zfYOj0W3Ax72" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,433,511</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zEsJHwwCVhHe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,291,548</span></td></tr>
  </table>

<p id="xdx_8A4_zSAP4gbQumZe" style="margin-top: 0; margin-bottom: 0">&#160;</p>



<p style="font: 4pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="margin-top: 0; margin-bottom: 0"/>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Loans
                                            and financing</b></span></td></tr></table>

<p id="xdx_892_ecustom--LoansAndFinancingExplanatory_zTt3dLIkxESj" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B8_zm3SzwoyE2Kf" style="display: none; visibility: hidden">Schedule of loans and financing</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    institution</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zB9RXIJFJVAj" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Banco
    Ita&#250; Unibanco S.A</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F22_zmBicpqB3fhl">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zYR9l0wMdXAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.62% p.y.</span></td>
    <td id="xdx_984_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zMd6gF9kkEXl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2023</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zuLdcpeoqIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">510,972</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_z8n583HwbbKg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">504,365</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zgOHluBj2Edd" title="Financial institution">Banco
    Votorantim</span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zZnlxaKoTEe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.65% p.y.</span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zlhSjcf7D22h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2021</span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zqYSXD2EwY69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3651">-</span></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_z5UcOoeiRcrj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">101,785</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zljZDy8OCAea" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">BNDES
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F2B_zA7LUbK9optk">(c)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_980_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zsDgiQxc1D7f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10.03%
    p.y.</span></td>
    <td id="xdx_988_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zHIVWpm4A1qa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2024</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_z9kLfBNBI75e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3660">-</span></span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zvyskOp0QlWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">471</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_903_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zBok37LEBPij" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FINEP
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F22_zkOEk5Nuq1Jf">(d)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zzIAMQ110FRc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">TJLP
    p.y.</span></td>
    <td id="xdx_981_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zko24wZWX3o2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2027</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zTicJgL5xpwi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,145</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zcXkhNP30Wk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,864</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zdnl6BDqLCDg" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Softbank
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F20_zUULCq1sRBM7">(f)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_z832kBOIMMog" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6.5%
    p.y.</span></td>
    <td id="xdx_982_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zFq3Wb4wpEId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2026</span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zKDjFTAF4TX7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">822,560</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zwnfUFyxiuq8" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Banco
    Ita&#250; Unibanco S.A</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F2D_zlY8kskBqIVc">(e)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zYzY8fAL4UI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.75% p.y.</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zV5azFwWzxGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2024</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zyyrDty0YKDc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,199</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20211231_zXcbIvravYPk" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,374,876</b></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20201231_zjjxY0DZLkTi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>617,485</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingCurrent_iI_c20211231_z1tnahTyvGs6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">128,720</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancingCurrent_iI_c20201231_zEnAh2msUbJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,162</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancingNonCurrent_iI_c20211231_z2AMx6ZuXH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,246,156</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancingNonCurrent_iI_c20201231_zRMYJYTEENb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">510,323</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0A_zTi7mUqwIWO1" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_z51L1HBzMn4b" style="font-family: Arial, Helvetica, Sans-Serif">On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1">500,000</span> adjusted by the CDI rate plus an interest rate of
<span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb">1.62</span>% per year and is repayable in three installments in October 2022, April 2023 and October 2023.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zalDbRqnSNfk" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_z810umuNjO51" style="font-family: Arial, Helvetica, Sans-Serif">On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ <span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4">100,000</span> adjusted by the CDI rate plus an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l">1.65</span>%
per year and was repaid at maturity on July 5, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_z9k3Dh9scuNh" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F18_zwCXLV6lCHHe" style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk">10.03</span>% per year and maturity in 2024.
This amount was prepaid in September 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F05_z42M0s1Bbhib" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_zYD7jefjnWq1" style="font-family: Arial, Helvetica, Sans-Serif">On July 23, 2019, Medcel entered
into a loan of R$ <span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount">16,153</span> with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$<span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche">6,734</span> and R$<span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche">4,130</span>, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zlqH3DSjUbDg" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_z79xim6Tpy76" style="font-family: Arial, Helvetica, Sans-Serif">On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount">30,000</span>. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of <span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate">1.75</span>% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zJ7yTusJG991" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_zsY2G5AhKIb3" style="font-family: Arial, Helvetica, Sans-Serif">On April 26, 2021, the Company issued
and sold <span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares">150,000</span> shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$<span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8">0.00005</span> per share of the Company for US$<span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5">150,000</span> thousands, equivalent to R$ <span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9">821,805</span> on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.</span></td>
</tr></table>

<p id="xdx_8A5_zIfvgl7MHz9j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Each Series A perpetual
convertible preferred share is entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&#8217;s discretion, into
the Company&#8217;s Class A common shares at an initial conversion price of US$25.35. The Company may require the conversion of any or
all of the Series A perpetual convertible preferred shares at any time on or after the three-year anniversary of the original issuance
date if certain conditions set forth in the certificate of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#8217;s
stock price is equal or above 150% of the conversion rate). The Company may also redeem any or all of the Series A perpetual convertible
preferred shares for cash, shares of its common shares or a combination thereof at its election, at any time on or after the seven-year
anniversary of the original issuance date as determined in the certificate of designation. On or after the five-year anniversary of the
original issuance date, the holders of the Series A convertible perpetual preferred shares shall have the right to redeem all of the
outstanding Series A convertible perpetual preferred shares for cash, the Company&#8217;s common shares or a combination thereof (at
the Company&#8217;s election, subject to certain conditions) to be determined in the certificate of designation. Upon the occurrence
of a change of control, the holders will have the right to redeem their Series A convertible perpetual preferred shares for cash at a
price set forth in the certificate of designation.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Series A convertible
perpetual preferred shares will be entitled with the same voting rights of the common shares only when converted into it.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company determined
that the Series A perpetual convertible preferred shares should be classified as financial liability at amortized cost upon their issuance
since is redeemable primarily according to the decision of the holder and there is a contractual obligation to deliver assets (cash,
shares of its common shares or a combination thereof) that could not be avoided by the Company in an event of redemption. The financial
liability is denominated in Brazilian Reais and thus not subject to foreign exchange changes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In addition, as
the entire instrument is classified as a liability, the embedded put option to redeem the Series A perpetual convertible preferred shares
for cash is an embedded derivative. The embedded derivative will not be treated separately once the exercise price of the option is closely
related to the host contract.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The initial transaction
costs that are directly attributable to the issuance of Series A perpetual convertible preferred shares were measured at fair value together
with the financial liability on initial measurement. The transaction costs totaled R$<span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210101__20211231_z7V09DW8wQTk" title="Transaction costs">13,030</span>, including legal counsels and advisors.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Leases</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
lease contracts for properties. The lease contracts generally have maturities in the lease terms between <span id="xdx_906_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEbEKLnEajnl" title="Contractual lease term::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3725">5</span></span> and <span id="xdx_90D_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zPBvxHEPo68" title="Contractual lease term::XDX::P30Y"><span style="-sec-ix-hidden: xdx2ixbrl3727">30</span></span> years. There are no
sublease or variable payments in-substance lease agreements in the period.</span></p>

<p id="xdx_895_ecustom--LeasesExplanatory_zdFVv4xpSlk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_z2Ngwn0Scl7d" style="display: none; visibility: hidden">Schedule of right-of-use assets and lease liabilities</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Set out below are
the carrying amounts of right-of-use assets and lease liabilities and the movements during the period</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use
    assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20200101__20201231_zqMCxYvkXOH5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">274,275</span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_c20200101__20201231_z13elCLROPzc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">284,515</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_c20200101__20201231_z6IRPRU2zli2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,743</span></td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_c20200101__20201231_zEwb6VKoZrvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,743</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_c20200101__20201231_znnBIG4RpgMl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,161</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_c20200101__20201231_z8Q38gDPoVci" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,161</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsBusinessCombinations_c20200101__20201231_zQIMNbNUtEF6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,855</span></td>
    <td id="xdx_98E_ecustom--BusinessCombinationsLeaseLiabilities_c20200101__20201231_zmBMNPscqWfj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,855</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20200101__20201231_zxJRBXE0VABi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,386)</span></td>
    <td id="xdx_987_ecustom--DepreciationExpenseLeaseLiabilities_c20200101__20201231_ztoJHksNIQwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_c20200101__20201231_zSJL3sOUeBic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3751">-</span></span></td>
    <td id="xdx_98E_eifrs-full--InterestExpenseOnLeaseLiabilities_c20200101__20201231_ztdCIYhn2xd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,458</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20200101__20201231_zRHrFTjKobl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20200101__20201231_zZmFBezSUrib" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,455)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsDisposals_c20200101__20201231_zfklWTEvp40a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,574)</span></td>
    <td id="xdx_98D_ecustom--LeaseLiabilitiesDisposals_c20200101__20201231_zT6cJrMY9Jad" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,574)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iS_c20210101__20211231_zsmJlIEdwvV9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>419,074</b></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesRightToUse_iS_c20210101__20211231_z1WBXaNYsR7c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>447,703</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20210101__20211231_z7BMii514BZ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_c20210101__20211231_zuERlh8VD2Qf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsRemeasurement_c20210101__20211231_zNgO35WReje3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesRemeasurement_c20210101__20211231_ze9Od1Y85TQa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsBusinessCombinations_c20210101__20211231_z26LFNnLEpt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td>
    <td id="xdx_984_ecustom--BusinessCombinationsLeaseLiabilities_c20210101__20211231_zEnCU0VThshd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20210101__20211231_zgUpk7wCIWPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,237)</span></td>
    <td id="xdx_986_ecustom--DepreciationExpenseLeaseLiabilities_c20210101__20211231_zDzLXE6FWy5l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3781">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_c20210101__20211231_zVNxOroU8ceb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3783">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_c20210101__20211231_zOZ5mQKnk673" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,212</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20210101__20211231_z98zlrLmRQc1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3787">-</span></span></td>
    <td id="xdx_982_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20210101__20211231_z8n1QD5C6SMd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(87,751)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsDisposals_c20210101__20211231_zNzxQZuSvoyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,316)</span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesDisposals_c20210101__20211231_zPa9mSlSONS3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,244)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20210101__20211231_zqh7jc5JGnUa" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>663,686</b></span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitieRightToUse_iE_c20210101__20211231_z9HvVroLhE3i" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>714,085</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsCurrent_iI_c20201231_zRgyXsBj6bpg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3799">-</span></span></td>
    <td id="xdx_980_eifrs-full--CurrentLeaseLiabilities_iI_c20201231_zaok1A04GPYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61,976</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_c20201231_zf8S8erXCa0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">419,074</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_c20201231_zDVL5zRrc4Wj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">385,727</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current </span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_c20211231_zzBoYoAOHOW8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3807">-</span></span></td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_c20211231_zH8nfPFzdmg4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,955</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsNonCurrent_iI_c20211231_znL8zaOo0366" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLeaseLiabilities_iI_c20211231_z7rV6IKfaR4c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">689,130</span></td></tr>
  </table>
<p id="xdx_8A6_zJVZs6BUTinl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company reassessed
its current versus non-current segregation methods for the year ended December 31, 2021. The current lease liabilities balances are presented
as the amount expected to be amortized from the principal in the next twelve months.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognized
lease expense from short-term leases and low-value assets of R$ <span id="xdx_906_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20210101__20211231_zUBwunBlu2J9" title="Amount recognized lease expense from short-term leases and low-value assets">11,229</span> for the year ended December 31, 2021 (R$ <span id="xdx_902_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20200101__20201231_zhznklNszsi1" title="Amount recognized lease expense from short-term leases and low-value assets">2,555</span> and R$ <span id="xdx_90B_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20190101__20191231_zwB0Ni97VgFg" title="Amount recognized lease expense from short-term leases and low-value assets">4,494</span> for
the years ended December 31, 2020 and 2019).</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Accounts
                                            payable to selling shareholders</b></span></td></tr></table>

<p id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_zwneqjNLUICj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zdyavAhnUimd" style="display: none; visibility: hidden">Schedule of accounts payable to selling shareholders</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IESP <sup id="xdx_F4E_zWKVmswV4FW1">(a)</sup></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z85FAX0S8Bqk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3823">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmq4trAf5RP9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">38,771
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FASA <sup id="xdx_F4F_zZK2jTl7IkOk">(b)</sup></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zHDyYiE9Zvc8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41,581</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zn7o6AOm8RN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,356
    </span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEMED <sup id="xdx_F41_zn0dW2zvySV2">(c)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z0JJNT8ctO73" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,233</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z6FOyUFC0rpb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">38,622
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC <sup id="xdx_F42_zqshtSFUUJp1">(d)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zTVdM1GIN6T1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Gyn0T3qRkc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">28,307
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniRedentor <sup id="xdx_F43_z60A7817VGR6">(e)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z1WnX2DYQNdk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,506</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zhGM91ycQBNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">97,773</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniS&#227;oLucas <sup id="xdx_F43_zh0awc82kzx3">(f)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zadNHOjGgTLi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,672</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z2UTq3y6tC3k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,386</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FCMPB <sup id="xdx_F45_zETWa31mD7Ma">(g)</sup></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6jFf3ch3JY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">149,175</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN2ftEHazwa1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">189,420</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FESAR <sup id="xdx_F48_zgceDiGCoM72">(h)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z7FFdVFhYtgj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5MX6rtar9Y2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,569</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of MEDPHONE <sup id="xdx_F4D_zXuPicD2So23">(i)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zrCRWkNvLQtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zfitZgNNXH7k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medicinae <sup id="xdx_F47_zGPDRY4hsnCi">(j)</sup></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zq7q1Uv4FbU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,887</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medical Harbour <sup id="xdx_F47_zzd3kqoEQ6R">(k)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znSSTKulYKoj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,801</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Cliquefarma <sup id="xdx_F4E_zFJxLok3zxa7">(l)</sup></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z3uHvbCFHZJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Shosp <sup id="xdx_F46_zQwb0PHQiFif">(m)</sup></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2DjnXTO02Zh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,141</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Unigranrio <sup id="xdx_F43_zJGhKY3IkE9e">(n)</sup></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z6o6KrnXQkh4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">249,979</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of RXPRO <sup id="xdx_F4B_zypPFxudJAOg">(o)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zZw1MMFKcix9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,245</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Guaranhuns <sup id="xdx_F43_zZ0sTE37enL5">(p)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zGa2EMCQqlmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,556</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20211231_zZaewIbiNLVb" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20201231_zEfXZBdmg33d" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>518,240</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20211231_zZR0JQXDprzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">239,849</span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20201231_zaKv1YAlf93j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">188,420</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20211231_z3UJBu42wWw" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">439,977</span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20201231_z6BKJz3iTOxe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">329,820</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ziNL8qn9OVxc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyBh4I5Cyeoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">300,237</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsPtTtFyRWVk" style="text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">177,730</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    flows</span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholderCashFlows_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRba8aLk3XMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(192,681)</span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholderCashFlows_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsMXqxUmkyO6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(134,518)</span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholderCashFlows_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zekqO0N1Y1U4" style="text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(92,688)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC and Guaranhus</span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zlf0ViKTCJt6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Acquisition of IPEC"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmet3t8zdbK6" style="text-align: right; line-height: 10pt" title="Acquisition of IPEC"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98C_eifrs-full--InterestExpense_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zh1XghtwXkw4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,915</span></td>
    <td id="xdx_988_eifrs-full--InterestExpense_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkQW4S3oAsn9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,884</span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z6jYxkHuRfg4" style="text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,977</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Installments
    on Business combinations</span></td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zBrFwYQP07c1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">243,816</span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zGWbt4hfcmj4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">343,140</span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk5EcJ66v1Te" style="text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,538</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Contingent
    consideration on Business combinations</span></td>
    <td id="xdx_981_ecustom--ContingentConsiderationOnBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze99p5bfPpuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Contingent consideration on Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,536</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation
    of legal proceedings disbursement</span></td>
    <td id="xdx_988_ecustom--CompensationOfLegalProceedingsDisbursement_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zYlPrTpTTmq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></span></td>
    <td id="xdx_98B_ecustom--CompensationOfLegalProceedingsDisbursement_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zfUU8fxRnMHa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,503)</span></td>
    <td id="xdx_98F_ecustom--CompensationOfLegalProceedingsDisbursement_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze4tL1PZawPa" style="text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,320)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing
    balance</b></span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20211231_zwWMZDfdXzz" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td>
    <td id="xdx_98B_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20201231_zzYBtX29kCH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>518,240</b></span></td>
    <td id="xdx_98E_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20191231_zkeE4Pu6R6H7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>300,237</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zv63289LzEth" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zgUAj77fQk92" style="font-family: Arial, Helvetica, Sans-Serif">On November 27, 2018, Afya Brazil
acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20180101__20181231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z4qWcJqh1xUd" title="Ownership Interest">80</span>% of IESP and R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zVuTOntw0072" title="Remaining accounts payable">106,200</span> is payable in three equal installments of R$<span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zxKyqP5yhY" title="Equal installments payables">35,400</span>, each adjusted by the CDI rate through the payment
date. The remaining installment was paid in November 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zhZQQRjmtG75" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z3QFuTYoEqH6" style="font-family: Arial, Helvetica, Sans-Serif">On April 3, 2019, Afya Brazil acquired
<span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z7XnVlpSfqu8" title="Ownership Interest">90</span>% of FASA and R$ <span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zs0rUtxXi5Cf" title="Remaining accounts payable">39,695</span> was paid in April 2020, R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zaXdD0P8Fxh2">29,770</span> was paid in April, 2021, and R$ <span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20220403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zq18SwOoMG7">29,770</span> is payable in April 2022; each installment
adjusted by the IPCA rate + 4.1% per year.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zNn6SbNXKow6" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zpiGi8IUG3Y9" style="font-family: Arial, Helvetica, Sans-Serif">On May 9, 2019, Afya Brazil acquired
<span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zO6RGgnXR905" title="Ownership Interest">100</span>% of IPEMED and R$ <span id="xdx_903_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zJRChPwWv7A8" title="Remaining accounts payable">45,303</span> is payable in five equal installments of R$ <span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zb0l4ohzl159" title="Equal installments payables">9,061</span>, adjusted by the CDI rate, and due annually in February
2020, 2021, 2022, 2023 and 2024.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zOt4w6Wkxz28" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_zLyO0cSJD5h7" style="font-family: Arial, Helvetica, Sans-Serif">On August 13, 2019, Afya Brazil
acquired <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zC8nvwJKAmlb" title="Ownership Interest">100</span>% of IPEC and R$<span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190813__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zc3VTX2xZwO" title="Remaining accounts payable">54,000</span> is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the
first and the second year from the transaction closing date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zXafWS45PoGj" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_zvV6Q4UkBYs1" style="font-family: Arial, Helvetica, Sans-Serif">On January 31, 2020, Afya Brazil
acquired <span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zemKfTaWOCW" title="Ownership Interest">100</span>% of UniRedentor and R$<span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF8be0Lxbtbd" title="Remaining accounts payable">100,000</span> is payable in five equal installments from January 2021 through July 2024, adjusted by the
CDI rate. The purchase consideration was adjusted by R$<span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zSOwnFQiVdd8" title="Equal installments payables">4,503</span> and such amount was deducted from the first installment paid in February
2021.</span></td>
</tr></table>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zB57gfdzaN2k" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_z4kvTsPsM6M6" style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zZJFOvx7ivQl" title="Ownership Interest">100</span>% of UniSL and R$ <span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zkx4sLnWGaZ7" title="Remaining accounts payable">60,456</span> is payable in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration
was adjusted by R$<span id="xdx_904_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zHcxL6Efv0dg" title="Equal installments payables">7,816</span> and such amount was deducted from the first installment paid on May 5, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F06_z35OSOwAaon2" style="font-family: Arial, Helvetica, Sans-Serif">(g)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_zcGrR7lQ5R4j" style="font-family: Arial, Helvetica, Sans-Serif">On November 9, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zPVFC9IyMQPl" title="Ownership Interest">100</span>% of FCMPB and R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZRPKMvZBp69" title="Remaining accounts payable">188,894</span> is payable in four installments through November 2024, adjusted by the CDI rate.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F04_zBAR9sLU1I7f" style="font-family: Arial, Helvetica, Sans-Serif">(h)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_ziEfKwWW2PD6" style="font-family: Arial, Helvetica, Sans-Serif">On November 3, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwuk4GghLIe4">100</span>% of FESAR paid in cash and R$<span id="xdx_903_ecustom--CashTransferredTransaction_iI_c20201103_zaQWkcVVQ525" title="Cash on the transaction closing date">1,569</span> of price adjustment was paid on February 25, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0C_z7wRV9wy7h85" style="font-family: Arial, Helvetica, Sans-Serif">(i)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zF4qniF3CIa" style="font-family: Arial, Helvetica, Sans-Serif">On November 4, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNx2GJ2g6oik">100</span>% of MedPhone paid in cash and R$<span id="xdx_902_ecustom--CashTransferredTransaction_iI_c20201104_zIuX9r673xQ5">36</span> of price adjustment was paid on February 2, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zYhXumGsklLl" style="font-family: Arial, Helvetica, Sans-Serif">(j)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_zvrhRBRUHY3c" style="font-family: Arial, Helvetica, Sans-Serif">On March 25, 2021, Afya Brazil acquired
<span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210323__20210325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zO6SyjqODtod">100</span>% of Medicinae and an earn-out (&#8220;contingent consideration&#8221;) of up of R$ <span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210305__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBEDWkEbyHn1">4,400</span> is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$<span id="xdx_907_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210325_zj2gQJModqXk">3,887</span> is based on the present value of the obligation
considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition
date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0B_zmrfcFiYSna2" style="font-family: Arial, Helvetica, Sans-Serif">(k)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_zKH6Z5xMI421" style="font-family: Arial, Helvetica, Sans-Serif">On April 8, 2021, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210408__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zCwaNP6gbIkc">100</span>% of Medical Harbour and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_900_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zWiugvjBH466">9,000</span> is payable in relation to product development
goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$<span id="xdx_902_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210408_ztq8TsDI9bo3">6,801</span> is based on the present value of the
obligation considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from
the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_zic2lNOonq9k" style="font-family: Arial, Helvetica, Sans-Serif">(l)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zAzhkm1LyH9d" style="font-family: Arial, Helvetica, Sans-Serif">On April 16, 2021, Afya Brazil acquired
<span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210416__20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZBAEeUDaQ4a">100</span>% of Cliquefarma and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z1aWp9bANHv6">3,000</span>, adjusted by the CDI rate, is payable in relation
to product development. The contingent consideration of R$<span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210416_zhVJ13vYYy8a">3,050</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zimx5sAe3Q5a" style="font-family: Arial, Helvetica, Sans-Serif">(m)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z3Ypn6VwQW9c" style="font-family: Arial, Helvetica, Sans-Serif">On May 13, 2021, Afya Brazil acquired
<span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210513__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zbv1BsGfHWVf">100</span>% of Shosp and R$ <span id="xdx_906_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20210513_z3ZUFmEpUbO5">454</span> will be paid, and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zGZHllMfQ7A3">1,793</span> is payable in relation
to product development. The contingent consideration of R$ <span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210513_zp4A5zkvUaH8">2,141</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zYxXw7KwaOEi" style="font-family: Arial, Helvetica, Sans-Serif">(n)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1C_z6d9bo4Byk1j" style="font-family: Arial, Helvetica, Sans-Serif">On August 4, 2021, Afya Brazil acquired
<span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210802__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zFSfON2j3lMc">100</span>% of Unigranrio. The adjusted aggregate purchase price is R$ <span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_c20211004_zj5L1805Wg13">618,956</span> of which 60% was paid in cash on the transaction closing date,
and 40% is payable in cash in four equal installments through 2022 to 2025, adjusted by the CDI rate.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F03_zPYdaXJ54hLh" style="font-family: Arial, Helvetica, Sans-Serif">(o)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_zG0eJg2Jb9i2" style="font-family: Arial, Helvetica, Sans-Serif">On October 01, 2021, Afya Brazil
acquired <span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zoNgvH2MPTc7">100</span>% of RXPRO and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZ9wnw1fvIOc">21,000</span> is payable in relation to revenue
achievements until 2024. The contingent consideration of R$ <span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20221101_z7TP8wlyiZV8">10,245</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0D_zFBWHTxNp5Rc" style="font-family: Arial, Helvetica, Sans-Serif">(p)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_zHY8VC1ZsVP1" style="font-family: Arial, Helvetica, Sans-Serif">On November 05, 2021, Afya Brazil
concluded the acquisition of <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211103__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwymGW7j6Drb">100</span>% of ITPAC Garanhuns and R$<span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20211105_zbhmCjeFIhad">54,000</span> was paid in cash on the transaction closing date, and (ii) R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zITzyB2teMSh">54,000</span>
is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the first and the second year from the
transaction closing date.</span></td>
</tr></table>

<p id="xdx_8A9_zwVza87MlcMe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<br/></span></p>




<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2.4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Notes
                                            payable</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">With
the acquisition of UniSL, Afya Brazil assumed notes payable regarding the previous acquisition of a portion of the operations of Universidade
Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018. Two of the UniSL campuses, located in the cities of Ji-Paran&#225;
and Porto Velho in the State of Rond&#244;nia, were acquired in such transaction. As of December 31, 2021, the notes payable of R$<span id="xdx_903_ecustom--NotesPayable1_iI_c20211231_zS5gl9hQJnTi" title="Notes payable">72,726</span>,
has a final maturity in 2023 and is adjusted by 100% of IPCA-E.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89F_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_z5DCGf8Y4wg8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B7_zJTQk38nruLk">Set out below are
the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020</span>:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Notes
    payable</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_982_ecustom--NotesPayables_iS_c20200101__20201231_zsgyxJTQLrq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_987_ecustom--BusinessCombination_c20200101__20201231_zEpHfKXIrc2k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,526</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_983_ecustom--Payments_c20200101__20201231_z5s1hgd150E6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,974)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_983_ecustom--MonetaryIndexation_c20200101__20201231_z5sFIIhY5sZ3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,629</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_983_ecustom--NotesPayables_iE_c20200101__20201231_zKzhEKGuq7M3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>76,181</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2021</span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iS_c20210101__20211231_zQj34gCMCMgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_98E_ecustom--Payments_c20210101__20211231_zfnn8PvVPfJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,068)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_982_ecustom--MonetaryIndexation_c20210101__20211231_zm5KCf2MpGn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,613</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_985_ecustom--NotesPayables_iE_c20210101__20211231_zVJ4rjE8NzCe" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,726</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20201231_zk3AyucBk55l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,503</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_988_ecustom--NoncurrentLiabilities1_iI_c20201231_zsrEYzmSBoid" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,678</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20211231_zqz2X3AcGCrj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,478</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_987_ecustom--NoncurrentLiabilities1_iI_c20211231_zDsDEsuFnyb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,248</span></td></tr>
  </table>
<p id="xdx_8A0_zU7lpfOmnbmc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Fair
                                            values </b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89E_ecustom--FairValuesExplanatory_zZU9RxJtTm0f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zZOUXTUSAMNb">The table below
is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts
that are reasonable approximation of fair values:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_980_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zlSrl1jMBG5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4039">-</span></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_ztw50xcwItNi" style="text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4041">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDWBYwMcpDag" style="vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDsTMBLsDEsh" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zoP3rH7SDWcg" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zMmzoQSdPNfh" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zpDlE02rC7H5" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zw00yKc1rcl2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231_zn9IsJRzjBp6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,442</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231_z9vAXN5tQtMg" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,442</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231_zvDerqFpVeNi" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,680
    </b></span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231_zzAU7wmjRS7c" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,680
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7eXKxNleE4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zmiCnYGnHSse" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,387,136</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zwWZlHXPlce4" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z4cagkzuI0Ze" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">637,723</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqy3kpIDoFR1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zb4COTQVfhqc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0tTACsYIcjc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyu1EH2P2C0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zAExwPDUDcSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_za8yg0zGZuNc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zANRVRvAK3u1" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3KlOM3pM9mh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zwHQ6rpBhmC5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrDFkE52IZtk" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zKd8zO5jweyk" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z5X9mEIKgvqe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231_zqheb4BLrFqj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,841,513</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231_zEQQF9NjmRmb" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,853,773</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20201231_zqT8L7GErqU8" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,659,609</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231_zzjde6jmSWKa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,679,847</b></span></td></tr>
  </table>
<p id="xdx_8A2_zTnT4uIAV0jk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company assessed that the fair values of cash and cash equivalents, current trade receivables and other current assets, trade payables,
advances from customers and other current liabilities approximate their carrying amounts largely due to the short-term maturities of
these instruments.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
fair value of interest-bearing borrowings and loans are determined by using the DCF method using discount rate that reflects the issuer&#8217;s
borrowing rate as of the end of the reporting period. The own non-performance risk at December 31, 2021 was assessed to be insignificant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            instruments risk management objectives and policies</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s principal financial liabilities comprise loans and financing, lease liabilities, accounts payable to selling shareholders,
notes payable, trade payables and advances from customers. The main purpose of these financial liabilities is to finance the Company&#8217;s
operations. The Company&#8217;s principal financial assets include trade receivables and cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company is
exposed to market risk, credit risk and liquidity risk. The Company monitors market, credit and liquidity risks in line with the objectives
in capital management and counts with the support, monitoring and oversight of the Board of&#160;Directors in decisions related to capital
management and its alignment with the objectives and risks. The Company&#8217;s policy is that no trading of derivatives for&#160;speculative
purposes may be undertaken. The Board of Directors reviews and agrees policies for managing each of these risks, which are summarized
below.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            instruments risk management objectives and policies</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
The Company&#8217;s exposure to market risk is related to interest rate risk and foreign currency risk.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The sensitivity
analysis in the following sections relate to the position as of December 31, 2021.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(i)
Interest rate risk</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company&#8217;s exposure to the risk of changes in market interest rates relates primarily to the Company&#8217;s
cash equivalents, loans and financing, accounts payable to selling shareholders and notes payable, with floating interest rates.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Sensitivity
analysis</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table demonstrates the sensitivity to a reasonably possible change in interest rates on cash equivalents, loans and financing
and accounts payable to selling shareholders and notes payable. With all variables held constant, the Company&#8217;s income before income
taxes is affected through the impact on floating interest rates, as follows:</span></p>

<p id="xdx_89F_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zHe53FQOmRll" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zat4SI5YH5wd" style="display: none; visibility: hidden">Schedule of sensitivity analysis effects on income statement</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Increase
    / decrease in basis points</b></span></td></tr>
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balance
    as of December, 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Index
    &#8211; % per year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Base
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>+75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;+150</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;-150</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    equivalents</span></td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zkMmVcQLnvu6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">636,847</span></td>
    <td id="xdx_98D_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100.38%
    CDI</span></td>
    <td id="xdx_98B_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zA95Ma8zHKxe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,440</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zDelf0lhW9xb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,776</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zfrjmrzbO768" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,776)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zGNW0hylZpS" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,553</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_z5FqeLfVGyh1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(9,553)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zR5BYkQ6ua3a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(510,972)</span></td>
    <td id="xdx_983_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI
    + 1,62%</span></td>
    <td id="xdx_98E_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zYrQiVkgZG7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(55,032)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zCDu5y3QwTva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,832)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zGvYyCPWFxvi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,832</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zL5sCZpPLF3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,665)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zjec1WlNflx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,665</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zvRceLz9iUhh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,199)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI
    + 1,75%</span></td>
    <td id="xdx_982_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zbldYpljfgye" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,401)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zHWpH13UYzRc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(234)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zluvRGbN4XVl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">234</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zn92w0pz9l0e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(468)</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zKfzG8913TJl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">468</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7kfyVoPNm84" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(10,145)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">TJLP</span></td>
    <td id="xdx_986_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zymYT2fjrLU" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(617)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0QEExR22rg5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(76)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zXlq3A2x2SYa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">76</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zPtpw6gYoE38" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(152)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zync6RthPxK4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zNzxR8xNO4n1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(612,121)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI</span></td>
    <td id="xdx_989_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zW022jV7R6xj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,009)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zibUHYUa7Oel" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,591)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zCZzXSwIz3Jk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,591</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zIE3nL0Sl9J5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(9,182)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_za9oDGDF1xgg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,182</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zLTcAtOYEOS9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(41,581)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPCA
    + 4,1%</span></td>
    <td id="xdx_985_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zyZynExQ2cTh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,708)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0sNJe5lIG5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(312)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zFEj6X8pkN6d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">312</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zUUwEl6Y6h3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(624)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zEXLvE4Mw6R1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">624</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zv9D85Z2GyGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(72,726)</span></td>
    <td id="xdx_980_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrh6F5yzAhkf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPCA</span></td>
    <td id="xdx_983_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zfF2DneRexki" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(531)</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zatr49n2q818" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(545)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_pn3n3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">545</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zuvc6ZEsPX39" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,091)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_ziI61PtYcwC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,091</span></td></tr>
  </table>
<p id="xdx_8AA_zjctsLlrBt5j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>(ii)
Foreign currency risk</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Foreign
currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange
rates. The Company&#8217;s exposure to the risk of changes in foreign exchange rates relates to cash and cash equivalents denominated
in U.S. dollars in the amount of R$<span id="xdx_908_eifrs-full--CreditExposure_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zeIXNN0O4jE9" title="Exposure risk">23,228</span> as of December 31, 2021 (December 31, 2020: R$<span id="xdx_903_eifrs-full--CreditExposure_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z6YWQ7TX1Ifa" title="Exposure risk">70,523</span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><span style="text-decoration: underline">Foreign
currency sensitivity</span></span></p>

<p id="xdx_89B_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zyr8Zg34xvOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zbUvoYfOqgxa" style="display: none; visibility: hidden">Schedule of currencies used in sensitivity analysis</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table demonstrates the sensitivity in the Company&#8217;s income before income taxes of a <span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_uPure_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpVCAKSniQMh" title="Percentage of sensitivity change in the Euro exchange rate">10</span>% change in the U.S. dollar exchange
rate (R$<span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zoAOQUxCI73i" title="Closing foreign exchange rate">5.5799</span> to U.S. dollar <span id="xdx_906_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__srt--CurrencyAxis__currency--EUR_z00xfSouENQ5" title="Closing foreign exchange rate">1.00</span>) as of December 31, 2021, with all other variables held constant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 37%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember_ztDJvmNDSlti" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,228</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember_zK6CpS8zyDUb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,323</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember_zpsVsSJOVS1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,323)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<p id="xdx_8A6_zjwEt9xbEXSi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Credit
                                            risk</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Credit
risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial
loss. The Company is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities,
including cash and cash equivalents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Customer
credit risk is managed by the Company based on the established policy, procedures and control relating to customer credit risk management.
Outstanding customer receivables are regularly monitored. See Note 7 for additional information on the Company&#8217;s trade receivables.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Credit
risk from balances with banks and financial institutions is management by the Company&#8217;s treasury department in accordance with
the Company&#8217;s policy. Investments&#160;of surplus funds are made only with approved counterparties and within limits assigned to
each counterparty.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s maximum exposure to credit risk for the components of the statements of financial position at December 31, 2021 and 2020
is the carrying amounts of its financial assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0"/><td style="width: 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.4.3</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Liquidity
                                            risk</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company&#8217;s
Management has responsibility for monitor liquidity risk. In order to achieve the Company&#8217;s objective, Management regularly reviews
the risk and maintains appropriate reserves, including bank credit facilities with first tier financial institutions. Management also
continuously monitors projected and actual cash flows and the combination of the maturity profiles of the financial assets and liabilities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The main requirements
for financial resources used by the Company arise from the need to make payments for suppliers, operating expenses, labor and social
obligations, loans and financing and accounts payable to selling shareholders.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_893_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_za0yScJSdrej" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zFkJPusodgkc">The
tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zR9ZkQIDins9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z5ESeiYiJu25" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4224">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zOvm3azUSBs6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4226">-</span></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXcsvktPk5lh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">-</span></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zfLFM8oJPa5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zAxP8BwZb9Bk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">217,903</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCmazm93nvAb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">585,686</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zIJrnlln4042" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">948,503</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7QoigujE0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,212</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeFK3fOUlXu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,753,304</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zglTCcVoV3j8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">103,003</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zp5n9N8ODbL4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">211,894</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zFaYTrBHa43b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">204,744</span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFkneZOqHSi2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,108,555</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zF8LfSWBn2Lj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,628,196</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSuGOEgdO9Zk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">246,059</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zSOb24gSUJta" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">445,066</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zTnAuGVP3Luc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,989</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zghUk6ER8yqk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4258">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDpcXG5ur67" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">780,114</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zIPwKdlJlYb1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,644</span></td>
    <td id="xdx_985_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z6BOp1GaV2D7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">74,306</span></td>
    <td id="xdx_98E_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z1N6g9dOfRv1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4266">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkTvLYtv4Moj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4268">-</span></span></td>
    <td id="xdx_988_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcOoi4gTMJXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">89,950</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHdgYToVRh4h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z4jVhcodwudk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4274">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEHsT2votfHh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4276">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zX70wZHR0elg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4278">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJ3EBS582on9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zejCy1whiy7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>756,292</b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zf3xtPAAbAY4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,316,952</b></span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_znnUWNIzipzd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,242,236</b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWZ5Ztlfr7Qh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,109,767</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zx88NWt85IIe" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,425,247</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHUzNQNtkepj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zmk8tw64dIek" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4294">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zPyPlVsWUS8b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zya1DGm6Zaf6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4298">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcu3rSjjuoag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zb5DxVkLnxbh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">125,137</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zXHoZ9KYiKBa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">566,157</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zL5GI9yVFTF7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,010</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_ztti00xRVKTh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,094</span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZHk0tkigzj5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">698,398</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_982_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHy6r1lGO0a4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,092</span></td>
    <td id="xdx_98E_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCJZr99KjTsh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">131,225</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zDk8gHEqyHLf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">124,114</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7bapOfNibzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">705,115</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zh7LW7LtcVzc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,023,546</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zajemD1YjNn9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,145</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zwey8TOCU595" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">262,340</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zxlxhQ84QTEj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,153</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zboMg8va7zJa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4328">-</span></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zs5k486his6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">534,638</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98F_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zYL7ZAGkP7O2" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,083</span></td>
    <td id="xdx_98C_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zLILVAJLuqMi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">83,803</span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zZgvcHYr2YP6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4336">-</span></span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zvHtRfvXMfde" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4338">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcnOG1lmTZe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,886</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zMvjaRfcnLLa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839</span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zdKLp1ZpCM1h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4344">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zLR7BgSFl1Xc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4346">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkghtfKDDgw5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4348">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zQeuxPIJCtHg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z3bZ3kUs2V93" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>490,039</b></span></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zQFuZyfnwZZc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,043,525</b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zAMKqlZrEICh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>209,277</b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zz1VRG3s4AV6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>708,209</b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAXiAJL5BLOf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,451,050</b></span></td></tr>
  </table>
<p id="xdx_8A0_zwOe0rLZM1k7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_897_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_zQIjwPYbRiLi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_z0ZCC6n1vFYh" style="display: none; visibility: hidden">Schedule of changes in liabilities arising from financing activities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.5</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Changes
                                            in liabilities arising from financing activities</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions
    <sup id="xdx_F59_zjmlxRS0kB19">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzKV1KrzomN6" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBhMABRspry2" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(158,076)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0IWU803TwE8" style="border-top: black 1pt solid; padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">809,539</span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zE251ENp5sa8" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,909</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zttz7OkvSqMj" style="border-top: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4372">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsELnO5IGU7c" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36,591</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z12f4fJYZuU6" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">428</span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zcau0ImGxAs" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zpineiBbhIl9" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlOf5eg67ARj" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(87,751)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zjLHdTlougR3" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,651</span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD66xhLXBfld" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,212</span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"> -</span> </td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs7pHPy5hh44" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,514</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYLqGr2Ib4I2" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,244)</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3T3KLwlRaJi" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zxh7TigBpiyh" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,648)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zyZD4UVYcmyl" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,648</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z3AaPlZtHqO9" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4398">-</span></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231_zc79fNAkOCFl" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zvz4G9Gc8K12" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(264,475)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_z0WhhH6xXUWf" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>986,838</b></span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zgOWWOfpIolg" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>136,121</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zHEs9vEAlam7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4408">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zE5qX9c3Ohsk" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,105</b></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zSdC8sXzBLuc" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,816)</b></span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231_zMmivOiIrttd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znNgfRvcvrL5" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,357</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z488AWFL9Pc1" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(155,090)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQRS8K72PG9" style="text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">605,041</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQGzat4E5Rf" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,031</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zxcFFwNfLEd5" style="text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,279</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z2yFEffKsgu3" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">75,815</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z3fQhUiEyV5j" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL4vlWbpDMa9" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zsjemhoyBpQ2" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">284,515</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdWYi7ZLYlA8" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(55,455)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg9GKhMDeIrj" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">98,904</span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJo0bAFtKMv" style="vertical-align: top; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,458</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx4oCQ5QMSuc" style="vertical-align: top; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">76,855</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAjwku3wyR92" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,574)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEwNsjCJhI8j" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zRPzgaQjMI1c" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(12,984)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zQFazbpww7P9" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,984</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ziEhcLhcy8Q1" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4450">-</span></span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231_z9O73Awb2TQi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>344,872</b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zXTJtxdYXYt7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(223,529)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_znMpIvd6m0a6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>716,929</b></span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zTNEZIwf4iP3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>54,489</b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zHoiW39bFVNi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,279</b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zwQnIS48Otcc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>152,670</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zGoDMH5X1lt8" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,522)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231_z2FUiU9hwEpj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2019</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zvIedUS2OSce" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,829</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAztwm1hTDFe" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(75,093)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zHzQ9tv2pVrf" style="text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,383</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zaQRffcT0426" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,025</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zX2e90SRtrF2" style="text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,126</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbScPCHhooj5" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">43,087</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zU8NOeGHXQGl" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4480">-</span></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zOdCTOm6NpEj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,357</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg6AfYkrklbd" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">212,360</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJFXc4dUb3vh" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(39,779)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zV7vCpqtxln6" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,100</span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z56k3GTEIkH8" style="vertical-align: top; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">31,469</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlsE1REWk4sa" style="vertical-align: top; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,365</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z45ORsY1yHKk" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4494">-</span></span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBpJyPU22eAh" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">284,515</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zPxIx3kYyRWk" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,107</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zXE7a5RQ5nU5" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(51,812)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zF3LHI3EOmD3" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,812</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuntcQFNIZ6d" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,107)</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231_zWjhmNV0jbFl" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>294,296</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231_ze9pHOp2ROnf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(166,684)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_z7YmPXLx5G6l" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>78,295</b></span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zoMYYBaUIlnj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>37,494</b></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zVuSmFJMulSj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,126</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zXDuM8hDZEo3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>104,452</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zy4hVBxUQKYi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,107)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231_zlBo7XnlR6i3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>344,872</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zC1w9HM6N3oc" style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1C_zmkOARTph9rj" style="font-family: Arial, Helvetica, Sans-Serif">The additions of loans and financing
include proceeds from the SoftBank transaction of R$<span id="xdx_905_ecustom--ProceedsFromLoansAndFinancing_c20210101__20211231_zPVJqip9Bt1a" title="Proceeds from loans and financing">822,569</span>, net of the transaction costs of R$<span id="xdx_90C_ecustom--NetOfTransactionCosts_iI_c20211231_zcVZhLnJfqc3" title="Net of the transaction costs">13,030</span>.</span></td>
</tr></table>

<p id="xdx_8AF_zrPuddarGcH9" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white">&#160;</p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinancialInstrumentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section Scope<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS07_g3-5A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinancialInstrumentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103665736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureFairValueMeasurementAbstract', window );"><strong>Fair Value Measurement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValueMeasurementExplanatory', window );">Fair value measurement</a></td>
<td class="text"><p id="xdx_809_ecustom--FairValueMeasurementExplanatory_zXXHNh7FBgE" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>14</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zgXvLEPyUS55">Fair
                                            value measurement</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89E_ecustom--ScheduleOfFairValueMeasurementExplanaory_zJdM6EE0ONbe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table provides the fair value measurement hierarchy of the Company&#8217;s assets and liabilities as of December 31, 2021 and
2020.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8B7_zuzV93xmQ3ec" style="display: none; visibility: hidden">Schedule of fair value measurement</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Quoted
    prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    unobservable inputs (Level 3)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zhCth7nfvbEa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_znrXf6XTbL7d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4531">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zh0cJ9cruixh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrCMoM2zWKQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4533">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_iI_c20211231_zStnHx8NqgQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,387,136)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZkKgWYT9iX5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,387,136)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_c20211231_zZ7P1fK7rEQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(714,085)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilities1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zPPxReUN5cC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(714,085)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231_zcj97k18b3I1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(679,826)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zWL81pm1CXx4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(679,826)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--FairValueNotesPayables1_iI_c20211231_zyHtMiPTzqL" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(72,726)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayables1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpuOJXK9a8yi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(72,726)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>

<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zIVPAfCRPCU" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zDdyksXKlg0c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zroCEOrEYjxh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVWLihjpycw4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    Cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231_zStMHCpteDac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwHOzYpyXmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancingLiabilities_iI_c20201231_zjh4MpveyTqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(637,723)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0Lv31jMWA7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(637,723)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesOne_iI_c20201231_zwBQDzdY2NT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(447,703)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesOne_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z7GRegCInEb5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(447,703)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231_zZ9n1MKhJrM8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(518,240)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zThldZNf5Lmb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(518,240)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231_zvYjDKuF67L4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,181)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zOQRkNJjWW8j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,181)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  </table>
<p id="xdx_8A8_z8kJNTy4GSF4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">There
were no transfers between Levels during 2021 and 2020.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103338968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureCapitalManagementAbstract', window );"><strong>Capital Management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalManagementExplanatory', window );">Capital management</a></td>
<td class="text"><p id="xdx_801_ecustom--CapitalManagementExplanatory_z3W4qDu8Ldi5" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>15</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_823_zi5FKcER2iB5">Capital
                                            management</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">For
the purposes of the Company&#8217;s capital management, capital considers total equity. The primary objective of the Company&#8217;s
capital management is to maximize the shareholder value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_890_ecustom--ScheduleOfCapitalManagementExplanatory_zSXw9J05DwR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company manages its capital structure and makes adjustments in light of changes in economic conditions and to maintain and adjust the
capital structure, the Company may adjust the dividend payment to shareholders, repurchase programs, return capital to shareholders or
issue new shares. The Company monitors capital using net debt and total equity. The Company includes within net debt, loans and financing,
lease liabilities, accounts payable to selling shareholders and notes payable less cash and cash equivalents and restricted cash.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zYbAG1njvf42" style="display: none; visibility: hidden">Schedule of capital management</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20211231_zcBAwwFSF051" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 3%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20201231_zOBjXxSE9zBi" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--LoansAndFinancing_iI_zfuNYegJ5Ic4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td></tr>
  <tr id="xdx_40B_eifrs-full--LeaseLiabilities_iI_zu3ceoK2G632" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr id="xdx_403_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_zngcvFUNVsji" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr id="xdx_403_eifrs-full--NotesAndDebenturesIssued_iI_zN6xagKBEBJ9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr id="xdx_400_ecustom--CashAndCashEquivalents1_iI_zetZoWqwVcBj" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    cash and cash equivalents</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(748,562)</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,045,042)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iI_zPcj7UmCh6w1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    restricted cash</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4591">-</span></span></td>
    <td style="text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,053)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NetDebt_iI_zy7btShsQYOk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    debt</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,092,951</b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>612,514</b></span></td></tr>
  <tr id="xdx_40D_ecustom--EquityOne1_iI_zQORETf8TjQ1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Total
    equity</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000,018</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,833,780</span></td></tr>
  <tr id="xdx_405_ecustom--EquityAndNetDebt1_iI_zPnbRiMXpDF6" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total
    equity and net debt</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,092,969</b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,446,294</b></span></td></tr>
  </table>
<p id="xdx_8A2_zUG8UFzdhGOh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">No
changes were made in the objectives, policies or processes for managing capital during the years ended December 31, 2021 and 2020.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103631432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsExplanatory', window );">Labor and social obligations</a></td>
<td class="text"><p id="xdx_801_ecustom--LaborAndSocialObligationsExplanatory_zKIey5nfNsR3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>16</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_826_zF2BQqIRskPj">Labor
                                            and social obligations</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Variable compensation (bonuses)</b></span></p>

<p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
Company recorded bonuses related to variable compensation of employees and management in cost of services and general and administrative
expenses of R$ <span id="xdx_90D_ecustom--ShareBasedCompensationOfEmployees_c20210101__20211231_ztVDnOMGr3uj">25,587</span>, R$ <span id="xdx_902_ecustom--ShareBasedCompensationOfEmployees_c20200101__20201231_zJRieRfYAZ84" title="Compensation of employees">9,514</span> and R$<span id="xdx_904_ecustom--ShareBasedCompensationOfEmployees_c20190101__20191231_zIjk60grz1sb">6,871</span> for the years ended December 31, 2021, 2020 and 2019, respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Afya Limited share-based compensation plan</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
stock options plan approved on August 30, 2019 as a result of the IPO will govern the issuance of equity incentive awards with respect
to Company&#8217;s Class A common shares. The fair value of the stock options was estimated at the grant date using the Binomial pricing
model, taking into account the terms and conditions on which the stock options were granted. The Company accounts for the stock options
plan as an equity-settled plan.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On July 29, 2020,
the board of directors approved a change in the strike price of the current share-based compensation plan. The strike price is now measured
in Brazilian Reais (where the Company&#8217;s operations are located and valuated) adjusted by CDI rate instead of U.S. dollar adjusted
by T-Bond. Furthermore, the first tranche had its vesting period extended from May 2020 to May 2021, including one year lock-up period
after the vesting period. This change was assessed as a modification by the Company and was accounted in accordance with IFRS 2.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As result, the
expense related to the share-based payment of the Company reflects the cost of the original award at grant date over the vesting period
plus the incremental fair value of the repriced options at modification date over the vesting period of the options.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_zmsYqQFDMnee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following table list the inputs to the model used to determine the incremental fair value of the stock options as result of the modification:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"/></p>

<p><span id="xdx_8B6_zDiFiXiF6J05" style="display: none; visibility: hidden">Schedule of model used to determine the fair value of the stock options</span></p>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"/>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified
    plan</b></span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original
    plan (*)</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span title="Strike price at the measurement date"><span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zmds9KRJts3c" title="Strike price at the measurement date::XDX::74"><span style="-sec-ix-hidden: xdx2ixbrl4611">74.38</span></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zfHQJSCbNWla" title="::XDX::99"><span style="-sec-ix-hidden: xdx2ixbrl4612">99.09</span></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zikEpRzdvrKd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Dividend yield"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0.0%</span></td>
    <td id="xdx_983_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zNs2TbZo0EOb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0.0%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Expected volatility"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcJuRknD5n66" title="Expected volatility, minimum">41</span>%
    - <span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziOKPFTlMpd3" title="Expected volatility, maximum">76</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvC04AGrVMB9" title="Expected volatility, minimum">42</span>%
    - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQnmBwyw9yX6" title="Expected volatility, maximum">76</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC7J3qP5Spvd" title="Risk-free interest rate, minimum">2.0</span>%
    - <span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTUGwEJczfg7" title="Risk-free interest rate, maximum">4.9</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFL775XlsT8j" title="Risk-free interest rate, minimum">0.2</span>%
    - <span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zl98hXWVL7Hc" title="Risk-free interest rate, maximum">0.4</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhhCcjUornw9" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC8kyN9npfh6" title="Expected life of stock options, maximum">4</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zArbdkriwVG1" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z48eQDHsKsdb" title="Expected life of stock options, maximum">4</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td id="xdx_98E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zANukntkjuIf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Share price at the measurement date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    133.68</span></td>
    <td id="xdx_988_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zmlQJLff5s15" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    133.68</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zs50DLgOtC9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Model used"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Binomial</span></td>
    <td id="xdx_982_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zoBcfJP3oiH3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Binomial</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zSYMFbIIVHMc">69.54</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zUPrRZuIRT93">57.12</span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(*) The strike price
of the original plan was based in U.S. dollars.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">On
January 25, 2021, March 25, 2021, April 26, 2021, </span><span style="font-family: Arial, Helvetica, Sans-Serif">June <span style="font-size: 11pt">1,
2021 and November 1, 2021, the Company granted <span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210123__20210125_zLQf4GTPqm8b" title="Number of stock option granted">545,000</span>, <span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210323__20210325_zuov2pSLaSJi">65,000</span>, <span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210423__20210426_zoibUUmIYKBc">139,000</span>, <span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210601__20210601_zRy0sLCQ3Z7b">180,000</span> and <span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20211101__20211101_zp0HRvV9K5b3">241,000</span> additional stock options, respectively:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>January
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>March
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>April
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>June
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>November
    2021</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_906_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210131_zN7MXTnWC9F" title="Strike price at the measurement date">115</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210331_zEZTVjWGQ4Si">105</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210430_zPe5CQsqH05c">105</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210630_zRivVyK90W8k">105</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20211130_zbvB8BLLBTU1">85</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210101__20210131_zWAzgjRRYcT9" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210301__20210331_z2PoNYhk6y9c">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210401__20210430_zz3M8yK9X9Ek">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210601__20210630_z3EbZIaazc2i">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20211101__20211130_zOAgHRoLQ2Hi">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z2v7QnO2LVkd" title="Expected volatility, minimum">38</span>%
    - <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEjBssXknPW6" title="Expected volatility, maximum">67</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1aMda4defl">42</span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKok13N0cTGe">65</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4oldicjdHc">43</span>%
    - <span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaf1Ku0j3Qx6">51</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYsbrfcpGnM3">43</span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zrEZ4neSZ3n5">63</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfMc4ilJUDU3">41</span>% - <span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdpffPNRg0t7">65</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBlfN2599uj7" title="Risk-free interest rate, minimum">2.1</span>%
    - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8a77JTiuyS8" title="Risk-free interest rate, maximum">7.1</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zAs2oRLyqTzg">5.2</span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLFcmzX3077d">8.5</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0O7jeGgONM3">5.1</span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2yZdPFq8ca9">8.1</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCffft5OLCSk">5.8</span>%
    - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8mipFFMqcf3">8.3</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zimeTnJOFLJ">10.4</span>% -
    <span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBWLgC10hwvk">12.5</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFx69OPM0vu5" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLc6QZbKjYmf" title="Expected life of stock options, maximum">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBWzBTxaLaB4">1</span>
    &#8211; <span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zopl7TeHH4M4">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4JIsUdPUPIc">1</span>
    &#8211;<span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQkbbAhNu99e"> 5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4Z7WDYfbKnd">1</span>
    &#8211; <span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXHsQ2vDMGJf">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zW5mYe6tYEil">1</span> &#8211;
    <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUcgeGO4owxj">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210131_zxisUK9o0gXj" title="Share price at the measurement date">129</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20210331_zNq7Y6QIPvZ1">108</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_900_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210430_zMcqRXffU9R9">119</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_901_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210630_zRZayV1UUICl">121</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$ <span id="xdx_905_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20211130_zNZzpLNQNjD6">8</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zVytSGbj2Jjd" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zkzwsvDcv6U3">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210401__20210430_zptc5uKQjDZ7">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210601__20210630_z7U9a5jvqC32">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20211101__20211130_zAUpEU1PNjF">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_905_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210131_zxiTJ8nhYXW8" title="Weighted average fair value at the measurement date">46.81</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20210331_zQOhrOZJWIUf">40.20</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210430_z6JY6YEPMur3">46.04</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90D_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210630_zYym4YcSD9qa">49.10</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20211130_zAEPF5yE6vfb">46.28</span></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<p id="xdx_8A2_zffesYa88Rfi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p id="xdx_89B_ecustom--ScheduleOfSharebasedCompensationPlan_zBxBX5mxpL8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and movements in stock options during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span><span id="xdx_8BB_zxUQPB34wi9i" style="display: none; visibility: hidden">Schedule of share-based compensation plan</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Weighted
    average exercise price (in Reais)</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Number
    of stock options</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2021</b></span></td>
    <td style="border-bottom: #365F91 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt; width: 40%"><span style="font-family: Arial, Helvetica, Sans-Serif">Outstanding
    at January 1</span></td>
    <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pii_c20210101__20211231_zwfeeWrUeHi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 32%" title="Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif">78.22</span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20210101__20211231_zcdB9ZmaJIZ1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">2,510,983</span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20200101__20201231_zR0b3iIYygG2" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right; width: 17%" title="Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif">2,364,214</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Granted</span></td>
    <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zrbY5z13g8rc" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"><span style="font-family: Arial, Helvetica, Sans-Serif">109.18</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210101__20211231_zjoev2zBy0yf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"><span style="font-family: Arial, Helvetica, Sans-Serif">1,170,000</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20200101__20201231_zQSDLBtuRH15" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">477,220</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Forfeited</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zqqEjz1OEfof" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">112.89</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20210101__20211231_zFqplPVq3xId" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">(60,000)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20200101__20201231_zH1ov44eBSug" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">(274,359)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_z7icwi64Avzk" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">78.15</span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20210101__20211231_zIhfOtvyGrW2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">(442,669)</span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20200101__20201231_z4r0CjzHreuf" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">(56,092)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Expired</span></td>
    <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zUGk3urD049i" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">78.21</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_c20210101__20211231_z9Rj84xZWVoc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">(91,586)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_d0_c20200101__20201231_zgDBbEeDI1Al" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Outstanding
    at December 31</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pii_c20210101__20211231_zS7kMhBO5ZM8" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>92.33</b></span></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_c20210101__20211231_zTQJ00NQ5Yo5" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>3,086,728</b></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_c20200101__20201231_zwKPzjW3T5j3" style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2,510,983</b></span></td></tr>
  </table>
<p id="xdx_8A7_zvQNsaGmBeJ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
share-based compensation expense, including the incremental fair value as result of the modification in 2020, recognized in general and
administrative expenses in the statement of income for the year ended December 31, 2021 was R$ <span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z0D9dtiP0Qi1">43,377</span> (December 31, 2020: R$ <span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zNTtE5UQwLVd" title="Share-based compensation expense">32,610</span> and
December 31, 2019: R$ <span id="xdx_906_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20190101__20191231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zwCf5a7wgTxf">18,114</span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>




<p style="font: 5pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Stock
options exercised during the year ended December 31, 2021 have been settled using the treasury shares of the Company. The reduction in
the treasury share equity component is equal to the cost incurred to acquire the shares, on a weighted average basis. Any difference
of the cash received from employees upon exercise of the options in relation to treasury shares weighted average cost is recorded in
paid-in-capital.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103664344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory', window );">Equity</a></td>
<td class="text"><p id="xdx_802_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zCUef4ng2Kgc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>17</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span><span id="xdx_823_zJS4iocWnIDe">Equity</span></span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Share capital</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">As
of December 31, 2021, the Company&#8217;s share capital was R$ <span id="xdx_90D_eifrs-full--IssuedCapital_iI_dxL_c20211231_zkFl3hylg87a" title="Share capital::XDX::17000"><span style="-sec-ix-hidden: xdx2ixbrl4763">17</span></span> (R$ <span id="xdx_908_ecustom--IssuedCapital2_iI_c20201231_z88OvZ8VC8v3" title="Share capital">17</span> as of December 31, 2020) represented by <span id="xdx_905_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20211231_zX0Fx6VyDrCf" title="Total number of shares">93,722,831</span> shares comprised
by <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zvn5jmKTCivg" title="Total number of shares">47,920,068</span> class A common shares and <span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zs72sWLDWoH8" title="Total number of shares">45,802,763</span> class B common shares (<span style="background-color: white"><span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231_zT9fwQzOQEtg" title="Total number of shares">93,146,731</span> </span>shares
comprised by <span style="background-color: white"><span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z05ixiCtVNs6">45,112,416</span> class A common shares and <span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_z50JrCbgbiOc">48,034,315</span> class B common shares</span> as of
December 31, 2020).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">b)
Afya Brazil</span></p>

<p style="font: bold 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; text-indent: 40pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Prior
to the completion of Afya&#8217;s IPO in July 2019, Afya Brazil was the predecessor of Afya. As such, the consolidated financial statements
reflect the operating results of Afya Brazil prior to the reorganization. As of December 31, 2018, Afya Brazil&#8217;s share capital
was R$ <span id="xdx_901_eifrs-full--IssuedCapital_iI_c20191231_zJYQI89axeM7">315,000</span> represented by <span id="xdx_900_eifrs-full--IssuedCapital_iI_c20181231_zZLmFUFKoIn6">1,443,541</span> shares, comprised of <span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z932MQo9lHii" title="Total number of shares">1,411,895</span> common shares, <span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zM5D7yrJisof">26,523</span> Class A preferred shares and <span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zB0PoDztupTl">5,123</span> Class
B preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Common
shares were the only class of shares with voting rights.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Class
A preferred shares had the following characteristics: <span id="xdx_90F_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_z7dSbZ9VTPi4" title="Description of ratio of convertible shares">(i) do not grant voting rights at the shareholders meetings; (ii) the right to
receive an amount, as dividend, per share equal to 17.7 times the amount received per common share; and (iii) were convertible into common
shares at the ratio of 1 preferred share for 17.7 common shares in the situations described in the Shareholders Agreemen</span>t.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_90D_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zLM9Y0GpEMFe" title="Description of ratio of convertible shares">Class
B preferred shares had no voting rights and had priority in capital reimbursement in case of liquidation of the Company, with no premium.
Class B preferred shares were convertible into common shares at the ratio of 1 Class B preferred share f1or 1 common share, in certain
situations.</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
April 26, 2018, the shareholders approved a capital increases of (i) R$<span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20180424__20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrotvYPmY3oa" title="Proceeds from issue of ordinary shares">55,000</span> through the issuance of <span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zMEPyv3MIj1i" title="Total number of shares">124,994</span> common shares; and (ii)
R$ <span id="xdx_901_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180423__20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zYkVqvEC1bz5" title="Proceeds from issue of preference shares">11,670</span> through the issuance of <span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zv2o9Y2DtU9j" title="Total number of shares">26,523</span> Class A preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
August 31, 2018, the Board of Directors approved a capital increase of R$<span id="xdx_902_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180825__20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zRX0kPJto14b">1,304</span> through the issuance of <span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zE3qjOUl7Px8">5,123</span> Class B preferred shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 4, 2018, the shareholders approved a capital increase of R$<span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20181202__20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zIgEZVeI2Wj3" title="Proceeds from issue of ordinary shares">99,999</span> through the issuance of <span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zYJluITyO1nf" title="Total number of shares">137,298</span> common shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 31, 2018, the shareholders approved a capital increase of R$ <span id="xdx_902_ecustom--CapitalIncreaseWithEarningsReserves_iI_c20181231_zALWCjrvlF1c" title="Capital increase with earnings reserves">80,541</span> with earnings reserves and retained earnings without an
issuance of new shares.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 8, 2019, the shareholders of Afya Brazil approved a renounce of dividends for the year ended December 31, 2016 of R$<span id="xdx_906_eifrs-full--DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_c20190306__20190308_zROQVh5V9oZ" title="Renounce of dividends for prior years">4,107</span>; and
an increase of capital through the issuance of <span id="xdx_90E_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190408__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zmHPUry4wrdl" title="Number of shares in entity held by entity or by its subsidiaries or associates | shares">37,200</span> common shares, in the amount of R$ <span id="xdx_904_eifrs-full--ParValuePerShare_iI_c20190308__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zbjgOufP8C2" title="Par value per share">0.01</span>, subscribed entirely by the shareholders
BR Health and certain members of the Esteves Family.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 12, 2019, the shareholders of Afya Brazil approved amongst other matters: (i) the change in its legal name to Afya Participa&#231;&#245;es
S.A.; (ii) a capital increase through the issuance of <span id="xdx_901_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zb3goYMjzMjg" title="Number of shares in entity held by entity or by its subsidiaries or associates shares">156,337</span> common shares, in the amount of R$ <span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190310__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zDuhNQLedbYh" title="Proceeds from issue of ordinary shares">150,000</span>, subscribed entirely by BR Health;
and (iii) the propose to repurchase <span id="xdx_904_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zFrC6ascDGZ" title="Repurchase of ordinary shares">160,000</span> common shares issued by the Company, at the acquisition price of R$ <span id="xdx_908_ecustom--AcquisitionPrice_iI_pid_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zjwVGIkFndg3" title="Acquisition price">206.25</span> per share, in
the total amount of R$<span id="xdx_902_ecustom--AcquisitionsHeldByShareholders_c20190311__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zeSTJRsAePd" title="Acquisitions held by shareholders">33,001</span>, all held by the shareholder Nicolau Carvalho Esteves. The Company's common shares object of the repurchase
approved were immediately canceled by the Company, without reduction of its share capital.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
March 29, 2019, Afya Brazil issued 378,696 common shares to the shareholders of BR Health and Guardaya, and had a capital increase of
R$ 122,062 and an additional paid-in capital of R$ 137,051.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">In
June 2019, Afya Brazil&#8217;s shareholders approved an increase of capital through the issuance of 157,202</span> common shares in
exchange of the acquisitions of FASA, IESP and Univa&#231;o minority interests, in the total amount of R$ 24,310<span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
June 18, 2019, the shareholders of Afya Brazil approved an increase of capital through the issuance of 27,211 common shares in exchange
of the acquisition of an addition 15% interest at UEPC, in the total amount of R$ 24,458, subscribed entirely by the shareholder Bozano
Educacional II Fundo de Investimento em Participa&#231;&#245;es Multiestrat&#233;gia.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">In
addition to the capital increase related to the acquisition of the non-controlling interests of FASA, IESP and Univa&#231;o and the
interest in UEPC, the Company had an additional paid-in capital of R$ <span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190615__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAUEPCMember_zrqr9NoSaq68" title="Proceeds from issue of ordinary shares">36,358</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>c)
Additional paid in capital</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the year ended December 31, 2021, Afya had capital increases regarding business combinations purchase price paid in shares totaling R$<span id="xdx_901_ecustom--ProceedsFromIssueOfOrdinarySharesOne_pid_c20210101__20211231_z7wg6v7PwYY7" title="Purchase prices paid shares">74,500</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Afya
also had additional paid in capital regarding capital reserves on transferring treasury shares from the exercise of stock options and
contribution of Afya Brazil shares paid to RX PRO selling shareholders, totaling R$<span id="xdx_90A_ecustom--AdditionalPaidinCapital1_iI_c20211231_z66XWCT1dKPb" title="Additional paid-in capital">21,861</span> and R$<span id="xdx_90C_ecustom--AdditionalPaidinCapital2_iI_c20211231_zsEJ1nhL7vga">783</span> respectively.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>d)
Dividends</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 8, 2019,
the shareholders of Afya Brazil approved the cancellation of dividends for the year ended December 31, 2016 of R$<span id="xdx_900_ecustom--CancellationOfDividend_c20190306__20190308_z0eYqwjQp8Of" title="Cancellation of dividend">4,107</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">On
June 13, 2019, Afya Brazil approved the payment of interim dividends totaling R$ <span id="xdx_905_eifrs-full--DividendPayables_iI_c20190613_zUXljSimK2Ib" title="Dividend payables">38,000</span> to Afya Brazil shareholders of record on June
13, 2019. The dividend amount was determined based on the Afya Brazil&#8217;s net income for the five months ended May 31, 2019 and were
paid on September 26, 2019. Afya and its public shareholders were not entitled to receive such dividends.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">At
the year ended December 31, 2021, CCSI and IESVAP approved the payment of interim dividends of R$ <span id="xdx_906_ecustom--InterimDividends_c20210101__20211231_zEuFBrFxT2Y7" title="Dividend paid">65,521</span>, which R$<span id="xdx_90E_ecustom--DividendsPaidClassifiedAsFinancingActivities1_c20210101__20211231_zNftfI9huwQ4" title="Dividends paid classified">46,873</span> was distributed
to Afya Brazil and R$ <span id="xdx_90F_eifrs-full--DividendsPaidToNoncontrollingInterests_c20210101__20211231_zc3TGUMrlo79" title="Dividends paid to non-controlling interests">18,648</span> to non-controlling shareholders.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>e)
Buy-back program</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">On
December 23, 2020, the Company announced that its Board of Directors has approved a share buy-back program. Under the share buyback program,
Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20201223__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zR6599ml2Jnf" title="Repurchase of ordinary shares">1,015,844</span> of its outstanding Class A common shares in the open market, based on prevailing market prices, or
in privately negotiated transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of
the repurchase or December 31, 2021, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On October 27,
2021, the Company&#8217;s board of directors approved a new share repurchase program. Afya may repurchase up to <span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zS451Ld9A0J6">1,383,108</span> of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on October
28, 2021 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
share buy-back program takes place in accordance with the conditions established by the Board of Directors. Afya intends to repurchase
the shares to execute the Stock Option Program for the executives of the Company. This program was concluded on October 21, 2021.</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">During
2021, the Company repurchased <span id="xdx_905_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211231_zPdPx82wfbp3">2,142,051</span> shares at the weighted average price of R$ <span id="xdx_907_eifrs-full--ParValuePerShare_iI_pii_c20211231_zwFXDTVZCKo5" title="Par value per share">99.76</span> (in Brazilian Reais) or US$ <span id="xdx_900_ecustom--IssuedCapital1_iI_c20211231_zRoMAvq2dqv4" title="Share capital">18.00</span>, amounting
to R$ <span id="xdx_900_ecustom--ProceedsFromIssueOfOrdinaryShares1_c20210101__20211231_zy3bagK4YOb2" title="Proceeds from issue of shares">213,722</span>. During year ended December 31, 2021, <span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231_zsoMUuhfkgWe" title="Total number of shares">442,669</span> of these shares were used by the Company any to settle the share-based program,
totaling R$<span id="xdx_907_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20210101__20211231_ztRxLozywXqf" title="Proceeds from issue of ordinary shares">55,197</span>.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--ScheduleOfTreasurySharesMovement_zFt2BV2K0pJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and <span id="xdx_8BD_zPN5GJUExpFk">movements in treasury</span> shares during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 52%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Number
    of shares</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 31%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Average
    price (in Brazilian Reais)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Outstanding
    at January 1, 2021</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding beginning period"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Repurchased</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,142,051</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99.76</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from exercise of options</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from exercise of options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(442,669)</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">124.08</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from shares contribution</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(44,455)</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">111.94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Outstanding
    at December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding ending period"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,654,927</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>92.23</b></span></td></tr>
  </table>

<p id="xdx_8B7_z1aX04b5fbje" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share capital, reserves and other equity interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103263992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (EPS)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory', window );">Earnings per share (EPS)</a></td>
<td class="text"><p id="xdx_80F_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zz7jiRkRTZxk" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>18</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_827_zAYWhsxScowg">Earnings
                                            per share (EPS)</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Basic
EPS is calculated by dividing net income attributable to the equity holders of the Company by the weighted average number of common shares
outstanding during the period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Diluted
EPS is calculated by dividing net income attributable to the equity holders of the parent by the weighted average number of common shares
outstanding during the period plus the weighted average number of shares that would be issued on conversion of all potential shares with
dilutive effects.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">Diluted
earnings per share are computed including stock options granted to key management using the treasury shares method when the effect is
dilutive. The Company has the stock option plan in the category of potentially dilutive shares.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_895_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zvO9wQw5hjxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table reflects the net income and share data used in the basic and diluted EPS calculations:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8BB_z1H4Ge2ZKZ7b" style="display: none; visibility: hidden">Schedule of earnings per share</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zW0x86suTJM1" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_498_20200101__20201231_z6FXBIQMmft8" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_491_20190101__20191231_z2eGmxKqSGx7" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_zxMCjhVeAKI1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable
    to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">223,326</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">292,075</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,916</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--WeightedAverageShares_pid_uShares_ze6o6kIW9NPd" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,291,480</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">92,683,848</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">75,969,797</span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pii_uShares_zmm94uY87Rqj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from
    stock options</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">811,818</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">951,920</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">221,846</span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustedWeightedAverageShares_pii_uShares_z8Ay99zJtfmh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,103,298</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,635,768</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,191,643</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_pii_uBRLPShares_zqVfvYX9qn35" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Basic
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.39</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3.15</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2.03
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pii_uBRLPShares_zbVlDHHNVrHk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.37</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3.12</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2.02
    </span></td></tr>
  </table>
<p id="xdx_8A1_zeZCTZtLrAL2" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEarningsPerShareExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS33_g70-73A_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEarningsPerShareExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103292584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueExplanatory', window );">Revenue</a></td>
<td class="text"><p id="xdx_809_eifrs-full--DisclosureOfRevenueExplanatory_zBTUQ9f7bSjh" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>19</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_822_z9pi8rv5BWQb">Revenue</span></b></span></td></tr></table>

<p id="xdx_89F_ecustom--ScheduleOfNetSalesRevenueExplanatory_zmHOcoHYmbL8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B5_z2IXdQRslSPf" style="display: none; visibility: hidden">Schedule of net sales revenue</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231_zyvynLrOqoZ7" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_497_20200101__20201231_zdZ3g4Wum2V" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_498_20190101__20191231_z5QGMDk6PTC" style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_zUkFa4r72yr6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees <sup id="xdx_F45_zcBDb6lUWZX3">(*)</sup></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,124,589</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,388,735</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">856,561</span></td></tr>
  <tr id="xdx_402_ecustom--OtherRevenue1_zJUnPlsRenj1" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">167,441</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">99,817</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,116</span></td></tr>
  <tr id="xdx_401_ecustom--DeductionAbstract_iB_zEc5q1UxzoJ6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deductions</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--DeductionOfGrantedDiscounts_zQ9WBcE1O59k" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Granted
    discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(229,254)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(89,017)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,767)</span></td></tr>
  <tr id="xdx_407_ecustom--DeductionOfEarlyPaymentDiscounts_zzoLznGIKNTb" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Early
    payment discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,879)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,299)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,523)</span></td></tr>
  <tr id="xdx_403_ecustom--DeductionOfReturnsOfNetRevenue_z86z3WFCYgId" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Returns</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(42,373)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,437)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,462)</span></td></tr>
  <tr id="xdx_401_ecustom--DeductionOfTaxes_zQ2t0uiFjn67" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Taxes</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(74,232)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,629)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,157)</span></td></tr>
  <tr id="xdx_40A_ecustom--DeductionOfProuni_zjrn8zhC0K08" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;PROUNI</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(176,921)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(107,979)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(61,138)</span></td></tr>
  <tr id="xdx_400_eifrs-full--RevenueFromContractsWithCustomers_zAJrnzH8RHul" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    revenue from contracts with customers</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr id="xdx_407_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zGuoiYiKyJKg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing
    of revenue recognition of net revenue from contracts with customers</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--FeeAndCommissionIncome_zSsyFi1ZWG8c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition,
    digital content and app subscription fees - Transferred over time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,128,558</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">713,827</span></td></tr>
  <tr id="xdx_400_ecustom--NetRevenueOtherTransferredPoint_zeFcdIT5s78" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    - Transferred at a point in time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,633</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,803</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zYduzUneiSzc" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">(*)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_zbUolZ3FsJd9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</span></td>
</tr></table>

<p id="xdx_8A8_z9EK9h3Mslm8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company`s revenue from contracts with customers are all in Brazil. The Company is not subject to the payment of the social integration
program tax (Programa de Integra&#231;&#227;o Social, or PIS) and the social contribution on revenues tax (Contribui&#231;&#227;o
para o Financiamento da Seguridade Social, or COFINS) on the revenue from under graduation degrees under the PROUNI program.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following table presents statements of income for the Company&#8217;s operating segments for the years ended December 31, 2021, 2020
and 2019:</span></p>

<p id="xdx_89D_ecustom--ScheduleOfRevenueBySegment_zU6FqluihLW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zVmMS04dsLNi">Schedule of revenue by segment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue
    by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types
    of services or goods</b></span></td>
    <td id="xdx_981_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKGt24N5mZxf" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGaco47k2cVh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQERCis6ZFF3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z6MgPp8SqUbk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_z3gA79fqz9R4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z3lOv2MtZ18i" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdpbYGmGCzih" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXxcd5Sfcwvc" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4945">-</span></span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z9P8a00yWMda" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4946">-</span></span></td>
    <td id="xdx_98F_ecustom--ProfessionalFeesExpense1_pn3n3_c20210101__20211231_zNMeeh1GxBM4" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,559,094</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXNi8C4Hkuqg" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDVGRRCqtxkf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">151,958</span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z7N2eKcdk0G3" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_z8XcJ394f622" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">160,277</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z98wkf2mrIif" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_98B_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zBV2rjetsya1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zaNuHUrjHX56" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_znxz0CTNR5a8" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zk25RXXHv6Vh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    over time</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zwcQttcSSTBc" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzEIlJGihbz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgI9x2Q2wrz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,795</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zT1tfP3pJT41" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    at a point in time</span></td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqwTvNOGotC4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxxlErX2jNQf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4968">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMoD9DADFXhg" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,163</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zBT7KScVc2I1" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_zBh34sN79DXa" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zlm1oRwiewva" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,002,461</b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLMNFS1srROb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>107,197</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zHLC1uFcizP7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>93,152</b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,619)</b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--SegmentOfBusinessOneUnitMember_zo128EkT9JZb" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">997,055</span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0EcPHU3jc2g" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,197</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_986_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231_zqh9I2xfCNee" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,104,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXeEqWgiG0kb" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,406</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIs5R1prWR0h" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,152</span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,619)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231_zlQhvD1JH3Za" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">96,939</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zx06Pcjlzle2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,002,461</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zs0U5zD1WAk6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>107,197</b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDp8jCOlamph" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>93,152</b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,619)</b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231_z2kNWpQBvzt1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLjVGEt3ZzY7" style="vertical-align: bottom; padding-right: 2.55pt; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">997,055</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvDdTtl2Oq8c" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,197</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfvak12265m6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,306</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231_zCdmUie0L504" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,128,558</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zuNtbBthRV94" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,406</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJrsOeAWUhYd" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,846</span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,619)</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231_zEbTNHEcj9nf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,633</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zd3fDHCdXNd4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>653,760</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zqVKN9jh84w2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,870</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2KsslMQdyig" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,880</b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zIq5DHUeOcn8" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,880)</b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231_zx9FQZa4jyLb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zO1X1lpTz9Da" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">648,957</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj3l7PlhqXN7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60,195</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98D_ecustom--ProfessionalFeesExpense1_pn3n3_c20190101__20191231_zigXcitC4lIf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">709,152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ3vUcYNlc1h" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,803</span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4M8QEFMhXj2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,675</span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zq1nk4cLDEr6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,880</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zXqmRjUEwSqi" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,880)</span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231_zbCA4pSUZzse" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41,478</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPSQqGx2ZTh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>653,760</b></span></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJ4632C6EWxi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,870</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMrlEGBiTpei" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,880</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zSgumwJU0Rbi" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,880)</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231_z6QVlZREvbLi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLOWEJKaZqBi" style="vertical-align: bottom; padding-right: -2.4pt; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">648,957</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWMDmSFiNtV3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,870</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231_zLI4e8HkYsv7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">713,827</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_988_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQa9pWMQebLh" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,803</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIJ01XzrNAfj" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,880</span></td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zNNTXj7dMPEf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,880)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231_zYeedTPsTeCb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,803</span></td></tr>
  </table>
<p id="xdx_8A4_zXHAwK07PHuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103630872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses and costs by nature<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory', window );">Expenses and costs by nature</a></td>
<td class="text"><p id="xdx_808_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zcMStsRPac4f" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>20</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zh6fe9yTcuSg">Expenses
                                            and costs by nature</span></b></span></td></tr></table>

<p id="xdx_897_ecustom--SummaryOfExpensesByNatureTableTextBlock_zZlnbaVBKAm8" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B9_zz5KIFrq1RKa" style="display: none; visibility: hidden">Schedule of expenses by nature</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zASNR3Tik5Z2" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20200101__20201231_z87ngSk9iQOk" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49C_20190101__20191231_zUvyNPNXpG1j" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--CostOfSales_zwR11BJJyiri" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(652,300)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(434,654)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(308,853)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zPnFjZj40Bmb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(622,615)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(402,855)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(239,120)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ExpenseByNature_zRr3fv2mxPzi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,274,915)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(837,509)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(547,973)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--Payroll_zrh1jzRDTwS7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(677,564)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(446,473)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(324,252)
    </span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_zC1BhQbjxRyc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital
    and medical agreements</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,449)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,988)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(16,429)
    </span></td></tr>
  <tr id="xdx_407_eifrs-full--DepreciationExpense_z1IUNSU8NyRk" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    and amortization</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(154,220)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,744)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(73,152)
    </span></td></tr>
  <tr id="xdx_408_ecustom--LeaseExpenses_zNFGvIx7vTYc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,229)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,555)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,494)</span></td></tr>
  <tr id="xdx_402_eifrs-full--UtilitiesExpense_zKGvIKSUZYB6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,643)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,892)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,628)
    </span></td></tr>
  <tr id="xdx_40C_eifrs-full--RepairsAndMaintenanceExpense_zIrk4OVrV6O7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,141)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,746)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,658)
    </span></td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_zrNf1Q369RTl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,377)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,610)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(18,114)</span></td></tr>
  <tr id="xdx_40C_ecustom--TaxExpenses_zRuKGSsZ31R" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,997)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,326)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,696)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--ServicesExpense_zC7DM0dyCPi6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical
    services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,881)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,037)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,271)</span></td></tr>
  <tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_zIGZ31SIkot4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales
    and marketing</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,506)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(18,361)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,966)</span></td></tr>
  <tr id="xdx_40A_ecustom--AllowanceForDoubtfulAccounts_zoHp1Ec5SfS6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance
    for doubtful accounts</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,819)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,081)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,040)</span></td></tr>
  <tr id="xdx_408_eifrs-full--TravelExpense_zodnFKTqumY6" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,542)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,550)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,054)</span></td></tr>
  <tr id="xdx_409_ecustom--ConsultingFees_zXuHmzH9bZ41" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting
    fees</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(38,818)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,276)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(13,060)</span></td></tr>
  <tr id="xdx_405_ecustom--Other_zUzBp07dkQr" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(103,729)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(66,870)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,159)</span></td></tr>
  <tr id="xdx_401_ecustom--ExpenseByNatureOne_iT_zKYFsO0wi141" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,274,915)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(837,509)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(547,973)</b></span></td></tr>
  </table>
<p id="xdx_8AB_zQsxiaGDAWvb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfExpensesByNatureExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of expenses by nature. [Refer: Expenses, by nature]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfExpensesByNatureExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103260264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory', window );">Finance result</a></td>
<td class="text"><p id="xdx_805_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zOAwpxR2FgB3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>21</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_825_zt33nKUGZvlg">Finance
                                            result</span></b></span></td></tr></table>

<p id="xdx_897_ecustom--ScheduleOfFinanceResult_zRtn4GBtjlA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B2_zVbwQGDP0Kh9" style="display: none; visibility: hidden">Schedule of finance result</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49B_20210101__20211231_zV5Euy2eB5ih" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_490_20200101__20201231_zyyaSJOhf6yf" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 5.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49F_20190101__20191231_zaiVwXKTJzL9" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--InvestmentIncome_zYnnf5Zwgjga" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    from financial investments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,773</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,479</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">25,965</span></td></tr>
  <tr id="xdx_400_ecustom--ChangesInFairValueOfDerivativeInstruments_zETaOgK8agah" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Changes
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5130">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,739</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5132">-</span></span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromInterest_zxPhDMuI8iEb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    received</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,040</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,876</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,680</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NetForeignExchangeGain_zVjIGHM6Ajc3" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5138">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5139">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,321</span></td></tr>
  <tr id="xdx_401_eifrs-full--OtherFinanceIncome_zcb4rfG6joFe" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,753</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,723</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_zD47KnUqqMm4" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    income</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,566</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>62,290</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,689</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ChangeInFairValueOfDerivativeInstruments_znyFRGXcxVDl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Change
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5150">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5151">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,780)</span></td></tr>
  <tr id="xdx_401_ecustom--InterestExpense1_ztvQ3LNvNyM" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,437)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(25,543)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,002)</span></td></tr>
  <tr id="xdx_408_ecustom--InterestExpenseOnLeaseLiabilities1_zT5P2x644es9" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense on lease liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,212)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(44,458)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,469)</span></td></tr>
  <tr id="xdx_403_ecustom--FinancialDiscountsGrantedExpenses_zeYxNw0kKkzb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial
    discounts granted</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(23,193)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,081)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(923)</span></td></tr>
  <tr id="xdx_404_eifrs-full--BankAndSimilarCharges_zttp0aut67Pf" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank
    fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,878)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,333)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,876)</span></td></tr>
  <tr id="xdx_409_eifrs-full--NetForeignExchangeLoss_zVPpI4SXYZh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(17,973)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,613)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5172">-</span></span></td></tr>
  <tr id="xdx_404_ecustom--TaxOnFinancialOperations_z9kUCMmq4fX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF
    taxes (taxes on financial transactions)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,306)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,661)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,801)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--OtherFinanceCost_zUApyGb0GNc5" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,797)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,580)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,514)</span></td></tr>
  <tr id="xdx_402_eifrs-full--FinanceCosts_iN_di_zpM1EJArnKi7" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(243,796)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(98,269)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(72,365)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceResult_zjql1nAyciV" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(179,230)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(35,979)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(20,676)</b></span></td></tr>
  </table>
<p id="xdx_8AF_znjpaFornZ3e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of finance income (cost). [Refer: Finance income (cost)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103361096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfIncomeTaxExplanatory', window );">Income taxes</a></td>
<td class="text"><p id="xdx_807_eifrs-full--DisclosureOfIncomeTaxExplanatory_zGuLbjeT7E1f" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>22</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_820_z5gdoexqvU0c">Income
                                            taxes</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Income taxes are
comprised of taxation over operations in Brazil, related to Corporate Income Tax ("IRPJ") and Social Contribution on Net Profit
("CSLL"). According to Brazilian tax legislation, income taxes and social contribution are assessed and paid by legal entity
and not on a consolidated basis.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Reconciliation
of income taxes expense</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89A_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_zOVESf5Xynl2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following is a reconciliation of income tax expense to profit (loss) for the year, calculated by applying the combined Brazilian statutory
rates at 34% for the years ended December 31, 2021, 2020 and 2019:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B3_zQFstNDjvwf" style="display: none; visibility: hidden">Schedule of reconciliation of income tax expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 56%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zlKxdtAQtCV4" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_496_20200101__20201231_zuEhJyWQZ9o7" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_499_20190101__20191231_z5IwB6tJzOS" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLossBeforeTax_zxizHVlqds7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>273,462</b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>335,054</b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>186,937</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income
    taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20210101__20211231_z9xqAugZTHN4" title="Statutory rates">34</span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20200101__20201231_zXNlgHWvuJed">34</span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20190101__20191231_zL4NDjvXzDtc">34</span>%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pii_z9Jw8nlf2kHl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory
    rates</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(92,977)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(113,918)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(63,559)</span></td></tr>
  <tr id="xdx_40C_ecustom--ReconciliationAdjustmentsAbstract_iB_pii_zxF1trvIRDj8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pii_zimGS9YP1gq3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities
    not subject to taxation</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,794)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,474)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,265)</span></td></tr>
  <tr id="xdx_40A_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pii_zHF5GuRbzrU8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive
    <sup id="xdx_F45_z3QBg1jC6bM5">(a)</sup></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">194,830</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">120,851</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,397</span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pii_ztuiRAsbA8Pd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax
    assets</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(86,233)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(41,319)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(19,342)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pii_zvnrnuCTsCL" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income
    tax regime effect <sup id="xdx_F47_zpWgkFpTW1wb">(b)</sup></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,066)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,640)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">351</span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustments_pii_zXVPe5J7Mu91" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,232)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,567</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5228">-</span></span></td></tr>
  <tr id="xdx_405_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pii_zk61X8wbPKNe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,293</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,866</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,757)</span></td></tr>
  <tr id="xdx_406_eifrs-full--CurrentTaxExpenseIncome_pii_zT3DjncGRDMd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense &#8211;
    current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(31,179)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(27,067)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(14,175)</b></span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxRateEffectFromChangeInTaxRate_pii_dp_uPure_zQjJMw8LZVV2" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11.40%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8.08%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7.58%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zybEHm3TG5Nf" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_z7hcORHSMY7b" style="font-family: Arial, Helvetica, Sans-Serif">The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0D_zUlifPwbXyal" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_zHtN0tns1nch" style="font-family: Arial, Helvetica, Sans-Serif">Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.</span></td>
</tr></table>

<p id="xdx_8AD_zSOCr1wZdpFi" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Deferred
income taxes</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021, the Company had unrecognized deferred income tax assets on temporary differences and tax losses in the amount of R$ <span id="xdx_902_eifrs-full--DeferredTaxExpenseIncome_c20210101__20211231_zU732Km70ZRj" title="Unrecognized deferred income tax assets">432,226</span>
(tax-basis) (R$ <span id="xdx_908_eifrs-full--DeferredTaxExpenseIncome_c20200101__20201231_zQ37nLecwVW4" title="Unrecognized deferred income tax assets">214,387</span> (tax-basis) as of December 31, 2020) which does not have any tax planning opportunities available that could
support the recognition of these temporary differences as deferred tax assets. Accordingly, the Company did not recognize deferred tax
assets.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfIncomeTaxExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS12_g79-88_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfIncomeTaxExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103359400">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance contracts and contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfInsuranceContractsExplanatory', window );">Insurance contracts and contingencies</a></td>
<td class="text"><p id="xdx_80D_eifrs-full--DisclosureOfInsuranceContractsExplanatory_zaU8rFfgppQ1" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>23</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_820_z7DHQZ3JX1zh">Insurance
                                            contracts and contingencies</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Insurance contracts</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company and
its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking in the market coverage compatible with
its size and operations.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Legal proceedings and contingencies</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_899_ecustom--ScheduleOfLegalProceedingsAndContingencies_zCjeLFkoBj6a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The provisions
related to labor, civil and taxes proceedings whose likelihood of loss is assessed as probable are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BA_z9iIAEb3Zzyg" style="display: none; visibility: hidden">Schedule of legal proceedings and contingencies</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2018</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z8UDO3SiwKFg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,233</b></span></td>
    <td id="xdx_981_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znA9eMVrxCn" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,232</b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBjyEpOS3yW6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5255">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zd3NiUXIP3Cl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,465</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zQo7x8ZyWDfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,301</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zW9cJqkEBTT3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,071</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHLNMLdpaue3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5263">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zJEeaKOhYIbc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,372</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHQHaP7e8ieh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">737</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zkRZZHOMAshc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,508</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFMIeGWTCOV9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMkfliPLzhWi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,245</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zY8daNmGE5x3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,770)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuCWvzFir1F5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,043)</span></td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBAIj2LDiYj2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5278">-</span></span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zzC2fHPV583l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2019</b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zf7PBBcYjDyf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,501</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zmonYaDRHCnb" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,768</b></span></td>
    <td id="xdx_983_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLv1QkxmcQPl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5284">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z3K5hDatdlmk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,269</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zdYGwM4Lqmt" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,741</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zs5IqC2vuyF8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,348</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zbbyvoi3MvO3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,487</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,576</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zeBdtifnQRJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">562</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq9oKLk6EVSg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,869</span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3CFb076mkie" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,853</span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">19,284</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98B_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z4OLg8ZshPV9" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,285)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zccjfXBLQBD" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,705)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zSwqsnEJZps7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5307">-</span></span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,990)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2020</b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze3puQZUVxac" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balances as of end of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,519</b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zSHII53AtlGl" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>13,280</b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zjpz44KKYkp9" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,340</b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zgR22mw7n2r4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,139</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze4s4nAt2ZL5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,597</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znSN8BC2m9Y6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,017</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zxT1u4yM7JK" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,638</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zf4JeejDjFF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions
    <sup id="xdx_F48_zf7Sl47iLX5d">*</sup></span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_fKg_____zKj0zwSsNKnc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,418</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2UNDxa6RFc7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,101</span></td>
    <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9wRoocXHyTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,225</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zdeRYaSdPmAf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,744</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFtJt91QLSBd" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,044)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zI9LtvfMCSIi" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,470)</span></td>
    <td id="xdx_98A_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zeQhGJuOw3zl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,334)</span></td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8YA4KKCj5h7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,848)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2021</b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zX8giQ4gU5Mj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,490</b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zJX2O4P55Jfa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,928</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHBevEWvLmxa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>99,869</b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zOJZyP2lUQJ4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,287</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_zTwrzJY5utsk" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zCbwxgxWXBY7" style="font-family: Arial, Helvetica, Sans-Serif">The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.</span></td>
</tr></table>

<p id="xdx_8A7_zuUbiMBqApJ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_896_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_zFatfWCJR4hh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">There are other
civil, labor, taxes and social security proceedings assessed by Management and its legal counsels as possible risk of loss, for which
no provisions are recognized, as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zk09jwvyWY3g" style="display: none; visibility: hidden">Schedule of social security proceedings assessed by Management</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 17%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_982_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVN1npePd7x5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,098</span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zaIEIzu4as5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,318</span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zDIk0IypT0g4" style="vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,570</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z8kMG0xChqwj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,501</span></td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,969</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2KQDeH9A2yd" style="vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,135</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes
    and social security</span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zejfGsQ62ggf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,459</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,375</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zfS1CcgPpF8g" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,583</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231_z3HPbKuhXzB6" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>66,058</b></span></td>
    <td id="xdx_98F_eifrs-full--OtherProvisions_c20201231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>66,662</b></span></td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_iI_pn3n3_c20191231_ztNLLA91sHP" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>50,288</b></span></td></tr>
  </table>
<p id="xdx_8AA_zVTS3MWAlVil" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
judicial deposits recorded in other assets (non-current) in the amount of R$ <span id="xdx_900_ecustom--JudicialDeposits_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Judicial deposits">18,825</span> as of December 31, 2021 (December 31, 2020: R$ <span id="xdx_906_ecustom--JudicialDeposits_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zn2vUkEoHn12" title="Judicial deposits">1,451</span>).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Under the terms
of the Share Purchase and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries
acquired, the Company assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and
civil), which are or will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission,
prior to or on the closing dates of the acquisitions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Accordingly, and
considering that the provisions for legal proceedings recorded by the Company that result from causes arising from events occurring prior
to the closing dates of the acquisitions, any liability for the amounts to be disbursed, in case of their effective materialization in
loss, belongs exclusively to the selling shareholders. In this context, the Agreements state that the Company and its subsidiaries are
indemnified and therefore exempt from any liability related to said contingent liabilities and, therefore, the provision amounts related
to such contingencies are presented in the non-current liabilities and the correspondent amount of R$ <span id="xdx_903_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_z3Fi2tG0ge5e" title="Contingencies correspondent amount">135,355</span> (December 31, 2020: R$
<span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zQQdBFFRe6Vd" title="Contingencies correspondent amount">53,499</span>) is presented in non-current other assets.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfInsuranceContractsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for insurance contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;doctype=Standard&amp;book=b&amp;dita_xref=IFRS04_g36-39M_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS17_g93-132_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfInsuranceContractsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103373704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Non-cash transactions<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsAbstract', window );"><strong>Non-cash Transactions</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureNoncashTransactionsExplanatory', window );">Non-cash transactions</a></td>
<td class="text"><p id="xdx_800_ecustom--DisclosureNoncashTransactionsExplanatory_z7SIn7x4vqV6" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>24</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_827_zqgwZ69J0JDj">Non-cash
                                            transactions</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">During the years
ended December 31, 2021, 2020 and 2019, the Company carried out non-cash transactions which are not reflected in the statement of cash
flows. The main non-cash transactions in 2021 were the issuance of shares for the acquisitions of iClinic, Cliquefarma, and RXPRO, addition
of the provision for legal proceedings with corresponding indemnification assets, additions and remeasurements of right-of-use assets
and lease liabilities.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureNoncashTransactionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureNoncashTransactionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670106444616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent events<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory', window );">Subsequent events</a></td>
<td class="text"><p id="xdx_80C_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zMvB6X2ICdca" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>25</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_821_zZJ3r6bDBff3">Subsequent
                                            events</span></b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>a)
Repurchase shares program</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On January 27,
2022, the Company&#8217;s board of directors approved a new share repurchase program. Afya may repurchase up to <span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zoPsJp6DiXC3" title="Repurchase shares program">1,874,457</span> of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January
27, 2022 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>b)
Medical schools authorizations</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 23,
2022, Afya announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#8220;MEC&#8221;)
authorized the operations of the medical schools in Abaetetuba, in the State of Par&#225;, and Itacoatiara, in the State of Amazonas,
both under Mais M&#233;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">On
March 16, 2022, MEC authorized the operations of the medical schools in </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt">Bragan&#231;a,
in the State of Par&#225;, and Manacapuru, in the State of Amazonas</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">,
both under Mais M&#233;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>c)
Acquisition of Al&#233;m da Medicina</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On February 24,
2022, Afya Brazil announced the acquisition of <span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pii_dp_uPure_c20220224__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicParticipacoesSAMember_zZ7kQn1Thc4k" title="Proportion of ownership interest">100</span>% of the total share capital of Al&#233;m da Medicina. The deal was closed March
4, 2022.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Al&#233;m da
Medicina is a medical content online platform for physicians and medical students that provides educational tools besides technical medical
content that can assist them throughout their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting,
and investment basics for physicians.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The aggregate purchase
price was R$16.000 paid in cash. An earn-out of up to R$19.200 can be paid related to gross revenue achievements for 2023 and 2024.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The acquisition
date fair value of each major class of consideration, including the allocation of the purchase price has not been completed by the Company
as of the issuance date of these annual financial statements. The impact on revenue and profit or loss of the combined entity for the
current reporting period as if the acquisition date had been as of the beginning of the annual reporting period is not available as the
Company did not conclude this acquisition by December 31, 2021. Therefore, these financial statements do not include this information.
The transaction costs to date amounted to R$ 211.&#160;Any goodwill generated in the transaction is not expected to be deductible for
tax purposes.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>d)
Bertelsmann Explores Increasing Stake in Afya </b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 7, 2022,
Afya announced that it was notified that Nicolau Carvalho Esteves and Ros&#226;ngela de Oliveira Tavares Esteves, or the Esteves family,
have made a binding offer to sell <span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220307__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_z5rW4jJu8cU8">6,000,000</span> Class B common shares of Afya at the purchase price of US$<span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20220307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zRlzg9QRHtj" title="Purchase prices per share">26.90</span> per share to an affiliate
of Bertelsmann SE&amp; Co. KGaA, or &#8220;Bertelsmann&#8221;. Bertelsmann&#8217;s acceptance of the offer remains subject to due diligence
and Bertelsmann board approval.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>e)
Medical Seats Increase in Centro Universit&#225;rio S&#227;o Lucas</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">On March 18, 2022,
Afya announced that MEC authorized the increase of 28 seats of Centro Universit&#225;rio S&#227;o Lucas, in Ji-Parana located in
the state of Rond&#244;nia.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The earn-out related
to the seats approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which: (i) 50% is payable
in 30 days, and (ii) 50% is payable in cash in two equal installments through 2024.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for events after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 10<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=10&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IAS10_g17-22_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670099943240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory', window );">a) Business combinations and goodwill</a></td>
<td class="text"><p id="xdx_845_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zXGmTUPzPJU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_866_zaEnDGm2gzv8">a)
Business combinations and goodwill</span> </b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Business combinations
are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred,
which is measured at acquisition date fair value, and the amount of any non-controlling interests in the acquiree. For each business
combination, the Company elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate
share of the acquiree&#8217;s identifiable net assets. Acquisition-related costs are expensed as incurred and included in general and
administrative expenses.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the Company
acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and designation in accordance
with the contractual terms, economic circumstances and pertinent conditions as of the acquisition date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is initially
measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interests
and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair value of the net assets
acquired is in excess of the aggregate consideration transferred, the Company re-assesses whether it has correctly identified all of
the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognized at the
acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration
transferred, then the gain is recognized in the consolidated statement of income.</span></p>




<p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Company&#8217;s cash-generating units that are expected to benefit
from the combination, irrespective of whether other assets or liabilities of the acquire are assigned to those units.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Where goodwill
has been allocated to a cash-generating unit (CGU) and part of the operation within that unit is disposed of, the goodwill associated
with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal. Goodwill
disposed in these circumstances is measured based on the relative values of the disposed operation and the portion of the cash-generating
unit retained.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory', window );">b) Current versus non-current classification</a></td>
<td class="text"><p id="xdx_84F_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zgzG63K0xsU1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zHhT9uXICLRb">b)
Current versus non-current classification</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company presents
assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it
is:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized or intended to be sold or consumed in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Held
                                            primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Expected
                                            to be realized within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Cash
                                            or cash equivalent unless restricted from being exchanged or used to settle a liability for
                                            at least twelve months after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All other assets
are classified as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A liability is
current when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is expected to be settled in the normal operating cycle;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is held primarily for the purpose of trading;</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">It
                                            is due to be settled within twelve months after the reporting period; or</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">There
                                            is no unconditional right to defer the settlement of the liability for at least twelve months
                                            after the reporting period.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company classifies
all other liabilities as non-current.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Deferred tax assets
and liabilities are classified as non-current assets and liabilities.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory', window );">c) Fair value measurement</a></td>
<td class="text"><p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z1UoK9K8FA54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_znBt0lSNy64l">c)
Fair value measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability
takes place either: (i) in the principal market for the asset or liability; or (ii) in the absence of a principal market, in the most
advantageous market for the asset or liability.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The principal or
the most advantageous market must be accessible by the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The fair value
of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A fair value measurement
of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest
and best use or by selling it to another market participant that would use the asset in its highest and best use.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company uses
valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">All assets and
liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy,
described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            1 &#8212; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            2 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is directly or indirectly observable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">&#8226;</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Level
                                            3 &#8212; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is unobservable.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets and
liabilities that are recognized in the financial statements at fair value on a recurring basis, the Company determines whether transfers
have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to
the fair value measurement as a whole) at the end of each reporting period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At each reporting
date, the Company analyzes the movements in the values of assets and liabilities which are required to be remeasured or re-assessed as
per the Company&#8217;s accounting policies. For this analysis, the Company verifies the major inputs applied in the latest valuation
by agreeing the information in the valuation computation to contracts and other relevant documents.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company also
compares the change in the fair value of each asset and liability with relevant external sources to determine whether the change is reasonable.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of fair value disclosures, the Company has determined classes of assets and liabilities on the basis of the nature, characteristics and
risks of the asset or liability and the level of the fair value hierarchy, as explained above.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory', window );">d) Financial instruments &#8211; initial recognition and measurement</a></td>
<td class="text"><p id="xdx_84B_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_ztYvUYq4jBpk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86C_zZNwJYQfZUg1">d)
Financial instruments &#8211; initial recognition and measurement</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial instrument
is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 14.2pt"/><td style="width: 14.15pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>i)</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
classification of financial assets at initial recognition depends on the financial asset&#8217;s contractual cash flow characteristics
and the Company&#8217;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair
value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. Trade receivables that do not
contain a significant financing component or for which the Company has applied the practical expedient, are measured at the transaction
price determined under IFRS 15.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">In order
for a financial asset to be classified and measured at amortized cost or fair value through OCI (Other Comprehensive Income), it needs
to give rise to cash flows that are &#8220;solely payments of principal and interest (SPPI)&#8221; on the principal amount outstanding.
This assessment is referred to as the SPPI test and is performed at an instrument level.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash
flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets,
or both.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Purchases
or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the market
place (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
purposes of subsequent measurement, financial assets are classified as: financial assets at amortized cost or financial assets at fair
value through profit or loss. There is no financial assets designated as fair value through OCI.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at amortized cost</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company measures financial assets at amortized cost if both of the following conditions are met:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The financial asset is held within a business model with the objective to hold financial assets in order to collect contractual cash
flows, and</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
on the principal amount outstanding.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at amortized cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. Gains and
losses are recognized in the statement of income when the asset is derecognized, modified or impaired.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
assets at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss include financial assets held for trading, financial assets designated upon initial recognition
at fair value through profit or loss, or financial assets mandatorily required to be measured at fair value. Financial assets are classified
as held for trading if they are acquired for the purpose of selling or repurchasing in the near term. Derivatives, including separated
embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial
assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit
or loss, irrespective of the business model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair
value recognized in the statement of income. This category includes derivative instruments.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e.,
removed from the Company&#8217;s statement of financial position) when:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The rights to receive cash flows from the asset have expired; or</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows
in full without material delay to a third party under a &#8216;pass-through&#8217; arrangement; and either (a) the Company has transferred
substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks
and rewards of the asset, but has transferred control of the asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">When
the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially
all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset
to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred asset
and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Company could be required to repay.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Impairment
of financial assets</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Further
disclosures relating to impairment of financial assets are also provided in the following notes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Significant accounting estimates and assumptions &#8211; Note 3</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#8226;
Trade receivables &#8211; Note 7</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company recognizes an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or loss.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and the cash flows the Company
expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash
flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">For
trade receivables, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit
risk, but instead recognizes an allowance for credit losses based on lifetime ECLs at each reporting date. The Company has established
a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors
and the economic environment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company considers a financial asset to be in default when internal or external information indicates that the Company is unlikely to
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Company. A financial
asset is written off when there is no reasonable expectation of recovering the contractual cash flows.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Initial
recognition and measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings,
payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company&#8217;s financial liabilities include trade payables, loans and financing, notes payable, lease liabilities, advances from costumers
and accounts payable to selling shareholders.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Subsequent
measurement</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">The
measurement of financial liabilities depends on their classification, as described below:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Financial
liabilities at fair value through profit or loss</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated
upon initial recognition as at fair value through profit or loss.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also
includes, when applicable, derivative financial instruments entered into by the Company that are not designated as hedging instruments
in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Loans
and borrowings</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">After
initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and
losses are recognized in the statement of income when the liabilities are derecognized as well as through the EIR amortization process.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR.
The EIR amortization is included as finance expenses in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Derecognition</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">A financial
liability is derecognized when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability
is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially
modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Offsetting
of financial instruments</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and
settle the liabilities simultaneously.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents', window );">e) Cash and cash equivalents</a></td>
<td class="text"><p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zDlIQMFTwAod" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_867_zDF9074Mtcx9">e)
Cash and cash equivalents</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Cash and cash equivalents
in the statement of financial position comprise cash at banks and on hand, and short-term financial investments with an original maturity
of three months or less, which are subject to an insignificant risk of changes in value.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For the purpose
of the statement of cash flows, cash and cash equivalents consist of cash and short-term financial investments, as they are considered
an integral part of the Company&#8217;s cash management.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory', window );">f) Restricted cash</a></td>
<td class="text"><p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_zo6V8jmS1mue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_863_zp9r4v6lemA4">f)
Restricted cash</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Restricted cash
in the statement of financial position comprise of financial investments in investment funds that serve as collateral for loan agreements
and other commitments.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories', window );">g) Inventories</a></td>
<td class="text"><p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zLO4ZjkpxVjj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zgKIkbUiRZ37">g)
Inventories</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Inventories are
valued at the lower of cost and net realizable value. The costs of inventories are based on the average cost method and include costs
incurred in the purchase of inventories and other costs incurred in bringing them to their current location and condition. Costs of purchased
inventory are determined after deducting any discounts and recoverable taxes.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory', window );">h) Property and equipment</a></td>
<td class="text"><p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zs5910DRxwp1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zN7I4VlTO1ya">h)
Property and equipment</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Property and equipment
is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Subsequent expenditures
are capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zgTXvHbXwfZh">Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Building</span></td>
    <td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">25
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Machinery
    and equipment</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Vehicles</span></td>
    <td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1239">4
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Furniture
    and fixtures</span></td>
    <td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1240">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">IT
    equipment</span></td>
    <td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1241">5
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Library
    books</span></td>
    <td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1242">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Laboratories
    and clinics</span></td>
    <td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Leasehold
    improvements</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1244">20
    years</span></span></td></tr>
  </table>

<p id="xdx_8AE_zExqFxbNA5be" style="margin-top: 0; margin-bottom: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>
<p style="font: 12pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><br/></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An item of property
and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefit is expected
from its use or disposal. Any gain or loss arising on the derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of income when the asset is derecognized.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The residual values,
useful lives and methods of depreciation of property and equipment are reviewed at each financial year end and adjusted prospectively,
if appropriate.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory', window );">i) Leases</a></td>
<td class="text"><p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z54pJUq5MSSk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zbLzWvYYJg3e">i)
Leases</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As from January
1, 2019, the determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the inception
of the contract. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a specific asset
(or assets) and the arrangement conveys a right to use the asset (or assets), even if that asset is (or those assets are) not explicitly
specified in an arrangement.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Company
as a lessee</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company
recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Right-of-use
assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets
are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Unless the Company is reasonably certain to obtain ownership
of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the
shorter of its estimated useful life and the lease term. Right-of use assets are subject to impairment.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Lease
liabilities</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">At the commencement
date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease
term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable
lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments
also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for
terminating a lease, if the lease term reflects the Company exercising the option to terminate. The variable lease payments that do not
depend on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In calculating
the present value of lease payments, the Company uses the incremental borrowing rate at the lease commencement date if the interest rate
implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect
the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured
if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment
to purchase the underlying asset.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif">Short-term
leases and leases of low-value assets</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company applies
the short-term lease recognition exemption to its short-term leases of properties (i.e., those leases that have a lease term of <span id="xdx_90A_ecustom--ContractualLeaseTerm_dxL_c20210101__20211231_zf5MLExeIDub" title="Lease term::XDX::P1Y"><span style="-sec-ix-hidden: xdx2ixbrl1248">12 </span></span>months
or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption
to leases that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense
on a straight-line basis over the lease term.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory', window );">j) Intangible assets</a></td>
<td class="text"><p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOKA4C8TmvD9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zJnbovsjkWMc">j)
Intangible assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is
their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated
amortization and accumulated impairment losses. Internally generated intangibles are not capitalized and the related expenditure is reflected
in the statement of income in the period in which the expenditure is incurred.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The useful lives
of intangible assets are assessed as finite or indefinite.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired.<br/></span></p>




<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The amortization
period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting
period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset
are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization
expense on intangible assets with finite lives is recognized in the statement of income in the expense category that is consistent with
the function of the intangible assets.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating
unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable.
If not, the change in useful life from indefinite to finite is made on a prospective basis.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">An intangible asset
is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory', window );">k) Impairment of non-financial assets</a></td>
<td class="text"><p id="xdx_84E_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zJ3A9hpxuzQ6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zacqbnkRPoBa">k)
Impairment of non-financial assets</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses,
at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment
testing for an asset is required, the Company estimates the asset&#8217;s recoverable amount. An asset&#8217;s recoverable amount is
the higher of an asset&#8217;s or CGU&#8217;s fair value less costs of disposal and its value in use. The recoverable amount is determined
for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups
of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written
down to its recoverable amount.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent
market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used. These
calculations are corroborated by valuation multiples, quoted share prices for publicly traded companies or other available fair value
indicators.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company bases
its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company&#8217;s
CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years, considering
the companies activities and maturation period of its graduate and undergraduate courses. A long-term growth rate is calculated and applied
to project future cash flows after the last projected year.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For impairment
testing, goodwill acquired through business combinations and licenses with indefinite useful lives are allocated to their respective
CGUs. The Company has defined each of its operating subsidiaries as a CGU, except for &#8220;Practice Management Tools &amp; Electronic
Prescription&#8221; and &#8220;Clinical Decision Software&#8221; where the subsidiaries were combined as one CGU following the business
strategic pillars and &#8220;Moc&#8221; where we have 2 different educational institution operating in the same municipality (Montes
Claros).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Whenever applicable,
impairment losses of continuing operations are recognized in the statement of income in expense categories consistent with the function
of the impaired asset.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">For assets excluding
goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset&#8217;s or CGU&#8217;s recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the
asset&#8217;s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation,
had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Goodwill is tested
for impairment annually as at December 31 and when circumstances indicate that the carrying value may be impaired.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Impairment is determined
for goodwill by assessing the recoverable amount of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount
of the CGU is less than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed
in future periods.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Intangible assets
with indefinite useful lives are tested for impairment annually as at December 31 at the CGU level, as appropriate, and when circumstances
indicate that the carrying value may be impaired.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PolicyExplanatoryInvestments', window );">l) Investments</a></td>
<td class="text"><p id="xdx_840_ecustom--PolicyExplanatoryInvestments_zp92p4k14z53" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86D_zm2GPpW2ebch">l)
Investments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Investments in
associates are initially recognized at consideration transferred and adjusted thereafter for the equity method, being increased or reduced
from its interest in the investee's income after the acquisition date. An associate is an entity over which the Company has significant
influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is
not control or joint control over those policies.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory', window );">m) Accounts payable to selling shareholders</a></td>
<td class="text"><p id="xdx_840_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_z7Btth29dxk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_865_zjIKH8Rtxiph">m)
Accounts payable to selling shareholders</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">These amounts represent
liabilities related to the acquisitions made by the Company which are not yet due. Accounts payable to selling shareholders are presented
as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their
fair value and subsequently measured at amortized cost using the effective interest method.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory', window );">n) Provisions</a></td>
<td class="text"><p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zYxyM6o1glsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_862_zazXTRkSedzl">n)
Provisions</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Provisions are
recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow
of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount
of the obligation. The expense relating to a provision is presented in the statement of income, net of any reimbursement, when applicable.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DividendsPayablePolicyExplanatory', window );">o) Dividends payable</a></td>
<td class="text"><p id="xdx_842_ecustom--DividendsPayablePolicyExplanatory_z397t1pS5jC3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86E_z15jdl7MGCZ3">o)
Dividends payable</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company recognizes
a liability to pay a dividend when the distribution is authorized and the distribution is no longer at the discretion of the Company.
The distribution is authorized when it is required to pay a minimum dividend of the net income for the year in accordance with the Brazilian
Corporate Law (applicable for Afya Brazil) and the Company&#8217;s By-Laws or is approved by the shareholders. A corresponding amount
is recognized directly in equity.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsPolicyExplanatory', window );">p) Labor and social obligations</a></td>
<td class="text"><p id="xdx_84E_ecustom--LaborAndSocialObligationsPolicyExplanatory_zyuMWjV52mJk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_86B_zInMviYYmc74">p)
Labor and social obligations</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Labor and social
obligations are expensed as the related service is provided. A liability is recognized for the amount expected to be paid if the Company
has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation
can be estimated reliably.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharebasedPaymentsPolicyExplanatory', window );">q) Share-based payments</a></td>
<td class="text"><p id="xdx_846_ecustom--SharebasedPaymentsPolicyExplanatory_zmQw3Ia7vck7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_864_zEpxtV9J1cY">q)
Share-based payments</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain key executives
of the Company receive remuneration in the form of share-based payments, whereby the executives render services as consideration for
equity instruments (equity-settled transactions).</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The expense of
equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">That expense is
recognized in general and administrative expenses, together with a corresponding increase in equity, over the period in which the service
and, where applicable, the performance conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#8217;s
best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of income for a period
represents the movement in cumulative expense recognized as at the beginning and end of that period.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Service and non-market
performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company&#8217;s best estimate of the number of equity instruments that will ultimately vest. Market
performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated
service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award
and lead to an immediate expensing of an award unless there are also service and/or performance conditions.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">No expense is recognized
for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include
a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition
is satisfied, provided that all other performance and/or service conditions are satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">When the terms
of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided
the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any
modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.
Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately
through the statement of income.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The dilutive effect
of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory', window );">r) Revenue from contracts with customers</a></td>
<td class="text"><p id="xdx_847_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zIAU51gxhdvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_869_zuG4RQveJnAk">r)
Revenue from contracts with customers</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Tuition fees
and other revenue</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company's revenue
consists primarily of tuition fees charged for medical courses. The Company also generates revenue from tuition fees for other undergraduate
courses, student fees, certain education-related activities, digital education content and subscription of digital services.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenues are recognized
when services are rendered to the customer and the performance obligation is satisfied.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from tuitions
and digital education content are recognized over time when services are rendered to the customer and the Company satisfies its performance
obligation under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for
those services. Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Other revenues
are recognized at a point in time when the service is rendered to the customer at an amount that reflects the consideration to which
the Company expects to be entitled in exchange for the service. Other revenues are presented net of the corresponding discounts, returns
and taxes.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Printed books,
e-books, healthcare payments, online platforms and marketing for pharmaceutical industry revenues are transferred at point in time</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Revenue from sale
of printed books, e-books, healthcare payments, online platforms and marketing for pharmaceutical industry are recognized at the point
in time when control of the asset or services is transferred to the customer, generally on delivery of the goods at the customer&#8217;s
location and permission to access the digital content. The Company considers whether there are other promises in the contract that are
separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price
for the printed books and e-books, the Company considers the effects of variable consideration, financing component, noncash consideration,
and consideration payable to the customer to be not significant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
concluded that it is the principal in its revenue arrangements.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company assesses
collectability on a portfolio basis prior to recording revenue. Generally, students cannot re-enroll for the next academic session without
satisfactory resolution of any past-due amounts. If a student withdraws from an institution, the Company's obligation to issue a refund
depends on the refund policy at that institution and the timing of the student's withdrawal. Generally, the refund obligations are reduced
over the course of the academic term.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>&#160;</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Trade
receivables </i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Trade receivables
represent the Company&#8217;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before
payment of the consideration is due). Refer to accounting policies of financial assets in Financial instruments &#8211; initial recognition
and subsequent measurement.</span></p>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><i>Advances
from customers</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Advances from customers
(a contract liability) are the obligation to transfer services to a customer for which the Company has received consideration (or an
amount of consideration is due) from the customer, as a result of pre-paid tuition, digital education content and mobile app subscription
for digital medical content received from customers and is recognized separately in current liabilities, when the payment is received.
Advances from customers are recognized as revenue when the Company performs all obligations related to the contract, generally in the
following month.</span></p>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPolicyExplanation', window );">s) Taxes</a></td>
<td class="text"><p id="xdx_84F_ecustom--TaxesPolicyExplanation_z5qycgmF9NF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><span id="xdx_868_z8LSmzg94np6">s)
Taxes</span></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
Company&#8217;s subsidiaries joined the PROUNI (<i>Programa Universidade para Todos &#8211; </i>University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number
of student enrollment for low-income students, and benefits from the exemption of the following federal taxes:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
taxes and social contribution</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">&#8226;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PIS
and COFINS</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">The
regulation of PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS.
For income from other teaching activities, PIS and COFINS are charged at rates of <span id="xdx_907_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z6M7MuXIJc7j" title="Tax rate">0.65</span>% and <span id="xdx_90C_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zQWtielBNzl6" title="Tax rate">3.00</span>%, respectively, and for non-teaching
activities, PIS is charged at a rate of <span id="xdx_90D_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_znwbL7c5ouAg" title="Tax rate">1.65</span>% and to COFINS at <span id="xdx_905_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zW2vj2NmWk9b" title="Tax rate">7.6</span>%.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><i>Current
income taxes</i></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white">Current
income taxes were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service,
specifically regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Current income
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates
and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2.4
Changes in accounting policies and disclosures</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>&#160;</b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"><span style="font-family: Arial, Helvetica, Sans-Serif"><b><i>New
standards, interpretations and amendments adopted by the Company</i></b></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Certain amendments
apply for the first time in 2021, but do not have an impact on these financial statements of the Company.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The Company has
not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.</span></p>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsAndGoodwillPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsAndGoodwillPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsPayablePolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsPayablePolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PolicyExplanatoryInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PolicyExplanatoryInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharebasedPaymentsPolicyExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharebasedPaymentsPolicyExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPolicyExplanation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPolicyExplanation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_36_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for provisions. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy for restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 117<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_117_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 46<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_46&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for revenue from contracts with customers.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Section Presentation<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g105-109_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Section Disclosure<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;doctype=Standard&amp;dita_xref=IFRS15_g110-129_TI<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103294264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock', window );">The table below is a list of the Company&#8217;s subsidiaries and associate:</a></td>
<td class="text"><p id="xdx_891_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zsVPd9Duk2yg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BF_ziR2Bi73TCt4">The table below
is a list of the Company&#8217;s subsidiaries and associate:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Direct
    and indirect interest</b></span></td></tr>
  <tr>
    <td style="border-bottom: black 1pt solid; width: 37%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Name</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Principal
    activities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Location</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Investment
    type</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z9jrchiGBFF5" title="Name">Afya
    Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Holding</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Nova
    Lima - MG</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zfPPjlT6Kkgk" title="Direct and indirect interest of subsidiary">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z81sgS5rqk5d">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zlLqRdcvRFHg" title="Name">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. &#8211; (&#8220;ITPAC Porto&#8221;)</span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Porto
    Nacional - TO</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zuPMmw3wfPnh">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_z1gCmCNpQ22l">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zp8cDC89brzd" title="Name">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos S.A. &#8211; (&#8220;ITPAC Araguaina&#8221;)</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Aragua&#237;na
    - TO</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zZr780lHnMKj">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_znkcPDndLpHg">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zzgTEeAITCaf" title="Name">Uni&#227;o
    Educacional do Vale do A&#231;o S.A. &#8211; (&#8220;UNIVA&#199;O&#8221;)</span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    undergraduate degree program</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Ipatinga
    - MG</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zw9mKjXKumXe">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zmRXUq8RcCQf">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8lUk4TjP301" title="Name">IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Jo&#227;o Del Rei - MG</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zhgnUXrf9B6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8zMttg6TuG2">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Name">Instituto
    de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Parna&#237;ba
    - PI</span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zXZfBs9lbLO1">80</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7YhIBToUkM">80</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Name">Centro
    de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)</span></span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    undergraduate degree program</span></td>
    <td id="xdx_987_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Itajub&#225;
    - MG</span></td>
    <td id="xdx_989_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zk7AvKsTopUg">60</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zR74VG9GF9n4">60</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Name">Instituto
    de Ensino Superior do Piau&#237; S.A. (&#8221;IESP&#8221;)</span> </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Teresina
    - PI</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1Fvs8Tu0qc6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zZLxsFwTVQV4">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zwVz5DAgrVC4" title="Name">Centro
    Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;)</span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zG1GHFtBdDc3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Outpatient
    care</span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zMRPtND9HMda" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Teresina
    - PI</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z1bd0JojSvSc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zPlN4mLVXMO7">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSCfLmYxV9Yb">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Name">FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)</span></span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Pato
    Branco - PR</span></td>
    <td id="xdx_988_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5itm1udu7si">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zNoH6J07gun">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zkBXSmgej9Vl" title="Name">Medcel
    Editora e Eventos S.A. (&#8220;Medcel&#8221;)</span> </span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWoGVwZ1Oz6b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medical
    education content</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zqPXxGnD3Icg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo - SP</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zFwBFHa8TK04" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWJfl7mO54r3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zIlljRou1qXd">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Name">Instituto
    Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;)</span> </span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zR9XvVblqBO5">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zBhFtS1cPyhe">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zcNVhEYP8Hfe" title="Name">ESMC
    Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;)</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zqkBLT94ust2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zWFpXKcyaYOd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zU7GNr6Ahbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zKCrhOJip3sl">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zeAarzahU0Jb">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Name">Instituto
    de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;)</span> </span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Graduate</span></td>
    <td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Belo
    Horizonte - MG</span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zvAR6lnmH631">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ztIOR3UOML5c">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Name">Instituto
    Paraense de Educa&#231;&#227;o e Cultura Ltda (&#8220;IPEC&#8221;)</span> </span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    degree programs</span></td>
    <td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marab&#225;
    - PA</span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zH1ceiFsZORe">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z78wqHEKQT44">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zH1Gzov441T5" title="Name">Sociedade
    Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;)</span> </span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zVJVK8SqdCEg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zWzd9WRAle0g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Itaperuna
    - RJ</span></td>
    <td id="xdx_987_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z26iLiewMOH" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z1pSxbqLpV8l">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z5Vsjtwez8q7">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z70LPVoBpu08">Centro
    Universit&#225;rio S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)</span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zDt07DaWPUYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z6e62UX5uqmf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Porto
    Velho - RO</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zSfSL4ghqbGk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zbQoGUiBXOC4">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zl14O4MVUBc6">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zrRJ83407jc4">Peb
    Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda (&#8220;PebMed&#8221;)</span></span></td>
    <td id="xdx_989_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z3KxsZNZJoGl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Content
    and clinical tools and online platform</span></td>
    <td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z06r92Wpk1Mj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro - RJ</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zwx3gE8e7o43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zZt2n2mB702a">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zEE4E4yT3B7k">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zDKOv7iS51ak">Faculdade
    de Ensino Superior da Amaz&#244;nia Reunida &#8211; (&#8220;FESAR&#8221;)</span></span></td>
    <td id="xdx_98E_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zkzNYLFNvlBl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zOhtVFZD7Cc2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Reden&#231;&#227;o
    &#8211; PA</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zv89I1HV3Mg5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zZ4rlxgEK94a">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zNgRf63Of6va">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zSQVD7WjIOii">Centro
    Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)</span></span></td>
    <td id="xdx_98F_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zxFuJ4TzS5w9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medicine
    degree programs</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zDkL5P7ERIYh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Jo&#227;o
    Pessoa &#8211; PB</span></td>
    <td id="xdx_980_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zY9m1ORoDnhe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zBgCynWMyzV1">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zR3jOGXQjyJ2">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_z4sfZ27y49ra">MedPhone
    Tecnologia em Sa&#250;de Ltda. (&#8220;MedPhone&#8221;)</span></span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zaHBVqt7IaTj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Content
    and clinical tools and online platform</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zA7SEKHrLVP9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recife
    &#8211; PE</span></td>
    <td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zkt9e1J0G1X4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zHI2Dlz7iHsb">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zpOstkaWEOdg">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zpRgK3ImWPFi">iClinic
    Desenvolvimento de Software Ltda (&#8220;iClinic&#8221;)</span>*</span></td>
    <td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zFTwhzrx3nA5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Electronic
    Medical Record, Clinical Management System</span></td>
    <td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zlVXzC2ylHSe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Ribeir&#227;o
    Preto - SP</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_z9PqGrLMOxpc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zdySchrxCPId">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zvUNn2HMeB7b">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zw9QhWexOPuh">Medicinae
    Solutions S.A. (&#8220;Medicinae&#8221;)</span>*</span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z7ns4bSXQK7j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Healthcare
    payments and financial services</span></td>
    <td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zQIYUa5bVxn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro &#8211; RJ</span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z9CmVh0K3cab" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zxhSU6hdsAn6">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zBxcDO4O3SBe">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zPFJIz7hWfK6">Medical
    Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)</span> * </span></td>
    <td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zwIp9XAoADei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Educational
    health and medical imaging</span></td>
    <td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zQsGUFEXuomg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Florian&#243;polis
    &#8211; SC</span></td>
    <td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zDwHTzZawaUe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zLPKrY4fz6d8">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_ze1vu47f0fvb">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zzPOLeuN3OBb">Cliquefarma
    Drogarias Online Ltda.(&#8220;Cliquefarma&#8221;)</span>* </span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zSHLOXonvx2b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Online
    platform</span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zVJ2NnB1MVi9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zJmAfpqxLCHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zaTbbqTjOQW5">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zTxJp3vO7E3e">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zG3JXW9mztmd">Shosp
    Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)*</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zToBTjW2TyD7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Electronic
    Medical Record, Clinical Management System</span></td>
    <td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zEee92923w5d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Rio
    de Janeiro &#8211; RJ</span></td>
    <td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z1rUwDHM3Mo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zpPjmUPHeXp3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z5Wub04kkKe3">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_z9MzGbzDeRZi">Sociedade
    Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;) *</span></span></td>
    <td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zr807cyaagH8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zKTB5doQXmMi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Montes
    Claros - MG</span></td>
    <td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zYpJQ0andVK5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zSt9MOyTyqVk">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zOXOqP0yuHZi">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zMS6ni7bueL6">Companhia
    Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura. (&#8220;Unigranrio&#8221;) *</span></span></td>
    <td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zUIIelInsaR1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    and graduate degree programs</span></td>
    <td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_z89RRuYvrq6g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Duque
    de Caxias - RJ</span></td>
    <td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zQ2lR5fHJMZ2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zWwnDDV4gEU">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zDL0RjrJPfj7">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zR5zY0CnhaZ9">Policl&#237;nica
    e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;) *</span></span></td>
    <td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zsoPxbXMt8Wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Medical
    Care</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zpZ3ZVyRo7ji" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Duque
    de Caxias - RJ</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zWT8ia76dsc4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zUZ3PipdfPcl">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zm7Ac6Qd74Y5">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zYZa9ItnOA7h">Sociedade
    Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) *</span></span></td>
    <td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zgFnX4WgFzXg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Basic
    Education</span></td>
    <td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zFx7qQwnQvm8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Palho&#231;a
    - SC</span></td>
    <td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zp4mHnx9s383" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6LF5Q7lAzml">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6RXromp2B59">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zUfp5LnGTZQ6">Instituto
    de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) *</span></span></td>
    <td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zbwI988zz4Wi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zxUZTVNXxla1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Palho&#231;a
    - SC</span></td>
    <td id="xdx_981_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_z2tNX8hq96D6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zfk7rzN3pg6j">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zJs3gY7NUhv">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zzEuP4VgRLy2">RX
    PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)</span></span></td>
    <td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zQgX8XxTHMK9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marketing
    for pharmaceutical industry</span></td>
    <td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zvgcWDbNbM22" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zmObsQxJcxGj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zyMXF4luwsq3">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_z1uMVf24jDik">100</span>%</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zl6TCLqYadkd">RX
    PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)</span></span></td>
    <td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zfsA4FvRPL0h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Marketing
    for pharmaceutical industry</span></td>
    <td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zYcbgW51QvLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">S&#227;o
    Paulo &#8211; SP</span></td>
    <td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zMnXUPAy3qbc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Subsidiary</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zO1th5XT7Tgb">100</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zcIYkH7cioyc">100</span>%</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zvcJDpsfLF3">Uni&#227;o
    Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;)</span> </span></td>
    <td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zLLXEsOvus75" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Undergraduate
    degree programs</span></td>
    <td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zdlQVhNz98i5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Bras&#237;lia
    - DF</span></td>
    <td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAnRWBRjJ3Tj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Associate</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zWfviYY5pRLb">30</span>%</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_z3F8ZHPm91Zh">30</span>%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">* See Note 5 for
further details of the business combinations during 2021.</span></p>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfEstimatedUsefulLives', window );">Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zgTXvHbXwfZh">Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Building</span></td>
    <td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1237">25
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Machinery
    and equipment</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1238">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Vehicles</span></td>
    <td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1239">4
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Furniture
    and fixtures</span></td>
    <td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1240">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">IT
    equipment</span></td>
    <td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1241">5
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Library
    books</span></td>
    <td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1242">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Laboratories
    and clinics</span></td>
    <td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1243">10
    years</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">Leasehold
    improvements</span></td>
    <td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"><span style="-sec-ix-hidden: xdx2ixbrl1244">20
    years</span></span></td></tr>
  </table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103292024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Segment information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory', window );">Schedule of assets and liabilities information for the company's operating segments</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zUXaad5h7Mt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
presents assets and liabilities information for the Company&#8217;s operating segments as of December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span id="xdx_8BD_z6Dl3226OiKg" style="display: none; visibility: hidden">Schedule of assets and liabilities information for the company's operating segments</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_984_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8MLTeLTx8Eg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,072,135
    </b></span></td>
    <td id="xdx_98E_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbVFzSw7bDIh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>105,629</b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3yTtB30bp4f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>272,122</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuz4SrTqbpZg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,449,886</b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zVZBuUmI6Jl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,480)</b></span></td>
    <td id="xdx_983_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCZHCBnPwmC3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,447,406</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCiYwv2SGRb2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,048,869</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSH91O5qMXPh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,737</span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVxSdq2WUk5c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">117,726</span></td>
    <td id="xdx_98D_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziklBiCLTjgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,209,332</span></td>
    <td id="xdx_98F_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU9TCYrspu92" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,480)</span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvNdOu3kDsO6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,206,852</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7XcCkhEw8Ae" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,023,266</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zA5VsNbylyS" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,892</span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6nefN7y2TRa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">154,396</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkVTThyKJ84j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,240,554</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zitjGMD2cAI5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1306">&#160;</span>-</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zp1ta45AlkXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,240,554</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7DmuYsO6lZ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,072,135</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zP4GuCZng308" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>105,629</b></span></td>
    <td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXnKRcfMoZu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>272,122</b></span></td>
    <td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdf9esFrs6Vi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,449,886</b></span></td>
    <td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGGsJ8njCp6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,480)</b></span></td>
    <td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfIsZb6DBfki" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,447,406</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z73qH9UhnQMb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">645,657</span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfbTKIYCgO4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,300</span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzXJcgzmKX24" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91,029</span></td>
    <td id="xdx_984_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyNFrZLEm6b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">768,986</span></td>
    <td id="xdx_988_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z9Y0teMUP8hc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;(2,480)</span></td>
    <td id="xdx_986_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL785sASxyQj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">766,506</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zMh8wjNmNWph" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,551,175</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVkQP8DwOvo2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">47,705</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znm34ac8P3fd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82,002</span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJofVDjsfYvl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,680,882</span></td>
    <td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMP1pP9NayAe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1328">&#160;</span>-</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeODj5QqzXEj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,680,882</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_98B_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zNPkui3JDCXb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,875,303</span></td>
    <td id="xdx_984_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLV03pSCs0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,624</span></td>
    <td id="xdx_989_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zhSqjOhCy4kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99,091</span></td>
    <td id="xdx_980_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zo9OCkJrIsqc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,000,018</span></td>
    <td id="xdx_98C_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zRZ9hVcHk6sf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1335">-</span></span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zudpHTwC1Sda" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,000,018</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxW6GOyh5p6a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td>
    <td id="xdx_982_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXztkO1pXN8c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1339">-</span></span></td>
    <td id="xdx_981_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zlgayYjOO0Xl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1340">&#160;</span>-</span></td>
    <td id="xdx_987_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYk7FhznPFY6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td>
    <td id="xdx_986_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zV9f0OAq88Kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1342">&#160;</span>-</span></td>
    <td id="xdx_984_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfLt9c28re4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,477</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F43_zEiPbqoS5K5k">(*)</sup></span></td>
    <td id="xdx_982_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_z8Z07kclveO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">220,202</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zOHURYnnL0hj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,682</span></td>
    <td id="xdx_98F_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zj2qXv5ttDLc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,095</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_z5zVSU1kxZ9c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">301,979</span></td>
    <td id="xdx_981_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zOUZ2Z6wHbk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1349">&#160;</span>-</span></td>
    <td id="xdx_989_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_zi078UuCD8pe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">301,979</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    assets</b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVM7VrXO608a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,541,988
    </b></span></td>
    <td id="xdx_981_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgIQqf9KZOw2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,300
    </b></span></td>
    <td id="xdx_98F_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBrPaJfVEQX" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182,920
    </b></span></td>
    <td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmcTOdyXAnV1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,208
    </b></span></td>
    <td id="xdx_98D_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTHUBYo8pXS1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(115)</b></span></td>
    <td id="xdx_98A_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIshRjt5PAn3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,093
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    assets</span></td>
    <td id="xdx_980_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlYP8VQec1Mk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,280,342
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeRXNhOfbFFh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,119
    </span></td>
    <td id="xdx_986_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zwTtaq8T745l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">85,155
    </span></td>
    <td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKj5GPP3vy68" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,405,616
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsxs1kTY0l7g" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(115)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zakpQFwpXwT2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,405,501
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    assets</span></td>
    <td id="xdx_984_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zWNHMq6L4Tkj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,261,646
    </span></td>
    <td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTdLd7DQ7cgb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,181
    </span></td>
    <td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ze5H4zjymO34" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">97,765
    </span></td>
    <td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIofv54SBTtf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,387,592
    </span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z6rLjJ6vCvi4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,387,592
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    liabilities and equity</b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLXdI8yhvmak" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,541,988
    </b></span></td>
    <td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOroIN3xZ24b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,300
    </b></span></td>
    <td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ztksHlB6YDT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182,920
    </b></span></td>
    <td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zEXJwQlkTYr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,208
    </b></span></td>
    <td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zBuTUknHMrZ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(115)</b></span></td>
    <td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfgSZbUDFxJ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,793,093
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Current
    liabilities</span></td>
    <td id="xdx_980_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeFbQFXF3xR9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">522,523
    </span></td>
    <td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zZcVnQoBRGV7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,491
    </span></td>
    <td id="xdx_989_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zebGn39LZbCb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52,480
    </span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkz0YGcVv4l7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">589,494
    </span></td>
    <td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zWpbe1lNJVR5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(115)</span></td>
    <td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKQeG0M01CU8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">589,379
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Non-current
    liabilities</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zfTLFbhfvCF1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,261,894
    </span></td>
    <td id="xdx_989_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwEQrwHchIYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">40,763
    </span></td>
    <td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2GNB2dTMx56" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,277
    </span></td>
    <td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZAp55oRudYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,369,934
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zEewhR4q3msk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,369,934
    </span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Equity</span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z5ZIZhCCkTj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,757,571
    </span></td>
    <td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z6yHBhIeJSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,046
    </span></td>
    <td id="xdx_986_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEK6hJIjxKN5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">63,163
    </span></td>
    <td id="xdx_982_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQfDgxPUEnhi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,833,780
    </span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrtD1T8lsJq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,833,780
    </span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Adjustments
    and eliminations</b></span></td>
    <td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other
    disclosures</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Investments
    in associate</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhMOYSlizIT5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfgWOhPRxtxj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo5DwTYI56Q8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,410</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Capital
    expenditures <sup id="xdx_F4C_zBxKJImE4Crc">(*)</sup></span></td>
    <td id="xdx_98A_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_zMVvAvt1rHAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">83,256</span></td>
    <td id="xdx_988_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zazZPeAwVhs1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,638</span></td>
    <td id="xdx_98E_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zAimAi2DWkI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,587</span></td>
    <td id="xdx_980_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_zxE3Uosvryii" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">109,481</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_z03yDhCO92Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">109,481</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 35pt; text-align: right"><span id="xdx_F0C_zR84OS3BjgG3" style="font-family: Arial, Helvetica, Sans-Serif">(*)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_ziC9kXBmC7V2" style="font-family: Arial, Helvetica, Sans-Serif">Capital expenditures consider
the acquisitions of property and equipment and intangible assets.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory', window );">Schedule of operating income for each operating segment</a></td>
<td class="text"><p id="xdx_896_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zsa5CU9Jbtv4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The following tables
present the statements of income for the Company&#8217;s operating segments for the years ended December 31, 2021 and 2020:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zjn7d2J1ixD2" style="display: none; visibility: hidden">Schedule of operating income for each operating segment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_981_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zmCnusGSmTfg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,498,408</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQIOTgtMh26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">72,983</span></td>
    <td id="xdx_980_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP54ICgmDHU7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,980</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zK07raONaxBh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcfR1uGvSje5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1419">-</span></span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09UC1Zy5hn" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,719,371</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zw5AvcJretxf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1423">-</span></span></td>
    <td id="xdx_984_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zNSYD9ibSAMj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1424">-</span></span></td>
    <td id="xdx_98B_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0tl7xWgZSBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_982_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zO22ITfRij4b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_989_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z6xohWGDzlxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,978)</span></td>
    <td id="xdx_98D_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn66q1dembFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1428">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_ztPUOoJKQnmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,498,408</b></span></td>
    <td id="xdx_98A_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRp5ZA1qfWih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>72,983</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJnYCEH3PiY2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>151,958</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ztEZXNY4shc3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,723,349</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zKZd8vNxlyda" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,978)</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfHKcGZgZhA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,719,371</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zx3qtbk8jZNk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(554,995)</span></td>
    <td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zyT8JV2Gp2U2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,773)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zqDEZH2cnAag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(50,510)</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z66YXzCxRKh7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(656,278)</span></td>
    <td id="xdx_980_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zur3vkJqsUf7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,978</span></td>
    <td id="xdx_981_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlYx00wRNTQe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(652,300)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z9QS1YcnAoP2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>943,413</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrBxOB0cCMi9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>22,210</b></span></td>
    <td id="xdx_989_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z9H6NAmQohve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>101,448</b></span></td>
    <td id="xdx_981_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhu6XTtM69Sk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td>
    <td id="xdx_983_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zLGmCzyOfPOc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1448">-</span></b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlW6DFTP8wj5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,067,071</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYDcXnseYfuk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(622,615)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    income, net</span></td>
    <td id="xdx_98E_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zwAh4f6K9YW5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1452">-</span></span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zK48EaYqAVOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1453">-</span></span></td>
    <td id="xdx_98A_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvFclGluazB7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1454">-</span></span></td>
    <td id="xdx_989_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYvCHApM9xM5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1455">-</span></span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zatEsAm3vxq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1456">-</span></span></td>
    <td id="xdx_984_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBH76Aw3eNwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,561)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zPLBOq91G2Rg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1459">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOFVsb2qbo7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1460">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znKL3ekNOds1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1461">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfFwq4OQufba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1462">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSYy2ypOt0Fl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1463">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDnIGbt5P0vk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>440,895</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td id="xdx_98E_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zZqpsQUYwAZj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1466">-</span></span></td>
    <td id="xdx_98A_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSITHa1kksR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1467">-</span></span></td>
    <td id="xdx_985_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zbQJAAMWjr9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1468">-</span></span></td>
    <td id="xdx_988_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuLoiW7eLipg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1469">-</span></span></td>
    <td id="xdx_98B_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4v3e95oYAil" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1470">-</span></span></td>
    <td id="xdx_98F_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54jzkPM69a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,566</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td id="xdx_982_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbXTcDAbzuue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1473">-</span></span></td>
    <td id="xdx_98F_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbP00rn6ptme" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1474">-</span></span></td>
    <td id="xdx_981_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFT7e649bJm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1475">-</span></span></td>
    <td id="xdx_987_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSnJm8O1U3G8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1476">-</span></span></td>
    <td id="xdx_98E_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zQV7Jyq4FzOe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1477">-</span></span></td>
    <td id="xdx_98A_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFv2ki8MtSkh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(243,796)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVeZqdFjTOF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1480">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zq3wPYfIg6A6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1481">-</span></span></td>
    <td id="xdx_987_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zdqkjn5rkXlh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1482">-</span></span></td>
    <td id="xdx_986_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zv9SJIrkjH6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1483">-</span></span></td>
    <td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znauMNkCHoFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1484">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGFvtvNu9mU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,797</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td id="xdx_98B_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zXocjNwis6fa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1487">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zG5u25ptKUwl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1488">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAP6Gsmv2A1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1489">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk12QYpcqIQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1490">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zIW64Gu5WRx8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1491">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z9wnRO1YUqL8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>273,462</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLC2mhBVl89k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1494">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRZMGfEXIET9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1495">-</span></span></td>
    <td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVJ1BEjQ8KHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1496">-</span></span></td>
    <td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zANwLJS6iHo3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1497">-</span></span></td>
    <td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4o67f8H9fc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1498">-</span></span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM9XoS9scxrd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,179)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrcm1bEkq25f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1501">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zapeaLWLGu58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1502">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3V2t2MyAd77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1503">-</span></b></span></td>
    <td id="xdx_98D_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zsVVHwddoLa2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1504">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsnawhcfXuza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl1505">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUctAe4vVO5c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>242,283</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDC8UDO21mWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,002,461</span></td>
    <td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zEcx1To2S5m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">107,197</span></td>
    <td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zCH41Ch9sFRh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">91,533</span></td>
    <td id="xdx_984_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfpKqpzJfUT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,201,191</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_982_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNl0cA8uXSQl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,201,191</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXBGfLYjAsS1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_980_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6CYVJGfNnsc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_98E_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcBy1toXIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,619)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98B_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zEkbeKC8ZqCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,002,461</b></span></td>
    <td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zo1e8oIrAxHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>107,197</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvwSFLaOvOs3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>93,152</b></span></td>
    <td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zywJFkXLb6Jl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,202,810</b></span></td>
    <td id="xdx_983_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zO6vs1JNkWRl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,619)</b></span></td>
    <td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcXG2AIYDrG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,201,191</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeCn3gsLjny3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(381,964)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwL2IG2m6mok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(40,000)</span></td>
    <td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zsUj6uQQ7cWd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,309)</span></td>
    <td id="xdx_982_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zybx7Xnboczd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(436,273)</span></td>
    <td id="xdx_987_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU3lLMUxiZpf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,619</span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOHk0pFEBM2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(434,654)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zelGlg74jymd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>620,497</b></span></td>
    <td id="xdx_987_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJO5ZwVr7Mt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>67,197</b></span></td>
    <td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znsxjwm2z3lc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>78,843</b></span></td>
    <td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdcwavh3dSy2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>766,537</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM6vuMDtlXz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>766,537</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn6SsoOwGUxl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="General and administrative expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(402,855)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--OtherGainsLosses_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJFBo8Q9APe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(347)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNoO3yoMY3O3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>363,335</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--FinanceIncome_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zU6qk3y1QKU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,290</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHlk40GClwb4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(98,269)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyAfEr5VyH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,698</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_989_eifrs-full--ProfitLossBeforeTax_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLEu9Zpk7vNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>335,054</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zi8fEVN7iCmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(27,067)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98A_eifrs-full--ProfitLoss_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLik8i0J3mTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>307,987</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    reportable segments</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">External
    customer</span></td>
    <td id="xdx_98F_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zoqVZTyudwld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">653,760</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhdvTR31m8K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">64,870</span></td>
    <td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zykdxQd49jg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,000</span></td>
    <td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSRuobNwycId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">750,630</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQ2kRrUNrq3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">750,630</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inter-segment</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2Q5Ljpj6918" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_98A_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zRdQikltGF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm42aORow3vb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,880)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    revenue</b></span></td>
    <td id="xdx_98C_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhoksJcN7Vu5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>653,760</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvGXbNp8r0h1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>64,870</b></span></td>
    <td id="xdx_980_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAZqhNaTN5g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>35,880</b></span></td>
    <td id="xdx_986_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7wlWUORR2K4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>754,510</b></span></td>
    <td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ziVhZtMXnQ5j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,880)</b></span></td>
    <td id="xdx_98E_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmUAZA7lHE82" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>750,630</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cost
    of services</span></td>
    <td id="xdx_98D_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPnzwgkBt38" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(279,066)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zh9iqzRdBhV8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(29,261)</span></td>
    <td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z60TTF6PBJdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,406)</span></td>
    <td id="xdx_98F_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAy7VCyaMOY6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(312,733)</span></td>
    <td id="xdx_989_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zhseQ1vqhRZ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,880</span></td>
    <td id="xdx_98E_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdd4gtywTZM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(308,853)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Gross
    profit</b></span></td>
    <td id="xdx_98F_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxEUKwLLX7Eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>374,694</b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdZiUuhYcQT9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>35,609</b></span></td>
    <td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrNW4RggKXLf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,474</b></span></td>
    <td id="xdx_984_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zNcqykE2YGdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>441,777</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_988_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zu2MRhWGTqd9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>441,777</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HwfjymDrrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(239,120)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    expenses, net</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--OtherGainsLosses_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8Lo6rOZeQPl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,594</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Operating
    income</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOepLPYaDEV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>205,251</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    income</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--FinanceIncome_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3DWf5MzwPCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,689</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Finance
    expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--FinanceExpense_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5xhI8ZChiL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(72,365)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Share
    of income of associate</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98C_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zS5vJ0Cwy856" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,362</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Income
    before income taxes</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWiU1UMM1rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>186,937</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Income
    taxes expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKsLvStPHT25" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,175)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    income </b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-</b></span></td>
    <td id="xdx_98E_eifrs-full--ProfitLoss_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXJCMcLQLWZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>172,762</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfOperatingSegmentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of operating segments. [Refer: Operating segments [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfOperatingSegmentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670099782376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock', window );">Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_zydnIkVgntta" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The preliminary
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zzwDCBsCntad" style="display: none; visibility: hidden">Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>iClinic</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medicinae</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Medical
    Harbour</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Cliquefarma</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Shosp</b></span></td>
    <td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unifipmoc</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Unigranrio</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>RXPRO</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zwtIXfJ3G7ag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,659</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zVjH5L39Ijak" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">201</span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zcbD4US4ZI4b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">47</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8C0vggHKqp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,009</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zYBnfQ05a0m1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">397</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zjmZh8ccMdGi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,140</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zwrrlblXCHTf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34,755</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHLyohhr0NGc" style="text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">91</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Restrict
    cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCash1_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zNztwnmvO589" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,050</span></td>
    <td id="xdx_98E_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zKdPH7Lzqlfe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1614">-</span></span></td>
    <td id="xdx_98A_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zgYRJOmTnsGb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1615">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z0GN1GUgLeQ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1616">-</span></span></td>
    <td id="xdx_984_ecustom--RestrictedCash1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zf8c1xQUgfr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1617">-</span></span></td>
    <td id="xdx_983_ecustom--RestrictedCash1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z53WzDOYrQ24" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1618">-</span></span></td>
    <td id="xdx_989_ecustom--RestrictedCash1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhzp36kGiWff" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1619">-</span></span></td>
    <td id="xdx_98F_ecustom--RestrictedCash1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zieeKPxVQcek" style="vertical-align: top; text-align: right" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1621">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    receivables</span></td>
    <td id="xdx_983_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zeVTSSHngSx9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,201</span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXCFVs0Xu2L8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1623">-</span></span></td>
    <td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zBh5ZZqtVXNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">159</span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSFPUvTrubR" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">501</span></td>
    <td id="xdx_986_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z9lKAvNygxB3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1626">-</span></span></td>
    <td id="xdx_98C_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zWR5hDBQBICg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34,309</span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zBe7w78O3lGg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">26,622</span></td>
    <td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zrZDNwOCHD54" style="vertical-align: top; text-align: right" title="Trade Receivales"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,211</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Inventories</span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zd4d5QuWRw3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1631">-</span></span></td>
    <td id="xdx_98F_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zCXBH1g6JvDc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1632">-</span></span></td>
    <td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zW5s2DvyuqR2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1633">-</span></span></td>
    <td id="xdx_985_ecustom--Inventories1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVqNE2o83APb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1634">-</span></span></td>
    <td id="xdx_984_ecustom--Inventories1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zWfUYfMxl3C2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1635">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zj95J1ynNjk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1636">-</span></span></td>
    <td id="xdx_988_ecustom--Inventories1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z3E4BawG4hb7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">352</span></td>
    <td id="xdx_986_ecustom--Inventories1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWxpeUjQ2QLh" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">246</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Recoverable
    taxes</span></td>
    <td id="xdx_987_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zjwdwX6QW9Z3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">72</span></td>
    <td id="xdx_989_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zmivR5K0WOMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">15</span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zTydqBTDti8k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1641">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfUwAObNp3g5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1642">-</span></span></td>
    <td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zvdJYDeaW7f5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_98F_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2kbPWa7BN4k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,295</span></td>
    <td id="xdx_98E_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zudRuLdAgU93" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">738</span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zNNWkT7XpOzc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">112</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    assets</span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zahU2d5tvIm2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">20</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_ztZkd1LjYYf2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1648">-</span></span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zjfiFhVkEIVh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2</span></td>
    <td id="xdx_987_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z4eG2MnZr7z4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1650">-</span></span></td>
    <td id="xdx_989_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOBHJcyVMtvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1651">-</span></span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2xNKVXvi7Nk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">702</span></td>
    <td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqJqfmsJCYFg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">12,159</span></td>
    <td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zC49thdaxI1" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">366</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Right-of-use
    assets</span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGTZCOqWuLCh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">88</span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9EegalhAM4j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1656">-</span></span></td>
    <td id="xdx_989_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z8EbQAtPTm47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1657">-</span></span></td>
    <td id="xdx_98C_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1bFVKAnQd59" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1658">-</span></span></td>
    <td id="xdx_98A_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zARWkuDMhblk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1659">-</span></span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zuIMjs6QsTPl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">52,079</span></td>
    <td id="xdx_985_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z0b35cYRyEx8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,265</span></td>
    <td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeUHmVdTTi67" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">82</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Property
    and equipment</span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zOWnSveQdmce" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">473</span></td>
    <td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zx352TrGEWag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">17</span></td>
    <td id="xdx_981_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zzVhGoC0Xg2h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">34</span></td>
    <td id="xdx_98F_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zlQBXOr4eWn6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1666">-</span></span></td>
    <td id="xdx_98A_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zocZsUxXX5cc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5</span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2qNOwYggSN9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">24,277</span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zrwg6iWBjLw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">40,775</span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeof2tPnW995" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">42</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Indemnification
    assets</span></td>
    <td id="xdx_98A_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zv3egaittoJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,252</span></td>
    <td id="xdx_986_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zhwse1stMJHk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1672">-</span></span></td>
    <td id="xdx_988_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zKKImePLzdXd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1673">-</span></span></td>
    <td id="xdx_987_ecustom--ImdemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXgs5yFqUBYe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1674">-</span></span></td>
    <td id="xdx_98F_ecustom--ImdemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zsw5pfgHZT43" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1675">-</span></span></td>
    <td id="xdx_981_ecustom--ImdemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zDRFWaVLS3d3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,331</span></td>
    <td id="xdx_989_ecustom--ImdemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zCgsmKa5V7Ef" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,669</span></td>
    <td id="xdx_983_ecustom--ImdemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zAp8B8hM9Pud" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1678">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Intangible
    assets</span></td>
    <td id="xdx_98A_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zyb3aTKfykM" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">84,987</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zz0kTozBblrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,518</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zeZhfZMc8GWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,359</span></td>
    <td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zioBiHHzsfe9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">14,991</span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zriVEy5xOCVi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,856</span></td>
    <td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zwOqcnJIIl3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">227,534</span></td>
    <td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zykk4coI7tZ1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">510,356</span></td>
    <td id="xdx_984_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6NkOBisldk" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,330</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z71bJDBx7DZa" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>95,802</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zB6vm6TmLgAh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,751</b></span></td>
    <td id="xdx_982_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z2vBKqRH3msl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,601</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8E0bvGY4JOh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>16,501</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_znZ2IPsbb6Rf" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,259</b></span></td>
    <td id="xdx_98C_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zRg1SJE6uyug" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>353,667</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9DniEVSUVUe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>784,691</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zt1RhNgaWt41" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>8,480</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Liabilities</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Trade
    payables</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zHyuniKOR8Gc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">619</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zdTd0tjSGTOe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1697">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zlaVkoIDPUV7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6</span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zELVprZOvSCb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">8</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHmGIWxJ7K76" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z7rixxBoo4ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">985</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z2P9gdvJ5562" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,197</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHJDs8hDFZU" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,060</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Loans
    and financing</span></td>
    <td id="xdx_986_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zrLa6f2WZfx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1704">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zzwGdN7xpwg6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1705">-</span></span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqCe2W0GYrK8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">299</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zcsDoYotJ8bd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">580</span></td>
    <td id="xdx_989_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRX9dZLrAnwd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1708">-</span></span></td>
    <td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zyY8xHlPVuYj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,179</span></td>
    <td id="xdx_987_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z8srDnSSSLPd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,533</span></td>
    <td id="xdx_988_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zO4SBH3HkqVj" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1711">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Labor
    and social obligations</span></td>
    <td id="xdx_98D_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zxBXGgCVmZN1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,414</span></td>
    <td id="xdx_980_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGJ8vzV5Hgn9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">159</span></td>
    <td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zscuFA8FckCg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4</span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAz4Rw6Ppf28" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">102</span></td>
    <td id="xdx_982_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHBV1pZQGxJf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">89</span></td>
    <td id="xdx_989_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zKcCjT8avFTf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,306</span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zGfJeCs9zGyd" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">22,854</span></td>
    <td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjaIwr2y9IGc" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">62</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Taxes
    and contributions payable</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zZ2fFPO8qXRk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">77</span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zT0hxQ8OtVT5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4</span></td>
    <td id="xdx_988_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zCvkX8wJW2Z1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZlRzKlQMxuj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">307</span></td>
    <td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zMvUPcZCGE3h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">123</span></td>
    <td id="xdx_98B_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zhGOF4ZB06ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">758</span></td>
    <td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcyrqeVSsOW" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">94,025</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwJ4tKmzGUne" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">100</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_986_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zst7tNJVY892" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,252</span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z7Auj4CvUws8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1729">-</span></span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zYQaVSrSikLf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1730">-</span></span></td>
    <td id="xdx_98E_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zCwmqBkOFFhk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1731">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zVOWJ7pb1424" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1732">-</span></span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zABEDqCX9bDh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">7,331</span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zh6PfGp51iO5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,669</span></td>
    <td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7NhuwDPUMac" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1735">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Leases
    liabilities</span></td>
    <td id="xdx_98C_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zz2G1gzJu8Zg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">88</span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zMIxg8UbmN01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1737">-</span></span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zuolztjgJEo4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1738">-</span></span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMs3ElPuT71l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1739">-</span></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zmHwWPACyx3k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1740">-</span></span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zUWygh0obg88" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">52,079</span></td>
    <td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zQ0bsuMLl7W7" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,265</span></td>
    <td id="xdx_985_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zxVMSx2HBQI6" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">82</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Advances
    from customers</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zX797RaT5Ks4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">400</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfyXM4VTDP86" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1745">-</span></span></td>
    <td id="xdx_98C_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znXXtY9MmHu3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">35</span></td>
    <td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zhNUe6QghYgb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zGDrZLhSggEg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">167</span></td>
    <td id="xdx_987_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zyLgGLgo3HN6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,745</span></td>
    <td id="xdx_985_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zNEU8656p6q5" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,387</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zhX4veV1vLvi" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1751">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Other
    liabilities</span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zgN3yNmWV7gg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1752">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9JsKcrvvmc1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1753">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zEi88OnO4qLk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1754">-</span></span></td>
    <td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfkXz9Qo5wdg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1755">-</span></span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z4FRKRt54z7d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1756">-</span></span></td>
    <td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zYdl9FwFsuH8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,739</span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9clBQgJw7bk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,878</span></td>
    <td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7IYuGaEO33g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1759">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKmsXmnA3HDk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>3,850</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zBIzYz5VHy2d" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>163</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z4wBUrWQ0I46" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>345</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZP5K2Holqg4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,000</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHyaH5AG0dp3" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>380</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zmz8P8Vdlgd2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>113,122</b></span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zolJcRpEOWP6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>295,808</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwYTYNoj2ET8" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>1,304</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zQ5fxvqaoCme" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>91,952</b></span></td>
    <td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zxuvaSVFlEzb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,588</b></span></td>
    <td id="xdx_98C_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_ziV6wP4QOr5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,256</b></span></td>
    <td id="xdx_98D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSGev9bCEwH1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>15,501</b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFtch7xFbYzj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>4,879</b></span></td>
    <td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zsYEBLuwSoNf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>240,545</b></span></td>
    <td id="xdx_980_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXtLcknO5EAg" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>488,883</b></span></td>
    <td id="xdx_984_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcG7RIuGVhwe" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,176</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Preliminary
    goodwill arising on acquisition</span></td>
    <td id="xdx_981_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_znce3FcKtQsh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">99,168</span></td>
    <td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zsiWkqMxBvH9" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,584</span></td>
    <td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z7ykbSwRV2i6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,022</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMCOxUv89k2e" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,588</span></td>
    <td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHZfHTtw9xTd" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,022</span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcU7nPSexrBi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">87,777</span></td>
    <td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqkOjB8qam4f" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">130,073</span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zflnfEBkbVXi" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">38,446</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z0FJUEIRMIB" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>191,120</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXdvMFXObbF1" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>9,172</b></span></td>
    <td id="xdx_986_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zNNpCFcNaWL7" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>11,278</b></span></td>
    <td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAnlV0Sfo0pa" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>22,089</b></span></td>
    <td id="xdx_989_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zLEjf5DEkY7b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>7,901</b></span></td>
    <td id="xdx_983_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z5eFVhCWgPrb" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>328,322</b></span></td>
    <td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zk2KNwWadx7a" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>618,956</b></span></td>
    <td id="xdx_98F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqwmsWOsXJj4" style="border-bottom: black 1pt solid; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>45,622</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid</span></td>
    <td id="xdx_981_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_ziedsoW7DRfc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">119,620</span></td>
    <td id="xdx_988_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGFhSIdhnFw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,600</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqmJhiEXno4a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,000</span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1ajmlEGDBOj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">16,166</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zEHlO2PsFFp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,855</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zVBQ0DlyNpyb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">328,322</span></td>
    <td id="xdx_98A_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zDh1LzvYiCw1" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">375,670</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z3r0KnrEwN0f" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,263</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Contingent
    consideration</span></td>
    <td id="xdx_982_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_fKCoqKQ_____zW2ibgJpQ7T2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1801">-</span></span></td>
    <td id="xdx_986_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_fKCoqKQ_____zPrB9eUny0Ic" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,572</span></td>
    <td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_fKCoqKQ_____zjX9spV1fQJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">6,278</span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_fKCoqKQ_____zWJYWKHdKVb1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">2,923</span></td>
    <td id="xdx_98D_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_fKCoqKQ_____z00b5mTAh6p3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">1,592</span></td>
    <td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCop_zLrJMURP4RN5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(*)</sup><span style="-sec-ix-hidden: xdx2ixbrl1806">-</span></span></td>
    <td id="xdx_98C_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCoqKQ_____zVozj4iDnJxi" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><sup>(**)</sup><span style="-sec-ix-hidden: xdx2ixbrl1807">-</span></span></td>
    <td id="xdx_98F_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_ztlNmgAuuiBf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,171</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Consideration
    to be transferred</span></td>
    <td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zfbJEFzkrZ4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1809">-</span></span></td>
    <td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zau9Y5BOJrUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1810">-</span></span></td>
    <td id="xdx_984_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zvQN9Axx6S9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1811">-</span></span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zDNakicKC1Qe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1812">-</span></span></td>
    <td id="xdx_98B_ecustom--ConsiderationToBeTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztsvu9qpEzc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">454</span></td>
    <td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXy56yRKZ931" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1814">-</span></span></td>
    <td id="xdx_98A_ecustom--ConsiderationToBeTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zF98bEbiNrCk" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">243,286</span></td>
    <td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z05PCzDawVr8" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">76</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Paid
    in shares</span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zDU5SDBtFKJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">71,500</span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGLHuYT9RL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1818">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zOtjBnq9pXhg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1819">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zS1QabTYdYi4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">3,000</span></td>
    <td id="xdx_983_ecustom--PaidInShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zUQQ8lm8aMN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1821">-</span></span></td>
    <td id="xdx_982_ecustom--PaidInShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhG2fcFWoNj8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1822">-</span></span></td>
    <td id="xdx_985_ecustom--PaidInShares_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zOo0CHhdQvlh" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><span style="-sec-ix-hidden: xdx2ixbrl1823">-</span></span></td>
    <td id="xdx_98C_ecustom--PaidInShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zfUxgugHQiLl" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,112</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Transaction
    costs of the acquisition (included in cash flows from operating activities) </span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zJqasYn0v6E3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">856</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfk8yIcx9Ja7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">117</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zIkvr0M6W70k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">144</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zmaeklgwo2N7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">336</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zhZnuJNf67V6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">188</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXkSvbiwoFE4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">177</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zqWQTSjixGyf" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">10,990</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6E6LnOQXhfa" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">264</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">Cash
    paid net of cash acquired with the subsidiary (included in cash flows from investing activities)</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKt7oPmwaHL" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">117,961</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z0mdhm7MiaX9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,399</span></td>
    <td id="xdx_98E_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z62Vu9TOlMUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">4,953</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfhBVCCMM4ee" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">15,157</span></td>
    <td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zNTt7VALLe8d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">5,458</span></td>
    <td id="xdx_988_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zD8KWoqdhRrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">322,182</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z48woKyFJInc" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">340,915</span></td>
    <td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zucUHqr8J9w2" style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt">30,172</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGa3sfVuzh6c" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>118,817</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zSbdbol3fAH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,516</b></span></td>
    <td id="xdx_988_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrUqBedfIAy6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,097</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXnvrcDlKGs1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>15,493</b></span></td>
    <td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOSkPnUfV7Jk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>5,646</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFeeTYAM5402" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>322,359</b></span></td>
    <td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zfnlapsyczbl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>351,905</b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zmXGGc2NhKEj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"><b>30,436</b></span></td></tr>
  </table>
<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 40 additional seats
still pending approval, which, if approved by the Ministry of Education, will result in a potential additional payment of up to
R$ 50,000.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">**</span></td><td style="width: 5pt"/><td style="text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock', window );">The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_zsNqcDkcP1aa" style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"><span id="xdx_8BE_zMeSHT02Wbp6">The
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:</span></span></p>

<p style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b> </b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniRedentor<sup id="xdx_F59_zAvFUToNjFz8">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>UniSL<sup id="xdx_F5F_zCrp9wUMkNth">**</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>PEBMED</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FESAR</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>MedPhone</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>FCMPB</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    and cash and equivalents</span></td>
    <td id="xdx_989_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zAVb3yo3wBJg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,796</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zNxa5tHdSZLf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,245</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zEOClRFGyeTg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,119</span></td>
    <td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zxkS1YUMKw0a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,236</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zK3fJxFOyUib" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z73IKoju1AF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    receivables </span></td>
    <td id="xdx_98E_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zgebA5hQHK2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,800</span></td>
    <td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zmwtcWPAC5O2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,567</span></td>
    <td id="xdx_981_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z5J7bC2F7m5d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,984</span></td>
    <td id="xdx_989_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDbopQFTRoDj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1990">-</span></span></td>
    <td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_ztSTqHM49wSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1992">-</span></span></td>
    <td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zjVTUcP68ki5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,148</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Inventories</span></td>
    <td id="xdx_98D_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zIYUiIS7KTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl1996">-</span></span></td>
    <td id="xdx_980_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zAORDJDdEw6i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">467</span></td>
    <td id="xdx_984_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_znAO7mDFhcYb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2000">-</span></span></td>
    <td id="xdx_982_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zLtyNUiPfRnh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2002">-</span></span></td>
    <td id="xdx_987_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zJA29mowuDqd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2004">-</span></span></td>
    <td id="xdx_98A_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zyhKgYKsRsn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2006">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Recoverable
    taxes</span></td>
    <td id="xdx_980_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLzQhKtmmn1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3</span></td>
    <td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdU8ltsEqaRj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">822</span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zTDrr01O6US7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2012">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrJovtlYZABf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2014">-</span></span></td>
    <td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zc822jJkMSz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2016">-</span></span></td>
    <td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVulIgfPSYg2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2018">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    assets</span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLlVTGuu8227" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,486</span></td>
    <td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zhKffr4l9Ioj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,251</span></td>
    <td id="xdx_985_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zCMHVcSXhRN7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">161</span></td>
    <td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zzbJUllMn8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42</span></td>
    <td id="xdx_983_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfRCws1fjAL1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9</span></td>
    <td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zevt8PCqwfkd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">123</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Indemnification
    assets</span></td>
    <td id="xdx_98B_ecustom--IndemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z2YfRdUlLECj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">710</span></td>
    <td id="xdx_984_ecustom--IndemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zHJ6GfXXjym4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,645</span></td>
    <td id="xdx_980_ecustom--IndemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z1BB1trtemak" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,350</span></td>
    <td id="xdx_985_ecustom--IndemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z4KMY1wZOVod" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,871</span></td>
    <td id="xdx_986_ecustom--IndemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zqzGNull8Fq2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2040">-</span></span></td>
    <td id="xdx_989_ecustom--IndemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zGbNk9BHa0D3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2042">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Right-of-use
    assets</span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zHAUsoWFdwR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,265</span></td>
    <td id="xdx_987_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zf2UGB0tyJN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,062</span></td>
    <td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zR4myGuTPKfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">865</span></td>
    <td id="xdx_983_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zIvd0Jkhm42d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2050">-</span></span></td>
    <td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zRBPD644qCH7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2052">-</span></span></td>
    <td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRQkSu6TAHE6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,663</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Property
    and equipment</span></td>
    <td id="xdx_980_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCxWtOhqSzAk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,207</span></td>
    <td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zypUcLIgkH49" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,144</span></td>
    <td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z6OJON8HlN59" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">391</span></td>
    <td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ztKSE8KkK655" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,176</span></td>
    <td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z1IgIrP2N5a4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2064">-</span></span></td>
    <td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zOraqDymNOfa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">962</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Intangible
    assets</span></td>
    <td id="xdx_981_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zoiVPseg9SA5" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">142,399</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z3UBQHD3wfU8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">314,097</span></td>
    <td id="xdx_985_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziE4HZePi3Qe" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,372</span></td>
    <td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zztkEPGfxmc7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">167,106</span></td>
    <td id="xdx_983_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQjfQEYLB78" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,727</span></td>
    <td id="xdx_980_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zCuTrBJS2Yed" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">264,782</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zG0Ql09YhReg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,666</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ztqESusg2JTg" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>421,300</b></span></td>
    <td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zs6YJCMJrGQ5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>83,242</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zf2XLTNzDKn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>201,431</b></span></td>
    <td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zakIjhXPqXg8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,796</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>297,778</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Liabilities</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Trade
    payables</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYVYWnqzF3M9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">746</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zUeODflqDsC" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,554</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zVHLo99fsbSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,024</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrAoBduLXoeh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">143</span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zciqmDMxQIWg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2100">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zYqvcBOcnoy" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">173</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7MFMjiQLnfl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">16,187</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z9UX0SPbVkUf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,541</span></td>
    <td id="xdx_983_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zRZgCBuidBY1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2108">-</span></span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z6wlcFGs5WLj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,087</span></td>
    <td id="xdx_98A_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zlYcE3rXpVU4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2112">-</span></span></td>
    <td id="xdx_98C_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zHWMKKvUX61a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2114">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease
    liabilities</span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zuTjCGJDqTQf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,265</span></td>
    <td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zbmDpqPWIV1f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,062</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zofQ8vOGAEL8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">865</span></td>
    <td id="xdx_982_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z1AIfhIdKzO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2122">-</span></span></td>
    <td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfXl2nWtp5M6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2124">-</span></span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zvSzwv0hrGV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,663</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Labor
    and social obligations</span></td>
    <td id="xdx_983_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZQtTVdjn7Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,471</span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zTm4DtlvHAsk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,070</span></td>
    <td id="xdx_987_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zmCpWtu8RVQ6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,786</span></td>
    <td id="xdx_988_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP5eWwj185oc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,801</span></td>
    <td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFj6WtjBDTNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2136">-</span></span></td>
    <td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z1eGhO7wZC47" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,832</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Taxes
    payable </span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zGyMOGfYZaEd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">850</span></td>
    <td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z8x56FftsgBb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,779</span></td>
    <td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zB167xTyiR26" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,210</span></td>
    <td id="xdx_985_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zQe2elXTOKYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">29</span></td>
    <td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQQwFxmywf5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2</span></td>
    <td id="xdx_98F_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVt8OMeZ03U9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Provision
    for legal proceedings</span></td>
    <td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z0GDZywEkHi7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">710</span></td>
    <td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zyzcOPBK1LJl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,645</span></td>
    <td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zFoEjEBYMY8d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,350</span></td>
    <td id="xdx_98F_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z8EmaEquKx6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,871</span></td>
    <td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zW9eaPY1rY8b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2160">-</span></span></td>
    <td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z6lBY2197RB3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2162">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Advances
    from customers</span></td>
    <td id="xdx_98D_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zU9OVtZgQ8eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,994</span></td>
    <td id="xdx_980_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zJsENwKvpIpg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,084</span></td>
    <td id="xdx_984_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zhenAaZMRQ2a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,312</span></td>
    <td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zH9Qck7htWMe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">759</span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZxnNK94xKGf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2172">-</span></span></td>
    <td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zcy4zBkrXJl2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,781</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--NotesPayables_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCu2FCwNbwO6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2176">-</span></span></td>
    <td id="xdx_986_ecustom--NotesPayables_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zVCVwA8tJib2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">80,526</span></td>
    <td id="xdx_981_ecustom--NotesPayables_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zx5J2lS5JmVc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2180">-</span></span></td>
    <td id="xdx_98A_ecustom--NotesPayables_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zk4QjeBuhmM8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2182">-</span></span></td>
    <td id="xdx_988_ecustom--NotesPayables_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zi6QsQiH4Aja" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2184">-</span></span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_ztexIzbGEB8k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2186">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Other
    liabilities</span></td>
    <td id="xdx_98E_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCbwHPDABXg2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2188">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z1b3gRLxDBW7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,754</span></td>
    <td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zqCIWe7c3oA3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2192">-</span></span></td>
    <td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zBbdYryDw0vg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2194">-</span></span></td>
    <td id="xdx_981_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVHvUY5i16cd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">228</span></td>
    <td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zlULXa3tMbj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2198">-</span></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYJkeeIrOMCh" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>44,223</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdvLlR3bqZDd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>232,015</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z9Bq5YYaGa61" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>34,547</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkrUtMYxydX1" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,690</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZrHEYduPMC4" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>230</b></span></td>
    <td id="xdx_98A_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zE1gAprjJYs3" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>29,454</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total
    identifiable net assets at fair value</b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zMuTCasS8IS2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>132,443</b></span></td>
    <td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zO5EeInsfHA7" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>189,285</b></span></td>
    <td id="xdx_986_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziB5IfohSoTc" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>48,695</b></span></td>
    <td id="xdx_987_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zO5IkSBPt9Lg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>190,741</b></span></td>
    <td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2MeYPvL7nX" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,566</b></span></td>
    <td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zJii1mi8hbM9" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>268,324</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #0D0E00">Goodwill
    arising on acquisition</span></td>
    <td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEBP0fVsvRh" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zeD5ej7YtfCj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td id="xdx_982_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zfsbdJODltpf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">84,175</span></td>
    <td id="xdx_983_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zNIvYgJo0kxb" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zIiqISV2FmK5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,843</span></td>
    <td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zXWghwhespDd" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Purchase
    consideration transferred</b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEAl8YBTEC3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>210,105</b></span></td>
    <td id="xdx_98E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpfJ9eg4bKi5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>193,705</b></span></td>
    <td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zzjkQ6xOOoK9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>132,870</b></span></td>
    <td id="xdx_98C_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zMVSb9ZWRxPc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>262,405</b></span></td>
    <td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zpDoOnBklbOk" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,409</b></span></td>
    <td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z85IH8rQhUe4" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>378,807</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid</span></td>
    <td id="xdx_983_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zjrHviUw1Q21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">114,607</span></td>
    <td id="xdx_980_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zxQDz4vAwmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,065</span></td>
    <td id="xdx_98C_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zjjP3lEhVQic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">115,339</span></td>
    <td id="xdx_98F_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDQcHzpwEIPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">260,836</span></td>
    <td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFrE7Fhwfpua" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,373</span></td>
    <td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWgoITNOLXMg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">189,913</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Payable
    in installments</span></td>
    <td id="xdx_983_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zTPu93oUK5G1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">95,498</span></td>
    <td id="xdx_98D_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpT2t0QR7Mc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52,640</span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zSGtZ0Esp2te" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2264">-</span></span></td>
    <td id="xdx_987_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zISaWfRjlkFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,569</span></td>
    <td id="xdx_986_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4UFAFAqtikk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36</span></td>
    <td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRhGJXWF9RCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">188,894</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Paid
    in Afya Brazil&#8217;s shares</span></td>
    <td id="xdx_98C_ecustom--PaidInAfyaBrazilsShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZdjBS4eo4F2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2272">-</span></span></td>
    <td id="xdx_98B_ecustom--PaidInAfyaBrazilsShares_iI_pp0i_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zZR29SxWh5ml" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2274">-</span></span></td>
    <td id="xdx_989_ecustom--PaidInAfyaBrazilsShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zDFZAGwkTe3i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,531</span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDP8i6MEP4H3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2278">-</span></span></td>
    <td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZnYuBkzFTNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2280">-</span></span></td>
    <td id="xdx_988_ecustom--PaidInAfyaBrazilsShares_iI_pii_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zQLsUbZrIDS" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2282">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><i>Analysis
    of cash flows on acquisition:</i></b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transaction
    costs (included in cash flows from operating activities)</span></td>
    <td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7sY5B4QLffc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,380</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pin3_c20200503__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zvPYmbPS5kX6" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,666</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zebx1JhzEYh5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">613</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zGRXSxClklu7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,047</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2WJXEDLrr0k" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zPT7QjmULYp9" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">721</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    paid, net of cash acquired with the subsidiary (included in cash flows from investing activities) </span></td>
    <td id="xdx_98B_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z5nxvCxmHf57" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">102,811</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">137,820</span></td>
    <td id="xdx_98A_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zXUNj4fH6FK2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">114,220</span></td>
    <td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zVKeYuO8YR14" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">256,600</span></td>
    <td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z13yUYixlnpj" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,313</span></td>
    <td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zuZKl77xuRU1" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">189,813</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    of cash flow on acquisition </b></span></td>
    <td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYkZLwsBvKQg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>104,191</b></span></td>
    <td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ziKynDSkF499" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>139,486</b></span></td>
    <td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zgCV2RnT839b" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>114,833</b></span></td>
    <td id="xdx_989_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zUwKk8nsj9K7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>258,647</b></span></td>
    <td id="xdx_981_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVGl60C0Oby7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>6,471</b></span></td>
    <td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201209__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zpObDsnvBPl8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>190,534</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; color: #0D0E00; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F06_ztIuyFXfHNm5" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_zaO3k9qNVr96" style="font-family: Arial, Helvetica, Sans-Serif">During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.</span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.25in; color: #0D0E00"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0D_ztROSjqJfKFh" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00">**</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_z3KRsfIOe955" style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00">During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p</span><span style="font-family: Arial, Helvetica, Sans-Serif">roperty
and equipment of R$7<span style="color: #0D0E00">.</span></span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember', window );">I Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_894_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zC4v6h0VeMj4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_zov9ELuceLXb" style="display: none; visibility: hidden">Schedule of acquisition of UniRedentor</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVMIRzdnM1Q" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210119__20210121__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z5WXLkJTe2ek" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember', window );">Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUnislTableTextBlock', window );">Schedule of acquisition of UniSL</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfUnislTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGAk6QiRz1oi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zu05rfh6d9Je" style="display: none; visibility: hidden">Schedule of acquisition of UniSL</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210323__20210325__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_ze6Zg5M2ZAWk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfFesarTableTextBlock', window );">Schedule of acquisition of FESAR</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfFesarTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zrWMfV6zM5F2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B6_z7UrP5URV2fc" style="display: none; visibility: hidden">Schedule
of acquisition of FESAR</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zsOFIQ0cjkO9" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210414__20210416__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z8UvFfDdR9gh" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_HarbourMember', window );">Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfPebmedTableTextBlock', window );">Schedule of acquisition of PEBMED</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfAcquisitionOfPebmedTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zKtdf2BhXfS9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zW5lALiYIUvk" style="display: none; visibility: hidden">Schedule of acquisition of PEBMED</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zyOszcZMTczk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z1sutBCAaPrl" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--ShospMember_zIt6dmS6HhHc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zRJn4wkUPehb" style="display: none; visibility: hidden">Schedule
of acquisition of MedPhone</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVrX3w2BfcB6" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210311__20210313__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zP8amaDKxti7" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember', window );">U N I F I P Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_893_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zlhKd4NkmGuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_zIOGWUEM2l1g" style="display: none; visibility: hidden">Schedule of acquisition of FCMPB</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember', window );">U N I G R A N [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUnigranTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfAcquisitionOfUnigranTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zyXgO4PauZ0j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BB_zWeg2ldwu09l">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zBMyQzLIX536" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zh0AZu39YWsk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_PXPROMember', window );">P X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfRXPROTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_892_ecustom--ScheduleOfAcquisitionOfRXPROTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKHdu9aa3eTj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zLLkcFdWjoij">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z3zRq7R9cJwb" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zeZZoDFgzDC2" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zwWF1IKRBx9h" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember', window );">Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z2fcWB3rBBlc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zjxRcRDmmTY7">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z7YEmaeRyFH9" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"><p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zin473Y7fpD4" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UniSLMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_89C_ecustom--ScheduleOfAcquisitionOfUnisl1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zCTapHyGyKZ4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BE_zbdcoyY1QUHb">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_984_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z75keHgw1i0c" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zwT9hpoM2CUh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember', window );">P E B M E D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_898_ecustom--ScheduleOfAcquisitionOfPebmed1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zXTNHJmUDlE4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zOiGDpc7oG1g">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zNmcdf3oWjei" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrpCM5e8RLhi" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zah1wOgtfIO3" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember', window );">Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfFesar1TableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfAcquisitionOfFesar1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zYfWbd8k9GH4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BC_zYGDzv9uTPV8">The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zaLtaUATzVif" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_986_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zyAQaPdz1ko7" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z3vbHMRhcPJe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B4_zpb10HpQncm2">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Trademark</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zOVS1YPmqEHc" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Relief
    from royalty</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zoXBh7qPJcph" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Developed
    technology intangible assets</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zRjmfbyWdBG5" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Replacement
    cost</b></span></p>
    <p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"><span style="font-family: Arial, Helvetica, Sans-Serif">This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember', window );">F C M P B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock', window );">The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</a></td>
<td class="text"><p id="xdx_891_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOBpQx2ren03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"><span id="xdx_8B3_zxZLgCnXCsEf">The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Intangible
    assets acquired</b></span></td>
    <td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Valuation
    technique</b></span></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: black"><b>Licenses</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zs5p8J3xdUik" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>With-and-without
    method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</span></p></td></tr>
  <tr style="background-color: white">
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Customer
    relationships</b></span></td>
    <td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Multi-period
    excess earnings method</b></span></p>
    <p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.</span></p></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfFesar1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfFesar1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfFesarTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfFesarTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfPebmedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfPebmedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfRXPROTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfRXPROTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfUnigranTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfUnigranTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfAcquisitionOfUnislTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfAcquisitionOfUnislTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_IClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_HarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_HarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_PXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_PXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103261704">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cash and cash equivalents (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory', window );">Schedule of cash and cash equivalents</a></td>
<td class="text"><p id="xdx_896_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zep5cpAxzMnk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_z6Tlk5tVKuTe" style="display: none; visibility: hidden">Schedule of cash and cash equivalents</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_494_20211231_zhIs5sZaH5Pf" style="border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20201231_z12DwGphZZZ3" style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--Cash_iI_zkyM9A130qQc" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and bank deposits</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,487</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,729</span></td></tr>
  <tr id="xdx_405_eifrs-full--CashEquivalents_iI_z7I6HlvNsys9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">660,075</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">987,313</span></td></tr>
  <tr id="xdx_406_eifrs-full--CashAndCashEquivalents_iI_zjXuW90T7sj2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif">&#160;Cash and cash
    equivalents</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>748,562</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,045,042</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103354296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Trade receivables (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory', window );">Schedule of trade accounts receivable, net and notes receivable</a></td>
<td class="text"><p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_z6b1Qk5I7Xmj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zX8Tm0BxMpJ7" style="display: none; visibility: hidden">Schedule of trade accounts receivable, net and notes receivable</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zaZofXwly2wk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">279,915</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z74W3KJi8Z31" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">195,318</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    content <sup id="xdx_F48_zUO4e8brM0M">(a)</sup></span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zOV30KCsXofj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">69,227</span></td>
    <td id="xdx_98F_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zg1672CjJlih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,931</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FIES</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zTCLIoJgxW24" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61,342</span></td>
    <td id="xdx_983_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8koS9msPeif" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">49,425</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Educational
    credits</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zQ4a75Of75n9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,375</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zlpqgXRsuZj2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,248</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Mobile
    app subscription <sup id="xdx_F4E_zOa0ciKTexrc">(b)</sup></span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_z1MV2dvkFeAk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,946</span></td>
    <td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_zWLBo9AKjKJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,526</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Others</span></td>
    <td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_z6I9Rx5eNiH" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,001</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zfn7aUmMY7Gh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,476</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--ReceivablesGross_iI_c20211231_zLBKL11Rm3y7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>450,806</b></span></td>
    <td id="xdx_98E_ecustom--ReceivablesGross_iI_c20201231_zLCSmEvtYPR2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>342,924</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(-)
    Allowance for doubtful accounts</span></td>
    <td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20211231_zBkEMKa2PMHi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(45,013)</span></td>
    <td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20201231_zZmq4vdSYDo9" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,980)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--TradeReceivables_iI_c20211231_zSTFHCVuTpjk" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>405,793</b></span></td>
    <td id="xdx_984_eifrs-full--TradeReceivables_iI_c20201231_zaqIgysBXjOb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>309,944</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_980_eifrs-full--CurrentTradeReceivables_iI_c20211231_zScJjlPWwHM4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">378,351</span></td>
    <td id="xdx_988_eifrs-full--CurrentTradeReceivables_iI_c20201231_zxihBwvEorl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">302,317</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zbmRZtLv3i1g" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zX4sEv6BVB7k" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zYXsJQ38ODgj" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1E_zEcoPHFhNVO8" style="font-family: Arial, Helvetica, Sans-Serif">Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zNzDoXuVEQU6" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_z6NwoKmSmTvg" style="font-family: Arial, Helvetica, Sans-Serif">Related to trade receivables
from mobile applications subscriptions for digital medical content.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory', window );">Schedule of aging of trade accounts receivable</a></td>
<td class="text"><p id="xdx_895_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_zAwhsbHdfyhe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">As of December
31, 2021 and 2020, the aging of trade receivables was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_zkokUPFKxvo" style="display: none; visibility: hidden">Schedule of aging of trade accounts receivable</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Neither
    past due nor impaired</span></td>
    <td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zmDSzjnGs491" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">184,382</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zyPih9uvje8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">145,076</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Past
    due</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1
    to 30 days</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zYU6waBpya8e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,932</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z6DNxDfqC5cl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,365</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31
    to 90 days</span></td>
    <td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zLUHzFxJit2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">69,299</span></td>
    <td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zlphyAszTvGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,198</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">91
    to 180 days</span></td>
    <td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zKXHpKOsyJ3e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,764</span></td>
    <td id="xdx_982_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zsqTxBBQZtAg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,521</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">More
    than 180 days</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zmiFGDiMyKX" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,429</span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_znlov2MSuhO6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,764</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231_zPG8AONvukig" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>450,806</b></span></td>
    <td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231_z4TICkXN3d39" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>342,924</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsExplanatory', window );">Schedule of allowance for doubtful accounts</a></td>
<td class="text"><p id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsExplanatory_zQ98EYNT8Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The changes in
the allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019, was as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zh6ifQJcKy49" style="display: none; visibility: hidden">Schedule of allowance for doubtful accounts</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 60%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_493_20210101__20211231_zQwptMmF38Hh" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_495_20200101__20201231_zWOPOHXBLRSb" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_494_20190101__20191231_zsQ3E8BXifx2" style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_zQHR6SKfOs2f" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the beginning of the period</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,980)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(14,763)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,537)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_z8ZbFhKS0wQj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,819)</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,081)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,040)</span></td></tr>
  <tr id="xdx_402_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_zmLORFRGbM52" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Write-offs</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,786</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,864</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,814&#160;&#160;&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_zIQ6MP0Y8gS6" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Balances
    at the end of the period</span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(45,013)</b></span></td>
    <td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(32,980)</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(14,763)
    </b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfTradeAndOtherReceivables1Explanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfTradeAndOtherReceivables1Explanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103267240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfRelatedPartiesExplanatory', window );">The table below summarizes the balances and transactions with related parties:</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfRelatedPartiesExplanatory_zHTPNSmwfAB3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B8_zA9nOBZYRjOc">The table below
summarizes the balances and transactions with related parties:</span></span></p>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49D_20211231_zFAMpuVZ6ke3" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_499_20201231_z8IkEVggsgqe" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_401_ecustom--TradeReceivablesRelatedPartyTransactions_iI_zVTPXnt6ywSf" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables <sup id="xdx_F47_zor9ngjglRtg">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">692</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">174</span></td></tr>
  <tr id="xdx_400_ecustom--CreditsWithShareholdersRelatedPartyTransactions_iI_zRKH3INWi5Ob" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Related
    parties <sup id="xdx_F42_zPsDLPAGjoB1">(b)</sup></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2509">-</span></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421</span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_zytw8aCO5ye1" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span style="display: none; visibility: hidden">TOTAL</span></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>692</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>595</b></span></td></tr>
  <tr id="xdx_407_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_z17ngage4Oo3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">692</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">174</span></td></tr>
  <tr id="xdx_402_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zOJRRKNzkTmd" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2518">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">421</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--AccountsPayableToSellingShareholders_iI_zRqWB7IxYx7l" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders <sup id="xdx_F4F_zx3htuzXoK11">(c)</sup></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,556</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2522">-</span></span></td></tr>
  <tr id="xdx_401_eifrs-full--AmountsPayableRelatedPartyTransactions_iTI_zjHCjdgL5nP8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="display: none; font-family: Arial, Helvetica, Sans-Serif; visibility: hidden">&#160;Total</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>54,556</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2525">-</span></b></span></td></tr>
  <tr id="xdx_401_ecustom--AccountsPayableCurrent1_iI_zD0CpvdKYxg7" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,278</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2528">-</span></span></td></tr>
  <tr id="xdx_400_ecustom--NoncurrentPayablesToRelatedParties1_iI_zk0v0IIndaP9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,278</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2531">-</span></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Other
    income</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UEPC
    <sup id="xdx_F40_ztkneTU0jBr4">(a)</sup></span></td>
    <td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zo377Gzq2ink" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">752</span></td>
    <td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zXqUxwWTdaa3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">104</span></td>
    <td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zy4r6G9wnxa6" style="vertical-align: top; text-align: right" title="Other income"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">557</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zKfnxqWhVlq2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>752</b></span></td>
    <td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231_z2hBRocfajw1" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>104</b></span></td>
    <td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231_zz9RW70uHdf3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>557</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    </b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">RVL
    Esteves Gest&#227;o Imobili&#225;ria S.A.</span></td>
    <td id="xdx_987_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z9MWpTJVG9Hb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,336</span></td>
    <td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zXDItSZyVpe2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,288</span></td>
    <td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOpXLwRJQoWg" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,417</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">UNIVA&#199;O
    Patrimonial Ltda.</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zXDNNpZ3zMB5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,210</span></td>
    <td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z72NlVDU4xY" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,915</span></td>
    <td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zZyKhU1V9m9g" style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,816</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IESVAP
    Patrimonial Ltda.</span></td>
    <td id="xdx_980_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zDrbBZrTCal3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,560</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zPFPbbEv8YNc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,470</span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zmhhRsQRSk7d" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,609</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_z6GM6uMWpsI5" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>23,106</b></span></td>
    <td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231_zq8uPh334pHc" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>17,673</b></span></td>
    <td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>15,842</b></span></td></tr>
  </table>
<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zIWsuYYX5gp" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_z5FfuMNv5D9k" style="font-family: Arial, Helvetica, Sans-Serif">Refers to sales of educational content
from Medcel to UEPC.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zLN6utXXTwe1" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zHL1ntwquFYg" style="font-family: Arial, Helvetica, Sans-Serif">Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F08_zRr8V9KKHa56" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_zDDVZy0CIS66" style="font-family: Arial, Helvetica, Sans-Serif">Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock', window );">Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following:</a></td>
<td class="text"><p id="xdx_892_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_zB80mLv5U6l4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zjGIIOd6WbXe">Key management
personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 4%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="width: 3%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Short-term
    employee benefits</span></td>
    <td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_zy5oJImO2QQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,933</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20200101__20201231_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,629</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20190101__20191231_pn3n3" style="text-align: right; line-height: 10.5pt" title="Short-term employee benefits"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,947</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation plan</span></td>
    <td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zFOzMHPWLGol" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,251</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--KeyManagementPersonnelCompensation_c20200101__20201231_pn3n3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,989</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--KeyManagementPersonnelCompensation_c20190101__20191231_pn3n3" style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,893</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zTsER7rH0PAl" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>32,184</b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20200101__20201231_zlHdUK86xtXg" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>33,618</b></span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>18,840</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfRelatedPartiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfRelatedPartiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103665176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Other assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><p id="xdx_893_ecustom--DisclosureOfOtherAssetsTableTextBlock_z0mZ8VPwyvU" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B1_z0iZVeWMgMua" style="display: none; visibility: hidden">Schedule
of Other Assets</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49A_20211231_ze0H6LTEmB39" style="border-bottom: black 1pt solid; vertical-align: top; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49E_20201231_zG4ahnYBdjRf" style="border-bottom: black 1pt solid; vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_maAzeR4_zGMAje5cFJJa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Indemnification
    assets <sup id="xdx_F4A_zckFy3zL5CEh">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">135,355</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;53,499</span></td></tr>
  <tr id="xdx_402_ecustom--JudicialDeposits_iI_maAzeR4_z4nMEHY7I5R8" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Judicial
    deposits</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">18,825</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;1,451</span></td></tr>
  <tr id="xdx_407_eifrs-full--CurrentPrepaidExpenses_iI_maAzeR4_zLTpYYE9zZfb" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Prepaid
    expenses</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,110</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2,291
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--OtherReceivables_iI_maAzeR4_zU0e0fR2ZLK3" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    FIES receivables</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">21,450</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,411</span></td></tr>
  <tr id="xdx_405_ecustom--OtherAssets1_iI_maAzeR4_zV0fIqT6dcq9" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    assets</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">37,099</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,999</span></td></tr>
  <tr id="xdx_402_ecustom--Assets1_iTI_mtAzeR4_zImaWDaO5qK2" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;<b>Total</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>222,839</b></span></td>
    <td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>&#160;103,651
    </b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_ecustom--CurrentAssets1_iI_z0uxoNiykdGk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,533</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">29,614</span></td></tr>
  <tr id="xdx_40E_ecustom--NoncurrentAssets1_iI_zwxeteUaAHSe" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">180,306</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">74,037</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zmlIUcWq5LB9" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_zQccXvRQc3Yj" style="font-family: Arial, Helvetica, Sans-Serif">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103661528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investment in associate (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfInvestments', window );">Schedule of investments</a></td>
<td class="text"><p id="xdx_893_ecustom--ScheduleOfInvestments_zzSKJ0qizyvd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">In connection with
the corporate reorganization, described in Note 1 regarding the merger with BR Health, the Company acquired a 30% interest in UEPC, a
medical school located in the Federal District, that offers higher education and post-graduate courses, both in person and long-distance
learning. The Company&#8217;s interest in UEPC is accounted for using the equity method. The following table illustrates the summarized
financial information of the Company&#8217;s investment in UEPC:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zegUpHFamie3" style="display: none; visibility: hidden">Schedule of investments</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_495_20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_ztuFjR6lWCCj" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_49F_20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zutTJWB1NOSh" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_400_eifrs-full--CurrentAssets_iI_ziNRzqN8aVLa" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">33,976</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">55,413</span></td></tr>
  <tr id="xdx_407_eifrs-full--NoncurrentAssets_iI_zkysyWkAnADj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    assets</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">109,805</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">82,575</span></td></tr>
  <tr id="xdx_403_eifrs-full--CurrentLiabilities_iI_zcdpcfOW3luf" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(35,049)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(34,531)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NoncurrentLiabilities_iI_zZJ0OrYijEZ5" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(91,086)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,132)</span></td></tr>
  <tr id="xdx_400_ecustom--EquityInAssociate_iI_pn3n3_zNdNHY5uOJ02" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Equity</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>17,646</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,325</b></span></td></tr>
  <tr id="xdx_40F_ecustom--CompanyShareInEquity1_iI_zncKuEDDgSdg" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Company&#8217;s
    share in equity &#8211; 30%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,294</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8,227</span></td></tr>
  <tr id="xdx_404_eifrs-full--Goodwill_iI_zTWHOCQEGj3e" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Goodwill</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,183</span></td></tr>
  <tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_znBr9zNPrT1d" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount of the investment</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,410</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_496_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zMGhJOUNcZQ9" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z01qreZIZnPe" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zd8VHpPGpZti" style="width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr id="xdx_40E_eifrs-full--Revenue_zxTnnxGzFvc8" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net
    revenue</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">127,618</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">113,965</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,816</span></td></tr>
  <tr id="xdx_40E_eifrs-full--CostOfSales_zZUBc69Iyqih" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(57,935)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,926)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,459)</span></td></tr>
  <tr id="xdx_408_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zli07pMMZvN2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,025)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(27,341)</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,476)</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_z9ZRA8rKUZOe" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Finance
    result</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,585)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,882)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,121)</span></td></tr>
  <tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_zd0sGZqBIs3i" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Income
    before income taxes</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>41,073</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,816</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>12,760</b></span></td></tr>
  <tr id="xdx_40F_eifrs-full--IncomeTaxExpenseContinuingOperations_zh29JpX4Fe12" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    taxes expenses</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,748)</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(252)</span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,275)</span></td></tr>
  <tr id="xdx_405_eifrs-full--ProfitLoss_z11LxfdFLAi2" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    income for the period</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>39,325</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,564</b></span></td>
    <td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>10,485</b></span></td></tr>
  <tr id="xdx_40C_ecustom--CompanyShareOfProfitss_zTbangbaaco6" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Company&#8217;s
    share of income for the period </b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>11,797</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>7,698</b></span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,362</b></span></td></tr>
  </table>
<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zx55YM9V8TE6" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zKWB50vA4P11" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z8lEV9pC1Lu" style="border-bottom: black 1pt solid; width: 14%; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_405_eifrs-full--InvestmentsInAssociates_iS_zWtjCksUTzqa" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">51,410</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">45,634</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2720">-</span></span></td></tr>
  <tr id="xdx_408_ecustom--MinorityInterestOfAcquiree_zlqSJLaQhuNi" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of minority interest (15%) in March 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2722">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2723">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,458</span></td></tr>
  <tr id="xdx_40A_ecustom--AdditionalMinorityInterestOfAcquiree_zC6y6OBKIP86" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of additional interest (15%) in June 2019</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2726">-</span></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2727">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,457</span></td></tr>
  <tr id="xdx_401_ecustom--DividendsReceived1_zeyf8wFxDexl" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    received</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,770)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,922)</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,643)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--DividendsReceived_zneCLdZD8Hr8" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividends
    receivable (included in Other assets)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,960)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2735">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl2736">-</span></span></td></tr>
  <tr id="xdx_40F_eifrs-full--ProfitLossOfAcquiree_zZ9lZe3En97g" style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    of income</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,797</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,698</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,362</span></td></tr>
  <tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iE_zdxGaReHhpy7" style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Closing
    balance</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>48,477</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,410</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>45,634</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103665736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and equipment (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory', window );">Schedule of detailed information about property, plant and equipment</a></td>
<td class="text"><p id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zBwyJ0giRUl3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0">&#160;</p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zXB5MRKKrsa9" style="display: none; visibility: hidden">Schedule
of detailed information about property, plant and equipment</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 24%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_ztR2ztUIgz46" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Building</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zWF4kv1Mf272" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Machinery
    and equipment</b></span></td>
    <td id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zk3CSQXZAzo" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Lands</b></span></td>
    <td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zqcdivLUIRk8" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Vehicles</b></span></td>
    <td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zScXVWbPlrOj" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Furniture
    and fixtures</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zN2CJpmui0ja" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>IT
    equipment</b></span></td>
    <td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_znYhjBfijHs5" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Library
    books</b></span></td>
    <td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LaboratoriesAndClinicsMember_zy8nGF7You35" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Laboratories
    and clinics</b></span></td>
    <td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_z1lVkTwLfhpd" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Leasehold
    improvements</b></span></td>
    <td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zEMD0wm5Ie93" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Construction
    in progress</b></span></td>
    <td id="xdx_4B6_z8qJbJuS5uMg" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zgRvAijtZECi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2750">-</span></b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,503</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,770</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>182</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>11,897</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,243</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>12,838</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>597</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>11,882</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,736</b></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>91,648</b></span></td></tr>
  <tr id="xdx_439_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zEa98fDb9NZ4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2762">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,235</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">422</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,976</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,241</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,205</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">34</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,488</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,525</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,964</span></td></tr>
  <tr id="xdx_43C_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zGspkmT9FpNd" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfers</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2774">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2775">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2776">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2777">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2778">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(525)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2780">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2781">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2782">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2783">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(525)</span></td></tr>
  <tr id="xdx_433_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zoBzLOAs4s5g" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2786">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,988</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2788">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">103</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,565</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,035</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,096</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">418</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">14,541</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">470</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">28,216</span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zRRN4GV3tug1" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2798">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>44,329</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>7,005</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>707</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,438</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>15,994</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,139</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,049</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,911</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>36,731</b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,303</b></span></td></tr>
  <tr id="xdx_436_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zXnm95dVmXBk" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2810">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">13,806</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">672</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2813">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,550</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,657</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,012</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2817">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">54,748</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,387</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>89,832</b></span></td></tr>
  <tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_ziefd94qkGxk" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,771</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,973</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,724</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">508</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,061</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,493</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,473</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2829">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,787</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,090</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>47,880</b></span></td></tr>
  <tr id="xdx_43A_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_z1DeFmkR0Vsh" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,148</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,395</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2836">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2837">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">367</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2840">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,049)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,559</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(43,502)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2844">-</span></b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zwgSj3L7hoD6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>25,919</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>68,503</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>13,401</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,215</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>29,131</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,511</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,624</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2853">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>122,005</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,706</b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>314,015</b></span></td></tr>
  <tr id="xdx_438_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zLjL82Q7WBaj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,384</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,268</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,451</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">111</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,075</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,511</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,392</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2865">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,720</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">59,957</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>125,869</b></span></td></tr>
  <tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zkTAUX2nG8qh" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2870">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,810</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2872">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">346</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">16,684</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,138</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,142</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2877">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,425</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,078</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>65,623</b></span></td></tr>
  <tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zmVa3mkW0ree" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F40_zfRRSU4R0uSb">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(14,213)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2884">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(205)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,862</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,985)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(86)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2889">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(550)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(417)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(17,532)</b></span></td></tr>
  <tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zdkueYwI1JVg" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">25,068</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2896">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2897">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">82</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2900">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2901">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,376</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(34,538)</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2904">-</span></b></span></td></tr>
  <tr id="xdx_436_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iE_zdyfnPjcixRb" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>52,433</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>77,371</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,852</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,467</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>69,834</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>53,184</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>30,072</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2913">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>152,976</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,786</b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>487,975</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Depreciation</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_435_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zyljSFzGWkT6" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2918">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(9,696)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2920">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(59)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,261)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,489)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,015)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(27)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(338)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2927">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(25,885)</b></span></td></tr>
  <tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zbhO1ufDHiua" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2930">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,097)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2932">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2933">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,629)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,495)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,648)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(359)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,317)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2939">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,545)</span></td></tr>
  <tr id="xdx_43F_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zHOXVqwwX09d" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2942">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2943">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2944">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2945">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2946">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2948">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2949">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2950">-</span></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2951">-</span></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447</span></td></tr>
  <tr id="xdx_434_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zEtqFc7DOExf" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2954">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(13,793)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2956">-</span></b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(59)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(5,890)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,537)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,663)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(386)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,655)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2963">-</span></b></span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(36,983)</b></span></td></tr>
  <tr id="xdx_43D_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zmXu7XEiXQC2" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2966">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,065)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2968">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(112)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,199)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,314)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,154)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(78)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,729)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2975">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(16,651)</span></td></tr>
  <tr id="xdx_430_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zW5xiZEyjQU1" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transfer</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2978">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(464)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2980">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2981">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2982">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2983">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2984">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">464</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2986">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2987">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl2988">-</span></span></td></tr>
  <tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_z7E17VH1y7Od" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2990">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(19,322)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2992">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(171)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,089)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,851)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,817)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2997">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,384)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl2999">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(53,634)</b></span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zGCt13y8OgLg" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Depreciation</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,673)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,215)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3004">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(196)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,601)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,529)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,416)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3009">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,831)</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3011">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(30,461)</span></td></tr>
  <tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zNwBYQYnFny7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F43_zFwjlOCX43gh">*</sup></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3014">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,146</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3016">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,194</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,458</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">633</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3021">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">350</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3023">-</span></span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,928</span></td></tr>
  <tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iE_zPlBfJXWFNej" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,673)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(16,391)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3028">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(220)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(12,496)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(14,922)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(13,600)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3033">-</span></b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,865)</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3035">-</span></b></span></td>
    <td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(68,167)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_430_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z4MrY4J9dN9i" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>50,760</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>60,980</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>18,852</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,247</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>57,338</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>38,262</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>16,472</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3045">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>144,111</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>31,786</b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>419,808</b></span></td></tr>
  <tr id="xdx_438_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zkuoCqmg5qWj" style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>25,919</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>49,181</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>13,401</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,044</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,042</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,660</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>10,807</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3057">-</span></b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>117,621</b></span></td>
    <td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,706</b></span></td>
    <td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>260,381</b></span></td></tr>
  </table>
<p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F09_zWaExgtmeRMc" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F11_z8MiGztrV118" style="font-family: Arial, Helvetica, Sans-Serif">the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103353128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><p id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_zgxmCWdKyXog" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BC_z6CNYptVO0dh" style="display: none; visibility: hidden">Schedule of intangible assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 24%; padding-right: 1.45pt; padding-left: 1.45pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Trademarks</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Customer
    relationships</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Education
    content</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Developed
    technology </b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Educational
    platform</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Software
    in progress</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Cost</b></span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkxsuhUaV5l9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>169,535</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhaDuACraDhe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>445,616</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHs2gwz7FaO4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3071">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPsSmKAbzb9h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>63,303</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zptr5G7guQEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>8,288</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfIJtY98dNm9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3077">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgVdcREIzvdh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3079">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf6tA5ZCKvg3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>577</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUiRBzQHaGd1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,175</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcF2rYhO8RKj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>688,494</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F44_zGflIxppYzX1">(i)</sup> <sup id="xdx_F42_zAmXwDBmqTAi">(ii)</sup></span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zKHd9jvJkPu7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,030</span></td>
    <td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z0zbWSeN8hL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zL8N7OhxPjhf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,101</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJjOI3pxaJA4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">8,769</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJBqYGmy7gil" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">875</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zecGZ2M4FaXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">122,775</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR1UoBsoDr43" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">285,844</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvviFS7HpiY6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">150,156</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeaCpQSf5Gzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">32,111</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z07h0F5KREy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">62,110</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znrhXtBCZ8Ni" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,305</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformAndSoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7iVNfDjgI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,845</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg8UJ7rr2Fr8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">550,371</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNumYlMzBxIl" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>459,409</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLoTM6YqnQY6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>703,772</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLr2xOJt0RF6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>32,111</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7XYVQlAfSmj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>125,413</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsWxj88AuHZ9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,389</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjEjhdNwkqb6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO81qsEtl7r4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3122">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWNQkVXU31Sa" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>12,191</b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpzHay8lTyRe" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,050</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvvRK5zgnxi8" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,361,640</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    </span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD0JnCltpD61" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,175</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeunoOf2RDW2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">15,227</span></td>
    <td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoY5CWPbrz2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">247</span></td>
    <td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zytdoG1JSEB6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,649</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5xrZd2YGPuj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Disposal"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(460)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_ecustom--Disposal_pn3n3_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlg4GHNqNo1a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(460)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zALR5Fv0JCNa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">351,247</span></td>
    <td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkjxVi1pGvM4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">747,498</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgn0GpcbgYVa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">42,903</span></td>
    <td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znu21tk3vc8a" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,126</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzyK3v3xPJte" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,117</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUKPVciX5vR4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">355</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqF30wiFGyKl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">484</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPz7SO6H8O6b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,303,730</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTQ1rtT6InQe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>810,656</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zomSze4aW6Y7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,451,270</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVHqcQBJ7rG7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>75,014</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbmI77B3unzg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>283,539</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD9tzR12okJb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>16,221</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkHU2FN390d" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUivKqpwPjZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>355</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrHMFJKqe5Sk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>27,902</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXHJ8vb2DkV6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,297</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyZxnBMFQGNg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,684,559</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Additions
    <sup id="xdx_F48_z75kiZZ6VCga">(iii)</sup></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z08XjpZh0qMj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z5J2Zgd32oA6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3172">-</span></span></td>
    <td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSO4JbJcODv9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">684</span></td>
    <td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zBdR4iXMAZR3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,044</span></td>
    <td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zCr11aO1hLWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3175">-</span></span></td>
    <td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zaEz9a8dB838" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">996</span></td>
    <td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zS0YV8HvJKgj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">39,686</span></td>
    <td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zQYmrFsHGW84" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">23,700</span></td>
    <td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zWwl093j8nwc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">176,110</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals
    <sup id="xdx_F4A_zZEoSxeGOff4">*</sup></span></td>
    <td id="xdx_98A_ecustom--Disposal_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zOF7zA2Ksu8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3180">-</span></span></td>
    <td id="xdx_985_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z4Rm6jRHskEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3181">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zzPdTfZ8IQ87" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3182">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z7Ml7PG2qXM5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3183">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zxqK38cQYOG6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,020</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z9yVKOOMngZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3185">-</span></span></td>
    <td id="xdx_988_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAfpD7EyucX1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3186">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zkWkDnVFplf4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,743)</span></td>
    <td id="xdx_98A_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zBS4JsvAGhql" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(417)</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zQZYCIVsM807" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,140)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Business
    combinations</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKg84LKNay84" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">373,680</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTMivMWO8NCc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">606,136</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3Dl9KSSdVgc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,355</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCVehoHl3O82" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,054</span></td>
    <td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzRqdd0WvCzi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,474</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zH9u7D27jOG8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">33,046</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXX7ElwXfpL6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">11,599</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl7dJ43XXPEg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,267</span></td>
    <td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgRntUVoIfl4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,234,611</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyIWtt7sa1g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,184,336</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAPIpgLTkPr5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,165,406</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWgb5DbKx6Sc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>133,369</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNS41JHdYfHe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>431,277</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhO2u0poXFEe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,759</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z01UObTkkUxb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>17,305</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHr9BvWD3WE8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>34,397</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7SLw7iMTnDa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>76,444</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN7Z7PDKTc65" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,847</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW6Co3FHS8J1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>4,093,140</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Amortization</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of January 1, 2019</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVTMWFTXcKm7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3227">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9VOEa0LPMX6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3229">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zY677rsPs7id" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3231">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDluYcBLQg89" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(2,945)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOXSiuHHtrA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,080)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z27eu706jec3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3237">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzwI10IbOTUe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3239">-</span></b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziv62DwYuaM2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3241">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK8e1ET41Lj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3243">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zP2S4NpLP8r" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,025)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhrweN45PrQ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,150)</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6IOj47FpXzk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(34,927)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJW5zpZm2r1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,456)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zs90LkueKM5j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,876)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zt7fch5NkyA" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(868)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYTtHO5sl67c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(43,277)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2019</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQmvxq2n688e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3255">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSu9HcwpMEn5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3257">-</span></b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbgv1P4XFhTf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,150)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgJoXUJ4msVg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(37,872)</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCbASu4xufMg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,536)</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjGhWA7ZVr44" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,876)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0NCtljo8nZ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3267">-</span></b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK34BN7uaF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(868)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziL4KQqog2wc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3271">-</span></b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRv64Sfjrd58" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(49,302)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuFsprRvxeXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,352)</span></td>
    <td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0C3m4tNdZl7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(47,960)</span></td>
    <td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4vpqQI1Pb4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,180)</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfiDzAUqRoS9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(2,816)</span></td>
    <td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbb1l4caHOaf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(32)</span></td>
    <td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOPpLfFpFxOh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,367)</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvU1BNA0OIZ2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(62,707)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zygf6PLXLsI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">460</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzfmtAqKJ6Nh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">460</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcY9MbR8nUPh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3284">-</span></b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqYkFl7Z3hKi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3286">-</span></b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJSgRwo85sd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(3,502)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH7fLAJ1wDp4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(85,832)</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0rnZC4GJW2h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(6,256)</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW5U72wxINI8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(7,692)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIx7B4AkeS7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(32)</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVDa8yMeN2gd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,235)</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zczVseOSEilc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3300">-</span></b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIYMYwyxNBWk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(111,549)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Amortization</span></td>
    <td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAF7Qly5ZWah" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3303">-</span></span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCybXu0S6oZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3304">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxBHx5BmYGCb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,027)</span></td>
    <td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zubKmkJvsSr5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,438)</span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EdFV6wvHi4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(5,844)</span></td>
    <td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znzLhDc6I1rg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(8,980)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx9BVkCtRRxl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(625)</span></td>
    <td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRh8kfUgG3b7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,608)</span></td>
    <td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgb9oFhb3f3c" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3311">-</span></span></td>
    <td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy60RBVK31uj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(80,522)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Disposals</span></td>
    <td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjS56W2a53k6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3313">-</span></span></td>
    <td id="xdx_98B_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaRwrN4jQncc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3314">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWx0KpoTeV8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3315">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKIWxUuidp11" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3316">-</span></span></td>
    <td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zniuF1KTm6S3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(599)</span></td>
    <td id="xdx_98F_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNSJ2wMjN4E8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3318">-</span></span></td>
    <td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztXIRdEGc6Pb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3319">-</span></span></td>
    <td id="xdx_989_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx80T1pUaD7h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">365</span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsl8H8S8gC0e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3321">-</span></span></td>
    <td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_za2dEqEd4pWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(234)</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgxV2qVoxrik" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3324">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZoR9jljaXpl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3326">-</span></b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRypdi6t7ic7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(8,529)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCGkk9S8s8ei" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(142,270)</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGLksVBw85s9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(12,699)</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1UoVgcFv9Ob" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(16,672)</b></span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbIWImgRqNY8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(657)</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuQKaZTOr9N1" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(11,478)</b></span></td>
    <td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC2BpddUhYGj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl3340">-</span></b></span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkf9uBnobtQ" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(192,305)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Net
    book value</b></span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zE8V3FvUgpW4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,184,336</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs06UttAd1j6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,165,406</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zhg2fl7uqYFc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>124,840</b></span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zFK1NxBXXfEa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>289,007</b></span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_znmlefgFDmD4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,060</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zcpKvMmISzH1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>633</b></span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zKvaXM4yuvl3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>33,740</b></span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOXO8lmqO1O8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>64,966</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zsGNAUEBbOQk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>28,847</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231_zrCyYTQlGNH3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>3,900,835</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zygN9kzpFb3j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>810,656</b></span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw1uNmd1WAG2" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,451,270</b></span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zHacTJWMU0x4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>71,512</b></span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJmT39SbdOD6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>197,707</b></span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zrkdGCswOQXj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,965</b></span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVOpwR97WGPl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>9,613</b></span></td>
    <td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zq0p7p2NQYIa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>323</b></span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zkrqGmCTUae1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>19,667</b></span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_z45HSGqjFwG4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,297</b></span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231_zooUxMWZ3Pwl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,573,010</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F00_zZu9Mg5u23Y7" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_zfAsL5DpRmci" style="font-family: Arial, Helvetica, Sans-Serif">the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F05_zKMB1nvNcvOa" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(i)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zuLRtVLlgLe6" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.</span></td>
</tr></table>

<p style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F06_zFr7UWC0GTN" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(ii)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_z4ydhiKEJR74" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#225;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.</span></td>
</tr></table>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F09_zQCa6c3fio5" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">(iii)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_zj85er5T4eEe" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal">On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock', window );">Schedule of assumptions for impairment test</a></td>
<td class="text"><p id="xdx_890_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_z6bXJpTV1et4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The carrying amounts
of goodwill and licenses with indefinite useful life by CGU and their carrying amount as of December 31, 2021 and 2020 was:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B6_zQ2HWeYUNpIc" style="display: none; visibility: hidden">Schedule of assumptions for impairment test</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="11" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-bottom: 9pt; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Carrying
    amount</b></span></td>
    </tr>
  <tr>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Goodwill</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Licenses
    with indefinite useful life</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>CGU</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2020</b></span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPTAN</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zbY6uLfmZk36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zQ44mvcqaUVb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">17,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zILJh7pp2P0e" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,214</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z7F4qyn8fxKb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">57,214</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDwKKaIHGISl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">140,522</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zT0DF7HP30ri" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">126,397</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESVAP</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zeAlZ1lG6jmb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,956</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z2jWHo6SBAL4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">27,956</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zhewlffkoZP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">81,366</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zN5TCgI8Bcnk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">81,366</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zpoP56TV7iH5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">112,260</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_znplQR4TgBth" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">112,898</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CCSI</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zEF9aIYGp6w3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_z4MLayuCI2dg" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJsfo1O1AnIh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,737</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zVzwvkUo4MW3" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">56,737</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zlj1p2hOL8f5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,030</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zn4bvgn4Xuk9" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">48,411</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IESP</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oudzNoxTH1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">73,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zFmUglBqt9nd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">73,838</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zp1WEpbSH0ng" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">179,693</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmoYi85jZk23" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">179,693</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zAvLjw9x63I3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">346,286</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zGuwFrKq5z7c" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">380,410</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FADEP</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6JJBTzO7Gnf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,661</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_ztPOG9HJe517" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">49,661</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zwkjEdn8wOVk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">70,606</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zzUfKFV3e7o4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">70,606</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zdUPnDfbZjDj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">153,791</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zZbQNT5am1Pk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">160,787</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medcel
    and CBBW<sup id="xdx_F48_zNSFhX0F0RO2">*</sup></span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zDfBOeCKubog" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,294</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z1JGVJeH9E6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,294</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z5uNFxi4L4k9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3439">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zFqBytiQsYEf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,300</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--CashGeneratingUnits_iI_pn3n3_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_fKg_____ztl9lzUOXBB1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">219,359</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FASA</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z8J5aIV2d8J5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,903</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zuF058AECMj8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,903</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zoWPq3zhxFC2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">144,507</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zL14y5Bxsnn4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">144,507</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zO1CnMq2b9Y8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">302,330</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zC4CVcHh4s5b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">267,279</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEMED</span></td>
    <td id="xdx_981_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zSn4IVr4r26g" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,647</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zZtwYkmG5cUd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,647</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zwk1TqrwtMa4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3460">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zB0wKsrmXjF7" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">126,965</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zATzj8DzHIT9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">119,227</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPEC</span></td>
    <td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zy3wu7ci7542" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3465">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z9ZTXYNTrxu" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zZfZtW4hTfvb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">108,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zXIuCaIclsbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">131,360</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbIvODB8kxLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">122,325</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniRedentor</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zooFqLCww3d1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zNfhLSfBRWn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,662</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zci9L4EpLiI7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121,477</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOr0ulV5Ag" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">121,477</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zXrgIGCutbea" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">246,320</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zV7tIYVAlFLl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">253,370</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">UniSL</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zIg3R16vOWyl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zfBfvoywZNuh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,420</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zVKFXgAP3Xal" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,387</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zCKJwtd6cwX" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">249,387</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zn4nr0KHUH56" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">305,044</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zYlwgzZ2e4yd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">258,234</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FESAR</span></td>
    <td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zSQ4xRAHWTva" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zrLi267lEdF8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">71,664</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zEEI52Bztufk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,616</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgVdNu8bS2xf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">141,616</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z964NDcXsZK3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">279,038</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zjHsiwYHJuRh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">263,914</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">FCMPB</span></td>
    <td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3Rkn0Ao1yFl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmQn89lLYon" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">110,483</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN7qrDgglIF" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYNYf4vh1LAe" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">235,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYvScuJiCTg9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">401,244</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNFFAxDs88z3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">380,682</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Practice
    Management Tools &amp; Electronic Prescription</span></td>
    <td id="xdx_982_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zQBq792otTv6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">113,362</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zLHyWfz1RyZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3523">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zuSb1p53M0K1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">227,909</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Clinical
    Decision Software</span></td>
    <td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z5TusdNxsOOh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zhQ298J9oL8b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,018</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z7J9B7c8kWKg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3527">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z2df3kzHhzJg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">147,592</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zxB4PyWZpbI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">149,805</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Medical
    Harbour</span></td>
    <td id="xdx_987_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zM6Ahi9d9bcb" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,022</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zXQs57WQt4Pb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3531">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z1hnh4QgkZrf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,150</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Moc</span></td>
    <td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_z5CwvpIq3x8j" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">87,777</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zaYmPTngbDOc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">184,597</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zGWUL66Ru19k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">5,649</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zYQ5lD9Dv0r8" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">356,789</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zbpEn8piGm3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,230</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Unigranrio</span></td>
    <td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKgF53O2SEEc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">130,073</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z9WlEuJYLFRe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">421,538</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zMTF6mdjYZnf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">630,185</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">RXPRO</span></td>
    <td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zuO3hAGg5vKc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">38,446</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zL5HKRinwMAk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl3542">-</span></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zkCZQE0iPnsc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">46,788</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    </tr>
  <tr style="background-color: White">
    <td style="width: 37%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 1%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 9%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    </tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F08_zKnFfqu5FuT" style="width: 95pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_z9LAT5xSQ9wg" style="font-family: Arial, Helvetica, Sans-Serif">CBBW as merged by Medcel on May 1,
2020.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock', window );">Schedule of estimated useful lives</a></td>
<td class="text"><p id="xdx_89B_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zDhySJj7Mhya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The estimated useful
lives of intangible assets are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B9_zNmiBNZ2nE37" style="display: none; visibility: hidden">Schedule of estimated useful lives</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; medicine</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_ztZshgpE3eKe" title="Estimated useful lives of intangible assets::XDX::P6Y"><span style="-sec-ix-hidden: xdx2ixbrl3554">6</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Customer
    relationships &#8211; other courses</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zT0Z181dGW43" title="Estimated useful lives of intangible assets::XDX::P4Y6M"><span style="-sec-ix-hidden: xdx2ixbrl3556">4.5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Software
    license</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zKckB0ycDaJi" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3558">5</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Education
    content</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVci0b1UmKDa" title="Estimated useful lives of intangible assets::XDX::P3Y"><span style="-sec-ix-hidden: xdx2ixbrl3560">3</span></span>
    years</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Trademarks</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxGX5pwOIP32" title="Estimated useful lives of intangible assets::XDX::P2Y"><span style="-sec-ix-hidden: xdx2ixbrl3562">2</span></span>
    - <span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLHLgPUum7Gd" title="Estimated useful lives of intangible assets::XDX::P30Y"><span style="-sec-ix-hidden: xdx2ixbrl3564">30</span></span> years</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt">Developed
    technology</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"><span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zteOoECwHqFj" title="Estimated useful lives of intangible assets::XDX::P5Y"><span style="-sec-ix-hidden: xdx2ixbrl3566">5</span></span>
    years</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670100055096">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialAssetsExplanatory', window );">Schedule of financial assets</a></td>
<td class="text"><p id="xdx_891_ecustom--FinancialAssetsExplanatory_zc1c86qjZ8bl" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.1</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            assets </b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_zGIRecehDRH5" style="display: none; visibility: hidden">Schedule of financial assets</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 62%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    and cash equivalents</span></td>
    <td id="xdx_980_eifrs-full--CashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z03ZdlVAmuyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">748,562</span></td>
    <td id="xdx_98F_eifrs-full--CashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z9DzQt2fYyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,045,042</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_98B_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zMOE0qi3k7wb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3576">-</span></span></td>
    <td id="xdx_985_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbZGaXJax9pj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables</span></td>
    <td id="xdx_98D_eifrs-full--TradeReceivables_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zojqVaJ0ymYc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">405,793</span></td>
    <td id="xdx_98F_eifrs-full--TradeReceivables_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfM93KhBTTch" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">309,944</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_981_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zSJzBDSCrOa7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,154,355</b></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zQhQFzLRiiS4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,357,039</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_984_eifrs-full--CurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRFOlrs3xDBe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,126,913</span></td>
    <td id="xdx_981_eifrs-full--CurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zYU2OCkrM039" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,347,359</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zPTsNaCmALXj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zKdgR5H3ZhF9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,680</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesExplanatory', window );">Schedule of financial liabilities</a></td>
<td class="text"><p id="xdx_897_ecustom--FinancialLiabilitiesExplanatory_z1BtDbTpK2P7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BF_zMFltixnOV3b" style="display: none; visibility: hidden">Schedule of financial liabilities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.2</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Financial
                                            liabilities</b></span></td></tr></table>

<p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 60%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>At
    amortized cost</b></span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGujMwpBIsql" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z9RVWJNX8MOf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zJsr3bK2PUq4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzQW49rQgfa2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zqnByovspL8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td id="xdx_98F_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zB7ahHdc6D5k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5pX9tYOjdF" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zo6A68v69oyf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_985_ecustom--NotePayable_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zwj5XlxPbf38" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_98C_ecustom--NotePayable_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z3WKaiaMZMuf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_98A_eifrs-full--Advances_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zkRg48MJ5Vyb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGyTy7ai7HR7" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBjRb4vqEDJg" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,015,196</b></span></td>
    <td id="xdx_984_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5ePpUjn3h7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,759,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_985_eifrs-full--CurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5UTx4cF9Dvf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">581,685</span></td>
    <td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFFsBL9CLegh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">467,643</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zfYOj0W3Ax72" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,433,511</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zEsJHwwCVhHe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,291,548</span></td></tr>
  </table>

<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancingExplanatory', window );">Schedule of loans and financing</a></td>
<td class="text"><p id="xdx_892_ecustom--LoansAndFinancingExplanatory_zTt3dLIkxESj" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B8_zm3SzwoyE2Kf" style="display: none; visibility: hidden">Schedule of loans and financing</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    institution</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Currency</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Interest
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Maturity</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90E_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zB9RXIJFJVAj" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Banco
    Ita&#250; Unibanco S.A</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F22_zmBicpqB3fhl">(a)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zYR9l0wMdXAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.62% p.y.</span></td>
    <td id="xdx_984_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zMd6gF9kkEXl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2023</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zuLdcpeoqIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">510,972</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_z8n583HwbbKg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">504,365</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zgOHluBj2Edd" title="Financial institution">Banco
    Votorantim</span> (b)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98B_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zZnlxaKoTEe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.65% p.y.</span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zlhSjcf7D22h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2021</span></td>
    <td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zqYSXD2EwY69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3651">-</span></span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_z5UcOoeiRcrj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">101,785</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zljZDy8OCAea" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">BNDES
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F2B_zA7LUbK9optk">(c)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_980_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zsDgiQxc1D7f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10.03%
    p.y.</span></td>
    <td id="xdx_988_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zHIVWpm4A1qa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2024</span></td>
    <td id="xdx_983_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_z9kLfBNBI75e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3660">-</span></span></td>
    <td id="xdx_988_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zvyskOp0QlWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">471</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_903_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zBok37LEBPij" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">FINEP
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F22_zkOEk5Nuq1Jf">(d)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zzIAMQ110FRc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">TJLP
    p.y.</span></td>
    <td id="xdx_981_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zko24wZWX3o2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2027</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zTicJgL5xpwi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,145</span></td>
    <td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zcXkhNP30Wk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,864</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zdnl6BDqLCDg" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Softbank
    </span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><sup id="xdx_F20_zUULCq1sRBM7">(f)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98E_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_z832kBOIMMog" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6.5%
    p.y.</span></td>
    <td id="xdx_982_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zFq3Wb4wpEId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2026</span></td>
    <td id="xdx_98F_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zKDjFTAF4TX7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">822,560</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span id="xdx_90A_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zwnfUFyxiuq8" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Banco
    Ita&#250; Unibanco S.A</span><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">. <sup id="xdx_F2D_zlY8kskBqIVc">(e)</sup></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Brazilian
    real</span></td>
    <td id="xdx_98F_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zYzY8fAL4UI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">CDI
    + 1.75% p.y.</span></td>
    <td id="xdx_98D_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zV5azFwWzxGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2024</span></td>
    <td id="xdx_98B_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zyyrDty0YKDc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,199</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20211231_zXcbIvravYPk" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,374,876</b></span></td>
    <td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20201231_zjjxY0DZLkTi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>617,485</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_ecustom--LoansAndFinancingCurrent_iI_c20211231_z1tnahTyvGs6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">128,720</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancingCurrent_iI_c20201231_zEnAh2msUbJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,162</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_ecustom--LoansAndFinancingNonCurrent_iI_c20211231_z2AMx6ZuXH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,246,156</span></td>
    <td id="xdx_987_ecustom--LoansAndFinancingNonCurrent_iI_c20201231_zRMYJYTEENb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">510,323</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0A_zTi7mUqwIWO1" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_z51L1HBzMn4b" style="font-family: Arial, Helvetica, Sans-Serif">On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1">500,000</span> adjusted by the CDI rate plus an interest rate of
<span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb">1.62</span>% per year and is repayable in three installments in October 2022, April 2023 and October 2023.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zalDbRqnSNfk" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_z810umuNjO51" style="font-family: Arial, Helvetica, Sans-Serif">On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ <span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4">100,000</span> adjusted by the CDI rate plus an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l">1.65</span>%
per year and was repaid at maturity on July 5, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_z9k3Dh9scuNh" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F18_zwCXLV6lCHHe" style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk">10.03</span>% per year and maturity in 2024.
This amount was prepaid in September 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F05_z42M0s1Bbhib" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_zYD7jefjnWq1" style="font-family: Arial, Helvetica, Sans-Serif">On July 23, 2019, Medcel entered
into a loan of R$ <span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount">16,153</span> with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$<span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche">6,734</span> and R$<span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche">4,130</span>, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zlqH3DSjUbDg" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F19_z79xim6Tpy76" style="font-family: Arial, Helvetica, Sans-Serif">On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount">30,000</span>. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of <span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate">1.75</span>% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zJ7yTusJG991" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_zsY2G5AhKIb3" style="font-family: Arial, Helvetica, Sans-Serif">On April 26, 2021, the Company issued
and sold <span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares">150,000</span> shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$<span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8">0.00005</span> per share of the Company for US$<span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5">150,000</span> thousands, equivalent to R$ <span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9">821,805</span> on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeasesExplanatory', window );">Schedule of right-of-use assets and lease liabilities</a></td>
<td class="text"><p id="xdx_895_ecustom--LeasesExplanatory_zdFVv4xpSlk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B9_z2Ngwn0Scl7d" style="display: none; visibility: hidden">Schedule of right-of-use assets and lease liabilities</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">Set out below are
the carrying amounts of right-of-use assets and lease liabilities and the movements during the period</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Right-of-use
    assets</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Lease
    liabilities</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20200101__20201231_zqMCxYvkXOH5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">274,275</span></td>
    <td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_c20200101__20201231_z13elCLROPzc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">284,515</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_c20200101__20201231_z6IRPRU2zli2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,743</span></td>
    <td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_c20200101__20201231_zEwb6VKoZrvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,743</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_c20200101__20201231_znnBIG4RpgMl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,161</span></td>
    <td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_c20200101__20201231_z8Q38gDPoVci" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">34,161</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsBusinessCombinations_c20200101__20201231_zQIMNbNUtEF6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,855</span></td>
    <td id="xdx_98E_ecustom--BusinessCombinationsLeaseLiabilities_c20200101__20201231_zmBMNPscqWfj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,855</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20200101__20201231_zxJRBXE0VABi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,386)</span></td>
    <td id="xdx_987_ecustom--DepreciationExpenseLeaseLiabilities_c20200101__20201231_ztoJHksNIQwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3749">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_c20200101__20201231_zSJL3sOUeBic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3751">-</span></span></td>
    <td id="xdx_98E_eifrs-full--InterestExpenseOnLeaseLiabilities_c20200101__20201231_ztdCIYhn2xd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">44,458</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20200101__20201231_zRHrFTjKobl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3755">-</span></span></td>
    <td id="xdx_98E_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20200101__20201231_zZmFBezSUrib" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(55,455)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_984_ecustom--RightofuseAssetsDisposals_c20200101__20201231_zfklWTEvp40a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,574)</span></td>
    <td id="xdx_98D_ecustom--LeaseLiabilitiesDisposals_c20200101__20201231_zT6cJrMY9Jad" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,574)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iS_c20210101__20211231_zsmJlIEdwvV9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>419,074</b></span></td>
    <td id="xdx_98F_ecustom--LeaseLiabilitiesRightToUse_iS_c20210101__20211231_z1WBXaNYsR7c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>447,703</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20210101__20211231_z7BMii514BZ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td>
    <td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_c20210101__20211231_zuERlh8VD2Qf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">62,689</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Remeasurement</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsRemeasurement_c20210101__20211231_zNgO35WReje3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td>
    <td id="xdx_980_ecustom--LeaseLiabilitiesRemeasurement_c20210101__20211231_ze9Od1Y85TQa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">95,962</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_989_ecustom--RightofuseAssetsBusinessCombinations_c20210101__20211231_z26LFNnLEpt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td>
    <td id="xdx_984_ecustom--BusinessCombinationsLeaseLiabilities_c20210101__20211231_zEnCU0VThshd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">139,514</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    expense</span></td>
    <td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20210101__20211231_zgUpk7wCIWPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,237)</span></td>
    <td id="xdx_986_ecustom--DepreciationExpenseLeaseLiabilities_c20210101__20211231_zDzLXE6FWy5l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3781">-</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_c20210101__20211231_zVNxOroU8ceb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3783">-</span></span></td>
    <td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_c20210101__20211231_zOZ5mQKnk673" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">67,212</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments
    of lease liabilities</span></td>
    <td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20210101__20211231_z98zlrLmRQc1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3787">-</span></span></td>
    <td id="xdx_982_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20210101__20211231_z8n1QD5C6SMd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(87,751)</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Disposals</span></td>
    <td id="xdx_986_ecustom--RightofuseAssetsDisposals_c20210101__20211231_zNzxQZuSvoyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,316)</span></td>
    <td id="xdx_987_ecustom--LeaseLiabilitiesDisposals_c20210101__20211231_zPa9mSlSONS3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,244)</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20210101__20211231_zqh7jc5JGnUa" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>663,686</b></span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitieRightToUse_iE_c20210101__20211231_z9HvVroLhE3i" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>714,085</b></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_98B_ecustom--RightofuseAssetsCurrent_iI_c20201231_zRgyXsBj6bpg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3799">-</span></span></td>
    <td id="xdx_980_eifrs-full--CurrentLeaseLiabilities_iI_c20201231_zaok1A04GPYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">61,976</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_c20201231_zf8S8erXCa0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">419,074</span></td>
    <td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_c20201231_zDVL5zRrc4Wj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">385,727</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current </span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_c20211231_zzBoYoAOHOW8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3807">-</span></span></td>
    <td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_c20211231_zH8nfPFzdmg4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,955</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98F_ecustom--RightofuseAssetsNonCurrent_iI_c20211231_znL8zaOo0366" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">663,686</span></td>
    <td id="xdx_988_eifrs-full--NoncurrentLeaseLiabilities_iI_c20211231_z7rV6IKfaR4c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">689,130</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersExplanatory', window );">Schedule of accounts payable to selling shareholders</a></td>
<td class="text"><p id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_zwneqjNLUICj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zdyavAhnUimd" style="display: none; visibility: hidden">Schedule of accounts payable to selling shareholders</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IESP <sup id="xdx_F4E_zWKVmswV4FW1">(a)</sup></span></td>
    <td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z85FAX0S8Bqk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3823">-</span></span></td>
    <td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmq4trAf5RP9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">38,771
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FASA <sup id="xdx_F4F_zZK2jTl7IkOk">(b)</sup></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zHDyYiE9Zvc8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41,581</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zn7o6AOm8RN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,356
    </span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEMED <sup id="xdx_F41_zn0dW2zvySV2">(c)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z0JJNT8ctO73" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">30,233</span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z6FOyUFC0rpb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">38,622
    </span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC <sup id="xdx_F42_zqshtSFUUJp1">(d)</sup></span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zTVdM1GIN6T1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3835">-</span></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Gyn0T3qRkc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">28,307
    </span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniRedentor <sup id="xdx_F43_z60A7817VGR6">(e)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z1WnX2DYQNdk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">85,506</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zhGM91ycQBNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">97,773</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of UniS&#227;oLucas <sup id="xdx_F43_zh0awc82kzx3">(f)</sup></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zadNHOjGgTLi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">42,672</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z2UTq3y6tC3k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">53,386</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FCMPB <sup id="xdx_F45_zETWa31mD7Ma">(g)</sup></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6jFf3ch3JY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">149,175</span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN2ftEHazwa1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">189,420</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of FESAR <sup id="xdx_F48_zgceDiGCoM72">(h)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z7FFdVFhYtgj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3851">-</span></span></td>
    <td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5MX6rtar9Y2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,569</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of MEDPHONE <sup id="xdx_F4D_zXuPicD2So23">(i)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zrCRWkNvLQtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3855">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zfitZgNNXH7k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medicinae <sup id="xdx_F47_zGPDRY4hsnCi">(j)</sup></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zq7q1Uv4FbU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,887</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Medical Harbour <sup id="xdx_F47_zzd3kqoEQ6R">(k)</sup></span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znSSTKulYKoj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,801</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Cliquefarma <sup id="xdx_F4E_zFJxLok3zxa7">(l)</sup></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z3uHvbCFHZJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,050</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Shosp <sup id="xdx_F46_zQwb0PHQiFif">(m)</sup></span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2DjnXTO02Zh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,141</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Unigranrio <sup id="xdx_F43_zJGhKY3IkE9e">(n)</sup></span></td>
    <td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z6o6KrnXQkh4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">249,979</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of RXPRO <sup id="xdx_F4B_zypPFxudJAOg">(o)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zZw1MMFKcix9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,245</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of Guaranhuns <sup id="xdx_F43_zZ0sTE37enL5">(p)</sup></span></td>
    <td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zGa2EMCQqlmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,556</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98A_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20211231_zZaewIbiNLVb" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td>
    <td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20201231_zEfXZBdmg33d" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>518,240</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20211231_zZR0JQXDprzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">239,849</span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20201231_zaKv1YAlf93j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">188,420</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current</span></td>
    <td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20211231_z3UJBu42wWw" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">439,977</span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20201231_z6BKJz3iTOxe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">329,820</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; white-space: nowrap; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Opening
    balance</span></td>
    <td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ziNL8qn9OVxc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyBh4I5Cyeoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">300,237</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsPtTtFyRWVk" style="text-align: right; line-height: 10pt" title="Opening balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">177,730</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    flows</span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholderCashFlows_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRba8aLk3XMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(192,681)</span></td>
    <td id="xdx_984_ecustom--AccountsPayableToSellingShareholderCashFlows_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsMXqxUmkyO6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(134,518)</span></td>
    <td id="xdx_98F_ecustom--AccountsPayableToSellingShareholderCashFlows_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zekqO0N1Y1U4" style="text-align: right; line-height: 10pt" title="Cash flows"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(92,688)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Acquisition
    of IPEC and Guaranhus</span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zlf0ViKTCJt6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Acquisition of IPEC"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmet3t8zdbK6" style="text-align: right; line-height: 10pt" title="Acquisition of IPEC"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">54,000</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest</span></td>
    <td id="xdx_98C_eifrs-full--InterestExpense_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zh1XghtwXkw4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">31,915</span></td>
    <td id="xdx_988_eifrs-full--InterestExpense_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkQW4S3oAsn9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,884</span></td>
    <td id="xdx_98D_eifrs-full--InterestExpense_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z6jYxkHuRfg4" style="text-align: right; line-height: 10pt" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">17,977</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Installments
    on Business combinations</span></td>
    <td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zBrFwYQP07c1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">243,816</span></td>
    <td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zGWbt4hfcmj4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">343,140</span></td>
    <td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk5EcJ66v1Te" style="text-align: right; line-height: 10pt" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">144,538</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Contingent
    consideration on Business combinations</span></td>
    <td id="xdx_981_ecustom--ContingentConsiderationOnBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze99p5bfPpuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Contingent consideration on Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,536</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Compensation
    of legal proceedings disbursement</span></td>
    <td id="xdx_988_ecustom--CompensationOfLegalProceedingsDisbursement_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zYlPrTpTTmq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl3915">-</span></span></td>
    <td id="xdx_98B_ecustom--CompensationOfLegalProceedingsDisbursement_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zfUU8fxRnMHa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,503)</span></td>
    <td id="xdx_98F_ecustom--CompensationOfLegalProceedingsDisbursement_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze4tL1PZawPa" style="text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,320)</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Closing
    balance</b></span></td>
    <td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20211231_zwWMZDfdXzz" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>679,826</b></span></td>
    <td id="xdx_98B_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20201231_zzYBtX29kCH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>518,240</b></span></td>
    <td id="xdx_98E_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20191231_zkeE4Pu6R6H7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>300,237</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zv63289LzEth" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1B_zgUAj77fQk92" style="font-family: Arial, Helvetica, Sans-Serif">On November 27, 2018, Afya Brazil
acquired <span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20180101__20181231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z4qWcJqh1xUd" title="Ownership Interest">80</span>% of IESP and R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zVuTOntw0072" title="Remaining accounts payable">106,200</span> is payable in three equal installments of R$<span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zxKyqP5yhY" title="Equal installments payables">35,400</span>, each adjusted by the CDI rate through the payment
date. The remaining installment was paid in November 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zhZQQRjmtG75" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z3QFuTYoEqH6" style="font-family: Arial, Helvetica, Sans-Serif">On April 3, 2019, Afya Brazil acquired
<span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z7XnVlpSfqu8" title="Ownership Interest">90</span>% of FASA and R$ <span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zs0rUtxXi5Cf" title="Remaining accounts payable">39,695</span> was paid in April 2020, R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zaXdD0P8Fxh2">29,770</span> was paid in April, 2021, and R$ <span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20220403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zq18SwOoMG7">29,770</span> is payable in April 2022; each installment
adjusted by the IPCA rate + 4.1% per year.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zNn6SbNXKow6" style="font-family: Arial, Helvetica, Sans-Serif">(c)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F14_zpiGi8IUG3Y9" style="font-family: Arial, Helvetica, Sans-Serif">On May 9, 2019, Afya Brazil acquired
<span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zO6RGgnXR905" title="Ownership Interest">100</span>% of IPEMED and R$ <span id="xdx_903_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zJRChPwWv7A8" title="Remaining accounts payable">45,303</span> is payable in five equal installments of R$ <span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zb0l4ohzl159" title="Equal installments payables">9,061</span>, adjusted by the CDI rate, and due annually in February
2020, 2021, 2022, 2023 and 2024.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F01_zOt4w6Wkxz28" style="font-family: Arial, Helvetica, Sans-Serif">(d)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_zLyO0cSJD5h7" style="font-family: Arial, Helvetica, Sans-Serif">On August 13, 2019, Afya Brazil
acquired <span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zC8nvwJKAmlb" title="Ownership Interest">100</span>% of IPEC and R$<span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190813__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zc3VTX2xZwO" title="Remaining accounts payable">54,000</span> is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the
first and the second year from the transaction closing date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zXafWS45PoGj" style="font-family: Arial, Helvetica, Sans-Serif">(e)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_zvV6Q4UkBYs1" style="font-family: Arial, Helvetica, Sans-Serif">On January 31, 2020, Afya Brazil
acquired <span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zemKfTaWOCW" title="Ownership Interest">100</span>% of UniRedentor and R$<span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF8be0Lxbtbd" title="Remaining accounts payable">100,000</span> is payable in five equal installments from January 2021 through July 2024, adjusted by the
CDI rate. The purchase consideration was adjusted by R$<span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zSOwnFQiVdd8" title="Equal installments payables">4,503</span> and such amount was deducted from the first installment paid in February
2021.</span></td>
</tr></table>




<p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F00_zB57gfdzaN2k" style="font-family: Arial, Helvetica, Sans-Serif">(f)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_z4kvTsPsM6M6" style="font-family: Arial, Helvetica, Sans-Serif">On May 5, 2020, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zZJFOvx7ivQl" title="Ownership Interest">100</span>% of UniSL and R$ <span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zkx4sLnWGaZ7" title="Remaining accounts payable">60,456</span> is payable in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration
was adjusted by R$<span id="xdx_904_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zHcxL6Efv0dg" title="Equal installments payables">7,816</span> and such amount was deducted from the first installment paid on May 5, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F06_z35OSOwAaon2" style="font-family: Arial, Helvetica, Sans-Serif">(g)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_zcGrR7lQ5R4j" style="font-family: Arial, Helvetica, Sans-Serif">On November 9, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zPVFC9IyMQPl" title="Ownership Interest">100</span>% of FCMPB and R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZRPKMvZBp69" title="Remaining accounts payable">188,894</span> is payable in four installments through November 2024, adjusted by the CDI rate.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F04_zBAR9sLU1I7f" style="font-family: Arial, Helvetica, Sans-Serif">(h)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_ziEfKwWW2PD6" style="font-family: Arial, Helvetica, Sans-Serif">On November 3, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwuk4GghLIe4">100</span>% of FESAR paid in cash and R$<span id="xdx_903_ecustom--CashTransferredTransaction_iI_c20201103_zaQWkcVVQ525" title="Cash on the transaction closing date">1,569</span> of price adjustment was paid on February 25, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0C_z7wRV9wy7h85" style="font-family: Arial, Helvetica, Sans-Serif">(i)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zF4qniF3CIa" style="font-family: Arial, Helvetica, Sans-Serif">On November 4, 2020, Afya Brazil
acquired <span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNx2GJ2g6oik">100</span>% of MedPhone paid in cash and R$<span id="xdx_902_ecustom--CashTransferredTransaction_iI_c20201104_zIuX9r673xQ5">36</span> of price adjustment was paid on February 2, 2021.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0F_zYhXumGsklLl" style="font-family: Arial, Helvetica, Sans-Serif">(j)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F10_zvrhRBRUHY3c" style="font-family: Arial, Helvetica, Sans-Serif">On March 25, 2021, Afya Brazil acquired
<span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210323__20210325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zO6SyjqODtod">100</span>% of Medicinae and an earn-out (&#8220;contingent consideration&#8221;) of up of R$ <span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210305__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBEDWkEbyHn1">4,400</span> is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$<span id="xdx_907_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210325_zj2gQJModqXk">3,887</span> is based on the present value of the obligation
considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition
date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0B_zmrfcFiYSna2" style="font-family: Arial, Helvetica, Sans-Serif">(k)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1F_zKH6Z5xMI421" style="font-family: Arial, Helvetica, Sans-Serif">On April 8, 2021, Afya Brazil acquired
<span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210408__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zCwaNP6gbIkc">100</span>% of Medical Harbour and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_900_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zWiugvjBH466">9,000</span> is payable in relation to product development
goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$<span id="xdx_902_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210408_ztq8TsDI9bo3">6,801</span> is based on the present value of the
obligation considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from
the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F09_zic2lNOonq9k" style="font-family: Arial, Helvetica, Sans-Serif">(l)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zAzhkm1LyH9d" style="font-family: Arial, Helvetica, Sans-Serif">On April 16, 2021, Afya Brazil acquired
<span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210416__20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZBAEeUDaQ4a">100</span>% of Cliquefarma and an earn-out (&#8220;contingent consideration&#8221;) of R$ <span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z1aWp9bANHv6">3,000</span>, adjusted by the CDI rate, is payable in relation
to product development. The contingent consideration of R$<span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210416_zhVJ13vYYy8a">3,050</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F02_zimx5sAe3Q5a" style="font-family: Arial, Helvetica, Sans-Serif">(m)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F16_z3Ypn6VwQW9c" style="font-family: Arial, Helvetica, Sans-Serif">On May 13, 2021, Afya Brazil acquired
<span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210513__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zbv1BsGfHWVf">100</span>% of Shosp and R$ <span id="xdx_906_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20210513_z3ZUFmEpUbO5">454</span> will be paid, and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zGZHllMfQ7A3">1,793</span> is payable in relation
to product development. The contingent consideration of R$ <span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210513_zp4A5zkvUaH8">2,141</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F07_zYxXw7KwaOEi" style="font-family: Arial, Helvetica, Sans-Serif">(n)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1C_z6d9bo4Byk1j" style="font-family: Arial, Helvetica, Sans-Serif">On August 4, 2021, Afya Brazil acquired
<span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210802__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zFSfON2j3lMc">100</span>% of Unigranrio. The adjusted aggregate purchase price is R$ <span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_c20211004_zj5L1805Wg13">618,956</span> of which 60% was paid in cash on the transaction closing date,
and 40% is payable in cash in four equal installments through 2022 to 2025, adjusted by the CDI rate.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F03_zPYdaXJ54hLh" style="font-family: Arial, Helvetica, Sans-Serif">(o)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_zG0eJg2Jb9i2" style="font-family: Arial, Helvetica, Sans-Serif">On October 01, 2021, Afya Brazil
acquired <span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zoNgvH2MPTc7">100</span>% of RXPRO and an earn-out (&#8220;contingent consideration&#8221;) of up to R$ <span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZ9wnw1fvIOc">21,000</span> is payable in relation to revenue
achievements until 2024. The contingent consideration of R$ <span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20221101_z7TP8wlyiZV8">10,245</span> is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.</span></td>
</tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F0D_zFBWHTxNp5Rc" style="font-family: Arial, Helvetica, Sans-Serif">(p)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F12_zHY8VC1ZsVP1" style="font-family: Arial, Helvetica, Sans-Serif">On November 05, 2021, Afya Brazil
concluded the acquisition of <span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211103__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwymGW7j6Drb">100</span>% of ITPAC Garanhuns and R$<span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20211105_zbhmCjeFIhad">54,000</span> was paid in cash on the transaction closing date, and (ii) R$<span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zITzyB2teMSh">54,000</span>
is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the first and the second year from the
transaction closing date.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock', window );">Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_z5DCGf8Y4wg8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B7_zJTQk38nruLk">Set out below are
the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020</span>:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Notes
    payable</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2020</span></td>
    <td id="xdx_982_ecustom--NotesPayables_iS_c20200101__20201231_zsgyxJTQLrq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4011">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_987_ecustom--BusinessCombination_c20200101__20201231_zEpHfKXIrc2k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,526</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_983_ecustom--Payments_c20200101__20201231_z5s1hgd150E6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,974)</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_983_ecustom--MonetaryIndexation_c20200101__20201231_z5sFIIhY5sZ3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,629</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td id="xdx_983_ecustom--NotesPayables_iE_c20200101__20201231_zKzhEKGuq7M3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>76,181</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">As
    of January 1, 2021</span></td>
    <td id="xdx_98B_ecustom--NotesPayables_iS_c20210101__20211231_zQj34gCMCMgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payments</span></td>
    <td id="xdx_98E_ecustom--Payments_c20210101__20211231_zfnn8PvVPfJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,068)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Monetary
    indexation</span></td>
    <td id="xdx_982_ecustom--MonetaryIndexation_c20210101__20211231_zm5KCf2MpGn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,613</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td id="xdx_985_ecustom--NotesPayables_iE_c20210101__20211231_zVJ4rjE8NzCe" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,726</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20201231_zk3AyucBk55l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,503</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_988_ecustom--NoncurrentLiabilities1_iI_c20201231_zsrEYzmSBoid" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">65,678</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Current
    liabilities</span></td>
    <td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20211231_zqz2X3AcGCrj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,478</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Non-current
    liabilities</span></td>
    <td id="xdx_987_ecustom--NoncurrentLiabilities1_iI_c20211231_zDsDEsuFnyb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">58,248</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValuesExplanatory', window );">The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:</a></td>
<td class="text"><p id="xdx_89E_ecustom--FairValuesExplanatory_zZU9RxJtTm0f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zZOUXTUSAMNb">The table below
is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts
that are reasonable approximation of fair values:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="vertical-align: top; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td>
    <td style="vertical-align: top; width: 1%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Carrying
    amount</b></span></td>
    <td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    assets</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    cash</span></td>
    <td id="xdx_980_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zlSrl1jMBG5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4039">-</span></span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_ztw50xcwItNi" style="text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4041">-</span></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDWBYwMcpDag" style="vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDsTMBLsDEsh" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zoP3rH7SDWcg" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zMmzoQSdPNfh" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zpDlE02rC7H5" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zw00yKc1rcl2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231_zn9IsJRzjBp6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,442</b></span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231_z9vAXN5tQtMg" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>27,442</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231_zvDerqFpVeNi" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,680
    </b></span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231_zzAU7wmjRS7c" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>9,680
    </b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Financial
    liabilities</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7eXKxNleE4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zmiCnYGnHSse" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,387,136</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zwWZlHXPlce4" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td>
    <td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z4cagkzuI0Ze" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">637,723</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqy3kpIDoFR1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zb4COTQVfhqc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0tTACsYIcjc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyu1EH2P2C0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zAExwPDUDcSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_za8yg0zGZuNc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zANRVRvAK3u1" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3KlOM3pM9mh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_982_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zwHQ6rpBhmC5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrDFkE52IZtk" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zKd8zO5jweyk" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z5X9mEIKgvqe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231_zqheb4BLrFqj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,841,513</b></span></td>
    <td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231_zEQQF9NjmRmb" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,853,773</b></span></td>
    <td style="vertical-align: top; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20201231_zqT8L7GErqU8" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,659,609</b></span></td>
    <td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231_zzjde6jmSWKa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,679,847</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock', window );">Schedule of sensitivity analysis effects on income statement</a></td>
<td class="text"><p id="xdx_89F_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zHe53FQOmRll" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B8_zat4SI5YH5wd" style="display: none; visibility: hidden">Schedule of sensitivity analysis effects on income statement</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Increase
    / decrease in basis points</b></span></td></tr>
  <tr>
    <td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Balance
    as of December, 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Index
    &#8211; % per year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Base
    rate</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>+75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>-75</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;+150</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>&#160;-150</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Cash
    equivalents</span></td>
    <td id="xdx_987_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zkMmVcQLnvu6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">636,847</span></td>
    <td id="xdx_98D_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">100.38%
    CDI</span></td>
    <td id="xdx_98B_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zA95Ma8zHKxe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">58,440</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zDelf0lhW9xb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,776</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zfrjmrzbO768" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,776)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zGNW0hylZpS" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,553</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_z5FqeLfVGyh1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(9,553)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_985_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zR5BYkQ6ua3a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(510,972)</span></td>
    <td id="xdx_983_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI
    + 1,62%</span></td>
    <td id="xdx_98E_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zYrQiVkgZG7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(55,032)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zCDu5y3QwTva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,832)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zGvYyCPWFxvi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">3,832</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zL5sCZpPLF3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(7,665)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zjec1WlNflx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,665</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_98B_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zvRceLz9iUhh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(31,199)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI
    + 1,75%</span></td>
    <td id="xdx_982_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zbldYpljfgye" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(3,401)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zHWpH13UYzRc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(234)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zluvRGbN4XVl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">234</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zn92w0pz9l0e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(468)</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zKfzG8913TJl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">468</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans
    and financing</span></td>
    <td id="xdx_983_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7kfyVoPNm84" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(10,145)</span></td>
    <td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">TJLP</span></td>
    <td id="xdx_986_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zymYT2fjrLU" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(617)</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0QEExR22rg5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(76)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zXlq3A2x2SYa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">76</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zPtpw6gYoE38" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(152)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zync6RthPxK4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zNzxR8xNO4n1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(612,121)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">CDI</span></td>
    <td id="xdx_989_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zW022jV7R6xj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(56,009)</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zibUHYUa7Oel" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,591)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zCZzXSwIz3Jk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,591</span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zIE3nL0Sl9J5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(9,182)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_za9oDGDF1xgg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">9,182</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zLTcAtOYEOS9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(41,581)</span></td>
    <td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPCA
    + 4,1%</span></td>
    <td id="xdx_985_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zyZynExQ2cTh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,708)</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0sNJe5lIG5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(312)</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zFEj6X8pkN6d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">312</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zUUwEl6Y6h3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(624)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zEXLvE4Mw6R1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">624</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Notes
    payable</span></td>
    <td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zv9D85Z2GyGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(72,726)</span></td>
    <td id="xdx_980_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrh6F5yzAhkf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">IPCA</span></td>
    <td id="xdx_983_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zfF2DneRexki" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(531)</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zatr49n2q818" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(545)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_pn3n3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">545</span></td>
    <td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zuvc6ZEsPX39" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,091)</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_ziI61PtYcwC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,091</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock', window );">Schedule of currencies used in sensitivity analysis</a></td>
<td class="text"><p id="xdx_89B_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zyr8Zg34xvOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B5_zbUvoYfOqgxa" style="display: none; visibility: hidden">Schedule of currencies used in sensitivity analysis</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table demonstrates the sensitivity in the Company&#8217;s income before income taxes of a <span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_uPure_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpVCAKSniQMh" title="Percentage of sensitivity change in the Euro exchange rate">10</span>% change in the U.S. dollar exchange
rate (R$<span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zoAOQUxCI73i" title="Closing foreign exchange rate">5.5799</span> to U.S. dollar <span id="xdx_906_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__srt--CurrencyAxis__currency--EUR_z00xfSouENQ5" title="Closing foreign exchange rate">1.00</span>) as of December 31, 2021, with all other variables held constant.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 37%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Exposure</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>+10%</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>-10%</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cash
    equivalents</span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember_ztDJvmNDSlti" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,228</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember_zK6CpS8zyDUb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,323</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember_zpsVsSJOVS1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,323)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock', window );">The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</a></td>
<td class="text"><p id="xdx_893_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_za0yScJSdrej" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B3_zFkJPusodgkc">The
tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zR9ZkQIDins9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z5ESeiYiJu25" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4224">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zOvm3azUSBs6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4226">-</span></span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXcsvktPk5lh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4228">-</span></span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zfLFM8oJPa5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,098</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zAxP8BwZb9Bk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">217,903</span></td>
    <td id="xdx_981_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCmazm93nvAb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">585,686</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zIJrnlln4042" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">948,503</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7QoigujE0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,212</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeFK3fOUlXu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,753,304</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_983_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zglTCcVoV3j8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">103,003</span></td>
    <td id="xdx_98D_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zp5n9N8ODbL4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">211,894</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zFaYTrBHa43b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">204,744</span></td>
    <td id="xdx_981_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFkneZOqHSi2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,108,555</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zF8LfSWBn2Lj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,628,196</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSuGOEgdO9Zk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">246,059</span></td>
    <td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zSOb24gSUJta" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">445,066</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zTnAuGVP3Luc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">88,989</span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zghUk6ER8yqk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4258">-</span></span></td>
    <td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDpcXG5ur67" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">780,114</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zIPwKdlJlYb1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,644</span></td>
    <td id="xdx_985_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z6BOp1GaV2D7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">74,306</span></td>
    <td id="xdx_98E_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z1N6g9dOfRv1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4266">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkTvLYtv4Moj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4268">-</span></span></td>
    <td id="xdx_988_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcOoi4gTMJXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">89,950</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_981_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHdgYToVRh4h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td>
    <td id="xdx_982_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z4jVhcodwudk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4274">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEHsT2votfHh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4276">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zX70wZHR0elg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4278">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJ3EBS582on9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">114,585</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zejCy1whiy7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>756,292</b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zf3xtPAAbAY4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,316,952</b></span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_znnUWNIzipzd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,242,236</b></span></td>
    <td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWZ5Ztlfr7Qh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,109,767</b></span></td>
    <td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zx88NWt85IIe" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,425,247</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom; background-color: white">
    <td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>As
    of December 31, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Less
    than 1 year</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1
    to 3 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3
    to 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>More
    than 5 years</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"><b>Total</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    payables</span></td>
    <td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHUzNQNtkepj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td>
    <td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zmk8tw64dIek" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4294">-</span></span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zPyPlVsWUS8b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4296">-</span></span></td>
    <td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zya1DGm6Zaf6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4298">-</span></span></td>
    <td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcu3rSjjuoag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,743</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zb5DxVkLnxbh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">125,137</span></td>
    <td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zXHoZ9KYiKBa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">566,157</span></td>
    <td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zL5GI9yVFTF7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,010</span></td>
    <td id="xdx_98C_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_ztti00xRVKTh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,094</span></td>
    <td id="xdx_982_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZHk0tkigzj5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">698,398</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_982_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHy6r1lGO0a4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,092</span></td>
    <td id="xdx_98E_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCJZr99KjTsh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">131,225</span></td>
    <td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zDk8gHEqyHLf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">124,114</span></td>
    <td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7bapOfNibzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">705,115</span></td>
    <td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zh7LW7LtcVzc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,023,546</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zajemD1YjNn9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">191,145</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zwey8TOCU595" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">262,340</span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zxlxhQ84QTEj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,153</span></td>
    <td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zboMg8va7zJa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4328">-</span></span></td>
    <td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zs5k486his6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">534,638</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98F_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zYL7ZAGkP7O2" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,083</span></td>
    <td id="xdx_98C_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zLILVAJLuqMi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">83,803</span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zZgvcHYr2YP6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4336">-</span></span></td>
    <td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zvHtRfvXMfde" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4338">-</span></span></td>
    <td id="xdx_980_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcnOG1lmTZe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,886</span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Advances
    from customers</span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zMvjaRfcnLLa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839</span></td>
    <td id="xdx_984_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zdKLp1ZpCM1h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4344">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zLR7BgSFl1Xc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4346">-</span></span></td>
    <td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkghtfKDDgw5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4348">-</span></span></td>
    <td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zQeuxPIJCtHg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">63,839</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z3bZ3kUs2V93" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>490,039</b></span></td>
    <td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zQFuZyfnwZZc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,043,525</b></span></td>
    <td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zAMKqlZrEICh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>209,277</b></span></td>
    <td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zz1VRG3s4AV6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>708,209</b></span></td>
    <td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAXiAJL5BLOf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,451,050</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory', window );">Schedule of changes in liabilities arising from financing activities</a></td>
<td class="text"><p id="xdx_897_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_zQIjwPYbRiLi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8BE_z0ZCC6n1vFYh" style="display: none; visibility: hidden">Schedule of changes in liabilities arising from financing activities</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.5in"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>13.5</b></span></td><td><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Changes
                                            in liabilities arising from financing activities</b></span></td></tr></table>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions
    <sup id="xdx_F59_zjmlxRS0kB19">*</sup></b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2021</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzKV1KrzomN6" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBhMABRspry2" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(158,076)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0IWU803TwE8" style="border-top: black 1pt solid; padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">809,539</span></td>
    <td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zE251ENp5sa8" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">68,909</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zttz7OkvSqMj" style="border-top: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4372">-</span></span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsELnO5IGU7c" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">36,591</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z12f4fJYZuU6" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">428</span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zcau0ImGxAs" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,374,876</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zpineiBbhIl9" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlOf5eg67ARj" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(87,751)</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zjLHdTlougR3" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">158,651</span></td>
    <td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD66xhLXBfld" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">67,212</span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"> -</span> </td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs7pHPy5hh44" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">139,514</span></td>
    <td id="xdx_983_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYLqGr2Ib4I2" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(11,244)</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3T3KLwlRaJi" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">714,085</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zxh7TigBpiyh" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(18,648)</span></td>
    <td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zyZD4UVYcmyl" style="padding-right: 0.6pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">18,648</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z3AaPlZtHqO9" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4398">-</span></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231_zc79fNAkOCFl" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zvz4G9Gc8K12" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(264,475)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_z0WhhH6xXUWf" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>986,838</b></span></td>
    <td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zgOWWOfpIolg" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>136,121</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zHEs9vEAlam7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b><span style="-sec-ix-hidden: xdx2ixbrl4408">-</span></b></span></td>
    <td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zE5qX9c3Ohsk" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>176,105</b></span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zSdC8sXzBLuc" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(10,816)</b></span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231_zMmivOiIrttd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>2,088,961</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2020</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2020</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znNgfRvcvrL5" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,357</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z488AWFL9Pc1" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(155,090)</span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQRS8K72PG9" style="text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">605,041</span></td>
    <td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQGzat4E5Rf" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">10,031</span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zxcFFwNfLEd5" style="text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">21,279</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z2yFEffKsgu3" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">75,815</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z3fQhUiEyV5j" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">52</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL4vlWbpDMa9" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">617,485</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zsjemhoyBpQ2" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">284,515</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdWYi7ZLYlA8" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(55,455)</span></td>
    <td id="xdx_986_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg9GKhMDeIrj" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">98,904</span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJo0bAFtKMv" style="vertical-align: top; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">44,458</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx4oCQ5QMSuc" style="vertical-align: top; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">76,855</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAjwku3wyR92" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(1,574)</span></td>
    <td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEwNsjCJhI8j" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">447,703</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zRPzgaQjMI1c" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(12,984)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zQFazbpww7P9" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">12,984</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ziEhcLhcy8Q1" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4450">-</span></span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231_z9O73Awb2TQi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>344,872</b></span></td>
    <td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zXTJtxdYXYt7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(223,529)</b></span></td>
    <td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_znMpIvd6m0a6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>716,929</b></span></td>
    <td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zTNEZIwf4iP3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>54,489</b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zHoiW39bFVNi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>21,279</b></span></td>
    <td id="xdx_986_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zwQnIS48Otcc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>152,670</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zGoDMH5X1lt8" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(1,522)</b></span></td>
    <td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231_z2FUiU9hwEpj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,065,188</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>January
    1, 2019</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Payments</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Additions</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Interest</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Foreign
    exchange movement</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Business
    combinations</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Other</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>December
    31, 2019</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Loans and financing</span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zvIedUS2OSce" style="text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">77,829</span></td>
    <td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAztwm1hTDFe" style="text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(75,093)</span></td>
    <td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zHzQ9tv2pVrf" style="text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">7,383</span></td>
    <td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zaQRffcT0426" style="text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">6,025</span></td>
    <td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zX2e90SRtrF2" style="text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">1,126</span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbScPCHhooj5" style="text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">43,087</span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zU8NOeGHXQGl" style="text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4480">-</span></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zOdCTOm6NpEj" style="text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">60,357</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Lease liabilities</span></td>
    <td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg6AfYkrklbd" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">212,360</span></td>
    <td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJFXc4dUb3vh" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(39,779)</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zV7vCpqtxln6" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">19,100</span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z56k3GTEIkH8" style="vertical-align: top; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">31,469</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlsE1REWk4sa" style="vertical-align: top; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">61,365</span></td>
    <td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z45ORsY1yHKk" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><span style="-sec-ix-hidden: xdx2ixbrl4494">-</span></span></td>
    <td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBpJyPU22eAh" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">284,515</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Dividends payable</span></td>
    <td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zPxIx3kYyRWk" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">4,107</span></td>
    <td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zXE7a5RQ5nU5" style="vertical-align: top; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(51,812)</span></td>
    <td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zF3LHI3EOmD3" style="vertical-align: top; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">51,812</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuntcQFNIZ6d" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(4,107)</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Total</b></span></td>
    <td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231_zWjhmNV0jbFl" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>294,296</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231_ze9pHOp2ROnf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(166,684)</b></span></td>
    <td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_z7YmPXLx5G6l" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>78,295</b></span></td>
    <td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zoMYYBaUIlnj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>37,494</b></span></td>
    <td id="xdx_980_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zVuSmFJMulSj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,126</b></span></td>
    <td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zXDuM8hDZEo3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>104,452</b></span></td>
    <td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zy4hVBxUQKYi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>(4,107)</b></span></td>
    <td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231_zlBo7XnlR6i3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>344,872</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.2in; text-align: right"><span id="xdx_F08_zC1w9HM6N3oc" style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1C_zmkOARTph9rj" style="font-family: Arial, Helvetica, Sans-Serif">The additions of loans and financing
include proceeds from the SoftBank transaction of R$<span id="xdx_905_ecustom--ProceedsFromLoansAndFinancing_c20210101__20211231_zPVJqip9Bt1a" title="Proceeds from loans and financing">822,569</span>, net of the transaction costs of R$<span id="xdx_90C_ecustom--NetOfTransactionCosts_iI_c20211231_zcVZhLnJfqc3" title="Net of the transaction costs">13,030</span>.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValuesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValuesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialAssetsExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialAssetsExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeasesExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeasesExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103274680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair value measurement (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureFairValueMeasurementAbstract', window );"><strong>Fair Value Measurement</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfFairValueMeasurementExplanaory', window );">Schedule of fair value measurement</a></td>
<td class="text"><p id="xdx_89E_ecustom--ScheduleOfFairValueMeasurementExplanaory_zJdM6EE0ONbe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table provides the fair value measurement hierarchy of the Company&#8217;s assets and liabilities as of December 31, 2021 and
2020.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8B7_zuzV93xmQ3ec" style="display: none; visibility: hidden">Schedule of fair value measurement</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Fair
    value measurement</b></span></td></tr>
  <tr>
    <td style="vertical-align: top; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; width: 11%; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Quoted
    prices in active markets (Level 1)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    observable inputs (Level 2)</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Significant
    unobservable inputs (Level 3)</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2021</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zhCth7nfvbEa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98E_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_znrXf6XTbL7d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4531">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zh0cJ9cruixh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,442</span></td>
    <td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrCMoM2zWKQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4533">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_988_ecustom--LoansAndFinancingLiabilities_iI_c20211231_zStnHx8NqgQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,387,136)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZkKgWYT9iX5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,387,136)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98B_ecustom--LeaseLiabilities1_iI_c20211231_zZ7P1fK7rEQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(714,085)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilities1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zPPxReUN5cC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(714,085)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_989_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231_zcj97k18b3I1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(679,826)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zWL81pm1CXx4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(679,826)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_981_ecustom--FairValueNotesPayables1_iI_c20211231_zyHtMiPTzqL" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(72,726)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayables1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpuOJXK9a8yi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(72,726)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>

<tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt">&#160;</td></tr>
<tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>December
    31, 2020</b></span></td>
    <td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Assets
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Trade
    receivables (non-current)</span></td>
    <td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zIVPAfCRPCU" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zDdyksXKlg0c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4548">-</span></span></td>
    <td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zroCEOrEYjxh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,627</span></td>
    <td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVWLihjpycw4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4550">-</span></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Restricted
    Cash</span></td>
    <td id="xdx_982_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231_zStMHCpteDac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwHOzYpyXmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,053</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Liabilities
    for which fair values are disclosed</b></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td id="xdx_98D_ecustom--LoansAndFinancingLiabilities_iI_c20201231_zjh4MpveyTqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(637,723)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0Lv31jMWA7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(637,723)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td id="xdx_98A_ecustom--LeaseLiabilitiesOne_iI_c20201231_zwBQDzdY2NT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(447,703)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_981_ecustom--LeaseLiabilitiesOne_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z7GRegCInEb5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(447,703)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td id="xdx_981_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231_zZ9n1MKhJrM8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(518,240)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zThldZNf5Lmb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(518,240)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td id="xdx_98E_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231_zvYjDKuF67L4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,181)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_984_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zOQRkNJjWW8j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(76,181)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureFairValueMeasurementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureFairValueMeasurementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFairValueMeasurementExplanaory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFairValueMeasurementExplanaory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103638680">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Capital management (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureCapitalManagementAbstract', window );"><strong>Capital Management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfCapitalManagementExplanatory', window );">Schedule of capital management</a></td>
<td class="text"><p id="xdx_890_ecustom--ScheduleOfCapitalManagementExplanatory_zSXw9J05DwR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
Company manages its capital structure and makes adjustments in light of changes in economic conditions and to maintain and adjust the
capital structure, the Company may adjust the dividend payment to shareholders, repurchase programs, return capital to shareholders or
issue new shares. The Company monitors capital using net debt and total equity. The Company includes within net debt, loans and financing,
lease liabilities, accounts payable to selling shareholders and notes payable less cash and cash equivalents and restricted cash.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B4_zYbAG1njvf42" style="display: none; visibility: hidden">Schedule of capital management</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20211231_zcBAwwFSF051" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="width: 3%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_499_20201231_zOBjXxSE9zBi" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_409_ecustom--LoansAndFinancing_iI_zfuNYegJ5Ic4" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Loans
    and financing</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,374,876</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">617,485</span></td></tr>
  <tr id="xdx_40B_eifrs-full--LeaseLiabilities_iI_zu3ceoK2G632" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">714,085</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">447,703</span></td></tr>
  <tr id="xdx_403_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_zngcvFUNVsji" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Accounts
    payable to selling shareholders</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">679,826</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">518,240</span></td></tr>
  <tr id="xdx_403_eifrs-full--NotesAndDebenturesIssued_iI_zN6xagKBEBJ9" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Notes
    payable</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,726</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,181</span></td></tr>
  <tr id="xdx_400_ecustom--CashAndCashEquivalents1_iI_zetZoWqwVcBj" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    cash and cash equivalents</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(748,562)</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,045,042)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iI_zPcj7UmCh6w1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Less:
    restricted cash</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4591">-</span></span></td>
    <td style="text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 8.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,053)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--NetDebt_iI_zy7btShsQYOk" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    debt</b></span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,092,951</b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>612,514</b></span></td></tr>
  <tr id="xdx_40D_ecustom--EquityOne1_iI_zQORETf8TjQ1" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Total
    equity</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,000,018</span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,833,780</span></td></tr>
  <tr id="xdx_405_ecustom--EquityAndNetDebt1_iI_zPnbRiMXpDF6" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total
    equity and net debt</b></span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,092,969</b></span></td>
    <td style="text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,446,294</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfCapitalManagementExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfCapitalManagementExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103185848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions', window );">Schedule of model used to determine the fair value of the stock options</a></td>
<td class="text"><p id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_zmsYqQFDMnee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following table list the inputs to the model used to determine the incremental fair value of the stock options as result of the modification:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"/></p>

<p><span id="xdx_8B6_zDiFiXiF6J05" style="display: none; visibility: hidden">Schedule of model used to determine the fair value of the stock options</span></p>



<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"/>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Modified
    plan</b></span></td>
    <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Original
    plan (*)</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span title="Strike price at the measurement date"><span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zmds9KRJts3c" title="Strike price at the measurement date::XDX::74"><span style="-sec-ix-hidden: xdx2ixbrl4611">74.38</span></span></span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zfHQJSCbNWla" title="::XDX::99"><span style="-sec-ix-hidden: xdx2ixbrl4612">99.09</span></span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zikEpRzdvrKd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Dividend yield"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0.0%</span></td>
    <td id="xdx_983_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zNs2TbZo0EOb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">0.0%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Expected volatility"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcJuRknD5n66" title="Expected volatility, minimum">41</span>%
    - <span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziOKPFTlMpd3" title="Expected volatility, maximum">76</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvC04AGrVMB9" title="Expected volatility, minimum">42</span>%
    - <span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQnmBwyw9yX6" title="Expected volatility, maximum">76</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC7J3qP5Spvd" title="Risk-free interest rate, minimum">2.0</span>%
    - <span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTUGwEJczfg7" title="Risk-free interest rate, maximum">4.9</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFL775XlsT8j" title="Risk-free interest rate, minimum">0.2</span>%
    - <span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zl98hXWVL7Hc" title="Risk-free interest rate, maximum">0.4</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhhCcjUornw9" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC8kyN9npfh6" title="Expected life of stock options, maximum">4</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zArbdkriwVG1" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z48eQDHsKsdb" title="Expected life of stock options, maximum">4</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td id="xdx_98E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zANukntkjuIf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Share price at the measurement date"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    133.68</span></td>
    <td id="xdx_988_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zmlQJLff5s15" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    133.68</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td id="xdx_98D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zs50DLgOtC9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Model used"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Binomial</span></td>
    <td id="xdx_982_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zoBcfJP3oiH3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Binomial</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zSYMFbIIVHMc">69.54</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zUPrRZuIRT93">57.12</span></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">(*) The strike price
of the original plan was based in U.S. dollars.</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt">On
January 25, 2021, March 25, 2021, April 26, 2021, </span><span style="font-family: Arial, Helvetica, Sans-Serif">June <span style="font-size: 11pt">1,
2021 and November 1, 2021, the Company granted <span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210123__20210125_zLQf4GTPqm8b" title="Number of stock option granted">545,000</span>, <span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210323__20210325_zuov2pSLaSJi">65,000</span>, <span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210423__20210426_zoibUUmIYKBc">139,000</span>, <span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210601__20210601_zRy0sLCQ3Z7b">180,000</span> and <span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20211101__20211101_zp0HRvV9K5b3">241,000</span> additional stock options, respectively:</span></span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>January
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>March
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>April
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>June
    2021</b></span></td>
    <td style="border-bottom: Black 1pt solid; width: 15%; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>November
    2021</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Strike
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_906_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210131_zN7MXTnWC9F" title="Strike price at the measurement date">115</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210331_zEZTVjWGQ4Si">105</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210430_zPe5CQsqH05c">105</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_903_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210630_zRivVyK90W8k">105</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20211130_zbvB8BLLBTU1">85</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Dividend
    yield (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210101__20210131_zWAzgjRRYcT9" title="Dividend yield">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210301__20210331_z2PoNYhk6y9c">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210401__20210430_zz3M8yK9X9Ek">0.0</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210601__20210630_z3EbZIaazc2i">0.0</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20211101__20211130_zOAgHRoLQ2Hi">0.0</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    volatility (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z2v7QnO2LVkd" title="Expected volatility, minimum">38</span>%
    - <span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEjBssXknPW6" title="Expected volatility, maximum">67</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1aMda4defl">42</span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKok13N0cTGe">65</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4oldicjdHc">43</span>%
    - <span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaf1Ku0j3Qx6">51</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYsbrfcpGnM3">43</span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zrEZ4neSZ3n5">63</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfMc4ilJUDU3">41</span>% - <span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdpffPNRg0t7">65</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Risk-free
    interest rate (%)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBlfN2599uj7" title="Risk-free interest rate, minimum">2.1</span>%
    - <span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8a77JTiuyS8" title="Risk-free interest rate, maximum">7.1</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zAs2oRLyqTzg">5.2</span>%
    - <span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLFcmzX3077d">8.5</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0O7jeGgONM3">5.1</span>%
    - <span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2yZdPFq8ca9">8.1</span>%</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCffft5OLCSk">5.8</span>%
    - <span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8mipFFMqcf3">8.3</span>%</span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zimeTnJOFLJ">10.4</span>% -
    <span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBWLgC10hwvk">12.5</span>%</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Expected
    life of stock options (years)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFx69OPM0vu5" title="Expected life of stock options, minimum">1</span>
    &#8211; <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLc6QZbKjYmf" title="Expected life of stock options, maximum">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBWzBTxaLaB4">1</span>
    &#8211; <span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zopl7TeHH4M4">5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4JIsUdPUPIc">1</span>
    &#8211;<span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQkbbAhNu99e"> 5</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4Z7WDYfbKnd">1</span>
    &#8211; <span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXHsQ2vDMGJf">5</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zW5mYe6tYEil">1</span> &#8211;
    <span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUcgeGO4owxj">5</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share
    price at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_908_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210131_zxisUK9o0gXj" title="Share price at the measurement date">129</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20210331_zNq7Y6QIPvZ1">108</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_900_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210430_zMcqRXffU9R9">119</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_901_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210630_zRZayV1UUICl">121</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$ <span id="xdx_905_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20211130_zNZzpLNQNjD6">8</span></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Model
    used</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zVytSGbj2Jjd" title="Model used">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zkzwsvDcv6U3">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210401__20210430_zptc5uKQjDZ7">Binomial</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210601__20210630_z7U9a5jvqC32">Binomial</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20211101__20211130_zAUpEU1PNjF">Binomial</span></span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average fair value at the measurement date</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_905_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210131_zxiTJ8nhYXW8" title="Weighted average fair value at the measurement date">46.81</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20210331_zQOhrOZJWIUf">40.20</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210430_z6JY6YEPMur3">46.04</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$
    <span id="xdx_90D_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210630_zYym4YcSD9qa">49.10</span></span></td>
    <td style="text-align: right; line-height: 10pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">R$<span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20211130_zAEPF5yE6vfb">46.28</span></span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfSharebasedCompensationPlan', window );">Schedule of share-based compensation plan</a></td>
<td class="text"><p id="xdx_89B_ecustom--ScheduleOfSharebasedCompensationPlan_zBxBX5mxpL8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and movements in stock options during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">&#160;</span><span id="xdx_8BB_zxUQPB34wi9i" style="display: none; visibility: hidden">Schedule of share-based compensation plan</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td rowspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Weighted
    average exercise price (in Reais)</b></span></td>
    <td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Number
    of stock options</b></span></td>
    </tr>
  <tr>
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2021</b></span></td>
    <td style="border-bottom: #365F91 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2020</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt; width: 40%"><span style="font-family: Arial, Helvetica, Sans-Serif">Outstanding
    at January 1</span></td>
    <td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pii_c20210101__20211231_zwfeeWrUeHi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 32%" title="Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif">78.22</span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20210101__20211231_zcdB9ZmaJIZ1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 11%"><span style="font-family: Arial, Helvetica, Sans-Serif">2,510,983</span></td>
    <td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20200101__20201231_zR0b3iIYygG2" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right; width: 17%" title="Outstanding at the beginning"><span style="font-family: Arial, Helvetica, Sans-Serif">2,364,214</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Granted</span></td>
    <td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zrbY5z13g8rc" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"><span style="font-family: Arial, Helvetica, Sans-Serif">109.18</span></td>
    <td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210101__20211231_zjoev2zBy0yf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"><span style="font-family: Arial, Helvetica, Sans-Serif">1,170,000</span></td>
    <td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20200101__20201231_zQSDLBtuRH15" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">477,220</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Forfeited</span></td>
    <td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zqqEjz1OEfof" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">112.89</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20210101__20211231_zFqplPVq3xId" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">(60,000)</span></td>
    <td id="xdx_981_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20200101__20201231_zH1ov44eBSug" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Forfeited"><span style="font-family: Arial, Helvetica, Sans-Serif">(274,359)</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Exercised</span></td>
    <td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_z7icwi64Avzk" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">78.15</span></td>
    <td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20210101__20211231_zIhfOtvyGrW2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">(442,669)</span></td>
    <td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20200101__20201231_z4r0CjzHreuf" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Exercised"><span style="font-family: Arial, Helvetica, Sans-Serif">(56,092)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">Expired</span></td>
    <td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zUGk3urD049i" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">78.21</span></td>
    <td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_c20210101__20211231_z9Rj84xZWVoc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">(91,586)</span></td>
    <td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_d0_c20200101__20201231_zgDBbEeDI1Al" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Expired"><span style="font-family: Arial, Helvetica, Sans-Serif">-</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>Outstanding
    at December 31</b></span></td>
    <td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pii_c20210101__20211231_zS7kMhBO5ZM8" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>92.33</b></span></td>
    <td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_c20210101__20211231_zTQJ00NQ5Yo5" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>3,086,728</b></span></td>
    <td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_c20200101__20201231_zwKPzjW3T5j3" style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Outstanding at the ending"><span style="font-family: Arial, Helvetica, Sans-Serif"><b>2,510,983</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSharebasedCompensationPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSharebasedCompensationPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103267240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfTreasurySharesMovement', window );">[custom:ScheduleOfTreasurySharesMovement]</a></td>
<td class="text"><p id="xdx_895_ecustom--ScheduleOfTreasurySharesMovement_zFt2BV2K0pJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table illustrates the number and <span id="xdx_8BD_zPN5GJUExpFk">movements in treasury</span> shares during the period:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 52%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Number
    of shares</b></span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; width: 31%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Average
    price (in Brazilian Reais)</b></span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Outstanding
    at January 1, 2021</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding beginning period"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">-</span></td>
    <td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Repurchased</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Repurchased"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">2,142,051</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">99.76</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from exercise of options</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from exercise of options"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(442,669)</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">124.08</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">Transferred
    from shares contribution</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from shares contribution"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">(44,455)</span></td>
    <td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt">111.94</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>Outstanding
    at December 31, 2021</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding ending period"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>1,654,927</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><b>92.23</b></span></td></tr>
  </table>

<p id="xdx_8B7_z1aX04b5fbje" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfTreasurySharesMovement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfTreasurySharesMovement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103211816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Earnings per share (EPS) (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureOfEarningsPerShareTableExplanatory', window );">Schedule of earnings per share</a></td>
<td class="text"><p id="xdx_895_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zvO9wQw5hjxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">The
following table reflects the net income and share data used in the basic and diluted EPS calculations:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span id="xdx_8BB_z1H4Ge2ZKZ7b" style="display: none; visibility: hidden">Schedule of earnings per share</span><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 52%; padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zW0x86suTJM1" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_498_20200101__20201231_z6FXBIQMmft8" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_491_20190101__20191231_z2eGmxKqSGx7" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Numerator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_zxMCjhVeAKI1" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Net income attributable
    to equity holders of the parent</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">223,326</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">292,075</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">153,916</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Denominator</b></span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40B_eifrs-full--WeightedAverageShares_pid_uShares_ze6o6kIW9NPd" style="vertical-align: top; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,291,480</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">92,683,848</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">75,969,797</span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pii_uShares_zmm94uY87Rqj" style="vertical-align: top; background-color: White">
    <td style="padding-right: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effects of dilution from
    stock options</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">811,818</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">951,920</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">221,846</span></td></tr>
  <tr id="xdx_400_eifrs-full--AdjustedWeightedAverageShares_pii_uShares_z8Ay99zJtfmh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Weighted
    average number of outstanding shares adjusted for the effect of dilution</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">94,103,298</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,635,768</span></td>
    <td style="padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">76,191,643</span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_pii_uBRLPShares_zqVfvYX9qn35" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Basic
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.39</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3.15</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2.03
    </span></td></tr>
  <tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pii_uBRLPShares_zbVlDHHNVrHk" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Diluted
    earnings per share (R$)</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2.37</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3.12</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;2.02
    </span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureOfEarningsPerShareTableExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureOfEarningsPerShareTableExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103364520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfNetSalesRevenueExplanatory', window );">Schedule of net sales revenue</a></td>
<td class="text"><p id="xdx_89F_ecustom--ScheduleOfNetSalesRevenueExplanatory_zmHOcoHYmbL8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B5_z2IXdQRslSPf" style="display: none; visibility: hidden">Schedule of net sales revenue</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49F_20210101__20211231_zyvynLrOqoZ7" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_497_20200101__20201231_zdZ3g4Wum2V" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_498_20190101__20191231_z5QGMDk6PTC" style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_zUkFa4r72yr6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees <sup id="xdx_F45_zcBDb6lUWZX3">(*)</sup></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,124,589</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,388,735</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">856,561</span></td></tr>
  <tr id="xdx_402_ecustom--OtherRevenue1_zJUnPlsRenj1" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">167,441</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">99,817</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">43,116</span></td></tr>
  <tr id="xdx_401_ecustom--DeductionAbstract_iB_zEc5q1UxzoJ6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Deductions</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_406_ecustom--DeductionOfGrantedDiscounts_zQ9WBcE1O59k" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Granted
    discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(229,254)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(89,017)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,767)</span></td></tr>
  <tr id="xdx_407_ecustom--DeductionOfEarlyPaymentDiscounts_zzoLznGIKNTb" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Early
    payment discounts</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,879)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(29,299)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,523)</span></td></tr>
  <tr id="xdx_403_ecustom--DeductionOfReturnsOfNetRevenue_z86z3WFCYgId" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Returns</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(42,373)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,437)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,462)</span></td></tr>
  <tr id="xdx_401_ecustom--DeductionOfTaxes_zQ2t0uiFjn67" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;Taxes</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(74,232)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(49,629)</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(28,157)</span></td></tr>
  <tr id="xdx_40A_ecustom--DeductionOfProuni_zjrn8zhC0K08" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">&#160;&#160;PROUNI</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(176,921)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(107,979)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(61,138)</span></td></tr>
  <tr id="xdx_400_eifrs-full--RevenueFromContractsWithCustomers_zAJrnzH8RHul" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Net
    revenue from contracts with customers</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr id="xdx_407_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zGuoiYiKyJKg" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing
    of revenue recognition of net revenue from contracts with customers</b></span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_403_eifrs-full--FeeAndCommissionIncome_zSsyFi1ZWG8c" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition,
    digital content and app subscription fees - Transferred over time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,128,558</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">713,827</span></td></tr>
  <tr id="xdx_400_ecustom--NetRevenueOtherTransferredPoint_zeFcdIT5s78" style="background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other
    - Transferred at a point in time</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,633</span></td>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,803</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F04_zYduzUneiSzc" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">(*)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F13_zbUolZ3FsJd9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfRevenueBySegment', window );">Schedule of revenue by segment</a></td>
<td class="text"><p id="xdx_89D_ecustom--ScheduleOfRevenueBySegment_zU6FqluihLW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B0_zVmMS04dsLNi">Schedule of revenue by segment</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue
    by segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types
    of services or goods</b></span></td>
    <td id="xdx_981_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKGt24N5mZxf" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGaco47k2cVh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQERCis6ZFF3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z6MgPp8SqUbk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_z3gA79fqz9R4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition
    fees</span></td>
    <td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z3lOv2MtZ18i" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdpbYGmGCzih" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXxcd5Sfcwvc" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4945">-</span></span></td>
    <td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z9P8a00yWMda" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4946">-</span></span></td>
    <td id="xdx_98F_ecustom--ProfessionalFeesExpense1_pn3n3_c20210101__20211231_zNMeeh1GxBM4" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,559,094</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXNi8C4Hkuqg" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDVGRRCqtxkf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">151,958</span></td>
    <td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z7N2eKcdk0G3" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_z8XcJ394f622" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">160,277</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z98wkf2mrIif" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,498,408</b></span></td>
    <td id="xdx_98B_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zBV2rjetsya1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>72,983</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zaNuHUrjHX56" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>151,958</b></span></td>
    <td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_znxz0CTNR5a8" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,978)</b></span></td>
    <td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zk25RXXHv6Vh" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,719,371</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    over time</span></td>
    <td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zwcQttcSSTBc" style="vertical-align: bottom; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,486,111</span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzEIlJGihbz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,983</span></td>
    <td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgI9x2Q2wrz8" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">81,795</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zT1tfP3pJT41" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,640,889</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top; text-align: justify"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred
    at a point in time</span></td>
    <td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqwTvNOGotC4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">12,297</span></td>
    <td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxxlErX2jNQf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl4968">-</span></span></td>
    <td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMoD9DADFXhg" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">70,163</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zBT7KScVc2I1" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,978)</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_zBh34sN79DXa" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">78,482</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zlm1oRwiewva" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,002,461</b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLMNFS1srROb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>107,197</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zHLC1uFcizP7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>93,152</b></span></td>
    <td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,619)</b></span></td>
    <td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--SegmentOfBusinessOneUnitMember_zo128EkT9JZb" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">997,055</span></td>
    <td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0EcPHU3jc2g" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,197</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_986_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231_zqh9I2xfCNee" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,104,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXeEqWgiG0kb" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,406</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIs5R1prWR0h" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">93,152</span></td>
    <td id="xdx_982_eifrs-full--OtherRevenue_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,619)</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231_zlQhvD1JH3Za" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">96,939</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zx06Pcjlzle2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,002,461</b></span></td>
    <td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zs0U5zD1WAk6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>107,197</b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDp8jCOlamph" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>93,152</b></span></td>
    <td id="xdx_987_ecustom--TimingRevenueRecognition_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,619)</b></span></td>
    <td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231_z2kNWpQBvzt1" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,201,191</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLjVGEt3ZzY7" style="vertical-align: bottom; padding-right: 2.55pt; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">997,055</span></td>
    <td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvDdTtl2Oq8c" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">107,197</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfvak12265m6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,306</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231_zCdmUie0L504" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,128,558</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zuNtbBthRV94" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,406</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJrsOeAWUhYd" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">68,846</span></td>
    <td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,619)</span></td>
    <td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231_zEbTNHEcj9nf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">72,633</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 28%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Revenue by
    segment</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Undergrad</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Continuing
    Education</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 13%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Digital
    Services</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 16%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Elimination
    (inter-segment transactions)</b></span></td>
    <td style="border-bottom: black 1pt solid; width: 17%; text-align: center"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Types of services or goods</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zd3fDHCdXNd4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>653,760</b></span></td>
    <td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zqVKN9jh84w2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,870</b></span></td>
    <td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2KsslMQdyig" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,880</b></span></td>
    <td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zIq5DHUeOcn8" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,880)</b></span></td>
    <td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231_zx9FQZa4jyLb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tuition fees</span></td>
    <td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zO1X1lpTz9Da" style="vertical-align: bottom; text-align: right" title="Tuition fees"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">648,957</span></td>
    <td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj3l7PlhqXN7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">60,195</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98D_ecustom--ProfessionalFeesExpense1_pn3n3_c20190101__20191231_zigXcitC4lIf" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">709,152</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ3vUcYNlc1h" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,803</span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4M8QEFMhXj2" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,675</span></td>
    <td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zq1nk4cLDEr6" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,880</span></td>
    <td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zXqmRjUEwSqi" style="vertical-align: bottom; text-align: right" title="Other"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,880)</span></td>
    <td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231_zbCA4pSUZzse" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">41,478</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Timing of revenue recognition</b></span></td>
    <td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPSQqGx2ZTh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>653,760</b></span></td>
    <td id="xdx_985_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJ4632C6EWxi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,870</b></span></td>
    <td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMrlEGBiTpei" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,880</b></span></td>
    <td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zSgumwJU0Rbi" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(3,880)</b></span></td>
    <td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231_z6QVlZREvbLi" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>750,630</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred over time</span></td>
    <td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLOWEJKaZqBi" style="vertical-align: bottom; padding-right: -2.4pt; text-align: right" title="Transferred over time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">648,957</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWMDmSFiNtV3" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">64,870</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231_zLI4e8HkYsv7" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">713,827</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: top"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Transferred at a point in
    time</span></td>
    <td id="xdx_988_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQa9pWMQebLh" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,803</span></td>
    <td style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">-</span></td>
    <td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIJ01XzrNAfj" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,880</span></td>
    <td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zNNTXj7dMPEf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,880)</span></td>
    <td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231_zYeedTPsTeCb" style="vertical-align: bottom; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">36,803</span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfNetSalesRevenueExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfNetSalesRevenueExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfRevenueBySegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfRevenueBySegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103661528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Expenses and costs by nature (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SummaryOfExpensesByNatureTableTextBlock', window );">Schedule of expenses by nature</a></td>
<td class="text"><p id="xdx_897_ecustom--SummaryOfExpensesByNatureTableTextBlock_zZlnbaVBKAm8" style="margin-top: 0; margin-bottom: 0"><span id="xdx_8B9_zz5KIFrq1RKa" style="display: none; visibility: hidden">Schedule of expenses by nature</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zASNR3Tik5Z2" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_49A_20200101__20201231_z87ngSk9iQOk" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49C_20190101__20191231_zUvyNPNXpG1j" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_eifrs-full--CostOfSales_zwR11BJJyiri" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Cost
    of services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(652,300)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(434,654)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(308,853)</span></td></tr>
  <tr id="xdx_40A_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zPnFjZj40Bmb" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">General
    and administrative expenses</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(622,615)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(402,855)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(239,120)</span></td></tr>
  <tr id="xdx_40F_eifrs-full--ExpenseByNature_zRr3fv2mxPzi" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,274,915)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(837,509)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(547,973)</b></span></td></tr>
  <tr style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_407_ecustom--Payroll_zrh1jzRDTwS7" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Payroll</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(677,564)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(446,473)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(324,252)
    </span></td></tr>
  <tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_zC1BhQbjxRyc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Hospital
    and medical agreements</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,449)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,988)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(16,429)
    </span></td></tr>
  <tr id="xdx_407_eifrs-full--DepreciationExpense_z1IUNSU8NyRk" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Depreciation
    and amortization</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(154,220)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,744)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(73,152)
    </span></td></tr>
  <tr id="xdx_408_ecustom--LeaseExpenses_zNFGvIx7vTYc" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Lease
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(11,229)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,555)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,494)</span></td></tr>
  <tr id="xdx_402_eifrs-full--UtilitiesExpense_zKGvIKSUZYB6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Utilities</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(10,643)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,892)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,628)
    </span></td></tr>
  <tr id="xdx_40C_eifrs-full--RepairsAndMaintenanceExpense_zIrk4OVrV6O7" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Maintenance</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,141)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(20,746)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,658)
    </span></td></tr>
  <tr id="xdx_401_ecustom--SharesBasedCompensation_zrNf1Q369RTl" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Share-based
    compensation</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(43,377)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,610)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(18,114)</span></td></tr>
  <tr id="xdx_40C_ecustom--TaxExpenses_zRuKGSsZ31R" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,997)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(5,326)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,696)</span></td></tr>
  <tr id="xdx_40E_eifrs-full--ServicesExpense_zC7DM0dyCPi6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Pedagogical
    services</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,881)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,037)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,271)</span></td></tr>
  <tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_zIGZ31SIkot4" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Sales
    and marketing</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,506)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(18,361)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(12,966)</span></td></tr>
  <tr id="xdx_40A_ecustom--AllowanceForDoubtfulAccounts_zoHp1Ec5SfS6" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Allowance
    for doubtful accounts</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(47,819)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(32,081)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,040)</span></td></tr>
  <tr id="xdx_408_eifrs-full--TravelExpense_zodnFKTqumY6" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Travel
    expenses</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,542)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,550)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,054)</span></td></tr>
  <tr id="xdx_409_ecustom--ConsultingFees_zXuHmzH9bZ41" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Consulting
    fees</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(38,818)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,276)</span></td>
    <td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(13,060)</span></td></tr>
  <tr id="xdx_405_ecustom--Other_zUzBp07dkQr" style="background-color: White">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(103,729)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(66,870)</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(39,159)</span></td></tr>
  <tr id="xdx_401_ecustom--ExpenseByNatureOne_iT_zKYFsO0wi141" style="background-color: rgb(213,234,234)">
    <td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(1,274,915)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(837,509)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(547,973)</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SummaryOfExpensesByNatureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SummaryOfExpensesByNatureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103273000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Finance result (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfFinanceResult', window );">Schedule of finance result</a></td>
<td class="text"><p id="xdx_897_ecustom--ScheduleOfFinanceResult_zRtn4GBtjlA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B2_zVbwQGDP0Kh9" style="display: none; visibility: hidden">Schedule of finance result</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_49B_20210101__20211231_zV5Euy2eB5ih" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_490_20200101__20201231_zyyaSJOhf6yf" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 5.6pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_49F_20190101__20191231_zaiVwXKTJzL9" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_eifrs-full--InvestmentIncome_zYnnf5Zwgjga" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income
    from financial investments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">35,773</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,479</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">25,965</span></td></tr>
  <tr id="xdx_400_ecustom--ChangesInFairValueOfDerivativeInstruments_zETaOgK8agah" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Changes
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5130">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">20,739</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5132">-</span></span></td></tr>
  <tr id="xdx_40B_eifrs-full--RevenueFromInterest_zxPhDMuI8iEb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    received</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">23,040</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11,876</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">9,680</span></td></tr>
  <tr id="xdx_40A_eifrs-full--NetForeignExchangeGain_zVjIGHM6Ajc3" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5138">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5139">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">13,321</span></td></tr>
  <tr id="xdx_401_eifrs-full--OtherFinanceIncome_zcb4rfG6joFe" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,753</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,196</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,723</span></td></tr>
  <tr id="xdx_406_eifrs-full--FinanceIncome_zD47KnUqqMm4" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    income</b></span></td>
    <td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>64,566</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>62,290</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>51,689</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40D_ecustom--ChangeInFairValueOfDerivativeInstruments_znyFRGXcxVDl" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Change
    in fair value of derivative instruments</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5150">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5151">-</span></span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,780)</span></td></tr>
  <tr id="xdx_401_ecustom--InterestExpense1_ztvQ3LNvNyM" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(108,437)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(25,543)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(24,002)</span></td></tr>
  <tr id="xdx_408_ecustom--InterestExpenseOnLeaseLiabilities1_zT5P2x644es9" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Interest
    expense on lease liabilities</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(67,212)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(44,458)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(31,469)</span></td></tr>
  <tr id="xdx_403_ecustom--FinancialDiscountsGrantedExpenses_zeYxNw0kKkzb" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Financial
    discounts granted</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(23,193)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,081)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(923)</span></td></tr>
  <tr id="xdx_404_eifrs-full--BankAndSimilarCharges_zttp0aut67Pf" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Bank
    fees</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,878)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,333)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,876)</span></td></tr>
  <tr id="xdx_409_eifrs-full--NetForeignExchangeLoss_zVPpI4SXYZh" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Foreign
    exchange differences</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(17,973)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,613)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5172">-</span></span></td></tr>
  <tr id="xdx_404_ecustom--TaxOnFinancialOperations_z9kUCMmq4fX2" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">IOF
    taxes (taxes on financial transactions)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,306)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,661)</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,801)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--OtherFinanceCost_zUApyGb0GNc5" style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(15,797)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,580)</span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,514)</span></td></tr>
  <tr id="xdx_402_eifrs-full--FinanceCosts_iN_di_zpM1EJArnKi7" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    expenses</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(243,796)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(98,269)</b></span></td>
    <td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(72,365)</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(213,234,234)">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40C_ecustom--FinanceResult_zjql1nAyciV" style="vertical-align: bottom; background-color: White">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Finance
    result</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(179,230)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(35,979)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(20,676)</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfFinanceResult">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfFinanceResult</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103355128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory', window );">Schedule of reconciliation of income tax expense</a></td>
<td class="text"><p id="xdx_89A_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_zOVESf5Xynl2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"><span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal">The
following is a reconciliation of income tax expense to profit (loss) for the year, calculated by applying the combined Brazilian statutory
rates at 34% for the years ended December 31, 2021, 2020 and 2019:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;<span id="xdx_8B3_zQFstNDjvwf" style="display: none; visibility: hidden">Schedule of reconciliation of income tax expense</span></span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="white-space: nowrap; width: 56%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td id="xdx_492_20210101__20211231_zlKxdtAQtCV4" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td id="xdx_496_20200101__20201231_zuEhJyWQZ9o7" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td id="xdx_499_20190101__20191231_z5IwB6tJzOS" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr id="xdx_402_eifrs-full--ProfitLossBeforeTax_zxizHVlqds7" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income before income taxes</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>273,462</b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>335,054</b></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>186,937</b></span></td></tr>
  <tr style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Combined statutory income
    taxes rate - %</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_901_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20210101__20211231_z9xqAugZTHN4" title="Statutory rates">34</span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_900_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20200101__20201231_zXNlgHWvuJed">34</span>%</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span id="xdx_90A_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20190101__20191231_zL4NDjvXzDtc">34</span>%</span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pii_z9Jw8nlf2kHl" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes at statutory
    rates</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(92,977)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(113,918)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(63,559)</span></td></tr>
  <tr id="xdx_40C_ecustom--ReconciliationAdjustmentsAbstract_iB_pii_zxF1trvIRDj8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reconciliation adjustments:</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pii_zimGS9YP1gq3" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Tax effect on loss from entities
    not subject to taxation</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(37,794)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(8,474)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,265)</span></td></tr>
  <tr id="xdx_40A_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pii_zHF5GuRbzrU8" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">PROUNI - Fiscal Incentive
    <sup id="xdx_F45_z3QBg1jC6bM5">(a)</sup></span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">194,830</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">120,851</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">73,397</span></td></tr>
  <tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pii_ztuiRAsbA8Pd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Unrecognized deferred tax
    assets</span></td>
    <td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(86,233)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(41,319)</span></td>
    <td style="vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(19,342)</span></td></tr>
  <tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pii_zvnrnuCTsCL" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Presumed profit income
    tax regime effect <sup id="xdx_F47_zpWgkFpTW1wb">(b)</sup></span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,066)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,640)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">351</span></td></tr>
  <tr id="xdx_408_ecustom--PermanentAdjustments_pii_zXVPe5J7Mu91" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Permanent adjustments</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(6,232)</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,567</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5228">-</span></span></td></tr>
  <tr id="xdx_405_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pii_zk61X8wbPKNe" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Other</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,293</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">15,866</span></td>
    <td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,757)</span></td></tr>
  <tr id="xdx_406_eifrs-full--CurrentTaxExpenseIncome_pii_zT3DjncGRDMd" style="background-color: rgb(213,234,234)">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Income taxes expense &#8211;
    current</span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(31,179)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(27,067)</b></span></td>
    <td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>(14,175)</b></span></td></tr>
  <tr id="xdx_406_eifrs-full--TaxRateEffectFromChangeInTaxRate_pii_dp_uPure_zQjJMw8LZVV2" style="background-color: White">
    <td style="white-space: nowrap"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Effective rate</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">11.40%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">8.08%</span></td>
    <td style="text-align: right; line-height: 115%"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7.58%</span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0B_zybEHm3TG5Nf" style="font-family: Arial, Helvetica, Sans-Serif">(a)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F17_z7hcORHSMY7b" style="font-family: Arial, Helvetica, Sans-Serif">The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.</span></td>
</tr></table>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 15pt; text-align: right"><span id="xdx_F0D_zUlifPwbXyal" style="font-family: Arial, Helvetica, Sans-Serif">(b)</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F1A_zHtN0tns1nch" style="font-family: Arial, Helvetica, Sans-Serif">Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.</span></td>
</tr></table>

<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103257768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfLegalProceedingsAndContingencies', window );">Schedule of legal proceedings and contingencies</a></td>
<td class="text"><p id="xdx_899_ecustom--ScheduleOfLegalProceedingsAndContingencies_zCjeLFkoBj6a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">The provisions
related to labor, civil and taxes proceedings whose likelihood of loss is assessed as probable are as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8BA_z9iIAEb3Zzyg" style="display: none; visibility: hidden">Schedule of legal proceedings and contingencies</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Labor</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Civil</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Taxes</b></span></td>
    <td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td></tr>
  <tr style="vertical-align: top">
    <td style="padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2018</b></span></td>
    <td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z8UDO3SiwKFg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,233</b></span></td>
    <td id="xdx_981_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znA9eMVrxCn" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>1,232</b></span></td>
    <td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBjyEpOS3yW6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5255">-</span></b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zd3NiUXIP3Cl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>3,465</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zQo7x8ZyWDfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,301</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zW9cJqkEBTT3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,071</span></td>
    <td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHLNMLdpaue3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5263">-</span></span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zJEeaKOhYIbc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,372</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHQHaP7e8ieh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">737</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zkRZZHOMAshc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">1,508</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFMIeGWTCOV9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5271">-</span></span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMkfliPLzhWi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,245</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zY8daNmGE5x3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,770)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuCWvzFir1F5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,043)</span></td>
    <td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBAIj2LDiYj2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5278">-</span></span></td>
    <td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zzC2fHPV583l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(4,813)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2019</b></span></td>
    <td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zf7PBBcYjDyf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,501</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zmonYaDRHCnb" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2,768</b></span></td>
    <td id="xdx_983_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLv1QkxmcQPl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b><span style="-sec-ix-hidden: xdx2ixbrl5284">-</span></b></span></td>
    <td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z3K5hDatdlmk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>5,269</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zdYGwM4Lqmt" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,741</span></td>
    <td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zs5IqC2vuyF8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,348</span></td>
    <td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zbbyvoi3MvO3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">27,487</span></td>
    <td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">32,576</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions</span></td>
    <td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zeBdtifnQRJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">562</span></td>
    <td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq9oKLk6EVSg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">10,869</span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3CFb076mkie" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,853</span></td>
    <td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">19,284</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_98B_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z4OLg8ZshPV9" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,285)</span></td>
    <td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zccjfXBLQBD" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(2,705)</span></td>
    <td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zSwqsnEJZps7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><span style="-sec-ix-hidden: xdx2ixbrl5307">-</span></span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(3,990)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2020</b></span></td>
    <td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze3puQZUVxac" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balances as of end of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>4,519</b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zSHII53AtlGl" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>13,280</b></span></td>
    <td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zjpz44KKYkp9" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>35,340</b></span></td>
    <td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zgR22mw7n2r4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>53,139</b></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Business
    combinations</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze4s4nAt2ZL5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">16,597</span></td>
    <td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znSN8BC2m9Y6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">6,017</span></td>
    <td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zxT1u4yM7JK" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">57,638</span></td>
    <td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zf4JeejDjFF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">80,252</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Additions
    <sup id="xdx_F48_zf7Sl47iLX5d">*</sup></span></td>
    <td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_fKg_____zKj0zwSsNKnc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,418</span></td>
    <td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2UNDxa6RFc7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,101</span></td>
    <td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9wRoocXHyTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">14,225</span></td>
    <td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zdeRYaSdPmAf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">24,744</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Reversals</span></td>
    <td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFtJt91QLSBd" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,044)</span></td>
    <td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zI9LtvfMCSIi" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(1,470)</span></td>
    <td id="xdx_98A_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zeQhGJuOw3zl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(7,334)</span></td>
    <td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8YA4KKCj5h7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">(9,848)</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Balances
    as of December 31, 2021</b></span></td>
    <td id="xdx_980_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zX8giQ4gU5Mj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>25,490</b></span></td>
    <td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zJX2O4P55Jfa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>22,928</b></span></td>
    <td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHBevEWvLmxa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>99,869</b></span></td>
    <td id="xdx_98F_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zOJZyP2lUQJ4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>148,287</b></span></td></tr>
  </table>
<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td id="xdx_F0C_zTwrzJY5utsk" style="width: 15pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">*</span></td><td style="width: 5pt"/><td style="text-align: justify"><span id="xdx_F15_zCbwxgxWXBY7" style="font-family: Arial, Helvetica, Sans-Serif">The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.</span></td>
</tr></table>

<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement', window );">Schedule of social security proceedings assessed by Management</a></td>
<td class="text"><p id="xdx_896_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_zFatfWCJR4hh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif">There are other
civil, labor, taxes and social security proceedings assessed by Management and its legal counsels as possible risk of loss, for which
no provisions are recognized, as follows:</span></p>

<p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Arial, Helvetica, Sans-Serif"><span id="xdx_8B2_zk09jwvyWY3g" style="display: none; visibility: hidden">Schedule of social security proceedings assessed by Management</span>&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: bottom; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2021</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2020</b></span></td>
    <td style="border-bottom: black 1pt solid; vertical-align: top; width: 17%; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>2019</b></span></td></tr>
  <tr>
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td>
    <td style="vertical-align: top; text-align: right"><span style="font-family: Arial, Helvetica, Sans-Serif">&#160;</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Labor</span></td>
    <td id="xdx_982_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVN1npePd7x5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">5,098</span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zaIEIzu4as5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">2,318</span></td>
    <td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zDIk0IypT0g4" style="vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">3,570</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Civil</span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z8kMG0xChqwj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">56,501</span></td>
    <td id="xdx_988_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">59,969</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2KQDeH9A2yd" style="vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">39,135</span></td></tr>
  <tr style="background-color: rgb(213,234,234)">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">Taxes
    and social security</span></td>
    <td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zejfGsQ62ggf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,459</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">4,375</span></td>
    <td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zfS1CcgPpF8g" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt">7,583</span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>Total</b></span></td>
    <td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231_z3HPbKuhXzB6" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>66,058</b></span></td>
    <td id="xdx_98F_eifrs-full--OtherProvisions_c20201231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>66,662</b></span></td>
    <td id="xdx_98A_eifrs-full--OtherProvisions_iI_pn3n3_c20191231_ztNLLA91sHP" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Total"><span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"><b>50,288</b></span></td></tr>
  </table>
<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfLegalProceedingsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfLegalProceedingsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670074274472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Corporate information (Details Narrative)<br></strong></div></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 10, 2020 </div>
<div>BRL (R$) </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 10, 2020 </div>
<div>USD ($) </div>
<div>shares</div>
</th>
<th class="th">
<div>Feb. 06, 2020 </div>
<div>BRL (R$) </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jul. 23, 2019 </div>
<div>BRL (R$) </div>
<div>R$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jul. 08, 2019</div></th>
<th class="th"><div>Jun. 18, 2019</div></th>
<th class="th"><div>Mar. 29, 2019</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>BRL (R$) </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>BRL (R$)</div>
</th>
<th class="th"><div>Oct. 01, 2021</div></th>
<th class="th"><div>Aug. 04, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
<th class="th"><div>May 13, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th">
<div>Jul. 18, 2019 </div>
<div>shares</div>
</th>
<th class="th"><div>Mar. 25, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital', window );">Description of exchanging and rights of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">exchanging
one common share into 28 Class A or Class B common shares<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issed (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,669<span></span>
</td>
<td class="nump">93,146,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 55,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">R$ (19,704,000)<span></span>
</td>
<td class="num">R$ (79,670,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TransferredAmountToGBankAccounts', window );">Transferred amount to bank accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,800<span></span>
</td>
<td class="nump">961,438<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Amount of legal proceedings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,081<span></span>
</td>
<td class="nump">R$ 6,545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issed (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,888,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of shares | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 68,060<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issed (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,805,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,744,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 992,778<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProceedsFromIssueOfOrdinarySharesNet', window );">Net proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">913,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionExpense', window );">Fee and commission expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">59,566<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherOfferingExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,104<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ShareIssueRelatedCost', window );">Share issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">79,670,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfAdditionalCommonSharesIssued', window );">Number of additional common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,019,928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member] | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">263,888<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProceedsFromIssueOfOrdinarySharesNet', window );">Net proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionExpense', window );">Fee and commission expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,833<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherOfferingExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 5,344<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issed (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,916,954<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfPerShares', window );">per share | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 19.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherOfferingExpenses', window );">Other offering expenses</a></td>
<td class="nump">R$ 1,066<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalSharesGrossProceeds', window );">Additional shares gross proceeds</a></td>
<td class="nump">30,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetProceedsOfAdditionalShares', window );">Net proceeds of additional shares</a></td>
<td class="nump">R$ 29,819<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member] | Underwriters [Member] | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfAdditionalCommonSharesIssued', window );">Number of additional common shares issued | shares</a></td>
<td class="nump">240,552<span></span>
</td>
<td class="nump">240,552<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalSharesGrossProceeds', window );">Additional shares gross proceeds</a></td>
<td class="nump">R$ 6,615<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetProceedsOfAdditionalShares', window );">Net proceeds of additional shares</a></td>
<td class="nump">R$ 6,387<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member] | Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherOfferingExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 18,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfAdditionalCommonSharesIssued', window );">Number of additional common shares issued | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,406,812<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalSharesGrossProceeds', window );">Additional shares gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 358,286<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetProceedsOfAdditionalShares', window );">Net proceeds of additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">339,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Initial Public Offering [Member] | Shareholders [Member] | United States of America, Dollars</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherOfferingExpenses', window );">Other offering expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,202<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalOfferingPrice', window );">Additional offering price | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 27.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalSharesGrossProceeds', window );">Additional shares gross proceeds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 83,048<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetProceedsOfAdditionalShares', window );">Net proceeds of additional shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 78,846<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember', window );">Class A Common Shares [Member] | Over Allotments [Member] | Underwriters [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Number of shares issed (shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,061,631<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraAndCBBWebMember', window );">Medcel Editora And C B B Web [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember', window );">Uniao Educacional Do Planalto Central S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary', window );">Proportion of ownership interest in subsidiary</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember', window );">Medical Harbour Aparelhos Medicos Hospitalarese Servicosem Tecnologia Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaMember', window );">Cliquefarma Drogarias Online Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiadaInformacaoLtdaMember', window );">Shosp Tecnologiada Informacao Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraodeEducacaoSuperiorLtdMember', window );">Sociedade Padraode Educacao Superior Ltd [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesdeTecnologiaLtdaMember', window );">R X P R O Solucoesde Tecnologia Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember', window );">Faculdade De Ciencias Medicas Da Paraiba [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LegalProceedingsProvision', window );">Amount of legal proceedings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 24,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_GuardayaEmpreendimentosAndParticipacoesSAMember', window );">Guardaya Empreendimentos And Participacoes S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalOfferingPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amoutn of additional offering price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalOfferingPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalSharesGrossProceeds">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount fo additional shares gross proceeds.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalSharesGrossProceeds</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetProceedsOfAdditionalShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net proceeds of additional shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetProceedsOfAdditionalShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfAdditionalCommonSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional common shares issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfAdditionalCommonSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfPerShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfPerShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherOfferingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amoun of other offering expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherOfferingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProceedsFromIssueOfOrdinarySharesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares, net.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProceedsFromIssueOfOrdinarySharesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TransferredAmountToGBankAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amoun of transferred amount to bank accounts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TransferredAmountToGBankAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LegalProceedingsProvision">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of provision for legal proceedings. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Section Example 10 A court case<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 87<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_87&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LegalProceedingsProvision</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestInSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestInSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the rights, preferences and restrictions attaching to a class of share capital including restrictions on the distribution of dividends and the repayment of capital. [Refer: Share capital [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ShareIssueRelatedCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cost related to the issuance of shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ShareIssueRelatedCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassACommonSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SaleOfStockAxis=afya_InitialPublicOfferingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SaleOfStockAxis=afya_InitialPublicOfferingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_USD">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_USD</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UnderwritersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UnderwritersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_ShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_ShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SaleOfStockAxis=afya_OverAllotmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SaleOfStockAxis=afya_OverAllotmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraAndCBBWebMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraAndCBBWebMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiadaInformacaoLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiadaInformacaoLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraodeEducacaoSuperiorLtdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraodeEducacaoSuperiorLtdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesdeTecnologiaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesdeTecnologiaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_GuardayaEmpreendimentosAndParticipacoesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_GuardayaEmpreendimentosAndParticipacoesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095319464">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The table below is a list of the Company&#8217;s subsidiaries and associate: (Details)<br></strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember', window );">Afya Participacoes S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Afya
    Participa&#231;&#245;es S.A. (&#8220;Afya Brazil&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Holding<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Nova
    Lima - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">10000.00%<span></span>
</td>
<td class="nump">10000.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember', window );">Instituto Tocantinense Presidente Antonio Carlos Porto S A Itpac Porto Nacional [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos Porto S.A. &#8211; (&#8220;ITPAC Porto&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto
    Nacional - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember', window );">Instituto Tocantinense Presidente Antonio Carlos S A I T P A C Araguaina [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    Tocantinense Presidente Ant&#244;nio Carlos S.A. &#8211; (&#8220;ITPAC Araguaina&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Aragua&#237;na
    - TO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember', window );">Uniao Educacional Do Vale Do Aco S A U N I V A C O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Uni&#227;o
    Educacional do Vale do A&#231;o S.A. &#8211; (&#8220;UNIVA&#199;O&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine
    undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ipatinga
    - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember', window );">I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#8220;IPTAN&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o
    Jo&#227;o Del Rei - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    de Educa&#231;&#227;o Superior do Vale do Parna&#237;ba S.A. (&#8220;IESVAP&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Parna&#237;ba
    - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember', window );">Centro De Ciencias Em Saude De Itajuba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Centro
    de Ci&#234;ncias em Sa&#250;de de Itajub&#225; S.A. (&#8220;CCSI&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine
    undergraduate degree program<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itajub&#225;
    - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">60.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember', window );">Instituto De Ensino Superior Do Piaui S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    de Ensino Superior do Piau&#237; S.A. (&#8221;IESP&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Teresina
    - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember', window );">Centro Integrado De Saude De Teresina C I S [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Centro
    Integrado de Sa&#250;de de Teresina (&#8220;CIS&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Outpatient
    care<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Teresina
    - PI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember', window );">F A D E P Faculdade Educacional De Pato Branco Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#8220;FADEP&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Pato
    Branco - PR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEEventosSAMedcelMember', window );">Medcel Editora E Eventos S A Medcel [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Medcel
    Editora e Eventos S.A. (&#8220;Medcel&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medical
    education content<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o
    Paulo - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember', window );">Instituto Educacional Santo Agostinho S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    Educacional Santo Agostinho S.A. (&#8220;FASA&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes
    Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember', window );">E S M C Educacao Superior Ltda E S M C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">ESMC
    Educa&#231;&#227;o Superior Ltda. (&#8220;ESMC&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes
    Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    de Pesquisa e Ensino M&#233;dico do Estado de Minas Gerais Ltda. (&#8220;IPEMED&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Graduate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Belo
    Horizonte - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember', window );">Instituto Paraensede Educacaoe Cultura Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    Paraense de Educa&#231;&#227;o e Cultura Ltda (&#8220;IPEC&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Marab&#225;
    - PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAUniRedentorMember', window );">Sociedade Universitaria Redentor S A Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Sociedade
    Universit&#225;ria Redentor S.A. (&#8220;UniRedentor&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Itaperuna
    - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaUniSLMember', window );">Centro Universitario Sao Lucas Ltda Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Centro
    Universit&#225;rio S&#227;o Lucas Ltda. (&#8220;UniSL&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Porto
    Velho - RO<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember', window );">Peb Med Instituicao De Pesquisa Medica E Servicos Ltda Peb Med [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Peb
    Med Institui&#231;&#227;o de Pesquisa M&#233;dica e Servi&#231;os Ltda (&#8220;PebMed&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Content
    and clinical tools and online platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio
    de Janeiro - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember', window );">Faculdade De Ensino Superior Da Amazonia Reunida F E S A R [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Faculdade
    de Ensino Superior da Amaz&#244;nia Reunida &#8211; (&#8220;FESAR&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Reden&#231;&#227;o
    &#8211; PA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember', window );">Centro Superior de Ciencias da Saude S/S Ltda (FCMPB) [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Centro
    Superior de Ci&#234;ncias da Sa&#250;de S/S Ltda. (&#8220;FCMPB&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medicine
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Jo&#227;o
    Pessoa &#8211; PB<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember', window );">Med Phone Tecnologia Em Saude Ltda Med Phone [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">MedPhone
    Tecnologia em Sa&#250;de Ltda. (&#8220;MedPhone&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Content
    and clinical tools and online platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Recife
    &#8211; PE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember', window );">I Clinic Desenvolvimento De Software Ltdai Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">iClinic
    Desenvolvimento de Software Ltda (&#8220;iClinic&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic
    Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Ribeir&#227;o
    Preto - SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsSAMedicinaeMember', window );">Medicinae Solutions S A Medicinae [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Medicinae
    Solutions S.A. (&#8220;Medicinae&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Healthcare
    payments and financial services<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio
    de Janeiro &#8211; RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember', window );">Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda Medical Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Medical
    Harbour Aparelhos M&#233;dico Hospitalares e Servi&#231;os em Tecnologia Ltda. (&#8220;Medical Harbour&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Educational
    health and medical imaging<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Florian&#243;polis
    &#8211; SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember', window );">Cliquefarma Drogarias Online Ltda Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Cliquefarma
    Drogarias Online Ltda.(&#8220;Cliquefarma&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Online
    platform<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o
    Paulo &#8211; SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtdaShospMember', window );">Shosp Tecnologia Da Informacao Ltda Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Shosp
    Tecnologia da Informa&#231;&#227;o Ltda. (&#8220;Shosp&#8221;)*<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Electronic
    Medical Record, Clinical Management System<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Rio
    de Janeiro &#8211; RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember', window );">Sociedade Padrao De Educacao Superior Ltda Unifip Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Sociedade
    Padr&#227;o de Educa&#231;&#227;o Superior Ltda. (&#8220;UnifipMoc&#8221;) *<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Montes
    Claros - MG<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember', window );">Companhia Nilza Cordeiro Herdy De Educacaoe Cultura Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Companhia
    Nilza Cordeiro Herdy de Educa&#231;&#227;o e Cultura. (&#8220;Unigranrio&#8221;) *<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    and graduate degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Duque
    de Caxias - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember', window );">Policlinica E Centro De Estetica Duque De Caxias Ltda Policlinica [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Policl&#237;nica
    e Centro de Est&#233;tica Duque de Caxias Ltda. (&#8220;Policl&#237;nica&#8221;) *<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Medical
    Care<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Duque
    de Caxias - RJ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember', window );">Sociedade Educacional De Palhoca S A Ltda S O C I E S P [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Sociedade
    Educacional de Palho&#231;a S/A Ltda. (&#8220;SOCIESP&#8221;) *<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Basic
    Education<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Palho&#231;a
    - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember', window );">Instituto De Ensino Superior De Palhoca S S Ltda I E S P P A L H O C A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Instituto
    de Ensino Superior de Palho&#231;a S/S Ltda. (&#8220;IESP PALHO&#199;A&#8221;) *<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Palho&#231;a
    - SC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember', window );">R X P R O Solucoes De Tecnologia Ltda R X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">RX
    PRO Solu&#231;&#245;es de Tecnologia Ltda. (&#8220;RX PRO&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Marketing
    for pharmaceutical industry<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o
    Paulo &#8211; SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember', window );">R X P R O L O G Transporte E Logistica Ltda R X P R O L O G [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">RX
    PRO LOG Transporte e Log&#237;stica Ltda. (&#8220;RX PRO LOG&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Marketing
    for pharmaceutical industry<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">S&#227;o
    Paulo &#8211; SP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Subsidiary<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember', window );">Uniao Educacional Do Planalto Central S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NameOfSubsidiary', window );">Name</a></td>
<td class="text">Uni&#227;o
    Educacional do Planalto Central S.A. (&#8220;UEPC&#8221;)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PrincipalActivities', window );">Principal activities</a></td>
<td class="text">Undergraduate
    degree programs<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary', window );">Location</a></td>
<td class="text">Bras&#237;lia
    - DF<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentType', window );">Investment type</a></td>
<td class="text">Associate<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Direct and indirect interest of subsidiary</a></td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The investment type of a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PrincipalActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PrincipalActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NameOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The name of a subsidiary. [Refer: Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NameOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_16_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 19B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_19B_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_AfyaParticipacoesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroIntegradoDeSaudeDeTeresinaCISMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEEventosSAMedcelMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelEditoraEEventosSAMedcelMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ESMCEducacaoSuperiorLtdaESMCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAUniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAUniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaUniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaUniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsSAMedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeSolutionsSAMedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtdaShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospTecnologiaDaInformacaoLtdaShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104985448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">25 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember', window );">Laboratories And Clinics [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment', window );">Useful lives of assets</a></td>
<td class="text">20 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670074101720">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of assets and liabilities information for the company's operating segments (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 6,447,406<span></span>
</td>
<td class="nump">R$ 4,793,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,206,852<span></span>
</td>
<td class="nump">1,405,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,240,554<span></span>
</td>
<td class="nump">3,387,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,447,406<span></span>
</td>
<td class="nump">4,793,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">766,506<span></span>
</td>
<td class="nump">589,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,680,882<span></span>
</td>
<td class="nump">1,369,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,000,018<span></span>
</td>
<td class="nump">2,833,780<span></span>
</td>
<td class="nump">R$ 2,113,726<span></span>
</td>
<td class="nump">R$ 590,354<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,447,406<span></span>
</td>
<td class="nump">4,793,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,206,852<span></span>
</td>
<td class="nump">1,405,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,240,554<span></span>
</td>
<td class="nump">3,387,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,447,406<span></span>
</td>
<td class="nump">4,793,093<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">766,506<span></span>
</td>
<td class="nump">589,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,680,882<span></span>
</td>
<td class="nump">1,369,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,000,018<span></span>
</td>
<td class="nump">2,833,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">48,477<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">301,979<span></span>
</td>
<td class="nump">109,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergrad [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,072,135<span></span>
</td>
<td class="nump">4,541,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,048,869<span></span>
</td>
<td class="nump">1,280,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,023,266<span></span>
</td>
<td class="nump">3,261,646<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,072,135<span></span>
</td>
<td class="nump">4,541,988<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">645,657<span></span>
</td>
<td class="nump">522,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,551,175<span></span>
</td>
<td class="nump">1,261,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,875,303<span></span>
</td>
<td class="nump">2,757,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">48,477<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">220,202<span></span>
</td>
<td class="nump">83,256<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,629<span></span>
</td>
<td class="nump">68,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,737<span></span>
</td>
<td class="nump">40,119<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">62,892<span></span>
</td>
<td class="nump">28,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">105,629<span></span>
</td>
<td class="nump">68,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">32,300<span></span>
</td>
<td class="nump">14,491<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,705<span></span>
</td>
<td class="nump">40,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,624<span></span>
</td>
<td class="nump">13,046<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">25,682<span></span>
</td>
<td class="nump">12,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Digital Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">272,122<span></span>
</td>
<td class="nump">182,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">117,726<span></span>
</td>
<td class="nump">85,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">154,396<span></span>
</td>
<td class="nump">97,765<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">272,122<span></span>
</td>
<td class="nump">182,920<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">91,029<span></span>
</td>
<td class="nump">52,480<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82,002<span></span>
</td>
<td class="nump">67,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">99,091<span></span>
</td>
<td class="nump">63,163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">56,095<span></span>
</td>
<td class="nump">13,587<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,449,886<span></span>
</td>
<td class="nump">4,793,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,209,332<span></span>
</td>
<td class="nump">1,405,616<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,240,554<span></span>
</td>
<td class="nump">3,387,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,449,886<span></span>
</td>
<td class="nump">4,793,208<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">768,986<span></span>
</td>
<td class="nump">589,494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,680,882<span></span>
</td>
<td class="nump">1,369,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,000,018<span></span>
</td>
<td class="nump">2,833,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">48,477<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">301,979<span></span>
</td>
<td class="nump">109,481<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Adjustments And Eliminations [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Assets', window );">Total assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_EquityAndLiabilities', window );">Total liabilities and equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">(115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,480)<span></span>
</td>
<td class="num">R$ (115)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Equity', window );">Equity</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Investments in associate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalExpenditures', window );">Capital expenditures</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Capital expenditures consider
the acquisitions of property and equipment and intangible assets.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalExpenditures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalExpenditures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Equity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of residual interest in the assets of the entity after deducting all its liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Equity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_EquityAndLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_EquityAndLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095207848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of operating income for each operating segment (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">R$ 1,945<span></span>
</td>
<td class="nump">R$ 1,719,371<span></span>
</td>
<td class="nump">R$ 1,201,191<span></span>
</td>
<td class="nump">R$ 750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
<td class="num">(434,654)<span></span>
</td>
<td class="num">(308,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
<td class="nump">766,537<span></span>
</td>
<td class="nump">441,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
<td class="num">(402,855)<span></span>
</td>
<td class="num">(239,120)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,895<span></span>
</td>
<td class="nump">363,335<span></span>
</td>
<td class="nump">205,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
<td class="nump">62,290<span></span>
</td>
<td class="nump">51,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
<td class="nump">335,054<span></span>
</td>
<td class="nump">186,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,179<span></span>
</td>
<td class="nump">27,067<span></span>
</td>
<td class="nump">14,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">750,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">750,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
<td class="num">(434,654)<span></span>
</td>
<td class="num">(308,853)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
<td class="nump">766,537<span></span>
</td>
<td class="nump">441,777<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
<td class="num">(402,855)<span></span>
</td>
<td class="num">(239,120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,561)<span></span>
</td>
<td class="num">(347)<span></span>
</td>
<td class="nump">2,594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">440,895<span></span>
</td>
<td class="nump">363,335<span></span>
</td>
<td class="nump">205,251<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
<td class="nump">62,290<span></span>
</td>
<td class="nump">51,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(243,796)<span></span>
</td>
<td class="num">(98,269)<span></span>
</td>
<td class="num">(72,365)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
<td class="nump">7,698<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
<td class="nump">335,054<span></span>
</td>
<td class="nump">186,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(31,179)<span></span>
</td>
<td class="num">(27,067)<span></span>
</td>
<td class="num">(14,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Undergrad [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
<td class="nump">1,002,461<span></span>
</td>
<td class="nump">653,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,498,408<span></span>
</td>
<td class="nump">1,002,461<span></span>
</td>
<td class="nump">653,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(554,995)<span></span>
</td>
<td class="num">(381,964)<span></span>
</td>
<td class="num">(279,066)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">943,413<span></span>
</td>
<td class="nump">620,497<span></span>
</td>
<td class="nump">374,694<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Continuing Education [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="nump">64,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">72,983<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="nump">64,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,773)<span></span>
</td>
<td class="num">(40,000)<span></span>
</td>
<td class="num">(29,261)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,210<span></span>
</td>
<td class="nump">67,197<span></span>
</td>
<td class="nump">35,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Digital Services [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">147,980<span></span>
</td>
<td class="nump">91,533<span></span>
</td>
<td class="nump">32,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">151,958<span></span>
</td>
<td class="nump">93,152<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(50,510)<span></span>
</td>
<td class="num">(14,309)<span></span>
</td>
<td class="num">(4,406)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,448<span></span>
</td>
<td class="nump">78,843<span></span>
</td>
<td class="nump">31,474<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Total Reportable Segments [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
<td class="nump">1,619<span></span>
</td>
<td class="nump">3,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,723,349<span></span>
</td>
<td class="nump">1,202,810<span></span>
</td>
<td class="nump">754,510<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(656,278)<span></span>
</td>
<td class="num">(436,273)<span></span>
</td>
<td class="num">(312,733)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,067,071<span></span>
</td>
<td class="nump">766,537<span></span>
</td>
<td class="nump">441,777<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember', window );">Operating segments [member] | Adjustments And Eliminations [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepositsFromExternalCustomer', window );">External customer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterSegment', window );">Inter-segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,978<span></span>
</td>
<td class="nump">R$ 1,619<span></span>
</td>
<td class="nump">R$ 3,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GrossProfit', window );">Gross profit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherGainsLosses', window );">Other expenses, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossFromOperatingActivities', window );">Operating income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceExpense', window );">Finance expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates', window );">Share of income of associate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepositsFromExternalCustomer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepositsFromExternalCustomer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterSegment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterSegment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherGainsLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gains (losses) that the entity does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherGainsLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossFromOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 32<br> -IssueDate 2021-01-01<br> -Paragraph IE33<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=32&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE33&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossFromOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentConsolidationItemsAxis=ifrs-full_OperatingSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_TotalReportableSegmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_AdjustmentsAndEliminationsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670070854360">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th" colspan="2"><div>Jul. 20, 2020</div></th>
<th class="th" colspan="2"><div>May 05, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 135,355,000<span></span>
</td>
<td class="nump">R$ 53,499,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 13,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicMember', window );">I Clinic [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 1,659,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,050,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,201,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">473,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,252,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">84,987,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">95,802,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">619,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,414,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,252,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">88,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">91,952,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">99,168,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">191,120,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">119,620,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">117,961,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">118,817,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember', window );">Medicinae [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">201,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,518,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,751,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">163,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,584,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">3,572,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">117,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,516,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember', window );">Medical Harbour [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">47,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">159,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,601,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">6,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">299,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">35,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">345,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">7,256,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,278,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">6,278,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,953,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 5,097,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember', window );">Cliquefarma [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,009,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">501,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,991,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,501,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">580,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">307,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,501,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,588,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,089,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,166,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,923,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">336,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">15,157,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 15,493,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaFipmocSAMember', window );">Sociedade Universitaria Fipmoc S A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 397,000<span></span>
</td>
<td class="nump">R$ 6,140,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,309,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,295,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">702,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,079,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,277,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,331,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">227,534,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">353,667,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">985,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,179,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,306,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">758,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,331,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,079,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 10,990,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember', window );">Sociedade Universitaria Granario S A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">34,755,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">26,622,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">352,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">738,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,159,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">87,265,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">40,775,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">71,669,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">510,356,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">784,691,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,197,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,533,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">22,854,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">94,025,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">71,669,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">87,265,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,745,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,387,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,739,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,878,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113,122,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">295,808,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">240,545,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">488,883,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,777,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">130,073,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,322,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">618,956,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">328,322,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">375,670,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">243,286,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">177,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">340,915,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 351,905,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">R X P R O [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 91,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,211,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">246,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">366,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,330,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,480,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,060,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">62,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">82,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,304,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">38,446,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">45,622,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,263,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,171,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">76,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,112,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 264,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">322,182,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,172,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 322,359,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 30,436,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCash1', window );">Restricted Cash</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade Receivales</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Inventories1', window );">[custom:Inventories1-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">[custom:RecoverableTaxesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">[custom:OtherAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">[custom:RightOfUseAssetsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property, plant and equipment recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ImdemnificationAssets', window );">[custom:ImdemnificationAssets-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Identifiable intangible assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,856,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,259,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade and other payables recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Borrowings recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">[custom:TaxesPayableAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">123,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">[custom:OtherLiabilitiesAsOfAcquisitionDate-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,879,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Goodwill recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,022,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Consideration transferred, acquisition-date fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,901,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,855,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate', window );">Contingent consideration recognised as of acquisition date</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,592,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsiderationToBeTransferred', window );">[custom:ConsiderationToBeTransferred-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInShares', window );">[custom:PaidInShares-0]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash and cash equivalents in subsidiary or businesses acquired or disposed</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,458,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">[custom:NetOfCashFlowOnAcquisition]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 5,646,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="11"></td></tr>
<tr><td colspan="11"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesFromCustomersAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesFromCustomersAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsiderationToBeTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsiderationToBeTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ImdemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ImdemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Inventories1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Inventories1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfCashFlowOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfCashFlowOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaidInShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaidInShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForLegalProceedingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecoverableTaxesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecoverableTaxesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedCash1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedCash1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaFipmocSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaFipmocSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104897032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant accounting policies (Details Narrative)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxAuthorityAxis=afya_ProgramOfSocialIntegrationMember', window );">Program of social integration ("pis") [member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">0.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxAuthorityAxis=afya_ProgramOfSocialIntegrationMember', window );">Program of social integration ("pis") [member] | Non-teaching activities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">1.65%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxAuthorityAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution for the financing of social security ("COFINS") [member] | Teaching Activities [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxAuthorityAxis=afya_ContributionForTheFinancingOfSocialSecurityMember', window );">Contribution for the financing of social security ("COFINS") [member] | Non-teaching activities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Tax rate</a></td>
<td class="nump">7.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContractualLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContractualLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxAuthorityAxis=afya_ProgramOfSocialIntegrationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxAuthorityAxis=afya_ProgramOfSocialIntegrationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_TeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProductsAndServicesAxis=afya_NonTeachingActivitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxAuthorityAxis=afya_ContributionForTheFinancingOfSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxAuthorityAxis=afya_ContributionForTheFinancingOfSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670074192968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of UniRedentor (Details)<br></strong></div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670100877176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of UniSL (Details)<br></strong></div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103568328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of PEBMED (Details)<br></strong></div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104736024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of FESAR (Details)<br></strong></div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104811064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of MedPhone (Details)<br></strong></div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103477448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of acquisition of FCMPB (Details)<br></strong></div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670094686312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 01, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Mar. 13, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Aug. 04, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
<th class="th"><div>May 05, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Sociedade Universitaria Redentor S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method
    The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Centro Universitario Sao Lucas Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Faculdade De Ciencias Medicas Da Paraiba [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Sociedade Universitaria Redentor S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Centro Universitario Sao Lucas Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Faculdade De Ciencias Medicas Da Paraiba [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember', window );">Sociedade Universitaria Granario S A [Member] | Licences [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember', window );">Sociedade Universitaria Granario S A [Member] | Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">R X P R O [Member] | Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">R X P R O [Member] | Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Relief
    from royalty<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">R X P R O [Member] | Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member] | Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member] | Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member] | Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember', window );">Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member] | Licences [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">With-and-without
    method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member] | Customer-related intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Multi-period
    excess earnings method<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member] | Brand names [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Relief
    from royalty<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member] | Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue', window );">Valuation technique</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Replacement
    cost<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph o<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_o_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_SociedadeUniversitariaRedentorSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_SociedadeUniversitariaRedentorSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_CentroUniversitarioSaoLucasLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_CentroUniversitarioSaoLucasLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaGranarioSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670072074216">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th"><div>Nov. 04, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
<th class="th"><div>May 05, 2020</div></th>
<th class="th"><div>May 05, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Dec. 09, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 72,726,000<span></span>
</td>
<td class="nump">R$ 76,181,000<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">135,355,000<span></span>
</td>
<td class="nump">R$ 53,499,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 13,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAMember', window );">Sociedade Universitaria Redentor S A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 11,796,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,265,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,207,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142,399,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">176,666,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">746,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,187,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,265,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">850,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">710,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,994,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,223,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,443,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">77,662,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">210,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,607,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">95,498,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,380,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">102,811,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 104,191,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaMember', window );">Centro Universitario Sao Lucas Ltda [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,245,000<span></span>
</td>
<td class="nump">R$ 3,245,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,567,000<span></span>
</td>
<td class="nump">21,567,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">467,000<span></span>
</td>
<td class="nump">467,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">822,000<span></span>
</td>
<td class="nump">822,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,251,000<span></span>
</td>
<td class="nump">7,251,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,645,000<span></span>
</td>
<td class="nump">12,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,062,000<span></span>
</td>
<td class="nump">42,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19,144,000<span></span>
</td>
<td class="nump">19,144,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">314,097,000<span></span>
</td>
<td class="nump">314,097,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">421,300,000<span></span>
</td>
<td class="nump">421,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,554,000<span></span>
</td>
<td class="nump">3,554,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">58,541,000<span></span>
</td>
<td class="nump">58,541,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,062,000<span></span>
</td>
<td class="nump">42,062,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,070,000<span></span>
</td>
<td class="nump">8,070,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,779,000<span></span>
</td>
<td class="nump">5,779,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,645,000<span></span>
</td>
<td class="nump">12,645,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,084,000<span></span>
</td>
<td class="nump">6,084,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,526,000<span></span>
</td>
<td class="nump">80,526,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">14,754,000<span></span>
</td>
<td class="nump">14,754,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">232,015,000<span></span>
</td>
<td class="nump">232,015,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189,285,000<span></span>
</td>
<td class="nump">189,285,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,420,000<span></span>
</td>
<td class="nump">4,420,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">193,705,000<span></span>
</td>
<td class="nump">193,705,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">141,065,000<span></span>
</td>
<td class="nump">141,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">52,640,000<span></span>
</td>
<td class="nump">52,640,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,666,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,820,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 139,486,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember', window );">Instituicao De Pesquisa Medicae Servicos Tecnologicos Da Area Da Saude S A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,119,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,984,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">391,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,372,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">83,242,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,024,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">865,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,786,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,350,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,312,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,547,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,695,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,175,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">132,870,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">115,339,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,531,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">613,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">114,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 114,833,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember', window );">Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,236,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,871,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,176,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">167,106,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">201,431,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">143,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,087,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,801,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,871,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">759,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,690,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,741,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">71,664,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">262,405,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">260,836,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,569,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,047,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">256,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 258,647,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 60,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,727,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,796,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">228,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">230,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,566,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,843,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,409,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,373,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">36,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">158,000<span></span>
</td>
<td class="nump">R$ 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,313,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 6,471,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember', window );">Faculdade De Ciencias Medicas Da Paraiba [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate', window );">Cash and cash and equivalents</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesAsOfAcquisitionDate', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">8,148,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate', window );">Inventories</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RecoverableTaxesAsOfAcquisitionDate', window );">Recoverable taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssetsAsOfAcquisitionDate', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">123,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndemnificationAssets', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightOfUseAssetsAsOfAcquisitionDate', window );">Right-of-use assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate', window );">Property and equipment</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">962,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate', window );">Intangible assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">264,782,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate', window );">Total Assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">297,778,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate', window );">Trade payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">173,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesAsOfAcquisitionDate', window );">Lease liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,663,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate', window );">Labor and social obligations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,832,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxesPayableAsOfAcquisitionDate', window );">Taxes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate', window );">Provision for legal proceedings</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdvancesFromCustomersAsOfAcquisitionDate', window );">Advances from customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,781,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherLiabilitiesAsOfAcquisitionDate', window );">Other liabilities</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate', window );">Total Liabilites</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,454,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Total identifiable net assets at fair value</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">268,324,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate', window );">Preliminary goodwill arising on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">110,483,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred', window );">Purchase consideration transferred</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">378,807,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashTransferred', window );">Cash paid</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">189,913,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PayablInInstallmentsAcquisitionDate', window );">Payable in installments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">188,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaidInAfyaBrazilsShares', window );">Paid in Afya Brazil's shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs (included in cash flows from operating activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">721,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013', window );">Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 189,813,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfCashFlowOnAcquisition', window );">Net of cash flow on acquisition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 190,534,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="13"></td></tr>
<tr><td colspan="13"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdvancesFromCustomersAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdvancesFromCustomersAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IndemnificationAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IndemnificationAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LaborAndSocialObligationsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LaborAndSocialObligationsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfCashFlowOnAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfCashFlowOnAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotesPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotesPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherLiabilitiesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherLiabilitiesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaidInAfyaBrazilsShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaidInAfyaBrazilsShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PayablInInstallmentsAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PayablInInstallmentsAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProvisionForLegalProceedingsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProvisionForLegalProceedingsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RecoverableTaxesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RecoverableTaxesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightOfUseAssetsAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightOfUseAssetsAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxesPayableAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxesPayableAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 40<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_40_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashTransferred">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph f<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_f_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashTransferred</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GoodwillRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GoodwillRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InventoryRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InventoryRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph IE72<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_IE72&amp;doctype=Illustrative%20Examples<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_SociedadeUniversitariaRedentorSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroUniversitarioSaoLucasLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FaculdadeDeCienciasMedicasDaParaibaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670105746968">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of cash and cash equivalents (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Cash', window );">Cash and bank deposits</a></td>
<td class="nump">R$ 88,487<span></span>
</td>
<td class="nump">R$ 57,729<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents</a></td>
<td class="nump">660,075<span></span>
</td>
<td class="nump">987,313<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">&#160;Cash and cash equivalents</a></td>
<td class="nump">R$ 748,562<span></span>
</td>
<td class="nump">R$ 1,045,042<span></span>
</td>
<td class="nump">R$ 943,209<span></span>
</td>
<td class="nump">R$ 62,260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits. [Refer: Cash on hand]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670073078168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business combinations (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 04, 2021</div></th>
<th class="th"><div>May 13, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Jan. 21, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 05, 2020</div></th>
<th class="th"><div>Nov. 04, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>Jul. 20, 2020</div></th>
<th class="th"><div>May 05, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Nov. 09, 2021</div></th>
<th class="th"><div>Jun. 01, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 13,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,945,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,719,371,000<span></span>
</td>
<td class="nump">R$ 1,201,191,000<span></span>
</td>
<td class="nump">R$ 750,630,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,462,000<span></span>
</td>
<td class="nump">335,054,000<span></span>
</td>
<td class="nump">R$ 186,937,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,435<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">926<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 158,000<span></span>
</td>
<td class="nump">R$ 158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">49,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 57<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">142<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember', window );">I Clinic [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$191,120 is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,456,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 8,250<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,158<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,320<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember', window );">Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$ 22,089 is comprised by:
(i) R$ 16,166 paid in cash; (ii) R$3,000 settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#8220;contingent
consideration&#8221;) of R$ 3,000 is payable in relation to product development. The contingent consideration of R$2,923 is based on
the present value of the obligation considering the facts and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">359,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,268,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,518<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,752<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_MedicinaeMember', window );">Medicinae [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$9,172 is comprised by: i) R$ 5,600 of which 100% was
paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up of R$ 4,400 is payable
in connection with product development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3,572 is based
on the present value of the obligation considering the facts and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_HarbourMember', window );">Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$11,278 is comprised by: i) R$ 5,000 of which
100% was paid in cash on the transaction closing date; and ii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 9,000
is payable in connection with product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration
of R$6,278 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 144<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfAcquiree', window );">Revenue of acquiree since acquisition date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueOfCombinedEntity', window );">Revenue of combined entity as if combination occurred at beginning of period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">268<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$7,901 is comprised by: i) R$ 5,855 was paid
in cash; ii) R$ 454 of consideration to be transferred; and iii) an earn-out (&#8220;contingent consideration&#8221;) of up to R$ 1,793
is payable in relation to product development. The contingent consideration of R$1,592 is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 188<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,376,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 448<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">82<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember', window );">U N I F I P Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price is R$ 328,322 and the total amount was paid in cash. There are 40 additional seats still pending approval,
which, if approved by the Ministry of Education, will result in a potential additional payment of up to R$ 50,000. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 177<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">69,887,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 19,458<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember', window );">U N I G R A N [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">The aggregate original purchase price of R$ 626,116
of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four equal installments through 2022 to
2025, adjusted by the CDI rate, was adjusted by R$7,160, because of the actual net debt, to R$618,956. There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200. Given the future event
that will trigger the potential payout is not under the Company&#8217;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="nump">R$ 10,990<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">123,369,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="nump">R$ 33,450<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_PXPROMember', window );">P X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price of R$45,622 is comprised by: i) R$ 30,263
was paid in cash; ii) R$ 76 to be paid as price adjustment, iii) R$5,112 settled with Afya's treasury shares on the transaction closing
date; and (iv) an earn-out (&#8220;contingent consideration&#8221;) of R$ 21,000 is payable in relation to revenue achievements. The
contingent consideration of R$10,171 is based on the present value of the obligation considering the facts and circumstances at the acquisition
date.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 264<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">907,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 984<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,155<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember', window );">Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The original purchase price of R$214,608, was adjusted by R$4,503
and was comprised by: i) R$114,607 paid in cash on the acquisition date; and ii) R$100,000 is payable in five equal installments from
January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4,503 was deducted from the first installment
due in January 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,380<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">96,065,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,952<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,931<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_UniSLMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The original
purchase consideration of R$201,521 was adjusted by R$7,816, of which: (i) 70% is payable in cash on the transaction closing date, and
(ii) 30% is payable in cash in three equal installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment
of R$7,816 was deducted from the first installment due in May 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember', window );">P E B M E D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The original purchase price of R$ 132,900 was adjusted by R$ 30 and was comprised
by: i) R$115,339 paid in cash on the acquisition date; and ii) R$ 17,531 was paid with Afya Brazil&#8217;s shares which were afterwards
contributed to the Company in exchange of issuance of 141,976 of its own shares.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 613<span></span>
</td>
<td class="nump">R$ 1,666<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,535,000<span></span>
</td>
<td class="nump">113,894,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,413<span></span>
</td>
<td class="nump">30,649<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,452<span></span>
</td>
<td class="nump">57,477<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,455<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalPaymentMade', window );">Additional payment made</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 80,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DecreasedInIncomeBeforeIncomeTaxes', window );">[custom:DecreasedInIncomeBeforeIncomeTaxes]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,813<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember', window );">Faculdade de Ensino Superior da Amazonia Reunida ("FESAR") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The aggregate purchase price was R$260,836, including the CDI rate adjustment
from the signing date and the real state of the operation, estimated at R$ 17,397, of which 100% was paid in cash on the closing of the
operation. The purchase consideration was adjusted by R$1,569 and was paid on February 25, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 6,280,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,751<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInRevenue', window );">Increase in revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">29,113<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseInIncomeBeforeIncomeTaxes', window );">Increase in income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 14,918<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember', window );">MedPhone Tecnologia em Saude Ltda ("MedPhone") [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The net purchase price was R$6,373 of which 100% was paid
in cash on the closing of the operation. The purchase price was adjusted to R$6,409, this price adjustment of R$ 36 was paid on February
2, 2021.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember', window );">F C M P B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Percentage of voting equity interests acquired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfAcquiree', window );">Description of acquiree</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The total net purchase price of R$379,913 was adjusted to
R$378,807 and is comprised of (i) R$189,913 paid in cash on the transaction closing date, and (ii) R$188,894 is payable in cash in four
equal installments through 2024, adjusted by the CDI rate.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 721<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,509,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income loss before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,570<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalPaymentMade">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalPaymentMade</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DecreasedInIncomeBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DecreasedInIncomeBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInIncomeBeforeIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInIncomeBeforeIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseInRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseInRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueOfCombinedEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The revenue of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Business combinations [member]; Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueOfCombinedEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_IClinicMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_IClinicMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_MedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_MedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_HarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_HarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UNIFIPMocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UNIGRANMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_PXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_PXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_PEBMEDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_MedPhoneTecnologiaEmSaudeLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BusinessCombinationsAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670073054600">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of trade accounts receivable, net and notes receivable (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 450,806<span></span>
</td>
<td class="nump">R$ 342,924<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccountsFoReceivable1', window );">(-) Allowance for doubtful accounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(45,013)<span></span>
</td>
<td class="num">(32,980)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables, net</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">405,793<span></span>
</td>
<td class="nump">309,944<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTradeReceivables', window );">Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">378,351<span></span>
</td>
<td class="nump">302,317<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,442<span></span>
</td>
<td class="nump">7,627<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember', window );">Tuition Fees [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">279,915<span></span>
</td>
<td class="nump">195,318<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember', window );">Educational Content [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">69,227<span></span>
</td>
<td class="nump">62,931<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember', window );">F I E S [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">61,342<span></span>
</td>
<td class="nump">49,425<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember', window );">Educational Credits [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,375<span></span>
</td>
<td class="nump">11,248<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember', window );">Mobile App Subscription [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="nump">20,946<span></span>
</td>
<td class="nump">13,526<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember', window );">Others [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivables, gross</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 14,001<span></span>
</td>
<td class="nump">R$ 10,476<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Related to trade receivables
from mobile applications subscriptions for digital medical content.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccountsFoReceivable1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccountsFoReceivable1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 68<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_68&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_TuitionFeesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_FIESMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_EducationalCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_MobileAppSubscriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_OthersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104974248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of aging of trade accounts receivable (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 450,806<span></span>
</td>
<td class="nump">R$ 342,924<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember', window );">Current [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">68,932<span></span>
</td>
<td class="nump">44,365<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember', window );">Later Than One Months And Not Later Than Three Months [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">69,299<span></span>
</td>
<td class="nump">57,198<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember', window );">Later than three months and not later than six months [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">55,764<span></span>
</td>
<td class="nump">51,521<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember', window );">Later Than One Eighty [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">72,429<span></span>
</td>
<td class="nump">44,764<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember', window );">Financial assets neither past due nor impaired [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReceivablesGross', window );">Trade receivable</a></td>
<td class="nump">R$ 184,382<span></span>
</td>
<td class="nump">R$ 145,076<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReceivablesGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReceivablesGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_CurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PastDueStatusAxis=afya_LaterThanOneEightyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ImpairmentOfFinancialAssetsAxis=ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104619256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of allowance for doubtful accounts (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Balances at the beginning of the period</a></td>
<td class="num">R$ (32,980)<span></span>
</td>
<td class="num">R$ (14,763)<span></span>
</td>
<td class="num">R$ (7,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets', window );">Additions</a></td>
<td class="num">(47,819)<span></span>
</td>
<td class="num">(32,081)<span></span>
</td>
<td class="num">(15,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable', window );">Write-offs</a></td>
<td class="nump">35,786<span></span>
</td>
<td class="nump">13,864<span></span>
</td>
<td class="nump">7,814<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets', window );">Balances at the end of the period</a></td>
<td class="num">R$ (45,013)<span></span>
</td>
<td class="num">R$ (32,980)<span></span>
</td>
<td class="num">R$ (14,763)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 16<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_16&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>111
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670072047608">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>The table below summarizes the balances and transactions with related parties: (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeReceivablesRelatedPartyTransactions', window );">Trade receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">R$ 692<span></span>
</td>
<td class="nump">R$ 174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CreditsWithShareholdersRelatedPartyTransactions', window );">Related parties</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsReceivableRelatedPartyTransactions', window );">&#160;TOTAL</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">692<span></span>
</td>
<td class="nump">595<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1', window );">Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">692<span></span>
</td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentAssetsOfRelatedParty1', window );">Non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="nump">421<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholders', window );">Accounts payable to selling shareholders</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="nump">54,556<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountsPayableRelatedPartyTransactions', window );">&#160;Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">54,556<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableCurrent1', window );">Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,278<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentPayablesToRelatedParties1', window );">Non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,278<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">752<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">R$ 557<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,106<span></span>
</td>
<td class="nump">17,673<span></span>
</td>
<td class="nump">15,842<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember', window );">U E P C [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherIncomeRelatedPartyTransactions', window );">Other income</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">752<span></span>
</td>
<td class="nump">104<span></span>
</td>
<td class="nump">557<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember', window );">R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,336<span></span>
</td>
<td class="nump">11,288<span></span>
</td>
<td class="nump">10,417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember', window );">U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,210<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember', window );">I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions', window );">Lease</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 4,560<span></span>
</td>
<td class="nump">R$ 3,470<span></span>
</td>
<td class="nump">R$ 2,609<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Refers to sales of educational content
from Medcel to UEPC.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableCurrent1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableCurrent1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CreditsWithShareholdersRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CreditsWithShareholdersRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssetsOfRelatedParty1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssetsOfRelatedParty1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherIncomeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherIncomeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherCurrentPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherCurrentPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeReceivablesRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeReceivablesRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsPayableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts payable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsPayableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountsReceivableRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 20<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_20&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountsReceivableRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeasesAsLesseeRelatedPartyTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of leases where the entity was the lessee in related party transactions. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 21<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_21_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeasesAsLesseeRelatedPartyTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_RVLEstevesGestaoImobiliariaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_UNIVACOPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_IESVAPPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670094647880">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cash and cash equivalents (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents (a)</a></td>
<td class="nump">R$ 660,075,000<span></span>
</td>
<td class="nump">R$ 987,313,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_CurrencyAxis=afya_USDMember', window );">U S D [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashEquivalents', window );">Cash equivalents (a)</a></td>
<td class="nump">R$ 23,228<span></span>
</td>
<td class="nump">R$ 70,523<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember', window );">Bank Certificates Of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument', window );">Percentage of average interest</a></td>
<td class="nump">100.38%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_InterbankCertificatesOfDepositMember', window );">Interbank Certificates Of Deposit [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument', window );">Percentage of average interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.95%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PercenatgeOfAverageInterestOnFinancialInstrument">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PercenatgeOfAverageInterestOnFinancialInstrument</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=afya_USDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=afya_USDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_BankCertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_InterbankCertificatesOfDepositMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_InterbankCertificatesOfDepositMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108356968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Key management personnel compensation included in the Company&#8217;s consolidated statement of income comprised the following: (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits', window );">Short-term employee benefits</a></td>
<td class="nump">R$ 11,933<span></span>
</td>
<td class="nump">R$ 9,629<span></span>
</td>
<td class="nump">R$ 4,947<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_KeyManagementPersonnelCompensation', window );">Share-based compensation plans</a></td>
<td class="nump">20,251<span></span>
</td>
<td class="nump">23,989<span></span>
</td>
<td class="nump">13,893<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity', window );">Total</a></td>
<td class="nump">R$ 32,184<span></span>
</td>
<td class="nump">R$ 33,618<span></span>
</td>
<td class="nump">R$ 18,840<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 18A<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18A&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 24<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=24&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>114
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670070776984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related parties (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 30, 2019</div></th>
<th class="th"><div>Sep. 06, 2018</div></th>
<th class="th"><div>Apr. 25, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember', window );">R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 417<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | R V L Esteves Gestao Imobiliaria S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 15,336<span></span>
</td>
<td class="nump">R$ 11,288<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | R V L Esteves Gestao Imobiliaria S A [Member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | R V L Esteves Gestao Imobiliaria S A [Member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerm', window );">Description of lease term</a></td>
<td class="text">(i) up to June 2022, R$40; (ii) after
June 2022 and until December 2028, 6.5% of the monthly net revenue of ITPAC<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | U N I V A C O Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 3,210<span></span>
</td>
<td class="nump">2,915<span></span>
</td>
<td class="nump">2,816<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member', window );">Lease Agreements 1 [Member] | I E S V A P Patrimonial Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ReserveQuantitiesLineItems', window );"><strong>Reserve Quantities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfEntitysRevenue', window );">Percentage of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7.50%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LesseeFinancesLeaseRenewalTerm', window );">Renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">20 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashOutflowForLeases', window );">Lease expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,560<span></span>
</td>
<td class="nump">R$ 3,470<span></span>
</td>
<td class="nump">R$ 2,609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DescriptionOfLeaseTerms', window );">Description of lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">The lease agreement is for an amount
equal to 7.5% of the monthly net revenue of IESVAP during 2018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about description of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfLeaseTerms">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfLeaseTerms</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LesseeFinancesLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LesseeFinancesLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashOutflowForLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_g&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashOutflowForLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfEntitysRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of the entity's revenue. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfEntitysRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ReserveQuantitiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ReserveQuantitiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_RVLEstevesGestaoImobiliariaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TypeOfArrangement1Axis=afya_LeaseAgreements1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_UNIVACOPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=afya_IESVAPPatrimonialLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670094656072">
<tr>
<th class="tl" colspan="2" rowspan="1"><div style="width: 200px;"><strong>Schedule of Other Assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate', window );">Indemnification assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">R$ 135,355<span></span>
</td>
<td class="nump">R$ 53,499<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,825<span></span>
</td>
<td class="nump">1,451<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentPrepaidExpenses', window );">Prepaid expenses</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,110<span></span>
</td>
<td class="nump">2,291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherReceivables', window );">Other FIES receivables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,450<span></span>
</td>
<td class="nump">10,411<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherAssets1', window );">Other assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">37,099<span></span>
</td>
<td class="nump">35,999<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Assets1', window );">&#160;Total</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">222,839<span></span>
</td>
<td class="nump">103,651<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CurrentAssets1', window );">Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">42,533<span></span>
</td>
<td class="nump">29,614<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentAssets1', window );">Non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 180,306<span></span>
</td>
<td class="nump">R$ 74,037<span></span>
</td>
</tr>
<tr><td colspan="3"></td></tr>
<tr><td colspan="3"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Assets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Assets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_JudicialDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_JudicialDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentPrepaidExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentPrepaidExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph g<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_g_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount receivable by the entity that it does not separately disclose in the same statement or note.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>116
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095036216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of investments (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,206,852<span></span>
</td>
<td class="nump">R$ 1,405,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,240,554<span></span>
</td>
<td class="nump">3,387,592<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">766,506<span></span>
</td>
<td class="nump">589,379<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,680,882<span></span>
</td>
<td class="nump">1,369,934<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="nump">R$ 1,945<span></span>
</td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">R$ 750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(652,300)<span></span>
</td>
<td class="num">(434,654)<span></span>
</td>
<td class="num">(308,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(622,615)<span></span>
</td>
<td class="num">(402,855)<span></span>
</td>
<td class="num">(239,120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance result</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,566<span></span>
</td>
<td class="nump">62,290<span></span>
</td>
<td class="nump">51,689<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">273,462<span></span>
</td>
<td class="nump">335,054<span></span>
</td>
<td class="nump">186,937<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,179<span></span>
</td>
<td class="nump">27,067<span></span>
</td>
<td class="nump">14,175<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">242,283<span></span>
</td>
<td class="nump">307,987<span></span>
</td>
<td class="nump">172,762<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable (included in Other assets)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,770<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember', window );">Associates [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentAssets', window );">Current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33,976<span></span>
</td>
<td class="nump">55,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentAssets', window );">Non-current assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">109,805<span></span>
</td>
<td class="nump">82,575<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLiabilities', window );">Current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(35,049)<span></span>
</td>
<td class="num">(34,531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLiabilities', window );">Non-current liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,086)<span></span>
</td>
<td class="num">(76,132)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EquityInAssociate', window );">Equity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,646<span></span>
</td>
<td class="nump">27,325<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CompanyShareInEquity1', window );">Company&#8217;s share in equity &#8211; 30%</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,294<span></span>
</td>
<td class="nump">8,227<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">43,183<span></span>
</td>
<td class="nump">43,183<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InvestmentGrossAmount', window );">Carrying amount of the investment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,477<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Revenue', window );">Net revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">127,618<span></span>
</td>
<td class="nump">113,965<span></span>
</td>
<td class="nump">85,816<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(57,935)<span></span>
</td>
<td class="num">(55,926)<span></span>
</td>
<td class="num">(39,459)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(24,025)<span></span>
</td>
<td class="num">(27,341)<span></span>
</td>
<td class="num">(29,476)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance result</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,585)<span></span>
</td>
<td class="num">(4,882)<span></span>
</td>
<td class="num">(4,121)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,073<span></span>
</td>
<td class="nump">25,816<span></span>
</td>
<td class="nump">12,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncomeTaxExpenseContinuingOperations', window );">Income taxes expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,748)<span></span>
</td>
<td class="num">(252)<span></span>
</td>
<td class="num">(2,275)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLoss', window );">Net income for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,325<span></span>
</td>
<td class="nump">25,564<span></span>
</td>
<td class="nump">10,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CompanyShareOfProfitss', window );">Company&#8217;s share of income for the period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
<td class="nump">7,698<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">51,410<span></span>
</td>
<td class="nump">45,634<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_MinorityInterestOfAcquiree', window );">Acquisition of minority interest (15%) in March 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,458<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalMinorityInterestOfAcquiree', window );">Acquisition of additional interest (15%) in June 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">24,457<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DividendsReceived1', window );">Dividends received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(11,770)<span></span>
</td>
<td class="num">(1,922)<span></span>
</td>
<td class="num">(5,643)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsReceived', window );">Dividends receivable (included in Other assets)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,960)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossOfAcquiree', window );">Share of income</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,797<span></span>
</td>
<td class="nump">7,698<span></span>
</td>
<td class="nump">2,362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentsInAssociates', window );">Closing balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 48,477<span></span>
</td>
<td class="nump">R$ 51,410<span></span>
</td>
<td class="nump">R$ 45,634<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalMinorityInterestOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalMinorityInterestOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareInEquity1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareInEquity1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompanyShareOfProfitss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompanyShareOfProfitss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsReceived1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsReceived1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EquityInAssociate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EquityInAssociate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InvestmentGrossAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InvestmentGrossAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_MinorityInterestOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_MinorityInterestOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.
Effective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends received.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncomeTaxExpenseContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause viii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_viii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph g<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_g&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncomeTaxExpenseContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentsInAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 27<br> -IssueDate 2021-01-01<br> -Paragraph 10<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=27&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_10&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentsInAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that do not meet the definition of current assets. [Refer: Current assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_ii&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_iv&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 69<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_69&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 18<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_18_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 24<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_24_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -Subparagraph a<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32_a_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective on first application of IFRS 9<br> -Name IFRS<br> -Number 4<br> -IssueDate 2021-01-01<br> -Paragraph 39L<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=4&amp;code=ifrs-tx-2021-en-b&amp;anchor=para_39L_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Note Effective 2023-01-01<br> -Name IFRS<br> -Number 17<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=17&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 81A<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81A_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossOfAcquiree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph q<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_q_i&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossOfAcquiree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Revenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 32<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_32&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 34<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_34&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B12<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B12_b_v&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_b&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Revenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=ifrs-full_AssociatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>117
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095814936">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of detailed information about property, plant and equipment (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 260,381<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">419,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 260,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">419,808<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">260,381<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember', window );">Buildings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,919<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">50,760<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,919<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember', window );">Machinery And Equipments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">49,181<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">60,980<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">49,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember', window );">Land [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,401<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember', window );">Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,044<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,247<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,044<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember', window );">Fixtures and fittings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,042<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">57,338<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember', window );">It Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,660<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">38,262<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,660<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember', window );">Library Books [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,807<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,472<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember', window );">Laboratories And Clinics [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember', window );">Leasehold improvements [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">117,621<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">117,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">144,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">117,621<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember', window );">Construction in progress [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,706<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">314,015<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">176,303<span></span>
</td>
<td class="nump">R$ 91,648<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">125,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">89,832<span></span>
</td>
<td class="nump">56,964<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(525)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">65,623<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">47,880<span></span>
</td>
<td class="nump">28,216<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(17,532)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">487,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">314,015<span></span>
</td>
<td class="nump">176,303<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">487,975<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">314,015<span></span>
</td>
<td class="nump">176,303<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Buildings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,919<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,384<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">25,068<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,148<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">6,771<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">62<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,919<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">52,433<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">25,919<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Machinery And Equipments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">68,503<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">44,329<span></span>
</td>
<td class="nump">30,503<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,268<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,806<span></span>
</td>
<td class="nump">9,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,395<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,810<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">8,973<span></span>
</td>
<td class="nump">3,988<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(14,213)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">68,503<span></span>
</td>
<td class="nump">44,329<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">77,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">68,503<span></span>
</td>
<td class="nump">44,329<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Land [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">13,401<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,005<span></span>
</td>
<td class="nump">2,770<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,451<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">672<span></span>
</td>
<td class="nump">4,235<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,724<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,401<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">18,852<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,401<span></span>
</td>
<td class="nump">7,005<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,215<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">707<span></span>
</td>
<td class="nump">182<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">422<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">346<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">508<span></span>
</td>
<td class="nump">103<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(205)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,467<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,215<span></span>
</td>
<td class="nump">707<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Fixtures and fittings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">29,131<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,438<span></span>
</td>
<td class="nump">11,897<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,075<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,550<span></span>
</td>
<td class="nump">6,976<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">82<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">82<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,061<span></span>
</td>
<td class="nump">2,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,862<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,834<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,131<span></span>
</td>
<td class="nump">21,438<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">69,834<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">29,131<span></span>
</td>
<td class="nump">21,438<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | It Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">15,994<span></span>
</td>
<td class="nump">10,243<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,511<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,657<span></span>
</td>
<td class="nump">4,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">367<span></span>
</td>
<td class="num">(525)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,138<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,493<span></span>
</td>
<td class="nump">2,035<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(4,985)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,511<span></span>
</td>
<td class="nump">15,994<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">53,184<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">28,511<span></span>
</td>
<td class="nump">15,994<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Library Books [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,624<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">18,139<span></span>
</td>
<td class="nump">12,838<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,392<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,012<span></span>
</td>
<td class="nump">1,205<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">5,142<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,473<span></span>
</td>
<td class="nump">4,096<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(86)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,624<span></span>
</td>
<td class="nump">18,139<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">30,072<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">21,624<span></span>
</td>
<td class="nump">18,139<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Laboratories And Clinics [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,049<span></span>
</td>
<td class="nump">597<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">34<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,049)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">418<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="nump">1,049<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Leasehold improvements [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">122,005<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">30,911<span></span>
</td>
<td class="nump">11,882<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,720<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">54,748<span></span>
</td>
<td class="nump">4,488<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,376<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">23,559<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,425<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,787<span></span>
</td>
<td class="nump">14,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(550)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">122,005<span></span>
</td>
<td class="nump">30,911<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">152,976<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">122,005<span></span>
</td>
<td class="nump">30,911<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member] | Construction in progress [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,706<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">36,731<span></span>
</td>
<td class="nump">10,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">59,957<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,387<span></span>
</td>
<td class="nump">25,525<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(34,538)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(43,502)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,078<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">5,090<span></span>
</td>
<td class="nump">470<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(417)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,706<span></span>
</td>
<td class="nump">36,731<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">31,786<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,706<span></span>
</td>
<td class="nump">36,731<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(53,634)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(36,983)<span></span>
</td>
<td class="num">(25,885)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">15,928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68,167)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53,634)<span></span>
</td>
<td class="num">(36,983)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(30,461)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(16,651)<span></span>
</td>
<td class="num">(11,545)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(68,167)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(53,634)<span></span>
</td>
<td class="num">(36,983)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Buildings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,673)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,673)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(1,673)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Machinery And Equipments [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(19,322)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(13,793)<span></span>
</td>
<td class="num">(9,696)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(464)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">10,146<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,391)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,322)<span></span>
</td>
<td class="num">(13,793)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,215)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,065)<span></span>
</td>
<td class="num">(4,097)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,391)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(19,322)<span></span>
</td>
<td class="num">(13,793)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Land [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Vehicles [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(171)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(59)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">147<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(220)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(196)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(112)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(220)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(171)<span></span>
</td>
<td class="num">(59)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Fixtures and fittings [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,089)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(5,890)<span></span>
</td>
<td class="num">(4,261)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,194<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,089)<span></span>
</td>
<td class="num">(5,890)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,601)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,199)<span></span>
</td>
<td class="num">(1,629)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,496)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,089)<span></span>
</td>
<td class="num">(5,890)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | It Equipment [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,851)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,537)<span></span>
</td>
<td class="num">(4,489)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,458<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">447<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,922)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,851)<span></span>
</td>
<td class="num">(6,537)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,529)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,314)<span></span>
</td>
<td class="num">(2,495)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(14,922)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,851)<span></span>
</td>
<td class="num">(6,537)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Library Books [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(10,817)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,663)<span></span>
</td>
<td class="num">(7,015)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13,600)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,817)<span></span>
</td>
<td class="num">(8,663)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,416)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,154)<span></span>
</td>
<td class="num">(1,648)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(13,600)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(10,817)<span></span>
</td>
<td class="num">(8,663)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Laboratories And Clinics [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(386)<span></span>
</td>
<td class="num">(27)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">464<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(78)<span></span>
</td>
<td class="num">(359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="num">(386)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Leasehold improvements [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,384)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,655)<span></span>
</td>
<td class="num">(338)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">350<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,865)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,384)<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(4,831)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,729)<span></span>
</td>
<td class="num">(1,317)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,865)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,384)<span></span>
</td>
<td class="num">(1,655)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member] | Construction in progress [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment', window );">Transfer</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DisposalsPropertyPlantAndEquipment', window );">Disposals</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2021</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationPropertyPlantAndEquipment', window );">Depreciation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PropertyPlantAndEquipment', window );">As of December 31, 2020</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause vii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_vii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 75<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_75_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DisposalsPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DisposalsPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 73<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_73_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_BuildingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_MachineryAndEquipmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_FixturesAndFittingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_ItEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LibraryBooksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=afya_LaboratoriesAndClinicsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis=ifrs-full_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>118
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095431944">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of intangible assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 2,573,010<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,900,835<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 2,573,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,900,835<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,573,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember', window );">Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,684,559<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,361,640<span></span>
</td>
<td class="nump">R$ 688,494<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">176,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">19,649<span></span>
</td>
<td class="nump">122,775<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,234,611<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,303,730<span></span>
</td>
<td class="nump">550,371<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(2,140)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,093,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,684,559<span></span>
</td>
<td class="nump">1,361,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,093,140<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,684,559<span></span>
</td>
<td class="nump">1,361,640<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember', window );">Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(111,549)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(49,302)<span></span>
</td>
<td class="num">(6,025)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(234)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(192,305)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(111,549)<span></span>
</td>
<td class="num">(49,302)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(80,522)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(62,707)<span></span>
</td>
<td class="num">(43,277)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(192,305)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(111,549)<span></span>
</td>
<td class="num">(49,302)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">810,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,184,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">810,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,184,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">810,656<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">810,656<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">459,409<span></span>
</td>
<td class="nump">169,535<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,030<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">373,680<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">351,247<span></span>
</td>
<td class="nump">285,844<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,184,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">810,656<span></span>
</td>
<td class="nump">459,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,184,336<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">810,656<span></span>
</td>
<td class="nump">459,409<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,451,270<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">703,772<span></span>
</td>
<td class="nump">445,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">108,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">606,136<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">747,498<span></span>
</td>
<td class="nump">150,156<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,165,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,451,270<span></span>
</td>
<td class="nump">703,772<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,165,406<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">1,451,270<span></span>
</td>
<td class="nump">703,772<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember', window );">Licences [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">71,512<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">124,840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">71,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">124,840<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">71,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">75,014<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,111<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">58,355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">42,903<span></span>
</td>
<td class="nump">32,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">133,369<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75,014<span></span>
</td>
<td class="nump">32,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">133,369<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">75,014<span></span>
</td>
<td class="nump">32,111<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,502)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,150)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,529)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,502)<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,027)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,352)<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,529)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,502)<span></span>
</td>
<td class="num">(1,150)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">197,707<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">289,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">289,007<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">197,707<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">283,539<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">125,413<span></span>
</td>
<td class="nump">63,303<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">684<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">147,054<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">158,126<span></span>
</td>
<td class="nump">62,110<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">431,277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">283,539<span></span>
</td>
<td class="nump">125,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">431,277<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">283,539<span></span>
</td>
<td class="nump">125,413<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember', window );">Customer-related intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(85,832)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(37,872)<span></span>
</td>
<td class="num">(2,945)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(142,270)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(85,832)<span></span>
</td>
<td class="num">(37,872)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(56,438)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(47,960)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(142,270)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(85,832)<span></span>
</td>
<td class="num">(37,872)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,965<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,060<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">16,221<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,389<span></span>
</td>
<td class="nump">8,288<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,044<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">4,175<span></span>
</td>
<td class="nump">1,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,474<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">3,117<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,020<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(460)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,221<span></span>
</td>
<td class="nump">9,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">21,759<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">16,221<span></span>
</td>
<td class="nump">9,389<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,256)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,536)<span></span>
</td>
<td class="num">(3,080)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(599)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">460<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,699)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,256)<span></span>
</td>
<td class="num">(4,536)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(5,844)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,180)<span></span>
</td>
<td class="num">(1,456)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(12,699)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(6,256)<span></span>
</td>
<td class="num">(4,536)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">9,613<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">633<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">9,613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,305<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,305<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">17,305<span></span>
</td>
<td class="nump">17,305<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(7,692)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(4,876)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,672)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,692)<span></span>
</td>
<td class="num">(4,876)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,980)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,816)<span></span>
</td>
<td class="num">(4,876)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(16,672)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,692)<span></span>
</td>
<td class="num">(4,876)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">323<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">33,740<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">355<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">996<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,397<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">355<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34,397<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">355<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(32)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(32)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(625)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(32)<span></span>
</td>
<td class="num">(34,927)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(657)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(32)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,667<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">64,966<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,667<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">27,902<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">12,191<span></span>
</td>
<td class="nump">577<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">39,686<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">15,227<span></span>
</td>
<td class="nump">8,769<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11,599<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">484<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(2,743)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,902<span></span>
</td>
<td class="nump">12,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">76,444<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,902<span></span>
</td>
<td class="nump">12,191<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember', window );">Educational Platform [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(8,235)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(868)<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">365<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,478)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,235)<span></span>
</td>
<td class="num">(868)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,608)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(7,367)<span></span>
</td>
<td class="num">(868)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(11,478)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(8,235)<span></span>
</td>
<td class="num">(868)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,297<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">2,297<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,050<span></span>
</td>
<td class="nump">1,175<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill', window );">Additions</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">23,700<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">247<span></span>
</td>
<td class="nump">875<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[2],[3]</sup></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">3,267<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="num">(417)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,297<span></span>
</td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">28,847<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,297<span></span>
</td>
<td class="nump">2,050<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember', window );">Software In Progress [Member] | Accumulated depreciation and amortisation [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at beginnning</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Disposal', window );">Disposal</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill, balance at end</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill', window );">Amortization</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsAndGoodwill', window );">Intangible assets and goodwill</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformAndSoftwareInProgressMember', window );">Educational Platform And Software In Progress [Member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,845<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyIntangibleAssetsMember', window );">Developed Technology Intangible Assets [Member] | Gross carrying amount [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill', window );">Business combinations</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 33,046<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 355<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="6"></td></tr>
<tr><td colspan="6"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#225;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Disposal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Disposal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph e<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_e_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsAndGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsAndGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_GrossCarryingAmountMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=ifrs-full_AccumulatedDepreciationAndAmortisationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_LicencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_CustomerrelatedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_SoftwareInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformAndSoftwareInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationalPlatformAndSoftwareInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_DevelopedTechnologyIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>119
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095243656">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of assumptions for impairment test (Details) - Carrying Amounts [Member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th" colspan="2"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">R$ 17,446<span></span>
</td>
<td class="nump">R$ 17,446<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">57,214<span></span>
</td>
<td class="nump">57,214<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">140,522<span></span>
</td>
<td class="nump">126,397<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">27,956<span></span>
</td>
<td class="nump">27,956<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">81,366<span></span>
</td>
<td class="nump">81,366<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">112,260<span></span>
</td>
<td class="nump">112,898<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Centro De Ciencias Em Saude De Itajuba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,664<span></span>
</td>
<td class="nump">4,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">56,737<span></span>
</td>
<td class="nump">56,737<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">49,030<span></span>
</td>
<td class="nump">48,411<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto De Ensino Superior Do Piaui S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">73,838<span></span>
</td>
<td class="nump">73,838<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">179,693<span></span>
</td>
<td class="nump">179,693<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">346,286<span></span>
</td>
<td class="nump">380,410<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F A D E P Faculdade Educacional De Pato Branco Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">49,661<span></span>
</td>
<td class="nump">49,661<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">70,606<span></span>
</td>
<td class="nump">70,606<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">153,791<span></span>
</td>
<td class="nump">160,787<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Medcel And C B B W [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">139,294<span></span>
</td>
<td class="nump">139,294<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">235,300<span></span>
</td>
<td class="nump">219,359<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Educacional Santo Agostinho S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">58,903<span></span>
</td>
<td class="nump">58,903<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">144,507<span></span>
</td>
<td class="nump">144,507<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">302,330<span></span>
</td>
<td class="nump">267,279<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,647<span></span>
</td>
<td class="nump">87,647<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">126,965<span></span>
</td>
<td class="nump">119,227<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Instituto Paraensede Educacaoe Cultura Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">108,000<span></span>
</td>
<td class="nump">108,000<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">131,360<span></span>
</td>
<td class="nump">122,325<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">77,662<span></span>
</td>
<td class="nump">77,662<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">121,477<span></span>
</td>
<td class="nump">121,477<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">246,320<span></span>
</td>
<td class="nump">253,370<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,420<span></span>
</td>
<td class="nump">4,420<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">249,387<span></span>
</td>
<td class="nump">249,387<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">305,044<span></span>
</td>
<td class="nump">258,234<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F E S A R [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">71,664<span></span>
</td>
<td class="nump">71,664<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">141,616<span></span>
</td>
<td class="nump">141,616<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">279,038<span></span>
</td>
<td class="nump">263,914<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">F C M P B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">110,483<span></span>
</td>
<td class="nump">110,483<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">235,018<span></span>
</td>
<td class="nump">235,018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">401,244<span></span>
</td>
<td class="nump">380,682<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Practice Management Tools And Electronic Prescription [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">113,362<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">227,909<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Clinical Decision Software [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,018<span></span>
</td>
<td class="nump">87,018<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">147,592<span></span>
</td>
<td class="nump">149,805<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Medical Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">4,022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">9,150<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Moc [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">87,777<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">184,597<span></span>
</td>
<td class="nump">5,649<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">356,789<span></span>
</td>
<td class="nump">R$ 7,230<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">130,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="nump">421,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">630,185<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember', window );">R X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Goodwill', window );">Goodwill</a></td>
<td class="nump">38,446<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife', window );">Licenses with indefinite useful life</a></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashGeneratingUnits', window );">Cash generating units</a></td>
<td class="nump">R$ 46,788<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">CBBW as merged by Medcel on May 1,
2020.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashGeneratingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashGeneratingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B67<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B67_d&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 122<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_122_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis=afya_CarryingAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CentroDeCienciasEmSaudeDeItajubaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelAndCBBWMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedcelAndCBBWMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PracticeManagementToolsAndElectronicPrescriptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_PracticeManagementToolsAndElectronicPrescriptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ClinicalDecisionSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ClinicalDecisionSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MocMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MocMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103311848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Other assets (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherCurrentAssets1', window );">TotalAssets</a></td>
<td class="nump">R$ 222,839<span></span>
</td>
<td class="nump">R$ 103,651<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherCurrentAssets1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherCurrentAssets1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>121
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095319224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of estimated useful lives (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember', window );">Customer Relationships Medicine [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember', window );">Customer Relationships Other Courses [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">4 years 6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember', window );">Computer software [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember', window );">Education Content [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember', window );">Brand names [member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">30 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember', window );">Technology-based intangible assets [member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill', window );">Estimated useful lives of intangible assets</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 38<br> -IssueDate 2021-01-01<br> -Paragraph 118<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=38&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_118_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsMedicineMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_CustomerRelationshipsOtherCoursesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_ComputerSoftwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=afya_EducationContentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_BrandNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_TechnologybasedIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>122
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108124136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of financial assets (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">R$ 748,562<span></span>
</td>
<td class="nump">R$ 1,045,042<span></span>
</td>
<td class="nump">R$ 943,209<span></span>
</td>
<td class="nump">R$ 62,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">405,793<span></span>
</td>
<td class="nump">309,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">27,442<span></span>
</td>
<td class="nump">9,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember', window );">Financial assets at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">748,562<span></span>
</td>
<td class="nump">1,045,042<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,053<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeReceivables', window );">Trade receivables</a></td>
<td class="nump">405,793<span></span>
</td>
<td class="nump">309,944<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Total</a></td>
<td class="nump">1,154,355<span></span>
</td>
<td class="nump">1,357,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialAssets', window );">Current</a></td>
<td class="nump">1,126,913<span></span>
</td>
<td class="nump">1,347,359<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialAssets', window );">Non-current</a></td>
<td class="nump">R$ 27,442<span></span>
</td>
<td class="nump">R$ 9,680<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial assets. [Refer: Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount due from customers for goods and services sold.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_FinancialAssetsAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>123
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670074108328">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of financial liabilities (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Lease liabilities</a></td>
<td class="nump">R$ 1,374,876<span></span>
</td>
<td class="nump">R$ 617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">R$ 284,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">2,841,513<span></span>
</td>
<td class="nump">1,659,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember', window );">Financial liabilities at amortised cost, class [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">59,098<span></span>
</td>
<td class="nump">35,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Lease liabilities</a></td>
<td class="nump">1,374,876<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayable', window );">Lease liabilities</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="nump">76,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="nump">114,585<span></span>
</td>
<td class="nump">63,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Total</a></td>
<td class="nump">3,015,196<span></span>
</td>
<td class="nump">1,759,191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentFinancialLiabilities', window );">Current</a></td>
<td class="nump">581,685<span></span>
</td>
<td class="nump">467,643<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentFinancialLiabilities', window );">Non-current</a></td>
<td class="nump">R$ 2,433,511<span></span>
</td>
<td class="nump">R$ 1,291,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Advances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Advances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentFinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current financial liabilities. [Refer: Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentFinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_FinancialLiabilitiesAtAmortisedCostMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>124
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670073921640">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of loans and financing (Details) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 26, 2021</div></th>
<th class="th"><div>Dec. 23, 2020</div></th>
<th class="th"><div>Jul. 23, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 23, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>Jul. 03, 2020</div></th>
<th class="th"><div>May 20, 2020</div></th>
<th class="th"><div>May 09, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,374,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing1', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,374,876<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancingCurrent', window );">Current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">128,720<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,162<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancingNonCurrent', window );">Non-current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,246,156<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">510,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesAuthorised', window );">Covertable preffered stock shares</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 0.00005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset', window );">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 821,805<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsByNameAxis=afya_FinanciadoradeEstudoseProjetosFINEPMember', window );">Financiadorade Estudose Projetos F I N E P [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IntrestRate', window );">Intrest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.62%<span></span>
</td>
<td class="nump">1.65%<span></span>
</td>
<td class="nump">10.03%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotionalAmount', window );">Loan amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 16,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BorrowingsAmountFirstTranche', window );">Borrowings amount first tranche</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,130<span></span>
</td>
<td class="nump">6,734<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset', window );">Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyThreeMember', window );">2023 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Banco
    Ita&#250; Unibanco S.A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CDI
    + 1.62% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 510,972<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">504,365<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyOneMember', window );">2021 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Banco
    Votorantim<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CDI
    + 1.65% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">101,785<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember', window );">2024 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">BNDES<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10.03%
    p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[3]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">471<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember', window );">2027 [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">FINEP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">TJLP
    p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2027<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[4]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,864<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentySixMember', window );">Twenty Twenty Six [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Softbank<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6.5%
    p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2026<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[5]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 822,560<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFour1Member', window );">Twenty Twenty Four 1 [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialInstitution', window );">Financial institution</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Banco
    Ita&#250; Unibanco S.A<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsInterestRateBasis', window );">Interest rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">CDI
    + 1.75% p.y.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BorrowingsMaturity', window );">Maturity</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[6]</sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 31,199<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="12"></td></tr>
<tr><td colspan="12"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1">500,000</span> adjusted by the CDI rate plus an interest rate of
<span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb">1.62</span>% per year and is repayable in three installments in October 2022, April 2023 and October 2023.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ <span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4">100,000</span> adjusted by the CDI rate plus an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l">1.65</span>%
per year and was repaid at maturity on July 5, 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of <span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk">10.03</span>% per year and maturity in 2024.
This amount was prepaid in September 2021.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[4]</td>
<td style="vertical-align: top;" valign="top">On July 23, 2019, Medcel entered
into a loan of R$ <span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount">16,153</span> with Financiadora de Estudos e Projetos (&#8220;FINEP&#8221;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$<span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche">6,734</span> and R$<span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche">4,130</span>, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[5]</td>
<td style="vertical-align: top;" valign="top">On April 26, 2021, the Company issued
and sold <span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares">150,000</span> shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$<span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8">0.00005</span> per share of the Company for US$<span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5">150,000</span> thousands, equivalent to R$ <span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9">821,805</span> on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[6]</td>
<td style="vertical-align: top;" valign="top">On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#250; Unibanco S.A. in the amount of R$ <span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount">30,000</span>. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of <span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate">1.75</span>% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BorrowingsAmountFirstTranche">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to borrowing first tranche.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BorrowingsAmountFirstTranche</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EqualInstallmentsPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equal installments payables due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EqualInstallmentsPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialInstitution">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about financial institution.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialInstitution</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IntrestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IntrestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to loans and financing current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to loans and financing non current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsInterestRateBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsInterestRateBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsMaturity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maturity of borrowings. [Refer: Borrowings]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 7<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_7&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsMaturity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 141<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_141_f&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal or face amount of a financial instrument, used to calculate payments made on that instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesAuthorised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares authorised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesAuthorised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BorrowingsByNameAxis=afya_FinanciadoradeEstudoseProjetosFINEPMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BorrowingsByNameAxis=afya_FinanciadoradeEstudoseProjetosFINEPMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyFourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentySevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentySixMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentySixMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=afya_TwentyTwentyFour1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=afya_TwentyTwentyFour1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>125
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670105541944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Intangible assets and goodwill (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections', window );">Discount rate applied to cash flow projections</a></td>
<td class="nump">12.10%<span></span>
</td>
<td class="nump">13.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember', window );">Goodwill [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections', window );">Description of key assumptions on which management has based cash flow projections</a></td>
<td class="text">An
increase of 25 basis points in management&#8217;s estimated discount rate applied to the cash flow projections of each CGU for the year
ended December 31, 2021, or a decrease of 25 basis points on estimated EBITDA would have not resulted in significant impacts on these
financial statements.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_d_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph e<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_e_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 134<br> -Subparagraph d<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_134_d_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 36<br> -IssueDate 2021-01-01<br> -Paragraph 135<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=36&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_135_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis=ifrs-full_GoodwillMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>126
<FILENAME>R88.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104683560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of right-of-use assets and lease liabilities (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at ending</a></td>
<td class="nump">R$ 419,074<span></span>
</td>
<td class="nump">R$ 274,275<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities, balance at beginning</a></td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">284,515<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionsToRightofuseAssets', window );">Right-of-use assets, additions</a></td>
<td class="nump">62,689<span></span>
</td>
<td class="nump">64,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionsToLeaseLiabilities', window );">Lease liabilities, additions</a></td>
<td class="nump">62,689<span></span>
</td>
<td class="nump">64,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsRemeasurement', window );">Right-of-use assets, remeasurement</a></td>
<td class="nump">95,962<span></span>
</td>
<td class="nump">34,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesRemeasurement', window );">Lease liabilities, remeasurement</a></td>
<td class="nump">95,962<span></span>
</td>
<td class="nump">34,161<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsBusinessCombinations', window );">Right-of-use assets, business combinations</a></td>
<td class="nump">139,514<span></span>
</td>
<td class="nump">76,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BusinessCombinationsLeaseLiabilities', window );">Lease liabilities, business combinations</a></td>
<td class="nump">139,514<span></span>
</td>
<td class="nump">76,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationRightofuseAssets', window );">Right-of-use assets, depreciation expense</a></td>
<td class="num">(43,237)<span></span>
</td>
<td class="num">(29,386)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DepreciationExpenseLeaseLiabilities', window );">Lease liabilities, depreciation expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsInterestExpense', window );">Right-of-use assets, interest expense</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpenseOnLeaseLiabilities', window );">Lease liabilities, interest expense</a></td>
<td class="nump">67,212<span></span>
</td>
<td class="nump">44,458<span></span>
</td>
<td class="nump">R$ 31,469<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsPaymentsOfLeaseLiabilities', window );">Right-of-use assets, payments of lease liabilities</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1', window );">Lease liabilities, payments of lease liabilities</a></td>
<td class="num">(87,751)<span></span>
</td>
<td class="num">(55,455)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsDisposals', window );">Right-of-use assets, disposals</a></td>
<td class="num">(10,316)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesDisposals', window );">Lease liabilities, disposals</a></td>
<td class="num">(11,244)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesRightToUse', window );">Lease liabilities, balance at beginning</a></td>
<td class="nump">447,703<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RightofuseAssets', window );">Right-of-use assets, balance at ending</a></td>
<td class="nump">663,686<span></span>
</td>
<td class="nump">419,074<span></span>
</td>
<td class="nump">R$ 274,275<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitieRightToUse', window );">Lease liabilities, balance at ending</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsCurrent', window );">Right-of-use assets, current</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentLeaseLiabilities', window );">Lease liabilities, current</a></td>
<td class="nump">24,955<span></span>
</td>
<td class="nump">61,976<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RightofuseAssetsNonCurrent', window );">Right-of-use assets, non-current</a></td>
<td class="nump">663,686<span></span>
</td>
<td class="nump">419,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentLeaseLiabilities', window );">Lease liabilities, non-current</a></td>
<td class="nump">R$ 689,130<span></span>
</td>
<td class="nump">R$ 385,727<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionsToLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionsToLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombinationsLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombinationsLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DepreciationExpenseLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DepreciationExpenseLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitieRightToUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitieRightToUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liabilities disposals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of lease liabilities re measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesRightToUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesRightToUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business combinations right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsDisposals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of right of use assets disposals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsDisposals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Interest expense right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non current right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsPaymentsOfLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of Payments of lease liabilities right to use of assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsPaymentsOfLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RightofuseAssetsRemeasurement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of right of use assets re measurement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RightofuseAssetsRemeasurement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionsToRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additions to right-of-use assets. [Refer: Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph h<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_h&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionsToRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationRightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationRightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpenseOnLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of interest expense on lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpenseOnLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current lease liabilities. [Refer: Lease liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RightofuseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph j<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_j&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RightofuseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>127
<FILENAME>R89.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670069431592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of accounts payable to selling shareholders (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="4">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Nov. 05, 2021</div></th>
<th class="th"><div>Oct. 01, 2021</div></th>
<th class="th"><div>Aug. 04, 2021</div></th>
<th class="th"><div>May 13, 2021</div></th>
<th class="th"><div>Apr. 16, 2021</div></th>
<th class="th"><div>Apr. 08, 2021</div></th>
<th class="th"><div>Mar. 25, 2021</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Nov. 01, 2022</div></th>
<th class="th"><div>Apr. 03, 2022</div></th>
<th class="th"><div>Oct. 04, 2021</div></th>
<th class="th"><div>Apr. 03, 2021</div></th>
<th class="th"><div>Mar. 05, 2021</div></th>
<th class="th"><div>Nov. 09, 2020</div></th>
<th class="th"><div>Nov. 04, 2020</div></th>
<th class="th"><div>Nov. 03, 2020</div></th>
<th class="th"><div>Oct. 01, 2020</div></th>
<th class="th"><div>May 05, 2020</div></th>
<th class="th"><div>Apr. 03, 2020</div></th>
<th class="th"><div>Jan. 31, 2020</div></th>
<th class="th"><div>Aug. 13, 2019</div></th>
<th class="th"><div>May 09, 2019</div></th>
<th class="th"><div>May 27, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 679,826<span></span>
</td>
<td class="nump">R$ 518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedParties1', window );">Accounts payable to selling shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersCurrent', window );">Current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">239,849<span></span>
</td>
<td class="nump">188,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersNonCurrent', window );">Non-current</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">439,977<span></span>
</td>
<td class="nump">329,820<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedParties2', window );">Closing balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="nump">R$ 300,237<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashTransferredTransaction', window );">Cash on the transaction closing date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 36<span></span>
</td>
<td class="nump">R$ 1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitObligationAtPresentValue', window );">Defined benefit obligation, at present value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 2,141<span></span>
</td>
<td class="nump">R$ 3,050<span></span>
</td>
<td class="nump">R$ 6,801<span></span>
</td>
<td class="nump">R$ 3,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations', window );">Transaction price allocated to remaining performance obligations</a></td>
<td class="nump">R$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 10,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy', window );">Non-current payables for purchase of energy</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 618,956<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember', window );">Accounts Payable To Selling Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="nump">300,237<span></span>
</td>
<td class="nump">177,730<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholderCashFlows', window );">Cash flows</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(192,681)<span></span>
</td>
<td class="num">(134,518)<span></span>
</td>
<td class="num">(92,688)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec', window );">Acquisition of IPEC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InterestExpense', window );">Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">31,915<span></span>
</td>
<td class="nump">13,884<span></span>
</td>
<td class="nump">17,977<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations', window );">Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">243,816<span></span>
</td>
<td class="nump">343,140<span></span>
</td>
<td class="nump">144,538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContingentConsiderationOnBusinessCombinations', window );">Contingent consideration on Business combinations</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,536<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CompensationOfLegalProceedingsDisbursement', window );">Compensation of legal proceedings disbursement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(4,503)<span></span>
</td>
<td class="num">R$ (1,320)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember', window );">Instituto De Ensino Superior Do Piaui S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 38,771<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 106,200<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 35,400<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember', window );">Instituto Educacional Santo Agostinho S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 41,581<span></span>
</td>
<td class="nump">R$ 70,356<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 29,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 29,770<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 39,695<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember', window );">Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 30,233<span></span>
</td>
<td class="nump">R$ 38,622<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 45,303<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties1', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 9,061<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember', window );">Instituto Paraensede Educacaoe Cultura Ltda [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 28,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 54,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember', window );">Uni Redentor [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 85,506<span></span>
</td>
<td class="nump">R$ 97,773<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,503<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember', window );">Uni S L [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,672<span></span>
</td>
<td class="nump">R$ 53,386<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 60,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EqualInstallmentsPayablesToRelatedParties', window );">Equal installments payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 7,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember', window );">F C M P B [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">149,175<span></span>
</td>
<td class="nump">R$ 189,420<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RemainingTradeAndOtherPayablesToRelatedParties', window );">Remaining accounts payable</a></td>
<td class="nump">R$ 54,000<span></span>
</td>
<td class="nump">R$ 21,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,793<span></span>
</td>
<td class="nump">R$ 3,000<span></span>
</td>
<td class="nump">R$ 9,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 188,894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember', window );">F E S A R [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 1,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneMember', window );">MEDPHONE [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 36<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember', window );">Medicinae [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,887<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember', window );">Medical Harbour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,801<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember', window );">Cliquefarma [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember', window );">Shosp [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,141<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember', window );">Unigranrio [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">249,979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember', window );">R X P R O [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,245<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember', window );">Guaranhuns [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Opening balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 54,556<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember', window );">Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests', window );">Ownership Interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholderCashFlows">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholder cash flows.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholderCashFlows</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders acquisition of ipec.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders business combinations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AccountsPayableToSellingShareholdersNonCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to accounts payable to selling shareholders non current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AccountsPayableToSellingShareholdersNonCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashTransferredTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashTransferredTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CompensationOfLegalProceedingsDisbursement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to compensation of legal proceedings disbursement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CompensationOfLegalProceedingsDisbursement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContingentConsiderationOnBusinessCombinations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContingentConsiderationOnBusinessCombinations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EqualInstallmentsPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of equal installments payables due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EqualInstallmentsPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EqualInstallmentsPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EqualInstallmentsPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RemainingTradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The remaining amount of payables due to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RemainingTradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherPayablesToRelatedParties1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherPayablesToRelatedParties1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherPayablesToRelatedParties2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherPayablesToRelatedParties2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitObligationAtPresentValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 19<br> -IssueDate 2021-01-01<br> -Paragraph 57<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=19&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_57_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitObligationAtPresentValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph f<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_f&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentPayablesForPurchaseOfEnergy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentPayablesForPurchaseOfEnergy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 12<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_12_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 120<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_120_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoEducacionalSantoAgostinhoSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoParaensedeEducacaoeCulturaLtdaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniRedentorMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniSLMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FCMPBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_FESARMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedPhoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicinaeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_MedicalHarbourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_CliquefarmaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_ShospMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UnigranrioMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_RXPROMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_GuaranhunsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>128
<FILENAME>R90.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104409576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable beginning</a></td>
<td class="nump">R$ 76,181<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BusinessCombination', window );">Business combination</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80,526<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Payments', window );">Payments</a></td>
<td class="num">(11,068)<span></span>
</td>
<td class="num">(5,974)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_MonetaryIndexation', window );">Monetary indexation</a></td>
<td class="nump">7,613<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayables', window );">Notes payable ending</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="nump">76,181<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CurrentLiabilities1', window );">Current liabilities</a></td>
<td class="nump">14,478<span></span>
</td>
<td class="nump">10,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NoncurrentLiabilities1', window );">Non-current liabilities</a></td>
<td class="nump">R$ 58,248<span></span>
</td>
<td class="nump">R$ 65,678<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CurrentLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CurrentLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_MonetaryIndexation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of monetary indexation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_MonetaryIndexation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NoncurrentLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NoncurrentLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotesPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotesPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Payments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Payments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>129
<FILENAME>R91.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095249848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The table below is a comparison of the carrying amounts and fair values of the Company&#8217;s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, at carrying amount</a></td>
<td class="nump">R$ 27,442<span></span>
</td>
<td class="nump">R$ 9,680<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">27,442<span></span>
</td>
<td class="nump">9,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">2,841,513<span></span>
</td>
<td class="nump">1,659,609<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">2,853,773<span></span>
</td>
<td class="nump">1,679,847<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">1,374,876<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">1,387,136<span></span>
</td>
<td class="nump">637,723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember', window );">Accounts Payable To Selling Shareholders [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember', window );">Notes Payable[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilities', window );">Financial liabilities, at carrying amount</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="nump">76,181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialLiabilitiesAtFairValue', window );">Financial liabilities, at fair value</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="nump">76,181<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_RestrictedCashMember', window );">Restricted Cash [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, at carrying amount</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember', window );">Trade receivables [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Financial assets, at carrying amount</a></td>
<td class="nump">27,442<span></span>
</td>
<td class="nump">7,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssetsAtFairValue', window );">Financial assets, at fair value</a></td>
<td class="nump">R$ 27,442<span></span>
</td>
<td class="nump">R$ 7,627<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssetsAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial assets. [Refer: At fair value [member]; Financial assets]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssetsAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity&#8217;s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity&#8217;s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialLiabilitiesAtFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialLiabilitiesAtFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_RestrictedCashMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_RestrictedCashMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=ifrs-full_TradeReceivablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>130
<FILENAME>R92.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670099539416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of sensitivity analysis effects on income statement (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="nump">R$ 27,442<span></span>
</td>
<td class="nump">R$ 9,680<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Cash Equivalents [Member] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">4,776<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Cash Equivalents [Member] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(4,776)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Cash Equivalents [Member] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">9,553<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Cash Equivalents [Member] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(9,553)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (510,972)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI
    + 1,62%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (55,032)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(3,832)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">3,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(7,665)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">7,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (31,199)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI
    + 1,75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (3,401)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(234)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">234<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(468)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">468<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (10,145)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">TJLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (617)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Loans And Financing [Member] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(76)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Loans And Financing [Member] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Loans And Financing [Member] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(152)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Loans And Financing [Member] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">152<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | AccountsPayableToSellingShareholdersOneMember</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (612,121)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (56,009)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | AccountsPayableToSellingShareholdersOneMember | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(4,591)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | AccountsPayableToSellingShareholdersOneMember | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">4,591<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | AccountsPayableToSellingShareholdersOneMember | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(9,182)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | AccountsPayableToSellingShareholdersOneMember | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">9,182<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Accounts payable to selling shareholders [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (41,581)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">IPCA
    + 4,1%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (1,708)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Accounts payable to selling shareholders [member] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(312)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Accounts payable to selling shareholders [member] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">312<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Accounts payable to selling shareholders [member] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(624)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Accounts payable to selling shareholders [member] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Notes Payable[Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="num">R$ (72,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">IPCA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="num">R$ (531)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Notes Payable[Member] | Increase in basis points +75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(545)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Notes Payable[Member] | Decrease in basis points -75 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">545<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Notes Payable[Member] | Increase in basis points +150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="num">(1,091)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Notes Payable[Member] | Decrease in basis points -150 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets', window );">Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets</a></td>
<td class="nump">1,091<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember', window );">Interest rate risk [member] | Floating interest rate [member] | Cash Equivalents [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinancialAssets', window );">Balance as of ending</a></td>
<td class="nump">R$ 636,847<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IndexRatePerYear', window );">Index - % per year</a></td>
<td class="text">100.38%
    CDI<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_BaseRate', window );">Base rate</a></td>
<td class="nump">R$ 58,440<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_BaseRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount refers to base rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_BaseRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IndexRatePerYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about index rate per year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IndexRatePerYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinancialAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity&#8217;s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity&#8217;s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity&#8217;s own equity instruments. For this purpose the entity&#8217;s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity&#8217;s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 25<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_25&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35H<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35H&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35I<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35I&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35M<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35M&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 35N<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35N&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinancialAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IFRS<br> -Number 13<br> -IssueDate 2021-01-01<br> -Paragraph 93<br> -Subparagraph h<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=13&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_93_h_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_InterestRateRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfInterestRatesAxis=ifrs-full_FloatingInterestRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_DecreaseBasisPointsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_DecreaseBasisPointsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_IncreaseBasisPointsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProbabilityOfDefaultAxis=afya_DecreaseBasisPointsOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProbabilityOfDefaultAxis=afya_DecreaseBasisPointsOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersSevenMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_AccountsPayableToSellingShareholdersSevenMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialLiabilitiesAxis=afya_NotesPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfFinancialAssetsAxis=afya_CashEquivalents1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>131
<FILENAME>R93.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108293544">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of currencies used in sensitivity analysis (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">R$ (296,480)<span></span>
</td>
<td class="nump">R$ 101,833<span></span>
</td>
<td class="nump">R$ 880,949<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Exposure [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">23,228<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Increase in Foreign Currency Sensitivity +10% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="nump">2,323<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Decrease in Foreign Currency Sensitivity -10% [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents', window );">Cash and cash equivalents</a></td>
<td class="num">R$ (2,323)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseInCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseInCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_ForeignCurrencyExposuresMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_IncreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RiskExposuresAxis=afya_DecreaseForeignCurrencyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>132
<FILENAME>R94.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670074120264">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>The tables below summarize the maturity profile of the Company&#8217;s financial liabilities based on contractual undiscounted amounts: (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,374,876<span></span>
</td>
<td class="nump">R$ 617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">R$ 284,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">59,098<span></span>
</td>
<td class="nump">35,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,753,304<span></span>
</td>
<td class="nump">698,398<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,628,196<span></span>
</td>
<td class="nump">1,023,546<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">780,114<span></span>
</td>
<td class="nump">534,638<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="nump">89,950<span></span>
</td>
<td class="nump">94,886<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="nump">114,585<span></span>
</td>
<td class="nump">63,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">4,425,247<span></span>
</td>
<td class="nump">2,451,050<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member] | Later than one year [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="nump">59,098<span></span>
</td>
<td class="nump">35,743<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">217,903<span></span>
</td>
<td class="nump">125,137<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">103,003<span></span>
</td>
<td class="nump">63,092<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">246,059<span></span>
</td>
<td class="nump">191,145<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="nump">15,644<span></span>
</td>
<td class="nump">11,083<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="nump">114,585<span></span>
</td>
<td class="nump">63,839<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">756,292<span></span>
</td>
<td class="nump">490,039<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member] | Later than one year and not later than three years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">585,686<span></span>
</td>
<td class="nump">566,157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">211,894<span></span>
</td>
<td class="nump">131,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">445,066<span></span>
</td>
<td class="nump">262,340<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="nump">74,306<span></span>
</td>
<td class="nump">83,803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,316,952<span></span>
</td>
<td class="nump">1,043,525<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member] | Later than three years and not later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">948,503<span></span>
</td>
<td class="nump">4,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">204,744<span></span>
</td>
<td class="nump">124,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">88,989<span></span>
</td>
<td class="nump">81,153<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">1,242,236<span></span>
</td>
<td class="nump">209,277<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember', window );">Liquidity risk [member] | Later than five years [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers', window );">Trade payables</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">1,212<span></span>
</td>
<td class="nump">3,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">1,108,555<span></span>
</td>
<td class="nump">705,115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotePayables', window );">Notes payable</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Advances', window );">Advances from customers</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialLiabilitiesContractualUndiscounted', window );">Financial liabilities contractual undiscounted</a></td>
<td class="nump">R$ 1,109,767<span></span>
</td>
<td class="nump">R$ 708,209<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialLiabilitiesContractualUndiscounted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of financial liabilities contractual undiscounted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialLiabilitiesContractualUndiscounted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotePayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of note payables.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotePayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Advances">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Advances</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToTradeSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payment due to suppliers for goods and services used in the entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToTradeSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_LiquidityRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MaturityAxis=ifrs-full_LaterThanFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>133
<FILENAME>R95.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095417240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of changes in liabilities arising from financing activities (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">R$ 1,065,188<span></span>
</td>
<td class="nump">R$ 344,872<span></span>
</td>
<td class="nump">R$ 294,296<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(264,475)<span></span>
</td>
<td class="num">(223,529)<span></span>
</td>
<td class="num">(166,684)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">986,838<span></span>
</td>
<td class="nump">716,929<span></span>
</td>
<td class="nump">78,295<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">136,121<span></span>
</td>
<td class="nump">54,489<span></span>
</td>
<td class="nump">37,494<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Foreign exchange movement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,279<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="nump">176,105<span></span>
</td>
<td class="nump">152,670<span></span>
</td>
<td class="nump">104,452<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="num">(10,816)<span></span>
</td>
<td class="num">(1,522)<span></span>
</td>
<td class="num">(4,107)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">2,088,961<span></span>
</td>
<td class="nump">1,065,188<span></span>
</td>
<td class="nump">344,872<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">2,088,961<span></span>
</td>
<td class="nump">1,065,188<span></span>
</td>
<td class="nump">344,872<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProceedsFromLoansAndFinancing', window );">Proceeds from loans and financing</a></td>
<td class="nump">822,569<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetOfTransactionCosts', window );">Net of the transaction costs</a></td>
<td class="nump">13,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember', window );">Loans And Financing [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">617,485<span></span>
</td>
<td class="nump">60,357<span></span>
</td>
<td class="nump">77,829<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(158,076)<span></span>
</td>
<td class="num">(155,090)<span></span>
</td>
<td class="num">(75,093)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">809,539<span></span>
</td>
<td class="nump">605,041<span></span>
</td>
<td class="nump">7,383<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">68,909<span></span>
</td>
<td class="nump">10,031<span></span>
</td>
<td class="nump">6,025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities', window );">Foreign exchange movement</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">21,279<span></span>
</td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="nump">36,591<span></span>
</td>
<td class="nump">75,815<span></span>
</td>
<td class="nump">43,087<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="nump">428<span></span>
</td>
<td class="nump">52<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">1,374,876<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
<td class="nump">60,357<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">1,374,876<span></span>
</td>
<td class="nump">617,485<span></span>
</td>
<td class="nump">60,357<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember', window );">Lease liabilities [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">284,515<span></span>
</td>
<td class="nump">212,360<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(87,751)<span></span>
</td>
<td class="num">(55,455)<span></span>
</td>
<td class="num">(39,779)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">158,651<span></span>
</td>
<td class="nump">98,904<span></span>
</td>
<td class="nump">19,100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities', window );">Interest</a></td>
<td class="nump">67,212<span></span>
</td>
<td class="nump">44,458<span></span>
</td>
<td class="nump">31,469<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities', window );">Business combination</a></td>
<td class="nump">139,514<span></span>
</td>
<td class="nump">76,855<span></span>
</td>
<td class="nump">61,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="num">(11,244)<span></span>
</td>
<td class="num">(1,574)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">284,515<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">284,515<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember', window );">Dividends Payable [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">4,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities', window );">Payments</a></td>
<td class="num">(18,648)<span></span>
</td>
<td class="num">(12,984)<span></span>
</td>
<td class="num">(51,812)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities', window );">Addition</a></td>
<td class="nump">18,648<span></span>
</td>
<td class="nump">12,984<span></span>
</td>
<td class="nump">51,812<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4,107)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, ending</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">4,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LiabilitiesArisingFromFinancingActivities', window );">Liabilities arising from financing activities, beginning</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">R$ 4,107<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of increase through interest on liabilities arising from financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetOfTransactionCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetOfTransactionCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProceedsFromLoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProceedsFromLoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Section A Statement of cash flows for an entity other than a financial institution<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS07_IE_A__IAS07_IE_A_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44B<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44B&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 44D<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_44D&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_LoansAndFinancingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=ifrs-full_LeaseLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis=afya_DividendsPayableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>134
<FILENAME>R96.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103973496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Financial assets and financial liabilities (Details Narrative)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>BRL (R$)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>BRL (R$)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination', window );">Transaction costs</a></td>
<td class="nump">R$ 13,030<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed', window );">Amount recognized lease expense from short-term leases and low-value assets</a></td>
<td class="nump">R$ 11,229<span></span>
</td>
<td class="nump">R$ 2,555<span></span>
</td>
<td class="nump">R$ 4,494<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NotesPayable1', window );">Notes payable</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CreditExposure', window );">Exposure risk</a></td>
<td class="nump">R$ 23,228<span></span>
</td>
<td class="nump">R$ 70,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SensitivityChangeInTheEuroExchangeRate', window );">Percentage of sensitivity change in the Euro exchange rate</a></td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="nump">5.5799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember', window );">Currency risk [member] | Euro Member Countries, Euro</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClosingForeignExchangeRate', window );">Closing foreign exchange rate | Number</a></td>
<td class="nump">1.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContractualLeaseTerm', window );">Contractual lease term</a></td>
<td class="text">30 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContractualLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContractualLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NotesPayable1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NotesPayable1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SensitivityChangeInTheEuroExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Information about percentage of sensitivity change in the euro exchange rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SensitivityChangeInTheEuroExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph m<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_m&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClosingForeignExchangeRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClosingForeignExchangeRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CreditExposure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of exposure to loss resulting from credit risk. [Refer: Credit risk [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph IG24<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_IG24_a&amp;doctype=Implementation%20Guidance&amp;book=b<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph IG25<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_IG25_b&amp;doctype=Implementation%20Guidance&amp;book=b<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Note Expiry date 2023-01-01<br> -Name IFRS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 36<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=7&amp;code=ifrs-tx-2017-en-b&amp;anchor=para_36_c&amp;doctype=Standard&amp;book=b<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CreditExposure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 53<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_53_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=ifrs-full_CurrencyRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CurrencyAxis=currency_EUR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CurrencyAxis=currency_EUR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>135
<FILENAME>R97.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670073815576">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of fair value measurement (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="nump">R$ 27,442<span></span>
</td>
<td class="nump">R$ 7,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancingLiabilities', window );">Loans and financing</a></td>
<td class="num">(1,387,136)<span></span>
</td>
<td class="num">(637,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilities1', window );">Lease liabilities</a></td>
<td class="num">(714,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities', window );">Accounts payable to selling shareholders</a></td>
<td class="num">(679,826)<span></span>
</td>
<td class="num">(518,240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValueNotesPayables1', window );">Notes payable</a></td>
<td class="num">(72,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCashAndCashEquivalents1', window );">Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesOne', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447,703)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValueNotesPayablesLiabilities', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,181)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember', window );">Level 2 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="nump">27,442<span></span>
</td>
<td class="nump">7,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancingLiabilities', window );">Loans and financing</a></td>
<td class="num">(1,387,136)<span></span>
</td>
<td class="num">(637,723)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilities1', window );">Lease liabilities</a></td>
<td class="num">(714,085)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities', window );">Accounts payable to selling shareholders</a></td>
<td class="num">(679,826)<span></span>
</td>
<td class="num">(518,240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValueNotesPayables1', window );">Notes payable</a></td>
<td class="num">(72,726)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RestrictedCashAndCashEquivalents1', window );">Restricted Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,053<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseLiabilitiesOne', window );">Lease liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(447,703)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FairValueNotesPayablesLiabilities', window );">Notes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76,181)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember', window );">Level 3 of fair value hierarchy [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember', window );">Not measured at fair value in statement of financial position but for which fair value is disclosed [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NoncurrentTradeReceivables', window );">Trade receivable (non-current)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueNotesPayables1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueNotesPayables1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FairValueNotesPayablesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FairValueNotesPayablesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseLiabilitiesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseLiabilitiesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RestrictedCashAndCashEquivalents1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RestrictedCashAndCashEquivalents1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TradeAndOtherPayablesToRelatedPartiesLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TradeAndOtherPayablesToRelatedPartiesLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NoncurrentTradeReceivables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of non-current trade receivables. [Refer: Trade receivables]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NoncurrentTradeReceivables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level2OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LevelsOfFairValueHierarchyAxis=ifrs-full_Level3OfFairValueHierarchyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_MeasurementAxis=ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>136
<FILENAME>R98.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670100012408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of capital management (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureCapitalManagementAbstract', window );"><strong>Capital Management</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LoansAndFinancing', window );">Loans and financing</a></td>
<td class="nump">R$ 1,374,876<span></span>
</td>
<td class="nump">R$ 617,485<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_LeaseLiabilities', window );">Lease liabilities</a></td>
<td class="nump">714,085<span></span>
</td>
<td class="nump">447,703<span></span>
</td>
<td class="nump">R$ 284,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TradeAndOtherPayablesToRelatedParties', window );">Accounts payable to selling shareholders</a></td>
<td class="nump">679,826<span></span>
</td>
<td class="nump">518,240<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NotesAndDebenturesIssued', window );">Notes payable</a></td>
<td class="nump">72,726<span></span>
</td>
<td class="nump">76,181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CashAndCashEquivalents1', window );">Less: cash and cash equivalents</a></td>
<td class="num">(748,562)<span></span>
</td>
<td class="num">(1,045,042)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RestrictedCashAndCashEquivalents', window );">Less: restricted cash</a></td>
<td class="text"> <span></span>
</td>
<td class="num">(2,053)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetDebt', window );">Net debt</a></td>
<td class="nump">2,092,951<span></span>
</td>
<td class="nump">612,514<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EquityOne1', window );">Total equity</a></td>
<td class="nump">3,000,018<span></span>
</td>
<td class="nump">2,833,780<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_EquityAndNetDebt1', window );">Total equity and net debt</a></td>
<td class="nump">R$ 5,092,969<span></span>
</td>
<td class="nump">R$ 3,446,294<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CashAndCashEquivalents1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CashAndCashEquivalents1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureCapitalManagementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureCapitalManagementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EquityAndNetDebt1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EquityAndNetDebt1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_EquityOne1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_EquityOne1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LoansAndFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LoansAndFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_LeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 16<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=16&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_LeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net debt of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NotesAndDebenturesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of notes and debentures issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NotesAndDebenturesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TradeAndOtherPayablesToRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of payables due to related parties. [Refer: Related parties [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TradeAndOtherPayablesToRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>137
<FILENAME>R99.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095282712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of model used to determine the fair value of the stock options (Details)<br> R$ / shares in Units, R$ in Thousands, Number in Thousands</strong></div></th>
<th class="th" colspan="5">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Jun. 30, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Apr. 30, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Jan. 31, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$) </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 8<span></span>
</td>
<td class="nump">R$ 121<span></span>
</td>
<td class="nump">R$ 119<span></span>
</td>
<td class="nump">R$ 108<span></span>
</td>
<td class="nump">R$ 129<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="nump">R$ 46.28<span></span>
</td>
<td class="nump">R$ 49.10<span></span>
</td>
<td class="nump">R$ 46.04<span></span>
</td>
<td class="nump">R$ 40.20<span></span>
</td>
<td class="nump">R$ 46.81<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGrante', window );">Strike price at the measurement date | R$</a></td>
<td class="nump">R$ 85<span></span>
</td>
<td class="nump">R$ 105<span></span>
</td>
<td class="nump">R$ 105<span></span>
</td>
<td class="nump">R$ 105<span></span>
</td>
<td class="nump">R$ 115<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember', window );">Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="nump">41.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="nump">43.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">38.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">10.40%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">2.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember', window );">Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">63.00%<span></span>
</td>
<td class="nump">51.00%<span></span>
</td>
<td class="nump">65.00%<span></span>
</td>
<td class="nump">67.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">12.50%<span></span>
</td>
<td class="nump">8.30%<span></span>
</td>
<td class="nump">8.10%<span></span>
</td>
<td class="nump">8.50%<span></span>
</td>
<td class="nump">7.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 74<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 133.68<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 69.54<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember', window );">Modified Plan [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.90%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted', window );">Strike price at the measurement date | R$</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted', window );">Share price at the measurement date | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 133.68<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted', window );">Model used</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Binomial<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne', window );">Weighted average fair value at the measurement date | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 57.12<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [Member] | Bottom of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.20%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember', window );">Original Plan [Member] | Top of range [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted', window );">Expected volatility, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">76.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted', window );">Risk-free interest rate, maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted', window );">Expected life of stock options, maximum | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGrante">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGrante</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_StrikePriceeAtMeasurementDateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_StrikePriceeAtMeasurementDateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionLifeShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The option life of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionLifeShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of an expected dividend used to calculate the fair value of share options granted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 47<br> -Subparagraph a<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_47_a_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_BottomOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RangeAxis=ifrs-full_TopOfRangeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_ModifiedPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=afya_OriginalPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>138
<FILENAME>R100.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104017048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of share-based compensation plan (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Apr. 26, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Mar. 25, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Jan. 25, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>Number </div>
<div>R$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DisclosureLaborAndSocialObligationsAbstract', window );"><strong>Labor And Social Obligations</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at the beginning | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 78.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at the beginning | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,510,983,000<span></span>
</td>
<td class="nump">2,364,214,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019', window );">Granted | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 109.18<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Granted | Number</a></td>
<td class="nump">241,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">139,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">545,000<span></span>
</td>
<td class="nump">1,170,000,000<span></span>
</td>
<td class="nump">477,220,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019', window );">Forfeited | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 112.89<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement', window );">Forfeited | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(60,000,000)<span></span>
</td>
<td class="num">(274,359,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019', window );">Exercised | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 78.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement', window );">Exercised | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(442,669,000)<span></span>
</td>
<td class="num">(56,092,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019', window );">Expired | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 78.21<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement', window );">Expired | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(91,586,000)<span></span>
</td>
<td class="nump">(0)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019', window );">Outstanding at the ending | R$ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 92.33<span></span>
</td>
<td class="nump">R$ 78.22<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfOutstandingShareOptions', window );">Outstanding at the ending | Number</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,086,728,000<span></span>
</td>
<td class="nump">2,510,983,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DisclosureLaborAndSocialObligationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DisclosureLaborAndSocialObligationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfOutstandingShareOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options outstanding in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfOutstandingShareOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options exercised in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options expired in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options forfeited in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iv<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iv&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause v<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_v&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>139
<FILENAME>R101.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103972120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Labor and social obligations (Details Narrative)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 01, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Jun. 01, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Apr. 26, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Mar. 25, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Jan. 25, 2021 </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>BRL (R$) </div>
<div>Number</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>BRL (R$)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ShareBasedCompensationOfEmployees', window );">Compensation of employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 25,587<span></span>
</td>
<td class="nump">R$ 9,514<span></span>
</td>
<td class="nump">R$ 6,871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement', window );">Number of stock option granted | Number</a></td>
<td class="nump">241,000<span></span>
</td>
<td class="nump">180,000<span></span>
</td>
<td class="nump">139,000<span></span>
</td>
<td class="nump">65,000<span></span>
</td>
<td class="nump">545,000<span></span>
</td>
<td class="nump">1,170,000,000<span></span>
</td>
<td class="nump">477,220,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember', window );">Share Based Compensation Plans [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees', window );">Share-based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 43,377<span></span>
</td>
<td class="nump">R$ 32,610<span></span>
</td>
<td class="nump">R$ 18,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ShareBasedCompensationOfEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ShareBasedCompensationOfEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of share options granted in a share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 2<br> -IssueDate 2021-01-01<br> -Paragraph 45<br> -Subparagraph b<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=2&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_45_b_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DefinedBenefitPlansAxis=afya_ShareBasedCompensationPlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>140
<FILENAME>R102.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104651528">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of earnings per share (Details) - BRL (R$)<br> R$ / shares in Units, R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends', window );">Net income attributable to equity holders of the parent</a></td>
<td class="nump">R$ 223,326<span></span>
</td>
<td class="nump">R$ 292,075<span></span>
</td>
<td class="nump">R$ 153,916<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_WeightedAverageShares', window );">Weighted average number of outstanding shares</a></td>
<td class="nump">93,291,480<span></span>
</td>
<td class="nump">92,683,848<span></span>
</td>
<td class="nump">75,969,797<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares', window );">Effects of dilution from stock options</a></td>
<td class="nump">811,818<span></span>
</td>
<td class="nump">951,920<span></span>
</td>
<td class="nump">221,846<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdjustedWeightedAverageShares', window );">Weighted average number of outstanding shares adjusted for the effect of dilution</a></td>
<td class="nump">94,103,298<span></span>
</td>
<td class="nump">93,635,768<span></span>
</td>
<td class="nump">76,191,643<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BasicEarningsLossPerShare', window );">Basic earnings per share (R$)</a></td>
<td class="nump">R$ 2.39<span></span>
</td>
<td class="nump">R$ 3.15<span></span>
</td>
<td class="nump">R$ 2.03<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DilutedEarningsLossPerShare', window );">Diluted earnings per share (R$)</a></td>
<td class="nump">R$ 2.37<span></span>
</td>
<td class="nump">R$ 3.12<span></span>
</td>
<td class="nump">R$ 2.02<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustedWeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustedWeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Section Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;doctype=Illustrative%20Examples&amp;dita_xref=IAS33_ex12_TI<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BasicEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BasicEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutedEarningsLossPerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 66<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_66&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 67<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_67&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutedEarningsLossPerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_WeightedAverageShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 33<br> -IssueDate 2021-01-01<br> -Paragraph 70<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=33&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_70_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_WeightedAverageShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>141
<FILENAME>R103.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104332488">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of net sales revenue (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">R$ 2,124,589<span></span>
</td>
<td class="nump">R$ 1,388,735<span></span>
</td>
<td class="nump">R$ 856,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_OtherRevenue1', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">167,441<span></span>
</td>
<td class="nump">99,817<span></span>
</td>
<td class="nump">43,116<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionAbstract', window );"><strong>Deductions</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionOfGrantedDiscounts', window );">&#160;&#160;Granted discounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(229,254)<span></span>
</td>
<td class="num">(89,017)<span></span>
</td>
<td class="num">(43,767)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionOfEarlyPaymentDiscounts', window );">&#160;&#160;Early payment discounts</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(49,879)<span></span>
</td>
<td class="num">(29,299)<span></span>
</td>
<td class="num">(8,523)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionOfReturnsOfNetRevenue', window );">&#160;&#160;Returns</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(42,373)<span></span>
</td>
<td class="num">(11,437)<span></span>
</td>
<td class="num">(7,462)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionOfTaxes', window );">&#160;&#160;Taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(74,232)<span></span>
</td>
<td class="num">(49,629)<span></span>
</td>
<td class="num">(28,157)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DeductionOfProuni', window );">&#160;&#160;PROUNI</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(176,921)<span></span>
</td>
<td class="num">(107,979)<span></span>
</td>
<td class="num">(61,138)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromContractsWithCustomers', window );">Net revenue from contracts with customers</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">750,630<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Tuition, digital content and app subscription fees - Transferred over time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,640,889<span></span>
</td>
<td class="nump">1,128,558<span></span>
</td>
<td class="nump">713,827<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Other - Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 78,482<span></span>
</td>
<td class="nump">R$ 72,633<span></span>
</td>
<td class="nump">R$ 36,803<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfEarlyPaymentDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfEarlyPaymentDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfGrantedDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfGrantedDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfProuni">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfProuni</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfReturnsOfNetRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfReturnsOfNetRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DeductionOfTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DeductionOfTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetRevenueOtherTransferredPoint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetRevenueOtherTransferredPoint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_OtherRevenue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_OtherRevenue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromContractsWithCustomers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity&#8217;s ordinary activities in exchange for consideration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 113<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_113_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 15<br> -IssueDate 2021-01-01<br> -Paragraph 114<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=15&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_114&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromContractsWithCustomers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>142
<FILENAME>R104.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670070780952">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of revenue by segment (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 1,719,371<span></span>
</td>
<td class="nump">R$ 1,201,191<span></span>
</td>
<td class="nump">R$ 750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">2,124,589<span></span>
</td>
<td class="nump">1,388,735<span></span>
</td>
<td class="nump">856,561<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProfessionalFeesExpense1', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,559,094<span></span>
</td>
<td class="nump">1,104,252<span></span>
</td>
<td class="nump">709,152<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">160,277<span></span>
</td>
<td class="nump">96,939<span></span>
</td>
<td class="nump">41,478<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,719,371<span></span>
</td>
<td class="nump">1,201,191<span></span>
</td>
<td class="nump">750,630<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,640,889<span></span>
</td>
<td class="nump">1,128,558<span></span>
</td>
<td class="nump">713,827<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">78,482<span></span>
</td>
<td class="nump">72,633<span></span>
</td>
<td class="nump">36,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_UndergradMember', window );">Undergrad [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,498,408<span></span>
</td>
<td class="nump">1,002,461<span></span>
</td>
<td class="nump">653,760<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,486,111<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">648,957<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,297<span></span>
</td>
<td class="nump">5,406<span></span>
</td>
<td class="nump">4,803<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,498,408<span></span>
</td>
<td class="nump">1,002,461<span></span>
</td>
<td class="nump">653,760<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">1,486,111<span></span>
</td>
<td class="nump">997,055<span></span>
</td>
<td class="nump">648,957<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">12,297<span></span>
</td>
<td class="nump">5,406<span></span>
</td>
<td class="nump">4,803<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember', window );">Continuing Education [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,983<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="nump">64,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,983<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60,195<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProfessionalFeesExpense1', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,675<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,983<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="nump">64,870<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">72,983<span></span>
</td>
<td class="nump">107,197<span></span>
</td>
<td class="nump">64,870<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember', window );">Digital Services [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">151,958<span></span>
</td>
<td class="nump">93,152<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">151,958<span></span>
</td>
<td class="nump">93,152<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">151,958<span></span>
</td>
<td class="nump">93,152<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FeeAndCommissionIncome', window );">Transferred over time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">81,795<span></span>
</td>
<td class="nump">24,306<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">70,163<span></span>
</td>
<td class="nump">68,846<span></span>
</td>
<td class="nump">35,880<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=ifrs-full_EliminationOfIntersegmentAmountsMember', window );">Elimination of intersegment amounts [member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices', window );">Types of services or goods</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfessionalFeesExpense', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"> <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherRevenue', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TimingRevenueRecognition', window );">Timing of revenue recognition</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">(3,880)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NetRevenueOtherTransferredPoint', window );">Transferred at a point in time</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">R$ (3,978)<span></span>
</td>
<td class="num">(1,619)<span></span>
</td>
<td class="num">R$ (3,880)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SegmentsAxis=afya_SegmentOfBusinessOneUnitMember', window );">Segment Of Business One Unit [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProfessionalFeesExpense1', window );">Tuition fees</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 997,055<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NetRevenueOtherTransferredPoint">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NetRevenueOtherTransferredPoint</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProfessionalFeesExpense1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProfessionalFeesExpense1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TimingRevenueRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TimingRevenueRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FeeAndCommissionIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income relating to fees and commissions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FeeAndCommissionIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PaymentsToSuppliersForGoodsAndServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to suppliers for goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 14<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_14_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PaymentsToSuppliersForGoodsAndServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfessionalFeesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of fees paid or payable for professional services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfessionalFeesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_UndergradMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_UndergradMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_ContinuingEducationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_ContinuingEducationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_DigitalServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_DigitalServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=ifrs-full_EliminationOfIntersegmentAmountsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=ifrs-full_EliminationOfIntersegmentAmountsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SegmentsAxis=afya_SegmentOfBusinessOneUnitMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SegmentsAxis=afya_SegmentOfBusinessOneUnitMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>143
<FILENAME>R105.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670108058120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of expenses by nature (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CostOfSales', window );">Cost of services</a></td>
<td class="num">R$ (652,300)<span></span>
</td>
<td class="num">R$ (434,654)<span></span>
</td>
<td class="num">R$ (308,853)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_GeneralAndAdministrativeExpense', window );">General and administrative expenses</a></td>
<td class="num">(622,615)<span></span>
</td>
<td class="num">(402,855)<span></span>
</td>
<td class="num">(239,120)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ExpenseByNature', window );">Total</a></td>
<td class="num">(1,274,915)<span></span>
</td>
<td class="num">(837,509)<span></span>
</td>
<td class="num">(547,973)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Payroll', window );">Payroll</a></td>
<td class="num">(677,564)<span></span>
</td>
<td class="num">(446,473)<span></span>
</td>
<td class="num">(324,252)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_HospitalAndMedicalAgreements', window );">Hospital and medical agreements</a></td>
<td class="num">(37,449)<span></span>
</td>
<td class="num">(37,988)<span></span>
</td>
<td class="num">(16,429)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DepreciationExpense', window );">Depreciation and amortization</a></td>
<td class="num">(154,220)<span></span>
</td>
<td class="num">(108,744)<span></span>
</td>
<td class="num">(73,152)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_LeaseExpenses', window );">Lease expenses</a></td>
<td class="num">(11,229)<span></span>
</td>
<td class="num">(2,555)<span></span>
</td>
<td class="num">(4,494)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UtilitiesExpense', window );">Utilities</a></td>
<td class="num">(10,643)<span></span>
</td>
<td class="num">(5,892)<span></span>
</td>
<td class="num">(6,628)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RepairsAndMaintenanceExpense', window );">Maintenance</a></td>
<td class="num">(47,141)<span></span>
</td>
<td class="num">(20,746)<span></span>
</td>
<td class="num">(8,658)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_SharesBasedCompensation', window );">Share-based compensation</a></td>
<td class="num">(43,377)<span></span>
</td>
<td class="num">(32,610)<span></span>
</td>
<td class="num">(18,114)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxExpenses', window );">Tax expenses</a></td>
<td class="num">(7,997)<span></span>
</td>
<td class="num">(5,326)<span></span>
</td>
<td class="num">(2,696)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ServicesExpense', window );">Pedagogical services</a></td>
<td class="num">(47,881)<span></span>
</td>
<td class="num">(24,037)<span></span>
</td>
<td class="num">(6,271)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SalesAndMarketingExpense', window );">Sales and marketing</a></td>
<td class="num">(39,506)<span></span>
</td>
<td class="num">(18,361)<span></span>
</td>
<td class="num">(12,966)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AllowanceForDoubtfulAccounts', window );">Allowance for doubtful accounts</a></td>
<td class="num">(47,819)<span></span>
</td>
<td class="num">(32,081)<span></span>
</td>
<td class="num">(15,040)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TravelExpense', window );">Travel expenses</a></td>
<td class="num">(7,542)<span></span>
</td>
<td class="num">(4,550)<span></span>
</td>
<td class="num">(7,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ConsultingFees', window );">Consulting fees</a></td>
<td class="num">(38,818)<span></span>
</td>
<td class="num">(31,276)<span></span>
</td>
<td class="num">(13,060)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_Other', window );">Other</a></td>
<td class="num">(103,729)<span></span>
</td>
<td class="num">(66,870)<span></span>
</td>
<td class="num">(39,159)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ExpenseByNatureOne', window );">Total</a></td>
<td class="num">R$ (1,274,915)<span></span>
</td>
<td class="num">R$ (837,509)<span></span>
</td>
<td class="num">R$ (547,973)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AllowanceForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AllowanceForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ConsultingFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ConsultingFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ExpenseByNatureOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ExpenseByNatureOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_HospitalAndMedicalAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_HospitalAndMedicalAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_LeaseExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_LeaseExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Other">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Other</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_Payroll">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_Payroll</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_SharesBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_SharesBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DepreciationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DepreciationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ExpenseByNature">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 99<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_99&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ExpenseByNature</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to general and administrative activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RepairsAndMaintenanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RepairsAndMaintenanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SalesAndMarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense relating to the marketing and selling of goods or services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SalesAndMarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ServicesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ServicesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TravelExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from travel.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TravelExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UtilitiesExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense arising from purchased utilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UtilitiesExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>144
<FILENAME>R106.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104703016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of finance result (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_InvestmentIncome', window );">Income from financial investments</a></td>
<td class="nump">R$ 35,773<span></span>
</td>
<td class="nump">R$ 24,479<span></span>
</td>
<td class="nump">R$ 25,965<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ChangesInFairValueOfDerivativeInstruments', window );">Changes in fair value of derivative instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="nump">20,739<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_RevenueFromInterest', window );">Interest received</a></td>
<td class="nump">23,040<span></span>
</td>
<td class="nump">11,876<span></span>
</td>
<td class="nump">9,680<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeGain', window );">Foreign exchange differences</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="nump">13,321<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceIncome', window );">Other</a></td>
<td class="nump">5,753<span></span>
</td>
<td class="nump">5,196<span></span>
</td>
<td class="nump">2,723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceIncome', window );">Finance income</a></td>
<td class="nump">64,566<span></span>
</td>
<td class="nump">62,290<span></span>
</td>
<td class="nump">51,689<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ChangeInFairValueOfDerivativeInstruments', window );">Change in fair value of derivative instruments</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
<td class="num">(1,780)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterestExpense1', window );">Interest expense</a></td>
<td class="num">(108,437)<span></span>
</td>
<td class="num">(25,543)<span></span>
</td>
<td class="num">(24,002)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterestExpenseOnLeaseLiabilities1', window );">Interest expense on lease liabilities</a></td>
<td class="num">(67,212)<span></span>
</td>
<td class="num">(44,458)<span></span>
</td>
<td class="num">(31,469)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinancialDiscountsGrantedExpenses', window );">Financial discounts granted</a></td>
<td class="num">(23,193)<span></span>
</td>
<td class="num">(8,081)<span></span>
</td>
<td class="num">(923)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_BankAndSimilarCharges', window );">Bank fees</a></td>
<td class="num">(7,878)<span></span>
</td>
<td class="num">(6,333)<span></span>
</td>
<td class="num">(2,876)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NetForeignExchangeLoss', window );">Foreign exchange differences</a></td>
<td class="num">(17,973)<span></span>
</td>
<td class="num">(4,613)<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxOnFinancialOperations', window );">IOF taxes (taxes on financial transactions)</a></td>
<td class="num">(3,306)<span></span>
</td>
<td class="num">(1,661)<span></span>
</td>
<td class="num">(6,801)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherFinanceCost', window );">Other</a></td>
<td class="num">(15,797)<span></span>
</td>
<td class="num">(7,580)<span></span>
</td>
<td class="num">(4,514)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_FinanceCosts', window );">Finance expenses</a></td>
<td class="num">(243,796)<span></span>
</td>
<td class="num">(98,269)<span></span>
</td>
<td class="num">(72,365)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_FinanceResult', window );">Finance result</a></td>
<td class="num">R$ (179,230)<span></span>
</td>
<td class="num">R$ (35,979)<span></span>
</td>
<td class="num">R$ (20,676)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ChangeInFairValueOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ChangeInFairValueOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ChangesInFairValueOfDerivativeInstruments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ChangesInFairValueOfDerivativeInstruments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinanceResult">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinanceResult</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_FinancialDiscountsGrantedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_FinancialDiscountsGrantedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpense1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpense1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterestExpenseOnLeaseLiabilities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterestExpenseOnLeaseLiabilities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxOnFinancialOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxOnFinancialOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_BankAndSimilarCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of bank and similar charges recognised by the entity as an expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_BankAndSimilarCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of costs associated with financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 82<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_82_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_FinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income associated with interest and other financing activities of the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_FinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_InvestmentIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of investment income, such as interest and dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 26<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -Subparagraph b<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=26&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35_b_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_InvestmentIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeGain">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeGain</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NetForeignExchangeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 21<br> -IssueDate 2021-01-01<br> -Paragraph 52<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=21&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_52_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 35<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_35&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NetForeignExchangeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherFinanceIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherFinanceIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_RevenueFromInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income arising from interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B13<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B13_e&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 112<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_112_c&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_RevenueFromInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>145
<FILENAME>R107.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670103552472">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Schedule of reconciliation of income tax expense (Details) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProfitLossBeforeTax', window );">Income before income taxes</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">R$ 273,462,000<span></span>
</td>
<td class="nump">R$ 335,054,000<span></span>
</td>
<td class="nump">R$ 186,937,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ApplicableTaxRate', window );">Statutory rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate', window );">Income taxes at statutory rates</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">R$ (92,977)<span></span>
</td>
<td class="num">R$ (113,918)<span></span>
</td>
<td class="num">R$ (63,559)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ReconciliationAdjustmentsAbstract', window );"><strong>Reconciliation adjustments:</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation', window );">Tax effect on loss from entities not subject to taxation</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(37,794)<span></span>
</td>
<td class="num">(8,474)<span></span>
</td>
<td class="num">(1,265)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive', window );">PROUNI - Fiscal Incentive</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">194,830<span></span>
</td>
<td class="nump">120,851<span></span>
</td>
<td class="nump">73,397<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_UnrecognisedDeferredTaxAssets', window );">Unrecognized deferred tax assets</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(86,233)<span></span>
</td>
<td class="num">(41,319)<span></span>
</td>
<td class="num">(19,342)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss', window );">Presumed profit income tax regime effect</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[2]</sup></td>
<td class="num">(7,066)<span></span>
</td>
<td class="num">(2,640)<span></span>
</td>
<td class="nump">351<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_PermanentAdjustments', window );">Permanent adjustments</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(6,232)<span></span>
</td>
<td class="nump">2,567<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense', window );">Other</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">4,293<span></span>
</td>
<td class="nump">15,866<span></span>
</td>
<td class="num">(3,757)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_CurrentTaxExpenseIncome', window );">Income taxes expense &#8211; current</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">R$ (31,179)<span></span>
</td>
<td class="num">R$ (27,067)<span></span>
</td>
<td class="num">R$ (14,175)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_TaxRateEffectFromChangeInTaxRate', window );">Effective rate</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">11.40%<span></span>
</td>
<td class="nump">8.08%<span></span>
</td>
<td class="nump">7.58%<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_PermanentAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_PermanentAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProgramaUniversidadeParaTodosFiscalIncentive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProgramaUniversidadeParaTodosFiscalIncentive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ReconciliationAdjustmentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ReconciliationAdjustmentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_UnrecognisedDeferredTaxAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_UnrecognisedDeferredTaxAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The applicable income tax rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CurrentTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 80<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_80_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CurrentTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProfitLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The profit (loss) before tax expense or income. [Refer: Profit (loss)]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 28<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_28_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Name IFRS<br> -Number 8<br> -IssueDate 2021-01-01<br> -Paragraph 23<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=8&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_23&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 103<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_103&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 102<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_102&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 5<br> -IssueDate 2021-01-01<br> -Paragraph 33<br> -Subparagraph b<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=5&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_33_b_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProfitLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseIncomeAtApplicableTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause i<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_i&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseIncomeAtApplicableTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxExpenseOtherThanIncomeTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense exclusive of income tax expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 85<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_85&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxExpenseOtherThanIncomeTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TaxRateEffectFromChangeInTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph c<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_c_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TaxRateEffectFromChangeInTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>146
<FILENAME>R108.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670096036952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Equity (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 18, 2019</div></th>
<th class="th"><div>Mar. 12, 2019</div></th>
<th class="th"><div>Mar. 12, 2019</div></th>
<th class="th"><div>Mar. 08, 2019</div></th>
<th class="th"><div>Dec. 04, 2018</div></th>
<th class="th"><div>Aug. 26, 2018</div></th>
<th class="th"><div>Apr. 26, 2018</div></th>
<th class="th"><div>Apr. 26, 2018</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 07, 2022</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
<th class="th"><div>Oct. 27, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 23, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Jun. 13, 2019</div></th>
<th class="th"><div>Apr. 08, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_IssuedCapital', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 17,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 315,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,443,541<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IssuedCapital2', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 17<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfSharesIssued1', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,722,831<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,669<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">93,146,731<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 55,197<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CapitalIncreaseWithEarningsReserves', window );">Capital increase with earnings reserves</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 80,541<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears', window );">Renounce of dividends for prior years</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 0.00005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,142,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProceedsFromIssueOfOrdinarySharesOne', window );">Purchase prices paid shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 74,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalPaidinCapital1', window );">Additional paid-in capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,861<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AdditionalPaidinCapital2', window );">[custom:AdditionalPaidinCapital2-0]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">783<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_CancellationOfDividend', window );">Cancellation of dividend</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 4,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendPayables', window );">Dividend payables</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 38,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_InterimDividends', window );">Dividend paid</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,521<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DividendsPaidClassifiedAsFinancingActivities1', window );">Dividends paid classified</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">46,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DividendsPaidToNoncontrollingInterests', window );">Dividends paid to non-controlling interests</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,648<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IssuedCapital1', window );">Share capital</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ProceedsFromIssueOfOrdinaryShares1', window );">Proceeds from issue of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 213,722<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember', window );">Uniao Educacional Do Planalto Central S A U E P C [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="nump">R$ 36,358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">47,920,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,112,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,874,457<span></span>
</td>
<td class="nump">1,383,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_NumberOfSharesIssued1', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">45,802,763<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,034,315<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member] | Nicolau Carvalho Esteves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">137,298<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">124,994<span></span>
</td>
<td class="nump">124,994<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,411,895<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99,999<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 55,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member] | B R Health [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares', window );">Proceeds from issue of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 150,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates', window );">Number of shares in entity held by entity or by its subsidiaries or associates shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">156,337<span></span>
</td>
<td class="nump">156,337<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 0.01<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member] | Nicolau Carvalho Esteves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Par value per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 26.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase of ordinary shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AcquisitionPrice', window );">Acquisition price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 206.25<span></span>
</td>
<td class="nump">R$ 206.25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_AcquisitionsHeldByShareholders', window );">Acquisitions held by shareholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 33,001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAPreferenceSharesMember', window );">Class A Preference Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26,523<span></span>
</td>
<td class="nump">26,523<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DescriptionOfRatioOfConvertibleShares', window );">Description of ratio of convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">(i) do not grant voting rights at the shareholders meetings; (ii) the right to
receive an amount, as dividend, per share equal to 17.7 times the amount received per common share; and (iii) were convertible into common
shares at the ratio of 1 preferred share for 17.7 common shares in the situations described in the Shareholders Agreemen<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfPreferenceShares', window );">Proceeds from issue of preference shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 11,670<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBPreferenceSharesMember', window );">Class B Preference Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_NumberOfSharesIssued', window );">Total number of shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,123<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_DescriptionOfRatioOfConvertibleShares', window );">Description of ratio of convertible shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Class
B preferred shares had no voting rights and had priority in capital reimbursement in case of liquidation of the Company, with no premium.
Class B preferred shares were convertible into common shares at the ratio of 1 Class B preferred share f1or 1 common share, in certain
situations.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ProceedsFromIssueOfPreferenceShares', window );">Proceeds from issue of preference shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 1,304<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AcquisitionsHeldByShareholders">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AcquisitionsHeldByShareholders</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalPaidinCapital1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalPaidinCapital1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_AdditionalPaidinCapital2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_AdditionalPaidinCapital2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CancellationOfDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CancellationOfDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_CapitalIncreaseWithEarningsReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_CapitalIncreaseWithEarningsReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DescriptionOfRatioOfConvertibleShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DescriptionOfRatioOfConvertibleShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_DividendsPaidClassifiedAsFinancingActivities1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_DividendsPaidClassifiedAsFinancingActivities1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_InterimDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_InterimDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IssuedCapital1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IssuedCapital1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IssuedCapital2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IssuedCapital2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_NumberOfSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_NumberOfSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProceedsFromIssueOfOrdinaryShares1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProceedsFromIssueOfOrdinaryShares1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ProceedsFromIssueOfOrdinarySharesOne">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ProceedsFromIssueOfOrdinarySharesOne</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendPayables">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends that the company has declared but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 55<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_55&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendPayables</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsPaidToNoncontrollingInterests">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph B10<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B10_a&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsPaidToNoncontrollingInterests</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of dividends relating to prior years, recognised as distributions to owners of the parent. [Refer: Parent [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_IssuedCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value of capital issued.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph e<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_e&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_IssuedCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_NumberOfSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued by the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 106<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_106_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_NumberOfSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ProceedsFromIssueOfPreferenceShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuing of preference shares. [Refer: Preference shares [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 7<br> -IssueDate 2021-01-01<br> -Paragraph 17<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=7&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_17&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ProceedsFromIssueOfPreferenceShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause vi<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_vi&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_NicolauCarvalhoEstevesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_NicolauCarvalhoEstevesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BRHealthMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_BRHealthMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAPreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAPreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBPreferenceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBPreferenceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>147
<FILENAME>R109.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670100676104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Schedule of legal proceedings and contingencies (Details) - Legal proceedings contingent liability [member] - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th" colspan="4">12 Months Ended</th>
</tr>
<tr>
<th class="th" colspan="2"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balances as of end of the year</a></td>
<td class="nump">R$ 53,139<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 5,269<span></span>
</td>
<td class="nump">R$ 3,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">80,252<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">32,576<span></span>
</td>
<td class="nump">4,372<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">24,744<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">19,284<span></span>
</td>
<td class="nump">2,245<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(9,848)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(3,990)<span></span>
</td>
<td class="num">(4,813)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">148,287<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">53,139<span></span>
</td>
<td class="nump">5,269<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Labour [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balances as of end of the year</a></td>
<td class="nump">4,519<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,501<span></span>
</td>
<td class="nump">2,233<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">16,597<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,741<span></span>
</td>
<td class="nump">3,301<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">5,418<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">562<span></span>
</td>
<td class="nump">737<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(1,044)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(1,285)<span></span>
</td>
<td class="num">(3,770)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">25,490<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">4,519<span></span>
</td>
<td class="nump">2,501<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Civil [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balances as of end of the year</a></td>
<td class="nump">13,280<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,768<span></span>
</td>
<td class="nump">1,232<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">6,017<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">2,348<span></span>
</td>
<td class="nump">1,071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">5,101<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">10,869<span></span>
</td>
<td class="nump">1,508<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(1,470)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="num">(2,705)<span></span>
</td>
<td class="num">(1,043)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">22,928<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">13,280<span></span>
</td>
<td class="nump">2,768<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Taxes [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balances as of end of the year</a></td>
<td class="nump">35,340<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions', window );">Business combinations</a></td>
<td class="nump">57,638<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">27,487<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_AdditionalProvisionsOtherProvisions', window );">Additions</a></td>
<td class="nump">14,225<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">7,853<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_UnusedProvisionReversedOtherProvisions', window );">Reversals</a></td>
<td class="num">(7,334)<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_Provisions', window );">Balance as of ending of the year</a></td>
<td class="nump">R$ 99,869<span></span>
</td>
<td class="fn" style="border-bottom: 0px;"></td>
<td class="nump">R$ 35,340<span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr><td colspan="5"></td></tr>
<tr><td colspan="5"><table class="outerFootnotes" width="100%"><tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.</td>
</tr></table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_AdditionalProvisionsOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of additional other provisions made. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph b<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_b&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_AdditionalProvisionsOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_Provisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of liabilities of uncertain timing or amount, including provisions for employee benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 54<br> -Subparagraph l<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_54_l&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_Provisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_UnusedProvisionReversedOtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount reversed for unused other provisions. [Refer: Other provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_UnusedProvisionReversedOtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>148
<FILENAME>R110.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670095420920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Schedule of social security proceedings assessed by Management (Details) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 66,058<span></span>
</td>
<td class="nump">R$ 66,662<span></span>
</td>
<td class="nump">R$ 50,288<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Labour [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">5,098<span></span>
</td>
<td class="nump">2,318<span></span>
</td>
<td class="nump">3,570<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Civil [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">56,501<span></span>
</td>
<td class="nump">59,969<span></span>
</td>
<td class="nump">39,135<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember', window );">Legal proceedings contingent liability [member] | Taxes And Social Security [Member] | Types Of Risk [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_OtherProvisions', window );">Total</a></td>
<td class="nump">R$ 4,459<span></span>
</td>
<td class="nump">R$ 4,375<span></span>
</td>
<td class="nump">R$ 7,583<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_OtherProvisions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of provisions other than provisions for employee benefits. [Refer: Provisions]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 37<br> -IssueDate 2021-01-01<br> -Paragraph 84<br> -Subparagraph a<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=37&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_84_a&amp;doctype=Standard<br> -URIDate 2021-03-24<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 78<br> -Subparagraph d<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_78_d&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_OtherProvisions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfContingentLiabilitiesAxis=ifrs-full_LegalProceedingsContingentLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_LabourMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_TypesOfRisksAxis=afya_TypesOfRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_CivilMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfProvisionsAxis=afya_TaxesAndSocialSecurityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>149
<FILENAME>R111.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670107213656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income taxes (Details Narrative) - BRL (R$)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_DeferredTaxExpenseIncome', window );">Unrecognized deferred income tax assets</a></td>
<td class="nump">R$ 432,226<span></span>
</td>
<td class="nump">R$ 214,387<span></span>
</td>
</tr>
</table>
<div style="display: none;"><table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_DeferredTaxExpenseIncome">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 12<br> -IssueDate 2021-01-01<br> -Paragraph 81<br> -Subparagraph g<br> -Clause ii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=12&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_81_g_ii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_DeferredTaxExpenseIncome</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table></div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>150
<FILENAME>R112.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670104335176">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Insurance contracts and contingencies (Details Narrative) - BRL (R$)<br> R$ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">R$ 18,825<span></span>
</td>
<td class="nump">R$ 1,451<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember', window );">Other Assets Non Current [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_JudicialDeposits', window );">Judicial deposits</a></td>
<td class="nump">18,825<span></span>
</td>
<td class="nump">1,451<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_ContingenciesCorrespondentAmount', window );">Contingencies correspondent amount</a></td>
<td class="nump">R$ 135,355<span></span>
</td>
<td class="nump">R$ 53,499<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_ContingenciesCorrespondentAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_ContingenciesCorrespondentAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_JudicialDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_JudicialDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfAssetsAxis=afya_OtherAssetsNonCurrentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>151
<FILENAME>R113.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.1</span><table class="report" border="0" cellspacing="2" id="idm139670094671256">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent events (Details Narrative) - R$ / shares<br></strong></div></th>
<th class="th"><div>Mar. 07, 2022</div></th>
<th class="th"><div>Feb. 24, 2022</div></th>
<th class="th"><div>Jan. 27, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Oct. 27, 2021</div></th>
<th class="th"><div>Aug. 04, 2021</div></th>
<th class="th"><div>Apr. 26, 2021</div></th>
<th class="th"><div>Dec. 23, 2020</div></th>
<th class="th"><div>Mar. 12, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase shares program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,142,051<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Proportion of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Purchase prices per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 99.76<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">R$ 0.00005<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicParticipacoesSAMember', window );">I Clinic Participacoes S A [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired', window );">Proportion of ownership interest</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember', window );">Class A Ordinary Shares [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase shares program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,874,457<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,383,108<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,015,844<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember', window );">Class B Ordinary Shares [Member] | Nicolau Carvalho Esteves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase shares program</a></td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember', window );">Ordinary shares [member] | Nicolau Carvalho Esteves [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_IfrsStatementLineItems', window );"><strong>IfrsStatementLineItems [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_afya_RepurchaseOfOrdinaryShares', window );">Repurchase shares program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">160,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_ifrs-full_ParValuePerShare', window );">Purchase prices per share</a></td>
<td class="nump">R$ 26.90<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_IfrsStatementLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_IfrsStatementLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_afya_RepurchaseOfOrdinaryShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">afya_RepurchaseOfOrdinaryShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>afya_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ParValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The nominal value per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IAS<br> -Number 1<br> -IssueDate 2021-01-01<br> -Paragraph 79<br> -Subparagraph a<br> -Clause iii<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&amp;num=1&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_79_a_iii&amp;doctype=Standard<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ParValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_PercentageOfVotingEquityInterestsAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name IFRS<br> -Number 3<br> -IssueDate 2021-01-01<br> -Paragraph B64<br> -Subparagraph c<br> -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&amp;num=3&amp;code=ifrs-tx-2021-en-r&amp;anchor=para_B64_c&amp;doctype=Appendix&amp;subtype=B<br> -URIDate 2021-03-24<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_PercentageOfVotingEquityInterestsAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ifrs-full_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicParticipacoesSAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_SignificantInvestmentsInSubsidiariesAxis=afya_IClinicParticipacoesSAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassAOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=afya_ClassBOrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_CategoriesOfRelatedPartiesAxis=afya_NicolauCarvalhoEstevesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_CategoriesOfRelatedPartiesAxis=afya_NicolauCarvalhoEstevesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>152
<FILENAME>afyaform20f_2021_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:afya="http://afya.com.br/20211231"
  xmlns:currency="http://xbrl.sec.gov/currency/2021"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:ifrs-full="http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="afya-20211231.xsd" xlink:type="simple"/>
    <context id="From2021-01-01to2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_dei_BusinessContactMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:BusinessContactMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_IssuedCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:IssuedCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:AdditionalPaidinCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TreasurySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:TreasurySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:ReserveOfSharebasedPaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OtherReservesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:OtherReservesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RetainedEarningsReserveMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">afya:RetainedEarningsReserveMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_RetainedEarningsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:EquityAttributableToOwnersOfParentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ComponentsOfEquityAxis">ifrs-full:NoncontrollingInterestsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-03-29_custom_GuardayaEmpreendimentosAndParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:GuardayaEmpreendimentosAndParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-29</instant>
        </period>
    </context>
    <context id="From2019-03-272019-03-29_custom_MedcelEditoraAndCBBWebMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraAndCBBWebMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-27</startDate>
            <endDate>2019-03-29</endDate>
        </period>
    </context>
    <context id="From2019-03-272019-03-29_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-27</startDate>
            <endDate>2019-03-29</endDate>
        </period>
    </context>
    <context id="From2019-06-162019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-16</startDate>
            <endDate>2019-06-18</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-18</instant>
        </period>
    </context>
    <context id="From2019-07-072019-07-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2019-07-07</startDate>
            <endDate>2019-07-08</endDate>
        </period>
    </context>
    <context id="AsOf2019-07-18_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-18</instant>
        </period>
    </context>
    <context id="AsOf2019-07-23_custom_UnderwritersMember_custom_OverAllotmentsMember_custom_ClassACommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:OverAllotmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="AsOf2019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="AsOf2019-07-23_custom_ClassACommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-22</startDate>
            <endDate>2019-07-23</endDate>
        </period>
    </context>
    <context id="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-22</startDate>
            <endDate>2019-07-23</endDate>
        </period>
    </context>
    <context id="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-06</instant>
        </period>
    </context>
    <context id="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-02-06</instant>
        </period>
    </context>
    <context id="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-06</endDate>
        </period>
    </context>
    <context id="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:ShareholdersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-06</endDate>
        </period>
    </context>
    <context id="AsOf2020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-10</instant>
        </period>
    </context>
    <context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:USD</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-10</endDate>
        </period>
    </context>
    <context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:SaleOfStockAxis">afya:InitialPublicOfferingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UnderwritersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-10</endDate>
        </period>
    </context>
    <context id="From2020-03-092020-03-10_custom_ClassACommonSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassACommonSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-03-09</startDate>
            <endDate>2020-03-10</endDate>
        </period>
    </context>
    <context id="AsOf2019-03-25_custom_MedcelEditoraAndCBBWebMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraAndCBBWebMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-25</instant>
        </period>
    </context>
    <context id="AsOf2021-04-08_custom_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-08</instant>
        </period>
    </context>
    <context id="AsOf2021-04-16_custom_CliquefarmaDrogariasOnlineLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="AsOf2021-05-13_custom_ShospTecnologiadaInformacaoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiadaInformacaoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="AsOf2021-06-01_custom_SociedadePadraodeEducacaoSuperiorLtdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraodeEducacaoSuperiorLtdMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="AsOf2021-08-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <context id="AsOf2021-10-01_custom_RXPROSolucoesdeTecnologiaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesdeTecnologiaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AfyaParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:AfyaParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeDoAcoSAUNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoValeDoAcoSAUNIVACOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroIntegradoDeSaudeDeTeresinaCISMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEEventosSAMedcelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MedcelEditoraEEventosSAMedcelMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelEditoraEEventosSAMedcelMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ESMCEducacaoSuperiorLtdaESMCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAUniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAUniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaUniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaUniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsSAMedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeSolutionsSAMedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaCliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaDrogariasOnlineLtdaCliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtdaShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospTecnologiaDaInformacaoLtdaShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtdaSOCIESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeEducacionalDePalhocaSALtdaSOCIESPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtdaRXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROSolucoesDeTecnologiaLtdaRXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtdaRXPROLOGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROLOGTransporteELogisticaLtdaRXPROLOGMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:TeachingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ProgramOfSocialIntegrationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TaxAuthorityAxis">afya:ContributionForTheFinancingOfSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProductsAndServicesAxis">afya:NonTeachingActivitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:TotalReportableSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentConsolidationItemsAxis">ifrs-full:OperatingSegmentsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:AdjustmentsAndEliminationsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_HarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UNIFIPMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UNIGRANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_PEBMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="AsOf2020-11-05_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-05</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03_custom_SociedadeUniversitariaFipmocSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-20</instant>
        </period>
    </context>
    <context id="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-05</instant>
        </period>
    </context>
    <context id="AsOf2020-01-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-20</instant>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-05_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_SociedadeUniversitariaGranarioSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_SociedadeUniversitariaFipmocSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaFipmocSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-01-302020-01-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-30</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-01-21_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-01-21</instant>
        </period>
    </context>
    <context id="From2021-03-232021-03-25_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="From2021-01-192021-01-21_custom_IClinicMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:IClinicMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-19</startDate>
            <endDate>2021-01-21</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-25_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="From2021-03-232021-03-25_custom_MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="From2021-03-232021-03-25_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-01_custom_HarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="From2021-04-062021-04-08_custom_HarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:HarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-06</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="From2021-04-062021-04-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-04-06</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-16_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="From2021-04-142021-04-16_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-14</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="From2021-05-112021-05-13_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-11</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_UNIFIPMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="From2021-06-012021-06-30_custom_UNIFIPMocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIFIPMocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="AsOf2021-08-04_custom_UNIGRANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-08-04</instant>
        </period>
    </context>
    <context id="From2021-08-022021-08-04_custom_UNIGRANMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UNIGRANMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-01_custom_PXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="From2020-09-282020-10-01_custom_PXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-09-28</startDate>
            <endDate>2020-10-01</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="From2020-01-282020-01-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-28</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-05_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-05</instant>
        </period>
    </context>
    <context id="From2020-05-032020-05-05_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-03</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-05-032020-05-05_custom_PEBMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-03</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="AsOf2020-07-20_custom_PEBMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-20</instant>
        </period>
    </context>
    <context id="From2020-07-182020-07-20_custom_PEBMEDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:PEBMEDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-18</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-01_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="AsOf2021-06-01_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-01</instant>
        </period>
    </context>
    <context id="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-04</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-04</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-09_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-09</instant>
        </period>
    </context>
    <context id="From2020-11-072020-11-09_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-07</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2021-01-192021-01-21_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-19</startDate>
            <endDate>2021-01-21</endDate>
        </period>
    </context>
    <context id="From2021-03-232021-03-25_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2021-04-142021-04-16_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-14</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2021-03-112021-03-13_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-11</startDate>
            <endDate>2021-03-13</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-04</endDate>
        </period>
    </context>
    <context id="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaGranarioSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-08-03</startDate>
            <endDate>2020-08-04</endDate>
        </period>
    </context>
    <context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_LicencesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BusinessCombinationsAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsOtherThanGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-05</instant>
        </period>
    </context>
    <context id="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-20</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-05</instant>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:SociedadeUniversitariaRedentorSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-30</startDate>
            <endDate>2020-01-31</endDate>
        </period>
    </context>
    <context id="From2020-05-032020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-03</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-07-19</startDate>
            <endDate>2020-07-20</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-03</endDate>
        </period>
    </context>
    <context id="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneTecnologiaEmSaudeLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-02</startDate>
            <endDate>2020-11-05</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-11-09</endDate>
        </period>
    </context>
    <context id="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroUniversitarioSaoLucasLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-04</startDate>
            <endDate>2020-05-05</endDate>
        </period>
    </context>
    <context id="From2020-11-082020-12-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FaculdadeDeCienciasMedicasDaParaibaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-11-08</startDate>
            <endDate>2020-12-09</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_BankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:BankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_InterbankCertificatesOfDepositMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:InterbankCertificatesOfDepositMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_USDMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">afya:USDMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TuitionFeesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:TuitionFeesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FIESMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:FIESMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalCreditsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:EducationalCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_MobileAppSubscriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:MobileAppSubscriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_OthersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:OthersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ImpairmentOfFinancialAssetsAxis">ifrs-full:FinancialAssetsNeitherPastDueNorImpairedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:CurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneMonthsAndNotLaterThanThreeMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">ifrs-full:LaterThanThreeMonthsAndNotLaterThanSixMonthsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LaterThanOneEightyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LaterThanOneEightyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:PastDueStatusAxis">afya:LaterThanOneEightyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_UEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoTocantinensePresidenteAntonioCarlosSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-09-05</startDate>
            <endDate>2018-09-06</endDate>
        </period>
    </context>
    <context id="From2019-10-292019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-10-29</startDate>
            <endDate>2019-10-30</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:RVLEstevesGestaoImobiliariaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:UNIVACOPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-23</startDate>
            <endDate>2018-04-25</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="afya:TypeOfArrangement1Axis">afya:LeaseAgreements1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">afya:IESVAPPatrimonialLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AssociatesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">ifrs-full:AssociatesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BuildingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:BuildingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_MachineryAndEquipmentsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:MachineryAndEquipmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LandMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_VehiclesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_FixturesAndFittingsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:FixturesAndFittingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ItEquipmentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:ItEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LibraryBooksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LibraryBooksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LaboratoriesAndClinicsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">afya:LaboratoriesAndClinicsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LeaseholdImprovementsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ConstructionInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfPropertyPlantAndEquipmentAxis">ifrs-full:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EducationalPlatformAndSoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformAndSoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:DevelopedTechnologyIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:GrossCarryingAmountMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:LicencesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">ifrs-full:AccumulatedDepreciationAndAmortisationMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_BrandNamesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:CustomerrelatedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_EducationalPlatformMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationalPlatformMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_SoftwareInProgressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:SoftwareInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CentroDeCienciasEmSaudeDeItajubaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FADEPFaculdadeEducacionalDePatoBrancoLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedcelAndCBBWMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:PracticeManagementToolsAndElectronicPrescriptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ClinicalDecisionSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MocMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis">afya:CarryingAmountsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_GoodwillMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:GoodwillMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CustomerRelationshipsMedicineMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsMedicineMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_CustomerRelationshipsOtherCoursesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:CustomerRelationshipsOtherCoursesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:ComputerSoftwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_EducationContentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">afya:EducationContentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:BrandNamesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfIntangibleAssetsAndGoodwillAxis">ifrs-full:TechnologybasedIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:FinancialAssetsAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:FinancialLiabilitiesAtAmortisedCostMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwentyTwentyThreeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyThreeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwentyTwentyOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwentyTwentyFourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_TwentyTwentySevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySevenMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentySixMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentySixMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFour1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_TwentyTwentyFour1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">afya:TwentyTwentyFour1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-10-01_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="AsOf2020-10-01_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-01</instant>
        </period>
    </context>
    <context id="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-09</instant>
        </period>
    </context>
    <context id="AsOf2020-07-03_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-03</instant>
        </period>
    </context>
    <context id="AsOf2020-05-20_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-20</instant>
        </period>
    </context>
    <context id="AsOf2019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-07-23</instant>
        </period>
    </context>
    <context id="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-07-22</startDate>
            <endDate>2019-07-23</endDate>
        </period>
    </context>
    <context id="From2020-12-222020-12-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-22</startDate>
            <endDate>2020-12-23</endDate>
        </period>
    </context>
    <context id="AsOf2020-10-23_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-23</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30_custom_FinanciadoradeEstudoseProjetosFINEPMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:BorrowingsByNameAxis">afya:FinanciadoradeEstudoseProjetosFINEPMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-04-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-04-26</instant>
        </period>
    </context>
    <context id="From2021-04-242021-04-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-04-24</startDate>
            <endDate>2021-04-26</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_CurrencyRiskMember_currency_EUR">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CurrencyAxis">currency:EUR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_FESARMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FESARMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MedPhoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_MedPhoneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedPhoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MedicinaeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicinaeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_MedicalHarbourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:MedicalHarbourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_CliquefarmaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:CliquefarmaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ShospMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:ShospMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_UnigranrioMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UnigranrioMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RXPROMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:RXPROMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_GuaranhunsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:GuaranhunsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2018-01-012018-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-01-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoDeEnsinoSuperiorDoPiauiSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-05-27</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-03</instant>
        </period>
    </context>
    <context id="AsOf2021-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-03</instant>
        </period>
    </context>
    <context id="AsOf2022-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoEducacionalSantoAgostinhoSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-04-03</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-08-13_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:InstitutoParaensedeEducacaoeCulturaLtdaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-13</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UniRedentorMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-01-31_custom_UniRedentorMember1110236375">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniRedentorMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-01-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-05-05_custom_UniSLMember1110236484">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-05</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-11-09_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-11-09</instant>
        </period>
    </context>
    <context id="AsOf2020-11-03">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2020-11-03</instant>
        </period>
    </context>
    <context id="AsOf2020-11-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2020-11-04</instant>
        </period>
    </context>
    <context id="From2021-03-232021-03-25_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="AsOf2021-03-05_custom_UniSLMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniSLMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-05</instant>
        </period>
    </context>
    <context id="AsOf2021-03-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-03-25</instant>
        </period>
    </context>
    <context id="From2021-04-082021-04-08_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-08</startDate>
            <endDate>2021-04-08</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-08_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-08</instant>
        </period>
    </context>
    <context id="AsOf2021-04-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-04-08</instant>
        </period>
    </context>
    <context id="From2021-04-162021-04-16_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-16</startDate>
            <endDate>2021-04-16</endDate>
        </period>
    </context>
    <context id="AsOf2021-04-16_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="AsOf2021-04-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-04-16</instant>
        </period>
    </context>
    <context id="From2021-05-132021-05-13_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-05-13</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <context id="AsOf2021-05-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="AsOf2021-05-13_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-05-13</instant>
        </period>
    </context>
    <context id="From2021-08-022021-08-04_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-08-02</startDate>
            <endDate>2021-08-04</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-04">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-10-04</instant>
        </period>
    </context>
    <context id="From2021-10-012021-10-01_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-10-01</endDate>
        </period>
    </context>
    <context id="AsOf2021-10-01_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-01</instant>
        </period>
    </context>
    <context id="AsOf2022-11-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2022-11-01</instant>
        </period>
    </context>
    <context id="From2021-11-032021-11-05_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-03</startDate>
            <endDate>2021-11-05</endDate>
        </period>
    </context>
    <context id="AsOf2021-11-05">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="AsOf2021-11-05_custom_FCMPBMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:FCMPBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-05</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_RestrictedCashMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:RestrictedCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_RestrictedCashMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:RestrictedCashMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_TradeReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_TradeReceivablesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">ifrs-full:TradeReceivablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialAssetsAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:CashEquivalents1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:AccountsPayableToSellingShareholdersSevenMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:IncreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsOneMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfFinancialLiabilitiesAxis">afya:NotesPayableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ProbabilityOfDefaultAxis">afya:DecreaseBasisPointsOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfInterestRatesAxis">ifrs-full:FloatingInterestRateMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:InterestRateRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_ForeignCurrencyExposuresMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:ForeignCurrencyExposuresMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_IncreaseForeignCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:IncreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_DecreaseForeignCurrencyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RiskExposuresAxis">afya:DecreaseForeignCurrencyMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:CurrencyRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanOneYearAndNotLaterThanThreeYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanThreeYearsAndNotLaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MaturityAxis">ifrs-full:LaterThanFiveYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LiquidityRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">ifrs-full:LiquidityRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_LoansAndFinancingMember1110241046">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember1110241156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_LoansAndFinancingMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:LoansAndFinancingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">ifrs-full:LeaseLiabilitiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_DividendsPayableMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LiabilitiesArisingFromFinancingActivitiesAxis">afya:DividendsPayableMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:MeasurementAxis">ifrs-full:NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level2OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_Level3OfFairValueHierarchyMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:LevelsOfFairValueHierarchyAxis">ifrs-full:Level3OfFairValueHierarchyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-232021-01-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-01-23</startDate>
            <endDate>2021-01-25</endDate>
        </period>
    </context>
    <context id="From2021-03-232021-03-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-03-23</startDate>
            <endDate>2021-03-25</endDate>
        </period>
    </context>
    <context id="From2021-04-232021-04-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-04-23</startDate>
            <endDate>2021-04-26</endDate>
        </period>
    </context>
    <context id="From2021-06-012021-06-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-01</endDate>
        </period>
    </context>
    <context id="From2021-11-012021-11-01">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-01</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_ShareBasedCompensationPlansMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:DefinedBenefitPlansAxis">afya:ShareBasedCompensationPlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_ModifiedPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OriginalPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ModifiedPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OriginalPlanMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:OriginalPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-01-31</instant>
        </period>
    </context>
    <context id="AsOf2021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="AsOf2021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-04-30</instant>
        </period>
    </context>
    <context id="AsOf2021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="AsOf2021-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="From2021-01-012021-01-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="From2021-03-012021-03-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-04-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-06-012021-06-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-11-012021-11-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-31</endDate>
        </period>
    </context>
    <context id="From2021-03-012021-03-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfSharebasedPaymentArrangementsAxis">afya:ModifiedPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-04-01</startDate>
            <endDate>2021-04-30</endDate>
        </period>
    </context>
    <context id="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-01</startDate>
            <endDate>2021-06-30</endDate>
        </period>
    </context>
    <context id="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:TopOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-11-01</startDate>
            <endDate>2021-11-30</endDate>
        </period>
    </context>
    <context id="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:RangeAxis">ifrs-full:BottomOfRangeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-03-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_ClassBOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassAPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ClassBPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2018-04-242018-04-26_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-24</startDate>
            <endDate>2018-04-26</endDate>
        </period>
    </context>
    <context id="AsOf2018-04-26_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-26</instant>
        </period>
    </context>
    <context id="From2018-04-232018-04-26_custom_ClassAPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-04-23</startDate>
            <endDate>2018-04-26</endDate>
        </period>
    </context>
    <context id="AsOf2018-04-26_custom_ClassAPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-04-26</instant>
        </period>
    </context>
    <context id="From2018-08-252018-08-26_custom_ClassBPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-08-25</startDate>
            <endDate>2018-08-26</endDate>
        </period>
    </context>
    <context id="AsOf2018-08-26_custom_ClassBPreferenceSharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBPreferenceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-08-26</instant>
        </period>
    </context>
    <context id="From2018-12-022018-12-04_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-12-02</startDate>
            <endDate>2018-12-04</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-04_ifrs-full_OrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-04</instant>
        </period>
    </context>
    <context id="From2019-03-062019-03-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <startDate>2019-03-06</startDate>
            <endDate>2019-03-08</endDate>
        </period>
    </context>
    <context id="AsOf2019-04-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-04-08</instant>
        </period>
    </context>
    <context id="AsOf2019-03-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-08</instant>
        </period>
    </context>
    <context id="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-12</instant>
        </period>
    </context>
    <context id="From2019-03-102019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:BRHealthMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-10</startDate>
            <endDate>2019-03-12</endDate>
        </period>
    </context>
    <context id="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-03-12</instant>
        </period>
    </context>
    <context id="From2019-03-112019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-03-11</startDate>
            <endDate>2019-03-12</endDate>
        </period>
    </context>
    <context id="From2019-06-152019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAUEPCMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:UniaoEducacionalDoPlanaltoCentralSAUEPCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-15</startDate>
            <endDate>2019-06-18</endDate>
        </period>
    </context>
    <context id="AsOf2019-06-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
        </entity>
        <period>
            <instant>2019-06-13</instant>
        </period>
    </context>
    <context id="AsOf2020-12-23_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-23</instant>
        </period>
    </context>
    <context id="AsOf2021-10-27_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-10-27</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_custom_SegmentOfBusinessOneUnitMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:SegmentOfBusinessOneUnitMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_UndergradMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:UndergradMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_ContinuingEducationMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:ContinuingEducationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_custom_DigitalServicesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">afya:DigitalServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SegmentsAxis">ifrs-full:EliminationOfIntersegmentAmountsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:LabourMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:CivilMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfContingentLiabilitiesAxis">ifrs-full:LegalProceedingsContingentLiabilityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfProvisionsAxis">afya:TaxesAndSocialSecurityMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:TypesOfRisksAxis">afya:TypesOfRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfAssetsAxis">afya:OtherAssetsNonCurrentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="AsOf2022-01-27_custom_ClassAOrdinarySharesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassAOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-01-27</instant>
        </period>
    </context>
    <context id="AsOf2022-02-24_custom_IClinicParticipacoesSAMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:SignificantInvestmentsInSubsidiariesAxis">afya:IClinicParticipacoesSAMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-02-24</instant>
        </period>
    </context>
    <context id="AsOf2022-03-07_custom_ClassBOrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">afya:ClassBOrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <context id="AsOf2022-03-07_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001771007</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ifrs-full:CategoriesOfRelatedPartiesAxis">afya:NicolauCarvalhoEstevesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ifrs-full:ClassesOfShareCapitalAxis">ifrs-full:OrdinarySharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-07</instant>
        </period>
    </context>
    <unit id="BRL">
        <measure>iso4217:BRL</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="BRLPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:BRL</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Pure">
        <measure>pure</measure>
    </unit>
    <unit id="N">
        <measure>afya:Number</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="USDBRL">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2021-01-01to2021-12-31">0001771007</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2021-01-01to2021-12-31">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus contextRef="From2021-01-01to2021-12-31">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus contextRef="From2021-01-01to2021-12-31">2021</dei:DocumentFiscalYearFocus>
    <dei:CurrentFiscalYearEndDate contextRef="From2021-01-01to2021-12-31">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityIncorporationStateCountryCode contextRef="From2021-01-01to2021-12-31">D5</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:EntityCurrentReportingStatus contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0045">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0046">Yes</dei:EntityInteractiveDataCurrent>
    <dei:DocumentAccountingStandard contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl0050">International Financial Reporting Standards</dei:DocumentAccountingStandard>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl0084"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TreasuryShares
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl0193"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0262"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0263"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherComprehensiveIncome
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0264"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0304"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0308"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0313"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0314"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0315"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0316"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0317"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0318"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0324"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0325"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0326"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0327"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0328"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0329"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0336"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0337"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0338"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0339"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0340"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0341"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0343"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0348"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0349"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0350"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0351"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0352"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0359"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0360"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0361"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0362"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0363"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0365"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0370"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0372"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0373"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0374"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0376"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0379"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0381"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0382"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0383"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0385"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0386"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0387"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0388"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0390"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0391"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0392"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0393"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0394"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0395"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0401"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0402"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0403"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0404"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0405"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0407"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0409"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0414"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0418"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0419"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0420"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0421"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0425"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0426"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0427"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0428"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0429"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0431"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0434"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0436"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0437"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0438"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0439"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0440"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0442"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0447"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0449"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0450"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0456"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0457"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0458"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0459"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0460"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0461"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0467"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0468"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0469"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0470"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0471"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0472"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0478"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0480"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0481"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0482"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0483"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0484"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0486"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0489"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0491"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0492"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0493"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0494"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0495"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0497"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0500"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0502"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0503"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0504"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0505"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0506"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0508"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0511"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0512"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0513"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0514"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0515"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0516"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0517"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0518"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0522"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0524"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0526"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0527"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0528"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0530"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0535"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0537"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0538"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0544"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0545"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0546"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0547"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0548"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0549"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0555"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0556"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0557"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0558"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0559"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0560"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0566"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0568"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0569"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0570"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0571"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0572"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0574"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0577"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0578"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0580"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0581"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0582"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0583"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0585"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0588"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0591"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0592"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0593"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0594"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0596"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0599"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0602"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0603"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0604"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0605"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0607"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0610"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0611"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0612"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0614"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0615"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0616"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      id="xdx2ixbrl0618"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_IssuedCapitalMember"
      id="xdx2ixbrl0621"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      id="xdx2ixbrl0622"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      id="xdx2ixbrl0623"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      id="xdx2ixbrl0624"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0625"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0626"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      id="xdx2ixbrl0627"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      id="xdx2ixbrl0628"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OtherReservesMember"
      id="xdx2ixbrl0636"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_custom_RetainedEarningsReserveMember"
      id="xdx2ixbrl0637"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0660"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0664"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0665"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0679"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsReceived
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0760"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsReceived
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0761"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaymentsOfNotesPayable
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0773"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:CashAdvancesAndLoansFromRelatedParties
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0779"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:CashAdvancesAndLoansFromRelatedParties
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0780"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0804"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TreasuryShares1
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0805"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalIncreaseOfFinancialActivities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0807"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0815"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:SharebasedCompensationPlanReceipts
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl0820"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:SharebasedCompensationPlanReceipts
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl0821"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl0823"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_BuildingsMember"
      id="xdx2ixbrl1237">P25Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_custom_MachineryAndEquipmentsMember"
      id="xdx2ixbrl1238">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_VehiclesMember"
      id="xdx2ixbrl1239">P4Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl1240">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_custom_ItEquipmentMember"
      id="xdx2ixbrl1241">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_custom_LibraryBooksMember"
      id="xdx2ixbrl1242">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl1243">P10Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl1244">P20Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment>
    <afya:ContractualLeaseTerm contextRef="From2021-01-01to2021-12-31" id="xdx2ixbrl1248">P1Y</afya:ContractualLeaseTerm>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1306"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1328"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1335"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1339"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1340"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1342"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1349"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1419"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1423"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1424"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      id="xdx2ixbrl1428"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1448"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1452"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1453"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1454"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1455"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1456"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1459"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1460"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1461"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1462"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1463"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1466"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1467"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1468"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1469"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1470"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1473"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1474"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1475"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1476"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1477"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1480"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1481"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1482"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1483"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1484"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1487"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1488"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1489"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1490"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1491"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1494"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1495"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1496"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1497"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1498"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      id="xdx2ixbrl1501"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      id="xdx2ixbrl1502"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      id="xdx2ixbrl1503"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      id="xdx2ixbrl1504"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      id="xdx2ixbrl1505"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1614"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1615"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1616"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1617"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      id="xdx2ixbrl1618"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1619"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RestrictedCash1
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1621"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1623"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1626"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      id="xdx2ixbrl1631"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1632"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1633"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1634"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1635"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Inventories1
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      id="xdx2ixbrl1636"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1641"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1642"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1648"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1650"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1651"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1656"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1657"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1658"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1659"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1666"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1672"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1673"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1674"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1675"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1678"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1697"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      id="xdx2ixbrl1704"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1705"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1708"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1711"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1729"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1730"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1731"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1732"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1735"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1737"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1738"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1739"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1740"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1745"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1751"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      id="xdx2ixbrl1752"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1753"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1754"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1755"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1756"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      id="xdx2ixbrl1759"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      id="xdx2ixbrl1801"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1806"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1807"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      id="xdx2ixbrl1809"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1810"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1811"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      id="xdx2ixbrl1812"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1814"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInShares
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      id="xdx2ixbrl1818"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInShares
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      id="xdx2ixbrl1819"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInShares
      contextRef="AsOf2020-11-03_custom_ShospMember"
      id="xdx2ixbrl1821"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInShares
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1822"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInShares
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      id="xdx2ixbrl1823"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl1990"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl1992"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      id="xdx2ixbrl1996"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2000"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2002"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2004"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2006"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2012"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2014"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2016"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2018"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2040"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2042"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2050"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2052"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2064"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2100"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2108"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2112"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2114"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2122"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2124"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2136"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2160"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2162"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2172"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      id="xdx2ixbrl2176"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2180"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2182"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2184"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2186"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      id="xdx2ixbrl2188"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2192"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2194"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2198"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      id="xdx2ixbrl2264"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      id="xdx2ixbrl2272"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      id="xdx2ixbrl2274"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      id="xdx2ixbrl2278"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      id="xdx2ixbrl2280"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      id="xdx2ixbrl2282"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CreditsWithShareholdersRelatedPartyTransactions
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl2509"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentAssetsOfRelatedParty1
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl2518"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableToSellingShareholders
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl2522"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmountsPayableRelatedPartyTransactions
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl2525"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AccountsPayableCurrent1
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl2528"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NoncurrentPayablesToRelatedParties1
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl2531"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member"
      id="xdx2ixbrl2563">P20Y</afya:OperatingLeaseTermOfContract>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member"
      id="xdx2ixbrl2567">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member"
      id="xdx2ixbrl2569">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      id="xdx2ixbrl2583">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <afya:OperatingLeaseTermOfContract
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="xdx2ixbrl2595">P20Y</afya:OperatingLeaseTermOfContract>
    <afya:LesseeFinancesLeaseRenewalTerm
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      id="xdx2ixbrl2597">P20Y</afya:LesseeFinancesLeaseRenewalTerm>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2018-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2720"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:MinorityInterestOfAcquiree
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2722"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:MinorityInterestOfAcquiree
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2723"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdditionalMinorityInterestOfAcquiree
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2726"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:AdditionalMinorityInterestOfAcquiree
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2727"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsReceived
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2735"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DividendsReceived
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      id="xdx2ixbrl2736"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2750"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2762"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2774"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      id="xdx2ixbrl2775"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2776"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2777"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2778"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2780"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2781"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2782"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2783"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2786"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2788"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2798"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2810"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2813"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2817"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2829"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2836"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2837"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2840"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2844"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2853"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2865"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2870"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2872"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2877"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2884"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2889"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      id="xdx2ixbrl2896"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2897"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2900"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2901"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl2904"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2913"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2918"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2920"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2927"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2930"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2932"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2933"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2939"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2942"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      id="xdx2ixbrl2943"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2944"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2945"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2946"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2948"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2949"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2950"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2951"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2954"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2956"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2963"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2966"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2968"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2975"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2978"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2980"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      id="xdx2ixbrl2981"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      id="xdx2ixbrl2982"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      id="xdx2ixbrl2983"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      id="xdx2ixbrl2984"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      id="xdx2ixbrl2986"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2987"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl2988"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl2990"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl2992"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl2997"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl2999"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl3004"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl3009"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl3011"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      id="xdx2ixbrl3014"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl3016"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl3021"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl3023"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LandMember"
      id="xdx2ixbrl3028"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl3033"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_ConstructionInProgressMember"
      id="xdx2ixbrl3035"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl3045"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_custom_LaboratoriesAndClinicsMember"
      id="xdx2ixbrl3057"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3071"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3077"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3079"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3122"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3172"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3175"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3180"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3181"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3182"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3183"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3185"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      id="xdx2ixbrl3186"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3227"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3229"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3231"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3237"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3239"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3241"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3243"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3255"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3257"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3267"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3271"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3284"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3286"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3300"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3303"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3304"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3311"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3313"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3314"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3315"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3316"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3318"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3319"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3321"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3324"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3326"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      id="xdx2ixbrl3340"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      id="xdx2ixbrl3439"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      id="xdx2ixbrl3460"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3465"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      id="xdx2ixbrl3523"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      id="xdx2ixbrl3527"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember"
      id="xdx2ixbrl3531"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      id="xdx2ixbrl3542"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_CustomerRelationshipsMedicineMember"
      id="xdx2ixbrl3554">P6Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_CustomerRelationshipsOtherCoursesMember"
      id="xdx2ixbrl3556">P4Y6M</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember"
      id="xdx2ixbrl3558">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember"
      id="xdx2ixbrl3560">P3Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_BottomOfRangeMember"
      id="xdx2ixbrl3562">P2Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_TopOfRangeMember"
      id="xdx2ixbrl3564">P30Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      id="xdx2ixbrl3566">P5Y</ifrs-full:UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      id="xdx2ixbrl3576"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentyOneMember"
      id="xdx2ixbrl3651"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentyFourMember"
      id="xdx2ixbrl3660"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ContractualLeaseTerm
      contextRef="From2021-01-012021-12-31_ifrs-full_BottomOfRangeMember"
      id="xdx2ixbrl3725">P5Y</afya:ContractualLeaseTerm>
    <afya:ContractualLeaseTerm
      contextRef="From2021-01-012021-12-31_ifrs-full_TopOfRangeMember"
      id="xdx2ixbrl3727">P30Y</afya:ContractualLeaseTerm>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl3749"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl3751"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl3755"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:DepreciationExpenseLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl3781"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsInterestExpense
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl3783"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsPaymentsOfLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl3787"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2020-12-31"
      id="xdx2ixbrl3799"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:RightofuseAssetsCurrent
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl3807"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      id="xdx2ixbrl3823"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      id="xdx2ixbrl3835"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_FESARMember"
      id="xdx2ixbrl3851"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_MedPhoneMember"
      id="xdx2ixbrl3855"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:CompensationOfLegalProceedingsDisbursement
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      id="xdx2ixbrl3915"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotesPayables
      contextRef="AsOf2019-12-31"
      id="xdx2ixbrl4011"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_custom_RestrictedCashMember"
      id="xdx2ixbrl4039"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2021-12-31_custom_RestrictedCashMember"
      id="xdx2ixbrl4041"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      id="xdx2ixbrl4224"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4226"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4228"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4258"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4266"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4268"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      id="xdx2ixbrl4274"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4276"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4278"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      id="xdx2ixbrl4294"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4296"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4298"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4328"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4336"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NotePayables
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4338"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      id="xdx2ixbrl4344"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      id="xdx2ixbrl4346"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      id="xdx2ixbrl4348"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      id="xdx2ixbrl4372"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl4398"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl4408"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_custom_DividendsPayableMember"
      id="xdx2ixbrl4450"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      id="xdx2ixbrl4480"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember"
      id="xdx2ixbrl4494"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2021-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember"
      id="xdx2ixbrl4531"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2021-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl4533"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2020-12-31_ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember"
      id="xdx2ixbrl4548"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2020-12-31_ifrs-full_Level3OfFairValueHierarchyMember"
      id="xdx2ixbrl4550"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2021-12-31"
      id="xdx2ixbrl4591"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-12-31_custom_ModifiedPlanMember"
      decimals="-3"
      id="xdx2ixbrl4611"
      unitRef="BRL">74000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-12-31_custom_OriginalPlanMember"
      decimals="-3"
      id="xdx2ixbrl4612"
      unitRef="BRL">99000</afya:StrikePriceeAtMeasurementDateShareOptionsGranted>
    <ifrs-full:IssuedCapital
      contextRef="AsOf2021-12-31"
      decimals="0"
      id="xdx2ixbrl4763"
      unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      id="xdx2ixbrl4945"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      id="xdx2ixbrl4946"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      id="xdx2ixbrl4968"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ChangesInFairValueOfDerivativeInstruments
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl5130"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ChangesInFairValueOfDerivativeInstruments
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl5132"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl5138"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl5139"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ChangeInFairValueOfDerivativeInstruments
      contextRef="From2021-01-01to2021-12-31"
      id="xdx2ixbrl5150"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:ChangeInFairValueOfDerivativeInstruments
      contextRef="From2020-01-012020-12-31"
      id="xdx2ixbrl5151"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl5172"
      unitRef="BRL"
      xsi:nil="true"/>
    <afya:PermanentAdjustments
      contextRef="From2019-01-012019-12-31"
      id="xdx2ixbrl5228"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Provisions
      contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5255"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5263"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5271"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5278"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:Provisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5284"
      unitRef="BRL"
      xsi:nil="true"/>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      id="xdx2ixbrl5307"
      unitRef="BRL"
      xsi:nil="true"/>
    <dei:DocumentType contextRef="From2021-01-01to2021-12-31">20-F</dei:DocumentType>
    <dei:DocumentRegistrationStatement contextRef="From2021-01-01to2021-12-31">false</dei:DocumentRegistrationStatement>
    <dei:DocumentAnnualReport contextRef="From2021-01-01to2021-12-31">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="From2021-01-01to2021-12-31">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentTransitionReport>
    <dei:DocumentShellCompanyReport contextRef="From2021-01-01to2021-12-31">false</dei:DocumentShellCompanyReport>
    <dei:EntityFileNumber contextRef="From2021-01-01to2021-12-31">001-38992</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="From2021-01-01to2021-12-31">AFYA LIMITED</dei:EntityRegistrantName>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-01to2021-12-31">Alameda Oscar Niemeyer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-01to2021-12-31">No. 119</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-01to2021-12-31">Nova Lima Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2021-01-01to2021-12-31">BR</dei:EntityAddressCountry>
    <dei:ContactPersonnelName contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">Virgilio Deloy Capobianco Gibbon</dei:ContactPersonnelName>
    <dei:CityAreaCode contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">55</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">3515-7550</dei:LocalPhoneNumber>
    <dei:ContactPersonnelEmailAddress contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">ir@afya.com.br</dei:ContactPersonnelEmailAddress>
    <dei:EntityAddressAddressLine1 contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">Alameda Oscar Niemeyer</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">No. 119</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">Minas Gerais</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry contextRef="From2021-01-012021-12-31_dei_BusinessContactMember">BR</dei:EntityAddressCountry>
    <dei:Security12bTitle contextRef="From2021-01-01to2021-12-31">Class A common shares</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="From2021-01-01to2021-12-31">AFYA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="From2021-01-01to2021-12-31">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">46265141</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="AsOf2021-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">45802763</dei:EntityCommonStockSharesOutstanding>
    <dei:EntityWellKnownSeasonedIssuer contextRef="From2021-01-01to2021-12-31">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="From2021-01-01to2021-12-31">No</dei:EntityVoluntaryFilers>
    <dei:EntityFilerCategory contextRef="From2021-01-01to2021-12-31">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntityEmergingGrowthCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="From2021-01-01to2021-12-31">true</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany contextRef="From2021-01-01to2021-12-31">false</dei:EntityShellCompany>
    <dei:AuditorFirmId contextRef="From2021-01-01to2021-12-31">1448</dei:AuditorFirmId>
    <dei:AuditorName contextRef="From2021-01-01to2021-12-31">ERNST &amp; YOUNG</dei:AuditorName>
    <dei:AuditorLocation contextRef="From2021-01-01to2021-12-31">Belo Horizonte, Brazil</dei:AuditorLocation>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">748562000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1045042000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CurrentTradeReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">378351000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">302317000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:Inventories contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">11827000</ifrs-full:Inventories>
    <ifrs-full:Inventories contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">7509000</ifrs-full:Inventories>
    <ifrs-full:CurrentTaxAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">25579000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:CurrentTaxAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">21019000</ifrs-full:CurrentTaxAssets>
    <ifrs-full:OtherCurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">42533000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:OtherCurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">29614000</ifrs-full:OtherCurrentAssets>
    <ifrs-full:CurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">1206852000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1405501000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentRestrictedCashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2053000</ifrs-full:NoncurrentRestrictedCashAndCashEquivalents>
    <afya:NoncurrentTradeReceivable contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27442000</afya:NoncurrentTradeReceivable>
    <afya:NoncurrentTradeReceivable contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">7627000</afya:NoncurrentTradeReceivable>
    <ifrs-full:OtherNoncurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">180306000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:OtherNoncurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">74037000</ifrs-full:OtherNoncurrentAssets>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">48477000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">51410000</ifrs-full:InvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">419808000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">260381000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:RightofuseAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">663686000</ifrs-full:RightofuseAssets>
    <ifrs-full:RightofuseAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">419074000</ifrs-full:RightofuseAssets>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3900835000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsOtherThanGoodwill contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2573010000</ifrs-full:IntangibleAssetsOtherThanGoodwill>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">5240554000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">3387592000</ifrs-full:NoncurrentAssets>
    <ifrs-full:Assets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">6447406000</ifrs-full:Assets>
    <ifrs-full:Assets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">4793093000</ifrs-full:Assets>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">59098000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:TradeAndOtherCurrentPayables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">35743000</ifrs-full:TradeAndOtherCurrentPayables>
    <ifrs-full:ShorttermBorrowings contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">128720000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:ShorttermBorrowings contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">107162000</ifrs-full:ShorttermBorrowings>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">24955000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">61976000</ifrs-full:CurrentLeaseLiabilities>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">239849000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">188420000</ifrs-full:TradeAndOtherCurrentPayablesToRelatedParties>
    <afya:NotePayableCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">14478000</afya:NotePayableCurrent>
    <afya:NotePayableCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">10503000</afya:NotePayableCurrent>
    <ifrs-full:CurrentDepositsFromCustomers contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">114585000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentDepositsFromCustomers contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">63839000</ifrs-full:CurrentDepositsFromCustomers>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">131294000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">77855000</ifrs-full:CurrentRecognisedLiabilitiesDefinedBenefitPlan>
    <afya:CurrentTaxesPayable contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">26715000</afya:CurrentTaxesPayable>
    <afya:CurrentTaxesPayable contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">32976000</afya:CurrentTaxesPayable>
    <ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">11649000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:CurrentTaxLiabilitiesCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">4574000</ifrs-full:CurrentTaxLiabilitiesCurrent>
    <ifrs-full:OtherCurrentLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">15163000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:OtherCurrentLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">6331000</ifrs-full:OtherCurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">766506000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">589379000</ifrs-full:CurrentLiabilities>
    <ifrs-full:LongtermBorrowings contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">1246156000</ifrs-full:LongtermBorrowings>
    <ifrs-full:LongtermBorrowings contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">510323000</ifrs-full:LongtermBorrowings>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">689130000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">385727000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:NoncurrentPayablesToRelatedParties contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">439977000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <ifrs-full:NoncurrentPayablesToRelatedParties contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">329820000</ifrs-full:NoncurrentPayablesToRelatedParties>
    <afya:NotesPayableNonCurrentLiabiites contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">58248000</afya:NotesPayableNonCurrentLiabiites>
    <afya:NotesPayableNonCurrentLiabiites contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">65678000</afya:NotesPayableNonCurrentLiabiites>
    <afya:NoncurrentTaxesPayable contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">96598000</afya:NoncurrentTaxesPayable>
    <afya:NoncurrentTaxesPayable contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">21425000</afya:NoncurrentTaxesPayable>
    <ifrs-full:LongtermLegalProceedingsProvision contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">148287000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:LongtermLegalProceedingsProvision contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">53139000</ifrs-full:LongtermLegalProceedingsProvision>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2486000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:OtherNoncurrentLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">3822000</ifrs-full:OtherNoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2680882000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1369934000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Liabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3447388000</ifrs-full:Liabilities>
    <ifrs-full:Liabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1959313000</ifrs-full:Liabilities>
    <ifrs-full:IssuedCapital contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">17000</ifrs-full:IssuedCapital>
    <ifrs-full:AdditionalPaidinCapital contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2375344000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:AdditionalPaidinCapital contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2323488000</ifrs-full:AdditionalPaidinCapital>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">94101000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:ReserveOfSharebasedPayments contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">50724000</ifrs-full:ReserveOfSharebasedPayments>
    <ifrs-full:TreasuryShares contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">152630000</ifrs-full:TreasuryShares>
    <ifrs-full:RetainedEarnings contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">631317000</ifrs-full:RetainedEarnings>
    <ifrs-full:RetainedEarnings contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">407991000</ifrs-full:RetainedEarnings>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2948149000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:EquityAttributableToOwnersOfParent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2782220000</ifrs-full:EquityAttributableToOwnersOfParent>
    <ifrs-full:NoncontrollingInterests contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">51869000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:NoncontrollingInterests contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">51560000</ifrs-full:NoncontrollingInterests>
    <ifrs-full:Equity contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3000018000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2833780000</ifrs-full:Equity>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">6447406000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">4793093000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:Revenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1719371000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1201191000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">750630000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-652300000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-434654000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-308853000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">766537000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">441777000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">622615000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">402855000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">239120000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-3561000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-347000</ifrs-full:OtherIncome>
    <ifrs-full:OtherIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">2594000</ifrs-full:OtherIncome>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">440895000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">363335000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">205251000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">62290000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">51689000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">243796000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">98269000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">72365000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-179230000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-35979000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:FinanceIncomeCost
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-20676000</ifrs-full:FinanceIncomeCost>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">11797000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">7698000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">2362000</ifrs-full:ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">335054000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">186937000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">31179000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">27067000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">14175000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToOwnersOfParent
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:ProfitLossAttributableToOwnersOfParent>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">18957000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">15912000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ProfitLossAttributableToNoncontrollingInterests
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">18846000</ifrs-full:ProfitLossAttributableToNoncontrollingInterests>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.39</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="BRLPShares">3.15</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.03</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="BRLPShares">3.12</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.02</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">315000000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">125014000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">2161000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_OtherReservesMember"
      decimals="-3"
      unitRef="BRL">7223000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_custom_RetainedEarningsReserveMember"
      decimals="-3"
      unitRef="BRL">52584000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">501982000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2018-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">88372000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2018-12-31" decimals="-3" unitRef="BRL">590354000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">18846000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">18846000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ComprehensiveIncome>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">150000000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">150000000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">150000000</afya:CapitalIncreaseWithCash>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">48768000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">36358000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">85126000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">-44774000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">40352000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">122062000</afya:CapitalIncreaseFromCorporateReorganization>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">137051000</afya:CapitalIncreaseFromCorporateReorganization>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">259113000</afya:CapitalIncreaseFromCorporateReorganization>
    <afya:CapitalIncreaseFromCorporateReorganization
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">259113000</afya:CapitalIncreaseFromCorporateReorganization>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">1000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">17627000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">18114000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">35742000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">35742000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">33001000</afya:AllocationToAdditionalPaidinCapital>
    <afya:AllocationToAdditionalPaidinCapital
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      decimals="-3"
      unitRef="BRL">-33001000</afya:AllocationToAdditionalPaidinCapital>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">-38000000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">-38000000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">-13812000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-51812000</ifrs-full:DividendsPaid>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      decimals="-3"
      unitRef="BRL">4107000</afya:DividendsCancelled>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">4107000</afya:DividendsCancelled>
    <afya:DividendsCancelled
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">4107000</afya:DividendsCancelled>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">-635830000</afya:CorporateReorganization>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">668904000</afya:CorporateReorganization>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">-2161000</afya:CorporateReorganization>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_ifrs-full_OtherReservesMember"
      decimals="-3"
      unitRef="BRL">-7223000</afya:CorporateReorganization>
    <afya:CorporateReorganization
      contextRef="From2019-01-012019-12-31_custom_RetainedEarningsReserveMember"
      decimals="-3"
      unitRef="BRL">-23690000</afya:CorporateReorganization>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">16000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">992762000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">992778000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">992778000</ifrs-full:IssueOfEquity>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">-79670000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">-79670000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-79670000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">1931047000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">18114000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">115916000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">2065094000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2019-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">48632000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">2113726000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">15912000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">15912000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">17531000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">17531000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">17531000</ifrs-full:IncreaseDecreaseThroughOtherContributionsByOwners>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">389170000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">389170000</ifrs-full:IssueOfEquity>
    <ifrs-full:IssueOfEquity
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">389170000</ifrs-full:IssueOfEquity>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">-19704000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">-19704000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-19704000</ifrs-full:ShareIssueRelatedCost>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">-12984000</ifrs-full:DividendsPaid>
    <ifrs-full:DividendsPaid
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-12984000</ifrs-full:DividendsPaid>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">5444000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">32610000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">38054000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">38054000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">2323488000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">50724000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">407991000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">2782220000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">51560000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2833780000</ifrs-full:Equity>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">18957000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">18957000</ifrs-full:ComprehensiveIncome>
    <ifrs-full:ComprehensiveIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ComprehensiveIncome>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:CapitalIncreaseWithCash
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">74500000</afya:CapitalIncreaseWithCash>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasuryShares1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">-21861000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      unitRef="BRL">55197000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">33336000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromExerciseOfOptions
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">33336000</afya:TreasurySharesTransferredFromExerciseOfOptions>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">-783000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      unitRef="BRL">5895000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">5112000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">5112000</afya:TreasurySharesTransferredFromSharesContributionOnBusinessCombination>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-012021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">43377000</ifrs-full:IncreaseDecreaseThroughSharebasedPaymentTransactions>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">-18648000</afya:DividendsDeclaredToNoncontrollingInterests>
    <afya:DividendsDeclaredToNoncontrollingInterests
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-18648000</afya:DividendsDeclaredToNoncontrollingInterests>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_IssuedCapitalMember"
      decimals="-3"
      unitRef="BRL">17000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_AdditionalPaidinCapitalMember"
      decimals="-3"
      unitRef="BRL">2375344000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_TreasurySharesMember"
      decimals="-3"
      unitRef="BRL">-152630000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_ReserveOfSharebasedPaymentsMember"
      decimals="-3"
      unitRef="BRL">94101000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_RetainedEarningsMember"
      decimals="-3"
      unitRef="BRL">631317000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_EquityAttributableToOwnersOfParentMember"
      decimals="-3"
      unitRef="BRL">2948149000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_NoncontrollingInterestsMember"
      decimals="-3"
      unitRef="BRL">51869000</ifrs-full:Equity>
    <ifrs-full:Equity contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3000018000</ifrs-full:Equity>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-273462000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-335054000</afya:IncomeLossBeforeIncomeTaxes>
    <afya:IncomeLossBeforeIncomeTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-186937000</afya:IncomeLossBeforeIncomeTaxes>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">154220000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">108744000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">73152000</ifrs-full:AdjustmentsForDepreciationAndAmortisationExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-1604000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-78000</ifrs-full:AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-2374000</ifrs-full:DisposalsIntangibleAssetsAndGoodwill>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">47819000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">32081000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <afya:AllowanceForDoubtfulAccountsOfOpeartingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">15040000</afya:AllowanceForDoubtfulAccountsOfOpeartingActivities>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">43377000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">32610000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForSharebasedPayments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">18114000</ifrs-full:AdjustmentsForSharebasedPayments>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">17973000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">4613000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-13321000</ifrs-full:AdjustmentsForUnrealisedForeignExchangeLossesGains>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-20739000</ifrs-full:AdjustmentsForFinanceCosts>
    <ifrs-full:AdjustmentsForFinanceCosts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">1780000</ifrs-full:AdjustmentsForFinanceCosts>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">108437000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">25543000</afya:AccruedInterestOfOpeartingActivities>
    <afya:AccruedInterestOfOpeartingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">24002000</afya:AccruedInterestOfOpeartingActivities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">67212000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">44458000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">31469000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">11797000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">7698000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <afya:ShareOfIncomeOfAssociateOfOpeartingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">2362000</afya:ShareOfIncomeOfAssociateOfOpeartingActivities>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">10664000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">5354000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForProvisions
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-2568000</ifrs-full:AdjustmentsForProvisions>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-79665000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-164286000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-35556000</ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-3720000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-3110000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInInventories
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-236000</ifrs-full:AdjustmentsForDecreaseIncreaseInInventories>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">2327000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">13709000</afya:IncreaseDecreaseInRecoverableTaxes>
    <afya:IncreaseDecreaseInRecoverableTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">3940000</afya:IncreaseDecreaseInRecoverableTaxes>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-19425000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-23902000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-7403000</ifrs-full:AdjustmentsForDecreaseIncreaseInOtherAssets>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">14479000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">4475000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">3029000</ifrs-full:AdjustmentsForIncreaseDecreaseInTradeAccountPayable>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-14902000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-552000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForIncomeTaxExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">4940000</ifrs-full:AdjustmentsForIncomeTaxExpense>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">36009000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1951000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">19324000</ifrs-full:AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">23449000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">11125000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:OtherAdjustmentsForNoncashItems
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">6124000</ifrs-full:OtherAdjustmentsForNoncashItems>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-2693000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">22771000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-10881000</ifrs-full:AdjustmentsForIncreaseDecreaseInOtherLiabilities>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">666550000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">390881000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:AdjustmentsForReconcileProfitLoss
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">307722000</ifrs-full:AdjustmentsForReconcileProfitLoss>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">35683000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">19374000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">8506000</ifrs-full:IncomeTaxesPaidRefundClassifiedAsOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">630867000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">371507000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:CashFlowsFromUsedInOperatingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">299216000</ifrs-full:CashFlowsFromUsedInOperatingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">125869000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">89832000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">56964000</ifrs-full:PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities>
    <ifrs-full:DividendsReceived
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">11770000</ifrs-full:DividendsReceived>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">150931000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">47753000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">64745000</ifrs-full:PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">8103000</afya:RestrictedCashOfInvestingActivities>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">14788000</afya:RestrictedCashOfInvestingActivities>
    <afya:RestrictedCashOfInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">7530000</afya:RestrictedCashOfInvestingActivities>
    <afya:PaymentsOfNotesPayable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-11068000</afya:PaymentsOfNotesPayable>
    <afya:PaymentsOfNotesPayable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-5974000</afya:PaymentsOfNotesPayable>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1006057000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">913991000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">241568000</ifrs-full:PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities>
    <ifrs-full:CashAdvancesAndLoansFromRelatedParties
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">1598000</ifrs-full:CashAdvancesAndLoansFromRelatedParties>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-1274052000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1042762000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <ifrs-full:CashFlowsFromUsedInInvestingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-354149000</ifrs-full:CashFlowsFromUsedInInvestingActivities>
    <afya:IssuanceOfLoansAndFinancing
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">809539000</afya:IssuanceOfLoansAndFinancing>
    <afya:IssuanceOfLoansAndFinancing
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">605041000</afya:IssuanceOfLoansAndFinancing>
    <afya:IssuanceOfLoansAndFinancing
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">7383000</afya:IssuanceOfLoansAndFinancing>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">158076000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">155090000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">75093000</ifrs-full:RepaymentsOfBorrowingsClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">87751000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">55455000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">39779000</ifrs-full:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities>
    <afya:TreasuryShares1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-213722000</afya:TreasuryShares1>
    <afya:CapitalIncreaseOfFinancialActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">5444000</afya:CapitalIncreaseOfFinancialActivities>
    <afya:CapitalIncreaseOfFinancialActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">167628000</afya:CapitalIncreaseOfFinancialActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">18648000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">12984000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:DividendsPaidClassifiedAsFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">51812000</ifrs-full:DividendsPaidClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">389170000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">992778000</ifrs-full:ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities>
    <afya:SharebasedCompensationPlanReceipts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">33336000</afya:SharebasedCompensationPlanReceipts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">19704000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:PaymentsForShareIssueCosts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">79670000</ifrs-full:PaymentsForShareIssueCosts>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">364678000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">756422000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:CashFlowsFromUsedInFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">921435000</ifrs-full:CashFlowsFromUsedInFinancingActivities>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-17973000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">16666000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">14447000</ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-296480000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">101833000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">880949000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1045042000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">943209000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2018-12-31" decimals="-3" unitRef="BRL">62260000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">748562000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1045042000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">943209000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_eifrs-full--DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory_zQazWaK7wYYf" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;1&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_822_zSAe1tVzeXy8"&gt;Corporate information&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Afya Limited (&#x201c;Afya&#x201d;),
collectively with its subsidiaries referred to as the &#x201c;Company&#x201d;, is a holding company incorporated under the laws of the
Cayman Islands on March 22, 2019. Afya Limited became the holding company of Afya Participa&#xe7;&#xf5;es S.A. (hereafter referred
to as &#x201c;Afya Brazil&#x201d;), formerly denominated NRE Participa&#xe7;&#xf5;es S.A., through the completion of the corporate
reorganization in July 2019. Up to that date, Afya Limited did not have commenced operations and had only nominal assets and liabilities
and no material contingent liabilities or commitments. Accordingly, Afya Limited&#x2019;s consolidated financial information substantially
reflect the operations of Afya Brazil after the corporate reorganization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company is
formed by a network of higher education and post graduate institutions focused on medicine located in 18 Brazilian states forming the
largest educational group by the number of medical seats in the country and by services that comprises the development and sale of electronically
distributed educational courses on medicine science, related printed and technological educational content. The Company also offers services
to empower the physicians in their daily routine providing supporting clinic decisions thought mobile app subscription and deliver practice
management tools through a SaaS model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Corporate
reorganization&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 29, 2019,
Afya Brazil merged (i) BR Health Participa&#xe7;&#xf5;es S.A. (&#x201c;BR Health&#x201d;), a wholly-owned subsidiary of Bozano Educacional
II Fundo de Investimento em Participa&#xe7;&#xf5;es Multiestrat&#xe9;gia (&#x201c;Crescera&#x201d;) that controlled Guardaya Empreendimentos
and Participa&#xe7;&#xf5;es S.A. (&#x201c;Guardaya&#x201d;) and was one of Afya Brazil&#x2019;s shareholders; and (ii) Guardaya which
owned &lt;span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190329__ifrs-full--BusinessCombinationsAxis__custom--GuardayaEmpreendimentosAndParticipacoesSAMember_zTSs8prpwbV6"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;%
of Medcel Editora e Eventos S.A. (&#x201c;Medcel Editora&#x201d;) and CBB Web Servi&#xe7;os e Transmiss&#xf5;es On Line S.A. (&#x201c;CBB
Web&#x201d;), focused on medical residency preparation courses located in the state of S&#xe3;o Paulo, resulting in the transfer to
Afya Brazil of &lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zZhCbWeb9P15" title="Proportion of ownership interest in subsidiary"&gt;100&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;%
of Medcel Editora and CBB Web and &lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190327__20190329__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAhGTBbODjkf" title="Proportion of ownership interest in subsidiary"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;%
of Uni&#xe3;o Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;), a medical school located in the Federal District. On June
18, 2019 Afya Brazil acquired an additional &lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestInSubsidiary_pid_dp_uPure_c20190616__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zcLSbrmUB804" title="Proportion of ownership interest in subsidiary"&gt;15&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;%
interest in UEPC resulting in an interest of &lt;b&gt;&lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zDUvlz9EscHb" title="Percentage of voting equity interests acquired"&gt;30&lt;/span&gt;&lt;/b&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 7, 2019,
each of Afya Brazil&#xb4;s shareholders had agreed to contribute their respective shares on Afya Brazil into Afya Limited, &lt;span id="xdx_90C_eifrs-full--RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital_c20190707__20190708_zqqSgLf0rXok" title="Description of exchanging and rights of shares"&gt;exchanging
one common share into 28 Class A or Class B common shares&lt;/span&gt; of Afya Limited. The holders of the Class A common shares and Class B common
shares have identical rights, except that (i) the holder of Class B common shares is entitled to 10 votes per share, whereas holders
of Class A common shares are entitled to one vote per share, (ii) Class B common shares have certain conversion rights and (iii) the
holders of Class B common shares are entitled to maintain their proportional ownership interest in the event that common shares and/or
preferred shares are proposed to be issued. The holders of Class A common shares and Class B common shares vote together as a single
class on all matters (including the election of directors) submitted to a vote of shareholders, unless otherwise required by law and
subject to certain exceptions.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Initial
public offering&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 18, 2019,
Afya Limited priced its initial public offering (&#x201c;IPO&#x201d;) of &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_c20190718__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"&gt;13,744,210&lt;/span&gt; Class A common shares, which began trading on the Nasdaq
Global Select Market (&#x201c;NASDAQ&#x201d;) on July 19, 2019 under the symbol &#x201c;AFYA&#x201d;. On July 23, 2019, the underwriters
exercised the option to buy an additional &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__custom--SaleOfStockAxis__custom--OverAllotmentsMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zeQgmPLluhy" title="Number of shares issed (shares)"&gt;2,061,631&lt;/span&gt; Class A common shares to cover over-allotments, totaling &lt;span id="xdx_905_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"&gt;15,805,841&lt;/span&gt; Class A common
shares, which &lt;span id="xdx_903_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_pdd" title="Number of shares issed (shares)"&gt;13,888,887&lt;/span&gt; Class A common shares were offered by Afya Limited and &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of shares issed (shares)"&gt;1,916,954&lt;/span&gt; Class A common shares were offered by the selling
shareholders at the initial public offering price. The initial offering price was US$ &lt;span id="xdx_90E_ecustom--NumberOfPerShares_iI_pid_uBRLPShares_c20190723__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zOI7f2nBetEc" title="per share"&gt;19.00&lt;/span&gt; per Class A common share.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 23, 2019,
the share capital of Afya Limited was increased by &lt;span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_c20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zHld9PSt37q3" title="Number of shares issed (shares)"&gt;13,888,887&lt;/span&gt; Class A shares through the proceeds received as a result of the IPO of
US$ &lt;span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_z4T2at628cIe" title="Proceeds from issue of shares"&gt;263,888&lt;/span&gt; thousand (or R$ &lt;span id="xdx_90A_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zoAfUHzaAdSi" title="Proceeds from issue of shares"&gt;992,778&lt;/span&gt;). The net proceeds from the IPO were US$ &lt;span id="xdx_905_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zdqkcqwYipk3" title="Net proceeds from issue of shares"&gt;242,711&lt;/span&gt; thousand (or R$ &lt;span id="xdx_90B_ecustom--ProceedsFromIssueOfOrdinarySharesNet_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zjDEP3lk5UCl" title="Net proceeds from issue of shares"&gt;913,108&lt;/span&gt;), after deducting US$ &lt;span id="xdx_904_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zMhznXuV3LTg" title="Fee and commission expense"&gt;15,833&lt;/span&gt;
thousand (or R$ &lt;span id="xdx_90D_eifrs-full--FeeAndCommissionExpense_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zPcqdPb29D06" title="Fee and commission expense"&gt;59,566&lt;/span&gt;) in underwriting discounts and commissions and other offering expenses totaled US$ &lt;span id="xdx_900_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD_zzttUX1Zesmi" title="Other offering expenses"&gt;5,344&lt;/span&gt; thousand (or R$ &lt;span id="xdx_90D_ecustom--OtherOfferingExpenses_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_zwTrsvDKuUMi" title="Other offering expenses"&gt;20,104&lt;/span&gt;).
The share issuance costs totaled R$ &lt;span id="xdx_902_eifrs-full--ShareIssueRelatedCost_c20190722__20190723__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pn3n3" title="Share issuance costs"&gt;79,670&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Afya Limited transferred
US$ &lt;span id="xdx_909_ecustom--TransferredAmountToGBankAccounts_c20210101__20211231_zmniPZSOQgi8" title="Transferred amount to bank accounts"&gt;251,800&lt;/span&gt; thousand (or R$ &lt;span id="xdx_902_ecustom--TransferredAmountToGBankAccounts_c20200101__20201231_zuvwKcw4a8u8" title="Transferred amount to bank accounts"&gt;961,438&lt;/span&gt;) of the net proceeds from the Cayman Islands to bank accounts in Brazil. These deposits were invested
on first-line financial institutions in Brazil and denominated in Brazilian reais.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Issuance
of additional common shares&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On February 6,
2020, Afya completed its follow-on public offering of &lt;span id="xdx_90B_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember_pdd" title="Number of additional common shares issued"&gt;3,019,928&lt;/span&gt; Class A common shares offered by the Company and &lt;span id="xdx_909_ecustom--NumberOfAdditionalCommonSharesIssued_c20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_pdd" title="Number of additional common shares issued"&gt;9,406,812&lt;/span&gt; Class A common
shares offered by the selling shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The offering price
was US$ &lt;span id="xdx_902_ecustom--AdditionalOfferingPrice_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_pdd" title="Additional offering price"&gt;27.50&lt;/span&gt; per Class A common share and gross proceeds of US$ &lt;span id="xdx_904_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zJ7mreNY4214" title="Additional shares gross proceeds"&gt;83,048&lt;/span&gt; thousand (R$ &lt;span id="xdx_90E_ecustom--AdditionalSharesGrossProceeds_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJeeASryH5Re" title="Additional shares gross proceeds"&gt;358,286&lt;/span&gt;). The Company received net proceeds of US$
&lt;span id="xdx_900_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_zUAlIhoBrTRj" title="Net proceeds of additional shares"&gt;78,846 &lt;/span&gt;thousand (R$ &lt;span id="xdx_906_ecustom--NetProceedsOfAdditionalShares_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_z0PXlltCxZx2" title="Net proceeds of additional shares"&gt;339,648&lt;/span&gt;), after deducting US$ &lt;span id="xdx_900_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember__srt--CurrencyAxis__currency--USD_z0TwEq31xdLl" title="Other offering expenses"&gt;4,202&lt;/span&gt; thousand (R$ &lt;span id="xdx_903_ecustom--OtherOfferingExpenses_c20200205__20200206__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--ShareholdersMember_zJ2kpzSUC4rl" title="Other offering expenses"&gt;18,638&lt;/span&gt;) in underwriting discounts, commissions and other offering
expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 10, 2020,
the underwriters exercised their option to acquire additional &lt;span id="xdx_900_ecustom--NumberOfAdditionalCommonSharesIssued_c20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_pdd" title="Number of additional common shares issued"&gt;240,552&lt;/span&gt; Class A common shares at the offering price, resulting in gross
proceeds of US$ &lt;span id="xdx_905_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zmb8OsxCNcga" title="Additional shares gross proceeds"&gt;6,615&lt;/span&gt; thousand (R$ &lt;span id="xdx_90B_ecustom--AdditionalSharesGrossProceeds_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zeOESRIFVE4j" title="Additional shares gross proceeds"&gt;30,884&lt;/span&gt;). The net proceeds from the additional shares were US$ &lt;span id="xdx_90F_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__srt--CurrencyAxis__currency--USD__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zZgOWrs6vvBk" title="Net proceeds of additional shares"&gt;6,387&lt;/span&gt; thousand (R$ &lt;span id="xdx_903_ecustom--NetProceedsOfAdditionalShares_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zoPt9P1kfc8d" title="Net proceeds of additional shares"&gt;29,819&lt;/span&gt;), after deducting
U$ 228 thousand (R$ &lt;span id="xdx_908_ecustom--OtherOfferingExpenses_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember__custom--SaleOfStockAxis__custom--InitialPublicOfferingMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UnderwritersMember_zW8z2nx53BFe" title="Other offering expenses"&gt;1,066&lt;/span&gt;) in underwriting discounts and commissions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;Afya
transferred US$ &lt;span id="xdx_90D_eifrs-full--ProceedsFromIssueOfOrdinaryShares_uUSDBRL_c20200309__20200310__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassACommonSharesMember_zGBVnaPPX0K7"&gt;68,060&lt;/span&gt; thousand (R$ 294,312) of the net proceeds to bank accounts in Brazil with an increase in the capital of Afya Brazil.
These deposits were invested in first-line financial institutions in Brazil and denominated in Brazilian reais.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Acquisitions
in 2021&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(&lt;span style="background-color: white"&gt;i)
On January 21, 2021, Afya Brazil acquired iClinic (comprised by iClinic Participa&#xe7;&#xf5;es S.A., iClinic Desenvolvimento de
Software Ltda. and Black River Brazil Participa&#xe7;&#xf5;es S.A.). iClinic is a SaaS model physician focused technology company
and the leading medical practice management software in Brazil. See Note 5.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(ii)
On March 25, 2021, Afya Brazil acquired Medicinae Solutions S.A. (&#x201c;Medicinae&#x201d;), through the acquisition of &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20190325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraAndCBBWebMember_zkE3PCYSJSJl" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of its shares.
Medicinae is a leading Brazilian healthcare technology company that specializes in healthcare payments and financial services. See Note
5.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(iii)
On April 8, 2021, Afya Brazil acquired &lt;span id="xdx_90A_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember_zMCsl38jUynh" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of Medical Harbour Aparelhos M&#xe9;dicos Hospitalares e Servi&#xe7;os
em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;). Medical Harbour offers educational health and medical imaging solutions through
an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration, and
knowledge of human anatomy with digital resources. See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(iv)
On April 16, 2021, Afya Brazil acquired &lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaMember_zsi0QUe7Ycbg" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of Cliquefarma Drogarias Online Ltda. (&#x201c;Cliquefarma&#x201d;),
a healthtech company operating a free-to-use website that tracks prescription drugs, cosmetics and personal hygiene product prices in
Brazil. See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(v)
On May 13, 2021, Afya Brazil acquired &lt;span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiadaInformacaoLtdaMember_zjOOWTIdjOCi" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of Shosp Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;),
which provides a clinical management software that offers all functionalities needed for clinics all over Brazil to manage their financials,
patients appointments, medical records, marketing, and others. See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(vi)
On June 1, 2021, Afya Brazil acquired &lt;span id="xdx_900_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraodeEducacaoSuperiorLtdMember_z80GEkQ1zN98" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda.
(&#x201c;UNIFIPMoc&#x201d;), which provides a post-secondary education institution with government authorization to offer on-campus, undergraduate
degrees programs in medicine and health, as well as other courses,in the states of Minas Gerais and Bahia. See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(vii)
On August 4, 2021, Afya Brazil acquired &lt;span id="xdx_90F_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804_zQk1K6CEdM" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of (&#x201c;Unigranrio&#x201d;), comprised of (i) Companhia Nilza
Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura; (ii) Instituto de Ensino Superior de Palho&#xe7;a S/S Ltda.; (iii) Sociedade Educacional
de Palho&#xe7;a S/S Ltda.; and (iv) Policl&#xed;nica e Centro de Est&#xe9;tica Duque de Caxias Ltda. Unigranrio is a post-secondary
education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs in medicine and
health, as well as other courses, in the States of Rio de Janeiro and Santa Catarina. See Note 5.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;(viii)
On &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;October 1, 2021, Afya Brazil &lt;span style="background-color: white"&gt;acquired
&lt;/span&gt;&lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesdeTecnologiaLtdaMember_z1LXS9gDUpI1" title="Percentage of voting equity interests acquired"&gt;100&lt;/span&gt;% of the total share capital of (&#x201c;RX PRO&#x201d;), comprised of (i) RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda.
and (ii) RX PRO LOG Transporte e Logistica Ltda.. RX PRO consists of a solution that connects physicians with the pharmaceutical industry,
providing specialized and personalized marketing for those companies, in a more convenient way for physicians. &lt;span style="background-color: white"&gt;See
Note 5.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(ix) On November
05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized the operation
of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement with Afya Brazil
pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical school in the city of
Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the transaction does not fall
under the definition of business, but an acquisition of license with indefinite useful life recognized in intangible assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: italic 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;&lt;span style="text-decoration: underline"&gt;COVID-19&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In December 2019,
a novel strain of coronavirus (COVID-19) was reported to have emerged in Wuhan, China. COVID-19 has since spread to most of the countries
around the globe, including every state in Brazil. On March 11, 2020, the World Health Organization declared the COVID-19 outbreak a
pandemic, and on March 20, 2020 the Brazilian federal government declared a national emergency with respect to COVID-19.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Since March 17,
2020, there has been some interruption of our on-campus activities due to Brazilian government authorities&#x2019; mandatory lockdowns.
We managed to rapidly adapt our business to these unusual times, and although there has been an interruption of our on-campus activities,
we are offering our non-practical educational activities to our students through our online platform (rather than on-site). Regarding
the offering of practical classes, we quickly resumed our in-hospital and health care residency programs for fifth and sixth-year students,
which represents the largest portion of our practical curriculum.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;During 2020, the
States of Rio de Janeiro, Par&#xe1;, Tocantins, Piau&#xed;, Rond&#xf4;nia, Bahia and Maranh&#xe3;o had issued state decrees granting
discounts to our students because of COVID-19. These mandatory discounts have been suspended as their constitutionality has been challenged
in the superior courts. As long as it has not been declared constitutional, we started to invoice our students without these discounts
and, from March 2021, with the discount granted during 2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Additionally, we
are also face individual and collective legal proceedings all across the country. On November 18, 2021, the Brazilian Federal Court of
Justice (STF) decided, by majority of the votes, that any lawsuit with decisions to apply linear discounts in monthly tuition fees for
private universities with respect to the COVID-19 pandemic are unconstitutional. The decisions were made in connection to the suits &#x201c;Argui&#xe7;&#xf5;es
de Descumprimento de Preceito Fundamental &#x2013; ADPF&#x201d;, numbers 706 e 713, distributed by ANUP (Associa&#xe7;&#xe3;o Nacional
das Universidades Particulares) e CRUB (Conselho de Reitores das Universidades Brasileiras), respectively. Therefore, the Company shall
not apply linear discounts in any active monthly tuition fees that are related to the effects to the Covid-19 pandemic. Regarding the
discounts granted by the date of issuance of these financial statements, the Company is charging back the students as final legal decisions
are given by Brazilian courts.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The total mandatory
discounts granted due to COVID-19, net of discounts that have been recovered from previous period, totaled R$ &lt;span id="xdx_903_eifrs-full--LegalProceedingsProvision_iI_c20211231_zKWFazDz5acd"&gt;33,081&lt;/span&gt; during 2021 and
R$ &lt;span id="xdx_90D_eifrs-full--LegalProceedingsProvision_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWD9XnjyR1de" title="Amount of legal proceedings"&gt;24,800&lt;/span&gt; was related to FCMPB (R$ &lt;span id="xdx_90F_eifrs-full--LegalProceedingsProvision_iI_c20201231_z9uJW14ffzJj" title="Amount of legal proceedings"&gt;6,545&lt;/span&gt; for the year ended December 31, 2020).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As of the date
of these financial statements, the COVID-19 pandemic has had no significant impact on the payment default rates of our students. Furthermore,
there have been no significant impacts on our financial performance and position of assets and there have been no significant changes
in our financial condition triggering impairment indicators in these financial statements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;By the date of
issuance of these financial statements all of the lockdown restrictions have been revoked by Brazilian authorities in our campus locations
and the Company has also successfully retaken all of its practical classes in medicines courses and all of its classroom classes.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2019-03-29_custom_GuardayaEmpreendimentosAndParticipacoesSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2019-03-272019-03-29_custom_MedcelEditoraAndCBBWebMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2019-03-272019-03-29_custom_UniaoEducacionalDoPlanaltoCentralSAMember"
      decimals="INF"
      unitRef="Pure">0.15</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:ProportionOfOwnershipInterestInSubsidiary
      contextRef="From2019-06-162019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember"
      decimals="INF"
      unitRef="Pure">0.15</ifrs-full:ProportionOfOwnershipInterestInSubsidiary>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAMember"
      decimals="INF"
      unitRef="Pure">0.30</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital contextRef="From2019-07-072019-07-08">exchanging
one common share into 28 Class A or Class B common shares</ifrs-full:RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-18_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="INF"
      unitRef="Shares">13744210</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_OverAllotmentsMember_custom_ClassACommonSharesMember"
      decimals="INF"
      unitRef="Shares">2061631</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="INF"
      unitRef="Shares">15805841</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember"
      decimals="INF"
      unitRef="Shares">13888887</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="INF"
      unitRef="Shares">1916954</ifrs-full:NumberOfSharesIssued>
    <afya:NumberOfPerShares
      contextRef="AsOf2019-07-23_custom_UnderwritersMember_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="INF"
      unitRef="BRLPShares">19.00</afya:NumberOfPerShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2019-07-23_custom_ClassACommonSharesMember"
      decimals="INF"
      unitRef="Shares">13888887</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD"
      decimals="0"
      unitRef="BRL">263888</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="0"
      unitRef="BRL">992778</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <afya:ProceedsFromIssueOfOrdinarySharesNet
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD"
      decimals="0"
      unitRef="BRL">242711</afya:ProceedsFromIssueOfOrdinarySharesNet>
    <afya:ProceedsFromIssueOfOrdinarySharesNet
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="0"
      unitRef="BRL">913108</afya:ProceedsFromIssueOfOrdinarySharesNet>
    <ifrs-full:FeeAndCommissionExpense
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD"
      decimals="0"
      unitRef="BRL">15833</ifrs-full:FeeAndCommissionExpense>
    <ifrs-full:FeeAndCommissionExpense
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="0"
      unitRef="BRL">59566</ifrs-full:FeeAndCommissionExpense>
    <afya:OtherOfferingExpenses
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD"
      decimals="0"
      unitRef="BRL">5344</afya:OtherOfferingExpenses>
    <afya:OtherOfferingExpenses
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="0"
      unitRef="BRL">20104</afya:OtherOfferingExpenses>
    <ifrs-full:ShareIssueRelatedCost
      contextRef="From2019-07-222019-07-23_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="-3"
      unitRef="BRL">79670000</ifrs-full:ShareIssueRelatedCost>
    <afya:TransferredAmountToGBankAccounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">251800</afya:TransferredAmountToGBankAccounts>
    <afya:TransferredAmountToGBankAccounts
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">961438</afya:TransferredAmountToGBankAccounts>
    <afya:NumberOfAdditionalCommonSharesIssued
      contextRef="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember"
      decimals="INF"
      unitRef="Shares">3019928</afya:NumberOfAdditionalCommonSharesIssued>
    <afya:NumberOfAdditionalCommonSharesIssued
      contextRef="AsOf2020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember"
      decimals="INF"
      unitRef="Shares">9406812</afya:NumberOfAdditionalCommonSharesIssued>
    <afya:AdditionalOfferingPrice
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD"
      decimals="INF"
      unitRef="BRLPShares">27.50</afya:AdditionalOfferingPrice>
    <afya:AdditionalSharesGrossProceeds
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD"
      decimals="0"
      unitRef="BRL">83048</afya:AdditionalSharesGrossProceeds>
    <afya:AdditionalSharesGrossProceeds
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember"
      decimals="0"
      unitRef="BRL">358286</afya:AdditionalSharesGrossProceeds>
    <afya:NetProceedsOfAdditionalShares
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD"
      decimals="0"
      unitRef="BRL">78846</afya:NetProceedsOfAdditionalShares>
    <afya:NetProceedsOfAdditionalShares
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember"
      decimals="0"
      unitRef="BRL">339648</afya:NetProceedsOfAdditionalShares>
    <afya:OtherOfferingExpenses
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember_currency_USD"
      decimals="0"
      unitRef="BRL">4202</afya:OtherOfferingExpenses>
    <afya:OtherOfferingExpenses
      contextRef="From2020-02-052020-02-06_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_ShareholdersMember"
      decimals="0"
      unitRef="BRL">18638</afya:OtherOfferingExpenses>
    <afya:NumberOfAdditionalCommonSharesIssued
      contextRef="AsOf2020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember"
      decimals="INF"
      unitRef="Shares">240552</afya:NumberOfAdditionalCommonSharesIssued>
    <afya:AdditionalSharesGrossProceeds
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember"
      decimals="0"
      unitRef="BRL">6615</afya:AdditionalSharesGrossProceeds>
    <afya:AdditionalSharesGrossProceeds
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember"
      decimals="0"
      unitRef="BRL">30884</afya:AdditionalSharesGrossProceeds>
    <afya:NetProceedsOfAdditionalShares
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_currency_USD_custom_UnderwritersMember"
      decimals="0"
      unitRef="BRL">6387</afya:NetProceedsOfAdditionalShares>
    <afya:NetProceedsOfAdditionalShares
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember"
      decimals="0"
      unitRef="BRL">29819</afya:NetProceedsOfAdditionalShares>
    <afya:OtherOfferingExpenses
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember_custom_InitialPublicOfferingMember_custom_UnderwritersMember"
      decimals="0"
      unitRef="BRL">1066</afya:OtherOfferingExpenses>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2020-03-092020-03-10_custom_ClassACommonSharesMember"
      decimals="0"
      unitRef="USDBRL">68060</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2019-03-25_custom_MedcelEditoraAndCBBWebMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-04-08_custom_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-04-16_custom_CliquefarmaDrogariasOnlineLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-05-13_custom_ShospTecnologiadaInformacaoLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-06-01_custom_SociedadePadraodeEducacaoSuperiorLtdMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired contextRef="AsOf2021-08-04" decimals="INF" unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-10-01_custom_RXPROSolucoesdeTecnologiaLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:LegalProceedingsProvision contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">33081</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:LegalProceedingsProvision
      contextRef="AsOf2021-12-31_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="0"
      unitRef="BRL">24800</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:LegalProceedingsProvision contextRef="AsOf2020-12-31" decimals="0" unitRef="BRL">6545</ifrs-full:LegalProceedingsProvision>
    <ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eifrs-full--DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory_z0iPNsYghpG2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82F_zNpHFSAhsv4b"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Significant
                                            accounting policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2.1
Basis for preparation of the consolidated financial statements&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS)
as issued by the International Accounting Standards Board (IASB).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
consolidated financial statements have been prepared on a historical cost basis, except for derivative financial instruments that have
been measured at fair value.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
corporate reorganization described in Note 1, occurred on July 7, 2019, was accounted for as a reorganization of entities under common
control whereby Afya Limited was created as a holding company of Afya Brazil. As a result, the assets and liabilities of Afya Brazil
is carried at historical cost and there was no step-up in basis or goodwill, or other intangible assets recorded as a result of the corporate
reorganization.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As
a result, the consolidated financial statements prepared by the Company subsequent to the completion of the reorganization are presented
&#x201c;as if&#x201d; Afya Brazil is the predecessor of the Company. Accordingly, these consolidated financial statements reflect: (i)
the historical operating results of Afya Brazil prior to the reorganization; (ii) the consolidated results of the Company and Afya Brazil
following the reorganization; (iii) the assets and liabilities of Afya Brazil at their historical cost; and (iv) the Company&#x2019;s
equity and earnings per share for all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Afya
Limited is a holding company, as such the primary source of revenue derives from its interest on the operational companies in Brazil.
As result, the Brazilian Real has been assessed as the Company`s functional currency.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The consolidated
financial statements are presented in Brazilian reais (&#x201c;BRL&#x201d; or &#x201c;R$&#x201d;), which is the Company&#x2019;s functional
and presentation currency. All amounts are rounded to the nearest thousand.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;These consolidated
financial statements as of and for the year ended December 31, 2021 were authorized for issue by the Board of Directors on March 31,
2022.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2.2
Basis consolidation&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zsVPd9Duk2yg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BF_ziR2Bi73TCt4"&gt;The table below
is a list of the Company&#x2019;s subsidiaries and associate:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Direct
    and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 37%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Principal
    activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Investment
    type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z9jrchiGBFF5" title="Name"&gt;Afya
    Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Holding&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Nova
    Lima - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zfPPjlT6Kkgk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z81sgS5rqk5d"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zlLqRdcvRFHg" title="Name"&gt;Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. &#x2013; (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Porto
    Nacional - TO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zuPMmw3wfPnh"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_z1gCmCNpQ22l"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zp8cDC89brzd" title="Name"&gt;Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos S.A. &#x2013; (&#x201c;ITPAC Araguaina&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Aragua&#xed;na
    - TO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zZr780lHnMKj"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_znkcPDndLpHg"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zzgTEeAITCaf" title="Name"&gt;Uni&#xe3;o
    Educacional do Vale do A&#xe7;o S.A. &#x2013; (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    undergraduate degree program&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Ipatinga
    - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zw9mKjXKumXe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zmRXUq8RcCQf"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8lUk4TjP301" title="Name"&gt;IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zhgnUXrf9B6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8zMttg6TuG2"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Name"&gt;Instituto
    de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Parna&#xed;ba
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zXZfBs9lbLO1"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7YhIBToUkM"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Name"&gt;Centro
    de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    undergraduate degree program&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Itajub&#xe1;
    - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zk7AvKsTopUg"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zR74VG9GF9n4"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Name"&gt;Instituto
    de Ensino Superior do Piau&#xed; S.A. (&#x201d;IESP&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Teresina
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1Fvs8Tu0qc6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zZLxsFwTVQV4"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zwVz5DAgrVC4" title="Name"&gt;Centro
    Integrado de Sa&#xfa;de de Teresina (&#x201c;CIS&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zG1GHFtBdDc3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Outpatient
    care&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zMRPtND9HMda" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Teresina
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z1bd0JojSvSc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zPlN4mLVXMO7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSCfLmYxV9Yb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Name"&gt;FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Pato
    Branco - PR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5itm1udu7si"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zNoH6J07gun"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zkBXSmgej9Vl" title="Name"&gt;Medcel
    Editora e Eventos S.A. (&#x201c;Medcel&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWoGVwZ1Oz6b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medical
    education content&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zqPXxGnD3Icg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo - SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zFwBFHa8TK04" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWJfl7mO54r3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zIlljRou1qXd"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Name"&gt;Instituto
    Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zR9XvVblqBO5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zBhFtS1cPyhe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_906_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zcNVhEYP8Hfe" title="Name"&gt;ESMC
    Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;ESMC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zqkBLT94ust2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zWFpXKcyaYOd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zU7GNr6Ahbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zKCrhOJip3sl"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zeAarzahU0Jb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Name"&gt;Instituto
    de Pesquisa e Ensino M&#xe9;dico do Estado de Minas Gerais Ltda. (&#x201c;IPEMED&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Graduate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Belo
    Horizonte - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zvAR6lnmH631"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ztIOR3UOML5c"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Name"&gt;Instituto
    Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda (&#x201c;IPEC&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marab&#xe1;
    - PA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zH1ceiFsZORe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z78wqHEKQT44"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zH1Gzov441T5" title="Name"&gt;Sociedade
    Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zVJVK8SqdCEg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zWzd9WRAle0g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Itaperuna
    - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z26iLiewMOH" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z1pSxbqLpV8l"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z5Vsjtwez8q7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z70LPVoBpu08"&gt;Centro
    Universit&#xe1;rio S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zDt07DaWPUYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z6e62UX5uqmf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Porto
    Velho - RO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zSfSL4ghqbGk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zbQoGUiBXOC4"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zl14O4MVUBc6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zrRJ83407jc4"&gt;Peb
    Med Institui&#xe7;&#xe3;o de Pesquisa M&#xe9;dica e Servi&#xe7;os Ltda (&#x201c;PebMed&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z3KxsZNZJoGl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Content
    and clinical tools and online platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z06r92Wpk1Mj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zwx3gE8e7o43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zZt2n2mB702a"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zEE4E4yT3B7k"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zDKOv7iS51ak"&gt;Faculdade
    de Ensino Superior da Amaz&#xf4;nia Reunida &#x2013; (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zkzNYLFNvlBl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zOhtVFZD7Cc2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Reden&#xe7;&#xe3;o
    &#x2013; PA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zv89I1HV3Mg5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zZ4rlxgEK94a"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zNgRf63Of6va"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zSQVD7WjIOii"&gt;Centro
    Superior de Ci&#xea;ncias da Sa&#xfa;de S/S Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zxFuJ4TzS5w9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zDkL5P7ERIYh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Jo&#xe3;o
    Pessoa &#x2013; PB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zY9m1ORoDnhe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zBgCynWMyzV1"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zR3jOGXQjyJ2"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_z4sfZ27y49ra"&gt;MedPhone
    Tecnologia em Sa&#xfa;de Ltda. (&#x201c;MedPhone&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zaHBVqt7IaTj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Content
    and clinical tools and online platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zA7SEKHrLVP9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Recife
    &#x2013; PE&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zkt9e1J0G1X4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zHI2Dlz7iHsb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zpOstkaWEOdg"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zpRgK3ImWPFi"&gt;iClinic
    Desenvolvimento de Software Ltda (&#x201c;iClinic&#x201d;)&lt;/span&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zFTwhzrx3nA5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Electronic
    Medical Record, Clinical Management System&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zlVXzC2ylHSe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Ribeir&#xe3;o
    Preto - SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_z9PqGrLMOxpc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zdySchrxCPId"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zvUNn2HMeB7b"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zw9QhWexOPuh"&gt;Medicinae
    Solutions S.A. (&#x201c;Medicinae&#x201d;)&lt;/span&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z7ns4bSXQK7j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Healthcare
    payments and financial services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zQIYUa5bVxn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro &#x2013; RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z9CmVh0K3cab" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zxhSU6hdsAn6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zBxcDO4O3SBe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zPFJIz7hWfK6"&gt;Medical
    Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt; * &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zwIp9XAoADei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Educational
    health and medical imaging&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zQsGUFEXuomg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Florian&#xf3;polis
    &#x2013; SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zDwHTzZawaUe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zLPKrY4fz6d8"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_ze1vu47f0fvb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zzPOLeuN3OBb"&gt;Cliquefarma
    Drogarias Online Ltda.(&#x201c;Cliquefarma&#x201d;)&lt;/span&gt;* &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zSHLOXonvx2b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Online
    platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zVJ2NnB1MVi9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zJmAfpqxLCHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zaTbbqTjOQW5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zTxJp3vO7E3e"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zG3JXW9mztmd"&gt;Shosp
    Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;)*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zToBTjW2TyD7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Electronic
    Medical Record, Clinical Management System&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zEee92923w5d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro &#x2013; RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z1rUwDHM3Mo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zpPjmUPHeXp3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z5Wub04kkKe3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_z9MzGbzDeRZi"&gt;Sociedade
    Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zr807cyaagH8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zKTB5doQXmMi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zYpJQ0andVK5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zSt9MOyTyqVk"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zOXOqP0yuHZi"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zMS6ni7bueL6"&gt;Companhia
    Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura. (&#x201c;Unigranrio&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zUIIelInsaR1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_z89RRuYvrq6g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Duque
    de Caxias - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zQ2lR5fHJMZ2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zWwnDDV4gEU"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zDL0RjrJPfj7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zR5zY0CnhaZ9"&gt;Policl&#xed;nica
    e Centro de Est&#xe9;tica Duque de Caxias Ltda. (&#x201c;Policl&#xed;nica&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zsoPxbXMt8Wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medical
    Care&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zpZ3ZVyRo7ji" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Duque
    de Caxias - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zWT8ia76dsc4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zUZ3PipdfPcl"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zm7Ac6Qd74Y5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zYZa9ItnOA7h"&gt;Sociedade
    Educacional de Palho&#xe7;a S/A Ltda. (&#x201c;SOCIESP&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zgFnX4WgFzXg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Basic
    Education&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zFx7qQwnQvm8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Palho&#xe7;a
    - SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zp4mHnx9s383" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6LF5Q7lAzml"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6RXromp2B59"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zUfp5LnGTZQ6"&gt;Instituto
    de Ensino Superior de Palho&#xe7;a S/S Ltda. (&#x201c;IESP PALHO&#xc7;A&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zbwI988zz4Wi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zxUZTVNXxla1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Palho&#xe7;a
    - SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_z2tNX8hq96D6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zfk7rzN3pg6j"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zJs3gY7NUhv"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zzEuP4VgRLy2"&gt;RX
    PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zQgX8XxTHMK9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marketing
    for pharmaceutical industry&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zvgcWDbNbM22" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zmObsQxJcxGj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zyMXF4luwsq3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_z1uMVf24jDik"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zl6TCLqYadkd"&gt;RX
    PRO LOG Transporte e Log&#xed;stica Ltda. (&#x201c;RX PRO LOG&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zfsA4FvRPL0h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marketing
    for pharmaceutical industry&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zYcbgW51QvLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zMnXUPAy3qbc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zO1th5XT7Tgb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zcIYkH7cioyc"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zvcJDpsfLF3"&gt;Uni&#xe3;o
    Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zLLXEsOvus75" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zdlQVhNz98i5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Bras&#xed;lia
    - DF&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAnRWBRjJ3Tj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zWfviYY5pRLb"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_z3F8ZHPm91Zh"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;* See Note 5 for
further details of the business combinations during 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_8AE_zBV9DnKyLmT2" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
financial information of the acquired subsidiaries is included in the Company&#x2019;s consolidated financial statements beginning on
the respective acquisition dates.&lt;br/&gt;
&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company consolidates the financial information for all entities it controls. Control is achieved when the Company is exposed to, or has
rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over
the investee. Consolidation of a subsidiary begins when the Company obtains control over the subsidiary and it ceases when the Company
loses control of the subsidiary. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the year are
included in the consolidated financial statements from the date the Company gains control until the date the Company ceases to control
the subsidiary.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When
necessary, adjustments are made to the financial statements of subsidiaries in order to bring their accounting policies in line with
the Company&#x2019;s accounting policies. All intra-group assets and liabilities, equity, income, expenses and cash flows relating to
transactions are eliminated in full on consolidation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A
change in the ownership interest of a subsidiary, without a loss of control, is accounted for as an equity transaction. If the Company
loses control over a subsidiary, it derecognizes the related assets (including goodwill), liabilities, non-controlling interest and other
components of equity, while any resulting gain or loss is recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Non-controlling
interests in the results and equity of subsidiaries are shown separately in the consolidated statements of financial position, consolidated
statements of income and comprehensive income and consolidated statements of changes in equity.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2.3
Summary of significant accounting policies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This note provides
a description of the significant accounting policies adopted in the preparation of these consolidated financial statements in addition
to other policies that have been disclosed in other notes to these consolidated financial statements. These policies have been consistently
applied to all periods presented.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
accounting policies have been consistently applied to all consolidated companies.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zXGmTUPzPJU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_866_zaEnDGm2gzv8"&gt;a)
Business combinations and goodwill&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Business combinations
are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred,
which is measured at acquisition date fair value, and the amount of any non-controlling interests in the acquiree. For each business
combination, the Company elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate
share of the acquiree&#x2019;s identifiable net assets. Acquisition-related costs are expensed as incurred and included in general and
administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When the Company
acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and designation in accordance
with the contractual terms, economic circumstances and pertinent conditions as of the acquisition date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Goodwill is initially
measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interests
and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair value of the net assets
acquired is in excess of the aggregate consideration transferred, the Company re-assesses whether it has correctly identified all of
the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognized at the
acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration
transferred, then the gain is recognized in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Company&#x2019;s cash-generating units that are expected to benefit
from the combination, irrespective of whether other assets or liabilities of the acquire are assigned to those units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Where goodwill
has been allocated to a cash-generating unit (CGU) and part of the operation within that unit is disposed of, the goodwill associated
with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal. Goodwill
disposed in these circumstances is measured based on the relative values of the disposed operation and the portion of the cash-generating
unit retained.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_858_zZ9yvLY2hpc1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zgzG63K0xsU1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zHhT9uXICLRb"&gt;b)
Current versus non-current classification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company presents
assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it
is:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected
                                            to be realized or intended to be sold or consumed in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Held
                                            primarily for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected
                                            to be realized within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Cash
                                            or cash equivalent unless restricted from being exchanged or used to settle a liability for
                                            at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All other assets
are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A liability is
current when:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is expected to be settled in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is held primarily for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is due to be settled within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;There
                                            is no unconditional right to defer the settlement of the liability for at least twelve months
                                            after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company classifies
all other liabilities as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Deferred tax assets
and liabilities are classified as non-current assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zgpvJcmdVX6g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z1UoK9K8FA54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_znBt0lSNy64l"&gt;c)
Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability
takes place either: (i) in the principal market for the asset or liability; or (ii) in the absence of a principal market, in the most
advantageous market for the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The principal or
the most advantageous market must be accessible by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The fair value
of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A fair value measurement
of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest
and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company uses
valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All assets and
liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy,
described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            1 &#x2014; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            2 &#x2014; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            3 &#x2014; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For assets and
liabilities that are recognized in the financial statements at fair value on a recurring basis, the Company determines whether transfers
have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to
the fair value measurement as a whole) at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At each reporting
date, the Company analyzes the movements in the values of assets and liabilities which are required to be remeasured or re-assessed as
per the Company&#x2019;s accounting policies. For this analysis, the Company verifies the major inputs applied in the latest valuation
by agreeing the information in the valuation computation to contracts and other relevant documents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company also
compares the change in the fair value of each asset and liability with relevant external sources to determine whether the change is reasonable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For the purpose
of fair value disclosures, the Company has determined classes of assets and liabilities on the basis of the nature, characteristics and
risks of the asset or liability and the level of the fair value hierarchy, as explained above.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_858_zqlMbMSo3f5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84B_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_ztYvUYq4jBpk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86C_zZNwJYQfZUg1"&gt;d)
Financial instruments &#x2013; initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial instrument
is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 14.2pt"/&gt;&lt;td style="width: 14.15pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics
and the Company&#x2019;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair
value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. Trade receivables that do not
contain a significant financing component or for which the Company has applied the practical expedient, are measured at the transaction
price determined under IFRS 15.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In order
for a financial asset to be classified and measured at amortized cost or fair value through OCI (Other Comprehensive Income), it needs
to give rise to cash flows that are &#x201c;solely payments of principal and interest (SPPI)&#x201d; on the principal amount outstanding.
This assessment is referred to as the SPPI test and is performed at an instrument level.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash
flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets,
or both.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Purchases
or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the market
place (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For
purposes of subsequent measurement, financial assets are classified as: financial assets at amortized cost or financial assets at fair
value through profit or loss. There is no financial assets designated as fair value through OCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
assets at amortized cost&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company measures financial assets at amortized cost if both of the following conditions are met:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The financial asset is held within a business model with the objective to hold financial assets in order to collect contractual cash
flows, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
on the principal amount outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at amortized cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. Gains and
losses are recognized in the statement of income when the asset is derecognized, modified or impaired.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
assets at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at fair value through profit or loss include financial assets held for trading, financial assets designated upon initial recognition
at fair value through profit or loss, or financial assets mandatorily required to be measured at fair value. Financial assets are classified
as held for trading if they are acquired for the purpose of selling or repurchasing in the near term. Derivatives, including separated
embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial
assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit
or loss, irrespective of the business model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair
value recognized in the statement of income. This category includes derivative instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial
asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e.,
removed from the Company&#x2019;s statement of financial position) when:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The rights to receive cash flows from the asset have expired; or&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows
in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement; and either (a) the Company has transferred
substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks
and rewards of the asset, but has transferred control of the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When
the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially
all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset
to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred asset
and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Company could be required to repay.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Impairment
of financial assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Further
disclosures relating to impairment of financial assets are also provided in the following notes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Significant accounting estimates and assumptions &#x2013; Note 3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Trade receivables &#x2013; Note 7&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company recognizes an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or loss.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and the cash flows the Company
expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash
flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For
trade receivables, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit
risk, but instead recognizes an allowance for credit losses based on lifetime ECLs at each reporting date. The Company has established
a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors
and the economic environment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company considers a financial asset to be in default when internal or external information indicates that the Company is unlikely to
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Company. A financial
asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings,
payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s financial liabilities include trade payables, loans and financing, notes payable, lease liabilities, advances from costumers
and accounts payable to selling shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
measurement of financial liabilities depends on their classification, as described below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
liabilities at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated
upon initial recognition as at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also
includes, when applicable, derivative financial instruments entered into by the Company that are not designated as hedging instruments
in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Loans
and borrowings&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;After
initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and
losses are recognized in the statement of income when the liabilities are derecognized as well as through the EIR amortization process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR.
The EIR amortization is included as finance expenses in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial
liability is derecognized when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability
is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially
modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Offsetting
of financial instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and
settle the liabilities simultaneously.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_zctr6eHpZJwk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zDlIQMFTwAod" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_867_zDF9074Mtcx9"&gt;e)
Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Cash and cash equivalents
in the statement of financial position comprise cash at banks and on hand, and short-term financial investments with an original maturity
of three months or less, which are subject to an insignificant risk of changes in value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For the purpose
of the statement of cash flows, cash and cash equivalents consist of cash and short-term financial investments, as they are considered
an integral part of the Company&#x2019;s cash management.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_z9FiFEU3Hcrj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_zo6V8jmS1mue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_863_zp9r4v6lemA4"&gt;f)
Restricted cash&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Restricted cash
in the statement of financial position comprise of financial investments in investment funds that serve as collateral for loan agreements
and other commitments.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_zniZLxzjTHze" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zLO4ZjkpxVjj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zgKIkbUiRZ37"&gt;g)
Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Inventories are
valued at the lower of cost and net realizable value. The costs of inventories are based on the average cost method and include costs
incurred in the purchase of inventories and other costs incurred in bringing them to their current location and condition. Costs of purchased
inventory are determined after deducting any discounts and recoverable taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zawMF2um1Ye" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zs5910DRxwp1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zN7I4VlTO1ya"&gt;h)
Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Property and equipment
is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Subsequent expenditures
are capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zgTXvHbXwfZh"&gt;Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;25
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;4
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1240"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;IT
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;5
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Library
    books&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Laboratories
    and clinics&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1244"&gt;20
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zExqFxbNA5be" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;An item of property
and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefit is expected
from its use or disposal. Any gain or loss arising on the derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of income when the asset is derecognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The residual values,
useful lives and methods of depreciation of property and equipment are reviewed at each financial year end and adjusted prospectively,
if appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_850_zP1wjw1OPeL6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z54pJUq5MSSk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zbLzWvYYJg3e"&gt;i)
Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As from January
1, 2019, the determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the inception
of the contract. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a specific asset
(or assets) and the arrangement conveys a right to use the asset (or assets), even if that asset is (or those assets are) not explicitly
specified in an arrangement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Company
as a lessee&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company applies
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company
recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Right-of-use
assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company recognizes
right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets
are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Unless the Company is reasonably certain to obtain ownership
of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the
shorter of its estimated useful life and the lease term. Right-of use assets are subject to impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Lease
liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the commencement
date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease
term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable
lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments
also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for
terminating a lease, if the lease term reflects the Company exercising the option to terminate. The variable lease payments that do not
depend on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In calculating
the present value of lease payments, the Company uses the incremental borrowing rate at the lease commencement date if the interest rate
implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect
the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured
if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment
to purchase the underlying asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Short-term
leases and leases of low-value assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company applies
the short-term lease recognition exemption to its short-term leases of properties (i.e., those leases that have a lease term of &lt;span id="xdx_90A_ecustom--ContractualLeaseTerm_dxL_c20210101__20211231_zf5MLExeIDub" title="Lease term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1248"&gt;12 &lt;/span&gt;&lt;/span&gt;months
or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption
to leases that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense
on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85B_zogGB7vJ1fPi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOKA4C8TmvD9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_zJnbovsjkWMc"&gt;j)
Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is
their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated
amortization and accumulated impairment losses. Internally generated intangibles are not capitalized and the related expenditure is reflected
in the statement of income in the period in which the expenditure is incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The useful lives
of intangible assets are assessed as finite or indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The amortization
period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting
period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset
are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization
expense on intangible assets with finite lives is recognized in the statement of income in the expense category that is consistent with
the function of the intangible assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating
unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable.
If not, the change in useful life from indefinite to finite is made on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;An intangible asset
is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_852_zxbnU4ApNj8g" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zJ3A9hpxuzQ6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zacqbnkRPoBa"&gt;k)
Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company assesses,
at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment
testing for an asset is required, the Company estimates the asset&#x2019;s recoverable amount. An asset&#x2019;s recoverable amount is
the higher of an asset&#x2019;s or CGU&#x2019;s fair value less costs of disposal and its value in use. The recoverable amount is determined
for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups
of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written
down to its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent
market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used. These
calculations are corroborated by valuation multiples, quoted share prices for publicly traded companies or other available fair value
indicators.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company bases
its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company&#x2019;s
CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years, considering
the companies activities and maturation period of its graduate and undergraduate courses. A long-term growth rate is calculated and applied
to project future cash flows after the last projected year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For impairment
testing, goodwill acquired through business combinations and licenses with indefinite useful lives are allocated to their respective
CGUs. The Company has defined each of its operating subsidiaries as a CGU, except for &#x201c;Practice Management Tools &amp;amp; Electronic
Prescription&#x201d; and &#x201c;Clinical Decision Software&#x201d; where the subsidiaries were combined as one CGU following the business
strategic pillars and &#x201c;Moc&#x201d; where we have 2 different educational institution operating in the same municipality (Montes
Claros).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Whenever applicable,
impairment losses of continuing operations are recognized in the statement of income in expense categories consistent with the function
of the impaired asset.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For assets excluding
goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the
asset&#x2019;s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation,
had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Goodwill is tested
for impairment annually as at December 31 and when circumstances indicate that the carrying value may be impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Impairment is determined
for goodwill by assessing the recoverable amount of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount
of the CGU is less than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed
in future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with indefinite useful lives are tested for impairment annually as at December 31 at the CGU level, as appropriate, and when circumstances
indicate that the carrying value may be impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85E_zM8v2dJCLAK5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--PolicyExplanatoryInvestments_zp92p4k14z53" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_zm2GPpW2ebch"&gt;l)
Investments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Investments in
associates are initially recognized at consideration transferred and adjusted thereafter for the equity method, being increased or reduced
from its interest in the investee's income after the acquisition date. An associate is an entity over which the Company has significant
influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is
not control or joint control over those policies.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_855_zJxqhdslJCqf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_840_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_z7Btth29dxk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_865_zjIKH8Rtxiph"&gt;m)
Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;These amounts represent
liabilities related to the acquisitions made by the Company which are not yet due. Accounts payable to selling shareholders are presented
as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their
fair value and subsequently measured at amortized cost using the effective interest method.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85C_z7QtDdjZo6bi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zYxyM6o1glsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zazXTRkSedzl"&gt;n)
Provisions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Provisions are
recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow
of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount
of the obligation. The expense relating to a provision is presented in the statement of income, net of any reimbursement, when applicable.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85E_zKd0Ih1nhaYc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_842_ecustom--DividendsPayablePolicyExplanatory_z397t1pS5jC3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86E_z15jdl7MGCZ3"&gt;o)
Dividends payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company recognizes
a liability to pay a dividend when the distribution is authorized and the distribution is no longer at the discretion of the Company.
The distribution is authorized when it is required to pay a minimum dividend of the net income for the year in accordance with the Brazilian
Corporate Law (applicable for Afya Brazil) and the Company&#x2019;s By-Laws or is approved by the shareholders. A corresponding amount
is recognized directly in equity.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85A_zEcLxXZFdrEb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84E_ecustom--LaborAndSocialObligationsPolicyExplanatory_zyuMWjV52mJk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86B_zInMviYYmc74"&gt;p)
Labor and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Labor and social
obligations are expensed as the related service is provided. A liability is recognized for the amount expected to be paid if the Company
has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation
can be estimated reliably.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_zY2GIsDa1tO" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_846_ecustom--SharebasedPaymentsPolicyExplanatory_zmQw3Ia7vck7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_864_zEpxtV9J1cY"&gt;q)
Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Certain key executives
of the Company receive remuneration in the form of share-based payments, whereby the executives render services as consideration for
equity instruments (equity-settled transactions).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The expense of
equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;That expense is
recognized in general and administrative expenses, together with a corresponding increase in equity, over the period in which the service
and, where applicable, the performance conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s
best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of income for a period
represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Service and non-market
performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company&#x2019;s best estimate of the number of equity instruments that will ultimately vest. Market
performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated
service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award
and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;No expense is recognized
for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include
a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition
is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When the terms
of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided
the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any
modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.
Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately
through the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The dilutive effect
of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_851_z0xnLBbFBRZf" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_847_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zIAU51gxhdvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zuG4RQveJnAk"&gt;r)
Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Tuition fees
and other revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company's revenue
consists primarily of tuition fees charged for medical courses. The Company also generates revenue from tuition fees for other undergraduate
courses, student fees, certain education-related activities, digital education content and subscription of digital services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenues are recognized
when services are rendered to the customer and the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenue from tuitions
and digital education content are recognized over time when services are rendered to the customer and the Company satisfies its performance
obligation under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for
those services. Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Other revenues
are recognized at a point in time when the service is rendered to the customer at an amount that reflects the consideration to which
the Company expects to be entitled in exchange for the service. Other revenues are presented net of the corresponding discounts, returns
and taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Printed books,
e-books, healthcare payments, online platforms and marketing for pharmaceutical industry revenues are transferred at point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenue from sale
of printed books, e-books, healthcare payments, online platforms and marketing for pharmaceutical industry are recognized at the point
in time when control of the asset or services is transferred to the customer, generally on delivery of the goods at the customer&#x2019;s
location and permission to access the digital content. The Company considers whether there are other promises in the contract that are
separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price
for the printed books and e-books, the Company considers the effects of variable consideration, financing component, noncash consideration,
and consideration payable to the customer to be not significant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
concluded that it is the principal in its revenue arrangements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company assesses
collectability on a portfolio basis prior to recording revenue. Generally, students cannot re-enroll for the next academic session without
satisfactory resolution of any past-due amounts. If a student withdraws from an institution, the Company's obligation to issue a refund
depends on the refund policy at that institution and the timing of the student's withdrawal. Generally, the refund obligations are reduced
over the course of the academic term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Trade
receivables &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Trade receivables
represent the Company&#x2019;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before
payment of the consideration is due). Refer to accounting policies of financial assets in Financial instruments &#x2013; initial recognition
and subsequent measurement.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Advances
from customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Advances from customers
(a contract liability) are the obligation to transfer services to a customer for which the Company has received consideration (or an
amount of consideration is due) from the customer, as a result of pre-paid tuition, digital education content and mobile app subscription
for digital medical content received from customers and is recognized separately in current liabilities, when the payment is received.
Advances from customers are recognized as revenue when the Company performs all obligations related to the contract, generally in the
following month.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_857_zeGkJvv1S2ol" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_84F_ecustom--TaxesPolicyExplanation_z5qycgmF9NF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_868_z8LSmzg94np6"&gt;s)
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
Company&#x2019;s subsidiaries joined the PROUNI (&lt;i&gt;Programa Universidade para Todos &#x2013; &lt;/i&gt;University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number
of student enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&#x2022;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
taxes and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&#x2022;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PIS
and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
regulation of PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS.
For income from other teaching activities, PIS and COFINS are charged at rates of &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z6M7MuXIJc7j" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_90C_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zQWtielBNzl6" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching
activities, PIS is charged at a rate of &lt;span id="xdx_90D_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_znwbL7c5ouAg" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_905_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zW2vj2NmWk9b" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&lt;i&gt;Current
income taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;Current
income taxes were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service,
specifically regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Current income
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates
and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2.4
Changes in accounting policies and disclosures&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;i&gt;New
standards, interpretations and amendments adopted by the Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Certain amendments
apply for the first time in 2021, but do not have an impact on these financial statements of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_85D_zTpuUYmQKRo7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory>
    <afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_ecustom--SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock_zsVPd9Duk2yg" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BF_ziR2Bi73TCt4"&gt;The table below
is a list of the Company&#x2019;s subsidiaries and associate:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Direct
    and indirect interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 37%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Name&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Principal
    activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Location&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Investment
    type&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z9jrchiGBFF5" title="Name"&gt;Afya
    Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Holding&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Nova
    Lima - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_zfPPjlT6Kkgk" title="Direct and indirect interest of subsidiary"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--AfyaParticipacoesSAMember_z81sgS5rqk5d"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zlLqRdcvRFHg" title="Name"&gt;Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. &#x2013; (&#x201c;ITPAC Porto&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Porto
    Nacional - TO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_zuPMmw3wfPnh"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember_z1gCmCNpQ22l"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zp8cDC89brzd" title="Name"&gt;Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos S.A. &#x2013; (&#x201c;ITPAC Araguaina&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Aragua&#xed;na
    - TO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_zZr780lHnMKj"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember_znkcPDndLpHg"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zzgTEeAITCaf" title="Name"&gt;Uni&#xe3;o
    Educacional do Vale do A&#xe7;o S.A. &#x2013; (&#x201c;UNIVA&#xc7;O&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    undergraduate degree program&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Ipatinga
    - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zw9mKjXKumXe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoValeDoAcoSAUNIVACOMember_zmRXUq8RcCQf"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8lUk4TjP301" title="Name"&gt;IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Jo&#xe3;o Del Rei - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zhgnUXrf9B6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z8zMttg6TuG2"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" title="Name"&gt;Instituto
    de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Parna&#xed;ba
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zXZfBs9lbLO1"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z7YhIBToUkM"&gt;80&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" title="Name"&gt;Centro
    de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    undergraduate degree program&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Itajub&#xe1;
    - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zk7AvKsTopUg"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zR74VG9GF9n4"&gt;60&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" title="Name"&gt;Instituto
    de Ensino Superior do Piau&#xed; S.A. (&#x201d;IESP&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Teresina
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z1Fvs8Tu0qc6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zZLxsFwTVQV4"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zwVz5DAgrVC4" title="Name"&gt;Centro
    Integrado de Sa&#xfa;de de Teresina (&#x201c;CIS&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zG1GHFtBdDc3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Outpatient
    care&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zMRPtND9HMda" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Teresina
    - PI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_z1bd0JojSvSc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zPlN4mLVXMO7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroIntegradoDeSaudeDeTeresinaCISMember_zSCfLmYxV9Yb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" title="Name"&gt;FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Pato
    Branco - PR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z5itm1udu7si"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zNoH6J07gun"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zkBXSmgej9Vl" title="Name"&gt;Medcel
    Editora e Eventos S.A. (&#x201c;Medcel&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWoGVwZ1Oz6b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medical
    education content&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zqPXxGnD3Icg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo - SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zFwBFHa8TK04" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zWJfl7mO54r3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelEditoraEEventosSAMedcelMember_zIlljRou1qXd"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" title="Name"&gt;Instituto
    Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zR9XvVblqBO5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zBhFtS1cPyhe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_906_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zcNVhEYP8Hfe" title="Name"&gt;ESMC
    Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;ESMC&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zqkBLT94ust2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zWFpXKcyaYOd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zU7GNr6Ahbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zKCrhOJip3sl"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ESMCEducacaoSuperiorLtdaESMCMember_zeAarzahU0Jb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" title="Name"&gt;Instituto
    de Pesquisa e Ensino M&#xe9;dico do Estado de Minas Gerais Ltda. (&#x201c;IPEMED&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Graduate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Belo
    Horizonte - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zvAR6lnmH631"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ztIOR3UOML5c"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" title="Name"&gt;Instituto
    Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda (&#x201c;IPEC&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marab&#xe1;
    - PA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zH1ceiFsZORe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z78wqHEKQT44"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zH1Gzov441T5" title="Name"&gt;Sociedade
    Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zVJVK8SqdCEg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Principal activities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_zWzd9WRAle0g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Location"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Itaperuna
    - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z26iLiewMOH" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Investment type"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z1pSxbqLpV8l"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAUniRedentorMember_z5Vsjtwez8q7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z70LPVoBpu08"&gt;Centro
    Universit&#xe1;rio S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zDt07DaWPUYj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_z6e62UX5uqmf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Porto
    Velho - RO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zSfSL4ghqbGk" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zbQoGUiBXOC4"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaUniSLMember_zl14O4MVUBc6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zrRJ83407jc4"&gt;Peb
    Med Institui&#xe7;&#xe3;o de Pesquisa M&#xe9;dica e Servi&#xe7;os Ltda (&#x201c;PebMed&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z3KxsZNZJoGl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Content
    and clinical tools and online platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_z06r92Wpk1Mj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zwx3gE8e7o43" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zZt2n2mB702a"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember_zEE4E4yT3B7k"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zDKOv7iS51ak"&gt;Faculdade
    de Ensino Superior da Amaz&#xf4;nia Reunida &#x2013; (&#x201c;FESAR&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zkzNYLFNvlBl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zOhtVFZD7Cc2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Reden&#xe7;&#xe3;o
    &#x2013; PA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zv89I1HV3Mg5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zZ4rlxgEK94a"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember_zNgRf63Of6va"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zSQVD7WjIOii"&gt;Centro
    Superior de Ci&#xea;ncias da Sa&#xfa;de S/S Ltda. (&#x201c;FCMPB&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zxFuJ4TzS5w9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medicine
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zDkL5P7ERIYh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Jo&#xe3;o
    Pessoa &#x2013; PB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zY9m1ORoDnhe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zBgCynWMyzV1"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember_zR3jOGXQjyJ2"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_z4sfZ27y49ra"&gt;MedPhone
    Tecnologia em Sa&#xfa;de Ltda. (&#x201c;MedPhone&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zaHBVqt7IaTj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Content
    and clinical tools and online platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zA7SEKHrLVP9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Recife
    &#x2013; PE&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zkt9e1J0G1X4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zHI2Dlz7iHsb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember_zpOstkaWEOdg"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zpRgK3ImWPFi"&gt;iClinic
    Desenvolvimento de Software Ltda (&#x201c;iClinic&#x201d;)&lt;/span&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zFTwhzrx3nA5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Electronic
    Medical Record, Clinical Management System&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zlVXzC2ylHSe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Ribeir&#xe3;o
    Preto - SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_z9PqGrLMOxpc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zdySchrxCPId"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember_zvUNn2HMeB7b"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zw9QhWexOPuh"&gt;Medicinae
    Solutions S.A. (&#x201c;Medicinae&#x201d;)&lt;/span&gt;*&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z7ns4bSXQK7j" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Healthcare
    payments and financial services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zQIYUa5bVxn" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro &#x2013; RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_z9CmVh0K3cab" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zxhSU6hdsAn6"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeSolutionsSAMedicinaeMember_zBxcDO4O3SBe"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90F_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zPFJIz7hWfK6"&gt;Medical
    Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)&lt;/span&gt; * &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zwIp9XAoADei" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Educational
    health and medical imaging&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zQsGUFEXuomg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Florian&#xf3;polis
    &#x2013; SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zDwHTzZawaUe" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_zLPKrY4fz6d8"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember_ze1vu47f0fvb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_904_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zzPOLeuN3OBb"&gt;Cliquefarma
    Drogarias Online Ltda.(&#x201c;Cliquefarma&#x201d;)&lt;/span&gt;* &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zSHLOXonvx2b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Online
    platform&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zVJ2NnB1MVi9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zJmAfpqxLCHj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zaTbbqTjOQW5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaDrogariasOnlineLtdaCliquefarmaMember_zTxJp3vO7E3e"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90E_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zG3JXW9mztmd"&gt;Shosp
    Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;)*&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zToBTjW2TyD7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Electronic
    Medical Record, Clinical Management System&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zEee92923w5d" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Rio
    de Janeiro &#x2013; RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z1rUwDHM3Mo" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_zpPjmUPHeXp3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospTecnologiaDaInformacaoLtdaShospMember_z5Wub04kkKe3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_z9MzGbzDeRZi"&gt;Sociedade
    Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zr807cyaagH8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zKTB5doQXmMi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Montes
    Claros - MG&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zYpJQ0andVK5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zSt9MOyTyqVk"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember_zOXOqP0yuHZi"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zMS6ni7bueL6"&gt;Companhia
    Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura. (&#x201c;Unigranrio&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zUIIelInsaR1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    and graduate degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_z89RRuYvrq6g" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Duque
    de Caxias - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zQ2lR5fHJMZ2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zWwnDDV4gEU"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember_zDL0RjrJPfj7"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zR5zY0CnhaZ9"&gt;Policl&#xed;nica
    e Centro de Est&#xe9;tica Duque de Caxias Ltda. (&#x201c;Policl&#xed;nica&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zsoPxbXMt8Wl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Medical
    Care&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zpZ3ZVyRo7ji" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Duque
    de Caxias - RJ&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zWT8ia76dsc4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zUZ3PipdfPcl"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_906_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember_zm7Ac6Qd74Y5"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zYZa9ItnOA7h"&gt;Sociedade
    Educacional de Palho&#xe7;a S/A Ltda. (&#x201c;SOCIESP&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zgFnX4WgFzXg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Basic
    Education&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zFx7qQwnQvm8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Palho&#xe7;a
    - SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_zp4mHnx9s383" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6LF5Q7lAzml"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeEducacionalDePalhocaSALtdaSOCIESPMember_z6RXromp2B59"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90B_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zUfp5LnGTZQ6"&gt;Instituto
    de Ensino Superior de Palho&#xe7;a S/S Ltda. (&#x201c;IESP PALHO&#xc7;A&#x201d;) *&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zbwI988zz4Wi" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zxUZTVNXxla1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Palho&#xe7;a
    - SC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_z2tNX8hq96D6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zfk7rzN3pg6j"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember_zJs3gY7NUhv"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_900_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zzEuP4VgRLy2"&gt;RX
    PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zQgX8XxTHMK9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marketing
    for pharmaceutical industry&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zvgcWDbNbM22" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zmObsQxJcxGj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_903_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_zyMXF4luwsq3"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROSolucoesDeTecnologiaLtdaRXPROMember_z1uMVf24jDik"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zl6TCLqYadkd"&gt;RX
    PRO LOG Transporte e Log&#xed;stica Ltda. (&#x201c;RX PRO LOG&#x201d;)&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zfsA4FvRPL0h" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Marketing
    for pharmaceutical industry&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zYcbgW51QvLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;S&#xe3;o
    Paulo &#x2013; SP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zMnXUPAy3qbc" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_901_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zO1th5XT7Tgb"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROLOGTransporteELogisticaLtdaRXPROLOGMember_zcIYkH7cioyc"&gt;100&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_907_eifrs-full--NameOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zvcJDpsfLF3"&gt;Uni&#xe3;o
    Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;)&lt;/span&gt; &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PrincipalActivities_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zLLXEsOvus75" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Undergraduate
    degree programs&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PrincipalPlaceOfBusinessOfSubsidiary_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zdlQVhNz98i5" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Bras&#xed;lia
    - DF&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InvestmentType_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zAnRWBRjJ3Tj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20210101__20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_zWfviYY5pRLb"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAMember_z3F8ZHPm91Zh"&gt;30&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;* See Note 5 for
further details of the business combinations during 2021.&lt;/span&gt;&lt;/p&gt;

</afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">Afya
    Participa&#xe7;&#xf5;es S.A. (&#x201c;Afya Brazil&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">Holding</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">Nova
    Lima - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      unitRef="Pure">100</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_AfyaParticipacoesSAMember"
      decimals="INF"
      unitRef="Pure">100</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos Porto S.A. &#x2013; (&#x201c;ITPAC Porto&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">Porto
    Nacional - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">Instituto
    Tocantinense Presidente Ant&#xf4;nio Carlos S.A. &#x2013; (&#x201c;ITPAC Araguaina&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">Aragua&#xed;na
    - TO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">Uni&#xe3;o
    Educacional do Vale do A&#xe7;o S.A. &#x2013; (&#x201c;UNIVA&#xc7;O&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">Medicine
    undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">Ipatinga
    - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_UniaoEducacionalDoValeDoAcoSAUNIVACOMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">IPTAN
    - Instituto de Ensino Superior Presidente Tancredo de Almeida Neves S.A. (&#x201c;IPTAN&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">S&#xe3;o
    Jo&#xe3;o Del Rei - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">Instituto
    de Educa&#xe7;&#xe3;o Superior do Vale do Parna&#xed;ba S.A. (&#x201c;IESVAP&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">Parna&#xed;ba
    - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="INF"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="INF"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">Centro
    de Ci&#xea;ncias em Sa&#xfa;de de Itajub&#xe1; S.A. (&#x201c;CCSI&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">Medicine
    undergraduate degree program</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">Itajub&#xe1;
    - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="INF"
      unitRef="Pure">0.60</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="INF"
      unitRef="Pure">0.60</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">Instituto
    de Ensino Superior do Piau&#xed; S.A. (&#x201d;IESP&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">Undergraduate
    and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">Teresina
    - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">Centro
    Integrado de Sa&#xfa;de de Teresina (&#x201c;CIS&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">Outpatient
    care</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">Teresina
    - PI</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CentroIntegradoDeSaudeDeTeresinaCISMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">FADEP
    - Faculdade Educacional de Pato Branco Ltda. (&#x201c;FADEP&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">Pato
    Branco - PR</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">Medcel
    Editora e Eventos S.A. (&#x201c;Medcel&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">Medical
    education content</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">S&#xe3;o
    Paulo - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_MedcelEditoraEEventosSAMedcelMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_MedcelEditoraEEventosSAMedcelMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">Instituto
    Educacional Santo Agostinho S.A. (&#x201c;FASA&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">Montes
    Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">ESMC
    Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;ESMC&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">Montes
    Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_ESMCEducacaoSuperiorLtdaESMCMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">Instituto
    de Pesquisa e Ensino M&#xe9;dico do Estado de Minas Gerais Ltda. (&#x201c;IPEMED&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">Graduate</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">Belo
    Horizonte - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">Instituto
    Paraense de Educa&#xe7;&#xe3;o e Cultura Ltda (&#x201c;IPEC&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">Medicine
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">Marab&#xe1;
    - PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">Sociedade
    Universit&#xe1;ria Redentor S.A. (&#x201c;UniRedentor&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">Undergraduate
    and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">Itaperuna
    - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_SociedadeUniversitariaRedentorSAUniRedentorMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">Centro
    Universit&#xe1;rio S&#xe3;o Lucas Ltda. (&#x201c;UniSL&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">Porto
    Velho - RO</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CentroUniversitarioSaoLucasLtdaUniSLMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">Peb
    Med Institui&#xe7;&#xe3;o de Pesquisa M&#xe9;dica e Servi&#xe7;os Ltda (&#x201c;PebMed&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">Content
    and clinical tools and online platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">Rio
    de Janeiro - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">Faculdade
    de Ensino Superior da Amaz&#xf4;nia Reunida &#x2013; (&#x201c;FESAR&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">Reden&#xe7;&#xe3;o
    &#x2013; PA</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">Centro
    Superior de Ci&#xea;ncias da Sa&#xfa;de S/S Ltda. (&#x201c;FCMPB&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">Medicine
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">Jo&#xe3;o
    Pessoa &#x2013; PB</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">MedPhone
    Tecnologia em Sa&#xfa;de Ltda. (&#x201c;MedPhone&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">Content
    and clinical tools and online platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">Recife
    &#x2013; PE</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">iClinic
    Desenvolvimento de Software Ltda (&#x201c;iClinic&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">Electronic
    Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">Ribeir&#xe3;o
    Preto - SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">Medicinae
    Solutions S.A. (&#x201c;Medicinae&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">Healthcare
    payments and financial services</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">Rio
    de Janeiro &#x2013; RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_MedicinaeSolutionsSAMedicinaeMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_MedicinaeSolutionsSAMedicinaeMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">Medical
    Harbour Aparelhos M&#xe9;dico Hospitalares e Servi&#xe7;os em Tecnologia Ltda. (&#x201c;Medical Harbour&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">Educational
    health and medical imaging</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">Florian&#xf3;polis
    &#x2013; SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">Cliquefarma
    Drogarias Online Ltda.(&#x201c;Cliquefarma&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">Online
    platform</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">S&#xe3;o
    Paulo &#x2013; SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">Shosp
    Tecnologia da Informa&#xe7;&#xe3;o Ltda. (&#x201c;Shosp&#x201d;)*</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">Electronic
    Medical Record, Clinical Management System</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">Rio
    de Janeiro &#x2013; RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_ShospTecnologiaDaInformacaoLtdaShospMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">Sociedade
    Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UnifipMoc&#x201d;) *</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">Montes
    Claros - MG</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">Companhia
    Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura. (&#x201c;Unigranrio&#x201d;) *</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">Undergraduate
    and graduate degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">Duque
    de Caxias - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">Policl&#xed;nica
    e Centro de Est&#xe9;tica Duque de Caxias Ltda. (&#x201c;Policl&#xed;nica&#x201d;) *</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">Medical
    Care</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">Duque
    de Caxias - RJ</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">Sociedade
    Educacional de Palho&#xe7;a S/A Ltda. (&#x201c;SOCIESP&#x201d;) *</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">Basic
    Education</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">Palho&#xe7;a
    - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">Instituto
    de Ensino Superior de Palho&#xe7;a S/S Ltda. (&#x201c;IESP PALHO&#xc7;A&#x201d;) *</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">Palho&#xe7;a
    - SC</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">RX
    PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. (&#x201c;RX PRO&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">Marketing
    for pharmaceutical industry</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">S&#xe3;o
    Paulo &#x2013; SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_RXPROSolucoesDeTecnologiaLtdaRXPROMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">RX
    PRO LOG Transporte e Log&#xed;stica Ltda. (&#x201c;RX PRO LOG&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">Marketing
    for pharmaceutical industry</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">S&#xe3;o
    Paulo &#x2013; SP</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember">Subsidiary</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NameOfSubsidiary contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">Uni&#xe3;o
    Educacional do Planalto Central S.A. (&#x201c;UEPC&#x201d;)</ifrs-full:NameOfSubsidiary>
    <afya:PrincipalActivities contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">Undergraduate
    degree programs</afya:PrincipalActivities>
    <ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">Bras&#xed;lia
    - DF</ifrs-full:PrincipalPlaceOfBusinessOfSubsidiary>
    <afya:InvestmentType contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember">Associate</afya:InvestmentType>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-01-012021-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember"
      decimals="INF"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_UniaoEducacionalDoPlanaltoCentralSAMember"
      decimals="INF"
      unitRef="Pure">0.30</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:BusinessCombinationsAndGoodwillPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_ecustom--BusinessCombinationsAndGoodwillPolicyExplanatory_zXGmTUPzPJU5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_866_zaEnDGm2gzv8"&gt;a)
Business combinations and goodwill&lt;/span&gt; &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Business combinations
are accounted for using the acquisition method. The cost of an acquisition is measured as the aggregate of the consideration transferred,
which is measured at acquisition date fair value, and the amount of any non-controlling interests in the acquiree. For each business
combination, the Company elects whether to measure the non-controlling interests in the acquiree at fair value or at the proportionate
share of the acquiree&#x2019;s identifiable net assets. Acquisition-related costs are expensed as incurred and included in general and
administrative expenses.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When the Company
acquires a business, it assesses the financial assets and liabilities assumed for appropriate classification and designation in accordance
with the contractual terms, economic circumstances and pertinent conditions as of the acquisition date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Goodwill is initially
measured at cost (being the excess of the aggregate of the consideration transferred and the amount recognized for non-controlling interests
and any previous interest held over the net identifiable assets acquired and liabilities assumed). If the fair value of the net assets
acquired is in excess of the aggregate consideration transferred, the Company re-assesses whether it has correctly identified all of
the assets acquired and all of the liabilities assumed and reviews the procedures used to measure the amounts to be recognized at the
acquisition date. If the reassessment still results in an excess of the fair value of net assets acquired over the aggregate consideration
transferred, then the gain is recognized in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 12pt/107% Times New Roman, Times, Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;After initial recognition,
goodwill is measured at cost less any accumulated impairment losses. For the purpose of impairment testing, goodwill acquired in a business
combination is, from the acquisition date, allocated to each of the Company&#x2019;s cash-generating units that are expected to benefit
from the combination, irrespective of whether other assets or liabilities of the acquire are assigned to those units.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Where goodwill
has been allocated to a cash-generating unit (CGU) and part of the operation within that unit is disposed of, the goodwill associated
with the disposed operation is included in the carrying amount of the operation when determining the gain or loss on disposal. Goodwill
disposed in these circumstances is measured based on the relative values of the disposed operation and the portion of the cash-generating
unit retained.&lt;/span&gt;&lt;/p&gt;

</afya:BusinessCombinationsAndGoodwillPolicyExplanatory>
    <afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_ecustom--CurrentVersusNoncurrentClassificationPoliciesExplanatory_zgzG63K0xsU1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zHhT9uXICLRb"&gt;b)
Current versus non-current classification&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company presents
assets and liabilities in the statement of financial position based on current/non-current classification. An asset is current when it
is:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected
                                            to be realized or intended to be sold or consumed in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Held
                                            primarily for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Expected
                                            to be realized within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Cash
                                            or cash equivalent unless restricted from being exchanged or used to settle a liability for
                                            at least twelve months after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All other assets
are classified as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A liability is
current when:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is expected to be settled in the normal operating cycle;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is held primarily for the purpose of trading;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;It
                                            is due to be settled within twelve months after the reporting period; or&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;There
                                            is no unconditional right to defer the settlement of the liability for at least twelve months
                                            after the reporting period.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company classifies
all other liabilities as non-current.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Deferred tax assets
and liabilities are classified as non-current assets and liabilities.&lt;/span&gt;&lt;/p&gt;

</afya:CurrentVersusNoncurrentClassificationPoliciesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_845_eifrs-full--DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory_z1UoK9K8FA54" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_znBt0lSNy64l"&gt;c)
Fair value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Fair value is the
price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at
the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability
takes place either: (i) in the principal market for the asset or liability; or (ii) in the absence of a principal market, in the most
advantageous market for the asset or liability.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The principal or
the most advantageous market must be accessible by the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The fair value
of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability,
assuming that market participants act in their economic best interest.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A fair value measurement
of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest
and best use or by selling it to another market participant that would use the asset in its highest and best use.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company uses
valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing
the use of relevant observable inputs and minimizing the use of unobservable inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All assets and
liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy,
described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            1 &#x2014; Quoted (unadjusted) market prices in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            2 &#x2014; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is directly or indirectly observable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Level
                                            3 &#x2014; Valuation techniques for which the lowest level input that is significant to the
                                            fair value measurement is unobservable.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For assets and
liabilities that are recognized in the financial statements at fair value on a recurring basis, the Company determines whether transfers
have occurred between levels in the hierarchy by re-assessing categorization (based on the lowest level input that is significant to
the fair value measurement as a whole) at the end of each reporting period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At each reporting
date, the Company analyzes the movements in the values of assets and liabilities which are required to be remeasured or re-assessed as
per the Company&#x2019;s accounting policies. For this analysis, the Company verifies the major inputs applied in the latest valuation
by agreeing the information in the valuation computation to contracts and other relevant documents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company also
compares the change in the fair value of each asset and liability with relevant external sources to determine whether the change is reasonable.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For the purpose
of fair value disclosures, the Company has determined classes of assets and liabilities on the basis of the nature, characteristics and
risks of the asset or liability and the level of the fair value hierarchy, as explained above.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory>
    <afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84B_ecustom--FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory_ztYvUYq4jBpk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86C_zZNwJYQfZUg1"&gt;d)
Financial instruments &#x2013; initial recognition and measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial instrument
is any contract that gives rise to a financial asset of one entity and a financial liability or equity instrument of another entity.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 14.2pt"/&gt;&lt;td style="width: 14.15pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;i)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
classification of financial assets at initial recognition depends on the financial asset&#x2019;s contractual cash flow characteristics
and the Company&#x2019;s business model for managing them. With the exception of trade receivables that do not contain a significant financing
component or for which the Company has applied the practical expedient, the Company initially measures a financial asset at its fair
value plus, in the case of a financial asset not at fair value through profit or loss, transaction costs. Trade receivables that do not
contain a significant financing component or for which the Company has applied the practical expedient, are measured at the transaction
price determined under IFRS 15.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In order
for a financial asset to be classified and measured at amortized cost or fair value through OCI (Other Comprehensive Income), it needs
to give rise to cash flows that are &#x201c;solely payments of principal and interest (SPPI)&#x201d; on the principal amount outstanding.
This assessment is referred to as the SPPI test and is performed at an instrument level.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s business model for managing financial assets refers to how it manages its financial assets in order to generate cash
flows. The business model determines whether cash flows will result from collecting contractual cash flows, selling the financial assets,
or both.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Purchases
or sales of financial assets that require delivery of assets within a time frame established by regulation or convention in the market
place (regular way trades) are recognized on the trade date, i.e., the date that the Company commits to purchase or sell the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For
purposes of subsequent measurement, financial assets are classified as: financial assets at amortized cost or financial assets at fair
value through profit or loss. There is no financial assets designated as fair value through OCI.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
assets at amortized cost&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company measures financial assets at amortized cost if both of the following conditions are met:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The financial asset is held within a business model with the objective to hold financial assets in order to collect contractual cash
flows, and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest
on the principal amount outstanding.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at amortized cost are subsequently measured using the effective interest (EIR) method and are subject to impairment. Gains and
losses are recognized in the statement of income when the asset is derecognized, modified or impaired.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
assets at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at fair value through profit or loss include financial assets held for trading, financial assets designated upon initial recognition
at fair value through profit or loss, or financial assets mandatorily required to be measured at fair value. Financial assets are classified
as held for trading if they are acquired for the purpose of selling or repurchasing in the near term. Derivatives, including separated
embedded derivatives, are also classified as held for trading unless they are designated as effective hedging instruments. Financial
assets with cash flows that are not solely payments of principal and interest are classified and measured at fair value through profit
or loss, irrespective of the business model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets at fair value through profit or loss are carried in the statement of financial position at fair value with net changes in fair
value recognized in the statement of income. This category includes derivative instruments.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial
asset (or, where applicable, a part of a financial asset or part of a group of similar financial assets) is primarily derecognized (i.e.,
removed from the Company&#x2019;s statement of financial position) when:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The rights to receive cash flows from the asset have expired; or&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
The Company has transferred its rights to receive cash flows from the asset or has assumed an obligation to pay the received cash flows
in full without material delay to a third party under a &#x2018;pass-through&#x2019; arrangement; and either (a) the Company has transferred
substantially all the risks and rewards of the asset, or (b) the Company has neither transferred nor retained substantially all the risks
and rewards of the asset, but has transferred control of the asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When
the Company has transferred its rights to receive cash flows from an asset or has entered into a pass-through arrangement, it evaluates
if, and to what extent, it has retained the risks and rewards of ownership. When it has neither transferred nor retained substantially
all of the risks and rewards of the asset, nor transferred control of the asset, the Company continues to recognize the transferred asset
to the extent of its continuing involvement. In that case, the Company also recognizes an associated liability. The transferred asset
and the associated liability are measured on a basis that reflects the rights and obligations that the Company has retained.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Continuing
involvement that takes the form of a guarantee over the transferred asset is measured at the lower of the original carrying amount of
the asset and the maximum amount of consideration that the Company could be required to repay.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Impairment
of financial assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Further
disclosures relating to impairment of financial assets are also provided in the following notes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Significant accounting estimates and assumptions &#x2013; Note 3&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Trade receivables &#x2013; Note 7&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company recognizes an allowance for expected credit losses (ECLs) for all debt instruments not held at fair value through profit or loss.
ECLs are based on the difference between the contractual cash flows due in accordance with the contract and the cash flows the Company
expects to receive, discounted at an approximation of the original effective interest rate. The expected cash flows will include cash
flows from the sale of collateral held or other credit enhancements that are integral to the contractual terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For
trade receivables, the Company applies a simplified approach in calculating ECLs. Therefore, the Company does not track changes in credit
risk, but instead recognizes an allowance for credit losses based on lifetime ECLs at each reporting date. The Company has established
a provision matrix that is based on its historical credit loss experience, adjusted for forward-looking factors specific to the debtors
and the economic environment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company considers a financial asset to be in default when internal or external information indicates that the Company is unlikely to
receive the outstanding contractual amounts in full before taking into account any credit enhancements held by the Company. A financial
asset is written off when there is no reasonable expectation of recovering the contractual cash flows.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;ii)&#160;&#160;&#160;&#160;&#160;&#160;&#160;Financial
liabilities&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Initial
recognition and measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings,
payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;All
financial liabilities are recognized initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable
transaction costs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s financial liabilities include trade payables, loans and financing, notes payable, lease liabilities, advances from costumers
and accounts payable to selling shareholders.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Subsequent
measurement&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
measurement of financial liabilities depends on their classification, as described below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Financial
liabilities at fair value through profit or loss&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated
upon initial recognition as at fair value through profit or loss.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities are classified as held for trading if they are incurred for the purpose of repurchasing in the near term. This category also
includes, when applicable, derivative financial instruments entered into by the Company that are not designated as hedging instruments
in hedge relationships as defined by IFRS 9. Gains or losses on liabilities held for trading are recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
liabilities designated upon initial recognition at fair value through profit or loss are designated at the initial date of recognition,
and only if the criteria in IFRS 9 are satisfied.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Loans
and borrowings&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;After
initial recognition, interest-bearing loans and borrowings are subsequently measured at amortized cost using the EIR method. Gains and
losses are recognized in the statement of income when the liabilities are derecognized as well as through the EIR amortization process.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Amortized
cost is calculated by taking into account any discount or premium on acquisition and fees or costs that are an integral part of the EIR.
The EIR amortization is included as finance expenses in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Derecognition&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;A financial
liability is derecognized when the obligation under the liability is discharged or cancelled or expires. When an existing financial liability
is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially
modified, such an exchange or modification is treated as the derecognition of the original liability and the recognition of a new liability.
The difference in the respective carrying amounts is recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Offsetting
of financial instruments&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial
assets and financial liabilities are offset and the net amount is reported in the statement of financial position if there is a currently
enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, to realize the assets and
settle the liabilities simultaneously.&lt;/span&gt;&lt;/p&gt;

</afya:FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_849_eifrs-full--DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents_zDlIQMFTwAod" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_867_zDF9074Mtcx9"&gt;e)
Cash and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Cash and cash equivalents
in the statement of financial position comprise cash at banks and on hand, and short-term financial investments with an original maturity
of three months or less, which are subject to an insignificant risk of changes in value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For the purpose
of the statement of cash flows, cash and cash equivalents consist of cash and short-term financial investments, as they are considered
an integral part of the Company&#x2019;s cash management.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents>
    <ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_840_eifrs-full--DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory_zo6V8jmS1mue" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_863_zp9r4v6lemA4"&gt;f)
Restricted cash&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Restricted cash
in the statement of financial position comprise of financial investments in investment funds that serve as collateral for loan agreements
and other commitments.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_eifrs-full--DescriptionOfAccountingPolicyForMeasuringInventories_zLO4ZjkpxVjj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zgKIkbUiRZ37"&gt;g)
Inventories&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Inventories are
valued at the lower of cost and net realizable value. The costs of inventories are based on the average cost method and include costs
incurred in the purchase of inventories and other costs incurred in bringing them to their current location and condition. Costs of purchased
inventory are determined after deducting any discounts and recoverable taxes.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForMeasuringInventories>
    <ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eifrs-full--DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory_zs5910DRxwp1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zN7I4VlTO1ya"&gt;h)
Property and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Property and equipment
is stated at cost, net of accumulated depreciation and accumulated impairment losses, if any.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Subsequent expenditures
are capitalized only if it is probable that the future economic benefits associated with the expenditure will flow to the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zgTXvHbXwfZh"&gt;Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;25
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;4
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1240"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;IT
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;5
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Library
    books&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Laboratories
    and clinics&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1244"&gt;20
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8AE_zExqFxbNA5be" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;An item of property
and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefit is expected
from its use or disposal. Any gain or loss arising on the derecognition of the asset (calculated as the difference between the net disposal
proceeds and the carrying amount of the asset) is included in the statement of income when the asset is derecognized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The residual values,
useful lives and methods of depreciation of property and equipment are reviewed at each financial year end and adjusted prospectively,
if appropriate.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory>
    <afya:ScheduleOfEstimatedUsefulLives contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89C_ecustom--ScheduleOfEstimatedUsefulLives_zTlP55bvvlse" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zgTXvHbXwfZh"&gt;Depreciation is
calculated on a straight-line basis over the estimated useful lives of the assets, as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 62%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Building&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--BuildingsMember_zkYakg3Ei7A9" style="width: 38%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Useful lives of assets::XDX::P25Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1237"&gt;25
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Machinery
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--MachineryAndEquipmentsMember_z5QkK9rQncL3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1238"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--VehiclesMember_z6a0wU1v50i8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P4Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1239"&gt;4
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Furniture
    and fixtures&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--FixturesAndFittingsMember_zGkBSDFyUvW9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1240"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;IT
    equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--ItEquipmentMember_z1kGa938QO8f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P5Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1241"&gt;5
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Library
    books&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LibraryBooksMember_zTR0u7lf1dPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1242"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Laboratories
    and clinics&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__custom--LaboratoriesAndClinicsMember_zzOzzkvRnwtc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P10Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1243"&gt;10
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Leasehold
    improvements&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment_dxL_c20210101__20211231__ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis__ifrs-full--LeaseholdImprovementsMember_zWciVLvi78sh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="::XDX::P20Y"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1244"&gt;20
    years&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:ScheduleOfEstimatedUsefulLives>
    <ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84A_eifrs-full--DescriptionOfAccountingPolicyForLeasesExplanatory_z54pJUq5MSSk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zbLzWvYYJg3e"&gt;i)
Leases&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As from January
1, 2019, the determination of whether an arrangement is (or contains) a lease is based on the substance of the arrangement at the inception
of the contract. The arrangement is, or contains, a lease if fulfilment of the arrangement is dependent on the use of a specific asset
(or assets) and the arrangement conveys a right to use the asset (or assets), even if that asset is (or those assets are) not explicitly
specified in an arrangement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Company
as a lessee&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company applies
a single recognition and measurement approach for all leases, except for short-term leases and leases of low-value assets. The Company
recognizes lease liabilities to make lease payments and right-of-use assets representing the right to use the underlying assets.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Right-of-use
assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company recognizes
right-of-use assets at the commencement date of the lease (i.e., the date the underlying asset is available for use). Right-of-use assets
are measured at cost, less any accumulated depreciation and impairment losses, and adjusted for any remeasurement of lease liabilities.
The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments
made at or before the commencement date less any lease incentives received. Unless the Company is reasonably certain to obtain ownership
of the leased asset at the end of the lease term, the recognized right-of-use assets are depreciated on a straight-line basis over the
shorter of its estimated useful life and the lease term. Right-of use assets are subject to impairment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Lease
liabilities&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the commencement
date of the lease, the Company recognizes lease liabilities measured at the present value of lease payments to be made over the lease
term. The lease payments include fixed payments (including in-substance fixed payments) less any lease incentives receivable, variable
lease payments that depend on an index or a rate, and amounts expected to be paid under residual value guarantees. The lease payments
also include the exercise price of a purchase option reasonably certain to be exercised by the Company and payments of penalties for
terminating a lease, if the lease term reflects the Company exercising the option to terminate. The variable lease payments that do not
depend on an index or a rate are recognized as expense in the period on which the event or condition that triggers the payment occurs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In calculating
the present value of lease payments, the Company uses the incremental borrowing rate at the lease commencement date if the interest rate
implicit in the lease is not readily determinable. After the commencement date, the amount of lease liabilities is increased to reflect
the accretion of interest and reduced for the lease payments made. In addition, the carrying amount of lease liabilities is remeasured
if there is a modification, a change in the lease term, a change in the in-substance fixed lease payments or a change in the assessment
to purchase the underlying asset.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Short-term
leases and leases of low-value assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company applies
the short-term lease recognition exemption to its short-term leases of properties (i.e., those leases that have a lease term of &lt;span id="xdx_90A_ecustom--ContractualLeaseTerm_dxL_c20210101__20211231_zf5MLExeIDub" title="Lease term::XDX::P1Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1248"&gt;12 &lt;/span&gt;&lt;/span&gt;months
or less from the commencement date and do not contain a purchase option). It also applies the lease of low-value assets recognition exemption
to leases that are considered of low value. Lease payments on short-term leases and leases of low-value assets are recognized as expense
on a straight-line basis over the lease term.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForLeasesExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_eifrs-full--DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory_zOKA4C8TmvD9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_zJnbovsjkWMc"&gt;j)
Intangible assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is
their fair value at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated
amortization and accumulated impairment losses. Internally generated intangibles are not capitalized and the related expenditure is reflected
in the statement of income in the period in which the expenditure is incurred.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The useful lives
of intangible assets are assessed as finite or indefinite.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible
asset may be impaired.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The amortization
period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each reporting
period. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset
are considered to modify the amortization period or method, as appropriate, and are treated as changes in accounting estimates. The amortization
expense on intangible assets with finite lives is recognized in the statement of income in the expense category that is consistent with
the function of the intangible assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating
unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable.
If not, the change in useful life from indefinite to finite is made on a prospective basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;An intangible asset
is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising upon
derecognition of the asset (calculated as the difference between the net disposal proceeds and the carrying amount of the asset) is included
in the statement of income.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory>
    <afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_ecustom--ImpairmentOfNonfinancialAssetsPolicyExplanatory_zJ3A9hpxuzQ6" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zacqbnkRPoBa"&gt;k)
Impairment of non-financial assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company assesses,
at each reporting date, whether there is an indication that an asset may be impaired. If any indication exists, or when annual impairment
testing for an asset is required, the Company estimates the asset&#x2019;s recoverable amount. An asset&#x2019;s recoverable amount is
the higher of an asset&#x2019;s or CGU&#x2019;s fair value less costs of disposal and its value in use. The recoverable amount is determined
for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or groups
of assets. When the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written
down to its recoverable amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In assessing value
in use, the estimated future cash flows are discounted to their present value using a pre-tax discount rate that reflects current market
assessments of the time value of money and the risks specific to the asset. In determining fair value less costs of disposal, recent
market transactions are taken into account. If no such transactions can be identified, an appropriate valuation model is used. These
calculations are corroborated by valuation multiples, quoted share prices for publicly traded companies or other available fair value
indicators.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company bases
its impairment calculation on detailed budgets and forecast calculations, which are prepared separately for each of the Company&#x2019;s
CGUs to which the individual assets are allocated. These budgets and forecast calculations generally cover a period of five years, considering
the companies activities and maturation period of its graduate and undergraduate courses. A long-term growth rate is calculated and applied
to project future cash flows after the last projected year.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For impairment
testing, goodwill acquired through business combinations and licenses with indefinite useful lives are allocated to their respective
CGUs. The Company has defined each of its operating subsidiaries as a CGU, except for &#x201c;Practice Management Tools &amp;amp; Electronic
Prescription&#x201d; and &#x201c;Clinical Decision Software&#x201d; where the subsidiaries were combined as one CGU following the business
strategic pillars and &#x201c;Moc&#x201d; where we have 2 different educational institution operating in the same municipality (Montes
Claros).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Whenever applicable,
impairment losses of continuing operations are recognized in the statement of income in expense categories consistent with the function
of the impaired asset.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For assets excluding
goodwill, an assessment is made at each reporting date to determine whether there is an indication that previously recognized impairment
losses no longer exist or have decreased. If such indication exists, the Company estimates the asset&#x2019;s or CGU&#x2019;s recoverable
amount. A previously recognized impairment loss is reversed only if there has been a change in the assumptions used to determine the
asset&#x2019;s recoverable amount since the last impairment loss was recognized. The reversal is limited so that the carrying amount of
the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation,
had no impairment loss been recognized for the asset in prior years. Such reversal is recognized in the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Goodwill is tested
for impairment annually as at December 31 and when circumstances indicate that the carrying value may be impaired.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Impairment is determined
for goodwill by assessing the recoverable amount of each CGU (or group of CGUs) to which the goodwill relates. When the recoverable amount
of the CGU is less than its carrying amount, an impairment loss is recognized. Impairment losses relating to goodwill cannot be reversed
in future periods.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets
with indefinite useful lives are tested for impairment annually as at December 31 at the CGU level, as appropriate, and when circumstances
indicate that the carrying value may be impaired.&lt;/span&gt;&lt;/p&gt;

</afya:ImpairmentOfNonfinancialAssetsPolicyExplanatory>
    <afya:PolicyExplanatoryInvestments contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_840_ecustom--PolicyExplanatoryInvestments_zp92p4k14z53" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86D_zm2GPpW2ebch"&gt;l)
Investments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Investments in
associates are initially recognized at consideration transferred and adjusted thereafter for the equity method, being increased or reduced
from its interest in the investee's income after the acquisition date. An associate is an entity over which the Company has significant
influence. Significant influence is the power to participate in the financial and operating policy decisions of the investee, but is
not control or joint control over those policies.&lt;/span&gt;&lt;/p&gt;

</afya:PolicyExplanatoryInvestments>
    <afya:AccountsPayableToSellingShareholdersPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_840_ecustom--AccountsPayableToSellingShareholdersPolicyExplanatory_z7Btth29dxk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_865_zjIKH8Rtxiph"&gt;m)
Accounts payable to selling shareholders&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;These amounts represent
liabilities related to the acquisitions made by the Company which are not yet due. Accounts payable to selling shareholders are presented
as current liabilities unless payment is not due within 12 months after the reporting period. They are recognized initially at their
fair value and subsequently measured at amortized cost using the effective interest method.&lt;/span&gt;&lt;/p&gt;

</afya:AccountsPayableToSellingShareholdersPolicyExplanatory>
    <ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_848_eifrs-full--DescriptionOfAccountingPolicyForProvisionsExplanatory_zYxyM6o1glsk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_862_zazXTRkSedzl"&gt;n)
Provisions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Provisions are
recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probable that an outflow
of resources embodying economic benefits will be required to settle the obligation, and a reliable estimate can be made of the amount
of the obligation. The expense relating to a provision is presented in the statement of income, net of any reimbursement, when applicable.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DescriptionOfAccountingPolicyForProvisionsExplanatory>
    <afya:DividendsPayablePolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_842_ecustom--DividendsPayablePolicyExplanatory_z397t1pS5jC3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86E_z15jdl7MGCZ3"&gt;o)
Dividends payable&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company recognizes
a liability to pay a dividend when the distribution is authorized and the distribution is no longer at the discretion of the Company.
The distribution is authorized when it is required to pay a minimum dividend of the net income for the year in accordance with the Brazilian
Corporate Law (applicable for Afya Brazil) and the Company&#x2019;s By-Laws or is approved by the shareholders. A corresponding amount
is recognized directly in equity.&lt;/span&gt;&lt;/p&gt;

</afya:DividendsPayablePolicyExplanatory>
    <afya:LaborAndSocialObligationsPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84E_ecustom--LaborAndSocialObligationsPolicyExplanatory_zyuMWjV52mJk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_86B_zInMviYYmc74"&gt;p)
Labor and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Labor and social
obligations are expensed as the related service is provided. A liability is recognized for the amount expected to be paid if the Company
has a present legal or constructive obligation to pay this amount as a result of past service provided by the employee and the obligation
can be estimated reliably.&lt;/span&gt;&lt;/p&gt;

</afya:LaborAndSocialObligationsPolicyExplanatory>
    <afya:SharebasedPaymentsPolicyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_846_ecustom--SharebasedPaymentsPolicyExplanatory_zmQw3Ia7vck7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_864_zEpxtV9J1cY"&gt;q)
Share-based payments&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Certain key executives
of the Company receive remuneration in the form of share-based payments, whereby the executives render services as consideration for
equity instruments (equity-settled transactions).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The expense of
equity-settled transactions is determined by the fair value at the date when the grant is made using an appropriate valuation model.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;That expense is
recognized in general and administrative expenses, together with a corresponding increase in equity, over the period in which the service
and, where applicable, the performance conditions are fulfilled (the vesting period). The cumulative expense recognized for equity-settled
transactions at each reporting date until the vesting date reflects the extent to which the vesting period has expired and the Company&#x2019;s
best estimate of the number of equity instruments that will ultimately vest. The expense or credit in the statement of income for a period
represents the movement in cumulative expense recognized as at the beginning and end of that period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Service and non-market
performance conditions are not taken into account when determining the grant date fair value of awards, but the likelihood of the conditions
being met is assessed as part of the Company&#x2019;s best estimate of the number of equity instruments that will ultimately vest. Market
performance conditions are reflected within the grant date fair value. Any other conditions attached to an award, but without an associated
service requirement, are considered to be non-vesting conditions. Non-vesting conditions are reflected in the fair value of an award
and lead to an immediate expensing of an award unless there are also service and/or performance conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;No expense is recognized
for awards that do not ultimately vest because non-market performance and/or service conditions have not been met. Where awards include
a market or non-vesting condition, the transactions are treated as vested irrespective of whether the market or non-vesting condition
is satisfied, provided that all other performance and/or service conditions are satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;When the terms
of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided
the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any
modification that increases the total fair value of the share-based payment transaction, or is otherwise beneficial to the employee.
Where an award is cancelled by the entity or by the counterparty, any remaining element of the fair value of the award is expensed immediately
through the statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The dilutive effect
of outstanding options is reflected as additional share dilution in the computation of diluted earnings per share.&lt;/span&gt;&lt;/p&gt;

</afya:SharebasedPaymentsPolicyExplanatory>
    <ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_847_eifrs-full--DisclosureOfRevenueFromContractsWithCustomersExplanatory_zIAU51gxhdvc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_869_zuG4RQveJnAk"&gt;r)
Revenue from contracts with customers&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Tuition fees
and other revenue&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company's revenue
consists primarily of tuition fees charged for medical courses. The Company also generates revenue from tuition fees for other undergraduate
courses, student fees, certain education-related activities, digital education content and subscription of digital services.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenues are recognized
when services are rendered to the customer and the performance obligation is satisfied.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenue from tuitions
and digital education content are recognized over time when services are rendered to the customer and the Company satisfies its performance
obligation under the contract at an amount that reflects the consideration to which the Company expects to be entitled in exchange for
those services. Revenues from tuitions are recognized net of scholarships and other discounts, refunds and taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Other revenues
are recognized at a point in time when the service is rendered to the customer at an amount that reflects the consideration to which
the Company expects to be entitled in exchange for the service. Other revenues are presented net of the corresponding discounts, returns
and taxes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Printed books,
e-books, healthcare payments, online platforms and marketing for pharmaceutical industry revenues are transferred at point in time&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Revenue from sale
of printed books, e-books, healthcare payments, online platforms and marketing for pharmaceutical industry are recognized at the point
in time when control of the asset or services is transferred to the customer, generally on delivery of the goods at the customer&#x2019;s
location and permission to access the digital content. The Company considers whether there are other promises in the contract that are
separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price
for the printed books and e-books, the Company considers the effects of variable consideration, financing component, noncash consideration,
and consideration payable to the customer to be not significant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
concluded that it is the principal in its revenue arrangements.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company assesses
collectability on a portfolio basis prior to recording revenue. Generally, students cannot re-enroll for the next academic session without
satisfactory resolution of any past-due amounts. If a student withdraws from an institution, the Company's obligation to issue a refund
depends on the refund policy at that institution and the timing of the student's withdrawal. Generally, the refund obligations are reduced
over the course of the academic term.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Trade
receivables &lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Trade receivables
represent the Company&#x2019;s right to an amount of consideration that is unconditional (i.e., only the passage of time is required before
payment of the consideration is due). Refer to accounting policies of financial assets in Financial instruments &#x2013; initial recognition
and subsequent measurement.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Advances
from customers&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Advances from customers
(a contract liability) are the obligation to transfer services to a customer for which the Company has received consideration (or an
amount of consideration is due) from the customer, as a result of pre-paid tuition, digital education content and mobile app subscription
for digital medical content received from customers and is recognized separately in current liabilities, when the payment is received.
Advances from customers are recognized as revenue when the Company performs all obligations related to the contract, generally in the
following month.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueFromContractsWithCustomersExplanatory>
    <afya:TaxesPolicyExplanation contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_84F_ecustom--TaxesPolicyExplanation_z5qycgmF9NF1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_868_z8LSmzg94np6"&gt;s)
Taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
Company&#x2019;s subsidiaries joined the PROUNI (&lt;i&gt;Programa Universidade para Todos &#x2013; &lt;/i&gt;University for All Program) program,
which is a federal program that exempts post-secondary institutions of some federal taxes in exchange for providing a certain number
of student enrollment for low-income students, and benefits from the exemption of the following federal taxes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&#x2022;&#160;&#160;&#160;&#160;&#160;&#160;&#160;Income
taxes and social contribution&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&#x2022;&#160;&#160;&#160;&#160;&#160;&#160;&#160;PIS
and COFINS&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
regulation of PROUNI defines that the revenue from traditional and technological graduation activities is exempt from PIS and COFINS.
For income from other teaching activities, PIS and COFINS are charged at rates of &lt;span id="xdx_907_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_z6M7MuXIJc7j" title="Tax rate"&gt;0.65&lt;/span&gt;% and &lt;span id="xdx_90C_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--TeachingActivitiesMember_zQWtielBNzl6" title="Tax rate"&gt;3.00&lt;/span&gt;%, respectively, and for non-teaching
activities, PIS is charged at a rate of &lt;span id="xdx_90D_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ProgramOfSocialIntegrationMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_znwbL7c5ouAg" title="Tax rate"&gt;1.65&lt;/span&gt;% and to COFINS at &lt;span id="xdx_905_eifrs-full--ApplicableTaxRate_dp_c20210101__20211231__custom--TaxAuthorityAxis__custom--ContributionForTheFinancingOfSocialSecurityMember__ifrs-full--ProductsAndServicesAxis__custom--NonTeachingActivitiesMember_zW2vj2NmWk9b" title="Tax rate"&gt;7.6&lt;/span&gt;%.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&lt;i&gt;Current
income taxes&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;Current
income taxes were calculated based on the criteria established by the Normative Instruction of the Brazilian Internal Revenue Service,
specifically regarding the PROUNI program, which allows exemption of these taxes from traditional and technological graduation activities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Current income
tax assets and liabilities are measured at the amount expected to be recovered from or paid to the taxation authorities. The tax rates
and tax laws used to compute the amount are those that are enacted or substantively enacted at the reporting date.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Management periodically
evaluates positions taken in the tax returns with respect to situations in which applicable tax regulations are subject to interpretation
and establishes provisions where appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2.4
Changes in accounting policies and disclosures&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;i&gt;New
standards, interpretations and amendments adopted by the Company&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Certain amendments
apply for the first time in 2021, but do not have an impact on these financial statements of the Company.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not early adopted any standard, interpretation or amendment that has been issued but is not yet effective.&lt;/span&gt;&lt;/p&gt;

</afya:TaxesPolicyExplanation>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember"
      decimals="INF"
      unitRef="Pure">0.0065</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_TeachingActivitiesMember"
      decimals="INF"
      unitRef="Pure">0.0300</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      unitRef="Pure">0.0165</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-012021-12-31_custom_ContributionForTheFinancingOfSocialSecurityMember_custom_NonTeachingActivitiesMember"
      decimals="INF"
      unitRef="Pure">0.076</ifrs-full:ApplicableTaxRate>
    <afya:SignificantAccountingEstimatesAndAssumptionsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_ecustom--SignificantAccountingEstimatesAndAssumptionsExplanatory_zzeUm1K0YJg7" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: bold 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;3&lt;/span&gt;&lt;/td&gt;&lt;td id="xdx_82D_zVay4qDcM8oj"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Significant
                                            accounting estimates and assumptions&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The preparation
of the Company&#x2019;s consolidated financial statements requires management to make judgments, estimates and assumptions that affect
the reported amounts of revenues, expenses, assets and liabilities, and the accompanying disclosures. Uncertainty about these assumptions
and estimates could result in outcomes that require a material adjustment to the carrying amount of assets or liabilities affected in
future periods. Accounting estimates and judgments are continually evaluated and are based on historical experience and other factors,
including expectations of future events that are believed to be reasonable under the circumstances. Revisions to estimates are recognized
prospectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Other disclosures
relating to the Company&#x2019;s exposure to risks and uncertainties includes:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Capital management &#x2013; Note 15&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Financial instruments risk management objectives and
policies &#x2013; Note 13.4&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;&#x2022;&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;
&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;Sensitivity analyses disclosures &#x2013; Note 13.4.1&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Estimates
and assumptions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The key assumptions
about the future and other key sources of estimated uncertainty as of the reporting date that include a significant risk of a material
adjustment to the carrying amounts of assets and liabilities within the next financial year, are described below. The Company based its
assumptions and estimates on parameters available when the consolidated financial statements were prepared. Existing circumstances and
assumptions about future developments, however, may change due to market changes or circumstances that arise and that are beyond the
Company&#x2019;s control. Such changes are reflected in the assumptions when they occur.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Identification
and fair-value measurement of assets and liabilities acquired in a business combination&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Business combinations
are accounted for using the acquisition method. Such method requires recognizing and measuring the identifiable assets acquired, the
liabilities assumed and any non-controlling interest in the acquiree. The Company, as the acquirer, must classify or designate the identifiable
assets and liabilities assumed on the basis of its own contractual terms, economic conditions, operating and accounting policies and
other relevant conditions as at the acquisition date. Such assessment requires judgments from the Company on the methods used to determine
the fair value of the assets acquired and liabilities assumed, including valuation techniques that may require prospective financial
information inputs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Impairment
of non-financial assets&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Impairment exists
when the carrying value of an asset or cash generating unit (&#x201c;CGU&#x201d;) or group of CGUs exceeds its recoverable amount, defined
as the higher of its fair value less costs of disposal and its value in use. The fair value less costs of disposal calculation is based
on data available from binding sales transactions, conducted at arm&#x2019;s length, for similar assets or observable market prices less
incremental costs of disposing of the asset. The value in use calculation is based on a discounted cash flow model (&#x201c;DCF&#x201d;
model). The cash flows are derived from the budget for the next five years and do not include restructuring activities to which the Company
has not yet committed or significant future investments that will enhance the performance of the assets of the CGU being tested. The
recoverable amount is sensitive to the discount rate used for the DCF model as well as to expected future cash-inflows and the growth
rate used for extrapolation purposes.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;These estimates
are most relevant to goodwill and indefinite lived intangible assets recognized by the Company. The key assumptions used to determine
the recoverable amount for each CGU, including a sensitivity analysis, are disclosed and further explained in Note 12.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Share-based
compensation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Estimating fair
value for share-based payment transactions requires determination of the most appropriate valuation model, which depends on the terms
and conditions of the grant. This estimate also requires determination of the most appropriate inputs to the valuation model including
the expected life of the share option or appreciation right, volatility and dividend yield and making assumptions about them. For the
measurement of the fair value of equity-settled transactions, the Company uses the Binomial model. As disclosed in Note 16 (b) the Company
had stock plans that were fully exercised on July 31, 2019, for which the Monte Carlo and Black &amp;amp; Scholes pricing model were used
for the Afya Brazil and Guardaya plans, respectively. The assumptions and models used for estimating fair value for share-based payment
transactions are disclosed in Note 16 (b).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Leases
- Estimating the incremental borrowing rate&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #263238"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company cannot
readily determine the interest rate implicit in the lease, therefore, it uses its incremental borrowing rate (IBR) to measure lease liabilities.
The IBR is the rate of interest that the Company would have to pay to borrow over a similar term, and with a similar security, the funds
necessary to obtain an asset of a similar value to the right-of-use asset in a similar economic environment. The IBR therefore reflects
what the Company &#x2018;would have to pay&#x2019;, which requires estimation when no observable rates are available (such as for subsidiaries
that do not enter into financing transactions) or when they need to be adjusted to reflect the terms and conditions of the lease (for
example, when leases are not in the subsidiary&#x2019;s functional currency).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company estimates
the IBR using observable inputs (such as market interest rates) when available and is required to make certain entity-specific estimates.&lt;/span&gt;&lt;/p&gt;

</afya:SignificantAccountingEstimatesAndAssumptionsExplanatory>
    <ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_806_eifrs-full--DisclosureOfEntitysReportableSegmentsExplanatory_zXiee9PB0UD8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;4&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_822_zPsVcVvCGsik"&gt;Segment
                                            information&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;During
2021, in connection with the recent acquisitions of digital and technology companies, the Company revised its operating segments. As
result, the Company has three operating segments as opposed to the previously reported Business Unit 1 (educational services through
undergraduate and graduate courses related to medicine, other health sciences and other undergraduate programs) and Business Unit 2 (residency
preparatory courses and medical post-graduate specialization programs, delivering printed and digital content, an online medical education
platform). The three reportable segments are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Undergrad, which provides educational services through undergraduate courses related to medicine, other health sciences and other undergraduate
programs;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022;
Continuing Education, which provides specialization programs and graduate courses; and&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#x2022; Digital
Services, which provides content and technology for medical education, clinical decisions software, practice management tools and electronic
medical records, doctor-patient relationship, telemedicine and digital prescription.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Due
to changes in operating segments, the segment information for the years ended December 31, 2020 and 2019 have been restated. Segment
information is presented consistently with the internal reports provided to the Company's Chief Executive Officer (CEO), which is the
Chief Operating Decision Maker (CODM) and is responsible for allocating resources, assessing the performance of the Company's operating
segments, and making the Company's strategic decisions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;No
operating segments have been aggregated to form the above reportable operating segments. There is only one geographic region and the
results are monitored and evaluated as a single business.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zUXaad5h7Mt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The following tables
presents assets and liabilities information for the Company&#x2019;s operating segments as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_8BD_z6Dl3226OiKg" style="display: none; visibility: hidden"&gt;Schedule of assets and liabilities information for the company's operating segments&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8MLTeLTx8Eg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,072,135
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbVFzSw7bDIh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;105,629&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3yTtB30bp4f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;272,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuz4SrTqbpZg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,449,886&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zVZBuUmI6Jl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,480)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCZHCBnPwmC3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,447,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCiYwv2SGRb2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,048,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSH91O5qMXPh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVxSdq2WUk5c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;117,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziklBiCLTjgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,209,332&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU9TCYrspu92" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,480)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvNdOu3kDsO6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,206,852&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7XcCkhEw8Ae" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,023,266&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zA5VsNbylyS" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,892&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6nefN7y2TRa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;154,396&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkVTThyKJ84j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,240,554&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zitjGMD2cAI5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zp1ta45AlkXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,240,554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7DmuYsO6lZ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,072,135&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zP4GuCZng308" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;105,629&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXnKRcfMoZu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;272,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdf9esFrs6Vi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,449,886&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGGsJ8njCp6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,480)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfIsZb6DBfki" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,447,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z73qH9UhnQMb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;645,657&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfbTKIYCgO4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,300&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzXJcgzmKX24" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91,029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyNFrZLEm6b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;768,986&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z9Y0teMUP8hc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;(2,480)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL785sASxyQj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;766,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zMh8wjNmNWph" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,551,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVkQP8DwOvo2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;47,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znm34ac8P3fd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82,002&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJofVDjsfYvl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,680,882&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMP1pP9NayAe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1328"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeODj5QqzXEj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,680,882&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zNPkui3JDCXb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,303&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLV03pSCs0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,624&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zhSqjOhCy4kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;99,091&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zo9OCkJrIsqc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zRZ9hVcHk6sf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1335"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zudpHTwC1Sda" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other
    disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments
    in associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxW6GOyh5p6a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXztkO1pXN8c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zlgayYjOO0Xl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1340"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYk7FhznPFY6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zV9f0OAq88Kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1342"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfLt9c28re4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital
    expenditures &lt;sup id="xdx_F43_zEiPbqoS5K5k"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_z8Z07kclveO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;220,202&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zOHURYnnL0hj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,682&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zj2qXv5ttDLc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,095&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_z5zVSU1kxZ9c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;301,979&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zOUZ2Z6wHbk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_zi078UuCD8pe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;301,979&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVM7VrXO608a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,541,988
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgIQqf9KZOw2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,300
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBrPaJfVEQX" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182,920
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmcTOdyXAnV1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,208
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTHUBYo8pXS1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(115)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIshRjt5PAn3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,093
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlYP8VQec1Mk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,280,342
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeRXNhOfbFFh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,119
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zwTtaq8T745l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;85,155
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKj5GPP3vy68" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,405,616
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsxs1kTY0l7g" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(115)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zakpQFwpXwT2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,405,501
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zWNHMq6L4Tkj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,261,646
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTdLd7DQ7cgb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,181
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ze5H4zjymO34" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;97,765
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIofv54SBTtf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,387,592
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z6rLjJ6vCvi4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,387,592
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLXdI8yhvmak" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,541,988
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOroIN3xZ24b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,300
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ztksHlB6YDT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182,920
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zEXJwQlkTYr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,208
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zBuTUknHMrZ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(115)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfgSZbUDFxJ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,093
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeFbQFXF3xR9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;522,523
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zZcVnQoBRGV7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,491
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zebGn39LZbCb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52,480
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkz0YGcVv4l7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;589,494
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zWpbe1lNJVR5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(115)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKQeG0M01CU8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;589,379
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zfTLFbhfvCF1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,261,894
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwEQrwHchIYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,763
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2GNB2dTMx56" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,277
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZAp55oRudYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,369,934
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zEewhR4q3msk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,369,934
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z5ZIZhCCkTj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,757,571
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z6yHBhIeJSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,046
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEK6hJIjxKN5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,163
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQfDgxPUEnhi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,833,780
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrtD1T8lsJq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,833,780
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other
    disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments
    in associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhMOYSlizIT5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfgWOhPRxtxj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo5DwTYI56Q8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital
    expenditures &lt;sup id="xdx_F4C_zBxKJImE4Crc"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_zMVvAvt1rHAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;83,256&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zazZPeAwVhs1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zAimAi2DWkI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,587&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_zxE3Uosvryii" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;109,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_z03yDhCO92Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;109,481&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 35pt; text-align: right"&gt;&lt;span id="xdx_F0C_zR84OS3BjgG3" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_ziC9kXBmC7V2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Capital expenditures consider
the acquisitions of property and equipment and intangible assets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A8_z6yXhYAnCmR1" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p id="xdx_896_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zsa5CU9Jbtv4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The following tables
present the statements of income for the Company&#x2019;s operating segments for the years ended December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zjn7d2J1ixD2" style="display: none; visibility: hidden"&gt;Schedule of operating income for each operating segment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zmCnusGSmTfg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,498,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQIOTgtMh26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP54ICgmDHU7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,980&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zK07raONaxBh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcfR1uGvSje5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1419"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09UC1Zy5hn" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zw5AvcJretxf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zNSYD9ibSAMj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0tl7xWgZSBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zO22ITfRij4b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z6xohWGDzlxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn66q1dembFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_ztPUOoJKQnmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRp5ZA1qfWih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJnYCEH3PiY2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ztEZXNY4shc3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,723,349&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zKZd8vNxlyda" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfHKcGZgZhA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zx3qtbk8jZNk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(554,995)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zyT8JV2Gp2U2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,773)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zqDEZH2cnAag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,510)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z66YXzCxRKh7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(656,278)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zur3vkJqsUf7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlYx00wRNTQe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z9QS1YcnAoP2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;943,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrBxOB0cCMi9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,210&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z9H6NAmQohve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhu6XTtM69Sk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zLGmCzyOfPOc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1448"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlW6DFTP8wj5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYDcXnseYfuk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    income, net&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zwAh4f6K9YW5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1452"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zK48EaYqAVOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1453"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvFclGluazB7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYvCHApM9xM5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zatEsAm3vxq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBH76Aw3eNwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zPLBOq91G2Rg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1459"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOFVsb2qbo7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1460"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znKL3ekNOds1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1461"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfFwq4OQufba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1462"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSYy2ypOt0Fl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1463"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDnIGbt5P0vk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;440,895&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zZqpsQUYwAZj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSITHa1kksR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1467"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zbQJAAMWjr9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1468"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuLoiW7eLipg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4v3e95oYAil" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54jzkPM69a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbXTcDAbzuue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1473"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbP00rn6ptme" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1474"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFT7e649bJm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSnJm8O1U3G8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zQV7Jyq4FzOe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1477"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFv2ki8MtSkh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(243,796)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVeZqdFjTOF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zq3wPYfIg6A6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zdqkjn5rkXlh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zv9SJIrkjH6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znauMNkCHoFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGFvtvNu9mU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zXocjNwis6fa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1487"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zG5u25ptKUwl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAP6Gsmv2A1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1489"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk12QYpcqIQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1490"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zIW64Gu5WRx8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1491"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z9wnRO1YUqL8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLC2mhBVl89k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRZMGfEXIET9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1495"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVJ1BEjQ8KHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1496"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zANwLJS6iHo3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4o67f8H9fc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM9XoS9scxrd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,179)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrcm1bEkq25f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1501"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zapeaLWLGu58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3V2t2MyAd77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1503"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zsVVHwddoLa2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsnawhcfXuza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUctAe4vVO5c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;242,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDC8UDO21mWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,002,461&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zEcx1To2S5m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zCH41Ch9sFRh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfpKqpzJfUT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,201,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNl0cA8uXSQl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,201,191&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXBGfLYjAsS1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6CYVJGfNnsc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcBy1toXIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zEkbeKC8ZqCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zo1e8oIrAxHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvwSFLaOvOs3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zywJFkXLb6Jl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,202,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zO6vs1JNkWRl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcXG2AIYDrG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeCn3gsLjny3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(381,964)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwL2IG2m6mok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(40,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zsUj6uQQ7cWd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,309)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zybx7Xnboczd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(436,273)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU3lLMUxiZpf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOHk0pFEBM2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(434,654)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zelGlg74jymd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;620,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJO5ZwVr7Mt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;67,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znsxjwm2z3lc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;78,843&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdcwavh3dSy2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;766,537&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM6vuMDtlXz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;766,537&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn6SsoOwGUxl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="General and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(402,855)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherGainsLosses_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJFBo8Q9APe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNoO3yoMY3O3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;363,335&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinanceIncome_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zU6qk3y1QKU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,290&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinanceExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHlk40GClwb4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(98,269)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyAfEr5VyH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,698&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossBeforeTax_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLEu9Zpk7vNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;335,054&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zi8fEVN7iCmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(27,067)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLoss_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLik8i0J3mTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;307,987&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zoqVZTyudwld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;653,760&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhdvTR31m8K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,870&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zykdxQd49jg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSRuobNwycId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;750,630&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQ2kRrUNrq3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;750,630&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2Q5Ljpj6918" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zRdQikltGF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm42aORow3vb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhoksJcN7Vu5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvGXbNp8r0h1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAZqhNaTN5g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7wlWUORR2K4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;754,510&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ziVhZtMXnQ5j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmUAZA7lHE82" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPnzwgkBt38" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(279,066)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zh9iqzRdBhV8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(29,261)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z60TTF6PBJdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,406)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAy7VCyaMOY6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(312,733)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zhseQ1vqhRZ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdd4gtywTZM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(308,853)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxEUKwLLX7Eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;374,694&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdZiUuhYcQT9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;35,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrNW4RggKXLf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,474&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zNcqykE2YGdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;441,777&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zu2MRhWGTqd9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;441,777&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HwfjymDrrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(239,120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherGainsLosses_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8Lo6rOZeQPl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,594&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOepLPYaDEV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;205,251&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinanceIncome_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3DWf5MzwPCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinanceExpense_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5xhI8ZChiL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(72,365)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zS5vJ0Cwy856" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,362&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWiU1UMM1rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;186,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKsLvStPHT25" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,175)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXJCMcLQLWZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;172,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zRe6tM3JCC43" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Seasonality
of operations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Undergrad
&#xb4;s and Continuing Education tuition revenues are related to the intake process and monthly tuition fees charged to students over
the period thus the Company do not have significant fluctuations during the semester.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Digital Services
are comprised mostly by Medcel, Pebmed and iClinic revenues. While Pebmed and iClinic do not have significant fluctuation regarding seasonality,
Medcel revenues are concentrated in the first and last quarter of the year, as a result of enrollments of Medcel&#x2019;s clients period.
The majority of Medcel&#x2019;s revenues is derived from printed books and e-books, which are recognized at the point in time when control
is transferred to the customer. Consequently, Digital Services segment generally has higher revenues and results of operations in the
first and last quarter of the year compared to the second and third quarters of the year.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory>
    <afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_ecustom--ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory_zUXaad5h7Mt9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The following tables
presents assets and liabilities information for the Company&#x2019;s operating segments as of December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span id="xdx_8BD_z6Dl3226OiKg" style="display: none; visibility: hidden"&gt;Schedule of assets and liabilities information for the company's operating segments&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z8MLTeLTx8Eg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,072,135
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbVFzSw7bDIh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;105,629&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3yTtB30bp4f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;272,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuz4SrTqbpZg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,449,886&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zVZBuUmI6Jl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,480)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Assets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zCZHCBnPwmC3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,447,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zCiYwv2SGRb2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,048,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSH91O5qMXPh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVxSdq2WUk5c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;117,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ziklBiCLTjgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,209,332&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU9TCYrspu92" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,480)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zvNdOu3kDsO6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,206,852&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7XcCkhEw8Ae" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,023,266&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zA5VsNbylyS" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,892&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z6nefN7y2TRa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;154,396&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkVTThyKJ84j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,240,554&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zitjGMD2cAI5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1306"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zp1ta45AlkXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,240,554&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z7DmuYsO6lZ2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,072,135&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zP4GuCZng308" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;105,629&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXnKRcfMoZu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;272,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdf9esFrs6Vi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,449,886&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zGGsJ8njCp6d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,480)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--EquityAndLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfIsZb6DBfki" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,447,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z73qH9UhnQMb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;645,657&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zfbTKIYCgO4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,300&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zzXJcgzmKX24" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91,029&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zyNFrZLEm6b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;768,986&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z9Y0teMUP8hc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;(2,480)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zL785sASxyQj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;766,506&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zMh8wjNmNWph" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,551,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zVkQP8DwOvo2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;47,705&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znm34ac8P3fd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82,002&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zJofVDjsfYvl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,680,882&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zMP1pP9NayAe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1328"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentLiabilities_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zeODj5QqzXEj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,680,882&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zNPkui3JDCXb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,875,303&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLV03pSCs0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,624&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zhSqjOhCy4kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;99,091&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zo9OCkJrIsqc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zRZ9hVcHk6sf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1335"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zudpHTwC1Sda" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other
    disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments
    in associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxW6GOyh5p6a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zXztkO1pXN8c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1339"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zlgayYjOO0Xl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1340"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYk7FhznPFY6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zV9f0OAq88Kc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1342"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InvestmentsInAssociates_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zxfLt9c28re4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,477&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital
    expenditures &lt;sup id="xdx_F43_zEiPbqoS5K5k"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_z8Z07kclveO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;220,202&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zOHURYnnL0hj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,682&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zj2qXv5ttDLc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,095&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_z5zVSU1kxZ9c" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;301,979&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_fKCop_zOUZ2Z6wHbk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1349"&gt;&#160;&lt;/span&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CapitalExpenditures_iI_c20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_zi078UuCD8pe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;301,979&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVM7VrXO608a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,541,988
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zgIQqf9KZOw2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,300
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zBrPaJfVEQX" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182,920
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zmcTOdyXAnV1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,208
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zTHUBYo8pXS1" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(115)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Assets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zIshRjt5PAn3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,093
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zlYP8VQec1Mk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,280,342
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zeRXNhOfbFFh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,119
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zwTtaq8T745l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;85,155
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zKj5GPP3vy68" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,405,616
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsxs1kTY0l7g" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(115)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zakpQFwpXwT2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,405,501
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zWNHMq6L4Tkj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,261,646
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zTdLd7DQ7cgb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,181
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ze5H4zjymO34" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;97,765
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zIofv54SBTtf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,387,592
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NoncurrentAssets_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z6rLjJ6vCvi4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,387,592
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    liabilities and equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLXdI8yhvmak" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total liabilities and equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,541,988
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOroIN3xZ24b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,300
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_ztksHlB6YDT6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182,920
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zEXJwQlkTYr4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,208
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zBuTUknHMrZ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(115)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--EquityAndLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfgSZbUDFxJ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,793,093
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeFbQFXF3xR9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;522,523
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zZcVnQoBRGV7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,491
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zebGn39LZbCb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52,480
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zkz0YGcVv4l7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;589,494
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zWpbe1lNJVR5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(115)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKQeG0M01CU8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;589,379
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zfTLFbhfvCF1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,261,894
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwEQrwHchIYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;40,763
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2GNB2dTMx56" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,277
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zZAp55oRudYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,369,934
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLiabilities_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zEewhR4q3msk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,369,934
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Equity&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z5ZIZhCCkTj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Equity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,757,571
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z6yHBhIeJSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,046
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zEK6hJIjxKN5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;63,163
    &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zQfDgxPUEnhi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,833,780
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Equity_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zrtD1T8lsJq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,833,780
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Adjustments
    and eliminations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other
    disclosures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Investments
    in associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhMOYSlizIT5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Investments in associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfgWOhPRxtxj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--InvestmentsInAssociates_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zo5DwTYI56Q8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Capital
    expenditures &lt;sup id="xdx_F4C_zBxKJImE4Crc"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_fKCop_zMVvAvt1rHAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Capital expenditures"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;83,256&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_fKCop_zazZPeAwVhs1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_fKCop_zAimAi2DWkI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,587&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_fKCop_zxE3Uosvryii" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;109,481&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--CapitalExpenditures_iI_c20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_fKCop_z03yDhCO92Yb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;109,481&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 35pt; text-align: right"&gt;&lt;span id="xdx_F0C_zR84OS3BjgG3" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_ziC9kXBmC7V2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Capital expenditures consider
the acquisitions of property and equipment and intangible assets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">6072135000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">105629000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">272122000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">6449886000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-2480000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">6447406000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1048869000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">42737000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">117726000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1209332000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-2480000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1206852000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">5023266000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">62892000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">154396000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">5240554000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">5240554000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">6072135000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">105629000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">272122000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">6449886000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-2480000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">6447406000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">645657000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">32300000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">91029000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">768986000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-2480000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">766506000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">2551175000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">47705000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">82002000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">2680882000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">2680882000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">2875303000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">25624000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">99091000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">3000018000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">3000018000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001345"
      unitRef="BRL">220202000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001346"
      unitRef="BRL">25682000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001347"
      unitRef="BRL">56095000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001348"
      unitRef="BRL">301979000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001350"
      unitRef="BRL">301979000</afya:CapitalExpenditures>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">4541988000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">68300000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">182920000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">4793208000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-115000</ifrs-full:Assets>
    <ifrs-full:Assets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">4793093000</ifrs-full:Assets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1280342000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">40119000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">85155000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1405616000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-115000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1405501000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">3261646000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">28181000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">97765000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">3387592000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">3387592000</ifrs-full:NoncurrentAssets>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">4541988000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">68300000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">182920000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">4793208000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-115000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:EquityAndLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">4793093000</ifrs-full:EquityAndLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">522523000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">14491000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">52480000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">589494000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-115000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">589379000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1261894000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">40763000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">67277000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1369934000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1369934000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">2757571000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">13046000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">63163000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">2833780000</ifrs-full:Equity>
    <ifrs-full:Equity
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">2833780000</ifrs-full:Equity>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <afya:CapitalExpenditures
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      id="Fact001402"
      unitRef="BRL">83256000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      id="Fact001403"
      unitRef="BRL">12638000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      id="Fact001404"
      unitRef="BRL">13587000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      id="Fact001405"
      unitRef="BRL">109481000</afya:CapitalExpenditures>
    <afya:CapitalExpenditures
      contextRef="AsOf2020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      id="Fact001406"
      unitRef="BRL">109481000</afya:CapitalExpenditures>
    <ifrs-full:DisclosureOfOperatingSegmentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_eifrs-full--DisclosureOfOperatingSegmentsExplanatory_zsa5CU9Jbtv4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The following tables
present the statements of income for the Company&#x2019;s operating segments for the years ended December 31, 2021 and 2020:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zjn7d2J1ixD2" style="display: none; visibility: hidden"&gt;Schedule of operating income for each operating segment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zmCnusGSmTfg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,498,408&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzQIOTgtMh26" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zP54ICgmDHU7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,980&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zK07raONaxBh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_pn3n3_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcfR1uGvSje5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1419"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z09UC1Zy5hn" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,719,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zw5AvcJretxf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inter-segment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1423"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zNSYD9ibSAMj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1424"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z0tl7xWgZSBf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zO22ITfRij4b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z6xohWGDzlxa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--InterSegment_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn66q1dembFk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1428"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_ztPUOoJKQnmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRp5ZA1qfWih" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJnYCEH3PiY2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_ztEZXNY4shc3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,723,349&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zKZd8vNxlyda" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zfHKcGZgZhA2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zx3qtbk8jZNk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(554,995)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zyT8JV2Gp2U2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,773)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zqDEZH2cnAag" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(50,510)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z66YXzCxRKh7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(656,278)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zur3vkJqsUf7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,978&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CostOfSales_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlYx00wRNTQe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_z9QS1YcnAoP2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;943,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zrBxOB0cCMi9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;22,210&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z9H6NAmQohve" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;101,448&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zhu6XTtM69Sk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zLGmCzyOfPOc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1448"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zlW6DFTP8wj5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,067,071&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zYDcXnseYfuk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    income, net&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zwAh4f6K9YW5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1452"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zK48EaYqAVOj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1453"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvFclGluazB7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1454"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zYvCHApM9xM5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1455"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zatEsAm3vxq1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1456"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherGainsLosses_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zBH76Aw3eNwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,561)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zPLBOq91G2Rg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1459"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zOFVsb2qbo7i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1460"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znKL3ekNOds1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1461"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfFwq4OQufba" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1462"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zSYy2ypOt0Fl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1463"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--ProfitLossFromOperatingActivities_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zDnIGbt5P0vk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;440,895&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zZqpsQUYwAZj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1466"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zSITHa1kksR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1467"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zbQJAAMWjr9c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1468"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zuLoiW7eLipg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1469"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4v3e95oYAil" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1470"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinanceIncome_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z54jzkPM69a4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,566&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zbXTcDAbzuue" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1473"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zbP00rn6ptme" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1474"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zFT7e649bJm3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1475"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSnJm8O1U3G8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1476"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zQV7Jyq4FzOe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1477"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--FinanceExpense_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zFv2ki8MtSkh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(243,796)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zVeZqdFjTOF2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zq3wPYfIg6A6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1481"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zdqkjn5rkXlh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1482"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zv9SJIrkjH6l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1483"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_znauMNkCHoFc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1484"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zGFvtvNu9mU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zXocjNwis6fa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1487"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zG5u25ptKUwl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1488"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAP6Gsmv2A1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1489"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zk12QYpcqIQ6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1490"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zIW64Gu5WRx8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1491"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z9wnRO1YUqL8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zLC2mhBVl89k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zRZMGfEXIET9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1495"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zVJ1BEjQ8KHe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1496"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zANwLJS6iHo3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1497"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_z4o67f8H9fc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1498"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM9XoS9scxrd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,179)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zrcm1bEkq25f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1501"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zapeaLWLGu58" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1502"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z3V2t2MyAd77" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1503"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zsVVHwddoLa2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1504"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zsnawhcfXuza" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1505"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ProfitLoss_c20210101__20211231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zUctAe4vVO5c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;242,283&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zDC8UDO21mWl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External costumer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,002,461&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zEcx1To2S5m" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zCH41Ch9sFRh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;91,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zfpKqpzJfUT2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,201,191&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--DepositsFromExternalCustomer_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNl0cA8uXSQl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,201,191&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXBGfLYjAsS1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z6CYVJGfNnsc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--InterSegment_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zcBy1toXIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zEkbeKC8ZqCf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zo1e8oIrAxHj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zvwSFLaOvOs3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zywJFkXLb6Jl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,202,810&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zO6vs1JNkWRl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Revenue_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zcXG2AIYDrG3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zeCn3gsLjny3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(381,964)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zwL2IG2m6mok" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(40,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zsUj6uQQ7cWd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,309)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zybx7Xnboczd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(436,273)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zU3lLMUxiZpf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CostOfSales_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOHk0pFEBM2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(434,654)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zelGlg74jymd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;620,497&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJO5ZwVr7Mt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;67,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_znsxjwm2z3lc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;78,843&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zdcwavh3dSy2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;766,537&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GrossProfit_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zM6vuMDtlXz2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;766,537&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zn6SsoOwGUxl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="General and administrative expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(402,855)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherGainsLosses_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zJFBo8Q9APe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(347)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossFromOperatingActivities_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zNoO3yoMY3O3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;363,335&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinanceIncome_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zU6qk3y1QKU9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,290&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinanceExpense_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zHlk40GClwb4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(98,269)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zyAfEr5VyH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,698&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ProfitLossBeforeTax_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLEu9Zpk7vNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;335,054&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncomeTaxExpenseContinuingOperations_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zi8fEVN7iCmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(27,067)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--ProfitLoss_c20200101__20201231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zLik8i0J3mTf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;307,987&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="6" style="border-bottom: black 1pt solid; padding-right: 2pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    reportable segments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;External
    customer&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zoqVZTyudwld" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="External customer"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;653,760&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zhdvTR31m8K" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;64,870&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zykdxQd49jg1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zSRuobNwycId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;750,630&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--DepositsFromExternalCustomer_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zbQ2kRrUNrq3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;750,630&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inter-segment&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2Q5Ljpj6918" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zRdQikltGF5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--InterSegment_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zm42aORow3vb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    revenue&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zhoksJcN7Vu5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net revenue"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvGXbNp8r0h1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zKAZqhNaTN5g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_z7wlWUORR2K4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;754,510&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_ziVhZtMXnQ5j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Revenue_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zmUAZA7lHE82" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPnzwgkBt38" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cost of services"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(279,066)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zh9iqzRdBhV8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(29,261)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z60TTF6PBJdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,406)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zAy7VCyaMOY6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(312,733)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--AdjustmentsAndEliminationsMember_zhseQ1vqhRZ5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CostOfSales_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zdd4gtywTZM3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(308,853)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Gross
    profit&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--UndergradMember_zxEUKwLLX7Eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Gross profit"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;374,694&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdZiUuhYcQT9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;35,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zrNW4RggKXLf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,474&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember__ifrs-full--SegmentsAxis__custom--TotalReportableSegmentsMember_zNcqykE2YGdh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;441,777&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GrossProfit_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zu2MRhWGTqd9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;441,777&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--GeneralAndAdministrativeExpense_iN_di_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5HwfjymDrrl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(239,120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    expenses, net&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherGainsLosses_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z8Lo6rOZeQPl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other expenses, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,594&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Operating
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfitLossFromOperatingActivities_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zOepLPYaDEV2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Operating income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;205,251&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinanceIncome_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z3DWf5MzwPCg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Finance
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--FinanceExpense_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_z5xhI8ZChiL1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Finance expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(72,365)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Share
    of income of associate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zS5vJ0Cwy856" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Share of income of associate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,362&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--ProfitLossBeforeTax_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zWiU1UMM1rf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income before income taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;186,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncomeTaxExpenseContinuingOperations_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zKsLvStPHT25" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Income taxes expenses"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,175)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    income &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--ProfitLoss_c20190101__20191231__ifrs-full--SegmentConsolidationItemsAxis__ifrs-full--OperatingSegmentsMember_zXJCMcLQLWZa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;172,762&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</ifrs-full:DisclosureOfOperatingSegmentsExplanatory>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1498408000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">147980000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1719371000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1719371000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">3978000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">3978000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-3978000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1498408000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">151958000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1723349000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-3978000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1719371000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">-554995000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">-50773000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">-50510000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">-656278000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">3978000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-652300000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">943413000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">22210000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">101448000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1067071000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">622615000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-3561000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">440895000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-243796000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">11797000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-31179000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">242283000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1002461000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">91533000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1201191000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1201191000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">1619000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1619000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-1619000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1002461000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">93152000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">1202810000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-1619000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">1201191000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">-381964000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">-40000000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">-14309000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">-436273000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">1619000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-434654000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">620497000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">67197000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">78843000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">766537000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">766537000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">402855000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-347000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">363335000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">62290000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-98269000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">7698000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">335054000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-27067000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">307987000</ifrs-full:ProfitLoss>
    <afya:DepositsFromExternalCustomer
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">653760000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">64870000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">32000000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">750630000</afya:DepositsFromExternalCustomer>
    <afya:DepositsFromExternalCustomer
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">750630000</afya:DepositsFromExternalCustomer>
    <afya:InterSegment
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">3880000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">3880000</afya:InterSegment>
    <afya:InterSegment
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-3880000</afya:InterSegment>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">653760000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">64870000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">35880000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">754510000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">-3880000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">750630000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">-279066000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">-29261000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">-4406000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">-312733000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_AdjustmentsAndEliminationsMember"
      decimals="-3"
      unitRef="BRL">3880000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-308853000</ifrs-full:CostOfSales>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">374694000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">35609000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">31474000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember_custom_TotalReportableSegmentsMember"
      decimals="-3"
      unitRef="BRL">441777000</ifrs-full:GrossProfit>
    <ifrs-full:GrossProfit
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">441777000</ifrs-full:GrossProfit>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">239120000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:OtherGainsLosses
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">2594000</ifrs-full:OtherGainsLosses>
    <ifrs-full:ProfitLossFromOperatingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">205251000</ifrs-full:ProfitLossFromOperatingActivities>
    <ifrs-full:FinanceIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">51689000</ifrs-full:FinanceIncome>
    <afya:FinanceExpense
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-72365000</afya:FinanceExpense>
    <ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">2362000</ifrs-full:AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">186937000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">-14175000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_OperatingSegmentsMember"
      decimals="-3"
      unitRef="BRL">172762000</ifrs-full:ProfitLoss>
    <ifrs-full:DisclosureOfBusinessCombinationsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80A_eifrs-full--DisclosureOfBusinessCombinationsExplanatory_zScZQhdJJykf" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;5&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_824_zOvRgZlfvy4h"&gt;Business
                                            combinations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;5.1
Acquisitions in 2021&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_zydnIkVgntta" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The preliminary
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zzwDCBsCntad" style="display: none; visibility: hidden"&gt;Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;iClinic&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Medicinae&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Medical
    Harbour&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Cliquefarma&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Shosp&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Unifipmoc&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Unigranrio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;RXPRO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zwtIXfJ3G7ag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,659&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zVjH5L39Ijak" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zcbD4US4ZI4b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;47&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8C0vggHKqp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zYBnfQ05a0m1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;397&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zjmZh8ccMdGi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zwrrlblXCHTf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34,755&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHLyohhr0NGc" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Restrict
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RestrictedCash1_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zNztwnmvO589" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,050&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zKdPH7Lzqlfe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1614"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zgYRJOmTnsGb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RestrictedCash1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z0GN1GUgLeQ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1616"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RestrictedCash1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zf8c1xQUgfr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1617"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RestrictedCash1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z53WzDOYrQ24" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1618"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RestrictedCash1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhzp36kGiWff" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1619"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RestrictedCash1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zieeKPxVQcek" style="vertical-align: top; text-align: right" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Trade
    receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zeVTSSHngSx9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,201&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXCFVs0Xu2L8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zBh5ZZqtVXNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSFPUvTrubR" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;501&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z9lKAvNygxB3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zWR5hDBQBICg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34,309&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zBe7w78O3lGg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;26,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zrZDNwOCHD54" style="vertical-align: top; text-align: right" title="Trade Receivales"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,211&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zd4d5QuWRw3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zCXBH1g6JvDc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zW5s2DvyuqR2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Inventories1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVqNE2o83APb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Inventories1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zWfUYfMxl3C2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Inventories1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zj95J1ynNjk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Inventories1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z3E4BawG4hb7" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;352&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Inventories1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWxpeUjQ2QLh" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Recoverable
    taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zjwdwX6QW9Z3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;72&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zmivR5K0WOMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;15&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zTydqBTDti8k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfUwAObNp3g5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zvdJYDeaW7f5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2kbPWa7BN4k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,295&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zudRuLdAgU93" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;738&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zNNWkT7XpOzc" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zahU2d5tvIm2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;20&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_ztZkd1LjYYf2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1648"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zjfiFhVkEIVh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z4eG2MnZr7z4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1650"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOBHJcyVMtvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1651"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2xNKVXvi7Nk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;702&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqJqfmsJCYFg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;12,159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zC49thdaxI1" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;366&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGTZCOqWuLCh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9EegalhAM4j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1656"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z8EbQAtPTm47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1bFVKAnQd59" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zARWkuDMhblk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1659"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zuIMjs6QsTPl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;52,079&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z0b35cYRyEx8" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeUHmVdTTi67" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zOWnSveQdmce" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;473&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zx352TrGEWag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;17&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zzVhGoC0Xg2h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zlQBXOr4eWn6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1666"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zocZsUxXX5cc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2qNOwYggSN9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;24,277&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zrwg6iWBjLw1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;40,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeof2tPnW995" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Indemnification
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zv3egaittoJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zhwse1stMJHk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zKKImePLzdXd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1673"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ImdemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXgs5yFqUBYe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1674"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ImdemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zsw5pfgHZT43" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ImdemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zDRFWaVLS3d3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,331&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ImdemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zCgsmKa5V7Ef" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ImdemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zAp8B8hM9Pud" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zyb3aTKfykM" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;84,987&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zz0kTozBblrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zeZhfZMc8GWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,359&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zioBiHHzsfe9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;14,991&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zriVEy5xOCVi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,856&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zwOqcnJIIl3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;227,534&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zykk4coI7tZ1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;510,356&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6NkOBisldk" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,330&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z71bJDBx7DZa" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;95,802&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zB6vm6TmLgAh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,751&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z2vBKqRH3msl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,601&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8E0bvGY4JOh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;16,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_znZ2IPsbb6Rf" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,259&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zRg1SJE6uyug" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;353,667&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9DniEVSUVUe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;784,691&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zt1RhNgaWt41" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;8,480&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zHyuniKOR8Gc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zdTd0tjSGTOe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1697"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zlaVkoIDPUV7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zELVprZOvSCb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHmGIWxJ7K76" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z7rixxBoo4ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z2P9gdvJ5562" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHJDs8hDFZU" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,060&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zrLa6f2WZfx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zzwGdN7xpwg6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1705"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqCe2W0GYrK8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zcsDoYotJ8bd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;580&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRX9dZLrAnwd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zyY8xHlPVuYj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,179&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z8srDnSSSLPd" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zO4SBH3HkqVj" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1711"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Labor
    and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zxBXGgCVmZN1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,414&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGJ8vzV5Hgn9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zscuFA8FckCg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAz4Rw6Ppf28" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;102&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHBV1pZQGxJf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;89&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zKcCjT8avFTf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,306&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zGfJeCs9zGyd" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;22,854&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjaIwr2y9IGc" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Taxes
    and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zZ2fFPO8qXRk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;77&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zT0hxQ8OtVT5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zCvkX8wJW2Z1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZlRzKlQMxuj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;307&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zMvUPcZCGE3h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;123&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zhGOF4ZB06ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;758&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcyrqeVSsOW" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;94,025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwJ4tKmzGUne" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Provision
    for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zst7tNJVY892" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z7Auj4CvUws8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1729"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zYQaVSrSikLf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zCwmqBkOFFhk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zVOWJ7pb1424" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zABEDqCX9bDh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,331&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zh6PfGp51iO5" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7NhuwDPUMac" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1735"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Leases
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zz2G1gzJu8Zg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zMIxg8UbmN01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zuolztjgJEo4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMs3ElPuT71l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zmHwWPACyx3k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zUWygh0obg88" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;52,079&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zQ0bsuMLl7W7" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zxVMSx2HBQI6" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zX797RaT5Ks4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;400&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfyXM4VTDP86" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znXXtY9MmHu3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;35&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zhNUe6QghYgb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zGDrZLhSggEg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;167&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zyLgGLgo3HN6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,745&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zNEU8656p6q5" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zhX4veV1vLvi" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zgN3yNmWV7gg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1752"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9JsKcrvvmc1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zEi88OnO4qLk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfkXz9Qo5wdg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z4FRKRt54z7d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zYdl9FwFsuH8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,739&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9clBQgJw7bk" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,878&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7IYuGaEO33g" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKmsXmnA3HDk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;3,850&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zBIzYz5VHy2d" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;163&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z4wBUrWQ0I46" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;345&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZP5K2Holqg4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHyaH5AG0dp3" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;380&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zmz8P8Vdlgd2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;113,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zolJcRpEOWP6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;295,808&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwYTYNoj2ET8" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,304&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Total
    identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zQ5fxvqaoCme" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;91,952&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zxuvaSVFlEzb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,588&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_ziV6wP4QOr5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,256&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSGev9bCEwH1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;15,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFtch7xFbYzj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,879&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zsYEBLuwSoNf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;240,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXtLcknO5EAg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;488,883&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcG7RIuGVhwe" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Preliminary
    goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_znce3FcKtQsh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;99,168&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zsiWkqMxBvH9" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,584&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z7ykbSwRV2i6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMCOxUv89k2e" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHZfHTtw9xTd" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcU7nPSexrBi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqkOjB8qam4f" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;130,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zflnfEBkbVXi" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;38,446&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Purchase
    consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z0FJUEIRMIB" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;191,120&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXdvMFXObbF1" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;9,172&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zNNpCFcNaWL7" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;11,278&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAnlV0Sfo0pa" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;22,089&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zLEjf5DEkY7b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,901&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z5eFVhCWgPrb" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;328,322&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zk2KNwWadx7a" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;618,956&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqwmsWOsXJj4" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;45,622&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_ziedsoW7DRfc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;119,620&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGFhSIdhnFw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,600&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqmJhiEXno4a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1ajmlEGDBOj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;16,166&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zEHlO2PsFFp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zVBQ0DlyNpyb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;328,322&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zDh1LzvYiCw1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;375,670&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z3r0KnrEwN0f" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,263&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Contingent
    consideration&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_fKCoqKQ_____zW2ibgJpQ7T2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_fKCoqKQ_____zPrB9eUny0Ic" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,572&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_fKCoqKQ_____zjX9spV1fQJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,278&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_fKCoqKQ_____zWJYWKHdKVb1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,923&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_fKCoqKQ_____z00b5mTAh6p3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,592&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCop_zLrJMURP4RN5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCoqKQ_____zVozj4iDnJxi" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;sup&gt;(**)&lt;/sup&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_ztlNmgAuuiBf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Consideration
    to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zfbJEFzkrZ4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zau9Y5BOJrUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zvQN9Axx6S9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zDNakicKC1Qe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ConsiderationToBeTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztsvu9qpEzc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;454&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXy56yRKZ931" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ConsiderationToBeTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zF98bEbiNrCk" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;243,286&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z05PCzDawVr8" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Paid
    in shares&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zDU5SDBtFKJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGLHuYT9RL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zOtjBnq9pXhg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zS1QabTYdYi4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PaidInShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zUQQ8lm8aMN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PaidInShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhG2fcFWoNj8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaidInShares_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zOo0CHhdQvlh" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zfUxgugHQiLl" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;i&gt;Analysis
    of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transaction
    costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zJqasYn0v6E3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;856&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfk8yIcx9Ja7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;117&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zIkvr0M6W70k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;144&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zmaeklgwo2N7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zhZnuJNf67V6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;188&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXkSvbiwoFE4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;177&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zqWQTSjixGyf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,990&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6E6LnOQXhfa" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;264&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKt7oPmwaHL" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;117,961&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z0mdhm7MiaX9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,399&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z62Vu9TOlMUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,953&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfhBVCCMM4ee" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;15,157&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zNTt7VALLe8d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,458&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zD8KWoqdhRrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;322,182&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z48woKyFJInc" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;340,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zucUHqr8J9w2" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Net
    of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGa3sfVuzh6c" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;118,817&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zSbdbol3fAH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,516&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrUqBedfIAy6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,097&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXnvrcDlKGs1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;15,493&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOSkPnUfV7Jk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFeeTYAM5402" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;322,359&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zfnlapsyczbl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;351,905&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zmXGGc2NhKEj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;30,436&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are 40 additional seats
still pending approval, which, if approved by the Ministry of Education, will result in a potential additional payment of up to
R$ 50,000.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A0_zrTGjrIsHock" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(a)
Acquisition of iClinic&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
January 21, 2021, Afya Brazil acquired &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zvPHUtenh4X9"&gt;100&lt;/span&gt;% of the share capital of iClinic (comprised by iClinic Participa&#xe7;&#xf5;es, iClinic
Desenvolvimento and Black River). &lt;span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zb7MG8Hx0K4g"&gt;The aggregate purchase price of R$191,120 is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;iClinic
is a SaaS model physician focused technology company and the leading medical practice management software in Brazil. iClinic empower
doctors to be more independent and have more control over their careers by digitalizing their daily routine, so they can increase their
productivity and deliver better healthcare services. With the acquisition of iClinic to our platform, Afya will make another step to
become the one stop shop for physicians in Brazil.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
acquisition of iClinic was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction
costs to date amount to R$&lt;span id="xdx_90D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zISAr3QvAayg" title="Transaction costs"&gt;856&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement
of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes
purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_894_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zC4v6h0VeMj4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B6_zov9ELuceLXb" style="display: none; visibility: hidden"&gt;Schedule of acquisition of UniRedentor&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVMIRzdnM1Q" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210119__20210121__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z5WXLkJTe2ek" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zGwfikASF2s4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, iClinic has contributed R$ &lt;span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zT4eOyWKiYa6" title="Net revenue"&gt;16,456&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90F_eifrs-full--ProfitLossBeforeTax_c20210119__20210121__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zuqR5KEoMeS6" title="Income loss before income taxes"&gt;8,250&lt;/span&gt; of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ &lt;span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zl8UGpJrZqAc" title="Increase in revenue"&gt;1,158&lt;/span&gt;
and income before income taxes would have been decreased by R$ &lt;span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zliEXjyoa2t8"&gt;1,320&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(b)
Acquisition of Medicinae&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 25, 2021,
Afya Brazil acquired &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zlkbAFRmtQZb"&gt;100&lt;/span&gt;% of the total share capital of Medicinae, a leading Brazilian healthcare technology company that specializes
in healthcare payments and financial services. &lt;span id="xdx_90C_eifrs-full--DescriptionOfAcquiree_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--MedicinaeMember_zwdd8oz27DZ6"&gt;The aggregate purchase price of R$9,172 is comprised by: i) R$ 5,600 of which 100% was
paid in cash on the transaction closing date; and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$ 4,400 is payable
in connection with product development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3,572 is based
on the present value of the obligation considering the facts and circumstances at the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;The
acquisition will expand Afya&#x2019;s digital health services, as it offers a unique financial platform that allows healthcare professionals
all over Brazil to manage receivables in an efficient and scalable way using FIDC (Receivables Investment Fund).&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Medicinae relieves
a number of challenges in the healthcare payments industry, as reduces long payment cycles for professionals and consolidates financial
information, improving the consumer financial experience. Afya&#x2019;s intention is to grow the Digital Services segment.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Medicinae was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zhLMnP9ZwlO9"&gt;117&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfUnislTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGAk6QiRz1oi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zu05rfh6d9Je" style="display: none; visibility: hidden"&gt;Schedule of acquisition of UniSL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210323__20210325__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_ze6Zg5M2ZAWk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zfKAWrFm0Jq8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, Medicinae has contributed R$ &lt;span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_z8VsqeG0tYa4" title="Transaction costs"&gt;359&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90D_eifrs-full--ProfitLossBeforeTax_c20210323__20210325__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXzcaLDn2U3"&gt;1,518&lt;/span&gt; of loss before income taxes to the Company. If the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ &lt;span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGXmC5Fqtkgk"&gt;105&lt;/span&gt;
and income before income taxes would have been decreased by R$ &lt;span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zKjvD9aArSk1"&gt;113&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(c)
Acquisition of Medical Harbour&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 8, 2021,
Afya Brazil acquired &lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zg5uTlNqJb0i"&gt;100&lt;/span&gt;% of the total share capital of Medical Harbour, which offers educational health and medical imaging solutions
through an interactive platform for anatomical study, 3D virtual dissection and analysis of medical images, which allow the exploration,
and knowledge of human anatomy with digital resources. &lt;span id="xdx_904_eifrs-full--DescriptionOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_z3neehsYlys8"&gt;The aggregate purchase price of R$11,278 is comprised by: i) R$ 5,000 of which
100% was paid in cash on the transaction closing date; and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ 9,000
is payable in connection with product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration
of R$6,278 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This acquisition
enables Afya to start providing a high quality solution to study the human body, allowing efficient classes and remote practical sessions
with greater student acceptance and scalability. Additionally, Afya will be able to distribute Medical Harbour solutions to all of its
ecosystem, creating B2C and B2B growth opportunities.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Medical Harbour was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zzYlEJ05a7P9"&gt;144&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Medical Harbour
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfAcquisitionOfPebmedTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zKtdf2BhXfS9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_zW5lALiYIUvk" style="display: none; visibility: hidden"&gt;Schedule of acquisition of PEBMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zyOszcZMTczk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z1sutBCAaPrl" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AC_ziJCec7O6Akb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; color: #222222"&gt;From
the date of acquisition, Medical Harbour has contributed R$ &lt;span id="xdx_90A_eifrs-full--RevenueOfAcquiree_c20210406__20210408__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zLaiI8OYwUI8" title="Revenue of acquiree since acquisition date"&gt;484&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210406__20210408_zdh3PUNoUarb" title="Net revenue"&gt;1,945&lt;/span&gt; of loss before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;for
the period ended December 31, 2021 &lt;span style="color: #222222"&gt;would have been increased by R$ &lt;span id="xdx_906_eifrs-full--RevenueOfCombinedEntity_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zrCyXP6dq4T9" title="Revenue of combined entity as if combination occurred at beginning of period"&gt;268&lt;/span&gt; and income before income taxes would
have been increased by R$ &lt;span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zbtQz7ZFDzqh" title="Income loss before income taxes"&gt;127&lt;/span&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/80% Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(d)
Acquisition of Cliquefarma&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #222222"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 16, 2021,
Afya Brazil acquired &lt;span id="xdx_905_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_ze4khYsatlWg"&gt;100&lt;/span&gt;% of the total share capital of Cliquefarma, a healthtech company operating a free-to-use website that tracks
prescription drugs, cosmetics and personal hygiene product prices in Brazil. &lt;span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zEanXusokxJl"&gt;The aggregate purchase price of R$ 22,089 is comprised by:
(i) R$ 16,166 paid in cash; (ii) R$3,000 settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#x201c;contingent
consideration&#x201d;) of R$ 3,000 is payable in relation to product development. The contingent consideration of R$2,923 is based on
the present value of the obligation considering the facts and circumstances at the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Users of Cliquefarma
can easily search for medications or healthcare products and compare prices from over 15,000 pharmacies in Brazil. The traffic generated
is monetized through a cost-per-click model, where drugstores pay for each click on their advertisements, a cost-per-acquisition, where
drugstores pay for each concluded sale.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Cliquefarma will enhance the Digital Services segment, creating the opportunity to leverage traffic and GMV with prescriptions generated
from Afya&#x2019;s physician ecosystem.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Cliquefarma was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210414__20210416__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zj66LApPJcEg" title="Transaction costs"&gt;336&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Cliquefarma
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfFesarTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zrWMfV6zM5F2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B6_z7UrP5URV2fc" style="display: none; visibility: hidden"&gt;Schedule
of acquisition of FESAR&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zsOFIQ0cjkO9" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210414__20210416__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z8UvFfDdR9gh" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A3_zxFaJcJ2wGUb" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, Cliquefarma has contributed R$ &lt;span id="xdx_903_eifrs-full--Revenue_pn3n3_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zLz0BHIL3Tg2"&gt;3,268&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zePGV8EXdhCi"&gt;1,752&lt;/span&gt; of income before income taxes to the Company. Should the
acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ &lt;span id="xdx_906_ecustom--IncreaseInRevenue_c20210101__20211231_z3hr7J1piBAl"&gt;1,435&lt;/span&gt; and income before income taxes would have been increased by R$ &lt;span id="xdx_903_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231_zHoQUO2Pfo7b" title="Income loss before income taxes"&gt;926&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(e)
Acquisition of Shosp&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 13, 2021,
Afya Brazil acquired &lt;span id="xdx_907_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zWCdfHCjvQV6"&gt;100&lt;/span&gt;% of the total share capital of Shosp, a clinical management software that offers all functionalities needed
for clinics all over Brazil to manage their financials, patients appointments, medical records, marketing, and others. Afya&#x2019;s intention
is to reinforce the Digital Services operating segment. &lt;span id="xdx_90F_eifrs-full--DescriptionOfAcquiree_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zl64E1rqsqO2"&gt;The aggregate purchase price of R$7,901 is comprised by: i) R$ 5,855 was paid
in cash; ii) R$ 454 of consideration to be transferred; and iii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ 1,793
is payable in relation to product development. The contingent consideration of R$1,592 is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Shosp was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_90F_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zS5MqJVrUo39"&gt;188&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Shosp and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--ShospMember_zIt6dmS6HhHc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B8_zRJn4wkUPehb" style="display: none; visibility: hidden"&gt;Schedule
of acquisition of MedPhone&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVrX3w2BfcB6" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210311__20210313__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zP8amaDKxti7" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z644E8379db1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, Shosp has contributed R$ &lt;span id="xdx_90B_eifrs-full--Revenue_pn3n3_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zsiWdXQTo7I4"&gt;1,376&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_909_eifrs-full--ProfitLossBeforeTax_c20210511__20210513__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zHfssh0JQNZa"&gt;448&lt;/span&gt; of income before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ &lt;span id="xdx_90F_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTh6ni3Ldoi1"&gt;306&lt;/span&gt;
and income before income taxes would have been decreased by R$ &lt;span id="xdx_907_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--ShospMember_zTGeMr13s5qf"&gt;82&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(f)
Acquisition of UNIFIPMoc&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On June 1, 2021,
Afya Brazil acquired &lt;span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zUgilgkEYKed"&gt;100&lt;/span&gt;% of the total share capital of Sociedade Padr&#xe3;o de Educa&#xe7;&#xe3;o Superior Ltda. (&#x201c;UNIFIPMoc&#x201d;).
&lt;span id="xdx_908_eifrs-full--DescriptionOfAcquiree_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zVfSlnQaZSXc"&gt;The aggregate purchase price is R$ 328,322 and the total amount was paid in cash. There are 40 additional seats still pending approval,
which, if approved by the Ministry of Education, will result in a potential additional payment of up to R$ 50,000. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;UNIFIPMoc is a
post-secondary education institution with government authorization to offer on-campus, undergraduate courses in medicine in the states
of Minas Gerais and Bahia. The acquisition is in line with the Company&#x2019;s strategy to focus on medical education, including medical
school.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of UNIFIPMoc was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_905_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zYOk5sV9EZdc"&gt;177&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of UnifipMoc
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zlhKd4NkmGuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BC_zIOGWUEM2l1g" style="display: none; visibility: hidden"&gt;Schedule of acquisition of FCMPB&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_zzosRnJ4uRa8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From
the date of acquisition, UNIFIPMoc has contributed R$ &lt;span id="xdx_906_eifrs-full--Revenue_pn3n3_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zxKEoQv35rg"&gt;69,887&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210601__20210630__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zB7knbp338H5"&gt;19,458&lt;/span&gt; of income before income taxes to the Company.
Should the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have
been increased by R$ &lt;span id="xdx_907_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zXFBMDDN7Jsb"&gt;46,150&lt;/span&gt; and income before income taxes would have been increased by R$ &lt;span id="xdx_906_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zfkuEWXScq89"&gt;12,847&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(g)
Acquisition of UNIGRAN&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 4, 2021,
Afya Brazil acquired &lt;span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVgBS8kKsHq"&gt;100&lt;/span&gt;% of the total share capital of Companhia Nilza Cordeiro Herdy de Educa&#xe7;&#xe3;o e Cultura, Instituto
de Ensino Superior de Palho&#xe7;a S/S Ltda., Sociedade Educacional de Palho&#xe7;a S/S Ltda., and Policl&#xed;nica e Centro de
Est&#xe9;tica Duque de Caxias Ltda. (combined denominated &#x201c;Unigranrio&#x201d;). &lt;span id="xdx_90B_eifrs-full--DescriptionOfAcquiree_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zDp9Lkzh44a4"&gt;The aggregate original purchase price of R$ 626,116
of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four equal installments through 2022 to
2025, adjusted by the CDI rate, was adjusted by R$7,160, because of the actual net debt, to R$618,956. There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Unigranrio is a
post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro and Santa Catarina&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of Unigranrio was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_909_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zKqyGF07nLW2"&gt;10,990&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of
income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of Unigranrio
and therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfAcquisitionOfUnigranTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zyXgO4PauZ0j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BB_zWeg2ldwu09l"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zBMyQzLIX536" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zh0AZu39YWsk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zBFJxXVdeKZ7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation technique
for property and equipment consists of determining the fair value of an asset by using methodologies like replacement costs, market value,
remaining useful life and physical depreciation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, Unigranrio has contributed R$ &lt;span id="xdx_908_eifrs-full--Revenue_pn3n3_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zsAGozjP5cU1"&gt;123,369&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_908_eifrs-full--ProfitLossBeforeTax_c20210802__20210804__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_z6o9kxarbBT6"&gt;33,450&lt;/span&gt; of income before income taxes to the Company. Should
the acquisition had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased
by R$ &lt;span id="xdx_908_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zV9cUuBYsyNj"&gt;150,456&lt;/span&gt; and income before income taxes would have been increased by R$ &lt;span id="xdx_90C_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zVhaZ3AMLxC5"&gt;22,191&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(h)
Acquisition of RXPRO&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 1, 2021,
Afya Brazil acquired &lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zSg67NDqZUZk"&gt;100&lt;/span&gt;% of RX PRO, comprised of (i) RX PRO Solu&#xe7;&#xf5;es de Tecnologia Ltda. and (ii) RX PRO LOG Transporte
e Logistica Ltda..Solu&#xe7;&#xf5;es de Tenologia Ltda. RX PRO consists of a solution that connects physicians with the pharmaceutical
industry, providing specialized and personalized marketing for those companies, in a more convenient way for physicians. Afya&#x2019;s
intention is to reinforce the Digital Services operating segment. &lt;span id="xdx_903_eifrs-full--DescriptionOfAcquiree_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zV1Dwlx8phE4"&gt;The aggregate purchase price of R$45,622 is comprised by: i) R$ 30,263
was paid in cash; ii) R$ 76 to be paid as price adjustment, iii) R$5,112 settled with Afya's treasury shares on the transaction closing
date; and (iv) an earn-out (&#x201c;contingent consideration&#x201d;) of R$ 21,000 is payable in relation to revenue achievements. The
contingent consideration of R$10,171 is based on the present value of the obligation considering the facts and circumstances at the acquisition
date.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of RXPRO was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_90A_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_za4ueQEPAnAi"&gt;264&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The preliminary goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
not yet finalized the valuation of all identifiable assets acquired and liabilities assumed in the business combination of RXPRO and
therefore some of these amounts are preliminary. These amounts may be adjusted when the valuations are finalized.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--ScheduleOfAcquisitionOfRXPROTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKHdu9aa3eTj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zLLkcFdWjoij"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z3zRq7R9cJwb" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zeZZoDFgzDC2" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zwWF1IKRBx9h" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A5_zXAUqLUKQkpj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;From the date of
acquisition, RXPRO has contributed R$ &lt;span id="xdx_902_eifrs-full--Revenue_pn3n3_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zTO1Cysirib"&gt;907&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200928__20201001__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zYNxu6P2qGZ4"&gt;984&lt;/span&gt; of loss before income taxes to the Company. Should the acquisition
had taken place at the beginning of the period, net revenue for the period ended December 31, 2021 would have been increased by R$ &lt;span id="xdx_904_ecustom--IncreaseInRevenue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKt5eZWV9Xf3"&gt;3,155&lt;/span&gt;
and income before income taxes would have been decreased by R$ &lt;span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zRgyTxXETXa4"&gt;325&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;5.2
Acquisitions in 2020&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_zsNqcDkcP1aa" style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&lt;span id="xdx_8BE_zMeSHT02Wbp6"&gt;The
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;UniRedentor&lt;sup id="xdx_F59_zAvFUToNjFz8"&gt;*&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;UniSL&lt;sup id="xdx_F5F_zCrp9wUMkNth"&gt;**&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;PEBMED&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;FESAR&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;MedPhone&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;FCMPB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zAVb3yo3wBJg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,796&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zNxa5tHdSZLf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,245&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zEOClRFGyeTg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,119&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zxkS1YUMKw0a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,236&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zK3fJxFOyUib" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z73IKoju1AF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade
    receivables &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zgebA5hQHK2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,800&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zmwtcWPAC5O2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,567&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z5J7bC2F7m5d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDbopQFTRoDj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_ztSTqHM49wSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zjVTUcP68ki5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zIYUiIS7KTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1996"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zAORDJDdEw6i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;467&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_znAO7mDFhcYb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2000"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zLtyNUiPfRnh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2002"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zJA29mowuDqd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2004"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zyhKgYKsRsn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Recoverable
    taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLzQhKtmmn1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdU8ltsEqaRj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;822&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zTDrr01O6US7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2012"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrJovtlYZABf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2014"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zc822jJkMSz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVulIgfPSYg2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2018"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLlVTGuu8227" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,486&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zhKffr4l9Ioj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,251&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zCMHVcSXhRN7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zzbJUllMn8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfRCws1fjAL1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zevt8PCqwfkd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;123&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Indemnification
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IndemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z2YfRdUlLECj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;710&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IndemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zHJ6GfXXjym4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,645&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IndemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z1BB1trtemak" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IndemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z4KMY1wZOVod" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IndemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zqzGNull8Fq2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2040"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zGbNk9BHa0D3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2042"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zHAUsoWFdwR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zf2UGB0tyJN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,062&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zR4myGuTPKfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;865&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zIvd0Jkhm42d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zRBPD644qCH7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRQkSu6TAHE6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCxWtOhqSzAk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,207&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zypUcLIgkH49" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,144&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z6OJON8HlN59" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;391&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ztKSE8KkK655" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z1IgIrP2N5a4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zOraqDymNOfa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zoiVPseg9SA5" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;142,399&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z3UBQHD3wfU8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;314,097&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziE4HZePi3Qe" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,372&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zztkEPGfxmc7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;167,106&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQjfQEYLB78" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,727&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zCuTrBJS2Yed" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;264,782&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zG0Ql09YhReg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,666&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ztqESusg2JTg" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;421,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zs6YJCMJrGQ5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;83,242&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zf2XLTNzDKn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;201,431&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zakIjhXPqXg8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,796&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;297,778&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYVYWnqzF3M9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;746&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zUeODflqDsC" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zVHLo99fsbSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrAoBduLXoeh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;143&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zciqmDMxQIWg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2100"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zYqvcBOcnoy" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;173&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7MFMjiQLnfl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;16,187&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z9UX0SPbVkUf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,541&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zRZgCBuidBY1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z6wlcFGs5WLj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,087&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zlYcE3rXpVU4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2112"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zHWMKKvUX61a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zuTjCGJDqTQf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zbmDpqPWIV1f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,062&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zofQ8vOGAEL8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;865&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z1AIfhIdKzO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfXl2nWtp5M6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zvSzwv0hrGV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Labor
    and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZQtTVdjn7Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,471&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zTm4DtlvHAsk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,070&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zmCpWtu8RVQ6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,786&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP5eWwj185oc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,801&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFj6WtjBDTNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z1eGhO7wZC47" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,832&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Taxes
    payable &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zGyMOGfYZaEd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;850&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z8x56FftsgBb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,779&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zB167xTyiR26" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zQe2elXTOKYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;29&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQQwFxmywf5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVt8OMeZ03U9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Provision
    for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z0GDZywEkHi7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;710&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zyzcOPBK1LJl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,645&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zFoEjEBYMY8d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z8EmaEquKx6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zW9eaPY1rY8b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z6lBY2197RB3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zU9OVtZgQ8eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,994&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zJsENwKvpIpg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,084&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zhenAaZMRQ2a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,312&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zH9Qck7htWMe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;759&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZxnNK94xKGf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zcy4zBkrXJl2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotesPayables_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCu2FCwNbwO6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NotesPayables_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zVCVwA8tJib2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;80,526&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotesPayables_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zx5J2lS5JmVc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NotesPayables_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zk4QjeBuhmM8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NotesPayables_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zi6QsQiH4Aja" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NotesPayables_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_ztexIzbGEB8k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCbwHPDABXg2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z1b3gRLxDBW7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,754&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zqCIWe7c3oA3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2192"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zBbdYryDw0vg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVHvUY5i16cd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;228&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zlULXa3tMbj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2198"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYJkeeIrOMCh" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;44,223&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdvLlR3bqZDd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;232,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z9Bq5YYaGa61" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;34,547&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkrUtMYxydX1" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,690&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZrHEYduPMC4" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;230&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zE1gAprjJYs3" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;29,454&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zMuTCasS8IS2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;132,443&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zO5EeInsfHA7" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;189,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziB5IfohSoTc" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;48,695&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zO5IkSBPt9Lg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;190,741&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2MeYPvL7nX" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zJii1mi8hbM9" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;268,324&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #0D0E00"&gt;Goodwill
    arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEBP0fVsvRh" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zeD5ej7YtfCj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zfsbdJODltpf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;84,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zNIvYgJo0kxb" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zIiqISV2FmK5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,843&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zXWghwhespDd" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Purchase
    consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEAl8YBTEC3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;210,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpfJ9eg4bKi5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;193,705&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zzjkQ6xOOoK9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;132,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zMVSb9ZWRxPc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;262,405&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zpDoOnBklbOk" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z85IH8rQhUe4" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;378,807&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zjrHviUw1Q21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;114,607&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zxQDz4vAwmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,065&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zjjP3lEhVQic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;115,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDQcHzpwEIPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;260,836&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFrE7Fhwfpua" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,373&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWgoITNOLXMg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;189,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Payable
    in installments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zTPu93oUK5G1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;95,498&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpT2t0QR7Mc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52,640&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zSGtZ0Esp2te" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zISaWfRjlkFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4UFAFAqtikk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRhGJXWF9RCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;188,894&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Paid
    in Afya Brazil&#x2019;s shares&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInAfyaBrazilsShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZdjBS4eo4F2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PaidInAfyaBrazilsShares_iI_pp0i_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zZR29SxWh5ml" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PaidInAfyaBrazilsShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zDFZAGwkTe3i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,531&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDP8i6MEP4H3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZnYuBkzFTNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PaidInAfyaBrazilsShares_iI_pii_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zQLsUbZrIDS" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;Analysis
    of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transaction
    costs (included in cash flows from operating activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7sY5B4QLffc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pin3_c20200503__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zvPYmbPS5kX6" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,666&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zebx1JhzEYh5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;613&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zGRXSxClklu7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,047&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2WJXEDLrr0k" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zPT7QjmULYp9" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    paid, net of cash acquired with the subsidiary (included in cash flows from investing activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z5nxvCxmHf57" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;102,811&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;137,820&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zXUNj4fH6FK2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;114,220&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zVKeYuO8YR14" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;256,600&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z13yUYixlnpj" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zuZKl77xuRU1" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;189,813&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYkZLwsBvKQg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;104,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ziKynDSkF499" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;139,486&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zgCV2RnT839b" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;114,833&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zUwKk8nsj9K7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;258,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVGl60C0Oby7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,471&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201209__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zpObDsnvBPl8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;190,534&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; color: #0D0E00; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F06_ztIuyFXfHNm5" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zaO3k9qNVr96" style="font-family: Arial, Helvetica, Sans-Serif"&gt;During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.25in; color: #0D0E00"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0D_ztROSjqJfKFh" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_z3KRsfIOe955" style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00"&gt;During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;roperty
and equipment of R$7&lt;span style="color: #0D0E00"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A6_zeDZBZbaaHOh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="color: #0D0E00"&gt;&#160;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -14.2pt; color: #0D0E00"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(a)
Acquisition of UniRedentor&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On January 31,
2020, Afya Brazil acquired &lt;span id="xdx_903_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zhjHb8uWIB8h"&gt;100&lt;/span&gt;% of the share capital of UniRedentor. &lt;span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zEDgTjf970E8"&gt;The original purchase price of R$214,608, was adjusted by R$4,503
and was comprised by: i) R$114,607 paid in cash on the acquisition date; and ii) R$100,000 is payable in five equal installments from
January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4,503 was deducted from the first installment
due in January 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;UniRedentor is
a post-secondary education institution with governmental authorization to offer on-campus, undergraduate degrees and graduate programs
in medicine and health, as well as other courses, in the State of Rio de Janeiro. The acquisition contributed with 112 medical school
seats, with a potential 44 additional medical school seats subject to the approval by MEC and is in line with the Company&#x2019;s strategy
to focus on medical education, including medical school.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of UniRedentor was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_902_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z4RzU6Q9YUJd"&gt;1,380&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of
income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z2fcWB3rBBlc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BE_zjxRcRDmmTY7"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z7YEmaeRyFH9" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zin473Y7fpD4" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zwwvqrnMvcpl" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;UniRedentor
contributed R$ &lt;span id="xdx_904_eifrs-full--Revenue_pn3n3_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z0z01XsnGzK4"&gt;96,065&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90A_eifrs-full--ProfitLossBeforeTax_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zsDEelRNmaj5"&gt;30,952&lt;/span&gt; of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ &lt;span id="xdx_909_ecustom--IncreaseInRevenue_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_zMqg9CnYbPNc"&gt;5,931&lt;/span&gt; and income before income taxes for 2020
would have been increased by R$ &lt;span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200128__20200131__ifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z5NfCkHU6i79"&gt;321&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(b)
Acquisition of UniSL&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 5, 2020,
Afya Brazil acquired &lt;span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zieGbQg07okj"&gt;100&lt;/span&gt;% of the total share capital of UniSL. UniSL is a post-secondary education institution with governmental authorization
to offer on-campus, undergraduate courses in medicine and health, as well as other courses, in the State of Rond&#xf4;nia. &lt;span id="xdx_907_eifrs-full--DescriptionOfAcquiree_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--UniSLMember_z0AOGqM8tGE"&gt;The original
purchase consideration of R$201,521 was adjusted by R$7,816, of which: (i) 70% is payable in cash on the transaction closing date, and
(ii) 30% is payable in cash in three equal installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment
of R$7,816 was deducted from the first installment due in May 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
contributed with 182 medical school seats. There are 100 additional seats still pending approval which, if approved by MEC, will result
in a potential additional payment of up to R$&lt;span id="xdx_90F_ecustom--AdditionalPaymentMade_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_z356B59gSgP" title="Additional payment made"&gt;80,000&lt;/span&gt;, adjusted by the CDI rate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Given the future
event that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably
estimated and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will
result in additional licenses, which will be measured accordingly if and when approved.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of UniSL was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zrpuLIKQtsEk"&gt;1,666&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of
income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89C_ecustom--ScheduleOfAcquisitionOfUnisl1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zCTapHyGyKZ4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BE_zbdcoyY1QUHb"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_984_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z75keHgw1i0c" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zwT9hpoM2CUh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_z6gRNBCjnpqc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;UniSL
contributed R$ &lt;span id="xdx_90D_eifrs-full--Revenue_pn3n3_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQAcobrdvYh1"&gt;113,894&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQB8tZH9PFob"&gt;30,649&lt;/span&gt; of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ &lt;span id="xdx_90D_ecustom--IncreaseInRevenue_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_znlaPHVgpD8c"&gt;57,477&lt;/span&gt; and income before income taxes for
2020 would have been increased by R$ &lt;span id="xdx_90A_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200503__20200505__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zbB2TNHrVCX5"&gt;9,455&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(c)
Acquisition of PEBMED&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 20, 2020,
Afya Brazil acquired &lt;span id="xdx_901_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zwRSu4NjQDn"&gt;100&lt;/span&gt;% of the share capital of PEBMED. &lt;span id="xdx_905_eifrs-full--DescriptionOfAcquiree_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDxIxlh0XL4"&gt;The original purchase price of R$ 132,900 was adjusted by R$ 30 and was comprised
by: i) R$115,339 paid in cash on the acquisition date; and ii) R$ 17,531 was paid with Afya Brazil&#x2019;s shares which were afterwards
contributed to the Company in exchange of issuance of 141,976 of its own shares.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;PEBMED offers content
and clinical tools for healthcare professionals, including web portals and mobile apps. With the integration of PEBMED into our platform,
Afya will continue to expand offerings for the medical professionals.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of PEBMED was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$ &lt;span id="xdx_906_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zQC1cck3vX4g"&gt;613&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of income.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired lease liabilities
using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured at an amount
equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_898_ecustom--ScheduleOfAcquisitionOfPebmed1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zXTNHJmUDlE4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zOiGDpc7oG1g"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zNmcdf3oWjei" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrpCM5e8RLhi" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zah1wOgtfIO3" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zZvi6L7Lzg13" style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;PEBMED
contributed R$ &lt;span id="xdx_905_eifrs-full--Revenue_pn3n3_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zviPVnG2oQbg"&gt;17,535&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90B_eifrs-full--ProfitLossBeforeTax_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zV87y7ZK8Y1f"&gt;3,413&lt;/span&gt; of income before income taxes to the Company in 2020. If the acquisition had taken
place at the beginning of the period, net revenue for 2020 would have been increased by R$ &lt;span id="xdx_905_ecustom--IncreaseInRevenue_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zDfEJiZKTmo4"&gt;17,452&lt;/span&gt; and income before income taxes for
2020 would have been increased by R$ &lt;span id="xdx_902_ecustom--DecreasedInIncomeBeforeIncomeTaxes_c20200718__20200720__ifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zZTmdgnIJuja"&gt;1,813&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.15pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(d)
Acquisition of FESAR&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 3,
2020, Afya Brazil acquired &lt;span id="xdx_90E_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zgw8od6U1fM6"&gt;100&lt;/span&gt;% of the share capital of FESAR. &lt;span id="xdx_90E_eifrs-full--DescriptionOfAcquiree_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkLFztzSRPA"&gt;The aggregate purchase price was R$260,836, including the CDI rate adjustment
from the signing date and the real state of the operation, estimated at R$ 17,397, of which 100% was paid in cash on the closing of the
operation. The purchase consideration was adjusted by R$1,569 and was paid on February 25, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;FESAR is a post-secondary
education institution with government authorization to offer on-campus, undergraduate courses in medicine and health, as well as other
courses, in the State of Par&#xe1; and medical course represents 70% of its 2019&#x2019;s net revenue. The acquisition contributed with
120 medical school seats.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
of FESAR was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Transaction costs
to date amount to R$&lt;span id="xdx_90E_ecustom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z0zrK9swxVLh"&gt;2,047&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement of
income.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At the acquisition
date, the fair value of the trade receivables acquired equals its carrying amount.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The goodwill recognized
includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill is allocated entirely
to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfAcquisitionOfFesar1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zYfWbd8k9GH4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zYGDzv9uTPV8"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zaLtaUATzVif" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_986_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zyAQaPdz1ko7" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A3_zD0Bff6SIUgg" style="font: 11pt/83% Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;FESAR
contributed R$ &lt;span id="xdx_906_eifrs-full--Revenue_pn3n3_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zaF1nUR1cAG6" title="Net revenue"&gt;6,280&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_901_eifrs-full--ProfitLossBeforeTax_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z21SJqBDOIAi" title="Income loss before income taxes"&gt;3,751&lt;/span&gt; of income before income taxes to the Company in 2020. If the acquisition had taken place
at the beginning of the period, net revenue for 2020 would have been increased by R$ &lt;span id="xdx_909_ecustom--IncreaseInRevenue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP3cNrQjCzLa" title="Increase in revenue"&gt;29,113&lt;/span&gt; and income before income taxes for 2020 would
have been increased by R$ &lt;span id="xdx_909_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zsAILdcpoxBi" title="Increase in income before income taxes"&gt;14,918&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(e)
Acquisition of MedPhone&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;On
November 4, 2020, Afya Brazil acquired &lt;span id="xdx_904_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20210601__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfhoCIpGaQ3l"&gt;100&lt;/span&gt;% of the share capital of MedPhone. &lt;span id="xdx_909_eifrs-full--DescriptionOfAcquiree_c20201102__20201104__ifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zv3hdwdWEsn" title="Description of acquiree"&gt;The net purchase price was R$6,373 of which 100% was paid
in cash on the closing of the operation. The purchase price was adjusted to R$6,409, this price adjustment of R$ 36 was paid on February
2, 2021.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;MedPhone
is a clinical decision and leaflet consultation app in Brazil, that helps physicians, medical students and other healthcare professionals
to make faster and more accurate decisions on a daily basis.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
acquisition of MedPhone was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;Transaction
costs to date amount to R$&lt;span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z6PV8ThsVeqh" title="Transaction costs"&gt;158&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement
of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;There
are no trade receivables, right of use assets or lease liabilities associated with the acquisition of MedPhone.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Digital Services segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z3vbHMRhcPJe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&lt;span id="xdx_8B4_zpb10HpQncm2"&gt;The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zOVS1YPmqEHc" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zoXBh7qPJcph" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zRjmfbyWdBG5" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zAlzKp1ya0u7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;Medphone
contributed R$ &lt;span id="xdx_90C_eifrs-full--Revenue_pn3n3_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zsOUGQBUigml" title="Net revenue"&gt;49&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_904_eifrs-full--ProfitLossBeforeTax_c20201102__20201104__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zguN7LWvW269" title="Income loss before income taxes"&gt;57&lt;/span&gt; of loss before income taxes to the Company in 2020. If the acquisition had taken place at
the beginning of the period, net revenue for 2020 would have been increased by R$ &lt;span id="xdx_90C_ecustom--IncreaseInRevenue_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4gqNdsrs9h4" title="Increase in revenue"&gt;142&lt;/span&gt; and income before income taxes for 2020 would have
been increased by R$ &lt;span id="xdx_904_ecustom--IncreaseInIncomeBeforeIncomeTaxes_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zh2nvdlmuErf"&gt;46&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;(f)
Acquisition of FCMPB&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;On
November 9, 2020, Afya Brazil acquired &lt;span id="xdx_902_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pid_dp_uPure_c20211109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_ztDqMNTY9mVg"&gt;100&lt;/span&gt;% of the share capital of FCMPB. &lt;span id="xdx_906_eifrs-full--DescriptionOfAcquiree_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zVygu7oAtge9"&gt;The total net purchase price of R$379,913 was adjusted to
R$378,807 and is comprised of (i) R$189,913 paid in cash on the transaction closing date, and (ii) R$188,894 is payable in cash in four
equal installments through 2024, adjusted by the CDI rate.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;FCMPB
is a post-secondary education institution with government authorization to offer on-campus, undergraduate courses in the State of Para&#xed;ba
and medical course represents 99% of its 2019&#x2019;s net revenue. The acquisition contributed with 157 medical school seats&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
acquisition of FCMPB was accounted for under IFRS 3 &#x2013; Business Combinations.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;Transaction
costs to date amount to R$&lt;span id="xdx_903_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zAlGYuNybu91"&gt;721&lt;/span&gt; and were expensed and are included in general and administrative expenses in the consolidated statement
of income.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;At
the acquisition date, the fair value of the trade receivables acquired equals its carrying amount. Afya Brazil measured the acquired
lease liabilities using the present value of the remaining lease payments at the date of acquisition. The right-of-use assets were measured
at an amount equal to the lease liabilities and adjusted to reflect the unfavorable terms of the lease relative to market terms.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;The
goodwill recognized includes the value of expected synergies arising from the acquisition, which is not separately recognized. Goodwill
is allocated entirely to Undergrad segment. The goodwill recognized is not expected to be deductible for income taxes purposes.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_891_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOBpQx2ren03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&lt;span id="xdx_8B3_zxZLgCnXCsEf"&gt;The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: black"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zs5p8J3xdUik" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_zRTgQCQd4Nba" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;FCMPB
contributed R$ &lt;span id="xdx_90A_eifrs-full--Revenue_pn3n3_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zMuF15x0bQAa" title="Net revenue"&gt;10,509&lt;/span&gt; of net revenue and R$ &lt;span id="xdx_90C_eifrs-full--ProfitLossBeforeTax_c20201107__20201109__ifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOVx47gvTNt6" title="Income loss before income taxes"&gt;3,570&lt;/span&gt; of income before income taxes to the Company in 2020. FCMPB was constituted through
a spin-off recently in August, 2020 and there is no information before this period to be presented.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfBusinessCombinationsExplanatory>
    <afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock_zydnIkVgntta" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The preliminary
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zzwDCBsCntad" style="display: none; visibility: hidden"&gt;Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;iClinic&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Medicinae&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Medical
    Harbour&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Cliquefarma&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Shosp&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 10%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Unifipmoc&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Unigranrio&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;RXPRO&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zwtIXfJ3G7ag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,659&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zVjH5L39Ijak" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;201&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zcbD4US4ZI4b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;47&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8C0vggHKqp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,009&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zYBnfQ05a0m1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;397&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zjmZh8ccMdGi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zwrrlblXCHTf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34,755&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_pn3n3_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHLyohhr0NGc" style="text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;91&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Restrict
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RestrictedCash1_iI_pn3n3_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zNztwnmvO589" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,050&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zKdPH7Lzqlfe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1614"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RestrictedCash1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zgYRJOmTnsGb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1615"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RestrictedCash1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z0GN1GUgLeQ2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1616"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RestrictedCash1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zf8c1xQUgfr6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1617"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RestrictedCash1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z53WzDOYrQ24" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1618"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RestrictedCash1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhzp36kGiWff" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1619"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RestrictedCash1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zieeKPxVQcek" style="vertical-align: top; text-align: right" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1621"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Trade
    receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zeVTSSHngSx9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,201&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXCFVs0Xu2L8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1623"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zBh5ZZqtVXNc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSFPUvTrubR" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;501&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z9lKAvNygxB3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1626"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zWR5hDBQBICg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34,309&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zBe7w78O3lGg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;26,622&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zrZDNwOCHD54" style="vertical-align: top; text-align: right" title="Trade Receivales"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,211&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zd4d5QuWRw3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1631"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zCXBH1g6JvDc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1632"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--Inventories1_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zW5s2DvyuqR2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1633"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Inventories1_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zVqNE2o83APb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1634"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Inventories1_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zWfUYfMxl3C2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1635"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Inventories1_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zj95J1ynNjk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1636"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Inventories1_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z3E4BawG4hb7" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;352&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Inventories1_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zWxpeUjQ2QLh" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;246&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Recoverable
    taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zjwdwX6QW9Z3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;72&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zmivR5K0WOMk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;15&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zTydqBTDti8k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1641"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfUwAObNp3g5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1642"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zvdJYDeaW7f5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2kbPWa7BN4k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,295&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zudRuLdAgU93" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;738&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zNNWkT7XpOzc" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zahU2d5tvIm2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;20&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_ztZkd1LjYYf2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1648"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zjfiFhVkEIVh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z4eG2MnZr7z4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1650"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOBHJcyVMtvd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1651"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2xNKVXvi7Nk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;702&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqJqfmsJCYFg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;12,159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zC49thdaxI1" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;366&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGTZCOqWuLCh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9EegalhAM4j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1656"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z8EbQAtPTm47" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1657"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1bFVKAnQd59" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1658"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zARWkuDMhblk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1659"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zuIMjs6QsTPl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;52,079&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z0b35cYRyEx8" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeUHmVdTTi67" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zOWnSveQdmce" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;473&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zx352TrGEWag" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;17&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zzVhGoC0Xg2h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;34&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zlQBXOr4eWn6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1666"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zocZsUxXX5cc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z2qNOwYggSN9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;24,277&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zrwg6iWBjLw1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;40,775&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zeof2tPnW995" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;42&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Indemnification
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zv3egaittoJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zhwse1stMJHk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1672"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ImdemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zKKImePLzdXd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1673"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--ImdemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXgs5yFqUBYe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1674"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ImdemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zsw5pfgHZT43" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1675"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ImdemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zDRFWaVLS3d3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,331&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ImdemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zCgsmKa5V7Ef" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ImdemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zAp8B8hM9Pud" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1678"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zyb3aTKfykM" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;84,987&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zz0kTozBblrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,518&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zeZhfZMc8GWk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,359&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zioBiHHzsfe9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;14,991&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zriVEy5xOCVi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,856&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zwOqcnJIIl3j" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;227,534&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zykk4coI7tZ1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;510,356&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6NkOBisldk" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,330&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z71bJDBx7DZa" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;95,802&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zB6vm6TmLgAh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,751&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z2vBKqRH3msl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,601&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z8E0bvGY4JOh" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;16,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_znZ2IPsbb6Rf" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,259&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zRg1SJE6uyug" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;353,667&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9DniEVSUVUe" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;784,691&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zt1RhNgaWt41" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;8,480&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zHyuniKOR8Gc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;619&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zdTd0tjSGTOe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1697"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zlaVkoIDPUV7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zELVprZOvSCb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;8&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHmGIWxJ7K76" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_z7rixxBoo4ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;985&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z2P9gdvJ5562" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zHJDs8hDFZU" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,060&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zrLa6f2WZfx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1704"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zzwGdN7xpwg6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1705"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqCe2W0GYrK8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zcsDoYotJ8bd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;580&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zRX9dZLrAnwd" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1708"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zyY8xHlPVuYj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,179&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z8srDnSSSLPd" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,533&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zO4SBH3HkqVj" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1711"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Labor
    and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zxBXGgCVmZN1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,414&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGJ8vzV5Hgn9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;159&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zscuFA8FckCg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAz4Rw6Ppf28" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;102&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHBV1pZQGxJf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;89&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zKcCjT8avFTf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,306&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zGfJeCs9zGyd" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;22,854&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zjaIwr2y9IGc" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;62&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Taxes
    and contributions payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zZ2fFPO8qXRk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;77&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zT0hxQ8OtVT5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zCvkX8wJW2Z1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZlRzKlQMxuj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;307&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zMvUPcZCGE3h" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;123&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zhGOF4ZB06ei" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;758&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcyrqeVSsOW" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;94,025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwJ4tKmzGUne" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Provision
    for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zst7tNJVY892" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,252&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z7Auj4CvUws8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1729"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zYQaVSrSikLf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1730"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zCwmqBkOFFhk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1731"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zVOWJ7pb1424" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1732"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zABEDqCX9bDh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;7,331&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zh6PfGp51iO5" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,669&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7NhuwDPUMac" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1735"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Leases
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zz2G1gzJu8Zg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;88&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zMIxg8UbmN01" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1737"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zuolztjgJEo4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1738"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMs3ElPuT71l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1739"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zmHwWPACyx3k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1740"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zUWygh0obg88" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;52,079&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zQ0bsuMLl7W7" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zxVMSx2HBQI6" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zX797RaT5Ks4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;400&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfyXM4VTDP86" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1745"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znXXtY9MmHu3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;35&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zhNUe6QghYgb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zGDrZLhSggEg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;167&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zyLgGLgo3HN6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,745&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zNEU8656p6q5" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,387&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zhX4veV1vLvi" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zgN3yNmWV7gg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1752"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z9JsKcrvvmc1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1753"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zEi88OnO4qLk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1754"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfkXz9Qo5wdg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z4FRKRt54z7d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1756"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zYdl9FwFsuH8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,739&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z9clBQgJw7bk" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,878&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z7IYuGaEO33g" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1759"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKmsXmnA3HDk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;3,850&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zBIzYz5VHy2d" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;163&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z4wBUrWQ0I46" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;345&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zZP5K2Holqg4" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,000&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHyaH5AG0dp3" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;380&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zmz8P8Vdlgd2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;113,122&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zolJcRpEOWP6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;295,808&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zwYTYNoj2ET8" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;1,304&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Total
    identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zQ5fxvqaoCme" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;91,952&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zxuvaSVFlEzb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,588&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_ziV6wP4QOr5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,256&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zSGev9bCEwH1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;15,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zFtch7xFbYzj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;4,879&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zsYEBLuwSoNf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;240,545&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXtLcknO5EAg" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;488,883&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zcG7RIuGVhwe" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,176&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Preliminary
    goodwill arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_znce3FcKtQsh" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;99,168&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zsiWkqMxBvH9" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,584&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z7ykbSwRV2i6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zMCOxUv89k2e" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,588&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zHZfHTtw9xTd" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,022&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zcU7nPSexrBi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zqkOjB8qam4f" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;130,073&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zflnfEBkbVXi" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;38,446&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Purchase
    consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_z0FJUEIRMIB" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;191,120&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zXdvMFXObbF1" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;9,172&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zNNpCFcNaWL7" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;11,278&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zAnlV0Sfo0pa" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;22,089&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zLEjf5DEkY7b" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;7,901&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z5eFVhCWgPrb" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;328,322&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zk2KNwWadx7a" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;618,956&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zqwmsWOsXJj4" style="border-bottom: black 1pt solid; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;45,622&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_ziedsoW7DRfc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;119,620&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGFhSIdhnFw6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,600&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zqmJhiEXno4a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z1ajmlEGDBOj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;16,166&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zEHlO2PsFFp6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zVBQ0DlyNpyb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;328,322&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zDh1LzvYiCw1" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;375,670&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z3r0KnrEwN0f" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,263&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Contingent
    consideration&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_fKCoqKQ_____zW2ibgJpQ7T2" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1801"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_fKCoqKQ_____zPrB9eUny0Ic" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,572&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_fKCoqKQ_____zjX9spV1fQJ8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;6,278&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_fKCoqKQ_____zWJYWKHdKVb1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;2,923&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_fKCoqKQ_____z00b5mTAh6p3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;1,592&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCop_zLrJMURP4RN5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;sup&gt;(*)&lt;/sup&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1806"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_fKCoqKQ_____zVozj4iDnJxi" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;sup&gt;(**)&lt;/sup&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ContingentConsiderationRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_ztlNmgAuuiBf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,171&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Consideration
    to be transferred&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zfbJEFzkrZ4l" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1809"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zau9Y5BOJrUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ConsiderationToBeTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zvQN9Axx6S9c" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1811"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zDNakicKC1Qe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1812"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ConsiderationToBeTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_ztsvu9qpEzc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;454&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ConsiderationToBeTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXy56yRKZ931" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1814"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ConsiderationToBeTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zF98bEbiNrCk" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;243,286&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ConsiderationToBeTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z05PCzDawVr8" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;76&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Paid
    in shares&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zDU5SDBtFKJ4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;71,500&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zGLHuYT9RL5d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1818"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInShares_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zOtjBnq9pXhg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1819"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zS1QabTYdYi4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;3,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PaidInShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zUQQ8lm8aMN7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1821"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PaidInShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zhG2fcFWoNj8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1822"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--PaidInShares_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zOo0CHhdQvlh" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zfUxgugHQiLl" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,112&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;&lt;i&gt;Analysis
    of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Transaction
    costs of the acquisition (included in cash flows from operating activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zJqasYn0v6E3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;856&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zfk8yIcx9Ja7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;117&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zIkvr0M6W70k" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;144&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zmaeklgwo2N7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zhZnuJNf67V6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;188&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zXkSvbiwoFE4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;177&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaFipmocSAMember_zqWQTSjixGyf" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;10,990&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_z6E6LnOQXhfa" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;264&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;Cash
    paid net of cash acquired with the subsidiary (included in cash flows from investing activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zKt7oPmwaHL" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;117,961&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_z0mdhm7MiaX9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,399&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z62Vu9TOlMUa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;4,953&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zfhBVCCMM4ee" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;15,157&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zNTt7VALLe8d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;5,458&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zD8KWoqdhRrc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;322,182&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_z48woKyFJInc" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;340,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zucUHqr8J9w2" style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;30,172&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;Net
    of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicMember_zGa3sfVuzh6c" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;118,817&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zSbdbol3fAH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,516&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zrUqBedfIAy6" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,097&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_zXnvrcDlKGs1" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;15,493&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_zOSkPnUfV7Jk" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;5,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zFeeTYAM5402" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;322,359&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--NetOfCashFlowOnAcquisition_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember_zfnlapsyczbl" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;351,905&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zmXGGc2NhKEj" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 7pt"&gt;&lt;b&gt;30,436&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are 40 additional seats
still pending approval, which, if approved by the Ministry of Education, will result in a potential additional payment of up to
R$ 50,000.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">1659000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">201000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">47000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">1009000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">397000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">6140000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">34755000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">91000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <afya:RestrictedCash1
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">6050000</afya:RestrictedCash1>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">1201000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">159000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">501000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">34309000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">26622000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">1211000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:Inventories1
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">352000</afya:Inventories1>
    <afya:Inventories1
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">246000</afya:Inventories1>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">72000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">15000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">1000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">1295000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">738000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">112000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">20000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">2000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">702000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">12159000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">366000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">88000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">52079000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">87265000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">82000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">473000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">17000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">34000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">5000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">24277000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">40775000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">42000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">1252000</afya:ImdemnificationAssets>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">7331000</afya:ImdemnificationAssets>
    <afya:ImdemnificationAssets
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">71669000</afya:ImdemnificationAssets>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">84987000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">4518000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">7359000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">14991000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">4856000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">227534000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">510356000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">6330000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">95802000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">4751000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">7601000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">16501000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">5259000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">353667000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">784691000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">8480000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">619000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">6000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">8000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">1000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">985000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">6197000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">1060000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">299000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">580000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">30179000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">5533000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">1414000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">159000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">4000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">102000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">89000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">5306000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">22854000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">62000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">77000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">4000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">1000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">307000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">123000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">758000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">94025000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">100000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">1252000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">7331000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">71669000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">88000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">52079000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">87265000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">82000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">400000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">35000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">3000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">167000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">10745000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">3387000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">5739000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">4878000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">3850000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">163000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">345000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">1000000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">380000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">113122000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">295808000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">1304000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">91952000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">4588000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">7256000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">15501000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">4879000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">240545000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">488883000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">7176000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">99168000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">4584000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">4022000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">6588000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">3022000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">87777000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">130073000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">38446000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">191120000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">9172000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">11278000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">22089000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">7901000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">328322000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">618956000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">45622000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">119620000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">5600000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">5000000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">16166000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">5855000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">328322000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">375670000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">30263000</ifrs-full:CashTransferred>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicinaeMember"
      decimals="-3"
      id="Fact001802"
      unitRef="BRL">3572000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      id="Fact001803"
      unitRef="BRL">6278000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      id="Fact001804"
      unitRef="BRL">2923000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      id="Fact001805"
      unitRef="BRL">1592000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">10171000</ifrs-full:ContingentConsiderationRecognisedAsOfAcquisitionDate>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">454000</afya:ConsiderationToBeTransferred>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">243286000</afya:ConsiderationToBeTransferred>
    <afya:ConsiderationToBeTransferred
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">76000</afya:ConsiderationToBeTransferred>
    <afya:PaidInShares
      contextRef="AsOf2020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">71500000</afya:PaidInShares>
    <afya:PaidInShares
      contextRef="AsOf2020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">3000000</afya:PaidInShares>
    <afya:PaidInShares
      contextRef="AsOf2020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">5112000</afya:PaidInShares>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-082020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">856000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-082020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">117000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">144000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">336000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-022020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">188000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-07-192020-07-20_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">177000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaFipmocSAMember"
      decimals="-3"
      unitRef="BRL">10990000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-01-012020-12-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">264000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-082020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">117961000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-082020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">5399000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">4953000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">15157000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-022020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">5458000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-07-192020-07-20_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">322182000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">340915000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-01-302020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">30172000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-082020-11-09_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">118817000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-082020-11-09_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">5516000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-082020-11-09_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">5097000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-022020-11-05_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">15493000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-022020-11-03_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">5646000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-07-192020-07-20_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">322359000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-05-042020-05-05_custom_SociedadeUniversitariaGranarioSAMember"
      decimals="-3"
      unitRef="BRL">351905000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-01-302020-01-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">30436000</afya:NetOfCashFlowOnAcquisition>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-01-21_custom_IClinicMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-03-232021-03-25_custom_IClinicMember">The aggregate purchase price of R$191,120 is comprised of: (i) 62.6% was paid in cash, and (ii) 37.4%
was settled with Afya's shares on the transaction closing date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-01-192021-01-21_custom_IClinicMember"
      decimals="0"
      unitRef="BRL">856</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock contextRef="From2021-01-012021-12-31_custom_IClinicMember">&lt;p id="xdx_894_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--IClinicMember_zC4v6h0VeMj4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B6_zov9ELuceLXb" style="display: none; visibility: hidden"&gt;Schedule of acquisition of UniRedentor&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98B_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVMIRzdnM1Q" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210119__20210121__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z5WXLkJTe2ek" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-01-192021-01-21_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-01-192021-01-21_custom_IClinicMember"
      decimals="-3"
      unitRef="BRL">16456000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-192021-01-21_custom_IClinicMember"
      decimals="0"
      unitRef="BRL">8250</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_IClinicMember"
      decimals="0"
      unitRef="BRL">1158</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_IClinicMember"
      decimals="0"
      unitRef="BRL">1320</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-03-25_custom_CliquefarmaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-03-232021-03-25_custom_MedicinaeMember">The aggregate purchase price of R$9,172 is comprised by: i) R$ 5,600 of which 100% was
paid in cash on the transaction closing date; and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$ 4,400 is payable
in connection with product development goals for 2021 and revenue achievements for 2022. The contingent consideration of R$3,572 is based
on the present value of the obligation considering the facts and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">117</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUnislTableTextBlock contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember">&lt;p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfUnislTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zGAk6QiRz1oi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zu05rfh6d9Je" style="display: none; visibility: hidden"&gt;Schedule of acquisition of UniSL&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210323__20210325__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_ze6Zg5M2ZAWk" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUnislTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-03-232021-03-25_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">359000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-03-232021-03-25_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">1518</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">105</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">113</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-06-01_custom_HarbourMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-04-062021-04-08_custom_HarbourMember">The aggregate purchase price of R$11,278 is comprised by: i) R$ 5,000 of which
100% was paid in cash on the transaction closing date; and ii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ 9,000
is payable in connection with product development goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration
of R$6,278 is based on the present value of the obligation considering the facts and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-04-062021-04-08_custom_HarbourMember"
      decimals="0"
      unitRef="BRL">144</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfPebmedTableTextBlock contextRef="From2021-01-012021-12-31_custom_HarbourMember">&lt;p id="xdx_890_ecustom--ScheduleOfAcquisitionOfPebmedTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--HarbourMember_zKtdf2BhXfS9" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_zW5lALiYIUvk" style="display: none; visibility: hidden"&gt;Schedule of acquisition of PEBMED&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zyOszcZMTczk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_z1sutBCAaPrl" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfPebmedTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-082020-11-09_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost
    This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:RevenueOfAcquiree
      contextRef="From2021-04-062021-04-08_custom_HarbourMember"
      decimals="0"
      unitRef="BRL">484</ifrs-full:RevenueOfAcquiree>
    <ifrs-full:Revenue
      contextRef="From2021-04-062021-04-08"
      decimals="-3"
      unitRef="BRL">1945000</ifrs-full:Revenue>
    <ifrs-full:RevenueOfCombinedEntity
      contextRef="From2021-01-012021-12-31_custom_HarbourMember"
      decimals="0"
      unitRef="BRL">268</ifrs-full:RevenueOfCombinedEntity>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_custom_HarbourMember"
      decimals="0"
      unitRef="BRL">127</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-04-16_custom_CliquefarmaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-04-142021-04-16_custom_CliquefarmaMember">The aggregate purchase price of R$ 22,089 is comprised by:
(i) R$ 16,166 paid in cash; (ii) R$3,000 settled with Afya's shares on the transaction closing date; and (iii) an earn-out (&#x201c;contingent
consideration&#x201d;) of R$ 3,000 is payable in relation to product development. The contingent consideration of R$2,923 is based on
the present value of the obligation considering the facts and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-04-142021-04-16_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">336</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfFesarTableTextBlock contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember">&lt;p id="xdx_89F_ecustom--ScheduleOfAcquisitionOfFesarTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--CliquefarmaMember_zrWMfV6zM5F2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B6_z7UrP5URV2fc" style="display: none; visibility: hidden"&gt;Schedule
of acquisition of FESAR&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_988_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zsOFIQ0cjkO9" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210414__20210416__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_z8UvFfDdR9gh" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfFesarTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-04-142021-04-16_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">3268000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_custom_CliquefarmaMember"
      decimals="0"
      unitRef="BRL">1752</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">1435</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">926</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-05-13_custom_ShospMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-05-112021-05-13_custom_ShospMember">The aggregate purchase price of R$7,901 is comprised by: i) R$ 5,855 was paid
in cash; ii) R$ 454 of consideration to be transferred; and iii) an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ 1,793
is payable in relation to product development. The contingent consideration of R$1,592 is based on the present value of the obligation
considering the facts and circumstances at the acquisition date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-05-112021-05-13_custom_ShospMember"
      decimals="0"
      unitRef="BRL">188</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock contextRef="From2021-01-012021-12-31_custom_ShospMember">&lt;p id="xdx_89B_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--ShospMember_zIt6dmS6HhHc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B8_zRJn4wkUPehb" style="display: none; visibility: hidden"&gt;Schedule
of acquisition of MedPhone&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zVrX3w2BfcB6" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210311__20210313__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zP8amaDKxti7" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-03-112021-03-13_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-05-112021-05-13_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">1376000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-05-112021-05-13_custom_ShospMember"
      decimals="0"
      unitRef="BRL">448</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_ShospMember"
      decimals="0"
      unitRef="BRL">306</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_ShospMember"
      decimals="0"
      unitRef="BRL">82</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-06-30_custom_UNIFIPMocMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember">The aggregate purchase price is R$ 328,322 and the total amount was paid in cash. There are 40 additional seats still pending approval,
which, if approved by the Ministry of Education, will result in a potential additional payment of up to R$ 50,000. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember"
      decimals="0"
      unitRef="BRL">177</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember">&lt;p id="xdx_893_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIFIPMocMember_zlhKd4NkmGuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BC_zIOGWUEM2l1g" style="display: none; visibility: hidden"&gt;Schedule of acquisition of FCMPB&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98D_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-082020-11-09_ifrs-full_LicencesMember">With-and-without
    method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-03_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember"
      decimals="-3"
      unitRef="BRL">69887000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-06-012021-06-30_custom_UNIFIPMocMember"
      decimals="0"
      unitRef="BRL">19458</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember"
      decimals="0"
      unitRef="BRL">46150</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_UNIFIPMocMember"
      decimals="0"
      unitRef="BRL">12847</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-08-04_custom_UNIGRANMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2021-08-022021-08-04_custom_UNIGRANMember">The aggregate original purchase price of R$ 626,116
of which 60% was paid in cash on the transaction closing date, and 40% is payable in cash in four equal installments through 2022 to
2025, adjusted by the CDI rate, was adjusted by R$7,160, because of the actual net debt, to R$618,956. There are 82 additional seats
still pending approval which, if approved by MEC, will result in a potential additional payment of up to R$90,200. Given the future event
that will trigger the potential payout is not under the Company&#x2019;s control, the probability of such payout cannot be reliably estimated
and thus the contingent consideration was not measured at acquisition date. Should the additional seats be approved it will result in
additional licenses, which will be measured accordingly if and when approved.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-08-022021-08-04_custom_UNIGRANMember"
      decimals="0"
      unitRef="BRL">10990</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUnigranTableTextBlock contextRef="From2021-01-012021-12-31_custom_UNIGRANMember">&lt;p id="xdx_891_ecustom--ScheduleOfAcquisitionOfUnigranTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UNIGRANMember_zyXgO4PauZ0j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BB_zWeg2ldwu09l"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zBMyQzLIX536" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200803__20200804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaGranarioSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zh0AZu39YWsk" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUnigranTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_LicencesMember">With-and-without
    method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-08-032020-08-04_custom_SociedadeUniversitariaGranarioSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2021-08-022021-08-04_custom_UNIGRANMember"
      decimals="-3"
      unitRef="BRL">123369000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-08-022021-08-04_custom_UNIGRANMember"
      decimals="0"
      unitRef="BRL">33450</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_UNIGRANMember"
      decimals="0"
      unitRef="BRL">150456</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_UNIGRANMember"
      decimals="0"
      unitRef="BRL">22191</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2020-10-01_custom_PXPROMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-09-282020-10-01_custom_PXPROMember">The aggregate purchase price of R$45,622 is comprised by: i) R$ 30,263
was paid in cash; ii) R$ 76 to be paid as price adjustment, iii) R$5,112 settled with Afya's treasury shares on the transaction closing
date; and (iv) an earn-out (&#x201c;contingent consideration&#x201d;) of R$ 21,000 is payable in relation to revenue achievements. The
contingent consideration of R$10,171 is based on the present value of the obligation considering the facts and circumstances at the acquisition
date.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-09-282020-10-01_custom_PXPROMember"
      decimals="0"
      unitRef="BRL">264</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfRXPROTableTextBlock contextRef="From2021-01-012021-12-31_custom_PXPROMember">&lt;p id="xdx_892_ecustom--ScheduleOfAcquisitionOfRXPROTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PXPROMember_zKHdu9aa3eTj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zLLkcFdWjoij"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_z3zRq7R9cJwb" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98F_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zeZZoDFgzDC2" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zwWF1IKRBx9h" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfRXPROTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-10-012021-10-01_custom_RXPROMember_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-09-282020-10-01_custom_PXPROMember"
      decimals="-3"
      unitRef="BRL">907000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-09-282020-10-01_custom_PXPROMember"
      decimals="0"
      unitRef="BRL">984</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2021-01-012021-12-31_custom_PXPROMember"
      decimals="0"
      unitRef="BRL">3155</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2021-01-012021-12-31_custom_PXPROMember"
      decimals="0"
      unitRef="BRL">325</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_ecustom--ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock_zsNqcDkcP1aa" style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&lt;span id="xdx_8BE_zMeSHT02Wbp6"&gt;The
fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/10.5pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 42%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt; &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;UniRedentor&lt;sup id="xdx_F59_zAvFUToNjFz8"&gt;*&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;UniSL&lt;sup id="xdx_F5F_zCrp9wUMkNth"&gt;**&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;PEBMED&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;FESAR&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;MedPhone&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;FCMPB&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    and cash and equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zAVb3yo3wBJg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,796&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zNxa5tHdSZLf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,245&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zEOClRFGyeTg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,119&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zxkS1YUMKw0a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,236&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zK3fJxFOyUib" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalentsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z73IKoju1AF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash and cash and equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade
    receivables &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zgebA5hQHK2b" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,800&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zmwtcWPAC5O2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,567&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z5J7bC2F7m5d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,984&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDbopQFTRoDj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1990"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_ztSTqHM49wSc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1992"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeReceivablesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zjVTUcP68ki5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,148&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Inventories&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zIYUiIS7KTd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl1996"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zAORDJDdEw6i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;467&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_znAO7mDFhcYb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2000"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zLtyNUiPfRnh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2002"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zJA29mowuDqd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2004"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--InventoryRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zyhKgYKsRsn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Inventories"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2006"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Recoverable
    taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLzQhKtmmn1g" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdU8ltsEqaRj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;822&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zTDrr01O6US7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2012"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrJovtlYZABf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2014"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zc822jJkMSz" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RecoverableTaxesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVulIgfPSYg2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Recoverable taxes"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2018"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zLlVTGuu8227" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,486&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zhKffr4l9Ioj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,251&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zCMHVcSXhRN7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zzbJUllMn8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfRCws1fjAL1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zevt8PCqwfkd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;123&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Indemnification
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--IndemnificationAssets_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z2YfRdUlLECj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;710&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--IndemnificationAssets_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zHJ6GfXXjym4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,645&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IndemnificationAssets_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z1BB1trtemak" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--IndemnificationAssets_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z4KMY1wZOVod" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IndemnificationAssets_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zqzGNull8Fq2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2040"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndemnificationAssets_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zGbNk9BHa0D3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Indemnification assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2042"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Right-of-use
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zHAUsoWFdwR5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zf2UGB0tyJN8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,062&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zR4myGuTPKfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;865&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zIvd0Jkhm42d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2050"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zRBPD644qCH7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2052"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RightOfUseAssetsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRQkSu6TAHE6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Property
    and equipment&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCxWtOhqSzAk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,207&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zypUcLIgkH49" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,144&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z6OJON8HlN59" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;391&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ztKSE8KkK655" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,176&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z1IgIrP2N5a4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2064"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zOraqDymNOfa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Property and equipment"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Intangible
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zoiVPseg9SA5" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;142,399&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z3UBQHD3wfU8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;314,097&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziE4HZePi3Qe" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,372&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zztkEPGfxmc7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;167,106&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQjfQEYLB78" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,727&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zCuTrBJS2Yed" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Intangible assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;264,782&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zG0Ql09YhReg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,666&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ztqESusg2JTg" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;421,300&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zs6YJCMJrGQ5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;83,242&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zf2XLTNzDKn3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;201,431&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zakIjhXPqXg8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,796&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssetsRecognisedAsOfAcquisitionDate_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;297,778&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYVYWnqzF3M9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;746&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zUeODflqDsC" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,554&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zVHLo99fsbSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zrAoBduLXoeh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;143&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zciqmDMxQIWg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2100"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zYqvcBOcnoy" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;173&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7MFMjiQLnfl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;16,187&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z9UX0SPbVkUf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,541&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zRZgCBuidBY1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2108"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z6wlcFGs5WLj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,087&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zlYcE3rXpVU4" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2112"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--BorrowingsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zHWMKKvUX61a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2114"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zuTjCGJDqTQf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,265&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zbmDpqPWIV1f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,062&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zofQ8vOGAEL8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;865&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z1AIfhIdKzO8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2122"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zfXl2nWtp5M6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2124"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zvSzwv0hrGV" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,663&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Labor
    and social obligations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZQtTVdjn7Fe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,471&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zTm4DtlvHAsk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,070&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zmCpWtu8RVQ6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,786&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zP5eWwj185oc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,801&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFj6WtjBDTNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2136"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LaborAndSocialObligationsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z1eGhO7wZC47" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Labor and social obligations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,832&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Taxes
    payable &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zGyMOGfYZaEd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;850&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z8x56FftsgBb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,779&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zB167xTyiR26" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zQe2elXTOKYc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;29&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zNQQwFxmywf5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--TaxesPayableAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zVt8OMeZ03U9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Taxes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Provision
    for legal proceedings&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z0GDZywEkHi7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;710&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zyzcOPBK1LJl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,645&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zFoEjEBYMY8d" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,350&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_z8EmaEquKx6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,871&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zW9eaPY1rY8b" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2160"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProvisionForLegalProceedingsAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z6lBY2197RB3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Provision for legal proceedings"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2162"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zU9OVtZgQ8eh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,994&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zJsENwKvpIpg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,084&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zhenAaZMRQ2a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,312&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zH9Qck7htWMe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;759&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZxnNK94xKGf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--AdvancesFromCustomersAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zcy4zBkrXJl2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,781&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotesPayables_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCu2FCwNbwO6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2176"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NotesPayables_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zVCVwA8tJib2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;80,526&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotesPayables_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zx5J2lS5JmVc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NotesPayables_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zk4QjeBuhmM8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NotesPayables_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zi6QsQiH4Aja" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2184"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NotesPayables_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_ztexIzbGEB8k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Other
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zCbwHPDABXg2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2188"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_z1b3gRLxDBW7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,754&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zqCIWe7c3oA3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2192"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zBbdYryDw0vg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2194"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVHvUY5i16cd" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;228&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--OtherLiabilitiesAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zlULXa3tMbj1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2198"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYJkeeIrOMCh" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;44,223&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zdvLlR3bqZDd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;232,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_z9Bq5YYaGa61" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;34,547&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zkrUtMYxydX1" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,690&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZrHEYduPMC4" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;230&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FinancialLiabilitiesRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zE1gAprjJYs3" style="border-top: black 1pt solid; border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total Liabilites"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;29,454&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total
    identifiable net assets at fair value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zMuTCasS8IS2" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;132,443&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zO5EeInsfHA7" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;189,285&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_ziB5IfohSoTc" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;48,695&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zO5IkSBPt9Lg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;190,741&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2MeYPvL7nX" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zJii1mi8hbM9" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total identifiable net assets at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;268,324&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt; color: #0D0E00"&gt;Goodwill
    arising on acquisition&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEBP0fVsvRh" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zeD5ej7YtfCj" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zfsbdJODltpf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;84,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zNIvYgJo0kxb" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zIiqISV2FmK5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,843&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--GoodwillRecognisedAsOfAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zXWghwhespDd" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Preliminary goodwill arising on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Purchase
    consideration transferred&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zeEAl8YBTEC3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;210,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpfJ9eg4bKi5" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;193,705&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zzjkQ6xOOoK9" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;132,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zMVSb9ZWRxPc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;262,405&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zpDoOnBklbOk" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitiondateFairValueOfTotalConsiderationTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_z85IH8rQhUe4" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Purchase consideration transferred"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;378,807&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    paid&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--CashTransferred_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zjrHviUw1Q21" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;114,607&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashTransferred_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zxQDz4vAwmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,065&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashTransferred_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zjjP3lEhVQic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;115,339&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashTransferred_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDQcHzpwEIPa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;260,836&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashTransferred_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zFrE7Fhwfpua" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,373&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CashTransferred_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zWgoITNOLXMg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;189,913&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Payable
    in installments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zTPu93oUK5G1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;95,498&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zpT2t0QR7Mc7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52,640&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zSGtZ0Esp2te" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2264"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zISaWfRjlkFe" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,569&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z4UFAFAqtikk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--PayablInInstallmentsAcquisitionDate_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zRhGJXWF9RCi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payable in installments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;188,894&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Paid
    in Afya Brazil&#x2019;s shares&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--PaidInAfyaBrazilsShares_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zZdjBS4eo4F2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2272"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--PaidInAfyaBrazilsShares_iI_pp0i_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zZR29SxWh5ml" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--PaidInAfyaBrazilsShares_iI_c20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zDFZAGwkTe3i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,531&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zDP8i6MEP4H3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--PaidInAfyaBrazilsShares_iI_c20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zZnYuBkzFTNc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2280"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--PaidInAfyaBrazilsShares_iI_pii_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zQLsUbZrIDS" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2282"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;i&gt;Analysis
    of cash flows on acquisition:&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transaction
    costs (included in cash flows from operating activities)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z7sY5B4QLffc" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,380&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_pin3_c20200503__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_zvPYmbPS5kX6" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Paid in Afya Brazil's shares"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,666&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zebx1JhzEYh5" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;613&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zGRXSxClklu7" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,047&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z2WJXEDLrr0k" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zPT7QjmULYp9" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Transaction costs (included in cash flows from operating activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;721&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    paid, net of cash acquired with the subsidiary (included in cash flows from investing activities) &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_z5nxvCxmHf57" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;102,811&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;137,820&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zXUNj4fH6FK2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;114,220&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zVKeYuO8YR14" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;256,600&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z13yUYixlnpj" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,313&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013_c20201108__20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zuZKl77xuRU1" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;189,813&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    of cash flow on acquisition &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetOfCashFlowOnAcquisition_c20200130__20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--SociedadeUniversitariaRedentorSAMember_zYkZLwsBvKQg" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;104,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetOfCashFlowOnAcquisition_pn3n3_c20200504__20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroUniversitarioSaoLucasLtdaMember_ziKynDSkF499" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;139,486&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NetOfCashFlowOnAcquisition_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember_zgCV2RnT839b" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;114,833&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zUwKk8nsj9K7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;258,647&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NetOfCashFlowOnAcquisition_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_zVGl60C0Oby7" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;6,471&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetOfCashFlowOnAcquisition_c20201108__20201209__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember_zpObDsnvBPl8" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Net of cash flow on acquisition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;190,534&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; color: #0D0E00; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F06_ztIuyFXfHNm5" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zaO3k9qNVr96" style="font-family: Arial, Helvetica, Sans-Serif"&gt;During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: -0.25in; color: #0D0E00"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0D_ztROSjqJfKFh" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00"&gt;**&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_z3KRsfIOe955" style="font-family: Arial, Helvetica, Sans-Serif; color: #0D0E00"&gt;During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;roperty
and equipment of R$7&lt;span style="color: #0D0E00"&gt;.&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">11796000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">3245000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">1119000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">4236000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">60000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">100000</ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">4800000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">21567000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">7984000</afya:TradeReceivablesAsOfAcquisitionDate>
    <afya:TradeReceivablesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">8148000</afya:TradeReceivablesAsOfAcquisitionDate>
    <ifrs-full:InventoryRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">467000</ifrs-full:InventoryRecognisedAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">3000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:RecoverableTaxesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">822000</afya:RecoverableTaxesAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">2486000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">7251000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">161000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">42000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">9000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:OtherAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">123000</afya:OtherAssetsAsOfAcquisitionDate>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">710000</afya:IndemnificationAssets>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">12645000</afya:IndemnificationAssets>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">12350000</afya:IndemnificationAssets>
    <afya:IndemnificationAssets
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">6871000</afya:IndemnificationAssets>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">10265000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">42062000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">865000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <afya:RightOfUseAssetsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">23663000</afya:RightOfUseAssetsAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">4207000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">19144000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">391000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">23176000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">962000</ifrs-full:PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">142399000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">314097000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">60372000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">167106000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">3727000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">264782000</ifrs-full:IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">176666000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">421300000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">83242000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">201431000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">3796000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">297778000</ifrs-full:FinancialAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">746000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">3554000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">9024000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">143000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">173000</ifrs-full:TradeAndOtherPayablesRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">16187000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">58541000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">1087000</ifrs-full:BorrowingsRecognisedAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">10265000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">42062000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">865000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LeaseLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">23663000</afya:LeaseLiabilitiesAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">4471000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">8070000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">1786000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">1801000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:LaborAndSocialObligationsAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">3832000</afya:LaborAndSocialObligationsAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">850000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">5779000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">1210000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">29000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">2000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:TaxesPayableAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">5000</afya:TaxesPayableAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">710000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">12645000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">12350000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:ProvisionForLegalProceedingsAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">6871000</afya:ProvisionForLegalProceedingsAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">10994000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">6084000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">9312000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">759000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:AdvancesFromCustomersAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">1781000</afya:AdvancesFromCustomersAsOfAcquisitionDate>
    <afya:NotesPayables
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">80526000</afya:NotesPayables>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">14754000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <afya:OtherLiabilitiesAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">228000</afya:OtherLiabilitiesAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">44223000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">232015000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">34547000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">10690000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">230000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">29454000</ifrs-full:FinancialLiabilitiesRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">132443000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">189285000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">48695000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">190741000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">3566000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">268324000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">77662000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">4420000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">84175000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">71664000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">2843000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:GoodwillRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">110483000</ifrs-full:GoodwillRecognisedAsOfAcquisitionDate>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">210105000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">193705000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">132870000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">262405000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">6409000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">378807000</ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">114607000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">141065000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">115339000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">260836000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">6373000</ifrs-full:CashTransferred>
    <ifrs-full:CashTransferred
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">189913000</ifrs-full:CashTransferred>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">95498000</afya:PayablInInstallmentsAcquisitionDate>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">52640000</afya:PayablInInstallmentsAcquisitionDate>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">1569000</afya:PayablInInstallmentsAcquisitionDate>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">36000</afya:PayablInInstallmentsAcquisitionDate>
    <afya:PayablInInstallmentsAcquisitionDate
      contextRef="AsOf2020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">188894000</afya:PayablInInstallmentsAcquisitionDate>
    <afya:PaidInAfyaBrazilsShares
      contextRef="AsOf2020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">17531000</afya:PaidInAfyaBrazilsShares>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">1380000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-05-032020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="0"
      unitRef="BRL">1666000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">613000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812"
      decimals="-3"
      unitRef="BRL">2047000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">158000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">721000</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">102811000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">137820000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">114220000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812"
      decimals="-3"
      unitRef="BRL">256600000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">6313000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013
      contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">189813000</ifrs-full:CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-01-302020-01-31_custom_SociedadeUniversitariaRedentorSAMember"
      decimals="-3"
      unitRef="BRL">104191000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember"
      decimals="-3"
      unitRef="BRL">139486000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-07-192020-07-20_custom_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember"
      decimals="-3"
      unitRef="BRL">114833000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember1110215812"
      decimals="-3"
      unitRef="BRL">258647000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="-3"
      unitRef="BRL">6471000</afya:NetOfCashFlowOnAcquisition>
    <afya:NetOfCashFlowOnAcquisition
      contextRef="From2020-11-082020-12-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember"
      decimals="-3"
      unitRef="BRL">190534000</afya:NetOfCashFlowOnAcquisition>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2020-01-31_custom_UniRedentorMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-01-282020-01-31_custom_UniRedentorMember">The original purchase price of R$214,608, was adjusted by R$4,503
and was comprised by: i) R$114,607 paid in cash on the acquisition date; and ii) R$100,000 is payable in five equal installments from
January 2021 to July 2024, adjusted by the CDI rate. The purchase consideration adjustment of R$4,503 was deducted from the first installment
due in January 2021.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-01-282020-01-31_custom_UniRedentorMember"
      decimals="0"
      unitRef="BRL">1380</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock contextRef="From2021-01-012021-12-31_custom_UniRedentorMember">&lt;p id="xdx_895_ecustom--ScheduleOfAcquisitionOfUniredentorTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniRedentorMember_z2fcWB3rBBlc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BE_zjxRcRDmmTY7"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z7YEmaeRyFH9" style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt" title="Valuation technique"&gt;&lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20210101__20211231__ifrs-full--BusinessCombinationsAxis__custom--SociedadeUniversitariaRedentorSAMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zin473Y7fpD4" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_LicencesMember">With-and-without
    method
    The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-01-282020-01-31_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">96065000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-01-282020-01-31_custom_UniRedentorMember"
      decimals="0"
      unitRef="BRL">30952</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2020-01-282020-01-31_custom_UniRedentorMember"
      decimals="0"
      unitRef="BRL">5931</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2020-01-282020-01-31_custom_UniRedentorMember"
      decimals="0"
      unitRef="BRL">321</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2020-05-05_custom_UniSLMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-05-032020-05-05_custom_UniSLMember">The original
purchase consideration of R$201,521 was adjusted by R$7,816, of which: (i) 70% is payable in cash on the transaction closing date, and
(ii) 30% is payable in cash in three equal installments through 2023, adjusted by the CDI rate. The purchase consideration adjustment
of R$7,816 was deducted from the first installment due in May 2021.</ifrs-full:DescriptionOfAcquiree>
    <afya:AdditionalPaymentMade
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">80000</afya:AdditionalPaymentMade>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">1666</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfUnisl1TableTextBlock contextRef="From2021-01-012021-12-31_custom_UniSLMember">&lt;p id="xdx_89C_ecustom--ScheduleOfAcquisitionOfUnisl1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--UniSLMember_zCTapHyGyKZ4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BE_zbdcoyY1QUHb"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_984_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_z75keHgw1i0c" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200504__20200505__ifrs-full--BusinessCombinationsAxis__custom--CentroUniversitarioSaoLucasLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zwT9hpoM2CUh" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfUnisl1TableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_LicencesMember">With-and-without
    method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-05-042020-05-05_custom_CentroUniversitarioSaoLucasLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="-3"
      unitRef="BRL">113894000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">30649</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">57477</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2020-05-032020-05-05_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">9455</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2020-07-20_custom_PEBMEDMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-07-182020-07-20_custom_PEBMEDMember">The original purchase price of R$ 132,900 was adjusted by R$ 30 and was comprised
by: i) R$115,339 paid in cash on the acquisition date; and ii) R$ 17,531 was paid with Afya Brazil&#x2019;s shares which were afterwards
contributed to the Company in exchange of issuance of 141,976 of its own shares.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-07-182020-07-20_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">613</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfPebmed1TableTextBlock contextRef="From2021-01-012021-12-31_custom_PEBMEDMember">&lt;p id="xdx_898_ecustom--ScheduleOfAcquisitionOfPebmed1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--PEBMEDMember_zXTNHJmUDlE4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zOiGDpc7oG1g"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/83% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_982_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zNmcdf3oWjei" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_983_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zrpCM5e8RLhi" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20200719__20200720__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zah1wOgtfIO3" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfPebmed1TableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-07-192020-07-20_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-07-182020-07-20_custom_PEBMEDMember"
      decimals="-3"
      unitRef="BRL">17535000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-07-182020-07-20_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">3413</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2020-07-182020-07-20_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">17452</afya:IncreaseInRevenue>
    <afya:DecreasedInIncomeBeforeIncomeTaxes
      contextRef="From2020-07-182020-07-20_custom_PEBMEDMember"
      decimals="0"
      unitRef="BRL">1813</afya:DecreasedInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-06-01_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">The aggregate purchase price was R$260,836, including the CDI rate adjustment
from the signing date and the real state of the operation, estimated at R$ 17,397, of which 100% was paid in cash on the closing of the
operation. The purchase consideration was adjusted by R$1,569 and was paid on February 25, 2021.</ifrs-full:DescriptionOfAcquiree>
    <afya:ScheduleOfAcquisitionOfFesar1TableTextBlock contextRef="From2021-01-012021-12-31_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember">&lt;p id="xdx_897_ecustom--ScheduleOfAcquisitionOfFesar1TableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_zYfWbd8k9GH4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BC_zYGDzv9uTPV8"&gt;The valuation techniques
used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zaLtaUATzVif" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_986_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201103__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zyAQaPdz1ko7" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfFesar1TableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_LicencesMember">With-and-without
    method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="-3"
      unitRef="BRL">6280000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="0"
      unitRef="BRL">3751</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="0"
      unitRef="BRL">29113</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2020-11-022020-11-03_custom_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember"
      decimals="0"
      unitRef="BRL">14918</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-06-01_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember">The net purchase price was R$6,373 of which 100% was paid
in cash on the closing of the operation. The purchase price was adjusted to R$6,409, this price adjustment of R$ 36 was paid on February
2, 2021.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390"
      decimals="0"
      unitRef="BRL">158</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock contextRef="From2021-01-012021-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember">&lt;p id="xdx_895_ecustom--ScheduleOfAcquisitionOfMedphoneTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember_z3vbHMRhcPJe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&lt;span id="xdx_8B4_zpb10HpQncm2"&gt;The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; text-align: center; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Trademark&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_989_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--BrandNamesMember_zOVS1YPmqEHc" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Relief
    from royalty&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the market remuneration of the use license granted to third parties. The value of the asset is restated by
    the savings of royalties that the owner would have to own the asset. It is necessary to determine a royalty rate that reflects the
    appropriate remuneration of the asset. The royalty payments, net of taxes, are discounted to present value.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_985_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zoXBh7qPJcph" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-top: 6pt; padding-bottom: 6pt; padding-left: 8.5pt; line-height: 80%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Developed
    technology intangible assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98E_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201102__20201105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneTecnologiaEmSaudeLtdaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zRjmfbyWdBG5" style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Replacement
    cost&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/80% Arial, Helvetica, Sans-Serif; margin: 6pt 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;This
    methodology is based on the estimated cost of replacing the referred asset with a new one (acquisition or reconstruction), adjusted
    to reflect the losses in value resulting from the physical deterioration and the functional and economic obsolescence of that asset.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfMedphoneTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_BrandNamesMember">Relief
    from royalty</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-022020-11-05_custom_MedPhoneTecnologiaEmSaudeLtdaMember_ifrs-full_TechnologybasedIntangibleAssetsMember">Replacement
    cost</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390"
      decimals="-3"
      unitRef="BRL">49000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-11-022020-11-04_custom_MedPhoneTecnologiaEmSaudeLtdaMember1110214390"
      decimals="0"
      unitRef="BRL">57</ifrs-full:ProfitLossBeforeTax>
    <afya:IncreaseInRevenue
      contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="0"
      unitRef="BRL">142</afya:IncreaseInRevenue>
    <afya:IncreaseInIncomeBeforeIncomeTaxes
      contextRef="From2020-01-012020-12-31_custom_MedPhoneTecnologiaEmSaudeLtdaMember"
      decimals="0"
      unitRef="BRL">46</afya:IncreaseInIncomeBeforeIncomeTaxes>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2021-11-09_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <ifrs-full:DescriptionOfAcquiree contextRef="From2020-11-072020-11-09_custom_FCMPBMember">The total net purchase price of R$379,913 was adjusted to
R$378,807 and is comprised of (i) R$189,913 paid in cash on the transaction closing date, and (ii) R$188,894 is payable in cash in four
equal installments through 2024, adjusted by the CDI rate.</ifrs-full:DescriptionOfAcquiree>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2020-11-072020-11-09_custom_FCMPBMember"
      decimals="0"
      unitRef="BRL">721</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock contextRef="From2021-01-012021-12-31_custom_FCMPBMember">&lt;p id="xdx_891_ecustom--ScheduleOfAcquisitionOfFcmpbTableTextBlock_hifrs-full--BusinessCombinationsAxis__custom--FCMPBMember_zOBpQx2ren03" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; background-color: white"&gt;&lt;span id="xdx_8B3_zxZLgCnXCsEf"&gt;The
valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #212121"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="border: black 1pt solid; width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Intangible
    assets acquired&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; border-right: black 1pt solid; border-bottom: black 1pt solid; width: 68%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 83%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Valuation
    technique&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: black"&gt;&lt;b&gt;Licenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98A_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--LicencesMember_zs5p8J3xdUik" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 0" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;With-and-without
    method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    with-and-without method consists of estimating the fair value of an asset by the difference between the value of this asset in two
    scenarios: a scenario considering the existence of the asset in question and another considering its non-existence.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: white"&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; vertical-align: top; padding-top: 12pt; padding-left: 10pt; line-height: 83%; text-indent: -10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-right: black 1pt solid; border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;p id="xdx_98C_eifrs-full--DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue_c20201108__20201109__ifrs-full--BusinessCombinationsAxis__custom--FaculdadeDeCienciasMedicasDaParaibaMember__ifrs-full--ClassesOfIntangibleAssetsOtherThanGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember" style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 14pt" title="Valuation technique"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Multi-period
    excess earnings method&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;
    &lt;p style="font: 9pt/83% Arial, Helvetica, Sans-Serif; margin: 12pt 0 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
    method considers the present value of net cash flows expected to be generated by customer relationships, by excluding any cash flows
    related to contributory assets.&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_LicencesMember">With-and-without
    method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue contextRef="From2020-11-082020-11-09_custom_FaculdadeDeCienciasMedicasDaParaibaMember_ifrs-full_CustomerrelatedIntangibleAssetsMember">Multi-period
    excess earnings method</ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue>
    <ifrs-full:Revenue
      contextRef="From2020-11-072020-11-09_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">10509000</ifrs-full:Revenue>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-11-072020-11-09_custom_FCMPBMember"
      decimals="0"
      unitRef="BRL">3570</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eifrs-full--DisclosureOfCashAndCashEquivalentsExplanatory_zRNddwx4n64" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;6&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_82E_zdNRbjiNGyYj"&gt;Cash
                                            and cash equivalents&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_896_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zep5cpAxzMnk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BF_z6Tlk5tVKuTe" style="display: none; visibility: hidden"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20211231_zhIs5sZaH5Pf" style="border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20201231_z12DwGphZZZ3" style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_zkyM9A130qQc" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    and bank deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,487&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,729&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashEquivalents_iI_z7I6HlvNsys9" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;660,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;987,313&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--CashAndCashEquivalents_iI_zjXuW90T7sj2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;Cash and cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;748,562&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,045,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_z28CIaNg5uaa" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Cash equivalents
correspond mainly to financial investments in Bank Certificates of Deposit (&#x201c;CDB&#x201d;) with highly rated financial institutions
and investments funds managed by highly rated financial institutions. As of December 31, 2021, the average interest on these investments
are equivalent to &lt;span id="xdx_90C_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--BankCertificatesOfDepositMember_ztaM2DvRaVdd" title="Percentage of average interest"&gt;100.38&lt;/span&gt;% of the Interbank Certificates of Deposit (&#x201c;CDI&#x201d;) (December 31, 2020: &lt;span id="xdx_90F_ecustom--PercenatgeOfAverageInterestOnFinancialInstrument_iI_pid_dp_uPure_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--InterbankCertificatesOfDepositMember_zf5VXktJJiT3" title="Percentage of average interest"&gt;90.95&lt;/span&gt;%). These funds are available
for immediate use and have insignificant risk of changes in value. Cash equivalents denominated in U.S. dollars totaled R$&lt;span id="xdx_90D_eifrs-full--CashEquivalents_iI_c20211231__srt--CurrencyAxis__custom--USDMember_zf5MmUtQshSi" title="Cash equivalents (a)"&gt;23,228&lt;/span&gt; as of
December 31, 2021 (December 31, 2020: R$&lt;span id="xdx_902_eifrs-full--CashEquivalents_iI_c20201231__srt--CurrencyAxis__custom--USDMember_zSrkruIrDXLg" title="Cash equivalents (a)"&gt;70,523&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory>
    <afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_ecustom--DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory_zep5cpAxzMnk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BF_z6Tlk5tVKuTe" style="display: none; visibility: hidden"&gt;Schedule of cash and cash equivalents&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 71%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20211231_zhIs5sZaH5Pf" style="border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20201231_z12DwGphZZZ3" style="border-bottom: black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: -5.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--Cash_iI_zkyM9A130qQc" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    and bank deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,487&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,729&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--CashEquivalents_iI_z7I6HlvNsys9" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;660,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;987,313&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--CashAndCashEquivalents_iI_zjXuW90T7sj2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;Cash and cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;748,562&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,045,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory>
    <ifrs-full:Cash contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">88487000</ifrs-full:Cash>
    <ifrs-full:Cash contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">57729000</ifrs-full:Cash>
    <ifrs-full:CashEquivalents contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">660075000</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">987313000</ifrs-full:CashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">748562000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1045042000</ifrs-full:CashAndCashEquivalents>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2021-12-31_custom_BankCertificatesOfDepositMember"
      decimals="INF"
      unitRef="Pure">1.0038</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <afya:PercenatgeOfAverageInterestOnFinancialInstrument
      contextRef="AsOf2020-12-31_custom_InterbankCertificatesOfDepositMember"
      decimals="INF"
      unitRef="Pure">0.9095</afya:PercenatgeOfAverageInterestOnFinancialInstrument>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2021-12-31_custom_USDMember"
      decimals="0"
      unitRef="BRL">23228</ifrs-full:CashEquivalents>
    <ifrs-full:CashEquivalents
      contextRef="AsOf2020-12-31_custom_USDMember"
      decimals="0"
      unitRef="BRL">70523</ifrs-full:CashEquivalents>
    <ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eifrs-full--DisclosureOfTradeAndOtherReceivablesExplanatory_zTSHSwTDNuse" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;7&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_821_zQysDuS9pYtl"&gt;Trade
                                            receivables&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_z6b1Qk5I7Xmj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zX8Tm0BxMpJ7" style="display: none; visibility: hidden"&gt;Schedule of trade accounts receivable, net and notes receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zaZofXwly2wk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;279,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z74W3KJi8Z31" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;195,318&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Educational
    content &lt;sup id="xdx_F48_zUO4e8brM0M"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zOV30KCsXofj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;69,227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zg1672CjJlih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FIES&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zTCLIoJgxW24" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;61,342&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8koS9msPeif" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Educational
    credits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zQ4a75Of75n9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,375&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zlpqgXRsuZj2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Mobile
    app subscription &lt;sup id="xdx_F4E_zOa0ciKTexrc"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_z1MV2dvkFeAk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,946&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_zWLBo9AKjKJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_z6I9Rx5eNiH" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,001&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zfn7aUmMY7Gh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,476&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_iI_c20211231_zLBKL11Rm3y7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;450,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_c20201231_zLCSmEvtYPR2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;342,924&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(-)
    Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20211231_zBkEMKa2PMHi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(45,013)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20201231_zZmq4vdSYDo9" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeReceivables_iI_c20211231_zSTFHCVuTpjk" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;405,793&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeReceivables_iI_c20201231_zaqIgysBXjOb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;309,944&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentTradeReceivables_iI_c20211231_zScJjlPWwHM4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;378,351&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentTradeReceivables_iI_c20201231_zxihBwvEorl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;302,317&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zbmRZtLv3i1g" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zX4sEv6BVB7k" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zYXsJQ38ODgj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1E_zEcoPHFhNVO8" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0B_zNzDoXuVEQU6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z6NwoKmSmTvg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Related to trade receivables
from mobile applications subscriptions for digital medical content.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zVsAlkpv1RL3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_zAwhsbHdfyhe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As of December
31, 2021 and 2020, the aging of trade receivables was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BE_zkokUPFKxvo" style="display: none; visibility: hidden"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Neither
    past due nor impaired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zmDSzjnGs491" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;184,382&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zyPih9uvje8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,076&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Past
    due&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1
    to 30 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zYU6waBpya8e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,932&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z6DNxDfqC5cl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31
    to 90 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zLUHzFxJit2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;69,299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zlphyAszTvGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,198&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;91
    to 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zKXHpKOsyJ3e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,764&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zsqTxBBQZtAg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,521&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;More
    than 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zmiFGDiMyKX" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,429&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_znlov2MSuhO6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,764&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231_zPG8AONvukig" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;450,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231_z4TICkXN3d39" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;342,924&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AE_zXoxPEMEX9k3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsExplanatory_zQ98EYNT8Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The changes in
the allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019, was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zh6ifQJcKy49" style="display: none; visibility: hidden"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 60%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_493_20210101__20211231_zQwptMmF38Hh" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20200101__20201231_zWOPOHXBLRSb" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231_zsQ3E8BXifx2" style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_zQHR6SKfOs2f" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances
    at the beginning of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,763)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,537)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_z8ZbFhKS0wQj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,040)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_zmLORFRGbM52" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,814&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_zIQ6MP0Y8gS6" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances
    at the end of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(45,013)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(32,980)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(14,763)
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zWV8Ndlnwiqj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory>
    <afya:DisclosureOfTradeAndOtherReceivables1Explanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--DisclosureOfTradeAndOtherReceivables1Explanatory_z6b1Qk5I7Xmj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zX8Tm0BxMpJ7" style="display: none; visibility: hidden"&gt;Schedule of trade accounts receivable, net and notes receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 66%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_zaZofXwly2wk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;279,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--TuitionFeesMember_z74W3KJi8Z31" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, gross"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;195,318&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Educational
    content &lt;sup id="xdx_F48_zUO4e8brM0M"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zOV30KCsXofj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;69,227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalContentMember_fKGEp_zg1672CjJlih" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,931&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FIES&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_zTCLIoJgxW24" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;61,342&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--FIESMember_z8koS9msPeif" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;49,425&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Educational
    credits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zQ4a75Of75n9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,375&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--EducationalCreditsMember_zlpqgXRsuZj2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Mobile
    app subscription &lt;sup id="xdx_F4E_zOa0ciKTexrc"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_z1MV2dvkFeAk" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,946&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--MobileAppSubscriptionMember_fKGIp_zWLBo9AKjKJe" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Others&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_z6I9Rx5eNiH" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,001&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--OthersMember_zfn7aUmMY7Gh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,476&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--ReceivablesGross_iI_c20211231_zLBKL11Rm3y7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;450,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--ReceivablesGross_iI_c20201231_zLCSmEvtYPR2" style="border-top: black 1pt solid; border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;342,924&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(-)
    Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20211231_zBkEMKa2PMHi" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="(-) Allowance for doubtful accounts"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(45,013)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--AllowanceForDoubtfulAccountsFoReceivable1_iNI_di_c20201231_zZmq4vdSYDo9" style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeReceivables_iI_c20211231_zSTFHCVuTpjk" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivables, net"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;405,793&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeReceivables_iI_c20201231_zaqIgysBXjOb" style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;309,944&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentTradeReceivables_iI_c20211231_zScJjlPWwHM4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;378,351&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--CurrentTradeReceivables_iI_c20201231_zxihBwvEorl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;302,317&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zbmRZtLv3i1g" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zX4sEv6BVB7k" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zYXsJQ38ODgj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1E_zEcoPHFhNVO8" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0B_zNzDoXuVEQU6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_z6NwoKmSmTvg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Related to trade receivables
from mobile applications subscriptions for digital medical content.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfTradeAndOtherReceivables1Explanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_TuitionFeesMember"
      decimals="-3"
      unitRef="BRL">279915000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_TuitionFeesMember"
      decimals="-3"
      unitRef="BRL">195318000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact002441"
      unitRef="BRL">69227000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_EducationalContentMember"
      decimals="-3"
      id="Fact002442"
      unitRef="BRL">62931000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_FIESMember"
      decimals="-3"
      unitRef="BRL">61342000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_FIESMember"
      decimals="-3"
      unitRef="BRL">49425000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      unitRef="BRL">5375000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_EducationalCreditsMember"
      decimals="-3"
      unitRef="BRL">11248000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact002447"
      unitRef="BRL">20946000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_MobileAppSubscriptionMember"
      decimals="-3"
      id="Fact002448"
      unitRef="BRL">13526000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_OthersMember"
      decimals="-3"
      unitRef="BRL">14001000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_OthersMember"
      decimals="-3"
      unitRef="BRL">10476000</afya:ReceivablesGross>
    <afya:ReceivablesGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">450806000</afya:ReceivablesGross>
    <afya:ReceivablesGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">342924000</afya:ReceivablesGross>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">45013000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <afya:AllowanceForDoubtfulAccountsFoReceivable1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">32980000</afya:AllowanceForDoubtfulAccountsFoReceivable1>
    <ifrs-full:TradeReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">405793000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">309944000</ifrs-full:TradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">378351000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:CurrentTradeReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">302317000</ifrs-full:CurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27442000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">7627000</ifrs-full:NoncurrentTradeReceivables>
    <afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_ecustom--DisclosureOfTradeAccountsReceivableByAgingExplanatory_zAwhsbHdfyhe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As of December
31, 2021 and 2020, the aging of trade receivables was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BE_zkokUPFKxvo" style="display: none; visibility: hidden"&gt;Schedule of aging of trade accounts receivable&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 67%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Neither
    past due nor impaired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zmDSzjnGs491" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;184,382&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--ImpairmentOfFinancialAssetsAxis__ifrs-full--FinancialAssetsNeitherPastDueNorImpairedMember_zyPih9uvje8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%" title="Trade receivable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;145,076&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Past
    due&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1
    to 30 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_zYU6waBpya8e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,932&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--CurrentMember_z6DNxDfqC5cl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 90%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31
    to 90 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zLUHzFxJit2g" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;69,299&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneMonthsAndNotLaterThanThreeMonthsMember_zlphyAszTvGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,198&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;91
    to 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zKXHpKOsyJ3e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,764&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__ifrs-full--LaterThanThreeMonthsAndNotLaterThanSixMonthsMember_zsqTxBBQZtAg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,521&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 7.1pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;More
    than 180 days&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20211231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_zmiFGDiMyKX" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,429&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231__ifrs-full--PastDueStatusAxis__custom--LaterThanOneEightyMember_znlov2MSuhO6" style="border-bottom: black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,764&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ReceivablesGross_iI_c20211231_zPG8AONvukig" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;450,806&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--ReceivablesGross_iI_c20201231_z4TICkXN3d39" style="border-bottom: black 1.5pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;342,924&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      unitRef="BRL">184382000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember"
      decimals="-3"
      unitRef="BRL">145076000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_ifrs-full_CurrentMember"
      decimals="-3"
      unitRef="BRL">68932000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_ifrs-full_CurrentMember"
      decimals="-3"
      unitRef="BRL">44365000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      unitRef="BRL">69299000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember"
      decimals="-3"
      unitRef="BRL">57198000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      unitRef="BRL">55764000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember"
      decimals="-3"
      unitRef="BRL">51521000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2021-12-31_custom_LaterThanOneEightyMember"
      decimals="-3"
      unitRef="BRL">72429000</afya:ReceivablesGross>
    <afya:ReceivablesGross
      contextRef="AsOf2020-12-31_custom_LaterThanOneEightyMember"
      decimals="-3"
      unitRef="BRL">44764000</afya:ReceivablesGross>
    <afya:ReceivablesGross contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">450806000</afya:ReceivablesGross>
    <afya:ReceivablesGross contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">342924000</afya:ReceivablesGross>
    <afya:AllowanceForDoubtfulAccountsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_ecustom--AllowanceForDoubtfulAccountsExplanatory_zQ98EYNT8Ygj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The changes in
the allowance for doubtful accounts for the years ended December 31, 2021, 2020 and 2019, was as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zh6ifQJcKy49" style="display: none; visibility: hidden"&gt;Schedule of allowance for doubtful accounts&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 60%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_493_20210101__20211231_zQwptMmF38Hh" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20200101__20201231_zWOPOHXBLRSb" style="border-bottom: black 1pt solid; vertical-align: top; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231_zsQ3E8BXifx2" style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iS_zQHR6SKfOs2f" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances
    at the beginning of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(14,763)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,537)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets_z8ZbFhKS0wQj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,040)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable_zmLORFRGbM52" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Write-offs&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,786&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,864&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,814&#160;&#160;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AllowanceAccountForCreditLossesOfFinancialAssets_iE_zIQ6MP0Y8gS6" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Balances
    at the end of the period&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(45,013)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(32,980)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(14,763)
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:AllowanceForDoubtfulAccountsExplanatory>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-32980000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">-14763000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2018-12-31" decimals="-3" unitRef="BRL">-7537000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-47819000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-32081000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-15040000</ifrs-full:AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">35786000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">13864000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">7814000</afya:WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-45013000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-32980000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">-14763000</ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets>
    <ifrs-full:DisclosureOfRelatedPartyExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_806_eifrs-full--DisclosureOfRelatedPartyExplanatory_zdAst755fjb4" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;8&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_825_zUUbyhNLmH97"&gt;Related
                                            parties&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfRelatedPartiesExplanatory_zHTPNSmwfAB3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B8_zA9nOBZYRjOc"&gt;The table below
summarizes the balances and transactions with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20211231_zFAMpuVZ6ke3" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20201231_z8IkEVggsgqe" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TradeReceivablesRelatedPartyTransactions_iI_zVTPXnt6ywSf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables &lt;sup id="xdx_F47_zor9ngjglRtg"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;174&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CreditsWithShareholdersRelatedPartyTransactions_iI_zRKH3INWi5Ob" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Related
    parties &lt;sup id="xdx_F42_zPsDLPAGjoB1"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_zytw8aCO5ye1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span style="display: none; visibility: hidden"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;692&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;595&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_z17ngage4Oo3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;174&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zOJRRKNzkTmd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccountsPayableToSellingShareholders_iI_zRqWB7IxYx7l" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders &lt;sup id="xdx_F4F_zx3htuzXoK11"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmountsPayableRelatedPartyTransactions_iTI_zjHCjdgL5nP8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Arial, Helvetica, Sans-Serif; visibility: hidden"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;54,556&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccountsPayableCurrent1_iI_zD0CpvdKYxg7" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NoncurrentPayablesToRelatedParties1_iI_zk0v0IIndaP9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Other
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UEPC
    &lt;sup id="xdx_F40_ztkneTU0jBr4"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zo377Gzq2ink" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;752&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zXqUxwWTdaa3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;104&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zy4r6G9wnxa6" style="vertical-align: top; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;557&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zKfnxqWhVlq2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;752&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231_z2hBRocfajw1" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;104&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231_zz9RW70uHdf3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;557&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RVL
    Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z9MWpTJVG9Hb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zXDItSZyVpe2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOpXLwRJQoWg" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,417&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UNIVA&#xc7;O
    Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zXDNNpZ3zMB5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z72NlVDU4xY" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zZyKhU1V9m9g" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP
    Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zDrbBZrTCal3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,560&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zPFPbbEv8YNc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,470&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zmhhRsQRSk7d" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,609&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_z6GM6uMWpsI5" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;23,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231_zq8uPh334pHc" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;17,673&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;15,842&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zIWsuYYX5gp" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_z5FfuMNv5D9k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Refers to sales of educational content
from Medcel to UEPC.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zLN6utXXTwe1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zHL1ntwquFYg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zRr8V9KKHa56" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_zDDVZy0CIS66" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zvyUrDYJypu5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Lease
agreements with RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Afya Brazil has
entered into lease agreements with RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A. (&#x201c;RVL&#x201d;), an entity controlled by the
shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive officer, as described below:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
June 21, 2016, RVL entered into lease agreements (as amended on April 26, 2018) with ITPAC &#x2013; Instituto Tocantinense Presidente
Ant&#xf4;nio Carlos S.A., or ITPAC, and Itpac Porto Nacional &#x2013; Instituto Tocantinense Presidente Antonio Carlos Porto S.A., or
ITPAC Porto Nacional, pursuant to which RVL Esteves Gest&#xe3;o Imobili&#xe1;ria S.A. agreed to lease campuses to ITPAC and ITPAC
Porto Nacional in the cities of Aragua&#xed;na and Porto Nacional, both located in the State of Tocantins. The lease agreements are
adjustable in accordance with the provisions of each lease agreement. The lease agreements are for an initial term of &lt;span id="xdx_903_ecustom--OperatingLeaseTermOfContract_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zpAlcTyi13u5" title="Lease term::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2563"&gt;20&lt;/span&gt;&lt;/span&gt; years, and are
renewable for an additional 20 years subject to the provisions of each lease agreement.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
November 1, 2016, RVL entered into a lease agreement with Afya Brazil, pursuant to which RVL agreed to lease to Afya Brazil certain offices
located in the city of Nova Lima, State of Minas Gerais, where Afya Brazil&#x2019;s principal executive offices are located. On February
9, 2019 the agreement was amended to extend lease terms and adjust the lease amounts, subject to certain discount conditions set forth
in the lease agreement and adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of five years, and may be renewable for an additional five years subject to the provisions of the lease agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
September 6, 2018, RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC campus
by RVL in the city of Palmas, State of Tocantins. The lease agreement is for an amount equal to &lt;span id="xdx_904_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180905__20180906__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoTocantinensePresidenteAntonioCarlosSAMember_zxnsAt16Trmk" title="Percentage of revenue"&gt;7.5&lt;/span&gt;% of the monthly net revenue of ITPAC
during the prior semester, which will start to become due once the new ITPAC campus becomes operational, subject to the provisions of
the lease agreement. The lease agreement is for an initial term of &lt;span id="xdx_90B_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zySCVqNvIqpb" title="Percentage of revenue::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2567"&gt;20&lt;/span&gt;&lt;/span&gt; years, starting on the date the new ITPAC campus becomes operational,
and is renewable for an additional &lt;span id="xdx_903_ecustom--LesseeFinancesLeaseRenewalTerm_dtYxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member_zQHBkRpjh266" title="Renewal term::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2569"&gt;20&lt;/span&gt;&lt;/span&gt; years subject to the provisions of the lease agreement.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 30,
2019, RVL entered into a lease agreement with IPTAN, pursuant to which RVL agreed to lease to IPTAN the new IPTAN medical campus, currently
under construction by RVL in the city of Santa In&#xea;s, State of Maranh&#xe3;o. The lease agreement is for a monthly amount equal
to (i) up to June 2020, R$12 and (ii) after June 2020 and until March 2024, 6.5% of the monthly net revenue of IPTAN&lt;/span&gt; assessed during
the prior semester, in each case adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial
term of 5 years counted from the conclusion of the construction works, and may be renewable for an additional 5 years subject to the
provisions of the lease agreement.&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 02, 2021,
RVL entered into a lease agreement with ITPAC, pursuant to which RVL agreed to lease to ITPAC the new ITPAC Garanhuns medical campus,
in the city of Garanhuns, State of Pernambuco. The lease agreement is for a monthly amount equal to &lt;span id="xdx_909_ecustom--DescriptionOfLeaseTerm_c20191029__20191030__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember" title="Description of lease term"&gt;(i) up to June 2022, R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_pn3n3" title="Lease expenses"&gt;40&lt;/span&gt;; (ii) after
June 2022 and until December 2028, &lt;span id="xdx_90D_eifrs-full--PercentageOfEntitysRevenue_dp_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsyxmYqwhPt8" title="Renewal term"&gt;6.5&lt;/span&gt;% of the monthly net revenue of ITPAC&lt;/span&gt; Garanhuns assessed during the prior semester, in each case
adjustable in accordance with the provisions of the lease agreement; and (iii) after 2029 the monthly amount should be adjust by inflation
rate (IPCA). The lease agreement is for a term of 20 years.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The lease payments
in connection with the lease agreements with RVL totaled R$&lt;span id="xdx_90D_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zCHhPIigyLa8" title="Lease expenses"&gt;15,336&lt;/span&gt; and R$&lt;span id="xdx_902_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zhH9eGt9GAbf" title="Lease expenses"&gt;11,288&lt;/span&gt; in the years ended December 31, 2021 and 2020, respectively.
In the year ended December 31, 2019, the lease payments in connection with the lease agreements with RVL totaled R$1&lt;span id="xdx_901_eifrs-full--CashOutflowForLeases_pn3n3_c20190101__20191231__dei--LegalEntityAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zRzsTFLo2Jh5" title="Lease expenses"&gt;0,417&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Lease
agreement with UNIVA&#xc7;O Patrimonial Ltda.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 14, 2016,
UNIVA&#xc7;O Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Ms. Ros&#xe2;ngela Esteves
is the chief executive officer, entered into a lease agreement with UNIVA&#xc7;O, a subsidiary of Afya Brazil, pursuant to which UNIVA&#xc7;O
Patrimonial Ltda. agreed to lease the UNIVA&#xc7;O campus to UNIVA&#xc7;O, located in the city of Ipatinga, State of Minas Gerais.
The lease agreement is adjustable in accordance with the provisions of the lease agreement. The lease agreement is for an initial term
of 20 years, and is renewable for an additional &lt;span id="xdx_90E_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zsdrHOPcqEac" title="Renewal term::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2583"&gt;20&lt;/span&gt;&lt;/span&gt; years subject to the provisions of the lease agreement. The lease payments in connection
with this lease agreement totaled R$&lt;span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_z400aEfi31l1" title="Lease expenses"&gt;3,210&lt;/span&gt; and R$&lt;span id="xdx_907_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_zqSmF7AMl80e" title="Lease expenses"&gt;2,915&lt;/span&gt; in the years ended December 31, 2021 and 2020, respectively. In the year ended
December 31, 2019, the lease payments in connection with this lease agreement totaled R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--UNIVACOPatrimonialLtdaMember_pn3n3" title="Lease expenses"&gt;2,816&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Lease
agreement with IESVAP Patrimonial Ltda.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 25, 2018,
IESVAP Patrimonial Ltda., an entity controlled by the shareholder Nicolau Carvalho Esteves and of which Mr. Renato Esteves is an executive
officer, entered into a lease agreement with IESVAP, a subsidiary of Afya Brazil, pursuant to which IESVAP Patrimonial Ltda. agreed to
lease the IESVAP campus to IESVAP located in the city of Parna&#xed;ba, State of Piau&#xed;. &lt;span id="xdx_90F_ecustom--DescriptionOfLeaseTerms_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zuBwNBw337Dd" title="Description of lease term"&gt;The lease agreement is for an amount
equal to &lt;span id="xdx_900_eifrs-full--PercentageOfEntitysRevenue_pid_dp_uPure_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zlLSOz759e35" title="Percentage of revenue"&gt;7.5&lt;/span&gt;% of the monthly net revenue of IESVAP during 2018&lt;/span&gt;. The lease agreement is for an initial term of &lt;span id="xdx_908_ecustom--OperatingLeaseTermOfContract_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zFbnwpS7847l" title="Lease term::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2595"&gt;20&lt;/span&gt;&lt;/span&gt; years, and is renewable
for an additional &lt;span id="xdx_905_ecustom--LesseeFinancesLeaseRenewalTerm_dxL_c20180423__20180425__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zf3p0TQJwte1" title="Renewal term::XDX::P20Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2597"&gt;20&lt;/span&gt;&lt;/span&gt; years subject to the provisions of the lease agreement. The lease payments in connection with this lease agreement
totaled R$&lt;span id="xdx_900_eifrs-full--CashOutflowForLeases_pn3n3_c20210101__20211231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_zbKeUwS942n8" title="Lease expenses"&gt;4,560&lt;/span&gt; and R$&lt;span id="xdx_903_eifrs-full--CashOutflowForLeases_pn3n3_c20200101__20201231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_z4u0hzmzA9wb" title="Lease expenses"&gt;3,470&lt;/span&gt; in the years ended December 31, 2021 and 2020, respectively. In the year ended December 31, 2019, the lease
payments in connection with this lease agreement totaled R$&lt;span id="xdx_908_eifrs-full--CashOutflowForLeases_c20190101__20191231__custom--TypeOfArrangement1Axis__custom--LeaseAgreements1Member__dei--LegalEntityAxis__custom--IESVAPPatrimonialLtdaMember_pn3n3" title="Lease expenses"&gt;2,609&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Key
management personnel compensation&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_892_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_zB80mLv5U6l4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zjGIIOd6WbXe"&gt;Key management
personnel compensation included in the Company&#x2019;s consolidated statement of income comprised the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Short-term
    employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_zy5oJImO2QQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,933&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20200101__20201231_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20190101__20191231_pn3n3" style="text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based
    compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zFOzMHPWLGol" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--KeyManagementPersonnelCompensation_c20200101__20201231_pn3n3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--KeyManagementPersonnelCompensation_c20190101__20191231_pn3n3" style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,893&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zTsER7rH0PAl" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20200101__20201231_zlHdUK86xtXg" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;33,618&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;18,840&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_zZPRnVfA1wXb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Compensation of
the Company&#x2019;s key management includes short-term employee benefits comprised by salaries, labor and social charges, and other ordinary
short-term employee benefits. The amounts disclosed in the table above are the amounts recognized as an expense in general and administrative
expenses during the reporting period related to key management personnel.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The executive officers
participate in share-based compensation plans described in Note 16 (b).&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRelatedPartyExplanatory>
    <afya:ScheduleOfRelatedPartiesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--ScheduleOfRelatedPartiesExplanatory_zHTPNSmwfAB3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B8_zA9nOBZYRjOc"&gt;The table below
summarizes the balances and transactions with related parties:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49D_20211231_zFAMpuVZ6ke3" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20201231_z8IkEVggsgqe" style="border-bottom: black 1pt solid; vertical-align: top; width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--TradeReceivablesRelatedPartyTransactions_iI_zVTPXnt6ywSf" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables &lt;sup id="xdx_F47_zor9ngjglRtg"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;174&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CreditsWithShareholdersRelatedPartyTransactions_iI_zRKH3INWi5Ob" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Related
    parties &lt;sup id="xdx_F42_zPsDLPAGjoB1"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2509"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmountsReceivableRelatedPartyTransactions_iI_zytw8aCO5ye1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span style="display: none; visibility: hidden"&gt;TOTAL&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;692&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;595&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TradeAndOtherCurrentPayablesToRelatedParties1_iI_z17ngage4Oo3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;692&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;174&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--NoncurrentAssetsOfRelatedParty1_iI_pn3n3_zOJRRKNzkTmd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2518"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;421&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--AccountsPayableToSellingShareholders_iI_zRqWB7IxYx7l" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders &lt;sup id="xdx_F4F_zx3htuzXoK11"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2522"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--AmountsPayableRelatedPartyTransactions_iTI_zjHCjdgL5nP8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="display: none; font-family: Arial, Helvetica, Sans-Serif; visibility: hidden"&gt;&#160;Total&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;54,556&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2525"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--AccountsPayableCurrent1_iI_zD0CpvdKYxg7" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2528"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NoncurrentPayablesToRelatedParties1_iI_zk0v0IIndaP9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,278&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 55%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Other
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UEPC
    &lt;sup id="xdx_F40_ztkneTU0jBr4"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zo377Gzq2ink" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;752&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zXqUxwWTdaa3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;104&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UEPCMember_zy4r6G9wnxa6" style="vertical-align: top; text-align: right" title="Other income"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;557&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20210101__20211231_zKfnxqWhVlq2" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;752&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20200101__20201231_z2hBRocfajw1" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;104&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--OtherIncomeRelatedPartyTransactions_pn3n3_c20190101__20191231_zz9RW70uHdf3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;557&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;RVL
    Esteves Gest&#xe3;o Imobili&#xe1;ria S.A.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_z9MWpTJVG9Hb" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,336&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zXDItSZyVpe2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,288&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--RVLEstevesGestaoImobiliariaSAMember_zOpXLwRJQoWg" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,417&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;UNIVA&#xc7;O
    Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zXDNNpZ3zMB5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,210&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_z72NlVDU4xY" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--UNIVACOPatrimonialLtdaMember_zZyKhU1V9m9g" style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IESVAP
    Patrimonial Ltda.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zDrbBZrTCal3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,560&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zPFPbbEv8YNc" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,470&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--IESVAPPatrimonialLtdaMember_zmhhRsQRSk7d" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,609&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20210101__20211231_z6GM6uMWpsI5" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;23,106&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_pn3n3_c20200101__20201231_zq8uPh334pHc" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;17,673&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeasesAsLesseeRelatedPartyTransactions_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Lease"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;15,842&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zIWsuYYX5gp" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_z5FfuMNv5D9k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Refers to sales of educational content
from Medcel to UEPC.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zLN6utXXTwe1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zHL1ntwquFYg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F08_zRr8V9KKHa56" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_zDDVZy0CIS66" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfRelatedPartiesExplanatory>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002506"
      unitRef="BRL">692000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:TradeReceivablesRelatedPartyTransactions
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact002507"
      unitRef="BRL">174000</afya:TradeReceivablesRelatedPartyTransactions>
    <afya:CreditsWithShareholdersRelatedPartyTransactions
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact002510"
      unitRef="BRL">421000</afya:CreditsWithShareholdersRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">692000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <ifrs-full:AmountsReceivableRelatedPartyTransactions contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">595000</ifrs-full:AmountsReceivableRelatedPartyTransactions>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">692000</afya:TradeAndOtherCurrentPayablesToRelatedParties1>
    <afya:TradeAndOtherCurrentPayablesToRelatedParties1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">174000</afya:TradeAndOtherCurrentPayablesToRelatedParties1>
    <afya:NoncurrentAssetsOfRelatedParty1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">421000</afya:NoncurrentAssetsOfRelatedParty1>
    <afya:AccountsPayableToSellingShareholders
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002521"
      unitRef="BRL">54556000</afya:AccountsPayableToSellingShareholders>
    <ifrs-full:AmountsPayableRelatedPartyTransactions contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">54556000</ifrs-full:AmountsPayableRelatedPartyTransactions>
    <afya:AccountsPayableCurrent1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27278000</afya:AccountsPayableCurrent1>
    <afya:NoncurrentPayablesToRelatedParties1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27278000</afya:NoncurrentPayablesToRelatedParties1>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_UEPCMember"
      decimals="-3"
      unitRef="BRL">752000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31_custom_UEPCMember"
      decimals="-3"
      unitRef="BRL">104000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31_custom_UEPCMember"
      decimals="-3"
      unitRef="BRL">557000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">752000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">104000</afya:OtherIncomeRelatedPartyTransactions>
    <afya:OtherIncomeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">557000</afya:OtherIncomeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">15336000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">11288000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">10417000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">3210000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2915000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2816000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-012021-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">4560000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">3470000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2609000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">23106000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">17673000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:LeasesAsLesseeRelatedPartyTransactions
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">15842000</ifrs-full:LeasesAsLesseeRelatedPartyTransactions>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2018-09-052018-09-06_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutoTocantinensePresidenteAntonioCarlosSAMember"
      decimals="INF"
      unitRef="Pure">0.075</ifrs-full:PercentageOfEntitysRevenue>
    <afya:DescriptionOfLeaseTerm contextRef="From2019-10-292019-10-30_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember_custom_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember">(i) up to June 2022, R$40; (ii) after
June 2022 and until December 2028, 6.5% of the monthly net revenue of ITPAC</afya:DescriptionOfLeaseTerm>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">40000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="INF"
      unitRef="Pure">0.065</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">15336000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_RVLEstevesGestaoImobiliariaSAMember"
      decimals="-3"
      unitRef="BRL">11288000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265"
      decimals="-3"
      unitRef="BRL">417000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">3210000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2915000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_UNIVACOPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2816000</ifrs-full:CashOutflowForLeases>
    <afya:DescriptionOfLeaseTerms contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember">The lease agreement is for an amount
equal to 7.5% of the monthly net revenue of IESVAP during 2018</afya:DescriptionOfLeaseTerms>
    <ifrs-full:PercentageOfEntitysRevenue
      contextRef="From2018-04-232018-04-25_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="INF"
      unitRef="Pure">0.075</ifrs-full:PercentageOfEntitysRevenue>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2021-01-012021-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">4560000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2020-01-012020-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">3470000</ifrs-full:CashOutflowForLeases>
    <ifrs-full:CashOutflowForLeases
      contextRef="From2019-01-012019-12-31_custom_LeaseAgreements1Member_custom_IESVAPPatrimonialLtdaMember"
      decimals="-3"
      unitRef="BRL">2609000</ifrs-full:CashOutflowForLeases>
    <afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_892_ecustom--SummaryOfKeyManagementPersonnelCompensationTableTextBlock_zB80mLv5U6l4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zjGIIOd6WbXe"&gt;Key management
personnel compensation included in the Company&#x2019;s consolidated statement of income comprised the following:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 66%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 4%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Short-term
    employee benefits&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_pn3n3_c20210101__20211231_zy5oJImO2QQ1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,933&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20200101__20201231_pn3n3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,629&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--KeyManagementPersonnelCompensationShorttermEmployeeBenefits_c20190101__20191231_pn3n3" style="text-align: right; line-height: 10.5pt" title="Short-term employee benefits"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,947&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based
    compensation plan&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--KeyManagementPersonnelCompensation_pn3n3_c20210101__20211231_zFOzMHPWLGol" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,251&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--KeyManagementPersonnelCompensation_c20200101__20201231_pn3n3" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,989&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--KeyManagementPersonnelCompensation_c20190101__20191231_pn3n3" style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt" title="Share-based compensation plans"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,893&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20210101__20211231_zTsER7rH0PAl" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;32,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_pn3n3_c20200101__20201231_zlHdUK86xtXg" style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;33,618&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity_c20190101__20191231_pn3n3" style="border-bottom: black 1.5pt double; text-align: right; line-height: 10.5pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;18,840&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">11933000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">9629000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">4947000</ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">20251000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">23989000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:KeyManagementPersonnelCompensation
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">13893000</ifrs-full:KeyManagementPersonnelCompensation>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">32184000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">33618000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">18840000</ifrs-full:AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity>
    <ifrs-full:DisclosureOfOtherAssetsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_eifrs-full--DisclosureOfOtherAssetsExplanatory_zyixwY9OtSE4" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;9&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_823_zWXLdiSWkG8g"&gt;Other
                                            assets&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As of December
31, 2021 the Company has R$&lt;span id="xdx_906_ecustom--OtherCurrentAssets1_iI_c20211231_z3h2ymb5Wthl" title="TotalAssets"&gt;222,839&lt;/span&gt; (R$ &lt;span id="xdx_909_ecustom--OtherCurrentAssets1_iI_c20201231_zy1Kug55MQGa" title="TotalAssets"&gt;103,651&lt;/span&gt; in December 31, 2020) accounted for as Others assets as follow:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--DisclosureOfOtherAssetsTableTextBlock_z0mZ8VPwyvU" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B1_z0iZVeWMgMua" style="display: none; visibility: hidden"&gt;Schedule
of Other Assets&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20211231_ze0H6LTEmB39" style="border-bottom: black 1pt solid; vertical-align: top; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49E_20201231_zG4ahnYBdjRf" style="border-bottom: black 1pt solid; vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_maAzeR4_zGMAje5cFJJa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Indemnification
    assets &lt;sup id="xdx_F4A_zckFy3zL5CEh"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;135,355&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;53,499&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--JudicialDeposits_iI_maAzeR4_z4nMEHY7I5R8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Judicial
    deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,825&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;1,451&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CurrentPrepaidExpenses_iI_maAzeR4_zLTpYYE9zZfb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Prepaid
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2,291
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_maAzeR4_zU0e0fR2ZLK3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    FIES receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,411&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OtherAssets1_iI_maAzeR4_zV0fIqT6dcq9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,099&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Assets1_iTI_mtAzeR4_zImaWDaO5qK2" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;222,839&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&#160;103,651
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--CurrentAssets1_iI_z0uxoNiykdGk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,533&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,614&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NoncurrentAssets1_iI_zwxeteUaAHSe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;180,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;74,037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F08_zmlIUcWq5LB9" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_zQccXvRQc3Yj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zBkj7WdPT4N5" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfOtherAssetsExplanatory>
    <afya:OtherCurrentAssets1 contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">222839</afya:OtherCurrentAssets1>
    <afya:OtherCurrentAssets1 contextRef="AsOf2020-12-31" decimals="0" unitRef="BRL">103651</afya:OtherCurrentAssets1>
    <afya:DisclosureOfOtherAssetsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_ecustom--DisclosureOfOtherAssetsTableTextBlock_z0mZ8VPwyvU" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B1_z0iZVeWMgMua" style="display: none; visibility: hidden"&gt;Schedule
of Other Assets&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 61%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20211231_ze0H6LTEmB39" style="border-bottom: black 1pt solid; vertical-align: top; width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49E_20201231_zG4ahnYBdjRf" style="border-bottom: black 1pt solid; vertical-align: top; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--IndemnificationAssetsRecognisedAsOfAcquisitionDate_iI_maAzeR4_zGMAje5cFJJa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Indemnification
    assets &lt;sup id="xdx_F4A_zckFy3zL5CEh"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;135,355&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;53,499&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--JudicialDeposits_iI_maAzeR4_z4nMEHY7I5R8" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Judicial
    deposits&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;18,825&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;1,451&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CurrentPrepaidExpenses_iI_maAzeR4_zLTpYYE9zZfb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Prepaid
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2,291
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--OtherReceivables_iI_maAzeR4_zU0e0fR2ZLK3" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    FIES receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;21,450&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,411&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--OtherAssets1_iI_maAzeR4_zV0fIqT6dcq9" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;37,099&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,999&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--Assets1_iTI_mtAzeR4_zImaWDaO5qK2" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;222,839&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&#160;103,651
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--CurrentAssets1_iI_z0uxoNiykdGk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,533&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;29,614&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_ecustom--NoncurrentAssets1_iI_zwxeteUaAHSe" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;180,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;74,037&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F08_zmlIUcWq5LB9" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_zQccXvRQc3Yj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:DisclosureOfOtherAssetsTableTextBlock>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2021-12-31"
      decimals="-3"
      id="Fact002633"
      unitRef="BRL">135355000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate
      contextRef="AsOf2020-12-31"
      decimals="-3"
      id="Fact002634"
      unitRef="BRL">53499000</ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate>
    <afya:JudicialDeposits contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">18825000</afya:JudicialDeposits>
    <afya:JudicialDeposits contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1451000</afya:JudicialDeposits>
    <ifrs-full:CurrentPrepaidExpenses contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">10110000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:CurrentPrepaidExpenses contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2291000</ifrs-full:CurrentPrepaidExpenses>
    <ifrs-full:OtherReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">21450000</ifrs-full:OtherReceivables>
    <ifrs-full:OtherReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">10411000</ifrs-full:OtherReceivables>
    <afya:OtherAssets1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">37099000</afya:OtherAssets1>
    <afya:OtherAssets1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">35999000</afya:OtherAssets1>
    <afya:Assets1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">222839000</afya:Assets1>
    <afya:Assets1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">103651000</afya:Assets1>
    <afya:CurrentAssets1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">42533000</afya:CurrentAssets1>
    <afya:CurrentAssets1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">29614000</afya:CurrentAssets1>
    <afya:NoncurrentAssets1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">180306000</afya:NoncurrentAssets1>
    <afya:NoncurrentAssets1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">74037000</afya:NoncurrentAssets1>
    <ifrs-full:DisclosureOfJointVenturesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eifrs-full--DisclosureOfJointVenturesExplanatory_zcSicmYBKOia" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;10&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_828_zDsDP9sGlhR7"&gt;Investment
                                            in associate&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--ScheduleOfInvestments_zzSKJ0qizyvd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In connection with
the corporate reorganization, described in Note 1 regarding the merger with BR Health, the Company acquired a 30% interest in UEPC, a
medical school located in the Federal District, that offers higher education and post-graduate courses, both in person and long-distance
learning. The Company&#x2019;s interest in UEPC is accounted for using the equity method. The following table illustrates the summarized
financial information of the Company&#x2019;s investment in UEPC:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zegUpHFamie3" style="display: none; visibility: hidden"&gt;Schedule of investments&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_ztuFjR6lWCCj" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zutTJWB1NOSh" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentAssets_iI_ziNRzqN8aVLa" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;33,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,413&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NoncurrentAssets_iI_zkysyWkAnADj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;109,805&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;82,575&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentLiabilities_iI_zcdpcfOW3luf" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(35,049)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(34,531)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NoncurrentLiabilities_iI_zZJ0OrYijEZ5" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,086)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,132)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--EquityInAssociate_iI_pn3n3_zNdNHY5uOJ02" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;17,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--CompanyShareInEquity1_iI_zncKuEDDgSdg" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Company&#x2019;s
    share in equity &#x2013; 30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,227&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Goodwill_iI_zTWHOCQEGj3e" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_znBr9zNPrT1d" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount of the investment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,410&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zMGhJOUNcZQ9" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z01qreZIZnPe" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zd8VHpPGpZti" style="width: 14%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--Revenue_zxTnnxGzFvc8" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net
    revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;127,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;113,965&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CostOfSales_zZUBc69Iyqih" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,935)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,926)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,459)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zli07pMMZvN2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(27,341)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,476)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinanceIncome_z9ZRA8rKUZOe" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Finance
    result&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,882)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,121)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_zd0sGZqBIs3i" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;41,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;12,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IncomeTaxExpenseContinuingOperations_zh29JpX4Fe12" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(252)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,275)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ProfitLoss_z11LxfdFLAi2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    income for the period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;39,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;10,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_zTbangbaaco6" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Company&#x2019;s
    share of income for the period &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;11,797&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;7,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zx55YM9V8TE6" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zKWB50vA4P11" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z8lEV9pC1Lu" style="border-bottom: black 1pt solid; width: 14%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InvestmentsInAssociates_iS_zWtjCksUTzqa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;45,634&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2720"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--MinorityInterestOfAcquiree_zlqSJLaQhuNi" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of minority interest (15%) in March 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2722"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2723"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,458&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AdditionalMinorityInterestOfAcquiree_zC6y6OBKIP86" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of additional interest (15%) in June 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2727"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,457&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DividendsReceived1_zeyf8wFxDexl" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends
    received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,770)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,922)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--DividendsReceived_zneCLdZD8Hr8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends
    receivable (included in Other assets)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2735"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossOfAcquiree_zZ9lZe3En97g" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,362&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iE_zdxGaReHhpy7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Closing
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,410&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;45,634&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zCGSMXs6lXm7" style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
Company tests at least annually the recoverability of the carrying amount of goodwill and there was no impairment for this goodwill.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfJointVenturesExplanatory>
    <afya:ScheduleOfInvestments contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_ecustom--ScheduleOfInvestments_zzSKJ0qizyvd" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In connection with
the corporate reorganization, described in Note 1 regarding the merger with BR Health, the Company acquired a 30% interest in UEPC, a
medical school located in the Federal District, that offers higher education and post-graduate courses, both in person and long-distance
learning. The Company&#x2019;s interest in UEPC is accounted for using the equity method. The following table illustrates the summarized
financial information of the Company&#x2019;s investment in UEPC:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zegUpHFamie3" style="display: none; visibility: hidden"&gt;Schedule of investments&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 61%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_495_20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_ztuFjR6lWCCj" style="width: 19%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zutTJWB1NOSh" style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--CurrentAssets_iI_ziNRzqN8aVLa" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;33,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;55,413&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--NoncurrentAssets_iI_zkysyWkAnADj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;109,805&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;82,575&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--CurrentLiabilities_iI_zcdpcfOW3luf" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(35,049)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(34,531)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NoncurrentLiabilities_iI_zZJ0OrYijEZ5" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(91,086)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,132)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--EquityInAssociate_iI_pn3n3_zNdNHY5uOJ02" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Equity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;17,646&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--CompanyShareInEquity1_iI_zncKuEDDgSdg" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Company&#x2019;s
    share in equity &#x2013; 30%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8,227&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--Goodwill_iI_zTWHOCQEGj3e" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,183&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_ecustom--InvestmentGrossAmount_iI_znBr9zNPrT1d" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount of the investment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,410&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zMGhJOUNcZQ9" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z01qreZIZnPe" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zd8VHpPGpZti" style="width: 14%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--Revenue_zxTnnxGzFvc8" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net
    revenue&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;127,618&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;113,965&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,816&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--CostOfSales_zZUBc69Iyqih" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(57,935)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,926)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,459)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zli07pMMZvN2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,025)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(27,341)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,476)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinanceIncome_z9ZRA8rKUZOe" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Finance
    result&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,585)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,882)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,121)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--ProfitLossBeforeTax_zd0sGZqBIs3i" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Income
    before income taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;41,073&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,816&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;12,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--IncomeTaxExpenseContinuingOperations_zh29JpX4Fe12" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income
    taxes expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,748)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(252)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,275)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--ProfitLoss_z11LxfdFLAi2" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    income for the period&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;39,325&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,564&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;10,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--CompanyShareOfProfitss_zTbangbaaco6" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Company&#x2019;s
    share of income for the period &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;11,797&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;7,698&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,362&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zx55YM9V8TE6" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20200101__20201231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_zKWB50vA4P11" style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_494_20190101__20191231__ifrs-full--CategoriesOfRelatedPartiesAxis__ifrs-full--AssociatesMember_z8lEV9pC1Lu" style="border-bottom: black 1pt solid; width: 14%; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--InvestmentsInAssociates_iS_zWtjCksUTzqa" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;51,410&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;45,634&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2720"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--MinorityInterestOfAcquiree_zlqSJLaQhuNi" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of minority interest (15%) in March 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2722"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2723"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,458&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AdditionalMinorityInterestOfAcquiree_zC6y6OBKIP86" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of additional interest (15%) in June 2019&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2726"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2727"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,457&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DividendsReceived1_zeyf8wFxDexl" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends
    received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,770)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,922)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,643)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--DividendsReceived_zneCLdZD8Hr8" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividends
    receivable (included in Other assets)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,960)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2735"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2736"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ProfitLossOfAcquiree_zZ9lZe3En97g" style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    of income&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,797&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,698&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,362&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--InvestmentsInAssociates_iE_zdxGaReHhpy7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Closing
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;48,477&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,410&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;45,634&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfInvestments>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">33976000</ifrs-full:CurrentAssets>
    <ifrs-full:CurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">55413000</ifrs-full:CurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">109805000</ifrs-full:NoncurrentAssets>
    <ifrs-full:NoncurrentAssets
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">82575000</ifrs-full:NoncurrentAssets>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-35049000</ifrs-full:CurrentLiabilities>
    <ifrs-full:CurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-34531000</ifrs-full:CurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-91086000</ifrs-full:NoncurrentLiabilities>
    <ifrs-full:NoncurrentLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-76132000</ifrs-full:NoncurrentLiabilities>
    <afya:EquityInAssociate
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">17646000</afya:EquityInAssociate>
    <afya:EquityInAssociate
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">27325000</afya:EquityInAssociate>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">5294000</afya:CompanyShareInEquity1>
    <afya:CompanyShareInEquity1
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">8227000</afya:CompanyShareInEquity1>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">43183000</ifrs-full:Goodwill>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">48477000</afya:InvestmentGrossAmount>
    <afya:InvestmentGrossAmount
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">51410000</afya:InvestmentGrossAmount>
    <ifrs-full:Revenue
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">127618000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">113965000</ifrs-full:Revenue>
    <ifrs-full:Revenue
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">85816000</ifrs-full:Revenue>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-57935000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-55926000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-39459000</ifrs-full:CostOfSales>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">24025000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">27341000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">29476000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-4585000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-4882000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-4121000</ifrs-full:FinanceIncome>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">41073000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">25816000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">12760000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-1748000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-252000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:IncomeTaxExpenseContinuingOperations
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-2275000</ifrs-full:IncomeTaxExpenseContinuingOperations>
    <ifrs-full:ProfitLoss
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">39325000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">25564000</ifrs-full:ProfitLoss>
    <ifrs-full:ProfitLoss
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">10485000</ifrs-full:ProfitLoss>
    <afya:CompanyShareOfProfitss
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">11797000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">7698000</afya:CompanyShareOfProfitss>
    <afya:CompanyShareOfProfitss
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">2362000</afya:CompanyShareOfProfitss>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">45634000</ifrs-full:InvestmentsInAssociates>
    <afya:MinorityInterestOfAcquiree
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">24458000</afya:MinorityInterestOfAcquiree>
    <afya:AdditionalMinorityInterestOfAcquiree
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">24457000</afya:AdditionalMinorityInterestOfAcquiree>
    <afya:DividendsReceived1
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-11770000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-1922000</afya:DividendsReceived1>
    <afya:DividendsReceived1
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-5643000</afya:DividendsReceived1>
    <ifrs-full:DividendsReceived
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">-2960000</ifrs-full:DividendsReceived>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2021-01-012021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">11797000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2020-01-012020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">7698000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:ProfitLossOfAcquiree
      contextRef="From2019-01-012019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">2362000</ifrs-full:ProfitLossOfAcquiree>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2021-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">48477000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2020-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">51410000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:InvestmentsInAssociates
      contextRef="AsOf2019-12-31_ifrs-full_AssociatesMember"
      decimals="-3"
      unitRef="BRL">45634000</ifrs-full:InvestmentsInAssociates>
    <ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eifrs-full--DisclosureOfPropertyPlantAndEquipmentExplanatory_zk4hRNRyM8dj" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;11&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_82C_zeKtI6PzYUJ2"&gt;Property
                                            and equipment&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;p id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zBwyJ0giRUl3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B0_zXB5MRKKrsa9" style="display: none; visibility: hidden"&gt;Schedule
of detailed information about property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 24%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_ztR2ztUIgz46" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zWF4kv1Mf272" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Machinery
    and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zk3CSQXZAzo" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zqcdivLUIRk8" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zScXVWbPlrOj" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Furniture
    and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zN2CJpmui0ja" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;IT
    equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_znYhjBfijHs5" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Library
    books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LaboratoriesAndClinicsMember_zy8nGF7You35" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Laboratories
    and clinics&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_z1lVkTwLfhpd" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Leasehold
    improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zEMD0wm5Ie93" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Construction
    in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B6_z8qJbJuS5uMg" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zgRvAijtZECi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2750"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,770&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;11,897&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,243&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;12,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;597&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;11,882&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,736&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;91,648&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zEa98fDb9NZ4" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2762"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;422&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,241&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,488&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,525&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,964&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zGspkmT9FpNd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2776"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2782"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2783"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zoBzLOAs4s5g" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,096&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;418&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,541&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;470&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,216&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zRRN4GV3tug1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2798"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;44,329&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;707&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,994&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,049&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,911&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;36,731&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,303&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zXnm95dVmXBk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,806&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2813"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,657&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;54,748&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,387&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;89,832&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_ziefd94qkGxk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,771&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,973&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,724&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;508&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,061&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,787&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,090&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;47,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_z1DeFmkR0Vsh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,148&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,395&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2837"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;367&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(43,502)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2844"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zwgSj3L7hoD6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,215&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;29,131&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,511&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2853"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;122,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;314,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zLjL82Q7WBaj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,511&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2865"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,720&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;59,957&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;125,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zkTAUX2nG8qh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,425&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,078&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;65,623&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zmVa3mkW0ree" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F40_zfRRSU4R0uSb"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,213)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2884"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,985)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(86)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2889"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(17,532)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zdkueYwI1JVg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2897"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,376&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(34,538)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2904"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iE_zdyfnPjcixRb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;52,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;77,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,467&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;69,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;53,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,072&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;152,976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;487,975&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zyljSFzGWkT6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(9,696)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2920"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(59)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,261)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,489)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,015)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(27)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(338)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2927"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(25,885)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zbhO1ufDHiua" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,097)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2932"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2933"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,629)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,495)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(359)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,317)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,545)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zHOXVqwwX09d" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2942"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2943"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2944"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2945"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2948"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2949"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2950"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2951"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zEtqFc7DOExf" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(13,793)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2956"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(59)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(5,890)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,537)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,663)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(386)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,655)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2963"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(36,983)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zmXu7XEiXQC2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2966"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,065)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(112)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,199)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,314)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,154)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(78)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2975"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(16,651)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zW5xiZEyjQU1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2978"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(464)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2982"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2983"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2984"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2987"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_z7E17VH1y7Od" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(19,322)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(171)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,089)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,817)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2997"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,384)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(53,634)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zGCt13y8OgLg" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,673)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,215)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,601)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,416)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3009"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,831)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(30,461)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zNwBYQYnFny7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F43_zFwjlOCX43gh"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3014"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3021"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3023"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iE_zPlBfJXWFNej" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,673)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(16,391)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(12,496)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(14,922)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(13,600)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3033"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,865)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3035"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(68,167)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z4MrY4J9dN9i" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;50,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;60,980&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,247&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;57,338&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;38,262&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;16,472&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3045"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;144,111&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;419,808&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zkuoCqmg5qWj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;49,181&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,044&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,660&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,807&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3057"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;117,621&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;260,381&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F09_zWaExgtmeRMc" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_z8MiGztrV118" style="font-family: Arial, Helvetica, Sans-Serif"&gt;the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zGVLKLv4lZkl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company assesses,
at each reporting date, whether there is an indication that a property and equipment asset may be impaired. If any indication exists,
the Company estimates the asset&#x2019;s recoverable amount. There were no indications of impairment of property and equipment as of and
for the years ended December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_eifrs-full--DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory_zBwyJ0giRUl3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B0_zXB5MRKKrsa9" style="display: none; visibility: hidden"&gt;Schedule
of detailed information about property, plant and equipment&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 24%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--BuildingsMember_ztR2ztUIgz46" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Building&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--MachineryAndEquipmentsMember_zWF4kv1Mf272" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Machinery
    and equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B0_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LandMember_zk3CSQXZAzo" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Lands&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BA_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--VehiclesMember_zqcdivLUIRk8" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Vehicles&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BE_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--FixturesAndFittingsMember_zScXVWbPlrOj" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Furniture
    and fixtures&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--ItEquipmentMember_zN2CJpmui0ja" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;IT
    equipment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B9_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LibraryBooksMember_znYhjBfijHs5" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 5%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Library
    books&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4BC_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_custom--LaboratoriesAndClinicsMember_zy8nGF7You35" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Laboratories
    and clinics&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B4_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--LeaseholdImprovementsMember_z1lVkTwLfhpd" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Leasehold
    improvements&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B1_ifrs-full--ClassesOfPropertyPlantAndEquipmentAxis_ifrs-full--ConstructionInProgressMember_zEMD0wm5Ie93" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Construction
    in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_4B6_z8qJbJuS5uMg" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zgRvAijtZECi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2750"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,770&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;182&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;11,897&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,243&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;12,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;597&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;11,882&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,736&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;91,648&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_439_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zEa98fDb9NZ4" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2762"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,235&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;422&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,976&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,241&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,205&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;34&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,488&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,525&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,964&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43C_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zGspkmT9FpNd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfers&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2774"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2775"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2776"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2777"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2778"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(525)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2780"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2782"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2783"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(525)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_433_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zoBzLOAs4s5g" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2786"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,988&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2788"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;103&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,565&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,035&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,096&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;418&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;14,541&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;470&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;28,216&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zRRN4GV3tug1" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2798"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;44,329&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;7,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;707&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,438&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;15,994&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,049&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,911&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;36,731&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,303&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zXnm95dVmXBk" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2810"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;13,806&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;672&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2813"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,550&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,657&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,012&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2817"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;54,748&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,387&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;89,832&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_ziefd94qkGxk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,771&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,973&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,724&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;508&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,061&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,493&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,473&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2829"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,787&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,090&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;47,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_z1DeFmkR0Vsh" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,148&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,395&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2836"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2837"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;367&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2840"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,049)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,559&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(43,502)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2844"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iS_zwgSj3L7hoD6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;68,503&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,215&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;29,131&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,511&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,624&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2853"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;122,005&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;314,015&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment_zLjL82Q7WBaj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,384&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,268&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,451&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;111&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,511&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,392&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2865"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,720&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;59,957&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;125,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment_zkTAUX2nG8qh" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2870"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,810&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2872"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;346&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;16,684&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,138&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,142&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2877"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,425&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,078&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;65,623&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zmVa3mkW0ree" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F40_zfRRSU4R0uSb"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(14,213)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2884"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(205)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,862&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,985)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(86)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2889"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(17,532)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43E_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zdkueYwI1JVg" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;25,068&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2896"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2897"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;82&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2900"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2901"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,376&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(34,538)&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2904"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_436_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_eifrs-full--PropertyPlantAndEquipment_iE_zdyfnPjcixRb" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;52,433&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;77,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,467&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;69,834&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;53,184&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;30,072&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2913"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;152,976&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;487,975&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Depreciation&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zyljSFzGWkT6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2918"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(9,696)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2920"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(59)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,261)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,489)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,015)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(27)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(338)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2927"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(25,885)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_437_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zbhO1ufDHiua" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2930"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,097)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2932"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2933"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,629)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,495)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(359)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,317)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2939"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,545)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43F_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zHOXVqwwX09d" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2942"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2943"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2944"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2945"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2948"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2949"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2950"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2951"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_434_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_zEtqFc7DOExf" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2954"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(13,793)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2956"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(59)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(5,890)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,537)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,663)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(386)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,655)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2963"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(36,983)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43D_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zmXu7XEiXQC2" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2966"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,065)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(112)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,199)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,314)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,154)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(78)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2975"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(16,651)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment_zW5xiZEyjQU1" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transfer&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2978"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(464)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2980"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2981"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2982"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2983"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2984"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;464&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2986"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2987"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2988"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_435_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iS_z7E17VH1y7Od" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2990"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(19,322)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2992"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(171)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,089)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,851)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,817)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2997"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,384)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl2999"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(53,634)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DepreciationPropertyPlantAndEquipment_iN_di_zGCt13y8OgLg" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Depreciation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,673)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,215)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3004"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(196)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,601)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,529)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,416)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3009"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,831)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(30,461)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_43A_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--DisposalsPropertyPlantAndEquipment_zNwBYQYnFny7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F43_zFwjlOCX43gh"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3014"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,146&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3016"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,194&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3021"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;350&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3023"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,928&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_431_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_eifrs-full--PropertyPlantAndEquipment_iE_zPlBfJXWFNej" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,673)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(16,391)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3028"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(220)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(12,496)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(14,922)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(13,600)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3033"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,865)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3035"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(68,167)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_430_c20211231_eifrs-full--PropertyPlantAndEquipment_iI_z4MrY4J9dN9i" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;50,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;60,980&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;18,852&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,247&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;57,338&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;38,262&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;16,472&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3045"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;144,111&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;31,786&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;419,808&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_438_c20201231_eifrs-full--PropertyPlantAndEquipment_iI_zkuoCqmg5qWj" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;25,919&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;49,181&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;13,401&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,044&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,042&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,660&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;10,807&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3057"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;117,621&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,706&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;260,381&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F09_zWaExgtmeRMc" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F11_z8MiGztrV118" style="font-family: Arial, Helvetica, Sans-Serif"&gt;the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">30503000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">2770000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">182000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">11897000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">10243000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">12838000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">597000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">11882000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">10736000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">91648000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">9838000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">4235000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">422000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">6976000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">4241000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">1205000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">34000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">4488000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">25525000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">56964000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">-525000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">-525000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">3988000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">103000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">2565000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">2035000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">4096000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">418000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">14541000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">470000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">28216000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">44329000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">7005000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">707000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">21438000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">15994000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">18139000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">1049000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">30911000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">36731000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">176303000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">13806000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">672000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">4550000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">9657000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">1012000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">54748000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">5387000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">89832000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">6771000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">8973000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">5724000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">508000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">3061000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">2493000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">2473000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">12787000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">5090000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">47880000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">19148000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">1395000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">82000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">367000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">-1049000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">23559000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">-43502000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">25919000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">68503000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">13401000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">1215000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">29131000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">28511000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">21624000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">122005000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">3706000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">314015000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">1384000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">10268000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">5451000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">111000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">21075000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">19511000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">3392000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">4720000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">59957000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">125869000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">12810000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">346000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">16684000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">10138000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">5142000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">17425000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">3078000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">65623000</ifrs-full:AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      id="Fact002882"
      unitRef="BRL">62000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact002883"
      unitRef="BRL">-14213000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact002885"
      unitRef="BRL">-205000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact002886"
      unitRef="BRL">2862000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact002887"
      unitRef="BRL">-4985000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact002888"
      unitRef="BRL">-86000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact002890"
      unitRef="BRL">-550000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      id="Fact002891"
      unitRef="BRL">-417000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact002892"
      unitRef="BRL">-17532000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">25068000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">3000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">82000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">9000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">9376000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">-34538000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">52433000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">77371000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">18852000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">1467000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">69834000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">53184000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">30072000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">152976000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">31786000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">487975000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">-9696000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">-59000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">-4261000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">-4489000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">-7015000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">-27000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">-338000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-25885000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">4097000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">1629000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">2495000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">1648000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">359000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">1317000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">11545000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">447000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">447000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">-13793000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">-59000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">-5890000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">-6537000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">-8663000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">-386000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">-1655000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-36983000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">5065000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">112000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">2199000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">4314000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">2154000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">78000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">2729000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">16651000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">-464000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LaboratoriesAndClinicsMember"
      decimals="-3"
      unitRef="BRL">464000</ifrs-full:IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">-19322000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">-171000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">-8089000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">-10851000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">-10817000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">-4384000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-53634000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">1673000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">7215000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">196000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">5601000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">7529000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">3416000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">4831000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DepreciationPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">30461000</ifrs-full:DepreciationPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      id="Fact003015"
      unitRef="BRL">10146000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      id="Fact003017"
      unitRef="BRL">147000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      id="Fact003018"
      unitRef="BRL">1194000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      id="Fact003019"
      unitRef="BRL">3458000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      id="Fact003020"
      unitRef="BRL">633000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      id="Fact003022"
      unitRef="BRL">350000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:DisposalsPropertyPlantAndEquipment
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      id="Fact003024"
      unitRef="BRL">15928000</ifrs-full:DisposalsPropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">-1673000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">-16391000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">-220000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">-12496000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">-14922000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">-13600000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">-8865000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-68167000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">50760000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">60980000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">18852000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">1247000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">57338000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">38262000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">16472000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">144111000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2021-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">31786000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">419808000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_BuildingsMember"
      decimals="-3"
      unitRef="BRL">25919000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_custom_MachineryAndEquipmentsMember"
      decimals="-3"
      unitRef="BRL">49181000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_LandMember"
      decimals="-3"
      unitRef="BRL">13401000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_VehiclesMember"
      decimals="-3"
      unitRef="BRL">1044000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_FixturesAndFittingsMember"
      decimals="-3"
      unitRef="BRL">21042000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_custom_ItEquipmentMember"
      decimals="-3"
      unitRef="BRL">17660000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_custom_LibraryBooksMember"
      decimals="-3"
      unitRef="BRL">10807000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_LeaseholdImprovementsMember"
      decimals="-3"
      unitRef="BRL">117621000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment
      contextRef="AsOf2020-12-31_ifrs-full_ConstructionInProgressMember"
      decimals="-3"
      unitRef="BRL">3706000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:PropertyPlantAndEquipment contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">260381000</ifrs-full:PropertyPlantAndEquipment>
    <ifrs-full:DisclosureOfIntangibleAssetsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eifrs-full--DisclosureOfIntangibleAssetsExplanatory_zxxqkltlzGje" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;12&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_822_zR55wnJWD8Fa"&gt;Intangible
                                            assets and goodwill&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_zgxmCWdKyXog" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BC_z6CNYptVO0dh" style="display: none; visibility: hidden"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 24%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Licenses
    with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Trademarks&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Education
    content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Developed
    technology &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Educational
    platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Software
    in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkxsuhUaV5l9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;169,535&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhaDuACraDhe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;445,616&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHs2gwz7FaO4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3071"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPsSmKAbzb9h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;63,303&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zptr5G7guQEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;8,288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfIJtY98dNm9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3077"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgVdcREIzvdh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3079"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf6tA5ZCKvg3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;577&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUiRBzQHaGd1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,175&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcF2rYhO8RKj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;688,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;sup id="xdx_F44_zGflIxppYzX1"&gt;(i)&lt;/sup&gt; &lt;sup id="xdx_F42_zAmXwDBmqTAi"&gt;(ii)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zKHd9jvJkPu7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z0zbWSeN8hL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zL8N7OhxPjhf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,101&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJjOI3pxaJA4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,769&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJBqYGmy7gil" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;875&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zecGZ2M4FaXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;122,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR1UoBsoDr43" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;285,844&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvviFS7HpiY6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;150,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeaCpQSf5Gzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z07h0F5KREy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znrhXtBCZ8Ni" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,305&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformAndSoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7iVNfDjgI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg8UJ7rr2Fr8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;550,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNumYlMzBxIl" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;459,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLoTM6YqnQY6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;703,772&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLr2xOJt0RF6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;32,111&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7XYVQlAfSmj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;125,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsWxj88AuHZ9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,389&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjEjhdNwkqb6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO81qsEtl7r4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3122"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWNQkVXU31Sa" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;12,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpzHay8lTyRe" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,050&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvvRK5zgnxi8" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,361,640&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD0JnCltpD61" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeunoOf2RDW2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoY5CWPbrz2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zytdoG1JSEB6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,649&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5xrZd2YGPuj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Disposal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(460)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Disposal_pn3n3_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlg4GHNqNo1a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zALR5Fv0JCNa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;351,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkjxVi1pGvM4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;747,498&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgn0GpcbgYVa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znu21tk3vc8a" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,126&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzyK3v3xPJte" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,117&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUKPVciX5vR4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqF30wiFGyKl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;484&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPz7SO6H8O6b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,303,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTQ1rtT6InQe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zomSze4aW6Y7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVHqcQBJ7rG7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;75,014&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbmI77B3unzg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;283,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD9tzR12okJb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;16,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkHU2FN390d" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUivKqpwPjZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrHMFJKqe5Sk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;27,902&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXHJ8vb2DkV6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyZxnBMFQGNg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,684,559&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;sup id="xdx_F48_z75kiZZ6VCga"&gt;(iii)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z08XjpZh0qMj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z5J2Zgd32oA6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSO4JbJcODv9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zBdR4iXMAZR3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zCr11aO1hLWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3175"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zaEz9a8dB838" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zS0YV8HvJKgj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zQYmrFsHGW84" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,700&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zWwl093j8nwc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;176,110&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F4A_zZEoSxeGOff4"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Disposal_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zOF7zA2Ksu8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z4Rm6jRHskEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3181"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zzPdTfZ8IQ87" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z7Ml7PG2qXM5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3183"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zxqK38cQYOG6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z9yVKOOMngZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAfpD7EyucX1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zkWkDnVFplf4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zBS4JsvAGhql" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zQZYCIVsM807" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKg84LKNay84" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;373,680&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTMivMWO8NCc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;606,136&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3Dl9KSSdVgc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCVehoHl3O82" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzRqdd0WvCzi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zH9u7D27jOG8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;33,046&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXX7ElwXfpL6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl7dJ43XXPEg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,267&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgRntUVoIfl4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,234,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyIWtt7sa1g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAPIpgLTkPr5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWgb5DbKx6Sc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;133,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNS41JHdYfHe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;431,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhO2u0poXFEe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z01UObTkkUxb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHr9BvWD3WE8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;34,397&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7SLw7iMTnDa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;76,444&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN7Z7PDKTc65" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW6Co3FHS8J1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,093,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVTMWFTXcKm7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3227"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9VOEa0LPMX6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3229"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zY677rsPs7id" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3231"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDluYcBLQg89" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,945)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOXSiuHHtrA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,080)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z27eu706jec3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3237"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzwI10IbOTUe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3239"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziv62DwYuaM2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3241"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK8e1ET41Lj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3243"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zP2S4NpLP8r" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,025)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhrweN45PrQ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6IOj47FpXzk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(34,927)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJW5zpZm2r1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,456)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zs90LkueKM5j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,876)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zt7fch5NkyA" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(868)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYTtHO5sl67c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(43,277)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQmvxq2n688e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3255"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSu9HcwpMEn5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3257"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbgv1P4XFhTf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,150)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgJoXUJ4msVg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(37,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCbASu4xufMg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,536)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjGhWA7ZVr44" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,876)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0NCtljo8nZ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK34BN7uaF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(868)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziL4KQqog2wc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRv64Sfjrd58" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(49,302)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuFsprRvxeXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,352)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0C3m4tNdZl7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(47,960)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4vpqQI1Pb4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfiDzAUqRoS9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,816)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbb1l4caHOaf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(32)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOPpLfFpFxOh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,367)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvU1BNA0OIZ2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,707)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zygf6PLXLsI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzfmtAqKJ6Nh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;460&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcY9MbR8nUPh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3284"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqYkFl7Z3hKi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJSgRwo85sd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,502)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH7fLAJ1wDp4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(85,832)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0rnZC4GJW2h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,256)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW5U72wxINI8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,692)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIx7B4AkeS7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(32)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVDa8yMeN2gd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,235)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zczVseOSEilc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3300"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIYMYwyxNBWk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(111,549)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAF7Qly5ZWah" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCybXu0S6oZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxBHx5BmYGCb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,027)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zubKmkJvsSr5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,438)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EdFV6wvHi4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,844)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znzLhDc6I1rg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(8,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx9BVkCtRRxl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(625)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRh8kfUgG3b7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgb9oFhb3f3c" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3311"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy60RBVK31uj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(80,522)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjS56W2a53k6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3313"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaRwrN4jQncc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3314"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWx0KpoTeV8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKIWxUuidp11" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zniuF1KTm6S3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(599)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNSJ2wMjN4E8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztXIRdEGc6Pb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx80T1pUaD7h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsl8H8S8gC0e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_za2dEqEd4pWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgxV2qVoxrik" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3324"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZoR9jljaXpl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRypdi6t7ic7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCGkk9S8s8ei" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(142,270)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGLksVBw85s9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(12,699)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1UoVgcFv9Ob" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(16,672)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbIWImgRqNY8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(657)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuQKaZTOr9N1" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,478)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC2BpddUhYGj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3340"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkf9uBnobtQ" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(192,305)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zE8V3FvUgpW4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs06UttAd1j6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zhg2fl7uqYFc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;124,840&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zFK1NxBXXfEa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;289,007&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_znmlefgFDmD4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zcpKvMmISzH1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;633&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zKvaXM4yuvl3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;33,740&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOXO8lmqO1O8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;64,966&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zsGNAUEBbOQk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231_zrCyYTQlGNH3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,900,835&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zygN9kzpFb3j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw1uNmd1WAG2" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zHacTJWMU0x4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;71,512&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJmT39SbdOD6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;197,707&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zrkdGCswOQXj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,965&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVOpwR97WGPl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,613&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zq0p7p2NQYIa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;323&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zkrqGmCTUae1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;19,667&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_z45HSGqjFwG4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231_zooUxMWZ3Pwl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,573,010&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F00_zZu9Mg5u23Y7" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_zfAsL5DpRmci" style="font-family: Arial, Helvetica, Sans-Serif"&gt;the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zKMB1nvNcvOa" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zuLRtVLlgLe6" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F06_zFr7UWC0GTN" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z4ydhiKEJR74" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#xe1;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zQCa6c3fio5" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zj85er5T4eEe" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A3_zh1ydSjV844i" style="font: italic bold 11pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Licenses with indefinite
useful life include intangible assets acquired through business combinations. The licenses for medicine and other courses granted by
the Ministry of Education (&#x201c;MEC&#x201d;) to the companies acquired have no expiration date and the Company has determined that these
assets have indefinite useful lives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For impairment
testing goodwill and licenses with indefinite useful lives acquired through business combinations are allocated to CGUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company performed
its annual impairment test on December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company tests
at least annually the recoverability of the carrying amount of goodwill and licenses with indefinite useful lives for each CGU. The process
of estimating these values involves the use of assumptions, judgments and estimates of future cash flows that represent the Company's
best estimate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There was no impairment
for goodwill and licenses with indefinite useful lives as of December 31, 2021, 2020 and 2019.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_z6bXJpTV1et4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The carrying amounts
of goodwill and licenses with indefinite useful life by CGU and their carrying amount as of December 31, 2021 and 2020 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B6_zQ2HWeYUNpIc" style="display: none; visibility: hidden"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-bottom: 9pt; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Licenses
    with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPTAN&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zbY6uLfmZk36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zQ44mvcqaUVb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zILJh7pp2P0e" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z7F4qyn8fxKb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDwKKaIHGISl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;140,522&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zT0DF7HP30ri" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;126,397&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IESVAP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zeAlZ1lG6jmb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z2jWHo6SBAL4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zhewlffkoZP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zN5TCgI8Bcnk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zpoP56TV7iH5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;112,260&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_znplQR4TgBth" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;112,898&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CCSI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zEF9aIYGp6w3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_z4MLayuCI2dg" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJsfo1O1AnIh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zVzwvkUo4MW3" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zlj1p2hOL8f5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zn4bvgn4Xuk9" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,411&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IESP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oudzNoxTH1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zFmUglBqt9nd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zp1WEpbSH0ng" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmoYi85jZk23" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zAvLjw9x63I3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;346,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zGuwFrKq5z7c" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;380,410&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FADEP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6JJBTzO7Gnf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_ztPOG9HJe517" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zwkjEdn8wOVk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zzUfKFV3e7o4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zdUPnDfbZjDj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;153,791&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zZbQNT5am1Pk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;160,787&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Medcel
    and CBBW&lt;sup id="xdx_F48_zNSFhX0F0RO2"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zDfBOeCKubog" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z1JGVJeH9E6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z5uNFxi4L4k9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zFqBytiQsYEf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_iI_pn3n3_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_fKg_____ztl9lzUOXBB1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;219,359&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FASA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z8J5aIV2d8J5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zuF058AECMj8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zoWPq3zhxFC2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zL14y5Bxsnn4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zO1CnMq2b9Y8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;302,330&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zC4CVcHh4s5b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;267,279&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPEMED&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zSn4IVr4r26g" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zZtwYkmG5cUd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zwk1TqrwtMa4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zB0wKsrmXjF7" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;126,965&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zATzj8DzHIT9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;119,227&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPEC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zy3wu7ci7542" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3465"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z9ZTXYNTrxu" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zZfZtW4hTfvb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zXIuCaIclsbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;131,360&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbIvODB8kxLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;122,325&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;UniRedentor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zooFqLCww3d1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zNfhLSfBRWn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zci9L4EpLiI7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOr0ulV5Ag" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zXrgIGCutbea" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;246,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zV7tIYVAlFLl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;253,370&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;UniSL&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zIg3R16vOWyl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zfBfvoywZNuh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zVKFXgAP3Xal" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;249,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zCKJwtd6cwX" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;249,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zn4nr0KHUH56" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;305,044&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zYlwgzZ2e4yd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;258,234&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FESAR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zSQ4xRAHWTva" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zrLi267lEdF8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zEEI52Bztufk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgVdNu8bS2xf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z964NDcXsZK3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;279,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zjHsiwYHJuRh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;263,914&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FCMPB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3Rkn0Ao1yFl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmQn89lLYon" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN7qrDgglIF" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYNYf4vh1LAe" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYvScuJiCTg9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;401,244&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNFFAxDs88z3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;380,682&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Practice
    Management Tools &amp;amp; Electronic Prescription&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zQBq792otTv6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;113,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zLHyWfz1RyZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3523"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zuSb1p53M0K1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;227,909&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Clinical
    Decision Software&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z5TusdNxsOOh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zhQ298J9oL8b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z7J9B7c8kWKg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3527"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z2df3kzHhzJg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,592&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zxB4PyWZpbI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;149,805&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Medical
    Harbour&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zM6Ahi9d9bcb" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zXQs57WQt4Pb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z1hnh4QgkZrf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,150&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Moc&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_z5CwvpIq3x8j" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zaYmPTngbDOc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;184,597&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zGWUL66Ru19k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,649&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zYQ5lD9Dv0r8" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;356,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zbpEn8piGm3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,230&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Unigranrio&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKgF53O2SEEc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;130,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z9WlEuJYLFRe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zMTF6mdjYZnf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;630,185&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;RXPRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zuO3hAGg5vKc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;38,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zL5HKRinwMAk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zkCZQE0iPnsc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;46,788&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 37%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F08_zKnFfqu5FuT" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_z9LAT5xSQ9wg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;CBBW as merged by Medcel on May 1,
2020.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A4_zJz10JLC0DNe" style="font: 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;The
main assumptions used by the Company to determine the value in use of the CGUs were:&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Student
enrollment&lt;/i&gt; &#x2013; refer to the number of students that are currently enrolled in each CGU.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Tuition fees
&lt;/i&gt;&#x2013; is the monthly fee charged to students.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Occupancy rate
&lt;/i&gt;&#x2013; the occupancy rate of the medical schools is the ratio of the number of &lt;i&gt;students effectively enrolled divided by the regulatory
capacity in a given period.&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Regulatory capacity
&lt;/i&gt;&#x2013; the regulatory capacity is defined by the number of medical schools seats available per year awarded by MEC, multiplied by
the number of years of operations since the seats were awarded.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Faculty &#x2013;
&lt;/i&gt;refer to the cost with faculty in the CGU, which means the amount paid to teachers and doctors.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Digital content
platform users &lt;/i&gt;&#x2013; refer to mobile app subscription, clinical management system, healthcare payments, medical imaging, online
courses for digital content users and marketing for pharmaceutical industry.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 10pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Capital expenditure
&lt;/i&gt;&#x2013; refers to investments to be made on intangible assets related to developments and platform improvements especially on the
digital services CGUs.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;Discount
rates&lt;/i&gt; - discount rates represent the current market assessment of the risks specific to the CGU being tested. The pre-tax discount
rate applied to cash flow projections is &lt;span id="xdx_908_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20211231_zTdloaaNAW3d" title="Discount rate applied to cash flow projections"&gt;12.10&lt;/span&gt;% in 2021 (&lt;span id="xdx_90B_eifrs-full--DescriptionOfDiscountRatesAppliedToCashFlowProjections_iI_pii_dp_uPure_c20201231_zcTO54Zv5HWj" title="Discount rate applied to cash flow projections"&gt;13.00&lt;/span&gt;% in 2020).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt 10.9pt; text-indent: -10.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Significant
estimate: impact of possible changes in key assumptions&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zuJWN0TfAbm9" title="Description of key assumptions on which management has based cash flow projections"&gt;An
increase of 25 basis points in management&#x2019;s estimated discount rate applied to the cash flow projections of each CGU for the year
ended December 31, 2021, or a decrease of 25 basis points on estimated EBITDA would have not resulted in significant impacts on these
financial statements.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Other
intangible assets&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 8pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 21.3pt; text-indent: -21.3pt; color: #365F91"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Intangible assets,
other than goodwill and licenses with indefinite useful lives, are valued separately for each acquisition and are amortized during each
useful life. The useful lives and methods of amortization of other intangibles are reviewed at each financial year end and adjusted prospectively,
if appropriate.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zDhySJj7Mhya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The estimated useful
lives of intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zNmiBNZ2nE37" style="display: none; visibility: hidden"&gt;Schedule of estimated useful lives&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Customer
    relationships &#x2013; medicine&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_ztZshgpE3eKe" title="Estimated useful lives of intangible assets::XDX::P6Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3554"&gt;6&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Customer
    relationships &#x2013; other courses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zT0Z181dGW43" title="Estimated useful lives of intangible assets::XDX::P4Y6M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;4.5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Software
    license&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zKckB0ycDaJi" title="Estimated useful lives of intangible assets::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3558"&gt;5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Education
    content&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVci0b1UmKDa" title="Estimated useful lives of intangible assets::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3560"&gt;3&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxGX5pwOIP32" title="Estimated useful lives of intangible assets::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3562"&gt;2&lt;/span&gt;&lt;/span&gt;
    - &lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLHLgPUum7Gd" title="Estimated useful lives of intangible assets::XDX::P30Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3564"&gt;30&lt;/span&gt;&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Developed
    technology&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zteOoECwHqFj" title="Estimated useful lives of intangible assets::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3566"&gt;5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zzCjzXUwfrkb" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For the years ended
December 31, 2021, 2020 and 2019, there were no indicatives that the Company&#x2019;s intangible assets with finite useful lives might
be impaired.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIntangibleAssetsExplanatory>
    <afya:SummaryOfIntangibleAssetsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--SummaryOfIntangibleAssetsTableTextBlock_zgxmCWdKyXog" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BC_z6CNYptVO0dh" style="display: none; visibility: hidden"&gt;Schedule of intangible assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 24%; padding-right: 1.45pt; padding-left: 1.45pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Licenses
    with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Trademarks&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Customer
    relationships&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 6%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Software&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Education
    content&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Developed
    technology &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 8%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Educational
    platform&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 9%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Software
    in progress&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 7%; padding-right: 1.45pt; padding-left: 1.45pt; text-align: center; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkxsuhUaV5l9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;169,535&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhaDuACraDhe" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;445,616&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHs2gwz7FaO4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3071"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPsSmKAbzb9h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;63,303&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zptr5G7guQEk" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;8,288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zfIJtY98dNm9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3077"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgVdcREIzvdh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3079"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zf6tA5ZCKvg3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;577&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUiRBzQHaGd1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,175&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zcF2rYhO8RKj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;688,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;sup id="xdx_F44_zGflIxppYzX1"&gt;(i)&lt;/sup&gt; &lt;sup id="xdx_F42_zAmXwDBmqTAi"&gt;(ii)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zKHd9jvJkPu7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,030&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____z0zbWSeN8hL9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zL8N7OhxPjhf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,101&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJjOI3pxaJA4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;8,769&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zJBqYGmy7gil" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;875&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGkpKGlpKQ_____zecGZ2M4FaXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;122,775&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR1UoBsoDr43" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;285,844&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvviFS7HpiY6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;150,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeaCpQSf5Gzi" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;32,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z07h0F5KREy3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;62,110&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znrhXtBCZ8Ni" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,305&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformAndSoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zR7iVNfDjgI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,845&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zg8UJ7rr2Fr8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;550,371&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNumYlMzBxIl" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;459,409&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLoTM6YqnQY6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;703,772&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zLr2xOJt0RF6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;32,111&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7XYVQlAfSmj" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;125,413&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zsWxj88AuHZ9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,389&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zjEjhdNwkqb6" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zO81qsEtl7r4" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3122"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWNQkVXU31Sa" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;12,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zpzHay8lTyRe" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,050&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zvvRK5zgnxi8" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,361,640&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD0JnCltpD61" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,175&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zeunoOf2RDW2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;15,227&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zQoY5CWPbrz2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zytdoG1JSEB6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,649&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z5xrZd2YGPuj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Disposal"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(460)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--Disposal_pn3n3_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zlg4GHNqNo1a" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(460)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zALR5Fv0JCNa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;351,247&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkjxVi1pGvM4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;747,498&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgn0GpcbgYVa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;42,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_znu21tk3vc8a" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,126&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzyK3v3xPJte" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,117&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUKPVciX5vR4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zqF30wiFGyKl" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;484&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zPz7SO6H8O6b" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,303,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTQ1rtT6InQe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zomSze4aW6Y7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zVHqcQBJ7rG7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;75,014&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zbmI77B3unzg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;283,539&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zD9tzR12okJb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;16,221&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkkHU2FN390d" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zUivKqpwPjZc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zrHMFJKqe5Sk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;27,902&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXHJ8vb2DkV6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zyZxnBMFQGNg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,684,559&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Additions
    &lt;sup id="xdx_F48_z75kiZZ6VCga"&gt;(iii)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z08XjpZh0qMj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___z5J2Zgd32oA6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zSO4JbJcODv9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;684&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zBdR4iXMAZR3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,044&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zCr11aO1hLWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3175"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zaEz9a8dB838" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;996&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zS0YV8HvJKgj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;39,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zQYmrFsHGW84" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;23,700&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKGlpaSk___zWwl093j8nwc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;176,110&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals
    &lt;sup id="xdx_F4A_zZEoSxeGOff4"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Disposal_pn3n3_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zOF7zA2Ksu8j" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3180"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z4Rm6jRHskEb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3181"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zzPdTfZ8IQ87" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3182"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z7Ml7PG2qXM5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3183"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zxqK38cQYOG6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____z9yVKOOMngZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3185"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zAfpD7EyucX1" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3186"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zkWkDnVFplf4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,743)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zBS4JsvAGhql" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(417)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_fKg_____zQZYCIVsM807" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,140)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zKg84LKNay84" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;373,680&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zTMivMWO8NCc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;606,136&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z3Dl9KSSdVgc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,355&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zCVehoHl3O82" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,054&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zzRqdd0WvCzi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,474&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--DevelopedTechnologyIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zH9u7D27jOG8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;33,046&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zXX7ElwXfpL6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;11,599&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zl7dJ43XXPEg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,267&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zgRntUVoIfl4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,234,611&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zkyIWtt7sa1g" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zAPIpgLTkPr5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zWgb5DbKx6Sc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;133,369&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zNS41JHdYfHe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;431,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zhO2u0poXFEe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,759&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z01UObTkkUxb" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;17,305&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zHr9BvWD3WE8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;34,397&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_z7SLw7iMTnDa" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;76,444&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zN7Z7PDKTc65" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zW6Co3FHS8J1" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;4,093,140&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Amortization&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of January 1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVTMWFTXcKm7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3227"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z9VOEa0LPMX6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3229"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zY677rsPs7id" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3231"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zDluYcBLQg89" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(2,945)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOXSiuHHtrA9" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,080)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z27eu706jec3" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3237"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzwI10IbOTUe" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3239"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziv62DwYuaM2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3241"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK8e1ET41Lj" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3243"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zP2S4NpLP8r" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,025)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zhrweN45PrQ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,150)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z6IOj47FpXzk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Amortization"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(34,927)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zJW5zpZm2r1l" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,456)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zs90LkueKM5j" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,876)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zt7fch5NkyA" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(868)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20190101__20191231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zYTtHO5sl67c" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(43,277)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQmvxq2n688e" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3255"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zSu9HcwpMEn5" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3257"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbgv1P4XFhTf" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,150)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgJoXUJ4msVg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(37,872)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCbASu4xufMg" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,536)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjGhWA7ZVr44" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,876)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0NCtljo8nZ2" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3267"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziK34BN7uaF6" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(868)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ziL4KQqog2wc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3271"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRv64Sfjrd58" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(49,302)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuFsprRvxeXb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,352)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0C3m4tNdZl7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(47,960)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4vpqQI1Pb4h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,180)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zfiDzAUqRoS9" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(2,816)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbb1l4caHOaf" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(32)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zOPpLfFpFxOh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,367)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvU1BNA0OIZ2" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(62,707)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zygf6PLXLsI4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;460&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--Disposal_c20200101__20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zzfmtAqKJ6Nh" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;460&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zcY9MbR8nUPh" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3284"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zqYkFl7Z3hKi" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3286"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zQJSgRwo85sd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(3,502)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zH7fLAJ1wDp4" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(85,832)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z0rnZC4GJW2h" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(6,256)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zW5U72wxINI8" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(7,692)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRIx7B4AkeS7" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(32)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zVDa8yMeN2gd" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,235)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zczVseOSEilc" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3300"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iS_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zIYMYwyxNBWk" style="border-bottom: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at beginnning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(111,549)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zAF7Qly5ZWah" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3303"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCybXu0S6oZa" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3304"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zxBHx5BmYGCb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,027)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zubKmkJvsSr5" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,438)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z4EdFV6wvHi4" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(5,844)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_znzLhDc6I1rg" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(8,980)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx9BVkCtRRxl" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(625)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRh8kfUgG3b7" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,608)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgb9oFhb3f3c" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3311"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AmortisationIntangibleAssetsOtherThanGoodwill_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zy60RBVK31uj" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(80,522)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zjS56W2a53k6" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3313"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zaRwrN4jQncc" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3314"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zvWx0KpoTeV8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3315"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zKIWxUuidp11" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3316"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zniuF1KTm6S3" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(599)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zNSJ2wMjN4E8" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3318"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_ztXIRdEGc6Pb" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3319"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zx80T1pUaD7h" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zsl8H8S8gC0e" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3321"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--Disposal_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_za2dEqEd4pWd" style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zgxV2qVoxrik" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3324"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zZoR9jljaXpl" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3326"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zRypdi6t7ic7" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(8,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zCGkk9S8s8ei" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(142,270)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zGLksVBw85s9" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(12,699)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_z1UoVgcFv9Ob" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(16,672)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zbIWImgRqNY8" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(657)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zuQKaZTOr9N1" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(11,478)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zC2BpddUhYGj" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3340"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsAndGoodwill_iE_c20210101__20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--AccumulatedDepreciationAndAmortisationMember_zkf9uBnobtQ" style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt" title="Intangible assets and goodwill, balance at end"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(192,305)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Net
    book value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 1.45pt; padding-left: 1.45pt; text-align: right; line-height: 7.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zE8V3FvUgpW4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,184,336&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zs06UttAd1j6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,165,406&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zhg2fl7uqYFc" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;124,840&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zFK1NxBXXfEa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;289,007&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_znmlefgFDmD4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,060&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zcpKvMmISzH1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;633&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zKvaXM4yuvl3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;33,740&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zOXO8lmqO1O8" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;64,966&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_zsGNAUEBbOQk" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;28,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20211231_zrCyYTQlGNH3" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;3,900,835&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 1.45pt; padding-left: 5.9pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--GoodwillMember_zygN9kzpFb3j" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;810,656&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--LicencesMember__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__ifrs-full--GrossCarryingAmountMember_zw1uNmd1WAG2" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,451,270&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember_zHacTJWMU0x4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;71,512&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--CustomerrelatedIntangibleAssetsMember_zJmT39SbdOD6" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;197,707&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zrkdGCswOQXj" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,965&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVOpwR97WGPl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;9,613&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zq0p7p2NQYIa" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;323&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationalPlatformMember_zkrqGmCTUae1" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;19,667&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--SoftwareInProgressMember_z45HSGqjFwG4" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,297&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsAndGoodwill_iI_c20201231_zooUxMWZ3Pwl" style="border-bottom: Black 1.5pt double; padding-right: 1.45pt; padding-left: 1.45pt; text-align: right" title="Intangible assets and goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,573,010&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 8pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F00_zZu9Mg5u23Y7" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_zfAsL5DpRmci" style="font-family: Arial, Helvetica, Sans-Serif"&gt;the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F05_zKMB1nvNcvOa" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zuLRtVLlgLe6" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F06_zFr7UWC0GTN" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(ii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z4ydhiKEJR74" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#xe1;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: italic 8pt/9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F09_zQCa6c3fio5" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;(iii)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zj85er5T4eEe" style="font-family: Arial, Helvetica, Sans-Serif; font-style: normal; font-weight: normal"&gt;On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfIntangibleAssetsTableTextBlock>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">169535000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">445616000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">63303000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">8288000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">577000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1175000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">688494000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003087"
      unitRef="BRL">4030000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003089"
      unitRef="BRL">108000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003091"
      unitRef="BRL">1101000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003092"
      unitRef="BRL">8769000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003093"
      unitRef="BRL">875000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003094"
      unitRef="BRL">122775000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">285844000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">150156000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">32111000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">62110000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">17305000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_custom_EducationalPlatformAndSoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2845000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">550371000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">459409000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">703772000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">32111000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">125413000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">9389000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">17305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">12191000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2050000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1361640000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">4175000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">15227000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">247000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">19649000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:Disposal
      contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">-460000</afya:Disposal>
    <afya:Disposal
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">-460000</afya:Disposal>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">351247000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">747498000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">42903000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">158126000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">3117000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">355000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">484000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1303730000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">810656000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1451270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">75014000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">283539000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">16221000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">17305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">355000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">27902000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2297000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2684559000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003171"
      unitRef="BRL">108000000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003173"
      unitRef="BRL">684000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003174"
      unitRef="BRL">3044000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003176"
      unitRef="BRL">996000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003177"
      unitRef="BRL">39686000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003178"
      unitRef="BRL">23700000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003179"
      unitRef="BRL">176110000</ifrs-full:AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003184"
      unitRef="BRL">1020000</afya:Disposal>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003187"
      unitRef="BRL">-2743000</afya:Disposal>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003188"
      unitRef="BRL">-417000</afya:Disposal>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      id="Fact003189"
      unitRef="BRL">-2140000</afya:Disposal>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">373680000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">606136000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">58355000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">147054000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1474000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_custom_DevelopedTechnologyIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">33046000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">11599000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">3267000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1234611000</ifrs-full:AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1184336000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2165406000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">133369000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">431277000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">21759000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">17305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">34397000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">76444000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">28847000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">4093140000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-2945000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-3080000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2018-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-6025000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-1150000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-34927000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-1456000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-4876000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-868000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2019-01-012019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-43277000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-1150000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-37872000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-4536000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-4876000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-868000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2019-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-49302000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-2352000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-47960000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-2180000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-2816000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-32000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-7367000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-62707000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:Disposal
      contextRef="From2020-01-012020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">460000</afya:Disposal>
    <afya:Disposal
      contextRef="From2020-01-012020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">460000</afya:Disposal>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-3502000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-85832000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-6256000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-7692000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-32000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-8235000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-111549000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-5027000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-56438000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-5844000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-8980000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-625000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-3608000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-80522000</ifrs-full:AmortisationIntangibleAssetsOtherThanGoodwill>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-599000</afya:Disposal>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">365000</afya:Disposal>
    <afya:Disposal
      contextRef="From2021-01-012021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-234000</afya:Disposal>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-8529000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-142270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-12699000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationContentMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-16672000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-657000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationalPlatformMember_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-11478000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_AccumulatedDepreciationAndAmortisationMember"
      decimals="-3"
      unitRef="BRL">-192305000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      unitRef="BRL">1184336000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">2165406000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      unitRef="BRL">124840000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      unitRef="BRL">289007000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      unitRef="BRL">9060000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationContentMember"
      decimals="-3"
      unitRef="BRL">633000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      unitRef="BRL">33740000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      unitRef="BRL">64966000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2021-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      unitRef="BRL">28847000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3900835000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_GoodwillMember"
      decimals="-3"
      unitRef="BRL">810656000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_LicencesMember_ifrs-full_GrossCarryingAmountMember"
      decimals="-3"
      unitRef="BRL">1451270000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_BrandNamesMember"
      decimals="-3"
      unitRef="BRL">71512000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_CustomerrelatedIntangibleAssetsMember"
      decimals="-3"
      unitRef="BRL">197707000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_ComputerSoftwareMember"
      decimals="-3"
      unitRef="BRL">9965000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationContentMember"
      decimals="-3"
      unitRef="BRL">9613000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_ifrs-full_TechnologybasedIntangibleAssetsMember"
      decimals="-3"
      unitRef="BRL">323000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_EducationalPlatformMember"
      decimals="-3"
      unitRef="BRL">19667000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill
      contextRef="AsOf2020-12-31_custom_SoftwareInProgressMember"
      decimals="-3"
      unitRef="BRL">2297000</ifrs-full:IntangibleAssetsAndGoodwill>
    <ifrs-full:IntangibleAssetsAndGoodwill contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2573010000</ifrs-full:IntangibleAssetsAndGoodwill>
    <afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_890_ecustom--SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock_z6bXJpTV1et4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The carrying amounts
of goodwill and licenses with indefinite useful life by CGU and their carrying amount as of December 31, 2021 and 2020 was:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B6_zQ2HWeYUNpIc" style="display: none; visibility: hidden"&gt;Schedule of assumptions for impairment test&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="11" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-bottom: 9pt; padding-left: 10.9pt; text-align: center; font-size: 9pt; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Goodwill&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Licenses
    with indefinite useful life&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;CGU&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPTAN&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zbY6uLfmZk36" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zQ44mvcqaUVb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;17,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zILJh7pp2P0e" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_z7F4qyn8fxKb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;57,214&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zDwKKaIHGISl" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;140,522&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember_zT0DF7HP30ri" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;126,397&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IESVAP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zeAlZ1lG6jmb" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z2jWHo6SBAL4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;27,956&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zhewlffkoZP1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zN5TCgI8Bcnk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;81,366&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_zpoP56TV7iH5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;112,260&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_znplQR4TgBth" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;112,898&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CCSI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zEF9aIYGp6w3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_z4MLayuCI2dg" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zJsfo1O1AnIh" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zVzwvkUo4MW3" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;56,737&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zlj1p2hOL8f5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,030&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CentroDeCienciasEmSaudeDeItajubaSAMember_zn4bvgn4Xuk9" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;48,411&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IESP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z4oudzNoxTH1" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zFmUglBqt9nd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;73,838&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zp1WEpbSH0ng" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmoYi85jZk23" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;179,693&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zAvLjw9x63I3" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;346,286&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zGuwFrKq5z7c" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;380,410&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FADEP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_z6JJBTzO7Gnf" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_ztPOG9HJe517" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;49,661&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zwkjEdn8wOVk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zzUfKFV3e7o4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;70,606&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zdUPnDfbZjDj" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;153,791&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FADEPFaculdadeEducacionalDePatoBrancoLtdaMember_zZbQNT5am1Pk" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;160,787&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Medcel
    and CBBW&lt;sup id="xdx_F48_zNSFhX0F0RO2"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zDfBOeCKubog" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z1JGVJeH9E6" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,294&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_z5uNFxi4L4k9" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3439"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_zFqBytiQsYEf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,300&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--CashGeneratingUnits_iI_pn3n3_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedcelAndCBBWMember_fKg_____ztl9lzUOXBB1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;219,359&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FASA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z8J5aIV2d8J5" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zuF058AECMj8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,903&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zoWPq3zhxFC2" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zL14y5Bxsnn4" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;144,507&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zO1CnMq2b9Y8" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;302,330&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zC4CVcHh4s5b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;267,279&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPEMED&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zSn4IVr4r26g" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zZtwYkmG5cUd" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,647&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zwk1TqrwtMa4" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3460"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zB0wKsrmXjF7" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;126,965&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zATzj8DzHIT9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;119,227&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPEC&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zy3wu7ci7542" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3465"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z9ZTXYNTrxu" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zZfZtW4hTfvb" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;108,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zXIuCaIclsbg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;131,360&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zbIvODB8kxLb" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;122,325&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;UniRedentor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zooFqLCww3d1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zNfhLSfBRWn8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,662&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zci9L4EpLiI7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zGOr0ulV5Ag" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;121,477&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zXrgIGCutbea" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;246,320&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zV7tIYVAlFLl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;253,370&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;UniSL&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zIg3R16vOWyl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zfBfvoywZNuh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,420&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zVKFXgAP3Xal" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;249,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zCKJwtd6cwX" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;249,387&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zn4nr0KHUH56" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;305,044&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zYlwgzZ2e4yd" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;258,234&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FESAR&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zSQ4xRAHWTva" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zrLi267lEdF8" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;71,664&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zEEI52Bztufk" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zgVdNu8bS2xf" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;141,616&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z964NDcXsZK3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;279,038&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_zjHsiwYHJuRh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;263,914&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;FCMPB&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z3Rkn0Ao1yFl" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zmQn89lLYon" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Goodwill"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;110,483&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN7qrDgglIF" style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYNYf4vh1LAe" style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Licenses with indefinite useful life"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;235,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zYvScuJiCTg9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;401,244&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNFFAxDs88z3" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash generating units"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;380,682&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Practice
    Management Tools &amp;amp; Electronic Prescription&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zQBq792otTv6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;113,362&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zLHyWfz1RyZ6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3523"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--PracticeManagementToolsAndElectronicPrescriptionMember_zuSb1p53M0K1" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;227,909&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Clinical
    Decision Software&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z5TusdNxsOOh" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Goodwill_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zhQ298J9oL8b" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z7J9B7c8kWKg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3527"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_z2df3kzHhzJg" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;147,592&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ClinicalDecisionSoftwareMember_zxB4PyWZpbI7" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;149,805&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Medical
    Harbour&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zM6Ahi9d9bcb" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,022&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_zXQs57WQt4Pb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_z1hnh4QgkZrf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,150&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Moc&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_z5CwvpIq3x8j" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;87,777&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zaYmPTngbDOc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;184,597&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zGWUL66Ru19k" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;5,649&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zYQ5lD9Dv0r8" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;356,789&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CashGeneratingUnits_iI_c20201231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MocMember_zbpEn8piGm3l" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,230&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Unigranrio&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zKgF53O2SEEc" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;130,073&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z9WlEuJYLFRe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;421,538&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_zMTF6mdjYZnf" style="vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;630,185&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;RXPRO&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Goodwill_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zuO3hAGg5vKc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;38,446&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IntangibleAssetsWithIndefiniteUsefulLife_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zL5HKRinwMAk" style="border-bottom: Black 1pt solid; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3542"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--CashGeneratingUnits_iI_c20211231__ifrs-full--CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis__custom--CarryingAmountsMember__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zkCZQE0iPnsc" style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;46,788&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="width: 37%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 1%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 9%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F08_zKnFfqu5FuT" style="width: 95pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_z9LAT5xSQ9wg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;CBBW as merged by Medcel on May 1,
2020.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">17446000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">57214000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">140522000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember"
      decimals="-3"
      unitRef="BRL">126397000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">27956000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">81366000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">112260000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="-3"
      unitRef="BRL">112898000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">4664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">56737000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">49030000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_CentroDeCienciasEmSaudeDeItajubaSAMember"
      decimals="-3"
      unitRef="BRL">48411000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">73838000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">179693000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">346286000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">380410000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">49661000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">70606000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">153791000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember"
      decimals="-3"
      unitRef="BRL">160787000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      unitRef="BRL">139294000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      unitRef="BRL">139294000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      unitRef="BRL">235300000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MedcelAndCBBWMember"
      decimals="-3"
      id="Fact003443"
      unitRef="BRL">219359000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">58903000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">144507000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">302330000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">267279000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">87647000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">87647000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">126965000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">119227000</afya:CashGeneratingUnits>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">108000000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">131360000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">122325000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">77662000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">121477000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">246320000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">253370000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">4420000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">249387000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">249387000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">305044000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">258234000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">71664000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">141616000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">279038000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">263914000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">110483000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">235018000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">401244000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">380682000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      unitRef="BRL">113362000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_PracticeManagementToolsAndElectronicPrescriptionMember"
      decimals="-3"
      unitRef="BRL">227909000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      unitRef="BRL">87018000</ifrs-full:Goodwill>
    <ifrs-full:Goodwill
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      unitRef="BRL">87018000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      unitRef="BRL">147592000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_ClinicalDecisionSoftwareMember"
      decimals="-3"
      unitRef="BRL">149805000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">4022000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">9150000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember"
      decimals="-3"
      unitRef="BRL">87777000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember"
      decimals="-3"
      unitRef="BRL">184597000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember"
      decimals="-3"
      unitRef="BRL">5649000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_MocMember"
      decimals="-3"
      unitRef="BRL">356789000</afya:CashGeneratingUnits>
    <afya:CashGeneratingUnits
      contextRef="AsOf2020-12-31_custom_CarryingAmountsMember_custom_MocMember"
      decimals="-3"
      unitRef="BRL">7230000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      unitRef="BRL">130073000</ifrs-full:Goodwill>
    <ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      unitRef="BRL">421538000</ifrs-full:IntangibleAssetsWithIndefiniteUsefulLife>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_UnigranrioMember"
      decimals="-3"
      unitRef="BRL">630185000</afya:CashGeneratingUnits>
    <ifrs-full:Goodwill
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">38446000</ifrs-full:Goodwill>
    <afya:CashGeneratingUnits
      contextRef="AsOf2021-12-31_custom_CarryingAmountsMember_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">46788000</afya:CashGeneratingUnits>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="AsOf2021-12-31" decimals="INF" unitRef="Pure">0.1210</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections contextRef="AsOf2020-12-31" decimals="INF" unitRef="Pure">0.1300</ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections>
    <ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections contextRef="From2021-01-012021-12-31_ifrs-full_GoodwillMember">An
increase of 25 basis points in management&#x2019;s estimated discount rate applied to the cash flow projections of each CGU for the year
ended December 31, 2021, or a decrease of 25 basis points on estimated EBITDA would have not resulted in significant impacts on these
financial statements.</ifrs-full:DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections>
    <afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89B_ecustom--SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock_zDhySJj7Mhya" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The estimated useful
lives of intangible assets are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B9_zNmiBNZ2nE37" style="display: none; visibility: hidden"&gt;Schedule of estimated useful lives&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 79%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Customer
    relationships &#x2013; medicine&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_907_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsMedicineMember_ztZshgpE3eKe" title="Estimated useful lives of intangible assets::XDX::P6Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3554"&gt;6&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Customer
    relationships &#x2013; other courses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_904_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--CustomerRelationshipsOtherCoursesMember_zT0Z181dGW43" title="Estimated useful lives of intangible assets::XDX::P4Y6M"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3556"&gt;4.5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Software
    license&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_900_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--ComputerSoftwareMember_zKckB0ycDaJi" title="Estimated useful lives of intangible assets::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3558"&gt;5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Education
    content&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_901_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__custom--EducationContentMember_zVci0b1UmKDa" title="Estimated useful lives of intangible assets::XDX::P3Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3560"&gt;3&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Trademarks&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_90B_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zxGX5pwOIP32" title="Estimated useful lives of intangible assets::XDX::P2Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3562"&gt;2&lt;/span&gt;&lt;/span&gt;
    - &lt;span id="xdx_909_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--BrandNamesMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLHLgPUum7Gd" title="Estimated useful lives of intangible assets::XDX::P30Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3564"&gt;30&lt;/span&gt;&lt;/span&gt; years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;Developed
    technology&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10pt"&gt;&lt;span id="xdx_908_eifrs-full--UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill_dxL_c20210101__20211231__ifrs-full--ClassesOfIntangibleAssetsAndGoodwillAxis__ifrs-full--TechnologybasedIntangibleAssetsMember_zteOoECwHqFj" title="Estimated useful lives of intangible assets::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3566"&gt;5&lt;/span&gt;&lt;/span&gt;
    years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock>
    <ifrs-full:DisclosureOfFinancialInstrumentsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_803_eifrs-full--DisclosureOfFinancialInstrumentsExplanatory_zo4u4iFsuux5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #0D0E00"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_821_zDSjz8RFnzF7"&gt;Financial
                                            assets and financial liabilities&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_891_ecustom--FinancialAssetsExplanatory_zc1c86qjZ8bl" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            assets &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_zGIRecehDRH5" style="display: none; visibility: hidden"&gt;Schedule of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 62%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At
    amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z03ZdlVAmuyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;748,562&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z9DzQt2fYyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,045,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zMOE0qi3k7wb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3576"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbZGaXJax9pj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeReceivables_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zojqVaJ0ymYc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;405,793&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeReceivables_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfM93KhBTTch" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;309,944&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zSJzBDSCrOa7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,154,355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zQhQFzLRiiS4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,357,039&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRFOlrs3xDBe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,126,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zYU2OCkrM039" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,347,359&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zPTsNaCmALXj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zKdgR5H3ZhF9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,680&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AD_z20UFcfpWMLa" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Financial instruments
at amortized cost include trade receivables and cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--FinancialLiabilitiesExplanatory_z1BtDbTpK2P7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BF_zMFltixnOV3b" style="display: none; visibility: hidden"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 60%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At
    amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGujMwpBIsql" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z9RVWJNX8MOf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zJsr3bK2PUq4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzQW49rQgfa2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zqnByovspL8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zB7ahHdc6D5k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5pX9tYOjdF" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zo6A68v69oyf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotePayable_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zwj5XlxPbf38" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NotePayable_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z3WKaiaMZMuf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Advances_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zkRg48MJ5Vyb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Advances_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGyTy7ai7HR7" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBjRb4vqEDJg" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,015,196&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5ePpUjn3h7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,759,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5UTx4cF9Dvf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;581,685&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFFsBL9CLegh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;467,643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zfYOj0W3Ax72" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,433,511&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zEsJHwwCVhHe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,291,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8A4_zSAP4gbQumZe" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;



&lt;p style="font: 4pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Loans
                                            and financing&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_892_ecustom--LoansAndFinancingExplanatory_zTt3dLIkxESj" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B8_zm3SzwoyE2Kf" style="display: none; visibility: hidden"&gt;Schedule of loans and financing&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    institution&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Interest
    rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zB9RXIJFJVAj" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Banco
    Ita&#xfa; Unibanco S.A&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;. &lt;sup id="xdx_F22_zmBicpqB3fhl"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zYR9l0wMdXAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.62% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zMd6gF9kkEXl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zuLdcpeoqIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;510,972&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_z8n583HwbbKg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;504,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zgOHluBj2Edd" title="Financial institution"&gt;Banco
    Votorantim&lt;/span&gt; (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zZnlxaKoTEe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.65% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zlhSjcf7D22h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zqYSXD2EwY69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3651"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_z5UcOoeiRcrj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;101,785&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zljZDy8OCAea" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;BNDES
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F2B_zA7LUbK9optk"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zsDgiQxc1D7f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10.03%
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zHIVWpm4A1qa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_z9kLfBNBI75e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3660"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zvyskOp0QlWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;471&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_903_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zBok37LEBPij" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FINEP
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F22_zkOEk5Nuq1Jf"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zzIAMQ110FRc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;TJLP
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zko24wZWX3o2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zTicJgL5xpwi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,145&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zcXkhNP30Wk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,864&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zdnl6BDqLCDg" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Softbank
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F20_zUULCq1sRBM7"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_z832kBOIMMog" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6.5%
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zFq3Wb4wpEId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zKDjFTAF4TX7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;822,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zwnfUFyxiuq8" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Banco
    Ita&#xfa; Unibanco S.A&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;. &lt;sup id="xdx_F2D_zlY8kskBqIVc"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zYzY8fAL4UI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.75% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zV5azFwWzxGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zyyrDty0YKDc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,199&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20211231_zXcbIvravYPk" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,374,876&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20201231_zjjxY0DZLkTi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;617,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancingCurrent_iI_c20211231_z1tnahTyvGs6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;128,720&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancingCurrent_iI_c20201231_zEnAh2msUbJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,162&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancingNonCurrent_iI_c20211231_z2AMx6ZuXH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,246,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancingNonCurrent_iI_c20201231_zRMYJYTEENb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;510,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0A_zTi7mUqwIWO1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_z51L1HBzMn4b" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ &lt;span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1"&gt;500,000&lt;/span&gt; adjusted by the CDI rate plus an interest rate of
&lt;span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb"&gt;1.62&lt;/span&gt;% per year and is repayable in three installments in October 2022, April 2023 and October 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F08_zalDbRqnSNfk" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_z810umuNjO51" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ &lt;span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4"&gt;100,000&lt;/span&gt; adjusted by the CDI rate plus an interest rate of &lt;span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l"&gt;1.65&lt;/span&gt;%
per year and was repaid at maturity on July 5, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F09_z9k3Dh9scuNh" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zwCXLV6lCHHe" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of &lt;span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk"&gt;10.03&lt;/span&gt;% per year and maturity in 2024.
This amount was prepaid in September 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F05_z42M0s1Bbhib" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_zYD7jefjnWq1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 23, 2019, Medcel entered
into a loan of R$ &lt;span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount"&gt;16,153&lt;/span&gt; with Financiadora de Estudos e Projetos (&#x201c;FINEP&#x201d;), a governmental agency focused on financing investments
on R&amp;amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$&lt;span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche"&gt;6,734&lt;/span&gt; and R$&lt;span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche"&gt;4,130&lt;/span&gt;, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0F_zlqH3DSjUbDg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_z79xim6Tpy76" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ &lt;span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount"&gt;30,000&lt;/span&gt;. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of &lt;span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate"&gt;1.75&lt;/span&gt;% per year and is repayable in three installments in July 2023, January 2024 and July 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F02_zJ7yTusJG991" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zsY2G5AhKIb3" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 26, 2021, the Company issued
and sold &lt;span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares"&gt;150,000&lt;/span&gt; shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8"&gt;0.00005&lt;/span&gt; per share of the Company for US$&lt;span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5"&gt;150,000&lt;/span&gt; thousands, equivalent to R$ &lt;span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9"&gt;821,805&lt;/span&gt; on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A5_zIfvgl7MHz9j" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Each Series A perpetual
convertible preferred share is entitled to a cash dividend of 6.5% per annum and is convertible, at the holder&#x2019;s discretion, into
the Company&#x2019;s Class A common shares at an initial conversion price of US$25.35. The Company may require the conversion of any or
all of the Series A perpetual convertible preferred shares at any time on or after the three-year anniversary of the original issuance
date if certain conditions set forth in the certificate of designation are met (if for 20 out of 30 consecutive trading days prior, Afya&#x2019;s
stock price is equal or above 150% of the conversion rate). The Company may also redeem any or all of the Series A perpetual convertible
preferred shares for cash, shares of its common shares or a combination thereof at its election, at any time on or after the seven-year
anniversary of the original issuance date as determined in the certificate of designation. On or after the five-year anniversary of the
original issuance date, the holders of the Series A convertible perpetual preferred shares shall have the right to redeem all of the
outstanding Series A convertible perpetual preferred shares for cash, the Company&#x2019;s common shares or a combination thereof (at
the Company&#x2019;s election, subject to certain conditions) to be determined in the certificate of designation. Upon the occurrence
of a change of control, the holders will have the right to redeem their Series A convertible perpetual preferred shares for cash at a
price set forth in the certificate of designation.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Series A convertible
perpetual preferred shares will be entitled with the same voting rights of the common shares only when converted into it.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company determined
that the Series A perpetual convertible preferred shares should be classified as financial liability at amortized cost upon their issuance
since is redeemable primarily according to the decision of the holder and there is a contractual obligation to deliver assets (cash,
shares of its common shares or a combination thereof) that could not be avoided by the Company in an event of redemption. The financial
liability is denominated in Brazilian Reais and thus not subject to foreign exchange changes.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In addition, as
the entire instrument is classified as a liability, the embedded put option to redeem the Series A perpetual convertible preferred shares
for cash is an embedded derivative. The embedded derivative will not be treated separately once the exercise price of the option is closely
related to the host contract.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 0.15pt; text-indent: -0.15pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The initial transaction
costs that are directly attributable to the issuance of Series A perpetual convertible preferred shares were measured at fair value together
with the financial liability on initial measurement. The transaction costs totaled R$&lt;span id="xdx_908_eifrs-full--AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination_c20210101__20211231_z7V09DW8wQTk" title="Transaction costs"&gt;13,030&lt;/span&gt;, including legal counsels and advisors.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2.2&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Leases&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
lease contracts for properties. The lease contracts generally have maturities in the lease terms between &lt;span id="xdx_906_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zEbEKLnEajnl" title="Contractual lease term::XDX::P5Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3725"&gt;5&lt;/span&gt;&lt;/span&gt; and &lt;span id="xdx_90D_ecustom--ContractualLeaseTerm_dtYxL_c20210101__20211231__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zPBvxHEPo68" title="Contractual lease term::XDX::P30Y"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3727"&gt;30&lt;/span&gt;&lt;/span&gt; years. There are no
sublease or variable payments in-substance lease agreements in the period.&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--LeasesExplanatory_zdFVv4xpSlk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_z2Ngwn0Scl7d" style="display: none; visibility: hidden"&gt;Schedule of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Set out below are
the carrying amounts of right-of-use assets and lease liabilities and the movements during the period&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20200101__20201231_zqMCxYvkXOH5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;274,275&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_c20200101__20201231_z13elCLROPzc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_c20200101__20201231_z6IRPRU2zli2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,743&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_c20200101__20201231_zEwb6VKoZrvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_c20200101__20201231_znnBIG4RpgMl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_c20200101__20201231_z8Q38gDPoVci" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,161&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsBusinessCombinations_c20200101__20201231_zQIMNbNUtEF6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BusinessCombinationsLeaseLiabilities_c20200101__20201231_zmBMNPscqWfj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20200101__20201231_zxJRBXE0VABi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,386)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepreciationExpenseLeaseLiabilities_c20200101__20201231_ztoJHksNIQwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_c20200101__20201231_zSJL3sOUeBic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestExpenseOnLeaseLiabilities_c20200101__20201231_ztdCIYhn2xd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,458&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments
    of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20200101__20201231_zRHrFTjKobl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20200101__20201231_zZmFBezSUrib" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,455)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsDisposals_c20200101__20201231_zfklWTEvp40a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LeaseLiabilitiesDisposals_c20200101__20201231_zT6cJrMY9Jad" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iS_c20210101__20211231_zsmJlIEdwvV9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;419,074&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesRightToUse_iS_c20210101__20211231_z1WBXaNYsR7c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;447,703&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20210101__20211231_z7BMii514BZ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_c20210101__20211231_zuERlh8VD2Qf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsRemeasurement_c20210101__20211231_zNgO35WReje3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesRemeasurement_c20210101__20211231_ze9Od1Y85TQa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsBusinessCombinations_c20210101__20211231_z26LFNnLEpt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--BusinessCombinationsLeaseLiabilities_c20210101__20211231_zEnCU0VThshd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20210101__20211231_zgUpk7wCIWPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,237)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepreciationExpenseLeaseLiabilities_c20210101__20211231_zDzLXE6FWy5l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_c20210101__20211231_zVNxOroU8ceb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3783"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_c20210101__20211231_zOZ5mQKnk673" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments
    of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20210101__20211231_z98zlrLmRQc1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20210101__20211231_z8n1QD5C6SMd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(87,751)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsDisposals_c20210101__20211231_zNzxQZuSvoyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesDisposals_c20210101__20211231_zPa9mSlSONS3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20210101__20211231_zqh7jc5JGnUa" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;663,686&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitieRightToUse_iE_c20210101__20211231_z9HvVroLhE3i" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;714,085&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsCurrent_iI_c20201231_zRgyXsBj6bpg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3799"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLeaseLiabilities_iI_c20201231_zaok1A04GPYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;61,976&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_c20201231_zf8S8erXCa0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;419,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_c20201231_zDVL5zRrc4Wj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;385,727&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_c20211231_zzBoYoAOHOW8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_c20211231_zH8nfPFzdmg4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,955&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsNonCurrent_iI_c20211231_znL8zaOo0366" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentLeaseLiabilities_iI_c20211231_z7rV6IKfaR4c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;689,130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zJVZs6BUTinl" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company reassessed
its current versus non-current segregation methods for the year ended December 31, 2021. The current lease liabilities balances are presented
as the amount expected to be amortized from the principal in the next twelve months.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company recognized
lease expense from short-term leases and low-value assets of R$ &lt;span id="xdx_906_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20210101__20211231_zUBwunBlu2J9" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;11,229&lt;/span&gt; for the year ended December 31, 2021 (R$ &lt;span id="xdx_902_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20200101__20201231_zhznklNszsi1" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;2,555&lt;/span&gt; and R$ &lt;span id="xdx_90B_eifrs-full--ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed_c20190101__20191231_zwB0Ni97VgFg" title="Amount recognized lease expense from short-term leases and low-value assets"&gt;4,494&lt;/span&gt; for
the years ended December 31, 2020 and 2019).&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2.3&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Accounts
                                            payable to selling shareholders&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_zwneqjNLUICj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zdyavAhnUimd" style="display: none; visibility: hidden"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IESP &lt;sup id="xdx_F4E_zWKVmswV4FW1"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z85FAX0S8Bqk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmq4trAf5RP9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;38,771
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FASA &lt;sup id="xdx_F4F_zZK2jTl7IkOk"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zHDyYiE9Zvc8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;41,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zn7o6AOm8RN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,356
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEMED &lt;sup id="xdx_F41_zn0dW2zvySV2"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z0JJNT8ctO73" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,233&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z6FOyUFC0rpb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;38,622
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEC &lt;sup id="xdx_F42_zqshtSFUUJp1"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zTVdM1GIN6T1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Gyn0T3qRkc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;28,307
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of UniRedentor &lt;sup id="xdx_F43_z60A7817VGR6"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z1WnX2DYQNdk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,506&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zhGM91ycQBNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;97,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of UniS&#xe3;oLucas &lt;sup id="xdx_F43_zh0awc82kzx3"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zadNHOjGgTLi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,672&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z2UTq3y6tC3k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,386&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FCMPB &lt;sup id="xdx_F45_zETWa31mD7Ma"&gt;(g)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6jFf3ch3JY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;149,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN2ftEHazwa1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;189,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FESAR &lt;sup id="xdx_F48_zgceDiGCoM72"&gt;(h)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z7FFdVFhYtgj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3851"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5MX6rtar9Y2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of MEDPHONE &lt;sup id="xdx_F4D_zXuPicD2So23"&gt;(i)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zrCRWkNvLQtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3855"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zfitZgNNXH7k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Medicinae &lt;sup id="xdx_F47_zGPDRY4hsnCi"&gt;(j)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zq7q1Uv4FbU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Medical Harbour &lt;sup id="xdx_F47_zzd3kqoEQ6R"&gt;(k)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znSSTKulYKoj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Cliquefarma &lt;sup id="xdx_F4E_zFJxLok3zxa7"&gt;(l)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z3uHvbCFHZJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Shosp &lt;sup id="xdx_F46_zQwb0PHQiFif"&gt;(m)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2DjnXTO02Zh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Unigranrio &lt;sup id="xdx_F43_zJGhKY3IkE9e"&gt;(n)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z6o6KrnXQkh4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;249,979&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of RXPRO &lt;sup id="xdx_F4B_zypPFxudJAOg"&gt;(o)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zZw1MMFKcix9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Guaranhuns &lt;sup id="xdx_F43_zZ0sTE37enL5"&gt;(p)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zGa2EMCQqlmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20211231_zZaewIbiNLVb" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20201231_zEfXZBdmg33d" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;518,240&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20211231_zZR0JQXDprzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;239,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20201231_zaKv1YAlf93j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;188,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20211231_z3UJBu42wWw" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;439,977&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20201231_z6BKJz3iTOxe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;329,820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ziNL8qn9OVxc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyBh4I5Cyeoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;300,237&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsPtTtFyRWVk" style="text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;177,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    flows&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholderCashFlows_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRba8aLk3XMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(192,681)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AccountsPayableToSellingShareholderCashFlows_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsMXqxUmkyO6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(134,518)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AccountsPayableToSellingShareholderCashFlows_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zekqO0N1Y1U4" style="text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(92,688)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEC and Guaranhus&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zlf0ViKTCJt6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Acquisition of IPEC"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmet3t8zdbK6" style="text-align: right; line-height: 10pt" title="Acquisition of IPEC"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--InterestExpense_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zh1XghtwXkw4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestExpense_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkQW4S3oAsn9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,884&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpense_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z6jYxkHuRfg4" style="text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,977&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Installments
    on Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zBrFwYQP07c1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;243,816&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zGWbt4hfcmj4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;343,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk5EcJ66v1Te" style="text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,538&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Contingent
    consideration on Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ContingentConsiderationOnBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze99p5bfPpuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Contingent consideration on Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,536&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Compensation
    of legal proceedings disbursement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CompensationOfLegalProceedingsDisbursement_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zYlPrTpTTmq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CompensationOfLegalProceedingsDisbursement_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zfUU8fxRnMHa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,503)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CompensationOfLegalProceedingsDisbursement_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze4tL1PZawPa" style="text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,320)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing
    balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20211231_zwWMZDfdXzz" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20201231_zzYBtX29kCH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;518,240&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20191231_zkeE4Pu6R6H7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;300,237&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F01_zv63289LzEth" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zgUAj77fQk92" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 27, 2018, Afya Brazil
acquired &lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20180101__20181231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z4qWcJqh1xUd" title="Ownership Interest"&gt;80&lt;/span&gt;% of IESP and R$&lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zVuTOntw0072" title="Remaining accounts payable"&gt;106,200&lt;/span&gt; is payable in three equal installments of R$&lt;span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zxKyqP5yhY" title="Equal installments payables"&gt;35,400&lt;/span&gt;, each adjusted by the CDI rate through the payment
date. The remaining installment was paid in November 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zhZQQRjmtG75" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z3QFuTYoEqH6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 3, 2019, Afya Brazil acquired
&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z7XnVlpSfqu8" title="Ownership Interest"&gt;90&lt;/span&gt;% of FASA and R$ &lt;span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zs0rUtxXi5Cf" title="Remaining accounts payable"&gt;39,695&lt;/span&gt; was paid in April 2020, R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zaXdD0P8Fxh2"&gt;29,770&lt;/span&gt; was paid in April, 2021, and R$ &lt;span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20220403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zq18SwOoMG7"&gt;29,770&lt;/span&gt; is payable in April 2022; each installment
adjusted by the IPCA rate + 4.1% per year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zNn6SbNXKow6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zpiGi8IUG3Y9" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 9, 2019, Afya Brazil acquired
&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zO6RGgnXR905" title="Ownership Interest"&gt;100&lt;/span&gt;% of IPEMED and R$ &lt;span id="xdx_903_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zJRChPwWv7A8" title="Remaining accounts payable"&gt;45,303&lt;/span&gt; is payable in five equal installments of R$ &lt;span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zb0l4ohzl159" title="Equal installments payables"&gt;9,061&lt;/span&gt;, adjusted by the CDI rate, and due annually in February
2020, 2021, 2022, 2023 and 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F01_zOt4w6Wkxz28" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_zLyO0cSJD5h7" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 13, 2019, Afya Brazil
acquired &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zC8nvwJKAmlb" title="Ownership Interest"&gt;100&lt;/span&gt;% of IPEC and R$&lt;span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190813__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zc3VTX2xZwO" title="Remaining accounts payable"&gt;54,000&lt;/span&gt; is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the
first and the second year from the transaction closing date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F07_zXafWS45PoGj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zvV6Q4UkBYs1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On January 31, 2020, Afya Brazil
acquired &lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zemKfTaWOCW" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniRedentor and R$&lt;span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF8be0Lxbtbd" title="Remaining accounts payable"&gt;100,000&lt;/span&gt; is payable in five equal installments from January 2021 through July 2024, adjusted by the
CDI rate. The purchase consideration was adjusted by R$&lt;span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zSOwnFQiVdd8" title="Equal installments payables"&gt;4,503&lt;/span&gt; and such amount was deducted from the first installment paid in February
2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zB57gfdzaN2k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z4kvTsPsM6M6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 5, 2020, Afya Brazil acquired
&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zZJFOvx7ivQl" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniSL and R$ &lt;span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zkx4sLnWGaZ7" title="Remaining accounts payable"&gt;60,456&lt;/span&gt; is payable in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration
was adjusted by R$&lt;span id="xdx_904_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zHcxL6Efv0dg" title="Equal installments payables"&gt;7,816&lt;/span&gt; and such amount was deducted from the first installment paid on May 5, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F06_z35OSOwAaon2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zcGrR7lQ5R4j" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 9, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zPVFC9IyMQPl" title="Ownership Interest"&gt;100&lt;/span&gt;% of FCMPB and R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZRPKMvZBp69" title="Remaining accounts payable"&gt;188,894&lt;/span&gt; is payable in four installments through November 2024, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F04_zBAR9sLU1I7f" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_ziEfKwWW2PD6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 3, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwuk4GghLIe4"&gt;100&lt;/span&gt;% of FESAR paid in cash and R$&lt;span id="xdx_903_ecustom--CashTransferredTransaction_iI_c20201103_zaQWkcVVQ525" title="Cash on the transaction closing date"&gt;1,569&lt;/span&gt; of price adjustment was paid on February 25, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0C_z7wRV9wy7h85" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zF4qniF3CIa" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 4, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNx2GJ2g6oik"&gt;100&lt;/span&gt;% of MedPhone paid in cash and R$&lt;span id="xdx_902_ecustom--CashTransferredTransaction_iI_c20201104_zIuX9r673xQ5"&gt;36&lt;/span&gt; of price adjustment was paid on February 2, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0F_zYhXumGsklLl" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(j)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zvrhRBRUHY3c" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 25, 2021, Afya Brazil acquired
&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210323__20210325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zO6SyjqODtod"&gt;100&lt;/span&gt;% of Medicinae and an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$ &lt;span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210305__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBEDWkEbyHn1"&gt;4,400&lt;/span&gt; is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$&lt;span id="xdx_907_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210325_zj2gQJModqXk"&gt;3,887&lt;/span&gt; is based on the present value of the obligation
considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition
date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0B_zmrfcFiYSna2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(k)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zKH6Z5xMI421" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 8, 2021, Afya Brazil acquired
&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210408__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zCwaNP6gbIkc"&gt;100&lt;/span&gt;% of Medical Harbour and an earn-out (&#x201c;contingent consideration&#x201d;) of R$ &lt;span id="xdx_900_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zWiugvjBH466"&gt;9,000&lt;/span&gt; is payable in relation to product development
goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$&lt;span id="xdx_902_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210408_ztq8TsDI9bo3"&gt;6,801&lt;/span&gt; is based on the present value of the
obligation considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from
the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F09_zic2lNOonq9k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(l)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zAzhkm1LyH9d" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 16, 2021, Afya Brazil acquired
&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210416__20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZBAEeUDaQ4a"&gt;100&lt;/span&gt;% of Cliquefarma and an earn-out (&#x201c;contingent consideration&#x201d;) of R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z1aWp9bANHv6"&gt;3,000&lt;/span&gt;, adjusted by the CDI rate, is payable in relation
to product development. The contingent consideration of R$&lt;span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210416_zhVJ13vYYy8a"&gt;3,050&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F02_zimx5sAe3Q5a" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(m)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z3Ypn6VwQW9c" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 13, 2021, Afya Brazil acquired
&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210513__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zbv1BsGfHWVf"&gt;100&lt;/span&gt;% of Shosp and R$ &lt;span id="xdx_906_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20210513_z3ZUFmEpUbO5"&gt;454&lt;/span&gt; will be paid, and an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ &lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zGZHllMfQ7A3"&gt;1,793&lt;/span&gt; is payable in relation
to product development. The contingent consideration of R$ &lt;span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210513_zp4A5zkvUaH8"&gt;2,141&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F07_zYxXw7KwaOEi" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(n)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_z6d9bo4Byk1j" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 4, 2021, Afya Brazil acquired
&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210802__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zFSfON2j3lMc"&gt;100&lt;/span&gt;% of Unigranrio. The adjusted aggregate purchase price is R$ &lt;span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_c20211004_zj5L1805Wg13"&gt;618,956&lt;/span&gt; of which 60% was paid in cash on the transaction closing date,
and 40% is payable in cash in four equal installments through 2022 to 2025, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F03_zPYdaXJ54hLh" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(o)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zG0eJg2Jb9i2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 01, 2021, Afya Brazil
acquired &lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zoNgvH2MPTc7"&gt;100&lt;/span&gt;% of RXPRO and an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ &lt;span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZ9wnw1fvIOc"&gt;21,000&lt;/span&gt; is payable in relation to revenue
achievements until 2024. The contingent consideration of R$ &lt;span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20221101_z7TP8wlyiZV8"&gt;10,245&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0D_zFBWHTxNp5Rc" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(p)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zHY8VC1ZsVP1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 05, 2021, Afya Brazil
concluded the acquisition of &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211103__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwymGW7j6Drb"&gt;100&lt;/span&gt;% of ITPAC Garanhuns and R$&lt;span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20211105_zbhmCjeFIhad"&gt;54,000&lt;/span&gt; was paid in cash on the transaction closing date, and (ii) R$&lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zITzyB2teMSh"&gt;54,000&lt;/span&gt;
is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the first and the second year from the
transaction closing date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A9_zwVza87MlcMe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2.4&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Notes
                                            payable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;With
the acquisition of UniSL, Afya Brazil assumed notes payable regarding the previous acquisition of a portion of the operations of Universidade
Luterana do Brasil (ULBRA) by UniSL in auction by the end of 2018. Two of the UniSL campuses, located in the cities of Ji-Paran&#xe1;
and Porto Velho in the State of Rond&#xf4;nia, were acquired in such transaction. As of December 31, 2021, the notes payable of R$&lt;span id="xdx_903_ecustom--NotesPayable1_iI_c20211231_zS5gl9hQJnTi" title="Notes payable"&gt;72,726&lt;/span&gt;,
has a final maturity in 2023 and is adjusted by 100% of IPCA-E.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_z5DCGf8Y4wg8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B7_zJTQk38nruLk"&gt;Set out below are
the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Notes
    payable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NotesPayables_iS_c20200101__20201231_zsgyxJTQLrq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BusinessCombination_c20200101__20201231_zEpHfKXIrc2k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Payments_c20200101__20201231_z5s1hgd150E6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,974)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary
    indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--MonetaryIndexation_c20200101__20201231_z5sFIIhY5sZ3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotesPayables_iE_c20200101__20201231_zKzhEKGuq7M3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;76,181&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NotesPayables_iS_c20210101__20211231_zQj34gCMCMgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Payments_c20210101__20211231_zfnn8PvVPfJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,068)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary
    indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--MonetaryIndexation_c20210101__20211231_zm5KCf2MpGn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotesPayables_iE_c20210101__20211231_zVJ4rjE8NzCe" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20201231_zk3AyucBk55l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,503&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NoncurrentLiabilities1_iI_c20201231_zsrEYzmSBoid" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20211231_zqz2X3AcGCrj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NoncurrentLiabilities1_iI_c20211231_zDsDEsuFnyb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zU7lpfOmnbmc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.3&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Fair
                                            values &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--FairValuesExplanatory_zZU9RxJtTm0f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zZOUXTUSAMNb"&gt;The table below
is a comparison of the carrying amounts and fair values of the Company&#x2019;s financial instruments, other than those carrying amounts
that are reasonable approximation of fair values:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zlSrl1jMBG5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_ztw50xcwItNi" style="text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4041"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDWBYwMcpDag" style="vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDsTMBLsDEsh" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zoP3rH7SDWcg" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zMmzoQSdPNfh" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zpDlE02rC7H5" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zw00yKc1rcl2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231_zn9IsJRzjBp6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231_z9vAXN5tQtMg" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231_zvDerqFpVeNi" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,680
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231_zzAU7wmjRS7c" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,680
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7eXKxNleE4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zmiCnYGnHSse" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,387,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zwWZlHXPlce4" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z4cagkzuI0Ze" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;637,723&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqy3kpIDoFR1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zb4COTQVfhqc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0tTACsYIcjc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyu1EH2P2C0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zAExwPDUDcSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_za8yg0zGZuNc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zANRVRvAK3u1" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3KlOM3pM9mh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zwHQ6rpBhmC5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrDFkE52IZtk" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zKd8zO5jweyk" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z5X9mEIKgvqe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231_zqheb4BLrFqj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,841,513&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231_zEQQF9NjmRmb" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,853,773&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20201231_zqT8L7GErqU8" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,659,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231_zzjde6jmSWKa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,679,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zTnT4uIAV0jk" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company assessed that the fair values of cash and cash equivalents, current trade receivables and other current assets, trade payables,
advances from customers and other current liabilities approximate their carrying amounts largely due to the short-term maturities of
these instruments.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
fair value of interest-bearing borrowings and loans are determined by using the DCF method using discount rate that reflects the issuer&#x2019;s
borrowing rate as of the end of the reporting period. The own non-performance risk at December 31, 2021 was assessed to be insignificant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.4&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            instruments risk management objectives and policies&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s principal financial liabilities comprise loans and financing, lease liabilities, accounts payable to selling shareholders,
notes payable, trade payables and advances from customers. The main purpose of these financial liabilities is to finance the Company&#x2019;s
operations. The Company&#x2019;s principal financial assets include trade receivables and cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company is
exposed to market risk, credit risk and liquidity risk. The Company monitors market, credit and liquidity risks in line with the objectives
in capital management and counts with the support, monitoring and oversight of the Board of&#160;Directors in decisions related to capital
management and its alignment with the objectives and risks. The Company&#x2019;s policy is that no trading of derivatives for&#160;speculative
purposes may be undertaken. The Board of Directors reviews and agrees policies for managing each of these risks, which are summarized
below.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.4.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            instruments risk management objectives and policies&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Market
risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices.
The Company&#x2019;s exposure to market risk is related to interest rate risk and foreign currency risk.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The sensitivity
analysis in the following sections relate to the position as of December 31, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;(i)
Interest rate risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Interest
rate risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market
interest rates. The Company&#x2019;s exposure to the risk of changes in market interest rates relates primarily to the Company&#x2019;s
cash equivalents, loans and financing, accounts payable to selling shareholders and notes payable, with floating interest rates.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Sensitivity
analysis&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table demonstrates the sensitivity to a reasonably possible change in interest rates on cash equivalents, loans and financing
and accounts payable to selling shareholders and notes payable. With all variables held constant, the Company&#x2019;s income before income
taxes is affected through the impact on floating interest rates, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89F_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zHe53FQOmRll" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B8_zat4SI5YH5wd" style="display: none; visibility: hidden"&gt;Schedule of sensitivity analysis effects on income statement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Increase
    / decrease in basis points&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Balance
    as of December, 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Index
    &#x2013; % per year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Base
    rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;+150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;-150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zkMmVcQLnvu6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;636,847&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100.38%
    CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zA95Ma8zHKxe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,440&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zDelf0lhW9xb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,776&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zfrjmrzbO768" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,776)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zGNW0hylZpS" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,553&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_z5FqeLfVGyh1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(9,553)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zR5BYkQ6ua3a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(510,972)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI
    + 1,62%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zYrQiVkgZG7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(55,032)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zCDu5y3QwTva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,832)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zGvYyCPWFxvi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,832&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zL5sCZpPLF3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,665)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zjec1WlNflx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zvRceLz9iUhh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,199)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI
    + 1,75%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zbldYpljfgye" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,401)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zHWpH13UYzRc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zluvRGbN4XVl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;234&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zn92w0pz9l0e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(468)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zKfzG8913TJl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;468&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7kfyVoPNm84" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(10,145)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;TJLP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zymYT2fjrLU" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(617)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0QEExR22rg5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(76)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zXlq3A2x2SYa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zPtpw6gYoE38" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(152)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zync6RthPxK4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zNzxR8xNO4n1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(612,121)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zW022jV7R6xj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,009)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zibUHYUa7Oel" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,591)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zCZzXSwIz3Jk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zIE3nL0Sl9J5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(9,182)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_za9oDGDF1xgg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,182&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zLTcAtOYEOS9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(41,581)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPCA
    + 4,1%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zyZynExQ2cTh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0sNJe5lIG5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(312)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zFEj6X8pkN6d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;312&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zUUwEl6Y6h3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(624)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zEXLvE4Mw6R1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zv9D85Z2GyGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrh6F5yzAhkf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPCA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zfF2DneRexki" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(531)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zatr49n2q818" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(545)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_pn3n3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;545&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zuvc6ZEsPX39" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_ziI61PtYcwC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,091&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zjctsLlrBt5j" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;&#160;&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;i&gt;(ii)
Foreign currency risk&lt;/i&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Foreign
currency risk is the risk that the fair value or future cash flows of an exposure will fluctuate because of changes in foreign exchange
rates. The Company&#x2019;s exposure to the risk of changes in foreign exchange rates relates to cash and cash equivalents denominated
in U.S. dollars in the amount of R$&lt;span id="xdx_908_eifrs-full--CreditExposure_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zeIXNN0O4jE9" title="Exposure risk"&gt;23,228&lt;/span&gt; as of December 31, 2021 (December 31, 2020: R$&lt;span id="xdx_903_eifrs-full--CreditExposure_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_z6YWQ7TX1Ifa" title="Exposure risk"&gt;70,523&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span style="text-decoration: underline"&gt;Foreign
currency sensitivity&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zyr8Zg34xvOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zbUvoYfOqgxa" style="display: none; visibility: hidden"&gt;Schedule of currencies used in sensitivity analysis&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table demonstrates the sensitivity in the Company&#x2019;s income before income taxes of a &lt;span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_uPure_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpVCAKSniQMh" title="Percentage of sensitivity change in the Euro exchange rate"&gt;10&lt;/span&gt;% change in the U.S. dollar exchange
rate (R$&lt;span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zoAOQUxCI73i" title="Closing foreign exchange rate"&gt;5.5799&lt;/span&gt; to U.S. dollar &lt;span id="xdx_906_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__srt--CurrencyAxis__currency--EUR_z00xfSouENQ5" title="Closing foreign exchange rate"&gt;1.00&lt;/span&gt;) as of December 31, 2021, with all other variables held constant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 37%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember_ztDJvmNDSlti" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,228&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember_zK6CpS8zyDUb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,323&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember_zpsVsSJOVS1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A6_zjwEt9xbEXSi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.4.2&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Credit
                                            risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Credit
risk is the risk that a counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial
loss. The Company is exposed to credit risk from its operating activities (primarily trade receivables) and from its financing activities,
including cash and cash equivalents.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Customer
credit risk is managed by the Company based on the established policy, procedures and control relating to customer credit risk management.
Outstanding customer receivables are regularly monitored. See Note 7 for additional information on the Company&#x2019;s trade receivables.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Credit
risk from balances with banks and financial institutions is management by the Company&#x2019;s treasury department in accordance with
the Company&#x2019;s policy. Investments&#160;of surplus funds are made only with approved counterparties and within limits assigned to
each counterparty.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company&#x2019;s maximum exposure to credit risk for the components of the statements of financial position at December 31, 2021 and 2020
is the carrying amounts of its financial assets.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0"/&gt;&lt;td style="width: 14.2pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.4.3&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Liquidity
                                            risk&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company&#x2019;s
Management has responsibility for monitor liquidity risk. In order to achieve the Company&#x2019;s objective, Management regularly reviews
the risk and maintains appropriate reserves, including bank credit facilities with first tier financial institutions. Management also
continuously monitors projected and actual cash flows and the combination of the maturity profiles of the financial assets and liabilities.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0.55pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The main requirements
for financial resources used by the Company arise from the need to make payments for suppliers, operating expenses, labor and social
obligations, loans and financing and accounts payable to selling shareholders.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_893_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_za0yScJSdrej" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zFkJPusodgkc"&gt;The
tables below summarize the maturity profile of the Company&#x2019;s financial liabilities based on contractual undiscounted amounts:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less
    than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1
    to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3
    to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More
    than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zR9ZkQIDins9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z5ESeiYiJu25" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4224"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zOvm3azUSBs6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4226"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXcsvktPk5lh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zfLFM8oJPa5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zAxP8BwZb9Bk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;217,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCmazm93nvAb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;585,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zIJrnlln4042" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;948,503&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7QoigujE0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,212&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeFK3fOUlXu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,753,304&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zglTCcVoV3j8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;103,003&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zp5n9N8ODbL4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;211,894&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zFaYTrBHa43b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;204,744&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFkneZOqHSi2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,108,555&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zF8LfSWBn2Lj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,628,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSuGOEgdO9Zk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;246,059&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zSOb24gSUJta" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;445,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zTnAuGVP3Luc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,989&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zghUk6ER8yqk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDpcXG5ur67" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;780,114&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zIPwKdlJlYb1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,644&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z6BOp1GaV2D7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;74,306&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z1N6g9dOfRv1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkTvLYtv4Moj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4268"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcOoi4gTMJXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;89,950&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHdgYToVRh4h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z4jVhcodwudk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEHsT2votfHh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zX70wZHR0elg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJ3EBS582on9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zejCy1whiy7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;756,292&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zf3xtPAAbAY4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,316,952&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_znnUWNIzipzd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,242,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWZ5Ztlfr7Qh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,109,767&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zx88NWt85IIe" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,425,247&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less
    than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1
    to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3
    to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More
    than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHUzNQNtkepj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zmk8tw64dIek" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zPyPlVsWUS8b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zya1DGm6Zaf6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcu3rSjjuoag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zb5DxVkLnxbh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;125,137&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zXHoZ9KYiKBa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;566,157&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zL5GI9yVFTF7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,010&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_ztti00xRVKTh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,094&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZHk0tkigzj5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;698,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHy6r1lGO0a4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,092&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCJZr99KjTsh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;131,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zDk8gHEqyHLf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;124,114&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7bapOfNibzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;705,115&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zh7LW7LtcVzc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,023,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zajemD1YjNn9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,145&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zwey8TOCU595" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;262,340&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zxlxhQ84QTEj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,153&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zboMg8va7zJa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4328"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zs5k486his6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;534,638&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zYL7ZAGkP7O2" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,083&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zLILVAJLuqMi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;83,803&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zZgvcHYr2YP6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4336"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zvHtRfvXMfde" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4338"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcnOG1lmTZe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,886&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zMvjaRfcnLLa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zdKLp1ZpCM1h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4344"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zLR7BgSFl1Xc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4346"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkghtfKDDgw5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4348"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zQeuxPIJCtHg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z3bZ3kUs2V93" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;490,039&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zQFuZyfnwZZc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,043,525&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zAMKqlZrEICh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;209,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zz1VRG3s4AV6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;708,209&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAXiAJL5BLOf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,451,050&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A0_zwOe0rLZM1k7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_897_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_zQIjwPYbRiLi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BE_z0ZCC6n1vFYh" style="display: none; visibility: hidden"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.5&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Changes
                                            in liabilities arising from financing activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions
    &lt;sup id="xdx_F59_zjmlxRS0kB19"&gt;*&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzKV1KrzomN6" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBhMABRspry2" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(158,076)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0IWU803TwE8" style="border-top: black 1pt solid; padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;809,539&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zE251ENp5sa8" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;68,909&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zttz7OkvSqMj" style="border-top: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsELnO5IGU7c" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z12f4fJYZuU6" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zcau0ImGxAs" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zpineiBbhIl9" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlOf5eg67ARj" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(87,751)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zjLHdTlougR3" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD66xhLXBfld" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt; -&lt;/span&gt; &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs7pHPy5hh44" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYLqGr2Ib4I2" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3T3KLwlRaJi" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zxh7TigBpiyh" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zyZD4UVYcmyl" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z3AaPlZtHqO9" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231_zc79fNAkOCFl" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zvz4G9Gc8K12" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(264,475)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_z0WhhH6xXUWf" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;986,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zgOWWOfpIolg" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;136,121&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zHEs9vEAlam7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4408"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zE5qX9c3Ohsk" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zSdC8sXzBLuc" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,816)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231_zMmivOiIrttd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znNgfRvcvrL5" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,357&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z488AWFL9Pc1" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(155,090)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQRS8K72PG9" style="text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;605,041&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQGzat4E5Rf" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,031&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zxcFFwNfLEd5" style="text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,279&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z2yFEffKsgu3" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;75,815&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z3fQhUiEyV5j" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL4vlWbpDMa9" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zsjemhoyBpQ2" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdWYi7ZLYlA8" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(55,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg9GKhMDeIrj" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;98,904&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJo0bAFtKMv" style="vertical-align: top; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;44,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx4oCQ5QMSuc" style="vertical-align: top; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAjwku3wyR92" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEwNsjCJhI8j" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zRPzgaQjMI1c" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(12,984)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zQFazbpww7P9" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ziEhcLhcy8Q1" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231_z9O73Awb2TQi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;344,872&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zXTJtxdYXYt7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(223,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_znMpIvd6m0a6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;716,929&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zTNEZIwf4iP3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;54,489&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zHoiW39bFVNi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,279&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zwQnIS48Otcc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;152,670&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zGoDMH5X1lt8" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,522)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231_z2FUiU9hwEpj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zvIedUS2OSce" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,829&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAztwm1hTDFe" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(75,093)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zHzQ9tv2pVrf" style="text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,383&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zaQRffcT0426" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zX2e90SRtrF2" style="text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,126&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbScPCHhooj5" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;43,087&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zU8NOeGHXQGl" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zOdCTOm6NpEj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,357&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg6AfYkrklbd" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;212,360&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJFXc4dUb3vh" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(39,779)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zV7vCpqtxln6" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,100&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z56k3GTEIkH8" style="vertical-align: top; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;31,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlsE1REWk4sa" style="vertical-align: top; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z45ORsY1yHKk" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBpJyPU22eAh" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zPxIx3kYyRWk" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,107&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zXE7a5RQ5nU5" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(51,812)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zF3LHI3EOmD3" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,812&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuntcQFNIZ6d" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,107)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231_zWjhmNV0jbFl" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;294,296&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231_ze9pHOp2ROnf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(166,684)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_z7YmPXLx5G6l" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;78,295&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zoMYYBaUIlnj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;37,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zVuSmFJMulSj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,126&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zXDuM8hDZEo3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;104,452&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zy4hVBxUQKYi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,107)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231_zlBo7XnlR6i3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;344,872&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F08_zC1w9HM6N3oc" style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zmkOARTph9rj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The additions of loans and financing
include proceeds from the SoftBank transaction of R$&lt;span id="xdx_905_ecustom--ProceedsFromLoansAndFinancing_c20210101__20211231_zPVJqip9Bt1a" title="Proceeds from loans and financing"&gt;822,569&lt;/span&gt;, net of the transaction costs of R$&lt;span id="xdx_90C_ecustom--NetOfTransactionCosts_iI_c20211231_zcVZhLnJfqc3" title="Net of the transaction costs"&gt;13,030&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AF_zrPuddarGcH9" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&#160;&lt;/p&gt;

</ifrs-full:DisclosureOfFinancialInstrumentsExplanatory>
    <afya:FinancialAssetsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_891_ecustom--FinancialAssetsExplanatory_zc1c86qjZ8bl" style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.1&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            assets &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_zGIRecehDRH5" style="display: none; visibility: hidden"&gt;Schedule of financial assets&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 62%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 19%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At
    amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z03ZdlVAmuyj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;748,562&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--CashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_z9DzQt2fYyue" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,045,042&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zMOE0qi3k7wb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3576"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--RestrictedCashAndCashEquivalents_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zbZGaXJax9pj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Restricted cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeReceivables_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zojqVaJ0ymYc" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;405,793&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeReceivables_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zfM93KhBTTch" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade receivables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;309,944&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zSJzBDSCrOa7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,154,355&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zQhQFzLRiiS4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,357,039&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zRFOlrs3xDBe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,126,913&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--CurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zYU2OCkrM039" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,347,359&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentFinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zPTsNaCmALXj" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentFinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--FinancialAssetsAtAmortisedCostMember_zKdgR5H3ZhF9" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,680&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:FinancialAssetsExplanatory>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">748562000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:CashAndCashEquivalents
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1045042000</ifrs-full:CashAndCashEquivalents>
    <ifrs-full:RestrictedCashAndCashEquivalents
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">2053000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">405793000</ifrs-full:TradeReceivables>
    <ifrs-full:TradeReceivables
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">309944000</ifrs-full:TradeReceivables>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1154355000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1357039000</ifrs-full:FinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1126913000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:CurrentFinancialAssets
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1347359000</ifrs-full:CurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">27442000</ifrs-full:NoncurrentFinancialAssets>
    <ifrs-full:NoncurrentFinancialAssets
      contextRef="AsOf2020-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">9680000</ifrs-full:NoncurrentFinancialAssets>
    <afya:FinancialLiabilitiesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--FinancialLiabilitiesExplanatory_z1BtDbTpK2P7" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BF_zMFltixnOV3b" style="display: none; visibility: hidden"&gt;Schedule of financial liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.2&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Financial
                                            liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 60%; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;At
    amortized cost&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGujMwpBIsql" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z9RVWJNX8MOf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zJsr3bK2PUq4" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zzQW49rQgfa2" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zqnByovspL8c" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zB7ahHdc6D5k" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5pX9tYOjdF" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zo6A68v69oyf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotePayable_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zwj5XlxPbf38" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NotePayable_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z3WKaiaMZMuf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Advances_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zkRg48MJ5Vyb" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Advances_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zGyTy7ai7HR7" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zBjRb4vqEDJg" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,015,196&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5ePpUjn3h7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,759,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--CurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_z5UTx4cF9Dvf" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;581,685&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--CurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zFFsBL9CLegh" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;467,643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentFinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zfYOj0W3Ax72" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,433,511&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentFinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--FinancialLiabilitiesAtAmortisedCostMember_zEsJHwwCVhHe" style="white-space: nowrap; vertical-align: top; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10.3pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,291,548&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

</afya:FinancialLiabilitiesExplanatory>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">59098000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">35743000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1374876000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">617485000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">714085000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">447703000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">679826000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">518240000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:NotePayable
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">72726000</afya:NotePayable>
    <afya:NotePayable
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">76181000</afya:NotePayable>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">114585000</ifrs-full:Advances>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">63839000</ifrs-full:Advances>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">3015196000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1759191000</ifrs-full:FinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">581685000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:CurrentFinancialLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">467643000</ifrs-full:CurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">2433511000</ifrs-full:NoncurrentFinancialLiabilities>
    <ifrs-full:NoncurrentFinancialLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember"
      decimals="-3"
      unitRef="BRL">1291548000</ifrs-full:NoncurrentFinancialLiabilities>
    <afya:LoansAndFinancingExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_892_ecustom--LoansAndFinancingExplanatory_zTt3dLIkxESj" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B8_zm3SzwoyE2Kf" style="display: none; visibility: hidden"&gt;Schedule of loans and financing&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 31%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    institution&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Currency&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Interest
    rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Maturity&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90E_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zB9RXIJFJVAj" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Banco
    Ita&#xfa; Unibanco S.A&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;. &lt;sup id="xdx_F22_zmBicpqB3fhl"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zYR9l0wMdXAj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.62% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zMd6gF9kkEXl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2023&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_zuLdcpeoqIm2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;510,972&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyThreeMember_fKGEp_z8n583HwbbKg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;504,365&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zgOHluBj2Edd" title="Financial institution"&gt;Banco
    Votorantim&lt;/span&gt; (b)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zZnlxaKoTEe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.65% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zlhSjcf7D22h" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--LoansAndFinancing_iI_pn3n3_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_zqYSXD2EwY69" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3651"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_pn3n3_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyOneMember_fKGIp_z5UcOoeiRcrj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;101,785&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zljZDy8OCAea" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;BNDES
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F2B_zA7LUbK9optk"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zsDgiQxc1D7f" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10.03%
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zHIVWpm4A1qa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_z9kLfBNBI75e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3660"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentyFourMember_fKGMp_zvyskOp0QlWj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;471&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_903_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zBok37LEBPij" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;FINEP
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F22_zkOEk5Nuq1Jf"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zzIAMQ110FRc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;TJLP
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zko24wZWX3o2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2027&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zTicJgL5xpwi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,145&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--MaturityAxis__custom--TwentyTwentySevenMember_fKGQp_zcXkhNP30Wk3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,864&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90F_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zdnl6BDqLCDg" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Softbank
    &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;sup id="xdx_F20_zUULCq1sRBM7"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_z832kBOIMMog" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6.5%
    p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zFq3Wb4wpEId" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2026&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentySixMember_fKGYp_zKDjFTAF4TX7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;822,560&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span id="xdx_90A_ecustom--FinancialInstitution_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zwnfUFyxiuq8" style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Banco
    Ita&#xfa; Unibanco S.A&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;. &lt;sup id="xdx_F2D_zlY8kskBqIVc"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Brazilian
    real&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--BorrowingsInterestRateBasis_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zYzY8fAL4UI8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Interest rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;CDI
    + 1.75% p.y.&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--BorrowingsMaturity_c20210101__20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zV5azFwWzxGg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt" title="Maturity"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2024&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--MaturityAxis__custom--TwentyTwentyFour1Member_fKGUp_zyyrDty0YKDc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,199&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20211231_zXcbIvravYPk" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,374,876&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancing1_iI_c20201231_zjjxY0DZLkTi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;617,485&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--LoansAndFinancingCurrent_iI_c20211231_z1tnahTyvGs6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;128,720&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancingCurrent_iI_c20201231_zEnAh2msUbJ8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,162&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--LoansAndFinancingNonCurrent_iI_c20211231_z2AMx6ZuXH0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,246,156&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LoansAndFinancingNonCurrent_iI_c20201231_zRMYJYTEENb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10.5pt" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;510,323&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0A_zTi7mUqwIWO1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_z51L1HBzMn4b" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ &lt;span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1"&gt;500,000&lt;/span&gt; adjusted by the CDI rate plus an interest rate of
&lt;span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb"&gt;1.62&lt;/span&gt;% per year and is repayable in three installments in October 2022, April 2023 and October 2023.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F08_zalDbRqnSNfk" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_z810umuNjO51" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ &lt;span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4"&gt;100,000&lt;/span&gt; adjusted by the CDI rate plus an interest rate of &lt;span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l"&gt;1.65&lt;/span&gt;%
per year and was repaid at maturity on July 5, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F09_z9k3Dh9scuNh" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F18_zwCXLV6lCHHe" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of &lt;span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk"&gt;10.03&lt;/span&gt;% per year and maturity in 2024.
This amount was prepaid in September 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F05_z42M0s1Bbhib" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_zYD7jefjnWq1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 23, 2019, Medcel entered
into a loan of R$ &lt;span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount"&gt;16,153&lt;/span&gt; with Financiadora de Estudos e Projetos (&#x201c;FINEP&#x201d;), a governmental agency focused on financing investments
on R&amp;amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$&lt;span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche"&gt;6,734&lt;/span&gt; and R$&lt;span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche"&gt;4,130&lt;/span&gt;, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0F_zlqH3DSjUbDg" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F19_z79xim6Tpy76" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ &lt;span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount"&gt;30,000&lt;/span&gt;. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of &lt;span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate"&gt;1.75&lt;/span&gt;% per year and is repayable in three installments in July 2023, January 2024 and July 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F02_zJ7yTusJG991" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_zsY2G5AhKIb3" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 26, 2021, the Company issued
and sold &lt;span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares"&gt;150,000&lt;/span&gt; shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$&lt;span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8"&gt;0.00005&lt;/span&gt; per share of the Company for US$&lt;span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5"&gt;150,000&lt;/span&gt; thousands, equivalent to R$ &lt;span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9"&gt;821,805&lt;/span&gt; on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:LoansAndFinancingExplanatory>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember"
      id="Fact003635">Banco
    Ita&#xfa; Unibanco S.A</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember"
      id="Fact003637">CDI
    + 1.62% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyThreeMember"
      id="Fact003639">2023</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentyThreeMember"
      decimals="-3"
      id="Fact003641"
      unitRef="BRL">510972000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_custom_TwentyTwentyThreeMember"
      decimals="-3"
      id="Fact003643"
      unitRef="BRL">504365000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember"
      id="Fact003645">Banco
    Votorantim</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember"
      id="Fact003647">CDI
    + 1.65% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyOneMember"
      id="Fact003649">2021</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_custom_TwentyTwentyOneMember"
      decimals="-3"
      id="Fact003653"
      unitRef="BRL">101785000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember"
      id="Fact003654">BNDES</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember"
      id="Fact003656">10.03%
    p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFourMember"
      id="Fact003658">2024</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_custom_TwentyTwentyFourMember"
      decimals="-3"
      id="Fact003662"
      unitRef="BRL">471000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember"
      id="Fact003663">FINEP</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember"
      id="Fact003665">TJLP
    p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySevenMember"
      id="Fact003667">2027</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentySevenMember"
      decimals="-3"
      id="Fact003669"
      unitRef="BRL">10145000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_custom_TwentyTwentySevenMember"
      decimals="-3"
      id="Fact003671"
      unitRef="BRL">10864000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember"
      id="Fact003672">Softbank</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember"
      id="Fact003674">6.5%
    p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentySixMember"
      id="Fact003676">2026</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentySixMember"
      decimals="-3"
      id="Fact003677"
      unitRef="BRL">822560000</afya:LoansAndFinancing>
    <afya:FinancialInstitution
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member"
      id="Fact003678">Banco
    Ita&#xfa; Unibanco S.A</afya:FinancialInstitution>
    <ifrs-full:BorrowingsInterestRateBasis
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member"
      id="Fact003680">CDI
    + 1.75% p.y.</ifrs-full:BorrowingsInterestRateBasis>
    <ifrs-full:BorrowingsMaturity
      contextRef="From2021-01-012021-12-31_custom_TwentyTwentyFour1Member"
      id="Fact003682">2024</ifrs-full:BorrowingsMaturity>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_custom_TwentyTwentyFour1Member"
      decimals="-3"
      id="Fact003683"
      unitRef="BRL">31199000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">1374876000</afya:LoansAndFinancing1>
    <afya:LoansAndFinancing1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">617485000</afya:LoansAndFinancing1>
    <afya:LoansAndFinancingCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">128720000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">107162000</afya:LoansAndFinancingCurrent>
    <afya:LoansAndFinancingNonCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">1246156000</afya:LoansAndFinancingNonCurrent>
    <afya:LoansAndFinancingNonCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">510323000</afya:LoansAndFinancingNonCurrent>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2020-10-01_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">500000000</afya:EqualInstallmentsPayablesToRelatedParties>
    <afya:IntrestRate
      contextRef="AsOf2020-10-01_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="INF"
      unitRef="Pure">0.0162</afya:IntrestRate>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">100000000</afya:EqualInstallmentsPayablesToRelatedParties>
    <afya:IntrestRate
      contextRef="AsOf2020-07-03_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="INF"
      unitRef="Pure">0.0165</afya:IntrestRate>
    <afya:IntrestRate
      contextRef="AsOf2020-05-20_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="INF"
      unitRef="Pure">0.1003</afya:IntrestRate>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="-3"
      unitRef="BRL">16153000</ifrs-full:NotionalAmount>
    <afya:BorrowingsAmountFirstTranche
      contextRef="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="-3"
      unitRef="BRL">6734000</afya:BorrowingsAmountFirstTranche>
    <afya:BorrowingsAmountFirstTranche
      contextRef="From2020-12-222020-12-23_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="-3"
      unitRef="BRL">4130000</afya:BorrowingsAmountFirstTranche>
    <ifrs-full:NotionalAmount
      contextRef="AsOf2020-10-23_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="-3"
      unitRef="BRL">30000000</ifrs-full:NotionalAmount>
    <afya:IntrestRate
      contextRef="AsOf2021-06-30_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="INF"
      unitRef="Pure">0.0175</afya:IntrestRate>
    <ifrs-full:NumberOfSharesAuthorised contextRef="AsOf2021-04-26" decimals="INF" unitRef="Shares">150000</ifrs-full:NumberOfSharesAuthorised>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2021-04-26"
      decimals="INF"
      unitRef="BRLPShares">0.00005</ifrs-full:ParValuePerShare>
    <ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset
      contextRef="From2019-07-222019-07-23_custom_FinanciadoradeEstudoseProjetosFINEPMember"
      decimals="-3"
      unitRef="BRL">150000000</ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset
      contextRef="From2021-04-242021-04-26"
      decimals="-3"
      unitRef="BRL">821805000</ifrs-full:ContributionsToPlanNetDefinedBenefitLiabilityAsset>
    <ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">13030</ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination>
    <afya:LeasesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_ecustom--LeasesExplanatory_zdFVv4xpSlk3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B9_z2Ngwn0Scl7d" style="display: none; visibility: hidden"&gt;Schedule of right-of-use assets and lease liabilities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Set out below are
the carrying amounts of right-of-use assets and lease liabilities and the movements during the period&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 55%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Right-of-use
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Lease
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--RightofuseAssets_iS_pn3n3_c20200101__20201231_zqMCxYvkXOH5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;274,275&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LeaseLiabilities_iS_c20200101__20201231_z13elCLROPzc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionsToRightofuseAssets_c20200101__20201231_z6IRPRU2zli2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,743&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--AdditionsToLeaseLiabilities_c20200101__20201231_zEwb6VKoZrvg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsRemeasurement_c20200101__20201231_znnBIG4RpgMl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,161&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--LeaseLiabilitiesRemeasurement_c20200101__20201231_z8Q38gDPoVci" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;34,161&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsBusinessCombinations_c20200101__20201231_zQIMNbNUtEF6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BusinessCombinationsLeaseLiabilities_c20200101__20201231_zmBMNPscqWfj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--DepreciationRightofuseAssets_c20200101__20201231_zxJRBXE0VABi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,386)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--DepreciationExpenseLeaseLiabilities_c20200101__20201231_ztoJHksNIQwj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3749"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsInterestExpense_c20200101__20201231_zSJL3sOUeBic" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3751"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--InterestExpenseOnLeaseLiabilities_c20200101__20201231_ztdCIYhn2xd7" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;44,458&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments
    of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20200101__20201231_zRHrFTjKobl6" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3755"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20200101__20201231_zZmFBezSUrib" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(55,455)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--RightofuseAssetsDisposals_c20200101__20201231_zfklWTEvp40a" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LeaseLiabilitiesDisposals_c20200101__20201231_zT6cJrMY9Jad" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iS_c20210101__20211231_zsmJlIEdwvV9" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;419,074&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--LeaseLiabilitiesRightToUse_iS_c20210101__20211231_z1WBXaNYsR7c" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;447,703&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionsToRightofuseAssets_c20210101__20211231_z7BMii514BZ2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--AdditionsToLeaseLiabilities_c20210101__20211231_zuERlh8VD2Qf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;62,689&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Remeasurement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsRemeasurement_c20210101__20211231_zNgO35WReje3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LeaseLiabilitiesRemeasurement_c20210101__20211231_ze9Od1Y85TQa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, remeasurement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;95,962&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--RightofuseAssetsBusinessCombinations_c20210101__20211231_z26LFNnLEpt4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--BusinessCombinationsLeaseLiabilities_c20210101__20211231_zEnCU0VThshd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--DepreciationRightofuseAssets_c20210101__20211231_zgUpk7wCIWPk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,237)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--DepreciationExpenseLeaseLiabilities_c20210101__20211231_zDzLXE6FWy5l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, depreciation expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3781"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsInterestExpense_c20210101__20211231_zVNxOroU8ceb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3783"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--InterestExpenseOnLeaseLiabilities_c20210101__20211231_zOZ5mQKnk673" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, interest expense"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments
    of lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--RightofuseAssetsPaymentsOfLeaseLiabilities_c20210101__20211231_z98zlrLmRQc1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3787"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1_c20210101__20211231_z8n1QD5C6SMd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, payments of lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(87,751)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Disposals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--RightofuseAssetsDisposals_c20210101__20211231_zNzxQZuSvoyh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,316)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--LeaseLiabilitiesDisposals_c20210101__20211231_zPa9mSlSONS3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, disposals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--RightofuseAssets_iE_c20210101__20211231_zqh7jc5JGnUa" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;663,686&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitieRightToUse_iE_c20210101__20211231_z9HvVroLhE3i" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, balance at ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;714,085&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--RightofuseAssetsCurrent_iI_c20201231_zRgyXsBj6bpg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3799"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--CurrentLeaseLiabilities_iI_c20201231_zaok1A04GPYg" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;61,976&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--RightofuseAssetsNonCurrent_iI_c20201231_zf8S8erXCa0i" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;419,074&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--NoncurrentLeaseLiabilities_iI_c20201231_zDVL5zRrc4Wj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;385,727&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current &lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsCurrent_iI_c20211231_zzBoYoAOHOW8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3807"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--CurrentLeaseLiabilities_iI_c20211231_zH8nfPFzdmg4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,955&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--RightofuseAssetsNonCurrent_iI_c20211231_znL8zaOo0366" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Right-of-use assets, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;663,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NoncurrentLeaseLiabilities_iI_c20211231_z7rV6IKfaR4c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities, non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;689,130&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:LeasesExplanatory>
    <ifrs-full:RightofuseAssets contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">274275000</ifrs-full:RightofuseAssets>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">284515000</ifrs-full:LeaseLiabilities>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">64743000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">64743000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">34161000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">34161000</afya:LeaseLiabilitiesRemeasurement>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">76855000</afya:RightofuseAssetsBusinessCombinations>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">76855000</afya:BusinessCombinationsLeaseLiabilities>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-29386000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">44458000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-55455000</afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1>
    <afya:RightofuseAssetsDisposals
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1574000</afya:RightofuseAssetsDisposals>
    <afya:LeaseLiabilitiesDisposals
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1574000</afya:LeaseLiabilitiesDisposals>
    <ifrs-full:RightofuseAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">419074000</ifrs-full:RightofuseAssets>
    <afya:LeaseLiabilitiesRightToUse contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">447703000</afya:LeaseLiabilitiesRightToUse>
    <ifrs-full:AdditionsToRightofuseAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">62689000</ifrs-full:AdditionsToRightofuseAssets>
    <afya:AdditionsToLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">62689000</afya:AdditionsToLeaseLiabilities>
    <afya:RightofuseAssetsRemeasurement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">95962000</afya:RightofuseAssetsRemeasurement>
    <afya:LeaseLiabilitiesRemeasurement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">95962000</afya:LeaseLiabilitiesRemeasurement>
    <afya:RightofuseAssetsBusinessCombinations
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">139514000</afya:RightofuseAssetsBusinessCombinations>
    <afya:BusinessCombinationsLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">139514000</afya:BusinessCombinationsLeaseLiabilities>
    <ifrs-full:DepreciationRightofuseAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-43237000</ifrs-full:DepreciationRightofuseAssets>
    <ifrs-full:InterestExpenseOnLeaseLiabilities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">67212000</ifrs-full:InterestExpenseOnLeaseLiabilities>
    <afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-87751000</afya:PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1>
    <afya:RightofuseAssetsDisposals
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-10316000</afya:RightofuseAssetsDisposals>
    <afya:LeaseLiabilitiesDisposals
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-11244000</afya:LeaseLiabilitiesDisposals>
    <ifrs-full:RightofuseAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">663686000</ifrs-full:RightofuseAssets>
    <afya:LeaseLiabilitieRightToUse contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">714085000</afya:LeaseLiabilitieRightToUse>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">61976000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">419074000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">385727000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:CurrentLeaseLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">24955000</ifrs-full:CurrentLeaseLiabilities>
    <afya:RightofuseAssetsNonCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">663686000</afya:RightofuseAssetsNonCurrent>
    <ifrs-full:NoncurrentLeaseLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">689130000</ifrs-full:NoncurrentLeaseLiabilities>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">11229</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">2555</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">4494</ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed>
    <afya:AccountsPayableToSellingShareholdersExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_ecustom--AccountsPayableToSellingShareholdersExplanatory_zwneqjNLUICj" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zdyavAhnUimd" style="display: none; visibility: hidden"&gt;Schedule of accounts payable to selling shareholders&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IESP &lt;sup id="xdx_F4E_zWKVmswV4FW1"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_z85FAX0S8Bqk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3823"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zmq4trAf5RP9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;38,771
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FASA &lt;sup id="xdx_F4F_zZK2jTl7IkOk"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zHDyYiE9Zvc8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;41,581&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zn7o6AOm8RN2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,356
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEMED &lt;sup id="xdx_F41_zn0dW2zvySV2"&gt;(c)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z0JJNT8ctO73" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;30,233&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_z6FOyUFC0rpb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;38,622
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEC &lt;sup id="xdx_F42_zqshtSFUUJp1"&gt;(d)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zTVdM1GIN6T1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3835"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_z5Gyn0T3qRkc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;28,307
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of UniRedentor &lt;sup id="xdx_F43_z60A7817VGR6"&gt;(e)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_z1WnX2DYQNdk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;85,506&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zhGM91ycQBNl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;97,773&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of UniS&#xe3;oLucas &lt;sup id="xdx_F43_zh0awc82kzx3"&gt;(f)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zadNHOjGgTLi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;42,672&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_z2UTq3y6tC3k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;53,386&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FCMPB &lt;sup id="xdx_F45_zETWa31mD7Ma"&gt;(g)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z6jFf3ch3JY3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;149,175&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zN2ftEHazwa1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;189,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of FESAR &lt;sup id="xdx_F48_zgceDiGCoM72"&gt;(h)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z7FFdVFhYtgj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3851"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FESARMember_z5MX6rtar9Y2" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,569&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of MEDPHONE &lt;sup id="xdx_F4D_zXuPicD2So23"&gt;(i)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zrCRWkNvLQtl" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3855"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedPhoneMember_zfitZgNNXH7k" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Medicinae &lt;sup id="xdx_F47_zGPDRY4hsnCi"&gt;(j)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicinaeMember_zq7q1Uv4FbU5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,887&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Medical Harbour &lt;sup id="xdx_F47_zzd3kqoEQ6R"&gt;(k)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--MedicalHarbourMember_znSSTKulYKoj" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,801&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Cliquefarma &lt;sup id="xdx_F4E_zFJxLok3zxa7"&gt;(l)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--CliquefarmaMember_z3uHvbCFHZJ4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,050&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Shosp &lt;sup id="xdx_F46_zQwb0PHQiFif"&gt;(m)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--ShospMember_z2DjnXTO02Zh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,141&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Unigranrio &lt;sup id="xdx_F43_zJGhKY3IkE9e"&gt;(n)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UnigranrioMember_z6o6KrnXQkh4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;249,979&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of RXPRO &lt;sup id="xdx_F4B_zypPFxudJAOg"&gt;(o)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--RXPROMember_zZw1MMFKcix9" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,245&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of Guaranhuns &lt;sup id="xdx_F43_zZ0sTE37enL5"&gt;(p)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--GuaranhunsMember_zGa2EMCQqlmd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,556&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20211231_zZaewIbiNLVb" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TradeAndOtherPayablesToRelatedParties1_iI_c20201231_zEfXZBdmg33d" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;518,240&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20211231_zZR0JQXDprzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;239,849&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AccountsPayableToSellingShareholdersCurrent_iI_c20201231_zaKv1YAlf93j" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;188,420&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20211231_z3UJBu42wWw" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;439,977&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AccountsPayableToSellingShareholdersNonCurrent_iI_c20201231_z6BKJz3iTOxe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;329,820&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; width: 57%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; white-space: nowrap; width: 18%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 12%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Opening
    balance&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ziNL8qn9OVxc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zyBh4I5Cyeoj" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;300,237&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsPtTtFyRWVk" style="text-align: right; line-height: 10pt" title="Opening balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;177,730&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    flows&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholderCashFlows_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zRba8aLk3XMc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(192,681)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--AccountsPayableToSellingShareholderCashFlows_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zsMXqxUmkyO6" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(134,518)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--AccountsPayableToSellingShareholderCashFlows_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zekqO0N1Y1U4" style="text-align: right; line-height: 10pt" title="Cash flows"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(92,688)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Acquisition
    of IPEC and Guaranhus&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zlf0ViKTCJt6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt; text-indent: 18.1pt" title="Acquisition of IPEC"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--AccountsPayableToSellingShareholdersAcquisitionOfIpec_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zmet3t8zdbK6" style="text-align: right; line-height: 10pt" title="Acquisition of IPEC"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;54,000&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--InterestExpense_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zh1XghtwXkw4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;31,915&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--InterestExpense_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zkQW4S3oAsn9" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,884&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--InterestExpense_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z6jYxkHuRfg4" style="text-align: right; line-height: 10pt" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;17,977&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Installments
    on Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zBrFwYQP07c1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;243,816&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zGWbt4hfcmj4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;343,140&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--AccountsPayableToSellingShareholdersBusinessCombinations_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zk5EcJ66v1Te" style="text-align: right; line-height: 10pt" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;144,538&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Contingent
    consideration on Business combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--ContingentConsiderationOnBusinessCombinations_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze99p5bfPpuc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Contingent consideration on Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,536&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Compensation
    of legal proceedings disbursement&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--CompensationOfLegalProceedingsDisbursement_c20210101__20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zYlPrTpTTmq9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl3915"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--CompensationOfLegalProceedingsDisbursement_c20200101__20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zfUU8fxRnMHa" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,503)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--CompensationOfLegalProceedingsDisbursement_c20190101__20191231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_ze4tL1PZawPa" style="text-align: right; line-height: 10pt" title="Compensation of legal proceedings disbursement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,320)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Closing
    balance&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20211231_zwWMZDfdXzz" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;679,826&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20201231_zzYBtX29kCH2" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;518,240&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TradeAndOtherPayablesToRelatedParties2_iI_c20191231_zkeE4Pu6R6H7" style="border-top: black 1pt solid; border-bottom: black 2.25pt double; text-align: right; line-height: 10pt" title="Closing balance"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;300,237&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F01_zv63289LzEth" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1B_zgUAj77fQk92" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 27, 2018, Afya Brazil
acquired &lt;span id="xdx_90F_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20180101__20181231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember_z4qWcJqh1xUd" title="Ownership Interest"&gt;80&lt;/span&gt;% of IESP and R$&lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zVuTOntw0072" title="Remaining accounts payable"&gt;106,200&lt;/span&gt; is payable in three equal installments of R$&lt;span id="xdx_903_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20180527__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoDeEnsinoSuperiorDoPiauiSAMember_zxKyqP5yhY" title="Equal installments payables"&gt;35,400&lt;/span&gt;, each adjusted by the CDI rate through the payment
date. The remaining installment was paid in November 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zhZQQRjmtG75" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z3QFuTYoEqH6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 3, 2019, Afya Brazil acquired
&lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_z7XnVlpSfqu8" title="Ownership Interest"&gt;90&lt;/span&gt;% of FASA and R$ &lt;span id="xdx_90B_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zs0rUtxXi5Cf" title="Remaining accounts payable"&gt;39,695&lt;/span&gt; was paid in April 2020, R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zaXdD0P8Fxh2"&gt;29,770&lt;/span&gt; was paid in April, 2021, and R$ &lt;span id="xdx_907_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20220403__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoEducacionalSantoAgostinhoSAMember_zq18SwOoMG7"&gt;29,770&lt;/span&gt; is payable in April 2022; each installment
adjusted by the IPCA rate + 4.1% per year.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zNn6SbNXKow6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(c)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F14_zpiGi8IUG3Y9" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 9, 2019, Afya Brazil acquired
&lt;span id="xdx_909_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zO6RGgnXR905" title="Ownership Interest"&gt;100&lt;/span&gt;% of IPEMED and R$ &lt;span id="xdx_903_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zJRChPwWv7A8" title="Remaining accounts payable"&gt;45,303&lt;/span&gt; is payable in five equal installments of R$ &lt;span id="xdx_90F_ecustom--EqualInstallmentsPayablesToRelatedParties1_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zb0l4ohzl159" title="Equal installments payables"&gt;9,061&lt;/span&gt;, adjusted by the CDI rate, and due annually in February
2020, 2021, 2022, 2023 and 2024.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F01_zOt4w6Wkxz28" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(d)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_zLyO0cSJD5h7" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 13, 2019, Afya Brazil
acquired &lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20190101__20191231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zC8nvwJKAmlb" title="Ownership Interest"&gt;100&lt;/span&gt;% of IPEC and R$&lt;span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20190813__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutoParaensedeEducacaoeCulturaLtdaMember_zc3VTX2xZwO" title="Remaining accounts payable"&gt;54,000&lt;/span&gt; is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the
first and the second year from the transaction closing date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F07_zXafWS45PoGj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(e)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zvV6Q4UkBYs1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On January 31, 2020, Afya Brazil
acquired &lt;span id="xdx_90D_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zemKfTaWOCW" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniRedentor and R$&lt;span id="xdx_902_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zF8be0Lxbtbd" title="Remaining accounts payable"&gt;100,000&lt;/span&gt; is payable in five equal installments from January 2021 through July 2024, adjusted by the
CDI rate. The purchase consideration was adjusted by R$&lt;span id="xdx_908_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200131__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniRedentorMember_zSOwnFQiVdd8" title="Equal installments payables"&gt;4,503&lt;/span&gt; and such amount was deducted from the first installment paid in February
2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F00_zB57gfdzaN2k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(f)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_z4kvTsPsM6M6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 5, 2020, Afya Brazil acquired
&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zZJFOvx7ivQl" title="Ownership Interest"&gt;100&lt;/span&gt;% of UniSL and R$ &lt;span id="xdx_90A_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zkx4sLnWGaZ7" title="Remaining accounts payable"&gt;60,456&lt;/span&gt; is payable in three equal installments through May 2023, adjusted by the CDI rate. The purchase consideration
was adjusted by R$&lt;span id="xdx_904_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20200505__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zHcxL6Efv0dg" title="Equal installments payables"&gt;7,816&lt;/span&gt; and such amount was deducted from the first installment paid on May 5, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F06_z35OSOwAaon2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(g)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zcGrR7lQ5R4j" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 9, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zPVFC9IyMQPl" title="Ownership Interest"&gt;100&lt;/span&gt;% of FCMPB and R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20201109__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZRPKMvZBp69" title="Remaining accounts payable"&gt;188,894&lt;/span&gt; is payable in four installments through November 2024, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F04_zBAR9sLU1I7f" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(h)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_ziEfKwWW2PD6" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 3, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwuk4GghLIe4"&gt;100&lt;/span&gt;% of FESAR paid in cash and R$&lt;span id="xdx_903_ecustom--CashTransferredTransaction_iI_c20201103_zaQWkcVVQ525" title="Cash on the transaction closing date"&gt;1,569&lt;/span&gt; of price adjustment was paid on February 25, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0C_z7wRV9wy7h85" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(i)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zF4qniF3CIa" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 4, 2020, Afya Brazil
acquired &lt;span id="xdx_905_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pid_dp_uPure_c20200101__20201231__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zNx2GJ2g6oik"&gt;100&lt;/span&gt;% of MedPhone paid in cash and R$&lt;span id="xdx_902_ecustom--CashTransferredTransaction_iI_c20201104_zIuX9r673xQ5"&gt;36&lt;/span&gt; of price adjustment was paid on February 2, 2021.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0F_zYhXumGsklLl" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(j)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F10_zvrhRBRUHY3c" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 25, 2021, Afya Brazil acquired
&lt;span id="xdx_908_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210323__20210325__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zO6SyjqODtod"&gt;100&lt;/span&gt;% of Medicinae and an earn-out (&#x201c;contingent consideration&#x201d;) of up of R$ &lt;span id="xdx_90F_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210305__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniSLMember_zBEDWkEbyHn1"&gt;4,400&lt;/span&gt; is payable in connection with product development
goals for 2021 and revenue achievements for 2022. The contingent consideration of R$&lt;span id="xdx_907_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210325_zj2gQJModqXk"&gt;3,887&lt;/span&gt; is based on the present value of the obligation
considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition
date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0B_zmrfcFiYSna2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(k)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1F_zKH6Z5xMI421" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 8, 2021, Afya Brazil acquired
&lt;span id="xdx_902_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210408__20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zCwaNP6gbIkc"&gt;100&lt;/span&gt;% of Medical Harbour and an earn-out (&#x201c;contingent consideration&#x201d;) of R$ &lt;span id="xdx_900_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210408__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zWiugvjBH466"&gt;9,000&lt;/span&gt; is payable in relation to product development
goals for 2021 and 2022 and revenue achievements for 2023. The contingent consideration of R$&lt;span id="xdx_902_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210408_ztq8TsDI9bo3"&gt;6,801&lt;/span&gt; is based on the present value of the
obligation considering the facts and circumstances at the acquisition date, and no relevant impacts were identified by management from
the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F09_zic2lNOonq9k" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(l)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zAzhkm1LyH9d" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On April 16, 2021, Afya Brazil acquired
&lt;span id="xdx_90E_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210416__20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZBAEeUDaQ4a"&gt;100&lt;/span&gt;% of Cliquefarma and an earn-out (&#x201c;contingent consideration&#x201d;) of R$ &lt;span id="xdx_905_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210416__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_z1aWp9bANHv6"&gt;3,000&lt;/span&gt;, adjusted by the CDI rate, is payable in relation
to product development. The contingent consideration of R$&lt;span id="xdx_909_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210416_zhVJ13vYYy8a"&gt;3,050&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F02_zimx5sAe3Q5a" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(m)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F16_z3Ypn6VwQW9c" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On May 13, 2021, Afya Brazil acquired
&lt;span id="xdx_904_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210513__20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zbv1BsGfHWVf"&gt;100&lt;/span&gt;% of Shosp and R$ &lt;span id="xdx_906_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20210513_z3ZUFmEpUbO5"&gt;454&lt;/span&gt; will be paid, and an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ &lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20210513__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zGZHllMfQ7A3"&gt;1,793&lt;/span&gt; is payable in relation
to product development. The contingent consideration of R$ &lt;span id="xdx_904_eifrs-full--DefinedBenefitObligationAtPresentValue_iI_c20210513_zp4A5zkvUaH8"&gt;2,141&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F07_zYxXw7KwaOEi" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(n)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_z6d9bo4Byk1j" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On August 4, 2021, Afya Brazil acquired
&lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20210802__20210804__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zFSfON2j3lMc"&gt;100&lt;/span&gt;% of Unigranrio. The adjusted aggregate purchase price is R$ &lt;span id="xdx_902_eifrs-full--NoncurrentPayablesForPurchaseOfEnergy_iI_c20211004_zj5L1805Wg13"&gt;618,956&lt;/span&gt; of which 60% was paid in cash on the transaction closing date,
and 40% is payable in cash in four equal installments through 2022 to 2025, adjusted by the CDI rate.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F03_zPYdaXJ54hLh" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(o)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zG0eJg2Jb9i2" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 01, 2021, Afya Brazil
acquired &lt;span id="xdx_90A_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211001__20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zoNgvH2MPTc7"&gt;100&lt;/span&gt;% of RXPRO and an earn-out (&#x201c;contingent consideration&#x201d;) of up to R$ &lt;span id="xdx_904_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zZ9wnw1fvIOc"&gt;21,000&lt;/span&gt; is payable in relation to revenue
achievements until 2024. The contingent consideration of R$ &lt;span id="xdx_909_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20221101_z7TP8wlyiZV8"&gt;10,245&lt;/span&gt; is based on the present value of the obligation considering the facts
and circumstances at the acquisition date, and no relevant impacts were identified by management from the acquisition date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F0D_zFBWHTxNp5Rc" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(p)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F12_zHY8VC1ZsVP1" style="font-family: Arial, Helvetica, Sans-Serif"&gt;On November 05, 2021, Afya Brazil
concluded the acquisition of &lt;span id="xdx_90C_eifrs-full--ProportionOfOwnershipInterestsHeldByNoncontrollingInterests_pii_dp_uPure_c20211103__20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zwymGW7j6Drb"&gt;100&lt;/span&gt;% of ITPAC Garanhuns and R$&lt;span id="xdx_90C_eifrs-full--TransactionPriceAllocatedToRemainingPerformanceObligations_iI_c20211105_zbhmCjeFIhad"&gt;54,000&lt;/span&gt; was paid in cash on the transaction closing date, and (ii) R$&lt;span id="xdx_90D_ecustom--RemainingTradeAndOtherPayablesToRelatedParties_iI_c20211105__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--FCMPBMember_zITzyB2teMSh"&gt;54,000&lt;/span&gt;
is payable in two equal installments, adjusted by the CDI rate, and due annually at the end of the first and the second year from the
transaction closing date.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:AccountsPayableToSellingShareholdersExplanatory>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">38771000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">41581000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">70356000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">30233000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">38622000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">28307000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">85506000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_UniRedentorMember"
      decimals="-3"
      unitRef="BRL">97773000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">42672000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">53386000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">149175000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">189420000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_FESARMember"
      decimals="-3"
      unitRef="BRL">1569000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_MedPhoneMember"
      decimals="-3"
      unitRef="BRL">36000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_MedicinaeMember"
      decimals="-3"
      unitRef="BRL">3887000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_MedicalHarbourMember"
      decimals="-3"
      unitRef="BRL">6801000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_CliquefarmaMember"
      decimals="-3"
      unitRef="BRL">3050000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_ShospMember"
      decimals="-3"
      unitRef="BRL">2141000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_UnigranrioMember"
      decimals="-3"
      unitRef="BRL">249979000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_RXPROMember"
      decimals="-3"
      unitRef="BRL">10245000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_GuaranhunsMember"
      decimals="-3"
      unitRef="BRL">54556000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:TradeAndOtherPayablesToRelatedParties1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">679826000</afya:TradeAndOtherPayablesToRelatedParties1>
    <afya:TradeAndOtherPayablesToRelatedParties1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">518240000</afya:TradeAndOtherPayablesToRelatedParties1>
    <afya:AccountsPayableToSellingShareholdersCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">239849000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">188420000</afya:AccountsPayableToSellingShareholdersCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">439977000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <afya:AccountsPayableToSellingShareholdersNonCurrent contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">329820000</afya:AccountsPayableToSellingShareholdersNonCurrent>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">518240000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">300237000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">177730000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">-192681000</afya:AccountsPayableToSellingShareholderCashFlows>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">-134518000</afya:AccountsPayableToSellingShareholderCashFlows>
    <afya:AccountsPayableToSellingShareholderCashFlows
      contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">-92688000</afya:AccountsPayableToSellingShareholderCashFlows>
    <afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">54000000</afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec>
    <afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec
      contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">54000000</afya:AccountsPayableToSellingShareholdersAcquisitionOfIpec>
    <ifrs-full:InterestExpense
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">31915000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">13884000</ifrs-full:InterestExpense>
    <ifrs-full:InterestExpense
      contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">17977000</ifrs-full:InterestExpense>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">243816000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">343140000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:AccountsPayableToSellingShareholdersBusinessCombinations
      contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">144538000</afya:AccountsPayableToSellingShareholdersBusinessCombinations>
    <afya:ContingentConsiderationOnBusinessCombinations
      contextRef="From2021-01-012021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">24536000</afya:ContingentConsiderationOnBusinessCombinations>
    <afya:CompensationOfLegalProceedingsDisbursement
      contextRef="From2020-01-012020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">-4503000</afya:CompensationOfLegalProceedingsDisbursement>
    <afya:CompensationOfLegalProceedingsDisbursement
      contextRef="From2019-01-012019-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">-1320000</afya:CompensationOfLegalProceedingsDisbursement>
    <afya:TradeAndOtherPayablesToRelatedParties2 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">679826000</afya:TradeAndOtherPayablesToRelatedParties2>
    <afya:TradeAndOtherPayablesToRelatedParties2 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">518240000</afya:TradeAndOtherPayablesToRelatedParties2>
    <afya:TradeAndOtherPayablesToRelatedParties2 contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">300237000</afya:TradeAndOtherPayablesToRelatedParties2>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2018-01-012018-12-31_custom_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember"
      decimals="INF"
      unitRef="Pure">0.80</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">106200000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2018-05-27_custom_InstitutoDeEnsinoSuperiorDoPiauiSAMember"
      decimals="-3"
      unitRef="BRL">35400000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2019-01-012019-12-31_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="INF"
      unitRef="Pure">0.90</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">39695000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">29770000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2022-04-03_custom_InstitutoEducacionalSantoAgostinhoSAMember"
      decimals="-3"
      unitRef="BRL">29770000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">45303000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties1
      contextRef="AsOf2019-05-09_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="-3"
      unitRef="BRL">9061000</afya:EqualInstallmentsPayablesToRelatedParties1>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2019-01-012019-12-31_custom_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2019-08-13_custom_InstitutoParaensedeEducacaoeCulturaLtdaMember"
      decimals="-3"
      unitRef="BRL">54000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_UniRedentorMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-01-31_custom_UniRedentorMember1110236375"
      decimals="-3"
      unitRef="BRL">100000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2020-01-31_custom_UniRedentorMember1110236375"
      decimals="-3"
      unitRef="BRL">4503000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_UniSLMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-05-05_custom_UniSLMember1110236484"
      decimals="-3"
      unitRef="BRL">60456000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:EqualInstallmentsPayablesToRelatedParties
      contextRef="AsOf2020-05-05_custom_UniSLMember1110236484"
      decimals="-3"
      unitRef="BRL">7816000</afya:EqualInstallmentsPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-11-09_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">188894000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:CashTransferredTransaction contextRef="AsOf2020-11-03" decimals="-3" unitRef="BRL">1569000</afya:CashTransferredTransaction>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2020-01-012020-12-31_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:CashTransferredTransaction contextRef="AsOf2020-11-04" decimals="-3" unitRef="BRL">36000</afya:CashTransferredTransaction>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-03-232021-03-25_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-03-05_custom_UniSLMember"
      decimals="-3"
      unitRef="BRL">4400000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AsOf2021-03-25" decimals="-3" unitRef="BRL">3887000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-04-082021-04-08_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-04-08_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">9000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AsOf2021-04-08" decimals="-3" unitRef="BRL">6801000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-04-162021-04-16_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-04-16_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">3000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AsOf2021-04-16" decimals="-3" unitRef="BRL">3050000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-05-132021-05-13_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="AsOf2021-05-13" decimals="-3" unitRef="BRL">454000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-05-13_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">1793000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:DefinedBenefitObligationAtPresentValue contextRef="AsOf2021-05-13" decimals="-3" unitRef="BRL">2141000</ifrs-full:DefinedBenefitObligationAtPresentValue>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-08-022021-08-04_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:NoncurrentPayablesForPurchaseOfEnergy contextRef="AsOf2021-10-04" decimals="-3" unitRef="BRL">618956000</ifrs-full:NoncurrentPayablesForPurchaseOfEnergy>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-10-012021-10-01_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-10-01_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">21000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="AsOf2022-11-01" decimals="-3" unitRef="BRL">10245000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests
      contextRef="From2021-11-032021-11-05_custom_FCMPBMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:ProportionOfOwnershipInterestsHeldByNoncontrollingInterests>
    <ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations contextRef="AsOf2021-11-05" decimals="-3" unitRef="BRL">54000000</ifrs-full:TransactionPriceAllocatedToRemainingPerformanceObligations>
    <afya:RemainingTradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-11-05_custom_FCMPBMember"
      decimals="-3"
      unitRef="BRL">54000000</afya:RemainingTradeAndOtherPayablesToRelatedParties>
    <afya:NotesPayable1 contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">72726</afya:NotesPayable1>
    <afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--ScheduleOfCarryingAmountOfNotesPayableTableTextBlock_z5DCGf8Y4wg8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B7_zJTQk38nruLk"&gt;Set out below are
the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020&lt;/span&gt;:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 75%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Notes
    payable&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2020&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NotesPayables_iS_c20200101__20201231_zsgyxJTQLrq3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4011"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--BusinessCombination_c20200101__20201231_zEpHfKXIrc2k" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,526&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--Payments_c20200101__20201231_z5s1hgd150E6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,974)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary
    indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--MonetaryIndexation_c20200101__20201231_z5sFIIhY5sZ3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--NotesPayables_iE_c20200101__20201231_zKzhEKGuq7M3" style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;76,181&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;As
    of January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--NotesPayables_iS_c20210101__20211231_zQj34gCMCMgj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payments&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--Payments_c20210101__20211231_zfnn8PvVPfJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,068)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Monetary
    indexation&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--MonetaryIndexation_c20210101__20211231_zm5KCf2MpGn9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Monetary indexation"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,613&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotesPayables_iE_c20210101__20211231_zVJ4rjE8NzCe" style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,726&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20201231_zk3AyucBk55l" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,503&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NoncurrentLiabilities1_iI_c20201231_zsrEYzmSBoid" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;65,678&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--CurrentLiabilities1_iI_c20211231_zqz2X3AcGCrj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Non-current
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NoncurrentLiabilities1_iI_c20211231_zDsDEsuFnyb1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Non-current liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;58,248&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock>
    <afya:BusinessCombination
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">80526000</afya:BusinessCombination>
    <afya:Payments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-5974000</afya:Payments>
    <afya:MonetaryIndexation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1629000</afya:MonetaryIndexation>
    <afya:NotesPayables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">76181000</afya:NotesPayables>
    <afya:NotesPayables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">76181000</afya:NotesPayables>
    <afya:Payments
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-11068000</afya:Payments>
    <afya:MonetaryIndexation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">7613000</afya:MonetaryIndexation>
    <afya:NotesPayables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">72726000</afya:NotesPayables>
    <afya:CurrentLiabilities1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">10503000</afya:CurrentLiabilities1>
    <afya:NoncurrentLiabilities1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">65678000</afya:NoncurrentLiabilities1>
    <afya:CurrentLiabilities1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">14478000</afya:CurrentLiabilities1>
    <afya:NoncurrentLiabilities1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">58248000</afya:NoncurrentLiabilities1>
    <afya:FairValuesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_ecustom--FairValuesExplanatory_zZU9RxJtTm0f" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zZOUXTUSAMNb"&gt;The table below
is a comparison of the carrying amounts and fair values of the Company&#x2019;s financial instruments, other than those carrying amounts
that are reasonable approximation of fair values:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: black 1pt solid; vertical-align: bottom; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 42%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; width: 1%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Carrying
    amount&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    assets&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zlSrl1jMBG5e" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4039"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_ztw50xcwItNi" style="text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4041"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDWBYwMcpDag" style="vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__custom--RestrictedCashMember_zDsTMBLsDEsh" style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zoP3rH7SDWcg" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zMmzoQSdPNfh" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialAssets_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zpDlE02rC7H5" style="border-bottom: Black 1pt solid; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialAssetsAxis__ifrs-full--TradeReceivablesMember_zw00yKc1rcl2" style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231_zn9IsJRzjBp6" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssetsAtFairValue_iI_c20211231_z9vAXN5tQtMg" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;27,442&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20201231_zvDerqFpVeNi" style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%" title="Financial assets, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,680
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialAssetsAtFairValue_iI_c20201231_zzAU7wmjRS7c" style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial assets, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;9,680
    &lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Financial
    liabilities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7eXKxNleE4i" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zmiCnYGnHSse" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,387,136&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zwWZlHXPlce4" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z4cagkzuI0Ze" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;637,723&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zqy3kpIDoFR1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zb4COTQVfhqc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_z0tTACsYIcjc" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__ifrs-full--LeaseLiabilitiesMember_zyu1EH2P2C0l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zAExwPDUDcSa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_za8yg0zGZuNc" style="vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_zANRVRvAK3u1" style="text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersMember_z3KlOM3pM9mh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FinancialLiabilities_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zwHQ6rpBhmC5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrDFkE52IZtk" style="border-bottom: Black 1pt solid; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--FinancialLiabilities_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zKd8zO5jweyk" style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_z5X9mEIKgvqe" style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FinancialLiabilities_iI_c20211231_zqheb4BLrFqj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,841,513&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20211231_zEQQF9NjmRmb" style="border-bottom: Black 1.5pt double; vertical-align: top; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,853,773&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialLiabilities_iI_c20201231_zqT8L7GErqU8" style="border-bottom: Black 1.5pt double; text-align: right; line-height: 115%" title="Financial liabilities, at carrying amount"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,659,609&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--FinancialLiabilitiesAtFairValue_iI_c20201231_zzjde6jmSWKa" style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%" title="Financial liabilities, at fair value"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,679,847&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:FairValuesExplanatory>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2020-12-31_custom_RestrictedCashMember"
      decimals="-3"
      unitRef="BRL">2053000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2020-12-31_custom_RestrictedCashMember"
      decimals="-3"
      unitRef="BRL">2053000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      unitRef="BRL">27442000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2021-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      unitRef="BRL">27442000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2020-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      unitRef="BRL">7627000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue
      contextRef="AsOf2020-12-31_ifrs-full_TradeReceivablesMember"
      decimals="-3"
      unitRef="BRL">7627000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27442000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27442000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialAssets contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">9680000</ifrs-full:FinancialAssets>
    <ifrs-full:FinancialAssetsAtFairValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">9680000</ifrs-full:FinancialAssetsAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">1374876000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">1387136000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">617485000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">637723000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">714085000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">714085000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">447703000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">447703000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">679826000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">679826000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">518240000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2020-12-31_custom_AccountsPayableToSellingShareholdersMember"
      decimals="-3"
      unitRef="BRL">518240000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2021-12-31_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">72726000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2021-12-31_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">72726000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities
      contextRef="AsOf2020-12-31_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">76181000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue
      contextRef="AsOf2020-12-31_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">76181000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2841513000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2853773000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <ifrs-full:FinancialLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1659609000</ifrs-full:FinancialLiabilities>
    <ifrs-full:FinancialLiabilitiesAtFairValue contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1679847000</ifrs-full:FinancialLiabilitiesAtFairValue>
    <afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock_zHe53FQOmRll" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B8_zat4SI5YH5wd" style="display: none; visibility: hidden"&gt;Schedule of sensitivity analysis effects on income statement&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Increase
    / decrease in basis points&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="width: 27%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Balance
    as of December, 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Index
    &#x2013; % per year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 14%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Base
    rate&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;+75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 6%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;-75&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;+150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&#160;-150&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zkMmVcQLnvu6" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;636,847&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;100.38%
    CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialAssetsAxis__custom--CashEquivalents1Member_zA95Ma8zHKxe" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;58,440&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zDelf0lhW9xb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,776&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zfrjmrzbO768" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,776)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zGNW0hylZpS" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,553&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--CashEquivalents1Member__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_z5FqeLfVGyh1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(9,553)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zR5BYkQ6ua3a" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(510,972)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI
    + 1,62%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember_zYrQiVkgZG7" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(55,032)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zCDu5y3QwTva" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,832)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zGvYyCPWFxvi" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;3,832&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zL5sCZpPLF3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(7,665)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingTwoMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zjec1WlNflx1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,665&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zvRceLz9iUhh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(31,199)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI
    + 1,75%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember_zbldYpljfgye" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(3,401)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zHWpH13UYzRc" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(234)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zluvRGbN4XVl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;234&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zn92w0pz9l0e" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(468)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zKfzG8913TJl" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;468&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_z7kfyVoPNm84" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(10,145)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;TJLP&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember_zymYT2fjrLU" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(617)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0QEExR22rg5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(76)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zXlq3A2x2SYa" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;76&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zPtpw6gYoE38" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(152)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--LoansAndFinancingMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zync6RthPxK4" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zNzxR8xNO4n1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(612,121)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;CDI&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember_zW022jV7R6xj" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(56,009)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zibUHYUa7Oel" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,591)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zCZzXSwIz3Jk" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zIE3nL0Sl9J5" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(9,182)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersOneMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_za9oDGDF1xgg" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;9,182&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zLTcAtOYEOS9" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(41,581)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center" title="Index - % per year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPCA
    + 4,1%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember_zyZynExQ2cTh" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,708)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_z0sNJe5lIG5i" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(312)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_zFEj6X8pkN6d" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;312&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zUUwEl6Y6h3b" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(624)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--AccountsPayableToSellingShareholdersSevenMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_zEXLvE4Mw6R1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;624&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--FinancialAssets_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zv9D85Z2GyGf" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Balance as of ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IndexRatePerYear_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zrh6F5yzAhkf" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;IPCA&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--BaseRate_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember_zfF2DneRexki" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Base rate"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(531)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsMember_zatr49n2q818" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(545)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsMember_pn3n3" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;545&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--IncreaseBasisPointsOneMember_zuvc6ZEsPX39" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,091)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--InterestRateRiskMember__ifrs-full--TypesOfInterestRatesAxis__ifrs-full--FloatingInterestRateMember__ifrs-full--ClassesOfFinancialLiabilitiesAxis__custom--NotesPayableMember__ifrs-full--ProbabilityOfDefaultAxis__custom--DecreaseBasisPointsOneMember_ziI61PtYcwC8" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,091&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member"
      decimals="-3"
      unitRef="BRL">636847000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member">100.38%
    CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member"
      decimals="-3"
      unitRef="BRL">58440000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">4776000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-4776000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">9553000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-9553000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember"
      decimals="-3"
      unitRef="BRL">-510972000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember">CDI
    + 1,62%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember"
      decimals="-3"
      unitRef="BRL">-55032000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-3832000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">3832000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-7665000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingTwoMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">7665000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember"
      decimals="-3"
      unitRef="BRL">-31199000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember">CDI
    + 1,75%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember"
      decimals="-3"
      unitRef="BRL">-3401000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-234000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">234000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-468000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingOneMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">468000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">-10145000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember">TJLP</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">-617000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-76000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">76000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-152000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_LoansAndFinancingMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">152000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember"
      decimals="-3"
      unitRef="BRL">-612121000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember">CDI</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember"
      decimals="-3"
      unitRef="BRL">-56009000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-4591000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">4591000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-9182000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersOneMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">9182000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember"
      decimals="-3"
      unitRef="BRL">-41581000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember">IPCA
    + 4,1%</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember"
      decimals="-3"
      unitRef="BRL">-1708000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-312000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">312000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-624000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_AccountsPayableToSellingShareholdersSevenMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">624000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:FinancialAssets
      contextRef="AsOf2021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">-72726000</ifrs-full:FinancialAssets>
    <afya:IndexRatePerYear contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember">IPCA</afya:IndexRatePerYear>
    <afya:BaseRate
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember"
      decimals="-3"
      unitRef="BRL">-531000</afya:BaseRate>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">-545000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsMember"
      decimals="-3"
      unitRef="BRL">545000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_IncreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">-1091000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets
      contextRef="From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_NotesPayableMember_custom_DecreaseBasisPointsOneMember"
      decimals="-3"
      unitRef="BRL">1091000</ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets>
    <ifrs-full:CreditExposure
      contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember"
      decimals="0"
      unitRef="BRL">23228</ifrs-full:CreditExposure>
    <ifrs-full:CreditExposure
      contextRef="AsOf2020-12-31_ifrs-full_CurrencyRiskMember"
      decimals="0"
      unitRef="BRL">70523</ifrs-full:CreditExposure>
    <afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89B_ecustom--SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock_zyr8Zg34xvOb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B5_zbUvoYfOqgxa" style="display: none; visibility: hidden"&gt;Schedule of currencies used in sensitivity analysis&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table demonstrates the sensitivity in the Company&#x2019;s income before income taxes of a &lt;span id="xdx_901_ecustom--SensitivityChangeInTheEuroExchangeRate_pid_dp_uPure_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zpVCAKSniQMh" title="Percentage of sensitivity change in the Euro exchange rate"&gt;10&lt;/span&gt;% change in the U.S. dollar exchange
rate (R$&lt;span id="xdx_900_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember_zoAOQUxCI73i" title="Closing foreign exchange rate"&gt;5.5799&lt;/span&gt; to U.S. dollar &lt;span id="xdx_906_eifrs-full--ClosingForeignExchangeRate_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__srt--CurrencyAxis__currency--EUR_z00xfSouENQ5" title="Closing foreign exchange rate"&gt;1.00&lt;/span&gt;) as of December 31, 2021, with all other variables held constant.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 37%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Exposure&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;+10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 21%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;-10%&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cash
    equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--ForeignCurrencyExposuresMember_ztDJvmNDSlti" style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,228&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--IncreaseForeignCurrencyMember_zK6CpS8zyDUb" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,323&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseInCashAndCashEquivalents_c20210101__20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--CurrencyRiskMember__ifrs-full--RiskExposuresAxis__custom--DecreaseForeignCurrencyMember_zpsVsSJOVS1" style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right" title="Cash and cash equivalents"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,323)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock>
    <afya:SensitivityChangeInTheEuroExchangeRate
      contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      unitRef="Pure">0.10</afya:SensitivityChangeInTheEuroExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember"
      decimals="INF"
      unitRef="N">5.5799</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:ClosingForeignExchangeRate
      contextRef="AsOf2021-12-31_ifrs-full_CurrencyRiskMember_currency_EUR"
      decimals="INF"
      unitRef="N">1.00</ifrs-full:ClosingForeignExchangeRate>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_ForeignCurrencyExposuresMember"
      decimals="-3"
      unitRef="BRL">23228000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_IncreaseForeignCurrencyMember"
      decimals="-3"
      unitRef="BRL">2323000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <ifrs-full:IncreaseDecreaseInCashAndCashEquivalents
      contextRef="From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_DecreaseForeignCurrencyMember"
      decimals="-3"
      unitRef="BRL">-2323000</ifrs-full:IncreaseDecreaseInCashAndCashEquivalents>
    <afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_893_ecustom--SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock_za0yScJSdrej" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B3_zFkJPusodgkc"&gt;The
tables below summarize the maturity profile of the Company&#x2019;s financial liabilities based on contractual undiscounted amounts:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less
    than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1
    to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3
    to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More
    than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zR9ZkQIDins9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z5ESeiYiJu25" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4224"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zOvm3azUSBs6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4226"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zXcsvktPk5lh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zfLFM8oJPa5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,098&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zAxP8BwZb9Bk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;217,903&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCmazm93nvAb" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;585,686&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zIJrnlln4042" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;948,503&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7QoigujE0Fj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,212&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancing_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zeFK3fOUlXu" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,753,304&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zglTCcVoV3j8" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;103,003&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zp5n9N8ODbL4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;211,894&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zFaYTrBHa43b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;204,744&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zFkneZOqHSi2" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,108,555&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zF8LfSWBn2Lj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,628,196&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zSuGOEgdO9Zk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;246,059&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zSOb24gSUJta" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;445,066&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zTnAuGVP3Luc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;88,989&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zghUk6ER8yqk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4258"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zvDpcXG5ur67" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;780,114&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zIPwKdlJlYb1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,644&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z6BOp1GaV2D7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;74,306&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_z1N6g9dOfRv1" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4266"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkTvLYtv4Moj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4268"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NotePayables_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcOoi4gTMJXe" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;89,950&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHdgYToVRh4h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_z4jVhcodwudk" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4274"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zEHsT2votfHh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4276"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zX70wZHR0elg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zJ3EBS582on9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;114,585&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zejCy1whiy7e" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;756,292&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zf3xtPAAbAY4" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,316,952&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_znnUWNIzipzd" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,242,236&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zWZ5Ztlfr7Qh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,109,767&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20211231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zx88NWt85IIe" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,425,247&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom; background-color: white"&gt;
    &lt;td style="white-space: nowrap; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;As
    of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Less
    than 1 year&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1
    to 3 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3
    to 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;More
    than 5 years&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt; color: #222222"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    payables&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHUzNQNtkepj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zmk8tw64dIek" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4294"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zPyPlVsWUS8b" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4296"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zya1DGm6Zaf6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4298"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--TradeAndOtherPayablesToTradeSuppliers_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcu3rSjjuoag" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Trade payables"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,743&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zb5DxVkLnxbh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;125,137&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zXHoZ9KYiKBa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;566,157&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zL5GI9yVFTF7" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,010&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_ztti00xRVKTh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,094&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--LoansAndFinancing_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zZHk0tkigzj5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;698,398&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zHy6r1lGO0a4" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,092&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zCJZr99KjTsh" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;131,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zDk8gHEqyHLf" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;124,114&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_z7bapOfNibzk" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;705,115&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LeaseLiabilities_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zh7LW7LtcVzc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,023,546&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zajemD1YjNn9" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;191,145&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zwey8TOCU595" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;262,340&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zxlxhQ84QTEj" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,153&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zboMg8va7zJa" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4328"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zs5k486his6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;534,638&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zYL7ZAGkP7O2" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,083&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zLILVAJLuqMi" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;83,803&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zZgvcHYr2YP6" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4336"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zvHtRfvXMfde" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4338"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NotePayables_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zcnOG1lmTZe1" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,886&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Advances
    from customers&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_zMvjaRfcnLLa" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zdKLp1ZpCM1h" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4344"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zLR7BgSFl1Xc" style="white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4346"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zkghtfKDDgw5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4348"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Advances_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zQeuxPIJCtHg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Advances from customers"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;63,839&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearMember_z3bZ3kUs2V93" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;490,039&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanOneYearAndNotLaterThanThreeYearsMember_zQFuZyfnwZZc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,043,525&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanThreeYearsAndNotLaterThanFiveYearsMember_zAMKqlZrEICh" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; white-space: nowrap; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;209,277&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember__ifrs-full--MaturityAxis__ifrs-full--LaterThanFiveYearsMember_zz1VRG3s4AV6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;708,209&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FinancialLiabilitiesContractualUndiscounted_iI_c20201231__ifrs-full--TypesOfRisksAxis__ifrs-full--LiquidityRiskMember_zAXiAJL5BLOf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Financial liabilities contractual undiscounted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,451,050&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">59098000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">59098000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">217903000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">585686000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">948503000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">1212000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">1753304000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">103003000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">211894000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">204744000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">1108555000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">1628196000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">246059000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">445066000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">88989000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">780114000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:NotePayables
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">15644000</afya:NotePayables>
    <afya:NotePayables
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">74306000</afya:NotePayables>
    <afya:NotePayables
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">89950000</afya:NotePayables>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">114585000</ifrs-full:Advances>
    <ifrs-full:Advances
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">114585000</ifrs-full:Advances>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">756292000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">1316952000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">1242236000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">1109767000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2021-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">4425247000</afya:FinancialLiabilitiesContractualUndiscounted>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">35743000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <ifrs-full:TradeAndOtherPayablesToTradeSuppliers
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">35743000</ifrs-full:TradeAndOtherPayablesToTradeSuppliers>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">125137000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">566157000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">4010000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">3094000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">698398000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">63092000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">131225000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">124114000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">705115000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">1023546000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">191145000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">262340000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">81153000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">534638000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <afya:NotePayables
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">11083000</afya:NotePayables>
    <afya:NotePayables
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">83803000</afya:NotePayables>
    <afya:NotePayables
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">94886000</afya:NotePayables>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">63839000</ifrs-full:Advances>
    <ifrs-full:Advances
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">63839000</ifrs-full:Advances>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearMember"
      decimals="-3"
      unitRef="BRL">490039000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember"
      decimals="-3"
      unitRef="BRL">1043525000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">209277000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember_ifrs-full_LaterThanFiveYearsMember"
      decimals="-3"
      unitRef="BRL">708209000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:FinancialLiabilitiesContractualUndiscounted
      contextRef="AsOf2020-12-31_ifrs-full_LiquidityRiskMember"
      decimals="-3"
      unitRef="BRL">2451050000</afya:FinancialLiabilitiesContractualUndiscounted>
    <afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory_zQIjwPYbRiLi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8BE_z0ZCC6n1vFYh" style="display: none; visibility: hidden"&gt;Schedule of changes in liabilities arising from financing activities&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;13.5&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Changes
                                            in liabilities arising from financing activities&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 23%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions
    &lt;sup id="xdx_F59_zjmlxRS0kB19"&gt;*&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 6%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zzKV1KrzomN6" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zBhMABRspry2" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(158,076)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z0IWU803TwE8" style="border-top: black 1pt solid; padding-right: -5.5pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;809,539&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zE251ENp5sa8" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;68,909&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zttz7OkvSqMj" style="border-top: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4372"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zsELnO5IGU7c" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;36,591&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z12f4fJYZuU6" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;428&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zcau0ImGxAs" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zpineiBbhIl9" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlOf5eg67ARj" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(87,751)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zjLHdTlougR3" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;158,651&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zD66xhLXBfld" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;67,212&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt; -&lt;/span&gt; &lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zs7pHPy5hh44" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;139,514&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zYLqGr2Ib4I2" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(11,244)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z3T3KLwlRaJi" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zxh7TigBpiyh" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(18,648)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zyZD4UVYcmyl" style="padding-right: 0.6pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;18,648&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20211231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_z3AaPlZtHqO9" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4398"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20210101__20211231_zc79fNAkOCFl" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.55pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zvz4G9Gc8K12" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.05pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(264,475)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_z0WhhH6xXUWf" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.7pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;986,838&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zgOWWOfpIolg" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.35pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;136,121&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zHEs9vEAlam7" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4408"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zE5qX9c3Ohsk" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;176,105&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20210101__20211231_zSdC8sXzBLuc" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -6.25pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(10,816)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20210101__20211231_zMmivOiIrttd" style="border-top: black 1pt solid; border-bottom: black 1pt solid; padding-right: -5.45pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;2,088,961&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_znNgfRvcvrL5" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,357&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z488AWFL9Pc1" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(155,090)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQRS8K72PG9" style="text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;605,041&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zIQGzat4E5Rf" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;10,031&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zxcFFwNfLEd5" style="text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;21,279&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z2yFEffKsgu3" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;75,815&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_z3fQhUiEyV5j" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;52&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zL4vlWbpDMa9" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zsjemhoyBpQ2" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zdWYi7ZLYlA8" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(55,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg9GKhMDeIrj" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;98,904&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJo0bAFtKMv" style="vertical-align: top; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;44,458&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zx4oCQ5QMSuc" style="vertical-align: top; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;76,855&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zAjwku3wyR92" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(1,574)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zEwNsjCJhI8j" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zRPzgaQjMI1c" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(12,984)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zQFazbpww7P9" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;12,984&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20201231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_ziEhcLhcy8Q1" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4450"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20200101__20201231_z9O73Awb2TQi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;344,872&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zXTJtxdYXYt7" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(223,529)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_znMpIvd6m0a6" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;716,929&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zTNEZIwf4iP3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;54,489&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zHoiW39bFVNi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;21,279&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zwQnIS48Otcc" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;152,670&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20200101__20201231_zGoDMH5X1lt8" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(1,522)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20200101__20201231_z2FUiU9hwEpj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,065,188&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 22%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;January
    1, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Payments&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Additions&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 8%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Interest&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Foreign
    exchange movement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 12%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Business
    combinations&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 7%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Other&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;December
    31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Loans and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zvIedUS2OSce" style="text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;77,829&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zAztwm1hTDFe" style="text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(75,093)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zHzQ9tv2pVrf" style="text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;7,383&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zaQRffcT0426" style="text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;6,025&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zX2e90SRtrF2" style="text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;1,126&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zbScPCHhooj5" style="text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;43,087&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zU8NOeGHXQGl" style="text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4480"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--LoansAndFinancingMember_zOdCTOm6NpEj" style="text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;60,357&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zg6AfYkrklbd" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;212,360&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zJFXc4dUb3vh" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(39,779)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zV7vCpqtxln6" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;19,100&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z56k3GTEIkH8" style="vertical-align: top; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;31,469&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zlsE1REWk4sa" style="vertical-align: top; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;61,365&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_z45ORsY1yHKk" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4494"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__ifrs-full--LeaseLiabilitiesMember_zBpJyPU22eAh" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;284,515&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Dividends payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--LiabilitiesArisingFromFinancingActivities_iI_c20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zPxIx3kYyRWk" style="vertical-align: top; text-align: right" title="Liabilities arising from financing activities, beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;4,107&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zXE7a5RQ5nU5" style="vertical-align: top; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(51,812)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zF3LHI3EOmD3" style="vertical-align: top; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;51,812&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231__ifrs-full--LiabilitiesArisingFromFinancingActivitiesAxis__custom--DividendsPayableMember_zuntcQFNIZ6d" style="vertical-align: bottom; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(4,107)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--LiabilitiesArisingFromFinancingActivities_iS_c20190101__20191231_zWjhmNV0jbFl" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;294,296&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities_c20190101__20191231_ze9pHOp2ROnf" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.2pt; padding-left: 5.4pt; text-align: right" title="Payments"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(166,684)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_z7YmPXLx5G6l" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -3.75pt; padding-left: 5.4pt; text-align: right" title="Addition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;78,295&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zoMYYBaUIlnj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.3pt; padding-left: 5.4pt; text-align: right" title="Interest"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;37,494&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zVuSmFJMulSj" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.4pt; padding-left: 5.4pt; text-align: right" title="Foreign exchange movement"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,126&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zXDuM8hDZEo3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5pt; padding-left: 5.4pt; text-align: right" title="Business combination"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;104,452&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities_c20190101__20191231_zy4hVBxUQKYi" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; padding-right: -5.1pt; padding-left: 5.4pt; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;(4,107)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--LiabilitiesArisingFromFinancingActivities_iE_c20190101__20191231_zlBo7XnlR6i3" style="border-top: black 1pt solid; border-bottom: black 1.5pt double; vertical-align: top; padding-right: -5.25pt; padding-left: 5.4pt; text-align: right" title="Liabilities arising from financing activities, ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;344,872&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 0.2in; text-align: right"&gt;&lt;span id="xdx_F08_zC1w9HM6N3oc" style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1C_zmkOARTph9rj" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The additions of loans and financing
include proceeds from the SoftBank transaction of R$&lt;span id="xdx_905_ecustom--ProceedsFromLoansAndFinancing_c20210101__20211231_zPVJqip9Bt1a" title="Proceeds from loans and financing"&gt;822,569&lt;/span&gt;, net of the transaction costs of R$&lt;span id="xdx_90C_ecustom--NetOfTransactionCosts_iI_c20211231_zcVZhLnJfqc3" title="Net of the transaction costs"&gt;13,030&lt;/span&gt;.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968"
      decimals="-3"
      unitRef="BRL">617485000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">-158076000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">809539000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">68909000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">36591000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">428000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_custom_LoansAndFinancingMember1110241046"
      decimals="-3"
      unitRef="BRL">1374876000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078"
      decimals="-3"
      unitRef="BRL">447703000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">-87751000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">158651000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">67212000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">139514000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">-11244000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2021-12-31_ifrs-full_LeaseLiabilitiesMember1110241156"
      decimals="-3"
      unitRef="BRL">714085000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">-18648000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-012021-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">18648000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1065188000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-264475000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">986838000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">136121000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">176105000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-10816000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2088961000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">60357000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">-155090000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">605041000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">10031000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">21279000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">75815000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">52000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_custom_LoansAndFinancingMember1110240968"
      decimals="-3"
      unitRef="BRL">617485000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">284515000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">-55455000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">98904000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">44458000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">76855000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">-1574000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2020-12-31_ifrs-full_LeaseLiabilitiesMember1110241078"
      decimals="-3"
      unitRef="BRL">447703000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">-12984000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">12984000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">344872000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-223529000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">716929000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">54489000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">21279000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">152670000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1522000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">1065188000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2018-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">77829000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">-75093000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">7383000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">6025000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">1126000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">43087000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2019-12-31_custom_LoansAndFinancingMember"
      decimals="-3"
      unitRef="BRL">60357000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2018-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">212360000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">-39779000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">19100000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">31469000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">61365000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2019-12-31_ifrs-full_LeaseLiabilitiesMember"
      decimals="-3"
      unitRef="BRL">284515000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities
      contextRef="AsOf2019-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">4107000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">-51812000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">51812000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31_custom_DividendsPayableMember"
      decimals="-3"
      unitRef="BRL">-4107000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2018-12-31" decimals="-3" unitRef="BRL">294296000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-166684000</ifrs-full:IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">78295000</ifrs-full:IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities>
    <afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">37494000</afya:IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">1126000</ifrs-full:IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">104452000</ifrs-full:IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-4107000</ifrs-full:IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities>
    <ifrs-full:LiabilitiesArisingFromFinancingActivities contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">344872000</ifrs-full:LiabilitiesArisingFromFinancingActivities>
    <afya:ProceedsFromLoansAndFinancing
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">822569000</afya:ProceedsFromLoansAndFinancing>
    <afya:NetOfTransactionCosts contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">13030000</afya:NetOfTransactionCosts>
    <afya:FairValueMeasurementExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_ecustom--FairValueMeasurementExplanatory_zXXHNh7FBgE" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;14&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_823_zgXvLEPyUS55"&gt;Fair
                                            value measurement&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89E_ecustom--ScheduleOfFairValueMeasurementExplanaory_zJdM6EE0ONbe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table provides the fair value measurement hierarchy of the Company&#x2019;s assets and liabilities as of December 31, 2021 and
2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span id="xdx_8B7_zuzV93xmQ3ec" style="display: none; visibility: hidden"&gt;Schedule of fair value measurement&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Quoted
    prices in active markets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Significant
    observable inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Significant
    unobservable inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zhCth7nfvbEa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_znrXf6XTbL7d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zh0cJ9cruixh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrCMoM2zWKQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4533"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancingLiabilities_iI_c20211231_zStnHx8NqgQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,387,136)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZkKgWYT9iX5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,387,136)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_iI_c20211231_zZ7P1fK7rEQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(714,085)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilities1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zPPxReUN5cC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(714,085)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231_zcj97k18b3I1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(679,826)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zWL81pm1CXx4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(679,826)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FairValueNotesPayables1_iI_c20211231_zyHtMiPTzqL" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FairValueNotesPayables1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpuOJXK9a8yi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zIVPAfCRPCU" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zDdyksXKlg0c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4548"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zroCEOrEYjxh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVWLihjpycw4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4550"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    Cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231_zStMHCpteDac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwHOzYpyXmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancingLiabilities_iI_c20201231_zjh4MpveyTqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(637,723)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0Lv31jMWA7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(637,723)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitiesOne_iI_c20201231_zwBQDzdY2NT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(447,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesOne_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z7GRegCInEb5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(447,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231_zZ9n1MKhJrM8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(518,240)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zThldZNf5Lmb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(518,240)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231_zvYjDKuF67L4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,181)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zOQRkNJjWW8j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,181)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A8_z8kJNTy4GSF4" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There
were no transfers between Levels during 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

</afya:FairValueMeasurementExplanatory>
    <afya:ScheduleOfFairValueMeasurementExplanaory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89E_ecustom--ScheduleOfFairValueMeasurementExplanaory_zJdM6EE0ONbe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table provides the fair value measurement hierarchy of the Company&#x2019;s assets and liabilities as of December 31, 2021 and
2020.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span id="xdx_8B7_zuzV93xmQ3ec" style="display: none; visibility: hidden"&gt;Schedule of fair value measurement&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="4" style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
    value measurement&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top; width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 11%; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Quoted
    prices in active markets (Level 1)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Significant
    observable inputs (Level 2)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Significant
    unobservable inputs (Level 3)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--NoncurrentTradeReceivables_iI_c20211231_zhCth7nfvbEa" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_znrXf6XTbL7d" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4531"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zh0cJ9cruixh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,442&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--NoncurrentTradeReceivables_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zrCMoM2zWKQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4533"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--LoansAndFinancingLiabilities_iI_c20211231_zStnHx8NqgQ8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,387,136)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zZkKgWYT9iX5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,387,136)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--LeaseLiabilities1_iI_c20211231_zZ7P1fK7rEQk" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(714,085)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilities1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zPPxReUN5cC8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(714,085)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231_zcj97k18b3I1" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(679,826)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zWL81pm1CXx4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(679,826)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--FairValueNotesPayables1_iI_c20211231_zyHtMiPTzqL" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FairValueNotesPayables1_iI_c20211231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zpuOJXK9a8yi" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(72,726)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="width: 44%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;December
    31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 11%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Assets
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Trade
    receivables (non-current)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--NoncurrentTradeReceivables_iI_c20201231_zIVPAfCRPCU" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Trade receivable (non-current)"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--MeasurementAxis__ifrs-full--NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember_zDdyksXKlg0c" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4548"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zroCEOrEYjxh" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,627&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--NoncurrentTradeReceivables_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level3OfFairValueHierarchyMember_zVWLihjpycw4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4550"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Restricted
    Cash&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231_zStMHCpteDac" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--RestrictedCashAndCashEquivalents1_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zwHOzYpyXmnc" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Restricted Cash"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,053&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Liabilities
    for which fair values are disclosed&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--LoansAndFinancingLiabilities_iI_c20201231_zjh4MpveyTqb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(637,723)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--LoansAndFinancingLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z0Lv31jMWA7f" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Loans and financing"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(637,723)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--LeaseLiabilitiesOne_iI_c20201231_zwBQDzdY2NT5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(447,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--LeaseLiabilitiesOne_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_z7GRegCInEb5" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Lease liabilities"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(447,703)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231_zZ9n1MKhJrM8" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(518,240)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TradeAndOtherPayablesToRelatedPartiesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zThldZNf5Lmb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Accounts payable to selling shareholders"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(518,240)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231_zvYjDKuF67L4" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,181)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--FairValueNotesPayablesLiabilities_iI_c20201231__ifrs-full--LevelsOfFairValueHierarchyAxis__ifrs-full--Level2OfFairValueHierarchyMember_zOQRkNJjWW8j" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Notes payable"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(76,181)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFairValueMeasurementExplanaory>
    <ifrs-full:NoncurrentTradeReceivables contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">27442000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">27442000</ifrs-full:NoncurrentTradeReceivables>
    <afya:LoansAndFinancingLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-1387136000</afya:LoansAndFinancingLiabilities>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-1387136000</afya:LoansAndFinancingLiabilities>
    <afya:LeaseLiabilities1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-714085000</afya:LeaseLiabilities1>
    <afya:LeaseLiabilities1
      contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-714085000</afya:LeaseLiabilities1>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-679826000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-679826000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:FairValueNotesPayables1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-72726000</afya:FairValueNotesPayables1>
    <afya:FairValueNotesPayables1
      contextRef="AsOf2021-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-72726000</afya:FairValueNotesPayables1>
    <ifrs-full:NoncurrentTradeReceivables contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">7627000</ifrs-full:NoncurrentTradeReceivables>
    <ifrs-full:NoncurrentTradeReceivables
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">7627000</ifrs-full:NoncurrentTradeReceivables>
    <afya:RestrictedCashAndCashEquivalents1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2053000</afya:RestrictedCashAndCashEquivalents1>
    <afya:RestrictedCashAndCashEquivalents1
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">2053000</afya:RestrictedCashAndCashEquivalents1>
    <afya:LoansAndFinancingLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-637723000</afya:LoansAndFinancingLiabilities>
    <afya:LoansAndFinancingLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-637723000</afya:LoansAndFinancingLiabilities>
    <afya:LeaseLiabilitiesOne contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-447703000</afya:LeaseLiabilitiesOne>
    <afya:LeaseLiabilitiesOne
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-447703000</afya:LeaseLiabilitiesOne>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-518240000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:TradeAndOtherPayablesToRelatedPartiesLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-518240000</afya:TradeAndOtherPayablesToRelatedPartiesLiabilities>
    <afya:FairValueNotesPayablesLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-76181000</afya:FairValueNotesPayablesLiabilities>
    <afya:FairValueNotesPayablesLiabilities
      contextRef="AsOf2020-12-31_ifrs-full_Level2OfFairValueHierarchyMember"
      decimals="-3"
      unitRef="BRL">-76181000</afya:FairValueNotesPayablesLiabilities>
    <afya:CapitalManagementExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_ecustom--CapitalManagementExplanatory_z3W4qDu8Ldi5" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;15&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_823_zi5FKcER2iB5"&gt;Capital
                                            management&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;For
the purposes of the Company&#x2019;s capital management, capital considers total equity. The primary objective of the Company&#x2019;s
capital management is to maximize the shareholder value.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_890_ecustom--ScheduleOfCapitalManagementExplanatory_zSXw9J05DwR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company manages its capital structure and makes adjustments in light of changes in economic conditions and to maintain and adjust the
capital structure, the Company may adjust the dividend payment to shareholders, repurchase programs, return capital to shareholders or
issue new shares. The Company monitors capital using net debt and total equity. The Company includes within net debt, loans and financing,
lease liabilities, accounts payable to selling shareholders and notes payable less cash and cash equivalents and restricted cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zYbAG1njvf42" style="display: none; visibility: hidden"&gt;Schedule of capital management&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20211231_zcBAwwFSF051" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20201231_zOBjXxSE9zBi" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LoansAndFinancing_iI_zfuNYegJ5Ic4" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--LeaseLiabilities_iI_zu3ceoK2G632" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_zngcvFUNVsji" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NotesAndDebenturesIssued_iI_zN6xagKBEBJ9" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashAndCashEquivalents1_iI_zetZoWqwVcBj" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Less:
    cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(748,562)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,045,042)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iI_zPcj7UmCh6w1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Less:
    restricted cash&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; text-indent: 8.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 8.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,053)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NetDebt_iI_zy7btShsQYOk" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    debt&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,092,951&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;612,514&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EquityOne1_iI_zQORETf8TjQ1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Total
    equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,833,780&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--EquityAndNetDebt1_iI_zPnbRiMXpDF6" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total
    equity and net debt&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,092,969&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,446,294&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A2_zUG8UFzdhGOh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;No
changes were made in the objectives, policies or processes for managing capital during the years ended December 31, 2021 and 2020.&lt;/span&gt;&lt;/p&gt;

</afya:CapitalManagementExplanatory>
    <afya:ScheduleOfCapitalManagementExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_890_ecustom--ScheduleOfCapitalManagementExplanatory_zSXw9J05DwR" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company manages its capital structure and makes adjustments in light of changes in economic conditions and to maintain and adjust the
capital structure, the Company may adjust the dividend payment to shareholders, repurchase programs, return capital to shareholders or
issue new shares. The Company monitors capital using net debt and total equity. The Company includes within net debt, loans and financing,
lease liabilities, accounts payable to selling shareholders and notes payable less cash and cash equivalents and restricted cash.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B4_zYbAG1njvf42" style="display: none; visibility: hidden"&gt;Schedule of capital management&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 64%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20211231_zcBAwwFSF051" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 3%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20201231_zOBjXxSE9zBi" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--LoansAndFinancing_iI_zfuNYegJ5Ic4" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Loans
    and financing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,374,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;617,485&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--LeaseLiabilities_iI_zu3ceoK2G632" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;714,085&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;447,703&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--TradeAndOtherPayablesToRelatedParties_iI_zngcvFUNVsji" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Accounts
    payable to selling shareholders&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;679,826&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;518,240&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--NotesAndDebenturesIssued_iI_zN6xagKBEBJ9" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Notes
    payable&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,726&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,181&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--CashAndCashEquivalents1_iI_zetZoWqwVcBj" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Less:
    cash and cash equivalents&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(748,562)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,045,042)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RestrictedCashAndCashEquivalents_iI_zPcj7UmCh6w1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Less:
    restricted cash&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4591"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; text-indent: 8.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 8.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,053)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--NetDebt_iI_zy7btShsQYOk" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    debt&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,092,951&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;612,514&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--EquityOne1_iI_zQORETf8TjQ1" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Total
    equity&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,000,018&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,833,780&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--EquityAndNetDebt1_iI_zPnbRiMXpDF6" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total
    equity and net debt&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,092,969&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,446,294&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfCapitalManagementExplanatory>
    <afya:LoansAndFinancing contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">1374876000</afya:LoansAndFinancing>
    <afya:LoansAndFinancing contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">617485000</afya:LoansAndFinancing>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">714085000</ifrs-full:LeaseLiabilities>
    <ifrs-full:LeaseLiabilities contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">447703000</ifrs-full:LeaseLiabilities>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">679826000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:TradeAndOtherPayablesToRelatedParties contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">518240000</ifrs-full:TradeAndOtherPayablesToRelatedParties>
    <ifrs-full:NotesAndDebenturesIssued contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">72726000</ifrs-full:NotesAndDebenturesIssued>
    <ifrs-full:NotesAndDebenturesIssued contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">76181000</ifrs-full:NotesAndDebenturesIssued>
    <afya:CashAndCashEquivalents1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">-748562000</afya:CashAndCashEquivalents1>
    <afya:CashAndCashEquivalents1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-1045042000</afya:CashAndCashEquivalents1>
    <ifrs-full:RestrictedCashAndCashEquivalents contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">-2053000</ifrs-full:RestrictedCashAndCashEquivalents>
    <ifrs-full:NetDebt contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">2092951000</ifrs-full:NetDebt>
    <ifrs-full:NetDebt contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">612514000</ifrs-full:NetDebt>
    <afya:EquityOne1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">3000018000</afya:EquityOne1>
    <afya:EquityOne1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">2833780000</afya:EquityOne1>
    <afya:EquityAndNetDebt1 contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">5092969000</afya:EquityAndNetDebt1>
    <afya:EquityAndNetDebt1 contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">3446294000</afya:EquityAndNetDebt1>
    <afya:LaborAndSocialObligationsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_801_ecustom--LaborAndSocialObligationsExplanatory_zKIey5nfNsR3" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;16&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_826_zF2BQqIRskPj"&gt;Labor
                                            and social obligations&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;a)
Variable compensation (bonuses)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
Company recorded bonuses related to variable compensation of employees and management in cost of services and general and administrative
expenses of R$ &lt;span id="xdx_90D_ecustom--ShareBasedCompensationOfEmployees_c20210101__20211231_ztVDnOMGr3uj"&gt;25,587&lt;/span&gt;, R$ &lt;span id="xdx_902_ecustom--ShareBasedCompensationOfEmployees_c20200101__20201231_zJRieRfYAZ84" title="Compensation of employees"&gt;9,514&lt;/span&gt; and R$&lt;span id="xdx_904_ecustom--ShareBasedCompensationOfEmployees_c20190101__20191231_zIjk60grz1sb"&gt;6,871&lt;/span&gt; for the years ended December 31, 2021, 2020 and 2019, respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;b)
Afya Limited share-based compensation plan&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
stock options plan approved on August 30, 2019 as a result of the IPO will govern the issuance of equity incentive awards with respect
to Company&#x2019;s Class A common shares. The fair value of the stock options was estimated at the grant date using the Binomial pricing
model, taking into account the terms and conditions on which the stock options were granted. The Company accounts for the stock options
plan as an equity-settled plan.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On July 29, 2020,
the board of directors approved a change in the strike price of the current share-based compensation plan. The strike price is now measured
in Brazilian Reais (where the Company&#x2019;s operations are located and valuated) adjusted by CDI rate instead of U.S. dollar adjusted
by T-Bond. Furthermore, the first tranche had its vesting period extended from May 2020 to May 2021, including one year lock-up period
after the vesting period. This change was assessed as a modification by the Company and was accounted in accordance with IFRS 2.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As result, the
expense related to the share-based payment of the Company reflects the cost of the original award at grant date over the vesting period
plus the incremental fair value of the repriced options at modification date over the vesting period of the options.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_zmsYqQFDMnee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
following table list the inputs to the model used to determine the incremental fair value of the stock options as result of the modification:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"/&gt;&lt;/p&gt;

&lt;p&gt;&lt;span id="xdx_8B6_zDiFiXiF6J05" style="display: none; visibility: hidden"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified
    plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original
    plan (*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span title="Strike price at the measurement date"&gt;&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zmds9KRJts3c" title="Strike price at the measurement date::XDX::74"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4611"&gt;74.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_908_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zfHQJSCbNWla" title="::XDX::99"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;99.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zikEpRzdvrKd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Dividend yield"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0.0%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zNs2TbZo0EOb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Expected volatility"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcJuRknD5n66" title="Expected volatility, minimum"&gt;41&lt;/span&gt;%
    - &lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziOKPFTlMpd3" title="Expected volatility, maximum"&gt;76&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvC04AGrVMB9" title="Expected volatility, minimum"&gt;42&lt;/span&gt;%
    - &lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQnmBwyw9yX6" title="Expected volatility, maximum"&gt;76&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free
    interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC7J3qP5Spvd" title="Risk-free interest rate, minimum"&gt;2.0&lt;/span&gt;%
    - &lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTUGwEJczfg7" title="Risk-free interest rate, maximum"&gt;4.9&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFL775XlsT8j" title="Risk-free interest rate, minimum"&gt;0.2&lt;/span&gt;%
    - &lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zl98hXWVL7Hc" title="Risk-free interest rate, maximum"&gt;0.4&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhhCcjUornw9" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC8kyN9npfh6" title="Expected life of stock options, maximum"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zArbdkriwVG1" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z48eQDHsKsdb" title="Expected life of stock options, maximum"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zANukntkjuIf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Share price at the measurement date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    133.68&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zmlQJLff5s15" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    133.68&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Model
    used&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zs50DLgOtC9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Model used"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Binomial&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zoBcfJP3oiH3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Binomial&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zSYMFbIIVHMc"&gt;69.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zUPrRZuIRT93"&gt;57.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(*) The strike price
of the original plan was based in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;On
January 25, 2021, March 25, 2021, April 26, 2021, &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;June &lt;span style="font-size: 11pt"&gt;1,
2021 and November 1, 2021, the Company granted &lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210123__20210125_zLQf4GTPqm8b" title="Number of stock option granted"&gt;545,000&lt;/span&gt;, &lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210323__20210325_zuov2pSLaSJi"&gt;65,000&lt;/span&gt;, &lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210423__20210426_zoibUUmIYKBc"&gt;139,000&lt;/span&gt;, &lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210601__20210601_zRy0sLCQ3Z7b"&gt;180,000&lt;/span&gt; and &lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20211101__20211101_zp0HRvV9K5b3"&gt;241,000&lt;/span&gt; additional stock options, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;January
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;March
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;April
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;June
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;November
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_906_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210131_zN7MXTnWC9F" title="Strike price at the measurement date"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210331_zEZTVjWGQ4Si"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210430_zPe5CQsqH05c"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_903_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210630_zRivVyK90W8k"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20211130_zbvB8BLLBTU1"&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210101__20210131_zWAzgjRRYcT9" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210301__20210331_z2PoNYhk6y9c"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210401__20210430_zz3M8yK9X9Ek"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210601__20210630_z3EbZIaazc2i"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20211101__20211130_zOAgHRoLQ2Hi"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z2v7QnO2LVkd" title="Expected volatility, minimum"&gt;38&lt;/span&gt;%
    - &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEjBssXknPW6" title="Expected volatility, maximum"&gt;67&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1aMda4defl"&gt;42&lt;/span&gt;%
    - &lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKok13N0cTGe"&gt;65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4oldicjdHc"&gt;43&lt;/span&gt;%
    - &lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaf1Ku0j3Qx6"&gt;51&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYsbrfcpGnM3"&gt;43&lt;/span&gt;%
    - &lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zrEZ4neSZ3n5"&gt;63&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfMc4ilJUDU3"&gt;41&lt;/span&gt;% - &lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdpffPNRg0t7"&gt;65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free
    interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBlfN2599uj7" title="Risk-free interest rate, minimum"&gt;2.1&lt;/span&gt;%
    - &lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8a77JTiuyS8" title="Risk-free interest rate, maximum"&gt;7.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zAs2oRLyqTzg"&gt;5.2&lt;/span&gt;%
    - &lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLFcmzX3077d"&gt;8.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0O7jeGgONM3"&gt;5.1&lt;/span&gt;%
    - &lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2yZdPFq8ca9"&gt;8.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCffft5OLCSk"&gt;5.8&lt;/span&gt;%
    - &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8mipFFMqcf3"&gt;8.3&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zimeTnJOFLJ"&gt;10.4&lt;/span&gt;% -
    &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBWLgC10hwvk"&gt;12.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFx69OPM0vu5" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLc6QZbKjYmf" title="Expected life of stock options, maximum"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBWzBTxaLaB4"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zopl7TeHH4M4"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4JIsUdPUPIc"&gt;1&lt;/span&gt;
    &#x2013;&lt;span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQkbbAhNu99e"&gt; 5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4Z7WDYfbKnd"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXHsQ2vDMGJf"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zW5mYe6tYEil"&gt;1&lt;/span&gt; &#x2013;
    &lt;span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUcgeGO4owxj"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_908_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210131_zxisUK9o0gXj" title="Share price at the measurement date"&gt;129&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20210331_zNq7Y6QIPvZ1"&gt;108&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_900_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210430_zMcqRXffU9R9"&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_901_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210630_zRZayV1UUICl"&gt;121&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$ &lt;span id="xdx_905_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20211130_zNZzpLNQNjD6"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Model
    used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zVytSGbj2Jjd" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zkzwsvDcv6U3"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210401__20210430_zptc5uKQjDZ7"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210601__20210630_z7U9a5jvqC32"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20211101__20211130_zAUpEU1PNjF"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_905_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210131_zxiTJ8nhYXW8" title="Weighted average fair value at the measurement date"&gt;46.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20210331_zQOhrOZJWIUf"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210430_z6JY6YEPMur3"&gt;46.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90D_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210630_zYym4YcSD9qa"&gt;49.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20211130_zAEPF5yE6vfb"&gt;46.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;p id="xdx_8A2_zffesYa88Rfi" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89B_ecustom--ScheduleOfSharebasedCompensationPlan_zBxBX5mxpL8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table illustrates the number and movements in stock options during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zxUQPB34wi9i" style="display: none; visibility: hidden"&gt;Schedule of share-based compensation plan&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Weighted
    average exercise price (in Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Number
    of stock options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: #365F91 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt; width: 40%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Outstanding
    at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pii_c20210101__20211231_zwfeeWrUeHi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 32%" title="Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.22&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20210101__20211231_zcdB9ZmaJIZ1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2,510,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20200101__20201231_zR0b3iIYygG2" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right; width: 17%" title="Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2,364,214&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zrbY5z13g8rc" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;109.18&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210101__20211231_zjoev2zBy0yf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;1,170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20200101__20201231_zQSDLBtuRH15" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;477,220&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zqqEjz1OEfof" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;112.89&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20210101__20211231_zFqplPVq3xId" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(60,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20200101__20201231_zH1ov44eBSug" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(274,359)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_z7icwi64Avzk" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.15&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20210101__20211231_zIhfOtvyGrW2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20200101__20201231_z4r0CjzHreuf" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(56,092)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zUGk3urD049i" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.21&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_c20210101__20211231_z9Rj84xZWVoc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(91,586)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_d0_c20200101__20201231_zgDBbEeDI1Al" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Outstanding
    at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pii_c20210101__20211231_zS7kMhBO5ZM8" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;92.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_c20210101__20211231_zTQJ00NQ5Yo5" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;3,086,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_c20200101__20201231_zwKPzjW3T5j3" style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2,510,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A7_zvQNsaGmBeJ" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
share-based compensation expense, including the incremental fair value as result of the modification in 2020, recognized in general and
administrative expenses in the statement of income for the year ended December 31, 2021 was R$ &lt;span id="xdx_90B_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20210101__20211231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_z0D9dtiP0Qi1"&gt;43,377&lt;/span&gt; (December 31, 2020: R$ &lt;span id="xdx_905_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20200101__20201231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zNTtE5UQwLVd" title="Share-based compensation expense"&gt;32,610&lt;/span&gt; and
December 31, 2019: R$ &lt;span id="xdx_906_eifrs-full--ExpenseFromSharebasedPaymentTransactionsWithEmployees_c20190101__20191231__ifrs-full--DefinedBenefitPlansAxis__custom--ShareBasedCompensationPlansMember_zwCf5a7wgTxf"&gt;18,114&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 5pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Stock
options exercised during the year ended December 31, 2021 have been settled using the treasury shares of the Company. The reduction in
the treasury share equity component is equal to the cost incurred to acquire the shares, on a weighted average basis. Any difference
of the cash received from employees upon exercise of the options in relation to treasury shares weighted average cost is recorded in
paid-in-capital.&lt;/span&gt;&lt;/p&gt;

</afya:LaborAndSocialObligationsExplanatory>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">25587</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">9514</afya:ShareBasedCompensationOfEmployees>
    <afya:ShareBasedCompensationOfEmployees
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">6871</afya:ShareBasedCompensationOfEmployees>
    <afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_ecustom--ScheduleOfModelUsedToDetermineFairValueOfStockOptions_zmsYqQFDMnee" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
following table list the inputs to the model used to determine the incremental fair value of the stock options as result of the modification:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"/&gt;&lt;/p&gt;

&lt;p&gt;&lt;span id="xdx_8B6_zDiFiXiF6J05" style="display: none; visibility: hidden"&gt;Schedule of model used to determine the fair value of the stock options&lt;/span&gt;&lt;/p&gt;



&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"/&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 58%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Modified
    plan&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Original
    plan (*)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span title="Strike price at the measurement date"&gt;&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zmds9KRJts3c" title="Strike price at the measurement date::XDX::74"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4611"&gt;74.38&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_908_ecustom--StrikePriceeAtMeasurementDateShareOptionsGranted_iI_dxL_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zfHQJSCbNWla" title="::XDX::99"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4612"&gt;99.09&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zikEpRzdvrKd" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Dividend yield"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0.0%&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pid_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zNs2TbZo0EOb" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Expected volatility"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zcJuRknD5n66" title="Expected volatility, minimum"&gt;41&lt;/span&gt;%
    - &lt;span id="xdx_907_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_ziOKPFTlMpd3" title="Expected volatility, maximum"&gt;76&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zvC04AGrVMB9" title="Expected volatility, minimum"&gt;42&lt;/span&gt;%
    - &lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQnmBwyw9yX6" title="Expected volatility, maximum"&gt;76&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free
    interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zC7J3qP5Spvd" title="Risk-free interest rate, minimum"&gt;2.0&lt;/span&gt;%
    - &lt;span id="xdx_904_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zTUGwEJczfg7" title="Risk-free interest rate, maximum"&gt;4.9&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFL775XlsT8j" title="Risk-free interest rate, minimum"&gt;0.2&lt;/span&gt;%
    - &lt;span id="xdx_90C_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zl98hXWVL7Hc" title="Risk-free interest rate, maximum"&gt;0.4&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90C_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zhhCcjUornw9" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zC8kyN9npfh6" title="Expected life of stock options, maximum"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zArbdkriwVG1" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z48eQDHsKsdb" title="Expected life of stock options, maximum"&gt;4&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zANukntkjuIf" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Share price at the measurement date"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    133.68&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zmlQJLff5s15" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    133.68&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Model
    used&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zs50DLgOtC9l" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt" title="Model used"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Binomial&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zoBcfJP3oiH3" style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Binomial&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember_zSYMFbIIVHMc"&gt;69.54&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20211231__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--OriginalPlanMember_zUPrRZuIRT93"&gt;57.12&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(*) The strike price
of the original plan was based in U.S. dollars.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;On
January 25, 2021, March 25, 2021, April 26, 2021, &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;June &lt;span style="font-size: 11pt"&gt;1,
2021 and November 1, 2021, the Company granted &lt;span id="xdx_900_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210123__20210125_zLQf4GTPqm8b" title="Number of stock option granted"&gt;545,000&lt;/span&gt;, &lt;span id="xdx_90D_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210323__20210325_zuov2pSLaSJi"&gt;65,000&lt;/span&gt;, &lt;span id="xdx_907_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210423__20210426_zoibUUmIYKBc"&gt;139,000&lt;/span&gt;, &lt;span id="xdx_904_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210601__20210601_zRy0sLCQ3Z7b"&gt;180,000&lt;/span&gt; and &lt;span id="xdx_90E_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20211101__20211101_zp0HRvV9K5b3"&gt;241,000&lt;/span&gt; additional stock options, respectively:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 33%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;January
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;March
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;April
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;June
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; width: 15%; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;November
    2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Strike
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_906_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210131_zN7MXTnWC9F" title="Strike price at the measurement date"&gt;115&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90C_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210331_zEZTVjWGQ4Si"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90E_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210430_zPe5CQsqH05c"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_903_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20210630_zRivVyK90W8k"&gt;105&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_90F_ecustom--StrikePriceeAtMeasurementDateShareOptionsGrante_iI_c20211130_zbvB8BLLBTU1"&gt;85&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Dividend
    yield (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_904_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210101__20210131_zWAzgjRRYcT9" title="Dividend yield"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210301__20210331_z2PoNYhk6y9c"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210401__20210430_zz3M8yK9X9Ek"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20210601__20210630_z3EbZIaazc2i"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--ExpectedDividendAsPercentageShareOptionsGranted_pii_dp_uPure_c20211101__20211130_zOAgHRoLQ2Hi"&gt;0.0&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    volatility (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z2v7QnO2LVkd" title="Expected volatility, minimum"&gt;38&lt;/span&gt;%
    - &lt;span id="xdx_903_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zEjBssXknPW6" title="Expected volatility, maximum"&gt;67&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--TypesOfSharebasedPaymentArrangementsAxis__custom--ModifiedPlanMember__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zo1aMda4defl"&gt;42&lt;/span&gt;%
    - &lt;span id="xdx_900_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zKok13N0cTGe"&gt;65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4oldicjdHc"&gt;43&lt;/span&gt;%
    - &lt;span id="xdx_909_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zaf1Ku0j3Qx6"&gt;51&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zYsbrfcpGnM3"&gt;43&lt;/span&gt;%
    - &lt;span id="xdx_90E_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zrEZ4neSZ3n5"&gt;63&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_908_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zfMc4ilJUDU3"&gt;41&lt;/span&gt;% - &lt;span id="xdx_90F_eifrs-full--DescriptionOfExpectedVolatilityShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zdpffPNRg0t7"&gt;65&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Risk-free
    interest rate (%)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBlfN2599uj7" title="Risk-free interest rate, minimum"&gt;2.1&lt;/span&gt;%
    - &lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8a77JTiuyS8" title="Risk-free interest rate, maximum"&gt;7.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zAs2oRLyqTzg"&gt;5.2&lt;/span&gt;%
    - &lt;span id="xdx_90E_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLFcmzX3077d"&gt;8.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z0O7jeGgONM3"&gt;5.1&lt;/span&gt;%
    - &lt;span id="xdx_900_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z2yZdPFq8ca9"&gt;8.1&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zCffft5OLCSk"&gt;5.8&lt;/span&gt;%
    - &lt;span id="xdx_901_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_z8mipFFMqcf3"&gt;8.3&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zimeTnJOFLJ"&gt;10.4&lt;/span&gt;% -
    &lt;span id="xdx_907_eifrs-full--DescriptionOfRiskFreeInterestRateShareOptionsGranted_pid_dp_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zBWLgC10hwvk"&gt;12.5&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Expected
    life of stock options (years)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90B_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zFx69OPM0vu5" title="Expected life of stock options, minimum"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210101__20210131__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zLc6QZbKjYmf" title="Expected life of stock options, maximum"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90F_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zBWzBTxaLaB4"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_901_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210301__20210331__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zopl7TeHH4M4"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90E_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4JIsUdPUPIc"&gt;1&lt;/span&gt;
    &#x2013;&lt;span id="xdx_909_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210401__20210430__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zQkbbAhNu99e"&gt; 5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90D_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_z4Z7WDYfbKnd"&gt;1&lt;/span&gt;
    &#x2013; &lt;span id="xdx_904_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20210601__20210630__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zXHsQ2vDMGJf"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--BottomOfRangeMember_zW5mYe6tYEil"&gt;1&lt;/span&gt; &#x2013;
    &lt;span id="xdx_907_eifrs-full--DescriptionOfOptionLifeShareOptionsGranted_c20211101__20211130__ifrs-full--RangeAxis__ifrs-full--TopOfRangeMember_zUcgeGO4owxj"&gt;5&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share
    price at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_908_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210131_zxisUK9o0gXj" title="Share price at the measurement date"&gt;129&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90B_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pid_c20210331_zNq7Y6QIPvZ1"&gt;108&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_900_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210430_zMcqRXffU9R9"&gt;119&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_901_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20210630_zRZayV1UUICl"&gt;121&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$ &lt;span id="xdx_905_ecustom--SharePriceFairValueAtMeasurementDateShareOptionsGranted_iI_pii_c20211130_zNZzpLNQNjD6"&gt;8&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Model
    used&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zVytSGbj2Jjd" title="Model used"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210101__20210131_zkzwsvDcv6U3"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_905_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210401__20210430_zptc5uKQjDZ7"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_902_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20210601__20210630_z7U9a5jvqC32"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_906_eifrs-full--DescriptionOfOptionPricingModelShareOptionsGranted_c20211101__20211130_zAUpEU1PNjF"&gt;Binomial&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average fair value at the measurement date&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_905_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210131_zxiTJ8nhYXW8" title="Weighted average fair value at the measurement date"&gt;46.81&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90E_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pid_c20210331_zQOhrOZJWIUf"&gt;40.20&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_907_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210430_z6JY6YEPMur3"&gt;46.04&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$
    &lt;span id="xdx_90D_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20210630_zYym4YcSD9qa"&gt;49.10&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 10pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;R$&lt;span id="xdx_904_ecustom--WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne_iI_pii_c20211130_zAEPF5yE6vfb"&gt;46.28&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
</afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.41</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.76</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.42</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.76</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.020</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.049</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.002</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.004</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">4000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">4000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-12-31_custom_ModifiedPlanMember"
      decimals="INF"
      unitRef="BRLPShares">133.68</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-12-31_custom_OriginalPlanMember"
      decimals="INF"
      unitRef="BRLPShares">133.68</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-01-012021-12-31_custom_ModifiedPlanMember">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-01-012021-12-31_custom_OriginalPlanMember">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-12-31_custom_ModifiedPlanMember"
      decimals="INF"
      unitRef="BRLPShares">69.54</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-12-31_custom_OriginalPlanMember"
      decimals="INF"
      unitRef="BRLPShares">57.12</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-01-232021-01-25"
      decimals="INF"
      unitRef="N">545000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-03-232021-03-25"
      decimals="INF"
      unitRef="N">65000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-04-232021-04-26"
      decimals="INF"
      unitRef="N">139000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-06-012021-06-01"
      decimals="INF"
      unitRef="N">180000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-11-012021-11-01"
      decimals="INF"
      unitRef="N">241000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante contextRef="AsOf2021-01-31" decimals="-3" unitRef="BRL">115000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante contextRef="AsOf2021-03-31" decimals="-3" unitRef="BRL">105000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante contextRef="AsOf2021-04-30" decimals="-3" unitRef="BRL">105000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante contextRef="AsOf2021-06-30" decimals="-3" unitRef="BRL">105000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <afya:StrikePriceeAtMeasurementDateShareOptionsGrante contextRef="AsOf2021-11-30" decimals="-3" unitRef="BRL">85000</afya:StrikePriceeAtMeasurementDateShareOptionsGrante>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-01-012021-01-31"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-03-012021-03-31"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-04-012021-04-30"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-06-012021-06-30"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted
      contextRef="From2021-11-012021-11-30"
      decimals="INF"
      unitRef="Pure">0.000</ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.38</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.67</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-03-012021-03-31_custom_ModifiedPlanMember_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.42</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.65</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.43</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.51</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.43</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.63</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.41</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.65</ifrs-full:DescriptionOfExpectedVolatilityShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.021</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.071</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.052</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.085</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.051</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.081</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.058</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.083</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.104</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember"
      decimals="INF"
      unitRef="Pure">0.125</ifrs-full:DescriptionOfRiskFreeInterestRateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-01-012021-01-31_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-03-012021-03-31_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-03-012021-03-31_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-04-012021-04-30_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-06-012021-06-30_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_BottomOfRangeMember"
      decimals="-3"
      unitRef="N">1000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionLifeShareOptionsGranted
      contextRef="From2021-11-012021-11-30_ifrs-full_TopOfRangeMember"
      decimals="-3"
      unitRef="N">5000</ifrs-full:DescriptionOfOptionLifeShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-01-31"
      decimals="INF"
      unitRef="BRLPShares">129</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-03-31"
      decimals="INF"
      unitRef="BRLPShares">108</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-04-30"
      decimals="INF"
      unitRef="BRLPShares">119</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="BRLPShares">121</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted
      contextRef="AsOf2021-11-30"
      decimals="INF"
      unitRef="BRLPShares">8</afya:SharePriceFairValueAtMeasurementDateShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-01-012021-01-31">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-01-012021-01-31">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-04-012021-04-30">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-06-012021-06-30">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted contextRef="From2021-11-012021-11-30">Binomial</ifrs-full:DescriptionOfOptionPricingModelShareOptionsGranted>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-01-31"
      decimals="INF"
      unitRef="BRLPShares">46.81</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-03-31"
      decimals="INF"
      unitRef="BRLPShares">40.20</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-04-30"
      decimals="INF"
      unitRef="BRLPShares">46.04</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-06-30"
      decimals="INF"
      unitRef="BRLPShares">49.10</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne
      contextRef="AsOf2021-11-30"
      decimals="INF"
      unitRef="BRLPShares">46.28</afya:WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne>
    <afya:ScheduleOfSharebasedCompensationPlan contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89B_ecustom--ScheduleOfSharebasedCompensationPlan_zBxBX5mxpL8b" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table illustrates the number and movements in stock options during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;span id="xdx_8BB_zxUQPB34wi9i" style="display: none; visibility: hidden"&gt;Schedule of share-based compensation plan&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td rowspan="2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Weighted
    average exercise price (in Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Number
    of stock options&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: #365F91 1pt solid; white-space: nowrap; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt; width: 40%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Outstanding
    at January 1&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iS_pii_c20210101__20211231_zwfeeWrUeHi1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 32%" title="Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.22&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20210101__20211231_zcdB9ZmaJIZ1" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right; width: 11%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2,510,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfOutstandingShareOptions_iS_c20200101__20201231_zR0b3iIYygG2" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right; width: 17%" title="Outstanding at the beginning"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;2,364,214&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Granted&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zrbY5z13g8rc" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;109.18&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20210101__20211231_zjoev2zBy0yf" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Granted"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;1,170,000&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--NumberOfShareOptionsGrantedInSharebasedPaymentArrangement_c20200101__20201231_zQSDLBtuRH15" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;477,220&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zqqEjz1OEfof" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;112.89&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20210101__20211231_zFqplPVq3xId" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(60,000)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement_c20200101__20201231_zH1ov44eBSug" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Forfeited"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(274,359)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Exercised&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019_pii_c20210101__20211231_z7icwi64Avzk" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.15&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20210101__20211231_zIhfOtvyGrW2" style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--NumberOfShareOptionsExercisedInSharebasedPaymentArrangement_c20200101__20201231_z4r0CjzHreuf" style="white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Exercised"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(56,092)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Expired&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019_pii_c20210101__20211231_zUGk3urD049i" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;78.21&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_c20210101__20211231_z9Rj84xZWVoc" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;(91,586)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--NumberOfShareOptionsExpiredInSharebasedPaymentArrangement_d0_c20200101__20201231_zgDBbEeDI1Al" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Expired"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;Outstanding
    at December 31&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019_iE_pii_c20210101__20211231_zS7kMhBO5ZM8" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;92.33&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--NumberOfOutstandingShareOptions_iE_c20210101__20211231_zTQJ00NQ5Yo5" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;3,086,728&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--NumberOfOutstandingShareOptions_iE_c20200101__20201231_zwKPzjW3T5j3" style="border-bottom: Black 1.5pt double; white-space: nowrap; vertical-align: top; padding-left: 0.1in; font-size: 10pt; text-align: right" title="Outstanding at the ending"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;2,510,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfSharebasedCompensationPlan>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2020-12-31"
      decimals="INF"
      unitRef="BRLPShares">78.22</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31" decimals="-3" unitRef="N">2510983000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2019-12-31" decimals="-3" unitRef="N">2364214000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">109.18</ifrs-full:WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="N">1170000000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="N">477220000</ifrs-full:NumberOfShareOptionsGrantedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">112.89</ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="N">-60000000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="N">-274359000</ifrs-full:NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">78.15</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="N">-442669000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="N">-56092000</ifrs-full:NumberOfShareOptionsExercisedInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">78.21</ifrs-full:WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="N">-91586000</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="N">-0</ifrs-full:NumberOfShareOptionsExpiredInSharebasedPaymentArrangement>
    <ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">92.33</ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2021-12-31" decimals="-3" unitRef="N">3086728000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:NumberOfOutstandingShareOptions contextRef="AsOf2020-12-31" decimals="-3" unitRef="N">2510983000</ifrs-full:NumberOfOutstandingShareOptions>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2021-01-012021-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="0"
      unitRef="BRL">43377</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2020-01-012020-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="0"
      unitRef="BRL">32610</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees
      contextRef="From2019-01-012019-12-31_custom_ShareBasedCompensationPlansMember"
      decimals="0"
      unitRef="BRL">18114</ifrs-full:ExpenseFromSharebasedPaymentTransactionsWithEmployees>
    <ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_802_eifrs-full--DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory_zCUef4ng2Kgc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;17&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span&gt;&lt;span id="xdx_823_zJS4iocWnIDe"&gt;Equity&lt;/span&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;a)
Share capital&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As
of December 31, 2021, the Company&#x2019;s share capital was R$ &lt;span id="xdx_90D_eifrs-full--IssuedCapital_iI_dxL_c20211231_zkFl3hylg87a" title="Share capital::XDX::17000"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4763"&gt;17&lt;/span&gt;&lt;/span&gt; (R$ &lt;span id="xdx_908_ecustom--IssuedCapital2_iI_c20201231_z88OvZ8VC8v3" title="Share capital"&gt;17&lt;/span&gt; as of December 31, 2020) represented by &lt;span id="xdx_905_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20211231_zX0Fx6VyDrCf" title="Total number of shares"&gt;93,722,831&lt;/span&gt; shares comprised
by &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zvn5jmKTCivg" title="Total number of shares"&gt;47,920,068&lt;/span&gt; class A common shares and &lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zs72sWLDWoH8" title="Total number of shares"&gt;45,802,763&lt;/span&gt; class B common shares (&lt;span style="background-color: white"&gt;&lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231_zT9fwQzOQEtg" title="Total number of shares"&gt;93,146,731&lt;/span&gt; &lt;/span&gt;shares
comprised by &lt;span style="background-color: white"&gt;&lt;span id="xdx_90A_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_z05ixiCtVNs6"&gt;45,112,416&lt;/span&gt; class A common shares and &lt;span id="xdx_901_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_z50JrCbgbiOc"&gt;48,034,315&lt;/span&gt; class B common shares&lt;/span&gt; as of
December 31, 2020).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;b)
Afya Brazil&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: bold 7pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white; text-indent: 40pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Prior
to the completion of Afya&#x2019;s IPO in July 2019, Afya Brazil was the predecessor of Afya. As such, the consolidated financial statements
reflect the operating results of Afya Brazil prior to the reorganization. As of December 31, 2018, Afya Brazil&#x2019;s share capital
was R$ &lt;span id="xdx_901_eifrs-full--IssuedCapital_iI_c20191231_zJYQI89axeM7"&gt;315,000&lt;/span&gt; represented by &lt;span id="xdx_900_eifrs-full--IssuedCapital_iI_c20181231_zZLmFUFKoIn6"&gt;1,443,541&lt;/span&gt; shares, comprised of &lt;span id="xdx_90C_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_z932MQo9lHii" title="Total number of shares"&gt;1,411,895&lt;/span&gt; common shares, &lt;span id="xdx_90B_eifrs-full--NumberOfSharesIssued_iI_pid_uShares_c20181231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zM5D7yrJisof"&gt;26,523&lt;/span&gt; Class A preferred shares and &lt;span id="xdx_90B_ecustom--NumberOfSharesIssued1_iI_pid_uShares_c20201231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember_zB0PoDztupTl"&gt;5,123&lt;/span&gt; Class
B preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Common
shares were the only class of shares with voting rights.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Class
A preferred shares had the following characteristics: &lt;span id="xdx_90F_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_z7dSbZ9VTPi4" title="Description of ratio of convertible shares"&gt;(i) do not grant voting rights at the shareholders meetings; (ii) the right to
receive an amount, as dividend, per share equal to 17.7 times the amount received per common share; and (iii) were convertible into common
shares at the ratio of 1 preferred share for 17.7 common shares in the situations described in the Shareholders Agreemen&lt;/span&gt;t.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_90D_ecustom--DescriptionOfRatioOfConvertibleShares_c20210101__20211231__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zLM9Y0GpEMFe" title="Description of ratio of convertible shares"&gt;Class
B preferred shares had no voting rights and had priority in capital reimbursement in case of liquidation of the Company, with no premium.
Class B preferred shares were convertible into common shares at the ratio of 1 Class B preferred share f1or 1 common share, in certain
situations.&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
April 26, 2018, the shareholders approved a capital increases of (i) R$&lt;span id="xdx_906_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20180424__20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zrotvYPmY3oa" title="Proceeds from issue of ordinary shares"&gt;55,000&lt;/span&gt; through the issuance of &lt;span id="xdx_906_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zMEPyv3MIj1i" title="Total number of shares"&gt;124,994&lt;/span&gt; common shares; and (ii)
R$ &lt;span id="xdx_901_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180423__20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zYkVqvEC1bz5" title="Proceeds from issue of preference shares"&gt;11,670&lt;/span&gt; through the issuance of &lt;span id="xdx_908_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180426__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAPreferenceSharesMember_zv2o9Y2DtU9j" title="Total number of shares"&gt;26,523&lt;/span&gt; Class A preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
August 31, 2018, the Board of Directors approved a capital increase of R$&lt;span id="xdx_902_eifrs-full--ProceedsFromIssueOfPreferenceShares_c20180825__20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zRX0kPJto14b"&gt;1,304&lt;/span&gt; through the issuance of &lt;span id="xdx_90D_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20180826__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBPreferenceSharesMember_zE3qjOUl7Px8"&gt;5,123&lt;/span&gt; Class B preferred shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
December 4, 2018, the shareholders approved a capital increase of R$&lt;span id="xdx_90E_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20181202__20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zIgEZVeI2Wj3" title="Proceeds from issue of ordinary shares"&gt;99,999&lt;/span&gt; through the issuance of &lt;span id="xdx_909_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20181204__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember_zYJluITyO1nf" title="Total number of shares"&gt;137,298&lt;/span&gt; common shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
December 31, 2018, the shareholders approved a capital increase of R$ &lt;span id="xdx_902_ecustom--CapitalIncreaseWithEarningsReserves_iI_c20181231_zALWCjrvlF1c" title="Capital increase with earnings reserves"&gt;80,541&lt;/span&gt; with earnings reserves and retained earnings without an
issuance of new shares.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
March 8, 2019, the shareholders of Afya Brazil approved a renounce of dividends for the year ended December 31, 2016 of R$&lt;span id="xdx_906_eifrs-full--DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears_c20190306__20190308_zROQVh5V9oZ" title="Renounce of dividends for prior years"&gt;4,107&lt;/span&gt;; and
an increase of capital through the issuance of &lt;span id="xdx_90E_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190408__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zmHPUry4wrdl" title="Number of shares in entity held by entity or by its subsidiaries or associates | shares"&gt;37,200&lt;/span&gt; common shares, in the amount of R$ &lt;span id="xdx_904_eifrs-full--ParValuePerShare_iI_c20190308__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zbjgOufP8C2" title="Par value per share"&gt;0.01&lt;/span&gt;, subscribed entirely by the shareholders
BR Health and certain members of the Esteves Family.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
March 12, 2019, the shareholders of Afya Brazil approved amongst other matters: (i) the change in its legal name to Afya Participa&#xe7;&#xf5;es
S.A.; (ii) a capital increase through the issuance of &lt;span id="xdx_901_eifrs-full--SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zb3goYMjzMjg" title="Number of shares in entity held by entity or by its subsidiaries or associates shares"&gt;156,337&lt;/span&gt; common shares, in the amount of R$ &lt;span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190310__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--BRHealthMember_zDuhNQLedbYh" title="Proceeds from issue of ordinary shares"&gt;150,000&lt;/span&gt;, subscribed entirely by BR Health;
and (iii) the propose to repurchase &lt;span id="xdx_904_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zFrC6ascDGZ" title="Repurchase of ordinary shares"&gt;160,000&lt;/span&gt; common shares issued by the Company, at the acquisition price of R$ &lt;span id="xdx_908_ecustom--AcquisitionPrice_iI_pid_c20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zjwVGIkFndg3" title="Acquisition price"&gt;206.25&lt;/span&gt; per share, in
the total amount of R$&lt;span id="xdx_902_ecustom--AcquisitionsHeldByShareholders_c20190311__20190312__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zeSTJRsAePd" title="Acquisitions held by shareholders"&gt;33,001&lt;/span&gt;, all held by the shareholder Nicolau Carvalho Esteves. The Company's common shares object of the repurchase
approved were immediately canceled by the Company, without reduction of its share capital.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
March 29, 2019, Afya Brazil issued 378,696 common shares to the shareholders of BR Health and Guardaya, and had a capital increase of
R$ 122,062 and an additional paid-in capital of R$ 137,051.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In
June 2019, Afya Brazil&#x2019;s shareholders approved an increase of capital through the issuance of 157,202&lt;/span&gt; common shares in
exchange of the acquisitions of FASA, IESP and Univa&#xe7;o minority interests, in the total amount of R$ 24,310&lt;span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
June 18, 2019, the shareholders of Afya Brazil approved an increase of capital through the issuance of 27,211 common shares in exchange
of the acquisition of an addition 15% interest at UEPC, in the total amount of R$ 24,458, subscribed entirely by the shareholder Bozano
Educacional II Fundo de Investimento em Participa&#xe7;&#xf5;es Multiestrat&#xe9;gia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;In
addition to the capital increase related to the acquisition of the non-controlling interests of FASA, IESP and Univa&#xe7;o and the
interest in UEPC, the Company had an additional paid-in capital of R$ &lt;span id="xdx_908_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20190615__20190618__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--UniaoEducacionalDoPlanaltoCentralSAUEPCMember_zrqr9NoSaq68" title="Proceeds from issue of ordinary shares"&gt;36,358&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;c)
Additional paid in capital&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At
the year ended December 31, 2021, Afya had capital increases regarding business combinations purchase price paid in shares totaling R$&lt;span id="xdx_901_ecustom--ProceedsFromIssueOfOrdinarySharesOne_pid_c20210101__20211231_z7wg6v7PwYY7" title="Purchase prices paid shares"&gt;74,500&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Afya
also had additional paid in capital regarding capital reserves on transferring treasury shares from the exercise of stock options and
contribution of Afya Brazil shares paid to RX PRO selling shareholders, totaling R$&lt;span id="xdx_90A_ecustom--AdditionalPaidinCapital1_iI_c20211231_z66XWCT1dKPb" title="Additional paid-in capital"&gt;21,861&lt;/span&gt; and R$&lt;span id="xdx_90C_ecustom--AdditionalPaidinCapital2_iI_c20211231_zsEJ1nhL7vga"&gt;783&lt;/span&gt; respectively.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;d)
Dividends&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 8, 2019,
the shareholders of Afya Brazil approved the cancellation of dividends for the year ended December 31, 2016 of R$&lt;span id="xdx_900_ecustom--CancellationOfDividend_c20190306__20190308_z0eYqwjQp8Of" title="Cancellation of dividend"&gt;4,107&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;On
June 13, 2019, Afya Brazil approved the payment of interim dividends totaling R$ &lt;span id="xdx_905_eifrs-full--DividendPayables_iI_c20190613_zUXljSimK2Ib" title="Dividend payables"&gt;38,000&lt;/span&gt; to Afya Brazil shareholders of record on June
13, 2019. The dividend amount was determined based on the Afya Brazil&#x2019;s net income for the five months ended May 31, 2019 and were
paid on September 26, 2019. Afya and its public shareholders were not entitled to receive such dividends.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;At
the year ended December 31, 2021, CCSI and IESVAP approved the payment of interim dividends of R$ &lt;span id="xdx_906_ecustom--InterimDividends_c20210101__20211231_zEuFBrFxT2Y7" title="Dividend paid"&gt;65,521&lt;/span&gt;, which R$&lt;span id="xdx_90E_ecustom--DividendsPaidClassifiedAsFinancingActivities1_c20210101__20211231_zNftfI9huwQ4" title="Dividends paid classified"&gt;46,873&lt;/span&gt; was distributed
to Afya Brazil and R$ &lt;span id="xdx_90F_eifrs-full--DividendsPaidToNoncontrollingInterests_c20210101__20211231_zc3TGUMrlo79" title="Dividends paid to non-controlling interests"&gt;18,648&lt;/span&gt; to non-controlling shareholders.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;e)
Buy-back program&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On
December 23, 2020, the Company announced that its Board of Directors has approved a share buy-back program. Under the share buyback program,
Afya may repurchase up to &lt;span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20201223__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zR6599ml2Jnf" title="Repurchase of ordinary shares"&gt;1,015,844&lt;/span&gt; of its outstanding Class A common shares in the open market, based on prevailing market prices, or
in privately negotiated transactions, over a period beginning on December 24, 2020 continuing until the earlier of the completion of
the repurchase or December 31, 2021, depending upon market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On October 27,
2021, the Company&#x2019;s board of directors approved a new share repurchase program. Afya may repurchase up to &lt;span id="xdx_900_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211027__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zS451Ld9A0J6"&gt;1,383,108&lt;/span&gt; of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on October
28, 2021 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
share buy-back program takes place in accordance with the conditions established by the Board of Directors. Afya intends to repurchase
the shares to execute the Stock Option Program for the executives of the Company. This program was concluded on October 21, 2021.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;During
2021, the Company repurchased &lt;span id="xdx_905_ecustom--RepurchaseOfOrdinaryShares_iI_pii_uShares_c20211231_zPdPx82wfbp3"&gt;2,142,051&lt;/span&gt; shares at the weighted average price of R$ &lt;span id="xdx_907_eifrs-full--ParValuePerShare_iI_pii_c20211231_zwFXDTVZCKo5" title="Par value per share"&gt;99.76&lt;/span&gt; (in Brazilian Reais) or US$ &lt;span id="xdx_900_ecustom--IssuedCapital1_iI_c20211231_zRoMAvq2dqv4" title="Share capital"&gt;18.00&lt;/span&gt;, amounting
to R$ &lt;span id="xdx_900_ecustom--ProceedsFromIssueOfOrdinaryShares1_c20210101__20211231_zy3bagK4YOb2" title="Proceeds from issue of shares"&gt;213,722&lt;/span&gt;. During year ended December 31, 2021, &lt;span id="xdx_902_eifrs-full--NumberOfSharesIssued_iI_pii_uShares_c20211231_zsoMUuhfkgWe" title="Total number of shares"&gt;442,669&lt;/span&gt; of these shares were used by the Company any to settle the share-based program,
totaling R$&lt;span id="xdx_907_eifrs-full--ProceedsFromIssueOfOrdinaryShares_c20210101__20211231_ztRxLozywXqf" title="Proceeds from issue of ordinary shares"&gt;55,197&lt;/span&gt;.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--ScheduleOfTreasurySharesMovement_zFt2BV2K0pJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table illustrates the number and &lt;span id="xdx_8BD_zPN5GJUExpFk"&gt;movements in treasury&lt;/span&gt; shares during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 52%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Number
    of shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; width: 31%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Average
    price (in Brazilian Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Outstanding
    at January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding beginning period"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,142,051&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;99.76&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transferred
    from exercise of options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from exercise of options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;124.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transferred
    from shares contribution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(44,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;111.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Outstanding
    at December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding ending period"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,654,927&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;92.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8B7_z1aX04b5fbje" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
</ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory>
    <afya:IssuedCapital2 contextRef="AsOf2020-12-31" decimals="0" unitRef="BRL">17</afya:IssuedCapital2>
    <afya:NumberOfSharesIssued1 contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">93722831</afya:NumberOfSharesIssued1>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2021-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">47920068</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2021-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">45802763</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued contextRef="AsOf2020-12-31" decimals="INF" unitRef="Shares">93146731</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2020-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">45112416</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2020-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">48034315</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:IssuedCapital contextRef="AsOf2019-12-31" decimals="0" unitRef="BRL">315000</ifrs-full:IssuedCapital>
    <ifrs-full:IssuedCapital contextRef="AsOf2018-12-31" decimals="0" unitRef="BRL">1443541</ifrs-full:IssuedCapital>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-12-31_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">1411895</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-12-31_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">26523</ifrs-full:NumberOfSharesIssued>
    <afya:NumberOfSharesIssued1
      contextRef="AsOf2020-12-31_custom_ClassBOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">5123</afya:NumberOfSharesIssued1>
    <afya:DescriptionOfRatioOfConvertibleShares contextRef="From2021-01-012021-12-31_custom_ClassAPreferenceSharesMember">(i) do not grant voting rights at the shareholders meetings; (ii) the right to
receive an amount, as dividend, per share equal to 17.7 times the amount received per common share; and (iii) were convertible into common
shares at the ratio of 1 preferred share for 17.7 common shares in the situations described in the Shareholders Agreemen</afya:DescriptionOfRatioOfConvertibleShares>
    <afya:DescriptionOfRatioOfConvertibleShares contextRef="From2021-01-012021-12-31_custom_ClassBPreferenceSharesMember">Class
B preferred shares had no voting rights and had priority in capital reimbursement in case of liquidation of the Company, with no premium.
Class B preferred shares were convertible into common shares at the ratio of 1 Class B preferred share f1or 1 common share, in certain
situations.</afya:DescriptionOfRatioOfConvertibleShares>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2018-04-242018-04-26_ifrs-full_OrdinarySharesMember"
      decimals="0"
      unitRef="BRL">55000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-04-26_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">124994</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfPreferenceShares
      contextRef="From2018-04-232018-04-26_custom_ClassAPreferenceSharesMember"
      decimals="0"
      unitRef="BRL">11670</ifrs-full:ProceedsFromIssueOfPreferenceShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-04-26_custom_ClassAPreferenceSharesMember"
      decimals="INF"
      unitRef="Shares">26523</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfPreferenceShares
      contextRef="From2018-08-252018-08-26_custom_ClassBPreferenceSharesMember"
      decimals="0"
      unitRef="BRL">1304</ifrs-full:ProceedsFromIssueOfPreferenceShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-08-26_custom_ClassBPreferenceSharesMember"
      decimals="INF"
      unitRef="Shares">5123</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2018-12-022018-12-04_ifrs-full_OrdinarySharesMember"
      decimals="0"
      unitRef="BRL">99999</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <ifrs-full:NumberOfSharesIssued
      contextRef="AsOf2018-12-04_ifrs-full_OrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">137298</ifrs-full:NumberOfSharesIssued>
    <afya:CapitalIncreaseWithEarningsReserves contextRef="AsOf2018-12-31" decimals="0" unitRef="BRL">80541</afya:CapitalIncreaseWithEarningsReserves>
    <ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears
      contextRef="From2019-03-062019-03-08"
      decimals="0"
      unitRef="BRL">4107</ifrs-full:DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="AsOf2019-04-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember"
      decimals="INF"
      unitRef="Shares">37200</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2019-03-08_ifrs-full_OrdinarySharesMember_custom_BRHealthMember"
      decimals="INF"
      unitRef="BRLPShares">0.01</ifrs-full:ParValuePerShare>
    <ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates
      contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember"
      decimals="INF"
      unitRef="Shares">156337</ifrs-full:SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2019-03-102019-03-12_ifrs-full_OrdinarySharesMember_custom_BRHealthMember"
      decimals="0"
      unitRef="BRL">150000</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember"
      decimals="INF"
      unitRef="Shares">160000</afya:RepurchaseOfOrdinaryShares>
    <afya:AcquisitionPrice
      contextRef="AsOf2019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember"
      decimals="INF"
      unitRef="BRLPShares">206.25</afya:AcquisitionPrice>
    <afya:AcquisitionsHeldByShareholders
      contextRef="From2019-03-112019-03-12_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember"
      decimals="0"
      unitRef="BRL">33001</afya:AcquisitionsHeldByShareholders>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2019-06-152019-06-18_custom_UniaoEducacionalDoPlanaltoCentralSAUEPCMember"
      decimals="0"
      unitRef="BRL">36358</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <afya:ProceedsFromIssueOfOrdinarySharesOne
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">74500</afya:ProceedsFromIssueOfOrdinarySharesOne>
    <afya:AdditionalPaidinCapital1 contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">21861</afya:AdditionalPaidinCapital1>
    <afya:AdditionalPaidinCapital2 contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">783</afya:AdditionalPaidinCapital2>
    <afya:CancellationOfDividend
      contextRef="From2019-03-062019-03-08"
      decimals="0"
      unitRef="BRL">4107</afya:CancellationOfDividend>
    <ifrs-full:DividendPayables contextRef="AsOf2019-06-13" decimals="0" unitRef="BRL">38000</ifrs-full:DividendPayables>
    <afya:InterimDividends
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">65521</afya:InterimDividends>
    <afya:DividendsPaidClassifiedAsFinancingActivities1
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">46873</afya:DividendsPaidClassifiedAsFinancingActivities1>
    <ifrs-full:DividendsPaidToNoncontrollingInterests
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">18648</ifrs-full:DividendsPaidToNoncontrollingInterests>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2020-12-23_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">1015844</afya:RepurchaseOfOrdinaryShares>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2021-10-27_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">1383108</afya:RepurchaseOfOrdinaryShares>
    <afya:RepurchaseOfOrdinaryShares contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">2142051</afya:RepurchaseOfOrdinaryShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">99.76</ifrs-full:ParValuePerShare>
    <afya:IssuedCapital1 contextRef="AsOf2021-12-31" decimals="0" unitRef="BRL">18.00</afya:IssuedCapital1>
    <afya:ProceedsFromIssueOfOrdinaryShares1
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">213722</afya:ProceedsFromIssueOfOrdinaryShares1>
    <ifrs-full:NumberOfSharesIssued contextRef="AsOf2021-12-31" decimals="INF" unitRef="Shares">442669</ifrs-full:NumberOfSharesIssued>
    <ifrs-full:ProceedsFromIssueOfOrdinaryShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">55197</ifrs-full:ProceedsFromIssueOfOrdinaryShares>
    <afya:ScheduleOfTreasurySharesMovement contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_ecustom--ScheduleOfTreasurySharesMovement_zFt2BV2K0pJc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table illustrates the number and &lt;span id="xdx_8BD_zPN5GJUExpFk"&gt;movements in treasury&lt;/span&gt; shares during the period:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 52%; padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; width: 17%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Number
    of shares&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; width: 31%; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Average
    price (in Brazilian Reais)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Outstanding
    at January 1, 2021&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding beginning period"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Repurchased&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Repurchased"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;2,142,051&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;99.76&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transferred
    from exercise of options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from exercise of options"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(442,669)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Average price"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;124.08&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;Transferred
    from shares contribution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Transferred from shares contribution"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;(44,455)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;111.94&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 9.35pt; padding-left: 9.35pt; font-size: 10pt; text-indent: -9.35pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;Outstanding
    at December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right" title="Share outstanding ending period"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;1,654,927&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 2.9pt; padding-left: 2.9pt; font-size: 10pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"&gt;&lt;b&gt;92.23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;

&lt;p id="xdx_8B7_z1aX04b5fbje" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
</afya:ScheduleOfTreasurySharesMovement>
    <ifrs-full:DisclosureOfEarningsPerShareExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80F_eifrs-full--DisclosureOfEarningsPerShareExplanatory_zz7jiRkRTZxk" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;18&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_827_zAYWhsxScowg"&gt;Earnings
                                            per share (EPS)&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Basic
EPS is calculated by dividing net income attributable to the equity holders of the Company by the weighted average number of common shares
outstanding during the period.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Diluted
EPS is calculated by dividing net income attributable to the equity holders of the parent by the weighted average number of common shares
outstanding during the period plus the weighted average number of shares that would be issued on conversion of all potential shares with
dilutive effects.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Diluted
earnings per share are computed including stock options granted to key management using the treasury shares method when the effect is
dilutive. The Company has the stock option plan in the category of potentially dilutive shares.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_895_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zvO9wQw5hjxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table reflects the net income and share data used in the basic and diluted EPS calculations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span id="xdx_8BB_z1H4Ge2ZKZ7b" style="display: none; visibility: hidden"&gt;Schedule of earnings per share&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zW0x86suTJM1" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_z6FXBIQMmft8" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20190101__20191231_z2eGmxKqSGx7" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_zxMCjhVeAKI1" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net income attributable
    to equity holders of the parent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;223,326&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;292,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--WeightedAverageShares_pid_uShares_ze6o6kIW9NPd" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average number of outstanding shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,291,480&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;92,683,848&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;75,969,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pii_uShares_zmm94uY87Rqj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effects of dilution from
    stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;811,818&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;951,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;221,846&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--AdjustedWeightedAverageShares_pii_uShares_z8Ay99zJtfmh" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average number of outstanding shares adjusted for the effect of dilution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,103,298&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,635,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,191,643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_pii_uBRLPShares_zqVfvYX9qn35" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Basic
    earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3.15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2.03
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pii_uBRLPShares_zbVlDHHNVrHk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Diluted
    earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2.02
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A1_zeZCTZtLrAL2" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEarningsPerShareExplanatory>
    <afya:DisclosureOfEarningsPerShareTableExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_895_ecustom--DisclosureOfEarningsPerShareTableExplanatory_zvO9wQw5hjxe" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
following table reflects the net income and share data used in the basic and diluted EPS calculations:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span id="xdx_8BB_z1H4Ge2ZKZ7b" style="display: none; visibility: hidden"&gt;Schedule of earnings per share&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="width: 52%; padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zW0x86suTJM1" style="border-bottom: Black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 0.5in; text-align: right; text-indent: 1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20200101__20201231_z6FXBIQMmft8" style="border-bottom: Black 1pt solid; width: 16%; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_491_20190101__20191231_z2eGmxKqSGx7" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Numerator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eifrs-full--AdjustmentToProfitLossForPreferenceShareDividends_zxMCjhVeAKI1" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Net income attributable
    to equity holders of the parent&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;223,326&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;292,075&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;153,916&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Denominator&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--WeightedAverageShares_pid_uShares_ze6o6kIW9NPd" style="vertical-align: top; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 8.6pt; text-align: justify; text-indent: -8.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average number of outstanding shares&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,291,480&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;92,683,848&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;75,969,797&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares_pii_uShares_zmm94uY87Rqj" style="vertical-align: top; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effects of dilution from
    stock options&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;811,818&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;951,920&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;221,846&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--AdjustedWeightedAverageShares_pii_uShares_z8Ay99zJtfmh" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 7.1pt; text-align: justify; line-height: 115%; text-indent: -7.1pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Weighted
    average number of outstanding shares adjusted for the effect of dilution&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;94,103,298&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,635,768&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;76,191,643&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BasicEarningsLossPerShare_pii_uBRLPShares_zqVfvYX9qn35" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Basic
    earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.39&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3.15&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2.03
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--DilutedEarningsLossPerShare_pii_uBRLPShares_zbVlDHHNVrHk" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Diluted
    earnings per share (R$)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2.37&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3.12&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;2.02
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:DisclosureOfEarningsPerShareTableExplanatory>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">223326000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">292075000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">153916000</ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends>
    <ifrs-full:WeightedAverageShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">93291480</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">92683848</ifrs-full:WeightedAverageShares>
    <ifrs-full:WeightedAverageShares
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">75969797</ifrs-full:WeightedAverageShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">811818</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">951920</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">221846</ifrs-full:DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Shares">94103298</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Shares">93635768</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:AdjustedWeightedAverageShares
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Shares">76191643</ifrs-full:AdjustedWeightedAverageShares>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.39</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="BRLPShares">3.15</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:BasicEarningsLossPerShare
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.03</ifrs-full:BasicEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.37</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="BRLPShares">3.12</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DilutedEarningsLossPerShare
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="BRLPShares">2.02</ifrs-full:DilutedEarningsLossPerShare>
    <ifrs-full:DisclosureOfRevenueExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_809_eifrs-full--DisclosureOfRevenueExplanatory_zBTUQ9f7bSjh" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;19&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_822_z9pi8rv5BWQb"&gt;Revenue&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_89F_ecustom--ScheduleOfNetSalesRevenueExplanatory_zmHOcoHYmbL8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B5_z2IXdQRslSPf" style="display: none; visibility: hidden"&gt;Schedule of net sales revenue&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231_zyvynLrOqoZ7" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_497_20200101__20201231_zdZ3g4Wum2V" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20190101__20191231_z5QGMDk6PTC" style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_zUkFa4r72yr6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees &lt;sup id="xdx_F45_zcBDb6lUWZX3"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,124,589&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,388,735&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;856,561&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OtherRevenue1_zJUnPlsRenj1" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;167,441&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;99,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,116&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeductionAbstract_iB_zEc5q1UxzoJ6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeductionOfGrantedDiscounts_zQ9WBcE1O59k" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Granted
    discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(229,254)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(89,017)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,767)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeductionOfEarlyPaymentDiscounts_zzoLznGIKNTb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Early
    payment discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,879)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,299)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,523)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeductionOfReturnsOfNetRevenue_z86z3WFCYgId" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Returns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(42,373)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,437)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,462)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeductionOfTaxes_zQ2t0uiFjn67" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(74,232)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,629)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,157)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeductionOfProuni_zjrn8zhC0K08" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;PROUNI&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(176,921)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(107,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(61,138)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--RevenueFromContractsWithCustomers_zAJrnzH8RHul" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zGuoiYiKyJKg" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing
    of revenue recognition of net revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FeeAndCommissionIncome_zSsyFi1ZWG8c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition,
    digital content and app subscription fees - Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,128,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;713,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NetRevenueOtherTransferredPoint_zeFcdIT5s78" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    - Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_zYduzUneiSzc" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_zbUolZ3FsJd9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A8_z9EK9h3Mslm8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The
Company`s revenue from contracts with customers are all in Brazil. The Company is not subject to the payment of the social integration
program tax (Programa de Integra&#xe7;&#xe3;o Social, or PIS) and the social contribution on revenues tax (Contribui&#xe7;&#xe3;o
para o Financiamento da Seguridade Social, or COFINS) on the revenue from under graduation degrees under the PROUNI program.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
following table presents statements of income for the Company&#x2019;s operating segments for the years ended December 31, 2021, 2020
and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89D_ecustom--ScheduleOfRevenueBySegment_zU6FqluihLW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B0_zVmMS04dsLNi"&gt;Schedule of revenue by segment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue
    by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types
    of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKGt24N5mZxf" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGaco47k2cVh" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQERCis6ZFF3" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z6MgPp8SqUbk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_z3gA79fqz9R4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z3lOv2MtZ18i" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdpbYGmGCzih" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXxcd5Sfcwvc" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4945"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z9P8a00yWMda" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProfessionalFeesExpense1_pn3n3_c20210101__20211231_zNMeeh1GxBM4" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,559,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXNi8C4Hkuqg" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDVGRRCqtxkf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;151,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z7N2eKcdk0G3" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_z8XcJ394f622" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;160,277&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z98wkf2mrIif" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zBV2rjetsya1" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zaNuHUrjHX56" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_znxz0CTNR5a8" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zk25RXXHv6Vh" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred
    over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zwcQttcSSTBc" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzEIlJGihbz8" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgI9x2Q2wrz8" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,795&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zT1tfP3pJT41" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred
    at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqwTvNOGotC4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxxlErX2jNQf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMoD9DADFXhg" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,163&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zBT7KScVc2I1" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_zBh34sN79DXa" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by
    segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zlm1oRwiewva" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLMNFS1srROb" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zHLC1uFcizP7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--SegmentOfBusinessOneUnitMember_zo128EkT9JZb" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;997,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0EcPHU3jc2g" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231_zqh9I2xfCNee" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,104,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXeEqWgiG0kb" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIs5R1prWR0h" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,152&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherRevenue_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231_zlQhvD1JH3Za" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;96,939&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zx06Pcjlzle2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zs0U5zD1WAk6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDp8jCOlamph" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231_z2kNWpQBvzt1" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLjVGEt3ZzY7" style="vertical-align: bottom; padding-right: 2.55pt; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;997,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvDdTtl2Oq8c" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfvak12265m6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231_zCdmUie0L504" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,128,558&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in
    time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zuNtbBthRV94" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJrsOeAWUhYd" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,846&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231_zEbTNHEcj9nf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by
    segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zd3fDHCdXNd4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zqVKN9jh84w2" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2KsslMQdyig" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zIq5DHUeOcn8" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231_zx9FQZa4jyLb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zO1X1lpTz9Da" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;648,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj3l7PlhqXN7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ProfessionalFeesExpense1_pn3n3_c20190101__20191231_zigXcitC4lIf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;709,152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ3vUcYNlc1h" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,803&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4M8QEFMhXj2" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,675&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zq1nk4cLDEr6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zXqmRjUEwSqi" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231_zbCA4pSUZzse" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;41,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPSQqGx2ZTh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJ4632C6EWxi" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMrlEGBiTpei" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zSgumwJU0Rbi" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231_z6QVlZREvbLi" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLOWEJKaZqBi" style="vertical-align: bottom; padding-right: -2.4pt; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;648,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWMDmSFiNtV3" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,870&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231_zLI4e8HkYsv7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;713,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in
    time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQa9pWMQebLh" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,803&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIJ01XzrNAfj" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zNNTXj7dMPEf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231_zYeedTPsTeCb" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8A4_zXHAwK07PHuc" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfRevenueExplanatory>
    <afya:ScheduleOfNetSalesRevenueExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89F_ecustom--ScheduleOfNetSalesRevenueExplanatory_zmHOcoHYmbL8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B5_z2IXdQRslSPf" style="display: none; visibility: hidden"&gt;Schedule of net sales revenue&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20210101__20211231_zyvynLrOqoZ7" style="width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_497_20200101__20201231_zdZ3g4Wum2V" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_498_20190101__20191231_z5QGMDk6PTC" style="border-bottom: Black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--ProfessionalFeesExpense_zUkFa4r72yr6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees &lt;sup id="xdx_F45_zcBDb6lUWZX3"&gt;(*)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,124,589&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,388,735&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;856,561&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_ecustom--OtherRevenue1_zJUnPlsRenj1" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;167,441&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;99,817&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;43,116&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeductionAbstract_iB_zEc5q1UxzoJ6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Deductions&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_ecustom--DeductionOfGrantedDiscounts_zQ9WBcE1O59k" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Granted
    discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(229,254)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(89,017)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,767)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--DeductionOfEarlyPaymentDiscounts_zzoLznGIKNTb" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Early
    payment discounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,879)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(29,299)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,523)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--DeductionOfReturnsOfNetRevenue_z86z3WFCYgId" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Returns&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(42,373)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,437)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,462)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--DeductionOfTaxes_zQ2t0uiFjn67" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;Taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(74,232)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(49,629)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(28,157)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--DeductionOfProuni_zjrn8zhC0K08" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&#160;&#160;PROUNI&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(176,921)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(107,979)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(61,138)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_eifrs-full--RevenueFromContractsWithCustomers_zAJrnzH8RHul" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Net
    revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers_zGuoiYiKyJKg" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing
    of revenue recognition of net revenue from contracts with customers&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eifrs-full--FeeAndCommissionIncome_zSsyFi1ZWG8c" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition,
    digital content and app subscription fees - Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,128,558&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;713,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--NetRevenueOtherTransferredPoint_zeFcdIT5s78" style="background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 30.25pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other
    - Transferred at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,633&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F04_zYduzUneiSzc" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;(*)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F13_zbUolZ3FsJd9" style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfNetSalesRevenueExplanatory>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      id="Fact004884"
      unitRef="BRL">2124589000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      id="Fact004885"
      unitRef="BRL">1388735000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      id="Fact004886"
      unitRef="BRL">856561000</ifrs-full:ProfessionalFeesExpense>
    <afya:OtherRevenue1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">167441000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">99817000</afya:OtherRevenue1>
    <afya:OtherRevenue1
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">43116000</afya:OtherRevenue1>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-229254000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-89017000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfGrantedDiscounts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-43767000</afya:DeductionOfGrantedDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-49879000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-29299000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfEarlyPaymentDiscounts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-8523000</afya:DeductionOfEarlyPaymentDiscounts>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-42373000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-11437000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfReturnsOfNetRevenue
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-7462000</afya:DeductionOfReturnsOfNetRevenue>
    <afya:DeductionOfTaxes
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-74232000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-49629000</afya:DeductionOfTaxes>
    <afya:DeductionOfTaxes
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-28157000</afya:DeductionOfTaxes>
    <afya:DeductionOfProuni
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-176921000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-107979000</afya:DeductionOfProuni>
    <afya:DeductionOfProuni
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-61138000</afya:DeductionOfProuni>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1719371000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1201191000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:RevenueFromContractsWithCustomers
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">750630000</ifrs-full:RevenueFromContractsWithCustomers>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1640889000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1128558000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">713827000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">78482000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">72633000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">36803000</afya:NetRevenueOtherTransferredPoint>
    <afya:ScheduleOfRevenueBySegment contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89D_ecustom--ScheduleOfRevenueBySegment_zU6FqluihLW8" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B0_zVmMS04dsLNi"&gt;Schedule of revenue by segment&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue
    by segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types
    of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zKGt24N5mZxf" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zGaco47k2cVh" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zQERCis6ZFF3" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z6MgPp8SqUbk" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20210101__20211231_z3gA79fqz9R4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z3lOv2MtZ18i" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zdpbYGmGCzih" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zXxcd5Sfcwvc" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4945"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--ProfessionalFeesExpense_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z9P8a00yWMda" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4946"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_ecustom--ProfessionalFeesExpense1_pn3n3_c20210101__20211231_zNMeeh1GxBM4" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,559,094&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXNi8C4Hkuqg" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDVGRRCqtxkf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;151,958&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_z7N2eKcdk0G3" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20210101__20211231_z8XcJ394f622" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;160,277&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_z98wkf2mrIif" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,498,408&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zBV2rjetsya1" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;72,983&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zaNuHUrjHX56" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;151,958&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_znxz0CTNR5a8" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,978)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--TimingRevenueRecognition_pn3n3_c20210101__20211231_zk25RXXHv6Vh" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,719,371&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred
    over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zwcQttcSSTBc" style="vertical-align: bottom; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,486,111&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zzEIlJGihbz8" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,983&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zgI9x2Q2wrz8" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;81,795&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--FeeAndCommissionIncome_pn3n3_c20210101__20211231_zT1tfP3pJT41" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,640,889&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred
    at a point in time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqwTvNOGotC4" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;12,297&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zxxlErX2jNQf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl4968"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMoD9DADFXhg" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;70,163&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zBT7KScVc2I1" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,978)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20210101__20211231_zBh34sN79DXa" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;78,482&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by
    segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zlm1oRwiewva" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zLMNFS1srROb" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zHLC1uFcizP7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--PaymentsToSuppliersForGoodsAndServices_c20200101__20201231_pn3n3" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--SegmentOfBusinessOneUnitMember_zo128EkT9JZb" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;997,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z0EcPHU3jc2g" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--ProfessionalFeesExpense1_pn3n3_c20200101__20201231_zqh9I2xfCNee" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,104,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zXeEqWgiG0kb" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIs5R1prWR0h" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;93,152&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherRevenue_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20200101__20201231_zlQhvD1JH3Za" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;96,939&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zx06Pcjlzle2" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,002,461&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zs0U5zD1WAk6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;107,197&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zDp8jCOlamph" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;93,152&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--TimingRevenueRecognition_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,619)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_ecustom--TimingRevenueRecognition_pn3n3_c20200101__20201231_z2kNWpQBvzt1" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,201,191&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLjVGEt3ZzY7" style="vertical-align: bottom; padding-right: 2.55pt; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;997,055&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zvDdTtl2Oq8c" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;107,197&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zfvak12265m6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,306&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--FeeAndCommissionIncome_pn3n3_c20200101__20201231_zCdmUie0L504" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,128,558&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in
    time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--UndergradMember_zuNtbBthRV94" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,406&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zJrsOeAWUhYd" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;68,846&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_ecustom--NetRevenueOtherTransferredPoint_c20200101__20201231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_pn3n3" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,619)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20200101__20201231_zEbTNHEcj9nf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;72,633&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 28%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Revenue by
    segment&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Undergrad&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Continuing
    Education&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 13%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Digital
    Services&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 16%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Elimination
    (inter-segment transactions)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; width: 17%; text-align: center"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Types of services or goods&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zd3fDHCdXNd4" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zqVKN9jh84w2" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_z2KsslMQdyig" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zIq5DHUeOcn8" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--PaymentsToSuppliersForGoodsAndServices_pn3n3_c20190101__20191231_zx9FQZa4jyLb" style="vertical-align: bottom; text-align: right" title="Types of services or goods"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tuition fees&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zO1X1lpTz9Da" style="vertical-align: bottom; text-align: right" title="Tuition fees"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;648,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--ProfessionalFeesExpense_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zj3l7PlhqXN7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;60,195&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--ProfessionalFeesExpense1_pn3n3_c20190101__20191231_zigXcitC4lIf" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;709,152&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQ3vUcYNlc1h" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,803&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_z4M8QEFMhXj2" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,675&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zq1nk4cLDEr6" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zXqmRjUEwSqi" style="vertical-align: bottom; text-align: right" title="Other"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--OtherRevenue_pn3n3_c20190101__20191231_zbCA4pSUZzse" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;41,478&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Timing of revenue recognition&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zqPSQqGx2ZTh" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;653,760&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zJ4632C6EWxi" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,870&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zMrlEGBiTpei" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,880&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zSgumwJU0Rbi" style="vertical-align: bottom; text-align: right" title="Timing of revenue recognition"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(3,880)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_ecustom--TimingRevenueRecognition_pn3n3_c20190101__20191231_z6QVlZREvbLi" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;750,630&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred over time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zLOWEJKaZqBi" style="vertical-align: bottom; padding-right: -2.4pt; text-align: right" title="Transferred over time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;648,957&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--ContinuingEducationMember_zWMDmSFiNtV3" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;64,870&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--FeeAndCommissionIncome_pn3n3_c20190101__20191231_zLI4e8HkYsv7" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;713,827&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: top"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Transferred at a point in
    time&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--UndergradMember_zQa9pWMQebLh" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,803&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;-&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__custom--DigitalServicesMember_zIJ01XzrNAfj" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,880&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231__ifrs-full--SegmentsAxis__ifrs-full--EliminationOfIntersegmentAmountsMember_zNNTXj7dMPEf" style="vertical-align: bottom; text-align: right" title="Transferred at a point in time"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,880)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_ecustom--NetRevenueOtherTransferredPoint_pn3n3_c20190101__20191231_zYeedTPsTeCb" style="vertical-align: bottom; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;36,803&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfRevenueBySegment>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1498408000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">151958000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3978000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1719371000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1486111000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</ifrs-full:ProfessionalFeesExpense>
    <afya:ProfessionalFeesExpense1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1559094000</afya:ProfessionalFeesExpense1>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">12297000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">151958000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3978000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">160277000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1498408000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">151958000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3978000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1719371000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1486111000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">72983000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">81795000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">1640889000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">12297000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">70163000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-012021-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3978000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">78482000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2020-01-012020-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1002461000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">93152000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-1619000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1201191000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <afya:ProfessionalFeesExpense1
      contextRef="From2020-01-012020-12-31_custom_SegmentOfBusinessOneUnitMember"
      decimals="-3"
      unitRef="BRL">997055000</afya:ProfessionalFeesExpense1>
    <afya:ProfessionalFeesExpense1
      contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</afya:ProfessionalFeesExpense1>
    <afya:ProfessionalFeesExpense1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1104252000</afya:ProfessionalFeesExpense1>
    <ifrs-full:OtherRevenue
      contextRef="From2020-01-012020-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">5406000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">93152000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-1619000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">96939000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2020-01-012020-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">1002461000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">93152000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-1619000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1201191000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2020-01-012020-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">997055000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2020-01-012020-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">107197000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">24306000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">1128558000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2020-01-012020-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">5406000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2020-01-012020-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">68846000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2020-01-012020-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-1619000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">72633000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">653760000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">64870000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">35880000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3880000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:PaymentsToSuppliersForGoodsAndServices
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">750630000</ifrs-full:PaymentsToSuppliersForGoodsAndServices>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">648957000</ifrs-full:ProfessionalFeesExpense>
    <ifrs-full:ProfessionalFeesExpense
      contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">60195000</ifrs-full:ProfessionalFeesExpense>
    <afya:ProfessionalFeesExpense1
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">709152000</afya:ProfessionalFeesExpense1>
    <ifrs-full:OtherRevenue
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">4803000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">4675000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">35880000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3880000</ifrs-full:OtherRevenue>
    <ifrs-full:OtherRevenue
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">41478000</ifrs-full:OtherRevenue>
    <afya:TimingRevenueRecognition
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">653760000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">64870000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">35880000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3880000</afya:TimingRevenueRecognition>
    <afya:TimingRevenueRecognition
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">750630000</afya:TimingRevenueRecognition>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">648957000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2019-01-012019-12-31_custom_ContinuingEducationMember"
      decimals="-3"
      unitRef="BRL">64870000</ifrs-full:FeeAndCommissionIncome>
    <ifrs-full:FeeAndCommissionIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">713827000</ifrs-full:FeeAndCommissionIncome>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2019-01-012019-12-31_custom_UndergradMember"
      decimals="-3"
      unitRef="BRL">4803000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2019-01-012019-12-31_custom_DigitalServicesMember"
      decimals="-3"
      unitRef="BRL">35880000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2019-01-012019-12-31_ifrs-full_EliminationOfIntersegmentAmountsMember"
      decimals="-3"
      unitRef="BRL">-3880000</afya:NetRevenueOtherTransferredPoint>
    <afya:NetRevenueOtherTransferredPoint
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">36803000</afya:NetRevenueOtherTransferredPoint>
    <ifrs-full:DisclosureOfExpensesByNatureExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_808_eifrs-full--DisclosureOfExpensesByNatureExplanatory_zcMStsRPac4f" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;20&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_825_zh6fe9yTcuSg"&gt;Expenses
                                            and costs by nature&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_897_ecustom--SummaryOfExpensesByNatureTableTextBlock_zZlnbaVBKAm8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B9_zz5KIFrq1RKa" style="display: none; visibility: hidden"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zASNR3Tik5Z2" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20200101__20201231_z87ngSk9iQOk" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49C_20190101__20191231_zUvyNPNXpG1j" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CostOfSales_zwR11BJJyiri" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(434,654)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(308,853)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zPnFjZj40Bmb" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(402,855)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(239,120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseByNature_zRr3fv2mxPzi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(837,509)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(547,973)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Payroll_zrh1jzRDTwS7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payroll&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(677,564)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(446,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(324,252)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_zC1BhQbjxRyc" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Hospital
    and medical agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,449)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,988)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(16,429)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DepreciationExpense_z1IUNSU8NyRk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(154,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,744)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(73,152)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LeaseExpenses_zNFGvIx7vTYc" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,229)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,555)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,494)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--UtilitiesExpense_zKGvIKSUZYB6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Utilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,643)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,892)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,628)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RepairsAndMaintenanceExpense_zIrk4OVrV6O7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,141)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,746)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,658)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SharesBasedCompensation_zrNf1Q369RTl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based
    compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,610)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(18,114)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TaxExpenses_zRuKGSsZ31R" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,997)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,326)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,696)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ServicesExpense_zC7DM0dyCPi6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Pedagogical
    services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,881)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,037)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_zIGZ31SIkot4" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Sales
    and marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(18,361)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,966)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AllowanceForDoubtfulAccounts_zoHp1Ec5SfS6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,040)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TravelExpense_zodnFKTqumY6" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Travel
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,542)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,054)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ConsultingFees_zXuHmzH9bZ41" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consulting
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(38,818)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,276)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(13,060)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Other_zUzBp07dkQr" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(103,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(66,870)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,159)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseByNatureOne_iT_zKYFsO0wi141" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(837,509)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(547,973)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AB_zQsxiaGDAWvb" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfExpensesByNatureExplanatory>
    <afya:SummaryOfExpensesByNatureTableTextBlock contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--SummaryOfExpensesByNatureTableTextBlock_zZlnbaVBKAm8" style="margin-top: 0; margin-bottom: 0"&gt;&lt;span id="xdx_8B9_zz5KIFrq1RKa" style="display: none; visibility: hidden"&gt;Schedule of expenses by nature&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="width: 53%; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zASNR3Tik5Z2" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49A_20200101__20201231_z87ngSk9iQOk" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49C_20190101__20191231_zUvyNPNXpG1j" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--CostOfSales_zwR11BJJyiri" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Cost
    of services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(652,300)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(434,654)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(308,853)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--GeneralAndAdministrativeExpense_iN_di_zPnFjZj40Bmb" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;General
    and administrative expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(622,615)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(402,855)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(239,120)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--ExpenseByNature_zRr3fv2mxPzi" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(837,509)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(547,973)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_ecustom--Payroll_zrh1jzRDTwS7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Payroll&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(677,564)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(446,473)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(324,252)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--HospitalAndMedicalAgreements_zC1BhQbjxRyc" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Hospital
    and medical agreements&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,449)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,988)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(16,429)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_407_eifrs-full--DepreciationExpense_z1IUNSU8NyRk" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Depreciation
    and amortization&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(154,220)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,744)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(73,152)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--LeaseExpenses_zNFGvIx7vTYc" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Lease
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(11,229)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,555)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,494)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--UtilitiesExpense_zKGvIKSUZYB6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Utilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(10,643)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,892)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,628)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_eifrs-full--RepairsAndMaintenanceExpense_zIrk4OVrV6O7" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Maintenance&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,141)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(20,746)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,658)
    &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--SharesBasedCompensation_zrNf1Q369RTl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Share-based
    compensation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(43,377)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,610)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(18,114)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--TaxExpenses_zRuKGSsZ31R" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,997)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(5,326)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,696)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40E_eifrs-full--ServicesExpense_zC7DM0dyCPi6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Pedagogical
    services&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,881)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,037)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,271)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--SalesAndMarketingExpense_zIGZ31SIkot4" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Sales
    and marketing&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,506)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(18,361)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(12,966)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--AllowanceForDoubtfulAccounts_zoHp1Ec5SfS6" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Allowance
    for doubtful accounts&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(47,819)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(32,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,040)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_eifrs-full--TravelExpense_zodnFKTqumY6" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Travel
    expenses&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,542)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,550)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,054)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_ecustom--ConsultingFees_zXuHmzH9bZ41" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Consulting
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(38,818)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,276)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(13,060)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_ecustom--Other_zUzBp07dkQr" style="background-color: White"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(103,729)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(66,870)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(39,159)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--ExpenseByNatureOne_iT_zKYFsO0wi141" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 3.5pt; padding-left: 3.5pt; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(1,274,915)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(837,509)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; padding-right: 3.5pt; padding-left: 3.5pt; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(547,973)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:SummaryOfExpensesByNatureTableTextBlock>
    <ifrs-full:CostOfSales
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-652300000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-434654000</ifrs-full:CostOfSales>
    <ifrs-full:CostOfSales
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-308853000</ifrs-full:CostOfSales>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">622615000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">402855000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:GeneralAndAdministrativeExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">239120000</ifrs-full:GeneralAndAdministrativeExpense>
    <ifrs-full:ExpenseByNature
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-1274915000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-837509000</ifrs-full:ExpenseByNature>
    <ifrs-full:ExpenseByNature
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-547973000</ifrs-full:ExpenseByNature>
    <afya:Payroll
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-677564000</afya:Payroll>
    <afya:Payroll
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-446473000</afya:Payroll>
    <afya:Payroll
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-324252000</afya:Payroll>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-37449000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-37988000</afya:HospitalAndMedicalAgreements>
    <afya:HospitalAndMedicalAgreements
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-16429000</afya:HospitalAndMedicalAgreements>
    <ifrs-full:DepreciationExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-154220000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-108744000</ifrs-full:DepreciationExpense>
    <ifrs-full:DepreciationExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-73152000</ifrs-full:DepreciationExpense>
    <afya:LeaseExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-11229000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-2555000</afya:LeaseExpenses>
    <afya:LeaseExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-4494000</afya:LeaseExpenses>
    <ifrs-full:UtilitiesExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-10643000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-5892000</ifrs-full:UtilitiesExpense>
    <ifrs-full:UtilitiesExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-6628000</ifrs-full:UtilitiesExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-47141000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-20746000</ifrs-full:RepairsAndMaintenanceExpense>
    <ifrs-full:RepairsAndMaintenanceExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-8658000</ifrs-full:RepairsAndMaintenanceExpense>
    <afya:SharesBasedCompensation
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-43377000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-32610000</afya:SharesBasedCompensation>
    <afya:SharesBasedCompensation
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-18114000</afya:SharesBasedCompensation>
    <afya:TaxExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-7997000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-5326000</afya:TaxExpenses>
    <afya:TaxExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-2696000</afya:TaxExpenses>
    <ifrs-full:ServicesExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-47881000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-24037000</ifrs-full:ServicesExpense>
    <ifrs-full:ServicesExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-6271000</ifrs-full:ServicesExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-39506000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-18361000</ifrs-full:SalesAndMarketingExpense>
    <ifrs-full:SalesAndMarketingExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-12966000</ifrs-full:SalesAndMarketingExpense>
    <afya:AllowanceForDoubtfulAccounts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-47819000</afya:AllowanceForDoubtfulAccounts>
    <afya:AllowanceForDoubtfulAccounts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-32081000</afya:AllowanceForDoubtfulAccounts>
    <afya:AllowanceForDoubtfulAccounts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-15040000</afya:AllowanceForDoubtfulAccounts>
    <ifrs-full:TravelExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-7542000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-4550000</ifrs-full:TravelExpense>
    <ifrs-full:TravelExpense
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-7054000</ifrs-full:TravelExpense>
    <afya:ConsultingFees
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-38818000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-31276000</afya:ConsultingFees>
    <afya:ConsultingFees
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-13060000</afya:ConsultingFees>
    <afya:Other
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-103729000</afya:Other>
    <afya:Other
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-66870000</afya:Other>
    <afya:Other
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-39159000</afya:Other>
    <afya:ExpenseByNatureOne
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-1274915000</afya:ExpenseByNatureOne>
    <afya:ExpenseByNatureOne
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-837509000</afya:ExpenseByNatureOne>
    <afya:ExpenseByNatureOne
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-547973000</afya:ExpenseByNatureOne>
    <ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_805_eifrs-full--DisclosureOfFinanceIncomeExpenseExplanatory_zOAwpxR2FgB3" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;21&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_825_zt33nKUGZvlg"&gt;Finance
                                            result&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_897_ecustom--ScheduleOfFinanceResult_zRtn4GBtjlA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B2_zVbwQGDP0Kh9" style="display: none; visibility: hidden"&gt;Schedule of finance result&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zV5Euy2eB5ih" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20200101__20201231_zyyaSJOhf6yf" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 5.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20190101__20191231_zaiVwXKTJzL9" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--InvestmentIncome_zYnnf5Zwgjga" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income
    from financial investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,773&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;25,965&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesInFairValueOfDerivativeInstruments_zETaOgK8agah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Changes
    in fair value of derivative instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5132"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RevenueFromInterest_zxPhDMuI8iEb" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,680&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NetForeignExchangeGain_zVjIGHM6Ajc3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign
    exchange differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5138"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5139"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,321&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherFinanceIncome_zcb4rfG6joFe" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,723&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinanceIncome_zD47KnUqqMm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;62,290&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,689&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ChangeInFairValueOfDerivativeInstruments_znyFRGXcxVDl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Change
    in fair value of derivative instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5150"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5151"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpense1_ztvQ3LNvNyM" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,437)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(25,543)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,002)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpenseOnLeaseLiabilities1_zT5P2x644es9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense on lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,212)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(44,458)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,469)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinancialDiscountsGrantedExpenses_zeYxNw0kKkzb" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Financial
    discounts granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(23,193)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BankAndSimilarCharges_zttp0aut67Pf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Bank
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,878)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,333)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,876)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--NetForeignExchangeLoss_zVPpI4SXYZh" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign
    exchange differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(17,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,613)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TaxOnFinancialOperations_z9kUCMmq4fX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IOF
    taxes (taxes on financial transactions)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,801)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--OtherFinanceCost_zUApyGb0GNc5" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,797)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,580)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,514)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_iN_di_zpM1EJArnKi7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(243,796)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(98,269)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(72,365)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinanceResult_zjql1nAyciV" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    result&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(179,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(35,979)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(20,676)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AF_znjpaFornZ3e" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory>
    <afya:ScheduleOfFinanceResult contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_897_ecustom--ScheduleOfFinanceResult_zRtn4GBtjlA5" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B2_zVbwQGDP0Kh9" style="display: none; visibility: hidden"&gt;Schedule of finance result&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="width: 56%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49B_20210101__20211231_zV5Euy2eB5ih" style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_490_20200101__20201231_zyyaSJOhf6yf" style="border-bottom: Black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right; text-indent: 5.6pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_49F_20190101__20191231_zaiVwXKTJzL9" style="border-bottom: Black 1pt solid; width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eifrs-full--InvestmentIncome_zYnnf5Zwgjga" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income
    from financial investments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;35,773&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,479&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;25,965&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_400_ecustom--ChangesInFairValueOfDerivativeInstruments_zETaOgK8agah" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Changes
    in fair value of derivative instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5130"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;20,739&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5132"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--RevenueFromInterest_zxPhDMuI8iEb" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    received&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;23,040&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11,876&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;9,680&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_eifrs-full--NetForeignExchangeGain_zVjIGHM6Ajc3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign
    exchange differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 0.3pt; text-align: right; text-indent: -0.3pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5138"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5139"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;13,321&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_eifrs-full--OtherFinanceIncome_zcb4rfG6joFe" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,753&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,196&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,723&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--FinanceIncome_zD47KnUqqMm4" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    income&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-top: Black 1pt solid; border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;64,566&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;62,290&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;51,689&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_ecustom--ChangeInFairValueOfDerivativeInstruments_znyFRGXcxVDl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Change
    in fair value of derivative instruments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5150"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5151"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,780)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_401_ecustom--InterestExpense1_ztvQ3LNvNyM" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(108,437)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(25,543)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(24,002)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--InterestExpenseOnLeaseLiabilities1_zT5P2x644es9" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Interest
    expense on lease liabilities&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(67,212)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(44,458)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(31,469)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_ecustom--FinancialDiscountsGrantedExpenses_zeYxNw0kKkzb" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Financial
    discounts granted&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(23,193)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,081)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(923)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eifrs-full--BankAndSimilarCharges_zttp0aut67Pf" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Bank
    fees&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,878)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,333)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,876)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_409_eifrs-full--NetForeignExchangeLoss_zVPpI4SXYZh" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Foreign
    exchange differences&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(17,973)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,613)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5172"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_ecustom--TaxOnFinancialOperations_z9kUCMmq4fX2" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;IOF
    taxes (taxes on financial transactions)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,306)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,661)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,801)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--OtherFinanceCost_zUApyGb0GNc5" style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(15,797)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,580)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,514)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--FinanceCosts_iN_di_zpM1EJArnKi7" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    expenses&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(243,796)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(98,269)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(72,365)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom; background-color: rgb(213,234,234)"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--FinanceResult_zjql1nAyciV" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Finance
    result&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(179,230)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(35,979)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(20,676)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfFinanceResult>
    <ifrs-full:InvestmentIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">35773000</ifrs-full:InvestmentIncome>
    <ifrs-full:InvestmentIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">24479000</ifrs-full:InvestmentIncome>
    <ifrs-full:InvestmentIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">25965000</ifrs-full:InvestmentIncome>
    <afya:ChangesInFairValueOfDerivativeInstruments
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">20739000</afya:ChangesInFairValueOfDerivativeInstruments>
    <ifrs-full:RevenueFromInterest
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">23040000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">11876000</ifrs-full:RevenueFromInterest>
    <ifrs-full:RevenueFromInterest
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">9680000</ifrs-full:RevenueFromInterest>
    <ifrs-full:NetForeignExchangeGain
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">13321000</ifrs-full:NetForeignExchangeGain>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">5753000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">5196000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:OtherFinanceIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">2723000</ifrs-full:OtherFinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">64566000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">62290000</ifrs-full:FinanceIncome>
    <ifrs-full:FinanceIncome
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">51689000</ifrs-full:FinanceIncome>
    <afya:ChangeInFairValueOfDerivativeInstruments
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-1780000</afya:ChangeInFairValueOfDerivativeInstruments>
    <afya:InterestExpense1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-108437000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-25543000</afya:InterestExpense1>
    <afya:InterestExpense1
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-24002000</afya:InterestExpense1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-67212000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-44458000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:InterestExpenseOnLeaseLiabilities1
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-31469000</afya:InterestExpenseOnLeaseLiabilities1>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-23193000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-8081000</afya:FinancialDiscountsGrantedExpenses>
    <afya:FinancialDiscountsGrantedExpenses
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-923000</afya:FinancialDiscountsGrantedExpenses>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-7878000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-6333000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:BankAndSimilarCharges
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-2876000</ifrs-full:BankAndSimilarCharges>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-17973000</ifrs-full:NetForeignExchangeLoss>
    <ifrs-full:NetForeignExchangeLoss
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-4613000</ifrs-full:NetForeignExchangeLoss>
    <afya:TaxOnFinancialOperations
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-3306000</afya:TaxOnFinancialOperations>
    <afya:TaxOnFinancialOperations
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-1661000</afya:TaxOnFinancialOperations>
    <afya:TaxOnFinancialOperations
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-6801000</afya:TaxOnFinancialOperations>
    <ifrs-full:OtherFinanceCost
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-15797000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-7580000</ifrs-full:OtherFinanceCost>
    <ifrs-full:OtherFinanceCost
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-4514000</ifrs-full:OtherFinanceCost>
    <ifrs-full:FinanceCosts
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">243796000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">98269000</ifrs-full:FinanceCosts>
    <ifrs-full:FinanceCosts
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">72365000</ifrs-full:FinanceCosts>
    <afya:FinanceResult
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">-179230000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">-35979000</afya:FinanceResult>
    <afya:FinanceResult
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">-20676000</afya:FinanceResult>
    <ifrs-full:DisclosureOfIncomeTaxExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_807_eifrs-full--DisclosureOfIncomeTaxExplanatory_zGuLbjeT7E1f" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;22&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_820_z5gdoexqvU0c"&gt;Income
                                            taxes&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; background-color: white"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Income taxes are
comprised of taxation over operations in Brazil, related to Corporate Income Tax ("IRPJ") and Social Contribution on Net Profit
("CSLL"). According to Brazilian tax legislation, income taxes and social contribution are assessed and paid by legal entity
and not on a consolidated basis.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Reconciliation
of income taxes expense&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_89A_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_zOVESf5Xynl2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
following is a reconciliation of income tax expense to profit (loss) for the year, calculated by applying the combined Brazilian statutory
rates at 34% for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B3_zQFstNDjvwf" style="display: none; visibility: hidden"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 56%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zlKxdtAQtCV4" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20200101__20201231_zuEhJyWQZ9o7" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20190101__20191231_z5IwB6tJzOS" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ProfitLossBeforeTax_zxizHVlqds7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;335,054&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;186,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Combined statutory income
    taxes rate - %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20210101__20211231_z9xqAugZTHN4" title="Statutory rates"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20200101__20201231_zXNlgHWvuJed"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20190101__20191231_zL4NDjvXzDtc"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pii_z9Jw8nlf2kHl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes at statutory
    rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(92,977)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(113,918)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(63,559)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ReconciliationAdjustmentsAbstract_iB_pii_zxF1trvIRDj8" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reconciliation adjustments:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pii_zimGS9YP1gq3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax effect on loss from entities
    not subject to taxation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,794)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,474)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pii_zHF5GuRbzrU8" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;PROUNI - Fiscal Incentive
    &lt;sup id="xdx_F45_z3QBg1jC6bM5"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;194,830&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;120,851&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,397&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pii_ztuiRAsbA8Pd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unrecognized deferred tax
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(86,233)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(41,319)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(19,342)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pii_zvnrnuCTsCL" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Presumed profit income
    tax regime effect &lt;sup id="xdx_F47_zpWgkFpTW1wb"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,066)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,640)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PermanentAdjustments_pii_zXVPe5J7Mu91" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Permanent adjustments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,232)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pii_zk61X8wbPKNe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,293&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,757)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--CurrentTaxExpenseIncome_pii_zT3DjncGRDMd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expense &#x2013;
    current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(31,179)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(27,067)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(14,175)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxRateEffectFromChangeInTaxRate_pii_dp_uPure_zQjJMw8LZVV2" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11.40%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8.08%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7.58%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0B_zybEHm3TG5Nf" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_z7hcORHSMY7b" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0D_zUlifPwbXyal" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zHtN0tns1nch" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8AD_zSOCr1wZdpFi" style="font: 9pt Arial, Helvetica, Sans-Serif; margin: 0 0 9pt; text-align: justify"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Deferred
income taxes&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0 0 0 10.9pt; text-indent: -10.9pt; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;As of December
31, 2021, the Company had unrecognized deferred income tax assets on temporary differences and tax losses in the amount of R$ &lt;span id="xdx_902_eifrs-full--DeferredTaxExpenseIncome_c20210101__20211231_zU732Km70ZRj" title="Unrecognized deferred income tax assets"&gt;432,226&lt;/span&gt;
(tax-basis) (R$ &lt;span id="xdx_908_eifrs-full--DeferredTaxExpenseIncome_c20200101__20201231_zQ37nLecwVW4" title="Unrecognized deferred income tax assets"&gt;214,387&lt;/span&gt; (tax-basis) as of December 31, 2020) which does not have any tax planning opportunities available that could
support the recognition of these temporary differences as deferred tax assets. Accordingly, the Company did not recognize deferred tax
assets.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfIncomeTaxExplanatory>
    <afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_89A_ecustom--ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory_zOVESf5Xynl2" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; text-indent: 0in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-weight: normal"&gt;The
following is a reconciliation of income tax expense to profit (loss) for the year, calculated by applying the combined Brazilian statutory
rates at 34% for the years ended December 31, 2021, 2020 and 2019:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;span id="xdx_8B3_zQFstNDjvwf" style="display: none; visibility: hidden"&gt;Schedule of reconciliation of income tax expense&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="white-space: nowrap; width: 56%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_492_20210101__20211231_zlKxdtAQtCV4" style="border-bottom: Black 1pt solid; white-space: nowrap; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_496_20200101__20201231_zuEhJyWQZ9o7" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 14%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_499_20190101__20191231_z5IwB6tJzOS" style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_402_eifrs-full--ProfitLossBeforeTax_zxizHVlqds7" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;273,462&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;335,054&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;186,937&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Combined statutory income
    taxes rate - %&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_901_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20210101__20211231_z9xqAugZTHN4" title="Statutory rates"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_900_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20200101__20201231_zXNlgHWvuJed"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span id="xdx_90A_eifrs-full--ApplicableTaxRate_pii_dp_uPure_c20190101__20191231_zL4NDjvXzDtc"&gt;34&lt;/span&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxExpenseIncomeAtApplicableTaxRate_pii_z9Jw8nlf2kHl" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes at statutory
    rates&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(92,977)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(113,918)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(63,559)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40C_ecustom--ReconciliationAdjustmentsAbstract_iB_pii_zxF1trvIRDj8" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reconciliation adjustments:&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_ecustom--TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation_pii_zimGS9YP1gq3" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Tax effect on loss from entities
    not subject to taxation&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(37,794)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(8,474)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,265)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--ProgramaUniversidadeParaTodosFiscalIncentive_pii_zHF5GuRbzrU8" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;PROUNI - Fiscal Incentive
    &lt;sup id="xdx_F45_z3QBg1jC6bM5"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;194,830&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;120,851&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;73,397&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40A_ecustom--UnrecognisedDeferredTaxAssets_pii_ztuiRAsbA8Pd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Unrecognized deferred tax
    assets&lt;/span&gt;&lt;/td&gt;
    &lt;td style="white-space: nowrap; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(86,233)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(41,319)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(19,342)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eifrs-full--TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss_pii_zvnrnuCTsCL" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Presumed profit income
    tax regime effect &lt;sup id="xdx_F47_zpWgkFpTW1wb"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,066)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,640)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;351&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_408_ecustom--PermanentAdjustments_pii_zXVPe5J7Mu91" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Permanent adjustments&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(6,232)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,567&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5228"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_405_eifrs-full--TaxExpenseOtherThanIncomeTaxExpense_pii_zk61X8wbPKNe" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Other&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,293&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;15,866&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,757)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--CurrentTaxExpenseIncome_pii_zT3DjncGRDMd" style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Income taxes expense &#x2013;
    current&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(31,179)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(27,067)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1.5pt double; vertical-align: bottom; text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;(14,175)&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eifrs-full--TaxRateEffectFromChangeInTaxRate_pii_dp_uPure_zQjJMw8LZVV2" style="background-color: White"&gt;
    &lt;td style="white-space: nowrap"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Effective rate&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;11.40%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;8.08%&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: right; line-height: 115%"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7.58%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0B_zybEHm3TG5Nf" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(a)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F17_z7hcORHSMY7b" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 15pt; text-align: right"&gt;&lt;span id="xdx_F0D_zUlifPwbXyal" style="font-family: Arial, Helvetica, Sans-Serif"&gt;(b)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F1A_zHtN0tns1nch" style="font-family: Arial, Helvetica, Sans-Serif"&gt;Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2021-01-01to2021-12-31"
      decimals="-3"
      unitRef="BRL">273462000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2020-01-012020-12-31"
      decimals="-3"
      unitRef="BRL">335054000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ProfitLossBeforeTax
      contextRef="From2019-01-012019-12-31"
      decimals="-3"
      unitRef="BRL">186937000</ifrs-full:ProfitLossBeforeTax>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:ApplicableTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.34</ifrs-full:ApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">-92977</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">-113918</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <ifrs-full:TaxExpenseIncomeAtApplicableTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">-63559</ifrs-full:TaxExpenseIncomeAtApplicableTaxRate>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">-37794</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">-8474</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">-1265</afya:TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="Fact005214"
      unitRef="BRL">194830</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact005215"
      unitRef="BRL">120851</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:ProgramaUniversidadeParaTodosFiscalIncentive
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      id="Fact005216"
      unitRef="BRL">73397</afya:ProgramaUniversidadeParaTodosFiscalIncentive>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">-86233</afya:UnrecognisedDeferredTaxAssets>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">-41319</afya:UnrecognisedDeferredTaxAssets>
    <afya:UnrecognisedDeferredTaxAssets
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">-19342</afya:UnrecognisedDeferredTaxAssets>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      id="Fact005222"
      unitRef="BRL">-7066</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      id="Fact005223"
      unitRef="BRL">-2640</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      id="Fact005224"
      unitRef="BRL">351</ifrs-full:TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss>
    <afya:PermanentAdjustments
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">-6232</afya:PermanentAdjustments>
    <afya:PermanentAdjustments
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">2567</afya:PermanentAdjustments>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">4293</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">15866</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:TaxExpenseOtherThanIncomeTaxExpense
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">-3757</ifrs-full:TaxExpenseOtherThanIncomeTaxExpense>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">-31179</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">-27067</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:CurrentTaxExpenseIncome
      contextRef="From2019-01-012019-12-31"
      decimals="0"
      unitRef="BRL">-14175</ifrs-full:CurrentTaxExpenseIncome>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2021-01-01to2021-12-31"
      decimals="INF"
      unitRef="Pure">0.1140</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2020-01-012020-12-31"
      decimals="INF"
      unitRef="Pure">0.0808</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:TaxRateEffectFromChangeInTaxRate
      contextRef="From2019-01-012019-12-31"
      decimals="INF"
      unitRef="Pure">0.0758</ifrs-full:TaxRateEffectFromChangeInTaxRate>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2021-01-01to2021-12-31"
      decimals="0"
      unitRef="BRL">432226</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DeferredTaxExpenseIncome
      contextRef="From2020-01-012020-12-31"
      decimals="0"
      unitRef="BRL">214387</ifrs-full:DeferredTaxExpenseIncome>
    <ifrs-full:DisclosureOfInsuranceContractsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80D_eifrs-full--DisclosureOfInsuranceContractsExplanatory_zaU8rFfgppQ1" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;23&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_820_z7DHQZ3JX1zh"&gt;Insurance
                                            contracts and contingencies&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;a)
Insurance contracts&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company and
its subsidiaries have a risk management program with the purpose of delimiting the risks, seeking in the market coverage compatible with
its size and operations.&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;b)
Legal proceedings and contingencies&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_899_ecustom--ScheduleOfLegalProceedingsAndContingencies_zCjeLFkoBj6a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The provisions
related to labor, civil and taxes proceedings whose likelihood of loss is assessed as probable are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BA_z9iIAEb3Zzyg" style="display: none; visibility: hidden"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z8UDO3SiwKFg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,233&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znA9eMVrxCn" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBjyEpOS3yW6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5255"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zd3NiUXIP3Cl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,465&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zQo7x8ZyWDfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,301&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zW9cJqkEBTT3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,071&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHLNMLdpaue3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5263"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zJEeaKOhYIbc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,372&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHQHaP7e8ieh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zkRZZHOMAshc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,508&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFMIeGWTCOV9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMkfliPLzhWi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zY8daNmGE5x3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,770)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuCWvzFir1F5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,043)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBAIj2LDiYj2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zzC2fHPV583l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zf7PBBcYjDyf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zmonYaDRHCnb" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,768&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLv1QkxmcQPl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5284"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z3K5hDatdlmk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,269&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zdYGwM4Lqmt" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,741&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zs5IqC2vuyF8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,348&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zbbyvoi3MvO3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,487&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,576&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zeBdtifnQRJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;562&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq9oKLk6EVSg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3CFb076mkie" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,853&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;19,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z4OLg8ZshPV9" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,285)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zccjfXBLQBD" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,705)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zSwqsnEJZps7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,990)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze3puQZUVxac" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balances as of end of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,519&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zSHII53AtlGl" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;13,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zjpz44KKYkp9" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zgR22mw7n2r4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze4s4nAt2ZL5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,597&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znSN8BC2m9Y6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,017&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zxT1u4yM7JK" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zf4JeejDjFF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions
    &lt;sup id="xdx_F48_zf7Sl47iLX5d"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_fKg_____zKj0zwSsNKnc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,418&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2UNDxa6RFc7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,101&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9wRoocXHyTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zdeRYaSdPmAf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,744&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFtJt91QLSBd" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zI9LtvfMCSIi" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zeQhGJuOw3zl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8YA4KKCj5h7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,848)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zX8giQ4gU5Mj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,490&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zJX2O4P55Jfa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,928&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHBevEWvLmxa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;99,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zOJZyP2lUQJ4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0C_zTwrzJY5utsk" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zCbwxgxWXBY7" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p id="xdx_8A7_zuUbiMBqApJ1" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p id="xdx_896_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_zFatfWCJR4hh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are other
civil, labor, taxes and social security proceedings assessed by Management and its legal counsels as possible risk of loss, for which
no provisions are recognized, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zk09jwvyWY3g" style="display: none; visibility: hidden"&gt;Schedule of social security proceedings assessed by Management&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Labor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVN1npePd7x5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zaIEIzu4as5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,318&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zDIk0IypT0g4" style="vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,570&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Civil&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z8kMG0xChqwj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,501&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,969&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2KQDeH9A2yd" style="vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,135&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Taxes
    and social security&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zejfGsQ62ggf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,459&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,375&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zfS1CcgPpF8g" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,583&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231_z3HPbKuhXzB6" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;66,058&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherProvisions_c20201231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;66,662&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherProvisions_iI_pn3n3_c20191231_ztNLLA91sHP" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;50,288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p id="xdx_8AA_zVTS3MWAlVil" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The Company has
judicial deposits recorded in other assets (non-current) in the amount of R$ &lt;span id="xdx_900_ecustom--JudicialDeposits_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_pn3n3" title="Judicial deposits"&gt;18,825&lt;/span&gt; as of December 31, 2021 (December 31, 2020: R$ &lt;span id="xdx_906_ecustom--JudicialDeposits_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zn2vUkEoHn12" title="Judicial deposits"&gt;1,451&lt;/span&gt;).&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Under the terms
of the Share Purchase and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries
acquired, the Company assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and
civil), which are or will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission,
prior to or on the closing dates of the acquisitions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Accordingly, and
considering that the provisions for legal proceedings recorded by the Company that result from causes arising from events occurring prior
to the closing dates of the acquisitions, any liability for the amounts to be disbursed, in case of their effective materialization in
loss, belongs exclusively to the selling shareholders. In this context, the Agreements state that the Company and its subsidiaries are
indemnified and therefore exempt from any liability related to said contingent liabilities and, therefore, the provision amounts related
to such contingencies are presented in the non-current liabilities and the correspondent amount of R$ &lt;span id="xdx_903_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20211231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_z3Fi2tG0ge5e" title="Contingencies correspondent amount"&gt;135,355&lt;/span&gt; (December 31, 2020: R$
&lt;span id="xdx_905_ecustom--ContingenciesCorrespondentAmount_iI_pn3n3_c20201231__ifrs-full--ClassesOfAssetsAxis__custom--OtherAssetsNonCurrentMember_zQQdBFFRe6Vd" title="Contingencies correspondent amount"&gt;53,499&lt;/span&gt;) is presented in non-current other assets.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfInsuranceContractsExplanatory>
    <afya:ScheduleOfLegalProceedingsAndContingencies contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_899_ecustom--ScheduleOfLegalProceedingsAndContingencies_zCjeLFkoBj6a" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The provisions
related to labor, civil and taxes proceedings whose likelihood of loss is assessed as probable are as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8BA_z9iIAEb3Zzyg" style="display: none; visibility: hidden"&gt;Schedule of legal proceedings and contingencies&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 40%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Labor&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Civil&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Taxes&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; vertical-align: top; width: 16%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: top"&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2018&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z8UDO3SiwKFg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,233&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znA9eMVrxCn" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;1,232&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBjyEpOS3yW6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5255"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iS_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zd3NiUXIP3Cl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;3,465&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zQo7x8ZyWDfh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,301&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zW9cJqkEBTT3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,071&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHLNMLdpaue3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5263"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zJEeaKOhYIbc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,372&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zHQHaP7e8ieh" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;737&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zkRZZHOMAshc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;1,508&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pin3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zFMIeGWTCOV9" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5271"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zMkfliPLzhWi" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,245&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zY8daNmGE5x3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,770)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zuCWvzFir1F5" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,043)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zBAIj2LDiYj2" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5278"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20190101__20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zzC2fHPV583l" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(4,813)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zf7PBBcYjDyf" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of beginning of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,501&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zmonYaDRHCnb" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2,768&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zLv1QkxmcQPl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5284"&gt;-&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--Provisions_iS_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z3K5hDatdlmk" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;5,269&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zdYGwM4Lqmt" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,741&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zs5IqC2vuyF8" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,348&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zbbyvoi3MvO3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;27,487&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Business combinations"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;32,576&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zeBdtifnQRJ5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;562&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_985_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zq9oKLk6EVSg" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;10,869&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z3CFb076mkie" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,853&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--AdditionalProvisionsOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Additions"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;19,284&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_z4OLg8ZshPV9" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,285)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zccjfXBLQBD" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(2,705)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zSwqsnEJZps7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl5307"&gt;-&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_c20200101__20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_pn3n3" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Reversals"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(3,990)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze3puQZUVxac" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balances as of end of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;4,519&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zSHII53AtlGl" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;13,280&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zjpz44KKYkp9" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;35,340&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eifrs-full--Provisions_iS_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zgR22mw7n2r4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;53,139&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Business
    combinations&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_ze4s4nAt2ZL5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;16,597&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_znSN8BC2m9Y6" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;6,017&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zxT1u4yM7JK" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;57,638&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--AcquisitionsThroughBusinessCombinationsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zf4JeejDjFF5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;80,252&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Additions
    &lt;sup id="xdx_F48_zf7Sl47iLX5d"&gt;*&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_989_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_fKg_____zKj0zwSsNKnc" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,418&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2UNDxa6RFc7" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,101&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_z9wRoocXHyTl" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;14,225&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--AdditionalProvisionsOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zdeRYaSdPmAf" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;24,744&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Reversals&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zFtJt91QLSBd" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,044)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_981_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zI9LtvfMCSIi" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(1,470)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zeQhGJuOw3zl" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(7,334)&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eifrs-full--UnusedProvisionReversedOtherProvisions_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_z8YA4KKCj5h7" style="border-bottom: Black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;(9,848)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Balances
    as of December 31, 2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_980_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember_zX8giQ4gU5Mj" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Balance as of ending of the year"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;25,490&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_986_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_zJX2O4P55Jfa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;22,928&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesMember_zHBevEWvLmxa" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;99,869&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--Provisions_iE_pn3n3_c20210101__20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember_zOJZyP2lUQJ4" style="border-bottom: Black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;148,287&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 9pt Arial, Helvetica, Sans-Serif; margin-top: 0; margin-bottom: 6pt; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td id="xdx_F0C_zTwrzJY5utsk" style="width: 15pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 5pt"/&gt;&lt;td style="text-align: justify"&gt;&lt;span id="xdx_F15_zCbwxgxWXBY7" style="font-family: Arial, Helvetica, Sans-Serif"&gt;The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

</afya:ScheduleOfLegalProceedingsAndContingencies>
    <ifrs-full:Provisions
      contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">2233000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">1232000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">3465000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">3301000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">1071000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">4372000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">737000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">1508000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">2245000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">-3770000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">-1043000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2019-01-012019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">-4813000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">2501000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">2768000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">5269000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">2741000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">2348000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">27487000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">32576000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">562000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">10869000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">7853000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">19284000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">-1285000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">-2705000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2020-01-012020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">-3990000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">4519000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">13280000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">35340000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">53139000</ifrs-full:Provisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">16597000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">6017000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">57638000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">80252000</ifrs-full:AcquisitionsThroughBusinessCombinationsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      id="Fact005319"
      unitRef="BRL">5418000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">5101000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">14225000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:AdditionalProvisionsOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">24744000</ifrs-full:AdditionalProvisionsOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">-1044000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">-1470000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">-7334000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:UnusedProvisionReversedOtherProvisions
      contextRef="From2021-01-012021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">-9848000</ifrs-full:UnusedProvisionReversedOtherProvisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember"
      decimals="-3"
      unitRef="BRL">25490000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">22928000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TaxesMember"
      decimals="-3"
      unitRef="BRL">99869000</ifrs-full:Provisions>
    <ifrs-full:Provisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember"
      decimals="-3"
      unitRef="BRL">148287000</ifrs-full:Provisions>
    <afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_896_ecustom--ScheduleOfSocialSecurityProceedingsAssessedByManagement_zFatfWCJR4hh" style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;There are other
civil, labor, taxes and social security proceedings assessed by Management and its legal counsels as possible risk of loss, for which
no provisions are recognized, as follows:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;span id="xdx_8B2_zk09jwvyWY3g" style="display: none; visibility: hidden"&gt;Schedule of social security proceedings assessed by Management&lt;/span&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; width: 51%; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2021&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: bottom; width: 17%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2020&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: black 1pt solid; vertical-align: top; width: 17%; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;2019&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="vertical-align: top; text-align: right"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Labor&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zVN1npePd7x5" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;5,098&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zaIEIzu4as5a" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;2,318&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--ClassesOfProvisionsAxis__custom--LabourMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember_zDIk0IypT0g4" style="vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;3,570&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Civil&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z8kMG0xChqwj" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;56,501&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_pn3n3" style="vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;59,969&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--CivilMember_z2KQDeH9A2yd" style="vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;39,135&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: rgb(213,234,234)"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;Taxes
    and social security&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eifrs-full--OtherProvisions_iI_pn3n3_c20211231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zejfGsQ62ggf" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,459&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_c20201231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_pn3n3" style="border-bottom: black 1pt solid; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;4,375&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eifrs-full--OtherProvisions_iI_pn3n3_c20191231__ifrs-full--ClassesOfContingentLiabilitiesAxis__ifrs-full--LegalProceedingsContingentLiabilityMember__ifrs-full--TypesOfRisksAxis__custom--TypesOfRiskMember__ifrs-full--ClassesOfProvisionsAxis__custom--TaxesAndSocialSecurityMember_zfS1CcgPpF8g" style="border-bottom: black 1pt solid; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;7,583&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="background-color: White"&gt;
    &lt;td style="vertical-align: bottom; padding-right: 5.4pt; padding-left: 5.4pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;Total&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98B_eifrs-full--OtherProvisions_iI_pn3n3_c20211231_z3HPbKuhXzB6" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;66,058&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eifrs-full--OtherProvisions_c20201231_pn3n3" style="border-bottom: black 1.5pt double; vertical-align: top; padding-right: 5.4pt; padding-left: 5.4pt; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;66,662&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98A_eifrs-full--OtherProvisions_iI_pn3n3_c20191231_ztNLLA91sHP" style="border-bottom: black 1.5pt double; vertical-align: top; text-align: right" title="Total"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 9pt"&gt;&lt;b&gt;50,288&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
</afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      unitRef="BRL">5098000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      unitRef="BRL">2318000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_LabourMember_custom_TypesOfRiskMember"
      decimals="-3"
      unitRef="BRL">3570000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">56501000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">59969000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_CivilMember"
      decimals="-3"
      unitRef="BRL">39135000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2021-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember"
      decimals="-3"
      unitRef="BRL">4459000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember"
      decimals="-3"
      unitRef="BRL">4375000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions
      contextRef="AsOf2019-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember_custom_TypesOfRiskMember_custom_TaxesAndSocialSecurityMember"
      decimals="-3"
      unitRef="BRL">7583000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="AsOf2021-12-31" decimals="-3" unitRef="BRL">66058000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="AsOf2020-12-31" decimals="-3" unitRef="BRL">66662000</ifrs-full:OtherProvisions>
    <ifrs-full:OtherProvisions contextRef="AsOf2019-12-31" decimals="-3" unitRef="BRL">50288000</ifrs-full:OtherProvisions>
    <afya:JudicialDeposits
      contextRef="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      unitRef="BRL">18825000</afya:JudicialDeposits>
    <afya:JudicialDeposits
      contextRef="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      unitRef="BRL">1451000</afya:JudicialDeposits>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2021-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      unitRef="BRL">135355000</afya:ContingenciesCorrespondentAmount>
    <afya:ContingenciesCorrespondentAmount
      contextRef="AsOf2020-12-31_custom_OtherAssetsNonCurrentMember"
      decimals="-3"
      unitRef="BRL">53499000</afya:ContingenciesCorrespondentAmount>
    <afya:DisclosureNoncashTransactionsExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_800_ecustom--DisclosureNoncashTransactionsExplanatory_z7SIn7x4vqV6" style="font: 11pt/107% Arial, Helvetica, Sans-Serif; margin: 0 0 8pt"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;24&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_827_zqgwZ69J0JDj"&gt;Non-cash
                                            transactions&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;During the years
ended December 31, 2021, 2020 and 2019, the Company carried out non-cash transactions which are not reflected in the statement of cash
flows. The main non-cash transactions in 2021 were the issuance of shares for the acquisitions of iClinic, Cliquefarma, and RXPRO, addition
of the provision for legal proceedings with corresponding indemnification assets, additions and remeasurements of right-of-use assets
and lease liabilities.&lt;/span&gt;&lt;/p&gt;

</afya:DisclosureNoncashTransactionsExplanatory>
    <ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory contextRef="From2021-01-01to2021-12-31">&lt;p id="xdx_80C_eifrs-full--DisclosureOfEventsAfterReportingPeriodExplanatory_zMvB6X2ICdca" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 11pt Arial, Helvetica, Sans-Serif; width: 100%; margin-top: 0; margin-bottom: 0; color: #C00000"&gt;&lt;tr style="vertical-align: top"&gt;
&lt;td style="width: 0.5in"/&gt;&lt;td style="width: 0.5in"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;25&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&lt;span id="xdx_821_zZJ3r6bDBff3"&gt;Subsequent
                                            events&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;a)
Repurchase shares program&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On January 27,
2022, the Company&#x2019;s board of directors approved a new share repurchase program. Afya may repurchase up to &lt;span id="xdx_90B_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220127__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassAOrdinarySharesMember_zoPsJp6DiXC3" title="Repurchase shares program"&gt;1,874,457&lt;/span&gt; of its outstanding
Class A common shares in the open market, based on prevailing market prices, or in privately negotiated transactions, beginning on January
27, 2022 until the earlier of the completion of the repurchase or December 31, 2022, depending upon market conditions.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;&#160;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;b)
Medical schools authorizations&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On February 23,
2022, Afya announced that the Secretary of Regulation and Supervision of Higher Education of the Ministry of Education (&#x201c;MEC&#x201d;)
authorized the operations of the medical schools in Abaetetuba, in the State of Par&#xe1;, and Itacoatiara, in the State of Amazonas,
both under Mais M&#xe9;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 12pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;On
March 16, 2022, MEC authorized the operations of the medical schools in &lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 10.5pt"&gt;Bragan&#xe7;a,
in the State of Par&#xe1;, and Manacapuru, in the State of Amazonas&lt;/span&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif; font-size: 11pt"&gt;,
both under Mais M&#xe9;dicos II program. With the authorizations, Afya reaches its third and fourth authorized schools to start operating
under the Mais Medicos II program. Each medical school will contribute with 50 seats.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;c)
Acquisition of Al&#xe9;m da Medicina&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On February 24,
2022, Afya Brazil announced the acquisition of &lt;span id="xdx_906_eifrs-full--PercentageOfVotingEquityInterestsAcquired_iI_pii_dp_uPure_c20220224__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--IClinicParticipacoesSAMember_zZ7kQn1Thc4k" title="Proportion of ownership interest"&gt;100&lt;/span&gt;% of the total share capital of Al&#xe9;m da Medicina. The deal was closed March
4, 2022.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;Al&#xe9;m da
Medicina is a medical content online platform for physicians and medical students that provides educational tools besides technical medical
content that can assist them throughout their careers. Its robust content includes mentoring for residency, soft skills, finance, accounting,
and investment basics for physicians.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The aggregate purchase
price was R$16.000 paid in cash. An earn-out of up to R$19.200 can be paid related to gross revenue achievements for 2023 and 2024.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The acquisition
date fair value of each major class of consideration, including the allocation of the purchase price has not been completed by the Company
as of the issuance date of these annual financial statements. The impact on revenue and profit or loss of the combined entity for the
current reporting period as if the acquisition date had been as of the beginning of the annual reporting period is not available as the
Company did not conclude this acquisition by December 31, 2021. Therefore, these financial statements do not include this information.
The transaction costs to date amounted to R$ 211.&#160;Any goodwill generated in the transaction is not expected to be deductible for
tax purposes.&lt;br/&gt;&lt;/span&gt;&lt;/p&gt;




&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;d)
Bertelsmann Explores Increasing Stake in Afya &lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 7, 2022,
Afya announced that it was notified that Nicolau Carvalho Esteves and Ros&#xe2;ngela de Oliveira Tavares Esteves, or the Esteves family,
have made a binding offer to sell &lt;span id="xdx_902_ecustom--RepurchaseOfOrdinaryShares_iI_pid_uShares_c20220307__ifrs-full--ClassesOfShareCapitalAxis__custom--ClassBOrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_z5rW4jJu8cU8"&gt;6,000,000&lt;/span&gt; Class B common shares of Afya at the purchase price of US$&lt;span id="xdx_90E_eifrs-full--ParValuePerShare_iI_pid_c20220307__ifrs-full--ClassesOfShareCapitalAxis__ifrs-full--OrdinarySharesMember__ifrs-full--CategoriesOfRelatedPartiesAxis__custom--NicolauCarvalhoEstevesMember_zRlzg9QRHtj" title="Purchase prices per share"&gt;26.90&lt;/span&gt; per share to an affiliate
of Bertelsmann SE&amp;amp; Co. KGaA, or &#x201c;Bertelsmann&#x201d;. Bertelsmann&#x2019;s acceptance of the offer remains subject to due diligence
and Bertelsmann board approval.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0; color: #C00000"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&lt;b&gt;e)
Medical Seats Increase in Centro Universit&#xe1;rio S&#xe3;o Lucas&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;On March 18, 2022,
Afya announced that MEC authorized the increase of 28 seats of Centro Universit&#xe1;rio S&#xe3;o Lucas, in Ji-Parana located in
the state of Rond&#xf4;nia.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 11pt Arial, Helvetica, Sans-Serif; margin: 0"&gt;&lt;span style="font-family: Arial, Helvetica, Sans-Serif"&gt;The earn-out related
to the seats approval is R$800 per seat, adjusted by the CDI rate from the closing until the payment date, of which: (i) 50% is payable
in 30 days, and (ii) 50% is payable in cash in two equal installments through 2024.&lt;/span&gt;&lt;/p&gt;

</ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2022-01-27_custom_ClassAOrdinarySharesMember"
      decimals="INF"
      unitRef="Shares">1874457</afya:RepurchaseOfOrdinaryShares>
    <ifrs-full:PercentageOfVotingEquityInterestsAcquired
      contextRef="AsOf2022-02-24_custom_IClinicParticipacoesSAMember"
      decimals="INF"
      unitRef="Pure">1</ifrs-full:PercentageOfVotingEquityInterestsAcquired>
    <afya:RepurchaseOfOrdinaryShares
      contextRef="AsOf2022-03-07_custom_ClassBOrdinarySharesMember_custom_NicolauCarvalhoEstevesMember"
      decimals="INF"
      unitRef="Shares">6000000</afya:RepurchaseOfOrdinaryShares>
    <ifrs-full:ParValuePerShare
      contextRef="AsOf2022-03-07_ifrs-full_OrdinarySharesMember_custom_NicolauCarvalhoEstevesMember"
      decimals="INF"
      unitRef="BRLPShares">26.90</ifrs-full:ParValuePerShare>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact001345"
          xlink:label="Fact001345"
          xlink:type="locator"/>
        <link:footnote id="Footnote001407" xlink:label="Footnote001407" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Capital expenditures consider
the acquisitions of property and equipment and intangible assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001345"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001346"
          xlink:label="Fact001346"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001346"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001347"
          xlink:label="Fact001347"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001347"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001348"
          xlink:label="Fact001348"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001348"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1349"
          xlink:label="xdx2ixbrl1349"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1349"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001350"
          xlink:label="Fact001350"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001350"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001402"
          xlink:label="Fact001402"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001402"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001403"
          xlink:label="Fact001403"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001403"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001404"
          xlink:label="Fact001404"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001404"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001405"
          xlink:label="Fact001405"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001405"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001406"
          xlink:label="Fact001406"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001406"
          xlink:to="Footnote001407"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1806"
          xlink:label="xdx2ixbrl1806"
          xlink:type="locator"/>
        <link:footnote id="Footnote002319" xlink:label="Footnote002319" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the measurement period, the
goodwill for the acquisition of UniRedentor was adjusted to R$77,662 as a result of an increase of intangible assets to R$142,399 and
a purchase price consideration adjustment of R$ 4,503.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1806"
          xlink:to="Footnote002319"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1801"
          xlink:label="xdx2ixbrl1801"
          xlink:type="locator"/>
        <link:footnote id="Footnote002320" xlink:label="Footnote002320" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">During the measurement
period, the goodwill for the acquisition of UniSL was adjusted to R$4,420 as a result of (i) a purchase consideration decrease of R$7,816
and (ii) adjustments increasing intangible assets to R$ 314,097 and a decrease in p</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1801"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001802"
          xlink:label="Fact001802"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001802"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001803"
          xlink:label="Fact001803"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001803"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001804"
          xlink:label="Fact001804"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001804"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact001805"
          xlink:label="Fact001805"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact001805"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl1807"
          xlink:label="xdx2ixbrl1807"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl1807"
          xlink:to="Footnote002320"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002441"
          xlink:label="Fact002441"
          xlink:type="locator"/>
        <link:footnote id="Footnote002465" xlink:label="Footnote002465" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Related to trade receivables
from sales of printed books, e-books and medical courses through digital platform from Medcel.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002441"
          xlink:to="Footnote002465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002442"
          xlink:label="Fact002442"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002442"
          xlink:to="Footnote002465"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002447"
          xlink:label="Fact002447"
          xlink:type="locator"/>
        <link:footnote id="Footnote002466" xlink:label="Footnote002466" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Related to trade receivables
from mobile applications subscriptions for digital medical content.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002447"
          xlink:to="Footnote002466"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002448"
          xlink:label="Fact002448"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002448"
          xlink:to="Footnote002466"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002506"
          xlink:label="Fact002506"
          xlink:type="locator"/>
        <link:footnote id="Footnote002559" xlink:label="Footnote002559" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refers to sales of educational content
from Medcel to UEPC.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002506"
          xlink:to="Footnote002559"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002507"
          xlink:label="Fact002507"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002507"
          xlink:to="Footnote002559"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2509"
          xlink:label="xdx2ixbrl2509"
          xlink:type="locator"/>
        <link:footnote id="Footnote002560" xlink:label="Footnote002560" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts to be reimbursed by the shareholders
to Afya Brazil, mainly related to payments of legal cost and advisory services recorded in other assets. This amount was paid in December
2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2509"
          xlink:to="Footnote002560"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002510"
          xlink:label="Fact002510"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002510"
          xlink:to="Footnote002560"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002521"
          xlink:label="Fact002521"
          xlink:type="locator"/>
        <link:footnote id="Footnote002561" xlink:label="Footnote002561" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Refers to amounts to be payable to
our shareholder Nicolau Carvalho Esteves regarding the agreement to which Afya Brazil acquired the right to develop ITPAC Garanhuns medical
school, a greenfield unit. 50% of the transaction is due in two equal annual installments, adjusted by the CDI rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002521"
          xlink:to="Footnote002561"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2522"
          xlink:label="xdx2ixbrl2522"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2522"
          xlink:to="Footnote002561"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002633"
          xlink:label="Fact002633"
          xlink:type="locator"/>
        <link:footnote id="Footnote002656" xlink:label="Footnote002656" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Under the terms of the Share Purchase
and Sale Agreements ("Agreements") between the Company and the selling shareholders of the subsidiaries acquired, the Company
assesses that the selling shareholders are exclusively responsible for any provisions (including labor, tax and civil), which are or
will be the subject of a claim by any third party, arising from the act or fact occurred, by action or omission, prior to or on the closing
dates of the acquisitions.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002633"
          xlink:to="Footnote002656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002634"
          xlink:label="Fact002634"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002634"
          xlink:to="Footnote002656"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002882"
          xlink:label="Fact002882"
          xlink:type="locator"/>
        <link:footnote id="Footnote003061" xlink:label="Footnote003061" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">the Company performed physical inventory
procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$431 of costs net of depreciation)
were recorded as disposals above.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002882"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002883"
          xlink:label="Fact002883"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002883"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2884"
          xlink:label="xdx2ixbrl2884"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2884"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002885"
          xlink:label="Fact002885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002885"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002886"
          xlink:label="Fact002886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002886"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002887"
          xlink:label="Fact002887"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002887"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002888"
          xlink:label="Fact002888"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002888"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl2889"
          xlink:label="xdx2ixbrl2889"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl2889"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002890"
          xlink:label="Fact002890"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002890"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002891"
          xlink:label="Fact002891"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002891"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact002892"
          xlink:label="Fact002892"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact002892"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3014"
          xlink:label="xdx2ixbrl3014"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3014"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003015"
          xlink:label="Fact003015"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003015"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3016"
          xlink:label="xdx2ixbrl3016"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3016"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003017"
          xlink:label="Fact003017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003017"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003018"
          xlink:label="Fact003018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003018"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003019"
          xlink:label="Fact003019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003019"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003020"
          xlink:label="Fact003020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003020"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3021"
          xlink:label="xdx2ixbrl3021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3021"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003022"
          xlink:label="Fact003022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003022"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3023"
          xlink:label="xdx2ixbrl3023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3023"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003024"
          xlink:label="Fact003024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003024"
          xlink:to="Footnote003061"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3180"
          xlink:label="xdx2ixbrl3180"
          xlink:type="locator"/>
        <link:footnote id="Footnote003373" xlink:label="Footnote003373" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">the Company performed physical
inventory procedures in some of the subsidiaries for the year ended December 31, 2021 and the final adjustments (R$103 of costs
net of depreciation) were recorded as disposals above.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3180"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3181"
          xlink:label="xdx2ixbrl3181"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3181"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3182"
          xlink:label="xdx2ixbrl3182"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3182"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3183"
          xlink:label="xdx2ixbrl3183"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3183"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003184"
          xlink:label="Fact003184"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003184"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3185"
          xlink:label="xdx2ixbrl3185"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3185"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3186"
          xlink:label="xdx2ixbrl3186"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3186"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003187"
          xlink:label="Fact003187"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003187"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003188"
          xlink:label="Fact003188"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003188"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003189"
          xlink:label="Fact003189"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003189"
          xlink:to="Footnote003373"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003087"
          xlink:label="Fact003087"
          xlink:type="locator"/>
        <link:footnote id="Footnote003374" xlink:label="Footnote003374" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
amount of R$4,030 added to goodwill relates to adjustments during the measurement period of the business combination of IESP in
respect to amounts to be included as part of the purchase price allocation at acquisition date mainly related to impairment of
receivables.</link:footnote>
        <link:footnote id="Footnote003375" xlink:label="Footnote003375" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
August 13, 2019, Afya Brazil entered into a purchase agreement with the shareholders of IPEC for the acquisition of 100% of IPEC.
IPEC was a non-operational postsecondary education institution with governmental authorization to offer on-campus post-secondary
undergraduate courses in medicine in the State of Par&#xe1;, that started its operation in September 2019. . Management assessed
the aspects of such transaction and concluded that the transaction does not fall under the definition of business, but an acquisition
of license with indefinite useful life recognized in intangible assets Prior to the acquisition date, IPEC had no significant
assets and liabilities. The purchase price of R$ 108,000 is comprised of: i) R$ 54,000 paid in cash on the acquisition date; ii)
R$ 54,000 is payable in two equal instalments of R$ 27,000 payable annually from August 13, 2020 to August 13, 2021, and adjusted
by the CDI rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003087"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003087"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003089"
          xlink:label="Fact003089"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003089"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003089"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003091"
          xlink:label="Fact003091"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003091"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003091"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003092"
          xlink:label="Fact003092"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003092"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003092"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003093"
          xlink:label="Fact003093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003093"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003093"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003094"
          xlink:label="Fact003094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003094"
          xlink:to="Footnote003374"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003094"
          xlink:to="Footnote003375"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003171"
          xlink:label="Fact003171"
          xlink:type="locator"/>
        <link:footnote id="Footnote003376" xlink:label="Footnote003376" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On
November 05, 2021 Secretary of Regulation and Supervision of Higher Education of the Ministry of Education ("MEC") authorized
the operation of 120 medical school seats in Garanhuns, for which our shareholder Nicolau Carvalho Esteves entered into an agreement
with Afya Brazil pursuant to which he assigned to Afya Brazil the right to develop the ITPAC Garanhuns greenfield unit, a medical
school in the city of Garanhuns, State of Pernambuco. Management assessed the aspects of such transaction and concluded that the
transaction does not fall under the definition of business, but an acquisition of license with indefinite useful life recognized
in intangible assets. Total purchase price was R$108,000 of which 50% was paid in cash on the transaction closing date and 50%
in two equal annual installments, adjusted by the CDI rate.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003171"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3172"
          xlink:label="xdx2ixbrl3172"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3172"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003173"
          xlink:label="Fact003173"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003173"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003174"
          xlink:label="Fact003174"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003174"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3175"
          xlink:label="xdx2ixbrl3175"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3175"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003176"
          xlink:label="Fact003176"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003176"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003177"
          xlink:label="Fact003177"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003177"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003178"
          xlink:label="Fact003178"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003178"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003179"
          xlink:label="Fact003179"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003179"
          xlink:to="Footnote003376"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003443"
          xlink:label="Fact003443"
          xlink:type="locator"/>
        <link:footnote id="Footnote003544" xlink:label="Footnote003544" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">CBBW as merged by Medcel on May 1,
2020.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003443"
          xlink:to="Footnote003544"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003635"
          xlink:label="Fact003635"
          xlink:type="locator"/>
        <link:footnote id="Footnote003696" xlink:label="Footnote003696" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On October 1, 2020, Afya Brazil
entered into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ <xhtml:span id="xdx_905_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20201001__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zBbujskvvgM1">500,000</xhtml:span> adjusted by the CDI rate plus an interest rate of
<xhtml:span id="xdx_90D_ecustom--IntrestRate_iI_pii_dp_uPure_c20201001__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zGn2EDxwDAnb">1.62</xhtml:span>% per year and is repayable in three installments in October 2022, April 2023 and October 2023.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003635"
          xlink:to="Footnote003696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003637"
          xlink:label="Fact003637"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003637"
          xlink:to="Footnote003696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003639"
          xlink:label="Fact003639"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003639"
          xlink:to="Footnote003696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003641"
          xlink:label="Fact003641"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003641"
          xlink:to="Footnote003696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003643"
          xlink:label="Fact003643"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003643"
          xlink:to="Footnote003696"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003645"
          xlink:label="Fact003645"
          xlink:type="locator"/>
        <link:footnote id="Footnote003699" xlink:label="Footnote003699" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On July 3, 2020, Afya Brazil entered
into a loan agreement with Banco Votorantim S.A. in the amount of R$ <xhtml:span id="xdx_900_ecustom--EqualInstallmentsPayablesToRelatedParties_iI_c20190509__ifrs-full--SignificantInvestmentsInSubsidiariesAxis__custom--InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember_zs2LIqC7J5x4">100,000</xhtml:span> adjusted by the CDI rate plus an interest rate of <xhtml:span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200703__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zheeiekxti6l">1.65</xhtml:span>%
per year and was repaid at maturity on July 5, 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003645"
          xlink:to="Footnote003699"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003647"
          xlink:label="Fact003647"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003647"
          xlink:to="Footnote003699"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003649"
          xlink:label="Fact003649"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003649"
          xlink:to="Footnote003699"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3651"
          xlink:label="xdx2ixbrl3651"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3651"
          xlink:to="Footnote003699"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003653"
          xlink:label="Fact003653"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003653"
          xlink:to="Footnote003699"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003654"
          xlink:label="Fact003654"
          xlink:type="locator"/>
        <link:footnote id="Footnote003702" xlink:label="Footnote003702" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On May 5, 2020, as a result of the
acquisition of UniSL, the Company assumed loans agreements with BNDES which has an interest rate of <xhtml:span id="xdx_907_ecustom--IntrestRate_iI_pid_dp_uPure_c20200520__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zdbKOVFMSBqk">10.03</xhtml:span>% per year and maturity in 2024.
This amount was prepaid in September 2021.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003654"
          xlink:to="Footnote003702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003656"
          xlink:label="Fact003656"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003656"
          xlink:to="Footnote003702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003658"
          xlink:label="Fact003658"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003658"
          xlink:to="Footnote003702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#xdx2ixbrl3660"
          xlink:label="xdx2ixbrl3660"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="xdx2ixbrl3660"
          xlink:to="Footnote003702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003662"
          xlink:label="Fact003662"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003662"
          xlink:to="Footnote003702"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003663"
          xlink:label="Fact003663"
          xlink:type="locator"/>
        <link:footnote id="Footnote003704" xlink:label="Footnote003704" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On July 23, 2019, Medcel entered
into a loan of R$ <xhtml:span id="xdx_908_eifrs-full--NotionalAmount_iI_c20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zp4iKYoZ2Oof" title="Loan amount">16,153</xhtml:span> with Financiadora de Estudos e Projetos (&#x201c;FINEP&#x201d;), a governmental agency focused on financing investments
on R&amp;D, which has an interest rate based on TJLP (Long term interest rate), and maturity in 2027. The first and second tranches of
R$<xhtml:span id="xdx_906_ecustom--BorrowingsAmountFirstTranche_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_pn3n3" title="Borrowings amount first tranche">6,734</xhtml:span> and R$<xhtml:span id="xdx_90A_ecustom--BorrowingsAmountFirstTranche_pn3n3_c20201222__20201223__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zxCESVMTCmsd" title="Borrowings amount first tranche">4,130</xhtml:span>, respectively, were drawdown in October 2019 and December 2020, respectively, in order to develop the Medical web
series and other digital content. There is no financial covenant related to this agreement. The total balance is guaranteed by a bank
warranty.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003663"
          xlink:to="Footnote003704"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003665"
          xlink:label="Fact003665"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003665"
          xlink:to="Footnote003704"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003667"
          xlink:label="Fact003667"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003667"
          xlink:to="Footnote003704"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003669"
          xlink:label="Fact003669"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003669"
          xlink:to="Footnote003704"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003671"
          xlink:label="Fact003671"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003671"
          xlink:to="Footnote003704"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003678"
          xlink:label="Fact003678"
          xlink:type="locator"/>
        <link:footnote id="Footnote003711" xlink:label="Footnote003711" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On October 28, 2020, UNIFIPmoc entered
into a loan with Banco Ita&#xfa; Unibanco S.A. in the amount of R$ <xhtml:span id="xdx_90C_eifrs-full--NotionalAmount_iI_c20201023__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zHFH1A2ow2se" title="Loan amount">30,000</xhtml:span>. On June 30, 2021 this agreement was amended and is now adjusted
by the CDI rate plus an interest rate of <xhtml:span id="xdx_90C_ecustom--IntrestRate_iI_pid_dp_uPure_c20210630__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zwudXqqTRi41" title="Intrest rate">1.75</xhtml:span>% per year and is repayable in three installments in July 2023, January 2024 and July 2024.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003678"
          xlink:to="Footnote003711"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003680"
          xlink:label="Fact003680"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003680"
          xlink:to="Footnote003711"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003682"
          xlink:label="Fact003682"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003682"
          xlink:to="Footnote003711"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003683"
          xlink:label="Fact003683"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003683"
          xlink:to="Footnote003711"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003672"
          xlink:label="Fact003672"
          xlink:type="locator"/>
        <link:footnote id="Footnote003716" xlink:label="Footnote003716" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">On April 26, 2021, the Company issued
and sold <xhtml:span id="xdx_902_eifrs-full--NumberOfSharesAuthorised_iI_pii_uShares_c20210426_zjAzfMXUfHBk" title="Covertable preffered stock shares">150,000</xhtml:span> shares of perpetual convertible preferred shares designated as Series A perpetual convertible preferred shares, with
a par value of U.S.$<xhtml:span id="xdx_901_eifrs-full--ParValuePerShare_iI_pii_c20210426_z5vyFAuyINJ8">0.00005</xhtml:span> per share of the Company for US$<xhtml:span id="xdx_904_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_pn3n3_c20190722__20190723__ifrs-full--BorrowingsByNameAxis__custom--FinanciadoradeEstudoseProjetosFINEPMember_zCbMmu4pgyl5">150,000</xhtml:span> thousands, equivalent to R$ <xhtml:span id="xdx_908_eifrs-full--ContributionsToPlanNetDefinedBenefitLiabilityAsset_c20210424__20210426_zBsUgIFR4cl9">821,805</xhtml:span> on the issuance date. The Series
A perpetual convertible preferred shares is a class of equity security that ranks senior to the common shares with respect to dividend
rights or rights upon liquidation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003672"
          xlink:to="Footnote003716"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003674"
          xlink:label="Fact003674"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003674"
          xlink:to="Footnote003716"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003676"
          xlink:label="Fact003676"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003676"
          xlink:to="Footnote003716"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact003677"
          xlink:label="Fact003677"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact003677"
          xlink:to="Footnote003716"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004884"
          xlink:label="Fact004884"
          xlink:type="locator"/>
        <link:footnote id="Footnote004931" xlink:label="Footnote004931" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">As mentioned
in Note 1, the Company assessed, in connection with the social distancing requirements, whether it has satisfied all performance
obligations of its contracts with customers, according to IFRS15, and concluded it was necessary to defer a portion of its net
revenues in the second semester of 2020. As result, R$2,361 of net revenue were deferred to the first semester of 2021 and recorded
in advances from customers.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004884"
          xlink:to="Footnote004931"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004885"
          xlink:label="Fact004885"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004885"
          xlink:to="Footnote004931"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact004886"
          xlink:label="Fact004886"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact004886"
          xlink:to="Footnote004931"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005214"
          xlink:label="Fact005214"
          xlink:type="locator"/>
        <link:footnote id="Footnote005241" xlink:label="Footnote005241" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The Company adhered to PROUNI,
established by Law 11,096 / 2005, which is a federal program that exempt companies of paying income taxes and social contribution.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005214"
          xlink:to="Footnote005241"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005215"
          xlink:label="Fact005215"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005215"
          xlink:to="Footnote005241"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005216"
          xlink:label="Fact005216"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005216"
          xlink:to="Footnote005241"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005222"
          xlink:label="Fact005222"
          xlink:type="locator"/>
        <link:footnote id="Footnote005242" xlink:label="Footnote005242" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Brazilian tax law establishes
that companies that generate gross revenues of up to R$ 78,000 in the prior fiscal year may calculate income taxes as a percentage
of gross revenue, using the presumed profit income tax regime. The effect of the presumed profit of certain subsidiaries represents
the difference between the taxation based on this method and the amount that would be due based on the statutory rate applied
to the taxable profit of the subsidiaries.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005222"
          xlink:to="Footnote005242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005223"
          xlink:label="Fact005223"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005223"
          xlink:to="Footnote005242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005224"
          xlink:label="Fact005224"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005224"
          xlink:to="Footnote005242"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact005319"
          xlink:label="Fact005319"
          xlink:type="locator"/>
        <link:footnote id="Footnote005332" xlink:label="Footnote005332" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amount of R$ 4,232 is
related to tax legal proceedings attributed to the selling shareholders (R$ 9,940 for the year ended December 31, 2020). The same
amount was recorded as indemnification assets in the statement of financial position in other assets.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact005319"
          xlink:to="Footnote005332"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>153
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M[CAU#5P ,XS)V_!=(+T04_5/;.J ."6G8);4.([Y6*=<W*&$]^>GU[1N9OK
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !9?YU44QG"=< &  #@'P  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;+6974_C.!2&KX=?8?5BM2L!;;XHS +:MK1,M5!8RLP(C?;"3=S6(HF[CD/I
M_/H]^:J!28_#2',#31J_?7+LO.<<YW0MY&.R9$R1YRB,D[/64JG5QW8[\9<L
MHLFA6+$8OID+&5$%AW+13E:2T2 ?%(5MN],Y:D>4QZWST_S<K3P_%:D*><QN
M)4G2**)RTV>A6)^UK%9UXHXOEBH[T3X_7=$%FS+U>74KX:B]50EXQ.*$BYA(
M-C]K]:R/?<_.!N17?.%LG;SX3+);F0GQF!V,@[-6)R-B(?-5)D'AWQ,;L##,
ME(#COU*TM?W-;.#+SY7Z*+]YN)D93=A A%]YH)9GK>,6"=B<IJ&Z$^M/K+PA
M+]/S19CD?\FZN-9U6\1/$R6B<C 01#PN_M/G,A!-!MCE@#P0[>*'<LH+JNCY
MJ11K(K.K02W[D-]J/AK@>)S-RE1)^);#.'4^$$],GK852&4GVGXYK%\,LW<,
MLVQR+6*U3,@P#ECP6J -#%L0NP+IVZCB!?,/B6/M$[MC6\F22I8@JL[V]IQ<
MU=FA.HP55QO2"P+02UA"OEW!%62L6)3\B^B[6WTWUW=W40L_A36JR/UFQ>K"
MB ^W.P<CA,+;4GBH3 \0@AQC%-)%'08^?D[#A"$<1UN.HV;1N&,+GBA)\P=O
MJBB$&T[7@>&")K#N%JS;#*P7QRD-@6\E9"T/KJ-DBN$<;W&.&ZX:2<'?\BCM
M1L*U3"$ZV3*=-&.:+L$BR4!$*QIO$"Q<SH1E=;1!=9J!W3+)19 9#@&KJWW:
M3%*EQ^Q]^)"Y#(;WPC^M9G@CGOBPM$K*$9Q.:A%QN=$#1F5K*OM=5 ^,2H0)
M%S/%2INQY:!"@U3*MU#H=.)R!P>6?>"@:-K'+=R)RT0QXB$CDS2:[4B*N$BG
M8QTXQR<G-H:D3=W"7;E$JKP4XC:A47V<#.EA]- C5^/K\?WP B/3-F_AMER2
M#6 N)<SC&$J 9_(WV]2RX5(=B%FW:W4Z78Q,^[R%&W1)-HY](<&X\@2T7V0@
M(B2X6@K(0"Z"^D :THB'06KWMW#+?EV4[%<?2%Z:W,3U9+AD+X2E$5!R P^6
MW)MPR+>;MTOX-:W."Q;NY"CM_5K4TN*2$W%(+.L$JQIU>K!Q3W^+-\B.8*KO
MQ3JN0S/(3<03A5N+Z-XUCVE"+IFD'*M$;9TI;-S:?R M%F,M)*[4O\. =)*P
M<5^_YPK<3LR)9?\^^X-,F9]*(*P%PI4&(845T2.^B"*H98SENZU3AHU[/%1(
M 8\79+J)9B*L1<,%,O/#2'2&L'%SK\)#AL_^DL8+MM..#4*3WO2B]P_&I%.$
MW2A%?(6*[> QAA4/DT@3$;. C),DK4]B!LT'?.9TDK ;)8DO(H1E#@U_GEME
M;?UA4)H(#$CG!KM1;JB*D**RS=<6I(?ZPLB@: B53@AVHX0PCA6X3;Y-D95$
MM$*M)<,5#63:_.U&YI]/'1E %EV('8Z%ZUQ1"0],S_<9"(%,4$AB';[. $ZC
M##",F%QDTWD)"FI9=3!UL 9!4^_B:,MW&C8'<.>9VY>K+0ZH#&K!<+E\@<1Y
M40-EUP@25.SS;3O[4AS=.]$)PL%MO8SLJXZP%AN7,<;SQ6X.;N;CP>B.]-*
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MC 9,9A? ]W,A5'60_<#VI?[Y_U!+ P04    " !9?YU4=P6L#Z '  "K(P
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MK"BJ,I$V4 CG,?0MUVT;]=2T+I7_>ZP]SZ #ATB>0X<(OE4OR?!-8GKP"E7
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M@ 7Z!?0C1HR0%:8 ^@%3*GF9*31IH!'-T^A[@$J!(HE6%534 :8N.,D,4&E
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M2S;,JI=*_?IW217M4D63CIE?V%HT3C?9@8H&A31W^JEZ!.*L@#@.$,<%XGA
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M0,.P;%7CEQ+2MLT1HZ!EY^VTSAI8%';>/'OM"$E$(X:M\E(":GX !0JA0&L
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MV;=/4:=WIF$N@"_ B)RN>B8RP4>]H(:]0J#S=)Q<C0A;E46V*]5:4F_/Z\2
MTAX.\8*:3UV?PJAS5@^@$%?5T%/2J?$S-.QGC O7"TXM>'537^5-W;=-5>GJ
M=SAO@8<%Y' 23FV' ^)PFC@\(2>$$N196U/C8.C%PPE]$#$M1,<=@W&T1[O]
MJBIS-:O7LO55J6#PE_2V:UA(DB)[/;,$<&K!*GSW%*CQ-33L:[R'V+LJJ\>5
MV,[3U<"VA_KGU.G7\C"O$.@\1\;FT+#-&<_GRH-,YXUO\+_2-8T%!?=JA'T!
M9@GA1,J%9U5#C=>A+]^L>3/9NY^-@%_P=Q38CN&4"Z<8N#C!.+6E9 G@4HPH
M\:Q%F7%@+.S ?N2^ X,.<( +#P .<?7/X@;!5-D7'FK&@K'+5SD.NJ6]^;@J
MJ\=%][!U])!5TG,)AT&'.ZFJYO9V"P!$,4J(O9L X!)E7'WFG!DOQL)>;.&C
M%65]U&_TC;W[LJ[UF%5N37_Q)+,6Y QL,,54>6;;V # E!+LG. !.(XQ]\Q1
M9DP:"YNTBY25BE\D.SXB<*52T(3!%SDOMSWFS2WFEQL?<NG6[_G)=>:M;.^'
M:^%=--PE&V\%'[\]7CU_/URXMK[_@-XMQPOD)LQXG_WWK%7#I5.V?JU"QF^%
MZKUVO"(^_M(WN^'2]*KI^V8[?-S(K)"M!JB_KYNF/_RB'W"\J'_[/U!+ P04
M    " !9?YU4V]8,_#0/  #M(P  &    'AL+W=O<FMS:&5E=',O<VAE970V
M+GAM;*5:6W/;-A9^YZ_ >+L[]@PCZVZY3C)C*TGK3IUX[*1]ADA(PH8B5 "4
MHOSZ_<X!>)&;N)G9A\04"1R<ZW<NY,N]L9_=6BDOOFR*TKTZ67N__?G\W&5K
MM9&N9[:JQ).EL1OI\=.NSMW6*IGSIDUQ/NSWI^<;J<N3UR_YWKU]_=)4OM"E
MNK?"59N-M(<;59C]JY/!27WC0:_6GFZ<OWZYE2OUJ/RG[;W%K_.&2JXWJG3:
ME,*JY:N3Z\'/-R-:SPO^T&KO.M>")%D8\YE^W.:O3OK$D"I4YHF"Q)^=FJNB
M($)@XZ](\Z0YDC9VKVOJ[UAVR+*03LU-\:?._?K5R>Q$Y&HIJ\(_F/VO*LHS
M(7J9*1S_+_9A[7!X(K+*>;.)F\'!1I?AK_P2]=#9,.M_9\,P;A@RW^$@YO*-
M]/+U2VOVPM)J4*,+%I5W@SE=DE$>O<53C7W^]=S8K;'2*Z'+8&+HZN6Y!VE:
M<)Y%,C>!S/ [9 9#<6=*OW;B;9FK_)C .7AJ&!O6C-T,GZ7X1F4],1JD8M@?
M#IZA-VH$'3&]\?\KZ/-D!N*;A,3U\B#%[WJCO<K%Z7_^-1L.^U=TDR\'5V=I
M E.Q+^Y4<8"5_5IH[Q -"Z=S+:U6CKQ<60L*W@CIA%\K$4G-S68KRT.DE@KM
MA!1K4^2Z7(DL/ 1#6<U<+BH8PC*)0NZ=,$NZ3N;RL)&EN'6%+'/<+<6=M-E:
M#(>DZ<%E[UB2A<KD1C&5IX>!("^]E];K3&\AZ7 TN,+_X\D59'GL7??$Z5H!
M*I8>G-2R)4&VCHK$C95?==%H2I!:E866<E4:.#W+\_[A[;-GI>#2FFJU9FZ)
MRT*Q:8+DHE%-8A5 3);Z:S"=+L5O%0X+XG_:DO+]6GJ18W%ZK(]<YZ(T7JSE
MCL\ /&6X#8RT3 Q6*7,\Q:T2) /W!>1URH=GA98+76@/<R?TNS0(9^A'8UF&
M$(**5>F[RX2Q?)3V. T(+*XSR$*V* ['[)$&!Q=7C@@Y4^B<%;<$"V5&]+L.
M2W[G)<Z317& 2I;DFZRHCC"UC8.!1##DD3+%L3)[XB.>SFM_= F;$GYT@+N6
MRA-$$]4UP!*D5%YE@1U2Q=8X+U96YE6(+N>UKP(C2P,L)$67 N3@ B7<VF0L
M'^PWF$46-7P;8GGEV(G(7\GK"VE7"L2;\Z",%9QE2XR1/&6U68 ?<,;D\=@I
M9#NB'<2M2F\/S"5V.&5W.E,NN FYFM5.A7C-%>+;;,E4O-S)0A%=SD/6E$0<
M"L^U\U8O*A*@RQ5.LD2J*ZC+-+E9"ET7+#&.*^DOT?<J6Y>F,"OF^I@4%I7^
MV"2R< ;L(!1=(P9%I-ILS3X:=[L^.)PLRUI^;1$+&OX,E7GB:&O-3C,:N&H+
M1_ ,#,!*G4$!F79L-+^F</1B8^#*2LCMEKTNLWK;V#Q7!0#1@B+EYTPE0"<4
M ZP^;Y#<FJB6XE'*1Q##EEZ+PD^C^4.#:)<!T=*DZ\+ E14AM#X3-P_B5R4+
MX/#S$!:1JEG>XI04>Z!B<7AA]B6(-E#.X'ACODH$]UNR2,8626YOQ3O LH'4
MXK;<P2.IOF'M?Y>'.Y07  $/6>G)Z&JE9</3W"J7(5IKEFJ'A+-2LLG%+Y6T
MN83X;^&C2I5Y.#! SP^)75-HCJ"=>TD>JI[@0P,_;BVMHGP!+[OB#:<:"F^8
MV:]UMDZ"T@;]OOAW D)W*L]4 7UI#\,*)=[NF-5C=HY7'3$UO[D1?ZJ%>"2W
M#B)AMQ(?+3QYHYUK!(2/_$YN?$09VQ-L[V:A8\Q!2$'=&CDI.\!?U58&F&QB
MM@-(%$:,0Z2B1QP\O+@R4'A5& IC1T9%R,25GCA<4O29(V?%WN^IIRLP70\F
M8=FG4M>G=3Q/P.?ND?'AOD;,H5:+>T?2?WI[/^\Z=@.#V1I1^%2T=PJFQ=,W
MC&(9,.8#)=%2)8-9B+KCO)']56G+@"5D#@D"4\PS(9DE; 9I8N)8.Y+2<UP
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M6IP^>_D4Q]. W[6Z,]'?&>YDV32?\,-E\=.C)PB0*E7>X0P2_G>K+E19XD0
MQK_MG(_\DOA@_+>;_0WM'?:RE$9=-.4_==%M?GKTXZ.L4"O9E]UU<_=6V?U\
MA_/E36GHO]D=CWUZ]BC+>],UE7T8(*ATS?^7GRT>H@=^?++G@3/[P!G!S0L1
ME*]D)U\\;YN[K,71,!O^05NEIP$X72-1;KH6?M7P7/?B1J]KO=*YK#O 4-[T
M=:?K=;9M2IUK99X_[F 1'/HXMQ.^Y G/]DQX>I:];^IN8[+7=:&*=(+' )T'
M\<R!^/+LWAE?J7R>/3V=96=/SD[OF>^IW_)3FN_;OV[+]T]XED53BHDIL[/Y
MJ7@IC389B%$&TK.5K22N;%99MU%9WM0&!A>R4T6VTK6L<RW+S'3P!8A 9[*/
M&R4NFFHKZ]W?__;CV>D/Y^: IS;R5F5+I6J[*(S3->VZ+6"T F[K-MEEW:FV
M)H#@\3=^HFNU;5K:R4TGZT*VA<F.+M]<WQP+:3)M3 _S+7>T@W2.14!">/1E
M _^#"18W+X_GM*$_M0&4Y6RC031:P'@)6# =2J8VLTQ]SM6V(RP7JM6W$F4^
MFEG7IFM[GKK;R([F%S1_I:3I<7[X=B5UF]W*LE<.SA8P 4"!'@(%*&O]A<E7
M*).W>LEH_;6! <"G39[WK87TE[[<93\@[Y[^8Y;= =HL?^"& 4K\8C@I\ 0
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MXY#S2V/_ NY'OUD?P*,(+>+4RP,][R&/< RB4UM:+>4 VM<WOR^N#F7.>![
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M?T&@$B489/M)8?) 4+EM@XHD5WW'^JLN>M/!DE^E02Q<[S[\G'T$[C58&%/
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M&(756'^ $L0P]?Q!H!QOWZD2R%SQF11)"H\9P)UM8*<?VU3]G!= 7('@8\(
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MXD?(OA9:WBYQZ/)UD8U;7(L8\4*0I,CRJ)H]ZIK<7!W'_<B!:]E1(N/(<L-
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MHH>YY'>P=^E\&9B#H@A(ZL<YS:Q;>E#6I/W=$PIGMS^@)V]X0$_<TP-Z<GA
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M'VD<%PT\&UI'-<<5U8E$P1O1EJFBAOUV@,?1_O/V3>;4;S?Y/ZZ>5&/X_O2
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M6AWF01*<%A[$MK)N(5K,=GR+CVA_[.XUS:*>4H@&I1%*@L9R'MPFU\O4Q?N
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M9WMNVS#,6_ZHWI3^N)8V2-:94FY#S!^%N'F8@;$W&G.0]8ZG)ZVG3L1/&Q\
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MB7WMQZHMWB8B_?>JVV,+EH,F2_:&:<&MT$QQ[P6303$I>2@]DX(KHYE4/.C
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M:F#0R>PVSZE952U:FD?T!#UZ"70!*[0\U&N@)TC]-C*X1N9IOTQ-W5347S
MY,GG6 TL4G_X'7VH":%%:QRJ+:OJ_Z#YG7J/^><_&ISU0%ZA.4JLPUTEMU@O
M2795/,4AXI:PZ@>"KQ*K3P6-5N<Q7K.O9ZRJE"+]YT4ULH@F"Z:[?ABIYZJK
M,7+VM(GP)OL-X 8H'3C6$" G];B!877JY5XW<1E^1)O^S):PQ9;-$.MK]F'-
M:/,SF/BM 2->G"L>T]B@881N-)NA_O2'H*3_2\H$'^-0+5M\V?;[;LR\X&'F
MW_5GX(E$FC;/3F%TT5WZB+GB/%+I4J@.^488=/Q=?Z\Y7YQ=2;9Q>,@7KX0
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M!YCKZ 6Y2-N@R!J!U\QPEC_'\G?HBZH5EO!(11AO'[ \I6/E=%[XECH$Y*[
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M4<6*VP!;^!7S_5>P:#"TX""2(O--M.EG;4G3]=I4HS9UM;_32CC'"EE+@)U
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M-1-X6,&A=@L 0MVYU"3@V#%W]E$\$M/;UU_OD]/;LG:02)]^ " ,91Q;29P
MA"A&7.$<^N .#HTM(Q]GY#X@&2=6@K#K2V^):[R8;R)"7.$F!*[GA)CO\GN[
MKN5Z(8.36%$84<N&&^#^J:Y2^S] 1OU&OCGN4Z_GXV2.%\D@I/=3Z:RVPWT>
M($R8Q)9'Y#\B84@# *Q'_9B@E^L3CN%18S%J[K)L>)2!_PWT<Q*'7]UV0WB?
M"&ECAU^7!0MZOA5Z\2']L$7LR1@AJJVA3'PKIH;%$_33;_<;?)A7_?W$IA]V
MX)^-P'$!B N*N5$$0&(+G^EU_L#A1L%)(#"$+9.R%70:P<4[SSF(9/T">:5G
MBV^>;:KTHI/]OCS?=WR+_^IS?WU8TP=47<^"G&\M>,_EN(XU11\KO)W1H5T5
M%7%Y;-D4I,= 7 !4AA [.^&&3HZP?405?1U6,]($ZJZZVC6 2UHQ#!S3.$ZB
M9IK0NS;POLW[I7E->-#BYQB$V3ZB<'TUY*8VO^YG/>P0+!K'"')":@I T)W$
M(;@!Q\21'?TK!51WM0-.2<34@NYB0P 6.@<TL&=H\']- 7N> M1&'!$!H.X2
M^PPWZ(=/'&J>L#V'6I_<*)%1   "";TT^?&-"0G,2Q/]*PA "&CHFS<72(/J
M=R"Z]Q&Z0O@\_EVH70S2UR/\>SXQ@@OLDWYP$Z(F]*:;4#^5#WUMSNT$U(5L
M\YZN>S;0;4H )_G/$\!)9@D015:,8R\BPK]'V3$OIK?[;5*'] ,Q$BK%IIYE
M0ZLYS -+7@@H/>K.!#*<Q.)>.\?RPT2_I^"% 3=[ZQ=;CG$.Q6M'E- #H8$H
M?3587_##LQ[[+G2DFU Z#<H^)#)%4'-)(+V(6NG-N1V;"._VLPW-H%O([4M[
M-)_XR9*N1&DZ:)O!R:.?X[@DIWC\(I7.R.B?WTC,6U1R[K>27HQ^-0H:_8Y_
M&ZO1P9'^ :G^;O_S6Q?Z5Z>&X?JWN]ZE]1UY\(5:8ZJ]C()G^F6F[DM;[?@W
MJ&ZK%N:#/VX4S&M- _!\7<$8F2^T0?^C9+_^#U!+ P04    " !9?YU4 T?T
MKH4#  "^"   &0   'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6RM5MMNXS80
M?==7#+1 D0#:Z!K+W3H&DFP7+9 4V23=/M/2R")"D2I)Q9N_[Y"R90>YH$7W
M11R2,V?F'$H<+39*/Y@6T<+W3DAS%K;6]I_BV%0M=LR<J!XE[31*=\S25*]C
MTVMDM0_J1)PER2SN&)?A<N'7;O1RH08KN,0;#6;H.J:?+E"HS5F8AKN%6[YN
MK5N(EXN>K?$.[9_]C:99/*'4O$-IN)*@L3D+S]-/%X7S]P[?.&[,@0V.R4JI
M!S?YO3X+$U<0"JRL0V T/.(E"N& J(R_MYCAE-(%'MH[]"^>.W%9,8.72OS%
M:]N>A?,0:FS8(.RMVOR&6SZG#J]2PO@G;$;?+ ^A&HQ5W3:8*NBX'$?V?:O#
M0< \>2,@VP9DONXQD:_R,[-LN=!J ]IY$YHS/%4?3<5QZ0[ESFK:Y11GEU\8
MU_#(Q(#0(3.#1E+<+F)+V,XCKK8X%R-.]@9.FL&UDK8U\*NLL7X.$%-14V79
MKK*+[%W$SUB=0)Y&D"59^@Y>/C'-/5[^'M-OGNGU6TR? 1<3<.&!B_\MX?LX
M:0$.*G@!!?<M!HT2] %QN0;+5@*AU^J1UVC M@C-JR5 RU$S7;5/H!KO=ZFZ
MGLFGGS[,L[3\Q0 S!BT-L@;!V8H+;CFZ91= !X#="O5T",XO(",Y@3NZ'.J!
MRB"_UY,'KW,)[I5E KX.RF(=])I7E(_OODYZL_6#J^CH"A]10'H,=WPM><,K
M1K%J95 _>OI<]L/>+WON-\@W/?/C8,<KV/$*SKT,)+&&3<NK]H 2B:$1:FXJ
MH0Q5?*]9C8$F".[A"5@J^;$:M"9VQY"545%D\'$R@JN]L/\JPY5BT@3N2!HN
MF:S<D1^E43XOHS2?'1/TLUEP1>)B<'A\1V5:1,G\U/ON[>"\JM0@B6C/GKPT
M5@'=C\)E,"U5T2I1HR: 6?ES-,_&9'L[^(,.;1]]5&91N76:S!?J)C]2W3*:
M927EVX[!+1I+KY![E2Z9:2&+DM/<B3^./T;[65X2N7P48[)?T[TH:#<9/??V
M?]#]-)U'69%X@+W]0O=9E,[34??)I#M"8["A!T@%5A.1QF&NT&X0)?C7WT ]
M:)=V]SG[$SIY[1*,#WI*AWKM.Z<!SV1L+]/JU)S/QYZT=Q\[^S73:RX-"&PH
M-#DI3T/08[<<)U;UOD.ME*5^Y\V6?C!0.P?:;Q0)L)VX!-,OR_(?4$L#!!0
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METF@QK$/B]9LJSB?Z8\3Z<D2YKF=\E&:7-EM07.FNKKEG'YQV@1/8^CQS=5
M\ 5'1@-MN7Z$D[:$!58F89)0@@(]ZD\G*5KI*.LG<1;\J^-<',$]$_ R'GN6
M9>-Q/X%,W)GGTM7P,0 UF=+9R$TXI[-DG/73X?0<(/,Z%[P1*'.694E_-)IB
MSG#4CZ8)3UFA$G03H.W9-,:5871.%T]UQCW19X@TIFD2IBFE_6@RZH\1LKW^
M[L+PFE^[HN*P'CIQ3IX\$CG8KJAU=ZY%K?[RN?'@;A0<WXUH=S?:5;> T[:"
M@0ZZDKM*VY5HOJP[L-NG1I>,&:UI/QV/*85#8\Z!_1B7K#L&0+ %H-RY_P"*
M)V4O@3::20DH=\7\_B;2&,>K37?1>5)X^9H;D6SSSD'!\T7;JQ:'!:4H7S(M
MC\%C74'C*C9X@\M\5V"('$NZLMQOW.?KC,#%Q1.$M@1!Q!4.I&L<& C4')FQ
MWI]GN;!\E\NE>MC6RON+;[MRZ.CX=5R.<;A<%<I&L9)/O/!,#6^!W5_&X8F5
M4,6%JB]RL5* 6?C2AXC!P3>>2IJ%^Y*%TIMK9_^Y9S>Z^UAV[;\1[:?[+VTX
M\W!X6RKE'$NC<#SLD?%?KWRGT2OWQ6BFFT97KKG$+44:GH#W<ZV;;8<WV'U"
MO/HO4$L#!!0    ( %E_G50="A&LUP@  "\6   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;*58;6_;.!+^KE]!^/8.#:#:>K,M-R^ D[:W*=!+D&SW
M[BLMT391271)*JG[Z^\92G+DV G:72!P;)$S\\QPYIFASAZ5_FK60ECVO2PJ
M<SY86[MY-QJ9;"U*;H9J(RJL+)4NN<5/O1J9C18\=T)E,8J"8#(JN:P&%V?N
MV:V^.%.U+60E;C4S=5ERO;T4A7H\'X2#[L&=7*TM/1A=G&WX2MP+^V5SJ_%K
MM-.2RU)41JJ*:;$\'\S#=Y<Q[7<;_I3BT?2^,_)DH=17^G&=GP\" B0*D5G2
MP/'O05R)HB!%@/&MU3G8F23!_O=.^T?G.WQ9<".N5/%?F=OU^2 =L%PL>5W8
M._7XNVC]&9.^3!7&?;+'9F\8#UA6&ZO*5A@(2EDU__GW-@X]@31X02!J!2*'
MNS'D4+[GEE^<:?7(-.V&-OKB7'72 "<K.I1[J[$J(6<O/GRKI=V>C2QTT9-1
MULI=-G+1"W)AQ#ZKRJX-^U#E(M]7, *('9*H0W(9O:KQO<B&+ Y]%@51^(J^
M>.=9[/0EO^S9JW)4!>_,AF?B?( T-T(_B,%%.&6-/L9/O/LUUX)E?",M+]C<
M>&K)@%Z4"Z%W'OC,K@6[4N6&5]M__2.-PNFI869/])$;=O<;@W+\S6)_&D5^
M&H<LF?JS*/"#2<J2L9\&D3^=Q+0A3";^E#:,_3",_"2<L"3U@SCQXW#,%B?>
M?+GE[%+S'[)@MUHJ[5GE@&0 4@A7"$!+VW:8KF]OF*S8I[K8 GDX\UE?"V$D
M!8A%#A^-4;K3,(3OJ.9L[;<F*J,*F7,K<K:4%:\R"2>-Q0.4L34>"HZJT>T&
MK6AN9;5":1N4D.FT=H8W!)^U\+4 [_!*_N#D@C-\&/0PW8-^/.A>&W0$S ^"
M@(5^DL3^. GI6QCZZ6S,HHD_CF*&(.,31UBJRG-*#'L44.7P5PA75G#CD'2K
MTJ[9@VK<(CXP0W9%>[PY!7 I-*+8;5[SW&E:J@+42"(9%D!30DMC96;>L3?R
MA.6*5<JRE>:5W=?->!-*IV^MBEQHPTHP ;:84PA#V@6/=B.2B'\FP(&,@PU+
M55?69PA&+A]D+JK<9SB2-ECB6XVC0_##Z7#*+&BXR8)&C+6*<B>1N0 U@J?0
MG9-EF':A0E(\"&WEHA!(,BC,]L+9>D"9H"B.X?,P(3JZ =$W8RAAG>O2UBXE
MX(8PF98+"+9K]_VPS%=:4!:VQW%Y_#@J]3S"\(867#)2^4-W5[U:R')1:^.2
MNUDP@IPH)*@BYUVQ]7C ;S($9F"^E'4Y]!P>=@3/:^%C+X;O!75L&5(<]\1]
MAQG:T;J]IT .V4WES>%P0770EM5!FO'-1BO* +Z+AZPRC 5&N(*@S$65C=LB
MBQ)_-DL8ZFLR#;KZ(COU"CVN5[]DZ%)QG;OZED@TJUXW1QN)1/TX2-J2A>(=
M-21_Q856YVP&U#,6QE,_FJ5[:O<1_Z+>-'"$ WV?N<[6+/5;XCW0]8P3>ZJU
MJ%"*F5/95;!QU4)*MH)K)J@S'Y#DI 61^&$P9>0:#B@8!CT\:"V_# AIM<))
M*DAH#"@6+-82F.L-:UZM*(691%458H6@5+P41#%.WRU'EF=R@[84Q>$I/I/Q
MJ3#>_7 ^;*GL2#CM6JMZM78FI#$U;P,2CB=^'*.MCH,F_R;-_RB8#*,QBV/\
MZOD;S?PCG8\4PK-XFOJ3V>19Y;5]Z7EL+N_8[X(7J'%BCG_72&2^Y?Z.1XZF
MA$?IB]8?3"*WD>@YSR55(S9NN,S?]FBG37<<7# .A^RZ\C[5E3C$O]_^#I.S
MVLO*3OO+$:5$B9AC!V<P_ M9^VLV(Y@,PT/B%]^;=/):<N49^-;(CF][X0/L
M?Q)O@DJ1FV#++Q]NK_RN05A%UMN6UH05/)6,X9BI%UTW ;F#AM#L%]OGGH*I
M?O!*>1_R.N-9<US7U^QC7:%IYP)G\P"[=(=!NHCRI21GGS'_2.P$C]-*?+J2
MW)WLSH]NBGN>/ #FQJUV_5DDZ%&EJK?H(E9CRJ#&UD7#G=+'^?W<9]<?[F]=
MXGVIY$.+3;D'4.#MPH>H->'K-;0FJ7\B7V,4Y#AE&4;4_:W]CCJWWNOD16.U
MRRPR>]AW-'A%Y^3EHC88Z]$)D3P+C*+-B+"I4>T4-G0WI%AG?E?2T$;"@#M-
M_#'X@FQYO#"J\?-EY$^6GYZXJP/"C-/#[&:H'=,&2V!KO>W,+K4J74C%=Z$S
MV90&[GW95\S(#6X<A>?.4"[J_@C?%5BKR8%")MS]C]W>W3!<?9T[_=+T][Q$
M.--)R*9IS/(3[_VNB]Q4;+\Q>3]=XDV6HH"+8C< _8WVM".;^!A#[UG=\*T;
MQ"#N4E:6/<-]K^/4]8*?2K:KJ_MK5PFHD3_GM[]@L?%B,L:D@_O:Q$^G,5'F
M)$F9./$NZ^W;!<<10QTF^W)OMHB<L[@ [E4:KYJ&3[;!9-1'CPQ*2._^E- ,
M?XMGUH:H=**OW:G2COX&O[E(EGR+/-Y53;UQ-P(_P-4I31)*DQM8=9"GOO?R
MK7?1X<R/#725>&Q1]&SMD+X&)$YQ)0Y2]@=HZKBGS/*O5!D%[O-4KSS+%%HR
M-1@WB;?WUJ:N#0/-\44AS1K 6KH_C'&+B8Z\2:T>M*="<0LHZ:RVS87QWI7T
MC2MIW,T;>%U!-!OE0S,\]V(XA'/2[-RARROP9D5-":MZ!]"F[)"]KXEF#D^C
MAS)GD1\F$0T0F'&'TPDR<TCC4>C>0; $:Y/)C*;W<#9UX7VZI%*$$,NBJ%W#
M:B^&5>U2ETJEQ+FZ^[[KLRW;>?]Q&[RGN_(<%QN.)MYP\1OL;:I:HIW<"2[-
MB7=36QQ(1;SJ(>4_\0H#U9:UKK*WWMW++GE_=*0K<L]Q;)]?.V9]T[IZ0E>4
M89 >2K5H]^@74A@3QA *P^$L>8[S@$> >#+&#2B:LEDTQ 7EV.NM4>\E7BGT
MRKVJ),.83IKW>;NGN[>A\^8EX-/VYE4JR'LE*YJSEQ -AM/QH+G0=C^LVKA7
M@@MEK2K=U[7@H 3:@/6E4K;[009V[X@O_@]02P,$%     @ 67^=5(;_-23J
M P  ,0D  !D   !X;"]W;W)K<VAE971S+W-H965T,C,N>&ULM59+C]LV$+[K
M5PR$'A) L"3*EJV%;2#[*-I#@L5NDYQIB;+8I4B%I-;QO\^0DAVENW%1(#W8
MXF/FFV^&PQFN#TH_F88Q"U];(<TF;*SMKN+8E UKJ9FICDG<J95NJ<6IWL>F
MTXQ67JD5,4F2/&XIE^%V[=?N]7:M>BNX9/<:3-^V5!^OF5"'39B&IX4'OF^L
M6XBWZX[NV2.S'[M[C;/XC%+QEDG#E03-ZDWX+KVZSIR\%_C$V<%,QN \V2GU
MY"9_5ILP<8288*5U"!0_S^R&">& D,:7$3,\FW2*T_$)_7?O._JRHX;=*/&9
M5[;9A*L0*E;37M@'=?B#C?XL'%ZIA/'_<!ADR2*$LC=6M:,R,FBY'+[TZQB'
MB<(J^8D"&16(YST8\BQOJ:7;M58'T$X:T=S N^JUD1R7[E >K<9=CGIV>T>U
MY')OH&-X5 W5#-[<W3^^7<<6T9U,7(Y(UP,2^0E22N"]DK8Q<"<K5OT($".M
M,S=RXG9-+B+>LG(&61H!24AZ 2\[^YIYO/DO\/4R4KJ"$UCP#S"XIH:7 0Z!
M&RBI*'M!+:M@=X2*/_,*E4#B;>.R5"T#:JWFN][2G6!@%=B& ?O2<WN$1HF*
M:0.J]JLWJNVH/#H@-SWXA$-@^LPTWA^0?;M#+BB-P"UFO&=E KR*QE+I#5>]
M=A^GC[RYJF9PRT6/,/\'XP[M2_MK"4,G>O-O> ,02E&+5:$7Z M#YTR/TFBG
M5!)5?%U!82H$=,HB4T[%2?7 ;1-4+C18-(#5-581\SU8[&4JN1_ZT;E]%RK1
M>P?P!I=/H#I7@PSL-95N'\/VQ(YXD242;UV0>G/RTV)Q-;T^GJBTS#;H]Z%A
M<HBU)X/NG/G-X*])?C1TB,_4,D:-2F3E-TH\W;U" ^C\V7'A#GMT=S#L48-:
M"2S<GIL_<"R:KJ(.)J99(:LQ$!76(73'1\%+[=R-\ +5$#YPN79*-!>7*WC$
M;E/UB(^<7@8W<!7 E8$$_](B^-"W>.16Z>##ZWD98( OYB0A6921'$A!HF2Y
M@'21146:![=,*BRS'OOSF&#!RP2;INAX3$46D2*-YJL$$#-?9=%JOH+E(BKR
M(EH6R^!N2"*G/D0:CZ76J@U^3)%5FD8K+##%(HT*YS#!^3S_CVQH]3<V#PPU
M]NUIUDR-%_,H31SKE2.?9XMHF2/C/$K1CWR>!4,I>R77WSS\]A;(+"L@FZ4+
M'"59<.%JG,273IPX<?):.8\G;0S/=^^;-58DU4L[=+3SZOD]\&YH@]_%A\?$
M>ZKW'(,I6(VJR6R)[5</#7J86-7YIKA3%ENL'S;XIF':">!^K?!BC!-GX/Q*
MVGX#4$L#!!0    ( %E_G52L1/F^CP8  )H/   9    >&PO=V]R:W-H965T
M<R]S:&5E=#(T+GAM;+U7VW+;-A!]YU=@U$['ZB 6P3L3VS.QD[1^:.*QG?:U
M$ E);"E" 2 K[M?W+$C*LB=.TI>./10ONV<O9[$+G.RT^=NNE'+L\[KM[.ED
MY=SFY6QFJY5:2WNL-ZK#EX4V:^GP:)8SNS%*UEYIW<ZB,,QF:]ETD[,3_^[*
MG)WHK6N;3ET99K?KM33WYZK5N].)F(POKIOERM&+V=G)1B[5C7(?-U<&3[,]
M2MVL56<;W3&C%J>3U^+E>4SR7N#W1NWLP3VC2.9:_TT/E_7I)"2'5*LJ1P@2
M/W?J0K4M <&-3P/F9&^2% _O1_1W/G;$,I=67>CVCZ9VJ]-),6&U6LAMZZ[U
M[E<UQ),27J5;ZZ]LU\N*>,*JK75Z/2C#@W73];_R\Y"' X4B?$8A&A0B[W=O
MR'OY1CIY=F+TCAF2!AK=^%"]-IQK.B+EQAE\;:#GSJ[5G>JVZF3F $:O9M6@
M>-XK1L\HBHC]ICNWLNQM5ZOZ,< ,7NQ=B497SJ.O(KY1U3&+!6=1&(FOX,7[
MT&*/E_SWT+ZJ2.O@I=W(2IU.4.A6F3LU.1,E&P#9#59&O6T5TPO68=U8V2J+
M"O5? _*>0@AQ$65PNVVH_(*%@LS1SU,6<1$E/"U*)GA<%#R/4U:D&4\S$7QP
M*V68R'*>)(*5)2]$SI*8"Y$%;V#35[(-?C&R<ZH.ZL96>MLY $=1R:,TF;*C
MHN2AR'$#O3S+I\%;:=K[8"/OL98<.]!)@)^7D"3=DFX*GD;Q-+A6;FLZDHAX
MG,?X( 1/8@*%9UDT#6[E9PHG3W@41U,/E44>JN BA=&KZP\?WU]",<]X&0F"
M"'->>G.9X"(NIL%[Y8(A:VQA])I5*"B#=6JQ"-QJ*']E+#*5BQ*N"-PAJUR4
M@N5IR+,X#&X;+(ME "Y&+*,JO>Q\VD>*OLO,R!5'8I>-DZV7I*3)KF9RLT'K
MFMO*-!L/[1E]P6Y!AETH8U3-]!WH<VA:\#-+0EYXE@62DJ8%RT7,BRCO60X>
M:TH881O=P%C3]1!YP9,B8GF$,&,69[P(XX JZ+5E1"5\0 U ^KUV9) !EEWH
M]49V]TQ:J_!?<X)#&-W0!7W$)&AUU2!"E(.3784,(D>?MHU1!&TYVZV4+\;&
ML96TJ''7V$5#GK8MVRCCYT%7J4#/VV8I?6%2MAND];D$<S3A2IN:K#G-+M]=
MWXB4^^Q"I6JW:"1D< >#<!@!8$Z0)-HL7*$$F9%5LM,]%)#U::.X0#[P+.*P
M#DH0I<5X3%G#8D:SYNSZ1]1U)IX6QTX9U9LB1F"6\!:-L>XIG/ ^4YV9NN=
MUG>4#3M4V!CQ,;M=J6 @Y4_[?77()/R@- /WW,A_FM;#[+EM$+EV5(Q_@=71
MT7&!P\,#?E%0:FD\/<'&:-RNF9.?V=%5_R 1,+OLA7[Z(8K%*URC_)5F-QZ
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M&387?Q$,+TYO_>5KI1VN<OZQQ=U9&C+ ][76[O!"$QQOX]?_ %!+ P04
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M1UE1FSG4%J0B8$S9>?9RCK5*@'Q3(R/J]53L._&\,&H(#(),+)V1HX],/#S
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M'WUSP"'Q^G80T/1/L.A!?<$7X/=-T_3Z!T[PT+3O:7G?_%]02P,$%     @
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ME% =#M'0BF)B;&Q)S"DRR[ /H#EV#VV,DV \'9_7*#]4 4%]N'>IM/A&R/9
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M.@]WZ29O?BX?_AYZ>TR4-ROSNOVG#STO']'9IF[*5;\8&JRRHGNFC[T?7K-
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MG*>"GY P:,UF#"O51NOB"#.7LE5"[Q(=I_(UEC7"K$2%,>"](T=,@2F)/OW
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M03U@QC5H?'%Z"*O'2CM:9,+CEC9'-%Z [M>:/FV'%^]@VD67_P!02P,$%
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MH^L@E^49&S?&H')[O5NMCHOMWD;^6O"9D,*CL%%1Z$;1Y4N^#M2<!JHYHKX
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ML58-%6J-I2BX9/3OU)I<Q\&CJ[E 64*CA&M#UOW-N\W#'=0XD"?*!CU[M]*
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MTI(;^-!1_" N-)= A^@4.>XDCE N0H0/R(C@,;6S]Q&UL6HR0Q<+Q +A6AQ
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M'LIV'R_G%;YL3C"'FA[$<UXI(+#(-=0)C6\'DAWVF"FO\*V@ZG3,*S@EB$N
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MQ8$VX/VZ[\?CA!2<KG*W_P-02P,$%     @ 67^=5*+PHQ,)#   M1L  !D
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MG7VUOWO[_/VDKWV?^RC%<[J\>Q_%4;V*(@3^K;ODOG3+7?'RLK9TW[I[C>#
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M3!L3AM+W1&2X#[V$0K.3R21?P43:>7B5<P3'.=$K'Y+"/N3SJ2U*'H2Q%ZF
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MU?P1+KD],6\F9OV)D_O"V@4QTUM"SV9V3BW74QMG))CZ*GGDIITY@9\ WI5
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M "2'%5)=%^.FNY",9*1(8KA\!^UZFV>,DOCL! S[GGQ%E6(HJ'S6DD0G(;A
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MXJ7G!W'=]]>!<2WA^J#(MLR1241(M1T4#4'5UT;J(_=PW$E?(>BKF"HK9*^
MU!0B;L>&:]A&[#?KEH(4K[K1C<X06PB7)IV8=YR73.M=]K;/5M8!C5 >G04\
M3;+/'. M*Y-)N]MT\]?F[%],30<Q? [AN'=6'AGJWOU% /7^D"[K8_/=W>ZO
M#D[JL_;KU^L_6;A*BOL4ZY[;&8:*H] <U&>#VA]5OG0G[^_R"NG0?7VP@ L%
MO8#GLQS)M?E!$W1_B_'V/U!+ P04    " !9?YU4;:.][FH#  !\"   &0
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M,Z$)API#HXL<.YGJ>UT_,;)U_64E#78K9];X>P#*.N!^)9'#;F(3##\<RW\
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M;"]W;W)K<VAE971S+W-H965T-#<N>&ULE55-;]LX$+WK5PR$'A) L"3*EJ7
M-E W6;2'%D'2W9YI:61I0Y$J2=7IO^^0<EP7;0ST8G'(F3=O/KTZ*/UD6D0+
MS[V09AVVU@XW<6RJ%GMN9FI 22^-TCVW).I]; :-O/9&O8A9DN1QSSL9;E;^
M[EYO5FJTHI-XK\&,?<_U]RT*=5B':?AR\=#M6^LNXLUJX'M\1/OO<*])BD\H
M==>C-)V2H+%9AV_3FVWF]+W"?QT>S-D97"0[I9Z<\*%>AXDCA (KZQ X?;[A
M.Q3" 1&-KT?,\.32&9Z?7]#_\;%3+#MN\)T27[K:MNNP"*'&AH_"/JC#>SS&
MLW!XE1+&_\)ATLWF(52CL:H_&A.#OI/3ES\?\W!F4"2O&+"C ?.\)T>>Y2VW
M?+/2Z@#::1.:._A0O361ZZ0KRJ/5]-J1G=W<<2T[N3<P()6JY1KAZN[^\1JN
M/O.=0'.]BBVY<<IQ=83<3I#L%<B4P4<E;6O@3M98_PH0$[\32?9"<LLN(MYB
M-8,LC8 E++V EYV"SCS>_!6\1VKM>A0(J@'\+0%_BO@RWN<6@T8):G!" NL2
MYQK6=9X!VR)(FJY.5JI'X+(^YKFF>L%HL*8GKT7=U55>H>[$:.F!*@$5%]4H
MN.MA<P.7J0<N02Y+"?VD9?!I[%%SJW3PZ8R!M;K;C9YF8!7@U[&SWZ%5HD9M
M'+ C,Q"<M,!8%F4L!U:R*%DN(%UD49GFP2U*1>WHL;_XUL<ZX-_(VY["'?L=
M42(D6@/&4D0N+YZA@3*+6)E&\R(!PLR++"KF!2P749F7T;)<!G=-XQ-'YCX/
M;G@;K?J AJ%Z C7X5$"1IE&1%E NTJAT 3.2Y_E?LN'U_S1DE&K:;SYN]-Y_
M<5[.HS1QK M'/L\6T3(GQGF44ASY/ NVKG#![^6 JX<WU\!F60G9+%W0*<F"
MVZFVE]273ITY=?:G;H_/QIWJN_=+S4"E1FFGR3_=GO;FVVE=_%2?ENY'KO<=
M)5-@0Z;);+D(04^+;!*L&OSRV"E+J\@?6]K]J)T"O3=*V1?!.3C]FVQ^ %!+
M P04    " !9?YU4]'+-"9P%   -#@  &0   'AL+W=O<FMS:&5E=',O<VAE
M970T."YX;6R]5\MNVS@4W>LK"&,6\8")1;U5) &:)IWIHFW@I#-KQJ)MH;+H
MDG3<_/V<2TE.8L1M!@6*!-:#O.>^SZ5.M]I\M4NE'/N^:EI[-EHZMWXSF=C9
M4JVD/=%KU6)EKLU*.CR:Q<2NC9*5%UHUDR@,L\E*UNWH_-2_NS;GIWKCFKI5
MUX;9S6HES<.%:O3V;"1&PXMIO5@Z>C$Y/UW+A;I1[LOZVN!ILD.IZI5J;:U;
M9M3\;/16O+E(:+_?\$^MMO;)/2-/[K3^2@\?JK-12 :I1LT<(4A<[M4[U30$
M!#.^]9BCG4H2?'H_H+_WOL.7.VG5.]W\6U=N>38J1JQ2<[EIW%1O_U:]/RGA
MS71C_2_;=GMC:)QMK-.K7AC/J[KMKO)['X<G D5X0"#J!2)O=Z?(6WDIG3P_
M-7K+#.T&&MUX5[TTC*M;2LJ-,UBM(>?.I^I>M1O%CF[E7:/L^'3B@$IKDUF/
M<-$A1 <01,0^ZM8M+;MJ*U4]!YC G)U-T6#31?1#Q$LU.V&QX"P*(_$#O'CG
M8^SQD@-X-ZCD:M,HIN>L19U;"4]14=[SEQS^!;B ;";#0_R(,KC=U%1]P5QA
MS]&?8Q9Q$24\+4HF>%P4/(]35J093S,1?'9+99C(<IXD@I4E+T3.DI@+D067
MT.D+V09_&=DZ5055;6=ZTSH 1U')HS09LZ.BY*'(<0.Y/,O'P94TS4.PE@]H
M)<>>R"3 STOL)-F2;@J>1O$XF"JW,2WMB'B<QU@0@B<Q@<*R+!H'M_([N9,G
M/(JCL8?*(@]5<)%"Z?7T\Y=/'R"89[R,!$&$.2^]NDQP$1?CX)-R01\U-C=Z
MQ68H(X,VM>@!M^RK7QF+2.6BA"D"=X@J%Z5@>1KR+ Z#VQI=L0B0BP'+J)E>
MM#[L0XI>I6;(%4=@%[63C=])09-MQ>1Z#>:ZLS-3KSVTS^@QNT4R[%P9HRJF
M[Y$^!\Z"G5D2\L)G62 H:5JP7,2\B/(NR\%S20DE;*UK**O;#B(O>%)$+(_@
M9LSBC!=A'% %O;6,4@D;4 /8_4D[4L@ R][IU5JV#TQ:J_!?<8*#&VU/@MYC
MVFCUK(:'* <GVQDBB!A]V]1&$;3E;+M4OAAKQY;2HL9=;><U6=HT;*V,'P?M
M3 7ZKJD7TA<F1;M&6 \%F(.#9]I4I,UI]N']]$:DW$<7(K-F _H@A5LHA,%P
M &."=H)E80H%R Q9)3WM8P%9'S;R"\D'GH4?UD$(6ZD93RAJ1EEP-6?3/U#7
MF=@OCJTRJE-%&8%:PIO7QKI]..%MICHS59<#6=U3-&Q?88/')S]@KV3'7LFK
MZ68P]>X!)BTH52_1UZ_@!?U "!Y?L2_@=;,PLD)YH>[:#37<%>C(IYU==MT2
MW"AS7U,,KAKJ2;\8'*&DE3D>H!S5O.QX;.Q#&=P^K)6E_K6#O#9LH75%?9^4
MZ(*PH"XHBYB)5/ 2K704@TN*\2,Q/.=9R!496%,,<L?X$VA"<&.9##0;@?5R
M6M@'S4(>Y7G/+.P L_P?VQX;/7A*$7M&%I H4V]I3Q[/)%^@B)T+><A%%N]4
M=]0QI!+9#7Y'*L,NE>Q *L,PPO  A6,0"%A=8JZE$08#ST0Y?F3V(94=P99E
MSL,TW4EUF10A)D\:]9E,D88,[_<02XR>N/QI&E]OUXM,OV\@AGOLK=D1?W"0
MZ ./,)B?%;Q(LIWBCOA_<Q+IQ'(XB5E*9XJ090E.#B&+4Q1I2%6'R_AQ(C_-
M7Y84Z(J<H:>$+VXJUI(BW"<OH;F&WRQ/]P$3M$A>_"2!K[3IQ=SMC.MDO7']
MD/Y)SCJKC_?5=5/Z)=*?/#FB8S(L_(<(C4J<Q;K3^N[M[EOG;7?$?]S>?2A]
ME&918]HV:@[1\"1/1\QT'Q_=@]-K?^"_TPYCR-\N\;VF#&W ^ESCQ- _D(+=
M%^#Y?U!+ P04    " !9?YU4Q$B(%+4#  !@!P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970T.2YX;6RE5=MNVS@0?==7$'ZR 6XD4M2ML WDTMT6V&"#)MU]
MIJ6Q+402O20=)_OU.T/93@HT18&^2+S,G#EG.!S.#\8^NBV 9\]]-[C%9.O]
M[D,<NWH+O7879@<#[JR-[;7'J=W$;F=!-\&I[V*9)'G<ZW:8+.=A[<XNYV;O
MNW: .\O<ON^U?;F"SAP6$S$Y+7QI-UM/"_%ROM,;N ?_=7=G<1:?49JVA\&U
M9F 6UHO)I?APE9)],/B[A8-[,V:D9&7,(TT^-XM)0H2@@]H3@L;?$UQ#UQ$0
MTOCWB#DYAR3'M^,3^N]!.VI9:0?7IONG;?QV,2DGK(&UWG?^BSE\@J.>C/!J
MT[GP98?1-D7C>N^\Z8_.R*!OA_&OGX]Y>.-0)N\XR*.##+S'0('EC?9Z.;?F
MP"Q9(QH-@M3@C>3:@0[EWEO<;='/+S\^X_$Z<$P/#:N-\XZM7MB@_=X"FS[H
M50=N-H\]AB*'N#["7HVP\AU8(=FM&?S6L8]# \VW #%R/!.5)Z)7\H>(-U!?
ML%1P)A,I?H"7GH6G 4^]@W>/Y=WL.V!FS>"4A+/T[RG^%;R(6!/U!#^BBJXQ
MTQ%:.K!/;8V6TSR3/$V2&9NJ5/$\4SA*DY*763J+_H !K.XB.B3=8!FTSEM-
M]?P::YI+R7.1$4(BT8]&,JVXD,DL>C!>=VPJN"P4KX)5F18\2RH<9:K@58%Q
M[O2+-1W:Y07NY<1!J9PKW$,V4G&9R5GTR;A=ZX]T>FC:&J'UQ@+@;<4"FB*P
M4@2,@ZHL<2 01%:SZ :P==2MIALYJNF-]>U_80'-,@PA*0D"I1>*"!0I%Q3U
M3\#+%[W*%:A%4A#)LZ!5<56I6?35MUWKVV"2\%P1]8R7E<1_SG-9SJ);;%8>
M!CW46..H72A!. E&S"DQF'ZTNM]J"[_1E6^BVO04]TA3I3PMBI 2S'B@6W(A
M,/B#?GY#$=5710B?RCPPS:L<LPR-WI@-I2UZ+0#D49:!A^))6@2VLA#(0^,=
M''.M[2/X=MA@Y K/+A\CISFY"<FK'-$O.VRT)"W"ELT:LU_Y]1[/IZ[-/IP.
M!1+5R#X)$47&$T5%8O43=-\(R)0,J<TRDEGP! L3JW=PV/602+0&LDNQ3@6=
M<TH%%FBE/,D1\B^_!4LGD?(BG%:>\[(@+*K,K/K)ROS>A8_?=+T>[";T=L>"
MS+$!GE?/S\?EV#5?S<>WYU;;33LXUL$:79.+(ILP._;S<>+-+O30E?'8D<-P
MBT\@6#+ _;4Q_C2A .='=?D_4$L#!!0    ( %E_G52L'O+;>0,  !0'   9
M    >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;)55VV[;.!!]UU<0>K(!)A))
M70/;0)UNL'TH&C3M[C,MC6PBDN@EZ4O_OD-)=E(@"; OXFWFS#G#X6AQTN;9
M[@ <.7=M;Y?ASKG]7139:@>=M+=Z#SV>--ITTN'2;".[-R#KP:EK(Q['6=1)
MU8>KQ;#W:%8+?7"MZN'1$'OH.FE^K:'5IV7(PLO&=[7=.;\1K19[N84G<#_W
MCP97T16E5AWT5NF>&&B6X2=VMQ;>?C#X1\')OIH3KV2C];-??*F78>P)00N5
M\P@2AR/<0]MZ(*3QWX097D-ZQ]?S"_K#H!VU;*2%>]W^JVJW6X9%2&IHY*%U
MW_7I;YCTI!ZOTJT=ON0TVO(\)-7!.MU-SLB@4_TXRO.4AU<.1?R. Y\<^,![
M##2P_"R=7"V,/A'CK1'-3P:I@S>24[V_E"=G\%2AGUL]J%[V%6!^+>H@LQ]R
MTX*=+R*'X-XDJB:@]0C$WP%BG'S5O=M9\E=?0_TG0(2LKM3XA=J:?XCX&:I;
M(A@E/.;L SQQE2H&O.0=O"<LZ/K0 M$-:?Z0_9;:#['\4[FS>UG!,L2W8,$<
M(5R1]R,$7H,7$N.'E<&7OM(=!(W1W62I9$M4?P3KL.2=)2*E>2X(3VB2EX2G
MM,S2X'XG^RW80/6DD<J0HVP/0[0:C#I*7^ (8ITYC" W&(WFHB0W&-$!<G&!
M@0K0KB9<T#B)"6.TR#-2TJR( ZQTK.,^@',UA"*U:AKT0R4>[88P005GP3>W
M T.08BKPR\J,<)IS$4SEA 2]/I(E-,TRDG'*RYBD#&.4DXC_H>&&S!C-BWC^
M(@+.V)4LX$%<T$3D<S+#%*6)\).$QC%_PQB;0 OX@DFKY$:URBD4-<MRRAE'
MOP13G18XP9I+LG(^B<&+"6IE*WWP;+9&(FR-403*]N$*&A<,QY*+>;"6_7/0
M@,?-,:T>+:-"#+1\FN<?9WC&<EKFWCJA&<,1[^W;0^#DV1^. ZIXJ1B'=*P<
M&ISUS*F(L[E/5Y:Q(781L_ET6S.&]U7Z5.4TQ6SZ("E+YM=+F_)D?0H%FGJD
MLJ <<X$^G(HL?3&^- R6EY0+CX856^;>%&LN0ZEO/=GH5:?JP&R'?FS)D-RQ
M:5UWKRW_T]CI7LS'_\57:;98)WBE#;K&MWD:$C/VX''A]'[H>QOML(L.TQW^
MML!X SQOM':7A0]P_1&N?@-02P,$%     @ 67^=5+^]?S'7!   \0D  !D
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M[0PBQWMTY%B^%%;<7&FU!<VK"8T'+E1G3>1DQT5Y;S5]E61G;]YTA6H1K'A
M ],/8MV@F5TM+$'S@D6Q@[D=8:(?P(01O%6=K0V\ZDHLSP$6Q.E +-H3NXU^
MBO@2BSG$H0]1$(4_P8L/@<8.+_D!WGN2<SDT"*HB,16J*V0CA5,&S<A#&@ ?
M2/ &G\K!SSU\J-&K5$,RE]T&I 'QGQR!5=!K54D+TT89,P-J-; UPB,*[4,A
MFF)HA,42UH\@^KYY9'Q>0%!K(E'"K1;?V$L'Q@H[6*4?/4TFQ,%"G%R<01I
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M!9#@:P8F3"L9A]*_E\Y,LBK5GW;(I($5GP%.^3HF$6;5E9I7A*G<F<Z^"V7
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MV;O98KDJ+O/3$?*>1\@NB#)S%ZA8YH]PYCM#!7?39KMF;'5BC"\9T!Q$(G=
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M<H1WC')-3(^&"020Z$F@)_)_[-6#C+>2+>+HT61&)NQCOKF0L0L>X<(MT,"
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M#INI<9RX//%, -<0GP"6/ 1'S\A83ER4@,$<L,.B.;'((3AS)L1SXA(%#NB
M(1K1B84/P>GCC^G$I0@<U '#XZA^*,[RAN# >9\_Z*K>Q563-YA?5+%(330$
MY;ILX1%7ZEBL:R8()QZIU)* XB2X2#9I\Y/27TRZOTSK;0D.^?E ,9_)GU#C
M.J_#L2#QWF3=M0ZP(V',(T]@HQ9$E#P7=,'_@T_Y4I>K,ED&GW\;I!_=2V]>
M,K^A%BWTVS(<ZO)"AHH2)HZ[WS7D@I,XBCS];\%"OS5[H4!:$O(HDLX<@?*<
M*&3< Q5JH4*_1P9#@10FI(S*XP@-&!HK(KGT"+4HH=\WBZ% &@-/ ""/02>
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M6G!P'!Q30<>!? 0<>  AV,!;AG"<(2-)QUTPQ"1T> R8"<I]FW+"\D/@_)A
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M)Z8[&@-S_ZXHZJ</307]FU-G_P!02P,$%     @ 67^=5*-<.R,M"@  *$D
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M>< <IS*<4SLW 'C\\1L YAB2X0S9L0%@/J&U##( A <98%)LD&O.-,Z1?38
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M&QX_X'1RK,"[MS&(;N/^O@,<8&![ @ZPC\,&V/$'Q_FCUTUQWY<\$Z%27B\
MCH=AT]N=03BJJ6PQF[BC&][A<W8(-@[<VZ.4>#?W?9B$I@2X!2ADV&(U"4=%
MXB16)I[E^#-?. X2XPU*/,6 ZAS]B+&.(YY@0&V.@L1X%Q%/,: Z1U#BM*X@
MGFY I;7'7T[I]>')!M3IZ$N<R+S#\PPHT=&8&./&X<$#ZG+$),;8:]?)8U):
MB7.WHZT^2DTX'A$?Z;))M]++$[AL$G+9E(Z:K 7@-!&L0=(S ,9HG:,/>W&D
M($<Z;!*X%:55T\4"4$22YHT1*%<4M?7@J$..LN(DX+ )HH77@X_3C C:;,*'
M,='>A2,9.=Z&DY -%PI/"D$XPEGH30B XSQLL>"DHR0YSH*3P(VID'#N30EP
M9RJ*N'=Q  Z<O=A:##CI^$J>Q(##LQR_VLK:HYCC#3@\Q8#J'$?)L08<GF!
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M%@0=;6'_JN4KH/'IVF_#X=$F>D2G@,"W P(+DH^VU"-(5?A]2]:J-\GG=_$
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M 6!4!GZ .>"T/0=RX4"S,)H<^2)9 V!T#4R3EM]D/N2'PGK:@E0+(#CJM"7
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M)DME5NL#Y.]71;%I_Z@=/!3EWTWZWOX_4$L#!!0    ( %E_G53F=YU8, ,
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MH#?&.JBJ;XEJ8&3A.M.5-%@!G9CA]Q<HNP#G4RG-P\ VN\T7W?P'4$L#!!0
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MOA[Q](:9#28>QR_+]<1]5 +/,HQ3)S_/@'RC:4'--%(PF>7L:P&2%!(2@L)
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M64+N:\+?S @G$R)4U,! R($-*)P9:.7 ?C2^F@%%#PR$(/AY+,X,- )AB.P
MV4P*BD88")'P\YB<&6@TQ 'X_CC=#XJ,&"@=\10R9P8:+3'SF8OLZP%%3PR$
MH!CC<V:@T1 SWPX=9$*AJ(B!D!&;4SJSSE6OWW@^@DJ*9!@(S?")K,V,\#<%
M A0DIQ3$+\/KS$ C.V8VPOR"(CL&0G?\T[B=&6@TR\QK-P.-GYB2,@C5\NGT
MSJQSB3 )S O]0\N/]QE%P R$@ODK7UW=%5LN-\:D%M\<ML.TRL)79UT90U9'
M$2O#07'\0JR.HDX&0IY\*JN3= Z1:^';U'50GZ=#;,@WX'02PLD$=%'TRD (
MEG%.)R',I\2FI M"FFS"Z22$DRD1*HF$D!D3G$[2V?=W$XP_J$G)"H1ZV)C2
M20A/4QI(R0,.G@?,*)^$<#,E1@72";VR,>63$)XFA*DHCX&0'ILP0@EH%,5.
MP)"DKBB*@9 4$WQ0 AJQL-,]J4Y?N0+UA%Z89(,2PL.4JZ,@/2$4-J.+$L+-
ME!C51ZL19(T!G9003J9$J" ^(0X^D4Y*"']3@E7 GU '4W13 AJM+T+H*T)?
M()2^I[--">%R2E,I:8!0^YJS40GA:DJ<2BH@Y+X47940#B9$I\A\@=#YFM!5
M"6C$NXR-/X4'%.TN$.)= S8J 8TDMWV4U6C]2@X@)+G/XZ(2T"AO'0][9J$B
MO05">_L\)BH!C>*6A=B]#$5R"Y3F=@H1E8!&3>N[-C)_]=2';!H^=DA?LT88
MZP188RBP34ACS4FH!#3:5XP*4Y2O0$A?3Z2@$L+?%.!1X)M2O[X,!96 1@<K
MC@U4>;]U!;$M,EZ(GJV2! @![4_CKA+0*&I]!]EL!8J@%@A%[>G,5=*YQ-B2
M[F&?XTVO2&:!T,S*G4D)M^*,BWET6AWD7JVPZRHMT^S&Z,%8X"N)Q7_)9_>#
MHED%0K1Z*F,5=P[1YY)1E)4B4@5"I6I"6<6=D]X66'"168:B&05"-(I34C%A
M/@$)??6YS(1ZR("2B@DG4R)4$@LAZR0HJ;BS_T$O@%PY)4^0>DU#4BHF/$UI
M(@7@?1S@S4BIN'/3G\GZ/M)6BK03"&VG,>L4=YYZ)"+RB!M0%)Q 2#A-2*48
M-!I.)H _Q&)0P)?0<1*T4MS9]W=M!$& P(TBU@1"K4D22W'GH;]K&^L&"MP2
M8DPSWB@FW$P8+XIL$PC=I@EO%(-&LTF-%@5W"=7FB<10#!K]IA,Z6(=5GXU/
MW)$EB)\8--)-Y.Z]HMP$0KIY.O$3$RZG=!T%:@FIISGQ$X-&]BEB1_:)*+)/
M('2?%+$3$PXFM)(B# 5"&6I"[,2$DRD1*AA-2$,-F)\8--)0%KG(\Y= 48<"
M(0]]'O<3@T8NROQ&5HQ$I\ X(1E]'OL3@TY1"K8;(NBIB$J!4I5.X7]BT"A+
MG2 ,L3><*-I2(,2E& ,4@T9/"F$486MA15(*A*;4G .*.U?]2,(0>:\"A.J[
M3@A /XT'B@E_4U! 07-*4/HR/% ,&A5JP!#D5T2H0*A0?QJ;$W>182OW, J!
MT'6!HFL%0MAZ.L?S]\XE%F5D>XY+1=DDDQ\.*>A.J$SU[]G[3)G](1:<97OU
M:EYNCJ]*O6Z&C]6AWB_-M/$Z%</]TVW)6XI'=-PS^>7LM77#ZT?.MZUU7&SN
MT^U^8=9V#)[GS>5N!^5=D8LJCS4=.TW[TM5#GWJCNOFER5#-/W%09*E1ATW$
M_"_1[:KL@>=/EAB\]PU:-S"U;N>^3\U,;S_[.PZ\QDW>S(W?-'3$GE@2?3)_
M_<9ZO,N:M[X*MT7Y2YN/;G@7\__Q9=M14FN9I]G&NGEJ_==W6;D2@T4L2]\<
MLU?;Z1N[M+$I19YM_BZ7N[(]U<9TCPCBMV*354U\;T2HC9BP+MJC^W9=YD7C
M\)?FY;/'!E1Z9_56U[_.E1?IBJGC;?L2ZDK SVY;[U^;>3QZ?-/UY_8-P8/C
M$7OWM>FGP]^:CM;\UK[S]UQ6LW^]]M>TO!5I0DRWUZ)*^VVSTBGW+ZS>?ZF+
M^_9UOC=%+>:W[<<[+E:595- _+XNQ/3S\*6IX/C>\(__#U!+ P04    " !9
M?YU4Y >=;GH"   H!P  &0   'AL+W=O<FMS:&5E=',O<VAE970V."YX;6R-
ME6MOFS 4AO^*Q:JIE;8 YIJ,(*U)JTW:I"K=Y;,#)\&JP=0V2??O9P-!Z4::
M? F^G.<]%SO'R9Z+)UD */12LDK.K4*I>F;;,BN@)'+":ZCTSH:+DB@]%5M;
MU@)(WD(EL['CA'9):&6E2;OV(-*$-XK1"AX$DDU9$O'G%AC?SRW7.BRLZ+90
M9L%.DYILX1'4S_I!Z)D]J.2TA$I27B$!F[GUV9W=^<:^-?A%82^/QLADLN;\
MR4R^YG/+,0$!@TP9!:(_.U@ 8T9(A_'<:UJ#2P,>CP_J]VWN.I<UD;#@[#?-
M53&W8@OEL"$-4RN^_P)]/H'1RSB3[2_:=[918*&LD8J7/:PC*&G5?<E+7X<C
MP/5/ +@'\+_ *0]>#WB7>O![P+\4"'J@3=WN<F\+MR2*I(G@>R2,M58S@[;Z
M+:WK12MS3QZ5T+M4<RI]U!<O;Q@@OD$9D04B5=X-X+FA.\*@4A)=+T$1RN0-
M^HAN5]_0]>KJ!JVN$*W0CX(W4D,RL96.QZC:6>_[MO.-3_A>0C9!GOL!80>[
M(_CB<MP9P9<7X^YT!+^['(]?X[8^@^$@\' 0N-7S3^@M#L5?D^I)7_6:2ZI&
MB]KIA"=T]*G$L1]'8_4\2P91A*=O).,-R7CGDSFZ0&-I= I!JV"ZV2X-0\>)
M@L3>'<?\O]DTCCS7&\Q>!>@/ ?IO!6BZ[TS6)(.YI=NK!+$#*WW_S@V=3XM3
M_X*Q)/QS%8W\. CQV&&<15W'#QQ_C%V>9:>^AYW16WT6#3$.G;$[8!]U&?.&
M?"=B2RN)&&RTEC,Q75=T?;F;*%ZWC6?-E6YC[;#03QD(8Z#W-YRKP\3TLN%Q
M3/\"4$L#!!0    ( %E_G51Q=N[7=A$  (%D   9    >&PO=V]R:W-H965T
M<R]S:&5E=#8Y+GAM;.V=6W/;.I* W_DK4-Z<W:2*8Q,$ 9*Y5<5VG#CQ+78R
MLU6GYH&2:(D[%*G#2WP\OWX;O B420)09,WLPSXDED5V \2EO^X&"+]]2+-_
MY(LP+-"?RSC)WQTLBF+U^N@HGR["99 ?IJLP@2OW:;8,"O@UFQ_EJRP,9I70
M,CZR+8L=+8,H.7C_MOKN)GO_-BV+.$K"FPSEY7(99(_'89P^O#O !^T7M]%\
M4? OCMZ_707S\"XL?JQN,OCM:*UE%BW#)(_2!&7A_;N##_CU#VP3+E'=\M<H
M?,@[GQ%_EDF:_H/_<CY[=V#Q*H5Q."VXC@!^_ Q/PCCFJJ B?S1:#]:%<L'N
MYU;[6?7T\#23( ]/TOAOT:Q8O#OP#M LO _*N+A-'SZ'S1-1KF^:QGGU/WJH
M[W7= S0M\R)=-L)0@V64U#^#/YN6Z AXUHB W0C8N@*D$2"Z DXCX.@*T$:
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M-J&NK$D$?+"</GHS^;;1LCF5[9&&$:S!<MC\\ER^Q4H3[S!9^PCCCA76'9W
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MH5B@3B;0^%(I^_R2W(+E-[>#_P!02P,$%     @ 67^=5' 2WJ(P!   \0L
M !D   !X;"]W;W)K<VAE971S+W-H965T-S<N>&ULG5;;;N,V$'W/5Q#JHM@
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M_PDVGF'229*;4H&&8;/X+B,V82!D+P)N+9?3G^<W8+Q5#=RM&BZF(+I45K\
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M0)K:0"I))92:@PX -\]D(@_MJIV=YW2T[++-PG<XJK$Z"V#U=#KK\006#&0
M=45:9*41&+ KRD(:Z7 %S-*LS!Q[7)G&\,R/X7]OZ^7ZH6EA"-ZF ]*36(ZJ
MS*:'\U2DCD'0Y)#YR>'3R[K[I/_VK19WLV7MGE1AG]BDF9#FG-IF*B_,@YT*
MF(E"D -),LU"F?2&<S-;/Z_6]1R%\"G0]M_T'QBXM >>\E0Z=K RS639&":#
M/)*!L\4B+W,3*H =@I0*V!F0<AB3YL9L##?BL@EP"@EC0AR*8H([3^Z86"6(
MGT;][#3YO\F@&HQ,LV*6GY"R,DV-61%MSHI T<!NRKP7' )Z[W=T."B:Q[,
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M>M_8J+XTG[Z]"5W$14C^9F.^3?Q5B_&JY8 &68<SLK1N%:"AO=XJ;'BPWHS
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M0H&%!R[Y<,'4W402K9Q@[^J(&0*&<(80/7MF2+&P3E!,,%2S2# 5.)&<LIY
M,*4V$5!J&S2CX %T2@I+>1P:9JDT:WNAG5*%<Z'F+*SQ1_V!MF,PKF =>\=1
MOP!J:5*E9BU8Z!I.;+>].VO!!)-B$_&DV 203CLG55HG:]C07FP5-#Q8;(=Q
M,3$V$1!C"P(W4$P[SU/S532WT$Y),NNEH%V'F(XZ,,$4V$1 @6W(UYS@"T+
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M>Z\/3V1, A0[GD)?.\K"U/C&7NH(9Y3SRSTQ8&8RUB"B@7%LV33S2>Q1/7K
M,>B=(.^Z(T&&'4]_'44[Z*^]U!&AD;C&AJ:_#&"UE%*F'RD#[("5F0!FMJ!)
M8&5]4U\&'<>&' .0%G+,-+,X%DI #NV W $.O3+?4()K."3S#24DAJ_$?$/@
M=#$-](..=Y 9QH%^<\/>Z\,7<BB1.CR>M=J+'M$KB>OAT*PU-)'Z,@J(O@@A
M,S.,"62V$\9=/R5<AZ?QR="\+7W)>Q?J7@!FA :&%X"9Q0N)TV'?W#,T(1:,
M#F &10<PL_BEO(YD1]V;]C7)K+JLLE5"-%]DW"<)2E -AR2+H<2T\)7(8@A
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MYH^F7'"&=XX>RJ8IY^W':99R-! &_/JD+)O-'Z*!Y[+ZHQWR3_\/4$L#!!0
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MK-PD+$N=_56$F=JEYP;XH9\$)O"S7 6ER5T8F_'H3^:ZPFQT%H/M&P!/^0;
M]@V #W\#X#;9!6>D%3M#9O6RI^4_F8;__<U^G/_$\I\<B?_$43)!3#+:Z%J7
M'90(=?6M)3D92_*E2E79S8$M(FJP***\2-7HN":6Y632FOE>T?P?5,U[70\(
M$(MQ,@W&B0//GO!:^<*P75VXQ3@Y$L:)(^7&$+>*ABX[A#"B'4HMQDD_QG^-
M0W"ORZF@)!T5NA;)9$HD$XMD<CB2B:,PPAEKSC@,FM6G<BR2Z31(IHZZ"(*$
M-U\EPW9UX9;,]$ADIHZ,FS",FO'KLJ,8\XXGC5HRTWXRE_'[ &['A"ZUU*53
M4I=:ZM+#J4L=Q0[2[M<!J[JPO4G(B68AVT!%1&+1"MQ!N[IP"UYZ)/!25_Y,
M/=*:,77DSU0@W#%<IQ:\M!^\G\%U-?2['Q6ZEKIT2NI22UUZ.'6I Z>P/1LS
M:%:?C;;49=-0ESEH2B"#S7K>L%U=N*4N.Q)UF8.FW R;F_,"+CN&9>>$OZ4N
M&ZI:+\ =6(++,<'++'?9E-QEEKOL<.ZR-E$A](AHEBZ&[>KB+'O9-.QE#J9B
MZL%64 S:U87O+0,YUCH0QT2A!U&+O0X[+#PF.O(R9MG+^MF[3,O%?+X&=RI6
MSU6T@2])$F55B?JZ7/&7)G'H5^ND_#2L5IR-"G7+:38EIYGE-#N<T\Q1BH88
M=^6]W!*83T/@_F8_/M+D%KW\2.CE#J26[.VHIW&+5#ZP>L/L"/UJQL\/JS6K
M#\E3_J92/2;PN&4LGY*QW#*6'\Y8WF:GX&U2#9K5I5G"\FD(V]_L >%IT<J/
MA%;N6F/'J6R.>)UV4G@=]02^M\IN<*JOBN*?5?J8%*-*"MQ"DT\)36ZAR0^'
M)F]#DWBH YG"(E-,@\S^9C\>D\(B4QP)F:*-3 EIQQA56&"*?F#>)?ZHU9F6
MC&)*,@I+1G$X&84+>;RKH",L\L0TR!.."JD@5#8'] X[RDC'2U%8[HDC<4\X
M4D7*N)!-G1N[GH7<'.&^A?C"DE ,5E:?4Q6G83(J3/=6$4\)06$A* Z'H' M
M8O \WC'XD1:#<AH,RO:8G"!(NY; 24LY>23*R3;E&#;)2L<;55K.R7[.W8/_
MFI'V/?C/F#"2EG9R2MI)2SMY..UDFW985-]1.+O,TDY.0[O^9C_^,I46=/)(
MH).# ",&>Z)/5$FP^A[+'BD^MC)F*ZK?:W%Y^16H#*QT^JP#\/@-;!>$F4'.
MG?H&X(__*C]_^N02/=_[<*SR+S_ RX!??M*U^?1HMW?SD=\"GEQ5W\(U]E](
M?G)EKKU]Q,A__RYP;D^Q^:KP3J7/89R!2#^9TWF?RB% NOE0;_,C3];5IVN/
M29XGJVKS1:M IZ6!.?Z4)/G[C_($N\\ES_\/4$L#!!0    ( %E_G52%>\:)
MU0$  !P$   9    >&PO=V]R:W-H965T<R]S:&5E=#@R+GAM;(V4:V_;(!2&
M_PI"_=!*6[!QDG:5;:E)-&W2+E&ZRV=B'\>HV'AP,K?_?H"=*)42K5\,!\[S
M<EXN3GMMGFP-@.2Y4:W-:(W8W3-FBQH:82>Z@];-5-HT EUH=LQV!D09H$8Q
M'D5SU@C9TCP-8VN3IWJ/2K:P-L3NFT:8EP4HW6<TIH>!C=S5Z =8GG9B!X^
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M>]AOZ-SCY5K:\$MVW=HI+LY;ZW2]#T8&M5#=ES_N"W$00.=' M@^@ 7>7:+
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M=;J::#$O[XMCH<WMLQS.S"<(2&M@WD^%T,\3>P5M/FH&OP%02P,$%     @
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M(>7RYP/+&RWGU7GL6ZFUG%674\''HC0O0/E$2KVZ,0VL?\2Q_Q=02P,$%
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M+PD:(S67M=1/K+][<Y"E_8\$2$YR+V06Q:;7Y2I<3]%;0<%>C4^O@>=)D'Q
M87?0ESEPE84TMH6Z"RPDN,EN9LF1>J3TZ?CL^\D1SX&9*CA>=PC:,#\D;M%\
MS1Z1G&I9REPP;UDW/!.""B9"N%-*+70NA0):/0#JK$MV_*1]UFBG8:H0A' L
M.FE[V@ZNH]"OXT?QQ=0[%W8J.30*2X8FG3Z_>+N8)(N-,TUHQA/CN+6'9<7#
M%ZT7X/O2&+?:> /M.!_]!5!+ P04    " !9?YU4R;=YK+ $  "'%@  &0
M 'AL+W=O<FMS:&5E=',O<VAE970X."YX;6RM6&MOHS@4_2L6ZH<9:5*P,:\J
MB31M=K4KS4A5NH_/3G 2-&!GL=-T_OT:0B" <4([7\(C]Q[.N0;?8T^///\A
M=I1*\):E3,RLG93[!]L6ZQW-B+CG>\K4/QN>9T2JRWQKBWU.25PF9:F-',>W
M,Y(P:SXM[SWG\RD_R#1A]#D'XI!E)/_Y2%-^G%G0.M]8)MN=+&[8\^F>;.D+
ME7_OGW-U9=<H<9)1)A+.0$XW,^LK?%@@KT@H(_Y)Z%%<G(-"RHKS'\7%G_',
M<@I&-*5K64 0=7BE3S1-"R3%X[\*U*J?621>GI_1?R_%*S$K(N@33_]-8KF;
M6:$%8KHAAU0N^?$/6@DJ":YY*LI?<*QB'0NL#T+RK$I6#+*$G8[DK2K$10+T
M!Q)0E8"Z"7@@P:T2W%L3<)6 R\J<I)1U6!!)YM.<'T%>1"NTXJ0L9IFMY">L
M&/<7F:M_$Y4GYR_J18H/*05\ _*B1A.^F1P$!40(*@4@+ 8I584%:4)629K(
MA KP:4$E25+Q&4S X_(;^+2\^PR6=R!AX*\=/PB5)::V5/R*I]CKBLOCB0L:
MX (1^,Z9W GP&XMIW :PE;!:'3JK>T1&Q 5=WP,7?@'(05!#Z.GV=$>3OK@Y
M'48&-6X]5FZ)AP?PEOWQ^:)>^I2PM;J6@+(X85M=W4^X_A#N'< P<@*LJ]#5
M5!1@%'@&>;B6AXWROG5?LY:X%=TFC WH.P%[)7 QT[W.,0X"QYW:KY=:^F$H
MQ![TZK 6;Z_F[8T?%A+'23&Q:3\#K\?#1WX8==AJHG" 73U9OR;KCRVRD:I_
M$U5-U##5H*8:C*]K3C.EX% <F-01#GI4(B_R48=P/\K%T(=ZPF%-.!Q;VZMT
MPYOH]J,,=*.:;O2.Z>0@5)@08,VS5<+(X(L1]2A!-_(@[C#OAP5^Z U\<=!I
MNI8S>JZXE7D%?96Z)L[$_:+CPO%UCZFR;>ND9 WHF[)U@FK)PQZI"7:1&W3)
M:^)0Y(;^ 'O4L$=C*W\S=R-RX7 ?Q)ZLZ<Q2>(+FK]2: UU/^@5 ;?5-!X;O
M:,$)DU0]1QJU&W'':/\X4%M[TY[AZ/Y\D_)^U_4#!+M3G"8,8^R%[;!%%6;P
M(R[$OLEMP::OPW<T]CWY6<SEHC#,/6.LU6]\R)B1_SA0NQ"-9X"C3</X,O0]
MPB0, @]VWP--G.?AP6FW<1/P'78B3L2>"Y+J*?==P@0Z+O2[E'5Q7H '&#=V
M H[V$V:^?9LP@1#A7F/3Q0WS;?P$-!N*#QAXV/<)'0??7O\U1@&9C<+[UTRH
MW_Y]W_7#[NAKXLZKJ=;,5<5]9"6%&H^!S![#/!0&T7W;$$#LA -?'VIL S+;
M!NTXK ]Y/N"+S7 C9LU? -26W'@%9/8*FC$P"7;[BU,<74Q[E9Q^F ^C8,#6
MH::Y(W-SUXX/XVQBHJSI[-HO1-/:VU](FW33H)&Y06LJ?(VR=^TC5(M;Z.HV
M>YZNY[JA%Z! ]_+8%SMT&<VWY4YGL50Y,'G:SJKOUKNI7\L]Q,[]1_BP..V)
M-C"G+=KO)%<3K%#=>*,@G?M T<U/NYZG"\GWY3[@BDO)L_)T1TE,\R) _;_A
M7)XOB@?4>\_S_P%02P,$%     @ 67^=5"L.@?$7"P  QT4  !D   !X;"]W
M;W)K<VAE971S+W-H965T.#DN>&ULM5QI;]NX%OTKA#$/F &FL4AJH8HD0-8V
M;=)ZG&[3XGV@;2861I9<+<GTWS]*EDPOU"7M/']IO?!0E[R\Y]Q+TCE^3K-_
M\JD0!?IW%B?Y26]:%//7_7X^GHH9SX_2N4CD-P]I-N.%?)L]]O-Y)OBD!LWB
M/G$<OS_C4=([/:X_&V2GQVE9Q%$B!AG*R]F,9[_.19P^G_1PK_U@&#U.B^J#
M_NGQG#^*>U%\G@\R^:Z_[&42S4221VF",O%PTCO#K\_.0J="U$V^1.(Y7WF-
MJK&,TO2?ZLW-Y*3G5":)6(R+J@\N_WL2%R*.JZZD(3^;7GO+AU; U==M[]?U
MZ.5H1CP7%VG\-9H4TY,>ZZ&)>.!E7 S3Y[>B&9%7]3=.X[S^%STW;9T>&I=Y
MD<X:L+1@%B6+__F_S4RL +#; 2 -@-@": .@M@"W ;B; -H!\!J 9_L$OP'X
MMH"@ 02V -8 F"T@; "A+0 [K><<:\C2V=;>QJV[L;6_<>MP;.UQW+H<;_F\
M$](Z'5M[';=NQ]9^QZWCL;7G<>MZ;.U[W#H?6WN?M-XGUMXGK??)EO>[ HLL
M@]W:^Z3U/K'V/FF]3ZR]3UKODRWO=XZE]3ZQ]CYIO4]J[_<7K%I3\B4O^.EQ
MECZCK&HO^ZM>U+Q>XR431TFE0?=%)K^-)*XXO9>B-BEC@=('*0?CM$R*',WY
M+SZ2GQ4IDF(A(8\HG_),3--X(K(<_7XI"A[%^1_H%3H?WJ+?A[_]@8:_H2A!
MGZ9IF?-DDA_W"VE>]9#^N#'E?&$*Z3#E0_ITA!SO3T0<@C7P"QC^<5Q(..Z$
M7\+PL_)1PMU.^!4,O^._$*:=Z&O#P^?9$<)^)_R-!=QAG?"W)MLEG'1/_ T,
MOQ3C(T2[)_Z=/=S1P-];PW&H@=_:PYD&?F>S9A?&$PW\@XWC:"?\H\V2[UZS
M _NGZ^!_62P;(%Z'-E,7=OK]W@;N=L(_V<!I)_RS/=GHX%_,;-',G []U=YO
M.O@W&/Z.)V# _6U!E NJTP;<=XNAAYWHLS,SG 2Z<.U+Y5O*'UG*'ZF[HQW=
MW3QD^7W!"R'+JN)6?GDC7^;H1_42U:__"SR%+I]"ZZ>X7:M%5HR5B(YXS).Q
MT%'LH@._HP.IK7X0,N+KZ-4(]3 CK@.,PUV.PP7'<6:9(.@&N.C9JWNN"N.G
MTW9$3ZN#V6[66O^D,=Q;&NZ!AE^4628=K+/+VWH@H2%SPPV[MIMAQES289>_
MM,L'[?J0)J_&W;;Y6P]U:1@&P89MV\THD5/;85NPM"V YRQ.<\.B#>Q\NMUL
MPZ<+G0],ZY@Z#J$!L([9<F@,'AK/IRA-4#&52SCC2<X7^R'C9L@320@Z16)&
M"W4!^LD(PYX? L,*E\,*P6%=B@?YR02-1")?%2@=Q=$CKT;V)^(%FF<BEPL-
M/?&XU WO*C392;"K36Z-0.IX.J5Y8P3ZS-$FM.8G,@:M%.RH^L@!)_73ROJ8
M9]%8(!['Z5BND$E%?YFH-OJJ13,76;TE*&-E9>;U=9!CI&S7<70S=F6&NIZK
MS6.-0.P0UX/F;*6FQ+:TUDI%CN3DH'F9C:<\KZM-N4BSQU_:I!<;EP5FH>=#
MMJH$ !,[31LTFO8I1?>-IMVO%KT_[L1L)#(H'\ J(<#T@'D'5H*-8<6VR#RP
M47*;*FZ[74O(:S2N:8>#(* =<H25AF.#B%>L_1"GS]K\ F\K]"L<$I_AS7'H
M&E+7J_+)]8%H&E8=LHZ!*-''L.J?C7^641[5E"(#X69P=:$=T;:N-[2P;J:I
MV;J52OXQK/\W22&D8F@3$[PMZ12'V-N<ZNUF6!*SNSD"3;-@-<U9'X%2>0S+
M_'DIU5SD.1JGLU&4=/+Q3=//6A+H4H8W$QE-.^I2O)7):-IAU_5HU\I1 H]A
MA;](DT*&<\6K8SF62!(37RRC!-F/-M2,UJ.^WCBBE)+ 2GF1SB3;Y+Q=U[%X
MY+'4S'0LQ$1:G:-)E(_*+*])3V<9_(#J..YU/N=C<=*K<YGL2?1.D:XD:CI:
M"UW7<^B&GXA9$^EFB;P^.4H2"2R)-TE>1$4I,X9+@:ZDZQ(I,Z7,&2(IBY<I
M&D2\C- ].K/1&;)2WAZROB5*S\B+*URXAUV<:RQX*0L"#(U+Z2<QZ.>SS%+R
M:31'$!T:.L&.<^0X_]&.90_D^E"4?!)8/H?+3'5SGU^[#=/T!N:+/ME,4M=M
M4XI(8$6\^EE*JHADC,CDNEJJ2]MT#';6=@<M@4H#(=N4#A*3#K:1>S4IQWPL
MV4W:>L\3^<G98RJ_3*:I=>0J\2+LD)&K)(7 DF(3N<9JR\4>TV[]FZ&!0\%,
MGBK]H;#^V,6JH1,@5O=&OC<@0U.04R4S%):9G8+\ S466D2F8;HZ=+ _]*L9
M2D,_A"I1JO2/PM7=,G@G @U$7N7=?*F_=S(M&:<3&=B2=R95DSN9-^7HC<RJ
MHAS=%A-N$]-T91OXD%4?5:I%7USU-3V >S:$4FT<F*',WSS.6A^)$BT*BY9E
M3,.=0#&]+_+]/LCU25#J2&%UW"FHOU.C-LIDWZ&094H;*:R-N^GV9VK<XO4<
M1[_Q]9UJBL2FL:YLH4IH*5PE[C:&[]2XFQLZ/I1\4B7-%)9FE7D,>,9E:24D
M12V2$)X*=%'&19EQ:YYRE9*ZS@%YRE5JY<)J9<%3< \[5 VN6; 8=: ]8U>I
MC@NKCAUK&3H!6&L?Y/I0E&2Y<&&W$_?\[9K/(K<WMM<M6SF+A$7N<Q*AH8P(
MF8=G5LM?B8[K'7+Y*UYW85ZW6?Y&,F>>YVB/A<W0L-J6A4:B=,"%=<!JP;\S
M=&*Q;!6INS"I[[1LO[GF$SJ-+JV;IEC=A5E]-[WYYIJ++P]4<T_1O@?7(55$
MW:-;FV#R%,=[^(#!Y"G.]0R<:PZFIH>U\W3B!V3SJ)\828S*#!>R6M&K9]@W
MLPH<0R?FP/$4JWHPJ^X4.']YQE+ W=J&J9%?S$C?<<&- 6_E\@><B^\6<5\\
MX\Y74!\-=%NF%,"#%> :7: [-$#G5C&GZ-@+#AESBF4]F&5M8DYW%!+B8/.H
MR#-3, M=<#/>4Q3L&?:\;*+NW-!)=WYVL3?R<F_DU=[(Z[V1;_9&OMT;^6X?
MY/K=+*6'/JR'.W'AN;_WI8X+,Y3@COL@9B@.0MTVSK492?7/?&-&AGKDT,):
MQF2<0^Y3F8</5Y?7Z*K>EA_:D*NO$@W_D$=JODH-_!<?J<$][% <^\:ZS7!%
MS5<)A@\G&'=7EX.W'S]<H1\SLU.4Q/N'+-G\E?N:+R[9X!YV<8KYD O*0GR5
M+OAPX57O@T<)%U:!HK(#_Y G6+Y2<__%)UC^]I6'Q05![059)1 !+!#UQ,G4
M\BW/1FEIM0L1*/H*#EDX!8K/@A<73L%VX;2XF*F=/L5P <QP%W'TLQ0//)M9
M[5\&BF,"]Y!3IU@G,)Q.6$S=]B6RQ658[=0I'@I@'KJ?IOG<:M)6KGL?LF@(
M%"T$+RX: LU]K/KJL7;2%%$$,%%\3J+'C"=9E-K,'%,TP ZY7<X4([ 7;Y<W
M/:S?[0K#(-3/'5,LP6"6&*)OLDX=HH]64Z<H@!WR1)0I1F O/A%EFGNKBQO1
MVIE3),%@DGA3<KGHIF5B=868*0I@_B&G3O$",^SM6DR=^5S/]<#-'+;RTPV8
M/M8OTC6'86M7Z;[P6-17ZGB6\&C$;>_F,$4D+#S@U(>*6,+_QXT60R>LLY3>
M%WB[!W Q _V5'ZI7?^+DCF>/D0R,6#S(GIRC2BVSQ1\-6;PITGG]V_516A3I
MK'XY%7PBLJJ!_/XA38OV3?5S^.7?;CG]'U!+ P04    " !9?YU4V.!98"D#
M   5"0  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,"YX;6R55MN.VS80_96!
MD(<$Z*XNMBY>V 9B;XL62(J%TZ3/E#2VB$BD2U+V^N\[I+2JLY:]Z8M$4C.'
MY\QP.)H?I?JN*T0#STTM],*KC-D_^+XN*FR8OI=[%/1E*U7##$W5SM=[A:QT
M3DWM1T&0^ WCPEO.W=J36LYE:VHN\$F!;IN&J=,*:WE<>*'WLK#AN\K8!7\Y
MW[,=?D'S=?^D:.8/*"5O4&@N!2C<+KR/X<-Z9NV=P3>.1WTV!JLDE_*[G?Q1
M+KS $L(:"V,1&+T.N,:ZMD!$XY\>TQNVM([GXQ?TWYQVTI(SC6M9_\U+4RV\
MS(,2MZRMS48>?\=>3VSQ"EEK]X1C;QMX4+3:R*9W)@8-%]V;/?=Q.',(DRL.
M4>\0O7:87G&8] X3)[1CYF0],L.6<R6/H*PUH=F!BXWS)C5<V"Q^,8J^<O(S
M2TH34'(AM_D$IA!,A5 PI4Y<[( ULA5DL04A#6K8LQ/+:P0F2F?8R -23HV&
MLE76P2Z>D"D-*$HLX1$+;')4, E_@2B(0N=*@P#>/Z)AO-8?X Y6FT_P?O/N
M VS> 1?P5R5;389Z[AL2::GZ12]HU0F*K@@*(_@LA:DT_&H)_ C@4W2&$$4O
M(5I%-Q%)POU ?X30^N?=@QMT)D/&)@YO>@7OSQ\2D>.."T&1'XM4!Y1< :)0
MITF8C4JZ2<'>+ ]ZSPI<>'1U:%0'])9P0]MTT#:]J6W5:EK1&@K9Y%PP6^EC
M]#J4V*'8>^JPS((X2N;^863S>-@\OKGY$SNYHSP6R?ABP[LP#))LV+'C-6(6
MS]+I.*]DX)7<Y$7'F0I%G:@P2GR^%I-5<K$W97?RBN"E49A$LW%^Z< O_1\'
MDLK^RFE,+PE&Z5G2.H8C5MTA':.8#12SFQ37K5*46J@YRWG-#<?1+&>7T9E.
MT]=)'K$*XF RSG V,)R]$41Q5_P<R]E;51UGT30;*YLW/9,X2;.Q.O;/.DR#
M:N<:KRU3Z@[=33JL#KW]HVMIK]97U/.[%OT?3/?#\)DINLHTU+@ER. ^I0BK
MK@EW$R/WKH_ETE!7=,.*_EM060/ZOI5T$/N)W6#X$UK^"U!+ P04    " !9
M?YU4>[C "IL$  !$%0  &0   'AL+W=O<FMS:&5E=',O<VAE970Y,2YX;6RU
M6-MNXS80_15"712[P#86J:M3VT#B8-$ V2)PTO8AZ ,MTS&QDNB2M)W\?8>2
M(BG1)7(6?K$I:69XYL+#(2<'(7^H#6,:/25QJJ;61NOM^6BDH@U+J#H36Y;"
ME[60"=7P*!]':BL9765*23PBMNV/$LI3:S;)WMW*V43L=,Q3=BN1VB4)E<^7
M+!:'J86MEQ<+_KC1YL5H-MG21W;']%_;6PE/H]+*BB<L55RD2++UU+K YW/'
M-@J9Q-^<'51MC(PK2R%^F(?KU=2R#2(6LT@;$Q3^]FS.XMA8 AS_%4:M<DZC
M6!^_6/^6.0_.+*EB<Q'_PU=Z,[5""ZW8FNYBO1"'/UCAD&?L12)6V2\Z%+*V
MA:*=TB(IE %!PM/\GSX5@:@I8+=#@10*9*B"4R@XF:,YLLRM*ZKI;"+% 4DC
M#=;,((M-I@W>\-2D\4Y+^,I!3\_N-PQINHP96IJ4(JX019%(ME1R!6$6:Z1!
M)*)2/O/T$=%$[%(-0ND*K2F7:$_C'5,O<G.CF3[_^DM(</"[0FN>TC3B-$8\
M55KNH "T^HH$R$I0H"G\"-5B'[YI1"6#4J& (T-(MULIGCCDCN?(:@#.T><K
MIBF/U1?T&[I<W*#/BT]?T.(33(SN-V*G +&:C#3$S'@^BHKX7.;Q(1WQN6+1
M&7+P5T1L@EO4Y\/5[=?J(\A4F2Y2IHMD]IP.>]=KJ>XTU<P$\@8^7L-0H0<S
M1-GXWYY9G'(6)YO%[9CE6YDUJA0S"8-DO$E16RASJWZ'5<@%"5R7M$7Q7<VQ
M'_;%SRT]<X_WK"JC-J=R@UYFT)#B?E9XL:\[T)3*$>];P'HE6&\@V)C3)8^Y
MYFQP+KPF[-#%'G;> &_*8=\;^_:X';M?8O<_B+T_VGX+;,\)@K>PFW+8#\:A
M&[3##DK802_L&T%3A2Z W H'(,8/WUFR9+)O886E^?"$RW=<SC(^7=V,FX%U
M C<,_#<):,KY&.2\]OACN]J/[),43F'V-? PP,Y;X"V"/A08<3J0UW92W%\[
ML%.Q.FKTD+Q;.;AB?GQ*ZL<5]^.AY/^!ZBELUX,;8->NE461A*:<ZP:!W96$
MBM_Q4((_LGR:!-X.O"G7"[SB>MQ/]A=1E'<^M_0YZW;N!;J#[M;$^VX#G=!&
MQ"LFU1 ZPA5+8_^41571*N[GU9\KJJ"Y8H'K26-E-^4\'!*W8QO&%6OC\#1%
M%0X$WI3K!5YM!+A_)_A3:%96U(#"(15-$_N$A4,J4B7]I/I3A5/8?K6H2= (
M?YN8CT/<'GU2Z]7)2<JF,/LN[!:Q'MC5!D#Z-X %@Y,:CS1;H3E5FR&$0RI^
M)NXIZZ:B4S*T=S[N"--OUERJG*LMC=C4VDJFF-PS:X;:3C2DI0&WO8YM@E2$
M38;VU8,/,/T6CW&II3GO=JG:&TC_WG OZ<J<\R/&]X:G!O5-I")O<LJ>FU1<
M2X9VW4=67+.3;CM@MH@%/NDX[C@5CSM#V^W!]518_- Q_UW5W*=F.D:U*RYS
MO_B=RD<.1[68K<&4?19 8&1^99<_:+'-;KV60FN19,,-@T*31@"^KP7LC<6#
MN4@K+TYG_P-02P,$%     @ 67^=5%/3MI*>"0  F%D  !D   !X;"]W;W)K
M<VAE971S+W-H965T.3(N>&ULW5Q=;]NX$GW?7T$86Z#%IK%(292T2 +DH\5F
MD7:#)'OO0[$/BD7'0F71*\I) ]P??RE9]C"U16H;4]FX#XUDDR,.=3QGCBC.
MP0,OOHH)8R7Z-LUR<3B8E.7LU^%0C"9L&HM]/F.Y_&;,BVE<RM/B;BAF!8N3
MNM,T&Q+'H<-IG.:#HX/ZL\OBZ(#/RRS-V66!Q'PZC8O'$Y;QA\,!'BP_N$KO
M)F7UP?#H8!;?L6M6_CF[+.39<&4E2:<L%RG/4<'&AX-C_.LI)F[5HV[RGY0]
M".485;[<<OZU.CE/#@=.-226L5%9V8CEGWMVRK*L,B4'\G=C=;"Z:-51/5Y:
M_UA[+[VYC04[Y=E_TZ2<' [" 4K8.)YGY15_^(TU'OF5O1'/1/T_>FC:.@,T
MFHN23YO.<@33-%_\C;\U,Z%TP+2E VDZD.\[>"T=W*9#/7/#Q<AJM\[B,CXZ
M*/@#*JK6TEIU4,]-W5MZD^;5?;PN"_EM*ON51]<2&,D\8XB/D:ANCYS5M'Q$
M<1YGCR(5B(W'<L8%DE.>YB,^94B4<<GDK2S1VS-6QFDFWJ'WZ.3J KV]^OD=
MNOI9-D0W$SX7<9Z(@V$IAUE=;#AJAG2R&!)I&1(FZ!//RXE '_*$)4\-#*5_
M*R?)TLD3HK5XQD;[R,5[B#@$;QC0:??NCF8X[FK.W=J>VV+O?%R(Z^4D7L@O
MS^6A0%^J0U0?_Z6YBK>ZBE=?Q6NYRDF<Q?F(H5A4]Y;E29K?;;H9"RNTQ8J\
MFR3P/+)IUHP](QKJYLM?>>)K/3G/2U8P4:)"SADJ4O$5?9FRZ2TK_D+_0Q\S
M'I?2-XDZM9G2XC06$_3A[WEZ'V=RQN5,?UI]=YZ/9/@3K,*L# <2\#.>5FU^
M"?Q5.XT/=.4#M7C/@]55 L-,-=Z\3=CBZ%WEV#A."R2=GS,TE1_.B\7/-Y'G
M)4=5.Y['M]FC]%V(]%9&@V7WJO<\Y[>"%?=Q]46:S^;EGNPSXG=Y*EA2M9@5
M?)R6B!<HDP;VT"V3!"-MQ]_V)/P$*S=&@84K?NU*13?W1UX0T(/A_88)"%<3
M$+X85,Y8"U3>=X-*M/(AL@@5[$#D=W8'+(TO*EK>M\,%*_2'_X6Q!?M.%\1@
M FX0FY@!YL)N/YA)\QXPXZYA)O)]MP4RP*M83ZPO$V.Z0@9(%?LV(0/$A^D.
MA1FZ'F8TF %>QB9B?AYFSG-1IN5<SLP-'\6Y;"QS=88N9>,TD?/&T'%>\CSE
M$EV%=!A=[Q_OH[?G-Y?'I^@=(.S+V4+AH(OXEF7:&PR4BT.;0 ):Q-%6$MK&
MC"8O];$3!40G+(!$B8E$$_9-RI\W:,8*],CB8M.0#$9.S\Y_0O+?+PCO4?)&
M-S @-J(GMI/JEU+!:.-XL'&*?,?5SA!0$R&O$?I;R/T)T":QJ?@(4!,Q4=,K
MBK6-+T]BK1M6J-L4:PD0&[$K%^T![KD*@@#I$IMRDP"OD1T2G&1=<6KP!OQ'
M[&K.EPAP';-) N1,;(I6%_C6[4FT]B% W VB-:#4WXPX%[C=M2M:7R+"=42<
M"WF%:U/RNLK#VIXD;Q\ASEV7O!K 05[AVI6\ +@SAC[D(LTYNI[+C#F5_BFP
MNRGB:K:3NMUQ-F5I$J//[)ZM('AY<_SYA_2,"_F#:U,8N\#1KEX8=]4SC1E-
MLNYB'$6Z,0&?NR8^[R)G#$94.1/X.CGC LFZ>I+5RIFFKVZ&/ ?KQ@$\Y^I%
MZ&OY)6Q!WGA RIYC<T$+>,\S\=XK(O_&ER?D3UQO<RCV@/:\ON2T=0 ^5^YX
MP-&>U15594EUA_2UMZZOV_$'[.CUI:Y?, !V3$8]X'+/IM[V@)^]GO1V+Q%P
M76^_]VC8@D!(!;R^]/8+1L"N"(3$Q+,IP'W@>G^'5HW]=0'>"D ?TA#?KOR^
MX'$NI,1.T,<TEQBK&G? @@\Y@F]3&OM N[Y>&G=5,(T937Z.'>SYNC$!1?LF
MBNZB8 Q&;GZ_N-2-1GES2<^66MG2]-5,"\6!;AA 3[YI#=8>8K>@-'S@/S^P
MB6S@&-_$,:^(9QM?OGO,V!+E@%!\NTK7@)GGB@,*C$5MJE,*M$![4J=],"-=
M5Z=MD*' .]2N-OWA,-,QFZ+ ;-2FH*3 5K0G0=E'G*$;%FRQW[)^1H$CJ5U%
M^<.!IBMJE'=\;:I "BQ(=VC5E:ZKP';0 $%3NR+P>#3B<XF"R_BQ<OB&7[-,
M7N/N>A(7;,*SA!7BCYPMT*&[:<"GU*9 "X#N KU ZYJ4-V:TV2?!W^^7>#HH
MX,; Q(U=LG*#D=.S<]U@@*8"/4UID_*FK^[5*.HXNM66 %@F,"TM]@CB+>3I
M ?!:X-D$.W!'8.*.5\2?C2]/GX?Y$=X<"P.@G<"NNONG,'INZAXHVUELRKT
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MOP@1A=7][X^SMLTH#4-(VF97=*@X'%&&?,6Q0W',6]S;93V-2K#EC]44!JH
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MEPQNN(.7)E/V ]C?2&COY<0JJ-ZNTW\!4$L#!!0    ( %E_G53/=A<!!00
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MAP*^8MM0W22/?_!B0'YF;YF$:?X7/19MW1Y:;E.51 58]R 2\?X_^UX$X@!
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M7>,"-BF!V;T+V-TES',O4/>7*->YA#V4^#1](_N=0Q\OH8[O6]89\JP ;E$
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M<(2R6FFQ:<%@P8:7S2_]V3KB$2#Q!@"D!9 > $<# +\%^'W D$E!"PCZ@&
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MB]E39P25R#C$*51!3<N,ERLXIS]J+IE1K<9HMV9V*[E&:ZI@%-!<+;G9S:)
M%9-V+"TS]D;<%7Q%;;]BY@8.1WOHD(]A%,R$S,UJ6J!/'Q<W.!S;,P*0K*AA
M # +[F!!,!@(P+AJ)&'8 U-,$$G+HET'9I0W;791-K0,+P:J<OC9,*4!!**F
MD3]!%V:243 RCF%H(6,_POLQ9Y^@=DRR9BD3M;"LT;?D4NF^.FQMELR0:?:
MYEOC#=5FN3WC$U?@3!Y-:""TLJ.Q\1IT(TV'VSWMQN]+.W3VGL_,6.YX?H&#
MTRL<.-Y :,&;9EI\6+KY'^ SE2L.FUBP)9CAG9C!63:C=7.C165GQSNA@9V]
M7#.:,VD$X/U20""V-V:![@^.Z7]02P,$%     @ 67^=5 J=$.:8!P  $B0
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MK]E_KLD#F:=4B?NJ^#//]/)F%(]()N;IIM /U?87T1 *3+Y95:CZ+]GNL"&
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M5ADMZH]$/T^A;FF3LB9I_<W;S2XX(1RSJ;<[[0- 1WT2L8%N >A($.-ZENP
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MZEI@?U\J90XW]0OZH[39_U!+ P04    " !9?YU4*LT_';H$  #P$@  &@
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M*[10PE*ZR]23./S!&D*>QHM%)JM?=*AM?=="\4XJD3?.$$'.B_J?OC:).''
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MU5*\FJFJA61Y.67,F%0S2RDNU!R*N590YPEC<K/0@TLSV0[^ U!+ P04
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MO<@8C1FC,2[*A\SL"^/QQZ3F\J\T3>,X2;"*SF9>!3.L;DD";W\V3!M$8#S
M]'NUQG<;[Y#G^P#;T^<Z!%LIWHG82O%: ^*O&T2DJ7^W,1Z(P'8!ZQW@]_-
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M:#FFA39>YP$OQJ0LM!S30A7$[UU>!*>*2M.N<+RYI"RT9+;0<9+AVKH65OV
M3N][/,:D++1DGUP[NTKBNQ'&I"RT9+;0'W*/Y_\@?G=&:UGYG@^GQ9B4A9;,
M%CI9*CD,15^$A8P#8U(66HZ8"_6K)[\\K9YTO!B3+#,>T4+J>1WEN54Q)F6A
M)7<NA##+C@S^ EXF0# F9:'EB!92)^LH%P@SHRR4C6DA!Z/FKK>Z'^!5O<.8
ME(4R9@N%BXYA-U</00T\9:%LQ%SH4)]?^IAXW591A7MZ1EDH&S$76A\OGEU<
M8TS*0MF(N= +YF&F*VA-RD+9B#-RE1$Z6'\,RJTRRD+9:U8R!Y/:&66A;$0+
M6;79-F_,^@WTH-.B^HS<[C*BA9[3BYW8=R%H@RV441;*N"T$YS5M\Q04^Z4^
M'PT7,&[N?<:!,'/*0CFSA0:7"'RL"2&\"W<241;*1\R%G-1^:N9!=54<HMH[
M/"#EE(7R$2U4M-9*[3>S]5,S2@<WG;)0/M:ZD#O.V8Y3MIRR4#ZBA?S.SPWP
M0BL.++CDE(7R4<JCSQ7!X(++G+)0/F(NM#XMB,&8E(7R46?D3@IB,"9EH7Q$
M"]6FA 2]Z^2-\9E1L"<])[=@CI@+=04G;U;"<_:S">%N3'H[YBMNM D#XVE,
M;LN,1S21/*WG"4#);9KQB"[2< TG_'AO#[4] 2BY<3,>,2<ZX*WVH/G-<8^?
MQN1NSGA$'\E#+=)+!5( 2N[KC$?,B]9'U4B0P0>@Y!;/>$0G65D8,&;U5 ?B
M)V\"4'*79\QLI4-!X<G\QT\!([G%,QY1297<P!BZLZ:0LNR&*!& DKL]XS&E
MU(_V3D*X[%L8D#$H_8P [H<$A*5RU-S7]'\\*^!5R^9F 2@I)>Z'!YQL[@J;
M-0 EI=0_3N"R^[A[_ZZ4,,[)\@M<Q,%Q7T%V9[M"LNY<R3SU&YS7;55]@&-_
MZD]&E(<G%AV>MO3^7U!+ P04    " !9?YU4(EQP%RD#  !80@  &@   'AL
M+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSS=M+3N- %(7AK: L ->M=[6 44^8
MMMA %,Q#Y*78K8;==P0#.*4>] 3Y'UGE*-=G8'V**G6N?HW;]?Q\V$]/S\?I
MXG6WW4_7JZ=Y/OX8AFGS-.[6T^7A..[/GSP<3KOU?%Z>'H?C>O.R?AP'[UP>
M3E]GK&ZNOLZ\N'L[CO\S\?#P\+P9?QXVOW?C?O['X.'/X?0R/8WCO+JX6Y\>
MQ_EZ-;QN/V]/P_O%+L^35Q>W]]>KT^V]K8:E WD)Y)</%"106#Y0E$!Q^4!)
M J7E V4)E)</5"1063Y0E4!U^4!- K7E YE3&1T@4H<U0&M3K@W@M2G8!A#;
ME&P#F&V*M@'4-F7; &Z;PFT N4WI-H#=IG@;0&^O>GN WE[U]@"]??=C&Z"W
M5[T]0&^O>GN WE[U]@"]O>KM 7I[U=L#]/:JMP?H[55O#] [J-X!H'=0O0-
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M4^_Y_-WQ\_GORX^;_0OSSO7P-<9T\Q=02P,$%     @ 67^=5/\^K5Z" @
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M;W!S+V%P<"YX;6Q02P$"% ,4    " !9?YU4X'C36^\    K @  $0
M        @ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " !9?YU4
MF5R<(Q &  "<)P  $P              @ '- 0  >&PO=&AE;64O=&AE;64Q
M+GAM;%!+ 0(4 Q0    ( %E_G513&<)UP 8  . ?   8              "
M@0X(  !X;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " !9?YU4
M=P6L#Z '  "K(P  &               @($$#P  >&PO=V]R:W-H965T<R]S
M:&5E=#(N>&UL4$L! A0#%     @ 67^=5/&Z_HR7!0  51<  !@
M     ("!VA8  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    (
M %E_G50>GE76X0H  !)?   8              " @:<<  !X;"]W;W)K<VAE
M971S+W-H965T-"YX;6Q02P$"% ,4    " !9?YU4)GG?@" *  "T+P  &
M            @(&^)P  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#
M%     @ 67^=5-O6#/PT#P  [2,  !@              ("!%#(  'AL+W=O
M<FMS:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( %E_G53:40C3CB@  %:(
M   8              " @7Y!  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q0
M2P$"% ,4    " !9?YU4M2[GJH\*   ,&P  &               @(%":@
M>&PO=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ 67^=5+BUDQF<
M"P  =R   !@              ("!!W4  'AL+W=O<FMS:&5E=',O<VAE970Y
M+GAM;%!+ 0(4 Q0    ( %E_G50-5/1P?!H  **$   9              "
M@=F   !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ 67^=
M5&^P5\^[ @  _04  !D              ("!C)L  'AL+W=O<FMS:&5E=',O
M<VAE970Q,2YX;6Q02P$"% ,4    " !9?YU4Q*85^T($   ="0  &0
M        @(%^G@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0
M   ( %E_G50+AVROC0D  &L:   9              " @?>B  !X;"]W;W)K
M<VAE971S+W-H965T,3,N>&UL4$L! A0#%     @ 67^=5!C>-9B1 P  -0<
M !D              ("!NZP  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q0
M2P$"% ,4    " !9?YU4"S*9,#X%   9"P  &0              @(&#L
M>&PO=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( %E_G50[]P2"
M"P<  /T.   9              " @?BU  !X;"]W;W)K<VAE971S+W-H965T
M,38N>&UL4$L! A0#%     @ 67^=5&U[2NW"#@  #R,  !D
M ("!.KT  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " !9
M?YU4G7L:::P:  "@3   &0              @($SS   >&PO=V]R:W-H965T
M<R]S:&5E=#$X+GAM;%!+ 0(4 Q0    ( %E_G50#1_2NA0,  +X(   9
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M970R,RYX;6Q02P$"% ,4    " !9?YU4K$3YOH\&  ":#P  &0
M    @('?! $ >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    (
M %E_G51)'WLPP0,  (L'   9              " @:4+ 0!X;"]W;W)K<VAE
M971S+W-H965T,C4N>&UL4$L! A0#%     @ 67^=5*W/WBES P  $0<  !D
M             ("!G0\! 'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"
M% ,4    " !9?YU4+KP@#Z %  #="P  &0              @(%'$P$ >&PO
M=V]R:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( %E_G52WQ'T.O@8
M )D/   9              " @1X9 0!X;"]W;W)K<VAE971S+W-H965T,C@N
M>&UL4$L! A0#%     @ 67^=5":_>$"] @  &@8  !D              ("!
M$R ! 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " !9?YU4
M\1;_NQ,'   U$   &0              @($'(P$ >&PO=V]R:W-H965T<R]S
M:&5E=#,P+GAM;%!+ 0(4 Q0    ( %E_G50$]?7],2\  .>F   9
M      " @5$J 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%
M  @ 67^=5*?4O._T"   11L  !D              ("!N5D! 'AL+W=O<FMS
M:&5E=',O<VAE970S,BYX;6Q02P$"% ,4    " !9?YU4:46%>8,'  #8%@
M&0              @('D8@$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+
M 0(4 Q0    ( %E_G51"2BZ=B0\  .!A   9              " @9YJ 0!X
M;"]W;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ 67^=5!0G5ILS
M @  O00  !D              ("!7GH! 'AL+W=O<FMS:&5E=',O<VAE970S
M-2YX;6Q02P$"% ,4    " !9?YU4LQ$J)W<$  "7"@  &0
M@('(? $ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( %E_
MG51,XD$-[ 0  'T*   9              " @7:! 0!X;"]W;W)K<VAE971S
M+W-H965T,S<N>&UL4$L! A0#%     @ 67^=5.%J'$=V P  Z@8  !D
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M=#0R+GAM;%!+ 0(4 Q0    ( %E_G51MH[WN:@,  'P(   9
M  " @4RS 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @
M67^=5! .<@:6 P  \ <  !D              ("![;8! 'AL+W=O<FMS:&5E
M=',O<VAE970T-"YX;6Q02P$"% ,4    " !9?YU4/;#18@X%  !W#   &0
M            @(&ZN@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4
M Q0    ( %E_G52#P<A+N0(  %X%   9              " @?^_ 0!X;"]W
M;W)K<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ 67^=5,E94XP0 P
M608  !D              ("![\(! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX
M;6Q02P$"% ,4    " !9?YU4]'+-"9P%   -#@  &0              @($V
MQ@$ >&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( %E_G53$
M2(@4M0,  & '   9              " @0G, 0!X;"]W;W)K<VAE971S+W-H
M965T-#DN>&UL4$L! A0#%     @ 67^=5*P>\MMY P  % <  !D
M     ("!]<\! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %E_G51+9#(B7P,  )8.   9              "
M@5_] 0!X;"]W;W)K<VAE971S+W-H965T-34N>&UL4$L! A0#%     @ 67^=
M5#S*Q07Z"   134  !D              ("!]0 " 'AL+W=O<FMS:&5E=',O
M<VAE970U-BYX;6Q02P$"% ,4    " !9?YU4HUP[(RT*   H20  &0
M        @($F"@( >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0
M   ( %E_G53+NO>@HA8  /6L   9              " @8H4 @!X;"]W;W)K
M<VAE971S+W-H965T-3@N>&UL4$L! A0#%     @ 67^=5.9WG5@P P  ?0P
M !D              ("!8RL" 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q0
M2P$"% ,4    " !9?YU4ED"&>J$#  #B#0  &0              @('*+@(
M>&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( %E_G53O1+U@
M, ,  +\*   9              " @:(R @!X;"]W;W)K<VAE971S+W-H965T
M-C$N>&UL4$L! A0#%     @ 67^=5/B8C8B< P  W0T  !D
M ("!"38" 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " !9
M?YU4N#>#^# #  "_"@  &0              @('<.0( >&PO=V]R:W-H965T
M<R]S:&5E=#8S+GAM;%!+ 0(4 Q0    ( %E_G514(,D?G0,  -\-   9
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M970V."YX;6Q02P$"% ,4    " !9?YU4<7;NUW81  "!9   &0
M    @(%R80( >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    (
M %E_G50B9+UKK@0  !\3   9              " @1]S @!X;"]W;W)K<VAE
M971S+W-H965T-S N>&UL4$L! A0#%     @ 67^=5$'/@UQ8 P  .PP  !D
M             ("!!'@" 'AL+W=O<FMS:&5E=',O<VAE970W,2YX;6Q02P$"
M% ,4    " !9?YU4"\2WR\@"   Z"   &0              @(&3>P( >&PO
M=V]R:W-H965T<R]S:&5E=#<R+GAM;%!+ 0(4 Q0    ( %E_G53DRFS*1 8
M )<8   9              " @9)^ @!X;"]W;W)K<VAE971S+W-H965T-S,N
M>&UL4$L! A0#%     @ 67^=5*?^LH6H @  _ @  !D              ("!
M#84" 'AL+W=O<FMS:&5E=',O<VAE970W-"YX;6Q02P$"% ,4    " !9?YU4
M0CUGN=$"  "Z!P  &0              @('LAP( >&PO=V]R:W-H965T<R]S
M:&5E=#<U+GAM;%!+ 0(4 Q0    ( %E_G51\13SV[00  ,45   9
M      " @?2* @!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%
M  @ 67^=5' 2WJ(P!   \0L  !D              ("!&) " 'AL+W=O<FMS
M:&5E=',O<VAE970W-RYX;6Q02P$"% ,4    " !9?YU4S\AI6C<'  !$(@
M&0              @(%_E ( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+
M 0(4 Q0    ( %E_G50J6+7"U!4  %>U   9              " @>V; @!X
M;"]W;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ 67^=5*D'W9X\
M%@  9Z$  !D              ("!^+$" 'AL+W=O<FMS:&5E=',O<VAE970X
M,"YX;6Q02P$"% ,4    " !9?YU4:%:L_SL)   Z.0  &0
M@(%KR ( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( %E_
MG52%>\:)U0$  !P$   9              " @=W1 @!X;"]W;W)K<VAE971S
M+W-H965T.#(N>&UL4$L! A0#%     @ 67^=5.7X#2LV P  X0T  !D
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M=#@W+GAM;%!+ 0(4 Q0    ( %E_G53)MWFLL 0  (<6   9
M  " @:GK @!X;"]W;W)K<VAE971S+W-H965T.#@N>&UL4$L! A0#%     @
M67^=5"L.@?$7"P  QT4  !D              ("!D/ " 'AL+W=O<FMS:&5E
M=',O<VAE970X.2YX;6Q02P$"% ,4    " !9?YU4V.!98"D#   5"0  &0
M            @('>^P( >&PO=V]R:W-H965T<R]S:&5E=#DP+GAM;%!+ 0(4
M Q0    ( %E_G51[N, *FP0  $05   9              " @3[_ @!X;"]W
M;W)K<VAE971S+W-H965T.3$N>&UL4$L! A0#%     @ 67^=5%/3MI*>"0
MF%D  !D              ("!$ 0# 'AL+W=O<FMS:&5E=',O<VAE970Y,BYX
M;6Q02P$"% ,4    " !9?YU42B/&IA #  !S"@  &0              @('E
M#0, >&PO=V]R:W-H965T<R]S:&5E=#DS+GAM;%!+ 0(4 Q0    ( %E_G51%
M)[<KM@8  ,,E   9              " @2P1 P!X;"]W;W)K<VAE971S+W-H
M965T.30N>&UL4$L! A0#%     @ 67^=5.C/)$FX!@  /R0  !D
M     ("!&1@# 'AL+W=O<FMS:&5E=',O<VAE970Y-2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( %E_G52L5//TF ,  .P.   :              "
M@><Q P!X;"]W;W)K<VAE971S+W-H965T,3 P+GAM;%!+ 0(4 Q0    ( %E_
MG53+27(Z+ ,   \+   :              " @;<U P!X;"]W;W)K<VAE971S
M+W-H965T,3 Q+GAM;%!+ 0(4 Q0    ( %E_G51[3 9E;P,  +8*   :
M          " @1LY P!X;"]W;W)K<VAE971S+W-H965T,3 R+GAM;%!+ 0(4
M Q0    ( %E_G52>>DOD+P4  .P0   :              " @<(\ P!X;"]W
M;W)K<VAE971S+W-H965T,3 S+GAM;%!+ 0(4 Q0    ( %E_G50*G1#FF <
M !(D   :              " @2E" P!X;"]W;W)K<VAE971S+W-H965T,3 T
M+GAM;%!+ 0(4 Q0    ( %E_G50"QTT;]@0  %83   :              "
M@?E) P!X;"]W;W)K<VAE971S+W-H965T,3 U+GAM;%!+ 0(4 Q0    ( %E_
MG50JS3\=N@0  / 2   :              " @2=/ P!X;"]W;W)K<VAE971S
M+W-H965T,3 V+GAM;%!+ 0(4 Q0    ( %E_G50SL(BUT 4  *(3   :
M          " @1E4 P!X;"]W;W)K<VAE971S+W-H965T,3 W+GAM;%!+ 0(4
M Q0    ( %E_G53.0X,63@D  *<O   :              " @2%: P!X;"]W
M;W)K<VAE971S+W-H965T,3 X+GAM;%!+ 0(4 Q0    ( %E_G50O!"Z8]04
M -P:   :              " @:=C P!X;"]W;W)K<VAE971S+W-H965T,3 Y
M+GAM;%!+ 0(4 Q0    ( %E_G518D?'7$@,  .4*   :              "
M@=1I P!X;"]W;W)K<VAE971S+W-H965T,3$P+GAM;%!+ 0(4 Q0    ( %E_
MG522+>:F&@(  -T$   :              " @1YM P!X;"]W;W)K<VAE971S
M+W-H965T,3$Q+GAM;%!+ 0(4 Q0    ( %E_G50-GX#ZA0(  /$&   :
M          " @7!O P!X;"]W;W)K<VAE971S+W-H965T,3$R+GAM;%!+ 0(4
M Q0    ( %E_G52G"-V<Q@,  %</   :              " @2UR P!X;"]W
M;W)K<VAE971S+W-H965T,3$S+GAM;%!+ 0(4 Q0    ( %E_G502>F#2!@,
M ! 0   -              "  2MV P!X;"]S='EL97,N>&UL4$L! A0#%
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K P!;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@    !Y 'D 5"$  .:( P    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>154
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>155
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>156
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1047</ContextCount>
  <ElementCount>593</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>230</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>00000002 - Statement - Consolidated statements of financial position</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfFinancialPosition</Role>
      <ShortName>Consolidated statements of financial position</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>00000003 - Statement - Consolidated statements of income and comprehensive income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome</Role>
      <ShortName>Consolidated statements of income and comprehensive income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>00000004 - Statement - Consolidated statements of changes in equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfChangesInEquity</Role>
      <ShortName>Consolidated statements of changes in equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>00000005 - Statement - Consolidated statements of cash flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/StatementsOfCashFlows</Role>
      <ShortName>Consolidated statements of cash flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>00000006 - Disclosure - Corporate information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformation</Role>
      <ShortName>Corporate information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>00000007 - Disclosure - Significant accounting policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingPolicies</Role>
      <ShortName>Significant accounting policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>00000008 - Disclosure - Significant accounting estimates and assumptions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions</Role>
      <ShortName>Significant accounting estimates and assumptions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>00000009 - Disclosure - Segment information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformation</Role>
      <ShortName>Segment information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>00000010 - Disclosure - Business combinations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinations</Role>
      <ShortName>Business combinations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>00000011 - Disclosure - Cash and cash equivalents</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalents</Role>
      <ShortName>Cash and cash equivalents</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>00000012 - Disclosure - Trade receivables</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivables</Role>
      <ShortName>Trade receivables</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>00000013 - Disclosure - Related parties</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedParties</Role>
      <ShortName>Related parties</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>00000014 - Disclosure - Other assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssets</Role>
      <ShortName>Other assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>00000015 - Disclosure - Investment in associate</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociate</Role>
      <ShortName>Investment in associate</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>00000016 - Disclosure - Property and equipment</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipment</Role>
      <ShortName>Property and equipment</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>00000017 - Disclosure - Intangible assets and goodwill</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwill</Role>
      <ShortName>Intangible assets and goodwill</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>00000018 - Disclosure - Financial assets and financial liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities</Role>
      <ShortName>Financial assets and financial liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>00000019 - Disclosure - Fair value measurement</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValueMeasurement</Role>
      <ShortName>Fair value measurement</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>00000020 - Disclosure - Capital management</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CapitalManagement</Role>
      <ShortName>Capital management</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>00000021 - Disclosure - Labor and social obligations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligations</Role>
      <ShortName>Labor and social obligations</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>00000022 - Disclosure - Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Equity</Role>
      <ShortName>Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>00000023 - Disclosure - Earnings per share (EPS)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareEps</Role>
      <ShortName>Earnings per share (EPS)</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>00000024 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>24</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>00000025 - Disclosure - Expenses and costs by nature</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ExpensesAndCostsByNature</Role>
      <ShortName>Expenses and costs by nature</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>25</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>00000026 - Disclosure - Finance result</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResult</Role>
      <ShortName>Finance result</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>26</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>00000027 - Disclosure - Income taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxes</Role>
      <ShortName>Income taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>00000028 - Disclosure - Insurance contracts and contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingencies</Role>
      <ShortName>Insurance contracts and contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>00000029 - Disclosure - Non-cash transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/Non-cashTransactions</Role>
      <ShortName>Non-cash transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>00000030 - Disclosure - Subsequent events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEvents</Role>
      <ShortName>Subsequent events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>00000031 - Disclosure - Significant accounting policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingPoliciesPolicies</Role>
      <ShortName>Significant accounting policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>00000032 - Disclosure - Significant accounting policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingPoliciesTables</Role>
      <ShortName>Significant accounting policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/SignificantAccountingPolicies</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>00000033 - Disclosure - Segment information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SegmentInformationTables</Role>
      <ShortName>Segment information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/SegmentInformation</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>00000034 - Disclosure - Business combinations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsTables</Role>
      <ShortName>Business combinations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinations</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>00000035 - Disclosure - Cash and cash equivalents (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsTables</Role>
      <ShortName>Cash and cash equivalents (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalents</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>00000036 - Disclosure - Trade receivables (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TradeReceivablesTables</Role>
      <ShortName>Trade receivables (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/TradeReceivables</ParentRole>
      <Position>36</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>00000037 - Disclosure - Related parties (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesTables</Role>
      <ShortName>Related parties (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedParties</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>00000038 - Disclosure - Other assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsTables</Role>
      <ShortName>Other assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssets</ParentRole>
      <Position>38</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>00000039 - Disclosure - Investment in associate (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InvestmentInAssociateTables</Role>
      <ShortName>Investment in associate (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/InvestmentInAssociate</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>00000040 - Disclosure - Property and equipment (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/PropertyAndEquipmentTables</Role>
      <ShortName>Property and equipment (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/PropertyAndEquipment</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>00000041 - Disclosure - Intangible assets and goodwill (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</Role>
      <ShortName>Intangible assets and goodwill (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwill</ParentRole>
      <Position>41</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>00000042 - Disclosure - Financial assets and financial liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</Role>
      <ShortName>Financial assets and financial liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>00000043 - Disclosure - Fair value measurement (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValueMeasurementTables</Role>
      <ShortName>Fair value measurement (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FairValueMeasurement</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>00000044 - Disclosure - Capital management (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CapitalManagementTables</Role>
      <ShortName>Capital management (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/CapitalManagement</ParentRole>
      <Position>44</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>00000045 - Disclosure - Labor and social obligations (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsTables</Role>
      <ShortName>Labor and social obligations (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligations</ParentRole>
      <Position>45</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>00000046 - Disclosure - Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityTables</Role>
      <ShortName>Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Equity</ParentRole>
      <Position>46</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>00000047 - Disclosure - Earnings per share (EPS) (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EarningsPerShareEpsTables</Role>
      <ShortName>Earnings per share (EPS) (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/EarningsPerShareEps</ParentRole>
      <Position>47</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>00000048 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/Revenue</ParentRole>
      <Position>48</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>00000049 - Disclosure - Expenses and costs by nature (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ExpensesAndCostsByNatureTables</Role>
      <ShortName>Expenses and costs by nature (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/ExpensesAndCostsByNature</ParentRole>
      <Position>49</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>00000050 - Disclosure - Finance result (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinanceResultTables</Role>
      <ShortName>Finance result (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinanceResult</ParentRole>
      <Position>50</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>00000051 - Disclosure - Income taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesTables</Role>
      <ShortName>Income taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxes</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>00000052 - Disclosure - Insurance contracts and contingencies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</Role>
      <ShortName>Insurance contracts and contingencies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingencies</ParentRole>
      <Position>52</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>00000053 - Disclosure - Corporate information (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CorporateInformationDetailsNarrative</Role>
      <ShortName>Corporate information (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CorporateInformation</ParentRole>
      <Position>53</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>00000054 - Disclosure - The table below is a list of the Company???s subsidiaries and associate: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails</Role>
      <ShortName>The table below is a list of the Company???s subsidiaries and associate: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails</Role>
      <ShortName>Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>00000056 - Disclosure - Schedule of assets and liabilities information for the company's operating segments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails</Role>
      <ShortName>Schedule of assets and liabilities information for the company's operating segments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>00000057 - Disclosure - Schedule of operating income for each operating segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails</Role>
      <ShortName>Schedule of operating income for each operating segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails</Role>
      <ShortName>Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>00000059 - Disclosure - Significant accounting policies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative</Role>
      <ShortName>Significant accounting policies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SignificantAccountingPoliciesTables</ParentRole>
      <Position>59</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails</Role>
      <ShortName>Schedule of acquisition of UniRedentor (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>00000061 - Disclosure - Schedule of acquisition of UniSL (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails</Role>
      <ShortName>Schedule of acquisition of UniSL (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails</Role>
      <ShortName>Schedule of acquisition of PEBMED (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>00000063 - Disclosure - Schedule of acquisition of FESAR (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails</Role>
      <ShortName>Schedule of acquisition of FESAR (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails</Role>
      <ShortName>Schedule of acquisition of MedPhone (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails</Role>
      <ShortName>Schedule of acquisition of FCMPB (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails</Role>
      <ShortName>The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails</Role>
      <ShortName>The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>00000068 - Disclosure - Schedule of cash and cash equivalents (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails</Role>
      <ShortName>Schedule of cash and cash equivalents (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>00000069 - Disclosure - Business combinations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/BusinessCombinationsDetailsNarrative</Role>
      <ShortName>Business combinations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/BusinessCombinationsTables</ParentRole>
      <Position>69</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails</Role>
      <ShortName>Schedule of trade accounts receivable, net and notes receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails</Role>
      <ShortName>Schedule of aging of trade accounts receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails</Role>
      <ShortName>Schedule of allowance for doubtful accounts (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails</Role>
      <ShortName>The table below summarizes the balances and transactions with related parties: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>00000074 - Disclosure - Cash and cash equivalents (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative</Role>
      <ShortName>Cash and cash equivalents (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/CashAndCashEquivalentsTables</ParentRole>
      <Position>74</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>00000075 - Disclosure - Key management personnel compensation included in the Company???s consolidated statement of income comprised the following: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails</Role>
      <ShortName>Key management personnel compensation included in the Company???s consolidated statement of income comprised the following: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>00000076 - Disclosure - Related parties (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/RelatedPartiesDetailsNarrative</Role>
      <ShortName>Related parties (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/RelatedPartiesTables</ParentRole>
      <Position>76</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>00000077 - Disclosure - Schedule of Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfOtherAssetsDetails</Role>
      <ShortName>Schedule of Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>00000078 - Disclosure - Schedule of investments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfInvestmentsDetails</Role>
      <ShortName>Schedule of investments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails</Role>
      <ShortName>Schedule of detailed information about property, plant and equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>00000080 - Disclosure - Schedule of intangible assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails</Role>
      <ShortName>Schedule of intangible assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>00000081 - Disclosure - Schedule of assumptions for impairment test (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails</Role>
      <ShortName>Schedule of assumptions for impairment test (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>00000082 - Disclosure - Other assets (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/OtherAssetsDetailsNarrative</Role>
      <ShortName>Other assets (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/OtherAssetsTables</ParentRole>
      <Position>82</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>00000083 - Disclosure - Schedule of estimated useful lives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails</Role>
      <ShortName>Schedule of estimated useful lives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>00000084 - Disclosure - Schedule of financial assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfFinancialAssetsDetails</Role>
      <ShortName>Schedule of financial assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>84</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>00000085 - Disclosure - Schedule of financial liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails</Role>
      <ShortName>Schedule of financial liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>00000086 - Disclosure - Schedule of loans and financing (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails</Role>
      <ShortName>Schedule of loans and financing (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative</Role>
      <ShortName>Intangible assets and goodwill (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IntangibleAssetsAndGoodwillTables</ParentRole>
      <Position>87</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R88.htm</HtmlFileName>
      <LongName>00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails</Role>
      <ShortName>Schedule of right-of-use assets and lease liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>88</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R89.htm</HtmlFileName>
      <LongName>00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails</Role>
      <ShortName>Schedule of accounts payable to selling shareholders (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>89</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R90.htm</HtmlFileName>
      <LongName>00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details</Role>
      <ShortName>Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>90</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R91.htm</HtmlFileName>
      <LongName>00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company???s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails</Role>
      <ShortName>The table below is a comparison of the carrying amounts and fair values of the Company???s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>91</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R92.htm</HtmlFileName>
      <LongName>00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails</Role>
      <ShortName>Schedule of sensitivity analysis effects on income statement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>92</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R93.htm</HtmlFileName>
      <LongName>00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails</Role>
      <ShortName>Schedule of currencies used in sensitivity analysis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>93</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R94.htm</HtmlFileName>
      <LongName>00000094 - Disclosure - The tables below summarize the maturity profile of the Company???s financial liabilities based on contractual undiscounted amounts: (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails</Role>
      <ShortName>The tables below summarize the maturity profile of the Company???s financial liabilities based on contractual undiscounted amounts: (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>94</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R95.htm</HtmlFileName>
      <LongName>00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails</Role>
      <ShortName>Schedule of changes in liabilities arising from financing activities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>95</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R96.htm</HtmlFileName>
      <LongName>00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative</Role>
      <ShortName>Financial assets and financial liabilities (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables</ParentRole>
      <Position>96</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R97.htm</HtmlFileName>
      <LongName>00000097 - Disclosure - Schedule of fair value measurement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails</Role>
      <ShortName>Schedule of fair value measurement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>97</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R98.htm</HtmlFileName>
      <LongName>00000098 - Disclosure - Schedule of capital management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfCapitalManagementDetails</Role>
      <ShortName>Schedule of capital management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>98</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R99.htm</HtmlFileName>
      <LongName>00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails</Role>
      <ShortName>Schedule of model used to determine the fair value of the stock options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>99</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R100.htm</HtmlFileName>
      <LongName>00000100 - Disclosure - Schedule of share-based compensation plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails</Role>
      <ShortName>Schedule of share-based compensation plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>100</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R101.htm</HtmlFileName>
      <LongName>00000101 - Disclosure - Labor and social obligations (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative</Role>
      <ShortName>Labor and social obligations (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/LaborAndSocialObligationsTables</ParentRole>
      <Position>101</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R102.htm</HtmlFileName>
      <LongName>00000102 - Disclosure - Schedule of earnings per share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfEarningsPerShareDetails</Role>
      <ShortName>Schedule of earnings per share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>102</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R103.htm</HtmlFileName>
      <LongName>00000103 - Disclosure - Schedule of net sales revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails</Role>
      <ShortName>Schedule of net sales revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>103</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R104.htm</HtmlFileName>
      <LongName>00000104 - Disclosure - Schedule of revenue by segment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails</Role>
      <ShortName>Schedule of revenue by segment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>104</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R105.htm</HtmlFileName>
      <LongName>00000105 - Disclosure - Schedule of expenses by nature (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfExpensesByNatureDetails</Role>
      <ShortName>Schedule of expenses by nature (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>105</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R106.htm</HtmlFileName>
      <LongName>00000106 - Disclosure - Schedule of finance result (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfFinanceResultDetails</Role>
      <ShortName>Schedule of finance result (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>106</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R107.htm</HtmlFileName>
      <LongName>00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails</Role>
      <ShortName>Schedule of reconciliation of income tax expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>107</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R108.htm</HtmlFileName>
      <LongName>00000108 - Disclosure - Equity (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/EquityDetailsNarrative</Role>
      <ShortName>Equity (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/EquityTables</ParentRole>
      <Position>108</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R109.htm</HtmlFileName>
      <LongName>00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails</Role>
      <ShortName>Schedule of legal proceedings and contingencies (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>109</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R110.htm</HtmlFileName>
      <LongName>00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails</Role>
      <ShortName>Schedule of social security proceedings assessed by Management (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>110</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R111.htm</HtmlFileName>
      <LongName>00000111 - Disclosure - Income taxes (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/IncomeTaxesDetailsNarrative</Role>
      <ShortName>Income taxes (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/IncomeTaxesTables</ParentRole>
      <Position>111</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R112.htm</HtmlFileName>
      <LongName>00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative</Role>
      <ShortName>Insurance contracts and contingencies (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/InsuranceContractsAndContingenciesTables</ParentRole>
      <Position>112</Position>
    </Report>
    <Report instance="afyaform20f_2021.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R113.htm</HtmlFileName>
      <LongName>00000113 - Disclosure - Subsequent events (Details Narrative)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://afya.com.br/role/SubsequentEventsDetailsNarrative</Role>
      <ShortName>Subsequent events (Details Narrative)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://afya.com.br/role/SubsequentEvents</ParentRole>
      <Position>113</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="20-F" original="afyaform20f_2021.htm">afyaform20f_2021.htm</File>
    <File>afya-20211231.xsd</File>
    <File>afya-20211231_cal.xml</File>
    <File>afya-20211231_def.xml</File>
    <File>afya-20211231_lab.xml</File>
    <File>afya-20211231_pre.xml</File>
    <File>ex01-2.htm</File>
    <File>ex02-1.htm</File>
    <File>ex12-1.htm</File>
    <File>ex12-2.htm</File>
    <File>ex13-1.htm</File>
    <File>ex13-2.htm</File>
    <File>ex23-1.htm</File>
    <File>ex8-1.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>afyaform20f_001.jpg</File>
    <File>afyaform20f_002.jpg</File>
    <File>afyaform20f_003.jpg</File>
    <File>afyaform20f_004.jpg</File>
    <File>afyaform20f_005.jpg</File>
    <File>afyaform20f_006.jpg</File>
    <File>afyaform20f_007.jpg</File>
    <File>afyaform20f_008.jpg</File>
    <File>afyaform20f_009.jpg</File>
    <File>afyaform20f_010.jpg</File>
    <File>afyaform20f_011.jpg</File>
    <File>afyaform20f_012.jpg</File>
    <File>afyaform20f_013.jpg</File>
    <File>afyaform20f_014.jpg</File>
    <File>afyaform20f_015.jpg</File>
    <File>afyaform20f_016.jpg</File>
    <File>afyaform20f_017.jpg</File>
    <File>afyaform20f_018.jpg</File>
    <File>afyaform20f_019.jpg</File>
    <File>afyaform20f_020.jpg</File>
    <File>afyaform20f_021.jpg</File>
    <File>afyaform20f_022.jpg</File>
    <File>afyaform20f_023.jpg</File>
    <File>afyaform20f_024.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="2442">http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full</BaseTaxonomy>
    <BaseTaxonomy items="44">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>159
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "afyaform20f_2021.htm": {
   "axisCustom": 3,
   "axisStandard": 34,
   "contextCount": 1047,
   "dts": {
    "calculationLink": {
     "local": [
      "afya-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "afya-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "afyaform20f_2021.htm"
     ]
    },
    "labelLink": {
     "local": [
      "afya-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "afya-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "afya-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.ifrs.org/taxonomy/2021-03-24/full_ifrs/full_ifrs-cor_2021-03-24.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 956,
   "entityCount": 1,
   "hidden": {
    "http://afya.com.br/20211231": 225,
    "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full": 371,
    "http://xbrl.sec.gov/dei/2021q4": 10,
    "total": 606
   },
   "keyCustom": 270,
   "keyStandard": 323,
   "memberCustom": 158,
   "memberStandard": 50,
   "nsprefix": "afya",
   "nsuri": "http://afya.com.br/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "00000001 - Document - Cover",
     "role": "http://afya.com.br/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000010 - Disclosure - Business combinations",
     "role": "http://afya.com.br/role/BusinessCombinations",
     "shortName": "Business combinations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R100": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlan",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
      "reportCount": 1,
      "unitRef": "BRLPShares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000100 - Disclosure - Schedule of share-based compensation plan (Details)",
     "role": "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails",
     "shortName": "Schedule of share-based compensation plan (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSharebasedCompensationPlan",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NumberOfOutstandingShareOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "N",
      "xsiNil": "false"
     }
    },
    "R101": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "afya:ShareBasedCompensationOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000101 - Disclosure - Labor and social obligations (Details Narrative)",
     "role": "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
     "shortName": "Labor and social obligations (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "afya:ShareBasedCompensationOfEmployees",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R102": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000102 - Disclosure - Schedule of earnings per share (Details)",
     "role": "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails",
     "shortName": "Schedule of earnings per share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfEarningsPerShareTableExplanatory",
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AdjustmentToProfitLossForPreferenceShareDividends",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R103": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfessionalFeesExpense",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000103 - Disclosure - Schedule of net sales revenue (Details)",
     "role": "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails",
     "shortName": "Schedule of net sales revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfNetSalesRevenueExplanatory",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:OtherRevenue1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R104": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegment",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000104 - Disclosure - Schedule of revenue by segment (Details)",
     "role": "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails",
     "shortName": "Schedule of revenue by segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRevenueBySegment",
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PaymentsToSuppliersForGoodsAndServices",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R105": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CostOfSales",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000105 - Disclosure - Schedule of expenses by nature (Details)",
     "role": "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails",
     "shortName": "Schedule of expenses by nature (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfExpensesByNatureTableTextBlock",
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:ExpenseByNature",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R106": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResult",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000106 - Disclosure - Schedule of finance result (Details)",
     "role": "http://afya.com.br/role/ScheduleOfFinanceResultDetails",
     "shortName": "Schedule of finance result (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFinanceResult",
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:InvestmentIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R107": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ProfitLossBeforeTax",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000107 - Disclosure - Schedule of reconciliation of income tax expense (Details)",
     "role": "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails",
     "shortName": "Schedule of reconciliation of income tax expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:TaxExpenseIncomeAtApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R108": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000108 - Disclosure - Equity (Details Narrative)",
     "role": "http://afya.com.br/role/EquityDetailsNarrative",
     "shortName": "Equity (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2019-12-31",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:IssuedCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R109": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLegalProceedingsAndContingencies",
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Provisions",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000109 - Disclosure - Schedule of legal proceedings and contingencies (Details)",
     "role": "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
     "shortName": "Schedule of legal proceedings and contingencies (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfLegalProceedingsAndContingencies",
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31_ifrs-full_LegalProceedingsContingentLiabilityMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Provisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000011 - Disclosure - Cash and cash equivalents",
     "role": "http://afya.com.br/role/CashAndCashEquivalents",
     "shortName": "Cash and cash equivalents",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R110": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement",
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000110 - Disclosure - Schedule of social security proceedings assessed by Management (Details)",
     "role": "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails",
     "shortName": "Schedule of social security proceedings assessed by Management (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfSocialSecurityProceedingsAssessedByManagement",
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:OtherProvisions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R111": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000111 - Disclosure - Income taxes (Details Narrative)",
     "role": "http://afya.com.br/role/IncomeTaxesDetailsNarrative",
     "shortName": "Income taxes (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DeferredTaxExpenseIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R112": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:JudicialDeposits",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000112 - Disclosure - Insurance contracts and contingencies (Details Narrative)",
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
     "shortName": "Insurance contracts and contingencies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_custom_OtherAssetsNonCurrentMember",
      "decimals": "-3",
      "lang": null,
      "name": "afya:JudicialDeposits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R113": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "afya:RepurchaseOfOrdinaryShares",
      "reportCount": 1,
      "unitRef": "Shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000113 - Disclosure - Subsequent events (Details Narrative)",
     "role": "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
     "shortName": "Subsequent events (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2022-02-24_custom_IClinicParticipacoesSAMember",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000012 - Disclosure - Trade receivables",
     "role": "http://afya.com.br/role/TradeReceivables",
     "shortName": "Trade receivables",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000013 - Disclosure - Related parties",
     "role": "http://afya.com.br/role/RelatedParties",
     "shortName": "Related parties",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRelatedPartyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000014 - Disclosure - Other assets",
     "role": "http://afya.com.br/role/OtherAssets",
     "shortName": "Other assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfOtherAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000015 - Disclosure - Investment in associate",
     "role": "http://afya.com.br/role/InvestmentInAssociate",
     "shortName": "Investment in associate",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfJointVenturesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000016 - Disclosure - Property and equipment",
     "role": "http://afya.com.br/role/PropertyAndEquipment",
     "shortName": "Property and equipment",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000017 - Disclosure - Intangible assets and goodwill",
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwill",
     "shortName": "Intangible assets and goodwill",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000018 - Disclosure - Financial assets and financial liabilities",
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities",
     "shortName": "Financial assets and financial liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:FairValueMeasurementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000019 - Disclosure - Fair value measurement",
     "role": "http://afya.com.br/role/FairValueMeasurement",
     "shortName": "Fair value measurement",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:FairValueMeasurementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000002 - Statement - Consolidated statements of financial position",
     "role": "http://afya.com.br/role/StatementsOfFinancialPosition",
     "shortName": "Consolidated statements of financial position",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Inventories",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:CapitalManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000020 - Disclosure - Capital management",
     "role": "http://afya.com.br/role/CapitalManagement",
     "shortName": "Capital management",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:CapitalManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000021 - Disclosure - Labor and social obligations",
     "role": "http://afya.com.br/role/LaborAndSocialObligations",
     "shortName": "Labor and social obligations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:LaborAndSocialObligationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000022 - Disclosure - Equity",
     "role": "http://afya.com.br/role/Equity",
     "shortName": "Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000023 - Disclosure - Earnings per share (EPS)",
     "role": "http://afya.com.br/role/EarningsPerShareEps",
     "shortName": "Earnings per share (EPS)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000024 - Disclosure - Revenue",
     "role": "http://afya.com.br/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000025 - Disclosure - Expenses and costs by nature",
     "role": "http://afya.com.br/role/ExpensesAndCostsByNature",
     "shortName": "Expenses and costs by nature",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000026 - Disclosure - Finance result",
     "role": "http://afya.com.br/role/FinanceResult",
     "shortName": "Finance result",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000027 - Disclosure - Income taxes",
     "role": "http://afya.com.br/role/IncomeTaxes",
     "shortName": "Income taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfIncomeTaxExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000028 - Disclosure - Insurance contracts and contingencies",
     "role": "http://afya.com.br/role/InsuranceContractsAndContingencies",
     "shortName": "Insurance contracts and contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000029 - Disclosure - Non-cash transactions",
     "role": "http://afya.com.br/role/Non-cashTransactions",
     "shortName": "Non-cash transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureNoncashTransactionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000003 - Statement - Consolidated statements of income and comprehensive income",
     "role": "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome",
     "shortName": "Consolidated statements of income and comprehensive income",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:OtherIncome",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000030 - Disclosure - Subsequent events",
     "role": "http://afya.com.br/role/SubsequentEvents",
     "shortName": "Subsequent events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEventsAfterReportingPeriodExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000031 - Disclosure - Significant accounting policies (Policies)",
     "role": "http://afya.com.br/role/SignificantAccountingPoliciesPolicies",
     "shortName": "Significant accounting policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:BusinessCombinationsAndGoodwillPolicyExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000032 - Disclosure - Significant accounting policies (Tables)",
     "role": "http://afya.com.br/role/SignificantAccountingPoliciesTables",
     "shortName": "Significant accounting policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000033 - Disclosure - Segment information (Tables)",
     "role": "http://afya.com.br/role/SegmentInformationTables",
     "shortName": "Segment information (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000034 - Disclosure - Business combinations (Tables)",
     "role": "http://afya.com.br/role/BusinessCombinationsTables",
     "shortName": "Business combinations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000035 - Disclosure - Cash and cash equivalents (Tables)",
     "role": "http://afya.com.br/role/CashAndCashEquivalentsTables",
     "shortName": "Cash and cash equivalents (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000036 - Disclosure - Trade receivables (Tables)",
     "role": "http://afya.com.br/role/TradeReceivablesTables",
     "shortName": "Trade receivables (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000037 - Disclosure - Related parties (Tables)",
     "role": "http://afya.com.br/role/RelatedPartiesTables",
     "shortName": "Related parties (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfRelatedPartiesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000038 - Disclosure - Other assets (Tables)",
     "role": "http://afya.com.br/role/OtherAssetsTables",
     "shortName": "Other assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfOtherAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000039 - Disclosure - Investment in associate (Tables)",
     "role": "http://afya.com.br/role/InvestmentInAssociateTables",
     "shortName": "Investment in associate (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31_ifrs-full_IssuedCapitalMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000004 - Statement - Consolidated statements of changes in equity",
     "role": "http://afya.com.br/role/StatementsOfChangesInEquity",
     "shortName": "Consolidated statements of changes in equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31_ifrs-full_IssuedCapitalMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Equity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000040 - Disclosure - Property and equipment (Tables)",
     "role": "http://afya.com.br/role/PropertyAndEquipmentTables",
     "shortName": "Property and equipment (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000041 - Disclosure - Intangible assets and goodwill (Tables)",
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables",
     "shortName": "Intangible assets and goodwill (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:FinancialAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000042 - Disclosure - Financial assets and financial liabilities (Tables)",
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables",
     "shortName": "Financial assets and financial liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:FinancialAssetsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfFairValueMeasurementExplanaory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000043 - Disclosure - Fair value measurement (Tables)",
     "role": "http://afya.com.br/role/FairValueMeasurementTables",
     "shortName": "Fair value measurement (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfFairValueMeasurementExplanaory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfCapitalManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000044 - Disclosure - Capital management (Tables)",
     "role": "http://afya.com.br/role/CapitalManagementTables",
     "shortName": "Capital management (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfCapitalManagementExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000045 - Disclosure - Labor and social obligations (Tables)",
     "role": "http://afya.com.br/role/LaborAndSocialObligationsTables",
     "shortName": "Labor and social obligations (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfTreasurySharesMovement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000046 - Disclosure - Equity (Tables)",
     "role": "http://afya.com.br/role/EquityTables",
     "shortName": "Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfTreasurySharesMovement",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfEarningsPerShareTableExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000047 - Disclosure - Earnings per share (EPS) (Tables)",
     "role": "http://afya.com.br/role/EarningsPerShareEpsTables",
     "shortName": "Earnings per share (EPS) (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfEarningsPerShareExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:DisclosureOfEarningsPerShareTableExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000048 - Disclosure - Revenue (Tables)",
     "role": "http://afya.com.br/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfRevenueExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfNetSalesRevenueExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfExpensesByNatureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000049 - Disclosure - Expenses and costs by nature (Tables)",
     "role": "http://afya.com.br/role/ExpensesAndCostsByNatureTables",
     "shortName": "Expenses and costs by nature (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfExpensesByNatureExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SummaryOfExpensesByNatureTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "00000005 - Statement - Consolidated statements of cash flows",
     "role": "http://afya.com.br/role/StatementsOfCashFlows",
     "shortName": "Consolidated statements of cash flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:IncomeLossBeforeIncomeTaxes",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfFinanceResult",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000050 - Disclosure - Finance result (Tables)",
     "role": "http://afya.com.br/role/FinanceResultTables",
     "shortName": "Finance result (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfFinanceIncomeExpenseExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfFinanceResult",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000051 - Disclosure - Income taxes (Tables)",
     "role": "http://afya.com.br/role/IncomeTaxesTables",
     "shortName": "Income taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfLegalProceedingsAndContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000052 - Disclosure - Insurance contracts and contingencies (Tables)",
     "role": "http://afya.com.br/role/InsuranceContractsAndContingenciesTables",
     "shortName": "Insurance contracts and contingencies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ifrs-full:DisclosureOfInsuranceContractsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:ScheduleOfLegalProceedingsAndContingencies",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-08-04",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000053 - Disclosure - Corporate information (Details Narrative)",
     "role": "http://afya.com.br/role/CorporateInformationDetailsNarrative",
     "shortName": "Corporate information (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2019-07-072019-07-08",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NameOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000054 - Disclosure - The table below is a list of the Company\u2019s subsidiaries and associate: (Details)",
     "role": "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
     "shortName": "The table below is a list of the Company\u2019s subsidiaries and associate: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_custom_AfyaParticipacoesSAMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:NameOfSubsidiary",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000055 - Disclosure - Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)",
     "role": "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
     "shortName": "Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Assets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000056 - Disclosure - Schedule of assets and liabilities information for the company's operating segments (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
     "shortName": "Schedule of assets and liabilities information for the company's operating segments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_OperatingSegmentsMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:Assets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-04-062021-04-08",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Revenue",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000057 - Disclosure - Schedule of operating income for each operating segment (Details)",
     "role": "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
     "shortName": "Schedule of operating income for each operating segment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfOperatingSegmentsExplanatory",
       "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_ifrs-full_OperatingSegmentsMember",
      "decimals": "-3",
      "lang": null,
      "name": "afya:DepositsFromExternalCustomer",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000058 - Disclosure - Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)",
     "role": "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
     "shortName": "Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-11-09_custom_IClinicMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
       "ifrs-full:DisclosureOfIncomeTaxExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000059 - Disclosure - Significant accounting policies (Details Narrative)",
     "role": "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative",
     "shortName": "Significant accounting policies (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "afya:TaxesPolicyExplanation",
       "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_custom_ProgramOfSocialIntegrationMember_custom_TeachingActivitiesMember",
      "decimals": "INF",
      "lang": null,
      "name": "ifrs-full:ApplicableTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000006 - Disclosure - Corporate information",
     "role": "http://afya.com.br/role/CorporateInformation",
     "shortName": "Corporate information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-07-192020-07-20_ifrs-full_BrandNamesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000060 - Disclosure - Schedule of acquisition of UniRedentor (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
     "shortName": "Schedule of acquisition of UniRedentor (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-07-192020-07-20_ifrs-full_BrandNamesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000061 - Disclosure - Schedule of acquisition of UniSL (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
     "shortName": "Schedule of acquisition of UniSL (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-07-192020-07-20_ifrs-full_BrandNamesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000062 - Disclosure - Schedule of acquisition of PEBMED (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
     "shortName": "Schedule of acquisition of PEBMED (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-07-192020-07-20_ifrs-full_BrandNamesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000063 - Disclosure - Schedule of acquisition of FESAR (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
     "shortName": "Schedule of acquisition of FESAR (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-07-192020-07-20_ifrs-full_BrandNamesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000064 - Disclosure - Schedule of acquisition of MedPhone (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
     "shortName": "Schedule of acquisition of MedPhone (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-11-082020-11-09_ifrs-full_LicencesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000065 - Disclosure - Schedule of acquisition of FCMPB (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
     "shortName": "Schedule of acquisition of FCMPB (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "p",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfFcmpbTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-11-082020-11-09_ifrs-full_LicencesMember",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000066 - Disclosure - The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)",
     "role": "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails",
     "shortName": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "td",
       "tr",
       "table",
       "afya:ScheduleOfAcquisitionOfUniredentorTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_custom_SociedadeUniversitariaRedentorSAMember_ifrs-full_LicencesMember",
      "decimals": null,
      "lang": "en-US",
      "name": "ifrs-full:DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:NotesPayables",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000067 - Disclosure - The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)",
     "role": "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
     "shortName": "The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-01-31_custom_SociedadeUniversitariaRedentorSAMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000068 - Disclosure - Schedule of cash and cash equivalents (Details)",
     "role": "http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails",
     "shortName": "Schedule of cash and cash equivalents (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R69": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-08-04",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PercentageOfVotingEquityInterestsAcquired",
      "reportCount": 1,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000069 - Disclosure - Business combinations (Details Narrative)",
     "role": "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
     "shortName": "Business combinations (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfBusinessCombinationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "afya:IncreaseInRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000007 - Disclosure - Significant accounting policies",
     "role": "http://afya.com.br/role/SignificantAccountingPolicies",
     "shortName": "Significant accounting policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R70": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:ReceivablesGross",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000070 - Disclosure - Schedule of trade accounts receivable, net and notes receivable (Details)",
     "role": "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
     "shortName": "Schedule of trade accounts receivable, net and notes receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:AllowanceForDoubtfulAccountsFoReceivable1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R71": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:ReceivablesGross",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000071 - Disclosure - Schedule of aging of trade accounts receivable (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails",
     "shortName": "Schedule of aging of trade accounts receivable (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAccountsReceivableByAgingExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_CurrentMember",
      "decimals": "-3",
      "lang": null,
      "name": "afya:ReceivablesGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R72": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:AllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000072 - Disclosure - Schedule of allowance for doubtful accounts (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails",
     "shortName": "Schedule of allowance for doubtful accounts (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:AllowanceForDoubtfulAccountsExplanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AllowanceAccountForCreditLossesOfFinancialAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R73": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:TradeReceivablesRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000073 - Disclosure - The table below summarizes the balances and transactions with related parties: (Details)",
     "role": "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails",
     "shortName": "The table below summarizes the balances and transactions with related parties: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfRelatedPartiesExplanatory",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:TradeReceivablesRelatedPartyTransactions",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R74": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashEquivalents",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000074 - Disclosure - Cash and cash equivalents (Details Narrative)",
     "role": "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
     "shortName": "Cash and cash equivalents (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfCashAndCashEquivalentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_custom_USDMember",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:CashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R75": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000075 - Disclosure - Key management personnel compensation included in the Company\u2019s consolidated statement of income comprised the following: (Details)",
     "role": "http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails",
     "shortName": "Key management personnel compensation included in the Company\u2019s consolidated statement of income comprised the following: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R76": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashOutflowForLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000076 - Disclosure - Related parties (Details Narrative)",
     "role": "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
     "shortName": "Related parties (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfRelatedPartyExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2019-01-012019-12-31_custom_RVLEstevesGestaoImobiliariaSAMember1110218265",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashOutflowForLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R77": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IndemnificationAssetsRecognisedAsOfAcquisitionDate",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000077 - Disclosure - Schedule of Other Assets (Details)",
     "role": "http://afya.com.br/role/ScheduleOfOtherAssetsDetails",
     "shortName": "Schedule of Other Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfOtherAssetsTableTextBlock",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentPrepaidExpenses",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R78": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000078 - Disclosure - Schedule of investments (Details)",
     "role": "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
     "shortName": "Schedule of investments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfInvestments",
       "ifrs-full:DisclosureOfJointVenturesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_AssociatesMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CurrentAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R79": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000079 - Disclosure - Schedule of detailed information about property, plant and equipment (Details)",
     "role": "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
     "shortName": "Schedule of detailed information about property, plant and equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "ifrs-full:DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
       "ifrs-full:DisclosureOfPropertyPlantAndEquipmentExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:PropertyPlantAndEquipment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SignificantAccountingEstimatesAndAssumptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000008 - Disclosure - Significant accounting estimates and assumptions",
     "role": "http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions",
     "shortName": "Significant accounting estimates and assumptions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "afya:SignificantAccountingEstimatesAndAssumptionsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R80": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfIntangibleAssetsTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000080 - Disclosure - Schedule of intangible assets (Details)",
     "role": "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
     "shortName": "Schedule of intangible assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfIntangibleAssetsTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31_ifrs-full_GrossCarryingAmountMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IntangibleAssetsAndGoodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R81": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000081 - Disclosure - Schedule of assumptions for impairment test (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
     "shortName": "Schedule of assumptions for impairment test (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_custom_CarryingAmountsMember_custom_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:Goodwill",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R82": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "afya:OtherCurrentAssets1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000082 - Disclosure - Other assets (Details Narrative)",
     "role": "http://afya.com.br/role/OtherAssetsDetailsNarrative",
     "shortName": "Other assets (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfOtherAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "afya:OtherCurrentAssets1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R83": {
     "firstAnchor": null,
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000083 - Disclosure - Schedule of estimated useful lives (Details)",
     "role": "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
     "shortName": "Schedule of estimated useful lives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R84": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000084 - Disclosure - Schedule of financial assets (Details)",
     "role": "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
     "shortName": "Schedule of financial assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:FinancialAssetsExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_FinancialAssetsAtAmortisedCostMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:CashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R85": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:LoansAndFinancing",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000085 - Disclosure - Schedule of financial liabilities (Details)",
     "role": "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
     "shortName": "Schedule of financial liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:FinancialLiabilitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_FinancialLiabilitiesAtAmortisedCostMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R86": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:LoansAndFinancing",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000086 - Disclosure - Schedule of loans and financing (Details)",
     "role": "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
     "shortName": "Schedule of loans and financing (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:LoansAndFinancingExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:LoansAndFinancing1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R87": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000087 - Disclosure - Intangible assets and goodwill (Details Narrative)",
     "role": "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
     "shortName": "Intangible assets and goodwill (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfIntangibleAssetsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:DescriptionOfDiscountRatesAppliedToCashFlowProjections",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    },
    "R88": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:RightofuseAssets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000088 - Disclosure - Schedule of right-of-use assets and lease liabilities (Details)",
     "role": "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
     "shortName": "Schedule of right-of-use assets and lease liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:LeasesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:AdditionsToRightofuseAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R89": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToRelatedParties",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000089 - Disclosure - Schedule of accounts payable to selling shareholders (Details)",
     "role": "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
     "shortName": "Schedule of accounts payable to selling shareholders (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:AccountsPayableToSellingShareholdersExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:TradeAndOtherPayablesToRelatedParties1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000009 - Disclosure - Segment information",
     "role": "http://afya.com.br/role/SegmentInformation",
     "shortName": "Segment information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "ifrs-full:DisclosureOfEntitysReportableSegmentsExplanatory",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R90": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:NotesPayables",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000090 - Disclosure - Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)",
     "role": "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details",
     "shortName": "Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020 (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2020-01-012020-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:BusinessCombination",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R91": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:FairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000091 - Disclosure - The table below is a comparison of the carrying amounts and fair values of the Company\u2019s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)",
     "role": "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails",
     "shortName": "The table below is a comparison of the carrying amounts and fair values of the Company\u2019s financial instruments, other than those carrying amounts that are reasonable approximation of fair values: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:FairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:FinancialAssetsAtFairValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R92": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:FairValuesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:FinancialAssets",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000092 - Disclosure - Schedule of sensitivity analysis effects on income statement (Details)",
     "role": "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
     "shortName": "Schedule of sensitivity analysis effects on income statement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_ifrs-full_InterestRateRiskMember_ifrs-full_FloatingInterestRateMember_custom_CashEquivalents1Member_custom_IncreaseBasisPointsMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R93": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000093 - Disclosure - Schedule of currencies used in sensitivity analysis (Details)",
     "role": "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
     "shortName": "Schedule of currencies used in sensitivity analysis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-012021-12-31_ifrs-full_CurrencyRiskMember_custom_ForeignCurrencyExposuresMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:IncreaseDecreaseInCashAndCashEquivalents",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R94": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:LoansAndFinancing",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000094 - Disclosure - The tables below summarize the maturity profile of the Company\u2019s financial liabilities based on contractual undiscounted amounts: (Details)",
     "role": "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails",
     "shortName": "The tables below summarize the maturity profile of the Company\u2019s financial liabilities based on contractual undiscounted amounts: (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31_ifrs-full_LiquidityRiskMember",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:TradeAndOtherPayablesToTradeSuppliers",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R95": {
     "firstAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2020-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000095 - Disclosure - Schedule of changes in liabilities arising from financing activities (Details)",
     "role": "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails",
     "shortName": "Schedule of changes in liabilities arising from financing activities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "b",
       "span",
       "td",
       "tr",
       "table",
       "afya:ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2018-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:LiabilitiesArisingFromFinancingActivities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R96": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "ifrs-full:AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000096 - Disclosure - Financial assets and financial liabilities (Details Narrative)",
     "role": "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
     "shortName": "Financial assets and financial liabilities (Details Narrative)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "p",
       "ifrs-full:DisclosureOfFinancialInstrumentsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-01-01to2021-12-31",
      "decimals": "0",
      "lang": null,
      "name": "ifrs-full:ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R97": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:DisclosureOfTradeAndOtherReceivables1Explanatory",
       "ifrs-full:DisclosureOfTradeAndOtherReceivablesExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "ifrs-full:NoncurrentTradeReceivables",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000097 - Disclosure - Schedule of fair value measurement (Details)",
     "role": "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails",
     "shortName": "Schedule of fair value measurement (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfFairValueMeasurementExplanaory",
       "afya:FairValueMeasurementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "afya:LoansAndFinancingLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R98": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "afya:LoansAndFinancing",
      "reportCount": 1,
      "unitRef": "BRL",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000098 - Disclosure - Schedule of capital management (Details)",
     "role": "http://afya.com.br/role/ScheduleOfCapitalManagementDetails",
     "shortName": "Schedule of capital management (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfCapitalManagementExplanatory",
       "afya:CapitalManagementExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "AsOf2021-12-31",
      "decimals": "-3",
      "lang": null,
      "name": "ifrs-full:NotesAndDebenturesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "BRL",
      "xsiNil": "false"
     }
    },
    "R99": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-11-012021-11-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "00000099 - Disclosure - Schedule of model used to determine the fair value of the stock options (Details)",
     "role": "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails",
     "shortName": "Schedule of model used to determine the fair value of the stock options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "span",
       "td",
       "tr",
       "table",
       "afya:ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
       "afya:LaborAndSocialObligationsExplanatory",
       "body",
       "html"
      ],
      "baseRef": "afyaform20f_2021.htm",
      "contextRef": "From2021-11-012021-11-30",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "ifrs-full:ExpectedDividendAsPercentageShareOptionsGranted",
      "reportCount": 1,
      "unique": true,
      "unitRef": "Pure",
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 230,
   "tag": {
    "afya_AccountsPayableCurrent1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AccountsPayableCurrent1",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "AccountsPayableCurrent1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholderCashFlows": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to accounts payable to selling shareholder cash flows.",
        "label": "Cash flows"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholderCashFlows",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AccountsPayableToSellingShareholders",
        "verboseLabel": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholders",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholdersAcquisitionOfIpec": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to accounts payable to selling shareholders acquisition of ipec.",
        "label": "Acquisition of IPEC"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersAcquisitionOfIpec",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholdersBusinessCombinations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to accounts payable to selling shareholders business combinations.",
        "label": "AccountsPayableToSellingShareholdersBusinessCombinations",
        "verboseLabel": "Business combinations"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersBusinessCombinations",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholdersCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to accounts payable to selling shareholders current.",
        "label": "AccountsPayableToSellingShareholdersCurrent",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholdersExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of accounts payable to selling shareholders"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_AccountsPayableToSellingShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for accounts payable to selling shareholders.",
        "label": "Accounts Payable To Selling Shareholders [Member]"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_AccountsPayableToSellingShareholdersNonCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to accounts payable to selling shareholders non current.",
        "label": "AccountsPayableToSellingShareholdersNonCurrent",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersNonCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AccountsPayableToSellingShareholdersOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for accounts payable to selling shareholders.",
        "label": "AccountsPayableToSellingShareholdersOneMember"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersOneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_AccountsPayableToSellingShareholdersPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "m) Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_AccountsPayableToSellingShareholdersSevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for accounts payable to selling share holders seven.",
        "label": "Accounts payable to selling shareholders [member]"
       }
      }
     },
     "localname": "AccountsPayableToSellingShareholdersSevenMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_AccruedInterestOfOpeartingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Accrued interest"
       }
      }
     },
     "localname": "AccruedInterestOfOpeartingActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AcquisitionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition price"
       }
      }
     },
     "localname": "AcquisitionPrice",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "afya_AcquisitionsHeldByShareholders": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisitions held by shareholders"
       }
      }
     },
     "localname": "AcquisitionsHeldByShareholders",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionalMinorityInterestOfAcquiree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of additional interest (15%) in June 2019"
       }
      }
     },
     "localname": "AdditionalMinorityInterestOfAcquiree",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionalOfferingPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amoutn of additional offering price.",
        "label": "Additional offering price"
       }
      }
     },
     "localname": "AdditionalOfferingPrice",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "afya_AdditionalPaidinCapital1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AdditionalPaidinCapital1",
        "verboseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidinCapital1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionalPaidinCapital2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AdditionalPaidinCapital2-0]"
       }
      }
     },
     "localname": "AdditionalPaidinCapital2",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionalPaymentMade": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional payment made"
       }
      }
     },
     "localname": "AdditionalPaymentMade",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionalSharesGrossProceeds": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount fo additional shares gross proceeds.",
        "label": "Additional shares gross proceeds"
       }
      }
     },
     "localname": "AdditionalSharesGrossProceeds",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdditionsToLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of additions to lease liabilities.",
        "label": "Lease liabilities, additions"
       }
      }
     },
     "localname": "AdditionsToLeaseLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AdjustmentsAndEliminationsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments And Eliminations [Member]"
       }
      }
     },
     "localname": "AdjustmentsAndEliminationsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_AdvancesFromCustomersAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:AdvancesFromCustomersAsOfAcquisitionDate-0]",
        "verboseLabel": "Advances from customers"
       }
      }
     },
     "localname": "AdvancesFromCustomersAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AfyaParticipacoesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Afya Participacoes S A [Member]"
       }
      }
     },
     "localname": "AfyaParticipacoesSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_AllocationToAdditionalPaidinCapital": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Allocation to additional paid-in capital"
       }
      }
     },
     "localname": "AllocationToAdditionalPaidinCapital",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AllowanceForDoubtfulAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AllowanceForDoubtfulAccounts",
        "verboseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccounts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AllowanceForDoubtfulAccountsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_AllowanceForDoubtfulAccountsFoReceivable1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "AllowanceForDoubtfulAccountsFoReceivable1",
        "negatedLabel": "(-) Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsFoReceivable1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_AllowanceForDoubtfulAccountsOfOpeartingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsOfOpeartingActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_Assets1": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets1",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "Assets1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_BRHealthMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "B R Health [Member]"
       }
      }
     },
     "localname": "BRHealthMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_BankCertificatesOfDepositMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Bank Certificates Of Deposit [Member]"
       }
      }
     },
     "localname": "BankCertificatesOfDepositMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_BaseRate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to base rate.",
        "label": "Base rate"
       }
      }
     },
     "localname": "BaseRate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_BorrowingsAmountFirstTranche": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to borrowing first tranche.",
        "label": "Borrowings amount first tranche"
       }
      }
     },
     "localname": "BorrowingsAmountFirstTranche",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_BusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business combination.",
        "label": "Business combination"
       }
      }
     },
     "localname": "BusinessCombination",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_BusinessCombinationsAndGoodwillPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "a) Business combinations and goodwill"
       }
      }
     },
     "localname": "BusinessCombinationsAndGoodwillPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_BusinessCombinationsLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business combinations.",
        "label": "Lease liabilities, business combinations"
       }
      }
     },
     "localname": "BusinessCombinationsLeaseLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CancellationOfDividend": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cancellation of dividend"
       }
      }
     },
     "localname": "CancellationOfDividend",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalExpenditures": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital expenditures"
       }
      }
     },
     "localname": "CapitalExpenditures",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalIncreaseFromCorporateReorganization": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital increase from the corporate reorganization"
       }
      }
     },
     "localname": "CapitalIncreaseFromCorporateReorganization",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalIncreaseOfFinancialActivities": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CapitalIncreaseOfFinancialActivities",
        "verboseLabel": "Capital increase"
       }
      }
     },
     "localname": "CapitalIncreaseOfFinancialActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalIncreaseWithCash": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital increase"
       }
      }
     },
     "localname": "CapitalIncreaseWithCash",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalIncreaseWithEarningsReserves": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital increase with earnings reserves"
       }
      }
     },
     "localname": "CapitalIncreaseWithEarningsReserves",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CapitalManagementExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital management"
       }
      }
     },
     "localname": "CapitalManagementExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CapitalManagement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_CarryingAmountsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying Amounts [Member]"
       }
      }
     },
     "localname": "CarryingAmountsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CashAndCashEquivalents1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Less: cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CashEquivalents1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for cash equivalents1.",
        "label": "Cash Equivalents [Member]"
       }
      }
     },
     "localname": "CashEquivalents1Member",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CashGeneratingUnits": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash generating units"
       }
      }
     },
     "localname": "CashGeneratingUnits",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CashTransferredTransaction": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash on the transaction closing date"
       }
      }
     },
     "localname": "CashTransferredTransaction",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CentroDeCienciasEmSaudeDeItajubaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro De Ciencias Em Saude De Itajuba S A [Member]"
       }
      }
     },
     "localname": "CentroDeCienciasEmSaudeDeItajubaSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CentroIntegradoDeSaudeDeTeresinaCISMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Integrado De Saude De Teresina C I S [Member]"
       }
      }
     },
     "localname": "CentroIntegradoDeSaudeDeTeresinaCISMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Superior de Ciencias da Saude S/S Ltda (FCMPB) [member]"
       }
      }
     },
     "localname": "CentroSuperiorDeCienciasDaSaudeSSLtdaFCMPBMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CentroUniversitarioSaoLucasLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Universitario Sao Lucas Ltda [Member]"
       }
      }
     },
     "localname": "CentroUniversitarioSaoLucasLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CentroUniversitarioSaoLucasLtdaUniSLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Centro Universitario Sao Lucas Ltda Uni S L [Member]"
       }
      }
     },
     "localname": "CentroUniversitarioSaoLucasLtdaUniSLMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ChangeInFairValueOfDerivativeInstruments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in fair value of derivative instruments"
       }
      }
     },
     "localname": "ChangeInFairValueOfDerivativeInstruments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ChangesInFairValueOfDerivativeInstruments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in fair value of derivative instruments"
       }
      }
     },
     "localname": "ChangesInFairValueOfDerivativeInstruments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of changes in liabilities arising from financing activities"
       }
      }
     },
     "localname": "ChangesInLiabilitiesArisingFromFinancingActivitiesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_CivilMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Civil [Member]"
       }
      }
     },
     "localname": "CivilMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClassACommonSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Common Shares [Member]"
       }
      }
     },
     "localname": "ClassACommonSharesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClassAOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Ordinary Shares [Member]"
       }
      }
     },
     "localname": "ClassAOrdinarySharesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClassAPreferenceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class A Preference Shares [Member]"
       }
      }
     },
     "localname": "ClassAPreferenceSharesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClassBOrdinarySharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Ordinary Shares [Member]"
       }
      }
     },
     "localname": "ClassBOrdinarySharesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClassBPreferenceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class B Preference Shares [Member]"
       }
      }
     },
     "localname": "ClassBPreferenceSharesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ClinicalDecisionSoftwareMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Clinical Decision Software [Member]"
       }
      }
     },
     "localname": "ClinicalDecisionSoftwareMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CliquefarmaDrogariasOnlineLtdaCliquefarmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma Drogarias Online Ltda Cliquefarma [Member]"
       }
      }
     },
     "localname": "CliquefarmaDrogariasOnlineLtdaCliquefarmaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CliquefarmaDrogariasOnlineLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma Drogarias Online Ltda [Member]"
       }
      }
     },
     "localname": "CliquefarmaDrogariasOnlineLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CliquefarmaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cliquefarma [Member]"
       }
      }
     },
     "localname": "CliquefarmaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Companhia Nilza Cordeiro Herdy De Educacaoe Cultura Unigranrio [Member]"
       }
      }
     },
     "localname": "CompanhiaNilzaCordeiroHerdyDeEducacaoeCulturaUnigranrioMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CompanyShareInEquity1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share in equity \u2013 30%"
       }
      }
     },
     "localname": "CompanyShareInEquity1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CompanyShareOfProfitss": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Company\u2019s share of income for the period"
       }
      }
     },
     "localname": "CompanyShareOfProfitss",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CompensationOfLegalProceedingsDisbursement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to compensation of legal proceedings disbursement.",
        "label": "Compensation of legal proceedings disbursement"
       }
      }
     },
     "localname": "CompensationOfLegalProceedingsDisbursement",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ConsiderationToBeTransferred": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ConsiderationToBeTransferred-0]"
       }
      }
     },
     "localname": "ConsiderationToBeTransferred",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ConsultingFees": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Consulting fees"
       }
      }
     },
     "localname": "ConsultingFees",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ContingenciesCorrespondentAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingencies correspondent amount"
       }
      }
     },
     "localname": "ContingenciesCorrespondentAmount",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ContingentConsiderationOnBusinessCombinations": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Contingent consideration on Business combinations"
       }
      }
     },
     "localname": "ContingentConsiderationOnBusinessCombinations",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ContinuingEducationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Continuing Education [Member]"
       }
      }
     },
     "localname": "ContinuingEducationMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ContractualLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease term",
        "verboseLabel": "Contractual lease term"
       }
      }
     },
     "localname": "ContractualLeaseTerm",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "afya_ContributionForTheFinancingOfSocialSecurityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent tax.",
        "label": "Contribution for the financing of social security (\"COFINS\") [member]"
       }
      }
     },
     "localname": "ContributionForTheFinancingOfSocialSecurityMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CorporateReorganization": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Corporate reorganization"
       }
      }
     },
     "localname": "CorporateReorganization",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CreditsWithShareholdersRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CreditsWithShareholdersRelatedPartyTransactions",
        "verboseLabel": "Related parties"
       }
      }
     },
     "localname": "CreditsWithShareholdersRelatedPartyTransactions",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CurrentAssets1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentAssets1",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentAssets1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CurrentLiabilities1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "CurrentLiabilities1",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CurrentTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 8.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes payable"
       }
      }
     },
     "localname": "CurrentTaxesPayable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_CurrentVersusNoncurrentClassificationPoliciesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "b) Current versus non-current classification"
       }
      }
     },
     "localname": "CurrentVersusNoncurrentClassificationPoliciesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_CustomerRelationshipsMedicineMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships Medicine [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsMedicineMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_CustomerRelationshipsOtherCoursesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer Relationships Other Courses [Member]"
       }
      }
     },
     "localname": "CustomerRelationshipsOtherCoursesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DecreaseBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for decrease basis points.",
        "label": "Decrease in basis points -75 [Member]"
       }
      }
     },
     "localname": "DecreaseBasisPointsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DecreaseBasisPointsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for decrease basis points one.",
        "label": "Decrease in basis points -150 [Member]"
       }
      }
     },
     "localname": "DecreaseBasisPointsOneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DecreaseForeignCurrencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent decrease in foreign currency sensitivity.",
        "label": "Decrease in Foreign Currency Sensitivity -10% [Member]"
       }
      }
     },
     "localname": "DecreaseForeignCurrencyMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DecreasedInIncomeBeforeIncomeTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:DecreasedInIncomeBeforeIncomeTaxes]"
       }
      }
     },
     "localname": "DecreasedInIncomeBeforeIncomeTaxes",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DeductionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deductions"
       }
      }
     },
     "localname": "DeductionAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_DeductionOfEarlyPaymentDiscounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Early payment discounts"
       }
      }
     },
     "localname": "DeductionOfEarlyPaymentDiscounts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DeductionOfGrantedDiscounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Granted discounts"
       }
      }
     },
     "localname": "DeductionOfGrantedDiscounts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DeductionOfProuni": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI"
       }
      }
     },
     "localname": "DeductionOfProuni",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DeductionOfReturnsOfNetRevenue": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Returns"
       }
      }
     },
     "localname": "DeductionOfReturnsOfNetRevenue",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DeductionOfTaxes": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes"
       }
      }
     },
     "localname": "DeductionOfTaxes",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DepositsFromExternalCustomer": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "External customer"
       }
      }
     },
     "localname": "DepositsFromExternalCustomer",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DepreciationExpenseLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of depreciation expense.",
        "label": "Lease liabilities, depreciation expense"
       }
      }
     },
     "localname": "DepreciationExpenseLeaseLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DescriptionOfLeaseTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about description of lease term.",
        "label": "Description of lease term"
       }
      }
     },
     "localname": "DescriptionOfLeaseTerm",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_DescriptionOfLeaseTerms": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "DescriptionOfLeaseTerms",
        "verboseLabel": "Description of lease term"
       }
      }
     },
     "localname": "DescriptionOfLeaseTerms",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_DescriptionOfRatioOfConvertibleShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Description of ratio of convertible shares"
       }
      }
     },
     "localname": "DescriptionOfRatioOfConvertibleShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_DevelopedTechnologyIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Developed Technology Intangible Assets [Member]"
       }
      }
     },
     "localname": "DevelopedTechnologyIntangibleAssetsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DigitalServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Digital Services [Member]"
       }
      }
     },
     "localname": "DigitalServicesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DisclosureCapitalManagementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Capital Management",
        "verboseLabel": "Schedule Of Capital Management"
       }
      }
     },
     "localname": "DisclosureCapitalManagementAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "xbrltype": "stringItemType"
    },
    "afya_DisclosureFairValueMeasurementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Measurement"
       }
      }
     },
     "localname": "DisclosureFairValueMeasurementAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "xbrltype": "stringItemType"
    },
    "afya_DisclosureLaborAndSocialObligationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labor And Social Obligations",
        "verboseLabel": "Schedule Of Share-based Compensation Plan"
       }
      }
     },
     "localname": "DisclosureLaborAndSocialObligationsAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "xbrltype": "stringItemType"
    },
    "afya_DisclosureNoncashTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash Transactions"
       }
      }
     },
     "localname": "DisclosureNoncashTransactionsAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "xbrltype": "stringItemType"
    },
    "afya_DisclosureNoncashTransactionsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-cash transactions"
       }
      }
     },
     "localname": "DisclosureNoncashTransactionsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/Non-cashTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of cash and cash equivalents"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutCashAndCashEquivalentsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureOfEarningsPerShareTableExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of earnings per share"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareTableExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEpsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureOfOtherAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of Other Assets"
       }
      }
     },
     "localname": "DisclosureOfOtherAssetsTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureOfTradeAccountsReceivableByAgingExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of aging of trade accounts receivable"
       }
      }
     },
     "localname": "DisclosureOfTradeAccountsReceivableByAgingExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureOfTradeAndOtherReceivables1Explanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of trade accounts receivable, net and notes receivable"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivables1Explanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TradeReceivablesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant Accounting Estimates And Assumptions"
       }
      }
     },
     "localname": "DisclosureSignificantAccountingEstimatesAndAssumptionsAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "xbrltype": "stringItemType"
    },
    "afya_Disposal": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Disposal"
       }
      }
     },
     "localname": "Disposal",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DividendsCancelled": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends cancelled"
       }
      }
     },
     "localname": "DividendsCancelled",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DividendsDeclaredToNoncontrollingInterests": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends declared to non-controlling interests"
       }
      }
     },
     "localname": "DividendsDeclaredToNoncontrollingInterests",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DividendsPaidClassifiedAsFinancingActivities1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends paid classified"
       }
      }
     },
     "localname": "DividendsPaidClassifiedAsFinancingActivities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_DividendsPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for the dividends payable.",
        "label": "Dividends Payable [Member]"
       }
      }
     },
     "localname": "DividendsPayableMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_DividendsPayablePolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "o) Dividends payable"
       }
      }
     },
     "localname": "DividendsPayablePolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_DividendsReceived1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "DividendsReceived1",
        "verboseLabel": "Dividends received"
       }
      }
     },
     "localname": "DividendsReceived1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ESMCEducacaoSuperiorLtdaESMCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "E S M C Educacao Superior Ltda E S M C [Member]"
       }
      }
     },
     "localname": "ESMCEducacaoSuperiorLtdaESMCMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EducationContentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Education Content [Member]"
       }
      }
     },
     "localname": "EducationContentMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EducationalContentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Content [Member]"
       }
      }
     },
     "localname": "EducationalContentMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EducationalCreditsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Credits [Member]"
       }
      }
     },
     "localname": "EducationalCreditsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EducationalPlatformAndSoftwareInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Platform And Software In Progress [Member]"
       }
      }
     },
     "localname": "EducationalPlatformAndSoftwareInProgressMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EducationalPlatformMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Educational Platform [Member]"
       }
      }
     },
     "localname": "EducationalPlatformMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_EqualInstallmentsPayablesToRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of equal installments payables due to related parties.",
        "label": "Equal installments payables"
       }
      }
     },
     "localname": "EqualInstallmentsPayablesToRelatedParties",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_EqualInstallmentsPayablesToRelatedParties1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "EqualInstallmentsPayablesToRelatedParties1",
        "verboseLabel": "Equal installments payables"
       }
      }
     },
     "localname": "EqualInstallmentsPayablesToRelatedParties1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_EquityAndNetDebt1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total equity and net debt"
       }
      }
     },
     "localname": "EquityAndNetDebt1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_EquityInAssociate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "EquityInAssociate",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "EquityInAssociate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_EquityOne1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Total equity"
       }
      }
     },
     "localname": "EquityOne1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ExpenseByNatureOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ExpenseByNatureOne",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "ExpenseByNatureOne",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FADEPFaculdadeEducacionalDePatoBrancoLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "F A D E P Faculdade Educacional De Pato Branco Ltda [Member]"
       }
      }
     },
     "localname": "FADEPFaculdadeEducacionalDePatoBrancoLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FCMPBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "F C M P B [Member]"
       }
      }
     },
     "localname": "FCMPBMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FESARMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "F E S A R [Member]"
       }
      }
     },
     "localname": "FESARMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FIESMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "F I E S [Member]"
       }
      }
     },
     "localname": "FIESMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FaculdadeDeCienciasMedicasDaParaibaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Faculdade De Ciencias Medicas Da Paraiba [Member]"
       }
      }
     },
     "localname": "FaculdadeDeCienciasMedicasDaParaibaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Faculdade De Ensino Superior Da Amazonia Reunida F E S A R [Member]"
       }
      }
     },
     "localname": "FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaFESARMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for faculdade de ensino superior de amazon amazonia reunida.",
        "label": "Faculdade de Ensino Superior da Amazonia Reunida (\"FESAR\") [member]"
       }
      }
     },
     "localname": "FaculdadeDeEnsinoSuperiorDaAmazoniaReunidaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FairValueMeasurementExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair value measurement"
       }
      }
     },
     "localname": "FairValueMeasurementExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurement"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_FairValueNotesPayables1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FairValueNotesPayables1",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "FairValueNotesPayables1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FairValueNotesPayablesLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FairValueNotesPayablesLiabilities",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "FairValueNotesPayablesLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FairValuesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The table below is a comparison of the carrying amounts and fair values of the Company\u2019s financial instruments, other than those carrying amounts that are reasonable approximation of fair values:"
       }
      }
     },
     "localname": "FairValuesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_FinanceExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance expenses"
       }
      }
     },
     "localname": "FinanceExpense",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FinanceResult": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "FinanceResult",
        "verboseLabel": "Finance result"
       }
      }
     },
     "localname": "FinanceResult",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FinanciadoradeEstudoseProjetosFINEPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financiadorade Estudose Projetos F I N E P [Member]"
       }
      }
     },
     "localname": "FinanciadoradeEstudoseProjetosFINEPMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_FinancialAssetsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial assets"
       }
      }
     },
     "localname": "FinancialAssetsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_FinancialDiscountsGrantedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Financial discounts granted"
       }
      }
     },
     "localname": "FinancialDiscountsGrantedExpenses",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FinancialInstitution": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about financial institution.",
        "label": "Financial institution"
       }
      }
     },
     "localname": "FinancialInstitution",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "d) Financial instruments \u2013 initial recognition and measurement"
       }
      }
     },
     "localname": "FinancialInstrumentsInitialRecognitionAndMeasurementPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_FinancialLiabilitiesContractualUndiscounted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of financial liabilities contractual undiscounted.",
        "label": "Financial liabilities contractual undiscounted"
       }
      }
     },
     "localname": "FinancialLiabilitiesContractualUndiscounted",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_FinancialLiabilitiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of financial liabilities"
       }
      }
     },
     "localname": "FinancialLiabilitiesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ForeignCurrencyExposuresMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent foreign currency exposures.",
        "label": "Exposure [Member]"
       }
      }
     },
     "localname": "ForeignCurrencyExposuresMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_GuaranhunsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guaranhuns [Member]"
       }
      }
     },
     "localname": "GuaranhunsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_GuardayaEmpreendimentosAndParticipacoesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Guardaya Empreendimentos And Participacoes S A [Member]"
       }
      }
     },
     "localname": "GuardayaEmpreendimentosAndParticipacoesSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_HarbourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Harbour [Member]"
       }
      }
     },
     "localname": "HarbourMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_HospitalAndMedicalAgreements": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Hospital and medical agreements"
       }
      }
     },
     "localname": "HospitalAndMedicalAgreements",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "I Clinic Desenvolvimento De Software Ltdai Clinic [Member]"
       }
      }
     },
     "localname": "IClinicDesenvolvimentoDeSoftwareLtdaiClinicMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IClinicMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "I Clinic [Member]"
       }
      }
     },
     "localname": "IClinicMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IClinicParticipacoesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "I Clinic Participacoes S A [Member]"
       }
      }
     },
     "localname": "IClinicParticipacoesSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IESVAPPatrimonialLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "I E S V A P Patrimonial Ltda [Member]"
       }
      }
     },
     "localname": "IESVAPPatrimonialLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "I P T A N Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S A [Member]"
       }
      }
     },
     "localname": "IPTANInstitutoDeEnsinoSuperiorPresidenteTrancredoDeAlmeidaNevesSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IfrsStatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "IfrsStatementLineItems [Line Items]"
       }
      }
     },
     "localname": "IfrsStatementLineItems",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails",
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails",
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_ImdemnificationAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ImdemnificationAssets-0]"
       }
      }
     },
     "localname": "ImdemnificationAssets",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ImpairmentOfNonfinancialAssetsPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "k) Impairment of non-financial assets"
       }
      }
     },
     "localname": "ImpairmentOfNonfinancialAssetsPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_IncomeLossBeforeIncomeTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncomeLossBeforeIncomeTaxes",
        "negatedLabel": "Income before income taxes"
       }
      }
     },
     "localname": "IncomeLossBeforeIncomeTaxes",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IncreaseBasisPointsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for increase basis points.",
        "label": "Increase in basis points +75 [Member]"
       }
      }
     },
     "localname": "IncreaseBasisPointsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IncreaseBasisPointsOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for increase basis points one.",
        "label": "Increase in basis points +150 [Member]"
       }
      }
     },
     "localname": "IncreaseBasisPointsOneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IncreaseDecreaseInOperatingLiabilities1Abstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changes in assets and liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLiabilities1Abstract",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_IncreaseDecreaseInRecoverableTaxes": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 15.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IncreaseDecreaseInRecoverableTaxes",
        "negatedLabel": "Recoverable taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInRecoverableTaxes",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IncreaseForeignCurrencyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent increse in foreign currency sensitivity.",
        "label": "Increase in Foreign Currency Sensitivity +10% [Member]"
       }
      }
     },
     "localname": "IncreaseForeignCurrencyMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_IncreaseInIncomeBeforeIncomeTaxes": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in income before income taxes"
       }
      }
     },
     "localname": "IncreaseInIncomeBeforeIncomeTaxes",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IncreaseInRevenue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase in revenue"
       }
      }
     },
     "localname": "IncreaseInRevenue",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of increase through interest on liabilities arising from financing activities.",
        "label": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities",
        "verboseLabel": "Interest"
       }
      }
     },
     "localname": "IncreaseThroughInterestOnLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IndemnificationAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Indemnification assets"
       }
      }
     },
     "localname": "IndemnificationAssets",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IndexRatePerYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about index rate per year.",
        "label": "Index - % per year"
       }
      }
     },
     "localname": "IndexRatePerYear",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_InitialPublicOfferingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent initial public offering.",
        "label": "Initial Public Offering [Member]"
       }
      }
     },
     "localname": "InitialPublicOfferingMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituicao De Pesquisa Medicae Servicos Tecnologicos Da Area Da Saude S A [Member]"
       }
      }
     },
     "localname": "InstituicaoDePesquisaMedicaeServicosTecnologicosDaAreaDaSaudeSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Educacao Superior Do Vale Do Parnaiba S A [Member]"
       }
      }
     },
     "localname": "InstitutoDeEducacaoSuperiorDoValeDoParnaibaSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior De Palhoca S S Ltda I E S P P A L H O C A [Member]"
       }
      }
     },
     "localname": "InstitutoDeEnsinoSuperiorDePalhocaSSLtdaIESPPALHOCAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoDeEnsinoSuperiorDoPiauiSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto De Ensino Superior Do Piaui S A [Member]"
       }
      }
     },
     "localname": "InstitutoDeEnsinoSuperiorDoPiauiSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoEducacionalSantoAgostinhoSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Educacional Santo Agostinho S A [Member]"
       }
      }
     },
     "localname": "InstitutoEducacionalSantoAgostinhoSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoParaensedeEducacaoeCulturaLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Paraensede Educacaoe Cultura Ltda [Member]"
       }
      }
     },
     "localname": "InstitutoParaensedeEducacaoeCulturaLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos Porto S A Itpac Porto Nacional [Member]"
       }
      }
     },
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosPortoSAItpacPortoNacionalMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Instituto Tocantinense Presidente Antonio Carlos S A I T P A C Araguaina [Member]"
       }
      }
     },
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosSAITPACAraguainaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutoTocantinensePresidenteAntonioCarlosSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for instituto tocantinense presidente antonio carlos s a.",
        "label": "Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member]"
       }
      }
     },
     "localname": "InstitutoTocantinensePresidenteAntonioCarlosSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for Institutode Ensino Superior Presidente Trancredode Almeida Neves SA.",
        "label": "Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member]"
       }
      }
     },
     "localname": "InstitutodeEnsinoSuperiorPresidenteTrancredodeAlmeidaNevesSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Institutode Pesquisae Ensino Medicodo Estadode Minas Gerais Ltda [Member]"
       }
      }
     },
     "localname": "InstitutodePesquisaeEnsinoMedicodoEstadodeMinasGeraisLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InterSegment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Inter-segment"
       }
      }
     },
     "localname": "InterSegment",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_InterbankCertificatesOfDepositMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Interbank Certificates Of Deposit [Member]"
       }
      }
     },
     "localname": "InterbankCertificatesOfDepositMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_InterestExpense1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_InterestExpenseOnLeaseLiabilities1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Interest expense on lease liabilities"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_InterimDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend paid"
       }
      }
     },
     "localname": "InterimDividends",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IntrestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intrest rate"
       }
      }
     },
     "localname": "IntrestRate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "afya_Inventories1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:Inventories1-0]"
       }
      }
     },
     "localname": "Inventories1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_InvestmentGrossAmount": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Carrying amount of the investment"
       }
      }
     },
     "localname": "InvestmentGrossAmount",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_InvestmentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The investment type of a subsidiary.",
        "label": "Investment type"
       }
      }
     },
     "localname": "InvestmentType",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_IssuanceOfLoansAndFinancing": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuance of loans and financing"
       }
      }
     },
     "localname": "IssuanceOfLoansAndFinancing",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IssuedCapital1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IssuedCapital1",
        "verboseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_IssuedCapital2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IssuedCapital2",
        "verboseLabel": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital2",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ItEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "It Equipment [Member]"
       }
      }
     },
     "localname": "ItEquipmentMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_JudicialDeposits": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": 2.0,
       "parentTag": "afya_Assets1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Judicial deposits"
       }
      }
     },
     "localname": "JudicialDeposits",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LaborAndSocialObligationsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LaborAndSocialObligationsAsOfAcquisitionDate-0]",
        "verboseLabel": "Labor and social obligations"
       }
      }
     },
     "localname": "LaborAndSocialObligationsAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LaborAndSocialObligationsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "LaborAndSocialObligationsExplanatory",
        "verboseLabel": "Labor and social obligations"
       }
      }
     },
     "localname": "LaborAndSocialObligationsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_LaborAndSocialObligationsPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "p) Labor and social obligations"
       }
      }
     },
     "localname": "LaborAndSocialObligationsPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_LaboratoriesAndClinicsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Laboratories And Clinics [Member]"
       }
      }
     },
     "localname": "LaboratoriesAndClinicsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LabourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Labour [Member]"
       }
      }
     },
     "localname": "LabourMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LaterThanOneEightyMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later Than One Eighty [Member]"
       }
      }
     },
     "localname": "LaterThanOneEightyMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LaterThanOneMonthsAndNotLaterThanThreeMonthsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Later Than One Months And Not Later Than Three Months [Member]"
       }
      }
     },
     "localname": "LaterThanOneMonthsAndNotLaterThanThreeMonthsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LeaseAgreements1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease Agreements 1 [Member]"
       }
      }
     },
     "localname": "LeaseAgreements1Member",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LeaseExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseExpenses",
        "verboseLabel": "Lease expenses"
       }
      }
     },
     "localname": "LeaseExpenses",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitieRightToUse": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseLiabilitieRightToUse",
        "periodEndLabel": "Lease liabilities, balance at ending"
       }
      }
     },
     "localname": "LeaseLiabilitieRightToUse",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilities1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseLiabilities1",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitiesAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:LeaseLiabilitiesAsOfAcquisitionDate-0]",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitiesDisposals": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of lease liabilities disposals.",
        "label": "Lease liabilities, disposals"
       }
      }
     },
     "localname": "LeaseLiabilitiesDisposals",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitiesOne": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseLiabilitiesOne",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilitiesOne",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitiesRemeasurement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of lease liabilities re measurement.",
        "label": "Lease liabilities, remeasurement"
       }
      }
     },
     "localname": "LeaseLiabilitiesRemeasurement",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeaseLiabilitiesRightToUse": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LeaseLiabilitiesRightToUse",
        "periodStartLabel": "Lease liabilities, balance at beginning"
       }
      }
     },
     "localname": "LeaseLiabilitiesRightToUse",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LeasesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of right-of-use assets and lease liabilities"
       }
      }
     },
     "localname": "LeasesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_LesseeFinancesLeaseRenewalTerm": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Renewal term"
       }
      }
     },
     "localname": "LesseeFinancesLeaseRenewalTerm",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "afya_LibraryBooksMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Library Books [Member]"
       }
      }
     },
     "localname": "LibraryBooksMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LoansAndFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LoansAndFinancing",
        "terseLabel": "Loans and financing",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LoansAndFinancing",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LoansAndFinancing1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LoansAndFinancing1",
        "verboseLabel": "Loans and financing"
       }
      }
     },
     "localname": "LoansAndFinancing1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LoansAndFinancingCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to loans and financing current.",
        "label": "LoansAndFinancingCurrent",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "LoansAndFinancingCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LoansAndFinancingExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of loans and financing"
       }
      }
     },
     "localname": "LoansAndFinancingExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_LoansAndFinancingLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "LoansAndFinancingLiabilities",
        "verboseLabel": "Loans and financing"
       }
      }
     },
     "localname": "LoansAndFinancingLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LoansAndFinancingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for loans and financing.",
        "label": "Loans And Financing [Member]"
       }
      }
     },
     "localname": "LoansAndFinancingMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LoansAndFinancingNonCurrent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount refers to loans and financing non current.",
        "label": "LoansAndFinancingNonCurrent",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "LoansAndFinancingNonCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_LoansAndFinancingOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for loans and financing one.",
        "label": "Instituto De Ensino Superior Presidente Trancredo De Almeida Neves S.A. (IPTAN) [Member] [Default Label]"
       }
      }
     },
     "localname": "LoansAndFinancingOneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_LoansAndFinancingTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for loans and financing two.",
        "label": "Instituto Tocantinense Presidente Antonio Carlos S.A. (ITPAC ) [Member] [Default Label]"
       }
      }
     },
     "localname": "LoansAndFinancingTwoMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MachineryAndEquipmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Machinery And Equipments [Member]"
       }
      }
     },
     "localname": "MachineryAndEquipmentsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedPhoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for medphone.",
        "label": "MEDPHONE [member]"
       }
      }
     },
     "localname": "MedPhoneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Med Phone Tecnologia Em Saude Ltda Med Phone [Member]"
       }
      }
     },
     "localname": "MedPhoneTecnologiaEmSaudeLtdaMedPhoneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedPhoneTecnologiaEmSaudeLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for med phone technologia em saude ltd.",
        "label": "MedPhone Tecnologia em Saude Ltda (\"MedPhone\") [member]"
       }
      }
     },
     "localname": "MedPhoneTecnologiaEmSaudeLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedcelAndCBBWMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medcel And C B B W [Member]"
       }
      }
     },
     "localname": "MedcelAndCBBWMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedcelEditoraAndCBBWebMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medcel Editora And C B B Web [Member]"
       }
      }
     },
     "localname": "MedcelEditoraAndCBBWebMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedcelEditoraEEventosSAMedcelMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medcel Editora E Eventos S A Medcel [Member]"
       }
      }
     },
     "localname": "MedcelEditoraEEventosSAMedcelMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour Aparelhos Medico Hospitalares E Servicos Em Tecnologia Ltda Medical Harbour [Member]"
       }
      }
     },
     "localname": "MedicalHarbourAparelhosMedicoHospitalaresEServicosEmTecnologiaLtdaMedicalHarbourMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour Aparelhos Medicos Hospitalarese Servicosem Tecnologia Ltda [Member]"
       }
      }
     },
     "localname": "MedicalHarbourAparelhosMedicosHospitalareseServicosemTecnologiaLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedicalHarbourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medical Harbour [Member]"
       }
      }
     },
     "localname": "MedicalHarbourMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedicinaeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicinae [Member]"
       }
      }
     },
     "localname": "MedicinaeMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MedicinaeSolutionsSAMedicinaeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Medicinae Solutions S A Medicinae [Member]"
       }
      }
     },
     "localname": "MedicinaeSolutionsSAMedicinaeMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MinorityInterestOfAcquiree": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Acquisition of minority interest (15%) in March 2019"
       }
      }
     },
     "localname": "MinorityInterestOfAcquiree",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_MobileAppSubscriptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Mobile App Subscription [Member]"
       }
      }
     },
     "localname": "MobileAppSubscriptionMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MocMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Moc [Member]"
       }
      }
     },
     "localname": "MocMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ModifiedPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Modified Plan [Member]"
       }
      }
     },
     "localname": "ModifiedPlanMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_MonetaryIndexation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of monetary indexation.",
        "label": "Monetary indexation"
       }
      }
     },
     "localname": "MonetaryIndexation",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NetOfCashFlowOnAcquisition": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:NetOfCashFlowOnAcquisition]",
        "verboseLabel": "Net of cash flow on acquisition"
       }
      }
     },
     "localname": "NetOfCashFlowOnAcquisition",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NetOfTransactionCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Net of the transaction costs"
       }
      }
     },
     "localname": "NetOfTransactionCosts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NetProceedsOfAdditionalShares": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net proceeds of additional shares.",
        "label": "Net proceeds of additional shares"
       }
      }
     },
     "localname": "NetProceedsOfAdditionalShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NetRevenueOtherTransferredPoint": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other - Transferred at a point in time",
        "verboseLabel": "Transferred at a point in time"
       }
      }
     },
     "localname": "NetRevenueOtherTransferredPoint",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NicolauCarvalhoEstevesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nicolau Carvalho Esteves [Member]"
       }
      }
     },
     "localname": "NicolauCarvalhoEstevesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_NonTeachingActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent services.",
        "label": "Non-teaching activities [member]"
       }
      }
     },
     "localname": "NonTeachingActivitiesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_NoncurrentAssets1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentAssets1",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentAssets1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NoncurrentAssetsOfRelatedParty1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentAssetsOfRelatedParty1",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentAssetsOfRelatedParty1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NoncurrentLiabilities1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentLiabilities1",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NoncurrentPayablesToRelatedParties1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentPayablesToRelatedParties1",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentPayablesToRelatedParties1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NoncurrentTaxesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentTaxesPayable",
        "verboseLabel": "Taxes payable"
       }
      }
     },
     "localname": "NoncurrentTaxesPayable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NoncurrentTradeReceivable": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NoncurrentTradeReceivable",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "NoncurrentTradeReceivable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NotePayable",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "NotePayable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotePayableCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Notes payable"
       }
      }
     },
     "localname": "NotePayableCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotePayables": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of note payables.",
        "label": "DerivativeLiabilitiesCrossCurrencyInterestRateSwaps [Default Label]",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotePayables",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotesPayable1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NotesPayable1",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesPayable1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotesPayableMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for notes payable.",
        "label": "Notes Payable[Member]"
       }
      }
     },
     "localname": "NotesPayableMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_NotesPayableNonCurrentLiabiites": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NotesPayableNonCurrentLiabiites",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesPayableNonCurrentLiabiites",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NotesPayables": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "NotesPayables",
        "periodEndLabel": "Notes payable ending",
        "periodStartLabel": "Notes payable beginning",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesPayables",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_NumberOfAdditionalCommonSharesIssued": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional common shares issued.",
        "label": "Number of additional common shares issued"
       }
      }
     },
     "localname": "NumberOfAdditionalCommonSharesIssued",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "afya_NumberOfPerShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "per share"
       }
      }
     },
     "localname": "NumberOfPerShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "afya_NumberOfSharesIssued1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total number of shares"
       }
      }
     },
     "localname": "NumberOfSharesIssued1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "afya_OperatingLeaseTermOfContract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "OperatingLeaseTermOfContract",
        "verboseLabel": "Lease term"
       }
      }
     },
     "localname": "OperatingLeaseTermOfContract",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "durationItemType"
    },
    "afya_OriginalPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Original Plan [Member]"
       }
      }
     },
     "localname": "OriginalPlanMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_Other": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other [Default Label]",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "Other",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherAssets1": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": 5.0,
       "parentTag": "afya_Assets1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "OtherAssets1",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssets1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:OtherAssetsAsOfAcquisitionDate-0]",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherAssetsNonCurrentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Assets Non Current [Member]"
       }
      }
     },
     "localname": "OtherAssetsNonCurrentMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_OtherCurrentAssets1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TotalAssets"
       }
      }
     },
     "localname": "OtherCurrentAssets1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/OtherAssetsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherIncomeRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Other income"
       }
      }
     },
     "localname": "OtherIncomeRelatedPartyTransactions",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherLiabilitiesAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:OtherLiabilitiesAsOfAcquisitionDate-0]",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherOfferingExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amoun of other offering expenses.",
        "label": "Other offering expenses"
       }
      }
     },
     "localname": "OtherOfferingExpenses",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OtherRevenue1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "OtherRevenue1",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherRevenue1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_OthersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Others [Member]"
       }
      }
     },
     "localname": "OthersMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_OverAllotmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent over allotments.",
        "label": "Over Allotments [Member]"
       }
      }
     },
     "localname": "OverAllotmentsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PEBMEDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "P E B M E D [Member]"
       }
      }
     },
     "localname": "PEBMEDMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PXPROMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "P X P R O [Member]"
       }
      }
     },
     "localname": "PXPROMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PaidInAfyaBrazilsShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Paid in Afya Brazil's shares"
       }
      }
     },
     "localname": "PaidInAfyaBrazilsShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PaidInShares": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:PaidInShares-0]"
       }
      }
     },
     "localname": "PaidInShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PayablInInstallmentsAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payable in installments"
       }
      }
     },
     "localname": "PayablInInstallmentsAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_Payments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of payments.",
        "label": "Payments"
       }
      }
     },
     "localname": "Payments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SetOutBelowAreCarryingAmountOfNotesPayableAndMovementsDuringYearsEndedDecember312021And2020Details"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Lease liabilities, payments of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PaymentsOfNotesPayable": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 5.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payments of notes payable"
       }
      }
     },
     "localname": "PaymentsOfNotesPayable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_Payroll": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Payroll"
       }
      }
     },
     "localname": "Payroll",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peb Med Instituicao De Pesquisa Medica E Servicos Ltda Peb Med [Member]"
       }
      }
     },
     "localname": "PebMedInstituicaoDePesquisaMedicaEServicosLtdaPebMedMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PercenatgeOfAverageInterestOnFinancialInstrument": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Percentage of average interest"
       }
      }
     },
     "localname": "PercenatgeOfAverageInterestOnFinancialInstrument",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "afya_PermanentAdjustments": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Permanent adjustments"
       }
      }
     },
     "localname": "PermanentAdjustments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Policlinica E Centro De Estetica Duque De Caxias Ltda Policlinica [Member]"
       }
      }
     },
     "localname": "PoliclinicaECentroDeEsteticaDuqueDeCaxiasLtdaPoliclinicaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PolicyExplanatoryInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "l) Investments"
       }
      }
     },
     "localname": "PolicyExplanatoryInvestments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_PracticeManagementToolsAndElectronicPrescriptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Practice Management Tools And Electronic Prescription [Member]"
       }
      }
     },
     "localname": "PracticeManagementToolsAndElectronicPrescriptionMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_PrincipalActivities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Principal activities"
       }
      }
     },
     "localname": "PrincipalActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_ProceedsFromIssueOfOrdinaryShares1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ProceedsFromIssueOfOrdinaryShares1",
        "verboseLabel": "Proceeds from issue of shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProceedsFromIssueOfOrdinarySharesNet": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares, net.",
        "label": "Net proceeds from issue of shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinarySharesNet",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProceedsFromIssueOfOrdinarySharesOne": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Purchase prices paid shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinarySharesOne",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProceedsFromLoansAndFinancing": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Proceeds from loans and financing"
       }
      }
     },
     "localname": "ProceedsFromLoansAndFinancing",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProfessionalFeesExpense1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ProfessionalFeesExpense1",
        "verboseLabel": "Tuition fees"
       }
      }
     },
     "localname": "ProfessionalFeesExpense1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProgramOfSocialIntegrationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent tax.",
        "label": "Program of social integration (\"pis\") [member]"
       }
      }
     },
     "localname": "ProgramOfSocialIntegrationMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ProgramaUniversidadeParaTodosFiscalIncentive": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "PROUNI - Fiscal Incentive"
       }
      }
     },
     "localname": "ProgramaUniversidadeParaTodosFiscalIncentive",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ProvisionForLegalProceedingsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ProvisionForLegalProceedingsAsOfAcquisitionDate-0]",
        "verboseLabel": "Provision for legal proceedings"
       }
      }
     },
     "localname": "ProvisionForLegalProceedingsAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RVLEstevesGestaoImobiliariaSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R V L Esteves Gestao Imobiliaria S A [Member]"
       }
      }
     },
     "localname": "RVLEstevesGestaoImobiliariaSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RXPROLOGTransporteELogisticaLtdaRXPROLOGMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O L O G Transporte E Logistica Ltda R X P R O L O G [Member]"
       }
      }
     },
     "localname": "RXPROLOGTransporteELogisticaLtdaRXPROLOGMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RXPROMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O [Member]"
       }
      }
     },
     "localname": "RXPROMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RXPROSolucoesDeTecnologiaLtdaRXPROMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O Solucoes De Tecnologia Ltda R X P R O [Member]"
       }
      }
     },
     "localname": "RXPROSolucoesDeTecnologiaLtdaRXPROMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RXPROSolucoesdeTecnologiaLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "R X P R O Solucoesde Tecnologia Ltda [Member]"
       }
      }
     },
     "localname": "RXPROSolucoesdeTecnologiaLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ReceivablesGross": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade receivables, gross",
        "verboseLabel": "Trade receivable"
       }
      }
     },
     "localname": "ReceivablesGross",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ReconciliationAdjustmentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reconciliation adjustments:"
       }
      }
     },
     "localname": "ReconciliationAdjustmentsAbstract",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_RecoverableTaxesAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RecoverableTaxesAsOfAcquisitionDate-0]",
        "verboseLabel": "Recoverable taxes"
       }
      }
     },
     "localname": "RecoverableTaxesAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RemainingTradeAndOtherPayablesToRelatedParties": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The remaining amount of payables due to related parties.",
        "label": "Remaining accounts payable"
       }
      }
     },
     "localname": "RemainingTradeAndOtherPayablesToRelatedParties",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RepurchaseOfOrdinaryShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Repurchase of ordinary shares",
        "verboseLabel": "Repurchase shares program"
       }
      }
     },
     "localname": "RepurchaseOfOrdinaryShares",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "afya_RestrictedCash1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCash1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RestrictedCashAndCashEquivalents1": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RestrictedCashAndCashEquivalents1",
        "verboseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RestrictedCashMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for restricted cash.",
        "label": "Restricted Cash [Member]"
       }
      }
     },
     "localname": "RestrictedCashMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RestrictedCashOfInvestingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "RestrictedCashOfInvestingActivities",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashOfInvestingActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RetainedEarningsReserveMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retained Earnings Reserve [Member]"
       }
      }
     },
     "localname": "RetainedEarningsReserveMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_RightOfUseAssetsAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:RightOfUseAssetsAsOfAcquisitionDate-0]",
        "verboseLabel": "Right-of-use assets"
       }
      }
     },
     "localname": "RightOfUseAssetsAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsBusinessCombinations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of business combinations right to use of assets.",
        "label": "Right-of-use assets, business combinations"
       }
      }
     },
     "localname": "RightofuseAssetsBusinessCombinations",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of current right to use of assets.",
        "label": "Right-of-use assets, current"
       }
      }
     },
     "localname": "RightofuseAssetsCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsDisposals": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of right of use assets disposals.",
        "label": "Right-of-use assets, disposals"
       }
      }
     },
     "localname": "RightofuseAssetsDisposals",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsInterestExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Interest expense right to use of assets.",
        "label": "Right-of-use assets, interest expense"
       }
      }
     },
     "localname": "RightofuseAssetsInterestExpense",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsNonCurrent": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of non current right to use of assets.",
        "label": "Right-of-use assets, non-current"
       }
      }
     },
     "localname": "RightofuseAssetsNonCurrent",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsPaymentsOfLeaseLiabilities": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of Payments of lease liabilities right to use of assets.",
        "label": "Right-of-use assets, payments of lease liabilities"
       }
      }
     },
     "localname": "RightofuseAssetsPaymentsOfLeaseLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_RightofuseAssetsRemeasurement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of right of use assets re measurement.",
        "label": "Right-of-use assets, remeasurement"
       }
      }
     },
     "localname": "RightofuseAssetsRemeasurement",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_SaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Axis represent sale of stock.",
        "label": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SaleOfStockAxis",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_SaleOfStockDomain": {
     "auth_ref": [],
     "localname": "SaleOfStockDomain",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ScheduleOfAcquisitionOfFcmpbTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfFcmpbTableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfFcmpbTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfFesar1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfFesar1TableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfFesar1TableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfFesarTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of FESAR"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfFesarTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfMedphoneTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfMedphoneTableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfMedphoneTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfPebmed1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfPebmed1TableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfPebmed1TableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfPebmedTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of PEBMED"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfPebmedTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfRXPROTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfRXPROTableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfRXPROTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfUnigranTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfUnigranTableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfUnigranTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfUniredentorTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfUniredentorTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfUnisl1TableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "ScheduleOfAcquisitionOfUnisl1TableTextBlock",
        "verboseLabel": "The valuation techniques used for measuring the fair value of separately identified intangible assets acquired were as follows:"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfUnisl1TableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAcquisitionOfUnislTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of acquisition of UniSL"
       }
      }
     },
     "localname": "ScheduleOfAcquisitionOfUnislTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assets and liabilities information for the company's operating segments"
       }
      }
     },
     "localname": "ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfCapitalManagementExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of capital management"
       }
      }
     },
     "localname": "ScheduleOfCapitalManagementExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CapitalManagementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfCarryingAmountOfNotesPayableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Set out below are the carrying amount of notes payable and the movements during the years ended December 31, 2021 and 2020"
       }
      }
     },
     "localname": "ScheduleOfCarryingAmountOfNotesPayableTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfEstimatedUsefulLives": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Depreciation is calculated on a straight-line basis over the estimated useful lives of the assets, as follows:"
       }
      }
     },
     "localname": "ScheduleOfEstimatedUsefulLives",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfFairValueMeasurementExplanaory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of fair value measurement"
       }
      }
     },
     "localname": "ScheduleOfFairValueMeasurementExplanaory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValueMeasurementTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfFinanceResult": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of finance result"
       }
      }
     },
     "localname": "ScheduleOfFinanceResult",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinanceResultTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfInvestments": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of investments"
       }
      }
     },
     "localname": "ScheduleOfInvestments",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociateTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfLegalProceedingsAndContingencies": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of legal proceedings and contingencies"
       }
      }
     },
     "localname": "ScheduleOfLegalProceedingsAndContingencies",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfModelUsedToDetermineFairValueOfStockOptions": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of model used to determine the fair value of the stock options"
       }
      }
     },
     "localname": "ScheduleOfModelUsedToDetermineFairValueOfStockOptions",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfNetSalesRevenueExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of net sales revenue"
       }
      }
     },
     "localname": "ScheduleOfNetSalesRevenueExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The fair values of the identifiable assets acquired and liabilities assumed as of each acquisition date were:"
       }
      }
     },
     "localname": "ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of preliminary fair values of the identifiable assets acquired and liabilities acquired"
       }
      }
     },
     "localname": "ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredtableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of reconciliation of income tax expense"
       }
      }
     },
     "localname": "ScheduleOfReconciliationOfIncomeTaxExpenseExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfRelatedPartiesExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The table below summarizes the balances and transactions with related parties:"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartiesExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfRevenueBySegment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of revenue by segment"
       }
      }
     },
     "localname": "ScheduleOfRevenueBySegment",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfSharebasedCompensationPlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of share-based compensation plan"
       }
      }
     },
     "localname": "ScheduleOfSharebasedCompensationPlan",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfSocialSecurityProceedingsAssessedByManagement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of social security proceedings assessed by Management"
       }
      }
     },
     "localname": "ScheduleOfSocialSecurityProceedingsAssessedByManagement",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ScheduleOfTreasurySharesMovement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:ScheduleOfTreasurySharesMovement]"
       }
      }
     },
     "localname": "ScheduleOfTreasurySharesMovement",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SegmentOfBusinessOneUnitMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Of Business One Unit [Member]"
       }
      }
     },
     "localname": "SegmentOfBusinessOneUnitMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SensitivityChangeInTheEuroExchangeRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about percentage of sensitivity change in the euro exchange rate.",
        "label": "Percentage of sensitivity change in the Euro exchange rate"
       }
      }
     },
     "localname": "SensitivityChangeInTheEuroExchangeRate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "afya_ShareBasedCompensationOfEmployees": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation of employees"
       }
      }
     },
     "localname": "ShareBasedCompensationOfEmployees",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ShareBasedCompensationPlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share Based Compensation Plans [Member]"
       }
      }
     },
     "localname": "ShareBasedCompensationPlansMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ShareOfIncomeOfAssociateOfOpeartingActivities": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "ShareOfIncomeOfAssociateOfOpeartingActivities",
        "negatedLabel": "Share of income of associate"
       }
      }
     },
     "localname": "ShareOfIncomeOfAssociateOfOpeartingActivities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_SharePriceFairValueAtMeasurementDateShareOptionsGranted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share price at the measurement date"
       }
      }
     },
     "localname": "SharePriceFairValueAtMeasurementDateShareOptionsGranted",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "afya_SharebasedCompensationPlanReceipts": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based compensation plan receipts"
       }
      }
     },
     "localname": "SharebasedCompensationPlanReceipts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_SharebasedPaymentsPolicyExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "q) Share-based payments"
       }
      }
     },
     "localname": "SharebasedPaymentsPolicyExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_ShareholdersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shareholders [Member]"
       }
      }
     },
     "localname": "ShareholdersMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SharesBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "SharesBasedCompensation",
        "verboseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "SharesBasedCompensation",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_ShospMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp [Member]"
       }
      }
     },
     "localname": "ShospMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ShospTecnologiaDaInformacaoLtdaShospMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp Tecnologia Da Informacao Ltda Shosp [Member]"
       }
      }
     },
     "localname": "ShospTecnologiaDaInformacaoLtdaShospMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_ShospTecnologiadaInformacaoLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Shosp Tecnologiada Informacao Ltda [Member]"
       }
      }
     },
     "localname": "ShospTecnologiadaInformacaoLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SignificantAccountingEstimatesAndAssumptionsExplanatory": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Significant accounting estimates and assumptions"
       }
      }
     },
     "localname": "SignificantAccountingEstimatesAndAssumptionsExplanatory",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingEstimatesAndAssumptions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SociedadeEducacionalDePalhocaSALtdaSOCIESPMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Educacional De Palhoca S A Ltda S O C I E S P [Member]"
       }
      }
     },
     "localname": "SociedadeEducacionalDePalhocaSALtdaSOCIESPMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Padrao De Educacao Superior Ltda Unifip Moc [Member]"
       }
      }
     },
     "localname": "SociedadePadraoDeEducacaoSuperiorLtdaUnifipMocMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadePadraodeEducacaoSuperiorLtdMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Padraode Educacao Superior Ltd [Member]"
       }
      }
     },
     "localname": "SociedadePadraodeEducacaoSuperiorLtdMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadeUniversitariaFipmocSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Fipmoc S A [Member]"
       }
      }
     },
     "localname": "SociedadeUniversitariaFipmocSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadeUniversitariaGranarioSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Granario S A [Member]"
       }
      }
     },
     "localname": "SociedadeUniversitariaGranarioSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadeUniversitariaRedentorSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Redentor S A [Member]"
       }
      }
     },
     "localname": "SociedadeUniversitariaRedentorSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SociedadeUniversitariaRedentorSAUniRedentorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Sociedade Universitaria Redentor S A Uni Redentor [Member]"
       }
      }
     },
     "localname": "SociedadeUniversitariaRedentorSAUniRedentorMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_SoftwareInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Software In Progress [Member]"
       }
      }
     },
     "localname": "SoftwareInProgressMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_StrikePriceeAtMeasurementDateShareOptionsGrante": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "StrikePriceeAtMeasurementDateShareOptionsGrante",
        "verboseLabel": "Strike price at the measurement date"
       }
      }
     },
     "localname": "StrikePriceeAtMeasurementDateShareOptionsGrante",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_StrikePriceeAtMeasurementDateShareOptionsGranted": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Strike price at the measurement date"
       }
      }
     },
     "localname": "StrikePriceeAtMeasurementDateShareOptionsGranted",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of assumptions for impairment test"
       }
      }
     },
     "localname": "SummaryOfAssumptionsForIntangibleAssetImpairmentTestTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The tables below summarize the maturity profile of the Company\u2019s financial liabilities based on contractual undiscounted amounts:"
       }
      }
     },
     "localname": "SummaryOfContractualMaturitiesOfFinancialLiabilitiesTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of currencies used in sensitivity analysis"
       }
      }
     },
     "localname": "SummaryOfCurrenciesUsedInSensitivityAnalysisTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of estimated useful lives"
       }
      }
     },
     "localname": "SummaryOfEstimatedUsefulLivesOfIntangibleAssetsTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfExpensesByNatureTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of expenses by nature"
       }
      }
     },
     "localname": "SummaryOfExpensesByNatureTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNatureTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfIntangibleAssetsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of intangible assets"
       }
      }
     },
     "localname": "SummaryOfIntangibleAssetsTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfKeyManagementPersonnelCompensationTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Key management personnel compensation included in the Company\u2019s consolidated statement of income comprised the following:"
       }
      }
     },
     "localname": "SummaryOfKeyManagementPersonnelCompensationTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Schedule of sensitivity analysis effects on income statement"
       }
      }
     },
     "localname": "SummaryOfSensitivityAnalysisEffectsOnIncomeStatementTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "The table below is a list of the Company\u2019s subsidiaries and associate:"
       }
      }
     },
     "localname": "SummaryOfSubsidiariesJointVenturesAndJointOperationsTableTextBlock",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_TaxAuthorityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Axis represent tax authority.",
        "label": "Tax Authority [Axis]"
       }
      }
     },
     "localname": "TaxAuthorityAxis",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_TaxAuthorityDomain": {
     "auth_ref": [],
     "localname": "TaxAuthorityDomain",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax effect on loss from entities not subject to taxation"
       }
      }
     },
     "localname": "TaxEffectOnIncomeFromEntitiesNotSubjectToTaxation",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TaxExpenses": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Tax expenses"
       }
      }
     },
     "localname": "TaxExpenses",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TaxOnFinancialOperations": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "IOF taxes (taxes on financial transactions)"
       }
      }
     },
     "localname": "TaxOnFinancialOperations",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TaxesAndSocialSecurityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes And Social Security [Member]"
       }
      }
     },
     "localname": "TaxesAndSocialSecurityMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TaxesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Taxes [Member]"
       }
      }
     },
     "localname": "TaxesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TaxesPayableAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "[custom:TaxesPayableAsOfAcquisitionDate-0]",
        "verboseLabel": "Taxes payable"
       }
      }
     },
     "localname": "TaxesPayableAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TaxesPolicyExplanation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "s) Taxes"
       }
      }
     },
     "localname": "TaxesPolicyExplanation",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "afya_TeachingActivitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Teaching Activities [Member]"
       }
      }
     },
     "localname": "TeachingActivitiesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition of net revenue from contracts with customers"
       }
      }
     },
     "localname": "TimingOfRevenueRecognitionOfNetRevenueFromContractsWithCustomers",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_TimingRevenueRecognition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Timing of revenue recognition"
       }
      }
     },
     "localname": "TimingRevenueRecognition",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TotalReportableSegmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Reportable Segments [Member]"
       }
      }
     },
     "localname": "TotalReportableSegmentsMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TradeAndOtherCurrentPayablesToRelatedParties1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Current"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TradeAndOtherPayablesToRelatedParties1": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TradeAndOtherPayablesToRelatedParties1",
        "verboseLabel": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToRelatedParties1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TradeAndOtherPayablesToRelatedParties2": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Closing balance"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToRelatedParties2",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TradeAndOtherPayablesToRelatedPartiesLiabilities": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TradeAndOtherPayablesToRelatedPartiesLiabilities",
        "verboseLabel": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToRelatedPartiesLiabilities",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TradeReceivablesAsOfAcquisitionDate": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Trade Receivales",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivablesAsOfAcquisitionDate",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TradeReceivablesRelatedPartyTransactions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "TradeReceivablesRelatedPartyTransactions",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivablesRelatedPartyTransactions",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TransferredAmountToGBankAccounts": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amoun of transferred amount to bank accounts.",
        "label": "Transferred amount to bank accounts"
       }
      }
     },
     "localname": "TransferredAmountToGBankAccounts",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TreasuryShares1": {
     "auth_ref": [],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares"
       }
      }
     },
     "localname": "TreasuryShares1",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows",
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TreasurySharesTransferredFromExerciseOfOptions": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred from exercise of options"
       }
      }
     },
     "localname": "TreasurySharesTransferredFromExerciseOfOptions",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TreasurySharesTransferredFromSharesContributionOnBusinessCombination": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Treasury shares transferred from shares contribution on business combination"
       }
      }
     },
     "localname": "TreasurySharesTransferredFromSharesContributionOnBusinessCombination",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_TuitionFeesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tuition Fees [Member]"
       }
      }
     },
     "localname": "TuitionFeesMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentyFour1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Twenty Four 1 [Member]"
       }
      }
     },
     "localname": "TwentyTwentyFour1Member",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentyFourMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for twenty twenty four.",
        "label": "2024 [Member]"
       }
      }
     },
     "localname": "TwentyTwentyFourMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentyOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for twenty twenty one.",
        "label": "2021 [Member]"
       }
      }
     },
     "localname": "TwentyTwentyOneMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentySevenMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This member stands for twenty twenty seven.",
        "label": "2027 [member]"
       }
      }
     },
     "localname": "TwentyTwentySevenMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentySixMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Twenty Twenty Six [Member]"
       }
      }
     },
     "localname": "TwentyTwentySixMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TwentyTwentyThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member stands for twenty twenty three.",
        "label": "2023 [Member]"
       }
      }
     },
     "localname": "TwentyTwentyThreeMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TypeOfArrangement1Axis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Type Of Arrangement 1 [Axis]",
        "verboseLabel": "TypeOfArrangement1Axis [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangement1Axis",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "afya_TypeOfArrangement1Domain": {
     "auth_ref": [],
     "localname": "TypeOfArrangement1Domain",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_TypesOfRiskMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Types Of Risk [Member]"
       }
      }
     },
     "localname": "TypesOfRiskMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UEPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U E P C [Member]"
       }
      }
     },
     "localname": "UEPCMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UNIFIPMocMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U N I F I P Moc [Member]"
       }
      }
     },
     "localname": "UNIFIPMocMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UNIGRANMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U N I G R A N [Member]"
       }
      }
     },
     "localname": "UNIGRANMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UNIVACOPatrimonialLtdaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U N I V A C O Patrimonial Ltda [Member]"
       }
      }
     },
     "localname": "UNIVACOPatrimonialLtdaMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_USDMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "U S D [Member]"
       }
      }
     },
     "localname": "USDMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UndergradMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Undergrad [Member]"
       }
      }
     },
     "localname": "UndergradMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UnderwritersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The member represent underwriters.",
        "label": "Underwriters [Member]"
       }
      }
     },
     "localname": "UnderwritersMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UniRedentorMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni Redentor [Member]"
       }
      }
     },
     "localname": "UniRedentorMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UniSLMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uni S L [Member]"
       }
      }
     },
     "localname": "UniSLMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UniaoEducacionalDoPlanaltoCentralSAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional Do Planalto Central S A [Member]"
       }
      }
     },
     "localname": "UniaoEducacionalDoPlanaltoCentralSAMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UniaoEducacionalDoPlanaltoCentralSAUEPCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional Do Planalto Central S A U E P C [Member]"
       }
      }
     },
     "localname": "UniaoEducacionalDoPlanaltoCentralSAUEPCMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UniaoEducacionalDoValeDoAcoSAUNIVACOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Uniao Educacional Do Vale Do Aco S A U N I V A C O [Member]"
       }
      }
     },
     "localname": "UniaoEducacionalDoValeDoAcoSAUNIVACOMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UnigranrioMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Unigranrio [Member]"
       }
      }
     },
     "localname": "UnigranrioMember",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "afya_UnrecognisedDeferredTaxAssets": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Unrecognized deferred tax assets"
       }
      }
     },
     "localname": "UnrecognisedDeferredTaxAssets",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "afya_WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted average fair value at the measurement date"
       }
      }
     },
     "localname": "WeightedAverageFairValueAtMeasurementDateShareOptionsGrantedOne",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "afya_WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "label": "Write-offs"
       }
      }
     },
     "localname": "WriteOffFromAllowancesForDoubfulAccountsOnTradeReceivable",
     "nsuri": "http://afya.com.br/20211231",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "currency_AllCurrenciesDomain": {
     "auth_ref": [],
     "localname": "AllCurrenciesDomain",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_EUR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Euro Member Countries, Euro"
       }
      }
     },
     "localname": "EUR",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "currency_USD": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "United States of America, Dollars"
       }
      }
     },
     "localname": "USD",
     "nsuri": "http://xbrl.sec.gov/currency/2021",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentDescription": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of changes contained within amended document.",
        "label": "Amendment Description"
       }
      }
     },
     "localname": "AmendmentDescription",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AnnualInformationForm": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.",
        "label": "Annual Information Form"
       }
      }
     },
     "localname": "AnnualInformationForm",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditedAnnualFinancialStatements": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.",
        "label": "Audited Annual Financial Statements"
       }
      }
     },
     "localname": "AuditedAnnualFinancialStatements",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r354",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm Id"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r354",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r354",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_BusinessContactMember": {
     "auth_ref": [
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Business contact for the entity",
        "label": "Business Contact [Member]"
       }
      }
     },
     "localname": "BusinessContactMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelEmailAddress": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Email address of contact personnel.",
        "label": "Contact Personnel Email Address"
       }
      }
     },
     "localname": "ContactPersonnelEmailAddress",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_ContactPersonnelName": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of contact personnel",
        "label": "Contact Personnel Name"
       }
      }
     },
     "localname": "ContactPersonnelName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page."
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAccountingStandard": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.",
        "label": "Document Accounting Standard"
       }
      }
     },
     "localname": "DocumentAccountingStandard",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "accountingStandardItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r354",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentPeriodStartDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.",
        "label": "Document Period Start Date"
       }
      }
     },
     "localname": "DocumentPeriodStartDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r355"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentRegistrationStatement": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a registration statement.",
        "label": "Document Registration Statement"
       }
      }
     },
     "localname": "DocumentRegistrationStatement",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentShellCompanyEventDate": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date of event requiring a shell company report.",
        "label": "Document Shell Company Event Date"
       }
      }
     },
     "localname": "DocumentShellCompanyEventDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentShellCompanyReport": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.",
        "label": "Document Shell Company Report"
       }
      }
     },
     "localname": "DocumentShellCompanyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r358"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r346"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not.  Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.",
        "label": "Entity Bankruptcy Proceedings, Reporting Current"
       }
      }
     },
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r362"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Elected Not To Use the Extended Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPrimarySicNumber": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.",
        "label": "Entity Primary SIC Number"
       }
      }
     },
     "localname": "EntityPrimarySicNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "sicNumberItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r360"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_Extension": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Extension number for local phone number.",
        "label": "Extension"
       }
      }
     },
     "localname": "Extension",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r354",
      "r356",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "trueItemType"
    },
    "dei_OtherReportingStandardItemNumber": {
     "auth_ref": [
      "r356"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.",
        "label": "Other Reporting Standard Item Number"
       }
      }
     },
     "localname": "OtherReportingStandardItemNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "otherReportingStandardItemNumberItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r351"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_Security12gTitle": {
     "auth_ref": [
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(g) registered security.",
        "label": "Title of 12(g) Security"
       }
      }
     },
     "localname": "Security12gTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r347"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SecurityReportingObligation": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.",
        "label": "Security Reporting Obligation"
       }
      }
     },
     "localname": "SecurityReportingObligation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "securityReportingObligationItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r361"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://afya.com.br/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "ifrs-full_AccumulatedDepreciationAndAmortisationMember": {
     "auth_ref": [
      "r65",
      "r73",
      "r134",
      "r147",
      "r150"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for accumulated depreciation and amortisation. [Refer: Depreciation and amortisation expense]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accumulated depreciation and amortisation [member]"
       }
      }
     },
     "localname": "AccumulatedDepreciationAndAmortisationMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AcquisitiondateFairValueOfTotalConsiderationTransferred": {
     "auth_ref": [
      "r249"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of the consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Consideration transferred, acquisition-date fair value",
        "verboseLabel": "Purchase consideration transferred"
       }
      }
     },
     "localname": "AcquisitiondateFairValueOfTotalConsiderationTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination": {
     "auth_ref": [
      "r253"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of acquisition-related costs for transactions recognised separately from the acquisition of assets and the assumption of liabilities in business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisition-related costs for transaction recognised separately from acquisition of assets and assumption of liabilities in business combination",
        "terseLabel": "Transaction costs",
        "verboseLabel": "Transaction costs (included in cash flows from operating activities)"
       }
      }
     },
     "localname": "AcquisitionrelatedCostsForTransactionRecognisedSeparatelyFromAcquisitionOfAssetsAndAssumptionOfLiabilitiesInBusinessCombination",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in intangible assets and goodwill resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, intangible assets and goodwill",
        "verboseLabel": "Business combinations"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsOtherProvisions": {
     "auth_ref": [
      "r128"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in other provisions resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, other provisions",
        "verboseLabel": "Business combinations"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r68"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in property, plant and equipment resulting from acquisitions through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Acquisitions through business combinations, property, plant and equipment",
        "verboseLabel": "Business combinations"
       }
      }
     },
     "localname": "AcquisitionsThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r332"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additional allowance for credit losses of financial assets recognised in profit or loss. [Refer: Allowance account for credit losses of financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions"
       }
      }
     },
     "localname": "AdditionalAllowanceRecognisedInProfitOrLossAllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionalPaidinCapital": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount received or receivable from the issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      },
      "en-us": {
       "role": {
        "label": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidinCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionalPaidinCapitalMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for amounts received from issuance of the entity's shares in excess of nominal value and amounts received from other transactions involving the entity's stock or stockholders."
       }
      },
      "en-us": {
       "role": {
        "label": "Additional paid-in capital [member]"
       }
      }
     },
     "localname": "AdditionalPaidinCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AdditionalProvisionsOtherProvisions": {
     "auth_ref": [
      "r126"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additional other provisions made. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additional provisions, other provisions",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionalProvisionsOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r135"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to intangible assets other than goodwill, other than those acquired through business combinations. [Refer: Business combinations [member]; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, intangible assets other than goodwill",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r66"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to property, plant and equipment other than those acquired through business combinations. [Refer: Business combinations [member]; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Additions other than through business combinations, property, plant and equipment",
        "verboseLabel": "Additions"
       }
      }
     },
     "localname": "AdditionsOtherThanThroughBusinessCombinationsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdditionsToRightofuseAssets": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of additions to right-of-use assets. [Refer: Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets, additions"
       }
      }
     },
     "localname": "AdditionsToRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustedWeightedAverageShares": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average number of ordinary shares outstanding plus the weighted average number of ordinary shares that would be issued on the conversion of all the dilutive potential ordinary shares into ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares adjusted for the effect of dilution"
       }
      }
     },
     "localname": "AdjustedWeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_AdjustmentToProfitLossForPreferenceShareDividends": {
     "auth_ref": [
      "r110",
      "r113"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustment to profit (loss) for non-participating preference share dividends to calculate profit (loss) attributable to ordinary equity holders of the parent entity. [Refer: Preference shares [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net income attributable to equity holders of the parent"
       }
      }
     },
     "localname": "AdjustmentToProfitLossForPreferenceShareDividends",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInInventories": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 14.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in inventories to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Inventories; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in inventories",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 19.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in loans and advances to customers to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Loans and advances to customers; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in loans and advances to customers",
        "verboseLabel": "Advances from customers"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInLoansAndAdvancesToCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInOtherAssets": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 16.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in other assets to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other assets; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in other assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInOtherAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 13.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for decrease (increase) in trade accounts receivable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for decrease (increase) in trade accounts receivable",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "AdjustmentsForDecreaseIncreaseInTradeAccountReceivable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for depreciation and amortisation expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Depreciation and amortisation expense; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation and amortization"
       }
      }
     },
     "localname": "AdjustmentsForDepreciationAndAmortisationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForFinanceCosts": {
     "auth_ref": [
      "r161"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for finance costs to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Finance costs; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net loss (gain) on derivatives"
       }
      }
     },
     "localname": "AdjustmentsForFinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "auth_ref": [
      "r162"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals investments in subsidiaries, joint ventures and associates to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries, joint ventures and associates reported in separate financial statements; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposal of investments in subsidiaries, joint ventures and associates",
        "verboseLabel": "Share of income of associate"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalOfInvestmentsInSubsidiariesJointVenturesAndAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for gain (loss) on disposals of property, plant and equipment to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss); Property, plant and equipment; Disposals, property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for gain (loss) on disposals, property, plant and equipment",
        "negatedLabel": "Disposals of property and equipment"
       }
      }
     },
     "localname": "AdjustmentsForGainLossOnDisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncomeTaxExpense": {
     "auth_ref": [
      "r166"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 18.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for income tax expense to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Taxes payables"
       }
      }
     },
     "localname": "AdjustmentsForIncomeTaxExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 21.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in other liabilities to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Other liabilities; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in other liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInOtherLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable": {
     "auth_ref": [
      "r159"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 17.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for increase (decrease) in trade accounts payable to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for increase (decrease) in trade accounts payable",
        "verboseLabel": "Trade payables"
       }
      }
     },
     "localname": "AdjustmentsForIncreaseDecreaseInTradeAccountPayable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForProvisions": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 12.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for provisions to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Provisions; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments for provisions",
        "verboseLabel": "Provision for legal proceedings"
       }
      }
     },
     "localname": "AdjustmentsForProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLoss": {
     "auth_ref": [
      "r162"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile profit (loss)",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForReconcileProfitLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to reconcile income before income taxes"
       }
      }
     },
     "localname": "AdjustmentsForReconcileProfitLossAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AdjustmentsForSharebasedPayments": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for share-based payments to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based compensation expense"
       }
      }
     },
     "localname": "AdjustmentsForSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AdjustmentsForUnrealisedForeignExchangeLossesGains": {
     "auth_ref": [
      "r160",
      "r178"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for unrealised foreign exchange losses (gains) to reconcile profit (loss) to net cash flow from (used in) operating activities. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange differences"
       }
      }
     },
     "localname": "AdjustmentsForUnrealisedForeignExchangeLossesGains",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Advances": {
     "auth_ref": [
      "r24",
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of advances received representing contract liabilities for performance obligations satisfied at a point in time. [Refer: Contract liabilities; Performance obligations satisfied at point in time [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Advances received, representing contract liabilities for performance obligations satisfied at point in time",
        "verboseLabel": "Advances from customers"
       }
      }
     },
     "localname": "Advances",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AggregatedMeasurementMember": {
     "auth_ref": [
      "r145",
      "r149",
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of measurement. It also represents the standard value for the 'Measurement' axis if no other member is used."
       }
      }
     },
     "localname": "AggregatedMeasurementMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AggregatedTimeBandsMember": {
     "auth_ref": [
      "r26",
      "r79",
      "r223",
      "r235",
      "r236",
      "r266",
      "r282",
      "r288",
      "r312",
      "r313",
      "r315",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated time bands. It also represents the standard value for the 'Maturity' axis if no other member is used."
       }
      }
     },
     "localname": "AggregatedTimeBandsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllLevelsOfFairValueHierarchyMember": {
     "auth_ref": [
      "r78",
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all levels of the fair value hierarchy. It also represents the standard value for the 'Levels of fair value hierarchy' axis if no other member is used."
       }
      }
     },
     "localname": "AllLevelsOfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_AllowanceAccountForCreditLossesOfFinancialAssets": {
     "auth_ref": [
      "r332"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of an allowance account used to record impairments to financial assets due to credit losses. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Allowance account for credit losses of financial assets",
        "periodEndLabel": "Balances at the end of the period",
        "periodStartLabel": "Balances at the beginning of the period"
       }
      }
     },
     "localname": "AllowanceAccountForCreditLossesOfFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAllowanceForDoubtfulAccountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmortisationIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of amortisation of intangible assets other than goodwill. [Refer: Depreciation and amortisation expense; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amortization"
       }
      }
     },
     "localname": "AmortisationIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity": {
     "auth_ref": [
      "r88"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount incurred by the entity for provision of key management personnel services that are provided by a separate management entity. [Refer: Key management personnel of entity or parent [member]; Separate management entities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amount incurred by entity for provision of key management personnel services provided by separate management entity",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "AmountIncurredByEntityForProvisionOfKeyManagementPersonnelServicesProvidedBySeparateManagementEntity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsPayableRelatedPartyTransactions": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts payable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amounts payable, related party transactions",
        "totalLabel": "Total"
       }
      }
     },
     "localname": "AmountsPayableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AmountsReceivableRelatedPartyTransactions": {
     "auth_ref": [
      "r87",
      "r91"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amounts receivable resulting from related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "TOTAL"
       }
      }
     },
     "localname": "AmountsReceivableRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ApplicableTaxRate": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The applicable income tax rate."
       }
      },
      "en-us": {
       "role": {
        "label": "Tax rate",
        "verboseLabel": "Statutory rates"
       }
      }
     },
     "localname": "ApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails",
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Assets": {
     "auth_ref": [
      "r24",
      "r210",
      "r211",
      "r212",
      "r299",
      "r302"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Total assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_AssociatesMember": {
     "auth_ref": [
      "r89",
      "r101",
      "r105",
      "r209",
      "r328",
      "r330"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entities over which the investor has significant influence."
       }
      },
      "en-us": {
       "role": {
        "label": "Associates [member]"
       }
      }
     },
     "localname": "AssociatesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BankAndSimilarCharges": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of bank and similar charges recognised by the entity as an expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Bank fees"
       }
      }
     },
     "localname": "BankAndSimilarCharges",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BasicEarningsLossPerShare": {
     "auth_ref": [
      "r108",
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator) divided by the weighted average number of ordinary shares outstanding during the period (the denominator)."
       }
      },
      "en-us": {
       "role": {
        "label": "Per common share",
        "verboseLabel": "Basic earnings per share (R$)"
       }
      }
     },
     "localname": "BasicEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_BasicEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Basic earnings per share"
       }
      }
     },
     "localname": "BasicEarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameAxis": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings by name [axis]"
       }
      }
     },
     "localname": "BorrowingsByNameAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsByNameMember": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all borrowings when disaggregated by name. It also represents the standard value for the 'Borrowings by name' axis if no other member is used. [Refer: Borrowings]"
       }
      }
     },
     "localname": "BorrowingsByNameMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BorrowingsInterestRateBasis": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The basis (reference rate) used for calculation of the interest rate on borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate"
       }
      }
     },
     "localname": "BorrowingsInterestRateBasis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsMaturity": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The maturity of borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity"
       }
      }
     },
     "localname": "BorrowingsMaturity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_BorrowingsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for borrowings assumed in a business combination. [Refer: Borrowings; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Borrowings recognised as of acquisition date",
        "verboseLabel": "Loans and financing"
       }
      }
     },
     "localname": "BorrowingsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_BottomOfRangeMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r243",
      "r281",
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the bottom of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Bottom of range [member]"
       }
      }
     },
     "localname": "BottomOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BrandNamesMember": {
     "auth_ref": [
      "r140"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing rights to a group of complementary assets such as a trademark (or service mark) and its related trade name, formulas, recipes and technological expertise. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Brand names [member]"
       }
      }
     },
     "localname": "BrandNamesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BuildingsMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of plant, property and equipment representing depreciable buildings and similar structures for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Buildings [member]"
       }
      }
     },
     "localname": "BuildingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_BusinessCombinationsAxis": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Business combinations [axis]"
       }
      }
     },
     "localname": "BusinessCombinationsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis": {
     "auth_ref": [
      "r65",
      "r70",
      "r134",
      "r138",
      "r146",
      "r147",
      "r148",
      "r149",
      "r150",
      "r259",
      "r272",
      "r273",
      "r335",
      "r342"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount [axis]"
       }
      }
     },
     "localname": "CarryingAmountAccumulatedDepreciationAmortisationAndImpairmentAndGrossCarryingAmountAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CarryingAmountMember": {
     "auth_ref": [
      "r70",
      "r138",
      "r146",
      "r148",
      "r149",
      "r259",
      "r272",
      "r273",
      "r335",
      "r341"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised in the statement of financial position (after deducting any accumulated depreciation or amortisation and accumulated impairment losses). It also represents the standard value for the 'Carrying amount, accumulated depreciation, amortisation and impairment and gross carrying amount' axis if no other member is used. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      }
     },
     "localname": "CarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Cash": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits. [Refer: Cash on hand]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and bank deposits"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAdvancesAndLoansFromRelatedParties": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from advances and loans from related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loans to related parties"
       }
      }
     },
     "localname": "CashAdvancesAndLoansFromRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalents": {
     "auth_ref": [
      "r18",
      "r175",
      "r203"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash on hand and demand deposits, along with short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value. [Refer: Cash; Cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents",
        "periodEndLabel": "Cash and cash equivalents at the end of the year",
        "periodStartLabel": "Cash and cash equivalents at the beginning of the year",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/StatementsOfCashFlows",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013": {
     "auth_ref": [
      "r167"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents in subsidiaries or other businesses over which control is obtained or lost. [Refer: Subsidiaries [member]; Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash equivalents in subsidiary or businesses acquired or disposed",
        "verboseLabel": "Cash paid, net of cash acquired with the subsidiary (included in cash flows from investing activities)"
       }
      }
     },
     "localname": "CashAndCashEquivalentsInSubsidiaryOrBusinessesAcquiredOrDisposed2013",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashAndCashEquivalentsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for cash and cash equivalents acquired in a business combination. [Refer: Cash and cash equivalents; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash and cash and equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashEquivalents": {
     "auth_ref": [
      "r175"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of short-term, highly liquid investments that are readily convertible to known amounts of cash and that are subject to an insignificant risk of changes in value."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash equivalents",
        "verboseLabel": "Cash equivalents (a)"
       }
      }
     },
     "localname": "CashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfCashAndCashEquivalentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivities": {
     "auth_ref": [
      "r151",
      "r177"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) financing activities, which are activities that result in changes in the size and composition of the contributed equity and borrowings of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) financing activities",
        "totalLabel": "Net cash flows from (used in) financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Financing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInFinancingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivities": {
     "auth_ref": [
      "r151",
      "r177"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) investing activities, which are the acquisition and disposal of long-term assets and other investments not included in cash equivalents."
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) investing activities",
        "totalLabel": "Net cash flows used in investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investing activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInInvestingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivities": {
     "auth_ref": [
      "r151",
      "r177"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from (used in) operating activities, which are the principal revenue-producing activities of the entity and other activities that are not investing or financing activities. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash flows from (used in) operating activities",
        "totalLabel": "Net cash flows from operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating activities"
       }
      }
     },
     "localname": "CashFlowsFromUsedInOperatingActivitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CashOutflowForLeases": {
     "auth_ref": [
      "r231"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for leases."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease expenses"
       }
      }
     },
     "localname": "CashOutflowForLeases",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CashTransferred": {
     "auth_ref": [
      "r248"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value, at acquisition date, of cash transferred as consideration in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Cash transferred",
        "verboseLabel": "Cash paid"
       }
      }
     },
     "localname": "CashTransferred",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CategoriesOfRelatedPartiesAxis": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Categories of related parties [axis]"
       }
      }
     },
     "localname": "CategoriesOfRelatedPartiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsAxis": {
     "auth_ref": [
      "r114",
      "r116",
      "r214",
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of assets [axis]"
       }
      }
     },
     "localname": "ClassesOfAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfAssetsMember": {
     "auth_ref": [
      "r114",
      "r214",
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a present economic resource controlled by the entity as a result of past events. Economic resource is a right that has the potential to produce economic benefits. It also represents the standard value for the 'Classes of assets' axis if no other member is used."
       }
      }
     },
     "localname": "ClassesOfAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClassesOfContingentLiabilitiesAxis": {
     "auth_ref": [
      "r129",
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of contingent liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfContingentLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialAssetsAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r311",
      "r323",
      "r325",
      "r326"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial assets [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfFinancialLiabilitiesAxis": {
     "auth_ref": [
      "r279",
      "r280",
      "r311",
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of financial liabilities [axis]"
       }
      }
     },
     "localname": "ClassesOfFinancialLiabilitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsAndGoodwillAxis": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets and goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsAndGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfIntangibleAssetsOtherThanGoodwillAxis": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of intangible assets other than goodwill [axis]"
       }
      }
     },
     "localname": "ClassesOfIntangibleAssetsOtherThanGoodwillAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfPropertyPlantAndEquipmentAxis": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of property, plant and equipment [axis]"
       }
      }
     },
     "localname": "ClassesOfPropertyPlantAndEquipmentAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfProvisionsAxis": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of other provisions [axis]"
       }
      }
     },
     "localname": "ClassesOfProvisionsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalAxis": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Classes of share capital [axis]"
       }
      }
     },
     "localname": "ClassesOfShareCapitalAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ClassesOfShareCapitalMember": {
     "auth_ref": [
      "r38"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for share capital of the entity. It also represents the standard value for the 'Classes of share capital' axis if no other member is used."
       }
      }
     },
     "localname": "ClassesOfShareCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/Cover",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ClosingForeignExchangeRate": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The spot exchange rate at the end of the reporting period. Exchange rate is the ratio of exchange for two currencies. Spot exchange rate is the exchange rate for immediate delivery."
       }
      },
      "en-us": {
       "role": {
        "label": "Closing foreign exchange rate"
       }
      }
     },
     "localname": "ClosingForeignExchangeRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_ComponentsOfEquityAxis": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Components of equity [axis]"
       }
      }
     },
     "localname": "ComponentsOfEquityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ComprehensiveIncome": {
     "auth_ref": [
      "r3",
      "r43",
      "r181",
      "r183",
      "r194",
      "r200"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Total comprehensive income",
        "totalLabel": "Total comprehensive income"
       }
      }
     },
     "localname": "ComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ComputerSoftwareMember": {
     "auth_ref": [
      "r141"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing computer software. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Computer software [member]"
       }
      }
     },
     "localname": "ComputerSoftwareMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ConstructionInProgressMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for expenditure capitalised during the construction of items of property, plant and equipment that are not yet available for use (ie not yet in the location and condition necessary for it to be capable of operating in the manner intended by the management). [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Construction in progress [member]"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContingentConsiderationRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount, at acquisition date, of contingent consideration arrangements recognised as consideration transferred in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Contingent consideration recognised as of acquisition date"
       }
      }
     },
     "localname": "ContingentConsiderationRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ContingentLiabilitiesMember": {
     "auth_ref": [
      "r131",
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for possible obligations that arise from past events and whose existence will be confirmed only by the occurrence or non-occurrence of one or more uncertain future events not wholly within the control of the entity; or, present obligations that arise from past events but are not recognised because (a) it is probable that an outflow of resources embodying economic benefits will be required to settle the obligations; or (b) the amount of the obligations cannot be measured with sufficient reliability. It also represents the standard value for the 'Classes of contingent liabilities' axis if no other member is used."
       }
      }
     },
     "localname": "ContingentLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ContributionsToPlanNetDefinedBenefitLiabilityAsset": {
     "auth_ref": [
      "r77"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease (increase) in the net defined benefit liability (asset) resulting from contributions to a defined benefit plan. [Refer: Net defined benefit liability (asset); Defined benefit plans [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Decrease (increase) in net defined benefit liability (asset) resulting from contributions to plan"
       }
      }
     },
     "localname": "ContributionsToPlanNetDefinedBenefitLiabilityAsset",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CostOfSales": {
     "auth_ref": [
      "r2",
      "r52"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of all expenses directly or indirectly attributed to the goods or services sold. Attributed expenses include, but are not limited to, costs previously included in the measurement of inventory that has now been sold, such as depreciation and maintenance of factory buildings and equipment used in the production process, unallocated production overheads, and abnormal amounts of production costs of inventories."
       }
      },
      "en-us": {
       "role": {
        "label": "Cost of services"
       }
      }
     },
     "localname": "CostOfSales",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CreditExposure": {
     "auth_ref": [
      "r333",
      "r337",
      "r338"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of exposure to loss resulting from credit risk. [Refer: Credit risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Exposure risk"
       }
      }
     },
     "localname": "CreditExposure",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrencyRiskMember": {
     "auth_ref": [
      "r292",
      "r316",
      "r317",
      "r318",
      "r319"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a type of market risk representing the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in foreign exchange rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Currency risk [member]"
       }
      }
     },
     "localname": "CurrencyRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentAssets": {
     "auth_ref": [
      "r27",
      "r194",
      "r196"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that the entity (a) expects to realise or intends to sell or consume in its normal operating cycle; (b) holds primarily for the purpose of trading; (c) expects to realise within twelve months after the reporting period; or (d) classifies as cash or cash equivalents (as defined in IAS 7) unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current assets [Default Label]",
        "totalLabel": "Total current assets",
        "verboseLabel": "Current assets"
       }
      }
     },
     "localname": "CurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current assets"
       }
      }
     },
     "localname": "CurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentDepositsFromCustomers": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current deposits from customers. [Refer: Deposits from customers]"
       }
      },
      "en-us": {
       "role": {
        "label": "Advances from customers"
       }
      }
     },
     "localname": "CurrentDepositsFromCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialAssets": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial assets",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentFinancialLiabilities": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current financial liabilities. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Current financial liabilities",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLeaseLiabilities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "verboseLabel": "Lease liabilities, current"
       }
      }
     },
     "localname": "CurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilities": {
     "auth_ref": [
      "r29",
      "r194",
      "r198"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Expiry date 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have an unconditional right to defer settlement for at least twelve months after the reporting period.\nEffective 2023-01-01: The amount of liabilities that: (a) the entity expects to settle in its normal operating cycle; (b) the entity holds primarily for the purpose of trading; (c) are due to be settled within twelve months after the reporting period; or (d) the entity does not have the right at the end of the reporting period to defer settlement for at least twelve months after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Current liabilities [Default Label]",
        "totalLabel": "Total current liabilities",
        "verboseLabel": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current liabilities"
       }
      }
     },
     "localname": "CurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_CurrentMember": {
     "auth_ref": [
      "r276",
      "r290",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a current time band."
       }
      },
      "en-us": {
       "role": {
        "label": "Current [member]"
       }
      }
     },
     "localname": "CurrentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_CurrentPrepaidExpenses": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": 3.0,
       "parentTag": "afya_Assets1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as a current asset for expenditures made prior to the period when the economic benefit will be realised."
       }
      },
      "en-us": {
       "role": {
        "label": "Prepaid expenses"
       }
      }
     },
     "localname": "CurrentPrepaidExpenses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentRecognisedLiabilitiesDefinedBenefitPlan": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 7.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current net defined benefit liability. [Refer: Net defined benefit liability]"
       }
      },
      "en-us": {
       "role": {
        "label": "Labor and social obligations"
       }
      }
     },
     "localname": "CurrentRecognisedLiabilitiesDefinedBenefitPlan",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxAssets": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The excess of amount paid for current tax in respect of current and prior periods over the amount due for those periods. Current tax is the amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Recoverable taxes"
       }
      }
     },
     "localname": "CurrentTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxExpenseIncome": {
     "auth_ref": [
      "r56"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income taxes payable (recoverable) in respect of the taxable profit (tax loss) for a period."
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes expense \u2013 current"
       }
      }
     },
     "localname": "CurrentTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTaxLiabilitiesCurrent": {
     "auth_ref": [
      "r21"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 9.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The current amount of current tax liabilities. [Refer: Current tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes payable"
       }
      }
     },
     "localname": "CurrentTaxLiabilitiesCurrent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CurrentTradeReceivables": {
     "auth_ref": [
      "r28",
      "r30"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables",
        "verboseLabel": "Current"
       }
      }
     },
     "localname": "CurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_CustomerrelatedIntangibleAssetsMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets related to customers. Such assets may include customer lists, order or production backlog, customer contracts and related customer relationships as well as non-contractual customer relationships."
       }
      },
      "en-us": {
       "role": {
        "label": "Customer-related intangible assets [member]"
       }
      }
     },
     "localname": "CustomerrelatedIntangibleAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DeferredTaxExpenseIncome": {
     "auth_ref": [
      "r59"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense (income) relating to changes in deferred tax liabilities and deferred tax assets. [Refer: Deferred tax assets; Deferred tax liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Unrecognized deferred income tax assets"
       }
      }
     },
     "localname": "DeferredTaxExpenseIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitObligationAtPresentValue": {
     "auth_ref": [
      "r80"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The present value, without deducting any plan assets, of expected future payments required to settle the obligation resulting from employee service in the current and prior periods. [Refer: Plan assets, at fair value]"
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit obligation, at present value"
       }
      }
     },
     "localname": "DefinedBenefitObligationAtPresentValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DefinedBenefitPlansAxis": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Defined benefit plans [axis]"
       }
      }
     },
     "localname": "DefinedBenefitPlansAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DefinedBenefitPlansMember": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for post-employment benefit plans other than defined contribution plans. Defined contribution plans are post-employment benefit plans under which an entity pays fixed contributions into a separate entity (a fund) and will have no legal or constructive obligation to pay further contributions if the fund does not hold sufficient assets to pay all employee benefits relating to employee service in the current and prior periods. It also represents the standard value for the 'Defined benefit plans' axis if no other member is used."
       }
      }
     },
     "localname": "DefinedBenefitPlansMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_DepreciationExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation expense. Depreciation is the systematic allocation of depreciable amounts of tangible assets over their useful lives."
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation expense",
        "verboseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r69",
      "r72"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of property, plant and equipment. [Refer: Depreciation and amortisation expense; Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Depreciation, property, plant and equipment",
        "negatedLabel": "Depreciation"
       }
      }
     },
     "localname": "DepreciationPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DepreciationRightofuseAssets": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of depreciation of right-of-use assets. [Refer: Depreciation and amortisation expense; Right-of-use assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets, depreciation expense"
       }
      }
     },
     "localname": "DepreciationRightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for business combinations. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Corporate information"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForBusinessCombinationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for fair value measurement. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "c) Fair value measurement"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForFairValueMeasurementExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "j) Intangible assets"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForIntangibleAssetsOtherThanGoodwillExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForLeasesExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for leases. A lease is an agreement whereby the lessor conveys to the lessee in return for a payment or series of payments the right to use an asset for an agreed period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "i) Leases"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForLeasesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForMeasuringInventories": {
     "auth_ref": [
      "r81"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for measuring inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "g) Inventories"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForMeasuringInventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "h) Property and equipment"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForProvisionsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for provisions. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "n) Provisions"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForProvisionsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r12"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy for restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "f) Restricted cash"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyForRestrictedCashAndCashEquivalentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents": {
     "auth_ref": [
      "r176"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the entity's accounting policy used to determine the components of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "e) Cash and cash equivalents"
       }
      }
     },
     "localname": "DescriptionOfAccountingPolicyToDetermineComponentsOfCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DescriptionOfAcquiree": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the business or businesses that the acquirer obtains control of in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of acquiree"
       }
      }
     },
     "localname": "DescriptionOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfDiscountRatesAppliedToCashFlowProjections": {
     "auth_ref": [
      "r120",
      "r121"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The discount rate applied to cash flow projections for a cash-generating unit (group of units). [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Discount rate applied to cash flow projections"
       }
      }
     },
     "localname": "DescriptionOfDiscountRatesAppliedToCashFlowProjections",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfExpectedVolatilityShareOptionsGranted": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The expected volatility of the share price used to calculate the fair value of the share options granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected volatility, maximum"
       }
      }
     },
     "localname": "DescriptionOfExpectedVolatilityShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections": {
     "auth_ref": [
      "r119",
      "r124"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of key assumptions on which management has based its cash flow projections for the period covered by the most recent budgets/forecasts for a cash-generating unit (group of units). Key assumptions are those to which the unit's (group of units') recoverable amount is most sensitive. [Refer: Cash-generating units [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of key assumptions on which management has based cash flow projections"
       }
      }
     },
     "localname": "DescriptionOfKeyAssumptionsOnWhichManagementHasBasedCashFlowProjections",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfOptionLifeShareOptionsGranted": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The option life of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Expected life of stock options, maximum"
       }
      }
     },
     "localname": "DescriptionOfOptionLifeShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_DescriptionOfOptionPricingModelShareOptionsGranted": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the option pricing model used for share options granted. [Refer: Option pricing model [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Model used"
       }
      }
     },
     "localname": "DescriptionOfOptionPricingModelShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DescriptionOfRiskFreeInterestRateShareOptionsGranted": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The implied yield currently available on zero-coupon government issues of the country in whose currency the exercise price for share options granted is expressed, with a remaining term equal to the expected term of the option being valued (based on the option's remaining contractual life and taking into account the effects of expected early exercise). [Refer: Government [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "DescriptionOfRiskFreeInterestRateShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue": {
     "auth_ref": [
      "r254"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the valuation techniques and significant inputs used to measure non-controlling interest in an acquiree measured at fair value for business combinations in which the acquirer holds less than 100 per cent of the equity interests in the acquiree at the acquisition date. [Refer: At fair value [member]; Business combinations [member]; Valuation techniques [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Valuation technique"
       }
      }
     },
     "localname": "DescriptionOfValuationTechniquesAndKeyModelInputsUsedForDeterminingNoncontrollingInterestInAnAcquireeMeasuredAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DilutedEarningsLossPerShare": {
     "auth_ref": [
      "r108",
      "r109"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of profit (loss) attributable to ordinary equity holders of the parent entity (the numerator), divided by the weighted average number of ordinary shares outstanding during the period (the denominator), both adjusted for the effects of all dilutive potential ordinary shares. [Refer: Ordinary shares [member]; Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Diluted earnings per share (R$)",
        "verboseLabel": "Per common share"
       }
      }
     },
     "localname": "DilutedEarningsLossPerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_DilutedEarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Diluted earnings per share"
       }
      }
     },
     "localname": "DilutedEarningsPerShareAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of dilutive potential ordinary shares that relate to the assumed exercise of the entity's share options."
       }
      },
      "en-us": {
       "role": {
        "label": "Effects of dilution from stock options"
       }
      }
     },
     "localname": "DilutiveEffectOfShareOptionsOnNumberOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more, and more than, twelve months after reporting date."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of amounts to be recovered or settled after twelve months for classes of assets and liabilities that contain amounts to be recovered or settled both no more and more than twelve months after reporting date [table]"
       }
      }
     },
     "localname": "DisclosureOfAmountsToBeRecoveredOrSettledAfterTwelveMonthsForClassesOfAssetsAndLiabilitiesThatContainAmountsToBeRecoveredOrSettledBothNoMoreAndMoreThanTwelveMonthsAfterReportingDateTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsExplanatory": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Business combinations"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinations"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfBusinessCombinationsTable": {
     "auth_ref": [
      "r257"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about business combination [table]"
       }
      }
     },
     "localname": "DisclosureOfBusinessCombinationsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfCashAndCashEquivalentsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of cash and cash equivalents. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of cash and cash equivalents [text block]",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "DisclosureOfCashAndCashEquivalentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfContingentLiabilitiesInBusinessCombinationTable": {
     "auth_ref": [
      "r252",
      "r258"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to contingent liabilities in business combinations."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of contingent liabilities in business combination [table]"
       }
      }
     },
     "localname": "DisclosureOfContingentLiabilitiesInBusinessCombinationTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDefinedBenefitPlansTable": {
     "auth_ref": [
      "r76"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to defined benefit plans."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of defined benefit plans [table]"
       }
      }
     },
     "localname": "DisclosureOfDefinedBenefitPlansTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutBorrowingsTable": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of borrowings."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about borrowings [table]"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutBorrowingsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of detailed information about property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Schedule of detailed information about property, plant and equipment"
       }
      }
     },
     "localname": "DisclosureOfDetailedInformationAboutPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipmentTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable": {
     "auth_ref": [
      "r220"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the disaggregation of revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of disaggregation of revenue from contracts with customers [table]"
       }
      }
     },
     "localname": "DisclosureOfDisaggregationOfRevenueFromContractsWithCustomersTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails",
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfEarningsPerShareExplanatory": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for earnings per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Earnings per share (EPS)"
       }
      }
     },
     "localname": "DisclosureOfEarningsPerShareExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EarningsPerShareEps"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment information"
       }
      }
     },
     "localname": "DisclosureOfEntitysReportableSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SegmentInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfEventsAfterReportingPeriodExplanatory": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for events after the reporting period."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsequent events"
       }
      }
     },
     "localname": "DisclosureOfEventsAfterReportingPeriodExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfExpensesByNatureExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of expenses by nature. [Refer: Expenses, by nature]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expenses and costs by nature"
       }
      }
     },
     "localname": "DisclosureOfExpensesByNatureExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ExpensesAndCostsByNature"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFairValueMeasurementOfAssetsTable": {
     "auth_ref": [
      "r214"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the fair value measurement of assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of fair value measurement of assets [table]"
       }
      }
     },
     "localname": "DisclosureOfFairValueMeasurementOfAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingenciesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinanceIncomeExpenseExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of finance income (cost). [Refer: Finance income (cost)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Finance result"
       }
      }
     },
     "localname": "DisclosureOfFinanceIncomeExpenseExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinanceResult"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsTable": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial assets that are either past due or impaired."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial assets that are either past due or impaired [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialAssetsThatAreEitherPastDueOrImpairedTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfFinancialInstrumentsExplanatory": {
     "auth_ref": [
      "r293"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for financial instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets and financial liabilities"
       }
      }
     },
     "localname": "DisclosureOfFinancialInstrumentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfFinancialLiabilitiesTable": {
     "auth_ref": [
      "r281"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to financial liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of financial liabilities [table]"
       }
      }
     },
     "localname": "DisclosureOfFinancialLiabilitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfIncomeTaxExplanatory": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for income taxes."
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes"
       }
      }
     },
     "localname": "DisclosureOfIncomeTaxExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfInsuranceContractsExplanatory": {
     "auth_ref": [
      "r324",
      "r331"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for insurance contracts."
       }
      },
      "en-us": {
       "role": {
        "label": "Insurance contracts and contingencies"
       }
      }
     },
     "localname": "DisclosureOfInsuranceContractsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/InsuranceContractsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsExplanatory": {
     "auth_ref": [
      "r144"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwill"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfIntangibleAssetsTable": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of intangible assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about intangible assets [table]"
       }
      }
     },
     "localname": "DisclosureOfIntangibleAssetsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfJointVenturesExplanatory": {
     "auth_ref": [
      "r101",
      "r105",
      "r208"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of joint ventures. [Refer: Joint ventures [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of joint ventures [text block]",
        "verboseLabel": "Investment in associate"
       }
      }
     },
     "localname": "DisclosureOfJointVenturesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/InvestmentInAssociate"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfNotesAndOtherExplanatoryInformationExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of notes and other explanatory information as part of a complete set of financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of notes and other explanatory information [text block]"
       }
      }
     },
     "localname": "DisclosureOfNotesAndOtherExplanatoryInformationExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsExplanatory": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of operating segments. [Refer: Operating segments [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Schedule of operating income for each operating segment"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SegmentInformationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfOperatingSegmentsTable": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to operating segments."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of operating segments [table]"
       }
      }
     },
     "localname": "DisclosureOfOperatingSegmentsTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfOtherAssetsExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of other assets. [Refer: Other assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of other assets [text block]",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "DisclosureOfOtherAssetsExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/OtherAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentExplanatory": {
     "auth_ref": [
      "r74"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of property, plant and equipment [text block]",
        "verboseLabel": "Property and equipment"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/PropertyAndEquipment"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r71"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to details of property, plant and equipment."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of detailed information about property, plant and equipment [table]"
       }
      }
     },
     "localname": "DisclosureOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInGoodwillTable": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in goodwill."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in goodwill [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInGoodwillTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of changes in intangible assets and goodwill."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of changes in intangible assets and goodwill [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfChangesInIntangibleAssetsAndGoodwillTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the reconciliation of liabilities arising from financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of reconciliation of liabilities arising from financing activities [table]"
       }
      }
     },
     "localname": "DisclosureOfReconciliationOfLiabilitiesArisingFromFinancingActivitiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfRelatedPartyExplanatory": {
     "auth_ref": [
      "r93"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Related parties"
       }
      }
     },
     "localname": "DisclosureOfRelatedPartyExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/RelatedParties"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue."
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue"
       }
      }
     },
     "localname": "DisclosureOfRevenueExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRevenueFromContractsWithCustomersExplanatory": {
     "auth_ref": [
      "r225",
      "r226"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for revenue from contracts with customers."
       }
      },
      "en-us": {
       "role": {
        "label": "r) Revenue from contracts with customers"
       }
      }
     },
     "localname": "DisclosureOfRevenueFromContractsWithCustomersExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable": {
     "auth_ref": [
      "r265"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to the risk management strategy in relation to hedge accounting."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of risk management strategy related to hedge accounting [table]"
       }
      }
     },
     "localname": "DisclosureOfRiskManagementStrategyRelatedToHedgeAccountingTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for share capital, reserves and other equity interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of share capital, reserves and other equity interest [text block]",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "DisclosureOfShareCapitalReservesAndOtherEquityInterestExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/Equity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfSignificantInvestmentsInSubsidiariesTable": {
     "auth_ref": [
      "r101",
      "r105",
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to subsidiaries."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of subsidiaries [table]"
       }
      }
     },
     "localname": "DisclosureOfSignificantInvestmentsInSubsidiariesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The entire disclosure for significant accounting policies applied by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of significant accounting policies [text block]",
        "verboseLabel": "Significant accounting policies"
       }
      }
     },
     "localname": "DisclosureOfSummaryOfSignificantAccountingPoliciesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to terms and conditions of share-based payment arrangements."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of terms and conditions of share-based payment arrangement [table]"
       }
      }
     },
     "localname": "DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisclosureOfTradeAndOtherReceivablesExplanatory": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The disclosure of trade and other receivables. [Refer: Trade and other receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of trade and other receivables [text block]",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "DisclosureOfTradeAndOtherReceivablesExplanatory",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TradeReceivables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesTable": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to transactions between related parties."
       }
      },
      "en-us": {
       "role": {
        "label": "Disclosure of transactions between related parties [table]"
       }
      }
     },
     "localname": "DisclosureOfTransactionsBetweenRelatedPartiesTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_DisposalsIntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r136"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in intangible assets and goodwill resulting from disposals. [Refer: Intangible assets and goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals, intangible assets and goodwill",
        "negatedLabel": "Disposals of intangible"
       }
      }
     },
     "localname": "DisposalsIntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DisposalsPropertyPlantAndEquipment": {
     "auth_ref": [
      "r67"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The decrease in property, plant and equipment resulting from disposals. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Disposals"
       }
      }
     },
     "localname": "DisposalsPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendPayables": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends that the company has declared but not yet paid."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividend payables"
       }
      }
     },
     "localname": "DividendPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaid": {
     "auth_ref": [
      "r9"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends recognised as distributions to owners."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends declared"
       }
      }
     },
     "localname": "DividendsPaid",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r165"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for dividends paid by the entity, classified as financing activities."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid, classified as financing activities",
        "negatedLabel": "Dividends paid to non-controlling interests"
       }
      }
     },
     "localname": "DividendsPaidClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsPaidToNoncontrollingInterests": {
     "auth_ref": [
      "r193"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends paid to non-controlling interests. [Refer: Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends paid to non-controlling interests"
       }
      }
     },
     "localname": "DividendsPaidToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsReceived": {
     "auth_ref": [
      "r195"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends received."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividends received",
        "verboseLabel": "Dividends receivable (included in Other assets)"
       }
      }
     },
     "localname": "DividendsReceived",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of dividends relating to prior years, recognised as distributions to owners of the parent. [Refer: Parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Renounce of dividends for prior years"
       }
      }
     },
     "localname": "DividendsRecognisedAsDistributionsToOwnersOfParentRelatingToPriorYears",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EffectOfExchangeRateChangesOnCashAndCashEquivalents": {
     "auth_ref": [
      "r163",
      "r164"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 4.0,
       "parentTag": "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The effect of exchange rate changes on cash and cash equivalents held or due in a foreign currency. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effect of exchange rate changes on cash and cash equivalents",
        "verboseLabel": "Net foreign exchange differences"
       }
      }
     },
     "localname": "EffectOfExchangeRateChangesOnCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EliminationOfIntersegmentAmountsMember": {
     "auth_ref": [
      "r305",
      "r309"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the elimination of intersegment amounts in the reconciliations of total segment amounts to amounts recognised in the entity's financial statements."
       }
      },
      "en-us": {
       "role": {
        "label": "Elimination of intersegment amounts [member]"
       }
      }
     },
     "localname": "EliminationOfIntersegmentAmountsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForBusinessCombinationsMember": {
     "auth_ref": [
      "r257",
      "r260"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Business combinations' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForBusinessCombinationsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/BusinessCombinationsTables",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForImpairmentOfFinancialAssetsMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Impairment of financial assets' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForImpairmentOfFinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForProbabilityOfDefaultMember": {
     "auth_ref": [
      "r275",
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Probability of default' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForProbabilityOfDefaultMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForRelatedPartiesMember": {
     "auth_ref": [
      "r90"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Categories of related parties' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForRelatedPartiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSegmentConsolidationItemsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Segment consolidation items' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForSegmentConsolidationItemsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EntitysTotalForSubsidiariesMember": {
     "auth_ref": [
      "r101",
      "r105",
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the standard value for the 'Subsidiaries' axis if no other member is used."
       }
      }
     },
     "localname": "EntitysTotalForSubsidiariesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Equity": {
     "auth_ref": [
      "r24",
      "r32",
      "r180",
      "r182",
      "r210",
      "r211",
      "r212"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of residual interest in the assets of the entity after deducting all its liabilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity [Default Label]",
        "periodEndLabel": "Ending balance, value",
        "periodStartLabel": "Beginning balance, value",
        "totalLabel": "Total equity",
        "verboseLabel": "Equity"
       }
      }
     },
     "localname": "Equity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_EquityAndLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the entity's equity and liabilities. [Refer: Equity; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Total liabilities and equity",
        "totalLabel": "Total liabilities and equity"
       }
      }
     },
     "localname": "EquityAndLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParent": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity attributable to the owners of the parent. This specifically excludes non-controlling interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent",
        "totalLabel": "Equity attributable to equity holders of the parent"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_EquityAttributableToOwnersOfParentMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity attributable to the owners of the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Equity attributable to owners of parent [member]"
       }
      }
     },
     "localname": "EquityAttributableToOwnersOfParentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_EquityMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the residual interest in the assets of the entity after deducting all its liabilities. It also represents the standard value for the 'Components of equity' axis if no other member is used."
       }
      }
     },
     "localname": "EquityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ExpectedDividendAsPercentageShareOptionsGranted": {
     "auth_ref": [
      "r245"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of an expected dividend used to calculate the fair value of share options granted."
       }
      },
      "en-us": {
       "role": {
        "label": "Dividend yield"
       }
      }
     },
     "localname": "ExpectedDividendAsPercentageShareOptionsGranted",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ExpenseByNature": {
     "auth_ref": [
      "r52"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses aggregated according to their nature (for example, depreciation, purchases of materials, transport costs, employee benefits and advertising costs), and not reallocated among functions within the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Expenses, by nature",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "ExpenseByNature",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseFromSharebasedPaymentTransactionsWithEmployees": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense from share-based payment transactions with employees. [Refer: Expense from share-based payment transactions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expense from share-based payment transactions with employees",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "ExpenseFromSharebasedPaymentTransactionsWithEmployees",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed": {
     "auth_ref": [
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the expense relating to leases of low-value assets accounted for applying paragraph 6 of IFRS 16. This expense shall not include the expense relating to short-term leases of low-value assets."
       }
      },
      "en-us": {
       "role": {
        "label": "Amount recognized lease expense from short-term leases and low-value assets"
       }
      }
     },
     "localname": "ExpenseRelatingToLeasesOfLowvalueAssetsForWhichRecognitionExemptionHasBeenUsed",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FeeAndCommissionExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to fees and commissions."
       }
      },
      "en-us": {
       "role": {
        "label": "Fee and commission expense"
       }
      }
     },
     "localname": "FeeAndCommissionExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FeeAndCommissionIncome": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income relating to fees and commissions."
       }
      },
      "en-us": {
       "role": {
        "label": "Tuition, digital content and app subscription fees - Transferred over time",
        "verboseLabel": "Transferred over time"
       }
      }
     },
     "localname": "FeeAndCommissionIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceCosts": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of costs associated with financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance costs",
        "negatedLabel": "Finance expenses",
        "negatedTerseLabel": "Finance expenses"
       }
      }
     },
     "localname": "FinanceCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncome": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_FinanceIncomeCost",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income",
        "terseLabel": "Finance result",
        "verboseLabel": "Finance income"
       }
      }
     },
     "localname": "FinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinanceIncomeCost": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income or cost associated with interest and other financing activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Finance income (cost)",
        "totalLabel": "Finance result"
       }
      }
     },
     "localname": "FinanceIncomeCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssets": {
     "auth_ref": [
      "r267",
      "r272",
      "r273",
      "r275",
      "r276"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that are: (a) cash; (b) an equity instrument of another entity; (c) a contractual right: (i) to receive cash or another financial asset from another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially favourable to the entity; or (d) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to receive a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose the entity\u2019s own equity instruments do not include puttable financial instruments classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. [Refer: Financial instruments, class [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, at carrying amount",
        "terseLabel": "Balance as of ending",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "FinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsAtAmortisedCostMember": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial assets measured at amortised cost class. [Refer: Financial assets at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets at amortised cost, class [member]"
       }
      }
     },
     "localname": "FinancialAssetsAtAmortisedCostMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsAtFairValue": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial assets. [Refer: At fair value [member]; Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets, at fair value"
       }
      }
     },
     "localname": "FinancialAssetsAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialAssetsMember": {
     "auth_ref": [
      "r279",
      "r280",
      "r311",
      "r323",
      "r325",
      "r326"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes of financial assets. It also represents the standard value for the 'Classes of financial assets' axis if no other member is used. [Refer: Financial assets]"
       }
      }
     },
     "localname": "FinancialAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsNeitherPastDueNorImpairedMember": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for financial assets that are neither past due nor impaired. A financial asset is past due when a counterparty has failed to make a payment when contractually due. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial assets neither past due nor impaired [member]"
       }
      }
     },
     "localname": "FinancialAssetsNeitherPastDueNorImpairedMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial assets acquired in a business combination. [Refer: Financial assets; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Total",
        "verboseLabel": "Total Assets"
       }
      }
     },
     "localname": "FinancialAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilities": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that are: (a) a contractual obligation: (i) to deliver cash or another financial asset to another entity; or (ii) to exchange financial assets or financial liabilities with another entity under conditions that are potentially unfavourable to the entity; or (b) a contract that will, or may be, settled in the entity\u2019s own equity instruments and is: (i) a non-derivative for which the entity is, or may be, obliged to deliver a variable number of the entity\u2019s own equity instruments; or (ii) a derivative that will, or may be, settled other than by the exchange of a fixed amount of cash or another financial asset for a fixed number of the entity\u2019s own equity instruments. For this purpose, rights, options or warrants to acquire a fixed number of the entity\u2019s own equity instruments for a fixed amount of any currency are equity instruments if the entity offers the rights, options or warrants pro rata to all of its existing owners of the same class of its own non-derivative equity instruments. Also, for those purposes the entity\u2019s own equity instruments do not include puttable financial instruments that are classified as equity instruments in accordance with paragraphs 16A-16B of IAS 32, instruments that impose on the entity an obligation to deliver to another party a pro rata share of the net assets of the entity only on liquidation and are classified as equity instruments in accordance with paragraphs 16C-16D of IAS 32, or instruments that are contracts for the future receipt or delivery of the entity\u2019s own equity instruments. As an exception, an instrument that meets the definition of a financial liability is classified as an equity instrument if it has all the features and meets the conditions in paragraphs 16A-16B or paragraphs 16C-16D of IAS 32. [Refer: Financial instruments, class [member]; Financial assets; Derivatives [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, at carrying amount",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "FinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtAmortisedCostMember": {
     "auth_ref": [
      "r283"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the financial liabilities measured at amortised cost class. [Refer: Financial liabilities at amortised cost]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities at amortised cost, class [member]"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtAmortisedCostMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilitiesAtFairValue": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The fair value of financial liabilities. [Refer: At fair value [member]; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Financial liabilities, at fair value"
       }
      }
     },
     "localname": "FinancialLiabilitiesAtFairValue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FinancialLiabilitiesMember": {
     "auth_ref": [
      "r279",
      "r280",
      "r311",
      "r325"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregated classes financial liabilities. It also represents the standard value for the 'Classes of financial liabilities' axis if no other member is used. [Refer: Financial liabilities]"
       }
      }
     },
     "localname": "FinancialLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FinancialLiabilitiesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for financial liabilities assumed in a business combination. [Refer: Financial liabilities; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Total Liabilites",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "FinancialLiabilitiesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_FixturesAndFittingsMember": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing fixtures and fittings that are not permanently attached to real property. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Fixtures and fittings [member]"
       }
      }
     },
     "localname": "FixturesAndFittingsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_FloatingInterestRateMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a non-fixed interest rate. [Refer: Interest rate risk [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Floating interest rate [member]"
       }
      }
     },
     "localname": "FloatingInterestRateMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r11"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to general and administrative activities of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "General and administrative expense",
        "negatedLabel": "General and administrative expenses"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Goodwill": {
     "auth_ref": [
      "r16",
      "r117",
      "r122",
      "r259"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognised. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GoodwillMember": {
     "auth_ref": [
      "r115"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill [member]"
       }
      }
     },
     "localname": "GoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GoodwillRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r257",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the business combination's acquisition date for goodwill. [Refer: Goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Goodwill recognised as of acquisition date",
        "verboseLabel": "Preliminary goodwill arising on acquisition"
       }
      }
     },
     "localname": "GoodwillRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_GrossCarryingAmountMember": {
     "auth_ref": [
      "r65",
      "r134",
      "r147",
      "r150",
      "r259",
      "r273",
      "r275",
      "r276",
      "r335",
      "r342"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the amount at which an asset is recognised before deducting any accumulated depreciation (amortisation) and accumulated impairment losses thereon. [Refer: Depreciation and amortisation expense; Impairment loss]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross carrying amount [member]"
       }
      }
     },
     "localname": "GrossCarryingAmountMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_GrossProfit": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue less cost of sales. [Refer: Cost of sales; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for identifiable intangible assets acquired in a business combination. [Refer: Intangible assets other than goodwill; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Identifiable intangible assets recognised as of acquisition date",
        "verboseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IdentifiableIntangibleAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ImpairmentOfFinancialAssetsAxis": {
     "auth_ref": [
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Impairment of financial assets [axis]"
       }
      }
     },
     "localname": "ImpairmentOfFinancialAssetsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Profit or loss [abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_IncomeTaxExpenseContinuingOperations": {
     "auth_ref": [
      "r49",
      "r55",
      "r57",
      "r58",
      "r96",
      "r206",
      "r298"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The aggregate amount included in the determination of profit (loss) for the period in respect of current tax and deferred tax. [Refer: Current tax expense (income); Deferred tax expense (income)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes expenses",
        "negatedLabel": "Income taxes expenses"
       }
      }
     },
     "localname": "IncomeTaxExpenseContinuingOperations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncomeTaxesPaidRefundClassifiedAsOperatingActivities": {
     "auth_ref": [
      "r153",
      "r166"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash flows from income taxes paid or refunded, classified as operating activities. [Refer: Income taxes paid (refund)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes paid (refund), classified as operating activities",
        "negatedLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaidRefundClassifiedAsOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInCashAndCashEquivalents": {
     "auth_ref": [
      "r175"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in cash and cash equivalents after the effect of exchange rate changes on cash and cash equivalents held in foreign currencies. [Refer: Cash and cash equivalents; Effect of exchange rate changes on cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in cash and cash equivalents after effect of exchange rate changes",
        "totalLabel": "Net increase in cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "IncreaseDecreaseInCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible decrease in an unobservable input. [Refer: Tax income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in fair value measurement due to reasonably possible decrease in unobservable input, recognised in profit or loss, before tax, assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleDecreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets": {
     "auth_ref": [
      "r213"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of increase (decrease) in the fair value measurement of assets, recognised in profit or loss before tax, due to a reasonably possible increase in an unobservable input. [Refer: Tax income (expense)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) in fair value measurement due to reasonably possible increase in unobservable input, recognised in profit or loss, before tax, assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInFairValueMeasurementDueToReasonablyPossibleIncreaseInUnobservableInputRecognisedInProfitOrLossBeforeTaxAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r170"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from the effect of changes in foreign exchange rates. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange movement"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughEffectOfChangesInForeignExchangeRatesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r168"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from financing cash flows. [Refer: Cash flows from (used in) financing activities; Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through financing cash flows, liabilities arising from financing activities",
        "verboseLabel": "Payments"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughFinancingCashFlowsLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r169"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from obtaining or losing control of subsidiaries or other businesses. [Refer: Liabilities arising from financing activities; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Increase (decrease) through obtaining or losing control of subsidiaries or other businesses, liabilities arising from financing activities",
        "verboseLabel": "Business combination"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughObtainingOrLosingControlOfSubsidiariesOrOtherBusinessesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r171"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in liabilities arising from financing activities resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherChangesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughOtherContributionsByOwners": {
     "auth_ref": [
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through other contributions by owners that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Capital increase from shares contribution of shareholders"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughOtherContributionsByOwners",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughSharebasedPaymentTransactions": {
     "auth_ref": [
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based compensation"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughSharebasedPaymentTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r70"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase (decrease) in property, plant and equipment resulting from transfers and changes that the entity does not separately disclose in the same statement or note. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Transfer"
       }
      }
     },
     "localname": "IncreaseDecreaseThroughTransfersAndOtherChangesPropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r172",
      "r178"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in liabilities arising from financing activities resulting from new leases. [Refer: Liabilities arising from financing activities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Addition"
       }
      }
     },
     "localname": "IncreaseThroughNewLeasesLiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IndemnificationAssetsRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r250"
     ],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": 1.0,
       "parentTag": "afya_Assets1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for indemnification assets acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Indemnification assets recognised as of acquisition date",
        "terseLabel": "Indemnification assets",
        "verboseLabel": "Total identifiable net assets at fair value"
       }
      }
     },
     "localname": "IndemnificationAssetsRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwill": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets and goodwill held by the entity. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets and goodwill [Default Label]",
        "periodEndLabel": "Intangible assets and goodwill, balance at end",
        "periodStartLabel": "Intangible assets and goodwill, balance at beginnning",
        "verboseLabel": "Intangible assets and goodwill"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsAndGoodwillMember": {
     "auth_ref": [
      "r139"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets and goodwill. It also represents the standard value for the 'Classes of intangible assets and goodwill' axis if no other member is used. [Refer: Goodwill; Intangible assets other than goodwill]"
       }
      }
     },
     "localname": "IntangibleAssetsAndGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/IntangibleAssetsAndGoodwillDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r16",
      "r138"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 7.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of identifiable non-monetary assets without physical substance. This amount does not include goodwill. [Refer: Goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IntangibleAssetsOtherThanGoodwillMember": {
     "auth_ref": [
      "r115",
      "r139",
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for intangible assets other than goodwill. It also represents the standard value for the 'Classes of intangible assets other than goodwill' axis if no other member is used. [Refer: Intangible assets other than goodwill]"
       }
      }
     },
     "localname": "IntangibleAssetsOtherThanGoodwillMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_IntangibleAssetsWithIndefiniteUsefulLife": {
     "auth_ref": [
      "r118",
      "r123",
      "r143"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of intangible assets assessed as having an indefinite useful life. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Licenses with indefinite useful life"
       }
      }
     },
     "localname": "IntangibleAssetsWithIndefiniteUsefulLife",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpense": {
     "auth_ref": [
      "r205",
      "r296",
      "r304"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestExpenseOnLeaseLiabilities": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of interest expense on lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accrued lease interest",
        "verboseLabel": "Lease liabilities, interest expense"
       }
      }
     },
     "localname": "InterestExpenseOnLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InterestRateRiskMember": {
     "auth_ref": [
      "r292",
      "r316",
      "r317",
      "r318",
      "r319"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the type of risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market interest rates. [Refer: Financial instruments, class [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Interest rate risk [member]"
       }
      }
     },
     "localname": "InterestRateRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_InterestRateTypesMember": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of interest rates. It also represents the standard value for the 'Types of interest rates' axis if no other member is used. [Refer: Interest rate risk [member]]"
       }
      }
     },
     "localname": "InterestRateTypesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Inventories": {
     "auth_ref": [
      "r17",
      "r28",
      "r82"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current inventories. [Refer: Inventories]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventories"
       }
      }
     },
     "localname": "Inventories",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InventoryRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for inventory acquired in a business combination. [Refer: Inventories; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Inventory recognised as of acquisition date",
        "verboseLabel": "Inventories"
       }
      }
     },
     "localname": "InventoryRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentIncome": {
     "auth_ref": [
      "r50",
      "r94"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investment income, such as interest and dividends."
       }
      },
      "en-us": {
       "role": {
        "label": "Income from financial investments"
       }
      }
     },
     "localname": "InvestmentIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInAssociates": {
     "auth_ref": [
      "r97"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in associates in an entity's separate financial statements. [Refer: Associates [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investments in associate",
        "periodEndLabel": "Closing balance",
        "periodStartLabel": "Opening balance"
       }
      }
     },
     "localname": "InvestmentsInAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of investments in subsidiaries, joint ventures and associates in an entity's separate financial statements. [Refer: Associates [member]; Joint ventures [member]; Subsidiaries [member]; Investments in subsidiaries reported in separate financial statements]"
       }
      },
      "en-us": {
       "role": {
        "label": "Investment in associate"
       }
      }
     },
     "localname": "InvestmentsInSubsidiariesJointVenturesAndAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssueOfEquity": {
     "auth_ref": [
      "r6"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The increase in equity through the issue of equity instruments."
       }
      },
      "en-us": {
       "role": {
        "label": "Issuance of common shares in follow-on public offering"
       }
      }
     },
     "localname": "IssueOfEquity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapital": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value of capital issued."
       }
      },
      "en-us": {
       "role": {
        "label": "Share capital"
       }
      }
     },
     "localname": "IssuedCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_IssuedCapitalMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing issued capital."
       }
      },
      "en-us": {
       "role": {
        "label": "Issued capital [member]"
       }
      }
     },
     "localname": "IssuedCapitalMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensation": {
     "auth_ref": [
      "r86"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based compensation plans"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensation",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_KeyManagementPersonnelCompensationShorttermEmployeeBenefits": {
     "auth_ref": [
      "r85"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of compensation to key management personnel in the form of short-term employee benefits. [Refer: Key management personnel of entity or parent [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Short-term employee benefits"
       }
      }
     },
     "localname": "KeyManagementPersonnelCompensationShorttermEmployeeBenefits",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/KeyManagementPersonnelCompensationIncludedInCompanysConsolidatedStatementOfIncomeComprisedFollowingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LandMember": {
     "auth_ref": [
      "r61"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing land held by the entity for use in operations. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Land [member]"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanFiveYearsMember": {
     "auth_ref": [
      "r235",
      "r236",
      "r282",
      "r287",
      "r291",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than five years [member]"
       }
      }
     },
     "localname": "LaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearAndNotLaterThanThreeYearsMember": {
     "auth_ref": [
      "r282",
      "r285",
      "r291"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year and not later than three years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year and not later than three years [member]"
       }
      }
     },
     "localname": "LaterThanOneYearAndNotLaterThanThreeYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanOneYearMember": {
     "auth_ref": [
      "r25",
      "r334",
      "r340"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than one year."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than one year [member]"
       }
      }
     },
     "localname": "LaterThanOneYearMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeMonthsAndNotLaterThanSixMonthsMember": {
     "auth_ref": [
      "r282",
      "r284",
      "r291",
      "r334",
      "r339"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three months and not later than six months."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three months and not later than six months [member]"
       }
      }
     },
     "localname": "LaterThanThreeMonthsAndNotLaterThanSixMonthsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LaterThanThreeYearsAndNotLaterThanFiveYearsMember": {
     "auth_ref": [
      "r282",
      "r286",
      "r291"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a time band of later than three years and not later than five years."
       }
      },
      "en-us": {
       "role": {
        "label": "Later than three years and not later than five years [member]"
       }
      }
     },
     "localname": "LaterThanThreeYearsAndNotLaterThanFiveYearsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseLiabilities": {
     "auth_ref": [
      "r227"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities related to the entity's leases. Lease is a contract, or part of a contract, that conveys the right to use an underlying asset for a period of time in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities [Default Label]",
        "periodStartLabel": "Lease liabilities, balance at beginning",
        "verboseLabel": "Lease liabilities"
       }
      }
     },
     "localname": "LeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LeaseLiabilitiesMember": {
     "auth_ref": [
      "r173",
      "r179"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities [member]"
       }
      }
     },
     "localname": "LeaseLiabilitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails",
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing improvements to assets held under a lease agreement."
       }
      },
      "en-us": {
       "role": {
        "label": "Leasehold improvements [member]"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LeasesAsLesseeRelatedPartyTransactions": {
     "auth_ref": [
      "r92"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of leases where the entity was the lessee in related party transactions. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease"
       }
      }
     },
     "localname": "LeasesAsLesseeRelatedPartyTransactions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowSummarizesBalancesAndTransactionsWithRelatedPartiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LegalProceedingsContingentLiabilityMember": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a contingent liability for legal proceedings. [Refer: Contingent liabilities [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Legal proceedings contingent liability [member]"
       }
      }
     },
     "localname": "LegalProceedingsContingentLiabilityMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LegalProceedingsProvision": {
     "auth_ref": [
      "r130",
      "r132"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of provision for legal proceedings. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Amount of legal proceedings"
       }
      }
     },
     "localname": "LegalProceedingsProvision",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_Level2OfFairValueHierarchyMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 2 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level2OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Level3OfFairValueHierarchyMember": {
     "auth_ref": [
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a category of the fair value hierarchy where inputs to the valuation techniques are unobservable inputs for the asset or liability. Unobservable inputs are inputs for which market data are not available and that are developed using the best information available about the assumptions that the market participants would use when pricing the asset or liability."
       }
      },
      "en-us": {
       "role": {
        "label": "Level 3 of fair value hierarchy [member]"
       }
      }
     },
     "localname": "Level3OfFairValueHierarchyMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LevelsOfFairValueHierarchyAxis": {
     "auth_ref": [
      "r78",
      "r211"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Levels of fair value hierarchy [axis]"
       }
      }
     },
     "localname": "LevelsOfFairValueHierarchyAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_Liabilities": {
     "auth_ref": [
      "r24",
      "r210",
      "r211",
      "r212",
      "r299",
      "r303"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_EquityAndLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of a present obligation of the entity to transfer an economic resource as a result of past events. Economic resource is a right that has the potential to produce economic benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities [Default Label]",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities"
       }
      }
     },
     "localname": "LiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivities": {
     "auth_ref": [
      "r174"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities for which cash flows were, or future cash flows will be, classified in the statement of cash flows as cash flows from financing activities. [Refer: Cash flows from (used in) financing activities; Liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities, beginning",
        "periodEndLabel": "Liabilities arising from financing activities, ending",
        "periodStartLabel": "Liabilities arising from financing activities, ending"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesAxis": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Liabilities arising from financing activities [axis]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_LiabilitiesArisingFromFinancingActivitiesMember": {
     "auth_ref": [
      "r174"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for liabilities arising from financing activities. It also represents the standard value for the 'Liabilities arising from financing activities' axis if no other member is used. [Refer: Liabilities arising from financing activities]"
       }
      }
     },
     "localname": "LiabilitiesArisingFromFinancingActivitiesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfChangesInLiabilitiesArisingFromFinancingActivitiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LicencesMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing the right to use certain intangible assets owned by another entity. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Licences [member]"
       }
      }
     },
     "localname": "LicencesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFcmpbDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LiquidityRiskMember": {
     "auth_ref": [
      "r268",
      "r316",
      "r317",
      "r318"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk that an entity will encounter difficulty in meeting obligations associated with financial liabilities that are settled by delivering cash or another financial asset. [Refer: Financial assets; Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Liquidity risk [member]"
       }
      }
     },
     "localname": "LiquidityRiskMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_LongtermBorrowings": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The non-current portion of non-current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current portion of non-current borrowings",
        "verboseLabel": "Loans and financing"
       }
      }
     },
     "localname": "LongtermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_LongtermLegalProceedingsProvision": {
     "auth_ref": [
      "r130",
      "r132"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current provision for legal proceedings. [Refer: Legal proceedings provision]"
       }
      },
      "en-us": {
       "role": {
        "label": "Provision for legal proceedings"
       }
      }
     },
     "localname": "LongtermLegalProceedingsProvision",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_MaturityAxis": {
     "auth_ref": [
      "r26",
      "r79",
      "r223",
      "r235",
      "r236",
      "r266",
      "r278",
      "r282",
      "r312",
      "r313",
      "r315",
      "r321"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Maturity [axis]"
       }
      }
     },
     "localname": "MaturityAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_MeasurementAxis": {
     "auth_ref": [
      "r145",
      "r149",
      "r210"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Measurement [axis]"
       }
      }
     },
     "localname": "MeasurementAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NameOfSubsidiary": {
     "auth_ref": [
      "r98",
      "r102",
      "r185",
      "r190"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The name of a subsidiary. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "localname": "NameOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NetDebt": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of net debt of the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Net debt"
       }
      }
     },
     "localname": "NetDebt",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeGain": {
     "auth_ref": [
      "r14",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net gain arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Foreign exchange differences"
       }
      }
     },
     "localname": "NetForeignExchangeGain",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NetForeignExchangeLoss": {
     "auth_ref": [
      "r14",
      "r84"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The net loss arising from exchange differences recognised in profit or loss, excluding those arising on financial instruments measured at fair value through profit or loss in accordance with IFRS 9. [Refer: Foreign exchange gain (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net foreign exchange loss",
        "verboseLabel": "Foreign exchange differences"
       }
      }
     },
     "localname": "NetForeignExchangeLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterests": {
     "auth_ref": [
      "r22",
      "r184",
      "r189"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Equity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of equity in a subsidiary not attributable, directly or indirectly, to a parent. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests"
       }
      }
     },
     "localname": "NoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncontrollingInterestsMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity in a subsidiary not attributable, directly or indirectly, to the parent."
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests [member]"
       }
      }
     },
     "localname": "NoncontrollingInterestsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NoncurrentAssets": {
     "auth_ref": [
      "r27",
      "r194",
      "r197"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that do not meet the definition of current assets. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current assets [Default Label]",
        "totalLabel": "Total non-current assets",
        "verboseLabel": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current assets"
       }
      }
     },
     "localname": "NoncurrentAssetsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentFinancialAssets": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial assets. [Refer: Financial assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial assets",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentFinancialAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentFinancialLiabilities": {
     "auth_ref": [
      "r267"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current financial liabilities. [Refer: Financial liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current financial liabilities",
        "verboseLabel": "Non-current"
       }
      }
     },
     "localname": "NoncurrentFinancialLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLeaseLiabilities": {
     "auth_ref": [
      "r227"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current lease liabilities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Lease liabilities",
        "verboseLabel": "Lease liabilities, non-current"
       }
      }
     },
     "localname": "NoncurrentLeaseLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilities": {
     "auth_ref": [
      "r29",
      "r194",
      "r199"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities that do not meet the definition of current liabilities. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current liabilities [Default Label]",
        "totalLabel": "Total non-current liabilities",
        "verboseLabel": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-current liabilities"
       }
      }
     },
     "localname": "NoncurrentLiabilitiesAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_NoncurrentPayablesForPurchaseOfEnergy": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables for the purchase of energy. [Refer: Payables for purchase of energy]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current payables for purchase of energy"
       }
      }
     },
     "localname": "NoncurrentPayablesForPurchaseOfEnergy",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentPayablesToRelatedParties": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current payables to related parties",
        "verboseLabel": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "NoncurrentPayablesToRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentRestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current restricted cash and cash equivalents. [Refer: Restricted cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Restricted cash"
       }
      }
     },
     "localname": "NoncurrentRestrictedCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NoncurrentTradeReceivables": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-current",
        "verboseLabel": "Trade receivable (non-current)"
       }
      }
     },
     "localname": "NoncurrentTradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember": {
     "auth_ref": [
      "r215"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for items not measured at fair value in the statement of financial position but for which fair value is disclosed. [Refer: At fair value [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Not measured at fair value in statement of financial position but for which fair value is disclosed [member]"
       }
      }
     },
     "localname": "NotMeasuredAtFairValueInStatementOfFinancialPositionButForWhichFairValueIsDisclosedMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFairValueMeasurementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_NotesAndDebenturesIssued": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of notes and debentures issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Notes and debentures issued",
        "verboseLabel": "Notes payable"
       }
      }
     },
     "localname": "NotesAndDebenturesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NotionalAmount": {
     "auth_ref": [
      "r11"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal or face amount of a financial instrument, used to calculate payments made on that instrument."
       }
      },
      "en-us": {
       "role": {
        "label": "Loan amount"
       }
      }
     },
     "localname": "NotionalAmount",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_NumberOfOutstandingShareOptions": {
     "auth_ref": [
      "r237",
      "r242",
      "r243"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options outstanding in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding at the ending",
        "periodStartLabel": "Outstanding at the beginning"
       }
      }
     },
     "localname": "NumberOfOutstandingShareOptions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExercisedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options exercised in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options exercised in share-based payment arrangement",
        "verboseLabel": "Exercised"
       }
      }
     },
     "localname": "NumberOfShareOptionsExercisedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsExpiredInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options expired in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options expired in share-based payment arrangement",
        "verboseLabel": "Expired"
       }
      }
     },
     "localname": "NumberOfShareOptionsExpiredInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options forfeited in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of share options forfeited in share-based payment arrangement",
        "verboseLabel": "Forfeited"
       }
      }
     },
     "localname": "NumberOfShareOptionsForfeitedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfShareOptionsGrantedInSharebasedPaymentArrangement": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of share options granted in a share-based payment arrangement."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of stock option granted",
        "verboseLabel": "Granted"
       }
      }
     },
     "localname": "NumberOfShareOptionsGrantedInSharebasedPaymentArrangement",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/LaborAndSocialObligationsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "ifrs-full_NumberOfSharesAuthorised": {
     "auth_ref": [
      "r34"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares authorised."
       }
      },
      "en-us": {
       "role": {
        "label": "Covertable preffered stock shares"
       }
      }
     },
     "localname": "NumberOfSharesAuthorised",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_NumberOfSharesIssued": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares issued by the entity."
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares issed (shares)",
        "verboseLabel": "Total number of shares"
       }
      }
     },
     "localname": "NumberOfSharesIssued",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_OperatingSegmentsMember": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for operating segments. An operating segment is a component of an entity: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same entity); (b) whose operating results are regularly reviewed by the entity\u2019s chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance; and (c) for which discrete financial information is available. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating segments [member]"
       }
      }
     },
     "localname": "OperatingSegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OrdinarySharesMember": {
     "auth_ref": [
      "r38",
      "r108"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for equity instruments that are subordinate to all other classes of equity instruments. It also represents the standard value for the 'Classes of ordinary shares' axis if no other member is used."
       }
      },
      "en-us": {
       "role": {
        "label": "Ordinary shares [member]"
       }
      }
     },
     "localname": "OrdinarySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherAdjustmentsForNoncashItems": {
     "auth_ref": [
      "r160"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 20.0,
       "parentTag": "ifrs-full_AdjustmentsForReconcileProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "Adjustments for non-cash items to reconcile profit (loss) to net cash flow from (used in) operating activities that the entity does not separately disclose in the same statement or note. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other adjustments for non-cash items",
        "verboseLabel": "Labor and social obligations"
       }
      }
     },
     "localname": "OtherAdjustmentsForNoncashItems",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherComprehensiveIncome": {
     "auth_ref": [
      "r5",
      "r42",
      "r51",
      "r202"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 2.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income and expense (including reclassification adjustments) that is not recognised in profit or loss as required or permitted by IFRSs. [Refer: IFRSs [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other comprehensive income"
       }
      }
     },
     "localname": "OtherComprehensiveIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentAssets": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_CurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current assets that the entity does not separately disclose in the same statement or note. [Refer: Current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other assets"
       }
      }
     },
     "localname": "OtherCurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherCurrentLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 10.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherFinanceCost": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance costs that the entity does not separately disclose in the same statement or note. [Refer: Finance costs]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other finance cost",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherFinanceCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherFinanceIncome": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of finance income that the entity does not separately disclose in the same statement or note. [Refer: Finance income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other finance income",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherFinanceIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherGainsLosses": {
     "auth_ref": [
      "r1",
      "r2"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The gains (losses) that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other expenses, net"
       }
      }
     },
     "localname": "OtherGainsLosses",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherIncome": {
     "auth_ref": [
      "r1",
      "r2",
      "r95"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossFromOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of operating income that the entity does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other (expenses) income, net"
       }
      }
     },
     "localname": "OtherIncome",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentAssets": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current assets that the entity does not separately disclose in the same statement or note. [Refer: Non-current assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current assets",
        "verboseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherNoncurrentAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherNoncurrentLiabilities": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 7.0,
       "parentTag": "ifrs-full_NoncurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of non-current liabilities that the entity does not separately disclose in the same statement or note. [Refer: Non-current liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other non-current liabilities",
        "verboseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherProvisions": {
     "auth_ref": [
      "r31",
      "r125"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of provisions other than provisions for employee benefits. [Refer: Provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other provisions",
        "verboseLabel": "Total"
       }
      }
     },
     "localname": "OtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherProvisionsMember": {
     "auth_ref": [
      "r128"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for provisions other than provisions for employee benefits. It also represents the standard value for the 'Classes of other provisions' axis if no other member is used. [Refer: Provisions]"
       }
      }
     },
     "localname": "OtherProvisionsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherReceivables": {
     "auth_ref": [
      "r30"
     ],
     "calculation": {
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails": {
       "order": 4.0,
       "parentTag": "afya_Assets1",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount receivable by the entity that it does not separately disclose in the same statement or note."
       }
      },
      "en-us": {
       "role": {
        "label": "Other FIES receivables"
       }
      }
     },
     "localname": "OtherReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOtherAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_OtherReservesMember": {
     "auth_ref": [
      "r8",
      "r39"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing reserves within equity, not including retained earnings. It also represents the standard value for the 'Reserves within equity' axis if no other member is used. [Refer: Retained earnings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other reserves [member]"
       }
      }
     },
     "localname": "OtherReservesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_OtherRevenue": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue arising from sources that the entity does not separately disclose in the same statement or note. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Other revenue",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "OtherRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ParValuePerShare": {
     "auth_ref": [
      "r35"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The nominal value per share."
       }
      },
      "en-us": {
       "role": {
        "label": "Par value per share",
        "verboseLabel": "Purchase prices per share"
       }
      }
     },
     "localname": "ParValuePerShare",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_PastDueStatusAxis": {
     "auth_ref": [
      "r276",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Past due status [axis]"
       }
      }
     },
     "localname": "PastDueStatusAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_PastDueStatusMember": {
     "auth_ref": [
      "r276",
      "r336"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all past-due statuses. It also represents the standard value for the 'Past due status' axis if no other member is used."
       }
      }
     },
     "localname": "PastDueStatusMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAgingOfTradeAccountsReceivableDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PaymentsForShareIssueCosts": {
     "auth_ref": [
      "r157"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for share issue costs."
       }
      },
      "en-us": {
       "role": {
        "label": "Payments for share issue costs",
        "negatedLabel": "Share issuance costs"
       }
      }
     },
     "localname": "PaymentsForShareIssueCosts",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r156"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for payment of lease liabilities, classified as financing activities. [Refer: Lease liabilities]"
       }
      },
      "en-us": {
       "role": {
        "label": "Payments of lease liabilities, classified as financing activities",
        "negatedLabel": "Payments of lease liabilities"
       }
      }
     },
     "localname": "PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PaymentsToSuppliersForGoodsAndServices": {
     "auth_ref": [
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to suppliers for goods and services."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of services or goods"
       }
      }
     },
     "localname": "PaymentsToSuppliersForGoodsAndServices",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PercentageOfEntitysRevenue": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of the entity's revenue. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of revenue"
       }
      }
     },
     "localname": "PercentageOfEntitysRevenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PercentageOfVotingEquityInterestsAcquired": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The percentage of voting equity interests acquired in a business combination. [Refer: Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Percentage of voting equity interests acquired",
        "verboseLabel": "Proportion of ownership interest"
       }
      }
     },
     "localname": "PercentageOfVotingEquityInterestsAcquired",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_PrincipalPlaceOfBusinessOfSubsidiary": {
     "auth_ref": [
      "r99",
      "r103",
      "r186",
      "r191"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The principal place of business of a subsidiary. [Refer: Principal place of business; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Location"
       }
      }
     },
     "localname": "PrincipalPlaceOfBusinessOfSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProbabilityOfDefaultAxis": {
     "auth_ref": [
      "r275",
      "r289"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Probability of default [axis]"
       }
      }
     },
     "localname": "ProbabilityOfDefaultAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from government grants, classified as financing activities. [Refer: Government [member]; Government grants]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from \u00a0shares public offering"
       }
      }
     },
     "localname": "ProceedsFromGovernmentGrantsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfOrdinaryShares": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of ordinary shares. [Refer: Ordinary shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of shares",
        "verboseLabel": "Proceeds from issue of ordinary shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfOrdinaryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProceedsFromIssueOfPreferenceShares": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash inflow from the issuing of preference shares. [Refer: Preference shares [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proceeds from issue of preference shares"
       }
      }
     },
     "localname": "ProceedsFromIssueOfPreferenceShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProductsAndServicesAxis": {
     "auth_ref": [
      "r224",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Products and services [axis]"
       }
      }
     },
     "localname": "ProductsAndServicesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProductsAndServicesMember": {
     "auth_ref": [
      "r224",
      "r306"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity's products and services. It also represents the standard value for the 'Products and services' axis if no other member is used."
       }
      }
     },
     "localname": "ProductsAndServicesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/SignificantAccountingPoliciesDetailsNarrative"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ProfessionalFeesExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of fees paid or payable for professional services."
       }
      },
      "en-us": {
       "role": {
        "label": "Tuition fees"
       }
      }
     },
     "localname": "ProfessionalFeesExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLoss": {
     "auth_ref": [
      "r4",
      "r41",
      "r158",
      "r181",
      "r183",
      "r194",
      "r299",
      "r301",
      "r314",
      "r327"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ComprehensiveIncome",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income]"
       }
      },
      "en-us": {
       "role": {
        "label": "Net income",
        "totalLabel": "Net income",
        "verboseLabel": "Net income for the period"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income attributable to"
       }
      }
     },
     "localname": "ProfitLossAttributableToAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_ProfitLossAttributableToNoncontrollingInterests": {
     "auth_ref": [
      "r44",
      "r188"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to non-controlling interests. [Refer: Profit (loss); Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Non-controlling interests"
       }
      }
     },
     "localname": "ProfitLossAttributableToNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossAttributableToOwnersOfParent": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from continuing and discontinued operations attributable to owners of the parent. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Equity holders of the parent"
       }
      }
     },
     "localname": "ProfitLossAttributableToOwnersOfParent",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossBeforeTax": {
     "auth_ref": [
      "r1",
      "r2",
      "r263",
      "r299",
      "r301"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) before tax expense or income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income before income taxes",
        "totalLabel": "Income before income taxes",
        "verboseLabel": "Income loss before income taxes"
       }
      }
     },
     "localname": "ProfitLossBeforeTax",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossFromOperatingActivities": {
     "auth_ref": [
      "r50",
      "r107"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) from operating activities of the entity. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Operating income",
        "totalLabel": "Operating income"
       }
      }
     },
     "localname": "ProfitLossFromOperatingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProfitLossOfAcquiree": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The profit (loss) of the acquiree, since the acquisition date, included in the consolidated statement of comprehensive income. [Refer: Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of income"
       }
      }
     },
     "localname": "ProfitLossOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipment": {
     "auth_ref": [
      "r15",
      "r70"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tangible assets that: (a) are held for use in the production or supply of goods or services, for rental to others, or for administrative purposes; and (b) are expected to be used during more than one period."
       }
      },
      "en-us": {
       "role": {
        "label": "Property and equipment",
        "periodEndLabel": "As of December 31, 2021",
        "periodStartLabel": "As of December 31, 2020",
        "verboseLabel": "As of December 31, 2020"
       }
      }
     },
     "localname": "PropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentMember": {
     "auth_ref": [
      "r71",
      "r115",
      "r234"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for property, plant and equipment. It also represents the standard value for the 'Classes of property, plant and equipment' axis if no other member is used. [Refer: Property, plant and equipment]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251",
      "r261"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for plant, property and equipment acquired in a business combination. [Refer: Property, plant and equipment; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Property, plant and equipment recognised as of acquisition date",
        "verboseLabel": "Property and equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestInSubsidiary": {
     "auth_ref": [
      "r100",
      "r104",
      "r192"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interest in a subsidiary attributable to the entity. [Refer: Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Proportion of ownership interest in subsidiary"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestInSubsidiary",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_ProportionOfOwnershipInterestsHeldByNoncontrollingInterests": {
     "auth_ref": [
      "r187"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The proportion of ownership interests in a subsidiary held by non-controlling interests. [Refer: Subsidiaries [member]; Non-controlling interests]"
       }
      },
      "en-us": {
       "role": {
        "label": "Direct and indirect interest of subsidiary",
        "verboseLabel": "Ownership Interest"
       }
      }
     },
     "localname": "ProportionOfOwnershipInterestsHeldByNoncontrollingInterests",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_Provisions": {
     "auth_ref": [
      "r20"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of liabilities of uncertain timing or amount, including provisions for employee benefits."
       }
      },
      "en-us": {
       "role": {
        "label": "Provisions",
        "periodEndLabel": "Balance as of ending of the year",
        "periodStartLabel": "Balances as of end of the year"
       }
      }
     },
     "localname": "Provisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of intangible assets, classified as investing activities. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of intangible assets, classified as investing activities",
        "negatedLabel": "Acquisition of intangibles assets"
       }
      }
     },
     "localname": "PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 6.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of long-term assets that the entity does not separately disclose in the same statement or note, classified as investing activities. [Refer: Assets]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of other long-term assets, classified as investing activities",
        "negatedLabel": "Acquisition of subsidiaries, net of cash acquired"
       }
      }
     },
     "localname": "PurchaseOfOtherLongtermAssetsClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities": {
     "auth_ref": [
      "r154"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow for the purchases of property, plant and equipment, classified as investing activities. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Purchase of property, plant and equipment, classified as investing activities",
        "negatedLabel": "Acquisition of property and equipment"
       }
      }
     },
     "localname": "PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RangeAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r243",
      "r281",
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Range [axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RangesMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r243",
      "r281",
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for aggregate ranges. It also represents the standard value for the 'Range' axis if no other member is used."
       }
      }
     },
     "localname": "RangesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RepairsAndMaintenanceExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expenses incurred for the day-to-day servicing of assets, which may include the cost of labour, consumables or small parts."
       }
      },
      "en-us": {
       "role": {
        "label": "Maintenance"
       }
      }
     },
     "localname": "RepairsAndMaintenanceExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities": {
     "auth_ref": [
      "r155"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "ifrs-full_CashFlowsFromUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The cash outflow to settle borrowings, classified as financing activities. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Repayments of borrowings, classified as financing activities",
        "negatedLabel": "Payments of loans and financing"
       }
      }
     },
     "localname": "RepaymentsOfBorrowingsClassifiedAsFinancingActivities",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfSharebasedPayments": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 3.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Share-based compensation reserve"
       }
      }
     },
     "localname": "ReserveOfSharebasedPayments",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ReserveOfSharebasedPaymentsMember": {
     "auth_ref": [
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity resulting from share-based payments."
       }
      },
      "en-us": {
       "role": {
        "label": "Reserve of share-based payments [member]"
       }
      }
     },
     "localname": "ReserveOfSharebasedPaymentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r24"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cash and cash equivalents whose use or withdrawal is restricted. [Refer: Cash and cash equivalents]"
       }
      },
      "en-us": {
       "role": {
        "label": "Less: restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails",
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarnings": {
     "auth_ref": [
      "r32",
      "r53"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 5.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "A component of equity representing the entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings"
       }
      }
     },
     "localname": "RetainedEarnings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RetainedEarningsMember": {
     "auth_ref": [
      "r8",
      "r10"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a component of equity representing an entity's cumulative undistributed earnings or deficit."
       }
      },
      "en-us": {
       "role": {
        "label": "Retained earnings [member]"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_Revenue": {
     "auth_ref": [
      "r1",
      "r2",
      "r46",
      "r194",
      "r201",
      "r263",
      "r294",
      "r300",
      "r306",
      "r307",
      "r308"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 1.0,
       "parentTag": "ifrs-full_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The income arising in the course of an entity's ordinary activities. Income is increases in assets, or decreases in liabilities, that result in increases in equity, other than those relating to contributions from holders of equity claims."
       }
      },
      "en-us": {
       "role": {
        "label": "Net revenue"
       }
      }
     },
     "localname": "Revenue",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfInvestmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromContractsWithCustomers": {
     "auth_ref": [
      "r219",
      "r220"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue from contracts with customers. A customer is a party that has contracted with an entity to obtain goods or services that are an output of the entity\u2019s ordinary activities in exchange for consideration."
       }
      },
      "en-us": {
       "role": {
        "label": "Net revenue from contracts with customers"
       }
      }
     },
     "localname": "RevenueFromContractsWithCustomers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfNetSalesRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueFromInterest": {
     "auth_ref": [
      "r11",
      "r204",
      "r295",
      "r304"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of income arising from interest."
       }
      },
      "en-us": {
       "role": {
        "label": "Interest received"
       }
      }
     },
     "localname": "RevenueFromInterest",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinanceResultDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueOfAcquiree": {
     "auth_ref": [
      "r255"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of revenue of the acquiree since the acquisition date included in the consolidated statement of comprehensive income. [Refer: Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue of acquiree since acquisition date"
       }
      }
     },
     "localname": "RevenueOfAcquiree",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RevenueOfCombinedEntity": {
     "auth_ref": [
      "r256"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The revenue of the combined entity as though the acquisition date for all business combinations that occurred during the year had been as of the beginning of the annual reporting period. [Refer: Business combinations [member]; Revenue]"
       }
      },
      "en-us": {
       "role": {
        "label": "Revenue of combined entity as if combination occurred at beginning of period"
       }
      }
     },
     "localname": "RevenueOfCombinedEntity",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightofuseAssets": {
     "auth_ref": [
      "r233"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 6.0,
       "parentTag": "ifrs-full_NoncurrentAssets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of assets that represent a lessee's right to use an underlying asset for the lease term. Underlying asset is an asset that is the subject of a lease, for which the right to use that asset has been provided by a lessor to a lessee."
       }
      },
      "en-us": {
       "role": {
        "label": "Right-of-use assets",
        "periodEndLabel": "Right-of-use assets, balance at ending",
        "periodStartLabel": "Right-of-use assets, balance at ending"
       }
      }
     },
     "localname": "RightofuseAssets",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfRight-of-useAssetsAndLeaseLiabilitiesDetails",
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The description of the rights, preferences and restrictions attaching to a class of share capital including restrictions on the distribution of dividends and the repayment of capital. [Refer: Share capital [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Description of exchanging and rights of shares"
       }
      }
     },
     "localname": "RightsPreferencesAndRestrictionsAttachingToClassOfShareCapital",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RiskExposuresAxis": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Risk variables [axis]"
       }
      }
     },
     "localname": "RiskExposuresAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_RiskExposuresMember": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the risk variables. It also represents the standard value for the 'Risk variables' axis if no other member is used."
       }
      }
     },
     "localname": "RiskExposuresMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SalesAndMarketingExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense relating to the marketing and selling of goods or services."
       }
      },
      "en-us": {
       "role": {
        "label": "Sales and marketing"
       }
      }
     },
     "localname": "SalesAndMarketingExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SegmentConsolidationItemsAxis": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segment consolidation items [axis]"
       }
      }
     },
     "localname": "SegmentConsolidationItemsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsAxis": {
     "auth_ref": [
      "r75",
      "r116",
      "r221",
      "r299",
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Segments [axis]"
       }
      }
     },
     "localname": "SegmentsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_SegmentsMember": {
     "auth_ref": [
      "r75",
      "r116",
      "r221",
      "r305",
      "r322"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all segments of an entity. It also represents the standard value for the 'Segments' axis if no other member is used."
       }
      }
     },
     "localname": "SegmentsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAssetsAndLiabilitiesInformationForCompanysOperatingSegmentsDetails",
      "http://afya.com.br/role/ScheduleOfOperatingIncomeForEachOperatingSegmentDetails",
      "http://afya.com.br/role/ScheduleOfRevenueBySegmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_ServicesExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from services."
       }
      },
      "en-us": {
       "role": {
        "label": "Pedagogical services"
       }
      }
     },
     "localname": "ServicesExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareIssueRelatedCost": {
     "auth_ref": [
      "r7"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of cost related to the issuance of shares."
       }
      },
      "en-us": {
       "role": {
        "label": "Shares issuance cost",
        "verboseLabel": "Share issuance costs"
       }
      }
     },
     "localname": "ShareIssueRelatedCost",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod": {
     "auth_ref": [
      "r48",
      "r297",
      "r304",
      "r329"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome": {
       "order": 3.0,
       "parentTag": "ifrs-full_ProfitLossBeforeTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The entity's share of the profit (loss) of associates and joint ventures accounted for using the equity method. [Refer: Associates [member]; Investments accounted for using equity method; Joint ventures [member]; Profit (loss)]"
       }
      },
      "en-us": {
       "role": {
        "label": "Share of income of associate"
       }
      }
     },
     "localname": "ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfIncomeAndComprehensiveIncome"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SharebasedPaymentArrangementsMember": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for an agreement between the entity or another group entity or any shareholder of the group entity and another party (including an employee) that entitles the other party to receive (a) cash or other assets of the entity for amounts that are based on the price (or value) of equity instruments (including shares or share options) of the entity or another group entity; or (b) equity instruments (including shares or share options) of the entity or another group entity, provided that the specified vesting conditions, if any, are met. It also represents the standard value for the 'Types of share-based payment arrangements' axis if no other member is used."
       }
      }
     },
     "localname": "SharebasedPaymentArrangementsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates": {
     "auth_ref": [
      "r37"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of shares in the entity held by the entity or by its subsidiaries or associates. [Refer: Associates [member]; Subsidiaries [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Number of shares in entity held by entity or by its subsidiaries or associates shares"
       }
      }
     },
     "localname": "SharesInEntityHeldByEntityOrByItsSubsidiariesOrAssociates",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative"
     ],
     "xbrltype": "sharesItemType"
    },
    "ifrs-full_ShorttermBorrowings": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 2.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current borrowings. [Refer: Borrowings]"
       }
      },
      "en-us": {
       "role": {
        "label": "Loans and financing"
       }
      }
     },
     "localname": "ShorttermBorrowings",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_SignificantInvestmentsInSubsidiariesAxis": {
     "auth_ref": [
      "r101",
      "r105",
      "r207"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Subsidiaries [axis]"
       }
      }
     },
     "localname": "SignificantInvestmentsInSubsidiariesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/BusinessCombinationsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfAssumptionsForImpairmentTestDetails",
      "http://afya.com.br/role/ScheduleOfLoansAndFinancingDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative",
      "http://afya.com.br/role/TableBelowIsListOfCompanysSubsidiariesAndAssociateDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of cash flows [abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityAbstract": {
     "auth_ref": [],
     "localname": "StatementOfChangesInEquityAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfChangesInEquityTable": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "Schedule disclosing information related to changes in equity."
       }
      },
      "en-us": {
       "role": {
        "label": "Statement of changes in equity [table]"
       }
      }
     },
     "localname": "StatementOfChangesInEquityTable",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/EquityDetailsNarrative",
      "http://afya.com.br/role/StatementsOfChangesInEquity",
      "http://afya.com.br/role/SubsequentEventsDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of financial position [abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount that represents the difference between the tax expense (income) and the product of the accounting profit multiplied by the applicable tax rate(s) that relates to expenses not deductible in determining taxable profit (tax loss). [Refer: Accounting profit]"
       }
      },
      "en-us": {
       "role": {
        "label": "Presumed profit income tax regime effect"
       }
      }
     },
     "localname": "TaxEffectOfExpenseNotDeductibleInDeterminingTaxableProfitTaxLoss",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseIncomeAtApplicableTaxRate": {
     "auth_ref": [
      "r57"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The product of the accounting profit multiplied by the applicable tax rate(s). [Refer: Accounting profit; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Income taxes at statutory rates"
       }
      }
     },
     "localname": "TaxExpenseIncomeAtApplicableTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxExpenseOtherThanIncomeTaxExpense": {
     "auth_ref": [
      "r50"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of tax expense exclusive of income tax expense."
       }
      },
      "en-us": {
       "role": {
        "label": "Tax expense other than income tax expense",
        "verboseLabel": "Other"
       }
      }
     },
     "localname": "TaxExpenseOtherThanIncomeTaxExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TaxRateEffectFromChangeInTaxRate": {
     "auth_ref": [
      "r58"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The tax rate effect on the reconciliation between the average effective tax rate and the applicable tax rate resulting from a change in tax rate. [Refer: Average effective tax rate; Applicable tax rate]"
       }
      },
      "en-us": {
       "role": {
        "label": "Effective rate"
       }
      }
     },
     "localname": "TaxRateEffectFromChangeInTaxRate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfReconciliationOfIncomeTaxExpenseDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ifrs-full_TechnologybasedIntangibleAssetsMember": {
     "auth_ref": [
      "r142"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of intangible assets representing assets based on technology. Such assets may include patented and unpatented technology, databases as well as trade secrets. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Technology-based intangible assets [member]"
       }
      }
     },
     "localname": "TechnologybasedIntangibleAssetsMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAcquisitionOfFesarDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfMedphoneDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfPebmedDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUniredentorDetails",
      "http://afya.com.br/role/ScheduleOfAcquisitionOfUnislDetails",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfIntangibleAssetsDetails",
      "http://afya.com.br/role/ValuationTechniquesUsedForMeasuringFairValueOfSeparatelyIdentifiedIntangibleAssetsAcquiredWereAsFollowsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TopOfRangeMember": {
     "auth_ref": [
      "r216",
      "r217",
      "r218",
      "r243",
      "r281",
      "r315"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for top of a range."
       }
      },
      "en-us": {
       "role": {
        "label": "Top of range [member]"
       }
      }
     },
     "localname": "TopOfRangeMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails",
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayables": {
     "auth_ref": [
      "r19"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 1.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current trade payables and current other payables. [Refer: Current trade payables; Other current payables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherCurrentPayablesToRelatedParties": {
     "auth_ref": [
      "r33"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_CurrentLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of current payables due to related parties. [Refer: Related parties [member]; Payables to related parties]"
       }
      },
      "en-us": {
       "role": {
        "label": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "TradeAndOtherCurrentPayablesToRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesRecognisedAsOfAcquisitionDate": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount recognised as of the acquisition date for trade and other payables assumed in a business combination. [Refer: Trade and other payables; Business combinations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade and other payables recognised as of acquisition date",
        "verboseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesRecognisedAsOfAcquisitionDate",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAssumedAsOfEachAcquisitionDateWereDetails",
      "http://afya.com.br/role/ScheduleOfPreliminaryFairValuesOfIdentifiableAssetsAcquiredAndLiabilitiesAcquiredDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesToRelatedParties": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payables due to related parties. [Refer: Related parties [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Opening balance",
        "verboseLabel": "Accounts payable to selling shareholders"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToRelatedParties",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails",
      "http://afya.com.br/role/ScheduleOfCapitalManagementDetails",
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeAndOtherPayablesToTradeSuppliers": {
     "auth_ref": [
      "r33"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of payment due to suppliers for goods and services used in the entity's business."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade payables [Default Label]",
        "verboseLabel": "Trade payables"
       }
      }
     },
     "localname": "TradeAndOtherPayablesToTradeSuppliers",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialLiabilitiesDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeReceivables": {
     "auth_ref": [
      "r30"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount due from customers for goods and services sold."
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables, net",
        "verboseLabel": "Trade receivables"
       }
      }
     },
     "localname": "TradeReceivables",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfFinancialAssetsDetails",
      "http://afya.com.br/role/ScheduleOfTradeAccountsReceivableNetAndNotesReceivableDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TradeReceivablesMember": {
     "auth_ref": [
      "r11",
      "r271",
      "r274",
      "r276"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for trade receivables. [Refer: Trade receivables]"
       }
      },
      "en-us": {
       "role": {
        "label": "Trade receivables [member]"
       }
      }
     },
     "localname": "TradeReceivablesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/TableBelowIsComparisonOfCarryingAmountsAndFairValuesOfCompanysFinancialInstrumentsOtherThanThoseCarryingAmountsThatAreReasonableApproximationOfFairValuesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TransactionPriceAllocatedToRemainingPerformanceObligations": {
     "auth_ref": [
      "r222"
     ],
     "crdr": "credit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of the transaction price allocated to the performance obligations that are unsatisfied (or partially unsatisfied) as of the end of the reporting period. The transaction price is the amount of consideration to which an entity expects to be entitled in exchange for transferring promised goods or services to a customer, excluding amounts collected on behalf of third parties (for example, some sales taxes). [Refer: Performance obligations [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Transaction price allocated to remaining performance obligations"
       }
      }
     },
     "localname": "TransactionPriceAllocatedToRemainingPerformanceObligations",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfAccountsPayableToSellingShareholdersDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TravelExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from travel."
       }
      },
      "en-us": {
       "role": {
        "label": "Travel expenses"
       }
      }
     },
     "localname": "TravelExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasuryShares": {
     "auth_ref": [
      "r32",
      "r106"
     ],
     "calculation": {
      "http://afya.com.br/role/StatementsOfFinancialPosition": {
       "order": 4.0,
       "parentTag": "ifrs-full_EquityAttributableToOwnersOfParent",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "An entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [Default Label]",
        "negatedLabel": "Treasury stock"
       }
      }
     },
     "localname": "TreasuryShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfFinancialPosition"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_TreasurySharesMember": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for the entity\u2019s own equity instruments, held by the entity or other members of the consolidated group."
       }
      },
      "en-us": {
       "role": {
        "label": "Treasury shares [member]"
       }
      }
     },
     "localname": "TreasurySharesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/StatementsOfChangesInEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfInterestRatesAxis": {
     "auth_ref": [
      "r277"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of interest rates [axis]"
       }
      }
     },
     "localname": "TypesOfInterestRatesAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksAxis": {
     "auth_ref": [
      "r264",
      "r269",
      "r270",
      "r316",
      "r317",
      "r318",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of risks [axis]"
       }
      }
     },
     "localname": "TypesOfRisksAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_TypesOfRisksMember": {
     "auth_ref": [
      "r264",
      "r269",
      "r270",
      "r316",
      "r317",
      "r318",
      "r320"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for all types of risks. It also represents the standard value for the 'Types of risks' axis if no other member is used."
       }
      }
     },
     "localname": "TypesOfRisksMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative",
      "http://afya.com.br/role/ScheduleOfCurrenciesUsedInSensitivityAnalysisDetails",
      "http://afya.com.br/role/ScheduleOfSensitivityAnalysisEffectsOnIncomeStatementDetails",
      "http://afya.com.br/role/ScheduleOfSocialSecurityProceedingsAssessedByManagementDetails",
      "http://afya.com.br/role/TablesBelowSummarizeMaturityProfileOfCompanysFinancialLiabilitiesBasedOnContractualUndiscountedAmountsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_TypesOfSharebasedPaymentArrangementsAxis": {
     "auth_ref": [
      "r244"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the members in the table and the line items or concepts that complete the table."
       }
      },
      "en-us": {
       "role": {
        "label": "Types of share-based payment arrangements [axis]"
       }
      }
     },
     "localname": "TypesOfSharebasedPaymentArrangementsAxis",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfModelUsedToDetermineFairValueOfStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ifrs-full_UnusedProvisionReversedOtherProvisions": {
     "auth_ref": [
      "r127"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount reversed for unused other provisions. [Refer: Other provisions]"
       }
      },
      "en-us": {
       "role": {
        "label": "Reversals"
       }
      }
     },
     "localname": "UnusedProvisionReversedOtherProvisions",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfLegalProceedingsAndContingenciesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill": {
     "auth_ref": [
      "r133"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for intangible assets other than goodwill. [Refer: Intangible assets other than goodwill]"
       }
      },
      "en-us": {
       "role": {
        "label": "Estimated useful lives of intangible assets"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimeIntangibleAssetsOtherThanGoodwill",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEstimatedUsefulLivesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment": {
     "auth_ref": [
      "r64"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The useful life, measured as period of time, used for property, plant and equipment. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Useful lives of assets"
       }
      }
     },
     "localname": "UsefulLifeMeasuredAsPeriodOfTimePropertyPlantAndEquipment",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "ifrs-full_UtilitiesExpense": {
     "auth_ref": [
      "r11"
     ],
     "crdr": "debit",
     "lang": {
      "en": {
       "role": {
        "documentation": "The amount of expense arising from purchased utilities."
       }
      },
      "en-us": {
       "role": {
        "label": "Utilities"
       }
      }
     },
     "localname": "UtilitiesExpense",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfExpensesByNatureDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ifrs-full_VehiclesMember": {
     "auth_ref": [
      "r63"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "This member stands for a class of property, plant and equipment representing vehicles used in the entity's operations, specifically to include aircraft, motor vehicles and ships. [Refer: Property, plant and equipment]"
       }
      },
      "en-us": {
       "role": {
        "label": "Vehicles [member]"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/DepreciationIsCalculatedOnStraight-lineBasisOverEstimatedUsefulLivesOfAssetsAsFollowsDetails",
      "http://afya.com.br/role/ScheduleOfDetailedInformationAboutPropertyPlantAndEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r240"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options exercised in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Exercised"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExercisedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r241"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options expired in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Expired"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsExpiredInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options forfeited in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Forfeited"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r238"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options granted in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Granted"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsGrantedInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019": {
     "auth_ref": [
      "r237",
      "r242"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The weighted average exercise price of share options outstanding in a share-based payment arrangement. [Refer: Weighted average [member]]"
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average exercise price of share options outstanding in share-based payment arrangement",
        "periodEndLabel": "Outstanding at the ending",
        "periodStartLabel": "Outstanding at the beginning"
       }
      }
     },
     "localname": "WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfShare-basedCompensationPlanDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ifrs-full_WeightedAverageShares": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en": {
       "role": {
        "documentation": "The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor."
       }
      },
      "en-us": {
       "role": {
        "label": "Weighted average number of outstanding shares"
       }
      }
     },
     "localname": "WeightedAverageShares",
     "nsuri": "http://xbrl.ifrs.org/taxonomy/2021-03-24/ifrs-full",
     "presentation": [
      "http://afya.com.br/role/ScheduleOfEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "srt_CurrencyAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Currency [Axis]"
       }
      }
     },
     "localname": "CurrencyAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://afya.com.br/role/CashAndCashEquivalentsDetailsNarrative",
      "http://afya.com.br/role/CorporateInformationDetailsNarrative",
      "http://afya.com.br/role/FinancialAssetsAndFinancialLiabilitiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Proved Developed and Undeveloped Oil and Gas Reserve Quantities [Table]"
       }
      }
     },
     "localname": "ProvedDevelopedAndUndevelopedOilAndGasReserveQuantitiesTable",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ReserveQuantitiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reserve Quantities [Line Items]"
       }
      }
     },
     "localname": "ReserveQuantitiesLineItems",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://afya.com.br/role/RelatedPartiesDetailsNarrative"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "10",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_10_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r1": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "102",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_102&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r10": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "108",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_108&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r100": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r101": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r102": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r103": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r104": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r105": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "17",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_17_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r106": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r107": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "32",
   "Paragraph": "IE33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=32&code=ifrs-tx-2021-en-r&anchor=para_IE33&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r108": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r109": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_67&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r11": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "112",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_112_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r110": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r111": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Paragraph": "70",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&anchor=para_70_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r112": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS33_g70-73A_TI",
   "URIDate": "2021-03-24"
  },
  "r113": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "33",
   "Section": "Example 12 Calculation and presentation of basic and diluted earnings per share (comprehensive example)",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=33&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS33_ex12_TI",
   "URIDate": "2021-03-24"
  },
  "r114": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "126",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_126&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r115": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r116": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "130",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_130_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r117": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r118": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r119": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r12": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r120": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_d_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r121": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "134",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_134_e_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r122": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r123": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r124": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "36",
   "Paragraph": "135",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=36&code=ifrs-tx-2021-en-r&anchor=para_135_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r125": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r126": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r127": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r128": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "84",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_84&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r129": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "86",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_86&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r13": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "117",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_117&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r130": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "87",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_87&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r131": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Paragraph": "88",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&anchor=para_88&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r132": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "37",
   "Section": "Example 10 A court case",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=37&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS37_IE_C_ex10__IAS37_IE_C_ex10_TI",
   "URIDate": "2021-03-24"
  },
  "r133": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r134": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r135": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r136": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r137": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r138": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r139": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "118",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_118&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r14": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r140": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r141": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r142": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "119",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_119&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r143": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Paragraph": "122",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&anchor=para_122_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r144": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "38",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=38&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS38_g118-128_TI",
   "URIDate": "2021-03-24"
  },
  "r145": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "32A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_32A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r146": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "76",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_76&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r147": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r148": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "40",
   "Paragraph": "79",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=40&code=ifrs-tx-2021-en-r&anchor=para_79_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r149": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "50",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_50&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r15": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r150": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "41",
   "Paragraph": "54",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=41&code=ifrs-tx-2021-en-r&anchor=para_54_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r151": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r152": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r153": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "14",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_14_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r154": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "16",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_16_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r155": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r156": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r157": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r158": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r159": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r16": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r160": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r161": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r162": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r163": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r164": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r165": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "31",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_31&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r166": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r167": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "40",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_40_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r168": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r169": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r17": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r170": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r171": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r172": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44B",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44B&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r173": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r174": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "44D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_44D&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r175": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r176": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "46",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_46&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r177": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Paragraph": "50",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&anchor=para_50_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r178": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "A Statement of cash flows for an entity other than a financial institution",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_A__IAS07_IE_A_TI",
   "URIDate": "2021-03-24"
  },
  "r179": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "7",
   "Section": "C Reconciliation of liabilities arising from financing activities",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=7&code=ifrs-tx-2021-en-r&doctype=Illustrative%20Examples&dita_xref=IAS07_IE_C__IAS07_IE_C_TI",
   "URIDate": "2021-03-24"
  },
  "r18": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r180": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r181": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "24",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_24_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r182": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r183": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "1",
   "Paragraph": "32",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=1&code=ifrs-tx-2021-en-r&anchor=para_32_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r184": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "10",
   "Paragraph": "22",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=10&code=ifrs-tx-2021-en-r&anchor=para_22&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r185": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r186": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r187": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r188": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r189": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "12",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_12_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r19": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "k",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_k&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r190": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r191": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r192": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "19B",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_19B_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r193": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r194": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B10",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B10_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r195": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r196": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r197": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r198": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r199": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_iv&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r2": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "103",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_103&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r20": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "l",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_l&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r200": {
   "Clause": "ix",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_ix&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r201": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_v&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r202": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B12",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B12_b_viii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r203": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r204": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_e&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r205": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r206": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B13",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B13_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r207": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r208": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_b&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r209": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "12",
   "Paragraph": "B4",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=12&code=ifrs-tx-2021-en-r&anchor=para_B4_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r21": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "n",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_n&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r210": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r211": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r212": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r213": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93_h_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r214": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "93",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_93&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r215": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r216": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "B6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_B6&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r217": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "13",
   "Paragraph": "IE63",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=13&code=ifrs-tx-2021-en-r&anchor=para_IE63&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r218": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "14",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=14&code=ifrs-tx-2021-en-r&anchor=para_33_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r219": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "113",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_113_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r22": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_q&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r220": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "114",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_114&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r221": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "115",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_115&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r222": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r223": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "120",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_120_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r224": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Paragraph": "B89",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&anchor=para_B89_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r225": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g110-129_TI",
   "URIDate": "2021-03-24"
  },
  "r226": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "15",
   "Section": "Presentation",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=15&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS15_g105-109_TI",
   "URIDate": "2021-03-24"
  },
  "r227": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "47",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r228": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r229": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r23": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "54",
   "Subparagraph": "r",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_54_r&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r230": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r231": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r232": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r233": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53_j&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r234": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "53",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_53&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r235": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "94",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_94&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r236": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "16",
   "Paragraph": "97",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=16&code=ifrs-tx-2021-en-r&anchor=para_97&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r237": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r238": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r239": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r24": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "55",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_55&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r240": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r241": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r242": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_b_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r243": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r244": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "45",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r245": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "2",
   "Paragraph": "47",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r246": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r247": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r248": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r249": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r25": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r250": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_g_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r251": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "i",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r252": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "j",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_j&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r253": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "m",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_m&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r254": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "o",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_o_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r255": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_q_i&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r256": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "Subparagraph": "q",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64_q_ii&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r257": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B64",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B64&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r258": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r259": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67_d&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r26": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "61",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_61&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r260": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "B67",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_B67&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r261": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Paragraph": "IE72",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&anchor=para_IE72&doctype=Illustrative%20Examples",
   "URIDate": "2021-03-24"
  },
  "r262": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "3",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=3&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS03_g59-63__IFRS03_g59-63_TI",
   "URIDate": "2021-03-24"
  },
  "r263": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "5",
   "Paragraph": "33",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=5&code=ifrs-tx-2021-en-r&anchor=para_33_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r264": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "21C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_21C&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r265": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "22A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_22A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r266": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "23B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_23B_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r267": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "25",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_25&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r268": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r269": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "33",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_33&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r27": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "66",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_66&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r270": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r271": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r272": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35H",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35H&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r273": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r274": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r275": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35M",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35M&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r276": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "35N",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_35N&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r277": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "39",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_39&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r278": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42E",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42E_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r279": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "42I",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_42I&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r28": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "68",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_68&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r280": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_6&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r281": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "7",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_7&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r282": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B11",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B11&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r283": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B2",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B2_a&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r284": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_c&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r285": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_e&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r286": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_f&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r287": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35_g&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r288": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "B35",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_B35&doctype=Appendix&subtype=B",
   "URIDate": "2021-03-24"
  },
  "r289": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20C",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG20C&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r29": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "69",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_69&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r290": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG20D",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG20D&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r291": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Paragraph": "IG31A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&anchor=para_IG31A&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r292": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Defined terms",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Appendix&subtype=A&dita_xref=IFRS07_APPA_TI",
   "URIDate": "2021-03-24"
  },
  "r293": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "7",
   "Section": "Scope",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS07_g3-5A_TI",
   "URIDate": "2021-03-24"
  },
  "r294": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r295": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r296": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r297": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r298": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "Subparagraph": "h",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23_h&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r299": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "23",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_23&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r3": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r30": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r300": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r301": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r302": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r303": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r304": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r305": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r306": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_32&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r307": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "33",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_33_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r308": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r309": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Paragraph": "IG4",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&anchor=para_IG4&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r31": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r310": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "8",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI",
   "URIDate": "2021-03-24"
  },
  "r311": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Number": "9",
   "Paragraph": "7.2.34",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.34&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r312": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r313": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "109A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_109A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r314": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "113",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_113_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r315": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "120",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_120&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r316": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "124",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_124&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r317": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "125",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_125&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r318": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "127",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_127&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r319": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r32": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r320": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "128",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_128_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r321": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "132",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_132_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r322": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "96",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_96_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r323": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Paragraph": "C32",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&anchor=para_C32&doctype=Appendix&subtype=C",
   "URIDate": "2021-03-24"
  },
  "r324": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "17",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IFRS17_g93-132_TI",
   "URIDate": "2021-03-24"
  },
  "r325": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective 2023-01-01",
   "Number": "9",
   "Paragraph": "7.2.42",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=9&code=ifrs-tx-2021-en-r&anchor=para_7.2.42&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r326": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r327": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39L",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39L_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r328": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r329": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Effective on first application of IFRS 9",
   "Number": "4",
   "Paragraph": "39M",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39M_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r33": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "78",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_78&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r330": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Paragraph": "39J",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&anchor=para_39J_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r331": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "4",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=4&code=ifrs-tx-2021-en-b&doctype=Standard&book=b&dita_xref=IFRS04_g36-39M_TI",
   "URIDate": "2021-03-24"
  },
  "r332": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "16",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_16&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r333": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "36",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_36_c&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r334": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_a&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r335": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37_b&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r336": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_37&doctype=Standard&book=b",
   "URIDate": "2021-03-24"
  },
  "r337": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG24",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG24_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r338": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG25",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG25_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r339": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_b&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r34": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r340": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG28",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG28_d&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r341": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29_a&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r342": {
   "IssueDate": "2021-01-01",
   "Name": "IFRS",
   "Note": "Expiry date 2023-01-01",
   "Number": "7",
   "Paragraph": "IG29",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2017-en-b&anchor=para_IG29&doctype=Implementation%20Guidance&book=b",
   "URIDate": "2021-03-24"
  },
  "r343": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12"
  },
  "r344": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r345": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r346": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r347": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r348": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "g"
  },
  "r349": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12, 13, 15d"
  },
  "r35": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r350": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r351": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r352": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "15",
   "Subsection": "d"
  },
  "r353": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r354": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r355": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r356": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r357": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r358": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r359": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r36": {
   "Clause": "v",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_v&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r360": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r361": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r362": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r37": {
   "Clause": "vi",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a_vi&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r38": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r39": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r4": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r40": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r41": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r42": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r43": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81A",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81A_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r44": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r45": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "81B",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_81B_a_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r46": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r47": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r48": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r49": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "82",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_82_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r5": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r50": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "85",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_85&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r51": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "91",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_91_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r52": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "99",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_99&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r53": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "IG6",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_IG6&doctype=Implementation%20Guidance",
   "URIDate": "2021-03-24"
  },
  "r54": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "10",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=10&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS10_g17-22_TI",
   "URIDate": "2021-03-24"
  },
  "r55": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "79",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_79&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r56": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "80",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_80_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r57": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r58": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_c_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r59": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Paragraph": "81",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&anchor=para_81_g_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r6": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r60": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "12",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=12&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS12_g79-88_TI",
   "URIDate": "2021-03-24"
  },
  "r61": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r62": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "Subparagraph": "g",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37_g&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r63": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "37",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_37&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r64": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r65": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r66": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r67": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r68": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r69": {
   "Clause": "vii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e_vii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r7": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r70": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "Subparagraph": "e",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73_e&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r71": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "73",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_73&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r72": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r73": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Paragraph": "75",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&anchor=para_75_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r74": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "16",
   "Section": "Disclosure",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=16&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS16_g73-79_TI",
   "URIDate": "2021-03-24"
  },
  "r75": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r76": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "138",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_138&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r77": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "141",
   "Subparagraph": "f",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_141_f&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r78": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "142",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_142&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r79": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "147",
   "Subparagraph": "c",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_147_c&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r8": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "106",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_106&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r80": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "19",
   "Paragraph": "57",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=19&code=ifrs-tx-2021-en-r&anchor=para_57_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r81": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r82": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "2",
   "Paragraph": "36",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=2&code=ifrs-tx-2021-en-r&anchor=para_36_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r83": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "20",
   "Paragraph": "28",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=20&code=ifrs-tx-2021-en-r&anchor=para_28&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r84": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "21",
   "Paragraph": "52",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=21&code=ifrs-tx-2021-en-r&anchor=para_52_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r85": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "Subparagraph": "a",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17_a&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r86": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "17",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_17&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r87": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18_b&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r88": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "18A",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_18A&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r89": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r9": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "1",
   "Paragraph": "107",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2021-en-r&anchor=para_107&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r90": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "19",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_19&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r91": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "20",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_20&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r92": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Paragraph": "21",
   "Subparagraph": "d",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&anchor=para_21_d&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r93": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "24",
   "Section": "Disclosures",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=24&code=ifrs-tx-2021-en-r&doctype=Standard&dita_xref=IAS24_g13-24_TI",
   "URIDate": "2021-03-24"
  },
  "r94": {
   "Clause": "iii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_iii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r95": {
   "Clause": "iv",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_iv&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r96": {
   "Clause": "viii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "26",
   "Paragraph": "35",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=26&code=ifrs-tx-2021-en-r&anchor=para_35_b_viii&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r97": {
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "10",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_10&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r98": {
   "Clause": "i",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_i&doctype=Standard",
   "URIDate": "2021-03-24"
  },
  "r99": {
   "Clause": "ii",
   "IssueDate": "2021-01-01",
   "Name": "IAS",
   "Number": "27",
   "Paragraph": "16",
   "Subparagraph": "b",
   "URI": "http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=27&code=ifrs-tx-2021-en-r&anchor=para_16_b_ii&doctype=Standard",
   "URIDate": "2021-03-24"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>160
<FILENAME>0001292814-22-001951-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001292814-22-001951-xbrl.zip
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ME"3X*3F/:/#I1<?$)2+L%Q2E^%I:@A+.+GLWM'<R-J%KD&4[F%\RR]?=*A6
M76 .4.^DI>%J$%4+C%]R@N@*5IY;S]<1V:*6Q;5#$^_D9L79(+^.L'[)$1Q
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MX^);.%)#X5I\A\_HP <&J---N<!O)K8KL ^$56/0<#9FJ_0"\6)$-1_\:1F
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MQSEOXBU"^@=8:0A&?/!5<<X"K%EFOR?S*5FY&*L&F]20$U_)*"6F^S?"B6T
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M^D*I^XUX7K7$*KMJ(7&O?.T_L__-+4%/Q",J4[[>*'H(1X1%QLH=1L&.817
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M!\PEA'SR+RCII60B2P8P&:TFG( &ERVKM. 4BZX!BOO@Y459JZ:T=#R3T=?
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M #5O';(/L//SBCZ_=I)/QO)/_RN2?R3Y]#<+KL(FY/&I!-J@:?/2UATK 9!
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MC=SFJ#O.XIU=>D]#!D$@6WDMDANP6#P,%=5ZB5R!\>^JUEU5S\4[NQ0:999
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M^*OFX"L.807BM7@!8=;L5KE%3Y3Q:2@B,,B;/GED%:=[JQM#=88P&:AFO(!
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MTBSA^9H&6WE9MD.+[KTA>L1;8 '<E'5/X*_W-]<WLSLJ/_=RK19G=L[B4C9
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MIY!G^QF2/2Z%K#I1O"@)&VJLY<BOD5-\W,&<S/ 2', LX3*F[<H'/PDVV[+
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M(AGHLL@:'&IF?OPW,^2,0A<Q')D.?%L\)NNT].7P46H:@B-"U\Y01,)VX@Q
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M['? E6-]I;BBI);&]L[8OC>*KQ[:[":79&N\JW HP$Q4$596HI29Q6[ZTR^
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MS9Y5*Q>R43.W89$V618MU,*SPT]YB@IVW95Z["2(>+Q(6@IN<%OTZ'GP\M6
M$N]];J1\3/-POJ<M#S_(HU^SU A[G;9I 8^F9U+).(A@@B>;;M7RH%-8FAV7
M>,/RT;0K5VIF* 2]L4(+M&.$5"H.-NB@39G0R(+';H%P618\$?JV!\0"^.%S
MAK3#2AL%?XN%-L#[%4.==!PLL8$HK!TR'= K@7[DL"QM5NE_[,NJ'L?DZ56&
MMSCGK9:&.68=;^2QA=_QQZ00!X4L44Y9-%"K Y 'BIY2I&K"^L*F-E6%\T6;
MDE0?QN<IBZAKTCC_(TV7Q&\QE?*<Y&T+%[8Q&6>H')KZU)<19JRT233I*2FD
M34(][P5J3(D74V':)K5;N" _?;RYOKG7YJ(31/RM\LC!]:L\X^=Q%*P<E+#*
M SZ"&W!-__^]CXQN%-3[A]5';2$/!7P6L0AL6,#]TVB*5X D+]SWX &LZ%]+
M)RS3Y_JX#Y+.0P*J#R&,+2F'"$@(SO*54</JNLB0UT&:KWN,]#I'V^L:?=[$
M:+AJ,<Q=BKK+$J.[#=%\W:&OJPROSC]<76J:X=%S?^VP!%;?$ \>QE&<$D1B
M4WP%SL$'^K^7\=S8IRYW=QL1WM.GX(^K@3@X-A.U^F*^5,P2ETHNYOOZ*W[;
MW_(!D(9+LE1,M5*+Y5HS*1\M=.*@H#U0R3TBPNUE:'1[V==?M3++,\UPNV.8
MBQMU=S)&=]VB^2;%:W!!>[M[VN?YNMI+VT2$OK)+7?4COHK+5*5#7*]E*.58
MKK;2E?<)7"ME+GE_%SEUB9N'5[_#:[S;DN11DPS93L]_]FX+-\2,W1JE./CC
M@%2=F7ND"VIEGI<[",7>%S"G_R7N)!,U ]-,Y8J!:%.UF*FFP&I+ME;=!]UL
MTEQ[)XXQ675,%'!).1U_RI8NN>M-7E$?\'.&5O2'JKRK7E#Q] +S]X2DGW&6
MV:7IM303*%VODY.*M+U6-H)3]4#@FC2^N#,#(+<#"#,$*FH);!I3T1_[.J=M
M;OH1;HUY-D5!SPE]%4 G&7TG4A'Q3P%-R.G+Q$#.Y$[@,-?%OJS(%A4%RF"%
MTFG5,G#*4MMS(^GBTJ1MM%&-B)(N>(66L-$]:Y0E[6'\]'U"R0M?"WU[AJ4S
M?2VU_=+7R:4Q?:U4(Z*O"UXQ-TJK>\:53Y*^MSA!N>J$E5K,<S9!*<A) L&1
M3$04DP(3\YG60DOOF<@GW6W$B?L2B:@9>(E$Y8IAB62J%IP_[EAMETBZ\"(/
M2R3U[9+#]Y-'2&[W27UEI9IMEHK^CF2X.-(?T[#1BH-J+E"%<5Q]A^A(&3RR
MF\^9>KTQ[.?^19RP^[#O4?G['I>PWN% ]6E54G:;UO3O2[@J$+R$?.M:U^P=
MR;#O>QF/\R&F=S0>9C4.HA_3%<7=C<PVOZJQL0X:\Z"U#X8O )<0L%>P_]:1
M%,=LF#TL=S9)W&!6CYGM%C>E2H&6,C4.*!8N)1K!V>T$4[,HN6Z5NDG,DGE>
MSF'^VP4J*KRF-:1BH"_1CM!.1-TD&U6\-;:6X+MFU" ?G$(.((4U1ZH%AFK@
M;@T:Q>4[_PH5S^Y$LM/SV'7;NS'HF<U*<?#* :G8KS:JH1CVZ5$37#]XZ.^8
MQ!10?TCB,:J8^BD<\;#:X_*A]$][S'/.(FV.:5'(7[X8%< ^1\Q4(H[B5<$2
MUDIK.< $ER[M+DD5S%CJ*NV]7&I9;V5O@MM10"48!Q,,Z*:$&(B#1G[Q S4W
M5X^:</'!4W_1X@*D/EB\>Q1'^0IXQ%#Q&W!%6W./M;N@\VI=.C"U;)#:+8,K
MK=U#P3A*WX!.6[MK^<7CR\DSSM!JMWO</Y=)@7?ZC)):<7_1YF;0?="Y6C8.
MCI@!"B'H7 -0%3#469HJ/%I+TVR,GWLC@PQ65_K#AW$4MP21D%R:BYS 6N;-
M=@=QP9+,N2UG&O7\KFA:NC%>U#0H!2>;*U)A\:#36G!U<\D;J4>.?D285:I[
M6%:7>_21%+5[2)XG>[X9WW=7SW%R>J&UBXV(:#T+N'CU]837>6T&[*@=D.X1
MR$G![J#DIDX@,*GQ_[&"U=YP?YPHZ?GF.!74R9UQ4[&(.*C")N2_:-E4<LGH
M6\^+?5&H%H"44KZ#A240IT'! Y&(6"/#)0;Y<IFE ]MN856?P+C+T0>25R\L
MR?!'4G6_/U'UYHEZY#_'BL?[O.>Z.+CEV]5$<+8=AEN\$9PJ *8!J"E0:_"\
MTM0:&#SE!MOG\4]@9!]B\HD>\1<-_0\SY3D<>+:SDY!A9SO!:\,1P,NK!#]R
M5G'2;VO2\S-$M%)D_?,2?VF?>FS.K_#F17?7IUHV2-,L@RMM@(>"P8EE@\[0
MF-8:BV_%7]U?:/;B!T_];<8+D/K=^.Y1'"4LX!'WXZ_ /;A8_.S\S[=7985>
M4?D>T:D$N=FRI6#, M1UT;A6:O[.VML[T9_!-^O$P11[H.*9_9_!+6B40:T-
M!NH^#AY\^GCS\^KB[AY6!=ZR1'B9_KR!7MYG/FHC[&%Z:J5P'!RR0"A/7OTS
M9<@%N ,#33_'"*X>?U[=6[-&*^XO;M ,N@\75,O&01DS0/':&!9UP!AS[YTO
M3U3C;KTJ"@H(L2V&=Y*52JVDOQ S+=0^SDPJ%@<WM-B$B#,JS")$!^+@'?AE
MM6 L^RV")5IMZ!R*7U?U3C-E44CZF[!HH?;3%:E8'&S08A.F*DP8]-*,"D=<
MU"G;59T2)=]MR.OW*<)\/>?W/[ _S^H_.5/H/RGT#<RN\@I7;Y+V0BKA@QD:
M:(P1DL?!F:#&)#* 2H%:;-EFH#D%5I$GJL2N3D5YB>ZIQY@=O$6KO*(=%+F
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MB7P<.!HGQD]T95IZ-I8^Z,H!P4 DEPTH'+.\9F"B'1&Q'2$[72W )SBG<J=
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M ;<+)C!2787*1@'/L&17G+SQ,:P5VZS4_%UQ:N]$?YVI62<.8MD#G3+J]V\
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MC_FLOJ9&.QRGC2ZI":U4C93-)KS"$*K3961.405Q1H=$PT8;/I-]!9XEN1C
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M RO3#DURC4O&!E94/05ZJV'_57.;CI4W!<P/F3#)]$/S6^N6Q:1)5#X%CNN
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MD24E3/%(2D*V"&14&#QS:3ICY#\9S_(>=' T*5C0[TW>9'B33:XD0AX/C"H
M#@Z+3B2"=RI:6))RYW)LR:!)A+=X6==<JSE9_\TC4O5N*)4"<,'@@(0;"HW8
MN**'J>-.TU@LT'0L-^)M:H;%:%<BZ7>DJX0Z[I@$L> $,V,3\TC4Z3@'(UM
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MFD\YNT !I<J("%?44[Y]??8-Z&SP ZYI8X5. VLS\?:#T\2LRF98%/3;SZF
M2A+"#*2"-UQ&:!:M5X["9=NZ8'/'O++[^@KA>"*@[*$*D0NU?+P5F:7&UI>5
M\ UT*GXKMQG\F&AJ^8@JO!&D>/PZ/TMBYYEN./X"JU6!KG"=QZJL+O?HKKC9
M[B"+ YT_K;(Q&\^DR_XCV$_)S#8CXOU1''&<SE74,(#T(>*FP8[:!BE;(BT
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MP8_T4W!'S0TBVPH?1140%C7 %BEL8T16_%5@]ERR]"]W>?GUH2K_@K:\7?I
MBHGB0E>NNJ31XU)64V0!&D47-4 5=\*7N6SCG*1" !L%+"50LJ,RZ*JD$_).
MAL5_(N8]3H>CJ'50_++'V_VGM$A?$#OP^6-*KJC+R":/DTOD1QPXEW>+821-
M%PYU:%W<(GG6ZJ2S\*S?T!L+T6H_D-!__<H^D1RZ;R3[E"0;]A7_\;BH73WB
MEWU=[DX$F1*9C*FBI)5W*$"DQ2FE3&.$'\K=!TK:A->-4\A;;C87U<K$9\M
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MK]H45GOF&W,_Q&,-KH^(;73:A=-"#M@)H_*8V)4SF&/V:TKGI-W8H#@%?\C
M2H&UGV]@/Y=/XMM/@T\;E@!>[.$"\_T;U0?JN_.",D)_W&$3&;K@,R\W?26
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MHMT]JZ"K?:Z*$N(-M!'GY=JXJ!)V5U-QO7MDY^KKW759T%;Q+;T K+(O1\:
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M:_(>9[1X,3$$,T,GX,,UHIX:EKFY0 UO8DNI\3G]MCK5^[*B %;?L**&^(@
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M"_5!_27HCU*O.W,"&"<3 4L>TU5"O.FX1=C HD"O*Y2)Q_Z(#$-[3=FJ/*6
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METD4  *T+<"D]"]CRFAC99PX73TLQE0 >MP!G-3KXX3N$.R=O9%1U%H>_P;
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M'Z=F(ZFX\VG0S48DF]'@'T5-T5F6,F%!^1B5G@UE/RA2?ARH(3)PN+]BA[Q
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M)FF*D\T531+Z5>3>*$.VFII#<;/H&VJ!FX)S?^':\8D1PQ5F(2:SU@4*F_V
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M>?& 7FG"E].%"+B-9J\1615%E%7SHU9C(*>27_?E@;O1A!X(69XI4@; ,P9
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M*D+.BY)U]S%?>C!+V33@_TX..1]-6R #(BZK2ZHCU&N;'F/1>(QR0K<T*5)
M9U]COMBMR7;'1R4@2YES8D#$:4U*4YA-9>,OS,]DM4[9G'\%"PN4)Z ]<RX2
M$A11T6F*N.#BU0O-?9['#E(5]ETI.XM_:Z$0_4C17RUYRL0^MQPUNV<L4UOW
MYO;.@N9:(*KBV-)Y:O?)74$^F7N_H9VS%^S@DI6,W'?-+U-GF7C)(]<";O&3
MD!]/=B5/-<N?KK.SQ^G:+7LP65B:(-KO/V%9BCBLJ[,WZ,RFD8D<_)U9=QCG
M50<V&\)8D=LNRHNHYI.TB]/K(<-9I.';UB61*"JPNY;:5463W1(UMW5Z302?
M'4I._9T.^<S-9W/IB!15'%630=+!V1-K+::"DN<*5-M\8\V/S0^%'*0CS8?Y
MAI-7RG#>MM])])*@F!4C*9Y<?:&?KU#\C]V#NY+YI._F[DTTL[D%%8#E'?(T
M#$F:)[!4(W"DQY+JUE/=%8J#2R\$G!NK6!P^O;.U<W[:;5J^17-I:W?N63.)
M:]BU+N0"V<\)96RW_=.*NK$/5. N3^$ -NS:&9SNOE2=8^I3N;H/5.S.C^@0
MUOW=19W6->,_OA&QRU;MI!2=H+!Y<3[7,N^^P%=^GWN%(_KUGCT0EHJ7<S=;
M%+^SHPSO.)RR_.6W%)<%N_8L'%7]JCVL^+(6=5GY-R:OXB,3PB9H$O$/3>AR
MP@\&D_)S__-?_O3IXQ__G4U8Y;-YB4>T^_"?]\7"?"X1-N "CV>JH0:H*&!4
M+,R H(]1%MVJ#':5R%A)S+36FZGZ#KRRV%C@IC7B+?@?3&6RL>"-#&P KW:B
M;*?B)L*@]IBBO7=5QF!9L5H)6#J>WL>,CS9+Z0L5>L/M>LSPG,N,A)Q7/(U3
M&A-ZC1)N4N8T2>EB>I_R$>8_/Y6E7S2Y.#U^8:"U<BQ(V0-]X(-\F4^OIPE:
M98C$ZLSV/@@[N^ ^'_IJF9ZMV-5/*,(W=!IP1?SR=/_3]'IF6.U*3L!]?FXK
M$,UE9&N&SE^F3WN5NL&W,2/QO@+)0:W$_4J0X) WF48;3$+TA-^T*VMOU)W=
M'7:<J_U*U[:5OJF5H-GI)=],Q**6A@[O-I3<76WU9(C-Q6:K8AGG-:&'2BBW
MFP7*1&F4^Q3]=Z9%#][=W55--\A,!72&"7=D$;C&$)01@UFF[N[NDJ"_J041
MD-7Y),+G5PD2QKG4EA<13L^W4]?W"\"$ O7W+^O09$89B,A6J:SIS>U\7PRJ
MNK/"<T[D2BRP^M* QE2@L/FV,6DI+GM%5P^5>6]OW[ HA2[FN/@UO%"QK"<T
M7\.W#8:!6&PO5!4-6?!#)YVN*/]+O*;0I0I   J3;YL*<R%90NMV\7C=4$,2
MB=\K48)T'&JU8;A0;,^A$,\Q^R4C#)6;FJ+B<4AO6<J7SA _\O62?<8)(DR[
M4G6F.M3RMCV)TS;8HO:D<,P=JKKBZRQ*LT1?5-60!A1(W[8@K41ENU[QEYB\
MX8215!2U?L;".</YF?)?[_X!*UL,IP.]@_!M<]):9%;/:M7!T 6B#URA\MG/
M_[!X !S68 2@H/FV53$7DJV$.?'P1EB: ,*G_,W>FA?E>V]WI?_%N(K62O2Z
M$(2BZ=O6IKL0[=>M/G'?H.D&_9/&PE!D,0G1W>UB^@RM86U""XJI;]N;3J*S
M:EKW ]E[3V]0[NQ9+(1ZW5T_SJ\ !M:$#!1$W[8V;05FS[TR7].X4L&^]'L7
M^ZOBCSHW"YP"-.7?MQU-"S'9.D5<\S8DN!%R>Z/16_$XX U>T&7ZE4M #(@4
M;=0G"7,Z4/!\V]FT%IG-=Z3X 12+!R3R2BNYXZ[XG6ZNZ7M"8?)MRV(@%A</
M?%4?G]IOGFYKCT]5*>BQM/ Q*/R^[6[L"M_).V"5OVJ>&#"D L78N\U/.W&=
MYZ&PFY/7L/(_:TK$P@E (PI]V_F8"^D\[X;5 VM*+\62;!^I>N_3CA040=^V
M/UT$9\MLYOF,:X*>2/1/="TD1Q+Z%YR$[S<U3R\?VBI!,1^IVHAVHPE%U[==
M4R^BM.7)HQ$)\GTUNMV%5]VR%*?\%S<9M_7\^(N^D<+!6&FL]N9U) H%VK?]
M43_"M&V<3\)%^ XN0(MIOE+,KN]O%W.880:3@:+IVTZHK<#.'G6X'U/NF!(#
MFD\?_C*[;AN&J*4'+6?GVT:ILP@M07OT5.7-R5.5^1^52,*[0X'S;7]D*B";
M.#W,/N?5JD2A9GS[P$?!A'W?CX3_78^6 1$H9K[M>MH)ZVQ)39KWZ;4Y3=+^
M4+Q\V[P8B\C?8CU/:"/RW4&5Y.MM!_0L@(Q1:W5R22Q2DJ-ID)(W(IZSD9T
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MEZAP2 *^C\7JQZ=.6[F/4FPE60FW-F6+HK^@Y)5FB5[ M:;N@Q7;2UG"MZT
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MRA3ZN,D (JWK@[9L%@+*]TT"P!?TS42503T'$$T-YL4J#OGU27FG"89 UVD
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M8X2-(59F6COPJ)IK/MH5%35R9\MC+K4)UYJ>EP,MF.7!A-$<#]XX<J:YNR^
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MEW<U?E7K3D-C\,6L#RN.E-G+Q/:P1U4:RX8];0L+^<D+[X:*Y5_#%O#OG^"
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ME=2^#T1=^O[2Q29H@:5\F<D/P-20ED:K#^I#2L[J3YH>OOBURPR1>3+V?QY
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M/]DL_GE-@O4CWVJN<BG]!;$KQ(J7CMIJ1Y=/#"E$IF>YNO<#'(K4/)/5.OU
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M8Q?CVL-<40OMB:L#.+3)YV9GP-@;A7]),G0C3!PDP<^)A_7<>257ZRPT*IV
M-KA13[N"K+M6HXV 'N=*Q/K)4!Q<YW5M.@#>J*,$C.2J/=N=F:994(CLS,PM
M@IJ@"^.W= DN,\I>GP5<+\: $?YVKCNH&^6-';@B]DFTRMZ&.GFTX-NMX+A
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M%7AP@\SD)ETJH!^,@T*N%INIB0"_P,A57A3YZVPIMVNGAG)X_)(3*F9J4<0
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MPGE._._V]Y+?P!F'5DLIAWD]<4<[8P @]8Z%_HSH8@B4(WO@;];N'2Q-U#+
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MS:9^U_19Q7;,]B97/F/2;=&W;;@%8,<U;_(#YI8FCO )?PASP#9(V=:O>2;
M\Y% #8:-L2922]?511=(7[[?[)!<*+\BF[Q3368F87==9M"!HOQL9J!,IYW@
MS3Z;A(NV(EO<XP57_!N-B77Z$4JQNLZ;%O+S:3, 7KR(X3G[N]7]6(6*[]"
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M?#8UN]<=2-9:.Q44L0)O56!*SGVJ9[DA86_(4M/(0K;!=OALW2!C\A7MG[X
M.4J6NQ55616[Y+>W^<Y]"DY[]#18!Y.'PAPZ";+;+?@?GMC-V[2F+@_]/\P9
M+'+-=3'B*LZ4:3L.(N<S$ZIS+PEOQ&8N4"[_"]=0GM''S-:FRO[7ISHI:IO:
M$%XX9?KC-YX+(V@4HK[[24E*];=1;\W'/SQQ4T3AT%M;""X%_ZE$S>!'PK<B
M6W!YS2;WI<VO\+3!0XOI8[-?THS9X@7 *PB_C)@+?AXSD;'_FU'O!4^3E);,
M&=EG/$R@#9G1W579G>G2PI5][GOQ'QSJP-AVJ;.(VJ=2JX%_.E0^LT#H-U.D
MNW-BP_@283/H"^";/-PGBU<2U;:PV)/.]VM_OD]B60W:[&>]IC<5'F5RHGSV
M]D7OINT>?KD=&Y@Z+Z7VRX.P<\:N?Q2DT/6(?*9&5DO6K0_?EOF%$N[)<UTJ
M4,_JC1?UNVB ] B2DM:#GQSIR%7S85[!G=W0?5M;'$-X7R;M-F6JQQ.K)+(,
M\%469"O!BY7D3GD_JYV5\]-3.TG&*9T^,SB+*]+BBRF["[BKO$A>/:;=4DM:
MW&V2A(<Z&F3S=8)4_)!DI3:@9DO7 T59AF\EUF8$"0MJ0[H=H[\R.*:A*A^)
MB:J.3.UGF>CY1LD4\V-IO4@L(F*\K^:LTX\3DIN6[E,^<)1)<3U?PJOQ$IZ<
M)%63)@1H41D;_'";-YY&9*'$^E*IY3N0PCG4\/%?7-=E-NX'X9MPTS8]+*Z)
MH,$%9^VQ2. %\6458_0B>[F < 7/M=; 9!KA?7P[]F],>)#R5IUY6@.\]9.%
MWE9=M_BIW;Z&L>W"8O?>Z;'&L@ZE9T4HUQ6H;,P.<-S'F$R>%8M6AS40C'8L
M/6Q *D:3YC88[^#]DZIES';L;*[%WN6OP1L)0WP?Q 0CK8RDATK8DEX^KXR8
MMIKNPLB23G+ %XO8C"7!8W#HH!]SN;%"P%,R-V.OV)>*?\S \+R]JGG!)IDO
M<7"DU,4!J<Q?=!@X,K9AU7R+^P+J_;S[9/25TZZ]"9)G@RUQ86A7A0U,-HVP
MF*RZ\("&]SEA[#%<6HRM,4.4<.\"$Y5"KZ^#PQPU_?&\K7F,<7T*S-TM9, O
M323X/WXGP,B/RBY]#10(85$!+FTQ/I/J/^<NJAIMIW>]CYP3( +A',E)E7S=
M>9Y)G5OETE"3E27#FFXN]%];R<R(%Q4O@ <Q#B==ZI3KRX(/SL2[0L?'>M O
M/D"&8WY!CS35&+4'EHOY'Z.>E!B>BT JL0TY:+RL#2$R+0'L"5)''%'C@-75
M_"71+L\PLGH7:#CP?J;B1O#0Y*V)07_<+Z[A\RH6%]"%D7*"%SPIT_3S "B9
MM)33DJ#:3(@!)0L9YK%?PQ,T6]"2UHTCC*NXF9#ISSK=F$<8I3MZ.92>[]!3
M4@QD(:*<"#>S&!7 4GW\EGCLVN<^1FFT;#QB#VP6EF9 'B12?NV=?4AJ!>D8
MU8\];+C >2,_]H:FEGAS3]J5[>HLD^X<<0S. 1J[!!J3YSH79>!=14R)QE Z
M?8&_:-9=NO697;%7@X(56K)(S5N=$B_V7K[;$"4^0UHLTJ @PYM'-E_7%\#[
M&O,I\2?;0[_WZ_FGVPD&^>6TC.EUPK8U7\^&?ZNP)U*8)NS<I?7\P_ 'RK#.
MS+AV_N>313<W=*ZC\VFGW YA]6Z.//-I9#09+B0D/F77PAD)H_H*@V#<EE!!
MQ'N=0D@F9NWL%6[=4O42"@H[Z:,HN\AOAXC^B5\8/AA#3:M2[8FB#%&[S %2
M82'@]H[:T/*Z+U/7GR8H\1$I/Y_B'AKH5\7O=B5IXQDJ,%Z/?OI6K7X[("0N
MOZ_3*6:;U-3RGADS;E]=/+@@<_ESZJ&;<SP#5>=^S)_$ YX'#HKXUHPV' 1.
M]^ND,=6&#I31 0(DSD$J;F7O0V,X=*E@.9*/(0PK>TN'Z@6 << H$TP!5?!4
M*@L\,V(*RLV@[N+TFW531@ Z[S[( /?7X:=IP(>I_<9.J%9ZN"Y+;@3*_W50
M>\<?^!5VP((_'NDD5Y:AHA)_?C]JV6+]B4-Y(B:+OIYT[;(H7RA>-% <:XH-
MN_\HSC7:YB,BO_NAC'=VQAR., ZVH%L^(34+)H8K>-0&-'!1@#J]$WM"2C;*
ML@!BM<[6QUYH#ZZY2BMM49!X]XO:+:US <0W8OLZK&4WBFC0_=BM&N'-@40W
MF'.V.M+;>ZC*WY,GV-YCV+K\7(T(<)9+A@0"/'*38L?)Z;QS$[+DA55YE+B#
MACJ9VX23ZQ"JJ;L>1?U9R5Q$[/^E>F^VLZ(#+L;6%0F:$O)7C)>'G!J2<@EE
M>ZVR?FLW3"'.IN )"5$=F)33U=]' G!2",_DO?(+Y8UTL2:GP-DTT-V/QIM%
M^6+]@3;(W4DATHCC S,6T[//?_60N8FI/53L9DOP97!X06SH7;Q0^,.,\*FP
M!I?^)Z>"C0A6LGEDJKWC$;J-H#E]?0>5J@)" +2 +Y/U<NJC8; W%E[M6I7:
M()62QB20IT0_99:,83<ODGS2L=GG*Y 2X5, 6\G%.)8&J[B;UZ@*8JJGX*78
M=&FZJX)<;&X$-H!077T<0>E>HY@% 4KG_::6$ZC9.+-;?<ZH_<W*FY(:HM:L
MB8:Z0!JJZCPTP)0"MM8EW8E YJ3_U$<(4T60)E1%4!2-!]E<3LT&MH5MQCC*
MC\Q<J1R56OSJ/0_[W*B6[JI?A]Q)H4FDCK[7PX\M$O/MQ&@I<&EM&C8#5<5Z
MY0H2,Z$S.&AI<A(!%PE#DD\Y-Z//]+LH *&HT%,NWU+U;XE\97$I$44<+-/U
M,CO_#_F[Y>WME*3KU<'DOZ:U3YDSQ:H?P63,E\5[*'3['_='. G1',GR^U7J
M1"@G)R=.,"4:\RH)VXH(#4DU:!+F'C3VT0K1^N(/SH!%QPRU&M::">]%R>&Z
MOV@:LZ<M @IHKX%?@O/?1+!DOQX-"R ?Q&J#*X\0+N<:S:.<&[AG>:C3H*TM
M8R 2(";Q2#D;VM*:=-8:092"P+[GK-BTP1>1(K;QQ,+ZR,(SMY&V-9!^!\DR
MU/RE*A=HEO2:[34C0KK[@<W'S<D,:0"=.)>T^;S)JE+I\N*(G3K:(M[0V%\>
M Z!1P.;Z,XR(.C\/6LE_@$R(3[5O(S(YSO@J)40,*05I '<1",*N-Z,#_O "
M:/06W9U[$[D9 >_3:E'MXRUQ\AH<98U^KRXWNH4])KIV7>R$:BN])_3$.OUM
M3GWB?Q<D_[GS0MK 1V&-?>$)4Y%%B?;VS,0TJ.WXZLK2HDP9.6Y;W+^(:88W
MI0:RY"JLNC/@ \FU5 \N<<RFSUS"&(989DE)<0($5,76__?[@?\6?FP5(N,:
MAJ0,#B3U[&OUN] R[:0\]^6)N4#?&ZC9?M>H85&R[IE'5J$</?;NJ(\L#5.-
MRL\ZL)S7)5FO>49?4E.Y_/U45RQ;OO-8J<*%2(=:U@O R/7X#+47JR]T" .7
M35C#AGJ4@BW#?01L,_L"*(C1F7PTL"D:V5(LMQ=7BM?Y],T\)/7<B*;W@S&[
M294M-Z/.2%_K(5Q\TZ@R#,@ZOS/EF Y<KNYT_(>KS^&T<?KUS[4VY+Y9V.DJ
MJQCBH6_V_&R)/2_+E%9N&V<C;-B@7K_D5WHR #TT#O#TM<F=IX)H47\M</UK
MO=HI'('/VV.Z##8(X()JBFJ?QX_;) R3/M-^?'9W&>Z]]L1'V]9NB+WV.2=K
MISV,5S06BD>F>I,Y4Y[G-0G2-S6M_!C-*!CM_,@4A2M?H:'^=A<B-9>DZ43Z
M5M:,]:&?+W7;3:2)XWUTHMNS&?>RPPM@A<KY3@<L4J;&5XWPUB)!YGN,.DYZ
MV?7>N^7CMG09O2U-5;X1U_C;@B^#L)I,][$5C9A=77A#M:$$5VWI6WMSP6"&
MB1? &+#/^%%Z)G/KIU%2;#0>R61BC 9ZDG)'UX4_KOKWONN)08:6^J3IA$"3
MN'L=*>Q>3S3&\)GQ2UIXQ'[6VXIWC@QZ45SVC'?@$]!AY=1)1Y4[I@1A$"QM
M$LE*E/4%0/\3+WP8*MTX'-!U3QT2MS1%;CVC0(*@4\R?@A48_0+XT^@O?V[O
MJY'9OV+R7JF>HH)1 TXENV<MMY8'GDXP8'0PO&U0#M.@M)L2/ J<]GA^7QO7
M\34&#83)6BDR(^KN6)A@GKW07PT=WLE\ <A#K<XH5)>TKQ=8-QEVU#*E11AF
MHK74>C*D#QM<%[.;PC;H&'E1I98T<\*$X9DV-V>+/3C0?'FED"J"Q=UOS!T7
M%>?HZE[XFD+:9"B),6QUS$HO !.G.R,DBQ9[M>E['<XBKY7127-'&\KD>,1(
MV6>@09]^:'].T4".;I,&LP"6>*CXDUF3$J1W]BO)?*&U4YY\'O[?95?-Z%8N
MS 5@P=8+ %>CU(3$ECMV<L\3(VKT^(]7>1M[;Y)PO;;0FS]BE_9=1)O.CY_@
M24K]ZQ9D>RHT\H=NBP\JQ ;>UW_J4T<:1N4#2%\ 0ODI\Q%_H#*B,\0Q)8L[
M/K&T$9*=GF4QN+90S:EX'8HO)DE:E[;%&_[Z"B+N];"NEL;/<=%KU.CY7J._
MFIY2EVI+O;*4)]O!EJNL>^%#96J;B:CB\SIT?#<U[+^GK]AIT&,2B6^TG)OF
M[^93NU\ H7%E)!R?#(2/=TH_^4R[#&E&.)F<^N,:3;:J%1X$<+@<)>?(D@(;
M&LV%*IDGKT1P26DC0VMG?GT]D-YTKECMT8<UC(,AGGW+U7-K-]2PE+[P;OG$
MD[+9O3U/5BJ(B/KLD5OO2&^G@"5E@NKAPN^)RV(NP>4)U&)1'71G7\<<O1>
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M$YZ;?WXB62&MVA[E9,;0UE+'2N;==YSD:NQ3XC3EU$QNUE_D3(:I&KKO56J
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M"*.X:L>.>#]&X7$2OR_';85A&+M.=[>T]<=-1>5:N(;*M02;\H?V,<?+O0L
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MA=SN$;QS'F\'DT(FY:)]1[U%)F42^'M  WS>(RO+J]S#9IR%R0K_RK@H%,(
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M>[]PO\MP4BBNOZS[L.35%F$M@_5IL+0UE)/6KH1,CI2N[835=MJ;A6]Q8G"
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ML@:Z,02"<[;R%*IU5>-A5-I'_2N_C]E56O(FK1 K8RFM+H<DQU?D57G9%J+
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MJM@\KL_,TE7:4A/8GS-\Q$%'23#RO6<4L8\VX7O?^$9#SC?(_<"0X)IC*\P
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M8=VJ^J+%)K=B)7Z#X;)=\\H0IUBWN.B\[!N[=+UH+!QSS\M"ZP@  %U:K>1
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M42X=/%P[;=^W&B\D7RL!O)_:7>X_VSV];KL4-PMHTO8]RQ9\JP&L*#N]*IV
M/W7PS[9<;9ZL?C&?!I)A=EU\=B%9:_9S4C(Y&G.*BUH1,)#UEW)K1_-;W[;H
MJ>B!'+1C3HG/0?L%BOY\UQST'4F!A4@V9&O<D^=L>E! ESI>5%PE">-[3'B*
M"TKFD,D#KV*)X7?C_L,_@+:;'L)AS#<K;L%&:V_&+'&5-'[KJV@8&;?)A'J,
MRI--($*8.J?ZML^5]YS7HEJ7<YV=9HGLT.0\,F@-RW@B%W\QN4^&B;-\7SZL
MTJUE(D+7.3_G\>!A^7E4O\+'AML9/]JQ8O7NV)9B$L!G0\3[(K:H8!R[,7<K
M*;LDD%]@@L-52N8#[UU==0?]5Z-/8LHN6O+/%'3E=&(I>X3N66CGK0IT/LPY
M+?JZ?&^-K0,C2Q<E,42> "U'&T[.;U!PJ((.7U[+9Q6?Y^^33I$+A22@('L.
M38B+5P=  ;VMDV9R:<6=++L\R1U^0B;FZU!XB?WK19^39QFC0^BB[K$X 8CX
M?QW_ R[JC%9BOCY;65,(]K;#XYWAGYZ@@6)27.@RM3%;.F]D65$H^]/>2_-E
MCACAJ%:\5J^8&.)X?T4\,X=+MV!T,%E(*BK-_RX4(T"?8Y-#V2$S[7-UT>=<
M:9=Q-2ZVD4#IZM(2$I+&EB%2AK?YW1]T=,>U^Q\91(*^+M2N8%?.[])7O;R>
MSZS:WKZL)FE)/M0_7QU?]'\A*7V@"=M,6E9[3@$KTRVKJ)S5$BFFE-8K@Y3H
MCJE40_5%+ ET':R-(,0\M<HBE;T>M4K%^:FLL_MPCCRWJ KXF^?9,6-*:*B*
M\QC+;@<03G 136J(UB3+JD/2D%80=K;S1E,.RN-)PJBX^-'G*6]J.JN>P++.
M%:Q]/N-I'9FQ7\QL/_2?^Y'>LIK=J]NV9-E$\>3#^3V_D'_Y90X>2#+%<]0>
M((%[FC&UV*D(GN'G,PWU>7VN2B_'+R@?S3Q)4@SCV<BFK5E>E8\U[<6\A>X[
MOH?NO*F?*1-^Z*U],6]I&X1ZZ!+18UF+X02'@+2?_0M&1-+7]+><.:7"N:E^
M03Q0QY8'O<+F$!&N.57)($PSC!DTM@E(QNQZ8*MZ%PZMJW8:8W!XEO1[%G]/
MBN(^>[QXIU(_A#AD^%IC^=/"(1XZ:*KJ-83QE!/&0V9)T#_R6Q9I<*_4*Y06
MA8E(J%^\4H7;EA&4TN\N13%>6F5RVM%HKSLKLVBM^IZ+OIP/5TWYE374P"+I
M%!G(3-M*QI#2Y[4+_LU+.L]<V<>_%9(F_XHA]X3&PPZ83[[S:\(=;F$=X\>=
MC+3NYIY;,)Q7_/W#K,MN:SM4=81T)1P[6<12W+'PO/A[AT7Z01ZLZ-GB"H!8
ML[-2!"F$5 /5V>;6&-)B4!+_DO^J*;X-B]M 8*FWV>=Y-,7PN)NAH9"Y,:7B
M YKC1RM%-$I9?!E6EG=C>#.LL#"9.GG/I1#AV3E.CN).PK5P<*N5A@9A<<5A
M#W)=7;W/DLAJ4*95/^E(TB="]\$Q)U(+AEU^AMQ\5/HA%&M:'\U=*]:"S2L0
MTJB]8(N-D'F\P55;MKQ'R39P.9\%T5Z[PF+O%)75JLL5$@E,Z>"?J9+[ZDWL
MOB^BXX(XPQW;*4\7.4M#O]% %\E^N.L3*QZZ05\5&J9<Z.=-N=4KRZH889B1
M]F>0@R32\=2M+I(=&"&#XPWD(H.UXYOFX1$[BBJ6HRII0C^DGJ+R?[N%F)BK
M@3Q-CC2&*X7*Y&YR6KPI4(]X/C&DK]T4]"-S;^9 I>/,!&6 N&",38F(LYQT
MC_FB\*LUQ['7XABX!O7,+*LI\-0PD[6JDK'QX*1/[/JCBM;ZX'?F.W'_ >HX
MI..]A158_4QO,WY(F8R:+VXD2WAXQW3-P=+GN@H&@5&UGG$Y27*4#8:ZJ7=0
MEQ\.@E!,4"PBL%V\IF%T_(53\9[J@+U$ZV4MP(.-WNQK]C"XKP.)OE4S*1N0
M+_X<(5[B8H/'L#*6DL@E7$)."1-S)?5B23JO?Q$J_.W>44;LQK&C3KA< XWO
M%D75GJ.3D,_A>CU9BFP<51TMQADE2:E,G8=';7,[);^MEO4?PB:@J%'B0*G:
M]V,$ZN2:E[':LBR!\3L:&KM?>]/U/ZF-9D@D?0#V.(>)SE+HI:)PT+QSA7HI
MLO /@C6G*%C^W ;U,[@V^YE]4LO@5['6RV,VA)BL;U8)P\_"[)M?FFUO3]1V
M=]7JMA]!\=G<':RPV:HF<*6.EFCQW^R, S1/+VD&(UZW3ZE:H5H;7&FK0\?*
MH?:7QY^RI_1:%R8LTRW2*]/=+,IS"P%WE6M",-I$4<$@)"61.8K&S-9R) 66
M=6VA*A5 9>TVEUHR'I<#K1JQPD8U6UF"[,^3'QE"PC=&GY$%\:#2)V;212;4
M+-)B17T!Z2F".3:18INUO+VY3F/D _/>F,ZT\4)2OQB="_-S$7U6CNV>WY?P
MP9NOA(U@!''E]OCLR8O?F024&M:]WD#;BEC_ !S-,C486)=EXG.U.> ;("V.
MVQM]S4I=R;6+ZG=DH<F]P^L?TF(H9F-7G@#$^[]C,WI]84_4[?9J6%8R>JM)
M T5@AV1_.P\/B\ D.E-Z2Z6G*R_'MYSC4^AR=(_5%C]*RFM9Z_1D\PFZ2KE!
MX6\3PG43SCP*])E(=&PA'D"<2?27#BVJY6,>N+WK[PWZSY$HQWC +U6:M95:
M4*=V=+^)!7L5.!QI\<?)5(44%P)+.9< VS!3]>/DY/D7C]*LYGL?&2@N^^P.
MAL2;TWRZ,6/XXO?CW7JITMJ:,T!(P_)XQ>(-Z((8,DI2*.&Y][ L=L&9-2DF
MZ$:>=?0\M1N88N\[/^)$HLFI$ ?7:2T(1NL(^@K6PRG9^N$AR5HR9?JEI$&1
M>&2((IE0\<8](8,8X5SL"D+J)W--,X<&PP$3G+,RO@2A\0\L$]8!I=M)+JH]
MR[0X->ZM5!_:KZ+)>GC"1B:WDM26I2@ZIPXW#8MBQI;)^2JV'S;=(^Z%:RDQ
M79ZSX$S0HL2B:W$/B#M:4MU/.P_\!8[^#>;1GIT<<@E1HZ6#B"8$.[3I>&N[
M<&B?B#;[5\=]:=L,86QI_+#F;Y/@<R-Q99)TC3?WIK*T&WFLZ_2MWJM\]DEZ
MC[AJPS \C%_2A:B?)VD^M[_-\&!P[E X[%#5:?F9][DS_'=)_\<V?;N)=YCW
M#L'7RO?BR_I-?P!?81F/A'\ ^'O42U<%OR\TC*KY:CVP@S&7ESN=F"SH$D4"
M"PEBS_(?[$FZ]09-]6P(&B-UEW@DG"ZK-:[+I5M3(<]K[:8%D5X5,\'G=\E
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MY%.J2;2$TZ<)=:5WY77P#T7;&)I=4MM97 /,I,"V0MS1J>PA\I,F)9C'\'$
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MTM[4O9(BR*/>C++$LT0#NQ ^E\CKU#!6U:/#OZJ#07I> 7VQ+6,V*;O6#,]
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MH.9BYE\MG<5WFV2OLC93^EU9?P*)O(Q<^(5_/#)84QCJ;!O/D"SM]L70?#1
M (GLBG_2+ENE1^\.,KTBF.)*&KT].#0@9EOK0TI54,KQ''/>PYB"<E;_(-B;
M*@UUVT*3-HL!0./Z@_92(@T'$5'4@EO^G;\P(LV2;*5A[P=5,+U9>$@ 5.!.
M0^ECV0"@7:[JI]GXB.!R\NISIA7W7,_0(^C<SXB:J[.)KV,&"[%R9R!=H3U
M2O9AO0)Z+7*:S8S>BI$W(P?:W[TJ($!/KK&XKNCY=O=H9S6^T7SA-# Y?MM4
M_B&KAFE1_K:RW7.IK&6.T\L_H@Z&F7#-> QQ<A"Q$GG/:"KU;E0$0=:1/:2:
M7X]>X#RI&)L()IO^YD[<C1[= ]QW<-C65LNFOL@C/%:F?@W.3[.@)E1T>M0K
M=IGB6D\6@FV*.+!&--=;>TG%FRONX[X&=8'I^32E<*QDOR'#!,Z(?D.T$6O2
M( )Y[LBQ5-I$;V#* QNY^C/%\B9$7\10Y,@R&T'&BOOR=!QVG+"R9>D=N^2J
MD<3(,TDO?>8GP,54S%?/X-X==Q7ZHG]Q$,7FPYGS4MDO9R),G4RI=W[F$J[C
MZ1\*]+,6,*8"P*!CI ,3E2\<LS3H$XWOWXP:XOB;R[NJ.3QD1/%C=XR\=:V'
M/<>Q8N\U!\:&0B;S,$M]O.E+03'#4",;6L.E]%K7,B8K8<LIB!U1GP=BWUN2
M<(@]G-L8!Q! I("MX9>&$^I2Z$?<O\.QHL-SI!^06H;+29U1E'H!NHNC,I6Y
MJ:N;X:Y8!M%L)004\SKPF-5E$CAMN(2]W*0VDB4FYV <C4B_TTHI6Y/1K::D
MVCQ?-SMT,;RM\B&N+-]'(+#/Z_;$#1!Q?&&;=*Q@70#2@G8%[']>U F?AH*!
M]*]GF69J-M)Q.[*]9),6\AW>FW&T),OI->=I$SHGA?2D4ORN#=)63=!NB6<A
M2V6(8::"->)'G(RR4.>\'+02WKKNQT6K][H)VL2X?^/TAOTJ@R 9>E:,E"5(
M@>.IU;-9[2KV38Q(:LMG_?I&*?;V5E,RPGD/RO^K1 _*&$?J_4)-NF+W9RZ)
M0+*\N]BT,CM,/B=D $BZU0R>G?G]G"ZGGQMC1=[^?U1SGN%PKNL"'D;TW@>)
M'L,@C%%&290H0XC>)1A$[P2)1"^#B=ZB]QY$[R+*B!8F.A&=(+H@Y&3M<\Z^
MKO/C[+76WFM?USD_[N_7]^M[G_=]G^?YKN?F>;T&JPF#C, W,E"<!W)*U ]9
MHCKP+)PIJ0TS2%FPPU^8GS;;D8[[6AOI"0F)D]["BH?D^?2G>8FHUI05A(/,
MBMG&L2[3Q@,ZRP.)A+TQW4U'Q(RR(&U\OPW&PD^BX]+\7E)0R@:Q\V NC]&;
MH\;Q4SW"<I+STH>8NZ=//0*;XE!&ST5)MBBG(PL>LY_UK>"%;=1<?"QE;6FI
MMDTO_VP;KS%!9".+D !&6UEY;IF>-*)$"6*B4ZA4PX36EJ-2(\W%LOI:U"%R
M3-;M[SE\N1"'*M9 O!-.VJ,OER]WDB:ZS?-=1@"8[M%[23+*PPC$5N$@LE>3
MOU6];5'_B#$;:&<NZ34L+(UT6(.]-9Z7Q[.\O_ J@P8-/SDI_@EXQT.5&.PA
M/M-3%T74-_;>Z\KN\+O&I"TRLC"!ZAT' ;!F &8ONG.G]-%#)D-^80FT$C^1
MUV!,SBU?'H+]@I8#6<]$XUXHOS/J"9@X(ZY/Y)M.9RBV3KMRHF+S-4G$U#IH
M](%E\4MR.>Z*?5\T7FU%P9*K',&%-O;A]'&S]AU&XV2IW6(T&ZMC"*FP1HZ'
M05V,EZA=48Q384@?;?REJSM4DFFT8[_(\_/M624H>UR"VU+*-IG4NQ;KO<SU
MPO>6$BK,.FSQRCKIUJHPTSL,I1/HQ"_CL9Z%.6O_7%9N_%Y9 _L%N\PJZ(UY
MI;J9%V<=::609!%KSSQGW5H?3P_"TQ,@)REWH'%Q+V"<#KE;KD)F#\Y+_5]S
M-448U4@HEVS7!2H9!=C8V%]"D#:(M)%-$?L,ZR>;:2](E\_!VC2&E$6QXU3I
M^J">H6I5Y83"#RYN<?6)!V:950=.C G?=D&E8H(>=2]TM_%H0\;L*%3-M3O4
M(!7&9HS3C1QBTNEEL_C):^(S[Q^8WU@I@E 8&+SJO2-%H'<I1/B5?J4U*[RF
M8DM4QL@\3.I#5-.ZY66(W2;^(K8*G3K^6BU9V1*F+BJ'.RF<0LWB-2_)9&_'
MI.NA0KU(N2=.]1GT*R-8XVR9BKFH&,<P$W:3U,7VN,BTVS8Q];99JBSZ<CMX
M/8F;2OK $B";M_D&"=L=\CJT8WI>=C^YIIK?\ ";5530,.$D8/:(4<](#G#6
M7:4Q8F8]RTLV-$+G#I '6L6-*!?J99WIT]><BRP2""I^D(RE:@7(;FFLMD [
M[PAO1ITI"NB,1_>K-8J3M5@&/T."1-V#,\NE")4<LIH^?K-LCW]&$LR:=M8'
MR<L+9/E\>K=2G&9;&SF]7+EUP3%K>GXX=*2"CX,<;[ M-"?^1\OTKZ+;AA5P
M)&9.2Y;Y(;AWXEQ3/^>[?K@X"PF6!*ZU:>3PWEL<M0<T7Q5;G];77\K[#D%I
MI-.;) VD+=NS=>O%]=&6 ;@WB;]DH V/LB!J.BB[.LSX/*MPF"XO,.-B/0 &
ME;$';: 7Z9/UB5%0Q'&5FZ/+7A705$%:2[H[[?G27?6F'7][DDP1S7C"E7A0
MT7MV!NH5!^?51NF#DQSR9D-H$&$WB+;Y5OV'JV!-!H_FH\#9:Q->9A5( +D)
MVK^L-&+VT:R<<*(0H2&1&MQ21OP)Z&N +;!VX(0.[TS8)-3.$&Q#?+>HN=3S
MZ_'X<@S;T\PS$.. 8?E+"N: :Y_<NBMYDX%96^ZXD+C.M/4?93GNA*.FEYH$
M)NFOAF6_D)#UQXH,>U 9;V.2Q,;%4UBBCM0.FP7BHL7\_,&OU-MIYD:</KLB
M="T.UA+.$,PM+SQQ/JVCNL><JLRAS-DRA@'$'6*K7ISK\"N(W^_N8<IH[!T7
MFJ%X**\G@0.RR _;A\+=D<67)#:EL/_/ ?JN8]JZWQGGIDNI,GUXHX)C\:'
M:IJ.]Y@KQ62 *+C*S@N26NQS.W' (B/72N]&W_SAO7=9Z4-3:C3\2J+0LC#E
M@>=!KNY@8%Y>\\#).;(A<B.,8T1IS0@.:"!@O/8IK:SG9?]8]89[J ]N>F.
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ML.PCY(QN7 3GV%28_]H'>[_]6=+K;$Z>_+B&NB/<KU@A;%&Z/<1T^O@VS4\
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M3\D;P^4=4.'U&Y&$METARB 'J^I9(NJ@F<T*A5(]48P'*=$Q1&Z8QNR'R:K
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M"X!P^]J.2B?A<:2N/CYKIK^SK!_I[-/CDD:91G&%N-P0$ZC)!RJ=[TO3EF+
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MQD>UE<>J.HG%'3+FW#;$G.=8Z2?&?"7+TG]%<OH>8OK 2%\8TA9.@T4Y\I:
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MNP-[TW\0TM*8;J __=GV7<N(19SU[1;I;%G>O8_R[$ZC7K@NDZ> S+ 8%?^
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M;P[^?1;#,16MLOB65L+L$*C&]\3$-NX2I4)7::JM[W0=;3J?H^K=A^'ZO/]
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MYE!.*X+GP(9&?2S.BLT\3<'T[4*8.:=7.E/03)2R7+?&]EYC2L<>]-/!?I6
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M8^U:R1!^N)?NXX?-E8&?>E!?;^.S+9\W64=]E:1U'OX+75881V3]'QJ%ACW
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M+<>,DR)'_\S5W;K-9(IV **I@AHSGPE?KB4><I/*S.E1X%V^T+E\Z'-+/DO
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M\M->N-T*DR^0L*67N. %X%O,FZ:>@J)XZODV__ K!_\.4,<"=EK43&<U+GB
M+B^<)_\*>U Y9YJ?>C56,BWDM9=&6UDA&MV%;[@08L6YEV0FRMI0M#1HS.^+
MFP>/E&2%A3%KNP:GB9SB^WRXA^:]3'/::05GH9V=06X.R3=YG#X2I/AK8CIC
MF/RD,CT7//;PX"M??TG_J2J*$;Z1!87%40J-A6<:3=-".T,93?#V&)/4BDJ'
M]@Y%X,'5D&O]33L P&C'.X& [?'83$C9%+!&R:A"%N&[8\.>$K\Y[2?7AK-S
M;G;<//S8:U'^&%"KN5'AR'[!<^PUAST?)53+5^,%GN>BW_HY;RG<PQG45J1>
MBL23!0CLJ!)5GD)'CVU[UM<HJ_;9@# -;]3MWC0*R-*W\WF([KOHHIC8-0?U
MD/-1<]/?C*6FRE!A:4&3CA -? QF,:W=LZ$ _>H!4]D?) :XDF6AKI?+D:DT
M)""&O073@V*Y': #P\9/P4WNV)]E10=#@VI>>4@+W0&>-+2REFEU<$'EYI-0
ME#*3)+%="E6T+QMS.UP+%SL=RWY6&IN;P!:,O(3PSK)%L79TYD"9#D4"<8A3
MSK=T!EK"7?,??7,$3;X_DR\KVEWTP.<':V%)X\#52K^^>7LX&L_CYHK5=P6=
MPJ^X!O]<2Y6[ S3D3R+=!T\ON.=.KI.4J3<_.SXEF'U3$N=*.*IBM?$FM4?B
M]6N<24:<H/OX9EQ.0K0PX&PW95#'M 0(T93&H>42YBY4I+G9YM4;L[KIF=N@
M2WY=YC+]+.MA!\?Y%(]C)>-3)])]45:%DO,=RMO"\Y2,F?-_Z\L=GBP)$HG3
M3HZM\M)+>4PR4ME^#V^NH9]L0Z.>.2YHS0:QWTQ5B%S:%W>2SNRMPPD](2+]
MXH.88&WG$WQ#\_WZ<;YZT+&TR)G1Q/&?\;V]U4]6>QNM-YS3$CG0KPFG 7BO
MRKO)I;F'^6J?! 330G!+;.R.>!%03:_9@)J)'],B31(4\R$?2QV]1P^/<; 2
M@_*W>JQME&,EW>\UQFY8WJ>)>_:B_P^49\#]J03J (/3KFWY7#-?N^SJ@,1O
MQ[E59'K2(GJ>P-\$AVB;\X:J:RM\>UU7MDS4"6-U!(*$*ZC<-OUMAKBS8^C0
M"\]US!DYUL0V0N(>ZEP!%S);K*C_Z+HT>6D]? ZEW5#1+;T#3%D8D#T--"Q@
MF5AL&'CV.IC+CN8^ =#3C._YA=H2*H3XT'JF\_6#_Q*!?A=/\#B$8DP51M#:
M!FE@9HNRN,H_10_?TR'NQ<_Z[A,Y]LO^%T;73M1&_DJ91>R7AOEUB7:QFQYG
M;<33%1<S%&>);UN<R<D>EJCP!#_XL,=UD_:8$AA^DJ@NNB9?E,34,?2/(53Y
M?]4P]PV48U,!4MA*7]'-E*<$<%3*W^8?VNPOG8\]P?0ZO0?\H"33T1CHF$W3
MG7OD8'X> FS/&VO^%@.\)TE37UV^9VETJW\-$_N0!'INC]J!!)[CT0]4I0,O
M]=@0OA==>*[5"RI=>PFT^"U*6'J0 (WTS;K&9C@%9O[U0>+'7[@,T:\TN+4^
M*[/4?^BQPZ7F][_A6B3#TU1W&%R:.[742CTU?M<QW^1*.5;#N0MR1_1SRU-!
M!*)LB[B/A87)<*3:TFG4OX74-L*R'X=UVB0X'A6W(!JO!K S*+35ULYS^37,
M'/#QV $&>">58HTMPF0^TNW6$%LJ=@93@LA*MA:SW9D]/DHF?LHWP T2N,-X
M0K!M8:C,J+J-Z^FW1N9B^P<ZYWI5>VN=#7&;_(,0OF5:ZZ1J+7G"0;Y%M6_;
M4)$#*7ZD7(HLRB !L&2J*M1&X& 8,XH[!^0:HL1V1%6O!X_+W11?=;S[50B+
M(+S5%_AZE(',=Y<YGJJ'&1=_<ELE^>6-?FJ3U*&E]' SP[NY#F;X*;I=KD>D
M3X$X+9A8[1&XHN>0P"G*F[;U+Z5'646_"9QZ'#&HOH5[W76E/.RU)'/B,HU!
MG0JRWF=WK BCZ8CUBEZ+>Z6S>:*%;ZY1Q590.H8=&#^(<4AXQ7&*36MP!R ,
M#'HGZ\Q%]6[ /G1/[L?8-_*6S,%IOU^^ 8W@HB#6UC05ZI<U<K>--!4G.TK:
MIG> 'VW7PL).582*?=2:7P+=^-XF:^:35GSI=39S:8('VTS:V?)V07FZL1_,
M7&C;<)';D7,JS?VU*&P0"@W7FB$UK$O[GC9O3!)7X+<62HK J)LXI XG[+YC
MD\LOB:E:7R[<@QM*<'&S;5G!DA13#6 CDQQ8MC+-8QT6$_NVD[[G+U^,90BY
MK$DK*SLQZ9=2'@F7[![QC/_[QSH,,_OP@@CJ[MD]C_.&:X2,4*2)H]OS=&3=
M(A=G(?6J>PE5$_/D%2[SI*Z4,]=N"OG,>(S+EX@0PT503%+[Z^-+;4L(QA[-
M10!JWHMT7:#2I#+VY@K&=2YU$%[4(1#H^@ !\059*O"IX+Q@U-OS:F/X5&30
M8EQC':=\P;!7:XNZ7>1,41*>O$K_=)*6^'Q.Y60U,E QW4?@0'[3"G!/H!Q[
MZ6.' K3$W<R8:I<X@L#=M=G(6I;<XLM,:"3GT)?_.<?\WX*Y2L+6).^)9!"U
M67-C<NP(2/E%>H<6<]SN#K')P?YI8V]?@8][8JYY2E^8$4->!XXA?C'GE&[N
M4OCQ%25QQ:#?$C%K]34".9PG2,$\?)&DDUGK4VE54[*:9M;B;];U1$[\@D@R
MV/!F/Y*'KZIJ=Q6B[N-\6Z$Z-BPY13.&J_C5Z;+2F.IK[B9AM!E$ Z=(LY-\
MSF_>X.9JL:.)/S?43FNB$>Q\\N5KT(9^( %=";"_UJJK:DM_^IU\E5E-G1?(
M QO$52@PZL_9K_-AQ/+W.T)WWL:KK $^O-@MBM$P ]?<\&H#*SSU\O-:HTS_
M%ABX*0HJ@P6NP#W;E_\.[VY1&[%@K^6ZM7^;8<97HGJM6+'PAX)"81>Q"H)&
M[WT0YR((:\?_'6.AJ'#(O>U6KA7DP=L@\<48JDRY!0G5<-=87GRE043(JUBH
M,(]0NOK9LG4BY-Q) ON6"_K"Q];:"I7E&>(<(-B]P"<*LCVH>;5AJ'EI%@)S
M#(/^];&D:ICRJR7J+ JJ7EA9XZB+D?)=/YIN:)<D[XWM[E#4B;MTK?]F7.\9
M1524VWZ;_J=5)/XQN(0OCT"PIV6C]<B$HA.GH;&AHR$1[=%@P;?$<ZS9(2OQ
MN.YX/M-]?%/#J4G+#C^D0Q=S!U!HB-2!+IC/AQVFY0:MG^SHR%>YM+KGK=+(
MPH%24&/,9OHGFQ1DZ_FU (AN-_I7RIF)RD;^"?T)>%660,+YLO@RF&KOI<F;
MCR$/MO?EME<]CR!?$4TY%-<S2[^'#_;G:]M57*8OH46\<;V=X>*CHD?]*"G?
MZN_42XLFZL4$SJ@7K(C*75M18D43>H:Z*;MI-\)"EZ<FA:O+%G4_Q:1Q-BQB
MV@K,0*<*J)4O^/R^?NCB@/P$)37/7@7=!G"KV5BX3&>L;$C98BF8K4G]"S;3
M0)ZUW7M_1[$:=\D<MW8!^E;D2-^?K=DZ=S%F+]JC,;6_55+/[6T"W7M[,*/C
M0IH86NBOOG"N]'?,#IT,M_VD ^L7T6<!H\#;1O(GEM1Y7*;7G%<=Y/L71;@H
ME(L,#T@+!B33<XXP?R'+_326^4@X:WF>4/GE$Y?GIG[K8$_U8D^(_Y9T\$D-
MDI@0^;/R:V'-IE(3Q;R61OZ#.T#]E*358S,3FCJ/>^XVHKH@__8T=5);K4]'
M?X%I]^ 8-;)T+-A.'LS: B&(GU][]S2HZ>R-ZIA4+7N<?^N[I8^F/%IG) $U
MH3YW@.EJ,'/WT^W,J S,HD: /_K92!H&IT3W4";'%SF:4F'Z&I$5I#!8(8Y4
MO0/L_'X#TH5R#A*K4+2!'+=+09]%"<I%>R3O ']G=U%:G %!6XFW?3 IYW*@
MS0H+O)F3O'><!)[Q^PEX]EK0R(_A\<\R=%)9]>Y((X*#<(-6?V=%TA_:I1[_
MI88PU_\B5C(1.'#]AZ9G9:%\5&M%75URD>_*8]TKEV*R<5&VSW/>&?$,%  P
M7 .(F=\6A\'J5HQMLGKH&4W65!0Y1P^(2WR#:V-Y3H#5#K:V$*0<^I= MG]5
M6])#T[%0+V_XC$[0UBL6M_=.7,;MTOKS[GPZP),IR6.X(DVW0/_I]V>F/^\
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M_EVY4-_E@H2&AH*&^TLN"$BWOP:@0L,0,\.B"2O#&3E\)F$)@ >*Q.?5_/Y
MRJIRCF[L.(& 0<:V07[QEVA_2_:?$RSP_Y9D_[M@_RK7(@ )"N)]\:!0 8*
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M=,,9S:%__A%FY $?SKON5HT<*CAG>OP*E>?%Z^<^,]U0@4]KOKB#FOJ4&]/
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MWQKKD"KEW0_6A_'&"5IFK3C;(W_NLOU<-Q"D#:[0NC-4@'*D5A K?!RKSU;
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M )%%*%:*@=]!I%^P]!O@PVCB$>?+@]UY+G_2$SX_A2382? \\X"@SF^M^ V
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MP+P\QC:GO#? Z\K4QW=3]1PUXU=;^'4$C:8NLY%WW&DZMXA=H$=V!K%(WQ]
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MA4?>/TR]9#^4MKZ)($=)J0;^*1DE_(?+-9?(6'06*G\W6?7W2@]8>DV\_P'
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M+30:-2J1CBY*$SV0P&;$EDEG"^'L<KSS#63"<Q>CBY#^OOMQ!P.2><@GR'Y
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M)U\D+J5JO=L4!LF-*^T>"JTCC"H;QW,"-Y7J?S@09-42%^>?5<=-?#X<NZ/
MY9LCO#PALB GJU8K.U YT^J.^+S='FV!I/20<6T7<)^0!AN@9!MPQ?;$!1A-
M?26WU1S7PZL:,8A EPWU]]?!#3N_!:X[2L40(FOG )'E0BYS[]N%,VH+TF(F
M-#.ZG^15-M*-<S5A%51JC.<ZDK\ABWSHT0D\GLI+?W-,,&[6B#?LT)T51^:Y
MS2JY*W^=YSK%,:AF48QDZHPCD6]E.<6'7A!5V='-)SB(4AGL,A40:N2T(MN'
M*!"[49U#7SS*'5>J!6JW1'P=PH66)P \5OG'7QHBDBX+&N28QU7=E30 WRI]
M'!_!_93V3;4@@]+T7!TBAZ;;0  SY/T7:WK7I6I_-)JV2RGDY4$4[H:\,U\A
M5)E+EKK,Z\\(-C1R'<+L+@4D];JYD,&JBD9#@D0FG6<GWUQ9^A>^(+0[:23C
MEH^R- XX,N\$]1@8T),*8MAX;MX1O/6Q:X\G9FN%M0/MRZ&$_>'%H2A)+7>-
MN^TBSLEE#4U53?3X,,V=2<:(A5J'U;J\3V5[<6\,\KBN'E4E2C,0KQ@^*!J:
MJLKYQ_M$5I=,1[LHBY^W^TANT<>AMT<T^ @=+LZJXT6.:[+Y=>[5)/K]4BCJ
M7_P.PF?O"/OF;2;3-0Q?B8&YO@T_S9[V*'GP5J;'-NFE@^!I83X5BN:&+._(
M:K5?GSHQ=DL<'RTV*-:#*N/]OCLGBE;(+9LUAD[B6;\Y[T>"0HMR)BJ04>)N
M_/@L'"%(W<=GB/)8"DKM#GI8H\5<UAB@.7.R6]/QN,CKMU_P7N5>B 1P]F$6
MD?;C8L  E])^(KXI(=0'(4,EI7YRY=K:1M.X,:(722EKHH2F_W*Y;-U7&QO+
MBB$=WD%G'V:L/[3#D7?#6CXA\.5*P7G@RUI$.OM>47WRU:)0EOB#@"DW6UT)
M2!K(HC+8THGLA519[E-?8@<NL7HZ$Y8W6@I<;>.]&02N6':V :BCBJAT;,%<
M#B$4W',G)J,)"6N8KZ:7U)#"P,VUEZIOSNK4+1Q&"XNVD^>Z7^!U5F'RV8E-
M;X0YK-82[1&&C,M:ERGV7/9^@CKQ?NH^RF?[.DLH^YZOL<_'U <'X5P;E<9F
M1XS>FX<:S$X+W@7 ,C%1#,2=8K+_^-X%PH:.T$YA47&(.K%5X3,S=A]#8N9M
MDLU^R=FE\3J_X9IN0;)L[F+N;+P!@MZ^FIXF#,EB"@8DCK;$\72C1287=6D6
MAZY!SI$"]XY%46 IE2]OJKB-S%U.3VI[-7C[1674\O7:.YPP;+$WVF4N G)U
M<7/N0[2'[6.3 [LH=DA89XO%.F?N,G7O9(7>RG\B%994$Y+<$"6'B^)QH:Q2
MLLLQ4_C.8,8&2=!'14\A29EM5)GVP2NV;%-,ILE@]"[$N.C3N^EID>93&__\
MWHS2V&IUU?!.!N0Q\Q8)PS Y8XK*-\9CM=%7]T:/SK\5B3WJK2-'"@L!5NIY
M<K?80>9R3I]=D65KQS<,&>C.[9L%HY./WV2Z^.E>"@W5)G3DG0S+6IIP:BN5
M#OJ-$(Q.G:E/]=_'=R;"OO.J5NH<H[IC3D I\TQ$>C@S3I/:R5G9N^NR\B&4
MX @?(3K[+%"SIGSOVP&S !N=Z2XY&-V@!'61J9)"SJ0U;5+,VA)1/&A[^9"&
M,C!EO_#NXW]YM^GO0QDO,A-@(2XBW.K$@-)6CWR;HXA^RIC'=S[G2'.TFC?E
MLGC2*1]#H8,_GK0HX&J(EGXORBYCQ245^[>T&H1%]S=[FT*V1E4QVPMZJA[A
M]#:BT%A_JC;TLPK9H*+Z'$AL5%HG_[<O37,V6/QNI,!1#U.O?B?_:&(2FR7I
MYZS@>]+&4I_"K)"<5OO%NK^B'0V)HO^C,IHY(M&]1>B0+AC V>1QTXN9X.:.
M=!1>40R]NI>LO5=\/U1KM-A FRG_<XXRGQ4MATZ7X:&F(=KM ;%!1=3J'802
M*>0CRHK,6-L:[P&D!P0K=^SI\YTSB1T%\BW: HB<$BUS<2\,J01X&DQ=.A;)
M&KR8>!UE8VL?!2B6N]H^0;*G,8QQ?^$M1"5<P12P+M:)2K#BW'AOC.5**[O=
MD6YSNB,2.X'T*@9(.%0H%ERLK+]%!ID=&P6]+@/)>&?@R:U*R7N=0W<\&9#J
M_U$=WT14;'[UHK9(#'AOC:P>I1/DG%&F8-W=!:XY.Q9N\19HV*HN6DAY=BCJ
M^.))">_7KZOU)ZNWZ<9VB@SJ:R QZ%3"QF98HT[D#W5L4.FS]^BFFB=L9<$$
MDR^E0:M\6F_+\0Z^1F!3W$(J%VCX6CG[&;Z1F$TZ<P]J33'WWO9R8#NN=NAR
M7<QN/PR0"GGRC/@KXFO#C8'"%[HSYFS9&U,66Q@ZD&Z.F9X76K>MV$7[)0U$
MM9)[^97')?VSX]9:+EZ-U D6 C-]H\D)A6[(__'-U8"XM.I#P4"<NV4$ II'
MJ!! N7;"X3,?*TWR 5W,W&/FW*1899L[5^;I+DU/9!F*IA4CNV.O(+Q\LS,X
M82&'V[(M<]016TK)LBY%T!$,8ZWM#&&+6(\K[_TH 66Q- NGN,,9<2-[YBI+
M6HNU-(&\$J7#L#"'32&&42>3'+W-<9!CY+15D;* E[!7ZEK68Z5/Q1O.(D8'
MUFGV#G?\Q5::M]IMJ]0UG/B-0PTITLWQ-IC?*)#:T"$_.K<?#7/.<6C"T,V$
MIN1)9S.SOP_.>!RP2OP.0_*"\JTYH8F]0;%98NS,>*5S=!^G('^Q]7XAXU>/
M^T8<%BGF=4/&(WK$R0R&.JXR_L%;8^^.U[(L&O#1E?YC[8 W[]Z/'8MQM4W+
MI[4_DY<-V$E%\'K3+FVI[0@:9&F;EVX<</I*-#NA'W1(?7W\S4*D_0)SO-C5
MR-["&F,;,%(W"^%\"0/N-J\1),_ACZ7C?6&.FR",#XN1<Z7_S2=0*>+\./MY
M.;\<4=O)Q?).W/@I.NFR:U&ZQ5TO"-G99^E0I>2^K%?-&=WW]*-PIH4A ^L@
M[L*%RVXVW+[[/G@&D)"OU0FA&#PT81AC7'ORI80?/2I/'Q6H=#,WNI=:PF_&
M*PGR?I05$(J$P0=M% \_.N',DK"G\;YV=45 ]A6JYJI)MU"O7?&NKV!6L97
M>*06J&@QX#" =A8H'6#V+2W@X8IJT.Z[NK0<&CM<897I_:+IEBEWL\1'/MM7
MP<_\9TAXXAZ<!1]S?F/B< L14))"#&%(_?M IET+6=P6=)I(S%QYZU1ZYUYT
M>@3]VV#Z>]$'OM7;6[KO#1OLXN=PW$_;.\H?A].9%;9TY WQ#0C4)AE[X[(1
MSDF=[G'%YGTV3GX9P])M^F0I2MM:26KN48,V&35GJG71T(K4;_,,X1+V==8J
M7UYD5>R5::_;;>#J,6E+X5-$Y3W^A+SLU\W;N221OA _1J)5W/B9%NA$;_%C
MPM'-U,0; "$IAV>W,>PZFA;B3KX(3Y\!F=Q_=ZK6LB14>ZAQI$]8F>^)S&9)
M+FV_ZBHJ6RO^Q76NFLQ^.C%8D S?@J!LT_[:AU8:LT:MVY$/%:PT0.N<6U%\
M9WIC:F0STGY-+@#-HR1[E4\@2.3Q]I3WZ(9/-V?%6*>YX[]\U$$<0,U\@-^0
M&[@ABB9UC)] F59?W@EJ3#=9%&&<.M!\T],_9NVVVK1 /0Y>I[.% 9[J5GGR
MG:5/Z?)!B;DD3!QS/-A*TE'N$Z_!+4\+P(,R2]"+="@NA2'45X/J=(S-$D__
M&QH,Z(W4K=O+"G9WLZ8O#^M7BW<A%HQ^<[R85K87$&UA2:LL,6$L3[+SOO>5
M$\D117XWO+^Z/RZR3B-R?0P#QG_LYPS?CW+J_K6/_GGTYO8""^_&5E:^5*);
MZTIA61)@_V'R.#.TA?11:<RXN[WCZEIOW-<=)R$^KF48L!=M(7*$6PT#&G-@
MP.M037C3%-MY?2Q9&01^K@%]Z1;F=7OX?IW6<XN@CV0\VK35P3U'=+;=1>]P
MMO1P8, =K%(8($8" W:+H1"JO:@MJB.<%.@%#-A2VDZC^D(  Q(H]Z,W&6::
MYJ@^N(A<T?)W7B.;P ]KNAC]!93IWT1*F&  N]#RHP$E^6+Z/>'BG%F7.(8B
M-KH8#C(CS7V],GZU#AE0>F_[@I%_[K?EG980ACR^)W!&HR0I16\RQA7;TF7%
M.ML2\G3B/1K((5A>ZKR8I#KH/,Y]^]99P.8=6G7&K'!@V;);R!UX$*VA>-?6
MT'=0B<@SA>,F33 HQ0*O^!(;;]FM(]UMW"8_#Y5VB:3=0&? PL%7()Q[[C?L
M>B:,J[GJXR+]I_NL'POG!(D:-<5UFXL-MW3ZQK8XI_Q7HW-U5G$-W_=ZU+?R
M/L\?O$6Q93J9_VX ]9O05*C*"+W[PQU<5X<ZY]A'!)=A#CF)%/R*@K/T=V[3
MQG32OER&0KK73^/4A\S3%>H2+51]] B=F>>L1J)J=K=U,BNS/;'>.V%^BV"E
M"6_+T0P*?D6Q'.8749TUQ!HKX/&@C$*:Y"X9K\R]J1I!A&T54ULM2<&.J18R
MXWLH+W?U1 _3UY4G%7*IJK3+WQNN5ON*\I%IVMGNZLJM!5D[%)+)5U<B]272
MSJ]B>:WG6M*J/@K)7_$=/1:,!+$+B;O,7SV86KM^?&T*9P8,T(8!62+1!=<9
M<DVECX4ERUZZ#4W=0+EMT?3FG/0(^];F!*@_B)7UY/Q]U[E9AZT[^9>"RDI2
M\D-^I>&X*(?,/%ZX @DQ(#R,9+:-;FA9&QW)]]WO;V!]XVZ);T/[?C2IE#HT
M,Y_[H_AX"JVS0&1%*PP0(CK,O'PF<C@$YM]O.GNVT[0VSG:Y#@/"V:[HG?4/
MMXBNC\ =V<D4 PJ7I*7?P&:!4#>V-9W&C/53#B*;^Y=M56(1]CHD^Q\&84"\
M5--N.I1K,(VUZ2-C_[!H.4)UFROQ4?[KM!.B$X\]Z-'0!ZJ0F-6>36BG;+)+
M[!3?]'UY?$<^\I!"V\(OVIJ3>6;85%.V#GLTR _[D:AT+E0'7>1-G\?-;"K0
MU4\\Y/1YBU0*#HP$1:KL'4-+V6?>EOM?%9<31.&5XL<4O!-RS:?NGR:5*S0[
MX9\"T=5)VMM;6='%<7:,46:/?QSA$N)I2W.A&QF]+>)&^.K1O62RB,![^TH*
M"P_<UW>HQW847QM%E2AKQB+Y15J]A0&8+G:Z6.[!F2[.,MP$?KPV=P3>B[0/
M\"YZ2Q^".C.UY#"<%%-?*N8 )!V,X!\H%E/7[UNV-WP;9*EX16-7P^S:_A2>
MO!\FKB[$X;)%M5^0M.#Y&=J5SZ+T#6S^'469!\'O@$WI=0X]KA\SV[_/+,0D
M:H\GXE^)K=.60'YSJ\NPG7QOY]E!8DGHFW6W?G&6QVXJ@2"3&):;BS/WAV=>
M!)$00)4_-O5%EE*TY$EF]M4)P1I1\F-(R(D#=[G12R/!"!MSJC,Y9ABPUF_=
M'R^(L]7Y,)?.G6,$#&$16<O)JPWX:,WU-AB_Z7''8STG#S,S&"!L[_6B0-,E
M;0IZP:1:&0MZMA!I;IND/0B>=+R_RWG$,F^A,<XS)';]WIZ67:JT8'V)1'CV
M+)=S_JYXGOZ\MG8">.BV>G3CELG(M)]<T_"\<D/X<O5+2 2]FN;9\[7P^7B9
M_I+!H@K9[I>0&HMW5MP2AF\15K+Y!!T%QWW'+[%#.[@/Y!Q7Q&SV13,*<IH3
M;G>(4DCJ0<B3>0*FG]74-U36^DK1X7#>VWF5G!3!6)2RP+3-Z KJN)AC\;E*
MT.(1V*$)1OCJ$S$S%JJ J2.9OGDRTE [D,-?<U"F)+7#T2]';?E@<*MBNFF^
M5:"KA5MQ_O%&L@7X4GD$ZA:RQ%JD(COR6PQ*M('B;;UL8H( 00M3&Z]N'@5S
MY;?J*]=/U&87(Q6@HQ4P(#G-+P_D>.CO&GE%'P<^7!-991#FA/\\1;KIL=(
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M?)FMPPZ.E-GH:W-+FA;L#/,6EQVEPG1C1P^O\\/)R"<"@W1>.=O;Q[*A+KY
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M<$Y2,7^Q(Q)KK)X2  .6C4=$MFIA */M6=AC_>:4]*M(5XJ'XO<V9)A*KHY
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MA]:'82VVS[B2$6H-.B>(92IZHX0STFQ!5]76Z8?&L6_?6 ;<H\96&=F#QWA
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MIDCB5UQI#;VG;-EB:\_\:3V;7!64+M *&M'WYF;]I/U,:9"2'V\,4%CPM$^
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MK*2PC("(J/ Q$H+3IT^3DY$S4E P"K.SL O_VR_<.X#Z%$$083 1P06 D)J
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MQ%5=#&7AN9*=#I F_SEM_KO!>^I]9IH?S[SG[1J455^_6H7XDCX'9OK)29F
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M.7+?OD-S]1>SDC7(G8@9TW%!FB6I<2*<I&]X6K!\U5ZLZ"L9(W7WTK<4:GG
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M;G>..&'NI+:P%S->G'G(I4K7WCO=XR=5N,+;WB_6E+R6<I G^[L/&8QW@G%
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MI]Z.W9]O6\%/#X:I#JKPY42&JSX^=)S NS2B-_C\ZA3^@N0XQR([[J%\=-R
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M+SN$>K3O[:3+=!!VJG]H8UI* %QH Q(,_W%_U+<ARY,A2P$XFLKVB8V KB7
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MZRU[JL<<A8-RE!JD;IF=VF:"Y+26+KVZU8/"4VMC]GFT[#$J+#\$Y1FA=Y%
M#^;;4+' .3[^/8QE@,V,LZ[FQ6U#F>M=E]0.II,F"DBX<"+;BF^F<>EK 7A?
MJ-7I-6XHWPR\2VOQ NE#C:.PH3R\#>=VLR'-;=0+?)CJA;?3JXI.MBWE_Y[V
MS>JI:'AM'<6< 5C.J@,R4==W1RHZ#\8=='A(VP_RZ*T_.6<\:+6QJWD<:F&3
M(]-Y+.+Z7_G3P_^^%_;[_P!02P,$%     @ 67^=5+_C@WKTC@  ]9P  !,
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MA']Y/<' 0,? ^@<OM"<^_ZA B/'T)2\FD:PNEK4;,2/?QV<D<HD%M9W83/S
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MI@FQJ:MY4"X!-:JZ>(B>4SSQ+A=7+K^H=-T3FB5W@5!OZ<NR\,YHNYDC;('
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M_3E0&NOSA=$TCWT26[&G^V2N>Q5%",?5R?EV2984.G]W/\%GM[ANA/JNYR,
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M>>W@GEB[N_76\[H78&X5E:!=C<BISO!SLTN7MD^Z>IEBHJP;UT2':%SG]K?
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M9%-:)H#8%D#%;'TQ;-)5I*0K3#3"81NX)+'SCW[J2:*KFIC][N,719(,REX
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M. GQM>-Z90^/GM/;@80^J^N0U5OE)\VOH^YJ(FO@AUI=DEJ<>#*+56/C@$>
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M^_#\\NXL3T'4T) P$9]X6**%"^65P/'Y9;6_;Z26D(6F@ZIFR9C-JM*,P'#
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MZ(_.VQZA$C]"PIR,&&X+)4O]1#KW\]0N0Y[=F'(+C?(XZT@BBT29& C4KMB
MJ<KVM1WBY,I/%<4M+O@?7JV)S"3KM49]&#Z3>3B\KCX!E'\0H0UG\+VFF$EW
M_Z 6-O# YF?[&5>EDWPF[JG_Q6X?SL!-E19+"6/@M ,[J #\(E 9*9A,]#O.
MC#E::'GPK;]-^=[439>3$$IYXI!GW2%-?%G:ET5A?$!6(IAT*<.6\#9"$3OF
MB#7&?RN[.JX@,37E@F&3JAZ]CZ"[W7NUVU3@S*3;*Z#4LKU_3N*'OL+V;]/D
M?E+4#6NW?UQ6"83(R@Q6">9K2YPOLG^+X?K4!],WA9<O'_NZKOO7W7220J(\
M4R7[CNR  -JF)>U)ZTU\%]D""/FJMGE*$!NWL$S4U1WZ<5_/T33X^\DC0'7V
M]='2JJI;<(<&\\<V?K3O<3>'EE\3YTV759B,;7,]FD-_\M\GKD 3\PEH@'"S
MKP_1<X-2W>T OYH8 >T78!^QZCR7M47J*,%7BA$/+VKP 6,/Y_WO#:']X0CV
M0-DUWU]/G(35&UF,N =3GN.+SWJ>*^)/,D=EQ9$'H"7O:A'UC0W0JM>\DMW4
MP4+?H*9UNV2G&N]N,(4B>ILC1]YCV]KN:9_\YLR-EVF>O@R)_$/CI]#H[]&^
MW(DE3H+>/\U*'QZ 9R24$/1MV0_[*K158KG(>U7C3@=C?RHMP97=\5]5[/_$
MJ+UV]:[AUL%P$$Y0\N=A^DN_RT< SF1J=-\FO@Q+&P^WE(71#WXPBZ/IK\N(
MIDS15<<\O ^??K.ASW,)+K_6G5[4@7>$FAG<3U4^%.WO:DP]*!;MOQCER2DS
M6U+$9I2+D=(&!E5VOG9V":D+?#<Q#\WF%GAZN/Z^T'-@([J]8MD<=,?Z66"'
MH?[>;)?0'+>2= '#[ /;#Y\^OWR"=PVG/I'5L*.2AAFGXFCDNDWLGYILN_L
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MW9I%MB$IR\BJ'/K&!E=<5632)Z3IBW8*]<;3RW+M1@\GPD_E\G L0O(@LK(
M"8C9Y 6S*!>Y^C+'M[N-=MO_XO%OI B&UX+F>N8,^T0JJC(N!C/7@:X^C=;O
M;AU6%C=2]S%X[J'#[Y-V(1EVOS+6F,DIJG9==G4*"1!S'=3.8+6>!T;7?D4+
M=AR_'7+TWEW1%)@"/7&DP1GYYT!5;Y902AW$SWA;GC:QA=UGV-',6I'-F]7]
MUJD"LV6D&L>%RPLX6^&H6@@+L'9AW5.E-#V#D2+Z..>1[XTY5U4LKC:;%DXA
M&H%89D*SO'9<^>43^@BQ1=$O_I^<O;R>])/<%O3[4L?D0&^6()ZMPMX2GVO8
MXF?<I';XGNXLBND9;]MF=-U',_6 -F8%1D$[YPTZAC[G:T;@ ;\',"YV AS#
M2:4:D\])WM_HZ)!7"_;:W!7;OZ:'U-)60QTJJ0-M[.,9MOZ*7/Q9%.74&+'_
M &Z.EPT:_'5K3R$XX _*50N>WOVJEN'9[333D?R(4LZ+\?%>(<DB&O'/[VR,
M/Y+[_HGHP,,SV^2$8?/$U9\R\>PR].UB/8K0BWOA6*:O?WGZ$FG["3W$>J'V
M.4N&"T;U)7BMXUWQB%^*:1[L(/FFC&;-ZO++O>"[Q$,P/W;XT9;-+P[&V44S
M<,4. 7[-.))('X8N$GP;3C*R4&S>^.$5=A_1N(K"_#05WYUAFTH/2G\ \7!M
M!)#,DPBVK5!DM@(T@GXS43-(%E5S4==G\"F&7K!PJZ9[3*SIFRLJ"??4'B0'
M!_6%Q-"*Q"V(S30P.2=,;O:;,4X%%\Q*?9\A'2E=:G7[J^LOBP<4)/^P1!H5
MO5\1,0U9K8:R[R1K-7O2;*NPX2V?<XJ[^>T;X^S&V0BE:Y]^/A]@810JCVR8
M]3BMOJR\) !EHE60^VL/OS,:><Q#'.LMWR)T'A# <S=4)D&U,.1&'^UM[ZE4
M]'FUI[UU6J-X3\;K\)XM_YN2\U\.S2@*!?^RM2/QSV<?;>OLD)A5&.2NWUB+
M!&!=E-91P0KGDQQ9V ;O[7.B_R;0-1_<:*"GREDN8$RCG\M3_,;+6U="FE9L
MK&FMR70//,2.&T^S,/ 8R"G:!;)%^SE^8;\DDM[:7-;DNQI&C5UJK_L8.4=F
MX\Q8$:&VR[52_33LUB)S,$XDOHRW.R5C @[$IZQW*HT7LM!&#GK@9B%GRAIK
M#S8#6__(F+-5J<:#S]N"G.N$D^="@PC&6IJ<ZG>8I:E8E'@_+,R-%I156.-$
MQJ%U[,JLM9G<SY &,@]F,$K.9V@>=.>V,.^_2\L0VD:\A\@,=^S@]=]Z]ST#
M@KX<NA;W;WT03FA]8W*!MX1^)5 H2^IT?#ZEXS1B3XH#G.KU83A?,&.:VHD;
M&,G95]]-"F1&L3\NI]>C_B;F.[5"#RNJC52;8G5L$(ZTN#?*\2PW019^M=[2
M)0FX!&S *G7GY9V'F-]5APL7FBL6&:BL#[)OJ5WILEX-9(Y[\4:6VQ#G&=NA
MF:,[+^PKY"RE(5$+I1Y.T!P<R2$A\^1%I5N._MP*B<H[X0Z'MO$&D/7<XCL9
M][%F@Z5H3/XX70?K@AAU]$['D\Z]$O0^0B8H!0<(*=8,G:X*;^5JZW-PY71
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M)U)=+U0*OXFJZG*1*$Q9WCG@G'3Y@P2X/@4Y@1@I 2*MEOZ(H7>:9G.75!=
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MVOY=3(E+$7P!.7-NW<P 4>IXB0EHY0_A9_7D&Y%IA?U(/1J6M@2LU,1B\YN
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M1Z%QP]][LEZ!ROL!C'^?7CDVOV>(#YKHP H8C'[_#"BL>#B89"YDV]^)TV*
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MHF??^5#ZF[)\GG+3S',>D1^NZ#KP@I@#A7JM]W-^-1/+/DE_)JH)2UP[WQX
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MV(1MS^HDK[A]W3(<#ZWG&;KDKQ[V/JE)N5'?'F^L^V&-?W%)HU&9#W; GAB
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MTU'4A3./S;76,B8%NJZZ:6.2OLL0ZV-!">/I\]U,X@[>^<:IL2*ZHOXR\6[
M_@7%2V4[ NN!@K*YR?0#,R1%;(E:')M);SGSJH]>!?C&JZ:X6Q9<ODCOIJ\!
MMMF8]DD^^TZ.!([2KJS8J!%N?6!^495PO4I@O^HX:#1-=R714=DLA\X'AU)4
M4FU3PKSN0JHJEA[.C[HGP;;!^8)Q0P-BV>^T.C6I__$];S9CU!NS>:VJTZ"%
MY9?DC>.\'!GV^\-,\A>/D-:$7R0N@L >_,0CS"0'@N'1CDA4%C#^\F,:YL"-
M^#&(923[GH:C(,DW/)S3<9MT]WQ.+XT1F\?^]PT$M/1T'>@8A(CK8OK%/ =
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M7]AA>&-##I@'Q .* $=:@H?O186;GN$GR_!!+'E\=NN%=0Q EUXR/PV,!,+
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MBJ%7<45E<G=Q.K^ THMM&TP7;[\[?G=C.NAL0:0L<G3Y#!2USA[_OAQ:T>.
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M:NSKJ0OJ>A\0-77ZS@OOD==0.8@ZBR:.:4CVK&&#,!K1_1[?5-*@,M$36S
M,%46Q,?W$6=( ]^;23*2)H;WA,MAL^-X8<FXJ<1'^J=AFG#.5LT7;W75,R^$
M66)6FUX"(&6'@=F!.8>[AQ]8*3K/  .Y&<_5V*(JT6ZFI Z)6'U'T$9]$GD*
M0FHL8K<]#HPD):(;(F,SU87E:@F--6^;-,\ DZV]6"/" DZ$F96+SMJZ+(/Z
MSTB&2?S>>2PP[^W<_YRN].U[6^)Q!B#-9Z3?5'//4A3V<UR%V%(^3N/N /]/
MJ!Z2XM7"T)WIBM)J$GEJRJ_S8_CQU>IAAV8WROJ,3B3HUPXFB ^ZH;,&G&=
MXPJR[O2"T?G6%J&'^H_X0#P4 )],$J-_U&MP _ZS52WA^"ED>1/G.1\L_R7/
MZ$D;L7#/JW!_T"8>_[-LP#]O/1F4%!X5R17NDY%$+M<D4]C/&"$O(R<<)PO]
MG*^JC"LR&R_,S*?('/@17@Q9@+^!;PM/G 'U\"A/SMD\#V:^'Q%+"?(=I>8T
MYM:#\@NA[R9+ +?)-20X0$,9X)1AG0'B^9>1&:@0M[)3#^A.OM5IO#@=S<#.
M&0#]T4;R6QO?3B)Q8BT)O(,1*INS$">-OJ\%W1NLB_-DW_)'R]XX5C#@68%N
MDU:< 7D(U!+6"KL06@8&_R8,OWVDBX8E'-0A/-4RX!T$2B>XH?,&$%"*U/;0
MQ1A['(%U<_X)Q]NA1UJ=;M*H5[GPU9ESOWA_/"CZ$73PU<_0>0/.9?IMZL(S
M(!^$=[LWQ.AE/*S!1GOB4P>E^4=46TMG0$M#KV<>MGM"ZQEPQ$QR!@P_0&M,
MPXDJ#KU3L'K&\($#X@#\+\DW;.RL0KCU$IH:S@#RKM#>G(+#'+MA:C;=>CK]
MH=Z0O3:4$$BL5]K0V*A,K+3#EC/@!J'0:;_.)!XN2H,;O&O='H(X" X.7SJ(
M%LVAT\RH8"WZO?J>"P;D=7,VU^!?;L 2<#E/,[)L41"=A///Z/>:-3,:OCJ*
MR)^V)!(YSURGW_HP :^$E!Q"6]_ 06:6\^8PP';6O=/W0/HZ]?H+XMF3JX?V
M"4)U9!A+<[]Y_C5_Q[7%JW_7H+)KYA*'A7O"3T%X*P/JSCR&7=X"Y[S1Z6'4
M"WVP74_);;V6%MXV/WD2Y8!FZ.Z"C^LL:4PE%$NCX,OT>UTY$ZL-4-/00W0?
M=#4FKV@Z?.9<5C$&M+[7XH'#0 /B_/PG!E1$R;5=6TJHUR-\I^X!P/C_52XQ
MNSV?:BE%[+.N"JH)?WH84H"DA:%UTE7;]]$&I-U#!UR2)JL[P-T(U*KVD+Y2
M8KOYB%WZ\?M(%4G[!-4?\8O\Z1K+71&84'!;A^%5E?55'3*UP,(H&"<"5U&7
M>TE>-W-CO<]4C\>*B](YJZ-^]9'X-/'5VL"[Q96&0Q8NS-GT6_E:)16O-K"C
M\:X^>!*F%;OV,C)\J[R3Z2'/T=-BMA"QM%1:EG2[0$DF=N#&<:]X*F//#6(5
M;33#\,U>GHY;3G1/*"7W>.\4YL%,AT)%FA-)^!]N*[A,5.3IFY>USM@],#K5
M\_3*_#B@LCS_#<_PN7Z^HY5*17G$QH+\&\6GX674 0&0\*H$<TH62:8"<&+)
MP&?"?+IO0Y.SQ%[?$5[?XFZA<O%Q"--2 )E6S"&% E_L]XHGV[IYFZTU8COZ
M/-'O1)6$$=T:X@Y$@[_F2I1D34=0[R@%T*^NU5'O%OWFXU?YCQT.#&D>:4@0
MZ+4TO467(SQA@EJ?#>C@<\FRX.QI5BI%"%?^".=(>N9L;28 2Y-[&Y"9I &M
MD4DB<'F*]]:MCIMB9?[[*47GIA$G )B-!190KFTOF1GR/YR[_L66J$4&;!5L
MTW7E(:U5<;,7XB'0/R1$XIY>_9GXR%#0OU8\U?',G+R2C\E(#]-\-I\:WKZ8
M Q]N.@,$3WA?['D\FU4ZNE9B?7QHO2A&+^YQ ]0;,B_>:G4)^J->YL%7<^""
MQ[K3Q*@(J=GBP1W%)%#B(0G'*Y-?O423^^OF_#).?=NV\Z/.@/FL8]!*'Z<H
M@C>XFK!/3/^Y5NL,B,Y8/37%6C&@@'<00_?FZ;?SW^^&'A%J@ZJB&7Y,DI\A
M# HBHS!X&0G_7&O4!YWC!<V&P>7S8+67:-CA)-@Z0W^\E/"YFGOZ*WSZ\=*W
MU7WO1XO(.K1L,W2O%QKE8M"4)WK=M T=CPVXE[78 KV/MXFD1UY8(VSKSD?=
M%52+WO#;:Z*WQ9EJ R]ZO-A>M)OM*S\#_.';(F _ZNNB (<$RC-@]@Q0. ,<
MAN"-2D?4>=!5[U\TV7/_1H,C:BOHJA\@B=1%2V. \^UGAJ(] \)",M K0P8M
MUD?7H.MA""7?NNW+ R F@P&[R\4U@@MJ;/O*'0R.Q@_?JNGJC.IDZ9J2DAM%
MD!CQ\CWY[T4='7^-.AK\&G74="-W85X'AXY^!'IJS[OI^%.3F9X!>YW#.EOM
MR/.0N=<*9&WRPAG0'IP"'R[/#_)7,3 ^9$8_L*1!U[2 L/F_&8E!T&_T8+\H
MZ3C<E#UY%,UA1!5!E#)2^?EI(6.OL"J@T7"!6E5+6HJZ*D5#@8[\X^Z<6R_,
M#?WV5F#V%XNF POG!YZ2QEK7HF(.(I^W(GCY_<A49 ;.PU40(TDD.]K_^C8C
M!Y'KFU!Z/Z->A7NEG(C[<:;;&B+.TLC]#R\"WM9]7Q FMXK)BX>4,P-M7'?W
M>7=Z@3VJK.FJRM(S0,6>#2Z%T+!:]#.XKC 1&9J$%0J3N$ZK"&E\UQS;!^1D
M=@('Z1TSM(;/1HZ#YMQY#4JE;[>;3XRU[W]!P+YV$(SI-0>(K 8/U3+H7C<M
M'N"6[;>]AK]C]BS"9)SMDPQ\Q- LX7.R1GZR4,$1V<U-32UV@Q4^6%Q'_(8:
M@YN)MX9I<J%E3;=='+^:7H'FN:-2^\=X=BP/EPT%C&^E!SE:ZL@3[[HH'HBF
M?]08#^(D3Y%Z^[&2=O(E3]U:UV7Y('F^3>+^ODI\,0# \,(!=LE*OD5%A?KD
M:PQF+AQ[_\R2[1:!G'M8'[:'#<=Z*(,"].QP."WV-XT7D("W-&^PJ7(4[V&:
MV*OW^N0E^=\SP;;E_A[&,9>>,?&/AU?EJQ720N8Y0J';*HP@6H$8:(9$;;]K
M2SABB8 /DY]CP3L_;9F!N<<Y',"5 NV@8W[ GSY()$K^P9?OVRX'6+_GLVP?
M#YKE 8Y9,;K8?RY\5>.@W]/ ?TWS%G]_D[NP,3N:N0=_D1GIH=RR[VO$6HJ[
M\*Z +F6HDBKEBJX"'C^I5+M2NJ3=4"UEM6/IB63/]GID:^E&A1[<?57L"C'U
MR)&Q=$F4RE'I["G\NNW18!4]:9.K[05B@B;&7#5S.$'(H-@AI/,;T\"UP,>2
M[PE"6=[&>[IF658+\):F/%M0-,;CC'=]W;JP!JR+X<TN7_9@%A3*KE*@Q%=B
MW%C7OT:/7"6FW^Z"1]G5778XD:\C],R>H>W7[:*/MGMA$%N9263Y(S0[.N+%
MB(M3W:UVR)SXO#*N:W?8F8"IZ=UUHI?#:?&FF[% ?:\PG_FT$IY2FD[[]OUP
MF88/>3+YH27$1WAZH$K41#ON=RVB?//.@%7?,X#!X,IS^K]&D 8@@LS?R\_F
MV3RZ878&/$:B<N;A1\]?U UYB:8AG5%A(%Y]I'(&W#X*E0%UUF#HJ<>/8/&Q
M?<ODMD3WJ:LT*F=!A $MH0G=0]*C7[)@+1,'GP';BJ YR'N#RFE$T]HCL<ZG
MU3OV0.E/+9=08KU5\%000]('$&TF)SDQ4SRX=*S%M+6)EOY ?TBQG=<V4[UJ
MFURO>??#'1NQ33WGINXC.@OXE,%G+T&E7W4LJ'BMX*MCH&FJ0X:BH;N3!PK*
MAV!'&33:3FT2"8E?UU(-.5I?\4QO;)1-VJX?$S&7F'[EG;TT7.F[<C44L]++
MKVHX]15#$C3N!N,>XVP:0/N'#"%CEU"TY.KD 43Q[[&BR/C68F@@O5JK]#C9
MCP2D&:B$+N[OL+#YX'>XJ*4T(XP:/AV,]WN$=_( WK8?"EJ!+O?Q7Y7ND >7
M\#GO?"P8<,+7 -UF,#W' +,W_HX9S\?05HRFN",M9 +O5I2/)/6FL8C7JE+V
M2'!A35_>.GG!SH-VO#T1%LR0T!F(I>%\HO:M,AN^5B;ZU2LG32,Y$X=QQ:=R
M!+*[5<E%G3=DR9YR[AUK.KTU0T@ZDL]_3:"F$;(N8GP^N2JP(H)MT6+B"'T3
MBU[FM+Z 81GY<7ITDQX!F,]>HP9)NO#YH&BP*VE]ZD4T'_1%2O$KI[ I%202
M%&L\&V W4#IQZTP?MCH#N$>2^WD#V0WY(KK&7@II"T9=/SYEP=S[%ZS]#QE6
M!)2/6'O>P?I#ZD5[23I-AD>J8Q^XI#YUO+WB5" 2[%YB*\JY51=/H_I):<+[
MI)F^&4)=4)MY8/<1_NG=I_C.G1$6E,"&"$N>5<9@ACOO.2QL_<<YJO=]UL@Q
MC(W\L+)2/%^.R*U%3$SHYKQ?GU;HD[%)U,I?HN9QN_,Q>@4C;(?!+;9CR_\5
MA?S+1V.9?*J7,J$-^OH._?ZWJT2E>3L]B^/XUWP"6!!*Y!;_&UF$WW[5J?DY
MTG)'\K/=J$A9Z&K L.RV]+N?!C>_I!;$&.V^H*VN'&YA^,-U#ZZ*C&F7IN?]
M+JKPC6E-6O$P3!:L;I3]C,"3P76$ZHRYC.6"5)@?M*9C222KZ*$E2B/# &90
MTZFEA6ULRWR1L]'R#! QKRA_)U.M?.=6<1A6N=4S?EXI=NXFY17+S%:VH?D0
M>7]:3[<>G./=_0P-R0$+^.(VIM(I#[G%M:  @)58#B;1!=A2/&(O?]>ROW^5
M@T 'U;ZF]RRM#1_[EG?VJL*,TZ>:JH!E?8(O9.8MA6L5&^:PU088;VL2^?9(
MKM;EZ,?((%*9UA?%\;1;S;7TEEF9LCS\ E(J.U?&XE-[<&4E;YF9_@4FQDU
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MA?O^/<_S>Y\_WO?SON_T.?LPSN,\S^-[?(_O<9PS%_DS^1NP6T=#6P. P6#
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M]MG7*G>C'FDUIC1,>'YYGMO>KGRO&*M'>II>;>\N=M9G#TT[C#%.$@?7VM^
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MU5*^6AVXP$X&0MJHM2?5><=^QX.^0I,0)HX>R/]NSK@A^GV_19]#%V^OUT@
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M[K&MBH&+,LS?3;C36'%3A;<GYH5VWE^=]T[N+W4_[R<HH>396SQO8Q#V+=&
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MZ:Y=0\DPYSIL4WBK.D*D5X&05W;)NQ$X&^4@4?#<QL%Q9SJ,T9"UWY<Y-_+
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ME&6-2/1?]^1GM9/Z+)A_RN"&.B/##>JB/WZ3>'O;TO[A$9N^D)3(7!H_$07
MD26V=_E.I?>9\6-SF\^;H1$3KL7%JY*3$[ XQN<W[D9YL3)<@O>I;#:4>W\,
M\B$"N!/Y2-JD0'#6=6@C@\LT^/&_3-@2LS"I<-HYD=9+S9:4:WWI_@[7993
M@J0CBN*Y=^$71*UEZ1%T3IFRA=O6!%O):YAZ;91%@]X;>G>_-2,_ XN(>9%G
MPU<6"'DH5LC(FT6\8,J0PX[L"P>.==$W)UXEIF:^[A+/%]*/;FIBXG(;:G_2
MR@!)YTDG)8G^_3+DR'H!O0FZ&VVG2BMQ!NUK9/(D;NF"[_S;E;1:=8^"E55^
M%@UJ:V<3](>YZ.D[*)$*,S4D2&\3&"YC<C7030\#(:/@N'/?93GD5J7'W?5A
M(L X](5Y,9G%HC@B NAI&W7WAA0D6$M9]]65DJ>;VW3<7UQ>V,CN;9 2N)^$
MN";UQ<1><-JNM77>FO2E'^3$^T]9?OPV=E;%EF$&5!3GLIY^DKS8R3@<%J6D
MT9WGBG8K>6!QN#'<I=.H[H]G_C]H,.+G_P502P,$%     @ 67^=5"%AF]RV
M-P  %$H  !,   !A9GEA9F]R;3(P9E\P,3(N:G!G[;L%5%W+MB:\\>"!X!K<
MW=V"N[L[!-?@D 39:'!WAPU!-N[N;@$"P5V#:Y-SSKOW=O=_W[VO[WG=/=[?
MBS'98XU9HU;-^7USKIJUJIX7GG\ 7LM(2$L (" @ $8O?X#G)8 8X!4L+!PL
MS"LX.#AX^%<(2!C(2(B(2+CH;U Q"/&(B0CQ" C>DC-2O26E)R,@H.:BH6=F
M86=G)Z;B$>!FY6=D8V?]U0D$/#P\$B(2#C(R#BL) 0GK?_AZ[@"@O8+@A1J%
M@B %0*)!0*%!//< B $ "!B(WR[ 'Q<$)!0T#"S<*W@$Q)<&X-< 2 @H*$AH
M*!@8:.@7K>^+'@"-!H-.PB("^T;9&([4"8,U\$O.*S+1JDY,E<E3<C83YR!X
M!"QL'%P\"DHJ:AI:=@Y.+FX>7K%WXA*24M(RJFKJ&II:VCJF9N86EE;6-BZN
M;NX>GA^\/G[Z'!P2&@:,C8M/2$Q*3DG-S<LO*"PJ+BFMKJD%U]4W-#9U=??T
M]O4/# Y-3<_,SLTO?%M<6]_8W-K>V=W;/SO_>7%Y=7US>_?++@@ %,2_7?^?
M=J&]V 4)#0T%#??++@A(CU\-T*!A2%A@T464X8R=WI"R!K["$/V24]4)3\:F
M<HIIXCR)@$7.OD9Q]LNTWRS[YPP+^E^R["^&_=6N10 2%,0+>%!H "' ]1UU
M;@!2M$ZEBZ^E.7&*FQLT?+I]HG">D*I>442+K4,VN\:7!ML4OQL%'8Y^/4WT
M%1HQ?R@%Z&G^4'7-;4VBIV!P)*ZTGG01'5&=6P:#&LM,>8< ?(9_'TC<"6F7
M"#?OBZ)HQ*M'NAB[#Z&=DQ1]W@AJ9TA?@\]KM96RCBO8M%;U%>J#$UIG;PD3
MK<I;WZC9:?2,79T+=P*KI9A==(1_'LG;N+!/UQ"*8RB]S052 _Z+"]06LK\F
M;WV8 SC0=6B4Y=N'*(:D;%&^65G$M()9>A-PW$"F;&@*PX+EF'W.SP6/7B^Q
M&[Z.NNGWOB9G9B'7YBX=9#.F<&>%O6N*$"+D]JFCQYMNCK+.K_8^SFC:]JHH
M;<D5K]'Q4 V-#63A[WRJW>6;UO+\'LRIX^>6:GFZ(W2F9&CZU)P*_40@])/9
MX!FPNEU),ZSQ#%#]IF2M,_P,@.#-0LE"I_B)K,W0VV@8W_=A_';4S2AP\*("
MNYOX&^L!W16#QOZVNHJ<LXR6Z5QSW!2X\()_1$6F,&N3SU%@=Z#"4+@A4?'(
MF'QLR=*H.?F4SZ1TR>;Z:I$Q\VMEEI,3GX1'G=/@=GF(]$J_>8/79(/7/&T3
M>"%:M:9=:C-QA>4MM2.NHHT=:*5TA;HI=*APC$.U]AGPB@P,*.&,JGD[A:T$
M3P70Q.<"VA,6-M5;^82:+;QU:']+*'7Q##A0!3,HJK;5SI#7A6$MDB^!HW"C
M(*@NLS%Q]?4.Q4IPX8!<""-3]8)A=B$D$<*0'X[TGM+H$SVFEE9ORXJKW(,U
MW.EHKXC2E2@4CLHR,M<DUO3J@X\OK5UO"UH2R"'2R=XLO[E35P7MTU]C32XO
M#9/IMH21Z[^.6KE _29SY,XGT#T7U.%6(;&DT_;UM$?3H]<\5;\,;7R%JM#:
MZ QY6=$)J9 O40JI^ P)X-\LS,O*NPS4&9IDM&P"L\KSLVV>GKG>H>G4XH(M
MC5Y(\EI9' /P7T @NCV3M:RYZ,BLB&W>$*2@N8RWFO:76)]3DW5-09P0T4TC
MT#'B0!W:<M[U/4DBFWM@&/E#]>!HV&?65RU)8F(2:3/UIHNT33=[FBC>K^?$
MJ4^;WJ]@):-L4K@;&L_?^=8->(<JWLQ%)A2,2(</)S28+K_#0,B4/8PTH$7;
M>P;$L=%U5>F,VSBL32/'L2SF!"!)@ES-T%E$BY4#8 5@N-U *M7<M/)C"G+;
MQ_Q"?O6:BJ:>7WL]GL XEM:7F$:>OB;1\E&XG 7IF<;CFMQ"&[JUJG J<AU9
MW2><.?[.E%!'&NNO&^X;BC+PM@4<5SM9/S@7:^<9SQ,E-(H#2J4)1OR(FFLR
M':IEWQO'RM\D\E??!3B)]X><;-HNK+6\JV^^3<8<U.B (UK6E!>'NJJFU5GD
M  ?IPMU^X80M]S_$7\H07?05W><QK;.PZH*$IYIKXJ6FD"^K=5'V=-][7_F>
M:,]OE,4B,MYX(B[N1M6.G\LU+F]9%O"NWA.R*WG,>[O)BYIN46H[)/C8?-*_
MYMA>.<)<CI7VG&6:PV15?B9/&FK0"E1C@[/1+_B@<8113C0EP1B>)YC&,7+>
MA$OU/C["&'M/5TU9+OCXN M(G2WRDIXA_@L(E/O]U-%Z(A @WW9A\O(C1ZS#
M,LKP9Q$>>CT 06Y6]E%A6!9LFW:0#%HSJ"0STJ1P.S/LYCS6X-EN(&M11D?=
M4.B1<8HZ/&:3U8,6PN;G/@F#63:][R,5=\/3#'/UM7,I,NSF.0#K;A,'YG:4
MBAR.>M' L>=^,?YG;$R5FU"@#2X 62_R&]CG?4"N=F?E9+O @&^V&;[-$YSM
M6G[0/AVA?^>LI_AQCCL*=4/:X<RR6U7P&]XZVN-.Z'I&"M$<X=AY'$=6H6V3
M00UV2I&AF'.K8N(WLGT^C8!\'>O]SR_Y">>?<8>*Q9=D&/(8P [Y/%NIC_#I
M7.PV#1@C5OV 0(B'. %Z2(:OIF@4MU)("-M'H!V"<6BG,D%GT:''$&E?Y=6T
MLI89%005#/S#39&)NI9@D:8X*Y<V!B^S.=G;C^G3>W@P&,K"_T=%=0;\BGV4
MUW8I"1Z)KC%2E[*E?H.RB)S7O# =]*GA_8" \/@S0">5-/_6Y%N_WKY'.UJ+
M/DS\-3),_A1K)Q&W,,3;+P>Z(6OJ 3-8'3>?/T\SGA$G+#9&AS0(\DVU'^0\
M R;DO:&?<%K3>J T[G7*PZA)G#JCI^+3=''6K+NJG8O': T_T: +<F@P9F_0
MK+2<;<SX")4QPQPY&-GC>B[3[='$AQE&?'PH&WABJ>YVR9?"%#&WZT%1$+")
M:]O4*,"13*7*]H3K0USWI7M_@WT*H#0\\:^EJR*DVT$-:2K;:V.M-O.1=)13
M8)O1G.PNH"RW#2D91PP7QU#A0GB93?Y[P@8&Z:R^FZ9J;S8B#;4D7+A#. UW
M /M(GWV1'4[ZQ(L5:DJ"X0KPFE<]2U-WON)5X42K(0\@'FH<_UST1-?@$GW)
M-%U56,>]/YZ:6S2Q%+VF_FG^7*LH%&>Y#XK=@J6C<.6!PHJ!W-97;I U.D';
M$6?>S6[-MLP?C;&"\:/,\8HGV0G-+MQ4'878-C/=E\P-D)PY8Y&\'@?.4D(6
MMX[!OA_AK%S=. 5X63[$(+"M#7Q!]8E?$0[(;G4<A\B:4=W_7;=]S4#HS#H6
M%4?DD[K&1X; F1V0]HUTB4!]N'QJ^['].GFE75?%(H%KT:!JS'4J=6[^R3]R
M"8*U@+6BF'IEA<98GW?(6WJI$<6I0 ',<;*;I(WFD.8D\:DBJ_5/:"ZDEZ:/
M$[9\DC=NUKYKQ>"T#+W%G@T7Y)1>QR0VCI[I<3+TJ1JI5147@^]KHR27[2$Z
M^D6IIJ$_F<H8U&IU"%QY;&=M"OL%L^ 9MH)X\N92M0KPOP0YBCNWT9^J/>'3
M'C MOE\J#_"=/C%8*MRKV?,2!\=7$.;0EPX)A5 1%ZB=$5CYL)7:BSM<>'"3
M\:\72%^REX4$M3.)?;[17+]=FT$)\W<T@%?S34G?L45=JS2#XS@7_WS0=Z8G
M(96*A4X#1P"\*Q)O>9J8!#'>4&K-1@DXC:K%?)WE28A\\4'^_C]TTG^6H,I0
M9\.FGJU&HGUMF2;OT[1EM%TXFVH8#R,BB#,X'08W;1\O75<%SMP!K89J];(/
M/U!U/P-NB6K;[W97[^ KW9*)!=K=4 U E,B>BMT;T81[*1OO(U"\"8O>SD\P
MX-7$W4<I.HVJC^F@M;BQ(/@7V$=QRP6<0J=4LM],-KM'Z 8OWE:JQ<XFKF7
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M763GQ&@T1F+$]6[.NKZQMJVZME5I$$W_8"8P*YX!X,7-@UM0&#6S#V"1@"O
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MSI)3S;Y\*O4SV>A=J^K'@N"M'R?JQI,!/&6<FM4+^O2G53C\E2:T:\I%%K;
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MILQSO\T%_B1AG\^X2741;.3=V0I'H)N4_Q!5BWHUN^UU&UQ5\3@]/622X?X
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MG+I5I4#&-29%..GB,12LV] 5C[I6^]8[M]AP*[6R7!2\ZJ4C/6,GE&ZS<(I
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M3Y[G][S/_WW_U_6_KO<=CNN^S;G/.=_O9SGGS!QB/W$,.*JJI*($D)&1 ;?
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MJ3V#.DD%6&GA6,OH89]IKSECFO.S;_5<#B&<GDS67$4O(SH[XR*]G$:I7N,
MCU:)L!6[@703]BQ+WKL=O19[T;_A*W+ :%XY*:*'E9;!HSF @,DD?S)[(N85
MGND\5.GL@\&O<@56J:ZK4U)WXJSP" &PACE+?5>IZ[.K/O;%?B3JYFMZ2=XV
M?#/&]L:V8/R3C=L*PMJ^OKDOZ\@_"%:-0IJ-=YHZ5A0?UQ*^M_+6V]G+,\U
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MVV>FMBP>)_R='7%Q6 ?L%_CS)P9Z*YN821&.W!VA@BG->YJ&\A"E>N-0\OQ
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MOP\S^BLU_4H<GGP<^PWB)XE<^D,4\]%U>X-S%/&9W/WFIPU3I^*-R39UOX,
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MNCYI:=H[/O*UP0X?"-3 R%8[8C%@:4 6@PE!'E\.EX=(P]#WY9=_6HK^QU)
MQYE2O58/FAT&%1L$?KKVP!Z1ZF+=V71?;CS)L8P)K,RJ'/8(+8JFFG,P%##]
M@:E:*6&7?AW=Q^TZNZT+JP;H;/2CK3JO_<D4F?JZNU@7PXS^!T^9LS/ NCM5
M$5;N* G(G6NBQYI;J1B*(-2MJL]S4HC^U/KT/4CRW1GW.*)$VYTM>ZI+7*@H
MICTFP]%Z3BI((CY$H]1CE"_">WFK7!:T<N=WHQ>*IZ=;P+JR-K84W=&IA^>7
M^3S_S>KKWX;$GK%L0*E1SZ]5)<^ZSN?^_K/+C=J"FZE"DQN)IS0]/DZVP+7L
M4V_I-R-/B?@-L8>+.2@.5E^$;;Y#YY,;1 )V1XN;(DSHS@M7]:AJ*M5*Q-U:
M=A"-_F%5U=^,9(M<1_NUMG&$;F?I4?8GL"%IO1[*J)W/F^BI8H3)>7RXT&3"
M49KP ]YRI3BI-_G)* ?(J3FOCLP#$!N&9<$RU/&20FM+.8)=AC'-TH#9=C+9
M:(7[@@TI;9 L$2NJ(&6$PN3_@#>+L,;PV;[5*P/)"0;MKV5(0\B3%9:I&/97
MTF>1V9B";)*SP:< AF/]%,_L$)IE]9%>BR.X\U@O5SON,SYEEBT,A7=NZ@J1
M^_IZ;_AZ2ODX*3G2S@N_/ W)RWN0\QV^!#SRW\KJ_[RIX0TI /JCYK6BH,XC
M2UW?RJ@9>:*BO=R5C+@N%8[W]%/2Y0\*:,)I)I(^H'&?\Q15\<529%K=ZG X
M[?&CZ:[O1WS(J*AJJFUXG\_5<.1N>NF0G$J1Z:?+>94B$\7"1-,HHSC<^</7
M?@'Q=GJUDAO/,&0C.*)!P!;W<']S[^0AKC+U<T$& #LN(<&(Q/*),H:Z$4K_
M((W:SM,%#Z8AJ3U+>)_020Q#KN&->D7+0VZ6\G1L-E]SPU1<SA3K;T^/,<$?
MG-IR=(/E-'Y@?T6[&_-W3\7T&IUBX@@QC3,:HRJKE2U+$$S08G3Y_'6-_\5&
ML=3*/JX\W[?OOFF1%-+,98]W7D8. '8C^OM#H6<YCV.5QK@[NS%\U!]()3*1
M.>5N'AM&V J&*!;7M-"^S2PP2X8G<T@ 9M-K+XZK@T=MOB9 X*T[+.CYT8G/
M&(@*/86W[%-/3>:K:<E[7X9ZD@#ET@1#5\4=#Z]T6UEJ4]UC9:<)A%60K@4R
M>+O=]+J>N!4=[$PNS,A1$%4?@(J8D^-6YI7W9X+B\[Z7]))(@.?];NO#,B+O
M+ZM+4['VR$:G^)*9RL=X/&W"K$\$LJ+$.<,Y*QW'PUL+0:U:Z?M)37-?JU%>
M"X@_]K(5%2(+MX2WCN9%()R\Y%;"5[-SD\,%L!&F:(JN:I<GG;2=>MK:G%V&
M![X.3@*.0=N=F(#+N";S5;XL?Y^YW02M]X+.6\F>:N&J:JE0#<]#DJT+7>^.
MY2AYFD#X=9HW @Q ;A<-#]R(JK:Z6[5\9560YZ< DIZ'\4&M7A6BQ#5+CL]3
M.NL0*_MF^W*H>\A>R5[K6>=N*9H2I6+YAX!-<_5VF#L?0 %V+F*T\S5GLGN"
M=_]CG/_?9O!*8E]V&.&#CL7]LZ<J>>M"MIZE\>W/)D@MR<2U$)(@Q!F)O!=Y
M%]C9B? 0Q&DP02!2-[>5S)RYS:RT%6[Q7.AL4M$D1[<-G=5';S#B<QM1]\VQ
M?F%$($0);8MOW]YBW0JWG_\ZF(LE("#"T&:<,4]P2-@>U8:AI0XKJMG\=(^=
M)DJ]9BFORNU\I; K?5?%K6P/9+%]2:(QT%V'UP]R)_Z. '?UUJ8VW5=D!QO5
MALD3W.\SM-Z2,_ ."G#>1HP=%S:C6VK=6 0=.(4][0B@;5+L_$%'%(5ZN5&7
MQP@_X 0%4'>;C<<JOF7Y2KPJ[[CPG6:/N-3&5@VW%FP@+=B902R*]J(*K-C*
MU*:7$6]\)3-W@R58_"+=5T!S#**>=^75XHWYA3!V@X9(ICLFTJ^/HNU!/B6&
MS9.!_.F\-K:@0NK>48NO1*NNRU,$6TXJR.CVRXV:C"+R&Q(V_!>A+6F!L^NO
M#TB')Q??5_0U,D@_JG[W")V&2/6;HS2%CP9#$XL/+//&'C<'9AZ;QR,6:%'#
MD]5?XNR'[%BF8A&VB"&EM":$S8_'?1)(P"%2J6D9M%8\1%O8-209=]H%*]J
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MM80FH?MOOMU*">T3NT\LLC@?MF^;=WUK^6Q8DY>2HB0NK:!5;EK(V'0L3OK
MP2%.XU/0D&S; <'$:"5#(;=/QE_E/$ZAH3:'.TE9)C4WKE^-^*:ECH (![=7
M.G9Z*=E*0+2- /&D@']L$MC;SZ]Q>3]EN77D 9UJ!$U@VLKCUF7U<(.G_(8B
M!V&U<!<;80JP7XJ(8+6>&VNSMC^ &@HYR1]]L4J(E!E<TB2=0Q:HNQXU%Z6K
M/A1%RR2C*2J:DZ/:@D(U8_.-F:>RA8NB$0%CG0XOBRYIZ3^D]:U7=)Q4$PI+
MZ:U[?H&4.GGQF\#0$:<:Z2MW9(VX:UW/*=4\-SG>3 &NGMK#?RY.04><W<N-
M3B4S/8$V0/P_MR!O_6Z=@J6YV@^1P:Q/;WW8E27IP&/8O6)ZJ[%(JNN> ?[)
M:R_5E :(>EA04YO<^\.O%,V[BU^9B/9>M;N-OY>>U)H6G(G([,BKS@KECQG0
M',O:QI3 SO=/S)"0U;2FL09CM[^DCI3Z]%&5DQ-43VGBH>E+TQ(&0ZQ(']3Q
M".Z^Q:6WS>=#[80Z('(TS3UVBK?\)DM26[I/X^"K>;?+; _>"E9L/GV_LF^*
M=^HJ!4#QOV'(C)N-C[N<:=\LH!:-XG5Y\PB?$*S7<[:]!<[?GFP3>X>4Q[.<
M5&\=%.<];W*#QD @U,P=6&"1"#LZHO]2\YR 4-[JWS.<4G?0&D@*"I 1!]+B
M;3I2Y&BJ5FQ7E\8_OM^;]^;=8\/O3P\H>=6:"S)8=HPC-5O>(:$N;4Y(<UNK
M4\;YA,#OQ.KV03T=E-YE?._$I ;JO<\D<1)1^-3KA'T0K01F)@CI-ESWXM12
MX//LX$RMP-=,3LV]L4#M3&6>1>M?F!<E'UI%O:UVKP0_6NB$T,&>W8[$&;I:
M7F[9\W7Z.GO+ "?AL.I1/SW'[K4V]5C Z$=84^IV)3#\DL9Q1S56Q#Z\)@*0
M@CY)EJ/QZ]]N7*X8^T(YJ.'0><1G,4&_F],I=O(];,VU.]1>(M(>M19R'KZR
M=B=T\.(#-;D8X)*CFI!\BDWAT8H*EXO"A6]X&B^<W!%#)QV^^VJ9L-/3*R5<
M92)GS3C$6T3=]NYX\W!@K?( L6CYDT.Q:,#YE@MZ5W=!9[T70(>"&F/!8':+
M5X/7X7)%&[238"Y+ /H"!O)#A0Q'5L/;ZZ#9>]@>)P<D4@!6N X%P+B53L>:
M5(^%0#C%YS4/5KF%C6LBLV^@9_+D<(1^>=(\DBC%+D]VU:4 GHVU 63<1PH@
MHO1*\]B1)VZ)G3WC1Q53LL4Z#Q0R>5V3KCUT4S*: O@EIE$ '#,X+QQO;5,Z
M7^FP-A1BV0U_/0NOKH_M/:$U=&'?VZ(BPP&9$^$RC_R[@//>:>JD%[?V];3Q
M'V6+A[I\N@D'E^_]N;SLYO)O_9?NBA%V]5BX-X:-F\!^#-51AT T&J!-O"RZ
M5Z[H$=JJ#QWV; B9O4LHOPQ=WM",'@[J7:Z#_0*ER#%!U)N3+4G%:FC-3M[/
M>8XP9Y/)>NQ\X!CVC4#S7VL"B];UX8.QKWD"Q-.N0O5/JM'L"3^B=SX2WS1E
M$5Q07/E)+_&3:REQ;^?L>,9GT(&<E7-?M)6>M2LSZ)PG* J-AP7HA.I?W$D!
MF.^^I0#JS/#I2 K  L=+MY6.B(B1YN#EZ9TG)LGE'UV0Q1;N 3(JF>448,MH
MZ,JI_-Y5)NK4H3/)G2?@+W,%&Z<\S?.%/_ "-".2%>C?C1>G?QE_-&LW#!E9
M/@3P\M)U1A_!HV>BQWL7=H23"3 \$G1YFD1O00'>HXCB2[FP)1Z18I5FD:_Z
M83^\+0&]E8!/AX&&J\N_#,,X)@X@G3W2D-GB(O%VY?Z!^=T4H%I3QX6 (DHV
MDF&V+L5I_G)MS4]2+G1H;(<(G#VKVR'0GO4*RR<P;UMEAH">C[?61T"!]:9^
M+*4.%$M<!O7WDR50,^S#1+>_W/J.CB[D''[=/(6]RSL:.E#-'CG77<?/$9-4
M",?!_=R?#)A#OP6^3#@-7:J"T@RB"NKN./2I:!LK&.M]E;YB.'!:X^.+0Y9F
M:.UQ(NO2O<;!PB<:*;+0D'%>.S]<KTAK\?F'W$<93C^C]:Y4D=#GD6/RVA_B
MQ4:CMF-;Q)FK00VTC2=C94$E"RND_JS8C,O),]BSGRX>=F#OT;A><-5)7.S&
MC<,F%( H)48!$BY0@%*?\,=&LJ^BS!YD"KEJCBS4KO')3MC5@KFT@9-H<20B
M%%W>A%YE1 ^HDZ%%?3:DZ "R6375+#G#YJA1LEK;HX=L'$/(\&7CUC>P%2,]
M"J!600'0#'1]X12@X0 %Z"U#*FNL2>\DEH9UC*GN;,HW+LV_J&81#7"]"?*Z
MR: MQW[,%F8_!_?(1^U2NGL1(ZW=!]]<'(8_"0H#;".\Z.GO( $5^KOAKV;1
M-02AZ*[$9-66(<Q,'H;L;44F@]RT.;FYN,#L%*S#M720&'H*EYN*R\V1!56=
M*K8)J#&<[(TF;-?'">%)T8%4/+CR@/EO\GT:O;8&2Z4=79[#76]K!5 )OE7:
M-NFY-68<9WP',[*J6"08I&2W@U63)JOL7.Z(PI&:TH_LS'NM:X?W:RF[<#=V
M.SF(K:6]=R^NZCJH"5D=)M^2B988LXSAO3*X5\Q."'2-%:(.BGR83$@F\_!X
M4P XA$S(V?5A 7J7;BZ+E*F"GN"#U^+ S<K/+P&-*R-F@%>^U"N0QG:5-U08
M>(4B/ Q@[7+H)_%U&]-A?#<*".OZ%P(JZ+O[F4ON^I.>OFN,H?.R'6 R+UO#
MYF?0^^'X2R/4B^G8V:<<Z@30BN-+J.T:9(D=-F3UF@*4ES7 A\$X]\JA?UX>
MZ3\FY#N7\F$!%BG4$OACQM"/@I#\,F+F6>0L#P:;Y_/E^)#R]?Y45WG'#\3,
M!C)/:(^M($3R/,O3^BHA)8ET_Z2Q?>XW1A%T"4EYRM3X 5BS*L7LH; DYHD4
MSIIW[.UUM[@_$4]1@#![]'A"JE3(4]%SXY52%R?P<+S"+(1(YECKBR9S8;:C
M<:!+[QF<(JX4$3J6,*<KT'L4X2M_>8+(X<ED IC;6WT<!")L^0/6 9I7- !;
MM]!;^>N=!FCA2UY9MX 12%0+.^@5C++O&*_# !)D#C/N 7IX =U+Z]N?L[&.
M9-PG*8$)U<3[Y!/.Z)EGKKYD-(0TBR2*703/:Q@P)YXH!<1!&\C70[W5(:%D
MKLW[)/BK[NX^+WH1]+JH$SG(/WK\J=^!;8*:8TS+WVC'C.N$.MVZG$.\PD/R
M,Q1;I?VJB&=;T8NU!@WCIEHK[E]:1*,=P:,/6WG8<QMVP#4Z!#U@AR&5F0S9
M)<^V$8.=T,7P5*?(.A5<R8?415=WUO"3L>(9BA.[4C^G)'F]+)*S:-)7,S3!
M&,F>1-!<6N_,;5@1H "?3&W('GQ+^-9WR \48$[>Z(YD5W2)<W,[@6VJU_"B
M;T92P.M*%FTC;0#76CK [D(!3.((*!PI<X3=CJS6AE[\7!KI20$Z7V7F+KR#
MYY'5$5 #2*,?5%^-84L#<@Q7S"C GLDJDJ?\'/= 7XD9WI$"!-Q&KZXX#$AJ
M&\>KNI GYY$W)6P8I)QA0E!]!$!MN[-R."_JIJ_<71K[5E C@(A8Y31*>TDT
M!:=*2P==X?,9%1U#J([,48 5/4\U)/%.#G5S%2L&BQD)O#1I'U&-0,DKJ>(M
M5^P\F4;1>.4V"C \B:;NXC\OAUYKVCA5PU_/@ D#"56')M]MHXIQ\PIK)W<U
MQ VR=)>?P-D$ZL$-9-.:V=I0Z(J>,I5C=F#.VX[$B@^#6S2^-$Q0FB@6N^$
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MY@$1"D6\?W0N*!<@E)IZ+*?+OS\.<(%^"3[O\N2ZEC( _XTL@8X;4;A](U1
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MAQW?UB#R/-0]7?WW_Z'74OHZ'QGIY7_*-_L<7VU>:^/../1^GI@SUP4&Z:A
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MO122E5OJP%(7PB05D-)"T^9T(ZE XA-D;-+W@LO6^5/H@D%/#9=X*,V;RJC
M#,T:+'4F4($E5I7%N/U%87^FDW$T-PSB*K(G#T:D=OIMRY_XL%\FUS.N78#Q
M2-(>%I4.[;+4)"P+JXR64R+#?KBY4Z2>WH"9]9XH+2]4].WJ0]8\_)S6^U]W
MIQZVJ:,"E^-BCVEZUK_K:Y%RO["Y58GT$?'&MBV("EP8QL]L2:!0^-#Y<C9+
MS'JTJ0DN7*](3/AIH9Y+Y<G^;<'@A7,_)WG_F 2R"[;N6@ZQ68P8?U"9OG\V
MDX[2U0(.[D(ODV7!GVLJO53[L8YOAF><8CDTJ;,%/;C+G;8)M)3>$K,EV..
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MNJ(\%5">!GNJT01SC!OE<C\5P$<ZQGE1@?5Y(G.1T62*!13 !LLZ"%<HS"O
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MF*./V!G564+$#F+(QQ[ZZ,R7)I@&1\ARRFK(\,74&55"J;V)_]A6AMNJJ8-
M2L/??^UF[S[Y?*RJ3L5+]UMW6* TX>L6.6TM9YLB)'0H15:K=YN^UJ#6$!1[
M9CMC<023T@D%V:7?OUVP8=Q)/:W""T]5&DP*XOGSC_1".W7EQ^ITW7N,C6[3
M9=4 R7&BB;#3-V";^(*ZCAI\XBSCU\F38RX483T .2+\#]\B@N$0'G;^*+MG
M&LY\W7OUT_DBX3NWT(R8KH@H.#7@GNL['Y?*DT[\]DQ36S01'OQ/H>3B32TO
MWN>1M5/YL8934M#V#SC/@PU1P^ZMP6ZL=XUE>;^'\D/QVJ?&[RB*Q8\%B<W\
MQ5=.UH;<MV-, FJPJJI/"'UZ]AP)9)2=X:,V?GU7PEG6AEWZ!V &;Z&8:N3D
MVX8^5CT9NNA_>9]5L@+TUN^"C*9^_G]02P,$%     @ 67^=5*6]Y*:])0
M?S4  !,   !A9GEA9F]R;3(P9E\P,3@N:G!G[7IY.)3MW_XM6Y;R*$N$(60+
M"=F-)5O*OI0UI6RIR"Y&26K(D! ]&8Q]+UOVHA#9MU(2"=FW8<9L[SVJ)WR?
MOLO[_G[_O,<[=1W=U[U<]V<Y/^?GO.XCTCO29^"/D]IZV@ %!05P#OP#D#X
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MS=AI+O$3-4%E4VE7/V.G_G-B#+V-/H983_?H,];R'$8Z[]R;L1:,(K$'+I.
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M$40F'A&$*2<+-(D:"?;HKG[7$C#0)C/$*LX"&\^/! 8FO/ &Z)#NNQVP4>O
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M);HU-HR=Q\GE<KV ^Q:9BG&$@P\RK_2._B%!MXIC_A8J1U XWX,.XN)V4%R
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M@$=VU -9;0@UGFT%J=$AQZEX.S!AIE2=EE4]%S%.A[Z:.U. E?.HY.=VS='
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M,(&]EF=B-6+6P).OT3UE*SF^9KYW3I%.L=Y@TP/O0$7)+!+E5,9![%6.Z73
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M?MT$!@4%!1T-G1 #@Y"+BI2*ZW_Y@K8#3Y!A=&&CX&"H =@G,'!/8*!=  4
MP"# _.4"_GK!P,+!(R B(:.@HCTNJ,4&8&'@X&#AX1 0X.$?O_5]_!Z ?X*
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MS)CMI-\? EK0<+W7"J2?N7.J?[D/WOC3$%3WE/Y3-6'8\/[<X8#2/R;4PC_
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MJ,M9928AUQ-R=3-@.-?:>J>0#\3>VUD9PD@YEH 72ZB+%5%GWWYD&1$);PT
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MKZR7N75R@Z=R'N8E.[?T!48X.'I]/V[-''+0MK0&$\>=,7^$)']\+\C2$"@
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M4]"&MMLSIMK7AH8:C!JQOMA%9'@C>:<F:#\4E6>\\SI?TJ^L3=*FEB9Q-54
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M#=Y23[]?4>PX8(?**N#RL98+-K)D <^:XHOI>/<L-C4Y^ZC+)\R=E(M/7GP
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M+H/"P0#/W$%"2H.H+;+=H&1],FQ*3$2$0E3'#MS9C=;F]$FF;4DC$PY^:-U
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M&B6QS\*E)K/LKO2;KW[#?TB.$Y:\,_I>@:.A[O=YRBN@M#^0RLSN9P%[O&I
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MT[YEZ8]OS(7Q5'3)3:7&L^VZ^+<:[5W\4YI;"T?\SX=Z8&@:UEAJ%$ ]QPZ
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MA#C#\Y_RPG\VMG)AQ+$HQ?RD!@E LNTC;OV?W)QJDV7E"4*9YF]U,9A05G>
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MDWWJRKYV4RR*7&XO_D!=:M7@<VU+34WJAE#6OK2=G%\2@"D5)EGB?JSNYA'
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M]=Q 73#4)/H#O&+UJV30^\+MRP<SONGZDX3MB1>*E!*A>4PISDM!4C7@3TB
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M](%0=#%A7#H&"KQ^Y:^%*3B:=P]"P;]U?R.?D6= \"OQ=BM;]>2IF5%F)='
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M)VSVP/A\>,H/=3TXRC.75!S&SD$(B+AX^ 2$U#2T=/0,G%S</+Q\_!\_B4L
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ML3(UMT^L0J.J?R5@UQNUX&EOU"*>P(-<D@]7I9!#C]^PN+V?DIFA?].?/5
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M?OI3MVX_$4F61F9(BZMYF)IF;YCK,,R2TY':,A63LER.^;1FZ?  "A-3.0*
M;A5>5UU>0ZB<5\$\>X7N>3-&4\<N/14!0O#\@/;W4IZEQJ_(0FWZ'&JS*$BD
M0-!U40*5F1FO?4CHT0W8@'Q8+*H.8.8YP3M<*8$B]][SML7>,-,1I.K<$5>)
M(G=3#==;LW?<+J6LSDYF <5W<:_A3>3!-S7;J$/*[$TZ*8?TAAV&02"Z/,@_
M%/0AR++R3/U2I[N;5#N [=:GCZE+4X3N1"LB=!>^\ZAR8(3JIYQF_?9/X5Q/
MMU*S@D_U!!16 ,I:' >YQAC&K'4)4AI>Y'6UD6T)/N7\\!+K$#'F>=MBL9^L
M3!OS;E@60&36M:B/A'G"R3S>8028D@MQ08 AG&R7&C$[1T-3Y][2^(S)3.1^
M>02MR%6A9X8&?2*/.*[QK2$"TD;GQ8<?ZEE&^/@Q-IHN2\&S@6G\@U%S3 K6
MN>Q.L4JZIXMS.EER1+3S&GI^E3VF+PKL,L\S:J@U5NZ]&^=8I.=1O<E!!RQB
M9>^2\Y/8<VXM5.H><8;&@K%^AGC@2*<JQTP.;LK9HGI5N(T>WA7S0=MZ5A=I
MLN^J46@V*(FS_<TIRD&A+\I7; N) .. ;MQ+E.2B(U7&[&", 4<>1:#7%330
MB7 X2!@JZF'^J[>2\GJGVXX?RS;].RD=IA"HAE= J-@FD27-C+X4N00S(\EX
MZY3T6M?TS?T9E>G7 !SY4=Y*$4B#->W#G^*<P^&3MI!.1U+GKOJDDY?\,B=$
M:O7I'1'UZ*\ N$8G?:PKDK O11UXSO58Y-VK"C=5!@0GE(_4ZJ-''AQG=E63
MC.G\]'-<>DQ2=-DLQ/;J!D5H$C;2"'/V%H9=0C-CR1S"@,FS\"=&"YDE)K<0
M9BLZOT[@1Z5H.-F?7W_1B>#@C'LZTYUU.)7V84;L(/6^E_;@^VW$^=N;Y-RK
M($A@1G8G)8K^HW$"2,Q9=S],KP^NB)70DV\[,*L$Y,OSG(_?WD AL-QEZC3_
M2.@0ZBOM@+YL\/GXA92 J.6VNC9/R";JRB \:[BM*_VGP0=GT3=T" KV')%R
M_MJHDCQ<8I&Q_\2V#7_[Y7WF;FML).4-UTQ,ZVVQ$2]OW7Q#4L-_&4S\(Z@
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M&!8*"75B._Q5:[@&NI1333).5+A.K9^V9\%?URM7=-\I93B/V#F15$AQ#P8
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MO-W &"QCUG15G4,1:YQI[QXC=5#E8<*[GYZM;67+C/V6BOV'PT+)XL(2\OT
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MW^%"99LK.V/)R@HV.<6'(=I8:2/N[=XQUT_9!UF/T[!V8[K"A)N\9+V\W:5
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M&V-1.O>&PA6U*T,07"C( ?$Y@TUNPH)R)6_^DFGWXKQ10V+>[N8,A3KW/BL
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M?H!@RFR(2Z'OXR/++SE"/L$35\7#DWF+TF>KY<-]WW!*H:Y\.QLWLST"&IT
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M!F^:1?(!1#>!S+_,B*8+VA=HEWGT%+R@BAOFOXZ]K!J%$U34U0:RN94CG9C
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MF8Q3]!OJ#J#V_/= .U- XU<(*2DF*2G6O9RD-T+,<G'![O1,%5""IF+I;"K
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MWQZ1LJD(AOG6NJ%LIY_7NQX#^8(V%:2$-!$/.F%4D>%I1\0?Z>$2,B?6IS5
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M^*0K2F_EOG(6)E#_HZU'_HHL3=X,[+(A/\8XQQUF^LM2< <?X<FJM)'*9&\
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M@=]5$0'(Q<'P !BEG,#)CZ,2*LV,SP!/B_R7LGYAK$W6_B\=9IS"Q=QZ[>^
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MJQ3<IA>?C'$L)_DZ"807&<.(V* 71O< *E@J4=.S;*G;QO+Q+ZI5Q_]T*<T
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M4\. =80,R-089)MPXE[E1&'JRSW%E1-[Y>6J<97?B]3Z4@F#:;%>NZE(%J3
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M0EFGT[/9K^QY>2%V/Q4^C>T&"?+B+CL^:T&9OW/6'>IM3J?X[!O#X U^/-O
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M%-Q6=(BX40>#V^+[P(_U]O3(3QANY<UQ]$[IK<O\&-:C%\8BE3Q,0@4*H4'
MZCWN,L)RWH'6BJ-,@_:E*G*$E=&LQNE<Z-J98_/.D=*)B?>;=JV!I!KCW*',
MW<L ^J!5'GR.^:C>2'#]PMU9W+YI"A;[F[:S72AFK$3MN/R\@B5MY'E;'S^I
MI_<5_2_S(7\>FWU<'(T=5$@YIL87+^N!NH>3J+#!"I847)Z:ZS=.);H[<4I!
M')]@ .Y"SZ;\>QH<U\[EHG!Q@9V;S;HP>)37(QMA+T\4$:CRILR<>RK'$*E4
MPU2^G8*CW]*("U>=_-V;!_ !Q*:6GWK7H^'GP56H5_U;*/%QTSV]J@7NY5 Y
M##!=ZG$-8S.)K;MV2UB;"LO\Q*,,>ES@@KJZU:&TJ@O2C96=8 J6LMU$2:04
M1SJLDORJ;RU,999$?OUID?HD\RA@22ONYC#5=(;Y"VB^0\Y@>2WW' ,8%%9W
MD +LO3B/V:N^,9<T:._L\[*A+E@Y/,(B6,>+%K45%Y7ZI&75T/$KWLK&V<F&
M@S[X:2P*(JEVG14E]XY:=@IB_1J4,"GGEX[>,[]Z;8=,C47!2&U#R](#P_$\
M([Q.4!&EQ0@<IGL+%'?LGCB#+_G]:=^FW&;?TPPBIV;*:B2D3(DT%_ ==:?0
M8M,E#!"^4[(Y%$EL5 //SCO<8.RRI.!(MB:!X!HR;!<ZS'M(OTP^T QN5(\H
MZ^TK,Q0./6H(]<VD8CHVWBQ8Q52 R$PQC#H*T/!U*M%^5 ]C6#,3V%4J<#Q7
M!B$8'L]N+G7QB;$VG%!,72E+JQG'S*CW&P3_U,U'?-;_/(4JT77 XKJO!08<
MQ\  8QB0]1"U3_QB[4'I9Q-EXW'75!Q<%L3J(X)K=,<'ZS'=X@F3T8IO;T_7
MJF7;OU4E9<MN;5H_W$T92@%T/@2(]N+KMZ,C4O]R$_K_8>+-D!(P4?9$SU)'
M6*7D($\.*-9=U%XH1S>QIG<I+_D4O*J)KMK)=WK-ULWJNJ<P@5KBD&7A-)PH
M[4"PPZ7#JH09_?C0-!JMS4 ,2:;-TQ1IV+106#[J7?4)Q4B?Z#G?%[\J3:O,
MMKD?;[%J6O,"T1F>+W4*4;$P3@5]'.5@B#H(9(R2,..PFM&RC81"C9%BL'YT
M+KJMQ0'G&!9".0@_$-V,ILA%9@OJM9Y^LW-WZ[(U%>L1$3/EPL[OYU*)X&Y/
MX!?LLKA-\JDM"CHHS/3#CQFF9QLP+PV9ZVDM\QQKWAEZ!>R8%H&KFTZ0;Q/@
M]E$^SK[V:)$A5TVM+8=*_LF'JG!T<H$M$%,Y>^I$6E-B\.PW&9S"DA>%&GG:
M)-]+!*FY#C_>A-H%FP0!>T0N29)DKX*7C;+?RY)VG?,RNFY^A7N87!=?O"'#
MIY.CF14]ON]Q+_,B,VP15B(:6D"-%JG'?NF>^3MCYK%Y#"]<^=JLUZBT4C 6
MA#;:$FX-O(586=*\,?Z_0#UC]_(9N[4>Q)/J>E;U9VAX]96J.N?(>!%[0]D%
MYF>)]*UQ@]$P &W';^:E93BVZF-6Z*YL+";-%I8LHR+WB"<+TO!:M)%R,]=Z
M.%+.FY8NR?-LFZ.#\SG,^+G8.91RJZ<96-'*7(H@T;R(TN'"@_O75>JS @U?
MPVYY,M? !C9BZL_\!,FCPS?LO70HWJ'7<^;VF!2V\K1<SAP<A2^Z1L" 7S<%
M/V(%Y_F"<>,!P]"_#,<H96Q-*HFPA)JL0[[M5M[XI*2.[.VCA[A#/HONR>>C
MVC?"K\JL%Q5/O710FD%1ZCPA_._T'^U$S>\<H#3$)(NFRQI++W:LS8J#!&CE
M2+?&<98ID>,F@MUR=_SDR+8_1\OJ1G.ADT]CYR50& 5/'#=O(5/8NN[H;"0F
M9?YR\5=[8L3![D@:L\+Q,K=1!2^7P-85BN?#/;Y%LA7UK=6MH3FV?^1]A=^*
MY=>!\A<L(QFARR+YB"7=LXKHP@$D(LO*H.QW\@^OIA0J[A3ZXPW.5)]F+YP)
MHZATU1 .B'W-?A:D)Y "GMXT'D<B);9)H.>\T?8Z)L6XZ>1.LN"@QMD=-2VC
M&:4M2]+,-XI$4V,9KG>PCNZ<%"3IQ*1L1Q"G'/#+M,CI8(@I)=+8B"3JICF4
M9EWP;,F3\,7RP1VM/Q"AS>Y@4%>;-$.YVR4^8&^.D'3E0J^O#[=7=Z#M,AQD
MLVF=?5DIE+@Q[B8[LF_L0S+93;#Y[EGM"WI&5Q1IAZA0=V745?/),O,HL^PJ
M=A$=V:6/4;T@4TO7>"<3+($AMT]<9I>H4XK>+:CG-F7-/Y3?<2:F.)%2)SHX
MURJTWV8%$.[S.OG=TGUC;]A]:OF+97P_)*,YBE7<(,5]-5O+Y>.^WC9_6/I<
MQR6W XGL:A#?%S$L>ZX\POGG#L5)VC2.*3C7CQQ\< 1X\$&J(/,S77"K^N7M
MZ^ XSW&RAGR\RN/)/<J#=NM"<OO$?HT\["'?0!S/_%TJ\G'KE;'-IK',II#)
MC4.KQ]W.09HZ7 FR3I1YW^=Q9*S14W EN@>YN*<(*KJWM2ANG0,WJN\8]L.L
M\]@WEK^N?T0G\P[-<J%^\C13?*&[L/9_V\+$^\$:8P @,21-)%JM8E.=T+KK
MOII<88KO#DD-%S#C.YR+6$("OZIRQ9B?GA??'HR4[N[.0OE,TBR:%T#&T93;
MEBF5(R/@LZ2RR,"5H<X&"M^+Y:SDM[9$]!<07/46WF4;6I(_$9K6E*3@+W"U
M$B8Y5( !O;3$R%_M-K'7.[S1L5RWS#8+EW;(^JO(#B;O=@@/Z8G"95QZR;!+
M;CX3"'UER'-D=5L.7O=V#'.UH=Q7LV']%JB2)'!76LA/W49_EK/W%8)M'CMF
MVGER9&=CZ$A16M 5S5K&13+QT^BI(C&RG^!<SV8\:ORJ&;A,;\4F5O5EQ3.'
MRV;VD;?/$L)(/+B3%QW*0]4W29:1RD.ADYH<D8+1<1.5@Z!CRM1B""+NFE)%
MK<_E*%N>&9$&D_A)[;DQ/4W0ZM&YJ%4%I:HL_0^M!7,YMJ?$F.1]Q#/1""!Z
M0!:!9HU6"92:2O5UU<*=G6J:?=X 6VR1!#H@,&<EM-7/Q?(3R1>^K_=XC_<Y
M25R4+CW29<4E>@Z;;5_"Q]Y6Z12U>L%0>I**.>EQSORKJ\$!&\(=*1?I!U^Z
MMRPU[^UK1  ))*3T>AR.<H,M:V;:6"_74Z.C16_FL'=C&_+^H;<+D[.2!!M&
MR"^7E_/<J U5)3W-[)SMS+#[N73FK,[2U%'2Y[GJ_"V#EI=:9R=REW1FFDF+
MBDRTXPU90TYX>R*??![DRE640?:[4&9379*;*+B7H<JZ) GF?^'R#(\9]45P
M1_K';J2-SGE$I:$#<7+?]EIR"4>N/2(FMA=$*QVM$7C,2'9#I"(.:OD5PMBO
MY@[X^"NOGF/Y,G"!5,+L= 1&+L:/-Q;CL;_VS<S)FUJ^KW9Y>6>8J#O.U3B:
M^M;JJ<1>TH33G=RD32&OQ9X\M]%M=((:$_-/HI?"R9_Z>S40"8^?RW6GX!1<
M"*.5KV3WN%K'2"'[K&0@<F6E+HRAIOKJCAZF5<7,WI('%#*>&D:BGA$THK>P
MA0N\F:)*E"W4$B76\AOM?9*OZE)>('=(YR.H_KBU]XZ0_SWBUV:$RH?^VW=L
M%_7)NDDRQ37%<;=GBD3'W>I;IQG/Z ]?J OS(W(I/MX1IPKYT_O_?P/I'%1]
M.]@:_YH?0VS[XNJ-EHPS;5B?*]U"M6V'=RLGLK= 85"U^Y+_@:.-/7V#1B$'
M4R/'AGQ.Z)H7ZJ@MJ?R3[A8!>@$F;R%3#\FT>8T!3YP"0\8,$/Y@+(8*;LT@
MBIK^8TVE@CFSR;*9>?0T_"/Y[JOEX)RW@QJ&"7>%"*1T7QJ)XTYW=T]/K&;E
M/E0&TOBIARBW[N^N-'<+?@@5Z!0<X/3@SAMPS>ISST/O2)QWIBTI+WYT8YDI
MCL008[5XW9R"O3YYGF.=-"NJ.+ 5HKG(FRC/FM.&S]V,_,@3+?M-^RQ6C.KB
MKXJLBOR73Z/8>PE?N"$ZM/ .['KAU,#3>O/;6<JH(8:J,A1QP@2%)@STYNYY
MH9,..9#_,^M9X:P@>?< FX$YTL/G4R_;-O!?0?*::;!,A-T<Q,DAQU$[K=!5
MXNJO[!_*@_87>?(VN&3[B;''KMWN@D:K&LOKRHACII0'S-\6QPDB,8'>1'0X
M^+=>%>O).WYPI"QQ=W=QPM?Y3%%XR%_,O(GSEH]+:#69^.M'*OR)<TT;+\\7
M\K'XRU6QFY&V#E.DEP. =MG)QRA/5T\*?J<#"Q-DAX;5_E]/.>VNRCZ'^/,Z
MG6F5E(V"*[!:+50).H<_W(^VHV"&9D0"MU/"SBN8?7OQ?3G,E3YR'3\U5K"K
M^$Z)6T2HXVE,*-Q7RX]$!"^3<62R)&FJ8H2_U$ISC'ZFZ]L\U8Y$[SZ8"GL%
M!$&(,663#^(4#C)65C"Q#D@Y2F7IL3"X<3"Q0BOR</)LV \&\NI5>K"2-%"-
M&*'B6QMP%W-.0_7PW(+\W?%A:D%3O(-H^5,_!#*9&F]TKN[VDB[F]X!AV)LD
MNG$1:M'YVY!^=96,LR7&<2R)A^G3EQPXPM%+8=GG*=@G!3O2E^2T.9KQ.<-R
M!'2.2W01X6]-& R36-ETG3I7VNUUM-N$7Q]WX56'_.R-H;!BOLNW&W^_CHB6
M7^W!MKY[Q5V"/Z?@2CF+(-QI8/12F2^4_! GP];.5VE$A)LIVMG9]DR*OG^,
M0%A0X4PD$08L(AVG8%LHF"B.JSIDZ6DOEI/BQ)RQA7L*'7M51/VZ;B6?;+0H
M$-M3J"IQH.P86 _/-Z/!<(JD./,'B8IN#Y]CWF%_J""_6[%CT^@PO88R21LV
MD2!(S'LI"USPE&P37Q;O+ADUA# VC,><*"X&!K0QR0HPT))["PR:(NE1ZBM4
ME_,K[Q*5:N?ZFZD9LQ*L(RK:@D"GV5.ZHV3NV=(Y1L;EJE?H6X4&*N-5(@A+
MHFP_*X]%VXF_T>NE2_(<L*\:5\FBM"F1^2ZA3%-<#*W(Y[B WTR0?:P>3W]J
M96,5OKQF>3UWZHUX "!-"0P GTS:M>CJT1S=@;&:T$?6CZ^"<4:)DQ1=;B>J
MCPJ8ZN)&V7[H;0*_--ZUN+3L5#N2%EIOM3)I[V3TREG9F6#GAP<F4?IP==&;
MZ!SM=').Q4V7C6553MI8?VG6FD<1$Q>D>K_<1+_1#3Q"!Y$N;WK3C-V_Y$4_
M J_JVZ%$YY>]O"J3>Q10;OFN>JD:R[<'>*_LH9WB^:L59<**LNC*,S'R'>N&
M+#+J('>4MU!4PJ?\/#"J!)(%M>G8^<V<BGL4P]U/!I>-\*J8=JS//J@2^ZS&
MQQ,G]6/6FPV:F>5W+UTB2E_:'S3CEA.Q5?F(#T&T@ 5?M3'K=W'8+R:5RURQ
M5(T%HN[\04?NCFE6V@I5QIH7F!HSFZ<$(KW<S%>"8/>(+CV+^(ICS:KC\3B7
M")35-NL('5+*[_44G1M*"^OV(&LNEXRH%H4G%:Z;CZE95SBB!ERNRD>?!K?$
M)F$LXPATT1,@C!5FO;_]9M;G;CW5&S\[+RO2W)CIMA9Q,Y';436R67F"-74L
M2UN5$)O$&%Z<>)GK-RO3+:[,A2O:8?4/W32J9V-=ANXNOMGE;6)"54D,KG74
MDXA7"8_4!=<:3-61LDS=9J]]B&-&1F?GU.KJWG!+;?S8X/H0GDZ\Y$?Q'"DJ
M2;S-^E/RXSYV&!#!E/I8SHY*TUI<7;^<S3KXIV(SW3S&OL[Y%H6W\UVLTT*;
M$W?P69#?ZNGBI"Q]TCN9ZJB^ .HUR\>?KQ$A&!M%(J(YVN935T*ORP*-1[YF
MEI_IE 5LJ!GP6S-$.B/BX#R?Z70=*A[AS6H88XI<O& ON$#YF5:?(#OR&2MW
MD&2 EB9&D4NPIXL'89M '9LHHE"), &G-A@/8EJFV_>0TBKW@5. _3.])4K0
M?:XG&N;LY,\,"R(AH]'7-M8V6,2<:)E- N\9'IJQHRK@KDG/5?#WE_&S:1Y]
M_%>JB+R85J)'OC<FRDQOO>=*2V//2&! ?DNSX10]R>J9Z>UE*JH_X?U4Q)<Q
M!GD80'?6Q[2&=] C32J(V[U69-@-,I,RV9;W2J(>&WL[-#>YR&D7B7[&%S)#
M[SOHIO;U7WWI8+)D42O]TXZ"^#8Q,7_4/F* *YW?&H&7?3++V$A#1X?5*KC7
M(>HKB'1M'LH[V&><K6FNM73_BEI%X5U+J%'D\Y*BF)Q2A7TTP,=+><'-)*AU
MW ,SI\_H [Z\'>M.)5'=Z$ZX<(?8CD WE.*1DL=:I"G2L)7-@4W]4-GK4I)N
M'! *NG+S(U<0,@6U5IF.QZQ>'>&O,F1\W7IV1YM+8WZC[LO=B$!"BLIW\3A<
MLH*"W8/F*&.\)ZNFF395!=4Q3'[ZY3:A B]87-;U!:P-G#WF*-9]HX(!G,6@
MY<)RR"/(1V'.\4-F3T4SLD7AA=3E!>:8NO9<%2]C\!-F;XSPY\+956C* K-S
MTM('TV ]&* %>/YK[_0)HYQ7/#%N=PZMS^,%L\(WUB-I-.OLS:FO)46X88 X
M&^[=<3DYH_1LU=6S,WZ6?/ ?[E?X9KMH2X1U"K&7FA%9(!?/D]+C87$BV$4<
MQ(',*9?FF_H/L__4H1S22KJ2?(N@ 5GZFL(N67<7>Q/_78WZGC:)% :D$/H_
M7&N!5[".AQZ ?/!1ZS!1ZL)#W_U +ZL ;= LVK(/;RC+=SJZ8!3EY\!EAYR$
M[^E?-B#/<01VI @ E?\LO774I>K2JI)WOTZ2';GRCJPW$:#/#7>/ZX:G(:"V
MY+,M.QCP>0P&G'PB?\&C=;4^=MZT&QH3M-FT@G"\=7\S#UG^! /N=:F/O:\=
MH!Z'X&,A")0CZ>OI!Q@ #U_+X(>2T1&=J7L:,0H8D"P<=H^3# .^Y2LHM=PR
M-@6>L\D6;&EP>(UL%LTQ"5>FT"?>4-RJI-C_O3-\-?+" #1<?_#6X!H,0,J"
M :O;_T(T4XH?D"W(-2X,L/Q4_E_08<]&<:S@4QY#69FT[*/(W%'N)$6EIW(/
M9GBJ/)%7#'-G:@^:YD$L*>TL:4' _Y1^*> /846(.=5&"P@(T%-:Q,&E07IY
MT00#FG<@U[G89IU14(:X&_T+&14I>QAP[&WJ504#KBF?P0!"F7L:,NH"&  %
MR?_^6C0\-;/2]%?-C*OH*(8L)]*=R514_SR:E:/':M?KY8(<Y3; T:#Z[T'@
M6$?A6-^:4@UAWQ_!  08<!":%K0! U: X0<;^$A"^E#6L&MQ'K V? IQ8F%
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M^.D5E&J5DW_ZA5/VZX^O"Y\_>[OV7&USJV\#:4$L_Z^G#/L6DA24DF9F(+D
MGH@,F@E9EYE8W6WGO\QS%^U^6^.DIJDYG</$Z8,9VB5P$.=FZLQW>4#!_M@S
MU1JEV83>+$:2EM4I8;D,ZQ$7Y\ G F74EW'R1)&FZ8&,9@)O#4F>)-GW<D?:
M*@WCS/S:L^LA]BU*CY%D"#3:/80$?%F?'##9BSE=V.:_/&:Z,:[Z)#7()2M
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M!-'4:967#;#!?[PE](='10 "798XKU&1ZP*BN=L:4A[_=+%*G-?Y"(#S!&<
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M-LTBBF4C"[6:V'0;@ZSLRP^L\&RNIUT,E7ND#&<,JE'2!.B"T?P%DA")UHB
MK3T),BPO%Y\BB0DSE2K>A_WM>U-$X$0TFF0F[-$\<8B<O@KHL$6D+U&T+^0T
M,%[K.T5B%EH*GG#2EDD0<PA7>[#<C^D,AQA0(C"QI-F3M!3&6"")9DG(]:N!
MP2)3XPT' . ,4+5^<5EQ9I DM+7/86,'\W$PT[;-J@Y?8FD,=K!56'3;H-2<
M#"[GR*JPJY@CI5JO##>5UF1AJ'MCS(VYIJ0UC.YMN1SE:3:) $AK;EM.<'6L
M,:8V=.H;&+=GV*H_2#$IH'WH9?C:[&OY,J<< K#%O-PDNVRC,-UK7I.^>T'
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MM<TRYQF( #A7C0 ,6[^+P[\.1@#F:'J;)ML-MN%TH$9+!"!KHIF%YHP  6@
MQO%[NB\LO4"*GR/1635N:\L+K1;_CE2+^O2AX%0M^T.8:P',FN.F??(\C2II
M-3AP5[-R%IS?N[/:%"PQZ! W[3-V';JE]:I:-[T:<TK\Y*EHYZ^Z,YOZF71O
M-S[<B8"\=S.,S1T%[B,8-6KU?@0->Z;=0JOJHJTBC3M?.>']F3Q"8=U,4*9^
M&G\PG"^5)'C>+48PKR8ZS_F&2Q,70JZ4:(BO^GRNY9#Z[*>2)<XQ6\P3MM#N
M'"Y27/#IM<N.ZJQEO)MJ%^$W5C;K&G&Y:<&M@%W\,=0Q5;1'\F[G4VSW!R>X
M1,L%P;:"A@# $4POW39 5"5O5M')JM,X2&XMAJ[GNTV)EOBO+A4=NW/]QA^V
M,8DZ<I+8S''C5S<+ST6^R5&:?SLM5I4DJF;%>08AR=C95ZD? #@(T!R3'5W<
M!BPB5<RM9?</%1.UZX&ZS;L6SO$#$("7/?I-P&UZ9$K\VMR79RGRMA&I8'J,
M=O+ N:]?=+M7'DTQO\&.8:B?6C0?=S\_S\N=R$FC&RU]RAULYK_]FN!9W?T8
M0&#PSL>][V(WT;HC,Y)<_=]DF5A\G3'B;'I!Z*N>U)95VM.S2H2CNB\8*LS[
MW"2T>?SM55XM^KX8B?[NI&-;X7DT]T.L\R8LK._K;L^#!Y_JW+M1*3]I:&[$
M#LCR%Q;D?SH+6TMZ+5;Z)4::7^O!\NQS1H>>6:>1AAQ(;9A=@MTC&S,'"*"-
MBS%R+$9>[-@Z\5%(TVN7//% 2\:,4 9S+M1/(#YY("?M)^R(KQAI,CI:O/D*
M&IQ]PWJSH?+T$[C?4G/!/]:)/CPFF_,;>N>Q<SLO,LF7NY,4V/6I5%,W:SJE
M1FTN\5MC4TV8A[<)C3OAUI:^3W-N<U;EC&['@XH>@@Q5E7+"$%-+2D5"UY\Y
MEB0Q!14?T4!SJ#<M<\_($O%]6'+7VF-4Z&8:RA.P-+C*XTOK-@[>QX X!/F:
M-?)&=\L8M)]6U4:/4F@OHX$IP8_$K 8 'K&@[MPBT%0GZ#33>M2Z_[UAR\-Q
M[6" .SA&Q>XTL%P*/CX*W8!/PA$ SLM1\\)(<&I) [07@X^CL! :P"O?,=/F
MXT*4-, L/4NU[D>Y"$8]^=8I,G8A/+?DKU[IP=/A8H)6\1%3QBM0'M"]^>;0
M!Y,.XCT X*&Z-M./FUH')@;8HMT$K=*\LSQPR9)[VW3M1?+>E6W3C3OJ3;J]
M!/TH8:3(KZ&JF_0KPI+<,0Y>!*"Z=Y3!;-C B:A/'KRO9XXZ=>/P8CM&5]_R
M*)'Q/4O0XA<VH$<K[+NAT6='0;ZLAH@O%9CQQ_TR)!:2+(OXK\QS!?8:Q"<,
MJJ?VO-&IC0U7_))0_T&?E)^\XW"V5NM^1V<^KZJ0ZO-"Q^&OES2SJK).)YX:
M0]2@[O 2T&0]W+CZ_D1PP4.5_$!MG,P7>:@Q;VO'8I0]5Y,ZCSJS33C](18K
MS;5N%I@/*@N9HF=XAX<_?8)7J,@V;-YD==3"PB<,SC&!UUS6YNHQ<LZ-]48,
M"E&-3U %GRBSWN<PK#DR#5/A=7@V(H<N\P!KO@52,YWV=5NCO)1,[@>Z!FWD
M8!#;2X99'7V2]?Y4W^MSYOV8D:T,._%.HFB-M_F)PMEG:.;6;F<YPJ6KM3IZ
M'SJ)$]2LK;].UK#G&*/0"\YF^NUS[>A@\W^*\L#F2*FP>^1A%,6Q^ *]JX"6
M\MI/G6\]XI@MW,EP,'*=E>QAU(S"/L:D);WX9T*P6,H-L!X!B XKU-]^V&=.
M57)2-5#08P=16"VHC?M^5;<4I[*TD/NV;KRL](QH=G"X59TL[HD->+>>R97K
M(A0ON["4WB.;)SLY^5[W^DO&4995(C8Q/"RRTZ=?%BSOD^&.1R#CY:L0?Q5U
M"WQS\:%]T"KYBZ9KE^;^!'3S-,+H!ALT< R&T=#6&V\U>/8K9$(2!X4':CUI
M&BZ=EO%?;GT:M>\8$?KV.L6%+V&9]4;DT\A*T#X6S8W"[)X\"M#KYVN9*0MY
M#2V5_6,3-NAJSO;"V1(&_--X?O&<RGUX&(XZH6+R1*@JX"IA]X1?K,7T=5>N
MF3:H1WX<NM.*?XM5G!M#FNL^+S<\_72!S!0MVQ <^<)?Q@<K,Y+H2!;&!8NP
M/3\_GM_^01>_+,F?=[X?K.5$ZZ\%(/Y.PUVX,YU*G.^%>XKMPI!,]][?836F
M,85:T:^6]FN7JO@%Q!E]&MW9"<TTNC]8 :<X2M)HTUYN*),W#U.!FS36)$;;
M%<PE)I_C&%=].R*)VS8K4AV];\I@T_-CT03L#/<HP59248L?U$Z3)P)6F]?P
M\ ]D2O\*=XW("*1PE%7'YQOI,+5&&^+E_]G%ENXS\IRL?HC!93V%W68"XZ/D
MPR"ICA5,_@ICQ4<BJS$JA4\_"LTY7I^H/.ZR%BT/^2!A\.7;"<<]87_WJX0(
M3W.A8LV3646[?,7S$*J\\,0Q2MLGCAB2 5.'K!K.-PR?>Q057<(\>[[)W-M7
MQ_SP5X;PD.5E;9#HAR"^:>T@0AQB(:9M>:$,G'#N;0^:5V;U/-C%,DGOT 5P
MO])38?3+B*=].2 &=9?[P+>1T9I4]5)U3:T'-85[E@>>?O2]>/%\*FN>CO1C
MU@50 _3Z8<8,/LS"L[P__@ N(\8#KT.&,M4[ZI7[","J\2C^+7<*:).H4#+X
M][?ZM5A+8&(_7?;4]66N10(<F%4[&%D$ 7CB_@U%S'S9[W+)G-1C5;J7H$OJ
ME[IP#WW0PHDLC,4 &S3$6GX#MZ[/2OTU>IL/1@#2*V\&*>!$G('0C;C)6P2
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MQ9"0H[Q;7K8,VEAMN8";(S?2@YU6@U/T,#@<^->Z_C$8"8"N-/KM2%?=XW,
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M6@KSR*SNN:_0%J*1/.B[-/H,-%!XKS.0<T$@B>46H_D50)(?2QLAY33%A;H
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M5YH=\9 \*PR;W--'4/>VCRO;^=&7H<W:US4A^3NN<(VS2CG9ZWJ)MG8?C88
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MIALVH?,MQ;*=QU-?/U1/F=2/VU:M2NT%:M!XRHI]\7U_R,PTI3+M)0X-;%R
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M;YF4HO.T,3Y>73HM X#E%.'ZC<;EMO$\P[>3)WQ+!-+@!6L #G5O66(]P&(
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MTB-)P.[3^MT8U\3WY6Q^CZM'1QW7R7&U),H&RU)UOO*<J.&WKO:+0TT&_C!
M8^?]3"JBPO=,*GPZ-FP5_H*[#!&/>^UH8\K\@E+.7OQ%(OP] _N.)YYQTVQS
M7,M=<[>A1'YZAXMOP: U'<_6!FQ"3ZU?EXH>=8M-$*_2GJ/);FO\&%-Y-F*U
M.3A(TE:SUH8EJNRK ^6*PW<L,F<LQ:8\%523?C,UBQWJV)60.@('9WFPUWZ2
M/:2!W6"/@+O&_5ON CE#DQK07Q'S#A7.4XO>-7VI;6@HLM<+%Y.,9[E4.&+W
MD7:*A.%L>Y"VNV3NG97W2*'LCKFB1CL0$\)\1.2_P*QTPN;)<BRYM#\3"S\E
M\:+N$ON*^&PTI_4:*O+KS](%=O 'T@U1!(5#'#Z*C$ZJ1.M\,7.JVV.U3% 2
MIM))M:7=S">.\%*!\;[J*=R1L ?KA\U+MN\%$['5QM9*]T50,1$175,!8,S&
MHZE;R?=&KSS%RFSB\2]("H01&*4\(:L9([DT"AZ5T)8_C%9#_SL*$_Q+<BB"
M#1>;YV(L-GZRTUA>*6Z4$*#;M>;8WK_F2:?^SR 6+N;?\M5L5K#.K .MFRER
MES7W.2Y&Z1NKFN#C!5K,&Q*>I)['B#E&.PQP0?X\WJZ/JN^)?Q2.I)'(8)FO
M:/ ZZ/\C#P7X[^0,9CNYCGQ N8LMNLH9CDCBE*H(_I%W59E39?JSUY_CC=QE
MCY$M]?#POD.80/FB#!"JUC&><?L_I4G^4G3"H.V_H+I@5Q!I:YZJUL _,:J/
ME\M37\);MR64'&DPIHI@X7$X/*"=X@F[6.U8W]5P3L06/VKB^*ET4T[:)4'%
M]WI^#^5/;16HE]0I>(?QD<SKW7-81E&V!>Z)_"=N"&5I^8-UBC#-)6'K5]96
MQRB?"!*%HYH", ;ZW"^D66  ]69SWOCP)-Z@TH^Z\=1] U5+"-%"H!6%WU=D
MYW^IA0*!,/ZI(6+_#^062HZD\'=&] PGXE?FA@[^\^)(OM@/$^CR=V8JRL-\
MT3T?JD@%4(+Z;7DX^1>1B])$!?ENQQH84<UN?$TI_#]ZM)/SAC"_1EYRW:+>
MK-L4&0Q@Q!QI<Z6?55F=TD$$]\5E@V=SP ,Y9V6/(8W&3^XENG<J"C/?SO)^
M1+NX204IS[^03+ -[R2VZ=*K\Z"T7Y=F@@$F&R>,5!/<)J_!R31W[E#1=&P8
M8'8(=$]A[N4NSF!4&Z^X=#.!_XT;:(YM,-HV<,1]78JA;$FRV-683!5<XTY8
M0(P^Q!$_<E",*;@EZJ[?HO)@E?[LYLJ"8( S5%DHNTROYQ?"XJE)LWW/1"?Q
MT[<2-1'3]%%+'\69,K3$D?%Z6)NX>LW"KWZ67#WT.<S-H# P2:CA W1#\<C\
MXCJR(O@%:CJ?ZF1A@,S9+O#=2ZKG49!]W A^>MT*? X3:4!WT^\HN3VR)I\U
M***K]+-6]TE(9UX>]_V40!^D&A)EF>!<'EEQMKK&[[5(RWY6BK(L>[*5W:(;
MR6^<R*F+ICHO"PK[^%W@D(:YCFCW5CMN7_F\6'E<]'O<9U24$T#><G^OJ(2V
M>]UCB4.=O.2.A\C'^[PB\_4BM5?"+L/=5]YKH;I./TB.9 022Y,:+"5Z8C>7
M>>62MVO::GE<O0:I+??3RX:06LB_?==IMK2*-9^F!ZE<\)AD12#'4.NK;@K5
MR"&^B!2D8UGM4L8E,.")T.:5D.?FZP? X<S:Q>]&9+ACT:DW/($ZSN=-WR4I
MC,3,B[R2&\0+M$[I2Y8B<4%"M3UHD9$&)MA_.\6DQUK/CD*B?H$9,,@D%[T8
M0QMR%]"_8_)#HN%#A'(?_ LQ!^W'E)YE_A8S5[9-V]Q>0T?J^H7Q>%<@TA#R
M>@,QBZT?9+-&L?[L2L%,!7>\48Q.0PB] 1/\BYDO#(\H N,GG%P$+OZN-UK%
M@8WX.2#&(E[9GYSN(EYKGB3[I(Y<%_HA07&2GCV<1X-P[K&/ @_(17;S_+M,
M\D6GR$HBLX+7^,0ZC"W$]#O9^655'^$((I)5?0D/$CY7#743FWTK;G.3!&,U
MOZA1VJ6,X0NG0S;Z6$+2FW)D@<V51MKM9HY-Q?-W#:4BPSD!O%+&1QM\I]^.
MZZ,P:AS9YL=#)93<U.9U9@9@@.# #8>DBX%5R;K4#$]A6[2^P%<5 /4O[G'R
MH#6EC&AUDT;Y;FODB(4%_@("C#X,>=D=:;E9PY")6]&6Q-I>XM4?0VYP'U@B
M'UTR'LTE+T8(]Y0)_5??.#H)PZ'[12'SB]J 43\/UTAB:IA!G>NV]0JF.[75
M%KKA7*TLMU,,O5&!)M,^MT-^%^S8 A^JX^_=E=6 %_0B4Q%W[81;\ES\0L%_
M:B9Y(30&;"SL;$QG2D2_HT\6'N@;8AIP[V'>C[W[VE8^5OTDNB#5E!\@\=DV
M*]&&^4W2ESH[9%=.+!N74Z$?^C2\(EH)!N<(MI^,3JWV9E5DS0J/$'N4G"@B
M^;/Y6?MQ*-)JZ[ZB^5GUHS3&3'&LR5Q%9_>3^"=$_MJ721#SW5*7(![JTVUT
M[\L)*QCD:4S+\&4&>J5,6E13%Y^UF34DO;>EZ L13OX<<;3U6(BR/0)'_IHW
M;$PB>8,J]O/T4<V>#'WJS,03TCF0"/BD%+G5I;2*=2 _9SHN9";>TIIH21]I
MZ#0Z!%X&I'?\<EEOG=;7SQ+EU#13L243FA(-(U[<>Q$YDG?NWYS^K6(JZV5$
MHBOQXB]\2N8H&""F N3/.IZ/-SC7<%IX+;7>-BHKO))LGG?GM61:R]0JYS'O
M1.-LL;MKOQ2#T=!+3+L\4F1LBGXU*?6]/&S01CBV0CC^>-8G!?5[MUW=J:>>
M97[ #CF21ZYMV/H/;SMDJQ2'PU'\I,C LI/J%AF\D['A7^I+'8?O.^C$D;^\
M:>BXVN63YZ*BD921=S::G])5BJK[^<HJ:.#K[D=!G5([6F#)_L$ZB6?XMA3-
MZQQ+U9# $3$\AC;-+26CB5*RB ->(<+LX5?GP;D6VVI2-!9OPZA_[Q80 6AS
M>P.M2D];)\G',F-F#K@YMHY=";!^$K>_N9P42#G#,I,JGF\/FV2+CC-)T!=U
M-E*92W&OZ*WS4)A5JC;5#^)%(7<*H_D4I8(_FB\W6G]=/"PFVC*M9_3S-W8)
M?>8\4;&@>+Z::L#":W&$USP^HWPR"W2YD\,(.^Q::9J&=4COZRJ<=#7(UVS<
MX 2Q^C>(.>C43G(29Y 1MI=ZYI[ZOU%R[;[4.(Q@51@M7-20)F()1J@4(1_P
M99'IHL4[WV_QA!2K\3$"[\Q5*Y?Q6YIQ.ZA,-7O2/&)8SA_Y>';A9\M<3QU0
M' D7)0QI7MG,+[5_MF=]<\$F(DMF1=IDX==+IAL"2%:LJ3ZG^!%O^K&B_VU@
MR &34,!7.&6D600OA! ^YL(E,W6'"IV7!.$_2BP=JTX2-#TZYWPQ-L4/%CS2
M%Q(V9D:H]9;M/RHP8P$R=$O'7F-\FO5&DJ>M\WN?>/4PK+S!$7PME=^HNE@H
M*JB(M&KF=S?)D^T<D,#17^36,KM<!&'-R0JA(<K\EU8%_PC.J'3>O)D7?8O&
MH<G).SI"/5^AJ)Q^ =OK]L=?;/DOZ9;WXF  QDL> CH@%-,2#>JCW'9[I-@H
MG=L2JJ.QT%4A7 =O1M:.'XZ28<5496M]HK-C*J?Z;N%'S\B!6(-_SEL>CPE?
M(-P<>CM<70:QM#ITDJF7@&,F*L>B4'8(,F)[..$'5 [IE=;*::KRH?#]9(-,
MP>S/J^9#RB$.L6V_WG+(^U0@>\/+;=!0MTI.F*:,)^A^GMY9=O<5<1DG\2F;
M8\LI7)Z^(D$>Q;:>=+O7RK/ @E'[0CQG";7:^M;6+["=[^WC'KSD/_&L_NN"
M* 7-A0&6V0/7P! L-O#]C?H*&4N4&PFZW>'98<= IHI,%-P86G_;7:.Q-(W\
MC14.H7I^5IMH4^FN&$5N]23YQ&+71>\ +]G'MD\+/S0$2X#(^H@J6.+"D:G>
M .9K,MHP&*"2GRX%!O!W70??(_VI$1K[;_GIS6=M3_#;SWZ__\_J+!LIY=\8
ML)8]&65CD#/<"94#L.>Q+5'C1'J8$)D0N=H+M"<6Q)-HZ#=,Y@(,#1"PF'W%
M:I&V_O#N_;-UQUC;M=07(!S5N9*4K!4-M1R'!\7FRDJ ?1/_, %:+/I?:!5U
M'J.7^9M9+%9?66Y'*=CY54=\=U/0'ED0-7)W46T"5A@@??R.0[7T!OFJV[[M
MK(R/\1E+0L!G+. _-115TG"?<:9'VQW^'P)"4;^MO[-XHE354,I;9E(:SK]G
MCDRUD\'X-<C\&WI^75@W4WO32'&A\1N;6C<J+OQ%V+% W#,01KWL@ &N,!)@
M 'BJ/[GOH->/#**OTVE(KR&<?[$=9M.?_V^\8B*C?\>%Z>N"8OX.8VY!(J9J
M:HO[-U_G%WJW%SM\@%]B:\2$8H>-[W2@(JD@: /&KGA']=2!I'F1]:G%T%CI
MA]#N%8K@50R**5Y1#%"#[#G.&-AD 2T2.*K#ZC022-C6E)9X<ZA9FHH^>=?9
MA35?VR]_O\1M@6T29MHB?IB:L1812%SY>F+_%BCS#I&BK^G28Z+35(=W:+3T
MR-WQ5#IIX]EU7T1"8T)[E2I>*2YE1:VS++WH]@5@?+ID(G(F^\HN!22*0?.G
M(?PY[TUNA5[]ZYHW@(E[%"?=4]_9,7MAGIQ0&RU4S(B!(R[$9;EB]223_Z60
MN:[#$\FU(_()OL"\K1U??+^2>6"TFM/C/)P/*!R82KD<S1CD* 5</Y8GK6;\
M.</",1DE:&BH>6]0 ,__NZ2^;2K_(:OY6%O:6O8<?2NA4MQ/FBG^,T!<+WX7
M;F2"M3J35WQ$8C_D2OPOBLG*'"D4J!Z5RLY/;^[+//4M"]3Y2Y;H/C).:U0<
MB642!^TK4^?H)8<V+FVK/4JL[^,=6;I+CP@AT"]]FB1" 7U2*6[6R5Q)_[C:
M:V[SFF#E]):EX&IA#A1GI22U3"<S%<!83%]JP\2W%W<."3&6K<E5N*N8;79X
MF%EU#%NVFY6?DD>:*)T&OI2@WMV%!,ICP ,N6-SU:@D4Z[SYNX+Q (A&%J^>
MI&U;@6<J@?0.O ^+GK345A_\$TDX#!>\O#>J-\\P_+.CZL<SC/ABWQN/[DCC
M3G0/J+J*B/3/@QUU3G=(G3>U7B_H?%C9KD$K-M"8>Y\Z^G39_BA>>+YH[@6,
M INULPV3^R6S);#*'@,9EW5NA$;UM7!RPW._"TBG%K\;-^9]'T;VZ"\K1+*0
M O(G=F_1Z;=H>R=B:?DRM=KI9BR'J8<CQZ0>E=]?2@0[PFC1V=#]D%!+<D2*
M=P[+W161A).(8&=!R[YC@BF&-]Q<[*#T)Z=RYU@DQ(3_?E9-!+&ZB(M!C:ZW
MZHD7Q'[9\$EZYFI8[SUENB?"9F-1^."1RB^0NE5NEIK9[+M8K:**&KL]G#Z$
M.+K1W30FNY<J4\U4&0<3B=8.3:X4?(E*3MS/[P,&='D2Q,FOEKZW*C[,X=$'
M6#Z1(XG56@B03&Z1>YUS:2\Q<<F>1"/40NZ/;EZ4#4UE^.J#O&I[RA?FN.UK
M)6V8HI[:GRY\KH;AVP5(G= =7W8?O@XX.)  "<\]T676U?I.(/@NX*W[(^(
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MZ!,I0OA%JC>&+Z+)>B3@N32C6--RW*;10*]7M)$-L#0Z$>)WMO.3I NP4 A
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M.T7*DCEQ0L,RV0[^DGYF_$I=3'OBA[4RUT\'2N=<2>C1>@R0'+R?*5ZQ@D)
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M[%[<O-OJ_,6OKJ&%_A4WF5^&<N#T! BL&L<WS1DZ(+H-JC](SQ>,Y8\%E;1
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M%X+%VZX=F[?"_TK!LURW1BZK<W;2;Q4)VF( R[?=-D^N*IM\^KR)_U#+S+9
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M))?M2RMG37/F:;I^'D_0!]=!%D;ZKUU/R))Y*"HR(>5L P.D<OOG^ABTP2C
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MGYQ8-2I$-?EYBJ[[Z^WL(<='9==,:ZGN^M(#\QIOG-*1D;A/ETSD:BW*OHO
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M2YV^S2?3S.7FOR"#8F?<+PLZ+N8.'R<<AZ/DB=A(1!2<P'PBH3_R XO?D6K
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M=$5>9M08]RN*B3A.R1TF+<4PJ9^=-NL DR+#Q.M"U3#I!(:3<(]\9LCF_Z4
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M"$:CW*D2R.)I'"&+#7)W('<', ^I-Y!Z4T7<0^8,9,X 0_8R!!)?(/&EDAR
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M\4+;$<6#N>7.&0(HQ?-.154)@%-@X.2@.%]L\H!%3]'2%.Q)?J'RI@>JI1P
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M$]A *)RBP 8"*(K&B@(;"'IN((! @$#H5?2SC%L'P#)@F08LTWS@RY6<L&,
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M2J"V<^PM9(,$ E#B+,;*+G1%T15M5Y61< %= :!$AQ] 5_2 BZYQE&BX@*X
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M91TB&5IDQD=E0;C[YVO^5;;T3']&Y]SCY430^O?Q[ =<);K1'68W<$7[?H3
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MKN&;QE]Y9O 'VQT;-@#+!H&M89(H"U)<(PJ//DG'B).""Z^PW&0K+#O,LK@
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M.&"AAC.Q#!O>+3JT@$)N$:]V/1.^0T,/EOA:'56U#_W^EPP/2)XG$!4N4K,
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MNJ/H=1]"L$L-@,5@OO 8 ]Q#%<#U-;;R_16\5/ELA?)LTO>E\5=J ],*7,^
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M!BL+#9](^5\V2:C("JVQ<Q"W."OW%C#UBBUX!J\[E7P,+QU_MIAY8&DG%[3
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M 4U%+P$^GA8<YVXKER/@2ID+M L0&48"H\@9:M/&II8WY^F]!!$N8##1F,,
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MA9!&PXQ*DWT1T$;3![8Y+*) Y%/O%*NQN-XL5G)(<R=S!3:AF+-5I5?[(AU
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ML CW<Z!WLOG<M^-I7]!IGY Q]?).FSGK+N*K];7YZ@N3=M3\$;T<Q>:<A6L
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MB^?+W_W7PT>/GH%-+7Z)"_,"[(/MNL)NORNJV0DW/<^47H8N.;50N!N 'AX
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M<&D.Z?HR^K$;I!,?'_D\CH$17B (7UD6QC(TAP=OSV&9ZPO]AS?V&A&S-:2
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M[Q&Y)G59X](4+%0*L!9M+>MLD5P!8Q>Y8#62)E:Y:CKM)->:I.NGUYP-:)(
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M;1*5 C*KLUJ*X;PJ\MO.9ZK1L>!?\6TG.(:5:??P %NS_OFT"B=1;$I?5QT
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M021V<1T>_+/NVN(SAC0QD*-OGORV]/PMB1%2'$24LKG](E66$>M'#?%L&)'
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MN!?AEE.R;=C63GIF!F:+\9/6[6*K"0C"'55JF)$MJ.@S<4WA#I>G9S3GF6Z
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M+(K2_:S@OR+I5((>P(,4#@],>;DPX>72]SDDFM]_A1&;GF%C<A8HA'#@&<\
MN>QRFKPYB,0B?^.\CK-+9MEL$J7HHR50(@OKV3+<!/OM/MFE/&L1J5C$1N0E
MN68NZ64;1UK@Q,=6ZA'I-K,3X=\T!B'H5[\<!>Y73' <E)B.*.^>/3T:XM+V
MHLF2FKII?-E%-5,#5:K_G\FQCY+_^C+F#2:J+;XLY:_)-]Z<.]H[PR5FK.+N
M=OB)3HF("TN",KIKQP"SAA-WHF63S:GT]@P2$'=<HR-X4QE#NX.<D1R&S[#7
M*6NL5;Y&CM<!.4QK&:LRGW<4)#[51@JM,V^Z& -!4@-_EL;<73KO>0,EW:AX
M?!S(+E)(BGIPVDWUZI2-%UZZ5_XU)XYUQC,;JCCT^ILVYM*U/EJ9DD@"M-?4
M>:B VW$6_E8+Z6(69T@!$!VR@) T9T^ZJA0%<\<>G[JPL('S4FJJ:EH-$U^T
M*1%N5E_IO#B%G*5A?Z-5 44"_L/V*?&+YW%J,SY]3HW."3#3V>DE6H\JEV'S
M'5=2$4)#OX&BTRZ>H@CUW-9VJO,6V58MA]J-V'X;\W)J 'Q[=OQVE$Y,=.+D
MG4P7V%;S)%BR^N<*<SUD-W';Q*\RY1#"/8K$<KRQ)NXRSWA#V[#C0HMVW2+K
M:&>=H=]5I0G+,[SLKJD:?'-;-1A5#1[<5@W^\ZL&7Z0T^[(YP7,P>9IPJ4^D
M\3+KF>V#&:$A=QEFAM2Q?5VZ2Z8=5G07ZO=J,0_!''=A1L).N:=_U,##7%HG
M#P-Z.%[=U9I#)8=4\[_;9LX[7W \9(BW0*T<^<9V'_S;\9R">83 NE5[H4![
M47\FH$'6HO]#<>?!W>)O1F(0YST",#-'Q5;2$$XY^8&0CV7"#H +AJ,(@#-=
MJU,A#>I1\+#P4/YEFD?AV>'!G8=W>3;"%8>!O[+Q&,-%'*GRA1D(+;OCAF-\
M)K?UH[NC73IZK$I_R^6=R,]YV_'U &=.@\(5P[]+9%V1)CAR;'L"^$W;+M7G
M8AS;AJ_'!W<U4GG@GFOAN-Z#H\/!>.7VDB&\3;4XB?I6\$/#';K>K_#"Z*17
MJC"I&0BA.P<_4SV?@>G^77U\5L]E2IL7G+%X=Q\5?Z>_)9\I_$<\*MRKF_C:
M5.JA,</"9C7Y9><@<(2DGR&<*)5*"#$7,KGP!S,AFB12$Y [-^)<18IG^:D(
M*0X;@O]B2-6?!KFG_.-868/G]L)D"5P-??VN83[FN&U51+N^QS][KA=LF# Q
M$/+0$M2Z;58BB@(6X8O3>A61%<BV:29#._ 9RJEX$O"JCLVGW&W0?=]&7YR&
MZZT>^&+3W0PWGG(MG+I!2LRCL2)D/_1;$:"[:'H<('S[*Y8)"3%NVH0)2^GW
MLVK6M>;8$HTX5VCHF EP[-_JOZ?Z6@>;X]&VBOR5%AC#4)LWKV7IU&9I ED1
M?C1M8I=U984$V4O])D1^M177-L8.AQK=3%70$))&>SLTR@(CS5BB^";&4J"A
M(JVKPG/UV1(E"B>EW31L#E53>?7OZF5P%*XZ[0V01OA589;4WM&F'I(6.O?2
MAH*J0<P9R%"57XN$MM(SDOB[(S$1L;F+F/,FX-=ROV+6,[)+_%/V+H<'.U_F
M?=8P.#%#I0FWA&O_M! W.2:&H'S"O3?OVG5!_; S)020E(Y,,NOS_2FK=/.M
M;FW7 K6-,\KDE</6XP>,M!^!881UFX<P#_][N4\7R"IA,%])(4IM!2;;^9PQ
M.LZCR"F7TT+NF%;RCS%9)P.BGT-EK(DI@DD4>G(ZB:BO^M/# ^!)A'P]BV21
ME)!$&HML$\YSX03TV( :-LP*G2SU?,SE'GG8V5(AAQ*N:YPCL[U-[U-ZT<7U
MF6-"%L5O(MW4;+8E=D0 "V8T\N\;A^/^-L$?C__TQP:U,@KUA/?X.&Y!'%YM
MX<S)W794H&'GC[\/S]@C!#/*"(U')S5235AEBCM3;096BMEY5^]R;XO/]6[#
M3'UQ][;X#.^6[36I*2J>VD;U3,Q7@47VT:=S(^N?V1 -)S(L0P+R7SJE%N.?
MLR$LZFI#3BM)S9JP7G!M^3%)_ T8D2[T,N&*.ZZI':L/K^\D>11$.:L6F(E,
MM$+F)-G-62L)Y6RS0.N J45>T>$'@#_.'LT?SQ/A_*N!R1":"=?8HIDT\K /
M)UO[NR*$E][&UM_ I;XTS9Y)+[N>G6N9T6_8.5NZ?Z*.ES0X]^3 0$:@Z>2X
M?ZAU=11<KQCYZ5*[4 LLU+#/I%&4ZZX;7'WA'6EYU+&(]W -/N%TY+U')^T.
MLE^L1'IQU\AS@7NA_ECJ60&^<+LT=\>GI>/R1SXOG%MA5,4UP\T>RU"C7JO)
MFRR]1LM#!G+/KT6XY\YUQC9.F(QN@$A3EJ68_&T) %K8A*N!DJ2A\ 1\QFS4
M (MI6206?<-AIUT8HANUD!&IK?8.[<]2;><LQ.>3$[G22NG:D*U@,$=!&+T8
M4'&)]S$UK<)ZL8+0L%3G$DX2QS?,Z\R(L8[;><:+KBV'.42@1#OSB(:FKU:I
M)W$;!OA_J.6:(Y FAY<W"=*^GD4>:41,GD]^B/B(/YNSWW!\CAD'IT\\1JGF
MD0Q#2;?SN??J3_9G;A*G9 FJ7X$O9-\-SKA0XN"-$*=)_3"#5[CQIKTNMT*=
MF_H8D3$%EIC"#'(@)&9W,GZW]__]Y'X!36O^0=MS[P(;<JXEX$@5X G43&O4
M&^;-;J8V1R0[@O]EP&QTI5!3O'68"H?1!AQ,#5=P5[2%SR@$(G*EJZ7%V;4^
MS[0D-UAGH7V1X'MZ9;0Q4Z"\E6@&#N"I%+0CFFTSU+VME/'$=A/KRZM>AL9:
MV^16TM8A3YI=\6!OA;Z7DV1,C3]Q[&%";3P#"SAYA. :AH_=L$CV[6V1;%0D
M>WA;)/O/+Y)]HCR2\RK"6-8HN2="B\BJM>O*$C8L\$0GT(GRJ4]Y'3Z&R,U$
M\CQ*2=$(WPJT:H5F9YO )1!P;;<](!I+L/S.5:9&^CH/#R3Y8;7]&TH9\;K^
MRZ13$-5/' 8W(7:' (2E:'T&E^=2.W@=W:ZQ:(XOG,0X:SE&'R4H([<PN\HT
MA,A&S*\RY$9_+S@.('"0Q+\ECR+=VEC$G)\/OS4@:0CV#GDX$'PYI\*H_'KU
M5C+X [/V*.7EO<=\BE!Q'AZ<P &@TLS(+RBGF/VBKP!O;X6L:^>HOD35IA#,
M3*.XL7^PM##87P-G2);F5!3FA9W#B71OVI@PBL5%RXW.6JK8RO3E+VP1TC*;
M2KY^,6]KN0&EM\26T?6LBC\6HJ>I"U2JS?1<.:>Y*[9O*/>57<.NXTC/W.&!
ML'';H4RD#(CT+.C\"OG5O-/@M<8.WU<7Q8_M4?%=^>B[Q[]_\-UWWV"+A_CB
MC&CGTN547(3,C/0V ;/=:U>)HVU1!8=3N9W7U'NK\X>(!2"#0$8)%@,8E8P,
M&X^@\/"7V@J07H1G7L-U,26IX6C*5(>CH\1#2M.?DQ-9/L/8B1QB$*!EM!_0
MA:-7NHWU,1S>7DK)1FM3"$7;I95$#1/O$9J5,F<>UPXN*7*;FA6FXA@L?$%*
M.9W&G%*I+(ZUI5J;OUU&P.*F/A/@,W!V0D.N*@-Z9J\3N:NC(& V7R'<RBR^
M4=&(MG9O'23L!'.SC(,;\7)_;2]JLJ7FZ^JV% $FTN>(LT22TLLLUA<+YO7*
M+C27?.QD50:(;N+'.4?V8O&,AE6%B/;,;==8-XM0SBQE9 76DM0%PO!MJ24-
M<_+52*.W\3@P;7HR6['$U@UD)10?$<&,_6FSL"((>S9,L"*;^ECR$G]+71LX
MFW1O-0-74VTIK?D5+YZ>+:%*@[JUU3VE0V CL:%0O"T6#0DRSDVQW6\VI9^E
M4K0:*,&HBHZ,WT*5=E=*(35$M,S4AHAK<[J2/H/(/BI>#QV44_JL]<H83G4'
M^)UC*8?5?!LV\Z7R<LN>TUV84$77[R,F8R6UI(<KS5Y/:0Q169]J;&1A24O'
MJNS"W&UD"<-U*[!*E\[7Z+(2@5[)1M/O!$38OP>].?@[I,MQW&X&L[S9&TZ]
M4R(NV]]]_!=WZ:A[6A8_O'KA$ ?FPQA)UQ;1MM-M+"G4-4S)>&TGODK8&)A^
M .1/U!JH%MP^E2__7 NJ[L(J$-)/2ZM"6\L[C1Z_;-72&4W0H?HYH<.V8TJ*
M+S$CBVDI:)1J4YB4ILVHV+)#?5''(CUQU *BN$)Y"^V-<0B]@JX'@I!"E;9@
M7UJ.RO8 ]!"C+&I%)".9U.\2FD<W_UF[$CT]2^A0=LRG<9F+*WTB!R[./[;J
MOXLZ*>.HF,<[*EZ%L$;YPASTWOH-J'D!^89&?5_FI9(^AJQE_"<N/Z.OJUZ3
MF*IJM7N]"\J0HTNSFL726/22F+ ._]0S.O!PKU@;B36+6OOP]7+2[VZ6M;Y9
MV"GQU297FKY$JTEC*IG'ANJC(2ODX*O^#7K@^+=@*W6[,=&7"ZN:EUVK=5F$
MAGWTV]Q4AL _"^=[-__P+S9YCJ;/=*D87F](X1.^A_L3SN+L,OA_]ZK-III]
M9',0ZS[:Q"*9[$UUS(ZX(18"E- ]B?R"LQF#5]!D199NQW)%N$CT]=0T];CP
M53,W?G)_AO*%>UE9#M:*V)O#7&F[AAI8(RI<=.1"(!LV[7E-QG626N;X8(C'
M8I66]-G/V^7V3!JOU^R!%"4VJ2PVBN=RQ%^)3(WN%EPL:W\N!YRP$>55@IG"
M]> #2F=_%E5$D)K,@V5EWB)IC&+K!N./Z<=^AGW39 I>-BX-N9["HC,+0CYW
M8'_]2M?*?>=75Y!.VJH%,$Y7;>?;I5+PPG'0Z@#WE[;>AU-0B8J4@":D(]PV
M+(_1Q"##&7;JVTS4V(8=;]%Y'=9OH_ !!8NO1H*)4RCO-K:V,!W7$>4\R 2)
M#:;:C=P6HFM)*E!947^:.N/4HWF%%92;PH[EBC[QMC?K.3.\U;#L5P]4:99M
MGZ<>X2MJI3/*3>SM5+US??IY:/82V^A=UV[TZD$. 4R[W]?-X<%?Z+6'ZX ?
M^-U_/7STX!DD9;]])HR[U;SM(\/N]W]Y]_)NF3:.K+\O.*9%]]>+H (ZRP=1
M=%3.)?>XR@8<&YH^85*?__CN96D.=85ULY=P<MK'[1Q8M 9-AH15$,!%IZ%Q
M?+:(=B#P,ZO]TX7'5@MX?S@\B(*8V+01"F-N?1YV9R_AFQ_YKS(YSY*H)"-U
M^Q"_HCLJQ(9W9NY#! T![&#M;<-S&A8%3'+A:W/W-8=U23,81U'[3W**^IBU
M$]"@0#>MG2%]&3)I"Y>GT4AVX1XX')ETP"$!SM*6^'Q"X5DK$W ,E 8IPO2[
M-^T9>WI;#AN5PQ[=EL-^7>6PR3O!^9^>_PQ'#*9\8+'I1@2;<U%U*VG7UOR!
MPSP(2#M1JL.,E18<YK@"L]AP%IA?<QB#C!6MBHR8$^K4%6.S)" C4KE" P*_
M7BC.H4/0QW&XO[./Q?97H4QWTJY1]*^>F<Y\;',@8UL$AX(.2W*WEK?E^#;M
M1HHE'K.!NT&Z\CES1S+?"6.CQ,>*? ^N($J0J"Q*,BD,ZOGV!#<3&$OVR_=J
M/ J[>0(5?*3XG6HM*Q.AK83EN7;DR023Q)6J]50-OCR@+Q#VZ;9#=. ":_08
M:]S&@F^WW7,3UAOG63L@+S-Z!?CB)+P2!@2K?4+*'#WN0@_13#_"AW8"YW60
MN?8X7%'UII;436(SY/[VX?P0B)B4G,B4PJ4RU.NG+%;IN*^2+"9XY)@G6M9B
M("(F-2FEYC]#QC+Q862OYR06,9;2S4&N _S&/ 1.?1&I$M?-W)9?=8O^=]O,
M/C+7$MZP4%GG\?C2A"<@=:11T)_Q^F_"-".I95!:"+1+\N,(4C?HH8K=*(GX
M+*)_E3+I^A-5VYHJE4)4+;#NHO@KPI208-!:B9!!&71ZW"&#&&WM>IMD=L,X
M$3P]C]SX+/<QY*-R)^TKFF1JY6-(\V>H[-+@[2X,R(]O&8:TP>D=_7U,H@W.
M>]7W[:RAURHY2'(Y&*+:0! 0D,J$^YXK#L(#[?33ZL\C' QG%%!,^MQ-KS8#
MS#_AJ+"GCKQ_$BO0O./BFP/$.]?D>F/<1=+^)9N6'&I,YPO4N9[[@A"PX8D.
M,<:M<>O[%N#XHH)W'WOBUO01@LD8('^51,W;+,>2V005QI@V""%@&&S]'69P
ML \6FF]-M/97F/T>P'(!WX;/!A_KK'>=JH,?16$Z&=^T(PV+>=YT6^9&3JO9
M1Y+;B87.?S%U=$C#AC>_^4_WN++"9E!<B16;65(3EZEOM]ILV2  *F\(S=^.
MB3B^4B_F1=;M,SBR68(H6-@LC:67G<^S'5_:3,NNE]8WM4/IE*3VEE$,;'UB
M668*K<=R%\I/NY14M1I@E,/_+;2+$/DT*1#0ID\D0_W8+1V5_3.I=;9]/=@P
MS9 >/_)WRKC&S6/J B?-M/##PGA,_!##%$^!IBF1+,7%,O+$Y!T>Q(2-LM3$
MR%Q)?$2;>.0OQ .FEX\[A'NE^'J#GPJW2?$\O.$=P[X\>%A^]\V3WS^\_^#Q
M74E+D*86W&[MX4&>E%'$$]M+I;?+^G_P7,F%0CDMQ#D]YD6+/%V8]6:]M%;K
M[7*Z[4#P'=:EFY)3I@<4QT)L?AV.-QJ9=6C&I(OWXWTA*:KLG2,Q=MY&I(&8
M_;I_D@/O(+//G@'V&[(GP3 UJ)'OB,\N!V0B,?FF?Q>[\&7_ PRT !&&>GG"
MM84;=9_"CB_!E51S-SPMO_WV 3;#-X;(MTJK$%_Z^2Q1WF1ML'<SMEX[>M2-
MDZ0U4-$X 3?1.\0 .$PWF:X6>6[0F8\_)'R+8&^BB@XORV0YLP<\<\ 1V#M$
M'N:R5XN:I8;^64Y#%H:^M$0C$ #!)M(XWJF/3HY*(A1*R9"*"79JDQD:R-Z
MY9.$(;,2B?J<_(9U<3,=JJ@EJ^)MJH\U6AD$!6.D8EOI WCS$])RAGD!P%:D
MY./31']L(T?YCJ/%*N7?@W?57:ZM8B"G&"M]7BW5G=YHG[ZMX5VC_K*"QS!#
M$B&:?92TS_:2L]:^,I!"?!:NM$#@+Q"M0MMVC6)/QD$>L3(NXRR^(80A([U
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M=;%@57_A,DRK/*SF,Z&3MTY\[65MO-9S+6GM3IZ073_&/W ZN9,N7]"^=Y-
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MA@T;&+V!E[@9J/ Y+\F6W\>#U0T8<'OL>Q+%,'C\M>%XB./6R<JBK,&^-J@
M9/NW(9>Q2V5&2\*6A6_+:*GB%3-F>X\9LT[&[/@Q8_:?GS%[&-@_P%6@%L%'
M*Z." ^='&IK%G4CGZ;AFX LJ.7S[MQY,A_+E51>%1R]%D"S'H^.@)DY[H'F=
MH\8( JZA!Q /7_RQB%\T0._VDD8"2!5Q#((V-7HS_73J@0%SSBS2)0/><NG0
MXQ2@07OZ"49I%:;7THM)@R<]07-)EWW>C6+E0!QY#1J#!%Q#!MWPW9<GU2T
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M"\0#.4R*MC@"=T%)1M%<UQ426T#FS5P9N-?UK<Z%OJDU?!_S4"S>ZO%47>J
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M52Y.(]M+C:+-#3;"+ 2E5&+T)ZUIFFMEXY3L]6KL0P)R&(LIG569HO $R&/
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MEX=;&<<!BH="*U%P"4VT"X7_URT@9>QKHJT.DM<(^-$#4,D2@(ZB$)?V-W#
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M2 SSTUDVJNB)= -TOWLRS7ZORJQ1G)8<F]XS8^=E<^,?)@_1<6X4;E/#L]/
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MGA\W>\Z$U9VE@\-ANE@<"5EU+7T8@QYPD#XE7_7XN)5?3^55SMZ5!S%(5^X
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MJU UM9B:KC^/J4EPY$+6],5HF9*8E2E W2VC95HCY$C<*5NUV]RG@<GQS/.
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M8;Z0;BX\G\O<;XS;*EQ1]U1AR,E<[PYDLIR"(\]'((6NNALCT6K5B'S8Z06
M=<R">AO/'AZJ_B?&VJURE[<11,<[@P.W1P*$5AT,[69<5Z"YLUU3$XX&<K _
MV/F4W\IN'NY^TJ^Y>UZ4F1#DQ6AS0W]^[YR'3S]USLG^X7V#9IE<-.>]IY\Z
MYY1-@(EH'OD-!^ N2->K$+%^RIHKN_M( +YUTON@2,/]$AX$#>*XQDXG.*2%
MGK/:GLZ<0*0'S/VGWWWU/88X;D<ZQ-#F>,"B#Q=:X6?,?,F6]_'>,P=ED&?Q
MX0N7F?>"%I?\BO2(Y&/?<P/B3[0% T<F*-#3OQP=[ 1<D$Y"(FT5%X[$^A^
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M>]A[.Y<J"O?"<,Q(<82 \;'Z!;_9?.VT]DP=Z,/>\<XM'5$XJ4][Q^]R%T$
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M^^@XR%M+9JM=8&@=!T%,+,/Z()\A^IC/]53Z\:#ZX8U1?J'NJC0BPJ^AT.?
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M$XM4(I/&,\'H%RA6S&'.<X;)4\P2%&V$#?2XE=IE /^"?4<TOG(:\;(?H@2
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M8UB&XNUXEQ':5PG)+M0B5V&S@:8@7/9>QRQ,+66P0.:0 81PB60&%A0LD$U
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M]/-DGF&,R9MDL+UP*F% \VQ]K3:/*[:B@"RDW"N41G=D[+WA+:&". :$76$
M<!(&EVDF_#/"[(SV^_(*=#LW&1!H 8YWI)'Q\B649-R U2:'9E@R-I6GNS4+
MTUFLDHK$DB?,RQ'Q=Q!LR>E2.XUH#A1YQ\]AWQ;T?R()-:"G&LZR, GG&=G8
MX7A.UTVJV_$\9\H@Q*P_. &$&2'/!#,9.Q<I9_,)+EL@=9"8H[95CC>0LP?4
MWI#"679MFU2SX!F=CSF208X&U5? C^%T%J?7Q#MM?8L+Y6@H>YW60*,ED'^=
M8\+(K6?J%,K%;$8Q49[&"GT[%1R^\0)@C;"U*HBLBVCF# :!/Y@J<GYGP,35
M&@B2]-SE45'2JJ/#!CGUZ"57R4Y)B7Q,*V4F!'3A[68A/.,+]M#D19\8'7(J
M,CI<7T7FOW0V3=)$H4'U4&AT')#K2;>A"M$1Y'LJ[(L% EM":H] T17.<8ES
M-[IV4EA<^DQT803LU_J(P6UT0]ZL33(:3 O7;!%7B:5 +?[E6F#<.C=D!&MY
MIA CR]"")9"PPE[=&B]H(-(>4GZCOXROQH(M8@B4!J1OO%>=UVQH+T44DK"H
M0@I5D('?=6O0G[<BYH\?;T!_F#9Z&-2?4)HI[%\=#_<-T#]N*OO V#^-*#?0
M/VG\W97=0BO7AJKA[K+%A-(:UO\*W']ZLUB--18LOE=LPE\BN#Z@^(XYF@ S
M2XD\4YF/TD]G?3FU.^$:-3+1 !MAU1!"A$K,8!SSFT&.WHT8QR401Q"9M\0X
MYO,IT>_.XYCI5B(*F_%]J)V"AD1Y9I/QX>X&-AN+=M!R'S@9EAML)+UVT"XM
M--K*!)]2?530F /W"6L<^&2SJ\*!RA(2EOL6*IAE;\\@9 54^<#H1V\Q^)$5
M6CWZ\0[NT1+/]@;OB =2<H\8@;B@[PU;@'C2T).--6X7V;4TYB.(8MQ0TO=3
M!.31=FI'GRH6:<OCX"KGPA'[7(T)7>=6^(!2#\2IU)'S=3LV7V9RHE<46=7C
M7A)6ZRRW!"-[CRX$ER A!ZN2N.9J.GV'L [D(46Q[Q!]B8A28\#JBN2Z3!GD
M2QS(RBWTX-97110+ .FM9;>I(+O?S"-']NX_A/L3AX-LOWB(Z/-<]JPS=\K
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M%4CEK[#%;!H<?/K*40E8AC;N)"T'Q8\R#F!2?#/T#@Z.WZ_/3+-5:T1^ANS
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MO^<NK)8DM5XS G)04N/2.>L./B5>.GY&59A:X#=[E73 7\MI%B9E*<=Q]:F
M##3(WGV'@OVQ/47 7W./"'-2<KVL">-!0BSY/,?:B@0E"Q9G*P.UG,_B;W*E
M!QRQBQ!$ >))J10#SE1OUQ_":HRN2;+F:/"*2,5E7-_9^.@FQ;IMGZ&+.P2U
M,*N86\M8SO^(W6;N",RB,_1WN_OE](<W .N,LG$^I34"A>-,[%O>\WN#/>7/
MJE?5CZK9$!R]97P_DH?R <Q4D#MG46#=FZ"T[X[=:P6P]%*1].C!LO>'0WSJ
MH-VF:W%6W9?R4NZVVB_UDUJ>*'L$0(93<?DI"@6&. A@'?M"76LYR2[V"X0
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M*7%$(-\HP?)LT9529&L90.5L%UAE[.H%XV)>\9M8CZ,5@-^?)[2%ZA$3A.+
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MH^(_K:+IWL4"_N#B.EC>@VDP8Y9S>N@Q-793 Z'W=>!"XY_:K7WG?>9-)5.
M 2^(V?1(_6D@J<!#&:IN(#L&AHS S JVUW,1*5)X;#1#R#P'KHZ69PI6%4,T
M.C)JD45ZCE84W$E]"AVY&<R)Z';>^B[HR-)H)5!I95_(,00Q:6^(_OJ\0 GO
MS;,1VGB!@.7A"YU6[TF-+&M62C' UMHQ^4K(MGQ=2O868Y_H8E4"R;56 5VW
M:D9"(&YL'*B%++];_&248ZNF<O>VGF[%T^UM/=WG[^D^C &UL/C)$JGE$B@Q
MEY[$3-I[!#/I%#QZ3*!YQRTOQ,+VEK\ DB7Z)!<LW=ILJ_<WY<8H$^80+DHN
M[,$WB/M#?$ET!@$$.5T/^-*<X7Q+!T385)/Z9 -*30D4)_$.2+&?=S:G.C1#
M/,#J3=*B>1 '%#NA\$! _([7B)2T.5^1;)/,"JI"M>OT6-58">R:-*O)VZIL
M/9HS;[!$STM 72+8%.2*%X+3F%X'0LE6)1DQF7 ]^[=4GN>20#<;Y:E5F::L
M9TGR%^G2--D# 51A^T)V,%6DXA4F,%R0;'?OY6M?U0G"2 +"[^XPY181%UN\
MJTHCRPJ7\9 W*.']K1*N*.'^5@D_?R6\-CVW_QA9/IV&!5_E),S_/8_R@( >
MH.'Z_;=3U' '5-0["43I'YT<'OC*:T>3X)BH<3,2>K\%(P1L?EL!]+1F)^BB
M!JK$GDG _BWI$*]@UG(0=\A9KO'>(7(/,B!<R=Y:VFB?JL5@TI?&90%]0LPY
M#D\2%0GB.N1<)K5 G%(DT=""^429%*L1,^NDE"K9;A:C.-P1VH CY U<']3J
ME(/K%/41=/AT!.H+A5FM*EUKCM>B03!L2#5*U)3L6"NLJR;*!9M#,3PZ^[M<
MSF5SAG&IH:X9HV@Z;0XA4@)0M CY8)XPL6NT2Z[*-[@A!]7,50>K@R=6"-?B
MF[0XKW)=#*(B*Y9Y Y:/6!<9)Y"X )97HE0$VVR<!S-=M61E8?#_JV07%@.G
M#@M7<$E63L6BH$N(GL$J0K.9N1<?VP?Q?@[T-OZ\;/GO<F#K;(;E_:U8-B_B
M.VH_ACX@V.KQX7M_-=PJW8P=3$<T&QP$Y:"@E=!8T4#<:V\-Q(J!.-@:B,_?
M0'P0.?6-$X*+111X<(E.@.7WAM9;&G8U<[73V5#QM+>B>%I/?;R$+PS7 )?J
MUX3/+Z.LH$X@V%Y(%0WKU.U\!@H3)VB@E6!#8K.?&:%B,V)./RLY^+O<LT:!
M(*Q1,#65ZIZ#J!-D3B4S1U?=(5-Y24GG=DZACD'A296U'L]CQR0[O<=A6J0#
MO4\'VKOM>;ZWE7^(A?>Y8)^J_0KP2+X_7H@9?6#3OJ8*M%QRH@)?E*;#7),0
MB5 %<9"4VJU@?K+  RX9*R94G>CZ5*Q1+UWBFJYZ^)DBB_""Z Y@L=6C"-D*
MG#9H*, 2F!('-36I%K7E(_P]5R]C:KHH<RRQ+V&:G+']CT3^<?3=R!PA;E+<
M^@'UWMI)SW:X]U:SH7ITB2M,8H2Z@'M??R+FHA*&(E@F?"GPBA31V(-.6AMA
MGR)$*UVES+%O8Z?8 T%&$(-=2M)RSYK0:?S%/A3B3L+SI<T"[X\=0+].'RA3
M+P$'W<RBA%;"[B#-1C!!4C<+9F^Y879,P(T(:TA?Z9E@DW&;)XKW=GI<QHW%
MUC7I7*ZP8F(DB2)$I@2^7"G<'_3]O?Z>SOO4(K!LR#,CD7D#N)1IS7C\2JVA
M$0,698<D%*C"D,H4GJ3$L/,8G+MWSDX1G/+ND;E[JY!OX?@BP?X6P@V8I)=2
M:)$1>Q:X_A?H^7,2R7#O-QN/$#I28V/L)+8T);*^,84C8NYH"N<LOPAF*D:H
MAV= 32WO[^D5J)#,5_PU).=!6,PP-T-R7BD)BHA<!%DP1@I)K'%94*EX$243
MN=M6@JG4;"#B-E#-1HQ-36SZ<2)\)]H<"T-IQLD$)<:4"RE&BK0[4JG(!"W4
MUP>F'YVQ4.#48R!RR=E9LD)!+V%7R!";%25H96*?5VHMKHV6:4J'3PW=TR-'
MI-X,V8]HP53L2]@ +#Z!<!S,F?WTVCL#/Y5XQ$)UC#3O.8AC$5JIK8NY_9*E
M/VX(472V(8I*B&)W&Z)X_B&*ARAN#..(Z?Q%-B8A]5\M+- ]H3^19 9I8[C)
M,$E1EC(*4VY769!;6S9&6)2ICF!H;*)A1?T0P$ &36PJD[%'$G)!\F\*(^+M
M,B]"P%7*L\MO14> LP*_G_ZTUVMU/9#$L6$-W:=&$*<_[>^WVNZ?P%F[2K-X
M H<GK!#M] UGD<L"1_HHN(S2EO>9,)@'TQ#;LU3:TK9VI9I4VV,R(N3'2B:1
M$+!F*0S]C.@8;$1_J+PZZE%!O%<!-MH#6P/W1[T4(P$94701,9"B^'1>IW!]
ME54C5K,A?H]2((I)L;L8"'G_CF>RB89P2W =H#%R1(/4<-X]?+GC\?VS"*OZ
MQAG?$^-$]7KE]CJ.GX'L4>QK8)"(]3'[T;A0??F=<</(D<OF2<D7I*#$4>(Q
M-;HT922O31BNR;:0KAAE)+6D8T%LO6DV=O?<83"FMM==-!"%\.$3F'/S$>EO
M!%[R.9.8MKP#SW11Q=KQ\)Q37?5MG<!28"(D\=S@5'.%A.GA-"J[1G4-5 JO
MVU>=3N,UDH;9#!.&7/R<'>>+]"HW7)EN*10EFE540*&L*W1YRL=%"Q!#*)10
MU"SB!5=4,%\ 0;*YX,0E'%A"O$%[B-+.9=+22"8],Q6]L-CVU&P5R6JGO2<
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M-6R1')ROV]<6BSJ/E>QS:1B/9V%WX$WFH:HXL;^C+%<\)?)4Y#O%])EIIDT
M5-5[<$FKP1+)W@5S.H(<Y?H)1-EIWGJ5I,K+W/:@^@K&'*@%:S9HQ=S4)*%J
M=5>;VD6JFR?B5,,+5$O<16#96"N(P%)%N)(60A;K-(&SN#Z$2M-NK"O@? MK
M3FT'+0Q '01"ZVW5'*+,'(@FR!H!$A+(QMH$7_JQH_2"N8 ]NQ,*=;V^V#O$
M[!:-FPW8M/PZ+T+0H_B%O,C0]AG-\XA8;Z?I)(SY#N.?08+,"YXQ+K<TC:3E
M&84Q=K#3LA@7DPXIR"X:FV&(],H$D;!YNL1?<K6ZM$/1[2Q><DVH<2>CP=8
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M&HH9W5O4^=1XAE:8FD?)FQ\X ;6XCY:Q6RSZD9T;Z$=PG0U3$TN17!.%C_#
MD;?"QDU(?68I1 =KE=/I(+4&OP+O@Q(Z$L$B8KFY)O360052>F%" F">V_$_
M:D9!E!W<IMJ 6AZ2Q.T+//L]'-*PB%0M^B-M!W'F)4C.A6Q8R;5-MH9^:<#W
M5K?%15\X"XTH%JHVIN%45DO+^WMZA3K!AX6_I%O"CT=Q+=<5,QESJX7.F*9/
M\<(<+==25LWT"X:!<_QC\0X\Q#JI\4Q@NF.\D&E&DDM^LMH)P6$N=G*,>4W
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M]Q>FNH.UD&#JRQ"(VXG:5\(-?01//3F>5D4-ZG ,N)CD:<*<X11_+!S779J
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MGQS83W;7MK(Q&&%#?7UVZNC.Q=E@$-O/V5WRINS1%=+#I_O?'.[O'S"G@I%
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M 6>_CIXR;X>^1&A<C9FV8R#-C;(#8LO'S@5.>#)QY DKZ9Z8;PGI!X,*3PO
M[2C_X&U,R7V3W,S@F$A ,BB.C]YSEEU?(Y<@F9]QWAI(<HN&I'FMI.FHN:X4
MPAYN0MA6"/ML$\+^ZX2P4DQQ38\Q<5:J'K_ELE*RLP/R5&'9_C$O_OE//8O
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M__^#[S;<0BN]^XGJ^' B]R/?>5B$:%0@K-*MC=[+*#HVH<6*K\F#M9PTJ%9
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M5J\+D<?/PD2&/ =R(/-%N0_1O4ZO-K=>2&]\UV 1+5E FKSNUL'T492]P8[
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MKI?\K;S+N1/!W"2:(/*+W(QIW1E;^EID&&(R*$@1B=LI=T!BN.OE+'DRB4D
MUAKY/(0$,4X9@?[WNNQXIEH628N=BC8@MQLT$\&<$U31SHZK*4IO,F#*OO6]
M[3/,<]"%T!Y*:K(-S"0Q4N96T02A>>QG4JJN%EIQSX5*=^D<MX,$3W^I:,!9
MD/F)2A/IO326;.MP6 E\1FYWY[32PD25(5@5G2(=B+&*O,/B^[82NOQMUL\X
M;]72/FJ,(QLY9>Z2<;$>+-@H;W=5^?$437G7H+Q?"UDB5_[K1NE_C:?;Y0VC
M:<14(J7-8$W>QSGCGKR3P>H+ZB0@R=R]JN!Y<'M4+7JU+9;?=OT@ $KQ/,Y<
M#EYY4)<67*3C5X)0RQ,,\FR 9"9MWJP8S86Y;#Y%=P??"+0\S/(L+9JI'216
MZ @[7725=3P%'E/L"6>&6,NSDG*F)V@5[*LE?;U[U;7FO;)OFWO3Q-@$]QI#
MI45WV'<K,T3%T:_JQ0=%'0O%.__*M[9U>EKW8<]DP7;A4XQ"[3LIK00[ZDY.
MXS2)24*Q 2D&BFXMEM(=%"4S1E0M@(LXY?Q#6!GCD$Y#J1O>O8J,^-O9^1H[
M0UUPWF'_F\J#GO7='2A U4P8.N^<:$VAB4#&7[F TY ;=JEG[;8*/2[WSMMN
M1L=1HWZ83Y1HB?NO5QF0%-RGSHT>A*UI^9S8QI,HX,4^O @YH:</,.=^<G?7
MSP'C]+J:*V(<%I-W!TK;G*,WDNRH9. LL"8]#>8;4=Z9SDQ7L2'AQ/?WQ0_"
MG!Q2:T?,V\9PG:DJ8TS%35-"OXA^X$0/V)?G[*VL,)>V] ^8)GD!']DM-+:U
M0H?74OQ;;PD\Y"*?=BTS3X6F2&B<.XT#3?(%2"R;%-I06\H"/>?,A'Z#N*7P
MO*.01AAJ_9:/<9L0^H=+8BNL="??HT^-E*0MWV!G&R-LBT#"2M[J>F>TS=G>
ML;"TG(5 G.9SYJO4=S<E-\MR7IM5PK29K',Q,VR#W3?Q?S2EEG69<JD"UOZ-
M<V07#,WVE@34G8..]166TE&:1V)U\/G8BF>F3XKGI: .^'\:ZA&]/Y:$_$ZR
M?H&FJM=YE%*D%+1S_IG;]$?[7[O"!"^"5??W<N?_,_3(1O=?XX++'I(!ZYH-
M$=5KO> =J1HURD7UKJ<'#GL.N?0#?_.*7'?KTW[CP0E /EQ9FP#G9UF3Q6EE
MK'<C\JG"!GS"Q6+HE,]RK8O]KR45,>BC&2]&L,#%P8W=]W*,JI7[+'SP879+
M5^5$_I1N7$X:<O!,T8;^MI^R?^:SH%7[H0K3\:;"U*PPT2\W):9_K1)3=WQ8
MN\;T@A.1HAQN!6HV8)8GD^Y7@P.TE&;9D7,ML!FY03D;1<NK:KZ6U;@ACLQ^
M7L!GSK*\Q>0].%-^\7=J2-IBH;FCDJ<V8L&01 _]RB?%(_]LE$TL<=$XZF/Y
M&3K)5*02CP;>S!CS$M[**Y]>:RB)>I8! P:^$][!4N'#EV/MBJB%4,[Z-/JQ
M('6??'(;AF)E@Q;AQO,.<@K:I97>Z7LR^A(W=:U'B-Q5$IUC^<G,I+$<Y YM
M&EG5OTE#5%X FT4W,3E:]'51LBS(T,/SG=)+]461.I2TT0=Q;\IY7=F@-+R#
M9)+"!D ::S3YGB*3J5)&+ALCY1GWU"97$WX%%(MU*(K#JJ1*22U9M<AKXIJ(
MMG/AD0<XY/HJ/LZ4?/SZT'0TT^XBA1S*K$0)KE"3K-F2YF/D[\B-N_5NG,<M
M-8;&[9LLJJ$+;QXLDZ"GRGZ6NC<JNK 5QJP3Y4[N2&]'2T.6:1;J%@8:0_YZ
MA/<T%U$<35Q[6$QCU#BOFHH\TQNR,C:#,<UA!V3. <RT%TL?9  PV<PGW<*=
M%FT/ED1UO%U?1EF6IP,9]@>]:A^=>P$QUDZ2<J-/(\.GY*0;)^4"9U(6^[R1
M(U[J+GV&; OLL_)=TO.]SLATO_Z/?SL\.OJ.5DU9XQF5!--"XK7-NNL"/4R?
M/SOX1HB8PI3Y;.6QNLZU5/"8[/NR]'2N#$8H-HK*# 5TK-?+1B:O5>JFOH$-
MOQ8<FHG.C.<3%LP096/5U*;S5,O/<FSP>I$V1UGGTB?)\NZCV4T_X]I1M#78
M^FB?LW8PCV@RPF8#MWA"[4_L%QN] Z1Y:6DSS +@D.##@;>#W$"(V/ MFJ(0
M9]^W]+'\ J<0ZZP7QL'FBH]QX=R92,0/VULR!:W';ZH<^RY/VBG70BC98 F+
M)3P/GF*Y/ DXHA%M[!2]O,=HTL)<!1D +P_WKFG.KN;%2+JW407 V1-]WUY.
M>'"2U>_3N:+?L[< #\=["%!O'-E*D9A?U(?D.;>W[&>T#M'^VE_8)MOU>)Y&
M#6GH=+;VK(L??A]Y6$YHI@!01PIB[CQ:G['\S9=,/\Z0I(![QO*6A6:&O*JI
M*3LHGIB+B67DO@4BNX IN59AE%2#>>,<&,K0EOIV_ CD-ZC*8N7R;YH$"LJP
MT;QFC6T7U?RY%H]JW14ME&S>AT\F#B(K=HBX*C*;R8]9+1@(KF^"/<?W%EFW
M[=P5H IA8E/7JF&+V/51DD/!6C<,@S$C<:NZ*_2EDJC4_FB6S--AM&[M%3#-
MW^.E&#-)-/NPU9'RGC4"L7@N \O#AB1Z+NS4_+8HYS6 (LICL<:2-=@*I=_,
M[",-R[.G?N3IPXZG\1P<'*1/]O?9V-JK4=Y]<H,T\J*CK_D=,PUB1D2N(XWR
M@$%?MI<""QI90 X[P]M#9EV[=PHEL/2-0O93!UE(0-(@^^TN9R'5@'2?+L#&
MGK$;"FP:"-+_FN=?X$_^W57SD8C&Q#GWQB)5L/*+%T_W#O?W#Z4%@OYC#Z]@
MC2R6$R6<.&;^EN=,P2!H03I*]#R$ZYJ[\_"WLAK1\_Q-SH>W LG6<@#=,I]%
MAW/XH@TAPR=5?(P='3[_1N\?M&&RN8HD2QUV1J\E:X&\#?;K][C%(:R"R\YR
M.G2EZ'S&B!&W19N>@3O:7*$^,+?8(/0D7.1'V6<(#&$$V^1@X@,M%R%'R46$
MC&^D"LNBQ5Q3^$J13]DL92O$)U.I:-@446LUJ=*EX]O>FH,045_MX?[A$4LT
MH6D$S[I3[*YZ8#57:5!X&]%@!@N5P732[JYZHP*MG$C0QKM\T+#M$9S";B7;
MD)M\*H;B-W1=G82[Q'..@>B)K. 6WDBOZT,4,TOLP#HY11W9W$M)^A=)>X)K
M>ZF2OOD1*>K7FPXEU9.A<OZY9,,Z45\/*UXI]5>5H?]TI.(<W+W5N%3OS>VO
M> \>BQP\[4%:CP(D57>2IH 93P_,2'",W-CB,5NA42UF'^D:-59<O%5Y,5DY
MBY%UV%K2V)7SU'.N)%,NX"289GYA G@=9Q^X% 6,*!TY 8UTE]'2J$2.;T[O
MC0N>&VYBT2X=O=\T;QD^[3L)D)[6!A[F!,/8A>('WO=ZHP2BS5'^,$[".!VP
MPA(FC1$T0HX=?Z= G%86O_K\PZQ?..=*=G/D:#M_"/[HR)^-VUL7"@>2ZUQJ
MT99>_25R?F,LAD/:HN3G@,LGN<SHW\?[WPWRE%,*]")UM5S^>NE5+&0)8#R[
M:2@HB)%S3=*B5,T:T9209:Z4GQ7A636H/4%^=E4;W!F6U"/+#)AV5RHQ5D"M
MRULZR+KJ&W="S/27QKP[FW#OQOYFO[=_O,+^]DGWU>I%3S?UHG:]Z&!3+_KK
MUXL>D>H3:%DQ^,^OLO\^W!^21PUR$T&']=JX,YN$"3+QHT= SD*G6,@5U/I^
MTA'_U0\0MBY%Q %$C<6@R"I+'$!$H9J6CB%<K+*RLKIRMO1?W4BYC(Y3NI(Y
MH^[G29"?:B%K.(AV4I1(83P*-]FUP5<ALXF-X)>XX_?%^#JIJSZMG>$"]/IC
M6D'_32YU[_?I]5?D!L_^\ZNODF]^<&,*UO$["OWV;"V'1B2Z,;RVQJWY,]V_
MQ]B];1/.O_UQE/7?AP:<UR]:0;[%IWZ^L,_T?\-]%@WP#^4J.OXTJJ*=@UW'
M,'3F(YU?S\"_@'Q8:[]PLE85;B>#;QSW]5YYIW6)$WK?MHW^=-Q.GSI?AWZ^
M3L\OE0+Z%'74TG3!!@T?#?_Z)4=69I(E/\\&V9]T5C""A^:%SIME,W,D,Z/?
M^>'DY>NSESH_)R,)7L9D#I/7</=H*H)9 #K4S\,G'%T'A_0=?&_)^?7$G5\O
MUW%^08N*YFV1DD<_RC2E?V8)_O4EHW :N5.(@I$!.?353(BL!+2M7"9:L@W+
MI<BI9R VP;W>,\N/N/Q7\QJ0@#H@O91,-6?3Y;!\4][2DB[&&;E3QECRFMYM
MG?Q$ORF$)RA4%#A(]RET1/\'4MX.)(+UG2/[,F F?J$2X( U_S"%GIPD50\/
MUQ?LG\?Z5.72.94Z"P_;<BC;6T<<XA]"TR1/E#TD&[$F1>:=#S>3V2A-=-:%
M]@$PSYJQ&+=Y$$?VDM]0<1@5^:W.!RX3Q)F81D&LC'*!@D:E<7S;O<<,@1ES
M<(ZD;8D5L=+DQL#%=Z:-HFV6R,727 :W7"0MZ ^R!UF?/^24CKY*"S$Y99SG
M@]KFP"^KBE<&SE])S@T +3%<1!1+*P^5K_$8Q_3GK&NWC,6Q,Q:1J=!6ZW_;
M?[E_MD_.Y?DO9Z^3)R>]1+_\ZYMW9Y=O?_XOLGZ7OYR\>I6<OGW]^NS-+Y=K
M5!><?-8*?VLFGKJ9X(<][B5O+\[>G?QR_N:GY.3-R^35^9N3-Z?G)S\G[\[^
MZ_SL-_[PXMW;RXNST^7/_3E&]LR-[&0M 8DUI&UOO9-^W<_X,&]O42/.[]97
M9Y5^5^T\'X2Y%I_Z%B8C%_AL;S%OGU4 ?+6GNS"1-:AAD#2,;6.BIG$_973S
MK11RZ$7EDP&Y(WLYBE ,"2JRR1XCTHH^4'+2NJ 0+<9+B,%!:^(=[+ GJN/.
MQE$QS)F$R4;*_2#XHNLO')=6XUXDOY?HF6:KZ![-,]])]DYJQ2X1'M;<<Z <
MI1X:B+,&&))!<OIZ=9V-9YNT4SOM=+A)._WUTTZ?Q;LM)A/R-&<"4C#Z*P$1
M J,D0.+Q%4-8"U5G1JU!"2=939<LN?3F6Y^8^EX38=W"7\C9S &/[(OWM-2B
M(#NDU;IY%5&!&<-EA&U<D)'#! ["7@EVMX9E?\Z20+GIUJ9PP6I<BZN"CC&$
MK>"XJ*J2-83RO7*RA^+-; [YW'4VO9UTFG/Q=&^R0?+\.'UQ]-Q+>3GT+J;?
ME_F/C](GAT_;7UM^7#C*>"D_T4%U-[O!=Y_N]UY\[<' [+*FCOC3;GCT-#TZ
M\#<,Q$XZ[WCPXIX[/GG6.VC><8W@ HC-:ET*:%_I(H^]YW%)IZFBQ+#8KQ%T
MBJA6P?HQ?GVB;,T>>JW IAT)"D-*?MY&'^C7,^BD/3_N'7YM#CMK\=E<H-0#
MC44I]<^<GKF$9S21QT]Z^U\S;/@C?[O/#_/TL+?_B#L?O-AU I?*=M?7'VYO
M/?BX!T]ZSQ_YN$^>KCA>> _MQSUZ\=C'3;ED/%+N*_Y-JA*B8?="/ZMOM)N"
MZ0G7&3Y+B9NL FNTBJKG75:!GK#F)E>$A\WFY&P\G2N6BVSG1,DD7*7T(_&!
MXNL"34.!M_JN-@8F"UHT/5\1B@$01J8?S97'RS%74A=P<;SODW7/$=6L,9R(
M,]6  <;0%!").'R;ENSC3&K2IGP)0_%><K)"R4' /X9 *2:UTG+5Q0?],7=P
MZZ,(GI2_"]IH1A_-6NV3OI6YJ8HM+3=BP:;<>C 'ZF,&[EPQUSDS;SGVM&P2
M@@ID'"A$5ZIVS1F@;QB6XW37_<:!R3].P@5U<!3@SYA1M_9-E6[W'Z;/CE\D
M"@88Y=U0.R 44-O^G&$VS/Q/O'/7>I*8Y5##(M3$ A$:-"Q& ' =5,R0=;78
MB+$L$63X_HILTFSN#8$5!'W,',"[NE;5]]]<_< 6[H!,V EY'4"QSIS4#WJS
M>'OJFP,-LKXHAJEM;]%6>";1;62O!!SJS1[7/?F^C.'4;)JI(7O>GC$>QSG&
MG,SC2_$=<!&[9K?55GC6QYMMOIUJ05>Y6@53MV.)^R!Q"A,*.[#18EEUE9YX
M5[+. ;$MP+X8+#V8>'3:N>ZIN:3!AWF.%M&",SO.>PXU>[$HXI5-"^\*K2LN
M*P1F_>'(D-',><QX3N<M>&/$(*+PWI;"9N$^ :FB7#^.4$.N61 -;8"(75,0
M10,^.()OM</=/'('51P!;O&*#+\,%#<]ZCW[.CF_.#U)_%@KWUZ&,QU<BN+W
M[R:"^98'X+]&@XYFD_L( YT%.L%I7VUO=3V1/4DO^<EKG?&!*T]%WM[D6N*1
M<-X=&K[F<YP16.UQQ<-BV/_U/&.P8>Y]4[4T@H*E7?9DL\M6W65G(7RYJTO'
M90S9W+5I8P)2P6AWGAN>E_9;ATH'M] *8)@6Q:"X!A$'/*\9,!><H;V#EG%6
M.S!B*%YC]U4/*UQ83:Z+S5I8=2V\S'-/DB=:161X& .:]:NRKN])5B/]'KW_
M4_Q@#WK4?$%N?YI/I#3FI8UXC3B]>K].F'6KR>SDWCW0'?V*O KII O??KQT
MD7&.Q?Z2!^XAX)#NAC5<SZU?@R/K_<,+((6^67T?[97^![EGWYW$WJ7/_PC=
MY&VN1P%M>DLJ6:U5V@[$&PA6A(^<G<*N->;HB2Y9060Y50+8W4K<A0E( SA'
M-^$,Z*]OSE^=7[PNI17I)QQ'-W/ #)H^A4,QJ*?0]CO4584JNZGX;6\=T;'>
MZC?JR#1R3'1*^PLM_H9/R?4_H56;55=TRS2A[_QCG@^SBA$/-V4]Y=^^^[^H
M=J;.^L8]H+4F0B>NF%W/*C[*\XD^B_W0I?<LJ6<3N\^NTK)YQ;D?3NND>)=C
M=Y45_^/RYS1Y=79Y\DZZBU^=OK[X\3/-<7+T].$I1FH5-[XX^Q&8((8IT-1>
MW)23?.FD)8^>LWM$!1\JPSW?E.':9;BC31GN+UB&VYR+S7/Q<D$.UC4S WS@
MU$H!?;[@D+R<<V//<#YJ)&/9X=;V(T="+BW)E<60<29-*+.Y$AA47KA_73PV
MF+-L/!*: <1GH-6!FI=ZYV1P1QGW#253LC+]0H@:I+0ICJ"A\B1;SDF>&UC@
M/6]"U0A()I?F'C^D^'.T",YH4RZ;Y8A"W+7 .D$6'"G<%95$'Y$"_3_Y(OG1
M[/?K'-"/I0B;SP&'441;S,7X/@>U/-\[$N8,ZVTI'%E^\?SQ-!2*<#+D.*$&
M]/ZDEJO):7<%=I.1N\_]D879-1C=^]Q.,.8-[Q<()I>S*W\RW^)I0ZY"_1YF
M#/B%,^K2LLT.0*-LXX)6K;H/HA3(.M^@!T/F^M+$/;A"Q6>0CVG*>!)K21RA
MOLXL6&TGU@BYH%QURSUO&H$H2+:.2%9\#WI1+YV8Y/YYV=[B3.K8)IIU-V@I
M89O"=$=UP(^Y\#K%.J3D+7U]M+SISAU0 %?09&=O>^N1$Y3$\\-UQ&?'O1=?
MI\DSSM%QB9@6\-=I(+: 8A.RENUI>VBAKH_,]&^/FX#_O59^3V_RQ#FH<VG%
M%GX=1Y\FQ"#,-84BT$"7K3#PN\?R7/W!;U.'D>#49O=ZV9=O!<5-^8";H[6&
M>6*GTZF+ NJ"6\##"F=PMC+2/&!>UEI_5#O'(]$I.V(:#$UV#;F1N^!$,EW5
M9%I4)S,?U?D=>%JD6N+JJ<B82D'5ERT"=$&MK(?<*[V3:4/]-6=^HO6.CK)K
MB9FZ,S1ILG/UX,\9;=U.[C @HF^TAMZA"):]=Q)#I[#I-+8=[N\2#8G 4)U-
M:_+I[;_B7JI]:2Q!2\A2=U#\QJ_,HVUZ\;P):0U_T^7.+VU2B]QG?V4:)?S"
M__SJV#V6/NE>)3[\L=M C4C*OH<PP77,\'6G2^)$Z3+;[QW'?6:K/5+H8Q]T
MM+H==H_3F^S_EW:@#/"LM0VQ ,+V&WX_G_("NM^I[\4[^OHC7M)'OI@'[GUP
M\/5?Y^7A.'4O9UTS\F(S(7_I"=G?3$@T(0<O/O^$T#C^JK/Q_(M9]X^UZ*O?
ML>NUK3Z*SM>U0R[<KY?_GHR+T0B1]<[![NXR[^#HJS_-D-_Y$3>'NY8A\L)?
M<7S-#.6?8:FY=_CD3_(.E4#,Q_E_F??H#%M+9[:ZOMHYW'^2'AX]3P^/CW<[
MG/=ETQ;E;#N?[ZL?7L=E)XN9_^/?7GR$J]@Y(0_?/9XTOF#GG!T^V^\]?_QH
M5I^.50=TD!X?'/2>_)F&]((&M/]G&M#Q\7[O\,\TH,/C(WUEJVV\WT3@^;/N
MMK=,$!GG'ZP8V^=NJ/K/N06?'/9>_*E>YM&+WO&?:4 'QX=_K@&]>/[G&L^3
M)[J"_A3'7M=&M(VW<[C[<7NO8P(ZM^-G#&Q62E)WC,QV\F-CN"6/9U/_IWA"
MV(;#_]F/>/#LJ/<)J8F_Q",^.>X]_9_]B$^>P2'I2"!\6:?D^ZL??OV(PAEP
M''\N^WC +V50SJ]&^:>_%9J.H^.G6'M7/_SIUM]G?]2#],6+_=[!O\K#'AX]
MA5OTK_"PSUX\Z1W]:SSJ$9T5SZ-'[;*FRQ[C4<[G*H;U:P?TV3GZ2)?R\_G=
M#.KXU[HQ\"M_Q(T9+O,'/;'>^-/6_3+O8K7%_K<EB8R=)W_8XG_^O+?_A[R1
M/^[&3_^H&Q_\0;N.GKBU^!UT=D-U_&6I>_<?P)3_;X<2?R1L#YA00WR!?7-D
MW!_*3+$*Y$L6Z&/^SV/%/&9/D)0/P?4 3PLY1JRUKP-]-[P'"/KXH<<(4ND5
M,ASI\U[R$>C3QF_3)ERQ^W4^?N3=Z^!!/!^:I^:U(%O?_;O&.5;@3?DCC@;"
MC]AG]A]P^]1CA_WNW]DM]5<+8;2]Y+'KWP$OC6@X^NM=KA/S^'&W)I*9<0WD
M^5BX\57>S^;0XKOFAGO@04T]QN\7%2Y[_-AE5REW;S!4#ST-MR03Y01T%^'?
M'L2E*L\/D_+B=5Q]PI0[#*WP[BDXO1(:U'B8M4#9 SI?I6*;" ]0Q&!<R/!N
M\M%4FQA!:9>A_52LZ#2K9X\?MG]Q-M3ED.(L6!C<^!)2UXM^D?88,)M5?5/>
MU<8 %X#V%5]<<^_K8\<MAMMSK?@N 9KI9>6X$'^LC-6^N^3CMLCG-H4Q"/IQ
MV&=YN$&!UHN QC6Z3)U_PF(Q\/M2*/B* .]'/M_.U>ZGF,3[;KD4#AZVEM4K
M/-V]M_ETIX4!^B!/0@?.:&0\\W$WW"S[8%3I.F!L1SMK#-[/ZP-4ZJS2JZM0
MV*[ (<1_9FKV6J41/\'(H%*G9' P5V%#V.I.%3ML53X4C5(C9/KB.S7JW_ G
M1V(R\-[X#^>L;A,];,6L>OJ7+""QJJW=,K6_>M.<LSZY:I0R$3S-89U!*U/;
MO3$.,>!NW]?&+*#=E.(?#D6D+WZ*.G<<5!?0[#GG%L_#[\ZATZ&B]?K1*[?K
MS_T5]&^!._1K[*M?F&-Q:E/ZBT[I*_05*<'5XYK07VR:T-M-Z$\V3>A_P2;T
M1W:Q(1-OO>!_./G@VM(.H?;2*U'#H(-,Z*>G\PI*&#5+H?)Q-9?&M.3[X@=:
MQ@7SZ*W2;7?@61T35BUW(IB_]BY[%+F-X PD\!FOP0\"P=N;;$(OL=(NNW?_
M?MP[?K[//[G\]X/>_GZJ,O'C,?G![# I.Y$C38NNW<WP?*#''P(6$0_ 15E*
M"0UV/V:3]WS 0@E&Q\VA!GGA\]' #BEC=*,KA $+JUPRTR$=3M)SKU/H9@.2
MV+B0GQY^!_A(KHL7S9S=,PW?Y*@3/>5HEGJTD]V!<P[MSJ->@M[V]I%RJ8KD
MB3]W7F:S3/]Z9E=]AQ9FHTD<^F..V?1\K'A5SF=&-# <07Q.G[UHO,?Z3ZHY
MM99]%6ATO;,U40OW7CG9:\92W4[6O])\'06:9MFH/Q<+$0ICQ#AL\LYOBX'?
MLX],O_PK3?&395,<1%K+9IM3+1^!T4U7?3\KM,>OPONQH@CG_1*4G]QQ;ST#
MES)[[SQ/]FF&9:.$Z/X?L\33]ZZM[;[1R1"P=_?#4?6#48W=J.CHB:(F1U*"
MTPC,,_220U;@8M+@\-.[!LR2';3"UTHVBG4(+CY1XLK''#J/K[*12*]K=-JX
MM&C&N1@77.8^U]ED&..3UB]&:+P+<_@ : Z:$G3F:^FDJ+HFJ[>]%7&,XYZR
MFD=>]U[3.6Y.D6D$Y\]TE.E#-+^Z?+Z\@![MC&H27TLH-S]FLGOLCL?S3ZX]
MJ^!!\QX4O3I939[F I2/N(UQO')0;AE8FIA P"X5L@1Y8:K:WJ'DY)C-F\KG
MG%6#]6#JVC[;8WT;DI[!A7G =]G"! C"F=S>:LA$R?JH./02'G@WG&BV"R^^
M%$E6E+#)2@3?YN9?(P'*"ANX0-5M6$R<P0WY-YM[0,FY'=N\$<L[;FVUV2#J
M)U=_.IJ+I\\\P)X<7R]3UR6YD#-+7U^\>_OKFW.>[5?G9Y<IS4?QPW@^FA7"
M0'RU<-?R(VPOICI8/G(C4720$:;)?&KU35J,=%L>?WR!'6_%=FEMGG;:-^^Q
MUTN6*C/UW[* !#\O[8@6)Z';#]F0(E9A#(\(LK)1+WG;7IMJCS)<09B8@Y'U
M%_U1;O6AI2>S4TWCC0HW/4L& 2.\&ULO.6E=G3E$PL<7>FF_SIE6L?6\''7Q
M>0_RHB8+6"9<V?)*FK\<9<+S[G*O;-O4"S#^3Z=\YD06PRFN5=#QPTPNQT6T
M:W"(YC<%$RJIL@.(L/@!.@X-D&+CFOI/6X">*S;*6=_(3=5V5&")R9>=F,E.
MT<M[Z4JK:7>]K$G%B+;NS#3B6J]12F&>II_<4UJ8GF[?;( ^?<#[RP:73(%N
M0Q O->S"1K)A"0G@P;XPESH>TVQP(Z1>-)%J/'>@JH4O""<1.R8'^[UG#5D%
M$7+9O8=K=#/Y'S'Y.*Z2G0,10_+G3F.VEP0D#R34Z<:;A'HKH7Z\2:C_]1/J
MJPNCXSO[78OIJQ_.W4D%"<1;)7H78$/;VYWF :F['&:?>HX^749F\GTQOD[J
MJO^?7V7#18:\Y^'^\+_W#Y_T?I]>?Y5DH]E_?O55\LT/:]5/&C\< 8 L[S!]
M=G0@X*S#],GS [-@JGNUQ%_!+P^>I<^?'O$W#X[3)T?[RQ+F_)46FQZDO^KY
MV/A&&P&':& 6J(][I2X,8C@?C=RH&*63US/6Q!(?JV )1 $P-OPRUBA@-?<7
M-/+C"-Q&(WH>C.A.)(BQPIFE#NGZ^7AL]*KDC_TNZ?"()I='(]I@0=FY<Q1T
M31YN4]*O,3*;=>00OE0*ZFV_/Z<3L+_@;/Y:F1U+=RLKVG3E7Q2ERDN/)1KC
M0- K@I@8*4VD4_MIY!0[ V&$*Y).4HE,@/='>0@!JW(83Q/8J27%!8V>,?S;
MC%ZKX]D=)H#2NA09V:@2,A-.-(\=ZR:ZK#$3\+#%[:#+@OX8Y,Z&Z4((A=%C
M==%(4%'BI$89ZV_2D)$X\JM\/A, "OUM6)A25B!&#>A;/JFM%@9XR@P9JD%5
M3LLYL(ML5[()679667#PR5I$8G(0--L\-&8,-V"R8$<1K&6@D&QX?:'- SRB
MT;)C ^A>",6[;'HBG<+:4";Y8,-*&?).=;4G_"$<9-PE0"MB*>-8K \L UI&
M,;G&R=9U\/3@,S%-VKHZ^J/(WQZ<^(^G1OQ+/--'4@C\%9XI("C\4_2 OHT.
MR3^J#^[_(YO]!_6%_4ENW=4;MH[BZB.4&2[I,5BVF-R35ZQ07"<G3M@ _LL[
M#Z]_Z[+07X;Z7^N+ < _;$4@C\Q!N;>W0K JRQY>D>=AXK8-)0@3<)BP*@:>
M>7WR"T&!^FQR6U3EA%U!W+NEF9HHW'2M<:X3I6 A2??V1PL6Q>3L4(?WO[V5
M!Z-7S\Z)+'!9=H#LPL(72[@O 6Y_()1]FU&\,"<O,A^PRLHHNZM5(IJ\WQJ9
MB>N2[*3<)JA%:FHPW=XZ?7.6)N=OSBY2R29RM?_MFY.S2X5[.]3V^82E$ O
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MXRHR(M43SHYLY:ZYF6HQ&YO+++6:J>#X9R9B<5*DB&Z:E9YPR4FJ-;<D"Z7
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MCY"GPJP-_P#X]PTQ,.P#O1*3X%! I_6:!3ZI7)ZF/T0H?4MYP)D-N.(F)@D
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M0KM>*TEM)Q?:.@RT>\^"D9DH__Q2D7KM$6M%G,6E(DM70!R\A 1F0P+MEY#
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M7FWC.2)%#>89L8(T&P[AVQ;#;>3[\O';.&%ML:]V5%W)G";U#QPJIP/($M_
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M"64B]'$4IG@&;[KDL*[."$?HX^\*U<:@<*IUJ&0F%;2:)![G3Z+I H@W-2T
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M$LMK=U_?D);W-O">\,16P!E<XXD]CZOUSQBG=/ Z=BY(:,7.I1_T?&0>.N_
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MZ9/G] 2/>-ZX($Z]BUF> S\%92-]U64$&T,,\SH@61F@ !QZ91"IZZFT%QG
M4HD^Y176&JSMEWPSZ[7+OGC%^1,G<9B->H%EUE\R<B8& O_][SCYAOM__)@,
M>V&2EW!P]4B]5OG,6NR W$(G8CM/&O2!P(Q]KBT"'1OE4D6;BI5Y;E^:G3=O
MSD0S_(>%)&2_E&N?)^SLS:&%,%D4>@5T]!+LLM^[/%7:^DE,,N1?[[UCERNH
M0N(L=($"3<XH:K.B(/S]6^!O%58(B4]<Q/X P]RVVNR9 )*1=?7*LJF";]%]
MU$(03P"N4L?5_!+ G)8N0T$'X&N:XTTR7FD6&6 =KO4S"TKY)(S9!L.FY*D6
M:!>I3H:Q!5BC./1ZZBX)C2BZ\2:J=/HZ0%@N=3[XM B--$.'0TP;7U,:'6WC
M-T;*FA0+=8V1U]=FV$0_2S333V):UXC^'HR96[/>B=4IC8P5,C]B9$\,':=L
MP\A8BH=E8]<Y[_^+[@-Q?4,'NE;\&H%?%,R1!EHX9FUU]13GRD\K9R;G/D0Q
M8Q^<1D3P2O0R[_B*OX_&"^VS4UIU/#(<[>OEA>9;%]>-MXV*1V2%RP;F]EX"
M<[.!N:.7P-R/$)@S0M22JTJ,XG!RG<'@CX.9R+W+64G^F,N_:]1B.(A)4_89
M)"^_H[1+IP6-5_\$0+_8"JEOPJU1E4L,;0"J_NPO) 3@3GVP93=.V$_1;HNZ
MIZ3C93R<]+SHF_/!FQR/V(328/"07Y:VGZL((8E],;-ML66R$69M;OT1T?"5
M]RGW$^B1<9R7'E#M$>=D9%[KEZ]O+NWIO*'QBE/Y<O[%,0*:T7MY2<5SY@<-
MTJG+#FBEA'Y!Z33IZ%ED0&,GOC=*RRCX6F-GN,64_@B0:CM+@W9]C$G)]TU8
M@B&J4^5K$>]JJ6.$V%Y*GJT0.U-B?X$ S"F_H#>+"Z](=H+A!X=-*GB9!76"
MP7M3!LW4=O+73Q]HD[&I&[TU%3G>XE&O^&%);X@"!@?IFBS!XCO<&45<$I-K
M;%]?&W&NN6UIU77+W>]DJH@?)0=RF?O)^;&R#_&?](%CLN6!B.GI(%#QU6&0
M,JQBG$7]($Q%%J3T-7ZX7I/_^!!?B8D!T]]S+H]5W&1T989EGR/T35U_KZ!-
M>3?,%N!6?O&O1AZ&#-1H_'[9+BZ]R%;&Z:B7>/3(I;8A*Y?(M^U6-&GZ)9S.
MFUMQ[?CK[T33OWN)_Z=$X83BX:AEZ.MFZ] M\M7J4;X@C4W8DG-\E93&VC=C
MS:QY=JCW?C+P,@PP\_Z!.(46CR%B*YU(:*4?<,"2=CT8Y['-O>YK%2%4$#T1
M\N].(Y\NF5><^X'Z-MF%?P03DI2%[#/%14H):',#(\I1'"KWG?X/G#M/.X2/
MQP27N"5/D$K/(9V]PM>(7=MP%0.]KD^G)]9CZ^BH"W(CT=+W;X$I=QV35#^)
M <3&-I2GHT;&4ZM#0U5>QS[IA=J_*%@5C#^'1BI9PHL"QP\\QGL (X5?F.5.
M;N;IL28B-U)CN%WF0FXV;JV%T+5E.^>;EP.S69\$%1Z?\^&I8":=6E.=WIZ[
MSN^\#^.>_Y?S=1*@#=1 D]+.^R0;$[F9L#=BTH;FNLW7=%*[FK":^H(UE6#J
MQP)#HB%ARM.:/QO^*N0RB1%P%_V%)H-'XU.V[TJ%M/BAT^/3RXM?[DI#L>(O
MZ92>&:7&)F1MDL/4[Q3X]KLP&ZFX^L[7=^]V9T>V)2[H.H/O(_(G,)35R)<Z
M_^"?&8QQ6VT%]J.]$WD <:GIJ,U6ZP _\<)I&J3%4.3QE].37]Y<5O!53P<\
MXD1 FL&R]:[(%<]1$XG4,T9_H3OYJ?>G3Z07V^X]_AA=V@-&$J)_'&Y4-RB7
M$HEWK?Q7%<FT1.^* 9.Y8K[=%)<$?P6/M)N+N&@1W#WQ)QX2:H1],#XONXM\
M7\-ZZ[L-LKIF1LJ#X%2-H+@!F-+8]OCGBJ?E?LN]QG]X(6WOI$&/N<X)BPEV
M]>9B$\!&$^2/*!:):3IZEF:Y<YWUI'*B)8O6O.$XFB1YMQ>9=I).:+.O6 MF
M.R2?:[U&.GX_=CZ1@4C<(T2O YH%S%3=?,HX\( 9FE.PA.R,NU!!CT(\Z+DA
M "*R)AN3)M^/A=!+IR@^^?Y$G%RI&82!#VVM>,C0\#@8+2!USPF/O?:^X"2E
M.FW?"H]=F["S#CW2@UWB<)=Z=H73J]<4!=!3)DK,\=1$X11=2VL[&Z+4' CQ
ME@W;MG>4B\G%- ^AVTK%4\LYOM>EO2.+;&X8M*G]L+GVSL[8=YP9\.G#_UG2
M_;[OYJ/AD3PFI14N]NN6M2U]@X&K6_:".I>_G+C.*6E$*?1@9;ZR]5I2!SE"
M$\!)&R.5XA^LW=!NM0[5IXF+F]\9G6\0,%1^A.9EWD !QNFX$PQ;A$I%4S<B
M_6OCDCVAW.RIW &*_BXHN;[-@^"I"1%A9;Y!V]+G6+/!TT4VAZ@SY>8$SB>B
M@3S3T/;D&Q=V6IIH:7"C*N'VO@T&@7-RG?V%-W<X@.R\#^#E/H\%@QCFDV1A
M<+ 3O0J<HR,X$]B7 *K5<]P5/B*T/,\_;:DA)C)@Z2-*7!]?:#(W_I)ZS6@Y
MDK!3#GI);([&O2S<19K5\4#0B3U \QN]2?<(RP5-*DQ4VC88 G +[A43+<U+
ME:*;((DC:_HSN;R.E<KKG'V\U FY;_V;33O=[BJ#5!ZXTF/$H4K//39S,AQ%
MAX/+S*G(3CHY.REI'=?9B+4-A9D]JXCDQAT'TUR=@V![.C*X5+U4 ?XZ__B<
M S(:A5V;"4YN)61D(+AX&J89YQ%Q3L2R!JUK[(78ZJP#=3MO1T=W\O<8&7"D
M/Q.-!?AC+.= WS63$R/<SM<3JZ&@;U^J6X>53UY=)=[ NJTTFDZH^WRY=.U5
M]R7$,Q/B:3=?0CS//\3S8)CMF;JDS<)LS_A*4M7&8-9--+(23L 0$E^!DQKG
M$;>F$;V >](IU%<2E #IQ7Z3J O^#9A3WQMQ*]C>U/D]H+DB>(U$PBGR<$C)
M8&/G?=#K(:^9$7U//ZEN2+TD]@:%4N"[BT$?$0^5-T%5&L_N;N/YXY\>;!_^
MJ;[*BQ%0MQ'M],XEW1?;M/V";;H9=*4[N-5F 43XW6H(F,W#RLTIG'T>T#T?
M,B Z1(-$2F]0]37F$$ ,FJ?S>[*#VSS0G!S<.V/KK^_@'O?N?9"SP^TC:^HR
MSO[M.?_,8'M]QX?W.XS$"]M(/(O@H)8N?)P9^%;YC"]5M&\NIL]WBP)3H6BM
M PZF0CN>CPM3KY$EE^/".,\#%N8N>:;22@I/ <F@]!B7@4!-KY81*]5G&N>E
M9/I6HS6HDFE=T#*3X+U?D7J5I<6R-)U73S]]LB+%<]CE$OX9<>-+V@>[170C
M8XE0F_]J2Y)5_M_XE3@9UT'LEW.L=)$B<I$J$L60-ZY).$\B%ALMS_?2C30Y
M3^73E]\O[81CGFON1&X>E.K7FT?N;-^M>5_F+.Q^7\HJ3(R^J6+TS8-">6CN
M2?*+.<,77T]>??[G;,!A-@7K]/C-/U3Q]6D*%*,\;49RZL/8^4><!/^&FV"C
M=ZFL8XAB(3>H^C>&,,COS0S-W150T7F,S?G4;@&?O/O$G.W3@%8<DTBYX?]L
MJ? L^B?J2@#DLZ3>K>4%50$+;@#5:KU&,T4OS9*I:\40T$\=GW9U!2,Q6N\O
M51]L@OEV]^?0OU)I,I)%AT]PBW:U%D077-F[?!U>Q=V$PQ-A=RN?J-E1%'>D
MVN>B*%IV@9ZFXT*0B(LR2 ?4R_KDIURI$:+M-")RE2Y8/M$R87<:,M$E8AQ^
M.>\>G$[G,EB9 XB"?19MYY]>Y <T4>5*SR73.(FO$F]4F2,AD=8_D"8:1$C.
MH+V,HP%\*J?1%7K);?8^S-77U)VP?R>^:3V@Y<D]M)^[9(T79= J)/NWZM8@
MW\J^-J=R;5 @$@;B#^OJH+M5.S/0V7CXR@2MG[FTQ4XVDG"3\MAKO49YS%R5
M_F-JDNLU.EI.DNU-G<_!U4=_XNR$2/="^C8_F&@/FI?BGGP\OGQ[_/__W?G]
M\OB+:M,=VW$/SR&JF$H]#C>F]M&]3A5,7@?(#[ SEM7EHT7'2,C(KU^>=&M=
M/Q$J^E(<FAO%B7WV!2P)$<0DM;3([]0KC-&0CS^XJF7N[2JH6\@<.G^_:]?<
MYM<K+_:;O6#UVA_7Q"=PJR[\*$JGX0W-Q.,:.U5:1.*<[EXQ!'FG>G>/;IO2
M'"TO<;P.QAML9CH',]!*F:T #*1#R_.)-,B M)FG)ZN1?EQNIS:#^+C&C?O
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M*D'7I!*<K)!*(*TN+E0,>6ZB\CTF^#:3W(VA*2[;7/*X=%,B#4JX<U72@E>
M4_+4,_6:?D@W@I.\%%2())Q$/22MJQ]8&<0&D^2XWV?TU2N #5J0TK>^]=)
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M8Z_QS$[T#^D $X[YO#UFE48TM6R>IV-,8K"+2=(/0.+E9^+HZB*M4OK 1=^
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MEZDMCFJ=EG=2JI_2I/M$C@[C!(PF_5CG9FK*4HA<S.B2RB W@I5.'MQ5CJ$
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M\4@3&@S^D1U.ZQ:EKD!@?37G)OM$XUZ4)3MN\A).%R8&]MLF^74-0)/KSA[
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MSE+C%M",#5YD,%BKK)0NC,ZWP?G'&'2<#AE\HVARN;0&F2.9 S$I_<2[P6F
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M34TW9XY8"NE3384YR%?+\XR_@)P10R2)V1Z,C3T=Y70[1B2MZY0[Z67@&+S
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MLYV3#'P"I@/\8F< '6O.[<VLABTYP<X)VJ>;!XV$G&F):<@R+2%Y38$PV(O
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M/L&XN.2HF(35,EA4)V.?PB0FLB"<UJFMM;3>EJ@C.F58YBPGPP<3Z\K7E.7
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MF%'N(JCU(KQ8F<D:S(-2,@RN4M3K(TORZC(HDD<,[\\M1RHH)2S'%*M@]):
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M5>1[YR?M0VYZX]8SMHI0C1@\Y8I#TYPKE5;_46Z&81Q_V9I<4PNIJGLV& J
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MO*ZARX$VNV'6;?T1C#M3NJ!^RNQ^1LR;/;2,FOYDE(\7=\%.D\L[;WL8[[6
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MZJU]<?'YN$/U$JV3D_;'=NOR^&A]3;_<69YFN[ H!5B+4*&6#6&%XVJ:"I?
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M:K9?3\T"LKBCIV9[U4_-SMQ3P\J=-A:E[)Y#Q'C+#;.W?(3(OYEOS& $/$A
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MCP67+]<7HG1I%$K!0MGR)7OT,LVF&EVA96J#P3QB"'U$SDZ":TP_W03Z![?
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MSOU,G <\D/,.UQR\X%#5DD;[]K51KUB#R1^=CZ#2?F"B1=-C'/N!7UYS4/G
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M*Z[6J%3Z]YK134/UE/!!B+EZBE1OVP?49H54.:BA<NI_R?3DI2&#D880IF;
M8/B*A9U8B26:$QBZ5/*S0M;P3UJ*L7;//2><W7665?:)<3@#N-P5NE1=WU%0
M5*)G]FA%M6HNJU5YG_FU+8584HX!]>-25OF?%\TK,14&5/SEYQX#*C=&T\+-
M1B;SR_H(+/^LFT:["9O1@E"A!=_JCHP;1 ?)&3&&Z^A*%5S8JE\9;Z9LG8^4
MJFCHI(_L-[)LZ:\47XY[/UH^S)]L$7T_%E%ESB*Z=K:[*FA^K'][_/FF^C)N
M_CE-3U->C-3U5< >7&391"K$O1#W('%W&OA]I9XTXYI:[]O7V[MGK2[M(6FV
M=Q4PMQE +?1!H0_RI@_FYS.23IN:)GOG%C6E\?P@[.O)_?EU:_+Y"=WV:XW.
M9TG91TE0HJ+OZ<$;.N!31>/NQ@G85>R4=(ZG"E[KMC6,J5 @29YJ!R2-,>]2
MHBM"I'[BTIR2N^_KAF4A8W"J&X;^"A*SI-NNFB\/=^>E/T-NW[5"B1+[6H<_
MSHJYG>686B^. J)$#T[J(_-0X^W#BTGW\7$B7>%6EZ04FC%!4L8X$HVIT.R:
M)36A:BE=-Q!))O+X@HM:D;L6U;K*]$N/4;1BNBT^ KN/GY<%19B' LL %DQZ
M((- 5TO;UE06NG K:L:G#\LL7:VL+OX/4(?UT%[P@WZ'5+Q8O"D9?CJR?/JE
M_FSTA!]JE)&XF;$<:YT.G-LRYWQDRM(I$ZGPM3W*[$L&ZNNJC(R,:%$^!UIT
M$\Y-6K7R55H4MMV:4.C6^&D<HP$JBK2PQI<(T+BL=\27A1P '' 6E>KCXR/J
MW>C?Q_4H6Q?2;7ABZ!?4:#;TI9!9?>F,EUKDNJ0=;X$6*D5$<@\TC-/CIDM,
MI! D[^=PGZ&A;BJ6>6'H@SK1AF M+2H_LWK*_C*?;N^53JXM2OE%TCJN*NP"
M1JB.BY(B]Q+9!?-EL<07^0ET22S<ZOW3-$;?FJ=%/M**+=^*$[P*KZ<I)I(]
MX8$SU 7<RJ=(@Q\L/$MC41<JRN1)O#=.V?L=[P?<1012:NONW$0-SH;G(JF4
MW@:H)(SK8E%@9($)R6U)JT6>I;GJZM$'A5K<#Y5C',!8H<4U(>7@(*3K$L_V
M)R+3,7 75>%7\_?5F_!;93M1]M!GQBPD*)ASCPLUN(F+Y,-)20?^RG2%+8R_
M?1 QQEH;+IY4RNSD'IT<$.63.>7A]O*M^MO<68_!SM38E=8!*]T^'-GZ7&BS
M&)8++_-4\BOJRT5.(P4DC;/#L11M'%DM<'7TBA(:7?UU)PCL&3M^SK/5YMD!
ML$4US1[Z@[,Q46>#K<.[JZ5A2S1;WG9[]*YUX^XGX^Q5SV["&3'&#FF>CS2C
M]G1-LYIW"AI6KP/I>O*JMUN3VS9;GPP'W8G&I:%=E4Q!2[I7S3/7PQV*EI..
MM2RKZO5S'':NJ"OE,EW:]:R/0K&GA(]B7*D@5FF^XN<-96HRR-X]ZA0?K>@#
M3D4?<,( A.J:FPU9#)X6T+FK_3'[OQ^,[LX:1/8^(F!IFW=.C*Y"/13J8:5Z
M$.<'!^E:S[^G]O9Z\O36:4U^?&F/?WZY>7@6]KW@N^BIS75/[3(K)AWYHCFA
M3+.E;?>.I$(1I2M@%9*6<>Z)8VB>BU3B&S2Q/ZBMUE6,VIO%\5>-\X>KG4V<
MW7-;;1R\6337AI>B8%Y,>K"L6*59OA@VL&^*QE@8(I;H2K3]Z$R ?ES76NOJ
MR:O*N((8C9.-* .G,F- %JVU*=>A>VJH%?@J7=UZ#7&A2^.B;)S%=E5:C-9&
M*\ZWT;K5@0"2-QV@6,O:]/=%4^.5L^KU=91!!>FV.I=[:K.A)W/04KN" Y.>
M^">"&U[TU^Z;H#&6C93H\IJ&Z0"M6/5J15>Y^S53N,JP_/+-^%T=G]?97,_[
M*YHIMI4'/V9*6*]5RW2IF&2Z+SK&N V4I04N4F-8V3?3<HUZDMHT] Y"6$!,
M^/%%,>&12Y9>6[PY^W+='8GYL_2F0#MC W2#4C%>J.$,,:FW_;@\^,=KV3+Q
M\2I@_XF%>YP2PL:8D>%I-MKD 6ZY0\.WBF5187)7S$VI>U7C?I;R; T>2),&
M^X%-;9.&+SLFW9]+"V+6,M4Q5?,*::GFC9<WXEQM+'*1YDG7UM<*3ILU'#4[
M;=;X/JJ5AP]7XL-KXO;ISCHPO*OIMRP(3+U@[4O!KB^)WX]Z+8L,+8KKMX/G
M5LUFJ&EB'TJ6I?ERE:[R?EW'*SHG@I3MG(HE"M;6JP/IO'8]J8VLUD1[>A%4
M\Y?</^OOT*#=F;)-LX(-Y[R74Z L=Z<B>;)NFA?]@III5Y%I<-BWIV6<RJQ:
MJM(\F_2"Z&2:0_8N^OOMJ+7T8<1;ONC\V O:TP1=\&!WCW%R_F>D6..Y5=)W
M6N7QJ?QXRG_I'>)*61LC16=8H1]RVQE6G5,!5Z8Y0G)=&BI@L+NA]O/:0Z,Q
MN58>6A/U%?WZ=O5R^O(C?WMD[W&IKC.3PT9 ZI.1;"4'R<@YGDLZ\5CD'/=
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M[M&?$=*P5F!%ACHY<3E<5EX"@IFGBSDW&_SIW\N$3:=8=/Y**M&9I3<S,RK
M+6770':0JCK1T?][Q[PCOV/-Y?[NJC1%MOI8P)B_X/N I0*DTKW$YMY_<>)%
MA8N$C]3#>(@PK:2VTOE(W8)PV8BZU3%NRMX/_>-^"O]ET:IR6?N_?P"1?C@U
MD/1\8L_:_!>HBDGAQ5091X-]$;L['(6"R8L0C"B;A7S$B \O1A\IQQC\WSI3
M8H2S+4R@]J=:=RP='UTK [@ Y;G8YS[EO>Z5W9G$'A^!;'?ZDM8#V5<T"I$B
MQE2<^$(WB-89@R]F4DB3D7Q\=(8Z:- &2YAG:0H;..2?#*@LF<)72N#)?76*
M;1<[6F67L/VG?/K["NQXJZ^/3#@[J10]-:2)HBKP0)!5Q7P/=]H2[\R$T2M\
MB\+INE8\^.<L*[2&&J_QK<FHP9]];??[KSK.@8\& ,B8O!$4DLL1U D5P"J4
M'Z>\6^ ,#K"W)OGL$?EI9Q"(GRH-3=!,[D_OPC6PA(W?;M O,6]-L:6_ MS@
MJ?]Z6FTMU"+H&D98HVN7!-?>%-/[CBO3'"&Y+@T52U)O"#NW)IJLE(;C+Z>?
M#?9= ,\&UIYLV 3B[V2% ;2T&: U. @VQB2U*2EPI@60OW.CVV_W+Y-?9^7T
M@LQO!O(#B*XY,L:V;>I"^O)LU9A?OV51ZZ87THO-(+U#)C)>4*-+0&U+)I*;
MTIAH"A?LCE;_?"M^LUZ:*>;I#0E,1APXL$\!O3_K?7UX_7UY7D/I!?0\!*"=
MD0FGQ<2U)/B"J5?G .S"6SX_JS\]3=3Z4XKY.0R\<_P\#[(+ZZ\[O?P@RM*E
MD%Y0:YN!ZKRZHE#=!?[A4CHM]P1M,DDQ]&>;01]0].B"+-V^?;MBI,9MK9]>
MD*NM2?-QQ(_?OHO?7E.B<\)W'>_&:$NB2@*L4_SR_[T3]XCS&.MVO#UK"VVA
MCH$?U,H6TWRU?6,EUN:)- (3OU0Z_AM?^BN-$AJVN<(&HOS7/J3.L_VP8[M$
MVX^3M.&I+-.$^<"E2>/,?$(;QB%XAB>*%C<B]D-8U_OS)&C7[S(*"9&X/U8]
M(=[=;) 3TDPR>QOO1<=N09Q$2XLN]<7&->JY?!LSZ)6_ HH+ (3P4>QEC&P5
MR79=HOG"WJ60=F#9P3[/[D>?H+*$O+!G"'KE&7S2P93@39HN:-<U'Q\2T1V&
M=W)785HU^(M6!^>+&)9A6RW\$\OQ\^T;MF_44NY;D^<?S5_MWLW-E\JLPBR^
MYHR@6K5]&-<!W1VJI'60Z?J)U!=)&TG&F"+9-YQT6\-L<4ZKBANX=?4MYTZ>
MRUO*4C,;70!<M M89L&EED]J)Y:E/26:89C-N\*BN@+90_S*5%,<C6$<D("-
ML!)Q4;@M/4P=7.RX]CXJ>,HMS\Q-N8T"VL&(^MK\5RQ[M-DR&Q//'0QA?#)T
ML6R?Y[@(S=)91*6=!&RMS '&@-$21Y?$"!HU\7F8>U.^X@;*-WM8B%/&PV8P
MXV!3AJ6K8H2EU0=#C)4)U1@H((HT7RD(L$" .%B[RM!\B#W??CFD+?NIT^3S
MADHHI829HIQU;VY?J,/NW$&*?JHL\4#F =C[ =)L81T& ,59XR\!F47 ZVLC
MX)XMKI/*Z?!/_;YQ^UQ+(@2>CE#WPB;7U1-8$BH*VH'U&=(=9<.N[-H0$VF*
M0H=%1<#RKXU1D89H<%B82TG"G'WI*!?H686>2DSH22EX8DS@I=E&VV;.<+C6
M_[ETBE_[Q8Y&X1=DBTJV'09B$R'D(=(LZ7AMB*G>!9WV,L1VK4]86^L3^HU:
MGXS0S]]OQ@7SI2NM< XW"A"GPR-<N\$V/$LO33%)+TN'-(*XB%[1.DQDT$'D
M(CI+2ZC(D(/(1?2 PL&<?>F(Z $="GHB>E!+Z$DI>-68P,N7IQ%YMG]6/,6"
M?GES&3-DM^V >!GP'0N"[=F)Y/V=2'>VC%.:#_#@;EGT0['Z=<GLMR9W/[OW
MRM6I_.4W=W!=-@Y2INE'@AKJ%7!#=0 Y64@]A^5OJ3N6_@U@@HWU43(--VR)
M"6BXR4#5572CE0_KT67(2^7#NF'Y=+/XL&Y63L$/ZX:E\_@"$_+X&?,RPH+/
MYA/\Y*_%G?I8V]^5*:)-6-8,6QR57D@3XL(=L52 [W&^-H'E0G6&['\_],&]
MZ/5)UV =N[988N#;S-.Q+3&MR4M?$[Y^K?WH?!;C2F]ET1OI L6=H4:$$UQ,
MX=%PY&5G5%R>Y&'FC&_,-RGQ9001_'@Q-Z[,WJF4]*0!ODSSI0WIE2%_3#AL
MAT0(ZY#D$_Q26(<FI<?/J4,2%GPNG^#O_4[9H;LFEFB6VS#!DEK*_;U_TL6?
M$#,!>?#:DATGT)7*<J_V^VQ2;D^$B\.>QCWSD?)BS$9Y,0Q"73>&NB%9Z [I
M1D_2E F9N]I2KEJ3JWZ]<7/ZIGY]*A?9LIE_:N^I<]!&&7-XRY.H^ 5J5K!,
M2IQ1EN-H9DU6.?/>:-*D27S6'5^AF9+?W+%\N*"EP_;!RF%]L)R"']:'2^GQ
M<^J#A04_;-XE8^#OY2+9H=O)E:HTR_H-4,RD21:66\.VA:07TMTQYHZX+'+G
M6X!+NC3^]<$ ?-I?;+8FE\_6;;WQY;PT/I#<X<J-(7D2@K7!BI6<D1:'+-^N
MV(YIE+AG5J'+7"6WCEDEIYY)&EAS%^/*61%N7[]QHODA95A.#NNEI?3X.?6R
MPH(?MK$]8^"G00_MT.?D2W1%V"[6G"+BA>7=L#T<Z85T;VRZ&Y[;;"&5FQVL
MJ:K>(3[4@QY@9I*TH/GXY5KY?/&]:94.+BTXPQ'>7RQ-L40M+!D]/LJH9(35
M 6$3'%ESYTC<*80DI,YQXWF:8?*;41/#YE3R:>V+8:W]G((?UEM(17%8S#HD
ML65) 65@ 9ID=1E8QOR4L'P7-KN24_"S;^F'A31L#W?V(0WHCHB<M#I37A3X
M$MG$NJTUJ1JWUZIP_WOP=95WD*-LU!1^&QA0MBJXB7*^N:@:-HZ>8OL_+*A;
M69XIA>FPS<EJ6',RI^"'#3ZG]/CY-,K6=IK,7;3[G&D8Y#>(OBWU>?(;$J91
MHIF+.*EVJ 3:62L6R],BNQSD+ZBR728E -LE=CVV-_./W)S*%+"ZI'60JB*9
MI%!8:_!K<JNTI>=5)7OY3*$L^$L=%S'99.V01HO A/4B,N\P"<Q6SD5*83IH
MCT%@PGH,.04_K,>1F@SF\KVS[V3#0HLSS3(;5IEFRU,(S5IA \\9 S\!UMQ+
MA5<$1DTO4<+R9,3BCA1!&C_[[827HA5N!<UPF.C*F+OFQ0?SJ7(8N9@I)FQ@
M\C";856-0=HF,02XUV6^1(O\EC&F-#E"R5,DZ6JQ<EFDJTP<C13IO,)"K]/.
MEL.R"V603!M/@&K@:+:\::E10;)%DI&950[=$B!2A>:XY8[GU43*"Y)W77S'
M\72YFN\D6F@='G:.:T[!S[X7%A)2+F(Q408A#<@"!/A][/J)$=AR;W3M@$AK
M(@^9RKC$2,:@?7!Y)8P*[-+;L.A=/!5B %>!,TY>T>!_8%/C7IU16U4Z\)8N
M/$GK993EUO6P>3DC+:,@MIL*FWH7,"[L)^W]5:OK-^]EV?L+O2L[6ZY$:/"W
M6K*6??##IE12>OS#-GM#K[7.&/B)7A@[3(B1NZ.RW;:7%)$E)%?R$<MW4@1I
M_ RX(V[:; >PQSDB 4P"UQU2)0OL6=VT6I,O=YQZ^W#]*G.KG*0<9<4('IQR
M.\7QDH# IK62D[.[\SJL3(?-$6R(B12Y*6L+;WU%) 7^2E DNDJ7*YM&1]>1
M+T..3>CUR9%@SKY$A[7\#Q0]83V+=>A)*7AA/8=UX&7,LPB)GM";GO.%GAU=
M@?MHW4KD-DPM(4/S>=CV@\QB(DF6WC5_!CAW5>S<<8SKW,'Y%IT[)^6EW+<F
MU^T)-ZJ;\O/XX))>_[4_G4HJ=N@<_TZRJ#/4(:J&XEF:PI3][Y]V3B4!P%\G
M"WX!C1HHY5VFO?R*?N,E28I\SKAIDG0RC*6K("B,D "1TN!9ML-?G'/>4Q*@
M'XP>V>LH](.C7%C^KL;(WZF%<G[_]9909LO5BU^*8QN9LB"Z;(FN^A;#%/3:
M@EZ[7#9&,^42S503T+\'0Z[XAZDLM-N)=)GW*W(J"+2"0+$(!PN.=L5W!_P\
M[N>\__RE8M]]^G__RY:9CWE@MR1@V9O7&@LP._?NDCMUGG@L]P"F_H!IMD(+
M  _\SDD3+ ')C\K:Y$?3T+N*=:V;9FMRRGSA1Q=/E]5&+X'T1SK2'+?(<LK7
MP&48("H/#!$]PUF*JPHH+>;8%JA(M.(GI3#'5<:39DMI"_3$50:43_24XRH#
M2BEX80OULVSC;5[=/S,8_,I .,8M X&?=A8%YZH<S51*FW62%&0+2;9=!L.3
M(.0ATBSIB#A).VW8]EO0B8EO=2M3H:MBI!& _%J?L*X/A@;J(\U47M 5\9-:
MD_LR:U3[CXJ@Q;:-*1T>X8-.MJSB W>\@#L>8DY9.JP1%)=7E'T'L9RHLY12
MF L/:!5Z*G%Y0#E%3UP>5$K!BZL](%^>AH_U4'B*!T:_PF7,,/$*WS$+!-NO
M$WFVUHD$6 PDF>@,V?]^Z(.CV.N3 ;-US%Y8,\"WF:=C6S.T)I-KT6 _H_/O
M2#BX]BNG%V6:FR0XH[I ?'?L8,>#-#R4D+S<UU60"S.C@V3"&EIA/:\4.YGK
M9N9L*BT;:_7$FY\J=(E?'L"=ET& 8EA7+Y^NG+C5ZNKL@Q_6U4OI\</NG,N8
M)Q,6_+#CF3(&_M[OE!VZ>5&NE_12+BSCABW/2B^D^^'1W3!<@&\DKO>-YF>M
MUYA>\X_R\/C]6_DPQ@BN'[#>U555?SV!U_(Q8CVLP$?<U) E3V?==-"]>C&\
M6*59GTDS>7%CJH=MQU>W6BB=??##^@$I/7Y.[?BPX(?=19 Q\!.],';HHD2Z
M.])+EK!<&;9"*+V0QL^ .^*F  >$6>N !,PS'WR^K55NV*=&NW-P"9AHH\W3
MR]3AQ+?$1-R8EB*/([XAECMV/0*&7;)5NN*S4#?"*M.4LMQ!&^$E)JP1GE/P
MPQKQ*3U^3HWPL."'C4AG"_P=72'[&.T=Z39)+:%"\VG$DI'T0)HD2^Z:OR)/
MISA37A0@K6QBDZLU^7JM#K^C9X93#B-/,@7?!@8HHP+-Y6PR=%C192,N2$N1
M1Q(:U*TLX93"=-CF+1O6O,TI^&'-XY0>/Y_F;6CPP\9R<PI^_HW&.8,J!9TA
M048E1U?%W#@M25!EU]@.,.%/H_:!+*TS>#  @_8WFZU)^<? -$[EYY>S5251
M.<Y$R"<$.;.Y! BP@Y&3TS:ID"J:2V@E5YJ<AV@EDRL%*@7)CGF54Z(%P6_B
M_184S9"/Q,6U+SAC3D0:.'L7"W5XCBZS&Q:"Y(S4824AK@&D*04OKO$Y^72X
MN+A&ZF0,/6G0@SLMC*.94LRW?7J)&Y+W^;AF!Z47$WMC\]WP;(!+7"8N,3MU
MB=E5"V>E"GJX'GT_ZW96C3S(44HKQ)I9CEF[6"F]/-_>8G&2CY9.SQK9%#O,
M,>,\:=^7HWF.IP51W)P(:?!QV^&ON+ED4!30#D;.=^&5EABZPD58,Y@]RH3E
MSTW6%*<7"G$#*#+F*,4N90F-%13P)*VJ7[=X08\5]-CIFM6*R-$<YQ>5*XS-
MW0S^*[%TJ5P08($ L3"WR// X.MQ&VY-:A[RJGG?^);9C&>Q,365EG0!X+[3
M3,5"T0+ ?-\Y:8(E('I?71N]]VY,?3;ZEPJ+AK?GJS:F9G I3K$FU1MB$>*J
MUTF+#;8%*L(6^*?.@ML"YKB*5-)L'FV!GD0WYV8?/7$5N:04O+A61*79L(M]
M)R [+5E@=[C\AN-IGBL7RV\2(=LN@]E)$/(0:9;XJAN1KI96+U@IZ#1/)TN?
M42H.41$XFA/Y*(5<W%I7T'=1ZJ_?3^,[=(/DZTH"K4OI< ^+G:DK+*)27"Y2
M]KW%4J*>4TIA+MRAE>A)=(UN]M$3ESN53O#*<56]Y\OM"+L%L' ;\TN_PG_,
M,/$*1S*]!$N/1WGA[U%V1B90"-Q)N]' [8OZH5C]NF3V6Q.#T7Z>?[G]R3SW
M#Z-+R'<;:D9K!,-:1A%W?:7)*_256ZD[EOX-8.V-]6S2O3D5@2XQN5W_4RJ'
M=;[RZ5R5PSI7^02_$M;Y2NGQPPX&S9AO$1;\L*./,@9^\I?&#CVK*/='>DD3
MEC/#ED>E%])8F3!FAR,$3P7X&_QJ?^,!0S0RQO;J&[8U:7\3SH3!D!6_H(.;
MNN<BPX;%WD2:468.*[81-W>ER>,("^I6=F\JIH429;0@L1O?A/.?CW]N*U8+
M%8Z+8W=1YL5+#&MMYQ3\L-9Z2H^?4VL[+/AAI_AG"_PD=>L^EOM$T[>I)4]H
M[@Q;89-:2&-BQ*T]C6WX*L#I.-_$Z2"SW;K(,)",(3M_0T9',5&CVQ@ZD\"O
M:Q=GXU_ELUJ-/8S<AY\C0EDS/%%=0!2%'$Q1>I?2;5QE4Q)"RWS$Y0PI\E;"
M"_TZL4A!WB10<]!B>7D03OJ7E^Z--+'Y9 O#5DHT6]VP8B"?GD@UK">24_##
M>C(I/7X^/9'0X(>-K6<,_+VIVUW.O>9IGM^PRBZ]% O+L!'K6%($Z2YX,^8<
M40A6BU:3MA)B^\4Z+GS$P@3?V-!.1R:0QH17!VU%(RN+6I/.2-*O&/VG(G2*
MQ)*O/^>\WO'@DH+_M1ULXC8K%YT9E:JP^B-LC4X._;R0\I1>[Z_B4Q>[VO7+
MAFI/BC!)^7ZT6"T=EMU19L*Z.=F'-*Q'E-+CY]2C"0M^V-Q%QL!/F6;=H9M7
MHL%F/C1M&[%V*$60[H]A8_;]UO-?@.LGK!UP$6UY;Q_QG=?QKS^_V.?#2-D1
M?$1:V)M>\0BI"-BP54[I==="@[I5'B&E,(6UFC.6&]G5ZKG5#?G)[_01>)JO
M%%D^S,EAW8J4'C^G;D%8\,-F#3(&?AKTT Y=H2CJ*+W$"\N[$2N34@3ICMDT
M9@<H!-<%>$"5U<FO,^5% 6K+)@"N JSR@QXPZ*,U^?.F7&F\TF":U8-+<4WQ
M9 ,C.]@"RP( T$X\"*,4%V,9E920.H$+ZRMDWRWBMG(A4@I3V!![/FUI+JPM
MG5/PP]KB*3U^3FWIL."'#4WG%/S,6Z.KRB?"6V0I&.$64"3!BG196%[^G=&>
MK>2IE5234Q@Z1!X-;CO=+>6\-;GZ?/[]\L?5/?N3/XQTR'_M3Z>2*FD=Y#@$
MDD4!!Q!!HGB6IC#&UFY]=<87@DGA,[LPN[,-V]NLC%W66E>F.4)RW&/06#]O
M>H?T2I,;%#/!DIY@Q]%\I43S@K!C"J;!NVL'W481:97TN RVQ-%E?GFTS_L]
MD.I@-.8NTG)5@0;3( T2F&JRAG1I^#F'-DD4IA<%E5VA(&-><>S*(:$A^F6P
M>_F=FU6'3<Q=3M2GJX)(LT)UOW9S?FF9](#]$IY;4% O3NK%T=9(,PQ#,^QR
ME&:1,+- S3]$TN'G_X9>3/Q+50'QJ]$PD(R> @AFHF)R:='X$,ZQ?!*6W<51
M'OJ(DCJX%%72QL!0QT>:;B&3 LU'P0-Q)K9G2"KPFV'A,3(6O!^H27A3LG!C
MHJ))6@>^ KX<7B F\H<%T "X_SDYH2X4I,K_4DVIASY2]^C/"&GXRF%%ECHY
M<:5&5EX6Q"90,FSPIW\O$Z:<8M'Y*Q$Z9NG-S(P*PT__$6Z@.DA5';GZOW?,
M._([OA;=W]U@FR);?3@VPV!A HX*2/9T$%9 <+]ZWW]QXD6%BX2/U,-XB#"M
MI+;2^4C=@AS9B+K5,6XJW@_]XWX*_\4%PN5NE[/_^P<0Z8=3\%:?3]H(I Z^
M84A(X<54&>L17\3N#D>A8/(B!"/*9B$?,>+#B]%'RHFS_F^=*3'"672Q MU8
MZXZEXZ-K90#6E3RGB8+E_1^6V870UST"?'PTDULLX!W)[%-=57\UTW/>"]T@
MBF>,),,\/D*:#(IG*5A,_LF UI+A![8:>'Q?M<+@&]15+#L'\#_ET]]7VO&1
MU==')@! *'%J2!-%5>"!(+.*^1ZNMS \M*_K:Z8?O/I@45^XZ1&>.6NQ+-<:
M:KS&MR8/Z,>W+]4;Z;DM@PX9#>"48_)&T)$N>U(GE)=QJ2"^?;> $PYP\J ,
MX%*[1:_4G3Z0--I^ <"RD>)1/U.##%2!*@U-T)+N3^_<),^>$C!5_%IL9)LS
M5*=9JVJEY9.TFIS+UIOX^%K^,U3>!<A1.Y1?&0-.UEFY6Z%ISLRM.F;NZE34
M#'=UC#%FBCO&QATO#+BWS\/V)2N%QEU6T<2$05.MA?6SBR:VZK#8W=OWQNCI
MSKSL1D93J'Q"$H#CZR;(U_ FA1EF?C<T**T+K+-P,OO11/*5UA@B0[* FC7P
M85X42T%FK6U:V*5I*:>MR0^^.1"&)>5KK[VO1'!\"'3]R"G03BIX"OI:USK]
M *]6O#NJD=L3!#L_5H#4E6;EVO8J0+Q@_I0X0?;O#](;,EL*P]ZV9*4UD.J3
MSI7<&IBUB[OF]:0N*:W)RY?*P+RL_*F=RQFHW8Y91FTLV:#8SJ.SQ9VR,.:V
M%]%4,?Q&C> K&&HO4YDK/"V4-QPU<+C48*;%?DS\M.#Y$LV4_(HL4J5(DT0P
M6W41##\E4)U7IJM\E*X>YF+.$*O)3W _$&?R0C?N$ #24534-/2N8F%@9S88
MPX(5]JB8=U;_\<_G+VI:R_5B9@D/AFQX+)TR7#RYET$B5T/:?)](YE N@$B5
M3<>L$. S- 3>5,AHC9HFUP8Z &)/VCA_PT,W$,@Q-[/S)(^=IS&GH[*F_^0F
MT@[L/()2)_Q4$OY*C;A[,>@X99I,2021D_4C2S:&G2UO!GLJ+L19HG-3]MMA
MXRM; @[EXEA7[)*J5) J'K-Q@5",2%=\2W*W(50.L1^33;DPE92GV5*4"5DK
M+<E+2=&P^=C0SA1SJ)MP#+ IAT"T<5.5- N QC420_Q^?"79X0?3)_Q0[_2N
M!N.SSR]W7%(6YZ9>7Z+WCXLN&Q2]2PT=O)&+"+E(RY]YN:U,;<)R>^FHHLO,
MEDHN R0+6;);WFK_8Z[Y,-G(0<6O6FRMJA?F5/T4KBO-DK2>TE91S32190)H
ME[HNORJJNEJI/[$7U:9L_AB\=7?E:Z16ORM3)!8Z7?TW#&_M);Q,\Y5">[O:
M>ZL1&&D%*F"P1;#UZZ;6:JJJO^*.7FS9ZZ.V!9Q<ZW1 E5DFWG>")&,^L1T<
MA+D\+1OMYHWQHI<.P=J=8LX&!<25DAT$DNI<C,'#U8HD[[ Q<^URMEB%%EF_
MOH!\:<6DB9-$4(7G:$;T:[),N[9.&-F)Q%#8$LT(JR.-P04:@3&4Y1;<X'OC
MV^AF)'P['58N=A:\3\D5LG*\.(7L:-KAWB%!7NHR<Z5K)F5N[XTM"9+075%F
MXTB4Y #!R=P/(LVRJ[W'@/NANN)^>-0,!,@&@. 7P+!V_M;I@\],BE20B>-0
M*VZ,+]KX[L)@E/&E> B>QBVRICX&QA7<##:R*%GI=I&!^\H.V-4($IHP/+;+
MG&Z%KE:6M^@=],41F41)7"4"W"1;TF<?-\G:R4CQH#SAHD"PJKAEER_$R#ZF
MLN*:N2"-SJBNFZL<D'O^]?SYZ?6U]G)@_L?T8E&!]M3?/:#]>[R<5H:WOX 3
M\G(@UTK(*&LE[ ;;[*%@0R7BE:O=EVAS#%WAET-WJ^>LID%5QXOD9,Q]NB)&
MB@8)GIQ"IV.,<%^</<MEPS2"_%;E^%]-B;DY"./>098-B+M$X2"T[HIH:0@&
MVJ7ESHBTL*9C(0=W0!($2<).YTIT2<B@H9X ?A.Y CB!9IA(595G"SM&;6B<
MJM"&=HU7#%TK4EM1U]P!P@7WW.1KCVJU=V F^=QUH&*$%9?"W,*J-3RUPVNA
M7*&Y3?=#%Q1),'XCT$)I=8E@ANZ%+3&<R,W L[3@.TMQ[<W S[P#DLMH=.T>
MU$:W9IHZ[B9 @6Y"<"GF\QVG#H<_S]Z>5I5BYL95()CSU%Z2ADWX27)1> @W
MQ*JU)!NQUBX="/"JJ\O^PV8!BT,G31)71H4N5S==V).&*R-13"?C5-"\SX"+
M,/']5:U:34-_44R\E338EW@[KY_QKXW&CX=#\R6FV)E5J*JHAP?#&GH'(7R8
MPXCO;Q1VG?'43D-,=+F<_QK]. F1Q'U0HODLCG[9,'NS&K'))GHYNE2.M)IM
M81[8W-IJSP0^CUO$>N:_<*>MR>35TAOU7Z>]U\2Z<5,V_^6_]J<ZR>V;;GH!
M^PK(,DD_KCI#U=Y&]J5O7DHN@$C5T)?:RJ$OK@2[_WXP)!DYI?%WJ(.4%SRC
M&$28]S?O&DVYUGZKRP\OY0,S[PBF;#",*:(.PJ#;\+X+RV3[Z,VL5,'P*QUJ
M:" 1BB5:>\*608&(Y?S$#)(@0;(F)%^B2Z4U%(@T?VP1X"OM!?ZF&W8<.N#^
M.7TM#?[<#KY*XX,H5_'@I+AI0@B-!U_[N%YXNN(S1JRX73:D4K(39VG6IX/I
M "Z4-5A/.!#!1[Y"@L,0> @MD(9L)'2FD_/!Z4MATA.4A]/^Y8-R8*Z+!T_.
M8-I\CIW=+'.SGI]V&)'F:)X[[)1E1'(D,F82[G$FBQ7O\>,WF<(6NNHS R',
M=7"^D4?1L/K(L&="!7L4OR7A2;N?U/D_U4/P* A.G''%!#,'? V$MYT\G+27
M@9!56N"*L-769$JV3PK4FD\A=V9OC=C0GO"82EI@EML3PEPFIRLND^7;TAN/
M:TKCU6F2^H\OIW<O_+=2]="&['C2)$,;2P=QPVPF0J&X:Y?U, (M5 YT.EO\
M-$IF6H)0638 4G^U[ CE"7DI#!>I^GY5VF.Z"VJV9"7@"A%_#)A3M=/X?,<?
M@E]"/-##NS<VM+T6V6<OSH@0@YU[F)1)U/\H^>SF2+_S$3^6$[D,!-^0U99C
M.Y<]J6L=4(77O,@O>!B%^:#72?8#&2LB6&7$"A>_?UT)I4,;D>^BR:FX!_)3
M'1=?AW![;.NXKV"W'7H??)EF?,+MAWV?;$^L9 NSZ&IIS0"Q'%PW6Q,AF:%!
M59KG(LT(9><N(SML-P?PK:YU)+-_9:'!B@OGD9W<WUL7?7Z"#L$UN9;:NILR
MT0 ,W."G4GH;3DI&1Q=7#0C.&F;:92J=IP4A]]=)$O1())?.TJQ/ZBKS%T4$
M_"9R&90!O9'N@C51JL6.+PSN_#"A@,OAYE'[^<2/]=J70RNS\J36YYJ]5G Z
M7"PR,DYL=0-J1P5$4>S0@DM&5>2/5$XNC\UC*6O8;S][O<K5-8G&C>F;/5+N
MA)*)S+'CZ$IEPS4WFY(O ]G[:!1)>!PU0XL^&XC"Y/#%%;<8KF_3.HJ*FH;>
M52P\<1M?6P^M@36[K_ =]ID36Y-*LXF>7[XW+W[E<'OP8O^H]R&R8@Y5:8R/
MK2&'O]QG/B@#9%*WZ)6ZTP>21MLOP)-M7L1][81MX*WV!.=WGQYT2U(+CVA1
M[GR8<9?#\\IENE3:<G'+H9(DD44Z57^=EWF_*!**D\G?,Q6ZPD6:K,HN3%9U
MDD[(;$J*#-\ %T)=E4Q3Z2I(KIG3<1@!D_3(_7)^?R=JYN.;=K^++$W*1F/8
M*/0TG\ 1%+EPC4*8;U&X;Y?)FQ)=%@NW:'=D3"1(5_7=61TO$5/I',5%ED1N
M,)$N,7%TWM<ELW^AZJ\F/NNCB2>?^U]9+/:-[/L*^T5Z?=R:7+YRC1^U1Y;M
MR8<SQVFZJ@<'=*DNQIU=7J"[>*.D*>+6CG,ZD*L,\+9.W,)QXBX=(Q[L\++?
MLHDM:5J0;P=.5(4%#;D#XNW%T4J2',D,G:U6:8Y=OK 6R3%W9^7;$PHU3BZ3
MZK^8]I>*:7_".D,/3_TPYQ7";% G'M,Y4N]%Z?Q^T.@?CGDW18I3U1/>E"MD
M-5- I$I6YTO!FR.CTY=,U.@V#>Q56..F*FE639//_XR4(8Z@>OU0'SG&#MML
MW(W6;$TJOZ3+VS]?JI_O2P=6>U'K -),Q9J.7]>[>.XZP2NIVD,N4O,GWA'"
M'MLSWRZ[4[D2^&C;SF,IJ+9+UTRLTB*?Q7ZD/1$A$8>L5*:K/FL.-J^K.(.3
MRTB337L0*9+QU6.7_^%KIR<+Y8O;&_6W<1"MJE-L>*=!H]79K)Q<+.N$8XE1
M=KSVJ9+_$@?O<X*WIU?*3,3MZ7N)=84%BO4'*D")<0$&]Y5F25I/::O('EJS
ML9V-/E\]?:\_= 65+>QLO#'50:=9S!3S,Q0VY+==ZLP20U?Y;1OY"F+M8@),
MA:Z4-BVT2(-RWRWNDVFR$>B*L&;^WOH]2G=P?D/I6$C&<5H,K>]5,[.K:[?L
M'Y%_TW]R.2Q)]AM3[.)GEGL_A)MDQ=#6$"RSP]M"I%F?47LYNRH2H$8B)5N@
MDL3<K-_>!KV):/P*7>(CS7LYG>G[IC0F=="-[JUNX?HR=VBD1\4_<M^?>K>W
M:*P>VCXM%SM3-T+#2'*'?QV"WE\UK=N?=_8R[HNEF74[)'.@]F,B1K(3ONCJ
MQE6ZJ=#Y(<,[%7ZC\ X3$-ZQ&QIUK6<A8Q QPO/;U)O?S+%V=9]8U6N:E+%?
M6,<<M4U%5B2\,(:F-&3A%TD]K(3?;1Q&Q'L#[W5SOMMEI(=FF#+-E YVR4B"
M%$O"OJ^"N5>M9G'$UL[QGTPQJ\!&WIW-+17EN>/":II,)HCA@]\A50)?IRD9
MRY&?R252Q_KX[+GZ?&!N 4&/TRBH4X:-(SB&L7:62DXNG-#&4C5B@B\_*! S
ME>,,4<R_7DWL;L@@7:JN#B\%*+]*A(KD6>L9UG[3UK,[_>7KI7!;^LP?>.O9
M"!!'*1K\ST%=A.XSX'F?3I?#:4U;:Y:$8]6]A&!HKB* [>Y;3Y<D]0M"[W:F
M+B-P=*6\=S+OJ=TM0<(EO2)=H%F?D:-+9"LZWW)@LN\',NZ#F [(4MUBLW;N
MP86B@84=W [W]' Q^OGYV1 O.H=C<DZ14K3#%0*\7P%F/?O>37.$O>%&UQVZ
M/^73:;#LMM=M3=#M[^?&'_G^"JUJ/\ACL,Q%T31GHV),D7ZWKHNK_,GO1D4E
M*[AHEY533)4N\1L.I2^(LXM$2YDI@=^UY21&EPJ916U"152\SVBXC;O/[M!P
M6H!QJAN&_@I S"6*?*RZN90^N2;:KV]/TE@J2:^K=O+F)J6_5%]UH'?#VJA"
M)/;::8^&2#.5-7/@"NIM3;U$JG1+<+E4EPM)H]5<Y!;WR=P^&/71-L/S\Y5E
M4R"O\<1\SZC\C>^@QFV_6?[^6;/NQ0-S59:O(XS+T(M2#D6=1>:U73HSN!-M
MT\JD@H!IN9/@2A)*:YK9,GLEQ8K^9,;25^E*9<TPF^#2"C<X]H"7MXR,\7U?
M,I#)S@?$ROSS^6VW5KZ^3&RF6YJN%A<7-B0FP<@!ZR+B_B_PQU[V98$%X[=_
MX2#NB9 E;"(C;%G%EU:X2ANU<IS/-%M=&BJ6I+I[JAI=1UE+JD^;-%%W9T+U
MY?&Z_#9>E;++HTWMH,H&1'$05DB7APLK(:4K+W@)OA#"B-7N3%!:$%8O+4VM
M_HL?P\F4[Y8K=)F+5,![ZC_Z#:_'V#C>\8R8'Z.&I=4?#V)3^,)D.+SC"'<Q
M  %.,-T-755Q\:X"+ !663$G:7YF7 @.VV787:3+PJ9]SP7-]AELY^BJN&U_
M=%H#&]MB/)D!HRPMLFL\O% K]IJ&WD%()H5ZESK01,-1G$M#TJPP0?:9+_!G
MHEP/?CY=CR>] W,&7!3:D)!E17;5E1T0H8:CMJIT*+W;A<\?1NHWK)O !CBK
MN<7+NB!J=&G<W>X?L4JS<8U[S3?^$U']U2K>IQ[)P:C.@CTD/-D&;TFNZX,A
MTDP)/P0/U"8#A(?6@GKGM,]_NG]*'?6Y>@C^!$'/"<&/TQ/HP1(U!#39TZ>'
MA^%*K'"^US/2+G>B\C3/^^W!.@ 2A;QRN:BMVRF/>W.;3:@^]2TTN= -PL^X
MAA/5==/RB:R\-=GNK^[#YP;[=&"&+D&-$_-VBEQ!M \DFA*:#P-&:>45+Z$+
M Y9E:Y=;EBM,7N,3F^$WF8*_*EWV\0C"1"/J$?H&9T,KL$*>#JW0&C5](%=Z
MPG@6\@XBXI:F:TH4\JI]R7\[HRO>SXK.]SN[(KTJ+-K"U_T&R?FR #+GYP46
MA-T189.XJ2JE,BWXE.XD2]8\D269F O'T@*_7+JY<LQ$T"5WWNVBCM7HGK]U
M^I+60W>2A>KD)[.AD6%4&IG#C;>:O<!Y-.*%</:,NBMY=N%]KS/*DX9&PXX4
MX<*+ZJ&DY.Z;7GQ 7/@&C4(..BE9P9%VA,=Y;;6+/&/*;JVA&('O]C)SJ4)7
M*YNN6\D9+7=%RD2<K3)=+F\8@TO;!;4;]"=3?R30@K \:WCCX:EN-=49LO]]
M%7@UV:X8N9':M]4OEQ?-7]?/B77ZIF^(R_0F<@M!\<! >URW)ML_H!F^XIGL
MLFE8,(4SQ<(RV%XJZ*M@AHN^$8W#H%ZBQ$ODUF%86N3]9AZL(5A*1O EB?!$
M[AE19.BJS^B]D"[1Q?*D;I^KY;XUN3O[_OWL'GUO5%:M8LO%Y#Z_/@.S[XP&
M\[E**,FBK#ZBVJBG:!H.\.E=\L(82<:FT0)\<$K61VT5A1P^FW8M%F;L\QKY
MJ9F-;KQJBF8$//7&+\)3T"LF>L49^!% IS ;CH]:1ZU47#GQ85N,;R(41W/E
M2,O?Q%#7R7EK<OOP^?)WM_'GNIY8'5,F[Q $?PM[>Q3:9NYVB"^I4Q%$NN0S
MA;J@1H;NZIQI]]W>I3/U_H^%5_W!S_\-O0CYEV)Q7' U.@:2 1;QOQ03V]S4
M(3[(_YR<4!<*4N5_J?NAJECPWAXNO?A(W0)^X47[U[^X,Y8Z.4G3T8NC?'J
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M0KOCEL]N3;Y)DQ_2U\KKKU_==Q$T+$':1AK$)G=;5^4P[.71'_/ZS.=<7H6
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MA09#_=7A]V%_;,)7XS'V-@84 Q0$T)\"I%GX2$-#?U&(DC1'0Y -LBNSHRH
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MP<@GBT4NV1/I\JH\6V"E%KVF3 O/<+"Q4X3.@E8HL QN*.,8IZ',.P*#FIN
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MCFHX&,L\V+\L72B_V(^SUJ9]N5XP'\<2YB--/PBF50,KC4]4'E*E9P&HXA0
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M#OPP4/6)]ANQFU?X=[41),&>'QP==C;KM]4?&^/+VXFO;V#<9SJ<2L3;AEJ
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M<@GP9N1367E0T=%JI%=$DHGD6D$DZ34*,(4>*Q=41$DXZ>4B4E(YE@H9H)%
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M"VPPB>^)SI!8=YM^6U$7/P3-3U@2>)21#B_307_=O0A33YN&RYZTQ#;.<+0
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M(E0U!<,Q*@X-DNWNS9&6>U]L$]7>TJ+QA?<%G=!QOS:MQX>ID)MRRPJ'2_*
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M&HSRCMAG1/)5+HVU'KVR!AEO$Y/LTX?BY4#]3(_]H\\L?)'E@*0VR:.'DD6
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MR,8WE46+K,.L4G=AY!IIA")*C4S'<=-ARG=!;L.'@",UXA,%G8ZZVHI<:'R
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M/I<['O"=]7=."LP^*7 TBE8=:SX62K]6=$DB@.75$&\&:VH;.?H2OS1:5\M
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M$R.L5]_:GV MQL?_N]B$<^WU=A0=B+._<QT)&#\Y@T?F]MML$7OCX)]W2!<
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M]H$%O0!(L8*<K?'W6>.AFFQ[TUF#!.,X=8C2<Y^Z6\WOBX/UJ6,O M(SQ^/
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M&GA/V4*'/A35GG.1YKYJ9_<>,10P^M>*$5>8,E[TJOH *D/AJ'' 9,:!AW%
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M2@B(C<_AR)5DL=QN/K6?A/ PFW[,)9-1QY((O3>&YXTZ+ 34A>R>U+''87W
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M'($+85A_$NB'P?!UD.(A*&$A)MJ*@E.FGGP%+:$Z.*HE]>UVV!P,RFEWUH>
MDZ@J#/;.J_;MCPR,D<A<+[NV\O)V4+T=*,15/1T*0V3P\>&!B<#@QE $*#=?
M,;B#@RL^1TR]_,32%#VA/Y+.1O@J.!+QQA (P087/%\YG,+VR Q?R)G0QF:W
M,Q'Z] /J2QU!(4H_,.>L!,X^<'7(,F^06/;!H$XLZ^/G-C-(AT+C%UZG93;&
MS(L=AP)7TVZZZFPV[IY5L)\B3G(H),&-'5]"6639AMP@/V[/*J1)!1B(0YS,
MD@@L]?[H9<4]*-2\=UX"*X#/[72!%:HM3%8>;QYUBEPQ9S62@J(C%U8Q6IRO
M/8FKS"O:]"KMX7X?!(;*V*00AOA2/\Q B(K/S.2Z4N%A4)LSG5'"9N87$)&(
MA4DB+/.EQ@>!$!%V;OOUZ[3*EQL$,8#?N#R0.9>>^/K%S__\"Z/1'S[R_EPL
MKEA3)WG)A9&D!DG>C+67L9PGKDH;,=%1U)Z@7@*8_)WK2(#P.6RBYS1%$GL_
M<O8?.XH.;N?\'?\3!U3,]91I1Q)^Y& ^N3J>DW("LR>)N#R!L-2^R'S'CYD
M"Q9W#.O"]>IU1;6OEG@O0V.$:(Q@Y@6]+V+HC484,C3N.!;(>>%)?7Y KTDZ
M@V34D(P@[6%O(,D;EV1XN(RBH>(]=8-?*=+'@,Q &3XHHYW4@:![<^J\,<F%
MA\EPYW8L^2LJ7T5[$R)#8_AHC"A_@]@[;#<^%,;H71NOV'NVW9,&/3P#:+@
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M+85DP;03\-#$Y]''W:(PN^(R."4>  D^LIZ$ $\[\0YF.>HTYX]M7-Q)KLE
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MLVR=&U)GBJ](,B1C ::*K>U-S]UT;_VMS&5/[Y>J+BMPO1/BU&5-+]?S5YZ
M_[/^6P!]^%/\=7P44'605*H;A)]0,5MZPZ138/W]W>K'1Q>B[L"Z?(K$,6 G
M@/^?!88&EC/%H:J-2_G=1XP,/H*<R 97%%,"Y!=;RFWSP8 %_###:0_*P"(!
M%] >93-AO\&>*K_*O5>GXI@*,@E)@J0F#<$YX(WEF:Z/ROD]N-MMYDE8G8@-
MO=NY[0(A6N2$(C?)!I5O2B-CZH0*6%/P2""R:2&LZ6^_SQ-JDHY)8@^X UK@
M0F _):/;,R%\!LI!_[<5$2H;M2?^]R^*)G^#_\^POQ4+]S]P?%10+$7_,+0/
M%4I# Q-U&<LA@[@*W8Y?IS,L,(FD M^73-5#XG@'Z).7IFAD\<.?V,T(W<A<
MG_'GG\0ETQH1VA/ \PQ@&  ZH>C13^P"LDVSR-RW02H*$ULM4VF)MH+U'%-J
MBQ;X 3Q=@42H_H<42)RD"$RUL#$AC.:_V$_U%\91I]S?6%^T7,R,!X#!T5G_
M5,$'Z,PI\_?Q$?R$I=BVYF-HX)7\OY;7&1\FI"$+V&/,%"9IA@75H@SV=3JC
MF*9:A"9.#B5=3HXN":"J"/XBUK"N(2O =F@/+'"MP*)- S 6()>M2&T=J+[6
M -%?U >(NI!>FB(BTZ7K)ED UT#B <;I E>^I2 CQ#*:=A_>;, ;K@@^'=UA
MI=LS^HIY?"0;DFV8EC>IKVN@C\L*-(W@&O!Y;?'#^PN\%*8!1 2XQ' ;J@F8
M#C S^#Z0#[+:@@)$'<*-N7^517 BF&DX0# J.-@1_#UX&WCW=<E4(,.C3QX?
M 7L+6/ (J.6^)C@3*"S MFP@2K&V(FIV&SX.L+/Y =[5.L4>?5"8.%>CP[<R
M'!/K::(-A:FGCY MUQ4[X&NZ ;X-S6C%=0$:"CAIM"=P,\"3@"$-;@KX?^#K
M8PI9@2.=XC3 :^#"*)\(E_;G?__GY 0KJ8HF_PO$9DOYC=64=T?185"3(GCL
MY,2/@,CJQU28P3?\<].1AEG'X,>?,8,O]R*(\07I_8GFQDS['HML=Z@.%7/*
M5RF=!(_"/X3?6'W04^"-$1NJ]!N[ 9+3/:@; YX-S02_]8__-?@G_RW\4(!O
M3/_O'W"2<PZU!Q8]:0".ZYPT%$!,\!Q1ZXL#:]+O0E[6W />W5G-""MZ76$%
M(^)!ZYDEF *R@M$UN%*[J@U'<C80]\X\EMKDL3_^W  '"<D5>)F Y$#<"W&Z
M6!-H9UV"KI-E@U^@P-PV=E#\[)FP_@UI1[MM.!:0*ZB[I7MWH:P%'*$"T\71
M-?!)#$F#/M"S[LYDM*M9'MM FTS<OR"O!AD=W@#(Y$CY^K)DD1[[AR0R?X=]
M//A?/L;6KHG3KL"H.CY:H R@)21*DN'HB F!0'> DC.Q<JE:PVCLOW_Q%$G^
MQGPS$@O:D=-B/D&OG'B2!'O,NOUE@5" D@ 3NY 8;IQDVB-(7N] X%IZ*=08
MG,QR+6O2=Q]9<=#Z@=FJ#0^U'C3"X>L=9A<$Y-2BE&8,[BT1H?4J,AO[,/"G
M? (#%@I^^!O7!!XW"F@INF+"N!W\F]QU8\C@=3Y&W[-<A3&EMD;*ZO@(2A4=
M6HJI7%A[?UEPCM.F.SQH')U\4P3NPX>H.8H?I0 TDA6@KR5%_8!JV!H'E(!=
M")@%4X%H 0Z".4!!721;3B<B4%W@<#CP"Z/G@G\<'VG(#]'&O(XYEN?#8-""
M@([0Q%9,I2L"M@$?<;_JA7W!CFST=R3<P&<#KW:*07\?Q=5/C.8)\.\P$=TX
MEV']G0'E!9TN7S*B%_-MJ-EMNAP,*0'?R0#[:FJ*Y.[!T9OBAV$BJQ78F-U1
M5V]W&20M(,N#KP$*=Q3;_53*T)O9'BW#D+U< 1*Z0R1SD/"QT/&/& G*&@G)
ME0&01RU$3U-%C(?ZETS=#2\/!H-!P&D%/K OR0-/.L7.O,>[X05-,R0DNF"F
MPH2?!=0NN&XZ<,)<+QHLU8+<ZW(HX'<-^ 4Z#./.?1?W\:/-NW$#(%FA[PYY
M#=I5KFS$;/%3L8!G[Y@0<[)]UOJ-S>)#^FZ7FWAY+DRHT&L$1$XV II2@8HE
MB3WH$YJ.\B.8FZ]);7"DFN(%#'TE?:]#B05CJF8=WNPZ>&Y.@TFAB8R1$"C9
MB;K2:WL3LR;/?'!MXD&Y?F/VDJ>J>S<,;=4-H,&:4,"%**(&F=,5M;Y\G]0S
M@5NEPL-1FRJZO[:HMQ!W>S)[W)4(I1DML+ &.P_]&R.+;\RT$P8UG^->A\:'
M4+QR).7JJ3&BCJQ:/4T<P"(['9:H  Y!^@7\QAT3]>./ST)3*@W^$[!1U6.C
M!9'A<=PD&">9CJ/,^OUUM0MDTXW2QZI&5P3B#_T"Q[QC"D1,1K4WX,K#2C#E
M7\S_Z<<T@&PZ4>[&>)8(CADTF?NL.05 ?AGB.([D_V8BA3\O_ .ND'+25MRJ
M1A[%@#:O !*\"J#RB'O==YEBX97#E,)4/7D%F>&*HJ*?V62%)WO*S#_(6(_M
MP9<B[H&,1,GB0J1E,,7EW+3V^7E_=\\EGM/EW?K9K;)D'9KRT.H,RWSKGL^B
MZSY52.QQU!PVF]"KT\VM)Q)[(WZICY0.<*8OE<$US.Z4]9YC6_= !P'7O*!
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MK4=C@\@*L(WT)$"V >ZL^@MJ6Q;G" )^SJV<A+5"$ 1R?!1$S*Y"P/Y&1(*
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M%_5%Y=(3-I%I- '%4-@8J&CP ;?-@&='(Y@*;&TP@0""G9B 5FXV@7GAMRN
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M*&WK&;PY'S*^P@ F&_W$+^"U^,:@DCB5X1>#/(D R//XR$=Y8CL'>:(Z2TR
M^T'C-SR4)[8^R!-B.5>B/>GE:$]4>UO]#^>?X41$)$5[)F(K,'PUZ0 INEO
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MW-B,JH.-+8(JC&'!HY*\:;Y=$LB=PNNRI&?C;LJ=&L<42?/=>K\=^^W+(Y.
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M<= %&SRU;IF*Z+P0;WNI=9T&TN9>AX]*B]+DOD,(6H(PQPDP9^;S=(H$3I'
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MS5,= Q[=FPC+L@Y!S83QT48C&]!;(=<)O:X?,@<>#C029,_U0O6G(M!)?;"
M@OT,(J\,$U4GZ)9M.J@,Z==X/H<G] S?8T)K:X;EE1:YRLZ=VS!1=1$ C-I0
M]7O.E-?>%&LZNN2-=T"85_!THPNXU&@ 4:=8TK@-!QPL@5RO&/#(3]G[]ZO[
MR[M.;S]YD03E,U= 5=T48PB4*K4"I1IC,6']ELP#I@*;V0RB&F--WS* JD!L
M.DLS'PJ<&N,)/]]\.ER%>C][858?<5AHZC9+* 5^<0DE.&,HIR)@4F<+_O:)
M25V A&2V"TF=S"/;K/+R^" \->EM E)C8 0:)UEV$2NX7;4CH%'!@Y;2(+M;
M-.H$3:JM0?WSJ5A_$A?>T6U@4>.@$;600IO4-?)I7>.*ND8FK6M,ZQK3NL9#
MJVN,1+<8D>WL*36!;$>.'C3?$HYL#UO_9QMC]1:JW*\R+J <11=@#"E0VNDA
MCKSJH*PN!]!&_F\1VR\M%"S,*Q3<WM-?A];-NU3H2!52%.<XQ.!.P/CJMNGI
M15W[7OQ6A\:%-EM$6'P=7BNU\SI!/39ZG!>-'Q<&6KXMOE;%K>CV(A6E]LP8
M2U0]&*%D<+^G=HCEA,!FF)-M\!9GJ+\C!+@G%1@,8:G-02SI -Y+!V!A@_P+
MH_C^J6WP8NCCL;[6O:Y6%7AS#/-_EC,62B56>!UF/TKW=>/FK33D?_SY?^#E
MG=Z?V(Z!2-@QU*ZF#J#T.LR;/:%_?]VYL=O@ +[T"52*N>MB(:YWXY/T:J5B
M+5O]FE2[5N1*V]!GZFR_!MWRUY5<F KB<(HE0<HD&RYMO)\=SQ@3Z=;2K:5;
M"U]'8[8:/RF2QBF:@?_Y-4<6S9%8R;%V\Z+5]HIC85,>6'KD-R@&+I<;;YI'
MKD65_W ]X)S"_RJ.UQAW]("MSP)QAP)POF ?-S?)1=*;%H7,;Y?N6[VC=NG#
M[$.#'AAT/W?1&A7<Y_V7GW<*/S9DT+@UYHK$W1ID6-"BCB #&8)PQQM'YU\2
MSP@+.X\NY,5,?+S($NR&O)A78#E+\*2,FFA<.8"]8(,[GQ5O/D76/I=K+U?-
MB*P8IV Y7/YDP?_Y_!GJR&-@3R#OF86)KH7<2<7'G1F*V) [RSK0)+8#OF(4
ME(IBP0>! Y+!+Q2WY8EAC5H]@I\+8M94Q()8$QU9&0O2XFU>JY;.!DH]JB!-
MN1=R;^8$4-+CWEA($H?PQ4ER8=/U'<A>DH3#:S;B[I(H.1I45 6EJ%NJ;M0<
M5*-A@C/KBD-#AUH+O/58#']V:N3S_?5EGQ!31H[.R"1Y HCF,7+4TX^!9Z'U
M'=U>R,?)LYO:"WY\9]Q@M]A%5SMH+5S2S8O/TNW@7FVD;+H>FXZLA1 ''@-G
M<@N;,"]DRU*<;"G$)TKSJ@*K$2Q7)P']4Q%-46V,F#-#ER^--X?,EMB4.==C
M3F&.#%U^['$H_,6-PB.$0AX70(H2'?] #1=\G-6XK^.J&UH<9_'1"M7Q=Q,2
MX6@IC2S;OCN_I,:*HC[=O_(@HAJH4B/$*2<J@,'@_(I+M4#PK\56.PM6=/NV
M]%C)YME;*@17'9Q4WY35]A&+H$B<Y1;"$!:R&KDFJR4F\L!>9!IYJI3ILG+*
MBH<16,C@2\ <RQ(,ZW#J7J((A8;1NRO5JT;A[<"9,KC.B:5()^KG25N5@:+\
M%P-TH=3/AJF1@D#\^',R73BW@)"YM0FY$]?:KM7?SZ\9H5^3O@GMJ/"T(]:F
MW0[]S[>'^KU4X?B.RAXX!;>A$O;F7O(XR? Q.)B'GFN'# _=#,#BJZY;82("
MY']QD+@\>OGY7BW7,I?UL0T6>,NDN9=AY2(722YN0*B=^6W9VVKAHB 7^YRZ
ME% ')Q/'<;AP9Y\DSXU9PVUC-N*WQ#AO>O8VTRV4VM)SXV#Y,90TH1!2*ZPT
MH3:A[EX<GBM[<'.O5II5O?WE"1G!7,YL2,B=.#P764KH&GVG\+Y<>W\%VC'A
M:9?=D'8[='@&[<O6\Z55M73ARU-P@5'VA7-3D./ !L51@WK4R2*"IQY8 +6#
M2(C3<#6\:U_:W:Y.CFO& EMU7S-IOL-BCSS$*2<J-45'-CKI-5EJ9^Z-?,]K
MME5\%ZMO(3@JR=)P*VRV#^>&IZC(?)9;D\\2X];4"Z9)D+?<?2USX'P84BN3
M$6QB=CWJ[L6M,2^,#UM[?LGFFM^$D!$,Y#6OZ:[<&@F(GK>+SG5M^$U(%R%<
MN?X=W*%7\^!HY5:S4GMN4=^$@OPFOLVAIT507^;@!*X(Q7?HNUYKG(0X-]I#
M_<QQ@ P:FP!HE][+'8Y?L_QL$^724#C#1Z_^YZ+ST<X\FO9ELVDRFE VWI:S
M49+%7]R\M0\_)H-3+!F9M=CHK)48)R9_??X@U9[:U9L5$NP[L5X2R^E(+CIC
M9B,SYE[\KV'CXE[3KG4^Y<"D .RBAW/H=7AM)RYBLYKO6V3S+7M%I@RV/VA<
M=)!Q=--_MZZK\F'SE?Q[O]F14\;:=]TA22U/=7SAU&%9EY6NR^;C2<WAO.M<
ML/']Q"HNX??A5%//S:I\KUT5\V^!//?$Y@[.O9Y[N(GRJC-D= 0;$YI[=N9*
MGU]P9\VGI[=!EPG+/(<IG2-QU#Y\:9+"N37ZYA"A>2HQ/C29RY&V:2M=L9/R
M7+*=: JGV>ARC@W+DWMQGYG+ZV>R_W+[8,@I^R7%@^9P/A,]8,-%8+2=^,[O
MP[,;L#Y?>J>^ F^%3-$Q$:JXA0@DVZ%O>M:XZ0BY<Y$HT-^)< LJ5+Y';K4*
MGW]B-$\<2XGB!%*!.@&XQ&WSWE)")#%VYQ*>9^\MX[$D]ZMCK&?P;0_.'PQQ
MSHGR#DD"I[CHQGQF3<[:F;O8I.[/<H0]N+CA0S%6DF7D5KAM+U Y"B>XS0I*
MHS!;8OS(*M,=G#GURF6SG3+CH;B4_!IBD5Z/4_?B798_9.*BT^XRE'SP3!G2
MBF0CF/_\VJ3<B?]6S54*',.\Y\\SWX9Z$:K4U[1\=^O*5>\Z-8>K9\^+W,'3
M<!MJ86\I1XK&.>[;9ATKI@%4AST8#Q2!O5Y[D/.C]='P%ZIHX/ID=;GH+Y.X
M!BCYST?[MOU>&V;'@7Y_]Y,G<!">Z+B=QGHD2)2'RN 4$;W#1BY63MR9VSKH
MW4M7Y5;GG!'",N+!:85M<>=><J$"3C+1FR'RL7)G8OQ<[O;B]H8_UV[8E'N_
MP@@16HB>Z2K&R=I[<8SMRUJ1O^Q<<BR;<O%AS0\!ACN9B0XA*L3,LSN) )#E
M5MFL4#>LR'P%-@T9!. B()PS,9-UAZ&!6U-\+PRZ-[=-\2L0=]<R:"]1 V%%
M:N-[Y*K+NBWJ+774[2A<IIJ<[-8%G4APMR!.?+R>&SY*7.S 4!\JEM(2:EDV
M4)#A;WHZAK=JJO=A7-BU"92HR +)4#@M1(>OY.)FUIV%%^C[W-UY@>XW[_D8
M>/6 -4[L#+R7^:4D@Q-"]-@8&S?_)B8 H1:9\Q>EHM)W2LK?L?)W$L,3'('3
MF;7*26)E__U J^U.L7+6_.Q*F933X^3T?8<P2"Z#DT3T& 8=/U?O)(QQ<_?6
MO"L^7^4RJ4D2.R/O& E.XQDJNCE"Q,^Y.XS4Y)VZF;NH4<^*G/)OW/R[G^H/
MCL$S?!RQG ,H__CQY[]_D1SQ.P0:)G"C2JHN0B)H"8W)G!%W&B$\MZO*N#=U
MW;!%#<L>9#BFL?+V1:%(LH(P&0[GN'GV3B/BA.WUF')GL1?[O5ASK!9U4=^0
M)Y.L(W;#J/O!+I X/7<8\&H^S<3 IXF)L5C<\T7^^L(\NV-3/MZ,CY,85.%I
MG)K;)6PUF\=@(^PEEM*DGJ[J-\/"I4ZG'+T11^\[> (8"&?H>45+J[F7C85[
M=Q(S$3OEM_93Y?VIQ:<,NS'#[CY((JQG[I+K<^CN R,]G4[%:0S<N9\0B)#!
M,YEYTWX;:X1!#KVD!1#[2A4;J@;H!2=W+;JI>T2&+ _C)*U"+-UMNMNOLMLO
M$PF>E7MH2+V[Y9XX0'/JHPTV1@MD=1DUG*UX2R0N6/S\\/RHOP]+]/48M8)V
M/GKK P/]13_V1$6$,TST['=\?+>S>/"]<EMH:N\%*[^*ZQ(C__;)BGLIL,-9
M-CJX+Q<;+R8FYOMP?F4(0M-JU,2460\TL"O@!!6=F;-Q,?-^!D!FC9SL7#T9
M2COEV^2';TDF^E3C?(P,NIO!ENI[MW#]>5=^;!TR3X;#ZY%$A)9+=(RDW&$%
MV//[AY2[!10?'#(]=REC]C-')!-'1Y]#CV5>&>"/X\X^33=(K;>BP?ISAFD:
M??"UY'GSF>O2]9MZ=Z4WM=%U1"\]^;X'YM*'//!$^?$DAY-\]'+@PF:<MC/_
M7;A_(FJ5QD/GOAF*T0Y8^&_(??MPW5D>9YGHW4OHS9@O,0Y[]:65SSFJG'LF
M#YXYPUJ:"\9OKP[11"7S7EQ9KJ])I3.+?;QZ.WB*;E7<[-V)Q8DUM%YV4X[<
MB>^J/4M%VGSJ/=PS!\^$(<4*&:'K;'Y3(N[0:SU_O+Z\_+A_XDCQVY!R0>^@
M+YS"O5)$?V2(%BQA65G(ZW,46B!0_9(0+\^IO^7/+@KO];N \0VW&GS-@_#Q
M4(_D$*><+-=NO:DAQ37Y:F<^7:-;Z+U7'LL/9!BV2K)(W JO'=#,$'I-5DN,
M!V<T[_B/V[-L\8I/6?$P,JSK3 RAUN/3O;B@9+;<;)?ER^'MH;-D2(.1BF#[
MKVDS[<IS:SYIE/YH]]AK[IO0+D*C4&)MVNW08?NH#?L?1-L\>SAP FY#'QS^
MJ)"#3RR*#<,<)Q8M T)?,*,!'H>&DJYT.H,6&UPKJ\LUM,CM>(V$>)\O=W;]
M07[3,Z5QFSFTYP6O?D".:(233Y1'RN#,&F.9<YORW,X\TWJ7*=C:QWG6ZD1C
MN0/5!#'PX3Z\51XG,M''T&<V9</$>*W=?._1=OCJPQV7LNGA>K(DGN&C@S#X
M#=EX+TYMA54>^V\DSQI2RK$'DF#EB>BJ/K\Y<^[$42^]<8_V6ZY0O]&^#C^&
M]-EI+E()QZ;TW*'S3BIG[=M,_R7/9+X.5;<N9?;BT=,X3^^R^:/;_B(YCGQ=
M_%2L"=0O%B&(C;[MU8<GQ%L_&US?GC6?7\3BN$,KVJ;_?H?CGJ\XW41YY#P;
MW1&BUV"DG;G@_"?+E9JVU<HU5O#180KM-9EK+]6]>"83?6[+.F(J,9YUCN0R
MG_6!6J6XE/N2[CU39'39QT;GSKTXS'<*I6A/]=O+9REEQ,0XQ51T<5A8B^%V
M-!3BKE_Z[ [Z33;EL7TV*XQ>>%5:BZMVZ(H_V/SMM?)"T/="REO[=[>7ETQ]
MC]QYQ30^ (D,W=TV.%-,4UJBAO5,0U(4N)LH-=NCY4J&>077J8R728A/3IP5
M7@;]8N=<'<?#1MN>?P"'XZ5'//]$>>V9-2Q7,@;6VYD7/QA*MY7<)7EUH47F
MO,-4"#&QXS[\?)+".29Z42T; T,FQO$O&<6W8N[Y^IF74X8]^,0ZA=-KQ$5+
MFS/T7F(%?+$K%M^=RT\N9=T#RK!S.+]&,1T3"Y/N)+[P*"ABY9DTG_G&EV+,
MD'EV+D)3+B(6JN[0O^>TW#-%"IEJCOZ6M%V 6?G:2>NL_"'JDI^W;II&%W-9
M!]BG$>*@_C(EL$#>_WY"7.9[X?;!?FG=\8%>EOY^I][X<%SEL >>*!^9)'!!
MB-Y*E=B$SW;F'U]8Q9O^Y4>OW&N%9K,DB\WM\=X^'&(.)_CHG,=LPGF)<83;
MBIX57ZZK=Y28<N;!>;X"3I/1LTGD!IR[%X_W7+B3.IFV_7BMI$R:9!\WPT;/
MF.<VX\:=N+8OG_K-I<!\7IXUOP0#AG1[,A&@^AN2<8>^K#1@AKF.^72A45^"
MF%N5)OOI*HUG^.6ALN^1PKXQ[*FJ\0C-H-"7_:;B^_"M\PY5RO=O&OW;<: :
M;2JI)>)AI6($0 VWDAX[\T$?\@_]+&]?J UJ!3D.4]A-G&^2W$N>P%DJ.O"3
M7,DZB7$B/]D+2JNQ%]T'Z8!9*^3UYR/$^;.K:+@7=ZK#W+TI.:?=O>:_ ;DB
MV+!\"'+MQ-]0N3OK3CUGLF_B-Z!0A*92N1 4VJ$K 4ZO/&R<%7-\YQO0:8'=
M\X4[_:+!/)$[_0:,<+1 \CK]YAO]\THAFWMJC6U!M-4D=_H-RZ811A90:U)J
M9T8[V:!;U:O/0NXQ$X)0218RBPWW$">?)'.>9/#,&@-,,VNR6F*,_/=\^5')
M2+21I0^<%4,*$B&"Y;BF(-F+^9]KR,_FH- G/EK?A) 1#$QR;4+NQ#%X./^X
M?V95DI/D Z?=-O3!/K!\%!]9%0AK\]@.71OM_NI)I.WKQAMYX)P65DHLL!N_
M8JKAQY___D5RQ.\0-2X!?BNY\VM$+<"PB1M5^7S1492R>7N=#TRG-FQ1P_Q=
M!]BV89BR8IX 2OR+-31 5(SLV9AE:*K\&_/^Z%9ESOE[0MB[L7+T5V2Z):HP
MD $7BIK7#+H19C1*/.R[,W]/_KC2JG3C_:4@;YE[DRRQ=\C2^_ @*9K""7(>
M F\U2PMQL71B_$HA]\X^/XMG(D>F++\+ED]B(2.PFEAFWH#'U3>"B.E&["<5
M9][;U\^? _DI9?Y=,/^^"R1) N>$>5#5U7P>ERV^LYI)\[SX+#N5ZSR3LO:.
M6'O7P0]Z/5;.QL?*.XR(%,E6MF>^73Q;=,K0.V+H_8P?$G!F;H:GL3(P-)=R
MX9/A2<E[ RHCSG8WJ$*?'EPKU+985VQ,M"S%MC#1QIJB:F(?HN8H8>X]/W'O
MR[JL=-WK"L\WBQ9-7#SIVJGG1:O&EVO4U*T/=2S3 N'PHTG1R9:H<!()G&^&
M62^>1,7&OSL+*-VR104X><WS;"9EWWC9=R_%![R 4_QZH2,N-NY-3.Q(S;'E
MIM&N&74IY>YXN3N)42*&!][S>LR?B8OY]Q(FNF7+G5JN8@M7K93/8^7SO0>$
M! +/,// ;CLTIW<5$J*NE>?*QU5&?TJY.'8NWG'LA\99;AZH*6I6=C.VW6'X
MYT)5R:[*MQO70LJ]L7/O?@(]'(_3U'J1GD,O 9HF^6_,>XV_B )1)(@??\X,
M0^ZKFA<$ I<':,06!AA!'%,U1-/8P/WT5TQ<D$<IYBI$\\'ZJ+8#[>T43>VJ
MNF@.L):W\06G<&AW>\7%#D6F1 5U,AF<XZ(WPN$WX<Z=A7"4 JN\99[M9OYM
MJ\R9Y*S#-CEV'W$<!F>HZ!V+J4WX-3%!FZ;5D"]N"YK=:Z;\O 5^3F+DAF=P
M,A.]YSR] </O)5!S4_YX;ET81.>SD?)V_+R][VA-A@1V1G3LWR9VQJYB,V7U
MO5Q[H$K=2S;EW.UP[JZK<W!^;IXS2FU.9%[=84#FZ;'5[K<5JU>04X[=#L?N
MI_L;2> ,OYQSOW#/B?\U_E0<4VJ+EN)N'% '7!;%1%$VS#;!=YN*:2IR]!Q!
M@/(RH'Q)5,T'&)R\;:)(9C[XI/KX0?L)R60U_CE7+^8#$P>\<UE\)(<6B5D=
M95V39(D*SU#@1@,S)H9LP<8,O+.H3:]Y(2@MIG&ILMO@WR0KI9TS]5XJ<00:
MSZS)TV2\/)V8R,[PK7/'?=[>&I="RO-;YODD1GE@;26?60\3D(_U3NPE^'/]
M4&L(+X_5SXJ4LO]VV7_?@2"*HW!F3>E/Q,WI.XD/]0K&K9[K:(W;3LK<VV?N
M'<>*.,#-\T8W[-K!W&T$B6?+Y[QYU[Y7F)2GM\_3>XDFT1D>YXG5T/(-T%PA
M"G^2$ES*BU;;'RB@RM'2;_"[>PX*O9GG'^I]G[RCQG!YN"WT-DGK5[KB?DT=
M9Z("-B3)X-S<2Q/%M%G(,#L+PGS>%8;,1[;?U:7OPB_[:8E*X@07/;V?#\<N
MB8EOO+U5:*W8?KA3OPT[)3+,0+(X34>?-%8*Q6Y["1T4[J3S8:]?+%?$;\)9
M^_?@"9RGHX]EH<(RT4Z\\I)9S)3:_6;/^4Y\LW/GF,Y$+Z1@PS+*#AW>QY91
MKM_<7CU=M[X1N^RGBH$7<(&,7L7P13J(>(-9O 8B.O@_RQ8U#3%S"+?3YVUW
MF;)>#GP] 7B1>L41:./^DCT;^Z'>&T^_[$'<*M1W.\19)\I)%5B<$:)WWRZL
MR5V[JQRH4S9Q5\U<2YF4N?;DT;(4SC'1 1KDFKR5& ^W=F:_$$6K1]G*H?%>
MN#;O%!=A&$1F/7+NQ8,LU\3'9O5-ZY0.CG+;D!K[=B])G.6B1RBXM1EN)]XF
M<U_*EK+OMMKII#RVGZX+&\V1C<A3.W1,J^VSBZ?'DE#-JREG[=5KY7%>6(YP
M^AZ9THJHRB/O-0O(B>5,<:AJ__V+I\C,;PNSVJ*Y>A9D/GC[5+FLPZ7<E:P:
M6F$?_NN+_):K,8K!E*C =5/EZ7<5>X8U>M6D7;R0!E\FPABW7"AJ]7J$NFNG
M\*5*";7/QS;;U;X^Q2*8Z$*$^Y48+ZM0>LF>]3MUA58/EYC+]-Y<0AQ4BC&#
ML_2\KFP1[/?EW+B?-&.%5[GK8H4YIP^7\<)*D0AS@*/1;3?C$_1G)]<9ENHW
MTI<G%4^$)Q4?3D6KZC[<F+LKZ[[Q8I8+M:]/LP5FU1?.::&BV3]97=0&EFJY
MVS2:F 03J$W-Z%M3"/-_@?Y84D.]1[(OG_^8;BS=V#?;V'?H\/CC#RJ7<$U9
MO[6 95O83U67-&!^(#T5D&9-T^AB1@_5^.LM#'[Q TUS^;4V*,14--%6Y#Q\
M;LDP QL:MZBH*3V@56U%&Y3 !@)?OFVZ/4:SN@Q^<+H]]Y>!,3-E/>< 0UBQ
MK+S1;:@Z B>,HBO ^]MQG"5C/;,YYNZJV0STIQ^_\]KGOW#NLHM%20S*)#S$
M9!^,,>F0PC5'U0S$/HOO<9J/GGI>B"K<RY7KJ3H]"I'1WKW;6;#LH_+<;51J
M;.>)6\,.3^_4%NX4>T+0VRWG();=*&YNK_(HE;[[OE%>"),4O,N4F&"FTO@D
M+]K#XG.;377<P=S'S DI)#?\RJTHG%V0NTG:=25)@G*OZUZBO6?5I]IG7NMH
M3B:]F8=R,V'JG]J\A(F$O$>R/$G%TDF2F#N<.PH (GD7<C<C;QXOGHJ%*],D
M.ND=/,P[N.,2+W!IUZEI3^!5XT=7;8<IF$H]<_?6O;]Z[@GIA3ND"\?OM_(M
M0RU/]W_ACK.334%P-,+*SVNA=)8)[DE?M=N8W58PR[^E@^6W2$57>^H68=&L
M>+@SP&'POXI@'Q^ =).28G!K^ERFN+658*^W9D&U>@9@7R!\Z#V&?UG]\R/_
MV3UOLIE9N.56SWGM'D6')<WBX(^D1H$)"N?)Z"5(L_CTF"X02S [CN/V=%JG
MTXMS:!>'/2&8/?:BH3,XO\9LI>RV[DT"0[9/]S=O3/.<*UU2Z?4ZM.N5[,@M
M[!Q&K7']9EM!Q7/]]AR"?;A4GIU;_KE*,NE-.[";ELA(+,OA'!']>G&[N%X[
M":B2].#^6?W4]-Y;>J,.^D;MOHO3&EG%;;E3^PJ/.B^76B;SZ53OYW103:]/
MXJ_/GJ.DL*L5OT97J]W6TF9.R5V  6X4>Q8$,(4!P,+T4 ^T) )KWC8A\Y3
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ML+TFG*X.#A.>OTLDU<U>H9]1Y57+ &Z1#DD N$1T[#9@[J$WE=X A&PJ)F#
M$TGL]AP+!Z(%T+MEBK(#V $0M@4NA848<?3+GFF G[M@'X"<71C\ O<<?:2M
MB)K=QJ$]W@>>(/QO W"#"1C),2T%+*^ZK%ZSX4*0BU0#/ 0RA:*:ALM^P7L
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M51,#MJRC^#$ </+ UC8525$_H#BTQF$;Y$0"4@"36!)-<X#0%TA"G$[$>;P
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M$-P),2IOB[K7/<)AT5691<,6PZ)A21*HAE?O)WKK-.U<E8;VL%:M9,,A9DE
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MQTJ][.?P6N_L\T9.Y2=+KT.NKG58^^'2J8\]0UFUP-8'T#33%>#\JY:*:LK
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MJ36EV]C=&U5FGH:1VE1K)55D:_K$-H=H[NMV=,7L6E)E#C.;3:/4+)@VMR-
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M8D$P 880SILH'0F""$^46@F"?5,:W%"K"6(O%9MN8C-0FB YA,3=O9X0+-8
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M<G$S?D RL]T&$C#6QS(,YD./65?'ICJR-SW C70^4Y9AW)+\;;5!;HV<WRR
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M#BPA$ C;[ DWK@2%!YX:0OOA*.RX$L*@:5AI3W0%8?[0*$)X\..68:5_=!Z
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MUQ@])G1_9LJ]#'R[Y3'"EPA(!1S#2LP"8#(@Y@%%PI\:S_KO?U@<8WYK!N4
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M2P!@U0$9C!P_:)Z!Y8ZDL/U*>,OT):(&U@SPC32 &$;L+=G7B!*PZ<:P=W4
M"GX""U"G<7-^!BY08,D%P+$-5B@*[;LEQ#(DX'*"KQN.G==4@:<*20-2QYSG
M709:1X> GT<^5 .H0QLM7@2KM=LBR@U ]:H)%.#$<5=DOBXKX"Z@"I#:HJJQ
ME22@) [%, R1;9T&O@' !%\!8?@W_)JF[&^!CK$7*O!&"]%4SU7]1H 4.#^;
MW"1#33>PQ3!$?E]#I"\+$!<D/5YQM*ZS"((=O<6YFE=5<!W0<PU=ZR S_$5@
M$"BS'P$#'.[74>:0%.H#>X'I3!X!9/1#PWD#[1?;S4&K,. ]/J9Y1B ;LD;O
M6H7M3H<1'\-/CI9TND9)6>F .HQ9HL.*0/C;(A:C1]YL51)TR80Z [*HU(3U
M?ZX8K5I /O< [SL"\1:L -PZCL:[INT#$'N&Z3QA\N5?__V#I'X_9-/VOW^/
M58TKPR>R'^HYP.^V!@%BPQ!:F@;^D7C3UBPW/!#=+4L%@AAJR7Y+!A(?*)YI
M18H494%3> M)\WJ/5UH:D@4BH@?$_*QB5B<*^?S,EMO32AP(3L,"XA6*'N<U
MMJZ!@M<QPJ<OAGNPJ1E^(8)W*5K7_C!?*R?3DU4C\(5J0Y84T0X, B'F;O7\
M;+37D<X49-,&XM2.)VH4*&V^4[<$S5,O(MNI18"*0/4BLK%:A%&:1;T(%)D&
M[9,Y509-'QAC<509>)>#)1H827W;WUK47M/[$Q3-@+Z?[6)!@( ;[?=/=):C
MDD:JR]%=Z%CC(#]3.*/P;]'J %X7KH$"<B4'EP36;PL?B-7/9XZB9&]A7P>D
M;L=W#N.IA2HL7'"(S)BG,F"A3I'9R!GWL+MLFM5M3M UJ]GR]/A']I3BO@N*
MG[&="^E',Z% =*U@8!:K#I4X$FZI7.0( G,D(_@)![)Q9/\)=BP3!B+'RVOQ
M/0D:?])W5QZ)RS'U3H<_6S".* %1UY'5*?XVI+&I:#_)BQU[=@@A!#@-$7GE
M *8G$1> 3@EH?" YQL$EQ_#VIL$9T/JD- 2H,C<HY.B:],U3C)?YI=2\(OY
MA-NND".Y)W$RB#2H!A9"^",' ^+0=C7GM@8V!R2U]&W+CNM__^?R$LE!]?T+
M^+)-X/Y4@:J M?:_$((DD,M+-V$KRKW5N=-)3]E%$_SB>@+1U?8Z-L%(]WHS
MWV'>RE]FX JVU33G%>0NIT'A N$W4AMT)8@WX(4*OQ%8^NT JJA!V-#<]%W_
MN+?!K]Q=N)E/5UG^^P^ I =0N^"AEW5=XMN7=0F@'KR'5_K\P)CU<&Q_QA/
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M_3OT1MS?9Y:;\+G:2U/K@A6/?W4U%P-5D(M7#(,PGR@&SS#UM+[Z!(:"W!A
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MN@X^40:(\R2 5( NB1=:$%%7(85 X.CY$3)JEFP[J0U),FSY<^VB039L!'3
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MEKZ[DBK*IJ7/&>NV4K&)4)YD,.&O=6"N\Z($@SWRN( #AA@D\+TNV:E6)Z(
MC'*MZ]P'E<)8@\F=KJ[U'.)%)*,+D[(*L-\UVXPX/W/U"E G/5D G !##T=J
M) 0<7\C(A@#MK?,SZ%X9=FSA$BAJYU/;YX)(@LP--;8M7YQ(PDAGVX@T#-M"
M&#E>NFRT@1T-T=20!5<L 9P 4H J'CP2H/P*J8%/P8,O3?Y[_$9G'= BL4UV
M<*\ Q^8V%*T/KM4^)<&QTH&O,!O93&"SW8<RDQ%.I8:[RPK<3M)Y=DV#">8<
M>'!Y\EQ8)="5Y0^Q^V&5 8E/E0P,:Z*B\7PQ^4**XYF^F6E K5WU^IJ][5:]
M*BWN,\V=+^;&>>Y+8BK1#:%P<8T35_C2LY)_0ID/WXC\-8^3U*YPXASR'0JU
M$DV]]^C;E\\HX 0+%"?D%;86)]C?)Q/: W]AZ@C'KA+C9(R[TDOGTQ^%QZ=J
M=,[/@ @#6#*!:0N4$P ]E'U=S3!LW2:T@)8#<A.@H"T-IJ/I(8Z$;\"Z]](@
M.=E327V!+OQDH-XM;Z1X8 IZ\;(M3S'P]^/#NQA+L?5)J3%?ZPGKK$8%S4XA
ME$>A^KBF^^ZEB-4:R7HG,9$*DPU 7,WA!9H2HT#$Q.%M\092AQM9(SE&":@9
MAL_I6L<6PAC\WU25TGC9'[.KOE@M=[8'^<5U4CT_DU4!F-].<H:@X;: !NUJ
M,K2H )E.=FV;<^QO:&<Y%"[.6@/3 M6V!CS5,WB+FUJP/7IX)0RVP3P&C,YE
M),'>-4+BJ*TZ4 1<Q4/AMW29 $63-653^5HFB?0U2Q$!HGH2HFI@@9)A*:;C
MA!@3=AWQJ#$R& U@,GKY15<+&<6Y<E-OAO6;KSZ$_*QK #R;^$SV7P*_(A=%
MJ/OIQ,>%?[;?0 DZ@) RYWP"/UOB=K(CDJ%S"?Q']K2+E?69@;T49>3G@8N>
MG]F.-TP,JDAS)()L=TL!KI,*0W5VJ%8>U]7#,!T02.![X-:A=C+13O>*P-_J
M\E FP(P78%^;XWGARY(-)T\&GPHOY^WBV2$4)98./0!XY?G9^+D-R7$&IE_D
MA 4ELZ4Y8831,WA7@#N[F!"/8;])EWJRU <OXDUG.1,^M[,#$EP1_$^$!1+@
M.B"TH*/B)(0 <.0&%'"ZU@5@-:6UMM,!*VO\ZAY3FW8&@$[ANS RIEO2Q72U
M;=7J@*4.2HVL*V/=\Q0]+W5<@]&9&GAC2M&$]L5,\44B-:G$_M%C/X:9UJ!Z
M]\D^M ;\Q2% #ZERHG0<^CP_<P@4$.%B/,,F=QCM5H!*-'Z%@GYF+3LNE?@8
M%CMRJOA.J%ER,F 'J/FNP@_@ 1%5^HWT !?7944VP2?.>8R+ZZK0DD1+L=7S
M/%@<MAUM>%TQV'0<=S[.NQB7K,D= .^BU$<J&K!44.<#L$D'1%,1W=_(**(/
M1+K"=PU@G[L_7<S7"'N6@FUUW'.T #;QYT*9-'U%+99)VQ\&4A,-G86+Z[3-
M;%"9PH79(35HA;7DKC$N%+$3-+*Z9(CP[$8(_$ ;F?=!9L?Q3 YX/0 ;$?C
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MG^K;]-=Q#_KNRC!D$]]RAZEU![#+0\"&(8ZO3J,2G.LO/Q7SN7RYHPG>YF%
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MW1ODDM8@7[SCUB-B_GF!(P!H_[*+!.P*H !;J@QL76 #:)06&=,Y>"_R5%T
MS>S4[S18N"[7[18]1DTK T8J2F9& JZ7)*8D%?Q@%F2^+BNP:X-A2.;$D]]+
M3&:8KC]T+*K;'"CT>LQLOIWP1F/6<1]@?\L 0@PPAO1ER8 AH,T'3/RU<=\M
MD.ZR"N4T<'&8)F4\-?.Y"B4HB7VA9L16U,8,MKK%&HYR*UA,<SPAJ#CLN(((
M))@3;W!$V/F97QD&C34>$13>L,4FQ)LY@-%2)YIJMGAHN:IM WRFRIKNQ#F
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M@!<MHY_S,^^WHE.L9RP =X:6QX!>@"WX!V"FQ?<<KK&M52@.7.R-T09689E
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MIL<HGAQ[6M$A*O!MU[3NW)[+J=[W;;:L,9S/+9/8)GMF8:'YW*9A2L!P#^-
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M^W6L?/LHYV"O@+\Z/D7"#XIH@Q )]F;&6??,I_I:*V'$>RL6!CZ%P10 @RB
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MBRU>1GJ:*H@B'(V.-"2]WM=TL>NC+)1UR\K9W4O- KQM>7;7:]=-#R4HW\&
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M")+=?F*T-%H^=YSATJWX7"0A!09-I>C@E"X)GAZ3Q%L?0/T2!?Q5+C;E41)
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MFDC$0TC$-2'>[,?DK3J\FY#WG40BQMX[^(,$8I2!7V\YN,>TO20B$A-BZ+(
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MG(PU]J-%4J-!J>YA61X>B'-2B,W0GY/Z\T!];Y:^6R-^.N*&I/=D?@S],@H
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M65:'T$UFR0)@<L(,.]U4FTWP:LO 0MJ2J/&:T!X[)DM6[8(AC/_G/RR!,[^
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M5P.0Y'''^S@;;L&AYH,!Q;(XTG_Q#[8Q[<!=(QF;%_05+ ^A"/+ (]^A(O'
M(X_5=MBA6.C "NCT2HN2M)EDK/%)1SK!],,PZHPR 5/8,<L?<O=23C>SE7+V
M>6HYFE>X!C(_COB;DB'7,6#AG1*#IHC@9PAC6RUL#(J1KAOCCO[V(+<PX0A
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MLKX+EN+NNI\.6'-6,;N/3[!.V>P#-0#E2+*@ =J&!&PSQ'>RF_/A+[,*!"0
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M;;-O20)89A^<3_,7*@)!<MR!T/U0GJ#7I<IMF$T"6@O*.7H>,LP-I2?][W]
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MLH' EA/ #(*IC5^:@_&#)BN5<>/'JF+\:9\(#4J8ZN!NN"'HYA;((HF?^UL
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MUTAZ)32*S#ZG*G@A^ 4RU$FLX.RK9R#GP;*H^L $V@;9=DL!*A)4,)("S/E
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MO?"?PL;8U;G!<(%3T6/"@#+&ZLU^-N[[_4:E4LTVINK*"^DPS3F,Z+B$NU0
MD( 8!+BPX[-+]>I<Z=3'PKZS/(77_XESWL=_;5^*7]0]]6GL/]>3\E\%8-!$
M=O>ONJCU1'!<)?NM$MV[JC+;C8'W \MVAV_R%]R@L%";GJ[X,IC26+VBC\_J
ML'AWKO=SC*=7M+B3](GZNA"?J2L/F(I%!/3:A+RDKR_US'BFWHKWV[VA#UG%
MQ0GAJ[C.-D-<'T?D5L^+^4R^\-QI'\*12LH9X0F<Y**[GWRRO%\AG9:M\M>5
MQF.#NB1W0!,')=/BD9M4YM1")V=7%ZIQMD,S9I$7\\_;K9O=$SCMW8</WED$
MILW *F'UD;6*)&"5=A(K:2\ D'8>U6AOH8J2QQ\B@BY&TE< =WQ?$H5C._[*
MW2E,\^WL#EF5MD[O.3'Q?HE54UAJE]3+GXK\.90.NEM]84Q*DA=^!$'A#!=E
M2JIOUW?R(A.0WKJY+18JI&F4[^H'*!E)W@O"T>ZD9\ISN80(FY80GQS=Q4V.
M'!0:RKC$'Z!T))6R$VF<9+V"]H1P=:*)1/34'1*\])N>)*%T%F5HF^D[$N?(
MQ<O&4"5Q*]DF+P';$:'8I$QL=#Q[:EJJ?&%R0B'D$)&0!J(;/ONW=ZWLP%0T
M\/@[37X )'<LH$Y2PME[5;QZK>\(7$YT_ )? QA,G#@LH<CC!!NVE&9S4A'@
M,!-GC=+% _W6H-)Z;1D/[[?C&N]$!57J%C0]&-Q:!V/\T1$OJ:]6KBBGM<QE
M/>&.9R(VP>"4I_^^:\FO4 @L3)B>^!C26,_RV<=36SDGWNOIP458NZ=^@TDI
M%F<(;E=U:D0,AM@R')<F6R9[QE.92#4(WNIRMO$D1I2:XQGN;C9-L775LC[D
MRHXD'986(48_[F/UOC/,DU<7]&L*:X3686$<)Y/#13J.6O,CWLIQ%<=5[.RU
M]F;Q5F*( +X(KM1X4\>J3.U$0WU<7=<[<W$M)"P1 6DWDWA@QWGR*?.^+[ ;
M*<N\A;I[3)3[?A"9/>$M=Z=*W=Z^H"RD)U:+A^D;OE].L46(#6)E1T*[Y?)S
MMI;2&%/OQ:?>?78X[N\+S-;Q5GAY$W%X&!4B6@M[#$[JS=OC^5F??AV_\&O"
MJ,R-QJ1.63;6,9B)=LIOT&==]9*83%HV MS58;Y9[:O4W8>PW1D;&V!X>BZ*
M_5"^$V"]CZ_:&DKO)$5Q;'>[4<H&V)Z4KTHQ.+T/UUAKBN XU^P^*#)QPQ(I
MG)$2CRC%<QM/"3B[9!# ;N3L?)O=K66$<8<RJS1@Q^ 4#8K]>K;?*3^*!XBB
M<KSBCZH;5\()B,U(7QGFG9QY>NB\- ]!"I,RU)R "TQ885Q)16TXKY1:?14W
MULB.))="WTZMKD/&9_5J\>*L\29J*9R_%!^#XX&YY.A@G*$CTL@1:22U>!='
MI)$CTL@1:60>:01:WB/2R.&^[X@TLCM((YFU0 %(T?%]27'5-$^3;N4O<LWG
M8I,YY,Y>4G3\:_!3PAD?CJ5QGB-6JMW8N, $7(A]/%X7Q;>.P'QN=T;F=N0B
MR3LRCL$%?C4!60]F9 4!\<G(4=>FJ=[>-T?*=GMJMR,<227H:!87A-4$H[ I
MP5@!)_CR@\U?/,AW#4U(OQ%*$'/$0Z"V"QGL)6RA:L2(>*5M_"46[E\EYFUT
M4T^_A&Q20.)( [($SM'+M4J:"\TBP(_D9D73N_D\7B?[CGPFU5YU+.:E'4$<
M<0FK-X&V[D0S BZRT<N("HES/\!C?J-5OJ1V/IZ+V\5>VP3+$_6/"9S<W6E-
MJ5N0YPW<<JR112NMM)\;2C_'J)=IO7J+@C62C+$EQ*5-]KN1_ J%-"*$: 6/
MP\+>T\.'QDM1;9"=], !K-M*ODE[RN "L>[$P]C8&V!"F5OA_JQPVWE^VV[2
M*3'6)FDW&9SCHQ?=)\1DG\31!ZF],XV;_)F1ZGKKU1F\\=S0^F =R69_GC^Z
MY;>'L\_*AY(>W;TVE,NNY'*6@L]%EXYQ/9=A>I6'U[&9PJ+@=5@8APXF<<9C
M$%<J$RWIA>PXKN*XBMVN&U@7RH6.TH4=1XCU4:K<?YQ_4:_5SDXT[L?4W;TK
ME0%LPO(0$)-=,1Q-Y;BSIR]EWWF>TEM_(F'F^\W[-=2S\ZQ2[<E[S_@4WN@S
M"3%]A1"NTAYT/Z\>B')=V0G;$!>HRZX$>3$CPRU&?-S]H_I:/AO6;_96$QQO
MVE>&=.$C-<['X:S>W#V=75U+KQ]9)5Y(EQ/JE-D92)==N)#/)BT; 8[KTVV^
M6RDHQ?XCG>8\51P,WXKCNA.WWZE;4&QG8WQSR<C"Q?N+.4QUO<DZ\AV'52:!
MWT0%:Z[=R"O% #<BK-"#'<L%OB3VGF[OY?I-9P?:]^-M[D[K/7^*-2._&3'U
MFS!R19#/8Z.8:;T=@A2F[,8ZERSO5TA_%(O5YS>^>5LZ:^V \HH9>V17<B!+
M+[K7%ZKQBRPWJR6S*N>V.WH[80;'<?:YI8;("WO$_GQQT 4[;_SYMS=AH9!A
M:N/GB\SG-<&7+@93C,X4HY0$[(;,U,;$]7GQK?%P_M15=V W8#__<W*"%119
M;?["2E);_HU5Y(^!K#6 7%(LB9V<.$>OJ0Q]L!.R\]@)UCXF?^>0?$\@:.R_
M B\:[73NP\1TJ;T_+DP8-P;,/$;,+!(+1'H![P."Z'*(%B$<9I!A?OPIG+A)
MX1#A-P8[EB!MI;K2^(T5P:FT"%74(6UXWOVM?YROP3\YNW!.A7,B_OT'4-*#
MJ#WPT).Z(4OO)W49G%7P'DG]E$;FA$2(8AS,9'D2>'.T6H 3HJ.(MOOQJMP"
MV[$E_#\Y@B68/$H)9X#BPVZ (>K+-E1,;_&UU#JO_?&GJ/=E$T1S&-"J4(<B
MZ97 "[$6L']: SP8O!#\ GD:2:S@[*MGR*8)W@A]C(X^,"6MB?KCLH8T5E0%
M''4@$8J) U6L@D]B.K0 GXHI6RMKHE4MRM@:>$\SY\\MJVY!AR? T@U>K_J'
M)/B_PKX/_$?HQ5=08JOI&2WM!<Y%6@:RKZ.?;1,I ]/7@R? @-5E\SF/O&(V
M5-T<&/)=RVY",+.CHM0'OP'_5B7@-.G&Z,>,42!FR^E#/J,V;MQ6^F:Y)#68
MEH<A20&%(ZF;T&(X@]:UQ%*X%0?\/Z3( I,V<-GSP%W$*:MH/^Q#Y/O7%4F'
MT'T6KHK@?U=_H/75B8!1;&W<X5JR.*HV!I4V4BI(K*QC&_;_@.(!Y#3[)E8?
M <F'\CA9L\=-U]2_B_6P(7^W,N@"5H\6#T@5OK(*GIU5]<;[[#D37>F%D ^H
MC5]5K2X]9J\S7>%':/=DCOY9L38>L]>7!>.#+%]/YR V%1,<9\!00!K@1PP5
M4ZD#C=X'O^DHS:8,I*K2Z,C- 3A%0.'+]E(]R)\J?#Q? #P68IC-W;S1IVB6
M@O-;:/3L7R93QN@PA1$IB"Y)3G F22O6RU2*9;JJO+.OTTZ49<ZL7RSH!@@+
MO6V/$/(WIBJ:?-*1K>^2)/M7S.AB%+F\FH 1,S4O9$Z!U]J5=U&YOWN/C6)L
M^BFVH+.]*):K>>43'H:C8JGXW#LGWPZ(8E$1[+:L**(5$!Q7E_;5S=SU34XH
M,5O$D@/NS5VK(H% JC;^+)-D]NIJI!C3ZJ>5;@<CG,L$#R'<F[4T%[A*LOS;
MM)Y9VM[EXJ\G'K.G%QI?%IMC*9PF0N>Q#Y8-\<!B^S"! 0>58YDC$X*9$-/]
M@-]]#B'@ KMX4_!W")4]BY9X+FNR(:D9K9EI=A5-,?N&U%>&L@/ZHA1K3:4V
M+FF%M]<WALAVZP'*W*_X,AT:W-ZJM3H8C4LS.YX$B%%0C4,[FKLKZ$LD)%%#
M,*?_*0KGR,5>_6#5<^18&(XE,4J!(2B@I8[\2H!?B5P_4[2(D]02_\K'JLQ"
MB-DK=[*"M7'9H%M#JOM5&N]%, ![5?6^I$8%P;>%&:X/:^J#NBKOH#R'@?N<
M$X!M1 LD3O$,+GK;BR/;5F9;HM&%0/,X2T2:P7UDV3*6)1N+L R/B[QG+!)G
M ]>>Y.22%:&M[>&@%^R?&YW@1DHC0U?5VMCHD&_C<K[Z6>$WY ?%IXWL3>SR
M^8A6]VMO>"NI3A[80>Y0LVQ+J9]LAI/A<,;;H!UIGW1BDP(:SP,)]F^;WJ$"
M44?K7NAF#_9H@,#Z5FY"YF3:AFP5&];&.3+;N:^_?95'C213FO$QS-G.-('9
MM7:%29-M'8Z(!C%W&QH;!"X,$WJ^ZY$C26MQP ]16(04//+#EQ_):G82&%7*
MXWR$5NRSI09YN6> !: F*N>N:DQ>/A0K#T)Q5'[?.>_:O2'7%557!Q(YMF>A
M'H#DNHK!%SF\E30B"Z1D65+\R([-*'62$'">.=2P*#(SDM7H/.TYM"&\1G?!
M*MS(DNG<=P'?O%@X'UY^\</JRX[XYFC]UD)"E1'LBT@B1V.&>5O1T210T0?M
M>R]G0:)ZF<+9R/?\AT7_9%4Q@S/B$JOHHX.I&:_ZH0\;:)3IS*_Q-5#$UY6'
MUY<LMW,N]60W!R&'4^]@GHM;4<D$SC&'FD.-R(I$53.+"Z*'DW;DPX95-(=S
ME$<Z*K2S/#NALRSW),6 DU%O)05L!';33VIVQY?&.W/W:#QR=T&WC"ERGUV;
M.##!#&+D-O0VP^,D0QZ\OHC,EF3=:P+G&>[(E(A,25:A"SC'KJ/025<[?4<R
M9#,+0@@(^ GW@S([M;%1;)'W-">6J^K.>=]H4R=UN"EK.0W7U@Y"<BVL!6_>
M;D6WTSC-+T*Z'H8:B<R,9&\G82?+H5XJ1&5%PA>3 DZ2JR5/7*";5>EKFKXN
M#Z[/*^8K399WP_T&BS_4W+6+;]M0R3PNB@>MD9?1/^'<"$T=JEL=AOK)*EY@
M L4EU/?1N[/C>1T(YDGZ(\?G;XGF*%=2=B]G79*;4EMO0PFSEG.@4!-S3-U2
M*D00CJF0,)Q(-OO!X 1]J$8R$A^2SF!3_)+CX*.OF5E]#3$S4!+'> >$T=K3
MO/4Y\)DKE^]ZG]D-QQEMQ56/[>SHT$33AZ-;J<,6<98X5*=N198D6[,GX#1W
M-*-1&))PPH/"16XUQSLS37AD5%7_A GX@F[D]4&]#W:9:330 (O:6+_HD6<-
MMM*J[)X+/MF9M1A >-1!#C>(2?8.#T)X48@8Q.=M>>7D0=?Z1>9(TIELXF"C
MI)7XD;!V9W&"60W#9Q9(OVI(0UF=^.9Z4RM<5S\&W9<@C9XBW]Q:_P'FM:<^
MQPP+MY/>9IEC\=ER-B3;SXZS[*%>-49@0L+-,CBQ##351RN+4Y\[IVOF0(7!
M0T&&]XS/@XON^$*LOS+DSGG9T[W8;K9\(.H9^0RSG-Q*GD0 ?O1!]T>'X$&R
MGC-$J#O43%5(#B3L*],XP:WF*[-3K8QF1M;&#^-LC^";[_?&;OC':-E')%9'
M%A$YMM,I0^-\Y.[%(V^25] <APM\5,_YR)@-H$2).,DN.3'+JZ[GD#/O-+FF
M5&OCZY>">4=\*N3&G.HC5/'F 521^"Y*P!&H>%^8=H0IWBV&I0ZD.-Q\]6QM
M?&]^*=)Y/O,TG,Y&@21*YT3RP/GJ/ ACGMJ/Y0=68;[(7=A-TF.("VA0M7RI
M-?2NTVOF/XJ8]1U%O.0YM?%=YK/W5:8*[2SM0?=(XXB/@XBW-(AX80QH_(.(
M^S2M73^<OP[5]H\_ME!%FT-LR##GLK71P_9$WLF)**/E!(P:]OY";5SN:\QY
MMO^F9MA4*JI9WF6IVOBQ_GE_GB\1UQUQLN*(0XQ;%@WFF>AW7LTMSC$.SEAZ
MQ$O.F&-N<18K>\HL^CKHETF/.<YZCCE^9,\&(TK.LDKGQ]SRO4;)^B\_1F3Z
MM683$YZSB4<CJ7)UUVEQH]:/L/F-N,A@_TK1P!E '^/B3'Y&&$)<\!Q"+"F/
MG\_7U:OQC1B9-$RZ)"1XLG#D8[SEHSO+"^10+#!B&\0/M>KCPE8;M3$[?>Q2
M&\IF'^(<6^YV;?RB:2WV];/]UI9^! NTES\0/=<7O] OGEUK;_;E.7#%;-\
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M\: ",^X;9\VR.W</#FRRVH2G<89;A*!8>G.QLW1,HG2$IEF<8!>+RO:6BLE
MX0L<+GI 3H4I! E_/YZH4LHYKO'$(;8UD[N%!.4=3["_UBHJVK#DS/C!XMSL
M@0R(#L C@&L*Q*4,=E?K*4JMV:L-2@-#KC6\G#/QZR,S:+]6+XK .>LK?;C
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M<&,>L< !KD<%X-M'XL;O_3(D3I-+<CF'0-HD7%T1IYG5AM%D%RXE+%^^96<
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ME=",:4&* TPE3/R:;#>XD_*=_FBX:9!/5U@MU@R'Q#_DAVDE98D%DC(@JX!
M(/E30W2 /W7<2VD=_,Y:</PYIN;4!RWT&%N]F7!ZB4/PCFTH%<W,\"DA =MK
M5ISEQL)NTV?YU<,H+GBUJX!99(/L.:!]18AQ#-_ <W2ZJBGO@HFY"=G[&8)K
MR=+':>3:) SZ%+,/N(\7&,RQF9U$JTSSE7PBJC7\>HGC(%2;/]BMW7QW6-WU
MVG?Q!HH;E#\M6AF.YAE.&<4T.%U@ (@P1S*S.57<(KZ!VTVU!/4\96S JO!+
MV,J"!!);_.O_>OK@_I/GC[?8(N>S?,?V&85UI\4YT_0F)KFW[8MD4-A_Z"E6
MZ=S!1;O@D7?@/RZ_"E?<@]&5FOFEDF*I0/KC,F_SZNI<4A=W&=DS\U_D%@ ^
MA]]>"?'I?^2G95.>[+,IG6S*DWTV99]-N7/9%*F+N<.)E(/4TM"BN.,*7GF?
M%S^8,B%\M5@0'>TON6P(KY +T.RV%VTL(W(_F'  0J@'36&<0+O?V]HG@MVA
M6.:/JNB@,Q)\"_[6N_NFRKGOH@,UX?R]HVYE/=*^FZ,"-+55>!V6A$DYV3PZ
M+RB=7^D9>) &,F@(M.0E#H)-@_/&7YAI@.%-UY8-V((/B%6P+AA=J#.:'&+C
M_)-X&,VP^T J!KY0I; ]5(D,GNJ,PSK)VCI%G0'%#$"$Q_&]#/NG$E@$PN9G
MJ>=6;;C#5!",G=F22"*%G ACF>D-4X_[P)62MUX9)IUC"/V#L.;LF<XI+[;4
M&E=I>^T\OTSECMEW#J.+>S_-SXO,!IZY5D0*1"0*1!;;6:EY1\(NH<]AHQR
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M"/\3TQA[B^WRU:YJ?0X'X4>ZTQW3?&*$23 WCMZF<#!5$[U4Y;G*%D5DWNY
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M;?FBV2 MV\ZL=>ZV 74RX$P$;QCTN%P3XUX3;SQJVWATE\I$7]C2<69'W*>
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MR0YOH&$N\^^F%:X)JV_>%G[UF5G!+L%[@.5#FX%@>$0=VN+2B@X864<;-;O
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M$*".G'58H2:75@Q5A+)BA5@?XI]<:L411PYW*.FX86*S[ND>YLSF&E7NW5P
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MSC::=<PJ)8DACWL9C"0I\3HC4MBF[BZO>+*(EEZ_W,[OBR^/^#29%K'[>>1
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M[MO4F^/M&0P3F_CSV<,"*8<:J%1U!SR10V\PGPU?8=#Q!U[A@:$@S1L,_:;
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M4K4P/!:+CM/0NXP7</NE#ANGV-K@DU_2P%./<:'1;5(,D-7HRLQ;EKTG&X[
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M7A"N]/?H/^VHI\-JVG389+_FTJ-*=:-!-BZX0LKO0,T5,](J1-D-'Z7VHCI
MH5$ -X;F]6.UA_%]>(& %)=)R+%']C5G]:,$%DX,:=Z)@SV?:+AX<B&3OH-B
M*\S%F"5.%8G5:H%44-Y4R@R$$""R S0!/,613UZ&$GJU%6B+V81<:M\@&#^
MTS@3V)LLEHUYK^$@;TJA7$]H+>+CDYEX0O,Y.4PSC*N5/&\>VS:+0MA'*NH5
MND:ZY10_^BCQH^>?B^R=7.UWXFH+@O[(L?+/[\'^WA,F&<OZOA<8U--GAD<M
MR5OLZX4[-+2FJ1_O\!%DJ)TTS7X8/!%5,;Y\B"?+R-_QWL N4%K4PHOAR_[D
MT>K!1$>@H0HQ(1A0]:A3AL1FKO)$PY3QLXO'3XXV0?%\.C"_B5 %B\*8HZ,S
MY,]_T#[]F,%4F<PF8,CRV,LKL<%T]5&&1,C^D)7+=S<(2Q ^7-QKOV2"]<XY
M9(0(#CQAVR#'Y]U:*3-@!^1.KJP0M+ EVH;=:SS"BW5*H8J J%CLPS;T,J)S
ME+O)LCYZ,W)J_,N#4 +52!B:@RN68OJC@V+/AI-)]5%,JA>?R:3ZH7:7W:6D
M]J^^F.X\]UY,-*)N95MC?]E]XE' /7JU>V!W6,^AHL&QO.>ZMU(::0 $JSTI
MYKL>P85[.M$%R!WCN)$$E=F_!/4BV4["I@%/"ORC14,ZM?R%^\O95%U3P =S
M3<$]84QB"Z&]I<RIC$E IGF@EI!'NN,$P0%#-,$$I_2TP[P5J3P_#R Z5<\E
MC'SO8[V]?;)7CH$WR\+MANVA)\$7SD]^26H+]Z%O2[:BB=CF&ERQZ88JOVFW
M&7KV,,VP!X).P^HO6!"&::MW!]"-B8 ;+Y*W<11GB-OE."T3_LFK!<L.DT;*
M)"SS2 __.Y\QIAB\(YP^52:2WEC:ZHHA#T6X)R%)N=*"YFM;2TL"S#L0W_HY
M[1:-1$&BUCVH<NSYHU.V=9!M??[HE&T]B9=\^L-XFA,JI@N=4N)\RG$3ZWZ]
MR?9N@7CY+[^%B#0['Z-Z<,DY=[01@!<3"Z9?1^8)>Q=!G,6Y<]Y".3G^=_<F
MIG ZJ-)07#]!#J0_U[#B5G#+L_4N-WE]XJ6AZC\VO1#RRHI*L?LM2<H5NEJ.
M.N,VT6T&V/JR(DA(S]:=-E3/7CD+I&ON&JGY;&2HN-A#Q99\W7[4BJ,>PXE)
M])Y',&W@BHW[!N9[N0\DDBH/0?_F@J%6DK#S6>\Q7[L]\9@'9V)*6]R8Y$XO
M9MJPP3LY>WQ.BRZLN?ELQ(O&/H@B]-5=[M/O"9&,L_GB\05;JE/^_VTEF5W7
MQ^JE*T=F/>+ [T;=*U"3NYOD6I1ZZ(09=G.;W# LF&0,G'?FHP&D)0=U.;'=
M*$]\^VYW<4P&\#2:AM<:TQ!]\]3  P,W)AFW]0<6AR"*&:E)'A(E1%2D&HUP
MY].H</M0ZZ^W-@5"YIUXN;L\/K4,Q10$X96NR0()P" @0Z !"G9@/H'#^HAU
M;U],9"5X/1X_#,N,^((BUESB!<C78P16AH,V IPQ*4$_IL6Z##R2-A[JZ]=Q
M98#9>ZR8W'9!?AO8LK.5)<M-A9&HC^X/J204S(;9=D5&U(!Q-SUTCM".I#9
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M73SUX;.0=>\G!S?9+\R>7T=:GIKDOO9R'H@LF.+O,WSM40!OM$P7A1Q[@P:
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M3!-\)0KH6PT"^4;3\U53SXL2AP!R-E%E>8<Z281#+29_X*KG11TMRX*4/7C
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MXN @ MLJ(Y&$YA<LE.8#@H0*$[>_(L>;W:D?RPH-D2I:[Q ;#MH>L2 8DC3
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MAQ4J7 AGUE%J:]K=P->(<7H*O\,N"^4NBB5KTQ>WL3"V'GQ%RBWA$W OY>%
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M8=@6HF]:B0T^-4VK>Q1K; >S&>9>+"5' 9JVC^>O^AJ3%.V>R?T*/@*BLLZ
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M)303%U2 LR:Z,0).UT[*T!Q96(_E:^S'L"+:9=N;+%CGB:4<BSYO'4U42@I
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M9&7/H7F*] /V^@F$J' 4Q-NC[HFVW:!$?;P^G@\7(_;Y_2.R@2EC5EGFXO5
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M8K19#O?.KD9?V6?WZW3\L1&J).NP=BO-F"MC8=BE6+(;%?/$*5XX[+/0,FQ
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M[.)W>[UP,;@:#J[JA?F1X)JNK+*5984V>LOK&]NZG7PJ[N/HVNY?4$L#!!0
M   ( %E_G512"+\Y@@,   D(   *    97@Q,RTQ+FAT;<U6;6_B1A#^CL1_
M&%EJ!!)OALNI 8)DC),@<8"P4S4?U_8:KVZ]Z]M=7T)_?6>-R36GJW1M^J&
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M2P$"% ,4    " !9?YU4:W"M#&P@  "4<@$ %0              @ '#,
M869Y82TR,#(Q,3(S,5]C86PN>&UL4$L! A0#%     @ 67^=5)#Z)/QL?0
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M>6%F;W)M,C!F7S P,2YJ<&=02P$"% ,4    " !9?YU47RA#(W]7  "Q9
M$P              @ '7BP( 869Y869O<FTR,&9?,# R+FIP9U!+ 0(4 Q0
M   ( %E_G513A0LZ2&<  -1R   3              "  8?C @!A9GEA9F]R
M;3(P9E\P,#,N:G!G4$L! A0#%     @ 67^=5.^9?>$B7P  "7(  !,
M         ( ! $L# &%F>6%F;W)M,C!F7S P-"YJ<&=02P$"% ,4    " !9
M?YU4C<&-G>A'  "450  $P              @ %3J@, 869Y869O<FTR,&9?
M,# U+FIP9U!+ 0(4 Q0    ( %E_G51\?*>6NCP  %A.   3
M  "  6SR P!A9GEA9F]R;3(P9E\P,#8N:G!G4$L! A0#%     @ 67^=5+Z+
M(=-V*@  ,3(  !,              ( !5R\$ &%F>6%F;W)M,C!F7S P-RYJ
M<&=02P$"% ,4    " !9?YU4O^.#>O2.  #UG   $P              @ '^
M600 869Y869O<FTR,&9?,# X+FIP9U!+ 0(4 Q0    ( %E_G511"X($+GX
M  V@   3              "  2/I! !A9GEA9F]R;3(P9E\P,#DN:G!G4$L!
M A0#%     @ 67^=5)^\G#"S)0  $C$  !,              ( !@F<% &%F
M>6%F;W)M,C!F7S Q,"YJ<&=02P$"% ,4    " !9?YU4[RIT7],K  !_.0
M$P              @ %FC04 869Y869O<FTR,&9?,#$Q+FIP9U!+ 0(4 Q0
M   ( %E_G50A89O<MC<  !1*   3              "  6JY!0!A9GEA9F]R
M;3(P9E\P,3(N:G!G4$L! A0#%     @ 67^=5/,G=QO3)@  E2X  !,
M         ( !4?$% &%F>6%F;W)M,C!F7S Q,RYJ<&=02P$"% ,4    " !9
M?YU4=9QT[E<U  !6.P  $P              @ %5& 8 869Y869O<FTR,&9?
M,#$T+FIP9U!+ 0(4 Q0    ( %E_G50F98R@71\  #8I   3
M  "  =U-!@!A9GEA9F]R;3(P9E\P,34N:G!G4$L! A0#%     @ 67^=5(@C
M (NE,@  CSX  !,              ( !:VT& &%F>6%F;W)M,C!F7S Q-BYJ
M<&=02P$"% ,4    " !9?YU4SS@RB[(>  #U*   $P              @ %!
MH 8 869Y869O<FTR,&9?,#$W+FIP9U!+ 0(4 Q0    ( %E_G52EO>2FO24
M '\U   3              "  22_!@!A9GEA9F]R;3(P9E\P,3@N:G!G4$L!
M A0#%     @ 67^=5%)49QGE)   4S,  !,              ( !$N4& &%F
M>6%F;W)M,C!F7S Q.2YJ<&=02P$"% ,4    " !9?YU469LQ"(8\  "35@
M$P              @ $H"@< 869Y869O<FTR,&9?,#(P+FIP9U!+ 0(4 Q0
M   ( %E_G53M59JM=+$  .W3   3              "  =]&!P!A9GEA9F]R
M;3(P9E\P,C$N:G!G4$L! A0#%     @ 67^=5"FR-M<ZBP  UY0  !,
M         ( !A/@' &%F>6%F;W)M,C!F7S R,BYJ<&=02P$"% ,4    " !9
M?YU4@/R_,LZ[  !XXP  $P              @ 'O@P@ 869Y869O<FTR,&9?
M,#(S+FIP9U!+ 0(4 Q0    ( %E_G528>]CS5$X  )AB   3
M  "  >X_"0!A9GEA9F]R;3(P9E\P,C0N:G!G4$L! A0#%     @ 67^=5*D#
M8@LL;0< 0Q-. !0              ( !<XX) &%F>6%F;W)M,C!F7S(P,C$N
M:'1M4$L! A0#%     @ 67^=5._()Z&UO@  32<%  H              ( !
MT?L0 &5X,#$M,BYH=&U02P$"% ,4    " !9?YU4"3>1^A).  #J:0$ "@
M            @ &NNA$ 97@P,BTQ+FAT;5!+ 0(4 Q0    ( %E_G51Q"-.C
M!P<  !0<   *              "  >@($@!E>#$R+3$N:'1M4$L! A0#%
M  @ 67^=5.]NL?(*!P  O1L   H              ( !%Q 2 &5X,3(M,BYH
M=&U02P$"% ,4    " !9?YU44@B_.8(#   )"   "@              @ %)
M%Q( 97@Q,RTQ+FAT;5!+ 0(4 Q0    ( %E_G50TA9T_F@,  +T(   *
M          "  ?,:$@!E>#$S+3(N:'1M4$L! A0#%     @ 67^=5&E7*68Z
M @  >P@   H              ( !M1X2 &5X,C,M,2YH=&U02P$"% ,4
M" !9?YU48^6R*X0&   -+@  "0              @ $7(1( 97@X+3$N:'1M
64$L%!@     F "8 9 D  ,(G$@    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
